DPD_drug_code,HC_last_status,HC_last_status_date,DPD_DIN,DPD_cleaned_brand_name,Number_of_AIS,ATC_code,ATC_term,DPD_compound_form,DPD_compound_route,mp_code,mp_formal_name,mp_status,ntp_code,ntp_formal_name,tm_code,tm_formal_name,BC_SCT_route_code,BC_SCT_route_name,BC_SCT_form_code,BC_SCT_form_name,BC_SCT_Unit_of_Presentation_code,BC_SCT_Unit_of_Presentation_name,Flag_Hazardous,Flag_BC_CPP,Flag_Biosimilar,Schedule
,,,,,,,,,,02480360,AUVI-Q (epinephrine 0.15 mg per 0.15 mL solution for injection syringe) KALEO INC,Inactive,9013250,epinephrine 0.15 mg per 0.15 mL solution for injection syringe,8000003,epinephrine,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,
,,,,,,,,,,02480379,AUVI-Q (epinephrine 0.3 mg per 0.3 mL solution for injection syringe) KALEO INC,Inactive,9001299,epinephrine 0.3 mg per 0.3 mL solution for injection syringe,8000003,epinephrine,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,
70790,Cancelled post market,2026-03-16,02246602,Neocitran Cold & Sore Throat Night,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02246602,NEOCITRAN COLD & SORE THROAT NIGHT (acetaminophen 325 mg per sachet and pheniramine maleate 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution) HALEON CANADA ULC,Active,9013850,acetaminophen 325 mg per sachet and pheniramine maleate 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution,8001883,acetaminophen and pheniramine and phenylephrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,,Non-Prescription Drugs
77936,Cancelled post market,2024-07-31,02293994,Neocitran Extra Strength Total Cold,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02293994,NEOCITRAN EXTRA STRENGTH TOTAL COLD (acetaminophen 650 mg per sachet and dextromethorphan hydrobromide 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution) HALEON CANADA ULC,Active,9013259,acetaminophen 650 mg per sachet and dextromethorphan hydrobromide 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution,8001334,acetaminophen and dextromethorphan and phenylephrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,,Non-Prescription Drugs
89389,Cancelled post market,2026-03-12,02409178,Neocitran Extra Strength Total Cold Night,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02409178,NEOCITRAN EXTRA STRENGTH TOTAL COLD NIGHT (acetaminophen 650 mg per sachet and diphenhydramine hydrochloride 25 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution) HALEON CANADA ULC,Active,9013856,acetaminophen 650 mg per sachet and diphenhydramine hydrochloride 25 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution,8001167,acetaminophen and diphenhydramine and phenylephrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,,Non-Prescription Drugs
89795,Cancelled post market,2026-02-10,02413280,Neocitran Total Cold Night,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02413280,NEOCITRAN TOTAL COLD NIGHT (acetaminophen 500 mg per sachet and diphenhydramine hydrochloride 25 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution) HALEON CANADA ULC,Active,9013851,acetaminophen 500 mg per sachet and diphenhydramine hydrochloride 25 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution,8001167,acetaminophen and diphenhydramine and phenylephrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,,Non-Prescription Drugs
94410,Cancelled post market,2026-03-16,02456982,Neocitran Extra Strength Cold & Sinus Night - Apple Cinnamon,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02456982,NEOCITRAN EXTRA STRENGTH COLD & SINUS NIGHT - APPLE CINNAMON (acetaminophen 650 mg per sachet and pheniramine maleate 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution) HALEON CANADA ULC,Active,9013636,acetaminophen 650 mg per sachet and pheniramine maleate 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution,8001883,acetaminophen and pheniramine and phenylephrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,,Non-Prescription Drugs
91045,Cancelled post market,2025-09-29,02425815,Refresh Optive Advanced Sensitive,3,S01XA20,Artificial tears and other indifferent preparations.,Emulsion,Ophthalmic,02425815,REFRESH OPTIVE ADVANCED SENSITIVE (carboxymethylcellulose sodium 0.5 % and glycerin 1 % and polysorbate 80 0.5 % ophthalmic drops) ABBVIE CORPORATION,Active,9013773,carboxymethylcellulose sodium 0.5 % and glycerin 1 % and polysorbate 80 0.5 % ophthalmic drops,8002223,carboxymethylcellulose and glycerin and polysorbate 80,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
92885,Cancelled post market,2025-04-28,02444062,Systane Ointment,3,S01XA20,Artificial tears and other indifferent preparations.,Ointment,Ophthalmic,02444062,SYSTANE OINTMENT (lanolin 3 % and mineral oil heavy 3 % and white petrolatum 94 % ophthalmic ointment) ALCON CANADA INC,Active,9013695,lanolin 3 % and mineral oil heavy 3 % and white petrolatum 94 % ophthalmic ointment,8002202,lanolin and mineral oil heavy and white petrolatum,54485002,Ophthalmic,385123004,Ophthalmic ointment,,,,,,Non-Prescription Drugs
97229,Cancelled post market,2022-08-16,02481812,Bacitracin Zinc Ointment USP,1,D06AX05,Bacitracin,Ointment,Topical,02481812,"BACITRACIN ZINC OINTMENT USP (bacitracin (bacitracin zinc) 500 unit per g cutaneous ointment) WATER-JEL TECHNOLOGIES, LLC",Active,9013864,bacitracin (bacitracin zinc) 500 unit per g cutaneous ointment,8001439,bacitracin,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Non-Prescription Drugs
100640,Cancelled post market,2025-12-31,02517043,BPO Facial Gel,1,D10AE01,Benzoyl peroxide,Gel,Topical,02517043,BPO FACIAL GEL (benzoyl peroxide 2.5 % cutaneous gel) ALUMIER EUROPE LTD,Active,9004913,benzoyl peroxide 2.5 % cutaneous gel,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,,Non-Prescription Drugs
19647,Cancelled post market,2025-03-07,02184478,Casodex,1,L02BB03,Bicalutamide,Tablet,Oral,02184478,CASODEX (bicalutamide 50 mg oral tablet) ASTRAZENECA CANADA INC,Active,9003010,bicalutamide 50 mg oral tablet,8001589,bicalutamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
68232,Cancelled post market,2026-04-14,02244265,Cancidas,1,J02AX04,Caspofungin,Powder for solution,Intravenous,02244265,CANCIDAS (caspofungin (caspofungin acetate) 50 mg per vial powder for solution for injection) MERCK CANADA INC,Active,9003635,caspofungin (caspofungin acetate) 50 mg per vial powder for solution for injection,8001174,caspofungin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
71470,Cancelled post market,2024-01-31,02247228,Stieprox Shampoo,1,D01AE14,Ciclopirox,Shampoo,Topical,02247228,STIEPROX SHAMPOO (ciclopirox olamine 1.5 % shampoo) GLAXOSMITHKLINE INC,Active,9001055,ciclopirox olamine 1.5 % shampoo,8000230,ciclopirox,41695006,Scalp structure,785908001,Shampoo,,,,,,Prescription
74235,Cancelled post market,2024-09-16,02257130,Sensipar,1,H05BX01,Cinacalcet,Tablet,Oral,02257130,SENSIPAR (cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet) AMGEN CANADA INC,Active,9003934,cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74236,Cancelled post market,2024-09-16,02257149,Sensipar,1,H05BX01,Cinacalcet,Tablet,Oral,02257149,SENSIPAR (cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet) AMGEN CANADA INC,Active,9003935,cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
67033,Cancelled post market,2025-11-28,02243158,Clindoxyl Gel,2,D10AF51,"Clindamycin, combinations",Gel,Topical,02243158,CLINDOXYL GEL (benzoyl peroxide 5 % and clindamycin (clindamycin phosphate) 1 % cutaneous gel) GLAXOSMITHKLINE INC,Active,9003644,benzoyl peroxide 5 % and clindamycin (clindamycin phosphate) 1 % cutaneous gel,8000924,benzoyl peroxide and clindamycin,448598008,Cutaneous,385100002,Gel,,,,,,Prescription
12944,Cancelled post market,2025-12-16,01934783,Robaxisal C 1/4,3,N02AA59,"Codeine, combinations excl. psycholeptics",Tablet,Oral,01934783,ROBAXISAL C 1/4 (acetylsalicylic acid 325 mg and codeine phosphate 16.2 mg and methocarbamol 400 mg oral tablet) GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC,Active,9002410,acetylsalicylic acid 325 mg and codeine phosphate 16.2 mg and methocarbamol 400 mg oral tablet,8000861,acetylsalicylic acid and codeine and methocarbamol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
12946,Cancelled post market,2025-12-15,01934791,Robaxisal C 1/2,3,N02AA59,"Codeine, combinations excl. psycholeptics",Tablet,Oral,01934791,ROBAXISAL C 1/2 (acetylsalicylic acid 325 mg and codeine phosphate 32.4 mg and methocarbamol 400 mg oral tablet) GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC,Active,9002411,acetylsalicylic acid 325 mg and codeine phosphate 32.4 mg and methocarbamol 400 mg oral tablet,8000861,acetylsalicylic acid and codeine and methocarbamol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
79794,Cancelled post market,2025-12-02,02312433,Pradaxa,1,B01AE07,Dabigatran etexilate,Capsule,Oral,02312433,PRADAXA (dabigatran etexilate (dabigatran etexilate mesilate) 75 mg oral capsule) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9001251,dabigatran etexilate (dabigatran etexilate mesilate) 75 mg oral capsule,8000378,dabigatran,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
102517,Cancelled post market,2025-04-17,02536390,Dexlansoprazole,1,A02BC06,Dexlansoprazole,Capsule (delayed release),"Nasogastric,Oral",02536390,DEXLANSOPRAZOLE (dexlansoprazole 30 mg gastro-resistant capsule) ALTIUS HEALTHCARE INC,Active,9001319,dexlansoprazole 30 mg gastro-resistant capsule,8000394,dexlansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
102518,Cancelled post market,2025-04-17,02536404,Dexlansoprazole,1,A02BC06,Dexlansoprazole,Capsule (delayed release),"Nasogastric,Oral",02536404,DEXLANSOPRAZOLE (dexlansoprazole 60 mg gastro-resistant capsule) ALTIUS HEALTHCARE INC,Active,9001320,dexlansoprazole 60 mg gastro-resistant capsule,8000394,dexlansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
197,Cancelled post market,2025-06-11,00013579,Gravol Im,1,R06AA11,Dimenhydrinate,Solution,Intramuscular,00013579,GRAVOL IM (dimenhydrinate 50 mg per 1 mL solution for injection vial) CHURCH & DWIGHT CANADA CORP,Active,9012705,dimenhydrinate 50 mg per 1 mL solution for injection vial,8001375,dimenhydrinate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
81142,Cancelled post market,2025-06-30,02326086,Docusate Sodium,1,A06AA02,Docusate sodium,Capsule,Oral,02326086,DOCUSATE SODIUM (docusate sodium 100 mg oral capsule) PRO DOC LIMITEE,Active,9002047,docusate sodium 100 mg oral capsule,8001045,docusate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
94871,Cancelled post market,2024-12-31,02461218,Tivicay,1,J05AJ03,Dolutegravir,Tablet,Oral,02461218,TIVICAY (dolutegravir (dolutegravir sodium) 10 mg oral tablet) VIIV HEALTHCARE ULC,Active,9006194,dolutegravir (dolutegravir sodium) 10 mg oral tablet,8001191,dolutegravir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94872,Cancelled post market,2024-12-31,02461226,Tivicay,1,J05AJ03,Dolutegravir,Tablet,Oral,02461226,TIVICAY (dolutegravir (dolutegravir sodium) 25 mg oral tablet) VIIV HEALTHCARE ULC,Active,9006195,dolutegravir (dolutegravir sodium) 25 mg oral tablet,8001191,dolutegravir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
20083,Cancelled post market,2025-12-08,02216205,Trusopt,1,S01EC03,Dorzolamide,Solution,Ophthalmic,02216205,TRUSOPT WITH PRESERVATIVE (dorzolamide (dorzolamide hydrochloride) 2 % ophthalmic drops) ELVIUM LIFE SCIENCES,Active,9003026,dorzolamide (dorzolamide hydrochloride) 2 % ophthalmic drops,8000899,dorzolamide,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
94579,Cancelled post market,2026-02-24,02458640,Lixiana,1,B01AF03,Edoxaban,Tablet,Oral,02458640,LIXIANA (edoxaban (edoxaban tosylate monohydrate) 15 mg oral tablet) SERVIER CANADA INC,Active,9006163,edoxaban (edoxaban tosylate) 15 mg oral tablet,8001759,edoxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94580,Cancelled post market,2026-02-24,02458659,Lixiana,1,B01AF03,Edoxaban,Tablet,Oral,02458659,LIXIANA (edoxaban (edoxaban tosylate monohydrate) 30 mg oral tablet) SERVIER CANADA INC,Active,9006164,edoxaban (edoxaban tosylate) 30 mg oral tablet,8001759,edoxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94581,Cancelled post market,2026-02-24,02458667,Lixiana,1,B01AF03,Edoxaban,Tablet,Oral,02458667,LIXIANA (edoxaban (edoxaban tosylate monohydrate) 60 mg oral tablet) SERVIER CANADA INC,Active,9006165,edoxaban (edoxaban tosylate) 60 mg oral tablet,8001759,edoxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
72003,Cancelled post market,2025-03-31,02247725,Fuzeon,1,J05AX07,Enfuvirtide,Powder for solution,Subcutaneous,02247725,FUZEON (enfuvirtide 108 mg per vial powder for solution for injection) HOFFMANN-LA ROCHE LIMITED,Active,9003820,enfuvirtide 108 mg per vial powder for solution for injection,8001457,enfuvirtide,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
75441,Cancelled post market,2024-10-01,02269007,Tarceva,1,L01EB02,Erlotinib,Tablet,Oral,02269007,TARCEVA (erlotinib (erlotinib hydrochloride) 25 mg oral tablet) HOFFMANN-LA ROCHE LIMITED,Active,9004246,erlotinib (erlotinib hydrochloride) 25 mg oral tablet,8001646,erlotinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
75442,Cancelled post market,2024-10-01,02269015,Tarceva,1,L01EB02,Erlotinib,Tablet,Oral,02269015,TARCEVA (erlotinib (erlotinib hydrochloride) 100 mg oral tablet) HOFFMANN-LA ROCHE LIMITED,Active,9004067,erlotinib (erlotinib hydrochloride) 100 mg oral tablet,8001646,erlotinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
75443,Cancelled post market,2024-10-01,02269023,Tarceva,1,L01EB02,Erlotinib,Tablet,Oral,02269023,TARCEVA (erlotinib (erlotinib hydrochloride) 150 mg oral tablet) HOFFMANN-LA ROCHE LIMITED,Active,9004068,erlotinib (erlotinib hydrochloride) 150 mg oral tablet,8001646,erlotinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
92466,Cancelled post market,2026-01-05,02440296,Nat-Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02440296,NAT-ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92467,Cancelled post market,2026-01-05,02440318,Nat-Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02440318,NAT-ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
9703,Cancelled post market,2024-09-25,00636622,Prozac Capsules 20 mg,1,N06AB03,Fluoxetine,Capsule,Oral,00636622,PROZAC CAPSULES 20MG (fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule) ELI LILLY CANADA INC,Active,9000325,fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
72486,Cancelled post market,2025-08-06,02248154,Gonal-F,1,G03GA05,Follitropin alfa,Powder for solution,"Intramuscular,Subcutaneous",02248154,"GONAL-F (follitropin alfa 75 unit per vial powder for solution for injection with diluent solution syringe) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013133,follitropin alfa 75 unit per vial powder for solution for injection with diluent solution syringe,8001475,follitropin alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
72486,Cancelled post market,2025-08-06,02248154,Gonal-F,1,G03GA05,Follitropin alfa,Powder for solution,"Intramuscular,Subcutaneous",02248154,"GONAL-F (follitropin alfa 75 unit per vial powder for solution for injection with diluent solution syringe) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013133,follitropin alfa 75 unit per vial powder for solution for injection with diluent solution syringe,8001475,follitropin alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
84654,Cancelled post market,2026-05-07,02361469,JAMP-Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02361469,JAMP-GABAPENTIN (gabapentin 100 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000519,gabapentin 100 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
84656,Cancelled post market,2026-05-07,02361485,JAMP-Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02361485,JAMP-GABAPENTIN (gabapentin 300 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000520,gabapentin 300 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
84657,Cancelled post market,2026-05-07,02361493,JAMP-Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02361493,JAMP-GABAPENTIN (gabapentin 400 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000521,gabapentin 400 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
37334,Cancelled post market,2024-05-14,02223252,Proctosedyl,4,C05AA01,Hydrocortisone,Ointment,Rectal,02223252,PROCTOSEDYL (dibucaine hydrochloride 0.5 % and esculin 1 % and framycetin sulfate 1 % and hydrocortisone 0.5 % rectal ointment) APTALIS PHARMA CANADA ULC,Active,9006369,dibucaine hydrochloride 0.5 % and esculin 1 % and framycetin sulfate 1 % and hydrocortisone 0.5 % rectal ointment,8000898,dibucaine and esculin and framycetin and hydrocortisone,37161004,Rectal,385184008,Rectal ointment,,,,,,Prescription
84765,Cancelled post market,2025-08-25,02362643,Advil Cold & Flu,2,M01AE51,"Ibuprofen, combinations",Tablet,Oral,02362643,ADVIL COLD & FLU (diphenhydramine citrate 38 mg and ibuprofen 200 mg oral tablet) GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC,Active,9004949,diphenhydramine citrate 38 mg and ibuprofen 200 mg oral tablet,8001188,diphenhydramine and ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
97187,Cancelled post market,2024-10-24,02481383,Tegsedi,1,N07XX15,Inotersen,Solution,Subcutaneous,02481383,"TEGSEDI (inotersen (inotersen sodium) 284 mg per 1.5 mL solution for injection syringe) AKCEA THERAPEUTICS, INC.",Active,9013964,inotersen (inotersen sodium) 284 mg per 1.5 mL solution for injection syringe,8002258,inotersen,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
96506,Cancelled post market,2025-12-31,02474875,Xultophy,2,A10AE56,Insulin degludec and liraglutide,Solution,Subcutaneous,02474875,XULTOPHY (insulin degludec 100 unit per mL and liraglutide 3.6 mg per mL solution for injection 3 mL pen) NOVO NORDISK CANADA INC,Active,9012822,insulin degludec 100 unit per mL and liraglutide 3.6 mg per mL solution for injection 3 mL pen,8001389,insulin degludec and liraglutide,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
96506,Cancelled post market,2025-12-31,02474875,Xultophy,2,A10AE56,Insulin degludec and liraglutide,Solution,Subcutaneous,02474875,XULTOPHY (insulin degludec 100 unit per mL and liraglutide 3.6 mg per mL solution for injection 3 mL pen) NOVO NORDISK CANADA INC,Active,9012822,insulin degludec 100 unit per mL and liraglutide 3.6 mg per mL solution for injection 3 mL pen,8001389,insulin degludec and liraglutide,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Prescription
95553,Cancelled post market,2026-03-27,02467135,Onivyde,1,L01CE02,Irinotecan,Suspension,Intravenous,02467135,ONIVYDE (irinotecan (irinotecan sucrose octasulfate liposomal) 43 mg per 10 mL suspension for injection vial) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9014222,irinotecan (irinotecan sucrose octasulfate liposomal) 43 mg per 10 mL suspension for injection vial,8002199,irinotecan (liposomal),738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
14518,Cancelled post market,2026-04-01,02047454,Sporanox,1,J02AC02,Itraconazole,Capsule,Oral,02047454,SPORANOX (itraconazole 100 mg oral capsule) JANSSEN INC,Active,9002587,itraconazole 100 mg oral capsule,8001208,itraconazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95819,Cancelled post market,2025-09-09,02469405,Prevymis,1,J05AX18,Letermovir,Solution,Intravenous,02469405,PREVYMIS 480 MG/24 ML SINGLE-DOSE VIAL (letermovir 480 mg per 24 mL solution for injection vial) MERCK CANADA INC,Active,9012507,letermovir 480 mg per 24 mL solution for injection vial,8001140,letermovir,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
12266,Cancelled post market,2024-07-31,01923986,Solarcaine First Aid Lidocaine Spray,1,D04AB01,Lidocaine,Aerosol,Topical,01923986,SOLARCAINE FIRST AID LIDOCAINE SPRAY (lidocaine 0.5 % cutaneous spray) WELLSPRING PHARMACEUTICAL CANADA CORP,Active,9002314,lidocaine 0.5 % cutaneous spray,8001837,lidocaine,448598008,Cutaneous,421720008,Spray,,,,,,Non-Prescription Drugs
87336,Cancelled post market,2025-08-19,02387786,Latuda,1,N05AE05,Lurasidone,Tablet,Oral,02387786,"LATUDA (lurasidone hydrochloride 120 mg oral tablet) SUMITOMO PHARMA CANADA, INC.",Active,9005097,lurasidone hydrochloride 120 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
13037,Cancelled post market,2025-11-14,00708917,Provera 2.5 mg Tablets,1,G03DA02,Medroxyprogesterone,Tablet,Oral,00708917,PROVERA 2.5MG TABLETS (medroxyprogesterone acetate 2.5 mg oral tablet) PFIZER CANADA ULC,Active,9000429,medroxyprogesterone acetate 2.5 mg oral tablet,8000018,medroxyprogesterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
430,Cancelled post market,2025-11-14,00030937,Provera 5 mg Tablets,1,G03DA02,Medroxyprogesterone,Tablet,Oral,00030937,PROVERA 5MG TABLETS (medroxyprogesterone acetate 5 mg oral tablet) PFIZER CANADA ULC,Active,9000027,medroxyprogesterone acetate 5 mg oral tablet,8000018,medroxyprogesterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
7480,Cancelled post market,2025-11-14,00729973,Provera 10 mg Tablets,1,G03DA02,Medroxyprogesterone,Tablet,Oral,00729973,PROVERA 10MG TABLETS (medroxyprogesterone acetate 10 mg oral tablet) PFIZER CANADA ULC,Active,9000275,medroxyprogesterone acetate 10 mg oral tablet,8000018,medroxyprogesterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
93562,Cancelled post market,2023-12-06,02449781,Nucala,1,R03DX09,Mepolizumab,Powder for solution,Subcutaneous,02449781,NUCALA (mepolizumab 100 mg per vial powder for solution for injection) GLAXOSMITHKLINE INC,Active,9005907,mepolizumab 100 mg per vial powder for solution for injection,8001066,mepolizumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
93562,Cancelled post market,2023-12-06,02449781,Nucala,1,R03DX09,Mepolizumab,Powder for solution,Subcutaneous,02449781,NUCALA (mepolizumab 100 mg per vial powder for solution for injection) GLAXOSMITHKLINE INC,Active,9005907,mepolizumab 100 mg per vial powder for solution for injection,8001066,mepolizumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
87469,Cancelled post market,2026-04-08,02389185,Komboglyze,2,A10BD10,Metformin and saxagliptin,Tablet,Oral,02389185,KOMBOGLYZE (metformin hydrochloride 1000 mg and saxagliptin (saxagliptin hydrochloride) 2.5 mg oral tablet) ASTRAZENECA CANADA INC,Active,9005227,metformin hydrochloride 1000 mg and saxagliptin (saxagliptin hydrochloride) 2.5 mg oral tablet,8001001,metformin and saxagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81955,Cancelled post market,2025-08-13,02333864,Janumet,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02333864,JANUMET (metformin hydrochloride 850 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) MERCK CANADA INC,Active,9001293,metformin hydrochloride 850 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103523,Cancelled post market,2026-03-13,02546558,Nordimet,1,L04AX03,Methotrexate,Solution,Subcutaneous,02546558,NORDIMET (methotrexate (methotrexate sodium) 10 mg per 0.4 mL solution for injection pen) NORDIC GROUP B.V.,Active,9015074,methotrexate (methotrexate sodium) 10 mg per 0.4 mL solution for injection pen,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,,Prescription
103525,Cancelled post market,2026-03-13,02546574,Nordimet,1,L04AX03,Methotrexate,Solution,Subcutaneous,02546574,NORDIMET (methotrexate (methotrexate sodium) 15 mg per 0.6 mL solution for injection pen) NORDIC GROUP B.V.,Active,9015075,methotrexate (methotrexate sodium) 15 mg per 0.6 mL solution for injection pen,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,,Prescription
103527,Cancelled post market,2026-03-13,02546590,Nordimet,1,L04AX03,Methotrexate,Solution,Subcutaneous,02546590,NORDIMET (methotrexate (methotrexate sodium) 20 mg per 0.8 mL solution for injection pen) NORDIC GROUP B.V.,Active,9015076,methotrexate (methotrexate sodium) 20 mg per 0.8 mL solution for injection pen,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,,Prescription
103529,Cancelled post market,2026-03-13,02546612,Nordimet,1,L04AX03,Methotrexate,Solution,Subcutaneous,02546612,NORDIMET (methotrexate (methotrexate sodium) 25 mg per mL solution for injection pen) NORDIC GROUP B.V.,Active,9015077,methotrexate (methotrexate sodium) 25 mg per mL solution for injection pen,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,,Prescription
69,Cancelled post market,2025-03-06,00050474,Methylene Bleu Liquid 2%,1,V03AB17,Methylthioninium chloride,Liquid,Oral,00050474,METHYLENE BLEU LIQ 2% (methylene blue 20 mg per mL oral solution) LABORATOIRE ATLAS INC,Active,9013830,methylene blue 20 mg per mL oral solution,8002140,methylene blue,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
12997,Cancelled post market,2024-11-26,01926861,Flagyl,1,G01AF01,Metronidazole,Cream,Vaginal,01926861,FLAGYL (metronidazole 10 % vaginal cream) SANOFI-AVENTIS CANADA INC,Active,9000050,metronidazole 10 % vaginal cream,8000038,metronidazole,16857009,Vaginal,385165005,Vaginal cream,,,,,,Prescription
72310,Cancelled post market,2025-10-18,02247997,Singulair,1,R03DC03,Montelukast,Granules,Oral,02247997,SINGULAIR (montelukast (montelukast sodium) 4 mg per sachet oral granules) ORGANON CANADA INC.,Active,9014703,montelukast (montelukast sodium) 4 mg per sachet oral granules,8000261,montelukast,26643006,Oral,420509004,Oral granules,733013000,Sachet (unit of presentation),,,,Prescription
80140,Cancelled post market,2025-11-11,02315890,Refresh Eye Allergy Relief,2,S01GA51,"Naphazoline, combinations",Solution,Ophthalmic,02315890,REFRESH EYE ALLERGY RELIEF (antazoline phosphate 0.51 % and naphazoline hydrochloride 0.051 % ophthalmic drops) ABBVIE CORPORATION,Active,9004514,antazoline phosphate 0.51 % and naphazoline hydrochloride 0.051 % ophthalmic drops,8001886,antazoline and naphazoline,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
101698,Cancelled post market,2026-03-16,02527804,Paxlovid,2,J05AE30,Nirmatrelvir and ritonavir,Tablet,Oral,02527804,PAXLOVID FOR MODERATE RENAL IMPAIRMENT (nirmatrelvir 150 mg oral tablet with ritonavir 100 mg oral tablet) PFIZER CANADA ULC,Active,9014643,nirmatrelvir 150 mg oral tablet with ritonavir 100 mg oral tablet,8002405,nirmatrelvir and ritonavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94576,Cancelled post market,2025-10-31,02458616,Nitisinone Tablets,1,A16AX04,Nitisinone,Tablet,Oral,02458616,NITISINONE TABLETS (nitisinone 2 mg oral tablet) CYCLE PHARMACEUTICALS LTD.,Active,9006102,nitisinone 2 mg oral tablet,8001675,nitisinone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94577,Cancelled post market,2025-10-31,02458624,Nitisinone Tablets,1,A16AX04,Nitisinone,Tablet,Oral,02458624,NITISINONE TABLETS (nitisinone 5 mg oral tablet) CYCLE PHARMACEUTICALS LTD.,Active,9006103,nitisinone 5 mg oral tablet,8001675,nitisinone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94578,Cancelled post market,2025-10-31,02458632,Nitisinone Tablets,1,A16AX04,Nitisinone,Tablet,Oral,02458632,NITISINONE TABLETS (nitisinone 10 mg oral tablet) CYCLE PHARMACEUTICALS LTD.,Active,9006077,nitisinone 10 mg oral tablet,8001675,nitisinone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99322,Cancelled post market,2026-05-04,02503786,Octreotide For Injectable Suspension,1,H01CB02,Octreotide,"Kit,Powder for suspension, sustained-release",Intramuscular,02503786,OCTREOTIDE FOR INJECTABLE SUSPENSION (octreotide (octreotide acetate) 30 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe) TEVA CANADA LIMITED,Active,9013475,octreotide (octreotide acetate) 30 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe,8002040,octreotide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),,,,Prescription
188,Cancelled post market,2024-05-13,00116882,Diovol Plus Tablets,3,A02AF02,Ordinary salt combinations and antiflatulents,Tablet,Oral,00116882,DIOVOL PLUS TABLETS (aluminum magnesium hydroxide carbonate 300 mg and magnesium hydroxide 100 mg and simethicone 25 mg oral tablet) CHURCH & DWIGHT CANADA CORP,Active,9013942,aluminum magnesium hydroxide carbonate 300 mg and magnesium hydroxide 100 mg and simethicone 25 mg oral tablet,8002251,aluminum magnesium hydroxide carbonate and magnesium hydroxide and simethicone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
83545,Cancelled post market,2025-07-11,02350238,Oxybutynin,1,G04BD04,Oxybutynin,Tablet,Oral,02350238,OXYBUTYNIN (oxybutynin chloride 5 mg oral tablet) SANIS HEALTH INC,Active,9000627,oxybutynin chloride 5 mg oral tablet,8000219,oxybutynin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92624,Cancelled post market,2026-04-24,02441853,Pantoprazole Magnesium,1,A02BC02,Pantoprazole,Tablet (enteric-coated),Oral,02441853,PANTOPRAZOLE MAGNESIUM (pantoprazole (pantoprazole magnesium) 40 mg gastro-resistant tablet) ALTIUS HEALTHCARE INC,Active,9001139,pantoprazole (pantoprazole magnesium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79204,Cancelled post market,2026-01-29,02306433,Alimta,1,L01BA04,Pemetrexed,Powder for solution,Intravenous,02306433,ALIMTA (pemetrexed (pemetrexed disodium) 100 mg per vial powder for solution for injection) ELI LILLY CANADA INC,Active,9004485,pemetrexed (pemetrexed disodium) 100 mg per vial powder for solution for injection,8001501,pemetrexed,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
86284,Cancelled post market,2025-10-31,02377225,Mozobil,1,L03AX16,Plerixafor,Solution,Subcutaneous,02377225,MOZOBIL (plerixafor 24 mg per 1.2 mL solution for injection vial) SANOFI-AVENTIS CANADA INC,Active,9013511,plerixafor 24 mg per 1.2 mL solution for injection vial,8002071,plerixafor,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
46885,Cancelled post market,2024-09-17,01914022,Urocit-K,1,A12BA02,Potassium citrate,Tablet (extended-release),Oral,01914022,UROCIT-K (potassium citrate 5 mEq prolonged-release oral tablet) MISSION PHARMACAL COMPANY,Active,9013988,potassium citrate 5 mEq prolonged-release oral tablet,8001871,potassium citrate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
50175,Cancelled post market,2025-09-04,02230897,Biltricide,1,P02BA01,Praziquantel,Tablet,Oral,02230897,BILTRICIDE (praziquantel 600 mg oral tablet) BAYER INC,Active,9003085,praziquantel 600 mg oral tablet,8001415,praziquantel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
62480,Cancelled post market,2026-01-30,02239028,Evista,1,G03XC01,Raloxifene,Tablet,Oral,02239028,EVISTA (raloxifene hydrochloride 60 mg oral tablet) ELI LILLY CANADA INC,Active,9003333,raloxifene hydrochloride 60 mg oral tablet,8001682,raloxifene,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
63426,Cancelled post market,2024-08-30,02239926,Gluconorm 2 mg,1,A10BX02,Repaglinide,Tablet,Oral,02239926,GLUCONORM 2.0MG (repaglinide 2 mg oral tablet) NOVO NORDISK CANADA INC,Active,9000858,repaglinide 2 mg oral tablet,8000273,repaglinide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97269,Cancelled post market,2025-08-15,02482215,Kuvan,1,A16AX07,Sapropterin,Powder,Oral,02482215,KUVAN (sapropterin dihydrochloride 500 mg per sachet powder for oral solution) BIOMARIN INTERNATIONAL LIMITED,Active,9014274,sapropterin dihydrochloride 500 mg per sachet powder for oral solution,8001929,sapropterin,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,,Prescription
2146,Cancelled post market,2026-01-12,00323098,Flamazine,1,D06BA01,Silver sulfadiazine,Cream,Topical,00323098,FLAMAZINE (silver sulfadiazine 1 % cutaneous cream) SMITH & NEPHEW INC,Active,9001723,silver sulfadiazine 1 % cutaneous cream,8001526,silver sulfadiazine,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
66943,Cancelled post market,2025-12-22,02243077,Humatrope,2,H01AC01,Somatropin,"Powder for solution,Liquid","Subcutaneous,Intramuscular",02243077,HUMATROPE (somatropin 6 mg per cartridge powder for solution for injection with diluent solution syringe) ELI LILLY CANADA INC,Active,9013752,somatropin 6 mg per cartridge powder for solution for injection with diluent solution syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,732988008,Cartridge,,,,Prescription
66943,Cancelled post market,2025-12-22,02243077,Humatrope,2,H01AC01,Somatropin,"Powder for solution,Liquid","Subcutaneous,Intramuscular",02243077,HUMATROPE (somatropin 6 mg per cartridge powder for solution for injection with diluent solution syringe) ELI LILLY CANADA INC,Active,9013752,somatropin 6 mg per cartridge powder for solution for injection with diluent solution syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,732988008,Cartridge,,,,Schedule D
66944,Cancelled post market,2025-12-22,02243078,Humatrope,2,H01AC01,Somatropin,"Liquid,Powder for solution","Intramuscular,Subcutaneous",02243078,HUMATROPE (somatropin 12 mg per cartridge powder for solution for injection with diluent solution syringe) ELI LILLY CANADA INC,Active,9013739,somatropin 12 mg per cartridge powder for solution for injection with diluent solution syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,732988008,Cartridge,,,,Schedule D
66944,Cancelled post market,2025-12-22,02243078,Humatrope,2,H01AC01,Somatropin,"Liquid,Powder for solution","Intramuscular,Subcutaneous",02243078,HUMATROPE (somatropin 12 mg per cartridge powder for solution for injection with diluent solution syringe) ELI LILLY CANADA INC,Active,9013739,somatropin 12 mg per cartridge powder for solution for injection with diluent solution syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,732988008,Cartridge,,,,Prescription
66945,Cancelled post market,2025-12-18,02243079,Humatrope,2,H01AC01,Somatropin,"Liquid,Powder for solution","Subcutaneous,Intramuscular",02243079,HUMATROPE (somatropin 24 mg per cartridge powder for solution for injection with diluent solution syringe) ELI LILLY CANADA INC,Active,9013746,somatropin 24 mg per cartridge powder for solution for injection with diluent solution syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,732988008,Cartridge,,,,Schedule D
66945,Cancelled post market,2025-12-18,02243079,Humatrope,2,H01AC01,Somatropin,"Liquid,Powder for solution","Subcutaneous,Intramuscular",02243079,HUMATROPE (somatropin 24 mg per cartridge powder for solution for injection with diluent solution syringe) ELI LILLY CANADA INC,Active,9013746,somatropin 24 mg per cartridge powder for solution for injection with diluent solution syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,732988008,Cartridge,,,,Prescription
18639,Cancelled post market,2023-03-22,02048485,Nolvadex-D Tablets 20 mg,1,L02BA01,Tamoxifen,Tablet,Oral,02048485,NOLVADEX-D TAB 20MG (tamoxifen (tamoxifen citrate) 20 mg oral tablet) ASTRAZENECA CANADA INC,Active,9002227,tamoxifen (tamoxifen citrate) 20 mg oral tablet,8001096,tamoxifen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
75550,Cancelled post market,2024-02-15,02270102,Flomax CR,1,G04CA02,Tamsulosin,Tablet (extended-release),Oral,02270102,FLOMAX CR (tamsulosin hydrochloride 0.4 mg prolonged-release oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9001127,tamsulosin hydrochloride 0.4 mg prolonged-release oral tablet,8000352,tamsulosin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73983,Cancelled post market,2026-02-24,02254689,Forteo,1,H05AA02,Teriparatide,Solution,Subcutaneous,02254689,FORTEO (teriparatide 20 mcg per actuation solution for injection pre-filled pen) ELI LILLY CANADA INC,Active,9014070,teriparatide 20 mcg per actuation solution for injection pre-filled pen,8001688,teriparatide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation (unit of presentation),,,,Prescription
73983,Cancelled post market,2026-02-24,02254689,Forteo,1,H05AA02,Teriparatide,Solution,Subcutaneous,02254689,FORTEO (teriparatide 20 mcg per actuation solution for injection pre-filled pen) ELI LILLY CANADA INC,Active,9014070,teriparatide 20 mcg per actuation solution for injection pre-filled pen,8001688,teriparatide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation (unit of presentation),,,,Schedule D
1275,Cancelled post market,2025-12-18,00029246,Delatestryl,1,G03BA03,Testosterone,Solution,Intramuscular,00029246,"DELATESTRYL (testosterone enanthate 1000 mg per 5 mL solution for injection ampoule) BAUSCH HEALTH, CANADA INC.",Active,9000013,testosterone enanthate 1000 mg per 5 mL solution for injection ampoule,8000006,testosterone,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),1.0,,,Controlled Drugs (CDSA IV)
1398,Cancelled post market,2025-07-18,00030783,Depo-Testosterone Inj 100 mg/mL,1,G03BA03,Testosterone,Solution,Intramuscular,00030783,DEPO-TESTOSTERONE INJ 100MG/ML (testosterone cypionate 1000 mg per 10 mL solution for injection vial) PFIZER CANADA ULC,Active,9000010,testosterone cypionate 1000 mg per 10 mL solution for injection vial,8000006,testosterone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Controlled Drugs (CDSA IV)
75881,Cancelled post market,2025-08-31,02273322,Aptivus,1,J05AE09,Tipranavir,Capsule,Oral,02273322,APTIVUS (tipranavir 250 mg oral capsule) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9004101,tipranavir 250 mg oral capsule,8001239,tipranavir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
76057,Cancelled post market,2025-08-18,02275066,Trosec,1,G04BD09,Trospium,Tablet,Oral,02275066,TROSEC (trospium chloride 20 mg oral tablet) SUNOVION PHARMACEUTICALS CANADA INC,Active,9004146,trospium chloride 20 mg oral tablet,8001115,trospium,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
66725,Cancelled post market,2025-09-30,02242893,Diurex Water Caplets,1,C03BD,Xanthine derivatives,Tablet,Oral,02242893,"DIUREX WATER CAPLETS (pamabrom 50 mg oral tablet) ALVA-AMCO PHARMACAL COMPANIES, LLC",Active,9003571,pamabrom 50 mg oral tablet,8002050,pamabrom,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
100572,Marketed,2022-05-13,02516365,Essential Energy Hydrating Day Cream,4,,,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103741,Marketed,2024-12-17,02548550,Sitagliptin,1,,,Tablet,Oral,02548550,SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 25 mg oral tablet) SANIS HEALTH INC,Active,9001387,sitagliptin (sitagliptin phosphate) 25 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106054,Marketed,2026-01-21,02557193,Lupin-Tolvaptan,2,,,Tablet,Oral,02557193,LUPIN-TOLVAPTAN (tolvaptan 15 mg oral tablet with tolvaptan 45 mg oral tablet) LUPIN PHARMA CANADA LIMITED,Active,9012160,tolvaptan 15 mg oral tablet with tolvaptan 45 mg oral tablet,8000986,tolvaptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106055,Marketed,2026-01-21,02557207,Lupin-Tolvaptan,2,,,Tablet,Oral,02557207,LUPIN-TOLVAPTAN (tolvaptan 30 mg oral tablet with tolvaptan 60 mg oral tablet) LUPIN PHARMA CANADA LIMITED,Active,9012162,tolvaptan 30 mg oral tablet with tolvaptan 60 mg oral tablet,8000986,tolvaptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106780,Marketed,2026-04-10,02565161,Yorvipath,1,,,Solution,Subcutaneous,02565161,YORVIPATH (palopegteriparatide 294 mcg per 0.98 mL solution for injection pen) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9015403,palopegteriparatide 294 mcg per 0.98 mL solution for injection pen,8002590,palopegteriparatide,738984000,Parenteral,385219001,Solution for injection,733006000,Pen(s),,,,Prescription
106781,Marketed,2026-04-10,02565188,Yorvipath,1,,,Solution,Subcutaneous,02565188,YORVIPATH (palopegteriparatide 420 mcg per 1.4 mL solution for injection pen) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9015404,palopegteriparatide 420 mcg per 1.4 mL solution for injection pen,8002590,palopegteriparatide,738984000,Parenteral,385219001,Solution for injection,733006000,Pen(s),,,,Prescription
81544,Marketed,2018-06-13,02329727,Draximage Dtpa,1,,,Powder for solution,"Intravenous,Inhalation",,,,,,,,,,,,,,,,,Schedule C
83145,Marketed,2019-04-01,02360845,Stannous Maa Kit,1,,,"Kit,Suspension",Intravenous,,,,,,,,,,,,,,,,,Schedule C
85949,Marketed,2018-09-17,02374285,Ruby-Fill,1,,,Solution,Intravenous,,,,,,,,,,,,,,,,,Schedule C
93393,Marketed,2026-04-21,02448262,JAMP Bilastine Oral Solution,2,,,Solution,Oral,02448262,JAMP BILASTINE ORAL SOLUTION (bilastine 10 mg per 4 mL oral solution) JAMP PHARMA CORPORATION,Active,9014657,bilastine 10 mg per 4 mL oral solution,8001590,bilastine,26643006,Oral,739006009,Solution,,,,,,Prescription
98097,Marketed,2020-02-14,02490935,Canesoral Combi 1 Day,2,,,"Cream,Capsule","Topical,Oral",02490935,CANESORAL COMBI 1 DAY (clotrimazole 2 % cutaneous cream with fluconazole 150 mg oral capsule) BAYER INC,Active,9014252,clotrimazole 2 % cutaneous cream with fluconazole 150 mg oral capsule,8000978,clotrimazole and fluconazole,26643006,Oral,421628006,Cutaneous cream,732937005,Capsule (unit of presentation),1.0,,,Non-Prescription Drugs
63900,Marketed,2010-11-25,02240358,Ziagen,1,J05AF06,Abacavir,Solution,Oral,02240358,ZIAGEN (abacavir (abacavir sulfate) 20 mg per mL oral solution) VIIV HEALTHCARE ULC,Active,9012559,abacavir (abacavir sulfate) 20 mg per mL oral solution,8001162,abacavir,26643006,Oral,385023001,Oral solution,,,1.0,,,Prescription
88178,Marketed,2016-03-15,02396769,Apo-Abacavir,1,J05AF06,Abacavir,Tablet,Oral,02396769,APO-ABACAVIR (abacavir (abacavir sulfate) 300 mg oral tablet) APOTEX INC,Active,9012561,abacavir (abacavir sulfate) 300 mg oral tablet,8001162,abacavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
97160,Marketed,2019-03-25,02480956,Mint-Abacavir,1,J05AF06,Abacavir,Tablet,Oral,02480956,MINT-ABACAVIR (abacavir (abacavir sulfate) 300 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9012561,abacavir (abacavir sulfate) 300 mg oral tablet,8001162,abacavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
76776,Marketed,2006-08-08,02282097,Orencia,1,L04AA24,Abatacept,Powder for solution,Intravenous,02282097,ORENCIA (abatacept 250 mg per vial powder for solution for injection) BRISTOL-MYERS SQUIBB CANADA,Active,9004196,abatacept 250 mg per vial powder for solution for injection,8001548,abatacept,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
76776,Marketed,2006-08-08,02282097,Orencia,1,L04AA24,Abatacept,Powder for solution,Intravenous,02282097,ORENCIA (abatacept 250 mg per vial powder for solution for injection) BRISTOL-MYERS SQUIBB CANADA,Active,9004196,abatacept 250 mg per vial powder for solution for injection,8001548,abatacept,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
88731,Marketed,2013-05-09,02402475,Orencia,1,L04AA24,Abatacept,Solution,Subcutaneous,02402475,ORENCIA (abatacept 125 mg per 1 mL solution for injection syringe) BRISTOL-MYERS SQUIBB CANADA,Active,9012880,abatacept 125 mg per 1 mL solution for injection syringe,8001548,abatacept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
88731,Marketed,2013-05-09,02402475,Orencia,1,L04AA24,Abatacept,Solution,Subcutaneous,02402475,ORENCIA (abatacept 125 mg per 1 mL solution for injection syringe) BRISTOL-MYERS SQUIBB CANADA,Active,9012880,abatacept 125 mg per 1 mL solution for injection syringe,8001548,abatacept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
97723,Marketed,2019-07-03,02487098,Verzenio,1,L01EF03,Abemaciclib,Tablet,Oral,02487098,VERZENIO (abemaciclib 50 mg oral tablet) ELI LILLY CANADA INC,Active,9013997,abemaciclib 50 mg oral tablet,8002268,abemaciclib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
97724,Marketed,2019-07-03,02487101,Verzenio,1,L01EF03,Abemaciclib,Tablet,Oral,02487101,VERZENIO (abemaciclib 100 mg oral tablet) ELI LILLY CANADA INC,Active,9013994,abemaciclib 100 mg oral tablet,8002268,abemaciclib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
97725,Marketed,2019-07-03,02487128,Verzenio,1,L01EF03,Abemaciclib,Tablet,Oral,02487128,VERZENIO (abemaciclib 150 mg oral tablet) ELI LILLY CANADA INC,Active,9013995,abemaciclib 150 mg oral tablet,8002268,abemaciclib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
97726,Marketed,2019-07-03,02487136,Verzenio,1,L01EF03,Abemaciclib,Tablet,Oral,02487136,VERZENIO (abemaciclib 200 mg oral tablet) ELI LILLY CANADA INC,Active,9013996,abemaciclib 200 mg oral tablet,8002268,abemaciclib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101082,Marketed,2022-03-28,02521644,Sandoz Abiraterone,1,L02BX03,Abiraterone,Tablet,Oral,02521644,SANDOZ ABIRATERONE (abiraterone acetate 500 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9006043,abiraterone acetate 500 mg oral tablet,8001549,abiraterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101887,Marketed,2023-01-30,02529629,JAMP Abiraterone,1,L02BX03,Abiraterone,Tablet,Oral,02529629,JAMP ABIRATERONE (abiraterone acetate 500 mg oral tablet) JAMP PHARMA CORPORATION,Active,9006043,abiraterone acetate 500 mg oral tablet,8001549,abiraterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102226,Marketed,2023-04-28,02533251,Reddy-Abiraterone,1,L02BX03,Abiraterone,Tablet,Oral,02533251,REDDY-ABIRATERONE (abiraterone acetate 500 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9006043,abiraterone acetate 500 mg oral tablet,8001549,abiraterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102915,Marketed,2025-10-01,02540452,PRZ-Abiraterone,1,L02BX03,Abiraterone,Tablet,Oral,02540452,PRZ-ABIRATERONE (abiraterone acetate 250 mg oral tablet) PHARMARIS CANADA INC,Active,9004897,abiraterone acetate 250 mg oral tablet,8001549,abiraterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102916,Marketed,2025-10-01,02540460,PRZ-Abiraterone,1,L02BX03,Abiraterone,Tablet,Oral,02540460,PRZ-ABIRATERONE (abiraterone acetate 500 mg oral tablet) PHARMARIS CANADA INC,Active,9006043,abiraterone acetate 500 mg oral tablet,8001549,abiraterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
85626,Marketed,2011-07-28,02371065,Zytiga,1,L02BX03,Abiraterone,Tablet,Oral,02371065,ZYTIGA (abiraterone acetate 250 mg oral tablet) JANSSEN INC,Active,9004897,abiraterone acetate 250 mg oral tablet,8001549,abiraterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
94420,Marketed,2016-09-22,02457113,Zytiga,1,L02BX03,Abiraterone,Tablet,Oral,02457113,ZYTIGA (abiraterone acetate 500 mg oral tablet) JANSSEN INC,Active,9006043,abiraterone acetate 500 mg oral tablet,8001549,abiraterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
96788,Marketed,2021-03-26,02477114,Reddy-Abiraterone,1,L02BX03,Abiraterone,Tablet,Oral,02477114,REDDY-ABIRATERONE (abiraterone acetate 250 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9004897,abiraterone acetate 250 mg oral tablet,8001549,abiraterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
97660,Marketed,2021-01-18,02486393,Sandoz Abiraterone,1,L02BX03,Abiraterone,Tablet,Oral,02486393,SANDOZ ABIRATERONE (abiraterone acetate 250 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9004897,abiraterone acetate 250 mg oral tablet,8001549,abiraterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98140,Marketed,2021-01-25,02491397,Apo-Abiraterone Film Coated Tablets,1,L02BX03,Abiraterone,Tablet,Oral,02491397,APO-ABIRATERONE FILM COATED TABLETS (abiraterone acetate 250 mg oral tablet) APOTEX INC,Active,9004897,abiraterone acetate 250 mg oral tablet,8001549,abiraterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98141,Marketed,2021-01-25,02491400,Apo-Abiraterone Film Coated Tablets,1,L02BX03,Abiraterone,Tablet,Oral,02491400,APO-ABIRATERONE FILM COATED TABLETS (abiraterone acetate 500 mg oral tablet) APOTEX INC,Active,9006043,abiraterone acetate 500 mg oral tablet,8001549,abiraterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98260,Marketed,2021-01-11,02492601,PMS-Abiraterone,1,L02BX03,Abiraterone,Tablet,Oral,02492601,PMS-ABIRATERONE (abiraterone acetate 250 mg oral tablet) PHARMASCIENCE INC,Active,9004897,abiraterone acetate 250 mg oral tablet,8001549,abiraterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98417,Marketed,2021-01-18,02494132,Nat-Abiraterone,1,L02BX03,Abiraterone,Tablet,Oral,02494132,NAT-ABIRATERONE (abiraterone acetate 250 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9004897,abiraterone acetate 250 mg oral tablet,8001549,abiraterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99112,Marketed,2021-01-11,02501503,PMS-Abiraterone,1,L02BX03,Abiraterone,Tablet,Oral,02501503,PMS-ABIRATERONE (abiraterone acetate 500 mg oral tablet) PHARMASCIENCE INC,Active,9006043,abiraterone acetate 500 mg oral tablet,8001549,abiraterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99188,Marketed,2021-02-22,02502305,JAMP Abiraterone,1,L02BX03,Abiraterone,Tablet,Oral,02502305,JAMP ABIRATERONE (abiraterone acetate 250 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004897,abiraterone acetate 250 mg oral tablet,8001549,abiraterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99344,Marketed,2021-02-03,02503980,Mar-Abiraterone,1,L02BX03,Abiraterone,Tablet,Oral,02503980,MAR-ABIRATERONE (abiraterone acetate 250 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9004897,abiraterone acetate 250 mg oral tablet,8001549,abiraterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99345,Marketed,2021-02-03,02503999,Mar-Abiraterone,1,L02BX03,Abiraterone,Tablet,Oral,02503999,MAR-ABIRATERONE (abiraterone acetate 500 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9006043,abiraterone acetate 500 mg oral tablet,8001549,abiraterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101760,Marketed,2022-09-29,02528363,Cibinqo,1,D11AH08,Abrocitinib,Tablet,Oral,02528363,CIBINQO (abrocitinib 50 mg oral tablet) PFIZER CANADA ULC,Active,9014772,abrocitinib 50 mg oral tablet,8002440,abrocitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101761,Marketed,2022-09-29,02528371,Cibinqo,1,D11AH08,Abrocitinib,Tablet,Oral,02528371,CIBINQO (abrocitinib 100 mg oral tablet) PFIZER CANADA ULC,Active,9014770,abrocitinib 100 mg oral tablet,8002440,abrocitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101762,Marketed,2022-09-29,02528398,Cibinqo,1,D11AH08,Abrocitinib,Tablet,Oral,02528398,CIBINQO (abrocitinib 200 mg oral tablet) PFIZER CANADA ULC,Active,9014771,abrocitinib 200 mg oral tablet,8002440,abrocitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102453,Marketed,2023-05-01,02535696,Calquence,1,L01EL02,Acalabrutinib,Tablet,Oral,02535696,CALQUENCE (acalabrutinib (acalabrutinib maleate) 100 mg oral tablet) ASTRAZENECA CANADA INC,Active,9015162,acalabrutinib (acalabrutinib maleate) 100 mg oral tablet,8002299,acalabrutinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,,Prescription
77863,Marketed,2010-05-28,02293269,Campral,1,N07BB03,Acamprosate,Tablet (delayed-release),Oral,02293269,CAMPRAL (acamprosate calcium 333 mg gastro-resistant tablet) MYLAN PHARMACEUTICALS ULC,Active,9004319,acamprosate calcium 333 mg gastro-resistant tablet,8001427,acamprosate,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98410,Marketed,2020-02-05,02494078,Mar-Acarbose,1,A10BF01,Acarbose,Tablet,Oral,02494078,MAR-ACARBOSE (acarbose 50 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9002886,acarbose 50 mg oral tablet,8001316,acarbose,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98411,Marketed,2020-02-05,02494086,Mar-Acarbose,1,A10BF01,Acarbose,Tablet,Oral,02494086,MAR-ACARBOSE (acarbose 100 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9002885,acarbose 100 mg oral tablet,8001316,acarbose,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
17826,Marketed,1995-12-31,02147602,Apo-Acebutolol,1,C07AB04,Acebutolol,Tablet,Oral,02147602,APO-ACEBUTOLOL (acebutolol (acebutolol hydrochloride) 100 mg oral tablet) APOTEX INC,Active,9000241,acebutolol (acebutolol hydrochloride) 100 mg oral tablet,8000110,acebutolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
17827,Marketed,1995-12-31,02147610,Apo-Acebutolol,1,C07AB04,Acebutolol,Tablet,Oral,02147610,APO-ACEBUTOLOL (acebutolol (acebutolol hydrochloride) 200 mg oral tablet) APOTEX INC,Active,9000242,acebutolol (acebutolol hydrochloride) 200 mg oral tablet,8000110,acebutolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
17828,Marketed,1995-12-31,02147629,Apo-Acebutolol,1,C07AB04,Acebutolol,Tablet,Oral,02147629,APO-ACEBUTOLOL (acebutolol (acebutolol hydrochloride) 400 mg oral tablet) APOTEX INC,Active,9000552,acebutolol (acebutolol hydrochloride) 400 mg oral tablet,8000110,acebutolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
42996,Marketed,2011-01-25,02204517,Teva-Acebutolol,1,C07AB04,Acebutolol,Tablet,Oral,02204517,TEVA-ACEBUTOLOL (acebutolol (acebutolol hydrochloride) 100 mg oral tablet) TEVA CANADA LIMITED,Active,9000241,acebutolol (acebutolol hydrochloride) 100 mg oral tablet,8000110,acebutolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
42997,Marketed,2011-01-25,02204525,Teva-Acebutolol,1,C07AB04,Acebutolol,Tablet,Oral,02204525,TEVA-ACEBUTOLOL (acebutolol (acebutolol hydrochloride) 200 mg oral tablet) TEVA CANADA LIMITED,Active,9000242,acebutolol (acebutolol hydrochloride) 200 mg oral tablet,8000110,acebutolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
42998,Marketed,2011-01-25,02204533,Teva-Acebutolol,1,C07AB04,Acebutolol,Tablet,Oral,02204533,TEVA-ACEBUTOLOL (acebutolol (acebutolol hydrochloride) 400 mg oral tablet) TEVA CANADA LIMITED,Active,9000552,acebutolol (acebutolol hydrochloride) 400 mg oral tablet,8000110,acebutolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100663,Marketed,2025-06-10,02517280,Children's Tylenol Easy Dissolve,1,N02BE01,Acetaminophen (paracetamol),Powder,Oral,02517280,CHILDREN'S TYLENOL EASY DISSOLVE (acetaminophen 160 mg per sachet oral powder) KENVUE CANADA INC.,Active,9014689,acetaminophen 160 mg per sachet oral powder,8001044,acetaminophen,26643006,Oral,385041009,Oral powder,733013000,Sachet (unit of presentation),,,,Non-Prescription Drugs
100858,Marketed,2023-01-13,02519305,Acetaminophen Injection,1,N02BE01,Acetaminophen (paracetamol),Solution,Intravenous,02519305,ACETAMINOPHEN INJECTION (acetaminophen 1000 mg per 100 mL solution for injection bag) BAXTER CORPORATION,Active,9014143,acetaminophen 1000 mg per 100 mL solution for injection bag,8001044,acetaminophen,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Prescription
100888,Marketed,2022-09-08,02519631,Arthritis Pain Relief,1,N02BE01,Acetaminophen (paracetamol),Tablet (extended-release),Oral,02519631,ARTHRITIS PAIN RELIEF (acetaminophen 650 mg prolonged-release oral tablet) GRANULES INDIA LIMITED,Active,9003431,acetaminophen 650 mg prolonged-release oral tablet,8001044,acetaminophen,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
101046,Marketed,2026-03-05,02521237,Extra Strength Tylenol Liquid Gels,1,N02BE01,Acetaminophen (paracetamol),Capsule,Oral,02521237,EXTRA STRENGTH TYLENOL LIQUID GELS (acetaminophen 500 mg oral capsule) KENVUE CANADA INC.,Active,9012407,acetaminophen 500 mg oral capsule,8001044,acetaminophen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
101484,Marketed,2025-06-27,02525844,Acetaminophen Extra Strength Tablets,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02525844,ACETAMINOPHEN EXTRA STRENGTH TABLETS (acetaminophen 500 mg oral tablet) GRANULES INDIA LIMITED,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
101709,Marketed,2022-09-14,02527901,Arthritis Pain Relief,1,N02BE01,Acetaminophen (paracetamol),Tablet (extended-release),Oral,02527901,ARTHRITIS PAIN RELIEF (acetaminophen 650 mg prolonged-release oral tablet) PHARMASCIENCE INC,Active,9003431,acetaminophen 650 mg prolonged-release oral tablet,8001044,acetaminophen,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
101916,Marketed,2025-10-06,02529939,Children's Tylenol Dye-Free Chewables,1,N02BE01,Acetaminophen (paracetamol),Tablet (chewable),Oral,02529939,CHILDREN'S TYLENOL DYE-FREE CHEWABLES (acetaminophen 160 mg chewable tablet) KENVUE CANADA INC.,Active,9002508,acetaminophen 160 mg chewable tablet,8001044,acetaminophen,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
102061,Marketed,2023-08-26,02531488,Vicks Nyquil Hot Remedy,3,N02BE01,Acetaminophen (paracetamol),Powder for solution,Oral,02531488,VICKS NYQUIL HOT REMEDY (acetaminophen 650 mg per sachet and diphenhydramine hydrochloride 25 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution) PROCTER & GAMBLE INC,Active,9013856,acetaminophen 650 mg per sachet and diphenhydramine hydrochloride 25 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution,8001167,acetaminophen and diphenhydramine and phenylephrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,,Non-Prescription Drugs
102375,Marketed,2025-05-12,02534851,Muscle & Body,1,N02BE01,Acetaminophen (paracetamol),Tablet (extended-release),Oral,02534851,MUSCLE & BODY (acetaminophen 650 mg prolonged-release oral tablet) GRANULES INDIA LIMITED,Active,9003431,acetaminophen 650 mg prolonged-release oral tablet,8001044,acetaminophen,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
102456,Marketed,2023-12-15,02535734,Acetaminophen Injection,1,N02BE01,Acetaminophen (paracetamol),Solution,Intravenous,02535734,ACETAMINOPHEN INJECTION (acetaminophen 100 mg per 10 mL solution for injection ampoule) B. BRAUN MELSUNGEN AG,Active,9014999,acetaminophen 100 mg per 10 mL solution for injection ampoule,8001044,acetaminophen,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
102457,Marketed,2023-12-15,02535742,Acetaminophen Injection,1,N02BE01,Acetaminophen (paracetamol),Solution,Intravenous,02535742,ACETAMINOPHEN INJECTION (acetaminophen 500 mg per 50 mL solution for injection bottle) B. BRAUN MELSUNGEN AG,Active,9015000,acetaminophen 500 mg per 50 mL solution for injection bottle,8001044,acetaminophen,738984000,Parenteral,385219001,Solution for injection,732986007,Bottle (unit of presentation),,,,Prescription
102458,Marketed,2024-01-22,02535750,Acetaminophen Injection,1,N02BE01,Acetaminophen (paracetamol),Solution,Intravenous,02535750,ACETAMINOPHEN INJECTION (acetaminophen 1000 mg per 100 mL solution for injection bottle) B. BRAUN MELSUNGEN AG,Active,9015011,acetaminophen 1000 mg per 100 mL solution for injection bottle,8001044,acetaminophen,738984000,Parenteral,385219001,Solution for injection,732986007,Bottle (unit of presentation),,,,Prescription
102713,Marketed,2025-05-12,02538407,Acetaminophen Extra Strength Red Tablets,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02538407,ACETAMINOPHEN EXTRA STRENGTH RED TABLETS (acetaminophen 500 mg oral tablet) GRANULES INDIA LIMITED,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
103723,Marketed,2025-04-14,02548356,Extra Strength Easy Tabs 500 mg,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02548356,EXTRA STRENGTH EASY TABS 500 MG (acetaminophen 500 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
103826,Marketed,2025-05-15,02549417,Extra Strength Tylenol Easy Dissolve,1,N02BE01,Acetaminophen (paracetamol),Powder,Oral,02549417,EXTRA STRENGTH TYLENOL EASY DISSOLVE (acetaminophen 500 mg per sachet oral powder) KENVUE CANADA INC.,Active,9015212,acetaminophen 500 mg per sachet oral powder,8001044,acetaminophen,26643006,Oral,385041009,Oral powder,733013000,Sachet,,,,Non-Prescription Drugs
103945,Marketed,2025-04-28,02550660,Regular Strength Acetaminophen,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02550660,REGULAR STRENGTH ACETAMINOPHEN (acetaminophen 325 mg oral tablet) LNK INTERNATIONAL INC.,Active,9001583,acetaminophen 325 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
104084,Marketed,2025-07-03,02552159,Acetaminophen Extra Strength Rapid Release Tablets,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02552159,ACETAMINOPHEN EXTRA STRENGTH RAPID RELEASE TABLETS (acetaminophen 500 mg oral tablet) GRANULES INDIA LIMITED,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
10450,Marketed,2015-08-12,00792691,PDP-Acetaminophen Solution 160 mg/5 mL,1,N02BE01,Acetaminophen (paracetamol),Solution,Oral,00792691,PDP-ACETAMINOPHEN SOLUTION 160MG/5ML (acetaminophen 160 mg per 5 mL oral solution) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9002330,acetaminophen 160 mg per 5 mL oral solution,8001044,acetaminophen,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
11794,Marketed,2019-11-20,01905856,Acetaminophen Chewable Tablets 80 mg,1,N02BE01,Acetaminophen (paracetamol),Tablet (chewable),Oral,01905856,ACETAMINOPHEN CHEWABLE TABLETS 80 MG (acetaminophen 80 mg chewable tablet) LABORATOIRES TRIANON INC.,Active,9002512,acetaminophen 80 mg chewable tablet,8001044,acetaminophen,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
13865,Marketed,2025-09-24,00863270,Tylenol Rapid Release,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,00863270,TYLENOL RAPID RELEASE (acetaminophen 500 mg oral tablet) KENVUE CANADA INC.,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
14130,Marketed,2011-04-06,02022214,Acétaminophène Comprimé Tablet 325,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02022214,ACÉTAMINOPHÈNE COMPRIMÉ TABLET 325 (acetaminophen 325 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001583,acetaminophen 325 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
14206,Marketed,2019-11-19,02017458,Acetaminophen Chewable Tablets 80 mg For Children,1,N02BE01,Acetaminophen (paracetamol),Tablet (chewable),Oral,02017458,ACETAMINOPHEN CHEWABLE TABLETS 80 MG FOR CHILDREN (acetaminophen 80 mg chewable tablet) LABORATOIRE RIVA INC.,Active,9002512,acetaminophen 80 mg chewable tablet,8001044,acetaminophen,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
14449,Marketed,2019-11-19,01996169,Acetaminophen Chewable Tablets 160 mg,1,N02BE01,Acetaminophen (paracetamol),Tablet (chewable),Oral,01996169,ACETAMINOPHEN CHEWABLE TABLETS 160 MG (acetaminophen 160 mg chewable tablet) LABORATOIRES TRIANON INC.,Active,9002508,acetaminophen 160 mg chewable tablet,8001044,acetaminophen,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
14450,Marketed,2019-11-20,02017431,Acetaminophen Chewable Tablets 160 mg For Children,1,N02BE01,Acetaminophen (paracetamol),Tablet (chewable),Oral,02017431,ACETAMINOPHEN CHEWABLE TABLETS 160 MG FOR CHILDREN (acetaminophen 160 mg chewable tablet) LABORATOIRE RIVA INC.,Active,9002508,acetaminophen 160 mg chewable tablet,8001044,acetaminophen,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
19418,Marketed,2024-01-17,01977415,Acetaminophen Caplets 325 mg,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,01977415,ACETAMINOPHEN CAPLETS 325 MG (acetaminophen 325 mg oral tablet) LABORATOIRES TRIANON INC.,Active,9001583,acetaminophen 325 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
19419,Marketed,2023-12-15,01977474,Acetaminophen Caplets 500 mg,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,01977474,ACETAMINOPHEN CAPLETS 500 MG (acetaminophen 500 mg oral tablet) LABORATOIRES TRIANON INC.,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
22086,Marketed,2018-08-31,01938088,JAMP Acetaminophen 325,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,01938088,JAMP ACETAMINOPHEN 325 (acetaminophen 325 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001583,acetaminophen 325 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
22143,Marketed,2018-09-07,01939122,JAMP Acetaminophen 500,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,01939122,JAMP ACETAMINOPHEN 500 (acetaminophen 500 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
42135,Marketed,2013-02-02,02027798,Pediatrix,1,N02BE01,Acetaminophen (paracetamol),Solution,Oral,02027798,PEDIATRIX (acetaminophen 160 mg per 5 mL oral solution) TEVA CANADA LIMITED,Active,9002330,acetaminophen 160 mg per 5 mL oral solution,8001044,acetaminophen,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
42136,Marketed,2013-02-02,02027801,Pediatrix Drops,1,N02BE01,Acetaminophen (paracetamol),Drops,Oral,02027801,PEDIATRIX DROPS (acetaminophen 80 mg per mL oral drops) TEVA CANADA LIMITED,Active,9002337,acetaminophen 80 mg per mL oral drops,8001044,acetaminophen,26643006,Oral,385018001,Oral drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
42341,Marketed,2025-06-16,02046059,Infants' Tylenol,1,N02BE01,Acetaminophen (paracetamol),Drops,Oral,02046059,INFANTS' TYLENOL (acetaminophen 80 mg per mL oral drops) KENVUE CANADA INC.,Active,9002337,acetaminophen 80 mg per mL oral drops,8001044,acetaminophen,26643006,Oral,385018001,Oral drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
42388,Marketed,2025-05-16,02046040,Children's Tylenol,1,N02BE01,Acetaminophen (paracetamol),Suspension,Oral,02046040,CHILDREN'S TYLENOL (acetaminophen 160 mg per 5 mL oral suspension) KENVUE CANADA INC.,Active,9002402,acetaminophen 160 mg per 5 mL oral suspension,8001044,acetaminophen,26643006,Oral,385024007,Oral suspension,,,,,,Non-Prescription Drugs
4733,Marketed,2020-04-08,00544981,Apo-Acetaminophen,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,00544981,APO-ACETAMINOPHEN (acetaminophen 325 mg oral tablet) APOTEX INC,Active,9001583,acetaminophen 325 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
4734,Marketed,2020-06-17,00545007,Apo-Acetaminophen Extra Strength,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,00545007,APO-ACETAMINOPHEN EXTRA STRENGTH (acetaminophen 500 mg oral tablet) APOTEX INC,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
48231,Marketed,2020-04-08,02229873,Apo-Acetaminophen Caplets,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02229873,APO-ACETAMINOPHEN CAPLETS (acetaminophen 325 mg oral tablet) APOTEX INC,Active,9001583,acetaminophen 325 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
48431,Marketed,2020-06-17,02229977,Apo-Acetaminophen Caplets Extra Strength,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02229977,APO-ACETAMINOPHEN CAPLETS EXTRA STRENGTH (acetaminophen 500 mg oral tablet) APOTEX INC,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
49357,Marketed,2013-04-24,02230434,Acet 120,1,N02BE01,Acetaminophen (paracetamol),Suppository,Rectal,02230434,ACET 120 (acetaminophen 120 mg suppository) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9002400,acetaminophen 120 mg suppository,8001044,acetaminophen,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,,Non-Prescription Drugs
49359,Marketed,2013-03-22,02230435,Acet 160,1,N02BE01,Acetaminophen (paracetamol),Suppository,Rectal,02230435,ACET 160 (acetaminophen 160 mg suppository) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9002510,acetaminophen 160 mg suppository,8001044,acetaminophen,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,,Non-Prescription Drugs
49360,Marketed,2013-04-30,02230436,Acet 325,1,N02BE01,Acetaminophen (paracetamol),Suppository,Rectal,02230436,ACET 325 (acetaminophen 325 mg suppository) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9002404,acetaminophen 325 mg suppository,8001044,acetaminophen,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,,Non-Prescription Drugs
49361,Marketed,2013-06-11,02230437,Acet 650,1,N02BE01,Acetaminophen (paracetamol),Suppository,Rectal,02230437,ACET 650 (acetaminophen 650 mg suppository) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9002407,acetaminophen 650 mg suppository,8001044,acetaminophen,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,,Non-Prescription Drugs
5035,Marketed,2013-10-10,00389218,Novo-Gesic,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,00389218,NOVO-GESIC (acetaminophen 325 mg oral tablet) TEVA CANADA LIMITED,Active,9001583,acetaminophen 325 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
5184,Marketed,2013-10-10,00482323,Novo-Gesic Forte,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,00482323,NOVO-GESIC FORTE (acetaminophen 500 mg oral tablet) TEVA CANADA LIMITED,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
5254,Marketed,2025-06-27,00559393,Tylenol Regular Strength,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,00559393,TYLENOL REGULAR STRENGTH (acetaminophen 325 mg oral tablet) KENVUE CANADA INC.,Active,9001583,acetaminophen 325 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
5255,Marketed,2025-09-25,00559407,Tylenol Extra Strength,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,00559407,TYLENOL EXTRA STRENGTH (acetaminophen 500 mg oral tablet) KENVUE CANADA INC.,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
5570,Marketed,2002-02-01,00605751,Acetaminophen Tablets 325 mg,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,00605751,ACETAMINOPHEN TABLETS 325 MG (acetaminophen 325 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9001583,acetaminophen 325 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
5571,Marketed,2002-02-01,00605778,Extra Strength Acetaminophen Tablets 500 mg,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,00605778,EXTRA STRENGTH ACETAMINOPHEN TABLETS 500 MG (acetaminophen 500 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
60900,Marketed,2019-11-20,02237562,Acetaminophen 160 mg Chewable Tablets,1,N02BE01,Acetaminophen (paracetamol),Tablet (chewable),Oral,02237562,ACETAMINOPHEN 160 MG CHEWABLE TABLETS (acetaminophen 160 mg chewable tablet) LABORATOIRES TRIANON INC.,Active,9002508,acetaminophen 160 mg chewable tablet,8001044,acetaminophen,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
62325,Marketed,2025-09-26,02238885,Tylenol Arthritis Pain 8 H,1,N02BE01,Acetaminophen (paracetamol),Tablet (extended-release),Oral,02238885,TYLENOL ARTHRITIS PAIN 8H (acetaminophen 650 mg prolonged-release oral tablet) KENVUE CANADA INC.,Active,9003431,acetaminophen 650 mg prolonged-release oral tablet,8001044,acetaminophen,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
64993,Marketed,2025-06-20,02241361,Children's Tylenol Chewables,1,N02BE01,Acetaminophen (paracetamol),Tablet (chewable),Oral,02241361,CHILDREN'S TYLENOL CHEWABLES (acetaminophen 160 mg chewable tablet) KENVUE CANADA INC.,Active,9002508,acetaminophen 160 mg chewable tablet,8001044,acetaminophen,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
68299,Marketed,2006-12-19,02244331,Taminol Caplets,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02244331,TAMINOL CAPLETS (acetaminophen 500 mg oral tablet) VIVA PHARMACEUTICAL INC.,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
70191,Marketed,2025-06-27,02246060,Tylenol Muscle & Body,1,N02BE01,Acetaminophen (paracetamol),Tablet (extended-release),Oral,02246060,TYLENOL MUSCLE & BODY (acetaminophen 650 mg prolonged-release oral tablet) KENVUE CANADA INC.,Active,9003431,acetaminophen 650 mg prolonged-release oral tablet,8001044,acetaminophen,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
73774,Marketed,2019-07-10,02252805,Acetaminophen 325 mg Tablets Regular Strength,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02252805,ACETAMINOPHEN 325MG TABLETS REGULAR STRENGTH (acetaminophen 325 mg oral tablet) CELLCHEM PHARMACEUTICALS INC.,Active,9001583,acetaminophen 325 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
73775,Marketed,2019-07-10,02252813,Acetaminophen 500 mg Tablets Extra Strength,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02252813,ACETAMINOPHEN 500MG TABLETS EXTRA STRENGTH (acetaminophen 500 mg oral tablet) CELLCHEM PHARMACEUTICALS INC.,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
74040,Marketed,2019-03-19,02255251,Acetaminophen 500 mg Tablets Extra Strength Easy To Swallow,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02255251,ACETAMINOPHEN 500 MG TABLETS EXTRA STRENGTH EASY TO SWALLOW (acetaminophen 500 mg oral tablet) CELLCHEM PHARMACEUTICALS INC.,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
75800,Marketed,2006-08-28,02272482,Acetaminophen Arthritis Pain,1,N02BE01,Acetaminophen (paracetamol),Tablet (extended-release),Oral,02272482,ACETAMINOPHEN ARTHRITIS PAIN (acetaminophen 650 mg prolonged-release oral tablet) PERRIGO INTERNATIONAL,Active,9003431,acetaminophen 650 mg prolonged-release oral tablet,8001044,acetaminophen,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
77128,Marketed,2006-10-10,02285797,Extra Strength Acetaminophen,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02285797,EXTRA STRENGTH ACETAMINOPHEN (acetaminophen 500 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
8387,Marketed,2025-04-17,00723908,Tylenol Extra Strength Caplets,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,00723908,TYLENOL EXTRA STRENGTH CAPLETS (acetaminophen 500 mg oral tablet) KENVUE CANADA INC.,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
84722,Marketed,2014-12-01,02362198,Acétaminophène Caplet 325,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02362198,ACÉTAMINOPHÈNE CAPLET 325 (acetaminophen 325 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001583,acetaminophen 325 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
84724,Marketed,2014-12-01,02362228,Acétaminophène Caplet 500,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02362228,ACÉTAMINOPHÈNE CAPLET 500 (acetaminophen 500 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
84726,Marketed,2011-09-26,02362244,Acetaminophen Tablets USP 500 mg,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02362244,ACETAMINOPHEN TABLETS USP 500 MG (acetaminophen 500 mg oral tablet) APOTEX INC,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
84736,Marketed,2011-06-01,02362341,Acetaminophen Caplets 325 mg,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02362341,ACETAMINOPHEN CAPLETS 325 MG (acetaminophen 325 mg oral tablet) APOTEX INC,Active,9001583,acetaminophen 325 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
84737,Marketed,2011-05-26,02362368,Acetaminophen Caplets 500 mg,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02362368,ACETAMINOPHEN CAPLETS 500 MG (acetaminophen 500 mg oral tablet) APOTEX INC,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
84743,Marketed,2011-05-31,02362422,Acetaminophen Tablets USP 325 mg,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02362422,ACETAMINOPHEN TABLETS USP 325 MG (acetaminophen 325 mg oral tablet) APOTEX INC,Active,9001583,acetaminophen 325 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
85632,Marketed,2012-04-16,02371146,Arthritis Pain Relief,1,N02BE01,Acetaminophen (paracetamol),Tablet (extended-release),Oral,02371146,ARTHRITIS PAIN RELIEF (acetaminophen 650 mg prolonged-release oral tablet) VITA HEALTH PRODUCTS INC,Active,9003431,acetaminophen 650 mg prolonged-release oral tablet,8001044,acetaminophen,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
8597,Marketed,2025-06-27,00723894,Tylenol Regular Strength Caplets,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,00723894,TYLENOL REGULAR STRENGTH CAPLETS (acetaminophen 325 mg oral tablet) KENVUE CANADA INC.,Active,9001583,acetaminophen 325 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
87537,Marketed,2018-08-03,02389908,Infants' Tylenol Fever & Sore Throat Pain,1,N02BE01,Acetaminophen (paracetamol),Drops,Oral,02389908,INFANTS' TYLENOL FEVER & SORE THROAT PAIN (acetaminophen 80 mg per mL oral drops) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9002337,acetaminophen 80 mg per mL oral drops,8001044,acetaminophen,26643006,Oral,385018001,Oral drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
87539,Marketed,2018-05-28,02389924,Children's Tylenol Fever & Sore Throat Pain,1,N02BE01,Acetaminophen (paracetamol),Suspension,Oral,02389924,CHILDREN'S TYLENOL FEVER & SORE THROAT PAIN (acetaminophen 160 mg per 5 mL oral suspension) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9002402,acetaminophen 160 mg per 5 mL oral suspension,8001044,acetaminophen,26643006,Oral,385024007,Oral suspension,,,,,,Non-Prescription Drugs
91942,Marketed,2015-07-06,02435144,Children's Tylenol Fever & Sore Throat Pain,1,N02BE01,Acetaminophen (paracetamol),Tablet (chewable),Oral,02435144,CHILDREN'S TYLENOL FEVER & SORE THROAT PAIN (acetaminophen 160 mg chewable tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9002508,acetaminophen 160 mg chewable tablet,8001044,acetaminophen,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
93341,Marketed,2025-11-14,02447819,Junior Strength Children's Acetaminophen Tablets,1,N02BE01,Acetaminophen (paracetamol),Tablet (chewable),Oral,02447819,JUNIOR STRENGTH CHILDREN'S ACETAMINOPHEN TABLETS (acetaminophen 160 mg chewable tablet) SIGMA LIFE SCIENCES INC.,Active,9002508,acetaminophen 160 mg chewable tablet,8001044,acetaminophen,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
94236,Marketed,2016-08-15,02455560,Muscle Aches And Body Pain Relief,1,N02BE01,Acetaminophen (paracetamol),Tablet (extended-release),Oral,02455560,MUSCLE ACHES AND BODY PAIN RELIEF (acetaminophen 650 mg prolonged-release oral tablet) VITA HEALTH PRODUCTS INC,Active,9003431,acetaminophen 650 mg prolonged-release oral tablet,8001044,acetaminophen,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
95882,Marketed,2019-03-14,02469928,Acetaminophen Extra Strength Liquid Gels,1,N02BE01,Acetaminophen (paracetamol),Capsule,Oral,02469928,ACETAMINOPHEN EXTRA STRENGTH LIQUID GELS (acetaminophen 500 mg oral capsule) LABORATOIRES TRIANON INC.,Active,9012407,acetaminophen 500 mg oral capsule,8001044,acetaminophen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
9627,Marketed,2024-03-27,00789798,Acetaminophen Tablets 500 mg,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,00789798,ACETAMINOPHEN TABLETS 500 MG (acetaminophen 500 mg oral tablet) LABORATOIRES TRIANON INC.,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
9628,Marketed,2024-01-24,00789801,Acetaminophen Tablets 325 mg,1,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,00789801,ACETAMINOPHEN TABLETS 325 MG (acetaminophen 325 mg oral tablet) LABORATOIRES TRIANON INC.,Active,9001583,acetaminophen 325 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
97378,Marketed,2019-09-13,02483343,Acetaminophen Injection,1,N02BE01,Acetaminophen (paracetamol),Solution,Intravenous,02483343,ACETAMINOPHEN INJECTION (acetaminophen 1000 mg per 100 mL solution for injection bag) AVIR PHARMA INC.,Active,9014143,acetaminophen 1000 mg per 100 mL solution for injection bag,8001044,acetaminophen,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Prescription
97700,Marketed,2021-05-23,02486830,Children's Acetaminophen Suspension,1,N02BE01,Acetaminophen (paracetamol),Suspension,Oral,02486830,CHILDREN'S ACETAMINOPHEN SUSPENSION (acetaminophen 160 mg per 5 mL oral suspension) JUNO OTC INC,Active,9002402,acetaminophen 160 mg per 5 mL oral suspension,8001044,acetaminophen,26643006,Oral,385024007,Oral suspension,,,,,,Non-Prescription Drugs
97715,Marketed,2020-01-14,02487004,Cough & Cold Relief,3,N02BE01,Acetaminophen (paracetamol),Powder for solution,Oral,02487004,COUGH & COLD RELIEF (acetaminophen 500 mg per sachet and dextromethorphan hydrobromide 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution) JUNO OTC INC,Active,9014236,acetaminophen 500 mg per sachet and dextromethorphan hydrobromide 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution,8001334,acetaminophen and dextromethorphan and phenylephrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,,Non-Prescription Drugs
100854,Marketed,2024-06-19,02519267,Advil Plus Acetaminophen,2,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02519267,ADVIL PLUS ACETAMINOPHEN (acetaminophen 250 mg and ibuprofen 125 mg oral tablet) HALEON CANADA ULC,Active,9014710,acetaminophen 250 mg and ibuprofen 125 mg oral tablet,8002354,acetaminophen and ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
10188,Marketed,2024-04-15,00843792,Neocitran Extra Strength Cold & Congestion,2,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,00843792,NEOCITRAN EXTRA STRENGTH COLD & CONGESTION (acetaminophen 650 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution) HALEON CANADA ULC,Active,9014184,acetaminophen 650 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution,8000843,acetaminophen and phenylephrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,,Non-Prescription Drugs
102063,Marketed,2023-08-26,02531518,Vicks Dayquil Hot Remedy,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02531518,VICKS DAYQUIL HOT REMEDY (acetaminophen 500 mg per sachet and dextromethorphan hydrobromide 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution) PROCTER & GAMBLE INC,Active,9014236,acetaminophen 500 mg per sachet and dextromethorphan hydrobromide 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution,8001334,acetaminophen and dextromethorphan and phenylephrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,,Non-Prescription Drugs
103325,Marketed,2025-07-10,02544687,Extra Strength Tylenol Daytime Relief,2,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02544687,EXTRA STRENGTH TYLENOL DAYTIME RELIEF (acetaminophen 500 mg and caffeine 65 mg oral tablet) KENVUE CANADA INC.,Active,9002060,acetaminophen 500 mg and caffeine 65 mg oral tablet,8000837,acetaminophen and caffeine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
103343,Marketed,2025-05-15,02544806,Combogesic IV,2,N02BE51,"Acetaminophen, comb excl psycholeptics",Solution,Intravenous,02544806,COMBOGESIC IV (acetaminophen 1000 mg per 100 mL and ibuprofen (ibuprofen sodium dihydrate) 300 mg per 100 mL solution for injection vial) AFT PHARMACEUTICALS (CAN) LIMITED,Active,9015211,acetaminophen 1000 mg per 100 mL and ibuprofen (ibuprofen sodium) 300 mg per 100 mL solution for injection vial,8002354,acetaminophen and ibuprofen,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,,,,Prescription
104039,Marketed,2025-07-07,02551667,Nyquil Cold & Flu Alcohol Free,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Syrup,Oral,02551667,NYQUIL COLD & FLU ALCOHOL FREE (acetaminophen 650 mg per 30 mL and chlorpheniramine maleate 4 mg per 30 mL and dextromethorphan hydrobromide 30 mg per 30 mL syrup) PROCTER & GAMBLE INC,Active,9015227,acetaminophen 650 mg per 30 mL and chlorpheniramine maleate 4 mg per 30 mL and dextromethorphan hydrobromide 30 mg per 30 mL syrup,8001319,acetaminophen and chlorpheniramine and dextromethorphan,26643006,Oral,385032004,Oral syrup,,,,,,Non-Prescription Drugs
104148,Marketed,2026-01-15,02552515,Neocitran Extra Strength Cold & Cough,2,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02552515,NEOCITRAN EXTRA STRENGTH COLD & COUGH (acetaminophen 650 mg per sachet and dextromethorphan hydrobromide 20 mg per sachet powder for oral solution) HALEON CANADA ULC,Active,9015333,acetaminophen 650 mg per sachet and dextromethorphan hydrobromide 20 mg per sachet powder for oral solution,8002570,acetaminophen and dextromethorphan,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet,,,,Non-Prescription Drugs
104150,Marketed,2026-01-15,02552531,Neocitran Extra Strength Cold & Cough Night,2,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02552531,NEOCITRAN EXTRA STRENGTH COLD & COUGH NIGHT (acetaminophen 650 mg per sachet and diphenhydramine hydrochloride 25 mg per sachet powder for oral solution) HALEON CANADA ULC,Active,9015334,acetaminophen 650 mg per sachet and diphenhydramine hydrochloride 25 mg per sachet powder for oral solution,8001166,acetaminophen and diphenhydramine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet,,,,Non-Prescription Drugs
104291,Marketed,2025-08-01,02554011,Buckley's Nighttime Complete Extra Strength Plus Mucus Relief,5,N02BE51,"Acetaminophen, comb excl psycholeptics",Syrup,Oral,02554011,BUCKLEY'S NIGHTTIME COMPLETE EXTRA STRENGTH PLUS MUCUS RELIEF (acetaminophen 500 mg per 5 mL and chlorpheniramine maleate 2 mg per 5 mL and dextromethorphan hydrobromide 10 mg per 5 mL and guaifenesin 100 mg per 5 mL and menthol 20 mg per 5 mL syrup) HALEON CANADA ULC,Active,9015241,acetaminophen 500 mg per 5 mL and chlorpheniramine maleate 2 mg per 5 mL and dextromethorphan hydrobromide 10 mg per 5 mL and guaifenesin 100 mg per 5 mL and menthol 20 mg per 5 mL syrup,8002550,acetaminophen and chlorpheniramine and dextromethorphan and guaifenesin and menthol,26643006,Oral,385032004,Oral syrup,,,,,,Non-Prescription Drugs
104302,Marketed,2025-08-01,02554143,Buckley's Nighttime Complete Extra Strength,4,N02BE51,"Acetaminophen, comb excl psycholeptics",Syrup,Oral,02554143,BUCKLEY'S NIGHTTIME COMPLETE EXTRA STRENGTH (acetaminophen 500 mg per 5 mL and chlorpheniramine maleate 2 mg per 5 mL and dextromethorphan hydrobromide 10 mg per 5 mL and menthol 20 mg per 5 mL syrup) HALEON CANADA ULC,Active,9015242,acetaminophen 500 mg per 5 mL and chlorpheniramine maleate 2 mg per 5 mL and dextromethorphan hydrobromide 10 mg per 5 mL and menthol 20 mg per 5 mL syrup,8002551,acetaminophen and chlorpheniramine and dextromethorphan and menthol,26643006,Oral,385032004,Oral syrup,,,,,,Non-Prescription Drugs
104343,Marketed,2026-01-15,02554593,Neocitran Ultra Strength Flu & Cold Night,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02554593,NEOCITRAN ULTRA STRENGTH FLU & COLD NIGHT (acetaminophen 1000 mg per sachet and chlorpheniramine maleate 4 mg per sachet and dextromethorphan hydrobromide 30 mg per sachet powder for oral solution) HALEON CANADA ULC,Active,9015331,acetaminophen 1000 mg per sachet and chlorpheniramine maleate 4 mg per sachet and dextromethorphan hydrobromide 30 mg per sachet powder for oral solution,8001319,acetaminophen and chlorpheniramine and dextromethorphan,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet,,,,Non-Prescription Drugs
104344,Marketed,2026-01-15,02554607,Neocitran Ultra Strength Flu & Cold,2,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02554607,NEOCITRAN ULTRA STRENGTH FLU & COLD (acetaminophen 1000 mg per sachet and dextromethorphan hydrobromide 30 mg per sachet powder for oral solution) HALEON CANADA ULC,Active,9015332,acetaminophen 1000 mg per sachet and dextromethorphan hydrobromide 30 mg per sachet powder for oral solution,8002570,acetaminophen and dextromethorphan,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet,,,,Non-Prescription Drugs
104430,Marketed,2026-03-23,02555549,Neocitran Ultra Strength Complete Cold Night,4,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02555549,NEOCITRAN ULTRA STRENGTH COMPLETE COLD NIGHT (acetaminophen 1000 mg per sachet and chlorpheniramine maleate 4 mg per sachet and dextromethorphan hydrobromide 30 mg per sachet and pseudoephedrine hydrochloride 60 mg per sachet powder for oral solution) HALEON CANADA ULC,Active,9013846,acetaminophen 1000 mg per sachet and chlorpheniramine maleate 4 mg per sachet and dextromethorphan hydrobromide 30 mg per sachet and pseudoephedrine hydrochloride 60 mg per sachet powder for oral solution,8001322,acetaminophen and chlorpheniramine and dextromethorphan and pseudoephedrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,,Non-Prescription Drugs
104463,Marketed,2026-03-23,02555905,Neocitran Ultra Strength Complete Cold,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02555905,NEOCITRAN ULTRA STRENGTH COMPLETE COLD (acetaminophen 1000 mg per sachet and dextromethorphan hydrobromide 30 mg per sachet and pseudoephedrine hydrochloride 60 mg per sachet powder for oral solution) HALEON CANADA ULC,Active,9013252,acetaminophen 1000 mg per sachet and dextromethorphan hydrobromide 30 mg per sachet and pseudoephedrine hydrochloride 60 mg per sachet powder for oral solution,8001335,acetaminophen and dextromethorphan and pseudoephedrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,,Non-Prescription Drugs
106181,Marketed,2026-03-05,02558572,Tylenol Dual Action Acetaminophen + Ibuprofen,2,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02558572,TYLENOL DUAL ACTION ACETAMINOPHEN + IBUPROFEN (acetaminophen 250 mg and ibuprofen 125 mg oral tablet) KENVUE CANADA INC.,Active,9014710,acetaminophen 250 mg and ibuprofen 125 mg oral tablet,8002354,acetaminophen and ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
106252,Marketed,2026-03-16,02559366,Nighttime Cold And Flu Relief,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Solution,Oral,02559366,NIGHTTIME COLD AND FLU RELIEF (acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 30 mg per 30 mL and doxylamine succinate 12.5 mg per 30 mL oral solution) H.J. SUTTON INDUSTRIES LTD.,Active,9005174,acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 30 mg per 30 mL and doxylamine succinate 12.5 mg per 30 mL oral solution,8001328,acetaminophen and dextromethorphan and doxylamine,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
13120,Marketed,2018-10-12,01938371,Extra Strength Sinutab Sinus Daytime,2,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,01938371,EXTRA STRENGTH SINUTAB SINUS DAYTIME (acetaminophen 500 mg and pseudoephedrine hydrochloride 30 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9002333,acetaminophen 500 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001338,acetaminophen and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
15805,Marketed,2007-11-15,02047667,Mersyndol With Codeine,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02047667,MERSYNDOL WITH CODEINE (acetaminophen 325 mg and codeine phosphate 8 mg and doxylamine succinate 5 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9001927,acetaminophen 325 mg and codeine phosphate 8 mg and doxylamine succinate 5 mg oral tablet,8000828,acetaminophen and codeine and doxylamine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
17113,Marketed,2018-10-12,01986988,Extra Strength Sinutab Sinus & Allergy,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,01986988,EXTRA STRENGTH SINUTAB SINUS & ALLERGY (acetaminophen 500 mg and chlorpheniramine maleate 2 mg and pseudoephedrine hydrochloride 30 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9002061,acetaminophen 500 mg and chlorpheniramine maleate 2 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001324,acetaminophen and chlorpheniramine and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
17880,Marketed,2010-05-01,02083736,Extra Strength Cold Medication Daytime Relief,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02083736,EXTRA STRENGTH COLD MEDICATION DAYTIME RELIEF (acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9002728,acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001335,acetaminophen and dextromethorphan and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
17887,Marketed,2010-05-01,02039842,Extra Strength Cold Medication Nighttime Relief,4,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02039842,EXTRA STRENGTH COLD MEDICATION NIGHTTIME RELIEF (acetaminophen 500 mg and chlorpheniramine maleate 2 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9002727,acetaminophen 500 mg and chlorpheniramine maleate 2 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001322,acetaminophen and chlorpheniramine and dextromethorphan and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
26863,Marketed,2018-10-04,02039982,Children's Tylenol Cold,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Suspension,Oral,02039982,CHILDREN'S TYLENOL COLD (acetaminophen 160 mg per 5 mL and chlorpheniramine maleate 1 mg per 5 mL and pseudoephedrine hydrochloride 15 mg per 5 mL oral suspension) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9003128,acetaminophen 160 mg per 5 mL and chlorpheniramine maleate 1 mg per 5 mL and pseudoephedrine hydrochloride 15 mg per 5 mL oral suspension,8001324,acetaminophen and chlorpheniramine and pseudoephedrine,26643006,Oral,385024007,Oral suspension,,,,,,Non-Prescription Drugs
26864,Marketed,2005-06-18,02039990,Children's Tylenol Cold And Cough,4,N02BE51,"Acetaminophen, comb excl psycholeptics",Suspension,Oral,02039990,CHILDREN'S TYLENOL COLD AND COUGH (acetaminophen 160 mg per 5 mL and chlorpheniramine maleate 1 mg per 5 mL and dextromethorphan hydrobromide 7.5 mg per 5 mL and pseudoephedrine hydrochloride 15 mg per 5 mL oral suspension) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9003129,acetaminophen 160 mg per 5 mL and chlorpheniramine maleate 1 mg per 5 mL and dextromethorphan hydrobromide 7.5 mg per 5 mL and pseudoephedrine hydrochloride 15 mg per 5 mL oral suspension,8001322,acetaminophen and chlorpheniramine and dextromethorphan and pseudoephedrine,26643006,Oral,385024007,Oral suspension,,,,,,Non-Prescription Drugs
32780,Marketed,2018-12-18,02047349,Hot Lemon Relief For Symptoms Of Cold And Flu Regular Strength,4,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02047349,HOT LEMON RELIEF FOR SYMPTOMS OF COLD AND FLU REGULAR STRENGTH (acetaminophen 325 mg per sachet and ascorbic acid 50 mg per sachet and pheniramine maleate 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution) CELLCHEM PHARMACEUTICALS INC.,Active,9013849,acetaminophen 325 mg per sachet and ascorbic acid 50 mg per sachet and pheniramine maleate 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution,8002166,acetaminophen and ascorbic acid and pheniramine and phenylephrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,,Non-Prescription Drugs
34150,Marketed,2010-05-01,02159546,Extra Strength Allergy Sinus Medication,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02159546,EXTRA STRENGTH ALLERGY SINUS MEDICATION (acetaminophen 500 mg and chlorpheniramine maleate 2 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9002061,acetaminophen 500 mg and chlorpheniramine maleate 2 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001324,acetaminophen and chlorpheniramine and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
37037,Marketed,2018-10-12,02215241,Extra Strength Sinutab Sinus Nighttime,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02215241,EXTRA STRENGTH SINUTAB SINUS NIGHTTIME (acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9003222,acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001336,acetaminophen and diphenhydramine and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
37051,Marketed,2024-04-15,02215403,Neocitran Extra Strength Cold & Sinus Night,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02215403,NEOCITRAN EXTRA STRENGTH COLD & SINUS NIGHT (acetaminophen 650 mg per sachet and pheniramine maleate 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution) HALEON CANADA ULC,Active,9013636,acetaminophen 650 mg per sachet and pheniramine maleate 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution,8001883,acetaminophen and pheniramine and phenylephrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,,Non-Prescription Drugs
37105,Marketed,2024-04-02,02217147,Neocitran Ultra Strength Total Flu Night,4,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02217147,NEOCITRAN ULTRA STRENGTH TOTAL FLU NIGHT (acetaminophen 1000 mg per sachet and chlorpheniramine maleate 4 mg per sachet and dextromethorphan hydrobromide 30 mg per sachet and pseudoephedrine hydrochloride 60 mg per sachet powder for oral solution) HALEON CANADA ULC,Active,9013846,acetaminophen 1000 mg per sachet and chlorpheniramine maleate 4 mg per sachet and dextromethorphan hydrobromide 30 mg per sachet and pseudoephedrine hydrochloride 60 mg per sachet powder for oral solution,8001322,acetaminophen and chlorpheniramine and dextromethorphan and pseudoephedrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,,Non-Prescription Drugs
37150,Marketed,2019-09-03,02218186,"Benylin Extra Strength All-In-One Cold, Flu & Cough",4,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02218186,"BENYLIN EXTRA STRENGTH ALL-IN-ONE COLD, FLU & COUGH (acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC",Active,9003127,acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001333,acetaminophen and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
47448,Marketed,2011-04-08,02229538,Children's Tylenol Cold & Stuffy Nose,2,N02BE51,"Acetaminophen, comb excl psycholeptics",Suspension,Oral,02229538,CHILDREN'S TYLENOL COLD & STUFFY NOSE (acetaminophen 160 mg per 5 mL and pseudoephedrine hydrochloride 15 mg per 5 mL oral suspension) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9003166,acetaminophen 160 mg per 5 mL and pseudoephedrine hydrochloride 15 mg per 5 mL oral suspension,8001338,acetaminophen and pseudoephedrine,26643006,Oral,385024007,Oral suspension,,,,,,Non-Prescription Drugs
61574,Marketed,2018-02-23,02238183,Acetaminophen With Antihistamine Nighttime,2,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02238183,ACETAMINOPHEN WITH ANTIHISTAMINE NIGHTTIME (acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg oral tablet) LABORATOIRES TRIANON INC.,Active,9005112,acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg oral tablet,8001166,acetaminophen and diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
62330,Marketed,2018-12-14,02238890,Hot Lemon Relief For Symptoms Of Cold And Flu Extra Strength,4,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02238890,HOT LEMON RELIEF FOR SYMPTOMS OF COLD AND FLU EXTRA STRENGTH (acetaminophen 650 mg per sachet and ascorbic acid 50 mg per sachet and pheniramine maleate 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution) CELLCHEM PHARMACEUTICALS INC.,Active,9013854,acetaminophen 650 mg per sachet and ascorbic acid 50 mg per sachet and pheniramine maleate 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution,8002166,acetaminophen and ascorbic acid and pheniramine and phenylephrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,,Non-Prescription Drugs
62615,Marketed,2018-10-01,02239159,Extra Strength Sudafed Head Cold & Sinus,2,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02239159,EXTRA STRENGTH SUDAFED HEAD COLD & SINUS (acetaminophen 500 mg and pseudoephedrine hydrochloride 60 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9003509,acetaminophen 500 mg and pseudoephedrine hydrochloride 60 mg oral tablet,8001338,acetaminophen and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
65249,Marketed,2024-03-22,02241592,"Buckley's Complete Extra Strength Cough, Cold And Flu Night",4,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02241592,"BUCKLEY'S COMPLETE EXTRA STRENGTH COUGH, COLD AND FLU NIGHT (acetaminophen 500 mg and chlorpheniramine maleate 2 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet) HALEON CANADA ULC",Active,9002727,acetaminophen 500 mg and chlorpheniramine maleate 2 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001322,acetaminophen and chlorpheniramine and dextromethorphan and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
65250,Marketed,2024-03-22,02241593,"Buckley's Complete Extra Strength Cough, Cold & Flu Day",3,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02241593,"BUCKLEY'S COMPLETE EXTRA STRENGTH COUGH, COLD & FLU DAY (acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet) HALEON CANADA ULC",Active,9002728,acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001335,acetaminophen and dextromethorphan and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
68230,Marketed,2002-01-09,02244263,Coltalin Cold & Allergy Tablets,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02244263,COLTALIN COLD & ALLERGY TABLETS (acetaminophen 325 mg and chlorpheniramine maleate 2 mg and phenylephrine hydrochloride 5 mg oral tablet) FORTUNE PHARMACAL CO. LTD.,Active,9002621,acetaminophen 325 mg and chlorpheniramine maleate 2 mg and phenylephrine hydrochloride 5 mg oral tablet,8001323,acetaminophen and chlorpheniramine and phenylephrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
69017,Marketed,2004-06-01,02245016,Sinus Medication,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02245016,SINUS MEDICATION (acetaminophen 500 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9003782,acetaminophen 500 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001337,acetaminophen and doxylamine and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
69814,Marketed,2019-09-03,02245710,"Benylin Extra Strength All-In-One Cough, Cold & Flu",4,N02BE51,"Acetaminophen, comb excl psycholeptics",Syrup,Oral,02245710,"BENYLIN EXTRA STRENGTH ALL-IN-ONE COUGH, COLD & FLU (acetaminophen 500 mg per 15 mL and dextromethorphan hydrobromide 15 mg per 15 mL and guaifenesin 100 mg per 15 mL and pseudoephedrine hydrochloride 30 mg per 15 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC",Active,9003812,acetaminophen 500 mg per 15 mL and dextromethorphan hydrobromide 15 mg per 15 mL and guaifenesin 100 mg per 15 mL and pseudoephedrine hydrochloride 30 mg per 15 mL syrup,8001333,acetaminophen and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
71050,Marketed,2018-12-18,02246848,"Hot Lemon Relief For Symptoms Of Cough, Cold And Flu Extra Strength",4,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02246848,"HOT LEMON RELIEF FOR SYMPTOMS OF COUGH, COLD AND FLU EXTRA STRENGTH (acetaminophen 650 mg per sachet and chlorpheniramine maleate 4 mg per sachet and dextromethorphan hydrobromide 20 mg per sachet and pseudoephedrine hydrochloride 60 mg per sachet powder for oral solution) CELLCHEM PHARMACEUTICALS INC.",Active,9013855,acetaminophen 650 mg per sachet and chlorpheniramine maleate 4 mg per sachet and dextromethorphan hydrobromide 20 mg per sachet and pseudoephedrine hydrochloride 60 mg per sachet powder for oral solution,8001322,acetaminophen and chlorpheniramine and dextromethorphan and pseudoephedrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,,Non-Prescription Drugs
72935,Marketed,2004-03-01,02248580,Extra Strength Flu Relief Daytime,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02248580,EXTRA STRENGTH FLU RELIEF DAYTIME (acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9002728,acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001335,acetaminophen and dextromethorphan and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
73003,Marketed,2004-04-01,02248646,Extra Strength Head Cold And Sinus,2,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02248646,EXTRA STRENGTH HEAD COLD AND SINUS (acetaminophen 500 mg and pseudoephedrine hydrochloride 60 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9003509,acetaminophen 500 mg and pseudoephedrine hydrochloride 60 mg oral tablet,8001338,acetaminophen and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
73064,Marketed,2004-01-07,02248700,Extra Strength Flu Relief Nightime,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02248700,EXTRA STRENGTH FLU RELIEF NIGHTIME (acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9003222,acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001336,acetaminophen and diphenhydramine and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
73592,Marketed,2026-05-14,02250993,"Benadryl Allergy, Sinus & Pain Total",3,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02250993,"BENADRYL ALLERGY, SINUS & PAIN TOTAL (acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet) KENVUE CANADA INC.",Active,9003222,acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001336,acetaminophen and diphenhydramine and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
73724,Marketed,2019-09-03,02252376,"Benylin Extra Strength All-In-One Cough, Cold & Flu Night",5,N02BE51,"Acetaminophen, comb excl psycholeptics",Syrup,Oral,02252376,"BENYLIN EXTRA STRENGTH ALL-IN-ONE COUGH, COLD & FLU NIGHT (acetaminophen 500 mg per 15 mL and chlorpheniramine maleate 2 mg per 15 mL and dextromethorphan hydrobromide 15 mg per 15 mL and guaifenesin 100 mg per 15 mL and pseudoephedrine hydrochloride 30 mg per 15 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC",Active,9004090,acetaminophen 500 mg per 15 mL and chlorpheniramine maleate 2 mg per 15 mL and dextromethorphan hydrobromide 15 mg per 15 mL and guaifenesin 100 mg per 15 mL and pseudoephedrine hydrochloride 30 mg per 15 mL syrup,8001320,acetaminophen and chlorpheniramine and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
73935,Marketed,2025-07-11,02254468,Tylenol Ultra Relief,2,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02254468,TYLENOL ULTRA RELIEF (acetaminophen 500 mg and caffeine 65 mg oral tablet) KENVUE CANADA INC.,Active,9002060,acetaminophen 500 mg and caffeine 65 mg oral tablet,8000837,acetaminophen and caffeine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
74181,Marketed,2019-11-01,02256576,"Benylin Extra Strength All-In-One Cold, Flu & Cough Night",3,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02256576,"BENYLIN EXTRA STRENGTH ALL-IN-ONE COLD, FLU & COUGH NIGHT (acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC",Active,9003222,acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001336,acetaminophen and diphenhydramine and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
74414,Marketed,2014-08-19,02258919,Daytime Cold & Flu Liquid Capsules,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Capsule,Oral,02258919,DAYTIME COLD & FLU LIQUID CAPSULES (acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9004003,acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral capsule,8001335,acetaminophen and dextromethorphan and pseudoephedrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
74415,Marketed,2017-04-13,02258927,Nighttime Cold & Flu Liquid Capsules,4,N02BE51,"Acetaminophen, comb excl psycholeptics",Capsule,Oral,02258927,NIGHTTIME COLD & FLU LIQUID CAPSULES (acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9004002,acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral capsule,8001331,acetaminophen and dextromethorphan and doxylamine and pseudoephedrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
75038,Marketed,2005-06-17,02264870,Ultra Headache Relief,2,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02264870,ULTRA HEADACHE RELIEF (acetaminophen 500 mg and caffeine 65 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9002060,acetaminophen 500 mg and caffeine 65 mg oral tablet,8000837,acetaminophen and caffeine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
75828,Marketed,2006-12-05,02272784,Vicks Dayquil Cold & Flu Multi-Symptom Relief Liquicaps,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Capsule,Oral,02272784,VICKS DAYQUIL COLD & FLU MULTI-SYMPTOM RELIEF LIQUICAPS (acetaminophen 325 mg and dextromethorphan hydrobromide 10 mg and phenylephrine hydrochloride 5 mg oral capsule) PROCTER & GAMBLE INC,Active,9004179,acetaminophen 325 mg and dextromethorphan hydrobromide 10 mg and phenylephrine hydrochloride 5 mg oral capsule,8001334,acetaminophen and dextromethorphan and phenylephrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
75829,Marketed,2025-04-09,02272792,Nyquil Cold & Flu Liquicaps,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Capsule,Oral,02272792,NYQUIL COLD & FLU LIQUICAPS (acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and doxylamine succinate 6.25 mg oral capsule) PROCTER & GAMBLE INC,Active,9004180,acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and doxylamine succinate 6.25 mg oral capsule,8001328,acetaminophen and dextromethorphan and doxylamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
75895,Marketed,2018-10-09,02273462,Benylin Extra Strength Cold & Sinus Day,2,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02273462,BENYLIN EXTRA STRENGTH COLD & SINUS DAY (acetaminophen 500 mg and phenylephrine hydrochloride 5 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9004190,acetaminophen 500 mg and phenylephrine hydrochloride 5 mg oral tablet,8000843,acetaminophen and phenylephrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
75929,Marketed,2006-06-11,02273810,Nyquil Sinus Liquicaps,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Capsule,Oral,02273810,NYQUIL SINUS LIQUICAPS (acetaminophen 325 mg and doxylamine succinate 6.25 mg and phenylephrine hydrochloride 5 mg oral capsule) PROCTER & GAMBLE INC,Active,9004169,acetaminophen 325 mg and doxylamine succinate 6.25 mg and phenylephrine hydrochloride 5 mg oral capsule,8000956,acetaminophen and doxylamine and phenylephrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
75930,Marketed,2006-06-11,02273829,Dayquil Sinus Liquicaps,2,N02BE51,"Acetaminophen, comb excl psycholeptics",Capsule,Oral,02273829,DAYQUIL SINUS LIQUICAPS (acetaminophen 325 mg and phenylephrine hydrochloride 5 mg oral capsule) PROCTER & GAMBLE INC,Active,9004170,acetaminophen 325 mg and phenylephrine hydrochloride 5 mg oral capsule,8000843,acetaminophen and phenylephrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
76086,Marketed,2022-02-24,02275201,Midol Complete,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02275201,MIDOL COMPLETE (acetaminophen 500 mg and caffeine 60 mg and pyrilamine maleate 15 mg oral tablet) BAYER INC,Active,9004175,acetaminophen 500 mg and caffeine 60 mg and pyrilamine maleate 15 mg oral tablet,8002005,acetaminophen and caffeine and pyrilamine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
76087,Marketed,2022-03-04,02275228,Midol PMS,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02275228,MIDOL PMS (acetaminophen 500 mg and pamabrom 25 mg and pyrilamine maleate 15 mg oral tablet) BAYER INC,Active,9003388,acetaminophen 500 mg and pamabrom 25 mg and pyrilamine maleate 15 mg oral tablet,8002006,acetaminophen and pamabrom and pyrilamine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
76167,Marketed,2006-07-24,02275996,Extra Strength Tylenol Flu Daytime,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02275996,EXTRA STRENGTH TYLENOL FLU DAYTIME (acetaminophen 500 mg and dextromethorphan hydrobromide 10 mg and phenylephrine hydrochloride 5 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9004189,acetaminophen 500 mg and dextromethorphan hydrobromide 10 mg and phenylephrine hydrochloride 5 mg oral tablet,8001334,acetaminophen and dextromethorphan and phenylephrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
76168,Marketed,2006-07-24,02276003,Extra Strength Tylenol Sinus Daytime,2,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02276003,EXTRA STRENGTH TYLENOL SINUS DAYTIME (acetaminophen 500 mg and phenylephrine hydrochloride 5 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9004190,acetaminophen 500 mg and phenylephrine hydrochloride 5 mg oral tablet,8000843,acetaminophen and phenylephrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
76170,Marketed,2006-07-24,02276038,Extra Strength Tylenol Sinus Nighttime,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02276038,EXTRA STRENGTH TYLENOL SINUS NIGHTTIME (acetaminophen 500 mg and chlorpheniramine maleate 2 mg and phenylephrine hydrochloride 5 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9002622,acetaminophen 500 mg and chlorpheniramine maleate 2 mg and phenylephrine hydrochloride 5 mg oral tablet,8001323,acetaminophen and chlorpheniramine and phenylephrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
76171,Marketed,2006-07-24,02276046,Extra Strength Tylenol Flu Nighttime,4,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02276046,EXTRA STRENGTH TYLENOL FLU NIGHTTIME (acetaminophen 500 mg and chlorpheniramine maleate 2 mg and dextromethorphan hydrobromide 10 mg and phenylephrine hydrochloride 5 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9004188,acetaminophen 500 mg and chlorpheniramine maleate 2 mg and dextromethorphan hydrobromide 10 mg and phenylephrine hydrochloride 5 mg oral tablet,8001321,acetaminophen and chlorpheniramine and dextromethorphan and phenylephrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
76185,Marketed,2006-07-24,02276186,Extra Strength Tylenol Cold Daytime,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02276186,EXTRA STRENGTH TYLENOL COLD DAYTIME (acetaminophen 500 mg and dextromethorphan hydrobromide 10 mg and phenylephrine hydrochloride 5 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9004189,acetaminophen 500 mg and dextromethorphan hydrobromide 10 mg and phenylephrine hydrochloride 5 mg oral tablet,8001334,acetaminophen and dextromethorphan and phenylephrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
76192,Marketed,2006-07-24,02276259,Extra Strength Tylenol Cold Nighttime,4,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02276259,EXTRA STRENGTH TYLENOL COLD NIGHTTIME (acetaminophen 500 mg and chlorpheniramine maleate 2 mg and dextromethorphan hydrobromide 10 mg and phenylephrine hydrochloride 5 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9004188,acetaminophen 500 mg and chlorpheniramine maleate 2 mg and dextromethorphan hydrobromide 10 mg and phenylephrine hydrochloride 5 mg oral tablet,8001321,acetaminophen and chlorpheniramine and dextromethorphan and phenylephrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
76469,Marketed,2006-08-31,02279150,Children's Tylenol Cold And Cough Nighttime,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Suspension,Oral,02279150,CHILDREN'S TYLENOL COLD AND COUGH NIGHTTIME (acetaminophen 160 mg per 5 mL and dextromethorphan hydrobromide 5 mg per 5 mL and diphenhydramine hydrochloride 6.25 mg per 5 mL oral suspension) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9004204,acetaminophen 160 mg per 5 mL and dextromethorphan hydrobromide 5 mg per 5 mL and diphenhydramine hydrochloride 6.25 mg per 5 mL oral suspension,8001325,acetaminophen and dextromethorphan and diphenhydramine,26643006,Oral,385024007,Oral suspension,,,,,,Non-Prescription Drugs
76530,Marketed,2024-03-06,02279703,Buckley's Complete,2,N02BE51,"Acetaminophen, comb excl psycholeptics",Solution,Oral,02279703,BUCKLEY'S COMPLETE (acetaminophen 325 mg per 5 mL and menthol 20 mg per 5 mL oral solution) HALEON CANADA ULC,Active,9013848,acetaminophen 325 mg per 5 mL and menthol 20 mg per 5 mL oral solution,8000962,acetaminophen and menthol,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
76681,Marketed,2007-04-01,02281147,Cold And Flu-In-One Extra Strength,4,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02281147,COLD AND FLU-IN-ONE EXTRA STRENGTH (acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9003127,acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001333,acetaminophen and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
77185,Marketed,2009-05-22,02286394,Total Cold And Flu,4,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02286394,TOTAL COLD AND FLU (acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9003127,acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001333,acetaminophen and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
77675,Marketed,2024-06-04,02291371,"Robitussin Total Cough, Cold & Flu Nighttime Extra Strength",4,N02BE51,"Acetaminophen, comb excl psycholeptics",Syrup,Oral,02291371,"ROBITUSSIN TOTAL COUGH, COLD & FLU NIGHTTIME EXTRA STRENGTH (acetaminophen 500 mg per 15 mL and chlorpheniramine maleate 2 mg per 15 mL and dextromethorphan hydrobromide 15 mg per 15 mL and pseudoephedrine hydrochloride 30 mg per 15 mL syrup) HALEON CANADA ULC",Active,9014351,acetaminophen 500 mg per 15 mL and chlorpheniramine maleate 2 mg per 15 mL and dextromethorphan hydrobromide 15 mg per 15 mL and pseudoephedrine hydrochloride 30 mg per 15 mL syrup,8001322,acetaminophen and chlorpheniramine and dextromethorphan and pseudoephedrine,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
78062,Marketed,2016-06-13,02295326,"Tylenol Complete Cold, Cough & Flu Plus Mucus Relief",4,N02BE51,"Acetaminophen, comb excl psycholeptics",Capsule,Oral,02295326,"TYLENOL COMPLETE COLD, COUGH & FLU PLUS MUCUS RELIEF (acetaminophen 250 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral capsule) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC",Active,9003805,acetaminophen 250 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral capsule,8001333,acetaminophen and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
78620,Marketed,2009-08-23,02300842,Dayquil Cold & Flu,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Liquid,Oral,02300842,DAYQUIL COLD & FLU (acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 20 mg per 30 mL and phenylephrine hydrochloride 10 mg per 30 mL oral solution) PROCTER & GAMBLE INC,Active,9004325,acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 20 mg per 30 mL and phenylephrine hydrochloride 10 mg per 30 mL oral solution,8001334,acetaminophen and dextromethorphan and phenylephrine,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
78913,Marketed,2008-03-11,02303833,Extra Strength Allergy Total,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02303833,EXTRA STRENGTH ALLERGY TOTAL (acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9003222,acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001336,acetaminophen and diphenhydramine and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
79084,Marketed,2009-05-22,02305305,Nighttime Total Cold And Flu,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02305305,NIGHTTIME TOTAL COLD AND FLU (acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9003222,acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001336,acetaminophen and diphenhydramine and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
79088,Marketed,2009-01-22,02305356,Cold & Sinus Liquid Fastgels,4,N02BE51,"Acetaminophen, comb excl psycholeptics",Capsule,Oral,02305356,COLD & SINUS LIQUID FASTGELS (acetaminophen 250 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9003805,acetaminophen 250 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral capsule,8001333,acetaminophen and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
79105,Marketed,2008-09-01,02305496,Benylin For Children All-In-One Cold & Fever,4,N02BE51,"Acetaminophen, comb excl psycholeptics",Suspension,Oral,02305496,BENYLIN FOR CHILDREN ALL-IN-ONE COLD & FEVER (acetaminophen 160 mg per 5 mL and chlorpheniramine maleate 1 mg per 5 mL and dextromethorphan hydrobromide 7.5 mg per 5 mL and pseudoephedrine hydrochloride 15 mg per 5 mL oral suspension) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9003129,acetaminophen 160 mg per 5 mL and chlorpheniramine maleate 1 mg per 5 mL and dextromethorphan hydrobromide 7.5 mg per 5 mL and pseudoephedrine hydrochloride 15 mg per 5 mL oral suspension,8001322,acetaminophen and chlorpheniramine and dextromethorphan and pseudoephedrine,26643006,Oral,385024007,Oral suspension,,,,,,Non-Prescription Drugs
79122,Marketed,2008-09-01,02305666,Benylin For Children All-In-One Cold & Fever Nightime,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Suspension,Oral,02305666,BENYLIN FOR CHILDREN ALL-IN-ONE COLD & FEVER NIGHTIME (acetaminophen 160 mg per 5 mL and dextromethorphan hydrobromide 5 mg per 5 mL and diphenhydramine hydrochloride 6.25 mg per 5 mL oral suspension) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9004204,acetaminophen 160 mg per 5 mL and dextromethorphan hydrobromide 5 mg per 5 mL and diphenhydramine hydrochloride 6.25 mg per 5 mL oral suspension,8001325,acetaminophen and dextromethorphan and diphenhydramine,26643006,Oral,385024007,Oral suspension,,,,,,Non-Prescription Drugs
79195,Marketed,2018-10-09,02306409,Benylin Extra Strength Cold & Sinus Night,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02306409,BENYLIN EXTRA STRENGTH COLD & SINUS NIGHT (acetaminophen 500 mg and chlorpheniramine maleate 2 mg and phenylephrine hydrochloride 5 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9002622,acetaminophen 500 mg and chlorpheniramine maleate 2 mg and phenylephrine hydrochloride 5 mg oral tablet,8001323,acetaminophen and chlorpheniramine and phenylephrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
79278,Marketed,2024-03-13,02307111,Buckleys Cold & Sinus,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Capsule,Oral,02307111,BUCKLEYS COLD & SINUS (acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral capsule) HALEON CANADA ULC,Active,9004003,acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral capsule,8001335,acetaminophen and dextromethorphan and pseudoephedrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
80682,Marketed,2019-11-01,02321432,"Benylin Extra Strength All-In-One Cough, Cold & Flu With Warming Sensation",4,N02BE51,"Acetaminophen, comb excl psycholeptics",Syrup,Oral,02321432,"BENYLIN EXTRA STRENGTH ALL-IN-ONE COUGH, COLD & FLU WITH WARMING SENSATION (acetaminophen 500 mg per 15 mL and dextromethorphan hydrobromide 15 mg per 15 mL and guaifenesin 100 mg per 15 mL and pseudoephedrine hydrochloride 30 mg per 15 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC",Active,9003812,acetaminophen 500 mg per 15 mL and dextromethorphan hydrobromide 15 mg per 15 mL and guaifenesin 100 mg per 15 mL and pseudoephedrine hydrochloride 30 mg per 15 mL syrup,8001333,acetaminophen and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
82084,Marketed,2024-03-22,02335239,Buckley's Complete Nighttime Softgels,4,N02BE51,"Acetaminophen, comb excl psycholeptics",Capsule,Oral,02335239,BUCKLEY'S COMPLETE NIGHTTIME SOFTGELS (acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral capsule) HALEON CANADA ULC,Active,9004002,acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral capsule,8001331,acetaminophen and dextromethorphan and doxylamine and pseudoephedrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
82152,Marketed,2024-03-13,02335948,Buckley's Complete + Mucus Relief,4,N02BE51,"Acetaminophen, comb excl psycholeptics",Capsule,Oral,02335948,BUCKLEY'S COMPLETE + MUCUS RELIEF (acetaminophen 250 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral capsule) HALEON CANADA ULC,Active,9003805,acetaminophen 250 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral capsule,8001333,acetaminophen and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
83004,Marketed,2019-01-10,02344548,Night Time Total Extra Strength,4,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02344548,NIGHT TIME TOTAL EXTRA STRENGTH (acetaminophen 650 mg per sachet and chlorpheniramine maleate 4 mg per sachet and dextromethorphan hydrobromide 20 mg per sachet and pseudoephedrine hydrochloride 60 mg per sachet powder for oral solution) CELLCHEM PHARMACEUTICALS INC.,Active,9013855,acetaminophen 650 mg per sachet and chlorpheniramine maleate 4 mg per sachet and dextromethorphan hydrobromide 20 mg per sachet and pseudoephedrine hydrochloride 60 mg per sachet powder for oral solution,8001322,acetaminophen and chlorpheniramine and dextromethorphan and pseudoephedrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,,Non-Prescription Drugs
83303,Marketed,2011-10-29,02347652,Benylin Extra Strength Mucus & Phlegm Plus Cold Relief,4,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02347652,BENYLIN EXTRA STRENGTH MUCUS & PHLEGM PLUS COLD RELIEF (acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9003127,acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001333,acetaminophen and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
83304,Marketed,2010-08-11,02347660,"Extra Strength Tylenol Complete Cold, Cough & Flu",4,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02347660,"EXTRA STRENGTH TYLENOL COMPLETE COLD, COUGH & FLU (acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC",Active,9003127,acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001333,acetaminophen and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
83343,Marketed,2010-08-11,02348071,Extra Strength Tylenol Cold & Sinus Daytime,2,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02348071,EXTRA STRENGTH TYLENOL COLD & SINUS DAYTIME (acetaminophen 500 mg and pseudoephedrine hydrochloride 30 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9002333,acetaminophen 500 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001338,acetaminophen and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
83344,Marketed,2010-08-11,02348098,Extra Strength Tylenol Cold & Sinus Nighttime,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02348098,EXTRA STRENGTH TYLENOL COLD & SINUS NIGHTTIME (acetaminophen 500 mg and chlorpheniramine maleate 2 mg and pseudoephedrine hydrochloride 30 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9002061,acetaminophen 500 mg and chlorpheniramine maleate 2 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001324,acetaminophen and chlorpheniramine and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
83481,Marketed,2016-06-01,02349523,Cold And Sinus Complete Liquid Gels,4,N02BE51,"Acetaminophen, comb excl psycholeptics",Capsule,Oral,02349523,COLD AND SINUS COMPLETE LIQUID GELS (acetaminophen 250 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9003805,acetaminophen 250 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral capsule,8001333,acetaminophen and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
84236,Marketed,2024-03-07,02357232,Buckley's Complete Plus Extra Strength Mucus Relief,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Syrup,Oral,02357232,BUCKLEY'S COMPLETE PLUS EXTRA STRENGTH MUCUS RELIEF (acetaminophen 325 mg per 5 mL and guaifenesin 200 mg per 5 mL and menthol 20 mg per 5 mL oral solution) HALEON CANADA ULC,Active,9013847,acetaminophen 325 mg per 5 mL and guaifenesin 200 mg per 5 mL and menthol 20 mg per 5 mL oral solution,8000994,acetaminophen and guaifenesin and menthol,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
85048,Marketed,2011-08-08,02365596,"Extra Strength Tylenol Complete Cold, Cough & Flu Plus Mucus Relief Nighttime",5,N02BE51,"Acetaminophen, comb excl psycholeptics",Syrup,Oral,02365596,"EXTRA STRENGTH TYLENOL COMPLETE COLD, COUGH & FLU PLUS MUCUS RELIEF NIGHTTIME (acetaminophen 1000 mg per 30 mL and chlorpheniramine maleate 4 mg per 30 mL and dextromethorphan hydrobromide 30 mg per 30 mL and guaifenesin 200 mg per 30 mL and pseudoephedrine hydrochloride 60 mg per 30 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC",Active,9004905,acetaminophen 1000 mg per 30 mL and chlorpheniramine maleate 4 mg per 30 mL and dextromethorphan hydrobromide 30 mg per 30 mL and guaifenesin 200 mg per 30 mL and pseudoephedrine hydrochloride 60 mg per 30 mL syrup,8001320,acetaminophen and chlorpheniramine and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
85049,Marketed,2011-08-08,02365618,Benylin Extra Strength Mucus & Phlegm Plus Cold Relief Night,5,N02BE51,"Acetaminophen, comb excl psycholeptics",Syrup,Oral,02365618,BENYLIN EXTRA STRENGTH MUCUS & PHLEGM PLUS COLD RELIEF NIGHT (acetaminophen 500 mg per 15 mL and chlorpheniramine maleate 2 mg per 15 mL and dextromethorphan hydrobromide 15 mg per 15 mL and guaifenesin 100 mg per 15 mL and pseudoephedrine hydrochloride 30 mg per 15 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9004090,acetaminophen 500 mg per 15 mL and chlorpheniramine maleate 2 mg per 15 mL and dextromethorphan hydrobromide 15 mg per 15 mL and guaifenesin 100 mg per 15 mL and pseudoephedrine hydrochloride 30 mg per 15 mL syrup,8001320,acetaminophen and chlorpheniramine and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
85062,Marketed,2011-08-08,02365731,"Extra Strength Tylenol Complete Cold, Cough & Flu Daytime",4,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02365731,"EXTRA STRENGTH TYLENOL COMPLETE COLD, COUGH & FLU DAYTIME (acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC",Active,9003127,acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001333,acetaminophen and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
85064,Marketed,2011-08-08,02365766,"Extra Strength Tylenol Complete Cold, Cough & Flu Nighttime",3,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02365766,"EXTRA STRENGTH TYLENOL COMPLETE COLD, COUGH & FLU NIGHTTIME (acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC",Active,9003222,acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001336,acetaminophen and diphenhydramine and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
85065,Marketed,2011-08-08,02365774,"Extra Strength Tylenol Complete Cold, Cough & Flu Plus Mucus Relief",4,N02BE51,"Acetaminophen, comb excl psycholeptics",Syrup,Oral,02365774,"EXTRA STRENGTH TYLENOL COMPLETE COLD, COUGH & FLU PLUS MUCUS RELIEF (acetaminophen 500 mg per 15 mL and dextromethorphan hydrobromide 15 mg per 15 mL and guaifenesin 100 mg per 15 mL and pseudoephedrine hydrochloride 30 mg per 15 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC",Active,9003812,acetaminophen 500 mg per 15 mL and dextromethorphan hydrobromide 15 mg per 15 mL and guaifenesin 100 mg per 15 mL and pseudoephedrine hydrochloride 30 mg per 15 mL syrup,8001333,acetaminophen and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
85106,Marketed,2011-08-08,02366207,Benylin Extra Strength Mucus & Phlegm Plus Cold Relief,4,N02BE51,"Acetaminophen, comb excl psycholeptics",Syrup,Oral,02366207,BENYLIN EXTRA STRENGTH MUCUS & PHLEGM PLUS COLD RELIEF (acetaminophen 500 mg per 15 mL and dextromethorphan hydrobromide 15 mg per 15 mL and guaifenesin 100 mg per 15 mL and pseudoephedrine hydrochloride 30 mg per 15 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9003812,acetaminophen 500 mg per 15 mL and dextromethorphan hydrobromide 15 mg per 15 mL and guaifenesin 100 mg per 15 mL and pseudoephedrine hydrochloride 30 mg per 15 mL syrup,8001333,acetaminophen and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
85347,Marketed,2012-04-25,02368528,Cold & Flu-In-One,7,N02BE51,"Acetaminophen, comb excl psycholeptics","Kit,Tablet",Oral,02368528,COLD & FLU-IN-ONE (acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet with acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9013254,acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet with acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001326,acetaminophen and dextromethorphan and diphenhydramine and guaifenesin and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
85348,Marketed,2012-08-14,02368536,Cold & Flu,7,N02BE51,"Acetaminophen, comb excl psycholeptics","Kit,Capsule",Oral,02368536,COLD & FLU (acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral capsule with acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9013028,acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral capsule with acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral capsule,8001331,acetaminophen and dextromethorphan and doxylamine and pseudoephedrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
85382,Marketed,2012-01-13,02368854,Sinus Medication Daytime Relief,2,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02368854,SINUS MEDICATION DAYTIME RELIEF (acetaminophen 500 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9002333,acetaminophen 500 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001338,acetaminophen and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
85947,Marketed,2024-10-08,02374277,Vicks Nyquil Cold & Flu,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Syrup,Oral,02374277,VICKS NYQUIL COLD & FLU (acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 30 mg per 30 mL and doxylamine succinate 12.5 mg per 30 mL oral solution) PROCTER & GAMBLE INC,Active,9005174,acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 30 mg per 30 mL and doxylamine succinate 12.5 mg per 30 mL oral solution,8001328,acetaminophen and dextromethorphan and doxylamine,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
86193,Marketed,2012-08-31,02376474,"Children's Tylenol Complete Cold, Cough & Fever",4,N02BE51,"Acetaminophen, comb excl psycholeptics",Suspension,Oral,02376474,"CHILDREN'S TYLENOL COMPLETE COLD, COUGH & FEVER (acetaminophen 160 mg per 5 mL and chlorpheniramine maleate 1 mg per 5 mL and dextromethorphan hydrobromide 7.5 mg per 5 mL and pseudoephedrine hydrochloride 15 mg per 5 mL oral suspension) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC",Active,9003129,acetaminophen 160 mg per 5 mL and chlorpheniramine maleate 1 mg per 5 mL and dextromethorphan hydrobromide 7.5 mg per 5 mL and pseudoephedrine hydrochloride 15 mg per 5 mL oral suspension,8001322,acetaminophen and chlorpheniramine and dextromethorphan and pseudoephedrine,26643006,Oral,385024007,Oral suspension,,,,,,Non-Prescription Drugs
86625,Marketed,2012-05-05,02380447,"Flu, Cough & Cold Complete",4,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02380447,"FLU, COUGH & COLD COMPLETE (acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC",Active,9003127,acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001333,acetaminophen and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
86911,Marketed,2012-08-28,02383357,Flu Relief,6,N02BE51,"Acetaminophen, comb excl psycholeptics","Kit,Tablet",Oral,02383357,FLU RELIEF (acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet with acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9013255,acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet with acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001327,acetaminophen and dextromethorphan and diphenhydramine and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
86912,Marketed,2012-12-10,02383365,Complete Liquid Capsules,8,N02BE51,"Acetaminophen, comb excl psycholeptics","Kit,Capsule",Oral,02383365,COMPLETE LIQUID CAPSULES (acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral capsule with acetaminophen 250 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9013253,acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral capsule with acetaminophen 250 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral capsule,8001329,acetaminophen and dextromethorphan and doxylamine and guaifenesin and pseudoephedrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
86913,Marketed,2012-06-28,02383373,Cold Medication,7,N02BE51,"Acetaminophen, comb excl psycholeptics","Tablet,Kit",Oral,02383373,COLD MEDICATION (acetaminophen 500 mg and chlorpheniramine maleate 2 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet with acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9013029,acetaminophen 500 mg and chlorpheniramine maleate 2 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet with acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001322,acetaminophen and chlorpheniramine and dextromethorphan and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
86935,Marketed,2012-05-05,02383608,Sinus Medication Day & Night,5,N02BE51,"Acetaminophen, comb excl psycholeptics","Kit,Tablet",Oral,02383608,SINUS MEDICATION DAY & NIGHT (acetaminophen 500 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral tablet with acetaminophen 500 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9012883,acetaminophen 500 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral tablet with acetaminophen 500 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001337,acetaminophen and doxylamine and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
86992,Marketed,2013-07-16,02384175,Total Cold & Flu Combo,7,N02BE51,"Acetaminophen, comb excl psycholeptics","Tablet,Kit",Oral,02384175,TOTAL COLD & FLU COMBO (acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet with acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9013254,acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet with acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001326,acetaminophen and dextromethorphan and diphenhydramine and guaifenesin and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
87089,Marketed,2014-07-15,02385252,Cold And Sinus Daytime Relief,2,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02385252,COLD AND SINUS DAYTIME RELIEF (acetaminophen 500 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9002333,acetaminophen 500 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001338,acetaminophen and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
87122,Marketed,2026-02-26,02385619,Extra Strength Tylenol Nighttime,2,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02385619,EXTRA STRENGTH TYLENOL NIGHTTIME (acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg oral tablet) KENVUE CANADA INC.,Active,9005112,acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg oral tablet,8001166,acetaminophen and diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
87328,Marketed,2012-07-03,02387697,"Flu, Cough & Cold Complete Day And Night",7,N02BE51,"Acetaminophen, comb excl psycholeptics","Tablet,Kit",Oral,02387697,"FLU, COUGH & COLD COMPLETE DAY AND NIGHT (acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet with acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC",Active,9013254,acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet with acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001326,acetaminophen and dextromethorphan and diphenhydramine and guaifenesin and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
87406,Marketed,2013-06-24,02388537,Cold And Sinus Relief Combo,5,N02BE51,"Acetaminophen, comb excl psycholeptics","Kit,Tablet",Oral,02388537,COLD AND SINUS RELIEF COMBO (acetaminophen 500 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral tablet with acetaminophen 500 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9012883,acetaminophen 500 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral tablet with acetaminophen 500 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001337,acetaminophen and doxylamine and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
88979,Marketed,2024-04-10,02404966,Neocitran Ultra Strength Total Flu,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02404966,NEOCITRAN ULTRA STRENGTH TOTAL FLU (acetaminophen 1000 mg per sachet and dextromethorphan hydrobromide 30 mg per sachet and pseudoephedrine hydrochloride 60 mg per sachet powder for oral solution) HALEON CANADA ULC,Active,9013252,acetaminophen 1000 mg per sachet and dextromethorphan hydrobromide 30 mg per sachet and pseudoephedrine hydrochloride 60 mg per sachet powder for oral solution,8001335,acetaminophen and dextromethorphan and pseudoephedrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,,Non-Prescription Drugs
88980,Marketed,2014-07-16,02404974,"Nighttime Flu, Cough & Cold Complete Relief Extra Strength",3,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02404974,"NIGHTTIME FLU, COUGH & COLD COMPLETE RELIEF EXTRA STRENGTH (acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC",Active,9003222,acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001336,acetaminophen and diphenhydramine and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
89422,Marketed,2014-08-15,02409534,Vicks Dayquil Complete Cold & Flu Liquid,4,N02BE51,"Acetaminophen, comb excl psycholeptics",Liquid,Oral,02409534,VICKS DAYQUIL COMPLETE COLD & FLU LIQUID (acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 20 mg per 30 mL and guaifenesin 400 mg per 30 mL and phenylephrine hydrochloride 10 mg per 30 mL oral solution) PROCTER & GAMBLE INC,Active,9013852,acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 20 mg per 30 mL and guaifenesin 400 mg per 30 mL and phenylephrine hydrochloride 10 mg per 30 mL oral solution,8001332,acetaminophen and dextromethorphan and guaifenesin and phenylephrine,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
89423,Marketed,2014-08-15,02409542,Vicks Nyquil Complete Cold & Flu,4,N02BE51,"Acetaminophen, comb excl psycholeptics",Liquid,Oral,02409542,VICKS NYQUIL COMPLETE COLD & FLU (acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 20 mg per 30 mL and doxylamine succinate 12.5 mg per 30 mL and phenylephrine hydrochloride 10 mg per 30 mL oral solution) PROCTER & GAMBLE INC,Active,9013755,acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 20 mg per 30 mL and doxylamine succinate 12.5 mg per 30 mL and phenylephrine hydrochloride 10 mg per 30 mL oral solution,8001330,acetaminophen and dextromethorphan and doxylamine and phenylephrine,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
90063,Marketed,2014-06-15,02416050,"Children's Tylenol Complete Cold, Cough & Fever Nighttime",3,N02BE51,"Acetaminophen, comb excl psycholeptics",Suspension,Oral,02416050,"CHILDREN'S TYLENOL COMPLETE COLD, COUGH & FEVER NIGHTTIME (acetaminophen 160 mg per 5 mL and dextromethorphan hydrobromide 5 mg per 5 mL and diphenhydramine hydrochloride 6.25 mg per 5 mL oral suspension) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC",Active,9004204,acetaminophen 160 mg per 5 mL and dextromethorphan hydrobromide 5 mg per 5 mL and diphenhydramine hydrochloride 6.25 mg per 5 mL oral suspension,8001325,acetaminophen and dextromethorphan and diphenhydramine,26643006,Oral,385024007,Oral suspension,,,,,,Non-Prescription Drugs
90552,Marketed,2018-12-17,02420937,Extra Strength Total Symptom Relief Sugar-Free,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02420937,EXTRA STRENGTH TOTAL SYMPTOM RELIEF SUGAR-FREE (acetaminophen 650 mg per sachet and diphenhydramine hydrochloride 25 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution) CELLCHEM PHARMACEUTICALS INC.,Active,9013856,acetaminophen 650 mg per sachet and diphenhydramine hydrochloride 25 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution,8001167,acetaminophen and diphenhydramine and phenylephrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,,Non-Prescription Drugs
91244,Marketed,2016-06-01,02427958,Cold & Sinus Liquid Capsules,7,N02BE51,"Acetaminophen, comb excl psycholeptics","Capsule,Kit",Oral,02427958,COLD & SINUS LIQUID CAPSULES (acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral capsule with acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9013028,acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral capsule with acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral capsule,8001331,acetaminophen and dextromethorphan and doxylamine and pseudoephedrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
91260,Marketed,2015-05-01,02428113,Complete Daytime Liquid Capsules,4,N02BE51,"Acetaminophen, comb excl psycholeptics",Capsule,Oral,02428113,COMPLETE DAYTIME LIQUID CAPSULES (acetaminophen 250 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9003805,acetaminophen 250 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral capsule,8001333,acetaminophen and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
91779,Marketed,2026-03-16,02433419,"Mucinex Multi-Action Congestion, Cold & Cough Solution",4,N02BE51,"Acetaminophen, comb excl psycholeptics",Solution,Oral,02433419,"MUCINEX MULTI-ACTION CONGESTION, COLD & COUGH SOLUTION (acetaminophen 650 mg per 20 mL and dextromethorphan hydrobromide 20 mg per 20 mL and guaifenesin 400 mg per 20 mL and phenylephrine hydrochloride 10 mg per 20 mL oral solution) RECKITT BENCKISER (CANADA) INC",Active,9014926,acetaminophen 650 mg per 20 mL and dextromethorphan hydrobromide 20 mg per 20 mL and guaifenesin 400 mg per 20 mL and phenylephrine hydrochloride 10 mg per 20 mL oral solution,8001332,acetaminophen and dextromethorphan and guaifenesin and phenylephrine,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
91781,Marketed,2026-03-03,02433435,"Mucinex Multi-Action Congestion, Cold & Cough",4,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02433435,"MUCINEX MULTI-ACTION CONGESTION, COLD & COUGH (acetaminophen 325 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 200 mg and phenylephrine hydrochloride 5 mg oral tablet) RECKITT BENCKISER (CANADA) INC",Active,9005568,acetaminophen 325 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 200 mg and phenylephrine hydrochloride 5 mg oral tablet,8001332,acetaminophen and dextromethorphan and guaifenesin and phenylephrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
91782,Marketed,2026-03-16,02433451,"Mucinex Multi-Action Congestion, Cold & Flu",3,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02433451,"MUCINEX MULTI-ACTION CONGESTION, COLD & FLU (acetaminophen 325 mg and guaifenesin 200 mg and phenylephrine hydrochloride 5 mg oral tablet) RECKITT BENCKISER (CANADA) INC",Active,9014416,acetaminophen 325 mg and guaifenesin 200 mg and phenylephrine hydrochloride 5 mg oral tablet,8001035,acetaminophen and guaifenesin and phenylephrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
96884,Marketed,2026-01-05,02478110,Extra Strength Tylenol Cold & Sinus Plus,2,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02478110,EXTRA STRENGTH TYLENOL COLD & SINUS PLUS (acetaminophen 500 mg and pseudoephedrine hydrochloride 60 mg oral tablet) KENVUE CANADA INC.,Active,9003509,acetaminophen 500 mg and pseudoephedrine hydrochloride 60 mg oral tablet,8001338,acetaminophen and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
97240,Marketed,2020-07-20,02481936,Dayquil Complete + Vicks Vapocool,4,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02481936,DAYQUIL COMPLETE + VICKS VAPOCOOL (acetaminophen 325 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 200 mg and phenylephrine hydrochloride 5 mg oral tablet) PROCTER & GAMBLE INC,Active,9005568,acetaminophen 325 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 200 mg and phenylephrine hydrochloride 5 mg oral tablet,8001332,acetaminophen and dextromethorphan and guaifenesin and phenylephrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
97241,Marketed,2020-07-20,02481928,Nyquil Complete + Vicks Vapocool,4,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02481928,NYQUIL COMPLETE + VICKS VAPOCOOL (acetaminophen 325 mg and dextromethorphan hydrobromide 10 mg and doxylamine succinate 6.25 mg and phenylephrine hydrochloride 5 mg oral tablet) PROCTER & GAMBLE INC,Active,9005739,acetaminophen 325 mg and dextromethorphan hydrobromide 10 mg and doxylamine succinate 6.25 mg and phenylephrine hydrochloride 5 mg oral tablet,8001330,acetaminophen and dextromethorphan and doxylamine and phenylephrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
97286,Marketed,2020-07-20,02482401,Nyquil Complete + Vicks Vapocool Cold & Flu Liquid,4,N02BE51,"Acetaminophen, comb excl psycholeptics",Liquid,Oral,02482401,NYQUIL COMPLETE + VICKS VAPOCOOL COLD & FLU LIQUID (acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 20 mg per 30 mL and doxylamine succinate 12.5 mg per 30 mL and phenylephrine hydrochloride 10 mg per 30 mL oral solution) PROCTER & GAMBLE INC,Active,9013755,acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 20 mg per 30 mL and doxylamine succinate 12.5 mg per 30 mL and phenylephrine hydrochloride 10 mg per 30 mL oral solution,8001330,acetaminophen and dextromethorphan and doxylamine and phenylephrine,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
97287,Marketed,2020-07-20,02482428,Dayquil Complete + Vicks Vapocool Cold & Flu Liquid,4,N02BE51,"Acetaminophen, comb excl psycholeptics",Solution,Oral,02482428,DAYQUIL COMPLETE + VICKS VAPOCOOL COLD & FLU LIQUID (acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 20 mg per 30 mL and guaifenesin 400 mg per 30 mL and phenylephrine hydrochloride 10 mg per 30 mL oral solution) PROCTER & GAMBLE INC,Active,9013852,acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 20 mg per 30 mL and guaifenesin 400 mg per 30 mL and phenylephrine hydrochloride 10 mg per 30 mL oral solution,8001332,acetaminophen and dextromethorphan and guaifenesin and phenylephrine,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
97379,Marketed,2019-07-08,02483351,Vicks Nyquil Complete Cold & Flu Liquicaps,4,N02BE51,"Acetaminophen, comb excl psycholeptics",Capsule,Oral,02483351,VICKS NYQUIL COMPLETE COLD & FLU LIQUICAPS (acetaminophen 325 mg and dextromethorphan hydrobromide 10 mg and doxylamine succinate 6.25 mg and phenylephrine hydrochloride 5 mg oral capsule) PROCTER & GAMBLE INC,Active,9013998,acetaminophen 325 mg and dextromethorphan hydrobromide 10 mg and doxylamine succinate 6.25 mg and phenylephrine hydrochloride 5 mg oral capsule,8001330,acetaminophen and dextromethorphan and doxylamine and phenylephrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
97380,Marketed,2019-07-08,02483378,Vicks Dayquil Complete Cold & Flu Liquicaps,4,N02BE51,"Acetaminophen, comb excl psycholeptics",Capsule,Oral,02483378,VICKS DAYQUIL COMPLETE COLD & FLU LIQUICAPS (acetaminophen 325 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 200 mg and phenylephrine hydrochloride 5 mg oral capsule) PROCTER & GAMBLE INC,Active,9013999,acetaminophen 325 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 200 mg and phenylephrine hydrochloride 5 mg oral capsule,8001332,acetaminophen and dextromethorphan and guaifenesin and phenylephrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
97739,Marketed,2020-01-14,02487233,Nighttime Cold,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02487233,NIGHTTIME COLD (acetaminophen 650 mg per sachet and diphenhydramine hydrochloride 25 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution) JUNO OTC INC,Active,9013856,acetaminophen 650 mg per sachet and diphenhydramine hydrochloride 25 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution,8001167,acetaminophen and diphenhydramine and phenylephrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,,Non-Prescription Drugs
97743,Marketed,2020-01-14,02487276,Daytime Cold,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02487276,DAYTIME COLD (acetaminophen 650 mg per sachet and dextromethorphan hydrobromide 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution) JUNO OTC INC,Active,9013259,acetaminophen 650 mg per sachet and dextromethorphan hydrobromide 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution,8001334,acetaminophen and dextromethorphan and phenylephrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,,Non-Prescription Drugs
97838,Marketed,2025-10-31,02488280,Combogesic,2,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02488280,COMBOGESIC (acetaminophen 325 mg and ibuprofen 97.5 mg oral tablet) AFT PHARMACEUTICALS (CAN) LIMITED,Active,9014417,acetaminophen 325 mg and ibuprofen 97.5 mg oral tablet,8002354,acetaminophen and ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
98285,Marketed,2021-05-19,02492857,Nighttime Cold & Flu Relief,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Solution,Oral,02492857,NIGHTTIME COLD & FLU RELIEF (acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 30 mg per 30 mL and doxylamine succinate 12.5 mg per 30 mL oral solution) JUNO OTC INC,Active,9005174,acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 30 mg per 30 mL and doxylamine succinate 12.5 mg per 30 mL oral solution,8001328,acetaminophen and dextromethorphan and doxylamine,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
98380,Marketed,2024-03-14,02493802,Buckley's Cold & Sinus 24 Hour Pack,7,N02BE51,"Acetaminophen, comb excl psycholeptics","Kit,Capsule",Oral,02493802,BUCKLEY'S COLD & SINUS 24 HOUR PACK (acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral tablet with acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet) HALEON CANADA ULC,Active,9014616,acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral tablet with acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001331,acetaminophen and dextromethorphan and doxylamine and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
98404,Marketed,2024-03-26,02494027,Buckley's Complete 24 Hour Pack,8,N02BE51,"Acetaminophen, comb excl psycholeptics","Capsule,Kit",Oral,02494027,BUCKLEY'S COMPLETE 24 HOUR PACK (acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral capsule with acetaminophen 250 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral capsule) HALEON CANADA ULC,Active,9013253,acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral capsule with acetaminophen 250 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral capsule,8001329,acetaminophen and dextromethorphan and doxylamine and guaifenesin and pseudoephedrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
99301,Marketed,2021-07-19,02503549,Nyquil Complete,4,N02BE51,"Acetaminophen, comb excl psycholeptics",Syrup,Oral,02503549,NYQUIL COMPLETE (acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 20 mg per 30 mL and doxylamine succinate 12.5 mg per 30 mL and phenylephrine hydrochloride 10 mg per 30 mL syrup) PROCTER & GAMBLE INC,Active,9014574,acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 20 mg per 30 mL and doxylamine succinate 12.5 mg per 30 mL and phenylephrine hydrochloride 10 mg per 30 mL syrup,8001330,acetaminophen and dextromethorphan and doxylamine and phenylephrine,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
99308,Marketed,2021-07-19,02503638,Dayquil Complete,4,N02BE51,"Acetaminophen, comb excl psycholeptics",Syrup,Oral,02503638,DAYQUIL COMPLETE (acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 20 mg per 30 mL and guaifenesin 400 mg per 30 mL and phenylephrine hydrochloride 10 mg per 30 mL syrup) PROCTER & GAMBLE INC,Active,9014575,acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 20 mg per 30 mL and guaifenesin 400 mg per 30 mL and phenylephrine hydrochloride 10 mg per 30 mL syrup,8001332,acetaminophen and dextromethorphan and guaifenesin and phenylephrine,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
99977,Marketed,2021-08-06,02510553,Coricidin Cold & Flu Liquid Gels,3,N02BE51,"Acetaminophen, comb excl psycholeptics",Capsule,Oral,02510553,CORICIDIN COLD & FLU LIQUID GELS (acetaminophen 325 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 200 mg oral capsule) BAYER INC,Active,9014591,acetaminophen 325 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 200 mg oral capsule,8002387,acetaminophen and dextromethorphan and guaifenesin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
102665,Marketed,2023-07-26,02537893,Acetazolamide For Injection USP,1,S01EC01,Acetazolamide,Powder for solution,Intravenous,02537893,ACETAZOLAMIDE FOR INJECTION USP (acetazolamide (acetazolamide sodium) 500 mg per vial powder for solution for injection) MARCAN PHARMACEUTICALS INC,Active,9004795,acetazolamide (acetazolamide sodium) 500 mg per vial powder for solution for injection,8001428,acetazolamide,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
4899,Marketed,2011-04-13,00545015,Acetazolamide,1,S01EC01,Acetazolamide,Tablet,Oral,00545015,ACETAZOLAMIDE (acetazolamide 250 mg oral tablet) AA PHARMA INC,Active,9001928,acetazolamide 250 mg oral tablet,8001428,acetazolamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
31096,Marketed,2011-10-05,02133326,Miochol-E,1,S01EB09,Acetylcholine,Powder for solution,Ophthalmic,02133326,MIOCHOL-E (acetylcholine chloride 20 mg per vial powder for solution for intraocular irrigation with diluent solution) BAUSCH & LOMB INC,Active,9013637,acetylcholine chloride 20 mg per vial powder for solution for intraocular irrigation with diluent solution,8001550,acetylcholine,372468001,Intraocular,421857007,Powder for eye solution,733026001,Vial (unit of presentation),,,,Prescription
102716,Marketed,2024-03-08,02538431,Acetylcysteine Solution USP,1,R05CB01,Acetylcysteine,Solution,"Intravenous,Oral,Inhalation",02538431,ACETYLCYSTEINE SOLUTION USP (acetylcysteine 200 mg per mL solution for injection 30 mL vial) STERIMAX INC,Active,9012773,acetylcysteine 200 mg per mL solution for injection 30 mL vial,8001429,acetylcysteine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
66965,Marketed,2022-05-10,02243098,Acetylcysteine Solution,1,R05CB01,Acetylcysteine,Solution,"Intravenous,Oral,Inhalation",77700646,ACETYLCYSTEINE SOLUTION (acetylcysteine 200 mg per mL solution for injection 10 mL vial) SANDOZ CANADA INCORPORATED,Active,9012772,acetylcysteine 200 mg per mL solution for injection 10 mL vial,8001429,acetylcysteine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
66965,Marketed,2022-05-10,02243098,Acetylcysteine Solution,1,R05CB01,Acetylcysteine,Solution,"Intravenous,Oral,Inhalation",77700647,ACETYLCYSTEINE SOLUTION (acetylcysteine 200 mg per mL solution for injection 30 mL vial) SANDOZ CANADA INCORPORATED,Active,9012773,acetylcysteine 200 mg per mL solution for injection 30 mL vial,8001429,acetylcysteine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
94721,Marketed,2023-06-13,02459906,Acetylcysteine Solution USP,1,R05CB01,Acetylcysteine,Solution,"Oral,Intravenous,Inhalation",77700650,ACETYLCYSTEINE SOLUTION USP (acetylcysteine 200 mg per mL solution for injection 10 mL vial) HIKMA CANADA LIMITED,Active,9012772,acetylcysteine 200 mg per mL solution for injection 10 mL vial,8001429,acetylcysteine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
94721,Marketed,2023-06-13,02459906,Acetylcysteine Solution USP,1,R05CB01,Acetylcysteine,Solution,"Oral,Intravenous,Inhalation",77700651,ACETYLCYSTEINE SOLUTION USP (acetylcysteine 200 mg per mL solution for injection 30 mL vial) HIKMA CANADA LIMITED,Active,9012773,acetylcysteine 200 mg per mL solution for injection 30 mL vial,8001429,acetylcysteine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
103995,Marketed,2026-05-08,02551217,Regular Strength ASA,1,N02BA01,Acetylsalicylic acid,Tablet,Oral,02551217,REGULAR STRENGTH ASA (acetylsalicylic acid 325 mg oral tablet) LNK INTERNATIONAL INC.,Active,9001640,acetylsalicylic acid 325 mg oral tablet,8000795,acetylsalicylic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
18349,Marketed,2007-07-20,02009013,Asaphen,1,N02BA01,Acetylsalicylic acid,Tablet (chewable),Oral,02009013,ASAPHEN (acetylsalicylic acid 80 mg chewable tablet) PHARMASCIENCE INC,Active,9002737,acetylsalicylic acid 80 mg chewable tablet,8000795,acetylsalicylic acid,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
19474,Marketed,2012-11-27,02150328,Aspirin Regular Strength,1,N02BA01,Acetylsalicylic acid,Tablet,Oral,02150328,ASPIRIN REGULAR STRENGTH (acetylsalicylic acid 325 mg oral tablet) BAYER INC,Active,9001640,acetylsalicylic acid 325 mg oral tablet,8000795,acetylsalicylic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
19475,Marketed,1995-12-31,02150336,Aspirin Extra Strength,1,N02BA01,Acetylsalicylic acid,Tablet,Oral,02150336,ASPIRIN EXTRA STRENGTH (acetylsalicylic acid 500 mg oral tablet) BAYER INC,Active,9002736,acetylsalicylic acid 500 mg oral tablet,8000795,acetylsalicylic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
19489,Marketed,2013-08-06,02150417,Aspirin Coated For Delayed Release Regular Strength,1,N02BA01,Acetylsalicylic acid,Tablet (delayed-release),Oral,02150417,ASPIRIN COATED FOR DELAYED RELEASE REGULAR STRENGTH (acetylsalicylic acid 325 mg gastro-resistant tablet) BAYER INC,Active,9001498,acetylsalicylic acid 325 mg gastro-resistant tablet,8000795,acetylsalicylic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
36346,Marketed,1999-12-01,02202352,Rivasa 80 mg Croquable - Tablets,1,N02BA01,Acetylsalicylic acid,Tablet (chewable),Oral,02202352,RIVASA 80MG CROQUABLE - TAB (acetylsalicylic acid 80 mg chewable tablet) LABORATOIRE RIVA INC.,Active,9002737,acetylsalicylic acid 80 mg chewable tablet,8000795,acetylsalicylic acid,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
36347,Marketed,2008-05-06,02202360,Rivasa Film-coated,1,N02BA01,Acetylsalicylic acid,Tablet,Oral,02202360,RIVASA FC (acetylsalicylic acid 80 mg oral tablet) LABORATOIRE RIVA INC.,Active,9003796,acetylsalicylic acid 80 mg oral tablet,8000795,acetylsalicylic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
4272,Marketed,2010-05-01,00530336,ASA 325 mg,1,N02BA01,Acetylsalicylic acid,Tablet,Oral,00530336,ASA 325MG (acetylsalicylic acid 325 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9001640,acetylsalicylic acid 325 mg oral tablet,8000795,acetylsalicylic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
61080,Marketed,2005-05-02,02237726,Aspirin 81 mg,1,B01AC06,Acetylsalicylic acid,Tablet (enteric-coated),Oral,02237726,ASPIRIN 81MG (acetylsalicylic acid 81 mg gastro-resistant tablet) BAYER INC,Active,9003295,acetylsalicylic acid 81 mg gastro-resistant tablet,8000795,acetylsalicylic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
61971,Marketed,2018-01-25,02238545,Asaphen E.C. 80 mg,1,N02BA01,Acetylsalicylic acid,Tablet (delayed-release),Oral,02238545,ASAPHEN E.C. 80 MG (acetylsalicylic acid 80 mg gastro-resistant tablet) PHARMASCIENCE INC,Active,9003337,acetylsalicylic acid 80 mg gastro-resistant tablet,8000795,acetylsalicylic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
65982,Marketed,2009-07-24,02242281,Entrophen,1,B01AC06,Acetylsalicylic acid,Tablet (delayed-release),Oral,02242281,ENTROPHEN (acetylsalicylic acid 81 mg gastro-resistant tablet) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9003295,acetylsalicylic acid 81 mg gastro-resistant tablet,8000795,acetylsalicylic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
67917,Marketed,2009-07-24,02243974,Entrophen Chewable,1,B01AC06,Acetylsalicylic acid,Tablet (chewable),Oral,02243974,ENTROPHEN CHEWABLE (acetylsalicylic acid 81 mg chewable tablet) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9003664,acetylsalicylic acid 81 mg chewable tablet,8000795,acetylsalicylic acid,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
68992,Marketed,2001-11-30,02244993,ASA 81 mg,1,B01AC06,Acetylsalicylic acid,Tablet (delayed-release),Oral,02244993,ASA 81 MG (acetylsalicylic acid 81 mg gastro-resistant tablet) PHARMASCIENCE INC,Active,9003295,acetylsalicylic acid 81 mg gastro-resistant tablet,8000795,acetylsalicylic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
75453,Marketed,2025-08-07,02269139,JAMP-ASA Chew,1,N02BA01,Acetylsalicylic acid,Tablet (chewable),Oral,02269139,JAMP-ASA CHEW (acetylsalicylic acid 80 mg chewable tablet) JAMP PHARMA CORPORATION,Active,9002737,acetylsalicylic acid 80 mg chewable tablet,8000795,acetylsalicylic acid,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
76929,Marketed,2009-09-21,02283700,Praxis ASA EC 81 mg Daily Low Dose,1,B01AC06,Acetylsalicylic acid,Tablet (delayed-release),Oral,02283700,PRAXIS ASA EC 81 MG DAILY LOW DOSE (acetylsalicylic acid 81 mg gastro-resistant tablet) PHARMASCIENCE INC,Active,9003295,acetylsalicylic acid 81 mg gastro-resistant tablet,8000795,acetylsalicylic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
76948,Marketed,2020-10-08,02283905,JAMP-ASA EC,1,N02BA01,Acetylsalicylic acid,Tablet (delayed-release),Oral,02283905,JAMP-ASA EC (acetylsalicylic acid 80 mg gastro-resistant tablet) JAMP PHARMA CORPORATION,Active,9003337,acetylsalicylic acid 80 mg gastro-resistant tablet,8000795,acetylsalicylic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
77528,Marketed,2007-05-22,02289970,Aspirin 81 mg Quick Chews,1,B01AC06,Acetylsalicylic acid,Tablet (chewable),Oral,02289970,ASPIRIN 81MG QUICK CHEWS (acetylsalicylic acid 81 mg chewable tablet) BAYER INC,Active,9003664,acetylsalicylic acid 81 mg chewable tablet,8000795,acetylsalicylic acid,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
79706,Marketed,2023-03-24,02311496,Pro-Aas EC - 80,1,N02BA01,Acetylsalicylic acid,Tablet (delayed-release),Oral,02311496,PRO-AAS EC - 80 (acetylsalicylic acid 80 mg gastro-resistant tablet) PRO DOC LIMITEE,Active,9003337,acetylsalicylic acid 80 mg gastro-resistant tablet,8000795,acetylsalicylic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
79707,Marketed,2025-09-17,02311518,Pro-Aas - 80 (Croquable),1,N02BA01,Acetylsalicylic acid,Tablet (chewable),Oral,02311518,PRO-AAS - 80 (CROQUABLE) (acetylsalicylic acid 80 mg chewable tablet) PRO DOC LIMITEE,Active,9002737,acetylsalicylic acid 80 mg chewable tablet,8000795,acetylsalicylic acid,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
84814,Marketed,2011-06-27,02363127,Enteric Coated Daily Low Dose ASA 81 mg,1,B01AC06,Acetylsalicylic acid,Tablet (delayed-release),Oral,02363127,ENTERIC COATED DAILY LOW DOSE ASA 81 MG (acetylsalicylic acid 81 mg gastro-resistant tablet) VITA HEALTH PRODUCTS INC,Active,9003295,acetylsalicylic acid 81 mg gastro-resistant tablet,8000795,acetylsalicylic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
85732,Marketed,2012-01-12,02372177,ASA 81 mg,1,B01AC06,Acetylsalicylic acid,Tablet (delayed-release),Oral,02372177,ASA 81 MG (acetylsalicylic acid 81 mg gastro-resistant tablet) VITA HEALTH PRODUCTS INC,Active,9003295,acetylsalicylic acid 81 mg gastro-resistant tablet,8000795,acetylsalicylic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
87994,Marketed,2013-05-01,02394790,ASA Daily Low Dose,1,B01AC06,Acetylsalicylic acid,Tablet (chewable),Oral,02394790,ASA DAILY LOW DOSE (acetylsalicylic acid 81 mg chewable tablet) PHARMASCIENCE INC,Active,9003664,acetylsalicylic acid 81 mg chewable tablet,8000795,acetylsalicylic acid,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
90486,Marketed,2014-03-20,02420279,Rivasa 81 mg EC,1,B01AC06,Acetylsalicylic acid,Tablet (delayed-release),Oral,02420279,RIVASA 81 MG EC (acetylsalicylic acid 81 mg gastro-resistant tablet) LABORATOIRE RIVA INC.,Active,9003295,acetylsalicylic acid 81 mg gastro-resistant tablet,8000795,acetylsalicylic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
91173,Marketed,2015-01-13,02427206,JAMP-ASA 81 mg EC,1,B01AC06,Acetylsalicylic acid,Tablet (enteric-coated),Oral,02427206,JAMP-ASA 81MG EC (acetylsalicylic acid 81 mg gastro-resistant tablet) VITA HEALTH PRODUCTS INC,Active,9003295,acetylsalicylic acid 81 mg gastro-resistant tablet,8000795,acetylsalicylic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
91435,Marketed,2015-02-11,02429950,M-ASA 80 mg Croquable,1,N02BA01,Acetylsalicylic acid,Tablet (chewable),Oral,02429950,M-ASA 80 MG CROQUABLE (acetylsalicylic acid 80 mg chewable tablet) MANTRA PHARMA INC,Active,9002737,acetylsalicylic acid 80 mg chewable tablet,8000795,acetylsalicylic acid,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
91745,Marketed,2015-05-06,02433044,ASA,1,B01AC06,Acetylsalicylic acid,Tablet (delayed-release),Oral,02433044,ASA (acetylsalicylic acid 81 mg gastro-resistant tablet) PHARMASCIENCE INC,Active,9003295,acetylsalicylic acid 81 mg gastro-resistant tablet,8000795,acetylsalicylic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
97547,Marketed,2019-02-01,02485222,Rivasa 80 mg EC,1,N02BA01,Acetylsalicylic acid,Tablet (delayed-release),Oral,02485222,RIVASA 80 MG EC (acetylsalicylic acid 80 mg gastro-resistant tablet) LABORATOIRE RIVA INC.,Active,9003337,acetylsalicylic acid 80 mg gastro-resistant tablet,8000795,acetylsalicylic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
104353,Marketed,2025-05-08,02554690,Apo-Butalbital-Acetylsalicylic Acid-Caffeine,3,N02BA71,"Acetylsalicylic acid, comb with psycholeptics",Capsule,Oral,02554690,APO-BUTALBITAL-ACETYLSALICYLIC ACID-CAFFEINE (acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg oral capsule) APOTEX INC,Active,9001668,acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg oral capsule,8000808,acetylsalicylic acid and butalbital and caffeine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,1.0,,Controlled Drugs (CDSA IV)
1233,Marketed,2020-01-21,00226327,Fiorinal,3,N02BA71,"Acetylsalicylic acid, comb with psycholeptics",Capsule,Oral,00226327,FIORINAL (acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg oral capsule) ARALEZ PHARMACEUTICALS CANADA INC,Active,9001668,acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg oral capsule,8000808,acetylsalicylic acid and butalbital and caffeine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,1.0,,Controlled Drugs (CDSA IV)
23671,Marketed,2015-11-23,01971409,Trianal Tablet,3,N02BA71,"Acetylsalicylic acid, comb with psycholeptics",Tablet,Oral,01971409,TRIANAL TABLET (acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg oral tablet) LABORATOIRE RIVA INC.,Active,9002002,acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg oral tablet,8000808,acetylsalicylic acid and butalbital and caffeine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Controlled Drugs (CDSA IV)
5779,Marketed,2017-11-09,00608211,Teva-Tecnal,3,N02BA71,"Acetylsalicylic acid, comb with psycholeptics",Tablet,Oral,00608211,TEVA-TECNAL (acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg oral tablet) TEVA CANADA LIMITED,Active,9002002,acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg oral tablet,8000808,acetylsalicylic acid and butalbital and caffeine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Controlled Drugs (CDSA IV)
6480,Marketed,2017-11-09,00608238,Teva-Tecnal,3,N02BA71,"Acetylsalicylic acid, comb with psycholeptics",Capsule,Oral,00608238,TEVA-TECNAL (acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg oral capsule) TEVA CANADA LIMITED,Active,9001668,acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg oral capsule,8000808,acetylsalicylic acid and butalbital and caffeine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,1.0,,Controlled Drugs (CDSA IV)
101144,Marketed,2022-02-25,02522306,Taro-Acyclovir,1,D06BB03,Aciclovir,Ointment,Topical,02522306,TARO-ACYCLOVIR (acyclovir 5 % cutaneous ointment) TARO PHARMACEUTICALS INC,Active,9000174,acyclovir 5 % cutaneous ointment,8000095,acyclovir,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Prescription
15525,Marketed,2020-12-22,02039524,Zovirax,1,D06BB03,Aciclovir,Cream,Topical,02039524,"ZOVIRAX (acyclovir 5 % cutaneous cream) BAUSCH HEALTH, CANADA INC.",Active,9000453,acyclovir 5 % cutaneous cream,8000095,acyclovir,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
4959,Marketed,2020-12-22,00569771,Zovirax,1,D06BB03,Aciclovir,Ointment,Topical,00569771,"ZOVIRAX (acyclovir 5 % cutaneous ointment) BAUSCH HEALTH, CANADA INC.",Active,9000174,acyclovir 5 % cutaneous ointment,8000095,acyclovir,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Prescription
96789,Marketed,2019-03-14,02477130,Apo-Acyclovir Ointment,1,D06BB03,Aciclovir,Ointment,Topical,02477130,APO-ACYCLOVIR OINTMENT (acyclovir 5 % cutaneous ointment) APOTEX INC,Active,9000174,acyclovir 5 % cutaneous ointment,8000095,acyclovir,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Prescription
88879,Marketed,2020-12-30,02404044,Xerese,2,D06BB53,"Aciclovir, combinations",Cream,Topical,02404044,"XERESE (acyclovir 5 % and hydrocortisone 1 % cutaneous cream) BAUSCH HEALTH, CANADA INC.",Active,9005293,acyclovir 5 % and hydrocortisone 1 % cutaneous cream,8001003,acyclovir and hydrocortisone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
16167,Marketed,2020-03-20,02070863,Soriatane,1,D05BB02,Acitretin,Capsule,Oral,02070863,SORIATANE (acitretin 25 mg oral capsule) ALLERGAN INC,Active,9012777,acitretin 25 mg oral capsule,8001430,acitretin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
16168,Marketed,2019-12-07,02070847,Soriatane,1,D05BB02,Acitretin,Capsule,Oral,02070847,SORIATANE (acitretin 10 mg oral capsule) ALLERGAN INC,Active,9012776,acitretin 10 mg oral capsule,8001430,acitretin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
95437,Marketed,2018-02-06,02466074,Taro-Acitretin,1,D05BB02,Acitretin,Capsule,Oral,02466074,TARO-ACITRETIN (acitretin 10 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9012776,acitretin 10 mg oral capsule,8001430,acitretin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
95438,Marketed,2018-03-26,02466082,Taro-Acitretin,1,D05BB02,Acitretin,Capsule,Oral,02466082,TARO-ACITRETIN (acitretin 25 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9012777,acitretin 25 mg oral capsule,8001430,acitretin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
95745,Marketed,2018-01-24,02468840,Mint-Acitretin,1,D05BB02,Acitretin,Capsule,Oral,02468840,MINT-ACITRETIN (acitretin 10 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9012776,acitretin 10 mg oral capsule,8001430,acitretin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
95746,Marketed,2018-01-24,02468859,Mint-Acitretin,1,D05BB02,Acitretin,Capsule,Oral,02468859,MINT-ACITRETIN (acitretin 25 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9012777,acitretin 25 mg oral capsule,8001430,acitretin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
89440,Marketed,2022-09-12,02409720,Tudorza Genuair,1,R03BB05,Aclidinium bromide,Powder (metered dose),Inhalation,02409720,TUDORZA GENUAIR (aclidinium bromide 400 mcg per actuation inhalation powder) COVIS PHARMA GMBH,Active,9005324,aclidinium bromide 400 mcg per actuation inhalation powder,8001070,aclidinium,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
101372,Marketed,2022-07-15,02524708,Mint-Acyclovir,1,J05AB01,Acyclovir,Tablet,Oral,02524708,MINT-ACYCLOVIR (acyclovir 200 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000500,acyclovir 200 mg oral tablet,8000095,acyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101373,Marketed,2022-07-15,02524716,Mint-Acyclovir,1,J05AB01,Acyclovir,Tablet,Oral,02524716,MINT-ACYCLOVIR (acyclovir 400 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000501,acyclovir 400 mg oral tablet,8000095,acyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101374,Marketed,2022-07-15,02524724,Mint-Acyclovir,1,J05AB01,Acyclovir,Tablet,Oral,02524724,MINT-ACYCLOVIR (acyclovir 800 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000502,acyclovir 800 mg oral tablet,8000095,acyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102038,Marketed,2024-08-06,02531224,Acyclovir Sodium Injection,1,J05AB01,Acyclovir,Solution,Intravenous,77701162,ACYCLOVIR SODIUM INJECTION (acyclovir (acyclovir sodium) 500 mg per 10 mL solution for injection vial) EUGIA PHARMA INC.,Active,9000800,acyclovir (acyclovir sodium) 500 mg per 10 mL solution for injection vial,8000095,acyclovir,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
102038,Marketed,2024-08-06,02531224,Acyclovir Sodium Injection,1,J05AB01,Acyclovir,Solution,Intravenous,77701163,ACYCLOVIR SODIUM INJECTION (acyclovir (acyclovir sodium) 1000 mg per 20 mL solution for injection vial) EUGIA PHARMA INC.,Active,9000799,acyclovir (acyclovir sodium) 1000 mg per 20 mL solution for injection vial,8000095,acyclovir,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
43018,Marketed,1997-08-22,02207621,Apo-Acyclovir,1,J05AB01,Acyclovir,Tablet,Oral,02207621,APO-ACYCLOVIR (acyclovir 200 mg oral tablet) APOTEX INC,Active,9000500,acyclovir 200 mg oral tablet,8000095,acyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
43019,Marketed,1997-08-22,02207648,Apo-Acyclovir,1,J05AB01,Acyclovir,Tablet,Oral,02207648,APO-ACYCLOVIR (acyclovir 400 mg oral tablet) APOTEX INC,Active,9000501,acyclovir 400 mg oral tablet,8000095,acyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
43020,Marketed,1997-08-22,02207656,Apo-Acyclovir,1,J05AB01,Acyclovir,Tablet,Oral,02207656,APO-ACYCLOVIR (acyclovir 800 mg oral tablet) APOTEX INC,Active,9000502,acyclovir 800 mg oral tablet,8000095,acyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
60218,Marketed,2015-09-30,02236926,Acyclovir Sodium Injection,1,J05AB01,Acyclovir,Solution,Intravenous,77700065,ACYCLOVIR SODIUM INJECTION (acyclovir (acyclovir sodium) 500 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9000800,acyclovir (acyclovir sodium) 500 mg per 10 mL solution for injection vial,8000095,acyclovir,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
60218,Marketed,2015-09-30,02236926,Acyclovir Sodium Injection,1,J05AB01,Acyclovir,Solution,Intravenous,77700066,ACYCLOVIR SODIUM INJECTION (acyclovir (acyclovir sodium) 1000 mg per 20 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9000799,acyclovir (acyclovir sodium) 1000 mg per 20 mL solution for injection vial,8000095,acyclovir,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
66188,Marketed,2009-12-04,02242463,Mylan-Acyclovir,1,J05AB01,Acyclovir,Tablet,Oral,02242463,MYLAN-ACYCLOVIR (acyclovir 400 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000501,acyclovir 400 mg oral tablet,8000095,acyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
66189,Marketed,2009-12-04,02242464,Mylan-Acyclovir,1,J05AB01,Acyclovir,Tablet,Oral,02242464,MYLAN-ACYCLOVIR (acyclovir 800 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000502,acyclovir 800 mg oral tablet,8000095,acyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
66607,Marketed,2010-02-12,02242784,Mylan-Acyclovir,1,J05AB01,Acyclovir,Tablet,Oral,02242784,MYLAN-ACYCLOVIR (acyclovir 200 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000500,acyclovir 200 mg oral tablet,8000095,acyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77144,Marketed,2011-01-25,02285959,Teva-Acyclovir,1,J05AB01,Acyclovir,Tablet,Oral,02285959,TEVA-ACYCLOVIR (acyclovir 200 mg oral tablet) TEVA CANADA LIMITED,Active,9000500,acyclovir 200 mg oral tablet,8000095,acyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77145,Marketed,2011-01-25,02285967,Teva-Acyclovir,1,J05AB01,Acyclovir,Tablet,Oral,02285967,TEVA-ACYCLOVIR (acyclovir 400 mg oral tablet) TEVA CANADA LIMITED,Active,9000501,acyclovir 400 mg oral tablet,8000095,acyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77146,Marketed,2011-01-25,02285975,Teva-Acyclovir,1,J05AB01,Acyclovir,Tablet,Oral,02285975,TEVA-ACYCLOVIR (acyclovir 800 mg oral tablet) TEVA CANADA LIMITED,Active,9000502,acyclovir 800 mg oral tablet,8000095,acyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98455,Marketed,2020-10-21,02494558,Acyclovir Sodium Injection,1,J05AB01,Acyclovir,Solution,Intravenous,77701023,ACYCLOVIR SODIUM INJECTION (acyclovir (acyclovir sodium) 1000 mg per 20 mL solution for injection vial) AURO PHARMA INC,Active,9000799,acyclovir (acyclovir sodium) 1000 mg per 20 mL solution for injection vial,8000095,acyclovir,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
98455,Marketed,2020-10-21,02494558,Acyclovir Sodium Injection,1,J05AB01,Acyclovir,Solution,Intravenous,77701024,ACYCLOVIR SODIUM INJECTION (acyclovir (acyclovir sodium) 500 mg per 10 mL solution for injection vial) AURO PHARMA INC,Active,9000800,acyclovir (acyclovir sodium) 500 mg per 10 mL solution for injection vial,8000095,acyclovir,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
100029,Marketed,2022-02-24,02511045,Abrilada,1,L04AB04,Adalimumab,Solution,Subcutaneous,02511045,ABRILADA (adalimumab 40 mg per 0.8 mL solution for injection pen) PFIZER CANADA ULC,Active,9014442,adalimumab 40 mg per 0.8 mL solution for injection pen,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,1.0,Prescription
100029,Marketed,2022-02-24,02511045,Abrilada,1,L04AB04,Adalimumab,Solution,Subcutaneous,02511045,ABRILADA (adalimumab 40 mg per 0.8 mL solution for injection pen) PFIZER CANADA ULC,Active,9014442,adalimumab 40 mg per 0.8 mL solution for injection pen,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,1.0,Schedule D
100030,Marketed,2022-03-07,02511053,Abrilada,1,L04AB04,Adalimumab,Solution,Subcutaneous,02511053,ABRILADA (adalimumab 40 mg per 0.8 mL solution for injection syringe) PFIZER CANADA ULC,Active,9014443,adalimumab 40 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
100030,Marketed,2022-03-07,02511053,Abrilada,1,L04AB04,Adalimumab,Solution,Subcutaneous,02511053,ABRILADA (adalimumab 40 mg per 0.8 mL solution for injection syringe) PFIZER CANADA ULC,Active,9014443,adalimumab 40 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
100031,Marketed,2023-03-13,02511061,Abrilada,1,L04AB04,Adalimumab,Solution,Subcutaneous,02511061,ABRILADA (adalimumab 20 mg per 0.4 mL solution for injection syringe) PFIZER CANADA ULC,Active,9014471,adalimumab 20 mg per 0.4 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
100031,Marketed,2023-03-13,02511061,Abrilada,1,L04AB04,Adalimumab,Solution,Subcutaneous,02511061,ABRILADA (adalimumab 20 mg per 0.4 mL solution for injection syringe) PFIZER CANADA ULC,Active,9014471,adalimumab 20 mg per 0.4 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
101282,Marketed,2024-06-21,02523760,Yuflyma,1,L04AB04,Adalimumab,Solution,Subcutaneous,02523760,YUFLYMA (adalimumab 40 mg per 0.4 mL solution for injection syringe) CELLTRION INC.,Active,9012596,adalimumab 40 mg per 0.4 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
101282,Marketed,2024-06-21,02523760,Yuflyma,1,L04AB04,Adalimumab,Solution,Subcutaneous,02523760,YUFLYMA (adalimumab 40 mg per 0.4 mL solution for injection syringe) CELLTRION INC.,Active,9012596,adalimumab 40 mg per 0.4 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
101284,Marketed,2024-06-21,02523779,Yuflyma,1,L04AB04,Adalimumab,Solution,Subcutaneous,02523779,YUFLYMA (adalimumab 40 mg per 0.4 mL solution for injection pen) CELLTRION INC.,Active,9012595,adalimumab 40 mg per 0.4 mL solution for injection pen,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
101284,Marketed,2024-06-21,02523779,Yuflyma,1,L04AB04,Adalimumab,Solution,Subcutaneous,02523779,YUFLYMA (adalimumab 40 mg per 0.4 mL solution for injection pen) CELLTRION INC.,Active,9012595,adalimumab 40 mg per 0.4 mL solution for injection pen,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
101299,Marketed,2022-05-19,02523949,Simlandi,1,L04AB04,Adalimumab,Solution,Subcutaneous,02523949,SIMLANDI PREFILLED SYRINGE (adalimumab 40 mg per 0.4 mL solution for injection syringe) JAMP PHARMA CORPORATION,Active,9012596,adalimumab 40 mg per 0.4 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
101299,Marketed,2022-05-19,02523949,Simlandi,1,L04AB04,Adalimumab,Solution,Subcutaneous,02523949,SIMLANDI PREFILLED SYRINGE (adalimumab 40 mg per 0.4 mL solution for injection syringe) JAMP PHARMA CORPORATION,Active,9012596,adalimumab 40 mg per 0.4 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
101300,Marketed,2022-04-13,02523957,Simlandi,1,L04AB04,Adalimumab,Solution,Subcutaneous,02523957,SIMLANDI AUTO-INJECTOR (adalimumab 40 mg per 0.4 mL solution for injection syringe) JAMP PHARMA CORPORATION,Active,9012596,adalimumab 40 mg per 0.4 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
101300,Marketed,2022-04-13,02523957,Simlandi,1,L04AB04,Adalimumab,Solution,Subcutaneous,02523957,SIMLANDI AUTO-INJECTOR (adalimumab 40 mg per 0.4 mL solution for injection syringe) JAMP PHARMA CORPORATION,Active,9012596,adalimumab 40 mg per 0.4 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
101301,Marketed,2022-05-19,02523965,Simlandi,1,L04AB04,Adalimumab,Solution,Subcutaneous,02523965,SIMLANDI (adalimumab 80 mg per 0.8 mL solution for injection syringe) JAMP PHARMA CORPORATION,Active,9014690,adalimumab 80 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
101301,Marketed,2022-05-19,02523965,Simlandi,1,L04AB04,Adalimumab,Solution,Subcutaneous,02523965,SIMLANDI (adalimumab 80 mg per 0.8 mL solution for injection syringe) JAMP PHARMA CORPORATION,Active,9014690,adalimumab 80 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
102246,Marketed,2023-10-25,02533480,Hadlima Pushtouch,1,L04AB04,Adalimumab,Solution,Subcutaneous,02533480,"HADLIMA PUSHTOUCH (adalimumab 40 mg per 0.4 mL solution for injection syringe) SAMSUNG BIOEPIS CO., LTD",Active,9012596,adalimumab 40 mg per 0.4 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
102246,Marketed,2023-10-25,02533480,Hadlima Pushtouch,1,L04AB04,Adalimumab,Solution,Subcutaneous,02533480,"HADLIMA PUSHTOUCH (adalimumab 40 mg per 0.4 mL solution for injection syringe) SAMSUNG BIOEPIS CO., LTD",Active,9012596,adalimumab 40 mg per 0.4 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
102247,Marketed,2023-10-25,02533472,Hadlima,1,L04AB04,Adalimumab,Solution,Subcutaneous,02533472,"HADLIMA (adalimumab 40 mg per 0.4 mL solution for injection syringe) SAMSUNG BIOEPIS CO., LTD",Active,9012596,adalimumab 40 mg per 0.4 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
102247,Marketed,2023-10-25,02533472,Hadlima,1,L04AB04,Adalimumab,Solution,Subcutaneous,02533472,"HADLIMA (adalimumab 40 mg per 0.4 mL solution for injection syringe) SAMSUNG BIOEPIS CO., LTD",Active,9012596,adalimumab 40 mg per 0.4 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
102395,Marketed,2024-06-21,02535076,Yuflyma,1,L04AB04,Adalimumab,Solution,Subcutaneous,02535076,YUFLYMA (adalimumab 80 mg per 0.8 mL solution for injection syringe) CELLTRION INC.,Active,9014690,adalimumab 80 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
102395,Marketed,2024-06-21,02535076,Yuflyma,1,L04AB04,Adalimumab,Solution,Subcutaneous,02535076,YUFLYMA (adalimumab 80 mg per 0.8 mL solution for injection syringe) CELLTRION INC.,Active,9014690,adalimumab 80 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
102396,Marketed,2024-06-21,02535084,Yuflyma,1,L04AB04,Adalimumab,Solution,Subcutaneous,02535084,YUFLYMA (adalimumab 80 mg per 0.8 mL solution for injection pen) CELLTRION INC.,Active,9014910,adalimumab 80 mg per 0.8 mL solution for injection pen,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,1.0,Schedule D
102396,Marketed,2024-06-21,02535084,Yuflyma,1,L04AB04,Adalimumab,Solution,Subcutaneous,02535084,YUFLYMA (adalimumab 80 mg per 0.8 mL solution for injection pen) CELLTRION INC.,Active,9014910,adalimumab 80 mg per 0.8 mL solution for injection pen,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,1.0,Prescription
103089,Marketed,2024-04-05,02542315,Hyrimoz,1,L04AB04,Adalimumab,Solution,Subcutaneous,02542315,HYRIMOZ (adalimumab 20 mg per 0.2 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9014352,adalimumab 20 mg per 0.2 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
103089,Marketed,2024-04-05,02542315,Hyrimoz,1,L04AB04,Adalimumab,Solution,Subcutaneous,02542315,HYRIMOZ (adalimumab 20 mg per 0.2 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9014352,adalimumab 20 mg per 0.2 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
103090,Marketed,2024-04-10,02542323,Hyrimoz,1,L04AB04,Adalimumab,Solution,Subcutaneous,02542323,HYRIMOZ (adalimumab 40 mg per 0.4 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9012596,adalimumab 40 mg per 0.4 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
103090,Marketed,2024-04-10,02542323,Hyrimoz,1,L04AB04,Adalimumab,Solution,Subcutaneous,02542323,HYRIMOZ (adalimumab 40 mg per 0.4 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9012596,adalimumab 40 mg per 0.4 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
103091,Marketed,2024-04-17,02542331,Hyrimoz,1,L04AB04,Adalimumab,Solution,Subcutaneous,02542331,HYRIMOZ (adalimumab 40 mg per 0.4 mL solution for injection pen) SANDOZ CANADA INCORPORATED,Active,9012595,adalimumab 40 mg per 0.4 mL solution for injection pen,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
103091,Marketed,2024-04-17,02542331,Hyrimoz,1,L04AB04,Adalimumab,Solution,Subcutaneous,02542331,HYRIMOZ (adalimumab 40 mg per 0.4 mL solution for injection pen) SANDOZ CANADA INCORPORATED,Active,9012595,adalimumab 40 mg per 0.4 mL solution for injection pen,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
103092,Marketed,2024-05-15,02542358,Hyrimoz,1,L04AB04,Adalimumab,Solution,Subcutaneous,02542358,HYRIMOZ (adalimumab 80 mg per 0.8 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9014690,adalimumab 80 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
103092,Marketed,2024-05-15,02542358,Hyrimoz,1,L04AB04,Adalimumab,Solution,Subcutaneous,02542358,HYRIMOZ (adalimumab 80 mg per 0.8 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9014690,adalimumab 80 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
103093,Marketed,2024-04-17,02542366,Hyrimoz,1,L04AB04,Adalimumab,Solution,Subcutaneous,02542366,HYRIMOZ (adalimumab 80 mg per 0.8 mL solution for injection pen) SANDOZ CANADA INCORPORATED,Active,9014910,adalimumab 80 mg per 0.8 mL solution for injection pen,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,1.0,Prescription
103093,Marketed,2024-04-17,02542366,Hyrimoz,1,L04AB04,Adalimumab,Solution,Subcutaneous,02542366,HYRIMOZ (adalimumab 80 mg per 0.8 mL solution for injection pen) SANDOZ CANADA INCORPORATED,Active,9014910,adalimumab 80 mg per 0.8 mL solution for injection pen,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,1.0,Schedule D
74379,Marketed,2012-11-23,02258595,Humira,1,L04AB04,Adalimumab,Solution,Subcutaneous,77701099,HUMIRA (adalimumab 40 mg per 0.8 mL solution for injection pen) ABBVIE CORPORATION,Active,9014442,adalimumab 40 mg per 0.8 mL solution for injection pen,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
74379,Marketed,2012-11-23,02258595,Humira,1,L04AB04,Adalimumab,Solution,Subcutaneous,77701100,HUMIRA (adalimumab 40 mg per 0.8 mL solution for injection syringe) ABBVIE CORPORATION,Active,9014443,adalimumab 40 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
74379,Marketed,2012-11-23,02258595,Humira,1,L04AB04,Adalimumab,Solution,Subcutaneous,77701101,HUMIRA (adalimumab 40 mg per 0.8 mL solution for injection vial) ABBVIE CORPORATION,Active,9012597,adalimumab 40 mg per 0.8 mL solution for injection vial,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
74379,Marketed,2012-11-23,02258595,Humira,1,L04AB04,Adalimumab,Solution,Subcutaneous,77701099,HUMIRA (adalimumab 40 mg per 0.8 mL solution for injection pen) ABBVIE CORPORATION,Active,9014442,adalimumab 40 mg per 0.8 mL solution for injection pen,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Prescription
74379,Marketed,2012-11-23,02258595,Humira,1,L04AB04,Adalimumab,Solution,Subcutaneous,77701100,HUMIRA (adalimumab 40 mg per 0.8 mL solution for injection syringe) ABBVIE CORPORATION,Active,9014443,adalimumab 40 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
74379,Marketed,2012-11-23,02258595,Humira,1,L04AB04,Adalimumab,Solution,Subcutaneous,77701101,HUMIRA (adalimumab 40 mg per 0.8 mL solution for injection vial) ABBVIE CORPORATION,Active,9012597,adalimumab 40 mg per 0.8 mL solution for injection vial,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
94543,Marketed,2024-04-23,02458357,Humira,1,L04AB04,Adalimumab,Solution,Subcutaneous,02458357,HUMIRA (adalimumab 40 mg per 0.4 mL solution for injection pen) ABBVIE CORPORATION,Active,9012595,adalimumab 40 mg per 0.4 mL solution for injection pen,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
94543,Marketed,2024-04-23,02458357,Humira,1,L04AB04,Adalimumab,Solution,Subcutaneous,02458357,HUMIRA (adalimumab 40 mg per 0.4 mL solution for injection pen) ABBVIE CORPORATION,Active,9012595,adalimumab 40 mg per 0.4 mL solution for injection pen,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
94546,Marketed,2024-04-23,02458349,Humira,1,L04AB04,Adalimumab,Solution,Subcutaneous,02458349,HUMIRA (adalimumab 40 mg per 0.4 mL solution for injection syringe) ABBVIE CORPORATION,Active,9012596,adalimumab 40 mg per 0.4 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
94546,Marketed,2024-04-23,02458349,Humira,1,L04AB04,Adalimumab,Solution,Subcutaneous,02458349,HUMIRA (adalimumab 40 mg per 0.4 mL solution for injection syringe) ABBVIE CORPORATION,Active,9012596,adalimumab 40 mg per 0.4 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
94649,Marketed,2021-02-19,02459299,Amgevita,1,L04AB04,Adalimumab,Solution,Subcutaneous,02459299,AMGEVITA SINGLE-USE PREFILLED SYRINGE (40MG/0.8ML) (adalimumab 40 mg per 0.8 mL solution for injection syringe) AMGEN CANADA INC,Active,9014443,adalimumab 40 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
94649,Marketed,2021-02-19,02459299,Amgevita,1,L04AB04,Adalimumab,Solution,Subcutaneous,02459299,AMGEVITA SINGLE-USE PREFILLED SYRINGE (40MG/0.8ML) (adalimumab 40 mg per 0.8 mL solution for injection syringe) AMGEN CANADA INC,Active,9014443,adalimumab 40 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
94650,Marketed,2021-02-19,02459302,Amgevita,1,L04AB04,Adalimumab,Solution,Subcutaneous,02459302,AMGEVITA SINGLE-USE PREFILLED AUTOINJECTOR (40MG/0.8ML) (adalimumab 40 mg per 0.8 mL solution for injection syringe) AMGEN CANADA INC,Active,9014443,adalimumab 40 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
94650,Marketed,2021-02-19,02459302,Amgevita,1,L04AB04,Adalimumab,Solution,Subcutaneous,02459302,AMGEVITA SINGLE-USE PREFILLED AUTOINJECTOR (40MG/0.8ML) (adalimumab 40 mg per 0.8 mL solution for injection syringe) AMGEN CANADA INC,Active,9014443,adalimumab 40 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
94651,Marketed,2021-02-19,02459310,Amgevita,1,L04AB04,Adalimumab,Solution,Subcutaneous,02459310,AMGEVITA (adalimumab 20 mg per 0.4 mL solution for injection syringe) AMGEN CANADA INC,Active,9014471,adalimumab 20 mg per 0.4 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
94651,Marketed,2021-02-19,02459310,Amgevita,1,L04AB04,Adalimumab,Solution,Subcutaneous,02459310,AMGEVITA (adalimumab 20 mg per 0.4 mL solution for injection syringe) AMGEN CANADA INC,Active,9014471,adalimumab 20 mg per 0.4 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
96243,Marketed,2021-02-19,02473097,Hadlima,1,L04AB04,Adalimumab,Solution,Subcutaneous,02473097,"HADLIMA (adalimumab 40 mg per 0.8 mL solution for injection syringe) SAMSUNG BIOEPIS CO., LTD",Active,9014443,adalimumab 40 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
96243,Marketed,2021-02-19,02473097,Hadlima,1,L04AB04,Adalimumab,Solution,Subcutaneous,02473097,"HADLIMA (adalimumab 40 mg per 0.8 mL solution for injection syringe) SAMSUNG BIOEPIS CO., LTD",Active,9014443,adalimumab 40 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
96244,Marketed,2021-02-19,02473100,Hadlima Pushtouch,1,L04AB04,Adalimumab,Solution,Subcutaneous,02473100,"HADLIMA PUSHTOUCH (adalimumab 40 mg per 0.8 mL solution for injection syringe) SAMSUNG BIOEPIS CO., LTD",Active,9014443,adalimumab 40 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
96244,Marketed,2021-02-19,02473100,Hadlima Pushtouch,1,L04AB04,Adalimumab,Solution,Subcutaneous,02473100,"HADLIMA PUSHTOUCH (adalimumab 40 mg per 0.8 mL solution for injection syringe) SAMSUNG BIOEPIS CO., LTD",Active,9014443,adalimumab 40 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
96431,Marketed,2020-08-18,02474263,Humira,1,L04AB04,Adalimumab,Solution,Subcutaneous,02474263,HUMIRA (adalimumab 20 mg per 0.2 mL solution for injection syringe) ABBVIE CORPORATION,Active,9014352,adalimumab 20 mg per 0.2 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
96431,Marketed,2020-08-18,02474263,Humira,1,L04AB04,Adalimumab,Solution,Subcutaneous,02474263,HUMIRA (adalimumab 20 mg per 0.2 mL solution for injection syringe) ABBVIE CORPORATION,Active,9014352,adalimumab 20 mg per 0.2 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
98214,Marketed,2021-02-15,02492156,Hyrimoz,1,L04AB04,Adalimumab,Solution,Subcutaneous,02492156,HYRIMOZ (adalimumab 40 mg per 0.8 mL solution for injection pen) SANDOZ CANADA INCORPORATED,Active,9014442,adalimumab 40 mg per 0.8 mL solution for injection pen,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,1.0,Prescription
98214,Marketed,2021-02-15,02492156,Hyrimoz,1,L04AB04,Adalimumab,Solution,Subcutaneous,02492156,HYRIMOZ (adalimumab 40 mg per 0.8 mL solution for injection pen) SANDOZ CANADA INCORPORATED,Active,9014442,adalimumab 40 mg per 0.8 mL solution for injection pen,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,1.0,Schedule D
98215,Marketed,2021-02-15,02492164,Hyrimoz,1,L04AB04,Adalimumab,Solution,Subcutaneous,02492164,HYRIMOZ (adalimumab 40 mg per 0.8 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9014443,adalimumab 40 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
98215,Marketed,2021-02-15,02492164,Hyrimoz,1,L04AB04,Adalimumab,Solution,Subcutaneous,02492164,HYRIMOZ (adalimumab 40 mg per 0.8 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9014443,adalimumab 40 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
99196,Marketed,2024-06-05,02502380,Hulio,1,L04AB04,Adalimumab,Solution,Subcutaneous,02502380,HULIO (adalimumab 20 mg per 0.4 mL solution for injection syringe) BIOSIMILAR COLLABORATIONS IRELAND LIMITED,Active,9014471,adalimumab 20 mg per 0.4 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
99196,Marketed,2024-06-05,02502380,Hulio,1,L04AB04,Adalimumab,Solution,Subcutaneous,02502380,HULIO (adalimumab 20 mg per 0.4 mL solution for injection syringe) BIOSIMILAR COLLABORATIONS IRELAND LIMITED,Active,9014471,adalimumab 20 mg per 0.4 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
99197,Marketed,2024-11-29,02502399,Hulio,1,L04AB04,Adalimumab,Solution,Subcutaneous,02502399,HULIO (adalimumab 40 mg per 0.8 mL solution for injection syringe) BIOSIMILAR COLLABORATIONS IRELAND LIMITED,Active,9014443,adalimumab 40 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
99197,Marketed,2024-11-29,02502399,Hulio,1,L04AB04,Adalimumab,Solution,Subcutaneous,02502399,HULIO (adalimumab 40 mg per 0.8 mL solution for injection syringe) BIOSIMILAR COLLABORATIONS IRELAND LIMITED,Active,9014443,adalimumab 40 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
99198,Marketed,2024-03-20,02502402,Hulio,1,L04AB04,Adalimumab,Solution,Subcutaneous,02502402,HULIO (adalimumab 40 mg per 0.8 mL solution for injection pen) BIOSIMILAR COLLABORATIONS IRELAND LIMITED,Active,9014442,adalimumab 40 mg per 0.8 mL solution for injection pen,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,1.0,Prescription
99198,Marketed,2024-03-20,02502402,Hulio,1,L04AB04,Adalimumab,Solution,Subcutaneous,02502402,HULIO (adalimumab 40 mg per 0.8 mL solution for injection pen) BIOSIMILAR COLLABORATIONS IRELAND LIMITED,Active,9014442,adalimumab 40 mg per 0.8 mL solution for injection pen,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,1.0,Schedule D
99222,Marketed,2021-02-16,02502674,Idacio,1,L04AB04,Adalimumab,Solution,Subcutaneous,02502674,IDACIO (adalimumab 40 mg per 0.8 mL solution for injection pen) FRESENIUS KABI CANADA LTD,Active,9014442,adalimumab 40 mg per 0.8 mL solution for injection pen,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,1.0,Prescription
99222,Marketed,2021-02-16,02502674,Idacio,1,L04AB04,Adalimumab,Solution,Subcutaneous,02502674,IDACIO (adalimumab 40 mg per 0.8 mL solution for injection pen) FRESENIUS KABI CANADA LTD,Active,9014442,adalimumab 40 mg per 0.8 mL solution for injection pen,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,1.0,Schedule D
99223,Marketed,2021-08-30,02502682,Idacio,1,L04AB04,Adalimumab,Solution,Subcutaneous,02502682,IDACIO (adalimumab 40 mg per 0.8 mL solution for injection syringe) FRESENIUS KABI CANADA LTD,Active,9014443,adalimumab 40 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
99223,Marketed,2021-08-30,02502682,Idacio,1,L04AB04,Adalimumab,Solution,Subcutaneous,02502682,IDACIO (adalimumab 40 mg per 0.8 mL solution for injection syringe) FRESENIUS KABI CANADA LTD,Active,9014443,adalimumab 40 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
99460,Marketed,2021-02-15,02505258,Hyrimoz,1,L04AB04,Adalimumab,Solution,Subcutaneous,02505258,HYRIMOZ (adalimumab 20 mg per 0.4 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9014471,adalimumab 20 mg per 0.4 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
99460,Marketed,2021-02-15,02505258,Hyrimoz,1,L04AB04,Adalimumab,Solution,Subcutaneous,02505258,HYRIMOZ (adalimumab 20 mg per 0.4 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9014471,adalimumab 20 mg per 0.4 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
20107,Marketed,1996-12-31,02148749,Differin,1,D10AD03,Adapalene,Gel,Topical,02148749,DIFFERIN (adapalene 0.1 % cutaneous gel) GALDERMA CANADA INC.,Active,9003004,adapalene 0.1 % cutaneous gel,8001242,adapalene,448598008,Cutaneous,385100002,Gel,,,,,,Prescription
50959,Marketed,1998-01-08,02231592,Differin,1,D10AD03,Adapalene,Cream,Topical,02231592,DIFFERIN (adapalene 0.1 % cutaneous cream) GALDERMA CANADA INC.,Active,9003199,adapalene 0.1 % cutaneous cream,8001242,adapalene,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
75946,Marketed,2007-07-19,02274000,Differin XP,1,D10AD03,Adapalene,Gel,Topical,02274000,DIFFERIN XP (adapalene 0.3 % cutaneous gel) GALDERMA CANADA INC.,Active,9004311,adapalene 0.3 % cutaneous gel,8001242,adapalene,448598008,Cutaneous,385100002,Gel,,,,,,Prescription
100638,Marketed,2022-01-26,02517205,Sandoz Adapalene / Benzoyl Peroxide Forte,2,D10AD53,"Adapalene, combinations",Gel,Topical,02517205,SANDOZ ADAPALENE / BENZOYL PEROXIDE FORTE (adapalene 0.3 % and benzoyl peroxide 2.5 % cutaneous gel) SANDOZ CANADA INCORPORATED,Active,9005841,adapalene 0.3 % and benzoyl peroxide 2.5 % cutaneous gel,8000983,adapalene and benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,,Prescription
85075,Marketed,2014-06-02,02365871,Tactupump,2,D10AD53,"Adapalene, combinations",Gel,Topical,02365871,TACTUPUMP (adapalene 0.1 % and benzoyl peroxide 2.5 % cutaneous gel) GALDERMA CANADA INC.,Active,9004871,adapalene 0.1 % and benzoyl peroxide 2.5 % cutaneous gel,8000983,adapalene and benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,,Prescription
93152,Marketed,2016-01-04,02446235,Tactupump Forte,2,D10AD53,"Adapalene, combinations",Gel,Topical,02446235,TACTUPUMP FORTE (adapalene 0.3 % and benzoyl peroxide 2.5 % cutaneous gel) GALDERMA CANADA INC.,Active,9005841,adapalene 0.3 % and benzoyl peroxide 2.5 % cutaneous gel,8000983,adapalene and benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,,Prescription
94404,Marketed,2019-10-01,02456923,Taro-Adapalene/Benzoyl Peroxide,2,D10AD53,"Adapalene, combinations",Gel,Topical,02456923,TARO-ADAPALENE/BENZOYL PEROXIDE (adapalene 0.1 % and benzoyl peroxide 2.5 % cutaneous gel) TARO PHARMACEUTICALS INC,Active,9004871,adapalene 0.1 % and benzoyl peroxide 2.5 % cutaneous gel,8000983,adapalene and benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,,Prescription
97906,Marketed,2021-06-21,02489007,Sandoz Adapalene / Benzoyl Peroxide,2,D10AD53,"Adapalene, combinations",Gel,Topical,02489007,SANDOZ ADAPALENE / BENZOYL PEROXIDE (adapalene 0.1 % and benzoyl peroxide 2.5 % cutaneous gel) SANDOZ CANADA INCORPORATED,Active,9004871,adapalene 0.1 % and benzoyl peroxide 2.5 % cutaneous gel,8000983,adapalene and benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,,Prescription
99442,Marketed,2022-01-24,02505053,Taro-Adapalene/Benzoyl Peroxide Forte,2,D10AD53,"Adapalene, combinations",Gel,Topical,02505053,TARO-ADAPALENE/BENZOYL PEROXIDE FORTE (adapalene 0.3 % and benzoyl peroxide 2.5 % cutaneous gel) TARO PHARMACEUTICALS INC,Active,9005841,adapalene 0.3 % and benzoyl peroxide 2.5 % cutaneous gel,8000983,adapalene and benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,,Prescription
75307,Marketed,2015-11-23,02267659,Adenosine Injection,1,C01EB10,Adenosine,Solution,Intravenous,02267659,ADENOSINE INJECTION (adenosine 6 mg per 2 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9013265,adenosine 6 mg per 2 mL solution for injection vial,8001885,adenosine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
94452,Marketed,2017-08-17,02457474,Adenosine Injection,1,C01EB10,Adenosine,Solution,Intravenous,02457474,ADENOSINE INJECTION (adenosine 6 mg per 2 mL solution for injection syringe) FRESENIUS KABI CANADA LTD,Active,9013264,adenosine 6 mg per 2 mL solution for injection syringe,8001885,adenosine,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
94453,Marketed,2017-08-17,02457482,Adenosine Injection,1,C01EB10,Adenosine,Solution,Intravenous,02457482,ADENOSINE INJECTION (adenosine 12 mg per 4 mL solution for injection syringe) FRESENIUS KABI CANADA LTD,Active,9013263,adenosine 12 mg per 4 mL solution for injection syringe,8001885,adenosine,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
100203,Marketed,2024-10-28,02512777,Sandoz AFAtinib,1,L01EB03,Afatinib,Tablet,Oral,02512777,SANDOZ AFATINIB (afatinib (afatinib dimaleate) 20 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005402,afatinib (afatinib dimaleate) 20 mg oral tablet,8001551,afatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100204,Marketed,2024-10-28,02512785,Sandoz AFAtinib,1,L01EB03,Afatinib,Tablet,Oral,02512785,SANDOZ AFATINIB (afatinib (afatinib dimaleate) 30 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005403,afatinib (afatinib dimaleate) 30 mg oral tablet,8001551,afatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100205,Marketed,2024-10-28,02512793,Sandoz AFAtinib,1,L01EB03,Afatinib,Tablet,Oral,02512793,SANDOZ AFATINIB (afatinib (afatinib dimaleate) 40 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005404,afatinib (afatinib dimaleate) 40 mg oral tablet,8001551,afatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100635,Marketed,2025-01-31,02517019,Mar-AFAtinib,1,L01EB03,Afatinib,Tablet,Oral,02517019,MAR-AFATINIB (afatinib (afatinib dimaleate) 20 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9005402,afatinib (afatinib dimaleate) 20 mg oral tablet,8001551,afatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100636,Marketed,2025-01-31,02517027,Mar-AFAtinib,1,L01EB03,Afatinib,Tablet,Oral,02517027,MAR-AFATINIB (afatinib (afatinib dimaleate) 30 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9005403,afatinib (afatinib dimaleate) 30 mg oral tablet,8001551,afatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100637,Marketed,2025-01-31,02517035,Mar-AFAtinib,1,L01EB03,Afatinib,Tablet,Oral,02517035,MAR-AFATINIB (afatinib (afatinib dimaleate) 40 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9005404,afatinib (afatinib dimaleate) 40 mg oral tablet,8001551,afatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
90026,Marketed,2014-01-17,02415666,Giotrif,1,L01EB03,Afatinib,Tablet,Oral,02415666,GIOTRIF (afatinib (afatinib dimaleate) 20 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9005402,afatinib (afatinib dimaleate) 20 mg oral tablet,8001551,afatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
90027,Marketed,2014-01-17,02415674,Giotrif,1,L01EB03,Afatinib,Tablet,Oral,02415674,GIOTRIF (afatinib (afatinib dimaleate) 30 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9005403,afatinib (afatinib dimaleate) 30 mg oral tablet,8001551,afatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
90028,Marketed,2014-01-17,02415682,Giotrif,1,L01EB03,Afatinib,Tablet,Oral,02415682,GIOTRIF (afatinib (afatinib dimaleate) 40 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9005404,afatinib (afatinib dimaleate) 40 mg oral tablet,8001551,afatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102467,Marketed,2026-05-22,02535858,Yesafili,1,S01LA05,Aflibercept,Solution,Intravitreal,02535858,YESAFILI (aflibercept 2 mg per 0.05 mL solution for injection vial) BIOCON BIOLOGICS CANADA INC,Active,9012884,aflibercept 2 mg per 0.05 mL solution for injection vial,8001552,aflibercept,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,1.0,Schedule D
102467,Marketed,2026-05-22,02535858,Yesafili,1,S01LA05,Aflibercept,Solution,Intravitreal,02535858,YESAFILI (aflibercept 2 mg per 0.05 mL solution for injection vial) BIOCON BIOLOGICS CANADA INC,Active,9012884,aflibercept 2 mg per 0.05 mL solution for injection vial,8001552,aflibercept,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,1.0,Prescription
103362,Marketed,2024-09-03,02545004,Eylea HD,1,S01LA05,Aflibercept,Solution,Intravitreal,02545004,EYLEA HD (aflibercept 8 mg per 0.07 mL solution for injection vial) BAYER INC,Active,9015080,aflibercept 8 mg per 0.07 mL solution for injection vial,8001552,aflibercept,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
103362,Marketed,2024-09-03,02545004,Eylea HD,1,S01LA05,Aflibercept,Solution,Intravitreal,02545004,EYLEA HD (aflibercept 8 mg per 0.07 mL solution for injection vial) BAYER INC,Active,9015080,aflibercept 8 mg per 0.07 mL solution for injection vial,8001552,aflibercept,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
103942,Marketed,2025-09-03,02550636,Pavblu,1,S01LA05,Aflibercept,Solution,Intravitreal,02550636,PAVBLU (aflibercept 2 mg per 0.05 mL solution for injection vial) AMGEN CANADA INC,Active,9012884,aflibercept 2 mg per 0.05 mL solution for injection vial,8001552,aflibercept,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,1.0,Prescription
103942,Marketed,2025-09-03,02550636,Pavblu,1,S01LA05,Aflibercept,Solution,Intravitreal,02550636,PAVBLU (aflibercept 2 mg per 0.05 mL solution for injection vial) AMGEN CANADA INC,Active,9012884,aflibercept 2 mg per 0.05 mL solution for injection vial,8001552,aflibercept,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,1.0,Schedule D
104305,Marketed,2025-07-02,02554178,Aflivu,1,S01LA05,Aflibercept,Solution,Intravitreal,02554178,AFLIVU (aflibercept 2 mg per 0.05 mL solution for injection syringe) APOTEX INC,Active,9014409,aflibercept 2 mg per 0.05 mL solution for injection syringe,8001552,aflibercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,1.0,Prescription
104305,Marketed,2025-07-02,02554178,Aflivu,1,S01LA05,Aflibercept,Solution,Intravitreal,02554178,AFLIVU (aflibercept 2 mg per 0.05 mL solution for injection syringe) APOTEX INC,Active,9014409,aflibercept 2 mg per 0.05 mL solution for injection syringe,8001552,aflibercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,1.0,Schedule D
104306,Marketed,2025-07-02,02554194,Aflivu,1,S01LA05,Aflibercept,Solution,Intravitreal,02554194,AFLIVU (aflibercept 2 mg per 0.05 mL solution for injection vial) APOTEX INC,Active,9012884,aflibercept 2 mg per 0.05 mL solution for injection vial,8001552,aflibercept,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,1.0,Prescription
104306,Marketed,2025-07-02,02554194,Aflivu,1,S01LA05,Aflibercept,Solution,Intravitreal,02554194,AFLIVU (aflibercept 2 mg per 0.05 mL solution for injection vial) APOTEX INC,Active,9012884,aflibercept 2 mg per 0.05 mL solution for injection vial,8001552,aflibercept,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,1.0,Schedule D
104362,Marketed,2025-04-07,02554798,Eylea HD,1,S01LA05,Aflibercept,Solution,Intravitreal,02554798,EYLEA HD (aflibercept 8 mg per 0.07 mL solution for injection syringe) BAYER INC,Active,9015182,aflibercept 8 mg per 0.07 mL solution for injection syringe,8001552,aflibercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe,1.0,,,Schedule D
104362,Marketed,2025-04-07,02554798,Eylea HD,1,S01LA05,Aflibercept,Solution,Intravitreal,02554798,EYLEA HD (aflibercept 8 mg per 0.07 mL solution for injection syringe) BAYER INC,Active,9015182,aflibercept 8 mg per 0.07 mL solution for injection syringe,8001552,aflibercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe,1.0,,,Prescription
106151,Marketed,2026-05-22,02558238,Yesafili,1,S01LA05,Aflibercept,Solution,Intravitreal,02558238,YESAFILI (aflibercept 2 mg per 0.05 mL solution for injection syringe) BIOCON BIOLOGICS CANADA INC,Active,9014409,aflibercept 2 mg per 0.05 mL solution for injection syringe,8001552,aflibercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,1.0,Schedule D
106151,Marketed,2026-05-22,02558238,Yesafili,1,S01LA05,Aflibercept,Solution,Intravitreal,02558238,YESAFILI (aflibercept 2 mg per 0.05 mL solution for injection syringe) BIOCON BIOLOGICS CANADA INC,Active,9014409,aflibercept 2 mg per 0.05 mL solution for injection syringe,8001552,aflibercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,1.0,Prescription
106539,Marketed,2026-02-09,02562510,Enzeevu,1,S01LA05,Aflibercept,Solution,Intravitreal,02562510,ENZEEVU (aflibercept 2 mg per 0.05 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9014409,aflibercept 2 mg per 0.05 mL solution for injection syringe,8001552,aflibercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,1.0,Schedule D
106539,Marketed,2026-02-09,02562510,Enzeevu,1,S01LA05,Aflibercept,Solution,Intravitreal,02562510,ENZEEVU (aflibercept 2 mg per 0.05 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9014409,aflibercept 2 mg per 0.05 mL solution for injection syringe,8001552,aflibercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,1.0,Prescription
106586,Marketed,2026-03-02,02563037,Eydenzelt,1,S01LA05,Aflibercept,Solution,Intravitreal,02563037,EYDENZELT (aflibercept 2 mg per 0.05 mL solution for injection vial) CELLTRION INC.,Active,9012884,aflibercept 2 mg per 0.05 mL solution for injection vial,8001552,aflibercept,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,1.0,Prescription
106586,Marketed,2026-03-02,02563037,Eydenzelt,1,S01LA05,Aflibercept,Solution,Intravitreal,02563037,EYDENZELT (aflibercept 2 mg per 0.05 mL solution for injection vial) CELLTRION INC.,Active,9012884,aflibercept 2 mg per 0.05 mL solution for injection vial,8001552,aflibercept,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,1.0,Schedule D
90055,Marketed,2013-12-23,02415992,Eylea,1,S01LA05,Aflibercept,Solution,Intravitreal,02415992,EYLEA (aflibercept 2 mg per 0.05 mL solution for injection vial) BAYER INC,Active,9012884,aflibercept 2 mg per 0.05 mL solution for injection vial,8001552,aflibercept,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
90055,Marketed,2013-12-23,02415992,Eylea,1,S01LA05,Aflibercept,Solution,Intravitreal,02415992,EYLEA (aflibercept 2 mg per 0.05 mL solution for injection vial) BAYER INC,Active,9012884,aflibercept 2 mg per 0.05 mL solution for injection vial,8001552,aflibercept,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99471,Marketed,2020-11-17,02505355,Eylea,1,S01LA05,Aflibercept,Solution,Intravitreal,02505355,EYLEA (aflibercept 2 mg per 0.05 mL solution for injection syringe) BAYER INC,Active,9014409,aflibercept 2 mg per 0.05 mL solution for injection syringe,8001552,aflibercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
99471,Marketed,2020-11-17,02505355,Eylea,1,S01LA05,Aflibercept,Solution,Intravitreal,02505355,EYLEA (aflibercept 2 mg per 0.05 mL solution for injection syringe) BAYER INC,Active,9014409,aflibercept 2 mg per 0.05 mL solution for injection syringe,8001552,aflibercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Schedule D
73392,Marketed,2021-10-13,02249057,Replagal,1,A16AB03,Agalsidase alfa,Solution,Intravenous,02249057,REPLAGAL (agalsidase alfa 3.5 mg per 3.5 mL solution for injection vial) TAKEDA CANADA INC,Active,9012885,agalsidase alfa 3.5 mg per 3.5 mL solution for injection vial,8001553,agalsidase alfa,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
73392,Marketed,2021-10-13,02249057,Replagal,1,A16AB03,Agalsidase alfa,Solution,Intravenous,02249057,REPLAGAL (agalsidase alfa 3.5 mg per 3.5 mL solution for injection vial) TAKEDA CANADA INC,Active,9012885,agalsidase alfa 3.5 mg per 3.5 mL solution for injection vial,8001553,agalsidase alfa,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
73340,Marketed,2024-04-08,02248965,Fabrazyme,1,A16AB04,Agalsidase beta,Powder for solution,Intravenous,02248965,FABRAZYME (agalsidase beta 5 mg per vial powder for solution for injection) SANOFI-AVENTIS CANADA INC,Active,9003938,agalsidase beta 5 mg per vial powder for solution for injection,8001554,agalsidase beta,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
73340,Marketed,2024-04-08,02248965,Fabrazyme,1,A16AB04,Agalsidase beta,Powder for solution,Intravenous,02248965,FABRAZYME (agalsidase beta 5 mg per vial powder for solution for injection) SANOFI-AVENTIS CANADA INC,Active,9003938,agalsidase beta 5 mg per vial powder for solution for injection,8001554,agalsidase beta,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
73341,Marketed,2024-04-08,02248966,Fabrazyme,1,A16AB04,Agalsidase beta,Powder for solution,Intravenous,02248966,FABRAZYME (agalsidase beta 35 mg per vial powder for solution for injection) SANOFI-AVENTIS CANADA INC,Active,9003895,agalsidase beta 35 mg per vial powder for solution for injection,8001554,agalsidase beta,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
73341,Marketed,2024-04-08,02248966,Fabrazyme,1,A16AB04,Agalsidase beta,Powder for solution,Intravenous,02248966,FABRAZYME (agalsidase beta 35 mg per vial powder for solution for injection) SANOFI-AVENTIS CANADA INC,Active,9003895,agalsidase beta 35 mg per vial powder for solution for injection,8001554,agalsidase beta,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
42926,Marketed,2012-12-04,02189100,Plasbumin-5,1,B05AA01,Albumin,Solution,Intravenous,,,,,,,,,,,,,,,,,Schedule D
43384,Marketed,2021-04-28,02223694,"Albumin (Human) 5% Solution, USP",1,B05AA01,Albumin,Solution,Intravenous,,,,,,,,,,,,,,,,,Schedule D
43385,Marketed,2012-09-11,02223708,Albumin (Human) 25% Solution USP,1,B05AA01,Albumin,Solution,Intravenous,,,,,,,,,,,,,,,,,Schedule D
75278,Marketed,2024-10-15,02267357,Octalbin 25%,1,B05AA01,Albumin,Solution,Intravenous,,,,,,,,,,,,,,,,,Schedule D
76013,Marketed,2008-01-15,02274655,Alburex - 5,1,B05AA01,Albumin,Solution,Intravenous,,,,,,,,,,,,,,,,,Schedule D
76014,Marketed,2007-10-16,02274663,Alburex - 25,1,B05AA01,Albumin,Solution,Intravenous,,,,,,,,,,,,,,,,,Schedule D
81516,Marketed,2018-08-21,02329417,Draximage Maa,1,B05AA01,Albumin,Powder for solution,Intravenous,,,,,,,,,,,,,,,,,Schedule C
18314,Marketed,2026-05-06,02130181,Proleukin,1,L03AC01,Aldesleukin,Powder for solution,Intravenous,02130181,PROLEUKIN (aldesleukin 22000000 unit per vial powder for solution for injection) IOVANCE BIOTHERAPEUTICS MANUFACTURING LLC,Active,9002738,aldesleukin 22000000 unit per vial powder for solution for injection,8001555,aldesleukin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
18314,Marketed,2026-05-06,02130181,Proleukin,1,L03AC01,Aldesleukin,Powder for solution,Intravenous,02130181,PROLEUKIN (aldesleukin 22000000 unit per vial powder for solution for injection) IOVANCE BIOTHERAPEUTICS MANUFACTURING LLC,Active,9002738,aldesleukin 22000000 unit per vial powder for solution for injection,8001555,aldesleukin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
94518,Marketed,2016-10-14,02458136,Alecensaro,1,L01ED03,Alectinib,Capsule,Oral,02458136,ALECENSARO (alectinib (alectinib hydrochloride) 150 mg oral capsule) HOFFMANN-LA ROCHE LIMITED,Active,9006051,alectinib (alectinib hydrochloride) 150 mg oral capsule,8001556,alectinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
77636,Marketed,2025-10-31,02290960,Mabcampath,1,L04AG06,Alemtuzumab,Solution,Intravenous,02290960,MABCAMPATH (alemtuzumab 30 mg per 1 mL solution for injection vial) SANOFI-AVENTIS CANADA INC,Active,9012887,alemtuzumab 30 mg per 1 mL solution for injection vial,8001557,alemtuzumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
77636,Marketed,2025-10-31,02290960,Mabcampath,1,L04AG06,Alemtuzumab,Solution,Intravenous,02290960,MABCAMPATH (alemtuzumab 30 mg per 1 mL solution for injection vial) SANOFI-AVENTIS CANADA INC,Active,9012887,alemtuzumab 30 mg per 1 mL solution for injection vial,8001557,alemtuzumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
90290,Marketed,2024-04-19,02418320,Lemtrada,1,L04AG06,Alemtuzumab,Solution,Intravenous,02418320,LEMTRADA (alemtuzumab 12 mg per 1.2 mL solution for injection vial) SANOFI-AVENTIS CANADA INC,Active,9012886,alemtuzumab 12 mg per 1.2 mL solution for injection vial,8001557,alemtuzumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
90290,Marketed,2024-04-19,02418320,Lemtrada,1,L04AG06,Alemtuzumab,Solution,Intravenous,02418320,LEMTRADA (alemtuzumab 12 mg per 1.2 mL solution for injection vial) SANOFI-AVENTIS CANADA INC,Active,9012886,alemtuzumab 12 mg per 1.2 mL solution for injection vial,8001557,alemtuzumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
101218,Marketed,2022-08-09,02523116,Nra-Alendronate,1,M05BA04,Alendronic acid,Tablet,Oral,02523116,NRA-ALENDRONATE (alendronic acid (alendronate sodium) 70 mg oral tablet) NORA PHARMA INC,Active,9000973,alendronic acid (alendronate sodium) 70 mg oral tablet,8000312,alendronic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101860,Marketed,2025-11-18,02529394,M-Alendronate,1,M05BA04,Alendronic acid,Tablet,Oral,02529394,M-ALENDRONATE (alendronic acid (alendronate sodium) 70 mg oral tablet) MANTRA PHARMA INC,Active,9000973,alendronic acid (alendronate sodium) 70 mg oral tablet,8000312,alendronic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
69356,Marketed,2022-05-03,02245329,Fosamax,1,M05BA04,Alendronic acid,Tablet,Oral,02245329,FOSAMAX (alendronic acid (alendronate sodium) 70 mg oral tablet) ORGANON CANADA INC.,Active,9000973,alendronic acid (alendronate sodium) 70 mg oral tablet,8000312,alendronic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73098,Marketed,2005-05-27,02248730,Apo-Alendronate,1,M05BA04,Alendronic acid,Tablet,Oral,02248730,APO-ALENDRONATE (alendronic acid (alendronate sodium) 70 mg oral tablet) APOTEX INC,Active,9000973,alendronic acid (alendronate sodium) 70 mg oral tablet,8000312,alendronic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74709,Marketed,2010-06-17,02261715,Teva-Alendronate,1,M05BA04,Alendronic acid,Tablet,Oral,02261715,TEVA-ALENDRONATE (alendronic acid (alendronate sodium) 70 mg oral tablet) TEVA CANADA LIMITED,Active,9000973,alendronic acid (alendronate sodium) 70 mg oral tablet,8000312,alendronic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75626,Marketed,2025-12-09,02270889,Riva-Alendronate,1,M05BA04,Alendronic acid,Tablet,Oral,02270889,RIVA-ALENDRONATE (alendronic acid (alendronate sodium) 70 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000973,alendronic acid (alendronate sodium) 70 mg oral tablet,8000312,alendronic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76957,Marketed,2006-08-15,02284006,PMS-Alendronate-Film-coated,1,M05BA04,Alendronic acid,Tablet,Oral,02284006,PMS-ALENDRONATE-FC (alendronic acid (alendronate sodium) 70 mg oral tablet) PHARMASCIENCE INC,Active,9000973,alendronic acid (alendronate sodium) 70 mg oral tablet,8000312,alendronic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77349,Marketed,2016-09-23,02288109,Sandoz Alendronate,1,M05BA04,Alendronic acid,Tablet,Oral,02288109,SANDOZ ALENDRONATE (alendronic acid (alendronate sodium) 70 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000973,alendronic acid (alendronate sodium) 70 mg oral tablet,8000312,alendronic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78508,Marketed,2022-01-27,02299712,Alendronate,1,M05BA04,Alendronic acid,Tablet,Oral,02299712,ALENDRONATE (alendronic acid (alendronate sodium) 70 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000973,alendronic acid (alendronate sodium) 70 mg oral tablet,8000312,alendronic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78840,Marketed,2024-01-02,02303078,Alendronate-70,1,M05BA04,Alendronic acid,Tablet,Oral,02303078,ALENDRONATE-70 (alendronic acid (alendronate sodium) 70 mg oral tablet) PRO DOC LIMITEE,Active,9000973,alendronic acid (alendronate sodium) 70 mg oral tablet,8000312,alendronic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83819,Marketed,2026-02-25,02352966,Alendronate,1,M05BA04,Alendronic acid,Tablet,Oral,02352966,ALENDRONATE (alendronic acid (alendronate sodium) 70 mg oral tablet) SANIS HEALTH INC,Active,9000973,alendronic acid (alendronate sodium) 70 mg oral tablet,8000312,alendronic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86732,Marketed,2012-03-20,02381478,ACH-Alendronate,1,M05BA04,Alendronic acid,Tablet,Oral,02381478,ACH-ALENDRONATE (alendronic acid (alendronate sodium) 5 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001064,alendronic acid (alendronate sodium) 5 mg oral tablet,8000312,alendronic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86733,Marketed,2012-03-20,02381486,ACH-Alendronate,1,M05BA04,Alendronic acid,Tablet,Oral,02381486,ACH-ALENDRONATE (alendronic acid (alendronate sodium) 10 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001025,alendronic acid (alendronate sodium) 10 mg oral tablet,8000312,alendronic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86734,Marketed,2012-03-20,02381494,ACH-Alendronate,1,M05BA04,Alendronic acid,Tablet,Oral,02381494,ACH-ALENDRONATE (alendronic acid (alendronate sodium) 70 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000973,alendronic acid (alendronate sodium) 70 mg oral tablet,8000312,alendronic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87407,Marketed,2012-07-26,02388545,Auro-Alendronate,1,M05BA04,Alendronic acid,Tablet,Oral,02388545,AURO-ALENDRONATE (alendronic acid (alendronate sodium) 10 mg oral tablet) AURO PHARMA INC,Active,9001025,alendronic acid (alendronate sodium) 10 mg oral tablet,8000312,alendronic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87408,Marketed,2012-07-26,02388553,Auro-Alendronate,1,M05BA04,Alendronic acid,Tablet,Oral,02388553,AURO-ALENDRONATE (alendronic acid (alendronate sodium) 70 mg oral tablet) AURO PHARMA INC,Active,9000973,alendronic acid (alendronate sodium) 70 mg oral tablet,8000312,alendronic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98988,Marketed,2022-07-22,02500175,JAMP Alendronate Sodium,1,M05BA04,Alendronic acid,Tablet,Oral,02500175,JAMP ALENDRONATE SODIUM (alendronic acid (alendronate sodium) 70 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000973,alendronic acid (alendronate sodium) 70 mg oral tablet,8000312,alendronic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99568,Marketed,2024-04-03,02506327,AG-Alendronate Sodium,1,M05BA04,Alendronic acid,Tablet,Oral,02506327,AG-ALENDRONATE SODIUM (alendronic acid (alendronate sodium) 70 mg oral tablet) ANGITA PHARMA INC.,Active,9000973,alendronic acid (alendronate sodium) 70 mg oral tablet,8000312,alendronic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100905,Marketed,2023-06-13,02519828,JAMP Alendronate / Vitamin D3,2,M05BB03,Alendronic acid and cholecalciferol,Tablet,Oral,02519828,JAMP ALENDRONATE / VITAMIN D3 (alendronic acid (alendronate sodium trihydrate) 70 mg and cholecalciferol 2800 unit oral tablet) JAMP PHARMA CORPORATION,Active,9006480,alendronic acid (alendronate sodium) 70 mg and cholecalciferol 2800 unit oral tablet,8000413,alendronic acid and cholecalciferol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100906,Marketed,2023-03-15,02519836,JAMP Alendronate / Vitamin D3,2,M05BB03,Alendronic acid and cholecalciferol,Tablet,Oral,02519836,JAMP ALENDRONATE / VITAMIN D3 (alendronic acid (alendronate sodium trihydrate) 70 mg and cholecalciferol 5600 unit oral tablet) JAMP PHARMA CORPORATION,Active,9006487,alendronic acid (alendronate sodium) 70 mg and cholecalciferol 5600 unit oral tablet,8000413,alendronic acid and cholecalciferol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76210,Marketed,2022-06-29,02276429,Fosavance,2,M05BB03,Alendronic acid and cholecalciferol,Tablet,Oral,02276429,FOSAVANCE (alendronic acid (alendronate sodium trihydrate) 70 mg and cholecalciferol 2800 unit oral tablet) ORGANON CANADA INC.,Active,9006480,alendronic acid (alendronate sodium) 70 mg and cholecalciferol 2800 unit oral tablet,8000413,alendronic acid and cholecalciferol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80047,Marketed,2022-07-05,02314940,Fosavance,2,M05BB03,Alendronic acid and cholecalciferol,Tablet,Oral,02314940,FOSAVANCE (alendronic acid (alendronate sodium trihydrate) 70 mg and cholecalciferol 5600 unit oral tablet) ORGANON CANADA INC.,Active,9006487,alendronic acid (alendronate sodium) 70 mg and cholecalciferol 5600 unit oral tablet,8000413,alendronic acid and cholecalciferol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94104,Marketed,2016-07-21,02454467,Apo-Alendronate/Vitamin D3,2,M05BB03,Alendronic acid and cholecalciferol,Tablet,Oral,02454467,APO-ALENDRONATE/VITAMIN D3 (alendronic acid (alendronate sodium) 70 mg and cholecalciferol 2800 unit oral tablet) APOTEX INC,Active,9006480,alendronic acid (alendronate sodium) 70 mg and cholecalciferol 2800 unit oral tablet,8000413,alendronic acid and cholecalciferol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94105,Marketed,2016-07-21,02454475,Apo-Alendronate/Vitamin D3,2,M05BB03,Alendronic acid and cholecalciferol,Tablet,Oral,02454475,APO-ALENDRONATE/VITAMIN D3 (alendronic acid (alendronate sodium) 70 mg and cholecalciferol 5600 unit oral tablet) APOTEX INC,Active,9006487,alendronic acid (alendronate sodium) 70 mg and cholecalciferol 5600 unit oral tablet,8000413,alendronic acid and cholecalciferol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101155,Marketed,2024-01-02,02522438,Glassia,1,B02AB02,Alfa1 antitrypsin,Solution,Intravenous,02522438,GLASSIA (alpha1-proteinase inhibitor human 1000 mg per 50 mL solution for injection vial) TAKEDA CANADA INC,Active,9015001,alpha1-proteinase inhibitor human 1000 mg per 50 mL solution for injection vial,8002214,alpha1-proteinase inhibitor human,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
43004,Marketed,2012-02-04,02204606,Prolastin-C,1,B02AB02,Alfa1 antitrypsin,Powder for solution,Intravenous,02204606,PROLASTIN-C (alpha1-proteinase inhibitor human 1000 mg per vial powder for solution for injection with diluent solution) GRIFOLS THERAPEUTICS LLC,Active,9013756,alpha1-proteinase inhibitor human 1000 mg per vial powder for solution for injection with diluent solution,8002214,alpha1-proteinase inhibitor human,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
102231,Marketed,2023-04-24,02533316,Sandoz Alfacalcidol,1,A11CC03,Alfacalcidol,Capsule,Oral,02533316,SANDOZ ALFACALCIDOL (alfacalcidol 0.25 mcg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001869,alfacalcidol 0.25 mcg oral capsule,8001339,alfacalcidol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
102232,Marketed,2023-04-24,02533324,Sandoz Alfacalcidol,1,A11CC03,Alfacalcidol,Capsule,Oral,02533324,SANDOZ ALFACALCIDOL (alfacalcidol 1 mcg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001870,alfacalcidol 1 mcg oral capsule,8001339,alfacalcidol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
63869,Marketed,2022-01-31,02240329,One-Alpha,1,A11CC03,Alfacalcidol,Drops,Oral,02240329,ONE-ALPHA (alfacalcidol 2 mcg per mL oral drops) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9003545,alfacalcidol 2 mcg per mL oral drops,8001339,alfacalcidol,26643006,Oral,385018001,Oral drops,732994000,Drop (unit of presentation),,,,Prescription
66245,Marketed,2022-01-31,02242502,One-Alpha,1,A11CC03,Alfacalcidol,Solution,Intravenous,77700601,ONE-ALPHA (alfacalcidol 2 mcg per 1 mL solution for injection ampoule) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9012689,alfacalcidol 2 mcg per 1 mL solution for injection ampoule,8001339,alfacalcidol,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
66245,Marketed,2022-01-31,02242502,One-Alpha,1,A11CC03,Alfacalcidol,Solution,Intravenous,77700602,ONE-ALPHA (alfacalcidol 1 mcg per 0.5 mL solution for injection ampoule) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9012688,alfacalcidol 1 mcg per 0.5 mL solution for injection ampoule,8001339,alfacalcidol,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
7292,Marketed,2022-01-31,00474517,One-Alpha,1,A11CC03,Alfacalcidol,Capsule,Oral,00474517,ONE-ALPHA (alfacalcidol 0.25 mcg oral capsule) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9001869,alfacalcidol 0.25 mcg oral capsule,8001339,alfacalcidol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
7293,Marketed,2022-01-31,00474525,One-Alpha,1,A11CC03,Alfacalcidol,Capsule,Oral,00474525,ONE-ALPHA (alfacalcidol 1 mcg oral capsule) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9001870,alfacalcidol 1 mcg oral capsule,8001339,alfacalcidol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
100907,Marketed,2022-02-24,02519844,Alfuzosin,1,G04CA01,Alfuzosin,Tablet (extended-release),Oral,02519844,ALFUZOSIN (alfuzosin hydrochloride 10 mg prolonged-release oral tablet) SANIS HEALTH INC,Active,9000974,alfuzosin hydrochloride 10 mg prolonged-release oral tablet,8000313,alfuzosin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
69657,Marketed,2006-03-30,02245565,Xatral,1,G04CA01,Alfuzosin,Tablet (extended-release),Oral,02245565,XATRAL (alfuzosin hydrochloride 10 mg prolonged-release oral tablet) SANOFI-AVENTIS CANADA INC,Active,9000974,alfuzosin hydrochloride 10 mg prolonged-release oral tablet,8000313,alfuzosin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78993,Marketed,2008-08-28,02304678,Sandoz Alfuzosin,1,G04CA01,Alfuzosin,Tablet (extended-release),Oral,02304678,SANDOZ ALFUZOSIN (alfuzosin hydrochloride 10 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9000974,alfuzosin hydrochloride 10 mg prolonged-release oral tablet,8000313,alfuzosin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80137,Marketed,2008-08-20,02315866,Apo-Alfuzosin,1,G04CA01,Alfuzosin,Tablet (extended-release),Oral,02315866,APO-ALFUZOSIN (alfuzosin hydrochloride 10 mg prolonged-release oral tablet) APOTEX INC,Active,9000974,alfuzosin hydrochloride 10 mg prolonged-release oral tablet,8000313,alfuzosin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92777,Marketed,2015-09-02,02443201,Auro-Alfuzosin,1,G04CA01,Alfuzosin,Tablet (extended-release),Oral,02443201,AURO-ALFUZOSIN (alfuzosin hydrochloride 10 mg prolonged-release oral tablet) AURO PHARMA INC,Active,9000974,alfuzosin hydrochloride 10 mg prolonged-release oral tablet,8000313,alfuzosin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93315,Marketed,2015-11-25,02447576,Alfuzosin,1,G04CA01,Alfuzosin,Tablet (extended-release),Oral,02447576,ALFUZOSIN (alfuzosin hydrochloride 10 mg prolonged-release oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000974,alfuzosin hydrochloride 10 mg prolonged-release oral tablet,8000313,alfuzosin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77041,Marketed,2025-03-04,02284863,Myozyme,1,A16AB07,Alglucosidase alfa,Powder for solution,Intravenous,02284863,MYOZYME (alglucosidase alfa 50 mg per vial powder for solution for injection) SANOFI-AVENTIS CANADA INC,Active,9004236,alglucosidase alfa 50 mg per vial powder for solution for injection,8001558,alglucosidase alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
77041,Marketed,2025-03-04,02284863,Myozyme,1,A16AB07,Alglucosidase alfa,Powder for solution,Intravenous,02284863,MYOZYME (alglucosidase alfa 50 mg per vial powder for solution for injection) SANOFI-AVENTIS CANADA INC,Active,9004236,alglucosidase alfa 50 mg per vial powder for solution for injection,8001558,alglucosidase alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
12419,Marketed,2022-10-20,01926306,Panectyl,1,R06AD01,Alimemazine,Tablet,Oral,01926306,PANECTYL (trimeprazine (trimeprazine tartrate) 2.5 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9001572,trimeprazine (trimeprazine tartrate) 2.5 mg oral tablet,8001541,trimeprazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
12651,Marketed,2022-10-20,01926292,Panectyl,1,R06AD01,Alimemazine,Tablet,Oral,01926292,PANECTYL (trimeprazine (trimeprazine tartrate) 5 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9001573,trimeprazine (trimeprazine tartrate) 5 mg oral tablet,8001541,trimeprazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103666,Marketed,2024-09-16,02547732,Praluent,1,C10AX14,Alirocumab,Solution,Subcutaneous,02547732,PRALUENT (alirocumab 300 mg per 2 mL solution for injection pen) SANOFI-AVENTIS CANADA INC,Active,9015086,alirocumab 300 mg per 2 mL solution for injection pen,8001243,alirocumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
103666,Marketed,2024-09-16,02547732,Praluent,1,C10AX14,Alirocumab,Solution,Subcutaneous,02547732,PRALUENT (alirocumab 300 mg per 2 mL solution for injection pen) SANOFI-AVENTIS CANADA INC,Active,9015086,alirocumab 300 mg per 2 mL solution for injection pen,8001243,alirocumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Prescription
94035,Marketed,2016-05-18,02453819,Praluent,1,C10AX14,Alirocumab,Solution,Subcutaneous,02453819,PRALUENT (alirocumab 75 mg per 1 mL solution for injection pen) SANOFI-AVENTIS CANADA INC,Active,9012602,alirocumab 75 mg per 1 mL solution for injection pen,8001243,alirocumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
94035,Marketed,2016-05-18,02453819,Praluent,1,C10AX14,Alirocumab,Solution,Subcutaneous,02453819,PRALUENT (alirocumab 75 mg per 1 mL solution for injection pen) SANOFI-AVENTIS CANADA INC,Active,9012602,alirocumab 75 mg per 1 mL solution for injection pen,8001243,alirocumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
94037,Marketed,2016-04-29,02453835,Praluent,1,C10AX14,Alirocumab,Solution,Subcutaneous,02453835,PRALUENT (alirocumab 150 mg per 1 mL solution for injection pen) SANOFI-AVENTIS CANADA INC,Active,9012600,alirocumab 150 mg per 1 mL solution for injection pen,8001243,alirocumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
94037,Marketed,2016-04-29,02453835,Praluent,1,C10AX14,Alirocumab,Solution,Subcutaneous,02453835,PRALUENT (alirocumab 150 mg per 1 mL solution for injection pen) SANOFI-AVENTIS CANADA INC,Active,9012600,alirocumab 150 mg per 1 mL solution for injection pen,8001243,alirocumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
96841,Marketed,2021-06-09,02477432,Hanzema,1,D11AH04,Alitretinoin,Capsule,Oral,02477432,HANZEMA (alitretinoin 10 mg oral capsule) DR. REDDY'S LABORATORIES INC,Active,9004810,alitretinoin 10 mg oral capsule,8001559,alitretinoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
96842,Marketed,2021-06-09,02477440,Hanzema,1,D11AH04,Alitretinoin,Capsule,Oral,02477440,HANZEMA (alitretinoin 30 mg oral capsule) DR. REDDY'S LABORATORIES INC,Active,9004790,alitretinoin 30 mg oral capsule,8001559,alitretinoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
19183,Marketed,2013-11-28,02130157,Allopurinol-200,1,M04AA01,Allopurinol,Tablet,Oral,02130157,ALLOPURINOL-200 (allopurinol 200 mg oral tablet) PRO DOC LIMITEE,Active,9000160,allopurinol 200 mg oral tablet,8000046,allopurinol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
4276,Marketed,2024-09-27,00402818,Apo-Allopurinol Tablets,1,M04AA01,Allopurinol,Tablet,Oral,00402818,APO-ALLOPURINOL TABLETS (allopurinol 100 mg oral tablet) APOTEX INC,Active,9000159,allopurinol 100 mg oral tablet,8000046,allopurinol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
4302,Marketed,2024-09-27,00402796,Apo-Allopurinol Tablets,1,M04AA01,Allopurinol,Tablet,Oral,00402796,APO-ALLOPURINOL TABLETS (allopurinol 300 mg oral tablet) APOTEX INC,Active,9000073,allopurinol 300 mg oral tablet,8000046,allopurinol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
4303,Marketed,2024-09-27,00479799,Apo-Allopurinol Tablets,1,M04AA01,Allopurinol,Tablet,Oral,00479799,APO-ALLOPURINOL TABLETS (allopurinol 200 mg oral tablet) APOTEX INC,Active,9000160,allopurinol 200 mg oral tablet,8000046,allopurinol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
4724,Marketed,2013-11-28,00555681,Allopurinol-100,1,M04AA01,Allopurinol,Tablet,Oral,00555681,ALLOPURINOL-100 (allopurinol 100 mg oral tablet) PRO DOC LIMITEE,Active,9000159,allopurinol 100 mg oral tablet,8000046,allopurinol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
4725,Marketed,2013-11-28,00555703,Allopurinol-300,1,M04AA01,Allopurinol,Tablet,Oral,00555703,ALLOPURINOL-300 (allopurinol 300 mg oral tablet) PRO DOC LIMITEE,Active,9000073,allopurinol 300 mg oral tablet,8000046,allopurinol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88136,Marketed,2013-04-17,02396327,Mar-Allopurinol,1,M04AA01,Allopurinol,Tablet,Oral,02396327,MAR-ALLOPURINOL (allopurinol 100 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000159,allopurinol 100 mg oral tablet,8000046,allopurinol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88137,Marketed,2013-04-17,02396335,Mar-Allopurinol,1,M04AA01,Allopurinol,Tablet,Oral,02396335,MAR-ALLOPURINOL (allopurinol 200 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000160,allopurinol 200 mg oral tablet,8000046,allopurinol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88138,Marketed,2013-04-17,02396343,Mar-Allopurinol,1,M04AA01,Allopurinol,Tablet,Oral,02396343,MAR-ALLOPURINOL (allopurinol 300 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000073,allopurinol 300 mg oral tablet,8000046,allopurinol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90624,Marketed,2025-06-05,02421593,JAMP Allopurinol,1,M04AA01,Allopurinol,Tablet,Oral,02421593,JAMP ALLOPURINOL (allopurinol 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000159,allopurinol 100 mg oral tablet,8000046,allopurinol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90625,Marketed,2025-03-20,02421607,JAMP Allopurinol,1,M04AA01,Allopurinol,Tablet,Oral,02421607,JAMP ALLOPURINOL (allopurinol 200 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000160,allopurinol 200 mg oral tablet,8000046,allopurinol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90626,Marketed,2025-03-20,02421615,JAMP Allopurinol,1,M04AA01,Allopurinol,Tablet,Oral,02421615,JAMP ALLOPURINOL (allopurinol 300 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000073,allopurinol 300 mg oral tablet,8000046,allopurinol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88339,Marketed,2013-07-22,02398435,Mylan-Almotriptan,1,N02CC05,Almotriptan,Tablet,Oral,02398435,MYLAN-ALMOTRIPTAN (almotriptan (almotriptan malate) 6.25 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9003847,almotriptan (almotriptan malate) 6.25 mg oral tablet,8001110,almotriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88340,Marketed,2013-07-22,02398443,Mylan-Almotriptan,1,N02CC05,Almotriptan,Tablet,Oral,02398443,MYLAN-ALMOTRIPTAN (almotriptan (almotriptan malate) 12.5 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9003846,almotriptan (almotriptan malate) 12.5 mg oral tablet,8001110,almotriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89013,Marketed,2013-07-22,02405334,Sandoz Almotriptan,1,N02CC05,Almotriptan,Tablet,Oral,02405334,SANDOZ ALMOTRIPTAN (almotriptan (almotriptan malate) 12.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003846,almotriptan (almotriptan malate) 12.5 mg oral tablet,8001110,almotriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90875,Marketed,2014-06-10,02424029,Almotriptan,1,N02CC05,Almotriptan,Tablet,Oral,02424029,ALMOTRIPTAN (almotriptan (almotriptan malate) 12.5 mg oral tablet) PRO DOC LIMITEE,Active,9003846,almotriptan (almotriptan malate) 12.5 mg oral tablet,8001110,almotriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91914,Marketed,2014-12-12,02434849,Teva-Almotriptan,1,N02CC05,Almotriptan,Tablet,Oral,02434849,TEVA-ALMOTRIPTAN (almotriptan (almotriptan malate) 12.5 mg oral tablet) TEVA CANADA LIMITED,Active,9003846,almotriptan (almotriptan malate) 12.5 mg oral tablet,8001110,almotriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95519,Marketed,2018-03-06,02466821,Almotriptan,1,N02CC05,Almotriptan,Tablet,Oral,02466821,ALMOTRIPTAN (almotriptan (almotriptan malate) 12.5 mg oral tablet) SANIS HEALTH INC,Active,9003846,almotriptan (almotriptan malate) 12.5 mg oral tablet,8001110,almotriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90182,Marketed,2014-04-30,02417189,Nesina,1,A10BH04,Alogliptin,Tablet,Oral,02417189,NESINA (alogliptin (alogliptin benzoate) 6.25 mg oral tablet) TAKEDA CANADA INC,Active,9005509,alogliptin (alogliptin benzoate) 6.25 mg oral tablet,8001072,alogliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90183,Marketed,2014-04-30,02417197,Nesina,1,A10BH04,Alogliptin,Tablet,Oral,02417197,NESINA (alogliptin (alogliptin benzoate) 12.5 mg oral tablet) TAKEDA CANADA INC,Active,9005508,alogliptin (alogliptin benzoate) 12.5 mg oral tablet,8001072,alogliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90184,Marketed,2014-05-13,02417200,Nesina,1,A10BH04,Alogliptin,Tablet,Oral,02417200,NESINA (alogliptin (alogliptin benzoate) 25 mg oral tablet) TAKEDA CANADA INC,Active,9005521,alogliptin (alogliptin benzoate) 25 mg oral tablet,8001072,alogliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98692,Marketed,2020-06-29,02497069,Piqray,1,L01EM03,Alpelisib,Tablet,Oral,02497069,PIQRAY (alpelisib 150 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014316,alpelisib 150 mg oral tablet,8002330,alpelisib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98693,Marketed,2020-06-29,02497077,Piqray,1,L01EM03,Alpelisib,Tablet,Oral,02497077,PIQRAY (alpelisib 200 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014317,alpelisib 200 mg oral tablet,8002330,alpelisib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98694,Marketed,2020-06-29,02497085,Piqray,2,L01EM03,Alpelisib,"Kit,Tablet",Oral,02497085,PIQRAY (alpelisib 50 mg oral tablet with alpelisib 200 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014318,alpelisib 50 mg oral tablet with alpelisib 200 mg oral tablet,8002330,alpelisib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
10904,Marketed,1990-12-31,00865397,Apo-Alpraz,1,N05BA12,Alprazolam,Tablet,Oral,00865397,APO-ALPRAZ (alprazolam 0.25 mg oral tablet) APOTEX INC,Active,9000161,alprazolam 0.25 mg oral tablet,8000088,alprazolam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
10905,Marketed,1990-12-31,00865400,Apo-Alpraz,1,N05BA12,Alprazolam,Tablet,Oral,00865400,APO-ALPRAZ (alprazolam 0.5 mg oral tablet) APOTEX INC,Active,9000162,alprazolam 0.5 mg oral tablet,8000088,alprazolam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
11484,Marketed,2022-03-22,01908189,Pro-Alprazolam,1,N05BA12,Alprazolam,Tablet,Oral,01908189,PRO-ALPRAZOLAM (alprazolam 0.25 mg oral tablet) PRO DOC LIMITEE,Active,9000161,alprazolam 0.25 mg oral tablet,8000088,alprazolam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
11485,Marketed,2022-03-22,01908170,Pro-Alprazolam,1,N05BA12,Alprazolam,Tablet,Oral,01908170,PRO-ALPRAZOLAM (alprazolam 0.5 mg oral tablet) PRO DOC LIMITEE,Active,9000162,alprazolam 0.5 mg oral tablet,8000088,alprazolam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
11803,Marketed,2011-05-07,01913484,Teva-Alprazolam,1,N05BA12,Alprazolam,Tablet,Oral,01913484,TEVA-ALPRAZOLAM (alprazolam 0.25 mg oral tablet) TEVA CANADA LIMITED,Active,9000161,alprazolam 0.25 mg oral tablet,8000088,alprazolam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
11804,Marketed,2011-05-07,01913492,Teva-Alprazolam,1,N05BA12,Alprazolam,Tablet,Oral,01913492,TEVA-ALPRAZOLAM (alprazolam 0.5 mg oral tablet) TEVA CANADA LIMITED,Active,9000162,alprazolam 0.5 mg oral tablet,8000088,alprazolam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
13685,Marketed,2023-04-20,00723770,Xanax,1,N05BA12,Alprazolam,Tablet,Oral,00723770,XANAX (alprazolam 1 mg oral tablet) BGP PHARMA ULC,Active,9000454,alprazolam 1 mg oral tablet,8000088,alprazolam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
13686,Marketed,2023-04-20,00813958,Xanax TS,1,N05BA12,Alprazolam,Tablet,Oral,00813958,XANAX TS (alprazolam 2 mg oral tablet) BGP PHARMA ULC,Active,9000455,alprazolam 2 mg oral tablet,8000088,alprazolam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
4471,Marketed,2023-04-20,00548359,Xanax,1,N05BA12,Alprazolam,Tablet,Oral,00548359,XANAX (alprazolam 0.25 mg oral tablet) BGP PHARMA ULC,Active,9000161,alprazolam 0.25 mg oral tablet,8000088,alprazolam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
4472,Marketed,2023-04-20,00548367,Xanax,1,N05BA12,Alprazolam,Tablet,Oral,00548367,XANAX (alprazolam 0.5 mg oral tablet) BGP PHARMA ULC,Active,9000162,alprazolam 0.5 mg oral tablet,8000088,alprazolam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
67530,Marketed,2001-04-16,02243611,Apo-Alpraz,1,N05BA12,Alprazolam,Tablet,Oral,02243611,APO-ALPRAZ (alprazolam 1 mg oral tablet) APOTEX INC,Active,9000454,alprazolam 1 mg oral tablet,8000088,alprazolam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
67531,Marketed,2020-10-05,02243612,Apo-Alpraz TS,1,N05BA12,Alprazolam,Tablet,Oral,02243612,APO-ALPRAZ TS (alprazolam 2 mg oral tablet) APOTEX INC,Active,9000455,alprazolam 2 mg oral tablet,8000088,alprazolam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
73070,Marketed,2022-03-22,02248706,Pro-Alprazolam,1,N05BA12,Alprazolam,Tablet,Oral,02248706,PRO-ALPRAZOLAM (alprazolam 1 mg oral tablet) PRO DOC LIMITEE,Active,9000454,alprazolam 1 mg oral tablet,8000088,alprazolam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
20353,Marketed,2005-11-09,02215756,Caverject Sterile Powder,1,G04BE01,Alprostadil,"Kit,Liquid,Powder for solution",Intracavernosal,02215756,CAVERJECT STERILE POWDER (alprostadil 20 mcg per vial powder for solution for injection with diluent solution syringe) PFIZER CANADA ULC,Active,9012888,alprostadil 20 mcg per vial powder for solution for injection with diluent solution syringe,8001431,alprostadil,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
43155,Marketed,2005-11-09,02215187,Caverject Sterile Powder - PWS 23.2 mcg/vial,1,G04BE01,Alprostadil,Powder for solution,Intracavernosal,,,,,,,,,,,,,,,,,Prescription
4802,Marketed,2006-05-23,00559253,Prostin VR Sterile Solution,1,C01EA01,Alprostadil,Solution,"Intravenous,Intra-arterial",00559253,PROSTIN VR STERILE SOLUTION (alprostadil 500 mcg per 1 mL solution for injection ampoule) PFIZER CANADA ULC,Active,9012778,alprostadil 500 mcg per 1 mL solution for injection ampoule,8001431,alprostadil,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
20105,Marketed,1996-12-31,02147440,Activase RT-Pa,2,B01AD02,Alteplase,"Liquid,Powder for solution",Intravenous,02147440,ACTIVASE RT-PA (alteplase 100 mg per vial powder for solution for injection with diluent solution) HOFFMANN-LA ROCHE LIMITED,Active,9012889,alteplase 100 mg per vial powder for solution for injection with diluent solution,8001561,alteplase,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
20105,Marketed,1996-12-31,02147440,Activase RT-Pa,2,B01AD02,Alteplase,"Liquid,Powder for solution",Intravenous,02147440,ACTIVASE RT-PA (alteplase 100 mg per vial powder for solution for injection with diluent solution) HOFFMANN-LA ROCHE LIMITED,Active,9012889,alteplase 100 mg per vial powder for solution for injection with diluent solution,8001561,alteplase,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
43443,Marketed,1998-04-12,02225689,Activase RT-Pa,2,B01AD02,Alteplase,"Liquid,Powder for solution",Intravenous,02225689,ACTIVASE RT-PA (alteplase 50 mg per vial powder for solution for injection with diluent solution) HOFFMANN-LA ROCHE LIMITED,Active,9012890,alteplase 50 mg per vial powder for solution for injection with diluent solution,8001561,alteplase,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
43443,Marketed,1998-04-12,02225689,Activase RT-Pa,2,B01AD02,Alteplase,"Liquid,Powder for solution",Intravenous,02225689,ACTIVASE RT-PA (alteplase 50 mg per vial powder for solution for injection with diluent solution) HOFFMANN-LA ROCHE LIMITED,Active,9012890,alteplase 50 mg per vial powder for solution for injection with diluent solution,8001561,alteplase,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
69976,Marketed,2002-09-26,02245859,Cathflo,1,B01AD02,Alteplase,Powder for solution,Instillation,02245859,CATHFLO (alteplase 2 mg per vial powder for solution for injection) HOFFMANN-LA ROCHE LIMITED,Active,9006376,alteplase 2 mg per vial powder for solution for injection,8001561,alteplase,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
69976,Marketed,2002-09-26,02245859,Cathflo,1,B01AD02,Alteplase,Powder for solution,Instillation,02245859,CATHFLO (alteplase 2 mg per vial powder for solution for injection) HOFFMANN-LA ROCHE LIMITED,Active,9006376,alteplase 2 mg per vial powder for solution for injection,8001561,alteplase,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
102731,Marketed,2023-07-20,02538601,Odan-Amantadine Syrup,1,N04BB01,Amantadine,Syrup,Oral,02538601,ODAN-AMANTADINE SYRUP (amantadine hydrochloride 50 mg per 5 mL syrup) ODAN LABORATORIES LTD,Active,9012891,amantadine hydrochloride 50 mg per 5 mL syrup,8001340,amantadine,26643006,Oral,739009002,Syrup,,,,,,Prescription
13464,Marketed,2017-03-15,01990403,PDP-Amantadine Hydrochloride Capsules,1,N04BB01,Amantadine,Capsule,Oral,01990403,PDP-AMANTADINE HYDROCHLORIDE CAPSULES (amantadine hydrochloride 100 mg oral capsule) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9002412,amantadine hydrochloride 100 mg oral capsule,8001340,amantadine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
14393,Marketed,2018-01-05,02022826,PDP-Amantadine Hydrochloride Syrup,1,N04BB01,Amantadine,Syrup,Oral,02022826,PDP-AMANTADINE HYDROCHLORIDE SYRUP (amantadine hydrochloride 50 mg per 5 mL syrup) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9012891,amantadine hydrochloride 50 mg per 5 mL syrup,8001340,amantadine,26643006,Oral,739009002,Syrup,,,,,,Prescription
79274,Marketed,2008-06-24,02307065,Volibris,1,C02KX02,Ambrisentan,Tablet,Oral,02307065,VOLIBRIS (ambrisentan 5 mg oral tablet) GLAXOSMITHKLINE INC,Active,9007109,ambrisentan 5 mg oral tablet,8000968,ambrisentan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
79275,Marketed,2008-06-24,02307073,Volibris,1,C02KX02,Ambrisentan,Tablet,Oral,02307073,VOLIBRIS (ambrisentan 10 mg oral tablet) GLAXOSMITHKLINE INC,Active,9007108,ambrisentan 10 mg oral tablet,8000968,ambrisentan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
96575,Marketed,2018-11-26,02475375,Apo-Ambrisentan,1,C02KX02,Ambrisentan,Tablet,Oral,02475375,APO-AMBRISENTAN (ambrisentan 5 mg oral tablet) APOTEX INC,Active,9007109,ambrisentan 5 mg oral tablet,8000968,ambrisentan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
96576,Marketed,2018-11-26,02475383,Apo-Ambrisentan,1,C02KX02,Ambrisentan,Tablet,Oral,02475383,APO-AMBRISENTAN (ambrisentan 10 mg oral tablet) APOTEX INC,Active,9007108,ambrisentan 10 mg oral tablet,8000968,ambrisentan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
70909,Marketed,2005-10-24,02246714,Taro-Amcinonide,1,D07AC11,Amcinonide,Cream,Topical,02246714,TARO-AMCINONIDE (amcinonide 0.1 % cutaneous cream) TARO PHARMACEUTICALS INC,Active,9002930,amcinonide 0.1 % cutaneous cream,8001244,amcinonide,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
106292,Marketed,2026-05-20,02559803,Dyanavel XR,1,N06BA01,Amfetamine,Tablet (extended-release),Oral,,,,,,,,,,,,,,,,,Controlled Drugs (CDSA I)
106293,Marketed,2026-05-20,02559811,Dyanavel XR,1,N06BA01,Amfetamine,Tablet (extended-release),Oral,,,,,,,,,,,,,,,,,Controlled Drugs (CDSA I)
106294,Marketed,2026-05-20,02559838,Dyanavel XR,1,N06BA01,Amfetamine,Tablet (extended-release),Oral,,,,,,,,,,,,,,,,,Controlled Drugs (CDSA I)
106295,Marketed,2026-05-20,02559846,Dyanavel XR,1,N06BA01,Amfetamine,Tablet (extended-release),Oral,,,,,,,,,,,,,,,,,Controlled Drugs (CDSA I)
73177,Marketed,2020-12-21,02248808,Adderall XR,1,N06BA01,Amfetamine,Capsule (extended release),Oral,02248808,ADDERALL XR (amphetamine mixed salts 5 mg prolonged-release oral capsule) TAKEDA CANADA INC,Active,9013799,amphetamine mixed salts 5 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
73178,Marketed,2021-09-23,02248809,Adderall XR,1,N06BA01,Amfetamine,Capsule (extended release),Oral,02248809,ADDERALL XR (amphetamine mixed salts 10 mg prolonged-release oral capsule) TAKEDA CANADA INC,Active,9013794,amphetamine mixed salts 10 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
73179,Marketed,2020-12-21,02248810,Adderall XR,1,N06BA01,Amfetamine,Capsule (extended release),Oral,02248810,ADDERALL XR (amphetamine mixed salts 15 mg prolonged-release oral capsule) TAKEDA CANADA INC,Active,9013795,amphetamine mixed salts 15 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
73180,Marketed,2020-12-21,02248811,Adderall XR,1,N06BA01,Amfetamine,Capsule (extended release),Oral,02248811,ADDERALL XR (amphetamine mixed salts 20 mg prolonged-release oral capsule) TAKEDA CANADA INC,Active,9013796,amphetamine mixed salts 20 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
73181,Marketed,2020-12-21,02248812,Adderall XR,1,N06BA01,Amfetamine,Capsule (extended release),Oral,02248812,ADDERALL XR (amphetamine mixed salts 25 mg prolonged-release oral capsule) TAKEDA CANADA INC,Active,9013797,amphetamine mixed salts 25 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
73182,Marketed,2021-09-30,02248813,Adderall XR,1,N06BA01,Amfetamine,Capsule (extended release),Oral,02248813,ADDERALL XR (amphetamine mixed salts 30 mg prolonged-release oral capsule) TAKEDA CANADA INC,Active,9013798,amphetamine mixed salts 30 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
92362,Marketed,2021-10-25,02439239,Teva-Amphetamine XR,1,N06BA01,Amfetamine,Capsule (extended release),Oral,02439239,TEVA-AMPHETAMINE XR (amphetamine mixed salts 5 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9013799,amphetamine mixed salts 5 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
92363,Marketed,2021-10-25,02439247,Teva-Amphetamine XR,1,N06BA01,Amfetamine,Capsule (extended release),Oral,02439247,TEVA-AMPHETAMINE XR (amphetamine mixed salts 10 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9013794,amphetamine mixed salts 10 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
92364,Marketed,2021-10-25,02439255,Teva-Amphetamine XR,1,N06BA01,Amfetamine,Capsule (extended release),Oral,02439255,TEVA-AMPHETAMINE XR (amphetamine mixed salts 15 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9013795,amphetamine mixed salts 15 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
92365,Marketed,2021-10-25,02439263,Teva-Amphetamine XR,1,N06BA01,Amfetamine,Capsule (extended release),Oral,02439263,TEVA-AMPHETAMINE XR (amphetamine mixed salts 20 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9013796,amphetamine mixed salts 20 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
92366,Marketed,2021-10-25,02439271,Teva-Amphetamine XR,1,N06BA01,Amfetamine,Capsule (extended release),Oral,02439271,TEVA-AMPHETAMINE XR (amphetamine mixed salts 25 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9013797,amphetamine mixed salts 25 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
92367,Marketed,2021-10-25,02439298,Teva-Amphetamine XR,1,N06BA01,Amfetamine,Capsule (extended release),Oral,02439298,TEVA-AMPHETAMINE XR (amphetamine mixed salts 30 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9013798,amphetamine mixed salts 30 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
93077,Marketed,2019-04-15,02445492,Apo-Amphetamine XR,1,N06BA01,Amfetamine,Capsule (extended release),Oral,02445492,APO-AMPHETAMINE XR (amphetamine mixed salts 5 mg prolonged-release oral capsule) APOTEX INC,Active,9013799,amphetamine mixed salts 5 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
93078,Marketed,2019-04-15,02445506,Apo-Amphetamine XR,1,N06BA01,Amfetamine,Capsule (extended release),Oral,02445506,APO-AMPHETAMINE XR (amphetamine mixed salts 10 mg prolonged-release oral capsule) APOTEX INC,Active,9013794,amphetamine mixed salts 10 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
93079,Marketed,2019-04-15,02445514,Apo-Amphetamine XR,1,N06BA01,Amfetamine,Capsule (extended release),Oral,02445514,APO-AMPHETAMINE XR (amphetamine mixed salts 15 mg prolonged-release oral capsule) APOTEX INC,Active,9013795,amphetamine mixed salts 15 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
93080,Marketed,2019-04-26,02445522,Apo-Amphetamine XR,1,N06BA01,Amfetamine,Capsule (extended release),Oral,02445522,APO-AMPHETAMINE XR (amphetamine mixed salts 20 mg prolonged-release oral capsule) APOTEX INC,Active,9013796,amphetamine mixed salts 20 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
93081,Marketed,2019-04-15,02445530,Apo-Amphetamine XR,1,N06BA01,Amfetamine,Capsule (extended release),Oral,02445530,APO-AMPHETAMINE XR (amphetamine mixed salts 25 mg prolonged-release oral capsule) APOTEX INC,Active,9013797,amphetamine mixed salts 25 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
93082,Marketed,2019-04-15,02445549,Apo-Amphetamine XR,1,N06BA01,Amfetamine,Capsule (extended release),Oral,02445549,APO-AMPHETAMINE XR (amphetamine mixed salts 30 mg prolonged-release oral capsule) APOTEX INC,Active,9013798,amphetamine mixed salts 30 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
94435,Marketed,2016-12-22,02457288,Sandoz Amphetamine XR,1,N06BA01,Amfetamine,Capsule (extended release),Oral,02457288,SANDOZ AMPHETAMINE XR (amphetamine mixed salts 5 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED,Active,9013799,amphetamine mixed salts 5 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
94436,Marketed,2016-12-22,02457296,Sandoz Amphetamine XR,1,N06BA01,Amfetamine,Capsule (extended release),Oral,02457296,SANDOZ AMPHETAMINE XR (amphetamine mixed salts 10 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED,Active,9013794,amphetamine mixed salts 10 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
94437,Marketed,2016-12-22,02457318,Sandoz Amphetamine XR,1,N06BA01,Amfetamine,Capsule (extended release),Oral,02457318,SANDOZ AMPHETAMINE XR (amphetamine mixed salts 15 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED,Active,9013795,amphetamine mixed salts 15 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
94438,Marketed,2016-12-22,02457326,Sandoz Amphetamine XR,1,N06BA01,Amfetamine,Capsule (extended release),Oral,02457326,SANDOZ AMPHETAMINE XR (amphetamine mixed salts 20 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED,Active,9013796,amphetamine mixed salts 20 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
94439,Marketed,2016-12-22,02457334,Sandoz Amphetamine XR,1,N06BA01,Amfetamine,Capsule (extended release),Oral,02457334,SANDOZ AMPHETAMINE XR (amphetamine mixed salts 25 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED,Active,9013797,amphetamine mixed salts 25 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
94440,Marketed,2016-12-22,02457342,Sandoz Amphetamine XR,1,N06BA01,Amfetamine,Capsule (extended release),Oral,02457342,SANDOZ AMPHETAMINE XR (amphetamine mixed salts 30 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED,Active,9013798,amphetamine mixed salts 30 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
99250,Marketed,2020-10-23,02502984,Firdapse,1,N07XX05,Amifampridine,Tablet,Oral,02502984,FIRDAPSE (amifampridine (amifampridine phosphate) 10 mg oral tablet) KYE PHARMACEUTICALS INC.,Active,9014418,amifampridine (amifampridine phosphate) 10 mg oral tablet,8002355,amifampridine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99254,Marketed,2023-01-24,02503034,Ruzurgi,1,N07XX05,Amifampridine,Tablet,Oral,02503034,RUZURGI (amifampridine 10 mg oral tablet) MEDUNIK CANADA,Active,9014419,amifampridine 10 mg oral tablet,8002355,amifampridine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101489,Marketed,2023-04-28,02525909,Amikacin Sulfate Injection,1,J01GB06,Amikacin,Solution,"Intravenous,Intramuscular",02525909,AMIKACIN SULFATE INJECTION (amikacin (amikacin sulfate) 500 mg per 2 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9012566,amikacin (amikacin sulfate) 500 mg per 2 mL solution for injection vial,8001169,amikacin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
101866,Marketed,2023-10-06,02529459,Amikacin Sulfate Injection,1,J01GB06,Amikacin,Solution,"Intravenous,Intramuscular",02529459,AMIKACIN SULFATE INJECTION (amikacin (amikacin sulfate) 500 mg per 2 mL solution for injection vial) JAMP PHARMA CORPORATION,Active,9012566,amikacin (amikacin sulfate) 500 mg per 2 mL solution for injection vial,8001169,amikacin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
66810,Marketed,2005-09-16,02242971,Amikacin Sulfate Injection USP,1,J01GB06,Amikacin,Liquid,"Intravenous,Intramuscular",02242971,AMIKACIN SULFATE INJECTION USP (amikacin (amikacin sulfate) 500 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012566,amikacin (amikacin sulfate) 500 mg per 2 mL solution for injection vial,8001169,amikacin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
97163,Marketed,2019-03-01,02481073,Amikacin Sulfate Injection USP,1,J01GB06,Amikacin,Solution,"Intravenous,Intramuscular",02481073,AMIKACIN SULFATE INJECTION USP (amikacin (amikacin sulfate) 500 mg per 2 mL solution for injection vial) MARCAN PHARMACEUTICALS INC,Active,9012566,amikacin (amikacin sulfate) 500 mg per 2 mL solution for injection vial,8001169,amikacin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
97689,Marketed,2019-07-31,02486717,Amikacin Sulfate Injection,1,J01GB06,Amikacin,Solution,"Intramuscular,Intravenous",02486717,AMIKACIN SULFATE INJECTION (amikacin (amikacin sulfate) 500 mg per 2 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9012566,amikacin (amikacin sulfate) 500 mg per 2 mL solution for injection vial,8001169,amikacin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
73433,Marketed,2011-04-04,02249510,Midamor,1,C03DB01,Amiloride,Tablet,Oral,02249510,MIDAMOR (amiloride hydrochloride 5 mg oral tablet) AA PHARMA INC,Active,9007115,amiloride hydrochloride 5 mg oral tablet,8000943,amiloride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
11329,Marketed,2013-10-16,00872296,Travasol,15,B05BA01,Amino acids,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
43947,Marketed,2015-01-23,02141450,20% Prosol,17,B05BA01,Amino acids,Liquid,Intravenous,,,,,,,,,,,,,,,,,Ethical
60165,Marketed,2014-12-19,02236875,Primene 10%,20,B05BA01,Amino acids,Liquid,Intravenous,,,,,,,,,,,,,,,,,Ethical
99955,Marketed,2023-01-25,02510324,Essepna,16,B05BA01,Amino acids,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
67875,Marketed,2025-07-22,02243933,Levulan Kerastick,1,L01XD04,Aminolevulinic acid,Powder for solution,Topical,02243933,"LEVULAN KERASTICK (aminolevulinic acid hydrochloride 20 % cutaneous solution 1.5 mL applicator) SUN PHARMACEUTICAL INDUSTRIES, INC.",Active,9013793,aminolevulinic acid hydrochloride 20 % cutaneous solution 1.5 mL applicator,8001563,aminolevulinic acid,448598008,Cutaneous,385108009,Cutaneous solution,732980001,Applicator (unit of presentation),,,,Prescription
99429,Marketed,2021-02-22,02504928,Gleolan,1,L01XD04,Aminolevulinic acid,Powder for solution,Oral,02504928,GLEOLAN (aminolevulinic acid hydrochloride 1.5 g per vial powder for oral solution) MEDEXUS PHARMACEUTICALS INC.,Active,9014472,aminolevulinic acid hydrochloride 1.5 g per vial powder for oral solution,8001563,aminolevulinic acid,26643006,Oral,385026009,Powder for oral solution,733026001,Vial (unit of presentation),,,,Prescription
5705,Marketed,1984-12-31,00582662,Aminophylline Inj 25 mg/mL,1,R03DA05,Aminophylline,Solution,Intravenous,00582662,AMINOPHYLLINE INJ 25MG/ML (aminophylline 250 mg per 10 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9012367,aminophylline 250 mg per 10 mL solution for injection vial,8001049,aminophylline,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
102093,Marketed,2023-04-12,02531844,JAMP Amiodarone,1,C01BD01,Amiodarone,Tablet,Oral,02531844,JAMP AMIODARONE (amiodarone hydrochloride 200 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000840,amiodarone hydrochloride 200 mg oral tablet,8000269,amiodarone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
63322,Marketed,2010-06-02,02239835,Teva-Amiodarone,1,C01BD01,Amiodarone,Tablet,Oral,02239835,TEVA-AMIODARONE (amiodarone hydrochloride 200 mg oral tablet) TEVA CANADA LIMITED,Active,9000840,amiodarone hydrochloride 200 mg oral tablet,8000269,amiodarone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
66036,Marketed,2005-09-16,02242325,Amiodarone Hydrochloride For Injection,1,C01BD01,Amiodarone,Solution,Intravenous,77700080,AMIODARONE HYDROCHLORIDE FOR INJECTION (amiodarone hydrochloride 150 mg per 3 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000909,amiodarone hydrochloride 150 mg per 3 mL solution for injection vial,8000269,amiodarone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
66036,Marketed,2005-09-16,02242325,Amiodarone Hydrochloride For Injection,1,C01BD01,Amiodarone,Solution,Intravenous,77700081,AMIODARONE HYDROCHLORIDE FOR INJECTION (amiodarone hydrochloride 450 mg per 9 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000910,amiodarone hydrochloride 450 mg per 9 mL solution for injection vial,8000269,amiodarone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
66036,Marketed,2005-09-16,02242325,Amiodarone Hydrochloride For Injection,1,C01BD01,Amiodarone,Solution,Intravenous,77700082,AMIODARONE HYDROCHLORIDE FOR INJECTION (amiodarone hydrochloride 900 mg per 18 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000911,amiodarone hydrochloride 900 mg per 18 mL solution for injection vial,8000269,amiodarone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
66199,Marketed,2000-07-28,02242472,PMS-Amiodarone,1,C01BD01,Amiodarone,Tablet,Oral,02242472,PMS-AMIODARONE (amiodarone hydrochloride 200 mg oral tablet) PHARMASCIENCE INC,Active,9000840,amiodarone hydrochloride 200 mg oral tablet,8000269,amiodarone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
67777,Marketed,2005-12-02,02243836,Sandoz Amiodarone,1,C01BD01,Amiodarone,Tablet,Oral,02243836,SANDOZ AMIODARONE (amiodarone hydrochloride 200 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000840,amiodarone hydrochloride 200 mg oral tablet,8000269,amiodarone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
69271,Marketed,2023-05-25,02245248,"Amiodarone Hydrochloride For Injection, USP",1,C01BD01,Amiodarone,Solution,Intravenous,02245248,"AMIODARONE HYDROCHLORIDE FOR INJECTION, USP (amiodarone hydrochloride 150 mg per 3 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9000909,amiodarone hydrochloride 150 mg per 3 mL solution for injection vial,8000269,amiodarone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
70344,Marketed,2003-09-05,02246194,Apo-Amiodarone Tablets,1,C01BD01,Amiodarone,Tablet,Oral,02246194,APO-AMIODARONE TABLETS (amiodarone hydrochloride 200 mg oral tablet) APOTEX INC,Active,9000840,amiodarone hydrochloride 200 mg oral tablet,8000269,amiodarone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71459,Marketed,2024-11-07,02247217,Riva-Amiodarone,1,C01BD01,Amiodarone,Tablet,Oral,02247217,RIVA-AMIODARONE (amiodarone hydrochloride 200 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000840,amiodarone hydrochloride 200 mg oral tablet,8000269,amiodarone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77754,Marketed,2007-04-03,02292173,PMS-Amiodarone,1,C01BD01,Amiodarone,Tablet,Oral,02292173,PMS-AMIODARONE (amiodarone hydrochloride 100 mg oral tablet) PHARMASCIENCE INC,Active,9001194,amiodarone hydrochloride 100 mg oral tablet,8000269,amiodarone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79532,Marketed,2008-07-04,02309661,Pro-Amiodarone - 200,1,C01BD01,Amiodarone,Tablet,Oral,02309661,PRO-AMIODARONE - 200 (amiodarone hydrochloride 200 mg oral tablet) PRO DOC LIMITEE,Active,9000840,amiodarone hydrochloride 200 mg oral tablet,8000269,amiodarone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84924,Marketed,2026-05-26,02364336,Amiodarone,1,C01BD01,Amiodarone,Tablet,Oral,02364336,AMIODARONE (amiodarone hydrochloride 200 mg oral tablet) SANIS HEALTH INC,Active,9000840,amiodarone hydrochloride 200 mg oral tablet,8000269,amiodarone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87109,Marketed,2012-06-10,02385465,Amiodarone,1,C01BD01,Amiodarone,Tablet,Oral,02385465,AMIODARONE (amiodarone hydrochloride 200 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000840,amiodarone hydrochloride 200 mg oral tablet,8000269,amiodarone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
2426,Marketed,2025-10-24,00370991,Pro-Amitriptyline,1,N06AA09,Amitriptyline,Tablet,Oral,00370991,PRO-AMITRIPTYLINE (amitriptyline hydrochloride 10 mg oral tablet) PRO DOC LIMITEE,Active,9000033,amitriptyline hydrochloride 10 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
2427,Marketed,2025-10-24,00371009,Pro-Amitriptyline,1,N06AA09,Amitriptyline,Tablet,Oral,00371009,PRO-AMITRIPTYLINE (amitriptyline hydrochloride 25 mg oral tablet) PRO DOC LIMITEE,Active,9000056,amitriptyline hydrochloride 25 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
3141,Marketed,2025-10-24,00456349,Pro-Amitriptyline,1,N06AA09,Amitriptyline,Tablet,Oral,00456349,PRO-AMITRIPTYLINE (amitriptyline hydrochloride 50 mg oral tablet) PRO DOC LIMITEE,Active,9000046,amitriptyline hydrochloride 50 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
8199,Marketed,2010-09-21,00754129,Elavil,1,N06AA09,Amitriptyline,Tablet,Oral,00754129,ELAVIL (amitriptyline hydrochloride 75 mg oral tablet) AA PHARMA INC,Active,9000114,amitriptyline hydrochloride 75 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91430,Marketed,2015-04-24,02429861,Mar-Amitriptyline,1,N06AA09,Amitriptyline,Tablet,Oral,02429861,MAR-AMITRIPTYLINE (amitriptyline hydrochloride 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000033,amitriptyline hydrochloride 10 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91431,Marketed,2015-04-24,02429888,Mar-Amitriptyline,1,N06AA09,Amitriptyline,Tablet,Oral,02429888,MAR-AMITRIPTYLINE (amitriptyline hydrochloride 25 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000056,amitriptyline hydrochloride 25 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91432,Marketed,2015-04-24,02429896,Mar-Amitriptyline,1,N06AA09,Amitriptyline,Tablet,Oral,02429896,MAR-AMITRIPTYLINE (amitriptyline hydrochloride 50 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000046,amitriptyline hydrochloride 50 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91433,Marketed,2015-04-27,02429918,Mar-Amitriptyline,1,N06AA09,Amitriptyline,Tablet,Oral,02429918,MAR-AMITRIPTYLINE (amitriptyline hydrochloride 75 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000114,amitriptyline hydrochloride 75 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
9346,Marketed,1998-12-12,00654515,PMS-Amitriptyline,1,N06AA09,Amitriptyline,Tablet,Oral,00654515,PMS-AMITRIPTYLINE (amitriptyline hydrochloride 25 mg oral tablet) PHARMASCIENCE INC,Active,9000056,amitriptyline hydrochloride 25 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
9417,Marketed,1998-12-12,00654523,PMS-Amitriptyline,1,N06AA09,Amitriptyline,Tablet,Oral,00654523,PMS-AMITRIPTYLINE (amitriptyline hydrochloride 10 mg oral tablet) PHARMASCIENCE INC,Active,9000033,amitriptyline hydrochloride 10 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
9418,Marketed,1998-12-12,00654507,PMS-Amitriptyline,1,N06AA09,Amitriptyline,Tablet,Oral,00654507,PMS-AMITRIPTYLINE (amitriptyline hydrochloride 50 mg oral tablet) PHARMASCIENCE INC,Active,9000046,amitriptyline hydrochloride 50 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94469,Marketed,2024-06-10,02457679,JAMP-Amitriptyline,1,N06AA09,Amitriptyline,Tablet,Oral,02457679,JAMP-AMITRIPTYLINE (amitriptyline hydrochloride 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000033,amitriptyline hydrochloride 10 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94471,Marketed,2024-06-10,02457695,JAMP-Amitriptyline,1,N06AA09,Amitriptyline,Tablet,Oral,02457695,JAMP-AMITRIPTYLINE (amitriptyline hydrochloride 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000056,amitriptyline hydrochloride 25 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94472,Marketed,2024-06-10,02457687,JAMP-Amitriptyline,1,N06AA09,Amitriptyline,Tablet,Oral,02457687,JAMP-AMITRIPTYLINE (amitriptyline hydrochloride 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000046,amitriptyline hydrochloride 50 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94473,Marketed,2024-06-10,02457660,JAMP-Amitriptyline,1,N06AA09,Amitriptyline,Tablet,Oral,02457660,JAMP-AMITRIPTYLINE (amitriptyline hydrochloride 75 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000114,amitriptyline hydrochloride 75 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95683,Marketed,2017-10-18,02468409,PMS-Amitriptyline,1,N06AA09,Amitriptyline,Tablet,Oral,02468409,PMS-AMITRIPTYLINE (amitriptyline hydrochloride 100 mg oral tablet) PHARMASCIENCE INC,Active,9012430,amitriptyline hydrochloride 100 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101529,Marketed,2022-04-26,02526182,Rybrevant,1,L01FX18,Amivantamab,Solution,Intravenous,02526182,RYBREVANT (amivantamab 350 mg per 7 mL solution for injection vial) JANSSEN INC,Active,9014711,amivantamab 350 mg per 7 mL solution for injection vial,8002422,amivantamab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
101529,Marketed,2022-04-26,02526182,Rybrevant,1,L01FX18,Amivantamab,Solution,Intravenous,02526182,RYBREVANT (amivantamab 350 mg per 7 mL solution for injection vial) JANSSEN INC,Active,9014711,amivantamab 350 mg per 7 mL solution for injection vial,8002422,amivantamab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
101162,Marketed,2022-09-21,02522500,PRZ-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02522500,PRZ-AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg oral tablet) PHARMARIS CANADA INC,Active,9001277,amlodipine (amlodipine besylate) 2.5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101163,Marketed,2022-10-03,02522519,PRZ-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02522519,PRZ-AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) PHARMARIS CANADA INC,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101164,Marketed,2022-09-21,02522527,PRZ-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02522527,PRZ-AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) PHARMARIS CANADA INC,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104184,Marketed,2025-09-25,02552868,amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02552868,AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg oral tablet) ANGITA PHARMA INC.,Active,9001277,amlodipine (amlodipine besylate) 2.5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104185,Marketed,2025-04-08,02552876,amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02552876,AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) ANGITA PHARMA INC.,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104186,Marketed,2025-09-25,02552884,amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02552884,AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) ANGITA PHARMA INC.,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106010,Marketed,2025-10-29,02556707,NB-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,,,,,,,,,,,,,,,,,Prescription
106011,Marketed,2025-08-26,02556715,NB-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,,,,,,,,,,,,,,,,,Prescription
106012,Marketed,2025-08-26,02556723,NB-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,,,,,,,,,,,,,,,,,Prescription
12938,Marketed,2023-08-02,00878928,Norvasc,1,C08CA01,Amlodipine,Tablet,Oral,00878928,NORVASC (amlodipine (amlodipine besylate) 5 mg oral tablet) BGP PHARMA ULC,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
12939,Marketed,2023-08-02,00878936,Norvasc,1,C08CA01,Amlodipine,Tablet,Oral,00878936,NORVASC (amlodipine (amlodipine besylate) 10 mg oral tablet) BGP PHARMA ULC,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75765,Marketed,2010-01-15,02272113,Mylan-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02272113,MYLAN-AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75766,Marketed,2010-01-14,02272121,Mylan-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02272121,MYLAN-AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75886,Marketed,2009-07-09,02273373,Apo-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02273373,APO-AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) APOTEX INC,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75887,Marketed,2009-07-09,02273381,Apo-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02273381,APO-AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) APOTEX INC,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76963,Marketed,2009-07-09,02284065,PMS-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02284065,PMS-AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) PHARMASCIENCE INC,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76964,Marketed,2009-07-09,02284073,PMS-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02284073,PMS-AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) PHARMASCIENCE INC,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76997,Marketed,2009-07-09,02284383,Sandoz amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02284383,SANDOZ AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76998,Marketed,2009-07-09,02284391,Sandoz amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02284391,SANDOZ AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78046,Marketed,2009-07-15,02295148,PMS-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02295148,PMS-AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg oral tablet) PHARMASCIENCE INC,Active,9001277,amlodipine (amlodipine besylate) 2.5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78283,Marketed,2024-11-08,02297485,Teva-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02297485,TEVA-AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) TEVA CANADA LIMITED,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78284,Marketed,2024-11-08,02297493,Teva-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02297493,TEVA-AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81213,Marketed,2017-05-29,02326795,amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02326795,AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg oral tablet) PRO DOC LIMITEE,Active,9001277,amlodipine (amlodipine besylate) 2.5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81214,Marketed,2017-06-08,02326809,amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02326809,AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) PRO DOC LIMITEE,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81215,Marketed,2017-05-24,02326817,amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02326817,AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) PRO DOC LIMITEE,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81620,Marketed,2009-08-05,02330474,Sandoz amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02330474,SANDOZ AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001277,amlodipine (amlodipine besylate) 2.5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81699,Marketed,2022-09-01,02331284,amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02331284,AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) SANIS HEALTH INC,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81700,Marketed,2022-09-01,02331292,amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02331292,AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) SANIS HEALTH INC,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81717,Marketed,2025-12-17,02331489,Riva-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02331489,RIVA-AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001277,amlodipine (amlodipine besylate) 2.5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81718,Marketed,2025-12-17,02331497,Riva-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02331497,RIVA-AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81719,Marketed,2025-12-17,02331500,Riva-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02331500,RIVA-AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84231,Marketed,2021-04-21,02357186,JAMP-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02357186,JAMP-AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001277,amlodipine (amlodipine besylate) 2.5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84232,Marketed,2025-04-04,02357194,JAMP-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02357194,JAMP-AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84233,Marketed,2021-03-25,02357208,JAMP-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02357208,JAMP-AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84766,Marketed,2011-02-16,02362651,Mint-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02362651,MINT-AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84767,Marketed,2011-02-16,02362678,Mint-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02362678,MINT-AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85416,Marketed,2024-09-27,02369222,AG-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02369222,AG-AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg oral tablet) ANGITA PHARMA INC.,Active,9001277,amlodipine (amlodipine besylate) 2.5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85417,Marketed,2021-05-31,02369230,AG-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02369230,AG-AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) ANGITA PHARMA INC.,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85418,Marketed,2021-05-31,02369249,AG-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02369249,AG-AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) ANGITA PHARMA INC.,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85684,Marketed,2021-08-06,02371707,Mar-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02371707,MAR-AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001277,amlodipine (amlodipine besylate) 2.5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85685,Marketed,2021-08-06,02371715,Mar-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02371715,MAR-AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85686,Marketed,2021-08-06,02371723,Mar-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02371723,MAR-AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87140,Marketed,2016-09-28,02385783,amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02385783,AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001277,amlodipine (amlodipine besylate) 2.5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87141,Marketed,2016-09-28,02385791,amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02385791,AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87142,Marketed,2016-09-28,02385805,amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02385805,AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87741,Marketed,2013-01-15,02392127,Bio-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02392127,BIO-AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg oral tablet) BIOMED PHARMA,Active,9001277,amlodipine (amlodipine besylate) 2.5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87742,Marketed,2013-01-15,02392135,Bio-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02392135,BIO-AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) BIOMED PHARMA,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87743,Marketed,2013-01-15,02392143,Bio-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02392143,BIO-AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) BIOMED PHARMA,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88206,Marketed,2013-02-12,02397072,Auro-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02397072,AURO-AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) AURO PHARMA INC,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88207,Marketed,2013-02-12,02397080,Auro-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02397080,AURO-AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) AURO PHARMA INC,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90417,Marketed,2023-02-22,02419556,ACH-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02419556,ACH-AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001277,amlodipine (amlodipine besylate) 2.5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90418,Marketed,2022-09-13,02419564,ACH-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02419564,ACH-AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90419,Marketed,2022-10-17,02419572,ACH-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02419572,ACH-AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91365,Marketed,2021-02-17,02429217,amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02429217,AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91366,Marketed,2021-02-17,02429225,amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02429225,AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95637,Marketed,2018-03-07,02468018,M-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02468018,M-AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg oral tablet) MANTRA PHARMA INC,Active,9001277,amlodipine (amlodipine besylate) 2.5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95638,Marketed,2017-12-14,02468026,M-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02468026,M-AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) MANTRA PHARMA INC,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95639,Marketed,2018-04-03,02468034,M-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02468034,M-AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) MANTRA PHARMA INC,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96694,Marketed,2023-12-05,02476452,Nra-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02476452,NRA-AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg oral tablet) NORA PHARMA INC,Active,9001277,amlodipine (amlodipine besylate) 2.5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96695,Marketed,2023-12-05,02476460,Nra-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02476460,NRA-AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) NORA PHARMA INC,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96696,Marketed,2023-12-05,02476479,Nra-amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02476479,NRA-AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) NORA PHARMA INC,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96905,Marketed,2023-04-07,02478587,amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02478587,AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg oral tablet) SANIS HEALTH INC,Active,9001277,amlodipine (amlodipine besylate) 2.5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97499,Marketed,2019-08-28,02484706,PDP-amLODIPine,1,C08CA01,Amlodipine,Solution,Oral,02484706,PDP-AMLODIPINE (amlodipine (amlodipine besylate) 5 mg per 5 mL oral solution) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9014145,amlodipine (amlodipine besylate) 5 mg per 5 mL oral solution,8000153,amlodipine,26643006,Oral,385023001,Oral solution,,,,,,Prescription
98084,Marketed,2024-09-30,02490781,amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02490781,AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg oral tablet) ALTAMED PHARMA,Active,9001277,amlodipine (amlodipine besylate) 2.5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98085,Marketed,2024-10-25,02490803,amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02490803,AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) ALTAMED PHARMA,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98086,Marketed,2024-10-25,02490811,amLODIPine,1,C08CA01,Amlodipine,Tablet,Oral,02490811,AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) ALTAMED PHARMA,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101436,Marketed,2022-11-03,02525348,Amoxicillin Capsules BP,1,J01CA04,Amoxicillin,Capsule,Oral,02525348,AMOXICILLIN CAPSULES BP (amoxicillin (amoxicillin trihydrate) 250 mg oral capsule) SANIS HEALTH INC,Active,9007158,amoxicillin 250 mg oral capsule,8000073,amoxicillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
101437,Marketed,2022-11-03,02525356,Amoxicillin Capsules BP,1,J01CA04,Amoxicillin,Capsule,Oral,02525356,AMOXICILLIN CAPSULES BP (amoxicillin (amoxicillin trihydrate) 500 mg oral capsule) SANIS HEALTH INC,Active,9007164,amoxicillin 500 mg oral capsule,8000073,amoxicillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
102111,Marketed,2023-12-22,02532042,PRZ-Amoxicillin,1,J01CA04,Amoxicillin,Capsule,Oral,02532042,PRZ-AMOXICILLIN (amoxicillin (amoxicillin trihydrate) 250 mg oral capsule) PHARMARIS CANADA INC,Active,9007158,amoxicillin 250 mg oral capsule,8000073,amoxicillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
102112,Marketed,2023-12-22,02532050,PRZ-Amoxicillin,1,J01CA04,Amoxicillin,Capsule,Oral,02532050,PRZ-AMOXICILLIN (amoxicillin (amoxicillin trihydrate) 500 mg oral capsule) PHARMARIS CANADA INC,Active,9007164,amoxicillin 500 mg oral capsule,8000073,amoxicillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
102462,Marketed,2023-04-17,02535793,JAMP-Amoxicillin,1,J01CA04,Amoxicillin,Powder for suspension,Oral,02535793,JAMP-AMOXICILLIN (amoxicillin (amoxicillin trihydrate) 125 mg per 5 mL oral suspension) JAMP PHARMA CORPORATION,Active,9007154,amoxicillin 125 mg per 5 mL oral suspension,8000073,amoxicillin,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
102464,Marketed,2023-04-18,02535815,JAMP-Amoxicillin,1,J01CA04,Amoxicillin,Powder for suspension,Oral,02535815,JAMP-AMOXICILLIN (amoxicillin (amoxicillin trihydrate) 250 mg per 5 mL oral suspension) JAMP PHARMA CORPORATION,Active,9007160,amoxicillin 250 mg per 5 mL oral suspension,8000073,amoxicillin,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
102617,Marketed,2024-03-14,02537451,AG-Amoxicillin,1,J01CA04,Amoxicillin,Powder for suspension,Oral,02537451,AG-AMOXICILLIN (amoxicillin (amoxicillin trihydrate) 250 mg per 5 mL oral suspension) ANGITA PHARMA INC.,Active,9007160,amoxicillin 250 mg per 5 mL oral suspension,8000073,amoxicillin,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
14506,Marketed,2013-06-04,02036355,Novamoxin,1,J01CA04,Amoxicillin,Tablet (chewable),Oral,02036355,NOVAMOXIN (amoxicillin (amoxicillin trihydrate) 250 mg chewable tablet) TEVA CANADA LIMITED,Active,9007157,amoxicillin 250 mg chewable tablet,8000073,amoxicillin,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Prescription
16954,Marketed,2013-06-04,01934163,Novamoxin,1,J01CA04,Amoxicillin,Granules for suspension,Oral,01934163,NOVAMOXIN SUGAR REDUCED (amoxicillin (amoxicillin trihydrate) 250 mg per 5 mL oral suspension) TEVA CANADA LIMITED,Active,9007160,amoxicillin 250 mg per 5 mL oral suspension,8000073,amoxicillin,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
3263,Marketed,2013-06-03,00406716,Novamoxin,1,J01CA04,Amoxicillin,Capsule,Oral,00406716,NOVAMOXIN (amoxicillin (amoxicillin trihydrate) 500 mg oral capsule) TEVA CANADA LIMITED,Active,9007164,amoxicillin 500 mg oral capsule,8000073,amoxicillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
3264,Marketed,2013-06-04,00406724,Novamoxin,1,J01CA04,Amoxicillin,Capsule,Oral,00406724,NOVAMOXIN (amoxicillin (amoxicillin trihydrate) 250 mg oral capsule) TEVA CANADA LIMITED,Active,9007158,amoxicillin 250 mg oral capsule,8000073,amoxicillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
3344,Marketed,2013-06-04,00452130,Novamoxin,1,J01CA04,Amoxicillin,Granules for suspension,Oral,00452130,NOVAMOXIN (amoxicillin (amoxicillin trihydrate) 250 mg per 5 mL oral suspension) TEVA CANADA LIMITED,Active,9007160,amoxicillin 250 mg per 5 mL oral suspension,8000073,amoxicillin,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
5822,Marketed,2019-10-30,00628115,Apo-Amoxi,1,J01CA04,Amoxicillin,Capsule,Oral,00628115,APO-AMOXI (amoxicillin (amoxicillin trihydrate) 250 mg oral capsule) APOTEX INC,Active,9007158,amoxicillin 250 mg oral capsule,8000073,amoxicillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
5823,Marketed,2019-10-30,00628123,Apo-Amoxi,1,J01CA04,Amoxicillin,Capsule,Oral,00628123,APO-AMOXI (amoxicillin (amoxicillin trihydrate) 500 mg oral capsule) APOTEX INC,Active,9007164,amoxicillin 500 mg oral capsule,8000073,amoxicillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
5824,Marketed,2020-06-08,00628131,Apo-Amoxi,1,J01CA04,Amoxicillin,Powder for suspension,Oral,00628131,APO-AMOXI (amoxicillin (amoxicillin trihydrate) 125 mg per 5 mL oral suspension) APOTEX INC,Active,9007154,amoxicillin 125 mg per 5 mL oral suspension,8000073,amoxicillin,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
5825,Marketed,2020-06-08,00628158,Apo-Amoxi,1,J01CA04,Amoxicillin,Powder for suspension,Oral,00628158,APO-AMOXI (amoxicillin (amoxicillin trihydrate) 250 mg per 5 mL oral suspension) APOTEX INC,Active,9007160,amoxicillin 250 mg per 5 mL oral suspension,8000073,amoxicillin,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
6510,Marketed,2020-06-22,00644315,Pro-Amox-500,1,J01CA04,Amoxicillin,Capsule,Oral,00644315,PRO-AMOX-500 (amoxicillin (amoxicillin trihydrate) 500 mg oral capsule) PRO DOC LIMITEE,Active,9007164,amoxicillin 500 mg oral capsule,8000073,amoxicillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
6511,Marketed,2020-11-30,00644331,Pro-Amox-250,1,J01CA04,Amoxicillin,Powder for suspension,Oral,00644331,PRO-AMOX-250 (amoxicillin (amoxicillin trihydrate) 250 mg per 5 mL oral suspension) PRO DOC LIMITEE,Active,9007160,amoxicillin 250 mg per 5 mL oral suspension,8000073,amoxicillin,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
83801,Marketed,2013-10-03,02352753,Amoxicillin,1,J01CA04,Amoxicillin,Granules for suspension,Oral,02352753,AMOXICILLIN (amoxicillin (amoxicillin trihydrate) 250 mg per 5 mL oral suspension) SANIS HEALTH INC,Active,9007160,amoxicillin 250 mg per 5 mL oral suspension,8000073,amoxicillin,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
83803,Marketed,2013-10-03,02352788,Amoxicillin,1,J01CA04,Amoxicillin,Granules for suspension,Oral,02352788,AMOXICILLIN SUGAR-REDUCED (amoxicillin (amoxicillin trihydrate) 250 mg per 5 mL oral suspension) SANIS HEALTH INC,Active,9007160,amoxicillin 250 mg per 5 mL oral suspension,8000073,amoxicillin,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
87364,Marketed,2012-07-26,02388073,Auro-Amoxicillin,1,J01CA04,Amoxicillin,Capsule,Oral,02388073,AURO-AMOXICILLIN (amoxicillin (amoxicillin trihydrate) 250 mg oral capsule) AURO PHARMA INC,Active,9007158,amoxicillin 250 mg oral capsule,8000073,amoxicillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87365,Marketed,2012-07-26,02388081,Auro-Amoxicillin,1,J01CA04,Amoxicillin,Capsule,Oral,02388081,AURO-AMOXICILLIN (amoxicillin (amoxicillin trihydrate) 500 mg oral capsule) AURO PHARMA INC,Active,9007164,amoxicillin 500 mg oral capsule,8000073,amoxicillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88640,Marketed,2020-10-31,02401509,Amoxicillin,1,J01CA04,Amoxicillin,Capsule,Oral,02401509,AMOXICILLIN (amoxicillin (amoxicillin trihydrate) 500 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9007164,amoxicillin 500 mg oral capsule,8000073,amoxicillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88644,Marketed,2013-02-14,02401541,Amoxicillin,1,J01CA04,Amoxicillin,Granules for suspension,Oral,02401541,AMOXICILLIN (amoxicillin (amoxicillin trihydrate) 250 mg per 5 mL oral suspension) SIVEM PHARMACEUTICALS ULC,Active,9007160,amoxicillin 250 mg per 5 mL oral suspension,8000073,amoxicillin,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
91747,Marketed,2015-12-07,02433060,JAMP-Amoxicillin,1,J01CA04,Amoxicillin,Capsule,Oral,02433060,JAMP-AMOXICILLIN (amoxicillin (amoxicillin trihydrate) 250 mg oral capsule) JAMP PHARMA CORPORATION,Active,9007158,amoxicillin 250 mg oral capsule,8000073,amoxicillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
91748,Marketed,2015-12-07,02433079,JAMP-Amoxicillin,1,J01CA04,Amoxicillin,Capsule,Oral,02433079,JAMP-AMOXICILLIN (amoxicillin (amoxicillin trihydrate) 500 mg oral capsule) JAMP PHARMA CORPORATION,Active,9007164,amoxicillin 500 mg oral capsule,8000073,amoxicillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
94573,Marketed,2021-10-14,02458586,Auro-Amoxicillin,1,J01CA04,Amoxicillin,Powder for suspension,Oral,02458586,AURO-AMOXICILLIN (amoxicillin (amoxicillin trihydrate) 125 mg per 5 mL oral suspension) AURO PHARMA INC,Active,9007154,amoxicillin 125 mg per 5 mL oral suspension,8000073,amoxicillin,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
94574,Marketed,2021-10-14,02458594,Auro-Amoxicillin,1,J01CA04,Amoxicillin,Powder for suspension,Oral,02458594,AURO-AMOXICILLIN (amoxicillin (amoxicillin trihydrate) 250 mg per 5 mL oral suspension) AURO PHARMA INC,Active,9007160,amoxicillin 250 mg per 5 mL oral suspension,8000073,amoxicillin,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
96865,Marketed,2018-09-06,02477726,AG-Amoxicillin,1,J01CA04,Amoxicillin,Capsule,Oral,02477726,AG-AMOXICILLIN (amoxicillin (amoxicillin trihydrate) 500 mg oral capsule) ANGITA PHARMA INC.,Active,9007164,amoxicillin 500 mg oral capsule,8000073,amoxicillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98576,Marketed,2024-04-29,02495864,Sandoz Amoxicillin,1,J01CA04,Amoxicillin,Powder for suspension,Oral,02495864,SANDOZ AMOXICILLIN (amoxicillin (amoxicillin trihydrate) 250 mg per 5 mL oral suspension) SANDOZ CANADA INCORPORATED,Active,9007160,amoxicillin 250 mg per 5 mL oral suspension,8000073,amoxicillin,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
101985,Marketed,2022-11-24,02530694,M-Amoxi Clav,2,J01CR02,Amoxicillin and beta-lactamase inhibitor,Powder for suspension,Oral,02530694,M-AMOXI CLAV (amoxicillin (amoxicillin trihydrate) 400 mg per 5 mL and clavulanic acid (potassium clavulanate) 57 mg per 5 mL oral suspension) MANTRA PHARMA INC,Active,9006262,amoxicillin 400 mg per 5 mL and clavulanic acid (potassium clavulanate) 57 mg per 5 mL oral suspension,8000154,amoxicillin and clavulanic acid,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
102484,Marketed,2024-02-20,02536021,Amoxicillin/Clav,2,J01CR02,Amoxicillin and beta-lactamase inhibitor,Tablet,Oral,02536021,AMOXICILLIN/CLAV (amoxicillin (amoxicillin trihydrate) 500 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) SANIS HEALTH INC,Active,9000402,amoxicillin 500 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet,8000154,amoxicillin and clavulanic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102485,Marketed,2024-02-20,02536048,Amoxicillin/Clav,2,J01CR02,Amoxicillin and beta-lactamase inhibitor,Tablet,Oral,02536048,AMOXICILLIN/CLAV (amoxicillin (amoxicillin trihydrate) 875 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) SANIS HEALTH INC,Active,9000823,amoxicillin 875 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet,8000154,amoxicillin and clavulanic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102526,Marketed,2023-07-10,02536498,Pro-Amoxi Clav,2,J01CR02,Amoxicillin and beta-lactamase inhibitor,Tablet,Oral,02536498,PRO-AMOXI CLAV (amoxicillin (amoxicillin trihydrate) 500 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) PRO DOC LIMITEE,Active,9000402,amoxicillin 500 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet,8000154,amoxicillin and clavulanic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102527,Marketed,2023-07-10,02536501,Pro-Amoxi Clav,2,J01CR02,Amoxicillin and beta-lactamase inhibitor,Tablet,Oral,02536501,PRO-AMOXI CLAV (amoxicillin (amoxicillin trihydrate) 875 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) PRO DOC LIMITEE,Active,9000823,amoxicillin 875 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet,8000154,amoxicillin and clavulanic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102817,Marketed,2024-07-22,02539411,JAMP Amoxi Clav Suspension,2,J01CR02,Amoxicillin and beta-lactamase inhibitor,Powder for suspension,Oral,02539411,JAMP AMOXI CLAV SUSPENSION (amoxicillin (amoxicillin trihydrate) 200 mg per 5 mL and clavulanic acid (potassium clavulanate) 28.5 mg per 5 mL oral suspension) JAMP PHARMA CORPORATION,Active,9006261,amoxicillin 200 mg per 5 mL and clavulanic acid (potassium clavulanate) 28.5 mg per 5 mL oral suspension,8000154,amoxicillin and clavulanic acid,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
102818,Marketed,2024-07-22,02539438,JAMP Amoxi Clav Suspension,2,J01CR02,Amoxicillin and beta-lactamase inhibitor,Powder for suspension,Oral,02539438,JAMP AMOXI CLAV SUSPENSION (amoxicillin (amoxicillin trihydrate) 250 mg per 5 mL and clavulanic acid (potassium clavulanate) 62.5 mg per 5 mL oral suspension) JAMP PHARMA CORPORATION,Active,9000992,amoxicillin 250 mg per 5 mL and clavulanic acid (potassium clavulanate) 62.5 mg per 5 mL oral suspension,8000154,amoxicillin and clavulanic acid,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
102819,Marketed,2024-07-22,02539446,JAMP Amoxi Clav Suspension,2,J01CR02,Amoxicillin and beta-lactamase inhibitor,Powder for suspension,Oral,02539446,JAMP AMOXI CLAV SUSPENSION (amoxicillin (amoxicillin trihydrate) 400 mg per 5 mL and clavulanic acid (potassium clavulanate) 57 mg per 5 mL oral suspension) JAMP PHARMA CORPORATION,Active,9006262,amoxicillin 400 mg per 5 mL and clavulanic acid (potassium clavulanate) 57 mg per 5 mL oral suspension,8000154,amoxicillin and clavulanic acid,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
103081,Marketed,2024-02-01,02542226,M-Amoxi Clav,2,J01CR02,Amoxicillin and beta-lactamase inhibitor,Powder for suspension,Oral,02542226,M-AMOXI CLAV (amoxicillin (amoxicillin trihydrate) 250 mg per 5 mL and clavulanic acid (potassium clavulanate) 62.5 mg per 5 mL oral suspension) MANTRA PHARMA INC,Active,9000992,amoxicillin 250 mg per 5 mL and clavulanic acid (potassium clavulanate) 62.5 mg per 5 mL oral suspension,8000154,amoxicillin and clavulanic acid,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
15208,Marketed,2003-02-10,01916882,Clavulin 125 F Oral Suspension,2,J01CR02,Amoxicillin and beta-lactamase inhibitor,Powder for suspension,Oral,01916882,CLAVULIN 125 F ORAL SUS (amoxicillin (amoxicillin trihydrate) 125 mg per 5 mL and clavulanic acid (potassium clavulanate) 31.25 mg per 5 mL oral suspension) GLAXOSMITHKLINE INC,Active,9000991,amoxicillin 125 mg per 5 mL and clavulanic acid (potassium clavulanate) 31.25 mg per 5 mL oral suspension,8000154,amoxicillin and clavulanic acid,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
15209,Marketed,2003-01-31,01916874,Clavulin 250 F Oral Suspension,2,J01CR02,Amoxicillin and beta-lactamase inhibitor,Powder for suspension,Oral,01916874,CLAVULIN 250 F ORAL SUS (amoxicillin (amoxicillin trihydrate) 250 mg per 5 mL and clavulanic acid (potassium clavulanate) 62.5 mg per 5 mL oral suspension) GLAXOSMITHKLINE INC,Active,9000992,amoxicillin 250 mg per 5 mL and clavulanic acid (potassium clavulanate) 62.5 mg per 5 mL oral suspension,8000154,amoxicillin and clavulanic acid,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
62268,Marketed,2002-12-17,02238830,Clavulin 400,2,J01CR02,Amoxicillin and beta-lactamase inhibitor,Powder for suspension,Oral,02238830,CLAVULIN 400 (amoxicillin (amoxicillin trihydrate) 400 mg per 5 mL and clavulanic acid (potassium clavulanate) 57 mg per 5 mL oral suspension) GLAXOSMITHKLINE INC,Active,9006262,amoxicillin 400 mg per 5 mL and clavulanic acid (potassium clavulanate) 57 mg per 5 mL oral suspension,8000154,amoxicillin and clavulanic acid,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
62269,Marketed,2003-01-15,02238831,Clavulin 200,2,J01CR02,Amoxicillin and beta-lactamase inhibitor,Powder for suspension,Oral,02238831,CLAVULIN 200 (amoxicillin (amoxicillin trihydrate) 200 mg per 5 mL and clavulanic acid (potassium clavulanate) 28.5 mg per 5 mL oral suspension) GLAXOSMITHKLINE INC,Active,9006261,amoxicillin 200 mg per 5 mL and clavulanic acid (potassium clavulanate) 28.5 mg per 5 mL oral suspension,8000154,amoxicillin and clavulanic acid,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
67257,Marketed,2020-02-10,02243350,Apo-Amoxi Clav,2,J01CR02,Amoxicillin and beta-lactamase inhibitor,Tablet,Oral,02243350,APO-AMOXI CLAV (amoxicillin (amoxicillin trihydrate) 250 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) APOTEX INC,Active,9000933,amoxicillin 250 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet,8000154,amoxicillin and clavulanic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
67258,Marketed,2020-02-10,02243351,Apo-Amoxi Clav,2,J01CR02,Amoxicillin and beta-lactamase inhibitor,Tablet,Oral,02243351,APO-AMOXI CLAV (amoxicillin (amoxicillin trihydrate) 500 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) APOTEX INC,Active,9000402,amoxicillin 500 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet,8000154,amoxicillin and clavulanic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
69723,Marketed,2019-07-03,02245623,Apo-Amoxi Clav,2,J01CR02,Amoxicillin and beta-lactamase inhibitor,Tablet,Oral,02245623,APO-AMOXI CLAV (amoxicillin (amoxicillin trihydrate) 875 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) APOTEX INC,Active,9000823,amoxicillin 875 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet,8000154,amoxicillin and clavulanic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96090,Marketed,2022-03-03,02471671,Auro-Amoxiclav,2,J01CR02,Amoxicillin and beta-lactamase inhibitor,Tablet,Oral,02471671,AURO-AMOXICLAV (amoxicillin (amoxicillin trihydrate) 250 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) AURO PHARMA INC,Active,9000933,amoxicillin 250 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet,8000154,amoxicillin and clavulanic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96091,Marketed,2022-03-03,02471698,Auro-Amoxiclav,2,J01CR02,Amoxicillin and beta-lactamase inhibitor,Tablet,Oral,02471698,AURO-AMOXICLAV (amoxicillin (amoxicillin trihydrate) 500 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) AURO PHARMA INC,Active,9000402,amoxicillin 500 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet,8000154,amoxicillin and clavulanic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96092,Marketed,2022-03-03,02471701,Auro-Amoxiclav,2,J01CR02,Amoxicillin and beta-lactamase inhibitor,Tablet,Oral,02471701,AURO-AMOXICLAV (amoxicillin (amoxicillin trihydrate) 875 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) AURO PHARMA INC,Active,9000823,amoxicillin 875 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet,8000154,amoxicillin and clavulanic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97300,Marketed,2019-03-01,02482576,Sandoz Amoxi-Clav Tablet,2,J01CR02,Amoxicillin and beta-lactamase inhibitor,Tablet,Oral,02482576,SANDOZ AMOXI-CLAV TABLET (amoxicillin (amoxicillin trihydrate) 500 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000402,amoxicillin 500 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet,8000154,amoxicillin and clavulanic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97301,Marketed,2019-03-01,02482584,Sandoz Amoxi-Clav Tablet,2,J01CR02,Amoxicillin and beta-lactamase inhibitor,Tablet,Oral,02482584,SANDOZ AMOXI-CLAV TABLET (amoxicillin (amoxicillin trihydrate) 875 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000823,amoxicillin 875 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet,8000154,amoxicillin and clavulanic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98581,Marketed,2020-07-03,02495910,Amoxicillin Sodium And Potassium Clavulanate For Injection,2,J01CR02,Amoxicillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02495910,AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION (amoxicillin (amoxicillin sodium) 500 mg per vial and clavulanic acid (potassium clavulanate) 100 mg per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9014338,amoxicillin (amoxicillin sodium) 500 mg per vial and clavulanic acid (potassium clavulanate) 100 mg per vial powder for solution for injection,8000154,amoxicillin and clavulanic acid,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
98582,Marketed,2020-07-03,02495929,Amoxicillin Sodium And Potassium Clavulanate For Injection,2,J01CR02,Amoxicillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02495929,AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION (amoxicillin (amoxicillin sodium) 1000 mg per vial and clavulanic acid (potassium clavulanate) 200 mg per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9014336,amoxicillin (amoxicillin sodium) 1000 mg per vial and clavulanic acid (potassium clavulanate) 200 mg per vial powder for solution for injection,8000154,amoxicillin and clavulanic acid,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
98583,Marketed,2020-07-03,02495937,Amoxicillin Sodium And Potassium Clavulanate For Injection,2,J01CR02,Amoxicillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02495937,AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION (amoxicillin (amoxicillin sodium) 2000 mg per vial and clavulanic acid (potassium clavulanate) 200 mg per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9014337,amoxicillin (amoxicillin sodium) 2000 mg per vial and clavulanic acid (potassium clavulanate) 200 mg per vial powder for solution for injection,8000154,amoxicillin and clavulanic acid,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
99763,Marketed,2021-12-24,02508249,JAMP Amoxi Clav,2,J01CR02,Amoxicillin and beta-lactamase inhibitor,Tablet,Oral,02508249,JAMP AMOXI CLAV (amoxicillin (amoxicillin trihydrate) 250 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000933,amoxicillin 250 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet,8000154,amoxicillin and clavulanic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99764,Marketed,2021-12-24,02508257,JAMP Amoxi Clav,2,J01CR02,Amoxicillin and beta-lactamase inhibitor,Tablet,Oral,02508257,JAMP AMOXI CLAV (amoxicillin (amoxicillin trihydrate) 500 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000402,amoxicillin 500 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet,8000154,amoxicillin and clavulanic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99765,Marketed,2021-12-24,02508265,JAMP Amoxi Clav,2,J01CR02,Amoxicillin and beta-lactamase inhibitor,Tablet,Oral,02508265,JAMP AMOXI CLAV (amoxicillin (amoxicillin trihydrate) 875 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000823,amoxicillin 875 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet,8000154,amoxicillin and clavulanic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99983,Marketed,2022-08-18,02510634,AG-Amoxi Clav,2,J01CR02,Amoxicillin and beta-lactamase inhibitor,Tablet,Oral,02510634,AG-AMOXI CLAV (amoxicillin (amoxicillin trihydrate) 500 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) ANGITA PHARMA INC.,Active,9000402,amoxicillin 500 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet,8000154,amoxicillin and clavulanic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99984,Marketed,2021-12-31,02510642,AG-Amoxi Clav,2,J01CR02,Amoxicillin and beta-lactamase inhibitor,Tablet,Oral,02510642,AG-AMOXI CLAV (amoxicillin (amoxicillin trihydrate) 875 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) ANGITA PHARMA INC.,Active,9000823,amoxicillin 875 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet,8000154,amoxicillin and clavulanic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
65288,Marketed,2012-07-24,02241630,Ambisome,1,J02AA01,Amphotericin b,Powder for solution,Intravenous,,,,,,,,,,,,,,,,,Prescription
933,Marketed,2020-01-02,00029149,Fungizone,1,J02AA01,Amphotericin b,Powder for solution,Intravenous,,,,,,,,,,,,,,,,,Prescription
101968,Marketed,2024-08-02,02530481,Ampicillin Sodium For Injection BP,1,J01CA01,Ampicillin,Powder for solution,"Intravenous,Intramuscular",02530481,AMPICILLIN SODIUM FOR INJECTION BP (ampicillin (ampicillin sodium) 500 mg per vial powder for solution for injection) EUGIA PHARMA INC.,Active,9002416,ampicillin (ampicillin sodium) 500 mg per vial powder for solution for injection,8001068,ampicillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
101969,Marketed,2024-08-02,02530503,Ampicillin Sodium For Injection BP,1,J01CA01,Ampicillin,Powder for solution,"Intravenous,Intramuscular",02530503,AMPICILLIN SODIUM FOR INJECTION BP (ampicillin (ampicillin sodium) 1 g per vial powder for solution for injection) EUGIA PHARMA INC.,Active,9003279,ampicillin (ampicillin sodium) 1 g per vial powder for solution for injection,8001068,ampicillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
101970,Marketed,2024-08-02,02530511,Ampicillin Sodium For Injection BP,1,J01CA01,Ampicillin,Powder for solution,Intravenous,02530511,AMPICILLIN SODIUM FOR INJECTION BP (ampicillin (ampicillin sodium) 2 g per vial powder for solution for injection) EUGIA PHARMA INC.,Active,9003272,ampicillin (ampicillin sodium) 2 g per vial powder for solution for injection,8001068,ampicillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
1124,Marketed,2015-07-10,00020885,Teva-Ampicillin,1,J01CA01,Ampicillin,Capsule,Oral,00020885,TEVA-AMPICILLIN (ampicillin (ampicillin trihydrate) 500 mg oral capsule) TEVA CANADA LIMITED,Active,9002007,ampicillin 500 mg oral capsule,8001068,ampicillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
1125,Marketed,2015-07-10,00020877,Teva-Ampicillin,1,J01CA01,Ampicillin,Capsule,Oral,00020877,TEVA-AMPICILLIN (ampicillin (ampicillin trihydrate) 250 mg oral capsule) TEVA CANADA LIMITED,Active,9002005,ampicillin 250 mg oral capsule,8001068,ampicillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
12261,Marketed,2014-05-22,00872644,"Ampicillin Sodium For Injection, USP",1,J01CA01,Ampicillin,Powder for solution,"Intravenous,Intramuscular",00872644,"AMPICILLIN SODIUM FOR INJECTION, USP (ampicillin (ampicillin sodium) 250 mg per vial powder for solution for injection) TEVA CANADA LIMITED",Active,9002415,ampicillin (ampicillin sodium) 250 mg per vial powder for solution for injection,8001068,ampicillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
12262,Marketed,2014-05-22,00872652,"Ampicillin Sodium For Injection, USP",1,J01CA01,Ampicillin,Powder for solution,"Intramuscular,Intravenous",00872652,"AMPICILLIN SODIUM FOR INJECTION, USP (ampicillin (ampicillin sodium) 500 mg per vial powder for solution for injection) TEVA CANADA LIMITED",Active,9002416,ampicillin (ampicillin sodium) 500 mg per vial powder for solution for injection,8001068,ampicillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
12267,Marketed,2014-05-22,01933345,"Ampicillin Sodium For Injection, USP",1,J01CA01,Ampicillin,Powder for solution,"Intramuscular,Intravenous",01933345,"AMPICILLIN SODIUM FOR INJECTION, USP (ampicillin (ampicillin sodium) 1 g per vial powder for solution for injection) TEVA CANADA LIMITED",Active,9003279,ampicillin (ampicillin sodium) 1 g per vial powder for solution for injection,8001068,ampicillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
12268,Marketed,2014-05-22,01933353,"Ampicillin Sodium For Injection, USP",1,J01CA01,Ampicillin,Powder for solution,"Intravenous,Intramuscular",01933353,"AMPICILLIN SODIUM FOR INJECTION, USP (ampicillin (ampicillin sodium) 2 g per vial powder for solution for injection) TEVA CANADA LIMITED",Active,9003272,ampicillin (ampicillin sodium) 2 g per vial powder for solution for injection,8001068,ampicillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
37491,Marketed,2019-08-16,02226995,"Ampicillin For Injection, USP",1,J01CA01,Ampicillin,Powder for solution,Intravenous,02226995,"AMPICILLIN FOR INJECTION, USP (ampicillin (ampicillin sodium) 2 g per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9003272,ampicillin (ampicillin sodium) 2 g per vial powder for solution for injection,8001068,ampicillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
37492,Marketed,2019-08-16,02227002,"Ampicillin For Injection, USP",1,J01CA01,Ampicillin,Powder for solution,"Intravenous,Intramuscular",02227002,"AMPICILLIN FOR INJECTION, USP (ampicillin (ampicillin sodium) 1 g per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9003279,ampicillin (ampicillin sodium) 1 g per vial powder for solution for injection,8001068,ampicillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
37493,Marketed,2019-08-16,02227010,"Ampicillin For Injection, USP",1,J01CA01,Ampicillin,Powder for solution,"Intramuscular,Intravenous",02227010,"AMPICILLIN FOR INJECTION, USP (ampicillin (ampicillin sodium) 500 mg per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9002416,ampicillin (ampicillin sodium) 500 mg per vial powder for solution for injection,8001068,ampicillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
37494,Marketed,2019-08-16,02227029,"Ampicillin For Injection, USP",1,J01CA01,Ampicillin,Powder for solution,"Intramuscular,Intravenous",02227029,"AMPICILLIN FOR INJECTION, USP (ampicillin (ampicillin sodium) 250 mg per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9002415,ampicillin (ampicillin sodium) 250 mg per vial powder for solution for injection,8001068,ampicillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
95004,Marketed,2017-10-20,02462303,Ampicillin Sodium For Injection BP,1,J01CA01,Ampicillin,Powder for solution,"Intramuscular,Intravenous",02462303,AMPICILLIN SODIUM FOR INJECTION BP (ampicillin (ampicillin sodium) 250 mg per vial powder for solution for injection) AURO PHARMA INC,Active,9002415,ampicillin (ampicillin sodium) 250 mg per vial powder for solution for injection,8001068,ampicillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
95005,Marketed,2017-10-20,02462311,Ampicillin Sodium For Injection BP,1,J01CA01,Ampicillin,Powder for solution,"Intramuscular,Intravenous",02462311,AMPICILLIN SODIUM FOR INJECTION BP (ampicillin (ampicillin sodium) 500 mg per vial powder for solution for injection) AURO PHARMA INC,Active,9002416,ampicillin (ampicillin sodium) 500 mg per vial powder for solution for injection,8001068,ampicillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
95006,Marketed,2017-10-20,02462338,Ampicillin Sodium For Injection BP,1,J01CA01,Ampicillin,Powder for solution,"Intramuscular,Intravenous",02462338,AMPICILLIN SODIUM FOR INJECTION BP (ampicillin (ampicillin sodium) 1 g per vial powder for solution for injection) AURO PHARMA INC,Active,9003279,ampicillin (ampicillin sodium) 1 g per vial powder for solution for injection,8001068,ampicillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
95007,Marketed,2017-10-20,02462346,Ampicillin Sodium For Injection BP,1,J01CA01,Ampicillin,Powder for solution,Intravenous,02462346,AMPICILLIN SODIUM FOR INJECTION BP (ampicillin (ampicillin sodium) 2 g per vial powder for solution for injection) AURO PHARMA INC,Active,9003272,ampicillin (ampicillin sodium) 2 g per vial powder for solution for injection,8001068,ampicillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
76047,Marketed,2006-01-06,02274949,PMS-Anagrelide,1,L01XX35,Anagrelide,Capsule,Oral,02274949,PMS-ANAGRELIDE (anagrelide (anagrelide hydrochloride monohydrate) 0.5 mg oral capsule) PHARMASCIENCE INC,Active,9003198,anagrelide (anagrelide hydrochloride) 0.5 mg oral capsule,8001565,anagrelide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
70033,Marketed,2011-06-22,02245913,Kineret,1,L04AC03,Anakinra,Solution,Subcutaneous,02245913,KINERET (anakinra 150 mg per mL solution for injection 0.67 mL syringe) SWEDISH ORPHAN BIOVITRUM AB (PUBL),Active,9012892,anakinra 150 mg per mL solution for injection 0.67 mL syringe,8001566,anakinra,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
70033,Marketed,2011-06-22,02245913,Kineret,1,L04AC03,Anakinra,Solution,Subcutaneous,02245913,KINERET (anakinra 150 mg per mL solution for injection 0.67 mL syringe) SWEDISH ORPHAN BIOVITRUM AB (PUBL),Active,9012892,anakinra 150 mg per mL solution for injection 0.67 mL syringe,8001566,anakinra,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
101913,Marketed,2025-05-29,02529904,Anastrozole,1,L02BG03,Anastrozole,Tablet,Oral,02529904,ANASTROZOLE (anastrozole 1 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102307,Marketed,2023-07-27,02534118,AG-Anastrozole,1,L02BG03,Anastrozole,Tablet,Oral,02534118,AG-ANASTROZOLE (anastrozole 1 mg oral tablet) ANGITA PHARMA INC.,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102927,Marketed,2025-09-29,02540584,JAMP Anastrozole Tablets,1,L02BG03,Anastrozole,Tablet,Oral,02540584,JAMP ANASTROZOLE TABLETS (anastrozole 1 mg oral tablet) JAMP PHARMA CORPORATION,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
104259,Marketed,2025-07-22,02553686,AG-Anastrozole Tablets,1,L02BG03,Anastrozole,Tablet,Oral,02553686,AG-ANASTROZOLE TABLETS (anastrozole 1 mg oral tablet) ANGITA PHARMA INC.,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
43395,Marketed,2002-01-25,02224135,Arimidex,1,L02BG03,Anastrozole,Tablet,Oral,02224135,ARIMIDEX (anastrozole 1 mg oral tablet) ASTRAZENECA CANADA INC,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
80614,Marketed,2012-10-25,02320738,PMS-Anastrozole,1,L02BG03,Anastrozole,Tablet,Oral,02320738,PMS-ANASTROZOLE (anastrozole 1 mg oral tablet) PHARMASCIENCE INC,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
82412,Marketed,2012-07-26,02338467,Sandoz Anastrozole,1,L02BG03,Anastrozole,Tablet,Oral,02338467,SANDOZ ANASTROZOLE (anastrozole 1 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
82471,Marketed,2012-10-25,02339080,JAMP-Anastrozole,1,L02BG03,Anastrozole,Tablet,Oral,02339080,JAMP-ANASTROZOLE (anastrozole 1 mg oral tablet) JAMP PHARMA CORPORATION,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
83640,Marketed,2014-10-23,02351218,ACH-Anastrozole,1,L02BG03,Anastrozole,Tablet,Oral,02351218,ACH-ANASTROZOLE (anastrozole 1 mg oral tablet) ACCORD HEALTHCARE INC,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
85053,Marketed,2012-10-25,02365650,Taro-Anastrozole,1,L02BG03,Anastrozole,Tablet,Oral,02365650,TARO-ANASTROZOLE (anastrozole 1 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
85968,Marketed,2012-10-25,02374420,Apo-Anastrozole,1,L02BG03,Anastrozole,Tablet,Oral,02374420,APO-ANASTROZOLE (anastrozole 1 mg oral tablet) APOTEX INC,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
86544,Marketed,2012-10-25,02379562,Mar-Anastrozole,1,L02BG03,Anastrozole,Tablet,Oral,02379562,MAR-ANASTROZOLE (anastrozole 1 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
87753,Marketed,2025-12-29,02392259,Riva-Anastrozole,1,L02BG03,Anastrozole,Tablet,Oral,02392259,RIVA-ANASTROZOLE (anastrozole 1 mg oral tablet) LABORATOIRE RIVA INC.,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
87775,Marketed,2013-01-15,02392488,Bio-Anastrozole,1,L02BG03,Anastrozole,Tablet,Oral,02392488,BIO-ANASTROZOLE (anastrozole 1 mg oral tablet) BIOMED PHARMA,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
88004,Marketed,2020-01-21,02394898,Teva-Anastrozole,1,L02BG03,Anastrozole,Tablet,Oral,02394898,TEVA-ANASTROZOLE (anastrozole 1 mg oral tablet) TEVA CANADA LIMITED,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
88072,Marketed,2025-10-30,02395649,Pro-Anastrozole,1,L02BG03,Anastrozole,Tablet,Oral,02395649,PRO-ANASTROZOLE (anastrozole 1 mg oral tablet) PRO DOC LIMITEE,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
90247,Marketed,2015-02-03,02417855,Nat-Anastrozole,1,L02BG03,Anastrozole,Tablet,Oral,02417855,NAT-ANASTROZOLE (anastrozole 1 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
92706,Marketed,2015-07-22,02442736,Anastrozole,1,L02BG03,Anastrozole,Tablet,Oral,02442736,ANASTROZOLE (anastrozole 1 mg oral tablet) SANIS HEALTH INC,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102725,Marketed,2024-05-27,02538539,Ondexxya,1,V03AB38,Andexanet alfa,Powder for solution,Intravenous,02538539,ONDEXXYA (andexanet alfa 200 mg per vial powder for solution for injection) ASTRAZENECA CANADA INC,Active,9015048,andexanet alfa 200 mg per vial powder for solution for injection,8002508,andexanet alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
102725,Marketed,2024-05-27,02538539,Ondexxya,1,V03AB38,Andexanet alfa,Powder for solution,Intravenous,02538539,ONDEXXYA (andexanet alfa 200 mg per vial powder for solution for injection) ASTRAZENECA CANADA INC,Active,9015048,andexanet alfa 200 mg per vial powder for solution for injection,8002508,andexanet alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
63884,Marketed,2005-03-31,02240344,Sialor,1,A16AX02,Anethole trithione,Tablet,Oral,02240344,SIALOR (anethole trithione 25 mg oral tablet) PHARMASCIENCE INC,Active,9003505,anethole trithione 25 mg oral tablet,8001567,anethole trithione,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Ethical
81644,Marketed,2010-01-25,02330695,Eraxis,1,J02AX06,Anidulafungin,Powder for solution,Intravenous,02330695,ERAXIS (anidulafungin 100 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9004633,anidulafungin 100 mg per vial powder for solution for injection,8001170,anidulafungin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
101194,Marketed,2022-03-01,02522845,Saphnelo,1,L04AG11,Anifrolumab,Solution,Intravenous,02522845,SAPHNELO (anifrolumab 300 mg per 2 mL solution for injection vial) ASTRAZENECA CANADA INC,Active,9014672,anifrolumab 300 mg per 2 mL solution for injection vial,8002411,anifrolumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
101194,Marketed,2022-03-01,02522845,Saphnelo,1,L04AG11,Anifrolumab,Solution,Intravenous,02522845,SAPHNELO (anifrolumab 300 mg per 2 mL solution for injection vial) ASTRAZENECA CANADA INC,Active,9014672,anifrolumab 300 mg per 2 mL solution for injection vial,8002411,anifrolumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
43218,Marketed,2023-03-24,02217457,Standardized Cat Hair Ap,1,V01AA11,Animals,Solution,"Subcutaneous,Intradermal",,,,,,,,,,,,,,,,,Schedule D
62882,Marketed,1999-04-19,02239410,Allergenic Extract-Standardized Cat Hair,1,V01AA11,Animals,Liquid,"Subcutaneous,Intracutaneous",,,,,,,,,,,,,,,,,Schedule D
60637,Marketed,2000-02-18,02237315,Pepto-Bismol Chewables,2,A02AX,"Antacids, other combinations",Tablet (chewable),Oral,02237315,PEPTO-BISMOL CHEWABLES (bismuth subsalicylate 262 mg and calcium carbonate 350 mg chewable tablet) PROCTER & GAMBLE INC,Active,9004592,bismuth subsalicylate 262 mg and calcium carbonate 350 mg chewable tablet,8001706,bismuth subsalicylate and calcium carbonate,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
87472,Marketed,2013-11-20,02389215,Stomach Relief Chewable Tablets,2,A02AX,"Antacids, other combinations",Tablet (chewable),Oral,02389215,STOMACH RELIEF CHEWABLE TABLETS (bismuth subsalicylate 262 mg and calcium carbonate 350 mg chewable tablet) GUARDIAN DRUG COMPANY INC,Active,9004592,bismuth subsalicylate 262 mg and calcium carbonate 350 mg chewable tablet,8001706,bismuth subsalicylate and calcium carbonate,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
78787,Marketed,2022-07-11,02302551,Winrho SDF,1,J06BB01,Anti-d (rh) immunoglobulin,Solution,"Intramuscular,Intravenous",,,,,,,,,,,,,,,,,Schedule D
78788,Marketed,2022-07-11,02302578,Winrho SDF,1,J06BB01,Anti-d (rh) immunoglobulin,Solution,"Intramuscular,Intravenous",,,,,,,,,,,,,,,,,Schedule D
104466,Marketed,2025-06-10,02555948,Rebyota,1,A07FA,Antidiarrheal microorganisms,Suspension,Rectal,02555948,REBYOTA (fecal microbiota 5e10 cfu per mL rectal suspension 150 mL bag) FERRING INC,Active,9015235,fecal microbiota 5e10 cfu per mL rectal suspension 150 mL bag,8002548,fecal microbiota,37161004,Rectal,385188006,Rectal suspension,732982009,Bag,,,,Schedule D
104466,Marketed,2025-06-10,02555948,Rebyota,1,A07FA,Antidiarrheal microorganisms,Suspension,Rectal,02555948,REBYOTA (fecal microbiota 5e10 cfu per mL rectal suspension 150 mL bag) FERRING INC,Active,9015235,fecal microbiota 5e10 cfu per mL rectal suspension 150 mL bag,8002548,fecal microbiota,37161004,Rectal,385188006,Rectal suspension,732982009,Bag,,,,Prescription
76500,Marketed,2023-09-11,02279401,Revatio,1,C02KX,Antihypertensives for pulmonary arterial hypertension,Tablet,Oral,02279401,REVATIO (sildenafil (sildenafil citrate) 20 mg oral tablet) BGP PHARMA ULC,Active,9001153,sildenafil (sildenafil citrate) 20 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80498,Marketed,2017-11-21,02319500,Teva-Sildenafil R,1,C02KX,Antihypertensives for pulmonary arterial hypertension,Tablet,Oral,02319500,TEVA-SILDENAFIL R (sildenafil (sildenafil citrate) 20 mg oral tablet) TEVA CANADA LIMITED,Active,9001153,sildenafil (sildenafil citrate) 20 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82711,Marketed,2023-09-11,02341611,Revatio,1,C02KX,Antihypertensives for pulmonary arterial hypertension,Solution,Intravenous,02341611,REVATIO (sildenafil (sildenafil citrate) 10 mg per 12.5 mL solution for injection vial) BGP PHARMA ULC,Active,9001321,sildenafil (sildenafil citrate) 10 mg per 12.5 mL solution for injection vial,8000268,sildenafil,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
89674,Marketed,2014-11-14,02412179,PMS-Sildenafil R,1,C02KX,Antihypertensives for pulmonary arterial hypertension,Tablet,Oral,02412179,PMS-SILDENAFIL R (sildenafil (sildenafil citrate) 20 mg oral tablet) PHARMASCIENCE INC,Active,9001153,sildenafil (sildenafil citrate) 20 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95846,Marketed,2021-02-08,02469669,JAMP-Sildenafil R,1,C02KX,Antihypertensives for pulmonary arterial hypertension,Tablet,Oral,02469669,JAMP-SILDENAFIL R (sildenafil (sildenafil citrate) 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001153,sildenafil (sildenafil citrate) 20 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
10025,Marketed,2019-08-16,00701785,Optimyxin,2,S03AA30,"Antiinfectives, combinations",Drops,"Otic,Ophthalmic",00701785,OPTIMYXIN (gramicidin 0.025 mg per mL and polymyxin B (polymyxin B sulfate) 10000 unit per mL ophthalmic/otic drops) EURO-PHARM INTERNATIONAL CANADA INC,Active,9013881,gramicidin 0.025 mg per mL and polymyxin B (polymyxin B sulfate) 10000 unit per mL ophthalmic/otic drops,8002242,gramicidin and polymyxin B,255204007,Multiple (ophthalmic or otic),420636007,Ear or eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
104107,Marketed,2025-04-09,02552418,Soothe Antibiotic Drops,2,S03AA30,"Antiinfectives, combinations",Drops,"Ophthalmic,Otic",02552418,SOOTHE ANTIBIOTIC DROPS (gramicidin 0.025 mg per mL and polymyxin B (polymyxin B sulfate) 10000 unit per mL ophthalmic/otic drops) BAUSCH & LOMB INC,Active,9013881,gramicidin 0.025 mg per mL and polymyxin B (polymyxin B sulfate) 10000 unit per mL ophthalmic/otic drops,8002242,gramicidin and polymyxin B,255204007,Multiple (ophthalmic or otic),420636007,Ear or eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
62611,Marketed,2026-04-27,02239155,Polysporin Plus Pain Relief Ear Drops,2,S02AA30,"Antiinfectives, combinations",Drops,Otic,02239155,POLYSPORIN PLUS PAIN RELIEF EAR DROPS (lidocaine hydrochloride 50 mg per mL and polymyxin B (polymyxin B sulfate) 10000 unit per mL otic drops) KENVUE CANADA INC.,Active,9013889,lidocaine hydrochloride 50 mg per mL and polymyxin B (polymyxin B sulfate) 10000 unit per mL otic drops,8002244,lidocaine and polymyxin B,10547007,Otic,385136004,Otic drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
62612,Marketed,2026-04-27,02239156,Polysporin Eye And Ear Drops Sterile,2,S03AA30,"Antiinfectives, combinations",Drops,"Ophthalmic,Otic",02239156,POLYSPORIN EYE AND EAR DROPS STERILE (gramicidin 0.025 mg per mL and polymyxin B (polymyxin B sulfate) 10000 unit per mL ophthalmic/otic drops) KENVUE CANADA INC.,Active,9013881,gramicidin 0.025 mg per mL and polymyxin B (polymyxin B sulfate) 10000 unit per mL ophthalmic/otic drops,8002242,gramicidin and polymyxin B,255204007,Multiple (ophthalmic or otic),420636007,Ear or eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
100865,Marketed,2021-09-13,02519380,Myinfla,1,M01,Antiinflammatory and antirheumatic products,Tablet (extended-release),Oral,02519380,MYINFLA (colchicine 0.5 mg prolonged-release oral tablet) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9014595,colchicine 0.5 mg prolonged-release oral tablet,8000047,colchicine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
55838,Marketed,2006-08-23,02234470,Atgam,1,L04AA03,Antilymphocyte immunoglobulin (horse),Solution,Intravenous,02234470,ATGAM (anti-thymocyte immunoglobulin equine 250 mg per 5 mL solution for injection ampoule) PFIZER CANADA ULC,Active,9013762,anti-thymocyte immunoglobulin equine 250 mg per 5 mL solution for injection ampoule,8002217,anti-thymocyte immunoglobulin equine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Schedule D
55838,Marketed,2006-08-23,02234470,Atgam,1,L04AA03,Antilymphocyte immunoglobulin (horse),Solution,Intravenous,02234470,ATGAM (anti-thymocyte immunoglobulin equine 250 mg per 5 mL solution for injection ampoule) PFIZER CANADA ULC,Active,9013762,anti-thymocyte immunoglobulin equine 250 mg per 5 mL solution for injection ampoule,8002217,anti-thymocyte immunoglobulin equine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
103146,Marketed,2024-10-16,02542943,Asparlas,1,L01,Antineoplastic agents,Solution,Intravenous,02542943,ASPARLAS (calaspargase pegol 3750 unit per 5 mL solution for injection vial) SERVIER CANADA INC,Active,9015107,calaspargase pegol 3750 unit per 5 mL solution for injection vial,8002516,calaspargase pegol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
103146,Marketed,2024-10-16,02542943,Asparlas,1,L01,Antineoplastic agents,Solution,Intravenous,02542943,ASPARLAS (calaspargase pegol 3750 unit per 5 mL solution for injection vial) SERVIER CANADA INC,Active,9015107,calaspargase pegol 3750 unit per 5 mL solution for injection vial,8002516,calaspargase pegol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
61169,Marketed,2022-01-28,02237810,Antithrombin III Nf,1,B01AB02,Antithrombin,"Kit,Powder for solution",Intravenous,02237810,ANTITHROMBIN III NF (antithrombin III human 900-1100 unit per vial powder for solution for injection with diluent solution) TAKEDA CANADA INC,Active,9014075,antithrombin III human 900-1100 unit per vial powder for solution for injection with diluent solution,8002274,antithrombin III human,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
61170,Marketed,2021-04-30,02237811,Antithrombin III Nf,1,B01AB02,Antithrombin,"Kit,Powder for solution",Intravenous,02237811,ANTITHROMBIN III NF (antithrombin III human 450-550 unit per vial powder for solution for injection with diluent solution) TAKEDA CANADA INC,Active,9014074,antithrombin III human 450-550 unit per vial powder for solution for injection with diluent solution,8002274,antithrombin III human,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
71005,Marketed,2014-05-06,02246805,Thymoglobulin,1,L04AA04,Antithymocyte immunoglobulin (rabbit),Powder for solution,Intravenous,02246805,THYMOGLOBULIN (anti-thymocyte immunoglobulin rabbit 25 mg per vial powder for solution for injection) SANOFI-AVENTIS CANADA INC,Active,9013763,anti-thymocyte immunoglobulin rabbit 25 mg per vial powder for solution for injection,8002218,anti-thymocyte immunoglobulin rabbit,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
71005,Marketed,2014-05-06,02246805,Thymoglobulin,1,L04AA04,Antithymocyte immunoglobulin (rabbit),Powder for solution,Intravenous,02246805,THYMOGLOBULIN (anti-thymocyte immunoglobulin rabbit 25 mg per vial powder for solution for injection) SANOFI-AVENTIS CANADA INC,Active,9013763,anti-thymocyte immunoglobulin rabbit 25 mg per vial powder for solution for injection,8002218,anti-thymocyte immunoglobulin rabbit,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
98706,Marketed,2020-09-21,02497220,Cabenuva,2,J05AR,"Antivirals for treatment of hiv infections, combinations","Kit,Suspension (extended-release)",Intramuscular,02497220,CABENUVA (cabotegravir 400 mg per 2 mL prolonged-release suspension for injection vial with rilpivirine 600 mg per 2 mL prolonged-release suspension for injection vial) VIIV HEALTHCARE ULC,Active,9014354,cabotegravir 400 mg per 2 mL prolonged-release suspension for injection vial with rilpivirine 600 mg per 2 mL prolonged-release suspension for injection vial,8002342,cabotegravir and rilpivirine,738984000,Parenteral,420873008,Prolonged-release suspension for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
98709,Marketed,2020-09-21,02497247,Cabenuva,2,J05AR,"Antivirals for treatment of hiv infections, combinations","Suspension (extended-release),Kit",Intramuscular,02497247,CABENUVA (cabotegravir 600 mg per 3 mL prolonged-release suspension for injection vial with rilpivirine 900 mg per 3 mL prolonged-release suspension for injection vial) VIIV HEALTHCARE ULC,Active,9014355,cabotegravir 600 mg per 3 mL prolonged-release suspension for injection vial with rilpivirine 900 mg per 3 mL prolonged-release suspension for injection vial,8002342,cabotegravir and rilpivirine,738984000,Parenteral,420873008,Prolonged-release suspension for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
102889,Marketed,2023-11-01,02540185,Erleada,1,L02BB05,Apalutamide,Tablet,Oral,02540185,ERLEADA (apalutamide 240 mg oral tablet) JANSSEN INC,Active,9014937,apalutamide 240 mg oral tablet,8002010,apalutamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
96913,Marketed,2018-07-27,02478374,Erleada,1,L02BB05,Apalutamide,Tablet,Oral,02478374,ERLEADA (apalutamide 60 mg oral tablet) JANSSEN INC,Active,9013407,apalutamide 60 mg oral tablet,8002010,apalutamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101451,Marketed,2026-02-26,02525518,Riva Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02525518,RIVA APIXABAN (apixaban 2.5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101452,Marketed,2026-02-26,02525526,Riva Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02525526,RIVA APIXABAN (apixaban 5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101517,Marketed,2022-10-05,02526050,Nra-Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02526050,NRA-APIXABAN (apixaban 2.5 mg oral tablet) NORA PHARMA INC,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101519,Marketed,2022-10-05,02526069,Nra-Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02526069,NRA-APIXABAN (apixaban 5 mg oral tablet) NORA PHARMA INC,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101724,Marketed,2022-09-21,02527979,Bio-Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02527979,BIO-APIXABAN (apixaban 2.5 mg oral tablet) BIOMED PHARMA,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101725,Marketed,2022-09-21,02527987,Bio-Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02527987,BIO-APIXABAN (apixaban 5 mg oral tablet) BIOMED PHARMA,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101810,Marketed,2022-09-20,02528924,JAMP Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02528924,JAMP APIXABAN (apixaban 2.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101811,Marketed,2022-09-20,02528932,JAMP Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02528932,JAMP APIXABAN (apixaban 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101820,Marketed,2022-09-21,02529009,M-Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02529009,M-APIXABAN (apixaban 2.5 mg oral tablet) MANTRA PHARMA INC,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101821,Marketed,2022-09-21,02529017,M-Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02529017,M-APIXABAN (apixaban 5 mg oral tablet) MANTRA PHARMA INC,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101914,Marketed,2022-10-28,02529912,AG-Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02529912,AG-APIXABAN (apixaban 2.5 mg oral tablet) ANGITA PHARMA INC.,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101915,Marketed,2022-10-28,02529920,AG-Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02529920,AG-APIXABAN (apixaban 5 mg oral tablet) ANGITA PHARMA INC.,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101986,Marketed,2022-11-01,02530708,Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02530708,APIXABAN (apixaban 2.5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101987,Marketed,2022-11-01,02530716,Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02530716,APIXABAN (apixaban 5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101988,Marketed,2022-09-26,02530724,Pro-Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02530724,PRO-APIXABAN (apixaban 2.5 mg oral tablet) PRO DOC LIMITEE,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101990,Marketed,2022-09-26,02530732,Pro-Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02530732,PRO-APIXABAN (apixaban 5 mg oral tablet) PRO DOC LIMITEE,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103555,Marketed,2024-04-22,02546884,Nra-Apixaban Tablets,1,B01AF02,Apixaban,Tablet,Oral,02546884,NRA-APIXABAN TABLETS (apixaban 2.5 mg oral tablet) NORA PHARMA INC,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103556,Marketed,2024-04-22,02546892,Nra-Apixaban Tablets,1,B01AF02,Apixaban,Tablet,Oral,02546892,NRA-APIXABAN TABLETS (apixaban 5 mg oral tablet) NORA PHARMA INC,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103770,Marketed,2024-11-06,02548879,Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02548879,APIXABAN (apixaban 2.5 mg oral tablet) SANIS HEALTH INC,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103771,Marketed,2024-11-06,02548887,Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02548887,APIXABAN (apixaban 5 mg oral tablet) SANIS HEALTH INC,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104255,Marketed,2025-06-05,02553635,NB-Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02553635,NB-APIXABAN (apixaban 2.5 mg oral tablet) NB PHARMA INC.,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104256,Marketed,2025-06-05,02553643,NB-Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02553643,NB-APIXABAN (apixaban 5 mg oral tablet) NB PHARMA INC.,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86287,Marketed,2012-02-01,02377233,Eliquis,1,B01AF02,Apixaban,Tablet,Oral,02377233,ELIQUIS (apixaban 2.5 mg oral tablet) BRISTOL-MYERS SQUIBB CANADA,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88264,Marketed,2012-12-21,02397714,Eliquis,1,B01AF02,Apixaban,Tablet,Oral,02397714,ELIQUIS (apixaban 5 mg oral tablet) BRISTOL-MYERS SQUIBB CANADA,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97524,Marketed,2023-09-22,02484994,Teva-Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02484994,TEVA-APIXABAN (apixaban 2.5 mg oral tablet) TEVA CANADA LIMITED,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97527,Marketed,2023-09-22,02485001,Teva-Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02485001,TEVA-APIXABAN (apixaban 5 mg oral tablet) TEVA CANADA LIMITED,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97697,Marketed,2022-11-28,02486806,Auro-Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02486806,AURO-APIXABAN (apixaban 2.5 mg oral tablet) AURO PHARMA INC,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97698,Marketed,2022-11-28,02486814,Auro-Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02486814,AURO-APIXABAN (apixaban 5 mg oral tablet) AURO PHARMA INC,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97756,Marketed,2022-06-20,02487381,Apo-Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02487381,APO-APIXABAN (apixaban 2.5 mg oral tablet) APOTEX INC,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97757,Marketed,2022-06-20,02487403,Apo-Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02487403,APO-APIXABAN (apixaban 5 mg oral tablet) APOTEX INC,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97767,Marketed,2026-05-11,02487519,Sandoz Apixaban Tablet,1,B01AF02,Apixaban,Tablet,Oral,02487519,SANDOZ APIXABAN TABLET (apixaban 2.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97768,Marketed,2026-05-12,02487527,Sandoz Apixaban Tablet,1,B01AF02,Apixaban,Tablet,Oral,02487527,SANDOZ APIXABAN TABLET (apixaban 5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97786,Marketed,2022-09-27,02487713,ACH-Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02487713,ACH-APIXABAN (apixaban 2.5 mg oral tablet) ACCORD HEALTHCARE INC,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97787,Marketed,2022-09-27,02487721,ACH-Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02487721,ACH-APIXABAN (apixaban 5 mg oral tablet) ACCORD HEALTHCARE INC,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97930,Marketed,2022-09-22,02489228,Sandoz Apixaban SDZ,1,B01AF02,Apixaban,Tablet,Oral,02489228,SANDOZ APIXABAN SDZ (apixaban 2.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97931,Marketed,2022-09-22,02489236,Sandoz Apixaban SDZ,1,B01AF02,Apixaban,Tablet,Oral,02489236,SANDOZ APIXABAN SDZ (apixaban 5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98239,Marketed,2022-09-21,02492369,Mar-Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02492369,MAR-APIXABAN (apixaban 2.5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98240,Marketed,2022-09-21,02492377,Mar-Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02492377,MAR-APIXABAN (apixaban 5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98281,Marketed,2022-09-21,02492814,Nat-Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02492814,NAT-APIXABAN (apixaban 2.5 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98282,Marketed,2022-09-21,02492822,Nat-Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02492822,NAT-APIXABAN (apixaban 5 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98535,Marketed,2023-04-17,02495430,Mint-Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02495430,MINT-APIXABAN (apixaban 2.5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98536,Marketed,2022-10-28,02495449,Mint-Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02495449,MINT-APIXABAN (apixaban 5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99968,Marketed,2022-09-21,02510464,Taro-Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02510464,TARO-APIXABAN (apixaban 2.5 mg oral tablet) SUN PHARMA CANADA INC,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99969,Marketed,2022-09-21,02510472,Taro-Apixaban,1,B01AF02,Apixaban,Tablet,Oral,02510472,TARO-APIXABAN (apixaban 5 mg oral tablet) SUN PHARMA CANADA INC,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
12993,Marketed,2023-05-19,00888354,Iopidine,1,S01EA03,Apraclonidine,Solution,Ophthalmic,00888354,IOPIDINE (apraclonidine (apraclonidine hydrochloride) 1 % ophthalmic drops) ESSENTIAL PHARMA SWITZERLAND GMBH,Active,9002418,apraclonidine (apraclonidine hydrochloride) 1 % ophthalmic drops,8001432,apraclonidine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
18228,Marketed,2023-05-19,02076306,Iopidine,1,S01EA03,Apraclonidine,Solution,Ophthalmic,02076306,IOPIDINE (apraclonidine (apraclonidine hydrochloride) 0.5 % ophthalmic drops) ESSENTIAL PHARMA SWITZERLAND GMBH,Active,9002740,apraclonidine (apraclonidine hydrochloride) 0.5 % ophthalmic drops,8001432,apraclonidine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
100820,Marketed,2022-11-14,02518910,GLN-Apremilast,1,L04AA32,Apremilast,Tablet,Oral,02518910,GLN-APREMILAST (apremilast 30 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9005619,apremilast 30 mg oral tablet,8001568,apremilast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101093,Marketed,2022-11-14,02521733,PMS-Apremilast,1,L04AA32,Apremilast,Tablet,Oral,02521733,PMS-APREMILAST (apremilast 30 mg oral tablet) PHARMASCIENCE INC,Active,9005619,apremilast 30 mg oral tablet,8001568,apremilast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101314,Marketed,2022-12-07,02524104,Auro-Apremilast,1,L04AA32,Apremilast,Tablet,Oral,02524104,AURO-APREMILAST (apremilast 30 mg oral tablet) AURO PHARMA INC,Active,9005619,apremilast 30 mg oral tablet,8001568,apremilast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101316,Marketed,2023-04-17,02524120,Auro-Apremilast,3,L04AA32,Apremilast,Tablet,Oral,02524120,AURO-APREMILAST (apremilast 10 mg oral tablet with apremilast 20 mg oral tablet with apremilast 30 mg oral tablet) AURO PHARMA INC,Active,9012893,apremilast 10 mg oral tablet with apremilast 20 mg oral tablet with apremilast 30 mg oral tablet,8001568,apremilast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101815,Marketed,2022-11-14,02528959,JAMP Apremilast,1,L04AA32,Apremilast,Tablet,Oral,02528959,JAMP APREMILAST (apremilast 30 mg oral tablet) JAMP PHARMA CORPORATION,Active,9005619,apremilast 30 mg oral tablet,8001568,apremilast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101816,Marketed,2022-11-14,02528967,JAMP Apremilast,3,L04AA32,Apremilast,Tablet,Oral,02528967,JAMP APREMILAST (apremilast 10 mg oral tablet with apremilast 20 mg oral tablet with apremilast 30 mg oral tablet) JAMP PHARMA CORPORATION,Active,9012893,apremilast 10 mg oral tablet with apremilast 20 mg oral tablet with apremilast 30 mg oral tablet,8001568,apremilast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101827,Marketed,2022-11-18,02529084,Sandoz Apremilast,1,L04AA32,Apremilast,Tablet,Oral,02529084,SANDOZ APREMILAST (apremilast 30 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005619,apremilast 30 mg oral tablet,8001568,apremilast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101828,Marketed,2024-01-30,02529092,Sandoz Apremilast,3,L04AA32,Apremilast,Tablet,Oral,02529092,SANDOZ APREMILAST (apremilast 10 mg oral tablet with apremilast 20 mg oral tablet with apremilast 30 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9012893,apremilast 10 mg oral tablet with apremilast 20 mg oral tablet with apremilast 30 mg oral tablet,8001568,apremilast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102693,Marketed,2023-09-28,02538180,Apo-Apremilast,1,L04AA32,Apremilast,Tablet,Oral,02538180,APO-APREMILAST (apremilast 30 mg oral tablet) APOTEX INC,Active,9005619,apremilast 30 mg oral tablet,8001568,apremilast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91864,Marketed,2022-01-10,02434318,Otezla,3,L04AA32,Apremilast,Tablet,Oral,02434318,OTEZLA (apremilast 10 mg oral tablet with apremilast 20 mg oral tablet with apremilast 30 mg oral tablet) AMGEN CANADA INC,Active,9012893,apremilast 10 mg oral tablet with apremilast 20 mg oral tablet with apremilast 30 mg oral tablet,8001568,apremilast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91866,Marketed,2021-01-18,02434334,Otezla,1,L04AA32,Apremilast,Tablet,Oral,02434334,OTEZLA (apremilast 30 mg oral tablet) AMGEN CANADA INC,Active,9005619,apremilast 30 mg oral tablet,8001568,apremilast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78410,Marketed,2007-09-24,02298791,Emend,1,A04AD12,Aprepitant,Capsule,Oral,02298791,EMEND (aprepitant 80 mg oral capsule) MERCK CANADA INC,Active,9004333,aprepitant 80 mg oral capsule,8001433,aprepitant,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
78411,Marketed,2007-09-24,02298805,Emend,1,A04AD12,Aprepitant,Capsule,Oral,02298805,EMEND (aprepitant 125 mg oral capsule) MERCK CANADA INC,Active,9004332,aprepitant 125 mg oral capsule,8001433,aprepitant,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
78412,Marketed,2007-09-24,02298813,Emend Tri-Pack,2,A04AD12,Aprepitant,"Capsule,Kit",Oral,02298813,EMEND TRI-PACK (aprepitant 80 mg oral capsule with aprepitant 125 mg oral capsule) MERCK CANADA INC,Active,9012894,aprepitant 80 mg oral capsule with aprepitant 125 mg oral capsule,8001433,aprepitant,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
103778,Marketed,2025-01-29,02548968,Argatroban,1,B01AE03,Argatroban,Solution,Intravenous,02548968,ARGATROBAN (argatroban 50 mg per 50 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9015163,argatroban 50 mg per 50 mL solution for injection vial,8001434,argatroban,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,,,,Prescription
106451,Marketed,2026-01-07,02561557,Argatroban For Injection,1,B01AE03,Argatroban,Solution,Intravenous,02561557,ARGATROBAN FOR INJECTION (argatroban 250 mg per 2.5 mL solution for injection vial) JUNO PHARMA CANADA INC.,Active,9012780,argatroban 250 mg per 2.5 mL solution for injection vial,8001434,argatroban,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
102326,Marketed,2023-07-20,02534320,Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02534320,ARIPIPRAZOLE (aripiprazole 2 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001287,aripiprazole 2 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102327,Marketed,2023-07-20,02534339,Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02534339,ARIPIPRAZOLE (aripiprazole 5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001289,aripiprazole 5 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102328,Marketed,2023-07-20,02534347,Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02534347,ARIPIPRAZOLE (aripiprazole 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001284,aripiprazole 10 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102329,Marketed,2023-07-20,02534355,Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02534355,ARIPIPRAZOLE (aripiprazole 15 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001285,aripiprazole 15 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102330,Marketed,2023-07-20,02534363,Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02534363,ARIPIPRAZOLE (aripiprazole 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001286,aripiprazole 20 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102331,Marketed,2023-07-20,02534371,Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02534371,ARIPIPRAZOLE (aripiprazole 30 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001288,aripiprazole 30 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104212,Marketed,2025-11-27,02553163,JAMP Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02553163,JAMP ARIPIPRAZOLE (aripiprazole 2 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001287,aripiprazole 2 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104213,Marketed,2025-11-27,02553171,JAMP Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02553171,JAMP ARIPIPRAZOLE (aripiprazole 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001289,aripiprazole 5 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104214,Marketed,2025-11-27,02553198,JAMP Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02553198,JAMP ARIPIPRAZOLE (aripiprazole 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001284,aripiprazole 10 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104215,Marketed,2025-11-27,02553201,JAMP Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02553201,JAMP ARIPIPRAZOLE (aripiprazole 15 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001285,aripiprazole 15 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104216,Marketed,2025-11-27,02553228,JAMP Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02553228,JAMP ARIPIPRAZOLE (aripiprazole 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001286,aripiprazole 20 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104217,Marketed,2025-11-27,02553236,JAMP Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02553236,JAMP ARIPIPRAZOLE (aripiprazole 30 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001288,aripiprazole 30 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104339,Marketed,2025-08-15,02554550,Solufy,1,N05AX12,Aripiprazole,Solution,Oral,02554550,SOLUFY (aripiprazole 1 mg per mL oral solution) ORIMED PHARMA INC,Active,9015243,aripiprazole 1 mg per mL oral solution,8000389,aripiprazole,26643006,Oral,385023001,Oral solution,,,,,,Prescription
104340,Marketed,2025-03-20,02554569,Abilify Asimtufii,1,N05AX12,Aripiprazole,Suspension (extended-release),Intramuscular,02554569,ABILIFY ASIMTUFII (aripiprazole 720 mg per 2.4 mL prolonged-release suspension for injection syringe) OTSUKA PHARMACEUTICAL CO LTD,Active,9015183,aripiprazole 720 mg per 2.4 mL prolonged-release suspension for injection syringe,8000389,aripiprazole,738984000,Parenteral,420873008,Prolonged-release suspension for injection,733020007,Syringe,,,,Prescription
104341,Marketed,2025-03-20,02554577,Abilify Asimtufii,1,N05AX12,Aripiprazole,Suspension (extended-release),Intramuscular,02554577,ABILIFY ASIMTUFII (aripiprazole 960 mg per 3.2 mL prolonged-release suspension for injection syringe) OTSUKA PHARMACEUTICAL CO LTD,Active,9015184,aripiprazole 960 mg per 3.2 mL prolonged-release suspension for injection syringe,8000389,aripiprazole,738984000,Parenteral,420873008,Prolonged-release suspension for injection,733020007,Syringe,,,,Prescription
80782,Marketed,2018-03-19,02322374,Abilify,1,N05AX12,Aripiprazole,Tablet,Oral,02322374,ABILIFY (aripiprazole 2 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9001287,aripiprazole 2 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80783,Marketed,2018-04-04,02322382,Abilify,1,N05AX12,Aripiprazole,Tablet,Oral,02322382,ABILIFY (aripiprazole 5 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9001289,aripiprazole 5 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80784,Marketed,2018-07-13,02322390,Abilify,1,N05AX12,Aripiprazole,Tablet,Oral,02322390,ABILIFY (aripiprazole 10 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9001284,aripiprazole 10 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80785,Marketed,2018-06-05,02322404,Abilify,1,N05AX12,Aripiprazole,Tablet,Oral,02322404,ABILIFY (aripiprazole 15 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9001285,aripiprazole 15 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80786,Marketed,2018-11-02,02322412,Abilify,1,N05AX12,Aripiprazole,Tablet,Oral,02322412,ABILIFY (aripiprazole 20 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9001286,aripiprazole 20 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80790,Marketed,2018-03-19,02322455,Abilify,1,N05AX12,Aripiprazole,Tablet,Oral,02322455,ABILIFY (aripiprazole 30 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9001288,aripiprazole 30 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90545,Marketed,2014-03-27,02420864,Abilify Maintena,1,N05AX12,Aripiprazole,"Powder for suspension, sustained-release,Kit",Intramuscular,02420864,ABILIFY MAINTENA (aripiprazole 300 mg per vial powder for prolonged-release suspension for injection with diluent solution) OTSUKA PHARMACEUTICAL CO LTD,Active,9006493,aripiprazole 300 mg per vial powder for prolonged-release suspension for injection with diluent solution,8000389,aripiprazole,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),,,,Prescription
90546,Marketed,2014-03-27,02420872,Abilify Maintena,1,N05AX12,Aripiprazole,"Powder for suspension, sustained-release,Kit",Intramuscular,02420872,ABILIFY MAINTENA (aripiprazole 400 mg per vial powder for prolonged-release suspension for injection with diluent solution) OTSUKA PHARMACEUTICAL CO LTD,Active,9006494,aripiprazole 400 mg per vial powder for prolonged-release suspension for injection with diluent solution,8000389,aripiprazole,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),,,,Prescription
93386,Marketed,2025-11-28,02448173,AG-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02448173,AG-ARIPIPRAZOLE (aripiprazole 2 mg oral tablet) ANGITA PHARMA INC.,Active,9001287,aripiprazole 2 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93387,Marketed,2025-11-28,02448181,AG-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02448181,AG-ARIPIPRAZOLE (aripiprazole 5 mg oral tablet) ANGITA PHARMA INC.,Active,9001289,aripiprazole 5 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93388,Marketed,2025-11-28,02448203,AG-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02448203,AG-ARIPIPRAZOLE (aripiprazole 10 mg oral tablet) ANGITA PHARMA INC.,Active,9001284,aripiprazole 10 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93389,Marketed,2025-11-28,02448211,AG-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02448211,AG-ARIPIPRAZOLE (aripiprazole 15 mg oral tablet) ANGITA PHARMA INC.,Active,9001285,aripiprazole 15 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93390,Marketed,2025-11-28,02448238,AG-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02448238,AG-ARIPIPRAZOLE (aripiprazole 20 mg oral tablet) ANGITA PHARMA INC.,Active,9001286,aripiprazole 20 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93391,Marketed,2025-11-28,02448246,AG-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02448246,AG-ARIPIPRAZOLE (aripiprazole 30 mg oral tablet) ANGITA PHARMA INC.,Active,9001288,aripiprazole 30 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94732,Marketed,2018-07-10,02460025,Auro-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02460025,AURO-ARIPIPRAZOLE (aripiprazole 2 mg oral tablet) AURO PHARMA INC,Active,9001287,aripiprazole 2 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94733,Marketed,2018-07-10,02460033,Auro-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02460033,AURO-ARIPIPRAZOLE (aripiprazole 5 mg oral tablet) AURO PHARMA INC,Active,9001289,aripiprazole 5 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94734,Marketed,2018-07-10,02460041,Auro-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02460041,AURO-ARIPIPRAZOLE (aripiprazole 10 mg oral tablet) AURO PHARMA INC,Active,9001284,aripiprazole 10 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94735,Marketed,2018-07-10,02460068,Auro-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02460068,AURO-ARIPIPRAZOLE (aripiprazole 15 mg oral tablet) AURO PHARMA INC,Active,9001285,aripiprazole 15 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94736,Marketed,2018-07-10,02460076,Auro-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02460076,AURO-ARIPIPRAZOLE (aripiprazole 20 mg oral tablet) AURO PHARMA INC,Active,9001286,aripiprazole 20 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94737,Marketed,2018-07-10,02460084,Auro-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02460084,AURO-ARIPIPRAZOLE (aripiprazole 30 mg oral tablet) AURO PHARMA INC,Active,9001288,aripiprazole 30 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95498,Marketed,2018-07-10,02466635,PMS-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02466635,PMS-ARIPIPRAZOLE (aripiprazole 2 mg oral tablet) PHARMASCIENCE INC,Active,9001287,aripiprazole 2 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95499,Marketed,2018-07-10,02466643,PMS-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02466643,PMS-ARIPIPRAZOLE (aripiprazole 5 mg oral tablet) PHARMASCIENCE INC,Active,9001289,aripiprazole 5 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95500,Marketed,2018-07-10,02466651,PMS-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02466651,PMS-ARIPIPRAZOLE (aripiprazole 10 mg oral tablet) PHARMASCIENCE INC,Active,9001284,aripiprazole 10 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95501,Marketed,2018-07-10,02466678,PMS-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02466678,PMS-ARIPIPRAZOLE (aripiprazole 15 mg oral tablet) PHARMASCIENCE INC,Active,9001285,aripiprazole 15 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95503,Marketed,2018-07-10,02466686,PMS-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02466686,PMS-ARIPIPRAZOLE (aripiprazole 20 mg oral tablet) PHARMASCIENCE INC,Active,9001286,aripiprazole 20 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95504,Marketed,2018-07-10,02466694,PMS-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02466694,PMS-ARIPIPRAZOLE (aripiprazole 30 mg oral tablet) PHARMASCIENCE INC,Active,9001288,aripiprazole 30 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96019,Marketed,2018-04-10,02471086,Apo-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02471086,APO-ARIPIPRAZOLE (aripiprazole 2 mg oral tablet) APOTEX INC,Active,9001287,aripiprazole 2 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96020,Marketed,2018-04-10,02471094,Apo-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02471094,APO-ARIPIPRAZOLE (aripiprazole 5 mg oral tablet) APOTEX INC,Active,9001289,aripiprazole 5 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96021,Marketed,2018-04-10,02471108,Apo-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02471108,APO-ARIPIPRAZOLE (aripiprazole 10 mg oral tablet) APOTEX INC,Active,9001284,aripiprazole 10 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96022,Marketed,2018-04-10,02471116,Apo-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02471116,APO-ARIPIPRAZOLE (aripiprazole 15 mg oral tablet) APOTEX INC,Active,9001285,aripiprazole 15 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96023,Marketed,2018-04-10,02471124,Apo-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02471124,APO-ARIPIPRAZOLE (aripiprazole 20 mg oral tablet) APOTEX INC,Active,9001286,aripiprazole 20 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96024,Marketed,2018-04-10,02471132,Apo-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02471132,APO-ARIPIPRAZOLE (aripiprazole 30 mg oral tablet) APOTEX INC,Active,9001288,aripiprazole 30 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96153,Marketed,2024-01-23,02472201,Nra-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02472201,NRA-ARIPIPRAZOLE (aripiprazole 2 mg oral tablet) NORA PHARMA INC,Active,9001287,aripiprazole 2 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96154,Marketed,2024-01-23,02472228,Nra-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02472228,NRA-ARIPIPRAZOLE (aripiprazole 5 mg oral tablet) NORA PHARMA INC,Active,9001289,aripiprazole 5 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96155,Marketed,2024-01-23,02472244,Nra-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02472244,NRA-ARIPIPRAZOLE (aripiprazole 10 mg oral tablet) NORA PHARMA INC,Active,9001284,aripiprazole 10 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96156,Marketed,2024-01-23,02472252,Nra-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02472252,NRA-ARIPIPRAZOLE (aripiprazole 15 mg oral tablet) NORA PHARMA INC,Active,9001285,aripiprazole 15 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96157,Marketed,2024-01-23,02472260,Nra-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02472260,NRA-ARIPIPRAZOLE (aripiprazole 20 mg oral tablet) NORA PHARMA INC,Active,9001286,aripiprazole 20 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96158,Marketed,2024-01-23,02472279,Nra-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02472279,NRA-ARIPIPRAZOLE (aripiprazole 30 mg oral tablet) NORA PHARMA INC,Active,9001288,aripiprazole 30 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96304,Marketed,2018-07-10,02473658,Sandoz Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02473658,SANDOZ ARIPIPRAZOLE (aripiprazole 2 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001287,aripiprazole 2 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96305,Marketed,2018-07-10,02473666,Sandoz Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02473666,SANDOZ ARIPIPRAZOLE (aripiprazole 5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001289,aripiprazole 5 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96306,Marketed,2018-07-10,02473674,Sandoz Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02473674,SANDOZ ARIPIPRAZOLE (aripiprazole 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001284,aripiprazole 10 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96307,Marketed,2018-07-10,02473682,Sandoz Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02473682,SANDOZ ARIPIPRAZOLE (aripiprazole 15 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001285,aripiprazole 15 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96308,Marketed,2018-07-10,02473690,Sandoz Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02473690,SANDOZ ARIPIPRAZOLE (aripiprazole 20 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001286,aripiprazole 20 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96309,Marketed,2018-07-10,02473704,Sandoz Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02473704,SANDOZ ARIPIPRAZOLE (aripiprazole 30 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001288,aripiprazole 30 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96994,Marketed,2018-08-22,02479346,Riva-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02479346,RIVA-ARIPIPRAZOLE (aripiprazole 2 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001287,aripiprazole 2 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96995,Marketed,2018-08-22,02479354,Riva-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02479354,RIVA-ARIPIPRAZOLE (aripiprazole 5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001289,aripiprazole 5 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96996,Marketed,2018-08-22,02479362,Riva-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02479362,RIVA-ARIPIPRAZOLE (aripiprazole 10 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001284,aripiprazole 10 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96997,Marketed,2018-08-22,02479370,Riva-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02479370,RIVA-ARIPIPRAZOLE (aripiprazole 15 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001285,aripiprazole 15 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96998,Marketed,2018-08-22,02479389,Riva-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02479389,RIVA-ARIPIPRAZOLE (aripiprazole 20 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001286,aripiprazole 20 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96999,Marketed,2018-08-22,02479397,Riva-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02479397,RIVA-ARIPIPRAZOLE (aripiprazole 30 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001288,aripiprazole 30 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97392,Marketed,2020-05-04,02483556,Mint-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02483556,MINT-ARIPIPRAZOLE (aripiprazole 2 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001287,aripiprazole 2 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97393,Marketed,2020-04-14,02483564,Mint-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02483564,MINT-ARIPIPRAZOLE (aripiprazole 5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001289,aripiprazole 5 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97394,Marketed,2020-04-14,02483572,Mint-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02483572,MINT-ARIPIPRAZOLE (aripiprazole 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001284,aripiprazole 10 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97395,Marketed,2020-04-14,02483580,Mint-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02483580,MINT-ARIPIPRAZOLE (aripiprazole 15 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001285,aripiprazole 15 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97396,Marketed,2020-04-14,02483599,Mint-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02483599,MINT-ARIPIPRAZOLE (aripiprazole 20 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001286,aripiprazole 20 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97397,Marketed,2020-04-14,02483602,Mint-Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02483602,MINT-ARIPIPRAZOLE (aripiprazole 30 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001288,aripiprazole 30 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97811,Marketed,2019-07-09,02488000,Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02488000,ARIPIPRAZOLE (aripiprazole 2 mg oral tablet) PRO DOC LIMITEE,Active,9001287,aripiprazole 2 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97812,Marketed,2019-07-09,02488019,Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02488019,ARIPIPRAZOLE (aripiprazole 5 mg oral tablet) PRO DOC LIMITEE,Active,9001289,aripiprazole 5 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97813,Marketed,2019-07-09,02488027,Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02488027,ARIPIPRAZOLE (aripiprazole 10 mg oral tablet) PRO DOC LIMITEE,Active,9001284,aripiprazole 10 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97814,Marketed,2019-07-09,02488035,Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02488035,ARIPIPRAZOLE (aripiprazole 15 mg oral tablet) PRO DOC LIMITEE,Active,9001285,aripiprazole 15 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97815,Marketed,2019-07-09,02488043,Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02488043,ARIPIPRAZOLE (aripiprazole 20 mg oral tablet) PRO DOC LIMITEE,Active,9001286,aripiprazole 20 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97816,Marketed,2019-07-09,02488051,Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02488051,ARIPIPRAZOLE (aripiprazole 30 mg oral tablet) PRO DOC LIMITEE,Active,9001288,aripiprazole 30 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99604,Marketed,2021-04-23,02506688,Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02506688,ARIPIPRAZOLE (aripiprazole 2 mg oral tablet) SANIS HEALTH INC,Active,9001287,aripiprazole 2 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99606,Marketed,2021-04-23,02506718,Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02506718,ARIPIPRAZOLE (aripiprazole 5 mg oral tablet) SANIS HEALTH INC,Active,9001289,aripiprazole 5 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99607,Marketed,2021-04-23,02506726,Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02506726,ARIPIPRAZOLE (aripiprazole 10 mg oral tablet) SANIS HEALTH INC,Active,9001284,aripiprazole 10 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99609,Marketed,2021-04-23,02506734,Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02506734,ARIPIPRAZOLE (aripiprazole 15 mg oral tablet) SANIS HEALTH INC,Active,9001285,aripiprazole 15 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99611,Marketed,2021-04-23,02506750,Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02506750,ARIPIPRAZOLE (aripiprazole 20 mg oral tablet) SANIS HEALTH INC,Active,9001286,aripiprazole 20 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99613,Marketed,2021-04-23,02506785,Aripiprazole,1,N05AX12,Aripiprazole,Tablet,Oral,02506785,ARIPIPRAZOLE (aripiprazole 30 mg oral tablet) SANIS HEALTH INC,Active,9001288,aripiprazole 30 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100263,Marketed,2022-03-11,02513420,Arsenic Trioxide For Injection,1,L01XX27,Arsenic trioxide,Solution,Intravenous,02513420,ARSENIC TRIOXIDE FOR INJECTION (arsenic trioxide 10 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9014217,arsenic trioxide 10 mg per 10 mL solution for injection vial,8001887,arsenic trioxide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
104322,Marketed,2025-05-27,02554364,Arsenic Trioxide For Injection,1,L01XX27,Arsenic trioxide,Solution,Intravenous,02554364,ARSENIC TRIOXIDE FOR INJECTION (arsenic trioxide 10 mg per 10 mL solution for injection vial) MARCAN PHARMACEUTICALS INC,Active,9014217,arsenic trioxide 10 mg per 10 mL solution for injection vial,8001887,arsenic trioxide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
97753,Marketed,2020-01-31,02487357,Arsenic Trioxide Solution For Injection,1,L01XX27,Arsenic trioxide,Solution,Intravenous,02487357,ARSENIC TRIOXIDE SOLUTION FOR INJECTION (arsenic trioxide 10 mg per 10 mL solution for injection vial) PHEBRA PTY LTD,Active,9014217,arsenic trioxide 10 mg per 10 mL solution for injection vial,8001887,arsenic trioxide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
98274,Marketed,2019-12-20,02492768,Arsenic Trioxide For Injection,1,L01XX27,Arsenic trioxide,Solution,Intravenous,02492768,ARSENIC TRIOXIDE FOR INJECTION (arsenic trioxide 10 mg per 10 mL solution for injection vial) STERIMAX INC,Active,9014217,arsenic trioxide 10 mg per 10 mL solution for injection vial,8001887,arsenic trioxide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
106490,Marketed,2026-04-17,02561980,Articaine Hydrochloride And Epinephrine Injection - N,2,N01BB58,"Articaine, combinations",Solution,Block/infiltration,02561980,ARTICAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION - N (articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.005 mg per mL solution for injection 1.7 mL cartridge) SEPTODONT,Active,9014076,articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.005 mg per mL solution for injection 1.7 mL cartridge,8001888,articaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Ethical
106491,Marketed,2026-04-17,02561999,Articaine Hydrochloride And Epinephrine Injection - SP,2,N01BB58,"Articaine, combinations",Solution,Block/infiltration,02561999,ARTICAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION - SP (articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.01 mg per mL solution for injection 1.7 mL cartridge) SEPTODONT,Active,9014078,articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.01 mg per mL solution for injection 1.7 mL cartridge,8001888,articaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Ethical
16508,Marketed,2001-09-20,01988530,Ultracaine D-S Injection,2,N01BB58,"Articaine, combinations",Solution,Block/infiltration,01988530,ULTRACAINE D-S INJECTION (articaine hydrochloride 40 mg per mL and epinephrine (epinephrine hydrochloride) 0.005 mg per mL solution for injection 1.7 mL cartridge) HANSAMED LIMITED,Active,9014080,articaine hydrochloride 40 mg per mL and epinephrine (epinephrine hydrochloride) 0.005 mg per mL solution for injection 1.7 mL cartridge,8001888,articaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Ethical
16511,Marketed,2001-05-22,01988557,Ultracaine D-S Forte Injection,2,N01BB58,"Articaine, combinations",Solution,Block/infiltration,01988557,ULTRACAINE D-S FORTE INJECTION (articaine hydrochloride 40 mg per mL and epinephrine (epinephrine hydrochloride) 0.01 mg per mL solution for injection 1.7 mL cartridge) HANSAMED LIMITED,Active,9014081,articaine hydrochloride 40 mg per mL and epinephrine (epinephrine hydrochloride) 0.01 mg per mL solution for injection 1.7 mL cartridge,8001888,articaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Ethical
16850,Marketed,1994-12-31,02123398,Septanest SP,2,N01BB58,"Articaine, combinations",Solution,Block/infiltration,02123398,SEPTANEST SP (articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.01 mg per mL solution for injection 1.7 mL cartridge) SEPTODONT,Active,9014078,articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.01 mg per mL solution for injection 1.7 mL cartridge,8001888,articaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Ethical
16851,Marketed,1994-12-31,02123371,Septanest N,2,N01BB58,"Articaine, combinations",Solution,Block/infiltration,02123371,SEPTANEST N (articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.005 mg per mL solution for injection 1.7 mL cartridge) SEPTODONT,Active,9014076,articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.005 mg per mL solution for injection 1.7 mL cartridge,8001888,articaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Ethical
72840,Marketed,2004-01-29,02248488,"4% Astracaine Dental With Epinephrine Forte 1:100,000 (0.01 mg/mL)",2,N01BB58,"Articaine, combinations",Solution,Block/infiltration,02248488,"4% ASTRACAINE DENTAL WITH EPINEPHRINE FORTE 1:100,000 (0.01MG/ML) (articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.01 mg per mL solution for injection 1.8 mL cartridge) DENTSPLY CANADA LIMITED",Active,9014079,articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.01 mg per mL solution for injection 1.8 mL cartridge,8001888,articaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Ethical
72841,Marketed,2004-01-29,02248489,"4% Astracaine Dental With Epinephrine 1:200,000 (0.005 mg/mL)",2,N01BB58,"Articaine, combinations",Solution,Block/infiltration,02248489,"4% ASTRACAINE DENTAL WITH EPINEPHRINE 1:200,000 (0.005MG/ML) (articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.005 mg per mL solution for injection 1.8 mL cartridge) DENTSPLY CANADA LIMITED",Active,9014077,articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.005 mg per mL solution for injection 1.8 mL cartridge,8001888,articaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Ethical
82513,Marketed,2023-05-18,02339536,Articaine Hydrochloride And Epinephrine Bitartrate Injection,2,N01BB58,"Articaine, combinations",Solution,Block/infiltration,02339536,ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE INJECTION (articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.005 mg per mL solution for injection 1.7 mL cartridge) PIERREL S.P.A.,Active,9014076,articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.005 mg per mL solution for injection 1.7 mL cartridge,8001888,articaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Ethical
82514,Marketed,2023-05-18,02339544,Articaine Hydrochloride And Epinephrine Bitartrate Injection,2,N01BB58,"Articaine, combinations",Solution,Block/infiltration,02339544,ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE INJECTION (articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.01 mg per mL solution for injection 1.7 mL cartridge) PIERREL S.P.A.,Active,9014078,articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.01 mg per mL solution for injection 1.7 mL cartridge,8001888,articaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Ethical
84694,Marketed,2023-05-18,02361906,"Orabloc 1:200,000",2,N01BB58,"Articaine, combinations",Solution,Block/infiltration,02361906,"ORABLOC 1:200,000 (articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.005 mg per mL solution for injection 1.7 mL cartridge) PIERREL S.P.A.",Active,9014076,articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.005 mg per mL solution for injection 1.7 mL cartridge,8001888,articaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Ethical
84695,Marketed,2023-05-18,02361914,"Orabloc 1:100,000",2,N01BB58,"Articaine, combinations",Solution,Block/infiltration,02361914,"ORABLOC 1:100,000 (articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.01 mg per mL solution for injection 1.7 mL cartridge) PIERREL S.P.A.",Active,9014078,articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.01 mg per mL solution for injection 1.7 mL cartridge,8001888,articaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Ethical
86711,Marketed,2012-04-13,02381311,Posicaine N,2,N01BB58,"Articaine, combinations",Solution,Block/infiltration,02381311,POSICAINE N (articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.005 mg per mL solution for injection 1.7 mL cartridge) NOVOCOL PHARMACEUTICAL OF CANADA INC,Active,9014076,articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.005 mg per mL solution for injection 1.7 mL cartridge,8001888,articaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Ethical
86712,Marketed,2012-04-13,02381338,Posicaine SP,2,N01BB58,"Articaine, combinations",Solution,Block/infiltration,02381338,POSICAINE SP (articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.01 mg per mL solution for injection 1.7 mL cartridge) NOVOCOL PHARMACEUTICAL OF CANADA INC,Active,9014078,articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.01 mg per mL solution for injection 1.7 mL cartridge,8001888,articaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Ethical
10032,Marketed,2019-09-16,00743445,Tears Naturale II,2,S01XA20,Artificial tears and other indifferent preparations.,Drops,Ophthalmic,00743445,TEARS NATURALE II (dextran 70 0.1 % and hypromellose 0.3 % ophthalmic drops) ALCON CANADA INC,Active,9002182,dextran 70 0.1 % and hypromellose 0.3 % ophthalmic drops,8002116,dextran 70 and hypromellose,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
104012,Marketed,2024-12-18,02551403,Miebo,1,S01XA20,Artificial tears and other indifferent preparations.,Solution,Ophthalmic,02551403,MIEBO (perfluorohexyloctane 100 % ophthalmic drops) BAUSCH & LOMB INC,Active,9015153,perfluorohexyloctane 100 % ophthalmic drops,8002529,perfluorohexyloctane,54485002,Ophthalmic,385125006,Eye drops solution,,,,,,Prescription
11138,Marketed,2024-05-23,00870153,Refresh Celluvisc,1,S01XA20,Artificial tears and other indifferent preparations.,Drops,Ophthalmic,00870153,REFRESH CELLUVISC (carboxymethylcellulose sodium 1 % ophthalmic drops) ABBVIE CORPORATION,Active,9013777,carboxymethylcellulose sodium 1 % ophthalmic drops,8002220,carboxymethylcellulose,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
13167,Marketed,2019-10-25,01943308,Tears Naturale Free,2,S01XA20,Artificial tears and other indifferent preparations.,Drops,Ophthalmic,01943308,TEARS NATURALE FREE (dextran 70 0.1 % and hypromellose 0.3 % ophthalmic drops) ALCON CANADA INC,Active,9002182,dextran 70 0.1 % and hypromellose 0.3 % ophthalmic drops,8002116,dextran 70 and hypromellose,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
15177,Marketed,2003-04-21,02007967,Amo Endosol Solution,6,S01XA20,Artificial tears and other indifferent preparations.,Solution,Intraocular,,,,,,,,,,,,,,,,,Ethical
16777,Marketed,2015-05-29,02125706,Soothe Night Time,2,S01XA20,Artificial tears and other indifferent preparations.,Ointment,Ophthalmic,02125706,SOOTHE NIGHT TIME (mineral oil heavy 20 % and petrolatum 80 % ophthalmic ointment) BAUSCH & LOMB INC,Active,9013714,mineral oil heavy 20 % and petrolatum 80 % ophthalmic ointment,8002206,mineral oil heavy and petrolatum,54485002,Ophthalmic,385123004,Ophthalmic ointment,,,,,,Non-Prescription Drugs
18791,Marketed,2024-10-16,02138670,Refresh,1,S01XA20,Artificial tears and other indifferent preparations.,Drops,Ophthalmic,02138670,REFRESH (polyvinyl alcohol 1.4 % ophthalmic drops) ABBVIE CORPORATION,Active,9001952,polyvinyl alcohol 1.4 % ophthalmic drops,8002073,polyvinyl alcohol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
27183,Marketed,2025-02-21,02049260,Refresh Plus,1,S01XA20,Artificial tears and other indifferent preparations.,Drops,Ophthalmic,02049260,REFRESH PLUS (carboxymethylcellulose sodium 0.5 % ophthalmic drops) ABBVIE CORPORATION,Active,9013775,carboxymethylcellulose sodium 0.5 % ophthalmic drops,8002220,carboxymethylcellulose,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
50289,Marketed,2024-09-17,02231008,Refresh Tears,1,S01XA20,Artificial tears and other indifferent preparations.,Drops,Ophthalmic,02231008,REFRESH TEARS (carboxymethylcellulose sodium 0.5 % ophthalmic drops) ABBVIE CORPORATION,Active,9013775,carboxymethylcellulose sodium 0.5 % ophthalmic drops,8002220,carboxymethylcellulose,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
65756,Marketed,2021-11-18,02242082,Preservative-Free Thera Tears Lubricant Eye Drops,1,S01XA20,Artificial tears and other indifferent preparations.,Drops,Ophthalmic,02242082,PRESERVATIVE-FREE THERA TEARS LUBRICANT EYE DROPS (carboxymethylcellulose sodium 0.25 % ophthalmic drops) MEDTECH PRODUCTS INC,Active,9013771,carboxymethylcellulose sodium 0.25 % ophthalmic drops,8002220,carboxymethylcellulose,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
66081,Marketed,2015-05-20,02242370,Soothe Dry Eyes,2,S01XA20,Artificial tears and other indifferent preparations.,Solution,Ophthalmic,02242370,SOOTHE DRY EYES (glycerin 0.3 % and propylene glycol 1 % ophthalmic drops) BAUSCH & LOMB INC,Active,9013561,glycerin 0.3 % and propylene glycol 1 % ophthalmic drops,8002127,glycerin and propylene glycol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
68637,Marketed,2025-04-11,02244650,Refresh Liquigel,1,S01XA20,Artificial tears and other indifferent preparations.,Solution,Ophthalmic,02244650,REFRESH LIQUIGEL (carboxymethylcellulose sodium 1 % ophthalmic drops) ABBVIE CORPORATION,Active,9013777,carboxymethylcellulose sodium 1 % ophthalmic drops,8002220,carboxymethylcellulose,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
70567,Marketed,2019-10-17,02246397,Tears Naturale Forte,3,S01XA20,Artificial tears and other indifferent preparations.,Solution,Ophthalmic,02246397,TEARS NATURALE FORTE (dextran 70 0.1 % and glycerin 0.2 % and hypromellose 0.3 % ophthalmic drops) ALCON CANADA INC,Active,9013544,dextran 70 0.1 % and glycerin 0.2 % and hypromellose 0.3 % ophthalmic drops,8002115,dextran 70 and glycerin and hypromellose,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
71788,Marketed,2004-03-24,02247538,Murine,2,S01XA20,Artificial tears and other indifferent preparations.,Solution,Ophthalmic,02247538,MURINE (polyvinyl alcohol 0.5% and povidone 0.6% ophthalmic drops) PRESTIGE BRANDS INC,Active,9013836,polyvinyl alcohol 0.5% and povidone 0.6% ophthalmic drops,8002074,polyvinyl alcohol and povidone,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
73225,Marketed,2021-11-18,02248854,Theratears Lubricant Eye Drops,1,S01XA20,Artificial tears and other indifferent preparations.,Solution,Ophthalmic,02248854,THERATEARS LUBRICANT EYE DROPS (carboxymethylcellulose sodium 0.25 % ophthalmic drops) MEDTECH PRODUCTS INC,Active,9013771,carboxymethylcellulose sodium 0.25 % ophthalmic drops,8002220,carboxymethylcellulose,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
78932,Marketed,2024-10-23,02304015,Refresh Contacts,1,S01XA20,Artificial tears and other indifferent preparations.,Solution,Ophthalmic,02304015,REFRESH CONTACTS (carboxymethylcellulose sodium 0.5 % ophthalmic drops) ABBVIE CORPORATION,Active,9013775,carboxymethylcellulose sodium 0.5 % ophthalmic drops,8002220,carboxymethylcellulose,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
793,Marketed,2023-04-19,00000809,Alcon Tears 0.5%,1,S01XA20,Artificial tears and other indifferent preparations.,Solution,Ophthalmic,00000809,ALCON TEARS 0.5% (hypromellose 0.5 % ophthalmic drops) ALCON CANADA INC,Active,9001644,hypromellose 0.5 % ophthalmic drops,8001484,hypromellose,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
794,Marketed,2023-04-19,00000817,Alcon Tears 1%,1,S01XA20,Artificial tears and other indifferent preparations.,Solution,Ophthalmic,00000817,ALCON TEARS 1% (hypromellose 1 % ophthalmic drops) ALCON CANADA INC,Active,9001660,hypromellose 1 % ophthalmic drops,8001484,hypromellose,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
80709,Marketed,2022-10-11,02321696,Lubricant Eye Drops/ Artificial Tears,2,S01XA20,Artificial tears and other indifferent preparations.,Drops,Ophthalmic,02321696,LUBRICANT EYE DROPS/ ARTIFICIAL TEARS (glycerin 0.3 % and propylene glycol 1 % ophthalmic drops) BAUSCH & LOMB INC,Active,9013561,glycerin 0.3 % and propylene glycol 1 % ophthalmic drops,8002127,glycerin and propylene glycol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
83970,Marketed,2025-02-05,02354535,Artificial Tears,2,S01XA20,Artificial tears and other indifferent preparations.,Solution,Ophthalmic,02354535,ARTIFICIAL TEARS (glycerin 0.2 % and hypromellose 0.2 % ophthalmic drops) JUNO OTC INC,Active,9013559,glycerin 0.2 % and hypromellose 0.2 % ophthalmic drops,8002122,glycerin and hypromellose,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
87535,Marketed,2025-02-04,02389886,Dry Eye Tears,2,S01XA20,Artificial tears and other indifferent preparations.,Solution,Ophthalmic,02389886,DRY EYE TEARS (glycerin 0.2 % and hypromellose 0.2 % ophthalmic drops) JUNO OTC INC,Active,9013559,glycerin 0.2 % and hypromellose 0.2 % ophthalmic drops,8002122,glycerin and hypromellose,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
88404,Marketed,2025-04-25,02399148,Refresh Optive Advanced,3,S01XA20,Artificial tears and other indifferent preparations.,Solution,Ophthalmic,02399148,REFRESH OPTIVE ADVANCED (carboxymethylcellulose sodium 0.5 % and glycerin 1 % and polysorbate 80 0.5 % ophthalmic drops) ABBVIE CORPORATION,Active,9013773,carboxymethylcellulose sodium 0.5 % and glycerin 1 % and polysorbate 80 0.5 % ophthalmic drops,8002223,carboxymethylcellulose and glycerin and polysorbate 80,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
91991,Marketed,2025-01-10,02435578,Refresh Optive Fusion,2,S01XA20,Artificial tears and other indifferent preparations.,Solution,Ophthalmic,02435578,REFRESH OPTIVE FUSION (carboxymethylcellulose sodium 0.5 % and glycerin 0.9 % ophthalmic drops) ABBVIE CORPORATION,Active,9013772,carboxymethylcellulose sodium 0.5 % and glycerin 0.9 % ophthalmic drops,8002222,carboxymethylcellulose and glycerin,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
92296,Marketed,2026-03-31,02438585,Visine For Dry Eye Tired Eye Relief,2,S01XA20,Artificial tears and other indifferent preparations.,Drops,Ophthalmic,02438585,VISINE FOR DRY EYE TIRED EYE RELIEF (glycerin 0.2 % and hypromellose 0.2 % ophthalmic drops) KENVUE CANADA INC.,Active,9013559,glycerin 0.2 % and hypromellose 0.2 % ophthalmic drops,8002122,glycerin and hypromellose,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
95175,Marketed,2025-07-09,02463652,Refresh Optive Gel Drops,2,S01XA20,Artificial tears and other indifferent preparations.,Solution,Ophthalmic,02463652,REFRESH OPTIVE GEL DROPS (carboxymethylcellulose sodium 1 % and glycerin 0.9 % ophthalmic drops) ABBVIE CORPORATION,Active,9013776,carboxymethylcellulose sodium 1 % and glycerin 0.9 % ophthalmic drops,8002222,carboxymethylcellulose and glycerin,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
95350,Marketed,2018-05-03,02465302,Soothe Restore,2,S01XA20,Artificial tears and other indifferent preparations.,Drops,Ophthalmic,02465302,SOOTHE RESTORE (mineral oil heavy 4.5 % and mineral oil light 1 % ophthalmic drops) BAUSCH & LOMB INC,Active,9013715,mineral oil heavy 4.5 % and mineral oil light 1 % ophthalmic drops,8002205,mineral oil heavy and mineral oil light,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
9820,Marketed,2024-07-09,00210889,Refresh Lacri-Lube,2,S01XA20,Artificial tears and other indifferent preparations.,Ointment,Ophthalmic,00210889,REFRESH LACRI-LUBE (mineral oil heavy 42.5 % and white petrolatum 57.3 % ophthalmic ointment) ABBVIE CORPORATION,Active,9013716,mineral oil heavy 42.5 % and white petrolatum 57.3 % ophthalmic ointment,8002207,mineral oil heavy and white petrolatum,54485002,Ophthalmic,385123004,Ophthalmic ointment,,,,,,Non-Prescription Drugs
101756,Marketed,2022-09-01,02528320,Scemblix,1,L01EA06,Asciminib,Tablet,Oral,02528320,SCEMBLIX (asciminib (asciminib hydrochloride) 20 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014754,asciminib (asciminib hydrochloride) 20 mg oral tablet,8002433,asciminib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101757,Marketed,2022-09-01,02528339,Scemblix,1,L01EA06,Asciminib,Tablet,Oral,02528339,SCEMBLIX (asciminib (asciminib hydrochloride) 40 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014755,asciminib (asciminib hydrochloride) 40 mg oral tablet,8002433,asciminib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
69229,Marketed,2015-09-15,02245214,Vitamin C,1,A11GA01,Ascorbic acid (vit c),Solution,"Subcutaneous,Intravenous,Intramuscular",02245214,VITAMIN C (ascorbic acid 500 mg per mL solution for injection 50 mL vial) MYLAN PHARMACEUTICALS ULC,Active,9013656,ascorbic acid 500 mg per mL solution for injection 50 mL vial,8002175,ascorbic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
84117,Marketed,2019-08-23,02355981,Ascor L 500,1,A11GA01,Ascorbic acid (vit c),Solution,"Subcutaneous,Intramuscular,Intravenous",02355981,ASCOR L 500 (ascorbic acid 500 mg per mL solution for injection 50 mL vial) MCGUFF PHARMACEUTICALS INC,Active,9013656,ascorbic acid 500 mg per mL solution for injection 50 mL vial,8002175,ascorbic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
9992,Marketed,2005-10-01,00780634,Vitamin C,1,A11GA01,Ascorbic acid (vit c),Liquid,"Intramuscular,Intravenous",00780634,VITAMIN C (ascorbic acid (sodium ascorbate) 500 mg per 2 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9013654,ascorbic acid (sodium ascorbate) 500 mg per 2 mL solution for injection ampoule,8002175,ascorbic acid,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
86017,Marketed,2022-04-19,02374803,Saphris,1,N05AH05,Asenapine,Tablet,Sublingual,02374803,SAPHRIS (asenapine (asenapine maleate) 5 mg sublingual tablet) ORGANON CANADA INC.,Active,9004958,asenapine (asenapine maleate) 5 mg sublingual tablet,8001435,asenapine,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,,Prescription
86018,Marketed,2022-05-12,02374811,Saphris,1,N05AH05,Asenapine,Tablet,Sublingual,02374811,SAPHRIS (asenapine (asenapine maleate) 10 mg sublingual tablet) ORGANON CANADA INC.,Active,9004957,asenapine (asenapine maleate) 10 mg sublingual tablet,8001435,asenapine,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,,Prescription
92969,Marketed,2015-10-20,02444615,Strensiq,1,A16AB13,Asfotase alfa,Solution,Subcutaneous,02444615,STRENSIQ (asfotase alfa 18 mg per 0.45 mL solution for injection vial) ALEXION PHARMA GMBH,Active,9012895,asfotase alfa 18 mg per 0.45 mL solution for injection vial,8001569,asfotase alfa,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
92969,Marketed,2015-10-20,02444615,Strensiq,1,A16AB13,Asfotase alfa,Solution,Subcutaneous,02444615,STRENSIQ (asfotase alfa 18 mg per 0.45 mL solution for injection vial) ALEXION PHARMA GMBH,Active,9012895,asfotase alfa 18 mg per 0.45 mL solution for injection vial,8001569,asfotase alfa,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
92970,Marketed,2016-06-07,02444623,Strensiq,1,A16AB13,Asfotase alfa,Solution,Subcutaneous,02444623,STRENSIQ (asfotase alfa 28 mg per 0.7 mL solution for injection vial) ALEXION PHARMA GMBH,Active,9012896,asfotase alfa 28 mg per 0.7 mL solution for injection vial,8001569,asfotase alfa,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
92970,Marketed,2016-06-07,02444623,Strensiq,1,A16AB13,Asfotase alfa,Solution,Subcutaneous,02444623,STRENSIQ (asfotase alfa 28 mg per 0.7 mL solution for injection vial) ALEXION PHARMA GMBH,Active,9012896,asfotase alfa 28 mg per 0.7 mL solution for injection vial,8001569,asfotase alfa,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
92971,Marketed,2016-06-01,02444631,Strensiq,1,A16AB13,Asfotase alfa,Solution,Subcutaneous,02444631,STRENSIQ (asfotase alfa 40 mg per 1 mL solution for injection vial) ALEXION PHARMA GMBH,Active,9012897,asfotase alfa 40 mg per 1 mL solution for injection vial,8001569,asfotase alfa,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
92971,Marketed,2016-06-01,02444631,Strensiq,1,A16AB13,Asfotase alfa,Solution,Subcutaneous,02444631,STRENSIQ (asfotase alfa 40 mg per 1 mL solution for injection vial) ALEXION PHARMA GMBH,Active,9012897,asfotase alfa 40 mg per 1 mL solution for injection vial,8001569,asfotase alfa,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
92972,Marketed,2016-02-17,02444658,Strensiq,1,A16AB13,Asfotase alfa,Solution,Subcutaneous,02444658,STRENSIQ (asfotase alfa 80 mg per 0.8 mL solution for injection vial) ALEXION PHARMA GMBH,Active,9012898,asfotase alfa 80 mg per 0.8 mL solution for injection vial,8001569,asfotase alfa,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
92972,Marketed,2016-02-17,02444658,Strensiq,1,A16AB13,Asfotase alfa,Solution,Subcutaneous,02444658,STRENSIQ (asfotase alfa 80 mg per 0.8 mL solution for injection vial) ALEXION PHARMA GMBH,Active,9012898,asfotase alfa 80 mg per 0.8 mL solution for injection vial,8001569,asfotase alfa,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
101958,Marketed,2023-05-03,02530406,Rylaze,1,L01XX02,Asparaginase,Solution,Intramuscular,02530406,RYLAZE (crisantaspase 10 mg per 0.5 mL solution for injection vial) JAZZ PHARMACEUTICALS IRELAND LIMITED,Active,9014854,crisantaspase 10 mg per 0.5 mL solution for injection vial,8002467,crisantaspase,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
101958,Marketed,2023-05-03,02530406,Rylaze,1,L01XX02,Asparaginase,Solution,Intramuscular,02530406,RYLAZE (crisantaspase 10 mg per 0.5 mL solution for injection vial) JAZZ PHARMACEUTICALS IRELAND LIMITED,Active,9014854,crisantaspase 10 mg per 0.5 mL solution for injection vial,8002467,crisantaspase,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
100234,Marketed,2023-01-26,02513102,JAMP Atazanavir,1,J05AE08,Atazanavir,Capsule,Oral,02513102,JAMP ATAZANAVIR (atazanavir (atazanavir sulfate) 150 mg oral capsule) JAMP PHARMA CORPORATION,Active,9003857,atazanavir (atazanavir sulfate) 150 mg oral capsule,8001171,atazanavir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
100235,Marketed,2023-01-26,02513110,JAMP Atazanavir,1,J05AE08,Atazanavir,Capsule,Oral,02513110,JAMP ATAZANAVIR (atazanavir (atazanavir sulfate) 200 mg oral capsule) JAMP PHARMA CORPORATION,Active,9003858,atazanavir (atazanavir sulfate) 200 mg oral capsule,8001171,atazanavir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
100236,Marketed,2023-01-31,02513129,JAMP Atazanavir,1,J05AE08,Atazanavir,Capsule,Oral,02513129,JAMP ATAZANAVIR (atazanavir (atazanavir sulfate) 300 mg oral capsule) JAMP PHARMA CORPORATION,Active,9004300,atazanavir (atazanavir sulfate) 300 mg oral capsule,8001171,atazanavir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
72967,Marketed,2004-01-09,02248611,Reyataz,1,J05AE08,Atazanavir,Capsule,Oral,02248611,REYATAZ (atazanavir (atazanavir sulfate) 200 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9003858,atazanavir (atazanavir sulfate) 200 mg oral capsule,8001171,atazanavir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
77952,Marketed,2007-05-31,02294176,Reyataz,1,J05AE08,Atazanavir,Capsule,Oral,02294176,REYATAZ (atazanavir (atazanavir sulfate) 300 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9004300,atazanavir (atazanavir sulfate) 300 mg oral capsule,8001171,atazanavir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
92854,Marketed,2017-04-18,02443791,Teva-Atazanavir,1,J05AE08,Atazanavir,Capsule,Oral,02443791,TEVA-ATAZANAVIR (atazanavir (atazanavir sulfate) 150 mg oral capsule) TEVA CANADA LIMITED,Active,9003857,atazanavir (atazanavir sulfate) 150 mg oral capsule,8001171,atazanavir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
92856,Marketed,2017-04-18,02443813,Teva-Atazanavir,1,J05AE08,Atazanavir,Capsule,Oral,02443813,TEVA-ATAZANAVIR (atazanavir (atazanavir sulfate) 200 mg oral capsule) TEVA CANADA LIMITED,Active,9003858,atazanavir (atazanavir sulfate) 200 mg oral capsule,8001171,atazanavir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
92857,Marketed,2017-04-18,02443821,Teva-Atazanavir,1,J05AE08,Atazanavir,Capsule,Oral,02443821,TEVA-ATAZANAVIR (atazanavir (atazanavir sulfate) 300 mg oral capsule) TEVA CANADA LIMITED,Active,9004300,atazanavir (atazanavir sulfate) 300 mg oral capsule,8001171,atazanavir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
94389,Marketed,2017-05-03,02456877,Mylan-Atazanavir,1,J05AE08,Atazanavir,Capsule,Oral,02456877,MYLAN-ATAZANAVIR (atazanavir (atazanavir sulfate) 150 mg oral capsule) MYLAN PHARMACEUTICALS ULC,Active,9003857,atazanavir (atazanavir sulfate) 150 mg oral capsule,8001171,atazanavir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
94390,Marketed,2017-05-03,02456885,Mylan-Atazanavir,1,J05AE08,Atazanavir,Capsule,Oral,02456885,MYLAN-ATAZANAVIR (atazanavir (atazanavir sulfate) 200 mg oral capsule) MYLAN PHARMACEUTICALS ULC,Active,9003858,atazanavir (atazanavir sulfate) 200 mg oral capsule,8001171,atazanavir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
94391,Marketed,2017-05-02,02456893,Mylan-Atazanavir,1,J05AE08,Atazanavir,Capsule,Oral,02456893,MYLAN-ATAZANAVIR (atazanavir (atazanavir sulfate) 300 mg oral capsule) MYLAN PHARMACEUTICALS ULC,Active,9004300,atazanavir (atazanavir sulfate) 300 mg oral capsule,8001171,atazanavir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
103020,Marketed,2024-01-05,02541564,Atenolol,1,C07AB03,Atenolol,Tablet,Oral,02541564,ATENOLOL (atenolol 25 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001004,atenolol 25 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
17905,Marketed,2022-02-28,02039532,Tenormin,1,C07AB03,Atenolol,Tablet,Oral,02039532,TENORMIN (atenolol 50 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9000286,atenolol 50 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
17906,Marketed,2022-02-28,02039540,Tenormin,1,C07AB03,Atenolol,Tablet,Oral,02039540,TENORMIN (atenolol 100 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9000285,atenolol 100 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
19691,Marketed,2017-11-22,02171791,Teva-Atenolol,1,C07AB03,Atenolol,Tablet,Oral,02171791,TEVA-ATENOLOL (atenolol 50 mg oral tablet) TEVA CANADA LIMITED,Active,9000286,atenolol 50 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
19692,Marketed,2017-11-22,02171805,Teva-Atenolol,1,C07AB03,Atenolol,Tablet,Oral,02171805,TEVA-ATENOLOL (atenolol 100 mg oral tablet) TEVA CANADA LIMITED,Active,9000285,atenolol 100 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
60939,Marketed,1998-03-31,02237600,PMS-Atenolol,1,C07AB03,Atenolol,Tablet,Oral,02237600,PMS-ATENOLOL (atenolol 50 mg oral tablet) PHARMASCIENCE INC,Active,9000286,atenolol 50 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
60940,Marketed,1998-03-31,02237601,PMS-Atenolol,1,C07AB03,Atenolol,Tablet,Oral,02237601,PMS-ATENOLOL (atenolol 100 mg oral tablet) PHARMASCIENCE INC,Active,9000285,atenolol 100 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
61718,Marketed,2024-01-05,02238316,Atenolol,1,C07AB03,Atenolol,Tablet,Oral,02238316,ATENOLOL (atenolol 50 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000286,atenolol 50 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
61719,Marketed,2024-01-05,02238318,Atenolol,1,C07AB03,Atenolol,Tablet,Oral,02238318,ATENOLOL (atenolol 100 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000285,atenolol 100 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
65768,Marketed,2000-05-23,02242093,Riva-Atenolol,1,C07AB03,Atenolol,Tablet,Oral,02242093,RIVA-ATENOLOL (atenolol 100 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000285,atenolol 100 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
65769,Marketed,2000-05-23,02242094,Riva-Atenolol,1,C07AB03,Atenolol,Tablet,Oral,02242094,RIVA-ATENOLOL (atenolol 50 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000286,atenolol 50 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
70768,Marketed,2002-11-28,02246581,PMS-Atenolol,1,C07AB03,Atenolol,Tablet,Oral,02246581,PMS-ATENOLOL (atenolol 25 mg oral tablet) PHARMASCIENCE INC,Active,9001004,atenolol 25 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75207,Marketed,2010-05-01,02266660,Teva-Atenolol,1,C07AB03,Atenolol,Tablet,Oral,02266660,TEVA-ATENOLOL (atenolol 25 mg oral tablet) TEVA CANADA LIMITED,Active,9001004,atenolol 25 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75337,Marketed,2020-01-23,02267985,Taro-Atenolol,1,C07AB03,Atenolol,Tablet,Oral,02267985,TARO-ATENOLOL (atenolol 50 mg oral tablet) SUN PHARMA CANADA INC,Active,9000286,atenolol 50 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75338,Marketed,2020-01-23,02267993,Taro-Atenolol,1,C07AB03,Atenolol,Tablet,Oral,02267993,TARO-ATENOLOL (atenolol 100 mg oral tablet) SUN PHARMA CANADA INC,Active,9000285,atenolol 100 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76301,Marketed,2006-07-12,02277379,Riva-Atenolol,1,C07AB03,Atenolol,Tablet,Oral,02277379,RIVA-ATENOLOL (atenolol 25 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001004,atenolol 25 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81205,Marketed,2026-04-27,02326701,Pro-Atenolol,1,C07AB03,Atenolol,Tablet,Oral,02326701,PRO-ATENOLOL (atenolol 25 mg oral tablet) PRO DOC LIMITEE,Active,9001004,atenolol 25 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85239,Marketed,2011-06-09,02367556,JAMP-Atenolol,1,C07AB03,Atenolol,Tablet,Oral,02367556,JAMP-ATENOLOL (atenolol 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001004,atenolol 25 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85240,Marketed,2011-06-09,02367564,JAMP-Atenolol,1,C07AB03,Atenolol,Tablet,Oral,02367564,JAMP-ATENOLOL (atenolol 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000286,atenolol 50 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85241,Marketed,2011-06-09,02367572,JAMP-Atenolol,1,C07AB03,Atenolol,Tablet,Oral,02367572,JAMP-ATENOLOL (atenolol 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000285,atenolol 100 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85283,Marketed,2011-06-13,02368013,Mint-Atenol,1,C07AB03,Atenolol,Tablet,Oral,02368013,MINT-ATENOL (atenolol 25 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001004,atenolol 25 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85284,Marketed,2011-06-13,02368021,Mint-Atenol,1,C07AB03,Atenolol,Tablet,Oral,02368021,MINT-ATENOL (atenolol 50 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000286,atenolol 50 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85285,Marketed,2011-06-13,02368048,Mint-Atenol,1,C07AB03,Atenolol,Tablet,Oral,02368048,MINT-ATENOL (atenolol 100 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000285,atenolol 100 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85413,Marketed,2018-07-18,02369192,AG-Atenolol,1,C07AB03,Atenolol,Tablet,Oral,02369192,AG-ATENOLOL (atenolol 100 mg oral tablet) ANGITA PHARMA INC.,Active,9000285,atenolol 100 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85710,Marketed,2012-10-22,02371979,Mar-Atenolol,1,C07AB03,Atenolol,Tablet,Oral,02371979,MAR-ATENOLOL (atenolol 25 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001004,atenolol 25 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85711,Marketed,2012-10-22,02371987,Mar-Atenolol,1,C07AB03,Atenolol,Tablet,Oral,02371987,MAR-ATENOLOL (atenolol 50 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000286,atenolol 50 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85712,Marketed,2012-10-22,02371995,Mar-Atenolol,1,C07AB03,Atenolol,Tablet,Oral,02371995,MAR-ATENOLOL (atenolol 100 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000285,atenolol 100 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85918,Marketed,2020-01-20,02373963,Taro-Atenolol,1,C07AB03,Atenolol,Tablet,Oral,02373963,TARO-ATENOLOL (atenolol 25 mg oral tablet) SUN PHARMA CANADA INC,Active,9001004,atenolol 25 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
9174,Marketed,1988-12-31,00773689,Apo-Atenol Tablets 50 mg,1,C07AB03,Atenolol,Tablet,Oral,00773689,APO-ATENOL TAB 50MG (atenolol 50 mg oral tablet) APOTEX INC,Active,9000286,atenolol 50 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
9175,Marketed,1988-12-31,00773697,Apo-Atenol Tablets 100 mg,1,C07AB03,Atenolol,Tablet,Oral,00773697,APO-ATENOL TAB 100MG (atenolol 100 mg oral tablet) APOTEX INC,Active,9000285,atenolol 100 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95482,Marketed,2017-10-20,02466465,Atenolol,1,C07AB03,Atenolol,Tablet,Oral,02466465,ATENOLOL (atenolol 50 mg oral tablet) SANIS HEALTH INC,Active,9000286,atenolol 50 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95483,Marketed,2017-10-20,02466473,Atenolol,1,C07AB03,Atenolol,Tablet,Oral,02466473,ATENOLOL (atenolol 100 mg oral tablet) SANIS HEALTH INC,Active,9000285,atenolol 100 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
9904,Marketed,2026-03-07,00828793,Pro-Atenolol,1,C07AB03,Atenolol,Tablet,Oral,00828793,PRO-ATENOLOL (atenolol 100 mg oral tablet) PRO DOC LIMITEE,Active,9000285,atenolol 100 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
9905,Marketed,2026-03-23,00828807,Pro-Atenolol,1,C07AB03,Atenolol,Tablet,Oral,00828807,PRO-ATENOLOL (atenolol 50 mg oral tablet) PRO DOC LIMITEE,Active,9000286,atenolol 50 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73131,Marketed,2020-09-24,02248763,AA-Atenidone,2,C07CB03,Atenolol and other diuretics,Tablet,Oral,02248763,AA-ATENIDONE (atenolol 50 mg and chlorthalidone 25 mg oral tablet) AA PHARMA INC,Active,9002741,atenolol 50 mg and chlorthalidone 25 mg oral tablet,8000879,atenolol and chlorthalidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73132,Marketed,2020-09-03,02248764,AA-Atenidone,2,C07CB03,Atenolol and other diuretics,Tablet,Oral,02248764,AA-ATENIDONE (atenolol 100 mg and chlorthalidone 25 mg oral tablet) AA PHARMA INC,Active,9002627,atenolol 100 mg and chlorthalidone 25 mg oral tablet,8000879,atenolol and chlorthalidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103502,Marketed,2024-05-16,02546310,Tecentriq SC,1,L01FF05,Atezolizumab,Solution,Subcutaneous,02546310,TECENTRIQ SC (atezolizumab 1875 mg per 15 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9015043,atezolizumab 1875 mg per 15 mL solution for injection vial,8001570,atezolizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
103502,Marketed,2024-05-16,02546310,Tecentriq SC,1,L01FF05,Atezolizumab,Solution,Subcutaneous,02546310,TECENTRIQ SC (atezolizumab 1875 mg per 15 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9015043,atezolizumab 1875 mg per 15 mL solution for injection vial,8001570,atezolizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
95089,Marketed,2017-05-02,02462990,Tecentriq,1,L01FF05,Atezolizumab,Solution,Intravenous,02462990,TECENTRIQ (atezolizumab 1200 mg per 20 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9012899,atezolizumab 1200 mg per 20 mL solution for injection vial,8001570,atezolizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
95089,Marketed,2017-05-02,02462990,Tecentriq,1,L01FF05,Atezolizumab,Solution,Intravenous,02462990,TECENTRIQ (atezolizumab 1200 mg per 20 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9012899,atezolizumab 1200 mg per 20 mL solution for injection vial,8001570,atezolizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
98241,Marketed,2019-10-16,02492393,Tecentriq,1,L01FF05,Atezolizumab,Solution,Intravenous,02492393,TECENTRIQ (atezolizumab 840 mg per 14 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9014159,atezolizumab 840 mg per 14 mL solution for injection vial,8001570,atezolizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
98241,Marketed,2019-10-16,02492393,Tecentriq,1,L01FF05,Atezolizumab,Solution,Intravenous,02492393,TECENTRIQ (atezolizumab 840 mg per 14 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9014159,atezolizumab 840 mg per 14 mL solution for injection vial,8001570,atezolizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
102287,Marketed,2023-03-24,02533979,Qulipta,1,N02CD07,Atogepant,Tablet,Oral,02533979,QULIPTA (atogepant 10 mg oral tablet) ABBVIE CORPORATION,Active,9014834,atogepant 10 mg oral tablet,8002461,atogepant,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102293,Marketed,2023-02-23,02533987,Qulipta,1,N02CD07,Atogepant,Tablet,Oral,02533987,QULIPTA (atogepant 30 mg oral tablet) ABBVIE CORPORATION,Active,9014835,atogepant 30 mg oral tablet,8002461,atogepant,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102294,Marketed,2023-03-01,02533995,Qulipta,1,N02CD07,Atogepant,Tablet,Oral,02533995,QULIPTA (atogepant 60 mg oral tablet) ABBVIE CORPORATION,Active,9014836,atogepant 60 mg oral tablet,8002461,atogepant,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
80008,Marketed,2012-06-01,02314541,Teva-Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02314541,TEVA-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule) TEVA CANADA LIMITED,Active,9001104,atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
80009,Marketed,2012-06-01,02314568,Teva-Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02314568,TEVA-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule) TEVA CANADA LIMITED,Active,9001105,atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
80010,Marketed,2012-06-01,02314576,Teva-Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02314576,TEVA-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule) TEVA CANADA LIMITED,Active,9001106,atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
80011,Marketed,2012-06-01,02314584,Teva-Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02314584,TEVA-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule) TEVA CANADA LIMITED,Active,9001107,atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
80012,Marketed,2012-06-01,02314592,Teva-Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02314592,TEVA-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule) TEVA CANADA LIMITED,Active,9001108,atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
80353,Marketed,2011-03-15,02318024,Apo-Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02318024,APO-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule) APOTEX INC,Active,9001104,atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
80354,Marketed,2011-03-15,02318032,Apo-Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02318032,APO-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule) APOTEX INC,Active,9001105,atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
80355,Marketed,2011-03-15,02318040,Apo-Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02318040,APO-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule) APOTEX INC,Active,9001106,atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
80356,Marketed,2011-07-19,02318059,Apo-Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02318059,APO-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule) APOTEX INC,Active,9001107,atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
80357,Marketed,2011-07-19,02318067,Apo-Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02318067,APO-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule) APOTEX INC,Active,9001108,atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
80358,Marketed,2011-07-19,02318075,Apo-Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02318075,APO-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 80 mg oral capsule) APOTEX INC,Active,9001302,atomoxetine (atomoxetine hydrochloride) 80 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
80359,Marketed,2011-07-19,02318083,Apo-Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02318083,APO-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 100 mg oral capsule) APOTEX INC,Active,9001303,atomoxetine (atomoxetine hydrochloride) 100 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
84752,Marketed,2014-02-28,02362511,Teva-Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02362511,TEVA-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 80 mg oral capsule) TEVA CANADA LIMITED,Active,9001302,atomoxetine (atomoxetine hydrochloride) 80 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
86676,Marketed,2012-06-13,02381028,PMS-Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02381028,PMS-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule) PHARMASCIENCE INC,Active,9001104,atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
86677,Marketed,2012-06-13,02381036,PMS-Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02381036,PMS-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule) PHARMASCIENCE INC,Active,9001105,atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
86678,Marketed,2012-06-13,02381044,PMS-Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02381044,PMS-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule) PHARMASCIENCE INC,Active,9001106,atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
86679,Marketed,2012-06-13,02381052,PMS-Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02381052,PMS-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule) PHARMASCIENCE INC,Active,9001107,atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
86680,Marketed,2012-06-13,02381060,PMS-Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02381060,PMS-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule) PHARMASCIENCE INC,Active,9001108,atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87200,Marketed,2012-05-30,02386410,Sandoz Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02386410,SANDOZ ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001104,atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87201,Marketed,2012-05-30,02386429,Sandoz Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02386429,SANDOZ ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001105,atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87202,Marketed,2012-05-30,02386437,Sandoz Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02386437,SANDOZ ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001106,atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87203,Marketed,2012-05-30,02386445,Sandoz Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02386445,SANDOZ ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001107,atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87204,Marketed,2012-05-30,02386453,Sandoz Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02386453,SANDOZ ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001108,atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87205,Marketed,2012-05-30,02386461,Sandoz Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02386461,SANDOZ ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 80 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001302,atomoxetine (atomoxetine hydrochloride) 80 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87206,Marketed,2012-05-30,02386488,Sandoz Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02386488,SANDOZ ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 100 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001303,atomoxetine (atomoxetine hydrochloride) 100 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88191,Marketed,2018-03-20,02396904,Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02396904,ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule) PRO DOC LIMITEE,Active,9001104,atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88192,Marketed,2017-10-18,02396912,Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02396912,ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule) PRO DOC LIMITEE,Active,9001105,atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88193,Marketed,2017-10-02,02396920,Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02396920,ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule) PRO DOC LIMITEE,Active,9001106,atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88194,Marketed,2017-09-07,02396939,Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02396939,ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule) PRO DOC LIMITEE,Active,9001107,atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88195,Marketed,2017-10-03,02396947,Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02396947,ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule) PRO DOC LIMITEE,Active,9001108,atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
89071,Marketed,2014-04-24,02405962,Riva-Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02405962,RIVA-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule) LABORATOIRE RIVA INC.,Active,9001104,atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
89072,Marketed,2014-04-24,02405970,Riva-Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02405970,RIVA-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule) LABORATOIRE RIVA INC.,Active,9001105,atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
89073,Marketed,2014-04-24,02405989,Riva-Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02405989,RIVA-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule) LABORATOIRE RIVA INC.,Active,9001106,atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
89074,Marketed,2014-04-24,02405997,Riva-Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02405997,RIVA-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule) LABORATOIRE RIVA INC.,Active,9001107,atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
89075,Marketed,2014-04-24,02406004,Riva-Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02406004,RIVA-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule) LABORATOIRE RIVA INC.,Active,9001108,atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
93116,Marketed,2015-10-07,02445883,Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02445883,ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9001104,atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
93118,Marketed,2015-10-07,02445905,Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02445905,ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9001105,atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
93120,Marketed,2015-10-07,02445913,Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02445913,ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9001106,atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
93121,Marketed,2015-10-07,02445948,Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02445948,ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9001107,atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
93122,Marketed,2015-10-07,02445956,Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02445956,ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9001108,atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95610,Marketed,2018-01-15,02467747,Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02467747,ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule) SANIS HEALTH INC,Active,9001104,atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95611,Marketed,2018-01-15,02467755,Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02467755,ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule) SANIS HEALTH INC,Active,9001105,atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95612,Marketed,2018-01-15,02467763,Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02467763,ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule) SANIS HEALTH INC,Active,9001106,atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95613,Marketed,2018-01-15,02467771,Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02467771,ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule) SANIS HEALTH INC,Active,9001107,atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95614,Marketed,2018-01-15,02467798,Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02467798,ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule) SANIS HEALTH INC,Active,9001108,atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95615,Marketed,2018-01-15,02467801,Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02467801,ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 80 mg oral capsule) SANIS HEALTH INC,Active,9001302,atomoxetine (atomoxetine hydrochloride) 80 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95616,Marketed,2018-01-15,02467828,Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02467828,ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 100 mg oral capsule) SANIS HEALTH INC,Active,9001303,atomoxetine (atomoxetine hydrochloride) 100 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96064,Marketed,2019-02-04,02471485,Auro-Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02471485,AURO-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule) AURO PHARMA INC,Active,9001104,atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96065,Marketed,2019-02-04,02471493,Auro-Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02471493,AURO-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule) AURO PHARMA INC,Active,9001105,atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96066,Marketed,2019-02-04,02471507,Auro-Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02471507,AURO-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule) AURO PHARMA INC,Active,9001106,atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96067,Marketed,2019-02-04,02471515,Auro-Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02471515,AURO-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule) AURO PHARMA INC,Active,9001107,atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96068,Marketed,2019-02-02,02471523,Auro-Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02471523,AURO-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule) AURO PHARMA INC,Active,9001108,atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96069,Marketed,2019-02-04,02471531,Auro-Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02471531,AURO-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 80 mg oral capsule) AURO PHARMA INC,Active,9001302,atomoxetine (atomoxetine hydrochloride) 80 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96070,Marketed,2019-02-04,02471558,Auro-Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02471558,AURO-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 100 mg oral capsule) AURO PHARMA INC,Active,9001303,atomoxetine (atomoxetine hydrochloride) 100 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
99616,Marketed,2023-02-23,02506807,JAMP Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02506807,JAMP ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001104,atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
99617,Marketed,2023-02-23,02506815,JAMP Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02506815,JAMP ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001105,atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
99618,Marketed,2023-01-30,02506823,JAMP Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02506823,JAMP ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001106,atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
99619,Marketed,2023-02-21,02506831,JAMP Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02506831,JAMP ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001107,atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
99620,Marketed,2023-01-30,02506858,JAMP Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02506858,JAMP ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001108,atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
99621,Marketed,2023-02-23,02506866,JAMP Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02506866,JAMP ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 80 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001302,atomoxetine (atomoxetine hydrochloride) 80 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
99622,Marketed,2023-02-23,02506874,JAMP Atomoxetine,1,N06BA09,Atomoxetine,Capsule,Oral,02506874,JAMP ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 100 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001303,atomoxetine (atomoxetine hydrochloride) 100 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
101074,Marketed,2022-09-19,02521555,PRZ-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02521555,PRZ-ATORVASTATIN (atorvastatin (atorvastatin calcium) 10 mg oral tablet) PHARMARIS CANADA INC,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101075,Marketed,2022-09-19,02521563,PRZ-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02521563,PRZ-ATORVASTATIN (atorvastatin (atorvastatin calcium) 20 mg oral tablet) PHARMARIS CANADA INC,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101076,Marketed,2022-09-19,02521571,PRZ-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02521571,PRZ-ATORVASTATIN (atorvastatin (atorvastatin calcium) 40 mg oral tablet) PHARMARIS CANADA INC,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101077,Marketed,2022-09-19,02521598,PRZ-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02521598,PRZ-ATORVASTATIN (atorvastatin (atorvastatin calcium) 80 mg oral tablet) PHARMARIS CANADA INC,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103422,Marketed,2026-01-13,02545462,Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02545462,ATORVASTATIN (atorvastatin (atorvastatin calcium) 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103423,Marketed,2026-01-13,02545470,Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02545470,ATORVASTATIN (atorvastatin (atorvastatin calcium) 20 mg oral tablet) TEVA CANADA LIMITED,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103424,Marketed,2026-01-13,02545489,Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02545489,ATORVASTATIN (atorvastatin (atorvastatin calcium) 40 mg oral tablet) TEVA CANADA LIMITED,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103425,Marketed,2026-01-13,02545497,Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02545497,ATORVASTATIN (atorvastatin (atorvastatin calcium) 80 mg oral tablet) TEVA CANADA LIMITED,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
49973,Marketed,2023-08-02,02230711,Lipitor,1,C10AA05,Atorvastatin,Tablet,Oral,02230711,LIPITOR (atorvastatin (atorvastatin calcium) 10 mg oral tablet) BGP PHARMA ULC,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
49974,Marketed,2023-08-02,02230713,Lipitor,1,C10AA05,Atorvastatin,Tablet,Oral,02230713,LIPITOR (atorvastatin (atorvastatin calcium) 20 mg oral tablet) BGP PHARMA ULC,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
49975,Marketed,2023-08-02,02230714,Lipitor,1,C10AA05,Atorvastatin,Tablet,Oral,02230714,LIPITOR (atorvastatin (atorvastatin calcium) 40 mg oral tablet) BGP PHARMA ULC,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
66964,Marketed,2023-08-02,02243097,Lipitor,1,C10AA05,Atorvastatin,Tablet,Oral,02243097,LIPITOR (atorvastatin (atorvastatin calcium) 80 mg oral tablet) BGP PHARMA ULC,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78058,Marketed,2010-05-19,02295261,Apo-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02295261,APO-ATORVASTATIN (atorvastatin (atorvastatin calcium propylene glycol solvate) 10 mg oral tablet) APOTEX INC,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78059,Marketed,2010-05-19,02295288,Apo-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02295288,APO-ATORVASTATIN (atorvastatin (atorvastatin calcium propylene glycol solvate) 20 mg oral tablet) APOTEX INC,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78060,Marketed,2010-05-19,02295296,Apo-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02295296,APO-ATORVASTATIN (atorvastatin (atorvastatin calcium propylene glycol solvate) 40 mg oral tablet) APOTEX INC,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78061,Marketed,2010-05-19,02295318,Apo-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02295318,APO-ATORVASTATIN (atorvastatin (atorvastatin calcium propylene glycol solvate) 80 mg oral tablet) APOTEX INC,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79651,Marketed,2017-06-06,02310899,Teva-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02310899,TEVA-ATORVASTATIN (atorvastatin (atorvastatin calcium) 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79652,Marketed,2017-06-06,02310902,Teva-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02310902,TEVA-ATORVASTATIN (atorvastatin (atorvastatin calcium) 20 mg oral tablet) TEVA CANADA LIMITED,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79653,Marketed,2017-06-06,02310910,Teva-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02310910,TEVA-ATORVASTATIN (atorvastatin (atorvastatin calcium) 40 mg oral tablet) TEVA CANADA LIMITED,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79654,Marketed,2017-06-06,02310929,Teva-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02310929,TEVA-ATORVASTATIN (atorvastatin (atorvastatin calcium) 80 mg oral tablet) TEVA CANADA LIMITED,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79921,Marketed,2024-05-03,02313707,Taro-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02313707,TARO-ATORVASTATIN (atorvastatin (atorvastatin calcium) 10 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79922,Marketed,2024-05-03,02313715,Taro-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02313715,TARO-ATORVASTATIN (atorvastatin (atorvastatin calcium) 20 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79923,Marketed,2024-05-03,02313723,Taro-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02313723,TARO-ATORVASTATIN (atorvastatin (atorvastatin calcium) 40 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79925,Marketed,2024-05-03,02313758,Taro-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02313758,TARO-ATORVASTATIN (atorvastatin (atorvastatin calcium) 80 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81036,Marketed,2010-05-19,02324946,Sandoz Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02324946,SANDOZ ATORVASTATIN (atorvastatin (atorvastatin calcium) 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81037,Marketed,2010-05-19,02324954,Sandoz Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02324954,SANDOZ ATORVASTATIN (atorvastatin (atorvastatin calcium) 20 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81038,Marketed,2010-05-19,02324962,Sandoz Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02324962,SANDOZ ATORVASTATIN (atorvastatin (atorvastatin calcium) 40 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81039,Marketed,2010-05-19,02324970,Sandoz Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02324970,SANDOZ ATORVASTATIN (atorvastatin (atorvastatin calcium) 80 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83185,Marketed,2010-08-03,02346486,Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02346486,ATORVASTATIN (atorvastatin (atorvastatin calcium propylene glycol solvate) 10 mg oral tablet) PRO DOC LIMITEE,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83192,Marketed,2010-08-03,02346494,Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02346494,ATORVASTATIN (atorvastatin (atorvastatin calcium propylene glycol solvate) 20 mg oral tablet) PRO DOC LIMITEE,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83193,Marketed,2010-08-03,02346508,Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02346508,ATORVASTATIN (atorvastatin (atorvastatin calcium propylene glycol solvate) 40 mg oral tablet) PRO DOC LIMITEE,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83194,Marketed,2010-08-03,02346516,Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02346516,ATORVASTATIN (atorvastatin (atorvastatin calcium propylene glycol solvate) 80 mg oral tablet) PRO DOC LIMITEE,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83405,Marketed,2025-05-29,02348705,Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02348705,ATORVASTATIN (atorvastatin (atorvastatin calcium) 10 mg oral tablet) SANIS HEALTH INC,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83406,Marketed,2025-04-29,02348713,Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02348713,ATORVASTATIN (atorvastatin (atorvastatin calcium) 20 mg oral tablet) SANIS HEALTH INC,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83407,Marketed,2025-04-29,02348721,Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02348721,ATORVASTATIN (atorvastatin (atorvastatin calcium) 40 mg oral tablet) SANIS HEALTH INC,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83408,Marketed,2025-05-29,02348748,Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02348748,ATORVASTATIN (atorvastatin (atorvastatin calcium) 80 mg oral tablet) SANIS HEALTH INC,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87642,Marketed,2012-09-10,02391058,JAMP-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02391058,JAMP-ATORVASTATIN (atorvastatin (atorvastatin calcium) 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87820,Marketed,2014-06-03,02392933,Mylan-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02392933,MYLAN-ATORVASTATIN (atorvastatin (atorvastatin calcium) 10 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87821,Marketed,2014-06-03,02392941,Mylan-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02392941,MYLAN-ATORVASTATIN (atorvastatin (atorvastatin calcium) 20 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87822,Marketed,2014-06-03,02392968,Mylan-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02392968,MYLAN-ATORVASTATIN (atorvastatin (atorvastatin calcium) 40 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87823,Marketed,2014-06-03,02392976,Mylan-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02392976,MYLAN-ATORVASTATIN (atorvastatin (atorvastatin calcium) 80 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89196,Marketed,2018-04-14,02407256,Auro-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02407256,AURO-ATORVASTATIN (atorvastatin (atorvastatin calcium) 10 mg oral tablet) AURO PHARMA INC,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89197,Marketed,2018-04-14,02407264,Auro-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02407264,AURO-ATORVASTATIN (atorvastatin (atorvastatin calcium) 20 mg oral tablet) AURO PHARMA INC,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89198,Marketed,2018-04-14,02407272,Auro-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02407272,AURO-ATORVASTATIN (atorvastatin (atorvastatin calcium) 40 mg oral tablet) AURO PHARMA INC,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89199,Marketed,2018-04-14,02407280,Auro-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02407280,AURO-ATORVASTATIN (atorvastatin (atorvastatin calcium) 80 mg oral tablet) AURO PHARMA INC,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89596,Marketed,2013-10-23,02411350,Atorvastatin-10,1,C10AA05,Atorvastatin,Tablet,Oral,02411350,ATORVASTATIN-10 (atorvastatin (atorvastatin calcium propylene glycol solvate) 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89597,Marketed,2013-10-23,02411369,Atorvastatin-20,1,C10AA05,Atorvastatin,Tablet,Oral,02411369,ATORVASTATIN-20 (atorvastatin (atorvastatin calcium propylene glycol solvate) 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89598,Marketed,2013-10-23,02411377,Atorvastatin-40,1,C10AA05,Atorvastatin,Tablet,Oral,02411377,ATORVASTATIN-40 (atorvastatin (atorvastatin calcium propylene glycol solvate) 40 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89599,Marketed,2013-10-23,02411385,Atorvastatin-80,1,C10AA05,Atorvastatin,Tablet,Oral,02411385,ATORVASTATIN-80 (atorvastatin (atorvastatin calcium propylene glycol solvate) 80 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90742,Marketed,2022-11-30,02422751,Riva-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02422751,RIVA-ATORVASTATIN (atorvastatin (atorvastatin calcium) 10 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90743,Marketed,2022-11-30,02422778,Riva-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02422778,RIVA-ATORVASTATIN (atorvastatin (atorvastatin calcium) 20 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90744,Marketed,2022-11-30,02422786,Riva-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02422786,RIVA-ATORVASTATIN (atorvastatin (atorvastatin calcium) 40 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90745,Marketed,2022-11-30,02422794,Riva-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02422794,RIVA-ATORVASTATIN (atorvastatin (atorvastatin calcium) 80 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94054,Marketed,2017-05-12,02454017,Mar-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02454017,MAR-ATORVASTATIN (atorvastatin (atorvastatin calcium) 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94055,Marketed,2017-05-12,02454025,Mar-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02454025,MAR-ATORVASTATIN (atorvastatin (atorvastatin calcium) 20 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94056,Marketed,2018-10-05,02454033,Mar-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02454033,MAR-ATORVASTATIN (atorvastatin (atorvastatin calcium) 40 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94057,Marketed,2018-10-05,02454041,Mar-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02454041,MAR-ATORVASTATIN (atorvastatin (atorvastatin calcium) 80 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94478,Marketed,2019-10-18,02457741,ACH-Atorvastatin Calcium,1,C10AA05,Atorvastatin,Tablet,Oral,02457741,ACH-ATORVASTATIN CALCIUM (atorvastatin (atorvastatin calcium) 10 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94479,Marketed,2019-10-18,02457768,ACH-Atorvastatin Calcium,1,C10AA05,Atorvastatin,Tablet,Oral,02457768,ACH-ATORVASTATIN CALCIUM (atorvastatin (atorvastatin calcium) 20 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94480,Marketed,2019-10-18,02457776,ACH-Atorvastatin Calcium,1,C10AA05,Atorvastatin,Tablet,Oral,02457776,ACH-ATORVASTATIN CALCIUM (atorvastatin (atorvastatin calcium) 40 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94481,Marketed,2019-10-18,02457784,ACH-Atorvastatin Calcium,1,C10AA05,Atorvastatin,Tablet,Oral,02457784,ACH-ATORVASTATIN CALCIUM (atorvastatin (atorvastatin calcium) 80 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96027,Marketed,2024-10-10,02471167,M-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02471167,M-ATORVASTATIN (atorvastatin (atorvastatin calcium) 10 mg oral tablet) MANTRA PHARMA INC,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96028,Marketed,2024-10-01,02471175,M-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02471175,M-ATORVASTATIN (atorvastatin (atorvastatin calcium) 20 mg oral tablet) MANTRA PHARMA INC,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96029,Marketed,2024-10-21,02471183,M-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02471183,M-ATORVASTATIN (atorvastatin (atorvastatin calcium) 40 mg oral tablet) MANTRA PHARMA INC,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96030,Marketed,2024-03-20,02471191,M-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02471191,M-ATORVASTATIN (atorvastatin (atorvastatin calcium) 80 mg oral tablet) MANTRA PHARMA INC,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96687,Marketed,2024-03-22,02476517,Nra-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02476517,NRA-ATORVASTATIN (atorvastatin (atorvastatin calcium) 10 mg oral tablet) NORA PHARMA INC,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96688,Marketed,2024-03-22,02476525,Nra-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02476525,NRA-ATORVASTATIN (atorvastatin (atorvastatin calcium) 20 mg oral tablet) NORA PHARMA INC,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96689,Marketed,2024-03-22,02476533,Nra-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02476533,NRA-ATORVASTATIN (atorvastatin (atorvastatin calcium) 40 mg oral tablet) NORA PHARMA INC,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96690,Marketed,2024-03-22,02476541,Nra-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02476541,NRA-ATORVASTATIN (atorvastatin (atorvastatin calcium) 80 mg oral tablet) NORA PHARMA INC,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97017,Marketed,2022-11-08,02479508,Mint-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02479508,MINT-ATORVASTATIN (atorvastatin (atorvastatin calcium) 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97018,Marketed,2022-11-08,02479516,Mint-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02479516,MINT-ATORVASTATIN (atorvastatin (atorvastatin calcium) 20 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97019,Marketed,2022-11-08,02479524,Mint-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02479524,MINT-ATORVASTATIN (atorvastatin (atorvastatin calcium) 40 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97020,Marketed,2023-12-28,02479532,Mint-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02479532,MINT-ATORVASTATIN (atorvastatin (atorvastatin calcium) 80 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97130,Marketed,2024-04-23,02481189,Bio-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02481189,BIO-ATORVASTATIN (atorvastatin (atorvastatin calcium) 10 mg oral tablet) BIOMED PHARMA,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97131,Marketed,2024-04-23,02481197,Bio-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02481197,BIO-ATORVASTATIN (atorvastatin (atorvastatin calcium) 20 mg oral tablet) BIOMED PHARMA,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97132,Marketed,2024-04-23,02481200,Bio-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02481200,BIO-ATORVASTATIN (atorvastatin (atorvastatin calcium) 40 mg oral tablet) BIOMED PHARMA,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97133,Marketed,2024-04-23,02481219,Bio-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02481219,BIO-ATORVASTATIN (atorvastatin (atorvastatin calcium) 80 mg oral tablet) BIOMED PHARMA,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99363,Marketed,2025-10-17,02504197,JAMP Atorvastatin Tablets,1,C10AA05,Atorvastatin,Tablet,Oral,02504197,JAMP ATORVASTATIN TABLETS (atorvastatin (atorvastatin calcium) 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99364,Marketed,2025-10-17,02504200,JAMP Atorvastatin Tablets,1,C10AA05,Atorvastatin,Tablet,Oral,02504200,JAMP ATORVASTATIN TABLETS (atorvastatin (atorvastatin calcium) 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99365,Marketed,2025-10-17,02504219,JAMP Atorvastatin Tablets,1,C10AA05,Atorvastatin,Tablet,Oral,02504219,JAMP ATORVASTATIN TABLETS (atorvastatin (atorvastatin calcium) 40 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99367,Marketed,2025-10-17,02504235,JAMP Atorvastatin Tablets,1,C10AA05,Atorvastatin,Tablet,Oral,02504235,JAMP ATORVASTATIN TABLETS (atorvastatin (atorvastatin calcium) 80 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99542,Marketed,2026-03-20,02506076,AG-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02506076,AG-ATORVASTATIN (atorvastatin (atorvastatin calcium) 10 mg oral tablet) ANGITA PHARMA INC.,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99543,Marketed,2026-03-20,02506084,AG-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02506084,AG-ATORVASTATIN (atorvastatin (atorvastatin calcium) 20 mg oral tablet) ANGITA PHARMA INC.,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99544,Marketed,2026-03-20,02506092,AG-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02506092,AG-ATORVASTATIN (atorvastatin (atorvastatin calcium) 40 mg oral tablet) ANGITA PHARMA INC.,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99545,Marketed,2026-03-20,02506106,AG-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02506106,AG-ATORVASTATIN (atorvastatin (atorvastatin calcium) 80 mg oral tablet) ANGITA PHARMA INC.,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99662,Marketed,2022-03-18,02507234,PMSC-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02507234,PMSC-ATORVASTATIN (atorvastatin (atorvastatin calcium) 10 mg oral tablet) PHARMASCIENCE INC,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99663,Marketed,2022-03-18,02507242,PMSC-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02507242,PMSC-ATORVASTATIN (atorvastatin (atorvastatin calcium) 20 mg oral tablet) PHARMASCIENCE INC,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99664,Marketed,2022-03-18,02507250,PMSC-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02507250,PMSC-ATORVASTATIN (atorvastatin (atorvastatin calcium) 40 mg oral tablet) PHARMASCIENCE INC,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99665,Marketed,2021-10-01,02507269,PMSC-Atorvastatin,1,C10AA05,Atorvastatin,Tablet,Oral,02507269,PMSC-ATORVASTATIN (atorvastatin (atorvastatin calcium) 80 mg oral tablet) PHARMASCIENCE INC,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75873,Marketed,2023-08-18,02273233,Caduet,2,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02273233,CADUET (amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 10 mg oral tablet) BGP PHARMA ULC,Active,9004111,amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75874,Marketed,2023-08-18,02273241,Caduet,2,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02273241,CADUET (amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 20 mg oral tablet) BGP PHARMA ULC,Active,9004112,amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75875,Marketed,2023-08-22,02273268,Caduet,2,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02273268,CADUET (amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 40 mg oral tablet) BGP PHARMA ULC,Active,9004113,amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75876,Marketed,2023-08-18,02273276,Caduet,2,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02273276,CADUET (amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 80 mg oral tablet) BGP PHARMA ULC,Active,9004114,amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75877,Marketed,2023-08-18,02273284,Caduet,2,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02273284,CADUET (amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 10 mg oral tablet) BGP PHARMA ULC,Active,9004107,amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75878,Marketed,2023-08-18,02273292,Caduet,2,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02273292,CADUET (amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 20 mg oral tablet) BGP PHARMA ULC,Active,9004108,amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75879,Marketed,2023-08-18,02273306,Caduet,2,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02273306,CADUET (amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 40 mg oral tablet) BGP PHARMA ULC,Active,9004109,amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75880,Marketed,2023-08-18,02273314,Caduet,2,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02273314,CADUET (amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 80 mg oral tablet) BGP PHARMA ULC,Active,9004110,amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84775,Marketed,2023-11-28,02362759,Mylan-amLODIPine/Atorvastatin,2,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02362759,MYLAN-AMLODIPINE/ATORVASTATIN (amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 10 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9004111,amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84776,Marketed,2023-11-28,02362767,Mylan-amLODIPine/Atorvastatin,2,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02362767,MYLAN-AMLODIPINE/ATORVASTATIN (amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 20 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9004112,amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84777,Marketed,2023-11-28,02362775,Mylan-amLODIPine/Atorvastatin,2,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02362775,MYLAN-AMLODIPINE/ATORVASTATIN (amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 40 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9004113,amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84778,Marketed,2023-11-28,02362783,Mylan-amLODIPine/Atorvastatin,2,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02362783,MYLAN-AMLODIPINE/ATORVASTATIN (amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 80 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9004114,amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84779,Marketed,2023-11-28,02362791,Mylan-amLODIPine/Atorvastatin,2,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02362791,MYLAN-AMLODIPINE/ATORVASTATIN (amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 10 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9004107,amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84780,Marketed,2023-11-28,02362805,Mylan-amLODIPine/Atorvastatin,2,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02362805,MYLAN-AMLODIPINE/ATORVASTATIN (amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 20 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9004108,amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84781,Marketed,2023-11-28,02362813,Mylan-amLODIPine/Atorvastatin,2,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02362813,MYLAN-AMLODIPINE/ATORVASTATIN (amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 40 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9004109,amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84782,Marketed,2023-11-28,02362821,Mylan-amLODIPine/Atorvastatin,2,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02362821,MYLAN-AMLODIPINE/ATORVASTATIN (amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 80 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9004110,amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89588,Marketed,2013-11-15,02411253,Apo-amLODIPine-Atorvastatin,2,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02411253,APO-AMLODIPINE-ATORVASTATIN (amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium propylene glycol solvate) 10 mg oral tablet) APOTEX INC,Active,9004111,amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89589,Marketed,2013-11-15,02411261,Apo-amLODIPine-Atorvastatin,2,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02411261,APO-AMLODIPINE-ATORVASTATIN (amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium propylene glycol solvate) 20 mg oral tablet) APOTEX INC,Active,9004112,amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89590,Marketed,2013-11-15,02411288,Apo-amLODIPine-Atorvastatin,2,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02411288,APO-AMLODIPINE-ATORVASTATIN (amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium propylene glycol solvate) 40 mg oral tablet) APOTEX INC,Active,9004113,amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89591,Marketed,2013-11-15,02411296,Apo-amLODIPine-Atorvastatin,2,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02411296,APO-AMLODIPINE-ATORVASTATIN (amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium propylene glycol solvate) 80 mg oral tablet) APOTEX INC,Active,9004114,amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89592,Marketed,2013-11-15,02411318,Apo-amLODIPine-Atorvastatin,2,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02411318,APO-AMLODIPINE-ATORVASTATIN (amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium propylene glycol solvate) 10 mg oral tablet) APOTEX INC,Active,9004107,amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89593,Marketed,2013-11-15,02411326,Apo-amLODIPine-Atorvastatin,2,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02411326,APO-AMLODIPINE-ATORVASTATIN (amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium propylene glycol solvate) 20 mg oral tablet) APOTEX INC,Active,9004108,amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89594,Marketed,2013-11-15,02411334,Apo-amLODIPine-Atorvastatin,2,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02411334,APO-AMLODIPINE-ATORVASTATIN (amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium propylene glycol solvate) 40 mg oral tablet) APOTEX INC,Active,9004109,amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89595,Marketed,2013-11-15,02411342,Apo-amLODIPine-Atorvastatin,2,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02411342,APO-AMLODIPINE-ATORVASTATIN (amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium propylene glycol solvate) 80 mg oral tablet) APOTEX INC,Active,9004110,amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101772,Marketed,2022-06-30,02528495,GLN-Atovaquone,1,P01AX06,Atovaquone,Suspension,Oral,02528495,GLN-ATOVAQUONE (atovaquone 750 mg per 5 mL oral suspension) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9002917,atovaquone 750 mg per 5 mL oral suspension,8001436,atovaquone,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
106001,Marketed,2026-03-11,02556618,Auro-Atovaquone,1,P01AX06,Atovaquone,Suspension,Oral,02556618,AURO-ATOVAQUONE (atovaquone 750 mg per 5 mL oral suspension) AURO PHARMA INC,Active,9002917,atovaquone 750 mg per 5 mL oral suspension,8001436,atovaquone,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
43212,Marketed,2002-02-25,02217422,Mepron,1,P01AX06,Atovaquone,Suspension,Oral,02217422,MEPRON (atovaquone 750 mg per 5 mL oral suspension) GLAXOSMITHKLINE INC,Active,9002917,atovaquone 750 mg per 5 mL oral suspension,8001436,atovaquone,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
16476,Marketed,2018-09-27,02023695,Atropine,1,S01FA01,Atropine,Solution,Ophthalmic,02023695,ATROPINE (atropine sulfate 1 % ophthalmic drops) PHARMA STULLN INC.,Active,9001601,atropine sulfate 1 % ophthalmic drops,8001571,atropine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
18862,Marketed,2022-12-20,02148358,Minims Atropine Sulphate,1,S01FA01,Atropine,Drops,Ophthalmic,02148358,MINIMS ATROPINE SULPHATE (atropine sulfate 1 % ophthalmic drops) BAUSCH & LOMB INC,Active,9001601,atropine sulfate 1 % ophthalmic drops,8001571,atropine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
254,Marketed,2023-09-11,00035017,Alcon Atropine,1,S01FA01,Atropine,Solution,Ophthalmic,00035017,ALCON ATROPINE (atropine sulfate 1 % ophthalmic drops) ALCON CANADA INC,Active,9001601,atropine sulfate 1 % ophthalmic drops,8001571,atropine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
3553,Marketed,2005-08-09,00392693,Atropine Sulfate Injection USP,1,A03BA01,Atropine,Solution,"Subcutaneous,Intravenous,Intramuscular",00392693,ATROPINE SULFATE INJECTION USP (atropine sulfate 0.6 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9012902,atropine sulfate 0.6 mg per 1 mL solution for injection ampoule,8001571,atropine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
3554,Marketed,2005-08-09,00392782,Atropine Sulfate Injection USP,1,A03BA01,Atropine,Solution,"Subcutaneous,Intravenous,Intramuscular",00392782,ATROPINE SULFATE INJECTION USP (atropine sulfate 0.4 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9012900,atropine sulfate 0.4 mg per 1 mL solution for injection ampoule,8001571,atropine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
91086,Marketed,2021-11-26,02426269,Atropine Sulfate Injection,1,A03BA01,Atropine,Solution,"Intravenous,Subcutaneous,Intramuscular",02426269,ATROPINE SULFATE INJECTION (atropine sulfate 0.5 mg per 5 mL solution for injection syringe) LABORATOIRE AGUETTANT,Active,9012901,atropine sulfate 0.5 mg per 5 mL solution for injection syringe,8001571,atropine,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
91087,Marketed,2021-11-26,02426277,Atropine Sulfate Injection,1,A03BA01,Atropine,Solution,"Intramuscular,Subcutaneous,Intravenous",02426277,ATROPINE SULFATE INJECTION (atropine sulfate 1 mg per 5 mL solution for injection syringe) LABORATOIRE AGUETTANT,Active,9012904,atropine sulfate 1 mg per 5 mL solution for injection syringe,8001571,atropine,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
91662,Marketed,2022-04-22,02432188,Atropine Injection BP,1,A03BA01,Atropine,Solution,"Subcutaneous,Intravenous,Intramuscular",02432188,ATROPINE INJECTION BP (atropine sulfate 0.4 mg per 1 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9012900,atropine sulfate 0.4 mg per 1 mL solution for injection ampoule,8001571,atropine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
91663,Marketed,2022-04-22,02432196,Atropine Injection BP,1,A03BA01,Atropine,Solution,"Intravenous,Intramuscular,Subcutaneous",02432196,ATROPINE INJECTION BP (atropine sulfate 0.6 mg per 1 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9012902,atropine sulfate 0.6 mg per 1 mL solution for injection ampoule,8001571,atropine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
15902,Marketed,2010-06-17,01916823,Ridaura,1,M01CB03,Auranofin,Capsule,Oral,01916823,RIDAURA (auranofin 3 mg oral capsule) XEDITON PHARMACEUTICALS INC,Active,9002523,auranofin 3 mg oral capsule,8001573,auranofin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
101573,Marketed,2022-11-04,02526662,Tavneos,1,L04AJ05,Avacopan,Capsule,Oral,02526662,TAVNEOS (avacopan 10 mg oral capsule) VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD,Active,9014790,avacopan 10 mg oral capsule,8002446,avacopan,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
101150,Marketed,2022-02-09,02522365,Nexviazyme,1,A16AB22,Avalglucosidase alfa,Powder for solution,Intravenous,02522365,NEXVIAZYME (avalglucosidase alfa 100 mg per vial powder for solution for injection) SANOFI-AVENTIS CANADA INC,Active,9014773,avalglucosidase alfa 100 mg per vial powder for solution for injection,8002441,avalglucosidase alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
101150,Marketed,2022-02-09,02522365,Nexviazyme,1,A16AB22,Avalglucosidase alfa,Powder for solution,Intravenous,02522365,NEXVIAZYME (avalglucosidase alfa 100 mg per vial powder for solution for injection) SANOFI-AVENTIS CANADA INC,Active,9014773,avalglucosidase alfa 100 mg per vial powder for solution for injection,8002441,avalglucosidase alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
104048,Marketed,2024-12-02,02551764,Ayvakyt,1,L01EX18,Avapritinib,Tablet,Oral,02551764,AYVAKYT (avapritinib 25 mg oral tablet) BLUEPRINT MEDICINES CORPORATION,Active,9015131,avapritinib 25 mg oral tablet,8002523,avapritinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,,Prescription
104049,Marketed,2024-12-02,02551772,Ayvakyt,1,L01EX18,Avapritinib,Tablet,Oral,02551772,AYVAKYT (avapritinib 50 mg oral tablet) BLUEPRINT MEDICINES CORPORATION,Active,9015132,avapritinib 50 mg oral tablet,8002523,avapritinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,,Prescription
104050,Marketed,2024-12-02,02551780,Ayvakyt,1,L01EX18,Avapritinib,Tablet,Oral,02551780,AYVAKYT (avapritinib 100 mg oral tablet) BLUEPRINT MEDICINES CORPORATION,Active,9015129,avapritinib 100 mg oral tablet,8002523,avapritinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,,Prescription
104051,Marketed,2024-12-02,02551799,Ayvakyt,1,L01EX18,Avapritinib,Tablet,Oral,02551799,AYVAKYT (avapritinib 200 mg oral tablet) BLUEPRINT MEDICINES CORPORATION,Active,9015130,avapritinib 200 mg oral tablet,8002523,avapritinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,,Prescription
103124,Marketed,2024-01-22,02542706,Doptelet,1,B02BX08,Avatrombopag,Tablet,Oral,02542706,DOPTELET (avatrombopag (avatrombopag maleate) 20 mg oral tablet) SWEDISH ORPHAN BIOVITRUM AB (PUBL),Active,9015002,avatrombopag (avatrombopag maleate) 20 mg oral tablet,8002494,avatrombopag,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
95856,Marketed,2017-12-18,02469723,Bavencio,1,L01FF04,Avelumab,Solution,Intravenous,02469723,"BAVENCIO (avelumab 200 mg per 10 mL solution for injection vial) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9012470,avelumab 200 mg per 10 mL solution for injection vial,8001141,avelumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
95856,Marketed,2017-12-18,02469723,Bavencio,1,L01FF04,Avelumab,Solution,Intravenous,02469723,"BAVENCIO (avelumab 200 mg per 10 mL solution for injection vial) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9012470,avelumab 200 mg per 10 mL solution for injection vial,8001141,avelumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
97587,Marketed,2019-11-27,02485648,Yescarta,1,L01XL03,Axicabtagene ciloleucel,Suspension,Intravenous,,,,,,,,,,,,,,,,,Prescription
97587,Marketed,2019-11-27,02485648,Yescarta,1,L01XL03,Axicabtagene ciloleucel,Suspension,Intravenous,,,,,,,,,,,,,,,,,Schedule D
87513,Marketed,2012-08-17,02389630,Inlyta,1,L01EK01,Axitinib,Tablet,Oral,02389630,INLYTA (axitinib 1 mg oral tablet) PFIZER CANADA ULC,Active,9005084,axitinib 1 mg oral tablet,8001574,axitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
87514,Marketed,2012-08-17,02389649,Inlyta,1,L01EK01,Axitinib,Tablet,Oral,02389649,INLYTA (axitinib 5 mg oral tablet) PFIZER CANADA ULC,Active,9005085,axitinib 5 mg oral tablet,8001574,axitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101883,Marketed,2023-04-17,02529599,azaCITIDine For Injection,1,L01BC07,Azacitidine,Powder for suspension,Subcutaneous,02529599,AZACITIDINE FOR INJECTION (azacitidine 100 mg per vial powder for suspension for injection) SANDOZ CANADA INCORPORATED,Active,9004618,azacitidine 100 mg per vial powder for suspension for injection,8001575,azacitidine,738984000,Parenteral,385224003,Powder for suspension for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
82233,Marketed,2025-02-07,02336707,Vidaza,1,L01BC07,Azacitidine,Powder for suspension,Subcutaneous,02336707,VIDAZA (azacitidine 100 mg per vial powder for suspension for injection) BRISTOL-MYERS SQUIBB CANADA,Active,9004618,azacitidine 100 mg per vial powder for suspension for injection,8001575,azacitidine,738984000,Parenteral,385224003,Powder for suspension for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
95068,Marketed,2017-10-25,02462826,azaCITIDine For Injection,1,L01BC07,Azacitidine,Powder for suspension,Subcutaneous,02462826,AZACITIDINE FOR INJECTION (azacitidine 100 mg per vial powder for suspension for injection) DR REDDY'S LABORATORIES LTD,Active,9004618,azacitidine 100 mg per vial powder for suspension for injection,8001575,azacitidine,738984000,Parenteral,385224003,Powder for suspension for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99452,Marketed,2024-10-15,02505177,azaCITIDine For Injection,1,L01BC07,Azacitidine,Powder for suspension,Subcutaneous,02505177,AZACITIDINE FOR INJECTION (azacitidine 100 mg per vial powder for suspension for injection) FRESENIUS KABI CANADA LTD,Active,9004618,azacitidine 100 mg per vial powder for suspension for injection,8001575,azacitidine,738984000,Parenteral,385224003,Powder for suspension for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99702,Marketed,2022-02-24,02507668,azaCITIDine For Injection,1,L01BC07,Azacitidine,Powder for suspension,Subcutaneous,02507668,AZACITIDINE FOR INJECTION (azacitidine 100 mg per vial powder for suspension for injection) HIKMA CANADA LIMITED,Active,9004618,azacitidine 100 mg per vial powder for suspension for injection,8001575,azacitidine,738984000,Parenteral,385224003,Powder for suspension for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99943,Marketed,2025-01-31,02510197,Onureg,1,L01BC07,Azacitidine,Tablet,Oral,02510197,ONUREG (azacitidine 200 mg oral tablet) BRISTOL-MYERS SQUIBB CANADA,Active,9014482,azacitidine 200 mg oral tablet,8001575,azacitidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99944,Marketed,2025-01-31,02510200,Onureg,1,L01BC07,Azacitidine,Tablet,Oral,02510200,ONUREG (azacitidine 300 mg oral tablet) BRISTOL-MYERS SQUIBB CANADA,Active,9014483,azacitidine 300 mg oral tablet,8001575,azacitidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
1192,Marketed,2018-01-18,00004596,Imuran,1,L04AX01,Azathioprine,Tablet,Oral,00004596,IMURAN (azathioprine 50 mg oral tablet) ASPEN PHARMACARE CANADA INC.,Active,9000036,azathioprine 50 mg oral tablet,8000027,azathioprine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
60109,Marketed,2010-04-23,02236819,Teva-azaTHIOprine,1,L04AX01,Azathioprine,Tablet,Oral,02236819,TEVA-AZATHIOPRINE (azathioprine 50 mg oral tablet) TEVA CANADA LIMITED,Active,9000036,azathioprine 50 mg oral tablet,8000027,azathioprine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
66740,Marketed,2000-10-17,02242907,Apo-azaTHIOprine,1,L04AX01,Azathioprine,Tablet,Oral,02242907,APO-AZATHIOPRINE (azathioprine 50 mg oral tablet) APOTEX INC,Active,9000036,azathioprine 50 mg oral tablet,8000027,azathioprine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
75617,Marketed,2020-04-16,02270811,Finacea,1,D10AX03,Azelaic acid,Gel,Topical,02270811,FINACEA (azelaic acid 15 % cutaneous gel) LEO PHARMA INC,Active,9004742,azelaic acid 15 % cutaneous gel,8001341,azelaic acid,448598008,Cutaneous,385100002,Gel,,,,,,Prescription
103567,Marketed,2025-02-26,02547015,Auro-Azilsartan Medoxomil,1,C09CA09,Azilsartan medoxomil,Tablet,Oral,02547015,AURO-AZILSARTAN MEDOXOMIL (azilsartan medoxomil (azilsartan medoxomil potassium) 40 mg oral tablet) AURO PHARMA INC,Active,9005126,azilsartan medoxomil (azilsartan medoxomil potassium) 40 mg oral tablet,8001074,azilsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103568,Marketed,2025-02-26,02547023,Auro-Azilsartan Medoxomil,1,C09CA09,Azilsartan medoxomil,Tablet,Oral,02547023,AURO-AZILSARTAN MEDOXOMIL (azilsartan medoxomil (azilsartan medoxomil potassium) 80 mg oral tablet) AURO PHARMA INC,Active,9005127,azilsartan medoxomil (azilsartan medoxomil potassium) 80 mg oral tablet,8001074,azilsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86721,Marketed,2021-07-13,02381389,Edarbi,1,C09CA09,Azilsartan medoxomil,Tablet,Oral,02381389,"EDARBI (azilsartan medoxomil (azilsartan medoxomil potassium) 40 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9005126,azilsartan medoxomil (azilsartan medoxomil potassium) 40 mg oral tablet,8001074,azilsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86722,Marketed,2021-07-13,02381397,Edarbi,1,C09CA09,Azilsartan medoxomil,Tablet,Oral,02381397,"EDARBI (azilsartan medoxomil (azilsartan medoxomil potassium) 80 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9005127,azilsartan medoxomil (azilsartan medoxomil potassium) 80 mg oral tablet,8001074,azilsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88267,Marketed,2021-07-13,02397749,Edarbyclor,2,C09DA09,Azilsartant medoximil and diuretics,Tablet,Oral,02397749,"EDARBYCLOR (azilsartan medoxomil (azilsartan medoxomil potassium) 40 mg and chlorthalidone 12.5 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9005203,azilsartan medoxomil (azilsartan medoxomil potassium) 40 mg and chlorthalidone 12.5 mg oral tablet,8001075,azilsartan and chlorthalidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88269,Marketed,2021-07-13,02397765,Edarbyclor,2,C09DA09,Azilsartant medoximil and diuretics,Tablet,Oral,02397765,"EDARBYCLOR (azilsartan medoxomil (azilsartan medoxomil potassium) 40 mg and chlorthalidone 25 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9005204,azilsartan medoxomil (azilsartan medoxomil potassium) 40 mg and chlorthalidone 25 mg oral tablet,8001075,azilsartan and chlorthalidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101288,Marketed,2022-05-17,02523825,Azithromycin For Injection,1,J01FA10,Azithromycin,Powder for solution,Intravenous,02523825,AZITHROMYCIN FOR INJECTION (azithromycin (azithromycin dihydrate) 500 mg per vial powder for solution for injection) JAMP PHARMA CORPORATION,Active,9000862,azithromycin 500 mg per vial powder for solution for injection,8000224,azithromycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
101347,Marketed,2023-03-01,02524449,Azithromycin For Injection,1,J01FA10,Azithromycin,Powder for solution,Intravenous,02524449,AZITHROMYCIN FOR INJECTION (azithromycin (azithromycin dihydrate) 500 mg per vial powder for solution for injection) GENERIC MEDICAL PARTNERS INC,Active,9000862,azithromycin 500 mg per vial powder for solution for injection,8000224,azithromycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
102056,Marketed,2024-10-08,02531429,"Azithromycin For Injection, USP",1,J01FA10,Azithromycin,Powder for solution,Intravenous,02531429,"AZITHROMYCIN FOR INJECTION, USP (azithromycin (azithromycin monohydrate) 500 mg per vial powder for solution for injection) EUGIA PHARMA INC.",Active,9000862,azithromycin 500 mg per vial powder for solution for injection,8000224,azithromycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
103468,Marketed,2025-02-26,02545969,Azithromycin,1,J01FA10,Azithromycin,Tablet,Oral,02545969,AZITHROMYCIN (azithromycin (azithromycin dihydrate) 250 mg oral tablet) 10445517 CANADA INC / NORTH PHARMACEUTICALS / DAC PHARMACEUTICALS,Active,9000839,azithromycin 250 mg oral tablet,8000224,azithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74701,Marketed,2006-01-04,02261634,PMS-Azithromycin,1,J01FA10,Azithromycin,Tablet,Oral,02261634,PMS-AZITHROMYCIN (azithromycin 250 mg oral tablet) PHARMASCIENCE INC,Active,9000839,azithromycin 250 mg oral tablet,8000224,azithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74702,Marketed,2006-01-04,02261642,PMS-Azithromycin,1,J01FA10,Azithromycin,Tablet,Oral,02261642,PMS-AZITHROMYCIN (azithromycin 600 mg oral tablet) PHARMASCIENCE INC,Active,9000736,azithromycin 600 mg oral tablet,8000224,azithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75127,Marketed,2016-03-11,02265826,Sandoz Azithromycin,1,J01FA10,Azithromycin,Tablet,Oral,02265826,SANDOZ AZITHROMYCIN (azithromycin (azithromycin dihydrate) 250 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000839,azithromycin 250 mg oral tablet,8000224,azithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75325,Marketed,2017-03-03,02267845,Teva-Azithromycin,1,J01FA10,Azithromycin,Tablet,Oral,02267845,TEVA-AZITHROMYCIN (azithromycin (azithromycin monohydrate hemiethanolate) 250 mg oral tablet) TEVA CANADA LIMITED,Active,9000839,azithromycin 250 mg oral tablet,8000224,azithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76094,Marketed,2024-06-18,02275309,Riva-Azithromycin,1,J01FA10,Azithromycin,Tablet,Oral,02275309,RIVA-AZITHROMYCIN (azithromycin (azithromycin dihydrate) 250 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000839,azithromycin 250 mg oral tablet,8000224,azithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79623,Marketed,2025-11-18,02310600,Pro-Azithromycine,1,J01FA10,Azithromycin,Tablet,Oral,02310600,PRO-AZITHROMYCINE (azithromycin (azithromycin dihydrate) 250 mg oral tablet) PRO DOC LIMITEE,Active,9000839,azithromycin 250 mg oral tablet,8000224,azithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81664,Marketed,2017-08-11,02330881,Azithromycin,1,J01FA10,Azithromycin,Tablet,Oral,02330881,AZITHROMYCIN (azithromycin (azithromycin dihydrate) 250 mg oral tablet) SANIS HEALTH INC,Active,9000839,azithromycin 250 mg oral tablet,8000224,azithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81804,Marketed,2021-10-27,02332388,Sandoz Azithromycin,1,J01FA10,Azithromycin,Powder for suspension,Oral,02332388,SANDOZ AZITHROMYCIN (azithromycin (azithromycin dihydrate) 100 mg per 5 mL oral suspension) SANDOZ CANADA INCORPORATED,Active,9006250,azithromycin 100 mg per 5 mL oral suspension,8000224,azithromycin,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
81805,Marketed,2021-10-27,02332396,Sandoz Azithromycin,1,J01FA10,Azithromycin,Powder for suspension,Oral,02332396,SANDOZ AZITHROMYCIN (azithromycin (azithromycin dihydrate) 200 mg per 5 mL oral suspension) SANDOZ CANADA INCORPORATED,Active,9006251,azithromycin 200 mg per 5 mL oral suspension,8000224,azithromycin,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
90013,Marketed,2014-03-06,02415542,Apo-Azithromycin Z,1,J01FA10,Azithromycin,Tablet,Oral,02415542,APO-AZITHROMYCIN Z (azithromycin (azithromycin dihydrate) 250 mg oral tablet) APOTEX INC,Active,9000839,azithromycin 250 mg oral tablet,8000224,azithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92678,Marketed,2018-01-05,02442434,Azithromycin,1,J01FA10,Azithromycin,Tablet,Oral,02442434,AZITHROMYCIN (azithromycin (azithromycin dihydrate) 250 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000839,azithromycin 250 mg oral tablet,8000224,azithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93868,Marketed,2016-09-29,02452308,JAMP-Azithromycin,1,J01FA10,Azithromycin,Tablet,Oral,02452308,JAMP-AZITHROMYCIN (azithromycin (azithromycin dihydrate) 250 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000839,azithromycin 250 mg oral tablet,8000224,azithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93870,Marketed,2023-03-31,02452324,Mar-Azithromycin,1,J01FA10,Azithromycin,Tablet,Oral,02452324,MAR-AZITHROMYCIN (azithromycin (azithromycin dihydrate) 250 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000839,azithromycin 250 mg oral tablet,8000224,azithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95383,Marketed,2017-10-25,02465604,"Azithromycin For Injection, USP",1,J01FA10,Azithromycin,Powder for solution,Intravenous,02465604,"AZITHROMYCIN FOR INJECTION, USP (azithromycin (azithromycin monohydrate) 500 mg per vial powder for solution for injection) AURO PHARMA INC",Active,9000862,azithromycin 500 mg per vial powder for solution for injection,8000224,azithromycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
96991,Marketed,2019-05-07,02479680,Nra-Azithromycin,1,J01FA10,Azithromycin,Tablet,Oral,02479680,NRA-AZITHROMYCIN (azithromycin (azithromycin dihydrate) 250 mg oral tablet) NORA PHARMA INC,Active,9000839,azithromycin 250 mg oral tablet,8000224,azithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97120,Marketed,2018-09-26,02480700,AG-Azithromycin,1,J01FA10,Azithromycin,Tablet,Oral,02480700,AG-AZITHROMYCIN (azithromycin (azithromycin dihydrate) 250 mg oral tablet) ANGITA PHARMA INC.,Active,9000839,azithromycin 250 mg oral tablet,8000224,azithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97283,Marketed,2019-10-30,02482363,Auro-Azithromycin,1,J01FA10,Azithromycin,Powder for suspension,Oral,02482363,AURO-AZITHROMYCIN (azithromycin (azithromycin dihydrate) 100 mg per 5 mL oral suspension) AURO PHARMA INC,Active,9006250,azithromycin 100 mg per 5 mL oral suspension,8000224,azithromycin,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
97284,Marketed,2019-10-30,02482371,Auro-Azithromycin,1,J01FA10,Azithromycin,Powder for suspension,Oral,02482371,AURO-AZITHROMYCIN (azithromycin (azithromycin dihydrate) 200 mg per 5 mL oral suspension) AURO PHARMA INC,Active,9006251,azithromycin 200 mg per 5 mL oral suspension,8000224,azithromycin,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
97419,Marketed,2019-04-16,02483890,Azithromycin For Injection USP,1,J01FA10,Azithromycin,Powder for solution,Intravenous,02483890,AZITHROMYCIN FOR INJECTION USP (azithromycin (azithromycin dihydrate) 500 mg per vial powder for solution for injection) STERIMAX INC,Active,9000862,azithromycin 500 mg per vial powder for solution for injection,8000224,azithromycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
99162,Marketed,2021-01-19,02502038,M-Azithromycin,1,J01FA10,Azithromycin,Tablet,Oral,02502038,M-AZITHROMYCIN (azithromycin (azithromycin dihydrate) 250 mg oral tablet) MANTRA PHARMA INC,Active,9000839,azithromycin 250 mg oral tablet,8000224,azithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81558,Marketed,2011-05-18,02329840,Cayston,1,J01DF01,Aztreonam,Powder for solution,Inhalation,02329840,CAYSTON (aztreonam 75 mg per vial powder for nebulizer solution with diluent solution) GILEAD SCIENCES CANADA INC,Active,9012781,aztreonam 75 mg per vial powder for nebulizer solution with diluent solution,8001172,aztreonam,738984000,Parenteral,385201005,Powder for nebulizer solution,733026001,Vial (unit of presentation),,,,Prescription
5863,Marketed,2012-07-19,00584908,Bacitin,1,D06AX05,Bacitracin,Ointment,Topical,00584908,BACITIN (bacitracin 500 unit per g cutaneous ointment) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9002008,bacitracin 500 unit per g cutaneous ointment,8001439,bacitracin,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Non-Prescription Drugs
69667,Marketed,2003-08-28,02245571,Baciject,1,J01XX10,Bacitracin,Powder for solution,"Intramuscular,Topical",02245571,BACIJECT (bacitracin 50000 unit per vial powder for solution for injection) STERIMAX INC,Active,9003824,bacitracin 50000 unit per vial powder for solution for injection,8001439,bacitracin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Ethical
93727,Marketed,2023-10-30,02451026,Bacitracin Ointment,1,D06AX05,Bacitracin,Ointment,Topical,02451026,BACITRACIN OINTMENT (bacitracin (bacitracin zinc) 500 unit per g cutaneous ointment) SAFETEC OF AMERICA INC,Active,9013864,bacitracin (bacitracin zinc) 500 unit per g cutaneous ointment,8001439,bacitracin,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Non-Prescription Drugs
103303,Marketed,2025-09-12,02544482,JAMP Baclofen,1,M03BX01,Baclofen,Tablet,Oral,02544482,JAMP BACLOFEN (baclofen 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000104,baclofen 10 mg oral tablet,8000066,baclofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103304,Marketed,2025-09-12,02544490,JAMP Baclofen,1,M03BX01,Baclofen,Tablet,Oral,02544490,JAMP BACLOFEN (baclofen 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000218,baclofen 20 mg oral tablet,8000066,baclofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103323,Marketed,2024-05-31,02544660,Baclofen,1,M03BX01,Baclofen,Tablet,Oral,02544660,BACLOFEN (baclofen 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000104,baclofen 10 mg oral tablet,8000066,baclofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103324,Marketed,2024-05-31,02544679,Baclofen,1,M03BX01,Baclofen,Tablet,Oral,02544679,BACLOFEN (baclofen 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000218,baclofen 20 mg oral tablet,8000066,baclofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104229,Marketed,2025-11-10,02553341,Baclofen Injection USP,1,M03BX01,Baclofen,Solution,Intrathecal,02553341,BACLOFEN INJECTION USP (baclofen 10 mg per 5 mL solution for injection ampoule) JAMP PHARMA CORPORATION,Active,9000508,baclofen 10 mg per 5 mL solution for injection ampoule,8000066,baclofen,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
15547,Marketed,1994-12-31,02063735,PMS-Baclofen,1,M03BX01,Baclofen,Tablet,Oral,02063735,PMS-BACLOFEN (baclofen 10 mg oral tablet) PHARMASCIENCE INC,Active,9000104,baclofen 10 mg oral tablet,8000066,baclofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
15548,Marketed,1994-12-31,02063743,PMS-Baclofen,1,M03BX01,Baclofen,Tablet,Oral,02063743,PMS-BACLOFEN (baclofen 20 mg oral tablet) PHARMASCIENCE INC,Active,9000218,baclofen 20 mg oral tablet,8000066,baclofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
16532,Marketed,2010-03-24,02088401,Mylan-Baclofen,1,M03BX01,Baclofen,Tablet,Oral,02088401,MYLAN-BACLOFEN (baclofen 20 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000218,baclofen 20 mg oral tablet,8000066,baclofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
16534,Marketed,2010-01-20,02088398,Mylan-Baclofen,1,M03BX01,Baclofen,Tablet,Oral,02088398,MYLAN-BACLOFEN (baclofen 10 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000104,baclofen 10 mg oral tablet,8000066,baclofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
17246,Marketed,1994-12-31,02139332,Apo-Baclofen,1,M03BX01,Baclofen,Tablet,Oral,02139332,APO-BACLOFEN (baclofen 10 mg oral tablet) APOTEX INC,Active,9000104,baclofen 10 mg oral tablet,8000066,baclofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
17247,Marketed,1994-12-31,02139391,Apo-Baclofen,1,M03BX01,Baclofen,Tablet,Oral,02139391,APO-BACLOFEN (baclofen 20 mg oral tablet) APOTEX INC,Active,9000218,baclofen 20 mg oral tablet,8000066,baclofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
20308,Marketed,2025-12-19,02152584,Pro-Baclofen,1,M03BX01,Baclofen,Tablet,Oral,02152584,PRO-BACLOFEN (baclofen 10 mg oral tablet) PRO DOC LIMITEE,Active,9000104,baclofen 10 mg oral tablet,8000066,baclofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
20309,Marketed,2026-04-15,02152592,Pro-Baclofen,1,M03BX01,Baclofen,Tablet,Oral,02152592,PRO-BACLOFEN (baclofen 20 mg oral tablet) PRO DOC LIMITEE,Active,9000218,baclofen 20 mg oral tablet,8000066,baclofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
65828,Marketed,2003-03-03,02242150,Riva-Baclofen,1,M03BX01,Baclofen,Tablet,Oral,02242150,RIVA-BACLOFEN (baclofen 10 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000104,baclofen 10 mg oral tablet,8000066,baclofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
65829,Marketed,2003-03-03,02242151,Riva-Baclofen,1,M03BX01,Baclofen,Tablet,Oral,02242151,RIVA-BACLOFEN (baclofen 20 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000218,baclofen 20 mg oral tablet,8000066,baclofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77246,Marketed,2010-02-25,02287021,Baclofen,1,M03BX01,Baclofen,Tablet,Oral,02287021,BACLOFEN (baclofen 10 mg oral tablet) SANIS HEALTH INC,Active,9000104,baclofen 10 mg oral tablet,8000066,baclofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77247,Marketed,2010-02-25,02287048,Baclofen,1,M03BX01,Baclofen,Tablet,Oral,02287048,BACLOFEN (baclofen 20 mg oral tablet) SANIS HEALTH INC,Active,9000218,baclofen 20 mg oral tablet,8000066,baclofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89827,Marketed,2018-01-12,02413620,Baclofen Injection,1,M03BX01,Baclofen,Solution,Intrathecal,02413620,BACLOFEN INJECTION (baclofen 0.05 mg per 1 mL solution for injection ampoule) STERIMAX INC,Active,9000506,baclofen 0.05 mg per 1 mL solution for injection ampoule,8000066,baclofen,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
89828,Marketed,2018-01-11,02413639,Baclofen Injection,1,M03BX01,Baclofen,Solution,Intrathecal,02413639,BACLOFEN INJECTION (baclofen 10 mg per 20 mL solution for injection ampoule) STERIMAX INC,Active,9000507,baclofen 10 mg per 20 mL solution for injection ampoule,8000066,baclofen,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
89829,Marketed,2018-01-11,02413647,Baclofen Injection,1,M03BX01,Baclofen,Solution,Intrathecal,02413647,BACLOFEN INJECTION (baclofen 10 mg per 5 mL solution for injection ampoule) STERIMAX INC,Active,9000508,baclofen 10 mg per 5 mL solution for injection ampoule,8000066,baclofen,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
94414,Marketed,2022-05-19,02457059,Baclofen Injection,1,M03BX01,Baclofen,Solution,Intrathecal,02457059,BACLOFEN INJECTION (baclofen 0.05 mg per 1 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9000506,baclofen 0.05 mg per 1 mL solution for injection ampoule,8000066,baclofen,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
94415,Marketed,2023-05-26,02457067,Baclofen Injection,1,M03BX01,Baclofen,Solution,Intrathecal,02457067,BACLOFEN INJECTION (baclofen 10 mg per 20 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9000507,baclofen 10 mg per 20 mL solution for injection ampoule,8000066,baclofen,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
94416,Marketed,2023-05-26,02457075,Baclofen Injection,1,M03BX01,Baclofen,Solution,Intrathecal,77700381,BACLOFEN INJECTION (baclofen 10 mg per 5 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9000508,baclofen 10 mg per 5 mL solution for injection ampoule,8000066,baclofen,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
94416,Marketed,2023-05-26,02457075,Baclofen Injection,1,M03BX01,Baclofen,Solution,Intrathecal,77700382,BACLOFEN INJECTION (baclofen 40 mg per 20 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9012413,baclofen 40 mg per 20 mL solution for injection ampoule,8000066,baclofen,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
97574,Marketed,2021-07-20,02485508,Baclofen Intrathecal,1,M03BX01,Baclofen,Solution,Intrathecal,02485508,BACLOFEN INTRATHECAL (baclofen 10 mg per 20 mL solution for injection vial) AVIR PHARMA INC.,Active,9014576,baclofen 10 mg per 20 mL solution for injection vial,8000066,baclofen,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
97575,Marketed,2021-07-20,02485516,Baclofen Intrathecal,1,M03BX01,Baclofen,Solution,Intrathecal,02485516,BACLOFEN INTRATHECAL (baclofen 40 mg per 20 mL solution for injection vial) AVIR PHARMA INC.,Active,9014577,baclofen 40 mg per 20 mL solution for injection vial,8000066,baclofen,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
101320,Marketed,2025-03-05,02524163,Xofluza,1,J05AX25,Baloxavir marboxil,Tablet,Oral,02524163,XOFLUZA (baloxavir marboxil 80 mg oral tablet) HOFFMANN-LA ROCHE LIMITED,Active,9015175,baloxavir marboxil 80 mg oral tablet,8002533,baloxavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,,Prescription
98624,Marketed,2025-09-25,02496364,Xofluza,1,J05AX25,Baloxavir marboxil,Tablet,Oral,02496364,XOFLUZA (baloxavir marboxil 20 mg oral tablet) HOFFMANN-LA ROCHE LIMITED,Active,9015261,baloxavir marboxil 20 mg oral tablet,8002533,baloxavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,,Prescription
98625,Marketed,2026-01-15,02496372,Xofluza,1,J05AX25,Baloxavir marboxil,Tablet,Oral,02496372,XOFLUZA (baloxavir marboxil 40 mg oral tablet) HOFFMANN-LA ROCHE LIMITED,Active,9015351,baloxavir marboxil 40 mg oral tablet,8002533,baloxavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,,Prescription
103336,Marketed,2024-04-09,02544768,Olumiant,1,L04AF02,Baricitinib,Tablet,Oral,02544768,OLUMIANT (baricitinib 4 mg oral tablet) ELI LILLY CANADA INC,Active,9015032,baricitinib 4 mg oral tablet,8002011,baricitinib,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
97056,Marketed,2018-09-27,02480018,Olumiant,1,L04AF02,Baricitinib,Tablet,Oral,02480018,OLUMIANT (baricitinib 2 mg oral tablet) ELI LILLY CANADA INC,Active,9013408,baricitinib 2 mg oral tablet,8002011,baricitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
66643,Marketed,2000-10-23,02242815,Simulect,1,L04AC02,Basiliximab,Powder for solution,Intravenous,02242815,SIMULECT (basiliximab 20 mg per vial powder for solution for injection) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9003529,basiliximab 20 mg per vial powder for solution for injection,8001576,basiliximab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
66643,Marketed,2000-10-23,02242815,Simulect,1,L04AC02,Basiliximab,Powder for solution,Intravenous,02242815,SIMULECT (basiliximab 20 mg per vial powder for solution for injection) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9003529,basiliximab 20 mg per vial powder for solution for injection,8001576,basiliximab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
19802,Marketed,2013-05-21,02153513,Oncotice,1,L03AX03,Bcg vaccine,Powder for solution,Intravesical,02153513,ONCOTICE (bacillus Calmette-Guérin substrain TICE 800000000 unit per vial powder for intravesical solution) MERCK CANADA INC,Active,9014445,bacillus Calmette-Guérin substrain TICE 800000000 unit per vial powder for intravesical solution,8002300,bacillus Calmette-Guérin substrain TICE,372471009,Intravesical,1231578000,Powder for intravesical solution,733026001,Vial (unit of presentation),1.0,,,Schedule D
19802,Marketed,2013-05-21,02153513,Oncotice,1,L03AX03,Bcg vaccine,Powder for solution,Intravesical,02153513,ONCOTICE (bacillus Calmette-Guérin substrain TICE 800000000 unit per vial powder for intravesical solution) MERCK CANADA INC,Active,9014445,bacillus Calmette-Guérin substrain TICE 800000000 unit per vial powder for intravesical solution,8002300,bacillus Calmette-Guérin substrain TICE,372471009,Intravesical,1231578000,Powder for intravesical solution,733026001,Vial (unit of presentation),1.0,,,Prescription
99797,Marketed,2021-08-30,02508613,Verity-BCG,1,L03AX03,Bcg vaccine,Powder for suspension,Intravesical,02508613,VERITY-BCG (bacillus Calmette-Guérin substrain Russian BCG-I 40 mg per vial powder for intravesical suspension) VERITY PHARMACEUTICALS INC.,Active,9014592,bacillus Calmette-Guérin substrain Russian BCG-I 40 mg per vial powder for intravesical suspension,8002388,bacillus Calmette-Guérin substrain Russian BCG-I,372471009,Intravesical,761907007,Powder for intravesical suspension,733026001,Vial (unit of presentation),1.0,,,Prescription
99797,Marketed,2021-08-30,02508613,Verity-BCG,1,L03AX03,Bcg vaccine,Powder for suspension,Intravesical,02508613,VERITY-BCG (bacillus Calmette-Guérin substrain Russian BCG-I 40 mg per vial powder for intravesical suspension) VERITY PHARMACEUTICALS INC.,Active,9014592,bacillus Calmette-Guérin substrain Russian BCG-I 40 mg per vial powder for intravesical suspension,8002388,bacillus Calmette-Guérin substrain Russian BCG-I,372471009,Intravesical,761907007,Powder for intravesical suspension,733026001,Vial (unit of presentation),1.0,,,Schedule D
28440,Marketed,2020-12-14,02089602,Propaderm,1,D07AC15,Beclometasone,Cream,Topical,02089602,"PROPADERM (beclomethasone dipropionate 0.025 % cutaneous cream) BAUSCH HEALTH, CANADA INC.",Active,9000793,beclomethasone dipropionate 0.025 % cutaneous cream,8000208,beclomethasone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
65700,Marketed,2021-01-01,02242029,Qvar,1,R03BA01,Beclometasone,Metered-dose aerosol,Inhalation,02242029,"QVAR (beclomethasone dipropionate 50 mcg per actuation pressurized inhalation) BAUSCH HEALTH, CANADA INC.",Active,9000907,beclomethasone dipropionate 50 mcg per actuation pressurized inhalation,8000208,beclomethasone,447694001,Inhalation,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,,Prescription
65701,Marketed,2021-01-01,02242030,Qvar,1,R03BA01,Beclometasone,Metered-dose aerosol,Inhalation,02242030,"QVAR (beclomethasone dipropionate 100 mcg per actuation pressurized inhalation) BAUSCH HEALTH, CANADA INC.",Active,9000906,beclomethasone dipropionate 100 mcg per actuation pressurized inhalation,8000208,beclomethasone,447694001,Inhalation,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,,Prescription
18874,Marketed,2010-06-25,02172712,Mylan-Beclo Aq,1,R01AD01,Beclomethasone,"Metered-dose aerosol,Suspension",Nasal,02172712,MYLAN-BECLO AQ (beclomethasone dipropionate 50 mcg per actuation nasal spray) MYLAN PHARMACEUTICALS ULC,Active,9000553,beclomethasone dipropionate 50 mcg per actuation nasal spray,8000208,beclomethasone,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,,Prescription
62232,Marketed,1998-10-07,02238796,Apo-Beclomethasone Nasal Spray,1,R01AD01,Beclomethasone,Suspension,Nasal,02238796,APO-BECLOMETHASONE NASAL SPRAY (beclomethasone dipropionate 50 mcg per actuation nasal spray) APOTEX INC,Active,9000553,beclomethasone dipropionate 50 mcg per actuation nasal spray,8000208,beclomethasone,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,,Prescription
106275,Marketed,2025-08-11,02559617,Blenrep,1,L01FX15,Belantamab mafodotin,Powder for solution,Intravenous,02559617,BLENREP (belantamab mafodotin 70 mg per vial powder for solution for injection) GLAXOSMITHKLINE INC,Active,9015263,belantamab mafodotin 70 mg per vial powder for solution for injection,8002552,belantamab mafodotin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,1.0,,,Schedule D
106275,Marketed,2025-08-11,02559617,Blenrep,1,L01FX15,Belantamab mafodotin,Powder for solution,Intravenous,02559617,BLENREP (belantamab mafodotin 70 mg per vial powder for solution for injection) GLAXOSMITHKLINE INC,Active,9015263,belantamab mafodotin 70 mg per vial powder for solution for injection,8002552,belantamab mafodotin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,1.0,,,Prescription
106276,Marketed,2025-08-11,02559625,Blenrep,1,L01FX15,Belantamab mafodotin,Powder for solution,Intravenous,02559625,BLENREP (belantamab mafodotin 100 mg per vial powder for solution for injection) GLAXOSMITHKLINE INC,Active,9015262,belantamab mafodotin 100 mg per vial powder for solution for injection,8002552,belantamab mafodotin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,1.0,,,Prescription
106276,Marketed,2025-08-11,02559625,Blenrep,1,L01FX15,Belantamab mafodotin,Powder for solution,Intravenous,02559625,BLENREP (belantamab mafodotin 100 mg per vial powder for solution for injection) GLAXOSMITHKLINE INC,Active,9015262,belantamab mafodotin 100 mg per vial powder for solution for injection,8002552,belantamab mafodotin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,1.0,,,Schedule D
85508,Marketed,2011-08-24,02370050,Benlysta,1,L04AG04,Belimumab,Powder for solution,Intravenous,02370050,BENLYSTA (belimumab 120 mg per vial powder for solution for injection) GLAXOSMITHKLINE INC,Active,9004915,belimumab 120 mg per vial powder for solution for injection,8001577,belimumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
85508,Marketed,2011-08-24,02370050,Benlysta,1,L04AG04,Belimumab,Powder for solution,Intravenous,02370050,BENLYSTA (belimumab 120 mg per vial powder for solution for injection) GLAXOSMITHKLINE INC,Active,9004915,belimumab 120 mg per vial powder for solution for injection,8001577,belimumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
85509,Marketed,2011-08-24,02370069,Benlysta,1,L04AG04,Belimumab,Powder for solution,Intravenous,02370069,BENLYSTA (belimumab 400 mg per vial powder for solution for injection) GLAXOSMITHKLINE INC,Active,9004916,belimumab 400 mg per vial powder for solution for injection,8001577,belimumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
85509,Marketed,2011-08-24,02370069,Benlysta,1,L04AG04,Belimumab,Powder for solution,Intravenous,02370069,BENLYSTA (belimumab 400 mg per vial powder for solution for injection) GLAXOSMITHKLINE INC,Active,9004916,belimumab 400 mg per vial powder for solution for injection,8001577,belimumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
95946,Marketed,2018-05-14,02470489,Benlysta,1,L04AG04,Belimumab,Solution,Subcutaneous,02470489,BENLYSTA (belimumab 200 mg per 1 mL solution for injection syringe) GLAXOSMITHKLINE INC,Active,9012905,belimumab 200 mg per 1 mL solution for injection syringe,8001577,belimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
95946,Marketed,2018-05-14,02470489,Benlysta,1,L04AG04,Belimumab,Solution,Subcutaneous,02470489,BENLYSTA (belimumab 200 mg per 1 mL solution for injection syringe) GLAXOSMITHKLINE INC,Active,9012905,belimumab 200 mg per 1 mL solution for injection syringe,8001577,belimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
101523,Marketed,2023-03-08,02526115,Rezurock,1,L04AA48,Belumosudil,Tablet,Oral,02526115,REZUROCK (belumosudil (belumosudil mesylate) 200 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9014838,belumosudil (belumosudil mesylate) 200 mg oral tablet,8002462,belumosudil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101808,Marketed,2022-09-01,02528908,Welireg,1,L01XX74,Belzutifan,Tablet,Oral,02528908,WELIREG (belzutifan 40 mg oral tablet) MERCK CANADA INC,Active,9014756,belzutifan 40 mg oral tablet,8002434,belzutifan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
106563,Marketed,2026-02-06,02562782,Nilemdo,1,C10AX15,Bempedoic acid,Tablet,Oral,02562782,NILEMDO (bempedoic acid 180 mg oral tablet) HLS THERAPEUTICS INC,Active,9015352,bempedoic acid 180 mg oral tablet,8002575,bempedoic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,,Prescription
75937,Marketed,2012-06-25,02273918,Benazepril,1,C09AA07,Benazepril,Tablet,Oral,02273918,BENAZEPRIL (benazepril hydrochloride 20 mg oral tablet) AA PHARMA INC,Active,9007801,benazepril hydrochloride 20 mg oral tablet,8000872,benazepril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77563,Marketed,2012-06-25,02290332,Benazepril,1,C09AA07,Benazepril,Tablet,Oral,02290332,BENAZEPRIL (benazepril hydrochloride 5 mg oral tablet) AA PHARMA INC,Active,9007802,benazepril hydrochloride 5 mg oral tablet,8000872,benazepril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77564,Marketed,2012-06-25,02290340,Benazepril,1,C09AA07,Benazepril,Tablet,Oral,02290340,BENAZEPRIL (benazepril hydrochloride 10 mg oral tablet) AA PHARMA INC,Active,9007800,benazepril hydrochloride 10 mg oral tablet,8000872,benazepril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101334,Marketed,2023-01-30,02524309,Benvyon,1,L01AA09,Bendamustine,Solution,Intravenous,77701119,BENVYON (bendamustine hydrochloride 100 mg per 4 mL solution for injection vial) PFIZER CANADA ULC,Active,9014825,bendamustine hydrochloride 100 mg per 4 mL solution for injection vial,8001578,bendamustine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
101334,Marketed,2023-01-30,02524309,Benvyon,1,L01AA09,Bendamustine,Solution,Intravenous,77701120,BENVYON (bendamustine hydrochloride 200 mg per 8 mL solution for injection vial) PFIZER CANADA ULC,Active,9014826,bendamustine hydrochloride 200 mg per 8 mL solution for injection vial,8001578,bendamustine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
101334,Marketed,2023-01-30,02524309,Benvyon,1,L01AA09,Bendamustine,Solution,Intravenous,77701121,BENVYON (bendamustine hydrochloride 25 mg per 1 mL solution for injection vial) PFIZER CANADA ULC,Active,9014827,bendamustine hydrochloride 25 mg per 1 mL solution for injection vial,8001578,bendamustine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
103059,Marketed,2025-09-08,02541998,Bendamustine Hydrochloride For Injection,1,L01AA09,Bendamustine,Powder for solution,Intravenous,02541998,BENDAMUSTINE HYDROCHLORIDE FOR INJECTION (bendamustine hydrochloride 25 mg per vial powder for solution for injection) EUGIA PHARMA INC.,Active,9005104,bendamustine hydrochloride 25 mg per vial powder for solution for injection,8001578,bendamustine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
103060,Marketed,2024-10-08,02542005,Bendamustine Hydrochloride For Injection,1,L01AA09,Bendamustine,Powder for solution,Intravenous,02542005,BENDAMUSTINE HYDROCHLORIDE FOR INJECTION (bendamustine hydrochloride 100 mg per vial powder for solution for injection) EUGIA PHARMA INC.,Active,9005103,bendamustine hydrochloride 100 mg per vial powder for solution for injection,8001578,bendamustine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
87781,Marketed,2018-04-09,02392550,Treanda,1,L01AA09,Bendamustine,Powder for solution,Intravenous,02392550,TREANDA (bendamustine hydrochloride 25 mg per vial powder for solution for injection) TEVA CANADA LIMITED,Active,9005104,bendamustine hydrochloride 25 mg per vial powder for solution for injection,8001578,bendamustine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
87782,Marketed,2018-04-09,02392569,Treanda,1,L01AA09,Bendamustine,Powder for solution,Intravenous,02392569,TREANDA (bendamustine hydrochloride 100 mg per vial powder for solution for injection) TEVA CANADA LIMITED,Active,9005103,bendamustine hydrochloride 100 mg per vial powder for solution for injection,8001578,bendamustine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
98670,Marketed,2021-03-02,02496852,Bendamustine Hydrochloride For Injection,1,L01AA09,Bendamustine,Powder for solution,Intravenous,02496852,BENDAMUSTINE HYDROCHLORIDE FOR INJECTION (bendamustine hydrochloride 25 mg per vial powder for solution for injection) ACCORD HEALTHCARE INC,Active,9005104,bendamustine hydrochloride 25 mg per vial powder for solution for injection,8001578,bendamustine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
98671,Marketed,2021-03-02,02496860,Bendamustine Hydrochloride For Injection,1,L01AA09,Bendamustine,Powder for solution,Intravenous,02496860,BENDAMUSTINE HYDROCHLORIDE FOR INJECTION (bendamustine hydrochloride 100 mg per vial powder for solution for injection) ACCORD HEALTHCARE INC,Active,9005103,bendamustine hydrochloride 100 mg per vial powder for solution for injection,8001578,bendamustine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
98673,Marketed,2021-02-25,02496887,Nat-Bendamustine,1,L01AA09,Bendamustine,Powder for solution,Intravenous,02496887,NAT-BENDAMUSTINE (bendamustine hydrochloride 25 mg per vial powder for solution for injection) NATCO PHARMA (CANADA) INC,Active,9005104,bendamustine hydrochloride 25 mg per vial powder for solution for injection,8001578,bendamustine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
98674,Marketed,2021-02-25,02496895,Nat-Bendamustine,1,L01AA09,Bendamustine,Powder for solution,Intravenous,02496895,NAT-BENDAMUSTINE (bendamustine hydrochloride 100 mg per vial powder for solution for injection) NATCO PHARMA (CANADA) INC,Active,9005103,bendamustine hydrochloride 100 mg per vial powder for solution for injection,8001578,bendamustine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99856,Marketed,2021-03-02,02509253,Bendamustine Hydrochloride For Injection,1,L01AA09,Bendamustine,Powder for solution,Intravenous,02509253,BENDAMUSTINE HYDROCHLORIDE FOR INJECTION (bendamustine hydrochloride 25 mg per vial powder for solution for injection) AURO PHARMA INC,Active,9005104,bendamustine hydrochloride 25 mg per vial powder for solution for injection,8001578,bendamustine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99857,Marketed,2021-03-02,02509261,Bendamustine Hydrochloride For Injection,1,L01AA09,Bendamustine,Powder for solution,Intravenous,02509261,BENDAMUSTINE HYDROCHLORIDE FOR INJECTION (bendamustine hydrochloride 100 mg per vial powder for solution for injection) AURO PHARMA INC,Active,9005103,bendamustine hydrochloride 100 mg per vial powder for solution for injection,8001578,bendamustine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
96262,Marketed,2018-03-28,02473232,Fasenra,1,R03DX10,Benralizumab,Solution,Subcutaneous,02473232,FASENRA (benralizumab 30 mg per 1 mL solution for injection syringe) ASTRAZENECA CANADA INC,Active,9012782,benralizumab 30 mg per 1 mL solution for injection syringe,8001440,benralizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
96262,Marketed,2018-03-28,02473232,Fasenra,1,R03DX10,Benralizumab,Solution,Subcutaneous,02473232,FASENRA (benralizumab 30 mg per 1 mL solution for injection syringe) ASTRAZENECA CANADA INC,Active,9012782,benralizumab 30 mg per 1 mL solution for injection syringe,8001440,benralizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
98601,Marketed,2021-01-13,02496135,Fasenra Pen,1,R03DX10,Benralizumab,Solution,Subcutaneous,02496135,FASENRA PEN (benralizumab 30 mg per 1 mL solution for injection pen) ASTRAZENECA CANADA INC,Active,9014446,benralizumab 30 mg per 1 mL solution for injection pen,8001440,benralizumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
98601,Marketed,2021-01-13,02496135,Fasenra Pen,1,R03DX10,Benralizumab,Solution,Subcutaneous,02496135,FASENRA PEN (benralizumab 30 mg per 1 mL solution for injection pen) ASTRAZENECA CANADA INC,Active,9014446,benralizumab 30 mg per 1 mL solution for injection pen,8001440,benralizumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Prescription
100018,Marketed,2022-04-20,02510901,Soapopular Antibacterial Hand Soap,1,D08AJ01,Benzalkonium,Solution,Topical (household),,,,,,,,,,,,,,,,,Non-Prescription Drugs
100244,Marketed,2021-03-08,02513226,Sani Hands Foam,1,D08AJ01,Benzalkonium,Solution,Topical (commercial),,,,,,,,,,,,,,,,,Non-Prescription Drugs
102623,Marketed,2024-07-12,02537524,Antibacterial Foaming Hand Soap,1,D08AJ01,Benzalkonium,Solution,Topical (commercial),,,,,,,,,,,,,,,,,Non-Prescription Drugs
102686,Marketed,2023-08-11,02538113,Antibacterial Hand Wipes,1,D08AJ01,Benzalkonium,Wipe,Topical (household),,,,,,,,,,,,,,,,,Non-Prescription Drugs
103872,Marketed,2025-01-13,02549905,Softsoap Antibacterial For Sensitive Skin,1,D08AJ01,Benzalkonium,Solution,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103914,Marketed,2024-11-11,02550326,Benzalkonium Chloride Wipes,1,D08AJ01,Benzalkonium,Wipe,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
62787,Marketed,1999-04-20,02239318,Ecocare 360,1,D08AJ01,Benzalkonium,Liquid,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
66672,Marketed,2001-03-01,02242842,Digisan E Foam Hand Sanitizer,1,D08AJ01,Benzalkonium,Liquid,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
70601,Marketed,2003-08-01,02246427,Keystone Foam Hand Sanitizer,1,D08AJ01,Benzalkonium,Liquid,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
75580,Marketed,2009-09-01,02270420,Soapopular,1,D08AJ01,Benzalkonium,Liquid,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
77627,Marketed,2016-11-30,02290855,X 3 Clean Germ Attack Hand Sanitizer,1,D08AJ01,Benzalkonium,Solution,Topical (household),,,,,,,,,,,,,,,,,Non-Prescription Drugs
83971,Marketed,2011-12-06,02354543,Loris 0.13% BZK,1,D08AJ01,Benzalkonium,Wipe,Topical (household),,,,,,,,,,,,,,,,,Non-Prescription Drugs
84093,Marketed,2016-08-23,02355736,Benzalkonium Chloride Antiseptic Towelette,1,D08AJ01,Benzalkonium,Wipe,Topical (household),,,,,,,,,,,,,,,,,Non-Prescription Drugs
85450,Marketed,2014-05-09,02369575,X 3 On-The-Go Antiseptic Spray,1,D08AJ01,Benzalkonium,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
88828,Marketed,2013-07-10,02403471,Purell Sanitizing Wipes,1,D08AJ01,Benzalkonium,Wipe,Topical (household),,,,,,,,,,,,,,,,,Non-Prescription Drugs
89148,Marketed,2014-01-20,02406802,Softsoap Antibacterial,1,D08AJ01,Benzalkonium,Solution,Topical (household),,,,,,,,,,,,,,,,,Non-Prescription Drugs
92173,Marketed,2016-04-01,02437384,Purell Hand Sanitizing Wipes,1,D08AJ01,Benzalkonium,Wipe,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
92527,Marketed,2023-10-24,02440903,Treksafe,1,D08AJ01,Benzalkonium,Wipe,Topical (household),,,,,,,,,,,,,,,,,Non-Prescription Drugs
92774,Marketed,2026-05-22,02443163,Medline Spectrum Advanced Antibacterial Lotion Soap,1,D08AJ01,Benzalkonium,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
92785,Marketed,2016-04-14,02443252,Kleenex Foam Hand Sanitizer,1,D08AJ01,Benzalkonium,Solution,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
94646,Marketed,2017-03-16,02459272,Hand Sanitizer Foam,1,D08AJ01,Benzalkonium,Solution,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
95295,Marketed,2023-10-18,02464802,Dial Foaming Antibacterial Hand Wash,1,D08AJ01,Benzalkonium,Solution,Topical (household),,,,,,,,,,,,,,,,,Non-Prescription Drugs
95297,Marketed,2023-10-17,02464829,Dial Antibacterial Hand Soap,1,D08AJ01,Benzalkonium,Solution,Topical (household),,,,,,,,,,,,,,,,,Non-Prescription Drugs
96151,Marketed,2018-06-27,02472236,Fuzion Ab Foaming Hand Soap,1,D08AJ01,Benzalkonium,Lotion,Topical (commercial),,,,,,,,,,,,,,,,,Non-Prescription Drugs
96159,Marketed,2019-08-19,02472287,Acclaim Ab,1,D08AJ01,Benzalkonium,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
96203,Marketed,2021-09-10,02472724,Energy Berry Baies Énergisantes Foaming Hand Soap Antibacterial,1,D08AJ01,Benzalkonium,Solution,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
96208,Marketed,2021-09-10,02472775,Spring Showers Pluies Printanières Foaming Hand Soap Antibacterial,1,D08AJ01,Benzalkonium,Solution,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
97037,Marketed,2020-03-31,02479729,Alcohol Free Foaming Hand Sanitizer,1,D08AJ01,Benzalkonium,Solution,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
97086,Marketed,2019-11-14,02480336,Dye Free Fragrance Free Antibacterial Foaming Hand Soap,1,D08AJ01,Benzalkonium,Solution,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
97147,Marketed,2019-03-27,02480816,Scott Antimicrobial Foam Skin Cleanser,1,D08AJ01,Benzalkonium,Solution,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
97189,Marketed,2019-02-18,02481456,Scott Foam Hand Sanitizer,1,D08AJ01,Benzalkonium,Solution,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98983,Marketed,2020-06-15,02500124,Foam-Care Ultra,1,D08AJ01,Benzalkonium,Solution,Topical (commercial),,,,,,,,,,,,,,,,,Non-Prescription Drugs
99098,Marketed,2021-01-08,02501368,Dove Care & Protect Hand Wash Antibacterial,1,D08AJ01,Benzalkonium,Solution,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
99175,Marketed,2020-07-16,02502178,Anti-Microbe M,1,D08AJ01,Benzalkonium,Solution,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
99178,Marketed,2020-08-28,02502208,Hand Sanitizer,1,D08AJ01,Benzalkonium,Solution,Topical (household),,,,,,,,,,,,,,,,,Non-Prescription Drugs
99238,Marketed,2020-11-04,02502852,FS Antimicrobial Hand Wash,1,D08AJ01,Benzalkonium,Solution,Topical (commercial),,,,,,,,,,,,,,,,,Non-Prescription Drugs
99564,Marketed,2022-02-01,02506300,Derma Solutions,1,D08AJ01,Benzalkonium,Solution,Topical (household),,,,,,,,,,,,,,,,,Non-Prescription Drugs
99761,Marketed,2022-02-21,02508222,Refresh Antibac Foam,1,D08AJ01,Benzalkonium,Solution,Topical (commercial),,,,,,,,,,,,,,,,,Non-Prescription Drugs
77729,Marketed,2014-09-23,02291924,Bicillin L-A,1,J01CE08,Benzathine benzylpenicillin,Suspension,Intramuscular,02291924,BICILLIN L-A (penicillin G benzathine 1200000 unit per 2 mL suspension for injection syringe) PFIZER CANADA ULC,Active,9012685,penicillin G benzathine 1200000 unit per 2 mL suspension for injection syringe,8001221,penicillin G benzathine,738984000,Parenteral,385220007,Suspension for injection,733020007,Syringe (unit of presentation),,,,Prescription
62344,Marketed,1999-07-23,02238903,Benztropine Omega,1,N04AC01,Benzatropine,Liquid,"Intramuscular,Intravenous",02238903,BENZTROPINE OMEGA (benztropine mesylate 2 mg per 2 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9000851,benztropine mesylate 2 mg per 2 mL solution for injection vial,8000067,benztropine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
8060,Marketed,2015-08-13,00706531,PDP-Benztropine,1,N04AC01,Benzatropine,Tablet,Oral,00706531,PDP-BENZTROPINE (benztropine mesylate 1 mg oral tablet) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9000267,benztropine mesylate 1 mg oral tablet,8000067,benztropine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75279,Marketed,2008-06-07,02267365,Ino-F-San Instant Hand Sanitizer,1,D08AJ08,Benzethonium chloride,Liquid,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
78942,Marketed,2017-01-05,02304112,Wet Ones,1,D08AJ08,Benzethonium chloride,Wipe,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
95992,Marketed,2018-03-29,02470853,Finipil,1,D08AJ08,Benzethonium chloride,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
99900,Marketed,2024-07-29,02509717,Vinda Antiseptic Wipes,1,D08AJ08,Benzethonium chloride,Wipe,Topical (household),,,,,,,,,,,,,,,,,Non-Prescription Drugs
100055,Marketed,2022-06-02,02511339,Salonpas Pain Relieving Cream,2,D04AB04,Benzocaine,Cream,Topical,02511339,"SALONPAS PAIN RELIEVING CREAM (benzyl alcohol 10 % and lidocaine hydrochloride 4 % cutaneous cream) HISAMITSU AMERICA, INC.",Active,9014797,benzyl alcohol 10 % and lidocaine hydrochloride 4 % cutaneous cream,8002450,benzyl alcohol and lidocaine,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
100062,Marketed,2022-12-14,02511428,Salonpas Pain Relieving Solution,2,D04AB04,Benzocaine,Solution,Topical,02511428,"SALONPAS PAIN RELIEVING SOLUTION (benzyl alcohol 10 % and lidocaine hydrochloride 4 % cutaneous solution) HISAMITSU AMERICA, INC.",Active,9014798,benzyl alcohol 10 % and lidocaine hydrochloride 4 % cutaneous solution,8002450,benzyl alcohol and lidocaine,448598008,Cutaneous,739006009,Solution,,,,,,Non-Prescription Drugs
100691,Marketed,2024-06-22,02517515,Clear Action Benzoyl Peroxide Acne Treatment 5%,1,D10AE01,Benzoyl peroxide,Gel,Topical,02517515,CLEAR ACTION BENZOYL PEROXIDE ACNE TREATMENT 5% (benzoyl peroxide 5 % cutaneous gel) CRLS,Active,9002908,benzoyl peroxide 5 % cutaneous gel,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,,Non-Prescription Drugs
102268,Marketed,2024-11-06,02533715,Acne Foaming Cleanser,1,D10AE01,Benzoyl peroxide,Gel,Topical,02533715,ACNE FOAMING CLEANSER (benzoyl peroxide 4 % cutaneous gel) CRLS,Active,9014655,benzoyl peroxide 4 % cutaneous gel,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,,Non-Prescription Drugs
102751,Marketed,2024-11-06,02538822,Clear Action Medicated Acne Gel,1,D10AE01,Benzoyl peroxide,Gel,Topical,02538822,CLEAR ACTION MEDICATED ACNE GEL (benzoyl peroxide 5 % cutaneous gel) CRLS,Active,9002908,benzoyl peroxide 5 % cutaneous gel,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,,Non-Prescription Drugs
106376,Marketed,2026-03-12,02560720,Epsolay,1,D10AE01,Benzoyl peroxide,Cream,Topical,02560720,EPSOLAY (benzoyl peroxide 5 % cutaneous cream) SEARCHLIGHT PHARMA INC,Active,9001934,benzoyl peroxide 5 % cutaneous cream,8000829,benzoyl peroxide,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
11862,Marketed,1991-12-31,01925199,Benzac W Wash Gel 10%,1,D10AE01,Benzoyl peroxide,Gel,Topical,01925199,BENZAC W WASH GEL 10% (benzoyl peroxide 10 % cutaneous gel) GALDERMA CANADA INC.,Active,9002343,benzoyl peroxide 10 % cutaneous gel,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,,Prescription
20299,Marketed,2003-04-23,02162121,Benzagel 5 Wash,1,D10AE01,Benzoyl peroxide,Solution,Topical,02162121,BENZAGEL 5 WASH (benzoyl peroxide 5 % cutaneous solution) COLUMBIA LABORATORIES CANADA INC,Active,9005256,benzoyl peroxide 5 % cutaneous solution,8000829,benzoyl peroxide,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Non-Prescription Drugs
34258,Marketed,2003-05-23,02162113,Benzagel 5 Gel,1,D10AE01,Benzoyl peroxide,Gel,Topical,02162113,BENZAGEL 5 GEL (benzoyl peroxide 5 % cutaneous gel) COLUMBIA LABORATORIES CANADA INC,Active,9002908,benzoyl peroxide 5 % cutaneous gel,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,,Non-Prescription Drugs
59870,Marketed,2026-03-10,02236396,Clean & Clear Persa-Gel 5,1,D10AE01,Benzoyl peroxide,Lotion,Topical,02236396,CLEAN & CLEAR PERSA-GEL 5 (benzoyl peroxide 5 % lotion) KENVUE CANADA INC.,Active,9003009,benzoyl peroxide 5 % lotion,8000829,benzoyl peroxide,448598008,Cutaneous,739000003,Lotion,,,,,,Non-Prescription Drugs
60085,Marketed,2014-08-07,02236796,Deep Pore Acne Vanishing Treatment,1,D10AE01,Benzoyl peroxide,Lotion,Topical,02236796,DEEP PORE ACNE VANISHING TREATMENT (benzoyl peroxide 5 % lotion) THE MENTHOLATUM COMPANY OF CANADA LTD,Active,9003009,benzoyl peroxide 5 % lotion,8000829,benzoyl peroxide,448598008,Cutaneous,739000003,Lotion,,,,,,Non-Prescription Drugs
77590,Marketed,2012-10-31,02290561,Clinique Acne Solutions All-Over Clearing Treatment,1,D10AE01,Benzoyl peroxide,Lotion,Topical,02290561,CLINIQUE ACNE SOLUTIONS ALL-OVER CLEARING TREATMENT (benzoyl peroxide 2.5 % lotion) CLINIQUE LABORATORIES DIST,Active,9004306,benzoyl peroxide 2.5 % lotion,8000829,benzoyl peroxide,448598008,Cutaneous,739000003,Lotion,,,,,,Non-Prescription Drugs
80728,Marketed,2009-06-02,02321874,Emergency Acne Vanishing Facial Cleanser,1,D10AE01,Benzoyl peroxide,Lotion,Topical,02321874,EMERGENCY ACNE VANISHING FACIAL CLEANSER (benzoyl peroxide 5 % lotion) THE MENTHOLATUM COMPANY OF CANADA LTD,Active,9003009,benzoyl peroxide 5 % lotion,8000829,benzoyl peroxide,448598008,Cutaneous,739000003,Lotion,,,,,,Non-Prescription Drugs
82243,Marketed,2011-06-07,02336812,Acne Treatment Lotion,1,D10AE01,Benzoyl peroxide,Lotion,Topical,02336812,ACNE TREATMENT LOTION (benzoyl peroxide 5 % lotion) VIVIER CANADA INCORPORATED,Active,9003009,benzoyl peroxide 5 % lotion,8000829,benzoyl peroxide,448598008,Cutaneous,739000003,Lotion,,,,,,Non-Prescription Drugs
84698,Marketed,2011-08-22,02361949,Benzagel Spot-On Acne Gel,1,D10AE01,Benzoyl peroxide,Gel,Topical,02361949,BENZAGEL SPOT-ON ACNE GEL (benzoyl peroxide 2.5 % cutaneous gel) COLUMBIA LABORATORIES CANADA INC,Active,9004913,benzoyl peroxide 2.5 % cutaneous gel,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,,Non-Prescription Drugs
87583,Marketed,2022-06-29,02390396,Proactiv Treat,1,D10AE01,Benzoyl peroxide,Gel,Topical,02390396,"PROACTIV TREAT (benzoyl peroxide 2.5 % cutaneous gel) ALCHEMEE, LLC",Active,9004913,benzoyl peroxide 2.5 % cutaneous gel,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,,Non-Prescription Drugs
87639,Marketed,2022-09-27,02391015,Proactiv Cleanse,1,D10AE01,Benzoyl peroxide,Gel,Topical,02391015,"PROACTIV CLEANSE (benzoyl peroxide 2.5 % cutaneous gel) ALCHEMEE, LLC",Active,9004913,benzoyl peroxide 2.5 % cutaneous gel,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,,Non-Prescription Drugs
87959,Marketed,2022-07-13,02394421,Proactiv+ Skin Smoothing Exfoliator,1,D10AE01,Benzoyl peroxide,Gel,Topical,02394421,"PROACTIV+ SKIN SMOOTHING EXFOLIATOR (benzoyl peroxide 2.5 % cutaneous gel) ALCHEMEE, LLC",Active,9004913,benzoyl peroxide 2.5 % cutaneous gel,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,,Non-Prescription Drugs
89090,Marketed,2025-09-23,02406179,Proactiv Solution 3-Step Acne Routine,2,D10AE01,Benzoyl peroxide,"Gel,Kit",Topical,02406179,"PROACTIV SOLUTION 3-STEP ACNE ROUTINE (benzoyl peroxide 2.5 % cutaneous gel with benzoyl peroxide 2.5 % cutaneous gel with toner solution) ALCHEMEE, LLC",Active,9014005,benzoyl peroxide 2.5 % cutaneous gel with benzoyl peroxide 2.5 % cutaneous gel with toner solution,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,,Non-Prescription Drugs
89587,Marketed,2022-09-15,02411245,Proactiv+ Pore Targeting Solution,1,D10AE01,Benzoyl peroxide,Gel,Topical,02411245,"PROACTIV+ PORE TARGETING SOLUTION (benzoyl peroxide 2.5 % cutaneous gel) ALCHEMEE, LLC",Active,9004913,benzoyl peroxide 2.5 % cutaneous gel,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,,Non-Prescription Drugs
89660,Marketed,2014-10-24,02412012,Benzoyl Peroxide Acne Treatment 5%,1,D10AE01,Benzoyl peroxide,Gel,Topical,02412012,BENZOYL PEROXIDE ACNE TREATMENT 5% (benzoyl peroxide 5 % cutaneous gel) CRLS,Active,9002908,benzoyl peroxide 5 % cutaneous gel,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,,Non-Prescription Drugs
89830,Marketed,2022-09-15,02413655,Proactiv Emergency Blemish Relief,1,D10AE01,Benzoyl peroxide,Cream,Topical,02413655,"PROACTIV EMERGENCY BLEMISH RELIEF (benzoyl peroxide 5 % cutaneous cream) ALCHEMEE, LLC",Active,9001934,benzoyl peroxide 5 % cutaneous cream,8000829,benzoyl peroxide,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
89896,Marketed,2015-02-02,02414309,Dual Intensive Acne Treatment,1,D10AE01,Benzoyl peroxide,"Lotion,Gel",Topical,02414309,"DUAL INTENSIVE ACNE TREATMENT (benzoyl peroxide 2.5 % cutaneous gel with benzoyl peroxide 2.5 % lotion) RODAN & FIELDS BEAUTY, LLC",Active,9014006,benzoyl peroxide 2.5 % cutaneous gel with benzoyl peroxide 2.5 % lotion,8000829,benzoyl peroxide,448598008,Cutaneous,739000003,Lotion,,,,,,Non-Prescription Drugs
89901,Marketed,2022-11-25,02414422,Proactiv+ 3 Piece Set,2,D10AE01,Benzoyl peroxide,"Gel,Kit",Topical,02414422,"PROACTIV+ 3 PIECE SET (benzoyl peroxide 2.5 % cutaneous gel with benzoyl peroxide 2.5 % cutaneous gel with moisturizer) ALCHEMEE, LLC",Active,9014004,benzoyl peroxide 2.5 % cutaneous gel with benzoyl peroxide 2.5 % cutaneous gel with moisturizer,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,,Non-Prescription Drugs
91785,Marketed,2015-12-10,02433486,Renewal Cleanser,1,D10AE01,Benzoyl peroxide,Lotion,Topical,02433486,"RENEWAL CLEANSER (benzoyl peroxide 2.5 % lotion) FRUIT OF THE EARTH, INC",Active,9004306,benzoyl peroxide 2.5 % lotion,8000829,benzoyl peroxide,448598008,Cutaneous,739000003,Lotion,,,,,,Non-Prescription Drugs
91786,Marketed,2015-12-10,02433494,Repairing Treatment,1,D10AE01,Benzoyl peroxide,Lotion,Topical,02433494,"REPAIRING TREATMENT (benzoyl peroxide 2.5 % lotion) FRUIT OF THE EARTH, INC",Active,9004306,benzoyl peroxide 2.5 % lotion,8000829,benzoyl peroxide,448598008,Cutaneous,739000003,Lotion,,,,,,Non-Prescription Drugs
92488,Marketed,2026-03-10,02440512,Stubborn Acne Spot Gel,1,D10AE01,Benzoyl peroxide,Gel,Topical,02440512,STUBBORN ACNE SPOT GEL (benzoyl peroxide 5 % cutaneous gel) KENVUE CANADA INC.,Active,9002908,benzoyl peroxide 5 % cutaneous gel,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,,Non-Prescription Drugs
92524,Marketed,2026-03-10,02440881,Stubborn Acne Cleanser,1,D10AE01,Benzoyl peroxide,Paste,Topical,02440881,STUBBORN ACNE CLEANSER (benzoyl peroxide 3.5 % cutaneous paste) KENVUE CANADA INC.,Active,9006122,benzoyl peroxide 3.5 % cutaneous paste,8000829,benzoyl peroxide,448598008,Cutaneous,739002006,Paste,,,,,,Non-Prescription Drugs
92884,Marketed,2015-12-10,02444054,Active Anti-Acne Treatment Kit,2,D10AE01,Benzoyl peroxide,"Lotion,Kit",Topical,02444054,"ACTIVE ANTI-ACNE TREATMENT KIT (benzoyl peroxide 2.5 % lotion with benzoyl peroxide 2.5 % lotion with toner solution) FRUIT OF THE EARTH, INC",Active,9014009,benzoyl peroxide 2.5 % lotion with benzoyl peroxide 2.5 % lotion with toner solution,8000829,benzoyl peroxide,448598008,Cutaneous,762065001,Cutaneous lotion,,,,,,Non-Prescription Drugs
94496,Marketed,2017-01-30,02457938,Stubborn Acne Solution,2,D10AE01,Benzoyl peroxide,"Kit,Gel,Paste",Topical,02457938,STUBBORN ACNE SOLUTION (benzoyl peroxide 2.5 % cutaneous gel with benzoyl peroxide 3.5 % cutaneous paste with moisturizer) JOHNSON & JOHNSON INC,Active,9014007,benzoyl peroxide 2.5 % cutaneous gel with benzoyl peroxide 3.5 % cutaneous paste with moisturizer,8000829,benzoyl peroxide,448598008,Cutaneous,385102005,Cutaneous paste,,,,,,Non-Prescription Drugs
95111,Marketed,2019-04-09,02463202,Acne Clearing Treatment,1,D10AE01,Benzoyl peroxide,Lotion,Topical,02463202,"ACNE CLEARING TREATMENT (benzoyl peroxide 2.5 % lotion) RODAN & FIELDS BEAUTY, LLC",Active,9004306,benzoyl peroxide 2.5 % lotion,8000829,benzoyl peroxide,448598008,Cutaneous,739000003,Lotion,,,,,,Non-Prescription Drugs
95112,Marketed,2019-04-09,02463210,Daily Acne Wash,1,D10AE01,Benzoyl peroxide,Cream,Topical,02463210,"DAILY ACNE WASH (benzoyl peroxide 5 % cutaneous cream) RODAN & FIELDS BEAUTY, LLC",Active,9001934,benzoyl peroxide 5 % cutaneous cream,8000829,benzoyl peroxide,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
95852,Marketed,2019-04-09,02469707,Rodan+Fields Spotless,2,D10AE01,Benzoyl peroxide,"Lotion,Cream,Kit",Topical,02469707,"RODAN+FIELDS SPOTLESS (benzoyl peroxide 5 % cutaneous cream with benzoyl peroxide 2.5 % lotion) RODAN & FIELDS BEAUTY, LLC",Active,9014010,benzoyl peroxide 5 % cutaneous cream with benzoyl peroxide 2.5 % lotion,8000829,benzoyl peroxide,448598008,Cutaneous,419179001,Kit,,,,,,Non-Prescription Drugs
98034,Marketed,2020-04-03,02490285,BPO 5,1,D10AE01,Benzoyl peroxide,Gel,Topical,02490285,BPO5 (benzoyl peroxide 5 % cutaneous gel) RGR PHARMA LTD.,Active,9002908,benzoyl peroxide 5 % cutaneous gel,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,,Non-Prescription Drugs
99403,Marketed,2022-01-21,02504634,Panoxyl Acne Wash,1,D10AE01,Benzoyl peroxide,Cream,Topical,02504634,PANOXYL ACNE WASH (benzoyl peroxide 4 % cutaneous cream) CROWN LABORATORIES INC.,Active,9014654,benzoyl peroxide 4 % cutaneous cream,8000829,benzoyl peroxide,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
99809,Marketed,2022-02-01,02508745,Acne Foaming Cleanser,1,D10AE01,Benzoyl peroxide,Gel,Topical,02508745,ACNE FOAMING CLEANSER (benzoyl peroxide 4 % cutaneous gel) CERAVE CANADA,Active,9014655,benzoyl peroxide 4 % cutaneous gel,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,,Non-Prescription Drugs
99914,Marketed,2025-08-14,02509865,Stubborn Acne Am Treatment,1,D10AE01,Benzoyl peroxide,Gel,Topical,02509865,STUBBORN ACNE AM TREATMENT (benzoyl peroxide 2.5 % cutaneous gel) KENVUE CANADA INC.,Active,9004913,benzoyl peroxide 2.5 % cutaneous gel,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,,Non-Prescription Drugs
88701,Marketed,2013-11-15,02402149,Acne Treatment System,2,D10AE51,"Benzoyl peroxide, combinations","Lotion,Kit,Liquid",Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
48059,Marketed,2014-03-27,02229777,Pharixia,1,A01AD02,Benzydamine,Mouthwash/gargle,Buccal,02229777,PHARIXIA (benzydamine hydrochloride 0.15 % gargle/mouthwash) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9012783,benzydamine hydrochloride 0.15 % gargle/mouthwash,8001245,benzydamine,26643006,Oral,764788008,Oropharyngeal solution,,,,,,Prescription
63013,Marketed,2018-01-19,02239537,PMS-Benzydamine,1,A01AD02,Benzydamine,Mouthwash/gargle,Buccal,02239537,PMS-BENZYDAMINE (benzydamine hydrochloride 0.15 % gargle/mouthwash) PHARMASCIENCE INC,Active,9012783,benzydamine hydrochloride 0.15 % gargle/mouthwash,8001245,benzydamine,26643006,Oral,764788008,Oropharyngeal solution,,,,,,Prescription
95103,Marketed,2017-08-11,02463105,Odan-Benzydamine,1,A01AD02,Benzydamine,Mouthwash/gargle,Buccal,02463105,ODAN-BENZYDAMINE (benzydamine hydrochloride 0.15 % gargle/mouthwash) ODAN LABORATORIES LTD,Active,9012783,benzydamine hydrochloride 0.15 % gargle/mouthwash,8001245,benzydamine,26643006,Oral,764788008,Oropharyngeal solution,,,,,,Prescription
98444,Marketed,2020-07-13,02494434,Pharixia Alcohol Free,1,A01AD02,Benzydamine,Mouthwash/gargle,Buccal,02494434,PHARIXIA ALCOHOL FREE (benzydamine hydrochloride 0.15 % gargle/mouthwash) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9012783,benzydamine hydrochloride 0.15 % gargle/mouthwash,8001245,benzydamine,26643006,Oral,764788008,Oropharyngeal solution,,,,,,Prescription
37244,Marketed,2015-06-26,02220261,"Penicillin G Sodium For Injection, USP",1,J01CE01,Benzylpenicillin,Powder for solution,"Intramuscular,Intravenous",02220261,"PENICILLIN G SODIUM FOR INJECTION, USP (penicillin G (penicillin G sodium) 1000000 unit per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9003055,penicillin G (penicillin G sodium) 1000000 unit per vial powder for solution for injection,8001411,penicillin G,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
37245,Marketed,2015-06-26,02220288,"Penicillin G Sodium For Injection, USP",1,J01CE01,Benzylpenicillin,Powder for solution,"Intramuscular,Intravenous",02220288,"PENICILLIN G SODIUM FOR INJECTION, USP (penicillin G (penicillin G sodium) 5000000 unit per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9003056,penicillin G (penicillin G sodium) 5000000 unit per vial powder for solution for injection,8001411,penicillin G,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
37246,Marketed,2015-09-15,02220296,"Penicillin G Sodium For Injection, USP",1,J01CE01,Benzylpenicillin,Powder for solution,"Intravenous,Intramuscular",02220296,"PENICILLIN G SODIUM FOR INJECTION, USP (penicillin G (penicillin G sodium) 10000000 unit per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9003054,penicillin G (penicillin G sodium) 10000000 unit per vial powder for solution for injection,8001411,penicillin G,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
101674,Marketed,2022-09-06,02527693,Orladeyo,1,B06AC06,Berotralstat,Capsule,Oral,02527693,ORLADEYO (berotralstat (berotralstat hydrochloride) 150 mg oral capsule) BIOCRYST PHARMACEUTICALS INC,Active,9014757,berotralstat (berotralstat hydrochloride) 150 mg oral capsule,8002435,berotralstat,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
82246,Marketed,2010-01-27,02336847,Besivance,1,S01AE08,Besifloxacin,Suspension,Ophthalmic,02336847,BESIVANCE (besifloxacin (besifloxacin hydrochloride) 0.6 % ophthalmic drops) BAUSCH & LOMB INC,Active,9013533,besifloxacin (besifloxacin hydrochloride) 0.6 % ophthalmic drops,8001584,besifloxacin,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
100892,Marketed,2022-07-27,02519682,M-Betahistine,1,N07CA01,Betahistine,Tablet,Oral,02519682,M-BETAHISTINE (betahistine hydrochloride 8 mg oral tablet) MANTRA PHARMA INC,Active,9001332,betahistine hydrochloride 8 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100893,Marketed,2022-07-25,02519690,M-Betahistine,1,N07CA01,Betahistine,Tablet,Oral,02519690,M-BETAHISTINE (betahistine hydrochloride 16 mg oral tablet) MANTRA PHARMA INC,Active,9000951,betahistine hydrochloride 16 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100894,Marketed,2022-07-25,02519704,M-Betahistine,1,N07CA01,Betahistine,Tablet,Oral,02519704,M-BETAHISTINE (betahistine hydrochloride 24 mg oral tablet) MANTRA PHARMA INC,Active,9001059,betahistine hydrochloride 24 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102687,Marketed,2023-10-20,02538121,Mint-Betahistine,1,N07CA01,Betahistine,Tablet,Oral,02538121,MINT-BETAHISTINE (betahistine hydrochloride 8 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001332,betahistine hydrochloride 8 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102688,Marketed,2023-10-20,02538148,Mint-Betahistine,1,N07CA01,Betahistine,Tablet,Oral,02538148,MINT-BETAHISTINE (betahistine hydrochloride 16 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000951,betahistine hydrochloride 16 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102689,Marketed,2023-10-31,02538156,Mint-Betahistine,1,N07CA01,Betahistine,Tablet,Oral,02538156,MINT-BETAHISTINE (betahistine hydrochloride 24 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001059,betahistine hydrochloride 24 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103354,Marketed,2024-06-05,02544911,Nra-Betahistine,1,N07CA01,Betahistine,Tablet,Oral,02544911,NRA-BETAHISTINE (betahistine hydrochloride 8 mg oral tablet) NORA PHARMA INC,Active,9001332,betahistine hydrochloride 8 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103355,Marketed,2024-06-05,02544938,Nra-Betahistine,1,N07CA01,Betahistine,Tablet,Oral,02544938,NRA-BETAHISTINE (betahistine hydrochloride 16 mg oral tablet) NORA PHARMA INC,Active,9000951,betahistine hydrochloride 16 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103356,Marketed,2024-06-05,02544946,Nra-Betahistine,1,N07CA01,Betahistine,Tablet,Oral,02544946,NRA-BETAHISTINE (betahistine hydrochloride 24 mg oral tablet) NORA PHARMA INC,Active,9001059,betahistine hydrochloride 24 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
67819,Marketed,2016-09-07,02243878,Serc,1,N07CA01,Betahistine,Tablet,Oral,02243878,SERC (betahistine hydrochloride 16 mg oral tablet) BGP PHARMA ULC,Active,9000951,betahistine hydrochloride 16 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
72312,Marketed,2016-06-20,02247998,Serc,1,N07CA01,Betahistine,Tablet,Oral,02247998,SERC (betahistine hydrochloride 24 mg oral tablet) BGP PHARMA ULC,Active,9001059,betahistine hydrochloride 24 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76586,Marketed,2014-01-09,02280183,Teva-Betahistine,1,N07CA01,Betahistine,Tablet,Oral,02280183,TEVA-BETAHISTINE (betahistine hydrochloride 8 mg oral tablet) TEVA CANADA LIMITED,Active,9001332,betahistine hydrochloride 8 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76587,Marketed,2014-01-09,02280191,Teva-Betahistine,1,N07CA01,Betahistine,Tablet,Oral,02280191,TEVA-BETAHISTINE (betahistine hydrochloride 16 mg oral tablet) TEVA CANADA LIMITED,Active,9000951,betahistine hydrochloride 16 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76588,Marketed,2014-01-09,02280205,Teva-Betahistine,1,N07CA01,Betahistine,Tablet,Oral,02280205,TEVA-BETAHISTINE (betahistine hydrochloride 24 mg oral tablet) TEVA CANADA LIMITED,Active,9001059,betahistine hydrochloride 24 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93496,Marketed,2015-11-30,02449145,Auro-Betahistine,1,N07CA01,Betahistine,Tablet,Oral,02449145,AURO-BETAHISTINE (betahistine hydrochloride 8 mg oral tablet) AURO PHARMA INC,Active,9001332,betahistine hydrochloride 8 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93497,Marketed,2015-11-30,02449153,Auro-Betahistine,1,N07CA01,Betahistine,Tablet,Oral,02449153,AURO-BETAHISTINE (betahistine hydrochloride 16 mg oral tablet) AURO PHARMA INC,Active,9000951,betahistine hydrochloride 16 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93498,Marketed,2015-11-30,02449161,Auro-Betahistine,1,N07CA01,Betahistine,Tablet,Oral,02449161,AURO-BETAHISTINE (betahistine hydrochloride 24 mg oral tablet) AURO PHARMA INC,Active,9001059,betahistine hydrochloride 24 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95480,Marketed,2022-09-28,02466449,Betahistine,1,N07CA01,Betahistine,Tablet,Oral,02466449,BETAHISTINE (betahistine hydrochloride 16 mg oral tablet) SANIS HEALTH INC,Active,9000951,betahistine hydrochloride 16 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95481,Marketed,2022-09-28,02466457,Betahistine,1,N07CA01,Betahistine,Tablet,Oral,02466457,BETAHISTINE (betahistine hydrochloride 24 mg oral tablet) SANIS HEALTH INC,Active,9001059,betahistine hydrochloride 24 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
61949,Marketed,2020-01-17,02238526,Cystadane,1,A16AA06,Betaine,Powder for solution,Oral,02238526,CYSTADANE (betaine 100 % powder for oral solution) RECORDATI RARE DISEASES CANADA INC,Active,9013764,betaine 100 % powder for oral solution,8001585,betaine,26643006,Oral,385026009,Powder for oral solution,,,,,,Prescription
10940,Marketed,2017-11-28,00849669,Teva-Topilene,1,D07AC01,Betamethasone,Ointment,Topical,00849669,TEVA-TOPILENE (betamethasone (betamethasone dipropionate) 0.05 % cutaneous ointment) TEVA CANADA LIMITED,Active,9000091,betamethasone (betamethasone dipropionate) 0.05 % cutaneous ointment,8000791,betamethasone dipropionate,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Prescription
10941,Marketed,2017-09-20,00809187,Teva-Topisone,1,D07AC01,Betamethasone,Lotion,Topical,00809187,TEVA-TOPISONE (betamethasone (betamethasone dipropionate) 0.05 % lotion) TEVA CANADA LIMITED,Active,9000095,betamethasone (betamethasone dipropionate) 0.05 % lotion,8000791,betamethasone dipropionate,448598008,Cutaneous,739000003,Lotion,,,,,,Prescription
12272,Marketed,1992-12-31,01925350,Taro-Sone,1,D07AC01,Betamethasone,Cream,Topical,01925350,TARO-SONE (betamethasone (betamethasone dipropionate) 0.05 % cutaneous cream) TARO PHARMACEUTICALS INC,Active,9000086,betamethasone (betamethasone dipropionate) 0.05 % cutaneous cream,8000791,betamethasone dipropionate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
13690,Marketed,2017-11-28,01927914,Teva-Topilene,1,D07AC01,Betamethasone,Lotion,Topical,01927914,TEVA-TOPILENE (betamethasone (betamethasone dipropionate) 0.05 % lotion) TEVA CANADA LIMITED,Active,9000095,betamethasone (betamethasone dipropionate) 0.05 % lotion,8000791,betamethasone dipropionate,448598008,Cutaneous,739000003,Lotion,,,,,,Prescription
13888,Marketed,2017-09-20,00805009,Teva-Topisone,1,D07AC01,Betamethasone,Ointment,Topical,00805009,TEVA-TOPISONE (betamethasone (betamethasone dipropionate) 0.05 % cutaneous ointment) TEVA CANADA LIMITED,Active,9000091,betamethasone (betamethasone dipropionate) 0.05 % cutaneous ointment,8000791,betamethasone dipropionate,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Prescription
13889,Marketed,2017-09-20,00804991,Teva-Topisone,1,D07AC01,Betamethasone,Cream,Topical,00804991,TEVA-TOPISONE (betamethasone (betamethasone dipropionate) 0.05 % cutaneous cream) TEVA CANADA LIMITED,Active,9000086,betamethasone (betamethasone dipropionate) 0.05 % cutaneous cream,8000791,betamethasone dipropionate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
14445,Marketed,2017-11-28,00849650,Teva-Topilene,1,D07AC01,Betamethasone,Cream,Topical,00849650,TEVA-TOPILENE (betamethasone (betamethasone dipropionate) 0.05 % cutaneous cream) TEVA CANADA LIMITED,Active,9000086,betamethasone (betamethasone dipropionate) 0.05 % cutaneous cream,8000791,betamethasone dipropionate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
19225,Marketed,2018-11-02,00750050,Teva-Ectosone,1,D07AC01,Betamethasone,Lotion,Topical,00750050,TEVA-ECTOSONE (betamethasone (betamethasone valerate) 0.1 % lotion) TEVA CANADA LIMITED,Active,9000121,betamethasone (betamethasone valerate) 0.1 % lotion,8000792,betamethasone valerate,448598008,Cutaneous,739000003,Lotion,,,,,,Prescription
2071,Marketed,2022-06-29,00323071,Diprosone,1,D07AC01,Betamethasone,Cream,Topical,00323071,DIPROSONE (betamethasone (betamethasone dipropionate) 0.05 % cutaneous cream) ORGANON CANADA INC.,Active,9000086,betamethasone (betamethasone dipropionate) 0.05 % cutaneous cream,8000791,betamethasone dipropionate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
2272,Marketed,2022-06-16,00344923,Diprosone,1,D07AC01,Betamethasone,Ointment,Topical,00344923,DIPROSONE (betamethasone (betamethasone dipropionate) 0.05 % cutaneous ointment) ORGANON CANADA INC.,Active,9000091,betamethasone (betamethasone dipropionate) 0.05 % cutaneous ointment,8000791,betamethasone dipropionate,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Prescription
2870,Marketed,2022-09-15,00417246,Diprosone,1,D07AC01,Betamethasone,Lotion,Topical,00417246,DIPROSONE (betamethasone (betamethasone dipropionate) 0.05 % lotion) ORGANON CANADA INC.,Active,9000095,betamethasone (betamethasone dipropionate) 0.05 % lotion,8000791,betamethasone dipropionate,448598008,Cutaneous,739000003,Lotion,,,,,,Prescription
354,Marketed,2022-08-04,00028096,Celestone Soluspan,2,H02AB01,Betamethasone,Suspension,"Intramuscular,Intrabursal,Intra-articular,Intradermal",00028096,CELESTONE SOLUSPAN (betamethasone acetate 3 mg per mL and betamethasone (betamethasone sodium phosphate) 3 mg per mL suspension for injection) ORGANON CANADA INC.,Active,9001611,betamethasone acetate 3 mg per mL and betamethasone (betamethasone sodium phosphate) 3 mg per mL suspension for injection,8000794,betamethasone acetate and betamethasone (base),738984000,Parenteral,385220007,Suspension for injection,,,,,,Prescription
4521,Marketed,2021-04-14,00535427,Teva-Ectosone,1,D07AC01,Betamethasone,Cream,Topical,00535427,TEVA-ECTOSONE (betamethasone (betamethasone valerate) 0.05 % cutaneous cream) TEVA CANADA LIMITED,Active,9000119,betamethasone (betamethasone valerate) 0.05 % cutaneous cream,8000792,betamethasone valerate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
4522,Marketed,2020-07-03,00535435,Teva-Ectosone,1,D07AC01,Betamethasone,Cream,Topical,00535435,TEVA-ECTOSONE (betamethasone (betamethasone valerate) 0.1 % cutaneous cream) TEVA CANADA LIMITED,Active,9000163,betamethasone (betamethasone valerate) 0.1 % cutaneous cream,8000792,betamethasone valerate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
5287,Marketed,2022-05-27,00578436,Diprosalic,2,D07XC01,Betamethasone,Ointment,Topical,00578436,DIPROSALIC (betamethasone (betamethasone dipropionate) 0.5 mg per g and salicylic acid 30 mg per g cutaneous ointment) ORGANON CANADA INC.,Active,9001960,betamethasone (betamethasone dipropionate) 0.5 mg per g and salicylic acid 30 mg per g cutaneous ointment,8000831,betamethasone dipropionate and salicylic acid,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Prescription
6529,Marketed,2023-08-08,00629367,Diprolene,1,D07AC01,Betamethasone,Ointment,Topical,00629367,DIPROLENE (betamethasone (betamethasone dipropionate) 0.05 % cutaneous ointment) ORGANON CANADA INC.,Active,9000091,betamethasone (betamethasone dipropionate) 0.05 % cutaneous ointment,8000791,betamethasone dipropionate,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Prescription
6822,Marketed,2018-11-02,00653209,Teva-Ectosone,1,D07AC01,Betamethasone,Lotion,Topical,00653209,TEVA-ECTOSONE (betamethasone (betamethasone valerate) 0.05 % lotion) TEVA CANADA LIMITED,Active,9000244,betamethasone (betamethasone valerate) 0.05 % lotion,8000792,betamethasone valerate,448598008,Cutaneous,739000003,Lotion,,,,,,Prescription
8972,Marketed,1979-12-31,00716618,Betaderm Crm 0.05%,1,D07AC01,Betamethasone,Cream,Topical,00716618,BETADERM CRM 0.05% (betamethasone (betamethasone valerate) 0.05 % cutaneous cream) TARO PHARMACEUTICALS INC,Active,9000119,betamethasone (betamethasone valerate) 0.05 % cutaneous cream,8000792,betamethasone valerate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
8973,Marketed,1988-12-31,00716650,Betaderm Ont 0.1%,1,D07AC01,Betamethasone,Ointment,Topical,00716650,BETADERM ONT 0.1% (betamethasone (betamethasone valerate) 0.1 % cutaneous ointment) TARO PHARMACEUTICALS INC,Active,9001366,betamethasone (betamethasone valerate) 0.1 % cutaneous ointment,8000792,betamethasone valerate,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Prescription
91194,Marketed,2020-08-07,02427419,Teva-Betamethasone/ Calcipotriol,2,D07XC01,Betamethasone,Ointment,Topical,02427419,TEVA-BETAMETHASONE/ CALCIPOTRIOL (betamethasone (betamethasone dipropionate) 0.5 mg per g and calcipotriol 50 mcg per g cutaneous ointment) TEVA CANADA LIMITED,Active,9003670,betamethasone (betamethasone dipropionate) 0.5 mg per g and calcipotriol 50 mcg per g cutaneous ointment,8000927,betamethasone dipropionate and calcipotriol,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Prescription
9268,Marketed,1979-12-31,00716626,Betaderm Crm 0.1%,1,D07AC01,Betamethasone,Cream,Topical,00716626,BETADERM CRM 0.1% (betamethasone (betamethasone valerate) 0.1 % cutaneous cream) TARO PHARMACEUTICALS INC,Active,9000163,betamethasone (betamethasone valerate) 0.1 % cutaneous cream,8000792,betamethasone valerate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
9269,Marketed,1979-12-31,00716634,Betaderm Lotion 0.1%,1,D07AC01,Betamethasone,Lotion,Topical,00716634,BETADERM LOTION 0.1% (betamethasone (betamethasone valerate) 0.1 % lotion) TARO PHARMACEUTICALS INC,Active,9000121,betamethasone (betamethasone valerate) 0.1 % lotion,8000792,betamethasone valerate,448598008,Cutaneous,739000003,Lotion,,,,,,Prescription
9270,Marketed,1979-12-31,00716642,Betaderm Ont 0.05%,1,D07AC01,Betamethasone,Ointment,Topical,00716642,BETADERM ONT 0.05% (betamethasone (betamethasone valerate) 0.05 % cutaneous ointment) TARO PHARMACEUTICALS INC,Active,9000120,betamethasone (betamethasone valerate) 0.05 % cutaneous ointment,8000792,betamethasone valerate,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Prescription
96510,Marketed,2018-10-03,02474883,Fucibet,2,D07CC01,Betamethasone and antibiotics,Cream,Topical,02474883,FUCIBET (betamethasone (betamethasone valerate) 0.1 % and fusidic acid 2 % cutaneous cream) LEO PHARMA INC,Active,9013267,betamethasone (betamethasone valerate) 0.1 % and fusidic acid 2 % cutaneous cream,8001892,betamethasone valerate and fusidic acid,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
12745,Marketed,2025-12-04,01947931,Duvoid,1,N07AB02,Bethanechol,Tablet,Oral,01947931,DUVOID (bethanechol chloride 25 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9002247,bethanechol chloride 25 mg oral tablet,8001587,bethanechol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
12746,Marketed,2025-12-04,01947958,Duvoid,1,N07AB02,Bethanechol,Tablet,Oral,01947958,DUVOID (bethanechol chloride 10 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9002246,bethanechol chloride 10 mg oral tablet,8001587,bethanechol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100992,Marketed,2021-11-09,02520729,Bambevi,1,L01FG01,Bevacizumab,Solution,Intravenous,02520729,BAMBEVI (bevacizumab 100 mg per 4 mL solution for injection vial) APOTEX INC,Active,9012911,bevacizumab 100 mg per 4 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
100992,Marketed,2021-11-09,02520729,Bambevi,1,L01FG01,Bevacizumab,Solution,Intravenous,02520729,BAMBEVI (bevacizumab 100 mg per 4 mL solution for injection vial) APOTEX INC,Active,9012911,bevacizumab 100 mg per 4 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
100993,Marketed,2021-11-09,02520737,Bambevi,1,L01FG01,Bevacizumab,Solution,Intravenous,02520737,BAMBEVI (bevacizumab 400 mg per 16 mL solution for injection vial) APOTEX INC,Active,9012912,bevacizumab 400 mg per 16 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
100993,Marketed,2021-11-09,02520737,Bambevi,1,L01FG01,Bevacizumab,Solution,Intravenous,02520737,BAMBEVI (bevacizumab 400 mg per 16 mL solution for injection vial) APOTEX INC,Active,9012912,bevacizumab 400 mg per 16 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
101131,Marketed,2025-08-07,02522160,Abevmy,1,L01FG01,Bevacizumab,Solution,Intravenous,02522160,ABEVMY (bevacizumab 400 mg per 16 mL solution for injection vial) BIOSIMILAR COLLABORATIONS IRELAND LIMITED,Active,9012912,bevacizumab 400 mg per 16 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
101131,Marketed,2025-08-07,02522160,Abevmy,1,L01FG01,Bevacizumab,Solution,Intravenous,02522160,ABEVMY (bevacizumab 400 mg per 16 mL solution for injection vial) BIOSIMILAR COLLABORATIONS IRELAND LIMITED,Active,9012912,bevacizumab 400 mg per 16 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
101132,Marketed,2025-08-07,02522179,Abevmy,1,L01FG01,Bevacizumab,Solution,Intravenous,02522179,ABEVMY (bevacizumab 100 mg per 4 mL solution for injection vial) BIOSIMILAR COLLABORATIONS IRELAND LIMITED,Active,9012911,bevacizumab 100 mg per 4 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
101132,Marketed,2025-08-07,02522179,Abevmy,1,L01FG01,Bevacizumab,Solution,Intravenous,02522179,ABEVMY (bevacizumab 100 mg per 4 mL solution for injection vial) BIOSIMILAR COLLABORATIONS IRELAND LIMITED,Active,9012911,bevacizumab 100 mg per 4 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
101187,Marketed,2022-06-27,02522829,Aybintio,1,L01FG01,Bevacizumab,Solution,Intravenous,02522829,"AYBINTIO (bevacizumab 100 mg per 4 mL solution for injection vial) SAMSUNG BIOEPIS CO., LTD",Active,9012911,bevacizumab 100 mg per 4 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
101187,Marketed,2022-06-27,02522829,Aybintio,1,L01FG01,Bevacizumab,Solution,Intravenous,02522829,"AYBINTIO (bevacizumab 100 mg per 4 mL solution for injection vial) SAMSUNG BIOEPIS CO., LTD",Active,9012911,bevacizumab 100 mg per 4 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription Recommended
101189,Marketed,2022-06-27,02522837,Aybintio,1,L01FG01,Bevacizumab,Solution,Intravenous,02522837,"AYBINTIO (bevacizumab 400 mg per 16 mL solution for injection vial) SAMSUNG BIOEPIS CO., LTD",Active,9012912,bevacizumab 400 mg per 16 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription Recommended
101189,Marketed,2022-06-27,02522837,Aybintio,1,L01FG01,Bevacizumab,Solution,Intravenous,02522837,"AYBINTIO (bevacizumab 400 mg per 16 mL solution for injection vial) SAMSUNG BIOEPIS CO., LTD",Active,9012912,bevacizumab 400 mg per 16 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
102312,Marketed,2024-03-28,02534177,Vegzelma,1,L01FG01,Bevacizumab,Solution,Intravenous,02534177,VEGZELMA (bevacizumab 100 mg per 4 mL solution for injection vial) CELLTRION INC.,Active,9012911,bevacizumab 100 mg per 4 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
102312,Marketed,2024-03-28,02534177,Vegzelma,1,L01FG01,Bevacizumab,Solution,Intravenous,02534177,VEGZELMA (bevacizumab 100 mg per 4 mL solution for injection vial) CELLTRION INC.,Active,9012911,bevacizumab 100 mg per 4 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
102313,Marketed,2024-03-28,02534185,Vegzelma,1,L01FG01,Bevacizumab,Solution,Intravenous,02534185,VEGZELMA (bevacizumab 400 mg per 16 mL solution for injection vial) CELLTRION INC.,Active,9012912,bevacizumab 400 mg per 16 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
102313,Marketed,2024-03-28,02534185,Vegzelma,1,L01FG01,Bevacizumab,Solution,Intravenous,02534185,VEGZELMA (bevacizumab 400 mg per 16 mL solution for injection vial) CELLTRION INC.,Active,9012912,bevacizumab 400 mg per 16 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
75642,Marketed,2005-11-02,02270994,Avastin,1,L01FG01,Bevacizumab,Solution,Intravenous,77700679,AVASTIN (bevacizumab 400 mg per 16 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9012912,bevacizumab 400 mg per 16 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
75642,Marketed,2005-11-02,02270994,Avastin,1,L01FG01,Bevacizumab,Solution,Intravenous,77700680,AVASTIN (bevacizumab 100 mg per 4 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9012911,bevacizumab 100 mg per 4 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
75642,Marketed,2005-11-02,02270994,Avastin,1,L01FG01,Bevacizumab,Solution,Intravenous,77700679,AVASTIN (bevacizumab 400 mg per 16 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9012912,bevacizumab 400 mg per 16 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
75642,Marketed,2005-11-02,02270994,Avastin,1,L01FG01,Bevacizumab,Solution,Intravenous,77700680,AVASTIN (bevacizumab 100 mg per 4 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9012911,bevacizumab 100 mg per 4 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
95974,Marketed,2019-08-01,02470748,Mvasi,1,L01FG01,Bevacizumab,Solution,Intravenous,02470748,MVASI (bevacizumab 100 mg per 4 mL solution for injection vial) AMGEN CANADA INC,Active,9012911,bevacizumab 100 mg per 4 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
95974,Marketed,2019-08-01,02470748,Mvasi,1,L01FG01,Bevacizumab,Solution,Intravenous,02470748,MVASI (bevacizumab 100 mg per 4 mL solution for injection vial) AMGEN CANADA INC,Active,9012911,bevacizumab 100 mg per 4 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
95975,Marketed,2019-08-01,02470756,Mvasi,1,L01FG01,Bevacizumab,Solution,Intravenous,02470756,MVASI (bevacizumab 400 mg per 16 mL solution for injection vial) AMGEN CANADA INC,Active,9012912,bevacizumab 400 mg per 16 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
95975,Marketed,2019-08-01,02470756,Mvasi,1,L01FG01,Bevacizumab,Solution,Intravenous,02470756,MVASI (bevacizumab 400 mg per 16 mL solution for injection vial) AMGEN CANADA INC,Active,9012912,bevacizumab 400 mg per 16 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
97952,Marketed,2019-09-25,02489430,Zirabev,1,L01FG01,Bevacizumab,Solution,Intravenous,02489430,ZIRABEV (bevacizumab 100 mg per 4 mL solution for injection vial) PFIZER CANADA ULC,Active,9012911,bevacizumab 100 mg per 4 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
97952,Marketed,2019-09-25,02489430,Zirabev,1,L01FG01,Bevacizumab,Solution,Intravenous,02489430,ZIRABEV (bevacizumab 100 mg per 4 mL solution for injection vial) PFIZER CANADA ULC,Active,9012911,bevacizumab 100 mg per 4 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
97953,Marketed,2019-09-25,02489449,Zirabev,1,L01FG01,Bevacizumab,Solution,Intravenous,02489449,ZIRABEV (bevacizumab 400 mg per 16 mL solution for injection vial) PFIZER CANADA ULC,Active,9012912,bevacizumab 400 mg per 16 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
97953,Marketed,2019-09-25,02489449,Zirabev,1,L01FG01,Bevacizumab,Solution,Intravenous,02489449,ZIRABEV (bevacizumab 400 mg per 16 mL solution for injection vial) PFIZER CANADA ULC,Active,9012912,bevacizumab 400 mg per 16 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
16968,Marketed,2020-12-03,02083523,Bezalip SR,1,C10AB02,Bezafibrate,Tablet (extended-release),Oral,02083523,BEZALIP SR (bezafibrate 400 mg prolonged-release oral tablet) ALLERGAN INC,Active,9002620,bezafibrate 400 mg prolonged-release oral tablet,8001246,bezafibrate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93984,Marketed,2016-04-06,02453312,JAMP-Bezafibrate SR,1,C10AB02,Bezafibrate,Tablet (extended-release),Oral,02453312,JAMP-BEZAFIBRATE SR (bezafibrate 400 mg prolonged-release oral tablet) JAMP PHARMA CORPORATION,Active,9002620,bezafibrate 400 mg prolonged-release oral tablet,8001246,bezafibrate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100844,Marketed,2022-04-28,02519178,Bicalutamide,1,L02BB03,Bicalutamide,Tablet,Oral,02519178,BICALUTAMIDE (bicalutamide 50 mg oral tablet) SANIS HEALTH INC,Active,9003010,bicalutamide 50 mg oral tablet,8001589,bicalutamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
75561,Marketed,2015-05-06,02270226,Teva-Bicalutamide,1,L02BB03,Bicalutamide,Tablet,Oral,02270226,TEVA-BICALUTAMIDE (bicalutamide 50 mg oral tablet) TEVA CANADA LIMITED,Active,9003010,bicalutamide 50 mg oral tablet,8001589,bicalutamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
76122,Marketed,2006-02-08,02275589,PMS-Bicalutamide,1,L02BB03,Bicalutamide,Tablet,Oral,02275589,PMS-BICALUTAMIDE (bicalutamide 50 mg oral tablet) PHARMASCIENCE INC,Active,9003010,bicalutamide 50 mg oral tablet,8001589,bicalutamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
79663,Marketed,2026-03-10,02311038,Pro-Bicalutamide,1,L02BB03,Bicalutamide,Tablet,Oral,02311038,PRO-BICALUTAMIDE (bicalutamide 50 mg oral tablet) PRO DOC LIMITEE,Active,9003010,bicalutamide 50 mg oral tablet,8001589,bicalutamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
81133,Marketed,2014-08-23,02325985,ACH-Bicalutamide,1,L02BB03,Bicalutamide,Tablet,Oral,02325985,ACH-BICALUTAMIDE (bicalutamide 50 mg oral tablet) ACCORD HEALTHCARE INC,Active,9003010,bicalutamide 50 mg oral tablet,8001589,bicalutamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
84234,Marketed,2026-05-21,02357216,JAMP Bicalutamide,1,L02BB03,Bicalutamide,Tablet,Oral,02357216,JAMP BICALUTAMIDE (bicalutamide 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003010,bicalutamide 50 mg oral tablet,8001589,bicalutamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100830,Marketed,2022-02-10,02519011,Blexten,1,R06AX29,Bilastine,Solution,Oral,02519011,BLEXTEN (bilastine 10 mg per 4 mL oral solution) ARALEZ PHARMACEUTICALS CANADA INC,Active,9014657,bilastine 10 mg per 4 mL oral solution,8001590,bilastine,26643006,Oral,739006009,Solution,,,,,,Prescription
100831,Marketed,2022-02-10,02519038,Blexten,1,R06AX29,Bilastine,Tablet (orally disintegrating),Oral,02519038,BLEXTEN (bilastine 10 mg orodispersible tablet) ARALEZ PHARMACEUTICALS CANADA INC,Active,9014656,bilastine 10 mg orodispersible tablet,8001590,bilastine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
102505,Marketed,2024-10-22,02536269,Sandoz Bilastine,1,R06AX29,Bilastine,Tablet,Oral,,,,,,,,,,,,,,,,,Prescription
103019,Marketed,2024-10-25,02541556,Auro-Bilastine,1,R06AX29,Bilastine,Tablet,Oral,02541556,AURO-BILASTINE (bilastine 20 mg oral tablet) AURO PHARMA INC,Active,9006072,bilastine 20 mg oral tablet,8001590,bilastine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103292,Marketed,2024-10-22,02544369,GLN-Bilastine,1,R06AX29,Bilastine,Tablet,Oral,02544369,GLN-BILASTINE (bilastine 20 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9006072,bilastine 20 mg oral tablet,8001590,bilastine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103547,Marketed,2024-10-22,02546795,JAMP Bilastine,1,R06AX29,Bilastine,Tablet,Oral,02546795,JAMP BILASTINE (bilastine 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9006072,bilastine 20 mg oral tablet,8001590,bilastine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103590,Marketed,2024-10-22,02547279,Mar-Bilastine,1,R06AX29,Bilastine,Tablet,Oral,02547279,MAR-BILASTINE (bilastine 20 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9006072,bilastine 20 mg oral tablet,8001590,bilastine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103730,Marketed,2024-10-24,02548410,M-Bilastine,1,R06AX29,Bilastine,Tablet,Oral,02548410,M-BILASTINE (bilastine 20 mg oral tablet) MANTRA PHARMA INC,Active,9006072,bilastine 20 mg oral tablet,8001590,bilastine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104063,Marketed,2024-10-30,02551934,Nra-Bilastine,1,R06AX29,Bilastine,Tablet,Oral,02551934,NRA-BILASTINE (bilastine 20 mg oral tablet) NORA PHARMA INC,Active,9006072,bilastine 20 mg oral tablet,8001590,bilastine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106452,Marketed,2026-04-30,02561565,PMS-Bilastine,1,R06AX29,Bilastine,Tablet,Oral,02561565,PMS-BILASTINE (bilastine 20 mg oral tablet) PHARMASCIENCE INC,Active,9006072,bilastine 20 mg oral tablet,8001590,bilastine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94066,Marketed,2019-05-30,02454130,Blexten,1,R06AX29,Bilastine,Tablet,Oral,02454130,BLEXTEN (bilastine 20 mg oral tablet) ARALEZ PHARMACEUTICALS CANADA INC,Active,9006072,bilastine 20 mg oral tablet,8001590,bilastine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101882,Marketed,2026-03-16,02529580,Bimatoprost RC,1,S01EE03,Bimatoprost,Solution,Ophthalmic,02529580,BIMATOPROST RC (bimatoprost 0.01 % ophthalmic drops) JUNO PHARMA CANADA INC.,Active,9001276,bimatoprost 0.01 % ophthalmic drops,8000315,bimatoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
102245,Marketed,2026-03-12,02533464,Zimed PF,1,S01EE03,Bimatoprost,Solution,Ophthalmic,02533464,ZIMED PF (bimatoprost 0.03 % ophthalmic drops) LUVO MEDICAL TECHNOLOGIES INC,Active,9000987,bimatoprost 0.03 % ophthalmic drops,8000315,bimatoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
106835,Marketed,2026-03-16,02565773,JAMP Bimatoprost Solution RC,1,S01EE03,Bimatoprost,Solution,Ophthalmic,02565773,JAMP BIMATOPROST SOLUTION RC (bimatoprost 0.01 % ophthalmic drops) JAMP PHARMA CORPORATION,Active,9001276,bimatoprost 0.01 % ophthalmic drops,8000315,bimatoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
81041,Marketed,2023-08-04,02324997,Lumigan RC,1,S01EE03,Bimatoprost,Solution,Ophthalmic,02324997,LUMIGAN RC (bimatoprost 0.01 % ophthalmic drops) ABBVIE CORPORATION,Active,9001276,bimatoprost 0.01 % ophthalmic drops,8000315,bimatoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
83612,Marketed,2024-06-21,02350939,Latisse,1,S01EE03,Bimatoprost,Solution,Topical,02350939,LATISSE (bimatoprost 0.03 % cutaneous solution) ABBVIE CORPORATION,Active,9001325,bimatoprost 0.03 % cutaneous solution,8000315,bimatoprost,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Prescription
91352,Marketed,2016-05-13,02429063,Vistitan,1,S01EE03,Bimatoprost,Solution,Ophthalmic,02429063,VISTITAN (bimatoprost 0.03 % ophthalmic drops) SANDOZ CANADA INCORPORATED,Active,9000987,bimatoprost 0.03 % ophthalmic drops,8000315,bimatoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
101427,Marketed,2022-03-30,02525267,Bimzelx,1,L04AC21,Bimekizumab,Solution,Subcutaneous,02525267,BIMZELX PRE-FILLED SYRINGE (bimekizumab 160 mg per 1 mL solution for injection syringe) UCB CANADA INC,Active,9014673,bimekizumab 160 mg per 1 mL solution for injection syringe,8002417,bimekizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
101427,Marketed,2022-03-30,02525267,Bimzelx,1,L04AC21,Bimekizumab,Solution,Subcutaneous,02525267,BIMZELX PRE-FILLED SYRINGE (bimekizumab 160 mg per 1 mL solution for injection syringe) UCB CANADA INC,Active,9014673,bimekizumab 160 mg per 1 mL solution for injection syringe,8002417,bimekizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
101428,Marketed,2022-03-30,02525275,Bimzelx,1,L04AC21,Bimekizumab,Solution,Subcutaneous,02525275,BIMZELX AUTOINJECTOR (bimekizumab 160 mg per 1 mL solution for injection syringe) UCB CANADA INC,Active,9014673,bimekizumab 160 mg per 1 mL solution for injection syringe,8002417,bimekizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
101428,Marketed,2022-03-30,02525275,Bimzelx,1,L04AC21,Bimekizumab,Solution,Subcutaneous,02525275,BIMZELX AUTOINJECTOR (bimekizumab 160 mg per 1 mL solution for injection syringe) UCB CANADA INC,Active,9014673,bimekizumab 160 mg per 1 mL solution for injection syringe,8002417,bimekizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
104253,Marketed,2025-04-07,02553619,Bimzelx,1,L04AC21,Bimekizumab,Solution,Subcutaneous,02553619,BIMZELX PREFILLED SYRINGE (bimekizumab 320 mg per 2 mL solution for injection syringe) UCB CANADA INC,Active,9015185,bimekizumab 320 mg per 2 mL solution for injection syringe,8002417,bimekizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe,,,,Prescription
104253,Marketed,2025-04-07,02553619,Bimzelx,1,L04AC21,Bimekizumab,Solution,Subcutaneous,02553619,BIMZELX PREFILLED SYRINGE (bimekizumab 320 mg per 2 mL solution for injection syringe) UCB CANADA INC,Active,9015185,bimekizumab 320 mg per 2 mL solution for injection syringe,8002417,bimekizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe,,,,Schedule D
104254,Marketed,2025-04-07,02553627,Bimzelx,1,L04AC21,Bimekizumab,Solution,Subcutaneous,02553627,BIMZELX AUTOINJECTOR (bimekizumab 320 mg per 2 mL solution for injection syringe) UCB CANADA INC,Active,9015185,bimekizumab 320 mg per 2 mL solution for injection syringe,8002417,bimekizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe,,,,Schedule D
104254,Marketed,2025-04-07,02553627,Bimzelx,1,L04AC21,Bimekizumab,Solution,Subcutaneous,02553627,BIMZELX AUTOINJECTOR (bimekizumab 320 mg per 2 mL solution for injection syringe) UCB CANADA INC,Active,9015185,bimekizumab 320 mg per 2 mL solution for injection syringe,8002417,bimekizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe,,,,Prescription
100232,Marketed,2021-07-05,02513080,Mektovi,1,L01EE03,Binimetinib,Tablet,Oral,02513080,MEKTOVI (binimetinib 15 mg oral tablet) PFIZER CANADA ULC,Active,9014593,binimetinib 15 mg oral tablet,8002389,binimetinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100967,Marketed,2024-06-03,02520478,Amb-Bisacodyl,1,A06AB02,Bisacodyl,Suppository,Rectal,02520478,AMB-BISACODYL (bisacodyl 10 mg suppository) AMBICARE PHARMACEUTICALS INC.,Active,9001563,bisacodyl 10 mg suppository,8000800,bisacodyl,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,,Non-Prescription Drugs
103975,Marketed,2025-04-01,02550997,"Bisacodyl Tablets, 5 mg",1,A06AB02,Bisacodyl,Tablet,Oral,02550997,"BISACODYL TABLETS, 5 MG (bisacodyl 5 mg oral tablet) TIME-CAP LABORATORIES, INC",Active,9002344,bisacodyl 5 mg oral tablet,8000800,bisacodyl,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
1553,Marketed,2020-10-16,00254142,Dulcolax,1,A06AB02,Bisacodyl,Tablet (enteric-coated),Oral,00254142,DULCOLAX (bisacodyl 5 mg gastro-resistant tablet) SANOFI CONSUMER HEALTH INC,Active,9001564,bisacodyl 5 mg gastro-resistant tablet,8000800,bisacodyl,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
1555,Marketed,2020-10-16,00003875,Dulcolax,1,A06AB02,Bisacodyl,Suppository,Rectal,00003875,DULCOLAX (bisacodyl 10 mg suppository) SANOFI CONSUMER HEALTH INC,Active,9001563,bisacodyl 10 mg suppository,8000800,bisacodyl,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,,Non-Prescription Drugs
37161,Marketed,2006-04-01,02219190,Carter's Little Pills,1,A06AB02,Bisacodyl,Tablet,Oral,02219190,CARTER'S LITTLE PILLS (bisacodyl 5 mg oral tablet) CHURCH & DWIGHT CANADA CORP,Active,9002344,bisacodyl 5 mg oral tablet,8000800,bisacodyl,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
61546,Marketed,2024-12-20,02238155,Codulax Tablets,1,A06AB02,Bisacodyl,Tablet,Oral,02238155,CODULAX TABLETS (bisacodyl 5 mg oral tablet) SIGMA LIFE SCIENCES INC.,Active,9002344,bisacodyl 5 mg oral tablet,8000800,bisacodyl,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
64686,Marketed,2024-09-27,02241091,The Magic Bullet,1,A06AB02,Bisacodyl,Suppository,Rectal,02241091,THE MAGIC BULLET (bisacodyl 10 mg suppository) SCI SUPPLY INC.,Active,9001563,bisacodyl 10 mg suppository,8000800,bisacodyl,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,,Non-Prescription Drugs
67779,Marketed,2003-04-01,02243838,Bisacodyl Tablets 5 mg,1,A06AB02,Bisacodyl,Tablet,Oral,02243838,BISACODYL TABLETS 5MG (bisacodyl 5 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9002344,bisacodyl 5 mg oral tablet,8000800,bisacodyl,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
70170,Marketed,2014-05-09,02246039,JAMP-Bisacodyl,1,A06AB02,Bisacodyl,Tablet,Oral,02246039,JAMP-BISACODYL (bisacodyl 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9002344,bisacodyl 5 mg oral tablet,8000800,bisacodyl,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
75889,Marketed,2005-12-07,02273411,Bisacodyl-Odan,1,A06AB02,Bisacodyl,Tablet (delayed-release),Oral,02273411,BISACODYL-ODAN (bisacodyl 5 mg gastro-resistant tablet) ODAN LABORATORIES LTD,Active,9001564,bisacodyl 5 mg gastro-resistant tablet,8000800,bisacodyl,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
76622,Marketed,2007-12-15,02280566,Silver Bullet Suppository,1,A06AB02,Bisacodyl,Suppository,Rectal,02280566,SILVER BULLET SUPPOSITORY (bisacodyl 10 mg suppository) D & C MOBILITY SOLUTIONS INC.,Active,9001563,bisacodyl 10 mg suppository,8000800,bisacodyl,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,,Non-Prescription Drugs
84651,Marketed,2014-01-30,02361450,Bisacodyl Suppository,1,A06AB02,Bisacodyl,Suppository,Rectal,02361450,BISACODYL SUPPOSITORY (bisacodyl 10 mg suppository) JAMP PHARMA CORPORATION,Active,9001563,bisacodyl 10 mg suppository,8000800,bisacodyl,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,,Non-Prescription Drugs
88276,Marketed,2021-02-17,02397854,Dulcolax For Women,1,A06AB02,Bisacodyl,Tablet,Oral,02397854,DULCOLAX FOR WOMEN (bisacodyl 5 mg oral tablet) SANOFI CONSUMER HEALTH INC,Active,9002344,bisacodyl 5 mg oral tablet,8000800,bisacodyl,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
90204,Marketed,2026-07-03,02417413,Bisacodyl Tablets,1,A06AB02,Bisacodyl,Tablet,Oral,02417413,BISACODYL TABLETS (bisacodyl 5 mg oral tablet) SIGMA LIFE SCIENCES INC.,Active,9002344,bisacodyl 5 mg oral tablet,8000800,bisacodyl,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
93629,Marketed,2024-12-27,02450232,Laxative For Women,1,A06AB02,Bisacodyl,Tablet,Oral,02450232,LAXATIVE FOR WOMEN (bisacodyl 5 mg oral tablet) SIGMA LIFE SCIENCES INC.,Active,9002344,bisacodyl 5 mg oral tablet,8000800,bisacodyl,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
97915,Marketed,2020-01-27,02489090,Bisacodyl Suppository,1,A06AB02,Bisacodyl,Suppository,Rectal,02489090,BISACODYL SUPPOSITORY (bisacodyl 10 mg suppository) ANGITA PHARMA INC.,Active,9001563,bisacodyl 10 mg suppository,8000800,bisacodyl,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,,Non-Prescription Drugs
98888,Marketed,2022-05-30,02499126,Bisacodyl Laxative,1,A06AB02,Bisacodyl,Tablet,Oral,02499126,BISACODYL LAXATIVE (bisacodyl 5 mg oral tablet) JUNO OTC INC,Active,9002344,bisacodyl 5 mg oral tablet,8000800,bisacodyl,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
104160,Marketed,2025-08-01,02552612,Jamplyte + Bisacodyl,6,A06AB52,"Bisacodyl, combinations","Powder for solution,Kit,Tablet (delayed-release)",Oral,,,,,,,,,,,,,,,,,Ethical
81164,Marketed,2010-06-06,02326302,Bi-Peglyte,6,A06AB52,"Bisacodyl, combinations","Powder for solution,Kit,Tablet (delayed-release)",Oral,,,,,,,,,,,,,,,,,Ethical
101991,Marketed,2023-11-12,02530759,Pepto-Bismol Extra Caplet,1,A07BB,Bismuth preparations,Tablet,Oral,02530759,PEPTO-BISMOL EXTRA CAPLET (bismuth subsalicylate 524 mg oral tablet) PROCTER & GAMBLE INC,Active,9014960,bismuth subsalicylate 524 mg oral tablet,8001705,bismuth subsalicylate,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
102336,Marketed,2023-03-06,02534436,Gastrovol Liquid Gels,1,A07BB,Bismuth preparations,Capsule,Oral,02534436,GASTROVOL LIQUID GELS (bismuth subsalicylate 262 mg oral capsule) CHURCH & DWIGHT CANADA CORP,Active,9014533,bismuth subsalicylate 262 mg oral capsule,8001705,bismuth subsalicylate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
42395,Marketed,1998-05-26,02097079,Pepto-Bismol,1,A07BB,Bismuth preparations,Suspension,Oral,02097079,PEPTO-BISMOL (bismuth subsalicylate 17.5 mg per mL oral suspension) PROCTER & GAMBLE INC,Active,9013035,bismuth subsalicylate 17.5 mg per mL oral suspension,8001705,bismuth subsalicylate,26643006,Oral,385024007,Oral suspension,,,,,,Non-Prescription Drugs
42736,Marketed,1998-05-26,02177994,Pepto Bismol Caplet - 262 mg/Caplet,1,A07BB,Bismuth preparations,Tablet,Oral,02177994,PEPTO BISMOL CAPLET - 262MG/CAPLET (bismuth subsalicylate 262 mg oral tablet) PROCTER & GAMBLE INC,Active,9003011,bismuth subsalicylate 262 mg oral tablet,8001705,bismuth subsalicylate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
47656,Marketed,2015-01-23,02229668,Pepto-Bismol Extra,1,A07BB,Bismuth preparations,Suspension,Oral,02229668,PEPTO-BISMOL EXTRA (bismuth subsalicylate 35 mg per mL oral suspension) PROCTER & GAMBLE INC,Active,9003541,bismuth subsalicylate 35 mg per mL oral suspension,8001705,bismuth subsalicylate,26643006,Oral,385024007,Oral suspension,,,,,,Non-Prescription Drugs
79869,Marketed,2021-11-05,02313162,Bismuth Subsalicylate Suspension,1,A07BB,Bismuth preparations,Suspension,Oral,02313162,BISMUTH SUBSALICYLATE SUSPENSION (bismuth subsalicylate 17.5 mg per mL oral suspension) GUARDIAN DRUG COMPANY INC,Active,9013035,bismuth subsalicylate 17.5 mg per mL oral suspension,8001705,bismuth subsalicylate,26643006,Oral,385024007,Oral suspension,,,,,,Non-Prescription Drugs
81194,Marketed,2010-02-01,02326582,Bismuth Subsalicylate Caplets,1,A07BB,Bismuth preparations,Tablet,Oral,02326582,BISMUTH SUBSALICYLATE CAPLETS (bismuth subsalicylate 262 mg oral tablet) GUARDIAN DRUG COMPANY INC,Active,9003011,bismuth subsalicylate 262 mg oral tablet,8001705,bismuth subsalicylate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
81398,Marketed,2022-03-03,02328453,Extra Strength Bismuth Subsalicylate Suspension,1,A07BB,Bismuth preparations,Suspension,Oral,02328453,EXTRA STRENGTH BISMUTH SUBSALICYLATE SUSPENSION (bismuth subsalicylate 35 mg per mL oral suspension) GUARDIAN DRUG COMPANY INC,Active,9003541,bismuth subsalicylate 35 mg per mL oral suspension,8001705,bismuth subsalicylate,26643006,Oral,385024007,Oral suspension,,,,,,Non-Prescription Drugs
94421,Marketed,2018-09-28,02457121,Bismuth Caplets,1,A07BB,Bismuth preparations,Tablet,Oral,02457121,BISMUTH CAPLETS (bismuth subsalicylate 262 mg oral tablet) JUNO OTC INC,Active,9003011,bismuth subsalicylate 262 mg oral tablet,8001705,bismuth subsalicylate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
95706,Marketed,2018-07-17,02468646,Regular Strength Bismuth,1,A07BB,Bismuth preparations,Suspension,Oral,02468646,REGULAR STRENGTH BISMUTH (bismuth subsalicylate 17.5 mg per mL oral suspension) JUNO OTC INC,Active,9013035,bismuth subsalicylate 17.5 mg per mL oral suspension,8001705,bismuth subsalicylate,26643006,Oral,385024007,Oral suspension,,,,,,Non-Prescription Drugs
96658,Marketed,2020-09-11,02475855,Extra Strength Bismuth,1,A07BB,Bismuth preparations,Suspension,Oral,02475855,EXTRA STRENGTH BISMUTH (bismuth subsalicylate 35 mg per mL oral suspension) JUNO OTC INC,Active,9003541,bismuth subsalicylate 35 mg per mL oral suspension,8001705,bismuth subsalicylate,26643006,Oral,385024007,Oral suspension,,,,,,Non-Prescription Drugs
98971,Marketed,2021-03-15,02499991,Pepto Bismol Liquicaps,1,A07BB,Bismuth preparations,Capsule,Oral,02499991,PEPTO BISMOL LIQUICAPS (bismuth subsalicylate 262 mg oral capsule) PROCTER & GAMBLE INC,Active,9014533,bismuth subsalicylate 262 mg oral capsule,8001705,bismuth subsalicylate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
71189,Marketed,2025-12-11,02246962,Pylera,3,A02BD08,"Bismuth subcitrate,tetracycline and metronidazole",Capsule,Oral,02246962,PYLERA (bismuth oxide (bismuth subcitrate potassium) 40 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule) LABORATOIRES JUVISE PHARMACEUTICALS,Active,9015293,bismuth oxide (bismuth subcitrate potassium) 40 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule,8002563,bismuth oxide and metronidazole and tetracycline,26643006,Oral,420692007,Oral capsule,732937005,Capsule,,,,Prescription
100809,Marketed,2022-03-18,02518791,JAMP Bisoprolol,1,C07AB07,Bisoprolol,Tablet,Oral,02518791,JAMP BISOPROLOL (bisoprolol fumarate 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001020,bisoprolol fumarate 10 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100810,Marketed,2022-03-18,02518805,JAMP Bisoprolol,1,C07AB07,Bisoprolol,Tablet,Oral,02518805,JAMP BISOPROLOL (bisoprolol fumarate 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001021,bisoprolol fumarate 5 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101037,Marketed,2022-03-18,02521156,AG-Bisoprolol,1,C07AB07,Bisoprolol,Tablet,Oral,02521156,AG-BISOPROLOL (bisoprolol fumarate 5 mg oral tablet) ANGITA PHARMA INC.,Active,9001021,bisoprolol fumarate 5 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101038,Marketed,2022-03-18,02521164,AG-Bisoprolol,1,C07AB07,Bisoprolol,Tablet,Oral,02521164,AG-BISOPROLOL (bisoprolol fumarate 10 mg oral tablet) ANGITA PHARMA INC.,Active,9001020,bisoprolol fumarate 10 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103004,Marketed,2025-11-25,02541394,PRZ-Bisoprolol,1,C07AB07,Bisoprolol,Tablet,Oral,02541394,PRZ-BISOPROLOL (bisoprolol fumarate 5 mg oral tablet) PHARMARIS CANADA INC,Active,9001021,bisoprolol fumarate 5 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103006,Marketed,2025-11-25,02541408,PRZ-Bisoprolol,1,C07AB07,Bisoprolol,Tablet,Oral,02541408,PRZ-BISOPROLOL (bisoprolol fumarate 10 mg oral tablet) PHARMARIS CANADA INC,Active,9001020,bisoprolol fumarate 10 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103278,Marketed,2024-06-11,02544245,Sandoz Bisoprolol Tablets,1,C07AB07,Bisoprolol,Tablet,Oral,02544245,SANDOZ BISOPROLOL TABLETS (bisoprolol fumarate 1.25 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9015049,bisoprolol fumarate 1.25 mg oral tablet,8000325,bisoprolol,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),,,,Prescription
103279,Marketed,2024-06-11,02544253,Sandoz Bisoprolol Tablets,1,C07AB07,Bisoprolol,Tablet,Oral,02544253,SANDOZ BISOPROLOL TABLETS (bisoprolol fumarate 2.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9015050,bisoprolol fumarate 2.5 mg oral tablet,8000325,bisoprolol,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),,,,Prescription
106179,Marketed,2026-05-12,02558556,NB-Bisoprolol Tablets,1,C07AB07,Bisoprolol,Tablet,Oral,02558556,NB-BISOPROLOL TABLETS (bisoprolol fumarate 5 mg oral tablet) NB PHARMA INC.,Active,9001021,bisoprolol fumarate 5 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106180,Marketed,2026-05-12,02558564,NB-Bisoprolol Tablets,1,C07AB07,Bisoprolol,Tablet,Oral,02558564,NB-BISOPROLOL TABLETS (bisoprolol fumarate 10 mg oral tablet) NB PHARMA INC.,Active,9001020,bisoprolol fumarate 10 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74136,Marketed,2004-08-10,02256134,Apo-Bisoprolol,1,C07AB07,Bisoprolol,Tablet,Oral,02256134,APO-BISOPROLOL (bisoprolol fumarate 5 mg oral tablet) APOTEX INC,Active,9001021,bisoprolol fumarate 5 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74140,Marketed,2004-08-10,02256177,Apo-Bisoprolol,1,C07AB07,Bisoprolol,Tablet,Oral,02256177,APO-BISOPROLOL (bisoprolol fumarate 10 mg oral tablet) APOTEX INC,Active,9001020,bisoprolol fumarate 10 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75288,Marketed,2013-12-17,02267470,Teva-Bisoprolol,1,C07AB07,Bisoprolol,Tablet,Oral,02267470,TEVA-BISOPROLOL (bisoprolol fumarate 5 mg oral tablet) TEVA CANADA LIMITED,Active,9001021,bisoprolol fumarate 5 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75289,Marketed,2013-12-17,02267489,Teva-Bisoprolol,1,C07AB07,Bisoprolol,Tablet,Oral,02267489,TEVA-BISOPROLOL (bisoprolol fumarate 10 mg oral tablet) TEVA CANADA LIMITED,Active,9001020,bisoprolol fumarate 10 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79267,Marketed,2008-07-04,02306999,Pro-Bisoprolol - 5,1,C07AB07,Bisoprolol,Tablet,Oral,02306999,PRO-BISOPROLOL - 5 (bisoprolol fumarate 5 mg oral tablet) PRO DOC LIMITEE,Active,9001021,bisoprolol fumarate 5 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79268,Marketed,2008-07-04,02307006,Pro-Bisoprolol - 10,1,C07AB07,Bisoprolol,Tablet,Oral,02307006,PRO-BISOPROLOL - 10 (bisoprolol fumarate 10 mg oral tablet) PRO DOC LIMITEE,Active,9001020,bisoprolol fumarate 10 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87691,Marketed,2020-08-27,02391589,Bisoprolol,1,C07AB07,Bisoprolol,Tablet,Oral,02391589,BISOPROLOL (bisoprolol fumarate 5 mg oral tablet) SANIS HEALTH INC,Active,9001021,bisoprolol fumarate 5 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87692,Marketed,2020-08-27,02391597,Bisoprolol,1,C07AB07,Bisoprolol,Tablet,Oral,02391597,BISOPROLOL (bisoprolol fumarate 10 mg oral tablet) SANIS HEALTH INC,Active,9001020,bisoprolol fumarate 10 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95384,Marketed,2019-02-05,02465612,Mint-Bisoprolol,1,C07AB07,Bisoprolol,Tablet,Oral,02465612,MINT-BISOPROLOL (bisoprolol fumarate 5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001021,bisoprolol fumarate 5 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95385,Marketed,2019-02-05,02465620,Mint-Bisoprolol,1,C07AB07,Bisoprolol,Tablet,Oral,02465620,MINT-BISOPROLOL (bisoprolol fumarate 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001020,bisoprolol fumarate 10 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98405,Marketed,2019-11-27,02494035,Sandoz Bisoprolol Tablets,1,C07AB07,Bisoprolol,Tablet,Oral,02494035,SANDOZ BISOPROLOL TABLETS (bisoprolol fumarate 5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001021,bisoprolol fumarate 5 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98406,Marketed,2019-11-27,02494043,Sandoz Bisoprolol Tablets,1,C07AB07,Bisoprolol,Tablet,Oral,02494043,SANDOZ BISOPROLOL TABLETS (bisoprolol fumarate 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001020,bisoprolol fumarate 10 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98546,Marketed,2024-12-24,02495562,Bisoprolol Tablets,1,C07AB07,Bisoprolol,Tablet,Oral,02495562,BISOPROLOL TABLETS (bisoprolol fumarate 5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001021,bisoprolol fumarate 5 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98547,Marketed,2024-12-24,02495570,Bisoprolol Tablets,1,C07AB07,Bisoprolol,Tablet,Oral,02495570,BISOPROLOL TABLETS (bisoprolol fumarate 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001020,bisoprolol fumarate 10 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100065,Marketed,2023-05-01,02511452,Bivalirudin For Injection,1,B01AE06,Bivalirudin,Powder for solution,Intravenous,02511452,BIVALIRUDIN FOR INJECTION (bivalirudin 250 mg per vial powder for solution for injection) JUNO PHARMACEUTICALS CORP.,Active,9012784,bivalirudin 250 mg per vial powder for solution for injection,8001441,bivalirudin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
102833,Marketed,2024-09-10,02539586,Bivalirudin For Injection,1,B01AE06,Bivalirudin,Powder for solution,Intravenous,02539586,BIVALIRUDIN FOR INJECTION (bivalirudin 250 mg per vial powder for solution for injection) FORMATIVE PHARMA INC.,Active,9012784,bivalirudin 250 mg per vial powder for solution for injection,8001441,bivalirudin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
70715,Marketed,2016-09-29,02246533,Angiomax,1,B01AE06,Bivalirudin,Powder for solution,Intravenous,02246533,ANGIOMAX (bivalirudin 250 mg per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9012784,bivalirudin 250 mg per vial powder for solution for injection,8001441,bivalirudin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
91953,Marketed,2019-04-23,02435268,Bivalirudin For Injection,1,B01AE06,Bivalirudin,Powder for solution,Intravenous,02435268,BIVALIRUDIN FOR INJECTION (bivalirudin 250 mg per vial powder for solution for injection) FRESENIUS KABI CANADA LTD,Active,9012784,bivalirudin 250 mg per vial powder for solution for injection,8001441,bivalirudin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
99489,Marketed,2021-03-05,02505517,Bivalirudin Injection,1,B01AE06,Bivalirudin,Solution,Intravenous,02505517,BIVALIRUDIN INJECTION (bivalirudin 250 mg per 50 mL solution for injection vial) AVIR PHARMA INC.,Active,9014474,bivalirudin 250 mg per 50 mL solution for injection vial,8001441,bivalirudin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
43892,Marketed,2017-08-08,02131692,Bleomycin For Injection USP,1,L01DC01,Bleomycin,Powder for solution,"Intramuscular,Intravenous,Intracavitary,Subcutaneous,Intra-arterial",02131692,BLEOMYCIN FOR INJECTION USP (bleomycin (bleomycin sulfate) 15 unit per vial powder for solution for injection) PFIZER CANADA ULC,Active,9003230,bleomycin (bleomycin sulfate) 15 unit per vial powder for solution for injection,8001591,bleomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
75142,Marketed,2016-08-25,02265982,Bleomycin For Injection,1,L01DC01,Bleomycin,Powder for solution,"Intramuscular,Intravenous,Subcutaneous,Intrapleural",02265982,BLEOMYCIN FOR INJECTION (bleomycin (bleomycin sulfate) 15 unit per vial powder for solution for injection) FRESENIUS KABI CANADA LTD,Active,9003230,bleomycin (bleomycin sulfate) 15 unit per vial powder for solution for injection,8001591,bleomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
93642,Marketed,2016-03-17,02450283,Blincyto,1,L01FX07,Blinatumomab,Powder for solution,Intravenous,02450283,BLINCYTO (blinatumomab 38.5 mcg per vial powder for solution for injection with solution stabilizer) AMGEN CANADA INC,Active,9012913,blinatumomab 38.5 mcg per vial powder for solution for injection with solution stabilizer,8001592,blinatumomab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
93642,Marketed,2016-03-17,02450283,Blincyto,1,L01FX07,Blinatumomab,Powder for solution,Intravenous,02450283,BLINCYTO (blinatumomab 38.5 mcg per vial powder for solution for injection with solution stabilizer) AMGEN CANADA INC,Active,9012913,blinatumomab 38.5 mcg per vial powder for solution for injection with solution stabilizer,8001592,blinatumomab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
75541,Marketed,2012-05-31,02270013,Octaplasma,1,B05AX03,Blood plasma,Solution,Intravenous,,,,,,,,,,,,,,,,,Schedule D
101888,Marketed,2023-10-31,02529637,"Anticoagulant Sodium Citrate Solution, USP",1,V07AC,"Blood transfusion, auxiliary products",Solution,Extracorporeal,02529637,"ANTICOAGULANT SODIUM CITRATE SOLUTION, USP (sodium citrate 4 g per 100 mL anticoagulant and preservative solution for blood) FRESENIUS KABI CANADA LTD",Active,9012862,sodium citrate 4 g per 100 mL anticoagulant and preservative solution for blood,8000852,sodium citrate,738984000,Parenteral,739006009,Solution,,,,,,Ethical
10497,Marketed,1990-12-31,00060313,Anticoagulant Sod Citrate Soltn 4 g/100 mL,1,V07AC,"Blood transfusion, auxiliary products",Solution,Extracorporeal,00060313,ANTICOAGULANT SOD CITRATE SOLTN 4GM/100ML (sodium citrate 4 g per 100 mL anticoagulant and preservative solution for blood) BAXTER CORPORATION,Active,9012862,sodium citrate 4 g per 100 mL anticoagulant and preservative solution for blood,8000852,sodium citrate,738984000,Parenteral,739006009,Solution,,,,,,Ethical
11330,Marketed,2018-09-19,00783668,Glycerolyte 57 Solution,5,V07AC,"Blood transfusion, auxiliary products",Solution,0-unassigned,00783668,GLYCEROLYTE 57 SOLUTION (glycerin 57 g per 100 mL and potassium chloride 30 mg per 100 mL and sodium lactate 1.6 g per 100 mL and sodium phosphate dibasic 124.2 mg per 100 mL and sodium phosphate monobasic 51.7 mg per 100 mL anticoagulant and preservative solution for blood) FRESENIUS KABI AG,Active,9013567,glycerin 57 g per 100 mL and potassium chloride 30 mg per 100 mL and sodium lactate 1.6 g per 100 mL and sodium phosphate dibasic 124.2 mg per 100 mL and sodium phosphate monobasic 51.7 mg per 100 mL anticoagulant and preservative solution for blood,8002126,glycerin and potassium chloride and sodium lactate and sodium phosphate dibasic and sodium phosphate monobasic,738984000,Parenteral,739006009,Solution,,,,,,Ethical
11376,Marketed,2018-03-28,00788139,Anticoagulant Citrate Dextrose Solution USP (ACD) Formula A,3,V07AC,"Blood transfusion, auxiliary products",Solution,Extracorporeal,,,,,,,,,,,,,,,,,Ethical
12168,Marketed,1991-12-31,00783625,12% Sodium Chlordie Processing Solution,1,V07AC,"Blood transfusion, auxiliary products",Solution,0-unassigned,,,,,,,,,,,,,,,,,Ethical
12171,Marketed,1991-12-31,00783641,Dextrose 0.2% And 0.9% Sod Chlor Solution,2,V07AC,"Blood transfusion, auxiliary products",Solution,Irrigation,,,,,,,,,,,,,,,,,Ethical
86313,Marketed,2024-06-11,02377411,"Anticoagulant Sodium Citrate 4% W/V Solution, USP",1,V07AC,"Blood transfusion, auxiliary products",Solution,Extracorporeal,02377411,"ANTICOAGULANT SODIUM CITRATE 4% W/V SOLUTION, USP (sodium citrate dihydrate 4 g per 100 mL anticoagulant and preservative solution for blood) BAXTER CORPORATION",Active,9012862,sodium citrate 4 g per 100 mL anticoagulant and preservative solution for blood,8000852,sodium citrate,738984000,Parenteral,739006009,Solution,,,,,,Ethical
87250,Marketed,2013-01-20,02386925,Sag-M,4,V07AC,"Blood transfusion, auxiliary products",Solution,Extracorporeal,,,,,,,,,,,,,,,,,Ethical
92892,Marketed,2016-08-22,02444097,Additive Solution Sodium Adenine Glucose Mannitol (Sagm),4,V07AC,"Blood transfusion, auxiliary products",Solution,Extracorporeal,,,,,,,,,,,,,,,,,Ethical
92893,Marketed,2016-08-22,02444100,Anticoagulant Solution Citrate Phosphate Dextrose (CPD),4,V07AC,"Blood transfusion, auxiliary products",Solution,Extracorporeal,,,,,,,,,,,,,,,,,Ethical
95858,Marketed,2018-06-20,02469731,Anticoagulant Citrate Dextrose Solution USP (ACD) Formula A,3,V07AC,"Blood transfusion, auxiliary products",Solution,Extracorporeal,,,,,,,,,,,,,,,,,Ethical
98197,Marketed,2021-11-05,02492067,SSP+,7,V07AC,"Blood transfusion, auxiliary products",Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
98207,Marketed,2022-12-18,02492075,SSP+,7,V07AC,"Blood transfusion, auxiliary products",Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
100110,Marketed,2022-07-18,02511932,Taro-Bortezomib,1,L01XG01,Bortezomib,Powder for solution,"Subcutaneous,Intravenous",02511932,TARO-BORTEZOMIB (bortezomib (bortezomib mannitol boronic ester) 2.5 mg per vial powder for solution for injection) TARO PHARMACEUTICALS INC,Active,9014320,bortezomib (bortezomib mannitol boronic ester) 2.5 mg per vial powder for solution for injection,8001593,bortezomib,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
103888,Marketed,2025-07-21,02550075,Bortezomib Injection,1,L01XG01,Bortezomib,Solution,"Subcutaneous,Intravenous",77701191,BORTEZOMIB INJECTION (bortezomib (bortezomib mannitol boronic ester) 2.5 mg per 1 mL solution for injection vial) DR REDDY'S LABORATORIES LTD,Active,9015246,bortezomib (bortezomib mannitol boronic ester) 2.5 mg per 1 mL solution for injection vial,8001593,bortezomib,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,1.0,,,Prescription
103888,Marketed,2025-07-21,02550075,Bortezomib Injection,1,L01XG01,Bortezomib,Solution,"Subcutaneous,Intravenous",77701192,BORTEZOMIB INJECTION (bortezomib (bortezomib mannitol boronic ester) 3.5 mg per 1.4 mL solution for injection vial) DR REDDY'S LABORATORIES LTD,Active,9015247,bortezomib (bortezomib mannitol boronic ester) 3.5 mg per 1.4 mL solution for injection vial,8001593,bortezomib,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,1.0,,,Prescription
74782,Marketed,2005-02-01,02262452,Velcade,1,L01XG01,Bortezomib,Powder for solution,"Intravenous,Subcutaneous",02262452,VELCADE (bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection) JANSSEN INC,Active,9004006,bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection,8001593,bortezomib,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
90813,Marketed,2015-05-20,02423405,Bortezomib For Injection,1,L01XG01,Bortezomib,Powder for solution,"Subcutaneous,Intravenous",02423405,BORTEZOMIB FOR INJECTION (bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection) TEVA CANADA LIMITED,Active,9004006,bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection,8001593,bortezomib,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
92278,Marketed,2020-12-30,02438399,Act Bortezomib,1,L01XG01,Bortezomib,Powder for solution,"Intravenous,Subcutaneous",02438399,ACT BORTEZOMIB (bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection) TEVA CANADA LIMITED,Active,9004006,bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection,8001593,bortezomib,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
93883,Marketed,2017-03-21,02452456,Bortezomib For Injection,1,L01XG01,Bortezomib,Powder for solution,"Subcutaneous,Intravenous",02452456,BORTEZOMIB FOR INJECTION (bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection) DR REDDY'S LABORATORIES LTD,Active,9004006,bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection,8001593,bortezomib,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
94301,Marketed,2019-03-25,02456176,Bortezomib,1,L01XG01,Bortezomib,Powder for solution,"Subcutaneous,Intravenous",02456176,BORTEZOMIB (bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection) APOTEX INC,Active,9004006,bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection,8001593,bortezomib,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
95502,Marketed,2018-06-05,02466708,PMS-Bortezomib,1,L01XG01,Bortezomib,Powder for solution,"Subcutaneous,Intravenous",02466708,PMS-BORTEZOMIB (bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection) PHARMASCIENCE INC,Active,9004006,bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection,8001593,bortezomib,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
95541,Marketed,2020-06-23,02467003,Bortezomib For Injection,1,L01XG01,Bortezomib,Powder for solution,"Subcutaneous,Intravenous",02467003,BORTEZOMIB FOR INJECTION (bortezomib (bortezomib mannitol boronic ester) 2.5 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9014320,bortezomib (bortezomib mannitol boronic ester) 2.5 mg per vial powder for solution for injection,8001593,bortezomib,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
97552,Marketed,2023-03-28,02485257,Bortezomib For Injection,1,L01XG01,Bortezomib,Powder for solution,"Intravenous,Subcutaneous",02485257,BORTEZOMIB FOR INJECTION (bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection) JUNO PHARMACEUTICALS CORP.,Active,9004006,bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection,8001593,bortezomib,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
98328,Marketed,2020-05-19,02493306,Bortezomib For Injection,1,L01XG01,Bortezomib,Powder for solution,"Intravenous,Subcutaneous",02493306,BORTEZOMIB FOR INJECTION (bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection) MARCAN PHARMACEUTICALS INC,Active,9004006,bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection,8001593,bortezomib,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
98883,Marketed,2021-04-12,02499061,Taro-Bortezomib,1,L01XG01,Bortezomib,Powder for solution,"Subcutaneous,Intravenous",02499061,TARO-BORTEZOMIB (bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection) TARO PHARMACEUTICALS INC,Active,9004006,bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection,8001593,bortezomib,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99283,Marketed,2022-01-31,02503352,Bortezomib For Injection SDZ,1,L01XG01,Bortezomib,Powder for solution,"Subcutaneous,Intravenous",02503352,BORTEZOMIB FOR INJECTION SDZ (bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9004006,bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection,8001593,bortezomib,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
68979,Marketed,2020-02-20,02244981,Tracleer,1,C02KX01,Bosentan,Tablet,Oral,02244981,TRACLEER (bosentan (bosentan monohydrate) 62.5 mg oral tablet) JANSSEN INC,Active,9012365,bosentan 62.5 mg oral tablet,8000929,bosentan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
68980,Marketed,2019-10-18,02244982,Tracleer,1,C02KX01,Bosentan,Tablet,Oral,02244982,TRACLEER (bosentan (bosentan monohydrate) 125 mg oral tablet) JANSSEN INC,Active,9012364,bosentan 125 mg oral tablet,8000929,bosentan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
86880,Marketed,2012-06-12,02383012,PMS-Bosentan,1,C02KX01,Bosentan,Tablet,Oral,02383012,PMS-BOSENTAN (bosentan (bosentan monohydrate) 62.5 mg oral tablet) PHARMASCIENCE INC,Active,9012365,bosentan 62.5 mg oral tablet,8000929,bosentan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
86881,Marketed,2012-06-12,02383020,PMS-Bosentan,1,C02KX01,Bosentan,Tablet,Oral,02383020,PMS-BOSENTAN (bosentan (bosentan monohydrate) 125 mg oral tablet) PHARMASCIENCE INC,Active,9012364,bosentan 125 mg oral tablet,8000929,bosentan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
97359,Marketed,2020-05-07,02483130,Taro-Bosentan,1,C02KX01,Bosentan,Tablet,Oral,02483130,TARO-BOSENTAN (bosentan (bosentan monohydrate) 62.5 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9012365,bosentan 62.5 mg oral tablet,8000929,bosentan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
97360,Marketed,2020-05-07,02483149,Taro-Bosentan,1,C02KX01,Bosentan,Tablet,Oral,02483149,TARO-BOSENTAN (bosentan (bosentan monohydrate) 125 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9012364,bosentan 125 mg oral tablet,8000929,bosentan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
106312,Marketed,2025-09-08,02560038,Reddy-Bosutinib,1,L01EA04,Bosutinib,Tablet,Oral,,,,,,,,,,,,,,1.0,,,Prescription
106313,Marketed,2025-09-08,02560046,Reddy-Bosutinib,1,L01EA04,Bosutinib,Tablet,Oral,,,,,,,,,,,,,,1.0,,,Prescription
90368,Marketed,2014-04-24,02419149,Bosulif,1,L01EA04,Bosutinib,Tablet,Oral,02419149,BOSULIF (bosutinib (bosutinib monohydrate) 100 mg oral tablet) PFIZER CANADA ULC,Active,9005500,bosutinib 100 mg oral tablet,8001594,bosutinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
90369,Marketed,2014-03-24,02419157,Bosulif,1,L01EA04,Bosutinib,Tablet,Oral,02419157,BOSULIF (bosutinib (bosutinib monohydrate) 500 mg oral tablet) PFIZER CANADA ULC,Active,9005476,bosutinib 500 mg oral tablet,8001594,bosutinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101740,Marketed,2024-11-08,02528142,Letybo,1,M03AX01,Botulinum toxin,Powder for solution,Intramuscular,02528142,LETYBO (letibotulinumtoxina 100 unit per vial powder for solution for injection) HUGEL CANADA INC.,Active,9014865,letibotulinumtoxina 100 unit per vial powder for solution for injection,8002469,letibotulinumtoxina,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
101740,Marketed,2024-11-08,02528142,Letybo,1,M03AX01,Botulinum toxin,Powder for solution,Intramuscular,02528142,LETYBO (letibotulinumtoxina 100 unit per vial powder for solution for injection) HUGEL CANADA INC.,Active,9014865,letibotulinumtoxina 100 unit per vial powder for solution for injection,8002469,letibotulinumtoxina,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
102069,Marketed,2023-06-20,02531577,Botox,1,M03AX01,Botulinum toxin,Powder for solution,"Intramuscular,Intradetrusorial,Intradermal",02531577,BOTOX (onabotulinumtoxinA 50 unit per vial powder for solution for injection) ABBVIE CORPORATION,Active,9014874,onabotulinumtoxinA 50 unit per vial powder for solution for injection,8002245,onabotulinumtoxinA,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
102069,Marketed,2023-06-20,02531577,Botox,1,M03AX01,Botulinum toxin,Powder for solution,"Intramuscular,Intradetrusorial,Intradermal",02531577,BOTOX (onabotulinumtoxinA 50 unit per vial powder for solution for injection) ABBVIE CORPORATION,Active,9014874,onabotulinumtoxinA 50 unit per vial powder for solution for injection,8002245,onabotulinumtoxinA,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
102070,Marketed,2023-10-11,02531585,Botox,1,M03AX01,Botulinum toxin,Powder for solution,"Intramuscular,Intradetrusorial,Intradermal",02531585,BOTOX (onabotulinumtoxinA 200 unit per vial powder for solution for injection) ABBVIE CORPORATION,Active,9014931,onabotulinumtoxinA 200 unit per vial powder for solution for injection,8002245,onabotulinumtoxinA,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
102070,Marketed,2023-10-11,02531585,Botox,1,M03AX01,Botulinum toxin,Powder for solution,"Intramuscular,Intradetrusorial,Intradermal",02531585,BOTOX (onabotulinumtoxinA 200 unit per vial powder for solution for injection) ABBVIE CORPORATION,Active,9014931,onabotulinumtoxinA 200 unit per vial powder for solution for injection,8002245,onabotulinumtoxinA,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
13476,Marketed,2023-11-13,01981501,Botox,1,M03AX01,Botulinum toxin,Powder for solution,"Intradermal,Intramuscular,Intradetrusorial",01981501,BOTOX (onabotulinumtoxinA 100 unit per vial powder for solution for injection) ABBVIE CORPORATION,Active,9013891,onabotulinumtoxinA 100 unit per vial powder for solution for injection,8002245,onabotulinumtoxinA,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
13476,Marketed,2023-11-13,01981501,Botox,1,M03AX01,Botulinum toxin,Powder for solution,"Intradermal,Intramuscular,Intradetrusorial",01981501,BOTOX (onabotulinumtoxinA 100 unit per vial powder for solution for injection) ABBVIE CORPORATION,Active,9013891,onabotulinumtoxinA 100 unit per vial powder for solution for injection,8002245,onabotulinumtoxinA,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
67653,Marketed,2023-12-06,02243721,Botox Cosmetic,1,M03AX01,Botulinum toxin,Powder for solution,Intramuscular,02243721,BOTOX COSMETIC (onabotulinumtoxinA 100 unit per vial powder for solution for injection) ABBVIE CORPORATION,Active,9013891,onabotulinumtoxinA 100 unit per vial powder for solution for injection,8002245,onabotulinumtoxinA,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
67653,Marketed,2023-12-06,02243721,Botox Cosmetic,1,M03AX01,Botulinum toxin,Powder for solution,Intramuscular,02243721,BOTOX COSMETIC (onabotulinumtoxinA 100 unit per vial powder for solution for injection) ABBVIE CORPORATION,Active,9013891,onabotulinumtoxinA 100 unit per vial powder for solution for injection,8002245,onabotulinumtoxinA,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
80952,Marketed,2021-09-23,02324032,Xeomin,1,M03AX01,Botulinum toxin,Powder for solution,"Intramuscular,Intraglandular",02324032,XEOMIN (incobotulinumtoxinA 100 unit per vial powder for solution for injection) MERZ PHARMACEUTICALS GMBH,Active,9013886,incobotulinumtoxinA 100 unit per vial powder for solution for injection,8002243,incobotulinumtoxinA,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
80952,Marketed,2021-09-23,02324032,Xeomin,1,M03AX01,Botulinum toxin,Powder for solution,"Intramuscular,Intraglandular",02324032,XEOMIN (incobotulinumtoxinA 100 unit per vial powder for solution for injection) MERZ PHARMACEUTICALS GMBH,Active,9013886,incobotulinumtoxinA 100 unit per vial powder for solution for injection,8002243,incobotulinumtoxinA,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
85628,Marketed,2021-07-16,02371081,Xeomin,1,M03AX01,Botulinum toxin,Powder for solution,"Intraglandular,Intramuscular",02371081,XEOMIN (incobotulinumtoxinA 50 unit per vial powder for solution for injection) MERZ PHARMACEUTICALS GMBH,Active,9013887,incobotulinumtoxinA 50 unit per vial powder for solution for injection,8002243,incobotulinumtoxinA,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
85628,Marketed,2021-07-16,02371081,Xeomin,1,M03AX01,Botulinum toxin,Powder for solution,"Intraglandular,Intramuscular",02371081,XEOMIN (incobotulinumtoxinA 50 unit per vial powder for solution for injection) MERZ PHARMACEUTICALS GMBH,Active,9013887,incobotulinumtoxinA 50 unit per vial powder for solution for injection,8002243,incobotulinumtoxinA,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
86922,Marketed,2012-07-05,02383489,Xeomin Cosmetic,1,M03AX01,Botulinum toxin,Powder for solution,Intramuscular,02383489,XEOMIN COSMETIC (incobotulinumtoxinA 100 unit per vial powder for solution for injection) MERZ PHARMACEUTICALS GMBH,Active,9013886,incobotulinumtoxinA 100 unit per vial powder for solution for injection,8002243,incobotulinumtoxinA,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
86922,Marketed,2012-07-05,02383489,Xeomin Cosmetic,1,M03AX01,Botulinum toxin,Powder for solution,Intramuscular,02383489,XEOMIN COSMETIC (incobotulinumtoxinA 100 unit per vial powder for solution for injection) MERZ PHARMACEUTICALS GMBH,Active,9013886,incobotulinumtoxinA 100 unit per vial powder for solution for injection,8002243,incobotulinumtoxinA,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
87332,Marketed,2021-12-03,02387735,Dysport Aesthetic,1,M03AX01,Botulinum toxin,Powder for solution,Intramuscular,02387735,DYSPORT AESTHETIC (abobotulinumtoxinA 300 unit per vial powder for solution for injection) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9013842,abobotulinumtoxinA 300 unit per vial powder for solution for injection,8002234,abobotulinumtoxinA,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
87332,Marketed,2021-12-03,02387735,Dysport Aesthetic,1,M03AX01,Botulinum toxin,Powder for solution,Intramuscular,02387735,DYSPORT AESTHETIC (abobotulinumtoxinA 300 unit per vial powder for solution for injection) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9013842,abobotulinumtoxinA 300 unit per vial powder for solution for injection,8002234,abobotulinumtoxinA,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
94296,Marketed,2022-04-06,02456117,Dysport Therapeutic,1,M03AX01,Botulinum toxin,Powder for solution,Intramuscular,02456117,DYSPORT THERAPEUTIC (abobotulinumtoxinA 500 unit per vial powder for solution for injection) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9013843,abobotulinumtoxinA 500 unit per vial powder for solution for injection,8002234,abobotulinumtoxinA,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
94296,Marketed,2022-04-06,02456117,Dysport Therapeutic,1,M03AX01,Botulinum toxin,Powder for solution,Intramuscular,02456117,DYSPORT THERAPEUTIC (abobotulinumtoxinA 500 unit per vial powder for solution for injection) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9013843,abobotulinumtoxinA 500 unit per vial powder for solution for injection,8002234,abobotulinumtoxinA,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
94749,Marketed,2022-04-06,02460203,Dysport Therapeutic,1,M03AX01,Botulinum toxin,Powder for solution,Intramuscular,02460203,DYSPORT THERAPEUTIC (abobotulinumtoxinA 300 unit per vial powder for solution for injection) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9013842,abobotulinumtoxinA 300 unit per vial powder for solution for injection,8002234,abobotulinumtoxinA,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
94749,Marketed,2022-04-06,02460203,Dysport Therapeutic,1,M03AX01,Botulinum toxin,Powder for solution,Intramuscular,02460203,DYSPORT THERAPEUTIC (abobotulinumtoxinA 300 unit per vial powder for solution for injection) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9013842,abobotulinumtoxinA 300 unit per vial powder for solution for injection,8002234,abobotulinumtoxinA,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
97069,Marketed,2019-10-16,02480158,Nuceiva,1,M03AX01,Botulinum toxin,Powder for solution,Intramuscular,02480158,NUCEIVA (prabotulinumtoxinA 100 unit per vial powder for solution for injection) EVOLUS INCORPORATED,Active,9014262,prabotulinumtoxinA 100 unit per vial powder for solution for injection,8002321,prabotulinumtoxinA,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
97069,Marketed,2019-10-16,02480158,Nuceiva,1,M03AX01,Botulinum toxin,Powder for solution,Intramuscular,02480158,NUCEIVA (prabotulinumtoxinA 100 unit per vial powder for solution for injection) EVOLUS INCORPORATED,Active,9014262,prabotulinumtoxinA 100 unit per vial powder for solution for injection,8002321,prabotulinumtoxinA,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
88626,Marketed,2025-10-09,02401347,Adcetris,1,L01FX05,Brentuximab vedotin,Powder for solution,Intravenous,02401347,ADCETRIS (brentuximab vedotin 50 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9005187,brentuximab vedotin 50 mg per vial powder for solution for injection,8001595,brentuximab vedotin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
88626,Marketed,2025-10-09,02401347,Adcetris,1,L01FX05,Brentuximab vedotin,Powder for solution,Intravenous,02401347,ADCETRIS (brentuximab vedotin 50 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9005187,brentuximab vedotin 50 mg per vial powder for solution for injection,8001595,brentuximab vedotin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
94950,Marketed,2017-04-19,02461749,Rexulti,1,N05AX16,Brexpiprazole,Tablet,Oral,02461749,REXULTI (brexpiprazole 0.25 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9006153,brexpiprazole 0.25 mg oral tablet,8001597,brexpiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94951,Marketed,2017-04-19,02461757,Rexulti,1,N05AX16,Brexpiprazole,Tablet,Oral,02461757,REXULTI (brexpiprazole 0.5 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9006154,brexpiprazole 0.5 mg oral tablet,8001597,brexpiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94952,Marketed,2017-04-19,02461765,Rexulti,1,N05AX16,Brexpiprazole,Tablet,Oral,02461765,REXULTI (brexpiprazole 1 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9006155,brexpiprazole 1 mg oral tablet,8001597,brexpiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94953,Marketed,2017-04-19,02461773,Rexulti,1,N05AX16,Brexpiprazole,Tablet,Oral,02461773,REXULTI (brexpiprazole 2 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9006156,brexpiprazole 2 mg oral tablet,8001597,brexpiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94954,Marketed,2017-04-19,02461781,Rexulti,1,N05AX16,Brexpiprazole,Tablet,Oral,02461781,REXULTI (brexpiprazole 3 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9006157,brexpiprazole 3 mg oral tablet,8001597,brexpiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94955,Marketed,2017-04-19,02461803,Rexulti,1,N05AX16,Brexpiprazole,Tablet,Oral,02461803,REXULTI (brexpiprazole 4 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9006158,brexpiprazole 4 mg oral tablet,8001597,brexpiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100600,Marketed,2021-12-16,02516667,Tecartus,1,L01XL06,Brexucabtagene autoleucel,Suspension,Intravenous,,,,,,,,,,,,,,,,,Schedule D
100600,Marketed,2021-12-16,02516667,Tecartus,1,L01XL06,Brexucabtagene autoleucel,Suspension,Intravenous,,,,,,,,,,,,,,,,,Prescription
102173,Marketed,2023-12-15,02532719,Tecartus,1,L01XL06,Brexucabtagene autoleucel,Suspension,Intravenous,,,,,,,,,,,,,,,,,Prescription
102173,Marketed,2023-12-15,02532719,Tecartus,1,L01XL06,Brexucabtagene autoleucel,Suspension,Intravenous,,,,,,,,,,,,,,,,,Schedule D
96982,Marketed,2018-08-31,02479206,Alunbrig,1,L01ED04,Brigatinib,Tablet,Oral,02479206,ALUNBRIG (brigatinib 30 mg oral tablet) TAKEDA CANADA INC,Active,9013411,brigatinib 30 mg oral tablet,8002014,brigatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
96983,Marketed,2018-08-31,02479214,Alunbrig,1,L01ED04,Brigatinib,Tablet,Oral,02479214,ALUNBRIG (brigatinib 90 mg oral tablet) TAKEDA CANADA INC,Active,9013412,brigatinib 90 mg oral tablet,8002014,brigatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
96984,Marketed,2018-08-31,02479222,Alunbrig,1,L01ED04,Brigatinib,Tablet,Oral,02479222,ALUNBRIG (brigatinib 180 mg oral tablet) TAKEDA CANADA INC,Active,9013410,brigatinib 180 mg oral tablet,8002014,brigatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
96985,Marketed,2018-08-31,02479230,Alunbrig,2,L01ED04,Brigatinib,"Tablet,Kit",Oral,02479230,ALUNBRIG (brigatinib 90 mg oral tablet with brigatinib 180 mg oral tablet) TAKEDA CANADA INC,Active,9013413,brigatinib 90 mg oral tablet with brigatinib 180 mg oral tablet,8002014,brigatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100474,Marketed,2021-07-20,02515350,Riva-Brimonidine,1,S01EA05,Brimonidine,Solution,Ophthalmic,02515350,RIVA-BRIMONIDINE (brimonidine tartrate 0.2 % ophthalmic drops) LABORATOIRE RIVA INC.,Active,9003188,brimonidine tartrate 0.2 % ophthalmic drops,8001103,brimonidine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
100476,Marketed,2023-05-31,02515377,Brimonidine Tartrate Ophthalmic Solution,1,S01EA05,Brimonidine,Solution,Ophthalmic,02515377,BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION (brimonidine tartrate 0.2 % ophthalmic drops) HIKMA CANADA LIMITED,Active,9003188,brimonidine tartrate 0.2 % ophthalmic drops,8001103,brimonidine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
100706,Marketed,2022-07-05,02517698,Lumify,1,S01EA05,Brimonidine,Solution,Ophthalmic,02517698,LUMIFY (brimonidine tartrate 0.025 % ophthalmic drops) BAUSCH & LOMB INC,Active,9014731,brimonidine tartrate 0.025 % ophthalmic drops,8001103,brimonidine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
60166,Marketed,2024-03-27,02236876,Alphagan,1,S01EA05,Brimonidine,Solution,Ophthalmic,02236876,ALPHAGAN (brimonidine tartrate 0.2 % ophthalmic drops) ABBVIE CORPORATION,Active,9003188,brimonidine tartrate 0.2 % ophthalmic drops,8001103,brimonidine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
72483,Marketed,2023-11-28,02248151,Alphagan P,1,S01EA05,Brimonidine,Solution,Ophthalmic,02248151,ALPHAGAN P (brimonidine tartrate 0.15 % ophthalmic drops) ABBVIE CORPORATION,Active,9003838,brimonidine tartrate 0.15 % ophthalmic drops,8001103,brimonidine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
78666,Marketed,2021-10-20,02301334,Brimonidine P,1,S01EA05,Brimonidine,Solution,Ophthalmic,02301334,BRIMONIDINE P (brimonidine tartrate 0.15 % ophthalmic drops) AA PHARMA INC,Active,9003838,brimonidine tartrate 0.15 % ophthalmic drops,8001103,brimonidine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
79097,Marketed,2008-02-08,02305429,Sandoz Brimonidine,1,S01EA05,Brimonidine,Solution,Ophthalmic,02305429,SANDOZ BRIMONIDINE (brimonidine tartrate 0.2 % ophthalmic drops) SANDOZ CANADA INCORPORATED,Active,9003188,brimonidine tartrate 0.2 % ophthalmic drops,8001103,brimonidine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
90580,Marketed,2014-03-24,02421208,Onreltea,1,D11AX21,Brimonidine,Gel,Topical,02421208,ONRELTEA (brimonidine (brimonidine tartrate) 0.33 % cutaneous gel) GALDERMA CANADA INC.,Active,9005477,brimonidine (brimonidine tartrate) 0.33 % cutaneous gel,8001103,brimonidine,448598008,Cutaneous,385100002,Gel,,,,,,Prescription
93504,Marketed,2026-01-21,02449226,JAMP Brimonidine,1,S01EA05,Brimonidine,Solution,Ophthalmic,02449226,JAMP BRIMONIDINE (brimonidine tartrate 0.2 % ophthalmic drops) JAMP PHARMA CORPORATION,Active,9003188,brimonidine tartrate 0.2 % ophthalmic drops,8001103,brimonidine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
99720,Marketed,2021-11-26,02507811,Med-Brimonidine,1,S01EA05,Brimonidine,Solution,Ophthalmic,02507811,MED-BRIMONIDINE (brimonidine tartrate 0.2 % ophthalmic drops) GENERIC MEDICAL PARTNERS INC,Active,9003188,brimonidine tartrate 0.2 % ophthalmic drops,8001103,brimonidine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
103227,Marketed,2026-03-10,02543842,Tembexa,1,J05AB17,Brincidofovir,Tablet,Oral,,,,,,,,,,,,,,1.0,,,Prescription Recommended
62313,Marketed,2018-03-14,02238873,Azopt,1,S01EC04,Brinzolamide,Suspension,Ophthalmic,02238873,AZOPT (brinzolamide 1 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012376,brinzolamide 1 % ophthalmic drops,8001100,brinzolamide,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
91973,Marketed,2018-04-18,02435411,Simbrinza,2,S01EC54,"Brinzolamide, combinations",Suspension,Ophthalmic,02435411,SIMBRINZA (brimonidine tartrate 0.2 % and brinzolamide 1 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012401,brimonidine tartrate 0.2 % and brinzolamide 1 % ophthalmic drops,8001127,brimonidine and brinzolamide,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
102737,Marketed,2024-09-10,02538679,Apo-Brivaracetam,1,N03AX23,Brivaracetam,Tablet,Oral,02538679,APO-BRIVARACETAM (brivaracetam 10 mg oral tablet) APOTEX INC,Active,9005956,brivaracetam 10 mg oral tablet,8001598,brivaracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102739,Marketed,2024-09-10,02538687,Apo-Brivaracetam,1,N03AX23,Brivaracetam,Tablet,Oral,02538687,APO-BRIVARACETAM (brivaracetam 25 mg oral tablet) APOTEX INC,Active,9005957,brivaracetam 25 mg oral tablet,8001598,brivaracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102740,Marketed,2024-09-10,02538695,Apo-Brivaracetam,1,N03AX23,Brivaracetam,Tablet,Oral,02538695,APO-BRIVARACETAM (brivaracetam 50 mg oral tablet) APOTEX INC,Active,9005958,brivaracetam 50 mg oral tablet,8001598,brivaracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102741,Marketed,2024-09-10,02538709,Apo-Brivaracetam,1,N03AX23,Brivaracetam,Tablet,Oral,02538709,APO-BRIVARACETAM (brivaracetam 75 mg oral tablet) APOTEX INC,Active,9005959,brivaracetam 75 mg oral tablet,8001598,brivaracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102742,Marketed,2024-09-10,02538717,Apo-Brivaracetam,1,N03AX23,Brivaracetam,Tablet,Oral,02538717,APO-BRIVARACETAM (brivaracetam 100 mg oral tablet) APOTEX INC,Active,9005955,brivaracetam 100 mg oral tablet,8001598,brivaracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102793,Marketed,2024-09-12,02539292,Auro-Brivaracetam,1,N03AX23,Brivaracetam,Tablet,Oral,02539292,AURO-BRIVARACETAM (brivaracetam 50 mg oral tablet) AURO PHARMA INC,Active,9005958,brivaracetam 50 mg oral tablet,8001598,brivaracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102794,Marketed,2024-09-12,02539306,Auro-Brivaracetam,1,N03AX23,Brivaracetam,Tablet,Oral,02539306,AURO-BRIVARACETAM (brivaracetam 100 mg oral tablet) AURO PHARMA INC,Active,9005955,brivaracetam 100 mg oral tablet,8001598,brivaracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93933,Marketed,2016-05-02,02452936,Brivlera,1,N03AX23,Brivaracetam,Tablet,Oral,02452936,BRIVLERA (brivaracetam 10 mg oral tablet) UCB CANADA INC,Active,9005956,brivaracetam 10 mg oral tablet,8001598,brivaracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93934,Marketed,2016-05-02,02452944,Brivlera,1,N03AX23,Brivaracetam,Tablet,Oral,02452944,BRIVLERA (brivaracetam 25 mg oral tablet) UCB CANADA INC,Active,9005957,brivaracetam 25 mg oral tablet,8001598,brivaracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93935,Marketed,2016-05-02,02452952,Brivlera,1,N03AX23,Brivaracetam,Tablet,Oral,02452952,BRIVLERA (brivaracetam 50 mg oral tablet) UCB CANADA INC,Active,9005958,brivaracetam 50 mg oral tablet,8001598,brivaracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93936,Marketed,2016-05-02,02452960,Brivlera,1,N03AX23,Brivaracetam,Tablet,Oral,02452960,BRIVLERA (brivaracetam 75 mg oral tablet) UCB CANADA INC,Active,9005959,brivaracetam 75 mg oral tablet,8001598,brivaracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93937,Marketed,2016-05-02,02452979,Brivlera,1,N03AX23,Brivaracetam,Tablet,Oral,02452979,BRIVLERA (brivaracetam 100 mg oral tablet) UCB CANADA INC,Active,9005955,brivaracetam 100 mg oral tablet,8001598,brivaracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93938,Marketed,2020-04-06,02452987,Brivlera,1,N03AX23,Brivaracetam,Solution,Oral,02452987,BRIVLERA (brivaracetam 10 mg per mL oral solution) UCB CANADA INC,Active,9014263,brivaracetam 10 mg per mL oral solution,8001598,brivaracetam,26643006,Oral,385023001,Oral solution,,,,,,Prescription
93939,Marketed,2018-10-10,02452995,Brivlera,1,N03AX23,Brivaracetam,Solution,Intravenous,02452995,BRIVLERA (brivaracetam 50 mg per 5 mL solution for injection vial) UCB CANADA INC,Active,9013414,brivaracetam 50 mg per 5 mL solution for injection vial,8001598,brivaracetam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
96302,Marketed,2019-06-07,02473623,Siliq,1,L04AC12,Brodalumab,Solution,Subcutaneous,02473623,"SILIQ (brodalumab 210 mg per 1.5 mL solution for injection syringe) BAUSCH HEALTH, CANADA INC.",Active,9013415,brodalumab 210 mg per 1.5 mL solution for injection syringe,8002015,brodalumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
96302,Marketed,2019-06-07,02473623,Siliq,1,L04AC12,Brodalumab,Solution,Subcutaneous,02473623,"SILIQ (brodalumab 210 mg per 1.5 mL solution for injection syringe) BAUSCH HEALTH, CANADA INC.",Active,9013415,brodalumab 210 mg per 1.5 mL solution for injection syringe,8002015,brodalumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
98684,Marketed,2020-05-15,02496976,Beovu,1,S01LA06,Brolucizumab,Solution,Intravitreal,02496976,BEOVU (brolucizumab 6 mg per 0.05 mL solution for injection syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014322,brolucizumab 6 mg per 0.05 mL solution for injection syringe,8002331,brolucizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
19047,Marketed,2022-01-20,02177188,Apo-Bromazepam,1,N05BA08,Bromazepam,Tablet,Oral,02177188,APO-BROMAZEPAM (bromazepam 6 mg oral tablet) APOTEX INC,Active,9000165,bromazepam 6 mg oral tablet,8000090,bromazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
19056,Marketed,2022-01-20,02177161,Apo-Bromazepam,1,N05BA08,Bromazepam,Tablet,Oral,02177161,APO-BROMAZEPAM (bromazepam 3 mg oral tablet) APOTEX INC,Active,9000164,bromazepam 3 mg oral tablet,8000090,bromazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
49693,Marketed,2015-05-29,02230584,Teva-Bromazepam,1,N05BA08,Bromazepam,Tablet,Oral,02230584,TEVA-BROMAZEPAM (bromazepam 3 mg oral tablet) TEVA CANADA LIMITED,Active,9000164,bromazepam 3 mg oral tablet,8000090,bromazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
49694,Marketed,2015-05-29,02230585,Teva-Bromazepam,1,N05BA08,Bromazepam,Tablet,Oral,02230585,TEVA-BROMAZEPAM (bromazepam 6 mg oral tablet) TEVA CANADA LIMITED,Active,9000165,bromazepam 6 mg oral tablet,8000090,bromazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
102655,Marketed,2023-06-12,02537788,Apo-Bromfenac,1,S01BC11,Bromfenac,Solution,Ophthalmic,02537788,APO-BROMFENAC (bromfenac (bromfenac sodium sesquihydrate) 0.07 % ophthalmic drops) APOTEX INC,Active,9012915,bromfenac (bromfenac sodium) 0.07 % ophthalmic drops,8001599,bromfenac,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
92351,Marketed,2015-09-25,02439123,Prolensa,1,S01BC11,Bromfenac,Solution,Ophthalmic,02439123,PROLENSA (bromfenac (bromfenac sodium sesquihydrate) 0.07 % ophthalmic drops) BAUSCH & LOMB INC,Active,9012915,bromfenac (bromfenac sodium) 0.07 % ophthalmic drops,8001599,bromfenac,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
16195,Marketed,2013-01-13,02087324,Bromocriptine,1,N04BC01,Bromocriptine,Tablet,Oral,02087324,BROMOCRIPTINE (bromocriptine (bromocriptine mesylate) 2.5 mg oral tablet) AA PHARMA INC,Active,9002633,bromocriptine (bromocriptine mesylate) 2.5 mg oral tablet,8001343,bromocriptine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
49403,Marketed,2012-10-17,02230454,Bromocriptine,1,N04BC01,Bromocriptine,Capsule,Oral,02230454,BROMOCRIPTINE (bromocriptine (bromocriptine mesylate) 5 mg oral capsule) AA PHARMA INC,Active,9003041,bromocriptine (bromocriptine mesylate) 5 mg oral capsule,8001343,bromocriptine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
100305,Marketed,2021-10-19,02513854,Jorveza,1,A07EA06,Budesonide,Tablet (orally disintegrating),Oral,02513854,JORVEZA (budesonide 0.5 mg orodispersible tablet) AVIR PHARMA INC.,Active,9014606,budesonide 0.5 mg orodispersible tablet,8000134,budesonide,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
102427,Marketed,2026-03-31,02535416,Teva-Budesonide,1,R03BA02,Budesonide,Suspension,Inhalation,02535416,TEVA-BUDESONIDE (budesonide 0.5 mg per 2 mL nebulizer suspension unit dose vial) TEVA CANADA LIMITED,Active,9000404,budesonide 0.5 mg per 2 mL nebulizer suspension unit dose vial,8000134,budesonide,738984000,Parenteral,739008005,Suspension,733026001,Vial (unit of presentation),,,,Prescription
10666,Marketed,2000-11-07,00851752,Pulmicort Turbuhaler,1,R03BA02,Budesonide,Powder (metered dose),Inhalation,00851752,PULMICORT TURBUHALER (budesonide 200 mcg per actuation inhalation powder) ASTRAZENECA CANADA INC,Active,9000344,budesonide 200 mcg per actuation inhalation powder,8000134,budesonide,447694001,Respiratory tract,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
10667,Marketed,2000-10-13,00852074,Pulmicort Turbuhaler,1,R03BA02,Budesonide,Powder (metered dose),Inhalation,00852074,PULMICORT TURBUHALER (budesonide 100 mcg per actuation inhalation powder) ASTRAZENECA CANADA INC,Active,9000342,budesonide 100 mcg per actuation inhalation powder,8000134,budesonide,447694001,Respiratory tract,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
12182,Marketed,2001-03-23,00851760,Pulmicort Turbuhaler,1,R03BA02,Budesonide,Powder (metered dose),Inhalation,00851760,PULMICORT TURBUHALER (budesonide 400 mcg per actuation inhalation powder) ASTRAZENECA CANADA INC,Active,9000406,budesonide 400 mcg per actuation inhalation powder,8000134,budesonide,447694001,Respiratory tract,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
13190,Marketed,2002-12-15,01978926,Pulmicort Nebuamp 0.5 mg/mL,1,R03BA02,Budesonide,Suspension,Inhalation,01978926,PULMICORT NEBUAMP 0.5 MG/ML (budesonide 1 mg per 2 mL nebulizer suspension unit dose vial) ASTRAZENECA CANADA INC,Active,9000405,budesonide 1 mg per 2 mL nebulizer suspension unit dose vial,8000134,budesonide,738984000,Parenteral,739008005,Suspension,733026001,Vial (unit of presentation),,,,Prescription
13191,Marketed,2000-01-29,01978918,Pulmicort Nebuamp 0.25 mg/mL,1,R03BA02,Budesonide,Suspension,Inhalation,01978918,PULMICORT NEBUAMP 0.25 MG/ML (budesonide 0.5 mg per 2 mL nebulizer suspension unit dose vial) ASTRAZENECA CANADA INC,Active,9000404,budesonide 0.5 mg per 2 mL nebulizer suspension unit dose vial,8000134,budesonide,738984000,Parenteral,739008005,Suspension,733026001,Vial (unit of presentation),,,,Prescription
16264,Marketed,2016-07-13,02052431,Entocort Enema,1,A07EA06,Budesonide,"Kit,Tablet,Enema",Rectal,02052431,ENTOCORT ENEMA (budesonide 2.3 mg tablet for rectal suspension with diluent solution) TILLOTTS PHARMA GMBH,Active,9014852,budesonide 2.3 mg tablet for rectal suspension with diluent solution,8000134,budesonide,37161004,Rectal,385193009,Tablet for rectal suspension,732936001,Tablet (unit of presentation),,,,Prescription
43511,Marketed,2000-01-29,02229099,Pulmicort Nebuamp 0.125 mg/mL,1,R03BA02,Budesonide,Suspension,Inhalation,02229099,PULMICORT NEBUAMP 0.125 MG/ML (budesonide 0.25 mg per 2 mL nebulizer suspension unit dose vial) ASTRAZENECA CANADA INC,Active,9000732,budesonide 0.25 mg per 2 mL nebulizer suspension unit dose vial,8000134,budesonide,738984000,Parenteral,739008005,Suspension,733026001,Vial (unit of presentation),,,,Prescription
43534,Marketed,2016-07-13,02229293,Entocort,1,A07EA06,Budesonide,Capsule (sustained-release),Oral,02229293,ENTOCORT (budesonide 3 mg prolonged-release oral capsule) TILLOTTS PHARMA GMBH,Active,9000696,budesonide 3 mg prolonged-release oral capsule,8000134,budesonide,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
49895,Marketed,2010-06-24,02230648,Mylan-Budesonide Aq,1,R01AD05,Budesonide,"Spray, metered dose",Nasal,02230648,MYLAN-BUDESONIDE AQ (budesonide 100 mcg per actuation nasal spray) MYLAN PHARMACEUTICALS ULC,Active,9000699,budesonide 100 mcg per actuation nasal spray,8000134,budesonide,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,,Prescription
51375,Marketed,2026-03-09,02231923,Rhinocort Aqua,1,R01AD05,Budesonide,"Spray, metered dose",Nasal,02231923,RHINOCORT AQUA (budesonide 64 mcg per actuation nasal spray) KENVUE CANADA INC.,Active,9000746,budesonide 64 mcg per actuation nasal spray,8000134,budesonide,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,,Prescription
64595,Marketed,2011-04-21,02241003,Mylan-Budesonide Aq,1,R01AD05,Budesonide,"Spray, metered dose",Nasal,02241003,MYLAN-BUDESONIDE AQ (budesonide 64 mcg per actuation nasal spray) MYLAN PHARMACEUTICALS ULC,Active,9000746,budesonide 64 mcg per actuation nasal spray,8000134,budesonide,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,,Prescription
94275,Marketed,2016-07-25,02455889,Cortiment,1,A07EA06,Budesonide,Tablet (delayed and extended release),Oral,02455889,CORTIMENT (budesonide 9 mg modified-release oral tablet) FERRING INC,Active,9001460,budesonide 9 mg modified-release oral tablet,8000134,budesonide,26643006,Oral,385061003,Modified-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95417,Marketed,2017-11-08,02465949,Teva-Budesonide,1,R03BA02,Budesonide,Suspension,Inhalation,02465949,TEVA-BUDESONIDE (budesonide 0.25 mg per 2 mL nebulizer suspension unit dose vial) TEVA CANADA LIMITED,Active,9000732,budesonide 0.25 mg per 2 mL nebulizer suspension unit dose vial,8000134,budesonide,738984000,Parenteral,739008005,Suspension,733026001,Vial (unit of presentation),,,,Prescription
95418,Marketed,2017-11-08,02465957,Teva-Budesonide,1,R03BA02,Budesonide,Suspension,Inhalation,02465957,TEVA-BUDESONIDE (budesonide 1 mg per 2 mL nebulizer suspension unit dose vial) TEVA CANADA LIMITED,Active,9000405,budesonide 1 mg per 2 mL nebulizer suspension unit dose vial,8000134,budesonide,738984000,Parenteral,739008005,Suspension,733026001,Vial (unit of presentation),,,,Prescription
98367,Marketed,2021-01-07,02493675,Jorveza,1,A07EA06,Budesonide,Tablet (orally disintegrating),Oral,02493675,JORVEZA (budesonide 1 mg orodispersible tablet) AVIR PHARMA INC.,Active,9014426,budesonide 1 mg orodispersible tablet,8000134,budesonide,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
98429,Marketed,2021-06-04,02494264,Taro-Budesonide,1,R03BA02,Budesonide,Suspension,Inhalation,02494264,TARO-BUDESONIDE (budesonide 0.25 mg per 2 mL nebulizer suspension unit dose vial) TARO PHARMACEUTICALS INC,Active,9000732,budesonide 0.25 mg per 2 mL nebulizer suspension unit dose vial,8000134,budesonide,738984000,Parenteral,739008005,Suspension,733026001,Vial (unit of presentation),,,,Prescription
98430,Marketed,2021-06-04,02494272,Taro-Budesonide,1,R03BA02,Budesonide,Suspension,Inhalation,02494272,TARO-BUDESONIDE (budesonide 0.5 mg per 2 mL nebulizer suspension unit dose vial) TARO PHARMACEUTICALS INC,Active,9000404,budesonide 0.5 mg per 2 mL nebulizer suspension unit dose vial,8000134,budesonide,738984000,Parenteral,739008005,Suspension,733026001,Vial (unit of presentation),,,,Prescription
98431,Marketed,2021-06-04,02494280,Taro-Budesonide,1,R03BA02,Budesonide,Suspension,Inhalation,02494280,TARO-BUDESONIDE (budesonide 1 mg per 2 mL nebulizer suspension unit dose vial) TARO PHARMACEUTICALS INC,Active,9000405,budesonide 1 mg per 2 mL nebulizer suspension unit dose vial,8000134,budesonide,738984000,Parenteral,739008005,Suspension,733026001,Vial (unit of presentation),,,,Prescription
98785,Marketed,2023-09-18,02498057,Uceris,1,A07EA06,Budesonide,Foam,Rectal,02498057,"UCERIS (budesonide 2 mg per actuation rectal foam) BAUSCH HEALTH, CANADA INC.",Active,9014911,budesonide 2 mg per actuation rectal foam,8000134,budesonide,37161004,Rectal,385185009,Rectal foam,732981002,Actuation (unit of presentation),,,,Prescription
106325,Marketed,2025-10-07,02560178,Hepcludex,1,J05AX28,Bulevirtide,Powder for solution,Subcutaneous,02560178,HEPCLUDEX (bulevirtide (bulevirtide acetate) 2 mg per vial powder for solution for injection) GILEAD SCIENCES CANADA INC,Active,9015264,bulevirtide (bulevirtide acetate) 2 mg per vial powder for solution for injection,8002557,bulevirtide,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,,,,Prescription
14322,Marketed,2023-04-14,00728276,Burinex,1,C03CA02,Bumetanide,Tablet,Oral,00728276,BURINEX (bumetanide 5 mg oral tablet) KARO PHARMA AB,Active,9008010,bumetanide 5 mg oral tablet,8000873,bumetanide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
14334,Marketed,2023-01-10,00728284,Burinex,1,C03CA02,Bumetanide,Tablet,Oral,00728284,BURINEX (bumetanide 1 mg oral tablet) KARO PHARMA AB,Active,9008009,bumetanide 1 mg oral tablet,8000873,bumetanide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100171,Marketed,2021-10-02,02512424,Bupivacaine Hydrochloride In Dextrose Injection USP,1,N01BB01,Bupivacaine,Solution,Intraspinal,02512424,BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP (bupivacaine hydrochloride 15 mg per 2 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9014607,bupivacaine hydrochloride 15 mg per 2 mL solution for injection vial,8001600,bupivacaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
102546,Marketed,2024-03-19,02536714,Bupivacaine Hydrochloride In Dextrose Injection USP,1,N01BB01,Bupivacaine,Solution,Intraspinal,02536714,BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP (bupivacaine hydrochloride 15 mg per 2 mL solution for injection ampoule) FORMATIVE PHARMA INC.,Active,9012918,bupivacaine hydrochloride 15 mg per 2 mL solution for injection ampoule,8001600,bupivacaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
16161,Marketed,2018-06-20,01976141,Sensorcaine,1,N01BB01,Bupivacaine,Solution,"Epidural,Block/infiltration",77700656,SENSORCAINE (bupivacaine hydrochloride 25 mg per 10 mL solution for injection ampoule) ASPEN PHARMACARE CANADA INC.,Active,9013269,bupivacaine hydrochloride 25 mg per 10 mL solution for injection ampoule,8001600,bupivacaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
16161,Marketed,2018-06-20,01976141,Sensorcaine,1,N01BB01,Bupivacaine,Solution,"Epidural,Block/infiltration",77700657,SENSORCAINE (bupivacaine hydrochloride 50 mg per 20 mL solution for injection vial) ASPEN PHARMACARE CANADA INC.,Active,9012923,bupivacaine hydrochloride 50 mg per 20 mL solution for injection vial,8001600,bupivacaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
16164,Marketed,2018-06-09,01976168,Sensorcaine,1,N01BB01,Bupivacaine,Solution,"Block/infiltration,Epidural",77700658,SENSORCAINE (bupivacaine hydrochloride 50 mg per 10 mL solution for injection ampoule) ASPEN PHARMACARE CANADA INC.,Active,9013270,bupivacaine hydrochloride 50 mg per 10 mL solution for injection ampoule,8001600,bupivacaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
16164,Marketed,2018-06-09,01976168,Sensorcaine,1,N01BB01,Bupivacaine,Solution,"Block/infiltration,Epidural",77700659,SENSORCAINE (bupivacaine hydrochloride 100 mg per 20 mL solution for injection vial) ASPEN PHARMACARE CANADA INC.,Active,9012916,bupivacaine hydrochloride 100 mg per 20 mL solution for injection vial,8001600,bupivacaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
65587,Marketed,2019-06-21,02241917,Marcaine,1,N01BB01,Bupivacaine,Solution,"Epidural,Retrobulbar",02241917,MARCAINE (bupivacaine hydrochloride 150 mg per 20 mL solution for injection vial) PFIZER CANADA ULC,Active,9012919,bupivacaine hydrochloride 150 mg per 20 mL solution for injection vial,8001600,bupivacaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
79145,Marketed,2019-06-06,02305909,Marcaine,1,N01BB01,Bupivacaine,Solution,Block/infiltration,02305909,MARCAINE (bupivacaine hydrochloride 250 mg per 50 mL solution for injection vial) PFIZER CANADA ULC,Active,9012921,bupivacaine hydrochloride 250 mg per 50 mL solution for injection vial,8001600,bupivacaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
92837,Marketed,2016-05-20,02443686,Bupivacaine Injection BP,1,N01BB01,Bupivacaine,Solution,"Epidural,Block/infiltration",77700696,BUPIVACAINE INJECTION BP (bupivacaine hydrochloride 50 mg per 20 mL solution for injection vial) STERIMAX INC,Active,9012923,bupivacaine hydrochloride 50 mg per 20 mL solution for injection vial,8001600,bupivacaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
92837,Marketed,2016-05-20,02443686,Bupivacaine Injection BP,1,N01BB01,Bupivacaine,Solution,"Epidural,Block/infiltration",77700697,BUPIVACAINE INJECTION BP (bupivacaine hydrochloride 25 mg per 10 mL solution for injection vial) STERIMAX INC,Active,9012920,bupivacaine hydrochloride 25 mg per 10 mL solution for injection vial,8001600,bupivacaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
92838,Marketed,2016-05-20,02443694,Bupivacaine Injection BP,1,N01BB01,Bupivacaine,Solution,"Epidural,Block/infiltration",77700698,BUPIVACAINE INJECTION BP (bupivacaine hydrochloride 100 mg per 20 mL solution for injection vial) STERIMAX INC,Active,9012916,bupivacaine hydrochloride 100 mg per 20 mL solution for injection vial,8001600,bupivacaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
92838,Marketed,2016-05-20,02443694,Bupivacaine Injection BP,1,N01BB01,Bupivacaine,Solution,"Epidural,Block/infiltration",77700699,BUPIVACAINE INJECTION BP (bupivacaine hydrochloride 50 mg per 10 mL solution for injection vial) STERIMAX INC,Active,9012922,bupivacaine hydrochloride 50 mg per 10 mL solution for injection vial,8001600,bupivacaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
94807,Marketed,2018-03-13,02460645,Bupivacaine Hydrochloride In Dextrose Injection USP,1,N01BB01,Bupivacaine,Solution,Intraspinal,02460645,BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP (bupivacaine hydrochloride 15 mg per 2 mL solution for injection ampoule) STERIMAX INC,Active,9012918,bupivacaine hydrochloride 15 mg per 2 mL solution for injection ampoule,8001600,bupivacaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
97900,Marketed,2022-08-15,02488930,"Bupivacaine Hydrochloride Injection, USP",1,N01BB01,Bupivacaine,Solution,"Epidural,Retrobulbar",77701116,"BUPIVACAINE HYDROCHLORIDE INJECTION, USP (bupivacaine hydrochloride 75 mg per 10 mL solution for injection vial) BAXTER CORPORATION",Active,9014581,bupivacaine hydrochloride 75 mg per 10 mL solution for injection vial,8001600,bupivacaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
97900,Marketed,2022-08-15,02488930,"Bupivacaine Hydrochloride Injection, USP",1,N01BB01,Bupivacaine,Solution,"Epidural,Retrobulbar",77701117,"BUPIVACAINE HYDROCHLORIDE INJECTION, USP (bupivacaine hydrochloride 150 mg per 20 mL solution for injection vial) BAXTER CORPORATION",Active,9012919,bupivacaine hydrochloride 150 mg per 20 mL solution for injection vial,8001600,bupivacaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
97900,Marketed,2022-08-15,02488930,"Bupivacaine Hydrochloride Injection, USP",1,N01BB01,Bupivacaine,Solution,"Epidural,Retrobulbar",77701118,"BUPIVACAINE HYDROCHLORIDE INJECTION, USP (bupivacaine hydrochloride 225 mg per 30 mL solution for injection vial) BAXTER CORPORATION",Active,9014580,bupivacaine hydrochloride 225 mg per 30 mL solution for injection vial,8001600,bupivacaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
16162,Marketed,2018-07-18,01976184,Sensorcaine With Epinephrine,2,N01BB51,"Bupivacaine, combinations",Solution,"Block/infiltration,Epidural",01976184,SENSORCAINE WITH EPINEPHRINE (bupivacaine hydrochloride 50 mg per 20 mL and epinephrine (epinephrine bitartrate) 0.1 mg per 20 mL solution for injection vial) ASPEN PHARMACARE CANADA INC.,Active,9014084,bupivacaine hydrochloride 50 mg per 20 mL and epinephrine (epinephrine bitartrate) 0.1 mg per 20 mL solution for injection vial,8001601,bupivacaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
16163,Marketed,2018-05-18,01976206,Sensorcaine With Epinephrine,2,N01BB51,"Bupivacaine, combinations",Solution,"Epidural,Block/infiltration",01976206,SENSORCAINE WITH EPINEPHRINE (bupivacaine hydrochloride 100 mg per 20 mL and epinephrine (epinephrine bitartrate) 0.1 mg per 20 mL solution for injection vial) ASPEN PHARMACARE CANADA INC.,Active,9014082,bupivacaine hydrochloride 100 mg per 20 mL and epinephrine (epinephrine bitartrate) 0.1 mg per 20 mL solution for injection vial,8001601,bupivacaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
65585,Marketed,2017-09-07,02241915,Marcaine E,2,N01BB51,"Bupivacaine, combinations",Solution,"Block/infiltration,Epidural",02241915,MARCAINE E (bupivacaine hydrochloride 50 mg per 20 mL and epinephrine (epinephrine bitartrate) 0.1 mg per 20 mL solution for injection vial) PFIZER CANADA ULC,Active,9014084,bupivacaine hydrochloride 50 mg per 20 mL and epinephrine (epinephrine bitartrate) 0.1 mg per 20 mL solution for injection vial,8001601,bupivacaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
65586,Marketed,2017-09-07,02241916,Marcaine E,2,N01BB51,"Bupivacaine, combinations",Solution,"Epidural,Block/infiltration",02241916,MARCAINE E (bupivacaine hydrochloride 100 mg per 20 mL and epinephrine (epinephrine bitartrate) 0.1 mg per 20 mL solution for injection vial) PFIZER CANADA ULC,Active,9014082,bupivacaine hydrochloride 100 mg per 20 mL and epinephrine (epinephrine bitartrate) 0.1 mg per 20 mL solution for injection vial,8001601,bupivacaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
86769,Marketed,2012-05-07,02381850,"Bupivacaine HCL 0.5% And Epinephrine 1:200,000 Injection",2,N01BB51,"Bupivacaine, combinations",Solution,Block/infiltration,02381850,"BUPIVACAINE HCL 0.5% AND EPINEPHRINE 1:200,000 INJECTION (bupivacaine hydrochloride 5 mg per mL and epinephrine (epinephrine bitartrate) 0.005 mg per mL solution for injection 1.8 mL cartridge) NOVOCOL PHARMACEUTICAL OF CANADA INC",Active,9014083,bupivacaine hydrochloride 5 mg per mL and epinephrine (epinephrine bitartrate) 0.005 mg per mL solution for injection 1.8 mL cartridge,8001601,bupivacaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Ethical
96430,Marketed,2019-04-12,02474247,Marcaine,2,N01BB51,"Bupivacaine, combinations",Solution,Block/infiltration,02474247,MARCAINE (bupivacaine hydrochloride 5 mg per mL and epinephrine (epinephrine bitartrate) 0.005 mg per mL solution for injection 1.8 mL cartridge) SEPTODONT INC,Active,9014083,bupivacaine hydrochloride 5 mg per mL and epinephrine (epinephrine bitartrate) 0.005 mg per mL solution for injection 1.8 mL cartridge,8001601,bupivacaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Ethical
82671,Marketed,2010-05-26,02341174,Butrans 5,1,N02AE01,Buprenorphine,Patch,Transdermal,02341174,BUTRANS 5 (buprenorphine 5 mcg per hour transdermal patch) PURDUE PHARMA,Active,9001317,buprenorphine 5 mcg per hour transdermal patch,8000775,buprenorphine,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,1.0,,Narcotics (CDSA I)
82675,Marketed,2010-05-26,02341212,Butrans 10,1,N02AE01,Buprenorphine,Patch,Transdermal,02341212,BUTRANS 10 (buprenorphine 10 mcg per hour transdermal patch) PURDUE PHARMA,Active,9001315,buprenorphine 10 mcg per hour transdermal patch,8000775,buprenorphine,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,1.0,,Narcotics (CDSA I)
82676,Marketed,2010-05-26,02341220,Butrans 20,1,N02AE01,Buprenorphine,Patch,Transdermal,02341220,BUTRANS 20 (buprenorphine 20 mcg per hour transdermal patch) PURDUE PHARMA,Active,9001316,buprenorphine 20 mcg per hour transdermal patch,8000775,buprenorphine,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,1.0,,Narcotics (CDSA I)
93692,Marketed,2016-06-15,02450771,Butrans 15,1,N02AE01,Buprenorphine,Patch,Transdermal,02450771,BUTRANS 15 (buprenorphine 15 mcg per hour transdermal patch) PURDUE PHARMA,Active,9001459,buprenorphine 15 mcg per hour transdermal patch,8000775,buprenorphine,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,1.0,,Narcotics (CDSA I)
97348,Marketed,2020-02-03,02483084,Sublocade,1,N07BC01,Buprenorphine,Solution (extended release),Subcutaneous,02483084,SUBLOCADE (buprenorphine 100 mg per 0.5 mL prolonged-release solution for injection syringe) INDIVIOR UK LIMITED,Active,9014238,buprenorphine 100 mg per 0.5 mL prolonged-release solution for injection syringe,8000775,buprenorphine,738984000,Parenteral,1231833006,Prolonged-release solution for injection,733020007,Syringe (unit of presentation),,1.0,,Narcotics (CDSA I)
97349,Marketed,2020-02-03,02483092,Sublocade,1,N07BC01,Buprenorphine,Solution (extended release),Subcutaneous,02483092,SUBLOCADE (buprenorphine 300 mg per 1.5 mL prolonged-release solution for injection syringe) INDIVIOR UK LIMITED,Active,9014239,buprenorphine 300 mg per 1.5 mL prolonged-release solution for injection syringe,8000775,buprenorphine,738984000,Parenteral,1231833006,Prolonged-release solution for injection,733020007,Syringe (unit of presentation),,1.0,,Narcotics (CDSA I)
78104,Marketed,2016-03-10,02295695,Suboxone,2,N07BC51,"Buprenorphine, combinations",Tablet,Sublingual,02295695,SUBOXONE (buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride dihydrate) 0.5 mg sublingual tablet) INDIVIOR UK LIMITED,Active,9001226,buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride) 0.5 mg sublingual tablet,8000372,buprenorphine and naloxone,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
78105,Marketed,2016-04-01,02295709,Suboxone,2,N07BC51,"Buprenorphine, combinations",Tablet,Sublingual,02295709,SUBOXONE (buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride dihydrate) 2 mg sublingual tablet) INDIVIOR UK LIMITED,Active,9001227,buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride) 2 mg sublingual tablet,8000372,buprenorphine and naloxone,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
90952,Marketed,2017-11-24,02424851,PMS-Buprenorphine-Naloxone,2,N07BC51,"Buprenorphine, combinations",Tablet,Sublingual,02424851,PMS-BUPRENORPHINE-NALOXONE (buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride dihydrate) 0.5 mg sublingual tablet) PHARMASCIENCE INC,Active,9001226,buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride) 0.5 mg sublingual tablet,8000372,buprenorphine and naloxone,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
90953,Marketed,2017-11-24,02424878,PMS-Buprenorphine-Naloxone,2,N07BC51,"Buprenorphine, combinations",Tablet,Sublingual,02424878,PMS-BUPRENORPHINE-NALOXONE (buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride dihydrate) 2 mg sublingual tablet) PHARMASCIENCE INC,Active,9001227,buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride) 2 mg sublingual tablet,8000372,buprenorphine and naloxone,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
94043,Marketed,2021-03-22,02453908,Teva-Buprenorphine/Naloxone,2,N07BC51,"Buprenorphine, combinations",Tablet,Sublingual,02453908,TEVA-BUPRENORPHINE/NALOXONE (buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride dihydrate) 0.5 mg sublingual tablet) TEVA CANADA LIMITED,Active,9001226,buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride) 0.5 mg sublingual tablet,8000372,buprenorphine and naloxone,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
94044,Marketed,2021-03-22,02453916,Teva-Buprenorphine/Naloxone,2,N07BC51,"Buprenorphine, combinations",Tablet,Sublingual,02453916,TEVA-BUPRENORPHINE/NALOXONE (buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride dihydrate) 2 mg sublingual tablet) TEVA CANADA LIMITED,Active,9001227,buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride) 2 mg sublingual tablet,8000372,buprenorphine and naloxone,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
95646,Marketed,2018-02-14,02468085,Suboxone,2,N07BC51,"Buprenorphine, combinations",Tablet,Sublingual,02468085,SUBOXONE (buprenorphine (buprenorphine hydrochloride) 12 mg and naloxone (naloxone hydrochloride dihydrate) 3 mg sublingual tablet) INDIVIOR UK LIMITED,Active,9012472,buprenorphine (buprenorphine hydrochloride) 12 mg and naloxone (naloxone hydrochloride) 3 mg sublingual tablet,8000372,buprenorphine and naloxone,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
95647,Marketed,2018-02-14,02468093,Suboxone,2,N07BC51,"Buprenorphine, combinations",Tablet,Sublingual,02468093,SUBOXONE (buprenorphine (buprenorphine hydrochloride) 16 mg and naloxone (naloxone hydrochloride dihydrate) 4 mg sublingual tablet) INDIVIOR UK LIMITED,Active,9012473,buprenorphine (buprenorphine hydrochloride) 16 mg and naloxone (naloxone hydrochloride) 4 mg sublingual tablet,8000372,buprenorphine and naloxone,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
99189,Marketed,2021-01-20,02502313,Suboxone,2,N07BC51,"Buprenorphine, combinations","Film, soluble","Buccal,Sublingual",02502313,SUBOXONE (buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride) 0.5 mg oromucosal film) INDIVIOR UK LIMITED,Active,9014448,buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride) 0.5 mg oromucosal film,8000372,buprenorphine and naloxone,37839007,Sublingual,420460001,Film,732995004,Film (unit of presentation),,1.0,,Narcotics (CDSA I)
99190,Marketed,2021-06-17,02502321,Suboxone,2,N07BC51,"Buprenorphine, combinations","Film, soluble","Sublingual,Buccal",02502321,SUBOXONE (buprenorphine (buprenorphine hydrochloride) 4 mg and naloxone (naloxone hydrochloride) 1 mg oromucosal film) INDIVIOR UK LIMITED,Active,9014541,buprenorphine (buprenorphine hydrochloride) 4 mg and naloxone (naloxone hydrochloride) 1 mg oromucosal film,8000372,buprenorphine and naloxone,37839007,Sublingual,420460001,Film,732995004,Film (unit of presentation),,1.0,,Narcotics (CDSA I)
99191,Marketed,2021-01-20,02502348,Suboxone,2,N07BC51,"Buprenorphine, combinations","Film, soluble","Sublingual,Buccal",02502348,SUBOXONE (buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride) 2 mg oromucosal film) INDIVIOR UK LIMITED,Active,9014449,buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride) 2 mg oromucosal film,8000372,buprenorphine and naloxone,37839007,Sublingual,420460001,Film,732995004,Film (unit of presentation),,1.0,,Narcotics (CDSA I)
99192,Marketed,2021-01-20,02502356,Suboxone,2,N07BC51,"Buprenorphine, combinations","Film, soluble","Buccal,Sublingual",02502356,SUBOXONE (buprenorphine (buprenorphine hydrochloride) 12 mg and naloxone (naloxone hydrochloride) 3 mg oromucosal film) INDIVIOR UK LIMITED,Active,9014447,buprenorphine (buprenorphine hydrochloride) 12 mg and naloxone (naloxone hydrochloride) 3 mg oromucosal film,8000372,buprenorphine and naloxone,37839007,Sublingual,420460001,Film,732995004,Film (unit of presentation),,1.0,,Narcotics (CDSA I)
61860,Marketed,2021-06-04,02238441,Zyban,1,N06AX12,Bupropion,Tablet (extended-release),Oral,02238441,"ZYBAN (bupropion hydrochloride 150 mg prolonged-release oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9000798,bupropion hydrochloride 150 mg prolonged-release oral tablet,8000257,bupropion,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76058,Marketed,2021-05-14,02275074,Odan Bupropion SR,1,N06AX12,Bupropion,Tablet (extended-release),Oral,02275074,ODAN BUPROPION SR (bupropion hydrochloride 100 mg prolonged-release oral tablet) ODAN LABORATORIES LTD,Active,9001158,bupropion hydrochloride 100 mg prolonged-release oral tablet,8000257,bupropion,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76059,Marketed,2021-05-14,02275082,Odan Bupropion SR,1,N06AX12,Bupropion,Tablet (extended-release),Oral,02275082,ODAN BUPROPION SR (bupropion hydrochloride 150 mg prolonged-release oral tablet) ODAN LABORATORIES LTD,Active,9000798,bupropion hydrochloride 150 mg prolonged-release oral tablet,8000257,bupropion,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76060,Marketed,2021-06-11,02275090,Wellbutrin XL,1,N06AX12,Bupropion,Tablet (extended-release),Oral,02275090,"WELLBUTRIN XL (bupropion hydrochloride 150 mg prolonged-release oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9000798,bupropion hydrochloride 150 mg prolonged-release oral tablet,8000257,bupropion,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76061,Marketed,2021-06-11,02275104,Wellbutrin XL,1,N06AX12,Bupropion,Tablet (extended-release),Oral,02275104,"WELLBUTRIN XL (bupropion hydrochloride 300 mg prolonged-release oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9001138,bupropion hydrochloride 300 mg prolonged-release oral tablet,8000257,bupropion,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92405,Marketed,2020-05-28,02439654,Teva-Bupropion XL,1,N06AX12,Bupropion,Tablet (extended-release),Oral,02439654,TEVA-BUPROPION XL (bupropion hydrochloride 150 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9000798,bupropion hydrochloride 150 mg prolonged-release oral tablet,8000257,bupropion,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92406,Marketed,2020-05-28,02439662,Teva-Bupropion XL,1,N06AX12,Bupropion,Tablet (extended-release),Oral,02439662,TEVA-BUPROPION XL (bupropion hydrochloride 300 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9001138,bupropion hydrochloride 300 mg prolonged-release oral tablet,8000257,bupropion,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96647,Marketed,2021-02-18,02475804,Taro-Bupropion XL,1,N06AX12,Bupropion,Tablet (extended-release),Oral,02475804,TARO-BUPROPION XL (bupropion hydrochloride 150 mg prolonged-release oral tablet) SUN PHARMA CANADA INC,Active,9000798,bupropion hydrochloride 150 mg prolonged-release oral tablet,8000257,bupropion,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96648,Marketed,2021-02-18,02475812,Taro-Bupropion XL,1,N06AX12,Bupropion,Tablet (extended-release),Oral,02475812,TARO-BUPROPION XL (bupropion hydrochloride 300 mg prolonged-release oral tablet) SUN PHARMA CANADA INC,Active,9001138,bupropion hydrochloride 300 mg prolonged-release oral tablet,8000257,bupropion,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96230,Marketed,2020-06-02,02472945,Contrave,2,A08AA62,Bupropion and naltrexone,Tablet (extended-release),Oral,02472945,"CONTRAVE (bupropion hydrochloride 90 mg and naltrexone hydrochloride 8 mg prolonged-release oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9012691,bupropion hydrochloride 90 mg and naltrexone hydrochloride 8 mg prolonged-release oral tablet,8001345,bupropion and naltrexone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97399,Marketed,2022-11-30,02483629,Crysvita,1,M05BX05,Burosumab,Solution,Subcutaneous,02483629,"CRYSVITA (burosumab 10 mg per 1 mL solution for injection vial) KYOWA KIRIN, INC.",Active,9013944,burosumab 10 mg per 1 mL solution for injection vial,8002252,burosumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
97399,Marketed,2022-11-30,02483629,Crysvita,1,M05BX05,Burosumab,Solution,Subcutaneous,02483629,"CRYSVITA (burosumab 10 mg per 1 mL solution for injection vial) KYOWA KIRIN, INC.",Active,9013944,burosumab 10 mg per 1 mL solution for injection vial,8002252,burosumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
97400,Marketed,2023-03-03,02483637,Crysvita,1,M05BX05,Burosumab,Solution,Subcutaneous,02483637,"CRYSVITA (burosumab 20 mg per 1 mL solution for injection vial) KYOWA KIRIN, INC.",Active,9013945,burosumab 20 mg per 1 mL solution for injection vial,8002252,burosumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
97400,Marketed,2023-03-03,02483637,Crysvita,1,M05BX05,Burosumab,Solution,Subcutaneous,02483637,"CRYSVITA (burosumab 20 mg per 1 mL solution for injection vial) KYOWA KIRIN, INC.",Active,9013945,burosumab 20 mg per 1 mL solution for injection vial,8002252,burosumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
97401,Marketed,2023-04-05,02483645,Crysvita,1,M05BX05,Burosumab,Solution,Subcutaneous,02483645,"CRYSVITA (burosumab 30 mg per 1 mL solution for injection vial) KYOWA KIRIN, INC.",Active,9013946,burosumab 30 mg per 1 mL solution for injection vial,8002252,burosumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
97401,Marketed,2023-04-05,02483645,Crysvita,1,M05BX05,Burosumab,Solution,Subcutaneous,02483645,"CRYSVITA (burosumab 30 mg per 1 mL solution for injection vial) KYOWA KIRIN, INC.",Active,9013946,burosumab 30 mg per 1 mL solution for injection vial,8002252,burosumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
43417,Marketed,2020-06-05,02225166,Suprefact,1,L02AE01,Buserelin,Solution,Subcutaneous,02225166,SUPREFACT (buserelin (buserelin acetate) 1 mg per mL solution for injection 5.5 mL vial) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9012924,buserelin (buserelin acetate) 1 mg per mL solution for injection 5.5 mL vial,8001602,buserelin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
100833,Marketed,2022-01-26,02519054,Mint-Buspirone,1,N05BE01,Buspirone,Tablet,Oral,02519054,MINT-BUSPIRONE (buspirone hydrochloride 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9003012,buspirone hydrochloride 10 mg oral tablet,8001247,buspirone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103936,Marketed,2024-09-24,02550555,Amb-Buspirone,1,N05BE01,Buspirone,Tablet,Oral,02550555,AMB-BUSPIRONE (buspirone hydrochloride 10 mg oral tablet) AMBICARE PHARMACEUTICALS INC.,Active,9003012,buspirone hydrochloride 10 mg oral tablet,8001247,buspirone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
43349,Marketed,2024-10-22,02223163,Pro-Buspirone,1,N05BE01,Buspirone,Tablet,Oral,02223163,PRO-BUSPIRONE (buspirone hydrochloride 10 mg oral tablet) PRO DOC LIMITEE,Active,9003012,buspirone hydrochloride 10 mg oral tablet,8001247,buspirone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
50220,Marketed,1997-05-26,02230942,PMS-Buspirone,1,N05BE01,Buspirone,Tablet,Oral,02230942,PMS-BUSPIRONE (buspirone hydrochloride 10 mg oral tablet) PHARMASCIENCE INC,Active,9003012,buspirone hydrochloride 10 mg oral tablet,8001247,buspirone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
50822,Marketed,2015-06-04,02231492,Teva-Buspirone,1,N05BE01,Buspirone,Tablet,Oral,02231492,TEVA-BUSPIRONE (buspirone hydrochloride 10 mg oral tablet) TEVA CANADA LIMITED,Active,9003012,buspirone hydrochloride 10 mg oral tablet,8001247,buspirone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93348,Marketed,2016-02-17,02447851,Buspirone,1,N05BE01,Buspirone,Tablet,Oral,02447851,BUSPIRONE (buspirone hydrochloride 10 mg oral tablet) SANIS HEALTH INC,Active,9003012,buspirone hydrochloride 10 mg oral tablet,8001247,buspirone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98992,Marketed,2020-10-30,02500213,Auro-Buspirone,1,N05BE01,Buspirone,Tablet,Oral,02500213,AURO-BUSPIRONE (buspirone hydrochloride 10 mg oral tablet) AURO PHARMA INC,Active,9003012,buspirone hydrochloride 10 mg oral tablet,8001247,buspirone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99918,Marketed,2021-10-29,02509911,JAMP Buspirone,1,N05BE01,Buspirone,Tablet,Oral,02509911,JAMP BUSPIRONE (buspirone hydrochloride 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003012,buspirone hydrochloride 10 mg oral tablet,8001247,buspirone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95184,Marketed,2017-10-04,02463733,Busulfan For Injection,1,L01AB01,Busulfan,Solution,Intravenous,02463733,BUSULFAN FOR INJECTION (busulfan 60 mg per 10 mL solution for injection vial) STERIMAX INC,Active,9012925,busulfan 60 mg per 10 mL solution for injection vial,8001603,busulfan,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
959,Marketed,2018-07-24,00004618,Myleran,1,L01AB01,Busulfan,Tablet,Oral,00004618,MYLERAN (busulfan 2 mg oral tablet) ASPEN PHARMACARE CANADA INC.,Active,9001541,busulfan 2 mg oral tablet,8001603,busulfan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
96833,Marketed,2019-03-29,02477343,PMS-Busulfan,1,L01AB01,Busulfan,Solution,Intravenous,02477343,PMS-BUSULFAN (busulfan 60 mg per 10 mL solution for injection vial) PHARMASCIENCE INC,Active,9012925,busulfan 60 mg per 10 mL solution for injection vial,8001603,busulfan,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
66247,Marketed,2015-04-17,02242504,Butorphanol Nasal Spray,1,N02AF01,Butorphanol,Solution,Nasal,02242504,BUTORPHANOL NASAL SPRAY (butorphanol tartrate 10 mg per mL nasal spray) AA PHARMA INC,Active,9000913,butorphanol tartrate 10 mg per mL nasal spray,8000776,butorphanol,46713006,Nasal,385157007,Nasal spray,,,,1.0,,Controlled Drugs (CDSA IV)
100163,Marketed,2021-08-19,02512335,Accel-Hyoscine,1,A03BB01,Butylscopolamine,Tablet,Oral,02512335,ACCEL-HYOSCINE (hyoscine butylbromide 10 mg oral tablet) ACCEL PHARMA INC,Active,9001758,hyoscine butylbromide 10 mg oral tablet,8001482,hyoscine butylbromide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Ethical
2481,Marketed,2021-10-28,00363812,Buscopan,1,A03BB01,Butylscopolamine,Tablet,Oral,00363812,BUSCOPAN (hyoscine butylbromide 10 mg oral tablet) SANOFI CONSUMER HEALTH INC,Active,9001758,hyoscine butylbromide 10 mg oral tablet,8001482,hyoscine butylbromide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Ethical
2483,Marketed,2022-08-16,00363839,Buscopan,1,A03BB01,Butylscopolamine,Solution,"Intramuscular,Subcutaneous,Intravenous",00363839,BUSCOPAN (hyoscine butylbromide 20 mg per 1 mL solution for injection ampoule) SANOFI CONSUMER HEALTH INC,Active,9012818,hyoscine butylbromide 20 mg per 1 mL solution for injection ampoule,8001482,hyoscine butylbromide,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
48226,Marketed,2007-05-28,02229868,Hyoscine Butylbromide Injection,1,A03BB01,Butylscopolamine,Solution,"Intravenous,Intramuscular,Subcutaneous",02229868,HYOSCINE BUTYLBROMIDE INJECTION (hyoscine butylbromide 20 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012819,hyoscine butylbromide 20 mg per 1 mL solution for injection vial,8001482,hyoscine butylbromide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
99778,Marketed,2024-06-04,02508419,Hyoscine Butylbromide Injection BP,1,A03BB01,Butylscopolamine,Solution,"Intravenous,Subcutaneous,Intramuscular",02508419,HYOSCINE BUTYLBROMIDE INJECTION BP (hyoscine butylbromide 20 mg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9012819,hyoscine butylbromide 20 mg per 1 mL solution for injection vial,8001482,hyoscine butylbromide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
83783,Marketed,2014-12-24,02352575,Berinert 500,1,B06AC01,"C1-inhibitor, plasma derived","Kit,Powder for solution",Intravenous,02352575,BERINERT 500 (C1 esterase inhibitor human 500 unit per vial powder for solution for injection with diluent solution) CSL BEHRING CANADA INC,Active,9013841,C1 esterase inhibitor human 500 unit per vial powder for solution for injection with diluent solution,8002233,C1 esterase inhibitor human,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
92040,Marketed,2015-05-06,02436078,Berinert 1500,1,B06AC01,"C1-inhibitor, plasma derived","Powder for solution,Kit",Intravenous,02436078,BERINERT 1500 (C1 esterase inhibitor human 1500 unit per vial powder for solution for injection with diluent solution) CSL BEHRING CANADA INC,Active,9013840,C1 esterase inhibitor human 1500 unit per vial powder for solution for injection with diluent solution,8002233,C1 esterase inhibitor human,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
95643,Marketed,2020-01-23,02468069,Haegarda,1,B06AC01,"C1-inhibitor, plasma derived","Kit,Powder for solution",Subcutaneous,02468069,HAEGARDA (C1 esterase inhibitor human 2000 unit per vial powder for solution for injection with diluent solution) CSL BEHRING CANADA INC,Active,9014234,C1 esterase inhibitor human 2000 unit per vial powder for solution for injection with diluent solution,8002233,C1 esterase inhibitor human,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
95644,Marketed,2020-01-23,02468077,Haegarda,1,B06AC01,"C1-inhibitor, plasma derived","Kit,Powder for solution",Subcutaneous,02468077,HAEGARDA (C1 esterase inhibitor human 3000 unit per vial powder for solution for injection with diluent solution) CSL BEHRING CANADA INC,Active,9014235,C1 esterase inhibitor human 3000 unit per vial powder for solution for injection with diluent solution,8002233,C1 esterase inhibitor human,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
104269,Marketed,2025-04-10,02553783,Cabazitaxel For Injection,1,L01CD04,Cabazitaxel,Solution,Intravenous,02553783,CABAZITAXEL FOR INJECTION (cabazitaxel 45 mg per 4.5 mL solution for injection vial) FORMATIVE PHARMA INC.,Active,9014218,cabazitaxel 45 mg per 4.5 mL solution for injection vial,8001604,cabazitaxel,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
104270,Marketed,2025-04-10,02553791,Cabazitaxel For Injection,1,L01CD04,Cabazitaxel,Solution,Intravenous,02553791,CABAZITAXEL FOR INJECTION (cabazitaxel 60 mg per 6 mL solution for injection vial) FORMATIVE PHARMA INC.,Active,9014219,cabazitaxel 60 mg per 6 mL solution for injection vial,8001604,cabazitaxel,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
97765,Marketed,2019-12-18,02487497,Cabazitaxel For Injection,1,L01CD04,Cabazitaxel,Solution,Intravenous,02487497,CABAZITAXEL FOR INJECTION (cabazitaxel 45 mg per 4.5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9014218,cabazitaxel 45 mg per 4.5 mL solution for injection vial,8001604,cabazitaxel,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
97766,Marketed,2019-12-18,02487500,Cabazitaxel For Injection,1,L01CD04,Cabazitaxel,Solution,Intravenous,02487500,CABAZITAXEL FOR INJECTION (cabazitaxel 60 mg per 6 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9014219,cabazitaxel 60 mg per 6 mL solution for injection vial,8001604,cabazitaxel,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
98553,Marketed,2020-06-01,02495635,Cabazitaxel For Injection,1,L01CD04,Cabazitaxel,Solution,Intravenous,02495635,CABAZITAXEL FOR INJECTION (cabazitaxel 60 mg per 1.5 mL solution for injection vial with diluent solution) DR REDDY'S LABORATORIES LTD,Active,9012926,cabazitaxel 60 mg per 1.5 mL solution for injection vial with diluent solution,8001604,cabazitaxel,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
103844,Marketed,2025-02-04,02549611,JAMP Cabergoline,1,G02CB03,Cabergoline,Tablet,Oral,02549611,JAMP CABERGOLINE (cabergoline 0.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003499,cabergoline 0.5 mg oral tablet,8001346,cabergoline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
66198,Marketed,2006-01-05,02242471,Dostinex,1,G02CB03,Cabergoline,Tablet,Oral,02242471,DOSTINEX (cabergoline 0.5 mg oral tablet) PFIZER CANADA ULC,Active,9003499,cabergoline 0.5 mg oral tablet,8001346,cabergoline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
94276,Marketed,2021-03-01,02455897,Apo-Cabergoline,1,G02CB03,Cabergoline,Tablet,Oral,02455897,APO-CABERGOLINE (cabergoline 0.5 mg oral tablet) APOTEX INC,Active,9003499,cabergoline 0.5 mg oral tablet,8001346,cabergoline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
103642,Marketed,2024-06-19,02547465,Apretude,1,J05AJ04,Cabotegravir,Tablet,Oral,02547465,APRETUDE (cabotegravir (cabotegravir sodium) 30 mg oral tablet) VIIV HEALTHCARE ULC,Active,9014353,cabotegravir (cabotegravir sodium) 30 mg oral tablet,8002341,cabotegravir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
103643,Marketed,2024-06-19,02547473,Apretude,1,J05AJ04,Cabotegravir,Suspension (extended-release),Intramuscular,02547473,APRETUDE (cabotegravir 600 mg per 3 mL prolonged-release suspension for injection vial) VIIV HEALTHCARE ULC,Active,9015051,cabotegravir 600 mg per 3 mL prolonged-release suspension for injection vial,8002341,cabotegravir,738984000,Parenteral,420873008,Prolonged-release suspension for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
98705,Marketed,2020-09-21,02497204,Vocabria,1,J05AJ04,Cabotegravir,Tablet,Oral,02497204,VOCABRIA (cabotegravir (cabotegravir sodium) 30 mg oral tablet) VIIV HEALTHCARE ULC,Active,9014353,cabotegravir (cabotegravir sodium) 30 mg oral tablet,8002341,cabotegravir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
97148,Marketed,2018-10-10,02480824,Cabometyx,1,L01EX07,Cabozantinib,Tablet,Oral,02480824,CABOMETYX (cabozantinib (cabozantinib malate) 20 mg oral tablet) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9013419,cabozantinib (cabozantinib malate) 20 mg oral tablet,8002016,cabozantinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
97149,Marketed,2018-10-10,02480832,Cabometyx,1,L01EX07,Cabozantinib,Tablet,Oral,02480832,CABOMETYX (cabozantinib (cabozantinib malate) 40 mg oral tablet) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9013420,cabozantinib (cabozantinib malate) 40 mg oral tablet,8002016,cabozantinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
97150,Marketed,2018-10-10,02480840,Cabometyx,1,L01EX07,Cabozantinib,Tablet,Oral,02480840,CABOMETYX (cabozantinib (cabozantinib malate) 60 mg oral tablet) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9013421,cabozantinib (cabozantinib malate) 60 mg oral tablet,8002016,cabozantinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101582,Marketed,2023-07-11,02526751,Caffeine Citrate Oral Solution USP,1,N06BC01,Caffeine,Solution,Oral,02526751,CAFFEINE CITRATE ORAL SOLUTION USP (caffeine citrate 20 mg per mL oral solution) OMEGA LABORATORIES LIMITED,Active,9014888,caffeine citrate 20 mg per mL oral solution,8002332,caffeine,26643006,Oral,739006009,Solution,,,,,,Prescription
101583,Marketed,2023-07-11,02526778,Caffeine Citrate Injection USP,1,N06BC01,Caffeine,Solution,Intravenous,02526778,CAFFEINE CITRATE INJECTION USP (caffeine citrate 60 mg per 3 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9014889,caffeine citrate 60 mg per 3 mL solution for injection vial,8002332,caffeine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
98662,Marketed,2020-07-13,02496771,Peyona,1,N06BC01,Caffeine,Solution,"Oral,Intravenous",02496771,PEYONA (caffeine citrate 20 mg per 1 mL solution for injection ampoule) CHIESI FARMACEUTICI S.P.A.,Active,9014339,caffeine citrate 20 mg per 1 mL solution for injection ampoule,8002332,caffeine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription Recommended
13340,Marketed,1992-12-31,01976133,Dovonex,1,D05AX02,Calcipotriol,Ointment,Topical,01976133,DOVONEX (calcipotriol 50 mcg per g cutaneous ointment) LEO PHARMA INC,Active,9002421,calcipotriol 50 mcg per g cutaneous ointment,8001248,calcipotriol,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Prescription
101421,Marketed,2022-06-01,02525178,Taro-Calcipotriol / Betamethasone Gel,2,D05AX52,"Calcipotriol, combinations",Gel,Topical,02525178,TARO-CALCIPOTRIOL / BETAMETHASONE GEL (betamethasone (betamethasone dipropionate) 0.5 mg per g and calcipotriol (calcipotriol monohydrate) 50 mcg per g cutaneous gel) TARO PHARMACEUTICALS INC,Active,9012655,betamethasone (betamethasone dipropionate) 0.5 mg per g and calcipotriol 50 mcg per g cutaneous gel,8000927,betamethasone dipropionate and calcipotriol,448598008,Cutaneous,385100002,Gel,,,,,,Prescription
68084,Marketed,2001-11-29,02244126,Dovobet Ointment,2,D05AX52,"Calcipotriol, combinations",Ointment,Topical,02244126,DOVOBET OINTMENT (betamethasone (betamethasone dipropionate) 0.5 mg per g and calcipotriol 50 mcg per g cutaneous ointment) LEO PHARMA INC,Active,9003670,betamethasone (betamethasone dipropionate) 0.5 mg per g and calcipotriol 50 mcg per g cutaneous ointment,8000927,betamethasone dipropionate and calcipotriol,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Prescription
80450,Marketed,2012-10-12,02319012,Dovobet Gel,2,D05AX52,"Calcipotriol, combinations",Gel,Topical,02319012,DOVOBET GEL (betamethasone (betamethasone dipropionate) 0.5 mg per g and calcipotriol (calcipotriol monohydrate) 50 mcg per g cutaneous gel) LEO PHARMA INC,Active,9012655,betamethasone (betamethasone dipropionate) 0.5 mg per g and calcipotriol 50 mcg per g cutaneous gel,8000927,betamethasone dipropionate and calcipotriol,448598008,Cutaneous,385100002,Gel,,,,,,Prescription
94445,Marketed,2016-11-11,02457393,Enstilar,2,D05AX52,"Calcipotriol, combinations","Aerosol, foam",Topical,02457393,ENSTILAR (betamethasone (betamethasone dipropionate) 0.5 mg per g and calcipotriol (calcipotriol monohydrate) 50 mcg per g cutaneous foam) LEO PHARMA INC,Active,9012654,betamethasone (betamethasone dipropionate) 0.5 mg per g and calcipotriol 50 mcg per g cutaneous foam,8000927,betamethasone dipropionate and calcipotriol,448598008,Cutaneous,421166008,Foam,,,,,,Prescription
12837,Marketed,2008-02-13,01926691,Calcimar,1,H05BA01,Calcitonin (salmon synthetic),Solution,"Intramuscular,Subcutaneous",01926691,CALCIMAR (calcitonin salmon 400 unit per 2 mL solution for injection vial) SANOFI-AVENTIS CANADA INC,Active,9012927,calcitonin salmon 400 unit per 2 mL solution for injection vial,8001605,calcitonin salmon,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
3429,Marketed,2022-03-14,00481815,Rocaltrol,1,A11CC04,Calcitriol,Capsule,Oral,00481815,ROCALTROL (calcitriol 0.5 mcg oral capsule) SEARCHLIGHT PHARMA INC,Active,9000124,calcitriol 0.5 mcg oral capsule,8000075,calcitriol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
3430,Marketed,2022-03-14,00481823,Rocaltrol,1,A11CC04,Calcitriol,Capsule,Oral,00481823,ROCALTROL (calcitriol 0.25 mcg oral capsule) SEARCHLIGHT PHARMA INC,Active,9000123,calcitriol 0.25 mcg oral capsule,8000075,calcitriol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
82422,Marketed,2010-04-09,02338572,Silkis,1,D05AX03,Calcitriol,Ointment,Topical,02338572,SILKIS (calcitriol 3 mcg per g cutaneous ointment) GALDERMA CANADA INC.,Active,9001309,calcitriol 3 mcg per g cutaneous ointment,8000075,calcitriol,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Prescription
88422,Marketed,2015-03-27,02399334,Calcitriol Injection USP,1,A11CC04,Calcitriol,Solution,Intravenous,02399334,CALCITRIOL INJECTION USP (calcitriol 1 mcg per 1 mL solution for injection ampoule) STERIMAX INC,Active,9001033,calcitriol 1 mcg per 1 mL solution for injection ampoule,8000075,calcitriol,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
91612,Marketed,2014-10-10,02431637,Calcitriol-Odan,1,A11CC04,Calcitriol,Capsule,Oral,02431637,CALCITRIOL-ODAN (calcitriol 0.25 mcg oral capsule) ODAN LABORATORIES LTD,Active,9000123,calcitriol 0.25 mcg oral capsule,8000075,calcitriol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
91613,Marketed,2014-10-10,02431645,Calcitriol-Odan,1,A11CC04,Calcitriol,Capsule,Oral,02431645,CALCITRIOL-ODAN (calcitriol 0.5 mcg oral capsule) ODAN LABORATORIES LTD,Active,9000124,calcitriol 0.5 mcg oral capsule,8000075,calcitriol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97594,Marketed,2019-06-03,02485710,Taro-Calcitriol,1,A11CC04,Calcitriol,Capsule,Oral,02485710,TARO-CALCITRIOL (calcitriol 0.25 mcg oral capsule) TARO PHARMACEUTICALS INC,Active,9000123,calcitriol 0.25 mcg oral capsule,8000075,calcitriol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97595,Marketed,2019-06-03,02485729,Taro-Calcitriol,1,A11CC04,Calcitriol,Capsule,Oral,02485729,TARO-CALCITRIOL (calcitriol 0.5 mcg oral capsule) TARO PHARMACEUTICALS INC,Active,9000124,calcitriol 0.5 mcg oral capsule,8000075,calcitriol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
10770,Marketed,1990-12-31,00821780,Calciject Inj 100 mg/mL,1,B05XA07,Calcium chloride,Liquid,Intravenous,77701010,CALCIJECT INJ 100MG/ML (calcium chloride 5000 mg per 50 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013037,calcium chloride 5000 mg per 50 mL solution for injection vial,8001710,calcium chloride,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
10770,Marketed,1990-12-31,00821780,Calciject Inj 100 mg/mL,1,B05XA07,Calcium chloride,Liquid,Intravenous,77701011,CALCIJECT INJ 100MG/ML (calcium chloride 1000 mg per 10 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013948,calcium chloride 1000 mg per 10 mL solution for injection vial,8001710,calcium chloride,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
4230,Marketed,2017-09-01,00294748,Calcium Chloride Injection USP,1,B05XA07,Calcium chloride,Solution,Intravenous,00294748,CALCIUM CHLORIDE INJECTION USP (calcium chloride 1000 mg per 10 mL solution for injection syringe) PFIZER CANADA ULC,Active,9013947,calcium chloride 1000 mg per 10 mL solution for injection syringe,8001710,calcium chloride,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Ethical
103709,Marketed,2025-02-14,02548208,JAMP Leucovorin,1,V03AF03,Calcium folinate,Tablet,Oral,02548208,JAMP LEUCOVORIN (leucovorin (leucovorin calcium) 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9002948,leucovorin (leucovorin calcium) 5 mg oral tablet,8001833,leucovorin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
18209,Marketed,2014-05-16,02087316,Leucovorin Calcium Injection,1,V03AF03,Calcium folinate,Solution,"Intramuscular,Intravenous",02087316,LEUCOVORIN CALCIUM INJECTION (leucovorin (leucovorin calcium) 500 mg per 50 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013189,leucovorin (leucovorin calcium) 500 mg per 50 mL solution for injection vial,8001833,leucovorin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
44146,Marketed,2012-03-02,02170493,Lederle Leucovorin,1,V03AF03,Calcium folinate,Tablet,Oral,02170493,LEDERLE LEUCOVORIN (leucovorin (leucovorin calcium) 5 mg oral tablet) PFIZER CANADA ULC,Active,9002948,leucovorin (leucovorin calcium) 5 mg oral tablet,8001833,leucovorin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
44265,Marketed,2018-04-11,02182998,Leucovorin Calcium Injection USP,1,V03AF03,Calcium folinate,Solution,Intravenous,02182998,LEUCOVORIN CALCIUM INJECTION USP (leucovorin (leucovorin calcium) 500 mg per 50 mL solution for injection vial) PFIZER CANADA ULC,Active,9013189,leucovorin (leucovorin calcium) 500 mg per 50 mL solution for injection vial,8001833,leucovorin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
44266,Marketed,2019-01-02,02183005,Leucovorin Calcium Injection USP,1,V03AF03,Calcium folinate,Solution,"Intravenous,Intramuscular",02183005,LEUCOVORIN CALCIUM INJECTION USP (leucovorin (leucovorin calcium) 50 mg per 5 mL solution for injection vial) PFIZER CANADA ULC,Active,9013188,leucovorin (leucovorin calcium) 50 mg per 5 mL solution for injection vial,8001833,leucovorin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
97064,Marketed,2019-09-19,02480042,Leucovorin Calcium Injection,1,V03AF03,Calcium folinate,Solution,"Intravenous,Intramuscular",02480042,LEUCOVORIN CALCIUM INJECTION (leucovorin (leucovorin calcium) 50 mg per 5 mL solution for injection vial) GENERIC MEDICAL PARTNERS INC,Active,9013188,leucovorin (leucovorin calcium) 50 mg per 5 mL solution for injection vial,8001833,leucovorin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
98337,Marketed,2019-12-02,02493357,Riva Leucovorin,1,V03AF03,Calcium folinate,Tablet,Oral,02493357,RIVA LEUCOVORIN (leucovorin (leucovorin calcium) 5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9002948,leucovorin (leucovorin calcium) 5 mg oral tablet,8001833,leucovorin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98666,Marketed,2021-01-12,02496828,Mint-Leucovorin,1,V03AF03,Calcium folinate,Tablet,Oral,02496828,MINT-LEUCOVORIN (leucovorin (leucovorin calcium) 5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9002948,leucovorin (leucovorin calcium) 5 mg oral tablet,8001833,leucovorin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98680,Marketed,2021-08-17,02496925,Leucovorin Calcium Injection,1,V03AF03,Calcium folinate,Solution,Intravenous,02496925,LEUCOVORIN CALCIUM INJECTION (leucovorin (leucovorin calcium) 1000 mg per 100 mL solution for injection vial) GENERIC MEDICAL PARTNERS INC,Active,9014700,leucovorin (leucovorin calcium) 1000 mg per 100 mL solution for injection vial,8001833,leucovorin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
101221,Marketed,2022-06-17,02523140,"Calcium Gluconate Injection, USP 10%",1,B05XA19,Calcium gluconate,Solution,Intravenous,02523140,"CALCIUM GLUCONATE INJECTION, USP 10% (calcium gluconate 100 mg per mL solution for injection 500 mL bag) BAXTER CORPORATION",Active,9014732,calcium gluconate 100 mg per mL solution for injection 500 mL bag,8002249,calcium gluconate,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Ethical
102734,Marketed,2025-10-06,02538644,2% Calcium Gluconate In Sodium Chloride Injection,1,B05XA19,Calcium gluconate,Solution,Intravenous,77701193,2% CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION (calcium gluconate 2000 mg per 100 mL solution for injection bag) FRESENIUS KABI CANADA LTD,Active,9015275,calcium gluconate 2000 mg per 100 mL solution for injection bag,8002249,calcium gluconate,738984000,Parenteral,385219001,Solution for injection,732982009,Bag,,,,Ethical
102734,Marketed,2025-10-06,02538644,2% Calcium Gluconate In Sodium Chloride Injection,1,B05XA19,Calcium gluconate,Solution,Intravenous,77701194,2% CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION (calcium gluconate 1000 mg per 50 mL solution for injection bag) FRESENIUS KABI CANADA LTD,Active,9015274,calcium gluconate 1000 mg per 50 mL solution for injection bag,8002249,calcium gluconate,738984000,Parenteral,385219001,Solution for injection,732982009,Bag,,,,Ethical
104384,Marketed,2025-04-17,02555042,Calcium Gluconate Injection USP 10%,1,B05XA19,Calcium gluconate,Solution,Intravenous,77701175,CALCIUM GLUCONATE INJECTION USP 10% (calcium gluconate 100 mg per mL solution for injection 100 mL vial) STERIMAX INC,Active,9013901,calcium gluconate 100 mg per mL solution for injection 100 mL vial,8002249,calcium gluconate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
104384,Marketed,2025-04-17,02555042,Calcium Gluconate Injection USP 10%,1,B05XA19,Calcium gluconate,Solution,Intravenous,77701176,CALCIUM GLUCONATE INJECTION USP 10% (calcium gluconate 1000 mg per 10 mL solution for injection vial) STERIMAX INC,Active,9013902,calcium gluconate 1000 mg per 10 mL solution for injection vial,8002249,calcium gluconate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
104384,Marketed,2025-04-17,02555042,Calcium Gluconate Injection USP 10%,1,B05XA19,Calcium gluconate,Solution,Intravenous,77701177,CALCIUM GLUCONATE INJECTION USP 10% (calcium gluconate 5000 mg per 50 mL solution for injection vial) STERIMAX INC,Active,9013903,calcium gluconate 5000 mg per 50 mL solution for injection vial,8002249,calcium gluconate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
106026,Marketed,2025-10-06,02556871,Calcium Gluconate In Sodium Chloride Injection,1,B05XA19,Calcium gluconate,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
18936,Marketed,2015-07-15,02141019,"Calcium Gluconate Injection, USP 10%",1,B05XA19,Calcium gluconate,Solution,Intravenous,77700838,"CALCIUM GLUCONATE INJECTION, USP 10% (calcium gluconate 1000 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013902,calcium gluconate 1000 mg per 10 mL solution for injection vial,8002249,calcium gluconate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
18936,Marketed,2015-07-15,02141019,"Calcium Gluconate Injection, USP 10%",1,B05XA19,Calcium gluconate,Solution,Intravenous,77700839,"CALCIUM GLUCONATE INJECTION, USP 10% (calcium gluconate 100 mg per mL solution for injection 100 mL vial) FRESENIUS KABI CANADA LTD",Active,9013901,calcium gluconate 100 mg per mL solution for injection 100 mL vial,8002249,calcium gluconate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
18936,Marketed,2015-07-15,02141019,"Calcium Gluconate Injection, USP 10%",1,B05XA19,Calcium gluconate,Solution,Intravenous,77700840,"CALCIUM GLUCONATE INJECTION, USP 10% (calcium gluconate 5000 mg per 50 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013903,calcium gluconate 5000 mg per 50 mL solution for injection vial,8002249,calcium gluconate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
103194,Marketed,2026-01-02,02543486,JAMP Canagliflozin,1,A10BK02,Canagliflozin,Tablet,Oral,02543486,JAMP CANAGLIFLOZIN (canagliflozin 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9005536,canagliflozin 100 mg oral tablet,8001126,canagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103195,Marketed,2026-01-02,02543494,JAMP Canagliflozin,1,A10BK02,Canagliflozin,Tablet,Oral,02543494,JAMP CANAGLIFLOZIN (canagliflozin 300 mg oral tablet) JAMP PHARMA CORPORATION,Active,9005527,canagliflozin 300 mg oral tablet,8001126,canagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106724,Marketed,2026-05-29,02564556,Apo-Canagliflozin,1,A10BK02,Canagliflozin,Tablet,Oral,02564556,APO-CANAGLIFLOZIN (canagliflozin 100 mg oral tablet) APOTEX INC,Active,9005536,canagliflozin 100 mg oral tablet,8001126,canagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106725,Marketed,2026-05-29,02564564,Apo-Canagliflozin,1,A10BK02,Canagliflozin,Tablet,Oral,02564564,APO-CANAGLIFLOZIN (canagliflozin 300 mg oral tablet) APOTEX INC,Active,9005527,canagliflozin 300 mg oral tablet,8001126,canagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91013,Marketed,2014-06-03,02425483,Invokana,1,A10BK02,Canagliflozin,Tablet,Oral,02425483,INVOKANA (canagliflozin 100 mg oral tablet) JANSSEN INC,Active,9005536,canagliflozin 100 mg oral tablet,8001126,canagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91014,Marketed,2014-05-28,02425491,Invokana,1,A10BK02,Canagliflozin,Tablet,Oral,02425491,INVOKANA (canagliflozin 300 mg oral tablet) JANSSEN INC,Active,9005527,canagliflozin 300 mg oral tablet,8001126,canagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99959,Marketed,2026-01-02,02510367,Auro-Canagliflozin,1,A10BK02,Canagliflozin,Tablet,Oral,02510367,AURO-CANAGLIFLOZIN (canagliflozin 100 mg oral tablet) AURO PHARMA INC,Active,9005536,canagliflozin 100 mg oral tablet,8001126,canagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99960,Marketed,2026-01-02,02510375,Auro-Canagliflozin,1,A10BK02,Canagliflozin,Tablet,Oral,02510375,AURO-CANAGLIFLOZIN (canagliflozin 300 mg oral tablet) AURO PHARMA INC,Active,9005527,canagliflozin 300 mg oral tablet,8001126,canagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94767,Marketed,2017-08-22,02460351,Ilaris,1,L04AC08,Canakinumab,Solution,Subcutaneous,02460351,ILARIS (canakinumab 150 mg per 1 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012928,canakinumab 150 mg per 1 mL solution for injection vial,8001606,canakinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
94767,Marketed,2017-08-22,02460351,Ilaris,1,L04AC08,Canakinumab,Solution,Subcutaneous,02460351,ILARIS (canakinumab 150 mg per 1 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012928,canakinumab 150 mg per 1 mL solution for injection vial,8001606,canakinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
102039,Marketed,2023-07-20,02531240,Nra-Candesartan HCTZ,2,C09DA06,Candersartan and diuretics,Tablet,Oral,02531240,NRA-CANDESARTAN HCTZ (candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet) NORA PHARMA INC,Active,9000946,candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102040,Marketed,2023-07-20,02531259,Nra-Candesartan HCTZ,2,C09DA06,Candersartan and diuretics,Tablet,Oral,02531259,NRA-CANDESARTAN HCTZ (candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet) NORA PHARMA INC,Active,9001282,candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102041,Marketed,2023-07-20,02531267,Nra-Candesartan HCTZ,2,C09DA06,Candersartan and diuretics,Tablet,Oral,02531267,NRA-CANDESARTAN HCTZ (candesartan cilexetil 32 mg and hydrochlorothiazide 25 mg oral tablet) NORA PHARMA INC,Active,9001283,candesartan cilexetil 32 mg and hydrochlorothiazide 25 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102488,Marketed,2024-02-21,02536064,Candesartan/HCTZ,2,C09DA06,Candersartan and diuretics,Tablet,Oral,02536064,CANDESARTAN/HCTZ (candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet) SANIS HEALTH INC,Active,9001282,candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
67964,Marketed,2025-06-10,02244021,Atacand Plus,2,C09DA06,Candersartan and diuretics,Tablet,Oral,02244021,ATACAND PLUS (candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9000946,candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81340,Marketed,2012-09-24,02327902,Sandoz Candesartan Plus,2,C09DA06,Candersartan and diuretics,Tablet,Oral,02327902,SANDOZ CANDESARTAN PLUS (candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000946,candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81858,Marketed,2025-06-19,02332922,Atacand Plus,2,C09DA06,Candersartan and diuretics,Tablet,Oral,02332922,ATACAND PLUS (candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9001282,candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81859,Marketed,2025-06-25,02332957,Atacand Plus,2,C09DA06,Candersartan and diuretics,Tablet,Oral,02332957,ATACAND PLUS (candesartan cilexetil 32 mg and hydrochlorothiazide 25 mg oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9001283,candesartan cilexetil 32 mg and hydrochlorothiazide 25 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87664,Marketed,2012-09-24,02391295,PMS-Candesartan-HCTZ,2,C09DA06,Candersartan and diuretics,Tablet,Oral,02391295,PMS-CANDESARTAN-HCTZ (candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet) PHARMASCIENCE INC,Active,9000946,candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87755,Marketed,2012-10-17,02392275,Candesartan-HCTZ,2,C09DA06,Candersartan and diuretics,Tablet,Oral,02392275,CANDESARTAN-HCTZ (candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet) PRO DOC LIMITEE,Active,9000946,candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87995,Marketed,2024-02-21,02394804,Candesartan/HCTZ,2,C09DA06,Candersartan and diuretics,Tablet,Oral,02394804,CANDESARTAN/HCTZ (candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet) SANIS HEALTH INC,Active,9000946,candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87997,Marketed,2012-10-18,02394812,Candesartan HCTZ,2,C09DA06,Candersartan and diuretics,Tablet,Oral,02394812,CANDESARTAN HCT (candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000946,candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88063,Marketed,2013-09-23,02395541,Teva-Candesartan/HCTZ,2,C09DA06,Candersartan and diuretics,Tablet,Oral,02395541,TEVA-CANDESARTAN/HCTZ (candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet) TEVA CANADA LIMITED,Active,9000946,candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88064,Marketed,2013-06-19,02395568,Teva-Candesartan/HCTZ,2,C09DA06,Candersartan and diuretics,Tablet,Oral,02395568,TEVA-CANDESARTAN/HCTZ (candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet) TEVA CANADA LIMITED,Active,9001282,candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90530,Marketed,2014-02-12,02420732,Sandoz Candesartan Plus,2,C09DA06,Candersartan and diuretics,Tablet,Oral,02420732,SANDOZ CANDESARTAN PLUS (candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001282,candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90531,Marketed,2014-02-12,02420740,Sandoz Candesartan Plus,2,C09DA06,Candersartan and diuretics,Tablet,Oral,02420740,SANDOZ CANDESARTAN PLUS (candesartan cilexetil 32 mg and hydrochlorothiazide 25 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001283,candesartan cilexetil 32 mg and hydrochlorothiazide 25 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90562,Marketed,2015-03-17,02421038,Auro-Candesartan HCTZ,2,C09DA06,Candersartan and diuretics,Tablet,Oral,02421038,AURO-CANDESARTAN HCT (candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet) AURO PHARMA INC,Active,9000946,candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90563,Marketed,2015-03-17,02421046,Auro-Candesartan HCTZ,2,C09DA06,Candersartan and diuretics,Tablet,Oral,02421046,AURO-CANDESARTAN HCT (candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet) AURO PHARMA INC,Active,9001282,candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90564,Marketed,2015-03-17,02421054,Auro-Candesartan HCTZ,2,C09DA06,Candersartan and diuretics,Tablet,Oral,02421054,AURO-CANDESARTAN HCT (candesartan cilexetil 32 mg and hydrochlorothiazide 25 mg oral tablet) AURO PHARMA INC,Active,9001283,candesartan cilexetil 32 mg and hydrochlorothiazide 25 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96264,Marketed,2020-03-23,02473240,JAMP Candesartan-HCTZ,2,C09DA06,Candersartan and diuretics,Tablet,Oral,02473240,JAMP CANDESARTAN-HCT (candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000946,candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96265,Marketed,2020-03-23,02473259,JAMP Candesartan-HCTZ,2,C09DA06,Candersartan and diuretics,Tablet,Oral,02473259,JAMP CANDESARTAN-HCT (candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001282,candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96266,Marketed,2020-03-23,02473267,JAMP Candesartan-HCTZ,2,C09DA06,Candersartan and diuretics,Tablet,Oral,02473267,JAMP CANDESARTAN-HCT (candesartan cilexetil 32 mg and hydrochlorothiazide 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001283,candesartan cilexetil 32 mg and hydrochlorothiazide 25 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101606,Marketed,2023-05-03,02527006,Nra-Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02527006,NRA-CANDESARTAN (candesartan cilexetil 4 mg oral tablet) NORA PHARMA INC,Active,9001114,candesartan cilexetil 4 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101607,Marketed,2022-11-15,02527014,Nra-Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02527014,NRA-CANDESARTAN (candesartan cilexetil 8 mg oral tablet) NORA PHARMA INC,Active,9000831,candesartan cilexetil 8 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101608,Marketed,2022-11-15,02527022,Nra-Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02527022,NRA-CANDESARTAN (candesartan cilexetil 16 mg oral tablet) NORA PHARMA INC,Active,9000830,candesartan cilexetil 16 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101609,Marketed,2022-11-15,02527030,Nra-Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02527030,NRA-CANDESARTAN (candesartan cilexetil 32 mg oral tablet) NORA PHARMA INC,Active,9001253,candesartan cilexetil 32 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101749,Marketed,2023-03-16,02528258,Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02528258,CANDESARTAN (candesartan cilexetil 4 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001114,candesartan cilexetil 4 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101750,Marketed,2023-03-16,02528266,Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02528266,CANDESARTAN (candesartan cilexetil 32 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001253,candesartan cilexetil 32 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102993,Marketed,2024-05-21,02541289,Apo-Candesartan Tablets,1,C09CA06,Candesartan,Tablet,Oral,02541289,APO-CANDESARTAN TABLETS (candesartan cilexetil 4 mg oral tablet) APOTEX INC,Active,9001114,candesartan cilexetil 4 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102994,Marketed,2024-05-21,02541297,Apo-Candesartan Tablets,1,C09CA06,Candesartan,Tablet,Oral,02541297,APO-CANDESARTAN TABLETS (candesartan cilexetil 8 mg oral tablet) APOTEX INC,Active,9000831,candesartan cilexetil 8 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102995,Marketed,2024-05-21,02541300,Apo-Candesartan Tablets,1,C09CA06,Candesartan,Tablet,Oral,02541300,APO-CANDESARTAN TABLETS (candesartan cilexetil 16 mg oral tablet) APOTEX INC,Active,9000830,candesartan cilexetil 16 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102996,Marketed,2024-05-21,02541319,Apo-Candesartan Tablets,1,C09CA06,Candesartan,Tablet,Oral,02541319,APO-CANDESARTAN TABLETS (candesartan cilexetil 32 mg oral tablet) APOTEX INC,Active,9001253,candesartan cilexetil 32 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
62546,Marketed,2025-06-19,02239090,Atacand,1,C09CA06,Candesartan,Tablet,Oral,02239090,ATACAND (candesartan cilexetil 4 mg oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9001114,candesartan cilexetil 4 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
62547,Marketed,2025-06-09,02239091,Atacand,1,C09CA06,Candesartan,Tablet,Oral,02239091,ATACAND (candesartan cilexetil 8 mg oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9000831,candesartan cilexetil 8 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
62548,Marketed,2025-07-07,02239092,Atacand,1,C09CA06,Candesartan,Tablet,Oral,02239092,ATACAND (candesartan cilexetil 16 mg oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9000830,candesartan cilexetil 16 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79720,Marketed,2025-06-11,02311658,Atacand,1,C09CA06,Candesartan,Tablet,Oral,02311658,ATACAND (candesartan cilexetil 32 mg oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9001253,candesartan cilexetil 32 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81228,Marketed,2011-04-26,02326957,Sandoz Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02326957,SANDOZ CANDESARTAN (candesartan cilexetil 4 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001114,candesartan cilexetil 4 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81229,Marketed,2011-04-26,02326965,Sandoz Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02326965,SANDOZ CANDESARTAN (candesartan cilexetil 8 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000831,candesartan cilexetil 8 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81230,Marketed,2011-04-26,02326973,Sandoz Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02326973,SANDOZ CANDESARTAN (candesartan cilexetil 16 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000830,candesartan cilexetil 16 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85116,Marketed,2012-06-01,02366312,Teva-Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02366312,TEVA-CANDESARTAN (candesartan cilexetil 8 mg oral tablet) TEVA CANADA LIMITED,Active,9000831,candesartan cilexetil 8 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85118,Marketed,2012-06-01,02366320,Teva-Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02366320,TEVA-CANDESARTAN (candesartan cilexetil 16 mg oral tablet) TEVA CANADA LIMITED,Active,9000830,candesartan cilexetil 16 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85119,Marketed,2012-06-01,02366339,Teva-Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02366339,TEVA-CANDESARTAN (candesartan cilexetil 32 mg oral tablet) TEVA CANADA LIMITED,Active,9001253,candesartan cilexetil 32 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86372,Marketed,2012-02-08,02377934,Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02377934,CANDESARTAN (candesartan cilexetil 8 mg oral tablet) PRO DOC LIMITEE,Active,9000831,candesartan cilexetil 8 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86373,Marketed,2012-02-08,02377942,Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02377942,CANDESARTAN (candesartan cilexetil 16 mg oral tablet) PRO DOC LIMITEE,Active,9000830,candesartan cilexetil 16 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86515,Marketed,2014-08-15,02379279,ACH-Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02379279,ACH-CANDESARTAN (candesartan cilexetil 8 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000831,candesartan cilexetil 8 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86516,Marketed,2014-08-15,02379287,ACH-Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02379287,ACH-CANDESARTAN (candesartan cilexetil 16 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000830,candesartan cilexetil 16 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86517,Marketed,2014-08-15,02379295,ACH-Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02379295,ACH-CANDESARTAN (candesartan cilexetil 32 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001253,candesartan cilexetil 32 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86646,Marketed,2020-03-04,02380684,Taro-Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02380684,TARO-CANDESARTAN (candesartan cilexetil 4 mg oral tablet) SUN PHARMA CANADA INC,Active,9001114,candesartan cilexetil 4 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86647,Marketed,2020-03-04,02380692,Taro-Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02380692,TARO-CANDESARTAN (candesartan cilexetil 8 mg oral tablet) SUN PHARMA CANADA INC,Active,9000831,candesartan cilexetil 8 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86648,Marketed,2020-03-04,02380706,Taro-Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02380706,TARO-CANDESARTAN (candesartan cilexetil 16 mg oral tablet) SUN PHARMA CANADA INC,Active,9000830,candesartan cilexetil 16 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86649,Marketed,2020-03-04,02380714,Taro-Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02380714,TARO-CANDESARTAN (candesartan cilexetil 32 mg oral tablet) SUN PHARMA CANADA INC,Active,9001253,candesartan cilexetil 32 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87208,Marketed,2020-04-20,02386518,JAMP-Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02386518,JAMP-CANDESARTAN (candesartan cilexetil 8 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000831,candesartan cilexetil 8 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87209,Marketed,2020-04-20,02386526,JAMP-Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02386526,JAMP-CANDESARTAN (candesartan cilexetil 16 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000830,candesartan cilexetil 16 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87210,Marketed,2020-04-20,02386534,JAMP-Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02386534,JAMP-CANDESARTAN (candesartan cilexetil 32 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001253,candesartan cilexetil 32 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87423,Marketed,2022-06-21,02388707,Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02388707,CANDESARTAN (candesartan cilexetil 8 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000831,candesartan cilexetil 8 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87424,Marketed,2022-06-21,02388715,Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02388715,CANDESARTAN (candesartan cilexetil 16 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000830,candesartan cilexetil 16 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87654,Marketed,2012-08-06,02391171,PMS-Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02391171,PMS-CANDESARTAN (candesartan cilexetil 4 mg oral tablet) PHARMASCIENCE INC,Active,9001114,candesartan cilexetil 4 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87655,Marketed,2012-08-06,02391198,PMS-Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02391198,PMS-CANDESARTAN (candesartan cilexetil 8 mg oral tablet) PHARMASCIENCE INC,Active,9000831,candesartan cilexetil 8 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87656,Marketed,2012-08-06,02391201,PMS-Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02391201,PMS-CANDESARTAN (candesartan cilexetil 16 mg oral tablet) PHARMASCIENCE INC,Active,9000830,candesartan cilexetil 16 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87657,Marketed,2012-08-06,02391228,PMS-Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02391228,PMS-CANDESARTAN (candesartan cilexetil 32 mg oral tablet) PHARMASCIENCE INC,Active,9001253,candesartan cilexetil 32 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90197,Marketed,2014-03-19,02417340,Sandoz Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02417340,SANDOZ CANDESARTAN (candesartan cilexetil 32 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001253,candesartan cilexetil 32 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90678,Marketed,2014-06-05,02422069,Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02422069,CANDESARTAN (candesartan cilexetil 32 mg oral tablet) PRO DOC LIMITEE,Active,9001253,candesartan cilexetil 32 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93106,Marketed,2018-06-28,02445786,Auro-Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02445786,AURO-CANDESARTAN (candesartan cilexetil 4 mg oral tablet) AURO PHARMA INC,Active,9001114,candesartan cilexetil 4 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93107,Marketed,2018-06-28,02445794,Auro-Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02445794,AURO-CANDESARTAN (candesartan cilexetil 8 mg oral tablet) AURO PHARMA INC,Active,9000831,candesartan cilexetil 8 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93108,Marketed,2019-02-11,02445808,Auro-Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02445808,AURO-CANDESARTAN (candesartan cilexetil 16 mg oral tablet) AURO PHARMA INC,Active,9000830,candesartan cilexetil 16 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93109,Marketed,2019-02-11,02445816,Auro-Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02445816,AURO-CANDESARTAN (candesartan cilexetil 32 mg oral tablet) AURO PHARMA INC,Active,9001253,candesartan cilexetil 32 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96769,Marketed,2023-04-14,02476908,Mint-Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02476908,MINT-CANDESARTAN (candesartan cilexetil 4 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001114,candesartan cilexetil 4 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96770,Marketed,2018-10-19,02476916,Mint-Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02476916,MINT-CANDESARTAN (candesartan cilexetil 8 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000831,candesartan cilexetil 8 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96771,Marketed,2018-10-19,02476924,Mint-Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02476924,MINT-CANDESARTAN (candesartan cilexetil 16 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000830,candesartan cilexetil 16 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96772,Marketed,2024-01-11,02476932,Mint-Candesartan,1,C09CA06,Candesartan,Tablet,Oral,02476932,MINT-CANDESARTAN (candesartan cilexetil 32 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001253,candesartan cilexetil 32 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99045,Marketed,2020-08-12,02500795,AG-Candesartan Tablets,1,C09CA06,Candesartan,Tablet,Oral,02500795,AG-CANDESARTAN TABLETS (candesartan cilexetil 8 mg oral tablet) ANGITA PHARMA INC.,Active,9000831,candesartan cilexetil 8 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99046,Marketed,2020-08-12,02500809,AG-Candesartan Tablets,1,C09CA06,Candesartan,Tablet,Oral,02500809,AG-CANDESARTAN TABLETS (candesartan cilexetil 16 mg oral tablet) ANGITA PHARMA INC.,Active,9000830,candesartan cilexetil 16 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99047,Marketed,2020-08-12,02500817,AG-Candesartan Tablets,1,C09CA06,Candesartan,Tablet,Oral,02500817,AG-CANDESARTAN TABLETS (candesartan cilexetil 32 mg oral tablet) ANGITA PHARMA INC.,Active,9001253,candesartan cilexetil 32 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102353,Marketed,2023-11-30,02534622,Kengrexal,1,B01AC25,Cangrelor,Powder for solution,Intravenous,02534622,KENGREXAL (cangrelor (cangrelor tetrasodium) 50 mg per vial powder for solution for injection) CHIESI FARMACEUTICI S.P.A.,Active,9014961,cangrelor (cangrelor tetrasodium) 50 mg per vial powder for solution for injection,8002489,cangrelor,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
103157,Marketed,2024-12-10,02543079,Epidiolex,1,N03AX24,Cannabidiol,Solution,Oral,,,,,,,,,,,,,,,,,Prescription
75157,Marketed,2024-12-17,02266121,Sativex,2,N02BG10,Cannabinoids,Spray,Buccal,02266121,SATIVEX (cannabidiol 2.5 mg per actuation and tetrahydrocannabinol 2.7 mg per actuation oromucosal spray) JAZZ PHARMACEUTICALS OPERATIONS UK LIMITED,Active,9013659,cannabidiol 2.5 mg per actuation and tetrahydrocannabinol 2.7 mg per actuation oromucosal spray,8002180,cannabidiol and tetrahydrocannabinol,372473007,Oromucosal,421720008,Spray,732981002,Actuation (unit of presentation),,,,Prescription
100438,Marketed,2021-10-22,02514982,Capecitabine,1,L01BC06,Capecitabine,Tablet,Oral,02514982,CAPECITABINE (capecitabine 150 mg oral tablet) SANIS HEALTH INC,Active,9003303,capecitabine 150 mg oral tablet,8001607,capecitabine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100439,Marketed,2021-10-22,02514990,Capecitabine,1,L01BC06,Capecitabine,Tablet,Oral,02514990,CAPECITABINE (capecitabine 500 mg oral tablet) SANIS HEALTH INC,Active,9003304,capecitabine 500 mg oral tablet,8001607,capecitabine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100911,Marketed,2022-06-15,02519879,Capecitabine,1,L01BC06,Capecitabine,Tablet,Oral,02519879,CAPECITABINE (capecitabine 150 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003303,capecitabine 150 mg oral tablet,8001607,capecitabine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100912,Marketed,2022-06-16,02519887,Capecitabine,1,L01BC06,Capecitabine,Tablet,Oral,02519887,CAPECITABINE (capecitabine 500 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003304,capecitabine 500 mg oral tablet,8001607,capecitabine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
90661,Marketed,2014-07-23,02421917,Sandoz Capecitabine,1,L01BC06,Capecitabine,Tablet,Oral,02421917,SANDOZ CAPECITABINE (capecitabine 150 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003303,capecitabine 150 mg oral tablet,8001607,capecitabine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
90662,Marketed,2014-07-23,02421925,Sandoz Capecitabine,1,L01BC06,Capecitabine,Tablet,Oral,02421925,SANDOZ CAPECITABINE (capecitabine 500 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003304,capecitabine 500 mg oral tablet,8001607,capecitabine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
91132,Marketed,2014-09-19,02426757,ACH-Capecitabine,1,L01BC06,Capecitabine,Tablet,Oral,02426757,ACH-CAPECITABINE (capecitabine 150 mg oral tablet) ACCORD HEALTHCARE INC,Active,9003303,capecitabine 150 mg oral tablet,8001607,capecitabine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
91133,Marketed,2014-09-19,02426765,ACH-Capecitabine,1,L01BC06,Capecitabine,Tablet,Oral,02426765,ACH-CAPECITABINE (capecitabine 500 mg oral tablet) ACCORD HEALTHCARE INC,Active,9003304,capecitabine 500 mg oral tablet,8001607,capecitabine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
94454,Marketed,2017-08-31,02457490,Taro-Capecitabine,1,L01BC06,Capecitabine,Tablet,Oral,02457490,TARO-CAPECITABINE (capecitabine 150 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9003303,capecitabine 150 mg oral tablet,8001607,capecitabine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
94455,Marketed,2017-08-31,02457504,Taro-Capecitabine,1,L01BC06,Capecitabine,Tablet,Oral,02457504,TARO-CAPECITABINE (capecitabine 500 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9003304,capecitabine 500 mg oral tablet,8001607,capecitabine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99738,Marketed,2021-10-05,02508028,Mint-Capecitabine,1,L01BC06,Capecitabine,Tablet,Oral,02508028,MINT-CAPECITABINE (capecitabine 500 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9003304,capecitabine 500 mg oral tablet,8001607,capecitabine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
103334,Marketed,2024-04-16,02544733,Truqap,1,L01EX27,Capivasertib,Tablet,Oral,02544733,TRUQAP (capivasertib 160 mg oral tablet) ASTRAZENECA CANADA INC,Active,9015033,capivasertib 160 mg oral tablet,8002504,capivasertib,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
103335,Marketed,2024-04-01,02544741,Truqap,1,L01EX27,Capivasertib,Tablet,Oral,02544741,TRUQAP (capivasertib 200 mg oral tablet) ASTRAZENECA CANADA INC,Active,9015034,capivasertib 200 mg oral tablet,8002504,capivasertib,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101646,Marketed,2022-09-16,02527391,Tabrecta,1,L01EP01,Capmatinib,Tablet,Oral,02527391,TABRECTA (capmatinib (capmatinib hydrochloride) 150 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014774,capmatinib (capmatinib hydrochloride) 150 mg oral tablet,8002442,capmatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101647,Marketed,2022-09-16,02527405,Tabrecta,1,L01EP01,Capmatinib,Tablet,Oral,02527405,TABRECTA (capmatinib (capmatinib hydrochloride) 200 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014775,capmatinib (capmatinib hydrochloride) 200 mg oral tablet,8002442,capmatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
103233,Marketed,2024-10-28,02543907,Noyada,1,C09AA01,Captopril,Solution,Oral,02543907,NOYADA (captopril 5 mg per 5 mL oral solution) ETHYPHARM INC,Active,9015133,captopril 5 mg per 5 mL oral solution,8000847,captopril,26643006,Oral,385023001,Oral solution,,,,,,Prescription
103234,Marketed,2024-10-28,02543915,Noyada,1,C09AA01,Captopril,Solution,Oral,02543915,NOYADA (captopril 25 mg per 5 mL oral solution) ETHYPHARM INC,Active,9015108,captopril 25 mg per 5 mL oral solution,8000847,captopril,26643006,Oral,385023001,Oral solution,,,,,,Prescription
10900,Marketed,1990-12-31,00893625,Apo-Capto Tablets 100 mg,1,C09AA01,Captopril,Tablet,Oral,00893625,APO-CAPTO TAB 100MG (captopril 100 mg oral tablet) APOTEX INC,Active,9008155,captopril 100 mg oral tablet,8000847,captopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
10906,Marketed,1990-12-31,00893595,Apo-Capto Tablets 12.5 mg,1,C09AA01,Captopril,Tablet,Oral,00893595,APO-CAPTO TAB 12.5MG (captopril 12.5 mg oral tablet) APOTEX INC,Active,9008156,captopril 12.5 mg oral tablet,8000847,captopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
10908,Marketed,1990-12-31,00893617,Apo-Capto Tablets 50 mg,1,C09AA01,Captopril,Tablet,Oral,00893617,APO-CAPTO TAB 50MG (captopril 50 mg oral tablet) APOTEX INC,Active,9008158,captopril 50 mg oral tablet,8000847,captopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
11760,Marketed,2011-07-06,01942964,Teva-Captopril,1,C09AA01,Captopril,Tablet,Oral,01942964,TEVA-CAPTOPRIL (captopril 12.5 mg oral tablet) TEVA CANADA LIMITED,Active,9008156,captopril 12.5 mg oral tablet,8000847,captopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
11763,Marketed,2011-07-06,01942972,Teva-Captopril,1,C09AA01,Captopril,Tablet,Oral,01942972,TEVA-CAPTOPRIL (captopril 25 mg oral tablet) TEVA CANADA LIMITED,Active,9008157,captopril 25 mg oral tablet,8000847,captopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
11764,Marketed,2011-07-06,01942980,Teva-Captopril,1,C09AA01,Captopril,Tablet,Oral,01942980,TEVA-CAPTOPRIL (captopril 50 mg oral tablet) TEVA CANADA LIMITED,Active,9008158,captopril 50 mg oral tablet,8000847,captopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
11765,Marketed,2011-07-06,01942999,Teva-Captopril,1,C09AA01,Captopril,Tablet,Oral,01942999,TEVA-CAPTOPRIL (captopril 100 mg oral tablet) TEVA CANADA LIMITED,Active,9008155,captopril 100 mg oral tablet,8000847,captopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
3906,Marketed,1980-12-31,00042544,Miostat Ophthalmic Liquid 0.01%,1,S01EB02,Carbachol,Solution,Intraocular,00042544,MIOSTAT OPHTHALMIC LIQ 0.01% (carbachol 0.01 % solution for injection 1.5 mL vial) ALCON CANADA INC,Active,9012929,carbachol 0.01 % solution for injection 1.5 mL vial,8001608,carbachol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
102988,Marketed,2024-04-19,02541238,Mint-Carbamazepine,1,N03AF01,Carbamazepine,Tablet,Oral,02541238,MINT-CARBAMAZEPINE (carbamazepine 200 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000047,carbamazepine 200 mg oral tablet,8000032,carbamazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
19729,Marketed,1999-06-10,02194333,Tegretol Suspension,1,N03AF01,Carbamazepine,Suspension,Oral,02194333,TEGRETOL SUSPENSION (carbamazepine 100 mg per 5 mL oral suspension) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9000678,carbamazepine 100 mg per 5 mL oral suspension,8000032,carbamazepine,26643006,Oral,385024007,Oral suspension,,,1.0,,,Prescription
68372,Marketed,2002-04-19,02244403,Taro-Carbamazepine Chewable Tablets,1,N03AF01,Carbamazepine,Tablet (chewable),Oral,02244403,TARO-CARBAMAZEPINE CHEWABLE TABLETS (carbamazepine 100 mg chewable tablet) TARO PHARMACEUTICALS INC,Active,9000219,carbamazepine 100 mg chewable tablet,8000032,carbamazepine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
68373,Marketed,2002-04-19,02244404,Taro-Carbamazepine Chewable Tablets,1,N03AF01,Carbamazepine,Tablet (chewable),Oral,02244404,TARO-CARBAMAZEPINE CHEWABLE TABLETS (carbamazepine 200 mg chewable tablet) TARO PHARMACEUTICALS INC,Active,9000220,carbamazepine 200 mg chewable tablet,8000032,carbamazepine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
74720,Marketed,2006-02-02,02261839,Sandoz-Carbamazepine CR,1,N03AF01,Carbamazepine,Tablet (extended-release),Oral,02261839,SANDOZ-CARBAMAZEPINE CR (carbamazepine 200 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9000288,carbamazepine 200 mg prolonged-release oral tablet,8000032,carbamazepine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
74721,Marketed,2006-02-02,02261847,Sandoz-Carbamazepine CR,1,N03AF01,Carbamazepine,Tablet (extended-release),Oral,02261847,SANDOZ-CARBAMAZEPINE CR (carbamazepine 400 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9000289,carbamazepine 400 mg prolonged-release oral tablet,8000032,carbamazepine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
777,Marketed,1997-12-15,00010405,Tegretol,1,N03AF01,Carbamazepine,Tablet,Oral,00010405,TEGRETOL (carbamazepine 200 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9000047,carbamazepine 200 mg oral tablet,8000032,carbamazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
8373,Marketed,1999-03-10,00773611,Tegretol CR,1,N03AF01,Carbamazepine,Tablet (extended-release),Oral,00773611,TEGRETOL CR (carbamazepine 200 mg prolonged-release oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9000288,carbamazepine 200 mg prolonged-release oral tablet,8000032,carbamazepine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
8374,Marketed,1998-08-18,00755583,Tegretol CR,1,N03AF01,Carbamazepine,Tablet (extended-release),Oral,00755583,TEGRETOL CR (carbamazepine 400 mg prolonged-release oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9000289,carbamazepine 400 mg prolonged-release oral tablet,8000032,carbamazepine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
85224,Marketed,2011-10-07,02367394,Taro-Carbamazepine,1,N03AF01,Carbamazepine,Suspension,Oral,02367394,TARO-CARBAMAZEPINE (carbamazepine 100 mg per 5 mL oral suspension) TARO PHARMACEUTICALS INC,Active,9000678,carbamazepine 100 mg per 5 mL oral suspension,8000032,carbamazepine,26643006,Oral,385024007,Oral suspension,,,1.0,,,Prescription
9242,Marketed,2010-11-26,00782718,Teva-Carbamazepine,1,N03AF01,Carbamazepine,Tablet,Oral,00782718,TEVA-CARBAMAZEPINE (carbamazepine 200 mg oral tablet) TEVA CANADA LIMITED,Active,9000047,carbamazepine 200 mg oral tablet,8000032,carbamazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
97932,Marketed,2020-09-14,02489244,Carbetocin Injection,1,H01BB03,Carbetocin,Solution,Intravenous,02489244,CARBETOCIN INJECTION (carbetocin 100 mcg per 1 mL solution for injection syringe) JUNO PHARMACEUTICALS CORP.,Active,9014240,carbetocin 100 mcg per 1 mL solution for injection syringe,8001609,carbetocin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
98638,Marketed,2020-08-05,02496526,Duratocin,1,H01BB03,Carbetocin,Solution,"Intravenous,Intramuscular",02496526,DURATOCIN (carbetocin 100 mcg per 1 mL solution for injection vial) FERRING INC,Active,9012930,carbetocin 100 mcg per 1 mL solution for injection vial,8001609,carbetocin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
100647,Marketed,2022-03-30,02517132,Dextrose Injection,1,B05BA03,Carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
10511,Marketed,2019-03-25,00060348,"5% Dextrose Injection, USP",1,B05BA03,Carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
13714,Marketed,1998-04-30,01924281,5% Dextrose Injection USP,1,B05BA03,Carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
14251,Marketed,1998-04-30,01924427,10% Dextrose Injection USP,1,B05BA03,Carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
18686,Marketed,2015-01-20,02014874,70% Dextrose Injection USP,1,B05BA03,Carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
2902,Marketed,2019-11-27,00037915,Dextrose Injection USP,1,B05BA03,Carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
59976,Marketed,2019-03-25,00060364,"10% Dextrose Injection, USP",1,B05BA03,Carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
88832,Marketed,2023-02-03,02403536,5% Dextrose Injection,1,B05BA03,Carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
95694,Marketed,2020-08-18,02468514,Dextrose Injection USP,1,B05BA03,Carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
13884,Marketed,2022-07-29,02014459,Carbon Dioxide USP,1,V03AN02,Carbon dioxide,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
19263,Marketed,2020-08-07,02154730,Carbon Dioxide U.S.P,1,V03AN02,Carbon dioxide,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
5687,Marketed,1911-12-31,00572861,Carbon Dioxide 100%,1,V03AN02,Carbon dioxide,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
17830,Marketed,2013-11-08,02125439,CARBOplatin Injection,1,L01XA02,Carboplatin,Solution,Intravenous,77700662,CARBOPLATIN INJECTION (carboplatin 150 mg per 15 mL solution for injection vial) TEVA CANADA LIMITED,Active,9012931,carboplatin 150 mg per 15 mL solution for injection vial,8001610,carboplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
17830,Marketed,2013-11-08,02125439,CARBOplatin Injection,1,L01XA02,Carboplatin,Solution,Intravenous,77700663,CARBOPLATIN INJECTION (carboplatin 450 mg per 45 mL solution for injection vial) TEVA CANADA LIMITED,Active,9012932,carboplatin 450 mg per 45 mL solution for injection vial,8001610,carboplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
17830,Marketed,2013-11-08,02125439,CARBOplatin Injection,1,L01XA02,Carboplatin,Solution,Intravenous,77700664,CARBOPLATIN INJECTION (carboplatin 600 mg per 60 mL solution for injection vial) TEVA CANADA LIMITED,Active,9012934,carboplatin 600 mg per 60 mL solution for injection vial,8001610,carboplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
17830,Marketed,2013-11-08,02125439,CARBOplatin Injection,1,L01XA02,Carboplatin,Solution,Intravenous,77700665,CARBOPLATIN INJECTION (carboplatin 50 mg per 5 mL solution for injection vial) TEVA CANADA LIMITED,Active,9012933,carboplatin 50 mg per 5 mL solution for injection vial,8001610,carboplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
43846,Marketed,2017-11-11,02126680,CARBOplatin Injection BP,1,L01XA02,Carboplatin,Solution,Intravenous,77700666,CARBOPLATIN INJECTION BP (carboplatin 450 mg per 45 mL solution for injection vial) PFIZER CANADA ULC,Active,9012932,carboplatin 450 mg per 45 mL solution for injection vial,8001610,carboplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
43846,Marketed,2017-11-11,02126680,CARBOplatin Injection BP,1,L01XA02,Carboplatin,Solution,Intravenous,77700667,CARBOPLATIN INJECTION BP (carboplatin 150 mg per 15 mL solution for injection vial) PFIZER CANADA ULC,Active,9012931,carboplatin 150 mg per 15 mL solution for injection vial,8001610,carboplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
43846,Marketed,2017-11-11,02126680,CARBOplatin Injection BP,1,L01XA02,Carboplatin,Solution,Intravenous,77700668,CARBOPLATIN INJECTION BP (carboplatin 600 mg per 60 mL solution for injection vial) PFIZER CANADA ULC,Active,9012934,carboplatin 600 mg per 60 mL solution for injection vial,8001610,carboplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
43846,Marketed,2017-11-11,02126680,CARBOplatin Injection BP,1,L01XA02,Carboplatin,Solution,Intravenous,77700669,CARBOPLATIN INJECTION BP (carboplatin 50 mg per 5 mL solution for injection vial) PFIZER CANADA ULC,Active,9012933,carboplatin 50 mg per 5 mL solution for injection vial,8001610,carboplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
80581,Marketed,2015-03-11,02320371,CARBOplatin Injection BP,1,L01XA02,Carboplatin,Solution,Intravenous,77700687,CARBOPLATIN INJECTION BP (carboplatin 450 mg per 45 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9012932,carboplatin 450 mg per 45 mL solution for injection vial,8001610,carboplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
80581,Marketed,2015-03-11,02320371,CARBOplatin Injection BP,1,L01XA02,Carboplatin,Solution,Intravenous,77700688,CARBOPLATIN INJECTION BP (carboplatin 150 mg per 15 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9012931,carboplatin 150 mg per 15 mL solution for injection vial,8001610,carboplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
80581,Marketed,2015-03-11,02320371,CARBOplatin Injection BP,1,L01XA02,Carboplatin,Solution,Intravenous,77700689,CARBOPLATIN INJECTION BP (carboplatin 50 mg per 5 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9012933,carboplatin 50 mg per 5 mL solution for injection vial,8001610,carboplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
101962,Marketed,2023-05-16,02530430,"Carboprost Tromethamine Injection, USP",1,G02AD04,Carboprost,Solution,Intramuscular,02530430,"CARBOPROST TROMETHAMINE INJECTION, USP (carboprost (carboprost tromethamine) 250 mcg per 1 mL solution for injection vial) DR REDDY'S LABORATORIES LTD",Active,9014853,carboprost (carboprost tromethamine) 250 mcg per 1 mL solution for injection vial,8001611,carboprost,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
102710,Marketed,2024-01-18,02538377,Carboprost Tromethamine Injection USP,1,G02AD04,Carboprost,Solution,Intramuscular,02538377,CARBOPROST TROMETHAMINE INJECTION USP (carboprost (carboprost tromethamine) 250 mcg per 1 mL solution for injection vial) JUNO PHARMACEUTICALS CORP.,Active,9014853,carboprost (carboprost tromethamine) 250 mcg per 1 mL solution for injection vial,8001611,carboprost,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
103545,Marketed,2025-02-13,02546779,Carboprost Tromethamine Injection,1,G02AD04,Carboprost,Solution,Intramuscular,02546779,CARBOPROST TROMETHAMINE INJECTION (carboprost (carboprost tromethamine) 250 mcg per 1 mL solution for injection vial) JAMP PHARMA CORPORATION,Active,9014853,carboprost (carboprost tromethamine) 250 mcg per 1 mL solution for injection vial,8001611,carboprost,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
49287,Marketed,2009-02-03,02230417,Hemabate,1,G02AD04,Carboprost,Solution,Intramuscular,02230417,HEMABATE (carboprost (carboprost tromethamine) 250 mcg per 1 mL solution for injection ampoule) PFIZER CANADA ULC,Active,9012935,carboprost (carboprost tromethamine) 250 mcg per 1 mL solution for injection ampoule,8001611,carboprost,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),1.0,,,Prescription
93728,Marketed,2016-02-11,02451034,Kyprolis,1,L01XG02,Carfilzomib,Powder for solution,Intravenous,02451034,KYPROLIS (carfilzomib 60 mg per vial powder for solution for injection) AMGEN CANADA INC,Active,9005877,carfilzomib 60 mg per vial powder for solution for injection,8001612,carfilzomib,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
94724,Marketed,2017-02-13,02459930,Kyprolis,1,L01XG02,Carfilzomib,Powder for solution,Intravenous,02459930,KYPROLIS (carfilzomib 10 mg per vial powder for solution for injection) AMGEN CANADA INC,Active,9006128,carfilzomib 10 mg per vial powder for solution for injection,8001612,carfilzomib,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
94725,Marketed,2017-02-06,02459949,Kyprolis,1,L01XG02,Carfilzomib,Powder for solution,Intravenous,02459949,KYPROLIS (carfilzomib 30 mg per vial powder for solution for injection) AMGEN CANADA INC,Active,9006126,carfilzomib 30 mg per vial powder for solution for injection,8001612,carfilzomib,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
92371,Marketed,2020-03-17,02439360,Carbaglu,1,A16AA05,Carglumic acid,Tablet for suspension,Oral,02439360,CARBAGLU (carglumic acid 200 mg dispersible oral tablet) RECORDATI RARE DISEASES,Active,9013806,carglumic acid 200 mg dispersible oral tablet,8001716,carglumic acid,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101585,Marketed,2024-01-05,02526794,Vraylar,1,N05AX15,Cariprazine,Capsule,Oral,02526794,VRAYLAR (cariprazine (cariprazine hydrochloride) 1.5 mg oral capsule) ABBVIE CORPORATION,Active,9014712,cariprazine (cariprazine hydrochloride) 1.5 mg oral capsule,8002425,cariprazine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
101586,Marketed,2024-05-14,02526808,Vraylar,1,N05AX15,Cariprazine,Capsule,Oral,02526808,VRAYLAR (cariprazine (cariprazine hydrochloride) 3 mg oral capsule) ABBVIE CORPORATION,Active,9014713,cariprazine (cariprazine hydrochloride) 3 mg oral capsule,8002425,cariprazine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
101587,Marketed,2024-02-05,02526816,Vraylar,1,N05AX15,Cariprazine,Capsule,Oral,02526816,VRAYLAR (cariprazine (cariprazine hydrochloride) 4.5 mg oral capsule) ABBVIE CORPORATION,Active,9014714,cariprazine (cariprazine hydrochloride) 4.5 mg oral capsule,8002425,cariprazine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
101588,Marketed,2024-02-08,02526824,Vraylar,1,N05AX15,Cariprazine,Capsule,Oral,02526824,VRAYLAR (cariprazine (cariprazine hydrochloride) 6 mg oral capsule) ABBVIE CORPORATION,Active,9014715,cariprazine (cariprazine hydrochloride) 6 mg oral capsule,8002425,cariprazine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
102096,Marketed,2023-05-18,02531879,Carmustine For Injection USP,1,L01AD01,Carmustine,Powder for solution,Intravenous,02531879,CARMUSTINE FOR INJECTION USP (carmustine 100 mg per vial powder for solution for injection with diluent solution) STERIMAX INC,Active,9013038,carmustine 100 mg per vial powder for solution for injection with diluent solution,8001717,carmustine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
2153,Marketed,2017-09-19,00297763,Bicnu,1,L01AD01,Carmustine,Powder for solution,Intravenous,00297763,BICNU (carmustine 100 mg per vial powder for solution for injection with diluent solution) MARCAN PHARMACEUTICALS INC,Active,9013038,carmustine 100 mg per vial powder for solution for injection with diluent solution,8001717,carmustine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
70034,Marketed,2003-08-04,02245914,PMS-Carvedilol,1,C07AG02,Carvedilol,Tablet,Oral,02245914,PMS-CARVEDILOL (carvedilol 3.125 mg oral tablet) PHARMASCIENCE INC,Active,9001047,carvedilol 3.125 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
70035,Marketed,2003-08-04,02245915,PMS-Carvedilol,1,C07AG02,Carvedilol,Tablet,Oral,02245915,PMS-CARVEDILOL (carvedilol 6.25 mg oral tablet) PHARMASCIENCE INC,Active,9001048,carvedilol 6.25 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
70036,Marketed,2003-08-04,02245916,PMS-Carvedilol,1,C07AG02,Carvedilol,Tablet,Oral,02245916,PMS-CARVEDILOL (carvedilol 12.5 mg oral tablet) PHARMASCIENCE INC,Active,9001045,carvedilol 12.5 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
70037,Marketed,2003-08-04,02245917,PMS-Carvedilol,1,C07AG02,Carvedilol,Tablet,Oral,02245917,PMS-CARVEDILOL (carvedilol 25 mg oral tablet) PHARMASCIENCE INC,Active,9001046,carvedilol 25 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
72245,Marketed,2003-08-06,02247935,Apo-Carvedilol,1,C07AG02,Carvedilol,Tablet,Oral,02247935,APO-CARVEDILOL (carvedilol 12.5 mg oral tablet) APOTEX INC,Active,9001045,carvedilol 12.5 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73120,Marketed,2018-10-24,02248752,Carvedilol,1,C07AG02,Carvedilol,Tablet,Oral,02248752,CARVEDILOL (carvedilol 3.125 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001047,carvedilol 3.125 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73121,Marketed,2018-07-06,02248753,Carvedilol,1,C07AG02,Carvedilol,Tablet,Oral,02248753,CARVEDILOL (carvedilol 6.25 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001048,carvedilol 6.25 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73122,Marketed,2018-07-06,02248754,Carvedilol,1,C07AG02,Carvedilol,Tablet,Oral,02248754,CARVEDILOL (carvedilol 12.5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001045,carvedilol 12.5 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73123,Marketed,2018-07-06,02248755,Carvedilol,1,C07AG02,Carvedilol,Tablet,Oral,02248755,CARVEDILOL (carvedilol 25 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001046,carvedilol 25 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73718,Marketed,2018-01-09,02252309,Teva-Carvedilol,1,C07AG02,Carvedilol,Tablet,Oral,02252309,TEVA-CARVEDILOL (carvedilol 3.125 mg oral tablet) TEVA CANADA LIMITED,Active,9001047,carvedilol 3.125 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73719,Marketed,2018-01-09,02252317,Teva-Carvedilol,1,C07AG02,Carvedilol,Tablet,Oral,02252317,TEVA-CARVEDILOL (carvedilol 6.25 mg oral tablet) TEVA CANADA LIMITED,Active,9001048,carvedilol 6.25 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73720,Marketed,2018-01-09,02252325,Teva-Carvedilol,1,C07AG02,Carvedilol,Tablet,Oral,02252325,TEVA-CARVEDILOL (carvedilol 12.5 mg oral tablet) TEVA CANADA LIMITED,Active,9001045,carvedilol 12.5 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73721,Marketed,2018-01-09,02252333,Teva-Carvedilol,1,C07AG02,Carvedilol,Tablet,Oral,02252333,TEVA-CARVEDILOL (carvedilol 25 mg oral tablet) TEVA CANADA LIMITED,Active,9001046,carvedilol 25 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80995,Marketed,2009-06-12,02324504,Carvedilol,1,C07AG02,Carvedilol,Tablet,Oral,02324504,CARVEDILOL (carvedilol 3.125 mg oral tablet) PRO DOC LIMITEE,Active,9001047,carvedilol 3.125 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80996,Marketed,2009-06-12,02324512,Carvedilol,1,C07AG02,Carvedilol,Tablet,Oral,02324512,CARVEDILOL (carvedilol 6.25 mg oral tablet) PRO DOC LIMITEE,Active,9001048,carvedilol 6.25 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80997,Marketed,2009-06-12,02324520,Carvedilol,1,C07AG02,Carvedilol,Tablet,Oral,02324520,CARVEDILOL (carvedilol 12.5 mg oral tablet) PRO DOC LIMITEE,Active,9001045,carvedilol 12.5 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80998,Marketed,2009-06-12,02324539,Carvedilol,1,C07AG02,Carvedilol,Tablet,Oral,02324539,CARVEDILOL (carvedilol 25 mg oral tablet) PRO DOC LIMITEE,Active,9001046,carvedilol 25 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84979,Marketed,2013-10-12,02364913,Carvedilol,1,C07AG02,Carvedilol,Tablet,Oral,02364913,CARVEDILOL (carvedilol 3.125 mg oral tablet) SANIS HEALTH INC,Active,9001047,carvedilol 3.125 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84980,Marketed,2013-10-12,02364921,Carvedilol,1,C07AG02,Carvedilol,Tablet,Oral,02364921,CARVEDILOL (carvedilol 6.25 mg oral tablet) SANIS HEALTH INC,Active,9001048,carvedilol 6.25 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84981,Marketed,2013-10-12,02364948,Carvedilol,1,C07AG02,Carvedilol,Tablet,Oral,02364948,CARVEDILOL (carvedilol 12.5 mg oral tablet) SANIS HEALTH INC,Active,9001045,carvedilol 12.5 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84982,Marketed,2013-10-12,02364956,Carvedilol,1,C07AG02,Carvedilol,Tablet,Oral,02364956,CARVEDILOL (carvedilol 25 mg oral tablet) SANIS HEALTH INC,Active,9001046,carvedilol 25 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85386,Marketed,2022-01-12,02368897,JAMP-Carvedilol,1,C07AG02,Carvedilol,Tablet,Oral,02368897,JAMP-CARVEDILOL (carvedilol 3.125 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001047,carvedilol 3.125 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85387,Marketed,2022-01-12,02368900,JAMP-Carvedilol,1,C07AG02,Carvedilol,Tablet,Oral,02368900,JAMP-CARVEDILOL (carvedilol 6.25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001048,carvedilol 6.25 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85388,Marketed,2022-01-12,02368919,JAMP-Carvedilol,1,C07AG02,Carvedilol,Tablet,Oral,02368919,JAMP-CARVEDILOL (carvedilol 12.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001045,carvedilol 12.5 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85389,Marketed,2022-01-12,02368927,JAMP-Carvedilol,1,C07AG02,Carvedilol,Tablet,Oral,02368927,JAMP-CARVEDILOL (carvedilol 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001046,carvedilol 25 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90306,Marketed,2014-02-06,02418495,Auro-Carvedilol,1,C07AG02,Carvedilol,Tablet,Oral,02418495,AURO-CARVEDILOL (carvedilol 3.125 mg oral tablet) AURO PHARMA INC,Active,9001047,carvedilol 3.125 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90307,Marketed,2014-02-06,02418509,Auro-Carvedilol,1,C07AG02,Carvedilol,Tablet,Oral,02418509,AURO-CARVEDILOL (carvedilol 6.25 mg oral tablet) AURO PHARMA INC,Active,9001048,carvedilol 6.25 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90308,Marketed,2014-02-06,02418517,Auro-Carvedilol,1,C07AG02,Carvedilol,Tablet,Oral,02418517,AURO-CARVEDILOL (carvedilol 12.5 mg oral tablet) AURO PHARMA INC,Active,9001045,carvedilol 12.5 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90309,Marketed,2014-02-06,02418525,Auro-Carvedilol,1,C07AG02,Carvedilol,Tablet,Oral,02418525,AURO-CARVEDILOL (carvedilol 25 mg oral tablet) AURO PHARMA INC,Active,9001046,carvedilol 25 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
68233,Marketed,2006-07-05,02244266,Cancidas,1,J02AX04,Caspofungin,Powder for solution,Intravenous,02244266,CANCIDAS (caspofungin (caspofungin acetate) 70 mg per vial powder for solution for injection) MERCK CANADA INC,Active,9003659,caspofungin (caspofungin acetate) 70 mg per vial powder for solution for injection,8001174,caspofungin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
94846,Marketed,2026-04-27,02460947,Caspofungin For Injection,1,J02AX04,Caspofungin,Powder for solution,Intravenous,02460947,CASPOFUNGIN FOR INJECTION (caspofungin (caspofungin acetate) 50 mg per vial powder for solution for injection) JUNO PHARMA CANADA INC.,Active,9003635,caspofungin (caspofungin acetate) 50 mg per vial powder for solution for injection,8001174,caspofungin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
94847,Marketed,2026-04-27,02460955,Caspofungin For Injection,1,J02AX04,Caspofungin,Powder for solution,Intravenous,02460955,CASPOFUNGIN FOR INJECTION (caspofungin (caspofungin acetate) 70 mg per vial powder for solution for injection) JUNO PHARMA CANADA INC.,Active,9003659,caspofungin (caspofungin acetate) 70 mg per vial powder for solution for injection,8001174,caspofungin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
97713,Marketed,2020-01-27,02486989,Caspofungin For Injection,1,J02AX04,Caspofungin,Powder for solution,Intravenous,02486989,CASPOFUNGIN FOR INJECTION (caspofungin (caspofungin acetate) 50 mg per vial powder for solution for injection) FRESENIUS KABI CANADA LTD,Active,9003635,caspofungin (caspofungin acetate) 50 mg per vial powder for solution for injection,8001174,caspofungin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
97714,Marketed,2020-01-27,02486997,Caspofungin For Injection,1,J02AX04,Caspofungin,Powder for solution,Intravenous,02486997,CASPOFUNGIN FOR INJECTION (caspofungin (caspofungin acetate) 70 mg per vial powder for solution for injection) FRESENIUS KABI CANADA LTD,Active,9003659,caspofungin (caspofungin acetate) 70 mg per vial powder for solution for injection,8001174,caspofungin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
87544,Marketed,2013-01-30,02389975,Tretten,1,B02BD11,Catridecacog,Powder for solution,Intravenous,02389975,TRETTEN (catridecacog 2500 unit per vial powder for solution for injection with diluent solution) NOVO NORDISK CANADA INC,Active,9013536,catridecacog 2500 unit per vial powder for solution for injection with diluent solution,8002018,catridecacog,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
103342,Marketed,2024-08-27,02544792,JAMP Cefadroxil,1,J01DB05,Cefadroxil,Capsule,Oral,02544792,JAMP CEFADROXIL (cefadroxil (cefadroxil monohydrate) 500 mg oral capsule) JAMP PHARMA CORPORATION,Active,9003412,cefadroxil 500 mg oral capsule,8001057,cefadroxil,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
56852,Marketed,2012-04-17,02235134,Teva-Cefadroxil,1,J01DB05,Cefadroxil,Capsule,Oral,02235134,TEVA-CEFADROXIL (cefadroxil (cefadroxil monohydrate) 500 mg oral capsule) TEVA CANADA LIMITED,Active,9003412,cefadroxil 500 mg oral capsule,8001057,cefadroxil,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
64363,Marketed,1999-08-31,02240774,Apo-Cefadroxil,1,J01DB05,Cefadroxil,Capsule,Oral,02240774,APO-CEFADROXIL (cefadroxil 500 mg oral capsule) APOTEX INC,Active,9003412,cefadroxil 500 mg oral capsule,8001057,cefadroxil,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
101048,Marketed,2022-05-31,02521253,Cephalexin,1,J01DB01,Cefalexin,Tablet,Oral,02521253,CEPHALEXIN (cephalexin (cephalexin monohydrate) 250 mg oral tablet) SANIS HEALTH INC,Active,9000096,cephalexin 250 mg oral tablet,8000040,cephalexin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101049,Marketed,2022-05-31,02521261,Cephalexin,1,J01DB01,Cefalexin,Tablet,Oral,02521261,CEPHALEXIN (cephalexin (cephalexin monohydrate) 500 mg oral tablet) SANIS HEALTH INC,Active,9000057,cephalexin 500 mg oral tablet,8000040,cephalexin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101766,Marketed,2023-02-24,02528436,JAMP Cephalexin Suspension,1,J01DB01,Cefalexin,Powder for suspension,Oral,02528436,JAMP CEPHALEXIN SUSPENSION (cephalexin (cephalexin monohydrate) 125 mg per 5 mL oral suspension) JAMP PHARMA CORPORATION,Active,9000559,cephalexin 125 mg per 5 mL oral suspension,8000040,cephalexin,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
101767,Marketed,2023-02-24,02528444,JAMP Cephalexin Suspension,1,J01DB01,Cefalexin,Powder for suspension,Oral,02528444,JAMP CEPHALEXIN SUSPENSION (cephalexin (cephalexin monohydrate) 250 mg per 5 mL oral suspension) JAMP PHARMA CORPORATION,Active,9000560,cephalexin 250 mg per 5 mL oral suspension,8000040,cephalexin,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
106546,Marketed,2026-02-16,02562596,Pro-Cephalexin,1,J01DB01,Cefalexin,Powder for suspension,Oral,02562596,PRO-CEPHALEXIN (cephalexin (cephalexin monohydrate) 250 mg per 5 mL oral suspension) PRO DOC LIMITEE,Active,9000560,cephalexin 250 mg per 5 mL oral suspension,8000040,cephalexin,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
3945,Marketed,2014-07-12,00342084,Teva-Cephalexin,1,J01DB01,Cefalexin,Capsule,Oral,00342084,TEVA-CEPHALEXIN (cephalexin (cephalexin monohydrate) 250 mg oral capsule) TEVA CANADA LIMITED,Active,9000126,cephalexin 250 mg oral capsule,8000040,cephalexin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
3946,Marketed,2014-07-11,00342114,Teva-Cephalexin,1,J01DB01,Cefalexin,Capsule,Oral,00342114,TEVA-CEPHALEXIN (cephalexin (cephalexin monohydrate) 500 mg oral capsule) TEVA CANADA LIMITED,Active,9000127,cephalexin 500 mg oral capsule,8000040,cephalexin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
5072,Marketed,2014-07-12,00342092,Teva-Cephalexin 250,1,J01DB01,Cefalexin,Powder for suspension,Oral,00342092,TEVA-CEPHALEXIN 250 (cephalexin (cephalexin monohydrate) 250 mg per 5 mL oral suspension) TEVA CANADA LIMITED,Active,9000560,cephalexin 250 mg per 5 mL oral suspension,8000040,cephalexin,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
5073,Marketed,2014-07-12,00342106,Teva-Cephalexin 125,1,J01DB01,Cefalexin,Powder for suspension,Oral,00342106,TEVA-CEPHALEXIN 125 (cephalexin (cephalexin monohydrate) 125 mg per 5 mL oral suspension) TEVA CANADA LIMITED,Active,9000559,cephalexin 125 mg per 5 mL oral suspension,8000040,cephalexin,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
5181,Marketed,2014-07-11,00583413,Teva-Cephalexin,1,J01DB01,Cefalexin,Tablet,Oral,00583413,TEVA-CEPHALEXIN (cephalexin (cephalexin monohydrate) 250 mg oral tablet) TEVA CANADA LIMITED,Active,9000096,cephalexin 250 mg oral tablet,8000040,cephalexin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
5182,Marketed,2014-07-11,00583421,Teva-Cephalexin,1,J01DB01,Cefalexin,Tablet,Oral,00583421,TEVA-CEPHALEXIN (cephalexin (cephalexin monohydrate) 500 mg oral tablet) TEVA CANADA LIMITED,Active,9000057,cephalexin 500 mg oral tablet,8000040,cephalexin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
9170,Marketed,1988-12-31,00768715,Apo-Cephalex,1,J01DB01,Cefalexin,Tablet,Oral,00768715,APO-CEPHALEX (cephalexin (cephalexin monohydrate) 500 mg oral tablet) APOTEX INC,Active,9000057,cephalexin 500 mg oral tablet,8000040,cephalexin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
9171,Marketed,1988-12-31,00768723,Apo-Cephalex,1,J01DB01,Cefalexin,Tablet,Oral,00768723,APO-CEPHALEX (cephalexin (cephalexin monohydrate) 250 mg oral tablet) APOTEX INC,Active,9000096,cephalexin 250 mg oral tablet,8000040,cephalexin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95784,Marketed,2018-12-04,02469170,Lupin-Cephalexin,1,J01DB01,Cefalexin,Powder for suspension,Oral,02469170,LUPIN-CEPHALEXIN (cephalexin (cephalexin monohydrate) 125 mg per 5 mL oral suspension) LUPIN PHARMA CANADA LIMITED,Active,9000559,cephalexin 125 mg per 5 mL oral suspension,8000040,cephalexin,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
95785,Marketed,2018-12-04,02469189,Lupin-Cephalexin,1,J01DB01,Cefalexin,Powder for suspension,Oral,02469189,LUPIN-CEPHALEXIN (cephalexin (cephalexin monohydrate) 250 mg per 5 mL oral suspension) LUPIN PHARMA CANADA LIMITED,Active,9000560,cephalexin 250 mg per 5 mL oral suspension,8000040,cephalexin,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
95956,Marketed,2018-07-30,02470578,Auro-Cephalexin,1,J01DB01,Cefalexin,Tablet,Oral,02470578,AURO-CEPHALEXIN (cephalexin (cephalexin monohydrate) 250 mg oral tablet) AURO PHARMA INC,Active,9000096,cephalexin 250 mg oral tablet,8000040,cephalexin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95957,Marketed,2018-07-30,02470586,Auro-Cephalexin,1,J01DB01,Cefalexin,Tablet,Oral,02470586,AURO-CEPHALEXIN (cephalexin (cephalexin monohydrate) 500 mg oral tablet) AURO PHARMA INC,Active,9000057,cephalexin 500 mg oral tablet,8000040,cephalexin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96025,Marketed,2025-09-26,02471140,Lupin-Cephalexin,1,J01DB01,Cefalexin,Tablet,Oral,02471140,LUPIN-CEPHALEXIN (cephalexin (cephalexin monohydrate) 250 mg oral tablet) LUPIN PHARMA CANADA LIMITED,Active,9000096,cephalexin 250 mg oral tablet,8000040,cephalexin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96026,Marketed,2025-09-26,02471159,Lupin-Cephalexin,1,J01DB01,Cefalexin,Tablet,Oral,02471159,LUPIN-CEPHALEXIN (cephalexin (cephalexin monohydrate) 500 mg oral tablet) LUPIN PHARMA CANADA LIMITED,Active,9000057,cephalexin 500 mg oral tablet,8000040,cephalexin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98468,Marketed,2023-01-26,02494698,JAMP Cephalexin,1,J01DB01,Cefalexin,Tablet,Oral,02494698,JAMP CEPHALEXIN (cephalexin (cephalexin monohydrate) 250 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000096,cephalexin 250 mg oral tablet,8000040,cephalexin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98469,Marketed,2023-01-26,02494701,JAMP Cephalexin,1,J01DB01,Cefalexin,Tablet,Oral,02494701,JAMP CEPHALEXIN (cephalexin (cephalexin monohydrate) 500 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000057,cephalexin 500 mg oral tablet,8000040,cephalexin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98555,Marketed,2020-10-22,02495651,Cephalexin,1,J01DB01,Cefalexin,Tablet,Oral,02495651,CEPHALEXIN (cephalexin (cephalexin monohydrate) 500 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000057,cephalexin 500 mg oral tablet,8000040,cephalexin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98755,Marketed,2020-07-23,02497743,Auro-Cephalexin,1,J01DB01,Cefalexin,Powder for suspension,Oral,02497743,AURO-CEPHALEXIN (cephalexin (cephalexin monohydrate) 125 mg per 5 mL oral suspension) AURO PHARMA INC,Active,9000559,cephalexin 125 mg per 5 mL oral suspension,8000040,cephalexin,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
98756,Marketed,2020-07-23,02497751,Auro-Cephalexin,1,J01DB01,Cefalexin,Powder for suspension,Oral,02497751,AURO-CEPHALEXIN (cephalexin (cephalexin monohydrate) 250 mg per 5 mL oral suspension) AURO PHARMA INC,Active,9000560,cephalexin 250 mg per 5 mL oral suspension,8000040,cephalexin,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
101381,Marketed,2022-08-05,02524791,Cefazolin Sodium For Injection BP,1,J01DB04,Cefazolin,Powder for solution,"Intramuscular,Intravenous",02524791,CEFAZOLIN SODIUM FOR INJECTION BP (cefazolin (cefazolin sodium) 2 g per vial powder for solution for injection) STERIMAX INC,Active,9014748,cefazolin (cefazolin sodium) 2 g per vial powder for solution for injection,8001175,cefazolin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
19521,Marketed,2013-04-13,02108119,Cefazolin For Injection,1,J01DB04,Cefazolin,Powder for solution,"Intravenous,Intramuscular",02108119,CEFAZOLIN FOR INJECTION (cefazolin (cefazolin sodium) 500 mg per vial powder for solution for injection) TEVA CANADA LIMITED,Active,9003323,cefazolin (cefazolin sodium) 500 mg per vial powder for solution for injection,8001175,cefazolin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
19532,Marketed,2013-04-13,02108127,Cefazolin For Injection,1,J01DB04,Cefazolin,Powder for solution,"Intravenous,Intramuscular",02108127,CEFAZOLIN FOR INJECTION (cefazolin (cefazolin sodium) 1 g per vial powder for solution for injection) TEVA CANADA LIMITED,Active,9002758,cefazolin (cefazolin sodium) 1 g per vial powder for solution for injection,8001175,cefazolin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
19534,Marketed,2013-04-13,02108135,Cefazolin For Injection,1,J01DB04,Cefazolin,Powder for solution,Intravenous,02108135,CEFAZOLIN FOR INJECTION (cefazolin (cefazolin sodium) 10 g per vial powder for solution for injection) TEVA CANADA LIMITED,Active,9002757,cefazolin (cefazolin sodium) 10 g per vial powder for solution for injection,8001175,cefazolin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
60453,Marketed,2015-12-30,02237138,"Cefazolin For Injection, USP",1,J01DB04,Cefazolin,Powder for solution,"Intramuscular,Intravenous",02237138,"CEFAZOLIN FOR INJECTION, USP (cefazolin (cefazolin sodium) 1 g per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9002758,cefazolin (cefazolin sodium) 1 g per vial powder for solution for injection,8001175,cefazolin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
60455,Marketed,2016-01-13,02237140,"Cefazolin For Injection, USP",1,J01DB04,Cefazolin,Powder for solution,Intravenous,02237140,"CEFAZOLIN FOR INJECTION, USP (cefazolin (cefazolin sodium) 10 g per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9002757,cefazolin (cefazolin sodium) 10 g per vial powder for solution for injection,8001175,cefazolin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
79454,Marketed,2008-04-18,02308932,Cefazolin For Injection USP,1,J01DB04,Cefazolin,Powder for solution,"Intramuscular,Intravenous",02308932,CEFAZOLIN FOR INJECTION USP (cefazolin (cefazolin sodium) 500 mg per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9003323,cefazolin (cefazolin sodium) 500 mg per vial powder for solution for injection,8001175,cefazolin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
79456,Marketed,2008-04-18,02308959,Cefazolin For Injection USP,1,J01DB04,Cefazolin,Powder for solution,"Intramuscular,Intravenous",02308959,CEFAZOLIN FOR INJECTION USP (cefazolin (cefazolin sodium) 1 g per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9002758,cefazolin (cefazolin sodium) 1 g per vial powder for solution for injection,8001175,cefazolin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
79457,Marketed,2008-04-18,02308967,Cefazolin For Injection USP,1,J01DB04,Cefazolin,Powder for solution,Intravenous,02308967,CEFAZOLIN FOR INJECTION USP (cefazolin (cefazolin sodium) 10 g per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9002757,cefazolin (cefazolin sodium) 10 g per vial powder for solution for injection,8001175,cefazolin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
88577,Marketed,2015-08-21,02401029,"Cefazolin For Injection, USP",1,J01DB04,Cefazolin,Powder for solution,Intravenous,02401029,"CEFAZOLIN FOR INJECTION, USP (cefazolin (cefazolin sodium) 100 g per bag powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9013277,cefazolin (cefazolin sodium) 100 g per bag powder for solution for injection,8001175,cefazolin,738984000,Parenteral,385223009,Powder for solution for injection,732982009,Bag (unit of presentation),,,,Prescription
92141,Marketed,2025-02-06,02437104,Cefazolin For Injection,1,J01DB04,Cefazolin,Powder for solution,"Intramuscular,Intravenous",02437104,CEFAZOLIN FOR INJECTION (cefazolin (cefazolin sodium) 500 mg per vial powder for solution for injection) HIKMA CANADA LIMITED,Active,9003323,cefazolin (cefazolin sodium) 500 mg per vial powder for solution for injection,8001175,cefazolin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
92142,Marketed,2023-12-21,02437112,Cefazolin For Injection,1,J01DB04,Cefazolin,Powder for solution,"Intramuscular,Intravenous",02437112,CEFAZOLIN FOR INJECTION (cefazolin (cefazolin sodium) 1 g per vial powder for solution for injection) HIKMA CANADA LIMITED,Active,9002758,cefazolin (cefazolin sodium) 1 g per vial powder for solution for injection,8001175,cefazolin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
92143,Marketed,2024-02-14,02437120,Cefazolin For Injection,1,J01DB04,Cefazolin,Powder for solution,Intravenous,02437120,CEFAZOLIN FOR INJECTION (cefazolin (cefazolin sodium) 10 g per vial powder for solution for injection) HIKMA CANADA LIMITED,Active,9002757,cefazolin (cefazolin sodium) 10 g per vial powder for solution for injection,8001175,cefazolin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
95364,Marketed,2023-06-06,02465469,Cefazolin Sodium For Injection BP,1,J01DB04,Cefazolin,Powder for solution,"Intravenous,Intramuscular",02465469,CEFAZOLIN SODIUM FOR INJECTION BP (cefazolin (cefazolin sodium) 1 g per vial powder for solution for injection) STERIMAX INC,Active,9002758,cefazolin (cefazolin sodium) 1 g per vial powder for solution for injection,8001175,cefazolin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
95365,Marketed,2023-06-06,02465477,Cefazolin Sodium For Injection BP,1,J01DB04,Cefazolin,Powder for solution,Intravenous,02465477,CEFAZOLIN SODIUM FOR INJECTION BP (cefazolin (cefazolin sodium) 10 g per vial powder for solution for injection) STERIMAX INC,Active,9002757,cefazolin (cefazolin sodium) 10 g per vial powder for solution for injection,8001175,cefazolin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
98620,Marketed,2025-03-06,02496313,"Cefazolin In Dextrose Injection, USP",1,J01DB04,Cefazolin,Solution,Intravenous,77701032,"CEFAZOLIN IN DEXTROSE INJECTION, USP (cefazolin (cefazolin sodium) 1000 mg per 50 mL solution for injection bag) BAXTER CORPORATION",Active,9014450,cefazolin (cefazolin sodium) 1000 mg per 50 mL solution for injection bag,8001175,cefazolin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Prescription
98620,Marketed,2025-03-06,02496313,"Cefazolin In Dextrose Injection, USP",1,J01DB04,Cefazolin,Solution,Intravenous,77701033,"CEFAZOLIN IN DEXTROSE INJECTION, USP (cefazolin (cefazolin sodium) 2000 mg per 100 mL solution for injection bag) BAXTER CORPORATION",Active,9014451,cefazolin (cefazolin sodium) 2000 mg per 100 mL solution for injection bag,8001175,cefazolin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Prescription
95586,Marketed,2018-05-14,02467496,Apo-Cefepime,1,J01DE01,Cefepime,Powder for solution,"Intramuscular,Intravenous",02467496,APO-CEFEPIME (cefepime (cefepime hydrochloride) 1 g per vial powder for solution for injection) APOTEX INC,Active,9012604,cefepime (cefepime hydrochloride) 1 g per vial powder for solution for injection,8001176,cefepime,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
95587,Marketed,2018-05-14,02467518,Apo-Cefepime,1,J01DE01,Cefepime,Powder for solution,Intravenous,02467518,APO-CEFEPIME (cefepime (cefepime hydrochloride) 2 g per vial powder for solution for injection) APOTEX INC,Active,9004526,cefepime (cefepime hydrochloride) 2 g per vial powder for solution for injection,8001176,cefepime,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
98885,Marketed,2022-05-25,02499096,Cefepime For Injection USP,1,J01DE01,Cefepime,Powder for solution,Intravenous,02499096,CEFEPIME FOR INJECTION USP (cefepime (cefepime hydrochloride) 2 g per vial powder for solution for injection) HIKMA CANADA LIMITED,Active,9004526,cefepime (cefepime hydrochloride) 2 g per vial powder for solution for injection,8001176,cefepime,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
10523,Marketed,2017-07-14,00868965,Suprax,1,J01DD08,Cefixime,Powder for suspension,Oral,00868965,SUPRAX (cefixime 100 mg per 5 mL oral suspension) ODAN LABORATORIES LTD,Active,9006322,cefixime 100 mg per 5 mL oral suspension,8001443,cefixime,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
10525,Marketed,2017-07-14,00868981,Suprax,1,J01DD08,Cefixime,Tablet,Oral,00868981,SUPRAX (cefixime 400 mg oral tablet) ODAN LABORATORIES LTD,Active,9002263,cefixime 400 mg oral tablet,8001443,cefixime,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91720,Marketed,2014-10-24,02432773,Auro-Cefixime,1,J01DD08,Cefixime,Tablet,Oral,02432773,AURO-CEFIXIME (cefixime 400 mg oral tablet) AURO PHARMA INC,Active,9002263,cefixime 400 mg oral tablet,8001443,cefixime,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95716,Marketed,2018-01-08,02468689,Auro-Cefixime,1,J01DD08,Cefixime,Powder for suspension,Oral,02468689,AURO-CEFIXIME (cefixime 100 mg per 5 mL oral suspension) AURO PHARMA INC,Active,9006322,cefixime 100 mg per 5 mL oral suspension,8001443,cefixime,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
91844,Marketed,2015-03-12,02434091,"Cefotaxime Sodium For Injection, BP",1,J01DD01,Cefotaxime,Powder for solution,"Intramuscular,Intravenous",02434091,"CEFOTAXIME SODIUM FOR INJECTION, BP (cefotaxime sodium 1 g per vial powder for solution for injection) STERIMAX INC",Active,9003830,cefotaxime sodium 1 g per vial powder for solution for injection,8001177,cefotaxime,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
91845,Marketed,2015-03-12,02434105,"Cefotaxime Sodium For Injection, BP",1,J01DD01,Cefotaxime,Powder for solution,"Intravenous,Intramuscular",02434105,"CEFOTAXIME SODIUM FOR INJECTION, BP (cefotaxime sodium 2 g per vial powder for solution for injection) STERIMAX INC",Active,9003817,cefotaxime sodium 2 g per vial powder for solution for injection,8001177,cefotaxime,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
19200,Marketed,2013-11-22,02128187,Cefoxitin For Injection,1,J01DC01,Cefoxitin,Powder for solution,"Intravenous,Intramuscular",02128187,CEFOXITIN FOR INJECTION (cefoxitin (cefoxitin sodium) 1 g per vial powder for solution for injection) TEVA CANADA LIMITED,Active,9002759,cefoxitin (cefoxitin sodium) 1 g per vial powder for solution for injection,8001178,cefoxitin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
19201,Marketed,2013-11-22,02128195,Cefoxitin For Injection,1,J01DC01,Cefoxitin,Powder for solution,"Intramuscular,Intravenous",02128195,CEFOXITIN FOR INJECTION (cefoxitin (cefoxitin sodium) 2 g per vial powder for solution for injection) TEVA CANADA LIMITED,Active,9002760,cefoxitin (cefoxitin sodium) 2 g per vial powder for solution for injection,8001178,cefoxitin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
77887,Marketed,2025-06-18,02293528,SPC-Cefprozil,1,J01DC10,Cefprozil,Tablet,Oral,02293528,SPC-CEFPROZIL (cefprozil (cefprozil monohydrate) 250 mg oral tablet) SUN PHARMA CANADA INC,Active,9000556,cefprozil 250 mg oral tablet,8000210,cefprozil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77888,Marketed,2025-06-18,02293536,SPC-Cefprozil,1,J01DC10,Cefprozil,Tablet,Oral,02293536,SPC-CEFPROZIL (cefprozil (cefprozil monohydrate) 500 mg oral tablet) SUN PHARMA CANADA INC,Active,9000558,cefprozil 500 mg oral tablet,8000210,cefprozil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77893,Marketed,2025-10-31,02293579,SPC-Cefprozil,1,J01DC10,Cefprozil,Powder for suspension,Oral,02293579,SPC-CEFPROZIL (cefprozil (cefprozil monohydrate) 250 mg per 5 mL oral suspension) SUN PHARMA CANADA INC,Active,9006240,cefprozil 250 mg per 5 mL oral suspension,8000210,cefprozil,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
81489,Marketed,2025-10-31,02329204,SPC-Cefprozil,1,J01DC10,Cefprozil,Powder for suspension,Oral,02329204,SPC-CEFPROZIL (cefprozil (cefprozil monohydrate) 125 mg per 5 mL oral suspension) SUN PHARMA CANADA INC,Active,9006239,cefprozil 125 mg per 5 mL oral suspension,8000210,cefprozil,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
83266,Marketed,2019-01-23,02347253,Auro-Cefprozil,1,J01DC10,Cefprozil,Tablet,Oral,02347253,AURO-CEFPROZIL (cefprozil 500 mg oral tablet) AURO PHARMA INC,Active,9000558,cefprozil 500 mg oral tablet,8000210,cefprozil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83267,Marketed,2024-03-01,02347261,Auro-Cefprozil,1,J01DC10,Cefprozil,Powder for suspension,Oral,02347261,AURO-CEFPROZIL (cefprozil (cefprozil monohydrate) 125 mg per 5 mL oral suspension) AURO PHARMA INC,Active,9006239,cefprozil 125 mg per 5 mL oral suspension,8000210,cefprozil,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
83268,Marketed,2024-03-01,02347288,Auro-Cefprozil,1,J01DC10,Cefprozil,Powder for suspension,Oral,02347288,AURO-CEFPROZIL (cefprozil (cefprozil monohydrate) 250 mg per 5 mL oral suspension) AURO PHARMA INC,Active,9006240,cefprozil 250 mg per 5 mL oral suspension,8000210,cefprozil,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
11370,Marketed,2015-11-03,00886971,"Ceftazidime For Injection, USP",1,J01DD02,Ceftazidime,Powder for solution,"Intramuscular,Intravenous",00886971,"CEFTAZIDIME FOR INJECTION, USP (ceftazidime 1 g per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9002345,ceftazidime 1 g per vial powder for solution for injection,8001179,ceftazidime,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
11371,Marketed,2016-10-04,00886963,"Ceftazidime For Injection, USP",1,J01DD02,Ceftazidime,Powder for solution,Intravenous,00886963,"CEFTAZIDIME FOR INJECTION, USP (ceftazidime 6 g per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9002347,ceftazidime 6 g per vial powder for solution for injection,8001179,ceftazidime,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
11372,Marketed,2015-12-04,00886955,"Ceftazidime For Injection, USP",1,J01DD02,Ceftazidime,Powder for solution,Intravenous,00886955,"CEFTAZIDIME FOR INJECTION, USP (ceftazidime 2 g per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9002346,ceftazidime 2 g per vial powder for solution for injection,8001179,ceftazidime,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
92221,Marketed,2015-05-28,02437848,Ceftazidime For Injection BP,1,J01DD02,Ceftazidime,Powder for solution,"Intravenous,Intramuscular",02437848,CEFTAZIDIME FOR INJECTION BP (ceftazidime (ceftazidime pentahydrate) 1 g per vial powder for solution for injection) STERIMAX INC,Active,9002345,ceftazidime 1 g per vial powder for solution for injection,8001179,ceftazidime,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
92222,Marketed,2015-05-29,02437856,Ceftazidime For Injection BP,1,J01DD02,Ceftazidime,Powder for solution,Intravenous,02437856,CEFTAZIDIME FOR INJECTION BP (ceftazidime (ceftazidime pentahydrate) 2 g per vial powder for solution for injection) STERIMAX INC,Active,9002346,ceftazidime 2 g per vial powder for solution for injection,8001179,ceftazidime,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
92223,Marketed,2015-06-08,02437864,Ceftazidime For Injection BP,1,J01DD02,Ceftazidime,Powder for solution,Intravenous,02437864,CEFTAZIDIME FOR INJECTION BP (ceftazidime (ceftazidime pentahydrate) 6 g per vial powder for solution for injection) STERIMAX INC,Active,9002347,ceftazidime 6 g per vial powder for solution for injection,8001179,ceftazidime,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
93212,Marketed,2018-03-20,02446685,Zevtera,1,J01DI01,Ceftobiprole medocaril,Powder for solution,Intravenous,02446685,ZEVTERA (ceftobiprole (ceftobiprole medocaril sodium) 500 mg per vial powder for solution for injection) AVIR PHARMA INC.,Active,9012785,ceftobiprole (ceftobiprole medocaril sodium) 500 mg per vial powder for solution for injection,8001444,ceftobiprole,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
93248,Marketed,2016-01-12,02446901,Zerbaxa,2,J01DI54,Ceftolozane and beta-lactamase inhibitor,Powder for solution,Intravenous,02446901,ZERBAXA (ceftolozane (ceftolozane sulfate) 1 g per vial and tazobactam (tazobactam sodium) 0.5 g per vial powder for solution for injection) MERCK CANADA INC,Active,9005850,ceftolozane (ceftolozane sulfate) 1 g per vial and tazobactam (tazobactam sodium) 0.5 g per vial powder for solution for injection,8001347,ceftolozane and tazobactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
77503,Marketed,2024-08-15,02289695,Ceftriaxone For Injection,1,J01DD04,Ceftriaxone,Powder for solution,"Intramuscular,Intravenous",02289695,CEFTRIAXONE FOR INJECTION (ceftriaxone (ceftriaxone sodium) 1 g per vial powder for solution for injection) FRESENIUS KABI CANADA LTD,Active,9004265,ceftriaxone (ceftriaxone sodium) 1 g per vial powder for solution for injection,8001180,ceftriaxone,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
77504,Marketed,2024-08-15,02289709,Ceftriaxone For Injection,1,J01DD04,Ceftriaxone,Powder for solution,"Intravenous,Intramuscular",02289709,CEFTRIAXONE FOR INJECTION (ceftriaxone (ceftriaxone sodium) 2 g per vial powder for solution for injection) FRESENIUS KABI CANADA LTD,Active,9004266,ceftriaxone (ceftriaxone sodium) 2 g per vial powder for solution for injection,8001180,ceftriaxone,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
77762,Marketed,2018-03-15,02292262,Ceftriaxone Sodium For Injection BP,1,J01DD04,Ceftriaxone,Powder for solution,"Intramuscular,Intravenous",02292262,CEFTRIAXONE SODIUM FOR INJECTION BP (ceftriaxone (ceftriaxone sodium) 250 mg per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9004294,ceftriaxone (ceftriaxone sodium) 250 mg per vial powder for solution for injection,8001180,ceftriaxone,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
77763,Marketed,2018-03-15,02292270,Ceftriaxone Sodium For Injection BP,1,J01DD04,Ceftriaxone,Powder for solution,"Intravenous,Intramuscular",02292270,CEFTRIAXONE SODIUM FOR INJECTION BP (ceftriaxone (ceftriaxone sodium) 1 g per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9004265,ceftriaxone (ceftriaxone sodium) 1 g per vial powder for solution for injection,8001180,ceftriaxone,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
77764,Marketed,2018-03-15,02292289,Ceftriaxone Sodium For Injection BP,1,J01DD04,Ceftriaxone,Powder for solution,"Intramuscular,Intravenous",02292289,CEFTRIAXONE SODIUM FOR INJECTION BP (ceftriaxone (ceftriaxone sodium) 2 g per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9004266,ceftriaxone (ceftriaxone sodium) 2 g per vial powder for solution for injection,8001180,ceftriaxone,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
77765,Marketed,2018-03-15,02292297,Ceftriaxone Sodium For Injection BP,1,J01DD04,Ceftriaxone,Powder for solution,Intravenous,02292297,CEFTRIAXONE SODIUM FOR INJECTION BP (ceftriaxone (ceftriaxone sodium) 10 g per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9004264,ceftriaxone (ceftriaxone sodium) 10 g per vial powder for solution for injection,8001180,ceftriaxone,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
81096,Marketed,2011-04-23,02325594,Ceftriaxone Sodium For Injection BP,1,J01DD04,Ceftriaxone,Powder for solution,"Intramuscular,Intravenous",02325594,CEFTRIAXONE SODIUM FOR INJECTION BP (ceftriaxone (ceftriaxone sodium) 250 mg per vial powder for solution for injection) STERIMAX INC,Active,9004294,ceftriaxone (ceftriaxone sodium) 250 mg per vial powder for solution for injection,8001180,ceftriaxone,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
81098,Marketed,2011-03-21,02325616,Ceftriaxone Sodium For Injection BP,1,J01DD04,Ceftriaxone,Powder for solution,"Intravenous,Intramuscular",02325616,CEFTRIAXONE SODIUM FOR INJECTION BP (ceftriaxone (ceftriaxone sodium) 1 g per vial powder for solution for injection) STERIMAX INC,Active,9004265,ceftriaxone (ceftriaxone sodium) 1 g per vial powder for solution for injection,8001180,ceftriaxone,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
81099,Marketed,2011-01-31,02325624,Ceftriaxone Sodium For Injection BP,1,J01DD04,Ceftriaxone,Powder for solution,"Intramuscular,Intravenous",02325624,CEFTRIAXONE SODIUM FOR INJECTION BP (ceftriaxone (ceftriaxone sodium) 2 g per vial powder for solution for injection) STERIMAX INC,Active,9004266,ceftriaxone (ceftriaxone sodium) 2 g per vial powder for solution for injection,8001180,ceftriaxone,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
81100,Marketed,2011-03-21,02325632,Ceftriaxone Sodium For Injection BP,1,J01DD04,Ceftriaxone,Powder for solution,Intravenous,02325632,CEFTRIAXONE SODIUM FOR INJECTION BP (ceftriaxone (ceftriaxone sodium) 10 g per vial powder for solution for injection) STERIMAX INC,Active,9004264,ceftriaxone (ceftriaxone sodium) 10 g per vial powder for solution for injection,8001180,ceftriaxone,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
89462,Marketed,2015-10-09,02409968,Ceftriaxone For Injection,1,J01DD04,Ceftriaxone,Powder for solution,Intravenous,02409968,CEFTRIAXONE FOR INJECTION (ceftriaxone (ceftriaxone sodium) 100 g per bag powder for solution for injection) FRESENIUS KABI CANADA LTD,Active,9013278,ceftriaxone (ceftriaxone sodium) 100 g per bag powder for solution for injection,8001180,ceftriaxone,738984000,Parenteral,385223009,Powder for solution for injection,732982009,Bag (unit of presentation),,,,Prescription
98943,Marketed,2021-03-18,02499711,"Ceftriaxone Injection, USP",1,J01DD04,Ceftriaxone,Solution,Intravenous,02499711,"CEFTRIAXONE INJECTION, USP (ceftriaxone (ceftriaxone sodium) 1000 mg per 50 mL solution for injection bag) BAXTER CORPORATION",Active,9014484,ceftriaxone (ceftriaxone sodium) 1000 mg per 50 mL solution for injection bag,8001180,ceftriaxone,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Prescription
98944,Marketed,2021-03-18,02499738,"Ceftriaxone Injection, USP",1,J01DD04,Ceftriaxone,Solution,Intravenous,02499738,"CEFTRIAXONE INJECTION, USP (ceftriaxone (ceftriaxone sodium) 2000 mg per 50 mL solution for injection bag) BAXTER CORPORATION",Active,9014485,ceftriaxone (ceftriaxone sodium) 2000 mg per 50 mL solution for injection bag,8001180,ceftriaxone,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Prescription
103583,Marketed,2024-09-27,02547198,JAMP Cefuroxime,1,J01DC02,Cefuroxime,Tablet,Oral,02547198,JAMP CEFUROXIME (cefuroxime (cefuroxime axetil) 250 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003346,cefuroxime (cefuroxime axetil) 250 mg oral tablet,8001076,cefuroxime,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103584,Marketed,2024-09-27,02547201,JAMP Cefuroxime,1,J01DC02,Cefuroxime,Tablet,Oral,02547201,JAMP CEFUROXIME (cefuroxime (cefuroxime axetil) 500 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003320,cefuroxime (cefuroxime axetil) 500 mg oral tablet,8001076,cefuroxime,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
43089,Marketed,2022-10-28,02212307,Ceftin,1,J01DC02,Cefuroxime,Granules for suspension,Oral,02212307,CEFTIN (cefuroxime (cefuroxime axetil) 125 mg per 5 mL oral suspension) SANDOZ CANADA INCORPORATED,Active,9014241,cefuroxime (cefuroxime axetil) 125 mg per 5 mL oral suspension,8001076,cefuroxime,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
65298,Marketed,2015-07-27,02241638,"Cefuroxime For Injection, USP",1,J01DC02,Cefuroxime,Powder for solution,Intravenous,02241638,"CEFUROXIME FOR INJECTION, USP (cefuroxime (cefuroxime sodium) 750 mg per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9003768,cefuroxime (cefuroxime sodium) 750 mg per vial powder for solution for injection,8001076,cefuroxime,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
65299,Marketed,2015-07-28,02241639,"Cefuroxime For Injection, USP",1,J01DC02,Cefuroxime,Powder for solution,Intravenous,02241639,"CEFUROXIME FOR INJECTION, USP (cefuroxime (cefuroxime sodium) 1.5 g per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9003770,cefuroxime (cefuroxime sodium) 1.5 g per vial powder for solution for injection,8001076,cefuroxime,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
68362,Marketed,2001-08-29,02244393,Apo-Cefuroxime,1,J01DC02,Cefuroxime,Tablet,Oral,02244393,APO-CEFUROXIME (cefuroxime (cefuroxime axetil) 250 mg oral tablet) APOTEX INC,Active,9003346,cefuroxime (cefuroxime axetil) 250 mg oral tablet,8001076,cefuroxime,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
68363,Marketed,2001-08-29,02244394,Apo-Cefuroxime,1,J01DC02,Cefuroxime,Tablet,Oral,02244394,APO-CEFUROXIME (cefuroxime (cefuroxime axetil) 500 mg oral tablet) APOTEX INC,Active,9003320,cefuroxime (cefuroxime axetil) 500 mg oral tablet,8001076,cefuroxime,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83030,Marketed,2021-01-11,02344823,Auro-Cefuroxime,1,J01DC02,Cefuroxime,Tablet,Oral,02344823,AURO-CEFUROXIME (cefuroxime (cefuroxime axetil) 250 mg oral tablet) AURO PHARMA INC,Active,9003346,cefuroxime (cefuroxime axetil) 250 mg oral tablet,8001076,cefuroxime,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83031,Marketed,2021-01-11,02344831,Auro-Cefuroxime,1,J01DC02,Cefuroxime,Tablet,Oral,02344831,AURO-CEFUROXIME (cefuroxime (cefuroxime axetil) 500 mg oral tablet) AURO PHARMA INC,Active,9003320,cefuroxime (cefuroxime axetil) 500 mg oral tablet,8001076,cefuroxime,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100645,Marketed,2021-11-09,02517116,PMSC-Celecoxib,1,M01AH01,Celecoxib,Capsule,Oral,02517116,PMSC-CELECOXIB (celecoxib 100 mg oral capsule) PHARMASCIENCE INC,Active,9000846,celecoxib 100 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
100646,Marketed,2022-04-27,02517124,PMSC-Celecoxib,1,M01AH01,Celecoxib,Capsule,Oral,02517124,PMSC-CELECOXIB (celecoxib 200 mg oral capsule) PHARMASCIENCE INC,Active,9000847,celecoxib 200 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
63442,Marketed,2023-09-26,02239941,Celebrex,1,M01AH01,Celecoxib,Capsule,Oral,02239941,CELEBREX (celecoxib 100 mg oral capsule) BGP PHARMA ULC,Active,9000846,celecoxib 100 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
63443,Marketed,2023-09-26,02239942,Celebrex,1,M01AH01,Celecoxib,Capsule,Oral,02239942,CELEBREX (celecoxib 200 mg oral capsule) BGP PHARMA ULC,Active,9000847,celecoxib 200 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
89713,Marketed,2014-11-17,02412497,Mint-Celecoxib,1,M01AH01,Celecoxib,Capsule,Oral,02412497,MINT-CELECOXIB (celecoxib 100 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9000846,celecoxib 100 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
89714,Marketed,2014-11-17,02412500,Mint-Celecoxib,1,M01AH01,Celecoxib,Capsule,Oral,02412500,MINT-CELECOXIB (celecoxib 200 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9000847,celecoxib 200 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90347,Marketed,2014-11-17,02418932,Apo-Celecoxib,1,M01AH01,Celecoxib,Capsule,Oral,02418932,APO-CELECOXIB (celecoxib 100 mg oral capsule) APOTEX INC,Active,9000846,celecoxib 100 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90348,Marketed,2014-11-17,02418940,Apo-Celecoxib,1,M01AH01,Celecoxib,Capsule,Oral,02418940,APO-CELECOXIB (celecoxib 200 mg oral capsule) APOTEX INC,Active,9000847,celecoxib 200 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90466,Marketed,2014-11-17,02420058,Mar-Celecoxib,1,M01AH01,Celecoxib,Capsule,Oral,02420058,MAR-CELECOXIB (celecoxib 100 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000846,celecoxib 100 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90467,Marketed,2014-11-17,02420066,Mar-Celecoxib,1,M01AH01,Celecoxib,Capsule,Oral,02420066,MAR-CELECOXIB (celecoxib 200 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000847,celecoxib 200 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90908,Marketed,2014-11-21,02424371,Celecoxib,1,M01AH01,Celecoxib,Capsule,Oral,02424371,CELECOXIB (celecoxib 100 mg oral capsule) PRO DOC LIMITEE,Active,9000846,celecoxib 100 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90909,Marketed,2014-11-21,02424398,Celecoxib,1,M01AH01,Celecoxib,Capsule,Oral,02424398,CELECOXIB (celecoxib 200 mg oral capsule) PRO DOC LIMITEE,Active,9000847,celecoxib 200 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90922,Marketed,2026-03-12,02424533,JAMP Celecoxib,1,M01AH01,Celecoxib,Capsule,Oral,02424533,JAMP CELECOXIB (celecoxib 100 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000846,celecoxib 100 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90923,Marketed,2026-03-12,02424541,JAMP Celecoxib,1,M01AH01,Celecoxib,Capsule,Oral,02424541,JAMP CELECOXIB (celecoxib 200 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000847,celecoxib 200 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
91003,Marketed,2014-11-17,02425386,Riva-Celecox,1,M01AH01,Celecoxib,Capsule,Oral,02425386,RIVA-CELECOX (celecoxib 100 mg oral capsule) LABORATOIRE RIVA INC.,Active,9000846,celecoxib 100 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
91004,Marketed,2014-11-17,02425394,Riva-Celecox,1,M01AH01,Celecoxib,Capsule,Oral,02425394,RIVA-CELECOX (celecoxib 200 mg oral capsule) LABORATOIRE RIVA INC.,Active,9000847,celecoxib 200 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
91097,Marketed,2014-12-05,02426382,Bio-Celecoxib,1,M01AH01,Celecoxib,Capsule,Oral,02426382,BIO-CELECOXIB (celecoxib 100 mg oral capsule) BIOMED PHARMA,Active,9000846,celecoxib 100 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
91098,Marketed,2014-12-05,02426390,Bio-Celecoxib,1,M01AH01,Celecoxib,Capsule,Oral,02426390,BIO-CELECOXIB (celecoxib 200 mg oral capsule) BIOMED PHARMA,Active,9000847,celecoxib 200 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
91412,Marketed,2018-07-04,02429675,Celecoxib,1,M01AH01,Celecoxib,Capsule,Oral,02429675,CELECOXIB (celecoxib 100 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000846,celecoxib 100 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
91413,Marketed,2018-07-04,02429683,Celecoxib,1,M01AH01,Celecoxib,Capsule,Oral,02429683,CELECOXIB (celecoxib 200 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000847,celecoxib 200 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
92062,Marketed,2021-02-02,02436299,Celecoxib,1,M01AH01,Celecoxib,Capsule,Oral,02436299,CELECOXIB (celecoxib 100 mg oral capsule) SANIS HEALTH INC,Active,9000846,celecoxib 100 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
92063,Marketed,2021-02-02,02436302,Celecoxib,1,M01AH01,Celecoxib,Capsule,Oral,02436302,CELECOXIB (celecoxib 200 mg oral capsule) SANIS HEALTH INC,Active,9000847,celecoxib 200 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
92190,Marketed,2019-05-13,02437570,AG-Celecoxib,1,M01AH01,Celecoxib,Capsule,Oral,02437570,AG-CELECOXIB (celecoxib 100 mg oral capsule) ANGITA PHARMA INC.,Active,9000846,celecoxib 100 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
92191,Marketed,2019-05-13,02437589,AG-Celecoxib,1,M01AH01,Celecoxib,Capsule,Oral,02437589,AG-CELECOXIB (celecoxib 200 mg oral capsule) ANGITA PHARMA INC.,Active,9000847,celecoxib 200 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
93095,Marketed,2015-12-02,02445670,Auro-Celecoxib,1,M01AH01,Celecoxib,Capsule,Oral,02445670,AURO-CELECOXIB (celecoxib 100 mg oral capsule) AURO PHARMA INC,Active,9000846,celecoxib 100 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
93096,Marketed,2015-12-02,02445689,Auro-Celecoxib,1,M01AH01,Celecoxib,Capsule,Oral,02445689,AURO-CELECOXIB (celecoxib 200 mg oral capsule) AURO PHARMA INC,Active,9000847,celecoxib 200 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97003,Marketed,2019-07-02,02479737,Nra-Celecoxib,1,M01AH01,Celecoxib,Capsule,Oral,02479737,NRA-CELECOXIB (celecoxib 100 mg oral capsule) NORA PHARMA INC,Active,9000846,celecoxib 100 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97004,Marketed,2019-07-02,02479745,Nra-Celecoxib,1,M01AH01,Celecoxib,Capsule,Oral,02479745,NRA-CELECOXIB (celecoxib 200 mg oral capsule) NORA PHARMA INC,Active,9000847,celecoxib 200 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98538,Marketed,2020-03-24,02495465,M-Celecoxib,1,M01AH01,Celecoxib,Capsule,Oral,02495465,M-CELECOXIB (celecoxib 100 mg oral capsule) MANTRA PHARMA INC,Active,9000846,celecoxib 100 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98539,Marketed,2020-03-24,02495473,M-Celecoxib,1,M01AH01,Celecoxib,Capsule,Oral,02495473,M-CELECOXIB (celecoxib 200 mg oral capsule) MANTRA PHARMA INC,Active,9000847,celecoxib 200 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97728,Marketed,2025-04-07,02487144,Libtayo,1,L01FF06,Cemiplimab,Solution,Intravenous,02487144,LIBTAYO (cemiplimab 350 mg per 7 mL solution for injection vial) REGENERON CANADA COMPANY,Active,9013950,cemiplimab 350 mg per 7 mL solution for injection vial,8002253,cemiplimab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
97728,Marketed,2025-04-07,02487144,Libtayo,1,L01FF06,Cemiplimab,Solution,Intravenous,02487144,LIBTAYO (cemiplimab 350 mg per 7 mL solution for injection vial) REGENERON CANADA COMPANY,Active,9013950,cemiplimab 350 mg per 7 mL solution for injection vial,8002253,cemiplimab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
102735,Marketed,2025-12-19,02538652,Xcopri,1,N03AX25,Cenobamate,Tablet,Oral,02538652,XCOPRI (cenobamate 12.5 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9014963,cenobamate 12.5 mg oral tablet,8002490,cenobamate,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102736,Marketed,2025-12-19,02538660,Xcopri,1,N03AX25,Cenobamate,Tablet,Oral,02538660,XCOPRI (cenobamate 25 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9014966,cenobamate 25 mg oral tablet,8002490,cenobamate,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102738,Marketed,2025-12-19,02538725,Xcopri,1,N03AX25,Cenobamate,Tablet,Oral,02538725,XCOPRI (cenobamate 50 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9014967,cenobamate 50 mg oral tablet,8002490,cenobamate,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102743,Marketed,2025-12-19,02538733,Xcopri,1,N03AX25,Cenobamate,Tablet,Oral,02538733,XCOPRI (cenobamate 100 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9014962,cenobamate 100 mg oral tablet,8002490,cenobamate,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102744,Marketed,2025-12-19,02538741,Xcopri,1,N03AX25,Cenobamate,Tablet,Oral,02538741,XCOPRI (cenobamate 150 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9014964,cenobamate 150 mg oral tablet,8002490,cenobamate,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102745,Marketed,2025-12-19,02538768,Xcopri,1,N03AX25,Cenobamate,Tablet,Oral,02538768,XCOPRI (cenobamate 200 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9014965,cenobamate 200 mg oral tablet,8002490,cenobamate,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102746,Marketed,2025-12-19,02538776,Xcopri,2,N03AX25,Cenobamate,"Tablet,Kit",Oral,02538776,XCOPRI TITRATION PACK 1 (cenobamate 12.5 mg oral tablet with cenobamate 25 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9015213,cenobamate 12.5 mg oral tablet with cenobamate 25 mg oral tablet,8002490,cenobamate,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,,Prescription
102747,Marketed,2025-12-19,02538784,Xcopri,2,N03AX25,Cenobamate,"Tablet,Kit",Oral,02538784,XCOPRI TITRATION PACK 2 (cenobamate 50 mg oral tablet with cenobamate 100 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9015214,cenobamate 50 mg oral tablet with cenobamate 100 mg oral tablet,8002490,cenobamate,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,,Prescription
81334,Marketed,2018-09-04,02327848,Neurolite,1,V09A,Central nervous system,"Powder for solution,Kit",Intravenous,,,,,,,,,,,,,,,,,Schedule C
92108,Marketed,2015-04-29,02436779,Zykadia,1,L01ED02,Ceritinib,Capsule,Oral,02436779,ZYKADIA (ceritinib 150 mg oral capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9005708,ceritinib 150 mg oral capsule,8001613,ceritinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
97435,Marketed,2019-03-18,02484013,Brineura,1,A16AB17,Cerliponase alfa,Solution,Intracerebroventricular,02484013,BRINEURA (cerliponase alfa 150 mg per 5 mL solution for injection vial with flushing solution) BIOMARIN INTERNATIONAL LIMITED,Active,9013951,cerliponase alfa 150 mg per 5 mL solution for injection vial with flushing solution,8002254,cerliponase alfa,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
97435,Marketed,2019-03-18,02484013,Brineura,1,A16AB17,Cerliponase alfa,Solution,Intracerebroventricular,02484013,BRINEURA (cerliponase alfa 150 mg per 5 mL solution for injection vial with flushing solution) BIOMARIN INTERNATIONAL LIMITED,Active,9013951,cerliponase alfa 150 mg per 5 mL solution for injection vial with flushing solution,8002254,cerliponase alfa,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
81737,Marketed,2009-08-31,02331675,Cimzia,1,L04AB05,Certolizumab pegol,Solution,Subcutaneous,02331675,CIMZIA SYRINGE (certolizumab pegol 200 mg per 1 mL solution for injection syringe) UCB CANADA INC,Active,9013041,certolizumab pegol 200 mg per 1 mL solution for injection syringe,8001718,certolizumab pegol,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
81737,Marketed,2009-08-31,02331675,Cimzia,1,L04AB05,Certolizumab pegol,Solution,Subcutaneous,02331675,CIMZIA SYRINGE (certolizumab pegol 200 mg per 1 mL solution for injection syringe) UCB CANADA INC,Active,9013041,certolizumab pegol 200 mg per 1 mL solution for injection syringe,8001718,certolizumab pegol,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
95373,Marketed,2017-08-04,02465574,Cimzia,1,L04AB05,Certolizumab pegol,Solution,Subcutaneous,02465574,CIMZIA AUTOINJECTOR (certolizumab pegol 200 mg per 1 mL solution for injection syringe) UCB CANADA INC,Active,9013041,certolizumab pegol 200 mg per 1 mL solution for injection syringe,8001718,certolizumab pegol,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
95373,Marketed,2017-08-04,02465574,Cimzia,1,L04AB05,Certolizumab pegol,Solution,Subcutaneous,02465574,CIMZIA AUTOINJECTOR (certolizumab pegol 200 mg per 1 mL solution for injection syringe) UCB CANADA INC,Active,9013041,certolizumab pegol 200 mg per 1 mL solution for injection syringe,8001718,certolizumab pegol,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
100119,Marketed,2021-04-20,02512025,M-Cetirizine,1,R06AE07,Cetirizine,Tablet,Oral,02512025,M-CETIRIZINE (cetirizine hydrochloride 20 mg oral tablet) MANTRA PHARMA INC,Active,9000972,cetirizine hydrochloride 20 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100508,Marketed,2025-08-08,02515695,Cetirizine,1,R06AE07,Cetirizine,Tablet,Oral,02515695,CETIRIZINE (cetirizine hydrochloride 20 mg oral tablet) SANIS HEALTH INC,Active,9000972,cetirizine hydrochloride 20 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100677,Marketed,2022-05-11,02517353,JAMP Cetirizine Tablets,1,R06AE07,Cetirizine,Tablet,Oral,02517353,JAMP CETIRIZINE TABLETS (cetirizine hydrochloride 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000972,cetirizine hydrochloride 20 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100694,Marketed,2022-06-01,02517566,Cetirizine Extra Strength,1,R06AE07,Cetirizine,Tablet,Oral,02517566,CETIRIZINE EXTRA STRENGTH (cetirizine hydrochloride 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000707,cetirizine hydrochloride 10 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
101788,Marketed,2023-02-24,02528681,Teva-Cetirizine,1,R06AE07,Cetirizine,Tablet,Oral,02528681,TEVA-CETIRIZINE (cetirizine hydrochloride 20 mg oral tablet) TEVA CANADA LIMITED,Active,9000972,cetirizine hydrochloride 20 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101792,Marketed,2023-04-19,02528738,Allergy Relief Liquid Gels,1,R06AE07,Cetirizine,Capsule,Oral,02528738,ALLERGY RELIEF LIQUID GELS (cetirizine hydrochloride 10 mg oral capsule) JUNO OTC INC,Active,9001383,cetirizine hydrochloride 10 mg oral capsule,8000237,cetirizine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
101942,Marketed,2023-04-13,02530236,Nra-Cetirizine Tablets,1,R06AE07,Cetirizine,Tablet,Oral,02530236,NRA-CETIRIZINE TABLETS (cetirizine hydrochloride 20 mg oral tablet) NORA PHARMA INC,Active,9000972,cetirizine hydrochloride 20 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102306,Marketed,2023-07-20,02534126,Cetirizine,1,R06AE07,Cetirizine,Tablet,Oral,02534126,CETIRIZINE (cetirizine hydrochloride 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000972,cetirizine hydrochloride 20 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
43369,Marketed,2026-03-12,02223546,Reactine,1,R06AE07,Cetirizine,Tablet,Oral,02223546,REACTINE (cetirizine hydrochloride 5 mg oral tablet) KENVUE CANADA INC.,Active,9000708,cetirizine hydrochloride 5 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
43370,Marketed,2026-03-12,02223554,Reactine,1,R06AE07,Cetirizine,Tablet,Oral,02223554,REACTINE (cetirizine hydrochloride 10 mg oral tablet) KENVUE CANADA INC.,Active,9000707,cetirizine hydrochloride 10 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
46803,Marketed,2026-04-17,01900978,Reactine 20 mg Tablet,1,R06AE07,Cetirizine,Tablet,Oral,01900978,REACTINE 20 MG TABLET (cetirizine hydrochloride 20 mg oral tablet) KENVUE CANADA INC.,Active,9000972,cetirizine hydrochloride 20 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
50975,Marketed,1998-10-21,02231603,Apo-Cetirizine,1,R06AE07,Cetirizine,Tablet,Oral,02231603,APO-CETIRIZINE (cetirizine hydrochloride 10 mg oral tablet) APOTEX INC,Active,9000707,cetirizine hydrochloride 10 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
61744,Marketed,2026-03-12,02238337,Reactine,1,R06AE07,Cetirizine,Syrup,Oral,02238337,REACTINE (cetirizine hydrochloride 5 mg per 5 mL syrup) KENVUE CANADA INC.,Active,9000877,cetirizine hydrochloride 5 mg per 5 mL syrup,8000237,cetirizine,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
63803,Marketed,1999-08-17,02240266,Allergy Relief,1,R06AE07,Cetirizine,Tablet,Oral,02240266,ALLERGY RELIEF (cetirizine hydrochloride 10 mg oral tablet) APOTEX INC,Active,9000707,cetirizine hydrochloride 10 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
80148,Marketed,2012-09-24,02315955,Extra Strength Allergy Relief,1,R06AE07,Cetirizine,Tablet,Oral,02315955,EXTRA STRENGTH ALLERGY RELIEF (cetirizine hydrochloride 10 mg oral tablet) PHARMASCIENCE INC,Active,9000707,cetirizine hydrochloride 10 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
80149,Marketed,2008-10-14,02315963,PMS-Cetirizine,1,R06AE07,Cetirizine,Tablet,Oral,02315963,PMS-CETIRIZINE (cetirizine hydrochloride 20 mg oral tablet) PHARMASCIENCE INC,Active,9000972,cetirizine hydrochloride 20 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84341,Marketed,2026-03-12,02358352,Reactine Fast Melt Junior,1,R06AE07,Cetirizine,Tablet (orally disintegrating),Oral,02358352,REACTINE FAST MELT JUNIOR (cetirizine hydrochloride 10 mg orodispersible tablet) KENVUE CANADA INC.,Active,9001412,cetirizine hydrochloride 10 mg orodispersible tablet,8000237,cetirizine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
85288,Marketed,2026-03-12,02368064,Reactine Allergy Liquid Gels,1,R06AE07,Cetirizine,Capsule (immediate release),Oral,02368064,REACTINE ALLERGY LIQUID GELS (cetirizine hydrochloride 10 mg oral capsule) KENVUE CANADA INC.,Active,9001383,cetirizine hydrochloride 10 mg oral capsule,8000237,cetirizine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
91167,Marketed,2015-10-13,02427141,Mar-Cetirizine,1,R06AE07,Cetirizine,Tablet,Oral,02427141,MAR-CETIRIZINE (cetirizine hydrochloride 20 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000972,cetirizine hydrochloride 20 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93668,Marketed,2025-07-04,02450526,Pro-Cetirizine,1,R06AE07,Cetirizine,Tablet,Oral,02450526,PRO-CETIRIZINE (cetirizine hydrochloride 20 mg oral tablet) PRO DOC LIMITEE,Active,9000972,cetirizine hydrochloride 20 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93812,Marketed,2026-03-05,02451778,JAMP-Cetirizine,1,R06AE07,Cetirizine,Tablet,Oral,02451778,JAMP-CETIRIZINE (cetirizine hydrochloride 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000707,cetirizine hydrochloride 10 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
93991,Marketed,2016-04-22,02453363,Apo-Cetirizine,1,R06AE07,Cetirizine,Tablet,Oral,02453363,APO-CETIRIZINE (cetirizine hydrochloride 20 mg oral tablet) APOTEX INC,Active,9000972,cetirizine hydrochloride 20 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95446,Marketed,2025-12-15,02466171,JAMP-Cetirizine,1,R06AE07,Cetirizine,Tablet,Oral,02466171,JAMP-CETIRIZINE (cetirizine hydrochloride 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000972,cetirizine hydrochloride 20 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95593,Marketed,2026-03-12,02467577,Reactine Rapid Dissolve,1,R06AE07,Cetirizine,Tablet (orally disintegrating),Oral,02467577,REACTINE RAPID DISSOLVE (cetirizine hydrochloride 10 mg orodispersible tablet) KENVUE CANADA INC.,Active,9001412,cetirizine hydrochloride 10 mg orodispersible tablet,8000237,cetirizine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
97710,Marketed,2026-03-12,02486954,Reactine Allergy,1,R06AE07,Cetirizine,Syrup,Oral,02486954,REACTINE ALLERGY (cetirizine hydrochloride 5 mg per 5 mL syrup) KENVUE CANADA INC.,Active,9000877,cetirizine hydrochloride 5 mg per 5 mL syrup,8000237,cetirizine,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
98634,Marketed,2020-08-20,02496461,Nat-Cetirizine,1,R06AE07,Cetirizine,Tablet,Oral,02496461,NAT-CETIRIZINE (cetirizine hydrochloride 10 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9000707,cetirizine hydrochloride 10 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
98635,Marketed,2020-08-19,02496488,Nat-Cetirizine,1,R06AE07,Cetirizine,Tablet,Oral,02496488,NAT-CETIRIZINE (cetirizine hydrochloride 20 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9000972,cetirizine hydrochloride 20 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99929,Marketed,2023-06-19,02510030,Bio-Cetirizine,1,R06AE07,Cetirizine,Tablet,Oral,02510030,BIO-CETIRIZINE (cetirizine hydrochloride 20 mg oral tablet) BIOMED PHARMA,Active,9000972,cetirizine hydrochloride 20 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
10565,Marketed,1990-12-31,00873195,Cetrimide Tincture 0.5%,1,D08AJ02,Cetrimonium,Tincture,Topical,00873195,CETRIMIDE TINCTURE 0.5% (cetrimide 0.5 % cutaneous solution) CANADIAN CUSTOM PACKAGING COMPANY,Active,9014018,cetrimide 0.5 % cutaneous solution,8002270,cetrimide,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Non-Prescription Drugs
12864,Marketed,1992-12-31,00874426,Cetrimide Cream 0.5%,1,D08AJ02,Cetrimonium,Cream,Topical,00874426,CETRIMIDE CREAM 0.5% (cetrimide 0.5 % cutaneous cream) CANADIAN CUSTOM PACKAGING COMPANY,Active,9014017,cetrimide 0.5 % cutaneous cream,8002270,cetrimide,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
72060,Marketed,2004-03-03,02247766,Cetrotide,1,H01CC02,Cetrorelix,Powder for solution,Subcutaneous,02247766,"CETROTIDE (cetrorelix (cetrorelix acetate) 0.25 mg per vial powder for solution for injection with diluent solution syringe) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013042,cetrorelix (cetrorelix acetate) 0.25 mg per vial powder for solution for injection with diluent solution syringe,8001719,cetrorelix,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
75672,Marketed,2010-04-30,02271249,Erbitux,1,L01FE01,Cetuximab,Solution,Intravenous,77700681,"ERBITUX (cetuximab 100 mg per 50 mL solution for injection vial) IMCLONE, LLC",Active,9012936,cetuximab 100 mg per 50 mL solution for injection vial,8001614,cetuximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
75672,Marketed,2010-04-30,02271249,Erbitux,1,L01FE01,Cetuximab,Solution,Intravenous,77700682,"ERBITUX (cetuximab 200 mg per 100 mL solution for injection vial) IMCLONE, LLC",Active,9012937,cetuximab 200 mg per 100 mL solution for injection vial,8001614,cetuximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
75672,Marketed,2010-04-30,02271249,Erbitux,1,L01FE01,Cetuximab,Solution,Intravenous,77700681,"ERBITUX (cetuximab 100 mg per 50 mL solution for injection vial) IMCLONE, LLC",Active,9012936,cetuximab 100 mg per 50 mL solution for injection vial,8001614,cetuximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
75672,Marketed,2010-04-30,02271249,Erbitux,1,L01FE01,Cetuximab,Solution,Intravenous,77700682,"ERBITUX (cetuximab 200 mg per 100 mL solution for injection vial) IMCLONE, LLC",Active,9012937,cetuximab 200 mg per 100 mL solution for injection vial,8001614,cetuximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
100015,Marketed,2026-05-21,02510871,Crest Pro-Health Gum Detoxify,1,R02AA06,Cetylpyridinium,Mouthwash,Buccal,02510871,CREST PRO-HEALTH GUM DETOXIFY (cetylpyridinium chloride 0.07 % mouthwash) PROCTER & GAMBLE INC,Active,9005673,cetylpyridinium chloride 0.07 % mouthwash,8001895,cetylpyridinium,26643006,Oral,764788008,Oropharyngeal solution,,,,,,Non-Prescription Drugs
100089,Marketed,2021-07-05,02511851,Crest Pro-Health Gum & Breath Purify,1,R02AA06,Cetylpyridinium,Mouthwash,Buccal,02511851,CREST PRO-HEALTH GUM & BREATH PURIFY (cetylpyridinium chloride 0.07 % mouthwash) PROCTER & GAMBLE INC,Active,9005673,cetylpyridinium chloride 0.07 % mouthwash,8001895,cetylpyridinium,26643006,Oral,764788008,Oropharyngeal solution,,,,,,Non-Prescription Drugs
101959,Marketed,2025-09-05,02530414,Colgate Total Active Prevention Gum Health,1,R02AA06,Cetylpyridinium,Mouthwash,Buccal,02530414,COLGATE TOTAL ACTIVE PREVENTION GUM HEALTH (cetylpyridinium chloride 0.075 % mouthwash) COLGATE-PALMOLIVE CANADA INC,Active,9014324,cetylpyridinium chloride 0.075 % mouthwash,8001895,cetylpyridinium,26643006,Oral,764788008,Oropharyngeal solution,,,,,,Non-Prescription Drugs
103117,Marketed,2024-07-12,02542617,Periogard Protect Cetylpyridinium Chloride Mouthwash,1,R02AA06,Cetylpyridinium,Mouthwash,Buccal,02542617,PERIOGARD PROTECT CETYLPYRIDINIUM CHLORIDE MOUTHWASH (cetylpyridinium chloride 0.075 % mouthwash) COLGATE-PALMOLIVE CANADA INC,Active,9014324,cetylpyridinium chloride 0.075 % mouthwash,8001895,cetylpyridinium,26643006,Oral,764788008,Oropharyngeal solution,,,,,,Non-Prescription Drugs
106728,Marketed,2026-05-07,02564599,Crest Pro-Health Complete Clean,1,R02AA06,Cetylpyridinium,Mouthwash,Buccal,02564599,CREST PRO-HEALTH COMPLETE CLEAN (cetylpyridinium chloride 0.07 % mouthwash) PROCTER & GAMBLE INC,Active,9005673,cetylpyridinium chloride 0.07 % mouthwash,8001895,cetylpyridinium,26643006,Oral,764788008,Oropharyngeal solution,,,,,,Non-Prescription Drugs
5812,Marketed,1984-12-31,00609900,Rince Bouche Antiseptique,1,R02AA06,Cetylpyridinium,Mouthwash,Buccal,00609900,RINCE BOUCHE ANTISEPTIQUE (cetylpyridinium chloride 0.05 % mouthwash) LABORATOIRE ATLAS INC,Active,9013779,cetylpyridinium chloride 0.05 % mouthwash,8001895,cetylpyridinium,26643006,Oral,764788008,Oropharyngeal solution,,,,,,Non-Prescription Drugs
67489,Marketed,2006-03-22,02243571,Antiseptic Oral Rinse,1,R02AA06,Cetylpyridinium,Mouthwash,Buccal,02243571,ANTISEPTIC ORAL RINSE (cetylpyridinium chloride 0.05 % mouthwash) SAGE PRODUCTS LLC,Active,9013779,cetylpyridinium chloride 0.05 % mouthwash,8001895,cetylpyridinium,26643006,Oral,764788008,Oropharyngeal solution,,,,,,Non-Prescription Drugs
75427,Marketed,2010-01-26,02268884,Crest Pro-Health Multi Protection,1,R02AA06,Cetylpyridinium,Mouthwash,Buccal,02268884,CREST PRO-HEALTH MULTI PROTECTION (cetylpyridinium chloride 0.07 % mouthwash) PROCTER & GAMBLE INC,Active,9005673,cetylpyridinium chloride 0.07 % mouthwash,8001895,cetylpyridinium,26643006,Oral,764788008,Oropharyngeal solution,,,,,,Non-Prescription Drugs
92853,Marketed,2025-04-22,02443783,Colgate Total Active Prevention,1,R02AA06,Cetylpyridinium,Mouthwash,Buccal,02443783,COLGATE TOTAL ACTIVE PREVENTION (cetylpyridinium chloride 0.07 % mouthwash) COLGATE-PALMOLIVE CANADA INC,Active,9005673,cetylpyridinium chloride 0.07 % mouthwash,8001895,cetylpyridinium,26643006,Oral,764788008,Oropharyngeal solution,,,,,,Non-Prescription Drugs
93375,Marketed,2026-01-04,02448068,Hello Clean Mint,1,R02AA06,Cetylpyridinium,Mouthwash,Dental,02448068,HELLO CLEAN MINT (cetylpyridinium chloride 0.075 % mouthwash) COLGATE-PALMOLIVE CANADA INC,Active,9014324,cetylpyridinium chloride 0.075 % mouthwash,8001895,cetylpyridinium,26643006,Oral,764788008,Oropharyngeal solution,,,,,,Non-Prescription Drugs
97708,Marketed,2022-05-11,02486938,Therabreath Healthy Gums Oral Rinse,1,R02AA06,Cetylpyridinium,Mouthwash,Buccal,02486938,THERABREATH HEALTHY GUMS ORAL RINSE (cetylpyridinium chloride 0.05 % mouthwash) CHURCH & DWIGHT CANADA CORP,Active,9013779,cetylpyridinium chloride 0.05 % mouthwash,8001895,cetylpyridinium,26643006,Oral,764788008,Oropharyngeal solution,,,,,,Non-Prescription Drugs
98513,Marketed,2026-05-13,02495198,Crest Pro-Health Nightly Bacteria Guard,1,R02AA06,Cetylpyridinium,Mouthwash,Buccal,02495198,CREST PRO-HEALTH NIGHTLY BACTERIA GUARD (cetylpyridinium chloride 0.07 % mouthwash) PROCTER & GAMBLE INC,Active,9005673,cetylpyridinium chloride 0.07 % mouthwash,8001895,cetylpyridinium,26643006,Oral,764788008,Oropharyngeal solution,,,,,,Non-Prescription Drugs
99377,Marketed,2026-02-11,02504340,Crest Pro-Health Germ Guard,1,R02AA06,Cetylpyridinium,Mouthwash,Buccal,02504340,CREST PRO-HEALTH GERM GUARD (cetylpyridinium chloride 0.07 % mouthwash) PROCTER & GAMBLE INC,Active,9005673,cetylpyridinium chloride 0.07 % mouthwash,8001895,cetylpyridinium,26643006,Oral,764788008,Oropharyngeal solution,,,,,,Non-Prescription Drugs
103787,Marketed,2024-10-28,02548984,Ixchiq,1,J07BP01,"Chikungunya, live attenuated",Powder for solution,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
71882,Marketed,2003-08-06,02247621,Chloral Hydrate Syrup Odan,1,N05CC01,Chloral hydrate,Syrup,Oral,02247621,CHLORAL HYDRATE SYRUP ODAN (chloral hydrate 500 mg per 5 mL syrup) ODAN LABORATORIES LTD,Active,9012567,chloral hydrate 500 mg per 5 mL syrup,8001097,chloral hydrate,26643006,Oral,739009002,Syrup,,,,,,Prescription
1193,Marketed,2017-11-01,00004626,Leukeran,1,L01AA02,Chlorambucil,Tablet,Oral,00004626,LEUKERAN (chlorambucil 2 mg oral tablet) ASPEN PHARMACARE CANADA INC.,Active,9012462,chlorambucil 2 mg oral tablet,8001091,chlorambucil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
2789,Marketed,2022-10-20,00312363,Chloromycetin Succinate Injection,1,J01BA01,Chloramphenicol,Powder for solution,Intravenous,00312363,CHLOROMYCETIN SUCCINATE INJECTION (chloramphenicol (chloramphenicol sodium succinate) 1 g per vial powder for solution for injection) SEARCHLIGHT PHARMA INC,Active,9001569,chloramphenicol (chloramphenicol sodium succinate) 1 g per vial powder for solution for injection,8001349,chloramphenicol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
4279,Marketed,2013-05-16,00522996,Chlordiazepoxide,1,N05BA02,Chlordiazepoxide,Capsule,Oral,00522996,CHLORDIAZEPOXIDE (chlordiazepoxide hydrochloride 25 mg oral capsule) AA PHARMA INC,Active,9001904,chlordiazepoxide hydrochloride 25 mg oral capsule,8001350,chlordiazepoxide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Targeted Substances (CDSA IV)
101576,Marketed,2022-12-15,02526697,Purell Antimicrobial Foam Handwash 2% CHG,1,D08AC02,Chlorhexidine,Solution,Topical (commercial),02526697,PURELL ANTIMICROBIAL FOAM HANDWASH 2% CHG (chlorhexidine gluconate 2 % cutaneous solution) GOJO CANADA INC,Active,9003552,chlorhexidine gluconate 2 % cutaneous solution,8000809,chlorhexidine,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Non-Prescription Drugs
10668,Marketed,1990-12-31,00832111,Dexidin Liquid 4%,1,D08AC02,Chlorhexidine,Solution,Topical,00832111,DEXIDIN LIQ 4% (chlorhexidine gluconate 4 % cutaneous solution) LABORATOIRE ATLAS INC,Active,9001683,chlorhexidine gluconate 4 % cutaneous solution,8000809,chlorhexidine,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Non-Prescription Drugs
10669,Marketed,1990-12-31,00832138,Dexidin 2 Detergent,1,D08AC02,Chlorhexidine,Solution,Topical,00832138,DEXIDIN 2 DETERGENT (chlorhexidine gluconate 2 % cutaneous solution) LABORATOIRE ATLAS INC,Active,9003552,chlorhexidine gluconate 2 % cutaneous solution,8000809,chlorhexidine,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Non-Prescription Drugs
10767,Marketed,1997-09-20,00658413,Baxedin Liquid 20%,1,D08AC02,Chlorhexidine,Solution,Topical,00658413,BAXEDIN LIQ 20% (chlorhexidine gluconate 20 % cutaneous solution) OMEGA LABORATORIES LIMITED,Active,9002648,chlorhexidine gluconate 20 % cutaneous solution,8000809,chlorhexidine,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Non-Prescription Drugs
13003,Marketed,1991-12-31,01939947,E-Z Scrub 747 4%,1,D08AC02,Chlorhexidine,Sponge,Topical (hospital/hc facilities),01939947,E-Z SCRUB 747 4% (chlorhexidine gluconate 4 % medicated sponge) BECTON DICKINSON,Active,9003013,chlorhexidine gluconate 4 % medicated sponge,8000809,chlorhexidine,448598008,Cutaneous,421288004,Sponge,733014006,Sponge (unit of presentation),,,,Non-Prescription Drugs
15801,Marketed,2001-08-28,02046245,Prevora Stage 1,1,A01AB03,Chlorhexidine,"Kit,Solution",Dental,02046245,PREVORA STAGE 1 (chlorhexidine acetate 10 % dental solution with sealant) CHX TECHNOLOGIES INC,Active,9012938,chlorhexidine acetate 10 % dental solution with sealant,8000809,chlorhexidine,372449004,Dental,385094000,Dental solution,,,,,,Prescription
17006,Marketed,1992-12-31,00832146,Chlorhexidine Gluconate Solution 0.05%,1,D08AC02,Chlorhexidine,Solution,Topical,00832146,CHLORHEXIDINE GLUCONATE SOLUTION 0.05% (chlorhexidine gluconate 0.05 % cutaneous solution) LABORATOIRE ATLAS INC,Active,9002430,chlorhexidine gluconate 0.05 % cutaneous solution,8000809,chlorhexidine,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Non-Prescription Drugs
20216,Marketed,1996-12-31,02209055,Oro-Clense,1,A01AB03,Chlorhexidine,Mouthwash,Buccal,02209055,ORO-CLENSE (chlorhexidine gluconate 0.12 % mouthwash) GERMIPHENE CORPORATION,Active,9002950,chlorhexidine gluconate 0.12 % mouthwash,8000809,chlorhexidine,26643006,Oral,764788008,Oropharyngeal solution,,,,,,Prescription
22030,Marketed,1999-07-21,01936441,Baxedin Pre-Op,1,D08AC02,Chlorhexidine,Solution,Topical,01936441,BAXEDIN PRE-OP (chlorhexidine gluconate 0.5 % cutaneous solution) OMEGA LABORATORIES LIMITED,Active,9003371,chlorhexidine gluconate 0.5 % cutaneous solution,8000809,chlorhexidine,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Non-Prescription Drugs
27903,Marketed,2026-01-16,02072955,Soluprep LD Sponge,1,D08AC02,Chlorhexidine,Sponge,Topical (hospital/hc facilities),02072955,SOLUPREP LD SPONGE (chlorhexidine gluconate 0.05 % medicated sponge) SOLVENTUM CANADA LIMITED,Active,9003148,chlorhexidine gluconate 0.05 % medicated sponge,8000809,chlorhexidine,448598008,Cutaneous,421288004,Sponge,733014006,Sponge (unit of presentation),,,,Non-Prescription Drugs
60786,Marketed,2024-10-31,02237452,Peridex Oral Rinse,1,A01AB03,Chlorhexidine,Mouthwash,Buccal,02237452,PERIDEX ORAL RINSE (chlorhexidine gluconate 0.12 % mouthwash) 3M HEALTHCARE CANADA COMPANY LIMITED,Active,9002950,chlorhexidine gluconate 0.12 % mouthwash,8000809,chlorhexidine,26643006,Oral,764788008,Oropharyngeal solution,,,,,,Prescription
62430,Marketed,2000-03-28,02238982,Dexidin 2 Solution,1,D08AC02,Chlorhexidine,Solution,Topical,02238982,DEXIDIN 2 SOLUTION (chlorhexidine gluconate 2 % cutaneous solution) LABORATOIRE ATLAS INC,Active,9003552,chlorhexidine gluconate 2 % cutaneous solution,8000809,chlorhexidine,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Non-Prescription Drugs
62715,Marketed,1999-02-28,02239252,Endure 400 Scrub-Stat 4,1,D08AC02,Chlorhexidine,Solution,Topical,02239252,ENDURE 400 SCRUB-STAT 4 (chlorhexidine gluconate 4 % cutaneous solution) ECOLAB CO,Active,9001683,chlorhexidine gluconate 4 % cutaneous solution,8000809,chlorhexidine,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Non-Prescription Drugs
63965,Marketed,1999-12-15,02240416,Endure 420 Cida-Stat,1,D08AC02,Chlorhexidine,Solution,Topical,02240416,ENDURE 420 CIDA-STAT (chlorhexidine gluconate 2 % cutaneous solution) ECOLAB CO,Active,9003552,chlorhexidine gluconate 2 % cutaneous solution,8000809,chlorhexidine,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Non-Prescription Drugs
63982,Marketed,2025-09-03,02240433,PMS-Chlorhexidine,1,A01AB03,Chlorhexidine,Mouthwash,Buccal,02240433,PMS-CHLORHEXIDINE (chlorhexidine gluconate 0.12 % mouthwash) PHARMASCIENCE INC,Active,9002950,chlorhexidine gluconate 0.12 % mouthwash,8000809,chlorhexidine,26643006,Oral,764788008,Oropharyngeal solution,,,,,,Prescription
69848,Marketed,2006-02-14,02245741,Antiseptic Body Cleanser,1,D08AC02,Chlorhexidine,Wipe,Topical,02245741,ANTISEPTIC BODY CLEANSER (chlorhexidine gluconate 2 % wipe) SAGE PRODUCTS LLC,Active,9004128,chlorhexidine gluconate 2 % wipe,8000809,chlorhexidine,448598008,Cutaneous,465925000,Wipe,465925000,Skin-cleaning wipe (physical object),,,,Non-Prescription Drugs
71177,Marketed,2002-12-04,02246950,Stanhexidine Aqueous 2% With 4% Isopropyl Alcohol,2,D08AC02,Chlorhexidine,Solution,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
75254,Marketed,2025-04-09,02267144,Hygenipak 2% CHG Foaming Skin Cleanser,1,D08AC02,Chlorhexidine,Solution,"Topical (commercial),Topical (hospital/hc facilities)",02267144,HYGENIPAK 2% CHG FOAMING SKIN CLEANSER (chlorhexidine gluconate 2 % cutaneous solution) SC JOHNSON PROFESSIONAL CA INC,Active,9003552,chlorhexidine gluconate 2 % cutaneous solution,8000809,chlorhexidine,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Non-Prescription Drugs
77648,Marketed,2016-01-25,02291096,Oro Clear,1,A01AB03,Chlorhexidine,Mouthwash,Buccal,02291096,ORO CLEAR (chlorhexidine gluconate 0.12 % mouthwash) GERMIPHENE CORPORATION,Active,9002950,chlorhexidine gluconate 0.12 % mouthwash,8000809,chlorhexidine,26643006,Oral,764788008,Oropharyngeal solution,,,,,,Prescription
78057,Marketed,2022-09-23,02295253,Chlorhexidine Solution,1,D08AC02,Chlorhexidine,Solution,Topical (commercial),02295253,CHLORHEXIDINE SOLUTION (chlorhexidine gluconate 2 % cutaneous solution) PARTNAR ANIMAL HEALTH INC.,Active,9003552,chlorhexidine gluconate 2 % cutaneous solution,8000809,chlorhexidine,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Non-Prescription Drugs
78102,Marketed,2022-09-23,02295679,Chlorhexidine 4% Antiseptic Hand Wash,1,D08AC02,Chlorhexidine,Solution,Topical (commercial),02295679,CHLORHEXIDINE 4% ANTISEPTIC HAND WASH (chlorhexidine gluconate 4 % cutaneous solution) PARTNAR ANIMAL HEALTH INC.,Active,9001683,chlorhexidine gluconate 4 % cutaneous solution,8000809,chlorhexidine,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Non-Prescription Drugs
84115,Marketed,2016-10-07,02355965,Loris 2% CHG Wipe/Serviette,1,D08AC02,Chlorhexidine,Wipe,Topical (household),02355965,LORIS 2% CHG WIPE/SERVIETTE (chlorhexidine gluconate 2 % wipe) LERNAPHARM (LORIS) INC.,Active,9004128,chlorhexidine gluconate 2 % wipe,8000809,chlorhexidine,448598008,Cutaneous,465925000,Wipe,465925000,Skin-cleaning wipe (physical object),,,,Non-Prescription Drugs
84308,Marketed,2014-07-10,02358018,Loris 2% CHG Solution,1,D08AC02,Chlorhexidine,Solution,Topical (household),02358018,LORIS 2% CHG SOLUTION (chlorhexidine gluconate 2 % cutaneous solution) LERNAPHARM (LORIS) INC.,Active,9003552,chlorhexidine gluconate 2 % cutaneous solution,8000809,chlorhexidine,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Non-Prescription Drugs
88992,Marketed,2021-10-27,02405091,Periogard Alcohol Free,1,A01AB03,Chlorhexidine,Solution,Buccal,02405091,PERIOGARD ALCOHOL FREE (chlorhexidine gluconate 0.12 % mouthwash) COLGATE-PALMOLIVE CANADA INC,Active,9002950,chlorhexidine gluconate 0.12 % mouthwash,8000809,chlorhexidine,26643006,Oral,764788008,Oropharyngeal solution,,,,,,Prescription
89318,Marketed,2025-12-18,02408430,Soluprep Aq Sponge,1,D08AC02,Chlorhexidine,Sponge,Topical (hospital/hc facilities),02408430,SOLUPREP AQ SPONGE (chlorhexidine gluconate 2 % medicated sponge) SOLVENTUM CANADA LIMITED,Active,9005433,chlorhexidine gluconate 2 % medicated sponge,8000809,chlorhexidine,448598008,Cutaneous,421288004,Sponge,733014006,Sponge (unit of presentation),,,,Non-Prescription Drugs
91589,Marketed,2025-12-18,02431483,Soluprep Aq Swab,1,D08AC02,Chlorhexidine,Swab,Topical (hospital/hc facilities),02431483,SOLUPREP AQ SWAB (chlorhexidine gluconate 2 % swab) SOLVENTUM CANADA LIMITED,Active,9005770,chlorhexidine gluconate 2 % swab,8000809,chlorhexidine,448598008,Cutaneous,233001000087106,Swab,,,,,,Non-Prescription Drugs
95071,Marketed,2025-06-25,02462842,Euro-Chlorhexidine,1,A01AB03,Chlorhexidine,Mouthwash,Buccal,02462842,EURO-CHLORHEXIDINE (chlorhexidine gluconate 0.12 % mouthwash) EURO-PHARM INTERNATIONAL CANADA INC,Active,9002950,chlorhexidine gluconate 0.12 % mouthwash,8000809,chlorhexidine,26643006,Oral,764788008,Oropharyngeal solution,,,,,,Prescription
9824,Marketed,1989-12-31,00832030,Dexidin 20,1,D08AC02,Chlorhexidine,Solution,Topical,00832030,DEXIDIN 20 (chlorhexidine gluconate 20 % cutaneous solution) LABORATOIRE ATLAS INC,Active,9002648,chlorhexidine gluconate 20 % cutaneous solution,8000809,chlorhexidine,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Non-Prescription Drugs
98313,Marketed,2025-02-23,02493160,PMS-Chlorhexidine Without Alcohol,1,A01AB03,Chlorhexidine,Mouthwash,Buccal,02493160,PMS-CHLORHEXIDINE WITHOUT ALCOHOL (chlorhexidine gluconate 0.12 % mouthwash) PHARMASCIENCE INC,Active,9002950,chlorhexidine gluconate 0.12 % mouthwash,8000809,chlorhexidine,26643006,Oral,764788008,Oropharyngeal solution,,,,,,Prescription
101459,Marketed,2024-12-24,02525585,Chloraprep Swabsticks,2,D08AC52,"Chlorhexidine, combinations",Swab,Topical (hospital/hc facilities),,,,,,,,,,,,,,,,,Non-Prescription Drugs
13289,Marketed,2002-10-10,01938991,Stanhexidine 2% With Isopropyl Alcohol 4%,2,D08AC52,"Chlorhexidine, combinations",Solution,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
13290,Marketed,2002-10-10,01938983,Stanhexidine 4% With Isopropyl Alcohol 4%,2,D08AC52,"Chlorhexidine, combinations",Solution,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
16494,Marketed,2025-12-24,02060019,Soluprep QD Wipe,2,D08AC52,"Chlorhexidine, combinations",Wipe,Topical (hospital/hc facilities),,,,,,,,,,,,,,,,,Non-Prescription Drugs
30398,Marketed,2025-12-18,02119803,Soluprep QD Swab,2,D08AC52,"Chlorhexidine, combinations",Swab,Topical (hospital/hc facilities),,,,,,,,,,,,,,,,,Non-Prescription Drugs
64263,Marketed,2000-02-02,02240680,Dexidin 0.5 Solution,2,D08AC52,"Chlorhexidine, combinations",Liquid,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
71113,Marketed,2026-03-03,02246888,Avagard CHG,2,D08AC52,"Chlorhexidine, combinations",Lotion,Topical (hospital/hc facilities),,,,,,,,,,,,,,,,,Non-Prescription Drugs
73640,Marketed,2004-07-07,02251477,Baxedin 2% - 70%,2,D08AC52,"Chlorhexidine, combinations",Solution,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
78280,Marketed,2009-02-24,02297442,Loris - IV,2,D08AC52,"Chlorhexidine, combinations",Swab,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
86791,Marketed,2025-12-18,02382040,Soluprep Swab,2,D08AC52,"Chlorhexidine, combinations",Swab,Topical (hospital/hc facilities),,,,,,,,,,,,,,,,,Non-Prescription Drugs
86799,Marketed,2025-12-24,02382113,Soluprep Applicator,2,D08AC52,"Chlorhexidine, combinations",Solution,Topical (hospital/hc facilities),,,,,,,,,,,,,,,,,Non-Prescription Drugs
87132,Marketed,2025-12-05,02385708,Soluprep Wipe,2,D08AC52,"Chlorhexidine, combinations",Wipe,Topical (hospital/hc facilities),,,,,,,,,,,,,,,,,Non-Prescription Drugs
97469,Marketed,2019-11-18,02484374,Chloraprep,2,D08AC52,"Chlorhexidine, combinations",Solution,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
100609,Marketed,2022-09-14,02516764,Ledaga,1,L01AA05,Chlormethine,Gel,Topical,02516764,LEDAGA (chlormethine (chlormethine hydrochloride) 160 mcg per g cutaneous gel) RECORDATI RARE DISEASES CANADA INC,Active,9014799,chlormethine (chlormethine hydrochloride) 160 mcg per g cutaneous gel,8002451,chlormethine,448598008,Cutaneous,385100002,Gel,,,1.0,,,Prescription
103981,Marketed,2025-03-04,02551063,Clorotekal,1,N01BA04,Chloroprocaine,Solution,Intrathecal,,,,,,,,,,,,,,,,,Ethical
12639,Marketed,1992-12-31,01977873,Germicidal Hand Soap Liquid 0.6%,1,D08AE05,Chloroxylenol,Liquid,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
18208,Marketed,2012-06-23,02131471,Virobex-P,1,D08AE05,Chloroxylenol,Liquid,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
41477,Marketed,2026-03-18,00373435,Dettol,1,D08AE05,Chloroxylenol,Solution,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
66677,Marketed,2001-03-01,02242847,Digiclean E Foam Hand Soap,1,D08AE05,Chloroxylenol,Liquid,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
76258,Marketed,2021-03-29,02276917,Quick Clean,1,D08AE05,Chloroxylenol,Gel,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
79962,Marketed,2009-11-10,02314126,Phenrex MVD,1,D08AE05,Chloroxylenol,Solution,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
92481,Marketed,2015-08-18,02440458,Purklenz,1,D08AE05,Chloroxylenol,Liquid,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
93459,Marketed,2017-02-28,02448866,Soft Care Defend Foam,1,D08AE05,Chloroxylenol,Liquid,Topical (commercial),,,,,,,,,,,,,,,,,Non-Prescription Drugs
93526,Marketed,2017-02-28,02449420,Soft Care Defend,1,D08AE05,Chloroxylenol,Liquid,Topical (commercial),,,,,,,,,,,,,,,,,Non-Prescription Drugs
97106,Marketed,2019-08-02,02480506,Applaud Ab Antiseptic Lotionized Hand Soap,1,D08AE05,Chloroxylenol,Lotion,Topical (commercial),,,,,,,,,,,,,,,,,Non-Prescription Drugs
579,Marketed,2019-06-13,00021288,Teva-Pheniram,1,R06AB04,Chlorpheniramine,Tablet,Oral,00021288,TEVA-PHENIRAM (chlorpheniramine maleate 4 mg oral tablet) TEVA CANADA LIMITED,Active,9001624,chlorpheniramine maleate 4 mg oral tablet,8001353,chlorpheniramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
1293,Marketed,2011-03-09,00232807,Teva-Chlorpromazine,1,N05AA01,Chlorpromazine,Tablet,Oral,00232807,TEVA-CHLORPROMAZINE (chlorpromazine (chlorpromazine hydrochloride) 50 mg oral tablet) TEVA CANADA LIMITED,Active,9001627,chlorpromazine (chlorpromazine hydrochloride) 50 mg oral tablet,8001357,chlorpromazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
1294,Marketed,2011-03-09,00232823,Teva-Chlorpromazine,1,N05AA01,Chlorpromazine,Tablet,Oral,00232823,TEVA-CHLORPROMAZINE (chlorpromazine (chlorpromazine hydrochloride) 25 mg oral tablet) TEVA CANADA LIMITED,Active,9001626,chlorpromazine (chlorpromazine hydrochloride) 25 mg oral tablet,8001357,chlorpromazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
1295,Marketed,2011-03-09,00232831,Teva-Chlorpromazine,1,N05AA01,Chlorpromazine,Tablet,Oral,00232831,TEVA-CHLORPROMAZINE (chlorpromazine (chlorpromazine hydrochloride) 100 mg oral tablet) TEVA CANADA LIMITED,Active,9001625,chlorpromazine (chlorpromazine hydrochloride) 100 mg oral tablet,8001357,chlorpromazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101285,Marketed,2022-12-01,02523795,JAMP Chlorthalidone,1,C03BA04,Chlortalidone,Tablet,Oral,02523795,JAMP CHLORTHALIDONE (chlorthalidone 12.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9014800,chlorthalidone 12.5 mg oral tablet,8000813,chlorthalidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101286,Marketed,2022-12-01,02523809,JAMP Chlorthalidone,1,C03BA04,Chlortalidone,Tablet,Oral,02523809,JAMP CHLORTHALIDONE (chlorthalidone 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9014801,chlorthalidone 25 mg oral tablet,8000813,chlorthalidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101287,Marketed,2022-12-02,02523817,JAMP Chlorthalidone,1,C03BA04,Chlortalidone,Tablet,Oral,02523817,JAMP CHLORTHALIDONE (chlorthalidone 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9008378,chlorthalidone 50 mg oral tablet,8000813,chlorthalidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106047,Marketed,2026-05-19,02557126,Mint-Chlorthalidone,1,C03BA04,Chlortalidone,Tablet,Oral,02557126,MINT-CHLORTHALIDONE (chlorthalidone 12.5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9014800,chlorthalidone 12.5 mg oral tablet,8000813,chlorthalidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106048,Marketed,2026-05-19,02557134,Mint-Chlorthalidone,1,C03BA04,Chlortalidone,Tablet,Oral,02557134,MINT-CHLORTHALIDONE (chlorthalidone 25 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9014801,chlorthalidone 25 mg oral tablet,8000813,chlorthalidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106049,Marketed,2026-05-19,02557142,Mint-Chlorthalidone,1,C03BA04,Chlortalidone,Tablet,Oral,02557142,MINT-CHLORTHALIDONE (chlorthalidone 50 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9008378,chlorthalidone 50 mg oral tablet,8000813,chlorthalidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
2467,Marketed,2023-10-12,00360279,Apo-Chlorthalidone,1,C03BA04,Chlortalidone,Tablet,Oral,00360279,APO-CHLORTHALIDONE (chlorthalidone 50 mg oral tablet) APOTEX INC,Active,9008378,chlorthalidone 50 mg oral tablet,8000813,chlorthalidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71450,Marketed,2011-08-15,02247208,Dukoral,5,J07AE01,"Cholera, inactivated, whole cell",Suspension,Oral,,,,,,,,,,,,,,,,,Schedule D
102690,Marketed,2024-08-28,02538164,Vaxchora,1,J07AE02,"Cholera, live attenuated",Powder for suspension,Oral,,,,,,,,,,,,,,,,,Schedule D
74742,Marketed,2004-12-20,02262088,Ovidrel,1,G03GA08,Choriogonadotropin alfa,Solution,Subcutaneous,02262088,"OVIDREL (choriogonadotropin alfa 250 mcg per 0.5 mL solution for injection syringe) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013812,choriogonadotropin alfa 250 mcg per 0.5 mL solution for injection syringe,8002227,choriogonadotropin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Schedule D
74742,Marketed,2004-12-20,02262088,Ovidrel,1,G03GA08,Choriogonadotropin alfa,Solution,Subcutaneous,02262088,"OVIDREL (choriogonadotropin alfa 250 mcg per 0.5 mL solution for injection syringe) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013812,choriogonadotropin alfa 250 mcg per 0.5 mL solution for injection syringe,8002227,choriogonadotropin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
85673,Marketed,2013-05-28,02371588,Ovidrel,1,G03GA08,Choriogonadotropin alfa,Solution,Subcutaneous,02371588,"OVIDREL (choriogonadotropin alfa 250 mcg per 0.5 mL solution for injection pen) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013811,choriogonadotropin alfa 250 mcg per 0.5 mL solution for injection pen,8002227,choriogonadotropin alfa,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,,Schedule D
85673,Marketed,2013-05-28,02371588,Ovidrel,1,G03GA08,Choriogonadotropin alfa,Solution,Subcutaneous,02371588,"OVIDREL (choriogonadotropin alfa 250 mcg per 0.5 mL solution for injection pen) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013811,choriogonadotropin alfa 250 mcg per 0.5 mL solution for injection pen,8002227,choriogonadotropin alfa,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,,Prescription
44257,Marketed,2022-04-06,02182904,Pregnyl,1,G03GA01,Chorionic gonadotrophin,"Powder for solution,Kit",Intramuscular,02182904,PREGNYL (chorionic gonadotropin 10000 unit per vial powder for solution for injection with diluent solution) ORGANON CANADA INC.,Active,9013047,chorionic gonadotropin 10000 unit per vial powder for solution for injection with diluent solution,8001723,chorionic gonadotropin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
44257,Marketed,2022-04-06,02182904,Pregnyl,1,G03GA01,Chorionic gonadotrophin,"Powder for solution,Kit",Intramuscular,02182904,PREGNYL (chorionic gonadotropin 10000 unit per vial powder for solution for injection with diluent solution) ORGANON CANADA INC.,Active,9013047,chorionic gonadotropin 10000 unit per vial powder for solution for injection with diluent solution,8001723,chorionic gonadotropin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
71705,Marketed,2015-11-13,02247459,"Chorionic Gonadotropin For Injection, USP",1,G03GA01,Chorionic gonadotrophin,Powder for solution,"Subcutaneous,Intramuscular",02247459,"CHORIONIC GONADOTROPIN FOR INJECTION, USP (chorionic gonadotropin 10000 unit per vial powder for solution for injection with diluent solution) FRESENIUS KABI CANADA LTD",Active,9013047,chorionic gonadotropin 10000 unit per vial powder for solution for injection with diluent solution,8001723,chorionic gonadotropin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
71705,Marketed,2015-11-13,02247459,"Chorionic Gonadotropin For Injection, USP",1,G03GA01,Chorionic gonadotrophin,Powder for solution,"Subcutaneous,Intramuscular",02247459,"CHORIONIC GONADOTROPIN FOR INJECTION, USP (chorionic gonadotropin 10000 unit per vial powder for solution for injection with diluent solution) FRESENIUS KABI CANADA LTD",Active,9013047,chorionic gonadotropin 10000 unit per vial powder for solution for injection with diluent solution,8001723,chorionic gonadotropin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
77111,Marketed,2021-09-09,02285606,Alvesco,1,R03BA08,Ciclesonide,"Aerosol, metered dose",Inhalation,02285606,ALVESCO (ciclesonide 100 mcg per actuation pressurized inhalation) COVIS PHARMA GMBH,Active,9001173,ciclesonide 100 mcg per actuation pressurized inhalation,8000367,ciclesonide,447694001,447694001,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,,Prescription
77112,Marketed,2021-02-10,02285614,Alvesco,1,R03BA08,Ciclesonide,"Aerosol, metered dose",Inhalation,02285614,ALVESCO (ciclesonide 200 mcg per actuation pressurized inhalation) COVIS PHARMA GMBH,Active,9001174,ciclesonide 200 mcg per actuation pressurized inhalation,8000367,ciclesonide,447694001,447694001,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,,Prescription
78899,Marketed,2022-08-11,02303671,Omnaris,1,R01AD13,Ciclesonide,"Spray, metered dose",Nasal,02303671,OMNARIS (ciclesonide 50 mcg per actuation nasal spray) COVIS PHARMA GMBH,Active,9001244,ciclesonide 50 mcg per actuation nasal spray,8000367,ciclesonide,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,,Prescription
43306,Marketed,2020-11-27,02221802,Loprox,1,D01AE14,Ciclopirox,Cream,Topical,02221802,"LOPROX (ciclopirox olamine 1 % cutaneous cream) BAUSCH HEALTH, CANADA INC.",Active,9000675,ciclopirox olamine 1 % cutaneous cream,8000230,ciclopirox,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
43307,Marketed,2020-11-27,02221810,Loprox,1,D01AE14,Ciclopirox,Lotion,Topical,02221810,"LOPROX (ciclopirox olamine 1 % lotion) BAUSCH HEALTH, CANADA INC.",Active,9000710,ciclopirox olamine 1 % lotion,8000230,ciclopirox,448598008,Cutaneous,739000003,Lotion,,,,,,Prescription
78435,Marketed,2008-04-18,02298953,Apo-Ciclopirox,1,D01AE14,Ciclopirox,Solution,Topical,02298953,APO-CICLOPIROX (ciclopirox 8 % cutaneous solution) APOTEX INC,Active,9001082,ciclopirox 8 % cutaneous solution,8000230,ciclopirox,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Prescription
83849,Marketed,2011-10-25,02353288,Taro-Ciclopirox,1,D01AE14,Ciclopirox,Solution,Topical,02353288,TARO-CICLOPIROX (ciclopirox 8 % cutaneous solution) TARO PHARMACEUTICALS INC,Active,9001082,ciclopirox 8 % cutaneous solution,8000230,ciclopirox,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Prescription
100190,Marketed,2022-12-08,02512629,Cequa,1,S01XA18,Ciclosporin,Solution,Ophthalmic,02512629,CEQUA (cyclosporine 0.09 % ophthalmic drops) SUN PHARMACEUTICAL INDUSTRIES LIMITED,Active,9014621,cyclosporine 0.09 % ophthalmic drops,8001253,cyclosporine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),1.0,,,Prescription
17799,Marketed,2014-07-12,02150670,Neoral,1,L04AD01,Ciclosporin,Capsule,Oral,02150670,NEORAL (cyclosporine 100 mg oral capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9002770,cyclosporine 100 mg oral capsule,8001253,cyclosporine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
17801,Marketed,2014-07-12,02150697,Neoral,1,L04AD01,Ciclosporin,Solution,Oral,02150697,NEORAL (cyclosporine 100 mg per mL oral solution) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9002771,cyclosporine 100 mg per mL oral solution,8001253,cyclosporine,26643006,Oral,385023001,Oral solution,,,1.0,,,Prescription
17813,Marketed,2014-07-12,02150689,Neoral,1,L04AD01,Ciclosporin,Capsule,Oral,02150689,NEORAL (cyclosporine 25 mg oral capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9002772,cyclosporine 25 mg oral capsule,8001253,cyclosporine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
17814,Marketed,2014-07-12,02150662,Neoral,1,L04AD01,Ciclosporin,Capsule,Oral,02150662,NEORAL (cyclosporine 50 mg oral capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9002773,cyclosporine 50 mg oral capsule,8001253,cyclosporine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
5790,Marketed,1998-07-30,00593257,Sandimmune IV,1,L04AD01,Ciclosporin,Solution,Intravenous,77700583,SANDIMMUNE I.V. (cyclosporine 250 mg per 5 mL solution for injection ampoule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012605,cyclosporine 250 mg per 5 mL solution for injection ampoule,8001253,cyclosporine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),1.0,,,Prescription
5790,Marketed,1998-07-30,00593257,Sandimmune IV,1,L04AD01,Ciclosporin,Solution,Intravenous,77700584,SANDIMMUNE I.V. (cyclosporine 50 mg per 1 mL solution for injection ampoule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012606,cyclosporine 50 mg per 1 mL solution for injection ampoule,8001253,cyclosporine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),1.0,,,Prescription
61016,Marketed,1998-10-02,02237671,Neoral,1,L04AD01,Ciclosporin,Capsule,Oral,02237671,NEORAL (cyclosporine 10 mg oral capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9003317,cyclosporine 10 mg oral capsule,8001253,cyclosporine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
66649,Marketed,2006-02-18,02242821,Sandoz cycloSPORINE,1,L04AD01,Ciclosporin,Capsule,Oral,02242821,SANDOZ CYCLOSPORINE (cyclosporine 100 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9002770,cyclosporine 100 mg oral capsule,8001253,cyclosporine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
71308,Marketed,2006-02-18,02247073,Sandoz cycloSPORINE,1,L04AD01,Ciclosporin,Capsule,Oral,02247073,SANDOZ CYCLOSPORINE (cyclosporine 25 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9002772,cyclosporine 25 mg oral capsule,8001253,cyclosporine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
71309,Marketed,2006-10-18,02247074,Sandoz cycloSPORINE,1,L04AD01,Ciclosporin,Capsule,Oral,02247074,SANDOZ CYCLOSPORINE (cyclosporine 50 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9002773,cyclosporine 50 mg oral capsule,8001253,cyclosporine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
84087,Marketed,2024-02-05,02355655,Restasis,1,S01XA18,Ciclosporin,Emulsion,Ophthalmic,02355655,RESTASIS (cyclosporine 0.05 % ophthalmic drops) ABBVIE CORPORATION,Active,9004774,cyclosporine 0.05 % ophthalmic drops,8001253,cyclosporine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),1.0,,,Prescription
95023,Marketed,2017-12-04,02462486,Teva-cycloSPORINE,1,S01XA18,Ciclosporin,Emulsion,Ophthalmic,02462486,TEVA-CYCLOSPORINE (cyclosporine 0.05 % ophthalmic drops) TEVA CANADA LIMITED,Active,9004774,cyclosporine 0.05 % ophthalmic drops,8001253,cyclosporine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),1.0,,,Prescription
96764,Marketed,2023-07-19,02476835,Restasis Multidose,1,S01XA18,Ciclosporin,Emulsion,Ophthalmic,02476835,RESTASIS MULTIDOSE (cyclosporine 0.05 % ophthalmic drops) ABBVIE CORPORATION,Active,9004774,cyclosporine 0.05 % ophthalmic drops,8001253,cyclosporine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),1.0,,,Prescription
97446,Marketed,2025-12-08,02484137,Verkazia,1,S01XA18,Ciclosporin,Emulsion,Ophthalmic,02484137,VERKAZIA (cyclosporine 0.1 % ophthalmic drops) APOTEX INC,Active,9013904,cyclosporine 0.1 % ophthalmic drops,8001253,cyclosporine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),1.0,,,Prescription
96392,Marketed,2018-07-11,02473925,Mar-Cidofovir,1,J05AB12,Cidofovir,Solution,Intravenous,02473925,MAR-CIDOFOVIR (cidofovir (cidofovir dihydrate) 375 mg per 5 mL solution for injection vial) MARCAN PHARMACEUTICALS INC,Active,9013428,cidofovir 375 mg per 5 mL solution for injection vial,8002019,cidofovir,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
13834,Marketed,2019-08-19,01911481,Inhibace,1,C09AA08,Cilazapril,Tablet,Oral,01911481,INHIBACE (cilazapril (cilazapril monohydrate) 5 mg oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9002541,cilazapril 5 mg oral tablet,8000874,cilazapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76935,Marketed,2010-01-07,02283778,Mylan-Cilazapril,1,C09AA08,Cilazapril,Tablet,Oral,02283778,MYLAN-CILAZAPRIL (cilazapril (cilazapril monohydrate) 1 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9012366,cilazapril 1 mg oral tablet,8000874,cilazapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76936,Marketed,2010-01-05,02283786,Mylan-Cilazapril,1,C09AA08,Cilazapril,Tablet,Oral,02283786,MYLAN-CILAZAPRIL (cilazapril (cilazapril monohydrate) 2.5 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9002540,cilazapril 2.5 mg oral tablet,8000874,cilazapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76937,Marketed,2010-01-07,02283794,Mylan-Cilazapril,1,C09AA08,Cilazapril,Tablet,Oral,02283794,MYLAN-CILAZAPRIL (cilazapril (cilazapril monohydrate) 5 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9002541,cilazapril 5 mg oral tablet,8000874,cilazapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77652,Marketed,2007-02-01,02291142,Apo-Cilazapril,1,C09AA08,Cilazapril,Tablet,Oral,02291142,APO-CILAZAPRIL (cilazapril (cilazapril monohydrate) 2.5 mg oral tablet) APOTEX INC,Active,9002540,cilazapril 2.5 mg oral tablet,8000874,cilazapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77653,Marketed,2007-02-01,02291150,Apo-Cilazapril,1,C09AA08,Cilazapril,Tablet,Oral,02291150,APO-CILAZAPRIL (cilazapril (cilazapril monohydrate) 5 mg oral tablet) APOTEX INC,Active,9002541,cilazapril 5 mg oral tablet,8000874,cilazapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
44252,Marketed,2018-12-12,02181479,Inhibace Plus,2,C09BA08,Cilazapril and diuretics,Tablet,Oral,02181479,INHIBACE PLUS (cilazapril (cilazapril monohydrate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9003374,cilazapril 5 mg and hydrochlorothiazide 12.5 mg oral tablet,8000909,cilazapril and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77051,Marketed,2006-08-23,02284987,Apo-Cilazapril/HCTZ,2,C09BA08,Cilazapril and diuretics,Tablet,Oral,02284987,APO-CILAZAPRIL/HCTZ (cilazapril (cilazapril monohydrate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet) APOTEX INC,Active,9003374,cilazapril 5 mg and hydrochlorothiazide 12.5 mg oral tablet,8000909,cilazapril and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
5195,Marketed,2019-10-04,00584215,Cimetidine,1,A02BA01,Cimetidine,Tablet,Oral,00584215,CIMETIDINE (cimetidine 200 mg oral tablet) AA PHARMA INC,Active,9001937,cimetidine 200 mg oral tablet,8001359,cimetidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
5196,Marketed,2019-10-23,00487872,Cimetidine,1,A02BA01,Cimetidine,Tablet,Oral,00487872,CIMETIDINE (cimetidine 300 mg oral tablet) AA PHARMA INC,Active,9001938,cimetidine 300 mg oral tablet,8001359,cimetidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100698,Marketed,2022-12-05,02517604,PMS-Cinacalcet,1,H05BX01,Cinacalcet,Tablet,Oral,02517604,PMS-CINACALCET (cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet) PHARMASCIENCE INC,Active,9003934,cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100699,Marketed,2022-12-05,02517612,PMS-Cinacalcet,1,H05BX01,Cinacalcet,Tablet,Oral,02517612,PMS-CINACALCET (cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet) PHARMASCIENCE INC,Active,9003935,cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100700,Marketed,2022-12-05,02517620,PMS-Cinacalcet,1,H05BX01,Cinacalcet,Tablet,Oral,02517620,PMS-CINACALCET (cinacalcet (cinacalcet hydrochloride) 90 mg oral tablet) PHARMASCIENCE INC,Active,9003936,cinacalcet (cinacalcet hydrochloride) 90 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101391,Marketed,2022-06-22,02524880,Cinacalcet,1,H05BX01,Cinacalcet,Tablet,Oral,02524880,CINACALCET (cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet) SANIS HEALTH INC,Active,9003934,cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91886,Marketed,2016-06-29,02434539,Mylan-Cinacalcet,1,H05BX01,Cinacalcet,Tablet,Oral,02434539,MYLAN-CINACALCET (cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9003934,cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91887,Marketed,2016-12-22,02434547,Mylan-Cinacalcet,1,H05BX01,Cinacalcet,Tablet,Oral,02434547,MYLAN-CINACALCET (cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9003935,cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91888,Marketed,2016-12-22,02434555,Mylan-Cinacalcet,1,H05BX01,Cinacalcet,Tablet,Oral,02434555,MYLAN-CINACALCET (cinacalcet (cinacalcet hydrochloride) 90 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9003936,cinacalcet (cinacalcet hydrochloride) 90 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92601,Marketed,2016-12-06,02441624,Teva-Cinacalcet,1,H05BX01,Cinacalcet,Tablet,Oral,02441624,TEVA-CINACALCET (cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet) TEVA CANADA LIMITED,Active,9003934,cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92602,Marketed,2016-12-06,02441632,Teva-Cinacalcet,1,H05BX01,Cinacalcet,Tablet,Oral,02441632,TEVA-CINACALCET (cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet) TEVA CANADA LIMITED,Active,9003935,cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92603,Marketed,2016-12-06,02441640,Teva-Cinacalcet,1,H05BX01,Cinacalcet,Tablet,Oral,02441640,TEVA-CINACALCET (cinacalcet (cinacalcet hydrochloride) 90 mg oral tablet) TEVA CANADA LIMITED,Active,9003936,cinacalcet (cinacalcet hydrochloride) 90 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93910,Marketed,2016-05-20,02452693,Apo-Cinacalcet,1,H05BX01,Cinacalcet,Tablet,Oral,02452693,APO-CINACALCET (cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet) APOTEX INC,Active,9003934,cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93911,Marketed,2016-05-20,02452707,Apo-Cinacalcet,1,H05BX01,Cinacalcet,Tablet,Oral,02452707,APO-CINACALCET (cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet) APOTEX INC,Active,9003935,cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93912,Marketed,2016-05-20,02452715,Apo-Cinacalcet,1,H05BX01,Cinacalcet,Tablet,Oral,02452715,APO-CINACALCET (cinacalcet (cinacalcet hydrochloride) 90 mg oral tablet) APOTEX INC,Active,9003936,cinacalcet (cinacalcet hydrochloride) 90 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96960,Marketed,2019-02-01,02478900,Auro-Cinacalcet,1,H05BX01,Cinacalcet,Tablet,Oral,02478900,AURO-CINACALCET (cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet) AURO PHARMA INC,Active,9003934,cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96962,Marketed,2019-02-01,02478919,Auro-Cinacalcet,1,H05BX01,Cinacalcet,Tablet,Oral,02478919,AURO-CINACALCET (cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet) AURO PHARMA INC,Active,9003935,cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96965,Marketed,2019-02-01,02478943,Auro-Cinacalcet,1,H05BX01,Cinacalcet,Tablet,Oral,02478943,AURO-CINACALCET (cinacalcet (cinacalcet hydrochloride) 90 mg oral tablet) AURO PHARMA INC,Active,9003936,cinacalcet (cinacalcet hydrochloride) 90 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97082,Marketed,2018-11-29,02480298,Mar-Cinacalcet,1,H05BX01,Cinacalcet,Tablet,Oral,02480298,MAR-CINACALCET (cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9003934,cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97083,Marketed,2018-11-29,02480301,Mar-Cinacalcet,1,H05BX01,Cinacalcet,Tablet,Oral,02480301,MAR-CINACALCET (cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9003935,cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97084,Marketed,2018-11-29,02480328,Mar-Cinacalcet,1,H05BX01,Cinacalcet,Tablet,Oral,02480328,MAR-CINACALCET (cinacalcet (cinacalcet hydrochloride) 90 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9003936,cinacalcet (cinacalcet hydrochloride) 90 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97245,Marketed,2018-12-11,02481987,M-Cinacalcet,1,H05BX01,Cinacalcet,Tablet,Oral,02481987,M-CINACALCET (cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet) MANTRA PHARMA INC,Active,9003934,cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97246,Marketed,2018-12-11,02481995,M-Cinacalcet,1,H05BX01,Cinacalcet,Tablet,Oral,02481995,M-CINACALCET (cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet) MANTRA PHARMA INC,Active,9003935,cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97247,Marketed,2018-12-11,02482002,M-Cinacalcet,1,H05BX01,Cinacalcet,Tablet,Oral,02482002,M-CINACALCET (cinacalcet (cinacalcet hydrochloride) 90 mg oral tablet) MANTRA PHARMA INC,Active,9003936,cinacalcet (cinacalcet hydrochloride) 90 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98980,Marketed,2025-10-07,02500094,JAMP Cinacalcet Tablets,1,H05BX01,Cinacalcet,Tablet,Oral,02500094,JAMP CINACALCET TABLETS (cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003934,cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98981,Marketed,2025-10-07,02500108,JAMP Cinacalcet Tablets,1,H05BX01,Cinacalcet,Tablet,Oral,02500108,JAMP CINACALCET TABLETS (cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003935,cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98982,Marketed,2021-02-15,02500116,JAMP Cinacalcet Tablets,1,H05BX01,Cinacalcet,Tablet,Oral,02500116,JAMP CINACALCET TABLETS (cinacalcet (cinacalcet hydrochloride) 90 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003936,cinacalcet (cinacalcet hydrochloride) 90 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106027,Marketed,2025-12-05,02556898,Pombiliti,1,A16AB23,Cipaglucosidase alfa,Powder for solution,Intravenous,02556898,POMBILITI (cipaglucosidase alfa 105 mg per vial powder for solution for injection) AMICUS THERAPEUTICS CANADA INC.,Active,9015294,cipaglucosidase alfa 105 mg per vial powder for solution for injection,8002564,cipaglucosidase alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,,,,Schedule D
106027,Marketed,2025-12-05,02556898,Pombiliti,1,A16AB23,Cipaglucosidase alfa,Powder for solution,Intravenous,02556898,POMBILITI (cipaglucosidase alfa 105 mg per vial powder for solution for injection) AMICUS THERAPEUTICS CANADA INC.,Active,9015294,cipaglucosidase alfa 105 mg per vial powder for solution for injection,8002564,cipaglucosidase alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,,,,Prescription
103580,Marketed,2025-02-26,02547147,Ciprofloxacin,1,J01MA02,Ciprofloxacin,Tablet,Oral,02547147,CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet) 10445517 CANADA INC / NORTH PHARMACEUTICALS / DAC PHARMACEUTICALS,Active,9000661,ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
12953,Marketed,2018-10-15,01945270,Ciloxan,1,S03AA07,Ciprofloxacin,Solution,Ophthalmic,01945270,CILOXAN (ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9000408,ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % ophthalmic drops,8000159,ciprofloxacin,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
42964,Marketed,2018-03-21,02200864,Ciloxan,1,S01AE03,Ciprofloxacin,Ointment,Ophthalmic,02200864,CILOXAN (ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % ophthalmic ointment) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9000817,ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % ophthalmic ointment,8000159,ciprofloxacin,54485002,Ophthalmic,385123004,Ophthalmic ointment,,,,,,Prescription
60849,Marketed,1998-09-15,02237514,Cipro Oral Suspension,1,J01MA02,Ciprofloxacin,Suspension,Oral,02237514,CIPRO ORAL SUSPENSION (ciprofloxacin 500 mg per 5 mL oral suspension) BAYER INC,Active,9006258,ciprofloxacin 500 mg per 5 mL oral suspension,8000159,ciprofloxacin,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
71582,Marketed,2017-10-11,02247339,Act Ciprofloxacin,1,J01MA02,Ciprofloxacin,Tablet,Oral,02247339,ACT CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 250 mg oral tablet) TEVA CANADA LIMITED,Active,9000660,ciprofloxacin (ciprofloxacin hydrochloride) 250 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71583,Marketed,2017-10-11,02247340,Act Ciprofloxacin,1,J01MA02,Ciprofloxacin,Tablet,Oral,02247340,ACT CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet) TEVA CANADA LIMITED,Active,9000661,ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71584,Marketed,2017-10-11,02247341,Act Ciprofloxacin,1,J01MA02,Ciprofloxacin,Tablet,Oral,02247341,ACT CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 750 mg oral tablet) TEVA CANADA LIMITED,Active,9000662,ciprofloxacin (ciprofloxacin hydrochloride) 750 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
72789,Marketed,2004-02-18,02248438,PMS-Ciprofloxacin,1,J01MA02,Ciprofloxacin,Tablet,Oral,02248438,PMS-CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet) PHARMASCIENCE INC,Active,9000661,ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73124,Marketed,2005-12-01,02248756,Sandoz Ciprofloxacin,1,J01MA02,Ciprofloxacin,Tablet,Oral,02248756,SANDOZ CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 250 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000660,ciprofloxacin (ciprofloxacin hydrochloride) 250 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73125,Marketed,2005-12-01,02248757,Sandoz Ciprofloxacin,1,J01MA02,Ciprofloxacin,Tablet,Oral,02248757,SANDOZ CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000661,ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73126,Marketed,2005-12-01,02248758,Sandoz Ciprofloxacin,1,J01MA02,Ciprofloxacin,Tablet,Oral,02248758,SANDOZ CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 750 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000662,ciprofloxacin (ciprofloxacin hydrochloride) 750 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73619,Marketed,2013-07-04,02251248,Riva-Ciprofloxacin,1,J01MA02,Ciprofloxacin,Tablet,Oral,02251248,RIVA-CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000661,ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78902,Marketed,2020-03-11,02303728,Taro-Ciproflox,1,J01MA02,Ciprofloxacin,Tablet,Oral,02303728,TARO-CIPROFLOX (ciprofloxacin (ciprofloxacin hydrochloride) 250 mg oral tablet) SUN PHARMA CANADA INC,Active,9000660,ciprofloxacin (ciprofloxacin hydrochloride) 250 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78903,Marketed,2020-03-11,02303736,Taro-Ciproflox,1,J01MA02,Ciprofloxacin,Tablet,Oral,02303736,TARO-CIPROFLOX (ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet) SUN PHARMA CANADA INC,Active,9000661,ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78904,Marketed,2020-03-11,02303744,Taro-Ciproflox,1,J01MA02,Ciprofloxacin,Tablet,Oral,02303744,TARO-CIPROFLOX (ciprofloxacin (ciprofloxacin hydrochloride) 750 mg oral tablet) SUN PHARMA CANADA INC,Active,9000662,ciprofloxacin (ciprofloxacin hydrochloride) 750 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79003,Marketed,2008-03-27,02304759,Ciprofloxacin Intravenous Infusion BP,1,J01MA02,Ciprofloxacin,Solution,Intravenous,77700551,CIPROFLOXACIN INTRAVENOUS INFUSION BP (ciprofloxacin 400 mg per 200 mL solution for injection bag) SANDOZ CANADA INCORPORATED,Active,9012477,ciprofloxacin 400 mg per 200 mL solution for injection bag,8000159,ciprofloxacin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Prescription
79003,Marketed,2008-03-27,02304759,Ciprofloxacin Intravenous Infusion BP,1,J01MA02,Ciprofloxacin,Solution,Intravenous,77700552,CIPROFLOXACIN INTRAVENOUS INFUSION BP (ciprofloxacin 200 mg per 100 mL solution for injection bag) SANDOZ CANADA INCORPORATED,Active,9012475,ciprofloxacin 200 mg per 100 mL solution for injection bag,8000159,ciprofloxacin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Prescription
80332,Marketed,2019-03-13,02317796,Pro-Ciprofloxacin,1,J01MA02,Ciprofloxacin,Tablet,Oral,02317796,PRO-CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 250 mg oral tablet) PRO DOC LIMITEE,Active,9000660,ciprofloxacin (ciprofloxacin hydrochloride) 250 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80333,Marketed,2019-03-13,02317818,Pro-Ciprofloxacin,1,J01MA02,Ciprofloxacin,Tablet,Oral,02317818,PRO-CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet) PRO DOC LIMITEE,Active,9000661,ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83851,Marketed,2026-05-14,02353318,Ciprofloxacin,1,J01MA02,Ciprofloxacin,Tablet,Oral,02353318,CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 250 mg oral tablet) SANIS HEALTH INC,Active,9000660,ciprofloxacin (ciprofloxacin hydrochloride) 250 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83852,Marketed,2026-05-14,02353326,Ciprofloxacin,1,J01MA02,Ciprofloxacin,Tablet,Oral,02353326,CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet) SANIS HEALTH INC,Active,9000661,ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86555,Marketed,2012-09-06,02379686,Mar-Ciprofloxacin,1,J01MA02,Ciprofloxacin,Tablet,Oral,02379686,MAR-CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 250 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000660,ciprofloxacin (ciprofloxacin hydrochloride) 250 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86556,Marketed,2012-09-06,02379694,Mar-Ciprofloxacin,1,J01MA02,Ciprofloxacin,Tablet,Oral,02379694,MAR-CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000661,ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86616,Marketed,2012-03-16,02380358,JAMP-Ciprofloxacin,1,J01MA02,Ciprofloxacin,Tablet,Oral,02380358,JAMP-CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 250 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000660,ciprofloxacin (ciprofloxacin hydrochloride) 250 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86617,Marketed,2012-03-16,02380366,JAMP-Ciprofloxacin,1,J01MA02,Ciprofloxacin,Tablet,Oral,02380366,JAMP-CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000661,ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86775,Marketed,2012-06-13,02381907,Auro-Ciprofloxacin,1,J01MA02,Ciprofloxacin,Tablet,Oral,02381907,AURO-CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 250 mg oral tablet) AURO PHARMA INC,Active,9000660,ciprofloxacin (ciprofloxacin hydrochloride) 250 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86776,Marketed,2012-06-13,02381923,Auro-Ciprofloxacin,1,J01MA02,Ciprofloxacin,Tablet,Oral,02381923,AURO-CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet) AURO PHARMA INC,Active,9000661,ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87170,Marketed,2014-12-19,02386119,Ciprofloxacin,1,J01MA02,Ciprofloxacin,Tablet,Oral,02386119,CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 250 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000660,ciprofloxacin (ciprofloxacin hydrochloride) 250 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87171,Marketed,2014-12-19,02386127,Ciprofloxacin,1,J01MA02,Ciprofloxacin,Tablet,Oral,02386127,CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000661,ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87272,Marketed,2012-07-03,02387131,Sandoz Ciprofloxacin,1,S01AE03,Ciprofloxacin,Solution,Ophthalmic,02387131,SANDOZ CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % ophthalmic drops) SANDOZ CANADA INCORPORATED,Active,9000408,ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % ophthalmic drops,8000159,ciprofloxacin,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
90104,Marketed,2014-01-14,02416433,PMS-Ciprofloxacin XL,1,J01MA02,Ciprofloxacin,Tablet (immediate and extended release),Oral,02416433,"PMS-CIPROFLOXACIN XL (ciprofloxacin (ciprofloxacin, ciprofloxacin hydrochloride) 500 mg prolonged-release oral tablet) PHARMASCIENCE INC",Active,9015330,"ciprofloxacin (ciprofloxacin, ciprofloxacin hydrochloride) 500 mg prolonged-release oral tablet",8000159,ciprofloxacin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet,,,,Prescription
90828,Marketed,2020-03-20,02423561,Mint-Ciproflox,1,J01MA02,Ciprofloxacin,Tablet,Oral,02423561,MINT-CIPROFLOX (ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000661,ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93011,Marketed,2016-06-17,02444887,Bio-Ciprofloxacin,1,J01MA02,Ciprofloxacin,Tablet,Oral,02444887,BIO-CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet) BIOMED PHARMA,Active,9000661,ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98201,Marketed,2020-12-03,02492008,Nra-Ciprofloxacin,1,J01MA02,Ciprofloxacin,Tablet,Oral,02492008,NRA-CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet) NORA PHARMA INC,Active,9000661,ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106606,Marketed,2026-01-13,02563266,Cisatracurium Besylate Injection USP Multi-Dose,1,M03AC11,Cisatracurium,Solution,Intravenous,02563266,CISATRACURIUM BESYLATE INJECTION USP MULTI-DOSE (cisatracurium (cisatracurium besylate) 20 mg per 10 mL solution for injection vial) STERIMAX INC,Active,9013537,cisatracurium (cisatracurium besylate) 20 mg per 10 mL solution for injection vial,8002106,cisatracurium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
89357,Marketed,2024-09-27,02408813,Cisatracurium Besylate Injection USP Multidose,1,M03AC11,Cisatracurium,Solution,Intravenous,02408813,CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE (cisatracurium (cisatracurium besylate) 20 mg per 10 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013537,cisatracurium (cisatracurium besylate) 20 mg per 10 mL solution for injection vial,8002106,cisatracurium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
102507,Marketed,2024-02-23,02536285,CISplatin Injection BP,1,L01XA01,Cisplatin,Solution,Intravenous,77701152,CISPLATIN INJECTION BP (cisplatin 50 mg per 50 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9013053,cisplatin 50 mg per 50 mL solution for injection vial,8001729,cisplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
102507,Marketed,2024-02-23,02536285,CISplatin Injection BP,1,L01XA01,Cisplatin,Solution,Intravenous,77701153,CISPLATIN INJECTION BP (cisplatin 100 mg per 100 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9013052,cisplatin 100 mg per 100 mL solution for injection vial,8001729,cisplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
43840,Marketed,2017-11-29,02126613,CISplatin Injection BP,1,L01XA01,Cisplatin,Solution,Intravenous,77700718,CISPLATIN INJECTION BP (cisplatin 50 mg per 50 mL solution for injection vial) PFIZER CANADA ULC,Active,9013053,cisplatin 50 mg per 50 mL solution for injection vial,8001729,cisplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
43840,Marketed,2017-11-29,02126613,CISplatin Injection BP,1,L01XA01,Cisplatin,Solution,Intravenous,77700719,CISPLATIN INJECTION BP (cisplatin 100 mg per 100 mL solution for injection vial) PFIZER CANADA ULC,Active,9013052,cisplatin 100 mg per 100 mL solution for injection vial,8001729,cisplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
84044,Marketed,2012-04-10,02355183,"CISplatin Injection, BP",1,L01XA01,Cisplatin,Solution,Intravenous,77700749,"CISPLATIN INJECTION, BP (cisplatin 100 mg per 100 mL solution for injection vial) ACCORD HEALTHCARE INC",Active,9013052,cisplatin 100 mg per 100 mL solution for injection vial,8001729,cisplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
84044,Marketed,2012-04-10,02355183,"CISplatin Injection, BP",1,L01XA01,Cisplatin,Solution,Intravenous,77700750,"CISPLATIN INJECTION, BP (cisplatin 50 mg per 50 mL solution for injection vial) ACCORD HEALTHCARE INC",Active,9013053,cisplatin 50 mg per 50 mL solution for injection vial,8001729,cisplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
84044,Marketed,2012-04-10,02355183,"CISplatin Injection, BP",1,L01XA01,Cisplatin,Solution,Intravenous,77700751,"CISPLATIN INJECTION, BP (cisplatin 10 mg per 10 mL solution for injection vial) ACCORD HEALTHCARE INC",Active,9013051,cisplatin 10 mg per 10 mL solution for injection vial,8001729,cisplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
88800,Marketed,2013-08-29,02403188,CISplatin Injection,1,L01XA01,Cisplatin,Solution,Intravenous,77700776,CISPLATIN INJECTION (cisplatin 10 mg per 10 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013051,cisplatin 10 mg per 10 mL solution for injection vial,8001729,cisplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
88800,Marketed,2013-08-29,02403188,CISplatin Injection,1,L01XA01,Cisplatin,Solution,Intravenous,77700777,CISPLATIN INJECTION (cisplatin 100 mg per 100 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013052,cisplatin 100 mg per 100 mL solution for injection vial,8001729,cisplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
88800,Marketed,2013-08-29,02403188,CISplatin Injection,1,L01XA01,Cisplatin,Solution,Intravenous,77700778,CISPLATIN INJECTION (cisplatin 50 mg per 50 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013053,cisplatin 50 mg per 50 mL solution for injection vial,8001729,cisplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
100286,Marketed,2025-08-19,02513684,AG-Citalopram Tablets,1,N06AB04,Citalopram,Tablet,Oral,02513684,AG-CITALOPRAM TABLETS (citalopram (citalopram hydrobromide) 20 mg oral tablet) ANGITA PHARMA INC.,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100287,Marketed,2025-07-22,02513692,AG-Citalopram Tablets,1,N06AB04,Citalopram,Tablet,Oral,02513692,AG-CITALOPRAM TABLETS (citalopram (citalopram hydrobromide) 40 mg oral tablet) ANGITA PHARMA INC.,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102119,Marketed,2023-11-13,02532123,M-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02532123,M-CITALOPRAM (citalopram (citalopram hydrobromide) 10 mg oral tablet) MANTRA PHARMA INC,Active,9001126,citalopram (citalopram hydrobromide) 10 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103156,Marketed,2024-01-30,02543060,AG-Citalopram Tablets,1,N06AB04,Citalopram,Tablet,Oral,02543060,AG-CITALOPRAM TABLETS (citalopram (citalopram hydrobromide) 30 mg oral tablet) ANGITA PHARMA INC.,Active,9001225,citalopram (citalopram hydrobromide) 30 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104472,Marketed,2025-07-16,02555999,NB-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02555999,NB-CITALOPRAM (citalopram (citalopram hydrobromide) 10 mg oral tablet) NB PHARMA INC.,Active,9001126,citalopram (citalopram hydrobromide) 10 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104473,Marketed,2025-07-16,02556006,NB-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02556006,NB-CITALOPRAM (citalopram (citalopram hydrobromide) 20 mg oral tablet) NB PHARMA INC.,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
63077,Marketed,1999-03-08,02239607,Celexa 20 mg,1,N06AB04,Citalopram,Tablet,Oral,02239607,CELEXA 20 MG (citalopram (citalopram hydrobromide) 20 mg oral tablet) LUNDBECK CANADA INC,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
63078,Marketed,1999-03-08,02239608,Celexa 40 mg,1,N06AB04,Citalopram,Tablet,Oral,02239608,CELEXA 40 MG (citalopram (citalopram hydrobromide) 40 mg oral tablet) LUNDBECK CANADA INC,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
70187,Marketed,2004-01-21,02246056,Apo-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02246056,APO-CITALOPRAM (citalopram (citalopram hydrobromide) 20 mg oral tablet) APOTEX INC,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
70188,Marketed,2004-01-21,02246057,Apo-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02246057,APO-CITALOPRAM (citalopram (citalopram hydrobromide) 40 mg oral tablet) APOTEX INC,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
72326,Marketed,2004-01-15,02248010,PMS-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02248010,PMS-CITALOPRAM (citalopram (citalopram hydrobromide) 20 mg oral tablet) PHARMASCIENCE INC,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
72327,Marketed,2004-01-15,02248011,PMS-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02248011,PMS-CITALOPRAM (citalopram (citalopram hydrobromide) 40 mg oral tablet) PHARMASCIENCE INC,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74277,Marketed,2024-11-07,02257513,Citalopram - 20,1,N06AB04,Citalopram,Tablet,Oral,02257513,CITALOPRAM - 20 (citalopram (citalopram hydrobromide) 20 mg oral tablet) PRO DOC LIMITEE,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74278,Marketed,2024-11-18,02257521,Citalopram - 40,1,N06AB04,Citalopram,Tablet,Oral,02257521,CITALOPRAM - 40 (citalopram (citalopram hydrobromide) 40 mg oral tablet) PRO DOC LIMITEE,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75597,Marketed,2005-09-10,02270609,PMS-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02270609,PMS-CITALOPRAM (citalopram (citalopram hydrobromide) 10 mg oral tablet) PHARMASCIENCE INC,Active,9001126,citalopram (citalopram hydrobromide) 10 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76120,Marketed,2011-11-28,02275562,Auro-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02275562,AURO-CITALOPRAM (citalopram (citalopram hydrobromide) 20 mg oral tablet) AURO PHARMA INC,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76121,Marketed,2011-11-28,02275570,Auro-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02275570,AURO-CITALOPRAM (citalopram (citalopram hydrobromide) 40 mg oral tablet) AURO PHARMA INC,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77858,Marketed,2010-11-03,02293218,Teva-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02293218,TEVA-CITALOPRAM (citalopram (citalopram hydrobromide) 20 mg oral tablet) TEVA CANADA LIMITED,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77859,Marketed,2010-11-03,02293226,Teva-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02293226,TEVA-CITALOPRAM (citalopram (citalopram hydrobromide) 40 mg oral tablet) TEVA CANADA LIMITED,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78149,Marketed,2026-03-26,02296152,CTP 30,1,N06AB04,Citalopram,Tablet,Oral,02296152,CTP 30 (citalopram (citalopram hydrobromide) 30 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9001225,citalopram (citalopram hydrobromide) 30 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78858,Marketed,2008-01-24,02303256,Riva-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02303256,RIVA-CITALOPRAM (citalopram (citalopram hydrobromide) 10 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001126,citalopram (citalopram hydrobromide) 10 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78859,Marketed,2008-01-28,02303264,Riva-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02303264,RIVA-CITALOPRAM (citalopram (citalopram hydrobromide) 20 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78860,Marketed,2008-01-28,02303272,Riva-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02303272,RIVA-CITALOPRAM (citalopram (citalopram hydrobromide) 40 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79783,Marketed,2010-11-03,02312336,Teva-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02312336,TEVA-CITALOPRAM (citalopram (citalopram hydrobromide) 10 mg oral tablet) TEVA CANADA LIMITED,Active,9001126,citalopram (citalopram hydrobromide) 10 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79893,Marketed,2025-08-15,02313405,JAMP-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02313405,JAMP-CITALOPRAM (citalopram (citalopram hydrobromide) 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79894,Marketed,2025-08-12,02313413,JAMP-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02313413,JAMP-CITALOPRAM (citalopram (citalopram hydrobromide) 40 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81046,Marketed,2024-08-14,02325047,Citalopram - 10,1,N06AB04,Citalopram,Tablet,Oral,02325047,CITALOPRAM - 10 (citalopram (citalopram hydrobromide) 10 mg oral tablet) PRO DOC LIMITEE,Active,9001126,citalopram (citalopram hydrobromide) 10 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82501,Marketed,2021-09-03,02339390,AG-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02339390,AG-CITALOPRAM (citalopram (citalopram hydrobromide) 20 mg oral tablet) ANGITA PHARMA INC.,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82502,Marketed,2021-10-13,02339404,AG-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02339404,AG-CITALOPRAM (citalopram (citalopram hydrobromide) 40 mg oral tablet) ANGITA PHARMA INC.,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83886,Marketed,2016-01-06,02353660,Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02353660,CITALOPRAM (citalopram (citalopram hydrobromide) 20 mg oral tablet) SANIS HEALTH INC,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83887,Marketed,2016-01-06,02353679,Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02353679,CITALOPRAM (citalopram (citalopram hydrobromide) 40 mg oral tablet) SANIS HEALTH INC,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85511,Marketed,2025-09-12,02370085,JAMP-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02370085,JAMP-CITALOPRAM (citalopram (citalopram hydrobromide) 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001126,citalopram (citalopram hydrobromide) 10 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85700,Marketed,2012-09-06,02371871,Mar-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02371871,MAR-CITALOPRAM (citalopram (citalopram hydrobromide) 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001126,citalopram (citalopram hydrobromide) 10 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85701,Marketed,2012-09-06,02371898,Mar-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02371898,MAR-CITALOPRAM (citalopram (citalopram hydrobromide) 20 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85702,Marketed,2012-09-06,02371901,Mar-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02371901,MAR-CITALOPRAM (citalopram (citalopram hydrobromide) 40 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85994,Marketed,2021-10-14,02374617,AG-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02374617,AG-CITALOPRAM (citalopram (citalopram hydrobromide) 10 mg oral tablet) ANGITA PHARMA INC.,Active,9001126,citalopram (citalopram hydrobromide) 10 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87351,Marketed,2024-02-27,02387948,Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02387948,CITALOPRAM (citalopram (citalopram hydrobromide) 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001126,citalopram (citalopram hydrobromide) 10 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87352,Marketed,2024-02-27,02387956,Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02387956,CITALOPRAM (citalopram (citalopram hydrobromide) 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87353,Marketed,2024-02-27,02387964,Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02387964,CITALOPRAM (citalopram (citalopram hydrobromide) 40 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89374,Marketed,2023-09-08,02409003,Natco-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02409003,NATCO-CITALOPRAM (citalopram (citalopram hydrobromide) 10 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9001126,citalopram (citalopram hydrobromide) 10 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91414,Marketed,2015-10-14,02429691,Mint-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02429691,MINT-CITALOPRAM (citalopram (citalopram hydrobromide) 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001126,citalopram (citalopram hydrobromide) 10 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91415,Marketed,2015-10-14,02429705,Mint-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02429705,MINT-CITALOPRAM (citalopram (citalopram hydrobromide) 20 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91416,Marketed,2015-10-14,02429713,Mint-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02429713,MINT-CITALOPRAM (citalopram (citalopram hydrobromide) 40 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91495,Marketed,2020-03-06,02430517,Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02430517,CITALOPRAM (citalopram (citalopram hydrobromide) 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001126,citalopram (citalopram hydrobromide) 10 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91496,Marketed,2020-03-06,02430541,Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02430541,CITALOPRAM (citalopram (citalopram hydrobromide) 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91497,Marketed,2020-03-06,02430568,Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02430568,CITALOPRAM (citalopram (citalopram hydrobromide) 40 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92865,Marketed,2023-09-18,02443880,Natco-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02443880,NATCO-CITALOPRAM (citalopram (citalopram hydrobromide) 20 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92866,Marketed,2023-09-15,02443899,Natco-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02443899,NATCO-CITALOPRAM (citalopram (citalopram hydrobromide) 40 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93099,Marketed,2015-10-14,02445719,Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02445719,CITALOPRAM (citalopram (citalopram hydrobromide) 10 mg oral tablet) SANIS HEALTH INC,Active,9001126,citalopram (citalopram hydrobromide) 10 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95617,Marketed,2023-11-13,02467836,M-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02467836,M-CITALOPRAM (citalopram (citalopram hydrobromide) 20 mg oral tablet) MANTRA PHARMA INC,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95618,Marketed,2023-11-13,02467844,M-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02467844,M-CITALOPRAM (citalopram (citalopram hydrobromide) 40 mg oral tablet) MANTRA PHARMA INC,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96828,Marketed,2025-11-21,02477637,Nra-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02477637,NRA-CITALOPRAM (citalopram (citalopram hydrobromide) 10 mg oral tablet) NORA PHARMA INC,Active,9001126,citalopram (citalopram hydrobromide) 10 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96829,Marketed,2025-11-21,02477645,Nra-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02477645,NRA-CITALOPRAM (citalopram (citalopram hydrobromide) 20 mg oral tablet) NORA PHARMA INC,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96830,Marketed,2025-11-21,02477653,Nra-Citalopram,1,N06AB04,Citalopram,Tablet,Oral,02477653,NRA-CITALOPRAM (citalopram (citalopram hydrobromide) 40 mg oral tablet) NORA PHARMA INC,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104223,Marketed,2025-12-22,02553295,Apo-Cladribine,1,L04AA40,Cladribine,Tablet,Oral,02553295,APO-CLADRIBINE (cladribine 10 mg oral tablet) APOTEX INC,Active,9013054,cladribine 10 mg oral tablet,8001730,cladribine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
80536,Marketed,2016-08-22,02319918,Cladribine Injection,1,L01BB04,Cladribine,Solution,Intravenous,02319918,CLADRIBINE INJECTION (cladribine 10 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9013055,cladribine 10 mg per 10 mL solution for injection vial,8001730,cladribine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
95915,Marketed,2017-11-30,02470179,Mavenclad,1,L04AA40,Cladribine,Tablet,Oral,02470179,"MAVENCLAD (cladribine 10 mg oral tablet) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013054,cladribine 10 mg oral tablet,8001730,cladribine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98457,Marketed,2020-08-19,02494574,Cladribine Injection,1,L01BB04,Cladribine,Solution,Intravenous,02494574,CLADRIBINE INJECTION (cladribine 10 mg per 10 mL solution for injection vial) GENERIC MEDICAL PARTNERS INC,Active,9013055,cladribine 10 mg per 10 mL solution for injection vial,8001730,cladribine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
12779,Marketed,2016-08-30,01984853,Biaxin Bid,1,J01FA09,Clarithromycin,Tablet,Oral,01984853,BIAXIN BID (clarithromycin 250 mg oral tablet) BGP PHARMA ULC,Active,9000409,clarithromycin 250 mg oral tablet,8000160,clarithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
17240,Marketed,2016-05-20,02126710,Biaxin Bid,1,J01FA09,Clarithromycin,Tablet,Oral,02126710,BIAXIN BID (clarithromycin 500 mg oral tablet) BGP PHARMA ULC,Active,9000509,clarithromycin 500 mg oral tablet,8000160,clarithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
18066,Marketed,2016-04-08,02146908,Biaxin,1,J01FA09,Clarithromycin,Granules for suspension,Oral,02146908,BIAXIN (clarithromycin 125 mg per 5 mL oral suspension) BGP PHARMA ULC,Active,9006241,clarithromycin 125 mg per 5 mL oral suspension,8000160,clarithromycin,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
68628,Marketed,2016-04-26,02244641,Biaxin,1,J01FA09,Clarithromycin,Granules for suspension,Oral,02244641,BIAXIN (clarithromycin 250 mg per 5 mL oral suspension) BGP PHARMA ULC,Active,9006277,clarithromycin 250 mg per 5 mL oral suspension,8000160,clarithromycin,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
75196,Marketed,2008-06-06,02266539,Sandoz Clarithromycin,1,J01FA09,Clarithromycin,Tablet,Oral,02266539,SANDOZ CLARITHROMYCIN (clarithromycin 250 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000409,clarithromycin 250 mg oral tablet,8000160,clarithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75197,Marketed,2008-06-06,02266547,Sandoz Clarithromycin,1,J01FA09,Clarithromycin,Tablet,Oral,02266547,SANDOZ CLARITHROMYCIN (clarithromycin 500 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000509,clarithromycin 500 mg oral tablet,8000160,clarithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76021,Marketed,2007-07-26,02274744,Apo-Clarithromycin,1,J01FA09,Clarithromycin,Tablet,Oral,02274744,APO-CLARITHROMYCIN (clarithromycin 250 mg oral tablet) APOTEX INC,Active,9000409,clarithromycin 250 mg oral tablet,8000160,clarithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76022,Marketed,2007-07-26,02274752,Apo-Clarithromycin,1,J01FA09,Clarithromycin,Tablet,Oral,02274752,APO-CLARITHROMYCIN (clarithromycin 500 mg oral tablet) APOTEX INC,Active,9000509,clarithromycin 500 mg oral tablet,8000160,clarithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80993,Marketed,2025-12-23,02324482,Pro-Clarithromycin,1,J01FA09,Clarithromycin,Tablet,Oral,02324482,PRO-CLARITHROMYCIN (clarithromycin 250 mg oral tablet) PRO DOC LIMITEE,Active,9000409,clarithromycin 250 mg oral tablet,8000160,clarithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80994,Marketed,2025-12-23,02324490,Pro-Clarithromycin,1,J01FA09,Clarithromycin,Tablet,Oral,02324490,PRO-CLARITHROMYCIN (clarithromycin 500 mg oral tablet) PRO DOC LIMITEE,Active,9000509,clarithromycin 500 mg oral tablet,8000160,clarithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84648,Marketed,2024-05-28,02361426,Taro-Clarithromycin,1,J01FA09,Clarithromycin,Tablet,Oral,02361426,TARO-CLARITHROMYCIN (clarithromycin 250 mg oral tablet) SUN PHARMA CANADA INC,Active,9000409,clarithromycin 250 mg oral tablet,8000160,clarithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84649,Marketed,2024-03-22,02361434,Taro-Clarithromycin,1,J01FA09,Clarithromycin,Tablet,Oral,02361434,TARO-CLARITHROMYCIN (clarithromycin 500 mg oral tablet) SUN PHARMA CANADA INC,Active,9000509,clarithromycin 500 mg oral tablet,8000160,clarithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87587,Marketed,2017-07-31,02390450,Taro-Clarithromycin,1,J01FA09,Clarithromycin,Powder for suspension,Oral,02390450,TARO-CLARITHROMYCIN (clarithromycin 250 mg per 5 mL oral suspension) TARO PHARMACEUTICALS INC,Active,9006277,clarithromycin 250 mg per 5 mL oral suspension,8000160,clarithromycin,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
87588,Marketed,2017-07-31,02390442,Taro-Clarithromycin,1,J01FA09,Clarithromycin,Powder for suspension,Oral,02390442,TARO-CLARITHROMYCIN (clarithromycin 125 mg per 5 mL oral suspension) TARO PHARMACEUTICALS INC,Active,9006241,clarithromycin 125 mg per 5 mL oral suspension,8000160,clarithromycin,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
88801,Marketed,2024-10-03,02403196,Teva-Clarithromycin XL,1,J01FA09,Clarithromycin,Tablet (extended-release),Oral,02403196,TEVA-CLARITHROMYCIN XL (clarithromycin 500 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9000985,clarithromycin 500 mg prolonged-release oral tablet,8000160,clarithromycin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89802,Marketed,2021-07-15,02413345,Apo-Clarithromycin XL,1,J01FA09,Clarithromycin,Tablet (extended-release),Oral,02413345,APO-CLARITHROMYCIN XL (clarithromycin 500 mg prolonged-release oral tablet) APOTEX INC,Active,9000985,clarithromycin 500 mg prolonged-release oral tablet,8000160,clarithromycin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92681,Marketed,2015-07-22,02442469,Clarithromycin,1,J01FA09,Clarithromycin,Tablet,Oral,02442469,CLARITHROMYCIN (clarithromycin 250 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000409,clarithromycin 250 mg oral tablet,8000160,clarithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92683,Marketed,2015-07-22,02442485,Clarithromycin,1,J01FA09,Clarithromycin,Tablet,Oral,02442485,CLARITHROMYCIN (clarithromycin 500 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000509,clarithromycin 500 mg oral tablet,8000160,clarithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95443,Marketed,2021-07-28,02466120,Clarithromycin,1,J01FA09,Clarithromycin,Tablet,Oral,02466120,CLARITHROMYCIN (clarithromycin 250 mg oral tablet) SANIS HEALTH INC,Active,9000409,clarithromycin 250 mg oral tablet,8000160,clarithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95444,Marketed,2021-07-28,02466139,Clarithromycin,1,J01FA09,Clarithromycin,Tablet,Oral,02466139,CLARITHROMYCIN (clarithromycin 500 mg oral tablet) SANIS HEALTH INC,Active,9000509,clarithromycin 500 mg oral tablet,8000160,clarithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96050,Marketed,2018-03-07,02471396,M-Clarithromycin,1,J01FA09,Clarithromycin,Tablet,Oral,02471396,M-CLARITHROMYCIN (clarithromycin 500 mg oral tablet) MANTRA PHARMA INC,Active,9000509,clarithromycin 500 mg oral tablet,8000160,clarithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102757,Marketed,2023-09-08,02538881,Winlevi,1,D10AX06,Clascoterone,Cream,Topical,02538881,WINLEVI (clascoterone 1 % cutaneous cream) SUN PHARMACEUTICAL INDUSTRIES LIMITED,Active,9014912,clascoterone 1 % cutaneous cream,8002477,clascoterone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
85108,Marketed,2023-08-04,02366223,Cleviprex,1,C08CA16,Clevidipine,Emulsion,Intravenous,77701130,CLEVIPREX (clevidipine 25 mg per 50 mL emulsion for injection vial) CHIESI FARMACEUTICI S.P.A.,Active,9014928,clevidipine 25 mg per 50 mL emulsion for injection vial,8002478,clevidipine,738984000,Parenteral,385221006,Emulsion for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
85108,Marketed,2023-08-04,02366223,Cleviprex,1,C08CA16,Clevidipine,Emulsion,Intravenous,77701131,CLEVIPREX (clevidipine 50 mg per 100 mL emulsion for injection vial) CHIESI FARMACEUTICI S.P.A.,Active,9014929,clevidipine 50 mg per 100 mL emulsion for injection vial,8002478,clevidipine,738984000,Parenteral,385221006,Emulsion for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
728,Marketed,2019-06-11,00115630,Librax,2,A03CA02,Clidinium and psycholeptics,Capsule,Oral,00115630,"LIBRAX (chlordiazepoxide hydrochloride 5 mg and clidinium bromide 2.5 mg oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9001584,chlordiazepoxide hydrochloride 5 mg and clidinium bromide 2.5 mg oral capsule,8001351,chlordiazepoxide and clidinium,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Targeted Substances (CDSA IV)
1225,Marketed,2004-12-16,00225851,Dalacin C Flavoured Granules,1,J01FF01,Clindamycin,Granules for solution,Oral,00225851,DALACIN C FLAVOURED GRANULES (clindamycin (clindamycin palmitate hydrochloride) 75 mg per 5 mL oral solution) PFIZER CANADA ULC,Active,9013056,clindamycin (clindamycin palmitate hydrochloride) 75 mg per 5 mL oral solution,8000036,clindamycin,26643006,Oral,385023001,Oral solution,,,,,,Prescription
15942,Marketed,2003-10-14,02060604,Dalacin Vaginal Cream,1,G01AA10,Clindamycin,Cream,Vaginal,02060604,DALACIN VAGINAL CREAM (clindamycin (clindamycin phosphate) 20 mg per g vaginal cream) PFIZER CANADA ULC,Active,9000510,clindamycin (clindamycin phosphate) 20 mg per g vaginal cream,8000036,clindamycin,16857009,Vaginal,385165005,Vaginal cream,,,,,,Prescription
1620,Marketed,2006-07-11,00260436,Dalacin C Phosphate,1,J01FF01,Clindamycin,Solution,"Intravenous,Intramuscular",77700238,DALACIN C PHOSPHATE (clindamycin (clindamycin phosphate) 300 mg per 2 mL solution for injection vial) PFIZER CANADA ULC,Active,9000064,clindamycin (clindamycin phosphate) 300 mg per 2 mL solution for injection vial,8000036,clindamycin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
1620,Marketed,2006-07-11,00260436,Dalacin C Phosphate,1,J01FF01,Clindamycin,Solution,"Intravenous,Intramuscular",77700239,DALACIN C PHOSPHATE (clindamycin (clindamycin phosphate) 600 mg per 4 mL solution for injection vial) PFIZER CANADA ULC,Active,9000065,clindamycin (clindamycin phosphate) 600 mg per 4 mL solution for injection vial,8000036,clindamycin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
1620,Marketed,2006-07-11,00260436,Dalacin C Phosphate,1,J01FF01,Clindamycin,Solution,"Intravenous,Intramuscular",77700240,DALACIN C PHOSPHATE (clindamycin (clindamycin phosphate) 150 mg per mL solution for injection 60 mL vial) PFIZER CANADA ULC,Active,9006264,clindamycin (clindamycin phosphate) 150 mg per mL solution for injection 60 mL vial,8000036,clindamycin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
1620,Marketed,2006-07-11,00260436,Dalacin C Phosphate,1,J01FF01,Clindamycin,Solution,"Intravenous,Intramuscular",77700241,DALACIN C PHOSPHATE (clindamycin (clindamycin phosphate) 900 mg per 6 mL solution for injection vial) PFIZER CANADA ULC,Active,9000067,clindamycin (clindamycin phosphate) 900 mg per 6 mL solution for injection vial,8000036,clindamycin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
49605,Marketed,2005-08-26,02230535,Clindamycin Injection USP,1,J01FF01,Clindamycin,Solution,Intravenous,77700235,CLINDAMYCIN INJECTION USP (clindamycin (clindamycin phosphate) 300 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000064,clindamycin (clindamycin phosphate) 300 mg per 2 mL solution for injection vial,8000036,clindamycin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
49605,Marketed,2005-08-26,02230535,Clindamycin Injection USP,1,J01FF01,Clindamycin,Solution,Intravenous,77700236,CLINDAMYCIN INJECTION USP (clindamycin (clindamycin phosphate) 600 mg per 4 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000065,clindamycin (clindamycin phosphate) 600 mg per 4 mL solution for injection vial,8000036,clindamycin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
49605,Marketed,2005-08-26,02230535,Clindamycin Injection USP,1,J01FF01,Clindamycin,Solution,Intravenous,77700237,CLINDAMYCIN INJECTION USP (clindamycin (clindamycin phosphate) 900 mg per 6 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000067,clindamycin (clindamycin phosphate) 900 mg per 6 mL solution for injection vial,8000036,clindamycin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
49612,Marketed,2005-08-26,02230540,Clindamycin Injection USP,1,J01FF01,Clindamycin,Liquid,"Intravenous,Intramuscular",77700233,CLINDAMYCIN INJECTION USP (clindamycin (clindamycin phosphate) 150 mg per mL solution for injection 120 mL vial) SANDOZ CANADA INCORPORATED,Active,9006263,clindamycin (clindamycin phosphate) 150 mg per mL solution for injection 120 mL vial,8000036,clindamycin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
49612,Marketed,2005-08-26,02230540,Clindamycin Injection USP,1,J01FF01,Clindamycin,Liquid,"Intravenous,Intramuscular",77700234,CLINDAMYCIN INJECTION USP (clindamycin (clindamycin phosphate) 150 mg per mL solution for injection 60 mL vial) SANDOZ CANADA INCORPORATED,Active,9006264,clindamycin (clindamycin phosphate) 150 mg per mL solution for injection 60 mL vial,8000036,clindamycin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
65371,Marketed,2011-01-24,02241709,Teva-Clindamycin,1,J01FF01,Clindamycin,Capsule,Oral,02241709,TEVA-CLINDAMYCIN (clindamycin (clindamycin hydrochloride) 150 mg oral capsule) TEVA CANADA LIMITED,Active,9000048,clindamycin (clindamycin hydrochloride) 150 mg oral capsule,8000036,clindamycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
65372,Marketed,2011-01-24,02241710,Teva-Clindamycin,1,J01FF01,Clindamycin,Capsule,Oral,02241710,TEVA-CLINDAMYCIN (clindamycin (clindamycin hydrochloride) 300 mg oral capsule) TEVA CANADA LIMITED,Active,9000562,clindamycin (clindamycin hydrochloride) 300 mg oral capsule,8000036,clindamycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
75233,Marketed,2005-10-03,02266938,Taro-Clindamycin,1,D10AF01,Clindamycin,Solution,Topical,02266938,TARO-CLINDAMYCIN (clindamycin (clindamycin phosphate) 1 % cutaneous solution) TARO PHARMACEUTICALS INC,Active,9000377,clindamycin (clindamycin phosphate) 1 % cutaneous solution,8000036,clindamycin,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Prescription
88532,Marketed,2022-02-11,02400529,Clindamycin,1,J01FF01,Clindamycin,Capsule,Oral,02400529,CLINDAMYCIN (clindamycin (clindamycin hydrochloride) 150 mg oral capsule) SANIS HEALTH INC,Active,9000048,clindamycin (clindamycin hydrochloride) 150 mg oral capsule,8000036,clindamycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88533,Marketed,2022-02-11,02400537,Clindamycin,1,J01FF01,Clindamycin,Capsule,Oral,02400537,CLINDAMYCIN (clindamycin (clindamycin hydrochloride) 300 mg oral capsule) SANIS HEALTH INC,Active,9000562,clindamycin (clindamycin hydrochloride) 300 mg oral capsule,8000036,clindamycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
89326,Marketed,2013-12-05,02408511,Clindamycin IV Infusion,1,J01FF01,Clindamycin,Solution,Intravenous,02408511,CLINDAMYCIN IV INFUSION (clindamycin (clindamycin phosphate) 600 mg per 50 mL solution for injection bag) SANDOZ CANADA INCORPORATED,Active,9001409,clindamycin (clindamycin phosphate) 600 mg per 50 mL solution for injection bag,8000036,clindamycin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Prescription
89327,Marketed,2013-12-05,02408538,Clindamycin IV Infusion,1,J01FF01,Clindamycin,Solution,Intravenous,02408538,CLINDAMYCIN IV INFUSION (clindamycin (clindamycin phosphate) 900 mg per 50 mL solution for injection bag) SANDOZ CANADA INCORPORATED,Active,9001410,clindamycin (clindamycin phosphate) 900 mg per 50 mL solution for injection bag,8000036,clindamycin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Prescription
92122,Marketed,2015-03-02,02436906,Auro-Clindamycin,1,J01FF01,Clindamycin,Capsule,Oral,02436906,AURO-CLINDAMYCIN (clindamycin (clindamycin hydrochloride) 150 mg oral capsule) AURO PHARMA INC,Active,9000048,clindamycin (clindamycin hydrochloride) 150 mg oral capsule,8000036,clindamycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
92123,Marketed,2015-03-02,02436914,Auro-Clindamycin,1,J01FF01,Clindamycin,Capsule,Oral,02436914,AURO-CLINDAMYCIN (clindamycin (clindamycin hydrochloride) 300 mg oral capsule) AURO PHARMA INC,Active,9000562,clindamycin (clindamycin hydrochloride) 300 mg oral capsule,8000036,clindamycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95045,Marketed,2021-12-22,02462656,Med-Clindamycin,1,J01FF01,Clindamycin,Capsule,Oral,02462656,MED-CLINDAMYCIN (clindamycin (clindamycin hydrochloride) 150 mg oral capsule) GENERIC MEDICAL PARTNERS INC,Active,9000048,clindamycin (clindamycin hydrochloride) 150 mg oral capsule,8000036,clindamycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95046,Marketed,2021-12-22,02462664,Med-Clindamycin,1,J01FF01,Clindamycin,Capsule,Oral,02462664,MED-CLINDAMYCIN (clindamycin (clindamycin hydrochloride) 300 mg oral capsule) GENERIC MEDICAL PARTNERS INC,Active,9000562,clindamycin (clindamycin hydrochloride) 300 mg oral capsule,8000036,clindamycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95691,Marketed,2017-10-13,02468484,Riva-Clindamycin,1,J01FF01,Clindamycin,Capsule,Oral,02468484,RIVA-CLINDAMYCIN (clindamycin (clindamycin hydrochloride) 300 mg oral capsule) LABORATOIRE RIVA INC.,Active,9000562,clindamycin (clindamycin hydrochloride) 300 mg oral capsule,8000036,clindamycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97049,Marketed,2019-05-28,02479923,M-Clindamycin,1,J01FF01,Clindamycin,Capsule,Oral,02479923,M-CLINDAMYCIN (clindamycin (clindamycin hydrochloride) 150 mg oral capsule) MANTRA PHARMA INC,Active,9000048,clindamycin (clindamycin hydrochloride) 150 mg oral capsule,8000036,clindamycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97050,Marketed,2019-05-28,02479931,M-Clindamycin,1,J01FF01,Clindamycin,Capsule,Oral,02479931,M-CLINDAMYCIN (clindamycin (clindamycin hydrochloride) 300 mg oral capsule) MANTRA PHARMA INC,Active,9000562,clindamycin (clindamycin hydrochloride) 300 mg oral capsule,8000036,clindamycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97408,Marketed,2019-09-27,02483734,JAMP Clindamycin,1,J01FF01,Clindamycin,Capsule,Oral,02483734,JAMP CLINDAMYCIN (clindamycin (clindamycin hydrochloride) 150 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000048,clindamycin (clindamycin hydrochloride) 150 mg oral capsule,8000036,clindamycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97409,Marketed,2019-09-27,02483742,JAMP Clindamycin,1,J01FF01,Clindamycin,Capsule,Oral,02483742,JAMP CLINDAMYCIN (clindamycin (clindamycin hydrochloride) 300 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000562,clindamycin (clindamycin hydrochloride) 300 mg oral capsule,8000036,clindamycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97571,Marketed,2019-11-26,02485478,Clindamycin Injection In 5% Dextrose,1,J01FF01,Clindamycin,Solution,Intravenous,02485478,CLINDAMYCIN INJECTION IN 5% DEXTROSE (clindamycin (clindamycin phosphate) 600 mg per 50 mL solution for injection bag) BAXTER CORPORATION,Active,9001409,clindamycin (clindamycin phosphate) 600 mg per 50 mL solution for injection bag,8000036,clindamycin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Prescription
97572,Marketed,2019-12-03,02485486,Clindamycin Injection In 5% Dextrose,1,J01FF01,Clindamycin,Solution,Intravenous,02485486,CLINDAMYCIN INJECTION IN 5% DEXTROSE (clindamycin (clindamycin phosphate) 900 mg per 50 mL solution for injection bag) BAXTER CORPORATION,Active,9001410,clindamycin (clindamycin phosphate) 900 mg per 50 mL solution for injection bag,8000036,clindamycin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Prescription
98373,Marketed,2020-07-06,02493748,Nra-Clindamycin,1,J01FF01,Clindamycin,Capsule,Oral,02493748,NRA-CLINDAMYCIN (clindamycin (clindamycin hydrochloride) 150 mg oral capsule) NORA PHARMA INC,Active,9000048,clindamycin (clindamycin hydrochloride) 150 mg oral capsule,8000036,clindamycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98374,Marketed,2020-07-06,02493756,Nra-Clindamycin,1,J01FF01,Clindamycin,Capsule,Oral,02493756,NRA-CLINDAMYCIN (clindamycin (clindamycin hydrochloride) 300 mg oral capsule) NORA PHARMA INC,Active,9000562,clindamycin (clindamycin hydrochloride) 300 mg oral capsule,8000036,clindamycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
103924,Marketed,2024-10-07,02550423,Cabtreo,3,D10AF51,"Clindamycin, combinations",Gel,Topical,02550423,"CABTREO (adapalene 0.15 % and benzoyl peroxide 3.1 % and clindamycin phosphate 1.2 % cutaneous gel) BAUSCH HEALTH, CANADA INC.",Active,9015085,adapalene 0.15 % and benzoyl peroxide 3.1 % and clindamycin phosphate 1.2 % cutaneous gel,8002515,adapalene and benzoyl peroxide and clindamycin,448598008,Cutaneous,421949005,Conventional release cutaneous gel,,,,,,Prescription
72824,Marketed,2021-03-29,02248472,Benzaclin,2,D10AF51,"Clindamycin, combinations",Gel,Topical,02248472,"BENZACLIN (benzoyl peroxide 5 % and clindamycin (clindamycin phosphate) 1 % cutaneous gel) BAUSCH HEALTH, CANADA INC.",Active,9003644,benzoyl peroxide 5 % and clindamycin (clindamycin phosphate) 1 % cutaneous gel,8000924,benzoyl peroxide and clindamycin,448598008,Cutaneous,385100002,Gel,,,,,,Prescription
84468,Marketed,2019-10-18,02359685,Biacna Topical Gel,2,D10AF51,"Clindamycin, combinations",Gel,Topical,02359685,"BIACNA TOPICAL GEL (clindamycin phosphate 1.2 % and tretinoin 0.025 % cutaneous gel) BAUSCH HEALTH, CANADA INC.",Active,9004872,clindamycin phosphate 1.2 % and tretinoin 0.025 % cutaneous gel,8000984,clindamycin and tretinoin,448598008,Cutaneous,385100002,Gel,,,1.0,,,Prescription
86863,Marketed,2013-08-20,02382822,Clindoxyl Adv Gel,2,D10AF51,"Clindamycin, combinations",Gel,Topical,02382822,CLINDOXYL ADV GEL (benzoyl peroxide 3 % and clindamycin (clindamycin phosphate) 1 % cutaneous gel) GLAXOSMITHKLINE INC,Active,9005309,benzoyl peroxide 3 % and clindamycin (clindamycin phosphate) 1 % cutaneous gel,8000924,benzoyl peroxide and clindamycin,448598008,Cutaneous,385100002,Gel,,,,,,Prescription
92456,Marketed,2015-08-05,02440180,Taro-Clindamycin/Benzoyl Peroxide Gel,2,D10AF51,"Clindamycin, combinations",Gel,Topical,02440180,TARO-CLINDAMYCIN/BENZOYL PEROXIDE GEL (benzoyl peroxide 5 % and clindamycin (clindamycin phosphate) 1 % cutaneous gel) TARO PHARMACEUTICALS INC,Active,9003644,benzoyl peroxide 5 % and clindamycin (clindamycin phosphate) 1 % cutaneous gel,8000924,benzoyl peroxide and clindamycin,448598008,Cutaneous,385100002,Gel,,,,,,Prescription
95265,Marketed,2017-07-24,02464519,Taro-Benzoyl Peroxide / Clindamycin Kit,2,D10AF51,"Clindamycin, combinations",Gel,Topical,02464519,TARO-BENZOYL PEROXIDE / CLINDAMYCIN KIT (benzoyl peroxide 5 % and clindamycin (clindamycin phosphate) 1 % cutaneous gel) TARO PHARMACEUTICALS INC,Active,9003644,benzoyl peroxide 5 % and clindamycin (clindamycin phosphate) 1 % cutaneous gel,8000924,benzoyl peroxide and clindamycin,448598008,Cutaneous,385100002,Gel,,,,,,Prescription
61740,Marketed,2017-01-10,02238334,Teva-Clobazam,1,N05BA09,Clobazam,Tablet,Oral,02238334,TEVA-CLOBAZAM (clobazam 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000711,clobazam 10 mg oral tablet,8000238,clobazam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Targeted Substances (CDSA IV)
68625,Marketed,2001-11-28,02244638,Apo-Clobazam,1,N05BA09,Clobazam,Tablet,Oral,02244638,APO-CLOBAZAM (clobazam 10 mg oral tablet) APOTEX INC,Active,9000711,clobazam 10 mg oral tablet,8000238,clobazam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Targeted Substances (CDSA IV)
100870,Marketed,2022-01-10,02519437,Reddy-Clobetasol Shampoo,1,D07AD01,Clobetasol,Shampoo,Topical,02519437,REDDY-CLOBETASOL SHAMPOO (clobetasol propionate 0.05 % shampoo) DR. REDDY'S LABORATORIES CANADA INC.,Active,9001098,clobetasol propionate 0.05 % shampoo,8000161,clobetasol,41695006,Scalp structure,785908001,Shampoo,,,,,,Prescription
102357,Marketed,2024-03-28,02534665,JAMP Clobetasol Spray,1,D07AD01,Clobetasol,Spray,Topical,02534665,JAMP CLOBETASOL SPRAY (clobetasol propionate 0.05 % cutaneous spray) JAMP PHARMA CORPORATION,Active,9006600,clobetasol propionate 0.05 % cutaneous spray,8000161,clobetasol,448598008,Cutaneous,421720008,Spray,,,,,,Prescription
13437,Marketed,2017-12-19,01910272,Teva-Clobetasol,1,D07AD01,Clobetasol,Cream,Topical,01910272,TEVA-CLOBETASOL (clobetasol propionate 0.05 % cutaneous cream) TEVA CANADA LIMITED,Active,9000410,clobetasol propionate 0.05 % cutaneous cream,8000161,clobetasol,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
13438,Marketed,2017-12-19,01910299,Teva-Clobetasol,1,D07AD01,Clobetasol,Lotion,Topical,01910299,TEVA-CLOBETASOL (clobetasol propionate 0.05 % lotion) TEVA CANADA LIMITED,Active,9000412,clobetasol propionate 0.05 % lotion,8000161,clobetasol,448598008,Cutaneous,739000003,Lotion,,,,,,Prescription
13439,Marketed,2017-12-19,01910280,Teva-Clobetasol,1,D07AD01,Clobetasol,Ointment,Topical,01910280,TEVA-CLOBETASOL (clobetasol propionate 0.05 % cutaneous ointment) TEVA CANADA LIMITED,Active,9000411,clobetasol propionate 0.05 % cutaneous ointment,8000161,clobetasol,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Prescription
14381,Marketed,2010-07-21,02024187,Mylan-Clobetasol Cream,1,D07AD01,Clobetasol,Cream,Topical,02024187,MYLAN-CLOBETASOL CREAM (clobetasol propionate 0.05 % cutaneous cream) MYLAN PHARMACEUTICALS ULC,Active,9000410,clobetasol propionate 0.05 % cutaneous cream,8000161,clobetasol,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
14382,Marketed,2010-08-31,02026767,Mylan-Clobetasol Ointment,1,D07AD01,Clobetasol,Ointment,Topical,02026767,MYLAN-CLOBETASOL OINTMENT (clobetasol propionate 0.05 % cutaneous ointment) MYLAN PHARMACEUTICALS ULC,Active,9000411,clobetasol propionate 0.05 % cutaneous ointment,8000161,clobetasol,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Prescription
36952,Marketed,2004-03-29,02213265,Dermovate Cream,1,D07AD01,Clobetasol,Cream,Topical,02213265,"DERMOVATE CREAM (clobetasol propionate 0.05 % cutaneous cream) TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Active,9000410,clobetasol propionate 0.05 % cutaneous cream,8000161,clobetasol,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
36953,Marketed,2004-04-06,02213273,Dermovate Ointment,1,D07AD01,Clobetasol,Ointment,Topical,02213273,"DERMOVATE OINTMENT (clobetasol propionate 0.05 % cutaneous ointment) TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Active,9000411,clobetasol propionate 0.05 % cutaneous ointment,8000161,clobetasol,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Prescription
36954,Marketed,2004-04-23,02213281,Dermovate Scalp Application,1,D07AD01,Clobetasol,Solution,Topical,02213281,"DERMOVATE SCALP APPLICATION (clobetasol propionate 0.05 % cutaneous solution) TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Active,9000945,clobetasol propionate 0.05 % cutaneous solution,8000161,clobetasol,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Prescription
43175,Marketed,2010-03-02,02216213,Mylan-Clobetasol Scalp Application,1,D07AD01,Clobetasol,Lotion,Topical,02216213,MYLAN-CLOBETASOL SCALP APPLICATION (clobetasol propionate 0.05 % lotion) MYLAN PHARMACEUTICALS ULC,Active,9000412,clobetasol propionate 0.05 % lotion,8000161,clobetasol,448598008,Cutaneous,739000003,Lotion,,,,,,Prescription
69609,Marketed,2005-10-03,02245522,"Taro-Clobetasol Topical Solution USP, 0.05%",1,D07AD01,Clobetasol,Solution,Topical,02245522,"TARO-CLOBETASOL TOPICAL SOLUTION USP, 0.05% (clobetasol propionate 0.05 % cutaneous solution) TARO PHARMACEUTICALS INC",Active,9000945,clobetasol propionate 0.05 % cutaneous solution,8000161,clobetasol,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Prescription
69610,Marketed,2005-10-03,02245523,"Taro-Clobetasol Cream USP, 0.05%",1,D07AD01,Clobetasol,Cream,Topical,02245523,"TARO-CLOBETASOL CREAM USP, 0.05% (clobetasol propionate 0.05 % cutaneous cream) TARO PHARMACEUTICALS INC",Active,9000410,clobetasol propionate 0.05 % cutaneous cream,8000161,clobetasol,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
69611,Marketed,2005-10-03,02245524,"Taro-Clobetasol Ointment USP, 0.05%",1,D07AD01,Clobetasol,Ointment,Topical,02245524,"TARO-CLOBETASOL OINTMENT USP, 0.05% (clobetasol propionate 0.05 % cutaneous ointment) TARO PHARMACEUTICALS INC",Active,9000411,clobetasol propionate 0.05 % cutaneous ointment,8000161,clobetasol,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Prescription
74161,Marketed,2004-12-15,02256371,Clobex Shampoo,1,D07AD01,Clobetasol,Shampoo,Topical,02256371,CLOBEX SHAMPOO (clobetasol propionate 0.05 % shampoo) GALDERMA CANADA INC.,Active,9001098,clobetasol propionate 0.05 % shampoo,8000161,clobetasol,41695006,Scalp structure,785908001,Shampoo,,,,,,Prescription
78510,Marketed,2007-12-19,02299739,Clobex Spray,1,D07AD01,Clobetasol,Spray,Topical,02299739,CLOBEX SPRAY (clobetasol propionate 0.05 % cutaneous spray) GALDERMA CANADA INC.,Active,9006600,clobetasol propionate 0.05 % cutaneous spray,8000161,clobetasol,448598008,Cutaneous,421720008,Spray,,,,,,Prescription
97970,Marketed,2019-08-26,02489619,Taro-Clobetasol Spray,1,D07AD01,Clobetasol,Spray,Topical,02489619,TARO-CLOBETASOL SPRAY (clobetasol propionate 0.05 % cutaneous spray) TARO PHARMACEUTICALS INC,Active,9006600,clobetasol propionate 0.05 % cutaneous spray,8000161,clobetasol,448598008,Cutaneous,421720008,Spray,,,,,,Prescription
98076,Marketed,2019-09-26,02490706,Odan Clobetasol Spray,1,D07AD01,Clobetasol,Spray,Topical,02490706,ODAN CLOBETASOL SPRAY (clobetasol propionate 0.05 % cutaneous spray) ODAN LABORATORIES LTD,Active,9006600,clobetasol propionate 0.05 % cutaneous spray,8000161,clobetasol,448598008,Cutaneous,421720008,Spray,,,,,,Prescription
98498,Marketed,2020-04-23,02495023,Sandoz Clobetasol,1,D07AD01,Clobetasol,Spray,Topical,02495023,SANDOZ CLOBETASOL (clobetasol propionate 0.05 % cutaneous spray) SANDOZ CANADA INCORPORATED,Active,9006600,clobetasol propionate 0.05 % cutaneous spray,8000161,clobetasol,448598008,Cutaneous,421720008,Spray,,,,,,Prescription
99554,Marketed,2020-12-22,02506203,Taro-Clobetasol Shampoo,1,D07AD01,Clobetasol,Shampoo,Topical,02506203,TARO-CLOBETASOL SHAMPOO (clobetasol propionate 0.05 % shampoo) TARO PHARMACEUTICALS INC,Active,9001098,clobetasol propionate 0.05 % shampoo,8000161,clobetasol,41695006,Scalp structure,785908001,Shampoo,,,,,,Prescription
37001,Marketed,2025-11-03,02214415,Spectro Eczemacare Medicated Cream,1,D07AB01,Clobetasone,Cream,Topical,02214415,SPECTRO ECZEMACARE MEDICATED CREAM (clobetasone butyrate 0.05 % cutaneous cream) HALEON CANADA ULC,Active,9003424,clobetasone butyrate 0.05 % cutaneous cream,8001617,clobetasone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
69944,Marketed,2025-11-07,02245828,Clasteon,1,M05BA02,Clodronic acid,Capsule,Oral,02245828,CLASTEON (clodronate disodium 400 mg oral capsule) KNIGHT THERAPEUTICS INC.,Active,9003906,clodronate disodium 400 mg oral capsule,8001360,clodronate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
81614,Marketed,2014-04-08,02330407,Clolar,1,L01BB06,Clofarabine,Solution,Intravenous,02330407,CLOLAR (clofarabine 20 mg per 20 mL solution for injection vial) SANOFI-AVENTIS CANADA INC,Active,9013057,clofarabine 20 mg per 20 mL solution for injection vial,8001732,clofarabine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
13907,Marketed,2022-11-24,01966294,Ulone,1,R05DB10,Clofedanol,Syrup,Oral,01966294,ULONE (clofedanol hydrochloride 25 mg per 5 mL syrup) BAUSCH & LOMB INC,Active,9001588,clofedanol hydrochloride 25 mg per 5 mL syrup,8001618,clofedanol,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
2039,Marketed,2021-03-12,00324019,Anafranil,1,N06AA04,Clomipramine,Tablet,Oral,00324019,ANAFRANIL (clomipramine hydrochloride 25 mg oral tablet) APOTEX INC,Active,9001698,clomipramine hydrochloride 25 mg oral tablet,8001250,clomipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
2164,Marketed,2021-03-12,00330566,Anafranil,1,N06AA04,Clomipramine,Tablet,Oral,00330566,ANAFRANIL (clomipramine hydrochloride 10 mg oral tablet) APOTEX INC,Active,9001731,clomipramine hydrochloride 10 mg oral tablet,8001250,clomipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
4382,Marketed,2021-03-12,00402591,Anafranil,1,N06AA04,Clomipramine,Tablet,Oral,00402591,ANAFRANIL (clomipramine hydrochloride 50 mg oral tablet) APOTEX INC,Active,9001906,clomipramine hydrochloride 50 mg oral tablet,8001250,clomipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98731,Marketed,2020-05-07,02497506,Taro-Clomipramine,1,N06AA04,Clomipramine,Capsule,Oral,02497506,TARO-CLOMIPRAMINE (clomipramine hydrochloride 25 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9014305,clomipramine hydrochloride 25 mg oral capsule,8001250,clomipramine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98733,Marketed,2020-05-07,02497514,Taro-Clomipramine,1,N06AA04,Clomipramine,Capsule,Oral,02497514,TARO-CLOMIPRAMINE (clomipramine hydrochloride 50 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9014306,clomipramine hydrochloride 50 mg oral capsule,8001250,clomipramine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
14587,Marketed,1993-12-31,02048728,PMS-Clonazepam,1,N03AE01,Clonazepam,Tablet,Oral,02048728,PMS-CLONAZEPAM (clonazepam 1 mg oral tablet) PHARMASCIENCE INC,Active,9000459,clonazepam 1 mg oral tablet,8000061,clonazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Targeted Substances (CDSA IV)
14589,Marketed,1993-12-31,02048736,PMS-Clonazepam,1,N03AE01,Clonazepam,Tablet,Oral,02048736,PMS-CLONAZEPAM (clonazepam 2 mg oral tablet) PHARMASCIENCE INC,Active,9000098,clonazepam 2 mg oral tablet,8000061,clonazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Targeted Substances (CDSA IV)
19048,Marketed,2021-06-11,02177897,Apo-Clonazepam,1,N03AE01,Clonazepam,Tablet,Oral,02177897,APO-CLONAZEPAM (clonazepam 2 mg oral tablet) APOTEX INC,Active,9000098,clonazepam 2 mg oral tablet,8000061,clonazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Targeted Substances (CDSA IV)
19063,Marketed,2021-06-11,02177889,Apo-Clonazepam,1,N03AE01,Clonazepam,Tablet,Oral,02177889,APO-CLONAZEPAM (clonazepam 0.5 mg oral tablet) APOTEX INC,Active,9000097,clonazepam 0.5 mg oral tablet,8000061,clonazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Targeted Substances (CDSA IV)
19221,Marketed,1995-12-31,02179660,PMS-Clonazepam,1,N03AE01,Clonazepam,Tablet,Oral,02179660,PMS-CLONAZEPAM (clonazepam 0.25 mg oral tablet) PHARMASCIENCE INC,Active,9000563,clonazepam 0.25 mg oral tablet,8000061,clonazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Targeted Substances (CDSA IV)
19628,Marketed,1996-12-31,02207818,PMS-Clonazepam-R,1,N03AE01,Clonazepam,Tablet,Oral,02207818,PMS-CLONAZEPAM-R (clonazepam 0.5 mg oral tablet) PHARMASCIENCE INC,Active,9000097,clonazepam 0.5 mg oral tablet,8000061,clonazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Targeted Substances (CDSA IV)
2568,Marketed,2023-01-31,00382825,Rivotril,1,N03AE01,Clonazepam,Tablet,Oral,00382825,RIVOTRIL (clonazepam 0.5 mg oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9000097,clonazepam 0.5 mg oral tablet,8000061,clonazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Targeted Substances (CDSA IV)
2569,Marketed,2023-01-31,00382841,Rivotril,1,N03AE01,Clonazepam,Tablet,Oral,00382841,RIVOTRIL (clonazepam 2 mg oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9000098,clonazepam 2 mg oral tablet,8000061,clonazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Targeted Substances (CDSA IV)
79715,Marketed,2014-07-26,02311593,Pro-Clonazepam,1,N03AE01,Clonazepam,Tablet,Oral,02311593,PRO-CLONAZEPAM (clonazepam 0.5 mg oral tablet) PRO DOC LIMITEE,Active,9000097,clonazepam 0.5 mg oral tablet,8000061,clonazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Targeted Substances (CDSA IV)
79716,Marketed,2008-07-09,02311607,Pro-Clonazepam,1,N03AE01,Clonazepam,Tablet,Oral,02311607,PRO-CLONAZEPAM (clonazepam 1 mg oral tablet) PRO DOC LIMITEE,Active,9000459,clonazepam 1 mg oral tablet,8000061,clonazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Targeted Substances (CDSA IV)
79718,Marketed,2008-07-09,02311615,Pro-Clonazepam,1,N03AE01,Clonazepam,Tablet,Oral,02311615,PRO-CLONAZEPAM (clonazepam 2 mg oral tablet) PRO DOC LIMITEE,Active,9000098,clonazepam 2 mg oral tablet,8000061,clonazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Targeted Substances (CDSA IV)
100518,Marketed,2022-02-02,02515784,Sandoz Clonidine,1,C02AC01,Clonidine,Tablet,Oral,02515784,SANDOZ CLONIDINE (clonidine hydrochloride 0.1 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000346,clonidine hydrochloride 0.1 mg oral tablet,8000135,clonidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100519,Marketed,2022-02-02,02515792,Sandoz Clonidine,1,C02AC01,Clonidine,Tablet,Oral,02515792,SANDOZ CLONIDINE (clonidine hydrochloride 0.2 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000347,clonidine hydrochloride 0.2 mg oral tablet,8000135,clonidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100559,Marketed,2022-02-02,02516217,Sandoz Clonidine,1,C02AC01,Clonidine,Tablet,Oral,02516217,SANDOZ CLONIDINE (clonidine hydrochloride 0.025 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001081,clonidine hydrochloride 0.025 mg oral tablet,8000135,clonidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101324,Marketed,2022-04-11,02524198,Mar-Clonidine,1,C02AC01,Clonidine,Tablet,Oral,02524198,MAR-CLONIDINE (clonidine hydrochloride 0.025 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001081,clonidine hydrochloride 0.025 mg oral tablet,8000135,clonidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101745,Marketed,2023-03-07,02528207,JAMP Clonidine,1,C02AC01,Clonidine,Tablet,Oral,02528207,JAMP CLONIDINE (clonidine hydrochloride 0.025 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001081,clonidine hydrochloride 0.025 mg oral tablet,8000135,clonidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102362,Marketed,2023-05-10,02534738,Mint-Clonidine,1,C02AC01,Clonidine,Tablet,Oral,02534738,MINT-CLONIDINE (clonidine hydrochloride 0.025 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001081,clonidine hydrochloride 0.025 mg oral tablet,8000135,clonidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102721,Marketed,2024-02-02,02538490,Clonidine,1,C02AC01,Clonidine,Tablet,Oral,02538490,CLONIDINE (clonidine hydrochloride 0.1 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000346,clonidine hydrochloride 0.1 mg oral tablet,8000135,clonidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102722,Marketed,2024-02-02,02538504,Clonidine,1,C02AC01,Clonidine,Tablet,Oral,02538504,CLONIDINE (clonidine hydrochloride 0.2 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000347,clonidine hydrochloride 0.2 mg oral tablet,8000135,clonidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102879,Marketed,2024-02-02,02540061,Clonidine,1,C02AC01,Clonidine,Tablet,Oral,02540061,CLONIDINE (clonidine hydrochloride 0.025 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001081,clonidine hydrochloride 0.025 mg oral tablet,8000135,clonidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
14713,Marketed,2014-01-17,02046148,Teva-Clonidine,1,C02AC01,Clonidine,Tablet,Oral,02046148,TEVA-CLONIDINE (clonidine hydrochloride 0.2 mg oral tablet) TEVA CANADA LIMITED,Active,9000347,clonidine hydrochloride 0.2 mg oral tablet,8000135,clonidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
14715,Marketed,2014-01-17,02046121,Teva-Clonidine,1,C02AC01,Clonidine,Tablet,Oral,02046121,TEVA-CLONIDINE (clonidine hydrochloride 0.1 mg oral tablet) TEVA CANADA LIMITED,Active,9000346,clonidine hydrochloride 0.1 mg oral tablet,8000135,clonidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78947,Marketed,2014-01-17,02304163,Teva-Clonidine,1,C02AC01,Clonidine,Tablet,Oral,02304163,TEVA-CLONIDINE (clonidine hydrochloride 0.025 mg oral tablet) TEVA CANADA LIMITED,Active,9001081,clonidine hydrochloride 0.025 mg oral tablet,8000135,clonidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94992,Marketed,2017-06-23,02462192,Mint-Clonidine,1,C02AC01,Clonidine,Tablet,Oral,02462192,MINT-CLONIDINE (clonidine hydrochloride 0.1 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000346,clonidine hydrochloride 0.1 mg oral tablet,8000135,clonidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94993,Marketed,2017-06-23,02462206,Mint-Clonidine,1,C02AC01,Clonidine,Tablet,Oral,02462206,MINT-CLONIDINE (clonidine hydrochloride 0.2 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000347,clonidine hydrochloride 0.2 mg oral tablet,8000135,clonidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
62114,Marketed,2007-04-10,02238682,Plavix,1,B01AC04,Clopidogrel,Tablet,Oral,02238682,PLAVIX (clopidogrel (clopidogrel bisulfate) 75 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9000818,clopidogrel (clopidogrel bisulfate) 75 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73770,Marketed,2011-12-19,02252767,Apo-Clopidogrel,1,B01AC04,Clopidogrel,Tablet,Oral,02252767,APO-CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 75 mg oral tablet) APOTEX INC,Active,9000818,clopidogrel (clopidogrel bisulfate) 75 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77854,Marketed,2011-12-14,02293161,Teva-Clopidogrel,1,B01AC04,Clopidogrel,Tablet,Oral,02293161,TEVA-CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 75 mg oral tablet) TEVA CANADA LIMITED,Active,9000818,clopidogrel (clopidogrel bisulfate) 75 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83336,Marketed,2011-12-14,02348004,PMS-Clopidogrel,1,B01AC04,Clopidogrel,Tablet,Oral,02348004,PMS-CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 75 mg oral tablet) PHARMASCIENCE INC,Active,9000818,clopidogrel (clopidogrel bisulfate) 75 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86568,Marketed,2020-06-26,02379813,Taro-Clopidogrel,1,B01AC04,Clopidogrel,Tablet,Oral,02379813,TARO-CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 75 mg oral tablet) SUN PHARMA CANADA INC,Active,9000818,clopidogrel (clopidogrel bisulfate) 75 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87143,Marketed,2012-06-11,02385813,Clopidogrel,1,B01AC04,Clopidogrel,Tablet,Oral,02385813,CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 75 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000818,clopidogrel (clopidogrel bisulfate) 75 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87363,Marketed,2013-01-02,02388065,Teva-Clopidogrel,1,B01AC04,Clopidogrel,Tablet,Oral,02388065,TEVA-CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 300 mg oral tablet) TEVA CANADA LIMITED,Active,9001290,clopidogrel (clopidogrel bisulfate) 300 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87405,Marketed,2019-05-30,02388529,Riva-Clopidogrel,1,B01AC04,Clopidogrel,Tablet,Oral,02388529,RIVA-CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 75 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000818,clopidogrel (clopidogrel bisulfate) 75 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87998,Marketed,2012-11-22,02394820,Clopidogrel,1,B01AC04,Clopidogrel,Tablet,Oral,02394820,CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 75 mg oral tablet) PRO DOC LIMITEE,Active,9000818,clopidogrel (clopidogrel bisulfate) 75 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88354,Marketed,2013-01-21,02398591,Apo-Clopidogrel,1,B01AC04,Clopidogrel,Tablet,Oral,02398591,APO-CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 300 mg oral tablet) APOTEX INC,Active,9001290,clopidogrel (clopidogrel bisulfate) 300 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88535,Marketed,2021-05-14,02400553,Clopidogrel,1,B01AC04,Clopidogrel,Tablet,Oral,02400553,CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 75 mg oral tablet) SANIS HEALTH INC,Active,9000818,clopidogrel (clopidogrel bisulfate) 75 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89366,Marketed,2023-03-29,02408910,Mint-Clopidogrel,1,B01AC04,Clopidogrel,Tablet,Oral,02408910,MINT-CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 75 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000818,clopidogrel (clopidogrel bisulfate) 75 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90014,Marketed,2014-01-15,02415550,JAMP-Clopidogrel,1,B01AC04,Clopidogrel,Tablet,Oral,02415550,JAMP-CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 75 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000818,clopidogrel (clopidogrel bisulfate) 75 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90094,Marketed,2014-02-06,02416387,Auro-Clopidogrel,1,B01AC04,Clopidogrel,Tablet,Oral,02416387,AURO-CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 75 mg oral tablet) AURO PHARMA INC,Active,9000818,clopidogrel (clopidogrel bisulfate) 75 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90695,Marketed,2023-06-14,02422255,Mar-Clopidogrel,1,B01AC04,Clopidogrel,Tablet,Oral,02422255,MAR-CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 75 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000818,clopidogrel (clopidogrel bisulfate) 75 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91644,Marketed,2022-02-10,02431971,AG-Clopidogrel,1,B01AC04,Clopidogrel,Tablet,Oral,02431971,AG-CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 75 mg oral tablet) ANGITA PHARMA INC.,Active,9000818,clopidogrel (clopidogrel bisulfate) 75 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93012,Marketed,2023-08-02,02444895,Bio-Clopidogrel,1,B01AC04,Clopidogrel,Tablet,Oral,02444895,BIO-CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 75 mg oral tablet) BIOMED PHARMA,Active,9000818,clopidogrel (clopidogrel bisulfate) 75 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97237,Marketed,2020-03-05,02482037,Nra-Clopidogrel,1,B01AC04,Clopidogrel,Tablet,Oral,02482037,NRA-CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 75 mg oral tablet) NORA PHARMA INC,Active,9000818,clopidogrel (clopidogrel bisulfate) 75 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99186,Marketed,2020-11-03,02502283,M-Clopidogrel,1,B01AC04,Clopidogrel,Tablet,Oral,02502283,M-CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 75 mg oral tablet) MANTRA PHARMA INC,Active,9000818,clopidogrel (clopidogrel bisulfate) 75 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
10899,Marketed,2013-04-10,00860697,Clorazepate,1,N05BA05,Clorazepate potassium,Capsule,Oral,00860697,CLORAZEPATE (clorazepate dipotassium 15 mg oral capsule) AA PHARMA INC,Active,9002269,clorazepate dipotassium 15 mg oral capsule,8001361,clorazepate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Targeted Substances (CDSA IV)
10902,Marketed,2013-04-10,00860689,Clorazepate,1,N05BA05,Clorazepate potassium,Capsule,Oral,00860689,CLORAZEPATE (clorazepate dipotassium 3.75 mg oral capsule) AA PHARMA INC,Active,9002270,clorazepate dipotassium 3.75 mg oral capsule,8001361,clorazepate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Targeted Substances (CDSA IV)
10903,Marketed,2013-05-16,00860700,Clorazepate,1,N05BA05,Clorazepate potassium,Capsule,Oral,00860700,CLORAZEPATE (clorazepate dipotassium 7.5 mg oral capsule) AA PHARMA INC,Active,9002271,clorazepate dipotassium 7.5 mg oral capsule,8001361,clorazepate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Targeted Substances (CDSA IV)
100712,Marketed,2022-05-03,02517760,Extra Strength Clotrimazole Extra Fort - Fluconazole Combi,2,G01AF02,Clotrimazole,"Capsule,Cream","Topical,Oral",02517760,EXTRA STRENGTH CLOTRIMAZOLE EXTRA FORT -FLUCONAZOLE COMBI (clotrimazole 2 % cutaneous cream with fluconazole 150 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9014252,clotrimazole 2 % cutaneous cream with fluconazole 150 mg oral capsule,8000978,clotrimazole and fluconazole,26643006,Oral,421628006,Cutaneous cream,732937005,Capsule (unit of presentation),1.0,,,Non-Prescription Drugs
103588,Marketed,2025-02-03,02547252,Canesten Soft Capsule 1,1,G01AF02,Clotrimazole,Vaginal capsule,Vaginal,02547252,CANESTEN SOFT CAPSULE 1 (clotrimazole 500 mg vaginal capsule) BAYER INC,Active,9015165,clotrimazole 500 mg vaginal capsule,8000773,clotrimazole,16857009,Vaginal,385175008,Vaginal capsule,732937005,Capsule,,,,Non-Prescription Drugs
103589,Marketed,2025-02-03,02547260,Canesten Combi 1 Day Soft Capsule + Extra Strength External Cream,2,G01AF02,Clotrimazole,"Vaginal capsule,Kit,Cream","Topical,Vaginal",02547260,CANESTEN COMBI 1 DAY SOFT CAPSULE + EXTRA STRENGTH EXTERNAL CREAM (clotrimazole 500 mg vaginal capsule with clotrimazole 2 % vaginal cream) BAYER INC,Active,9015166,clotrimazole 500 mg vaginal capsule with clotrimazole 2 % vaginal cream,8000773,clotrimazole,16857009,Vaginal,385175008,Vaginal capsule,733021006,System,,,,Non-Prescription Drugs
11893,Marketed,2022-07-05,00812382,Clotrimaderm Topical,1,D01AC01,Clotrimazole,Cream,Topical,00812382,CLOTRIMADERM TOPICAL (clotrimazole 1 % cutaneous cream) TARO PHARMACEUTICALS INC,Active,9000290,clotrimazole 1 % cutaneous cream,8000773,clotrimazole,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
19479,Marketed,2008-09-09,02150840,Canesten Comfortab 3,1,G01AF02,Clotrimazole,Vaginal tablet,Vaginal,02150840,CANESTEN COMFORTAB 3 (clotrimazole 200 mg vaginal tablet) BAYER INC,Active,9000564,clotrimazole 200 mg vaginal tablet,8000773,clotrimazole,16857009,Vaginal,385055001,Tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
19480,Marketed,2008-09-09,02150859,Canesten Comfortab 1,1,G01AF02,Clotrimazole,Vaginal tablet,Vaginal,02150859,CANESTEN COMFORTAB 1 (clotrimazole 500 mg vaginal tablet) BAYER INC,Active,9000565,clotrimazole 500 mg vaginal tablet,8000773,clotrimazole,16857009,Vaginal,385055001,Tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
19483,Marketed,2018-11-09,02150891,Canesten 6 Day Internal Cream,1,G01AF02,Clotrimazole,Cream,Vaginal,02150891,CANESTEN 6 DAY INTERNAL CREAM (clotrimazole 1 % vaginal cream) BAYER INC,Active,9000311,clotrimazole 1 % vaginal cream,8000773,clotrimazole,16857009,Vaginal,385165005,Vaginal cream,,,,,,Non-Prescription Drugs
19484,Marketed,2018-11-09,02150905,Canesten 3 Day Internal Cream,1,G01AF02,Clotrimazole,Cream,Vaginal,02150905,CANESTEN 3 DAY INTERNAL CREAM (clotrimazole 2 % vaginal cream) BAYER INC,Active,9000312,clotrimazole 2 % vaginal cream,8000773,clotrimazole,16857009,Vaginal,385165005,Vaginal cream,,,,,,Non-Prescription Drugs
19487,Marketed,1995-12-31,02150867,Canesten 1% Topical Cream,1,D01AC01,Clotrimazole,Cream,Topical,02150867,CANESTEN 1% TOPICAL CREAM (clotrimazole 1 % cutaneous cream) BAYER INC,Active,9000290,clotrimazole 1 % cutaneous cream,8000773,clotrimazole,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
44016,Marketed,2020-05-01,02150883,Canesten 1 Day Internal Cream,1,G01AF02,Clotrimazole,Cream,Vaginal,02150883,CANESTEN 1 DAY INTERNAL CREAM (clotrimazole 10 % vaginal cream) BAYER INC,Active,9000729,clotrimazole 10 % vaginal cream,8000773,clotrimazole,16857009,Vaginal,385165005,Vaginal cream,,,,,,Non-Prescription Drugs
47168,Marketed,2020-10-16,02229378,Clotrimazole Vaginal 6,1,G01AF02,Clotrimazole,Cream,Vaginal,02229378,CLOTRIMAZOLE VAGINAL 6 (clotrimazole 1 % vaginal cream) TARO PHARMACEUTICALS INC,Active,9000311,clotrimazole 1 % vaginal cream,8000773,clotrimazole,16857009,Vaginal,385165005,Vaginal cream,,,,,,Non-Prescription Drugs
47180,Marketed,2020-10-16,02229379,Clotrimazole Vaginal 3,1,G01AF02,Clotrimazole,Cream,Vaginal,02229379,CLOTRIMAZOLE VAGINAL 3 (clotrimazole 2 % vaginal cream) TARO PHARMACEUTICALS INC,Active,9000312,clotrimazole 2 % vaginal cream,8000773,clotrimazole,16857009,Vaginal,385165005,Vaginal cream,,,,,,Non-Prescription Drugs
47181,Marketed,2022-10-07,02229380,Clotrimazole Topical,1,D01AC01,Clotrimazole,Cream,Topical,02229380,CLOTRIMAZOLE TOPICAL (clotrimazole 1 % cutaneous cream) TARO PHARMACEUTICALS INC,Active,9000290,clotrimazole 1 % cutaneous cream,8000773,clotrimazole,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
49563,Marketed,2018-11-09,02230509,Canesten Combi 1 Day Internal + External Creams,2,G01AF02,Clotrimazole,"Cream,Kit","Vaginal,Topical",02230509,CANESTEN COMBI 1 DAY INTERNAL + EXTERNAL CREAMS (clotrimazole 1 % cutaneous cream with clotrimazole 10 % vaginal cream) BAYER INC,Active,9006468,clotrimazole 1 % cutaneous cream with clotrimazole 10 % vaginal cream,8000773,clotrimazole,16857009,Vaginal,385165005,Vaginal cream,,,,,,Non-Prescription Drugs
62905,Marketed,2020-02-14,02239432,Canesten External Antifungal Cream,1,D01AC01,Clotrimazole,Cream,Topical,02239432,CANESTEN EXTERNAL ANTIFUNGAL CREAM (clotrimazole 1 % cutaneous cream) BAYER INC,Active,9000290,clotrimazole 1 % cutaneous cream,8000773,clotrimazole,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
74951,Marketed,2023-02-16,02264099,Canesten Combi 3 Day,2,G01AF02,Clotrimazole,"Kit,Cream,Vaginal tablet","Vaginal,Topical",02264099,CANESTEN COMBI 3 DAY (clotrimazole 1 % cutaneous cream with clotrimazole 200 mg vaginal tablet) BAYER INC,Active,9006482,clotrimazole 1 % cutaneous cream with clotrimazole 200 mg vaginal tablet,8000773,clotrimazole,16857009,Vaginal,385178005,Vaginal tablet,733021006,System,,,,Non-Prescription Drugs
74952,Marketed,2023-02-21,02264102,Canesten Combi 1 Day,2,G01AF02,Clotrimazole,"Cream,Vaginal tablet,Kit","Topical,Vaginal",02264102,CANESTEN COMBI 1 DAY (clotrimazole 1 % cutaneous cream with clotrimazole 500 mg vaginal tablet) BAYER INC,Active,9006481,clotrimazole 1 % cutaneous cream with clotrimazole 500 mg vaginal tablet,8000773,clotrimazole,16857009,Vaginal,385178005,Vaginal tablet,733021006,System,,,,Non-Prescription Drugs
79727,Marketed,2010-03-10,02311720,Canesten External Cream,1,G01AF02,Clotrimazole,Cream,"Vaginal,Topical",02311720,CANESTEN EXTERNAL CREAM (clotrimazole 1 % cutaneous cream) BAYER INC,Active,9000290,clotrimazole 1 % cutaneous cream,8000773,clotrimazole,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
95015,Marketed,2020-10-16,02462397,Clotrimazole External Antifungal Cream,1,G01AF02,Clotrimazole,Cream,Topical,02462397,CLOTRIMAZOLE EXTERNAL ANTIFUNGAL CREAM (clotrimazole 1 % cutaneous cream) TARO PHARMACEUTICALS INC,Active,9000290,clotrimazole 1 % cutaneous cream,8000773,clotrimazole,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
98096,Marketed,2020-02-14,02490927,Canesten Extra Strength External Antifungal Cream,1,G01AF02,Clotrimazole,Cream,Topical,02490927,CANESTEN EXTRA STRENGTH EXTERNAL ANTIFUNGAL CREAM (clotrimazole 2 % cutaneous cream) BAYER INC,Active,9014251,clotrimazole 2 % cutaneous cream,8000773,clotrimazole,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
9926,Marketed,2020-02-21,00812366,Clotrimaderm Vaginal 6,1,G01AF02,Clotrimazole,Cream,Vaginal,00812366,CLOTRIMADERM VAGINAL 6 (clotrimazole 1 % vaginal cream) TARO PHARMACEUTICALS INC,Active,9000311,clotrimazole 1 % vaginal cream,8000773,clotrimazole,16857009,Vaginal,385165005,Vaginal cream,,,,,,Non-Prescription Drugs
9927,Marketed,2020-02-21,00812374,Clotrimaderm Vaginal 3,1,G01AF02,Clotrimazole,Cream,Vaginal,00812374,CLOTRIMADERM VAGINAL 3 (clotrimazole 2 % vaginal cream) TARO PHARMACEUTICALS INC,Active,9000312,clotrimazole 2 % vaginal cream,8000773,clotrimazole,16857009,Vaginal,385165005,Vaginal cream,,,,,,Non-Prescription Drugs
99284,Marketed,2021-06-19,02503360,Clotrimazole Extra Strength External Antifungal Cream,1,G01AF02,Clotrimazole,Cream,Vaginal,02503360,CLOTRIMAZOLE EXTRA STRENGTH EXTERNAL ANTIFUNGAL CREAM (clotrimazole 2 % cutaneous cream) TARO PHARMACEUTICALS INC,Active,9014251,clotrimazole 2 % cutaneous cream,8000773,clotrimazole,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
2233,Marketed,2016-09-29,00337765,Teva-Cloxacillin,1,J01CF02,Cloxacillin,Capsule,Oral,00337765,TEVA-CLOXACILLIN (cloxacillin (cloxacillin sodium) 250 mg oral capsule) TEVA CANADA LIMITED,Active,9001732,cloxacillin (cloxacillin sodium) 250 mg oral capsule,8001362,cloxacillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
2234,Marketed,2016-09-29,00337773,Teva-Cloxacillin,1,J01CF02,Cloxacillin,Capsule,Oral,00337773,TEVA-CLOXACILLIN (cloxacillin (cloxacillin sodium) 500 mg oral capsule) TEVA CANADA LIMITED,Active,9001733,cloxacillin (cloxacillin sodium) 500 mg oral capsule,8001362,cloxacillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
3794,Marketed,2016-09-29,00337757,Teva-Cloxacillin,1,J01CF02,Cloxacillin,Granules for solution,Oral,00337757,TEVA-CLOXACILLIN (cloxacillin (cloxacillin sodium) 125 mg per 5 mL oral solution) TEVA CANADA LIMITED,Active,9013058,cloxacillin (cloxacillin sodium) 125 mg per 5 mL oral solution,8001362,cloxacillin,26643006,Oral,385023001,Oral solution,,,,,,Prescription
85225,Marketed,2011-09-14,02367408,Cloxacillin For Injection,1,J01CF02,Cloxacillin,Powder for solution,"Intravenous,Intramuscular",02367408,CLOXACILLIN FOR INJECTION (cloxacillin (cloxacillin sodium) 500 mg per vial powder for solution for injection) STERIMAX INC,Active,9004924,cloxacillin (cloxacillin sodium) 500 mg per vial powder for solution for injection,8001362,cloxacillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
85226,Marketed,2011-07-28,02367416,Cloxacillin For Injection,1,J01CF02,Cloxacillin,Powder for solution,Intravenous,02367416,CLOXACILLIN FOR INJECTION (cloxacillin (cloxacillin sodium) 1 g per vial powder for solution for injection) STERIMAX INC,Active,9012696,cloxacillin (cloxacillin sodium) 1 g per vial powder for solution for injection,8001362,cloxacillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
85227,Marketed,2011-07-28,02367424,Cloxacillin For Injection,1,J01CF02,Cloxacillin,Powder for solution,Intravenous,02367424,CLOXACILLIN FOR INJECTION (cloxacillin (cloxacillin sodium) 2 g per vial powder for solution for injection) STERIMAX INC,Active,9012698,cloxacillin (cloxacillin sodium) 2 g per vial powder for solution for injection,8001362,cloxacillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
88492,Marketed,2013-04-03,02400081,Cloxacillin For Injection,1,J01CF02,Cloxacillin,Powder for solution,Intravenous,02400081,CLOXACILLIN FOR INJECTION (cloxacillin (cloxacillin sodium) 10 g per vial powder for solution for injection) STERIMAX INC,Active,9005216,cloxacillin (cloxacillin sodium) 10 g per vial powder for solution for injection,8001362,cloxacillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
99993,Marketed,2022-02-17,02510731,JAMP Cloxacillin,1,J01CF02,Cloxacillin,Capsule,Oral,02510731,JAMP CLOXACILLIN (cloxacillin (cloxacillin sodium) 250 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001732,cloxacillin (cloxacillin sodium) 250 mg oral capsule,8001362,cloxacillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
99994,Marketed,2022-02-17,02510758,JAMP Cloxacillin,1,J01CF02,Cloxacillin,Capsule,Oral,02510758,JAMP CLOXACILLIN (cloxacillin (cloxacillin sodium) 500 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001733,cloxacillin (cloxacillin sodium) 500 mg oral capsule,8001362,cloxacillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
104347,Marketed,2025-05-29,02554631,Gen-Clozapine,1,N05AH02,Clozapine,Tablet (orally disintegrating),Oral,02554631,GEN-CLOZAPINE (clozapine 12.5 mg orodispersible tablet) MYLAN PHARMACEUTICALS ULC,Active,9015216,clozapine 12.5 mg orodispersible tablet,8000147,clozapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet,,,,Prescription
104348,Marketed,2025-05-29,02554658,Gen-Clozapine,1,N05AH02,Clozapine,Tablet (orally disintegrating),Oral,02554658,GEN-CLOZAPINE (clozapine 25 mg orodispersible tablet) MYLAN PHARMACEUTICALS ULC,Active,9015218,clozapine 25 mg orodispersible tablet,8000147,clozapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet,,,,Prescription
104349,Marketed,2025-05-29,02554666,Gen-Clozapine,1,N05AH02,Clozapine,Tablet (orally disintegrating),Oral,02554666,GEN-CLOZAPINE (clozapine 50 mg orodispersible tablet) MYLAN PHARMACEUTICALS ULC,Active,9015219,clozapine 50 mg orodispersible tablet,8000147,clozapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet,,,,Prescription
104350,Marketed,2025-05-29,02554674,Gen-Clozapine,1,N05AH02,Clozapine,Tablet (orally disintegrating),Oral,02554674,GEN-CLOZAPINE (clozapine 100 mg orodispersible tablet) MYLAN PHARMACEUTICALS ULC,Active,9015215,clozapine 100 mg orodispersible tablet,8000147,clozapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet,,,,Prescription
104351,Marketed,2025-05-29,02554682,Gen-Clozapine,1,N05AH02,Clozapine,Tablet (orally disintegrating),Oral,02554682,GEN-CLOZAPINE (clozapine 200 mg orodispersible tablet) MYLAN PHARMACEUTICALS ULC,Active,9015217,clozapine 200 mg orodispersible tablet,8000147,clozapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet,,,,Prescription
11421,Marketed,2016-04-08,00894745,Clozaril,1,N05AH02,Clozapine,Tablet,Oral,00894745,CLOZARIL (clozapine 100 mg oral tablet) HLS THERAPEUTICS INC,Active,9000378,clozapine 100 mg oral tablet,8000147,clozapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
11422,Marketed,2016-04-08,00894737,Clozaril,1,N05AH02,Clozapine,Tablet,Oral,00894737,CLOZARIL (clozapine 25 mg oral tablet) HLS THERAPEUTICS INC,Active,9000379,clozapine 25 mg oral tablet,8000147,clozapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71485,Marketed,2010-02-09,02247243,Gen-Clozapine,1,N05AH02,Clozapine,Tablet,Oral,02247243,GEN-CLOZAPINE (clozapine 25 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000379,clozapine 25 mg oral tablet,8000147,clozapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71486,Marketed,2009-10-15,02247244,Gen-Clozapine,1,N05AH02,Clozapine,Tablet,Oral,02247244,GEN-CLOZAPINE (clozapine 100 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000378,clozapine 100 mg oral tablet,8000147,clozapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
72354,Marketed,2016-11-21,02248034,AA-Clozapine,1,N05AH02,Clozapine,Tablet,Oral,02248034,AA-CLOZAPINE (clozapine 25 mg oral tablet) AA PHARMA INC,Active,9000379,clozapine 25 mg oral tablet,8000147,clozapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
72355,Marketed,2016-11-21,02248035,AA-Clozapine,1,N05AH02,Clozapine,Tablet,Oral,02248035,AA-CLOZAPINE (clozapine 100 mg oral tablet) AA PHARMA INC,Active,9000378,clozapine 100 mg oral tablet,8000147,clozapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79038,Marketed,2010-11-22,02305003,Gen-Clozapine,1,N05AH02,Clozapine,Tablet,Oral,02305003,GEN-CLOZAPINE (clozapine 50 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9001239,clozapine 50 mg oral tablet,8000147,clozapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79039,Marketed,2010-11-24,02305011,Gen-Clozapine,1,N05AH02,Clozapine,Tablet,Oral,02305011,GEN-CLOZAPINE (clozapine 200 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9001238,clozapine 200 mg oral tablet,8000147,clozapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94589,Marketed,2017-02-27,02458748,AA-Clozapine,1,N05AH02,Clozapine,Tablet,Oral,02458748,AA-CLOZAPINE (clozapine 50 mg oral tablet) AA PHARMA INC,Active,9001239,clozapine 50 mg oral tablet,8000147,clozapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94590,Marketed,2017-02-27,02458756,AA-Clozapine,1,N05AH02,Clozapine,Tablet,Oral,02458756,AA-CLOZAPINE (clozapine 200 mg oral tablet) AA PHARMA INC,Active,9001238,clozapine 200 mg oral tablet,8000147,clozapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98072,Marketed,2019-12-18,02490668,Clozaril,1,N05AH02,Clozapine,Tablet,Oral,02490668,CLOZARIL (clozapine 50 mg oral tablet) HLS THERAPEUTICS INC,Active,9001239,clozapine 50 mg oral tablet,8000147,clozapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98073,Marketed,2019-12-18,02490676,Clozaril,1,N05AH02,Clozapine,Tablet,Oral,02490676,CLOZARIL (clozapine 200 mg oral tablet) HLS THERAPEUTICS INC,Active,9001238,clozapine 200 mg oral tablet,8000147,clozapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102197,Marketed,2024-02-13,02532964,Rebinyn,1,B02BD04,Coagulation factor ix,Powder for solution,Intravenous,02532964,REBINYN (nonacog beta pegol 3000 unit per vial powder for solution for injection with diluent solution syringe) NOVO NORDISK CANADA INC,Active,9015018,nonacog beta pegol 3000 unit per vial powder for solution for injection with diluent solution syringe,8002284,nonacog beta pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,,,,Schedule D
43011,Marketed,2021-11-05,02206021,Immunine VH,1,B02BD04,Coagulation factor ix,Powder for solution,Intravenous,02206021,IMMUNINE VH (coagulation factor IX human 480-720 unit per vial powder for solution for injection with diluent solution) TAKEDA CANADA INC,Active,9014089,coagulation factor IX human 480-720 unit per vial powder for solution for injection with diluent solution,8002277,coagulation factor IX human,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
77916,Marketed,2012-07-31,02293773,Benefix,1,B02BD04,Coagulation factor ix,Powder for solution,Intravenous,02293773,BENEFIX (nonacog alfa 500 unit per vial powder for solution for injection with diluent solution syringe) PFIZER CANADA ULC,Active,9014122,nonacog alfa 500 unit per vial powder for solution for injection with diluent solution syringe,8002283,nonacog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
77917,Marketed,2012-09-11,02293781,Benefix,1,B02BD04,Coagulation factor ix,Powder for solution,Intravenous,02293781,BENEFIX (nonacog alfa 1000 unit per vial powder for solution for injection with diluent solution syringe) PFIZER CANADA ULC,Active,9014119,nonacog alfa 1000 unit per vial powder for solution for injection with diluent solution syringe,8002283,nonacog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
77918,Marketed,2012-05-03,02293803,Benefix,1,B02BD04,Coagulation factor ix,Powder for solution,Intravenous,02293803,BENEFIX (nonacog alfa 2000 unit per vial powder for solution for injection with diluent solution syringe) PFIZER CANADA ULC,Active,9014120,nonacog alfa 2000 unit per vial powder for solution for injection with diluent solution syringe,8002283,nonacog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
87824,Marketed,2013-02-12,02392984,Benefix,1,B02BD04,Coagulation factor ix,Powder for solution,Intravenous,02392984,BENEFIX (nonacog alfa 3000 unit per vial powder for solution for injection with diluent solution syringe) PFIZER CANADA ULC,Active,9014121,nonacog alfa 3000 unit per vial powder for solution for injection with diluent solution syringe,8002283,nonacog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
90757,Marketed,2022-05-13,02422913,Alprolix,1,B02BD04,Coagulation factor ix,"Kit,Powder for solution",Intravenous,02422913,ALPROLIX (eftrenonacog alfa 500 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9014169,eftrenonacog alfa 500 unit per vial powder for solution for injection with diluent solution syringe,8002301,eftrenonacog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
90758,Marketed,2021-09-22,02422921,Alprolix,1,B02BD04,Coagulation factor ix,"Kit,Powder for solution",Intravenous,02422921,ALPROLIX (eftrenonacog alfa 1000 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9014166,eftrenonacog alfa 1000 unit per vial powder for solution for injection with diluent solution syringe,8002301,eftrenonacog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
90759,Marketed,2021-09-22,02422948,Alprolix,1,B02BD04,Coagulation factor ix,"Kit,Powder for solution",Intravenous,02422948,ALPROLIX (eftrenonacog alfa 2000 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9014167,eftrenonacog alfa 2000 unit per vial powder for solution for injection with diluent solution syringe,8002301,eftrenonacog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
90760,Marketed,2021-10-22,02422956,Alprolix,1,B02BD04,Coagulation factor ix,"Kit,Powder for solution",Intravenous,02422956,ALPROLIX (eftrenonacog alfa 3000 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9014168,eftrenonacog alfa 3000 unit per vial powder for solution for injection with diluent solution syringe,8002301,eftrenonacog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
91641,Marketed,2021-09-28,02431947,Rixubis,1,B02BD04,Coagulation factor ix,"Kit,Powder for solution",Intravenous,02431947,RIXUBIS (nonacog gamma 1000 unit per vial powder for solution for injection with diluent solution) TAKEDA CANADA INC,Active,9013587,nonacog gamma 1000 unit per vial powder for solution for injection with diluent solution,8002149,nonacog gamma,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
91642,Marketed,2021-10-22,02431955,Rixubis,1,B02BD04,Coagulation factor ix,"Powder for solution,Kit",Intravenous,02431955,RIXUBIS (nonacog gamma 2000 unit per vial powder for solution for injection with diluent solution) TAKEDA CANADA INC,Active,9013588,nonacog gamma 2000 unit per vial powder for solution for injection with diluent solution,8002149,nonacog gamma,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
91643,Marketed,2021-09-28,02431963,Rixubis,1,B02BD04,Coagulation factor ix,"Kit,Powder for solution",Intravenous,02431963,RIXUBIS (nonacog gamma 3000 unit per vial powder for solution for injection with diluent solution) TAKEDA CANADA INC,Active,9014126,nonacog gamma 3000 unit per vial powder for solution for injection with diluent solution,8002149,nonacog gamma,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
95917,Marketed,2018-03-23,02470187,Rebinyn,1,B02BD04,Coagulation factor ix,Powder for solution,Intravenous,02470187,REBINYN (nonacog beta pegol 500 unit per vial powder for solution for injection with diluent solution syringe) NOVO NORDISK CANADA INC,Active,9014125,nonacog beta pegol 500 unit per vial powder for solution for injection with diluent solution syringe,8002284,nonacog beta pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
95924,Marketed,2018-03-23,02470268,Rebinyn,1,B02BD04,Coagulation factor ix,Powder for solution,Intravenous,02470268,REBINYN (nonacog beta pegol 1000 unit per vial powder for solution for injection with diluent solution syringe) NOVO NORDISK CANADA INC,Active,9014123,nonacog beta pegol 1000 unit per vial powder for solution for injection with diluent solution syringe,8002284,nonacog beta pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
95925,Marketed,2018-03-23,02470276,Rebinyn,1,B02BD04,Coagulation factor ix,Powder for solution,Intravenous,02470276,REBINYN (nonacog beta pegol 2000 unit per vial powder for solution for injection with diluent solution syringe) NOVO NORDISK CANADA INC,Active,9014124,nonacog beta pegol 2000 unit per vial powder for solution for injection with diluent solution syringe,8002284,nonacog beta pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
78001,Marketed,2008-07-08,02294664,Octaplex,6,B02BD01,"Coagulation factor ix, ii, vii and x in comb","Kit,Powder for solution",Intravenous,,,,,,,,,,,,,,,,,Schedule D
84428,Marketed,2011-07-28,02359251,Beriplex P/N 500,6,B02BD01,"Coagulation factor ix, ii, vii and x in comb",Powder for solution,Intravenous,,,,,,,,,,,,,,,,,Schedule D
89540,Marketed,2013-11-21,02410826,Beriplex P/N 1000,6,B02BD01,"Coagulation factor ix, ii, vii and x in comb",Powder for solution,Intravenous,,,,,,,,,,,,,,,,,Schedule D
91926,Marketed,2015-08-11,02434970,Octaplex,6,B02BD01,"Coagulation factor ix, ii, vii and x in comb","Kit,Powder for solution",Intravenous,,,,,,,,,,,,,,,,,Schedule D
90174,Marketed,2015-05-05,02417103,Niastase RT,1,B02BD08,Coagulation factor viia,"Powder for solution,Kit",Intravenous,02417103,NIASTASE RT (eptacog alfa (activated) 1 mg per vial powder for solution for injection with diluent solution syringe) NOVO NORDISK CANADA INC,Active,9013548,eptacog alfa (activated) 1 mg per vial powder for solution for injection with diluent solution syringe,8002119,eptacog alfa (activated),738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
90175,Marketed,2015-05-05,02417111,Niastase RT,1,B02BD08,Coagulation factor viia,"Kit,Powder for solution",Intravenous,02417111,NIASTASE RT (eptacog alfa (activated) 2 mg per vial powder for solution for injection with diluent solution syringe) NOVO NORDISK CANADA INC,Active,9013549,eptacog alfa (activated) 2 mg per vial powder for solution for injection with diluent solution syringe,8002119,eptacog alfa (activated),738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
90176,Marketed,2015-05-05,02417138,Niastase RT,1,B02BD08,Coagulation factor viia,"Powder for solution,Kit",Intravenous,02417138,NIASTASE RT (eptacog alfa (activated) 5 mg per vial powder for solution for injection with diluent solution syringe) NOVO NORDISK CANADA INC,Active,9013550,eptacog alfa (activated) 5 mg per vial powder for solution for injection with diluent solution syringe,8002119,eptacog alfa (activated),738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
79508,Marketed,2012-02-17,02309483,Xyntha,1,B02BD02,Coagulation factor viii,"Powder for solution,Kit",Intravenous,02309483,XYNTHA (moroctocog alfa 250 unit per vial powder for solution for injection with diluent solution syringe) PFIZER CANADA ULC,Active,9013583,moroctocog alfa 250 unit per vial powder for solution for injection with diluent solution syringe,8002147,moroctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
79509,Marketed,2012-07-09,02309491,Xyntha,1,B02BD02,Coagulation factor viii,"Powder for solution,Kit",Intravenous,02309491,XYNTHA (moroctocog alfa 500 unit per vial powder for solution for injection with diluent solution syringe) PFIZER CANADA ULC,Active,9013585,moroctocog alfa 500 unit per vial powder for solution for injection with diluent solution syringe,8002147,moroctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
85926,Marketed,2019-09-27,02374064,Xyntha Solofuse,1,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02374064,XYNTHA SOLOFUSE (moroctocog alfa 500 unit powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9014224,moroctocog alfa 500 unit powder for solution for injection with diluent solution per syringe,8002147,moroctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
85927,Marketed,2012-04-13,02374072,Xyntha Solofuse,1,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02374072,XYNTHA SOLOFUSE (moroctocog alfa 1000 unit powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9013581,moroctocog alfa 1000 unit powder for solution for injection with diluent solution per syringe,8002147,moroctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
85928,Marketed,2012-05-08,02374080,Xyntha Solofuse,1,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02374080,XYNTHA SOLOFUSE (moroctocog alfa 2000 unit powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9013582,moroctocog alfa 2000 unit powder for solution for injection with diluent solution per syringe,8002147,moroctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
85929,Marketed,2012-05-08,02374099,Xyntha Solofuse,1,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02374099,XYNTHA SOLOFUSE (moroctocog alfa 3000 unit powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9013584,moroctocog alfa 3000 unit powder for solution for injection with diluent solution per syringe,8002147,moroctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
91477,Marketed,2022-05-20,02430290,Eloctate,1,B02BD02,Coagulation factor viii,"Powder for solution,Kit",Intravenous,02430290,ELOCTATE (efmoroctocog alfa 250 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9014102,efmoroctocog alfa 250 unit per vial powder for solution for injection with diluent solution syringe,8002280,efmoroctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
91479,Marketed,2021-09-13,02430304,Eloctate,1,B02BD02,Coagulation factor viii,"Powder for solution,Kit",Intravenous,02430304,ELOCTATE (efmoroctocog alfa 500 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9014104,efmoroctocog alfa 500 unit per vial powder for solution for injection with diluent solution syringe,8002280,efmoroctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
91480,Marketed,2021-09-10,02430312,Eloctate,1,B02BD02,Coagulation factor viii,"Powder for solution,Kit",Intravenous,02430312,ELOCTATE (efmoroctocog alfa 750 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9014105,efmoroctocog alfa 750 unit per vial powder for solution for injection with diluent solution syringe,8002280,efmoroctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
91481,Marketed,2021-11-03,02430320,Eloctate,1,B02BD02,Coagulation factor viii,"Powder for solution,Kit",Intravenous,02430320,ELOCTATE (efmoroctocog alfa 1000 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9014099,efmoroctocog alfa 1000 unit per vial powder for solution for injection with diluent solution syringe,8002280,efmoroctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
91482,Marketed,2021-11-10,02430339,Eloctate,1,B02BD02,Coagulation factor viii,"Powder for solution,Kit",Intravenous,02430339,ELOCTATE (efmoroctocog alfa 1500 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9014100,efmoroctocog alfa 1500 unit per vial powder for solution for injection with diluent solution syringe,8002280,efmoroctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
91483,Marketed,2021-10-29,02430347,Eloctate,1,B02BD02,Coagulation factor viii,"Powder for solution,Kit",Intravenous,02430347,ELOCTATE (efmoroctocog alfa 2000 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9014101,efmoroctocog alfa 2000 unit per vial powder for solution for injection with diluent solution syringe,8002280,efmoroctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
91484,Marketed,2022-01-13,02430355,Eloctate,1,B02BD02,Coagulation factor viii,"Powder for solution,Kit",Intravenous,02430355,ELOCTATE (efmoroctocog alfa 3000 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9014103,efmoroctocog alfa 3000 unit per vial powder for solution for injection with diluent solution syringe,8002280,efmoroctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
91946,Marketed,2018-03-23,02435187,Zonovate,1,B02BD02,Coagulation factor viii,"Powder for solution,Kit",Intravenous,02435187,ZONOVATE (turoctocog alfa 250 unit per vial powder for solution for injection with diluent solution syringe) NOVO NORDISK CANADA INC,Active,9013623,turoctocog alfa 250 unit per vial powder for solution for injection with diluent solution syringe,8002165,turoctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
91947,Marketed,2018-03-23,02435195,Zonovate,1,B02BD02,Coagulation factor viii,"Kit,Powder for solution",Intravenous,02435195,ZONOVATE (turoctocog alfa 500 unit per vial powder for solution for injection with diluent solution syringe) NOVO NORDISK CANADA INC,Active,9013625,turoctocog alfa 500 unit per vial powder for solution for injection with diluent solution syringe,8002165,turoctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
91948,Marketed,2018-03-23,02435209,Zonovate,1,B02BD02,Coagulation factor viii,"Powder for solution,Kit",Intravenous,02435209,ZONOVATE (turoctocog alfa 1000 unit per vial powder for solution for injection with diluent solution syringe) NOVO NORDISK CANADA INC,Active,9013620,turoctocog alfa 1000 unit per vial powder for solution for injection with diluent solution syringe,8002165,turoctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
91949,Marketed,2018-03-23,02435217,Zonovate,1,B02BD02,Coagulation factor viii,"Powder for solution,Kit",Intravenous,02435217,ZONOVATE (turoctocog alfa 1500 unit per vial powder for solution for injection with diluent solution syringe) NOVO NORDISK CANADA INC,Active,9013621,turoctocog alfa 1500 unit per vial powder for solution for injection with diluent solution syringe,8002165,turoctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
91950,Marketed,2018-03-23,02435225,Zonovate,1,B02BD02,Coagulation factor viii,"Powder for solution,Kit",Intravenous,02435225,ZONOVATE (turoctocog alfa 2000 unit per vial powder for solution for injection with diluent solution syringe) NOVO NORDISK CANADA INC,Active,9013622,turoctocog alfa 2000 unit per vial powder for solution for injection with diluent solution syringe,8002165,turoctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
91951,Marketed,2018-03-23,02435233,Zonovate,1,B02BD02,Coagulation factor viii,"Powder for solution,Kit",Intravenous,02435233,ZONOVATE (turoctocog alfa 3000 unit per vial powder for solution for injection with diluent solution syringe) NOVO NORDISK CANADA INC,Active,9013624,turoctocog alfa 3000 unit per vial powder for solution for injection with diluent solution syringe,8002165,turoctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
93300,Marketed,2021-06-08,02447401,Obizur,1,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02447401,OBIZUR (susoctocog alfa 500 unit per vial powder for solution for injection with diluent solution syringe) TAKEDA CANADA INC,Active,9014141,susoctocog alfa 500 unit per vial powder for solution for injection with diluent solution syringe,8002288,susoctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
93366,Marketed,2025-12-11,02447967,Altuviiio,1,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02447967,ALTUVIIIO (efanesoctocog alfa 3000 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9015298,efanesoctocog alfa 3000 unit per vial powder for solution for injection with diluent solution syringe,8002565,efanesoctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,,,,Prescription
93366,Marketed,2025-12-11,02447967,Altuviiio,1,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02447967,ALTUVIIIO (efanesoctocog alfa 3000 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9015298,efanesoctocog alfa 3000 unit per vial powder for solution for injection with diluent solution syringe,8002565,efanesoctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,,,,Schedule D
93381,Marketed,2025-12-09,02448122,Altuviiio,1,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02448122,ALTUVIIIO (efanesoctocog alfa 500 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9015300,efanesoctocog alfa 500 unit per vial powder for solution for injection with diluent solution syringe,8002565,efanesoctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,,,,Schedule D
93381,Marketed,2025-12-09,02448122,Altuviiio,1,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02448122,ALTUVIIIO (efanesoctocog alfa 500 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9015300,efanesoctocog alfa 500 unit per vial powder for solution for injection with diluent solution syringe,8002565,efanesoctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,,,,Prescription
93382,Marketed,2025-12-09,02448130,Altuviiio,1,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02448130,ALTUVIIIO (efanesoctocog alfa 1000 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9015297,efanesoctocog alfa 1000 unit per vial powder for solution for injection with diluent solution syringe,8002565,efanesoctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,,,,Schedule D
93382,Marketed,2025-12-09,02448130,Altuviiio,1,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02448130,ALTUVIIIO (efanesoctocog alfa 1000 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9015297,efanesoctocog alfa 1000 unit per vial powder for solution for injection with diluent solution syringe,8002565,efanesoctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,,,,Prescription
93383,Marketed,2025-12-19,02448149,Altuviiio,1,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02448149,ALTUVIIIO (efanesoctocog alfa 2000 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9015337,efanesoctocog alfa 2000 unit per vial powder for solution for injection with diluent solution syringe,8002565,efanesoctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,,,,Prescription
93383,Marketed,2025-12-19,02448149,Altuviiio,1,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02448149,ALTUVIIIO (efanesoctocog alfa 2000 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9015337,efanesoctocog alfa 2000 unit per vial powder for solution for injection with diluent solution syringe,8002565,efanesoctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,,,,Schedule D
93384,Marketed,2025-12-09,02448157,Altuviiio,1,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02448157,ALTUVIIIO (efanesoctocog alfa 4000 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9015299,efanesoctocog alfa 4000 unit per vial powder for solution for injection with diluent solution syringe,8002565,efanesoctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,,,,Schedule D
93384,Marketed,2025-12-09,02448157,Altuviiio,1,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02448157,ALTUVIIIO (efanesoctocog alfa 4000 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9015299,efanesoctocog alfa 4000 unit per vial powder for solution for injection with diluent solution syringe,8002565,efanesoctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,,,,Prescription
93773,Marketed,2016-07-20,02451441,Kovaltry,1,B02BD02,Coagulation factor viii,"Kit,Powder for solution",Intravenous,02451441,KOVALTRY (octocog alfa 250 unit per vial powder for solution for injection with diluent solution syringe) BAYER INC,Active,9014133,octocog alfa 250 unit per vial powder for solution for injection with diluent solution syringe,8002285,octocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
93774,Marketed,2016-07-06,02451468,Kovaltry,1,B02BD02,Coagulation factor viii,"Powder for solution,Kit",Intravenous,02451468,KOVALTRY (octocog alfa 500 unit per vial powder for solution for injection with diluent solution syringe) BAYER INC,Active,9014137,octocog alfa 500 unit per vial powder for solution for injection with diluent solution syringe,8002285,octocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
93775,Marketed,2016-07-06,02451476,Kovaltry,1,B02BD02,Coagulation factor viii,"Kit,Powder for solution",Intravenous,02451476,KOVALTRY (octocog alfa 1000 unit per vial powder for solution for injection with diluent solution syringe) BAYER INC,Active,9014128,octocog alfa 1000 unit per vial powder for solution for injection with diluent solution syringe,8002285,octocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
93776,Marketed,2016-07-15,02451484,Kovaltry,1,B02BD02,Coagulation factor viii,"Powder for solution,Kit",Intravenous,02451484,KOVALTRY (octocog alfa 2000 unit per vial powder for solution for injection with diluent solution syringe) BAYER INC,Active,9014131,octocog alfa 2000 unit per vial powder for solution for injection with diluent solution syringe,8002285,octocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
93777,Marketed,2016-08-18,02451492,Kovaltry,1,B02BD02,Coagulation factor viii,"Powder for solution,Kit",Intravenous,02451492,KOVALTRY (octocog alfa 3000 unit per vial powder for solution for injection with diluent solution syringe) BAYER INC,Active,9014135,octocog alfa 3000 unit per vial powder for solution for injection with diluent solution syringe,8002285,octocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
94622,Marketed,2021-08-13,02459078,Adynovate,1,B02BD02,Coagulation factor viii,"Powder for solution,Kit",Intravenous,02459078,ADYNOVATE (rurioctocog alfa pegol 2000 unit per vial powder for solution for injection with diluent solution) TAKEDA CANADA INC,Active,9014230,rurioctocog alfa pegol 2000 unit per vial powder for solution for injection with diluent solution,8002314,rurioctocog alfa pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
97224,Marketed,2020-04-08,02481766,Jivi,1,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02481766,JIVI (damoctocog alfa pegol 500 unit per vial powder for solution for injection with diluent solution syringe) BAYER INC,Active,9014288,damoctocog alfa pegol 500 unit per vial powder for solution for injection with diluent solution syringe,8002319,damoctocog alfa pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
97225,Marketed,2020-03-11,02481774,Jivi,1,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02481774,JIVI (damoctocog alfa pegol 1000 unit per vial powder for solution for injection with diluent solution syringe) BAYER INC,Active,9014286,damoctocog alfa pegol 1000 unit per vial powder for solution for injection with diluent solution syringe,8002319,damoctocog alfa pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
97226,Marketed,2020-03-11,02481782,Jivi,1,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02481782,JIVI (damoctocog alfa pegol 2000 unit per vial powder for solution for injection with diluent solution syringe) BAYER INC,Active,9014287,damoctocog alfa pegol 2000 unit per vial powder for solution for injection with diluent solution syringe,8002319,damoctocog alfa pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
97227,Marketed,2020-01-27,02481790,Jivi,1,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02481790,JIVI (damoctocog alfa pegol 3000 unit per vial powder for solution for injection with diluent solution syringe) BAYER INC,Active,9014253,damoctocog alfa pegol 3000 unit per vial powder for solution for injection with diluent solution syringe,8002319,damoctocog alfa pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
98013,Marketed,2022-03-10,02490064,Esperoct,1,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02490064,ESPEROCT (turoctocog alfa pegol 500 unit per vial powder for solution for injection with diluent solution syringe) NOVO NORDISK CANADA INC,Active,9014687,turoctocog alfa pegol 500 unit per vial powder for solution for injection with diluent solution syringe,8002415,turoctocog alfa pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
98014,Marketed,2022-03-10,02490072,Esperoct,1,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02490072,ESPEROCT (turoctocog alfa pegol 1000 unit per vial powder for solution for injection with diluent solution syringe) NOVO NORDISK CANADA INC,Active,9014685,turoctocog alfa pegol 1000 unit per vial powder for solution for injection with diluent solution syringe,8002415,turoctocog alfa pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
98016,Marketed,2022-03-10,02490099,Esperoct,1,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02490099,ESPEROCT (turoctocog alfa pegol 2000 unit per vial powder for solution for injection with diluent solution syringe) NOVO NORDISK CANADA INC,Active,9014686,turoctocog alfa pegol 2000 unit per vial powder for solution for injection with diluent solution syringe,8002415,turoctocog alfa pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
98017,Marketed,2022-09-15,02490102,Esperoct,1,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02490102,ESPEROCT (turoctocog alfa pegol 3000 unit per vial powder for solution for injection with diluent solution syringe) NOVO NORDISK CANADA INC,Active,9014769,turoctocog alfa pegol 3000 unit per vial powder for solution for injection with diluent solution syringe,8002415,turoctocog alfa pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
98830,Marketed,2021-07-16,02498537,Adynovate,1,B02BD02,Coagulation factor viii,"Powder for solution,Kit",Intravenous,02498537,ADYNOVATE (2 ML DILUENT) - SINGLE USE VIAL (rurioctocog alfa pegol 250 unit per vial powder for solution for injection with diluent solution) TAKEDA CANADA INC,Active,9014231,rurioctocog alfa pegol 250 unit per vial powder for solution for injection with diluent solution,8002314,rurioctocog alfa pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
98831,Marketed,2021-08-13,02498545,Adynovate,1,B02BD02,Coagulation factor viii,"Kit,Powder for solution",Intravenous,02498545,ADYNOVATE (2 ML DILUENT) - SINGLE USE VIAL (rurioctocog alfa pegol 500 unit per vial powder for solution for injection with diluent solution) TAKEDA CANADA INC,Active,9014232,rurioctocog alfa pegol 500 unit per vial powder for solution for injection with diluent solution,8002314,rurioctocog alfa pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
98834,Marketed,2021-08-13,02498588,Adynovate,1,B02BD02,Coagulation factor viii,"Powder for solution,Kit",Intravenous,02498588,ADYNOVATE (2 ML DILUENT) - SINGLE USE VIAL (rurioctocog alfa pegol 1000 unit per vial powder for solution for injection with diluent solution) TAKEDA CANADA INC,Active,9014229,rurioctocog alfa pegol 1000 unit per vial powder for solution for injection with diluent solution,8002314,rurioctocog alfa pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
98835,Marketed,2021-08-27,02498596,Adynovate,1,B02BD02,Coagulation factor viii,"Kit,Powder for solution",Intravenous,02498596,ADYNOVATE (2 ML DILUENT) - SINGLE USE VIAL (rurioctocog alfa pegol 1500 unit per vial powder for solution for injection with diluent solution) TAKEDA CANADA INC,Active,9014612,rurioctocog alfa pegol 1500 unit per vial powder for solution for injection with diluent solution,8002314,rurioctocog alfa pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
98837,Marketed,2021-02-23,02498626,Adynovate,1,B02BD02,Coagulation factor viii,"Powder for solution,Kit",Intravenous,02498626,ADYNOVATE (rurioctocog alfa pegol 3000 unit per vial powder for solution for injection with diluent solution) TAKEDA CANADA INC,Active,9014389,rurioctocog alfa pegol 3000 unit per vial powder for solution for injection with diluent solution,8002314,rurioctocog alfa pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
90329,Marketed,2014-04-03,02418738,Corifact 250,1,B02BD07,Coagulation factor xiii,Powder for solution,Intravenous,02418738,CORIFACT 250 (coagulation factor XIII human 250 unit per vial powder for solution for injection with diluent solution) CSL BEHRING CANADA INC,Active,9014096,coagulation factor XIII human 250 unit per vial powder for solution for injection with diluent solution,8002279,coagulation factor XIII human,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
90330,Marketed,2014-04-03,02418746,Corifact 1250,1,B02BD07,Coagulation factor xiii,Powder for solution,Intravenous,02418746,CORIFACT 1250 (coagulation factor XIII human 1250 unit per vial powder for solution for injection with diluent solution) CSL BEHRING CANADA INC,Active,9014095,coagulation factor XIII human 1250 unit per vial powder for solution for injection with diluent solution,8002279,coagulation factor XIII human,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
93872,Marketed,2016-04-06,02452340,Cotellic,1,L01EE02,Cobimetinib,Tablet,Oral,02452340,COTELLIC (cobimetinib (cobimetinib fumarate) 20 mg oral tablet) HOFFMANN-LA ROCHE LIMITED,Active,9005928,cobimetinib (cobimetinib fumarate) 20 mg oral tablet,8001619,cobimetinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
104345,Marketed,2025-05-08,02554615,Apo-Butalbital-Acetylsalicylic Acid-Caffeine-Codeine-C 1/4,4,N02AA79,"Codein, combinations with psycholeptics",Capsule,Oral,02554615,APO-BUTALBITAL-ACETYLSALICYLIC ACID-CAFFEINE-CODEINE-C 1/4 (acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 15 mg oral capsule) APOTEX INC,Active,9001651,acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 15 mg oral capsule,8000805,acetylsalicylic acid and butalbital and caffeine and codeine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,1.0,,Narcotics (CDSA I)
104346,Marketed,2025-05-08,02554623,Apo-Butalbital-Acetylsalicylic Acid-Caffeine-Codeine-C 1/2,4,N02AA79,"Codein, combinations with psycholeptics",Capsule,Oral,02554623,APO-BUTALBITAL-ACETYLSALICYLIC ACID-CAFFEINE-CODEINE-C 1/2 (acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule) APOTEX INC,Active,9001652,acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule,8000805,acetylsalicylic acid and butalbital and caffeine and codeine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,1.0,,Narcotics (CDSA I)
6419,Marketed,2017-11-20,00608181,Teva-Tecnal C 1/2,4,N02AA79,"Codein, combinations with psycholeptics",Capsule,Oral,00608181,TEVA-TECNAL C 1/2 (acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule) TEVA CANADA LIMITED,Active,9001652,acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule,8000805,acetylsalicylic acid and butalbital and caffeine and codeine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,1.0,,Narcotics (CDSA I)
6479,Marketed,2017-11-20,00608203,Teva-Tecnal C 1/4,4,N02AA79,"Codein, combinations with psycholeptics",Capsule,Oral,00608203,TEVA-TECNAL C 1/4 (acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 15 mg oral capsule) TEVA CANADA LIMITED,Active,9001651,acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 15 mg oral capsule,8000805,acetylsalicylic acid and butalbital and caffeine and codeine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,1.0,,Narcotics (CDSA I)
872,Marketed,2020-10-21,00176192,Fiorinal-C 1/4,4,N02AA79,"Codein, combinations with psycholeptics",Capsule,Oral,00176192,FIORINAL-C 1/4 (acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 15 mg oral capsule) ARALEZ PHARMACEUTICALS CANADA INC,Active,9001651,acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 15 mg oral capsule,8000805,acetylsalicylic acid and butalbital and caffeine and codeine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,1.0,,Narcotics (CDSA I)
873,Marketed,2018-12-10,00176206,Fiorinal-C 1/2,4,N02AA79,"Codein, combinations with psycholeptics",Capsule,Oral,00176206,FIORINAL-C 1/2 (acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule) ARALEZ PHARMACEUTICALS CANADA INC,Active,9001652,acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule,8000805,acetylsalicylic acid and butalbital and caffeine and codeine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,1.0,,Narcotics (CDSA I)
16474,Marketed,2015-10-14,02009757,Codeine 30,1,R05DA04,Codeine,Tablet,Oral,02009757,CODEINE 30 (codeine phosphate 30 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000182,codeine phosphate 30 mg oral tablet,8000069,codeine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
19049,Marketed,1995-12-31,02163799,Codeine Contin 200 mg Controlled Release Tablets,1,R05DA04,Codeine,Tablet (extended-release),Oral,02163799,"CODEINE CONTIN 200MG CONTROLLED RELEASE TAB (codeine (codeine monohydrate, codeine sulfate trihydrate) 200 mg prolonged-release oral tablet) PURDUE PHARMA",Active,9000568,"codeine (codeine, codeine sulfate) 200 mg prolonged-release oral tablet",8000069,codeine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
19050,Marketed,1995-12-31,02163748,Codeine Contin 100 mg Controlled Release Tablets,1,R05DA04,Codeine,Tablet (extended-release),Oral,02163748,"CODEINE CONTIN 100MG CONTROLLED RELEASE TAB (codeine (codeine monohydrate, codeine sulfate trihydrate) 100 mg prolonged-release oral tablet) PURDUE PHARMA",Active,9000566,"codeine (codeine, codeine sulfate) 100 mg prolonged-release oral tablet",8000069,codeine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
19051,Marketed,1995-12-31,02163780,Codeine Contin 150 mg Controlled Release Tablets,1,R05DA04,Codeine,Tablet (extended-release),Oral,02163780,"CODEINE CONTIN 150MG CONTROLLED RELEASE TAB (codeine (codeine monohydrate, codeine sulfate trihydrate) 150 mg prolonged-release oral tablet) PURDUE PHARMA",Active,9000567,"codeine (codeine, codeine sulfate) 150 mg prolonged-release oral tablet",8000069,codeine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
2982,Marketed,1978-12-31,00380571,Linctus Codeine Blanc,1,R05DA04,Codeine,Solution,Oral,00380571,LINCTUS CODEINE BLANC (codeine phosphate 10 mg per 5 mL oral solution) LABORATOIRE ATLAS INC,Active,9006199,codeine phosphate 10 mg per 5 mL oral solution,8000069,codeine,26643006,Oral,385023001,Oral solution,,,,1.0,,Narcotics (CDSA I)
49057,Marketed,1997-03-13,02230302,Codeine Contin 50 mg Controlled Release Tablets,1,R05DA04,Codeine,Tablet (extended-release),Oral,02230302,"CODEINE CONTIN 50MG CONTROLLED RELEASE TAB (codeine (codeine monohydrate, codeine sulfate trihydrate) 50 mg prolonged-release oral tablet) PURDUE PHARMA",Active,9000709,"codeine (codeine, codeine sulfate) 50 mg prolonged-release oral tablet",8000069,codeine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
6415,Marketed,2017-11-17,00593435,Teva-Codeine,1,R05DA04,Codeine,Tablet,Oral,00593435,TEVA-CODEINE (codeine phosphate 15 mg oral tablet) TEVA CANADA LIMITED,Active,9000181,codeine phosphate 15 mg oral tablet,8000069,codeine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
6416,Marketed,2017-11-17,00593451,Teva-Codeine,1,R05DA04,Codeine,Tablet,Oral,00593451,TEVA-CODEINE (codeine phosphate 30 mg oral tablet) TEVA CANADA LIMITED,Active,9000182,codeine phosphate 30 mg oral tablet,8000069,codeine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
943,Marketed,1986-12-18,00050024,Codeine Phosphate Syrup,1,R05DA04,Codeine,Syrup,Oral,00050024,CODEINE PHOSPHATE SYRUP (codeine phosphate 25 mg per 5 mL syrup) LABORATOIRE ATLAS INC,Active,9006207,codeine phosphate 25 mg per 5 mL syrup,8000069,codeine,26643006,Oral,739009002,Syrup,,,,1.0,,Narcotics (CDSA I)
11384,Marketed,1991-12-31,00816027,PMS-Acetaminophen With Codeine Elixir,2,N02AJ06,Codeine and paracetamol,Elixir,Oral,00816027,PMS-ACETAMINOPHEN WITH CODEINE ELIXIR (acetaminophen 160 mg per 5 mL and codeine phosphate 8 mg per 5 mL oral solution) PHARMASCIENCE INC,Active,9000371,acetaminophen 160 mg per 5 mL and codeine phosphate 8 mg per 5 mL oral solution,8000065,acetaminophen and codeine,26643006,Oral,385023001,Oral solution,,,,,,Narcotics (CDSA I)
31568,Marketed,2014-01-17,02143933,Acetaminophen With Codeine - Caplet,3,N02AJ06,Codeine and paracetamol,Tablet,Oral,02143933,ACETAMINOPHEN WITH CODEINE - CAPLET (acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet) TEVA CANADA LIMITED,Active,9000243,acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet,8000023,acetaminophen and caffeine and codeine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
33917,Marketed,2019-11-25,02154234,"Acetaminophen, Caffeine And Codeine Phosphate Tablets",3,N02AJ06,Codeine and paracetamol,Tablet,Oral,02154234,"ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE TABLETS (acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet) LABORATOIRE RIVA INC.",Active,9000243,acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet,8000023,acetaminophen and caffeine and codeine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
5780,Marketed,2017-06-08,00608882,Teva-Emtec-30,2,N02AJ06,Codeine and paracetamol,Tablet,Oral,00608882,TEVA-EMTEC-30 (acetaminophen 300 mg and codeine phosphate 30 mg oral tablet) TEVA CANADA LIMITED,Active,9000194,acetaminophen 300 mg and codeine phosphate 30 mg oral tablet,8000065,acetaminophen and codeine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
6346,Marketed,2018-10-19,00653276,Teva-Lenoltec No. 3,3,N02AJ06,Codeine and paracetamol,Tablet,Oral,00653276,TEVA-LENOLTEC NO. 3 (acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 30 mg oral tablet) TEVA CANADA LIMITED,Active,9000032,acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 30 mg oral tablet,8000023,acetaminophen and caffeine and codeine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
6763,Marketed,2019-07-04,00653233,Teva-Lenoltec No. 1,3,N02AJ06,Codeine and paracetamol,Tablet,Oral,00653233,TEVA-LENOLTEC NO. 1 (acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet) TEVA CANADA LIMITED,Active,9000243,acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet,8000023,acetaminophen and caffeine and codeine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
6764,Marketed,2018-10-19,00653241,Teva-Lenoltec No. 2,3,N02AJ06,Codeine and paracetamol,Tablet,Oral,00653241,TEVA-LENOLTEC NO. 2 (acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 15 mg oral tablet) TEVA CANADA LIMITED,Active,9000031,acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 15 mg oral tablet,8000023,acetaminophen and caffeine and codeine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
6824,Marketed,2018-10-05,00621463,Teva-Lenoltec No. 4,2,N02AJ06,Codeine and paracetamol,Tablet,Oral,00621463,TEVA-LENOLTEC NO. 4 (acetaminophen 300 mg and codeine phosphate 60 mg oral tablet) TEVA CANADA LIMITED,Active,9000103,acetaminophen 300 mg and codeine phosphate 60 mg oral tablet,8000065,acetaminophen and codeine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
9626,Marketed,2015-10-14,00789828,Triatec-30,2,N02AJ06,Codeine and paracetamol,Tablet,Oral,00789828,TRIATEC-30 (acetaminophen 300 mg and codeine phosphate 30 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000194,acetaminophen 300 mg and codeine phosphate 30 mg oral tablet,8000065,acetaminophen and codeine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
12942,Marketed,2024-11-19,01934767,Robaxacet-8,3,N02AA59,"Codeine, combinations excl. psycholeptics",Tablet,Oral,01934767,ROBAXACET-8 (acetaminophen 325 mg and codeine phosphate 8 mg and methocarbamol 400 mg oral tablet) HALEON CANADA ULC,Active,9002403,acetaminophen 325 mg and codeine phosphate 8 mg and methocarbamol 400 mg oral tablet,8000859,acetaminophen and codeine and methocarbamol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
5069,Marketed,1982-12-31,00572349,Colchicine Tablets 0.6 mg,1,M04AC01,Colchicine,Tablet,Oral,00572349,COLCHICINE TAB 0.6MG (colchicine 0.6 mg oral tablet) ODAN LABORATORIES LTD,Active,9000074,colchicine 0.6 mg oral tablet,8000047,colchicine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
85904,Marketed,2011-10-07,02373823,JAMP-Colchicine,1,M04AC01,Colchicine,Tablet,Oral,02373823,JAMP-COLCHICINE (colchicine 0.6 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000074,colchicine 0.6 mg oral tablet,8000047,colchicine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
88705,Marketed,2013-02-27,02402181,PMS-Colchicine,1,M04AC01,Colchicine,Tablet,Oral,02402181,PMS-COLCHICINE (colchicine 0.6 mg oral tablet) PHARMASCIENCE INC,Active,9000074,colchicine 0.6 mg oral tablet,8000047,colchicine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
94355,Marketed,2019-10-10,02456559,Euro-Colchicine,1,M04AC01,Colchicine,Tablet,Oral,02456559,EURO-COLCHICINE (colchicine 0.6 mg oral tablet) EURO-PHARM INTERNATIONAL CANADA INC,Active,9000074,colchicine 0.6 mg oral tablet,8000047,colchicine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
103554,Marketed,2024-04-30,02546876,Vitamin D3,1,A11CC05,Colecalciferol,Tablet,Oral,02546876,VITAMIN D3 (cholecalciferol 10000 unit oral tablet) JAMP PHARMA CORPORATION,Active,9006461,cholecalciferol 10000 unit oral tablet,8000172,cholecalciferol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
12345,Marketed,2022-03-02,00821772,D-Tabs,1,A11CC05,Colecalciferol,Tablet,Oral,00821772,D-TABS (cholecalciferol 10000 unit oral tablet) LABORATOIRE RIVA INC.,Active,9006461,cholecalciferol 10000 unit oral tablet,8000172,cholecalciferol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73813,Marketed,2020-09-24,02253178,Sandoz D 10 000,1,A11CC05,Colecalciferol,Capsule,Oral,02253178,SANDOZ D 10 000 (cholecalciferol 10000 unit oral capsule) SANDOZ CANADA INCORPORATED,Active,9006479,cholecalciferol 10000 unit oral capsule,8000172,cholecalciferol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
85666,Marketed,2018-07-05,02371502,Euro-D 50000 IU,1,A11CC05,Colecalciferol,Capsule,Oral,02371502,EURO-D 50000 IU (cholecalciferol 50000 unit oral capsule) EURO-PHARM INTERNATIONAL CANADA INC,Active,9006491,cholecalciferol 50000 unit oral capsule,8000172,cholecalciferol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90259,Marketed,2014-01-16,02417995,Vitamine D 10 000,1,A11CC05,Colecalciferol,Tablet,Oral,02417995,VITAMINE D 10 000 (cholecalciferol 10000 unit oral tablet) PRO DOC LIMITEE,Active,9006461,cholecalciferol 10000 unit oral tablet,8000172,cholecalciferol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92661,Marketed,2017-10-16,02442256,Luxa-D,1,A11CC05,Colecalciferol,Capsule,Oral,02442256,LUXA-D (cholecalciferol 2000 unit oral capsule) ORIMED PHARMA INC,Active,9006496,cholecalciferol 2000 unit oral capsule,8000172,cholecalciferol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
92662,Marketed,2026-03-19,02442264,Luxa-D,1,A11CC05,Colecalciferol,Capsule,Oral,02442264,LUXA-D (cholecalciferol 5000 unit oral capsule) ORIMED PHARMA INC,Active,9006498,cholecalciferol 5000 unit oral capsule,8000172,cholecalciferol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
92663,Marketed,2026-05-25,02442272,Luxa-D,1,A11CC05,Colecalciferol,Capsule,Oral,02442272,LUXA-D (cholecalciferol 10000 unit oral capsule) ORIMED PHARMA INC,Active,9006479,cholecalciferol 10000 unit oral capsule,8000172,cholecalciferol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
92664,Marketed,2026-03-19,02442280,Luxa-D,1,A11CC05,Colecalciferol,Capsule,Oral,02442280,LUXA-D (cholecalciferol 25000 unit oral capsule) ORIMED PHARMA INC,Active,9006497,cholecalciferol 25000 unit oral capsule,8000172,cholecalciferol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
93491,Marketed,2015-11-20,02449099,JAMP-Vitamin D,1,A11CC05,Colecalciferol,Capsule,Oral,02449099,JAMP-VITAMIN D (cholecalciferol 10000 unit oral capsule) JAMP PHARMA CORPORATION,Active,9006479,cholecalciferol 10000 unit oral capsule,8000172,cholecalciferol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
93493,Marketed,2016-06-23,02449110,JAMP-Vitamin D,1,A11CC05,Colecalciferol,Capsule,Oral,02449110,JAMP-VITAMIN D (cholecalciferol 50000 unit oral capsule) JAMP PHARMA CORPORATION,Active,9006491,cholecalciferol 50000 unit oral capsule,8000172,cholecalciferol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95272,Marketed,2017-08-16,02464594,Euro D 10 000,1,A11CC05,Colecalciferol,Capsule,Oral,02464594,EURO D 10 000 (cholecalciferol 10000 unit oral capsule) EURO-PHARM INTERNATIONAL CANADA INC,Active,9006479,cholecalciferol 10000 unit oral capsule,8000172,cholecalciferol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98866,Marketed,2025-08-28,02498944,AG-Vitamine D Tablets,1,A11CC05,Colecalciferol,Tablet,Oral,02498944,AG-VITAMINE D TABLETS (cholecalciferol 10000 unit oral tablet) ANGITA PHARMA INC.,Active,9006461,cholecalciferol 10000 unit oral tablet,8000172,cholecalciferol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85917,Marketed,2020-12-09,02373955,Lodalis,1,C10AC04,Colesevelam,Tablet,Oral,02373955,"LODALIS (colesevelam hydrochloride 625 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9004983,colesevelam hydrochloride 625 mg oral tablet,8001251,colesevelam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91692,Marketed,2020-12-09,02432463,Lodalis,1,C10AC04,Colesevelam,Powder for suspension,Oral,02432463,"LODALIS (colesevelam hydrochloride 3.75 g per sachet powder for oral suspension) BAUSCH HEALTH, CANADA INC.",Active,9013782,colesevelam hydrochloride 3.75 g per sachet powder for oral suspension,8001251,colesevelam,26643006,Oral,385027000,Powder for oral suspension,733013000,Sachet (unit of presentation),,,,Prescription
98409,Marketed,2020-07-23,02494051,Apo-Colesevelam,1,C10AC04,Colesevelam,Tablet,Oral,02494051,APO-COLESEVELAM (colesevelam hydrochloride 625 mg oral tablet) APOTEX INC,Active,9004983,colesevelam hydrochloride 625 mg oral tablet,8001251,colesevelam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
18627,Marketed,2006-07-18,02132680,Colestid Tablets,1,C10AC02,Colestipol,Tablet,Oral,02132680,COLESTID TABLETS (colestipol hydrochloride 1 g oral tablet) PFIZER CANADA ULC,Active,9002769,colestipol hydrochloride 1 g oral tablet,8001252,colestipol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
14332,Marketed,2017-02-17,00890960,Olestyr,1,C10AC01,Colestyramine,Powder for suspension,Oral,00890960,OLESTYR LIGHT POWDER SUGAR FREE (cholestyramine 4 g per sachet powder for oral suspension) PHARMASCIENCE INC,Active,9013781,cholestyramine 4 g per sachet powder for oral suspension,8001311,cholestyramine,26643006,Oral,385027000,Powder for oral suspension,733013000,Sachet (unit of presentation),,,,Prescription
19757,Marketed,2017-10-18,02210320,Olestyr,1,C10AC01,Colestyramine,Powder for suspension,Oral,02210320,OLESTYR REGULAR POWDER (cholestyramine 4 g per sachet powder for oral suspension) PHARMASCIENCE INC,Active,9013781,cholestyramine 4 g per sachet powder for oral suspension,8001311,cholestyramine,26643006,Oral,385027000,Powder for oral suspension,733013000,Sachet (unit of presentation),,,,Prescription
94242,Marketed,2016-12-23,02455609,Cholestyramine-Odan,1,C10AC01,Colestyramine,Powder for suspension,Oral,02455609,CHOLESTYRAMINE-ODAN (cholestyramine 4 g per sachet powder for oral suspension) ODAN LABORATORIES LTD,Active,9013781,cholestyramine 4 g per sachet powder for oral suspension,8001311,cholestyramine,26643006,Oral,385027000,Powder for oral suspension,733013000,Sachet (unit of presentation),,,,Prescription
96937,Marketed,2020-02-10,02478595,JAMP-Cholestyramine,1,C10AC01,Colestyramine,Powder for suspension,Oral,02478595,JAMP-CHOLESTYRAMINE SUGAR FREE (cholestyramine 4 g per sachet powder for oral suspension) JAMP PHARMA CORPORATION,Active,9013781,cholestyramine 4 g per sachet powder for oral suspension,8001311,cholestyramine,26643006,Oral,385027000,Powder for oral suspension,733013000,Sachet (unit of presentation),,,,Prescription
103531,Marketed,2024-06-10,02546639,Colistimethate For Injection USP,1,J01XB01,Colistin,Powder for solution,"Intramuscular,Intravenous",,,,,,,,,,,,,,,,,Prescription
5524,Marketed,2024-07-25,00476420,Coly-Mycin M,1,J01XB01,Colistin,Powder for solution,"Intramuscular,Intravenous",00476420,COLY-MYCIN M (colistin (colistimethate sodium) 150 mg per vial powder for solution for injection) SEARCHLIGHT PHARMA INC,Active,9001712,colistin (colistimethate sodium) 150 mg per vial powder for solution for injection,8001181,colistin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
68839,Marketed,2002-04-15,02244849,Colistimethate For Injection U.S.P.,1,J01XB01,Colistin,Powder for solution,"Intramuscular,Intravenous",02244849,COLISTIMETHATE FOR INJECTION U.S.P. (colistin (colistimethate sodium) 150 mg per vial powder for solution for injection) STERIMAX INC,Active,9001712,colistin (colistimethate sodium) 150 mg per vial powder for solution for injection,8001181,colistin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
88833,Marketed,2024-12-17,02403544,"Colistimethate For Injection, USP",1,J01XB01,Colistin,Powder for solution,"Intravenous,Intramuscular",02403544,"COLISTIMETHATE FOR INJECTION, USP (colistin (colistimethate sodium) 150 mg per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9001712,colistin (colistimethate sodium) 150 mg per vial powder for solution for injection,8001181,colistin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
13890,Marketed,1993-12-31,02014440,"Oxygen USP, Helium USP, Medical Gas Mixture",2,V03AN20,Combination,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
13894,Marketed,1993-12-31,02014378,"Oxygen USP, Nitrogen Nf, Medical Gas Mixture",2,V03AN20,Combination,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
13910,Marketed,1993-12-31,02014432,"Carbon Dioxide USP, Oxygen USP Medical G.M.",2,V03AN20,Combination,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
19100,Marketed,2020-08-06,02182238,Co-Ne-O 2-N 2 Mixture,4,V03AN20,Combination,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
19101,Marketed,2020-08-06,02154773,Co-He-O 2-N 2 Mixture,4,V03AN20,Combination,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
19290,Marketed,2022-02-21,02154846,Helium / Oxygen Mixture,2,V03AN20,Combination,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
19293,Marketed,2020-08-07,02154749,Carbogen,2,V03AN20,Combination,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
90106,Marketed,2025-04-17,02416468,Heliox 70/30,2,V03AN20,Combination,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
100339,Marketed,2023-04-10,02514222,Vistaseal,2,B02BC30,Combinations,Solution,Topical,,,,,,,,,,,,,,,,,Schedule D
100342,Marketed,2022-02-16,02514257,Vistaseal,2,B02BC30,Combinations,Solution,Topical,,,,,,,,,,,,,,,,,Schedule D
100961,Marketed,2023-07-31,02520419,Nyquil Kids,3,R05DA20,Combinations,Syrup,Oral,02520419,NYQUIL KIDS (dextromethorphan hydrobromide 10 mg per 15 mL and doxylamine succinate 6.25 mg per 15 mL and phenylephrine hydrochloride 5 mg per 15 mL syrup) PROCTER & GAMBLE INC,Active,9014903,dextromethorphan hydrobromide 10 mg per 15 mL and doxylamine succinate 6.25 mg per 15 mL and phenylephrine hydrochloride 5 mg per 15 mL syrup,8002380,dextromethorphan and doxylamine and phenylephrine,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
101204,Marketed,2024-08-20,02522969,Jack & Jill Bedtime Honey Cough & Cold,2,R05DA20,Combinations,Syrup,Oral,02522969,JACK & JILL BEDTIME HONEY COUGH & COLD (dextromethorphan hydrobromide 7.5 mg per 5 mL and doxylamine succinate 3.125 mg per 5 mL syrup) HALEON CANADA ULC,Active,9014146,dextromethorphan hydrobromide 7.5 mg per 5 mL and doxylamine succinate 3.125 mg per 5 mL syrup,8001369,dextromethorphan and doxylamine,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
102260,Marketed,2024-08-13,02533626,Jack & Jill Multi-Symptom Cold & Cough,2,R05DA20,Combinations,Syrup,Oral,02533626,JACK & JILL MULTI-SYMPTOM COLD & COUGH (dextromethorphan hydrobromide 7.5 mg per 5 mL and pseudoephedrine hydrochloride 15 mg per 5 mL syrup) HALEON CANADA ULC,Active,9002454,dextromethorphan hydrobromide 7.5 mg per 5 mL and pseudoephedrine hydrochloride 15 mg per 5 mL syrup,8001373,dextromethorphan and pseudoephedrine,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
10939,Marketed,1990-12-31,00800007,Tis-U-Sol Solution,5,B05CB10,Combinations,Liquid,Irrigation,,,,,,,,,,,,,,,,,Ethical
12504,Marketed,2019-04-18,01944746,Benylin For Children Cough & Cold,2,R05DA20,Combinations,Syrup,Oral,01944746,BENYLIN FOR CHILDREN COUGH & COLD (dextromethorphan hydrobromide 7.5 mg per 5 mL and pseudoephedrine hydrochloride 15 mg per 5 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9002454,dextromethorphan hydrobromide 7.5 mg per 5 mL and pseudoephedrine hydrochloride 15 mg per 5 mL syrup,8001373,dextromethorphan and pseudoephedrine,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
14075,Marketed,2013-11-01,02014076,Clinimix E,19,B05BA10,Combinations,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
14076,Marketed,2013-11-01,02013967,Clinimix E,19,B05BA10,Combinations,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
14077,Marketed,2013-11-02,02013886,Clinimix,15,B05BA10,Combinations,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
14551,Marketed,2024-05-15,02044013,Robitussin Children's Cough And Cold,2,R05DA20,Combinations,Syrup,Oral,02044013,ROBITUSSIN CHILDREN'S COUGH AND COLD (dextromethorphan hydrobromide 7.5 mg per 5 mL and pseudoephedrine hydrochloride 15 mg per 5 mL syrup) HALEON CANADA ULC,Active,9002454,dextromethorphan hydrobromide 7.5 mg per 5 mL and pseudoephedrine hydrochloride 15 mg per 5 mL syrup,8001373,dextromethorphan and pseudoephedrine,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
18550,Marketed,2013-11-02,02013940,Clinimix,15,B05BA10,Combinations,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
19143,Marketed,2013-11-02,02046709,Clinimix,15,B05BA10,Combinations,Liquid,Intravenous,,,,,,,,,,,,,,,,,Ethical
19610,Marketed,2013-11-02,02013932,Clinimix,15,B05BA10,Combinations,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
20291,Marketed,2013-11-01,02142384,Clinimix E,20,B05BA10,Combinations,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
20329,Marketed,2018-03-05,02169126,Teva-Cotridin,3,R05DA20,Combinations,Syrup,Oral,02169126,TEVA-COTRIDIN (codeine phosphate 10 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL and triprolidine hydrochloride 2 mg per 5 mL syrup) TEVA CANADA LIMITED,Active,9001575,codeine phosphate 10 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL and triprolidine hydrochloride 2 mg per 5 mL syrup,8002113,codeine and pseudoephedrine and triprolidine,26643006,Oral,739009002,Syrup,,,,,,Narcotics (CDSA I)
2148,Marketed,2020-06-26,00299561,Creo-Rectal Adultes/Adults,3,R05CA10,Combinations,Suppository,Rectal,00299561,CREO-RECTAL ADULTES/ADULTS (camphor 5 mg and diphenylpyraline hydrochloride 1.5 mg and guaiacol carbonate 600 mg suppository) LABORATOIRES CONFAB INC,Active,9001505,camphor 5 mg and diphenylpyraline hydrochloride 1.5 mg and guaiacol carbonate 600 mg suppository,8002178,camphor and diphenylpyraline and guaiacol,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,,Non-Prescription Drugs
2150,Marketed,2020-06-26,00299596,Creo-Rectal Enfants/Children,3,R05CA10,Combinations,Suppository,Rectal,00299596,CREO-RECTAL ENFANTS/CHILDREN (camphor 2 mg and diphenylpyraline hydrochloride 0.5 mg and guaiacol carbonate 200 mg suppository) LABORATOIRES CONFAB INC,Active,9001504,camphor 2 mg and diphenylpyraline hydrochloride 0.5 mg and guaiacol carbonate 200 mg suppository,8002178,camphor and diphenylpyraline and guaiacol,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,,Non-Prescription Drugs
26564,Marketed,1996-09-19,02028867,Cetacaine Liquid,3,N01BB20,Combinations,Liquid,Topical,02028867,CETACAINE LIQUID (benzocaine 14 % and butamben 2 % and tetracaine hydrochloride 2 % oromucosal solution) CETYLITE INDUSTRIES INC.,Active,9013800,benzocaine 14 % and butamben 2 % and tetracaine hydrochloride 2 % oromucosal solution,8002012,benzocaine and butamben and tetracaine,372473007,Oromucosal,385070000,Oromucosal solution,,,,,,Ethical
2787,Marketed,2022-07-19,00319724,Demo-Cineol Enfants/Children,4,R05CA10,Combinations,Suppository,Rectal,00319724,DEMO-CINEOL ENFANTS/CHILDREN (camphor 20 mg and eucalyptol 185 mg and guaiacol 90 mg and guaiacol carbonate 100 mg suppository) LABORATOIRES CONFAB INC,Active,9001777,camphor 20 mg and eucalyptol 185 mg and guaiacol 90 mg and guaiacol carbonate 100 mg suppository,8002179,camphor and eucalyptol and guaiacol,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,,Non-Prescription Drugs
3823,Marketed,2019-09-10,00498807,Sorbitol Mannitol Irrigation,2,B05CX10,Combinations,Solution,Irrigation,00498807,SORBITOL MANNITOL IRRIGATION (mannitol 5.4 mg per mL and sorbitol 27 mg per mL irrigation solution 3000 mL bag) ICU MEDICAL CANADA INC,Active,9013705,mannitol 5.4 mg per mL and sorbitol 27 mg per mL irrigation solution 3000 mL bag,8002139,mannitol and sorbitol,372471009,Intravesical,785898006,Solution for irrigation,732982009,Bag (unit of presentation),,,,Ethical
49687,Marketed,2002-11-06,02230578,Twinrix,2,J07BC20,Combinations,Suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
50030,Marketed,1997-03-26,02230769,Dalmacol,5,R05DA20,Combinations,Syrup,Oral,02230769,DALMACOL (alcohol anhydrous 0.25 mL per 5 mL and doxylamine succinate 6 mg per 5 mL and etafedrine hydrochloride 16.65 mg per 5 mL and hydrocodone bitartrate 1.65 mg per 5 mL and sodium citrate 200 mg per 5 mL syrup) LABORATOIRE RIVA INC.,Active,9006201,alcohol anhydrous 0.25 mL per 5 mL and doxylamine succinate 6 mg per 5 mL and etafedrine hydrochloride 16.65 mg per 5 mL and hydrocodone bitartrate 1.65 mg per 5 mL and sodium citrate 200 mg per 5 mL syrup,8000779,alcohol anhydrous and doxylamine and etafedrine and hydrocodone and sodium citrate,26643006,Oral,739009002,Syrup,,,,1.0,,Narcotics (CDSA I)
60885,Marketed,2002-10-21,02237548,Twinrix Junior,2,J07BC20,Combinations,Suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
6645,Marketed,2022-07-19,00319716,Demo-Cineol Adultes/Adults,4,R05CA10,Combinations,Suppository,Rectal,00319716,DEMO-CINEOL ADULTES/ADULTS (camphor 40 mg and eucalyptol 370 mg and guaiacol 180 mg and guaiacol carbonate 200 mg suppository) LABORATOIRES CONFAB INC,Active,9002063,camphor 40 mg and eucalyptol 370 mg and guaiacol 180 mg and guaiacol carbonate 200 mg suppository,8002179,camphor and eucalyptol and guaiacol,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,,Non-Prescription Drugs
75882,Marketed,2024-12-05,02273330,Nyquil Kids Cough & Cold,2,R05DA20,Combinations,Syrup,Oral,02273330,NYQUIL KIDS COUGH & COLD (chlorpheniramine maleate 2 mg per 15 mL and dextromethorphan hydrobromide 15 mg per 15 mL oral solution) PROCTER & GAMBLE INC,Active,9013810,chlorpheniramine maleate 2 mg per 15 mL and dextromethorphan hydrobromide 15 mg per 15 mL oral solution,8001354,chlorpheniramine and dextromethorphan,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
79504,Marketed,2025-11-14,02309440,Coldaside Cough & Cold,2,R05DA20,Combinations,Tablet,Oral,02309440,COLDASIDE COUGH & COLD (chlorpheniramine maleate 4 mg and dextromethorphan hydrobromide 30 mg oral tablet) SIGMA LIFE SCIENCES INC.,Active,9003861,chlorpheniramine maleate 4 mg and dextromethorphan hydrobromide 30 mg oral tablet,8001354,chlorpheniramine and dextromethorphan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
81134,Marketed,2010-02-11,02325993,Oraqix,2,N01BB20,Combinations,Gel,Topical,02325993,ORAQIX (lidocaine 2.5 % and prilocaine 2.5 % cutaneous gel) DENTSPLY CANADA LIMITED,Active,9004644,lidocaine 2.5 % and prilocaine 2.5 % cutaneous gel,8001841,lidocaine and prilocaine,448598008,Cutaneous,385100002,Gel,,,,,,Non-Prescription Drugs
81147,Marketed,2016-02-15,02326132,Tisseel,4,B02BC30,Combinations,Kit,Topical,,,,,,,,,,,,,,,,,Schedule D
81147,Marketed,2016-02-15,02326132,Tisseel,4,B02BC30,Combinations,Kit,Topical,,,,,,,,,,,,,,,,,Prescription
81150,Marketed,2016-12-13,02326167,Artiss,4,B02BC30,Combinations,Solution,Topical,,,,,,,,,,,,,,,,,Schedule D
81150,Marketed,2016-12-13,02326167,Artiss,4,B02BC30,Combinations,Solution,Topical,,,,,,,,,,,,,,,,,Prescription
81151,Marketed,2016-04-22,02326175,Tisseel,4,B02BC30,Combinations,Solution,Topical,,,,,,,,,,,,,,,,,Prescription
81151,Marketed,2016-04-22,02326175,Tisseel,4,B02BC30,Combinations,Solution,Topical,,,,,,,,,,,,,,,,,Schedule D
83774,Marketed,2011-02-28,02352494,Periolimel 2.5% E,25,B05BA10,Combinations,Emulsion,Intravenous,,,,,,,,,,,,,,,,,Ethical
83779,Marketed,2011-01-19,02352532,Olimel 5.7% E,25,B05BA10,Combinations,Emulsion,Intravenous,,,,,,,,,,,,,,,,,Ethical
83780,Marketed,2019-09-19,02352540,Olimel 5.7%,20,B05BA10,Combinations,Emulsion,Intravenous,,,,,,,,,,,,,,,,,Ethical
8601,Marketed,2019-12-23,00758566,Lactated Ringer's Irrigation,4,B05CB10,Combinations,Solution,Irrigation,,,,,,,,,,,,,,,,,Ethical
87985,Marketed,2024-05-10,02394707,Robitussin Children's Cough & Cold Bedtime,3,R05DA20,Combinations,Syrup,Oral,02394707,ROBITUSSIN CHILDREN'S COUGH & COLD BEDTIME (brompheniramine maleate 2 mg per 5 mL and dextromethorphan hydrobromide 10 mg per 5 mL and phenylephrine hydrochloride 5 mg per 5 mL oral solution) HALEON CANADA ULC,Active,9004258,brompheniramine maleate 2 mg per 5 mL and dextromethorphan hydrobromide 10 mg per 5 mL and phenylephrine hydrochloride 5 mg per 5 mL oral solution,8001344,brompheniramine and dextromethorphan and phenylephrine,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
92505,Marketed,2015-09-15,02440687,Smofkabiven Electrolyte Free,21,B05BA10,Combinations,Emulsion,Intravenous,,,,,,,,,,,,,,,,,Ethical
92506,Marketed,2015-09-15,02440695,Smofkabiven,27,B05BA10,Combinations,Emulsion,Intravenous,,,,,,,,,,,,,,,,,Ethical
94308,Marketed,2017-02-14,02456206,Smofkabiven Peripheral,27,B05BA10,Combinations,Emulsion,Intravenous,,,,,,,,,,,,,,,,,Ethical
95965,Marketed,2021-10-21,02470640,Pergoveris,2,G03GA30,Combinations,Solution,Subcutaneous,02470640,"PERGOVERIS (follitropin alfa 300 unit per 0.48 mL and lutropin alfa 150 unit per 0.48 mL solution for injection pen) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9014622,follitropin alfa 300 unit per 0.48 mL and lutropin alfa 150 unit per 0.48 mL solution for injection pen,8001782,follitropin alfa and lutropin alfa,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,,Prescription
95965,Marketed,2021-10-21,02470640,Pergoveris,2,G03GA30,Combinations,Solution,Subcutaneous,02470640,"PERGOVERIS (follitropin alfa 300 unit per 0.48 mL and lutropin alfa 150 unit per 0.48 mL solution for injection pen) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9014622,follitropin alfa 300 unit per 0.48 mL and lutropin alfa 150 unit per 0.48 mL solution for injection pen,8001782,follitropin alfa and lutropin alfa,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,,Schedule D
95966,Marketed,2021-10-29,02470659,Pergoveris,2,G03GA30,Combinations,Solution,Subcutaneous,02470659,"PERGOVERIS (follitropin alfa 450 unit per 0.72 mL and lutropin alfa 225 unit per 0.72 mL solution for injection pen) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9014623,follitropin alfa 450 unit per 0.72 mL and lutropin alfa 225 unit per 0.72 mL solution for injection pen,8001782,follitropin alfa and lutropin alfa,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,,Prescription
95966,Marketed,2021-10-29,02470659,Pergoveris,2,G03GA30,Combinations,Solution,Subcutaneous,02470659,"PERGOVERIS (follitropin alfa 450 unit per 0.72 mL and lutropin alfa 225 unit per 0.72 mL solution for injection pen) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9014623,follitropin alfa 450 unit per 0.72 mL and lutropin alfa 225 unit per 0.72 mL solution for injection pen,8001782,follitropin alfa and lutropin alfa,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,,Schedule D
95967,Marketed,2021-10-29,02470667,Pergoveris,2,G03GA30,Combinations,Solution,Subcutaneous,02470667,"PERGOVERIS (follitropin alfa 900 unit per 1.44 mL and lutropin alfa 450 unit per 1.44 mL solution for injection pen) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9014624,follitropin alfa 900 unit per 1.44 mL and lutropin alfa 450 unit per 1.44 mL solution for injection pen,8001782,follitropin alfa and lutropin alfa,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,,Prescription
95967,Marketed,2021-10-29,02470667,Pergoveris,2,G03GA30,Combinations,Solution,Subcutaneous,02470667,"PERGOVERIS (follitropin alfa 900 unit per 1.44 mL and lutropin alfa 450 unit per 1.44 mL solution for injection pen) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9014624,follitropin alfa 900 unit per 1.44 mL and lutropin alfa 450 unit per 1.44 mL solution for injection pen,8001782,follitropin alfa and lutropin alfa,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,,Schedule D
96873,Marketed,2021-07-26,02477947,Olimel 7.6%,20,B05BA10,Combinations,Emulsion,Intravenous,,,,,,,,,,,,,,,,,Ethical
96874,Marketed,2018-10-25,02477955,Olimel 7.6% E,25,B05BA10,Combinations,Emulsion,Intravenous,,,,,,,,,,,,,,,,,Ethical
97569,Marketed,2024-05-16,02485443,Robitussin Honey Cough & Cold Nighttime,2,R05DA20,Combinations,Syrup,Oral,02485443,ROBITUSSIN HONEY COUGH & COLD NIGHTTIME (dextromethorphan hydrobromide 7.5 mg per 5 mL and doxylamine succinate 3.125 mg per 5 mL syrup) HALEON CANADA ULC,Active,9014146,dextromethorphan hydrobromide 7.5 mg per 5 mL and doxylamine succinate 3.125 mg per 5 mL syrup,8001369,dextromethorphan and doxylamine,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
9829,Marketed,1989-12-31,00799963,Cystosol W 3% Hexitols,2,B05CX10,Combinations,Liquid,Irrigation,00799963,CYSTOSOL W 3% HEXITOLS (mannitol 5 mg per mL and sorbitol 25 mg per mL irrigation solution 3000 mL bag) BAXTER CORPORATION,Active,9013922,mannitol 5 mg per mL and sorbitol 25 mg per mL irrigation solution 3000 mL bag,8002139,mannitol and sorbitol,372471009,Intravesical,785898006,Solution for irrigation,732982009,Bag (unit of presentation),,,,Ethical
9830,Marketed,1989-12-31,00799971,Lactated Ringer's Irrigation Sol,4,B05CB10,Combinations,Liquid,Irrigation,,,,,,,,,,,,,,,,,Ethical
98816,Marketed,2021-10-01,02498413,Clinimix E,20,B05BA10,Combinations,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
98819,Marketed,2020-12-01,02498421,Clinimix E,20,B05BA10,Combinations,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
98820,Marketed,2022-04-01,02498448,Clinimix,16,B05BA10,Combinations,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
98821,Marketed,2023-04-26,02498456,Clinimix,16,B05BA10,Combinations,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
98822,Marketed,2020-11-19,02498464,Clinimix,16,B05BA10,Combinations,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
99138,Marketed,2021-07-09,02501775,Smofkabiven Extra Nitrogen Electrolyte Free,21,B05BA10,Combinations,Emulsion,Intravenous,,,,,,,,,,,,,,,,,Ethical
99142,Marketed,2021-05-05,02501813,Smofkabiven Extra Nitrogen,27,B05BA10,Combinations,Emulsion,Intravenous,,,,,,,,,,,,,,,,,Ethical
99307,Marketed,2021-07-19,02503611,Nyquil Cough DM + Congestion,3,R05DA20,Combinations,Syrup,Oral,02503611,NYQUIL COUGH DM + CONGESTION (dextromethorphan hydrobromide 10 mg per 15 mL and doxylamine succinate 6.25 mg per 15 mL and phenylephrine hydrochloride 5 mg per 15 mL syrup) PROCTER & GAMBLE INC,Active,9014903,dextromethorphan hydrobromide 10 mg per 15 mL and doxylamine succinate 6.25 mg per 15 mL and phenylephrine hydrochloride 5 mg per 15 mL syrup,8002380,dextromethorphan and doxylamine and phenylephrine,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
20134,Marketed,1996-12-31,02181908,Polyderm Ointment USP,2,D06AX30,Combinations of antibiotics,Ointment,Topical,02181908,POLYDERM OINTMENT USP (bacitracin (bacitracin zinc) 500 unit per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment) TARO PHARMACEUTICALS INC,Active,9013862,bacitracin (bacitracin zinc) 500 unit per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment,8002239,bacitracin and polymyxin B,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Non-Prescription Drugs
48982,Marketed,2002-06-10,02230251,Antibiotic Ointment USP,2,D06AX30,Combinations of antibiotics,Ointment,Topical,02230251,ANTIBIOTIC OINTMENT USP (bacitracin (bacitracin zinc) 500 unit per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment) TARO PHARMACEUTICALS INC,Active,9013862,bacitracin (bacitracin zinc) 500 unit per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment,8002239,bacitracin and polymyxin B,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Non-Prescription Drugs
50105,Marketed,2025-08-26,02230844,Polysporin Antibiotic Cream,2,D06AX30,Combinations of antibiotics,Cream,Topical,02230844,POLYSPORIN ANTIBIOTIC CREAM (gramicidin 0.25 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous cream) KENVUE CANADA INC.,Active,9013885,gramicidin 0.25 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous cream,8002242,gramicidin and polymyxin B,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
60209,Marketed,2019-02-19,02236917,Ozonol Antibiotics Plus,3,D06AX30,Combinations of antibiotics,Ointment,Topical,02236917,OZONOL ANTIBIOTICS PLUS (bacitracin 500 unit per g and lidocaine hydrochloride 40 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment) EXZELL PHARMA INC,Active,9013865,bacitracin 500 unit per g and lidocaine hydrochloride 40 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment,8002238,bacitracin and lidocaine and polymyxin B,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Non-Prescription Drugs
60248,Marketed,2026-03-25,02236954,Band-Aid Brand Adhesive Bandages Plus Antibiotic,2,D06AX30,Combinations of antibiotics,"Pad,Ointment",Topical,02236954,BAND-AID BRAND ADHESIVE BANDAGES PLUS ANTIBIOTIC (bacitracin (bacitracin zinc) 500 unit per g and polymyxin B (polymyxin B sulfate) 10000 unit per g dressing) KENVUE CANADA INC.,Active,9013899,bacitracin (bacitracin zinc) 500 unit per g and polymyxin B (polymyxin B sulfate) 10000 unit per g dressing,8002239,bacitracin and polymyxin B,448598008,Cutaneous,353983009,Medicated dressing,732993006,Dressing (unit of presentation),,,,Non-Prescription Drugs
60545,Marketed,2025-08-26,02237226,Polysporin Triple Antibiotic Ointment,3,D06AX30,Combinations of antibiotics,Ointment,Topical,02237226,POLYSPORIN TRIPLE ANTIBIOTIC OINTMENT (bacitracin (bacitracin zinc) 500 unit per g and gramicidin 0.25 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment) KENVUE CANADA INC.,Active,9013860,bacitracin (bacitracin zinc) 500 unit per g and gramicidin 0.25 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment,8002237,bacitracin and gramicidin and polymyxin B,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Non-Prescription Drugs
60546,Marketed,2025-08-26,02237227,Polysporin Antibiotic Ointment,2,D06AX30,Combinations of antibiotics,Ointment,Topical,02237227,POLYSPORIN ANTIBIOTIC OINTMENT (bacitracin (bacitracin zinc) 500 unit per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment) KENVUE CANADA INC.,Active,9013862,bacitracin (bacitracin zinc) 500 unit per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment,8002239,bacitracin and polymyxin B,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Non-Prescription Drugs
62658,Marketed,2025-08-27,02239201,Polysporin Plus Pain Relief,3,D06AX30,Combinations of antibiotics,Cream,Topical,02239201,POLYSPORIN PLUS PAIN RELIEF (gramicidin 0.25 mg per g and lidocaine hydrochloride 50 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous cream) KENVUE CANADA INC.,Active,9013884,gramicidin 0.25 mg per g and lidocaine hydrochloride 50 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous cream,8002241,gramicidin and lidocaine and polymyxin B,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
64139,Marketed,2025-08-26,02240568,Polysporin Complete,4,D06AX30,Combinations of antibiotics,Ointment,Topical,02240568,POLYSPORIN COMPLETE (bacitracin (bacitracin zinc) 500 unit per g and gramicidin 0.25 mg per g and lidocaine 50 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment) KENVUE CANADA INC.,Active,9013859,bacitracin (bacitracin zinc) 500 unit per g and gramicidin 0.25 mg per g and lidocaine 50 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment,8002236,bacitracin and gramicidin and lidocaine and polymyxin B,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Non-Prescription Drugs
70888,Marketed,2003-01-20,02246693,Triple Antibiotic Ointment,3,D06AX30,Combinations of antibiotics,Ointment,Topical,02246693,TRIPLE ANTIBIOTIC OINTMENT (bacitracin (bacitracin zinc) 500 unit per g and gramicidin 0.25 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment) TARO PHARMACEUTICALS INC,Active,9013860,bacitracin (bacitracin zinc) 500 unit per g and gramicidin 0.25 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment,8002237,bacitracin and gramicidin and polymyxin B,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Non-Prescription Drugs
72525,Marketed,2025-08-26,02248189,Polysporin For Kids,3,D06AX30,Combinations of antibiotics,Cream,Topical,02248189,POLYSPORIN FOR KIDS (gramicidin 0.25 mg per g and lidocaine hydrochloride 50 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous cream) KENVUE CANADA INC.,Active,9013884,gramicidin 0.25 mg per g and lidocaine hydrochloride 50 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous cream,8002241,gramicidin and lidocaine and polymyxin B,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
78974,Marketed,2009-07-30,02304457,Antibiotic Plus Pain Relief Cream,3,D06AX30,Combinations of antibiotics,Cream,Topical,02304457,ANTIBIOTIC PLUS PAIN RELIEF CREAM (gramicidin 0.25 mg per g and lidocaine hydrochloride 50 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous cream) TARO PHARMACEUTICALS INC,Active,9013884,gramicidin 0.25 mg per g and lidocaine hydrochloride 50 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous cream,8002241,gramicidin and lidocaine and polymyxin B,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
78975,Marketed,2009-01-23,02304465,Complete Antibiotic Ointment,4,D06AX30,Combinations of antibiotics,Ointment,Topical,02304465,COMPLETE ANTIBIOTIC OINTMENT (bacitracin (bacitracin zinc) 500 unit per g and gramicidin 0.25 mg per g and lidocaine 50 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment) TARO PHARMACEUTICALS INC,Active,9013859,bacitracin (bacitracin zinc) 500 unit per g and gramicidin 0.25 mg per g and lidocaine 50 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment,8002236,bacitracin and gramicidin and lidocaine and polymyxin B,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Non-Prescription Drugs
80057,Marketed,2009-07-30,02315033,Antibiotic Cream For Kids,3,D06AX30,Combinations of antibiotics,Cream,Topical,02315033,ANTIBIOTIC CREAM FOR KIDS (gramicidin 0.25 mg per g and lidocaine hydrochloride 50 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous cream) TARO PHARMACEUTICALS INC,Active,9013884,gramicidin 0.25 mg per g and lidocaine hydrochloride 50 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous cream,8002241,gramicidin and lidocaine and polymyxin B,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
80317,Marketed,2010-10-26,02317656,Original Antibiotic Cream,2,D06AX30,Combinations of antibiotics,Cream,Topical,02317656,ORIGINAL ANTIBIOTIC CREAM (gramicidin 0.25 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous cream) TARO PHARMACEUTICALS INC,Active,9013885,gramicidin 0.25 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous cream,8002242,gramicidin and polymyxin B,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
8398,Marketed,1987-12-31,00621366,Bioderm Ointment,2,D06AX30,Combinations of antibiotics,Ointment,Topical,00621366,BIODERM OINTMENT (bacitracin 500 unit per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment) ODAN LABORATORIES LTD,Active,9013866,bacitracin 500 unit per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment,8002239,bacitracin and polymyxin B,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Non-Prescription Drugs
62695,Marketed,2012-08-02,02239234,Sandoz Polytrimethoprim,2,S01AA30,Combinations of different antibiotics,Solution,Ophthalmic,02239234,SANDOZ POLYTRIMETHOPRIM (polymyxin B (polymyxin B sulfate) 10000 unit per mL and trimethoprim (trimethoprim sulfate) 1 mg per mL ophthalmic drops) SANDOZ CANADA INCORPORATED,Active,9013894,polymyxin B (polymyxin B sulfate) 10000 unit per mL and trimethoprim (trimethoprim sulfate) 1 mg per mL ophthalmic drops,8002247,polymyxin B and trimethoprim,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
84489,Marketed,2021-06-03,02359928,Sterisporin,2,S01AA30,Combinations of different antibiotics,Ointment,Ophthalmic,02359928,STERISPORIN (bacitracin (bacitracin zinc) 500 unit per g and polymyxin B (polymyxin B sulfate) 10000 unit per g ophthalmic ointment) STERI-MED PHARMA INC.,Active,9013863,bacitracin (bacitracin zinc) 500 unit per g and polymyxin B (polymyxin B sulfate) 10000 unit per g ophthalmic ointment,8002239,bacitracin and polymyxin B,54485002,Ophthalmic,385123004,Ophthalmic ointment,,,,,,Non-Prescription Drugs
5535,Marketed,2017-08-16,00590215,TPN Electrolytes,5,B05XA30,Combinations of electrolytes,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
100000,Marketed,2021-03-31,02510804,COOLA Classic Face SPF 50 Sunscreen Lotion Fragrance-Free,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
100001,Marketed,2021-03-31,02510812,COOLA Classic Face SPF 50 Sunscreen Lotion White Tea Scent,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
100165,Marketed,2021-09-22,02512351,Olay Regenerist SPF 30 Hydrating Collagen Peptide 24,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
100167,Marketed,2021-09-22,02512386,Olay Regenerist SPF 30 Hydrating Retinol 24 + Peptides,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
100276,Marketed,2025-08-15,02513560,Total Effects 7 In One Moisturizer With SPF Broad Spectrum SPF 30,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
100283,Marketed,2021-03-24,02513641,Rodan+Fields Reverse Kit,4,D02BA30,Combinations of protectives against uv-radiation,"Lotion,Kit",Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
100284,Marketed,2021-03-24,02513668,Rodan + Fields Unblemish Kit,5,D02BA30,Combinations of protectives against uv-radiation,"Gel,Lotion,Kit",Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
100299,Marketed,2025-08-08,02513765,Total Effects 7 In One Moisturizer With SPF Broad Spectrum SPF 15,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
100303,Marketed,2021-03-24,02513838,Rodan+Fields Redefine,3,D02BA30,Combinations of protectives against uv-radiation,"Kit,Cream",Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
100325,Marketed,2022-07-28,02514079,Color Control Oil-Free Moisturizer Broad Spectrum SPF 30,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
100356,Marketed,2025-06-04,02514419,7 In One Tone Correcting CC  Cream With SPF,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
100520,Marketed,2022-04-13,02515806,Ultra-Light UV Lotion,6,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
100574,Marketed,2022-03-14,02516403,Photo Regul Cream / Crème Unifying Protective Face Care / Soin Protecteur Visage Unificateur SPF 25 / FPS 25,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
100649,Marketed,2022-02-10,02517159,Aquagel Defense 50,4,D02BA30,Combinations of protectives against uv-radiation,Gel,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
100653,Marketed,2021-12-11,02517191,Face Mist,4,D02BA30,Combinations of protectives against uv-radiation,Solution,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
100737,Marketed,2022-04-13,02518031,FPS 60 Lotion UV Ultra-Légère,7,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
100759,Marketed,2022-05-09,02518279,Super-C SPF 30,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
100770,Marketed,2025-05-16,02518384,Ultra Sheer Moisturizing Face Serum Sunscreen,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
100877,Marketed,2023-01-01,02519526,Hawaiian Sunscreen SPF 50+,4,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
100880,Marketed,2022-04-08,02519550,Urban Environment Oil-Free,4,D02BA30,Combinations of protectives against uv-radiation,Emulsion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
100922,Marketed,2022-12-12,02519992,Lift & Firm Y-Zone Crème Jour Haute Fermeté FPS 20,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101061,Marketed,2022-03-21,02521415,COOLA Daily Protection SPF 50 Refreshing Water Cream Sunscreen,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101062,Marketed,2024-07-19,02521423,COOLA Hydrating Sunscreen Lotion Pina Colada Scent,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101081,Marketed,2022-07-21,02521636,Urban Environment Fresh - Moisture,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101084,Marketed,2022-03-21,02521660,COOLA Classic Face SPF 30 Sunscreen Lotion Cucumber Scent,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101115,Marketed,2024-07-19,02521989,COOLA Clear Sunscreen Spray Guava Mango Scent,4,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101118,Marketed,2024-07-19,02522012,COOLA Hydrating Sunscreen Lotion Guava Mango Scent,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101152,Marketed,2022-03-21,02522381,COOLA Daily Protection SPF 30 Sun Silk Drops Sunscreen,3,D02BA30,Combinations of protectives against uv-radiation,Solution,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101180,Marketed,2024-02-13,02522691,Olay Hyaluronic Hydrating Facial Moisturizer With SPF,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101202,Marketed,2022-06-02,02522942,Aqua-Fluid,5,D02BA30,Combinations of protectives against uv-radiation,Emulsion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101226,Marketed,2023-01-15,02523183,Super Fluid UV Defense,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101233,Marketed,2023-02-09,02523213,Premium Sunscreen Lotion With Instant Bronzer Broad Spectrum SPF 15,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101235,Marketed,2022-04-25,02523248,COOLA Liplux Original,3,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101257,Marketed,2022-04-15,02523477,COOLA Dew Good Illuminating Serum Sunscreen,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101258,Marketed,2022-03-21,02523485,COOLA Classic Sunscreen Stick SPF 30 Tropical Coconut Scent,3,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101357,Marketed,2023-02-09,02524554,Glow 30,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101388,Marketed,2023-03-10,02524872,Clé De Peau Beauté Soin Protecteur Pour Les Lèvres Protective Lip Treatment 25,3,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101405,Marketed,2023-04-15,02525062,Face Daily UV Anti-Aging Moisturizer,7,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101410,Marketed,2023-04-15,02525089,Face Daily UV Anti-Dry Moisturizer,7,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101422,Marketed,2023-02-13,02525216,Crème UV Protectrice Protective UV Cream,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101442,Marketed,2023-01-16,02525402,Blue Lizard Australian Sunscreen 50 SPF Kids,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101444,Marketed,2023-01-16,02525429,Blue Lizard Australian Sunscreen 50 SPF Sport,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101464,Marketed,2025-03-03,02525631,Moisturizing Sunscreen Lotion For Face And Body,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101467,Marketed,2025-07-10,02525720,Kids Moisturizing Sunscreen Lotion For Face And Body,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101511,Marketed,2025-09-11,02525984,Aveeno Positively Radiant Daily Moisturizer SPF 15,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101512,Marketed,2025-09-10,02525992,Aveeno Positively Radiant Daily Moisturizer SPF 30,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101534,Marketed,2024-01-24,02526239,UV+Age Daily,7,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101569,Marketed,2023-01-10,02526611,Banana Boat Simply Protect Kids Kids Sunscreen Spray SPF 50+,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101571,Marketed,2023-01-10,02526646,Banana Boat Simply Protect Baby Baby Sunscreen Spray SPF 50+,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101589,Marketed,2024-01-30,02526859,Eucerin Complete Hydration Lotion,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101590,Marketed,2024-01-30,02526832,Eucerin Age Defense,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101591,Marketed,2024-04-01,02526840,Eucerin Anti-Shine,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101592,Marketed,2024-01-30,02526867,Eucerin Complete Hydration Spray,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101632,Marketed,2023-02-20,02527251,Coppertone Lotion Sunscreen SPF 50 Complete,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101633,Marketed,2023-02-20,02527278,Coppertone Lotion Sunscreen SPF 30 Complete,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101635,Marketed,2023-02-20,02527294,Coppertone Spray Sunscreen SPF 30 Complete,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101637,Marketed,2023-02-20,02527316,Coppertone Spray Sunscreen SPF 50 Complete,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101661,Marketed,2024-05-08,02527545,Ultra-Hydrating UV Lotion,7,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101663,Marketed,2023-01-10,02527561,Banana Boat Dry Balance Clear Sunscreen Spray SPF 50+,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101665,Marketed,2023-01-10,02527596,Banana Boat Simply Protect Sport Sport Sunscreen Spray SPF 50+,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101694,Marketed,2024-04-10,02527766,Anthelios Dermo-Kids 50+,7,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101699,Marketed,2023-05-01,02527812,Anthelios Age Correct,6,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101708,Marketed,2025-03-01,02527898,Facial Moisturizing Lotion SPF 30,5,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101729,Marketed,2023-04-06,02528029,Adaptasun Sea And Tropics Protective Body Lotion SPF 30,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101832,Marketed,2023-09-04,02529130,Fluid SPF 15,2,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101850,Marketed,2023-03-08,02529289,Urban Environment Vita-Clear,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101857,Marketed,2023-03-24,02529351,Your Skin But Better CC +,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101858,Marketed,2025-08-22,02529378,Invisible Daily Defense Sunscreen,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101859,Marketed,2025-09-17,02529386,Invisible Daily Defense Body Mist Sunscreen,4,D02BA30,Combinations of protectives against uv-radiation,Aerosol,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101901,Marketed,2024-10-10,02529777,Hydrating Lip Protectant Stick SPF 15,3,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101940,Marketed,2023-04-06,02530201,Isa Knox Anew Solaire 50 SPF / FPS Active Face & Body,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101941,Marketed,2024-06-13,02530228,Isa Knox Anew Solaire 50 SPF / FPS Everyday Face,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101976,Marketed,2023-05-01,02530597,Even Better Brightening Moisturizer,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102027,Marketed,2023-07-28,02531119,Vitamin Enriched Skin Tint SPF 15,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102074,Marketed,2023-05-15,02531623,Unseen Sunscreen Body,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102088,Marketed,2023-05-15,02531771,Lip Screen Shine,4,D02BA30,Combinations of protectives against uv-radiation,Ointment,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102152,Marketed,2023-05-01,02532492,Moisture Surge SPF 28 Sheer Hydrator,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102153,Marketed,2023-04-24,02532506,Skin Firming Retinol Moisturizer,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102227,Marketed,2023-08-16,02533278,Daytime Defender Sunscreen Broad Spectrum SPF 30,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102230,Marketed,2024-01-19,02533308,Futurist Skintint Serum,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102240,Marketed,2023-04-14,02533405,Premium Beauty Balm,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102241,Marketed,2023-11-01,02533413,Hawaiian Tropic Sunscreen Oil Spray,2,D02BA30,Combinations of protectives against uv-radiation,Oil,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102242,Marketed,2023-04-14,02533421,BB Premium Beauty Balm,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102407,Marketed,2024-05-26,02535203,Clear Sunscreen Face Stick,4,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102461,Marketed,2026-01-05,02535785,Degil Sun 30 SPF FPS,5,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102478,Marketed,2023-12-01,02535955,Sheer Touch Leaves Skin Radiant SPF 50,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102479,Marketed,2023-12-01,02535963,Sheer Touch Leaves Skin Radiant SPF 30,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102480,Marketed,2023-12-01,02535971,Sheer Touch Leaves Skin Radiant SPF 15,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102565,Marketed,2024-02-14,02536927,Daily Sheer Broad-Spectrum Sunscreen SPF 50 Water/Sweat Resistant (40 Minutes),4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102586,Marketed,2026-04-02,02537133,Glow Screen Sunrise,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102587,Marketed,2024-04-01,02537141,Every. Single. Face. Watery Lotion,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102605,Marketed,2023-10-11,02537338,Kids 50 Clear Sunscreen Lotion,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102625,Marketed,2023-12-01,02537540,Banana Boat Kids Sunscreen Lotion Roll-On,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102626,Marketed,2023-12-01,02537559,Banana Boat Kids Sunscreen Spray,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102660,Marketed,2024-05-15,02537826,COOLA Classic Face Mist Sunscreen,3,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102677,Marketed,2023-12-01,02538016,Banana Boat Daily Protect Face Sunscreen Lotion,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102697,Marketed,2024-06-19,02538229,Dynamic Skin Recovery,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102703,Marketed,2024-05-09,02538296,Glow Screen Dawn,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102704,Marketed,2024-04-04,02538318,Glow Screen Golden Hour,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102705,Marketed,2024-04-01,02538326,Glow Screen Sunset,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102720,Marketed,2024-05-01,02538482,Weightless Skin Foundation SPF 15,2,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102723,Marketed,2025-09-10,02538512,Kids Sunscreen Stick,4,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102724,Marketed,2025-08-19,02538520,Invisible Daily Defense Face Serum Sunscreen,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102727,Marketed,2024-01-01,02538547,Bioré UV Aqua Rich Weightless Moisturizer,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102729,Marketed,2024-01-08,02538571,Bioré UV Aqua Rich Weightless Moisturizer Hydratant Léger,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102730,Marketed,2024-07-01,02538598,Revitalizing Supreme+ Youth Power Creme,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102752,Marketed,2023-12-01,02538830,Silk Hydration Weightless Sunscreen Spray SPF 30,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102753,Marketed,2023-12-01,02538849,Silk Hydration Weightless Sunscreen Spray SPF 50+,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102760,Marketed,2025-06-04,02538938,Anthelios 50+,7,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102762,Marketed,2023-12-01,02538946,Silk Hydration Weightless Sunscreen Lotion SPF 50+,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102766,Marketed,2024-07-02,02538997,Youth-Extending Daily Hydrating Fluid,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102775,Marketed,2023-12-01,02539098,Silk Hydration Face SPF 30,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102777,Marketed,2024-04-19,02539128,Ultra Sun Protector Spray,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102783,Marketed,2024-06-12,02539187,Ultra Sun Protector Lotion,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102787,Marketed,2023-12-01,02539225,Silk Hydration Weightless Sunscreen Lotion SPF 30,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102797,Marketed,2023-12-01,02539349,Silk Hydration Serum SPF 30,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102798,Marketed,2023-12-01,02539330,Silk Hydration Face Serum SPF 50,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102815,Marketed,2024-07-01,02539381,Sun Soleil,4,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102816,Marketed,2025-01-01,02539403,Soothing Care SPF 15,2,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102832,Marketed,2024-04-01,02539578,Glow Stick,3,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102863,Marketed,2023-08-14,02539918,Broad Spectrum SPF 45,2,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102864,Marketed,2023-08-14,02539926,Universal Tinted Moisturizer SPF 46,2,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102880,Marketed,2024-02-01,02540088,Smart SPF 30 Wrinkle Correcting Cream,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102887,Marketed,2024-07-30,02540169,Revitalift Anti-Wrinkle + Firming,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102922,Marketed,2024-04-05,02540525,Supreme Hydrating Facial Screen,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102923,Marketed,2024-04-16,02540533,Extreme Hydrating Body + Hand Screen,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102930,Marketed,2023-10-10,02540614,Invisible Sunscreen,4,D02BA30,Combinations of protectives against uv-radiation,Gel,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102987,Marketed,2023-12-01,02541211,Banana Boat Kids Sunscreen Lotion,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102990,Marketed,2024-12-28,02541254,Bright Reveal SPF 50+,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103010,Marketed,2025-08-26,02541459,Complete + Facial Moisturizer With SPF Broad Spectrum SPF 40,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103067,Marketed,2025-02-10,02542072,Émulsion UV Protectrice Pour Le Corps Protective UV Emulsion For Body,4,D02BA30,Combinations of protectives against uv-radiation,Emulsion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103097,Marketed,2024-04-30,02542404,Watermelon Glow Dew Balm,3,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103105,Marketed,2024-03-11,02542498,Five Star Lip Protection,3,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103132,Marketed,2024-09-17,02542781,Unseen Sunscreen Lip Protector,4,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103145,Marketed,2024-03-25,02542927,CC + Natural Matte,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103151,Marketed,2026-01-10,02543001,Cabanaclear Water Gel Lotion,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103164,Marketed,2024-08-01,02543141,Nourishing Day Cream Crème De Jour Nourrissante SPF 15 FPS 15,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103169,Marketed,2024-04-01,02543206,Beyond Screen UV Serum,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103181,Marketed,2024-08-01,02543346,Every Sun Day Sun Fluid,5,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103183,Marketed,2024-04-10,02543362,Hello Sunshine,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103191,Marketed,2026-01-05,02543443,Degil Sun 50 SPF FPS,5,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103200,Marketed,2024-08-01,02543540,Refreshing Day Cream Crème De Jour Rafraîchissante SPF 15 FPS 15,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103226,Marketed,2024-06-01,02543834,Dailyscreen Hydrating Daily Cream,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103232,Marketed,2024-09-10,02543893,Timewise Repair Volu-Firm Day Cream Sunscreen Broad Spectrum SPF 30,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103242,Marketed,2024-06-04,02544008,Fave Fluid SPF 50+ Ultralight Screen,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103308,Marketed,2026-01-30,02544539,Hydrating Glow Mist,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103320,Marketed,2024-05-01,02544636,Daywear Multi-Protection 24 H-Moisture Creme,2,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103351,Marketed,2026-01-30,02544873,Glow + Go Lip Oil,4,D02BA30,Combinations of protectives against uv-radiation,Oil,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103352,Marketed,2024-05-01,02544881,Resilience Multi-Effect Tri-Peptide Face And Neck Creme,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103389,Marketed,2025-05-09,02545098,Hueguard Invisible Sunscreen Stick,4,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103410,Marketed,2024-07-25,02545322,Smart Tone Broad-Spectrum Sunscreen SPF 50,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103417,Marketed,2024-07-07,02545403,Laneige Hydro UV Defense Ex,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103419,Marketed,2024-06-04,02545438,Sheen Hydrating Lip Balm SPF 50,3,D02BA30,Combinations of protectives against uv-radiation,Ointment,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103431,Marketed,2024-08-12,02545551,Multi-Vita Clear Coat Broad Spectrum SPF 50,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103456,Marketed,2024-05-07,02545829,Rodan + Fields Plumping Lip Oil,2,D02BA30,Combinations of protectives against uv-radiation,Oil,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103519,Marketed,2025-02-26,02546507,Olay Glow + Protect SPF Stick,4,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103521,Marketed,2025-09-11,02546523,Ultra Gentle Daily Facial Moisturizer SPF 30,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103548,Marketed,2026-01-27,02546809,Collagen Peptide SPF Moisturizer,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103565,Marketed,2024-08-05,02546981,Queen Screen Luminising Skinscreen,5,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103566,Marketed,2024-11-07,02547007,Foundation Primer Sunscreen Broad Spectrum SPF 15,4,D02BA30,Combinations of protectives against uv-radiation,Gel,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103596,Marketed,2025-12-16,02547325,Future Solution LX Universal Defense,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103645,Marketed,2025-03-11,02547503,Protec(Tint),3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103649,Marketed,2025-06-03,02547554,COOLA Daily Protection Refreshing Water Plumping Gel Serum,4,D02BA30,Combinations of protectives against uv-radiation,Gel,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103672,Marketed,2025-10-30,02547791,Coppertone Sunscreen SPF 30 Spray Sport,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103713,Marketed,2025-01-01,02548240,Island Sport Face Sweat Resistant Sunscreen Spritz SPF 30,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103715,Marketed,2025-04-02,02548267,Unseen Sunscreen Stick,4,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103719,Marketed,2025-01-01,02548291,Island Sport Sweat Resistant Sunscreen Spritz SPF 30,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103720,Marketed,2024-08-27,02548313,Belif SPF/FPS 45,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103769,Marketed,2025-09-11,02548860,Sport Active Defense Sunscreen SPF 70,4,D02BA30,Combinations of protectives against uv-radiation,Aerosol,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103777,Marketed,2025-09-11,02548941,Kids Sunscreen Spray,4,D02BA30,Combinations of protectives against uv-radiation,Aerosol,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103804,Marketed,2025-11-03,02549174,COOLA Hydrating Sunscreen Lotion Tropical Coconut Scent,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103805,Marketed,2025-11-03,02549182,COOLA Hydrating Sunscreen Lotion Fragrance Free,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103832,Marketed,2025-05-15,02549484,C 5 Sheer Moisturizer,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103875,Marketed,2025-02-25,02549948,Sunscreen Broad Spectrum SPF 50,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103876,Marketed,2025-07-10,02549956,Hydrating Sunscreen Milk,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103899,Marketed,2025-10-21,02550156,Coppertone Sunscreen SPF 50 Spray Sport,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103902,Marketed,2025-10-31,02550180,Coppertone Sunscreen SPF 50 Spray Kids,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103927,Marketed,2025-08-01,02550466,Prisma Protect,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103940,Marketed,2025-01-08,02550601,Roc Deep Wrinkle Daily Moisturizer SPF 30,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103965,Marketed,2024-12-06,02550873,Banana Boat Ultra Sport Smartmist Sunscreen Spray,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103968,Marketed,2025-03-06,02550911,COOLA Dew Good Illuminating Body Melt Sunscreen Lotion,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
104011,Marketed,2025-04-03,02551381,Ultra Protection,4,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
104022,Marketed,2025-02-03,02551489,UV Brightening Daily Cream,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
104040,Marketed,2025-04-09,02551675,Clear Daily Soothing UV Defense,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
104043,Marketed,2026-02-01,02551713,Even Better Hydrating Vitamin Makeup,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
104064,Marketed,2025-04-28,02551942,Watermelon Glow Dewy Defense,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
104080,Marketed,2025-04-09,02552116,Suntouchable Whoa Glow SPF 30 Sunscreen,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
104097,Marketed,2025-09-11,02552299,Sport Face Active Defense,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
104102,Marketed,2025-06-09,02552345,Preen Screen Reapplication Mist Skinscreen,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
104106,Marketed,2025-01-31,02552396,Your Skin But Better CC + Nude Glow,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
104161,Marketed,2025-03-03,02552647,Lait Famille - Visage & Corps,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
104163,Marketed,2025-03-03,02552663,Lait Visage & Corps,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
104166,Marketed,2025-04-30,02552701,Super Brightening SPF 50 Active Moisturizer,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
104176,Marketed,2025-03-10,02552795,Coppertone Sunscreen Lotion Sport Face SPF 50,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
104177,Marketed,2025-04-30,02552809,Super Wrinkle-Fighting SPF 50 Active Moisturizer,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
104188,Marketed,2025-04-28,02552922,Spray Visage & Corps,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
104210,Marketed,2025-06-11,02553147,Light Day Sunscreen,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
104227,Marketed,2025-06-24,02553325,Every Sun Day Ultra-Sheer Priming Sunscreen Stick,4,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
104228,Marketed,2025-05-21,02553333,Broad Spectrum SPF 30 Holy Hydration! Face Cream,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
104243,Marketed,2025-04-30,02553503,Super Mattifying Oil & Pore Control SPF 50 Active Moisturizer,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
104263,Marketed,2025-07-01,02553732,Dramatically Different Moisturizing Lotion+ SPF 50,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
104292,Marketed,2026-01-28,02554038,Unseen Sunscreen SPF 50,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
104298,Marketed,2025-05-01,02554100,Water Drench Sheer Tint,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
104354,Marketed,2025-05-29,02554712,Super Crème With SPF Broad Spectrum SPF 30,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
104376,Marketed,2025-07-14,02554941,Ultra Sun Protector Cream,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
104394,Marketed,2025-07-03,02555158,Bioré UV Aqua Rich Glowy Moisturizer,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
104418,Marketed,2025-05-30,02555417,Avon Beyond Glow 30,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
104419,Marketed,2025-05-30,02555425,Avon Beyond Glow 50,5,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
104431,Marketed,2026-01-24,02555557,Hydro Boost Hyaluronic Acid Moisturizer SPF 50,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
104440,Marketed,2025-11-14,02555662,Australian Gold Ultimate Hydration 50,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
104500,Marketed,2025-05-15,02556308,Olay Total Effects Advanced,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
106007,Marketed,2026-02-04,02556677,Clear Body Sunscreen Spray,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
106008,Marketed,2025-08-25,02556685,Peppermint,2,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
106030,Marketed,2026-03-03,02556936,Brightening Daily UV Fluid,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
106031,Marketed,2026-03-03,02556944,Brightening Daily UV Fluid Glow,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
106069,Marketed,2026-02-05,02557355,Ultra Sheer Face Stick,4,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
106072,Marketed,2025-12-30,02557398,Face SPF 50+ Sunscreen Lotion,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
106074,Marketed,2025-09-17,02557428,Supra Screen,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
106079,Marketed,2026-01-12,02557479,Facial Moisturizing Lotion SPF 50,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
106088,Marketed,2025-12-30,02557576,SPF 50+ Sunscreen Lotion,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
106089,Marketed,2026-01-27,02557584,SPF 50+ Sunscreen Spray,4,D02BA30,Combinations of protectives against uv-radiation,Aerosol,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
106094,Marketed,2026-04-15,02557630,Photo Finish Invisible SPF 45,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
106096,Marketed,2026-01-27,02557657,Face SPF 50+ Sunscreen Mist,4,D02BA30,Combinations of protectives against uv-radiation,Aerosol,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
106112,Marketed,2026-02-01,02557827,UV Solutions Hydrating,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
106128,Marketed,2026-02-01,02557991,UV Solutions Mattifying,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
106135,Marketed,2026-01-27,02558068,Lip Balm With SPF 50+,3,D02BA30,Combinations of protectives against uv-radiation,Paste,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
106136,Marketed,2026-01-14,02558076,Ultra Sheer Dry-Touch Sunscreen SPF 100,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
106141,Marketed,2026-02-03,02558122,Ultra Sheer Invisible Gel Face Sunscreen,4,D02BA30,Combinations of protectives against uv-radiation,Gel,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
106149,Marketed,2026-04-01,02558203,Clinique For Men Daily Hydrator SPF 50,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
106150,Marketed,2026-02-20,02558211,Ultra Sun Protector Clear Stick,4,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
106164,Marketed,2026-02-01,02558394,Face Sunscreen Stick,4,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
106168,Marketed,2026-03-04,02558432,The Milky Sunscreen,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
106186,Marketed,2025-09-18,02558629,Youthscreen,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
106248,Marketed,2026-02-26,02559315,Multi-Intensive Day SPF 15,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
106288,Marketed,2025-12-01,02559757,Banana Boat Kids Smartmist Sunscreen Spray,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
106310,Marketed,2025-12-08,02560003,Multi-Defense Replenishing Lotion SPF 45,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
106314,Marketed,2025-12-09,02560054,Multi-Defense Replenishing Cream SPF 45,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
106324,Marketed,2026-04-08,02560151,Sulwhasoo Perfecting Cushion Broad Spectrum SPF 46,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
106397,Marketed,2026-04-01,02560968,Sequin Supreme Glow-Boosting Facial Screen,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
106419,Marketed,2026-01-05,02561204,Age Control Supreme Sublime Advanced Crème De Jour FPS 30 Day Cream SPF 30,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
106531,Marketed,2026-01-02,02562421,Ultra Hydrating Sunscreen,6,D02BA30,Combinations of protectives against uv-radiation,Gel,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
106579,Marketed,2026-05-11,02562960,Round Lab Birch Moisturizing Sunscreen,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
18554,Marketed,1995-12-31,02035472,Dormer 211 Face Cream SPF 15,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
42376,Marketed,2013-06-18,02093006,Marcelle/ Oil Free Multi-Défense Lotion SPF 15 FPS/ Fluide Multi-Défense Sans Huile,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
42377,Marketed,2013-06-06,02093014,Marcelle/Multi-Defense Cream/Crème Multi-Défense/SPF 15 FPS,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
42607,Marketed,2014-02-13,02157292,Blistex DCT,5,D02BA30,Combinations of protectives against uv-radiation,Ointment,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
64883,Marketed,2021-01-07,02241273,Reversa Crème Anti-Rides Contour Des Yeux FPS 15,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
65907,Marketed,2002-06-01,02242226,Dormer 211 SPF 30,5,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
67232,Marketed,2001-06-19,02243329,Cetaphil Daily Facial Moisturizer SPF 15,2,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
68850,Marketed,2002-09-01,02244858,Reversa UV Creme Visage Et Cou FPS 15,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
75697,Marketed,2013-06-22,02271508,Clinique For Men SPF 21 Moisturizer,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
76603,Marketed,2007-03-01,02280353,Ombrelle Cream SPF 60,5,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
79215,Marketed,2018-08-23,02306441,Flawless Effect Liquid Foundation Broad Spectrum SPF 15,2,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
79420,Marketed,2008-09-11,02308576,Deep Moisture Renewal With SPF 15,2,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
80045,Marketed,2022-05-04,02314924,Eltamd Skincare UV Sport SPF 50,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
80135,Marketed,2009-01-21,02315831,Cetaphil Daily Facial Moisturizer   (SPF 50),5,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
80199,Marketed,2009-03-25,02316498,Clinique SPF 50 Face Cream,5,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
80776,Marketed,2022-04-22,02322307,Eltamd Skincare UV Daily SPF 40,2,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
81175,Marketed,2012-09-24,02326426,Prevage Anti-Aging Moisture Lotion SPF 30,5,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
83908,Marketed,2011-01-19,02353873,Anew Platinum Day Cream,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
83966,Marketed,2018-04-23,02354497,Photoderm SPF/FPS 50+ Lait,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
83967,Marketed,2018-04-23,02354500,Photoderm SPF/FPS 40 Spray,3,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
84055,Marketed,2010-10-18,02355302,Prevage Anti-Aging Eye Cream SPF 15,2,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
85102,Marketed,2012-09-24,02366169,Prevage Anti-Aging Moisture Cream SPF 30,5,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
85281,Marketed,2012-03-01,02367998,Clinique Even Better Makeup SPF 15,3,D02BA30,Combinations of protectives against uv-radiation,Emulsion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
85335,Marketed,2026-03-12,02368382,Rapid Wrinkle Repair Moisturizer,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
85341,Marketed,2011-07-26,02368455,Foundation Primer Plus SPF 15,2,D02BA30,Combinations of protectives against uv-radiation,Gel,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
85343,Marketed,2011-06-30,02368463,Lip Conditioner SPF 15,2,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
85558,Marketed,2012-03-01,02370425,Clinique Redness Solutions Makeup SPF 15 With Probiotic Technology,3,D02BA30,Combinations of protectives against uv-radiation,Emulsion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
85697,Marketed,2012-01-16,02371847,Ceramide Premiere Intense Moisture And Renewal Activation Cream SPF 30,5,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
85940,Marketed,2012-02-15,02374196,SPF 45 Sport Clear Continuous Spray,5,D02BA30,Combinations of protectives against uv-radiation,Aerosol,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
85941,Marketed,2023-10-18,02374218,Sport Clear Spray Sunscreen,5,D02BA30,Combinations of protectives against uv-radiation,Aerosol,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
85986,Marketed,2019-07-22,02374536,Cetaphil Pro Dermacontrol Oil Control Moisturizer,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
86119,Marketed,2017-05-01,02375788,SPF 30 Spray-On Alcohol-Free Sunscreen,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
86192,Marketed,2026-02-03,02376466,Regenerist Enhancing Uva/Uvb Lotion With SPF 15,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
86761,Marketed,2021-05-08,02381753,Moisture Therapy Lip Balm SPF 25,2,D02BA30,Combinations of protectives against uv-radiation,Ointment,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
86786,Marketed,2021-05-08,02381990,Double-Duty Face Moisturizer SPF 20,2,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
86907,Marketed,2012-09-01,02383314,Phelityl Day Lotion SPF 15,2,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
87051,Marketed,2012-10-01,02384825,Clinique Repairwear Uplifting Firming Cream SPF 15 Very Dry To Dry,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
87052,Marketed,2012-10-01,02384833,Clinique Repairwear Uplifting Firming Cream SPF 15 Dry Combination To Combination Oily,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
87316,Marketed,2015-01-12,02387557,Triple Age Repair Moisturizer,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
87370,Marketed,2016-01-25,02388154,Sunscreen Oil Spray,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
87518,Marketed,2012-09-01,02389681,Firmarine Day Cream SPF 30 Crème De Jour SPF 30,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
87816,Marketed,2013-02-11,02392895,Elizabeth Arden Nourishing Lip Balm SPF 20,2,D02BA30,Combinations of protectives against uv-radiation,Ointment,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
88402,Marketed,2013-04-29,02399113,Anti-Aging Complex Emulsion Broad Spectrum SPF 30,5,D02BA30,Combinations of protectives against uv-radiation,Emulsion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
88679,Marketed,2022-04-13,02401916,Bare Skin Feel UV Lotion,6,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
88698,Marketed,2013-05-20,02402114,Clinique Moisture Surge CC  Cream Hydrating Colour Corrector SPF 30,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
88702,Marketed,2014-12-18,02402157,SPF 60 Anthelios XL Lotion,6,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
88834,Marketed,2013-06-05,02403552,Preventage Firming Defense Crème Normal/Dry Broad Spectrum SPF 15,2,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
88835,Marketed,2013-06-17,02403560,Preventage Firming Defense Crème Normal/Oily Broad Spectrum SPF 15,2,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
88967,Marketed,2013-08-28,02404842,Anti-Aging Complex Eye Treatment Broad Spectrum SPF 15,2,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
89158,Marketed,2013-07-18,02406926,Marcelle/CC /Cream/Crème Complete Correction/Correction Complète/SPF 35 FPS,2,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
89171,Marketed,2016-04-19,02407051,Rodan+Fields Essentials Lip Shield,4,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
89192,Marketed,2014-04-24,02407205,Essential-C Day Moisture Broad Spectrum SPF 30 Pa+++,5,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
89463,Marketed,2014-09-01,02409976,LA Mer The SPF 50 UV Protecting Fluid,5,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
89471,Marketed,2014-01-06,02410044,FPS 30 Soin Complet,6,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
89473,Marketed,2014-01-06,02410060,FPS 60 Soin Complet,6,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
89557,Marketed,2018-03-23,02410923,Cerave,5,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
89908,Marketed,2014-02-16,02414430,Mary Kay CC  Cream,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
89965,Marketed,2015-01-12,02415038,M.A.C Prep + Prime Face Protect Lotion SPF 50,5,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
89994,Marketed,2019-12-03,02415321,SPF 30 FPS Sunscreen Lotion Lotion Écran Solaire,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
90154,Marketed,2014-03-25,02416921,Sunscreen Stick SPF 50+,5,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
90618,Marketed,2017-05-01,02421542,Broad Spectrum SPF FPS 50,5,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
90920,Marketed,2025-08-15,02424517,Total Effects 7 In One Featherweight Moisturizer With SPF,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
90992,Marketed,2015-02-01,02425289,Haute Exigence Jour SPF 20 Multi-Intensive,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
91075,Marketed,2014-09-02,02426145,CC  Cream Broad Spectrum SPF 30,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
91470,Marketed,2016-01-04,02430215,Banana Boat Kids Sunscreen Lotion SPF/FPS 60,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
91549,Marketed,2015-12-14,02431041,Dry Oil Sunscreen,4,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
91576,Marketed,2022-04-22,02431343,UV Daily Tinted,2,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
91585,Marketed,2024-05-02,02431432,Anew Ultimate Multi-Performance Day Cream Crème De Jour Broad Spectrum SPF 25 À Large Spectre FPS 25,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
91586,Marketed,2022-08-02,02431440,Q10 Power TM/MC Anti-Wrinkle Firming Day Cream,5,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
91835,Marketed,2017-06-02,02434016,Teint Lumière,2,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
91939,Marketed,2015-05-11,02435101,Reversa Creme FPS 30,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
91979,Marketed,2015-03-27,02435489,SPF FPS 40 Lotion,5,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
92015,Marketed,2015-07-18,02435802,Reversa Crème Radiance FPS 30,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
92153,Marketed,2015-04-07,02437236,High Protection Lotion SPF 50+,5,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
92160,Marketed,2015-04-07,02437309,High Protection Spray SPF 50+,5,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
92171,Marketed,2015-09-15,02437376,M.A.C. Studio Waterweight SPF 30 Foundation,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
92215,Marketed,2022-07-14,02437775,Vivier Sheer SPF 45,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
92260,Marketed,2015-06-15,02438232,Renergie Lift Multi-Action SPF 15 Firming Moisturizing Cream All Skin Types,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
92515,Marketed,2019-06-17,02440792,Dentec Lotion,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
92523,Marketed,2016-01-18,02440873,Absolutely Ageless Daily Moisturizer,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
92717,Marketed,2025-08-22,02442779,Uva/Uvb Moisturizing Cream,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
92910,Marketed,2025-06-13,02444208,Age Defying Anti-Wrinkle Lotion With SPF,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
92912,Marketed,2016-05-01,02444216,Origins Plantscription SPF 25 Power Anti-Aging Cream,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
93187,Marketed,2016-02-15,02446529,UV 50 Ecran Multi-Protection SPF 50,4,D02BA30,Combinations of protectives against uv-radiation,Emulsion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
93191,Marketed,2016-03-01,02446545,Emulsion SPF 50+,5,D02BA30,Combinations of protectives against uv-radiation,Emulsion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
93192,Marketed,2020-06-19,02446553,Kids Spray,5,D02BA30,Combinations of protectives against uv-radiation,Emulsion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
93254,Marketed,2024-06-03,02446979,Multi-Action Cream SPF 30,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
93309,Marketed,2016-03-17,02447509,Life Brand Sport Sunscreen Broad Spectrum Spray,4,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
93310,Marketed,2016-04-20,02447517,Sunscreen Face Lotion,5,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
93311,Marketed,2016-03-08,02447525,Sunscreen Continuous Spray No Pumping Needed,4,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
93312,Marketed,2016-03-16,02447533,Kids Sunscreen Continuous Spray,5,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
93321,Marketed,2016-02-11,02447630,Sport Sunscreen,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
93322,Marketed,2016-03-07,02447649,Sunscreen Continuous Spray,4,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
93336,Marketed,2016-02-22,02447770,SPF 30 Sport Endurance,6,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
93346,Marketed,2016-10-19,02447843,SPF 60 Sport Endurance,6,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
93368,Marketed,2026-03-19,02447983,Glow Gloss,4,D02BA30,Combinations of protectives against uv-radiation,Ointment,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
93442,Marketed,2021-04-23,02448718,Ultra Light Advanced Continuous Spray Lotion,5,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
93545,Marketed,2016-07-14,02449617,SPF 50+ FPS Ultra Lotion,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
93546,Marketed,2017-01-17,02449625,SPF 50+ FPS Ultra,5,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
93921,Marketed,2021-01-20,02452804,Coppertone Lotion Sunscreen SPF 30 Sport,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
94010,Marketed,2020-07-14,02453541,No 7 Protect & Perfect Intense Advanced Day Cream,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
94131,Marketed,2019-12-11,02454602,Hawaiian Tropic Island Sport Sweat Resistant Sunscreen Spray SPF 30,3,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
94316,Marketed,2017-02-15,02456273,UV 50 Ecran Teinté Multi-Protection SPF 50,4,D02BA30,Combinations of protectives against uv-radiation,Emulsion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
94463,Marketed,2017-06-15,02457571,Origins Ginzing SPF 40 Energy-Boosting Tinted Moisturizer,5,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
94656,Marketed,2022-04-29,02459353,Ultra-Light Refreshing UV Lotion,6,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
94759,Marketed,2020-04-27,02460300,No 7 Lift & Luminate Triple Action Day Cream,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
94764,Marketed,2017-03-28,02460327,Timeless Illuminating Makeup Broad Spectrum SPF 30,2,D02BA30,Combinations of protectives against uv-radiation,Emulsion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
94837,Marketed,2025-06-17,02460882,Age Defying Classic Lotion With SPF,2,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
94854,Marketed,2020-11-13,02461048,Complete* Dry Touch Sunscreen/Écran Solaire,5,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
94857,Marketed,2022-03-04,02461072,Complete* Dry Touch,5,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
94867,Marketed,2025-08-26,02461188,Complete Lightweight Lotion With SPF Broad Spectrum SPF 30,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
94870,Marketed,2025-06-04,02461196,Complete Hydrating Cream With SPF,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
94873,Marketed,2025-06-13,02461242,Complete Lightweight Lotion With SPF Broad Spectrum SPF 15 Sensitive,2,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
94874,Marketed,2025-08-21,02461234,Complete Lightweight Lotion With SPF Broad Spectrum SPF 15,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
94877,Marketed,2025-08-01,02461269,Complete Lightweight Lotion With SPF Broad Spectrum 15 For Combination/Oily Skin,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
94970,Marketed,2017-09-08,02461943,Future Solution LX Total Protective Cream E,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
94981,Marketed,2017-06-05,02462079,Marcelle Revival+ Skin Renewal Anti-Aging Day Cream SPF 15,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
94986,Marketed,2018-06-01,02462125,SPF 50 Broad Spectrum Kids,5,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
94990,Marketed,2018-06-01,02462176,SPF/FPS 50 Broad Spectrum Alcohol Free Sunscreen,5,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
94991,Marketed,2018-06-01,02462184,SPF/FPS 30 Broad Spectrum Alcohol Free Sunscreen,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
95201,Marketed,2018-01-01,02463911,Olay Luminous Whip,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
95202,Marketed,2026-01-30,02463938,Whip Regenerist,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
95203,Marketed,2018-01-01,02463946,Olay Total Effects Whip,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
95248,Marketed,2019-09-01,02464322,SPF 50+ Kids (80 Minutes) Water Resistant,5,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
95288,Marketed,2019-02-07,02464748,Marcelle Sheer Tint Moisturizer Hydratant Teinté Translucide SPF 30 FPS,2,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
95318,Marketed,2017-12-10,02464977,Banana Boat Kids Tear-Free Sunscreen Spray SPF 50+,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
95414,Marketed,2019-09-01,02465884,Complete Sensitive Advanced [80 Minutes] Water/Sweat Resistant Lotion SPF 60,5,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
95472,Marketed,2018-05-11,02466376,Anti-Shine Anthelios XL Dry Touch Gel-Cream,5,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
95476,Marketed,2022-05-11,02466406,Anti-Shine Dry Touch UV Lotion,5,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
95486,Marketed,2018-03-19,02466511,Bobbi Brown Primer Plus Protection SPF 50,5,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
95491,Marketed,2021-02-22,02466570,Nourishing Day Cream,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
95492,Marketed,2021-02-22,02466589,Refreshing Day Cream,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
95508,Marketed,2018-10-01,02466724,Revitalift Anti-Wrinkle + Firming Day Cream,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
95550,Marketed,2023-02-14,02467100,Coppertone Sunscreen Stick SPF 50 Water Babies,3,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
95734,Marketed,2018-04-09,02468808,Hydratant Défense FPS 30,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
95951,Marketed,2018-09-24,02470527,Matrix Support With Sunscreen Broad Spectrum SPF 30,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
96009,Marketed,2019-02-01,02470993,SPF 60 Kids Wet'N Protect,6,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
96099,Marketed,2018-03-07,02471795,Tanning Oil Huile Bronzante 15,4,D02BA30,Combinations of protectives against uv-radiation,Oil,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
96113,Marketed,2021-09-08,02471906,Regular Lip Balm,2,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
96176,Marketed,2021-09-28,02472449,Berry Lip Balm,2,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
96178,Marketed,2021-09-28,02472465,Mint Lip Balm,2,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
96253,Marketed,2018-04-21,02473178,Reversa Urban Protection Hydrating Care SPF 30 Soin Hydratant Protection Urbaine FPS 30,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
96549,Marketed,2020-04-24,02475189,Complete Moisture,2,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
96579,Marketed,2019-10-03,02475405,Banana Boat Ultra Sport Sunscreen Lotion SPF 50+,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
96580,Marketed,2021-01-30,02475413,Coppertone Lotion Sunscreen SPF 50 Sport,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
96704,Marketed,2019-05-29,02476118,Face & Neck Multi Action Visage Et Cou Multi Action Day Cream / Crème De Jour SPF 30 / FPS 30,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
96825,Marketed,2019-04-30,02477297,Lait Solaire Corps Lotion Protectrice Corps FPS 30,6,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
96827,Marketed,2019-04-30,02477319,Soin Solaire Visage Crème Protectrice Visage FPS 50 Plus,5,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
96858,Marketed,2019-10-03,02477521,Banana Boat Ultra Sport Sunscreen Lotion SPF 30,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
96859,Marketed,2019-10-11,02477548,Banana Boat Ultra Sport Clear Sunscreen Spray SPF 30,3,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
96860,Marketed,2019-10-15,02477556,Banana Boat Ultra Sport Clear Sunscreen Spray SPF 50 Plus,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
96901,Marketed,2021-01-30,02478250,Coppertone Spray Sunscreen SPF 30 Sport,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
96902,Marketed,2020-04-09,02478269,Coppertone Lotion Sunscreen SPF 50 Kids,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
96904,Marketed,2021-04-02,02478285,Coppertone Spray Sunscreen SPF 30 Sun Guard,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
96970,Marketed,2020-04-02,02478986,Premium Sunscreen Face Lotion Sun Bum Face 50,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
96971,Marketed,2019-04-08,02478994,Premium Sunscreen Lotion Sun Bum 30,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
96972,Marketed,2019-04-08,02479001,Premium Sunscreen Lotion Sun Bum 50,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
96973,Marketed,2019-01-04,02479028,Benefiance Wrinkle Smoothing Day Cream,5,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
97178,Marketed,2018-12-17,02481294,Extra-Firming Jour FPS/SPF 15,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
97242,Marketed,2024-09-23,02481944,Ultra-Light Moisturizing Lotion,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
97249,Marketed,2019-12-23,02482010,Sheer Hydration Sunscreen Broad Spectrum SPF 40,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
97264,Marketed,2026-02-02,02482177,Regenerist Micro-Sculpting Lotion With SPF,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
97289,Marketed,2020-07-09,02482444,Makeup Setting Spray Pulvérisation Pour Fixer Le Maquillage,3,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
97377,Marketed,2019-04-08,02483335,Premium Sunscreen Spray Sun Bum 30,4,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
97407,Marketed,2019-04-08,02483726,Premium Sunscreen Spray Sun Bum 50,4,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
97412,Marketed,2019-03-19,02483777,Facial Fuel,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
97422,Marketed,2019-07-28,02483866,Oil And Pore Control Mattifier Broad Spectrum SPF 45,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
97460,Marketed,2025-07-31,02484285,Hydro Boost Gel Cream SPF 25,4,D02BA30,Combinations of protectives against uv-radiation,Gel,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
97662,Marketed,2025-08-14,02486407,Ultra Sheer Dry-Touch Sunscreen SPF 30,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
97667,Marketed,2025-10-22,02486474,Ultra Sheer Body Mist Sunscreen SPF 30,4,D02BA30,Combinations of protectives against uv-radiation,Aerosol,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
97785,Marketed,2021-01-30,02487705,Coppertone Spray Sunscreen SPF 50 Kids,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
97790,Marketed,2025-10-14,02487764,Face Sunscreen SPF 45,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
97794,Marketed,2025-08-14,02487780,Dry-Touch Sunscreen SPF 45,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
97795,Marketed,2021-01-30,02487799,Coppertone Lotion Sunscreen SPF 50 Waterbabies,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
97800,Marketed,2025-09-12,02487845,Clear Face Sunscreen Lotion,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
97804,Marketed,2019-11-01,02487926,Ultra-Rich Hydration,2,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
97805,Marketed,2020-04-09,02487934,Coppertone Spray Sunscreen SPF 50 Sport,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
97806,Marketed,2025-10-22,02487942,Ultra Sheer Body Mist Sunscreen SPF 45,4,D02BA30,Combinations of protectives against uv-radiation,Aerosol,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
97823,Marketed,2020-04-09,02488124,Coppertone Lotion Sunscreen SPF 30 Glow,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
97839,Marketed,2019-08-07,02488299,Iope Air Cushion,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
97856,Marketed,2020-10-07,02488477,Sensitive Skin Sunscreen Continuous Spray SPF 50 Plus,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
97857,Marketed,2019-11-11,02488485,Sport Sunscreen Lotion SPF 30,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
97876,Marketed,2020-02-27,02488663,Kids Sunscreen Continuous Spray SPF 50+,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
97890,Marketed,2019-11-11,02488825,Kids Sunscreen Stick SPF 50+,3,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
97917,Marketed,2020-05-29,02489112,Sun Ultimate Face Cream / Crème Visage,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
97925,Marketed,2020-02-01,02489155,Ombrelle Kids Lotion Wet'N Protect,6,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
97966,Marketed,2020-02-19,02489589,Face Anti-Shine Cream,5,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98009,Marketed,2020-04-15,02490021,Ultra Fluide Visage,7,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98040,Marketed,2021-02-03,02490358,Coppertone Clear Blue Sunscreen,4,D02BA30,Combinations of protectives against uv-radiation,Gel,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98043,Marketed,2020-06-04,02490382,Kids Sunscreen Lotion SPF 50+,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98045,Marketed,2021-04-14,02490404,Ultra Fluide Corps,7,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98050,Marketed,2020-11-09,02490455,Matte Defense SPF 30,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98055,Marketed,2020-03-15,02490501,Age Perfect Rosy Tone Day Cream,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98090,Marketed,2019-11-04,02490862,Sport Sunscreen Continuous Spray SPF 30,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98103,Marketed,2020-04-02,02491001,Rodan + Fields Essentials Face + Body Sunscreen,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98104,Marketed,2020-01-14,02491028,Sensitive Skin Sunscreen Lotion SPF 50+,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98105,Marketed,2020-02-19,02491036,Sport Sunscreen Lotion SPF 50+,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98108,Marketed,2020-03-21,02491052,Sport Sunscreen Continuous Spray SPF 50+,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98116,Marketed,2020-02-15,02491141,Revitalift Triple Power LZR Day Lotion,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98139,Marketed,2024-07-08,02491389,Sport 30 Pump Spray Gel Sunscreen Écran Solaire Gel En Vaporisateur,4,D02BA30,Combinations of protectives against uv-radiation,Gel,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98155,Marketed,2019-11-01,02491567,Sport 50 Continuous Spray Sunscreen Ecran Solaire En Vaporisateur,4,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98178,Marketed,2020-03-10,02491761,Rodan + Fields Unblemish Invisible Matte Defense,4,D02BA30,Combinations of protectives against uv-radiation,Gel,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98206,Marketed,2020-02-17,02492059,Moisture Surge Sheertint Hydrator SPF 25,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98230,Marketed,2019-11-01,02492261,Sport 30 Continuous Spray Sunscreen Écran Solaire En Vaporisateur,4,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98246,Marketed,2020-06-10,02492458,Toleriane Sensitive Crème UV,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98279,Marketed,2020-01-01,02492792,Olay Sensitive,2,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98283,Marketed,2020-09-16,02492830,Rodan + Fields Redefine Triple Defense Lotion,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98284,Marketed,2020-09-16,02492849,Rodan + Fields Redefine Triple Defense Cream,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98294,Marketed,2019-12-15,02492962,Rénergie Lift Multi-Action Ultra SPF 30,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98295,Marketed,2020-03-01,02492970,Superdefense City Block Daily Energy + Face Protector SPF 50,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98305,Marketed,2022-05-06,02493063,Sunthera 3 SPF 30 Lipbalm,4,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98306,Marketed,2021-02-11,02493071,Sunthera 3 SPF 30 Continuous Spray,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98307,Marketed,2020-05-01,02493098,Olay Regenerist Whip Sun Protection Factor 40,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98308,Marketed,2021-04-16,02493101,Sunthera 3 SPF 50+ Sun Protection Lotion,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98342,Marketed,2021-05-06,02493403,Sunthera 3 SPF 30 Sun Protection Lotion,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98343,Marketed,2021-08-06,02493411,Sunthera 3 SPF 50+ Continuous Spray,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98344,Marketed,2021-05-01,02493438,Sunthera 3 Sport SPF 50+ Continuous Spray,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98377,Marketed,2020-02-27,02493772,Sunscreen Continuous Spray SPF 30 Sport,4,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98412,Marketed,2020-02-27,02494094,Sunscreen Continuous Spray SPF 50 Kids,4,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98413,Marketed,2020-02-27,02494108,Sunscreen Continuous Spray SPF 30,4,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98422,Marketed,2021-03-02,02494183,Sunthera 3 Kids SPF 50+ Continuous Spray Sunscreen Broad Spectrum Uva/Uvb Protection,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98423,Marketed,2023-05-03,02494191,Sunthera 3 Sport SPF 50+ Sun Protection Lotion,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98424,Marketed,2021-12-10,02494205,Émulsion Hydratante Visage FPS 30,4,D02BA30,Combinations of protectives against uv-radiation,Emulsion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98425,Marketed,2022-01-20,02494213,Sunthera 3 Kids SPF 50+ Sun Protection Lotion,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98446,Marketed,2020-05-15,02494450,Crème Solaire Visage Toucher Sec FPS 30,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98447,Marketed,2020-05-15,02494469,Lait Solaire Corps FPS 50+,5,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98448,Marketed,2020-05-15,02494477,Crème Solaire Visage Toucher Sec FPS 50+,5,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98460,Marketed,2020-02-11,02494604,Futurist Hydra Rescue Moisturizing Makeup Fond De Teint Hydratant SPF/FPS 45,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98465,Marketed,2020-05-15,02494655,Crème Solaire Corps FPS 30,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98476,Marketed,2020-06-01,02494787,Hawaiian Tropic Island Sport Sweat Resistant Sunscreen Lotion SPF 30,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98477,Marketed,2020-08-26,02494795,Hawaiian Tropic Island Sport Sweat Resistant Sunscreen Lotion SPF 50,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98480,Marketed,2020-02-27,02494825,Sunscreen Lotion 30 SPF/FPS Sport,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98481,Marketed,2020-02-27,02494833,Kids Sunscreen Lotion 50+,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98492,Marketed,2024-05-09,02494949,Play Everyday Lotion,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98493,Marketed,2020-12-15,02494965,SPF 50 Face Cream,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98494,Marketed,2023-01-12,02494973,Sunscreen Lotion 50 SPF/FPS Sport,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98499,Marketed,2021-01-31,02495031,Hawaiian Tropic Island Sport Sweat Resistant Sunscreen Spray SPF 50,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98511,Marketed,2020-02-27,02495163,Sunscreen Lotion 30 SPF FPS,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98512,Marketed,2020-02-27,02495171,Sunscreen Lotion 50 SPF FPS,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98514,Marketed,2020-02-27,02495201,Sunscreen Continuous Spray SPF 50,4,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98515,Marketed,2020-02-27,02495228,Sunscreen Continuous Spray SPF 50 Sport,4,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98540,Marketed,2023-09-30,02495481,Unseen Sunscreen,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98558,Marketed,2021-07-20,02495694,Ultra Facial Cream/Crème SPF 30,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98611,Marketed,2025-07-31,02496240,Neutrogena Clear Face Sunscreen Lotion,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98618,Marketed,2022-04-22,02496291,Eltamd Skincare UV Clear,2,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98644,Marketed,2025-05-29,02496585,Hydro Boost Water Gel Lotion Sunscreen,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98664,Marketed,2025-09-05,02496798,Protect + Hydrate Moisturizing Sunscreen SPF 30,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98665,Marketed,2025-08-27,02496801,Protect + Hydrate Moisturizing Sunscreen SPF 50,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98672,Marketed,2020-12-11,02496879,Ultra Sun Protector Cream Crème Solaire Ultra Protection 50+,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98678,Marketed,2020-09-01,02496909,Healthy Glow All-In-One Tinted Moisturizer Broad Spectrum SPF 25,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98691,Marketed,2020-12-11,02497050,Ultra Sun Protector Lotion Lait Solaire Ultra Protection 50+,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98695,Marketed,2021-05-16,02497093,Stokoderm Sunscreen Pure,4,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98696,Marketed,2021-03-25,02497123,Life Brand Sunscreen Lotion SPF 50+,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98716,Marketed,2025-09-05,02497336,Protect + Hydrate Face,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98717,Marketed,2020-10-30,02497344,Instant Bronzer Instantané 15,3,D02BA30,Combinations of protectives against uv-radiation,Gel,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98752,Marketed,2021-04-20,02497727,Life Brand Kids Sunscreen Lotion SPF 50+,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98759,Marketed,2021-03-19,02497794,Life Brand Sunscreen Lotion SPF 30,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98761,Marketed,2021-04-15,02497816,Life Brand Sunscreen Face Lotion SPF 50+,5,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98788,Marketed,2021-03-09,02498081,Rodan + Fields Reverse Brightening Defense Fluid Lotion,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
98882,Marketed,2021-03-03,02499053,Life Brand Sport Sunscreen Continuous Spray SPF 50+,5,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
99028,Marketed,2021-03-11,02500612,Sunscreen Face Stick / Écran Solaire Bâton,4,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
99070,Marketed,2020-10-30,02501058,Instant Bronzer Instantané 30 Continuous Spray Sunscreen,4,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
99071,Marketed,2020-10-30,02501066,Instant Bronzer Instantané 15 Continuous Spray Sunscreen,3,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
99101,Marketed,2021-04-12,02501384,Clear Sunscreen Stick 50+,4,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
99103,Marketed,2020-10-13,02501406,Sunscreen Lip Balm,4,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
99165,Marketed,2020-10-30,02502054,Instant Bronzer Instantané 30 Spray Gel Sunscreen,4,D02BA30,Combinations of protectives against uv-radiation,Gel,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
99166,Marketed,2020-10-30,02502062,Instant Bronzer Instantané 4 Spray Gel Sunscreen,2,D02BA30,Combinations of protectives against uv-radiation,Gel,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
99209,Marketed,2025-05-16,02502526,Ultra Sheer Body Mist Sunscreen,4,D02BA30,Combinations of protectives against uv-radiation,Aerosol,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
99210,Marketed,2025-07-31,02502534,Ultra Sheer Dry-Touch Sunscreen,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
99211,Marketed,2025-07-31,02502542,Ultra Sheer Face Sunscreen,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
99248,Marketed,2021-04-14,02502968,Artistry Skin Nutrition Balancing Matte Day Lotion,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
99249,Marketed,2021-04-16,02502976,Artistry Skin Nutrition Hydrating Day Lotion,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
99261,Marketed,2023-03-13,02503107,Glowscreen,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
99426,Marketed,2021-12-10,02504871,Lotion Solaire Corps FPS 30,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
99466,Marketed,2021-01-25,02505290,Banana Boat Daily Protect Sunscreen Lotion SPF 50+,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
99467,Marketed,2021-01-25,02505304,Banana Boat Daily Protect Sunscreen Lotion SPF 30,4,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
99531,Marketed,2021-01-25,02505959,Banana Boat Daily Protect Sunscreen Spray SPF 30,3,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
99532,Marketed,2021-01-25,02505967,Banana Boat Daily Protect Sunscreen Spray SPF 50+,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
99541,Marketed,2020-12-11,02506068,Scalp Mist,4,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
99683,Marketed,2022-04-08,02507439,Sensitive Expert+ Face,5,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
99684,Marketed,2022-04-08,02507447,Sensitive Expert+ Sunscreen,5,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
99705,Marketed,2021-03-10,02507692,Nivea Men Sensitive,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
99854,Marketed,2023-02-01,02509237,Ultra Light Advanced Lotion,7,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
99932,Marketed,2024-07-15,02510065,COOLA Clear Sunscreen Spray Tropical Coconut Scent,3,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
99933,Marketed,2022-04-22,02510073,Eltamd Skincare UV Clear Tinted,2,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
99934,Marketed,2024-07-12,02510081,COOLA Clear Sunscreen Spray Fragrance Free,4,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
99956,Marketed,2024-07-12,02510332,COOLA Clear Sunscreen Spray Pina Colada Scent,3,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
99963,Marketed,2021-09-22,02510405,Artistry Skin Nutrition Renewing Reactivation Day Cream,3,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
99964,Marketed,2021-09-22,02510413,Artistry Skin Nutrition Renewing Reactivation Day Lotion,3,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
15704,Marketed,2012-06-19,02043440,Premarin Vaginal Cream,1,G03CA57,Conjugated estrogens,Cream,Vaginal,02043440,PREMARIN VAGINAL CREAM (conjugated estrogens 0.625 mg per g vaginal cream) PFIZER CANADA ULC,Active,9000511,conjugated estrogens 0.625 mg per g vaginal cream,8000021,conjugated estrogens,16857009,Vaginal,385165005,Vaginal cream,,,1.0,,,Prescription
16736,Marketed,2014-01-29,02043386,Premarin Intravenous,1,G03CA57,Conjugated estrogens,Powder for solution,"Intravenous,Intramuscular",02043386,PREMARIN INTRAVENOUS (conjugated estrogens 25 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9000512,conjugated estrogens 25 mg per vial powder for solution for injection,8000021,conjugated estrogens,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
89930,Marketed,2014-10-03,02414678,Premarin,1,G03CA57,Conjugated estrogens,Tablet (extended-release),Oral,02414678,PREMARIN (conjugated estrogens 0.3 mg prolonged-release oral tablet) PFIZER CANADA ULC,Active,9001431,conjugated estrogens 0.3 mg prolonged-release oral tablet,8000021,conjugated estrogens,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
89931,Marketed,2014-10-03,02414686,Premarin,1,G03CA57,Conjugated estrogens,Tablet (extended-release),Oral,02414686,PREMARIN (conjugated estrogens 0.625 mg prolonged-release oral tablet) PFIZER CANADA ULC,Active,9001432,conjugated estrogens 0.625 mg prolonged-release oral tablet,8000021,conjugated estrogens,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
89932,Marketed,2014-10-03,02414694,Premarin,1,G03CA57,Conjugated estrogens,Tablet (extended-release),Oral,02414694,PREMARIN (conjugated estrogens 1.25 mg prolonged-release oral tablet) PFIZER CANADA ULC,Active,9001433,conjugated estrogens 1.25 mg prolonged-release oral tablet,8000021,conjugated estrogens,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
91723,Marketed,2023-06-09,02432854,Duavive,2,G03CC07,Conjugated estrogens and bazedoxifene,Tablet (immediate and extended release),Oral,02432854,DUAVIVE (bazedoxifene (bazedoxifene acetate) 20 mg and conjugated estrogens 0.45 mg prolonged-release oral tablet) PFIZER CANADA ULC,Active,9015292,bazedoxifene (bazedoxifene acetate) 20 mg and conjugated estrogens 0.45 mg prolonged-release oral tablet,8001889,bazedoxifene and conjugated estrogens,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet,1.0,,,Prescription
90012,Marketed,2018-04-20,02415534,Durezol,1,S01BA,"Corticosteroids, plain",Emulsion,Ophthalmic,02415534,DUREZOL (difluprednate 0.05 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012791,difluprednate 0.05 % ophthalmic drops,8001452,difluprednate,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
1802,Marketed,2019-06-17,00280437,Cortisone Acetate,1,H02AB10,Cortisone,Tablet,Oral,00280437,"CORTISONE ACETATE (cortisone acetate 25 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9001700,cortisone acetate 25 mg oral tablet,8001446,cortisone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103049,Marketed,2024-09-13,02541882,Cough & Chest Congestion Regular Strength,2,R05FB02,Cough suppressants and expectorants,Syrup,Oral,02541882,COUGH & CHEST CONGESTION REGULAR STRENGTH (dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 100 mg per 5 mL syrup) CRLS,Active,9002350,dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 100 mg per 5 mL syrup,8001370,dextromethorphan and guaifenesin,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
103050,Marketed,2024-12-20,02541890,Cough & Chest Congestion Extra Strength,2,R05FB02,Cough suppressants and expectorants,Syrup,Oral,02541890,COUGH & CHEST CONGESTION EXTRA STRENGTH (dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL syrup) CRLS,Active,9003243,dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL syrup,8001370,dextromethorphan and guaifenesin,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
102992,Marketed,2024-09-17,02541270,Spikevax,1,J07BN01,"Covid-19, rna-based vaccine",Dispersion,Intramuscular,02541270,"SPIKEVAX (SARSCoV2 S-protein mRNA, 5'(m7G-5'-ppp-5'-Gm), 3'polyA 0.1 mg per mL dispersion for injection 2.5 mL vial) MODERNA BIOPHARMA CANADA CORPORATION",Active,9015112,"SARSCoV2 S-protein mRNA, 5'(m7G-5'-ppp-5'-Gm), 3'polyA 0.1 mg per mL dispersion for injection 2.5 mL vial",8002519,"SARSCoV2 S-protein mRNA, 5'(m7G-5'-ppp-5'-Gm), 3'polyA",738984000,Parenteral,1230185002,Dispersion,733026001,Vial (unit of presentation),,,,Schedule D
103044,Marketed,2024-09-30,02541823,Comirnaty,1,J07BN01,"Covid-19, rna-based vaccine",Suspension,Intramuscular,77701144,"COMIRNATY (SARSCoV2 S-protein mRNA, 5'[m27,3'-oGppp(m12'-O)ApG], 3'polyA+linker 30 mcg per 0.3 mL suspension for injection 0.3 mL vial) BIONTECH MANUFACTURING GMBH",Active,9015118,"SARSCoV2 S-protein mRNA, 5'[m27,3'-oGppp(m12'-O)ApG], 3'polyA+linker 30 mcg per 0.3 mL suspension for injection 0.3 mL vial",8002518,"SARSCoV2 S-protein mRNA, 5'[m27,3'-oGppp(m12'-O)ApG], 3'polyA+linker",738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,,Schedule D
103044,Marketed,2024-09-30,02541823,Comirnaty,1,J07BN01,"Covid-19, rna-based vaccine",Suspension,Intramuscular,77701145,"COMIRNATY (SARSCoV2 S-protein mRNA, 5'[m27,3'-oGppp(m12'-O)ApG], 3'polyA+linker 30 mcg per 0.3 mL suspension for injection 1.8 mL vial) BIONTECH MANUFACTURING GMBH",Active,9015119,"SARSCoV2 S-protein mRNA, 5'[m27,3'-oGppp(m12'-O)ApG], 3'polyA+linker 30 mcg per 0.3 mL suspension for injection 1.8 mL vial",8002518,"SARSCoV2 S-protein mRNA, 5'[m27,3'-oGppp(m12'-O)ApG], 3'polyA+linker",738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,,Schedule D
103046,Marketed,2025-09-03,02541858,Comirnaty,1,J07BN01,"Covid-19, rna-based vaccine",Suspension,Intramuscular,77701146,"COMIRNATY (SARSCoV2 S-protein mRNA, 5'[m27,3'-oGppp(m12'-O)ApG], 3'polyA+linker 10 mcg per 0.3 mL suspension for injection 0.3 mL vial) BIONTECH MANUFACTURING GMBH",Active,9015116,"SARSCoV2 S-protein mRNA, 5'[m27,3'-oGppp(m12'-O)ApG], 3'polyA+linker 10 mcg per 0.3 mL suspension for injection 0.3 mL vial",8002518,"SARSCoV2 S-protein mRNA, 5'[m27,3'-oGppp(m12'-O)ApG], 3'polyA+linker",738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,,Schedule D
103046,Marketed,2025-09-03,02541858,Comirnaty,1,J07BN01,"Covid-19, rna-based vaccine",Suspension,Intramuscular,77701147,"COMIRNATY (SARSCoV2 S-protein mRNA, 5'[m27,3'-oGppp(m12'-O)ApG], 3'polyA+linker 10 mcg per 0.3 mL suspension for injection 1.8 mL vial) BIONTECH MANUFACTURING GMBH",Active,9015117,"SARSCoV2 S-protein mRNA, 5'[m27,3'-oGppp(m12'-O)ApG], 3'polyA+linker 10 mcg per 0.3 mL suspension for injection 1.8 mL vial",8002518,"SARSCoV2 S-protein mRNA, 5'[m27,3'-oGppp(m12'-O)ApG], 3'polyA+linker",738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,,Schedule D
104073,Marketed,2025-09-03,02552035,Comirnaty,1,J07BN01,"Covid-19, rna-based vaccine",Suspension,Intramuscular,02552035,"COMIRNATY (SARSCoV2 S-protein mRNA, 5'[m27,3'-oGppp(m12'-O)ApG], 3'polyA+linker 30 mcg per 0.3 mL suspension for injection syringe) BIONTECH MANUFACTURING GMBH",Active,9015270,"SARSCoV2 S-protein mRNA, 5'[m27,3'-oGppp(m12'-O)ApG], 3'polyA+linker 30 mcg per 0.3 mL suspension for injection syringe",8002518,"SARSCoV2 S-protein mRNA, 5'[m27,3'-oGppp(m12'-O)ApG], 3'polyA+linker",738984000,Parenteral,385220007,Suspension for injection,733020007,Syringe,,,,Schedule D
106107,Marketed,2025-08-25,02557770,Spikevax,1,J07BN01,"Covid-19, rna-based vaccine",Dispersion,Intramuscular,02557770,"SPIKEVAX (SARSCoV2 S-protein mRNA, 5'(m7G-5'-ppp-5'-Gm), 3'polyA 50 mcg per 0.5 mL dispersion for injection syringe) MODERNA BIOPHARMA CANADA CORPORATION",Active,9015258,"SARSCoV2 S-protein mRNA, 5'(m7G-5'-ppp-5'-Gm), 3'polyA 50 mcg per 0.5 mL dispersion for injection syringe",8002519,"SARSCoV2 S-protein mRNA, 5'(m7G-5'-ppp-5'-Gm), 3'polyA",738984000,Parenteral,1230185002,Dispersion for injection,733020007,Syringe,,,,Schedule D
96774,Marketed,2018-08-29,02476991,Eucrisa,1,D11AH06,Crisaborole,Ointment,Topical,02476991,EUCRISA (crisaborole 2 % cutaneous ointment) PFIZER CANADA ULC,Active,9013673,crisaborole 2 % cutaneous ointment,8002186,crisaborole,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Prescription
86999,Marketed,2012-05-10,02384256,Xalkori,1,L01ED01,Crizotinib,Capsule,Oral,02384256,XALKORI (crizotinib 200 mg oral capsule) PFIZER CANADA ULC,Active,9005038,crizotinib 200 mg oral capsule,8001620,crizotinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
87000,Marketed,2012-05-10,02384264,Xalkori,1,L01ED01,Crizotinib,Capsule,Oral,02384264,XALKORI (crizotinib 250 mg oral capsule) PFIZER CANADA ULC,Active,9005039,crizotinib 250 mg oral capsule,8001620,crizotinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
13857,Marketed,2012-08-21,02009277,Cromolyn Eye Drops,1,S01GX01,Cromoglicic acid,Solution,Ophthalmic,02009277,CROMOLYN EYE DROPS (cromolyn sodium 2 % ophthalmic drops) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9002548,cromolyn sodium 2 % ophthalmic drops,8001077,cromolyn,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
4114,Marketed,2025-03-05,00500895,Nalcrom,1,A07EB01,Cromoglicic acid,Capsule,Oral,00500895,NALCROM (cromolyn sodium 100 mg oral capsule) LUPIN PHARMA CANADA LIMITED,Active,9001907,cromolyn sodium 100 mg oral capsule,8001077,cromolyn,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
104492,Marketed,2025-11-10,02558262,Piasky,1,L04AJ07,Crovalimab,Solution,"Subcutaneous,Intravenous",02558262,PIASKY (crovalimab 340 mg per 2 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9015276,crovalimab 340 mg per 2 mL solution for injection vial,8002559,crovalimab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,,,,Prescription
13324,Marketed,2019-02-14,01987003,Cyanocobalamin Injection USP,1,B03BA01,Cyanocobalamin,Solution,"Subcutaneous,Intramuscular",77700964,CYANOCOBALAMIN INJECTION USP (cyanocobalamin 10000 mcg per 10 mL solution for injection vial) STERIMAX INC,Active,9013676,cyanocobalamin 10000 mcg per 10 mL solution for injection vial,8002187,cyanocobalamin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
13324,Marketed,2019-02-14,01987003,Cyanocobalamin Injection USP,1,B03BA01,Cyanocobalamin,Solution,"Subcutaneous,Intramuscular",77700965,CYANOCOBALAMIN INJECTION USP (cyanocobalamin 30000 mcg per 30 mL solution for injection vial) STERIMAX INC,Active,9013677,cyanocobalamin 30000 mcg per 30 mL solution for injection vial,8002187,cyanocobalamin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
4432,Marketed,2005-07-20,00521515,Vitamin B12,1,B03BA01,Cyanocobalamin,Solution,"Subcutaneous,Intramuscular",77700959,VITAMIN B12 (cyanocobalamin 30000 mcg per 30 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013677,cyanocobalamin 30000 mcg per 30 mL solution for injection vial,8002187,cyanocobalamin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
4432,Marketed,2005-07-20,00521515,Vitamin B12,1,B03BA01,Cyanocobalamin,Solution,"Subcutaneous,Intramuscular",77700960,VITAMIN B12 (cyanocobalamin 1000 mcg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9013675,cyanocobalamin 1000 mcg per 1 mL solution for injection ampoule,8002187,cyanocobalamin,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
4432,Marketed,2005-07-20,00521515,Vitamin B12,1,B03BA01,Cyanocobalamin,Solution,"Subcutaneous,Intramuscular",77700961,VITAMIN B12 (cyanocobalamin 10000 mcg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013676,cyanocobalamin 10000 mcg per 10 mL solution for injection vial,8002187,cyanocobalamin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
95136,Marketed,2022-04-20,02463393,Cyanocobalamin Injection USP,1,B03BA01,Cyanocobalamin,Solution,"Subcutaneous,Intramuscular",02463393,CYANOCOBALAMIN INJECTION USP (cyanocobalamin 1000 mcg per 1 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9013675,cyanocobalamin 1000 mcg per 1 mL solution for injection ampoule,8002187,cyanocobalamin,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
95368,Marketed,2023-03-24,02465507,Cyanocobalamin Injection USP,1,B03BA01,Cyanocobalamin,Solution,"Subcutaneous,Intramuscular",02465507,CYANOCOBALAMIN INJECTION USP (cyanocobalamin 10000 mcg per 10 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9013676,cyanocobalamin 10000 mcg per 10 mL solution for injection vial,8002187,cyanocobalamin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
15912,Marketed,2016-12-22,02080052,Teva-Cyclobenzaprine,1,M03BX08,Cyclobenzaprine,Tablet,Oral,02080052,TEVA-CYCLOBENZAPRINE (cyclobenzaprine hydrochloride 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000513,cyclobenzaprine hydrochloride 10 mg oral tablet,8000196,cyclobenzaprine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
18806,Marketed,2021-06-18,02177145,Apo-Cyclobenzaprine,1,M03BX08,Cyclobenzaprine,Tablet,Oral,02177145,APO-CYCLOBENZAPRINE (cyclobenzaprine hydrochloride 10 mg oral tablet) APOTEX INC,Active,9000513,cyclobenzaprine hydrochloride 10 mg oral tablet,8000196,cyclobenzaprine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
19827,Marketed,1996-12-31,02212048,PMS-Cyclobenzaprine - Tablets 10 mg,1,M03BX08,Cyclobenzaprine,Tablet,Oral,02212048,PMS-CYCLOBENZAPRINE - TAB 10MG (cyclobenzaprine hydrochloride 10 mg oral tablet) PHARMASCIENCE INC,Active,9000513,cyclobenzaprine hydrochloride 10 mg oral tablet,8000196,cyclobenzaprine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
43292,Marketed,2026-02-12,02220644,Pro-Cyclobenzaprine,1,M03BX08,Cyclobenzaprine,Tablet,Oral,02220644,PRO-CYCLOBENZAPRINE (cyclobenzaprine hydrochloride 10 mg oral tablet) PRO DOC LIMITEE,Active,9000513,cyclobenzaprine hydrochloride 10 mg oral tablet,8000196,cyclobenzaprine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
65753,Marketed,2018-10-05,02242079,Riva-Cyclobenzaprine,1,M03BX08,Cyclobenzaprine,Tablet,Oral,02242079,RIVA-CYCLOBENZAPRINE (cyclobenzaprine hydrochloride 10 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000513,cyclobenzaprine hydrochloride 10 mg oral tablet,8000196,cyclobenzaprine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77249,Marketed,2026-05-04,02287064,Cyclobenzaprine,1,M03BX08,Cyclobenzaprine,Tablet,Oral,02287064,CYCLOBENZAPRINE (cyclobenzaprine hydrochloride 10 mg oral tablet) SANIS HEALTH INC,Active,9000513,cyclobenzaprine hydrochloride 10 mg oral tablet,8000196,cyclobenzaprine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83419,Marketed,2011-06-15,02348853,Auro-Cyclobenzaprine,1,M03BX08,Cyclobenzaprine,Tablet,Oral,02348853,AURO-CYCLOBENZAPRINE (cyclobenzaprine hydrochloride 10 mg oral tablet) AURO PHARMA INC,Active,9000513,cyclobenzaprine hydrochloride 10 mg oral tablet,8000196,cyclobenzaprine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84222,Marketed,2019-01-02,02357127,JAMP-Cyclobenzaprine,1,M03BX08,Cyclobenzaprine,Tablet,Oral,02357127,JAMP-CYCLOBENZAPRINE (cyclobenzaprine hydrochloride 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000513,cyclobenzaprine hydrochloride 10 mg oral tablet,8000196,cyclobenzaprine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90926,Marketed,2014-10-01,02424584,Cyclobenzaprine,1,M03BX08,Cyclobenzaprine,Tablet,Oral,02424584,CYCLOBENZAPRINE (cyclobenzaprine hydrochloride 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000513,cyclobenzaprine hydrochloride 10 mg oral tablet,8000196,cyclobenzaprine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97566,Marketed,2020-12-22,02485419,AG-Cyclobenzaprine,1,M03BX08,Cyclobenzaprine,Tablet,Oral,02485419,AG-CYCLOBENZAPRINE (cyclobenzaprine hydrochloride 10 mg oral tablet) ANGITA PHARMA INC.,Active,9000513,cyclobenzaprine hydrochloride 10 mg oral tablet,8000196,cyclobenzaprine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
1530,Marketed,2018-12-04,00252506,Cyclogyl,1,S01FA04,Cyclopentolate,Drops,Ophthalmic,00252506,CYCLOGYL (cyclopentolate hydrochloride 1 % ophthalmic drops) ALCON CANADA INC,Active,9001684,cyclopentolate hydrochloride 1 % ophthalmic drops,8001622,cyclopentolate,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
18742,Marketed,2023-01-18,02148382,Minims Cyclopentolate Hydrochloride,1,S01FA04,Cyclopentolate,Solution,Ophthalmic,02148382,MINIMS CYCLOPENTOLATE HYDROCHLORIDE (cyclopentolate hydrochloride 1 % ophthalmic drops) BAUSCH & LOMB INC,Active,9001684,cyclopentolate hydrochloride 1 % ophthalmic drops,8001622,cyclopentolate,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
5997,Marketed,2021-05-11,00626627,Odan-Cyclopentolate,1,S01FA04,Cyclopentolate,Solution,Ophthalmic,00626627,ODAN-CYCLOPENTOLATE (cyclopentolate hydrochloride 1 % ophthalmic drops) ODAN LABORATORIES LTD,Active,9001684,cyclopentolate hydrochloride 1 % ophthalmic drops,8001622,cyclopentolate,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
103541,Marketed,2025-06-06,02546736,Cyclophosphamide For Injection USP,1,L01AA01,Cyclophosphamide,Powder for solution,Intravenous,02546736,CYCLOPHOSPHAMIDE FOR INJECTION USP (cyclophosphamide 1000 mg per vial powder for solution for injection) ANDONE PHARMACEUTICAL INC,Active,9003840,cyclophosphamide 1000 mg per vial powder for solution for injection,8001736,cyclophosphamide,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
103542,Marketed,2025-06-06,02546744,Cyclophosphamide For Injection USP,1,L01AA01,Cyclophosphamide,Powder for solution,Intravenous,02546744,CYCLOPHOSPHAMIDE FOR INJECTION USP (cyclophosphamide 2000 mg per vial powder for solution for injection) ANDONE PHARMACEUTICAL INC,Active,9003836,cyclophosphamide 2000 mg per vial powder for solution for injection,8001736,cyclophosphamide,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
103661,Marketed,2024-09-27,02547686,Cyclophosphamide For Injection USP,1,L01AA01,Cyclophosphamide,Powder for solution,Intravenous,02547686,CYCLOPHOSPHAMIDE FOR INJECTION USP (cyclophosphamide 1000 mg per vial powder for solution for injection) STERIMAX INC,Active,9003840,cyclophosphamide 1000 mg per vial powder for solution for injection,8001736,cyclophosphamide,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
103662,Marketed,2024-09-27,02547694,Cyclophosphamide For Injection USP,1,L01AA01,Cyclophosphamide,Powder for solution,Intravenous,02547694,CYCLOPHOSPHAMIDE FOR INJECTION USP (cyclophosphamide 2000 mg per vial powder for solution for injection) STERIMAX INC,Active,9003836,cyclophosphamide 2000 mg per vial powder for solution for injection,8001736,cyclophosphamide,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
65460,Marketed,2003-10-03,02241795,Procytox Tablets 25 mg,1,L01AA01,Cyclophosphamide,Tablet,Oral,02241795,PROCYTOX TAB 25MG (cyclophosphamide 25 mg oral tablet) BAXTER CORPORATION,Active,9003518,cyclophosphamide 25 mg oral tablet,8001736,cyclophosphamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
65461,Marketed,2003-09-09,02241796,Procytox Tablets 50 mg,1,L01AA01,Cyclophosphamide,Tablet,Oral,02241796,PROCYTOX TAB 50MG (cyclophosphamide 50 mg oral tablet) BAXTER CORPORATION,Active,9003514,cyclophosphamide 50 mg oral tablet,8001736,cyclophosphamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
65462,Marketed,2003-08-11,02241797,Procytox,1,L01AA01,Cyclophosphamide,Powder for solution,Intravenous,02241797,PROCYTOX (cyclophosphamide 200 mg per vial powder for solution for injection) BAXTER CORPORATION,Active,9003542,cyclophosphamide 200 mg per vial powder for solution for injection,8001736,cyclophosphamide,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
65463,Marketed,2003-07-28,02241798,Procytox,1,L01AA01,Cyclophosphamide,Powder for solution,Intravenous,02241798,PROCYTOX (cyclophosphamide 500 mg per vial powder for solution for injection) BAXTER CORPORATION,Active,9003530,cyclophosphamide 500 mg per vial powder for solution for injection,8001736,cyclophosphamide,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
65464,Marketed,2003-11-18,02241799,Procytox,1,L01AA01,Cyclophosphamide,Powder for solution,Intravenous,02241799,PROCYTOX (cyclophosphamide 1000 mg per vial powder for solution for injection) BAXTER CORPORATION,Active,9003840,cyclophosphamide 1000 mg per vial powder for solution for injection,8001736,cyclophosphamide,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
65465,Marketed,2003-11-03,02241800,Procytox,1,L01AA01,Cyclophosphamide,Powder for solution,Intravenous,02241800,PROCYTOX (cyclophosphamide 2000 mg per vial powder for solution for injection) BAXTER CORPORATION,Active,9003836,cyclophosphamide 2000 mg per vial powder for solution for injection,8001736,cyclophosphamide,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
102209,Marketed,2023-05-26,02533065,Mar-Cyproheptadine,1,R06AX02,Cyproheptadine,Tablet,Oral,02533065,MAR-CYPROHEPTADINE (cyproheptadine hydrochloride 4 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9002941,cyproheptadine hydrochloride 4 mg oral tablet,8001365,cyproheptadine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
81790,Marketed,2021-04-15,02332248,JAMP-Cyproheptadine,1,R06AX02,Cyproheptadine,Tablet,Oral,02332248,JAMP-CYPROHEPTADINE (cyproheptadine hydrochloride 4 mg oral tablet) JAMP PHARMA CORPORATION,Active,9002941,cyproheptadine hydrochloride 4 mg oral tablet,8001365,cyproheptadine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
95509,Marketed,2023-11-03,02466732,Euro-Cyproheptadine 2 mg/5 mL,1,R06AX02,Cyproheptadine,Syrup,Oral,02466732,EURO-CYPROHEPTADINE 2MG/5ML (cyproheptadine hydrochloride 2 mg per 5 mL syrup) EURO-PHARM INTERNATIONAL CANADA INC,Active,9003804,cyproheptadine hydrochloride 2 mg per 5 mL syrup,8001365,cyproheptadine,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
70015,Marketed,2011-03-22,02245898,Cyproterone,1,G03HA01,Cyproterone,Tablet,Oral,02245898,CYPROTERONE (cyproterone acetate 50 mg oral tablet) AA PHARMA INC,Active,9002103,cyproterone acetate 50 mg oral tablet,8000841,cyproterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
7394,Marketed,2025-05-08,00704431,Androcur,1,G03HA01,Cyproterone,Tablet,Oral,00704431,ANDROCUR (cyproterone acetate 50 mg oral tablet) AMDIPHARM LIMITED,Active,9002103,cyproterone acetate 50 mg oral tablet,8000841,cyproterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
87616,Marketed,2012-10-02,02390760,Med-Cyproterone,1,G03HA01,Cyproterone,Tablet,Oral,02390760,MED-CYPROTERONE (cyproterone acetate 50 mg oral tablet) GENERIC MEDICAL PARTNERS INC,Active,9002103,cyproterone acetate 50 mg oral tablet,8000841,cyproterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
88085,Marketed,2012-11-28,02395797,Riva-Cyproterone,1,G03HA01,Cyproterone,Tablet,Oral,02395797,RIVA-CYPROTERONE (cyproterone acetate 50 mg oral tablet) LABORATOIRE RIVA INC.,Active,9002103,cyproterone acetate 50 mg oral tablet,8000841,cyproterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
106712,Marketed,2026-03-19,02564424,Amb-Cyproterone Acetate / Ethinyl Estradiol,2,G03HB01,Cyproterone and estrogen,Tablet,Oral,02564424,AMB-CYPROTERONE ACETATE / ETHINYL ESTRADIOL (cyproterone acetate 2 mg and ethinyl estradiol 35 mcg oral tablet) AMBICARE PHARMACEUTICALS INC.,Active,9008629,cyproterone acetate 2 mg and ethinyl estradiol 35 mcg oral tablet,8000256,cyproterone and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
53444,Marketed,2007-12-17,02233542,Diane-35,2,G03HB01,Cyproterone and estrogen,Tablet,Oral,02233542,DIANE-35 (cyproterone acetate 2 mg and ethinyl estradiol 35 mcg oral tablet) BAYER INC,Active,9008629,cyproterone acetate 2 mg and ethinyl estradiol 35 mcg oral tablet,8000256,cyproterone and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
77558,Marketed,2026-02-17,02290308,Cyestra-35,2,G03HB01,Cyproterone and estrogen,Tablet,Oral,02290308,CYESTRA-35 (cyproterone acetate 2 mg and ethinyl estradiol 35 mcg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9008629,cyproterone acetate 2 mg and ethinyl estradiol 35 mcg oral tablet,8000256,cyproterone and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
79517,Marketed,2018-03-08,02309556,Teva-Cyproterone / Ethinyl Estradiol,2,G03HB01,Cyproterone and estrogen,Tablet,Oral,02309556,TEVA-CYPROTERONE / ETHINYL ESTRADIOL (cyproterone acetate 2 mg and ethinyl estradiol 35 mcg oral tablet) TEVA CANADA LIMITED,Active,9008629,cyproterone acetate 2 mg and ethinyl estradiol 35 mcg oral tablet,8000256,cyproterone and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
90968,Marketed,2020-08-05,02425017,Taro-Cyproterone/Ethinyl Estradiol,2,G03HB01,Cyproterone and estrogen,Tablet,Oral,02425017,TARO-CYPROTERONE/ETHINYL ESTRADIOL (cyproterone acetate 2 mg and ethinyl estradiol 35 mcg oral tablet) SUN PHARMA CANADA INC,Active,9008629,cyproterone acetate 2 mg and ethinyl estradiol 35 mcg oral tablet,8000256,cyproterone and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
92104,Marketed,2018-05-04,02436736,Cléo -35,2,G03HB01,Cyproterone and estrogen,Tablet,Oral,02436736,CLÉO -35 (cyproterone acetate 2 mg and ethinyl estradiol 35 mcg oral tablet) ALTIUS HEALTHCARE INC,Active,9008629,cyproterone acetate 2 mg and ethinyl estradiol 35 mcg oral tablet,8000256,cyproterone and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100469,Marketed,2022-04-21,02515296,Cytarabine Injection,1,L01BC01,Cytarabine,Solution,"Intrathecal,Subcutaneous,Intravenous",02515296,CYTARABINE INJECTION (cytarabine 2000 mg per 20 mL solution for injection vial) STERIMAX INC,Active,9013064,cytarabine 2000 mg per 20 mL solution for injection vial,8001737,cytarabine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
43843,Marketed,2017-09-12,02126656,Cytarabine Injection,1,L01BC01,Cytarabine,Solution,"Intrathecal,Intravenous,Subcutaneous",77700720,CYTARABINE INJECTION (cytarabine 100 mg per 1 mL solution for injection vial) PFIZER CANADA ULC,Active,9013061,cytarabine 100 mg per 1 mL solution for injection vial,8001737,cytarabine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
43843,Marketed,2017-09-12,02126656,Cytarabine Injection,1,L01BC01,Cytarabine,Solution,"Intrathecal,Intravenous,Subcutaneous",77700721,CYTARABINE INJECTION (cytarabine 1000 mg per 10 mL solution for injection vial) PFIZER CANADA ULC,Active,9013063,cytarabine 1000 mg per 10 mL solution for injection vial,8001737,cytarabine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
43843,Marketed,2017-09-12,02126656,Cytarabine Injection,1,L01BC01,Cytarabine,Solution,"Intrathecal,Intravenous,Subcutaneous",77700722,CYTARABINE INJECTION (cytarabine 2000 mg per 20 mL solution for injection vial) PFIZER CANADA ULC,Active,9013064,cytarabine 2000 mg per 20 mL solution for injection vial,8001737,cytarabine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
89145,Marketed,2017-02-16,02406772,PMS-Cytarabine,1,L01BC01,Cytarabine,Solution,"Subcutaneous,Intravenous,Intrathecal",77700781,PMS-CYTARABINE (cytarabine 2000 mg per 20 mL solution for injection vial) PHARMASCIENCE INC,Active,9013064,cytarabine 2000 mg per 20 mL solution for injection vial,8001737,cytarabine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
89145,Marketed,2017-02-16,02406772,PMS-Cytarabine,1,L01BC01,Cytarabine,Solution,"Subcutaneous,Intravenous,Intrathecal",77700782,PMS-CYTARABINE (cytarabine 1000 mg per 10 mL solution for injection vial) PHARMASCIENCE INC,Active,9013063,cytarabine 1000 mg per 10 mL solution for injection vial,8001737,cytarabine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
100489,Marketed,2021-07-06,02515490,Vyxeos,2,L01XY01,Cytarabine and daunorubicin,Powder,Intravenous,,,,,,,,,,,,,,1.0,,,Prescription
51418,Marketed,2022-06-27,02231962,Cytogam,1,J06BB09,Cytomegalovirus immunoglobulin,Solution,Intravenous,,,,,,,,,,,,,,,,,Schedule D
79795,Marketed,2008-07-03,02312441,Pradaxa,1,B01AE07,Dabigatran etexilate,Capsule,Oral,02312441,PRADAXA (dabigatran etexilate (dabigatran etexilate mesilate) 110 mg oral capsule) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9001250,dabigatran etexilate (dabigatran etexilate mesilate) 110 mg oral capsule,8000378,dabigatran,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
84384,Marketed,2013-03-28,02358808,Pradaxa,1,B01AE07,Dabigatran etexilate,Capsule,Oral,02358808,PRADAXA (dabigatran etexilate (dabigatran etexilate mesilate) 150 mg oral capsule) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9001327,dabigatran etexilate (dabigatran etexilate mesilate) 150 mg oral capsule,8000378,dabigatran,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95754,Marketed,2019-08-14,02468891,Apo-Dabigatran,1,B01AE07,Dabigatran etexilate,Capsule,Oral,02468891,APO-DABIGATRAN (dabigatran etexilate (dabigatran etexilate mesilate) 75 mg oral capsule) APOTEX INC,Active,9001251,dabigatran etexilate (dabigatran etexilate mesilate) 75 mg oral capsule,8000378,dabigatran,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95755,Marketed,2022-10-05,02468905,Apo-Dabigatran,1,B01AE07,Dabigatran etexilate,Capsule,Oral,02468905,APO-DABIGATRAN (dabigatran etexilate (dabigatran etexilate mesilate) 110 mg oral capsule) APOTEX INC,Active,9001250,dabigatran etexilate (dabigatran etexilate mesilate) 110 mg oral capsule,8000378,dabigatran,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95756,Marketed,2019-02-04,02468913,Apo-Dabigatran,1,B01AE07,Dabigatran etexilate,Capsule,Oral,02468913,APO-DABIGATRAN (dabigatran etexilate (dabigatran etexilate mesilate) 150 mg oral capsule) APOTEX INC,Active,9001327,dabigatran etexilate (dabigatran etexilate mesilate) 150 mg oral capsule,8000378,dabigatran,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
102878,Marketed,2023-11-30,02540053,Tafinlar,1,L01EC02,Dabrafenib,Tablet for suspension,Oral,02540053,TAFINLAR (dabrafenib (dabrafenib mesylate) 10 mg dispersible oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014972,dabrafenib (dabrafenib mesylate) 10 mg dispersible oral tablet,8001623,dabrafenib,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
89429,Marketed,2016-09-27,02409607,Tafinlar,1,L01EC02,Dabrafenib,Capsule,Oral,02409607,TAFINLAR (dabrafenib (dabrafenib mesylate) 50 mg oral capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9005313,dabrafenib (dabrafenib mesylate) 50 mg oral capsule,8001623,dabrafenib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
89430,Marketed,2016-05-04,02409615,Tafinlar,1,L01EC02,Dabrafenib,Capsule,Oral,02409615,TAFINLAR (dabrafenib (dabrafenib mesylate) 75 mg oral capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9005314,dabrafenib (dabrafenib mesylate) 75 mg oral capsule,8001623,dabrafenib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
65081,Marketed,2017-05-31,02241445,Dacarbazine For Injection BP,1,L01AX04,Dacarbazine,Powder for solution,Intravenous,02241445,DACARBAZINE FOR INJECTION BP (dacarbazine 600 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9012787,dacarbazine 600 mg per vial powder for solution for injection,8001447,dacarbazine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
250,Marketed,2019-12-01,00213071,Cosmegen,1,L01DA01,Dactinomycin,Powder for solution,Intravenous,00213071,COSMEGEN (dactinomycin 0.5 mg per vial powder for solution for injection) RECORDATI RARE DISEASES CANADA INC,Active,9001593,dactinomycin 0.5 mg per vial powder for solution for injection,8001738,dactinomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
97107,Marketed,2026-05-01,02480522,Xydalba,1,J01XA04,Dalbavancin,Powder for solution,Intravenous,02480522,XYDALBA (dalbavancin (dalbavancin hydrochloride) 500 mg per vial powder for solution for injection) KNIGHT THERAPEUTICS INC.,Active,9014534,dalbavancin (dalbavancin hydrochloride) 500 mg per vial powder for solution for injection,8002369,dalbavancin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
18306,Marketed,2005-05-03,02132648,Fragmin,1,B01AB04,Dalteparin,Solution,"Subcutaneous,Intravenous",02132648,FRAGMIN (dalteparin sodium 5000 unit per 0.2 mL solution for injection syringe) PFIZER CANADA ULC,Active,9012615,dalteparin sodium 5000 unit per 0.2 mL solution for injection syringe,8001254,dalteparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
18307,Marketed,2005-07-12,02132621,Fragmin,1,B01AB04,Dalteparin,Solution,"Intravenous,Subcutaneous",02132621,FRAGMIN (dalteparin sodium 2500 unit per 0.2 mL solution for injection syringe) PFIZER CANADA ULC,Active,9012612,dalteparin sodium 2500 unit per 0.2 mL solution for injection syringe,8001254,dalteparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
50478,Marketed,2005-05-20,02231171,Fragmin,1,B01AB04,Dalteparin,Solution,"Subcutaneous,Intravenous",02231171,FRAGMIN (dalteparin sodium 25000 unit per mL solution for injection 3.8 mL vial) PFIZER CANADA ULC,Active,9012613,dalteparin sodium 25000 unit per mL solution for injection 3.8 mL vial,8001254,dalteparin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
83790,Marketed,2011-02-01,02352648,Fragmin,1,B01AB04,Dalteparin,Solution,"Intravenous,Subcutaneous",02352648,FRAGMIN (dalteparin sodium 7500 unit per 0.3 mL solution for injection syringe) PFIZER CANADA ULC,Active,9012616,dalteparin sodium 7500 unit per 0.3 mL solution for injection syringe,8001254,dalteparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
83791,Marketed,2011-02-01,02352656,Fragmin,1,B01AB04,Dalteparin,Solution,"Subcutaneous,Intravenous",02352656,FRAGMIN (dalteparin sodium 10000 unit per 0.4 mL solution for injection syringe) PFIZER CANADA ULC,Active,9012607,dalteparin sodium 10000 unit per 0.4 mL solution for injection syringe,8001254,dalteparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
83792,Marketed,2011-02-01,02352664,Fragmin,1,B01AB04,Dalteparin,Solution,"Intravenous,Subcutaneous",02352664,FRAGMIN (dalteparin sodium 12500 unit per 0.5 mL solution for injection syringe) PFIZER CANADA ULC,Active,9012609,dalteparin sodium 12500 unit per 0.5 mL solution for injection syringe,8001254,dalteparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
83793,Marketed,2011-02-01,02352672,Fragmin,1,B01AB04,Dalteparin,Solution,"Subcutaneous,Intravenous",02352672,FRAGMIN (dalteparin sodium 15000 unit per 0.6 mL solution for injection syringe) PFIZER CANADA ULC,Active,9012610,dalteparin sodium 15000 unit per 0.6 mL solution for injection syringe,8001254,dalteparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
83794,Marketed,2011-02-01,02352680,Fragmin,1,B01AB04,Dalteparin,Solution,"Intravenous,Subcutaneous",02352680,FRAGMIN (dalteparin sodium 18000 unit per 0.72 mL solution for injection syringe) PFIZER CANADA ULC,Active,9012611,dalteparin sodium 18000 unit per 0.72 mL solution for injection syringe,8001254,dalteparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
91522,Marketed,2015-03-25,02430789,Fragmin,1,B01AB04,Dalteparin,Solution,"Subcutaneous,Intravenous",02430789,FRAGMIN (dalteparin sodium 3500 unit per 0.28 mL solution for injection syringe) PFIZER CANADA ULC,Active,9012614,dalteparin sodium 3500 unit per 0.28 mL solution for injection syringe,8001254,dalteparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
98458,Marketed,2020-06-08,02494582,Fragmin,1,B01AB04,Dalteparin,Solution,"Subcutaneous,Intravenous",02494582,FRAGMIN (dalteparin sodium 16500 unit per 0.66 mL solution for injection syringe) PFIZER CANADA ULC,Active,9014340,dalteparin sodium 16500 unit per 0.66 mL solution for injection syringe,8001254,dalteparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
18868,Marketed,2018-11-06,02129043,Orgaran,1,B01AB09,Danaparoid,Solution,"Subcutaneous,Intravenous",02129043,ORGARAN (danaparoid sodium 750 unit per 0.6 mL solution for injection ampoule) ASPEN PHARMACARE CANADA INC.,Active,9012617,danaparoid sodium 750 unit per 0.6 mL solution for injection ampoule,8001255,danaparoid,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
14747,Marketed,2009-02-06,02018160,Cyclomen,1,G03XA01,Danazol,Capsule,Oral,02018160,CYCLOMEN (danazol 200 mg oral capsule) SANOFI-AVENTIS CANADA INC,Active,9001685,danazol 200 mg oral capsule,8001624,danazol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
15163,Marketed,2008-08-06,02018152,Cyclomen,1,G03XA01,Danazol,Capsule,Oral,02018152,CYCLOMEN (danazol 100 mg oral capsule) SANOFI-AVENTIS CANADA INC,Active,9001753,danazol 100 mg oral capsule,8001624,danazol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
103882,Marketed,2024-11-07,02550040,Voydeya,1,L04AJ09,Danicopan,Tablet,Oral,02550040,VOYDEYA 150 MG DOSE (danicopan 50 mg oral tablet with danicopan 100 mg oral tablet) ALEXION PHARMA GMBH,Active,9015146,danicopan 50 mg oral tablet with danicopan 100 mg oral tablet,8002524,danicopan,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,,Prescription
103886,Marketed,2024-11-07,02550059,Voydeya,1,L04AJ09,Danicopan,Tablet,Oral,02550059,VOYDEYA 200 MG DOSE (danicopan 100 mg oral tablet) ALEXION PHARMA GMBH,Active,9015145,danicopan 100 mg oral tablet,8002524,danicopan,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,,Prescription
101921,Marketed,2023-03-29,02529998,"Dantrolene Sodium For Injection, USP",1,M03CA01,Dantrolene,Powder for solution,Intravenous,02529998,"DANTROLENE SODIUM FOR INJECTION, USP (dantrolene sodium 20 mg per vial powder for solution for injection) HIKMA CANADA LIMITED",Active,9012788,dantrolene sodium 20 mg per vial powder for solution for injection,8001448,dantrolene,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
14017,Marketed,2026-01-16,01997572,Dantrium Intravenous,1,M03CA01,Dantrolene,Powder for solution,Intravenous,01997572,DANTRIUM INTRAVENOUS (dantrolene sodium 20 mg per vial powder for solution for injection) KNIGHT THERAPEUTICS INC.,Active,9012788,dantrolene sodium 20 mg per vial powder for solution for injection,8001448,dantrolene,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
14019,Marketed,2026-01-27,01997602,Dantrium Capsules,1,M03CA01,Dantrolene,Capsule,Oral,01997602,DANTRIUM CAPSULES (dantrolene sodium 25 mg oral capsule) KNIGHT THERAPEUTICS INC.,Active,9012789,dantrolene sodium 25 mg oral capsule,8001448,dantrolene,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
100803,Marketed,2023-05-17,02518732,Sandoz Dapagliflozin,1,A10BK01,Dapagliflozin,Tablet,Oral,02518732,SANDOZ DAPAGLIFLOZIN (dapagliflozin 5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9014863,dapagliflozin 5 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100804,Marketed,2023-05-17,02518740,Sandoz Dapagliflozin,1,A10BK01,Dapagliflozin,Tablet,Oral,02518740,SANDOZ DAPAGLIFLOZIN (dapagliflozin 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9014860,dapagliflozin 10 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100909,Marketed,2023-05-23,02519852,GLN-Dapagliflozin,1,A10BK01,Dapagliflozin,Tablet,Oral,02519852,GLN-DAPAGLIFLOZIN (dapagliflozin 5 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9014863,dapagliflozin 5 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100910,Marketed,2023-05-23,02519860,GLN-Dapagliflozin,1,A10BK01,Dapagliflozin,Tablet,Oral,02519860,GLN-DAPAGLIFLOZIN (dapagliflozin 10 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9014860,dapagliflozin 10 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101624,Marketed,2023-05-16,02527189,Apo-Dapagliflozin,1,A10BK01,Dapagliflozin,Tablet,Oral,02527189,APO-DAPAGLIFLOZIN (dapagliflozin 5 mg oral tablet) APOTEX INC,Active,9014863,dapagliflozin 5 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101625,Marketed,2023-05-16,02527197,Apo-Dapagliflozin,1,A10BK01,Dapagliflozin,Tablet,Oral,02527197,APO-DAPAGLIFLOZIN (dapagliflozin 10 mg oral tablet) APOTEX INC,Active,9014860,dapagliflozin 10 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101817,Marketed,2023-06-06,02528975,Riva-Dapagliflozin,1,A10BK01,Dapagliflozin,Tablet,Oral,02528975,RIVA-DAPAGLIFLOZIN (dapagliflozin 5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9014863,dapagliflozin 5 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101818,Marketed,2023-06-06,02528983,Riva-Dapagliflozin,1,A10BK01,Dapagliflozin,Tablet,Oral,02528983,RIVA-DAPAGLIFLOZIN (dapagliflozin 10 mg oral tablet) LABORATOIRE RIVA INC.,Active,9014860,dapagliflozin 10 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102050,Marketed,2023-05-15,02531364,JAMP Dapagliflozin,1,A10BK01,Dapagliflozin,Tablet,Oral,02531364,JAMP DAPAGLIFLOZIN (dapagliflozin 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9014863,dapagliflozin 5 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102051,Marketed,2023-05-15,02531372,JAMP Dapagliflozin,1,A10BK01,Dapagliflozin,Tablet,Oral,02531372,JAMP DAPAGLIFLOZIN (dapagliflozin 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9014860,dapagliflozin 10 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102054,Marketed,2023-05-16,02531402,Auro-Dapagliflozin,1,A10BK01,Dapagliflozin,Tablet,Oral,02531402,AURO-DAPAGLIFLOZIN (dapagliflozin 5 mg oral tablet) AURO PHARMA INC,Active,9014863,dapagliflozin 5 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102055,Marketed,2023-05-16,02531410,Auro-Dapagliflozin,1,A10BK01,Dapagliflozin,Tablet,Oral,02531410,AURO-DAPAGLIFLOZIN (dapagliflozin 10 mg oral tablet) AURO PHARMA INC,Active,9014860,dapagliflozin 10 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102067,Marketed,2023-05-15,02531550,PMS-Dapagliflozin,1,A10BK01,Dapagliflozin,Tablet,Oral,02531550,PMS-DAPAGLIFLOZIN (dapagliflozin 5 mg oral tablet) PHARMASCIENCE INC,Active,9014863,dapagliflozin 5 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102068,Marketed,2023-05-15,02531569,PMS-Dapagliflozin,1,A10BK01,Dapagliflozin,Tablet,Oral,02531569,PMS-DAPAGLIFLOZIN (dapagliflozin 10 mg oral tablet) PHARMASCIENCE INC,Active,9014860,dapagliflozin 10 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102206,Marketed,2023-05-15,02533049,AG-Dapagliflozin,1,A10BK01,Dapagliflozin,Tablet,Oral,02533049,AG-DAPAGLIFLOZIN (dapagliflozin 5 mg oral tablet) ANGITA PHARMA INC.,Active,9014863,dapagliflozin 5 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102207,Marketed,2023-05-15,02533057,AG-Dapagliflozin,1,A10BK01,Dapagliflozin,Tablet,Oral,02533057,AG-DAPAGLIFLOZIN (dapagliflozin 10 mg oral tablet) ANGITA PHARMA INC.,Active,9014860,dapagliflozin 10 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102415,Marketed,2023-05-17,02535297,M-Dapagliflozin,1,A10BK01,Dapagliflozin,Tablet,Oral,02535297,M-DAPAGLIFLOZIN (dapagliflozin 5 mg oral tablet) MANTRA PHARMA INC,Active,9014863,dapagliflozin 5 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102416,Marketed,2023-05-17,02535300,M-Dapagliflozin,1,A10BK01,Dapagliflozin,Tablet,Oral,02535300,M-DAPAGLIFLOZIN (dapagliflozin 10 mg oral tablet) MANTRA PHARMA INC,Active,9014860,dapagliflozin 10 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102636,Marketed,2023-05-29,02537656,Pro-Dapagliflozin,1,A10BK01,Dapagliflozin,Tablet,Oral,02537656,PRO-DAPAGLIFLOZIN (dapagliflozin 5 mg oral tablet) PRO DOC LIMITEE,Active,9014863,dapagliflozin 5 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102637,Marketed,2023-05-29,02537664,Pro-Dapagliflozin,1,A10BK01,Dapagliflozin,Tablet,Oral,02537664,PRO-DAPAGLIFLOZIN (dapagliflozin 10 mg oral tablet) PRO DOC LIMITEE,Active,9014860,dapagliflozin 10 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102706,Marketed,2023-08-01,02538334,Nra-Dapagliflozin,1,A10BK01,Dapagliflozin,Tablet,Oral,02538334,NRA-DAPAGLIFLOZIN (dapagliflozin 5 mg oral tablet) NORA PHARMA INC,Active,9014863,dapagliflozin 5 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102707,Marketed,2023-08-01,02538342,Nra-Dapagliflozin,1,A10BK01,Dapagliflozin,Tablet,Oral,02538342,NRA-DAPAGLIFLOZIN (dapagliflozin 10 mg oral tablet) NORA PHARMA INC,Active,9014860,dapagliflozin 10 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103167,Marketed,2026-01-05,02543184,Accel-Dapagliflozin,1,A10BK01,Dapagliflozin,Tablet,Oral,02543184,ACCEL-DAPAGLIFLOZIN (dapagliflozin 5 mg oral tablet) ACCEL PHARMA INC,Active,9014863,dapagliflozin 5 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103168,Marketed,2026-01-05,02543192,Accel-Dapagliflozin,1,A10BK01,Dapagliflozin,Tablet,Oral,02543192,ACCEL-DAPAGLIFLOZIN (dapagliflozin 10 mg oral tablet) ACCEL PHARMA INC,Active,9014860,dapagliflozin 10 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106429,Marketed,2026-05-12,02561328,Dapagliflozin,1,A10BK01,Dapagliflozin,Tablet,Oral,02561328,DAPAGLIFLOZIN (dapagliflozin 5 mg oral tablet) SANIS HEALTH INC,Active,9014863,dapagliflozin 5 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106430,Marketed,2026-05-12,02561336,Dapagliflozin,1,A10BK01,Dapagliflozin,Tablet,Oral,02561336,DAPAGLIFLOZIN (dapagliflozin 10 mg oral tablet) SANIS HEALTH INC,Active,9014860,dapagliflozin 10 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91977,Marketed,2015-01-16,02435462,Forxiga,1,A10BK01,Dapagliflozin,Tablet,Oral,02435462,FORXIGA (dapagliflozin (dapagliflozin propanediol monohydrate) 5 mg oral tablet) ASTRAZENECA CANADA INC,Active,9012664,dapagliflozin (dapagliflozin propanediol) 5 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91978,Marketed,2015-01-16,02435470,Forxiga,1,A10BK01,Dapagliflozin,Tablet,Oral,02435470,FORXIGA (dapagliflozin (dapagliflozin propanediol monohydrate) 10 mg oral tablet) ASTRAZENECA CANADA INC,Active,9012661,dapagliflozin (dapagliflozin propanediol) 10 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76674,Marketed,2020-06-04,02281074,Aczone,1,D10AX05,Dapsone,Gel,Topical,02281074,"ACZONE (dapsone 5 % cutaneous gel) BAUSCH HEALTH, CANADA INC.",Active,9004944,dapsone 5 % cutaneous gel,8001183,dapsone,448598008,Cutaneous,385100002,Gel,,,,,,Prescription
97168,Marketed,2018-11-13,02481227,Mar-Dapsone,1,J04BA02,Dapsone,Tablet,Oral,02481227,MAR-DAPSONE (dapsone 100 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9002656,dapsone 100 mg oral tablet,8001183,dapsone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95367,Marketed,2018-01-17,02465493,Cubicin Rf,1,J01XX09,Daptomycin,Powder for solution,Intravenous,02465493,CUBICIN RF (daptomycin 500 mg per vial powder for solution for injection) CUBIST PHARMACEUTICALS LLC,Active,9004358,daptomycin 500 mg per vial powder for solution for injection,8001184,daptomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
98052,Marketed,2020-11-19,02490463,Daptomycin For Injection,1,J01XX09,Daptomycin,Powder for solution,Intravenous,02490463,DAPTOMYCIN FOR INJECTION (daptomycin 500 mg per vial powder for solution for injection) DR REDDY'S LABORATORIES LTD,Active,9004358,daptomycin 500 mg per vial powder for solution for injection,8001184,daptomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
98087,Marketed,2020-10-27,02490838,Daptomycin For Injection,1,J01XX09,Daptomycin,Powder for solution,Intravenous,02490838,DAPTOMYCIN FOR INJECTION (daptomycin 500 mg per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9004358,daptomycin 500 mg per vial powder for solution for injection,8001184,daptomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
94282,Marketed,2016-07-12,02455951,Darzalex,1,L01FC01,Daratumumab,Solution,Intravenous,02455951,DARZALEX (daratumumab 100 mg per 5 mL solution for injection vial) JANSSEN INC,Active,9013066,daratumumab 100 mg per 5 mL solution for injection vial,8001739,daratumumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
94282,Marketed,2016-07-12,02455951,Darzalex,1,L01FC01,Daratumumab,Solution,Intravenous,02455951,DARZALEX (daratumumab 100 mg per 5 mL solution for injection vial) JANSSEN INC,Active,9013066,daratumumab 100 mg per 5 mL solution for injection vial,8001739,daratumumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
94283,Marketed,2016-07-12,02455978,Darzalex,1,L01FC01,Daratumumab,Solution,Intravenous,02455978,DARZALEX (daratumumab 400 mg per 20 mL solution for injection vial) JANSSEN INC,Active,9013067,daratumumab 400 mg per 20 mL solution for injection vial,8001739,daratumumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
94283,Marketed,2016-07-12,02455978,Darzalex,1,L01FC01,Daratumumab,Solution,Intravenous,02455978,DARZALEX (daratumumab 400 mg per 20 mL solution for injection vial) JANSSEN INC,Active,9013067,daratumumab 400 mg per 20 mL solution for injection vial,8001739,daratumumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
99226,Marketed,2020-08-12,02502712,Darzalex SC,1,L01FC01,Daratumumab,Solution,Subcutaneous,02502712,DARZALEX SC (daratumumab 1800 mg per 15 mL solution for injection vial) JANSSEN INC,Active,9014341,daratumumab 1800 mg per 15 mL solution for injection vial,8001739,daratumumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
99226,Marketed,2020-08-12,02502712,Darzalex SC,1,L01FC01,Daratumumab,Solution,Subcutaneous,02502712,DARZALEX SC (daratumumab 1800 mg per 15 mL solution for injection vial) JANSSEN INC,Active,9014341,daratumumab 1800 mg per 15 mL solution for injection vial,8001739,daratumumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
87706,Marketed,2013-12-11,02391740,Aranesp,1,B03XA02,Darbepoetin alfa,Solution,"Intravenous,Subcutaneous",02391740,ARANESP (darbepoetin alfa 40 mcg per 0.4 mL solution for injection syringe) AMGEN CANADA INC,Active,9012949,darbepoetin alfa 40 mcg per 0.4 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
87706,Marketed,2013-12-11,02391740,Aranesp,1,B03XA02,Darbepoetin alfa,Solution,"Intravenous,Subcutaneous",02391740,ARANESP (darbepoetin alfa 40 mcg per 0.4 mL solution for injection syringe) AMGEN CANADA INC,Active,9012949,darbepoetin alfa 40 mcg per 0.4 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
87707,Marketed,2014-05-07,02391759,Aranesp,1,B03XA02,Darbepoetin alfa,Solution,"Subcutaneous,Intravenous",02391759,ARANESP (darbepoetin alfa 50 mcg per 0.5 mL solution for injection syringe) AMGEN CANADA INC,Active,9012950,darbepoetin alfa 50 mcg per 0.5 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
87707,Marketed,2014-05-07,02391759,Aranesp,1,B03XA02,Darbepoetin alfa,Solution,"Subcutaneous,Intravenous",02391759,ARANESP (darbepoetin alfa 50 mcg per 0.5 mL solution for injection syringe) AMGEN CANADA INC,Active,9012950,darbepoetin alfa 50 mcg per 0.5 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
87708,Marketed,2014-01-27,02391767,Aranesp,1,B03XA02,Darbepoetin alfa,Solution,"Subcutaneous,Intravenous",02391767,ARANESP (darbepoetin alfa 80 mcg per 0.4 mL solution for injection syringe) AMGEN CANADA INC,Active,9012953,darbepoetin alfa 80 mcg per 0.4 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
87708,Marketed,2014-01-27,02391767,Aranesp,1,B03XA02,Darbepoetin alfa,Solution,"Subcutaneous,Intravenous",02391767,ARANESP (darbepoetin alfa 80 mcg per 0.4 mL solution for injection syringe) AMGEN CANADA INC,Active,9012953,darbepoetin alfa 80 mcg per 0.4 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
87709,Marketed,2014-03-26,02391775,Aranesp,1,B03XA02,Darbepoetin alfa,Solution,"Subcutaneous,Intravenous",02391775,ARANESP (darbepoetin alfa 100 mcg per 0.5 mL solution for injection syringe) AMGEN CANADA INC,Active,9012942,darbepoetin alfa 100 mcg per 0.5 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
87709,Marketed,2014-03-26,02391775,Aranesp,1,B03XA02,Darbepoetin alfa,Solution,"Subcutaneous,Intravenous",02391775,ARANESP (darbepoetin alfa 100 mcg per 0.5 mL solution for injection syringe) AMGEN CANADA INC,Active,9012942,darbepoetin alfa 100 mcg per 0.5 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
87710,Marketed,2014-02-10,02391783,Aranesp,1,B03XA02,Darbepoetin alfa,Solution,"Subcutaneous,Intravenous",02391783,ARANESP (darbepoetin alfa 130 mcg per 0.65 mL solution for injection syringe) AMGEN CANADA INC,Active,9012943,darbepoetin alfa 130 mcg per 0.65 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
87710,Marketed,2014-02-10,02391783,Aranesp,1,B03XA02,Darbepoetin alfa,Solution,"Subcutaneous,Intravenous",02391783,ARANESP (darbepoetin alfa 130 mcg per 0.65 mL solution for injection syringe) AMGEN CANADA INC,Active,9012943,darbepoetin alfa 130 mcg per 0.65 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
87711,Marketed,2014-04-21,02391791,Aranesp,1,B03XA02,Darbepoetin alfa,Solution,"Intravenous,Subcutaneous",02391791,ARANESP (darbepoetin alfa 150 mcg per 0.3 mL solution for injection syringe) AMGEN CANADA INC,Active,9012944,darbepoetin alfa 150 mcg per 0.3 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
87711,Marketed,2014-04-21,02391791,Aranesp,1,B03XA02,Darbepoetin alfa,Solution,"Intravenous,Subcutaneous",02391791,ARANESP (darbepoetin alfa 150 mcg per 0.3 mL solution for injection syringe) AMGEN CANADA INC,Active,9012944,darbepoetin alfa 150 mcg per 0.3 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
87712,Marketed,2014-05-05,02391805,Aranesp,1,B03XA02,Darbepoetin alfa,Solution,"Subcutaneous,Intravenous",02391805,ARANESP (darbepoetin alfa 200 mcg per 0.4 mL solution for injection syringe) AMGEN CANADA INC,Active,9012946,darbepoetin alfa 200 mcg per 0.4 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
87712,Marketed,2014-05-05,02391805,Aranesp,1,B03XA02,Darbepoetin alfa,Solution,"Subcutaneous,Intravenous",02391805,ARANESP (darbepoetin alfa 200 mcg per 0.4 mL solution for injection syringe) AMGEN CANADA INC,Active,9012946,darbepoetin alfa 200 mcg per 0.4 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
87714,Marketed,2013-11-04,02391821,Aranesp,1,B03XA02,Darbepoetin alfa,Solution,"Subcutaneous,Intravenous",02391821,ARANESP (darbepoetin alfa 300 mcg per 0.6 mL solution for injection syringe) AMGEN CANADA INC,Active,9012948,darbepoetin alfa 300 mcg per 0.6 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
87714,Marketed,2013-11-04,02391821,Aranesp,1,B03XA02,Darbepoetin alfa,Solution,"Subcutaneous,Intravenous",02391821,ARANESP (darbepoetin alfa 300 mcg per 0.6 mL solution for injection syringe) AMGEN CANADA INC,Active,9012948,darbepoetin alfa 300 mcg per 0.6 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
87760,Marketed,2013-08-16,02392313,Aranesp,1,B03XA02,Darbepoetin alfa,Solution,"Intravenous,Subcutaneous",02392313,ARANESP (darbepoetin alfa 10 mcg per 0.4 mL solution for injection syringe) AMGEN CANADA INC,Active,9012941,darbepoetin alfa 10 mcg per 0.4 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
87760,Marketed,2013-08-16,02392313,Aranesp,1,B03XA02,Darbepoetin alfa,Solution,"Intravenous,Subcutaneous",02392313,ARANESP (darbepoetin alfa 10 mcg per 0.4 mL solution for injection syringe) AMGEN CANADA INC,Active,9012941,darbepoetin alfa 10 mcg per 0.4 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
87761,Marketed,2014-03-12,02392321,Aranesp,1,B03XA02,Darbepoetin alfa,Solution,"Subcutaneous,Intravenous",02392321,ARANESP (darbepoetin alfa 20 mcg per 0.5 mL solution for injection syringe) AMGEN CANADA INC,Active,9012945,darbepoetin alfa 20 mcg per 0.5 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
87761,Marketed,2014-03-12,02392321,Aranesp,1,B03XA02,Darbepoetin alfa,Solution,"Subcutaneous,Intravenous",02392321,ARANESP (darbepoetin alfa 20 mcg per 0.5 mL solution for injection syringe) AMGEN CANADA INC,Active,9012945,darbepoetin alfa 20 mcg per 0.5 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
87762,Marketed,2014-03-03,02392348,Aranesp,1,B03XA02,Darbepoetin alfa,Solution,"Subcutaneous,Intravenous",02392348,ARANESP (darbepoetin alfa 30 mcg per 0.3 mL solution for injection syringe) AMGEN CANADA INC,Active,9012947,darbepoetin alfa 30 mcg per 0.3 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
87762,Marketed,2014-03-03,02392348,Aranesp,1,B03XA02,Darbepoetin alfa,Solution,"Subcutaneous,Intravenous",02392348,ARANESP (darbepoetin alfa 30 mcg per 0.3 mL solution for injection syringe) AMGEN CANADA INC,Active,9012947,darbepoetin alfa 30 mcg per 0.3 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
87763,Marketed,2014-04-03,02392356,Aranesp,1,B03XA02,Darbepoetin alfa,Solution,"Subcutaneous,Intravenous",02392356,ARANESP (darbepoetin alfa 60 mcg per 0.3 mL solution for injection syringe) AMGEN CANADA INC,Active,9012952,darbepoetin alfa 60 mcg per 0.3 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
87763,Marketed,2014-04-03,02392356,Aranesp,1,B03XA02,Darbepoetin alfa,Solution,"Subcutaneous,Intravenous",02392356,ARANESP (darbepoetin alfa 60 mcg per 0.3 mL solution for injection syringe) AMGEN CANADA INC,Active,9012952,darbepoetin alfa 60 mcg per 0.3 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
87764,Marketed,2014-02-24,02392364,Aranesp,1,B03XA02,Darbepoetin alfa,Solution,"Intravenous,Subcutaneous",02392364,ARANESP (darbepoetin alfa 500 mcg per 1 mL solution for injection syringe) AMGEN CANADA INC,Active,9012951,darbepoetin alfa 500 mcg per 1 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
87764,Marketed,2014-02-24,02392364,Aranesp,1,B03XA02,Darbepoetin alfa,Solution,"Intravenous,Subcutaneous",02392364,ARANESP (darbepoetin alfa 500 mcg per 1 mL solution for injection syringe) AMGEN CANADA INC,Active,9012951,darbepoetin alfa 500 mcg per 1 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
102616,Marketed,2023-07-12,02537443,Quviviq,1,N05CJ03,Daridorexant,Tablet,Oral,02537443,QUVIVIQ (daridorexant (daridorexant hydrochloride) 50 mg oral tablet) IDORSIA PHARMACEUTICALS LTD,Active,9014890,daridorexant (daridorexant hydrochloride) 50 mg oral tablet,8002471,daridorexant,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75871,Marketed,2019-04-02,02273217,Enablex,1,G04BD10,Darifenacin,Tablet (extended-release),Oral,02273217,ENABLEX (darifenacin (darifenacin hydrobromide) 7.5 mg prolonged-release oral tablet) SEARCHLIGHT PHARMA INC,Active,9004148,darifenacin (darifenacin hydrobromide) 7.5 mg prolonged-release oral tablet,8001114,darifenacin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75872,Marketed,2019-04-02,02273225,Enablex,1,G04BD10,Darifenacin,Tablet (extended-release),Oral,02273225,ENABLEX (darifenacin (darifenacin hydrobromide) 15 mg prolonged-release oral tablet) SEARCHLIGHT PHARMA INC,Active,9004147,darifenacin (darifenacin hydrobromide) 15 mg prolonged-release oral tablet,8001114,darifenacin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93889,Marketed,2021-07-28,02452529,Apo-Darifenacin,1,G04BD10,Darifenacin,Tablet (extended-release),Oral,02452529,APO-DARIFENACIN (darifenacin (darifenacin hydrobromide) 15 mg prolonged-release oral tablet) APOTEX INC,Active,9004147,darifenacin (darifenacin hydrobromide) 15 mg prolonged-release oral tablet,8001114,darifenacin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93890,Marketed,2021-07-28,02452510,Apo-Darifenacin,1,G04BD10,Darifenacin,Tablet (extended-release),Oral,02452510,APO-DARIFENACIN (darifenacin (darifenacin hydrobromide) 7.5 mg prolonged-release oral tablet) APOTEX INC,Active,9004148,darifenacin (darifenacin hydrobromide) 7.5 mg prolonged-release oral tablet,8001114,darifenacin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98186,Marketed,2021-12-24,02491869,JAMP Darifenacin,1,G04BD10,Darifenacin,Tablet (extended-release),Oral,02491869,JAMP DARIFENACIN (darifenacin (darifenacin hydrobromide) 7.5 mg prolonged-release oral tablet) JAMP PHARMA CORPORATION,Active,9004148,darifenacin (darifenacin hydrobromide) 7.5 mg prolonged-release oral tablet,8001114,darifenacin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98187,Marketed,2021-12-24,02491877,JAMP Darifenacin,1,G04BD10,Darifenacin,Tablet (extended-release),Oral,02491877,JAMP DARIFENACIN (darifenacin (darifenacin hydrobromide) 15 mg prolonged-release oral tablet) JAMP PHARMA CORPORATION,Active,9004147,darifenacin (darifenacin hydrobromide) 15 mg prolonged-release oral tablet,8001114,darifenacin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98622,Marketed,2020-03-24,02496348,Nubeqa,1,L02BB06,Darolutamide,Tablet,Oral,02496348,NUBEQA (darolutamide 300 mg oral tablet) BAYER INC,Active,9014289,darolutamide 300 mg oral tablet,8002324,darolutamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101054,Marketed,2022-04-25,02521342,Darunavir,1,J05AE10,Darunavir,Tablet,Oral,02521342,DARUNAVIR (darunavir 600 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004524,darunavir 600 mg oral tablet,8001185,darunavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101055,Marketed,2022-04-25,02521350,Darunavir,1,J05AE10,Darunavir,Tablet,Oral,02521350,DARUNAVIR (darunavir 800 mg oral tablet) JAMP PHARMA CORPORATION,Active,9005128,darunavir 800 mg oral tablet,8001185,darunavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97636,Marketed,2020-03-18,02486121,Auro-Darunavir,1,J05AE10,Darunavir,Tablet,Oral,02486121,AURO-DARUNAVIR (darunavir (darunavir propylene glycolate) 600 mg oral tablet) AURO PHARMA INC,Active,9004524,darunavir 600 mg oral tablet,8001185,darunavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97637,Marketed,2020-03-18,02486148,Auro-Darunavir,1,J05AE10,Darunavir,Tablet,Oral,02486148,AURO-DARUNAVIR (darunavir (darunavir propylene glycolate) 800 mg oral tablet) AURO PHARMA INC,Active,9005128,darunavir 800 mg oral tablet,8001185,darunavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97741,Marketed,2020-02-14,02487241,Apo-Darunavir,1,J05AE10,Darunavir,Tablet,Oral,02487241,APO-DARUNAVIR (darunavir 600 mg oral tablet) APOTEX INC,Active,9004524,darunavir 600 mg oral tablet,8001185,darunavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97742,Marketed,2020-02-14,02487268,Apo-Darunavir,1,J05AE10,Darunavir,Tablet,Oral,02487268,APO-DARUNAVIR (darunavir 800 mg oral tablet) APOTEX INC,Active,9005128,darunavir 800 mg oral tablet,8001185,darunavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91108,Marketed,2014-08-28,02426501,Prezcobix,2,J05AR14,Darunavir and cobicistat,Tablet,Oral,02426501,PREZCOBIX (cobicistat 150 mg and darunavir (darunavir ethanolate) 800 mg oral tablet) JANSSEN INC,Active,9005578,cobicistat 150 mg and darunavir 800 mg oral tablet,8001312,cobicistat and darunavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100414,Marketed,2021-09-16,02514737,Reddy-daSATinib,1,L01EA02,Dasatinib,Tablet,Oral,02514737,REDDY-DASATINIB (dasatinib (dasatinib (s)-propylene glycol) 20 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9013070,dasatinib 20 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100415,Marketed,2021-09-16,02514745,Reddy-daSATinib,1,L01EA02,Dasatinib,Tablet,Oral,02514745,REDDY-DASATINIB (dasatinib (dasatinib (s)-propylene glycol) 50 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9013071,dasatinib 50 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100416,Marketed,2021-09-16,02514753,Reddy-daSATinib,1,L01EA02,Dasatinib,Tablet,Oral,02514753,REDDY-DASATINIB (dasatinib (dasatinib (s)-propylene glycol) 70 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9013072,dasatinib 70 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100417,Marketed,2021-09-16,02514761,Reddy-daSATinib,1,L01EA02,Dasatinib,Tablet,Oral,02514761,REDDY-DASATINIB (dasatinib (dasatinib (s)-propylene glycol) 80 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9013073,dasatinib 80 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100418,Marketed,2021-09-16,02514788,Reddy-daSATinib,1,L01EA02,Dasatinib,Tablet,Oral,02514788,REDDY-DASATINIB (dasatinib (dasatinib (s)-propylene glycol) 100 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9013068,dasatinib 100 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100419,Marketed,2021-09-16,02514796,Reddy-daSATinib,1,L01EA02,Dasatinib,Tablet,Oral,02514796,REDDY-DASATINIB (dasatinib (dasatinib (s)-propylene glycol) 140 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9013069,dasatinib 140 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
77850,Marketed,2007-04-13,02293129,Sprycel,1,L01EA02,Dasatinib,Tablet,Oral,02293129,SPRYCEL (dasatinib (dasatinib monohydrate) 20 mg oral tablet) BRISTOL-MYERS SQUIBB CANADA,Active,9013070,dasatinib 20 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
77851,Marketed,2007-04-13,02293137,Sprycel,1,L01EA02,Dasatinib,Tablet,Oral,02293137,SPRYCEL (dasatinib (dasatinib monohydrate) 50 mg oral tablet) BRISTOL-MYERS SQUIBB CANADA,Active,9013071,dasatinib 50 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
77852,Marketed,2007-04-13,02293145,Sprycel,1,L01EA02,Dasatinib,Tablet,Oral,02293145,SPRYCEL (dasatinib (dasatinib monohydrate) 70 mg oral tablet) BRISTOL-MYERS SQUIBB CANADA,Active,9013072,dasatinib 70 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
80564,Marketed,2009-05-04,02320193,Sprycel,1,L01EA02,Dasatinib,Tablet,Oral,02320193,SPRYCEL (dasatinib (dasatinib monohydrate) 100 mg oral tablet) BRISTOL-MYERS SQUIBB CANADA,Active,9013068,dasatinib 100 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
84581,Marketed,2011-09-02,02360810,Sprycel,1,L01EA02,Dasatinib,Tablet,Oral,02360810,SPRYCEL (dasatinib (dasatinib monohydrate) 80 mg oral tablet) BRISTOL-MYERS SQUIBB CANADA,Active,9013073,dasatinib 80 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
84582,Marketed,2011-03-29,02360829,Sprycel,1,L01EA02,Dasatinib,Tablet,Oral,02360829,SPRYCEL (dasatinib (dasatinib monohydrate) 140 mg oral tablet) BRISTOL-MYERS SQUIBB CANADA,Active,9013069,dasatinib 140 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
95971,Marketed,2020-01-06,02470705,Apo-daSATinib,1,L01EA02,Dasatinib,Tablet,Oral,02470705,APO-DASATINIB (dasatinib 20 mg oral tablet) APOTEX INC,Active,9013070,dasatinib 20 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
95972,Marketed,2020-01-06,02470713,Apo-daSATinib,1,L01EA02,Dasatinib,Tablet,Oral,02470713,APO-DASATINIB (dasatinib 50 mg oral tablet) APOTEX INC,Active,9013071,dasatinib 50 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
95973,Marketed,2020-01-06,02470721,Apo-daSATinib,1,L01EA02,Dasatinib,Tablet,Oral,02470721,APO-DASATINIB (dasatinib 100 mg oral tablet) APOTEX INC,Active,9013068,dasatinib 100 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
96907,Marketed,2021-05-05,02478307,Teva-daSATinib,1,L01EA02,Dasatinib,Tablet,Oral,02478307,TEVA-DASATINIB (dasatinib (dasatinib monohydrate) 20 mg oral tablet) TEVA CANADA LIMITED,Active,9013070,dasatinib 20 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
96908,Marketed,2021-05-05,02478315,Teva-daSATinib,1,L01EA02,Dasatinib,Tablet,Oral,02478315,TEVA-DASATINIB (dasatinib (dasatinib monohydrate) 50 mg oral tablet) TEVA CANADA LIMITED,Active,9013071,dasatinib 50 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
96909,Marketed,2021-05-05,02478323,Teva-daSATinib,1,L01EA02,Dasatinib,Tablet,Oral,02478323,TEVA-DASATINIB (dasatinib (dasatinib monohydrate) 70 mg oral tablet) TEVA CANADA LIMITED,Active,9013072,dasatinib 70 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
96910,Marketed,2021-05-05,02478331,Teva-daSATinib,1,L01EA02,Dasatinib,Tablet,Oral,02478331,TEVA-DASATINIB (dasatinib (dasatinib monohydrate) 80 mg oral tablet) TEVA CANADA LIMITED,Active,9013073,dasatinib 80 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
96911,Marketed,2021-05-05,02478358,Teva-daSATinib,1,L01EA02,Dasatinib,Tablet,Oral,02478358,TEVA-DASATINIB (dasatinib (dasatinib monohydrate) 100 mg oral tablet) TEVA CANADA LIMITED,Active,9013068,dasatinib 100 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
97193,Marketed,2020-01-06,02481499,Apo-daSATinib,1,L01EA02,Dasatinib,Tablet,Oral,02481499,APO-DASATINIB (dasatinib 70 mg oral tablet) APOTEX INC,Active,9013072,dasatinib 70 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
97194,Marketed,2020-01-06,02481502,Apo-daSATinib,1,L01EA02,Dasatinib,Tablet,Oral,02481502,APO-DASATINIB (dasatinib 80 mg oral tablet) APOTEX INC,Active,9013073,dasatinib 80 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98902,Marketed,2021-03-04,02499282,Taro-daSATinib,1,L01EA02,Dasatinib,Tablet,Oral,02499282,TARO-DASATINIB (dasatinib 20 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9013070,dasatinib 20 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98904,Marketed,2021-03-04,02499304,Taro-daSATinib,1,L01EA02,Dasatinib,Tablet,Oral,02499304,TARO-DASATINIB (dasatinib 50 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9013071,dasatinib 50 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98905,Marketed,2021-03-04,02499312,Taro-daSATinib,1,L01EA02,Dasatinib,Tablet,Oral,02499312,TARO-DASATINIB (dasatinib 70 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9013072,dasatinib 70 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98906,Marketed,2021-03-04,02499320,Taro-daSATinib,1,L01EA02,Dasatinib,Tablet,Oral,02499320,TARO-DASATINIB (dasatinib 80 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9013073,dasatinib 80 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98907,Marketed,2021-03-04,02499339,Taro-daSATinib,1,L01EA02,Dasatinib,Tablet,Oral,02499339,TARO-DASATINIB (dasatinib 100 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9013068,dasatinib 100 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98908,Marketed,2021-03-04,02499347,Taro-daSATinib,1,L01EA02,Dasatinib,Tablet,Oral,02499347,TARO-DASATINIB (dasatinib 140 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9013069,dasatinib 140 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102786,Marketed,2024-01-31,02539209,DAUNOrubicin Hydrochloride Injection,1,L01DB02,Daunorubicin,Solution,Intravenous,02539209,DAUNORUBICIN HYDROCHLORIDE INJECTION (daunorubicin (daunorubicin hydrochloride) 20 mg per 4 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9015013,daunorubicin (daunorubicin hydrochloride) 20 mg per 4 mL solution for injection vial,8001741,daunorubicin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
13226,Marketed,2022-10-14,01926683,Cerubidine,1,L01DB02,Daunorubicin,Powder for solution,Intravenous,01926683,CERUBIDINE (daunorubicin (daunorubicin hydrochloride) 20 mg per vial powder for solution for injection) SEARCHLIGHT PHARMA INC,Active,9001671,daunorubicin (daunorubicin hydrochloride) 20 mg per vial powder for solution for injection,8001741,daunorubicin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
97510,Marketed,2021-03-24,02484811,Demylocan,1,L01BC08,Decitabine,Powder,Intravenous,02484811,DEMYLOCAN (decitabine 50 mg per vial powder for solution for injection) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9014535,decitabine 50 mg per vial powder for solution for injection,8002370,decitabine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99121,Marketed,2025-06-04,02501600,Inqovi,2,L01BC58,"Decitabine, combinations",Tablet,Oral,02501600,"INQOVI (cedazuridine 100 mg and decitabine 35 mg oral tablet) TAIHO PHARMA CANADA, INC.",Active,9014398,cedazuridine 100 mg and decitabine 35 mg oral tablet,8002348,cedazuridine and decitabine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101695,Marketed,2024-08-14,02527774,Auro-Deferasirox (Type J),1,V03AC03,Deferasirox,Tablet,Oral,02527774,AURO-DEFERASIROX (TYPE J) (deferasirox 90 mg oral tablet) AURO PHARMA INC,Active,9005917,deferasirox 90 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101696,Marketed,2024-08-14,02527782,Auro-Deferasirox (Type J),1,V03AC03,Deferasirox,Tablet,Oral,02527782,AURO-DEFERASIROX (TYPE J) (deferasirox 180 mg oral tablet) AURO PHARMA INC,Active,9005915,deferasirox 180 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101697,Marketed,2024-08-14,02527790,Auro-Deferasirox (Type J),1,V03AC03,Deferasirox,Tablet,Oral,02527790,AURO-DEFERASIROX (TYPE J) (deferasirox 360 mg oral tablet) AURO PHARMA INC,Active,9005916,deferasirox 360 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101753,Marketed,2022-08-31,02528290,PMS-Deferasirox (Type J),1,V03AC03,Deferasirox,Tablet,Oral,02528290,PMS-DEFERASIROX (TYPE J) (deferasirox 90 mg oral tablet) PHARMASCIENCE INC,Active,9005917,deferasirox 90 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101754,Marketed,2022-09-30,02528304,PMS-Deferasirox (Type J),1,V03AC03,Deferasirox,Tablet,Oral,02528304,PMS-DEFERASIROX (TYPE J) (deferasirox 180 mg oral tablet) PHARMASCIENCE INC,Active,9005915,deferasirox 180 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101755,Marketed,2022-08-31,02528312,PMS-Deferasirox (Type J),1,V03AC03,Deferasirox,Tablet,Oral,02528312,PMS-DEFERASIROX (TYPE J) (deferasirox 360 mg oral tablet) PHARMASCIENCE INC,Active,9005916,deferasirox 360 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77283,Marketed,2006-11-10,02287420,Exjade,1,V03AC03,Deferasirox,Tablet for suspension,Oral,02287420,EXJADE (deferasirox 125 mg dispersible oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9004226,deferasirox 125 mg dispersible oral tablet,8001626,deferasirox,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77284,Marketed,2006-11-10,02287439,Exjade,1,V03AC03,Deferasirox,Tablet for suspension,Oral,02287439,EXJADE (deferasirox 250 mg dispersible oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9004227,deferasirox 250 mg dispersible oral tablet,8001626,deferasirox,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77285,Marketed,2006-11-10,02287447,Exjade,1,V03AC03,Deferasirox,Tablet for suspension,Oral,02287447,EXJADE (deferasirox 500 mg dispersible oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9004228,deferasirox 500 mg dispersible oral tablet,8001626,deferasirox,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93864,Marketed,2016-03-24,02452219,Jadenu,1,V03AC03,Deferasirox,Tablet,Oral,02452219,JADENU (deferasirox 90 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9005917,deferasirox 90 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93865,Marketed,2016-03-24,02452227,Jadenu,1,V03AC03,Deferasirox,Tablet,Oral,02452227,JADENU (deferasirox 180 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9005915,deferasirox 180 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93866,Marketed,2016-03-24,02452235,Jadenu,1,V03AC03,Deferasirox,Tablet,Oral,02452235,JADENU (deferasirox 360 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9005916,deferasirox 360 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94918,Marketed,2017-06-26,02461544,Apo-Deferasirox,1,V03AC03,Deferasirox,Tablet for suspension,Oral,02461544,APO-DEFERASIROX (deferasirox 125 mg dispersible oral tablet) APOTEX INC,Active,9004226,deferasirox 125 mg dispersible oral tablet,8001626,deferasirox,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94919,Marketed,2017-06-29,02461552,Apo-Deferasirox,1,V03AC03,Deferasirox,Tablet for suspension,Oral,02461552,APO-DEFERASIROX (deferasirox 250 mg dispersible oral tablet) APOTEX INC,Active,9004227,deferasirox 250 mg dispersible oral tablet,8001626,deferasirox,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94920,Marketed,2017-06-26,02461560,Apo-Deferasirox,1,V03AC03,Deferasirox,Tablet for suspension,Oral,02461560,APO-DEFERASIROX (deferasirox 500 mg dispersible oral tablet) APOTEX INC,Active,9004228,deferasirox 500 mg dispersible oral tablet,8001626,deferasirox,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95161,Marketed,2017-06-26,02463520,Taro-Deferasirox,1,V03AC03,Deferasirox,Tablet for suspension,Oral,02463520,TARO-DEFERASIROX (deferasirox 125 mg dispersible oral tablet) TARO PHARMACEUTICALS INC,Active,9004226,deferasirox 125 mg dispersible oral tablet,8001626,deferasirox,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95162,Marketed,2017-06-26,02463539,Taro-Deferasirox,1,V03AC03,Deferasirox,Tablet for suspension,Oral,02463539,TARO-DEFERASIROX (deferasirox 250 mg dispersible oral tablet) TARO PHARMACEUTICALS INC,Active,9004227,deferasirox 250 mg dispersible oral tablet,8001626,deferasirox,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95163,Marketed,2017-06-30,02463547,Taro-Deferasirox,1,V03AC03,Deferasirox,Tablet for suspension,Oral,02463547,TARO-DEFERASIROX (deferasirox 500 mg dispersible oral tablet) TARO PHARMACEUTICALS INC,Active,9004228,deferasirox 500 mg dispersible oral tablet,8001626,deferasirox,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95259,Marketed,2017-07-04,02464454,Sandoz Deferasirox,1,V03AC03,Deferasirox,Tablet for suspension,Oral,02464454,SANDOZ DEFERASIROX (deferasirox 125 mg dispersible oral tablet) SANDOZ CANADA INCORPORATED,Active,9004226,deferasirox 125 mg dispersible oral tablet,8001626,deferasirox,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95260,Marketed,2017-07-04,02464462,Sandoz Deferasirox,1,V03AC03,Deferasirox,Tablet for suspension,Oral,02464462,SANDOZ DEFERASIROX (deferasirox 250 mg dispersible oral tablet) SANDOZ CANADA INCORPORATED,Active,9004227,deferasirox 250 mg dispersible oral tablet,8001626,deferasirox,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95261,Marketed,2017-07-04,02464470,Sandoz Deferasirox,1,V03AC03,Deferasirox,Tablet for suspension,Oral,02464470,SANDOZ DEFERASIROX (deferasirox 500 mg dispersible oral tablet) SANDOZ CANADA INCORPORATED,Active,9004228,deferasirox 500 mg dispersible oral tablet,8001626,deferasirox,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96437,Marketed,2018-04-25,02474328,PMS-Deferasirox,1,V03AC03,Deferasirox,Tablet for suspension,Oral,02474328,PMS-DEFERASIROX (deferasirox 125 mg dispersible oral tablet) PHARMASCIENCE INC,Active,9004226,deferasirox 125 mg dispersible oral tablet,8001626,deferasirox,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96438,Marketed,2018-04-25,02474336,PMS-Deferasirox,1,V03AC03,Deferasirox,Tablet for suspension,Oral,02474336,PMS-DEFERASIROX (deferasirox 250 mg dispersible oral tablet) PHARMASCIENCE INC,Active,9004227,deferasirox 250 mg dispersible oral tablet,8001626,deferasirox,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96439,Marketed,2018-04-25,02474344,PMS-Deferasirox,1,V03AC03,Deferasirox,Tablet for suspension,Oral,02474344,PMS-DEFERASIROX (deferasirox 500 mg dispersible oral tablet) PHARMASCIENCE INC,Active,9004228,deferasirox 500 mg dispersible oral tablet,8001626,deferasirox,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97553,Marketed,2019-05-29,02485265,Apo-Deferasirox (Type J),1,V03AC03,Deferasirox,Tablet,Oral,02485265,APO-DEFERASIROX (TYPE J) (deferasirox 90 mg oral tablet) APOTEX INC,Active,9005917,deferasirox 90 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97554,Marketed,2019-05-29,02485273,Apo-Deferasirox (Type J),1,V03AC03,Deferasirox,Tablet,Oral,02485273,APO-DEFERASIROX (TYPE J) (deferasirox 180 mg oral tablet) APOTEX INC,Active,9005915,deferasirox 180 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97555,Marketed,2019-05-29,02485281,Apo-Deferasirox (Type J),1,V03AC03,Deferasirox,Tablet,Oral,02485281,APO-DEFERASIROX (TYPE J) (deferasirox 360 mg oral tablet) APOTEX INC,Active,9005916,deferasirox 360 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97996,Marketed,2021-04-19,02489899,Sandoz Deferasirox (Type J),1,V03AC03,Deferasirox,Tablet,Oral,02489899,SANDOZ DEFERASIROX (TYPE J) (deferasirox 90 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005917,deferasirox 90 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97997,Marketed,2021-04-19,02489902,Sandoz Deferasirox (Type J),1,V03AC03,Deferasirox,Tablet,Oral,02489902,SANDOZ DEFERASIROX (TYPE J) (deferasirox 180 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005915,deferasirox 180 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97998,Marketed,2021-04-19,02489910,Sandoz Deferasirox (Type J),1,V03AC03,Deferasirox,Tablet,Oral,02489910,SANDOZ DEFERASIROX (TYPE J) (deferasirox 360 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005916,deferasirox 360 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99672,Marketed,2021-03-04,02507315,Taro-Deferasirox (Type J),1,V03AC03,Deferasirox,Tablet,Oral,02507315,TARO-DEFERASIROX (TYPE J) (deferasirox 90 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9005917,deferasirox 90 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99673,Marketed,2021-03-04,02507323,Taro-Deferasirox (Type J),1,V03AC03,Deferasirox,Tablet,Oral,02507323,TARO-DEFERASIROX (TYPE J) (deferasirox 180 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9005915,deferasirox 180 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99674,Marketed,2021-03-04,02507331,Taro-Deferasirox (Type J),1,V03AC03,Deferasirox,Tablet,Oral,02507331,TARO-DEFERASIROX (TYPE J) (deferasirox 360 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9005916,deferasirox 360 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102533,Marketed,2023-06-05,02536579,Ferriprox MR,1,V03AC02,Deferiprone,Tablet (extended-release),Oral,02536579,FERRIPROX MR (deferiprone 1000 mg prolonged-release oral tablet) CHIESI CANADA CORP.,Active,9014864,deferiprone 1000 mg prolonged-release oral tablet,8001627,deferiprone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
104207,Marketed,2025-03-03,02553112,Taro-Deferiprone,1,V03AC02,Deferiprone,Tablet,Oral,02553112,TARO-DEFERIPRONE (deferiprone 1000 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9005707,deferiprone 1000 mg oral tablet,8001627,deferiprone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
92086,Marketed,2020-03-12,02436523,Ferriprox,1,V03AC02,Deferiprone,Solution,Oral,02436523,FERRIPROX (deferiprone 500 mg per 5 mL oral solution) CHIESI CANADA CORP.,Active,9013813,deferiprone 500 mg per 5 mL oral solution,8001627,deferiprone,26643006,Oral,385023001,Oral solution,,,1.0,,,Prescription
92087,Marketed,2020-03-12,02436531,Ferriprox,1,V03AC02,Deferiprone,Tablet,Oral,02436531,FERRIPROX (deferiprone 500 mg oral tablet) CHIESI CANADA CORP.,Active,9005913,deferiprone 500 mg oral tablet,8001627,deferiprone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
92088,Marketed,2020-03-12,02436558,Ferriprox,1,V03AC02,Deferiprone,Tablet,Oral,02436558,FERRIPROX (deferiprone 1000 mg oral tablet) CHIESI CANADA CORP.,Active,9005707,deferiprone 1000 mg oral tablet,8001627,deferiprone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
13546,Marketed,1999-05-10,01981242,Desferal 500 mg,1,V03AC01,Deferoxamine,Powder for solution,"Intramuscular,Intravenous,Intraperitoneal,Subcutaneous",01981242,DESFERAL 500MG (deferoxamine mesylate 500 mg per vial powder for solution for injection) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9002445,deferoxamine mesylate 500 mg per vial powder for solution for injection,8001742,deferoxamine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
65257,Marketed,2017-07-12,02241600,Deferoxamine Mesylate For Injection,1,V03AC01,Deferoxamine,Powder for solution,"Intravenous,Subcutaneous,Intraperitoneal,Intramuscular",02241600,DEFEROXAMINE MESYLATE FOR INJECTION (deferoxamine mesylate 500 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9002445,deferoxamine mesylate 500 mg per vial powder for solution for injection,8001742,deferoxamine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
71256,Marketed,2018-08-08,02247022,Deferoxamine Mesylate For Injection,1,V03AC01,Deferoxamine,Powder for solution,"Intravenous,Intraperitoneal,Intramuscular,Subcutaneous",02247022,DEFEROXAMINE MESYLATE FOR INJECTION (deferoxamine mesylate 2 g per vial powder for solution for injection) PFIZER CANADA ULC,Active,9003634,deferoxamine mesylate 2 g per vial powder for solution for injection,8001742,deferoxamine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
95424,Marketed,2017-09-06,02465981,Defitelio,1,B01AX01,Defibrotide,Solution,Intravenous,02465981,DEFITELIO (defibrotide 200 mg per 2.5 mL solution for injection vial) JAZZ PHARMACEUTICALS IRELAND LIMITED,Active,9012482,defibrotide 200 mg per 2.5 mL solution for injection vial,8001133,defibrotide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
95424,Marketed,2017-09-06,02465981,Defitelio,1,B01AX01,Defibrotide,Solution,Intravenous,02465981,DEFITELIO (defibrotide 200 mg per 2.5 mL solution for injection vial) JAZZ PHARMACEUTICALS IRELAND LIMITED,Active,9012482,defibrotide 200 mg per 2.5 mL solution for injection vial,8001133,defibrotide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
82263,Marketed,2009-11-24,02337029,Firmagon,1,L02BX02,Degarelix,Powder for solution,Subcutaneous,02337029,FIRMAGON (degarelix (degarelix acetate) 80 mg per vial powder for solution for injection with diluent solution syringe) FERRING INC,Active,9013075,degarelix (degarelix acetate) 80 mg per vial powder for solution for injection with diluent solution syringe,8001743,degarelix,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
82264,Marketed,2009-11-24,02337037,Firmagon,1,L02BX02,Degarelix,Powder for solution,Subcutaneous,02337037,FIRMAGON (degarelix (degarelix acetate) 120 mg per vial powder for solution for injection with diluent solution syringe) FERRING INC,Active,9013074,degarelix (degarelix acetate) 120 mg per vial powder for solution for injection with diluent solution syringe,8001743,degarelix,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
104328,Marketed,2026-02-02,02554429,Baxdela,1,J01MA23,Delafloxacin,Tablet,Oral,02554429,BAXDELA (delafloxacin (delafloxacin meglumine) 450 mg oral tablet) XEDITON PHARMACEUTICALS INC,Active,9015354,delafloxacin (delafloxacin meglumine) 450 mg oral tablet,8002576,delafloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,,Prescription
104329,Marketed,2026-02-02,02554437,Baxdela,1,J01MA23,Delafloxacin,Powder for solution,Intravenous,02554437,BAXDELA (delafloxacin (delafloxacin meglumine) 300 mg per vial powder for solution for injection) XEDITON PHARMACEUTICALS INC,Active,9015353,delafloxacin (delafloxacin meglumine) 300 mg per vial powder for solution for injection,8002576,delafloxacin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,,,,Prescription
106374,Marketed,2025-08-28,02560704,Anzupgo,1,D11AH11,Delgocitinib,Cream,Topical,02560704,ANZUPGO (delgocitinib 20 mg per g cutaneous cream) LEO PHARMA INC,Active,9015252,delgocitinib 20 mg per g cutaneous cream,8002554,delgocitinib,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
103418,Marketed,2024-07-25,02545411,Jubbonti,1,M05BX04,Denosumab,Solution,Subcutaneous,02545411,JUBBONTI (denosumab 60 mg per 1 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9012955,denosumab 60 mg per 1 mL solution for injection syringe,8001628,denosumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
103418,Marketed,2024-07-25,02545411,Jubbonti,1,M05BX04,Denosumab,Solution,Subcutaneous,02545411,JUBBONTI (denosumab 60 mg per 1 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9012955,denosumab 60 mg per 1 mL solution for injection syringe,8001628,denosumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
103450,Marketed,2024-06-26,02545764,Wyost,1,M05BX04,Denosumab,Solution,Subcutaneous,02545764,WYOST (denosumab 120 mg per 1.7 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013076,denosumab 120 mg per 1.7 mL solution for injection vial,8001628,denosumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
103450,Marketed,2024-06-26,02545764,Wyost,1,M05BX04,Denosumab,Solution,Subcutaneous,02545764,WYOST (denosumab 120 mg per 1.7 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013076,denosumab 120 mg per 1.7 mL solution for injection vial,8001628,denosumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
106391,Marketed,2025-10-30,02560895,Osenvelt,1,M05BX04,Denosumab,Solution,Subcutaneous,02560895,OSENVELT (denosumab 120 mg per 1.7 mL solution for injection vial) CELLTRION INC.,Active,9013076,denosumab 120 mg per 1.7 mL solution for injection vial,8001628,denosumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
106391,Marketed,2025-10-30,02560895,Osenvelt,1,M05BX04,Denosumab,Solution,Subcutaneous,02560895,OSENVELT (denosumab 120 mg per 1.7 mL solution for injection vial) CELLTRION INC.,Active,9013076,denosumab 120 mg per 1.7 mL solution for injection vial,8001628,denosumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
106393,Marketed,2025-10-30,02560917,Stoboclo,1,M05BX04,Denosumab,Solution,Subcutaneous,02560917,STOBOCLO (denosumab 60 mg per 1 mL solution for injection syringe) CELLTRION INC.,Active,9012955,denosumab 60 mg per 1 mL solution for injection syringe,8001628,denosumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
106393,Marketed,2025-10-30,02560917,Stoboclo,1,M05BX04,Denosumab,Solution,Subcutaneous,02560917,STOBOCLO (denosumab 60 mg per 1 mL solution for injection syringe) CELLTRION INC.,Active,9012955,denosumab 60 mg per 1 mL solution for injection syringe,8001628,denosumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
82897,Marketed,2010-08-12,02343541,Prolia,1,M05BX04,Denosumab,Solution,Subcutaneous,02343541,PROLIA (denosumab 60 mg per 1 mL solution for injection syringe) AMGEN CANADA INC,Active,9012955,denosumab 60 mg per 1 mL solution for injection syringe,8001628,denosumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
82897,Marketed,2010-08-12,02343541,Prolia,1,M05BX04,Denosumab,Solution,Subcutaneous,02343541,PROLIA (denosumab 60 mg per 1 mL solution for injection syringe) AMGEN CANADA INC,Active,9012955,denosumab 60 mg per 1 mL solution for injection syringe,8001628,denosumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
85304,Marketed,2011-06-06,02368153,Xgeva,1,M05BX04,Denosumab,Solution,Subcutaneous,02368153,XGEVA (denosumab 120 mg per 1.7 mL solution for injection vial) AMGEN CANADA INC,Active,9013076,denosumab 120 mg per 1.7 mL solution for injection vial,8001628,denosumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
85304,Marketed,2011-06-06,02368153,Xgeva,1,M05BX04,Denosumab,Solution,Subcutaneous,02368153,XGEVA (denosumab 120 mg per 1.7 mL solution for injection vial) AMGEN CANADA INC,Active,9013076,denosumab 120 mg per 1.7 mL solution for injection vial,8001628,denosumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
92869,Marketed,2024-03-05,02443910,Belkyra,1,D11AX24,Deoxycholic acid,Solution,Subcutaneous,02443910,BELKYRA (deoxycholic acid 20 mg per 2 mL solution for injection vial) ABBVIE CORPORATION,Active,9012956,deoxycholic acid 20 mg per 2 mL solution for injection vial,8001629,deoxycholic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
100757,Marketed,2022-05-17,02518252,Vablys,1,G01AC05,Dequalinium,Vaginal tablet,Vaginal,02518252,VABLYS (dequalinium chloride 10 mg vaginal tablet) DUCHESNAY INC,Active,9014716,dequalinium chloride 10 mg vaginal tablet,8001630,dequalinium,16857009,Vaginal,385055001,Tablet,732936001,Tablet (unit of presentation),,,,Prescription
101172,Marketed,2023-10-11,02522616,Dequadin Oral Spray,1,R02AA02,Dequalinium,Solution,Buccal,02522616,DEQUADIN ORAL SPRAY (dequalinium chloride 0.5 % oromucosal spray) PHARMASCIENCE INC,Active,9014791,dequalinium chloride 0.5 % oromucosal spray,8001630,dequalinium,372473007,Oromucosal,385073003,Oromucosal spray,,,,,,Non-Prescription Drugs
28979,Marketed,2024-09-05,02100207,Dequadin,1,R02AA02,Dequalinium,Lozenge,Oral,02100207,DEQUADIN (dequalinium chloride 0.25 mg lozenge) PHARMASCIENCE INC,Active,9003076,dequalinium chloride 0.25 mg lozenge,8001630,dequalinium,26643006,Oral,385087003,Lozenge,733000006,Lozenge,,,,Non-Prescription Drugs
43455,Marketed,2000-08-01,02227428,Suprane,1,N01AB07,Desflurane,Liquid,Inhalation,,,,,,,,,,,,,,,,,Prescription
20014,Marketed,2022-12-16,02216248,Desipramine,1,N06AA01,Desipramine,Tablet,Oral,02216248,DESIPRAMINE (desipramine hydrochloride 10 mg oral tablet) AA PHARMA INC,Active,9014804,desipramine hydrochloride 10 mg oral tablet,8001449,desipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
20015,Marketed,2022-12-16,02216256,Desipramine,1,N06AA01,Desipramine,Tablet,Oral,02216256,DESIPRAMINE (desipramine hydrochloride 25 mg oral tablet) AA PHARMA INC,Active,9014806,desipramine hydrochloride 25 mg oral tablet,8001449,desipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
20021,Marketed,2022-12-16,02216280,Desipramine,1,N06AA01,Desipramine,Tablet,Oral,02216280,DESIPRAMINE (desipramine hydrochloride 100 mg oral tablet) AA PHARMA INC,Active,9014805,desipramine hydrochloride 100 mg oral tablet,8001449,desipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
20022,Marketed,2022-12-16,02216272,Desipramine,1,N06AA01,Desipramine,Tablet,Oral,02216272,DESIPRAMINE (desipramine hydrochloride 75 mg oral tablet) AA PHARMA INC,Active,9014808,desipramine hydrochloride 75 mg oral tablet,8001449,desipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
20023,Marketed,2022-12-16,02216264,Desipramine,1,N06AA01,Desipramine,Tablet,Oral,02216264,DESIPRAMINE (desipramine hydrochloride 50 mg oral tablet) AA PHARMA INC,Active,9014807,desipramine hydrochloride 50 mg oral tablet,8001449,desipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103474,Marketed,2024-11-29,02546019,Desloratadine,1,R06AX27,Desloratadine,Tablet,Oral,02546019,DESLORATADINE (desloratadine 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003690,desloratadine 5 mg oral tablet,8001366,desloratadine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
67861,Marketed,2017-02-03,02243919,Aerius,1,R06AX27,Desloratadine,Tablet,Oral,02243919,AERIUS (desloratadine 5 mg oral tablet) BAYER INC,Active,9003690,desloratadine 5 mg oral tablet,8001366,desloratadine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
71435,Marketed,2017-05-25,02247193,Aerius Kids,1,R06AX27,Desloratadine,Syrup,Oral,02247193,AERIUS KIDS (desloratadine 0.5 mg per mL syrup) BAYER INC,Active,9004028,desloratadine 0.5 mg per mL syrup,8001366,desloratadine,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
78346,Marketed,2012-12-15,02298155,Desloratadine Allergy Control,1,R06AX27,Desloratadine,Tablet,Oral,02298155,DESLORATADINE ALLERGY CONTROL (desloratadine 5 mg oral tablet) PHARMASCIENCE INC,Active,9003690,desloratadine 5 mg oral tablet,8001366,desloratadine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
100269,Marketed,2021-10-13,02513579,Bipazen,1,H01BA02,Desmopressin,Solution,"Subcutaneous,Intravenous,Intramuscular",02513579,BIPAZEN (desmopressin acetate 4 mcg per 1 mL solution for injection ampoule) KVR PHARMACEUTICALS INC.,Active,9012790,desmopressin acetate 4 mcg per 1 mL solution for injection ampoule,8001259,desmopressin,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
13867,Marketed,1993-12-31,00873993,DDAVP Inj 4 mcg/mL,1,H01BA02,Desmopressin,Liquid,"Intravenous,Subcutaneous,Intramuscular",00873993,DDAVP INJ 4MCG/ML (desmopressin acetate 4 mcg per 1 mL solution for injection ampoule) FERRING INC,Active,9012790,desmopressin acetate 4 mcg per 1 mL solution for injection ampoule,8001259,desmopressin,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
18289,Marketed,1995-12-31,02024179,Octostim Liquid Inj. 15 mcg/mL,1,H01BA02,Desmopressin,Solution,"Subcutaneous,Intravenous",02024179,OCTOSTIM LIQ INJ. 15MCG/ML (desmopressin acetate 15 mcg per 1 mL solution for injection ampoule) FERRING INC,Active,9012700,desmopressin acetate 15 mcg per 1 mL solution for injection ampoule,8001259,desmopressin,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
66190,Marketed,2011-03-10,02242465,Desmopressin Spray,1,H01BA02,Desmopressin,"Spray, metered dose",Nasal,02242465,DESMOPRESSIN SPRAY (desmopressin acetate 10 mcg per actuation nasal spray) AA PHARMA INC,Active,9002181,desmopressin acetate 10 mcg per actuation nasal spray,8001259,desmopressin,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,,Prescription
76960,Marketed,2022-04-07,02284030,Apo-Desmopressin,1,H01BA02,Desmopressin,Tablet,Oral,02284030,APO-DESMOPRESSIN (desmopressin acetate 0.1 mg oral tablet) APOTEX INC,Active,9002781,desmopressin acetate 0.1 mg oral tablet,8001259,desmopressin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76961,Marketed,2022-04-07,02284049,Apo-Desmopressin,1,H01BA02,Desmopressin,Tablet,Oral,02284049,APO-DESMOPRESSIN (desmopressin acetate 0.2 mg oral tablet) APOTEX INC,Active,9002782,desmopressin acetate 0.2 mg oral tablet,8001259,desmopressin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77052,Marketed,2006-11-02,02284995,DDAVP Melt,1,H01BA02,Desmopressin,Tablet (orally disintegrating),Sublingual,02284995,DDAVP MELT (desmopressin (desmopressin acetate) 60 mcg sublingual tablet) FERRING INC,Active,9014737,desmopressin (desmopressin acetate) 60 mcg sublingual tablet,8001259,desmopressin,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,,Prescription
77053,Marketed,2006-11-02,02285002,DDAVP Melt,1,H01BA02,Desmopressin,Tablet (orally disintegrating),Sublingual,02285002,DDAVP MELT (desmopressin (desmopressin acetate) 120 mcg sublingual tablet) FERRING INC,Active,9014733,desmopressin (desmopressin acetate) 120 mcg sublingual tablet,8001259,desmopressin,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,,Prescription
78965,Marketed,2008-01-23,02304368,PMS-Desmopressin,1,H01BA02,Desmopressin,Tablet,Oral,02304368,PMS-DESMOPRESSIN (desmopressin acetate (desmopressin acetate trihydrate) 0.1 mg oral tablet) PHARMASCIENCE INC,Active,9002781,desmopressin acetate 0.1 mg oral tablet,8001259,desmopressin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78966,Marketed,2021-11-25,02304376,PMS-Desmopressin,1,H01BA02,Desmopressin,Tablet,Oral,02304376,PMS-DESMOPRESSIN (desmopressin acetate (desmopressin acetate trihydrate) 0.2 mg oral tablet) PHARMASCIENCE INC,Active,9002782,desmopressin acetate 0.2 mg oral tablet,8001259,desmopressin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104524,Marketed,2025-08-18,02556553,Miley 21,2,G03AA09,Desogestrel and estrogen,Tablet,Oral,02556553,MILEY 21 (desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet) AMBICARE PHARMACEUTICALS INC.,Active,9008751,desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet,8000179,desogestrel and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
104525,Marketed,2025-08-18,02556561,Miley 28,2,G03AA09,Desogestrel and estrogen,Tablet,Oral,02556561,MILEY 28 (desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet with lactose oral tablet) AMBICARE PHARMACEUTICALS INC.,Active,9008752,desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet with lactose oral tablet,8000179,desogestrel and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
14354,Marketed,2022-05-19,02042487,Marvelon 21,2,G03AA09,Desogestrel and estrogen,Tablet,Oral,02042487,MARVELON 21 (desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet) ORGANON CANADA INC.,Active,9008751,desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet,8000179,desogestrel and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
14355,Marketed,2022-06-17,02042479,Marvelon 28,2,G03AA09,Desogestrel and estrogen,Tablet,Oral,02042479,MARVELON 28 (desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet with lactose oral tablet) ORGANON CANADA INC.,Active,9008752,desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet with lactose oral tablet,8000179,desogestrel and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
74243,Marketed,2019-05-13,02257238,Linessa 28,6,G03AB05,Desogestrel and estrogen,Tablet,Oral,02257238,LINESSA 28 (desogestrel 100 mcg and estradiol 25 mcg oral tablet with desogestrel 125 mcg and estradiol 25 mcg oral tablet with desogestrel 150 mcg and ethinyl estradiol 25 mcg oral tablet with lactose oral tablet) ASPEN PHARMACARE CANADA INC.,Active,9008749,desogestrel 100 mcg and estradiol 25 mcg oral tablet with desogestrel 125 mcg and estradiol 25 mcg oral tablet with desogestrel 150 mcg and ethinyl estradiol 25 mcg oral tablet with lactose oral tablet,8000179,desogestrel and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
75841,Marketed,2019-02-15,02272903,Linessa 21,6,G03AB05,Desogestrel and estrogen,Tablet,Oral,02272903,LINESSA 21 (desogestrel 100 mcg and estradiol 25 mcg oral tablet with desogestrel 125 mcg and estradiol 25 mcg oral tablet with desogestrel 150 mcg and ethinyl estradiol 25 mcg oral tablet) ASPEN PHARMACARE CANADA INC.,Active,9008750,desogestrel 100 mcg and estradiol 25 mcg oral tablet with desogestrel 125 mcg and estradiol 25 mcg oral tablet with desogestrel 150 mcg and ethinyl estradiol 25 mcg oral tablet,8000179,desogestrel and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
80270,Marketed,2015-05-28,02317192,Apri 21,2,G03AA09,Desogestrel and estrogen,Tablet,Oral,02317192,APRI 21 (desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet) TEVA CANADA LIMITED,Active,9008751,desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet,8000179,desogestrel and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
80272,Marketed,2015-05-28,02317206,Apri 28,2,G03AA09,Desogestrel and estrogen,Tablet,Oral,02317206,APRI 28 (desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet with lactose oral tablet) TEVA CANADA LIMITED,Active,9008752,desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet with lactose oral tablet,8000179,desogestrel and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
88154,Marketed,2016-09-19,02396491,Freya 21,2,G03AA09,Desogestrel and estrogen,Tablet,Oral,02396491,FREYA 21 (desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9008751,desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet,8000179,desogestrel and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
88165,Marketed,2016-09-19,02396610,Freya 28,2,G03AA09,Desogestrel and estrogen,Tablet,Oral,02396610,FREYA 28 (desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet with lactose oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9008752,desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet with lactose oral tablet,8000179,desogestrel and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
89490,Marketed,2014-01-07,02410249,Mirvala 21,2,G03AA09,Desogestrel and estrogen,Tablet,Oral,02410249,MIRVALA 21 (desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet) APOTEX INC,Active,9008751,desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet,8000179,desogestrel and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
89491,Marketed,2014-01-07,02410257,Mirvala 28,2,G03AA09,Desogestrel and estrogen,Tablet,Oral,02410257,MIRVALA 28 (desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet with lactose oral tablet) APOTEX INC,Active,9008752,desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet with lactose oral tablet,8000179,desogestrel and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
43536,Marketed,2015-09-25,02229315,PDP-Desonide,1,D07AB08,Desonide,Cream,Topical,02229315,PDP-DESONIDE (desonide 0.05 % cutaneous cream) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9002961,desonide 0.05 % cutaneous cream,8001260,desonide,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
43537,Marketed,2014-08-06,02229323,PDP-Desonide,1,D07AB08,Desonide,Ointment,Topical,02229323,PDP-DESONIDE (desonide 0.05 % cutaneous ointment) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9003043,desonide 0.05 % cutaneous ointment,8001260,desonide,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Prescription
43314,Marketed,2019-06-26,02221896,Topicort,1,D07AC03,Desoximetasone,Cream,Topical,02221896,"TOPICORT (desoximetasone 0.25 % cutaneous cream) BAUSCH HEALTH, CANADA INC.",Active,9003069,desoximetasone 0.25 % cutaneous cream,8001261,desoximetasone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
43315,Marketed,2020-10-19,02221918,Topicort,1,D07AC03,Desoximetasone,Cream,Topical,02221918,"TOPICORT (desoximetasone 0.05 % cutaneous cream) BAUSCH HEALTH, CANADA INC.",Active,9002955,desoximetasone 0.05 % cutaneous cream,8001261,desoximetasone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
43316,Marketed,2020-10-19,02221926,Topicort,1,D07AC03,Desoximetasone,Gel,Topical,02221926,"TOPICORT (desoximetasone 0.05 % cutaneous gel) BAUSCH HEALTH, CANADA INC.",Active,9002979,desoximetasone 0.05 % cutaneous gel,8001261,desoximetasone,448598008,Cutaneous,385100002,Gel,,,,,,Prescription
43317,Marketed,2020-10-19,02221934,Topicort,1,D07AC03,Desoximetasone,Ointment,Topical,02221934,"TOPICORT (desoximetasone 0.25 % cutaneous ointment) BAUSCH HEALTH, CANADA INC.",Active,9003070,desoximetasone 0.25 % cutaneous ointment,8001261,desoximetasone,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Prescription
101462,Marketed,2024-08-12,02525615,AG-Desvenlafaxine,1,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02525615,AG-DESVENLAFAXINE (desvenlafaxine (desvenlafaxine succinate) 50 mg prolonged-release oral tablet) ANGITA PHARMA INC.,Active,9001271,desvenlafaxine (desvenlafaxine succinate) 50 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101463,Marketed,2023-05-12,02525623,AG-Desvenlafaxine,1,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02525623,AG-DESVENLAFAXINE (desvenlafaxine (desvenlafaxine succinate) 100 mg prolonged-release oral tablet) ANGITA PHARMA INC.,Active,9001272,desvenlafaxine (desvenlafaxine succinate) 100 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102121,Marketed,2024-02-12,02532158,Taro-Desvenlafaxine,1,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02532158,TARO-DESVENLAFAXINE (desvenlafaxine (desvenlafaxine succinate) 50 mg prolonged-release oral tablet) TARO PHARMACEUTICALS INC,Active,9001271,desvenlafaxine (desvenlafaxine succinate) 50 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102122,Marketed,2024-02-12,02532166,Taro-Desvenlafaxine,1,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02532166,TARO-DESVENLAFAXINE (desvenlafaxine (desvenlafaxine succinate) 100 mg prolonged-release oral tablet) TARO PHARMACEUTICALS INC,Active,9001272,desvenlafaxine (desvenlafaxine succinate) 100 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102398,Marketed,2023-05-25,02535106,Desvenlafaxine,1,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02535106,DESVENLAFAXINE (desvenlafaxine 50 mg prolonged-release oral tablet) SANIS HEALTH INC,Active,9012484,desvenlafaxine 50 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102399,Marketed,2023-05-25,02535114,Desvenlafaxine,1,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02535114,DESVENLAFAXINE (desvenlafaxine 100 mg prolonged-release oral tablet) SANIS HEALTH INC,Active,9012483,desvenlafaxine 100 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102714,Marketed,2024-05-30,02538415,Sandoz Desvenlafaxine,1,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02538415,SANDOZ DESVENLAFAXINE (desvenlafaxine 50 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9012484,desvenlafaxine 50 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102715,Marketed,2024-05-30,02538423,Sandoz Desvenlafaxine,1,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02538423,SANDOZ DESVENLAFAXINE (desvenlafaxine 100 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9012483,desvenlafaxine 100 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103213,Marketed,2024-04-12,02543672,Desvenlafaxine,1,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02543672,DESVENLAFAXINE (desvenlafaxine 50 mg prolonged-release oral tablet) PRO DOC LIMITEE,Active,9012484,desvenlafaxine 50 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103214,Marketed,2024-04-12,02543680,Desvenlafaxine,1,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02543680,DESVENLAFAXINE (desvenlafaxine 100 mg prolonged-release oral tablet) PRO DOC LIMITEE,Active,9012483,desvenlafaxine 100 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104377,Marketed,2025-05-13,02554968,Desvenlafaxine,1,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02554968,DESVENLAFAXINE (desvenlafaxine 50 mg prolonged-release oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9012484,desvenlafaxine 50 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104378,Marketed,2025-05-13,02554976,Desvenlafaxine,1,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02554976,DESVENLAFAXINE (desvenlafaxine 100 mg prolonged-release oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9012483,desvenlafaxine 100 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80650,Marketed,2014-12-06,02321092,Pristiq,1,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02321092,PRISTIQ (desvenlafaxine (desvenlafaxine succinate) 50 mg prolonged-release oral tablet) PFIZER CANADA ULC,Active,9001271,desvenlafaxine (desvenlafaxine succinate) 50 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80651,Marketed,2014-12-06,02321106,Pristiq,1,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02321106,PRISTIQ (desvenlafaxine (desvenlafaxine succinate) 100 mg prolonged-release oral tablet) PFIZER CANADA ULC,Active,9001272,desvenlafaxine (desvenlafaxine succinate) 100 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94528,Marketed,2022-02-14,02458217,Teva-Desvenlafaxine,1,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02458217,TEVA-DESVENLAFAXINE (desvenlafaxine (desvenlafaxine succinate) 50 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9001271,desvenlafaxine (desvenlafaxine succinate) 50 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94529,Marketed,2022-02-14,02458225,Teva-Desvenlafaxine,1,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02458225,TEVA-DESVENLAFAXINE (desvenlafaxine (desvenlafaxine succinate) 100 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9001272,desvenlafaxine (desvenlafaxine succinate) 100 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95539,Marketed,2017-10-20,02466988,Apo-Desvenlafaxine,1,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02466988,APO-DESVENLAFAXINE (desvenlafaxine 50 mg prolonged-release oral tablet) APOTEX INC,Active,9012484,desvenlafaxine 50 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95540,Marketed,2017-10-20,02466996,Apo-Desvenlafaxine,1,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02466996,APO-DESVENLAFAXINE (desvenlafaxine 100 mg prolonged-release oral tablet) APOTEX INC,Active,9012483,desvenlafaxine 100 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98506,Marketed,2022-02-14,02495139,JAMP Desvenlafaxine,1,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02495139,JAMP DESVENLAFAXINE (desvenlafaxine (desvenlafaxine succinate) 50 mg prolonged-release oral tablet) JAMP PHARMA CORPORATION,Active,9001271,desvenlafaxine (desvenlafaxine succinate) 50 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98510,Marketed,2022-02-14,02495147,JAMP Desvenlafaxine,1,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02495147,JAMP DESVENLAFAXINE (desvenlafaxine (desvenlafaxine succinate) 100 mg prolonged-release oral tablet) JAMP PHARMA CORPORATION,Active,9001272,desvenlafaxine (desvenlafaxine succinate) 100 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102205,Marketed,2023-02-14,02533030,Sotyktu,1,L04AF07,Deucravacitinib,Tablet,Oral,02533030,SOTYKTU (deucravacitinib 6 mg oral tablet) BRISTOL-MYERS SQUIBB CANADA,Active,9014839,deucravacitinib 6 mg oral tablet,8002463,deucravacitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101779,Marketed,2022-11-25,02528584,Odan-Dexamethasone Elixir,1,H02AB02,Dexamethasone,Elixir,Oral,02528584,ODAN-DEXAMETHASONE ELIXIR (dexamethasone 0.5 mg per 5 mL oral solution) ODAN LABORATORIES LTD,Active,9001097,dexamethasone 0.5 mg per 5 mL oral solution,8000028,dexamethasone (base),26643006,Oral,385023001,Oral solution,,,,,,Prescription
12208,Marketed,2005-09-01,00874582,Dexamethasone Sod Phosph Inj 10 mg/mL USP,1,H02AB02,Dexamethasone,Liquid,"Intrasynovial,Intramuscular,Intravenous",00874582,DEXAMETHASONE SOD PHOSPH INJ 10MG/ML USP (dexamethasone (dexamethasone sodium phosphate) 10 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9006551,dexamethasone (dexamethasone sodium phosphate) 10 mg per 1 mL solution for injection vial,8000028,dexamethasone (base),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
12967,Marketed,1992-12-31,01946897,PMS-Dexamethasone Elixir,1,H02AB02,Dexamethasone,Elixir,Oral,01946897,PMS-DEXAMETHASONE ELIXIR (dexamethasone 0.5 mg per 5 mL oral solution) PHARMASCIENCE INC,Active,9001097,dexamethasone 0.5 mg per 5 mL oral solution,8000028,dexamethasone (base),26643006,Oral,385023001,Oral solution,,,,,,Prescription
13255,Marketed,2015-07-31,01977547,"Dexamethasone Sodium Phosphate Injection, USP",1,H02AB02,Dexamethasone,Solution,"Intravenous,Intra-articular,Intramuscular",01977547,"DEXAMETHASONE SODIUM PHOSPHATE INJECTION, USP (dexamethasone phosphate (dexamethasone sodium phosphate) 20 mg per 5 mL solution for injection vial) STERIMAX INC",Active,9000315,dexamethasone phosphate (dexamethasone sodium phosphate) 20 mg per 5 mL solution for injection vial,8000114,dexamethasone phosphate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
16262,Marketed,2019-03-28,02023865,Dexamethasone,1,S03BA01,Dexamethasone,Solution,"Otic,Ophthalmic",02023865,DEXAMETHASONE (dexamethasone sodium phosphate 0.1 % ophthalmic/otic drops) PHARMA STULLN INC.,Active,9006235,dexamethasone sodium phosphate 0.1 % ophthalmic/otic drops,8000137,dexamethasone sodium phosphate,255204007,Multiple (ophthalmic or otic),420636007,Ear or eye drops,732994000,Drop (unit of presentation),,,,Prescription
23194,Marketed,2023-10-11,01964070,PMS-Dexamethasone,1,H02AB02,Dexamethasone,Tablet,Oral,01964070,PMS-DEXAMETHASONE (dexamethasone 4 mg oral tablet) PHARMASCIENCE INC,Active,9000651,dexamethasone 4 mg oral tablet,8000028,dexamethasone (base),26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
23261,Marketed,2023-10-11,01964976,PMS-Dexamethasone,1,H02AB02,Dexamethasone,Tablet,Oral,01964976,PMS-DEXAMETHASONE (dexamethasone 0.5 mg oral tablet) PHARMASCIENCE INC,Active,9000648,dexamethasone 0.5 mg oral tablet,8000028,dexamethasone (base),26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
2620,Marketed,2018-02-22,00042560,Maxidex,1,S01BA01,Dexamethasone,Suspension,Ophthalmic,00042560,MAXIDEX (dexamethasone 0.1 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9000099,dexamethasone 0.1 % ophthalmic drops,8000028,dexamethasone (base),54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
36480,Marketed,1999-08-19,02204266,Dexamethasone-Omega,1,H02AB02,Dexamethasone,Liquid,"Intravenous,Soft tissue injection,Intra-articular,Intralesional,Intramuscular",02204266,DEXAMETHASONE-OMEGA (dexamethasone phosphate (dexamethasone sodium phosphate) 4 mg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9006265,dexamethasone phosphate (dexamethasone sodium phosphate) 4 mg per 1 mL solution for injection vial,8000114,dexamethasone phosphate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
36481,Marketed,1999-08-19,02204274,Dexamethasone-Omega,1,H02AB02,Dexamethasone,Liquid,"Intramuscular,Intravenous",77700242,DEXAMETHASONE-OMEGA (dexamethasone phosphate (dexamethasone sodium phosphate) 100 mg per 10 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9000352,dexamethasone phosphate (dexamethasone sodium phosphate) 100 mg per 10 mL solution for injection vial,8000114,dexamethasone phosphate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
36481,Marketed,1999-08-19,02204274,Dexamethasone-Omega,1,H02AB02,Dexamethasone,Liquid,"Intramuscular,Intravenous",77700243,DEXAMETHASONE-OMEGA (dexamethasone phosphate (dexamethasone sodium phosphate) 10 mg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9006266,dexamethasone phosphate (dexamethasone sodium phosphate) 10 mg per 1 mL solution for injection vial,8000114,dexamethasone phosphate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
4591,Marketed,2018-01-19,00042579,Maxidex,1,S01BA01,Dexamethasone,Ointment,Ophthalmic,00042579,MAXIDEX (dexamethasone 0.1 % ophthalmic ointment) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9000037,dexamethasone 0.1 % ophthalmic ointment,8000028,dexamethasone (base),54485002,Ophthalmic,385123004,Ophthalmic ointment,,,,,,Prescription
6593,Marketed,2005-09-01,00664227,Dexamethasone Sodium Phosphate Inj USP 4 mg/mL,1,H02AB02,Dexamethasone,Solution,"Intramuscular,Intrasynovial,Intravenous",00664227,DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML (dexamethasone phosphate (dexamethasone sodium phosphate) 20 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000315,dexamethasone phosphate (dexamethasone sodium phosphate) 20 mg per 5 mL solution for injection vial,8000114,dexamethasone phosphate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
73487,Marketed,2004-03-08,02250055,Apo-Dexamethasone,1,H02AB02,Dexamethasone,Tablet,Oral,02250055,APO-DEXAMETHASONE (dexamethasone 4 mg oral tablet) APOTEX INC,Active,9000651,dexamethasone 4 mg oral tablet,8000028,dexamethasone (base),26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74650,Marketed,2004-11-17,02261081,Apo-Dexamethasone,1,H02AB02,Dexamethasone,Tablet,Oral,02261081,APO-DEXAMETHASONE (dexamethasone 0.5 mg oral tablet) APOTEX INC,Active,9000648,dexamethasone 0.5 mg oral tablet,8000028,dexamethasone (base),26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76497,Marketed,2006-06-08,02279363,PMS-Dexamethasone,1,H02AB02,Dexamethasone,Tablet,Oral,02279363,PMS-DEXAMETHASONE (dexamethasone 2 mg oral tablet) PHARMASCIENCE INC,Active,9001152,dexamethasone 2 mg oral tablet,8000028,dexamethasone (base),26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84844,Marketed,2024-03-11,02363445,Ozurdex,1,S01BA01,Dexamethasone,Implant,Intravitreal,02363445,OZURDEX (dexamethasone 0.7 mg intravitreal implant) ABBVIE CORPORATION,Active,9001348,dexamethasone 0.7 mg intravitreal implant,8000028,dexamethasone (base),418401004,Intravitreal,385286003,Implant,732996003,Implant (unit of presentation),,,,Prescription
87333,Marketed,2013-05-08,02387743,Dexamethasone Omega Unidose,1,H02AB02,Dexamethasone,Solution,"Intrasynovial,Intramuscular,Intravenous",02387743,DEXAMETHASONE OMEGA UNIDOSE (dexamethasone phosphate (dexamethasone sodium phosphate) 10 mg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9006266,dexamethasone phosphate (dexamethasone sodium phosphate) 10 mg per 1 mL solution for injection vial,8000114,dexamethasone phosphate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
103219,Marketed,2025-08-21,02543745,Levodexa,2,S01CA01,Dexamethasone and antiinfectives,Solution,Ophthalmic,02543745,LEVODEXA (dexamethasone (dexamethasone sodium phosphate) 0.1 % and levofloxacin (levofloxacin hemihydrate) 0.5 % ophthalmic drops) XEDITON PHARMACEUTICALS INC,Active,9015253,dexamethasone (dexamethasone sodium phosphate) 0.1 % and levofloxacin 0.5 % ophthalmic drops,8002555,dexamethasone (base) and levofloxacin,54485002,Ophthalmic,385125006,Eye drops solution,,,,,,Prescription
10971,Marketed,2018-04-26,00778915,Tobradex,2,S01CA01,Dexamethasone and antiinfectives,Ointment,Ophthalmic,00778915,TOBRADEX (dexamethasone 0.1 % and tobramycin 0.3 % ophthalmic ointment) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9002274,dexamethasone 0.1 % and tobramycin 0.3 % ophthalmic ointment,8000848,dexamethasone (base) and tobramycin,54485002,Ophthalmic,385123004,Ophthalmic ointment,,,,,,Prescription
11068,Marketed,2018-05-10,00778907,Tobradex,2,S01CA01,Dexamethasone and antiinfectives,Suspension,Ophthalmic,00778907,TOBRADEX (dexamethasone 0.1 % and tobramycin 0.3 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9002273,dexamethasone 0.1 % and tobramycin 0.3 % ophthalmic drops,8000848,dexamethasone (base) and tobramycin,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
2423,Marketed,2019-03-18,00358177,Maxitrol,3,S01CA01,Dexamethasone and antiinfectives,Ointment,Ophthalmic,00358177,MAXITROL (dexamethasone 0.1 % and neomycin (neomycin sulfate) 3.5 mg per g and polymyxin B (polymyxin B sulfate) 6000 unit per g ophthalmic ointment) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9013868,dexamethasone 0.1 % and neomycin (neomycin sulfate) 3.5 mg per g and polymyxin B (polymyxin B sulfate) 6000 unit per g ophthalmic ointment,8002240,dexamethasone (base) and neomycin and polymyxin B,54485002,Ophthalmic,385123004,Ophthalmic ointment,,,,,,Prescription
259,Marketed,2018-06-01,00042676,Maxitrol,3,S01CA01,Dexamethasone and antiinfectives,Suspension,Ophthalmic,00042676,MAXITROL (dexamethasone 0.1 % and neomycin (neomycin sulfate) 3.5 mg per mL and polymyxin B (polymyxin B sulfate) 6000 unit per mL ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9013869,dexamethasone 0.1 % and neomycin (neomycin sulfate) 3.5 mg per mL and polymyxin B (polymyxin B sulfate) 6000 unit per mL ophthalmic drops,8002240,dexamethasone (base) and neomycin and polymyxin B,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
37363,Marketed,2024-07-30,02224623,Sofracort,3,S03CA01,Dexamethasone and antiinfectives,Drops,"Otic,Ophthalmic",02224623,SOFRACORT (dexamethasone (dexamethasone sodium metasulphobenzoate) 0.5 mg per mL and framycetin sulfate 5 mg per mL and gramicidin 0.05 mg per mL ophthalmic/otic drops) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9006374,dexamethasone (dexamethasone sodium metasulphobenzoate) 0.5 mg per mL and framycetin sulfate 5 mg per mL and gramicidin 0.05 mg per mL ophthalmic/otic drops,8000932,dexamethasone (base) and framycetin and gramicidin,255204007,Multiple (ophthalmic or otic),420636007,Ear or eye drops,732994000,Drop (unit of presentation),,,,Prescription
73758,Marketed,2018-06-11,02252716,Ciprodex,2,S02CA06,Dexamethasone and antiinfectives,Suspension,Otic,02252716,CIPRODEX (ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % and dexamethasone 0.1 % otic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9001079,ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % and dexamethasone 0.1 % otic drops,8000338,ciprofloxacin and dexamethasone (base),10547007,Otic,385136004,Otic drops,732994000,Drop (unit of presentation),,,,Prescription
97239,Marketed,2020-11-23,02481901,Taro-Ciprofloxacin/Dexamethasone,2,S02CA06,Dexamethasone and antiinfectives,Suspension,Otic,02481901,TARO-CIPROFLOXACIN/DEXAMETHASONE (ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % and dexamethasone 0.1 % otic drops) TARO PHARMACEUTICALS INC,Active,9001079,ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % and dexamethasone 0.1 % otic drops,8000338,ciprofloxacin and dexamethasone (base),10547007,Otic,385136004,Otic drops,732994000,Drop (unit of presentation),,,,Prescription
99623,Marketed,2021-01-26,02506882,Sandoz Ciprofloxacin / Dexamethasone,2,S02CA06,Dexamethasone and antiinfectives,Suspension,Otic,02506882,SANDOZ CIPROFLOXACIN / DEXAMETHASONE (ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % and dexamethasone 0.1 % otic drops) SANDOZ CANADA INCORPORATED,Active,9001079,ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % and dexamethasone 0.1 % otic drops,8000338,ciprofloxacin and dexamethasone (base),10547007,Otic,385136004,Otic drops,732994000,Drop (unit of presentation),,,,Prescription
15210,Marketed,2026-02-25,01924567,Dexedrine Spansule,1,N06BA02,Dexamfetamine,Capsule (sustained-release),Oral,01924567,DEXEDRINE SPANSULE (dextroamphetamine sulfate 15 mg prolonged-release oral capsule) KNIGHT THERAPEUTICS INC.,Active,9000415,dextroamphetamine sulfate 15 mg prolonged-release oral capsule,8000162,dextroamphetamine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
15211,Marketed,2026-02-25,01924559,Dexedrine Spansule,1,N06BA02,Dexamfetamine,Capsule (sustained-release),Oral,01924559,DEXEDRINE SPANSULE (dextroamphetamine sulfate 10 mg prolonged-release oral capsule) KNIGHT THERAPEUTICS INC.,Active,9000414,dextroamphetamine sulfate 10 mg prolonged-release oral capsule,8000162,dextroamphetamine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
15225,Marketed,2026-02-25,01924516,Dexedrine,1,N06BA02,Dexamfetamine,Tablet,Oral,01924516,DEXEDRINE (dextroamphetamine sulfate 5 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9000416,dextroamphetamine sulfate 5 mg oral tablet,8000162,dextroamphetamine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA I)
92781,Marketed,2018-10-31,02443236,Dextroamphetamine,1,N06BA02,Dexamfetamine,Tablet,Oral,02443236,DEXTROAMPHETAMINE (dextroamphetamine sulfate 5 mg oral tablet) AA PHARMA INC,Active,9000416,dextroamphetamine sulfate 5 mg oral tablet,8000162,dextroamphetamine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA I)
93401,Marketed,2025-08-13,02448319,Teva-Dextroamphetamine SR,1,N06BA02,Dexamfetamine,Capsule (sustained-release),Oral,02448319,TEVA-DEXTROAMPHETAMINE SR (dextroamphetamine sulfate 10 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9000414,dextroamphetamine sulfate 10 mg prolonged-release oral capsule,8000162,dextroamphetamine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
93402,Marketed,2025-08-13,02448327,Teva-Dextroamphetamine SR,1,N06BA02,Dexamfetamine,Capsule (sustained-release),Oral,02448327,TEVA-DEXTROAMPHETAMINE SR (dextroamphetamine sulfate 15 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9000415,dextroamphetamine sulfate 15 mg prolonged-release oral capsule,8000162,dextroamphetamine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
101819,Marketed,2024-02-26,02528991,Apo-Dexlansoprazole,1,A02BC06,Dexlansoprazole,Capsule (delayed release),"Oral,Nasogastric",02528991,APO-DEXLANSOPRAZOLE (dexlansoprazole 30 mg gastro-resistant capsule) APOTEX INC,Active,9001319,dexlansoprazole 30 mg gastro-resistant capsule,8000394,dexlansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
101822,Marketed,2024-02-26,02529025,Apo-Dexlansoprazole,1,A02BC06,Dexlansoprazole,Capsule (delayed release),"Nasogastric,Oral",02529025,APO-DEXLANSOPRAZOLE (dexlansoprazole 60 mg gastro-resistant capsule) APOTEX INC,Active,9001320,dexlansoprazole 60 mg gastro-resistant capsule,8000394,dexlansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
84014,Marketed,2017-01-13,02354950,Dexilant,1,A02BC06,Dexlansoprazole,Capsule (delayed release),"Nasogastric,Oral",02354950,DEXILANT (dexlansoprazole 30 mg gastro-resistant capsule) TAKEDA CANADA INC,Active,9001319,dexlansoprazole 30 mg gastro-resistant capsule,8000394,dexlansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
84015,Marketed,2017-01-13,02354969,Dexilant,1,A02BC06,Dexlansoprazole,Capsule (delayed release),"Oral,Nasogastric",02354969,DEXILANT (dexlansoprazole 60 mg gastro-resistant capsule) TAKEDA CANADA INC,Active,9001320,dexlansoprazole 60 mg gastro-resistant capsule,8000394,dexlansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
100316,Marketed,2024-06-05,02513978,"dexmedeTOMidine Hydrochloride For Injection, USP",1,N05CM18,Dexmedetomidine,Solution,Intravenous,02513978,"DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP (dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg per 2 mL solution for injection vial) BAXTER CORPORATION",Active,9012485,dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg per 2 mL solution for injection vial,8001118,dexmedetomidine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
101806,Marketed,2024-10-07,02528886,dexmedeTOMidine Hydrochloride For Injection,1,N05CM18,Dexmedetomidine,Solution,Intravenous,02528886,DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION (dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg per 2 mL solution for injection vial) EUGIA PHARMA INC.,Active,9012485,dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg per 2 mL solution for injection vial,8001118,dexmedetomidine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
102581,Marketed,2023-11-03,02537109,dexmedeTOMidine Hydrochloride Injection,1,N05CM18,Dexmedetomidine,Solution,Intravenous,77701141,DEXMEDETOMIDINE HYDROCHLORIDE INJECTION (dexmedetomidine (dexmedetomidine hydrochloride) 1000 mcg per 250 mL solution for injection bag) HIKMA CANADA LIMITED,Active,9014973,dexmedetomidine (dexmedetomidine hydrochloride) 1000 mcg per 250 mL solution for injection bag,8001118,dexmedetomidine,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),1.0,,,Prescription
102581,Marketed,2023-11-03,02537109,dexmedeTOMidine Hydrochloride Injection,1,N05CM18,Dexmedetomidine,Solution,Intravenous,77701142,DEXMEDETOMIDINE HYDROCHLORIDE INJECTION (dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg per 50 mL solution for injection bag) HIKMA CANADA LIMITED,Active,9014974,dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg per 50 mL solution for injection bag,8001118,dexmedetomidine,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),1.0,,,Prescription
102581,Marketed,2023-11-03,02537109,dexmedeTOMidine Hydrochloride Injection,1,N05CM18,Dexmedetomidine,Solution,Intravenous,77701143,DEXMEDETOMIDINE HYDROCHLORIDE INJECTION (dexmedetomidine (dexmedetomidine hydrochloride) 400 mcg per 100 mL solution for injection bag) HIKMA CANADA LIMITED,Active,9014975,dexmedetomidine (dexmedetomidine hydrochloride) 400 mcg per 100 mL solution for injection bag,8001118,dexmedetomidine,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),1.0,,,Prescription
92145,Marketed,2019-03-04,02437147,Precedex,1,N05CM18,Dexmedetomidine,Solution,Intravenous,77700571,PRECEDEX (dexmedetomidine (dexmedetomidine hydrochloride) 400 mcg per 100 mL solution for injection vial) PFIZER CANADA ULC,Active,9012487,dexmedetomidine (dexmedetomidine hydrochloride) 400 mcg per 100 mL solution for injection vial,8001118,dexmedetomidine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
92145,Marketed,2019-03-04,02437147,Precedex,1,N05CM18,Dexmedetomidine,Solution,Intravenous,77700572,PRECEDEX (dexmedetomidine (dexmedetomidine hydrochloride) 80 mcg per 20 mL solution for injection vial) PFIZER CANADA ULC,Active,9012488,dexmedetomidine (dexmedetomidine hydrochloride) 80 mcg per 20 mL solution for injection vial,8001118,dexmedetomidine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
92145,Marketed,2019-03-04,02437147,Precedex,1,N05CM18,Dexmedetomidine,Solution,Intravenous,77700573,PRECEDEX (dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg per 50 mL solution for injection vial) PFIZER CANADA ULC,Active,9012486,dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg per 50 mL solution for injection vial,8001118,dexmedetomidine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
95254,Marketed,2019-10-10,02464381,dexmedeTOMidine Hydrochloride For Injection,1,N05CM18,Dexmedetomidine,Solution,Intravenous,02464381,DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION (dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg per 2 mL solution for injection vial) AURO PHARMA INC,Active,9012485,dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg per 2 mL solution for injection vial,8001118,dexmedetomidine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
95633,Marketed,2026-02-20,02467976,"dexmedeTOMidine Hydrochloride For Injection, USP",1,N05CM18,Dexmedetomidine,Solution,Intravenous,02467976,"DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP (dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg per 2 mL solution for injection vial) JUNO PHARMA CANADA INC.",Active,9012485,dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg per 2 mL solution for injection vial,8001118,dexmedetomidine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
96831,Marketed,2019-03-29,02477327,dexmedeTOMidine Hydrochloride For Injection,1,N05CM18,Dexmedetomidine,Solution,Intravenous,02477327,DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION (dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg per 2 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9012485,dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg per 2 mL solution for injection vial,8001118,dexmedetomidine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
97754,Marketed,2026-02-20,02487365,dexmedeTOMidine Hydrochloride Injection,1,N05CM18,Dexmedetomidine,Solution,Intravenous,02487365,DEXMEDETOMIDINE HYDROCHLORIDE INJECTION (dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg per 50 mL solution for injection vial) JUNO PHARMA CANADA INC.,Active,9012486,dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg per 50 mL solution for injection vial,8001118,dexmedetomidine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
97755,Marketed,2026-02-20,02487373,dexmedeTOMidine Hydrochloride Injection,1,N05CM18,Dexmedetomidine,Solution,Intravenous,02487373,DEXMEDETOMIDINE HYDROCHLORIDE INJECTION (dexmedetomidine (dexmedetomidine hydrochloride) 400 mcg per 100 mL solution for injection vial) JUNO PHARMA CANADA INC.,Active,9012487,dexmedetomidine (dexmedetomidine hydrochloride) 400 mcg per 100 mL solution for injection vial,8001118,dexmedetomidine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
103261,Marketed,2025-06-21,02544083,Dexrazoxane For Injection,1,V03AF02,Dexrazoxane,Powder for solution,Intravenous,02544083,DEXRAZOXANE FOR INJECTION (dexrazoxane 250 mg per vial powder for solution for injection) JUNO PHARMACEUTICALS CORP.,Active,9002784,dexrazoxane 250 mg per vial powder for solution for injection,8001745,dexrazoxane,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
18480,Marketed,2009-02-03,02153432,Zinecard,1,V03AF02,Dexrazoxane,Powder for solution,Intravenous,02153432,ZINECARD (dexrazoxane 250 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9002784,dexrazoxane 250 mg per vial powder for solution for injection,8001745,dexrazoxane,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
1743,Marketed,2017-09-21,00224227,LMD 10% In 0.9% Sodium Chloride,2,B05AA55,"Dextran,combinations",Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
1744,Marketed,2017-09-20,00224235,LMD 10% In Dextrose 5%,2,B05AA55,"Dextran,combinations",Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
100054,Marketed,2024-03-06,02511320,Buckley's Dry Cough Extra Strength,1,R05DA09,Dextromethorphan,Solution,Oral,02511320,BUCKLEY'S DRY COUGH EXTRA STRENGTH (dextromethorphan hydrobromide 15 mg per 5 mL syrup) HALEON CANADA ULC,Active,9001832,dextromethorphan hydrobromide 15 mg per 5 mL syrup,8001368,dextromethorphan,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
102364,Marketed,2024-06-03,02534754,Dry Cough Relief Extra Strength,1,R05DA09,Dextromethorphan,Syrup,Oral,02534754,DRY COUGH RELIEF EXTRA STRENGTH (dextromethorphan hydrobromide 15 mg per 5 mL syrup) CRLS,Active,9001832,dextromethorphan hydrobromide 15 mg per 5 mL syrup,8001368,dextromethorphan,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
103815,Marketed,2025-07-07,02549360,Dayquil Kids Honey,1,R05DA09,Dextromethorphan,Syrup,Oral,02549360,DAYQUIL KIDS HONEY (dextromethorphan hydrobromide 10 mg per 15 mL syrup) PROCTER & GAMBLE INC,Active,9015233,dextromethorphan hydrobromide 10 mg per 15 mL syrup,8001368,dextromethorphan,26643006,Oral,385032004,Oral syrup,,,,,,Non-Prescription Drugs
11847,Marketed,2013-01-11,01928791,Koffex DM (Sucrose Free),1,R05DA09,Dextromethorphan,Syrup,Oral,01928791,KOFFEX DM (SUCROSE FREE) (dextromethorphan hydrobromide 15 mg per 5 mL syrup) TEVA CANADA LIMITED,Active,9001832,dextromethorphan hydrobromide 15 mg per 5 mL syrup,8001368,dextromethorphan,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
11848,Marketed,2013-01-11,01928783,Koffex DM,1,R05DA09,Dextromethorphan,Syrup,Oral,01928783,KOFFEX DM (dextromethorphan hydrobromide 15 mg per 5 mL syrup) TEVA CANADA LIMITED,Active,9001832,dextromethorphan hydrobromide 15 mg per 5 mL syrup,8001368,dextromethorphan,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
12411,Marketed,2026-01-28,01944738,Benylin Extra Strength Dry Cough,1,R05DA09,Dextromethorphan,Syrup,Oral,01944738,BENYLIN EXTRA STRENGTH DRY COUGH (dextromethorphan hydrobromide 15 mg per 5 mL syrup) KENVUE CANADA INC.,Active,9001832,dextromethorphan hydrobromide 15 mg per 5 mL syrup,8001368,dextromethorphan,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
12788,Marketed,2013-01-09,01928775,Balminil DM (3 mg/mL Sucrose Free),1,R05DA09,Dextromethorphan,Syrup,Oral,01928775,BALMINIL DM (3MG/ML SUCROSE FREE) (dextromethorphan hydrobromide 15 mg per 5 mL syrup) TEVA CANADA LIMITED,Active,9001832,dextromethorphan hydrobromide 15 mg per 5 mL syrup,8001368,dextromethorphan,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
37038,Marketed,2026-05-14,02215268,Benylin For Children Dry Cough,1,R05DA09,Dextromethorphan,Solution,Oral,02215268,BENYLIN FOR CHILDREN DRY COUGH (dextromethorphan hydrobromide 7.5 mg per 5 mL oral solution) KENVUE CANADA INC.,Active,9013870,dextromethorphan hydrobromide 7.5 mg per 5 mL oral solution,8001368,dextromethorphan,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
4590,Marketed,1981-12-31,00522791,Bronchophan Forte DM Syr,1,R05DA09,Dextromethorphan,Syrup,Oral,00522791,BRONCHOPHAN FORTE DM SYR (dextromethorphan hydrobromide 15 mg per 5 mL syrup) LABORATOIRE ATLAS INC,Active,9001832,dextromethorphan hydrobromide 15 mg per 5 mL syrup,8001368,dextromethorphan,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
73742,Marketed,2024-06-14,02252554,Robitussin DM Coughgels Liqui-Gels Toux,1,R05DA09,Dextromethorphan,Capsule,Oral,02252554,ROBITUSSIN DM COUGHGELS LIQUI-GELS TOUX (dextromethorphan hydrobromide 15 mg oral capsule) HALEON CANADA ULC,Active,9004070,dextromethorphan hydrobromide 15 mg oral capsule,8001368,dextromethorphan,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
81407,Marketed,2018-10-30,02328550,Technelite,1,V09,Diagnostic radiopharmaceuticals,Solution,"Oral,Intravenous,Instillation",,,,,,,,,,,,,,,,,Schedule C
101402,Marketed,2022-06-16,02524996,Diacetylmorphine Hydrochloride,1,N07BC06,Diamorphine,Powder for solution,"Intravenous,Intramuscular",02524996,DIACETYLMORPHINE HYDROCHLORIDE (diamorphine hydrochloride 200 mg per vial powder for solution for injection) PHARMASCIENCE INC,Active,9014809,diamorphine hydrochloride 200 mg per vial powder for solution for injection,8002454,diamorphine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
101403,Marketed,2022-04-11,02525003,Diacetylmorphine Hydrochloride,1,N07BC06,Diamorphine,Powder for solution,"Intravenous,Intramuscular",02525003,DIACETYLMORPHINE HYDROCHLORIDE (diamorphine hydrochloride 5000 mg per vial powder for solution for injection) PHARMASCIENCE INC,Active,9014810,diamorphine hydrochloride 5000 mg per vial powder for solution for injection,8002454,diamorphine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
37570,Marketed,1997-04-22,02228564,Gastrografin,2,V08AA01,Diatrizoic acid,Solution,"Rectal,Oral",,,,,,,,,,,,,,,,,Ethical
100835,Marketed,2022-04-21,02519070,Diastat,1,N05BA01,Diazepam,Gel,Rectal,02519070,"DIASTAT (diazepam 10 mg per 2 mL rectal gel tube) BAUSCH HEALTH, CANADA INC.",Active,9014676,diazepam 10 mg per 2 mL rectal gel tube,8000048,diazepam,37161004,Rectal,385100002,Gel,,,,,,Targeted Substances (CDSA IV)
100836,Marketed,2022-04-21,02519089,Diastat,1,N05BA01,Diazepam,Gel,Rectal,02519089,"DIASTAT (diazepam 15 mg per 3 mL rectal gel tube) BAUSCH HEALTH, CANADA INC.",Active,9000879,diazepam 15 mg per 3 mL rectal gel tube,8000048,diazepam,37161004,Rectal,385100002,Gel,,,,,,Targeted Substances (CDSA IV)
2657,Marketed,2019-06-13,00362158,Diazepam,1,N05BA01,Diazepam,Tablet,Oral,00362158,DIAZEPAM (diazepam 5 mg oral tablet) AA PHARMA INC,Active,9000075,diazepam 5 mg oral tablet,8000048,diazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
3178,Marketed,2024-11-01,00013285,Valium,1,N05BA01,Diazepam,Tablet,Oral,00013285,VALIUM (diazepam 5 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9000075,diazepam 5 mg oral tablet,8000048,diazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
3290,Marketed,2019-08-27,00405329,Diazepam,1,N05BA01,Diazepam,Tablet,Oral,00405329,DIAZEPAM (diazepam 2 mg oral tablet) AA PHARMA INC,Active,9000128,diazepam 2 mg oral tablet,8000048,diazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
3291,Marketed,2020-05-07,00405337,Diazepam,1,N05BA01,Diazepam,Tablet,Oral,00405337,DIAZEPAM (diazepam 10 mg oral tablet) AA PHARMA INC,Active,9000108,diazepam 10 mg oral tablet,8000048,diazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
3721,Marketed,2005-09-19,00399728,Diazepam Injection USP,1,N05BA01,Diazepam,Solution,"Intravenous,Intramuscular",00399728,DIAZEPAM INJECTION USP (diazepam 10 mg per 2 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9001477,diazepam 10 mg per 2 mL solution for injection ampoule,8000048,diazepam,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Targeted Substances (CDSA IV)
61553,Marketed,2021-08-18,02238162,Diastat,1,N05BA01,Diazepam,Gel,Rectal,77700067,"DIASTAT (diazepam 2.5 mg per 0.5 mL rectal gel tube) BAUSCH HEALTH, CANADA INC.",Inactive,9000881,diazepam 2.5 mg per 0.5 mL rectal gel tube,8000048,diazepam,37161004,Rectal,385100002,Gel,,,,,,Targeted Substances (CDSA IV)
61553,Marketed,2021-08-18,02238162,Diastat,1,N05BA01,Diazepam,Gel,Rectal,77700068,"DIASTAT (diazepam 5 mg per 1 mL rectal gel tube) BAUSCH HEALTH, CANADA INC.",Active,9000882,diazepam 5 mg per 1 mL rectal gel tube,8000048,diazepam,37161004,Rectal,385100002,Gel,,,,,,Targeted Substances (CDSA IV)
61553,Marketed,2021-08-18,02238162,Diastat,1,N05BA01,Diazepam,Gel,Rectal,77700069,"DIASTAT (diazepam 7.5 mg per 1.5 mL rectal gel tube) BAUSCH HEALTH, CANADA INC.",Inactive,9000883,diazepam 7.5 mg per 1.5 mL rectal gel tube,8000048,diazepam,37161004,Rectal,385100002,Gel,,,,,,Targeted Substances (CDSA IV)
61553,Marketed,2021-08-18,02238162,Diastat,1,N05BA01,Diazepam,Gel,Rectal,77700071,"DIASTAT (diazepam 20 mg per 4 mL rectal gel tube) BAUSCH HEALTH, CANADA INC.",Inactive,9000880,diazepam 20 mg per 4 mL rectal gel tube,8000048,diazepam,37161004,Rectal,385100002,Gel,,,,,,Targeted Substances (CDSA IV)
6269,Marketed,2012-10-19,00503347,Proglycem,1,V03AH01,Diazoxide,Capsule,Oral,00503347,PROGLYCEM (diazoxide 100 mg oral capsule) MERCK CANADA INC,Active,9002046,diazoxide 100 mg oral capsule,8001631,diazoxide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
86098,Marketed,2013-03-07,02375567,Antibacterial Throat Lozenges,2,R02AA03,Dichlorobenzyl alcohol,Lozenge,Oral,02375567,ANTIBACTERIAL THROAT LOZENGES (amylmetacresol 0.6 mg and dichlorobenzyl alcohol 1.2 mg lozenge) QUIMICA CANADA LIMITED,Active,9005064,amylmetacresol 0.6 mg and dichlorobenzyl alcohol 1.2 mg lozenge,8002093,amylmetacresol and dichlorobenzyl alcohol,26643006,Oral,385087003,Lozenge,733000006,Lozenge (unit of presentation),,,,Non-Prescription Drugs
86869,Marketed,2026-03-09,02382881,Cepacol Sensations Sore Throat & Blocked Nose,3,R02AA03,Dichlorobenzyl alcohol,Lozenge,Oral,02382881,CEPACOL SENSATIONS SORE THROAT & BLOCKED NOSE (amylmetacresol 0.6 mg and dichlorobenzyl alcohol 1.2 mg and levomenthol 8 mg lozenge) RECKITT BENCKISER (CANADA) INC,Active,9013761,amylmetacresol 0.6 mg and dichlorobenzyl alcohol 1.2 mg and levomenthol 8 mg lozenge,8002216,amylmetacresol and dichlorobenzyl alcohol and levomenthol,26643006,Oral,385087003,Lozenge,733000006,Lozenge (unit of presentation),,,,Non-Prescription Drugs
86872,Marketed,2026-03-10,02382938,Cepacol Sensations,2,R02AA03,Dichlorobenzyl alcohol,Lozenge,Oral,02382938,CEPACOL SENSATIONS (amylmetacresol 0.6 mg and dichlorobenzyl alcohol 1.2 mg lozenge) RECKITT BENCKISER (CANADA) INC,Active,9005064,amylmetacresol 0.6 mg and dichlorobenzyl alcohol 1.2 mg lozenge,8002093,amylmetacresol and dichlorobenzyl alcohol,26643006,Oral,385087003,Lozenge,733000006,Lozenge (unit of presentation),,,,Non-Prescription Drugs
87415,Marketed,2026-03-10,02388642,Cepacol Sensations Sore Throat & Cough,3,R02AA03,Dichlorobenzyl alcohol,Lozenge,Oral,02388642,CEPACOL SENSATIONS SORE THROAT & COUGH (amylmetacresol 0.6 mg and dichlorobenzyl alcohol 1.2 mg and menthol 8 mg lozenge) RECKITT BENCKISER (CANADA) INC,Active,9005063,amylmetacresol 0.6 mg and dichlorobenzyl alcohol 1.2 mg and menthol 8 mg lozenge,8002094,amylmetacresol and dichlorobenzyl alcohol and menthol,26643006,Oral,385087003,Lozenge,733000006,Lozenge (unit of presentation),,,,Non-Prescription Drugs
88981,Marketed,2026-04-15,02404982,Cepacol Children's Fruity Strawberry,2,R02AA03,Dichlorobenzyl alcohol,Lozenge,Oral,02404982,CEPACOL CHILDREN'S FRUITY STRAWBERRY (amylmetacresol 0.6 mg and dichlorobenzyl alcohol 1.2 mg lozenge) RECKITT BENCKISER (CANADA) INC,Active,9005064,amylmetacresol 0.6 mg and dichlorobenzyl alcohol 1.2 mg lozenge,8002093,amylmetacresol and dichlorobenzyl alcohol,26643006,Oral,385087003,Lozenge,733000006,Lozenge (unit of presentation),,,,Non-Prescription Drugs
10036,Marketed,1989-12-31,00839175,Apo-Diclo,1,M01AB05,Diclofenac,Tablet (enteric-coated),Oral,00839175,APO-DICLO (diclofenac sodium 25 mg gastro-resistant tablet) APOTEX INC,Active,9000316,diclofenac sodium 25 mg gastro-resistant tablet,8000082,diclofenac,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
10037,Marketed,1989-12-31,00839183,Apo-Diclo,1,M01AB05,Diclofenac,Tablet (enteric-coated),Oral,00839183,APO-DICLO (diclofenac sodium 50 mg gastro-resistant tablet) APOTEX INC,Active,9000146,diclofenac sodium 50 mg gastro-resistant tablet,8000082,diclofenac,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102344,Marketed,2024-02-09,02534525,JAMP Diclofenac,1,S01BC03,Diclofenac,Solution,Ophthalmic,02534525,JAMP DICLOFENAC (diclofenac sodium 0.1 % ophthalmic drops) JAMP PHARMA CORPORATION,Active,9000380,diclofenac sodium 0.1 % ophthalmic drops,8000082,diclofenac,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
104363,Marketed,2025-09-03,02554801,Voltaren Emulgel Active,1,M02AA15,Diclofenac,Gel,Topical,02554801,VOLTAREN EMULGEL ACTIVE (diclofenac diethylamine 1.16 % cutaneous gel) HALEON CANADA ULC,Active,9001255,diclofenac diethylamine 1.16 % cutaneous gel,8000082,diclofenac,448598008,Cutaneous,385100002,Gel,,,,,,Non-Prescription Drugs
10772,Marketed,2026-01-15,00870978,Pro-Diclofenac,1,M01AB05,Diclofenac,Tablet (delayed-release),Oral,00870978,PRO-DICLOFENAC (diclofenac sodium 50 mg gastro-resistant tablet) PRO DOC LIMITEE,Active,9000146,diclofenac sodium 50 mg gastro-resistant tablet,8000082,diclofenac,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
13805,Marketed,1998-08-27,00881635,Voltaren Rapide,1,M01AB05,Diclofenac,Tablet,Oral,00881635,VOLTAREN RAPIDE (diclofenac potassium 50 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9000461,diclofenac potassium 50 mg oral tablet,8000082,diclofenac,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
16471,Marketed,1994-12-31,02091194,Apo-Diclo SR,1,M01AB05,Diclofenac,Tablet (extended-release),Oral,02091194,APO-DICLO SR (diclofenac sodium 100 mg prolonged-release oral tablet) APOTEX INC,Active,9000221,diclofenac sodium 100 mg prolonged-release oral tablet,8000082,diclofenac,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
18239,Marketed,2010-10-09,02158582,Teva-Diclofenac SR,1,M01AB05,Diclofenac,Tablet (extended-release),Oral,02158582,TEVA-DICLOFENAC SR (diclofenac sodium 75 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9000317,diclofenac sodium 75 mg prolonged-release oral tablet,8000082,diclofenac,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
19125,Marketed,2019-12-23,02162814,Apo-Diclo SR,1,M01AB05,Diclofenac,Tablet (extended-release),Oral,02162814,APO-DICLO SR (diclofenac sodium 75 mg prolonged-release oral tablet) APOTEX INC,Active,9000317,diclofenac sodium 75 mg prolonged-release oral tablet,8000082,diclofenac,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
62824,Marketed,2010-10-09,02239355,Teva-Diclofenac-K,1,M01AB05,Diclofenac,Tablet,Oral,02239355,TEVA-DICLOFENAC-K (diclofenac potassium 50 mg oral tablet) TEVA CANADA LIMITED,Active,9000461,diclofenac potassium 50 mg oral tablet,8000082,diclofenac,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
6461,Marketed,2000-06-16,00632724,Voltaren,1,M01AB05,Diclofenac,Suppository,Rectal,00632724,VOLTAREN (diclofenac sodium 50 mg suppository) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9000223,diclofenac sodium 50 mg suppository,8000082,diclofenac,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,,Prescription
71508,Marketed,2025-11-21,02247265,Pennsaid,1,M02AA15,Diclofenac,Solution,Topical,02247265,PENNSAID (diclofenac sodium 1.5 % cutaneous solution) KNIGHT THERAPEUTICS INC.,Active,9001019,diclofenac sodium 1.5 % cutaneous solution,8000082,diclofenac,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Prescription
74714,Marketed,2006-02-02,02261774,Sandoz Diclofenac Rapide,1,M01AB05,Diclofenac,Tablet,Oral,02261774,SANDOZ DICLOFENAC RAPIDE (diclofenac potassium 50 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000461,diclofenac potassium 50 mg oral tablet,8000082,diclofenac,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74727,Marketed,2008-10-01,02261928,Sandoz-Diclofenac,1,M01AB05,Diclofenac,Suppository,Rectal,02261928,SANDOZ-DICLOFENAC (diclofenac sodium 50 mg suppository) SANDOZ CANADA INCORPORATED,Active,9000223,diclofenac sodium 50 mg suppository,8000082,diclofenac,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,,Prescription
78791,Marketed,2008-05-12,02302616,PMS-Diclofenac,1,M01AB05,Diclofenac,Tablet (delayed-release),Oral,02302616,PMS-DICLOFENAC (diclofenac sodium 25 mg gastro-resistant tablet) PHARMASCIENCE INC,Active,9000316,diclofenac sodium 25 mg gastro-resistant tablet,8000082,diclofenac,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78792,Marketed,2008-05-12,02302624,PMS-Diclofenac,1,M01AB05,Diclofenac,Tablet (delayed-release),Oral,02302624,PMS-DICLOFENAC (diclofenac sodium 50 mg gastro-resistant tablet) PHARMASCIENCE INC,Active,9000146,diclofenac sodium 50 mg gastro-resistant tablet,8000082,diclofenac,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82423,Marketed,2025-01-29,02338580,Voltaren Emulgel Joint Pain Regular Strength,1,M02AA15,Diclofenac,Gel,Topical,02338580,VOLTAREN EMULGEL JOINT PAIN REGULAR STRENGTH (diclofenac diethylamine 1.16 % cutaneous gel) HALEON CANADA ULC,Active,9001255,diclofenac diethylamine 1.16 % cutaneous gel,8000082,diclofenac,448598008,Cutaneous,385100002,Gel,,,,,,Non-Prescription Drugs
86754,Marketed,2019-08-08,02381680,Cambia,1,M01AB05,Diclofenac,Powder for solution,Oral,02381680,CAMBIA (diclofenac potassium 50 mg per sachet powder for oral solution) ARALEZ PHARMACEUTICALS CANADA INC,Active,9001385,diclofenac potassium 50 mg per sachet powder for oral solution,8000082,diclofenac,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,,Prescription
87843,Marketed,2024-09-26,02393190,Voltaren Emulgel Extra Strength,1,M02AA15,Diclofenac,Gel,Topical,02393190,VOLTAREN EMULGEL EXTRA STRENGTH (diclofenac diethylamine 2.32 % cutaneous gel) HALEON CANADA ULC,Active,9001434,diclofenac diethylamine 2.32 % cutaneous gel,8000082,diclofenac,448598008,Cutaneous,385100002,Gel,,,,,,Non-Prescription Drugs
90557,Marketed,2014-03-31,02420988,Taro-Diclofenac,1,M02AA15,Diclofenac,Solution,Topical,02420988,TARO-DICLOFENAC (diclofenac sodium 1.5 % cutaneous solution) TARO PHARMACEUTICALS INC,Active,9001019,diclofenac sodium 1.5 % cutaneous solution,8000082,diclofenac,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Prescription
95324,Marketed,2025-01-29,02465035,Voltaren Emulgel Back & Muscle Pain,1,M02AA15,Diclofenac,Gel,Topical,02465035,VOLTAREN EMULGEL BACK & MUSCLE PAIN (diclofenac diethylamine 1.16 % cutaneous gel) HALEON CANADA ULC,Active,9001255,diclofenac diethylamine 1.16 % cutaneous gel,8000082,diclofenac,448598008,Cutaneous,385100002,Gel,,,,,,Non-Prescription Drugs
95325,Marketed,2024-09-26,02465043,Voltaren Emulgel Joint Pain Extra Strength,1,M02AA15,Diclofenac,Gel,Topical,02465043,VOLTAREN EMULGEL JOINT PAIN EXTRA STRENGTH (diclofenac diethylamine 2.32 % cutaneous gel) HALEON CANADA ULC,Active,9001434,diclofenac diethylamine 2.32 % cutaneous gel,8000082,diclofenac,448598008,Cutaneous,385100002,Gel,,,,,,Non-Prescription Drugs
96140,Marketed,2018-07-25,02472309,JAMP Diclofenac Topical Solution,1,M02AA15,Diclofenac,Solution,Topical,02472309,JAMP DICLOFENAC TOPICAL SOLUTION (diclofenac sodium 1.5 % cutaneous solution) JAMP PHARMA CORPORATION,Active,9001019,diclofenac sodium 1.5 % cutaneous solution,8000082,diclofenac,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Prescription
96535,Marketed,2019-03-29,02475065,Diclofenac,1,S01BC03,Diclofenac,Solution,Ophthalmic,02475065,DICLOFENAC (diclofenac sodium 0.1 % ophthalmic drops) PHARMA STULLN INC.,Active,9000380,diclofenac sodium 0.1 % ophthalmic drops,8000082,diclofenac,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
9889,Marketed,2010-10-09,00808547,Teva-Diclofenac EC,1,M01AB05,Diclofenac,Tablet (enteric-coated),Oral,00808547,TEVA-DICLOFENAC EC (diclofenac sodium 50 mg gastro-resistant tablet) TEVA CANADA LIMITED,Active,9000146,diclofenac sodium 50 mg gastro-resistant tablet,8000082,diclofenac,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
13636,Marketed,2005-11-21,01917056,Arthrotec 50,2,M01AB55,"Diclofenac, combinations",Tablet (delayed-release),Oral,01917056,ARTHROTEC 50 (diclofenac sodium 50 mg and misoprostol 200 mcg gastro-resistant tablet) PFIZER CANADA ULC,Active,9001399,diclofenac sodium 50 mg and misoprostol 200 mcg gastro-resistant tablet,8000180,diclofenac and misoprostol,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
48191,Marketed,2006-01-12,02229837,Arthrotec 75,2,M01AB55,"Diclofenac, combinations",Tablet (delayed-release),Oral,02229837,ARTHROTEC 75 (diclofenac sodium 75 mg and misoprostol 200 mcg gastro-resistant tablet) PFIZER CANADA ULC,Active,9001400,diclofenac sodium 75 mg and misoprostol 200 mcg gastro-resistant tablet,8000180,diclofenac and misoprostol,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
82718,Marketed,2014-07-22,02341689,GD-Diclofenac/Misoprostol 50,2,M01AB55,"Diclofenac, combinations",Tablet (delayed-release),Oral,02341689,GD-DICLOFENAC/MISOPROSTOL 50 (diclofenac sodium 50 mg and misoprostol 200 mcg gastro-resistant tablet) GENMED A DIVISION OF PFIZER CANADA ULC,Active,9001399,diclofenac sodium 50 mg and misoprostol 200 mcg gastro-resistant tablet,8000180,diclofenac and misoprostol,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
82719,Marketed,2014-07-22,02341697,GD-Diclofenac/Misoprostol 75,2,M01AB55,"Diclofenac, combinations",Tablet (delayed-release),Oral,02341697,GD-DICLOFENAC/MISOPROSTOL 75 (diclofenac sodium 75 mg and misoprostol 200 mcg gastro-resistant tablet) GENMED A DIVISION OF PFIZER CANADA ULC,Active,9001400,diclofenac sodium 75 mg and misoprostol 200 mcg gastro-resistant tablet,8000180,diclofenac and misoprostol,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
89812,Marketed,2018-12-11,02413469,PMS-Diclofenac-Misoprostol,2,M01AB55,"Diclofenac, combinations",Tablet (delayed-release),Oral,02413469,PMS-DICLOFENAC-MISOPROSTOL (diclofenac sodium 50 mg and misoprostol 200 mcg gastro-resistant tablet) PHARMASCIENCE INC,Active,9001399,diclofenac sodium 50 mg and misoprostol 200 mcg gastro-resistant tablet,8000180,diclofenac and misoprostol,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
89813,Marketed,2018-12-11,02413477,PMS-Diclofenac-Misoprostol,2,M01AB55,"Diclofenac, combinations",Tablet (delayed-release),Oral,02413477,PMS-DICLOFENAC-MISOPROSTOL (diclofenac sodium 75 mg and misoprostol 200 mcg gastro-resistant tablet) PHARMASCIENCE INC,Active,9001400,diclofenac sodium 75 mg and misoprostol 200 mcg gastro-resistant tablet,8000180,diclofenac and misoprostol,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
4710,Marketed,2022-06-10,00557102,Riva-Dicyclomine,1,A03AA07,Dicycloverine,Capsule,Oral,00557102,RIVA-DICYCLOMINE (dicyclomine hydrochloride 10 mg oral capsule) LABORATOIRE RIVA INC.,Active,9001714,dicyclomine hydrochloride 10 mg oral capsule,8001374,dicyclomine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Ethical
85095,Marketed,2011-08-08,02366088,JAMP-Dicyclomine HCL,1,A03AA07,Dicycloverine,Tablet,Oral,02366088,JAMP-DICYCLOMINE HCL (dicyclomine hydrochloride 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9002799,dicyclomine hydrochloride 20 mg oral tablet,8001374,dicyclomine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Ethical
87694,Marketed,2012-10-23,02391619,JAMP-Dicyclomine HCL,1,A03AA07,Dicycloverine,Tablet,Oral,02391619,JAMP-DICYCLOMINE HCL (dicyclomine hydrochloride 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9002798,dicyclomine hydrochloride 10 mg oral tablet,8001374,dicyclomine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Ethical
103207,Marketed,2024-04-23,02543613,M-Dienogest,1,G03DB08,Dienogest,Tablet,Oral,02543613,M-DIENOGEST (dienogest 2 mg oral tablet) MANTRA PHARMA INC,Active,9004945,dienogest 2 mg oral tablet,8001450,dienogest,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104041,Marketed,2025-06-30,02551683,Mar-Dienogest,1,G03DB08,Dienogest,Tablet,Oral,02551683,MAR-DIENOGEST (dienogest 2 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9004945,dienogest 2 mg oral tablet,8001450,dienogest,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86025,Marketed,2011-10-25,02374900,Visanne,1,G03DB08,Dienogest,Tablet,Oral,02374900,VISANNE (dienogest 2 mg oral tablet) BAYER INC,Active,9004945,dienogest 2 mg oral tablet,8001450,dienogest,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98304,Marketed,2020-04-14,02493055,Aspen-Dienogest,1,G03DB08,Dienogest,Tablet,Oral,02493055,ASPEN-DIENOGEST (dienogest 2 mg oral tablet) ASPEN PHARMACARE CANADA INC.,Active,9004945,dienogest 2 mg oral tablet,8001450,dienogest,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98796,Marketed,2020-12-10,02498189,JAMP Dienogest,1,G03DB08,Dienogest,Tablet,Oral,02498189,JAMP DIENOGEST (dienogest 2 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004945,dienogest 2 mg oral tablet,8001450,dienogest,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101892,Marketed,2023-02-06,02529688,Korsuva,1,V03AX04,Difelikefalin,Solution,Intravenous,02529688,KORSUVA (difelikefalin (difelikefalin acetate) 50 mcg per 1 mL solution for injection vial) VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD,Active,9014828,difelikefalin (difelikefalin acetate) 50 mcg per 1 mL solution for injection vial,8002460,difelikefalin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
84609,Marketed,2011-11-04,02361043,Digifab,1,V03AB24,Digitalis antitoxin,Powder for solution,Intravenous,,,,,,,,,,,,,,,,,Schedule D
84609,Marketed,2011-11-04,02361043,Digifab,1,V03AB24,Digitalis antitoxin,Powder for solution,Intravenous,,,,,,,,,,,,,,,,,Prescription
104325,Marketed,2025-07-22,02554399,Auro-Digoxin,1,C01AA05,Digoxin,Tablet,Oral,02554399,AURO-DIGOXIN (digoxin 0.0625 mg oral tablet) AURO PHARMA INC,Active,9001155,digoxin 0.0625 mg oral tablet,8000198,digoxin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104326,Marketed,2025-07-22,02554402,Auro-Digoxin,1,C01AA05,Digoxin,Tablet,Oral,02554402,AURO-DIGOXIN (digoxin 0.125 mg oral tablet) AURO PHARMA INC,Active,9001156,digoxin 0.125 mg oral tablet,8000198,digoxin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
15757,Marketed,2005-10-06,02048264,Digoxin Injection C.S.D.,1,C01AA05,Digoxin,Liquid,"Intramuscular,Intravenous",02048264,DIGOXIN INJECTION C.S.D. (digoxin 0.5 mg per 2 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9000517,digoxin 0.5 mg per 2 mL solution for injection ampoule,8000198,digoxin,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
66031,Marketed,2023-10-06,02242320,PMS-Digoxin,1,C01AA05,Digoxin,Solution,Oral,02242320,PMS-DIGOXIN (digoxin 0.05 mg per mL oral solution) PHARMASCIENCE INC,Active,9000941,digoxin 0.05 mg per mL oral solution,8000198,digoxin,26643006,Oral,385023001,Oral solution,,,,,,Prescription
82129,Marketed,2023-07-05,02335700,PMS-Digoxin,1,C01AA05,Digoxin,Tablet,Oral,02335700,PMS-DIGOXIN (digoxin 0.0625 mg oral tablet) PHARMASCIENCE INC,Active,9001155,digoxin 0.0625 mg oral tablet,8000198,digoxin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82130,Marketed,2023-07-10,02335719,PMS-Digoxin,1,C01AA05,Digoxin,Tablet,Oral,02335719,PMS-DIGOXIN (digoxin 0.125 mg oral tablet) PHARMASCIENCE INC,Active,9001156,digoxin 0.125 mg oral tablet,8000198,digoxin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98827,Marketed,2026-01-16,02498502,JAMP Digoxin,1,C01AA05,Digoxin,Tablet,Oral,02498502,JAMP DIGOXIN (digoxin 0.0625 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001155,digoxin 0.0625 mg oral tablet,8000198,digoxin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98828,Marketed,2026-01-20,02498510,JAMP Digoxin,1,C01AA05,Digoxin,Tablet,Oral,02498510,JAMP DIGOXIN (digoxin 0.125 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001156,digoxin 0.125 mg oral tablet,8000198,digoxin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
415,Marketed,2004-07-30,00027243,Dihydroergotamine (Dhe),1,N02CA01,Dihydroergotamine,Solution,"Intravenous,Intramuscular,Subcutaneous",00027243,DIHYDROERGOTAMINE (DHE) (dihydroergotamine mesylate 1 mg per 1 mL solution for injection ampoule) STERIMAX INC,Active,9012957,dihydroergotamine mesylate 1 mg per 1 mL solution for injection ampoule,8001632,dihydroergotamine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),1.0,,,Prescription
43498,Marketed,2004-11-01,02228947,Migranal Nasal Spray 4 mg/mL,1,N02CA01,Dihydroergotamine,Liquid,Nasal,02228947,MIGRANAL NASAL SPRAY 4MG/ML (dihydroergotamine mesylate 0.5 mg per actuation nasal spray) STERIMAX INC,Active,9013547,dihydroergotamine mesylate 0.5 mg per actuation nasal spray,8001632,dihydroergotamine,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),1.0,,,Prescription
100327,Marketed,2021-10-07,02514095,dilTIAZem Hydrochloride Injection,1,C08DB01,Diltiazem,Solution,Intravenous,77701097,DILTIAZEM HYDROCHLORIDE INJECTION (diltiazem hydrochloride 50 mg per 10 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9000721,diltiazem hydrochloride 50 mg per 10 mL solution for injection vial,8000122,diltiazem,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
100327,Marketed,2021-10-07,02514095,dilTIAZem Hydrochloride Injection,1,C08DB01,Diltiazem,Solution,Intravenous,77701098,DILTIAZEM HYDROCHLORIDE INJECTION (diltiazem hydrochloride 25 mg per 5 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9000720,diltiazem hydrochloride 25 mg per 5 mL solution for injection vial,8000122,diltiazem,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
100545,Marketed,2021-10-15,02516101,dilTIAZem T,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02516101,DILTIAZEM T (diltiazem hydrochloride 120 mg prolonged-release oral capsule) SANIS HEALTH INC,Active,9000569,diltiazem hydrochloride 120 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
100546,Marketed,2021-10-15,02516128,dilTIAZem T,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02516128,DILTIAZEM T (diltiazem hydrochloride 180 mg prolonged-release oral capsule) SANIS HEALTH INC,Active,9000570,diltiazem hydrochloride 180 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
100547,Marketed,2021-10-15,02516136,dilTIAZem T,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02516136,DILTIAZEM T (diltiazem hydrochloride 240 mg prolonged-release oral capsule) SANIS HEALTH INC,Active,9000571,diltiazem hydrochloride 240 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
100548,Marketed,2021-10-15,02516144,dilTIAZem T,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02516144,DILTIAZEM T (diltiazem hydrochloride 300 mg prolonged-release oral capsule) SANIS HEALTH INC,Active,9000572,diltiazem hydrochloride 300 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
100549,Marketed,2021-10-15,02516152,dilTIAZem T,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02516152,DILTIAZEM T (diltiazem hydrochloride 360 mg prolonged-release oral capsule) SANIS HEALTH INC,Active,9000728,diltiazem hydrochloride 360 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
101730,Marketed,2022-12-16,02528037,JAMP dilTIAZem CD,1,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02528037,JAMP DILTIAZEM CD (diltiazem hydrochloride 120 mg prolonged-release oral capsule) JAMP PHARMA CORPORATION,Active,9000569,diltiazem hydrochloride 120 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
101731,Marketed,2022-12-16,02528045,JAMP dilTIAZem CD,1,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02528045,JAMP DILTIAZEM CD (diltiazem hydrochloride 180 mg prolonged-release oral capsule) JAMP PHARMA CORPORATION,Active,9000570,diltiazem hydrochloride 180 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
101732,Marketed,2022-12-16,02528053,JAMP dilTIAZem CD,1,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02528053,JAMP DILTIAZEM CD (diltiazem hydrochloride 240 mg prolonged-release oral capsule) JAMP PHARMA CORPORATION,Active,9000571,diltiazem hydrochloride 240 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
101733,Marketed,2022-12-16,02528061,JAMP dilTIAZem CD,1,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02528061,JAMP DILTIAZEM CD (diltiazem hydrochloride 300 mg prolonged-release oral capsule) JAMP PHARMA CORPORATION,Active,9000572,diltiazem hydrochloride 300 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
102963,Marketed,2023-10-04,02540924,Pro-dilTIAZem CD,1,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02540924,PRO-DILTIAZEM CD (diltiazem hydrochloride 120 mg prolonged-release oral capsule) PRO DOC LIMITEE,Active,9000569,diltiazem hydrochloride 120 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
102964,Marketed,2023-10-04,02540932,Pro-dilTIAZem CD,1,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02540932,PRO-DILTIAZEM CD (diltiazem hydrochloride 180 mg prolonged-release oral capsule) PRO DOC LIMITEE,Active,9000570,diltiazem hydrochloride 180 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
102965,Marketed,2023-10-04,02540940,Pro-dilTIAZem CD,1,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02540940,PRO-DILTIAZEM CD (diltiazem hydrochloride 240 mg prolonged-release oral capsule) PRO DOC LIMITEE,Active,9000571,diltiazem hydrochloride 240 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
102966,Marketed,2023-10-05,02540959,Pro-dilTIAZem CD,1,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02540959,PRO-DILTIAZEM CD (diltiazem hydrochloride 300 mg prolonged-release oral capsule) PRO DOC LIMITEE,Active,9000572,diltiazem hydrochloride 300 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
103480,Marketed,2024-08-26,02546086,M-dilTIAZem CD,1,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02546086,M-DILTIAZEM CD (diltiazem hydrochloride 120 mg prolonged-release oral capsule) MANTRA PHARMA INC,Active,9000569,diltiazem hydrochloride 120 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
103481,Marketed,2024-08-26,02546094,M-dilTIAZem CD,1,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02546094,M-DILTIAZEM CD (diltiazem hydrochloride 180 mg prolonged-release oral capsule) MANTRA PHARMA INC,Active,9000570,diltiazem hydrochloride 180 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
103482,Marketed,2024-08-26,02546108,M-dilTIAZem CD,1,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02546108,M-DILTIAZEM CD (diltiazem hydrochloride 240 mg prolonged-release oral capsule) MANTRA PHARMA INC,Active,9000571,diltiazem hydrochloride 240 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
103483,Marketed,2024-08-26,02546116,M-dilTIAZem CD,1,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02546116,M-DILTIAZEM CD (diltiazem hydrochloride 300 mg prolonged-release oral capsule) MANTRA PHARMA INC,Active,9000572,diltiazem hydrochloride 300 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
103512,Marketed,2024-08-23,02546434,M-dilTIAZem T,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02546434,M-DILTIAZEM T (diltiazem hydrochloride 120 mg prolonged-release oral capsule) MANTRA PHARMA INC,Active,9000569,diltiazem hydrochloride 120 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
103513,Marketed,2024-08-23,02546442,M-dilTIAZem T,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02546442,M-DILTIAZEM T (diltiazem hydrochloride 180 mg prolonged-release oral capsule) MANTRA PHARMA INC,Active,9000570,diltiazem hydrochloride 180 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
103514,Marketed,2024-08-23,02546450,M-dilTIAZem T,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02546450,M-DILTIAZEM T (diltiazem hydrochloride 240 mg prolonged-release oral capsule) MANTRA PHARMA INC,Active,9000571,diltiazem hydrochloride 240 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
103515,Marketed,2024-08-23,02546469,M-dilTIAZem T,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02546469,M-DILTIAZEM T (diltiazem hydrochloride 300 mg prolonged-release oral capsule) MANTRA PHARMA INC,Active,9000572,diltiazem hydrochloride 300 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
103516,Marketed,2024-08-23,02546477,M-dilTIAZem T,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02546477,M-DILTIAZEM T (diltiazem hydrochloride 360 mg prolonged-release oral capsule) MANTRA PHARMA INC,Active,9000728,diltiazem hydrochloride 360 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
47431,Marketed,1997-01-31,02229526,Apo-Diltiaz CD,1,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02229526,APO-DILTIAZ CD (diltiazem hydrochloride 300 mg prolonged-release oral capsule) APOTEX INC,Active,9000572,diltiazem hydrochloride 300 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
50278,Marketed,2019-01-09,02230997,Apo-Diltiaz CD,1,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02230997,APO-DILTIAZ CD (diltiazem hydrochloride 120 mg prolonged-release oral capsule) APOTEX INC,Active,9000569,diltiazem hydrochloride 120 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
50279,Marketed,1997-03-27,02230998,Apo-Diltiaz CD,1,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02230998,APO-DILTIAZ CD (diltiazem hydrochloride 180 mg prolonged-release oral capsule) APOTEX INC,Active,9000570,diltiazem hydrochloride 180 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
50280,Marketed,1997-03-27,02230999,Apo-Diltiaz CD,1,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02230999,APO-DILTIAZ CD (diltiazem hydrochloride 240 mg prolonged-release oral capsule) APOTEX INC,Active,9000571,diltiazem hydrochloride 240 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
50458,Marketed,2021-06-04,02231150,Tiazac,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02231150,"TIAZAC (diltiazem hydrochloride 120 mg prolonged-release oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9000569,diltiazem hydrochloride 120 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
50459,Marketed,2021-06-04,02231151,Tiazac,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02231151,"TIAZAC (diltiazem hydrochloride 180 mg prolonged-release oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9000570,diltiazem hydrochloride 180 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
50460,Marketed,2021-06-04,02231152,Tiazac,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02231152,"TIAZAC (diltiazem hydrochloride 240 mg prolonged-release oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9000571,diltiazem hydrochloride 240 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
50461,Marketed,2021-06-04,02231154,Tiazac,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02231154,"TIAZAC (diltiazem hydrochloride 300 mg prolonged-release oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9000572,diltiazem hydrochloride 300 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
50462,Marketed,2021-06-04,02231155,Tiazac,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02231155,"TIAZAC (diltiazem hydrochloride 360 mg prolonged-release oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9000728,diltiazem hydrochloride 360 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
66289,Marketed,2024-10-07,02242538,Teva-dilTIAZem CD,1,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02242538,TEVA-DILTIAZEM CD (diltiazem hydrochloride 120 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9000569,diltiazem hydrochloride 120 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
66290,Marketed,2024-10-07,02242539,Teva-dilTIAZem CD,1,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02242539,TEVA-DILTIAZEM CD (diltiazem hydrochloride 180 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9000570,diltiazem hydrochloride 180 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
66291,Marketed,2024-10-07,02242540,Teva-dilTIAZem CD,1,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02242540,TEVA-DILTIAZEM CD (diltiazem hydrochloride 240 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9000571,diltiazem hydrochloride 240 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
66292,Marketed,2024-10-07,02242541,Teva-dilTIAZem CD,1,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02242541,TEVA-DILTIAZEM CD (diltiazem hydrochloride 300 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9000572,diltiazem hydrochloride 300 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
68717,Marketed,2005-09-15,02244728,dilTIAZem Hydrochloride Injection,1,C08DB01,Diltiazem,Solution,Intravenous,77700086,DILTIAZEM HYDROCHLORIDE INJECTION (diltiazem hydrochloride 25 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000720,diltiazem hydrochloride 25 mg per 5 mL solution for injection vial,8000122,diltiazem,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
68717,Marketed,2005-09-15,02244728,dilTIAZem Hydrochloride Injection,1,C08DB01,Diltiazem,Solution,Intravenous,77700087,DILTIAZEM HYDROCHLORIDE INJECTION (diltiazem hydrochloride 50 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000721,diltiazem hydrochloride 50 mg per 10 mL solution for injection vial,8000122,diltiazem,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
74195,Marketed,2021-06-04,02256738,Tiazac XC,1,C08DB01,Diltiazem,Tablet (extended-release),Oral,02256738,"TIAZAC XC (diltiazem hydrochloride 120 mg prolonged-release oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9001083,diltiazem hydrochloride 120 mg prolonged-release oral tablet,8000122,diltiazem,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74196,Marketed,2021-06-04,02256746,Tiazac XC,1,C08DB01,Diltiazem,Tablet (extended-release),Oral,02256746,"TIAZAC XC (diltiazem hydrochloride 180 mg prolonged-release oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9001084,diltiazem hydrochloride 180 mg prolonged-release oral tablet,8000122,diltiazem,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74197,Marketed,2021-06-04,02256754,Tiazac XC,1,C08DB01,Diltiazem,Tablet (extended-release),Oral,02256754,"TIAZAC XC (diltiazem hydrochloride 240 mg prolonged-release oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9001085,diltiazem hydrochloride 240 mg prolonged-release oral tablet,8000122,diltiazem,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74198,Marketed,2021-06-04,02256762,Tiazac XC,1,C08DB01,Diltiazem,Tablet (extended-release),Oral,02256762,"TIAZAC XC (diltiazem hydrochloride 300 mg prolonged-release oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9001086,diltiazem hydrochloride 300 mg prolonged-release oral tablet,8000122,diltiazem,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74199,Marketed,2021-06-04,02256770,Tiazac XC,1,C08DB01,Diltiazem,Tablet (extended-release),Oral,02256770,"TIAZAC XC (diltiazem hydrochloride 360 mg prolonged-release oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9001087,diltiazem hydrochloride 360 mg prolonged-release oral tablet,8000122,diltiazem,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75715,Marketed,2021-09-09,02271605,Teva-dilTIAZem HCL ER,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02271605,"TEVA-DILTIAZEM HCL ER (diltiazem hydrochloride 120 mg prolonged-release oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9000569,diltiazem hydrochloride 120 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
75716,Marketed,2021-09-09,02271613,Teva-dilTIAZem HCL ER,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02271613,"TEVA-DILTIAZEM HCL ER (diltiazem hydrochloride 180 mg prolonged-release oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9000570,diltiazem hydrochloride 180 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
75717,Marketed,2021-09-09,02271621,Teva-dilTIAZem HCL ER,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02271621,"TEVA-DILTIAZEM HCL ER (diltiazem hydrochloride 240 mg prolonged-release oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9000571,diltiazem hydrochloride 240 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
75718,Marketed,2021-09-09,02271648,Teva-dilTIAZem HCL ER,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02271648,"TEVA-DILTIAZEM HCL ER (diltiazem hydrochloride 300 mg prolonged-release oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9000572,diltiazem hydrochloride 300 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
75719,Marketed,2021-09-09,02271656,Teva-dilTIAZem HCL ER,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02271656,"TEVA-DILTIAZEM HCL ER (diltiazem hydrochloride 360 mg prolonged-release oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9000728,diltiazem hydrochloride 360 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
85560,Marketed,2024-10-23,02370441,Teva-dilTIAZem T,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02370441,TEVA-DILTIAZEM T (diltiazem hydrochloride 120 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9000569,diltiazem hydrochloride 120 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
85564,Marketed,2024-10-23,02370492,Teva-dilTIAZem T,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02370492,TEVA-DILTIAZEM T (diltiazem hydrochloride 180 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9000570,diltiazem hydrochloride 180 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
85565,Marketed,2024-10-23,02370506,Teva-dilTIAZem T,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02370506,TEVA-DILTIAZEM T (diltiazem hydrochloride 240 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9000571,diltiazem hydrochloride 240 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
85566,Marketed,2024-10-23,02370514,Teva-dilTIAZem T,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02370514,TEVA-DILTIAZEM T (diltiazem hydrochloride 300 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9000572,diltiazem hydrochloride 300 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
85567,Marketed,2024-10-23,02370522,Teva-dilTIAZem T,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02370522,TEVA-DILTIAZEM T (diltiazem hydrochloride 360 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9000728,diltiazem hydrochloride 360 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88523,Marketed,2022-04-20,02400421,dilTIAZem CD,1,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02400421,DILTIAZEM CD (diltiazem hydrochloride 120 mg prolonged-release oral capsule) SANIS HEALTH INC,Active,9000569,diltiazem hydrochloride 120 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88524,Marketed,2022-04-20,02400448,dilTIAZem CD,1,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02400448,DILTIAZEM CD (diltiazem hydrochloride 180 mg prolonged-release oral capsule) SANIS HEALTH INC,Active,9000570,diltiazem hydrochloride 180 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88525,Marketed,2022-04-20,02400456,dilTIAZem CD,1,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02400456,DILTIAZEM CD (diltiazem hydrochloride 240 mg prolonged-release oral capsule) SANIS HEALTH INC,Active,9000571,diltiazem hydrochloride 240 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88526,Marketed,2022-04-20,02400464,dilTIAZem CD,1,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02400464,DILTIAZEM CD (diltiazem hydrochloride 300 mg prolonged-release oral capsule) SANIS HEALTH INC,Active,9000572,diltiazem hydrochloride 300 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
91375,Marketed,2022-06-27,02429322,Teva-dilTIAZem XC,1,C08DB01,Diltiazem,Tablet (extended-release),Oral,02429322,TEVA-DILTIAZEM XC (diltiazem hydrochloride 180 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9001084,diltiazem hydrochloride 180 mg prolonged-release oral tablet,8000122,diltiazem,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91376,Marketed,2022-06-27,02429330,Teva-dilTIAZem XC,1,C08DB01,Diltiazem,Tablet (extended-release),Oral,02429330,TEVA-DILTIAZEM XC (diltiazem hydrochloride 240 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9001085,diltiazem hydrochloride 240 mg prolonged-release oral tablet,8000122,diltiazem,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91377,Marketed,2022-06-27,02429349,Teva-dilTIAZem XC,1,C08DB01,Diltiazem,Tablet (extended-release),Oral,02429349,TEVA-DILTIAZEM XC (diltiazem hydrochloride 300 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9001086,diltiazem hydrochloride 300 mg prolonged-release oral tablet,8000122,diltiazem,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91378,Marketed,2022-06-27,02429357,Teva-dilTIAZem XC,1,C08DB01,Diltiazem,Tablet (extended-release),Oral,02429357,TEVA-DILTIAZEM XC (diltiazem hydrochloride 360 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9001087,diltiazem hydrochloride 360 mg prolonged-release oral tablet,8000122,diltiazem,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
9172,Marketed,2020-10-28,00771376,AA-Diltiaz,1,C08DB01,Diltiazem,Tablet,Oral,00771376,AA-DILTIAZ (diltiazem hydrochloride 30 mg oral tablet) AA PHARMA INC,Active,9000291,diltiazem hydrochloride 30 mg oral tablet,8000122,diltiazem,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
9173,Marketed,2020-06-22,00771384,AA-Diltiaz,1,C08DB01,Diltiazem,Tablet,Oral,00771384,AA-DILTIAZ (diltiazem hydrochloride 60 mg oral tablet) AA PHARMA INC,Active,9000292,diltiazem hydrochloride 60 mg oral tablet,8000122,diltiazem,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93126,Marketed,2024-05-09,02445999,dilTIAZem CD,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02445999,DILTIAZEM CD (diltiazem hydrochloride 120 mg prolonged-release oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000569,diltiazem hydrochloride 120 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
93127,Marketed,2024-05-09,02446006,dilTIAZem CD,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02446006,DILTIAZEM CD (diltiazem hydrochloride 180 mg prolonged-release oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000570,diltiazem hydrochloride 180 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
93128,Marketed,2024-05-09,02446014,dilTIAZem CD,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02446014,DILTIAZEM CD (diltiazem hydrochloride 240 mg prolonged-release oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000571,diltiazem hydrochloride 240 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
93129,Marketed,2024-05-09,02446022,dilTIAZem CD,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02446022,DILTIAZEM CD (diltiazem hydrochloride 300 mg prolonged-release oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000572,diltiazem hydrochloride 300 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95355,Marketed,2018-05-28,02465353,Mar-dilTIAZem T,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02465353,MAR-DILTIAZEM T (diltiazem hydrochloride 120 mg prolonged-release oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000569,diltiazem hydrochloride 120 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95356,Marketed,2018-05-28,02465361,Mar-dilTIAZem T,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02465361,MAR-DILTIAZEM T (diltiazem hydrochloride 180 mg prolonged-release oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000570,diltiazem hydrochloride 180 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95357,Marketed,2018-05-28,02465388,Mar-dilTIAZem T,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02465388,MAR-DILTIAZEM T (diltiazem hydrochloride 240 mg prolonged-release oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000571,diltiazem hydrochloride 240 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95358,Marketed,2018-05-22,02465396,Mar-dilTIAZem T,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02465396,MAR-DILTIAZEM T (diltiazem hydrochloride 300 mg prolonged-release oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000572,diltiazem hydrochloride 300 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95359,Marketed,2018-05-22,02465418,Mar-dilTIAZem T,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02465418,MAR-DILTIAZEM T (diltiazem hydrochloride 360 mg prolonged-release oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000728,diltiazem hydrochloride 360 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97439,Marketed,2020-03-30,02484064,Mar-dilTIAZem CD,1,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02484064,MAR-DILTIAZEM CD (diltiazem hydrochloride 120 mg prolonged-release oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000569,diltiazem hydrochloride 120 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97440,Marketed,2020-03-30,02484072,Mar-dilTIAZem CD,1,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02484072,MAR-DILTIAZEM CD (diltiazem hydrochloride 180 mg prolonged-release oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000570,diltiazem hydrochloride 180 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97441,Marketed,2020-03-30,02484080,Mar-dilTIAZem CD,1,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02484080,MAR-DILTIAZEM CD (diltiazem hydrochloride 240 mg prolonged-release oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000571,diltiazem hydrochloride 240 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97442,Marketed,2020-03-30,02484099,Mar-dilTIAZem CD,1,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02484099,MAR-DILTIAZEM CD (diltiazem hydrochloride 300 mg prolonged-release oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000572,diltiazem hydrochloride 300 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98529,Marketed,2021-07-03,02495376,JAMP dilTIAZem T,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02495376,JAMP DILTIAZEM T (diltiazem hydrochloride 120 mg prolonged-release oral capsule) JAMP PHARMA CORPORATION,Active,9000569,diltiazem hydrochloride 120 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98530,Marketed,2021-07-03,02495384,JAMP dilTIAZem T,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02495384,JAMP DILTIAZEM T (diltiazem hydrochloride 180 mg prolonged-release oral capsule) JAMP PHARMA CORPORATION,Active,9000570,diltiazem hydrochloride 180 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98531,Marketed,2021-07-03,02495392,JAMP dilTIAZem T,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02495392,JAMP DILTIAZEM T (diltiazem hydrochloride 240 mg prolonged-release oral capsule) JAMP PHARMA CORPORATION,Active,9000571,diltiazem hydrochloride 240 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98532,Marketed,2021-07-03,02495406,JAMP dilTIAZem T,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02495406,JAMP DILTIAZEM T (diltiazem hydrochloride 300 mg prolonged-release oral capsule) JAMP PHARMA CORPORATION,Active,9000572,diltiazem hydrochloride 300 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98533,Marketed,2021-07-03,02495414,JAMP dilTIAZem T,1,C08DB01,Diltiazem,Capsule (extended release),Oral,02495414,JAMP DILTIAZEM T (diltiazem hydrochloride 360 mg prolonged-release oral capsule) JAMP PHARMA CORPORATION,Active,9000728,diltiazem hydrochloride 360 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
102529,Marketed,2024-08-27,02536536,dimenhyDRINATE Injection USP,1,R06AA11,Dimenhydrinate,Solution,"Intramuscular,Intravenous",02536536,DIMENHYDRINATE INJECTION USP (dimenhydrinate 250 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012703,dimenhydrinate 250 mg per 5 mL solution for injection vial,8001375,dimenhydrinate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
1256,Marketed,2021-05-18,00230197,Kids Gravol Liquid,1,R06AA11,Dimenhydrinate,Syrup,Oral,00230197,KIDS GRAVOL LIQUID (dimenhydrinate 15 mg per 5 mL syrup) CHURCH & DWIGHT CANADA CORP,Active,9001512,dimenhydrinate 15 mg per 5 mL syrup,8001375,dimenhydrinate,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
193,Marketed,2021-01-04,00013609,Gravol Suppositories,1,R06AA11,Dimenhydrinate,Suppository,Rectal,00013609,GRAVOL SUPPOSITORIES (dimenhydrinate 100 mg suppository) CHURCH & DWIGHT CANADA CORP,Active,9001511,dimenhydrinate 100 mg suppository,8001375,dimenhydrinate,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,,Non-Prescription Drugs
2890,Marketed,2022-01-30,00392545,Confab dimenhyDRINATE 100 mg,1,R06AA11,Dimenhydrinate,Suppository,Rectal,00392545,CONFAB DIMENHYDRINATE 100 MG (dimenhydrinate 100 mg suppository) LABORATOIRES CONFAB INC,Active,9001511,dimenhydrinate 100 mg suppository,8001375,dimenhydrinate,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,,Non-Prescription Drugs
2891,Marketed,2022-01-30,00392553,Confab dimenhyDRINATE 50 mg,1,R06AA11,Dimenhydrinate,Suppository,Rectal,00392553,CONFAB DIMENHYDRINATE 50 MG (dimenhydrinate 50 mg suppository) LABORATOIRES CONFAB INC,Active,9001715,dimenhydrinate 50 mg suppository,8001375,dimenhydrinate,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,,Non-Prescription Drugs
3397,Marketed,2023-03-22,00392537,dimenhyDRINATE Injection USP,1,R06AA11,Dimenhydrinate,Solution,"Intravenous,Intramuscular",77700589,DIMENHYDRINATE INJECTION USP (dimenhydrinate 250 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Inactive,9012703,dimenhydrinate 250 mg per 5 mL solution for injection vial,8001375,dimenhydrinate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
3397,Marketed,2023-03-22,00392537,dimenhyDRINATE Injection USP,1,R06AA11,Dimenhydrinate,Solution,"Intravenous,Intramuscular",77700590,DIMENHYDRINATE INJECTION USP (dimenhydrinate 50 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9012704,dimenhydrinate 50 mg per 1 mL solution for injection ampoule,8001375,dimenhydrinate,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
3595,Marketed,2005-08-08,00392731,dimenhyDRINATE Injection USP,1,R06AA11,Dimenhydrinate,Solution,Intravenous,77700591,DIMENHYDRINATE INJECTION USP (dimenhydrinate 10 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012702,dimenhydrinate 10 mg per 1 mL solution for injection vial,8001375,dimenhydrinate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
3595,Marketed,2005-08-08,00392731,dimenhyDRINATE Injection USP,1,R06AA11,Dimenhydrinate,Solution,Intravenous,77700592,DIMENHYDRINATE INJECTION USP (dimenhydrinate 10 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9012701,dimenhydrinate 10 mg per 1 mL solution for injection ampoule,8001375,dimenhydrinate,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
3944,Marketed,2021-03-22,00013803,Gravol Tablets,1,R06AA11,Dimenhydrinate,Tablet,Oral,00013803,GRAVOL TABLETS (dimenhydrinate 50 mg oral tablet) CHURCH & DWIGHT CANADA CORP,Active,9001628,dimenhydrinate 50 mg oral tablet,8001375,dimenhydrinate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
5572,Marketed,2010-05-01,00605786,Travel Tabs 50 mg,1,R06AA11,Dimenhydrinate,Tablet,Oral,00605786,TRAVEL TABS 50 MG (dimenhydrinate 50 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9001628,dimenhydrinate 50 mg oral tablet,8001375,dimenhydrinate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
65184,Marketed,2010-05-01,02241532,Anti-Nauseant,1,R06AA11,Dimenhydrinate,Tablet,Oral,02241532,ANTI-NAUSEANT (dimenhydrinate 50 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9001628,dimenhydrinate 50 mg oral tablet,8001375,dimenhydrinate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
69468,Marketed,2020-08-25,02245416,JAMP-dimenhyDRINATE,1,R06AA11,Dimenhydrinate,Tablet,Oral,02245416,JAMP-DIMENHYDRINATE (dimenhydrinate 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001628,dimenhydrinate 50 mg oral tablet,8001375,dimenhydrinate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
69984,Marketed,2021-05-04,02245867,Gravol Liquid Gels,1,R06AA11,Dimenhydrinate,Capsule,Oral,02245867,GRAVOL LIQUID GELS (dimenhydrinate 50 mg oral capsule) CHURCH & DWIGHT CANADA CORP,Active,9003754,dimenhydrinate 50 mg oral capsule,8001375,dimenhydrinate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
73930,Marketed,2012-11-14,02254409,Gravol Immediate Release & Long Acting Caplets,1,R06AA11,Dimenhydrinate,Tablet (combined release),Oral,02254409,GRAVOL IMMEDIATE RELEASE & LONG ACTING CAPLETS (dimenhydrinate 100 mg prolonged-release oral tablet) CHURCH & DWIGHT CANADA CORP,Active,9015295,dimenhydrinate 100 mg prolonged-release oral tablet,8001375,dimenhydrinate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet,,,,Non-Prescription Drugs
86986,Marketed,2021-06-08,02384116,Kids Gravol Chewables,1,R06AA11,Dimenhydrinate,Tablet (chewable),Oral,02384116,KIDS GRAVOL CHEWABLES (dimenhydrinate 15 mg chewable tablet) CHURCH & DWIGHT CANADA CORP,Active,9002661,dimenhydrinate 15 mg chewable tablet,8001375,dimenhydrinate,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
86988,Marketed,2021-06-18,02384132,Gravol Chewables,1,R06AA11,Dimenhydrinate,Tablet (chewable),Oral,02384132,GRAVOL CHEWABLES (dimenhydrinate 50 mg chewable tablet) CHURCH & DWIGHT CANADA CORP,Active,9001840,dimenhydrinate 50 mg chewable tablet,8001375,dimenhydrinate,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
91339,Marketed,2022-04-22,02428954,dimenhyDRINATE Injection USP,1,R06AA11,Dimenhydrinate,Solution,"Intravenous,Intramuscular",77700626,DIMENHYDRINATE INJECTION USP (dimenhydrinate 50 mg per 1 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9012704,dimenhydrinate 50 mg per 1 mL solution for injection ampoule,8001375,dimenhydrinate,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
91952,Marketed,2022-04-22,02435241,dimenhyDRINATE Injection USP,1,R06AA11,Dimenhydrinate,Solution,"Intravenous,Intramuscular",02435241,DIMENHYDRINATE INJECTION USP (dimenhydrinate 250 mg per 5 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9012703,dimenhydrinate 250 mg per 5 mL solution for injection vial,8001375,dimenhydrinate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
9585,Marketed,2021-06-01,00783595,Kids Gravol Suppositories,1,R06AA11,Dimenhydrinate,Suppository,Rectal,00783595,KIDS GRAVOL SUPPOSITORIES (dimenhydrinate 25 mg suppository) CHURCH & DWIGHT CANADA CORP,Active,9002187,dimenhydrinate 25 mg suppository,8001375,dimenhydrinate,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,,Non-Prescription Drugs
98056,Marketed,2020-02-24,02490528,Gaviscon Nausea,1,R06AA11,Dimenhydrinate,Tablet,Oral,02490528,GAVISCON NAUSEA (dimenhydrinate 50 mg oral tablet) MEDTECH PRODUCTS INC,Active,9001628,dimenhydrinate 50 mg oral tablet,8001375,dimenhydrinate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
98298,Marketed,2020-08-04,02493004,Anti-Nauseant Liquid Gels,1,R06AA11,Dimenhydrinate,Capsule,Oral,02493004,ANTI-NAUSEANT LIQUID GELS (dimenhydrinate 50 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9003754,dimenhydrinate 50 mg oral capsule,8001375,dimenhydrinate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
100300,Marketed,2021-10-04,02513781,Sandoz Dimethyl Fumarate Delayed-Release Capsules,1,L04AX07,Dimethyl fumarate,Capsule (delayed release),Oral,02513781,SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES (dimethyl fumarate 120 mg gastro-resistant capsule) SANDOZ CANADA INCORPORATED,Active,9005220,dimethyl fumarate 120 mg gastro-resistant capsule,8001904,dimethyl fumarate,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
100301,Marketed,2021-10-04,02513803,Sandoz Dimethyl Fumarate Delayed-Release Capsules,1,L04AX07,Dimethyl fumarate,Capsule (delayed release),Oral,02513803,SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES (dimethyl fumarate 240 mg gastro-resistant capsule) SANDOZ CANADA INCORPORATED,Active,9005422,dimethyl fumarate 240 mg gastro-resistant capsule,8001904,dimethyl fumarate,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
100540,Marketed,2021-10-04,02516047,JAMP Dimethyl Fumarate,1,L04AX07,Dimethyl fumarate,Capsule (delayed release),Oral,02516047,JAMP DIMETHYL FUMARATE (dimethyl fumarate 120 mg gastro-resistant capsule) JAMP PHARMA CORPORATION,Active,9005220,dimethyl fumarate 120 mg gastro-resistant capsule,8001904,dimethyl fumarate,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
100541,Marketed,2021-10-04,02516055,JAMP Dimethyl Fumarate,1,L04AX07,Dimethyl fumarate,Capsule (delayed release),Oral,02516055,JAMP DIMETHYL FUMARATE (dimethyl fumarate 240 mg gastro-resistant capsule) JAMP PHARMA CORPORATION,Active,9005422,dimethyl fumarate 240 mg gastro-resistant capsule,8001904,dimethyl fumarate,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
102941,Marketed,2024-06-07,02540746,Auro-Dimethyl Fumarate,1,L04AX07,Dimethyl fumarate,Capsule (delayed release),Oral,02540746,AURO-DIMETHYL FUMARATE (dimethyl fumarate 120 mg gastro-resistant capsule) AURO PHARMA INC,Active,9005220,dimethyl fumarate 120 mg gastro-resistant capsule,8001904,dimethyl fumarate,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
102942,Marketed,2024-06-07,02540754,Auro-Dimethyl Fumarate,1,L04AX07,Dimethyl fumarate,Capsule (delayed release),Oral,02540754,AURO-DIMETHYL FUMARATE (dimethyl fumarate 240 mg gastro-resistant capsule) AURO PHARMA INC,Active,9005422,dimethyl fumarate 240 mg gastro-resistant capsule,8001904,dimethyl fumarate,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88926,Marketed,2013-04-12,02404508,Tecfidera,1,L04AX07,Dimethyl fumarate,Capsule (delayed release),Oral,02404508,TECFIDERA (dimethyl fumarate 120 mg gastro-resistant capsule) BIOGEN CANADA INC,Active,9005220,dimethyl fumarate 120 mg gastro-resistant capsule,8001904,dimethyl fumarate,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90480,Marketed,2014-02-04,02420201,Tecfidera,1,L04AX07,Dimethyl fumarate,Capsule (delayed release),Oral,02420201,TECFIDERA (dimethyl fumarate 240 mg gastro-resistant capsule) BIOGEN CANADA INC,Active,9005422,dimethyl fumarate 240 mg gastro-resistant capsule,8001904,dimethyl fumarate,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98478,Marketed,2021-10-19,02494809,GLN-Dimethyl Fumarate,1,L04AX07,Dimethyl fumarate,Capsule (delayed release),Oral,02494809,GLN-DIMETHYL FUMARATE (dimethyl fumarate 120 mg gastro-resistant capsule) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9005220,dimethyl fumarate 120 mg gastro-resistant capsule,8001904,dimethyl fumarate,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98479,Marketed,2021-10-21,02494817,GLN-Dimethyl Fumarate,1,L04AX07,Dimethyl fumarate,Capsule (delayed release),Oral,02494817,GLN-DIMETHYL FUMARATE (dimethyl fumarate 240 mg gastro-resistant capsule) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9005422,dimethyl fumarate 240 mg gastro-resistant capsule,8001904,dimethyl fumarate,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98689,Marketed,2021-10-04,02497026,PMS-Dimethyl Fumarate,1,L04AX07,Dimethyl fumarate,Capsule (delayed release),Oral,02497026,PMS-DIMETHYL FUMARATE (dimethyl fumarate 120 mg gastro-resistant capsule) PHARMASCIENCE INC,Active,9005220,dimethyl fumarate 120 mg gastro-resistant capsule,8001904,dimethyl fumarate,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98690,Marketed,2021-10-04,02497034,PMS-Dimethyl Fumarate,1,L04AX07,Dimethyl fumarate,Capsule (delayed release),Oral,02497034,PMS-DIMETHYL FUMARATE (dimethyl fumarate 240 mg gastro-resistant capsule) PHARMASCIENCE INC,Active,9005422,dimethyl fumarate 240 mg gastro-resistant capsule,8001904,dimethyl fumarate,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
99224,Marketed,2021-10-04,02502690,Mar-Dimethyl Fumarate,1,L04AX07,Dimethyl fumarate,Capsule (delayed release),Oral,02502690,MAR-DIMETHYL FUMARATE (dimethyl fumarate 120 mg gastro-resistant capsule) MARCAN PHARMACEUTICALS INC,Active,9005220,dimethyl fumarate 120 mg gastro-resistant capsule,8001904,dimethyl fumarate,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
99225,Marketed,2021-10-04,02502704,Mar-Dimethyl Fumarate,1,L04AX07,Dimethyl fumarate,Capsule (delayed release),Oral,02502704,MAR-DIMETHYL FUMARATE (dimethyl fumarate 240 mg gastro-resistant capsule) MARCAN PHARMACEUTICALS INC,Active,9005422,dimethyl fumarate 240 mg gastro-resistant capsule,8001904,dimethyl fumarate,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
99514,Marketed,2021-10-04,02505762,Apo-Dimethyl Fumarate,1,L04AX07,Dimethyl fumarate,Capsule (delayed release),Oral,02505762,APO-DIMETHYL FUMARATE (dimethyl fumarate 120 mg gastro-resistant capsule) APOTEX INC,Active,9005220,dimethyl fumarate 120 mg gastro-resistant capsule,8001904,dimethyl fumarate,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
99515,Marketed,2021-10-04,02505770,Apo-Dimethyl Fumarate,1,L04AX07,Dimethyl fumarate,Capsule (delayed release),Oral,02505770,APO-DIMETHYL FUMARATE (dimethyl fumarate 240 mg gastro-resistant capsule) APOTEX INC,Active,9005422,dimethyl fumarate 240 mg gastro-resistant capsule,8001904,dimethyl fumarate,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
3769,Marketed,2018-10-31,00493392,Rimso-50,1,G04BX13,Dimethyl sulfoxide,Solution,Intravesical,00493392,RIMSO-50 (dimethyl sulfoxide 50 % intravesical solution 50 mL vial) MYLAN PHARMACEUTICALS ULC,Active,9014164,dimethyl sulfoxide 50 % intravesical solution 50 mL vial,8002118,dimethyl sulfoxide,738984000,Parenteral,385242008,Intravesical solution,733026001,Vial (unit of presentation),,,,Prescription
85900,Marketed,2012-01-06,02373785,Nyda,1,P03AX05,Dimeticone,Solution,Topical,02373785,NYDA (dimethicone 50 % cutaneous solution) G POHL-BOSKAMP GMBH & CO KG,Active,9004965,dimethicone 50 % cutaneous solution,8001633,dimethicone,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Non-Prescription Drugs
10492,Marketed,2006-06-19,00860786,Prepidil Gel,1,G02AD02,Dinoprostone,Gel,Intracervical,00860786,PREPIDIL GEL (dinoprostone 0.5 mg per 2.5 mL endocervical gel syringe) PFIZER CANADA ULC,Active,9013433,dinoprostone 0.5 mg per 2.5 mL endocervical gel syringe,8001635,dinoprostone,372450004,Endocervical,385100002,Gel,733020007,Syringe (unit of presentation),1.0,,,Prescription
11830,Marketed,2006-06-12,01919679,Prostin E 2 Vaginal Gel,1,G02AD02,Dinoprostone,Gel,Vaginal,01919679,PROSTIN E2 VAGINAL GEL (dinoprostone 1 mg per 3 g vaginal gel syringe) PFIZER CANADA ULC,Active,9013434,dinoprostone 1 mg per 3 g vaginal gel syringe,8001635,dinoprostone,16857009,Vaginal,385100002,Gel,733020007,Syringe (unit of presentation),1.0,,,Prescription
11831,Marketed,2006-05-15,01919687,Prostin E 2 Vaginal Gel,1,G02AD02,Dinoprostone,Gel,Vaginal,01919687,PROSTIN E2 VAGINAL GEL (dinoprostone 2 mg per 3 g vaginal gel syringe) PFIZER CANADA ULC,Active,9013435,dinoprostone 2 mg per 3 g vaginal gel syringe,8001635,dinoprostone,16857009,Vaginal,385100002,Gel,733020007,Syringe (unit of presentation),1.0,,,Prescription
2684,Marketed,2006-07-04,00400688,Prostin E 2 Tablets,1,G02AD02,Dinoprostone,Tablet,Oral,00400688,PROSTIN E2 TABLETS (dinoprostone 0.5 mg oral tablet) PFIZER CANADA ULC,Active,9001783,dinoprostone 0.5 mg oral tablet,8001635,dinoprostone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
50327,Marketed,1997-06-17,02231047,Cervidil,1,G02AD02,Dinoprostone,Insert,Vaginal,02231047,CERVIDIL (dinoprostone 0.3 mg per hour vaginal delivery system) FERRING INC,Active,9014165,dinoprostone 0.3 mg per hour vaginal delivery system,8001635,dinoprostone,16857009,Vaginal,420873008,Prolonged-release suspension for injection,733021006,System,1.0,,,Prescription
97347,Marketed,2019-05-01,02483076,Unituxin,1,L01FX06,Dinutuximab beta,Solution,Intravenous,02483076,UNITUXIN (dinutuximab 17.5 mg per 5 mL solution for injection vial) UNITED THERAPEUTICS CORPORATION,Active,9013956,dinutuximab 17.5 mg per 5 mL solution for injection vial,8002256,dinutuximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
103206,Marketed,2025-07-01,02543591,Zzzquil Sleep Aid,1,R06AA02,Diphenhydramine,Solution,Oral,02543591,ZZZQUIL SLEEP AID (diphenhydramine hydrochloride 50 mg per 30 mL oral solution) PROCTER & GAMBLE INC,Active,9005685,diphenhydramine hydrochloride 50 mg per 30 mL oral solution,8001187,diphenhydramine,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
10874,Marketed,2016-10-18,00757683,PDP-diphenhydrAMINE,1,R06AA02,Diphenhydramine,Capsule,Oral,00757683,PDP-DIPHENHYDRAMINE (diphenhydramine hydrochloride 25 mg oral capsule) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9002296,diphenhydramine hydrochloride 25 mg oral capsule,8001187,diphenhydramine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
10875,Marketed,2020-11-20,00757691,PDP-diphenhydrAMINE Extra Strength/ Extra Fort,1,R06AA02,Diphenhydramine,Capsule,Oral,00757691,PDP-DIPHENHYDRAMINE EXTRA STRENGTH/ EXTRA FORT (diphenhydramine hydrochloride 50 mg oral capsule) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9001882,diphenhydramine hydrochloride 50 mg oral capsule,8001187,diphenhydramine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
11762,Marketed,2012-06-06,01934414,Nytol Extra Strength Sleep Aid Caplet 50 mg,1,R06AA02,Diphenhydramine,Tablet,Oral,01934414,NYTOL EXTRA STRENGTH SLEEP AID CAPLET 50MG (diphenhydramine hydrochloride 50 mg oral tablet) MEDTECH PRODUCTS INC,Active,9001939,diphenhydramine hydrochloride 50 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
12743,Marketed,2025-10-21,01946986,Unisom,1,R06AA02,Diphenhydramine,Tablet,Oral,01946986,UNISOM (diphenhydramine hydrochloride 50 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9001939,diphenhydramine hydrochloride 50 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
13782,Marketed,2026-03-16,02017849,Benadryl Allergy,1,R06AA02,Diphenhydramine,Tablet,Oral,02017849,BENADRYL ALLERGY (diphenhydramine hydrochloride 25 mg oral tablet) KENVUE CANADA INC.,Active,9001841,diphenhydramine hydrochloride 25 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
15516,Marketed,2026-03-16,02019736,Benadryl Allergy Liquid,1,R06AA02,Diphenhydramine,Solution,Oral,02019736,BENADRYL ALLERGY LIQUID (diphenhydramine hydrochloride 12.5 mg per 5 mL oral solution) KENVUE CANADA INC.,Active,9002356,diphenhydramine hydrochloride 12.5 mg per 5 mL oral solution,8001187,diphenhydramine,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
15880,Marketed,2026-03-09,02019698,Children's Benadryl Allergy Liquid,1,R06AA02,Diphenhydramine,Solution,Oral,02019698,CHILDREN'S BENADRYL ALLERGY LIQUID (diphenhydramine hydrochloride 6.25 mg per 5 mL syrup) KENVUE CANADA INC.,Active,9003730,diphenhydramine hydrochloride 6.25 mg per 5 mL syrup,8001187,diphenhydramine,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
17781,Marketed,2013-04-11,02097575,Allernix Extra Strength,1,R06AA02,Diphenhydramine,Tablet,Oral,02097575,ALLERNIX EXTRA STRENGTH (diphenhydramine hydrochloride 50 mg oral tablet) TEVA CANADA LIMITED,Active,9001939,diphenhydramine hydrochloride 50 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
17794,Marketed,2013-04-11,02097583,Allernix,1,R06AA02,Diphenhydramine,Tablet,Oral,02097583,ALLERNIX (diphenhydramine hydrochloride 25 mg oral tablet) TEVA CANADA LIMITED,Active,9001841,diphenhydramine hydrochloride 25 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
31477,Marketed,1999-07-26,02141728,Allergy Formula Caplets,1,R06AA02,Diphenhydramine,Tablet,Oral,02141728,ALLERGY FORMULA CAPLETS (diphenhydramine hydrochloride 25 mg oral tablet) PERRIGO INTERNATIONAL,Active,9001841,diphenhydramine hydrochloride 25 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
37198,Marketed,1997-10-28,02219336,Diphenist,1,R06AA02,Diphenhydramine,Liquid,"Intravenous,Intramuscular",02219336,DIPHENIST (diphenhydramine hydrochloride 50 mg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9012686,diphenhydramine hydrochloride 50 mg per 1 mL solution for injection vial,8001187,diphenhydramine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
3775,Marketed,2019-11-01,00489867,Dormiphen Extra-Fort Capsule,1,R06AA02,Diphenhydramine,Capsule,Oral,00489867,DORMIPHEN EXTRA-FORT CAPSULE (diphenhydramine hydrochloride 50 mg oral capsule) LABORATOIRE LALCO INC.,Active,9001882,diphenhydramine hydrochloride 50 mg oral capsule,8001187,diphenhydramine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
41558,Marketed,2013-04-11,00538493,Calamine Lotion With Antihistamine,2,D04AA32,Diphenhydramine,Suspension,Topical,00538493,CALAMINE LOTION WITH ANTIHISTAMINE (calamine 8 % and diphenhydramine hydrochloride 1 % cutaneous suspension) TEVA CANADA LIMITED,Active,9001899,calamine 8 % and diphenhydramine hydrochloride 1 % cutaneous suspension,8001707,calamine and diphenhydramine,448598008,Cutaneous,739008005,Suspension,,,,,,Non-Prescription Drugs
47391,Marketed,2009-08-10,02229492,Allergy Formula,1,R06AA02,Diphenhydramine,Tablet,Oral,02229492,ALLERGY FORMULA (diphenhydramine hydrochloride 25 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9001841,diphenhydramine hydrochloride 25 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
48413,Marketed,2012-05-23,02229959,Sleep-Eze Extra Strength Caplets,1,R06AA02,Diphenhydramine,Tablet,Oral,02229959,SLEEP-EZE EXTRA STRENGTH CAPLETS (diphenhydramine hydrochloride 50 mg oral tablet) MEDTECH PRODUCTS INC,Active,9001939,diphenhydramine hydrochloride 50 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
48414,Marketed,2012-05-24,02229960,Sleep-Eze Regular Strength Caplets,1,R06AA02,Diphenhydramine,Tablet,Oral,02229960,SLEEP-EZE REGULAR STRENGTH CAPLETS (diphenhydramine hydrochloride 25 mg oral tablet) MEDTECH PRODUCTS INC,Active,9001841,diphenhydramine hydrochloride 25 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
49476,Marketed,2009-12-15,02230485,Sleep Aid,1,R06AA02,Diphenhydramine,Tablet,Oral,02230485,SLEEP AID (diphenhydramine hydrochloride 50 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9001939,diphenhydramine hydrochloride 50 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
5187,Marketed,2012-06-06,00583332,Extra Strength Nytol Tablets 50 mg,1,R06AA02,Diphenhydramine,Tablet,Oral,00583332,EXTRA STRENGTH NYTOL TAB 50MG (diphenhydramine hydrochloride 50 mg oral tablet) MEDTECH PRODUCTS INC,Active,9001939,diphenhydramine hydrochloride 50 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
5430,Marketed,2005-08-12,00596612,diphenhydrAMINE Hydrochloride Injection USP,1,R06AA02,Diphenhydramine,Liquid,"Intravenous,Intramuscular",00596612,DIPHENHYDRAMINE HYDROCHLORIDE INJECTION USP (diphenhydramine hydrochloride 50 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012686,diphenhydramine hydrochloride 50 mg per 1 mL solution for injection vial,8001187,diphenhydramine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
60487,Marketed,2012-06-06,02237169,Extra Strength Nytol Quickgels,1,R06AA02,Diphenhydramine,Capsule,Oral,02237169,EXTRA STRENGTH NYTOL QUICKGELS (diphenhydramine hydrochloride 50 mg oral capsule) MEDTECH PRODUCTS INC,Active,9001882,diphenhydramine hydrochloride 50 mg oral capsule,8001187,diphenhydramine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
61146,Marketed,2019-11-01,02237789,Dormiphen Extra-Fort Comprime,1,R06AA02,Diphenhydramine,Tablet,Oral,02237789,DORMIPHEN EXTRA-FORT COMPRIME (diphenhydramine hydrochloride 50 mg oral tablet) LABORATOIRE LALCO INC.,Active,9001939,diphenhydramine hydrochloride 50 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
62073,Marketed,2012-05-24,02238644,Sleep-Eze Extra Strength Gelcaps,1,R06AA02,Diphenhydramine,Capsule,Oral,02238644,SLEEP-EZE EXTRA STRENGTH GELCAPS (diphenhydramine hydrochloride 50 mg oral capsule) MEDTECH PRODUCTS INC,Active,9001882,diphenhydramine hydrochloride 50 mg oral capsule,8001187,diphenhydramine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
62481,Marketed,2002-02-14,02239029,Nadryl 25 mg,1,R06AA02,Diphenhydramine,Tablet,Oral,02239029,NADRYL 25MG (diphenhydramine hydrochloride 25 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001841,diphenhydramine hydrochloride 25 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
62594,Marketed,2026-04-28,02239138,Extra Strength Benadryl Allergy Nighttime,1,R06AA02,Diphenhydramine,Tablet,Oral,02239138,EXTRA STRENGTH BENADRYL ALLERGY NIGHTTIME (diphenhydramine hydrochloride 50 mg oral tablet) KENVUE CANADA INC.,Active,9001939,diphenhydramine hydrochloride 50 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
65100,Marketed,2000-10-13,02241462,Lotion Calamine Avec Antihistaminique,2,D04AA32,Diphenhydramine,Suspension,Topical,02241462,LOTION CALAMINE AVEC ANTIHISTAMINIQUE (calamine 8 % and diphenhydramine hydrochloride 1 % cutaneous suspension) LABORATOIRE ATLAS INC,Active,9001899,calamine 8 % and diphenhydramine hydrochloride 1 % cutaneous suspension,8001707,calamine and diphenhydramine,448598008,Cutaneous,739008005,Suspension,,,,,,Non-Prescription Drugs
68166,Marketed,2009-12-15,02244203,Sleep Aid Liquid Fastgels,1,R06AA02,Diphenhydramine,Capsule,Oral,02244203,SLEEP AID LIQUID FASTGELS (diphenhydramine hydrochloride 50 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9001882,diphenhydramine hydrochloride 50 mg oral capsule,8001187,diphenhydramine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
71812,Marketed,2007-12-20,02247560,Anti-Itch Cream,1,D04AA32,Diphenhydramine,Cream,Topical,02247560,ANTI-ITCH CREAM (diphenhydramine hydrochloride 2 % cutaneous cream) TARO PHARMACEUTICALS INC,Active,9002568,diphenhydramine hydrochloride 2 % cutaneous cream,8001187,diphenhydramine,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
73230,Marketed,2026-01-28,02248858,Benylin For Children Cough Night,1,R06AA02,Diphenhydramine,Solution,Oral,02248858,BENYLIN FOR CHILDREN COUGH NIGHT (diphenhydramine hydrochloride 6.25 mg per 5 mL syrup) KENVUE CANADA INC.,Active,9003730,diphenhydramine hydrochloride 6.25 mg per 5 mL syrup,8001187,diphenhydramine,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
73231,Marketed,2012-08-31,02248859,Benylin Sleep Time,1,R06AA02,Diphenhydramine,Liquid,Oral,02248859,BENYLIN SLEEP TIME (diphenhydramine hydrochloride 12.5 mg per 5 mL oral solution) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9002356,diphenhydramine hydrochloride 12.5 mg per 5 mL oral solution,8001187,diphenhydramine,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
74279,Marketed,2020-12-02,02257548,JAMP diphenhydrAMINE 25 mg,1,R06AA02,Diphenhydramine,Tablet,Oral,02257548,JAMP DIPHENHYDRAMINE 25 MG (diphenhydramine hydrochloride 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001841,diphenhydramine hydrochloride 25 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
74280,Marketed,2021-11-01,02257556,JAMP diphenhydrAMINE 50 mg,1,R06AA02,Diphenhydramine,Tablet,Oral,02257556,JAMP DIPHENHYDRAMINE 50 MG (diphenhydramine hydrochloride 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001939,diphenhydramine hydrochloride 50 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
76653,Marketed,2026-04-14,02280868,Benadryl Bug Bite Relief,2,D04AA32,Diphenhydramine,Solution,Topical,02280868,BENADRYL BUG BITE RELIEF (diphenhydramine hydrochloride 2 % and zinc acetate 0.1 % cutaneous solution) KENVUE CANADA INC.,Active,9013818,diphenhydramine hydrochloride 2 % and zinc acetate 0.1 % cutaneous solution,8001754,diphenhydramine and zinc acetate,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Non-Prescription Drugs
78380,Marketed,2009-01-30,02298503,diphenhydrAMINE Hydrochloride Elixir USP,1,R06AA02,Diphenhydramine,Elixir,Oral,02298503,DIPHENHYDRAMINE HYDROCHLORIDE ELIXIR USP (diphenhydramine hydrochloride 12.5 mg per 5 mL oral solution) JAMP PHARMA CORPORATION,Active,9002356,diphenhydramine hydrochloride 12.5 mg per 5 mL oral solution,8001187,diphenhydramine,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
78954,Marketed,2026-05-14,02304252,Benadryl Allergy Liquigels,1,R06AA02,Diphenhydramine,Capsule,Oral,02304252,BENADRYL ALLERGY LIQUIGELS (diphenhydramine hydrochloride 25 mg oral capsule) KENVUE CANADA INC.,Active,9002296,diphenhydramine hydrochloride 25 mg oral capsule,8001187,diphenhydramine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
79190,Marketed,2008-07-11,02306352,Allergy Formula Liquid Capsules,1,R06AA02,Diphenhydramine,Capsule,Oral,02306352,ALLERGY FORMULA LIQUID CAPSULES (diphenhydramine hydrochloride 25 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9002296,diphenhydramine hydrochloride 25 mg oral capsule,8001187,diphenhydramine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
80667,Marketed,2009-11-05,02321270,Extra Strength Allergy Formula Liquid Capsules,1,R06AA02,Diphenhydramine,Capsule,Oral,02321270,EXTRA STRENGTH ALLERGY FORMULA LIQUID CAPSULES (diphenhydramine hydrochloride 50 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9001882,diphenhydramine hydrochloride 50 mg oral capsule,8001187,diphenhydramine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
83395,Marketed,2010-08-03,02348608,Sleep-Eze,1,R06AA02,Diphenhydramine,Tablet,Oral,02348608,SLEEP-EZE (diphenhydramine hydrochloride 25 mg oral tablet) PRESTIGE BRANDS INC,Active,9001841,diphenhydramine hydrochloride 25 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
85056,Marketed,2018-10-16,02365685,Regular Strength Sleep Aid,1,R06AA02,Diphenhydramine,Capsule,Oral,02365685,REGULAR STRENGTH SLEEP AID (diphenhydramine hydrochloride 25 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9002296,diphenhydramine hydrochloride 25 mg oral capsule,8001187,diphenhydramine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
85449,Marketed,2024-12-13,02369567,"diphenhydrAMINE Hydrochloride Injection, USP",1,R06AA02,Diphenhydramine,Solution,"Intramuscular,Intravenous",02369567,"DIPHENHYDRAMINE HYDROCHLORIDE INJECTION, USP (diphenhydramine hydrochloride 50 mg per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9012686,diphenhydramine hydrochloride 50 mg per 1 mL solution for injection vial,8001187,diphenhydramine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
86902,Marketed,2013-02-12,02383268,Zzzquil,1,R06AA02,Diphenhydramine,Capsule,Oral,02383268,ZZZQUIL (diphenhydramine hydrochloride 25 mg oral capsule) PROCTER & GAMBLE INC,Active,9002296,diphenhydramine hydrochloride 25 mg oral capsule,8001187,diphenhydramine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
89394,Marketed,2020-01-10,02409224,Extra Strength Dormex Capsules,1,R06AA02,Diphenhydramine,Capsule,Oral,02409224,EXTRA STRENGTH DORMEX CAPSULES (diphenhydramine hydrochloride 50 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9001882,diphenhydramine hydrochloride 50 mg oral capsule,8001187,diphenhydramine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
89397,Marketed,2019-01-07,02409259,Extra Strength Dormex Caplets,1,R06AA02,Diphenhydramine,Tablet,Oral,02409259,EXTRA STRENGTH DORMEX CAPLETS (diphenhydramine hydrochloride 50 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9001939,diphenhydramine hydrochloride 50 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
90439,Marketed,2014-08-15,02419769,Zzzquil Liquid,1,R06AA02,Diphenhydramine,Liquid,Oral,02419769,ZZZQUIL LIQUID (diphenhydramine hydrochloride 50 mg per 30 mL oral solution) PROCTER & GAMBLE INC,Active,9005685,diphenhydramine hydrochloride 50 mg per 30 mL oral solution,8001187,diphenhydramine,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
91657,Marketed,2015-03-30,02432129,Sleep-Eze Eze-Liquid,1,R06AA02,Diphenhydramine,Solution,Oral,02432129,SLEEP-EZE EZE-LIQUID (diphenhydramine hydrochloride 50 mg per 30 mL oral solution) MEDTECH PRODUCTS INC,Active,9005685,diphenhydramine hydrochloride 50 mg per 30 mL oral solution,8001187,diphenhydramine,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
95281,Marketed,2018-06-14,02464683,Nighttime Sleep Aid,1,R06AA02,Diphenhydramine,Solution,Oral,02464683,NIGHTTIME SLEEP AID (diphenhydramine hydrochloride 50 mg per 30 mL oral solution) JUNO OTC INC,Active,9005685,diphenhydramine hydrochloride 50 mg per 30 mL oral solution,8001187,diphenhydramine,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
95330,Marketed,2018-09-10,02465108,Allergy Formula,1,R06AA02,Diphenhydramine,Solution,Oral,02465108,ALLERGY FORMULA (diphenhydramine hydrochloride 12.5 mg per 5 mL oral solution) JUNO OTC INC,Active,9002356,diphenhydramine hydrochloride 12.5 mg per 5 mL oral solution,8001187,diphenhydramine,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
95910,Marketed,2026-04-24,02470144,Extra Strength Benadryl Allergy,1,R06AA02,Diphenhydramine,Tablet,Oral,02470144,EXTRA STRENGTH BENADRYL ALLERGY (diphenhydramine hydrochloride 50 mg oral tablet) KENVUE CANADA INC.,Active,9001939,diphenhydramine hydrochloride 50 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
96508,Marketed,2018-12-03,02474867,Sleep-Eze Eze-Free,1,R06AA02,Diphenhydramine,Solution,Oral,02474867,SLEEP-EZE EZE-FREE (diphenhydramine hydrochloride 50 mg per 30 mL oral solution) MEDTECH PRODUCTS INC,Active,9005685,diphenhydramine hydrochloride 50 mg per 30 mL oral solution,8001187,diphenhydramine,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
96880,Marketed,2025-08-15,02478072,Children's Benadryl Bug Bite Relief,2,D04AA32,Diphenhydramine,Solution,Topical,02478072,CHILDREN'S BENADRYL BUG BITE RELIEF (diphenhydramine hydrochloride 2 % and zinc acetate 0.1 % cutaneous solution) KENVUE CANADA INC.,Active,9013818,diphenhydramine hydrochloride 2 % and zinc acetate 0.1 % cutaneous solution,8001754,diphenhydramine and zinc acetate,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Non-Prescription Drugs
96896,Marketed,2020-04-24,02478242,Children's Clear Allergy Formula,1,R06AA02,Diphenhydramine,Solution,Oral,02478242,CHILDREN'S CLEAR ALLERGY FORMULA (diphenhydramine hydrochloride 6.25 mg per 5 mL oral solution) JUNO OTC INC,Active,9014315,diphenhydramine hydrochloride 6.25 mg per 5 mL oral solution,8001187,diphenhydramine,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
96950,Marketed,2018-12-03,02478757,Sleep-Eze Extra Strength Minis,1,R06AA02,Diphenhydramine,Tablet,Oral,02478757,SLEEP-EZE EXTRA STRENGTH MINIS (diphenhydramine hydrochloride 50 mg oral tablet) MEDTECH PRODUCTS INC,Active,9001939,diphenhydramine hydrochloride 50 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
97036,Marketed,2026-03-16,02479710,Allergy Formula Caplets,1,R06AA02,Diphenhydramine,Tablet,Oral,02479710,ALLERGY FORMULA CAPLETS (diphenhydramine hydrochloride 25 mg oral tablet) SIGMA LIFE SCIENCES INC.,Active,9001841,diphenhydramine hydrochloride 25 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
97511,Marketed,2025-06-19,02484838,Benadryl Itch Stopping Cream,2,D04AA32,Diphenhydramine,Cream,Topical,02484838,BENADRYL ITCH STOPPING CREAM (diphenhydramine hydrochloride 2 % and zinc acetate 0.1 % cutaneous cream) KENVUE CANADA INC.,Active,9014242,diphenhydramine hydrochloride 2 % and zinc acetate 0.1 % cutaneous cream,8001754,diphenhydramine and zinc acetate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
98098,Marketed,2021-01-06,02490943,Allergy Formula Extra Strength,1,R06AA02,Diphenhydramine,Tablet,Oral,02490943,ALLERGY FORMULA EXTRA STRENGTH (diphenhydramine hydrochloride 50 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9001939,diphenhydramine hydrochloride 50 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
98867,Marketed,2022-05-23,02498952,Sleep Aid,1,R06AA02,Diphenhydramine,Tablet,Oral,02498952,SLEEP AID (diphenhydramine hydrochloride 50 mg oral tablet) JUNO OTC INC,Active,9001939,diphenhydramine hydrochloride 50 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
99502,Marketed,2022-05-26,02505649,Children's Allergy Formula Rapid Melts,1,R06AA02,Diphenhydramine,Tablet (orally disintegrating),Oral,02505649,CHILDREN'S ALLERGY FORMULA RAPID MELTS (diphenhydramine hydrochloride 12.5 mg orodispersible tablet) JUNO OTC INC,Active,9014717,diphenhydramine hydrochloride 12.5 mg orodispersible tablet,8001187,diphenhydramine,372473007,Oromucosal,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
50217,Marketed,2024-03-25,02230939,Buckley's Nighttime Cough & Congestion,2,R06AA52,"Diphenhydramine, combinations",Syrup,Oral,02230939,BUCKLEY'S NIGHTTIME COUGH & CONGESTION (diphenhydramine hydrochloride 12.5 mg per 5 mL and menthol 22 mg per 5 mL syrup) HALEON CANADA ULC,Active,9003110,diphenhydramine hydrochloride 12.5 mg per 5 mL and menthol 22 mg per 5 mL syrup,8001753,diphenhydramine and menthol,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
937,Marketed,2006-01-23,00036323,Lomotil,2,A07DA01,Diphenoxylate,Tablet,Oral,00036323,LOMOTIL (atropine sulfate 0.025 mg and diphenoxylate hydrochloride 2.5 mg oral tablet) PFIZER CANADA ULC,Active,9001574,atropine sulfate 0.025 mg and diphenoxylate hydrochloride 2.5 mg oral tablet,8001572,atropine and diphenoxylate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
102369,Marketed,2024-05-06,02534797,Pentacel,11,J07CA06,Dipht-hemoph influen b-pertuss-polio-tetanus,Suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
74234,Marketed,2026-04-06,02257122,Infanrix-Ipv/Hib,9,J07CA06,Dipht-hemoph influen b-pertuss-polio-tetanus,Suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
102368,Marketed,2024-05-06,02534789,Quadracel,9,J07CA02,Diphtheria-pertussis-poliomyelitis-tetanus,Suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
73878,Marketed,2008-12-04,02253852,Infanrix Hexa,11,J07CA02,Diphtheria-pertussis-poliomyelitis-tetanus,Suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
79806,Marketed,2010-10-22,02312557,Boostrix-Polio,8,J07CA02,Diphtheria-pertussis-poliomyelitis-tetanus,Suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
83726,Marketed,2011-03-11,02352044,Adacel-Polio,9,J07CA02,Diphtheria-pertussis-poliomyelitis-tetanus,Suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
6720,Marketed,2024-02-08,00637734,Persantine,1,B01AC07,Dipyridamole,Solution,Intravenous,00637734,PERSANTINE (dipyridamole 50 mg per 10 mL solution for injection vial) GLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE,Active,9012618,dipyridamole 50 mg per 10 mL solution for injection vial,8001262,dipyridamole,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
68448,Marketed,2015-09-11,02244475,"Dipyridamole Injection, USP",1,B01AC07,Dipyridamole,Liquid,Intravenous,02244475,"DIPYRIDAMOLE INJECTION, USP (dipyridamole 50 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9012618,dipyridamole 50 mg per 10 mL solution for injection vial,8001262,dipyridamole,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
37379,Marketed,2021-01-04,02224801,Rythmodan,1,C01BA03,Disopyramide,Capsule,Oral,02224801,RYTHMODAN (disopyramide 100 mg oral capsule) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9003828,disopyramide 100 mg oral capsule,8001376,disopyramide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
65680,Marketed,2005-10-06,02242010,DOBUTamine Injection USP,1,C01CA07,Dobutamine,Liquid,Intravenous,02242010,DOBUTAMINE INJECTION USP (dobutamine (dobutamine hydrochloride) 250 mg per 20 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012960,dobutamine (dobutamine hydrochloride) 250 mg per 20 mL solution for injection vial,8001636,dobutamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
95055,Marketed,2024-07-12,02462729,DOBUTamine Injection USP,1,C01CA07,Dobutamine,Solution,Intravenous,02462729,DOBUTAMINE INJECTION USP (dobutamine (dobutamine hydrochloride) 250 mg per 20 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9012960,dobutamine (dobutamine hydrochloride) 250 mg per 20 mL solution for injection vial,8001636,dobutamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
84699,Marketed,2017-06-16,02361957,DOCEtaxel Injection USP,1,L01CD02,Docetaxel,Solution,Intravenous,77700752,DOCETAXEL INJECTION USP (docetaxel 80 mg per 8 mL solution for injection vial) PFIZER CANADA ULC,Active,9013083,docetaxel 80 mg per 8 mL solution for injection vial,8001755,docetaxel,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
84699,Marketed,2017-06-16,02361957,DOCEtaxel Injection USP,1,L01CD02,Docetaxel,Solution,Intravenous,77700753,DOCETAXEL INJECTION USP (docetaxel 160 mg per 16 mL solution for injection vial) PFIZER CANADA ULC,Active,9013077,docetaxel 160 mg per 16 mL solution for injection vial,8001755,docetaxel,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
84699,Marketed,2017-06-16,02361957,DOCEtaxel Injection USP,1,L01CD02,Docetaxel,Solution,Intravenous,77700754,DOCETAXEL INJECTION USP (docetaxel 20 mg per 2 mL solution for injection vial) PFIZER CANADA ULC,Active,9013080,docetaxel 20 mg per 2 mL solution for injection vial,8001755,docetaxel,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
92370,Marketed,2016-06-02,02439336,DOCEtaxel Injection,1,L01CD02,Docetaxel,Solution,Intravenous,77700813,DOCETAXEL INJECTION (docetaxel 160 mg per 16 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013077,docetaxel 160 mg per 16 mL solution for injection vial,8001755,docetaxel,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
92370,Marketed,2016-06-02,02439336,DOCEtaxel Injection,1,L01CD02,Docetaxel,Solution,Intravenous,77700814,DOCETAXEL INJECTION (docetaxel 20 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013080,docetaxel 20 mg per 2 mL solution for injection vial,8001755,docetaxel,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
92370,Marketed,2016-06-02,02439336,DOCEtaxel Injection,1,L01CD02,Docetaxel,Solution,Intravenous,77700815,DOCETAXEL INJECTION (docetaxel 80 mg per 8 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013083,docetaxel 80 mg per 8 mL solution for injection vial,8001755,docetaxel,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
94508,Marketed,2017-10-17,02458020,DOCEtaxel Injection,1,L01CD02,Docetaxel,Solution,Intravenous,77700816,DOCETAXEL INJECTION (docetaxel 20 mg per 1 mL solution for injection vial) BIOLYSE PHARMA CORPORATION,Active,9013079,docetaxel 20 mg per 1 mL solution for injection vial,8001755,docetaxel,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
94508,Marketed,2017-10-17,02458020,DOCEtaxel Injection,1,L01CD02,Docetaxel,Solution,Intravenous,77700817,DOCETAXEL INJECTION (docetaxel 160 mg per 8 mL solution for injection vial) BIOLYSE PHARMA CORPORATION,Active,9013078,docetaxel 160 mg per 8 mL solution for injection vial,8001755,docetaxel,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
94508,Marketed,2017-10-17,02458020,DOCEtaxel Injection,1,L01CD02,Docetaxel,Solution,Intravenous,77700818,DOCETAXEL INJECTION (docetaxel 80 mg per 4 mL solution for injection vial) BIOLYSE PHARMA CORPORATION,Active,9013082,docetaxel 80 mg per 4 mL solution for injection vial,8001755,docetaxel,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
101967,Marketed,2025-05-08,02530538,Nra-Docusate Sodium,1,A06AA02,Docusate sodium,Capsule,Oral,02530538,NRA-DOCUSATE SODIUM (docusate sodium 100 mg oral capsule) NORA PHARMA INC,Active,9002047,docusate sodium 100 mg oral capsule,8001045,docusate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
102519,Marketed,2023-09-30,02536412,Stool Softener Clear,1,A06AA02,Docusate sodium,Capsule,Oral,02536412,STOOL SOFTENER CLEAR (docusate sodium 100 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9002047,docusate sodium 100 mg oral capsule,8001045,docusate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
11520,Marketed,2013-06-11,00870226,Ratio-Docusate Sodium,1,A06AA02,Docusate sodium,Syrup,Oral,00870226,RATIO-DOCUSATE SODIUM (docusate sodium 20 mg per 5 mL syrup) TEVA CANADA LIMITED,Active,9002359,docusate sodium 20 mg per 5 mL syrup,8001045,docusate,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
14487,Marketed,1993-12-31,01994344,Soflax Capsules 100 mg,1,A06AA02,Docusate sodium,Capsule,Oral,01994344,SOFLAX CAPSULES 100MG (docusate sodium 100 mg oral capsule) PHARMASCIENCE INC,Active,9002047,docusate sodium 100 mg oral capsule,8001045,docusate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
28280,Marketed,2024-11-29,02086018,Colace Syrup,1,A06AA02,Docusate sodium,Syrup,Oral,02086018,COLACE SYRUP (docusate sodium 20 mg per 5 mL syrup) PHARMASCIENCE INC,Active,9002359,docusate sodium 20 mg per 5 mL syrup,8001045,docusate,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
28453,Marketed,2024-11-19,02090163,Colace,1,A06AA02,Docusate sodium,Solution,Oral,02090163,COLACE (docusate sodium 10 mg per mL oral solution) PHARMASCIENCE INC,Active,9014938,docusate sodium 10 mg per mL oral solution,8001045,docusate,26643006,Oral,739006009,Solution,,,,,,Non-Prescription Drugs
29540,Marketed,2024-12-24,02106256,Colace Capsules,1,A06AA02,Docusate sodium,Capsule,Oral,02106256,COLACE CAPSULES (docusate sodium 100 mg oral capsule) PHARMASCIENCE INC,Active,9002047,docusate sodium 100 mg oral capsule,8001045,docusate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
52463,Marketed,1998-08-07,02232969,Stool Softener,1,A06AA02,Docusate sodium,Capsule,Oral,02232969,STOOL SOFTENER (docusate sodium 100 mg oral capsule) PERRIGO INTERNATIONAL,Active,9002047,docusate sodium 100 mg oral capsule,8001045,docusate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
61679,Marketed,1998-09-02,02238283,Sirop Docusate De Sodium U.S.P. 4 mg/mL,1,A06AA02,Docusate sodium,Syrup,Oral,02238283,SIROP DOCUSATE DE SODIUM U.S.P. 4MG/ML (docusate sodium 20 mg per 5 mL syrup) LABORATOIRE ATLAS INC,Active,9002359,docusate sodium 20 mg per 5 mL syrup,8001045,docusate,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
6258,Marketed,1985-12-31,00514888,Selax Capsules 100 mg,1,A06AA02,Docusate sodium,Capsule,Oral,00514888,SELAX CAP 100MG (docusate sodium 100 mg oral capsule) ODAN LABORATORIES LTD,Active,9002047,docusate sodium 100 mg oral capsule,8001045,docusate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
70070,Marketed,2016-04-04,02245946,JAMP-Docusate Sodium,1,A06AA02,Docusate sodium,Capsule,Oral,02245946,JAMP-DOCUSATE SODIUM (docusate sodium 100 mg oral capsule) JAMP PHARMA CORPORATION,Active,9002047,docusate sodium 100 mg oral capsule,8001045,docusate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
71630,Marketed,2018-05-23,02247385,Sandoz Docusate Sodium,1,A06AA02,Docusate sodium,Capsule,Oral,02247385,SANDOZ DOCUSATE SODIUM (docusate sodium 100 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9002047,docusate sodium 100 mg oral capsule,8001045,docusate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
7365,Marketed,1986-12-31,00703494,PMS-Docusate Sodium,1,A06AA02,Docusate sodium,Capsule,Oral,00703494,PMS-DOCUSATE SODIUM (docusate sodium 100 mg oral capsule) PHARMASCIENCE INC,Active,9002047,docusate sodium 100 mg oral capsule,8001045,docusate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
76671,Marketed,2012-09-05,02281031,Stool Softener,1,A06AA02,Docusate sodium,Capsule,Oral,02281031,STOOL SOFTENER (docusate sodium 100 mg oral capsule) PHARMASCIENCE INC,Active,9002047,docusate sodium 100 mg oral capsule,8001045,docusate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
84243,Marketed,2011-01-10,02357305,Stool Softener,1,A06AA02,Docusate sodium,Capsule,Oral,02357305,STOOL SOFTENER (docusate sodium 100 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9002047,docusate sodium 100 mg oral capsule,8001045,docusate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
8974,Marketed,2010-12-18,00716731,Taro-Docusate,1,A06AA02,Docusate sodium,Capsule,Oral,00716731,TARO-DOCUSATE (docusate sodium 100 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9002047,docusate sodium 100 mg oral capsule,8001045,docusate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
91138,Marketed,2014-07-16,02426838,Docusate Sodium,1,A06AA02,Docusate sodium,Capsule,Oral,02426838,DOCUSATE SODIUM (docusate sodium 100 mg oral capsule) SANIS HEALTH INC,Active,9002047,docusate sodium 100 mg oral capsule,8001045,docusate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
92166,Marketed,2019-09-24,02437317,M-Docusate Sodium 100 mg,1,A06AA02,Docusate sodium,Capsule,Oral,02437317,M-DOCUSATE SODIUM 100 MG (docusate sodium 100 mg oral capsule) MANTRA PHARMA INC,Active,9002047,docusate sodium 100 mg oral capsule,8001045,docusate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
97454,Marketed,2024-12-12,02484226,Colace Clear,1,A06AA02,Docusate sodium,Capsule,Oral,02484226,COLACE CLEAR (docusate sodium 100 mg oral capsule) PHARMASCIENCE INC,Active,9002047,docusate sodium 100 mg oral capsule,8001045,docusate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
101558,Marketed,2022-09-21,02526492,Enemeez,1,A06AG10,"Docusate sodium, incl combinations",Enema,Rectal,02526492,"ENEMEEZ (docusate sodium 283 mg per 5 mL rectal liquid) QUEST PRODUCTS, LLC",Active,9014777,docusate sodium 283 mg per 5 mL rectal liquid,8001045,docusate,37161004,Rectal,420699003,Liquid,,,,,,Non-Prescription Drugs
100071,Marketed,2022-01-31,02511517,Tivicay,1,J05AJ03,Dolutegravir,Tablet for suspension,Oral,02511517,TIVICAY (dolutegravir (dolutegravir sodium) 5 mg dispersible oral tablet) VIIV HEALTHCARE ULC,Active,9014658,dolutegravir (dolutegravir sodium) 5 mg dispersible oral tablet,8001191,dolutegravir,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106017,Marketed,2026-04-29,02556782,PMS-Dolutegravir,1,J05AJ03,Dolutegravir,Tablet,Oral,02556782,PMS-DOLUTEGRAVIR (dolutegravir (dolutegravir sodium) 50 mg oral tablet) PHARMASCIENCE INC,Active,9005361,dolutegravir (dolutegravir sodium) 50 mg oral tablet,8001191,dolutegravir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89957,Marketed,2013-11-08,02414945,Tivicay,1,J05AJ03,Dolutegravir,Tablet,Oral,02414945,TIVICAY (dolutegravir (dolutegravir sodium) 50 mg oral tablet) VIIV HEALTHCARE ULC,Active,9005361,dolutegravir (dolutegravir sodium) 50 mg oral tablet,8001191,dolutegravir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96645,Marketed,2018-06-04,02475774,Juluca,2,J05AR21,Dolutegravir and rilpivirine,Tablet,Oral,02475774,JULUCA (dolutegravir (dolutegravir sodium) 50 mg and rilpivirine (rilpivirine hydrochloride) 25 mg oral tablet) VIIV HEALTHCARE ULC,Active,9012706,dolutegravir (dolutegravir sodium) 50 mg and rilpivirine (rilpivirine hydrochloride) 25 mg oral tablet,8001377,dolutegravir and rilpivirine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103190,Marketed,2026-05-26,02543435,JAMP Domperidone Tablets,1,A03FA03,Domperidone,Tablet,Oral,02543435,JAMP DOMPERIDONE TABLETS (domperidone (domperidone maleate) 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000463,domperidone (domperidone maleate) 10 mg oral tablet,8000181,domperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106483,Marketed,2026-04-21,02561905,Nra-Domperidone,1,A03FA03,Domperidone,Tablet,Oral,02561905,NRA-DOMPERIDONE (domperidone (domperidone maleate) 10 mg oral tablet) NORA PHARMA INC,Active,9000463,domperidone (domperidone maleate) 10 mg oral tablet,8000181,domperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
13180,Marketed,2018-04-12,01912070,Teva-Domperidone,1,A03FA03,Domperidone,Tablet,Oral,01912070,TEVA-DOMPERIDONE (domperidone (domperidone maleate) 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000463,domperidone (domperidone maleate) 10 mg oral tablet,8000181,domperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
43813,Marketed,2015-03-07,02103613,Apo-Domperidone,1,A03FA03,Domperidone,Tablet,Oral,02103613,APO-DOMPERIDONE (domperidone (domperidone maleate) 10 mg oral tablet) APOTEX INC,Active,9000463,domperidone (domperidone maleate) 10 mg oral tablet,8000181,domperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
60147,Marketed,2025-09-23,02236857,Pro-Domperidone,1,A03FA03,Domperidone,Tablet,Oral,02236857,PRO-DOMPERIDONE (domperidone (domperidone maleate) 10 mg oral tablet) PRO DOC LIMITEE,Active,9000463,domperidone (domperidone maleate) 10 mg oral tablet,8000181,domperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
61748,Marketed,2018-10-04,02238341,Domperidone,1,A03FA03,Domperidone,Tablet,Oral,02238341,DOMPERIDONE (domperidone (domperidone maleate) 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000463,domperidone (domperidone maleate) 10 mg oral tablet,8000181,domperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75346,Marketed,2021-11-30,02268078,Taro-Domperidone,1,A03FA03,Domperidone,Tablet,Oral,02268078,TARO-DOMPERIDONE (domperidone (domperidone maleate) 10 mg oral tablet) SUN PHARMA CANADA INC,Active,9000463,domperidone (domperidone maleate) 10 mg oral tablet,8000181,domperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83565,Marketed,2013-05-10,02350440,Domperidone,1,A03FA03,Domperidone,Tablet,Oral,02350440,DOMPERIDONE (domperidone (domperidone maleate) 10 mg oral tablet) SANIS HEALTH INC,Active,9000463,domperidone (domperidone maleate) 10 mg oral tablet,8000181,domperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85414,Marketed,2017-09-19,02369206,JAMP-Domperidone,1,A03FA03,Domperidone,Tablet,Oral,02369206,JAMP-DOMPERIDONE (domperidone (domperidone maleate) 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000463,domperidone (domperidone maleate) 10 mg oral tablet,8000181,domperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88864,Marketed,2014-01-02,02403870,Mar-Domperidone,1,A03FA03,Domperidone,Tablet,Oral,02403870,MAR-DOMPERIDONE (domperidone (domperidone maleate) 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000463,domperidone (domperidone maleate) 10 mg oral tablet,8000181,domperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93024,Marketed,2016-04-26,02445034,Bio-Domperidone,1,A03FA03,Domperidone,Tablet,Oral,02445034,BIO-DOMPERIDONE (domperidone (domperidone maleate) 10 mg oral tablet) BIOMED PHARMA,Active,9000463,domperidone (domperidone maleate) 10 mg oral tablet,8000181,domperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95069,Marketed,2022-08-30,02462834,PRZ-Domperidone,1,A03FA03,Domperidone,Tablet,Oral,02462834,PRZ-DOMPERIDONE (domperidone (domperidone maleate) 10 mg oral tablet) PHARMARIS CANADA INC,Active,9000463,domperidone (domperidone maleate) 10 mg oral tablet,8000181,domperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102424,Marketed,2023-10-16,02535386,Nra-Donepezil,1,N06DA02,Donepezil,Tablet,Oral,02535386,NRA-DONEPEZIL (donepezil hydrochloride 5 mg oral tablet) NORA PHARMA INC,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102425,Marketed,2023-10-16,02535394,Nra-Donepezil,1,N06DA02,Donepezil,Tablet,Oral,02535394,NRA-DONEPEZIL (donepezil hydrochloride 10 mg oral tablet) NORA PHARMA INC,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
51491,Marketed,1997-08-20,02232043,Aricept,1,N06DA02,Donepezil,Tablet,Oral,02232043,ARICEPT (donepezil hydrochloride 5 mg oral tablet) PFIZER CANADA ULC,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
51492,Marketed,1997-08-20,02232044,Aricept,1,N06DA02,Donepezil,Tablet,Oral,02232044,ARICEPT (donepezil hydrochloride 10 mg oral tablet) PFIZER CANADA ULC,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80779,Marketed,2013-12-27,02322331,PMS-Donepezil,1,N06DA02,Donepezil,Tablet,Oral,02322331,PMS-DONEPEZIL (donepezil hydrochloride (donepezil hydrochloride monohydrate) 5 mg oral tablet) PHARMASCIENCE INC,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80780,Marketed,2013-12-27,02322358,PMS-Donepezil,1,N06DA02,Donepezil,Tablet,Oral,02322358,PMS-DONEPEZIL (donepezil hydrochloride (donepezil hydrochloride monohydrate) 10 mg oral tablet) PHARMASCIENCE INC,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81417,Marketed,2013-12-27,02328666,Sandoz Donepezil,1,N06DA02,Donepezil,Tablet,Oral,02328666,SANDOZ DONEPEZIL (donepezil hydrochloride 5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81419,Marketed,2013-12-27,02328682,Sandoz Donepezil,1,N06DA02,Donepezil,Tablet,Oral,02328682,SANDOZ DONEPEZIL (donepezil hydrochloride 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82618,Marketed,2013-12-27,02340607,Teva-Donepezil,1,N06DA02,Donepezil,Tablet,Oral,02340607,TEVA-DONEPEZIL (donepezil hydrochloride 5 mg oral tablet) TEVA CANADA LIMITED,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82619,Marketed,2013-12-27,02340615,Teva-Donepezil,1,N06DA02,Donepezil,Tablet,Oral,02340615,TEVA-DONEPEZIL (donepezil hydrochloride 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84728,Marketed,2013-12-27,02362260,Apo-Donepezil,1,N06DA02,Donepezil,Tablet,Oral,02362260,APO-DONEPEZIL (donepezil hydrochloride (donepezil hydrochloride monohydrate) 5 mg oral tablet) APOTEX INC,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84729,Marketed,2014-12-27,02362279,Apo-Donepezil,1,N06DA02,Donepezil,Tablet,Oral,02362279,APO-DONEPEZIL (donepezil hydrochloride (donepezil hydrochloride monohydrate) 10 mg oral tablet) APOTEX INC,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86735,Marketed,2020-03-10,02381508,Taro-Donepezil,1,N06DA02,Donepezil,Tablet,Oral,02381508,TARO-DONEPEZIL (donepezil hydrochloride 5 mg oral tablet) SUN PHARMA CANADA INC,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86736,Marketed,2020-03-10,02381516,Taro-Donepezil,1,N06DA02,Donepezil,Tablet,Oral,02381516,TARO-DONEPEZIL (donepezil hydrochloride 10 mg oral tablet) SUN PHARMA CANADA INC,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88536,Marketed,2013-12-27,02400561,Auro-Donepezil,1,N06DA02,Donepezil,Tablet,Oral,02400561,AURO-DONEPEZIL (donepezil hydrochloride 5 mg oral tablet) AURO PHARMA INC,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88537,Marketed,2013-12-27,02400588,Auro-Donepezil,1,N06DA02,Donepezil,Tablet,Oral,02400588,AURO-DONEPEZIL (donepezil hydrochloride 10 mg oral tablet) AURO PHARMA INC,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88696,Marketed,2014-01-06,02402092,Mar-Donepezil,1,N06DA02,Donepezil,Tablet,Oral,02402092,MAR-DONEPEZIL (donepezil hydrochloride 5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88697,Marketed,2014-01-06,02402106,Mar-Donepezil,1,N06DA02,Donepezil,Tablet,Oral,02402106,MAR-DONEPEZIL (donepezil hydrochloride 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88749,Marketed,2022-12-12,02402645,ACH-Donepezil,1,N06DA02,Donepezil,Tablet,Oral,02402645,ACH-DONEPEZIL (donepezil hydrochloride 5 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88750,Marketed,2023-08-04,02402653,ACH-Donepezil,1,N06DA02,Donepezil,Tablet,Oral,02402653,ACH-DONEPEZIL (donepezil hydrochloride 10 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89334,Marketed,2019-06-11,02408600,Mint-Donepezil,1,N06DA02,Donepezil,Tablet,Oral,02408600,MINT-DONEPEZIL (donepezil hydrochloride 5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89335,Marketed,2019-06-11,02408619,Mint-Donepezil,1,N06DA02,Donepezil,Tablet,Oral,02408619,MINT-DONEPEZIL (donepezil hydrochloride 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89756,Marketed,2013-12-27,02412853,Bio-Donepezil,1,N06DA02,Donepezil,Tablet,Oral,02412853,BIO-DONEPEZIL (donepezil hydrochloride 5 mg oral tablet) BIOMED PHARMA,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89757,Marketed,2013-12-27,02412861,Bio-Donepezil,1,N06DA02,Donepezil,Tablet,Oral,02412861,BIO-DONEPEZIL (donepezil hydrochloride 10 mg oral tablet) BIOMED PHARMA,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90097,Marketed,2025-10-02,02416417,Pro-Donepezil,1,N06DA02,Donepezil,Tablet,Oral,02416417,PRO-DONEPEZIL (donepezil hydrochloride (donepezil hydrochloride monohydrate) 5 mg oral tablet) PRO DOC LIMITEE,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90098,Marketed,2025-10-02,02416425,Pro-Donepezil,1,N06DA02,Donepezil,Tablet,Oral,02416425,PRO-DONEPEZIL (donepezil hydrochloride (donepezil hydrochloride monohydrate) 10 mg oral tablet) PRO DOC LIMITEE,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90157,Marketed,2014-09-26,02416948,JAMP-Donepezil Tablets,1,N06DA02,Donepezil,Tablet,Oral,02416948,JAMP-DONEPEZIL TABLETS (donepezil hydrochloride 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90158,Marketed,2014-09-26,02416956,JAMP-Donepezil Tablets,1,N06DA02,Donepezil,Tablet,Oral,02416956,JAMP-DONEPEZIL TABLETS (donepezil hydrochloride 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90516,Marketed,2025-07-08,02420597,Donepezil,1,N06DA02,Donepezil,Tablet,Oral,02420597,DONEPEZIL (donepezil hydrochloride 5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90517,Marketed,2025-07-08,02420600,Donepezil,1,N06DA02,Donepezil,Tablet,Oral,02420600,DONEPEZIL (donepezil hydrochloride 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91139,Marketed,2025-07-31,02426846,Donepezil,1,N06DA02,Donepezil,Tablet,Oral,02426846,DONEPEZIL (donepezil hydrochloride 5 mg oral tablet) SANIS HEALTH INC,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91140,Marketed,2025-06-27,02426854,Donepezil,1,N06DA02,Donepezil,Tablet,Oral,02426854,DONEPEZIL (donepezil hydrochloride 10 mg oral tablet) SANIS HEALTH INC,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91711,Marketed,2021-05-10,02432684,AG-Donepezil,1,N06DA02,Donepezil,Tablet,Oral,02432684,AG-DONEPEZIL (donepezil hydrochloride 5 mg oral tablet) ANGITA PHARMA INC.,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91712,Marketed,2021-05-10,02432692,AG-Donepezil,1,N06DA02,Donepezil,Tablet,Oral,02432692,AG-DONEPEZIL (donepezil hydrochloride 10 mg oral tablet) ANGITA PHARMA INC.,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95583,Marketed,2017-12-14,02467453,M-Donepezil,1,N06DA02,Donepezil,Tablet,Oral,02467453,M-DONEPEZIL (donepezil hydrochloride 5 mg oral tablet) MANTRA PHARMA INC,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95584,Marketed,2017-12-14,02467461,M-Donepezil,1,N06DA02,Donepezil,Tablet,Oral,02467461,M-DONEPEZIL (donepezil hydrochloride 10 mg oral tablet) MANTRA PHARMA INC,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96563,Marketed,2018-05-16,02475278,Donepezil,1,N06DA02,Donepezil,Tablet,Oral,02475278,DONEPEZIL (donepezil hydrochloride 5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
11624,Marketed,1990-12-31,00761834,DOPamine HCL 3.2 mg/mL Dextrose 5% Inj USP,2,C01CA04,Dopamine,Solution,Intravenous,,,,,,,,,,,,,,,,,Prescription
11625,Marketed,1990-12-31,00761826,DOPamine HCL 1.6 mg/mL Dextrose 5% Inj USP,2,C01CA04,Dopamine,Solution,Intravenous,,,,,,,,,,,,,,,,,Prescription
12256,Marketed,1992-12-31,00761850,DOPamine HCL 0.8 mg/mL Dextrose 5% Inj USP,2,C01CA04,Dopamine,Solution,Intravenous,,,,,,,,,,,,,,,,,Prescription
97199,Marketed,2018-11-14,02481545,Pifeltro,1,J05AG06,Doravirine,Tablet,Oral,02481545,PIFELTRO (doravirine 100 mg oral tablet) MERCK CANADA INC,Active,9013682,doravirine 100 mg oral tablet,8002188,doravirine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
15483,Marketed,1998-06-23,02046733,Pulmozyme,1,R05CB13,Dornase alfa (desoxyribonuclease),Solution,Inhalation,02046733,PULMOZYME (dornase alfa 2.5 mg per 2.5 mL nebulizer solution unit dose vial) HOFFMANN-LA ROCHE LIMITED,Active,9013957,dornase alfa 2.5 mg per 2.5 mL nebulizer solution unit dose vial,8001637,dornase alfa,738984000,Parenteral,385198000,Solution for nebuliser,733026001,Vial (unit of presentation),,,,Prescription
15483,Marketed,1998-06-23,02046733,Pulmozyme,1,R05CB13,Dornase alfa (desoxyribonuclease),Solution,Inhalation,02046733,PULMOZYME (dornase alfa 2.5 mg per 2.5 mL nebulizer solution unit dose vial) HOFFMANN-LA ROCHE LIMITED,Active,9013957,dornase alfa 2.5 mg per 2.5 mL nebulizer solution unit dose vial,8001637,dornase alfa,738984000,Parenteral,385198000,Solution for nebuliser,733026001,Vial (unit of presentation),,,,Schedule D
101151,Marketed,2023-09-28,02522373,Dorzolamide,1,S01EC03,Dorzolamide,Solution,Ophthalmic,02522373,DORZOLAMIDE (dorzolamide (dorzolamide hydrochloride) 2 % ophthalmic drops) JAMP PHARMA CORPORATION,Active,9003026,dorzolamide (dorzolamide hydrochloride) 2 % ophthalmic drops,8000899,dorzolamide,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
80181,Marketed,2012-02-04,02316307,Sandoz Dorzolamide,1,S01EC03,Dorzolamide,Solution,Ophthalmic,02316307,SANDOZ DORZOLAMIDE (dorzolamide (dorzolamide hydrochloride) 2 % ophthalmic drops) SANDOZ CANADA INCORPORATED,Active,9003026,dorzolamide (dorzolamide hydrochloride) 2 % ophthalmic drops,8000899,dorzolamide,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
94429,Marketed,2023-05-26,02457210,Med-Dorzolamide,1,S01EC03,Dorzolamide,Solution,Ophthalmic,02457210,MED-DORZOLAMIDE (dorzolamide (dorzolamide hydrochloride) 2 % ophthalmic drops) GENERIC MEDICAL PARTNERS INC,Active,9003026,dorzolamide (dorzolamide hydrochloride) 2 % ophthalmic drops,8000899,dorzolamide,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
101252,Marketed,2022-02-22,02523434,Jemperli,1,L01FF07,Dostarlimab,Solution,Intravenous,02523434,JEMPERLI (dostarlimab 500 mg per 10 mL solution for injection vial) GLAXOSMITHKLINE INC,Active,9014677,dostarlimab 500 mg per 10 mL solution for injection vial,8002413,dostarlimab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
101252,Marketed,2022-02-22,02523434,Jemperli,1,L01FF07,Dostarlimab,Solution,Intravenous,02523434,JEMPERLI (dostarlimab 500 mg per 10 mL solution for injection vial) GLAXOSMITHKLINE INC,Active,9014677,dostarlimab 500 mg per 10 mL solution for injection vial,8002413,dostarlimab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
64159,Marketed,1999-07-22,02240588,Apo-Doxazosin,1,C02CA04,Doxazosin,Tablet,Oral,02240588,APO-DOXAZOSIN (doxazosin (doxazosin mesylate) 1 mg oral tablet) APOTEX INC,Active,9000418,doxazosin (doxazosin mesylate) 1 mg oral tablet,8000163,doxazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
64160,Marketed,1999-07-22,02240589,Apo-Doxazosin,1,C02CA04,Doxazosin,Tablet,Oral,02240589,APO-DOXAZOSIN (doxazosin (doxazosin mesylate) 2 mg oral tablet) APOTEX INC,Active,9000419,doxazosin (doxazosin mesylate) 2 mg oral tablet,8000163,doxazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
64161,Marketed,1999-07-22,02240590,Apo-Doxazosin,1,C02CA04,Doxazosin,Tablet,Oral,02240590,APO-DOXAZOSIN (doxazosin (doxazosin mesylate) 4 mg oral tablet) APOTEX INC,Active,9000420,doxazosin (doxazosin mesylate) 4 mg oral tablet,8000163,doxazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
66535,Marketed,2014-02-07,02242728,Teva-Doxazosin,1,C02CA04,Doxazosin,Tablet,Oral,02242728,TEVA-DOXAZOSIN (doxazosin (doxazosin mesylate) 1 mg oral tablet) TEVA CANADA LIMITED,Active,9000418,doxazosin (doxazosin mesylate) 1 mg oral tablet,8000163,doxazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
66536,Marketed,2014-02-07,02242729,Teva-Doxazosin,1,C02CA04,Doxazosin,Tablet,Oral,02242729,TEVA-DOXAZOSIN (doxazosin (doxazosin mesylate) 2 mg oral tablet) TEVA CANADA LIMITED,Active,9000419,doxazosin (doxazosin mesylate) 2 mg oral tablet,8000163,doxazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
66537,Marketed,2014-02-07,02242730,Teva-Doxazosin,1,C02CA04,Doxazosin,Tablet,Oral,02242730,TEVA-DOXAZOSIN (doxazosin (doxazosin mesylate) 4 mg oral tablet) TEVA CANADA LIMITED,Active,9000420,doxazosin (doxazosin mesylate) 4 mg oral tablet,8000163,doxazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98001,Marketed,2020-05-06,02489937,JAMP-Doxazosin,1,C02CA04,Doxazosin,Tablet,Oral,02489937,JAMP-DOXAZOSIN (doxazosin (doxazosin mesylate) 1 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000418,doxazosin (doxazosin mesylate) 1 mg oral tablet,8000163,doxazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98002,Marketed,2020-05-06,02489945,JAMP-Doxazosin,1,C02CA04,Doxazosin,Tablet,Oral,02489945,JAMP-DOXAZOSIN (doxazosin (doxazosin mesylate) 2 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000419,doxazosin (doxazosin mesylate) 2 mg oral tablet,8000163,doxazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98003,Marketed,2020-05-06,02489953,JAMP-Doxazosin,1,C02CA04,Doxazosin,Tablet,Oral,02489953,JAMP-DOXAZOSIN (doxazosin (doxazosin mesylate) 4 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000420,doxazosin (doxazosin mesylate) 4 mg oral tablet,8000163,doxazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106227,Marketed,2025-08-06,02559080,Mar-Doxepin,1,N06AA12,Doxepin,Capsule,Oral,02559080,MAR-DOXEPIN (doxepin (doxepin hydrochloride) 10 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9001657,doxepin (doxepin hydrochloride) 10 mg oral capsule,8001263,doxepin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
106228,Marketed,2025-08-06,02559099,Mar-Doxepin,1,N06AA12,Doxepin,Capsule,Oral,02559099,MAR-DOXEPIN (doxepin (doxepin hydrochloride) 25 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9001658,doxepin (doxepin hydrochloride) 25 mg oral capsule,8001263,doxepin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
106229,Marketed,2025-08-06,02559102,Mar-Doxepin,1,N06AA12,Doxepin,Capsule,Oral,02559102,MAR-DOXEPIN (doxepin (doxepin hydrochloride) 50 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9001659,doxepin (doxepin hydrochloride) 50 mg oral capsule,8001263,doxepin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
106230,Marketed,2025-08-06,02559110,Mar-Doxepin,1,N06AA12,Doxepin,Capsule,Oral,02559110,MAR-DOXEPIN (doxepin (doxepin hydrochloride) 75 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9002459,doxepin (doxepin hydrochloride) 75 mg oral capsule,8001263,doxepin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
106231,Marketed,2025-08-06,02559129,Mar-Doxepin,1,N06AA12,Doxepin,Capsule,Oral,02559129,MAR-DOXEPIN (doxepin (doxepin hydrochloride) 100 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9002457,doxepin (doxepin hydrochloride) 100 mg oral capsule,8001263,doxepin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
106242,Marketed,2026-05-22,02559250,JAMP Doxepin,1,N06AA12,Doxepin,Capsule,Oral,02559250,JAMP DOXEPIN (doxepin (doxepin hydrochloride) 10 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001657,doxepin (doxepin hydrochloride) 10 mg oral capsule,8001263,doxepin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
106243,Marketed,2026-05-22,02559269,JAMP Doxepin,1,N06AA12,Doxepin,Capsule,Oral,02559269,JAMP DOXEPIN (doxepin (doxepin hydrochloride) 25 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001658,doxepin (doxepin hydrochloride) 25 mg oral capsule,8001263,doxepin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
106244,Marketed,2026-05-20,02559277,JAMP Doxepin,1,N06AA12,Doxepin,Capsule,Oral,02559277,JAMP DOXEPIN (doxepin (doxepin hydrochloride) 50 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001659,doxepin (doxepin hydrochloride) 50 mg oral capsule,8001263,doxepin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
106245,Marketed,2026-05-22,02559285,JAMP Doxepin,1,N06AA12,Doxepin,Capsule,Oral,02559285,JAMP DOXEPIN (doxepin (doxepin hydrochloride) 75 mg oral capsule) JAMP PHARMA CORPORATION,Active,9002459,doxepin (doxepin hydrochloride) 75 mg oral capsule,8001263,doxepin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
106246,Marketed,2026-05-22,02559293,JAMP Doxepin,1,N06AA12,Doxepin,Capsule,Oral,02559293,JAMP DOXEPIN (doxepin (doxepin hydrochloride) 100 mg oral capsule) JAMP PHARMA CORPORATION,Active,9002457,doxepin (doxepin hydrochloride) 100 mg oral capsule,8001263,doxepin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
15104,Marketed,2025-11-13,02050048,Apo-Doxepin,1,N06AA12,Doxepin,Capsule,Oral,02050048,APO-DOXEPIN (doxepin (doxepin hydrochloride) 100 mg oral capsule) APOTEX INC,Active,9002457,doxepin (doxepin hydrochloride) 100 mg oral capsule,8001263,doxepin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
15106,Marketed,2025-11-13,02050005,Apo-Doxepin,1,N06AA12,Doxepin,Capsule,Oral,02050005,APO-DOXEPIN (doxepin (doxepin hydrochloride) 25 mg oral capsule) APOTEX INC,Active,9001658,doxepin (doxepin hydrochloride) 25 mg oral capsule,8001263,doxepin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
15107,Marketed,2025-11-13,02050013,Apo-Doxepin,1,N06AA12,Doxepin,Capsule,Oral,02050013,APO-DOXEPIN (doxepin (doxepin hydrochloride) 50 mg oral capsule) APOTEX INC,Active,9001659,doxepin (doxepin hydrochloride) 50 mg oral capsule,8001263,doxepin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
15108,Marketed,2025-11-13,02050021,Apo-Doxepin,1,N06AA12,Doxepin,Capsule,Oral,02050021,APO-DOXEPIN (doxepin (doxepin hydrochloride) 75 mg oral capsule) APOTEX INC,Active,9002459,doxepin (doxepin hydrochloride) 75 mg oral capsule,8001263,doxepin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
15118,Marketed,2026-01-09,02049996,Apo-Doxepin,1,N06AA12,Doxepin,Capsule,Oral,02049996,APO-DOXEPIN (doxepin (doxepin hydrochloride) 10 mg oral capsule) APOTEX INC,Active,9001657,doxepin (doxepin hydrochloride) 10 mg oral capsule,8001263,doxepin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
2049,Marketed,2018-11-12,00326925,Sinequan,1,N06AA12,Doxepin,Capsule,Oral,00326925,SINEQUAN (doxepin (doxepin hydrochloride) 100 mg oral capsule) AA PHARMA INC,Active,9002457,doxepin (doxepin hydrochloride) 100 mg oral capsule,8001263,doxepin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
2780,Marketed,2018-11-12,00400750,Sinequan,1,N06AA12,Doxepin,Capsule,Oral,00400750,SINEQUAN (doxepin (doxepin hydrochloride) 75 mg oral capsule) AA PHARMA INC,Active,9002459,doxepin (doxepin hydrochloride) 75 mg oral capsule,8001263,doxepin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88319,Marketed,2026-01-22,02398257,Silenor,1,N06AA12,Doxepin,Tablet,Oral,02398257,SILENOR (doxepin (doxepin hydrochloride) 3 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9005151,doxepin (doxepin hydrochloride) 3 mg oral tablet,8001263,doxepin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88320,Marketed,2026-01-22,02398265,Silenor,1,N06AA12,Doxepin,Tablet,Oral,02398265,SILENOR (doxepin (doxepin hydrochloride) 6 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9005152,doxepin (doxepin hydrochloride) 6 mg oral tablet,8001263,doxepin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
944,Marketed,2017-12-29,00024325,Sinequan,1,N06AA12,Doxepin,Capsule,Oral,00024325,SINEQUAN (doxepin (doxepin hydrochloride) 10 mg oral capsule) AA PHARMA INC,Active,9001657,doxepin (doxepin hydrochloride) 10 mg oral capsule,8001263,doxepin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
945,Marketed,2018-02-01,00024333,Sinequan,1,N06AA12,Doxepin,Capsule,Oral,00024333,SINEQUAN (doxepin (doxepin hydrochloride) 25 mg oral capsule) AA PHARMA INC,Active,9001658,doxepin (doxepin hydrochloride) 25 mg oral capsule,8001263,doxepin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
946,Marketed,2018-03-13,00024341,Sinequan,1,N06AA12,Doxepin,Capsule,Oral,00024341,SINEQUAN (doxepin (doxepin hydrochloride) 50 mg oral capsule) AA PHARMA INC,Active,9001659,doxepin (doxepin hydrochloride) 50 mg oral capsule,8001263,doxepin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
42944,Marketed,2018-06-08,02194465,DOXOrubicin Hydrochloride For Injection USP,1,L01DB01,Doxorubicin,Powder for solution,"Intravesical,Intravenous",,,,,,,,,,,,,,1.0,,,Prescription
42945,Marketed,2018-06-08,02194473,DOXOrubicin Hydrochloride For Injection USP,1,L01DB01,Doxorubicin,Powder for solution,"Intravesical,Intravenous",,,,,,,,,,,,,,1.0,,,Prescription
61804,Marketed,2022-03-04,02238389,Caelyx,1,L01DB01,Doxorubicin,Suspension,Intravenous,,,,,,,,,,,,,,1.0,,,Prescription
86785,Marketed,2019-05-27,02381982,"DOXOrubicin Injection, BP",1,L01DB01,Doxorubicin,Solution,"Intravesical,Intravenous",,,,,,,,,,,,,,1.0,,,Prescription
89399,Marketed,2014-02-27,02409275,DOXOrubicin Hydrochloride Injection,1,L01DB01,Doxorubicin,Solution,"Intravenous,Intravesical",,,,,,,,,,,,,,1.0,,,Prescription
89506,Marketed,2014-05-21,02410397,DOXOrubicin,1,L01DB01,Doxorubicin,Solution,"Intravenous,Intravesical",,,,,,,,,,,,,,1.0,,,Prescription
98300,Marketed,2020-05-19,02493020,Taro-DOXOrubicin Liposomal,1,L01DB01,Doxorubicin,Suspension,Intravenous,,,,,,,,,,,,,,1.0,,,Prescription
100192,Marketed,2021-09-01,02512645,Apo-Doxycycline MR,1,J01AA02,Doxycycline,Capsule (immediate and delayed release),Oral,02512645,APO-DOXYCYCLINE MR (doxycycline (doxycycline monohydrate) 40 mg modified-release oral capsule) APOTEX INC,Active,9001394,doxycycline 40 mg modified-release oral capsule,8000117,doxycycline,26643006,Oral,385054002,Modified-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
10024,Marketed,1989-12-31,00860751,Doxycin Tablets 100 mg,1,J01AA02,Doxycycline,Tablet,Oral,00860751,DOXYCIN TAB 100MG (doxycycline (doxycycline hyclate) 100 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000318,doxycycline (doxycycline hyclate) 100 mg oral tablet,8000117,doxycycline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
10117,Marketed,2014-02-07,00725250,Teva-Doxycycline,1,J01AA02,Doxycycline,Capsule,Oral,00725250,TEVA-DOXYCYCLINE (doxycycline (doxycycline hyclate) 100 mg oral capsule) TEVA CANADA LIMITED,Active,9000268,doxycycline (doxycycline hyclate) 100 mg oral capsule,8000117,doxycycline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
101777,Marketed,2024-05-03,02528568,JAMP Doxycycline,1,A01AB22,Doxycycline,Capsule,Oral,02528568,JAMP DOXYCYCLINE (doxycycline (doxycycline hyclate) 20 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001050,doxycycline (doxycycline hyclate) 20 mg oral capsule,8000117,doxycycline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
101814,Marketed,2024-05-03,02528940,JAMP Doxycycline Capsules,1,J01AA02,Doxycycline,Capsule,Oral,02528940,JAMP DOXYCYCLINE CAPSULES (doxycycline (doxycycline hyclate) 100 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000268,doxycycline (doxycycline hyclate) 100 mg oral capsule,8000117,doxycycline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
102504,Marketed,2023-09-01,02536250,PRZ-Doxycycline,1,J01AA02,Doxycycline,Tablet,Oral,02536250,PRZ-DOXYCYCLINE (doxycycline (doxycycline hyclate) 100 mg oral tablet) PHARMARIS CANADA INC,Active,9000318,doxycycline (doxycycline hyclate) 100 mg oral tablet,8000117,doxycycline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103193,Marketed,2024-06-05,02543478,M-Doxycycline,1,J01AA02,Doxycycline,Tablet,Oral,02543478,M-DOXYCYCLINE (doxycycline (doxycycline hyclate) 100 mg oral tablet) MANTRA PHARMA INC,Active,9000318,doxycycline (doxycycline hyclate) 100 mg oral tablet,8000117,doxycycline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
10383,Marketed,1990-12-31,00874256,Apo-Doxy-Tabs,1,J01AA02,Doxycycline,Tablet,Oral,00874256,APO-DOXY-TABS (doxycycline (doxycycline hyclate) 100 mg oral tablet) APOTEX INC,Active,9000318,doxycycline (doxycycline hyclate) 100 mg oral tablet,8000117,doxycycline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104323,Marketed,2026-03-26,02554372,JAMP Doxycycline Tablets,1,J01AA02,Doxycycline,Tablet,Oral,02554372,JAMP DOXYCYCLINE TABLETS (doxycycline (doxycycline hyclate) 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000318,doxycycline (doxycycline hyclate) 100 mg oral tablet,8000117,doxycycline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106029,Marketed,2026-03-26,02556928,AG-Doxycycline,1,J01AA02,Doxycycline,Tablet,Oral,02556928,AG-DOXYCYCLINE (doxycycline (doxycycline hyclate) 100 mg oral tablet) ANGITA PHARMA INC.,Active,9000318,doxycycline (doxycycline hyclate) 100 mg oral tablet,8000117,doxycycline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106175,Marketed,2025-12-12,02558505,Nra-Doxycycline,1,J01AA02,Doxycycline,Tablet,Oral,02558505,NRA-DOXYCYCLINE (doxycycline (doxycycline hyclate) 100 mg oral tablet) NORA PHARMA INC,Active,9000318,doxycycline (doxycycline hyclate) 100 mg oral tablet,8000117,doxycycline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106441,Marketed,2025-11-24,02561441,Doxycycline For Injection USP,1,J01AA02,Doxycycline,Powder for solution,Intravenous,02561441,DOXYCYCLINE FOR INJECTION USP (doxycycline (doxycycline hyclate) 100 mg per vial powder for solution for injection) STERIMAX INC,Active,9015277,doxycycline (doxycycline hyclate) 100 mg per vial powder for solution for injection,8000117,doxycycline,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,,,,Prescription
10897,Marketed,1990-12-31,00887064,Doxytab,1,J01AA02,Doxycycline,Tablet,Oral,00887064,DOXYTAB (doxycycline (doxycycline hyclate) 100 mg oral tablet) PRO DOC LIMITEE,Active,9000318,doxycycline (doxycycline hyclate) 100 mg oral tablet,8000117,doxycycline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
18421,Marketed,2014-02-07,02158574,Teva-Doxycycline,1,J01AA02,Doxycycline,Tablet,Oral,02158574,TEVA-DOXYCYCLINE (doxycycline (doxycycline hyclate) 100 mg oral tablet) TEVA CANADA LIMITED,Active,9000318,doxycycline (doxycycline hyclate) 100 mg oral tablet,8000117,doxycycline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71343,Marketed,2025-12-01,02247104,PMS-Doxycycline,1,A01AB22,Doxycycline,Capsule,Oral,02247104,PMS-DOXYCYCLINE (doxycycline (doxycycline hyclate) 20 mg oral capsule) PHARMASCIENCE INC,Active,9001050,doxycycline (doxycycline hyclate) 20 mg oral capsule,8000117,doxycycline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
7627,Marketed,1987-12-31,00740713,Apo-Doxy,1,J01AA02,Doxycycline,Capsule,Oral,00740713,APO-DOXY (doxycycline (doxycycline hyclate) 100 mg oral capsule) APOTEX INC,Active,9000268,doxycycline (doxycycline hyclate) 100 mg oral capsule,8000117,doxycycline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
83642,Marketed,2015-03-25,02351234,Doxycycline Capsules,1,J01AA02,Doxycycline,Capsule,Oral,02351234,DOXYCYCLINE CAPSULES (doxycycline (doxycycline hyclate) 100 mg oral capsule) SANIS HEALTH INC,Active,9000268,doxycycline (doxycycline hyclate) 100 mg oral capsule,8000117,doxycycline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
83643,Marketed,2015-03-25,02351242,Doxycycline Tablets,1,J01AA02,Doxycycline,Tablet,Oral,02351242,DOXYCYCLINE TABLETS (doxycycline (doxycycline hyclate) 100 mg oral tablet) SANIS HEALTH INC,Active,9000318,doxycycline (doxycycline hyclate) 100 mg oral tablet,8000117,doxycycline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86128,Marketed,2012-11-29,02375885,Apprilon,1,J01AA02,Doxycycline,Capsule (immediate and delayed release),Oral,02375885,APPRILON (doxycycline (doxycycline monohydrate) 40 mg modified-release oral capsule) GALDERMA CANADA INC.,Active,9001394,doxycycline 40 mg modified-release oral capsule,8000117,doxycycline,26643006,Oral,385054002,Modified-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
104153,Marketed,2025-04-17,02552574,Alog-Doxylamine/Pyridoxine,2,R06AA59,"Doxylamine, combinations",Tablet (delayed-release),Oral,02552574,ALOG-DOXYLAMINE/PYRIDOXINE (doxylamine succinate 10 mg and pyridoxine hydrochloride 10 mg gastro-resistant tablet) ANALOG PHARMA CANADA INC.,Active,9001975,doxylamine succinate 10 mg and pyridoxine hydrochloride 10 mg gastro-resistant tablet,8001905,doxylamine and pyridoxine,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
5509,Marketed,1983-12-31,00609129,Diclectin,2,R06AA59,"Doxylamine, combinations",Tablet (delayed-release),Oral,00609129,DICLECTIN (doxylamine succinate 10 mg and pyridoxine hydrochloride 10 mg gastro-resistant tablet) DUCHESNAY INC,Active,9001975,doxylamine succinate 10 mg and pyridoxine hydrochloride 10 mg gastro-resistant tablet,8001905,doxylamine and pyridoxine,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89091,Marketed,2017-07-10,02406187,PMS-Doxylamine-Pyridoxine,2,R06AA59,"Doxylamine, combinations",Tablet (delayed-release),Oral,02406187,PMS-DOXYLAMINE-PYRIDOXINE (doxylamine succinate 10 mg and pyridoxine hydrochloride 10 mg gastro-resistant tablet) PHARMASCIENCE INC,Active,9001975,doxylamine succinate 10 mg and pyridoxine hydrochloride 10 mg gastro-resistant tablet,8001905,doxylamine and pyridoxine,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89791,Marketed,2017-08-11,02413248,Apo-Doxylamine/B6,2,R06AA59,"Doxylamine, combinations",Tablet (delayed-release),Oral,02413248,APO-DOXYLAMINE/B6 (doxylamine succinate 10 mg and pyridoxine hydrochloride 10 mg gastro-resistant tablet) APOTEX INC,Active,9001975,doxylamine succinate 10 mg and pyridoxine hydrochloride 10 mg gastro-resistant tablet,8001905,doxylamine and pyridoxine,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81672,Marketed,2009-09-28,02330989,Multaq,1,C01BD07,Dronedarone,Tablet,Oral,02330989,MULTAQ (dronedarone (dronedarone hydrochloride) 400 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9004593,dronedarone (dronedarone hydrochloride) 400 mg oral tablet,8001638,dronedarone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101192,Marketed,2022-04-20,02522802,Slynd,1,G03AC10,Drospirenone,Tablet,Oral,02522802,SLYND (drospirenone 4 mg oral tablet) DUCHESNAY INC,Active,9014678,drospirenone 4 mg oral tablet,8002419,drospirenone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100241,Marketed,2021-06-15,02513218,Nextstellis,2,G03AA18,Drospirenone and estetrol,Tablet,Oral,02513218,NEXTSTELLIS (drospirenone 3 mg and estetrol monohydrate 15 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9014542,drospirenone 3 mg and estetrol 15 mg oral tablet,8002372,drospirenone and estetrol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
74710,Marketed,2007-12-13,02261723,Yasmin 21,2,G03AA12,Drospirenone and estrogen,Tablet,Oral,02261723,YASMIN 21 (drospirenone 3 mg and ethinyl estradiol 30 mcg oral tablet) BAYER INC,Active,9006564,drospirenone 3 mg and ethinyl estradiol 30 mcg oral tablet,8000345,drospirenone and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
74711,Marketed,2007-11-28,02261731,Yasmin 28,2,G03AA12,Drospirenone and estrogen,Tablet,Oral,02261731,YASMIN 28 (drospirenone 3 mg and ethinyl estradiol 30 mcg oral tablet with lactose oral tablet) BAYER INC,Active,9006565,drospirenone 3 mg and ethinyl estradiol 30 mcg oral tablet with lactose oral tablet,8000345,drospirenone and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
75422,Marketed,2008-10-20,02268825,Angeliq,2,G03FA17,Drospirenone and estrogen,Tablet,Oral,02268825,ANGELIQ (drospirenone 1 mg and estradiol 1 mg oral tablet) BAYER INC,Active,9004467,drospirenone 1 mg and estradiol 1 mg oral tablet,8000970,drospirenone and estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
80656,Marketed,2009-01-06,02321157,Yaz,2,G03AA12,Drospirenone and estrogen,Tablet,Oral,02321157,YAZ (drospirenone 3 mg and ethinyl estradiol 20 mcg oral tablet with lactose oral tablet) BAYER INC,Active,9006572,drospirenone 3 mg and ethinyl estradiol 20 mcg oral tablet with lactose oral tablet,8000345,drospirenone and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
87302,Marketed,2013-03-01,02387433,Yaz Plus,4,G03AA12,Drospirenone and estrogen,Tablet,Oral,02387433,YAZ PLUS (drospirenone 3 mg and ethinyl estradiol 20 mcg and levomefolate calcium 451 mcg oral tablet with levomefolate calcium 451 mcg oral tablet) BAYER INC,Active,9006607,drospirenone 3 mg and ethinyl estradiol 20 mcg and levomefolate calcium 451 mcg oral tablet with levomefolate calcium 451 mcg oral tablet,8002190,drospirenone and ethinyl estradiol and levomefolic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
89544,Marketed,2020-09-01,02410788,Zamine 21,2,G03AA12,Drospirenone and estrogen,Tablet,Oral,02410788,ZAMINE 21 (drospirenone 3 mg and ethinyl estradiol 30 mcg oral tablet) APOTEX INC,Active,9006564,drospirenone 3 mg and ethinyl estradiol 30 mcg oral tablet,8000345,drospirenone and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
89545,Marketed,2020-09-01,02410796,Zamine 28,2,G03AA12,Drospirenone and estrogen,Tablet,Oral,02410796,ZAMINE 28 (drospirenone 3 mg and ethinyl estradiol 30 mcg oral tablet with lactose oral tablet) APOTEX INC,Active,9006565,drospirenone 3 mg and ethinyl estradiol 30 mcg oral tablet with lactose oral tablet,8000345,drospirenone and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
89999,Marketed,2020-09-01,02415380,Mya,2,G03AA12,Drospirenone and estrogen,Tablet,Oral,02415380,MYA (drospirenone 3 mg and ethinyl estradiol 20 mcg oral tablet with lactose oral tablet) APOTEX INC,Active,9006572,drospirenone 3 mg and ethinyl estradiol 20 mcg oral tablet with lactose oral tablet,8000345,drospirenone and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
90606,Marketed,2021-10-22,02421437,Drospirenone And Ethinyl Estradiol Tablets USP 21,2,G03AA12,Drospirenone and estrogen,Tablet,Oral,02421437,DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 21 (drospirenone 3 mg and ethinyl estradiol 30 mcg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9006564,drospirenone 3 mg and ethinyl estradiol 30 mcg oral tablet,8000345,drospirenone and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
90607,Marketed,2021-10-22,02421445,Drospirenone And Ethinyl Estradiol Tablets USP 28,2,G03AA12,Drospirenone and estrogen,Tablet,Oral,02421445,DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 28 (drospirenone 3 mg and ethinyl estradiol 30 mcg oral tablet with lactose oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9006565,drospirenone 3 mg and ethinyl estradiol 30 mcg oral tablet with lactose oral tablet,8000345,drospirenone and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
94980,Marketed,2021-09-07,02462060,Drospirenone And Ethinyl Estradiol Tablets USP,2,G03AA12,Drospirenone and estrogen,Tablet,Oral,02462060,DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP (drospirenone 3 mg and ethinyl estradiol 20 mcg oral tablet with lactose oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9006572,drospirenone 3 mg and ethinyl estradiol 20 mcg oral tablet with lactose oral tablet,8000345,drospirenone and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
93430,Marketed,2016-01-08,02448599,Trulicity,1,A10BJ05,Dulaglutide,Solution,Subcutaneous,02448599,TRULICITY (dulaglutide 0.75 mg per 0.5 mL solution for injection syringe) ELI LILLY CANADA INC,Active,9013089,dulaglutide 0.75 mg per 0.5 mL solution for injection syringe,8001639,dulaglutide,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
93430,Marketed,2016-01-08,02448599,Trulicity,1,A10BJ05,Dulaglutide,Solution,Subcutaneous,02448599,TRULICITY (dulaglutide 0.75 mg per 0.5 mL solution for injection syringe) ELI LILLY CANADA INC,Active,9013089,dulaglutide 0.75 mg per 0.5 mL solution for injection syringe,8001639,dulaglutide,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
93431,Marketed,2015-11-24,02448602,Trulicity,1,A10BJ05,Dulaglutide,Solution,Subcutaneous,02448602,TRULICITY (dulaglutide 1.5 mg per 0.5 mL solution for injection pen) ELI LILLY CANADA INC,Active,9013090,dulaglutide 1.5 mg per 0.5 mL solution for injection pen,8001639,dulaglutide,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
93431,Marketed,2015-11-24,02448602,Trulicity,1,A10BJ05,Dulaglutide,Solution,Subcutaneous,02448602,TRULICITY (dulaglutide 1.5 mg per 0.5 mL solution for injection pen) ELI LILLY CANADA INC,Active,9013090,dulaglutide 1.5 mg per 0.5 mL solution for injection pen,8001639,dulaglutide,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Prescription
100179,Marketed,2023-11-17,02512505,JAMP Duloxetine Capsules,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02512505,JAMP DULOXETINE CAPSULES (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) JAMP PHARMA CORPORATION,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
101196,Marketed,2022-04-04,02522861,Accel-Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02522861,ACCEL-DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) ACCEL PHARMA INC,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
101197,Marketed,2022-04-04,02522888,Accel-Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02522888,ACCEL-DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) ACCEL PHARMA INC,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
91389,Marketed,2016-05-02,02429446,PMS-Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02429446,PMS-DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) PHARMASCIENCE INC,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
91391,Marketed,2016-05-02,02429454,PMS-Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02429454,PMS-DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) PHARMASCIENCE INC,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
92097,Marketed,2016-05-02,02436647,Auro-Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02436647,AURO-DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) AURO PHARMA INC,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
92098,Marketed,2016-05-02,02436655,Auro-Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02436655,AURO-DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) AURO PHARMA INC,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
92335,Marketed,2016-05-02,02438984,Mint-Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02438984,MINT-DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) MINT PHARMACEUTICALS INC,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
92336,Marketed,2016-05-02,02438992,Mint-Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02438992,MINT-DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) MINT PHARMACEUTICALS INC,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
92433,Marketed,2016-05-02,02439948,Sandoz Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02439948,SANDOZ DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) SANDOZ CANADA INCORPORATED,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
92434,Marketed,2016-05-02,02439956,Sandoz Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02439956,SANDOZ DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) SANDOZ CANADA INCORPORATED,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
92479,Marketed,2016-05-03,02440423,Apo-Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02440423,APO-DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) APOTEX INC,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
92480,Marketed,2016-05-03,02440431,Apo-Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02440431,APO-DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) APOTEX INC,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
93136,Marketed,2019-05-14,02446081,Mar-Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02446081,MAR-DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) MARCAN PHARMACEUTICALS INC,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
93137,Marketed,2019-05-14,02446103,Mar-Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02446103,MAR-DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) MARCAN PHARMACEUTICALS INC,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
93831,Marketed,2016-05-03,02451913,JAMP-Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02451913,JAMP-DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) JAMP PHARMA CORPORATION,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
93832,Marketed,2016-05-03,02451921,JAMP-Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02451921,JAMP-DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) JAMP PHARMA CORPORATION,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
93902,Marketed,2025-10-10,02452650,Pro-Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02452650,PRO-DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) PRO DOC LIMITEE,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
93903,Marketed,2025-10-10,02452669,Pro-Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02452669,PRO-DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) PRO DOC LIMITEE,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
94019,Marketed,2016-05-05,02453630,Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02453630,DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) SIVEM PHARMACEUTICALS ULC,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
94020,Marketed,2016-05-05,02453649,Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02453649,DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) SIVEM PHARMACEUTICALS ULC,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
94374,Marketed,2020-04-24,02456753,Teva-Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02456753,TEVA-DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) TEVA CANADA LIMITED,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
94375,Marketed,2020-04-24,02456761,Teva-Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02456761,TEVA-DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) TEVA CANADA LIMITED,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
94427,Marketed,2025-10-15,02457199,Taro-Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02457199,TARO-DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) TARO PHARMACEUTICALS INC,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
94428,Marketed,2025-10-15,02457202,Taro-Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02457202,TARO-DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) TARO PHARMACEUTICALS INC,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96254,Marketed,2019-06-27,02473208,M-Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02473208,M-DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) MANTRA PHARMA INC,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96255,Marketed,2019-06-27,02473216,M-Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02473216,M-DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) MANTRA PHARMA INC,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96567,Marketed,2018-07-19,02475308,AG-Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02475308,AG-DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) ANGITA PHARMA INC.,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96568,Marketed,2018-07-19,02475316,AG-Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02475316,AG-DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) ANGITA PHARMA INC.,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97213,Marketed,2023-10-05,02481952,Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02481952,DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) ALTAMED PHARMA,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97214,Marketed,2023-09-20,02481960,Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02481960,DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) ALTAMED PHARMA,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97243,Marketed,2019-03-06,02482126,Nra-Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02482126,NRA-DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) NORA PHARMA INC,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97244,Marketed,2019-03-06,02482134,Nra-Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02482134,NRA-DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) NORA PHARMA INC,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98503,Marketed,2020-04-06,02495082,Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02495082,DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) LABORATOIRE RIVA INC.,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98504,Marketed,2020-04-06,02495090,Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02495090,DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) LABORATOIRE RIVA INC.,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
99712,Marketed,2023-02-17,02507722,Bio-Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02507722,BIO-DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) BIOMED PHARMA,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
99716,Marketed,2023-02-17,02507765,Bio-Duloxetine,1,N06AX21,Duloxetine,Capsule (delayed release),Oral,02507765,BIO-DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) BIOMED PHARMA,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
101328,Marketed,2022-06-23,02524252,Dupixent,1,D11AH05,Dupilumab,Solution,Subcutaneous,02524252,DUPIXENT (dupilumab 200 mg per 1.14 mL solution for injection pen) SANOFI-AVENTIS CANADA INC,Active,9014738,dupilumab 200 mg per 1.14 mL solution for injection pen,8001148,dupilumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Prescription
101328,Marketed,2022-06-23,02524252,Dupixent,1,D11AH05,Dupilumab,Solution,Subcutaneous,02524252,DUPIXENT (dupilumab 200 mg per 1.14 mL solution for injection pen) SANOFI-AVENTIS CANADA INC,Active,9014738,dupilumab 200 mg per 1.14 mL solution for injection pen,8001148,dupilumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
95935,Marketed,2018-02-06,02470365,Dupixent,1,D11AH05,Dupilumab,Solution,Subcutaneous,02470365,DUPIXENT (dupilumab 300 mg per 2 mL solution for injection syringe) SANOFI-AVENTIS CANADA INC,Active,9012489,dupilumab 300 mg per 2 mL solution for injection syringe,8001148,dupilumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
95935,Marketed,2018-02-06,02470365,Dupixent,1,D11AH05,Dupilumab,Solution,Subcutaneous,02470365,DUPIXENT (dupilumab 300 mg per 2 mL solution for injection syringe) SANOFI-AVENTIS CANADA INC,Active,9012489,dupilumab 300 mg per 2 mL solution for injection syringe,8001148,dupilumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
98251,Marketed,2019-11-29,02492504,Dupixent,1,D11AH05,Dupilumab,Solution,Subcutaneous,02492504,DUPIXENT (dupilumab 200 mg per 1.14 mL solution for injection syringe) SANOFI-AVENTIS CANADA INC,Active,9014202,dupilumab 200 mg per 1.14 mL solution for injection syringe,8001148,dupilumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
98251,Marketed,2019-11-29,02492504,Dupixent,1,D11AH05,Dupilumab,Solution,Subcutaneous,02492504,DUPIXENT (dupilumab 200 mg per 1.14 mL solution for injection syringe) SANOFI-AVENTIS CANADA INC,Active,9014202,dupilumab 200 mg per 1.14 mL solution for injection syringe,8001148,dupilumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
99930,Marketed,2021-05-27,02510049,Dupixent,1,D11AH05,Dupilumab,Solution,Subcutaneous,02510049,DUPIXENT (dupilumab 300 mg per 2 mL solution for injection pen) SANOFI-AVENTIS CANADA INC,Active,9014543,dupilumab 300 mg per 2 mL solution for injection pen,8001148,dupilumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
99930,Marketed,2021-05-27,02510049,Dupixent,1,D11AH05,Dupilumab,Solution,Subcutaneous,02510049,DUPIXENT (dupilumab 300 mg per 2 mL solution for injection pen) SANOFI-AVENTIS CANADA INC,Active,9014543,dupilumab 300 mg per 2 mL solution for injection pen,8001148,dupilumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Prescription
95736,Marketed,2017-11-20,02468816,Imfinzi,1,L01FF03,Durvalumab,Solution,Intravenous,77700574,IMFINZI (durvalumab 120 mg per 2.4 mL solution for injection vial) ASTRAZENECA CANADA INC,Active,9012490,durvalumab 120 mg per 2.4 mL solution for injection vial,8001138,durvalumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
95736,Marketed,2017-11-20,02468816,Imfinzi,1,L01FF03,Durvalumab,Solution,Intravenous,77700575,IMFINZI (durvalumab 500 mg per 10 mL solution for injection vial) ASTRAZENECA CANADA INC,Active,9012491,durvalumab 500 mg per 10 mL solution for injection vial,8001138,durvalumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
95736,Marketed,2017-11-20,02468816,Imfinzi,1,L01FF03,Durvalumab,Solution,Intravenous,77700574,IMFINZI (durvalumab 120 mg per 2.4 mL solution for injection vial) ASTRAZENECA CANADA INC,Active,9012490,durvalumab 120 mg per 2.4 mL solution for injection vial,8001138,durvalumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
95736,Marketed,2017-11-20,02468816,Imfinzi,1,L01FF03,Durvalumab,Solution,Intravenous,77700575,IMFINZI (durvalumab 500 mg per 10 mL solution for injection vial) ASTRAZENECA CANADA INC,Active,9012491,durvalumab 500 mg per 10 mL solution for injection vial,8001138,durvalumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
103240,Marketed,2024-07-22,02543990,Pro-Dutasteride,1,G04CB02,Dutasteride,Capsule,Oral,02543990,PRO-DUTASTERIDE (dutasteride 0.5 mg oral capsule) PRO DOC LIMITEE,Active,9001054,dutasteride 0.5 mg oral capsule,8000330,dutasteride,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
103488,Marketed,2025-03-17,02546167,JAMP Dutasteride Capsules,1,G04CB02,Dutasteride,Capsule,Oral,02546167,JAMP DUTASTERIDE CAPSULES (dutasteride 0.5 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001054,dutasteride 0.5 mg oral capsule,8000330,dutasteride,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
72107,Marketed,2003-11-14,02247813,Avodart,1,G04CB02,Dutasteride,Capsule,Oral,02247813,AVODART (dutasteride 0.5 mg oral capsule) GLAXOSMITHKLINE INC,Active,9001054,dutasteride 0.5 mg oral capsule,8000330,dutasteride,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
88899,Marketed,2014-07-18,02404206,Apo-Dutasteride,1,G04CB02,Dutasteride,Capsule,Oral,02404206,APO-DUTASTERIDE (dutasteride 0.5 mg oral capsule) APOTEX INC,Active,9001054,dutasteride 0.5 mg oral capsule,8000330,dutasteride,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
89301,Marketed,2014-07-16,02408287,Teva-Dutasteride,1,G04CB02,Dutasteride,Capsule,Oral,02408287,TEVA-DUTASTERIDE (dutasteride 0.5 mg oral capsule) TEVA CANADA LIMITED,Active,9001054,dutasteride 0.5 mg oral capsule,8000330,dutasteride,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
90086,Marketed,2014-10-10,02416298,Med-Dutasteride,1,G04CB02,Dutasteride,Capsule,Oral,02416298,MED-DUTASTERIDE (dutasteride 0.5 mg oral capsule) GENERIC MEDICAL PARTNERS INC,Active,9001054,dutasteride 0.5 mg oral capsule,8000330,dutasteride,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
90912,Marketed,2024-06-17,02424444,Sandoz Dutasteride,1,G04CB02,Dutasteride,Capsule,Oral,02424444,SANDOZ DUTASTERIDE (dutasteride 0.5 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001054,dutasteride 0.5 mg oral capsule,8000330,dutasteride,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
91226,Marketed,2014-09-18,02427753,Riva-Dutasteride,1,G04CB02,Dutasteride,Capsule,Oral,02427753,RIVA-DUTASTERIDE (dutasteride 0.5 mg oral capsule) LABORATOIRE RIVA INC.,Active,9001054,dutasteride 0.5 mg oral capsule,8000330,dutasteride,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
91334,Marketed,2014-09-19,02428873,Mint-Dutasteride,1,G04CB02,Dutasteride,Capsule,Oral,02428873,MINT-DUTASTERIDE (dutasteride 0.5 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9001054,dutasteride 0.5 mg oral capsule,8000330,dutasteride,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
91345,Marketed,2025-10-23,02429012,Dutasteride,1,G04CB02,Dutasteride,Capsule,Oral,02429012,DUTASTERIDE (dutasteride 0.5 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9001054,dutasteride 0.5 mg oral capsule,8000330,dutasteride,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
92760,Marketed,2026-01-21,02443058,Dutasteride,1,G04CB02,Dutasteride,Capsule,Oral,02443058,DUTASTERIDE (dutasteride 0.5 mg oral capsule) SANIS HEALTH INC,Active,9001054,dutasteride 0.5 mg oral capsule,8000330,dutasteride,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
95804,Marketed,2018-06-04,02469308,Auro-Dutasteride,1,G04CB02,Dutasteride,Capsule,Oral,02469308,AURO-DUTASTERIDE (dutasteride 0.5 mg oral capsule) AURO PHARMA INC,Active,9001054,dutasteride 0.5 mg oral capsule,8000330,dutasteride,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
97515,Marketed,2019-11-07,02484870,JAMP Dutasteride,1,G04CB02,Dutasteride,Capsule,Oral,02484870,JAMP DUTASTERIDE (dutasteride 0.5 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001054,dutasteride 0.5 mg oral capsule,8000330,dutasteride,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
97590,Marketed,2025-08-19,02485672,AG-Dutasteride,1,G04CB02,Dutasteride,Capsule,Oral,02485672,AG-DUTASTERIDE (dutasteride 0.5 mg oral capsule) ANGITA PHARMA INC.,Active,9001054,dutasteride 0.5 mg oral capsule,8000330,dutasteride,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
98062,Marketed,2024-01-02,02490587,Nra-Dutasteride,1,G04CB02,Dutasteride,Capsule,Oral,02490587,NRA-DUTASTERIDE (dutasteride 0.5 mg oral capsule) NORA PHARMA INC,Active,9001054,dutasteride 0.5 mg oral capsule,8000330,dutasteride,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
80774,Marketed,2013-09-16,02322285,Soliris,1,L04AJ01,Eculizumab,Solution,Intravenous,02322285,SOLIRIS (eculizumab 300 mg per 30 mL solution for injection vial) ALEXION PHARMA GMBH,Active,9012965,eculizumab 300 mg per 30 mL solution for injection vial,8001641,eculizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
80774,Marketed,2013-09-16,02322285,Soliris,1,L04AJ01,Eculizumab,Solution,Intravenous,02322285,SOLIRIS (eculizumab 300 mg per 30 mL solution for injection vial) ALEXION PHARMA GMBH,Active,9012965,eculizumab 300 mg per 30 mL solution for injection vial,8001641,eculizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
102163,Marketed,2026-03-06,02532611,Radicava,1,N07XX14,Edaravone,Suspension,Oral,02532611,RADICAVA (edaravone 105 mg per 5 mL oral suspension) TANABE PHARMA CORPORATION,Active,9014830,edaravone 105 mg per 5 mL oral suspension,8002305,edaravone,26643006,Oral,385024007,Oral suspension,,,1.0,,,Prescription
104235,Marketed,2025-05-06,02553414,Sandoz Edoxaban,1,B01AF03,Edoxaban,Tablet,Oral,02553414,SANDOZ EDOXABAN (edoxaban (edoxaban tosylate monohydrate) 15 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9006163,edoxaban (edoxaban tosylate) 15 mg oral tablet,8001759,edoxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104236,Marketed,2025-05-06,02553422,Sandoz Edoxaban,1,B01AF03,Edoxaban,Tablet,Oral,02553422,SANDOZ EDOXABAN (edoxaban (edoxaban tosylate monohydrate) 30 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9006164,edoxaban (edoxaban tosylate) 30 mg oral tablet,8001759,edoxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104237,Marketed,2025-05-06,02553430,Sandoz Edoxaban,1,B01AF03,Edoxaban,Tablet,Oral,02553430,SANDOZ EDOXABAN (edoxaban (edoxaban tosylate monohydrate) 60 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9006165,edoxaban (edoxaban tosylate) 60 mg oral tablet,8001759,edoxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104307,Marketed,2025-05-05,02554208,Teva-Edoxaban,1,B01AF03,Edoxaban,Tablet,Oral,02554208,TEVA-EDOXABAN (edoxaban (edoxaban tosylate monohydrate) 15 mg oral tablet) TEVA CANADA LIMITED,Active,9006163,edoxaban (edoxaban tosylate) 15 mg oral tablet,8001759,edoxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104308,Marketed,2025-05-05,02554216,Teva-Edoxaban,1,B01AF03,Edoxaban,Tablet,Oral,02554216,TEVA-EDOXABAN (edoxaban (edoxaban tosylate monohydrate) 30 mg oral tablet) TEVA CANADA LIMITED,Active,9006164,edoxaban (edoxaban tosylate) 30 mg oral tablet,8001759,edoxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104309,Marketed,2025-05-05,02554224,Teva-Edoxaban,1,B01AF03,Edoxaban,Tablet,Oral,02554224,TEVA-EDOXABAN (edoxaban (edoxaban tosylate monohydrate) 60 mg oral tablet) TEVA CANADA LIMITED,Active,9006165,edoxaban (edoxaban tosylate) 60 mg oral tablet,8001759,edoxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106033,Marketed,2025-07-17,02556960,Pro-Edoxaban,1,B01AF03,Edoxaban,Tablet,Oral,02556960,PRO-EDOXABAN (edoxaban (edoxaban tosylate monohydrate) 30 mg oral tablet) PRO DOC LIMITEE,Active,9006164,edoxaban (edoxaban tosylate) 30 mg oral tablet,8001759,edoxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106034,Marketed,2025-07-17,02556979,Pro-Edoxaban,1,B01AF03,Edoxaban,Tablet,Oral,02556979,PRO-EDOXABAN (edoxaban (edoxaban tosylate monohydrate) 60 mg oral tablet) PRO DOC LIMITEE,Active,9006165,edoxaban (edoxaban tosylate) 60 mg oral tablet,8001759,edoxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106062,Marketed,2025-05-16,02557282,JAMP Edoxaban,1,B01AF03,Edoxaban,Tablet,Oral,02557282,JAMP EDOXABAN (edoxaban (edoxaban tosylate monohydrate) 30 mg oral tablet) JAMP PHARMA CORPORATION,Active,9006164,edoxaban (edoxaban tosylate) 30 mg oral tablet,8001759,edoxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106063,Marketed,2025-05-16,02557290,JAMP Edoxaban,1,B01AF03,Edoxaban,Tablet,Oral,02557290,JAMP EDOXABAN (edoxaban (edoxaban tosylate monohydrate) 60 mg oral tablet) JAMP PHARMA CORPORATION,Active,9006165,edoxaban (edoxaban tosylate) 60 mg oral tablet,8001759,edoxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86737,Marketed,2013-07-30,02381524,Mylan-Efavirenz,1,J05AG03,Efavirenz,Tablet,Oral,02381524,MYLAN-EFAVIRENZ (efavirenz 600 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9003764,efavirenz 600 mg oral tablet,8001192,efavirenz,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87524,Marketed,2013-07-30,02389762,Teva-Efavirenz,1,J05AG03,Efavirenz,Tablet,Oral,02389762,TEVA-EFAVIRENZ (efavirenz 600 mg oral tablet) TEVA CANADA LIMITED,Active,9003764,efavirenz 600 mg oral tablet,8001192,efavirenz,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90299,Marketed,2014-03-03,02418428,Auro-Efavirenz,1,J05AG03,Efavirenz,Tablet,Oral,02418428,AURO-EFAVIRENZ (efavirenz 600 mg oral tablet) AURO PHARMA INC,Active,9003764,efavirenz 600 mg oral tablet,8001192,efavirenz,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103023,Marketed,2023-11-06,02541599,Vyvgart,1,L04AL01,Efgartigimod alfa,Solution,Intravenous,02541599,VYVGART (efgartigimod alfa 400 mg per 20 mL solution for injection vial) ARGENX BV,Active,9014976,efgartigimod alfa 400 mg per 20 mL solution for injection vial,8002491,efgartigimod alfa,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
103023,Marketed,2023-11-06,02541599,Vyvgart,1,L04AL01,Efgartigimod alfa,Solution,Intravenous,02541599,VYVGART (efgartigimod alfa 400 mg per 20 mL solution for injection vial) ARGENX BV,Active,9014976,efgartigimod alfa 400 mg per 20 mL solution for injection vial,8002491,efgartigimod alfa,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
106549,Marketed,2026-01-20,02562634,Vyvgart SC,1,L04AL01,Efgartigimod alfa,Solution,Subcutaneous,02562634,VYVGART SC (efgartigimod alfa 1000 mg per 5 mL solution for injection syringe) ARGENX BV,Active,9015355,efgartigimod alfa 1000 mg per 5 mL solution for injection syringe,8002491,efgartigimod alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe,,,,Prescription
106549,Marketed,2026-01-20,02562634,Vyvgart SC,1,L04AL01,Efgartigimod alfa,Solution,Subcutaneous,02562634,VYVGART SC (efgartigimod alfa 1000 mg per 5 mL solution for injection syringe) ARGENX BV,Active,9015355,efgartigimod alfa 1000 mg per 5 mL solution for injection syringe,8002491,efgartigimod alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe,,,,Schedule D
89805,Marketed,2020-01-21,02413388,Jublia,1,D01AC19,Efinaconazole,Solution,Topical,02413388,"JUBLIA (efinaconazole 10 % cutaneous solution) BAUSCH HEALTH, CANADA INC.",Active,9005554,efinaconazole 10 % cutaneous solution,8001264,efinaconazole,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Prescription
67778,Marketed,2015-12-04,02243837,Vaniqa,1,D11AX16,Eflornithine,Cream,Topical,02243837,VANIQA (eflornithine hydrochloride 13.9 % cutaneous cream) CIPHER PHARMACEUTICALS INC,Active,9004095,eflornithine hydrochloride 13.9 % cutaneous cream,8001642,eflornithine,448598008,Cutaneous,421628006,Cutaneous cream,,,1.0,,,Prescription
106038,Marketed,2025-05-20,02557010,Iqirvo,1,A05AX06,Elafibranor,Tablet,Oral,02557010,IQIRVO (elafibranor 80 mg oral tablet) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9015202,elafibranor 80 mg oral tablet,8002543,elafibranor,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,,Prescription
97182,Marketed,2018-10-30,02481332,Orilissa,1,H01CC03,Elagolix,Tablet,Oral,02481332,ORILISSA (elagolix (elagolix sodium) 150 mg oral tablet) ABBVIE CORPORATION,Active,9013436,elagolix (elagolix sodium) 150 mg oral tablet,8002021,elagolix,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
97183,Marketed,2019-05-24,02481340,Orilissa,1,H01CC03,Elagolix,Tablet,Oral,02481340,ORILISSA (elagolix (elagolix sodium) 200 mg oral tablet) ABBVIE CORPORATION,Active,9013905,elagolix (elagolix sodium) 200 mg oral tablet,8002021,elagolix,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
12186,Marketed,1998-09-03,01931636,Lactated Ringer's Injection USP,4,B05BB01,Electrolytes,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
12741,Marketed,1998-06-17,01931628,Isolyte S (Multi-Electrolyte Injection),5,B05BB01,Electrolytes,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
1628,Marketed,1957-12-31,00061085,"Lactated Ringer's Injection, USP",4,B05BB01,Electrolytes,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
1745,Marketed,2019-12-19,00039470,Lactated Ringer's Injection,4,B05BB01,Electrolytes,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
21757,Marketed,1998-06-17,01931679,Isolyte S PH 7.4 (Multi-Electrolyte Injection),7,B05BB01,Electrolytes,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
67329,Marketed,2001-05-31,02243421,Potassium Chloride In Lactated Ringer's Injection,4,B05BB01,Electrolytes,Liquid,Intravenous,,,,,,,,,,,,,,,,,Ethical
75479,Marketed,2008-03-31,02269414,Potassium Chloride In Sodium Chloride Injection USP,2,B05BB01,Electrolytes,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
82495,Marketed,2010-12-23,02339358,Plasma-Lyte A Injection,5,B05BB01,Electrolytes,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
9826,Marketed,2013-01-29,00786209,(20 Mmol/L) Potassium Chloride In 0.9% Sodium Chloride Injection USP,2,B05BB01,Electrolytes,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
9827,Marketed,2013-01-21,00786217,(40 Mmol/L) Potassium Chloride In 0.9% Sodium Chloride Injection USP,2,B05BB01,Electrolytes,Liquid,Intravenous,,,,,,,,,,,,,,,,,Ethical
102495,Marketed,2024-06-25,02536145,Micro+ Te Pediatric,5,B05XA31,Electrolytes in comb with other drugs,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
104175,Marketed,2025-05-30,02552787,Micro+6 Regular,6,B05XA31,Electrolytes in comb with other drugs,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
16226,Marketed,2006-07-19,02091100,Micro Plus 6  (Pediatric),6,B05XA31,Electrolytes in comb with other drugs,Liquid,Intravenous,,,,,,,,,,,,,,,,,Ethical
19923,Marketed,2024-05-03,02091135,Micro +4 Regular Strength,4,B05XA31,Electrolytes in comb with other drugs,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
98749,Marketed,2020-12-01,02497697,Addnutriv,9,B05XA31,Electrolytes in comb with other drugs,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
99695,Marketed,2021-06-18,02507587,Micro+6 Concentrate,6,B05XA31,Electrolytes in comb with other drugs,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
10041,Marketed,2013-01-21,00438049,(20 Mmol/L) Potassium Chloride In 5% Dextrose Injection USP,2,B05BB02,Electrolytes with carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
10042,Marketed,2013-01-21,00438030,(40 Mmol/L) Potassium Chloride In 5% Dextrose Injection USP,2,B05BB02,Electrolytes with carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
10044,Marketed,2013-01-21,00437999,(20 Mmol/L) Potassium Chloride In 5% Dextrose And 0.45% Sodium Chloride Injection USP,3,B05BB02,Electrolytes with carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
10045,Marketed,2013-01-20,00438006,(40 Mmol/L)Potassium Chloride In 5% Dextrose And 0.45% Sodium Chloride Injection USP,3,B05BB02,Electrolytes with carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
10438,Marketed,1990-12-31,00060704,Dextrose 5% And 0.2% Sod Chloride Inj,2,B05BB02,Electrolytes with carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
10439,Marketed,1990-12-31,00060739,Dextrose 5% And 0.45% Sod Chloride Inj,2,B05BB02,Electrolytes with carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
10440,Marketed,1990-12-31,00060747,Dextrose 5% And 0.9% Sod Chloride Inj,2,B05BB02,Electrolytes with carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
10441,Marketed,1990-12-31,00060755,Dextrose 10% And 0.9% Sod Chloride Inj,2,B05BB02,Electrolytes with carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
10515,Marketed,1990-12-31,00060712,Dextrose 3.3% And 0.3% Sod Chloride Inj,2,B05BB02,Electrolytes with carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
10866,Marketed,2013-01-21,00786292,(20 Mmol/L) Potassium Chloride In 5% Dextrose And 0.9% Sodium Chloride Injection USP,3,B05BB02,Electrolytes with carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
10867,Marketed,1990-12-31,00786306,Potass Chlor 40 mEq 5% Dex And 0.9% Sod Chlor,3,B05BB02,Electrolytes with carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
13033,Marketed,1998-05-01,01927531,5% Dextrose And 0.45% Sodium Chloride Injection USP,2,B05BB02,Electrolytes with carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
13288,Marketed,1998-05-01,01924435,5% Dextrose And 0.9% Sodium Chloride Injection USP,2,B05BB02,Electrolytes with carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
1673,Marketed,1973-12-31,00061131,"Lactated Ringer's And 5% Dextrose Injection, USP",5,B05BB02,Electrolytes with carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
1750,Marketed,2020-09-15,00038903,5% Dextrose And 0.45% Sodium Chloride,2,B05BB02,Electrolytes with carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
21753,Marketed,1998-10-01,01931598,0.15% Potassium Chloride In 5% Dextrose And 0.20% Sodium Chloride Injection USP,3,B05BB02,Electrolytes with carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
3132,Marketed,2013-01-21,00438014,(20 Mmol/L) Potassium Chloride In 3.3% Dextrose And 0.3% Sodium Chloride Injection USP,3,B05BB02,Electrolytes with carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
3133,Marketed,2013-01-21,00438022,(40 Mmol/L) Potassium Chloride In 3.3% Dextrose And 0.3% Sodium Chloride Injection USP,3,B05BB02,Electrolytes with carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
100048,Marketed,2021-07-22,02511266,Eletriptan,1,N02CC06,Eletriptan,Tablet,Oral,02511266,ELETRIPTAN (eletriptan (eletriptan hydrobromide) 20 mg oral tablet) SANIS HEALTH INC,Active,9003961,eletriptan (eletriptan hydrobromide) 20 mg oral tablet,8001112,eletriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100049,Marketed,2021-07-22,02511274,Eletriptan,1,N02CC06,Eletriptan,Tablet,Oral,02511274,ELETRIPTAN (eletriptan (eletriptan hydrobromide) 40 mg oral tablet) SANIS HEALTH INC,Active,9003962,eletriptan (eletriptan hydrobromide) 40 mg oral tablet,8001112,eletriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100735,Marketed,2022-06-01,02518015,Apo-Eletriptan Tablets,1,N02CC06,Eletriptan,Tablet,Oral,02518015,APO-ELETRIPTAN TABLETS (eletriptan (eletriptan hydrobromide) 20 mg oral tablet) APOTEX INC,Active,9003961,eletriptan (eletriptan hydrobromide) 20 mg oral tablet,8001112,eletriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100736,Marketed,2022-06-01,02518023,Apo-Eletriptan Tablets,1,N02CC06,Eletriptan,Tablet,Oral,02518023,APO-ELETRIPTAN TABLETS (eletriptan (eletriptan hydrobromide) 40 mg oral tablet) APOTEX INC,Active,9003962,eletriptan (eletriptan hydrobromide) 40 mg oral tablet,8001112,eletriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74152,Marketed,2023-08-30,02256290,Relpax,1,N02CC06,Eletriptan,Tablet,Oral,02256290,RELPAX (eletriptan (eletriptan hydrobromide) 20 mg oral tablet) BGP PHARMA ULC,Active,9003961,eletriptan (eletriptan hydrobromide) 20 mg oral tablet,8001112,eletriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74153,Marketed,2023-08-30,02256304,Relpax,1,N02CC06,Eletriptan,Tablet,Oral,02256304,RELPAX (eletriptan (eletriptan hydrobromide) 40 mg oral tablet) BGP PHARMA ULC,Active,9003962,eletriptan (eletriptan hydrobromide) 40 mg oral tablet,8001112,eletriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82774,Marketed,2023-12-05,02342235,Mylan-Eletriptan,1,N02CC06,Eletriptan,Tablet,Oral,02342235,MYLAN-ELETRIPTAN (eletriptan (eletriptan hydrobromide) 20 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9003961,eletriptan (eletriptan hydrobromide) 20 mg oral tablet,8001112,eletriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82775,Marketed,2023-12-05,02342243,Mylan-Eletriptan,1,N02CC06,Eletriptan,Tablet,Oral,02342243,MYLAN-ELETRIPTAN (eletriptan (eletriptan hydrobromide) 40 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9003962,eletriptan (eletriptan hydrobromide) 40 mg oral tablet,8001112,eletriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86796,Marketed,2013-12-20,02382091,Teva-Eletriptan,1,N02CC06,Eletriptan,Tablet,Oral,02382091,TEVA-ELETRIPTAN (eletriptan (eletriptan hydrobromide) 20 mg oral tablet) TEVA CANADA LIMITED,Active,9003961,eletriptan (eletriptan hydrobromide) 20 mg oral tablet,8001112,eletriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86797,Marketed,2013-12-20,02382105,Teva-Eletriptan,1,N02CC06,Eletriptan,Tablet,Oral,02382105,TEVA-ELETRIPTAN (eletriptan (eletriptan hydrobromide) 40 mg oral tablet) TEVA CANADA LIMITED,Active,9003962,eletriptan (eletriptan hydrobromide) 40 mg oral tablet,8001112,eletriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97013,Marketed,2019-02-01,02479451,Auro-Eletriptan,1,N02CC06,Eletriptan,Tablet,Oral,02479451,AURO-ELETRIPTAN (eletriptan (eletriptan hydrobromide) 20 mg oral tablet) AURO PHARMA INC,Active,9003961,eletriptan (eletriptan hydrobromide) 20 mg oral tablet,8001112,eletriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97014,Marketed,2019-02-01,02479478,Auro-Eletriptan,1,N02CC06,Eletriptan,Tablet,Oral,02479478,AURO-ELETRIPTAN (eletriptan (eletriptan hydrobromide) 40 mg oral tablet) AURO PHARMA INC,Active,9003962,eletriptan (eletriptan hydrobromide) 40 mg oral tablet,8001112,eletriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98004,Marketed,2026-05-06,02489961,Pro-Eletriptan,1,N02CC06,Eletriptan,Tablet,Oral,02489961,PRO-ELETRIPTAN (eletriptan (eletriptan hydrobromide) 20 mg oral tablet) PRO DOC LIMITEE,Active,9003961,eletriptan (eletriptan hydrobromide) 20 mg oral tablet,8001112,eletriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98005,Marketed,2026-05-06,02489988,Pro-Eletriptan,1,N02CC06,Eletriptan,Tablet,Oral,02489988,PRO-ELETRIPTAN (eletriptan (eletriptan hydrobromide) 40 mg oral tablet) PRO DOC LIMITEE,Active,9003962,eletriptan (eletriptan hydrobromide) 40 mg oral tablet,8001112,eletriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98368,Marketed,2026-03-31,02493683,JAMP Eletriptan,1,N02CC06,Eletriptan,Tablet,Oral,02493683,JAMP ELETRIPTAN (eletriptan (eletriptan hydrobromide) 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003961,eletriptan (eletriptan hydrobromide) 20 mg oral tablet,8001112,eletriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98369,Marketed,2026-03-31,02493691,JAMP Eletriptan,1,N02CC06,Eletriptan,Tablet,Oral,02493691,JAMP ELETRIPTAN (eletriptan (eletriptan hydrobromide) 40 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003962,eletriptan (eletriptan hydrobromide) 40 mg oral tablet,8001112,eletriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95117,Marketed,2024-10-14,02463261,Cerdelga,1,A16AX10,Eliglustat,Capsule,Oral,02463261,CERDELGA (eliglustat (eliglustat tartrate) 84 mg oral capsule) SANOFI-AVENTIS CANADA INC,Active,9012796,eliglustat (eliglustat tartrate) 84 mg oral capsule,8001454,eliglustat,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
91171,Marketed,2014-08-27,02427184,Vimizim,1,A16AB12,Elosulfase alfa,Solution,Intravenous,02427184,VIMIZIM (elosulfase alfa 5 mg per 5 mL solution for injection vial) BIOMARIN INTERNATIONAL LIMITED,Active,9013091,elosulfase alfa 5 mg per 5 mL solution for injection vial,8001760,elosulfase alfa,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
91171,Marketed,2014-08-27,02427184,Vimizim,1,A16AB12,Elosulfase alfa,Solution,Intravenous,02427184,VIMIZIM (elosulfase alfa 5 mg per 5 mL solution for injection vial) BIOMARIN INTERNATIONAL LIMITED,Active,9013091,elosulfase alfa 5 mg per 5 mL solution for injection vial,8001760,elosulfase alfa,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
103201,Marketed,2024-01-23,02543559,Elrexfio,1,L01FX32,Elranatamab,Solution,Subcutaneous,02543559,ELREXFIO (elranatamab 44 mg per 1.1 mL solution for injection vial) PFIZER CANADA ULC,Active,9015024,elranatamab 44 mg per 1.1 mL solution for injection vial,8002498,elranatamab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
103201,Marketed,2024-01-23,02543559,Elrexfio,1,L01FX32,Elranatamab,Solution,Subcutaneous,02543559,ELREXFIO (elranatamab 44 mg per 1.1 mL solution for injection vial) PFIZER CANADA ULC,Active,9015024,elranatamab 44 mg per 1.1 mL solution for injection vial,8002498,elranatamab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
103202,Marketed,2024-01-23,02543567,Elrexfio,1,L01FX32,Elranatamab,Solution,Subcutaneous,02543567,ELREXFIO (elranatamab 76 mg per 1.9 mL solution for injection vial) PFIZER CANADA ULC,Active,9015025,elranatamab 76 mg per 1.9 mL solution for injection vial,8002498,elranatamab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
103202,Marketed,2024-01-23,02543567,Elrexfio,1,L01FX32,Elranatamab,Solution,Subcutaneous,02543567,ELREXFIO (elranatamab 76 mg per 1.9 mL solution for injection vial) PFIZER CANADA ULC,Active,9015025,elranatamab 76 mg per 1.9 mL solution for injection vial,8002498,elranatamab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
84687,Marketed,2016-03-24,02361825,Revolade,1,B02BX05,Eltrombopag,Tablet,Oral,02361825,REVOLADE (eltrombopag (eltrombopag olamine) 25 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9004860,eltrombopag (eltrombopag olamine) 25 mg oral tablet,8001906,eltrombopag,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
84688,Marketed,2016-02-16,02361833,Revolade,1,B02BX05,Eltrombopag,Tablet,Oral,02361833,REVOLADE (eltrombopag (eltrombopag olamine) 50 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9004855,eltrombopag (eltrombopag olamine) 50 mg oral tablet,8001906,eltrombopag,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99608,Marketed,2023-05-23,02506742,Apo-Eltrombopag,1,B02BX05,Eltrombopag,Tablet,Oral,02506742,APO-ELTROMBOPAG (eltrombopag (eltrombopag olamine) 25 mg oral tablet) APOTEX INC,Active,9004860,eltrombopag (eltrombopag olamine) 25 mg oral tablet,8001906,eltrombopag,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99610,Marketed,2023-05-23,02506769,Apo-Eltrombopag,1,B02BX05,Eltrombopag,Tablet,Oral,02506769,APO-ELTROMBOPAG (eltrombopag (eltrombopag olamine) 50 mg oral tablet) APOTEX INC,Active,9004855,eltrombopag (eltrombopag olamine) 50 mg oral tablet,8001906,eltrombopag,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
94840,Marketed,2025-06-09,02460890,Viberzi,1,A07DA06,Eluxadoline,Tablet,Oral,02460890,VIBERZI (eluxadoline 75 mg oral tablet) ABBVIE CORPORATION,Active,9006161,eluxadoline 75 mg oral tablet,8001761,eluxadoline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94841,Marketed,2025-03-03,02460904,Viberzi,1,A07DA06,Eluxadoline,Tablet,Oral,02460904,VIBERZI (eluxadoline 100 mg oral tablet) ABBVIE CORPORATION,Active,9006160,eluxadoline 100 mg oral tablet,8001761,eluxadoline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97030,Marketed,2018-10-19,02479621,Hemlibra,1,B02BX06,Emicizumab,Solution,Subcutaneous,02479621,HEMLIBRA (emicizumab 30 mg per 1 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9014256,emicizumab 30 mg per 1 mL solution for injection vial,8002320,emicizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
97030,Marketed,2018-10-19,02479621,Hemlibra,1,B02BX06,Emicizumab,Solution,Subcutaneous,02479621,HEMLIBRA (emicizumab 30 mg per 1 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9014256,emicizumab 30 mg per 1 mL solution for injection vial,8002320,emicizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
97031,Marketed,2018-10-19,02479648,Hemlibra,1,B02BX06,Emicizumab,Solution,Subcutaneous,02479648,HEMLIBRA (emicizumab 60 mg per 0.4 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9014257,emicizumab 60 mg per 0.4 mL solution for injection vial,8002320,emicizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
97031,Marketed,2018-10-19,02479648,Hemlibra,1,B02BX06,Emicizumab,Solution,Subcutaneous,02479648,HEMLIBRA (emicizumab 60 mg per 0.4 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9014257,emicizumab 60 mg per 0.4 mL solution for injection vial,8002320,emicizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
97032,Marketed,2019-02-21,02479656,Hemlibra,1,B02BX06,Emicizumab,Solution,Subcutaneous,02479656,HEMLIBRA (emicizumab 105 mg per 0.7 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9014254,emicizumab 105 mg per 0.7 mL solution for injection vial,8002320,emicizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
97032,Marketed,2019-02-21,02479656,Hemlibra,1,B02BX06,Emicizumab,Solution,Subcutaneous,02479656,HEMLIBRA (emicizumab 105 mg per 0.7 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9014254,emicizumab 105 mg per 0.7 mL solution for injection vial,8002320,emicizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
97033,Marketed,2018-11-27,02479664,Hemlibra,1,B02BX06,Emicizumab,Solution,Subcutaneous,02479664,HEMLIBRA (emicizumab 150 mg per 1 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9014255,emicizumab 150 mg per 1 mL solution for injection vial,8002320,emicizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
97033,Marketed,2018-11-27,02479664,Hemlibra,1,B02BX06,Emicizumab,Solution,Subcutaneous,02479664,HEMLIBRA (emicizumab 150 mg per 1 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9014255,emicizumab 150 mg per 1 mL solution for injection vial,8002320,emicizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
92871,Marketed,2015-08-11,02443937,Jardiance,1,A10BK03,Empagliflozin,Tablet,Oral,02443937,JARDIANCE (empagliflozin 10 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9005754,empagliflozin 10 mg oral tablet,8001455,empagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92872,Marketed,2015-08-11,02443945,Jardiance,1,A10BK03,Empagliflozin,Tablet,Oral,02443945,JARDIANCE (empagliflozin 25 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9005755,empagliflozin 25 mg oral tablet,8001455,empagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94099,Marketed,2016-06-03,02454416,Descovy,2,J05AR17,Emtricitabine and tenofovir alafenamide,Tablet,Oral,02454416,DESCOVY (emtricitabine 200 mg and tenofovir alafenamide (tenofovir alafenamide hemifumarate) 10 mg oral tablet) GILEAD SCIENCES CANADA INC,Active,9005979,emtricitabine 200 mg and tenofovir alafenamide (tenofovir alafenamide hemifumarate) 10 mg oral tablet,8001197,emtricitabine and tenofovir alafenamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94100,Marketed,2016-06-03,02454424,Descovy,2,J05AR17,Emtricitabine and tenofovir alafenamide,Tablet,Oral,02454424,DESCOVY (emtricitabine 200 mg and tenofovir alafenamide (tenofovir alafenamide hemifumarate) 25 mg oral tablet) GILEAD SCIENCES CANADA INC,Active,9005980,emtricitabine 200 mg and tenofovir alafenamide (tenofovir alafenamide hemifumarate) 25 mg oral tablet,8001197,emtricitabine and tenofovir alafenamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96935,Marketed,2018-08-08,02478579,Biktarvy,3,J05AR20,"Emtricitabine, tenofovir alafenamide and bictegravir",Tablet,Oral,02478579,BIKTARVY (bictegravir (bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (tenofovir alafenamide hemifumarate) 25 mg oral tablet) GILEAD SCIENCES CANADA INC,Active,9013409,bictegravir (bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (tenofovir alafenamide hemifumarate) 25 mg oral tablet,8002013,bictegravir and emtricitabine and tenofovir alafenamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94909,Marketed,2017-03-20,02461463,Odefsey,3,J05AR19,"Emtricitabine, tenofovir alafenamide and rilpivirine",Tablet,Oral,02461463,ODEFSEY (emtricitabine 200 mg and rilpivirine (rilpivirine hydrochloride) 25 mg and tenofovir alafenamide (tenofovir alafenamide hemifumarate) 25 mg oral tablet) GILEAD SCIENCES CANADA INC,Active,9006139,emtricitabine 200 mg and rilpivirine (rilpivirine hydrochloride) 25 mg and tenofovir alafenamide (tenofovir alafenamide hemifumarate) 25 mg oral tablet,8001195,emtricitabine and rilpivirine and tenofovir alafenamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96312,Marketed,2018-04-25,02473720,Symtuza,4,J05AR22,"Emtricitabine, tenofovir alafenamide, darunavir and cobicistat",Tablet,Oral,02473720,SYMTUZA (cobicistat 150 mg and darunavir (darunavir ethanolate) 800 mg and emtricitabine 200 mg and tenofovir alafenamide (tenofovir alafenamide hemifumarate) 10 mg oral tablet) JANSSEN INC,Active,9012699,cobicistat 150 mg and darunavir 800 mg and emtricitabine 200 mg and tenofovir alafenamide (tenofovir alafenamide hemifumarate) 10 mg oral tablet,8001363,cobicistat and darunavir and emtricitabine and tenofovir alafenamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93532,Marketed,2016-02-03,02449498,Genvoya,4,J05AR18,"Emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat",Tablet,Oral,02449498,GENVOYA (cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide (tenofovir alafenamide hemifumarate) 10 mg oral tablet) GILEAD SCIENCES CANADA INC,Active,9005870,cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide (tenofovir alafenamide hemifumarate) 10 mg oral tablet,8001313,cobicistat and elvitegravir and emtricitabine and tenofovir alafenamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100873,Marketed,2022-12-14,02519461,JAMP Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate,3,J05AR06,"Emtricitabine, tenofovir disoproxil and efavirenz",Tablet,Oral,02519461,JAMP EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE (efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004343,efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet,8001193,efavirenz and emtricitabine and tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87876,Marketed,2017-07-26,02393549,Teva-Efavirenz/Emtricitabine/Tenofovir,3,J05AR06,"Emtricitabine, tenofovir disoproxil and efavirenz",Tablet,Oral,02393549,TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR (efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet) TEVA CANADA LIMITED,Active,9004343,efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet,8001193,efavirenz and emtricitabine and tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94902,Marketed,2017-07-31,02461412,Mylan-Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate,3,J05AR06,"Emtricitabine, tenofovir disoproxil and efavirenz",Tablet,Oral,02461412,MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE (efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9004343,efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet,8001193,efavirenz and emtricitabine and tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95665,Marketed,2018-09-04,02468247,Apo-Efavirenz-Emtricitabine-Tenofovir,3,J05AR06,"Emtricitabine, tenofovir disoproxil and efavirenz",Tablet,Oral,02468247,APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR (efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet) APOTEX INC,Active,9004343,efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet,8001193,efavirenz and emtricitabine and tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96916,Marketed,2020-03-18,02478404,Auro-Efavirenz-Emtricitabine-Tenofovir,3,J05AR06,"Emtricitabine, tenofovir disoproxil and efavirenz",Tablet,Oral,02478404,AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR (efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet) AURO PHARMA INC,Active,9004343,efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet,8001193,efavirenz and emtricitabine and tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85932,Marketed,2014-10-04,02374129,Complera,3,J05AR08,"Emtricitabine, tenofovir disoproxil and rilpivirine",Tablet,Oral,02374129,COMPLERA (emtricitabine 200 mg and rilpivirine (rilpivirine hydrochloride) 25 mg and tenofovir disoproxil fumarate 300 mg oral tablet) GILEAD SCIENCES CANADA INC,Active,9004942,emtricitabine 200 mg and rilpivirine (rilpivirine hydrochloride) 25 mg and tenofovir disoproxil fumarate 300 mg oral tablet,8001196,emtricitabine and rilpivirine and tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88208,Marketed,2012-12-20,02397137,Stribild,4,J05AR09,"Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat",Tablet,Oral,02397137,STRIBILD (cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet) GILEAD SCIENCES CANADA INC,Active,9005142,cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet,8001314,cobicistat and elvitegravir and emtricitabine and tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
14385,Marketed,1993-12-31,02020025,Apo-Enalapril,1,C09AA02,Enalapril,Tablet,Oral,02020025,APO-ENALAPRIL (enalapril maleate 2.5 mg oral tablet) APOTEX INC,Active,9000466,enalapril maleate 2.5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
14386,Marketed,1993-12-31,02019884,Apo-Enalapril,1,C09AA02,Enalapril,Tablet,Oral,02019884,APO-ENALAPRIL (enalapril maleate 5 mg oral tablet) APOTEX INC,Active,9000467,enalapril maleate 5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
14387,Marketed,1993-12-31,02019892,Apo-Enalapril,1,C09AA02,Enalapril,Tablet,Oral,02019892,APO-ENALAPRIL (enalapril maleate 10 mg oral tablet) APOTEX INC,Active,9000464,enalapril maleate 10 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
14388,Marketed,1993-12-31,02019906,Apo-Enalapril,1,C09AA02,Enalapril,Tablet,Oral,02019906,APO-ENALAPRIL (enalapril maleate 20 mg oral tablet) APOTEX INC,Active,9000465,enalapril maleate 20 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77724,Marketed,2017-08-18,02291878,Act Enalapril,1,C09AA02,Enalapril,Tablet,Oral,02291878,ACT ENALAPRIL (enalapril maleate 2.5 mg oral tablet) TEVA CANADA LIMITED,Active,9000466,enalapril maleate 2.5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77725,Marketed,2017-08-18,02291886,Act Enalapril,1,C09AA02,Enalapril,Tablet,Oral,02291886,ACT ENALAPRIL (enalapril maleate 5 mg oral tablet) TEVA CANADA LIMITED,Active,9000467,enalapril maleate 5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77726,Marketed,2017-08-18,02291894,Act Enalapril,1,C09AA02,Enalapril,Tablet,Oral,02291894,ACT ENALAPRIL (enalapril maleate 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000464,enalapril maleate 10 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77727,Marketed,2017-08-18,02291908,Act Enalapril,1,C09AA02,Enalapril,Tablet,Oral,02291908,ACT ENALAPRIL (enalapril maleate 20 mg oral tablet) TEVA CANADA LIMITED,Active,9000465,enalapril maleate 20 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78528,Marketed,2007-10-17,02299933,Sandoz Enalapril,1,C09AA02,Enalapril,Tablet,Oral,02299933,SANDOZ ENALAPRIL (enalapril maleate 2.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000466,enalapril maleate 2.5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78529,Marketed,2007-10-17,02299941,Sandoz Enalapril,1,C09AA02,Enalapril,Tablet,Oral,02299941,SANDOZ ENALAPRIL (enalapril maleate 5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000467,enalapril maleate 5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78530,Marketed,2007-10-17,02299968,Sandoz Enalapril,1,C09AA02,Enalapril,Tablet,Oral,02299968,SANDOZ ENALAPRIL (enalapril maleate 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000464,enalapril maleate 10 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78531,Marketed,2007-10-17,02299976,Sandoz Enalapril,1,C09AA02,Enalapril,Tablet,Oral,02299976,SANDOZ ENALAPRIL (enalapril maleate 20 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000465,enalapril maleate 20 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79698,Marketed,2008-07-04,02311402,Pro-Enalapril - 2.5,1,C09AA02,Enalapril,Tablet,Oral,02311402,PRO-ENALAPRIL - 2.5 (enalapril maleate 2.5 mg oral tablet) PRO DOC LIMITEE,Active,9000466,enalapril maleate 2.5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79699,Marketed,2008-07-04,02311410,Pro-Enalapril - 5,1,C09AA02,Enalapril,Tablet,Oral,02311410,PRO-ENALAPRIL - 5 (enalapril maleate 5 mg oral tablet) PRO DOC LIMITEE,Active,9000467,enalapril maleate 5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79700,Marketed,2008-07-04,02311429,Pro-Enalapril - 10,1,C09AA02,Enalapril,Tablet,Oral,02311429,PRO-ENALAPRIL - 10 (enalapril maleate 10 mg oral tablet) PRO DOC LIMITEE,Active,9000464,enalapril maleate 10 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79701,Marketed,2008-07-04,02311437,Pro-Enalapril - 20,1,C09AA02,Enalapril,Tablet,Oral,02311437,PRO-ENALAPRIL - 20 (enalapril maleate 20 mg oral tablet) PRO DOC LIMITEE,Active,9000465,enalapril maleate 20 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
8102,Marketed,2022-04-07,00670901,Vasotec,1,C09AA02,Enalapril,Tablet,Oral,00670901,VASOTEC (enalapril maleate 10 mg oral tablet) ORGANON CANADA INC.,Active,9000464,enalapril maleate 10 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
8103,Marketed,2022-06-17,00670928,Vasotec,1,C09AA02,Enalapril,Tablet,Oral,00670928,VASOTEC (enalapril maleate 20 mg oral tablet) ORGANON CANADA INC.,Active,9000465,enalapril maleate 20 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
8111,Marketed,2022-04-11,00708879,Vasotec,1,C09AA02,Enalapril,Tablet,Oral,00708879,VASOTEC (enalapril maleate 5 mg oral tablet) ORGANON CANADA INC.,Active,9000467,enalapril maleate 5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83747,Marketed,2022-02-15,02352230,Taro-Enalapril,1,C09AA02,Enalapril,Tablet,Oral,02352230,TARO-ENALAPRIL (enalapril maleate 2.5 mg oral tablet) SUN PHARMA CANADA INC,Active,9000466,enalapril maleate 2.5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83748,Marketed,2022-02-15,02352249,Taro-Enalapril,1,C09AA02,Enalapril,Tablet,Oral,02352249,TARO-ENALAPRIL (enalapril maleate 5 mg oral tablet) SUN PHARMA CANADA INC,Active,9000467,enalapril maleate 5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83749,Marketed,2022-02-15,02352257,Taro-Enalapril,1,C09AA02,Enalapril,Tablet,Oral,02352257,TARO-ENALAPRIL (enalapril maleate 10 mg oral tablet) SUN PHARMA CANADA INC,Active,9000464,enalapril maleate 10 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83750,Marketed,2022-02-15,02352265,Taro-Enalapril,1,C09AA02,Enalapril,Tablet,Oral,02352265,TARO-ENALAPRIL (enalapril maleate 20 mg oral tablet) SUN PHARMA CANADA INC,Active,9000465,enalapril maleate 20 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87402,Marketed,2024-05-22,02388499,Enalaprilat Injection USP,1,C09AA02,Enalapril,Solution,Intravenous,77700621,ENALAPRILAT INJECTION USP (enalaprilat 1.25 mg per 1 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9005100,enalaprilat 1.25 mg per 1 mL solution for injection vial,8001378,enalaprilat,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
87402,Marketed,2024-05-22,02388499,Enalaprilat Injection USP,1,C09AA02,Enalapril,Solution,Intravenous,77700622,ENALAPRILAT INJECTION USP (enalaprilat 2.5 mg per 2 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9002460,enalaprilat 2.5 mg per 2 mL solution for injection vial,8001378,enalaprilat,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
88543,Marketed,2022-01-07,02400650,Enalapril,1,C09AA02,Enalapril,Tablet,Oral,02400650,ENALAPRIL (enalapril maleate 2.5 mg oral tablet) SANIS HEALTH INC,Active,9000466,enalapril maleate 2.5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88544,Marketed,2022-01-07,02400669,Enalapril,1,C09AA02,Enalapril,Tablet,Oral,02400669,ENALAPRIL (enalapril maleate 5 mg oral tablet) SANIS HEALTH INC,Active,9000467,enalapril maleate 5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88545,Marketed,2022-01-07,02400677,Enalapril,1,C09AA02,Enalapril,Tablet,Oral,02400677,ENALAPRIL (enalapril maleate 10 mg oral tablet) SANIS HEALTH INC,Active,9000464,enalapril maleate 10 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88546,Marketed,2022-01-07,02400685,Enalapril,1,C09AA02,Enalapril,Tablet,Oral,02400685,ENALAPRIL (enalapril maleate 20 mg oral tablet) SANIS HEALTH INC,Active,9000465,enalapril maleate 20 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92748,Marketed,2018-10-04,02442957,Enalapril,1,C09AA02,Enalapril,Tablet,Oral,02442957,ENALAPRIL (enalapril maleate 2.5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000466,enalapril maleate 2.5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92749,Marketed,2018-10-04,02442965,Enalapril,1,C09AA02,Enalapril,Tablet,Oral,02442965,ENALAPRIL (enalapril maleate 5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000467,enalapril maleate 5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92750,Marketed,2018-10-04,02442973,Enalapril,1,C09AA02,Enalapril,Tablet,Oral,02442973,ENALAPRIL (enalapril maleate 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000464,enalapril maleate 10 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92751,Marketed,2018-10-04,02442981,Enalapril,1,C09AA02,Enalapril,Tablet,Oral,02442981,ENALAPRIL (enalapril maleate 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000465,enalapril maleate 20 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92998,Marketed,2019-03-20,02444771,Mar-Enalapril,1,C09AA02,Enalapril,Tablet,Oral,02444771,MAR-ENALAPRIL (enalapril maleate 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000464,enalapril maleate 10 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92999,Marketed,2019-03-20,02444798,Mar-Enalapril,1,C09AA02,Enalapril,Tablet,Oral,02444798,MAR-ENALAPRIL (enalapril maleate 20 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000465,enalapril maleate 20 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94669,Marketed,2019-03-20,02459450,Mar-Enalapril,1,C09AA02,Enalapril,Tablet,Oral,02459450,MAR-ENALAPRIL (enalapril maleate 2.5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000466,enalapril maleate 2.5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94670,Marketed,2019-03-20,02459469,Mar-Enalapril,1,C09AA02,Enalapril,Tablet,Oral,02459469,MAR-ENALAPRIL (enalapril maleate 5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000467,enalapril maleate 5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96497,Marketed,2019-02-25,02474786,JAMP Enalapril,1,C09AA02,Enalapril,Tablet,Oral,02474786,JAMP ENALAPRIL (enalapril maleate 2.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000466,enalapril maleate 2.5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96498,Marketed,2019-02-25,02474794,JAMP Enalapril,1,C09AA02,Enalapril,Tablet,Oral,02474794,JAMP ENALAPRIL (enalapril maleate 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000467,enalapril maleate 5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96499,Marketed,2019-02-25,02474808,JAMP Enalapril,1,C09AA02,Enalapril,Tablet,Oral,02474808,JAMP ENALAPRIL (enalapril maleate 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000464,enalapril maleate 10 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96500,Marketed,2019-02-25,02474816,JAMP Enalapril,1,C09AA02,Enalapril,Tablet,Oral,02474816,JAMP ENALAPRIL (enalapril maleate 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000465,enalapril maleate 20 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
10913,Marketed,2022-02-01,00657298,Vaseretic,2,C09BA02,Enalapril and diuretics,Tablet,Oral,00657298,VASERETIC (enalapril maleate 10 mg and hydrochlorothiazide 25 mg oral tablet) ORGANON CANADA INC.,Active,9004832,enalapril maleate 10 mg and hydrochlorothiazide 25 mg oral tablet,8000849,enalapril and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83816,Marketed,2017-12-28,02352923,Enalapril Maleate/HCTZ,2,C09BA02,Enalapril and diuretics,Tablet,Oral,02352923,ENALAPRIL MALEATE/HCTZ (enalapril maleate 5 mg and hydrochlorothiazide 12.5 mg oral tablet) AA PHARMA INC,Active,9004833,enalapril maleate 5 mg and hydrochlorothiazide 12.5 mg oral tablet,8000849,enalapril and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83817,Marketed,2017-12-28,02352931,Enalapril Maleate/HCTZ,2,C09BA02,Enalapril and diuretics,Tablet,Oral,02352931,ENALAPRIL MALEATE/HCTZ (enalapril maleate 10 mg and hydrochlorothiazide 25 mg oral tablet) AA PHARMA INC,Active,9004832,enalapril maleate 10 mg and hydrochlorothiazide 25 mg oral tablet,8000849,enalapril and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81890,Marketed,2013-10-09,02333279,Ixiaro,1,J07BA02,"Encephalitis, japanese, inactivated, whole virus",Suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
100233,Marketed,2021-07-05,02513099,Braftovi,1,L01EC03,Encorafenib,Capsule,Oral,02513099,BRAFTOVI (encorafenib 75 mg oral capsule) PFIZER CANADA ULC,Active,9014597,encorafenib 75 mg oral capsule,8002390,encorafenib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
101108,Marketed,2025-09-19,02521903,Padcev,1,L01FX13,Enfortumab vedotin,Powder for solution,Intravenous,02521903,PADCEV (enfortumab vedotin 20 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9014639,enfortumab vedotin 20 mg per vial powder for solution for injection,8002402,enfortumab vedotin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
101108,Marketed,2025-09-19,02521903,Padcev,1,L01FX13,Enfortumab vedotin,Powder for solution,Intravenous,02521903,PADCEV (enfortumab vedotin 20 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9014639,enfortumab vedotin 20 mg per vial powder for solution for injection,8002402,enfortumab vedotin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
101109,Marketed,2025-09-19,02521911,Padcev,1,L01FX13,Enfortumab vedotin,Powder for solution,Intravenous,02521911,PADCEV (enfortumab vedotin 30 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9014819,enfortumab vedotin 30 mg per vial powder for solution for injection,8002402,enfortumab vedotin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
101109,Marketed,2025-09-19,02521911,Padcev,1,L01FX13,Enfortumab vedotin,Powder for solution,Intravenous,02521911,PADCEV (enfortumab vedotin 30 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9014819,enfortumab vedotin 30 mg per vial powder for solution for injection,8002402,enfortumab vedotin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
102130,Marketed,2023-03-09,02532247,Elonox,1,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02532247,ELONOX (enoxaparin sodium 30 mg per 0.3 mL solution for injection syringe) FRESENIUS KABI CANADA LTD,Active,9012623,enoxaparin sodium 30 mg per 0.3 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
102131,Marketed,2023-03-09,02532255,Elonox,1,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02532255,ELONOX (enoxaparin sodium 40 mg per 0.4 mL solution for injection syringe) FRESENIUS KABI CANADA LTD,Active,9012624,enoxaparin sodium 40 mg per 0.4 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
102132,Marketed,2023-03-09,02532263,Elonox,1,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02532263,ELONOX (enoxaparin sodium 60 mg per 0.6 mL solution for injection syringe) FRESENIUS KABI CANADA LTD,Active,9012625,enoxaparin sodium 60 mg per 0.6 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
102133,Marketed,2023-03-09,02532271,Elonox,1,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02532271,ELONOX (enoxaparin sodium 80 mg per 0.8 mL solution for injection syringe) FRESENIUS KABI CANADA LTD,Active,9012626,enoxaparin sodium 80 mg per 0.8 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
102134,Marketed,2023-03-09,02532298,Elonox,1,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02532298,ELONOX (enoxaparin sodium 100 mg per 1 mL solution for injection syringe) FRESENIUS KABI CANADA LTD,Active,9012619,enoxaparin sodium 100 mg per 1 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
102135,Marketed,2023-03-09,02532301,Elonox HP,1,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02532301,ELONOX HP (enoxaparin sodium 120 mg per 0.8 mL solution for injection syringe) FRESENIUS KABI CANADA LTD,Active,9012621,enoxaparin sodium 120 mg per 0.8 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
102136,Marketed,2023-03-17,02532328,Elonox HP,1,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02532328,ELONOX HP (enoxaparin sodium 150 mg per 1 mL solution for injection syringe) FRESENIUS KABI CANADA LTD,Active,9012622,enoxaparin sodium 150 mg per 1 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
102870,Marketed,2024-10-15,02539977,Axberi,1,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02539977,AXBERI (enoxaparin sodium 30 mg per 0.3 mL solution for injection syringe) BAXTER CORPORATION,Active,9012623,enoxaparin sodium 30 mg per 0.3 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
102871,Marketed,2024-10-15,02539985,Axberi,1,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02539985,AXBERI (enoxaparin sodium 40 mg per 0.4 mL solution for injection syringe) BAXTER CORPORATION,Active,9012624,enoxaparin sodium 40 mg per 0.4 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
102873,Marketed,2024-10-01,02540002,Axberi,1,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02540002,AXBERI (enoxaparin sodium 60 mg per 0.6 mL solution for injection syringe) BAXTER CORPORATION,Active,9012625,enoxaparin sodium 60 mg per 0.6 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
102874,Marketed,2024-10-01,02540010,Axberi,1,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02540010,AXBERI (enoxaparin sodium 80 mg per 0.8 mL solution for injection syringe) BAXTER CORPORATION,Active,9012626,enoxaparin sodium 80 mg per 0.8 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
102875,Marketed,2024-10-01,02540029,Axberi HP,1,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02540029,AXBERI HP (enoxaparin sodium 120 mg per 0.8 mL solution for injection syringe) BAXTER CORPORATION,Active,9012621,enoxaparin sodium 120 mg per 0.8 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
102876,Marketed,2024-10-15,02540037,Axberi HP,1,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02540037,AXBERI HP (enoxaparin sodium 150 mg per 1 mL solution for injection syringe) BAXTER CORPORATION,Active,9012622,enoxaparin sodium 150 mg per 1 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
102877,Marketed,2024-10-15,02540045,Axberi,1,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02540045,AXBERI (enoxaparin sodium 100 mg per 1 mL solution for injection syringe) BAXTER CORPORATION,Active,9012619,enoxaparin sodium 100 mg per 1 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
14049,Marketed,2012-02-04,02012472,Lovenox,1,B01AB05,Enoxaparin,Solution,Subcutaneous,02012472,LOVENOX (enoxaparin sodium 30 mg per 0.3 mL solution for injection syringe) SANOFI-AVENTIS CANADA INC,Active,9012623,enoxaparin sodium 30 mg per 0.3 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
59932,Marketed,2007-02-22,02236564,Lovenox With Preservative 300 mg/3 mL,1,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02236564,LOVENOX WITH PRESERVATIVE 300MG/3ML (enoxaparin sodium 100 mg per mL solution for injection 3 mL vial) SANOFI-AVENTIS CANADA INC,Active,9012620,enoxaparin sodium 100 mg per mL solution for injection 3 mL vial,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
60174,Marketed,2012-02-04,02236883,Lovenox,1,B01AB05,Enoxaparin,Solution,Subcutaneous,02236883,LOVENOX (enoxaparin sodium 40 mg per 0.4 mL solution for injection syringe) SANOFI-AVENTIS CANADA INC,Active,9012624,enoxaparin sodium 40 mg per 0.4 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
66484,Marketed,2012-02-04,02242692,Lovenox HP,1,B01AB05,Enoxaparin,Solution,Subcutaneous,02242692,LOVENOX HP (enoxaparin sodium 120 mg per 0.8 mL solution for injection syringe) SANOFI-AVENTIS CANADA INC,Active,9012621,enoxaparin sodium 120 mg per 0.8 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
86422,Marketed,2012-11-13,02378426,Lovenox,1,B01AB05,Enoxaparin,Solution,Subcutaneous,02378426,LOVENOX (enoxaparin sodium 60 mg per 0.6 mL solution for injection syringe) SANOFI-AVENTIS CANADA INC,Active,9012625,enoxaparin sodium 60 mg per 0.6 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
86423,Marketed,2012-09-11,02378434,Lovenox,1,B01AB05,Enoxaparin,Solution,Subcutaneous,02378434,LOVENOX (enoxaparin sodium 80 mg per 0.8 mL solution for injection syringe) SANOFI-AVENTIS CANADA INC,Active,9012626,enoxaparin sodium 80 mg per 0.8 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
86424,Marketed,2012-09-21,02378442,Lovenox,1,B01AB05,Enoxaparin,Solution,Subcutaneous,02378442,LOVENOX (enoxaparin sodium 100 mg per 1 mL solution for injection syringe) SANOFI-AVENTIS CANADA INC,Active,9012619,enoxaparin sodium 100 mg per 1 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
86426,Marketed,2012-12-07,02378469,Lovenox HP,1,B01AB05,Enoxaparin,Solution,Subcutaneous,02378469,LOVENOX HP (enoxaparin sodium 150 mg per 1 mL solution for injection syringe) SANOFI-AVENTIS CANADA INC,Active,9012622,enoxaparin sodium 150 mg per 1 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
99582,Marketed,2026-05-28,02506459,Noromby,1,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02506459,NOROMBY (enoxaparin sodium 30 mg per 0.3 mL solution for injection syringe) JUNO PHARMA CANADA INC.,Active,9012623,enoxaparin sodium 30 mg per 0.3 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
99583,Marketed,2026-05-28,02506467,Noromby,1,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02506467,NOROMBY (enoxaparin sodium 40 mg per 0.4 mL solution for injection syringe) JUNO PHARMA CANADA INC.,Active,9012624,enoxaparin sodium 40 mg per 0.4 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
99584,Marketed,2026-05-28,02506475,Noromby,1,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02506475,NOROMBY (enoxaparin sodium 60 mg per 0.6 mL solution for injection syringe) JUNO PHARMA CANADA INC.,Active,9012625,enoxaparin sodium 60 mg per 0.6 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
99585,Marketed,2026-05-28,02506483,Noromby,1,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02506483,NOROMBY (enoxaparin sodium 80 mg per 0.8 mL solution for injection syringe) JUNO PHARMA CANADA INC.,Active,9012626,enoxaparin sodium 80 mg per 0.8 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
99586,Marketed,2026-05-28,02506491,Noromby,1,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02506491,NOROMBY (enoxaparin sodium 100 mg per 1 mL solution for injection syringe) JUNO PHARMA CANADA INC.,Active,9012619,enoxaparin sodium 100 mg per 1 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
99587,Marketed,2026-05-28,02506505,Noromby HP,1,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02506505,NOROMBY HP (enoxaparin sodium 120 mg per 0.8 mL solution for injection syringe) JUNO PHARMA CANADA INC.,Active,9012621,enoxaparin sodium 120 mg per 0.8 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
99588,Marketed,2026-05-28,02506513,Noromby HP,1,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02506513,NOROMBY HP (enoxaparin sodium 150 mg per 1 mL solution for injection syringe) JUNO PHARMA CANADA INC.,Active,9012622,enoxaparin sodium 150 mg per 1 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
99688,Marketed,2021-06-09,02507501,Inclunox,1,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02507501,INCLUNOX (enoxaparin sodium 30 mg per 0.3 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9012623,enoxaparin sodium 30 mg per 0.3 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
99689,Marketed,2021-05-04,02507528,Inclunox,1,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02507528,INCLUNOX (enoxaparin sodium 40 mg per 0.4 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9012624,enoxaparin sodium 40 mg per 0.4 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
99690,Marketed,2021-05-04,02507536,Inclunox,1,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02507536,INCLUNOX (enoxaparin sodium 60 mg per 0.6 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9012625,enoxaparin sodium 60 mg per 0.6 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
99691,Marketed,2021-05-04,02507544,Inclunox,1,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02507544,INCLUNOX (enoxaparin sodium 80 mg per 0.8 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9012626,enoxaparin sodium 80 mg per 0.8 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
99692,Marketed,2021-05-04,02507552,Inclunox,1,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02507552,INCLUNOX (enoxaparin sodium 100 mg per 1 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9012619,enoxaparin sodium 100 mg per 1 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
99693,Marketed,2021-05-04,02507560,Inclunox HP,1,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02507560,INCLUNOX HP (enoxaparin sodium 120 mg per 0.8 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9012621,enoxaparin sodium 120 mg per 0.8 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
99694,Marketed,2021-05-04,02507579,Inclunox HP,1,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02507579,INCLUNOX HP (enoxaparin sodium 150 mg per 1 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9012622,enoxaparin sodium 150 mg per 1 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
99839,Marketed,2021-04-09,02509075,Redesca,1,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02509075,"REDESCA (enoxaparin sodium 30 mg per 0.3 mL solution for injection syringe) SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD.",Active,9012623,enoxaparin sodium 30 mg per 0.3 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
99840,Marketed,2021-04-09,02509083,Redesca,1,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02509083,"REDESCA (enoxaparin sodium 40 mg per 0.4 mL solution for injection syringe) SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD.",Active,9012624,enoxaparin sodium 40 mg per 0.4 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
99841,Marketed,2021-04-09,02509091,Redesca,1,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02509091,"REDESCA (enoxaparin sodium 60 mg per 0.6 mL solution for injection syringe) SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD.",Active,9012625,enoxaparin sodium 60 mg per 0.6 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
99842,Marketed,2021-04-09,02509105,Redesca,1,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02509105,"REDESCA (enoxaparin sodium 80 mg per 0.8 mL solution for injection syringe) SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD.",Active,9012626,enoxaparin sodium 80 mg per 0.8 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
99843,Marketed,2021-04-09,02509113,Redesca,1,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02509113,"REDESCA (enoxaparin sodium 100 mg per 1 mL solution for injection syringe) SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD.",Active,9012619,enoxaparin sodium 100 mg per 1 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
99844,Marketed,2021-04-09,02509121,Redesca,1,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02509121,"REDESCA (enoxaparin sodium 300 mg per 3 mL solution for injection vial) SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD.",Active,9014487,enoxaparin sodium 300 mg per 3 mL solution for injection vial,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
99845,Marketed,2021-04-09,02509148,Redesca HP,1,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02509148,"REDESCA HP (enoxaparin sodium 120 mg per 0.8 mL solution for injection syringe) SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD.",Active,9012621,enoxaparin sodium 120 mg per 0.8 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
99846,Marketed,2021-04-09,02509156,Redesca HP,1,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02509156,"REDESCA HP (enoxaparin sodium 150 mg per 1 mL solution for injection syringe) SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD.",Active,9012622,enoxaparin sodium 150 mg per 1 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
102475,Marketed,2024-02-21,02535939,Mint-Entacapone,1,N04BX02,Entacapone,Tablet,Oral,02535939,MINT-ENTACAPONE (entacapone 200 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9003617,entacapone 200 mg oral tablet,8001458,entacapone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86097,Marketed,2012-03-29,02375559,Teva-Entacapone,1,N04BX02,Entacapone,Tablet,Oral,02375559,TEVA-ENTACAPONE (entacapone 200 mg oral tablet) TEVA CANADA LIMITED,Active,9003617,entacapone 200 mg oral tablet,8001458,entacapone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86585,Marketed,2012-03-30,02380005,Sandoz Entacapone,1,N04BX02,Entacapone,Tablet,Oral,02380005,SANDOZ ENTACAPONE (entacapone 200 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003617,entacapone 200 mg oral tablet,8001458,entacapone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101620,Marketed,2022-10-20,02527154,Entecavir,1,J05AF10,Entecavir,Tablet,Oral,02527154,ENTECAVIR (entecavir 0.5 mg oral tablet) SANIS HEALTH INC,Active,9004212,entecavir 0.5 mg oral tablet,8001199,entecavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
76788,Marketed,2006-09-12,02282224,Baraclude,1,J05AF10,Entecavir,Tablet,Oral,02282224,BARACLUDE (entecavir 0.5 mg oral tablet) BRISTOL-MYERS SQUIBB CANADA,Active,9004212,entecavir 0.5 mg oral tablet,8001199,entecavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
88196,Marketed,2013-01-18,02396955,Apo-Entecavir,1,J05AF10,Entecavir,Tablet,Oral,02396955,APO-ENTECAVIR (entecavir 0.5 mg oral tablet) APOTEX INC,Active,9004212,entecavir 0.5 mg oral tablet,8001199,entecavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
91502,Marketed,2014-09-09,02430576,PMS-Entecavir,1,J05AF10,Entecavir,Tablet,Oral,02430576,PMS-ENTECAVIR (entecavir 0.5 mg oral tablet) PHARMASCIENCE INC,Active,9004212,entecavir 0.5 mg oral tablet,8001199,entecavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
91503,Marketed,2018-09-02,02430584,PMS-Entecavir,1,J05AF10,Entecavir,Tablet,Oral,02430584,PMS-ENTECAVIR (entecavir 1 mg oral tablet) PHARMASCIENCE INC,Active,9005584,entecavir 1 mg oral tablet,8001199,entecavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
93451,Marketed,2015-12-01,02448777,Auro-Entecavir,1,J05AF10,Entecavir,Tablet,Oral,02448777,AURO-ENTECAVIR (entecavir (entecavir monohydrate) 0.5 mg oral tablet) AURO PHARMA INC,Active,9004212,entecavir 0.5 mg oral tablet,8001199,entecavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
94033,Marketed,2020-12-01,02453797,Entecavir Tablets,1,J05AF10,Entecavir,Tablet,Oral,02453797,ENTECAVIR TABLETS (entecavir (entecavir monohydrate) 0.5 mg oral tablet) STRIDES PHARMA CANADA INC,Active,9004212,entecavir 0.5 mg oral tablet,8001199,entecavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
95562,Marketed,2019-02-21,02467232,JAMP Entecavir,1,J05AF10,Entecavir,Tablet,Oral,02467232,JAMP ENTECAVIR (entecavir (entecavir monohydrate) 0.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004212,entecavir 0.5 mg oral tablet,8001199,entecavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
97047,Marketed,2020-03-11,02479907,Accel-Entecavir,1,J05AF10,Entecavir,Tablet,Oral,02479907,ACCEL-ENTECAVIR (entecavir (entecavir monohydrate) 0.5 mg oral tablet) ACCEL PHARMA INC,Active,9004212,entecavir 0.5 mg oral tablet,8001199,entecavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
97614,Marketed,2020-01-06,02485907,Mint-Entecavir,1,J05AF10,Entecavir,Tablet,Oral,02485907,MINT-ENTECAVIR (entecavir (entecavir monohydrate) 0.5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9004212,entecavir 0.5 mg oral tablet,8001199,entecavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98496,Marketed,2020-03-10,02495007,Rozlytrek,1,L01EX14,Entrectinib,Capsule,Oral,02495007,ROZLYTREK (entrectinib 100 mg oral capsule) HOFFMANN-LA ROCHE LIMITED,Active,9014295,entrectinib 100 mg oral capsule,8002325,entrectinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
98497,Marketed,2020-03-04,02495015,Rozlytrek,1,L01EX14,Entrectinib,Capsule,Oral,02495015,ROZLYTREK (entrectinib 200 mg oral capsule) HOFFMANN-LA ROCHE LIMITED,Active,9014296,entrectinib 200 mg oral capsule,8002325,entrectinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
100461,Marketed,2026-02-20,02515229,JAMP Enzalutamide,1,L02BB04,Enzalutamide,Capsule,Oral,02515229,JAMP ENZALUTAMIDE (enzalutamide 40 mg oral capsule) JAMP PHARMA CORPORATION,Active,9005262,enzalutamide 40 mg oral capsule,8001644,enzalutamide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
106167,Marketed,2026-03-30,02558424,Reddy-Enzalutamide,1,L02BB04,Enzalutamide,Capsule,Oral,02558424,REDDY-ENZALUTAMIDE (enzalutamide 40 mg oral capsule) DR REDDY'S LABORATORIES LTD,Active,9005262,enzalutamide 40 mg oral capsule,8001644,enzalutamide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
106553,Marketed,2026-03-30,02562677,Apo-Enzalutamide,1,L02BB04,Enzalutamide,Capsule,Oral,02562677,APO-ENZALUTAMIDE (enzalutamide 40 mg oral capsule) APOTEX INC,Active,9005262,enzalutamide 40 mg oral capsule,8001644,enzalutamide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
89203,Marketed,2013-06-07,02407329,Xtandi,1,L02BB04,Enzalutamide,Capsule,Oral,02407329,XTANDI (enzalutamide 40 mg oral capsule) ASTELLAS PHARMA CANADA INC,Active,9005262,enzalutamide 40 mg oral capsule,8001644,enzalutamide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
98471,Marketed,2026-03-30,02494736,Auro-Enzalutamide,1,L02BB04,Enzalutamide,Capsule,Oral,02494736,AURO-ENZALUTAMIDE (enzalutamide 40 mg oral capsule) AURO PHARMA INC,Active,9005262,enzalutamide 40 mg oral capsule,8001644,enzalutamide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
103087,Marketed,2023-12-18,02542293,Epkinly,1,L01FX27,Epcoritamab,Solution,Subcutaneous,02542293,EPKINLY (epcoritamab 4 mg per 0.8 mL solution for injection vial) ABBVIE CORPORATION,Active,9015004,epcoritamab 4 mg per 0.8 mL solution for injection vial,8002492,epcoritamab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
103087,Marketed,2023-12-18,02542293,Epkinly,1,L01FX27,Epcoritamab,Solution,Subcutaneous,02542293,EPKINLY (epcoritamab 4 mg per 0.8 mL solution for injection vial) ABBVIE CORPORATION,Active,9015004,epcoritamab 4 mg per 0.8 mL solution for injection vial,8002492,epcoritamab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
103088,Marketed,2023-12-18,02542307,Epkinly,1,L01FX27,Epcoritamab,Solution,Subcutaneous,02542307,EPKINLY (epcoritamab 48 mg per 0.8 mL solution for injection vial) ABBVIE CORPORATION,Active,9015003,epcoritamab 48 mg per 0.8 mL solution for injection vial,8002492,epcoritamab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
103088,Marketed,2023-12-18,02542307,Epkinly,1,L01FX27,Epcoritamab,Solution,Subcutaneous,02542307,EPKINLY (epcoritamab 48 mg per 0.8 mL solution for injection vial) ABBVIE CORPORATION,Active,9015003,epcoritamab 48 mg per 0.8 mL solution for injection vial,8002492,epcoritamab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
11096,Marketed,2005-08-12,00876534,ePHEDrine Sulfate Injection USP,1,C01CA26,Ephedrine,Solution,"Subcutaneous,Intramuscular,Intravenous",00876534,EPHEDRINE SULFATE INJECTION USP (ephedrine sulfate 50 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9012368,ephedrine sulfate 50 mg per 1 mL solution for injection ampoule,8001078,ephedrine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
101036,Marketed,2022-05-18,02521148,Epinephrine Injection,1,C01CA24,Epinephrine,Solution,Intravenous,02521148,EPINEPHRINE INJECTION (epinephrine (epinephrine bitartrate) 1 mg per 10 mL solution for injection syringe) LABORATOIRE AGUETTANT,Active,9014720,epinephrine (epinephrine bitartrate) 1 mg per 10 mL solution for injection syringe,8000003,epinephrine,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Ethical
1508,Marketed,2022-10-06,00155365,Adrenalin Topical Solution,1,B02BC09,Epinephrine,Solution,Topical,00155365,ADRENALIN TOPICAL SOLUTION (epinephrine (epinephrine hydrochloride) 1 mg per mL cutaneous solution) SEARCHLIGHT PHARMA INC,Active,9014635,epinephrine (epinephrine hydrochloride) 1 mg per mL cutaneous solution,8000003,epinephrine,448598008,Cutaneous,739006009,Solution,,,,,,Prescription
3883,Marketed,2026-05-20,00509558,Epipen,1,C01CA24,Epinephrine,Solution,Intramuscular,00509558,EPIPEN (epinephrine 0.3 mg per 0.3 mL solution for injection syringe) VIATRIS SPECIALTY LLC,Active,9001299,epinephrine 0.3 mg per 0.3 mL solution for injection syringe,8000003,epinephrine,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Ethical
5970,Marketed,2026-05-20,00578657,Epipen JR,1,C01CA24,Epinephrine,Solution,Intramuscular,00578657,EPIPEN JR (epinephrine 0.15 mg per 0.3 mL solution for injection syringe) VIATRIS SPECIALTY LLC,Active,9001298,epinephrine 0.15 mg per 0.3 mL solution for injection syringe,8000003,epinephrine,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Ethical
8352,Marketed,2018-03-16,00710814,Epinephrine Injection USP,1,C01CA24,Epinephrine,Solution,"Intracardiac,Intravenous",00710814,EPINEPHRINE INJECTION USP (epinephrine 1 mg per 10 mL solution for injection syringe) PFIZER CANADA ULC,Active,9000272,epinephrine 1 mg per 10 mL solution for injection syringe,8000003,epinephrine,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Ethical
9164,Marketed,2018-03-16,00721891,Epinephrine Injection USP,1,C01CA24,Epinephrine,Solution,"Intramuscular,Subcutaneous,Intratracheal,Intravenous,Intracardiac",00721891,EPINEPHRINE INJECTION USP (epinephrine 1 mg per 1 mL solution for injection ampoule) PFIZER CANADA ULC,Active,9000294,epinephrine 1 mg per 1 mL solution for injection ampoule,8000003,epinephrine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
92016,Marketed,2023-06-27,02435810,Epinephrine Injection USP,1,C01CA24,Epinephrine,Solution,"Intramuscular,Subcutaneous,Intratracheal,Intravenous",02435810,EPINEPHRINE INJECTION USP (epinephrine 1 mg per 1 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9000294,epinephrine 1 mg per 1 mL solution for injection ampoule,8000003,epinephrine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
940,Marketed,2023-05-24,00155357,Adrenalin,1,C01CA24,Epinephrine,Solution,"Subcutaneous,Intravenous,Ophthalmic,Intracardiac,Intramuscular,Intraspinal",77700211,ADRENALIN (epinephrine (epinephrine hydrochloride) 1 mg per 1 mL solution for injection ampoule) SEARCHLIGHT PHARMA INC,Active,9000003,epinephrine (epinephrine hydrochloride) 1 mg per 1 mL solution for injection ampoule,8000003,epinephrine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
940,Marketed,2023-05-24,00155357,Adrenalin,1,C01CA24,Epinephrine,Solution,"Subcutaneous,Intravenous,Ophthalmic,Intracardiac,Intramuscular,Intraspinal",77700212,ADRENALIN (epinephrine (epinephrine hydrochloride) 30 mg per 30 mL solution for injection vial) SEARCHLIGHT PHARMA INC,Active,9015026,epinephrine (epinephrine hydrochloride) 30 mg per 30 mL solution for injection vial,8000003,epinephrine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
80958,Marketed,2026-04-24,02324091,Epirubicin Hydrochloride Injection,1,L01DB03,Epirubicin,Solution,Intravenous,77700744,EPIRUBICIN HYDROCHLORIDE INJECTION (epirubicin hydrochloride 10 mg per 5 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013092,epirubicin hydrochloride 10 mg per 5 mL solution for injection vial,8001764,epirubicin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
80958,Marketed,2026-04-24,02324091,Epirubicin Hydrochloride Injection,1,L01DB03,Epirubicin,Solution,Intravenous,77700745,EPIRUBICIN HYDROCHLORIDE INJECTION (epirubicin hydrochloride 150 mg per 75 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013094,epirubicin hydrochloride 150 mg per 75 mL solution for injection vial,8001764,epirubicin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
80958,Marketed,2026-04-24,02324091,Epirubicin Hydrochloride Injection,1,L01DB03,Epirubicin,Solution,Intravenous,77700746,EPIRUBICIN HYDROCHLORIDE INJECTION (epirubicin hydrochloride 50 mg per 25 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013097,epirubicin hydrochloride 50 mg per 25 mL solution for injection vial,8001764,epirubicin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
80958,Marketed,2026-04-24,02324091,Epirubicin Hydrochloride Injection,1,L01DB03,Epirubicin,Solution,Intravenous,77700747,EPIRUBICIN HYDROCHLORIDE INJECTION (epirubicin hydrochloride 2 mg per mL solution for injection 100 mL vial) TEVA CANADA LIMITED,Active,9013095,epirubicin hydrochloride 2 mg per mL solution for injection 100 mL vial,8001764,epirubicin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
80958,Marketed,2026-04-24,02324091,Epirubicin Hydrochloride Injection,1,L01DB03,Epirubicin,Solution,Intravenous,77700748,EPIRUBICIN HYDROCHLORIDE INJECTION (epirubicin hydrochloride 20 mg per 10 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013096,epirubicin hydrochloride 20 mg per 10 mL solution for injection vial,8001764,epirubicin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
103185,Marketed,2024-06-18,02543389,JAMP Eplerenone,1,C03DA04,Eplerenone,Tablet,Oral,02543389,JAMP EPLERENONE (eplerenone 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9009287,eplerenone 25 mg oral tablet,8000973,eplerenone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103186,Marketed,2024-06-18,02543397,JAMP Eplerenone,1,C03DA04,Eplerenone,Tablet,Oral,02543397,JAMP EPLERENONE (eplerenone 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9009288,eplerenone 50 mg oral tablet,8000973,eplerenone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80855,Marketed,2023-07-07,02323052,Inspra,1,C03DA04,Eplerenone,Tablet,Oral,02323052,INSPRA (eplerenone 25 mg oral tablet) BGP PHARMA ULC,Active,9009287,eplerenone 25 mg oral tablet,8000973,eplerenone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80856,Marketed,2023-07-07,02323060,Inspra,1,C03DA04,Eplerenone,Tablet,Oral,02323060,INSPRA (eplerenone 50 mg oral tablet) BGP PHARMA ULC,Active,9009288,eplerenone 50 mg oral tablet,8000973,eplerenone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96055,Marketed,2018-04-09,02471442,Mint-Eplerenone,1,C03DA04,Eplerenone,Tablet,Oral,02471442,MINT-EPLERENONE (eplerenone 25 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9009287,eplerenone 25 mg oral tablet,8000973,eplerenone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96056,Marketed,2018-04-09,02471450,Mint-Eplerenone,1,C03DA04,Eplerenone,Tablet,Oral,02471450,MINT-EPLERENONE (eplerenone 50 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9009288,eplerenone 50 mg oral tablet,8000973,eplerenone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103775,Marketed,2024-10-07,02548909,Wainua,1,N07XX21,Eplontersen,Solution,Subcutaneous,02548909,WAINUA (eplontersen (eplontersen sodium) 45 mg per 0.8 mL solution for injection syringe) ASTRAZENECA CANADA INC,Active,9015110,eplontersen (eplontersen sodium) 45 mg per 0.8 mL solution for injection syringe,8002517,eplontersen,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
50121,Marketed,2003-02-25,02230845,Flolan,1,B01AC09,Epoprostenol,Powder for solution,Intravenous,02230845,FLOLAN (epoprostenol (epoprostenol sodium) 0.5 mg per vial powder for solution for injection with diluent solution) GLAXOSMITHKLINE INC,Active,9013283,epoprostenol (epoprostenol sodium) 0.5 mg per vial powder for solution for injection with diluent solution,8001766,epoprostenol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
50122,Marketed,2003-02-19,02230848,Flolan,1,B01AC09,Epoprostenol,Powder for solution,Intravenous,02230848,FLOLAN (epoprostenol (epoprostenol sodium) 1.5 mg per vial powder for solution for injection with diluent solution) GLAXOSMITHKLINE INC,Active,9013284,epoprostenol (epoprostenol sodium) 1.5 mg per vial powder for solution for injection with diluent solution,8001766,epoprostenol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
88240,Marketed,2020-11-05,02397447,Caripul,1,B01AC09,Epoprostenol,Powder for solution,Intravenous,02397447,CARIPUL (epoprostenol (epoprostenol sodium) 0.5 mg per vial powder for solution for injection) JANSSEN INC,Active,9003122,epoprostenol (epoprostenol sodium) 0.5 mg per vial powder for solution for injection,8001766,epoprostenol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
88241,Marketed,2020-05-26,02397455,Caripul,1,B01AC09,Epoprostenol,Powder for solution,Intravenous,02397455,CARIPUL (epoprostenol (epoprostenol sodium) 1.5 mg per vial powder for solution for injection) JANSSEN INC,Active,9003123,epoprostenol (epoprostenol sodium) 1.5 mg per vial powder for solution for injection,8001766,epoprostenol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
102949,Marketed,2024-05-16,02540819,Eptifibatide Injection,1,B01AC16,Eptifibatide,Solution,Intravenous,02540819,EPTIFIBATIDE INJECTION (eptifibatide 75 mg per 100 mL solution for injection vial) JUNO PHARMACEUTICALS CORP.,Active,9013109,eptifibatide 75 mg per 100 mL solution for injection vial,8001767,eptifibatide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
102950,Marketed,2024-05-16,02540827,Eptifibatide Injection,1,B01AC16,Eptifibatide,Solution,Intravenous,02540827,EPTIFIBATIDE INJECTION (eptifibatide 20 mg per 10 mL solution for injection vial) JUNO PHARMACEUTICALS CORP.,Active,9013285,eptifibatide 20 mg per 10 mL solution for injection vial,8001767,eptifibatide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
100002,Marketed,2022-08-17,02510839,Vyepti,1,N02CD05,Eptinezumab,Solution,Intravenous,02510839,VYEPTI (eptinezumab 100 mg per 1 mL solution for injection vial) LUNDBECK CANADA INC,Active,9014760,eptinezumab 100 mg per 1 mL solution for injection vial,8002431,eptinezumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
100002,Marketed,2022-08-17,02510839,Vyepti,1,N02CD05,Eptinezumab,Solution,Intravenous,02510839,VYEPTI (eptinezumab 100 mg per 1 mL solution for injection vial) LUNDBECK CANADA INC,Active,9014760,eptinezumab 100 mg per 1 mL solution for injection vial,8002431,eptinezumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
103084,Marketed,2024-07-01,02542269,Vyepti,1,N02CD05,Eptinezumab,Solution,Intravenous,02542269,VYEPTI (eptinezumab 300 mg per 3 mL solution for injection vial) LUNDBECK CANADA INC,Active,9015062,eptinezumab 300 mg per 3 mL solution for injection vial,8002431,eptinezumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
103084,Marketed,2024-07-01,02542269,Vyepti,1,N02CD05,Eptinezumab,Solution,Intravenous,02542269,VYEPTI (eptinezumab 300 mg per 3 mL solution for injection vial) LUNDBECK CANADA INC,Active,9015062,eptinezumab 300 mg per 3 mL solution for injection vial,8002431,eptinezumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
98320,Marketed,2019-12-09,02493217,Balversa,1,L01EN01,Erdafitinib,Tablet,Oral,02493217,BALVERSA (erdafitinib 3 mg oral tablet) JANSSEN INC,Active,9014204,erdafitinib 3 mg oral tablet,8002307,erdafitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98321,Marketed,2019-12-09,02493225,Balversa,1,L01EN01,Erdafitinib,Tablet,Oral,02493225,BALVERSA (erdafitinib 4 mg oral tablet) JANSSEN INC,Active,9014205,erdafitinib 4 mg oral tablet,8002307,erdafitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98322,Marketed,2019-12-09,02493233,Balversa,1,L01EN01,Erdafitinib,Tablet,Oral,02493233,BALVERSA (erdafitinib 5 mg oral tablet) JANSSEN INC,Active,9014206,erdafitinib 5 mg oral tablet,8002307,erdafitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
97029,Marketed,2018-12-04,02479613,Aimovig,1,N02CD01,Erenumab,Solution,Subcutaneous,02479613,AIMOVIG (erenumab 70 mg per 1 mL solution for injection syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9013683,erenumab 70 mg per 1 mL solution for injection syringe,8002191,erenumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
97029,Marketed,2018-12-04,02479613,Aimovig,1,N02CD01,Erenumab,Solution,Subcutaneous,02479613,AIMOVIG (erenumab 70 mg per 1 mL solution for injection syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9013683,erenumab 70 mg per 1 mL solution for injection syringe,8002191,erenumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
97746,Marketed,2019-05-22,02487306,Aimovig,1,N02CD01,Erenumab,Solution,Subcutaneous,02487306,AIMOVIG (erenumab 140 mg per 1 mL solution for injection syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014025,erenumab 140 mg per 1 mL solution for injection syringe,8002191,erenumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
97746,Marketed,2019-05-22,02487306,Aimovig,1,N02CD01,Erenumab,Solution,Subcutaneous,02487306,AIMOVIG (erenumab 140 mg per 1 mL solution for injection syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014025,erenumab 140 mg per 1 mL solution for injection syringe,8002191,erenumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
92564,Marketed,2023-06-29,02441241,Ergonovine Maleate Injection USP,1,G02AB03,Ergometrine,Solution,"Intramuscular,Intravenous",02441241,ERGONOVINE MALEATE INJECTION USP (ergonovine maleate 0.25 mg per 1 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9013111,ergonovine maleate 0.25 mg per 1 mL solution for injection ampoule,8001769,ergonovine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),1.0,,,Prescription
102778,Marketed,2024-01-08,02539136,Nat-eriBULin,1,L01XX41,Eribulin,Solution,Intravenous,02539136,NAT-ERIBULIN (eribulin mesylate 1 mg per 2 mL solution for injection vial) NATCO PHARMA (CANADA) INC,Active,9013112,eribulin mesylate 1 mg per 2 mL solution for injection vial,8001645,eribulin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
103467,Marketed,2025-07-11,02545950,eriBULin Mesylate Injection,1,L01XX41,Eribulin,Solution,Intravenous,02545950,ERIBULIN MESYLATE INJECTION (eribulin mesylate 1 mg per 2 mL solution for injection vial) DR REDDY'S LABORATORIES LTD,Active,9013112,eribulin mesylate 1 mg per 2 mL solution for injection vial,8001645,eribulin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
86314,Marketed,2012-03-19,02377438,Halaven,1,L01XX41,Eribulin,Solution,Intravenous,02377438,HALAVEN (eribulin mesylate 1 mg per 2 mL solution for injection vial) EISAI LIMITED,Active,9013112,eribulin mesylate 1 mg per 2 mL solution for injection vial,8001645,eribulin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
86351,Marketed,2014-12-08,02377691,Teva-Erlotinib,1,L01EB02,Erlotinib,Tablet,Oral,02377691,TEVA-ERLOTINIB (erlotinib (erlotinib hydrochloride) 25 mg oral tablet) TEVA CANADA LIMITED,Active,9004246,erlotinib (erlotinib hydrochloride) 25 mg oral tablet,8001646,erlotinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
86352,Marketed,2014-12-08,02377705,Teva-Erlotinib,1,L01EB02,Erlotinib,Tablet,Oral,02377705,TEVA-ERLOTINIB (erlotinib (erlotinib hydrochloride) 100 mg oral tablet) TEVA CANADA LIMITED,Active,9004067,erlotinib (erlotinib hydrochloride) 100 mg oral tablet,8001646,erlotinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
86353,Marketed,2014-12-08,02377713,Teva-Erlotinib,1,L01EB02,Erlotinib,Tablet,Oral,02377713,TEVA-ERLOTINIB (erlotinib (erlotinib hydrochloride) 150 mg oral tablet) TEVA CANADA LIMITED,Active,9004068,erlotinib (erlotinib hydrochloride) 150 mg oral tablet,8001646,erlotinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
94097,Marketed,2016-07-28,02454394,PMS-Erlotinib,1,L01EB02,Erlotinib,Tablet,Oral,02454394,PMS-ERLOTINIB (erlotinib (erlotinib hydrochloride) 150 mg oral tablet) PHARMASCIENCE INC,Active,9004068,erlotinib (erlotinib hydrochloride) 150 mg oral tablet,8001646,erlotinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
94960,Marketed,2017-08-22,02461862,Apo-Erlotinib,1,L01EB02,Erlotinib,Tablet,Oral,02461862,APO-ERLOTINIB (erlotinib (erlotinib hydrochloride) 25 mg oral tablet) APOTEX INC,Active,9004246,erlotinib (erlotinib hydrochloride) 25 mg oral tablet,8001646,erlotinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
94961,Marketed,2017-08-22,02461870,Apo-Erlotinib,1,L01EB02,Erlotinib,Tablet,Oral,02461870,APO-ERLOTINIB (erlotinib (erlotinib hydrochloride) 100 mg oral tablet) APOTEX INC,Active,9004067,erlotinib (erlotinib hydrochloride) 100 mg oral tablet,8001646,erlotinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
94962,Marketed,2017-08-22,02461889,Apo-Erlotinib,1,L01EB02,Erlotinib,Tablet,Oral,02461889,APO-ERLOTINIB (erlotinib (erlotinib hydrochloride) 150 mg oral tablet) APOTEX INC,Active,9004068,erlotinib (erlotinib hydrochloride) 150 mg oral tablet,8001646,erlotinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100038,Marketed,2021-01-27,02511150,Ertapenem For Injection,1,J01DH03,Ertapenem,Powder for solution,"Intramuscular,Intravenous",02511150,ERTAPENEM FOR INJECTION (ertapenem (ertapenem sodium) 1 g per vial powder for solution for injection) DR REDDY'S LABORATORIES LTD,Active,9003822,ertapenem (ertapenem sodium) 1 g per vial powder for solution for injection,8001200,ertapenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
102591,Marketed,2024-07-23,02537176,Ertapenem For Injection,1,J01DH03,Ertapenem,Powder for solution,"Intramuscular,Intravenous",02537176,ERTAPENEM FOR INJECTION (ertapenem (ertapenem sodium) 1 g per vial powder for solution for injection) EUGIA PHARMA INC.,Active,9003822,ertapenem (ertapenem sodium) 1 g per vial powder for solution for injection,8001200,ertapenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
71683,Marketed,2006-07-06,02247437,Invanz,1,J01DH03,Ertapenem,Powder for solution,"Intramuscular,Intravenous",02247437,INVANZ (ertapenem (ertapenem sodium) 1 g per vial powder for solution for injection) MERCK CANADA INC,Active,9003822,ertapenem (ertapenem sodium) 1 g per vial powder for solution for injection,8001200,ertapenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
98083,Marketed,2021-01-05,02490773,Ertapenem For Injection,1,J01DH03,Ertapenem,Powder for solution,"Intramuscular,Intravenous",02490773,ERTAPENEM FOR INJECTION (ertapenem (ertapenem sodium) 1 g per vial powder for solution for injection) JUNO PHARMACEUTICALS CORP.,Active,9003822,ertapenem (ertapenem sodium) 1 g per vial powder for solution for injection,8001200,ertapenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
98213,Marketed,2021-10-08,02492148,Ertapenem For Injection,1,J01DH03,Ertapenem,Powder for solution,"Intramuscular,Intravenous",02492148,ERTAPENEM FOR INJECTION (ertapenem (ertapenem sodium) 1 g per vial powder for solution for injection) AURO PHARMA INC,Active,9003822,ertapenem (ertapenem sodium) 1 g per vial powder for solution for injection,8001200,ertapenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
98600,Marketed,2021-06-07,02496127,Ertapenem For Injection,1,J01DH03,Ertapenem,Powder for solution,"Intramuscular,Intravenous",02496127,ERTAPENEM FOR INJECTION (ertapenem (ertapenem sodium) 1 g per vial powder for solution for injection) FRESENIUS KABI CANADA LTD,Active,9003822,ertapenem (ertapenem sodium) 1 g per vial powder for solution for injection,8001200,ertapenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
11423,Marketed,2015-06-09,01912755,PDP-Erythromycin,1,S01AA17,Erythromycin,Ointment,Ophthalmic,01912755,PDP-ERYTHROMYCIN (erythromycin 5 mg per g ophthalmic ointment) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9000381,erythromycin 5 mg per g ophthalmic ointment,8000037,erythromycin,54485002,Ophthalmic,385123004,Ophthalmic ointment,,,,,,Prescription
31467,Marketed,2023-07-20,02141574,Erythromycin,1,S01AA17,Erythromycin,Ointment,Ophthalmic,02141574,ERYTHROMYCIN (erythromycin 5 mg per g ophthalmic ointment) PHARMA STULLN INC.,Active,9000381,erythromycin 5 mg per g ophthalmic ointment,8000037,erythromycin,54485002,Ophthalmic,385123004,Ophthalmic ointment,,,,,,Prescription
81202,Marketed,2022-04-07,02326663,Erythromycin Ophthalmic Ointment USP,1,S01AA17,Erythromycin,Ointment,Ophthalmic,02326663,ERYTHROMYCIN OPHTHALMIC OINTMENT USP (erythromycin 5 mg per g ophthalmic ointment) STERI-MED PHARMA INC.,Active,9000381,erythromycin 5 mg per g ophthalmic ointment,8000037,erythromycin,54485002,Ophthalmic,385123004,Ophthalmic ointment,,,,,,Prescription
9396,Marketed,2009-05-04,00682268,Erythrocin IV,1,J01FA01,Erythromycin,Powder for solution,Intravenous,00682268,ERYTHROCIN I.V. (erythromycin (erythromycin lactobionate) 500 mg per vial powder for solution for injection) AMDIPHARM LIMITED,Active,9000296,erythromycin (erythromycin lactobionate) 500 mg per vial powder for solution for injection,8000037,erythromycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
9397,Marketed,2009-05-12,00682276,Erythrocin IV,1,J01FA01,Erythromycin,Powder for solution,Intravenous,00682276,ERYTHROCIN I.V. (erythromycin (erythromycin lactobionate) 1 g per vial powder for solution for injection) AMDIPHARM LIMITED,Active,9000295,erythromycin (erythromycin lactobionate) 1 g per vial powder for solution for injection,8000037,erythromycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
43428,Marketed,2020-10-01,02225271,Benzamycin,2,D10AF52,"Erythromycin, combinations",Gel,Topical,02225271,"BENZAMYCIN (benzoyl peroxide 5 % and erythromycin 3 % cutaneous gel) BAUSCH HEALTH, CANADA INC.",Active,9012907,benzoyl peroxide 5 % and erythromycin 3 % cutaneous gel,8000897,benzoyl peroxide and erythromycin,448598008,Cutaneous,385100002,Gel,,,,,,Prescription
50949,Marketed,1997-09-19,02231583,Eprex Sterile Solution 1000 IU/0.5 mL,1,B03XA01,Erythropoietin,Solution,"Subcutaneous,Intravenous",02231583,EPREX STERILE SOLUTION 1000IU/0.5ML (epoetin alfa 1000 unit per 0.5 mL solution for injection syringe) JANSSEN INC,Active,9013098,epoetin alfa 1000 unit per 0.5 mL solution for injection syringe,8001765,epoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
50949,Marketed,1997-09-19,02231583,Eprex Sterile Solution 1000 IU/0.5 mL,1,B03XA01,Erythropoietin,Solution,"Subcutaneous,Intravenous",02231583,EPREX STERILE SOLUTION 1000IU/0.5ML (epoetin alfa 1000 unit per 0.5 mL solution for injection syringe) JANSSEN INC,Active,9013098,epoetin alfa 1000 unit per 0.5 mL solution for injection syringe,8001765,epoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
50950,Marketed,1997-09-19,02231584,Eprex Sterile Solution 2000 IU/0.5 mL,1,B03XA01,Erythropoietin,Solution,"Subcutaneous,Intravenous",02231584,EPREX STERILE SOLUTION 2000IU/0.5ML (epoetin alfa 2000 unit per 0.5 mL solution for injection syringe) JANSSEN INC,Active,9013100,epoetin alfa 2000 unit per 0.5 mL solution for injection syringe,8001765,epoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
50950,Marketed,1997-09-19,02231584,Eprex Sterile Solution 2000 IU/0.5 mL,1,B03XA01,Erythropoietin,Solution,"Subcutaneous,Intravenous",02231584,EPREX STERILE SOLUTION 2000IU/0.5ML (epoetin alfa 2000 unit per 0.5 mL solution for injection syringe) JANSSEN INC,Active,9013100,epoetin alfa 2000 unit per 0.5 mL solution for injection syringe,8001765,epoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
50951,Marketed,1997-09-19,02231585,Eprex Sterile Solution 3000 IU/0.3 mL,1,B03XA01,Erythropoietin,Solution,"Subcutaneous,Intravenous",02231585,EPREX STERILE SOLUTION 3000IU/0.3ML (epoetin alfa 3000 unit per 0.3 mL solution for injection syringe) JANSSEN INC,Active,9013102,epoetin alfa 3000 unit per 0.3 mL solution for injection syringe,8001765,epoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
50951,Marketed,1997-09-19,02231585,Eprex Sterile Solution 3000 IU/0.3 mL,1,B03XA01,Erythropoietin,Solution,"Subcutaneous,Intravenous",02231585,EPREX STERILE SOLUTION 3000IU/0.3ML (epoetin alfa 3000 unit per 0.3 mL solution for injection syringe) JANSSEN INC,Active,9013102,epoetin alfa 3000 unit per 0.3 mL solution for injection syringe,8001765,epoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
50952,Marketed,1997-09-19,02231586,Eprex Sterile Solution 4000 IU/0.4 mL,1,B03XA01,Erythropoietin,Solution,"Subcutaneous,Intravenous",02231586,EPREX STERILE SOLUTION 4000IU/0.4ML (epoetin alfa 4000 unit per 0.4 mL solution for injection syringe) JANSSEN INC,Active,9013104,epoetin alfa 4000 unit per 0.4 mL solution for injection syringe,8001765,epoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
50952,Marketed,1997-09-19,02231586,Eprex Sterile Solution 4000 IU/0.4 mL,1,B03XA01,Erythropoietin,Solution,"Subcutaneous,Intravenous",02231586,EPREX STERILE SOLUTION 4000IU/0.4ML (epoetin alfa 4000 unit per 0.4 mL solution for injection syringe) JANSSEN INC,Active,9013104,epoetin alfa 4000 unit per 0.4 mL solution for injection syringe,8001765,epoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
50953,Marketed,1997-09-19,02231587,Eprex Sterile Solution 10000 IU/1 mL,1,B03XA01,Erythropoietin,Solution,"Subcutaneous,Intravenous",02231587,EPREX STERILE SOLUTION 10000IU/1.0ML (epoetin alfa 10000 unit per 1 mL solution for injection syringe) JANSSEN INC,Active,9013099,epoetin alfa 10000 unit per 1 mL solution for injection syringe,8001765,epoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
50953,Marketed,1997-09-19,02231587,Eprex Sterile Solution 10000 IU/1 mL,1,B03XA01,Erythropoietin,Solution,"Subcutaneous,Intravenous",02231587,EPREX STERILE SOLUTION 10000IU/1.0ML (epoetin alfa 10000 unit per 1 mL solution for injection syringe) JANSSEN INC,Active,9013099,epoetin alfa 10000 unit per 1 mL solution for injection syringe,8001765,epoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
64311,Marketed,1999-12-21,02240722,Eprex Sterile Solution 40000 IU/mL,1,B03XA01,Erythropoietin,Solution,"Subcutaneous,Intravenous",02240722,EPREX STERILE SOLUTION 40000IU/ML (epoetin alfa 40000 unit per 1 mL solution for injection syringe) JANSSEN INC,Active,9013105,epoetin alfa 40000 unit per 1 mL solution for injection syringe,8001765,epoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
64311,Marketed,1999-12-21,02240722,Eprex Sterile Solution 40000 IU/mL,1,B03XA01,Erythropoietin,Solution,"Subcutaneous,Intravenous",02240722,EPREX STERILE SOLUTION 40000IU/ML (epoetin alfa 40000 unit per 1 mL solution for injection syringe) JANSSEN INC,Active,9013105,epoetin alfa 40000 unit per 1 mL solution for injection syringe,8001765,epoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
67133,Marketed,2005-08-24,02243239,Eprex Sterile Solution,1,B03XA01,Erythropoietin,Solution,"Intravenous,Subcutaneous",02243239,EPREX STERILE SOLUTION (epoetin alfa 20000 unit per 0.5 mL solution for injection syringe) JANSSEN INC,Active,9013101,epoetin alfa 20000 unit per 0.5 mL solution for injection syringe,8001765,epoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
67133,Marketed,2005-08-24,02243239,Eprex Sterile Solution,1,B03XA01,Erythropoietin,Solution,"Intravenous,Subcutaneous",02243239,EPREX STERILE SOLUTION (epoetin alfa 20000 unit per 0.5 mL solution for injection syringe) JANSSEN INC,Active,9013101,epoetin alfa 20000 unit per 0.5 mL solution for injection syringe,8001765,epoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
67308,Marketed,2002-07-01,02243400,Eprex Sterile Solution 5000 IU/0.5 mL,1,B03XA01,Erythropoietin,Solution,"Subcutaneous,Intravenous",02243400,EPREX STERILE SOLUTION 5000IU/0.5ML (epoetin alfa 5000 unit per 0.5 mL solution for injection syringe) JANSSEN INC,Active,9013106,epoetin alfa 5000 unit per 0.5 mL solution for injection syringe,8001765,epoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
67308,Marketed,2002-07-01,02243400,Eprex Sterile Solution 5000 IU/0.5 mL,1,B03XA01,Erythropoietin,Solution,"Subcutaneous,Intravenous",02243400,EPREX STERILE SOLUTION 5000IU/0.5ML (epoetin alfa 5000 unit per 0.5 mL solution for injection syringe) JANSSEN INC,Active,9013106,epoetin alfa 5000 unit per 0.5 mL solution for injection syringe,8001765,epoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
67309,Marketed,2001-02-20,02243401,Eprex Sterile Solution 6000 IU/0.6 mL,1,B03XA01,Erythropoietin,Solution,"Subcutaneous,Intravenous",02243401,EPREX STERILE SOLUTION 6000 IU/0.6 ML (epoetin alfa 6000 unit per 0.6 mL solution for injection syringe) JANSSEN INC,Active,9013107,epoetin alfa 6000 unit per 0.6 mL solution for injection syringe,8001765,epoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
67309,Marketed,2001-02-20,02243401,Eprex Sterile Solution 6000 IU/0.6 mL,1,B03XA01,Erythropoietin,Solution,"Subcutaneous,Intravenous",02243401,EPREX STERILE SOLUTION 6000 IU/0.6 ML (epoetin alfa 6000 unit per 0.6 mL solution for injection syringe) JANSSEN INC,Active,9013107,epoetin alfa 6000 unit per 0.6 mL solution for injection syringe,8001765,epoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
67311,Marketed,2001-02-20,02243403,Eprex Sterile Solution 8000 IU/0.8 mL,1,B03XA01,Erythropoietin,Solution,"Subcutaneous,Intravenous",02243403,EPREX STERILE SOLUTION 8000 IU/0.8 ML (epoetin alfa 8000 unit per 0.8 mL solution for injection syringe) JANSSEN INC,Active,9013108,epoetin alfa 8000 unit per 0.8 mL solution for injection syringe,8001765,epoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
67311,Marketed,2001-02-20,02243403,Eprex Sterile Solution 8000 IU/0.8 mL,1,B03XA01,Erythropoietin,Solution,"Subcutaneous,Intravenous",02243403,EPREX STERILE SOLUTION 8000 IU/0.8 ML (epoetin alfa 8000 unit per 0.8 mL solution for injection syringe) JANSSEN INC,Active,9013108,epoetin alfa 8000 unit per 0.8 mL solution for injection syringe,8001765,epoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
77409,Marketed,2007-11-19,02288680,Eprex Sterile Solution,1,B03XA01,Erythropoietin,Solution,"Subcutaneous,Intravenous",02288680,EPREX STERILE SOLUTION (epoetin alfa 30000 unit per 0.75 mL solution for injection syringe) JANSSEN INC,Active,9013103,epoetin alfa 30000 unit per 0.75 mL solution for injection syringe,8001765,epoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
77409,Marketed,2007-11-19,02288680,Eprex Sterile Solution,1,B03XA01,Erythropoietin,Solution,"Subcutaneous,Intravenous",02288680,EPREX STERILE SOLUTION (epoetin alfa 30000 unit per 0.75 mL solution for injection syringe) JANSSEN INC,Active,9013103,epoetin alfa 30000 unit per 0.75 mL solution for injection syringe,8001765,epoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
100019,Marketed,2025-04-16,02510944,AG-Escitalopram Tablets,1,N06AB10,Escitalopram,Tablet,Oral,02510944,AG-ESCITALOPRAM TABLETS (escitalopram (escitalopram oxalate) 10 mg oral tablet) ANGITA PHARMA INC.,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100020,Marketed,2025-04-16,02510952,AG-Escitalopram Tablets,1,N06AB10,Escitalopram,Tablet,Oral,02510952,AG-ESCITALOPRAM TABLETS (escitalopram (escitalopram oxalate) 20 mg oral tablet) ANGITA PHARMA INC.,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100193,Marketed,2021-06-25,02512653,Kye-Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02512653,KYE-ESCITALOPRAM (escitalopram (escitalopram oxalate) 15 mg oral tablet) KYE PHARMACEUTICALS INC.,Active,9014545,escitalopram (escitalopram oxalate) 15 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104373,Marketed,2025-08-29,02554909,Natco-Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02554909,NATCO-ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104375,Marketed,2025-08-29,02554933,Natco-Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02554933,NATCO-ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74862,Marketed,2005-02-14,02263238,Cipralex  -10 mg,1,N06AB10,Escitalopram,Tablet,Oral,02263238,CIPRALEX  -10MG (escitalopram (escitalopram oxalate) 10 mg oral tablet) LUNDBECK CANADA INC,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74864,Marketed,2005-02-14,02263254,Cipralex  -20 mg,1,N06AB10,Escitalopram,Tablet,Oral,02263254,CIPRALEX  -20MG (escitalopram (escitalopram oxalate) 20 mg oral tablet) LUNDBECK CANADA INC,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78034,Marketed,2014-09-10,02295016,Apo-Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02295016,APO-ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) APOTEX INC,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78035,Marketed,2014-09-10,02295024,Apo-Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02295024,APO-ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) APOTEX INC,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79506,Marketed,2014-09-10,02309467,Mylan-Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02309467,MYLAN-ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79507,Marketed,2014-09-10,02309475,Mylan-Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02309475,MYLAN-ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80368,Marketed,2014-09-10,02318180,Teva-Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02318180,TEVA-ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) TEVA CANADA LIMITED,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80371,Marketed,2014-09-10,02318202,Teva-Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02318202,TEVA-ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) TEVA CANADA LIMITED,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84901,Marketed,2014-09-10,02364077,Sandoz Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02364077,SANDOZ ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84902,Marketed,2014-09-10,02364085,Sandoz Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02364085,SANDOZ ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87111,Marketed,2026-03-13,02385481,SPC-Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02385481,SPC-ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) SUN PHARMA CANADA INC,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87112,Marketed,2026-03-13,02385503,SPC-Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02385503,SPC-ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) SUN PHARMA CANADA INC,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88231,Marketed,2014-09-10,02397358,Auro-Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02397358,AURO-ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) AURO PHARMA INC,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88233,Marketed,2014-09-10,02397374,Auro-Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02397374,AURO-ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) AURO PHARMA INC,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89210,Marketed,2015-03-19,02407418,Mint-Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02407418,MINT-ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89212,Marketed,2015-03-19,02407434,Mint-Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02407434,MINT-ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90820,Marketed,2014-09-10,02423480,Mar-Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02423480,MAR-ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90822,Marketed,2014-09-10,02423502,Mar-Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02423502,MAR-ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90910,Marketed,2014-09-15,02424401,Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02424401,ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) PRO DOC LIMITEE,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90911,Marketed,2014-09-15,02424428,Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02424428,ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) PRO DOC LIMITEE,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91347,Marketed,2018-11-01,02429039,Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02429039,ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91348,Marketed,2018-11-01,02429047,Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02429047,ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91422,Marketed,2023-04-26,02429780,Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02429780,ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91423,Marketed,2023-04-26,02429799,Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02429799,ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91451,Marketed,2014-09-18,02430118,Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02430118,ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) SANIS HEALTH INC,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91453,Marketed,2014-09-18,02430126,Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02430126,ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) SANIS HEALTH INC,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91896,Marketed,2016-06-10,02434652,ACH-Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02434652,ACH-ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91897,Marketed,2016-06-10,02434660,ACH-Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02434660,ACH-ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94081,Marketed,2020-05-01,02454297,Act Escitalopram ODT,1,N06AB10,Escitalopram,Tablet (orally disintegrating),Oral,02454297,ACT ESCITALOPRAM ODT (escitalopram 10 mg orodispersible tablet) TEVA CANADA LIMITED,Active,9001389,escitalopram 10 mg orodispersible tablet,8000346,escitalopram,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
94082,Marketed,2020-05-01,02454300,Act Escitalopram ODT,1,N06AB10,Escitalopram,Tablet (orally disintegrating),Oral,02454300,ACT ESCITALOPRAM ODT (escitalopram 20 mg orodispersible tablet) TEVA CANADA LIMITED,Active,9001390,escitalopram 20 mg orodispersible tablet,8000346,escitalopram,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
95793,Marketed,2021-08-10,02469243,PMS-Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02469243,PMS-ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) PHARMASCIENCE INC,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95794,Marketed,2021-08-10,02469251,PMS-Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02469251,PMS-ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) PHARMASCIENCE INC,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96051,Marketed,2026-03-23,02471418,M-Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02471418,M-ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) MANTRA PHARMA INC,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96052,Marketed,2026-03-23,02471426,M-Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02471426,M-ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) MANTRA PHARMA INC,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96678,Marketed,2024-03-08,02476851,Nra-Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02476851,NRA-ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) NORA PHARMA INC,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96679,Marketed,2024-03-08,02476878,Nra-Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02476878,NRA-ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) NORA PHARMA INC,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96819,Marketed,2018-09-06,02477742,AG-Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02477742,AG-ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) ANGITA PHARMA INC.,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96821,Marketed,2018-09-06,02477769,AG-Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02477769,AG-ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) ANGITA PHARMA INC.,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97143,Marketed,2019-06-19,02481154,Bio-Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02481154,BIO-ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) BIOMED PHARMA,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97145,Marketed,2019-06-19,02481170,Bio-Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02481170,BIO-ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) BIOMED PHARMA,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99822,Marketed,2023-12-22,02508893,JAMP Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02508893,JAMP ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99823,Marketed,2023-12-24,02508907,JAMP Escitalopram,1,N06AB10,Escitalopram,Tablet,Oral,02508907,JAMP ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98903,Marketed,2020-06-11,02499290,Spravato,1,N06AX27,Esketamine,Solution,Nasal,02499290,SPRAVATO (esketamine (esketamine hydrochloride) 28 mg per 2 actuation nasal spray) JANSSEN INC,Active,9014326,esketamine (esketamine hydrochloride) 28 mg per 2 actuation nasal spray,8002333,esketamine,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,,Narcotics (CDSA I)
101648,Marketed,2025-05-08,02527421,Auro-Eslicarbazepine,1,N03AF04,Eslicarbazepine,Tablet,Oral,02527421,AURO-ESLICARBAZEPINE (eslicarbazepine acetate 200 mg oral tablet) AURO PHARMA INC,Active,9005561,eslicarbazepine acetate 200 mg oral tablet,8001462,eslicarbazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101649,Marketed,2025-05-08,02527448,Auro-Eslicarbazepine,1,N03AF04,Eslicarbazepine,Tablet,Oral,02527448,AURO-ESLICARBAZEPINE (eslicarbazepine acetate 400 mg oral tablet) AURO PHARMA INC,Active,9005562,eslicarbazepine acetate 400 mg oral tablet,8001462,eslicarbazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101650,Marketed,2025-05-08,02527456,Auro-Eslicarbazepine,1,N03AF04,Eslicarbazepine,Tablet,Oral,02527456,AURO-ESLICARBAZEPINE (eslicarbazepine acetate 600 mg oral tablet) AURO PHARMA INC,Active,9005563,eslicarbazepine acetate 600 mg oral tablet,8001462,eslicarbazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101651,Marketed,2025-05-08,02527464,Auro-Eslicarbazepine,1,N03AF04,Eslicarbazepine,Tablet,Oral,02527464,AURO-ESLICARBAZEPINE (eslicarbazepine acetate 800 mg oral tablet) AURO PHARMA INC,Active,9005564,eslicarbazepine acetate 800 mg oral tablet,8001462,eslicarbazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102669,Marketed,2025-05-06,02537931,Apo-Eslicarbazepine,1,N03AF04,Eslicarbazepine,Tablet,Oral,02537931,APO-ESLICARBAZEPINE (eslicarbazepine acetate 200 mg oral tablet) APOTEX INC,Active,9005561,eslicarbazepine acetate 200 mg oral tablet,8001462,eslicarbazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102670,Marketed,2025-05-06,02537958,Apo-Eslicarbazepine,1,N03AF04,Eslicarbazepine,Tablet,Oral,02537958,APO-ESLICARBAZEPINE (eslicarbazepine acetate 400 mg oral tablet) APOTEX INC,Active,9005562,eslicarbazepine acetate 400 mg oral tablet,8001462,eslicarbazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102671,Marketed,2025-05-06,02537966,Apo-Eslicarbazepine,1,N03AF04,Eslicarbazepine,Tablet,Oral,02537966,APO-ESLICARBAZEPINE (eslicarbazepine acetate 600 mg oral tablet) APOTEX INC,Active,9005563,eslicarbazepine acetate 600 mg oral tablet,8001462,eslicarbazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102672,Marketed,2025-05-06,02537974,Apo-Eslicarbazepine,1,N03AF04,Eslicarbazepine,Tablet,Oral,02537974,APO-ESLICARBAZEPINE (eslicarbazepine acetate 800 mg oral tablet) APOTEX INC,Active,9005564,eslicarbazepine acetate 800 mg oral tablet,8001462,eslicarbazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
91141,Marketed,2024-05-30,02426862,Aptiom,1,N03AF04,Eslicarbazepine,Tablet,Oral,02426862,"APTIOM (eslicarbazepine acetate 200 mg oral tablet) SUMITOMO PHARMA CANADA, INC.",Active,9005561,eslicarbazepine acetate 200 mg oral tablet,8001462,eslicarbazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
91142,Marketed,2024-04-12,02426870,Aptiom,1,N03AF04,Eslicarbazepine,Tablet,Oral,02426870,"APTIOM (eslicarbazepine acetate 400 mg oral tablet) SUMITOMO PHARMA CANADA, INC.",Active,9005562,eslicarbazepine acetate 400 mg oral tablet,8001462,eslicarbazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
91143,Marketed,2024-05-15,02426889,Aptiom,1,N03AF04,Eslicarbazepine,Tablet,Oral,02426889,"APTIOM (eslicarbazepine acetate 600 mg oral tablet) SUMITOMO PHARMA CANADA, INC.",Active,9005563,eslicarbazepine acetate 600 mg oral tablet,8001462,eslicarbazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
91145,Marketed,2024-02-07,02426897,Aptiom,1,N03AF04,Eslicarbazepine,Tablet,Oral,02426897,"APTIOM (eslicarbazepine acetate 800 mg oral tablet) SUMITOMO PHARMA CANADA, INC.",Active,9005564,eslicarbazepine acetate 800 mg oral tablet,8001462,eslicarbazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
42910,Marketed,2000-08-01,02188880,Brevibloc Injection 10 mg/mL,1,C07AB09,Esmolol,Solution,Intravenous,02188880,BREVIBLOC INJECTION 10MG/ML (esmolol hydrochloride 100 mg per 10 mL solution for injection vial) BAXTER CORPORATION,Active,9009341,esmolol hydrochloride 100 mg per 10 mL solution for injection vial,8000895,esmolol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
79483,Marketed,2008-09-12,02309238,Brevibloc Premixed Injection,1,C07AB09,Esmolol,Solution,Intravenous,02309238,BREVIBLOC PREMIXED INJECTION (esmolol hydrochloride 10 mg per mL solution for injection 250 mL bag) BAXTER CORPORATION,Active,9009340,esmolol hydrochloride 10 mg per mL solution for injection 250 mL bag,8000895,esmolol,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Prescription
100932,Marketed,2022-03-16,02520109,M-Esomeprazole,1,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02520109,M-ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet) MANTRA PHARMA INC,Active,9000952,esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100933,Marketed,2022-03-16,02520117,M-Esomeprazole,1,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02520117,M-ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet) MANTRA PHARMA INC,Active,9000953,esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100989,Marketed,2022-06-27,02520699,Esomeprazole,1,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02520699,ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet) JAMP PHARMA CORPORATION,Active,9000952,esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100990,Marketed,2022-06-28,02520702,Esomeprazole,1,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02520702,ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet) JAMP PHARMA CORPORATION,Active,9000953,esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101769,Marketed,2023-03-06,02528479,PMSC-Esomeprazole Dr,1,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02528479,PMSC-ESOMEPRAZOLE DR (esomeprazole (esomeprazole magnesium dihydrate) 20 mg gastro-resistant tablet) PHARMASCIENCE INC,Active,9000952,esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101770,Marketed,2023-03-06,02528487,PMSC-Esomeprazole Dr,1,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02528487,PMSC-ESOMEPRAZOLE DR (esomeprazole (esomeprazole magnesium dihydrate) 40 mg gastro-resistant tablet) PHARMASCIENCE INC,Active,9000953,esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102419,Marketed,2024-03-20,02535335,Esomeprazole,1,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02535335,ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium dihydrate) 20 mg gastro-resistant tablet) SANIS HEALTH INC,Active,9000952,esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106098,Marketed,2025-12-16,02557673,Riva-Esomeprazole,1,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02557673,RIVA-ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet) LABORATOIRE RIVA INC.,Active,9000952,esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106099,Marketed,2025-11-28,02557681,Riva-Esomeprazole,1,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02557681,RIVA-ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet) LABORATOIRE RIVA INC.,Active,9000953,esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
68498,Marketed,2001-08-20,02244521,Nexium - 20 mg,1,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02244521,NEXIUM - 20MG (esomeprazole (esomeprazole magnesium trihydrate) 20 mg gastro-resistant tablet) ASTRAZENECA CANADA INC,Active,9000952,esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
68499,Marketed,2001-08-20,02244522,Nexium - 40 mg,1,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02244522,NEXIUM - 40MG (esomeprazole (esomeprazole magnesium trihydrate) 40 mg gastro-resistant tablet) ASTRAZENECA CANADA INC,Active,9000953,esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78581,Marketed,2008-01-02,02300524,Nexium,1,A02BC05,Esomeprazole,"Granules for suspension, delayed release",Oral,02300524,NEXIUM (esomeprazole (esomeprazole magnesium trihydrate) 10 mg per sachet gastro-resistant granules for oral suspension) ASTRAZENECA CANADA INC,Active,9001231,esomeprazole (esomeprazole magnesium) 10 mg per sachet gastro-resistant granules for oral suspension,8000303,esomeprazole,26643006,Oral,385029002,Granules for oral suspension,733013000,Sachet (unit of presentation),,,,Prescription
82472,Marketed,2021-09-20,02339099,Apo-Esomeprazole,1,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02339099,APO-ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet) APOTEX INC,Active,9000952,esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82473,Marketed,2021-09-20,02339102,Apo-Esomeprazole,1,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02339102,APO-ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet) APOTEX INC,Active,9000953,esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87999,Marketed,2021-09-20,02394839,Esomeprazole,1,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02394839,ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet) PRO DOC LIMITEE,Active,9000952,esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88000,Marketed,2021-08-27,02394847,Esomeprazole,1,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02394847,ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet) PRO DOC LIMITEE,Active,9000953,esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90860,Marketed,2019-09-11,02423855,Teva-Esomeprazole,1,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02423855,TEVA-ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium dihydrate) 20 mg gastro-resistant tablet) TEVA CANADA LIMITED,Active,9000952,esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90861,Marketed,2019-09-11,02423863,Teva-Esomeprazole,1,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02423863,TEVA-ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium dihydrate) 40 mg gastro-resistant tablet) TEVA CANADA LIMITED,Active,9000953,esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90870,Marketed,2022-03-07,02423979,Taro-Esomeprazole,1,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02423979,TARO-ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet) SUN PHARMA CANADA INC,Active,9000952,esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90871,Marketed,2022-03-07,02423987,Taro-Esomeprazole,1,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02423987,TARO-ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet) SUN PHARMA CANADA INC,Active,9000953,esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91561,Marketed,2021-07-23,02431173,Esomeprazole,1,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02431173,ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium dihydrate) 40 mg gastro-resistant tablet) SANIS HEALTH INC,Active,9000953,esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92684,Marketed,2022-01-12,02442493,Esomeprazole,1,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02442493,ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet) SIVEM PHARMACEUTICALS ULC,Active,9000952,esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92685,Marketed,2022-01-12,02442507,Esomeprazole,1,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02442507,ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet) SIVEM PHARMACEUTICALS ULC,Active,9000953,esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92986,Marketed,2026-05-08,02444712,Nexium 24 Hr,1,A02BC05,Esomeprazole,Capsule (delayed release),Oral,02444712,NEXIUM 24HR (esomeprazole (esomeprazole magnesium trihydrate) 20 mg gastro-resistant capsule) HALEON CANADA ULC,Active,9001461,esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant capsule,8000303,esomeprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
94844,Marketed,2018-09-25,02460920,Sandoz Esomeprazole,1,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02460920,SANDOZ ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium dihydrate) 20 mg gastro-resistant tablet) SANDOZ CANADA INCORPORATED,Active,9000952,esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94845,Marketed,2018-09-25,02460939,Sandoz Esomeprazole,1,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02460939,SANDOZ ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium dihydrate) 40 mg gastro-resistant tablet) SANDOZ CANADA INCORPORATED,Active,9000953,esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97006,Marketed,2020-04-20,02479419,MYL-Esomeprazole,1,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02479419,MYL-ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium trihydrate) 20 mg gastro-resistant tablet) MYLAN PHARMACEUTICALS ULC,Active,9000952,esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97007,Marketed,2020-04-20,02479427,MYL-Esomeprazole,1,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02479427,MYL-ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium trihydrate) 40 mg gastro-resistant tablet) MYLAN PHARMACEUTICALS ULC,Active,9000953,esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
18640,Marketed,2006-04-13,02168898,Estring,1,G03CA03,Estradiol,Ring (slow-release),Vaginal,02168898,ESTRING (estradiol 7.5 mcg per 24 hour vaginal delivery system) PFIZER CANADA ULC,Active,9009358,estradiol 7.5 mcg per 24 hour vaginal delivery system,8000213,estradiol,16857009,Vaginal,764772008,Prolonged-release vaginal ring,733021006,System (unit of presentation),1.0,,,Prescription
50849,Marketed,2008-08-15,02231509,Climara 50,1,G03CA03,Estradiol,Patch,Transdermal,02231509,CLIMARA 50 (estradiol (estradiol hemihydrate) 50 mcg per 24 hour transdermal patch) BAYER INC,Active,9009364,estradiol 50 mcg per 24 hour transdermal patch,8000213,estradiol,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),1.0,,,Prescription
62136,Marketed,2022-03-24,02238704,Estrogel,1,G03CA03,Estradiol,Gel,Transdermal,02238704,ESTROGEL (estradiol (estradiol hemihydrate) 0.06 % transdermal gel) ORGANON CANADA INC.,Active,9009349,estradiol 0.06 % transdermal gel,8000213,estradiol,45890007,Transdermal,385100002,Gel,,,1.0,,,Prescription
67942,Marketed,2022-12-06,02243999,Estradot 37.5,1,G03CA03,Estradiol,Patch,Transdermal,02243999,ESTRADOT 37.5 (estradiol 37.5 mcg per 24 hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9009360,estradiol 37.5 mcg per 24 hour transdermal patch,8000213,estradiol,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),1.0,,,Prescription
67943,Marketed,2022-12-07,02244000,Estradot 50,1,G03CA03,Estradiol,Patch,Transdermal,02244000,ESTRADOT 50 (estradiol 50 mcg per 24 hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9009364,estradiol 50 mcg per 24 hour transdermal patch,8000213,estradiol,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),1.0,,,Prescription
67944,Marketed,2022-12-06,02244001,Estradot 75,1,G03CA03,Estradiol,Patch,Transdermal,02244001,ESTRADOT 75 (estradiol 75 mcg per 24 hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9009365,estradiol 75 mcg per 24 hour transdermal patch,8000213,estradiol,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),1.0,,,Prescription
67945,Marketed,2022-12-06,02244002,Estradot 100,1,G03CA03,Estradiol,Patch,Transdermal,02244002,ESTRADOT 100 (estradiol 100 mcg per 24 hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9009356,estradiol 100 mcg per 24 hour transdermal patch,8000213,estradiol,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),1.0,,,Prescription
69776,Marketed,2022-12-06,02245676,Estradot 25,1,G03CA03,Estradiol,Patch,Transdermal,02245676,ESTRADOT 25 (estradiol 25 mcg per 24 hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9009359,estradiol 25 mcg per 24 hour transdermal patch,8000213,estradiol,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),1.0,,,Prescription
71196,Marketed,2006-01-12,02246967,Sandoz Estradiol Derm 50,1,G03CA03,Estradiol,Patch,Transdermal,02246967,SANDOZ ESTRADIOL DERM 50 (estradiol (estradiol hemihydrate) 50 mcg per 24 hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9009364,estradiol 50 mcg per 24 hour transdermal patch,8000213,estradiol,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),1.0,,,Prescription
71197,Marketed,2006-01-12,02246968,Sandoz Estradiol Derm 75,1,G03CA03,Estradiol,Patch,Transdermal,02246968,SANDOZ ESTRADIOL DERM 75 (estradiol (estradiol hemihydrate) 75 mcg per 24 hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9009365,estradiol 75 mcg per 24 hour transdermal patch,8000213,estradiol,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),1.0,,,Prescription
71198,Marketed,2006-01-12,02246969,Sandoz Estradiol Derm 100,1,G03CA03,Estradiol,Patch,Transdermal,02246969,SANDOZ ESTRADIOL DERM 100 (estradiol (estradiol hemihydrate) 100 mcg per 24 hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9009356,estradiol 100 mcg per 24 hour transdermal patch,8000213,estradiol,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),1.0,,,Prescription
71749,Marketed,2008-07-30,02247499,Climara 25,1,G03CA03,Estradiol,Patch,Transdermal,02247499,CLIMARA 25 (estradiol (estradiol hemihydrate) 25 mcg per 24 hour transdermal patch) BAYER INC,Active,9009359,estradiol 25 mcg per 24 hour transdermal patch,8000213,estradiol,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),1.0,,,Prescription
71750,Marketed,2008-06-25,02247500,Climara 75,1,G03CA03,Estradiol,Patch,Transdermal,02247500,CLIMARA 75 (estradiol (estradiol hemihydrate) 75 mcg per 24 hour transdermal patch) BAYER INC,Active,9009365,estradiol 75 mcg per 24 hour transdermal patch,8000213,estradiol,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),1.0,,,Prescription
81084,Marketed,2010-09-22,02325462,Vagifem 10,1,G03CA03,Estradiol,Vaginal tablet,Vaginal,02325462,VAGIFEM 10 (estradiol (estradiol hemihydrate) 10 mcg vaginal tablet) NOVO NORDISK CANADA INC,Active,9009355,estradiol 10 mcg vaginal tablet,8000213,estradiol,16857009,Vaginal,385055001,Tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
90950,Marketed,2019-08-26,02424835,Divigel,1,G03CA03,Estradiol,Gel,Transdermal,02424835,DIVIGEL 0.5MG PACK (estradiol 0.1 % transdermal gel 0.5 mg sachet) SEARCHLIGHT PHARMA INC,Active,9012569,estradiol 0.1 % transdermal gel 0.5 mg sachet,8000213,estradiol,45890007,Transdermal,385100002,Gel,733013000,Sachet (unit of presentation),1.0,,,Prescription
90951,Marketed,2019-08-26,02424843,Divigel,1,G03CA03,Estradiol,Gel,Transdermal,02424843,DIVIGEL 1MG PACK (estradiol 0.1 % transdermal gel 1 mg sachet) SEARCHLIGHT PHARMA INC,Active,9012570,estradiol 0.1 % transdermal gel 1 mg sachet,8000213,estradiol,45890007,Transdermal,385100002,Gel,733013000,Sachet (unit of presentation),1.0,,,Prescription
90959,Marketed,2018-11-29,02424924,Divigel,1,G03CA03,Estradiol,Gel,Transdermal,02424924,DIVIGEL 0.25 MG PACK (estradiol 0.1 % transdermal gel 0.25 mg sachet) SEARCHLIGHT PHARMA INC,Active,9012568,estradiol 0.1 % transdermal gel 0.25 mg sachet,8000213,estradiol,45890007,Transdermal,385100002,Gel,733013000,Sachet (unit of presentation),1.0,,,Prescription
93486,Marketed,2016-02-29,02449048,Lupin-Estradiol,1,G03CA03,Estradiol,Tablet,Oral,02449048,LUPIN-ESTRADIOL (estradiol (estradiol hemihydrate) 0.5 mg oral tablet) LUPIN PHARMA CANADA LIMITED,Active,9009352,estradiol 0.5 mg oral tablet,8000213,estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
93487,Marketed,2016-02-29,02449056,Lupin-Estradiol,1,G03CA03,Estradiol,Tablet,Oral,02449056,LUPIN-ESTRADIOL (estradiol (estradiol hemihydrate) 1 mg oral tablet) LUPIN PHARMA CANADA LIMITED,Active,9009354,estradiol 1 mg oral tablet,8000213,estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
93488,Marketed,2016-02-29,02449064,Lupin-Estradiol,1,G03CA03,Estradiol,Tablet,Oral,02449064,LUPIN-ESTRADIOL (estradiol (estradiol hemihydrate) 2 mg oral tablet) LUPIN PHARMA CANADA LIMITED,Active,9009357,estradiol 2 mg oral tablet,8000213,estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99313,Marketed,2023-11-14,02503689,Imvexxy,1,G03CA03,Estradiol,Insert,Vaginal,02503689,IMVEXXY (estradiol (estradiol hemihydrate) 4 mcg vaginal capsule) KNIGHT THERAPEUTICS INC.,Active,9014940,estradiol 4 mcg vaginal capsule,8000213,estradiol,16857009,Vaginal,385175008,Vaginal capule,732937005,Capsule (unit of presentation),1.0,,,Prescription
99314,Marketed,2023-11-14,02503697,Imvexxy,1,G03CA03,Estradiol,Insert,Vaginal,02503697,IMVEXXY (estradiol (estradiol hemihydrate) 10 mcg vaginal capsule) KNIGHT THERAPEUTICS INC.,Active,9014939,estradiol 10 mcg vaginal capsule,8000213,estradiol,16857009,Vaginal,385175008,Vaginal capule,732937005,Capsule (unit of presentation),1.0,,,Prescription
7645,Marketed,2016-08-18,00727369,Estragyn Vaginal Cream,1,G03CA07,Estrone,Cream,Vaginal,00727369,ESTRAGYN VAGINAL CREAM (estrone 0.1 % vaginal cream) SEARCHLIGHT PHARMA INC,Active,9002106,estrone 0.1 % vaginal cream,8001647,estrone,16857009,Vaginal,385165005,Vaginal cream,,,1.0,,,Prescription
103828,Marketed,2024-09-03,02549433,Mar-Eszopiclone,1,N05CF04,Eszopiclone,Tablet,Oral,02549433,MAR-ESZOPICLONE (eszopiclone 1 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9014379,eszopiclone 1 mg oral tablet,8002347,eszopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103829,Marketed,2024-09-03,02549441,Mar-Eszopiclone,1,N05CF04,Eszopiclone,Tablet,Oral,02549441,MAR-ESZOPICLONE (eszopiclone 2 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9014380,eszopiclone 2 mg oral tablet,8002347,eszopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103830,Marketed,2024-09-03,02549468,Mar-Eszopiclone,1,N05CF04,Eszopiclone,Tablet,Oral,02549468,MAR-ESZOPICLONE (eszopiclone 3 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9014381,eszopiclone 3 mg oral tablet,8002347,eszopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103992,Marketed,2024-12-10,02551187,M-Eszopiclone,1,N05CF04,Eszopiclone,Tablet,Oral,02551187,M-ESZOPICLONE (eszopiclone 1 mg oral tablet) MANTRA PHARMA INC,Active,9014379,eszopiclone 1 mg oral tablet,8002347,eszopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103993,Marketed,2024-12-10,02551195,M-Eszopiclone,1,N05CF04,Eszopiclone,Tablet,Oral,02551195,M-ESZOPICLONE (eszopiclone 2 mg oral tablet) MANTRA PHARMA INC,Active,9014380,eszopiclone 2 mg oral tablet,8002347,eszopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103994,Marketed,2024-12-10,02551209,M-Eszopiclone,1,N05CF04,Eszopiclone,Tablet,Oral,02551209,M-ESZOPICLONE (eszopiclone 3 mg oral tablet) MANTRA PHARMA INC,Active,9014381,eszopiclone 3 mg oral tablet,8002347,eszopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93974,Marketed,2026-01-20,02453207,Lunesta,1,N05CF04,Eszopiclone,Tablet,Oral,02453207,"LUNESTA (eszopiclone 1 mg oral tablet) SUMITOMO PHARMA CANADA, INC.",Active,9014379,eszopiclone 1 mg oral tablet,8002347,eszopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93975,Marketed,2026-01-20,02453215,Lunesta,1,N05CF04,Eszopiclone,Tablet,Oral,02453215,LUNESTA (eszopiclone 2 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9014380,eszopiclone 2 mg oral tablet,8002347,eszopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93976,Marketed,2026-01-22,02453223,Lunesta,1,N05CF04,Eszopiclone,Tablet,Oral,02453223,LUNESTA (eszopiclone 3 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9014381,eszopiclone 3 mg oral tablet,8002347,eszopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74372,Marketed,2020-12-22,02258528,Edecrin,1,C03CC01,Etacrynic acid,Tablet,Oral,02258528,"EDECRIN (ethacrynic acid 25 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9009371,ethacrynic acid 25 mg oral tablet,8000804,ethacrynic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95012,Marketed,2024-02-29,02462362,Ethacrynate Sodium,1,C03CC01,Etacrynic acid,Powder for solution,Intravenous,02462362,ETHACRYNATE SODIUM (ethacrynic acid (ethacrynate sodium) 50 mg per vial powder for solution for injection) STERIMAX INC,Active,9009370,ethacrynic acid (ethacrynate sodium) 50 mg per vial powder for solution for injection,8000804,ethacrynic acid,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
101948,Marketed,2024-04-05,02530295,Rymti,1,L04AB01,Etanercept,Solution,Subcutaneous,02530295,RYMTI 1 ML SINGLE-USE PRE-FILLED SYRINGE (etanercept 50 mg per 1 mL solution for injection syringe) LUPIN PHARMA CANADA LIMITED,Active,9012968,etanercept 50 mg per 1 mL solution for injection syringe,8001266,etanercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
101948,Marketed,2024-04-05,02530295,Rymti,1,L04AB01,Etanercept,Solution,Subcutaneous,02530295,RYMTI 1 ML SINGLE-USE PRE-FILLED SYRINGE (etanercept 50 mg per 1 mL solution for injection syringe) LUPIN PHARMA CANADA LIMITED,Active,9012968,etanercept 50 mg per 1 mL solution for injection syringe,8001266,etanercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
101949,Marketed,2024-04-05,02530309,Rymti,1,L04AB01,Etanercept,Solution,Subcutaneous,02530309,RYMTI 1 ML SINGLE-USE PRE-FILLED AUTO-INJECTOR PEN (etanercept 50 mg per 1 mL solution for injection syringe) LUPIN PHARMA CANADA LIMITED,Active,9012968,etanercept 50 mg per 1 mL solution for injection syringe,8001266,etanercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
101949,Marketed,2024-04-05,02530309,Rymti,1,L04AB01,Etanercept,Solution,Subcutaneous,02530309,RYMTI 1 ML SINGLE-USE PRE-FILLED AUTO-INJECTOR PEN (etanercept 50 mg per 1 mL solution for injection syringe) LUPIN PHARMA CANADA LIMITED,Active,9012968,etanercept 50 mg per 1 mL solution for injection syringe,8001266,etanercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
76019,Marketed,2005-12-21,02274728,Enbrel,1,L04AB01,Etanercept,Solution,Subcutaneous,02274728,ENBREL (etanercept 50 mg per 1 mL solution for injection syringe) IMMUNEX CORPORATION,Active,9012968,etanercept 50 mg per 1 mL solution for injection syringe,8001266,etanercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
76019,Marketed,2005-12-21,02274728,Enbrel,1,L04AB01,Etanercept,Solution,Subcutaneous,02274728,ENBREL (etanercept 50 mg per 1 mL solution for injection syringe) IMMUNEX CORPORATION,Active,9012968,etanercept 50 mg per 1 mL solution for injection syringe,8001266,etanercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
94214,Marketed,2016-09-23,02455323,Brenzys,1,L04AB01,Etanercept,Solution,Subcutaneous,02455323,"BRENZYS PRE-FILLED SYRINGE (etanercept 50 mg per 1 mL solution for injection syringe) SAMSUNG BIOEPIS CO., LTD",Active,9012968,etanercept 50 mg per 1 mL solution for injection syringe,8001266,etanercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
94214,Marketed,2016-09-23,02455323,Brenzys,1,L04AB01,Etanercept,Solution,Subcutaneous,02455323,"BRENZYS PRE-FILLED SYRINGE (etanercept 50 mg per 1 mL solution for injection syringe) SAMSUNG BIOEPIS CO., LTD",Active,9012968,etanercept 50 mg per 1 mL solution for injection syringe,8001266,etanercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
94215,Marketed,2016-09-13,02455331,Brenzys,1,L04AB01,Etanercept,Solution,Subcutaneous,02455331,"BRENZYS PRE-FILLED AUTO-INJECTOR (etanercept 50 mg per 1 mL solution for injection syringe) SAMSUNG BIOEPIS CO., LTD",Active,9012968,etanercept 50 mg per 1 mL solution for injection syringe,8001266,etanercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
94215,Marketed,2016-09-13,02455331,Brenzys,1,L04AB01,Etanercept,Solution,Subcutaneous,02455331,"BRENZYS PRE-FILLED AUTO-INJECTOR (etanercept 50 mg per 1 mL solution for injection syringe) SAMSUNG BIOEPIS CO., LTD",Active,9012968,etanercept 50 mg per 1 mL solution for injection syringe,8001266,etanercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
95072,Marketed,2017-08-04,02462850,Erelzi,1,L04AB01,Etanercept,Solution,Subcutaneous,02462850,ERELZI SENSOREADY PEN. SINGLE USE. (etanercept 50 mg per 1 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9012968,etanercept 50 mg per 1 mL solution for injection syringe,8001266,etanercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
95072,Marketed,2017-08-04,02462850,Erelzi,1,L04AB01,Etanercept,Solution,Subcutaneous,02462850,ERELZI SENSOREADY PEN. SINGLE USE. (etanercept 50 mg per 1 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9012968,etanercept 50 mg per 1 mL solution for injection syringe,8001266,etanercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
95073,Marketed,2017-08-04,02462869,Erelzi,1,L04AB01,Etanercept,Solution,Subcutaneous,02462869,ERELZI PREFILLED SYRINGE WITH NEEDLE GUARD. SINGLE USE. (etanercept 50 mg per 1 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9012968,etanercept 50 mg per 1 mL solution for injection syringe,8001266,etanercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
95073,Marketed,2017-08-04,02462869,Erelzi,1,L04AB01,Etanercept,Solution,Subcutaneous,02462869,ERELZI PREFILLED SYRINGE WITH NEEDLE GUARD. SINGLE USE. (etanercept 50 mg per 1 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9012968,etanercept 50 mg per 1 mL solution for injection syringe,8001266,etanercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
95074,Marketed,2017-12-08,02462877,Erelzi,1,L04AB01,Etanercept,Solution,Subcutaneous,02462877,ERELZI (etanercept 25 mg per 0.5 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9013113,etanercept 25 mg per 0.5 mL solution for injection syringe,8001266,etanercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
95074,Marketed,2017-12-08,02462877,Erelzi,1,L04AB01,Etanercept,Solution,Subcutaneous,02462877,ERELZI (etanercept 25 mg per 0.5 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9013113,etanercept 25 mg per 0.5 mL solution for injection syringe,8001266,etanercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
1471,Marketed,2019-07-10,00247960,Etibi,1,J04AK02,Ethambutol,Tablet,Oral,00247960,"ETIBI (ethambutol hydrochloride 100 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9001686,ethambutol hydrochloride 100 mg oral tablet,8001201,ethambutol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
1472,Marketed,2019-07-10,00247979,Etibi,1,J04AK02,Ethambutol,Tablet,Oral,00247979,"ETIBI (ethambutol hydrochloride 400 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9001687,ethambutol hydrochloride 400 mg oral tablet,8001201,ethambutol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103451,Marketed,2024-06-19,02545772,Mar-Ethosuximide,1,N03AD01,Ethosuximide,Capsule,Oral,02545772,MAR-ETHOSUXIMIDE (ethosuximide 250 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9001576,ethosuximide 250 mg oral capsule,8001463,ethosuximide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
103582,Marketed,2024-06-25,02547171,Odan-Ethosuximide,1,N03AD01,Ethosuximide,Capsule,Oral,02547171,ODAN-ETHOSUXIMIDE (ethosuximide 250 mg oral capsule) ODAN LABORATORIES LTD,Active,9001576,ethosuximide 250 mg oral capsule,8001463,ethosuximide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
731,Marketed,2022-10-11,00023485,Zarontin Syrup,1,N03AD01,Ethosuximide,Syrup,Oral,00023485,ZARONTIN SYRUP (ethosuximide 250 mg per 5 mL syrup) SEARCHLIGHT PHARMA INC,Active,9001605,ethosuximide 250 mg per 5 mL syrup,8001463,ethosuximide,26643006,Oral,739009002,Syrup,,,,,,Prescription
771,Marketed,2022-10-11,00022799,Zarontin,1,N03AD01,Ethosuximide,Capsule,Oral,00022799,ZARONTIN (ethosuximide 250 mg oral capsule) SEARCHLIGHT PHARMA INC,Active,9001576,ethosuximide 250 mg oral capsule,8001463,ethosuximide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
2570,Marketed,2017-07-13,00386685,Lipiodol Ultra Fluid,1,V08AD01,Ethyl esters of iodised fatty acids,Liquid,"Intracavitary,Parenteral (unspecified)",,,,,,,,,,,,,,,,,Ethical
102621,Marketed,2024-07-03,02537508,"Etomidate Injection, USP",1,N01AX07,Etomidate,Solution,Intravenous,77701160,"ETOMIDATE INJECTION, USP (etomidate 20 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9014427,etomidate 20 mg per 10 mL solution for injection vial,8002356,etomidate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
102621,Marketed,2024-07-03,02537508,"Etomidate Injection, USP",1,N01AX07,Etomidate,Solution,Intravenous,77701161,"ETOMIDATE INJECTION, USP (etomidate 40 mg per 20 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9014428,etomidate 40 mg per 20 mL solution for injection vial,8002356,etomidate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
98840,Marketed,2020-09-14,02498650,Tomvi,1,N01AX07,Etomidate,Solution,Intravenous,77701030,TOMVI (etomidate 40 mg per 20 mL solution for injection vial) STERIMAX INC,Active,9014428,etomidate 40 mg per 20 mL solution for injection vial,8002356,etomidate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
98840,Marketed,2020-09-14,02498650,Tomvi,1,N01AX07,Etomidate,Solution,Intravenous,77701031,TOMVI (etomidate 20 mg per 10 mL solution for injection vial) STERIMAX INC,Active,9014427,etomidate 20 mg per 10 mL solution for injection vial,8002356,etomidate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
98924,Marketed,2022-09-08,02499509,Nexplanon,1,G03AC08,Etonogestrel,Implant,Subcutaneous,02499509,NEXPLANON (etonogestrel 68 mg implant) ORGANON CANADA INC.,Active,9014360,etonogestrel 68 mg implant,8002344,etonogestrel,34206005,Subcutaneous,385286003,Implant,732996003,Implant (unit of presentation),1.0,,,Prescription
104164,Marketed,2025-06-20,02552671,Etoposide Injection,1,L01CB01,Etoposide,Solution,Intravenous,77701184,ETOPOSIDE INJECTION (etoposide 100 mg per 5 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9013114,etoposide 100 mg per 5 mL solution for injection vial,8001772,etoposide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
104164,Marketed,2025-06-20,02552671,Etoposide Injection,1,L01CB01,Etoposide,Solution,Intravenous,77701185,ETOPOSIDE INJECTION (etoposide 200 mg per 10 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9013116,etoposide 200 mg per 10 mL solution for injection vial,8001772,etoposide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
104164,Marketed,2025-06-20,02552671,Etoposide Injection,1,L01CB01,Etoposide,Solution,Intravenous,77701186,ETOPOSIDE INJECTION (etoposide 400 mg per 20 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9013117,etoposide 400 mg per 20 mL solution for injection vial,8001772,etoposide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
16507,Marketed,2014-04-12,02080036,Etoposide Injection,1,L01CB01,Etoposide,Solution,Intravenous,77700713,ETOPOSIDE INJECTION (etoposide 100 mg per 5 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013114,etoposide 100 mg per 5 mL solution for injection vial,8001772,etoposide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
16507,Marketed,2014-04-12,02080036,Etoposide Injection,1,L01CB01,Etoposide,Solution,Intravenous,77700714,ETOPOSIDE INJECTION (etoposide 1000 mg per 50 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013115,etoposide 1000 mg per 50 mL solution for injection vial,8001772,etoposide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
16507,Marketed,2014-04-12,02080036,Etoposide Injection,1,L01CB01,Etoposide,Solution,Intravenous,77700715,ETOPOSIDE INJECTION (etoposide 500 mg per 25 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013118,etoposide 500 mg per 25 mL solution for injection vial,8001772,etoposide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
16507,Marketed,2014-04-12,02080036,Etoposide Injection,1,L01CB01,Etoposide,Solution,Intravenous,77700716,ETOPOSIDE INJECTION (etoposide 200 mg per 10 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013116,etoposide 200 mg per 10 mL solution for injection vial,8001772,etoposide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
16507,Marketed,2014-04-12,02080036,Etoposide Injection,1,L01CB01,Etoposide,Solution,Intravenous,77700717,ETOPOSIDE INJECTION (etoposide 400 mg per 20 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013117,etoposide 400 mg per 20 mL solution for injection vial,8001772,etoposide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
5963,Marketed,2020-01-02,00616192,Vepesid,1,L01CB01,Etoposide,Capsule,Oral,00616192,VEPESID (etoposide 50 mg oral capsule) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9002019,etoposide 50 mg oral capsule,8001772,etoposide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
103109,Marketed,2026-05-13,02542560,Hemgenix,1,B02BD16,Etranacogene dezaparvovec,Suspension,Intravenous,,,,,,,,,,,,,,1.0,,,Prescription
103109,Marketed,2026-05-13,02542560,Hemgenix,1,B02BD16,Etranacogene dezaparvovec,Suspension,Intravenous,,,,,,,,,,,,,,1.0,,,Schedule D
103353,Marketed,2024-04-18,02544903,Velsipity,1,L04AE05,Etrasimod,Tablet,Oral,02544903,VELSIPITY (etrasimod (etrasimod L-arginine) 2 mg oral tablet) PFIZER CANADA ULC,Active,9015035,etrasimod (etrasimod L-arginine) 2 mg oral tablet,8002505,etrasimod,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),,,,Prescription
79246,Marketed,2008-03-27,02306778,Intelence,1,J05AG04,Etravirine,Tablet,Oral,02306778,INTELENCE (etravirine 100 mg oral tablet) JANSSEN INC,Active,9004386,etravirine 100 mg oral tablet,8001202,etravirine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86137,Marketed,2011-12-12,02375931,Intelence,1,J05AG04,Etravirine,Tablet,Oral,02375931,INTELENCE (etravirine 200 mg oral tablet) JANSSEN INC,Active,9004954,etravirine 200 mg oral tablet,8001202,etravirine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101930,Marketed,2023-04-05,02530090,Nat-Everolimus,1,L04AH02,Everolimus,Tablet,Oral,02530090,NAT-EVEROLIMUS (everolimus 2.5 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9004904,everolimus 2.5 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101931,Marketed,2023-04-05,02530104,Nat-Everolimus,1,L04AH02,Everolimus,Tablet,Oral,02530104,NAT-EVEROLIMUS (everolimus 5 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9004667,everolimus 5 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101933,Marketed,2023-04-05,02530120,Nat-Everolimus,1,L04AH02,Everolimus,Tablet,Oral,02530120,NAT-EVEROLIMUS (everolimus 10 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9004628,everolimus 10 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102144,Marketed,2024-08-27,02532409,Reddy-Everolimus,1,L04AH02,Everolimus,Tablet,Oral,02532409,REDDY-EVEROLIMUS (everolimus 2.5 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9004904,everolimus 2.5 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102145,Marketed,2024-08-27,02532417,Reddy-Everolimus,1,L04AH02,Everolimus,Tablet,Oral,02532417,REDDY-EVEROLIMUS (everolimus 5 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9004667,everolimus 5 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102147,Marketed,2024-08-27,02532433,Reddy-Everolimus,1,L04AH02,Everolimus,Tablet,Oral,02532433,REDDY-EVEROLIMUS (everolimus 10 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9004628,everolimus 10 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
82511,Marketed,2010-03-15,02339501,Afinitor,1,L04AH02,Everolimus,Tablet,Oral,02339501,AFINITOR (everolimus 5 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9004667,everolimus 5 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
82512,Marketed,2010-01-19,02339528,Afinitor,1,L04AH02,Everolimus,Tablet,Oral,02339528,AFINITOR (everolimus 10 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9004628,everolimus 10 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
85419,Marketed,2011-08-05,02369257,Afinitor,1,L04AH02,Everolimus,Tablet,Oral,02369257,AFINITOR (everolimus 2.5 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9004904,everolimus 2.5 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
91028,Marketed,2014-11-28,02425645,Afinitor Disperz,1,L04AH02,Everolimus,Tablet for suspension,Oral,02425645,AFINITOR DISPERZ (everolimus 2 mg dispersible oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9005615,everolimus 2 mg dispersible oral tablet,8001650,everolimus,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
91029,Marketed,2014-11-28,02425653,Afinitor Disperz,1,L04AH02,Everolimus,Tablet for suspension,Oral,02425653,AFINITOR DISPERZ (everolimus 3 mg dispersible oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9005616,everolimus 3 mg dispersible oral tablet,8001650,everolimus,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
91030,Marketed,2014-11-28,02425661,Afinitor Disperz,1,L04AH02,Everolimus,Tablet for suspension,Oral,02425661,AFINITOR DISPERZ (everolimus 5 mg dispersible oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9005617,everolimus 5 mg dispersible oral tablet,8001650,everolimus,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
95113,Marketed,2019-12-06,02463229,Teva-Everolimus,1,L04AH02,Everolimus,Tablet,Oral,02463229,TEVA-EVEROLIMUS (everolimus 2.5 mg oral tablet) TEVA CANADA LIMITED,Active,9004904,everolimus 2.5 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
95114,Marketed,2019-12-06,02463237,Teva-Everolimus,1,L04AH02,Everolimus,Tablet,Oral,02463237,TEVA-EVEROLIMUS (everolimus 5 mg oral tablet) TEVA CANADA LIMITED,Active,9004667,everolimus 5 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
95116,Marketed,2019-12-06,02463253,Teva-Everolimus,1,L04AH02,Everolimus,Tablet,Oral,02463253,TEVA-EVEROLIMUS (everolimus 10 mg oral tablet) TEVA CANADA LIMITED,Active,9004628,everolimus 10 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98290,Marketed,2020-09-17,02492911,Sandoz Everolimus,1,L04AH02,Everolimus,Tablet,Oral,02492911,SANDOZ EVEROLIMUS (everolimus 2.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9004904,everolimus 2.5 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98291,Marketed,2020-09-17,02492938,Sandoz Everolimus,1,L04AH02,Everolimus,Tablet,Oral,02492938,SANDOZ EVEROLIMUS (everolimus 5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9004667,everolimus 5 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98292,Marketed,2020-09-17,02492946,Sandoz Everolimus,1,L04AH02,Everolimus,Tablet,Oral,02492946,SANDOZ EVEROLIMUS (everolimus 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9004628,everolimus 10 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99407,Marketed,2021-09-08,02504677,PMS-Everolimus,1,L04AH02,Everolimus,Tablet,Oral,02504677,PMS-EVEROLIMUS (everolimus 2.5 mg oral tablet) PHARMASCIENCE INC,Active,9004904,everolimus 2.5 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99408,Marketed,2021-09-08,02504685,PMS-Everolimus,1,L04AH02,Everolimus,Tablet,Oral,02504685,PMS-EVEROLIMUS (everolimus 5 mg oral tablet) PHARMASCIENCE INC,Active,9004667,everolimus 5 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99409,Marketed,2021-09-08,02504693,PMS-Everolimus,1,L04AH02,Everolimus,Tablet,Oral,02504693,PMS-EVEROLIMUS (everolimus 10 mg oral tablet) PHARMASCIENCE INC,Active,9004628,everolimus 10 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
103038,Marketed,2023-11-21,02541769,Evkeeza,1,C10AX17,Evinacumab,Solution,Intravenous,77701139,EVKEEZA (evinacumab 345 mg per 2.3 mL solution for injection vial) ULTRAGENYX PHARMACEUTICAL INC,Active,9014942,evinacumab 345 mg per 2.3 mL solution for injection vial,8002486,evinacumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
103038,Marketed,2023-11-21,02541769,Evkeeza,1,C10AX17,Evinacumab,Solution,Intravenous,77701140,EVKEEZA (evinacumab 1200 mg per 8 mL solution for injection vial) ULTRAGENYX PHARMACEUTICAL INC,Active,9014941,evinacumab 1200 mg per 8 mL solution for injection vial,8002486,evinacumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
103038,Marketed,2023-11-21,02541769,Evkeeza,1,C10AX17,Evinacumab,Solution,Intravenous,77701139,EVKEEZA (evinacumab 345 mg per 2.3 mL solution for injection vial) ULTRAGENYX PHARMACEUTICAL INC,Active,9014942,evinacumab 345 mg per 2.3 mL solution for injection vial,8002486,evinacumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
103038,Marketed,2023-11-21,02541769,Evkeeza,1,C10AX17,Evinacumab,Solution,Intravenous,77701140,EVKEEZA (evinacumab 1200 mg per 8 mL solution for injection vial) ULTRAGENYX PHARMACEUTICAL INC,Active,9014941,evinacumab 1200 mg per 8 mL solution for injection vial,8002486,evinacumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
93132,Marketed,2015-09-28,02446057,Repatha,1,C10AX13,Evolocumab,Solution,Subcutaneous,02446057,REPATHA (evolocumab 140 mg per 1 mL solution for injection syringe) AMGEN CANADA INC,Active,9012628,evolocumab 140 mg per 1 mL solution for injection syringe,8001268,evolocumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
93132,Marketed,2015-09-28,02446057,Repatha,1,C10AX13,Evolocumab,Solution,Subcutaneous,02446057,REPATHA (evolocumab 140 mg per 1 mL solution for injection syringe) AMGEN CANADA INC,Active,9012628,evolocumab 140 mg per 1 mL solution for injection syringe,8001268,evolocumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
66502,Marketed,2004-11-16,02242705,Aromasin,1,L02BG06,Exemestane,Tablet,Oral,02242705,AROMASIN (exemestane 25 mg oral tablet) PFIZER CANADA ULC,Active,9003510,exemestane 25 mg oral tablet,8001109,exemestane,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
87564,Marketed,2020-01-31,02390183,Act Exemestane,1,L02BG06,Exemestane,Tablet,Oral,02390183,ACT EXEMESTANE (exemestane 25 mg oral tablet) TEVA CANADA LIMITED,Active,9003510,exemestane 25 mg oral tablet,8001109,exemestane,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
89256,Marketed,2013-12-02,02407841,Med-Exemestane,1,L02BG06,Exemestane,Tablet,Oral,02407841,MED-EXEMESTANE (exemestane 25 mg oral tablet) GENERIC MEDICAL PARTNERS INC,Active,9003510,exemestane 25 mg oral tablet,8001109,exemestane,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102520,Marketed,2024-01-11,02536420,Nra-Ezetimibe Tablets,1,C10AX09,Ezetimibe,Tablet,Oral,02536420,NRA-EZETIMIBE TABLETS (ezetimibe 10 mg oral tablet) NORA PHARMA INC,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71771,Marketed,2022-04-22,02247521,Ezetrol,1,C10AX09,Ezetimibe,Tablet,Oral,02247521,EZETROL (ezetimibe 10 mg oral tablet) ORGANON CANADA INC.,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83931,Marketed,2014-09-15,02354101,Teva-Ezetimibe,1,C10AX09,Ezetimibe,Tablet,Oral,02354101,TEVA-EZETIMIBE (ezetimibe 10 mg oral tablet) TEVA CANADA LIMITED,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90096,Marketed,2014-09-15,02416409,PMS-Ezetimibe,1,C10AX09,Ezetimibe,Tablet,Oral,02416409,PMS-EZETIMIBE (ezetimibe 10 mg oral tablet) PHARMASCIENCE INC,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90134,Marketed,2014-09-15,02416778,Sandoz Ezetimibe,1,C10AX09,Ezetimibe,Tablet,Oral,02416778,SANDOZ EZETIMIBE (ezetimibe 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90416,Marketed,2026-03-11,02419548,SPC-Ezetimibe,1,C10AX09,Ezetimibe,Tablet,Oral,02419548,SPC-EZETIMIBE (ezetimibe 10 mg oral tablet) SUN PHARMA CANADA INC,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90723,Marketed,2018-04-19,02422549,Ezetimibe,1,C10AX09,Ezetimibe,Tablet,Oral,02422549,EZETIMIBE (ezetimibe 10 mg oral tablet) PRO DOC LIMITEE,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90733,Marketed,2014-09-15,02422662,Mar-Ezetimibe,1,C10AX09,Ezetimibe,Tablet,Oral,02422662,MAR-EZETIMIBE (ezetimibe 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90797,Marketed,2014-09-15,02423235,JAMP-Ezetimibe,1,C10AX09,Ezetimibe,Tablet,Oral,02423235,JAMP-EZETIMIBE (ezetimibe 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90798,Marketed,2014-09-15,02423243,Mint-Ezetimibe,1,C10AX09,Ezetimibe,Tablet,Oral,02423243,MINT-EZETIMIBE (ezetimibe 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90986,Marketed,2014-10-08,02425211,Bio-Ezetimibe,1,C10AX09,Ezetimibe,Tablet,Oral,02425211,BIO-EZETIMIBE (ezetimibe 10 mg oral tablet) BIOMED PHARMA,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91025,Marketed,2014-09-17,02425610,ACH-Ezetimibe,1,C10AX09,Ezetimibe,Tablet,Oral,02425610,ACH-EZETIMIBE (ezetimibe 10 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91410,Marketed,2017-03-07,02429659,Ezetimibe,1,C10AX09,Ezetimibe,Tablet,Oral,02429659,EZETIMIBE (ezetimibe 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91572,Marketed,2022-08-04,02431300,Ezetimibe,1,C10AX09,Ezetimibe,Tablet,Oral,02431300,EZETIMIBE (ezetimibe 10 mg oral tablet) SANIS HEALTH INC,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94824,Marketed,2024-06-17,02460750,GLN-Ezetimibe,1,C10AX09,Ezetimibe,Tablet,Oral,02460750,GLN-EZETIMIBE (ezetimibe 10 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95581,Marketed,2017-12-14,02467437,M-Ezetimibe,1,C10AX09,Ezetimibe,Tablet,Oral,02467437,M-EZETIMIBE (ezetimibe 10 mg oral tablet) MANTRA PHARMA INC,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95800,Marketed,2018-04-25,02469286,Auro-Ezetimibe,1,C10AX09,Ezetimibe,Tablet,Oral,02469286,AURO-EZETIMIBE (ezetimibe 10 mg oral tablet) AURO PHARMA INC,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96664,Marketed,2018-07-20,02475898,AG-Ezetimibe,1,C10AX09,Ezetimibe,Tablet,Oral,02475898,AG-EZETIMIBE (ezetimibe 10 mg oral tablet) ANGITA PHARMA INC.,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96932,Marketed,2024-06-11,02478544,Ezetimibe,1,C10AX09,Ezetimibe,Tablet,Oral,02478544,EZETIMIBE (ezetimibe 10 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
42981,Marketed,2021-07-29,02202581,Feiba Nf,1,B02BD03,Factor viii inhibitor bypassing activity,"Kit,Powder for solution",Intravenous,02202581,FEIBA NF (anti-inhibitor coagulant complex 700-1300 unit per vial powder for solution for injection with diluent solution) TAKEDA CANADA INC,Active,9014374,anti-inhibitor coagulant complex 700-1300 unit per vial powder for solution for injection with diluent solution,8002169,anti-inhibitor coagulant complex,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
83912,Marketed,2021-07-29,02353903,Feiba Nf,1,B02BD03,Factor viii inhibitor bypassing activity,"Powder for solution,Kit",Intravenous,02353903,FEIBA NF (anti-inhibitor coagulant complex 1750-3250 unit per vial powder for solution for injection with diluent solution) TAKEDA CANADA INC,Active,9014373,anti-inhibitor coagulant complex 1750-3250 unit per vial powder for solution for injection with diluent solution,8002169,anti-inhibitor coagulant complex,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
18768,Marketed,2025-02-13,02177102,Famvir,1,J05AB09,Famciclovir,Tablet,Oral,02177102,FAMVIR (famciclovir 500 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9002808,famciclovir 500 mg oral tablet,8001203,famciclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
43513,Marketed,2025-02-13,02229110,Famvir,1,J05AB09,Famciclovir,Tablet,Oral,02229110,FAMVIR (famciclovir 125 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9002928,famciclovir 125 mg oral tablet,8001203,famciclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
43514,Marketed,2025-02-13,02229129,Famvir,1,J05AB09,Famciclovir,Tablet,Oral,02229129,FAMVIR (famciclovir 250 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9002929,famciclovir 250 mg oral tablet,8001203,famciclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77739,Marketed,2007-02-22,02292025,Apo-Famciclovir,1,J05AB09,Famciclovir,Tablet,Oral,02292025,APO-FAMCICLOVIR (famciclovir 125 mg oral tablet) APOTEX INC,Active,9002928,famciclovir 125 mg oral tablet,8001203,famciclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77741,Marketed,2007-02-22,02292041,Apo-Famciclovir,1,J05AB09,Famciclovir,Tablet,Oral,02292041,APO-FAMCICLOVIR (famciclovir 250 mg oral tablet) APOTEX INC,Active,9002929,famciclovir 250 mg oral tablet,8001203,famciclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77742,Marketed,2007-02-22,02292068,Apo-Famciclovir,1,J05AB09,Famciclovir,Tablet,Oral,02292068,APO-FAMCICLOVIR (famciclovir 500 mg oral tablet) APOTEX INC,Active,9002808,famciclovir 500 mg oral tablet,8001203,famciclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102708,Marketed,2025-01-27,02538350,Acid Controller Maximum Strength,1,A02BA03,Famotidine,Tablet,Oral,02538350,ACID CONTROLLER MAXIMUM STRENGTH (famotidine 20 mg oral tablet) ANGITA PHARMA INC.,Active,9002571,famotidine 20 mg oral tablet,8001380,famotidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
102732,Marketed,2024-04-30,02538628,Mint-Famotidine,1,A02BA03,Famotidine,Tablet,Oral,02538628,MINT-FAMOTIDINE (famotidine 20 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9002571,famotidine 20 mg oral tablet,8001380,famotidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102733,Marketed,2024-04-30,02538636,Mint-Famotidine,1,A02BA03,Famotidine,Tablet,Oral,02538636,MINT-FAMOTIDINE (famotidine 40 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9002572,famotidine 40 mg oral tablet,8001380,famotidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103798,Marketed,2024-11-13,02549107,Famotidine,1,A02BA03,Famotidine,Tablet,Oral,02549107,FAMOTIDINE (famotidine 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9002571,famotidine 20 mg oral tablet,8001380,famotidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103799,Marketed,2024-11-13,02549115,Famotidine,1,A02BA03,Famotidine,Tablet,Oral,02549115,FAMOTIDINE (famotidine 40 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9002572,famotidine 40 mg oral tablet,8001380,famotidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
13654,Marketed,2014-04-03,02022133,Teva-Famotidine,1,A02BA03,Famotidine,Tablet,Oral,02022133,TEVA-FAMOTIDINE (famotidine 20 mg oral tablet) TEVA CANADA LIMITED,Active,9002571,famotidine 20 mg oral tablet,8001380,famotidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
13655,Marketed,2014-04-03,02022141,Teva-Famotidine,1,A02BA03,Famotidine,Tablet,Oral,02022141,TEVA-FAMOTIDINE (famotidine 40 mg oral tablet) TEVA CANADA LIMITED,Active,9002572,famotidine 40 mg oral tablet,8001380,famotidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
42879,Marketed,2025-11-28,02185938,Pepcid AC,1,A02BA03,Famotidine,Tablet,Oral,02185938,PEPCID AC (famotidine 10 mg oral tablet) KENVUE CANADA INC.,Active,9002889,famotidine 10 mg oral tablet,8001380,famotidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
72016,Marketed,2003-10-30,02247735,Famotidine Omega -(Without Preservative),1,A02BA03,Famotidine,Solution,Intravenous,02247735,FAMOTIDINE OMEGA -(WITHOUT PRESERVATIVE) (famotidine 20 mg per 2 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9012708,famotidine 20 mg per 2 mL solution for injection vial,8001380,famotidine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
72026,Marketed,2003-10-31,02247745,"Famotidine Omega  -(With Preservative,Benzyl Alcohol)",1,A02BA03,Famotidine,Solution,Intravenous,77700609,"FAMOTIDINE OMEGA  -(WITH PRESERVATIVE,BENZYL ALCOHOL) (famotidine 40 mg per 4 mL solution for injection vial) OMEGA LABORATORIES LIMITED",Active,9012709,famotidine 40 mg per 4 mL solution for injection vial,8001380,famotidine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
72026,Marketed,2003-10-31,02247745,"Famotidine Omega  -(With Preservative,Benzyl Alcohol)",1,A02BA03,Famotidine,Solution,Intravenous,77700610,"FAMOTIDINE OMEGA  -(WITH PRESERVATIVE,BENZYL ALCOHOL) (famotidine 10 mg per mL solution for injection 20 mL vial) OMEGA LABORATORIES LIMITED",Active,9012707,famotidine 10 mg per mL solution for injection 20 mL vial,8001380,famotidine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
75884,Marketed,2025-11-28,02273357,Maximum Strength Pepcid AC,1,A02BA03,Famotidine,Tablet,Oral,02273357,MAXIMUM STRENGTH PEPCID AC (famotidine 20 mg oral tablet) KENVUE CANADA INC.,Active,9002571,famotidine 20 mg oral tablet,8001380,famotidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
83631,Marketed,2024-10-24,02351102,Famotidine,1,A02BA03,Famotidine,Tablet,Oral,02351102,FAMOTIDINE (famotidine 20 mg oral tablet) SANIS HEALTH INC,Active,9002571,famotidine 20 mg oral tablet,8001380,famotidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83632,Marketed,2024-10-24,02351110,Famotidine,1,A02BA03,Famotidine,Tablet,Oral,02351110,FAMOTIDINE (famotidine 40 mg oral tablet) SANIS HEALTH INC,Active,9002572,famotidine 40 mg oral tablet,8001380,famotidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99714,Marketed,2021-09-21,02507749,JAMP Famotidine,1,A02BA03,Famotidine,Tablet,Oral,02507749,JAMP FAMOTIDINE (famotidine 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9002571,famotidine 20 mg oral tablet,8001380,famotidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99715,Marketed,2021-09-17,02507757,JAMP Famotidine,1,A02BA03,Famotidine,Tablet,Oral,02507757,JAMP FAMOTIDINE (famotidine 40 mg oral tablet) JAMP PHARMA CORPORATION,Active,9002572,famotidine 40 mg oral tablet,8001380,famotidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99923,Marketed,2021-09-21,02509970,AG-Famotidine,1,A02BA03,Famotidine,Tablet,Oral,02509970,AG-FAMOTIDINE (famotidine 20 mg oral tablet) ANGITA PHARMA INC.,Active,9002571,famotidine 20 mg oral tablet,8001380,famotidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99924,Marketed,2021-09-21,02509989,AG-Famotidine,1,A02BA03,Famotidine,Tablet,Oral,02509989,AG-FAMOTIDINE (famotidine 40 mg oral tablet) ANGITA PHARMA INC.,Active,9002572,famotidine 40 mg oral tablet,8001380,famotidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
66915,Marketed,2025-12-18,02243053,Pepcid Complete,3,A02BA53,"Famotidine, combinations",Tablet (chewable),Oral,02243053,PEPCID COMPLETE (calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet) KENVUE CANADA INC.,Active,9003599,calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet,8002096,calcium carbonate and famotidine and magnesium hydroxide,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
86577,Marketed,2026-01-08,02379910,Fampyra,1,N07XX07,Fampridine,Tablet (extended-release),Oral,02379910,FAMPYRA (fampridine 10 mg prolonged-release oral tablet) MERZ THERAPEUTICS GMBH,Active,9004991,fampridine 10 mg prolonged-release oral tablet,8001651,fampridine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97285,Marketed,2020-11-24,02482398,Taro-Fampridine,1,N07XX07,Fampridine,Tablet (extended-release),Oral,02482398,TARO-FAMPRIDINE (fampridine 10 mg prolonged-release oral tablet) TARO PHARMACEUTICALS INC,Active,9004991,fampridine 10 mg prolonged-release oral tablet,8001651,fampridine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98608,Marketed,2021-04-12,02496216,PMS-Fampridine,1,N07XX07,Fampridine,Tablet (extended-release),Oral,02496216,PMS-FAMPRIDINE (fampridine 10 mg prolonged-release oral tablet) PHARMASCIENCE INC,Active,9004991,fampridine 10 mg prolonged-release oral tablet,8001651,fampridine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101666,Marketed,2022-07-18,02527618,Vabysmo,1,S01LA09,Faricimab,Solution,Intravitreal,02527618,VABYSMO (faricimab 6 mg per 0.05 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9014739,faricimab 6 mg per 0.05 mL solution for injection vial,8002427,faricimab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
101666,Marketed,2022-07-18,02527618,Vabysmo,1,S01LA09,Faricimab,Solution,Intravitreal,02527618,VABYSMO (faricimab 6 mg per 0.05 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9014739,faricimab 6 mg per 0.05 mL solution for injection vial,8002427,faricimab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
104289,Marketed,2025-06-30,02554003,Vabysmo,1,S01LA09,Faricimab,Solution,Intravitreal,02554003,VABYSMO (faricimab 6 mg per 0.05 mL solution for injection syringe) HOFFMANN-LA ROCHE LIMITED,Active,9015234,faricimab 6 mg per 0.05 mL solution for injection syringe,8002427,faricimab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe,,,,Prescription
104289,Marketed,2025-06-30,02554003,Vabysmo,1,S01LA09,Faricimab,Solution,Intravitreal,02554003,VABYSMO (faricimab 6 mg per 0.05 mL solution for injection syringe) HOFFMANN-LA ROCHE LIMITED,Active,9015234,faricimab 6 mg per 0.05 mL solution for injection syringe,8002427,faricimab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe,,,,Schedule D
18647,Marketed,2015-10-19,02065673,Intralipid 20%,1,B05BA02,Fat emulsions,Emulsion,Intravenous,,,,,,,,,,,,,,,,,Ethical
82981,Marketed,2012-03-28,02344327,Clinoleic 20%,2,B05BA02,Fat emulsions,Emulsion,Intravenous,,,,,,,,,,,,,,,,,Ethical
88197,Marketed,2016-02-09,02396963,Smoflipid 20%,4,B05BA02,Fat emulsions,Emulsion,Intravenous,,,,,,,,,,,,,,,,,Ethical
102225,Marketed,2023-05-15,02533243,Auro-Febuxostat,1,M04AA03,Febuxostat,Tablet,Oral,02533243,AURO-FEBUXOSTAT (febuxostat (febuxostat hemihydrate) 80 mg oral tablet) AURO PHARMA INC,Active,9004776,febuxostat 80 mg oral tablet,8001652,febuxostat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102857,Marketed,2023-12-07,02539837,Febuxostat,1,M04AA03,Febuxostat,Tablet,Oral,02539837,FEBUXOSTAT (febuxostat (febuxostat hemihydrate) 80 mg oral tablet) SANIS HEALTH INC,Active,9004776,febuxostat 80 mg oral tablet,8001652,febuxostat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103827,Marketed,2025-04-25,02549425,M-Febuxostat,1,M04AA03,Febuxostat,Tablet,Oral,02549425,M-FEBUXOSTAT (febuxostat (febuxostat hemihydrate) 80 mg oral tablet) MANTRA PHARMA INC,Active,9004776,febuxostat 80 mg oral tablet,8001652,febuxostat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95449,Marketed,2019-11-28,02466198,Teva-Febuxostat,1,M04AA03,Febuxostat,Tablet,Oral,02466198,TEVA-FEBUXOSTAT (febuxostat (febuxostat hemihydrate) 80 mg oral tablet) TEVA CANADA LIMITED,Active,9004776,febuxostat 80 mg oral tablet,8001652,febuxostat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96300,Marketed,2019-05-16,02473607,Mar-Febuxostat,1,M04AA03,Febuxostat,Tablet,Oral,02473607,MAR-FEBUXOSTAT (febuxostat (febuxostat hemihydrate) 80 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9004776,febuxostat 80 mg oral tablet,8001652,febuxostat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98091,Marketed,2020-02-25,02490870,JAMP Febuxostat,1,M04AA03,Febuxostat,Tablet,Oral,02490870,JAMP FEBUXOSTAT (febuxostat 80 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004776,febuxostat 80 mg oral tablet,8001652,febuxostat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99202,Marketed,2025-02-03,02502445,Inrebic,1,L01EJ02,Fedratinib,Capsule,Oral,02502445,INREBIC (fedratinib (fedratinib hydrochloride) 100 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9014546,fedratinib (fedratinib hydrochloride) 100 mg oral capsule,8002374,fedratinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
12458,Marketed,2024-08-07,00851779,Plendil,1,C08CA02,Felodipine,Tablet (extended-release),Oral,00851779,PLENDIL (felodipine 5 mg prolonged-release oral tablet) GLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE,Active,9000423,felodipine 5 mg prolonged-release oral tablet,8000165,felodipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
12459,Marketed,2024-08-07,00851787,Plendil,1,C08CA02,Felodipine,Tablet (extended-release),Oral,00851787,PLENDIL (felodipine 10 mg prolonged-release oral tablet) GLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE,Active,9000422,felodipine 10 mg prolonged-release oral tablet,8000165,felodipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
15574,Marketed,2024-08-07,02057778,Plendil,1,C08CA02,Felodipine,Tablet (extended-release),Oral,02057778,PLENDIL (felodipine 2.5 mg prolonged-release oral tablet) GLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE,Active,9000518,felodipine 2.5 mg prolonged-release oral tablet,8000165,felodipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76593,Marketed,2006-08-15,02280264,Sandoz Felodipine,1,C08CA02,Felodipine,Tablet (extended-release),Oral,02280264,SANDOZ FELODIPINE (felodipine 5 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9000423,felodipine 5 mg prolonged-release oral tablet,8000165,felodipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76594,Marketed,2006-08-15,02280272,Sandoz Felodipine,1,C08CA02,Felodipine,Tablet (extended-release),Oral,02280272,SANDOZ FELODIPINE (felodipine 10 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9000422,felodipine 10 mg prolonged-release oral tablet,8000165,felodipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93875,Marketed,2016-04-22,02452367,Apo-Felodipine,1,C08CA02,Felodipine,Tablet (extended-release),Oral,02452367,APO-FELODIPINE (felodipine 2.5 mg prolonged-release oral tablet) APOTEX INC,Active,9000518,felodipine 2.5 mg prolonged-release oral tablet,8000165,felodipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93876,Marketed,2016-04-22,02452375,Apo-Felodipine,1,C08CA02,Felodipine,Tablet (extended-release),Oral,02452375,APO-FELODIPINE (felodipine 5 mg prolonged-release oral tablet) APOTEX INC,Active,9000423,felodipine 5 mg prolonged-release oral tablet,8000165,felodipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93877,Marketed,2016-04-22,02452383,Apo-Felodipine,1,C08CA02,Felodipine,Tablet (extended-release),Oral,02452383,APO-FELODIPINE (felodipine 10 mg prolonged-release oral tablet) APOTEX INC,Active,9000422,felodipine 10 mg prolonged-release oral tablet,8000165,felodipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
63352,Marketed,2020-01-21,02239864,AA-Feno-Micro,1,C10AB05,Fenofibrate,Capsule,Oral,02239864,AA-FENO-MICRO (fenofibrate 200 mg oral capsule) AA PHARMA INC,Active,9000841,fenofibrate 200 mg oral capsule,8000225,fenofibrate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
65259,Marketed,2016-03-08,02241602,Lipidil Supra,1,C10AB05,Fenofibrate,Tablet,Oral,02241602,LIPIDIL SUPRA (fenofibrate 160 mg oral tablet) BGP PHARMA ULC,Active,9000886,fenofibrate 160 mg oral tablet,8000225,fenofibrate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
67060,Marketed,2019-11-15,02243180,AA-Feno-Micro,1,C10AB05,Fenofibrate,Capsule,Oral,02243180,AA-FENO-MICRO (fenofibrate 67 mg oral capsule) AA PHARMA INC,Active,9000931,fenofibrate 67 mg oral capsule,8000225,fenofibrate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
71082,Marketed,2021-09-24,02246859,AA-Feno-Super,1,C10AB05,Fenofibrate,Tablet,Oral,02246859,AA-FENO-SUPER (fenofibrate 100 mg oral tablet) AA PHARMA INC,Active,9001142,fenofibrate 100 mg oral tablet,8000225,fenofibrate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71083,Marketed,2021-09-24,02246860,AA-Feno-Super,1,C10AB05,Fenofibrate,Tablet,Oral,02246860,AA-FENO-SUPER (fenofibrate 160 mg oral tablet) AA PHARMA INC,Active,9000886,fenofibrate 160 mg oral tablet,8000225,fenofibrate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75447,Marketed,2016-04-12,02269074,Lipidil EZ,1,C10AB05,Fenofibrate,Tablet,Oral,02269074,LIPIDIL EZ (fenofibrate 48 mg oral tablet) BGP PHARMA ULC,Active,9001123,fenofibrate 48 mg oral tablet,8000225,fenofibrate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75448,Marketed,2015-04-01,02269082,Lipidil EZ,1,C10AB05,Fenofibrate,Tablet,Oral,02269082,LIPIDIL EZ (fenofibrate 145 mg oral tablet) BGP PHARMA ULC,Active,9001122,fenofibrate 145 mg oral tablet,8000225,fenofibrate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87610,Marketed,2012-12-12,02390698,Sandoz Fenofibrate E,1,C10AB05,Fenofibrate,Tablet,Oral,02390698,SANDOZ FENOFIBRATE E (fenofibrate 48 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001123,fenofibrate 48 mg oral tablet,8000225,fenofibrate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87611,Marketed,2012-08-24,02390701,Sandoz Fenofibrate E,1,C10AB05,Fenofibrate,Tablet,Oral,02390701,SANDOZ FENOFIBRATE E (fenofibrate 145 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001122,fenofibrate 145 mg oral tablet,8000225,fenofibrate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94139,Marketed,2025-11-07,02454696,SPC-Fenofibrate E,1,C10AB05,Fenofibrate,Tablet,Oral,02454696,SPC-FENOFIBRATE E (fenofibrate 145 mg oral tablet) SUN PHARMA CANADA INC,Active,9001122,fenofibrate 145 mg oral tablet,8000225,fenofibrate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
63983,Marketed,2005-08-26,02240434,Fentanyl Citrate Injection USP,1,N01AH01,Fentanyl,Solution,"Intramuscular,Epidural,Intravenous",77700447,FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9000321,fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,,Narcotics (CDSA I)
63983,Marketed,2005-08-26,02240434,Fentanyl Citrate Injection USP,1,N01AH01,Fentanyl,Solution,"Intramuscular,Epidural,Intravenous",77700448,FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 250 mcg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000885,fentanyl (fentanyl citrate) 250 mcg per 5 mL solution for injection vial,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
63983,Marketed,2005-08-26,02240434,Fentanyl Citrate Injection USP,1,N01AH01,Fentanyl,Solution,"Intramuscular,Epidural,Intravenous",77700449,FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000324,fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection vial,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
63983,Marketed,2005-08-26,02240434,Fentanyl Citrate Injection USP,1,N01AH01,Fentanyl,Solution,"Intramuscular,Epidural,Intravenous",77700450,FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 1000 mcg per 20 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000320,fentanyl (fentanyl citrate) 1000 mcg per 20 mL solution for injection vial,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
63983,Marketed,2005-08-26,02240434,Fentanyl Citrate Injection USP,1,N01AH01,Fentanyl,Solution,"Intramuscular,Epidural,Intravenous",77700451,FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 50 mcg per mL solution for injection 50 mL vial) SANDOZ CANADA INCORPORATED,Active,9014297,fentanyl (fentanyl citrate) 50 mcg per mL solution for injection 50 mL vial,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
76857,Marketed,2012-12-21,02282941,Teva-Fentanyl,1,N02AB03,Fentanyl,Patch,Transdermal,02282941,TEVA-FENTANYL (fentanyl 25 mcg per hour transdermal patch) TEVA CANADA LIMITED,Active,9001162,fentanyl 25 mcg per hour transdermal patch,8000127,fentanyl,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,1.0,,Narcotics (CDSA I)
76858,Marketed,2012-12-21,02282968,Teva-Fentanyl,1,N02AB03,Fentanyl,Patch,Transdermal,02282968,TEVA-FENTANYL (fentanyl 50 mcg per hour transdermal patch) TEVA CANADA LIMITED,Active,9001163,fentanyl 50 mcg per hour transdermal patch,8000127,fentanyl,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,1.0,,Narcotics (CDSA I)
76859,Marketed,2012-12-21,02282976,Teva-Fentanyl,1,N02AB03,Fentanyl,Patch,Transdermal,02282976,TEVA-FENTANYL (fentanyl 75 mcg per hour transdermal patch) TEVA CANADA LIMITED,Active,9001164,fentanyl 75 mcg per hour transdermal patch,8000127,fentanyl,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,1.0,,Narcotics (CDSA I)
76860,Marketed,2012-12-21,02282984,Teva-Fentanyl,1,N02AB03,Fentanyl,Patch,Transdermal,02282984,TEVA-FENTANYL (fentanyl 100 mcg per hour transdermal patch) TEVA CANADA LIMITED,Active,9001161,fentanyl 100 mcg per hour transdermal patch,8000127,fentanyl,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,1.0,,Narcotics (CDSA I)
79746,Marketed,2012-12-21,02311925,Teva-Fentanyl,1,N02AB03,Fentanyl,Patch,Transdermal,02311925,TEVA-FENTANYL (fentanyl 12 mcg per hour transdermal patch) TEVA CANADA LIMITED,Active,9001249,fentanyl 12 mcg per hour transdermal patch,8000127,fentanyl,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,1.0,,Narcotics (CDSA I)
81243,Marketed,2010-11-01,02327112,Sandoz Fentanyl Patch,1,N02AB03,Fentanyl,Patch,Transdermal,02327112,SANDOZ FENTANYL PATCH (fentanyl 12 mcg per hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9001249,fentanyl 12 mcg per hour transdermal patch,8000127,fentanyl,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,1.0,,Narcotics (CDSA I)
81244,Marketed,2010-11-01,02327120,Sandoz Fentanyl Patch,1,N02AB03,Fentanyl,Patch,Transdermal,02327120,SANDOZ FENTANYL PATCH (fentanyl 25 mcg per hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9001162,fentanyl 25 mcg per hour transdermal patch,8000127,fentanyl,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,1.0,,Narcotics (CDSA I)
81245,Marketed,2010-11-01,02327139,Sandoz Fentanyl Patch,1,N02AB03,Fentanyl,Patch,Transdermal,02327139,SANDOZ FENTANYL PATCH (fentanyl 37 mcg per hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9001326,fentanyl 37 mcg per hour transdermal patch,8000127,fentanyl,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,1.0,,Narcotics (CDSA I)
81246,Marketed,2010-11-01,02327147,Sandoz Fentanyl Patch,1,N02AB03,Fentanyl,Patch,Transdermal,02327147,SANDOZ FENTANYL PATCH (fentanyl 50 mcg per hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9001163,fentanyl 50 mcg per hour transdermal patch,8000127,fentanyl,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,1.0,,Narcotics (CDSA I)
81247,Marketed,2010-11-01,02327155,Sandoz Fentanyl Patch,1,N02AB03,Fentanyl,Patch,Transdermal,02327155,SANDOZ FENTANYL PATCH (fentanyl 75 mcg per hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9001164,fentanyl 75 mcg per hour transdermal patch,8000127,fentanyl,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,1.0,,Narcotics (CDSA I)
81248,Marketed,2010-11-01,02327163,Sandoz Fentanyl Patch,1,N02AB03,Fentanyl,Patch,Transdermal,02327163,SANDOZ FENTANYL PATCH (fentanyl 100 mcg per hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9001161,fentanyl 100 mcg per hour transdermal patch,8000127,fentanyl,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,1.0,,Narcotics (CDSA I)
86987,Marketed,2021-01-19,02384124,Fentanyl Citrate Injection SDZ,1,N01AH01,Fentanyl,Solution,"Epidural,Intravenous,Intramuscular",77700486,FENTANYL CITRATE INJECTION SDZ (fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9000321,fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,,Narcotics (CDSA I)
86987,Marketed,2021-01-19,02384124,Fentanyl Citrate Injection SDZ,1,N01AH01,Fentanyl,Solution,"Epidural,Intravenous,Intramuscular",77700487,FENTANYL CITRATE INJECTION SDZ (fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9000323,fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection ampoule,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,,Narcotics (CDSA I)
89270,Marketed,2014-05-14,02408007,Fentora,1,N02AB03,Fentanyl,Tablet (effervescent),"Buccal,Sublingual",02408007,FENTORA (fentanyl (fentanyl citrate) 100 mcg buccal tablet) TEVA CANADA LIMITED,Active,9001424,fentanyl (fentanyl citrate) 100 mcg buccal tablet,8000127,fentanyl,54471007,Buccal,385055001,Tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
89271,Marketed,2014-05-14,02408015,Fentora,1,N02AB03,Fentanyl,Tablet (effervescent),"Buccal,Sublingual",02408015,FENTORA (fentanyl (fentanyl citrate) 200 mcg buccal tablet) TEVA CANADA LIMITED,Active,9001425,fentanyl (fentanyl citrate) 200 mcg buccal tablet,8000127,fentanyl,54471007,Buccal,385055001,Tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
89272,Marketed,2014-05-14,02408023,Fentora,1,N02AB03,Fentanyl,Tablet (effervescent),"Sublingual,Buccal",02408023,FENTORA (fentanyl (fentanyl citrate) 400 mcg buccal tablet) TEVA CANADA LIMITED,Active,9001426,fentanyl (fentanyl citrate) 400 mcg buccal tablet,8000127,fentanyl,54471007,Buccal,385055001,Tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
89273,Marketed,2014-05-14,02408031,Fentora,1,N02AB03,Fentanyl,Tablet (effervescent),"Sublingual,Buccal",02408031,FENTORA (fentanyl (fentanyl citrate) 600 mcg buccal tablet) TEVA CANADA LIMITED,Active,9001427,fentanyl (fentanyl citrate) 600 mcg buccal tablet,8000127,fentanyl,54471007,Buccal,385055001,Tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
89274,Marketed,2014-05-14,02408058,Fentora,1,N02AB03,Fentanyl,Tablet (effervescent),"Buccal,Sublingual",02408058,FENTORA (fentanyl (fentanyl citrate) 800 mcg buccal tablet) TEVA CANADA LIMITED,Active,9001428,fentanyl (fentanyl citrate) 800 mcg buccal tablet,8000127,fentanyl,54471007,Buccal,385055001,Tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
98602,Marketed,2020-09-09,02496143,Fentanyl Injection BP,1,N01AH01,Fentanyl,Solution,"Intravenous,Intramuscular,Epidural",02496143,FENTANYL INJECTION BP (fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule) STERIMAX INC,Active,9000321,fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,,Narcotics (CDSA I)
98603,Marketed,2020-04-23,02496151,Fentanyl Injection BP,1,N01AH01,Fentanyl,Solution,"Intravenous,Intramuscular,Epidural",02496151,FENTANYL INJECTION BP (fentanyl (fentanyl citrate) 250 mcg per 5 mL solution for injection vial) STERIMAX INC,Active,9000885,fentanyl (fentanyl citrate) 250 mcg per 5 mL solution for injection vial,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
98604,Marketed,2020-04-23,02496178,Fentanyl Injection BP,1,N01AH01,Fentanyl,Solution,"Intramuscular,Intravenous,Epidural",02496178,FENTANYL INJECTION BP (fentanyl (fentanyl citrate) 1000 mcg per 20 mL solution for injection vial) STERIMAX INC,Active,9000320,fentanyl (fentanyl citrate) 1000 mcg per 20 mL solution for injection vial,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
98605,Marketed,2020-04-23,02496186,Fentanyl Injection BP,1,N01AH01,Fentanyl,Solution,"Intramuscular,Epidural,Intravenous",02496186,FENTANYL INJECTION BP (fentanyl (fentanyl citrate) 50 mcg per mL solution for injection 50 mL vial) STERIMAX INC,Active,9014297,fentanyl (fentanyl citrate) 50 mcg per mL solution for injection 50 mL vial,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
99116,Marketed,2021-06-18,02501554,"Fentanyl Citrate Injection, USP",1,N01AH01,Fentanyl,Solution,"Intramuscular,Intravenous,Epidural",77701082,"FENTANYL CITRATE INJECTION, USP (fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9014567,fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection vial,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
99116,Marketed,2021-06-18,02501554,"Fentanyl Citrate Injection, USP",1,N01AH01,Fentanyl,Solution,"Intramuscular,Intravenous,Epidural",77701083,"FENTANYL CITRATE INJECTION, USP (fentanyl (fentanyl citrate) 250 mcg per 5 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9000885,fentanyl (fentanyl citrate) 250 mcg per 5 mL solution for injection vial,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
99116,Marketed,2021-06-18,02501554,"Fentanyl Citrate Injection, USP",1,N01AH01,Fentanyl,Solution,"Intramuscular,Intravenous,Epidural",77701084,"FENTANYL CITRATE INJECTION, USP (fentanyl (fentanyl citrate) 50 mcg per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9014568,fentanyl (fentanyl citrate) 50 mcg per 1 mL solution for injection vial,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
99116,Marketed,2021-06-18,02501554,"Fentanyl Citrate Injection, USP",1,N01AH01,Fentanyl,Solution,"Intramuscular,Intravenous,Epidural",77701085,"FENTANYL CITRATE INJECTION, USP (fentanyl (fentanyl citrate) 50 mcg per mL solution for injection 50 mL vial) FRESENIUS KABI CANADA LTD",Active,9014297,fentanyl (fentanyl citrate) 50 mcg per mL solution for injection 50 mL vial,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
99116,Marketed,2021-06-18,02501554,"Fentanyl Citrate Injection, USP",1,N01AH01,Fentanyl,Solution,"Intramuscular,Intravenous,Epidural",77701086,"FENTANYL CITRATE INJECTION, USP (fentanyl (fentanyl citrate) 1000 mcg per 20 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9000320,fentanyl (fentanyl citrate) 1000 mcg per 20 mL solution for injection vial,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
99638,Marketed,2022-06-06,02506963,Fentanyl Citrate Injection,1,N01AH01,Fentanyl,Solution,"Intramuscular,Intravenous,Epidural",77701109,FENTANYL CITRATE INJECTION (fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection ampoule) JAMP PHARMA CORPORATION,Active,9000323,fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection ampoule,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,,Narcotics (CDSA I)
99638,Marketed,2022-06-06,02506963,Fentanyl Citrate Injection,1,N01AH01,Fentanyl,Solution,"Intramuscular,Intravenous,Epidural",77701110,FENTANYL CITRATE INJECTION (fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule) JAMP PHARMA CORPORATION,Active,9000321,fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,,Narcotics (CDSA I)
103946,Marketed,2025-02-28,02550679,Accrufer,1,B03AB10,Ferric maltol,Capsule,Oral,02550679,ACCRUFER (iron (ferric maltol) 30 mg oral capsule) KYE PHARMACEUTICALS INC.,Active,9015177,iron (ferric maltol) 30 mg oral capsule,8002534,ferric maltol,26643006,Oral,420692007,Oral capsule,732937005,Capsule,,,,Prescription
101095,Marketed,2022-05-02,02521768,Sandoz Fesoterodine Fumarate,1,G04BD11,Fesoterodine,Tablet (extended-release),Oral,02521768,SANDOZ FESOTERODINE FUMARATE (fesoterodine fumarate 4 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9005022,fesoterodine fumarate 4 mg prolonged-release oral tablet,8001123,fesoterodine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101096,Marketed,2022-05-02,02521776,Sandoz Fesoterodine Fumarate,1,G04BD11,Fesoterodine,Tablet (extended-release),Oral,02521776,SANDOZ FESOTERODINE FUMARATE (fesoterodine fumarate 8 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9005023,fesoterodine fumarate 8 mg prolonged-release oral tablet,8001123,fesoterodine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102481,Marketed,2026-05-21,02535998,ACH-Fesoterodine,1,G04BD11,Fesoterodine,Tablet (extended-release),Oral,02535998,ACH-FESOTERODINE (fesoterodine fumarate 4 mg prolonged-release oral tablet) ACCORD HEALTHCARE INC,Active,9005022,fesoterodine fumarate 4 mg prolonged-release oral tablet,8001123,fesoterodine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102482,Marketed,2026-05-21,02536005,ACH-Fesoterodine,1,G04BD11,Fesoterodine,Tablet (extended-release),Oral,02536005,ACH-FESOTERODINE (fesoterodine fumarate 8 mg prolonged-release oral tablet) ACCORD HEALTHCARE INC,Active,9005023,fesoterodine fumarate 8 mg prolonged-release oral tablet,8001123,fesoterodine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86587,Marketed,2012-04-19,02380021,Toviaz,1,G04BD11,Fesoterodine,Tablet (extended-release),Oral,02380021,TOVIAZ (fesoterodine fumarate 4 mg prolonged-release oral tablet) PFIZER CANADA ULC,Active,9005022,fesoterodine fumarate 4 mg prolonged-release oral tablet,8001123,fesoterodine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86588,Marketed,2012-04-19,02380048,Toviaz,1,G04BD11,Fesoterodine,Tablet (extended-release),Oral,02380048,TOVIAZ (fesoterodine fumarate 8 mg prolonged-release oral tablet) PFIZER CANADA ULC,Active,9005023,fesoterodine fumarate 8 mg prolonged-release oral tablet,8001123,fesoterodine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101047,Marketed,2023-01-19,02521245,Allegra Hives,1,R06AX26,Fexofenadine,Tablet,Oral,02521245,ALLEGRA HIVES (fexofenadine hydrochloride 60 mg oral tablet) SANOFI CONSUMER HEALTH INC,Active,9003118,fexofenadine hydrochloride 60 mg oral tablet,8001466,fexofenadine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
50779,Marketed,2019-11-15,02231462,Allegra 12 Hour,1,R06AX26,Fexofenadine,Tablet,Oral,02231462,ALLEGRA 12 HOUR (fexofenadine hydrochloride 60 mg oral tablet) SANOFI CONSUMER HEALTH INC,Active,9003118,fexofenadine hydrochloride 60 mg oral tablet,8001466,fexofenadine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
66647,Marketed,2019-11-15,02242819,Allegra 24 Hour,1,R06AX26,Fexofenadine,Tablet,Oral,02242819,ALLEGRA 24 HOUR (fexofenadine hydrochloride 120 mg oral tablet) SANOFI CONSUMER HEALTH INC,Active,9003554,fexofenadine hydrochloride 120 mg oral tablet,8001466,fexofenadine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
104252,Marketed,2025-03-11,02553600,Veozah,1,G02CX06,Fezolinetant,Tablet,Oral,02553600,VEOZAH (fezolinetant 45 mg oral tablet) ASTELLAS PHARMA CANADA INC,Active,9015176,fezolinetant 45 mg oral tablet,8002535,fezolinetant,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,,Prescription
87858,Marketed,2013-01-31,02393352,Riastap,1,B02BB01,"Fibrinogen, human",Powder for solution,Intravenous,02393352,RIASTAP (fibrinogen human 1 g per vial powder for solution for injection with diluent solution) CSL BEHRING CANADA INC,Active,9014111,fibrinogen human 1 g per vial powder for solution for injection with diluent solution,8002281,fibrinogen human,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
95274,Marketed,2018-08-08,02464616,Fibryga,1,B02BB01,"Fibrinogen, human",Powder for solution,Intravenous,02464616,FIBRYGA (fibrinogen human 1 g per vial powder for solution for injection) OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H,Active,9014110,fibrinogen human 1 g per vial powder for solution for injection,8002281,fibrinogen human,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
87275,Marketed,2016-09-20,02387174,Dificid,1,A07AA12,Fidaxomicin,Tablet,Oral,02387174,DIFICID (fidaxomicin 200 mg oral tablet) MERCK CANADA INC,Active,9005056,fidaxomicin 200 mg oral tablet,8001773,fidaxomicin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101023,Marketed,2024-01-24,02520990,Nypozi,1,L03AA02,Filgrastim,Solution,"Intravenous,Subcutaneous",02520990,"NYPOZI (filgrastim 300 mcg per 0.5 mL solution for injection syringe) TANVEX BIOPHARMA USA, INC.",Active,9013119,filgrastim 300 mcg per 0.5 mL solution for injection syringe,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
101023,Marketed,2024-01-24,02520990,Nypozi,1,L03AA02,Filgrastim,Solution,"Intravenous,Subcutaneous",02520990,"NYPOZI (filgrastim 300 mcg per 0.5 mL solution for injection syringe) TANVEX BIOPHARMA USA, INC.",Active,9013119,filgrastim 300 mcg per 0.5 mL solution for injection syringe,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
101024,Marketed,2024-01-24,02521008,Nypozi,1,L03AA02,Filgrastim,Solution,"Intravenous,Subcutaneous",02521008,"NYPOZI (filgrastim 480 mcg per 0.8 mL solution for injection syringe) TANVEX BIOPHARMA USA, INC.",Active,9013121,filgrastim 480 mcg per 0.8 mL solution for injection syringe,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
101024,Marketed,2024-01-24,02521008,Nypozi,1,L03AA02,Filgrastim,Solution,"Intravenous,Subcutaneous",02521008,"NYPOZI (filgrastim 480 mcg per 0.8 mL solution for injection syringe) TANVEX BIOPHARMA USA, INC.",Active,9013121,filgrastim 480 mcg per 0.8 mL solution for injection syringe,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
104522,Marketed,2025-09-16,02556537,Filra,1,L03AA02,Filgrastim,Solution,"Subcutaneous,Intravenous",02556537,FILRA (filgrastim 300 mcg per 0.5 mL solution for injection syringe) JAMP PHARMA CORPORATION,Active,9013119,filgrastim 300 mcg per 0.5 mL solution for injection syringe,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
104522,Marketed,2025-09-16,02556537,Filra,1,L03AA02,Filgrastim,Solution,"Subcutaneous,Intravenous",02556537,FILRA (filgrastim 300 mcg per 0.5 mL solution for injection syringe) JAMP PHARMA CORPORATION,Active,9013119,filgrastim 300 mcg per 0.5 mL solution for injection syringe,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
104523,Marketed,2025-09-16,02556545,Filra,1,L03AA02,Filgrastim,Solution,"Intravenous,Subcutaneous",02556545,FILRA (filgrastim 480 mcg per 0.8 mL solution for injection syringe) JAMP PHARMA CORPORATION,Active,9013121,filgrastim 480 mcg per 0.8 mL solution for injection syringe,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
104523,Marketed,2025-09-16,02556545,Filra,1,L03AA02,Filgrastim,Solution,"Intravenous,Subcutaneous",02556545,FILRA (filgrastim 480 mcg per 0.8 mL solution for injection syringe) JAMP PHARMA CORPORATION,Active,9013121,filgrastim 480 mcg per 0.8 mL solution for injection syringe,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
12474,Marketed,2002-06-20,01968017,Neupogen,1,L03AA02,Filgrastim,Solution,"Intravenous,Subcutaneous",77700711,NEUPOGEN (filgrastim 480 mcg per 1.6 mL solution for injection vial) AMGEN CANADA INC,Active,9013122,filgrastim 480 mcg per 1.6 mL solution for injection vial,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
12474,Marketed,2002-06-20,01968017,Neupogen,1,L03AA02,Filgrastim,Solution,"Intravenous,Subcutaneous",77700712,NEUPOGEN (filgrastim 300 mcg per 1 mL solution for injection vial) AMGEN CANADA INC,Active,9013120,filgrastim 300 mcg per 1 mL solution for injection vial,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
12474,Marketed,2002-06-20,01968017,Neupogen,1,L03AA02,Filgrastim,Solution,"Intravenous,Subcutaneous",77700711,NEUPOGEN (filgrastim 480 mcg per 1.6 mL solution for injection vial) AMGEN CANADA INC,Active,9013122,filgrastim 480 mcg per 1.6 mL solution for injection vial,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
12474,Marketed,2002-06-20,01968017,Neupogen,1,L03AA02,Filgrastim,Solution,"Intravenous,Subcutaneous",77700712,NEUPOGEN (filgrastim 300 mcg per 1 mL solution for injection vial) AMGEN CANADA INC,Active,9013120,filgrastim 300 mcg per 1 mL solution for injection vial,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
90471,Marketed,2016-01-28,02420104,Neupogen,1,L03AA02,Filgrastim,Solution,"Intravenous,Subcutaneous",02420104,NEUPOGEN (filgrastim 300 mcg per 0.5 mL solution for injection syringe) AMGEN CANADA INC,Active,9013119,filgrastim 300 mcg per 0.5 mL solution for injection syringe,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
90471,Marketed,2016-01-28,02420104,Neupogen,1,L03AA02,Filgrastim,Solution,"Intravenous,Subcutaneous",02420104,NEUPOGEN (filgrastim 300 mcg per 0.5 mL solution for injection syringe) AMGEN CANADA INC,Active,9013119,filgrastim 300 mcg per 0.5 mL solution for injection syringe,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
90472,Marketed,2016-02-02,02420112,Neupogen,1,L03AA02,Filgrastim,Solution,"Subcutaneous,Intravenous",02420112,NEUPOGEN (filgrastim 480 mcg per 0.8 mL solution for injection syringe) AMGEN CANADA INC,Active,9013121,filgrastim 480 mcg per 0.8 mL solution for injection syringe,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
90472,Marketed,2016-02-02,02420112,Neupogen,1,L03AA02,Filgrastim,Solution,"Subcutaneous,Intravenous",02420112,NEUPOGEN (filgrastim 480 mcg per 0.8 mL solution for injection syringe) AMGEN CANADA INC,Active,9013121,filgrastim 480 mcg per 0.8 mL solution for injection syringe,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
92587,Marketed,2016-03-17,02441489,Grastofil,1,L03AA02,Filgrastim,Solution,"Intravenous,Subcutaneous",02441489,GRASTOFIL (filgrastim 300 mcg per 0.5 mL solution for injection syringe) APOTEX INC,Active,9013119,filgrastim 300 mcg per 0.5 mL solution for injection syringe,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
92587,Marketed,2016-03-17,02441489,Grastofil,1,L03AA02,Filgrastim,Solution,"Intravenous,Subcutaneous",02441489,GRASTOFIL (filgrastim 300 mcg per 0.5 mL solution for injection syringe) APOTEX INC,Active,9013119,filgrastim 300 mcg per 0.5 mL solution for injection syringe,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
94117,Marketed,2016-11-28,02454548,Grastofil,1,L03AA02,Filgrastim,Solution,"Subcutaneous,Intravenous",02454548,GRASTOFIL (filgrastim 480 mcg per 0.8 mL solution for injection syringe) APOTEX INC,Active,9013121,filgrastim 480 mcg per 0.8 mL solution for injection syringe,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
94117,Marketed,2016-11-28,02454548,Grastofil,1,L03AA02,Filgrastim,Solution,"Subcutaneous,Intravenous",02454548,GRASTOFIL (filgrastim 480 mcg per 0.8 mL solution for injection syringe) APOTEX INC,Active,9013121,filgrastim 480 mcg per 0.8 mL solution for injection syringe,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
97581,Marketed,2020-05-11,02485575,Nivestym,1,L03AA02,Filgrastim,Solution,"Subcutaneous,Intravenous",02485575,NIVESTYM (filgrastim 300 mcg per 0.5 mL solution for injection syringe) PFIZER CANADA ULC,Active,9013119,filgrastim 300 mcg per 0.5 mL solution for injection syringe,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
97581,Marketed,2020-05-11,02485575,Nivestym,1,L03AA02,Filgrastim,Solution,"Subcutaneous,Intravenous",02485575,NIVESTYM (filgrastim 300 mcg per 0.5 mL solution for injection syringe) PFIZER CANADA ULC,Active,9013119,filgrastim 300 mcg per 0.5 mL solution for injection syringe,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
97582,Marketed,2020-05-11,02485583,Nivestym,1,L03AA02,Filgrastim,Solution,"Intravenous,Subcutaneous",02485583,NIVESTYM (filgrastim 480 mcg per 0.8 mL solution for injection syringe) PFIZER CANADA ULC,Active,9013121,filgrastim 480 mcg per 0.8 mL solution for injection syringe,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
97582,Marketed,2020-05-11,02485583,Nivestym,1,L03AA02,Filgrastim,Solution,"Intravenous,Subcutaneous",02485583,NIVESTYM (filgrastim 480 mcg per 0.8 mL solution for injection syringe) PFIZER CANADA ULC,Active,9013121,filgrastim 480 mcg per 0.8 mL solution for injection syringe,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
97583,Marketed,2020-06-10,02485591,Nivestym,1,L03AA02,Filgrastim,Solution,"Intravenous,Subcutaneous",02485591,NIVESTYM (filgrastim 300 mcg per 1 mL solution for injection vial) PFIZER CANADA ULC,Active,9013120,filgrastim 300 mcg per 1 mL solution for injection vial,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
97583,Marketed,2020-06-10,02485591,Nivestym,1,L03AA02,Filgrastim,Solution,"Intravenous,Subcutaneous",02485591,NIVESTYM (filgrastim 300 mcg per 1 mL solution for injection vial) PFIZER CANADA ULC,Active,9013120,filgrastim 300 mcg per 1 mL solution for injection vial,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
97588,Marketed,2020-06-10,02485656,Nivestym,1,L03AA02,Filgrastim,Solution,"Subcutaneous,Intravenous",02485656,NIVESTYM (filgrastim 480 mcg per 1.6 mL solution for injection vial) PFIZER CANADA ULC,Active,9013122,filgrastim 480 mcg per 1.6 mL solution for injection vial,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
97588,Marketed,2020-06-10,02485656,Nivestym,1,L03AA02,Filgrastim,Solution,"Subcutaneous,Intravenous",02485656,NIVESTYM (filgrastim 480 mcg per 1.6 mL solution for injection vial) PFIZER CANADA ULC,Active,9013122,filgrastim 480 mcg per 1.6 mL solution for injection vial,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
101160,Marketed,2026-05-15,02522489,M-Finasteride,1,G04CB01,Finasteride,Tablet,Oral,02522489,M-FINASTERIDE (finasteride 5 mg oral tablet) MANTRA PHARMA INC,Active,9000424,finasteride 5 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101704,Marketed,2023-04-18,02527847,Bio-Finasteride,1,G04CB01,Finasteride,Tablet,Oral,02527847,BIO-FINASTERIDE (finasteride 5 mg oral tablet) BIOMED PHARMA,Active,9000424,finasteride 5 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102447,Marketed,2026-04-21,02535637,Nra-Finasteride,1,G04CB01,Finasteride,Tablet,Oral,02535637,NRA-FINASTERIDE (finasteride 5 mg oral tablet) NORA PHARMA INC,Active,9000424,finasteride 5 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102614,Marketed,2024-05-15,02537427,Mint-Finasteride,1,D11AX10,Finasteride,Tablet,Oral,02537427,MINT-FINASTERIDE (finasteride 1 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000803,finasteride 1 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
104332,Marketed,2026-03-02,02554461,JAMP Finasteride Tablets,1,D11AX10,Finasteride,Tablet,Oral,02554461,JAMP FINASTERIDE TABLETS (finasteride 1 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000803,finasteride 1 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
13370,Marketed,2022-07-19,02010909,Proscar,1,G04CB01,Finasteride,Tablet,Oral,02010909,PROSCAR (finasteride 5 mg oral tablet) ORGANON CANADA INC.,Active,9000424,finasteride 5 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
61606,Marketed,2022-05-11,02238213,Propecia,1,D11AX10,Finasteride,Tablet,Oral,02238213,PROPECIA (finasteride 1 mg oral tablet) ORGANON CANADA INC.,Active,9000803,finasteride 1 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
79578,Marketed,2010-03-17,02310112,PMS-Finasteride,1,G04CB01,Finasteride,Tablet,Oral,02310112,PMS-FINASTERIDE (finasteride 5 mg oral tablet) PHARMASCIENCE INC,Active,9000424,finasteride 5 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
80561,Marketed,2010-05-13,02320169,PMS-Finasteride,1,D11AX10,Finasteride,Tablet,Oral,02320169,PMS-FINASTERIDE (finasteride 1 mg oral tablet) PHARMASCIENCE INC,Active,9000803,finasteride 1 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
80802,Marketed,2020-10-20,02322579,Sandoz Finasteride,1,G04CB01,Finasteride,Tablet,Oral,02322579,SANDOZ FINASTERIDE (finasteride 5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000424,finasteride 5 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
82509,Marketed,2010-05-12,02339471,Sandoz Finasteride A,1,D11AX10,Finasteride,Tablet,Oral,02339471,SANDOZ FINASTERIDE A (finasteride 1 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000803,finasteride 1 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
83386,Marketed,2011-08-12,02348500,Teva-Finasteride,1,G04CB01,Finasteride,Tablet,Oral,02348500,TEVA-FINASTERIDE (finasteride 5 mg oral tablet) TEVA CANADA LIMITED,Active,9000424,finasteride 5 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
83549,Marketed,2026-05-07,02350270,Pro-Finasteride,1,G04CB01,Finasteride,Tablet,Oral,02350270,PRO-FINASTERIDE (finasteride 5 mg oral tablet) PRO DOC LIMITEE,Active,9000424,finasteride 5 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
84031,Marketed,2014-11-13,02355043,ACH-Finasteride,1,G04CB01,Finasteride,Tablet,Oral,02355043,ACH-FINASTERIDE (finasteride 5 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000424,finasteride 5 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
84235,Marketed,2014-10-11,02357224,JAMP-Finasteride,1,G04CB01,Finasteride,Tablet,Oral,02357224,JAMP-FINASTERIDE (finasteride 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000424,finasteride 5 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
85961,Marketed,2021-02-03,02374404,AG-Finasteride,1,G04CB01,Finasteride,Tablet,Oral,02374404,AG-FINASTERIDE (finasteride 5 mg oral tablet) ANGITA PHARMA INC.,Active,9000424,finasteride 5 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
87534,Marketed,2012-07-25,02389878,Mint-Finasteride,1,G04CB01,Finasteride,Tablet,Oral,02389878,MINT-FINASTERIDE (finasteride 5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000424,finasteride 5 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
89058,Marketed,2013-05-30,02405814,Auro-Finasteride,1,G04CB01,Finasteride,Tablet,Oral,02405814,AURO-FINASTERIDE (finasteride 5 mg oral tablet) AURO PHARMA INC,Active,9000424,finasteride 5 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
91262,Marketed,2014-11-12,02428148,Auro-Finasteride 1 mg,1,D11AX10,Finasteride,Tablet,Oral,02428148,AURO-FINASTERIDE 1MG (finasteride 1 mg oral tablet) AURO PHARMA INC,Active,9000803,finasteride 1 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
93028,Marketed,2015-10-14,02445077,Finasteride,1,G04CB01,Finasteride,Tablet,Oral,02445077,FINASTERIDE (finasteride 5 mg oral tablet) SANIS HEALTH INC,Active,9000424,finasteride 5 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
93029,Marketed,2015-10-14,02445085,Finasteride,1,D11AX10,Finasteride,Tablet,Oral,02445085,FINASTERIDE (finasteride 1 mg oral tablet) SANIS HEALTH INC,Active,9000803,finasteride 1 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
93313,Marketed,2015-11-25,02447541,Finasteride,1,G04CB01,Finasteride,Tablet,Oral,02447541,FINASTERIDE (finasteride 5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000424,finasteride 5 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
93314,Marketed,2015-11-25,02447568,Finasteride,1,D11AX10,Finasteride,Tablet,Oral,02447568,FINASTERIDE (finasteride 1 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000803,finasteride 1 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
94182,Marketed,2024-06-27,02455013,Riva-Finasteride,1,G04CB01,Finasteride,Tablet,Oral,02455013,RIVA-FINASTERIDE (finasteride 5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000424,finasteride 5 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102100,Marketed,2022-11-22,02531917,Kerendia,1,C03DA05,Finerenone,Tablet,Oral,02531917,KERENDIA (finerenone 10 mg oral tablet) BAYER INC,Active,9014792,finerenone 10 mg oral tablet,8002447,finerenone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102101,Marketed,2022-11-22,02531925,Kerendia,1,C03DA05,Finerenone,Tablet,Oral,02531925,KERENDIA (finerenone 20 mg oral tablet) BAYER INC,Active,9014793,finerenone 20 mg oral tablet,8002447,finerenone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
85038,Marketed,2011-03-28,02365480,Gilenya,1,L04AE01,Fingolimod,Capsule,Oral,02365480,GILENYA (fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9004852,fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule,8001775,fingolimod,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
95841,Marketed,2019-10-24,02469618,Taro-Fingolimod,1,L04AE01,Fingolimod,Capsule,Oral,02469618,TARO-FINGOLIMOD (fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9004852,fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule,8001775,fingolimod,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
95854,Marketed,2019-09-25,02469715,Mylan-Fingolimod,1,L04AE01,Fingolimod,Capsule,Oral,02469715,MYLAN-FINGOLIMOD (fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule) MYLAN PHARMACEUTICALS ULC,Active,9004852,fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule,8001775,fingolimod,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
95865,Marketed,2019-08-30,02469782,PMS-Fingolimod,1,L04AE01,Fingolimod,Capsule,Oral,02469782,PMS-FINGOLIMOD (fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule) PHARMASCIENCE INC,Active,9004852,fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule,8001775,fingolimod,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
96603,Marketed,2019-12-11,02475669,ACH-Fingolimod,1,L04AE01,Fingolimod,Capsule,Oral,02475669,ACH-FINGOLIMOD (fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule) ACCORD HEALTHCARE INC,Active,9004852,fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule,8001775,fingolimod,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
97297,Marketed,2019-01-03,02482533,Gilenya,1,L04AE01,Fingolimod,Capsule,Oral,02482533,GILENYA (fingolimod (fingolimod hydrochloride) 0.25 mg oral capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9013686,fingolimod (fingolimod hydrochloride) 0.25 mg oral capsule,8001775,fingolimod,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
97303,Marketed,2019-10-31,02482606,Sandoz Fingolimod,1,L04AE01,Fingolimod,Capsule,Oral,02482606,SANDOZ FINGOLIMOD (fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9004852,fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule,8001775,fingolimod,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
97793,Marketed,2019-10-31,02487772,JAMP Fingolimod,1,L04AE01,Fingolimod,Capsule,Oral,02487772,JAMP FINGOLIMOD (fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule) JAMP PHARMA CORPORATION,Active,9004852,fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule,8001775,fingolimod,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
100542,Marketed,2023-06-08,02516063,AG-Flecainide,1,C01BC04,Flecainide,Tablet,Oral,02516063,AG-FLECAINIDE (flecainide acetate 50 mg oral tablet) ANGITA PHARMA INC.,Active,9002141,flecainide acetate 50 mg oral tablet,8001381,flecainide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100543,Marketed,2023-06-08,02516071,AG-Flecainide,1,C01BC04,Flecainide,Tablet,Oral,02516071,AG-FLECAINIDE (flecainide acetate 100 mg oral tablet) ANGITA PHARMA INC.,Active,9001620,flecainide acetate 100 mg oral tablet,8001381,flecainide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102370,Marketed,2023-10-24,02534800,Flecainide,1,C01BC04,Flecainide,Tablet,Oral,02534800,FLECAINIDE (flecainide acetate 50 mg oral tablet) SANIS HEALTH INC,Active,9002141,flecainide acetate 50 mg oral tablet,8001381,flecainide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102371,Marketed,2023-10-24,02534819,Flecainide,1,C01BC04,Flecainide,Tablet,Oral,02534819,FLECAINIDE (flecainide acetate 100 mg oral tablet) SANIS HEALTH INC,Active,9001620,flecainide acetate 100 mg oral tablet,8001381,flecainide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76117,Marketed,2017-12-15,02275538,Apo-Flecainide,1,C01BC04,Flecainide,Tablet,Oral,02275538,APO-FLECAINIDE (flecainide acetate 50 mg oral tablet) APOTEX INC,Active,9002141,flecainide acetate 50 mg oral tablet,8001381,flecainide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76118,Marketed,2017-12-15,02275546,Apo-Flecainide,1,C01BC04,Flecainide,Tablet,Oral,02275546,APO-FLECAINIDE (flecainide acetate 100 mg oral tablet) APOTEX INC,Active,9001620,flecainide acetate 100 mg oral tablet,8001381,flecainide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94726,Marketed,2017-02-27,02459957,Auro-Flecainide,1,C01BC04,Flecainide,Tablet,Oral,02459957,AURO-FLECAINIDE (flecainide acetate 50 mg oral tablet) AURO PHARMA INC,Active,9002141,flecainide acetate 50 mg oral tablet,8001381,flecainide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94727,Marketed,2017-02-27,02459965,Auro-Flecainide,1,C01BC04,Flecainide,Tablet,Oral,02459965,AURO-FLECAINIDE (flecainide acetate 100 mg oral tablet) AURO PHARMA INC,Active,9001620,flecainide acetate 100 mg oral tablet,8001381,flecainide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98370,Marketed,2020-10-27,02493705,JAMP Flecainide,1,C01BC04,Flecainide,Tablet,Oral,02493705,JAMP FLECAINIDE (flecainide acetate 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9002141,flecainide acetate 50 mg oral tablet,8001381,flecainide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98371,Marketed,2020-11-13,02493713,JAMP Flecainide,1,C01BC04,Flecainide,Tablet,Oral,02493713,JAMP FLECAINIDE (flecainide acetate 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001620,flecainide acetate 100 mg oral tablet,8001381,flecainide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96294,Marketed,2026-03-02,02473550,Addyi,1,G02CX02,Flibanserin,Tablet,Oral,02473550,ADDYI (flibanserin 100 mg oral tablet) SPROUT PHARMACEUTICALS INC,Active,9013687,flibanserin 100 mg oral tablet,8002196,flibanserin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94968,Marketed,2018-08-13,02461927,Neuraceq,1,V09AX06,Florbetaben 18f,Solution,Intravenous,,,,,,,,,,,,,,,,,Schedule C
100680,Marketed,2022-01-14,02517396,Fluconazole,1,J02AC01,Fluconazole,Tablet,Oral,02517396,FLUCONAZOLE (fluconazole 50 mg oral tablet) SANIS HEALTH INC,Active,9002304,fluconazole 50 mg oral tablet,8000850,fluconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100681,Marketed,2022-01-14,02517418,Fluconazole,1,J02AC01,Fluconazole,Tablet,Oral,02517418,FLUCONAZOLE (fluconazole 100 mg oral tablet) SANIS HEALTH INC,Active,9002302,fluconazole 100 mg oral tablet,8000850,fluconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101044,Marketed,2022-05-12,02521229,Fluconazole-150,1,J02AC01,Fluconazole,Capsule,Oral,02521229,FLUCONAZOLE-150 (fluconazole 150 mg oral capsule) SANIS HEALTH INC,Active,9002809,fluconazole 150 mg oral capsule,8000850,fluconazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Non-Prescription Drugs
102377,Marketed,2023-10-24,02534886,Fluconazole,1,J02AC01,Fluconazole,Tablet,Oral,02534886,FLUCONAZOLE (fluconazole 50 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9002304,fluconazole 50 mg oral tablet,8000850,fluconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102378,Marketed,2023-10-24,02534894,Fluconazole,1,J02AC01,Fluconazole,Tablet,Oral,02534894,FLUCONAZOLE (fluconazole 100 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9002302,fluconazole 100 mg oral tablet,8000850,fluconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
103678,Marketed,2025-03-11,02547864,JAMP Fluconazole 150 mg,1,J02AC01,Fluconazole,Capsule,Oral,02547864,JAMP FLUCONAZOLE 150 MG (fluconazole 150 mg oral capsule) JAMP PHARMA CORPORATION,Active,9002809,fluconazole 150 mg oral capsule,8000850,fluconazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Non-Prescription Drugs
104234,Marketed,2025-08-22,02553406,M-Fluconazole-150,1,J02AC01,Fluconazole,Capsule,Oral,02553406,M-FLUCONAZOLE-150 (fluconazole 150 mg oral capsule) MANTRA PHARMA INC,Active,9002809,fluconazole 150 mg oral capsule,8000850,fluconazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Non-Prescription Drugs
10954,Marketed,1990-12-31,00891835,Diflucan,1,J02AC01,Fluconazole,Solution,Intravenous,00891835,DIFLUCAN (fluconazole 200 mg per 100 mL solution for injection vial) PFIZER CANADA ULC,Active,9012554,fluconazole 200 mg per 100 mL solution for injection vial,8000850,fluconazole,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
17789,Marketed,2019-07-25,02141442,Diflucan One,1,J02AC01,Fluconazole,Capsule,Oral,02141442,DIFLUCAN ONE (fluconazole 150 mg oral capsule) PFIZER CANADA ULC,Active,9002809,fluconazole 150 mg oral capsule,8000850,fluconazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Non-Prescription Drugs
18010,Marketed,1995-12-31,02024152,Diflucan,1,J02AC01,Fluconazole,Powder for solution,Oral,02024152,DIFLUCAN (fluconazole 50 mg per 5 mL oral solution) PFIZER CANADA ULC,Active,9014361,fluconazole 50 mg per 5 mL oral solution,8000850,fluconazole,26643006,Oral,385023001,Oral solution,,,1.0,,,Prescription
60693,Marketed,2024-08-29,02237370,Apo-Fluconazole,1,J02AC01,Fluconazole,Tablet,Oral,02237370,APO-FLUCONAZOLE (fluconazole 50 mg oral tablet) APOTEX INC,Active,9002304,fluconazole 50 mg oral tablet,8000850,fluconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
60694,Marketed,2024-08-29,02237371,Apo-Fluconazole,1,J02AC01,Fluconazole,Tablet,Oral,02237371,APO-FLUCONAZOLE (fluconazole 100 mg oral tablet) APOTEX INC,Active,9002302,fluconazole 100 mg oral tablet,8000850,fluconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
65565,Marketed,2011-03-02,02241895,Apo-Fluconazole-150,1,J02AC01,Fluconazole,Capsule,Oral,02241895,APO-FLUCONAZOLE-150 (fluconazole 150 mg oral capsule) APOTEX INC,Active,9002809,fluconazole 150 mg oral capsule,8000850,fluconazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Non-Prescription Drugs
69316,Marketed,2010-04-16,02245292,Mylan-Fluconazole,1,J02AC01,Fluconazole,Tablet,Oral,02245292,MYLAN-FLUCONAZOLE (fluconazole 50 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9002304,fluconazole 50 mg oral tablet,8000850,fluconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
69317,Marketed,2009-12-17,02245293,Mylan-Fluconazole,1,J02AC01,Fluconazole,Tablet,Oral,02245293,MYLAN-FLUCONAZOLE (fluconazole 100 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9002302,fluconazole 100 mg oral tablet,8000850,fluconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
69743,Marketed,2002-06-05,02245643,PMS-Fluconazole,1,J02AC01,Fluconazole,Tablet,Oral,02245643,PMS-FLUCONAZOLE (fluconazole 50 mg oral tablet) PHARMASCIENCE INC,Active,9002304,fluconazole 50 mg oral tablet,8000850,fluconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
69744,Marketed,2002-06-05,02245644,PMS-Fluconazole,1,J02AC01,Fluconazole,Tablet,Oral,02245644,PMS-FLUCONAZOLE (fluconazole 100 mg oral tablet) PHARMASCIENCE INC,Active,9002302,fluconazole 100 mg oral tablet,8000850,fluconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
74071,Marketed,2014-11-01,02255510,Riva-Fluconazole,1,J02AC01,Fluconazole,Capsule,Oral,02255510,RIVA-FLUCONAZOLE (fluconazole 150 mg oral capsule) LABORATOIRE RIVA INC.,Active,9002809,fluconazole 150 mg oral capsule,8000850,fluconazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Non-Prescription Drugs
74685,Marketed,2017-02-10,02261472,Fluconazole In Sodium Chloride Injection USP,1,J02AC01,Fluconazole,Solution,Intravenous,77700274,FLUCONAZOLE IN SODIUM CHLORIDE INJECTION USP (fluconazole 200 mg per 100 mL solution for injection bag) BAXTER CORPORATION,Active,9006593,fluconazole 200 mg per 100 mL solution for injection bag,8000850,fluconazole,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),1.0,,,Prescription
74685,Marketed,2017-02-10,02261472,Fluconazole In Sodium Chloride Injection USP,1,J02AC01,Fluconazole,Solution,Intravenous,77700275,FLUCONAZOLE IN SODIUM CHLORIDE INJECTION USP (fluconazole 400 mg per 200 mL solution for injection bag) BAXTER CORPORATION,Active,9006594,fluconazole 400 mg per 200 mL solution for injection bag,8000850,fluconazole,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),1.0,,,Prescription
76691,Marketed,2020-04-16,02281260,Act Fluconazole,1,J02AC01,Fluconazole,Tablet,Oral,02281260,ACT FLUCONAZOLE (fluconazole 50 mg oral tablet) TEVA CANADA LIMITED,Active,9002304,fluconazole 50 mg oral tablet,8000850,fluconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
76692,Marketed,2020-04-16,02281279,Act Fluconazole,1,J02AC01,Fluconazole,Tablet,Oral,02281279,ACT FLUCONAZOLE (fluconazole 100 mg oral tablet) TEVA CANADA LIMITED,Active,9002302,fluconazole 100 mg oral tablet,8000850,fluconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
79630,Marketed,2008-07-08,02310686,Pro-Fluconazole,1,J02AC01,Fluconazole,Tablet,Oral,02310686,PRO-FLUCONAZOLE (fluconazole 100 mg oral tablet) PRO DOC LIMITEE,Active,9002302,fluconazole 100 mg oral tablet,8000850,fluconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
79724,Marketed,2010-03-10,02311690,Canesoral,1,J02AC01,Fluconazole,Capsule,Oral,02311690,CANESORAL (fluconazole 150 mg oral capsule) BAYER INC,Active,9002809,fluconazole 150 mg oral capsule,8000850,fluconazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Non-Prescription Drugs
83738,Marketed,2011-03-25,02352133,Fluconazole 150,1,J02AC01,Fluconazole,Capsule,Oral,02352133,FLUCONAZOLE 150 (fluconazole 150 mg oral capsule) APOTEX INC,Active,9002809,fluconazole 150 mg oral capsule,8000850,fluconazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Non-Prescription Drugs
86844,Marketed,2012-10-25,02382628,Monicure Combo,2,J02AC01,Fluconazole,"Capsule,Kit,Cream","Oral,Topical",02382628,"MONICURE COMBO (fluconazole 150 mg oral capsule with miconazole nitrate 2 % cutaneous cream) INSIGHT PHARMACEUTICALS, LLC",Active,9012806,fluconazole 150 mg oral capsule with miconazole nitrate 2 % cutaneous cream,8001382,fluconazole and miconazole,255204007,Multiple (oral and cutaneous),420692007,Oral capsule,732937005,Capsule,1.0,,,Non-Prescription Drugs
87397,Marketed,2012-10-18,02388448,Fluconazole Injection SDZ,1,J02AC01,Fluconazole,Solution,Intravenous,02388448,FLUCONAZOLE INJECTION SDZ (fluconazole 200 mg per 100 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012554,fluconazole 200 mg per 100 mL solution for injection vial,8000850,fluconazole,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
91325,Marketed,2016-12-14,02428792,Mar-Fluconazole-150,1,J02AC01,Fluconazole,Capsule,Oral,02428792,MAR-FLUCONAZOLE-150 (fluconazole 150 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9002809,fluconazole 150 mg oral capsule,8000850,fluconazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Non-Prescription Drugs
91671,Marketed,2015-01-08,02432471,JAMP-Fluconazole,1,J02AC01,Fluconazole,Capsule,Oral,02432471,JAMP-FLUCONAZOLE (fluconazole 150 mg oral capsule) JAMP PHARMA CORPORATION,Active,9002809,fluconazole 150 mg oral capsule,8000850,fluconazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Non-Prescription Drugs
91806,Marketed,2025-01-17,02433702,Nra-Fluconazole-150,1,J02AC01,Fluconazole,Capsule,Oral,02433702,NRA-FLUCONAZOLE-150 (fluconazole 150 mg oral capsule) NORA PHARMA INC,Active,9002809,fluconazole 150 mg oral capsule,8000850,fluconazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Non-Prescription Drugs
94989,Marketed,2019-09-20,02462168,Bio-Fluconazole,1,J02AC01,Fluconazole,Capsule,Oral,02462168,BIO-FLUCONAZOLE (fluconazole 150 mg oral capsule) BIOMED PHARMA,Active,9002809,fluconazole 150 mg oral capsule,8000850,fluconazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Non-Prescription Drugs
70384,Marketed,2014-02-28,02246226,Fludara,1,L01BB05,Fludarabine,Tablet,Oral,02246226,FLUDARA (fludarabine phosphate 10 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9003755,fludarabine phosphate 10 mg oral tablet,8001776,fludarabine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
76943,Marketed,2014-02-08,02283859,Fludarabine Phosphate For Injection,1,L01BB05,Fludarabine,Solution,Intravenous,02283859,FLUDARABINE PHOSPHATE FOR INJECTION (fludarabine phosphate 50 mg per 2 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013123,fludarabine phosphate 50 mg per 2 mL solution for injection vial,8001776,fludarabine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
92295,Marketed,2022-08-25,02438577,"Fludarabine Phosphate Injection, USP",1,L01BB05,Fludarabine,Solution,Intravenous,02438577,"FLUDARABINE PHOSPHATE INJECTION, USP (fludarabine phosphate 50 mg per 2 mL solution for injection vial) ACCORD HEALTHCARE INC",Active,9013123,fludarabine phosphate 50 mg per 2 mL solution for injection vial,8001776,fludarabine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
81315,Marketed,2024-02-12,02327740,Fluglucoscan,1,V09IX04,Fludeoxyglucose (18f),Solution,Intravenous,,,,,,,,,,,,,,,,,Schedule C
81437,Marketed,2018-08-03,02328739,18 F-Fludeoxyglucose (18 F-FDG),1,V09IX04,Fludeoxyglucose (18f),Solution,Intravenous,,,,,,,,,,,,,,,,,Schedule C
88689,Marketed,2018-08-13,02402017,Naf Plus,1,V09IX04,Fludeoxyglucose (18f),Solution,Intravenous,,,,,,,,,,,,,,,,,Schedule C
89749,Marketed,2025-04-25,02412837,Fludeoxyglucose (18 F) Injection,1,V09IX04,Fludeoxyglucose (18f),Solution,Intravenous,,,,,,,,,,,,,,,,,Schedule C
91763,Marketed,2018-09-28,02433230,Fludeoxyglucose (18 F) Injection,1,V09IX04,Fludeoxyglucose (18f),Solution,Intravenous,,,,,,,,,,,,,,,,,Schedule C
92276,Marketed,2019-07-26,02438380,Atlantiscan,1,V09IX04,Fludeoxyglucose (18f),Solution,Intravenous,,,,,,,,,,,,,,,,,Schedule C
94822,Marketed,2019-10-16,02460734,[F-18]-Fludeoxyglucose (FDG) Injection,1,V09IX04,Fludeoxyglucose (18f),Solution,Intravenous,,,,,,,,,,,,,,,,,Schedule C
95011,Marketed,2018-10-17,02462354,Fludeoxyglucose (F-18),1,V09IX04,Fludeoxyglucose (18f),Solution,Intravenous,,,,,,,,,,,,,,,,,Schedule C
95083,Marketed,2020-02-04,02462958,Cyclodx,1,V09IX04,Fludeoxyglucose (18f),Solution,Intravenous,,,,,,,,,,,,,,,,,Schedule C
95555,Marketed,2021-10-20,02467151,Fludeoxyglucose [F-18] FDG Injection,1,V09IX04,Fludeoxyglucose (18f),Solution,Intravenous,,,,,,,,,,,,,,,,,Schedule C
104092,Marketed,2025-05-20,02552248,JAMP Fludrocortisone,1,H02AA02,Fludrocortisone,Tablet,Oral,02552248,JAMP FLUDROCORTISONE (fludrocortisone acetate 0.1 mg oral tablet) JAMP PHARMA CORPORATION,Active,9012630,fludrocortisone acetate 0.1 mg oral tablet,8001269,fludrocortisone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
19460,Marketed,2026-03-24,02086026,Florinef,1,H02AA02,Fludrocortisone,Tablet,Oral,02086026,FLORINEF (fludrocortisone acetate 0.1 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9012630,fludrocortisone acetate 0.1 mg oral tablet,8001269,fludrocortisone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73439,Marketed,2005-09-15,02249561,Flumazenil Injection,1,V03AB25,Flumazenil,Solution,Intravenous,02249561,FLUMAZENIL INJECTION (flumazenil 0.5 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013124,flumazenil 0.5 mg per 5 mL solution for injection vial,8001777,flumazenil,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
75176,Marketed,2025-09-20,02266342,"Flumazenil Injection, USP",1,V03AB25,Flumazenil,Solution,Intravenous,77700738,"FLUMAZENIL INJECTION, USP (flumazenil 0.5 mg per 5 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013124,flumazenil 0.5 mg per 5 mL solution for injection vial,8001777,flumazenil,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
75176,Marketed,2025-09-20,02266342,"Flumazenil Injection, USP",1,V03AB25,Flumazenil,Solution,Intravenous,77700739,"FLUMAZENIL INJECTION, USP (flumazenil 1 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013125,flumazenil 1 mg per 10 mL solution for injection vial,8001777,flumazenil,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
631,Marketed,2025-12-19,00074462,Locacorten Vioform,2,D07CB05,Flumetasone and antibiotics,Cream,Topical,00074462,LOCACORTEN VIOFORM (clioquinol 3 % and flumethasone pivalate 0.02 % cutaneous cream) KNIGHT THERAPEUTICS INC.,Active,9001633,clioquinol 3 % and flumethasone pivalate 0.02 % cutaneous cream,8001899,clioquinol and flumethasone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
868,Marketed,2025-12-23,00074454,Locacorten Vioform Eardrops,2,S02CA02,Flumetasone and antiinfectives,Drops,Otic,00074454,LOCACORTEN VIOFORM EARDROPS (clioquinol 1 % and flumethasone pivalate 0.02 % otic drops) KNIGHT THERAPEUTICS INC.,Active,9001643,clioquinol 1 % and flumethasone pivalate 0.02 % otic drops,8001899,clioquinol and flumethasone,10547007,Otic,385136004,Otic drops,732994000,Drop (unit of presentation),,,,Prescription
70217,Marketed,2011-12-01,02246082,Flunarizine,1,N07CA03,Flunarizine,Capsule,Oral,02246082,FLUNARIZINE (flunarizine (flunarizine hydrochloride) 5 mg oral capsule) AA PHARMA INC,Active,9003743,flunarizine (flunarizine hydrochloride) 5 mg oral capsule,8001468,flunarizine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
13875,Marketed,1991-12-31,00873292,Derma Smoothe/FS Liquid 0.01%,1,D07AC04,Fluocinolone acetonide,Emulsion,Topical,00873292,DERMA SMOOTHE/FS LIQ 0.01% (fluocinolone acetonide 0.01 % cutaneous emulsion) HILL DERMACEUTICALS INC,Active,9013291,fluocinolone acetonide 0.01 % cutaneous emulsion,8001778,fluocinolone,448598008,Cutaneous,738998008,Emulsion,,,,,,Prescription
78584,Marketed,2008-01-09,02300559,Dermotic Oil Ear Drops,1,S02BA08,Fluocinolone acetonide,Solution,Otic,02300559,DERMOTIC OIL EAR DROPS (fluocinolone acetonide 0.01 % otic drops) HILL DERMACEUTICALS INC,Active,9004368,fluocinolone acetonide 0.01 % otic drops,8001778,fluocinolone,10547007,Otic,385136004,Otic drops,732994000,Drop (unit of presentation),,,,Prescription
94696,Marketed,2023-01-25,02459655,Otixal,2,S02CA05,Fluocinolone acetonide and antiinfectives,Solution,Otic,02459655,OTIXAL (ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % and fluocinolone acetonide 0.025 % otic drops) MEDEXUS PHARMACEUTICALS INC.,Active,9006171,ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % and fluocinolone acetonide 0.025 % otic drops,8001728,ciprofloxacin and fluocinolone,10547007,Otic,385136004,Otic drops,732994000,Drop (unit of presentation),,,,Prescription
5439,Marketed,2004-04-06,00598933,Tiamol Cream 0.05%,1,D07AC08,Fluocinonide,Cream,Topical,00598933,"TIAMOL CREAM 0.05% (fluocinonide 0.05 % cutaneous cream) TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Active,9001977,fluocinonide 0.05 % cutaneous cream,8001270,fluocinonide,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
60294,Marketed,2023-12-07,02236996,Lyderm,1,D07AC08,Fluocinonide,Ointment,Topical,02236996,"LYDERM (fluocinonide 0.05 % cutaneous ointment) TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Active,9002813,fluocinonide 0.05 % cutaneous ointment,8001270,fluocinonide,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Prescription
60295,Marketed,2023-12-07,02236997,Lyderm,1,D07AC08,Fluocinonide,Gel,Topical,02236997,"LYDERM (fluocinonide 0.05 % cutaneous gel) TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Active,9002812,fluocinonide 0.05 % cutaneous gel,8001270,fluocinonide,448598008,Cutaneous,385100002,Gel,,,,,,Prescription
9276,Marketed,2023-12-06,00716863,Lyderm,1,D07AC08,Fluocinonide,Cream,Topical,00716863,"LYDERM (fluocinonide 0.05 % cutaneous cream) TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Active,9001977,fluocinonide 0.05 % cutaneous cream,8001270,fluocinonide,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
18747,Marketed,2022-12-28,02148390,Minims Fluorescein Sodium,1,S01JA01,Fluorescein,Drops,Ophthalmic,02148390,MINIMS FLUORESCEIN SODIUM (fluorescein sodium 2 % ophthalmic drops) BAUSCH & LOMB INC,Active,9002815,fluorescein sodium 2 % ophthalmic drops,8001469,fluorescein,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Ethical
19197,Marketed,1995-12-31,02160773,Diofluor Strips,1,S01JA01,Fluorescein,Strip,Ophthalmic,02160773,DIOFLUOR STRIPS (fluorescein sodium 1 mg ophthalmic strip) DIOPTIC PHARMACEUTICALS INC,Active,9002668,fluorescein sodium 1 mg ophthalmic strip,8001469,fluorescein,54485002,Ophthalmic,758679000,Strip,733018009,Strip,,,,Ethical
1470,Marketed,2024-03-28,00247855,FML,1,S01BA07,Fluorometholone,Suspension,Ophthalmic,00247855,FML (fluorometholone 0.1 % ophthalmic drops) ABBVIE CORPORATION,Active,9001688,fluorometholone 0.1 % ophthalmic drops,8001470,fluorometholone (base),54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
42778,Marketed,2012-07-24,00432814,Sandoz Fluorometholone,1,S01BA07,Fluorometholone,Suspension,Ophthalmic,00432814,SANDOZ FLUOROMETHOLONE (fluorometholone 0.1 % ophthalmic drops) SANDOZ CANADA INCORPORATED,Active,9001688,fluorometholone 0.1 % ophthalmic drops,8001470,fluorometholone (base),54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
10015,Marketed,2009-03-06,00012882,Fluorouracil Injection,1,L01BC02,Fluorouracil,Solution,Intravenous,77700962,FLUOROURACIL INJECTION (fluorouracil 500 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013557,fluorouracil 500 mg per 10 mL solution for injection vial,8001779,fluorouracil,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
10015,Marketed,2009-03-06,00012882,Fluorouracil Injection,1,L01BC02,Fluorouracil,Solution,Intravenous,77700963,FLUOROURACIL INJECTION (fluorouracil 50 mg per mL solution for injection 100 mL vial) SANDOZ CANADA INCORPORATED,Active,9013556,fluorouracil 50 mg per mL solution for injection 100 mL vial,8001779,fluorouracil,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
2138,Marketed,2021-06-10,00330582,Efudex,1,L01BC02,Fluorouracil,Cream,Topical,00330582,"EFUDEX (fluorouracil 5 % cutaneous cream) BAUSCH HEALTH, CANADA INC.",Active,9001736,fluorouracil 5 % cutaneous cream,8001779,fluorouracil,448598008,Cutaneous,421628006,Cutaneous cream,,,1.0,,,Prescription
89810,Marketed,2017-06-15,02413450,Fluorouracil Injection USP,1,L01BC02,Fluorouracil,Solution,Intravenous,02413450,FLUOROURACIL INJECTION USP (fluorouracil 50 mg per mL solution for injection 100 mL vial) ACCORD HEALTHCARE INC,Active,9013556,fluorouracil 50 mg per mL solution for injection 100 mL vial,8001779,fluorouracil,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
96316,Marketed,2021-12-02,02473763,Fluorouracil Injection,1,L01BC02,Fluorouracil,Solution,Intravenous,02473763,FLUOROURACIL INJECTION (fluorouracil 500 mg per 10 mL solution for injection vial) BIOLYSE PHARMA CORPORATION,Active,9013557,fluorouracil 500 mg per 10 mL solution for injection vial,8001779,fluorouracil,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
96320,Marketed,2019-06-06,02473771,Fluorouracil Injection,1,L01BC02,Fluorouracil,Solution,Intravenous,02473771,FLUOROURACIL INJECTION (fluorouracil 50 mg per mL solution for injection 100 mL vial) BIOLYSE PHARMA CORPORATION,Active,9013556,fluorouracil 50 mg per mL solution for injection 100 mL vial,8001779,fluorouracil,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
97559,Marketed,2019-06-25,02485346,Tolak,1,L01BC02,Fluorouracil,Cream,Topical,02485346,TOLAK (fluorouracil (fluorouracil sodium) 4 % cutaneous cream) HILL DERMACEUTICALS INC,Active,9013962,fluorouracil (fluorouracil sodium) 4 % cutaneous cream,8001779,fluorouracil,448598008,Cutaneous,421628006,Cutaneous cream,,,1.0,,,Prescription
91338,Marketed,2016-02-19,02428946,Actikerall,2,L01BC52,"Fluorouracil, combinations",Solution,Topical,02428946,ACTIKERALL (fluorouracil 0.5 % and salicylic acid 10 % cutaneous solution) CIPHER PHARMACEUTICALS INC,Active,9005885,fluorouracil 0.5 % and salicylic acid 10 % cutaneous solution,8001780,fluorouracil and salicylic acid,448598008,Cutaneous,385108009,Cutaneous solution,,,1.0,,,Prescription
101864,Marketed,2024-10-17,02529432,M-Fluoxetine,1,N06AB03,Fluoxetine,Capsule,Oral,02529432,M-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule) MANTRA PHARMA INC,Active,9000469,fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
101865,Marketed,2024-10-17,02529440,M-Fluoxetine,1,N06AB03,Fluoxetine,Capsule,Oral,02529440,M-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule) MANTRA PHARMA INC,Active,9000325,fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
103543,Marketed,2025-04-28,02546752,JAMP Fluoxetine Solution,1,N06AB03,Fluoxetine,Solution,Oral,02546752,JAMP FLUOXETINE SOLUTION (fluoxetine (fluoxetine hydrochloride) 20 mg per 5 mL oral solution) JAMP PHARMA CORPORATION,Active,9000733,fluoxetine (fluoxetine hydrochloride) 20 mg per 5 mL oral solution,8000128,fluoxetine,26643006,Oral,385023001,Oral solution,,,,,,Prescription
19064,Marketed,2001-12-22,02177587,PMS-Fluoxetine,1,N06AB03,Fluoxetine,Capsule,Oral,02177587,PMS-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule) PHARMASCIENCE INC,Active,9000325,fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
19074,Marketed,2001-12-22,02177579,PMS-Fluoxetine,1,N06AB03,Fluoxetine,Capsule,Oral,02177579,PMS-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule) PHARMASCIENCE INC,Active,9000469,fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
19895,Marketed,2010-10-09,02216590,Teva-Fluoxetine,1,N06AB03,Fluoxetine,Capsule,Oral,02216590,TEVA-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule) TEVA CANADA LIMITED,Active,9000325,fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
19916,Marketed,2010-10-09,02216582,Teva-Fluoxetine,1,N06AB03,Fluoxetine,Capsule,Oral,02216582,TEVA-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule) TEVA CANADA LIMITED,Active,9000469,fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
19961,Marketed,2022-01-20,02216361,Apo-Fluoxetine,1,N06AB03,Fluoxetine,Capsule,Oral,02216361,APO-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule) APOTEX INC,Active,9000325,fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
19962,Marketed,2022-01-20,02216353,Apo-Fluoxetine,1,N06AB03,Fluoxetine,Capsule,Oral,02216353,APO-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule) APOTEX INC,Active,9000469,fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
50635,Marketed,2022-01-20,02231328,Apo-Fluoxetine,1,N06AB03,Fluoxetine,Solution,Oral,02231328,APO-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 20 mg per 5 mL oral solution) APOTEX INC,Active,9000733,fluoxetine (fluoxetine hydrochloride) 20 mg per 5 mL oral solution,8000128,fluoxetine,26643006,Oral,385023001,Oral solution,,,,,,Prescription
77154,Marketed,2017-01-27,02286068,Fluoxetine,1,N06AB03,Fluoxetine,Capsule,Oral,02286068,FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule) SANIS HEALTH INC,Active,9000469,fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
77155,Marketed,2015-10-08,02286076,Fluoxetine,1,N06AB03,Fluoxetine,Capsule,Oral,02286076,FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule) SANIS HEALTH INC,Active,9000325,fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
79103,Marketed,2010-10-22,02305461,Riva-Fluoxetine,1,N06AB03,Fluoxetine,Capsule,Oral,02305461,RIVA-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule) LABORATOIRE RIVA INC.,Active,9000469,fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
79104,Marketed,2009-09-21,02305488,Riva-Fluoxetine,1,N06AB03,Fluoxetine,Capsule,Oral,02305488,RIVA-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule) LABORATOIRE RIVA INC.,Active,9000325,fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
80053,Marketed,2025-11-28,02314991,Pro-Fluoxetine,1,N06AB03,Fluoxetine,Capsule,Oral,02314991,PRO-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule) PRO DOC LIMITEE,Active,9000469,fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
80054,Marketed,2008-10-15,02315009,Pro-Fluoxetine,1,N06AB03,Fluoxetine,Capsule,Oral,02315009,PRO-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule) PRO DOC LIMITEE,Active,9000325,fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
85969,Marketed,2023-02-15,02374447,Fluoxetine,1,N06AB03,Fluoxetine,Capsule,Oral,02374447,FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000469,fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
85980,Marketed,2023-02-15,02374455,Fluoxetine,1,N06AB03,Fluoxetine,Capsule,Oral,02374455,FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000325,fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
86635,Marketed,2020-11-12,02380560,Mint-Fluoxetine,1,N06AB03,Fluoxetine,Capsule,Oral,02380560,MINT-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9000469,fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
86636,Marketed,2020-11-12,02380579,Mint-Fluoxetine,1,N06AB03,Fluoxetine,Capsule,Oral,02380579,MINT-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9000325,fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
86901,Marketed,2019-09-04,02383241,ACH-Fluoxetine,1,N06AB03,Fluoxetine,Capsule,Oral,02383241,ACH-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule) ACCORD HEALTHCARE INC,Active,9000325,fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87125,Marketed,2012-07-24,02385627,Auro-Fluoxetine,1,N06AB03,Fluoxetine,Capsule,Oral,02385627,AURO-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule) AURO PHARMA INC,Active,9000469,fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87126,Marketed,2012-07-24,02385635,Auro-Fluoxetine,1,N06AB03,Fluoxetine,Capsule,Oral,02385635,AURO-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule) AURO PHARMA INC,Active,9000325,fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87199,Marketed,2021-10-22,02386402,JAMP-Fluoxetine,1,N06AB03,Fluoxetine,Capsule,Oral,02386402,JAMP-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000325,fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87817,Marketed,2025-03-21,02392909,Mar-Fluoxetine,1,N06AB03,Fluoxetine,Capsule,Oral,02392909,MAR-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000469,fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87818,Marketed,2025-03-21,02392917,Mar-Fluoxetine,1,N06AB03,Fluoxetine,Capsule,Oral,02392917,MAR-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000325,fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87867,Marketed,2019-09-04,02393441,ACH-Fluoxetine,1,N06AB03,Fluoxetine,Capsule,Oral,02393441,ACH-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule) ACCORD HEALTHCARE INC,Active,9000469,fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88677,Marketed,2021-10-22,02401894,JAMP-Fluoxetine,1,N06AB03,Fluoxetine,Capsule,Oral,02401894,JAMP-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000469,fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
93411,Marketed,2024-12-05,02448424,Bio-Fluoxetine,1,N06AB03,Fluoxetine,Capsule,Oral,02448424,BIO-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule) BIOMED PHARMA,Active,9000469,fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
93412,Marketed,2024-12-05,02448432,Bio-Fluoxetine,1,N06AB03,Fluoxetine,Capsule,Oral,02448432,BIO-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule) BIOMED PHARMA,Active,9000325,fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
94657,Marketed,2017-01-24,02459361,Odan-Fluoxetine,1,N06AB03,Fluoxetine,Solution,Oral,02459361,ODAN-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 20 mg per 5 mL oral solution) ODAN LABORATORIES LTD,Active,9000733,fluoxetine (fluoxetine hydrochloride) 20 mg per 5 mL oral solution,8000128,fluoxetine,26643006,Oral,385023001,Oral solution,,,,,,Prescription
95277,Marketed,2018-02-21,02464640,PMS-Fluoxetine,1,N06AB03,Fluoxetine,Capsule,Oral,02464640,PMS-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 40 mg oral capsule) PHARMASCIENCE INC,Active,9012453,fluoxetine (fluoxetine hydrochloride) 40 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95278,Marketed,2018-08-01,02464659,PMS-Fluoxetine,1,N06AB03,Fluoxetine,Capsule,Oral,02464659,PMS-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 60 mg oral capsule) PHARMASCIENCE INC,Active,9012971,fluoxetine (fluoxetine hydrochloride) 60 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
99331,Marketed,2024-10-23,02503875,Nra-Fluoxetine,1,N06AB03,Fluoxetine,Capsule,Oral,02503875,NRA-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule) NORA PHARMA INC,Active,9000469,fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
99332,Marketed,2024-10-23,02503883,Nra-Fluoxetine,1,N06AB03,Fluoxetine,Capsule,Oral,02503883,NRA-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule) NORA PHARMA INC,Active,9000325,fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
18737,Marketed,1995-12-31,02156040,Fluanxol Depot 10%- Liquid Im 100 mg/mL,1,N05AF01,Flupentixol,Solution,Intramuscular,02156040,FLUANXOL DEPOT 10%- LIQ IM 100MG/ML (flupentixol decanoate 100 mg per 1 mL solution for injection ampoule) LUNDBECK CANADA INC,Active,9013126,flupentixol decanoate 100 mg per 1 mL solution for injection ampoule,8001472,flupentixol,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
18739,Marketed,1995-12-31,02156008,Fluanxol 0.5 mg - Tablets,1,N05AF01,Flupentixol,Tablet,Oral,02156008,FLUANXOL 0.5MG - TAB (flupentixol (flupentixol dihydrochloride) 0.5 mg oral tablet) LUNDBECK CANADA INC,Active,9002818,flupentixol (flupentixol dihydrochloride) 0.5 mg oral tablet,8001472,flupentixol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
18740,Marketed,1995-12-31,02156016,Fluanxol 3 mg - Tablets,1,N05AF01,Flupentixol,Tablet,Oral,02156016,FLUANXOL 3MG - TAB (flupentixol (flupentixol dihydrochloride) 3 mg oral tablet) LUNDBECK CANADA INC,Active,9002819,flupentixol (flupentixol dihydrochloride) 3 mg oral tablet,8001472,flupentixol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
18800,Marketed,1995-12-31,02156032,Fluanxol Depot 2% - Liquid Im 20 mg/mL,1,N05AF01,Flupentixol,Solution,Intramuscular,02156032,FLUANXOL DEPOT 2% -LIQ IM 20MG/ML (flupentixol decanoate 20 mg per 1 mL solution for injection ampoule) LUNDBECK CANADA INC,Active,9013127,flupentixol decanoate 20 mg per 1 mL solution for injection ampoule,8001472,flupentixol,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
2858,Marketed,2012-07-10,00405345,Fluphenazine,1,N05AB02,Fluphenazine,Tablet,Oral,00405345,FLUPHENAZINE (fluphenazine hydrochloride 1 mg oral tablet) AA PHARMA INC,Active,9001785,fluphenazine hydrochloride 1 mg oral tablet,8001473,fluphenazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
2860,Marketed,2014-03-12,00405361,Fluphenazine,1,N05AB02,Fluphenazine,Tablet,Oral,00405361,FLUPHENAZINE (fluphenazine hydrochloride 5 mg oral tablet) AA PHARMA INC,Active,9001788,fluphenazine hydrochloride 5 mg oral tablet,8001473,fluphenazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
2861,Marketed,2012-07-10,00410632,Fluphenazine,1,N05AB02,Fluphenazine,Tablet,Oral,00410632,FLUPHENAZINE (fluphenazine hydrochloride 2 mg oral tablet) AA PHARMA INC,Active,9001787,fluphenazine hydrochloride 2 mg oral tablet,8001473,fluphenazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
4728,Marketed,2015-12-17,00521698,Flurazepam,1,N05CD01,Flurazepam,Capsule,Oral,00521698,FLURAZEPAM (flurazepam hydrochloride 15 mg oral capsule) AA PHARMA INC,Active,9000168,flurazepam hydrochloride 15 mg oral capsule,8000091,flurazepam,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Targeted Substances (CDSA IV)
4729,Marketed,2015-05-06,00521701,Flurazepam,1,N05CD01,Flurazepam,Capsule,Oral,00521701,FLURAZEPAM (flurazepam hydrochloride 30 mg oral capsule) AA PHARMA INC,Active,9000169,flurazepam hydrochloride 30 mg oral capsule,8000091,flurazepam,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Targeted Substances (CDSA IV)
11465,Marketed,2019-08-13,01912038,Flurbiprofen,1,M01AE09,Flurbiprofen,Tablet,Oral,01912038,FLURBIPROFEN (flurbiprofen 100 mg oral tablet) AA PHARMA INC,Active,9002362,flurbiprofen 100 mg oral tablet,8001474,flurbiprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
11466,Marketed,2019-06-07,01912046,Flurbiprofen,1,M01AE09,Flurbiprofen,Tablet,Oral,01912046,FLURBIPROFEN (flurbiprofen 50 mg oral tablet) AA PHARMA INC,Active,9002363,flurbiprofen 50 mg oral tablet,8001474,flurbiprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
61987,Marketed,2020-05-25,02238560,Flutamide,1,L02BB01,Flutamide,Tablet,Oral,02238560,FLUTAMIDE (flutamide 250 mg oral tablet) AA PHARMA INC,Active,9003045,flutamide 250 mg oral tablet,8001654,flutamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100023,Marketed,2021-04-26,02510987,Apo-Fluticasone HFA,1,R03BA05,Fluticasone,Metered-dose aerosol,"Inhalation,Oral",02510987,APO-FLUTICASONE HFA (fluticasone propionate 250 mcg per actuation pressurized inhalation) APOTEX INC,Active,9000968,fluticasone propionate 250 mcg per actuation pressurized inhalation,8000173,fluticasone,447694001,Inhalation,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,,Prescription
101564,Marketed,2022-11-22,02526557,Apo-Fluticasone HFA,1,R03BA05,Fluticasone,Metered-dose aerosol,"Inhalation,Oral",02526557,APO-FLUTICASONE HFA (fluticasone propionate 125 mcg per actuation pressurized inhalation) APOTEX INC,Active,9000967,fluticasone propionate 125 mcg per actuation pressurized inhalation,8000173,fluticasone,447694001,Inhalation,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,,Prescription
101764,Marketed,2025-02-27,02528428,Apo-Fluticasone HFA,1,R03BA05,Fluticasone,"Aerosol, metered dose","Inhalation,Oral",02528428,APO-FLUTICASONE HFA (fluticasone propionate 50 mcg per actuation pressurized inhalation) APOTEX INC,Active,9000969,fluticasone propionate 50 mcg per actuation pressurized inhalation,8000173,fluticasone,447694001,Inhalation,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,,Prescription
60565,Marketed,2003-12-22,02237245,Flovent Diskus,1,R03BA05,Fluticasone,Powder,Inhalation,02237245,FLOVENT DISKUS (fluticasone propionate 100 mcg per actuation inhalation powder) GLAXOSMITHKLINE INC,Active,9000794,fluticasone propionate 100 mcg per actuation inhalation powder,8000173,fluticasone,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
60566,Marketed,2003-01-06,02237246,Flovent Diskus,1,R03BA05,Fluticasone,Powder,Inhalation,02237246,FLOVENT DISKUS (fluticasone propionate 250 mcg per actuation inhalation powder) GLAXOSMITHKLINE INC,Active,9000795,fluticasone propionate 250 mcg per actuation inhalation powder,8000173,fluticasone,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
60567,Marketed,2002-12-19,02237247,Flovent Diskus,1,R03BA05,Fluticasone,Powder,Inhalation,02237247,FLOVENT DISKUS (fluticasone propionate 500 mcg per actuation inhalation powder) GLAXOSMITHKLINE INC,Active,9000796,fluticasone propionate 500 mcg per actuation inhalation powder,8000173,fluticasone,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
68258,Marketed,2001-12-20,02244291,Flovent HFA,1,R03BA05,Fluticasone,Metered-dose aerosol,"Inhalation,Oral",02244291,FLOVENT HFA (fluticasone propionate 50 mcg per actuation pressurized inhalation) GLAXOSMITHKLINE INC,Active,9000969,fluticasone propionate 50 mcg per actuation pressurized inhalation,8000173,fluticasone,447694001,Inhalation,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,,Prescription
68259,Marketed,2001-12-20,02244292,Flovent HFA,1,R03BA05,Fluticasone,Metered-dose aerosol,"Inhalation,Oral",02244292,FLOVENT HFA (fluticasone propionate 125 mcg per actuation pressurized inhalation) GLAXOSMITHKLINE INC,Active,9000967,fluticasone propionate 125 mcg per actuation pressurized inhalation,8000173,fluticasone,447694001,Inhalation,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,,Prescription
68260,Marketed,2001-12-20,02244293,Flovent HFA,1,R03BA05,Fluticasone,Metered-dose aerosol,"Inhalation,Oral",02244293,FLOVENT HFA (fluticasone propionate 250 mcg per actuation pressurized inhalation) GLAXOSMITHKLINE INC,Active,9000968,fluticasone propionate 250 mcg per actuation pressurized inhalation,8000173,fluticasone,447694001,Inhalation,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,,Prescription
72648,Marketed,2024-07-24,02248307,Flonase Allergy Relief,1,R01AD08,Fluticasone,"Spray, metered dose",Nasal,02248307,FLONASE ALLERGY RELIEF (fluticasone propionate 50 mcg per actuation nasal spray) HALEON CANADA ULC,Active,9000452,fluticasone propionate 50 mcg per actuation nasal spray,8000173,fluticasone,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,,Non-Prescription Drugs
78009,Marketed,2007-07-05,02294745,Apo-Fluticasone,1,R01AD08,Fluticasone,"Spray, metered dose",Nasal,02294745,APO-FLUTICASONE (fluticasone propionate 50 mcg per actuation nasal spray) APOTEX INC,Active,9000452,fluticasone propionate 50 mcg per actuation nasal spray,8000173,fluticasone,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,,Prescription
94027,Marketed,2017-09-28,02453738,Teva-Fluticasone,1,R01AD08,Fluticasone,Metered-dose pump,Nasal,02453738,TEVA-FLUTICASONE (fluticasone propionate 50 mcg per actuation nasal spray) TEVA CANADA LIMITED,Active,9000452,fluticasone propionate 50 mcg per actuation nasal spray,8000173,fluticasone,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,,Prescription
94795,Marketed,2017-07-19,02460513,24 Hr Nasal Allergy Relief,1,R01AD08,Fluticasone,"Spray, metered dose",Nasal,02460513,24HR NASAL ALLERGY RELIEF (fluticasone propionate 50 mcg per actuation nasal spray) APOTEX INC,Active,9000452,fluticasone propionate 50 mcg per actuation nasal spray,8000173,fluticasone,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,,Non-Prescription Drugs
95626,Marketed,2020-09-30,02467917,Aermony Respiclick,1,R03BA05,Fluticasone,Powder (metered dose),Inhalation,02467917,AERMONY RESPICLICK (fluticasone propionate 232 mcg per actuation inhalation powder) TEVA CANADA LIMITED,Active,9014383,fluticasone propionate 232 mcg per actuation inhalation powder,8000173,fluticasone,447694001,Respiratory tract,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
99262,Marketed,2022-08-31,02503115,PMS-Fluticasone HFA,1,R03BA05,Fluticasone,Metered-dose aerosol,"Inhalation,Oral",02503115,PMS-FLUTICASONE HFA (fluticasone propionate 50 mcg per actuation pressurized inhalation) PHARMASCIENCE INC,Active,9000969,fluticasone propionate 50 mcg per actuation pressurized inhalation,8000173,fluticasone,447694001,Inhalation,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,,Prescription
99263,Marketed,2022-04-18,02503123,PMS-Fluticasone HFA,1,R03BA05,Fluticasone,Metered-dose aerosol,"Inhalation,Oral",02503123,PMS-FLUTICASONE HFA (fluticasone propionate 125 mcg per actuation pressurized inhalation) PHARMASCIENCE INC,Active,9000967,fluticasone propionate 125 mcg per actuation pressurized inhalation,8000173,fluticasone,447694001,Inhalation,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,,Prescription
99264,Marketed,2021-01-21,02503131,PMS-Fluticasone HFA,1,R03BA05,Fluticasone,Metered-dose aerosol,"Oral,Inhalation",02503131,PMS-FLUTICASONE HFA (fluticasone propionate 250 mcg per actuation pressurized inhalation) PHARMASCIENCE INC,Active,9000968,fluticasone propionate 250 mcg per actuation pressurized inhalation,8000173,fluticasone,447694001,Inhalation,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,,Prescription
78388,Marketed,2007-10-22,02298589,Avamys,1,R01AD12,Fluticasone furoate,"Spray, metered dose",Nasal,02298589,AVAMYS (fluticasone furoate 27.5 mcg per actuation nasal spray) GLAXOSMITHKLINE INC,Active,9001222,fluticasone furoate 27.5 mcg per actuation nasal spray,8000173,fluticasone,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,,Prescription
93200,Marketed,2016-01-26,02446561,Arnuity Ellipta,1,R03BA09,Fluticasone furoate,Powder,"Inhalation,Oral",02446561,ARNUITY ELLIPTA (fluticasone furoate 100 mcg per actuation inhalation powder) GLAXOSMITHKLINE INC,Active,9001454,fluticasone furoate 100 mcg per actuation inhalation powder,8000173,fluticasone,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
93201,Marketed,2015-12-14,02446588,Arnuity Ellipta,1,R03BA09,Fluticasone furoate,Powder,"Oral,Inhalation",02446588,ARNUITY ELLIPTA (fluticasone furoate 200 mcg per actuation inhalation powder) GLAXOSMITHKLINE INC,Active,9001452,fluticasone furoate 200 mcg per actuation inhalation powder,8000173,fluticasone,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
101952,Marketed,2023-08-16,02530341,Mylan-Azelastine/Fluticasone,2,R01AD58,"Fluticasone, combinations","Spray, metered dose",Nasal,02530341,MYLAN-AZELASTINE/FLUTICASONE (azelastine hydrochloride 137 mcg per actuation and fluticasone propionate 50 mcg per actuation nasal spray) MYLAN PHARMACEUTICALS ULC,Active,9005686,azelastine hydrochloride 137 mcg per actuation and fluticasone propionate 50 mcg per actuation nasal spray,8001438,azelastine and fluticasone,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,,Prescription
102955,Marketed,2023-10-31,02540886,Apo-Azelastine/Fluticasone,2,R01AD58,"Fluticasone, combinations","Spray, metered dose",Nasal,02540886,APO-AZELASTINE/FLUTICASONE (azelastine hydrochloride 137 mcg per actuation and fluticasone propionate 50 mcg per actuation nasal spray) APOTEX INC,Active,9005686,azelastine hydrochloride 137 mcg per actuation and fluticasone propionate 50 mcg per actuation nasal spray,8001438,azelastine and fluticasone,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,,Prescription
91729,Marketed,2018-07-31,02432889,Dymista,2,R01AD58,"Fluticasone, combinations","Spray, metered dose",Nasal,02432889,DYMISTA (azelastine hydrochloride 137 mcg per actuation and fluticasone propionate 50 mcg per actuation nasal spray) BGP PHARMA ULC,Active,9005686,azelastine hydrochloride 137 mcg per actuation and fluticasone propionate 50 mcg per actuation nasal spray,8001438,azelastine and fluticasone,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,,Prescription
78461,Marketed,2012-12-11,02299224,Teva-Fluvastatin,1,C10AA04,Fluvastatin,Capsule,Oral,02299224,TEVA-FLUVASTATIN (fluvastatin (fluvastatin sodium) 20 mg oral capsule) TEVA CANADA LIMITED,Active,9002671,fluvastatin (fluvastatin sodium) 20 mg oral capsule,8001271,fluvastatin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
78462,Marketed,2012-12-11,02299232,Teva-Fluvastatin,1,C10AA04,Fluvastatin,Capsule,Oral,02299232,TEVA-FLUVASTATIN (fluvastatin (fluvastatin sodium) 40 mg oral capsule) TEVA CANADA LIMITED,Active,9002672,fluvastatin (fluvastatin sodium) 40 mg oral capsule,8001271,fluvastatin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
11751,Marketed,2016-08-26,01919369,Luvox,1,N06AB08,Fluvoxamine,Tablet,Oral,01919369,LUVOX (fluvoxamine maleate 100 mg oral tablet) BGP PHARMA ULC,Active,9002364,fluvoxamine maleate 100 mg oral tablet,8001272,fluvoxamine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
11752,Marketed,2017-01-09,01919342,Luvox,1,N06AB08,Fluvoxamine,Tablet,Oral,01919342,LUVOX (fluvoxamine maleate 50 mg oral tablet) BGP PHARMA ULC,Active,9002365,fluvoxamine maleate 50 mg oral tablet,8001272,fluvoxamine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
50637,Marketed,2022-09-22,02231329,Apo-Fluvoxamine,1,N06AB08,Fluvoxamine,Tablet,Oral,02231329,APO-FLUVOXAMINE (fluvoxamine maleate 50 mg oral tablet) APOTEX INC,Active,9002365,fluvoxamine maleate 50 mg oral tablet,8001272,fluvoxamine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
50638,Marketed,2022-09-22,02231330,Apo-Fluvoxamine,1,N06AB08,Fluvoxamine,Tablet,Oral,02231330,APO-FLUVOXAMINE (fluvoxamine maleate 100 mg oral tablet) APOTEX INC,Active,9002364,fluvoxamine maleate 100 mg oral tablet,8001272,fluvoxamine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74072,Marketed,2024-02-16,02255529,Teva-Fluvoxamine,1,N06AB08,Fluvoxamine,Tablet,Oral,02255529,TEVA-FLUVOXAMINE (fluvoxamine maleate 50 mg oral tablet) TEVA CANADA LIMITED,Active,9002365,fluvoxamine maleate 50 mg oral tablet,8001272,fluvoxamine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74073,Marketed,2024-02-16,02255537,Teva-Fluvoxamine,1,N06AB08,Fluvoxamine,Tablet,Oral,02255537,TEVA-FLUVOXAMINE (fluvoxamine maleate 100 mg oral tablet) TEVA CANADA LIMITED,Active,9002364,fluvoxamine maleate 100 mg oral tablet,8001272,fluvoxamine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
3002,Marketed,2019-01-15,00426849,Folic Acid,1,B03BB01,Folic acid,Tablet,Oral,00426849,FOLIC ACID (folic acid 5 mg oral tablet) AA PHARMA INC,Active,9000109,folic acid 5 mg oral tablet,8000055,folic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
31358,Marketed,2022-01-14,02139480,"Folic Acid Injection, USP",1,B03BB01,Folic acid,Solution,"Subcutaneous,Intravenous,Intramuscular",02139480,"FOLIC ACID INJECTION, USP (folic acid (sodium folate) 50 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9006567,folic acid (sodium folate) 50 mg per 10 mL solution for injection vial,8000055,folic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
85094,Marketed,2024-02-07,02366061,JAMP-Folic Acid,1,B03BB01,Folic acid,Tablet,Oral,02366061,JAMP-FOLIC ACID (folic acid 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000109,folic acid 5 mg oral tablet,8000055,folic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75576,Marketed,2005-09-06,02270382,Gonal-F Pen,1,G03GA05,Follitropin alfa,Solution,Subcutaneous,02270382,"GONAL-F PEN (follitropin alfa 900 unit per 1.44 mL solution for injection pen) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9015395,follitropin alfa 900 unit per 1.44 mL solution for injection pen,8001475,follitropin alfa,738984000,Parenteral,385219001,Solution for injection,733006000,Pen(s),1.0,,,Schedule D
75576,Marketed,2005-09-06,02270382,Gonal-F Pen,1,G03GA05,Follitropin alfa,Solution,Subcutaneous,02270382,"GONAL-F PEN (follitropin alfa 900 unit per 1.44 mL solution for injection pen) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9015395,follitropin alfa 900 unit per 1.44 mL solution for injection pen,8001475,follitropin alfa,738984000,Parenteral,385219001,Solution for injection,733006000,Pen(s),1.0,,,Prescription
75577,Marketed,2005-09-06,02270390,Gonal-F Pen,1,G03GA05,Follitropin alfa,Solution,Subcutaneous,02270390,"GONAL-F PEN (follitropin alfa 450 unit per 0.72 mL solution for injection pen) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9015394,follitropin alfa 450 unit per 0.72 mL solution for injection pen,8001475,follitropin alfa,738984000,Parenteral,385219001,Solution for injection,733006000,Pen(s),1.0,,,Prescription
75577,Marketed,2005-09-06,02270390,Gonal-F Pen,1,G03GA05,Follitropin alfa,Solution,Subcutaneous,02270390,"GONAL-F PEN (follitropin alfa 450 unit per 0.72 mL solution for injection pen) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9015394,follitropin alfa 450 unit per 0.72 mL solution for injection pen,8001475,follitropin alfa,738984000,Parenteral,385219001,Solution for injection,733006000,Pen(s),1.0,,,Schedule D
75578,Marketed,2005-09-06,02270404,Gonal-F Pen,1,G03GA05,Follitropin alfa,Solution,Subcutaneous,02270404,"GONAL-F PEN (follitropin alfa 300 unit per 0.48 mL solution for injection pen) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9015393,follitropin alfa 300 unit per 0.48 mL solution for injection pen,8001475,follitropin alfa,738984000,Parenteral,385219001,Solution for injection,733006000,Pen(s),1.0,,,Schedule D
75578,Marketed,2005-09-06,02270404,Gonal-F Pen,1,G03GA05,Follitropin alfa,Solution,Subcutaneous,02270404,"GONAL-F PEN (follitropin alfa 300 unit per 0.48 mL solution for injection pen) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9015393,follitropin alfa 300 unit per 0.48 mL solution for injection pen,8001475,follitropin alfa,738984000,Parenteral,385219001,Solution for injection,733006000,Pen(s),1.0,,,Prescription
67891,Marketed,2022-08-10,02243948,Puregon,1,G03GA06,Follitropin beta,Solution,Subcutaneous,,,,,,,,,,,,,,1.0,,,Schedule D
67891,Marketed,2022-08-10,02243948,Puregon,1,G03GA06,Follitropin beta,Solution,Subcutaneous,,,,,,,,,,,,,,1.0,,,Prescription
97762,Marketed,2019-11-01,02487462,Rekovelle,1,G03GA10,Follitropin delta,Solution,Subcutaneous,02487462,REKOVELLE (follitropin delta 12 mcg per 0.36 mL solution for injection pen) FERRING INC,Active,9014190,follitropin delta 12 mcg per 0.36 mL solution for injection pen,8001477,follitropin delta,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,,Prescription
97762,Marketed,2019-11-01,02487462,Rekovelle,1,G03GA10,Follitropin delta,Solution,Subcutaneous,02487462,REKOVELLE (follitropin delta 12 mcg per 0.36 mL solution for injection pen) FERRING INC,Active,9014190,follitropin delta 12 mcg per 0.36 mL solution for injection pen,8001477,follitropin delta,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,,Schedule D
97763,Marketed,2019-11-01,02487470,Rekovelle,1,G03GA10,Follitropin delta,Solution,Subcutaneous,02487470,REKOVELLE (follitropin delta 36 mcg per 1.08 mL solution for injection pen) FERRING INC,Active,9014191,follitropin delta 36 mcg per 1.08 mL solution for injection pen,8001477,follitropin delta,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,,Prescription
97763,Marketed,2019-11-01,02487470,Rekovelle,1,G03GA10,Follitropin delta,Solution,Subcutaneous,02487470,REKOVELLE (follitropin delta 36 mcg per 1.08 mL solution for injection pen) FERRING INC,Active,9014191,follitropin delta 36 mcg per 1.08 mL solution for injection pen,8001477,follitropin delta,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,,Schedule D
97764,Marketed,2019-11-01,02487489,Rekovelle,1,G03GA10,Follitropin delta,Solution,Subcutaneous,02487489,REKOVELLE (follitropin delta 72 mcg per 2.16 mL solution for injection pen) FERRING INC,Active,9014192,follitropin delta 72 mcg per 2.16 mL solution for injection pen,8001477,follitropin delta,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,,Prescription
97764,Marketed,2019-11-01,02487489,Rekovelle,1,G03GA10,Follitropin delta,Solution,Subcutaneous,02487489,REKOVELLE (follitropin delta 72 mcg per 2.16 mL solution for injection pen) FERRING INC,Active,9014192,follitropin delta 72 mcg per 2.16 mL solution for injection pen,8001477,follitropin delta,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,,Schedule D
66820,Marketed,2026-04-08,02242980,Antizol,1,V03AB34,Fomepizole,Liquid,Intravenous,02242980,ANTIZOL (fomepizole 1.5 g per 1.5 mL solution for injection vial) KNIGHT THERAPEUTICS INC.,Active,9013292,fomepizole 1.5 g per 1.5 mL solution for injection vial,8001907,fomepizole,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
92000,Marketed,2015-09-22,02435667,Fomepizole For Injection,1,V03AB34,Fomepizole,Solution,Intravenous,02435667,FOMEPIZOLE FOR INJECTION (fomepizole 1.5 g per 1.5 mL solution for injection vial) STERIMAX INC,Active,9013292,fomepizole 1.5 g per 1.5 mL solution for injection vial,8001907,fomepizole,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
69618,Marketed,2018-07-10,02245531,Arixtra,1,B01AX05,Fondaparinux,Solution,"Intravenous,Subcutaneous",02245531,ARIXTRA (fondaparinux sodium 2.5 mg per 0.5 mL solution for injection syringe) ASPEN PHARMACARE CANADA INC.,Active,9013137,fondaparinux sodium 2.5 mg per 0.5 mL solution for injection syringe,8001655,fondaparinux,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
74328,Marketed,2018-07-17,02258056,Arixtra,1,B01AX05,Fondaparinux,Solution,Subcutaneous,02258056,ARIXTRA (fondaparinux sodium 7.5 mg per 0.6 mL solution for injection syringe) ASPEN PHARMACARE CANADA INC.,Active,9013138,fondaparinux sodium 7.5 mg per 0.6 mL solution for injection syringe,8001655,fondaparinux,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
89154,Marketed,2014-03-21,02406853,Fondaparinux Sodium Injection,1,B01AX05,Fondaparinux,Solution,"Subcutaneous,Intravenous",02406853,FONDAPARINUX SODIUM INJECTION (fondaparinux sodium 2.5 mg per 0.5 mL solution for injection syringe) DR REDDY'S LABORATORIES LTD,Active,9013137,fondaparinux sodium 2.5 mg per 0.5 mL solution for injection syringe,8001655,fondaparinux,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
89156,Marketed,2014-03-21,02406896,Fondaparinux Sodium Injection,1,B01AX05,Fondaparinux,Solution,Subcutaneous,02406896,FONDAPARINUX SODIUM INJECTION (fondaparinux sodium 7.5 mg per 0.6 mL solution for injection syringe) DR REDDY'S LABORATORIES LTD,Active,9013138,fondaparinux sodium 7.5 mg per 0.6 mL solution for injection syringe,8001655,fondaparinux,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
60542,Marketed,2016-06-01,02237224,Oxeze Turbuhaler,1,R03AC13,Formoterol,Powder,Inhalation,02237224,OXEZE TURBUHALER (formoterol fumarate dihydrate 12 mcg per actuation inhalation powder) ASTRAZENECA CANADA INC,Active,9012379,formoterol fumarate 12 mcg per actuation inhalation powder,8000902,formoterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
60543,Marketed,2016-06-01,02237225,Oxeze Turbuhaler,1,R03AC13,Formoterol,Powder,Inhalation,02237225,OXEZE TURBUHALER (formoterol fumarate dihydrate 6 mcg per actuation inhalation powder) ASTRAZENECA CANADA INC,Active,9012460,formoterol fumarate 6 mcg per actuation inhalation powder,8000902,formoterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
92396,Marketed,2022-09-15,02439530,Duaklir Genuair,2,R03AL05,Formoterol and aclidinium bromide,Powder (metered dose),Inhalation,02439530,DUAKLIR GENUAIR (aclidinium bromide 400 mcg per actuation and formoterol fumarate dihydrate 12 mcg per actuation inhalation powder) COVIS PHARMA GMBH,Active,9005740,aclidinium bromide 400 mcg per actuation and formoterol fumarate 12 mcg per actuation inhalation powder,8001071,aclidinium and formoterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
69428,Marketed,2002-02-08,02245385,Symbicort 100 Turbuhaler,2,R03AK07,Formoterol and budesonide,Powder,Inhalation,02245385,SYMBICORT 100 TURBUHALER (budesonide 100 mcg per actuation and formoterol fumarate dihydrate 6 mcg per actuation inhalation powder) ASTRAZENECA CANADA INC,Active,9012377,budesonide 100 mcg per actuation and formoterol fumarate 6 mcg per actuation inhalation powder,8000930,budesonide and formoterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
69429,Marketed,2002-02-08,02245386,Symbicort 200 Turbuhaler,2,R03AK07,Formoterol and budesonide,Powder,Inhalation,02245386,SYMBICORT 200 TURBUHALER (budesonide 200 mcg per actuation and formoterol fumarate dihydrate 6 mcg per actuation inhalation powder) ASTRAZENECA CANADA INC,Active,9012378,budesonide 200 mcg per actuation and formoterol fumarate 6 mcg per actuation inhalation powder,8000930,budesonide and formoterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
84680,Marketed,2022-02-22,02361752,Zenhale,2,R03AK09,Formoterol and mometasone,"Aerosol, metered dose",Inhalation,02361752,ZENHALE (formoterol fumarate dihydrate 5 mcg per actuation and mometasone furoate 100 mcg per actuation pressurized inhalation) ORGANON CANADA INC.,Active,9012380,formoterol fumarate 5 mcg per actuation and mometasone furoate 100 mcg per actuation pressurized inhalation,8000982,formoterol and mometasone,447694001,Inhalation,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,,Prescription
84681,Marketed,2022-04-05,02361760,Zenhale,2,R03AK09,Formoterol and mometasone,"Aerosol, metered dose",Inhalation,02361760,ZENHALE (formoterol fumarate dihydrate 5 mcg per actuation and mometasone furoate 200 mcg per actuation pressurized inhalation) ORGANON CANADA INC.,Active,9012381,formoterol fumarate 5 mcg per actuation and mometasone furoate 200 mcg per actuation pressurized inhalation,8000982,formoterol and mometasone,447694001,Inhalation,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,,Prescription
100738,Marketed,2024-01-05,02518058,Breztri Aerosphere,3,R03AL11,"Formoterol, glycopyrronium bromide and budesonide","Aerosol, metered dose",Inhalation,02518058,BREZTRI AEROSPHERE (budesonide 160 mcg per actuation and formoterol fumarate dihydrate 5 mcg per actuation and glycopyrronium (glycopyrronium bromide) 7.2 mcg per actuation pressurized inhalation) ASTRAZENECA CANADA INC,Active,9014844,budesonide 160 mcg per actuation and formoterol fumarate 5 mcg per actuation and glycopyrronium (glycopyrronium bromide) 7.2 mcg per actuation pressurized inhalation,8002401,budesonide and formoterol and glycopyrronium,447694001,Respiratory tract,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,,Prescription
99528,Marketed,2021-03-30,02505924,Vocarvi,1,J05AD01,Foscarnet,Solution,Intravenous,02505924,VOCARVI (foscarnet sodium 6000 mg per 250 mL solution for injection bag) STERIMAX INC,Active,9014794,foscarnet sodium 6000 mg per 250 mL solution for injection bag,8002448,foscarnet,738984000,Parenteral,385219001,solution for injection,732982009,Bag (unit of presentation),1.0,,,Prescription
63874,Marketed,2026-04-01,02240335,Monurol,1,J01XX01,Fosfomycin,Powder for solution,Oral,02240335,MONUROL (fosfomycin (fosfomycin tromethamine) 3 g per sachet powder for oral solution) KNIGHT THERAPEUTICS INC.,Active,9013558,fosfomycin (fosfomycin tromethamine) 3 g per sachet powder for oral solution,8001657,fosfomycin,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,,Prescription
96331,Marketed,2018-08-02,02473801,JAMP-Fosfomycin,1,J01XX01,Fosfomycin,Powder for solution,Oral,02473801,JAMP-FOSFOMYCIN (fosfomycin (fosfomycin tromethamine) 3 g per sachet powder for oral solution) JAMP PHARMA CORPORATION,Active,9013558,fosfomycin (fosfomycin tromethamine) 3 g per sachet powder for oral solution,8001657,fosfomycin,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,,Prescription
97819,Marketed,2020-02-12,02488086,IVozfo,1,J01XX01,Fosfomycin,Powder for solution,Intravenous,02488086,IVOZFO (fosfomycin (fosfomycin sodium) 4 g per vial powder for solution for injection) VERITY PHARMACEUTICALS INC.,Active,9014260,fosfomycin (fosfomycin sodium) 4 g per vial powder for solution for injection,8001657,fosfomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
72096,Marketed,2010-05-01,02247802,Teva-Fosinopril,1,C09AA09,Fosinopril,Tablet,Oral,02247802,TEVA-FOSINOPRIL (fosinopril sodium 10 mg oral tablet) TEVA CANADA LIMITED,Active,9001057,fosinopril sodium 10 mg oral tablet,8000332,fosinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
72097,Marketed,2010-05-01,02247803,Teva-Fosinopril,1,C09AA09,Fosinopril,Tablet,Oral,02247803,TEVA-FOSINOPRIL (fosinopril sodium 20 mg oral tablet) TEVA CANADA LIMITED,Active,9001058,fosinopril sodium 20 mg oral tablet,8000332,fosinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75144,Marketed,2005-04-27,02266008,Apo-Fosinopril,1,C09AA09,Fosinopril,Tablet,Oral,02266008,APO-FOSINOPRIL (fosinopril sodium 10 mg oral tablet) APOTEX INC,Active,9001057,fosinopril sodium 10 mg oral tablet,8000332,fosinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75145,Marketed,2005-04-27,02266016,Apo-Fosinopril,1,C09AA09,Fosinopril,Tablet,Oral,02266016,APO-FOSINOPRIL (fosinopril sodium 20 mg oral tablet) APOTEX INC,Active,9001058,fosinopril sodium 20 mg oral tablet,8000332,fosinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94662,Marketed,2017-04-11,02459388,Fosinopril,1,C09AA09,Fosinopril,Tablet,Oral,02459388,FOSINOPRIL (fosinopril sodium 10 mg oral tablet) SANIS HEALTH INC,Active,9001057,fosinopril sodium 10 mg oral tablet,8000332,fosinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94663,Marketed,2017-04-11,02459396,Fosinopril,1,C09AA09,Fosinopril,Tablet,Oral,02459396,FOSINOPRIL (fosinopril sodium 20 mg oral tablet) SANIS HEALTH INC,Active,9001058,fosinopril sodium 20 mg oral tablet,8000332,fosinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102649,Marketed,2024-02-05,02537702,Vyalev,2,N04BA07,Foslevodopa and decarboxylase inhibitor,Solution,Subcutaneous,,,,,,,,,,,,,,,,,Prescription
50269,Marketed,2022-10-07,02230988,Cerebyx,1,N03AB05,Fosphenytoin,Solution,"Intravenous,Intramuscular",77700642,CEREBYX (fosphenytoin sodium 750 mg per 10 mL solution for injection vial) SEARCHLIGHT PHARMA INC,Active,9012814,fosphenytoin sodium 750 mg per 10 mL solution for injection vial,8001478,fosphenytoin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
50269,Marketed,2022-10-07,02230988,Cerebyx,1,N03AB05,Fosphenytoin,Solution,"Intravenous,Intramuscular",77700643,CEREBYX (fosphenytoin sodium 150 mg per 2 mL solution for injection vial) SEARCHLIGHT PHARMA INC,Active,9012813,fosphenytoin sodium 150 mg per 2 mL solution for injection vial,8001478,fosphenytoin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99741,Marketed,2022-08-15,02508052,Tavalisse,1,B02BX09,Fostamatinib,Tablet,Oral,02508052,TAVALISSE (fostamatinib (fostamatinib disodium) 100 mg oral tablet) MEDISON PHARMA CANADA INC.,Active,9014438,fostamatinib (fostamatinib disodium) 100 mg oral tablet,8002362,fostamatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99742,Marketed,2022-07-04,02508060,Tavalisse,1,B02BX09,Fostamatinib,Tablet,Oral,02508060,TAVALISSE (fostamatinib (fostamatinib disodium) 150 mg oral tablet) MEDISON PHARMA CANADA INC.,Active,9014439,fostamatinib (fostamatinib disodium) 150 mg oral tablet,8002362,fostamatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101006,Marketed,2022-04-26,02520869,Rukobia,1,J05AX29,Fostemsavir,Tablet (extended-release),Oral,02520869,RUKOBIA (fostemsavir (fostemsavir tromethamine) 600 mg prolonged-release oral tablet) VIIV HEALTHCARE ULC,Active,9014693,fostemsavir (fostemsavir tromethamine) 600 mg prolonged-release oral tablet,8002423,fostemsavir,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98765,Marketed,2020-08-04,02497859,Ajovy,1,N02CD03,Fremanezumab,Solution,Subcutaneous,02497859,AJOVY SINGLE DOSE PREFILLED SYRINGE (fremanezumab 225 mg per 1.5 mL solution for injection syringe) TEVA CANADA LIMITED,Active,9014362,fremanezumab 225 mg per 1.5 mL solution for injection syringe,8002337,fremanezumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
98765,Marketed,2020-08-04,02497859,Ajovy,1,N02CD03,Fremanezumab,Solution,Subcutaneous,02497859,AJOVY SINGLE DOSE PREFILLED SYRINGE (fremanezumab 225 mg per 1.5 mL solution for injection syringe) TEVA CANADA LIMITED,Active,9014362,fremanezumab 225 mg per 1.5 mL solution for injection syringe,8002337,fremanezumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
99876,Marketed,2021-04-01,02509474,Ajovy,1,N02CD03,Fremanezumab,Solution,Subcutaneous,02509474,AJOVY SINGLE-DOSE PREFILLED AUTOINJECTOR (fremanezumab 225 mg per 1.5 mL solution for injection syringe) TEVA CANADA LIMITED,Active,9014362,fremanezumab 225 mg per 1.5 mL solution for injection syringe,8002337,fremanezumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
99876,Marketed,2021-04-01,02509474,Ajovy,1,N02CD03,Fremanezumab,Solution,Subcutaneous,02509474,AJOVY SINGLE-DOSE PREFILLED AUTOINJECTOR (fremanezumab 225 mg per 1.5 mL solution for injection syringe) TEVA CANADA LIMITED,Active,9014362,fremanezumab 225 mg per 1.5 mL solution for injection syringe,8002337,fremanezumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
102432,Marketed,2023-12-27,02535475,Frovatriptan,1,N02CC07,Frovatriptan,Tablet,Oral,02535475,FROVATRIPTAN (frovatriptan (frovatriptan succinate) 2.5 mg oral tablet) SANIS HEALTH INC,Active,9004362,frovatriptan (frovatriptan succinate) 2.5 mg oral tablet,8001384,frovatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74230,Marketed,2026-05-05,02257084,Frova,1,N02CC07,Frovatriptan,Tablet,Oral,02257084,FROVA (frovatriptan (frovatriptan succinate) 2.5 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9004362,frovatriptan (frovatriptan succinate) 2.5 mg oral tablet,8001384,frovatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90043,Marketed,2024-08-09,02415844,Teva-Frovatriptan,1,N02CC07,Frovatriptan,Tablet,Oral,02415844,TEVA-FROVATRIPTAN (frovatriptan (frovatriptan succinate) 2.5 mg oral tablet) ENDO OPERATIONS LTD.,Active,9004362,frovatriptan (frovatriptan succinate) 2.5 mg oral tablet,8001384,frovatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91106,Marketed,2020-06-23,02426471,Apo-Frovatriptan,1,N02CC07,Frovatriptan,Tablet,Oral,02426471,APO-FROVATRIPTAN (frovatriptan (frovatriptan succinate monohydrate) 2.5 mg oral tablet) APOTEX INC,Active,9004362,frovatriptan (frovatriptan succinate) 2.5 mg oral tablet,8001384,frovatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98700,Marketed,2021-01-19,02497131,JAMP Frovatriptan,1,N02CC07,Frovatriptan,Tablet,Oral,02497131,JAMP FROVATRIPTAN (frovatriptan (frovatriptan succinate monohydrate) 2.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004362,frovatriptan (frovatriptan succinate) 2.5 mg oral tablet,8001384,frovatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99896,Marketed,2022-06-10,02509687,Mint-Frovatriptan,1,N02CC07,Frovatriptan,Tablet,Oral,02509687,MINT-FROVATRIPTAN (frovatriptan (frovatriptan succinate) 2.5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9004362,frovatriptan (frovatriptan succinate) 2.5 mg oral tablet,8001384,frovatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104019,Marketed,2024-10-30,02551454,Fruzaqla,1,L01EK04,Fruquintinib,Capsule,Oral,02551454,FRUZAQLA (fruquintinib 1 mg oral capsule) TAKEDA CANADA INC,Active,9015136,fruquintinib 1 mg oral capsule,8002525,fruquintinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule,1.0,,,Prescription
104020,Marketed,2024-10-30,02551462,Fruzaqla,1,L01EK04,Fruquintinib,Capsule,Oral,02551462,FRUZAQLA (fruquintinib 5 mg oral capsule) TAKEDA CANADA INC,Active,9015137,fruquintinib 5 mg oral capsule,8002525,fruquintinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule,1.0,,,Prescription
101980,Marketed,2024-09-12,02530635,Fulvestrant Injectable,1,L02BA03,Fulvestrant,Solution,Intramuscular,02530635,FULVESTRANT INJECTABLE (fulvestrant 250 mg per 5 mL solution for injection syringe) JAMP PHARMA CORPORATION,Active,9013139,fulvestrant 250 mg per 5 mL solution for injection syringe,8001783,fulvestrant,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
102508,Marketed,2023-12-18,02536293,Fulvestrant Injection,1,L02BA03,Fulvestrant,Solution,Intramuscular,02536293,FULVESTRANT INJECTION (fulvestrant 250 mg per 5 mL solution for injection syringe) FORMATIVE PHARMA INC.,Active,9013139,fulvestrant 250 mg per 5 mL solution for injection syringe,8001783,fulvestrant,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
106218,Marketed,2025-09-30,02558971,Fulvestrant Injection,1,L02BA03,Fulvestrant,Solution,Intramuscular,02558971,FULVESTRANT INJECTION (fulvestrant 250 mg per 5 mL solution for injection syringe) STERIMAX INC,Active,9013139,fulvestrant 250 mg per 5 mL solution for injection syringe,8001783,fulvestrant,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
72981,Marketed,2004-06-14,02248624,Faslodex,1,L02BA03,Fulvestrant,Solution,Intramuscular,02248624,FASLODEX (fulvestrant 250 mg per 5 mL solution for injection syringe) ASTRAZENECA CANADA INC,Active,9013139,fulvestrant 250 mg per 5 mL solution for injection syringe,8001783,fulvestrant,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
94743,Marketed,2019-01-15,02460130,Teva-Fulvestrant Injection,1,L02BA03,Fulvestrant,Solution,Intramuscular,02460130,TEVA-FULVESTRANT INJECTION (fulvestrant 250 mg per 5 mL solution for injection syringe) TEVA CANADA LIMITED,Active,9013139,fulvestrant 250 mg per 5 mL solution for injection syringe,8001783,fulvestrant,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
97398,Marketed,2019-02-01,02483610,Fulvestrant Injection,1,L02BA03,Fulvestrant,Solution,Intramuscular,02483610,FULVESTRANT INJECTION (fulvestrant 250 mg per 5 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9013139,fulvestrant 250 mg per 5 mL solution for injection syringe,8001783,fulvestrant,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
101655,Marketed,2023-04-04,02527499,Furosemide Special Injection,1,C03CA01,Furosemide,Solution,Intravenous,02527499,FUROSEMIDE SPECIAL INJECTION (furosemide 250 mg per 25 mL solution for injection vial) JAMP PHARMA CORPORATION,Active,9009618,furosemide 250 mg per 25 mL solution for injection vial,8000057,furosemide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
101656,Marketed,2024-01-23,02527502,Furosemide Injection USP,1,C03CA01,Furosemide,Solution,"Intramuscular,Intravenous",77701148,FUROSEMIDE INJECTION USP (furosemide 20 mg per 2 mL solution for injection vial) JAMP PHARMA CORPORATION,Active,9009617,furosemide 20 mg per 2 mL solution for injection vial,8000057,furosemide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
101656,Marketed,2024-01-23,02527502,Furosemide Injection USP,1,C03CA01,Furosemide,Solution,"Intramuscular,Intravenous",77701149,FUROSEMIDE INJECTION USP (furosemide 40 mg per 4 mL solution for injection vial) JAMP PHARMA CORPORATION,Active,9009623,furosemide 40 mg per 4 mL solution for injection vial,8000057,furosemide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
19189,Marketed,2022-01-10,00667080,Pro-Furosemide,1,C03CA01,Furosemide,Tablet,Oral,00667080,PRO-FUROSEMIDE (furosemide 80 mg oral tablet) PRO DOC LIMITEE,Active,9009625,furosemide 80 mg oral tablet,8000057,furosemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
2333,Marketed,2012-07-11,00337730,Teva-Furosemide,1,C03CA01,Furosemide,Tablet,Oral,00337730,TEVA-FUROSEMIDE (furosemide 20 mg oral tablet) TEVA CANADA LIMITED,Active,9009614,furosemide 20 mg oral tablet,8000057,furosemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
2447,Marketed,2012-07-11,00337749,Teva-Furosemide,1,C03CA01,Furosemide,Tablet,Oral,00337749,TEVA-FUROSEMIDE (furosemide 40 mg oral tablet) TEVA CANADA LIMITED,Active,9009619,furosemide 40 mg oral tablet,8000057,furosemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
2472,Marketed,1976-12-31,00362166,Apo-Furosemide,1,C03CA01,Furosemide,Tablet,Oral,00362166,APO-FUROSEMIDE (furosemide 40 mg oral tablet) APOTEX INC,Active,9009619,furosemide 40 mg oral tablet,8000057,furosemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
2798,Marketed,1977-12-31,00396788,Apo-Furosemide,1,C03CA01,Furosemide,Tablet,Oral,00396788,APO-FUROSEMIDE (furosemide 20 mg oral tablet) APOTEX INC,Active,9009614,furosemide 20 mg oral tablet,8000057,furosemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
2851,Marketed,2022-01-10,00397792,Pro-Furosemide,1,C03CA01,Furosemide,Tablet,Oral,00397792,PRO-FUROSEMIDE (furosemide 40 mg oral tablet) PRO DOC LIMITEE,Active,9009619,furosemide 40 mg oral tablet,8000057,furosemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
37372,Marketed,2008-03-20,02224720,Lasix Oral Solution,1,C03CA01,Furosemide,Solution,Oral,02224720,LASIX ORAL SOLUTION (furosemide 10 mg per mL oral solution) SANOFI-AVENTIS CANADA INC,Active,9009613,furosemide 10 mg per mL oral solution,8000057,furosemide,26643006,Oral,385023001,Oral solution,,,,,,Prescription
37375,Marketed,2008-05-07,02224755,Lasix Special,1,C03CA01,Furosemide,Tablet,Oral,02224755,LASIX SPECIAL (furosemide 500 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9009624,furosemide 500 mg oral tablet,8000057,furosemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
3809,Marketed,2022-01-10,00496723,Pro-Furosemide,1,C03CA01,Furosemide,Tablet,Oral,00496723,PRO-FUROSEMIDE (furosemide 20 mg oral tablet) PRO DOC LIMITEE,Active,9009614,furosemide 20 mg oral tablet,8000057,furosemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
4431,Marketed,2005-10-25,00527033,Furosemide Inj USP,1,C03CA01,Furosemide,Liquid,"Intramuscular,Intravenous",77700284,FUROSEMIDE INJ USP (furosemide 20 mg per 2 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9009615,furosemide 20 mg per 2 mL solution for injection ampoule,8000057,furosemide,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
4431,Marketed,2005-10-25,00527033,Furosemide Inj USP,1,C03CA01,Furosemide,Liquid,"Intramuscular,Intravenous",77700285,FUROSEMIDE INJ USP (furosemide 40 mg per 4 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9009621,furosemide 40 mg per 4 mL solution for injection ampoule,8000057,furosemide,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
6827,Marketed,1986-12-31,00707570,Apo-Furosemide,1,C03CA01,Furosemide,Tablet,Oral,00707570,APO-FUROSEMIDE (furosemide 80 mg oral tablet) APOTEX INC,Active,9009625,furosemide 80 mg oral tablet,8000057,furosemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83669,Marketed,2015-03-25,02351420,Furosemide,1,C03CA01,Furosemide,Tablet,Oral,02351420,FUROSEMIDE (furosemide 20 mg oral tablet) SANIS HEALTH INC,Active,9009614,furosemide 20 mg oral tablet,8000057,furosemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83670,Marketed,2015-03-25,02351439,Furosemide,1,C03CA01,Furosemide,Tablet,Oral,02351439,FUROSEMIDE (furosemide 40 mg oral tablet) SANIS HEALTH INC,Active,9009619,furosemide 40 mg oral tablet,8000057,furosemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83671,Marketed,2015-03-25,02351447,Furosemide,1,C03CA01,Furosemide,Tablet,Oral,02351447,FUROSEMIDE (furosemide 80 mg oral tablet) SANIS HEALTH INC,Active,9009625,furosemide 80 mg oral tablet,8000057,furosemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86837,Marketed,2012-07-26,02382539,Furosemide Injection SDZ,1,C03CA01,Furosemide,Solution,"Intramuscular,Intravenous",77700278,FUROSEMIDE INJECTION SDZ (furosemide 20 mg per 2 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9009615,furosemide 20 mg per 2 mL solution for injection ampoule,8000057,furosemide,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
86837,Marketed,2012-07-26,02382539,Furosemide Injection SDZ,1,C03CA01,Furosemide,Solution,"Intramuscular,Intravenous",77700279,FUROSEMIDE INJECTION SDZ (furosemide 40 mg per 4 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9009621,furosemide 40 mg per 4 mL solution for injection ampoule,8000057,furosemide,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
86984,Marketed,2022-04-29,02384094,Furosemide Injection USP,1,C03CA01,Furosemide,Solution,"Intramuscular,Intravenous",02384094,FUROSEMIDE INJECTION USP (furosemide 20 mg per 2 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9009615,furosemide 20 mg per 2 mL solution for injection ampoule,8000057,furosemide,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
9240,Marketed,2012-07-11,00765953,Teva-Furosemide,1,C03CA01,Furosemide,Tablet,Oral,00765953,TEVA-FUROSEMIDE (furosemide 80 mg oral tablet) TEVA CANADA LIMITED,Active,9009625,furosemide 80 mg oral tablet,8000057,furosemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94899,Marketed,2017-07-31,02461404,Furosemide Injection USP,1,C03CA01,Furosemide,Solution,"Intramuscular,Intravenous",77700522,FUROSEMIDE INJECTION USP (furosemide 20 mg per 2 mL solution for injection vial) STERIMAX INC,Active,9009617,furosemide 20 mg per 2 mL solution for injection vial,8000057,furosemide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
94899,Marketed,2017-07-31,02461404,Furosemide Injection USP,1,C03CA01,Furosemide,Solution,"Intramuscular,Intravenous",77700523,FUROSEMIDE INJECTION USP (furosemide 40 mg per 4 mL solution for injection vial) STERIMAX INC,Active,9009623,furosemide 40 mg per 4 mL solution for injection vial,8000057,furosemide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
95511,Marketed,2018-07-30,02466759,Mint-Furosemide,1,C03CA01,Furosemide,Tablet,Oral,02466759,MINT-FUROSEMIDE (furosemide 20 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9009614,furosemide 20 mg oral tablet,8000057,furosemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95512,Marketed,2018-07-30,02466767,Mint-Furosemide,1,C03CA01,Furosemide,Tablet,Oral,02466767,MINT-FUROSEMIDE (furosemide 40 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9009619,furosemide 40 mg oral tablet,8000057,furosemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95513,Marketed,2018-07-30,02466775,Mint-Furosemide,1,C03CA01,Furosemide,Tablet,Oral,02466775,MINT-FUROSEMIDE (furosemide 80 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9009625,furosemide 80 mg oral tablet,8000057,furosemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97109,Marketed,2021-05-10,02480530,Furosemide Injection USP,1,C03CA01,Furosemide,Solution,"Intramuscular,Intravenous",77701073,FUROSEMIDE INJECTION USP (furosemide 40 mg per 4 mL solution for injection vial) MARCAN PHARMACEUTICALS INC,Active,9009623,furosemide 40 mg per 4 mL solution for injection vial,8000057,furosemide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
97109,Marketed,2021-05-10,02480530,Furosemide Injection USP,1,C03CA01,Furosemide,Solution,"Intramuscular,Intravenous",77701074,FUROSEMIDE INJECTION USP (furosemide 20 mg per 2 mL solution for injection vial) MARCAN PHARMACEUTICALS INC,Active,9009617,furosemide 20 mg per 2 mL solution for injection vial,8000057,furosemide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
101735,Marketed,2024-05-22,02528096,Taro-Fusidic Acid,1,D06AX01,Fusidic acid,Cream,Topical,,,,,,,,,,,,,,,,,Prescription
5637,Marketed,1984-12-31,00586668,Fucidin Cream 2%,1,D06AX01,Fusidic acid,Cream,Topical,00586668,FUCIDIN CREAM 2% (fusidic acid 2 % cutaneous cream) LEO PHARMA INC,Active,9000199,fusidic acid 2 % cutaneous cream,8000104,fusidic acid,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
5638,Marketed,1984-12-31,00586676,Fucidin Ointment 2%,1,D06AX01,Fusidic acid,Ointment,Topical,00586676,FUCIDIN OINTMENT 2% (fusidate sodium 2 % cutaneous ointment) LEO PHARMA INC,Active,9002020,fusidate sodium 2 % cutaneous ointment,8000104,fusidic acid,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Prescription
67803,Marketed,2014-10-10,02243862,Fucithalmic,1,S01AA13,Fusidic acid,Drops,Ophthalmic,02243862,FUCITHALMIC WITH PRESERVATIVE (fusidic acid 1 % ophthalmic drops) AMDIPHARM LIMITED,Active,9000949,fusidic acid 1 % ophthalmic drops,8000104,fusidic acid,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
102411,Marketed,2024-03-07,02535246,JAMP Gabapentin Capsules,1,N02BF01,Gabapentin,Capsule,Oral,02535246,JAMP GABAPENTIN CAPSULES (gabapentin 100 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000519,gabapentin 100 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
102412,Marketed,2024-03-07,02535254,JAMP Gabapentin Capsules,1,N02BF01,Gabapentin,Capsule,Oral,02535254,JAMP GABAPENTIN CAPSULES (gabapentin 300 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000520,gabapentin 300 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
102413,Marketed,2024-03-07,02535262,JAMP Gabapentin Capsules,1,N02BF01,Gabapentin,Capsule,Oral,02535262,JAMP GABAPENTIN CAPSULES (gabapentin 400 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000521,gabapentin 400 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
103883,Marketed,2025-06-02,02550016,Nra-Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02550016,NRA-GABAPENTIN (gabapentin 100 mg oral capsule) NORA PHARMA INC,Active,9000519,gabapentin 100 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
103884,Marketed,2025-06-02,02550024,Nra-Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02550024,NRA-GABAPENTIN (gabapentin 300 mg oral capsule) NORA PHARMA INC,Active,9000520,gabapentin 300 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
103885,Marketed,2025-06-02,02550032,Nra-Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02550032,NRA-GABAPENTIN (gabapentin 400 mg oral capsule) NORA PHARMA INC,Active,9000521,gabapentin 400 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
15944,Marketed,2023-05-05,02084260,Neurontin,1,N02BF01,Gabapentin,Capsule,Oral,02084260,NEURONTIN (gabapentin 100 mg oral capsule) BGP PHARMA ULC,Active,9000519,gabapentin 100 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
15945,Marketed,2023-05-05,02084279,Neurontin,1,N02BF01,Gabapentin,Capsule,Oral,02084279,NEURONTIN (gabapentin 300 mg oral capsule) BGP PHARMA ULC,Active,9000520,gabapentin 300 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
16210,Marketed,2023-05-05,02084287,Neurontin,1,N02BF01,Gabapentin,Capsule,Oral,02084287,NEURONTIN (gabapentin 400 mg oral capsule) BGP PHARMA ULC,Active,9000521,gabapentin 400 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
63199,Marketed,2023-05-05,02239717,Neurontin,1,N02BF01,Gabapentin,Tablet,Oral,02239717,NEURONTIN (gabapentin 600 mg oral tablet) BGP PHARMA ULC,Active,9000891,gabapentin 600 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
63200,Marketed,2023-05-05,02239718,Neurontin,1,N02BF01,Gabapentin,Tablet,Oral,02239718,NEURONTIN (gabapentin 800 mg oral tablet) BGP PHARMA ULC,Active,9000892,gabapentin 800 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
67356,Marketed,2001-02-23,02243446,PMS-Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02243446,PMS-GABAPENTIN (gabapentin 100 mg oral capsule) PHARMASCIENCE INC,Active,9000519,gabapentin 100 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
67357,Marketed,2001-02-23,02243447,PMS-Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02243447,PMS-GABAPENTIN (gabapentin 300 mg oral capsule) PHARMASCIENCE INC,Active,9000520,gabapentin 300 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
67358,Marketed,2001-02-23,02243448,PMS-Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02243448,PMS-GABAPENTIN (gabapentin 400 mg oral capsule) PHARMASCIENCE INC,Active,9000521,gabapentin 400 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
68271,Marketed,2001-08-27,02244304,Apo-Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02244304,APO-GABAPENTIN (gabapentin 100 mg oral capsule) APOTEX INC,Active,9000519,gabapentin 100 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
68273,Marketed,2001-08-27,02244305,Apo-Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02244305,APO-GABAPENTIN (gabapentin 300 mg oral capsule) APOTEX INC,Active,9000520,gabapentin 300 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
68274,Marketed,2001-08-27,02244306,Apo-Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02244306,APO-GABAPENTIN (gabapentin 400 mg oral capsule) APOTEX INC,Active,9000521,gabapentin 400 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
68490,Marketed,2010-04-21,02244513,Teva-Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02244513,TEVA-GABAPENTIN (gabapentin 100 mg oral capsule) TEVA CANADA LIMITED,Active,9000519,gabapentin 100 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
68491,Marketed,2010-04-21,02244514,Teva-Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02244514,TEVA-GABAPENTIN (gabapentin 300 mg oral capsule) TEVA CANADA LIMITED,Active,9000520,gabapentin 300 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
68492,Marketed,2010-04-21,02244515,Teva-Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02244515,TEVA-GABAPENTIN (gabapentin 400 mg oral capsule) TEVA CANADA LIMITED,Active,9000521,gabapentin 400 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
70477,Marketed,2018-04-13,02246314,Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02246314,GABAPENTIN (gabapentin 100 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000519,gabapentin 100 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
70478,Marketed,2018-04-13,02246315,Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02246315,GABAPENTIN (gabapentin 300 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000520,gabapentin 300 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
70479,Marketed,2018-04-13,02246316,Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02246316,GABAPENTIN (gabapentin 400 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000521,gabapentin 400 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
71589,Marketed,2010-04-21,02247346,Teva-Gabapentin,1,N02BF01,Gabapentin,Tablet,Oral,02247346,TEVA-GABAPENTIN (gabapentin 800 mg oral tablet) TEVA CANADA LIMITED,Active,9000892,gabapentin 800 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
72809,Marketed,2010-04-21,02248457,Teva-Gabapentin,1,N02BF01,Gabapentin,Tablet,Oral,02248457,TEVA-GABAPENTIN (gabapentin 600 mg oral tablet) TEVA CANADA LIMITED,Active,9000891,gabapentin 600 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73612,Marketed,2026-01-22,02251167,Riva-Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02251167,RIVA-GABAPENTIN (gabapentin 100 mg oral capsule) LABORATOIRE RIVA INC.,Active,9000519,gabapentin 100 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
73613,Marketed,2026-01-22,02251175,Riva-Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02251175,RIVA-GABAPENTIN (gabapentin 300 mg oral capsule) LABORATOIRE RIVA INC.,Active,9000520,gabapentin 300 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
73614,Marketed,2026-01-22,02251183,Riva-Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02251183,RIVA-GABAPENTIN (gabapentin 400 mg oral capsule) LABORATOIRE RIVA INC.,Active,9000521,gabapentin 400 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
74506,Marketed,2026-05-13,02259796,Riva-Gabapentin,1,N02BF01,Gabapentin,Tablet,Oral,02259796,RIVA-GABAPENTIN (gabapentin 600 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000891,gabapentin 600 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74507,Marketed,2026-05-13,02259818,Riva-Gabapentin,1,N02BF01,Gabapentin,Tablet,Oral,02259818,RIVA-GABAPENTIN (gabapentin 800 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000892,gabapentin 800 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77872,Marketed,2020-07-15,02293358,Apo-Gabapentin,1,N02BF01,Gabapentin,Tablet,Oral,02293358,APO-GABAPENTIN (gabapentin 600 mg oral tablet) APOTEX INC,Active,9000891,gabapentin 600 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77873,Marketed,2020-08-04,02293366,Apo-Gabapentin,1,N02BF01,Gabapentin,Tablet,Oral,02293366,APO-GABAPENTIN (gabapentin 800 mg oral tablet) APOTEX INC,Active,9000892,gabapentin 800 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79608,Marketed,2008-10-27,02310449,Pro-Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02310449,PRO-GABAPENTIN (gabapentin 100 mg oral capsule) PRO DOC LIMITEE,Active,9000519,gabapentin 100 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
79609,Marketed,2008-10-27,02310457,Pro-Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02310457,PRO-GABAPENTIN (gabapentin 300 mg oral capsule) PRO DOC LIMITEE,Active,9000520,gabapentin 300 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
79610,Marketed,2008-10-27,02310465,Pro-Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02310465,PRO-GABAPENTIN (gabapentin 400 mg oral capsule) PRO DOC LIMITEE,Active,9000521,gabapentin 400 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
79611,Marketed,2020-08-07,02310473,Pro-Gabapentin,1,N02BF01,Gabapentin,Tablet,Oral,02310473,PRO-GABAPENTIN (gabapentin 600 mg oral tablet) PRO DOC LIMITEE,Active,9000891,gabapentin 600 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79612,Marketed,2020-08-07,02310481,Pro-Gabapentin,1,N02BF01,Gabapentin,Tablet,Oral,02310481,PRO-GABAPENTIN (gabapentin 800 mg oral tablet) PRO DOC LIMITEE,Active,9000892,gabapentin 800 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80660,Marketed,2011-06-15,02321203,Auro-Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02321203,AURO-GABAPENTIN (gabapentin 100 mg oral capsule) AURO PHARMA INC,Active,9000519,gabapentin 100 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
80661,Marketed,2011-06-15,02321211,Auro-Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02321211,AURO-GABAPENTIN (gabapentin 300 mg oral capsule) AURO PHARMA INC,Active,9000520,gabapentin 300 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
80662,Marketed,2011-06-15,02321238,Auro-Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02321238,AURO-GABAPENTIN (gabapentin 400 mg oral capsule) AURO PHARMA INC,Active,9000521,gabapentin 400 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
83846,Marketed,2013-10-10,02353245,Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02353245,GABAPENTIN (gabapentin 100 mg oral capsule) SANIS HEALTH INC,Active,9000519,gabapentin 100 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
83847,Marketed,2013-10-10,02353253,Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02353253,GABAPENTIN (gabapentin 300 mg oral capsule) SANIS HEALTH INC,Active,9000520,gabapentin 300 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
83848,Marketed,2013-10-10,02353261,Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02353261,GABAPENTIN (gabapentin 400 mg oral capsule) SANIS HEALTH INC,Active,9000521,gabapentin 400 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87375,Marketed,2019-05-02,02388200,Gabapentin,1,N02BF01,Gabapentin,Tablet,Oral,02388200,GABAPENTIN (gabapentin 600 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000891,gabapentin 600 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87376,Marketed,2019-03-22,02388219,Gabapentin,1,N02BF01,Gabapentin,Tablet,Oral,02388219,GABAPENTIN (gabapentin 800 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000892,gabapentin 800 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87778,Marketed,2025-11-18,02392526,ACH-Gabapentin,1,N02BF01,Gabapentin,Tablet,Oral,02392526,ACH-GABAPENTIN (gabapentin 600 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000891,gabapentin 600 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87779,Marketed,2025-11-18,02392534,ACH-Gabapentin,1,N02BF01,Gabapentin,Tablet,Oral,02392534,ACH-GABAPENTIN (gabapentin 800 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000892,gabapentin 800 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89363,Marketed,2023-08-25,02408880,Mint-Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02408880,MINT-GABAPENTIN (gabapentin 100 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9000519,gabapentin 100 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
89364,Marketed,2023-08-25,02408899,Mint-Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02408899,MINT-GABAPENTIN (gabapentin 300 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9000520,gabapentin 300 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
89365,Marketed,2023-08-25,02408902,Mint-Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02408902,MINT-GABAPENTIN (gabapentin 400 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9000521,gabapentin 400 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
89563,Marketed,2019-09-27,02410990,GLN-Gabapentin,1,N02BF01,Gabapentin,Tablet,Oral,02410990,GLN-GABAPENTIN (gabapentin 600 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9000891,gabapentin 600 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89564,Marketed,2019-05-29,02411008,GLN-Gabapentin,1,N02BF01,Gabapentin,Tablet,Oral,02411008,GLN-GABAPENTIN (gabapentin 800 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9000892,gabapentin 800 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90145,Marketed,2025-11-18,02416840,ACH-Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02416840,ACH-GABAPENTIN (gabapentin 100 mg oral capsule) ACCORD HEALTHCARE INC,Active,9000519,gabapentin 100 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90146,Marketed,2025-11-18,02416859,ACH-Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02416859,ACH-GABAPENTIN (gabapentin 300 mg oral capsule) ACCORD HEALTHCARE INC,Active,9000520,gabapentin 300 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90147,Marketed,2025-11-18,02416867,ACH-Gabapentin,1,N02BF01,Gabapentin,Capsule,Oral,02416867,ACH-GABAPENTIN (gabapentin 400 mg oral capsule) ACCORD HEALTHCARE INC,Active,9000521,gabapentin 400 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
91281,Marketed,2019-01-29,02428334,Auro-Gabapentin Tablets,1,N02BF01,Gabapentin,Tablet,Oral,02428334,AURO-GABAPENTIN TABLETS (gabapentin 600 mg oral tablet) AURO PHARMA INC,Active,9000891,gabapentin 600 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91282,Marketed,2019-01-29,02428342,Auro-Gabapentin Tablets,1,N02BF01,Gabapentin,Tablet,Oral,02428342,AURO-GABAPENTIN TABLETS (gabapentin 800 mg oral tablet) AURO PHARMA INC,Active,9000892,gabapentin 800 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91570,Marketed,2020-08-06,02431289,Gabapentin,1,N02BF01,Gabapentin,Tablet,Oral,02431289,GABAPENTIN (gabapentin 600 mg oral tablet) SANIS HEALTH INC,Active,9000891,gabapentin 600 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91652,Marketed,2023-05-19,02432072,Gabapentin,1,N02BF01,Gabapentin,Tablet,Oral,02432072,GABAPENTIN (gabapentin 600 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000891,gabapentin 600 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91653,Marketed,2023-05-19,02432080,Gabapentin,1,N02BF01,Gabapentin,Tablet,Oral,02432080,GABAPENTIN (gabapentin 800 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000892,gabapentin 800 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
72643,Marketed,2004-10-28,02248302,Multihance,1,V08CA08,Gadobenic acid,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
104258,Marketed,2025-04-07,02553678,Pixxoscan,1,V08CA09,Gadobutrol,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
64684,Marketed,2008-02-05,02241089,Gadovist 1,1,V08CA09,Gadobutrol,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
44188,Marketed,2006-10-19,02172771,Omniscan,1,V08CA03,Gadodiamide,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
13384,Marketed,2008-04-10,01989987,Magnevist,1,V08CA01,Gadopentetic acid,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
94652,Marketed,2017-09-22,02459329,Dotarem,1,V08CA02,Gadoteric acid,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
43507,Marketed,1998-09-08,02229056,Prohance,1,V08CA04,Gadoteridol,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
82625,Marketed,2010-02-04,02340666,Primovist,1,V08CA10,Gadoxetic acid,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
80244,Marketed,2020-07-20,02316943,Pat-Galantamine ER,1,N06DA04,Galantamine,Capsule (extended release),Oral,02316943,PAT-GALANTAMINE ER (galantamine (galantamine hydrobromide) 8 mg prolonged-release oral capsule) JANSSEN INC,Active,9001330,galantamine (galantamine hydrobromide) 8 mg prolonged-release oral capsule,8000396,galantamine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
80245,Marketed,2020-04-07,02316951,Pat-Galantamine ER,1,N06DA04,Galantamine,Capsule (extended release),Oral,02316951,PAT-GALANTAMINE ER (galantamine (galantamine hydrobromide) 16 mg prolonged-release oral capsule) JANSSEN INC,Active,9001328,galantamine (galantamine hydrobromide) 16 mg prolonged-release oral capsule,8000396,galantamine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
80246,Marketed,2020-07-29,02316978,Pat-Galantamine ER,1,N06DA04,Galantamine,Capsule (extended release),Oral,02316978,PAT-GALANTAMINE ER (galantamine (galantamine hydrobromide) 24 mg prolonged-release oral capsule) JANSSEN INC,Active,9001329,galantamine (galantamine hydrobromide) 24 mg prolonged-release oral capsule,8000396,galantamine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
82505,Marketed,2011-11-13,02339439,Mylan-Galantamine ER,1,N06DA04,Galantamine,Capsule (extended release),Oral,02339439,MYLAN-GALANTAMINE ER (galantamine (galantamine hydrobromide) 8 mg prolonged-release oral capsule) MYLAN PHARMACEUTICALS ULC,Active,9001330,galantamine (galantamine hydrobromide) 8 mg prolonged-release oral capsule,8000396,galantamine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
82506,Marketed,2011-11-13,02339447,Mylan-Galantamine ER,1,N06DA04,Galantamine,Capsule (extended release),Oral,02339447,MYLAN-GALANTAMINE ER (galantamine (galantamine hydrobromide) 16 mg prolonged-release oral capsule) MYLAN PHARMACEUTICALS ULC,Active,9001328,galantamine (galantamine hydrobromide) 16 mg prolonged-release oral capsule,8000396,galantamine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
82507,Marketed,2011-11-13,02339455,Mylan-Galantamine ER,1,N06DA04,Galantamine,Capsule (extended release),Oral,02339455,MYLAN-GALANTAMINE ER (galantamine (galantamine hydrobromide) 24 mg prolonged-release oral capsule) MYLAN PHARMACEUTICALS ULC,Active,9001329,galantamine (galantamine hydrobromide) 24 mg prolonged-release oral capsule,8000396,galantamine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90981,Marketed,2014-06-12,02425157,Auro-Galantamine ER,1,N06DA04,Galantamine,Capsule (extended release),Oral,02425157,AURO-GALANTAMINE ER (galantamine (galantamine hydrobromide) 8 mg prolonged-release oral capsule) AURO PHARMA INC,Active,9001330,galantamine (galantamine hydrobromide) 8 mg prolonged-release oral capsule,8000396,galantamine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90982,Marketed,2014-06-12,02425165,Auro-Galantamine ER,1,N06DA04,Galantamine,Capsule (extended release),Oral,02425165,AURO-GALANTAMINE ER (galantamine (galantamine hydrobromide) 16 mg prolonged-release oral capsule) AURO PHARMA INC,Active,9001328,galantamine (galantamine hydrobromide) 16 mg prolonged-release oral capsule,8000396,galantamine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90983,Marketed,2014-06-12,02425173,Auro-Galantamine ER,1,N06DA04,Galantamine,Capsule (extended release),Oral,02425173,AURO-GALANTAMINE ER (galantamine (galantamine hydrobromide) 24 mg prolonged-release oral capsule) AURO PHARMA INC,Active,9001329,galantamine (galantamine hydrobromide) 24 mg prolonged-release oral capsule,8000396,galantamine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
92757,Marketed,2016-01-11,02443015,Galantamine ER,1,N06DA04,Galantamine,Capsule (extended release),Oral,02443015,GALANTAMINE ER (galantamine (galantamine hydrobromide) 8 mg prolonged-release oral capsule) SANIS HEALTH INC,Active,9001330,galantamine (galantamine hydrobromide) 8 mg prolonged-release oral capsule,8000396,galantamine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
92758,Marketed,2016-01-11,02443023,Galantamine ER,1,N06DA04,Galantamine,Capsule (extended release),Oral,02443023,GALANTAMINE ER (galantamine (galantamine hydrobromide) 16 mg prolonged-release oral capsule) SANIS HEALTH INC,Active,9001328,galantamine (galantamine hydrobromide) 16 mg prolonged-release oral capsule,8000396,galantamine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
92759,Marketed,2016-01-11,02443031,Galantamine ER,1,N06DA04,Galantamine,Capsule (extended release),Oral,02443031,GALANTAMINE ER (galantamine (galantamine hydrobromide) 24 mg prolonged-release oral capsule) SANIS HEALTH INC,Active,9001329,galantamine (galantamine hydrobromide) 24 mg prolonged-release oral capsule,8000396,galantamine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98107,Marketed,2019-10-07,02491060,Emgality,1,N02CD02,Galcanezumab,Solution,Subcutaneous,02491060,EMGALITY (galcanezumab 120 mg per 1 mL solution for injection syringe) ELI LILLY CANADA INC,Active,9014194,galcanezumab 120 mg per 1 mL solution for injection syringe,8002302,galcanezumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
98107,Marketed,2019-10-07,02491060,Emgality,1,N02CD02,Galcanezumab,Solution,Subcutaneous,02491060,EMGALITY (galcanezumab 120 mg per 1 mL solution for injection syringe) ELI LILLY CANADA INC,Active,9014194,galcanezumab 120 mg per 1 mL solution for injection syringe,8002302,galcanezumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
98110,Marketed,2019-10-02,02491087,Emgality,1,N02CD02,Galcanezumab,Solution,Subcutaneous,02491087,EMGALITY (galcanezumab 120 mg per 1 mL solution for injection pen) ELI LILLY CANADA INC,Active,9014193,galcanezumab 120 mg per 1 mL solution for injection pen,8002302,galcanezumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Prescription
98110,Marketed,2019-10-02,02491087,Emgality,1,N02CD02,Galcanezumab,Solution,Subcutaneous,02491087,EMGALITY (galcanezumab 120 mg per 1 mL solution for injection pen) ELI LILLY CANADA INC,Active,9014193,galcanezumab 120 mg per 1 mL solution for injection pen,8002302,galcanezumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
99448,Marketed,2021-01-11,02505134,Emgality,1,N02CD02,Galcanezumab,Solution,Subcutaneous,02505134,EMGALITY (galcanezumab 100 mg per 1 mL solution for injection syringe) ELI LILLY CANADA INC,Active,9014454,galcanezumab 100 mg per 1 mL solution for injection syringe,8002302,galcanezumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
99448,Marketed,2021-01-11,02505134,Emgality,1,N02CD02,Galcanezumab,Solution,Subcutaneous,02505134,EMGALITY (galcanezumab 100 mg per 1 mL solution for injection syringe) ELI LILLY CANADA INC,Active,9014454,galcanezumab 100 mg per 1 mL solution for injection syringe,8002302,galcanezumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
102092,Marketed,2023-04-03,02531836,Illuccix,1,V09IX14,Gallium (68ga) gozetotide,Powder for solution,Intravenous,,,,,,,,,,,,,,,,,Schedule C
102582,Marketed,2024-02-28,02537117,Locametz,1,V09IX14,Gallium (68ga) gozetotide,"Powder for solution,Kit",Intravenous,,,,,,,,,,,,,,,,,Schedule C
81328,Marketed,2019-07-22,02327813,Gallium (Ga 67) Citrate Injection,1,V09HX01,Gallium 67 ga citrate,Solution,Intravenous,,,,,,,,,,,,,,,,,Schedule C
89735,Marketed,2014-01-01,02412683,Naglazyme,1,A16AB08,Galsufase,Solution,Intravenous,02412683,NAGLAZYME (galsulfase 5 mg per 5 mL solution for injection vial) BIOMARIN PHARMACEUTICAL INC.,Active,9013140,galsulfase 5 mg per 5 mL solution for injection vial,8001784,galsulfase,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
89735,Marketed,2014-01-01,02412683,Naglazyme,1,A16AB08,Galsufase,Solution,Intravenous,02412683,NAGLAZYME (galsulfase 5 mg per 5 mL solution for injection vial) BIOMARIN PHARMACEUTICAL INC.,Active,9013140,galsulfase 5 mg per 5 mL solution for injection vial,8001784,galsulfase,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
101971,Marketed,2023-09-26,02530546,Eyezirgan,1,S01AD09,Ganciclovir,Gel,Ophthalmic,,,,,,,,,,,,,,1.0,,,Prescription
102588,Marketed,2023-10-04,02537168,Ganciclovir For Injection,1,J05AB06,Ganciclovir,Powder for solution,Intravenous,02537168,GANCICLOVIR FOR INJECTION (ganciclovir (ganciclovir sodium) 500 mg per vial powder for solution for injection) FORMATIVE PHARMA INC.,Active,9002820,ganciclovir (ganciclovir sodium) 500 mg per vial powder for solution for injection,8001205,ganciclovir,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
19553,Marketed,2019-08-09,02162695,Cytovene,1,J05AB06,Ganciclovir,Powder for solution,Intravenous,02162695,CYTOVENE (ganciclovir (ganciclovir sodium) 500 mg per vial powder for solution for injection) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9002820,ganciclovir (ganciclovir sodium) 500 mg per vial powder for solution for injection,8001205,ganciclovir,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
88956,Marketed,2025-11-14,02404761,"Ganciclovir For Injection, USP",1,J05AB06,Ganciclovir,Powder for solution,Intravenous,02404761,"GANCICLOVIR FOR INJECTION, USP (ganciclovir (ganciclovir sodium) 500 mg per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9002820,ganciclovir (ganciclovir sodium) 500 mg per vial powder for solution for injection,8001205,ganciclovir,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
96577,Marketed,2021-07-19,02475391,Ganciclovir For Injection USP,1,J05AB06,Ganciclovir,Powder for solution,Intravenous,02475391,GANCICLOVIR FOR INJECTION USP (ganciclovir (ganciclovir sodium) 500 mg per vial powder for solution for injection) STERIMAX INC,Active,9002820,ganciclovir (ganciclovir sodium) 500 mg per vial powder for solution for injection,8001205,ganciclovir,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
69741,Marketed,2022-05-17,02245641,Orgalutran,1,H01CC01,Ganirelix,Solution,Subcutaneous,02245641,ORGALUTRAN (ganirelix (ganirelix acetate) 250 mcg per 0.5 mL solution for injection syringe) ORGANON CANADA INC.,Active,9013294,ganirelix (ganirelix acetate) 250 mcg per 0.5 mL solution for injection syringe,8001785,ganirelix,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
106290,Marketed,2025-10-24,02559773,Andembry,1,B06AC07,Garadacimab,Solution,Subcutaneous,02559773,ANDEMBRY (garadacimab 200 mg per 1.2 mL solution for injection pen) CSL BEHRING CANADA INC,Active,9015356,garadacimab 200 mg per 1.2 mL solution for injection pen,8002572,garadacimab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen(s),,,,Prescription
106290,Marketed,2025-10-24,02559773,Andembry,1,B06AC07,Garadacimab,Solution,Subcutaneous,02559773,ANDEMBRY (garadacimab 200 mg per 1.2 mL solution for injection pen) CSL BEHRING CANADA INC,Active,9015356,garadacimab 200 mg per 1.2 mL solution for injection pen,8002572,garadacimab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen(s),,,,Schedule D
102224,Marketed,2024-12-05,02533235,JAMP Gatifloxacin,1,S01AE06,Gatifloxacin,Solution,Ophthalmic,02533235,JAMP GATIFLOXACIN (gatifloxacin 0.3 % ophthalmic drops) JAMP PHARMA CORPORATION,Active,9003959,gatifloxacin 0.3 % ophthalmic drops,8001479,gatifloxacin,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
74247,Marketed,2023-12-06,02257270,Zymar,1,S01AE06,Gatifloxacin,Solution,Ophthalmic,02257270,ZYMAR (gatifloxacin 0.3 % ophthalmic drops) ABBVIE CORPORATION,Active,9003959,gatifloxacin 0.3 % ophthalmic drops,8001479,gatifloxacin,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
81256,Marketed,2019-11-15,02327260,Apo-Gatifloxacin,1,S01AE06,Gatifloxacin,Solution,Ophthalmic,02327260,APO-GATIFLOXACIN (gatifloxacin (gatifloxacin hemihydrate) 0.3 % ophthalmic drops) APOTEX INC,Active,9003959,gatifloxacin 0.3 % ophthalmic drops,8001479,gatifloxacin,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
73040,Marketed,2003-12-17,02248676,Iressa,1,L01EB01,Gefitinib,Tablet,Oral,02248676,IRESSA (gefitinib 250 mg oral tablet) ASTRAZENECA CANADA INC,Active,9003851,gefitinib 250 mg oral tablet,8001786,gefitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
95642,Marketed,2017-10-18,02468050,Apo-Gefitinib,1,L01EB01,Gefitinib,Tablet,Oral,02468050,APO-GEFITINIB (gefitinib 250 mg oral tablet) APOTEX INC,Active,9003851,gefitinib 250 mg oral tablet,8001786,gefitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
97788,Marketed,2019-06-26,02487748,Sandoz Gefitinib,1,L01EB01,Gefitinib,Tablet,Oral,02487748,SANDOZ GEFITINIB (gefitinib 250 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003851,gefitinib 250 mg oral tablet,8001786,gefitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99033,Marketed,2020-12-23,02500663,JAMP Gefitinib,1,L01EB01,Gefitinib,Tablet,Oral,02500663,JAMP GEFITINIB (gefitinib 250 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003851,gefitinib 250 mg oral tablet,8001786,gefitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
88767,Marketed,2017-08-31,02402831,Gemcitabine Injection,1,L01BC05,Gemcitabine,Solution,Intravenous,77700773,GEMCITABINE INJECTION (gemcitabine (gemcitabine hydrochloride) 38 mg per mL solution for injection 5.3 mL vial) PFIZER CANADA ULC,Active,9013143,gemcitabine (gemcitabine hydrochloride) 38 mg per mL solution for injection 5.3 mL vial,8001787,gemcitabine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
88767,Marketed,2017-08-31,02402831,Gemcitabine Injection,1,L01BC05,Gemcitabine,Solution,Intravenous,77700774,GEMCITABINE INJECTION (gemcitabine (gemcitabine hydrochloride) 38 mg per mL solution for injection 26.3 mL vial) PFIZER CANADA ULC,Active,9013141,gemcitabine (gemcitabine hydrochloride) 38 mg per mL solution for injection 26.3 mL vial,8001787,gemcitabine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
88767,Marketed,2017-08-31,02402831,Gemcitabine Injection,1,L01BC05,Gemcitabine,Solution,Intravenous,77700775,GEMCITABINE INJECTION (gemcitabine (gemcitabine hydrochloride) 38 mg per mL solution for injection 52.6 mL vial) PFIZER CANADA ULC,Active,9013144,gemcitabine (gemcitabine hydrochloride) 38 mg per mL solution for injection 52.6 mL vial,8001787,gemcitabine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
89685,Marketed,2013-09-24,02412292,Gemcitabine Injection,1,L01BC05,Gemcitabine,Solution,Intravenous,77700795,GEMCITABINE INJECTION (gemcitabine (gemcitabine hydrochloride) 40 mg per mL solution for injection 5 mL vial) SANDOZ CANADA INCORPORATED,Active,9013146,gemcitabine (gemcitabine hydrochloride) 40 mg per mL solution for injection 5 mL vial,8001787,gemcitabine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
89685,Marketed,2013-09-24,02412292,Gemcitabine Injection,1,L01BC05,Gemcitabine,Solution,Intravenous,77700796,GEMCITABINE INJECTION (gemcitabine (gemcitabine hydrochloride) 40 mg per mL solution for injection 50 mL vial) SANDOZ CANADA INCORPORATED,Active,9013147,gemcitabine (gemcitabine hydrochloride) 40 mg per mL solution for injection 50 mL vial,8001787,gemcitabine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
89685,Marketed,2013-09-24,02412292,Gemcitabine Injection,1,L01BC05,Gemcitabine,Solution,Intravenous,77700797,GEMCITABINE INJECTION (gemcitabine (gemcitabine hydrochloride) 40 mg per mL solution for injection 25 mL vial) SANDOZ CANADA INCORPORATED,Active,9013145,gemcitabine (gemcitabine hydrochloride) 40 mg per mL solution for injection 25 mL vial,8001787,gemcitabine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
17230,Marketed,2015-07-14,02142074,Teva-Gemfibrozil,1,C10AB04,Gemfibrozil,Tablet,Oral,02142074,TEVA-GEMFIBROZIL (gemfibrozil 600 mg oral tablet) TEVA CANADA LIMITED,Active,9002574,gemfibrozil 600 mg oral tablet,8001658,gemfibrozil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98440,Marketed,2020-03-11,02494388,Mylotarg,1,L01FX02,Gemtuzumab ozogamicin,Powder for solution,Intravenous,02494388,MYLOTARG (gemtuzumab ozogamicin 4.5 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9014298,gemtuzumab ozogamicin 4.5 mg per vial powder for solution for injection,8002326,gemtuzumab ozogamicin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
98440,Marketed,2020-03-11,02494388,Mylotarg,1,L01FX02,Gemtuzumab ozogamicin,Powder for solution,Intravenous,02494388,MYLOTARG (gemtuzumab ozogamicin 4.5 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9014298,gemtuzumab ozogamicin 4.5 mg per vial powder for solution for injection,8002326,gemtuzumab ozogamicin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
18242,Marketed,1995-12-31,02082136,Gentamicin(E),1,J01GB03,Gentamicin,Solution,Intravenous,02082136,GENTAMICIN(E) (gentamicin (gentamicin sulfate) 100 mg per 100 mL solution for injection bag) BAXTER CORPORATION,Active,9012571,gentamicin (gentamicin sulfate) 100 mg per 100 mL solution for injection bag,8001206,gentamicin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Prescription
18243,Marketed,1995-12-31,02082152,Gentamicin(E),1,J01GB03,Gentamicin,Solution,Intravenous,02082152,GENTAMICIN(E) (gentamicin (gentamicin sulfate) 80 mg per 50 mL solution for injection bag) BAXTER CORPORATION,Active,9012575,gentamicin (gentamicin sulfate) 80 mg per 50 mL solution for injection bag,8001206,gentamicin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Prescription
66434,Marketed,2005-08-18,02242652,Gentamicin Injection USP,1,J01GB03,Gentamicin,Solution,"Intravenous,Intramuscular",02242652,GENTAMICIN INJECTION USP (gentamicin (gentamicin sulfate) 80 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012574,gentamicin (gentamicin sulfate) 80 mg per 2 mL solution for injection vial,8001206,gentamicin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
75394,Marketed,2005-08-29,02268531,Gentamicin Injection USP,1,J01GB03,Gentamicin,Solution,"Intravenous,Intramuscular",02268531,GENTAMICIN INJECTION USP (gentamicin (gentamicin sulfate) 20 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012572,gentamicin (gentamicin sulfate) 20 mg per 2 mL solution for injection vial,8001206,gentamicin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
94412,Marketed,2024-01-11,02457008,Gentamicin Injection USP,1,J01GB03,Gentamicin,Solution,"Intravenous,Intramuscular",02457008,GENTAMICIN INJECTION USP (gentamicin (gentamicin sulfate) 80 mg per 2 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9012573,gentamicin (gentamicin sulfate) 80 mg per 2 mL solution for injection ampoule,8001206,gentamicin,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
95943,Marketed,2024-01-11,02470462,Gentamicin Injection USP,1,J01GB03,Gentamicin,Solution,"Intravenous,Intramuscular",02470462,GENTAMICIN INJECTION USP (gentamicin (gentamicin sulfate) 20 mg per 2 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9013906,gentamicin (gentamicin sulfate) 20 mg per 2 mL solution for injection ampoule,8001206,gentamicin,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
98500,Marketed,2020-02-03,02495058,Xospata,1,L01EX13,Gilteritinib,Tablet,Oral,02495058,XOSPATA (gilteritinib (gilteritinib fumarate) 40 mg oral tablet) ASTELLAS PHARMA CANADA INC,Active,9014243,gilteritinib (gilteritinib fumarate) 40 mg oral tablet,8002317,gilteritinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99566,Marketed,2020-12-01,02506343,Givlaari,1,A16AX16,Givosiran,Solution,Subcutaneous,02506343,GIVLAARI (givosiran (givosiran sodium) 189 mg per 1 mL solution for injection vial) ALNYLAM NETHERLANDS B.V.,Active,9014547,givosiran (givosiran sodium) 189 mg per 1 mL solution for injection vial,8002375,givosiran,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
98824,Marketed,2020-08-10,02498472,Daurismo,1,L01XJ03,Glasdegib,Tablet,Oral,02498472,DAURISMO (glasdegib (glasdegib maleate) 25 mg oral tablet) PFIZER CANADA ULC,Active,9014364,glasdegib (glasdegib maleate) 25 mg oral tablet,8002345,glasdegib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98825,Marketed,2020-08-10,02498480,Daurismo,1,L01XJ03,Glasdegib,Tablet,Oral,02498480,DAURISMO (glasdegib (glasdegib maleate) 100 mg oral tablet) PFIZER CANADA ULC,Active,9014363,glasdegib (glasdegib maleate) 100 mg oral tablet,8002345,glasdegib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
103009,Marketed,2024-04-11,02541440,Glatiramer Acetate Injection,1,L03AX13,Glatiramer acetate,Solution,Subcutaneous,02541440,GLATIRAMER ACETATE INJECTION (glatiramer acetate 20 mg per 1 mL solution for injection syringe) MYLAN PHARMACEUTICALS ULC,Active,9013295,glatiramer acetate 20 mg per 1 mL solution for injection syringe,8001788,glatiramer,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
69719,Marketed,2016-01-28,02245619,Copaxone,1,L03AX13,Glatiramer acetate,Solution,Subcutaneous,02245619,COPAXONE (glatiramer acetate 20 mg per 1 mL solution for injection syringe) TEVA CANADA LIMITED,Active,9013295,glatiramer acetate 20 mg per 1 mL solution for injection syringe,8001788,glatiramer,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
94398,Marketed,2016-08-26,02456915,Copaxone,1,L03AX13,Glatiramer acetate,Solution,Subcutaneous,02456915,COPAXONE (glatiramer acetate 40 mg per 1 mL solution for injection syringe) TEVA CANADA LIMITED,Active,9013296,glatiramer acetate 40 mg per 1 mL solution for injection syringe,8001788,glatiramer,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
94809,Marketed,2017-08-21,02460661,Glatect,1,L03AX13,Glatiramer acetate,Solution,Subcutaneous,02460661,GLATECT (glatiramer acetate 20 mg per 1 mL solution for injection syringe) PHARMASCIENCE INC,Active,9013295,glatiramer acetate 20 mg per 1 mL solution for injection syringe,8001788,glatiramer,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
101158,Marketed,2022-04-22,02522470,Maviret,2,J05AP57,Glecaprevir and pibrentasvir,Granules,Oral,02522470,MAVIRET (glecaprevir 50 mg per sachet and pibrentasvir 20 mg per sachet oral granules) ABBVIE CORPORATION,Active,9014694,glecaprevir 50 mg per sachet and pibrentasvir 20 mg per sachet oral granules,8001136,glecaprevir and pibrentasvir,26643006,Oral,420509004,Oral granules,733013000,Sachet (unit of presentation),,,,Prescription
95591,Marketed,2017-09-13,02467550,Maviret,2,J05AP57,Glecaprevir and pibrentasvir,Tablet,Oral,02467550,MAVIRET (glecaprevir 100 mg and pibrentasvir 40 mg oral tablet) ABBVIE CORPORATION,Active,9012419,glecaprevir 100 mg and pibrentasvir 40 mg oral tablet,8001136,glecaprevir and pibrentasvir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
11727,Marketed,1991-12-31,01913662,Apo Glyburide Tablets 5 mg,1,A10BB01,Glibenclamide,Tablet,Oral,01913662,APO GLYBURIDE TAB 5MG (glyburide 5 mg oral tablet) APOTEX INC,Active,9000250,glyburide 5 mg oral tablet,8000115,glyburide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
11728,Marketed,1991-12-31,01913654,Apo Glyburide Tablets 2.5 mg,1,A10BB01,Glibenclamide,Tablet,Oral,01913654,APO GLYBURIDE TAB 2.5MG (glyburide 2.5 mg oral tablet) APOTEX INC,Active,9000383,glyburide 2.5 mg oral tablet,8000115,glyburide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
11780,Marketed,2010-10-09,01913670,Teva-Glyburide,1,A10BB01,Glibenclamide,Tablet,Oral,01913670,TEVA-GLYBURIDE (glyburide 2.5 mg oral tablet) TEVA CANADA LIMITED,Active,9000383,glyburide 2.5 mg oral tablet,8000115,glyburide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
11781,Marketed,2010-10-09,01913689,Teva-Glyburide,1,A10BB01,Glibenclamide,Tablet,Oral,01913689,TEVA-GLYBURIDE (glyburide 5 mg oral tablet) TEVA CANADA LIMITED,Active,9000250,glyburide 5 mg oral tablet,8000115,glyburide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83567,Marketed,2017-03-01,02350467,Glyburide,1,A10BB01,Glibenclamide,Tablet,Oral,02350467,GLYBURIDE (glyburide 5 mg oral tablet) SANIS HEALTH INC,Active,9000250,glyburide 5 mg oral tablet,8000115,glyburide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
61497,Marketed,2014-02-11,02238103,Teva-Gliclazide,1,A10BB09,Gliclazide,Tablet,Oral,02238103,TEVA-GLICLAZIDE (gliclazide 80 mg oral tablet) TEVA CANADA LIMITED,Active,9000357,gliclazide 80 mg oral tablet,8000139,gliclazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
66827,Marketed,2001-04-04,02242987,Diamicron MR,1,A10BB09,Gliclazide,Tablet (extended-release),Oral,02242987,DIAMICRON MR (gliclazide 30 mg prolonged-release oral tablet) SERVIER CANADA INC,Active,9000938,gliclazide 30 mg prolonged-release oral tablet,8000139,gliclazide,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
69269,Marketed,2002-07-02,02245247,Apo-Gliclazide,1,A10BB09,Gliclazide,Tablet,Oral,02245247,APO-GLICLAZIDE (gliclazide 80 mg oral tablet) APOTEX INC,Active,9000357,gliclazide 80 mg oral tablet,8000139,gliclazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77250,Marketed,2014-06-10,02287072,Gliclazide,1,A10BB09,Gliclazide,Tablet,Oral,02287072,GLICLAZIDE (gliclazide 80 mg oral tablet) SANIS HEALTH INC,Active,9000357,gliclazide 80 mg oral tablet,8000139,gliclazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78313,Marketed,2014-12-12,02297795,Apo-Gliclazide MR,1,A10BB09,Gliclazide,Tablet (extended-release),Oral,02297795,APO-GLICLAZIDE MR (gliclazide 30 mg prolonged-release oral tablet) APOTEX INC,Active,9000938,gliclazide 30 mg prolonged-release oral tablet,8000139,gliclazide,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84157,Marketed,2010-12-09,02356422,Diamicron MR,1,A10BB09,Gliclazide,Tablet (extended-release),Oral,02356422,DIAMICRON MR (gliclazide 60 mg prolonged-release oral tablet) SERVIER CANADA INC,Active,9001331,gliclazide 60 mg prolonged-release oral tablet,8000139,gliclazide,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89182,Marketed,2015-04-14,02407124,Apo-Gliclazide MR,1,A10BB09,Gliclazide,Tablet (extended-release),Oral,02407124,APO-GLICLAZIDE MR (gliclazide 60 mg prolonged-release oral tablet) APOTEX INC,Active,9001331,gliclazide 60 mg prolonged-release oral tablet,8000139,gliclazide,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90799,Marketed,2014-06-02,02423286,Mint-Gliclazide MR,1,A10BB09,Gliclazide,Tablet (extended-release),Oral,02423286,MINT-GLICLAZIDE MR (gliclazide 30 mg prolonged-release oral tablet) MINT PHARMACEUTICALS INC,Active,9000938,gliclazide 30 mg prolonged-release oral tablet,8000139,gliclazide,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90800,Marketed,2025-04-16,02423294,Mint-Gliclazide MR,1,A10BB09,Gliclazide,Tablet (extended-release),Oral,02423294,MINT-GLICLAZIDE MR (gliclazide 60 mg prolonged-release oral tablet) MINT PHARMACEUTICALS INC,Active,9001331,gliclazide 60 mg prolonged-release oral tablet,8000139,gliclazide,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91420,Marketed,2024-10-04,02429764,JAMP Gliclazide-MR,1,A10BB09,Gliclazide,Tablet (extended-release),Oral,02429764,JAMP GLICLAZIDE-MR (gliclazide 30 mg prolonged-release oral tablet) JAMP PHARMA CORPORATION,Active,9000938,gliclazide 30 mg prolonged-release oral tablet,8000139,gliclazide,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91421,Marketed,2024-10-04,02429772,JAMP Gliclazide-MR,1,A10BB09,Gliclazide,Tablet (extended-release),Oral,02429772,JAMP GLICLAZIDE-MR (gliclazide 60 mg prolonged-release oral tablet) JAMP PHARMA CORPORATION,Active,9001331,gliclazide 60 mg prolonged-release oral tablet,8000139,gliclazide,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92302,Marketed,2015-08-07,02438658,Mylan-Gliclazide MR,1,A10BB09,Gliclazide,Tablet (extended-release),Oral,02438658,MYLAN-GLICLAZIDE MR (gliclazide 30 mg prolonged-release oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000938,gliclazide 30 mg prolonged-release oral tablet,8000139,gliclazide,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92369,Marketed,2021-02-22,02439328,Taro-Gliclazide MR,1,A10BB09,Gliclazide,Tablet (extended-release),Oral,02439328,TARO-GLICLAZIDE MR (gliclazide 60 mg prolonged-release oral tablet) SUN PHARMA CANADA INC,Active,9001331,gliclazide 60 mg prolonged-release oral tablet,8000139,gliclazide,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94883,Marketed,2017-06-02,02461323,Sandoz Gliclazide MR,1,A10BB09,Gliclazide,Tablet (extended-release),Oral,02461323,SANDOZ GLICLAZIDE MR (gliclazide 30 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9000938,gliclazide 30 mg prolonged-release oral tablet,8000139,gliclazide,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94884,Marketed,2017-06-02,02461331,Sandoz Gliclazide MR,1,A10BB09,Gliclazide,Tablet (extended-release),Oral,02461331,SANDOZ GLICLAZIDE MR (gliclazide 60 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9001331,gliclazide 60 mg prolonged-release oral tablet,8000139,gliclazide,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95168,Marketed,2021-02-22,02463571,Taro-Gliclazide MR,1,A10BB09,Gliclazide,Tablet (extended-release),Oral,02463571,TARO-GLICLAZIDE MR (gliclazide 30 mg prolonged-release oral tablet) SUN PHARMA CANADA INC,Active,9000938,gliclazide 30 mg prolonged-release oral tablet,8000139,gliclazide,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97374,Marketed,2025-02-03,02483300,AG-Gliclazide MR,1,A10BB09,Gliclazide,Tablet (extended-release),Oral,02483300,AG-GLICLAZIDE MR (gliclazide 30 mg prolonged-release oral tablet) ANGITA PHARMA INC.,Active,9000938,gliclazide 30 mg prolonged-release oral tablet,8000139,gliclazide,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97375,Marketed,2025-02-03,02483319,AG-Gliclazide MR,1,A10BB09,Gliclazide,Tablet (extended-release),Oral,02483319,AG-GLICLAZIDE MR (gliclazide 60 mg prolonged-release oral tablet) ANGITA PHARMA INC.,Active,9001331,gliclazide 60 mg prolonged-release oral tablet,8000139,gliclazide,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75494,Marketed,2006-01-28,02269589,Sandoz Glimepiride,1,A10BB12,Glimepiride,Tablet,Oral,02269589,SANDOZ GLIMEPIRIDE (glimepiride 1 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003702,glimepiride 1 mg oral tablet,8001480,glimepiride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75495,Marketed,2006-01-28,02269597,Sandoz Glimepiride,1,A10BB12,Glimepiride,Tablet,Oral,02269597,SANDOZ GLIMEPIRIDE (glimepiride 2 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003703,glimepiride 2 mg oral tablet,8001480,glimepiride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75497,Marketed,2006-01-28,02269619,Sandoz Glimepiride,1,A10BB12,Glimepiride,Tablet,Oral,02269619,SANDOZ GLIMEPIRIDE (glimepiride 4 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003704,glimepiride 4 mg oral tablet,8001480,glimepiride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102531,Marketed,2023-07-05,02536552,Columvi,1,L01FX28,Glofitamab,Solution,Intravenous,02536552,COLUMVI (glofitamab 2.5 mg per 2.5 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9014893,glofitamab 2.5 mg per 2.5 mL solution for injection vial,8002472,glofitamab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
102531,Marketed,2023-07-05,02536552,Columvi,1,L01FX28,Glofitamab,Solution,Intravenous,02536552,COLUMVI (glofitamab 2.5 mg per 2.5 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9014893,glofitamab 2.5 mg per 2.5 mL solution for injection vial,8002472,glofitamab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
102532,Marketed,2023-07-05,02536560,Columvi,1,L01FX28,Glofitamab,Solution,Intravenous,02536560,COLUMVI (glofitamab 10 mg per 10 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9014892,glofitamab 10 mg per 10 mL solution for injection vial,8002472,glofitamab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
102532,Marketed,2023-07-05,02536560,Columvi,1,L01FX28,Glofitamab,Solution,Intravenous,02536560,COLUMVI (glofitamab 10 mg per 10 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9014892,glofitamab 10 mg per 10 mL solution for injection vial,8002472,glofitamab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
98243,Marketed,2024-09-23,02492415,Baqsimi,1,H04AA01,Glucagon,Powder,Nasal,02492415,"BAQSIMI (glucagon 3 mg per actuation nasal powder) AMPHASTAR PHARMACEUTICALS, INC.",Active,9014207,glucagon 3 mg per actuation nasal powder,8001385,glucagon,46713006,Nasal,385156003,Nasal powder,732981002,Actuation (unit of presentation),,,,Ethical
14183,Marketed,1977-12-31,02020939,Sclerodex,2,C05BB56,"Glucose, combinations",Liquid,Intravenous,,,,,,,,,,,,,,,,,Ethical
93983,Marketed,2016-11-03,02453304,Ravicti,1,A16AX09,Glycerol phenylbutyrate,Liquid,Oral,02453304,RAVICTI (glycerol phenylbutyrate 1.1 g per mL oral liquid) HORIZON THERAPEUTICS IRELAND DAC,Active,9006061,glycerol phenylbutyrate 1.1 g per mL oral liquid,8001915,phenylbutyric acid,26643006,Oral,420699003,Liquid,,,,,,Prescription
10706,Marketed,2025-10-17,00778869,Nitroject,1,C01DA02,Glyceryl trinitrate,Solution,Intravenous,00778869,NITROJECT (nitroglycerin 50 mg per 10 mL solution for injection vial) JUNO PHARMA CANADA INC.,Active,9000302,nitroglycerin 50 mg per 10 mL solution for injection vial,8000044,nitroglycerin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
11225,Marketed,2018-07-12,01911902,Nitro-Dur 0.4,1,C01DA02,Glyceryl trinitrate,Patch (extended release),Transdermal,01911902,NITRO-DUR 0.4 (nitroglycerin 0.4 mg per hour transdermal patch) USPHARMA LTD,Active,9010876,nitroglycerin 0.4 mg per hour transdermal patch,8000044,nitroglycerin,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,,Ethical
11226,Marketed,2018-07-12,01911929,Nitro-Dur 0.6,1,C01DA02,Glyceryl trinitrate,Patch (extended release),Transdermal,01911929,NITRO-DUR 0.6 (nitroglycerin 0.6 mg per hour transdermal patch) USPHARMA LTD,Active,9010877,nitroglycerin 0.6 mg per hour transdermal patch,8000044,nitroglycerin,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,,Ethical
11227,Marketed,2018-07-12,01911910,Nitro-Dur 0.2,1,C01DA02,Glyceryl trinitrate,Patch (extended release),Transdermal,01911910,NITRO-DUR 0.2 (nitroglycerin 0.2 mg per hour transdermal patch) USPHARMA LTD,Active,9010873,nitroglycerin 0.2 mg per hour transdermal patch,8000044,nitroglycerin,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,,Ethical
1253,Marketed,2023-08-03,00037621,Nitrostat,1,C01DA02,Glyceryl trinitrate,Tablet,Sublingual,00037621,NITROSTAT (nitroglycerin 0.6 mg sublingual tablet) BGP PHARMA ULC,Active,9010878,nitroglycerin 0.6 mg sublingual tablet,8000044,nitroglycerin,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,,Ethical
1254,Marketed,2023-08-03,00037613,Nitrostat,1,C01DA02,Glyceryl trinitrate,Tablet,Sublingual,00037613,NITROSTAT (nitroglycerin 0.3 mg sublingual tablet) BGP PHARMA ULC,Active,9010874,nitroglycerin 0.3 mg sublingual tablet,8000044,nitroglycerin,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,,Ethical
14742,Marketed,2018-07-12,02011271,Nitro-Dur 0.8,1,C01DA02,Glyceryl trinitrate,Patch (extended release),Transdermal,02011271,NITRO-DUR 0.8 (nitroglycerin 0.8 mg per hour transdermal patch) USPHARMA LTD,Active,9010879,nitroglycerin 0.8 mg per hour transdermal patch,8000044,nitroglycerin,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,,Ethical
18085,Marketed,1995-12-31,02145316,Nitroglycerin In 5% Dextrose Inj.-400 mcg/mL,2,C01DA02,Glyceryl trinitrate,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
18086,Marketed,1995-12-31,02145308,Nitroglycerin In 5% Dextrose Inj.-200 mcg/mL,2,C01DA02,Glyceryl trinitrate,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
49993,Marketed,2026-02-02,02230732,Trinipatch 0.2,1,C01DA02,Glyceryl trinitrate,Patch,Transdermal,02230732,TRINIPATCH 0.2 (nitroglycerin 0.2 mg per hour transdermal patch) KNIGHT THERAPEUTICS INC.,Active,9010873,nitroglycerin 0.2 mg per hour transdermal patch,8000044,nitroglycerin,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,,Ethical
49995,Marketed,2026-02-02,02230733,Trinipatch 0.4,1,C01DA02,Glyceryl trinitrate,Patch,Transdermal,02230733,TRINIPATCH 0.4 (nitroglycerin 0.4 mg per hour transdermal patch) KNIGHT THERAPEUTICS INC.,Active,9010876,nitroglycerin 0.4 mg per hour transdermal patch,8000044,nitroglycerin,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,,Ethical
49996,Marketed,2026-02-03,02230734,Trinipatch 0.6,1,C01DA02,Glyceryl trinitrate,Patch,Transdermal,02230734,TRINIPATCH 0.6 (nitroglycerin 0.6 mg per hour transdermal patch) KNIGHT THERAPEUTICS INC.,Active,9010877,nitroglycerin 0.6 mg per hour transdermal patch,8000044,nitroglycerin,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,,Ethical
50758,Marketed,2008-02-25,02231441,Nitrolingual Pumpspray,1,C01DA02,Glyceryl trinitrate,Metered-dose pump,Sublingual,02231441,NITROLINGUAL PUMPSPRAY (nitroglycerin 0.4 mg per actuation sublingual spray) SANOFI-AVENTIS CANADA INC,Active,9010875,nitroglycerin 0.4 mg per actuation sublingual spray,8000044,nitroglycerin,37839007,Sublingual,421720008,Spray,732981002,Actuation (unit of presentation),,,,Ethical
62447,Marketed,2011-02-26,02238998,Rho-Nitro Pumpspray,1,C01DA02,Glyceryl trinitrate,Metered-dose pump,Sublingual,02238998,RHO-NITRO PUMPSPRAY (nitroglycerin 0.4 mg per actuation sublingual spray) SANDOZ CANADA INCORPORATED,Active,9010875,nitroglycerin 0.4 mg per actuation sublingual spray,8000044,nitroglycerin,37839007,Sublingual,421720008,Spray,732981002,Actuation (unit of presentation),,,,Ethical
89213,Marketed,2013-06-04,02407442,Mylan-Nitro Patch 0.2,1,C01DA02,Glyceryl trinitrate,Patch (extended release),Transdermal,02407442,MYLAN-NITRO PATCH 0.2 (nitroglycerin 0.2 mg per hour transdermal patch) MYLAN PHARMACEUTICALS ULC,Active,9010873,nitroglycerin 0.2 mg per hour transdermal patch,8000044,nitroglycerin,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,,Ethical
89214,Marketed,2013-06-04,02407450,Mylan-Nitro Patch 0.4,1,C01DA02,Glyceryl trinitrate,Patch (extended release),Transdermal,02407450,MYLAN-NITRO PATCH 0.4 (nitroglycerin 0.4 mg per hour transdermal patch) MYLAN PHARMACEUTICALS ULC,Active,9010876,nitroglycerin 0.4 mg per hour transdermal patch,8000044,nitroglycerin,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,,Ethical
89215,Marketed,2013-06-04,02407469,Mylan-Nitro Patch 0.6,1,C01DA02,Glyceryl trinitrate,Patch (extended release),Transdermal,02407469,MYLAN-NITRO PATCH 0.6 (nitroglycerin 0.6 mg per hour transdermal patch) MYLAN PHARMACEUTICALS ULC,Active,9010877,nitroglycerin 0.6 mg per hour transdermal patch,8000044,nitroglycerin,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,,Ethical
89216,Marketed,2013-06-04,02407477,Mylan-Nitro Patch 0.8,1,C01DA02,Glyceryl trinitrate,Patch (extended release),Transdermal,02407477,MYLAN-NITRO PATCH 0.8 (nitroglycerin 0.8 mg per hour transdermal patch) MYLAN PHARMACEUTICALS ULC,Active,9010879,nitroglycerin 0.8 mg per hour transdermal patch,8000044,nitroglycerin,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,,Ethical
3865,Marketed,2020-02-10,00498793,Glycine Irrigation USP,1,B05CX03,Glycine,Solution,Irrigation,,,,,,,,,,,,,,,,,Ethical
9828,Marketed,1989-12-31,00799955,Glycine 1.5% Irrigation USP Sol,1,B05CX03,Glycine,Liquid,Irrigation,,,,,,,,,,,,,,,,,Ethical
100293,Marketed,2022-04-01,02513749,Glycopyrrolate Injection USP,1,A03AB02,Glycopyrronium,Solution,"Intravenous,Intramuscular",02513749,GLYCOPYRROLATE INJECTION USP (glycopyrrolate 0.4 mg per 2 mL solution for injection vial) JAMP PHARMA CORPORATION,Active,9012983,glycopyrrolate 0.4 mg per 2 mL solution for injection vial,8001082,glycopyrronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
102141,Marketed,2024-01-18,02532379,Glycopyrrolate Injection USP,1,A03AB02,Glycopyrronium,Solution,"Intramuscular,Intravenous",02532379,GLYCOPYRROLATE INJECTION USP (glycopyrrolate 4 mg per 20 mL solution for injection vial) JAMP PHARMA CORPORATION,Active,9012985,glycopyrrolate 4 mg per 20 mL solution for injection vial,8001082,glycopyrronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
14577,Marketed,2005-09-21,02039508,Glycopyrrolate Injection USP,1,A03AB02,Glycopyrronium,Solution,"Intramuscular,Intravenous",77700654,GLYCOPYRROLATE INJECTION USP (glycopyrrolate 0.4 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012983,glycopyrrolate 0.4 mg per 2 mL solution for injection vial,8001082,glycopyrronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
14577,Marketed,2005-09-21,02039508,Glycopyrrolate Injection USP,1,A03AB02,Glycopyrronium,Solution,"Intramuscular,Intravenous",77700655,GLYCOPYRROLATE INJECTION USP (glycopyrrolate 4 mg per 20 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012985,glycopyrrolate 4 mg per 20 mL solution for injection vial,8001082,glycopyrronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
86865,Marketed,2012-07-13,02382849,Glycopyrrolate Injection Multidose,1,A03AB02,Glycopyrronium,Solution,"Intravenous,Intramuscular",02382849,GLYCOPYRROLATE INJECTION MULTIDOSE (glycopyrrolate 4 mg per 20 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9012985,glycopyrrolate 4 mg per 20 mL solution for injection vial,8001082,glycopyrronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
86866,Marketed,2012-06-29,02382857,Glycopyrrolate Injection,1,A03AB02,Glycopyrronium,Liquid,"Intravenous,Intramuscular",77700694,GLYCOPYRROLATE INJECTION (glycopyrrolate 0.2 mg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9012982,glycopyrrolate 0.2 mg per 1 mL solution for injection vial,8001082,glycopyrronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
86866,Marketed,2012-06-29,02382857,Glycopyrrolate Injection,1,A03AB02,Glycopyrronium,Liquid,"Intravenous,Intramuscular",77700695,GLYCOPYRROLATE INJECTION (glycopyrrolate 0.4 mg per 2 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9012983,glycopyrrolate 0.4 mg per 2 mL solution for injection vial,8001082,glycopyrronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
95811,Marketed,2022-11-01,02469332,Cuvposa,1,A03AB02,Glycopyrronium,Solution,Oral,02469332,CUVPOSA (glycopyrrolate 1 mg per 5 mL oral solution) MEDEXUS PHARMACEUTICALS INC.,Active,9012984,glycopyrrolate 1 mg per 5 mL oral solution,8001082,glycopyrronium,26643006,Oral,385023001,Oral solution,,,,,,Prescription
96360,Marketed,2021-05-26,02473879,Glycopyrrolate Injection USP,1,A03AB02,Glycopyrronium,Solution,"Intravenous,Intramuscular",02473879,GLYCOPYRROLATE INJECTION USP (glycopyrrolate 0.2 mg per 1 mL solution for injection vial) STERIMAX INC,Active,9012982,glycopyrrolate 0.2 mg per 1 mL solution for injection vial,8001082,glycopyrronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
96361,Marketed,2021-05-26,02473895,Glycopyrrolate Injection USP,1,A03AB02,Glycopyrronium,Solution,"Intramuscular,Intravenous",02473895,GLYCOPYRROLATE INJECTION USP (glycopyrrolate 0.4 mg per 2 mL solution for injection vial) STERIMAX INC,Active,9012983,glycopyrrolate 0.4 mg per 2 mL solution for injection vial,8001082,glycopyrronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
96362,Marketed,2021-05-26,02473887,Glycopyrrolate Injection USP,1,A03AB02,Glycopyrronium,Solution,"Intravenous,Intramuscular",02473887,GLYCOPYRROLATE INJECTION USP (glycopyrrolate 4 mg per 20 mL solution for injection vial) STERIMAX INC,Active,9012985,glycopyrrolate 4 mg per 20 mL solution for injection vial,8001082,glycopyrronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
88007,Marketed,2013-01-14,02394936,Seebri Breezhaler,1,R03BB06,Glycopyrronium bromide,Capsule,Inhalation,02394936,SEEBRI BREEZHALER (glycopyrronium (glycopyrronium bromide) 50 mcg inhalation powder capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9005156,glycopyrronium (glycopyrronium bromide) 50 mcg inhalation powder capsule,8001082,glycopyrronium,447694001,Inhalation,385207009,Powder for inhalation,732937005,Capsule,,,,Prescription
81020,Marketed,2013-09-20,02324776,Simponi,1,L04AB06,Golimumab,Solution,Subcutaneous,02324776,SIMPONI SINGLE-USE PRE-FILLED SYRINGE (golimumab 50 mg per 0.5 mL solution for injection syringe) JANSSEN INC,Active,9013152,golimumab 50 mg per 0.5 mL solution for injection syringe,8001790,golimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
81020,Marketed,2013-09-20,02324776,Simponi,1,L04AB06,Golimumab,Solution,Subcutaneous,02324776,SIMPONI SINGLE-USE PRE-FILLED SYRINGE (golimumab 50 mg per 0.5 mL solution for injection syringe) JANSSEN INC,Active,9013152,golimumab 50 mg per 0.5 mL solution for injection syringe,8001790,golimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
81021,Marketed,2013-09-20,02324784,Simponi,1,L04AB06,Golimumab,Solution,Subcutaneous,02324784,SIMPONI SINGLE-USE AUTOINJECTOR (golimumab 50 mg per 0.5 mL solution for injection syringe) JANSSEN INC,Active,9013152,golimumab 50 mg per 0.5 mL solution for injection syringe,8001790,golimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
81021,Marketed,2013-09-20,02324784,Simponi,1,L04AB06,Golimumab,Solution,Subcutaneous,02324784,SIMPONI SINGLE-USE AUTOINJECTOR (golimumab 50 mg per 0.5 mL solution for injection syringe) JANSSEN INC,Active,9013152,golimumab 50 mg per 0.5 mL solution for injection syringe,8001790,golimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
89785,Marketed,2013-10-03,02413175,Simponi,1,L04AB06,Golimumab,Solution,Subcutaneous,02413175,SIMPONI SINGLE-USE PRE-FILLED SYRINGE (golimumab 100 mg per 1 mL solution for injection syringe) JANSSEN INC,Active,9013151,golimumab 100 mg per 1 mL solution for injection syringe,8001790,golimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
89785,Marketed,2013-10-03,02413175,Simponi,1,L04AB06,Golimumab,Solution,Subcutaneous,02413175,SIMPONI SINGLE-USE PRE-FILLED SYRINGE (golimumab 100 mg per 1 mL solution for injection syringe) JANSSEN INC,Active,9013151,golimumab 100 mg per 1 mL solution for injection syringe,8001790,golimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
89786,Marketed,2013-10-03,02413183,Simponi,1,L04AB06,Golimumab,Solution,Subcutaneous,02413183,SIMPONI SINGLE-USE AUTOINJECTOR (golimumab 100 mg per 1 mL solution for injection syringe) JANSSEN INC,Active,9013151,golimumab 100 mg per 1 mL solution for injection syringe,8001790,golimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
89786,Marketed,2013-10-03,02413183,Simponi,1,L04AB06,Golimumab,Solution,Subcutaneous,02413183,SIMPONI SINGLE-USE AUTOINJECTOR (golimumab 100 mg per 1 mL solution for injection syringe) JANSSEN INC,Active,9013151,golimumab 100 mg per 1 mL solution for injection syringe,8001790,golimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
90217,Marketed,2013-12-12,02417472,Simponi IV,1,L04AB06,Golimumab,Solution,Intravenous,02417472,SIMPONI I.V. (golimumab 50 mg per 4 mL solution for injection vial) JANSSEN INC,Active,9013153,golimumab 50 mg per 4 mL solution for injection vial,8001790,golimumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
90217,Marketed,2013-12-12,02417472,Simponi IV,1,L04AB06,Golimumab,Solution,Intravenous,02417472,SIMPONI I.V. (golimumab 50 mg per 4 mL solution for injection vial) JANSSEN INC,Active,9013153,golimumab 50 mg per 4 mL solution for injection vial,8001790,golimumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
16216,Marketed,2018-02-28,02049325,Zoladex,1,L02AE03,Goserelin,Implant,Subcutaneous,02049325,ZOLADEX (goserelin (goserelin acetate) 3.6 mg implant) TERSERA THERAPEUTICS LLC,Active,9002677,goserelin (goserelin acetate) 3.6 mg implant,8001792,goserelin,34206005,Subcutaneous,385286003,Implant,732996003,Implant (unit of presentation),1.0,,,Prescription
43433,Marketed,2018-02-28,02225905,Zoladex LA,1,L02AE03,Goserelin,Implant,Subcutaneous,02225905,ZOLADEX LA (goserelin (goserelin acetate) 10.8 mg implant) TERSERA THERAPEUTICS LLC,Active,9002907,goserelin (goserelin acetate) 10.8 mg implant,8001792,goserelin,34206005,Subcutaneous,385286003,Implant,732996003,Implant (unit of presentation),1.0,,,Prescription
79450,Marketed,2016-09-16,02308894,Apo-Granisetron,1,A04AA02,Granisetron,Tablet,Oral,02308894,APO-GRANISETRON (granisetron (granisetron hydrochloride) 1 mg oral tablet) APOTEX INC,Active,9004515,granisetron (granisetron hydrochloride) 1 mg oral tablet,8001116,granisetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80824,Marketed,2009-05-14,02322765,Granisetron Hydrochloride Injection,1,A04AA02,Granisetron,Liquid,Intravenous,77700553,GRANISETRON HYDROCHLORIDE INJECTION (granisetron (granisetron hydrochloride) 4 mg per 4 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9012496,granisetron (granisetron hydrochloride) 4 mg per 4 mL solution for injection vial,8001116,granisetron,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
80824,Marketed,2009-05-14,02322765,Granisetron Hydrochloride Injection,1,A04AA02,Granisetron,Liquid,Intravenous,77700554,GRANISETRON HYDROCHLORIDE INJECTION (granisetron (granisetron hydrochloride) 1 mg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9012494,granisetron (granisetron hydrochloride) 1 mg per 1 mL solution for injection vial,8001116,granisetron,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
93873,Marketed,2016-03-01,02452359,Nat-Granisetron,1,A04AA02,Granisetron,Tablet,Oral,02452359,NAT-GRANISETRON (granisetron (granisetron hydrochloride) 1 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9004515,granisetron (granisetron hydrochloride) 1 mg oral tablet,8001116,granisetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
61900,Marketed,2023-06-22,02238480,Standardized Grass Pollen - Kentucky Bluegrass (100000 BAU/mL),1,V01AA02,Grass pollen,Solution,"Subcutaneous,Percutaneous",,,,,,,,,,,,,,,,,Schedule D
61905,Marketed,2024-03-25,02238485,Standardized Grass Pollen - Orchard Grass (100000 BAU/mL),1,V01AA02,Grass pollen,Solution,"Percutaneous,Subcutaneous",,,,,,,,,,,,,,,,,Schedule D
61909,Marketed,2023-09-25,02238489,"Standardized Grass Pollen - Redtop (100,000 BAU/mL)",1,V01AA02,Grass pollen,Solution,"Percutaneous,Subcutaneous",,,,,,,,,,,,,,,,,Schedule D
61913,Marketed,2023-09-20,02238493,"Standardized Grass Pollen - Sweet Vernal Grass (100,000 BAU/mL)",1,V01AA02,Grass pollen,Solution,"Subcutaneous,Percutaneous",,,,,,,,,,,,,,,,,Schedule D
61918,Marketed,2024-02-23,02238497,Standardized Grass Pollen - Timothy (100000 BAU/mL),1,V01AA02,Grass pollen,Solution,"Percutaneous,Subcutaneous",,,,,,,,,,,,,,,,,Schedule D
61922,Marketed,2023-03-24,02238501,Standardized Grass Pollen - Perennial Ryegrass (100000 BAU/mL),1,V01AA02,Grass pollen,Solution,"Percutaneous,Subcutaneous",,,,,,,,,,,,,,,,,Schedule D
66453,Marketed,2000-10-30,02242664,Allergenic Extract - Standardized Grass Pollen - Timothy,1,V01AA02,Grass pollen,Liquid,"Subcutaneous,Intracutaneous",,,,,,,,,,,,,,,,,Schedule D
66455,Marketed,2019-04-03,02242666,Allergenic Extract - Standardized Grass Pollen - Kentucky Blue/June,1,V01AA02,Grass pollen,Liquid,"Intracutaneous,Subcutaneous",,,,,,,,,,,,,,,,,Schedule D
66457,Marketed,2019-08-28,02242668,Allergenic Extract - Standardized Grass Pollen - Sweet Vernal,1,V01AA02,Grass pollen,Liquid,"Intracutaneous,Subcutaneous",,,,,,,,,,,,,,,,,Schedule D
66459,Marketed,2000-10-30,02242670,Allergenic Extract - Standardized Grass Pollen - Red Top,1,V01AA02,Grass pollen,Liquid,"Intracutaneous,Subcutaneous",,,,,,,,,,,,,,,,,Schedule D
66461,Marketed,2019-04-03,02242672,Allergenic Extract - Standardized Grass Pollen - Meadow Fescue,1,V01AA02,Grass pollen,Liquid,"Subcutaneous,Intracutaneous",,,,,,,,,,,,,,,,,Schedule D
66463,Marketed,2000-10-31,02242674,Allergenic Extract - Standardized Grass Pollen - Orchard,1,V01AA02,Grass pollen,Liquid,"Subcutaneous,Intracutaneous",,,,,,,,,,,,,,,,,Schedule D
66465,Marketed,2019-04-03,02242676,Allergenic Extract - Standardized Grass Pollen - Perennial Rye,1,V01AA02,Grass pollen,Liquid,"Intracutaneous,Subcutaneous",,,,,,,,,,,,,,,,,Schedule D
66518,Marketed,2001-04-01,02242713,Allergy Canada Allergen Extract - Alum Precipitated,1,V01AA02,Grass pollen,Liquid,Subcutaneous,,,,,,,,,,,,,,,,,Schedule D
81083,Marketed,2009-07-30,02325454,Allergenic Extract - Standardized June Grass Pollen,1,V01AA02,Grass pollen,Liquid,"Subcutaneous,Percutaneous,Intradermal",,,,,,,,,,,,,,,,,Schedule D
81085,Marketed,2009-07-30,02325470,Allergenic Extract - Standardized Timothy Grass Pollen,1,V01AA02,Grass pollen,Liquid,"Intradermal,Subcutaneous,Percutaneous",,,,,,,,,,,,,,,,,Schedule D
81086,Marketed,2009-07-30,02325489,Allergenic Extract - Standardized Orchard Grass Pollen,1,V01AA02,Grass pollen,Liquid,"Subcutaneous,Intradermal,Percutaneous",,,,,,,,,,,,,,,,,Schedule D
81087,Marketed,2009-07-30,02325497,Allergenic Extract - Standardized Redtop Grass Pollen,1,V01AA02,Grass pollen,Liquid,"Subcutaneous,Intradermal,Percutaneous",,,,,,,,,,,,,,,,,Schedule D
81088,Marketed,2009-07-30,02325500,Allergenic Extract - Standardized Perennnial Rye Grass Pollen,1,V01AA02,Grass pollen,Liquid,"Percutaneous,Subcutaneous,Intradermal",,,,,,,,,,,,,,,,,Schedule D
81089,Marketed,2009-07-30,02325519,Allergenic Extract - Standardized Sweet Vernal Grass Pollen,1,V01AA02,Grass pollen,Liquid,"Intradermal,Percutaneous,Subcutaneous",,,,,,,,,,,,,,,,,Schedule D
81090,Marketed,2009-07-30,02325527,Allergenic Extract - Standardized Meadow Fescue Grass Pollen,1,V01AA02,Grass pollen,Liquid,"Percutaneous,Subcutaneous,Intradermal",,,,,,,,,,,,,,,,,Schedule D
81092,Marketed,2009-07-30,02325543,Allergenic Extract - Mixture Of 5 Standardized Grass Pollen,5,V01AA02,Grass pollen,Liquid,"Percutaneous,Subcutaneous,Intradermal",,,,,,,,,,,,,,,,,Schedule D
86772,Marketed,2015-05-22,02381885,Oralair,1,V01AA02,Grass pollen,Tablet,Sublingual,,,,,,,,,,,,,,,,,Prescription
86772,Marketed,2015-05-22,02381885,Oralair,1,V01AA02,Grass pollen,Tablet,Sublingual,,,,,,,,,,,,,,,,,Schedule D
86773,Marketed,2015-05-22,02381893,Oralair,1,V01AA02,Grass pollen,Tablet,Sublingual,,,,,,,,,,,,,,,,,Schedule D
86773,Marketed,2015-05-22,02381893,Oralair,1,V01AA02,Grass pollen,Tablet,Sublingual,,,,,,,,,,,,,,,,,Prescription
90288,Marketed,2017-11-06,02418304,Grastek,1,V01AA02,Grass pollen,Tablet (orally disintegrating),Sublingual,,,,,,,,,,,,,,,,,Schedule D
90288,Marketed,2017-11-06,02418304,Grastek,1,V01AA02,Grass pollen,Tablet (orally disintegrating),Sublingual,,,,,,,,,,,,,,,,,Prescription
90842,Marketed,2017-11-06,02423723,Ragwitek,1,V01AA02,Grass pollen,Tablet (orally disintegrating),Sublingual,,,,,,,,,,,,,,,,,Schedule D
90842,Marketed,2017-11-06,02423723,Ragwitek,1,V01AA02,Grass pollen,Tablet (orally disintegrating),Sublingual,,,,,,,,,,,,,,,,,Prescription
91016,Marketed,2019-04-17,02425513,Allergenic Extracts - 7 Grass Mix,7,V01AA02,Grass pollen,Liquid,Subcutaneous,,,,,,,,,,,,,,,,,Schedule D
93285,Marketed,2015-11-10,02447304,"Allergenic Extracts, K-O-R-T Grass Mixture",4,V01AA02,Grass pollen,Solution,"Intracutaneous,Subcutaneous",,,,,,,,,,,,,,,,,Schedule D
102365,Marketed,2024-12-30,02534762,Mucus & Phlegm Relief Extra Strength,1,R05CA03,Guaifenesin,Syrup,Oral,02534762,MUCUS & PHLEGM RELIEF EXTRA STRENGTH (guaifenesin 200 mg per 5 mL syrup) CRLS,Active,9002826,guaifenesin 200 mg per 5 mL syrup,8000821,guaifenesin,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
19044,Marketed,2024-05-23,02142783,Robitussin Extra Strength Mucus And Phlegm,1,R05CA03,Guaifenesin,Syrup,Oral,02142783,ROBITUSSIN EXTRA STRENGTH MUCUS AND PHLEGM (guaifenesin 200 mg per 5 mL syrup) HALEON CANADA ULC,Active,9002826,guaifenesin 200 mg per 5 mL syrup,8000821,guaifenesin,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
30557,Marketed,2005-10-06,02121999,Bronchophan Expectorant (Sans Sucrose),1,R05CA03,Guaifenesin,Syrup,Oral,02121999,BRONCHOPHAN EXPECTORANT (SANS SUCROSE) (guaifenesin 100 mg per 5 mL syrup) LABORATOIRE ATLAS INC,Active,9001847,guaifenesin 100 mg per 5 mL syrup,8000821,guaifenesin,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
41989,Marketed,2013-01-04,00609951,Balminil Expectorant (Sucrose Free),1,R05CA03,Guaifenesin,Syrup,Oral,00609951,BALMINIL EXPECTORANT (SUCROSE FREE) (guaifenesin 100 mg per 5 mL syrup) TEVA CANADA LIMITED,Active,9001847,guaifenesin 100 mg per 5 mL syrup,8000821,guaifenesin,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
75089,Marketed,2026-04-14,02265427,Benylin Extra Strength Chest Congestion & Cold,2,R05CA03,Guaifenesin,Syrup,Oral,02265427,BENYLIN EXTRA STRENGTH CHEST CONGESTION & COLD (guaifenesin 200 mg per 5 mL and menthol 15 mg per 5 mL syrup) KENVUE CANADA INC.,Active,9004092,guaifenesin 200 mg per 5 mL and menthol 15 mg per 5 mL syrup,8000953,guaifenesin and menthol,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
77454,Marketed,2024-03-05,02289164,Buckley's Chest Congestion,2,R05CA03,Guaifenesin,Syrup,Oral,02289164,BUCKLEY'S CHEST CONGESTION (guaifenesin 100 mg per 5 mL and menthol 10 mg per 5 mL syrup) HALEON CANADA ULC,Active,9004322,guaifenesin 100 mg per 5 mL and menthol 10 mg per 5 mL syrup,8000953,guaifenesin and menthol,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
80636,Marketed,2011-07-27,02320940,Benylin Extra Strength Mucus & Phlegm,2,R05CA03,Guaifenesin,Syrup,Oral,02320940,BENYLIN EXTRA STRENGTH MUCUS & PHLEGM (guaifenesin 200 mg per 5 mL and menthol 15 mg per 5 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9004092,guaifenesin 200 mg per 5 mL and menthol 15 mg per 5 mL syrup,8000953,guaifenesin and menthol,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
83190,Marketed,2024-03-13,02346451,Buckley's Mucus & Phlegm,2,R05CA03,Guaifenesin,Syrup,Oral,02346451,BUCKLEY'S MUCUS & PHLEGM (guaifenesin 100 mg per 5 mL and menthol 10 mg per 5 mL syrup) HALEON CANADA ULC,Active,9004322,guaifenesin 100 mg per 5 mL and menthol 10 mg per 5 mL syrup,8000953,guaifenesin and menthol,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
91903,Marketed,2026-03-03,02434725,Mucinex Chest Congestion,1,R05CA03,Guaifenesin,Tablet (immediate and extended release),Oral,02434725,MUCINEX CHEST CONGESTION (guaifenesin 600 mg prolonged-release oral tablet) RECKITT BENCKISER (CANADA) INC,Active,9015302,guaifenesin 600 mg prolonged-release oral tablet,8000821,guaifenesin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet,,,,Non-Prescription Drugs
97024,Marketed,2019-07-02,02479869,Benylin Extra Strength Sore Throat & Cough,2,R05CA03,Guaifenesin,Syrup,Oral,02479869,BENYLIN EXTRA STRENGTH SORE THROAT & COUGH (guaifenesin 200 mg per 5 mL and menthol 15 mg per 5 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9004092,guaifenesin 200 mg per 5 mL and menthol 15 mg per 5 mL syrup,8000953,guaifenesin and menthol,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
101263,Marketed,2022-01-27,02523558,JAMP Guanfacine XR,1,C02AC02,Guanfacine,Tablet (extended-release),Oral,02523558,JAMP GUANFACINE XR (guanfacine (guanfacine hydrochloride) 1 mg prolonged-release oral tablet) JAMP PHARMA CORPORATION,Active,9005296,guanfacine (guanfacine hydrochloride) 1 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101264,Marketed,2022-01-26,02523566,JAMP Guanfacine XR,1,C02AC02,Guanfacine,Tablet (extended-release),Oral,02523566,JAMP GUANFACINE XR (guanfacine (guanfacine hydrochloride) 2 mg prolonged-release oral tablet) JAMP PHARMA CORPORATION,Active,9005297,guanfacine (guanfacine hydrochloride) 2 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101265,Marketed,2022-01-27,02523574,JAMP Guanfacine XR,1,C02AC02,Guanfacine,Tablet (extended-release),Oral,02523574,JAMP GUANFACINE XR (guanfacine (guanfacine hydrochloride) 3 mg prolonged-release oral tablet) JAMP PHARMA CORPORATION,Active,9005298,guanfacine (guanfacine hydrochloride) 3 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101266,Marketed,2022-01-27,02523582,JAMP Guanfacine XR,1,C02AC02,Guanfacine,Tablet (extended-release),Oral,02523582,JAMP GUANFACINE XR (guanfacine (guanfacine hydrochloride) 4 mg prolonged-release oral tablet) JAMP PHARMA CORPORATION,Active,9005299,guanfacine (guanfacine hydrochloride) 4 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101278,Marketed,2022-01-31,02523728,Apo-Guanfacine XR,1,C02AC02,Guanfacine,Tablet (extended-release),Oral,02523728,APO-GUANFACINE XR (guanfacine (guanfacine hydrochloride) 1 mg prolonged-release oral tablet) APOTEX INC,Active,9005296,guanfacine (guanfacine hydrochloride) 1 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101279,Marketed,2022-01-31,02523736,Apo-Guanfacine XR,1,C02AC02,Guanfacine,Tablet (extended-release),Oral,02523736,APO-GUANFACINE XR (guanfacine (guanfacine hydrochloride) 2 mg prolonged-release oral tablet) APOTEX INC,Active,9005297,guanfacine (guanfacine hydrochloride) 2 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101280,Marketed,2022-01-31,02523744,Apo-Guanfacine XR,1,C02AC02,Guanfacine,Tablet (extended-release),Oral,02523744,APO-GUANFACINE XR (guanfacine (guanfacine hydrochloride) 3 mg prolonged-release oral tablet) APOTEX INC,Active,9005298,guanfacine (guanfacine hydrochloride) 3 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101281,Marketed,2022-01-31,02523752,Apo-Guanfacine XR,1,C02AC02,Guanfacine,Tablet (extended-release),Oral,02523752,APO-GUANFACINE XR (guanfacine (guanfacine hydrochloride) 4 mg prolonged-release oral tablet) APOTEX INC,Active,9005299,guanfacine (guanfacine hydrochloride) 4 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101414,Marketed,2026-05-05,02525127,AG-Guanfacine XR,1,C02AC02,Guanfacine,Tablet (extended-release),Oral,02525127,AG-GUANFACINE XR (guanfacine (guanfacine hydrochloride) 1 mg prolonged-release oral tablet) ANGITA PHARMA INC.,Active,9005296,guanfacine (guanfacine hydrochloride) 1 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101415,Marketed,2026-05-05,02525135,AG-Guanfacine XR,1,C02AC02,Guanfacine,Tablet (extended-release),Oral,02525135,AG-GUANFACINE XR (guanfacine (guanfacine hydrochloride) 2 mg prolonged-release oral tablet) ANGITA PHARMA INC.,Active,9005297,guanfacine (guanfacine hydrochloride) 2 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101416,Marketed,2026-05-05,02525143,AG-Guanfacine XR,1,C02AC02,Guanfacine,Tablet (extended-release),Oral,02525143,AG-GUANFACINE XR (guanfacine (guanfacine hydrochloride) 3 mg prolonged-release oral tablet) ANGITA PHARMA INC.,Active,9005298,guanfacine (guanfacine hydrochloride) 3 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101417,Marketed,2026-05-05,02525151,AG-Guanfacine XR,1,C02AC02,Guanfacine,Tablet (extended-release),Oral,02525151,AG-GUANFACINE XR (guanfacine (guanfacine hydrochloride) 4 mg prolonged-release oral tablet) ANGITA PHARMA INC.,Active,9005299,guanfacine (guanfacine hydrochloride) 4 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101423,Marketed,2026-05-04,02525224,Pro-Guanfacine XR,1,C02AC02,Guanfacine,Tablet (extended-release),Oral,02525224,PRO-GUANFACINE XR (guanfacine (guanfacine hydrochloride) 1 mg prolonged-release oral tablet) PRO DOC LIMITEE,Active,9005296,guanfacine (guanfacine hydrochloride) 1 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101424,Marketed,2026-05-04,02525232,Pro-Guanfacine XR,1,C02AC02,Guanfacine,Tablet (extended-release),Oral,02525232,PRO-GUANFACINE XR (guanfacine (guanfacine hydrochloride) 2 mg prolonged-release oral tablet) PRO DOC LIMITEE,Active,9005297,guanfacine (guanfacine hydrochloride) 2 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101425,Marketed,2026-05-04,02525240,Pro-Guanfacine XR,1,C02AC02,Guanfacine,Tablet (extended-release),Oral,02525240,PRO-GUANFACINE XR (guanfacine (guanfacine hydrochloride) 3 mg prolonged-release oral tablet) PRO DOC LIMITEE,Active,9005298,guanfacine (guanfacine hydrochloride) 3 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101426,Marketed,2026-05-04,02525259,Pro-Guanfacine XR,1,C02AC02,Guanfacine,Tablet (extended-release),Oral,02525259,PRO-GUANFACINE XR (guanfacine (guanfacine hydrochloride) 4 mg prolonged-release oral tablet) PRO DOC LIMITEE,Active,9005299,guanfacine (guanfacine hydrochloride) 4 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106599,Marketed,2026-04-30,02563185,Sandoz Guanfacine XR,1,C02AC02,Guanfacine,Tablet (extended-release),Oral,02563185,SANDOZ GUANFACINE XR (guanfacine (guanfacine hydrochloride) 1 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9005296,guanfacine (guanfacine hydrochloride) 1 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106600,Marketed,2026-04-30,02563193,Sandoz Guanfacine XR,1,C02AC02,Guanfacine,Tablet (extended-release),Oral,02563193,SANDOZ GUANFACINE XR (guanfacine (guanfacine hydrochloride) 2 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9005297,guanfacine (guanfacine hydrochloride) 2 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106601,Marketed,2026-04-30,02563207,Sandoz Guanfacine XR,1,C02AC02,Guanfacine,Tablet (extended-release),Oral,02563207,SANDOZ GUANFACINE XR (guanfacine (guanfacine hydrochloride) 3 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9005298,guanfacine (guanfacine hydrochloride) 3 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106602,Marketed,2026-04-30,02563215,Sandoz Guanfacine XR,1,C02AC02,Guanfacine,Tablet (extended-release),Oral,02563215,SANDOZ GUANFACINE XR (guanfacine (guanfacine hydrochloride) 4 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9005299,guanfacine (guanfacine hydrochloride) 4 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89383,Marketed,2021-08-24,02409100,Intuniv XR,1,C02AC02,Guanfacine,Tablet (extended-release),Oral,02409100,INTUNIV XR (guanfacine (guanfacine hydrochloride) 1 mg prolonged-release oral tablet) TAKEDA CANADA INC,Active,9005296,guanfacine (guanfacine hydrochloride) 1 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89384,Marketed,2021-07-29,02409119,Intuniv XR,1,C02AC02,Guanfacine,Tablet (extended-release),Oral,02409119,INTUNIV XR (guanfacine (guanfacine hydrochloride) 2 mg prolonged-release oral tablet) TAKEDA CANADA INC,Active,9005297,guanfacine (guanfacine hydrochloride) 2 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89385,Marketed,2021-09-01,02409127,Intuniv XR,1,C02AC02,Guanfacine,Tablet (extended-release),Oral,02409127,INTUNIV XR (guanfacine (guanfacine hydrochloride) 3 mg prolonged-release oral tablet) TAKEDA CANADA INC,Active,9005298,guanfacine (guanfacine hydrochloride) 3 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89386,Marketed,2021-07-26,02409135,Intuniv XR,1,C02AC02,Guanfacine,Tablet (extended-release),Oral,02409135,INTUNIV XR (guanfacine (guanfacine hydrochloride) 4 mg prolonged-release oral tablet) TAKEDA CANADA INC,Active,9005299,guanfacine (guanfacine hydrochloride) 4 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106233,Marketed,2025-08-15,02559145,Tremfya,1,L04AC16,Guselkumab,Solution,Subcutaneous,02559145,TREMFYA (guselkumab 200 mg per 2 mL solution for injection pen) JANSSEN INC,Active,9015256,guselkumab 200 mg per 2 mL solution for injection pen,8001142,guselkumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen(s),,,,Schedule D
106233,Marketed,2025-08-15,02559145,Tremfya,1,L04AC16,Guselkumab,Solution,Subcutaneous,02559145,TREMFYA (guselkumab 200 mg per 2 mL solution for injection pen) JANSSEN INC,Active,9015256,guselkumab 200 mg per 2 mL solution for injection pen,8001142,guselkumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen(s),,,,Prescription
106234,Marketed,2025-08-15,02559153,Tremfya IV,1,L04AC16,Guselkumab,Solution,Intravenous,02559153,TREMFYA I.V. (guselkumab 200 mg per 20 mL solution for injection vial) JANSSEN INC,Active,9015255,guselkumab 200 mg per 20 mL solution for injection vial,8001142,guselkumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,,,,Schedule D
106234,Marketed,2025-08-15,02559153,Tremfya IV,1,L04AC16,Guselkumab,Solution,Intravenous,02559153,TREMFYA I.V. (guselkumab 200 mg per 20 mL solution for injection vial) JANSSEN INC,Active,9015255,guselkumab 200 mg per 20 mL solution for injection vial,8001142,guselkumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,,,,Prescription
106934,Marketed,2026-05-04,02566877,Tremfya,1,L04AC16,Guselkumab,Solution,Subcutaneous,02566877,TREMFYA (guselkumab 100 mg per 1 mL solution for injection pen) JANSSEN INC,Active,9015420,guselkumab 100 mg per 1 mL solution for injection pen,8001142,guselkumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen(s),,,,Prescription
106934,Marketed,2026-05-04,02566877,Tremfya,1,L04AC16,Guselkumab,Solution,Subcutaneous,02566877,TREMFYA (guselkumab 100 mg per 1 mL solution for injection pen) JANSSEN INC,Active,9015420,guselkumab 100 mg per 1 mL solution for injection pen,8001142,guselkumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen(s),,,,Schedule D
95860,Marketed,2017-11-27,02469758,Tremfya,1,L04AC16,Guselkumab,Solution,Subcutaneous,02469758,TREMFYA (guselkumab 100 mg per 1 mL solution for injection syringe) JANSSEN INC,Active,9012497,guselkumab 100 mg per 1 mL solution for injection syringe,8001142,guselkumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
95860,Marketed,2017-11-27,02469758,Tremfya,1,L04AC16,Guselkumab,Solution,Subcutaneous,02469758,TREMFYA (guselkumab 100 mg per 1 mL solution for injection syringe) JANSSEN INC,Active,9012497,guselkumab 100 mg per 1 mL solution for injection syringe,8001142,guselkumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
97748,Marketed,2019-05-20,02487314,Tremfya One-Press,1,L04AC16,Guselkumab,Solution,Subcutaneous,02487314,TREMFYA ONE-PRESS (guselkumab 100 mg per 1 mL solution for injection syringe) JANSSEN INC,Active,9012497,guselkumab 100 mg per 1 mL solution for injection syringe,8001142,guselkumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
97748,Marketed,2019-05-20,02487314,Tremfya One-Press,1,L04AC16,Guselkumab,Solution,Subcutaneous,02487314,TREMFYA ONE-PRESS (guselkumab 100 mg per 1 mL solution for injection syringe) JANSSEN INC,Active,9012497,guselkumab 100 mg per 1 mL solution for injection syringe,8001142,guselkumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
10026,Marketed,2005-09-15,00808652,Haloperidol Inj 5 mg/mL USP,1,N05AD01,Haloperidol,Liquid,Intramuscular,00808652,HALOPERIDOL INJ 5MG/ML USP (haloperidol 5 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9000326,haloperidol 5 mg per 1 mL solution for injection ampoule,8000084,haloperidol,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
16902,Marketed,2005-08-26,02130300,Haloperidol LA,1,N05AD01,Haloperidol,Liquid,Intramuscular,77700024,HALOPERIDOL LA (haloperidol (haloperidol decanoate) 100 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9000522,haloperidol (haloperidol decanoate) 100 mg per 1 mL solution for injection ampoule,8000084,haloperidol,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
16902,Marketed,2005-08-26,02130300,Haloperidol LA,1,N05AD01,Haloperidol,Liquid,Intramuscular,77700025,HALOPERIDOL LA (haloperidol (haloperidol decanoate) 500 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000524,haloperidol (haloperidol decanoate) 500 mg per 5 mL solution for injection vial,8000084,haloperidol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
5859,Marketed,2016-09-12,00363650,Teva-Haloperidol,1,N05AD01,Haloperidol,Tablet,Oral,00363650,TEVA-HALOPERIDOL (haloperidol 5 mg oral tablet) TEVA CANADA LIMITED,Active,9000200,haloperidol 5 mg oral tablet,8000084,haloperidol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
7128,Marketed,2016-09-12,00363685,Teva-Haloperidol,1,N05AD01,Haloperidol,Tablet,Oral,00363685,TEVA-HALOPERIDOL (haloperidol 0.5 mg oral tablet) TEVA CANADA LIMITED,Active,9000149,haloperidol 0.5 mg oral tablet,8000084,haloperidol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
7129,Marketed,2016-09-12,00363677,Teva-Haloperidol,1,N05AD01,Haloperidol,Tablet,Oral,00363677,TEVA-HALOPERIDOL (haloperidol 1 mg oral tablet) TEVA CANADA LIMITED,Active,9000150,haloperidol 1 mg oral tablet,8000084,haloperidol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
7130,Marketed,2016-09-12,00363669,Teva-Haloperidol,1,N05AD01,Haloperidol,Tablet,Oral,00363669,TEVA-HALOPERIDOL (haloperidol 2 mg oral tablet) TEVA CANADA LIMITED,Active,9000252,haloperidol 2 mg oral tablet,8000084,haloperidol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
7131,Marketed,2016-09-12,00713449,Teva-Haloperidol,1,N05AD01,Haloperidol,Tablet,Oral,00713449,TEVA-HALOPERIDOL (haloperidol 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000251,haloperidol 10 mg oral tablet,8000084,haloperidol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85088,Marketed,2011-09-19,02366010,Haloperidol Injection,1,N05AD01,Haloperidol,Solution,Intramuscular,02366010,HALOPERIDOL INJECTION (haloperidol 5 mg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9001362,haloperidol 5 mg per 1 mL solution for injection vial,8000084,haloperidol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
89112,Marketed,2016-01-21,02406411,"Haloperidol Injection, USP",1,N05AD01,Haloperidol,Solution,Intramuscular,77700123,"HALOPERIDOL INJECTION, USP (haloperidol 5 mg per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9001362,haloperidol 5 mg per 1 mL solution for injection vial,8000084,haloperidol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
89112,Marketed,2016-01-21,02406411,"Haloperidol Injection, USP",1,N05AD01,Haloperidol,Solution,Intramuscular,77700124,"HALOPERIDOL INJECTION, USP (haloperidol 50 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9001435,haloperidol 50 mg per 10 mL solution for injection vial,8000084,haloperidol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
13883,Marketed,2022-05-04,02014475,Helium USP,1,V03AN03,Helium,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
5688,Marketed,1911-12-31,00572888,Helium 100%,1,V03AN03,Helium,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
96951,Marketed,2018-12-05,02478765,Panhematin,1,B06AB01,Hematin,Powder for solution,Intravenous,02478765,PANHEMATIN (hemin 268 mg per vial powder for solution for injection) RECORDATI RARE DISEASES CANADA INC,Active,9013688,hemin 268 mg per vial powder for solution for injection,8002197,hemin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
96951,Marketed,2018-12-05,02478765,Panhematin,1,B06AB01,Hematin,Powder for solution,Intravenous,02478765,PANHEMATIN (hemin 268 mg per vial powder for solution for injection) RECORDATI RARE DISEASES CANADA INC,Active,9013688,hemin 268 mg per vial powder for solution for injection,8002197,hemin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
10009,Marketed,2024-04-12,00799823,Dianeal Pd101 CAPD Solution With 2.5% Dextrose,5,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis (intraperitoneal),,,,,,,,,,,,,,,,,Ethical
10143,Marketed,2024-04-12,00799807,Dianeal Pd101 CAPD Solution With 4.25% Dextrose,5,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis (intraperitoneal),,,,,,,,,,,,,,,,,Ethical
10144,Marketed,2024-04-12,00799815,Dianeal Pd101 CAPD Solution With 1.5% Dextrose,5,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis (intraperitoneal),,,,,,,,,,,,,,,,,Ethical
101744,Marketed,2023-02-16,02528193,Magnesium Chloride For Hemodialysis 5.15,1,B05ZA,"Hemodialytics, concentrates",Powder for solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
102272,Marketed,2023-01-16,02533758,Acid Concentrate A 1243,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
102273,Marketed,2023-08-16,02533766,Acid Concentrate A 1255,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
102274,Marketed,2023-01-10,02533774,Acid Concentrate A 1228,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
102276,Marketed,2023-02-07,02533782,Acid Concentrate A 1241,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
102278,Marketed,2023-02-22,02533820,Acid Concentrate A 1246,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
102279,Marketed,2023-01-20,02533812,Acid Concentrate A 1245,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
102280,Marketed,2023-08-27,02533839,Acid Concentrate A 1252,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
102281,Marketed,2023-02-09,02533847,Acid Concentrate A 1242,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
102282,Marketed,2023-01-23,02533871,Acid Concentrate A 1263,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
102283,Marketed,2023-08-24,02533855,Acid Concentrate A 1231,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
102284,Marketed,2023-08-27,02533863,Acid Concentrate A 1265,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
102286,Marketed,2023-01-23,02533898,Acid Concentrate A 1267,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
10512,Marketed,2024-04-12,00799793,Dianeal Pd101 CAPD Solution With 0.5% Dextrose,5,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis (intraperitoneal),,,,,,,,,,,,,,,,,Ethical
10820,Marketed,2024-05-06,00890197,Acid Concentrate D12207,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
10863,Marketed,2024-04-12,00865095,Dianeal Pd4 CAPD Solution With 1.5% Dextrose And 2.5 mEq/L Calcium,5,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis (intraperitoneal),,,,,,,,,,,,,,,,,Ethical
10864,Marketed,2024-04-12,00865109,Dianeal Pd4 CAPD Solution With 2.5% Dextrose And 2.5 mEq/L Calcium,5,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis (intraperitoneal),,,,,,,,,,,,,,,,,Ethical
10865,Marketed,2024-04-12,00865117,Dianeal Pd4 CAPD Solution With 4.25% Dextrose And 2.5 mEq/L Calcium,5,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis (intraperitoneal),,,,,,,,,,,,,,,,,Ethical
13833,Marketed,2024-05-06,01905740,K+ 45,1,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
18200,Marketed,2024-05-13,02158159,Acid Concentrate D12264,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
18202,Marketed,2024-05-08,02158221,Acid Concentrate D12262,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
18268,Marketed,2024-05-08,02158329,Acid Concentrate D12248,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
18310,Marketed,2024-04-26,02161060,Calcium-45 0.25-4.5,1,B05ZA,"Hemodialytics, concentrates",Powder for solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
18321,Marketed,2024-04-29,02160986,Calcium-45 0.5-4.5,1,B05ZA,"Hemodialytics, concentrates",Powder for solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
20040,Marketed,2024-05-08,02217244,Acid Concentrate D12236,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
20041,Marketed,2024-05-09,02217643,Acid Concentrate D12290,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
20044,Marketed,2024-05-09,02217554,Acid Concentrate D12293,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
20046,Marketed,2024-05-10,02217635,Acid Concentrate D12302,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
20111,Marketed,2024-05-08,02217597,Acid Concentrate D12300,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
20112,Marketed,2024-04-26,02219301,Magnesium-45 0.5-4.5,1,B05ZA,"Hemodialytics, concentrates",Powder for solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
20114,Marketed,2024-05-09,02218879,Acid Concentrate D12275,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
20115,Marketed,2024-05-08,02217260,Acid Concentrate D12299,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
20116,Marketed,2024-05-09,02217252,Acid Concentrate D12286,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
20118,Marketed,2024-05-10,02217600,Acid Concentrate D12305,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
20119,Marketed,2024-05-06,02217619,Acid Concentrate D12294,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
20121,Marketed,2024-05-09,02217279,Acid Concentrate D12291,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
34878,Marketed,2024-05-09,02178125,Acid Concentrate D12272,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
34881,Marketed,2024-05-09,02178168,Acid Concentrate D12316,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
36836,Marketed,2024-05-06,02210835,Acid Concentrate 2182,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
62965,Marketed,2024-05-06,02239491,Acid Concentrate 2156,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
66962,Marketed,2024-04-18,02243095,Prismasol 0,5,B05ZA,"Hemodialytics, concentrates",Solution,"Intravenous,Haemodialysis",,,,,,,,,,,,,,,,,Ethical
6775,Marketed,2024-05-07,00691623,Bicarbonate Concentrate D17000,1,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
71993,Marketed,2024-05-23,02247721,Physioneal 40 Glucose 1.36%,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis (intraperitoneal),,,,,,,,,,,,,,,,,Ethical
71997,Marketed,2024-05-23,02247722,Physioneal 40 Glucose 2.27%,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis (intraperitoneal),,,,,,,,,,,,,,,,,Ethical
71998,Marketed,2024-05-27,02247723,Physioneal 40 Glucose 3.86%,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis (intraperitoneal),,,,,,,,,,,,,,,,,Ethical
73309,Marketed,2005-07-04,02248934,Bicarbonate Concentrate B38,1,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
73901,Marketed,2023-07-14,02254085,Acid Concentrate A 1230,5,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
73916,Marketed,2023-07-14,02254247,Acid Concentrate A 1227,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
73917,Marketed,2023-07-14,02254255,Acid Concentrate A 1226,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
73919,Marketed,2023-07-14,02254298,Acid Concentrate A 1225,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
73921,Marketed,2023-07-14,02254301,Acid Concentrate A 1224,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
73922,Marketed,2023-07-17,02254328,Acid Concentrate A 1223,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
73923,Marketed,2023-07-17,02254336,Acid Concentrate A 1222,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
73924,Marketed,2023-07-14,02254344,Acid Concentrate A 1221,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
74786,Marketed,2023-07-14,02262479,Acid Concentrate A 1261,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
74787,Marketed,2023-07-17,02262487,Acid Concentrate A 1262,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
74791,Marketed,2023-07-14,02262525,Acid Concentrate A 1266,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
75411,Marketed,2023-07-17,02268728,Acid Concentrate A 1294,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
75808,Marketed,2023-07-14,02272563,Acid Concentrate A 1275,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
75810,Marketed,2023-07-14,02272598,Acid Concentrate A 1277,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
75812,Marketed,2023-07-14,02272628,Acid Concentrate A 1279,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
76040,Marketed,2024-04-18,02274876,Prism 0 Cal,4,B05ZA,"Hemodialytics, concentrates",Solution,"Intravenous,Haemodialysis",,,,,,,,,,,,,,,,,Ethical
76310,Marketed,2024-04-29,02277476,Prismasol 4,7,B05ZA,"Hemodialytics, concentrates",Solution,"Haemodialysis,Intravenous",,,,,,,,,,,,,,,,,Ethical
81095,Marketed,2022-02-01,02325586,Bibag,1,B05ZA,"Hemodialytics, concentrates",Powder for solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
81113,Marketed,2010-01-23,02325772,Hemacart,1,B05ZA,"Hemodialytics, concentrates",Powder for solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
81227,Marketed,2020-08-19,02326949,Naturalyte H-229,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
81238,Marketed,2020-11-11,02327066,Naturalyte H-616,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
81262,Marketed,2020-08-26,02327309,Naturalyte H-401,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
81265,Marketed,2020-08-17,02327333,Naturalyte H-332,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
81270,Marketed,2021-02-12,02327384,Naturalyte H-260,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
81272,Marketed,2020-09-04,02327406,Naturalyte H-226,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
81275,Marketed,2020-09-04,02327422,Naturalyte H-402,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
81279,Marketed,2020-08-27,02327465,Naturalyte H-225,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
81282,Marketed,2020-08-14,02327503,Naturalyte H-330,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
81283,Marketed,2020-10-13,02327511,Naturalyte H-410,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
81284,Marketed,2020-09-18,02327538,Naturalyte H-408,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
81574,Marketed,2020-11-05,02329980,Naturalyte H-208,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
81577,Marketed,2020-08-20,02330016,Naturalyte H-623,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
81578,Marketed,2020-10-28,02330024,Naturalyte H-201,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
81579,Marketed,2020-08-12,02330032,Naturalyte H-624,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
81592,Marketed,2021-10-06,02330164,Naturalyte H-608,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
81593,Marketed,2020-10-21,02330172,Naturalyte H-200,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
81598,Marketed,2020-08-18,02330229,Naturalyte H-320,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
81601,Marketed,2020-08-13,02330253,Naturalyte H-232,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
84860,Marketed,2013-12-20,02363615,Nxstage Pureflow Dialysate Concentrate (Sak-301),6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
84861,Marketed,2013-11-13,02363631,Nxstage Pureflow Dialysate Concentrate (Sak 304),6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
84863,Marketed,2013-07-05,02363666,Nxstage Pureflow Dialysate Concentrate (Sak-302),6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
85372,Marketed,2024-05-23,02368730,Physioneal 40 Glucose 1.36% Clear-Flex,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis (intraperitoneal),,,,,,,,,,,,,,,,,Ethical
85373,Marketed,2024-05-23,02368749,Physioneal 40 Glucose 3.86% Clear-Flex,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis (intraperitoneal),,,,,,,,,,,,,,,,,Ethical
85374,Marketed,2024-05-23,02368757,Physioneal 40 Glucose 2.27% Clear-Flex,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis (intraperitoneal),,,,,,,,,,,,,,,,,Ethical
87315,Marketed,2013-03-26,02387549,Calcium Chloride For Haemodialysis,1,B05ZA,"Hemodialytics, concentrates",Powder,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
88829,Marketed,2024-04-29,02403498,Bicart,1,B05ZA,"Hemodialytics, concentrates",Powder,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
88830,Marketed,2024-04-29,02403501,Bicart,1,B05ZA,"Hemodialytics, concentrates",Powder,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
89853,Marketed,2021-01-15,02413892,Hemosate Ultra HS 1125,7,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
89855,Marketed,2021-01-15,02413906,Hemosate Ultra HS 2125,7,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
89856,Marketed,2021-01-15,02413914,Hemosate Ultra HS 3125,7,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
89857,Marketed,2021-01-15,02413922,Hemosate Ultra HS 4125,7,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
89944,Marketed,2024-05-06,02414813,Selectbag One (Ax 125 G),5,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
89945,Marketed,2024-05-06,02414821,Selectbag One (Ax 150 G),5,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
89948,Marketed,2024-05-06,02414856,Selectbag One (Ax 225 G),5,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
89953,Marketed,2024-05-06,02414902,Selectbag One (Ax 325 G),5,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
90007,Marketed,2024-05-06,02415461,Selectbag One (Ax 250 G),5,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
90008,Marketed,2024-05-13,02415488,Selectbag One (Ax 450 G),5,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
90009,Marketed,2024-05-10,02415496,Selectbag One (Ax 2525 G),5,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
90011,Marketed,2024-05-08,02415526,Selectbag One (Ax 350 G),5,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
90988,Marketed,2024-05-08,02425246,Bicart Select Combi-Pak,2,B05ZA,"Hemodialytics, concentrates","Powder for solution,Kit",Haemodialysis,,,,,,,,,,,,,,,,,Ethical
92024,Marketed,2023-07-14,02435918,Acid Concentrate A 1296,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
92029,Marketed,2023-07-14,02435950,Acid Concentrate A 1298,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
92030,Marketed,2023-07-14,02435969,Acid Concentrate A 1297,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
92790,Marketed,2026-02-20,02443279,Nxstage Pureflow Solution,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
92791,Marketed,2026-02-19,02443287,Nxstage Pureflow Solution,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
97789,Marketed,2022-04-26,02487756,Bibag,1,B05ZA,"Hemodialytics, concentrates",Powder for solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
9852,Marketed,2024-05-08,00860565,Acid Concentrate D12201,6,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
92609,Marketed,2024-04-19,02441691,Prism 0 Cal B22 K 0/0,3,B05ZB,Hemofiltrates,Solution,"Intravenous,Haemodialysis",,,,,,,,,,,,,,,,,Ethical
98660,Marketed,2024-05-06,02496755,Regiocit,2,B05ZB,Hemofiltrates,Solution,Extracorporeal,,,,,,,,,,,,,,,,,Ethical
13140,Marketed,2006-07-14,01959034,Act-Hib,2,J07AG01,"Hemophilus influenzae b, purified antig. conjugated","Kit,Powder for solution",Intramuscular,,,,,,,,,,,,,,,,,Schedule D
103735,Marketed,2024-09-26,02548488,Heparin Sodium Injection USP,1,B01AB01,Heparin,Solution,"Subcutaneous,Intravenous",02548488,HEPARIN SODIUM INJECTION USP (heparin sodium 5000 unit per 0.5 mL solution for injection vial) STERIMAX INC,Active,9012996,heparin sodium 5000 unit per 0.5 mL solution for injection vial,8001274,heparin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
10526,Marketed,1987-12-31,00453811,Heparin Leo Inj 1000 units/mL,1,B01AB01,Heparin,Liquid,"Intravenous,Subcutaneous",00453811,HEPARIN LEO INJ 1000UNIT/ML (heparin sodium 10000 unit per 10 mL solution for injection vial) LEO PHARMA INC,Active,9012990,heparin sodium 10000 unit per 10 mL solution for injection vial,8001274,heparin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
17227,Marketed,2017-06-13,01990748,Heparin Sodium In 0.9% Sodium Chloride Injection,1,B01AB01,Heparin,Solution,Intravenous,77700660,HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION (heparin sodium 2000 unit per 1000 mL solution for injection bag) PFIZER CANADA ULC,Active,9012992,heparin sodium 2000 unit per 1000 mL solution for injection bag,8001274,heparin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Ethical
17227,Marketed,2017-06-13,01990748,Heparin Sodium In 0.9% Sodium Chloride Injection,1,B01AB01,Heparin,Solution,Intravenous,77700661,HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION (heparin sodium 1000 unit per 500 mL solution for injection bag) PFIZER CANADA ULC,Active,9012987,heparin sodium 1000 unit per 500 mL solution for injection bag,8001274,heparin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Ethical
74973,Marketed,2015-09-09,02264307,"Heparin Sodium Injection, USP",1,B01AB01,Heparin,Solution,"Intravenous,Subcutaneous",77700674,"HEPARIN SODIUM INJECTION, USP (heparin sodium 50000 unit per 5 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9012997,heparin sodium 50000 unit per 5 mL solution for injection vial,8001274,heparin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
74973,Marketed,2015-09-09,02264307,"Heparin Sodium Injection, USP",1,B01AB01,Heparin,Solution,"Intravenous,Subcutaneous",77700675,"HEPARIN SODIUM INJECTION, USP (heparin sodium 10000 unit per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9012989,heparin sodium 10000 unit per 1 mL solution for injection vial,8001274,heparin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
74976,Marketed,2015-10-08,02264315,"Heparin Sodium Injection, USP",1,B01AB01,Heparin,Solution,"Subcutaneous,Intravenous",77700676,"HEPARIN SODIUM INJECTION, USP (heparin sodium 10000 unit per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9012990,heparin sodium 10000 unit per 10 mL solution for injection vial,8001274,heparin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
74976,Marketed,2015-10-08,02264315,"Heparin Sodium Injection, USP",1,B01AB01,Heparin,Solution,"Subcutaneous,Intravenous",77700677,"HEPARIN SODIUM INJECTION, USP (heparin sodium 1000 unit per mL solution for injection 30 mL vial) FRESENIUS KABI CANADA LTD",Active,9012988,heparin sodium 1000 unit per mL solution for injection 30 mL vial,8001274,heparin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
74976,Marketed,2015-10-08,02264315,"Heparin Sodium Injection, USP",1,B01AB01,Heparin,Solution,"Subcutaneous,Intravenous",77700678,"HEPARIN SODIUM INJECTION, USP (heparin sodium 1000 unit per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9012986,heparin sodium 1000 unit per 1 mL solution for injection vial,8001274,heparin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
78841,Marketed,2008-05-19,02303086,Heparin Sodium Injection USP    (Multidose vial-With Preservative),1,B01AB01,Heparin,Solution,"Subcutaneous,Intravenous",77700683,HEPARIN SODIUM INJECTION USP    (MULTIDOSE VIAL-WITH PRESERVATIVE) (heparin sodium 10000 unit per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012990,heparin sodium 10000 unit per 10 mL solution for injection vial,8001274,heparin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
78841,Marketed,2008-05-19,02303086,Heparin Sodium Injection USP    (Multidose vial-With Preservative),1,B01AB01,Heparin,Solution,"Subcutaneous,Intravenous",77700684,HEPARIN SODIUM INJECTION USP    (MULTIDOSE VIAL-WITH PRESERVATIVE) (heparin sodium 1000 unit per mL solution for injection 30 mL vial) SANDOZ CANADA INCORPORATED,Active,9012988,heparin sodium 1000 unit per mL solution for injection 30 mL vial,8001274,heparin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
8042,Marketed,1984-12-31,00727520,Heparin Leo 100 units/mL,1,B01AB01,Heparin,Solution,Extracorporeal,00727520,HEPARIN LEO 100UNIT/ML (heparin sodium 100 unit per mL lock flush solution 10 mL vial) LEO PHARMA INC,Active,9015303,heparin sodium 100 unit per mL lock flush solution 10 mL vial,8001274,heparin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,,,,Ethical
86817,Marketed,2013-03-01,02382326,Heparin Sodium Injection USP,1,B01AB01,Heparin,Solution,"Intravenous,Subcutaneous",02382326,HEPARIN SODIUM INJECTION USP (heparin sodium 10000 unit per 1 mL solution for injection vial) PFIZER CANADA ULC,Active,9012989,heparin sodium 10000 unit per 1 mL solution for injection vial,8001274,heparin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
87773,Marketed,2015-08-31,02392453,"Heparin Sodium Injection, USP",1,B01AB01,Heparin,Solution,"Intravenous,Subcutaneous",02392453,"HEPARIN SODIUM INJECTION, USP (heparin sodium 5000 unit per 0.5 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9012996,heparin sodium 5000 unit per 0.5 mL solution for injection vial,8001274,heparin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
94407,Marketed,2016-11-17,02456958,Heparin Sodium Injection USP,1,B01AB01,Heparin,Solution,Subcutaneous,02456958,HEPARIN SODIUM INJECTION USP (heparin sodium 5000 unit per 0.5 mL solution for injection syringe) STERINOVA INC.,Active,9012995,heparin sodium 5000 unit per 0.5 mL solution for injection syringe,8001274,heparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Ethical
10521,Marketed,1990-12-31,00828750,Heparin Sod And 0.9% Sod Chloride Inj,2,B01AB51,"Heparin, combinations",Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
16794,Marketed,1998-09-03,01935941,"Heparin Sodium In 5% Dextrose Injection, 25000 units/500 mL",4,B01AB51,"Heparin, combinations",Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
36794,Marketed,1998-06-17,02209713,Heparin Sodium 20000 Units In 5% Dextrose Inj,2,B01AB51,"Heparin, combinations",Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
36795,Marketed,1998-06-17,02209721,Heparin Sodium 25000 Units In 5% Dextrose Inj,2,B01AB51,"Heparin, combinations",Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
20256,Marketed,2002-09-23,02187078,Havrix 1440,1,J07BC02,"Hepatitis a, inactivated, whole virus",Suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
47865,Marketed,2007-10-23,02229702,Vaqta,1,J07BC02,"Hepatitis a, inactivated, whole virus",Suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
50339,Marketed,2002-08-22,02231056,Havrix 720 Junior,1,J07BC02,"Hepatitis a, inactivated, whole virus",Suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
61149,Marketed,2006-08-14,02237792,Avaxim,1,J07BC02,"Hepatitis a, inactivated, whole virus",Suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
100923,Marketed,2023-02-21,02520001,Hyperhep B,1,J06BB04,Hepatitis b immunoglobulin,Solution,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
100934,Marketed,2022-08-16,02520125,Hyperhep B,1,J06BB04,Hepatitis b immunoglobulin,Solution,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
77637,Marketed,2022-11-10,02290979,Hepagam B,1,J06BB04,Hepatitis b immunoglobulin,Solution,"Intramuscular,Intravenous",,,,,,,,,,,,,,,,,Schedule D
106443,Marketed,2026-05-08,02561476,Recombivax HB,1,J07BC01,"Hepatitis b, purified antigen",Solution,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
106444,Marketed,2026-04-14,02561484,Recombivax HB,1,J07BC01,"Hepatitis b, purified antigen",Solution,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
67606,Marketed,2006-02-07,02243676,Recombivax HB,1,J07BC01,"Hepatitis b, purified antigen",Suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
70103,Marketed,2006-04-10,02245977,Recombivax HB,1,J07BC01,"Hepatitis b, purified antigen",Suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
97717,Marketed,2019-10-07,02487020,Engerix-B,1,J07BC01,"Hepatitis b, purified antigen",Suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
97718,Marketed,2019-11-15,02487039,Engerix-B,1,J07BC01,"Hepatitis b, purified antigen",Suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
11321,Marketed,2020-11-16,00895466,Bradosol Lozenges Extra Strength 3.5 mg,1,R02AA12,Hexylresorcinol,Lozenge,Oral,00895466,BRADOSOL LOZENGES EXTRA STRENGTH 3.5MG (hexylresorcinol 3.5 mg lozenge) COLUMBIA LABORATORIES CANADA INC,Active,9014400,hexylresorcinol 3.5 mg lozenge,8001795,hexylresorcinol,26643006,Oral,385087003,Lozenge,733000006,Lozenge (unit of presentation),,,,Non-Prescription Drugs
67829,Marketed,2026-03-17,02243888,Strepsils Anaesthetic Formula,1,R02AA12,Hexylresorcinol,Lozenge,Oral,02243888,STREPSILS ANAESTHETIC FORMULA (hexylresorcinol 2.4 mg lozenge) RECKITT BENCKISER (CANADA) INC,Active,9002371,hexylresorcinol 2.4 mg lozenge,8001795,hexylresorcinol,26643006,Oral,385087003,Lozenge,733000006,Lozenge,,,,Non-Prescription Drugs
74940,Marketed,2026-03-13,02263998,Strepsils Extra Black Cherry,2,R02AA12,Hexylresorcinol,Lozenge,Oral,02263998,STREPSILS EXTRA BLACK CHERRY (hexylresorcinol 2.4 mg and levomenthol 4 mg lozenge) RECKITT BENCKISER (CANADA) INC,Active,9013568,hexylresorcinol 2.4 mg and levomenthol 4 mg lozenge,8002129,hexylresorcinol and levomenthol,26643006,Oral,385087003,Lozenge,733000006,Lozenge (unit of presentation),,,,Non-Prescription Drugs
37349,Marketed,2026-04-23,02223937,"Allergenic Extract Standardized Mite DP (10,000 Au/mL)",1,V01AA03,House dust mites,Solution,"Percutaneous,Subcutaneous",,,,,,,,,,,,,,,,,Schedule D
37350,Marketed,2023-03-24,02223945,"Allergenic Extract Standardized Mite DP (30,000 Au/mL)",1,V01AA03,House dust mites,Solution,"Subcutaneous,Percutaneous",,,,,,,,,,,,,,,,,Schedule D
37352,Marketed,2023-03-24,02223961,"Allergenic Extract Standardized Mite DF (30,000 Au/mL)",1,V01AA03,House dust mites,Solution,"Percutaneous,Subcutaneous",,,,,,,,,,,,,,,,,Schedule D
37354,Marketed,2025-12-04,02223996,"Allergenic Extract Mixture Of Standardized Mites (5,000 Au/mL)",2,V01AA03,House dust mites,Solution,"Percutaneous,Subcutaneous",,,,,,,,,,,,,,,,,Schedule D
43205,Marketed,2004-08-26,02217082,"Allergenic Extract, Standardardized Mite, D. Farinae",1,V01AA03,House dust mites,Liquid,"Subcutaneous,Percutaneous,Intradermal",,,,,,,,,,,,,,,,,Schedule D
43207,Marketed,2004-08-26,02217104,"Allergenic Extract, Standardized Mite, D.Pteronyssinus",1,V01AA03,House dust mites,Liquid,"Subcutaneous,Percutaneous,Intradermal",,,,,,,,,,,,,,,,,Schedule D
50628,Marketed,1999-03-15,02231321,Allergenic Extract - Standardized Mite Dermatophagoides Farinae,1,V01AA03,House dust mites,Liquid,"Intracutaneous,Subcutaneous",,,,,,,,,,,,,,,,,Schedule D
50631,Marketed,1999-03-15,02231324,Allergenic Extract - Standardized Mite Dermatophagoides Pteronyssinus,1,V01AA03,House dust mites,Liquid,"Subcutaneous,Intracutaneous",,,,,,,,,,,,,,,,,Schedule D
50632,Marketed,2002-08-20,02231325,Allergenic Extract - Standardized Mite Mix,2,V01AA03,House dust mites,Liquid,"Intracutaneous,Subcutaneous",,,,,,,,,,,,,,,,,Schedule D
75630,Marketed,2006-02-28,02270919,"Allergenic Extract, Standardized Mite Mixed",2,V01AA03,House dust mites,Liquid,"Subcutaneous,Intradermal,Percutaneous",,,,,,,,,,,,,,,,,Schedule D
95174,Marketed,2017-11-06,02463644,Acarizax,2,V01AA03,House dust mites,Tablet,Sublingual,,,,,,,,,,,,,,,,,Schedule D
95174,Marketed,2017-11-06,02463644,Acarizax,2,V01AA03,House dust mites,Tablet,Sublingual,,,,,,,,,,,,,,,,,Prescription
76872,Marketed,2006-09-19,02283093,Menopur,1,G03GA02,Human menopausal gonadotrophin,Powder for solution,Subcutaneous,02283093,MENOPUR (menotropins 75 unit per vial powder for solution for injection with diluent solution) FERRING INC,Active,9013224,menotropins 75 unit per vial powder for solution for injection with diluent solution,8001847,menotropins,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
76872,Marketed,2006-09-19,02283093,Menopur,1,G03GA02,Human menopausal gonadotrophin,Powder for solution,Subcutaneous,02283093,MENOPUR (menotropins 75 unit per vial powder for solution for injection with diluent solution) FERRING INC,Active,9013224,menotropins 75 unit per vial powder for solution for injection with diluent solution,8001847,menotropins,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
100550,Marketed,2023-07-26,02516160,"Hydralazine Hydrochloride Injection, USP",1,C02DB02,Hydralazine,Solution,Intravenous,02516160,"HYDRALAZINE HYDROCHLORIDE INJECTION, USP (hydralazine hydrochloride 20 mg per 1 mL solution for injection vial) AURO PHARMA INC",Active,9012384,hydralazine hydrochloride 20 mg per 1 mL solution for injection vial,8000851,hydralazine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
102648,Marketed,2024-10-07,02537699,"Hydralazine Hydrochloride Injection, USP",1,C02DB02,Hydralazine,Solution,Intravenous,02537699,"HYDRALAZINE HYDROCHLORIDE INJECTION, USP (hydralazine hydrochloride 20 mg per 1 mL solution for injection vial) EUGIA PHARMA INC.",Active,9012384,hydralazine hydrochloride 20 mg per 1 mL solution for injection vial,8000851,hydralazine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
102854,Marketed,2024-02-29,02539802,Hydralazine,1,C02DB02,Hydralazine,Tablet,Oral,02539802,HYDRALAZINE (hydralazine hydrochloride 10 mg oral tablet) SANIS HEALTH INC,Active,9002309,hydralazine hydrochloride 10 mg oral tablet,8000851,hydralazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102855,Marketed,2024-02-29,02539810,Hydralazine,1,C02DB02,Hydralazine,Tablet,Oral,02539810,HYDRALAZINE (hydralazine hydrochloride 25 mg oral tablet) SANIS HEALTH INC,Active,9002373,hydralazine hydrochloride 25 mg oral tablet,8000851,hydralazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102856,Marketed,2024-02-29,02539829,Hydralazine,1,C02DB02,Hydralazine,Tablet,Oral,02539829,HYDRALAZINE (hydralazine hydrochloride 50 mg oral tablet) SANIS HEALTH INC,Active,9002374,hydralazine hydrochloride 50 mg oral tablet,8000851,hydralazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
11047,Marketed,2017-10-02,00441619,Apo-Hydralazine,1,C02DB02,Hydralazine,Tablet,Oral,00441619,APO-HYDRALAZINE (hydralazine hydrochloride 10 mg oral tablet) APOTEX INC,Active,9002309,hydralazine hydrochloride 10 mg oral tablet,8000851,hydralazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
11626,Marketed,2017-10-02,00441627,Apo-Hydralazine,1,C02DB02,Hydralazine,Tablet,Oral,00441627,APO-HYDRALAZINE (hydralazine hydrochloride 25 mg oral tablet) APOTEX INC,Active,9002373,hydralazine hydrochloride 25 mg oral tablet,8000851,hydralazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
11627,Marketed,2017-10-02,00441635,Apo-Hydralazine,1,C02DB02,Hydralazine,Tablet,Oral,00441635,APO-HYDRALAZINE (hydralazine hydrochloride 50 mg oral tablet) APOTEX INC,Active,9002374,hydralazine hydrochloride 50 mg oral tablet,8000851,hydralazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94490,Marketed,2017-08-28,02457865,JAMP-Hydralazine,1,C02DB02,Hydralazine,Tablet,Oral,02457865,JAMP-HYDRALAZINE (hydralazine hydrochloride 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9002309,hydralazine hydrochloride 10 mg oral tablet,8000851,hydralazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94491,Marketed,2017-08-28,02457873,JAMP-Hydralazine,1,C02DB02,Hydralazine,Tablet,Oral,02457873,JAMP-HYDRALAZINE (hydralazine hydrochloride 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9002373,hydralazine hydrochloride 25 mg oral tablet,8000851,hydralazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94492,Marketed,2017-08-28,02457881,JAMP-Hydralazine,1,C02DB02,Hydralazine,Tablet,Oral,02457881,JAMP-HYDRALAZINE (hydralazine hydrochloride 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9002374,hydralazine hydrochloride 50 mg oral tablet,8000851,hydralazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95730,Marketed,2018-04-13,02468778,Mint-Hydralazine,1,C02DB02,Hydralazine,Tablet,Oral,02468778,MINT-HYDRALAZINE (hydralazine hydrochloride 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9002309,hydralazine hydrochloride 10 mg oral tablet,8000851,hydralazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95731,Marketed,2018-02-16,02468786,Mint-Hydralazine,1,C02DB02,Hydralazine,Tablet,Oral,02468786,MINT-HYDRALAZINE (hydralazine hydrochloride 25 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9002373,hydralazine hydrochloride 25 mg oral tablet,8000851,hydralazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95732,Marketed,2018-02-16,02468794,Mint-Hydralazine,1,C02DB02,Hydralazine,Tablet,Oral,02468794,MINT-HYDRALAZINE (hydralazine hydrochloride 50 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9002374,hydralazine hydrochloride 50 mg oral tablet,8000851,hydralazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
4280,Marketed,2020-10-15,00312800,Apo-Hydrochlorothiazide,1,C03AA03,Hydrochlorothiazide,Tablet,Oral,00312800,APO-HYDROCHLOROTHIAZIDE (hydrochlorothiazide 50 mg oral tablet) APOTEX INC,Active,9000044,hydrochlorothiazide 50 mg oral tablet,8000031,hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
4281,Marketed,2020-10-15,00326844,Apo-Hydrochlorothiazide,1,C03AA03,Hydrochlorothiazide,Tablet,Oral,00326844,APO-HYDROCHLOROTHIAZIDE (hydrochlorothiazide 25 mg oral tablet) APOTEX INC,Active,9000043,hydrochlorothiazide 25 mg oral tablet,8000031,hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71631,Marketed,2014-05-26,02247386,PMS-Hydrochlorothiazide,1,C03AA03,Hydrochlorothiazide,Tablet,Oral,02247386,PMS-HYDROCHLOROTHIAZIDE (hydrochlorothiazide 25 mg oral tablet) PHARMASCIENCE INC,Active,9000043,hydrochlorothiazide 25 mg oral tablet,8000031,hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71632,Marketed,2013-10-18,02247387,PMS-Hydrochlorothiazide,1,C03AA03,Hydrochlorothiazide,Tablet,Oral,02247387,PMS-HYDROCHLOROTHIAZIDE (hydrochlorothiazide 50 mg oral tablet) PHARMASCIENCE INC,Active,9000044,hydrochlorothiazide 50 mg oral tablet,8000031,hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75953,Marketed,2013-11-20,02274086,PMS-Hydrochlorothiazide,1,C03AA03,Hydrochlorothiazide,Tablet,Oral,02274086,PMS-HYDROCHLOROTHIAZIDE (hydrochlorothiazide 12.5 mg oral tablet) PHARMASCIENCE INC,Active,9001134,hydrochlorothiazide 12.5 mg oral tablet,8000031,hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
778,Marketed,2011-02-17,00021474,Teva-Hydrochlorothiazide,1,C03AA03,Hydrochlorothiazide,Tablet,Oral,00021474,TEVA-HYDROCHLOROTHIAZIDE (hydrochlorothiazide 25 mg oral tablet) TEVA CANADA LIMITED,Active,9000043,hydrochlorothiazide 25 mg oral tablet,8000031,hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
812,Marketed,2011-02-17,00021482,Teva-Hydrochlorothiazide,1,C03AA03,Hydrochlorothiazide,Tablet,Oral,00021482,TEVA-HYDROCHLOROTHIAZIDE (hydrochlorothiazide 50 mg oral tablet) TEVA CANADA LIMITED,Active,9000044,hydrochlorothiazide 50 mg oral tablet,8000031,hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81335,Marketed,2020-10-19,02327856,Apo-Hydrochlorothiazide,1,C03AA03,Hydrochlorothiazide,Tablet,Oral,02327856,APO-HYDROCHLOROTHIAZIDE (hydrochlorothiazide 12.5 mg oral tablet) APOTEX INC,Active,9001134,hydrochlorothiazide 12.5 mg oral tablet,8000031,hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84556,Marketed,2026-03-18,02360594,Hydrochlorothiazide,1,C03AA03,Hydrochlorothiazide,Tablet,Oral,02360594,HYDROCHLOROTHIAZIDE (hydrochlorothiazide 25 mg oral tablet) SANIS HEALTH INC,Active,9000043,hydrochlorothiazide 25 mg oral tablet,8000031,hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91057,Marketed,2018-08-30,02425947,Mint-Hydrochlorothiazide,1,C03AA03,Hydrochlorothiazide,Tablet,Oral,02425947,MINT-HYDROCHLOROTHIAZIDE (hydrochlorothiazide 12.5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001134,hydrochlorothiazide 12.5 mg oral tablet,8000031,hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91079,Marketed,2018-08-30,02426196,Mint-Hydrochlorothiazide,1,C03AA03,Hydrochlorothiazide,Tablet,Oral,02426196,MINT-HYDROCHLOROTHIAZIDE (hydrochlorothiazide 25 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000043,hydrochlorothiazide 25 mg oral tablet,8000031,hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97711,Marketed,2019-08-14,02486962,Hydrochlorothiazide,1,C03AA03,Hydrochlorothiazide,Tablet,Oral,02486962,HYDROCHLOROTHIAZIDE (hydrochlorothiazide 25 mg oral tablet) PRO DOC LIMITEE,Active,9000043,hydrochlorothiazide 25 mg oral tablet,8000031,hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
10494,Marketed,2019-10-30,00784400,AA-Amilzide,2,C03EA01,Hydrochlorothiazide and potassium-sparing agents,Tablet,Oral,00784400,AA-AMILZIDE (amiloride hydrochloride 5 mg and hydrochlorothiazide 50 mg oral tablet) AA PHARMA INC,Active,9007114,amiloride hydrochloride 5 mg and hydrochlorothiazide 50 mg oral tablet,8000844,amiloride and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
4523,Marketed,2011-05-07,00532657,Teva-Triamterene/HCTZ,2,C03EA01,Hydrochlorothiazide and potassium-sparing agents,Tablet,Oral,00532657,TEVA-TRIAMTERENE/HCTZ (hydrochlorothiazide 25 mg and triamterene 50 mg oral tablet) TEVA CANADA LIMITED,Active,9000172,hydrochlorothiazide 25 mg and triamterene 50 mg oral tablet,8000092,hydrochlorothiazide and triamterene,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
5672,Marketed,1984-12-31,00441775,Apo-Triazide,2,C03EA01,Hydrochlorothiazide and potassium-sparing agents,Tablet,Oral,00441775,APO-TRIAZIDE (hydrochlorothiazide 25 mg and triamterene 50 mg oral tablet) APOTEX INC,Active,9000172,hydrochlorothiazide 25 mg and triamterene 50 mg oral tablet,8000092,hydrochlorothiazide and triamterene,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
5858,Marketed,2011-06-29,00613231,Teva-Spironolactone/HCTZ,2,C03EA01,Hydrochlorothiazide and potassium-sparing agents,Tablet,Oral,00613231,TEVA-SPIRONOLACTONE/HCTZ (hydrochlorothiazide 25 mg and spironolactone 25 mg oral tablet) TEVA CANADA LIMITED,Active,9009869,hydrochlorothiazide 25 mg and spironolactone 25 mg oral tablet,8000802,hydrochlorothiazide and spironolactone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
6892,Marketed,2011-06-29,00657182,Teva-Spironolactone/HCTZ,2,C03EA01,Hydrochlorothiazide and potassium-sparing agents,Tablet,Oral,00657182,TEVA-SPIRONOLACTONE/HCTZ (hydrochlorothiazide 50 mg and spironolactone 50 mg oral tablet) TEVA CANADA LIMITED,Active,9009877,hydrochlorothiazide 50 mg and spironolactone 50 mg oral tablet,8000802,hydrochlorothiazide and spironolactone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
80973,Marketed,2016-07-08,02324253,PDP-Hydrocodone,1,R05DA03,Hydrocodone,Syrup,Oral,02324253,PDP-HYDROCODONE (hydrocodone bitartrate 5 mg per 5 mL syrup) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9009884,hydrocodone bitartrate 5 mg per 5 mL syrup,8000777,hydrocodone,26643006,Oral,739009002,Syrup,,,,1.0,,Narcotics (CDSA I)
10052,Marketed,1989-12-31,00770957,Pramox HC Cream,2,D07XA01,Hydrocortisone,Cream,Topical,00770957,PRAMOX HC CREAM (hydrocortisone (hydrocortisone acetate) 1 % and pramoxine hydrochloride 1 % cutaneous cream) DERMTEK PHARMA INC,Active,9013963,hydrocortisone (hydrocortisone acetate) 1 % and pramoxine hydrochloride 1 % cutaneous cream,8001797,hydrocortisone and pramoxine,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
101351,Marketed,2022-11-22,02524465,Auro-Hydrocortisone,1,H02AB09,Hydrocortisone,Tablet,Oral,02524465,AURO-HYDROCORTISONE (hydrocortisone 10 mg oral tablet) AURO PHARMA INC,Active,9000011,hydrocortisone 10 mg oral tablet,8000008,hydrocortisone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101352,Marketed,2022-11-22,02524473,Auro-Hydrocortisone,1,H02AB09,Hydrocortisone,Tablet,Oral,02524473,AURO-HYDROCORTISONE (hydrocortisone 20 mg oral tablet) AURO PHARMA INC,Active,9000012,hydrocortisone 20 mg oral tablet,8000008,hydrocortisone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
15948,Marketed,1994-12-31,01954210,Pramox HC Lotion,2,D07XA01,Hydrocortisone,Lotion,Topical,01954210,PRAMOX HC LOTION (hydrocortisone (hydrocortisone acetate) 1 % and pramoxine hydrochloride 1 % lotion) DERMTEK PHARMA INC,Active,9002681,hydrocortisone (hydrocortisone acetate) 1 % and pramoxine hydrochloride 1 % lotion,8001797,hydrocortisone and pramoxine,448598008,Cutaneous,739000003,Lotion,,,,,,Non-Prescription Drugs
18240,Marketed,1995-12-31,02128446,Anodan-HC Ointment,2,C05AA01,Hydrocortisone,Ointment,"Rectal,Topical",02128446,ANODAN-HC OINTMENT (hydrocortisone acetate 0.5 % and zinc sulfate 0.5 % rectal ointment) ODAN LABORATORIES LTD,Active,9001911,hydrocortisone acetate 0.5 % and zinc sulfate 0.5 % rectal ointment,8000812,hydrocortisone and zinc sulfate,37161004,Rectal,385184008,Rectal ointment,,,,,,Prescription
2219,Marketed,2009-02-03,00030600,Solu-Cortef,1,H02AB09,Hydrocortisone,Powder for solution,"Intramuscular,Intravenous",00030600,SOLU-CORTEF (hydrocortisone (hydrocortisone sodium succinate) 100 mg powder for solution for injection with diluent solution per vial) PFIZER CANADA ULC,Active,9012632,hydrocortisone (hydrocortisone sodium succinate) 100 mg powder for solution for injection with diluent solution per vial,8000008,hydrocortisone,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
2220,Marketed,2009-02-03,00030619,Solu-Cortef,1,H02AB09,Hydrocortisone,Powder for solution,"Intramuscular,Intravenous",00030619,SOLU-CORTEF (hydrocortisone (hydrocortisone sodium succinate) 250 mg powder for solution for injection with diluent solution per vial) PFIZER CANADA ULC,Active,9012633,hydrocortisone (hydrocortisone sodium succinate) 250 mg powder for solution for injection with diluent solution per vial,8000008,hydrocortisone,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
2221,Marketed,2009-02-03,00030627,Solu-Cortef,1,H02AB09,Hydrocortisone,Powder for solution,"Intravenous,Intramuscular",00030627,SOLU-CORTEF (hydrocortisone (hydrocortisone sodium succinate) 500 mg powder for solution for injection with diluent solution per vial) PFIZER CANADA ULC,Active,9012634,hydrocortisone (hydrocortisone sodium succinate) 500 mg powder for solution for injection with diluent solution per vial,8000008,hydrocortisone,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
2222,Marketed,2009-02-03,00030635,Solu-Cortef,1,H02AB09,Hydrocortisone,Powder for solution,"Intramuscular,Intravenous",00030635,SOLU-CORTEF (hydrocortisone (hydrocortisone sodium succinate) 1 g powder for solution for injection with diluent solution per vial) PFIZER CANADA ULC,Active,9012631,hydrocortisone (hydrocortisone sodium succinate) 1 g powder for solution for injection with diluent solution per vial,8000008,hydrocortisone,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
37454,Marketed,2018-01-22,02226383,Teva-Proctosone,4,C05AA01,Hydrocortisone,Ointment,Rectal,02226383,TEVA-PROCTOSONE (dibucaine hydrochloride 0.5 % and esculin 1 % and framycetin sulfate 1 % and hydrocortisone 0.5 % rectal ointment) TEVA CANADA LIMITED,Active,9006369,dibucaine hydrochloride 0.5 % and esculin 1 % and framycetin sulfate 1 % and hydrocortisone 0.5 % rectal ointment,8000898,dibucaine and esculin and framycetin and hydrocortisone,37161004,Rectal,385184008,Rectal ointment,,,,,,Prescription
432,Marketed,2005-06-21,00030910,Cortef,1,H02AB09,Hydrocortisone,Tablet,Oral,00030910,CORTEF (hydrocortisone 10 mg oral tablet) PFIZER CANADA ULC,Active,9000011,hydrocortisone 10 mg oral tablet,8000008,hydrocortisone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
433,Marketed,2005-05-27,00030929,Cortef,1,H02AB09,Hydrocortisone,Tablet,Oral,00030929,CORTEF (hydrocortisone 20 mg oral tablet) PFIZER CANADA ULC,Active,9000012,hydrocortisone 20 mg oral tablet,8000008,hydrocortisone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
4389,Marketed,2017-03-03,00505773,Anusol-HC Ointment,2,C05AA01,Hydrocortisone,Ointment,Rectal,00505773,ANUSOL-HC OINTMENT (hydrocortisone acetate 0.5 % and zinc sulfate 0.5 % rectal ointment) CHURCH & DWIGHT CANADA CORP,Active,9001911,hydrocortisone acetate 0.5 % and zinc sulfate 0.5 % rectal ointment,8000812,hydrocortisone and zinc sulfate,37161004,Rectal,385184008,Rectal ointment,,,,,,Prescription
4630,Marketed,2017-03-03,00476285,Anusol-HC Suppositories,2,C05AA01,Hydrocortisone,Suppository,Rectal,00476285,ANUSOL-HC SUPPOSITORIES (hydrocortisone acetate 10 mg and zinc sulfate 10 mg suppository) CHURCH & DWIGHT CANADA CORP,Active,9001737,hydrocortisone acetate 10 mg and zinc sulfate 10 mg suppository,8000812,hydrocortisone and zinc sulfate,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,,Prescription
55837,Marketed,1998-01-23,02234466,Proctodan-HC Ointment,3,C05AA01,Hydrocortisone,Ointment,"Topical,Rectal",02234466,PROCTODAN-HC OINTMENT (hydrocortisone acetate 0.5 % and pramoxine hydrochloride 1 % and zinc sulfate 0.5 % rectal ointment) ODAN LABORATORIES LTD,Active,9001910,hydrocortisone acetate 0.5 % and pramoxine hydrochloride 1 % and zinc sulfate 0.5 % rectal ointment,8001798,hydrocortisone and pramoxine and zinc sulfate,37161004,Rectal,385184008,Rectal ointment,,,,,,Prescription
59873,Marketed,1998-08-13,02236399,Anodan-HC 10 mg Suppositories,2,C05AA01,Hydrocortisone,Suppository,Rectal,02236399,ANODAN-HC 10MG SUPPOSITORIES (hydrocortisone acetate 10 mg and zinc sulfate 10 mg suppository) ODAN LABORATORIES LTD,Active,9001737,hydrocortisone acetate 10 mg and zinc sulfate 10 mg suppository,8000812,hydrocortisone and zinc sulfate,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,,Prescription
64442,Marketed,2000-03-23,02240851,Proctodan-HC Suppositories,3,C05AA01,Hydrocortisone,Suppository,Rectal,02240851,PROCTODAN-HC SUPPOSITORIES (hydrocortisone acetate 10 mg and pramoxine hydrochloride 20 mg and zinc sulfate 10 mg suppository) ODAN LABORATORIES LTD,Active,9001809,hydrocortisone acetate 10 mg and pramoxine hydrochloride 20 mg and zinc sulfate 10 mg suppository,8001798,hydrocortisone and pramoxine and zinc sulfate,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,,Prescription
66824,Marketed,2004-03-30,02242984,Hydroval Cream 0.2%,1,D07AA02,Hydrocortisone,Cream,Topical,02242984,"HYDROVAL CREAM 0.2% (hydrocortisone valerate 0.2 % cutaneous cream) TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Active,9000926,hydrocortisone valerate 0.2 % cutaneous cream,8000008,hydrocortisone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
66825,Marketed,2004-04-06,02242985,Hydroval Ointment 0.2%,1,D07AA02,Hydrocortisone,Ointment,Topical,02242985,"HYDROVAL OINTMENT 0.2% (hydrocortisone valerate 0.2 % cutaneous ointment) TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Active,9000927,hydrocortisone valerate 0.2 % cutaneous ointment,8000008,hydrocortisone,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Prescription
71565,Marketed,2003-08-06,02247322,Proctol Ointment,4,C05AA01,Hydrocortisone,Ointment,Rectal,02247322,PROCTOL OINTMENT (dibucaine hydrochloride 0.5 % and esculin 1 % and framycetin sulfate 1 % and hydrocortisone 0.5 % rectal ointment) ODAN LABORATORIES LTD,Active,9006369,dibucaine hydrochloride 0.5 % and esculin 1 % and framycetin sulfate 1 % and hydrocortisone 0.5 % rectal ointment,8000898,dibucaine and esculin and framycetin and hydrocortisone,37161004,Rectal,385184008,Rectal ointment,,,,,,Prescription
72190,Marketed,2004-03-15,02247882,Proctol Suppositories,4,C05AA01,Hydrocortisone,Suppository,Rectal,02247882,PROCTOL SUPPOSITORIES (dibucaine hydrochloride 5 mg and esculin 10 mg and framycetin sulfate 10 mg and hydrocortisone 5 mg suppository) ODAN LABORATORIES LTD,Active,9003053,dibucaine hydrochloride 5 mg and esculin 10 mg and framycetin sulfate 10 mg and hydrocortisone 5 mg suppository,8000898,dibucaine and esculin and framycetin and hydrocortisone,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,,Prescription
87281,Marketed,2012-07-23,02387239,Jampzinc-HC,2,C05AA01,Hydrocortisone,Ointment,"Rectal,Topical",02387239,JAMPZINC-HC (hydrocortisone acetate 0.5 % and zinc sulfate monohydrate 0.5 % rectal ointment) JAMP PHARMA CORPORATION,Active,9001911,hydrocortisone acetate 0.5 % and zinc sulfate 0.5 % rectal ointment,8000812,hydrocortisone and zinc sulfate,37161004,Rectal,385184008,Rectal ointment,,,,,,Prescription
95822,Marketed,2019-06-04,02469421,Sandoz Hydrocortisone,1,D07AA02,Hydrocortisone,Cream,Topical,02469421,SANDOZ HYDROCORTISONE (hydrocortisone 2.5 % cutaneous cream) SANDOZ CANADA INCORPORATED,Active,9000187,hydrocortisone 2.5 % cutaneous cream,8000008,hydrocortisone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
62005,Marketed,1998-11-11,02238578,Fucidin H,2,D07CA01,Hydrocortisone and antibiotics,Cream,Topical,02238578,FUCIDIN H (fusidic acid 2 % and hydrocortisone acetate 1 % cutaneous cream) LEO PHARMA INC,Active,9003329,fusidic acid 2 % and hydrocortisone acetate 1 % cutaneous cream,8000908,fusidic acid and hydrocortisone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
810,Marketed,2025-09-24,00074500,Vioform Hydrocortisone,2,D07CA01,Hydrocortisone and antibiotics,Cream,Topical,00074500,VIOFORM HYDROCORTISONE (clioquinol 3 % and hydrocortisone 1 % cutaneous cream) KNIGHT THERAPEUTICS INC.,Active,9001554,clioquinol 3 % and hydrocortisone 1 % cutaneous cream,8000798,clioquinol and hydrocortisone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
100362,Marketed,2022-08-24,02514435,HYDROmorphone Hydrochloride Injection USP,1,N02AA03,Hydromorphone,Solution,"Intramuscular,Subcutaneous,Intravenous",02514435,HYDROMORPHONE HYDROCHLORIDE INJECTION USP (hydromorphone hydrochloride 1 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9014761,hydromorphone hydrochloride 1 mg per 1 mL solution for injection vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
101889,Marketed,2023-02-22,02529645,HYDROmorphone Hydrochloride Injection USP,1,N02AA03,Hydromorphone,Solution,"Intravenous,Intramuscular,Subcutaneous",02529645,HYDROMORPHONE HYDROCHLORIDE INJECTION USP (hydromorphone hydrochloride 2 mg per 1 mL solution for injection ampoule) JAMP PHARMA CORPORATION,Active,9000203,hydromorphone hydrochloride 2 mg per 1 mL solution for injection ampoule,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,,Narcotics (CDSA I)
11363,Marketed,1991-12-31,00885428,PMS-HYDROmorphone Tablets 8 mg,1,N02AA03,Hydromorphone,Tablet,Oral,00885428,PMS-HYDROMORPHONE TAB 8MG (hydromorphone hydrochloride 8 mg oral tablet) PHARMASCIENCE INC,Active,9000328,hydromorphone hydrochloride 8 mg oral tablet,8000106,hydromorphone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
11413,Marketed,1991-12-31,00885444,PMS-HYDROmorphone Tablets 1 mg,1,N02AA03,Hydromorphone,Tablet,Oral,00885444,PMS-HYDROMORPHONE TAB 1MG (hydromorphone hydrochloride 1 mg oral tablet) PHARMASCIENCE INC,Active,9000253,hydromorphone hydrochloride 1 mg oral tablet,8000106,hydromorphone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
11425,Marketed,1991-12-31,00885401,PMS-HYDROmorphone Tablets 4 mg,1,N02AA03,Hydromorphone,Tablet,Oral,00885401,PMS-HYDROMORPHONE TAB 4MG (hydromorphone hydrochloride 4 mg oral tablet) PHARMASCIENCE INC,Active,9000204,hydromorphone hydrochloride 4 mg oral tablet,8000106,hydromorphone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
11428,Marketed,1991-12-31,00885436,PMS-HYDROmorphone Tablets 2 mg,1,N02AA03,Hydromorphone,Tablet,Oral,00885436,PMS-HYDROMORPHONE TAB 2MG (hydromorphone hydrochloride 2 mg oral tablet) PHARMASCIENCE INC,Active,9000202,hydromorphone hydrochloride 2 mg oral tablet,8000106,hydromorphone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
11870,Marketed,1991-12-31,01916386,PMS HYDROmorphone Sirop 1 mg/mL,1,N02AA03,Hydromorphone,Syrup,Oral,01916386,PMS HYDROMORPHONE SIROP 1MG/ML (hydromorphone hydrochloride 1 mg per mL syrup) PHARMASCIENCE INC,Active,9000384,hydromorphone hydrochloride 1 mg per mL syrup,8000106,hydromorphone,26643006,Oral,739009002,Syrup,,,,1.0,,Narcotics (CDSA I)
18315,Marketed,2005-10-08,02145901,HYDROmorphone Hydrochloride Injection USP,1,N02AA03,Hydromorphone,Solution,"Subcutaneous,Intramuscular,Intravenous",02145901,HYDROMORPHONE HYDROCHLORIDE INJECTION USP (hydromorphone hydrochloride 2 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9000203,hydromorphone hydrochloride 2 mg per 1 mL solution for injection ampoule,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,,Narcotics (CDSA I)
18323,Marketed,2005-08-26,02145928,HYDROmorphone HP 10,1,N02AA03,Hydromorphone,Solution,"Intramuscular,Intravenous,Subcutaneous",77700290,HYDROMORPHONE HP 10 (hydromorphone hydrochloride 100 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000579,hydromorphone hydrochloride 100 mg per 10 mL solution for injection vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
18323,Marketed,2005-08-26,02145928,HYDROmorphone HP 10,1,N02AA03,Hydromorphone,Solution,"Intramuscular,Intravenous,Subcutaneous",77700291,HYDROMORPHONE HP 10 (hydromorphone hydrochloride 10 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000201,hydromorphone hydrochloride 10 mg per 1 mL solution for injection vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
18323,Marketed,2005-08-26,02145928,HYDROmorphone HP 10,1,N02AA03,Hydromorphone,Solution,"Intramuscular,Intravenous,Subcutaneous",77700292,HYDROMORPHONE HP 10 (hydromorphone hydrochloride 10 mg per mL solution for injection 50 mL vial) SANDOZ CANADA INCORPORATED,Active,9006204,hydromorphone hydrochloride 10 mg per mL solution for injection 50 mL vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
18323,Marketed,2005-08-26,02145928,HYDROmorphone HP 10,1,N02AA03,Hydromorphone,Solution,"Intramuscular,Intravenous,Subcutaneous",77700293,HYDROMORPHONE HP 10 (hydromorphone hydrochloride 50 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000206,hydromorphone hydrochloride 50 mg per 5 mL solution for injection vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
18324,Marketed,2005-08-26,02146126,HYDROmorphone HP 50,1,N02AA03,Hydromorphone,Solution,"Intravenous,Subcutaneous,Intramuscular",77700297,HYDROMORPHONE HP 50 (hydromorphone hydrochloride 250 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000582,hydromorphone hydrochloride 250 mg per 5 mL solution for injection vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
18324,Marketed,2005-08-26,02146126,HYDROmorphone HP 50,1,N02AA03,Hydromorphone,Solution,"Intravenous,Subcutaneous,Intramuscular",77700298,HYDROMORPHONE HP 50 (hydromorphone hydrochloride 500 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000584,hydromorphone hydrochloride 500 mg per 10 mL solution for injection vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
18324,Marketed,2005-08-26,02146126,HYDROmorphone HP 50,1,N02AA03,Hydromorphone,Solution,"Intravenous,Subcutaneous,Intramuscular",77700299,HYDROMORPHONE HP 50 (hydromorphone hydrochloride 50 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000585,hydromorphone hydrochloride 50 mg per 1 mL solution for injection vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
18324,Marketed,2005-08-26,02146126,HYDROmorphone HP 50,1,N02AA03,Hydromorphone,Solution,"Intravenous,Subcutaneous,Intramuscular",77700300,HYDROMORPHONE HP 50 (hydromorphone hydrochloride 50 mg per mL solution for injection 50 mL vial) SANDOZ CANADA INCORPORATED,Active,9006245,hydromorphone hydrochloride 50 mg per mL solution for injection 50 mL vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
18325,Marketed,2005-08-26,02145936,HYDROmorphone HP 20,1,N02AA03,Hydromorphone,Solution,"Intramuscular,Subcutaneous,Intravenous",77700294,HYDROMORPHONE HP 20 (hydromorphone hydrochloride 20 mg per mL solution for injection 50 mL vial) SANDOZ CANADA INCORPORATED,Active,9012635,hydromorphone hydrochloride 20 mg per mL solution for injection 50 mL vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
18325,Marketed,2005-08-26,02145936,HYDROmorphone HP 20,1,N02AA03,Hydromorphone,Solution,"Intramuscular,Subcutaneous,Intravenous",77700295,HYDROMORPHONE HP 20 (hydromorphone hydrochloride 100 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9006243,hydromorphone hydrochloride 100 mg per 5 mL solution for injection vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
18325,Marketed,2005-08-26,02145936,HYDROmorphone HP 20,1,N02AA03,Hydromorphone,Solution,"Intramuscular,Subcutaneous,Intravenous",77700296,HYDROMORPHONE HP 20 (hydromorphone hydrochloride 20 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9006244,hydromorphone hydrochloride 20 mg per 1 mL solution for injection vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
18556,Marketed,1995-12-31,02125323,Hydromorph Contin-Controlled Release Capsules - 3 mg,1,N02AA03,Hydromorphone,Capsule (sustained-release),Oral,02125323,HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG (hydromorphone hydrochloride 3 mg prolonged-release oral capsule) PURDUE PHARMA,Active,9000583,hydromorphone hydrochloride 3 mg prolonged-release oral capsule,8000106,hydromorphone,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,,Narcotics (CDSA I)
18558,Marketed,1995-12-31,02125331,Hydromorph Contin-Controlled Release Capsules - 6 mg,1,N02AA03,Hydromorphone,Capsule (sustained-release),Oral,02125331,HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 6MG (hydromorphone hydrochloride 6 mg prolonged-release oral capsule) PURDUE PHARMA,Active,9000586,hydromorphone hydrochloride 6 mg prolonged-release oral capsule,8000106,hydromorphone,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,,Narcotics (CDSA I)
20171,Marketed,1996-12-31,02125366,Hydromorph Contin-Controlled Release Capsules - 12 mg,1,N02AA03,Hydromorphone,Capsule (sustained-release),Oral,02125366,HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 12MG (hydromorphone hydrochloride 12 mg prolonged-release oral capsule) PURDUE PHARMA,Active,9000679,hydromorphone hydrochloride 12 mg prolonged-release oral capsule,8000106,hydromorphone,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,,Narcotics (CDSA I)
20172,Marketed,1996-12-31,02125382,Hydromorph Contin-Controlled Release Capsules - 24 mg,1,N02AA03,Hydromorphone,Capsule (sustained-release),Oral,02125382,HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 24MG (hydromorphone hydrochloride 24 mg prolonged-release oral capsule) PURDUE PHARMA,Active,9000680,hydromorphone hydrochloride 24 mg prolonged-release oral capsule,8000106,hydromorphone,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,,Narcotics (CDSA I)
43838,Marketed,1998-02-16,02125390,Hydromorph Contin-Controlled Release Capsules - 30 mg,1,N02AA03,Hydromorphone,Capsule (sustained-release),Oral,02125390,HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 30MG (hydromorphone hydrochloride 30 mg prolonged-release oral capsule) PURDUE PHARMA,Active,9000781,hydromorphone hydrochloride 30 mg prolonged-release oral capsule,8000106,hydromorphone,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,,Narcotics (CDSA I)
5939,Marketed,2009-01-21,00125083,Dilaudid,1,N02AA03,Hydromorphone,Tablet,Oral,00125083,DILAUDID (hydromorphone hydrochloride 2 mg oral tablet) PURDUE PHARMA,Active,9000202,hydromorphone hydrochloride 2 mg oral tablet,8000106,hydromorphone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
5940,Marketed,2008-12-29,00125121,Dilaudid,1,N02AA03,Hydromorphone,Tablet,Oral,00125121,DILAUDID (hydromorphone hydrochloride 4 mg oral tablet) PURDUE PHARMA,Active,9000204,hydromorphone hydrochloride 4 mg oral tablet,8000106,hydromorphone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
67480,Marketed,2001-07-03,02243562,Hydromorph Contin-Controlled Release Capsules - 18 mg,1,N02AA03,Hydromorphone,Capsule (sustained-release),Oral,02243562,HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 18MG (hydromorphone hydrochloride 18 mg prolonged-release oral capsule) PURDUE PHARMA,Active,9000948,hydromorphone hydrochloride 18 mg prolonged-release oral capsule,8000106,hydromorphone,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,,Narcotics (CDSA I)
6889,Marketed,2008-12-12,00705438,Dilaudid,1,N02AA03,Hydromorphone,Tablet,Oral,00705438,DILAUDID (hydromorphone hydrochloride 1 mg oral tablet) PURDUE PHARMA,Active,9000253,hydromorphone hydrochloride 1 mg oral tablet,8000106,hydromorphone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
84452,Marketed,2011-04-14,02359502,Hydromorph Contin,1,N02AA03,Hydromorphone,Capsule (sustained-release),Oral,02359502,HYDROMORPH CONTIN (hydromorphone hydrochloride 4.5 mg prolonged-release oral capsule) PURDUE PHARMA,Active,9001340,hydromorphone hydrochloride 4.5 mg prolonged-release oral capsule,8000106,hydromorphone,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,,Narcotics (CDSA I)
84453,Marketed,2011-04-14,02359510,Hydromorph Contin,1,N02AA03,Hydromorphone,Capsule (sustained-release),Oral,02359510,HYDROMORPH CONTIN (hydromorphone hydrochloride 9 mg prolonged-release oral capsule) PURDUE PHARMA,Active,9001341,hydromorphone hydrochloride 9 mg prolonged-release oral capsule,8000106,hydromorphone,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,,Narcotics (CDSA I)
84905,Marketed,2012-12-18,02364115,Apo-HYDROmorphone,1,N02AA03,Hydromorphone,Tablet,Oral,02364115,APO-HYDROMORPHONE (hydromorphone hydrochloride 1 mg oral tablet) APOTEX INC,Active,9000253,hydromorphone hydrochloride 1 mg oral tablet,8000106,hydromorphone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
84906,Marketed,2012-12-18,02364123,Apo-HYDROmorphone,1,N02AA03,Hydromorphone,Tablet,Oral,02364123,APO-HYDROMORPHONE (hydromorphone hydrochloride 2 mg oral tablet) APOTEX INC,Active,9000202,hydromorphone hydrochloride 2 mg oral tablet,8000106,hydromorphone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
84907,Marketed,2012-12-18,02364131,Apo-HYDROmorphone,1,N02AA03,Hydromorphone,Tablet,Oral,02364131,APO-HYDROMORPHONE (hydromorphone hydrochloride 4 mg oral tablet) APOTEX INC,Active,9000204,hydromorphone hydrochloride 4 mg oral tablet,8000106,hydromorphone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
84908,Marketed,2012-12-18,02364158,Apo-HYDROmorphone,1,N02AA03,Hydromorphone,Tablet,Oral,02364158,APO-HYDROMORPHONE (hydromorphone hydrochloride 8 mg oral tablet) APOTEX INC,Active,9000328,hydromorphone hydrochloride 8 mg oral tablet,8000106,hydromorphone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
94803,Marketed,2017-02-06,02460602,HYDROmorphone Hydrochloride Injection,1,N02AA03,Hydromorphone,Solution,"Intravenous,Subcutaneous,Intramuscular",02460602,HYDROMORPHONE HYDROCHLORIDE INJECTION (hydromorphone hydrochloride 2 mg per 1 mL solution for injection ampoule) STERIMAX INC,Active,9000203,hydromorphone hydrochloride 2 mg per 1 mL solution for injection ampoule,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,,Narcotics (CDSA I)
94804,Marketed,2017-02-06,02460610,HYDROmorphone Hydrochloride Injection HP 10,1,N02AA03,Hydromorphone,Solution,"Intravenous,Intramuscular,Subcutaneous",77700301,HYDROMORPHONE HYDROCHLORIDE INJECTION HP 10 (hydromorphone hydrochloride 100 mg per 10 mL solution for injection ampoule) STERIMAX INC,Active,9001473,hydromorphone hydrochloride 100 mg per 10 mL solution for injection ampoule,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,,Narcotics (CDSA I)
94804,Marketed,2017-02-06,02460610,HYDROmorphone Hydrochloride Injection HP 10,1,N02AA03,Hydromorphone,Solution,"Intravenous,Intramuscular,Subcutaneous",77700302,HYDROMORPHONE HYDROCHLORIDE INJECTION HP 10 (hydromorphone hydrochloride 10 mg per 1 mL solution for injection ampoule) STERIMAX INC,Active,9001474,hydromorphone hydrochloride 10 mg per 1 mL solution for injection ampoule,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,,Narcotics (CDSA I)
9509,Marketed,2008-12-29,00786543,Dilaudid,1,N02AA03,Hydromorphone,Tablet,Oral,00786543,DILAUDID (hydromorphone hydrochloride 8 mg oral tablet) PURDUE PHARMA,Active,9000328,hydromorphone hydrochloride 8 mg oral tablet,8000106,hydromorphone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
95689,Marketed,2018-06-20,02468468,HYDROmorphone Hydrochloride Injection HP Forte,1,N02AA03,Hydromorphone,Solution,"Intramuscular,Intravenous,Subcutaneous",02468468,HYDROMORPHONE HYDROCHLORIDE INJECTION HP FORTE (hydromorphone hydrochloride 1000 mg per 10 mL solution for injection vial) STERIMAX INC,Active,9000966,hydromorphone hydrochloride 1000 mg per 10 mL solution for injection vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
95820,Marketed,2018-08-21,02469413,HYDROmorphone Hydrochloride Injection HP 50,1,N02AA03,Hydromorphone,Solution,"Intravenous,Subcutaneous,Intramuscular",77700957,HYDROMORPHONE HYDROCHLORIDE INJECTION HP 50 (hydromorphone hydrochloride 50 mg per mL solution for injection 50 mL vial) STERIMAX INC,Active,9006245,hydromorphone hydrochloride 50 mg per mL solution for injection 50 mL vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
95820,Marketed,2018-08-21,02469413,HYDROmorphone Hydrochloride Injection HP 50,1,N02AA03,Hydromorphone,Solution,"Intravenous,Subcutaneous,Intramuscular",77700958,HYDROMORPHONE HYDROCHLORIDE INJECTION HP 50 (hydromorphone hydrochloride 50 mg per 1 mL solution for injection vial) STERIMAX INC,Active,9000585,hydromorphone hydrochloride 50 mg per 1 mL solution for injection vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
97577,Marketed,2019-09-18,02485532,HYDROmorphone Hydrochloride Injection USP,1,N02AA03,Hydromorphone,Solution,Intravenous,02485532,HYDROMORPHONE HYDROCHLORIDE INJECTION USP (hydromorphone hydrochloride 20 mg per 50 mL solution for injection bag) STERINOVA INC.,Active,9014172,hydromorphone hydrochloride 20 mg per 50 mL solution for injection bag,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,1.0,,Narcotics (CDSA I)
97578,Marketed,2019-08-28,02485540,HYDROmorphone Hydrochloride Injection USP,1,N02AA03,Hydromorphone,Solution,Intravenous,02485540,HYDROMORPHONE HYDROCHLORIDE INJECTION USP (hydromorphone hydrochloride 40 mg per 100 mL solution for injection bag) STERINOVA INC.,Active,9014173,hydromorphone hydrochloride 40 mg per 100 mL solution for injection bag,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,1.0,,Narcotics (CDSA I)
98169,Marketed,2020-11-10,02491680,"HYDROmorphone Hydrochloride Injection, USP",1,N02AA03,Hydromorphone,Solution,"Intramuscular,Intravenous,Subcutaneous",77701025,"HYDROMORPHONE HYDROCHLORIDE INJECTION, USP (hydromorphone hydrochloride 10 mg per mL solution for injection 50 mL vial) FRESENIUS KABI CANADA LTD",Active,9006204,hydromorphone hydrochloride 10 mg per mL solution for injection 50 mL vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
98169,Marketed,2020-11-10,02491680,"HYDROmorphone Hydrochloride Injection, USP",1,N02AA03,Hydromorphone,Solution,"Intramuscular,Intravenous,Subcutaneous",77701026,"HYDROMORPHONE HYDROCHLORIDE INJECTION, USP (hydromorphone hydrochloride 10 mg per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9000201,hydromorphone hydrochloride 10 mg per 1 mL solution for injection vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
98169,Marketed,2020-11-10,02491680,"HYDROmorphone Hydrochloride Injection, USP",1,N02AA03,Hydromorphone,Solution,"Intramuscular,Intravenous,Subcutaneous",77701027,"HYDROMORPHONE HYDROCHLORIDE INJECTION, USP (hydromorphone hydrochloride 50 mg per 5 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9000206,hydromorphone hydrochloride 50 mg per 5 mL solution for injection vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
98170,Marketed,2020-11-10,02491699,"HYDROmorphone Hydrochloride Injection, USP",1,N02AA03,Hydromorphone,Solution,"Intravenous,Intramuscular,Subcutaneous",02491699,"HYDROMORPHONE HYDROCHLORIDE INJECTION, USP (hydromorphone hydrochloride 2 mg per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9014412,hydromorphone hydrochloride 2 mg per 1 mL solution for injection vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
98171,Marketed,2022-09-29,02491702,Erfa Hydroquinone,1,D11AX11,Hydroquinone,Gel,Topical,02491702,ERFA HYDROQUINONE (hydroquinone 4 % cutaneous gel) SEARCHLIGHT PHARMA INC,Active,9003775,hydroquinone 4 % cutaneous gel,8001661,hydroquinone,448598008,Cutaneous,385100002,Gel,,,,,,Prescription
86078,Marketed,2016-07-22,02375370,Cyanokit,1,V03AB33,Hydroxocobalamin,Powder for solution,Intravenous,02375370,CYANOKIT (hydroxocobalamin 5 g per vial powder for solution for injection) SERB S.A.,Active,9005116,hydroxocobalamin 5 g per vial powder for solution for injection,8001799,hydroxocobalamin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
102698,Marketed,2023-10-04,02538237,Xywav,4,N07XX04,Hydroxybutyric acid,Solution,Oral,02538237,XYWAV (calcium oxybate 0.234 g per mL and magnesium oxybate 0.096 g per mL and potassium oxybate 0.13 g per mL and sodium oxybate 0.04 g per mL oral solution) JAZZ PHARMACEUTICALS IRELAND LIMITED,Active,9015164,calcium oxybate 0.234 g per mL and magnesium oxybate 0.096 g per mL and potassium oxybate 0.13 g per mL and sodium oxybate 0.04 g per mL oral solution,8002536,calcium oxybate and magnesium oxybate and potassium oxybate and sodium oxybate,26643006,Oral,385023001,Oral solution,,,,,,Controlled Drugs (CDSA I)
75367,Marketed,2018-01-03,02268272,Xyrem,1,N07XX04,Hydroxybutyric acid,Solution,Oral,02268272,XYREM (sodium oxybate 500 mg per mL oral solution) JAZZ PHARMACEUTICALS IRELAND LIMITED,Active,9004321,sodium oxybate 500 mg per mL oral solution,8002542,sodium oxybate,26643006,Oral,385023001,Oral solution,,,,,,Controlled Drugs (CDSA I)
101945,Marketed,2023-05-01,02530260,Riva-hydroxyUREA,1,L01XX05,Hydroxycarbamide,Capsule,Oral,02530260,RIVA-HYDROXYUREA (hydroxyurea 500 mg oral capsule) LABORATOIRE RIVA INC.,Active,9001850,hydroxyurea 500 mg oral capsule,8001662,hydroxyurea,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
3453,Marketed,2022-11-18,00465283,Hydrea,1,L01XX05,Hydroxycarbamide,Capsule,Oral,00465283,HYDREA (hydroxyurea 500 mg oral capsule) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9001850,hydroxyurea 500 mg oral capsule,8001662,hydroxyurea,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
66754,Marketed,2010-01-29,02242920,Mylan-hydroxyUREA,1,L01XX05,Hydroxycarbamide,Capsule,Oral,02242920,MYLAN-HYDROXYUREA (hydroxyurea 500 mg oral capsule) MYLAN PHARMACEUTICALS ULC,Active,9001850,hydroxyurea 500 mg oral capsule,8001662,hydroxyurea,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
72247,Marketed,2017-12-12,02247937,Apo-hydroxyUREA,1,L01XX05,Hydroxycarbamide,Capsule,Oral,02247937,APO-HYDROXYUREA (hydroxyurea 500 mg oral capsule) APOTEX INC,Active,9001850,hydroxyurea 500 mg oral capsule,8001662,hydroxyurea,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
100105,Marketed,2021-09-14,02511886,Nra-Hydroxychloroquine,1,P01BA02,Hydroxychloroquine,Tablet,Oral,02511886,NRA-HYDROXYCHLOROQUINE (hydroxychloroquine sulfate 200 mg oral tablet) NORA PHARMA INC,Active,9000018,hydroxychloroquine sulfate 200 mg oral tablet,8000012,hydroxychloroquine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100862,Marketed,2022-04-18,02519348,Hydroxychloroquine,1,P01BA02,Hydroxychloroquine,Tablet,Oral,02519348,HYDROXYCHLOROQUINE (hydroxychloroquine sulfate 200 mg oral tablet) SANIS HEALTH INC,Active,9000018,hydroxychloroquine sulfate 200 mg oral tablet,8000012,hydroxychloroquine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
14735,Marketed,2007-09-26,02017709,Plaquenil,1,P01BA02,Hydroxychloroquine,Tablet,Oral,02017709,PLAQUENIL (hydroxychloroquine sulfate 200 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9000018,hydroxychloroquine sulfate 200 mg oral tablet,8000012,hydroxychloroquine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
70886,Marketed,2002-12-13,02246691,Apo-Hydroxyquine,1,P01BA02,Hydroxychloroquine,Tablet,Oral,02246691,APO-HYDROXYQUINE (hydroxychloroquine sulfate 200 mg oral tablet) APOTEX INC,Active,9000018,hydroxychloroquine sulfate 200 mg oral tablet,8000012,hydroxychloroquine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90966,Marketed,2014-06-10,02424991,Mint-Hydroxychloroquine,1,P01BA02,Hydroxychloroquine,Tablet,Oral,02424991,MINT-HYDROXYCHLOROQUINE (hydroxychloroquine sulfate 200 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000018,hydroxychloroquine sulfate 200 mg oral tablet,8000012,hydroxychloroquine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98143,Marketed,2020-02-06,02491427,JAMP Hydroxychloroquine Sulfate,1,P01BA02,Hydroxychloroquine,Tablet,Oral,02491427,JAMP HYDROXYCHLOROQUINE SULFATE (hydroxychloroquine sulfate 200 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000018,hydroxychloroquine sulfate 200 mg oral tablet,8000012,hydroxychloroquine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76364,Marketed,2015-04-18,02278057,Voluven,1,B05AA07,Hydroxyethylstarch,Solution,Intravenous,,,,,,,,,,,,,,,,,Prescription
84242,Marketed,2015-11-26,02357291,Volulyte,1,B05AA07,Hydroxyethylstarch,Solution,Intravenous,,,,,,,,,,,,,,,,,Prescription
316,Marketed,2022-10-14,00024694,Atarax,1,N05BB01,Hydroxyzine,Syrup,Oral,00024694,ATARAX (hydroxyzine hydrochloride 10 mg per 5 mL syrup) SEARCHLIGHT PHARMA INC,Active,9000014,hydroxyzine hydrochloride 10 mg per 5 mL syrup,8000009,hydroxyzine,26643006,Oral,739009002,Syrup,,,,,,Prescription
7391,Marketed,2019-01-24,00646016,Hydroxyzine,1,N05BB01,Hydroxyzine,Capsule,Oral,00646016,HYDROXYZINE (hydroxyzine hydrochloride 50 mg oral capsule) AA PHARMA INC,Active,9000256,hydroxyzine hydrochloride 50 mg oral capsule,8000009,hydroxyzine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
7392,Marketed,2019-03-28,00646024,Hydroxyzine,1,N05BB01,Hydroxyzine,Capsule,Oral,00646024,HYDROXYZINE (hydroxyzine hydrochloride 25 mg oral capsule) AA PHARMA INC,Active,9000255,hydroxyzine hydrochloride 25 mg oral capsule,8000009,hydroxyzine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
7393,Marketed,2019-02-14,00646059,Hydroxyzine,1,N05BB01,Hydroxyzine,Capsule,Oral,00646059,HYDROXYZINE (hydroxyzine hydrochloride 10 mg oral capsule) AA PHARMA INC,Active,9000254,hydroxyzine hydrochloride 10 mg oral capsule,8000009,hydroxyzine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
8118,Marketed,2005-09-21,00742813,Hydroxyzine Hydrochloride Injection USP,1,N05BB01,Hydroxyzine,Liquid,Intramuscular,00742813,HYDROXYZINE HYDROCHLORIDE INJECTION USP (hydroxyzine hydrochloride 50 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000274,hydroxyzine hydrochloride 50 mg per 1 mL solution for injection vial,8000009,hydroxyzine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
74647,Marketed,2021-04-12,02261057,"Balance 1.5% Glucose, 1.25 Mmol/L Calcium",5,B05DB,Hypertonic solutions,Solution,Haemodialysis (intraperitoneal),,,,,,,,,,,,,,,,,Ethical
74648,Marketed,2021-05-17,02261065,"Balance 4.25% Glucose, 1.25 Mmol/L Calcium",5,B05DB,Hypertonic solutions,Solution,Haemodialysis (intraperitoneal),,,,,,,,,,,,,,,,,Ethical
74649,Marketed,2021-04-08,02261073,"Balance 2.3% Glucose, 1.25 Mmol/L Calcium",5,B05DB,Hypertonic solutions,Solution,Haemodialysis (intraperitoneal),,,,,,,,,,,,,,,,,Ethical
102892,Marketed,2023-11-13,02540215,Imbruvica,1,L01EL01,Ibrutinib,Suspension,Oral,02540215,IMBRUVICA (ibrutinib 70 mg per mL oral suspension) JANSSEN INC,Active,9014943,ibrutinib 70 mg per mL oral suspension,8001800,ibrutinib,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
91874,Marketed,2014-11-19,02434407,Imbruvica,1,L01EL01,Ibrutinib,Capsule,Oral,02434407,IMBRUVICA (ibrutinib 140 mg oral capsule) JANSSEN INC,Active,9005610,ibrutinib 140 mg oral capsule,8001800,ibrutinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
10294,Marketed,2020-11-05,00441643,Apo-Ibuprofen,1,M01AE01,Ibuprofen,Tablet,Oral,00441643,APO-IBUPROFEN (ibuprofen 200 mg oral tablet) APOTEX INC,Active,9000059,ibuprofen 200 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
103444,Marketed,2025-06-16,02545691,Ibuprofen Mini Liquid Capsules,1,M01AE01,Ibuprofen,Capsule,Oral,02545691,IBUPROFEN MINI LIQUID CAPSULES (ibuprofen 200 mg oral capsule) JUNO OTC INC,Active,9000921,ibuprofen 200 mg oral capsule,8000043,ibuprofen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
104264,Marketed,2025-12-30,02553724,JAMP Ibuprofen Suspension,1,M01AE01,Ibuprofen,Suspension,Oral,02553724,JAMP IBUPROFEN SUSPENSION (ibuprofen 100 mg per 5 mL oral suspension) JAMP PHARMA CORPORATION,Active,9000757,ibuprofen 100 mg per 5 mL oral suspension,8000043,ibuprofen,26643006,Oral,385024007,Oral suspension,,,,,,Non-Prescription Drugs
106345,Marketed,2026-03-19,02560380,Advil Migraine & Headache,1,M01AE01,Ibuprofen,Capsule,Oral,02560380,ADVIL MIGRAINE & HEADACHE (ibuprofen 400 mg oral capsule) HALEON CANADA ULC,Active,9001080,ibuprofen 400 mg oral capsule,8000043,ibuprofen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
13452,Marketed,2025-05-22,01933531,Advil Caplets,1,M01AE01,Ibuprofen,Tablet,Oral,01933531,ADVIL CAPLETS (ibuprofen 200 mg oral tablet) HALEON CANADA ULC,Active,9000059,ibuprofen 200 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
13625,Marketed,2025-05-22,01933558,Advil Tablets,1,M01AE01,Ibuprofen,Tablet,Oral,01933558,ADVIL TABLETS (ibuprofen 200 mg oral tablet) HALEON CANADA ULC,Active,9000059,ibuprofen 200 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
19585,Marketed,2026-03-01,02186934,Motrin 200 mg,1,M01AE01,Ibuprofen,Tablet,Oral,02186934,MOTRIN 200MG (ibuprofen 200 mg oral tablet) KENVUE CANADA INC.,Active,9000059,ibuprofen 200 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
51742,Marketed,2025-08-21,02232297,Children's Advil,1,M01AE01,Ibuprofen,Suspension,Oral,02232297,CHILDREN'S ADVIL (ibuprofen 100 mg per 5 mL oral suspension) HALEON CANADA ULC,Active,9000757,ibuprofen 100 mg per 5 mL oral suspension,8000043,ibuprofen,26643006,Oral,385024007,Oral suspension,,,,,,Non-Prescription Drugs
5432,Marketed,2020-11-05,00506052,Apo-Ibuprofen,1,M01AE01,Ibuprofen,Tablet,Oral,00506052,APO-IBUPROFEN (ibuprofen 400 mg oral tablet) APOTEX INC,Active,9000190,ibuprofen 400 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
5433,Marketed,2021-01-06,00441651,Apo-Ibuprofen,1,M01AE01,Ibuprofen,Tablet,Oral,00441651,APO-IBUPROFEN (ibuprofen 300 mg oral tablet) APOTEX INC,Active,9000189,ibuprofen 300 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
5917,Marketed,2020-12-28,00585114,Apo-Ibuprofen Tablets 600 mg,1,M01AE01,Ibuprofen,Tablet,Oral,00585114,APO-IBUPROFEN TAB 600MG (ibuprofen 600 mg oral tablet) APOTEX INC,Active,9000207,ibuprofen 600 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
62054,Marketed,2026-02-11,02238626,Infants' Motrin,1,M01AE01,Ibuprofen,Drops,Oral,02238626,INFANTS' MOTRIN (ibuprofen 40 mg per mL oral drops) KENVUE CANADA INC.,Active,9012636,ibuprofen 40 mg per mL oral drops,8000043,ibuprofen,26643006,Oral,385018001,Oral drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
65432,Marketed,2025-04-28,02241769,Advil Liqui-Gels,1,M01AE01,Ibuprofen,Capsule,Oral,02241769,ADVIL LIQUI-GELS (ibuprofen 200 mg oral capsule) HALEON CANADA ULC,Active,9000921,ibuprofen 200 mg oral capsule,8000043,ibuprofen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
66076,Marketed,2026-02-11,02242365,Children's Motrin,1,M01AE01,Ibuprofen,Suspension,Oral,02242365,CHILDREN'S MOTRIN (ibuprofen 100 mg per 5 mL oral suspension) KENVUE CANADA INC.,Active,9000757,ibuprofen 100 mg per 5 mL oral suspension,8000043,ibuprofen,26643006,Oral,385024007,Oral suspension,,,,,,Non-Prescription Drugs
66270,Marketed,2025-08-21,02242522,Advil Pediatric Drops,1,M01AE01,Ibuprofen,Drops,Oral,02242522,ADVIL PEDIATRIC DROPS (ibuprofen 40 mg per mL oral drops) HALEON CANADA ULC,Active,9012636,ibuprofen 40 mg per mL oral drops,8000043,ibuprofen,26643006,Oral,385018001,Oral drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
66413,Marketed,2026-03-01,02242632,Motrin 300 mg,1,M01AE01,Ibuprofen,Tablet,Oral,02242632,MOTRIN 300MG (ibuprofen 300 mg oral tablet) KENVUE CANADA INC.,Active,9000189,ibuprofen 300 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
66438,Marketed,2026-03-01,02242658,Motrin 400 mg,1,M01AE01,Ibuprofen,Tablet,Oral,02242658,MOTRIN 400MG (ibuprofen 400 mg oral tablet) KENVUE CANADA INC.,Active,9000190,ibuprofen 400 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
68562,Marketed,2025-05-22,02244577,Advil Extra Strength Caplets,1,M01AE01,Ibuprofen,Tablet,Oral,02244577,ADVIL EXTRA STRENGTH CAPLETS (ibuprofen 400 mg oral tablet) HALEON CANADA ULC,Active,9000190,ibuprofen 400 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
70575,Marketed,2025-08-21,02246403,Junior Strength Advil,1,M01AE01,Ibuprofen,Tablet (chewable),Oral,02246403,JUNIOR STRENGTH ADVIL (ibuprofen 100 mg chewable tablet) HALEON CANADA ULC,Active,9001018,ibuprofen 100 mg chewable tablet,8000043,ibuprofen,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
72567,Marketed,2025-04-28,02248231,Advil Extra Strength Liqui-Gels,1,M01AE01,Ibuprofen,Capsule,Oral,02248231,ADVIL EXTRA STRENGTH LIQUI-GELS (ibuprofen 400 mg oral capsule) HALEON CANADA ULC,Active,9001080,ibuprofen 400 mg oral capsule,8000043,ibuprofen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
74314,Marketed,2022-12-16,02257912,Ibuprofen 200 mg,1,M01AE01,Ibuprofen,Tablet,Oral,02257912,IBUPROFEN 200 MG (ibuprofen 200 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000059,ibuprofen 200 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
75835,Marketed,2021-12-01,02272849,Ibuprofen Tablets 200 mg,1,M01AE01,Ibuprofen,Tablet,Oral,02272849,IBUPROFEN TABLETS 200 MG (ibuprofen 200 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9000059,ibuprofen 200 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
75836,Marketed,2006-04-07,02272857,Ibuprofen Caplets 200 mg,1,M01AE01,Ibuprofen,Tablet,Oral,02272857,IBUPROFEN CAPLETS 200 MG (ibuprofen 200 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9000059,ibuprofen 200 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
76585,Marketed,2007-08-30,02280175,Children's Ibuprofen Suspension,1,M01AE01,Ibuprofen,Suspension,Oral,02280175,CHILDREN'S IBUPROFEN SUSPENSION (ibuprofen 100 mg per 5 mL oral suspension) PERRIGO INTERNATIONAL,Active,9000757,ibuprofen 100 mg per 5 mL oral suspension,8000043,ibuprofen,26643006,Oral,385024007,Oral suspension,,,,,,Non-Prescription Drugs
78292,Marketed,2026-02-26,02297582,Motrin Liquid Gels 200 mg,1,M01AE01,Ibuprofen,Capsule,Oral,02297582,MOTRIN LIQUID GELS 200MG (ibuprofen 200 mg oral capsule) KENVUE CANADA INC.,Active,9000921,ibuprofen 200 mg oral capsule,8000043,ibuprofen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
80029,Marketed,2020-10-16,02314754,Ibuprofen Tablets,1,M01AE01,Ibuprofen,Tablet,Oral,02314754,IBUPROFEN TABLETS (ibuprofen 200 mg oral tablet) PHARMASCIENCE INC,Active,9000059,ibuprofen 200 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
80030,Marketed,2020-10-16,02314762,Ibuprofen Caplets,1,M01AE01,Ibuprofen,Tablet,Oral,02314762,IBUPROFEN CAPLETS (ibuprofen 200 mg oral tablet) PHARMASCIENCE INC,Active,9000059,ibuprofen 200 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
80031,Marketed,2012-01-04,02314770,Extra Strength Ibuprofen,1,M01AE01,Ibuprofen,Tablet,Oral,02314770,EXTRA STRENGTH IBUPROFEN (ibuprofen 400 mg oral tablet) PHARMASCIENCE INC,Active,9000190,ibuprofen 400 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
80286,Marketed,2022-12-16,02317338,Ibuprofen 400 mg,1,M01AE01,Ibuprofen,Tablet,Oral,02317338,IBUPROFEN 400 MG (ibuprofen 400 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000190,ibuprofen 400 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
81395,Marketed,2025-08-21,02328429,Junior Strength Advil Fever From Colds Or Flu,1,M01AE01,Ibuprofen,Tablet (chewable),Oral,02328429,JUNIOR STRENGTH ADVIL FEVER FROM COLDS OR FLU (ibuprofen 100 mg chewable tablet) HALEON CANADA ULC,Active,9001018,ibuprofen 100 mg chewable tablet,8000043,ibuprofen,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
81396,Marketed,2025-08-21,02328437,Children's Advil Fever From Colds Or Flu,1,M01AE01,Ibuprofen,Suspension,Oral,02328437,CHILDREN'S ADVIL FEVER FROM COLDS OR FLU (ibuprofen 100 mg per 5 mL oral suspension) HALEON CANADA ULC,Active,9000757,ibuprofen 100 mg per 5 mL oral suspension,8000043,ibuprofen,26643006,Oral,385024007,Oral suspension,,,,,,Non-Prescription Drugs
84091,Marketed,2025-05-22,02355701,Advil Muscle And Joint,1,M01AE01,Ibuprofen,Tablet,Oral,02355701,ADVIL MUSCLE AND JOINT (ibuprofen 400 mg oral tablet) HALEON CANADA ULC,Active,9000190,ibuprofen 400 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
84240,Marketed,2011-03-31,02357275,Ibuprofen Liquid Capsules,1,M01AE01,Ibuprofen,Capsule,Oral,02357275,IBUPROFEN LIQUID CAPSULES (ibuprofen 200 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9000921,ibuprofen 200 mg oral capsule,8000043,ibuprofen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
84241,Marketed,2011-06-10,02357283,Extra Strength Ibuprofen Liquid Capsules,1,M01AE01,Ibuprofen,Capsule,Oral,02357283,EXTRA STRENGTH IBUPROFEN LIQUID CAPSULES (ibuprofen 400 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9001080,ibuprofen 400 mg oral capsule,8000043,ibuprofen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
85290,Marketed,2017-01-26,02368080,Ibuprofen Caplets,1,M01AE01,Ibuprofen,Tablet,Oral,02368080,IBUPROFEN CAPLETS (ibuprofen 200 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9000059,ibuprofen 200 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
85291,Marketed,2011-08-05,02368099,Ibuprofen Extra Strength Caplets,1,M01AE01,Ibuprofen,Tablet,Oral,02368099,IBUPROFEN EXTRA STRENGTH CAPLETS (ibuprofen 400 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9000190,ibuprofen 400 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
85942,Marketed,2016-11-10,02374226,Muscle & Joint,1,M01AE01,Ibuprofen,Tablet,Oral,02374226,MUSCLE & JOINT (ibuprofen 400 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9000190,ibuprofen 400 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
86208,Marketed,2016-09-15,02376598,Ibuprofen Liquid Gel Capsules,1,M01AE01,Ibuprofen,Capsule,Oral,02376598,IBUPROFEN LIQUID GEL CAPSULES (ibuprofen 200 mg oral capsule) APOTEX INC,Active,9000921,ibuprofen 200 mg oral capsule,8000043,ibuprofen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
86209,Marketed,2012-07-15,02376601,Extra Strength Ibuprofen Liquid Gel Capsules,1,M01AE01,Ibuprofen,Capsule,Oral,02376601,EXTRA STRENGTH IBUPROFEN LIQUID GEL CAPSULES (ibuprofen 400 mg oral capsule) APOTEX INC,Active,9001080,ibuprofen 400 mg oral capsule,8000043,ibuprofen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
86271,Marketed,2012-09-12,02377101,Ibuprofen Muscle And Joint,1,M01AE01,Ibuprofen,Tablet,Oral,02377101,IBUPROFEN MUSCLE AND JOINT (ibuprofen 400 mg oral tablet) PHARMASCIENCE INC,Active,9000190,ibuprofen 400 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
86413,Marketed,2026-02-26,02378310,Motrin Liquid Gels 400 mg,1,M01AE01,Ibuprofen,Capsule,Oral,02378310,MOTRIN LIQUID GELS 400 MG (ibuprofen 400 mg oral capsule) KENVUE CANADA INC.,Active,9001080,ibuprofen 400 mg oral capsule,8000043,ibuprofen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
90021,Marketed,2025-04-28,02415623,Advil Arthritis Pain,1,M01AE01,Ibuprofen,Capsule,Oral,02415623,ADVIL ARTHRITIS PAIN (ibuprofen 400 mg oral capsule) HALEON CANADA ULC,Active,9001080,ibuprofen 400 mg oral capsule,8000043,ibuprofen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
92408,Marketed,2021-02-17,02439689,Ibuprofen,1,M01AE01,Ibuprofen,Tablet,Oral,02439689,IBUPROFEN (ibuprofen 200 mg oral tablet) APOTEX INC,Active,9000059,ibuprofen 200 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
92825,Marketed,2025-05-22,02443562,Advil 12 Hour,1,M01AE01,Ibuprofen,Tablet (extended-release),Oral,02443562,ADVIL 12 HOUR (ibuprofen 600 mg prolonged-release oral tablet) HALEON CANADA ULC,Active,9001462,ibuprofen 600 mg prolonged-release oral tablet,8000043,ibuprofen,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
97565,Marketed,2024-08-23,02485400,Advil Mini-Gels,1,M01AE01,Ibuprofen,Capsule,Oral,02485400,ADVIL MINI-GELS (ibuprofen 200 mg oral capsule) HALEON CANADA ULC,Active,9000921,ibuprofen 200 mg oral capsule,8000043,ibuprofen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
98438,Marketed,2021-03-22,02494353,Ibuprofen Liquid Gels,1,M01AE01,Ibuprofen,Capsule,Oral,02494353,IBUPROFEN LIQUID GELS (ibuprofen 200 mg oral capsule) PHARMASCIENCE INC,Active,9000921,ibuprofen 200 mg oral capsule,8000043,ibuprofen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
14492,Marketed,2025-09-26,02036312,Advil Cold And Sinus,2,M01AE51,"Ibuprofen, combinations",Tablet,Oral,02036312,ADVIL COLD AND SINUS (ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet) HALEON CANADA ULC,Active,9002580,ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001387,ibuprofen and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
65897,Marketed,2026-05-15,02242217,Sudafed Sinus Advance,2,M01AE51,"Ibuprofen, combinations",Tablet,Oral,02242217,SUDAFED SINUS ADVANCE (ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet) KENVUE CANADA INC.,Active,9002580,ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001387,ibuprofen and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
73002,Marketed,2025-05-16,02248645,Advil Cold & Sinus Plus,3,M01AE51,"Ibuprofen, combinations",Tablet,Oral,02248645,ADVIL COLD & SINUS PLUS (chlorpheniramine maleate 2 mg and ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet) HALEON CANADA ULC,Active,9003926,chlorpheniramine maleate 2 mg and ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001355,chlorpheniramine and ibuprofen and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
73565,Marketed,2025-09-26,02250705,Advil Cold & Sinus Liqui-Gels,2,M01AE51,"Ibuprofen, combinations",Capsule,Oral,02250705,ADVIL COLD & SINUS LIQUI-GELS (ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral capsule) HALEON CANADA ULC,Active,9004057,ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral capsule,8001387,ibuprofen and pseudoephedrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
75302,Marketed,2025-09-26,02267616,Advil Cold And Sinus Daytime,2,M01AE51,"Ibuprofen, combinations",Tablet,Oral,02267616,ADVIL COLD AND SINUS DAYTIME (ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet) HALEON CANADA ULC,Active,9002580,ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001387,ibuprofen and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
75304,Marketed,2025-05-16,02267632,Advil Cold And Sinus Nighttime,3,M01AE51,"Ibuprofen, combinations",Tablet,Oral,02267632,ADVIL COLD AND SINUS NIGHTTIME (chlorpheniramine maleate 2 mg and ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet) HALEON CANADA ULC,Active,9003926,chlorpheniramine maleate 2 mg and ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001355,chlorpheniramine and ibuprofen and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
83757,Marketed,2011-10-14,02352281,Cold + Sinus,2,M01AE51,"Ibuprofen, combinations",Tablet,Oral,02352281,COLD + SINUS (ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9002580,ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001387,ibuprofen and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
84104,Marketed,2025-08-28,02355841,Advil Nighttime,2,M01AE51,"Ibuprofen, combinations",Capsule,Oral,02355841,ADVIL NIGHTTIME (diphenhydramine hydrochloride 25 mg and ibuprofen 200 mg oral capsule) HALEON CANADA ULC,Active,9004807,diphenhydramine hydrochloride 25 mg and ibuprofen 200 mg oral capsule,8001188,diphenhydramine and ibuprofen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
84427,Marketed,2011-04-19,02359243,Cold + Sinus Plus,3,M01AE51,"Ibuprofen, combinations",Tablet,Oral,02359243,COLD + SINUS PLUS (chlorpheniramine maleate 2 mg and ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9003926,chlorpheniramine maleate 2 mg and ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001355,chlorpheniramine and ibuprofen and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
87360,Marketed,2014-05-23,02388030,Cold + Sinus Daytime Cold + Sinus Nighttime,5,M01AE51,"Ibuprofen, combinations","Tablet,Kit",Oral,02388030,COLD + SINUS DAYTIME COLD + SINUS NIGHTTIME (chlorpheniramine maleate 2 mg and ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet with ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9012940,chlorpheniramine maleate 2 mg and ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet with ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001355,chlorpheniramine and ibuprofen and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
88459,Marketed,2026-02-26,02399733,Advil Cold & Sinus Convenience Pack,5,M01AE51,"Ibuprofen, combinations","Tablet,Kit",Oral,02399733,ADVIL COLD & SINUS CONVENIENCE PACK (chlorpheniramine maleate 2 mg and ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet with ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet) HALEON CANADA ULC,Active,9012940,chlorpheniramine maleate 2 mg and ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet with ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001355,chlorpheniramine and ibuprofen and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
88592,Marketed,2025-08-05,02401193,Advil Flu,2,M01AE51,"Ibuprofen, combinations",Capsule,Oral,02401193,ADVIL FLU (diphenhydramine hydrochloride 25 mg and ibuprofen 200 mg oral capsule) HALEON CANADA ULC,Active,9004807,diphenhydramine hydrochloride 25 mg and ibuprofen 200 mg oral capsule,8001188,diphenhydramine and ibuprofen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
96076,Marketed,2025-05-16,02471604,"Advil Cold, Sinus & Flu Extra Strength",3,M01AE51,"Ibuprofen, combinations",Tablet,Oral,02471604,"ADVIL COLD, SINUS & FLU EXTRA STRENGTH (chlorpheniramine maleate 4 mg and ibuprofen 400 mg and pseudoephedrine hydrochloride 60 mg oral tablet) HALEON CANADA ULC",Active,9013044,chlorpheniramine maleate 4 mg and ibuprofen 400 mg and pseudoephedrine hydrochloride 60 mg oral tablet,8001355,chlorpheniramine and ibuprofen and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
66196,Marketed,2017-10-03,02242470,Corvert,1,C01BD05,Ibutilide,Solution,Intravenous,02242470,CORVERT (ibutilide fumarate 1 mg per 10 mL solution for injection vial) PFIZER CANADA ULC,Active,9012576,ibutilide fumarate 1 mg per 10 mL solution for injection vial,8001108,ibutilide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
103650,Marketed,2024-10-04,02547562,Icatibant Injection,1,B06AC02,Icatibant,Solution,Subcutaneous,02547562,ICATIBANT INJECTION (icatibant (icatibant acetate) 30 mg per 3 mL solution for injection syringe) JAMP PHARMA CORPORATION,Active,9013298,icatibant (icatibant acetate) 30 mg per 3 mL solution for injection syringe,8001801,icatibant,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
91034,Marketed,2021-07-21,02425696,Firazyr,1,B06AC02,Icatibant,Solution,Subcutaneous,02425696,FIRAZYR (icatibant (icatibant acetate) 30 mg per 3 mL solution for injection syringe) TAKEDA CANADA INC,Active,9013298,icatibant (icatibant acetate) 30 mg per 3 mL solution for injection syringe,8001801,icatibant,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
89467,Marketed,2014-11-04,02410028,IDArubicin,1,L01DB06,Idarubicin,Solution,Intravenous,77700786,IDARUBICIN (idarubicin hydrochloride 20 mg per 20 mL solution for injection vial) PFIZER CANADA ULC,Active,9013156,idarubicin hydrochloride 20 mg per 20 mL solution for injection vial,8001802,idarubicin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
89467,Marketed,2014-11-04,02410028,IDArubicin,1,L01DB06,Idarubicin,Solution,Intravenous,77700787,IDARUBICIN (idarubicin hydrochloride 10 mg per 10 mL solution for injection vial) PFIZER CANADA ULC,Active,9013155,idarubicin hydrochloride 10 mg per 10 mL solution for injection vial,8001802,idarubicin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
89467,Marketed,2014-11-04,02410028,IDArubicin,1,L01DB06,Idarubicin,Solution,Intravenous,77700788,IDARUBICIN (idarubicin hydrochloride 5 mg per 5 mL solution for injection vial) PFIZER CANADA ULC,Active,9013157,idarubicin hydrochloride 5 mg per 5 mL solution for injection vial,8001802,idarubicin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
94091,Marketed,2016-05-24,02454343,Praxbind,1,V03AB37,Idarucizimab,Solution,Intravenous,02454343,PRAXBIND (idarucizumab 2500 mg per 50 mL solution for injection vial) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9013158,idarucizumab 2500 mg per 50 mL solution for injection vial,8001803,idarucizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
94091,Marketed,2016-05-24,02454343,Praxbind,1,V03AB37,Idarucizimab,Solution,Intravenous,02454343,PRAXBIND (idarucizumab 2500 mg per 50 mL solution for injection vial) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9013158,idarucizumab 2500 mg per 50 mL solution for injection vial,8001803,idarucizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
92318,Marketed,2015-04-21,02438798,Zydelig,1,L01EM01,Idelalisib,Tablet,Oral,02438798,ZYDELIG (idelalisib 100 mg oral tablet) GILEAD SCIENCES CANADA INC,Active,9005701,idelalisib 100 mg oral tablet,8001804,idelalisib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92319,Marketed,2015-04-21,02438801,Zydelig,1,L01EM01,Idelalisib,Tablet,Oral,02438801,ZYDELIG (idelalisib 150 mg oral tablet) GILEAD SCIENCES CANADA INC,Active,9005702,idelalisib 150 mg oral tablet,8001804,idelalisib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78165,Marketed,2021-02-11,02296314,Elaprase,1,A16AB09,Idursulfase,Solution,Intravenous,02296314,ELAPRASE (idursulfase 6 mg per 3 mL solution for injection vial) TAKEDA CANADA INC,Active,9013159,idursulfase 6 mg per 3 mL solution for injection vial,8001805,idursulfase,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
78165,Marketed,2021-02-11,02296314,Elaprase,1,A16AB09,Idursulfase,Solution,Intravenous,02296314,ELAPRASE (idursulfase 6 mg per 3 mL solution for injection vial) TAKEDA CANADA INC,Active,9013159,idursulfase 6 mg per 3 mL solution for injection vial,8001805,idursulfase,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
64988,Marketed,2003-09-09,02241356,Ifex,1,L01AA06,Ifosfamide,Powder for solution,Intravenous,02241356,IFEX (ifosfamide 3 g per vial powder for solution for injection) BAXTER CORPORATION,Active,9003555,ifosfamide 3 g per vial powder for solution for injection,8001806,ifosfamide,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
64989,Marketed,2003-09-09,02241357,Ifex,1,L01AA06,Ifosfamide,Powder for solution,Intravenous,02241357,IFEX (ifosfamide 1 g per vial powder for solution for injection) BAXTER CORPORATION,Active,9003576,ifosfamide 1 g per vial powder for solution for injection,8001806,ifosfamide,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
101043,Marketed,2024-04-29,02521202,iMAtinib,1,L01EA01,Imatinib,Tablet,Oral,02521202,IMATINIB (imatinib (imatinib mesylate) 100 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9004037,imatinib (imatinib mesylate) 100 mg oral tablet,8001807,imatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101045,Marketed,2024-04-29,02521210,iMAtinib,1,L01EA01,Imatinib,Tablet,Oral,02521210,IMATINIB (imatinib (imatinib mesylate) 400 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9003965,imatinib (imatinib mesylate) 400 mg oral tablet,8001807,imatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
73824,Marketed,2005-04-05,02253275,Gleevec,1,L01EA01,Imatinib,Tablet,Oral,02253275,GLEEVEC (imatinib (imatinib mesylate) 100 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9004037,imatinib (imatinib mesylate) 100 mg oral tablet,8001807,imatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
73825,Marketed,2004-10-25,02253283,Gleevec,1,L01EA01,Imatinib,Tablet,Oral,02253283,GLEEVEC (imatinib (imatinib mesylate) 400 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9003965,imatinib (imatinib mesylate) 400 mg oral tablet,8001807,imatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
84058,Marketed,2013-04-19,02355337,Apo-iMAtinib,1,L01EA01,Imatinib,Tablet,Oral,02355337,APO-IMATINIB (imatinib (imatinib mesylate) 100 mg oral tablet) APOTEX INC,Active,9004037,imatinib (imatinib mesylate) 100 mg oral tablet,8001807,imatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
84059,Marketed,2013-04-19,02355345,Apo-iMAtinib,1,L01EA01,Imatinib,Tablet,Oral,02355345,APO-IMATINIB (imatinib (imatinib mesylate) 400 mg oral tablet) APOTEX INC,Active,9003965,imatinib (imatinib mesylate) 400 mg oral tablet,8001807,imatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
88225,Marketed,2017-08-11,02397285,Nat-iMAtinib,1,L01EA01,Imatinib,Tablet,Oral,02397285,NAT-IMATINIB (imatinib (imatinib mesylate) 100 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9004037,imatinib (imatinib mesylate) 100 mg oral tablet,8001807,imatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
88226,Marketed,2017-08-11,02397293,Nat-iMAtinib,1,L01EA01,Imatinib,Tablet,Oral,02397293,NAT-IMATINIB (imatinib (imatinib mesylate) 400 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9003965,imatinib (imatinib mesylate) 400 mg oral tablet,8001807,imatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
88465,Marketed,2013-04-02,02399806,Teva-iMAtinib,1,L01EA01,Imatinib,Tablet,Oral,02399806,TEVA-IMATINIB (imatinib (imatinib mesylate) 100 mg oral tablet) TEVA CANADA LIMITED,Active,9004037,imatinib (imatinib mesylate) 100 mg oral tablet,8001807,imatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
88466,Marketed,2013-05-22,02399814,Teva-iMAtinib,1,L01EA01,Imatinib,Tablet,Oral,02399814,TEVA-IMATINIB (imatinib (imatinib mesylate) 400 mg oral tablet) TEVA CANADA LIMITED,Active,9003965,imatinib (imatinib mesylate) 400 mg oral tablet,8001807,imatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98101,Marketed,2020-11-24,02490986,ACH-iMAtinib,1,L01EA01,Imatinib,Tablet,Oral,02490986,ACH-IMATINIB (imatinib (imatinib mesylate) 100 mg oral tablet) ACCORD HEALTHCARE INC,Active,9004037,imatinib (imatinib mesylate) 100 mg oral tablet,8001807,imatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98102,Marketed,2020-11-24,02490994,ACH-iMAtinib,1,L01EA01,Imatinib,Tablet,Oral,02490994,ACH-IMATINIB (imatinib (imatinib mesylate) 400 mg oral tablet) ACCORD HEALTHCARE INC,Active,9003965,imatinib (imatinib mesylate) 400 mg oral tablet,8001807,imatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98235,Marketed,2020-06-19,02492334,Mint-iMAtinib,1,L01EA01,Imatinib,Tablet,Oral,02492334,MINT-IMATINIB (imatinib (imatinib mesylate) 100 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9004037,imatinib (imatinib mesylate) 100 mg oral tablet,8001807,imatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98236,Marketed,2020-06-19,02492342,Mint-iMAtinib,1,L01EA01,Imatinib,Tablet,Oral,02492342,MINT-IMATINIB (imatinib (imatinib mesylate) 400 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9003965,imatinib (imatinib mesylate) 400 mg oral tablet,8001807,imatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99400,Marketed,2021-04-07,02504596,iMAtinib,1,L01EA01,Imatinib,Tablet,Oral,02504596,IMATINIB (imatinib (imatinib mesylate) 100 mg oral tablet) SANIS HEALTH INC,Active,9004037,imatinib (imatinib mesylate) 100 mg oral tablet,8001807,imatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99401,Marketed,2021-04-07,02504618,iMAtinib,1,L01EA01,Imatinib,Tablet,Oral,02504618,IMATINIB (imatinib (imatinib mesylate) 400 mg oral tablet) SANIS HEALTH INC,Active,9003965,imatinib (imatinib mesylate) 400 mg oral tablet,8001807,imatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
10748,Marketed,2022-03-10,00611174,Lotriderm,2,D01AC20,Imidazoles/triazoles in combination with corticosteroids,Cream,Topical,00611174,LOTRIDERM (betamethasone (betamethasone dipropionate) 0.05 % and clotrimazole 1 % cutaneous cream) ORGANON CANADA INC.,Active,9002245,betamethasone (betamethasone dipropionate) 0.05 % and clotrimazole 1 % cutaneous cream,8000846,betamethasone dipropionate and clotrimazole,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
98629,Marketed,2020-04-06,02496410,Taro-Clotrimazole/Betamethasone Dipropionate,2,D01AC20,Imidazoles/triazoles in combination with corticosteroids,Cream,Topical,02496410,TARO-CLOTRIMAZOLE/BETAMETHASONE DIPROPIONATE (betamethasone (betamethasone dipropionate) 0.05 % and clotrimazole 1 % cutaneous cream) TARO PHARMACEUTICALS INC,Active,9002245,betamethasone (betamethasone dipropionate) 0.05 % and clotrimazole 1 % cutaneous cream,8000846,betamethasone dipropionate and clotrimazole,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
65414,Marketed,2025-03-06,02241751,Cerezyme,1,A16AB02,Imiglucerase,Powder for solution,Intravenous,02241751,CEREZYME (imiglucerase 400 unit per vial powder for solution for injection) SANOFI-AVENTIS CANADA INC,Active,9003496,imiglucerase 400 unit per vial powder for solution for injection,8001808,imiglucerase,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
65414,Marketed,2025-03-06,02241751,Cerezyme,1,A16AB02,Imiglucerase,Powder for solution,Intravenous,02241751,CEREZYME (imiglucerase 400 unit per vial powder for solution for injection) SANOFI-AVENTIS CANADA INC,Active,9003496,imiglucerase 400 unit per vial powder for solution for injection,8001808,imiglucerase,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
83696,Marketed,2021-05-31,02351706,Taro-Imipenem-Cilastatin,2,J01DH51,Imipenem and cilastatin,Powder for solution,Intravenous,02351706,TARO-IMIPENEM-CILASTATIN (cilastatin (cilastatin sodium) 500 mg per vial and imipenem 500 mg per vial powder for solution for injection) SUN PHARMA CANADA INC,Active,9002101,cilastatin (cilastatin sodium) 500 mg per vial and imipenem 500 mg per vial powder for solution for injection,8001358,cilastatin and imipenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
84340,Marketed,2010-12-21,02358344,Imipenem And Cilastatin For Injection USP,2,J01DH51,Imipenem and cilastatin,Powder for solution,Intravenous,02358344,IMIPENEM AND CILASTATIN FOR INJECTION USP (cilastatin (cilastatin sodium) 500 mg per vial and imipenem 500 mg per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9002101,cilastatin (cilastatin sodium) 500 mg per vial and imipenem 500 mg per vial powder for solution for injection,8001358,cilastatin and imipenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
106794,Marketed,2026-05-07,02565323,Recarbrio,3,J01DH56,"Imipenem, cilastatin and relebactam",Powder for solution,Intravenous,02565323,RECARBRIO (cilastatin (cilastatin sodium) 500 mg per vial and imipenem 500 mg per vial and relebactam 250 mg per vial powder for solution for injection) MERCK CANADA INC,Active,9015412,cilastatin (cilastatin sodium) 500 mg per vial and imipenem 500 mg per vial and relebactam 250 mg per vial powder for solution for injection,8002594,cilastatin and imipenem and relebactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,,,,Prescription
10008,Marketed,2026-01-20,00644579,Apo-Imipramine Tablets,1,N06AA02,Imipramine,Tablet,Oral,00644579,APO-IMIPRAMINE TABLETS (imipramine hydrochloride 75 mg oral tablet) APOTEX INC,Active,9002199,imipramine hydrochloride 75 mg oral tablet,8001388,imipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103504,Marketed,2024-11-29,02546337,JAMP Imipramine,1,N06AA02,Imipramine,Tablet,Oral,02546337,JAMP IMIPRAMINE (imipramine hydrochloride 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001672,imipramine hydrochloride 10 mg oral tablet,8001388,imipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103505,Marketed,2024-11-29,02546345,JAMP Imipramine,1,N06AA02,Imipramine,Tablet,Oral,02546345,JAMP IMIPRAMINE (imipramine hydrochloride 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001673,imipramine hydrochloride 25 mg oral tablet,8001388,imipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103506,Marketed,2024-11-29,02546353,JAMP Imipramine,1,N06AA02,Imipramine,Tablet,Oral,02546353,JAMP IMIPRAMINE (imipramine hydrochloride 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001674,imipramine hydrochloride 50 mg oral tablet,8001388,imipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103507,Marketed,2024-11-29,02546361,JAMP Imipramine,1,N06AA02,Imipramine,Tablet,Oral,02546361,JAMP IMIPRAMINE (imipramine hydrochloride 75 mg oral tablet) JAMP PHARMA CORPORATION,Active,9002199,imipramine hydrochloride 75 mg oral tablet,8001388,imipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
2211,Marketed,2026-01-20,00312797,Apo-Imipramine Tablets,1,N06AA02,Imipramine,Tablet,Oral,00312797,APO-IMIPRAMINE TABLETS (imipramine hydrochloride 25 mg oral tablet) APOTEX INC,Active,9001673,imipramine hydrochloride 25 mg oral tablet,8001388,imipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
2212,Marketed,2026-01-20,00326852,Apo-Imipramine Tablets,1,N06AA02,Imipramine,Tablet,Oral,00326852,APO-IMIPRAMINE TABLETS (imipramine hydrochloride 50 mg oral tablet) APOTEX INC,Active,9001674,imipramine hydrochloride 50 mg oral tablet,8001388,imipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
2444,Marketed,2026-01-20,00360201,Apo-Imipramine Tablets,1,N06AA02,Imipramine,Tablet,Oral,00360201,APO-IMIPRAMINE TABLETS (imipramine hydrochloride 10 mg oral tablet) APOTEX INC,Active,9001672,imipramine hydrochloride 10 mg oral tablet,8001388,imipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
62979,Marketed,2019-06-18,02239505,Aldara P,1,D06BB10,Imiquimod,Cream,Topical,77701004,"ALDARA P (imiquimod 5 % cutaneous cream sachet) BAUSCH HEALTH, CANADA INC.",Active,9013910,imiquimod 5 % cutaneous cream sachet,8001809,imiquimod,448598008,Cutaneous,421628006,Cutaneous cream,733013000,Sachet (unit of presentation),,,,Prescription
62979,Marketed,2019-06-18,02239505,Aldara P,1,D06BB10,Imiquimod,Cream,Topical,77701005,"ALDARA P (imiquimod 5 % cutaneous cream pump) BAUSCH HEALTH, CANADA INC.",Active,9013909,imiquimod 5 % cutaneous cream pump,8001809,imiquimod,448598008,Cutaneous,421628006,Cutaneous cream,732981002,Actuation (unit of presentation),,,,Prescription
82603,Marketed,2020-10-30,02340445,Zyclara,1,D06BB10,Imiquimod,Cream,Topical,77701006,"ZYCLARA (imiquimod 3.75 % cutaneous cream pump) BAUSCH HEALTH, CANADA INC.",Active,9013907,imiquimod 3.75 % cutaneous cream pump,8001809,imiquimod,448598008,Cutaneous,421628006,Cutaneous cream,732981002,Actuation (unit of presentation),,,,Prescription
82603,Marketed,2020-10-30,02340445,Zyclara,1,D06BB10,Imiquimod,Cream,Topical,77701007,"ZYCLARA (imiquimod 3.75 % cutaneous cream sachet) BAUSCH HEALTH, CANADA INC.",Active,9013908,imiquimod 3.75 % cutaneous cream sachet,8001809,imiquimod,448598008,Cutaneous,421628006,Cutaneous cream,733013000,Sachet (unit of presentation),,,,Prescription
85046,Marketed,2019-07-02,02365561,Vyloma,1,D06BB10,Imiquimod,Cream,Topical,77701008,"VYLOMA (imiquimod 3.75 % cutaneous cream sachet) BAUSCH HEALTH, CANADA INC.",Active,9013908,imiquimod 3.75 % cutaneous cream sachet,8001809,imiquimod,448598008,Cutaneous,421628006,Cutaneous cream,733013000,Sachet (unit of presentation),,,,Prescription
85046,Marketed,2019-07-02,02365561,Vyloma,1,D06BB10,Imiquimod,Cream,Topical,77701009,"VYLOMA (imiquimod 3.75 % cutaneous cream pump) BAUSCH HEALTH, CANADA INC.",Active,9013907,imiquimod 3.75 % cutaneous cream pump,8001809,imiquimod,448598008,Cutaneous,421628006,Cutaneous cream,732981002,Actuation (unit of presentation),,,,Prescription
97338,Marketed,2019-01-23,02482983,Taro-Imiquimod Pump,1,D06BB10,Imiquimod,Cream,Topical,02482983,TARO-IMIQUIMOD PUMP (imiquimod 5 % cutaneous cream pump) TARO PHARMACEUTICALS INC,Active,9013909,imiquimod 5 % cutaneous cream pump,8001809,imiquimod,448598008,Cutaneous,421628006,Cutaneous cream,732981002,Actuation (unit of presentation),,,,Prescription
101339,Marketed,2023-11-07,02524368,Hyqvia,2,J06BA01,"Immunoglobulins, normal human, for extravasc. adm",Solution,Subcutaneous,,,,,,,,,,,,,,,,,Schedule D
101340,Marketed,2023-11-07,02524376,Hyqvia,2,J06BA01,"Immunoglobulins, normal human, for extravasc. adm",Solution,Subcutaneous,,,,,,,,,,,,,,,,,Schedule D
101341,Marketed,2023-11-07,02524384,Hyqvia,2,J06BA01,"Immunoglobulins, normal human, for extravasc. adm",Solution,Subcutaneous,,,,,,,,,,,,,,,,,Schedule D
101342,Marketed,2023-11-07,02524392,Hyqvia,2,J06BA01,"Immunoglobulins, normal human, for extravasc. adm",Solution,Subcutaneous,,,,,,,,,,,,,,,,,Schedule D
101343,Marketed,2023-11-07,02524406,Hyqvia,2,J06BA01,"Immunoglobulins, normal human, for extravasc. adm",Solution,Subcutaneous,,,,,,,,,,,,,,,,,Schedule D
102422,Marketed,2024-02-15,02535424,Hizentra,1,J06BA01,"Immunoglobulins, normal human, for extravasc. adm",Solution,Subcutaneous,,,,,,,,,,,,,,,,,Schedule D
94943,Marketed,2021-12-03,02461692,Cuvitru,1,J06BA01,"Immunoglobulins, normal human, for extravasc. adm",Solution,Subcutaneous,,,,,,,,,,,,,,,,,Schedule D
95095,Marketed,2017-09-21,02463059,Hizentra,1,J06BA01,"Immunoglobulins, normal human, for extravasc. adm",Solution,Subcutaneous,,,,,,,,,,,,,,,,,Schedule D
95096,Marketed,2017-09-21,02463067,Hizentra,1,J06BA01,"Immunoglobulins, normal human, for extravasc. adm",Solution,Subcutaneous,,,,,,,,,,,,,,,,,Schedule D
97678,Marketed,2020-03-27,02486598,Gamastan,1,J06BA01,"Immunoglobulins, normal human, for extravasc. adm",Solution,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
98804,Marketed,2021-05-13,02498251,Hizentra,1,J06BA01,"Immunoglobulins, normal human, for extravasc. adm",Solution,Subcutaneous,,,,,,,,,,,,,,,,,Schedule D
50794,Marketed,2022-02-09,02231470,Gammagard S/D,1,J06BA02,"Immunoglobulins, normal human, for intravasc. adm.","Solution,Powder for solution,Kit",Intravenous,,,,,,,,,,,,,,,,,Schedule D
72002,Marketed,2012-09-11,02247724,Gamunex,1,J06BA02,"Immunoglobulins, normal human, for intravasc. adm.",Solution,"Intravenous,Subcutaneous",,,,,,,,,,,,,,,,,Schedule D
76352,Marketed,2012-10-09,02277921,Igivnex,1,J06BA02,"Immunoglobulins, normal human, for intravasc. adm.",Solution,"Subcutaneous,Intravenous",,,,,,,,,,,,,,,,,Schedule D
76503,Marketed,2021-12-06,02279444,Gammagard Liquid,1,J06BA02,"Immunoglobulins, normal human, for intravasc. adm.",Solution,Intravenous,,,,,,,,,,,,,,,,,Schedule D
78988,Marketed,2009-01-08,02304619,Privigen,1,J06BA02,"Immunoglobulins, normal human, for intravasc. adm.",Solution,Intravenous,,,,,,,,,,,,,,,,,Schedule D
104427,Marketed,2025-04-10,02555476,Itovebi,1,L01EM06,Inavolisib,Tablet,Oral,02555476,ITOVEBI (inavolisib 3 mg oral tablet) HOFFMANN-LA ROCHE LIMITED,Active,9015188,inavolisib 3 mg oral tablet,8002537,inavolisib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,,Prescription Recommended
104428,Marketed,2025-04-10,02555484,Itovebi,1,L01EM06,Inavolisib,Tablet,Oral,02555484,ITOVEBI (inavolisib 9 mg oral tablet) HOFFMANN-LA ROCHE LIMITED,Active,9015189,inavolisib 9 mg oral tablet,8002537,inavolisib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,,Prescription
100766,Marketed,2022-09-26,02518376,Leqvio,1,C10AX16,Inclisiran,Solution,Subcutaneous,02518376,LEQVIO (inclisiran (inclisiran sodium) 284 mg per 1.5 mL solution for injection syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014795,inclisiran (inclisiran sodium) 284 mg per 1.5 mL solution for injection syringe,8002444,inclisiran,738984000,Parenteral,385219001,solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
90285,Marketed,2014-03-05,02418282,Ultibro Breezhaler,2,R03AL04,Indacaterol and glycopyrronium bromide,Capsule,Inhalation,02418282,ULTIBRO BREEZHALER (glycopyrronium (glycopyrronium bromide) 50 mcg and indacaterol (indacaterol maleate) 110 mcg inhalation powder capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9005460,glycopyrronium (glycopyrronium bromide) 50 mcg and indacaterol (indacaterol maleate) 110 mcg inhalation powder capsule,8001083,glycopyrronium and indacaterol,447694001,Inhalation,385207009,Powder for inhalation,732937005,Capsule,,,,Prescription
98847,Marketed,2020-08-19,02498685,Atectura Breezhaler,2,R03AK14,Indacaterol and mometasone,Capsule,Inhalation,02498685,ATECTURA BREEZHALER (indacaterol (indacaterol acetate) 150 mcg and mometasone furoate 80 mcg inhalation powder capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014347,indacaterol (indacaterol acetate) 150 mcg and mometasone furoate 80 mcg inhalation powder capsule,8002339,indacaterol and mometasone,447694001,Respiratory tract,385207009,Powder for inhalation,732937005,Capsule,,,,Prescription
98848,Marketed,2020-08-19,02498693,Atectura Breezhaler,2,R03AK14,Indacaterol and mometasone,Capsule,Inhalation,02498693,ATECTURA BREEZHALER (indacaterol (indacaterol acetate) 150 mcg and mometasone furoate 320 mcg inhalation powder capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014346,indacaterol (indacaterol acetate) 150 mcg and mometasone furoate 320 mcg inhalation powder capsule,8002339,indacaterol and mometasone,447694001,Respiratory tract,385207009,Powder for inhalation,732937005,Capsule,,,,Prescription
98849,Marketed,2020-08-19,02498707,Atectura Breezhaler,2,R03AK14,Indacaterol and mometasone,Capsule,Inhalation,02498707,ATECTURA BREEZHALER (indacaterol (indacaterol acetate) 150 mcg and mometasone furoate 160 mcg inhalation powder capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014345,indacaterol (indacaterol acetate) 150 mcg and mometasone furoate 160 mcg inhalation powder capsule,8002339,indacaterol and mometasone,447694001,Respiratory tract,385207009,Powder for inhalation,732937005,Capsule,,,,Prescription
99087,Marketed,2020-11-05,02501244,Enerzair Breezhaler,3,R03AL12,"Indacaterol, glycopyrronium bromide and mometasone",Capsule,Inhalation,02501244,ENERZAIR BREEZHALER (glycopyrronium (glycopyrronium bromide) 50 mcg and indacaterol (indacaterol acetate) 150 mcg and mometasone furoate 160 mcg inhalation powder capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014399,glycopyrronium (glycopyrronium bromide) 50 mcg and indacaterol (indacaterol acetate) 150 mcg and mometasone furoate 160 mcg inhalation powder capsule,8002349,glycopyrronium and indacaterol and mometasone,447694001,Respiratory tract,385207009,Powder for inhalation,732937005,Capsule,,,,Prescription
18065,Marketed,2009-11-16,02153483,Mylan-Indapamide,1,C03BA11,Indapamide,Tablet,Oral,02153483,MYLAN-INDAPAMIDE (indapamide 2.5 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000177,indapamide 2.5 mg oral tablet,8000097,indapamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
43381,Marketed,2002-01-22,02223678,Apo-Indapamide 2.5 mg Tablets,1,C03BA11,Indapamide,Tablet,Oral,02223678,APO-INDAPAMIDE 2.5MG TABLETS (indapamide 2.5 mg oral tablet) APOTEX INC,Active,9000177,indapamide 2.5 mg oral tablet,8000097,indapamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
63577,Marketed,2009-11-13,02240067,Mylan-Indapamide,1,C03BA11,Indapamide,Tablet,Oral,02240067,MYLAN-INDAPAMIDE (indapamide 1.25 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000587,indapamide 1.25 mg oral tablet,8000097,indapamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
69270,Marketed,2002-11-08,02245246,Apo-Indapamide 1.25 mg Tablets,1,C03BA11,Indapamide,Tablet,Oral,02245246,APO-INDAPAMIDE 1.25 MG TABLETS (indapamide 1.25 mg oral tablet) APOTEX INC,Active,9000587,indapamide 1.25 mg oral tablet,8000097,indapamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81467,Marketed,2019-02-26,02329026,Indium (111 In) Oxine Solution,1,V09HB,Indium 111 in compounds,Solution,Intravenous,,,,,,,,,,,,,,,,,Schedule C
81479,Marketed,2019-02-26,02329093,Indium Dtpa In 111,1,V09AX01,Indium 111 in pentetic acid,Solution,Intrathecal,,,,,,,,,,,,,,,,,Schedule C
81497,Marketed,2019-10-06,02329271,Octreoscan,2,V09IB01,Indium 111 in pentetreotide,"Solution,Powder for solution,Kit",Intravenous,,,,,,,,,,,,,,,,,Schedule C
101703,Marketed,2023-11-09,02527839,SPY Agent Green Kit For Advanced Imaging Modality (Aim) And Pinpoint,1,V04CX01,Indocyanine green,"Powder for solution,Kit",Intravenous,,,,,,,,,,,,,,,,,Ethical
97402,Marketed,2023-11-08,02483653,SPY Agent Green,1,V04CX01,Indocyanine green,Powder for solution,"Interstitial,Intradermal,Intravenous",,,,,,,,,,,,,,,,,Ethical
97403,Marketed,2023-11-09,02483661,SPY Agent Green Kit For SPY Elite,1,V04CX01,Indocyanine green,"Powder for solution,Kit",Intravenous,,,,,,,,,,,,,,,,,Ethical
97404,Marketed,2023-11-09,02483688,SPY Agent Green Kit For Advanced Imaging Modality (Aim) And Pinpoint,1,V04CX01,Indocyanine green,"Powder for solution,Kit",Intravenous,,,,,,,,,,,,,,,,,Ethical
97405,Marketed,2023-11-09,02483696,SPY Agent Green Lymphatics Kit For Advanced Imaging Modality (Aim) And Pinpoint,1,V04CX01,Indocyanine green,"Powder for solution,Kit",Interstitial,,,,,,,,,,,,,,,,,Ethical
97602,Marketed,2019-06-11,02485796,"Indocyanine Green For Injection, USP",1,V04CX01,Indocyanine green,Powder for solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
98842,Marketed,2023-11-09,02498677,SPY Agent Green Kit For SPY-Phi,1,V04CX01,Indocyanine green,"Kit,Powder for solution","Intradermal,Interstitial,Intravenous",,,,,,,,,,,,,,,,,Ethical
4129,Marketed,2015-07-15,00337420,Teva-Indomethacin,1,M01AB01,Indometacin,Capsule,Oral,00337420,TEVA-INDOMETHACIN (indomethacin 25 mg oral capsule) TEVA CANADA LIMITED,Active,9000151,indomethacin 25 mg oral capsule,8000085,indomethacin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
4130,Marketed,2015-07-14,00337439,Teva-Indomethacin,1,M01AB01,Indometacin,Capsule,Oral,00337439,TEVA-INDOMETHACIN (indomethacin 50 mg oral capsule) TEVA CANADA LIMITED,Active,9000152,indomethacin 50 mg oral capsule,8000085,indomethacin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
51232,Marketed,2023-08-23,02231799,Odan-Indomethacin,1,M01AB01,Indometacin,Suppository,Rectal,02231799,ODAN-INDOMETHACIN (indomethacin 50 mg suppository) ODAN LABORATORIES LTD,Active,9000758,indomethacin 50 mg suppository,8000085,indomethacin,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,,Prescription
51233,Marketed,2025-05-01,02231800,Odan-Indomethacin,1,M01AB01,Indometacin,Suppository,Rectal,02231800,ODAN-INDOMETHACIN (indomethacin 100 mg suppository) ODAN LABORATORIES LTD,Active,9000470,indomethacin 100 mg suppository,8000085,indomethacin,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,,Prescription
94917,Marketed,2017-04-03,02461536,Mint-Indomethacin,1,M01AB01,Indometacin,Capsule,Oral,02461536,MINT-INDOMETHACIN (indomethacin 50 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9000152,indomethacin 50 mg oral capsule,8000085,indomethacin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
94956,Marketed,2017-04-03,02461811,Mint-Indomethacin,1,M01AB01,Indometacin,Capsule,Oral,02461811,MINT-INDOMETHACIN (indomethacin 25 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9000151,indomethacin 25 mg oral capsule,8000085,indomethacin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98897,Marketed,2021-07-08,02499223,Auro-Indomethacin,1,M01AB01,Indometacin,Capsule,Oral,02499223,AURO-INDOMETHACIN (indomethacin 50 mg oral capsule) AURO PHARMA INC,Active,9000152,indomethacin 50 mg oral capsule,8000085,indomethacin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
103236,Marketed,2025-03-31,02543931,Uplizna,1,L04AG10,Inebilizumab,Solution,Intravenous,02543931,UPLIZNA (inebilizumab 100 mg per 10 mL solution for injection vial) AMGEN CANADA INC,Active,9015096,inebilizumab 100 mg per 10 mL solution for injection vial,8002513,inebilizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
103236,Marketed,2025-03-31,02543931,Uplizna,1,L04AG10,Inebilizumab,Solution,Intravenous,02543931,UPLIZNA (inebilizumab 100 mg per 10 mL solution for injection vial) AMGEN CANADA INC,Active,9015096,inebilizumab 100 mg per 10 mL solution for injection vial,8002513,inebilizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
100077,Marketed,2024-06-28,02511584,Remsima SC,1,L04AB02,Infliximab,"Kit,Solution",Subcutaneous,02511584,REMSIMA SC (infliximab 120 mg per 1 mL solution for injection pen) CELLTRION INC.,Active,9014548,infliximab 120 mg per 1 mL solution for injection pen,8001275,infliximab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,1.0,Schedule D
100077,Marketed,2024-06-28,02511584,Remsima SC,1,L04AB02,Infliximab,"Kit,Solution",Subcutaneous,02511584,REMSIMA SC (infliximab 120 mg per 1 mL solution for injection pen) CELLTRION INC.,Active,9014548,infliximab 120 mg per 1 mL solution for injection pen,8001275,infliximab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,1.0,Prescription
101230,Marketed,2025-04-01,02523191,Ixifi,1,L04AB02,Infliximab,Powder for solution,Intravenous,02523191,IXIFI (infliximab 100 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9003611,infliximab 100 mg per vial powder for solution for injection,8001275,infliximab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
101230,Marketed,2025-04-01,02523191,Ixifi,1,L04AB02,Infliximab,Powder for solution,Intravenous,02523191,IXIFI (infliximab 100 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9003611,infliximab 100 mg per vial powder for solution for injection,8001275,infliximab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
67959,Marketed,2011-11-22,02244016,Remicade,1,L04AB02,Infliximab,Powder for solution,Intravenous,02244016,REMICADE (infliximab 100 mg per vial powder for solution for injection) JANSSEN INC,Active,9003611,infliximab 100 mg per vial powder for solution for injection,8001275,infliximab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
67959,Marketed,2011-11-22,02244016,Remicade,1,L04AB02,Infliximab,Powder for solution,Intravenous,02244016,REMICADE (infliximab 100 mg per vial powder for solution for injection) JANSSEN INC,Active,9003611,infliximab 100 mg per vial powder for solution for injection,8001275,infliximab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
90410,Marketed,2025-03-12,02419475,Remdantry,1,L04AB02,Infliximab,Powder for solution,Intravenous,02419475,REMDANTRY (infliximab 100 mg per vial powder for solution for injection) CELLTRION INC.,Active,9003611,infliximab 100 mg per vial powder for solution for injection,8001275,infliximab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
90410,Marketed,2025-03-12,02419475,Remdantry,1,L04AB02,Infliximab,Powder for solution,Intravenous,02419475,REMDANTRY (infliximab 100 mg per vial powder for solution for injection) CELLTRION INC.,Active,9003611,infliximab 100 mg per vial powder for solution for injection,8001275,infliximab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
95936,Marketed,2018-03-22,02470373,Renflexis,1,L04AB02,Infliximab,Powder for solution,Intravenous,02470373,"RENFLEXIS (infliximab 100 mg per vial powder for solution for injection) SAMSUNG BIOEPIS CO., LTD",Active,9003611,infliximab 100 mg per vial powder for solution for injection,8001275,infliximab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
95936,Marketed,2018-03-22,02470373,Renflexis,1,L04AB02,Infliximab,Powder for solution,Intravenous,02470373,"RENFLEXIS (infliximab 100 mg per vial powder for solution for injection) SAMSUNG BIOEPIS CO., LTD",Active,9003611,infliximab 100 mg per vial powder for solution for injection,8001275,infliximab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
98681,Marketed,2020-06-01,02496933,Avsola,1,L04AB02,Infliximab,Powder for solution,Intravenous,02496933,AVSOLA (infliximab 100 mg per vial powder for solution for injection) AMGEN CANADA INC,Active,9003611,infliximab 100 mg per vial powder for solution for injection,8001275,infliximab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
98681,Marketed,2020-06-01,02496933,Avsola,1,L04AB02,Infliximab,Powder for solution,Intravenous,02496933,AVSOLA (infliximab 100 mg per vial powder for solution for injection) AMGEN CANADA INC,Active,9003611,infliximab 100 mg per vial powder for solution for injection,8001275,infliximab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
104261,Marketed,2025-09-10,02553708,Flucelvax,3,J07BB02,"Influenza, inactivated, split virus or surface antigen",Suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
84739,Marketed,2017-09-08,02362384,Fluad,3,J07BB02,"Influenza, inactivated, split virus or surface antigen",Suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
85059,Marketed,2025-09-10,02365707,Fluzone,3,J07BB02,"Influenza, inactivated, split virus or surface antigen",Suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
85079,Marketed,2025-09-10,02365936,Fluzone,3,J07BB02,"Influenza, inactivated, split virus or surface antigen",Suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
88676,Marketed,2025-03-21,02401886,Arepanrix H5 N 1,1,J07BB02,"Influenza, inactivated, split virus or surface antigen",Emulsion,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
90524,Marketed,2025-09-08,02420686,Fluviral,3,J07BB02,"Influenza, inactivated, split virus or surface antigen",Suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
93092,Marketed,2025-09-10,02445646,Fluzone High-Dose,3,J07BB02,"Influenza, inactivated, split virus or surface antigen",Suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
97512,Marketed,2019-10-17,02484854,Influvac Tetra,4,J07BB02,"Influenza, inactivated, split virus or surface antigen",Suspension,"Subcutaneous,Intramuscular",,,,,,,,,,,,,,,,,Schedule D
75489,Marketed,2025-09-15,02269562,Influvac,3,J07BB01,"Influenza, inactivated, whole virus",Suspension,"Subcutaneous,Intramuscular",,,,,,,,,,,,,,,,,Schedule D
83789,Marketed,2025-09-25,02352621,Flumist,3,J07BB03,"Influenza, live attenuated",Spray,Nasal,,,,,,,,,,,,,,,,,Schedule D
64296,Marketed,2013-05-07,02240713,Imunovir,1,J05AX05,Inosine pranobex,Tablet,Oral,02240713,IMUNOVIR (inosine pranobex 500 mg oral tablet) KORA HEALTHCARE,Active,9003452,inosine pranobex 500 mg oral tablet,8001207,inosine pranobex,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96383,Marketed,2018-05-03,02473909,Besponsa,1,L01FB01,Inotuzumab ozogamicin,Powder for solution,Intravenous,02473909,BESPONSA (inotuzumab ozogamicin 0.9 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9012820,inotuzumab ozogamicin 0.9 mg per vial powder for solution for injection,8001485,inotuzumab ozogamicin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
96383,Marketed,2018-05-03,02473909,Besponsa,1,L01FB01,Inotuzumab ozogamicin,Powder for solution,Intravenous,02473909,BESPONSA (inotuzumab ozogamicin 0.9 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9012820,inotuzumab ozogamicin 0.9 mg per vial powder for solution for injection,8001485,inotuzumab ozogamicin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
43270,Marketed,2019-02-04,02220075,Hymenoptera Venom Product - Honey Bee Venom (550 mcg),1,V01AA07,Insects,Powder for solution,Subcutaneous,,,,,,,,,,,,,,,,,Schedule D
43271,Marketed,2024-03-25,02220083,Hymenoptera Venom Products-Yellow Hornet Venom Protein (550 mcg),1,V01AA07,Insects,Powder for solution,Subcutaneous,,,,,,,,,,,,,,,,,Schedule D
43272,Marketed,2018-11-19,02220091,Hymenoptera Venom Product-Wasp Venom Protein (550 mcg),1,V01AA07,Insects,Powder for solution,Subcutaneous,,,,,,,,,,,,,,,,,Schedule D
43274,Marketed,2013-01-04,02220113,Hymenoptera Venom Product - Yellow Jacket Venom Protein (550 mcg),1,V01AA07,Insects,Powder for solution,Subcutaneous,,,,,,,,,,,,,,,,,Schedule D
43302,Marketed,2017-02-22,02221314,Hymenoptera Venom Product-Mixed Vespid Venom Protein (1650 mcg),3,V01AA07,Insects,Powder for solution,Subcutaneous,,,,,,,,,,,,,,,,,Schedule D
101884,Marketed,2023-07-28,02529602,Myxredlin,1,A10AB01,Insulin (human),Solution,Intravenous,,,,,,,,,,,,,,,,1.0,Prescription
101884,Marketed,2023-07-28,02529602,Myxredlin,1,A10AB01,Insulin (human),Solution,Intravenous,,,,,,,,,,,,,,,,1.0,Schedule D
12568,Marketed,1997-12-11,01959212,Humulin 30/70 Cartridge,2,A10AD01,Insulin (human),Suspension,Subcutaneous,01959212,HUMULIN 30/70 CARTRIDGE (insulin human 30 unit per mL and insulin isophane human 70 unit per mL suspension for injection 3 mL cartridge) ELI LILLY CANADA INC,Active,9012720,insulin human 30 unit per mL and insulin isophane human 70 unit per mL suspension for injection 3 mL cartridge,8001392,insulin human and insulin isophane human,738984000,Parenteral,385220007,Suspension for injection,732988008,Cartridge (unit of presentation),,,,Schedule D
12569,Marketed,1997-12-11,01959220,Humulin R Cartridge,1,A10AB01,Insulin (human),Solution,"Subcutaneous,Intravenous,Intramuscular",01959220,HUMULIN R CARTRIDGE (insulin human 100 unit per mL solution for injection 3 mL cartridge) ELI LILLY CANADA INC,Active,9012717,insulin human 100 unit per mL solution for injection 3 mL cartridge,8001391,insulin human,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Schedule D
12570,Marketed,2010-09-20,01959239,Humulin N (Cartridge),1,A10AC01,Insulin (human),Suspension,Subcutaneous,01959239,HUMULIN N (CARTRIDGE) (insulin isophane human 100 unit per mL suspension for injection 3 mL cartridge) ELI LILLY CANADA INC,Active,9000426,insulin isophane human 100 unit per mL suspension for injection 3 mL cartridge,8000168,insulin isophane human,738984000,Parenteral,385220007,Suspension for injection,732988008,Cartridge (unit of presentation),,,,Schedule D
14260,Marketed,2011-01-08,02024233,Novolin Ge Toronto,1,A10AB01,Insulin (human),Solution,"Intramuscular,Intravenous,Subcutaneous",02024233,NOVOLIN GE TORONTO (insulin human 100 unit per mL solution for injection 10 mL vial) NOVO NORDISK CANADA INC,Active,9012716,insulin human 100 unit per mL solution for injection 10 mL vial,8001391,insulin human,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
14261,Marketed,2011-01-08,02024225,Novolin Ge NPH,1,A10AC01,Insulin (human),Suspension,Subcutaneous,02024225,NOVOLIN GE NPH (insulin isophane human 100 unit per mL suspension for injection 10 mL vial) NOVO NORDISK CANADA INC,Active,9000471,insulin isophane human 100 unit per mL suspension for injection 10 mL vial,8000168,insulin isophane human,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,,Schedule D
14265,Marketed,2011-01-08,02025248,Novolin Ge 30/70 Penfill,2,A10AD01,Insulin (human),Suspension,Subcutaneous,02025248,NOVOLIN GE 30/70 PENFILL (insulin human 30 unit per mL and insulin isophane human 70 unit per mL suspension for injection 3 mL cartridge) NOVO NORDISK CANADA INC,Active,9012720,insulin human 30 unit per mL and insulin isophane human 70 unit per mL suspension for injection 3 mL cartridge,8001392,insulin human and insulin isophane human,738984000,Parenteral,385220007,Suspension for injection,732988008,Cartridge (unit of presentation),,,,Schedule D
14266,Marketed,2011-01-08,02024268,Novolin Ge NPH Penfill,1,A10AC01,Insulin (human),Suspension,Subcutaneous,02024268,NOVOLIN GE NPH PENFILL (insulin isophane human 100 unit per mL suspension for injection 3 mL cartridge) NOVO NORDISK CANADA INC,Active,9000426,insulin isophane human 100 unit per mL suspension for injection 3 mL cartridge,8000168,insulin isophane human,738984000,Parenteral,385220007,Suspension for injection,732988008,Cartridge (unit of presentation),,,,Schedule D
14269,Marketed,2011-01-08,02024217,Novolin Ge 30/70,2,A10AD01,Insulin (human),Suspension,Subcutaneous,02024217,NOVOLIN GE 30/70 (insulin human 30 unit per mL and insulin isophane human 70 unit per mL suspension for injection 10 mL vial) NOVO NORDISK CANADA INC,Active,9012719,insulin human 30 unit per mL and insulin isophane human 70 unit per mL suspension for injection 10 mL vial,8001392,insulin human and insulin isophane human,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,,Schedule D
14459,Marketed,2011-01-08,02024284,Novolin Ge Toronto Penfill,1,A10AB01,Insulin (human),Solution,"Subcutaneous,Intravenous,Intramuscular",02024284,NOVOLIN GE TORONTO PENFILL (insulin human 100 unit per mL solution for injection 3 mL cartridge) NOVO NORDISK CANADA INC,Active,9012717,insulin human 100 unit per mL solution for injection 3 mL cartridge,8001391,insulin human,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Schedule D
5325,Marketed,1997-12-11,00586714,Humulin R,1,A10AB01,Insulin (human),Solution,"Intravenous,Subcutaneous,Intramuscular",77700632,HUMULIN R (insulin human 100 unit per mL solution for injection 3 mL vial) ELI LILLY CANADA INC,Active,9012826,insulin human 100 unit per mL solution for injection 3 mL vial,8001391,insulin human,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
5325,Marketed,1997-12-11,00586714,Humulin R,1,A10AB01,Insulin (human),Solution,"Intravenous,Subcutaneous,Intramuscular",77700633,HUMULIN R (insulin human 100 unit per mL solution for injection 10 mL vial) ELI LILLY CANADA INC,Active,9012716,insulin human 100 unit per mL solution for injection 10 mL vial,8001391,insulin human,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
5326,Marketed,1997-12-11,00587737,Humulin N,1,A10AC01,Insulin (human),Suspension,Subcutaneous,77701034,HUMULIN N (insulin isophane human 100 unit per mL suspension for injection 10 mL vial) ELI LILLY CANADA INC,Active,9000471,insulin isophane human 100 unit per mL suspension for injection 10 mL vial,8000168,insulin isophane human,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,,Schedule D
5326,Marketed,1997-12-11,00587737,Humulin N,1,A10AC01,Insulin (human),Suspension,Subcutaneous,77701035,HUMULIN N (insulin isophane human 100 unit per mL suspension for injection 3 mL vial) ELI LILLY CANADA INC,Active,9014488,insulin isophane human 100 unit per mL suspension for injection 3 mL vial,8000168,insulin isophane human,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,,Schedule D
88825,Marketed,2013-09-13,02403447,Humulin N (Kwikpen),1,A10AC01,Insulin (human),Suspension,Subcutaneous,02403447,HUMULIN N (KWIKPEN) (insulin isophane human 100 unit per mL suspension for injection 3 mL pen) ELI LILLY CANADA INC,Active,9001407,insulin isophane human 100 unit per mL suspension for injection 3 mL pen,8000168,insulin isophane human,738984000,Parenteral,385220007,Suspension for injection,733006000,Pen (unit of presentation),,,,Schedule D
89971,Marketed,2014-03-03,02415089,Humulin R (Kwikpen),1,A10AB01,Insulin (human),Solution,"Intramuscular,Subcutaneous",02415089,HUMULIN R (KWIKPEN) (insulin human 100 unit per mL solution for injection 3 mL pen) ELI LILLY CANADA INC,Active,9012718,insulin human 100 unit per mL solution for injection 3 mL pen,8001391,insulin human,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
95524,Marketed,2017-10-20,02466864,Entuzity Kwikpen,1,A10AD01,Insulin (human),Solution,Subcutaneous,02466864,ENTUZITY KWIKPEN (insulin human 500 unit per mL solution for injection 3 mL pen) ELI LILLY CANADA INC,Active,9012723,insulin human 500 unit per mL solution for injection 3 mL pen,8001391,insulin human,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
9788,Marketed,1997-12-11,00795879,Humulin 30/70 (Insulin Human Biosynth Inj),2,A10AD01,Insulin (human),Suspension,Subcutaneous,00795879,HUMULIN 30/70 (INSULIN HUMAN BIOSYNTH INJ) (insulin human 30 unit per mL and insulin isophane human 70 unit per mL suspension for injection 10 mL vial) ELI LILLY CANADA INC,Active,9012719,insulin human 30 unit per mL and insulin isophane human 70 unit per mL suspension for injection 10 mL vial,8001392,insulin human and insulin isophane human,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,,Schedule D
76152,Marketed,2006-04-01,02275864,Hypurin NPH Insulin Isophane Pork,1,A10AC03,Insulin (pork),Suspension,"Intramuscular,Subcutaneous",02275864,HYPURIN NPH INSULIN ISOPHANE PORK (insulin isophane pork 100 unit per mL suspension for injection 10 mL vial) WOCKHARDT UK LIMITED,Active,9012724,insulin isophane pork 100 unit per mL suspension for injection 10 mL vial,8001393,insulin isophane pork,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,,Schedule D
76153,Marketed,2006-04-01,02275872,Hypurin Regular Insulin Pork,1,A10AB03,Insulin (pork),Solution,"Subcutaneous,Intravenous,Intramuscular",02275872,HYPURIN REGULAR INSULIN PORK (insulin pork 100 unit per mL solution for injection 10 mL vial) WOCKHARDT UK LIMITED,Active,9012729,insulin pork 100 unit per mL solution for injection 10 mL vial,8001281,insulin pork,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
101021,Marketed,2026-05-07,02520974,Kirsty,1,A10AB05,Insulin aspart,Solution,Subcutaneous,02520974,KIRSTY (insulin aspart 100 unit per mL solution for injection 3 mL pen) BIOCON BIOLOGICS CANADA INC,Active,9001476,insulin aspart 100 unit per mL solution for injection 3 mL pen,8000307,insulin aspart,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,1.0,Schedule D
101847,Marketed,2022-11-03,02529254,Trurapi,1,A10AB05,Insulin aspart,Solution,"Intravenous,Subcutaneous",02529254,TRURAPI (insulin aspart 100 unit per mL solution for injection 10 mL vial) SANOFI-AVENTIS CANADA INC,Active,9000990,insulin aspart 100 unit per mL solution for injection 10 mL vial,8000307,insulin aspart,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
68321,Marketed,2001-10-31,02244353,Novorapid,1,A10AB05,Insulin aspart,Solution,Subcutaneous,02244353,NOVORAPID 3ML PENFILL CARTRIDGE (insulin aspart 100 unit per mL solution for injection 3 mL cartridge) NOVO NORDISK CANADA INC,Active,9000962,insulin aspart 100 unit per mL solution for injection 3 mL cartridge,8000307,insulin aspart,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Schedule D
69441,Marketed,2002-06-12,02245397,Novorapid,1,A10AB05,Insulin aspart,Solution,Subcutaneous,02245397,NOVORAPID (insulin aspart 100 unit per mL solution for injection 10 mL vial) NOVO NORDISK CANADA INC,Active,9000990,insulin aspart 100 unit per mL solution for injection 10 mL vial,8000307,insulin aspart,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
75090,Marketed,2005-09-12,02265435,Novomix 30,2,A10AD05,Insulin aspart,Suspension,Subcutaneous,02265435,NOVOMIX 30 (insulin aspart 30 unit per mL and insulin aspart protamine 70 unit per mL suspension for injection 3 mL cartridge) NOVO NORDISK CANADA INC,Active,9013160,insulin aspart 30 unit per mL and insulin aspart protamine 70 unit per mL suspension for injection 3 mL cartridge,8000950,insulin aspart and insulin aspart protamine,738984000,Parenteral,385220007,Suspension for injection,732988008,Cartridge (unit of presentation),,,,Schedule D
94775,Marketed,2017-03-03,02460408,Fiasp,1,A10AB05,Insulin aspart,Solution,Subcutaneous,02460408,FIASP (insulin aspart 100 unit per mL solution for injection 10 mL vial) NOVO NORDISK CANADA INC,Active,9000990,insulin aspart 100 unit per mL solution for injection 10 mL vial,8000307,insulin aspart,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
94776,Marketed,2017-03-03,02460416,Fiasp,1,A10AB05,Insulin aspart,Solution,Subcutaneous,02460416,FIASP (insulin aspart 100 unit per mL solution for injection 3 mL cartridge) NOVO NORDISK CANADA INC,Active,9000962,insulin aspart 100 unit per mL solution for injection 3 mL cartridge,8000307,insulin aspart,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Schedule D
94777,Marketed,2017-03-03,02460424,Fiasp,1,A10AB05,Insulin aspart,Solution,Subcutaneous,02460424,FIASP (insulin aspart 100 unit per mL solution for injection 3 mL pen) NOVO NORDISK CANADA INC,Active,9001476,insulin aspart 100 unit per mL solution for injection 3 mL pen,8000307,insulin aspart,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
99592,Marketed,2021-03-30,02506564,Trurapi,1,A10AB05,Insulin aspart,Solution,Subcutaneous,02506564,TRURAPI (insulin aspart 100 unit per mL solution for injection 3 mL cartridge) SANOFI-AVENTIS CANADA INC,Active,9000962,insulin aspart 100 unit per mL solution for injection 3 mL cartridge,8000307,insulin aspart,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,1.0,Schedule D
99593,Marketed,2021-03-30,02506572,Trurapi,1,A10AB05,Insulin aspart,Solution,Subcutaneous,02506572,TRURAPI (insulin aspart 100 unit per mL solution for injection 3 mL pen) SANOFI-AVENTIS CANADA INC,Active,9001476,insulin aspart 100 unit per mL solution for injection 3 mL pen,8000307,insulin aspart,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,1.0,Schedule D
95622,Marketed,2023-01-30,02467860,Tresiba,1,A10AE06,Insulin degludec,Solution,Subcutaneous,02467860,TRESIBA (insulin degludec 100 unit per mL solution for injection 3 mL cartridge) NOVO NORDISK CANADA INC,Active,9014831,insulin degludec 100 unit per mL solution for injection 3 mL cartridge,8001137,insulin degludec,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge,,,,Schedule D
95623,Marketed,2017-09-15,02467879,Tresiba,1,A10AE06,Insulin degludec,Solution,Subcutaneous,02467879,TRESIBA (insulin degludec 100 unit per mL solution for injection 3 mL pen) NOVO NORDISK CANADA INC,Active,9012499,insulin degludec 100 unit per mL solution for injection 3 mL pen,8001137,insulin degludec,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
95624,Marketed,2017-09-15,02467887,Tresiba,1,A10AE06,Insulin degludec,Solution,Subcutaneous,02467887,TRESIBA (insulin degludec 200 unit per mL solution for injection 3 mL pen) NOVO NORDISK CANADA INC,Active,9012500,insulin degludec 200 unit per mL solution for injection 3 mL pen,8001137,insulin degludec,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
75736,Marketed,2005-11-14,02271842,Levemir Penfill,1,A10AE05,Insulin detemir,Solution,Subcutaneous,02271842,LEVEMIR PENFILL (insulin detemir 100 unit per mL solution for injection 3 mL cartridge) NOVO NORDISK CANADA INC,Active,9001131,insulin detemir 100 unit per mL solution for injection 3 mL cartridge,8000353,insulin detemir,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Schedule D
101554,Marketed,2024-07-12,02526441,Semglee,1,A10AE04,Insulin glargine,Solution,Subcutaneous,02526441,SEMGLEE (insulin glargine 100 unit per mL solution for injection 3 mL pen) BIOCON SDN.BHD,Active,9001210,insulin glargine 100 unit per mL solution for injection 3 mL pen,8000317,insulin glargine,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,1.0,Schedule D
69790,Marketed,2007-10-23,02245689,Lantus,1,A10AE04,Insulin glargine,Solution,Subcutaneous,02245689,LANTUS (insulin glargine 100 unit per mL solution for injection 10 mL vial) SANOFI-AVENTIS CANADA INC,Active,9000994,insulin glargine 100 unit per mL solution for injection 10 mL vial,8000317,insulin glargine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
73683,Marketed,2006-05-04,02251930,Lantus,1,A10AE04,Insulin glargine,Solution,Subcutaneous,02251930,LANTUS (insulin glargine 100 unit per mL solution for injection 3 mL cartridge) SANOFI-AVENTIS CANADA INC,Active,9001143,insulin glargine 100 unit per mL solution for injection 3 mL cartridge,8000317,insulin glargine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Schedule D
77967,Marketed,2007-09-24,02294338,Lantus,1,A10AE04,Insulin glargine,Solution,Subcutaneous,02294338,LANTUS (insulin glargine 100 unit per mL solution for injection 3 mL pen) SANOFI-AVENTIS CANADA INC,Active,9001210,insulin glargine 100 unit per mL solution for injection 3 mL pen,8000317,insulin glargine,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
92621,Marketed,2015-07-15,02441829,Toujeo Solostar,1,A10AE04,Insulin glargine,Solution,Subcutaneous,02441829,TOUJEO SOLOSTAR (insulin glargine 300 unit per mL solution for injection 1.5 mL pen) SANOFI-AVENTIS CANADA INC,Active,9001447,insulin glargine 300 unit per mL solution for injection 1.5 mL pen,8000317,insulin glargine,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
93005,Marketed,2015-12-18,02444844,Basaglar,1,A10AE04,Insulin glargine,Solution,Subcutaneous,02444844,BASAGLAR (insulin glargine 100 unit per mL solution for injection 3 mL cartridge) ELI LILLY CANADA INC,Active,9001143,insulin glargine 100 unit per mL solution for injection 3 mL cartridge,8000317,insulin glargine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,1.0,Schedule D
94916,Marketed,2017-08-18,02461528,Basaglar,1,A10AE04,Insulin glargine,Solution,Subcutaneous,02461528,BASAGLAR KWIKPEN - 80 UNITS PER INJECTION DELIVERY (insulin glargine 100 unit per mL solution for injection 3 mL pen) ELI LILLY CANADA INC,Active,9001210,insulin glargine 100 unit per mL solution for injection 3 mL pen,8000317,insulin glargine,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,1.0,Schedule D
98339,Marketed,2020-02-04,02493373,Toujeo Doublestar,1,A10AE04,Insulin glargine,Solution,Subcutaneous,02493373,TOUJEO DOUBLESTAR (insulin glargine 300 unit per mL solution for injection 3 mL pen) SANOFI-AVENTIS CANADA INC,Active,9014245,insulin glargine 300 unit per mL solution for injection 3 mL pen,8000317,insulin glargine,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
96906,Marketed,2018-09-12,02478293,Soliqua,2,A10AE54,Insulin glargine and lixisenatide,Solution,Subcutaneous,02478293,SOLIQUA (insulin glargine 100 unit per mL and lixisenatide 33 mcg per mL solution for injection 3 mL pen) SANOFI-AVENTIS CANADA INC,Active,9013299,insulin glargine 100 unit per mL and lixisenatide 33 mcg per mL solution for injection 3 mL pen,8001811,insulin glargine and lixisenatide,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,,Schedule D
96906,Marketed,2018-09-12,02478293,Soliqua,2,A10AE54,Insulin glargine and lixisenatide,Solution,Subcutaneous,02478293,SOLIQUA (insulin glargine 100 unit per mL and lixisenatide 33 mcg per mL solution for injection 3 mL pen) SANOFI-AVENTIS CANADA INC,Active,9013299,insulin glargine 100 unit per mL and lixisenatide 33 mcg per mL solution for injection 3 mL pen,8001811,insulin glargine and lixisenatide,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,,Prescription
76506,Marketed,2008-09-22,02279460,Apidra,1,A10AB06,Insulin glulisine,Solution,Subcutaneous,02279460,APIDRA (insulin glulisine 100 unit per mL solution for injection 10 mL vial) SANOFI-AVENTIS CANADA INC,Active,9012823,insulin glulisine 100 unit per mL solution for injection 10 mL vial,8001390,insulin glulisine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
76507,Marketed,2009-10-01,02279479,Apidra,1,A10AB06,Insulin glulisine,Solution,Subcutaneous,02279479,APIDRA (insulin glulisine 100 unit per mL solution for injection 3 mL cartridge) SANOFI-AVENTIS CANADA INC,Active,9012824,insulin glulisine 100 unit per mL solution for injection 3 mL cartridge,8001390,insulin glulisine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Schedule D
77968,Marketed,2008-09-22,02294346,Apidra,1,A10AB06,Insulin glulisine,Solution,Subcutaneous,02294346,APIDRA (insulin glulisine 100 unit per mL solution for injection 3 mL pen) SANOFI-AVENTIS CANADA INC,Active,9012825,insulin glulisine 100 unit per mL solution for injection 3 mL pen,8001390,insulin glulisine,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
103492,Marketed,2024-06-13,02546205,Awiqli,1,A10AE07,Insulin icodec,Solution,Subcutaneous,02546205,AWIQLI (insulin icodec 700 unit per mL solution for injection 1 mL pen) NOVO NORDISK CANADA INC,Active,9015054,insulin icodec 700 unit per mL solution for injection 1 mL pen,8002509,insulin icodec,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
103493,Marketed,2024-06-13,02546213,Awiqli,1,A10AE07,Insulin icodec,Solution,Subcutaneous,02546213,AWIQLI (insulin icodec 700 unit per mL solution for injection 1.5 mL pen) NOVO NORDISK CANADA INC,Active,9015053,insulin icodec 700 unit per mL solution for injection 1.5 mL pen,8002509,insulin icodec,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
103494,Marketed,2024-06-13,02546221,Awiqli,1,A10AE07,Insulin icodec,Solution,Subcutaneous,02546221,AWIQLI (insulin icodec 700 unit per mL solution for injection 3 mL pen) NOVO NORDISK CANADA INC,Active,9015055,insulin icodec 700 unit per mL solution for injection 3 mL pen,8002509,insulin icodec,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
47871,Marketed,1997-09-17,02229704,Humalog,1,A10AB04,Insulin lispro,Solution,"Intravenous,Subcutaneous,Intramuscular",02229704,HUMALOG (insulin lispro 100 unit per mL solution for injection 10 mL vial) ELI LILLY CANADA INC,Active,9000671,insulin lispro 100 unit per mL solution for injection 10 mL vial,8000787,insulin lispro,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
47872,Marketed,1998-05-25,02229705,Humalog (Cartridge),1,A10AB04,Insulin lispro,Solution,"Subcutaneous,Intravenous,Intramuscular",02229705,HUMALOG (CARTRIDGE) (insulin lispro 100 unit per mL solution for injection 3 mL cartridge) ELI LILLY CANADA INC,Active,9000673,insulin lispro 100 unit per mL solution for injection 3 mL cartridge,8000787,insulin lispro,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Schedule D
63832,Marketed,1999-07-05,02240294,Humalog Mix 25 (Cartridge),2,A10AD04,Insulin lispro,Suspension,Subcutaneous,02240294,HUMALOG MIX 25 (CARTRIDGE) (insulin lispro 25 unit per mL and insulin lispro protamine 75 unit per mL suspension for injection 3 mL cartridge) ELI LILLY CANADA INC,Active,9012725,insulin lispro 25 unit per mL and insulin lispro protamine 75 unit per mL suspension for injection 3 mL cartridge,8001394,insulin lispro and insulin lispro protamine,738984000,Parenteral,385220007,Suspension for injection,732988008,Cartridge (unit of presentation),,,,Schedule D
63835,Marketed,2013-03-08,02240297,Humalog Mix 50 (Cartridge),2,A10AD04,Insulin lispro,Suspension,Subcutaneous,02240297,HUMALOG MIX 50 (CARTRIDGE) (insulin lispro 50 unit per mL and insulin lispro protamine 50 unit per mL suspension for injection 3 mL cartridge) ELI LILLY CANADA INC,Active,9012727,insulin lispro 50 unit per mL and insulin lispro protamine 50 unit per mL suspension for injection 3 mL cartridge,8001394,insulin lispro and insulin lispro protamine,738984000,Parenteral,385220007,Suspension for injection,732988008,Cartridge (unit of presentation),,,,Schedule D
88822,Marketed,2013-08-14,02403412,Humalog (Kwikpen),1,A10AB04,Insulin lispro,Solution,"Intravenous,Intramuscular,Subcutaneous",02403412,HUMALOG (KWIKPEN) (insulin lispro 100 unit per mL solution for injection 3 mL pen) ELI LILLY CANADA INC,Active,9001406,insulin lispro 100 unit per mL solution for injection 3 mL pen,8000787,insulin lispro,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
88823,Marketed,2013-09-30,02403420,Humalog Mix 25 (Kwikpen),2,A10AD04,Insulin lispro,Suspension,Subcutaneous,02403420,HUMALOG MIX 25 (KWIKPEN) (insulin lispro 25 unit per mL and insulin lispro protamine 75 unit per mL suspension for injection 3 mL pen) ELI LILLY CANADA INC,Active,9012726,insulin lispro 25 unit per mL and insulin lispro protamine 75 unit per mL suspension for injection 3 mL pen,8001394,insulin lispro and insulin lispro protamine,738984000,Parenteral,385220007,Suspension for injection,733006000,Pen (unit of presentation),,,,Schedule D
88824,Marketed,2014-01-23,02403439,Humalog Mix 50 (Kwikpen),2,A10AD04,Insulin lispro,Suspension,Subcutaneous,02403439,HUMALOG MIX 50 (KWIKPEN) (insulin lispro 50 unit per mL and insulin lispro protamine 50 unit per mL suspension for injection 3 mL pen) ELI LILLY CANADA INC,Active,9012728,insulin lispro 50 unit per mL and insulin lispro protamine 50 unit per mL suspension for injection 3 mL pen,8001394,insulin lispro and insulin lispro protamine,738984000,Parenteral,385220007,Suspension for injection,733006000,Pen (unit of presentation),,,,Schedule D
92402,Marketed,2015-09-14,02439611,Humalog 200 Units/mL Kwikpen,1,A10AB04,Insulin lispro,Solution,Subcutaneous,02439611,HUMALOG 200 UNITS/ML KWIKPEN (insulin lispro 200 unit per mL solution for injection 3 mL pen) ELI LILLY CANADA INC,Active,9001449,insulin lispro 200 unit per mL solution for injection 3 mL pen,8000787,insulin lispro,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
95877,Marketed,2019-11-22,02469898,Admelog,1,A10AB04,Insulin lispro,Solution,Subcutaneous,02469898,ADMELOG (insulin lispro 100 unit per mL solution for injection 3 mL cartridge) SANOFI-AVENTIS CANADA INC,Active,9000673,insulin lispro 100 unit per mL solution for injection 3 mL cartridge,8000787,insulin lispro,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,1.0,Schedule D
95880,Marketed,2019-11-22,02469871,Admelog Solostar,1,A10AB04,Insulin lispro,Solution,Subcutaneous,02469871,ADMELOG SOLOSTAR (insulin lispro 100 unit per mL solution for injection 3 mL pen) SANOFI-AVENTIS CANADA INC,Active,9001406,insulin lispro 100 unit per mL solution for injection 3 mL pen,8000787,insulin lispro,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,1.0,Schedule D
95881,Marketed,2019-11-22,02469901,Admelog,1,A10AB04,Insulin lispro,Solution,Subcutaneous,02469901,ADMELOG (insulin lispro 100 unit per mL solution for injection 10 mL vial) SANOFI-AVENTIS CANADA INC,Active,9000671,insulin lispro 100 unit per mL solution for injection 10 mL vial,8000787,insulin lispro,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
95912,Marketed,2018-04-06,02470152,Humalog,1,A10AB04,Insulin lispro,Solution,Subcutaneous,02470152,HUMALOG JUNIOR KWIKPEN (insulin lispro 100 unit per mL solution for injection 3 mL pen) ELI LILLY CANADA INC,Active,9001406,insulin lispro 100 unit per mL solution for injection 3 mL pen,8000787,insulin lispro,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
60641,Marketed,1998-02-23,02237319,Rebif,1,L03AB07,Interferon beta-1a,Solution,Subcutaneous,02237319,"REBIF (interferon beta-1a 22 mcg per 0.5 mL solution for injection syringe) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013167,interferon beta-1a 22 mcg per 0.5 mL solution for injection syringe,8001814,interferon beta-1a (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
60641,Marketed,1998-02-23,02237319,Rebif,1,L03AB07,Interferon beta-1a,Solution,Subcutaneous,02237319,"REBIF (interferon beta-1a 22 mcg per 0.5 mL solution for injection syringe) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013167,interferon beta-1a 22 mcg per 0.5 mL solution for injection syringe,8001814,interferon beta-1a (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
60642,Marketed,1998-02-24,02237320,Rebif,1,L03AB07,Interferon beta-1a,Solution,Subcutaneous,02237320,"REBIF (interferon beta-1a 44 mcg per 0.5 mL solution for injection syringe) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013168,interferon beta-1a 44 mcg per 0.5 mL solution for injection syringe,8001814,interferon beta-1a (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
60642,Marketed,1998-02-24,02237320,Rebif,1,L03AB07,Interferon beta-1a,Solution,Subcutaneous,02237320,"REBIF (interferon beta-1a 44 mcg per 0.5 mL solution for injection syringe) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013168,interferon beta-1a 44 mcg per 0.5 mL solution for injection syringe,8001814,interferon beta-1a (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
75459,Marketed,2005-12-02,02269201,Avonex,1,L03AB07,Interferon beta-1a,Solution,Intramuscular,02269201,AVONEX (interferon beta-1a 30 mcg per 0.5 mL solution for injection syringe) BIOGEN CANADA INC,Active,9013912,interferon beta-1a 30 mcg per 0.5 mL solution for injection syringe,8001814,interferon beta-1a (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
75459,Marketed,2005-12-02,02269201,Avonex,1,L03AB07,Interferon beta-1a,Solution,Intramuscular,02269201,AVONEX (interferon beta-1a 30 mcg per 0.5 mL solution for injection syringe) BIOGEN CANADA INC,Active,9013912,interferon beta-1a 30 mcg per 0.5 mL solution for injection syringe,8001814,interferon beta-1a (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
80376,Marketed,2009-05-14,02318253,Rebif,1,L03AB07,Interferon beta-1a,Solution,Subcutaneous,02318253,"REBIF (interferon beta-1a 66 mcg per 1.5 mL solution for injection cartridge) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013169,interferon beta-1a 66 mcg per 1.5 mL solution for injection cartridge,8001814,interferon beta-1a (conventional),738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Schedule D
80376,Marketed,2009-05-14,02318253,Rebif,1,L03AB07,Interferon beta-1a,Solution,Subcutaneous,02318253,"REBIF (interferon beta-1a 66 mcg per 1.5 mL solution for injection cartridge) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013169,interferon beta-1a 66 mcg per 1.5 mL solution for injection cartridge,8001814,interferon beta-1a (conventional),738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Prescription
80377,Marketed,2009-05-14,02318261,Rebif,1,L03AB07,Interferon beta-1a,Solution,Subcutaneous,02318261,"REBIF (interferon beta-1a 132 mcg per 1.5 mL solution for injection cartridge) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013166,interferon beta-1a 132 mcg per 1.5 mL solution for injection cartridge,8001814,interferon beta-1a (conventional),738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Prescription
80377,Marketed,2009-05-14,02318261,Rebif,1,L03AB07,Interferon beta-1a,Solution,Subcutaneous,02318261,"REBIF (interferon beta-1a 132 mcg per 1.5 mL solution for injection cartridge) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013166,interferon beta-1a 132 mcg per 1.5 mL solution for injection cartridge,8001814,interferon beta-1a (conventional),738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Schedule D
19241,Marketed,2008-01-29,02169649,Betaseron,1,L03AB08,Interferon beta-1b,Powder for solution,Subcutaneous,02169649,BETASERON (interferon beta-1b 0.3 mg per vial powder for solution for injection) BAYER INC,Active,9002829,interferon beta-1b 0.3 mg per vial powder for solution for injection,8001815,interferon beta-1b,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
19241,Marketed,2008-01-29,02169649,Betaseron,1,L03AB08,Interferon beta-1b,Powder for solution,Subcutaneous,02169649,BETASERON (interferon beta-1b 0.3 mg per vial powder for solution for injection) BAYER INC,Active,9002829,interferon beta-1b 0.3 mg per vial powder for solution for injection,8001815,interferon beta-1b,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
87259,Marketed,2019-02-26,02387034,Adreview,1,V09IX01,Iobenguane (123 i),Solution,Intravenous,,,,,,,,,,,,,,,,,Schedule C
95962,Marketed,2018-11-15,02470624,Datscan,1,V09AB03,Iodine ioflupane 123 i,Solution,Intravenous,,,,,,,,,,,,,,,,,Schedule C
104285,Marketed,2025-05-29,02553953,Iodixanol Injection 270,1,V08AB09,Iodixanol,Solution,"Intra-arterial,Intravenous",,,,,,,,,,,,,,,,,Ethical
104286,Marketed,2025-05-29,02553961,Iodixanol Injection 320,1,V08AB09,Iodixanol,Solution,"Intra-arterial,Intravenous",,,,,,,,,,,,,,,,,Ethical
18685,Marketed,2021-09-08,02145766,Visipaque 270,1,V08AB09,Iodixanol,Solution,"Intra-arterial,Intravenous",,,,,,,,,,,,,,,,,Ethical
18694,Marketed,2021-09-02,02145774,Visipaque 320,1,V08AB09,Iodixanol,Solution,"Intra-arterial,Intravenous",,,,,,,,,,,,,,,,,Ethical
44185,Marketed,2023-12-29,02172739,Omnipaque 240,1,V08AB02,Iohexol,Solution,"Oral,Intra-articular,Subarachnoidal,Rectal,Intravascular",,,,,,,,,,,,,,,,,Ethical
44186,Marketed,2024-01-03,02172747,Omnipaque 300,1,V08AB02,Iohexol,Solution,"Rectal,Intra-articular,Intravascular,Subarachnoidal,Oral",,,,,,,,,,,,,,,,,Ethical
44187,Marketed,2023-12-29,02172755,Omnipaque 350,1,V08AB02,Iohexol,Solution,"Intravascular,Oral",,,,,,,,,,,,,,,,,Ethical
43504,Marketed,1998-01-08,02229013,Isovue 200 Injection,1,V08AB04,Iopamidol,Solution,"Subarachnoidal,Intravascular",,,,,,,,,,,,,,,,,Ethical
43505,Marketed,1998-01-08,02229021,Isovue 300 Injection,1,V08AB04,Iopamidol,Liquid,Intravascular,,,,,,,,,,,,,,,,,Ethical
43506,Marketed,1998-01-08,02229048,Isovue 370 Injection,1,V08AB04,Iopamidol,Liquid,Intravascular,,,,,,,,,,,,,,,,,Ethical
65799,Marketed,2001-07-30,02242121,Isovue Multipack-370,1,V08AB04,Iopamidol,Liquid,Intravascular,,,,,,,,,,,,,,,,,Ethical
65800,Marketed,2001-07-30,02242122,Isovue Multipack-300,1,V08AB04,Iopamidol,Liquid,Intravascular,,,,,,,,,,,,,,,,,Ethical
16179,Marketed,2007-04-19,02078600,Ultravist 300,1,V08AB05,Iopromide,Solution,Intravascular,,,,,,,,,,,,,,,,,Ethical
16180,Marketed,2007-04-18,02078619,Ultravist 370,1,V08AB05,Iopromide,Solution,Intravascular,,,,,,,,,,,,,,,,,Ethical
86525,Marketed,2012-03-08,02379384,Yervoy,1,L01FX04,Ipilimumab,Solution,Intravenous,77700763,YERVOY (ipilimumab 200 mg per 40 mL solution for injection vial) BRISTOL-MYERS SQUIBB CANADA,Active,9013172,ipilimumab 200 mg per 40 mL solution for injection vial,8001816,ipilimumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
86525,Marketed,2012-03-08,02379384,Yervoy,1,L01FX04,Ipilimumab,Solution,Intravenous,77700764,YERVOY (ipilimumab 50 mg per 10 mL solution for injection vial) BRISTOL-MYERS SQUIBB CANADA,Active,9013173,ipilimumab 50 mg per 10 mL solution for injection vial,8001816,ipilimumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
86525,Marketed,2012-03-08,02379384,Yervoy,1,L01FX04,Ipilimumab,Solution,Intravenous,77700763,YERVOY (ipilimumab 200 mg per 40 mL solution for injection vial) BRISTOL-MYERS SQUIBB CANADA,Active,9013172,ipilimumab 200 mg per 40 mL solution for injection vial,8001816,ipilimumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
86525,Marketed,2012-03-08,02379384,Yervoy,1,L01FX04,Ipilimumab,Solution,Intravenous,77700764,YERVOY (ipilimumab 50 mg per 10 mL solution for injection vial) BRISTOL-MYERS SQUIBB CANADA,Active,9013173,ipilimumab 50 mg per 10 mL solution for injection vial,8001816,ipilimumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
103113,Marketed,2024-08-15,02542587,JAMP Ipratropium HFA,1,R03BB01,Ipratropium bromide,Metered-dose aerosol,Inhalation,02542587,JAMP IPRATROPIUM HFA (ipratropium bromide 20 mcg per actuation pressurized inhalation) JAMP PHARMA CORPORATION,Active,9001074,ipratropium bromide 20 mcg per actuation pressurized inhalation,8000202,ipratropium,447694001,447694001,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,,Prescription
16947,Marketed,2024-03-28,02126222,AA-Ipravent,1,R03BB01,Ipratropium bromide,Solution,Inhalation,02126222,AA-IPRAVENT (ipratropium bromide 250 mcg per mL nebulizer solution 20 mL bottle) AA PHARMA INC,Active,9000527,ipratropium bromide 250 mcg per mL nebulizer solution 20 mL bottle,8000202,ipratropium,738984000,Parenteral,385198000,Solution for nebuliser,,,,,,Prescription
43176,Marketed,2012-07-12,02216221,Teva-Ipratropium Sterinebs,1,R03BB01,Ipratropium bromide,Solution,Inhalation,77700374,TEVA-IPRATROPIUM STERINEBS (ipratropium bromide 250 mcg per 1 mL nebulizer solution unit dose vial) TEVA CANADA LIMITED,Active,9000754,ipratropium bromide 250 mcg per 1 mL nebulizer solution unit dose vial,8000202,ipratropium,447694001,Inhalation,385198000,Solution for nebuliser,733026001,Vial (unit of presentation),,,,Prescription
43176,Marketed,2012-07-12,02216221,Teva-Ipratropium Sterinebs,1,R03BB01,Ipratropium bromide,Solution,Inhalation,77700375,TEVA-IPRATROPIUM STERINEBS (ipratropium bromide 500 mcg per 2 mL nebulizer solution unit dose vial) TEVA CANADA LIMITED,Active,9000756,ipratropium bromide 500 mcg per 2 mL nebulizer solution unit dose vial,8000202,ipratropium,447694001,Inhalation,385198000,Solution for nebuliser,733026001,Vial (unit of presentation),,,,Prescription
50442,Marketed,2001-06-08,02231135,PMS-Ipratropium,1,R03BB01,Ipratropium bromide,Solution,Inhalation,02231135,PMS-IPRATROPIUM (ipratropium bromide 250 mcg per 2 mL nebulizer solution unit dose vial) PHARMASCIENCE INC,Active,9000755,ipratropium bromide 250 mcg per 2 mL nebulizer solution unit dose vial,8000202,ipratropium,447694001,Inhalation,385198000,Solution for nebuliser,733026001,Vial (unit of presentation),,,,Prescription
50551,Marketed,1997-10-29,02231244,PMS-Ipratropium,1,R03BB01,Ipratropium bromide,Solution,Inhalation,02231244,PMS-IPRATROPIUM (ipratropium bromide 250 mcg per 1 mL nebulizer solution unit dose vial) PHARMASCIENCE INC,Active,9000754,ipratropium bromide 250 mcg per 1 mL nebulizer solution unit dose vial,8000202,ipratropium,447694001,Inhalation,385198000,Solution for nebuliser,733026001,Vial (unit of presentation),,,,Prescription
50552,Marketed,1997-10-29,02231245,PMS-Ipratropium,1,R03BB01,Ipratropium bromide,Solution,Inhalation,02231245,PMS-IPRATROPIUM (ipratropium bromide 500 mcg per 2 mL nebulizer solution unit dose vial) PHARMASCIENCE INC,Active,9000756,ipratropium bromide 500 mcg per 2 mL nebulizer solution unit dose vial,8000202,ipratropium,447694001,Inhalation,385198000,Solution for nebuliser,733026001,Vial (unit of presentation),,,,Prescription
63098,Marketed,1999-04-15,02239627,PMS-Ipratropium,1,R03BB01,Ipratropium bromide,Solution,Nasal,02239627,PMS-IPRATROPIUM (ipratropium bromide 21 mcg per actuation nasal spray) PHARMASCIENCE INC,Active,9000588,ipratropium bromide 21 mcg per actuation nasal spray,8000202,ipratropium,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,,Prescription
70219,Marketed,2014-05-28,02246084,Ipravent,1,R01AX03,Ipratropium bromide,Solution,Nasal,02246084,IPRAVENT (ipratropium bromide 42 mcg per actuation nasal spray) AA PHARMA INC,Active,9000640,ipratropium bromide 42 mcg per actuation nasal spray,8000202,ipratropium,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,,Prescription
71950,Marketed,2004-03-24,02247686,Atrovent HFA,1,R03BB01,Ipratropium bromide,Metered-dose aerosol,Inhalation,02247686,ATROVENT HFA (ipratropium bromide 20 mcg per actuation pressurized inhalation) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9001074,ipratropium bromide 20 mcg per actuation pressurized inhalation,8000202,ipratropium,447694001,447694001,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,,Prescription
104318,Marketed,2025-03-28,02554313,Fabhalta,1,L04AJ08,Iptacopan,Capsule,Oral,02554313,FABHALTA (iptacopan (iptacopan hydrochloride) 200 mg oral capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9015190,iptacopan (iptacopan hydrochloride) 200 mg oral capsule,8002538,iptacopan,26643006,Oral,420692007,Oral capsule,732937005,Capsule,1.0,,,Prescription
101375,Marketed,2023-06-08,02524732,Riva-Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02524732,RIVA-IRBESARTAN (irbesartan 75 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000802,irbesartan 75 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101376,Marketed,2023-06-08,02524740,Riva-Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02524740,RIVA-IRBESARTAN (irbesartan 150 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000805,irbesartan 150 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101377,Marketed,2023-06-08,02524759,Riva-Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02524759,RIVA-IRBESARTAN (irbesartan 300 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000806,irbesartan 300 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101383,Marketed,2022-07-25,02524813,M-Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02524813,M-IRBESARTAN (irbesartan 75 mg oral tablet) MANTRA PHARMA INC,Active,9000802,irbesartan 75 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101384,Marketed,2022-07-25,02524821,M-Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02524821,M-IRBESARTAN (irbesartan 150 mg oral tablet) MANTRA PHARMA INC,Active,9000805,irbesartan 150 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101385,Marketed,2022-07-25,02524848,M-Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02524848,M-IRBESARTAN (irbesartan 300 mg oral tablet) MANTRA PHARMA INC,Active,9000806,irbesartan 300 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103401,Marketed,2025-02-04,02545225,JAMP Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02545225,JAMP IRBESARTAN (irbesartan 75 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000802,irbesartan 75 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103402,Marketed,2025-02-04,02545233,JAMP Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02545233,JAMP IRBESARTAN (irbesartan 150 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000805,irbesartan 150 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103403,Marketed,2025-02-04,02545241,JAMP Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02545241,JAMP IRBESARTAN (irbesartan 300 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000806,irbesartan 300 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103710,Marketed,2025-03-12,02548216,AG-Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02548216,AG-IRBESARTAN (irbesartan 75 mg oral tablet) ANGITA PHARMA INC.,Active,9000802,irbesartan 75 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103711,Marketed,2025-02-15,02548224,AG-Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02548224,AG-IRBESARTAN (irbesartan 150 mg oral tablet) ANGITA PHARMA INC.,Active,9000805,irbesartan 150 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103712,Marketed,2025-02-14,02548232,AG-Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02548232,AG-IRBESARTAN (irbesartan 300 mg oral tablet) ANGITA PHARMA INC.,Active,9000806,irbesartan 300 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106316,Marketed,2026-04-29,02560070,NB-Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02560070,NB-IRBESARTAN (irbesartan 75 mg oral tablet) NB PHARMA INC.,Active,9000802,irbesartan 75 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106317,Marketed,2026-04-29,02560089,NB-Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02560089,NB-IRBESARTAN (irbesartan 150 mg oral tablet) NB PHARMA INC.,Active,9000805,irbesartan 150 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106318,Marketed,2026-04-29,02560097,NB-Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02560097,NB-IRBESARTAN (irbesartan 300 mg oral tablet) NB PHARMA INC.,Active,9000806,irbesartan 300 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
61289,Marketed,2007-05-14,02237924,Avapro,1,C09CA04,Irbesartan,Tablet,Oral,02237924,AVAPRO (irbesartan 150 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9000805,irbesartan 150 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
61290,Marketed,2007-05-03,02237925,Avapro,1,C09CA04,Irbesartan,Tablet,Oral,02237925,AVAPRO (irbesartan 300 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9000806,irbesartan 300 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80190,Marketed,2018-06-11,02316390,Teva-Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02316390,TEVA-IRBESARTAN (irbesartan 75 mg oral tablet) TEVA CANADA LIMITED,Active,9000802,irbesartan 75 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80191,Marketed,2018-06-11,02316404,Teva-Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02316404,TEVA-IRBESARTAN (irbesartan 150 mg oral tablet) TEVA CANADA LIMITED,Active,9000805,irbesartan 150 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80192,Marketed,2018-06-11,02316412,Teva-Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02316412,TEVA-IRBESARTAN (irbesartan 300 mg oral tablet) TEVA CANADA LIMITED,Active,9000806,irbesartan 300 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80257,Marketed,2011-03-24,02317060,PMS-Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02317060,PMS-IRBESARTAN (irbesartan 75 mg oral tablet) PHARMASCIENCE INC,Active,9000802,irbesartan 75 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80258,Marketed,2011-03-24,02317079,PMS-Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02317079,PMS-IRBESARTAN (irbesartan 150 mg oral tablet) PHARMASCIENCE INC,Active,9000805,irbesartan 150 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80259,Marketed,2011-03-24,02317087,PMS-Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02317087,PMS-IRBESARTAN (irbesartan 300 mg oral tablet) PHARMASCIENCE INC,Active,9000806,irbesartan 300 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81399,Marketed,2011-03-21,02328461,Sandoz Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02328461,SANDOZ IRBESARTAN (irbesartan 75 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000802,irbesartan 75 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81400,Marketed,2011-03-21,02328488,Sandoz Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02328488,SANDOZ IRBESARTAN (irbesartan 150 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000805,irbesartan 150 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81401,Marketed,2011-03-21,02328496,Sandoz Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02328496,SANDOZ IRBESARTAN (irbesartan 300 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000806,irbesartan 300 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85004,Marketed,2011-05-27,02365197,Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02365197,IRBESARTAN (irbesartan 75 mg oral tablet) PRO DOC LIMITEE,Active,9000802,irbesartan 75 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85005,Marketed,2011-05-27,02365200,Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02365200,IRBESARTAN (irbesartan 150 mg oral tablet) PRO DOC LIMITEE,Active,9000805,irbesartan 150 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85006,Marketed,2011-05-27,02365219,Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02365219,IRBESARTAN (irbesartan 300 mg oral tablet) PRO DOC LIMITEE,Active,9000806,irbesartan 300 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85748,Marketed,2025-11-25,02372347,Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02372347,IRBESARTAN (irbesartan 75 mg oral tablet) SANIS HEALTH INC,Active,9000802,irbesartan 75 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85751,Marketed,2024-07-04,02372371,Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02372371,IRBESARTAN (irbesartan 150 mg oral tablet) SANIS HEALTH INC,Active,9000805,irbesartan 150 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85752,Marketed,2025-11-25,02372398,Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02372398,IRBESARTAN (irbesartan 300 mg oral tablet) SANIS HEALTH INC,Active,9000806,irbesartan 300 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87092,Marketed,2012-06-10,02385287,Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02385287,IRBESARTAN (irbesartan 75 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000802,irbesartan 75 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87093,Marketed,2012-06-10,02385295,Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02385295,IRBESARTAN (irbesartan 150 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000805,irbesartan 150 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87094,Marketed,2012-06-10,02385309,Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02385309,IRBESARTAN (irbesartan 300 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000806,irbesartan 300 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89149,Marketed,2020-03-03,02406810,Taro-Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02406810,TARO-IRBESARTAN (irbesartan 75 mg oral tablet) SUN PHARMA CANADA INC,Active,9000802,irbesartan 75 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89150,Marketed,2020-03-03,02406829,Taro-Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02406829,TARO-IRBESARTAN (irbesartan 150 mg oral tablet) SUN PHARMA CANADA INC,Active,9000805,irbesartan 150 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89151,Marketed,2020-03-03,02406837,Taro-Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02406837,TARO-IRBESARTAN (irbesartan 300 mg oral tablet) SUN PHARMA CANADA INC,Active,9000806,irbesartan 300 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90771,Marketed,2021-05-17,02422980,Mint-Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02422980,MINT-IRBESARTAN (irbesartan 75 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000802,irbesartan 75 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90772,Marketed,2021-04-28,02422999,Mint-Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02422999,MINT-IRBESARTAN (irbesartan 150 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000805,irbesartan 150 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90773,Marketed,2021-04-28,02423006,Mint-Irbesartan,1,C09CA04,Irbesartan,Tablet,Oral,02423006,MINT-IRBESARTAN (irbesartan 300 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000806,irbesartan 300 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
65483,Marketed,2007-06-11,02241818,Avalide,2,C09DA04,Irbesartan and diuretics,Tablet,Oral,02241818,AVALIDE (hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9000887,hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
65484,Marketed,2007-05-14,02241819,Avalide,2,C09DA04,Irbesartan and diuretics,Tablet,Oral,02241819,AVALIDE (hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9000888,hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81403,Marketed,2011-03-24,02328518,PMS-Irbesartan-HCTZ,2,C09DA04,Irbesartan and diuretics,Tablet,Oral,02328518,PMS-IRBESARTAN-HCTZ (hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet) PHARMASCIENCE INC,Active,9000887,hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81404,Marketed,2011-03-24,02328526,PMS-Irbesartan-HCTZ,2,C09DA04,Irbesartan and diuretics,Tablet,Oral,02328526,PMS-IRBESARTAN-HCTZ (hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet) PHARMASCIENCE INC,Active,9000888,hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81405,Marketed,2011-03-24,02328534,PMS-Irbesartan-HCTZ,2,C09DA04,Irbesartan and diuretics,Tablet,Oral,02328534,PMS-IRBESARTAN-HCTZ (hydrochlorothiazide 25 mg and irbesartan 300 mg oral tablet) PHARMASCIENCE INC,Active,9001339,hydrochlorothiazide 25 mg and irbesartan 300 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81624,Marketed,2018-06-13,02330512,Teva-Irbesartan HCTZ,2,C09DA04,Irbesartan and diuretics,Tablet,Oral,02330512,TEVA-IRBESARTAN HCTZ (hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet) TEVA CANADA LIMITED,Active,9000887,hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81625,Marketed,2018-06-13,02330520,Teva-Irbesartan HCTZ,2,C09DA04,Irbesartan and diuretics,Tablet,Oral,02330520,TEVA-IRBESARTAN HCTZ (hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet) TEVA CANADA LIMITED,Active,9000888,hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81626,Marketed,2018-06-13,02330539,Teva-Irbesartan HCTZ,2,C09DA04,Irbesartan and diuretics,Tablet,Oral,02330539,TEVA-IRBESARTAN HCTZ (hydrochlorothiazide 25 mg and irbesartan 300 mg oral tablet) TEVA CANADA LIMITED,Active,9001339,hydrochlorothiazide 25 mg and irbesartan 300 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82301,Marketed,2011-03-21,02337428,Sandoz Irbesartan HCTZ,2,C09DA04,Irbesartan and diuretics,Tablet,Oral,02337428,SANDOZ IRBESARTAN HCT (hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000887,hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82302,Marketed,2011-03-21,02337436,Sandoz Irbesartan HCTZ,2,C09DA04,Irbesartan and diuretics,Tablet,Oral,02337436,SANDOZ IRBESARTAN HCT (hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000888,hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82303,Marketed,2011-03-21,02337444,Sandoz Irbesartan HCTZ,2,C09DA04,Irbesartan and diuretics,Tablet,Oral,02337444,SANDOZ IRBESARTAN HCT (hydrochlorothiazide 25 mg and irbesartan 300 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001339,hydrochlorothiazide 25 mg and irbesartan 300 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85001,Marketed,2026-03-20,02365162,Pro-Irbesartan-HCTZ,2,C09DA04,Irbesartan and diuretics,Tablet,Oral,02365162,PRO-IRBESARTAN-HCTZ (hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet) PRO DOC LIMITEE,Active,9000887,hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85002,Marketed,2026-03-20,02365170,Pro-Irbesartan-HCTZ,2,C09DA04,Irbesartan and diuretics,Tablet,Oral,02365170,PRO-IRBESARTAN-HCTZ (hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet) PRO DOC LIMITEE,Active,9000888,hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85003,Marketed,2026-03-20,02365189,Pro-Irbesartan-HCTZ,2,C09DA04,Irbesartan and diuretics,Tablet,Oral,02365189,PRO-IRBESARTAN-HCTZ (hydrochlorothiazide 25 mg and irbesartan 300 mg oral tablet) PRO DOC LIMITEE,Active,9001339,hydrochlorothiazide 25 mg and irbesartan 300 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85799,Marketed,2026-01-21,02372886,Irbesartan/HCTZ,2,C09DA04,Irbesartan and diuretics,Tablet,Oral,02372886,IRBESARTAN/HCTZ (hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet) SANIS HEALTH INC,Active,9000887,hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85800,Marketed,2026-01-21,02372894,Irbesartan/HCTZ,2,C09DA04,Irbesartan and diuretics,Tablet,Oral,02372894,IRBESARTAN/HCTZ (hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet) SANIS HEALTH INC,Active,9000888,hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85801,Marketed,2026-01-21,02372908,Irbesartan/HCTZ,2,C09DA04,Irbesartan and diuretics,Tablet,Oral,02372908,IRBESARTAN/HCTZ (hydrochlorothiazide 25 mg and irbesartan 300 mg oral tablet) SANIS HEALTH INC,Active,9001339,hydrochlorothiazide 25 mg and irbesartan 300 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87095,Marketed,2012-06-10,02385317,Irbesartan HCTZ,2,C09DA04,Irbesartan and diuretics,Tablet,Oral,02385317,IRBESARTAN HCT (hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000887,hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87096,Marketed,2012-06-12,02385325,Irbesartan HCTZ,2,C09DA04,Irbesartan and diuretics,Tablet,Oral,02385325,IRBESARTAN HCT (hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000888,hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87097,Marketed,2012-06-10,02385333,Irbesartan HCTZ,2,C09DA04,Irbesartan and diuretics,Tablet,Oral,02385333,IRBESARTAN HCT (hydrochlorothiazide 25 mg and irbesartan 300 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001339,hydrochlorothiazide 25 mg and irbesartan 300 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101797,Marketed,2024-02-28,02528789,Irinotecan Hydrochloride Injection,1,L01CE02,Irinotecan,Solution,Intravenous,02528789,IRINOTECAN HYDROCHLORIDE INJECTION (irinotecan hydrochloride 500 mg per 25 mL solution for injection vial) EUGIA PHARMA INC.,Active,9012672,irinotecan hydrochloride 500 mg per 25 mL solution for injection vial,8002198,irinotecan (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
101799,Marketed,2024-08-12,02528800,Irinotecan Hydrochloride Injection,1,L01CE02,Irinotecan,Solution,Intravenous,02528800,IRINOTECAN HYDROCHLORIDE INJECTION (irinotecan hydrochloride 100 mg per 5 mL solution for injection vial) EUGIA PHARMA INC.,Active,9012669,irinotecan hydrochloride 100 mg per 5 mL solution for injection vial,8002198,irinotecan (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
74343,Marketed,2018-03-13,02258218,Irinotecan Hydrochloride Injection USP,1,L01CE02,Irinotecan,Solution,Intravenous,77700865,IRINOTECAN HYDROCHLORIDE INJECTION USP (irinotecan hydrochloride 40 mg per 2 mL solution for injection vial) PFIZER CANADA ULC,Active,9012671,irinotecan hydrochloride 40 mg per 2 mL solution for injection vial,8002198,irinotecan (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
74343,Marketed,2018-03-13,02258218,Irinotecan Hydrochloride Injection USP,1,L01CE02,Irinotecan,Solution,Intravenous,77700866,IRINOTECAN HYDROCHLORIDE INJECTION USP (irinotecan hydrochloride 100 mg per 5 mL solution for injection vial) PFIZER CANADA ULC,Active,9012669,irinotecan hydrochloride 100 mg per 5 mL solution for injection vial,8002198,irinotecan (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
74343,Marketed,2018-03-13,02258218,Irinotecan Hydrochloride Injection USP,1,L01CE02,Irinotecan,Solution,Intravenous,77700867,IRINOTECAN HYDROCHLORIDE INJECTION USP (irinotecan hydrochloride 500 mg per 25 mL solution for injection vial) PFIZER CANADA ULC,Active,9012672,irinotecan hydrochloride 500 mg per 25 mL solution for injection vial,8002198,irinotecan (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
79791,Marketed,2014-04-30,02312409,Irinotecan For Injection,1,L01CE02,Irinotecan,Solution,Intravenous,77700872,IRINOTECAN FOR INJECTION (irinotecan hydrochloride 40 mg per 2 mL solution for injection vial) TEVA CANADA LIMITED,Active,9012671,irinotecan hydrochloride 40 mg per 2 mL solution for injection vial,8002198,irinotecan (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
79791,Marketed,2014-04-30,02312409,Irinotecan For Injection,1,L01CE02,Irinotecan,Solution,Intravenous,77700873,IRINOTECAN FOR INJECTION (irinotecan hydrochloride 500 mg per 25 mL solution for injection vial) TEVA CANADA LIMITED,Active,9012672,irinotecan hydrochloride 500 mg per 25 mL solution for injection vial,8002198,irinotecan (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
79791,Marketed,2014-04-30,02312409,Irinotecan For Injection,1,L01CE02,Irinotecan,Solution,Intravenous,77700874,IRINOTECAN FOR INJECTION (irinotecan hydrochloride 100 mg per 5 mL solution for injection vial) TEVA CANADA LIMITED,Active,9012669,irinotecan hydrochloride 100 mg per 5 mL solution for injection vial,8002198,irinotecan (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
84269,Marketed,2019-01-15,02357585,Irinotecan Hydrochloride Injection USP,1,L01CE02,Irinotecan,Solution,Intravenous,77700879,IRINOTECAN HYDROCHLORIDE INJECTION USP (irinotecan hydrochloride (irinotecan hydrochloride trihydrate) 500 mg per 25 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9012672,irinotecan hydrochloride 500 mg per 25 mL solution for injection vial,8002198,irinotecan (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
84269,Marketed,2019-01-15,02357585,Irinotecan Hydrochloride Injection USP,1,L01CE02,Irinotecan,Solution,Intravenous,77700880,IRINOTECAN HYDROCHLORIDE INJECTION USP (irinotecan hydrochloride (irinotecan hydrochloride trihydrate) 40 mg per 2 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9012671,irinotecan hydrochloride 40 mg per 2 mL solution for injection vial,8002198,irinotecan (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
84269,Marketed,2019-01-15,02357585,Irinotecan Hydrochloride Injection USP,1,L01CE02,Irinotecan,Solution,Intravenous,77700881,IRINOTECAN HYDROCHLORIDE INJECTION USP (irinotecan hydrochloride (irinotecan hydrochloride trihydrate) 100 mg per 5 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9012669,irinotecan hydrochloride 100 mg per 5 mL solution for injection vial,8002198,irinotecan (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
93881,Marketed,2024-05-22,02452421,"Irinotecan Hydrochloride Injection, USP",1,L01CE02,Irinotecan,Solution,Intravenous,77701154,"IRINOTECAN HYDROCHLORIDE INJECTION, USP (irinotecan hydrochloride (irinotecan hydrochloride trihydrate) 40 mg per 2 mL solution for injection vial) GENERIC MEDICAL PARTNERS INC",Active,9012671,irinotecan hydrochloride 40 mg per 2 mL solution for injection vial,8002198,irinotecan (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
93881,Marketed,2024-05-22,02452421,"Irinotecan Hydrochloride Injection, USP",1,L01CE02,Irinotecan,Solution,Intravenous,77701155,"IRINOTECAN HYDROCHLORIDE INJECTION, USP (irinotecan hydrochloride (irinotecan hydrochloride trihydrate) 100 mg per 5 mL solution for injection vial) GENERIC MEDICAL PARTNERS INC",Active,9012669,irinotecan hydrochloride 100 mg per 5 mL solution for injection vial,8002198,irinotecan (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
93881,Marketed,2024-05-22,02452421,"Irinotecan Hydrochloride Injection, USP",1,L01CE02,Irinotecan,Solution,Intravenous,77701156,"IRINOTECAN HYDROCHLORIDE INJECTION, USP (irinotecan hydrochloride (irinotecan hydrochloride trihydrate) 300 mg per 15 mL solution for injection vial) GENERIC MEDICAL PARTNERS INC",Active,9012670,irinotecan hydrochloride 300 mg per 15 mL solution for injection vial,8002198,irinotecan (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
93881,Marketed,2024-05-22,02452421,"Irinotecan Hydrochloride Injection, USP",1,L01CE02,Irinotecan,Solution,Intravenous,77701157,"IRINOTECAN HYDROCHLORIDE INJECTION, USP (irinotecan hydrochloride (irinotecan hydrochloride trihydrate) 500 mg per 25 mL solution for injection vial) GENERIC MEDICAL PARTNERS INC",Active,9012672,irinotecan hydrochloride 500 mg per 25 mL solution for injection vial,8002198,irinotecan (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99090,Marketed,2022-05-19,02501279,Irinotecan Hydrochloride Injection,1,L01CE02,Irinotecan,Solution,Intravenous,02501279,IRINOTECAN HYDROCHLORIDE INJECTION (irinotecan hydrochloride 100 mg per 5 mL solution for injection vial) AURO PHARMA INC,Active,9012669,irinotecan hydrochloride 100 mg per 5 mL solution for injection vial,8002198,irinotecan (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99092,Marketed,2022-05-19,02501295,Irinotecan Hydrochloride Injection,1,L01CE02,Irinotecan,Solution,Intravenous,02501295,IRINOTECAN HYDROCHLORIDE INJECTION (irinotecan hydrochloride 500 mg per 25 mL solution for injection vial) AURO PHARMA INC,Active,9012672,irinotecan hydrochloride 500 mg per 25 mL solution for injection vial,8002198,irinotecan (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
102454,Marketed,2023-11-03,02535718,Pregnancy Multivitamin,17,B03AE04,"Iron, multivitamins and minerals",Tablet,Oral,,,,,,,,,,,,,,,,,Prescription
102618,Marketed,2023-12-04,02537478,Pregnancy Multivitamin Folic 5,17,B03AE04,"Iron, multivitamins and minerals",Tablet,Oral,,,,,,,,,,,,,,,,,Prescription
104157,Marketed,2025-02-06,02552620,Pregvit,17,B03AE04,"Iron, multivitamins and minerals",Tablet,Oral,,,,,,,,,,,,,,,,,Prescription
104158,Marketed,2025-03-31,02552639,Pregvit Folic 5,17,B03AE04,"Iron, multivitamins and minerals",Tablet,Oral,,,,,,,,,,,,,,,,,Prescription
103479,Marketed,2024-11-07,02546078,Ferinject,1,B03AC,"Iron, parenteral preparations",Dispersion,Intravenous,77701170,FERINJECT (iron (ferric carboxymaltose) 100 mg per 2 mL dispersion for injection vial) VIFOR (INTERNATIONAL) INC.,Active,9015168,iron (ferric carboxymaltose) 100 mg per 2 mL dispersion for injection vial,8002527,ferric carboxymaltose,738984000,Parenteral,1230185002,Dispersion for injection,733026001,Vial,,,,Prescription
103479,Marketed,2024-11-07,02546078,Ferinject,1,B03AC,"Iron, parenteral preparations",Dispersion,Intravenous,77701171,FERINJECT (iron (ferric carboxymaltose) 500 mg per 10 mL dispersion for injection vial) VIFOR (INTERNATIONAL) INC.,Active,9015169,iron (ferric carboxymaltose) 500 mg per 10 mL dispersion for injection vial,8002527,ferric carboxymaltose,738984000,Parenteral,1230185002,Dispersion for injection,733026001,Vial,,,,Prescription
103479,Marketed,2024-11-07,02546078,Ferinject,1,B03AC,"Iron, parenteral preparations",Dispersion,Intravenous,77701172,FERINJECT (iron (ferric carboxymaltose) 1000 mg per 20 mL dispersion for injection vial) VIFOR (INTERNATIONAL) INC.,Active,9015167,iron (ferric carboxymaltose) 1000 mg per 20 mL dispersion for injection vial,8002527,ferric carboxymaltose,738984000,Parenteral,1230185002,Dispersion for injection,733026001,Vial,,,,Prescription
67236,Marketed,2010-02-26,02243333,Ferrlecit,1,B03AC,"Iron, parenteral preparations",Solution,Intravenous,02243333,FERRLECIT (iron (sodium ferric gluconate complex) 62.5 mg per 5 mL solution for injection vial) SANOFI-AVENTIS CANADA INC,Active,9013823,iron (sodium ferric gluconate complex) 62.5 mg per 5 mL solution for injection vial,8002232,sodium ferric gluconate complex,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
67648,Marketed,2019-06-19,02243716,Venofer,1,B03AC,"Iron, parenteral preparations",Solution,Intravenous,02243716,"VENOFER (iron (iron sucrose) 100 mg per 5 mL solution for injection vial) AMERICAN REGENT, INC",Active,9013439,iron (iron sucrose) 100 mg per 5 mL solution for injection vial,8002230,iron sucrose,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
96866,Marketed,2022-01-14,02477777,Monoferric,1,B03AC,"Iron, parenteral preparations",Solution,Intravenous,77700987,MONOFERRIC (iron (ferric derisomaltose) 1000 mg per 10 mL solution for injection vial) PHARMACOSMOS A/S,Active,9013691,iron (ferric derisomaltose) 1000 mg per 10 mL solution for injection vial,8002229,ferric derisomaltose,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
96866,Marketed,2022-01-14,02477777,Monoferric,1,B03AC,"Iron, parenteral preparations",Solution,Intravenous,77700988,MONOFERRIC (iron (ferric derisomaltose) 500 mg per 5 mL solution for injection vial) PHARMACOSMOS A/S,Active,9013692,iron (ferric derisomaltose) 500 mg per 5 mL solution for injection vial,8002229,ferric derisomaltose,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
96866,Marketed,2022-01-14,02477777,Monoferric,1,B03AC,"Iron, parenteral preparations",Solution,Intravenous,77700989,MONOFERRIC (iron (ferric derisomaltose) 100 mg per 1 mL solution for injection vial) PHARMACOSMOS A/S,Active,9013690,iron (ferric derisomaltose) 100 mg per 1 mL solution for injection vial,8002229,ferric derisomaltose,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
99244,Marketed,2021-01-12,02502917,PMS-Iron Sucrose,1,B03AC,"Iron, parenteral preparations",Solution,Intravenous,02502917,PMS-IRON SUCROSE (iron (iron sucrose) 100 mg per 5 mL solution for injection vial) PHARMASCIENCE INC,Active,9013439,iron (iron sucrose) 100 mg per 5 mL solution for injection vial,8002230,iron sucrose,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
98801,Marketed,2020-07-03,02498235,Sarclisa,1,L01FC02,Isatuximab,Solution,Intravenous,02498235,SARCLISA (isatuximab 100 mg per 5 mL solution for injection vial) SANOFI-AVENTIS CANADA INC,Active,9014327,isatuximab 100 mg per 5 mL solution for injection vial,8002334,isatuximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
98801,Marketed,2020-07-03,02498235,Sarclisa,1,L01FC02,Isatuximab,Solution,Intravenous,02498235,SARCLISA (isatuximab 100 mg per 5 mL solution for injection vial) SANOFI-AVENTIS CANADA INC,Active,9014327,isatuximab 100 mg per 5 mL solution for injection vial,8002334,isatuximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
98802,Marketed,2020-07-03,02498243,Sarclisa,1,L01FC02,Isatuximab,Solution,Intravenous,02498243,SARCLISA (isatuximab 500 mg per 25 mL solution for injection vial) SANOFI-AVENTIS CANADA INC,Active,9014328,isatuximab 500 mg per 25 mL solution for injection vial,8002334,isatuximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
98802,Marketed,2020-07-03,02498243,Sarclisa,1,L01FC02,Isatuximab,Solution,Intravenous,02498243,SARCLISA (isatuximab 500 mg per 25 mL solution for injection vial) SANOFI-AVENTIS CANADA INC,Active,9014328,isatuximab 500 mg per 25 mL solution for injection vial,8002334,isatuximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
104221,Marketed,2025-05-12,02553279,Cresemba,1,J02AC05,Isavuconazole,Capsule,Oral,02553279,CRESEMBA (isavuconazole (isavuconazonium sulfate) 40 mg oral capsule) AVIR PHARMA INC.,Active,9015203,isavuconazole (isavuconazonium sulfate) 40 mg oral capsule,8002259,isavuconazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule,,,,Prescription
97432,Marketed,2019-05-02,02483971,Cresemba,1,J02AC05,Isavuconazole,Capsule,Oral,02483971,CRESEMBA (isavuconazole (isavuconazonium sulfate) 100 mg oral capsule) AVIR PHARMA INC.,Active,9013965,isavuconazole (isavuconazonium sulfate) 100 mg oral capsule,8002259,isavuconazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97433,Marketed,2019-05-31,02483998,Cresemba,1,J02AC05,Isavuconazole,Powder for solution,Intravenous,02483998,CRESEMBA (isavuconazole (isavuconazonium sulfate) 200 mg per vial powder for solution for injection) AVIR PHARMA INC.,Active,9013966,isavuconazole (isavuconazonium sulfate) 200 mg per vial powder for solution for injection,8002259,isavuconazole,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
20160,Marketed,2000-01-01,02188856,Forane,1,N01AB06,Isoflurane,Liquid,Inhalation,,,,,,,,,,,,,,,,,Prescription
51381,Marketed,2015-09-25,02231929,Isoflurane USP,1,N01AB06,Isoflurane,Liquid,Inhalation,,,,,,,,,,,,,,,,,Prescription
5718,Marketed,2015-01-16,00577790,PDP-Isoniazid,1,J04AC01,Isoniazid,Tablet,Oral,00577790,PDP-ISONIAZID (isoniazid 100 mg oral tablet) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9001689,isoniazid 100 mg oral tablet,8001395,isoniazid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
5719,Marketed,2015-01-20,00577804,PDP-Isoniazid,1,J04AC01,Isoniazid,Tablet,Oral,00577804,PDP-ISONIAZID (isoniazid 300 mg oral tablet) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9001690,isoniazid 300 mg oral tablet,8001395,isoniazid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
5720,Marketed,2015-05-04,00577812,PDP-Isoniazid,1,J04AC01,Isoniazid,Solution,Oral,00577812,PDP-ISONIAZID (isoniazid 50 mg per 5 mL oral solution) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9002027,isoniazid 50 mg per 5 mL oral solution,8001395,isoniazid,26643006,Oral,385023001,Oral solution,,,,,,Prescription
11642,Marketed,2005-10-05,00897639,Isoproterenol Hydrochloride Injection USP,1,C01CA02,Isoprenaline,Solution,"Intramuscular,Subcutaneous,Intravenous",77700709,ISOPROTERENOL HYDROCHLORIDE INJECTION USP (isoproterenol hydrochloride 1 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013175,isoproterenol hydrochloride 1 mg per 5 mL solution for injection vial,8001820,isoproterenol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
11642,Marketed,2005-10-05,00897639,Isoproterenol Hydrochloride Injection USP,1,C01CA02,Isoprenaline,Solution,"Intramuscular,Subcutaneous,Intravenous",77700710,ISOPROTERENOL HYDROCHLORIDE INJECTION USP (isoproterenol hydrochloride 0.2 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9013174,isoproterenol hydrochloride 0.2 mg per 1 mL solution for injection ampoule,8001820,isoproterenol,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
99218,Marketed,2020-12-11,02502615,Isoproterenol Hydrochloride Injection USP,1,C01CA02,Isoprenaline,Solution,"Subcutaneous,Intramuscular,Intravenous",02502615,ISOPROTERENOL HYDROCHLORIDE INJECTION USP (isoproterenol hydrochloride 0.2 mg per 1 mL solution for injection vial) MARCAN PHARMACEUTICALS INC,Active,9014455,isoproterenol hydrochloride 0.2 mg per 1 mL solution for injection vial,8001820,isoproterenol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
99219,Marketed,2021-01-06,02502623,Isoproterenol Hydrochloride Injection USP,1,C01CA02,Isoprenaline,Solution,"Intramuscular,Subcutaneous,Intravenous",02502623,ISOPROTERENOL HYDROCHLORIDE INJECTION USP (isoproterenol hydrochloride 1 mg per 5 mL solution for injection vial) MARCAN PHARMACEUTICALS INC,Active,9013175,isoproterenol hydrochloride 1 mg per 5 mL solution for injection vial,8001820,isoproterenol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
4730,Marketed,2011-08-17,00441686,Isdn,1,C01DA08,Isosorbide dinitrate,Tablet,Oral,00441686,ISDN (isosorbide dinitrate 10 mg oral tablet) AA PHARMA INC,Active,9001942,isosorbide dinitrate 10 mg oral tablet,8000830,isosorbide dinitrate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Ethical
4731,Marketed,2011-05-10,00441694,Isdn,1,C01DA08,Isosorbide dinitrate,Tablet,Oral,00441694,ISDN (isosorbide dinitrate 30 mg oral tablet) AA PHARMA INC,Active,9001943,isosorbide dinitrate 30 mg oral tablet,8000830,isosorbide dinitrate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Ethical
16804,Marketed,2022-12-15,02126559,Imdur,1,C01DA14,Isosorbide mononitrate,Tablet (extended-release),Oral,02126559,IMDUR (isosorbide mononitrate 60 mg prolonged-release oral tablet) JUNO PHARMACEUTICALS CORP.,Active,9000528,isosorbide mononitrate 60 mg prolonged-release oral tablet,8000203,isosorbide mononitrate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Ethical
75834,Marketed,2006-03-03,02272830,Apo-Ismn,1,C01DA14,Isosorbide mononitrate,Tablet (extended-release),Oral,02272830,APO-ISMN (isosorbide mononitrate 60 mg prolonged-release oral tablet) APOTEX INC,Active,9000528,isosorbide mononitrate 60 mg prolonged-release oral tablet,8000203,isosorbide mononitrate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Ethical
78661,Marketed,2007-11-08,02301288,PMS-Ismn,1,C01DA14,Isosorbide mononitrate,Tablet (extended-release),Oral,02301288,PMS-ISMN (isosorbide mononitrate 60 mg prolonged-release oral tablet) PHARMASCIENCE INC,Active,9000528,isosorbide mononitrate 60 mg prolonged-release oral tablet,8000203,isosorbide mononitrate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Ethical
79692,Marketed,2008-07-04,02311321,Pro-Ismn - 60,1,C01DA14,Isosorbide mononitrate,Tablet (extended-release),Oral,02311321,PRO-ISMN - 60 (isosorbide mononitrate 60 mg prolonged-release oral tablet) PRO DOC LIMITEE,Active,9000528,isosorbide mononitrate 60 mg prolonged-release oral tablet,8000203,isosorbide mononitrate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Ethical
64397,Marketed,2024-04-12,02240806,Extraneal,5,B05DA,Isotonic solutions,Solution,Haemodialysis (intraperitoneal),,,,,,,,,,,,,,,,,Ethical
102771,Marketed,2023-09-26,02539047,Absorica LD,1,D10BA01,Isotretinoin,Capsule,Oral,02539047,ABSORICA LD (isotretinoin 8 mg oral capsule) SUN PHARMACEUTICAL INDUSTRIES LIMITED,Active,9014917,isotretinoin 8 mg oral capsule,8001283,isotretinoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
102772,Marketed,2023-09-26,02539055,Absorica LD,1,D10BA01,Isotretinoin,Capsule,Oral,02539055,ABSORICA LD (isotretinoin 16 mg oral capsule) SUN PHARMACEUTICAL INDUSTRIES LIMITED,Active,9014914,isotretinoin 16 mg oral capsule,8001283,isotretinoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
102773,Marketed,2023-09-26,02539063,Absorica LD,1,D10BA01,Isotretinoin,Capsule,Oral,02539063,ABSORICA LD (isotretinoin 24 mg oral capsule) SUN PHARMACEUTICAL INDUSTRIES LIMITED,Active,9014915,isotretinoin 24 mg oral capsule,8001283,isotretinoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
102774,Marketed,2023-09-26,02539071,Absorica LD,1,D10BA01,Isotretinoin,Capsule,Oral,02539071,ABSORICA LD (isotretinoin 32 mg oral capsule) SUN PHARMACEUTICAL INDUSTRIES LIMITED,Active,9014916,isotretinoin 32 mg oral capsule,8001283,isotretinoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
5128,Marketed,2025-09-10,00582344,Accutane,1,D10BA01,Isotretinoin,Capsule,Oral,00582344,ACCUTANE (isotretinoin 10 mg oral capsule) CHEPLAPHARM SCHWEIZ GMBH,Active,9001985,isotretinoin 10 mg oral capsule,8001283,isotretinoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
5129,Marketed,2025-09-05,00582352,Accutane,1,D10BA01,Isotretinoin,Capsule,Oral,00582352,ACCUTANE (isotretinoin 40 mg oral capsule) CHEPLAPHARM SCHWEIZ GMBH,Active,9001986,isotretinoin 40 mg oral capsule,8001283,isotretinoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
74319,Marketed,2010-03-01,02257955,Clarus,1,D10BA01,Isotretinoin,Capsule,Oral,02257955,CLARUS (isotretinoin 10 mg oral capsule) MYLAN PHARMACEUTICALS ULC,Active,9001985,isotretinoin 10 mg oral capsule,8001283,isotretinoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
74320,Marketed,2010-03-01,02257963,Clarus,1,D10BA01,Isotretinoin,Capsule,Oral,02257963,CLARUS (isotretinoin 40 mg oral capsule) MYLAN PHARMACEUTICALS ULC,Active,9001986,isotretinoin 40 mg oral capsule,8001283,isotretinoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
88198,Marketed,2013-05-07,02396971,Epuris,1,D10BA01,Isotretinoin,Capsule,Oral,02396971,EPURIS (isotretinoin 10 mg oral capsule) CIPHER PHARMACEUTICALS INC,Active,9001985,isotretinoin 10 mg oral capsule,8001283,isotretinoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
88199,Marketed,2013-05-07,02396998,Epuris,1,D10BA01,Isotretinoin,Capsule,Oral,02396998,EPURIS (isotretinoin 20 mg oral capsule) CIPHER PHARMACEUTICALS INC,Active,9005240,isotretinoin 20 mg oral capsule,8001283,isotretinoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
88200,Marketed,2013-05-07,02397005,Epuris,1,D10BA01,Isotretinoin,Capsule,Oral,02397005,EPURIS (isotretinoin 30 mg oral capsule) CIPHER PHARMACEUTICALS INC,Active,9005241,isotretinoin 30 mg oral capsule,8001283,isotretinoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
88201,Marketed,2013-05-07,02397013,Epuris,1,D10BA01,Isotretinoin,Capsule,Oral,02397013,EPURIS (isotretinoin 40 mg oral capsule) CIPHER PHARMACEUTICALS INC,Active,9001986,isotretinoin 40 mg oral capsule,8001283,isotretinoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
95031,Marketed,2017-05-18,02462559,Mint-Itraconazole,1,J02AC02,Itraconazole,Capsule,Oral,02462559,MINT-ITRACONAZOLE (itraconazole 100 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9002587,itraconazole 100 mg oral capsule,8001208,itraconazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97463,Marketed,2019-07-31,02484315,JAMP Itraconazole Oral Solution,1,J02AC02,Itraconazole,Solution,Oral,02484315,JAMP ITRACONAZOLE ORAL SOLUTION (itraconazole 10 mg per mL oral solution) JAMP PHARMA CORPORATION,Active,9003125,itraconazole 10 mg per mL oral solution,8001208,itraconazole,26643006,Oral,385023001,Oral solution,,,,,,Prescription
98587,Marketed,2020-07-08,02495988,Odan Itraconazole,1,J02AC02,Itraconazole,Solution,Oral,02495988,ODAN ITRACONAZOLE (itraconazole 10 mg per mL oral solution) ODAN LABORATORIES LTD,Active,9003125,itraconazole 10 mg per mL oral solution,8001208,itraconazole,26643006,Oral,385023001,Oral solution,,,,,,Prescription
94728,Marketed,2017-03-17,02459973,Lancora,1,C01EB17,Ivabradine,Tablet,Oral,02459973,LANCORA (ivabradine (ivabradine hydrochloride) 5 mg oral tablet) SERVIER CANADA INC,Active,9006137,ivabradine (ivabradine hydrochloride) 5 mg oral tablet,8001821,ivabradine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
94729,Marketed,2017-03-17,02459981,Lancora,1,C01EB17,Ivabradine,Tablet,Oral,02459981,LANCORA (ivabradine (ivabradine hydrochloride) 7.5 mg oral tablet) SERVIER CANADA INC,Active,9006138,ivabradine (ivabradine hydrochloride) 7.5 mg oral tablet,8001821,ivabradine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100863,Marketed,2021-09-01,02519364,Kalydeco,1,R07AX02,Ivacaftor,Granules,Oral,02519364,KALYDECO (ivacaftor 25 mg per sachet oral granules) VERTEX PHARMACEUTICALS (CANADA) INCORPORATED,Active,9014697,ivacaftor 25 mg per sachet oral granules,8001663,ivacaftor,26643006,Oral,420509004,Oral granules,733013000,Sachet (unit of presentation),,,,Prescription
103192,Marketed,2023-12-07,02543451,Kalydeco,1,R07AX02,Ivacaftor,Granules,Oral,02543451,KALYDECO (ivacaftor 13.4 mg per sachet oral granules) VERTEX PHARMACEUTICALS (CANADA) INCORPORATED,Active,9015063,ivacaftor 13.4 mg per sachet oral granules,8001663,ivacaftor,26643006,Oral,420509004,Oral granules,733013000,Sachet (unit of presentation),,,,Prescription
88237,Marketed,2012-11-27,02397412,Kalydeco,1,R07AX02,Ivacaftor,Tablet,Oral,02397412,KALYDECO (ivacaftor 150 mg oral tablet) VERTEX PHARMACEUTICALS (CANADA) INCORPORATED,Active,9005135,ivacaftor 150 mg oral tablet,8001663,ivacaftor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92696,Marketed,2015-09-14,02442612,Kalydeco,1,R07AX02,Ivacaftor,Granules,Oral,02442612,KALYDECO (ivacaftor 50 mg per sachet oral granules) VERTEX PHARMACEUTICALS (CANADA) INCORPORATED,Active,9014698,ivacaftor 50 mg per sachet oral granules,8001663,ivacaftor,26643006,Oral,420509004,Oral granules,733013000,Sachet (unit of presentation),,,,Prescription
92697,Marketed,2015-09-14,02442620,Kalydeco,1,R07AX02,Ivacaftor,Granules,Oral,02442620,KALYDECO (ivacaftor 75 mg per sachet oral granules) VERTEX PHARMACEUTICALS (CANADA) INCORPORATED,Active,9014699,ivacaftor 75 mg per sachet oral granules,8001663,ivacaftor,26643006,Oral,420509004,Oral granules,733013000,Sachet (unit of presentation),,,,Prescription
102579,Marketed,2023-04-14,02537087,Orkambi,2,R07AX30,Ivacaftor and lumacaftor,Granules,Oral,02537087,ORKAMBI (ivacaftor 94 mg per sachet and lumacaftor 75 mg per sachet oral granules) VERTEX PHARMACEUTICALS (CANADA) INCORPORATED,Active,9014846,ivacaftor 94 mg per sachet and lumacaftor 75 mg per sachet oral granules,8001664,ivacaftor and lumacaftor,26643006,Oral,420509004,Oral granules,733013000,Sachet (unit of presentation),,,,Prescription
93762,Marketed,2016-01-27,02451379,Orkambi,2,R07AX30,Ivacaftor and lumacaftor,Tablet,Oral,02451379,ORKAMBI (ivacaftor 125 mg and lumacaftor 200 mg oral tablet) VERTEX PHARMACEUTICALS (CANADA) INCORPORATED,Active,9005865,ivacaftor 125 mg and lumacaftor 200 mg oral tablet,8001664,ivacaftor and lumacaftor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95094,Marketed,2017-05-03,02463040,Orkambi,2,R07AX30,Ivacaftor and lumacaftor,Tablet,Oral,02463040,ORKAMBI (ivacaftor 125 mg and lumacaftor 100 mg oral tablet) VERTEX PHARMACEUTICALS (CANADA) INCORPORATED,Active,9006170,ivacaftor 125 mg and lumacaftor 100 mg oral tablet,8001664,ivacaftor and lumacaftor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97420,Marketed,2018-12-14,02483831,Orkambi,2,R07AX30,Ivacaftor and lumacaftor,Granules,Oral,02483831,ORKAMBI (ivacaftor 125 mg per sachet and lumacaftor 100 mg per sachet oral granules) VERTEX PHARMACEUTICALS (CANADA) INCORPORATED,Active,9014695,ivacaftor 125 mg per sachet and lumacaftor 100 mg per sachet oral granules,8001664,ivacaftor and lumacaftor,26643006,Oral,420509004,Oral granules,733013000,Sachet (unit of presentation),,,,Prescription
97421,Marketed,2018-12-14,02483858,Orkambi,2,R07AX30,Ivacaftor and lumacaftor,Granules,Oral,02483858,ORKAMBI (ivacaftor 188 mg per sachet and lumacaftor 150 mg per sachet oral granules) VERTEX PHARMACEUTICALS (CANADA) INCORPORATED,Active,9014696,ivacaftor 188 mg per sachet and lumacaftor 150 mg per sachet oral granules,8001664,ivacaftor and lumacaftor,26643006,Oral,420509004,Oral granules,733013000,Sachet (unit of presentation),,,,Prescription
96881,Marketed,2018-06-28,02478080,Symdeko,3,R07AX31,Ivacaftor and tezacaftor,Tablet,Oral,02478080,SYMDEKO (ivacaftor 150 mg oral tablet with ivacaftor 150 mg and tezacaftor 100 mg oral tablet) VERTEX PHARMACEUTICALS (CANADA) INCORPORATED,Active,9013441,ivacaftor 150 mg oral tablet with ivacaftor 150 mg and tezacaftor 100 mg oral tablet,8002027,ivacaftor and tezacaftor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100648,Marketed,2021-06-22,02517140,Trikafta,4,R07AX32,"Ivacaftor, tezacaftor and elexacaftor",Tablet,Oral,02517140,TRIKAFTA (elexacaftor 100 mg and ivacaftor 75 mg and tezacaftor 50 mg oral tablet with ivacaftor 150 mg oral tablet) VERTEX PHARMACEUTICALS (CANADA) INCORPORATED,Active,9014544,elexacaftor 100 mg and ivacaftor 75 mg and tezacaftor 50 mg oral tablet with ivacaftor 150 mg oral tablet,8002373,elexacaftor and ivacaftor and tezacaftor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101574,Marketed,2022-04-22,02526670,Trikafta,4,R07AX32,"Ivacaftor, tezacaftor and elexacaftor",Tablet,Oral,02526670,TRIKAFTA (elexacaftor 50 mg and ivacaftor 37.5 mg and tezacaftor 25 mg oral tablet with ivacaftor 75 mg oral tablet) VERTEX PHARMACEUTICALS (CANADA) INCORPORATED,Active,9014692,elexacaftor 50 mg and ivacaftor 37.5 mg and tezacaftor 25 mg oral tablet with ivacaftor 75 mg oral tablet,8002373,elexacaftor and ivacaftor and tezacaftor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103085,Marketed,2023-10-27,02542277,Trikafta,4,R07AX32,"Ivacaftor, tezacaftor and elexacaftor",Granules,Oral,02542277,TRIKAFTA (elexacaftor 100 mg per sachet and ivacaftor 75 mg per sachet and tezacaftor 50 mg per sachet oral granules with ivacaftor 75 mg per sachet oral granules) VERTEX PHARMACEUTICALS (CANADA) INCORPORATED,Active,9014977,elexacaftor 100 mg per sachet and ivacaftor 75 mg per sachet and tezacaftor 50 mg per sachet oral granules with ivacaftor 75 mg per sachet oral granules,8002373,elexacaftor and ivacaftor and tezacaftor,26643006,Oral,420509004,Oral granules,733013000,Sachet (unit of presentation),,,,Prescription
103086,Marketed,2023-10-27,02542285,Trikafta,4,R07AX32,"Ivacaftor, tezacaftor and elexacaftor",Granules,Oral,02542285,TRIKAFTA (elexacaftor 80 mg per sachet and ivacaftor 60 mg per sachet and tezacaftor 40 mg per sachet oral granules with ivacaftor 59.5 mg per sachet oral granules) VERTEX PHARMACEUTICALS (CANADA) INCORPORATED,Active,9014978,elexacaftor 80 mg per sachet and ivacaftor 60 mg per sachet and tezacaftor 40 mg per sachet oral granules with ivacaftor 59.5 mg per sachet oral granules,8002373,elexacaftor and ivacaftor and tezacaftor,26643006,Oral,420509004,Oral granules,733013000,Sachet (unit of presentation),,,,Prescription
92470,Marketed,2015-05-25,02440342,Rosiver,1,D11AX22,Ivermectin,Cream,Topical,02440342,ROSIVER (ivermectin 1 % cutaneous cream) GALDERMA CANADA INC.,Active,9005722,ivermectin 1 % cutaneous cream,8001486,ivermectin,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
97110,Marketed,2018-11-06,02480557,Stromectol,1,P02CF01,Ivermectin,Tablet,Oral,02480557,STROMECTOL (ivermectin 3 mg oral tablet) MERCK CANADA INC,Active,9013442,ivermectin 3 mg oral tablet,8001486,ivermectin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103879,Marketed,2024-10-28,02549980,Tibsovo,1,L01XM02,Ivosidenib,Tablet (immediate release),Oral,02549980,TIBSOVO (ivosidenib 250 mg oral tablet) SERVIER CANADA INC,Active,9015121,ivosidenib 250 mg oral tablet,8002520,ivosidenib,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
94382,Marketed,2016-09-21,02456796,Ninlaro,1,L01XG03,Ixazomib,Capsule,Oral,02456796,NINLARO (ixazomib (ixazomib citrate) 2.3 mg oral capsule) TAKEDA CANADA INC,Active,9006040,ixazomib (ixazomib citrate) 2.3 mg oral capsule,8001822,ixazomib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
94383,Marketed,2016-09-21,02456818,Ninlaro,1,L01XG03,Ixazomib,Capsule,Oral,02456818,NINLARO (ixazomib (ixazomib citrate) 3 mg oral capsule) TAKEDA CANADA INC,Active,9006041,ixazomib (ixazomib citrate) 3 mg oral capsule,8001822,ixazomib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
94384,Marketed,2016-09-21,02456826,Ninlaro,1,L01XG03,Ixazomib,Capsule,Oral,02456826,NINLARO (ixazomib (ixazomib citrate) 4 mg oral capsule) TAKEDA CANADA INC,Active,9006042,ixazomib (ixazomib citrate) 4 mg oral capsule,8001822,ixazomib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
94193,Marketed,2023-03-20,02455102,Taltz,1,L04AC13,Ixekizumab,Solution,Subcutaneous,02455102,TALTZ AUTOINJECTOR (ixekizumab 80 mg per 1 mL solution for injection syringe) ELI LILLY CANADA INC,Active,9013176,ixekizumab 80 mg per 1 mL solution for injection syringe,8001823,ixekizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
94193,Marketed,2023-03-20,02455102,Taltz,1,L04AC13,Ixekizumab,Solution,Subcutaneous,02455102,TALTZ AUTOINJECTOR (ixekizumab 80 mg per 1 mL solution for injection syringe) ELI LILLY CANADA INC,Active,9013176,ixekizumab 80 mg per 1 mL solution for injection syringe,8001823,ixekizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
94194,Marketed,2023-04-12,02455110,Taltz,1,L04AC13,Ixekizumab,Solution,Subcutaneous,02455110,TALTZ SYRINGE (ixekizumab 80 mg per 1 mL solution for injection syringe) ELI LILLY CANADA INC,Active,9013176,ixekizumab 80 mg per 1 mL solution for injection syringe,8001823,ixekizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
94194,Marketed,2023-04-12,02455110,Taltz,1,L04AC13,Ixekizumab,Solution,Subcutaneous,02455110,TALTZ SYRINGE (ixekizumab 80 mg per 1 mL solution for injection syringe) ELI LILLY CANADA INC,Active,9013176,ixekizumab 80 mg per 1 mL solution for injection syringe,8001823,ixekizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
102449,Marketed,2023-11-14,02535645,"Ketamine Injection, BP",1,N01AX03,Ketamine,Solution,"Intramuscular,Intravenous",77701132,"KETAMINE INJECTION, BP (ketamine (ketamine hydrochloride) 100 mg per 2 mL solution for injection vial) STERIMAX INC",Active,9013443,ketamine (ketamine hydrochloride) 100 mg per 2 mL solution for injection vial,8002028,ketamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Narcotics (CDSA I)
102449,Marketed,2023-11-14,02535645,"Ketamine Injection, BP",1,N01AX03,Ketamine,Solution,"Intramuscular,Intravenous",77701133,"KETAMINE INJECTION, BP (ketamine (ketamine hydrochloride) 500 mg per 10 mL solution for injection vial) STERIMAX INC",Active,9013446,ketamine (ketamine hydrochloride) 500 mg per 10 mL solution for injection vial,8002028,ketamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Narcotics (CDSA I)
103925,Marketed,2025-12-03,02550431,"Ketamine Hydrochloride Injection, USP",1,N01AX03,Ketamine,Solution,"Intravenous,Intramuscular",02550431,"KETAMINE HYDROCHLORIDE INJECTION, USP (ketamine (ketamine hydrochloride) 200 mg per 20 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013445,ketamine (ketamine hydrochloride) 200 mg per 20 mL solution for injection vial,8002028,ketamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Narcotics (CDSA I)
103926,Marketed,2025-12-03,02550458,"Ketamine Hydrochloride Injection, USP",1,N01AX03,Ketamine,Solution,"Intramuscular,Intravenous",02550458,"KETAMINE HYDROCHLORIDE INJECTION, USP (ketamine (ketamine hydrochloride) 500 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013446,ketamine (ketamine hydrochloride) 500 mg per 10 mL solution for injection vial,8002028,ketamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Narcotics (CDSA I)
1214,Marketed,2023-10-16,00224391,Ketalar,1,N01AX03,Ketamine,Solution,"Intravenous,Intramuscular",00224391,KETALAR (ketamine (ketamine hydrochloride) 200 mg per 20 mL solution for injection vial) SEARCHLIGHT PHARMA INC,Active,9013445,ketamine (ketamine hydrochloride) 200 mg per 20 mL solution for injection vial,8002028,ketamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Narcotics (CDSA I)
1215,Marketed,2024-02-12,00224405,Ketalar,1,N01AX03,Ketamine,Solution,"Intravenous,Intramuscular",00224405,KETALAR (ketamine (ketamine hydrochloride) 500 mg per 10 mL solution for injection vial) SEARCHLIGHT PHARMA INC,Active,9013446,ketamine (ketamine hydrochloride) 500 mg per 10 mL solution for injection vial,8002028,ketamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Narcotics (CDSA I)
70995,Marketed,2005-09-21,02246795,Ketamine Hydrochloride Injection USP,1,N01AX03,Ketamine,Solution,"Intramuscular,Intravenous",77700929,KETAMINE HYDROCHLORIDE INJECTION USP (ketamine (ketamine hydrochloride) 20 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013444,ketamine (ketamine hydrochloride) 20 mg per 2 mL solution for injection vial,8002028,ketamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Narcotics (CDSA I)
70995,Marketed,2005-09-21,02246795,Ketamine Hydrochloride Injection USP,1,N01AX03,Ketamine,Solution,"Intramuscular,Intravenous",77700930,KETAMINE HYDROCHLORIDE INJECTION USP (ketamine (ketamine hydrochloride) 200 mg per 20 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013445,ketamine (ketamine hydrochloride) 200 mg per 20 mL solution for injection vial,8002028,ketamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Narcotics (CDSA I)
70996,Marketed,2005-09-21,02246796,Ketamine Hydrochloride Injection USP,1,N01AX03,Ketamine,Solution,"Intramuscular,Intravenous",77700931,KETAMINE HYDROCHLORIDE INJECTION USP (ketamine (ketamine hydrochloride) 100 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013443,ketamine (ketamine hydrochloride) 100 mg per 2 mL solution for injection vial,8002028,ketamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Narcotics (CDSA I)
70996,Marketed,2005-09-21,02246796,Ketamine Hydrochloride Injection USP,1,N01AX03,Ketamine,Solution,"Intramuscular,Intravenous",77700932,KETAMINE HYDROCHLORIDE INJECTION USP (ketamine (ketamine hydrochloride) 500 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013446,ketamine (ketamine hydrochloride) 500 mg per 10 mL solution for injection vial,8002028,ketamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Narcotics (CDSA I)
44259,Marketed,2019-03-18,02182920,Nizoral,1,D01AC08,Ketoconazole,Shampoo,Topical,02182920,"NIZORAL (ketoconazole 2 % shampoo) KRAMER LABORATORIES, INC",Active,9002234,ketoconazole 2 % shampoo,8001209,ketoconazole,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
50343,Marketed,2014-03-29,02231061,Teva-Ketoconazole,1,J02AB02,Ketoconazole,Tablet,Oral,02231061,TEVA-KETOCONAZOLE (ketoconazole 200 mg oral tablet) TEVA CANADA LIMITED,Active,9003213,ketoconazole 200 mg oral tablet,8001209,ketoconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
60554,Marketed,2021-11-08,02237235,Apo-Ketoconazole,1,J02AB02,Ketoconazole,Tablet,Oral,02237235,APO-KETOCONAZOLE (ketoconazole 200 mg oral tablet) APOTEX INC,Active,9003213,ketoconazole 200 mg oral tablet,8001209,ketoconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
69762,Marketed,2004-03-19,02245662,Ketoderm Cream 2%,1,D01AC08,Ketoconazole,Cream,Topical,02245662,"KETODERM CREAM 2% (ketoconazole 2 % cutaneous cream) TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Active,9003719,ketoconazole 2 % cutaneous cream,8001209,ketoconazole,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
10134,Marketed,2012-01-03,00842664,Ketoprofen-E,1,M01AE03,Ketoprofen,Tablet (enteric-coated),Oral,00842664,KETOPROFEN-E (ketoprofen 100 mg gastro-resistant tablet) AA PHARMA INC,Active,9002201,ketoprofen 100 mg gastro-resistant tablet,8001824,ketoprofen,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
10135,Marketed,2011-02-17,00790435,Ketoprofen-E,1,M01AE03,Ketoprofen,Tablet (enteric-coated),Oral,00790435,KETOPROFEN-E (ketoprofen 50 mg gastro-resistant tablet) AA PHARMA INC,Active,9002202,ketoprofen 50 mg gastro-resistant tablet,8001824,ketoprofen,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
19115,Marketed,2011-06-01,02172577,Ketoprofen SR,1,M01AE03,Ketoprofen,Tablet (extended-release),Oral,02172577,KETOPROFEN SR (ketoprofen 200 mg prolonged-release oral tablet) AA PHARMA INC,Active,9002832,ketoprofen 200 mg prolonged-release oral tablet,8001824,ketoprofen,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100012,Marketed,2023-04-18,02510855,JAMP Ketorolac,1,M01AB15,Ketorolac,Tablet,Oral,02510855,JAMP KETOROLAC (ketorolac tromethamine 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000590,ketorolac tromethamine 10 mg oral tablet,8000169,ketorolac,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101242,Marketed,2024-01-29,02523310,Ketorolac Tromethamine Injection USP,1,M01AB15,Ketorolac,Solution,Intramuscular,02523310,KETOROLAC TROMETHAMINE INJECTION USP (ketorolac tromethamine 30 mg per 1 mL solution for injection vial) JAMP PHARMA CORPORATION,Active,9000848,ketorolac tromethamine 30 mg per 1 mL solution for injection vial,8000169,ketorolac,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
13121,Marketed,2023-10-05,01968300,Acular,1,S01BC05,Ketorolac,Solution,Ophthalmic,01968300,ACULAR (ketorolac tromethamine 0.5 % ophthalmic drops) ABBVIE CORPORATION,Active,9000427,ketorolac tromethamine 0.5 % ophthalmic drops,8000169,ketorolac,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
19348,Marketed,2018-07-30,02162660,Toradol,1,M01AB15,Ketorolac,Tablet,Oral,02162660,TORADOL (ketorolac tromethamine 10 mg oral tablet) AA PHARMA INC,Active,9000590,ketorolac tromethamine 10 mg oral tablet,8000169,ketorolac,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
43510,Marketed,2017-12-11,02229080,Apo-Ketorolac,1,M01AB15,Ketorolac,Tablet,Oral,02229080,APO-KETOROLAC (ketorolac tromethamine 10 mg oral tablet) APOTEX INC,Active,9000590,ketorolac tromethamine 10 mg oral tablet,8000169,ketorolac,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
44090,Marketed,2015-11-16,02162644,Toradol Im,1,M01AB15,Ketorolac,Solution,Intramuscular,02162644,TORADOL IM (ketorolac tromethamine 10 mg per 1 mL solution for injection ampoule) ATNAHS PHARMA UK LIMITED,Active,9000663,ketorolac tromethamine 10 mg per 1 mL solution for injection ampoule,8000169,ketorolac,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
63447,Marketed,2005-09-21,02239944,Ketorolac Tromethamine Injection USP,1,M01AB15,Ketorolac,Solution,Intramuscular,02239944,KETOROLAC TROMETHAMINE INJECTION USP (ketorolac tromethamine 30 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000848,ketorolac tromethamine 30 mg per 1 mL solution for injection vial,8000169,ketorolac,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
68945,Marketed,2015-08-27,02244947,"Ketorolac Tromethamine Injection, USP",1,M01AB15,Ketorolac,Liquid,Intramuscular,77700088,"KETOROLAC TROMETHAMINE INJECTION, USP (ketorolac tromethamine 30 mg per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9000848,ketorolac tromethamine 30 mg per 1 mL solution for injection vial,8000169,ketorolac,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
68945,Marketed,2015-08-27,02244947,"Ketorolac Tromethamine Injection, USP",1,M01AB15,Ketorolac,Liquid,Intramuscular,77700089,"KETOROLAC TROMETHAMINE INJECTION, USP (ketorolac tromethamine 60 mg per 2 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9000986,ketorolac tromethamine 60 mg per 2 mL solution for injection vial,8000169,ketorolac,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
69937,Marketed,2014-08-19,02245821,Ketorolac,1,S01BC05,Ketorolac,Solution,Ophthalmic,02245821,KETOROLAC (ketorolac tromethamine 0.5 % ophthalmic drops) AA PHARMA INC,Active,9000427,ketorolac tromethamine 0.5 % ophthalmic drops,8000169,ketorolac,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
85428,Marketed,2024-06-04,02369362,Acuvail,1,S01BC05,Ketorolac,Solution,Ophthalmic,02369362,ACUVAIL (ketorolac tromethamine 0.45 % ophthalmic drops) ABBVIE CORPORATION,Active,9001373,ketorolac tromethamine 0.45 % ophthalmic drops,8000169,ketorolac,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
92801,Marketed,2021-07-27,02443376,"Ketorolac Tromethamine Injection, USP",1,M01AB15,Ketorolac,Solution,Intramuscular,02443376,"KETOROLAC TROMETHAMINE INJECTION, USP (ketorolac tromethamine 30 mg per 1 mL solution for injection vial) JUNO PHARMACEUTICALS CORP.",Active,9000848,ketorolac tromethamine 30 mg per 1 mL solution for injection vial,8000169,ketorolac,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
94908,Marketed,2019-06-28,02461455,Mint-Ketorolac,1,M01AB15,Ketorolac,Tablet,Oral,02461455,MINT-KETOROLAC (ketorolac tromethamine 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000590,ketorolac tromethamine 10 mg oral tablet,8000169,ketorolac,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95332,Marketed,2017-08-16,02465124,Mar-Ketorolac,1,M01AB15,Ketorolac,Tablet,Oral,02465124,MAR-KETOROLAC (ketorolac tromethamine 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000590,ketorolac tromethamine 10 mg oral tablet,8000169,ketorolac,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103126,Marketed,2025-02-21,02542722,JAMP Ketotifen Ophthalmic,1,S01GX08,Ketotifen,Solution,Ophthalmic,02542722,JAMP KETOTIFEN OPHTHALMIC (ketotifen (ketotifen fumarate) 0.25 mg per mL ophthalmic drops) JAMP PHARMA CORPORATION,Active,9003504,ketotifen (ketotifen fumarate) 0.25 mg per mL ophthalmic drops,8001396,ketotifen,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
10832,Marketed,2010-11-02,00577308,Zaditen,1,R06AX17,Ketotifen,Tablet,Oral,00577308,ZADITEN (ketotifen (ketotifen fumarate) 1 mg oral tablet) TEVA CANADA LIMITED,Active,9002311,ketotifen (ketotifen fumarate) 1 mg oral tablet,8001396,ketotifen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
66035,Marketed,2012-08-10,02242324,Zaditor,1,S01GX08,Ketotifen,Solution,Ophthalmic,02242324,ZADITOR (ketotifen (ketotifen fumarate) 0.25 mg per mL ophthalmic drops) LABORATOIRES THEA,Active,9003504,ketotifen (ketotifen fumarate) 0.25 mg per mL ophthalmic drops,8001396,ketotifen,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
103015,Marketed,2024-05-24,02541505,Labetalol Hydrochloride Injection USP,1,C07AG01,Labetalol,Solution,Intravenous,02541505,LABETALOL HYDROCHLORIDE INJECTION USP (labetalol hydrochloride 100 mg per 20 mL solution for injection vial) JAMP PHARMA CORPORATION,Active,9010186,labetalol hydrochloride 100 mg per 20 mL solution for injection vial,8000894,labetalol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
29542,Marketed,2025-12-29,02106272,Trandate,1,C07AG01,Labetalol,Tablet,Oral,02106272,TRANDATE (labetalol hydrochloride 100 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9010185,labetalol hydrochloride 100 mg oral tablet,8000894,labetalol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
29543,Marketed,2025-12-29,02106280,Trandate,1,C07AG01,Labetalol,Tablet,Oral,02106280,TRANDATE (labetalol hydrochloride 200 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9010187,labetalol hydrochloride 200 mg oral tablet,8000894,labetalol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
51066,Marketed,2005-09-21,02231689,Labetalol Hydrochloride Injection USP,1,C07AG01,Labetalol,Solution,Intravenous,02231689,LABETALOL HYDROCHLORIDE INJECTION USP (labetalol hydrochloride 100 mg per 20 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9010186,labetalol hydrochloride 100 mg per 20 mL solution for injection vial,8000894,labetalol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
67456,Marketed,2020-07-14,02243538,Apo-Labetalol,1,C07AG01,Labetalol,Tablet,Oral,02243538,APO-LABETALOL (labetalol hydrochloride 100 mg oral tablet) APOTEX INC,Active,9010185,labetalol hydrochloride 100 mg oral tablet,8000894,labetalol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
67457,Marketed,2020-07-14,02243539,Apo-Labetalol,1,C07AG01,Labetalol,Tablet,Oral,02243539,APO-LABETALOL (labetalol hydrochloride 200 mg oral tablet) APOTEX INC,Active,9010187,labetalol hydrochloride 200 mg oral tablet,8000894,labetalol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87077,Marketed,2021-05-26,02385120,Labetalol Hydrochloride Injection USP,1,C07AG01,Labetalol,Solution,Intravenous,02385120,LABETALOL HYDROCHLORIDE INJECTION USP (labetalol hydrochloride 100 mg per 20 mL solution for injection vial) STERIMAX INC,Active,9010186,labetalol hydrochloride 100 mg per 20 mL solution for injection vial,8000894,labetalol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
87646,Marketed,2017-08-01,02391090,Labetalol Hydrochloride Injection USP,1,C07AG01,Labetalol,Solution,Intravenous,02391090,LABETALOL HYDROCHLORIDE INJECTION USP (labetalol hydrochloride 100 mg per 20 mL solution for injection vial) PFIZER CANADA ULC,Active,9010186,labetalol hydrochloride 100 mg per 20 mL solution for injection vial,8000894,labetalol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
94413,Marketed,2018-06-02,02457040,Labetalol Hydrochloride Injection,1,C07AG01,Labetalol,Solution,Intravenous,77700628,LABETALOL HYDROCHLORIDE INJECTION (labetalol hydrochloride 100 mg per 20 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9010186,labetalol hydrochloride 100 mg per 20 mL solution for injection vial,8000894,labetalol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
94413,Marketed,2018-06-02,02457040,Labetalol Hydrochloride Injection,1,C07AG01,Labetalol,Solution,Intravenous,77700629,LABETALOL HYDROCHLORIDE INJECTION (labetalol hydrochloride 200 mg per 40 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9010188,labetalol hydrochloride 200 mg per 40 mL solution for injection vial,8000894,labetalol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
97949,Marketed,2019-09-04,02489406,Riva-Labetalol,1,C07AG01,Labetalol,Tablet,Oral,02489406,RIVA-LABETALOL (labetalol hydrochloride 100 mg oral tablet) LABORATOIRE RIVA INC.,Active,9010185,labetalol hydrochloride 100 mg oral tablet,8000894,labetalol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97950,Marketed,2019-09-04,02489414,Riva-Labetalol,1,C07AG01,Labetalol,Tablet,Oral,02489414,RIVA-LABETALOL (labetalol hydrochloride 200 mg oral tablet) LABORATOIRE RIVA INC.,Active,9010187,labetalol hydrochloride 200 mg oral tablet,8000894,labetalol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100212,Marketed,2024-11-26,02512874,Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02512874,LACOSAMIDE (lacosamide 50 mg oral tablet) SANIS HEALTH INC,Active,9004783,lacosamide 50 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100213,Marketed,2024-11-26,02512882,Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02512882,LACOSAMIDE (lacosamide 100 mg oral tablet) SANIS HEALTH INC,Active,9004780,lacosamide 100 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100214,Marketed,2024-11-26,02512890,Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02512890,LACOSAMIDE (lacosamide 150 mg oral tablet) SANIS HEALTH INC,Active,9004781,lacosamide 150 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100215,Marketed,2024-11-26,02512904,Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02512904,LACOSAMIDE (lacosamide 200 mg oral tablet) SANIS HEALTH INC,Active,9004782,lacosamide 200 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106769,Marketed,2026-04-29,02565056,Riva-Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02565056,RIVA-LACOSAMIDE (lacosamide 50 mg oral tablet) LABORATOIRE RIVA INC.,Active,9004783,lacosamide 50 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106770,Marketed,2026-04-29,02565064,Riva-Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02565064,RIVA-LACOSAMIDE (lacosamide 100 mg oral tablet) LABORATOIRE RIVA INC.,Active,9004780,lacosamide 100 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106771,Marketed,2026-04-29,02565072,Riva-Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02565072,RIVA-LACOSAMIDE (lacosamide 150 mg oral tablet) LABORATOIRE RIVA INC.,Active,9004781,lacosamide 150 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106772,Marketed,2026-04-29,02565080,Riva-Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02565080,RIVA-LACOSAMIDE (lacosamide 200 mg oral tablet) LABORATOIRE RIVA INC.,Active,9004782,lacosamide 200 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84272,Marketed,2010-10-21,02357615,Vimpat,1,N03AX18,Lacosamide,Tablet,Oral,02357615,VIMPAT (lacosamide 50 mg oral tablet) UCB CANADA INC,Active,9004783,lacosamide 50 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84273,Marketed,2010-10-21,02357623,Vimpat,1,N03AX18,Lacosamide,Tablet,Oral,02357623,VIMPAT (lacosamide 100 mg oral tablet) UCB CANADA INC,Active,9004780,lacosamide 100 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84274,Marketed,2010-10-21,02357631,Vimpat,1,N03AX18,Lacosamide,Tablet,Oral,02357631,VIMPAT (lacosamide 150 mg oral tablet) UCB CANADA INC,Active,9004781,lacosamide 150 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84275,Marketed,2010-10-21,02357658,Vimpat,1,N03AX18,Lacosamide,Tablet,Oral,02357658,VIMPAT (lacosamide 200 mg oral tablet) UCB CANADA INC,Active,9004782,lacosamide 200 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84276,Marketed,2011-09-20,02357666,Vimpat,1,N03AX18,Lacosamide,Solution,Intravenous,02357666,VIMPAT (lacosamide 200 mg per 20 mL solution for injection vial) UCB CANADA INC,Active,9013302,lacosamide 200 mg per 20 mL solution for injection vial,8001825,lacosamide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
96224,Marketed,2018-10-01,02472902,Teva-Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02472902,TEVA-LACOSAMIDE (lacosamide 50 mg oral tablet) TEVA CANADA LIMITED,Active,9004783,lacosamide 50 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96225,Marketed,2018-10-01,02472910,Teva-Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02472910,TEVA-LACOSAMIDE (lacosamide 100 mg oral tablet) TEVA CANADA LIMITED,Active,9004780,lacosamide 100 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96226,Marketed,2018-10-01,02472929,Teva-Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02472929,TEVA-LACOSAMIDE (lacosamide 150 mg oral tablet) TEVA CANADA LIMITED,Active,9004781,lacosamide 150 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96228,Marketed,2018-10-01,02472937,Teva-Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02472937,TEVA-LACOSAMIDE (lacosamide 200 mg oral tablet) TEVA CANADA LIMITED,Active,9004782,lacosamide 200 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96485,Marketed,2018-10-01,02474670,Sandoz Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02474670,SANDOZ LACOSAMIDE (lacosamide 50 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9004783,lacosamide 50 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96486,Marketed,2018-10-01,02474689,Sandoz Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02474689,SANDOZ LACOSAMIDE (lacosamide 100 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9004780,lacosamide 100 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96487,Marketed,2018-10-01,02474697,Sandoz Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02474697,SANDOZ LACOSAMIDE (lacosamide 150 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9004781,lacosamide 150 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96488,Marketed,2018-10-01,02474700,Sandoz Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02474700,SANDOZ LACOSAMIDE (lacosamide 200 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9004782,lacosamide 200 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96571,Marketed,2018-10-01,02475332,Auro-Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02475332,AURO-LACOSAMIDE (lacosamide 50 mg oral tablet) AURO PHARMA INC,Active,9004783,lacosamide 50 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96572,Marketed,2018-10-01,02475340,Auro-Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02475340,AURO-LACOSAMIDE (lacosamide 100 mg oral tablet) AURO PHARMA INC,Active,9004780,lacosamide 100 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96573,Marketed,2018-10-01,02475359,Auro-Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02475359,AURO-LACOSAMIDE (lacosamide 150 mg oral tablet) AURO PHARMA INC,Active,9004781,lacosamide 150 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96574,Marketed,2018-10-01,02475367,Auro-Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02475367,AURO-LACOSAMIDE (lacosamide 200 mg oral tablet) AURO PHARMA INC,Active,9004782,lacosamide 200 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96892,Marketed,2018-10-01,02478196,Pharma-Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02478196,PHARMA-LACOSAMIDE (lacosamide 50 mg oral tablet) PHARMASCIENCE INC,Active,9004783,lacosamide 50 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96893,Marketed,2018-10-01,02478218,Pharma-Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02478218,PHARMA-LACOSAMIDE (lacosamide 100 mg oral tablet) PHARMASCIENCE INC,Active,9004780,lacosamide 100 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96894,Marketed,2018-10-01,02478226,Pharma-Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02478226,PHARMA-LACOSAMIDE (lacosamide 150 mg oral tablet) PHARMASCIENCE INC,Active,9004781,lacosamide 150 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96895,Marketed,2018-10-01,02478234,Pharma-Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02478234,PHARMA-LACOSAMIDE (lacosamide 200 mg oral tablet) PHARMASCIENCE INC,Active,9004782,lacosamide 200 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97796,Marketed,2025-11-17,02487802,ZDS-Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02487802,ZDS-LACOSAMIDE (lacosamide 50 mg oral tablet) ZYDUS PHARMACEUTICALS (CANADA) INC,Active,9004783,lacosamide 50 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97797,Marketed,2025-11-17,02487810,ZDS-Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02487810,ZDS-LACOSAMIDE (lacosamide 100 mg oral tablet) ZYDUS PHARMACEUTICALS (CANADA) INC,Active,9004780,lacosamide 100 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97798,Marketed,2025-11-17,02487829,ZDS-Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02487829,ZDS-LACOSAMIDE (lacosamide 150 mg oral tablet) ZYDUS PHARMACEUTICALS (CANADA) INC,Active,9004781,lacosamide 150 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97799,Marketed,2025-11-17,02487837,ZDS-Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02487837,ZDS-LACOSAMIDE (lacosamide 200 mg oral tablet) ZYDUS PHARMACEUTICALS (CANADA) INC,Active,9004782,lacosamide 200 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97848,Marketed,2020-03-06,02488388,JAMP-Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02488388,JAMP-LACOSAMIDE (lacosamide 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004783,lacosamide 50 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97849,Marketed,2020-03-06,02488396,JAMP-Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02488396,JAMP-LACOSAMIDE (lacosamide 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004780,lacosamide 100 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97850,Marketed,2020-03-06,02488418,JAMP-Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02488418,JAMP-LACOSAMIDE (lacosamide 150 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004781,lacosamide 150 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97851,Marketed,2020-03-07,02488426,JAMP-Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02488426,JAMP-LACOSAMIDE (lacosamide 200 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004782,lacosamide 200 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97936,Marketed,2021-04-27,02489287,ACH-Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02489287,ACH-LACOSAMIDE (lacosamide 50 mg oral tablet) ACCORD HEALTHCARE INC,Active,9004783,lacosamide 50 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97937,Marketed,2021-04-27,02489295,ACH-Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02489295,ACH-LACOSAMIDE (lacosamide 100 mg oral tablet) ACCORD HEALTHCARE INC,Active,9004780,lacosamide 100 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97938,Marketed,2021-04-27,02489309,ACH-Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02489309,ACH-LACOSAMIDE (lacosamide 150 mg oral tablet) ACCORD HEALTHCARE INC,Active,9004781,lacosamide 150 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97939,Marketed,2021-04-27,02489317,ACH-Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02489317,ACH-LACOSAMIDE (lacosamide 200 mg oral tablet) ACCORD HEALTHCARE INC,Active,9004782,lacosamide 200 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98058,Marketed,2019-11-25,02490544,Mint-Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02490544,MINT-LACOSAMIDE (lacosamide 50 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9004783,lacosamide 50 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98059,Marketed,2019-11-25,02490552,Mint-Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02490552,MINT-LACOSAMIDE (lacosamide 100 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9004780,lacosamide 100 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98060,Marketed,2019-11-25,02490560,Mint-Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02490560,MINT-LACOSAMIDE (lacosamide 150 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9004781,lacosamide 150 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98061,Marketed,2019-11-25,02490579,Mint-Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02490579,MINT-LACOSAMIDE (lacosamide 200 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9004782,lacosamide 200 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99152,Marketed,2021-12-24,02501910,AG-Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02501910,AG-LACOSAMIDE (lacosamide 50 mg oral tablet) ANGITA PHARMA INC.,Active,9004783,lacosamide 50 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99154,Marketed,2021-12-24,02501937,AG-Lacosamide,1,N03AX18,Lacosamide,Tablet,Oral,02501937,AG-LACOSAMIDE (lacosamide 150 mg oral tablet) ANGITA PHARMA INC.,Active,9004781,lacosamide 150 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
12699,Marketed,2013-07-11,00854409,Ratio-Lactulose,1,A06AD11,Lactulose,Solution,Oral,00854409,RATIO-LACTULOSE (lactulose 667 mg per mL oral solution) TEVA CANADA LIMITED,Active,9010195,lactulose 667 mg per mL oral solution,8000840,lactulose,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
71628,Marketed,2016-06-22,02247383,Pharma-Lactulose,1,A06AD11,Lactulose,Solution,Oral,02247383,PHARMA-LACTULOSE (lactulose 667 mg per mL oral solution) PHARMASCIENCE INC,Active,9010195,lactulose 667 mg per mL oral solution,8000840,lactulose,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
78124,Marketed,2008-08-21,02295881,JAMP-Lactulose,1,A06AD11,Lactulose,Solution,Oral,02295881,JAMP-LACTULOSE (lactulose 667 mg per mL oral solution) JAMP PHARMA CORPORATION,Active,9010195,lactulose 667 mg per mL oral solution,8000840,lactulose,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
81724,Marketed,2014-02-22,02331551,Teva-Lactulose,1,A06AD11,Lactulose,Solution,Oral,02331551,TEVA-LACTULOSE (lactulose 667 mg per mL oral solution) TEVA CANADA LIMITED,Active,9010195,lactulose 667 mg per mL oral solution,8000840,lactulose,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
89682,Marketed,2023-06-19,02412268,Lactulose,1,A06AD11,Lactulose,Solution,Oral,02412268,LACTULOSE (lactulose 667 mg per mL oral solution) SANIS HEALTH INC,Active,9010195,lactulose 667 mg per mL oral solution,8000840,lactulose,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
95818,Marketed,2018-04-02,02469391,PMS-Lactulose-Pharma,1,A06AD11,Lactulose,Solution,Oral,02469391,PMS-LACTULOSE-PHARMA (lactulose 667 mg per mL oral solution) PHARMASCIENCE INC,Active,9010195,lactulose 667 mg per mL oral solution,8000840,lactulose,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
100175,Marketed,2021-08-16,02512467,JAMP lamiVUDine HBV,1,J05AF05,Lamivudine,Tablet,Oral,02512467,JAMP LAMIVUDINE HBV (lamivudine 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003336,lamivudine 100 mg oral tablet,8001210,lamivudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
19614,Marketed,2013-11-15,02192683,3TC,1,J05AF05,Lamivudine,Tablet,Oral,02192683,3TC (lamivudine 150 mg oral tablet) VIIV HEALTHCARE ULC,Active,9002835,lamivudine 150 mg oral tablet,8001210,lamivudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
19615,Marketed,2014-01-31,02192691,3TC,1,J05AF05,Lamivudine,Solution,Oral,02192691,3TC (lamivudine 10 mg per mL oral solution) VIIV HEALTHCARE ULC,Active,9002834,lamivudine 10 mg per mL oral solution,8001210,lamivudine,26643006,Oral,385023001,Oral solution,,,,,,Prescription
72120,Marketed,2013-11-28,02247825,3TC,1,J05AF05,Lamivudine,Tablet,Oral,02247825,3TC (lamivudine 300 mg oral tablet) VIIV HEALTHCARE ULC,Active,9003827,lamivudine 300 mg oral tablet,8001210,lamivudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85400,Marketed,2012-05-18,02369052,Apo-lamiVUDine,1,J05AF05,Lamivudine,Tablet,Oral,02369052,APO-LAMIVUDINE (lamivudine 150 mg oral tablet) APOTEX INC,Active,9002835,lamivudine 150 mg oral tablet,8001210,lamivudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85401,Marketed,2012-05-18,02369060,Apo-lamiVUDine,1,J05AF05,Lamivudine,Tablet,Oral,02369060,APO-LAMIVUDINE (lamivudine 300 mg oral tablet) APOTEX INC,Active,9003827,lamivudine 300 mg oral tablet,8001210,lamivudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87847,Marketed,2016-01-22,02393239,Apo-lamiVUDine HBV,1,J05AF05,Lamivudine,Tablet,Oral,02393239,APO-LAMIVUDINE HBV (lamivudine 100 mg oral tablet) APOTEX INC,Active,9003336,lamivudine 100 mg oral tablet,8001210,lamivudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99652,Marketed,2021-03-16,02507110,JAMP lamiVUDine,1,J05AF05,Lamivudine,Tablet,Oral,02507110,JAMP LAMIVUDINE (lamivudine 150 mg oral tablet) JAMP PHARMA CORPORATION,Active,9002835,lamivudine 150 mg oral tablet,8001210,lamivudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99653,Marketed,2021-03-16,02507129,JAMP lamiVUDine,1,J05AF05,Lamivudine,Tablet,Oral,02507129,JAMP LAMIVUDINE (lamivudine 300 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003827,lamivudine 300 mg oral tablet,8001210,lamivudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88441,Marketed,2020-11-03,02399539,Apo-Abacavir-lamiVUDine,2,J05AR02,Lamivudine and abacavir,Tablet,Oral,02399539,APO-ABACAVIR-LAMIVUDINE (abacavir (abacavir sulfate) 600 mg and lamivudine 300 mg oral tablet) APOTEX INC,Active,9012563,abacavir (abacavir sulfate) 600 mg and lamivudine 300 mg oral tablet,8001164,abacavir and lamivudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
90124,Marketed,2016-03-14,02416662,Teva-Abacavir/lamiVUDine,2,J05AR02,Lamivudine and abacavir,Tablet,Oral,02416662,TEVA-ABACAVIR/LAMIVUDINE (abacavir (abacavir sulfate) 600 mg and lamivudine 300 mg oral tablet) TEVA CANADA LIMITED,Active,9012563,abacavir (abacavir sulfate) 600 mg and lamivudine 300 mg oral tablet,8001164,abacavir and lamivudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
93683,Marketed,2016-03-29,02450682,Mylan-Abacavir/lamiVUDine,2,J05AR02,Lamivudine and abacavir,Tablet,Oral,02450682,MYLAN-ABACAVIR/LAMIVUDINE (abacavir (abacavir sulfate) 600 mg and lamivudine 300 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9012563,abacavir (abacavir sulfate) 600 mg and lamivudine 300 mg oral tablet,8001164,abacavir and lamivudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
94109,Marketed,2016-08-31,02454513,Auro-Abacavir/lamiVUDine,2,J05AR02,Lamivudine and abacavir,Tablet,Oral,02454513,AURO-ABACAVIR/LAMIVUDINE (abacavir (abacavir sulfate) 600 mg and lamivudine 300 mg oral tablet) AURO PHARMA INC,Active,9012563,abacavir (abacavir sulfate) 600 mg and lamivudine 300 mg oral tablet,8001164,abacavir and lamivudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98745,Marketed,2022-02-22,02497654,JAMP Abacavir / lamiVUDine,2,J05AR02,Lamivudine and abacavir,Tablet,Oral,02497654,JAMP ABACAVIR / LAMIVUDINE (abacavir (abacavir sulfate) 600 mg and lamivudine 300 mg oral tablet) JAMP PHARMA CORPORATION,Active,9012563,abacavir (abacavir sulfate) 600 mg and lamivudine 300 mg oral tablet,8001164,abacavir and lamivudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98173,Marketed,2019-09-09,02491753,Dovato,2,J05AR25,Lamivudine and dolutegravir,Tablet,Oral,02491753,DOVATO (dolutegravir (dolutegravir sodium) 50 mg and lamivudine 300 mg oral tablet) VIIV HEALTHCARE ULC,Active,9014147,dolutegravir (dolutegravir sodium) 50 mg and lamivudine 300 mg oral tablet,8002291,dolutegravir and lamivudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91536,Marketed,2014-10-22,02430932,Triumeq,3,J05AR13,"Lamivudine, abacavir and dolutegravir",Tablet,Oral,02430932,TRIUMEQ (abacavir (abacavir sulfate) 600 mg and dolutegravir (dolutegravir sodium) 50 mg and lamivudine 300 mg oral tablet) VIIV HEALTHCARE ULC,Active,9012562,abacavir (abacavir sulfate) 600 mg and dolutegravir (dolutegravir sodium) 50 mg and lamivudine 300 mg oral tablet,8001163,abacavir and dolutegravir and lamivudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
97302,Marketed,2018-12-10,02482592,Delstrigo,3,J05AR24,"Lamivudine, tenofovir disoproxil and doravirine",Tablet,Oral,02482592,DELSTRIGO (doravirine 100 mg and lamivudine 300 mg and tenofovir disoproxil fumarate 300 mg oral tablet) MERCK CANADA INC,Active,9013681,doravirine 100 mg and lamivudine 300 mg and tenofovir disoproxil fumarate 300 mg oral tablet,8002189,doravirine and lamivudine and tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103127,Marketed,2024-06-21,02542730,JAMP lamoTRIgine,1,N03AX09,Lamotrigine,Tablet,Oral,02542730,JAMP LAMOTRIGINE (lamotrigine 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000593,lamotrigine 25 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103128,Marketed,2024-06-21,02542749,JAMP lamoTRIgine,1,N03AX09,Lamotrigine,Tablet,Oral,02542749,JAMP LAMOTRIGINE (lamotrigine 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000591,lamotrigine 100 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103129,Marketed,2024-06-21,02542757,JAMP lamoTRIgine,1,N03AX09,Lamotrigine,Tablet,Oral,02542757,JAMP LAMOTRIGINE (lamotrigine 150 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000592,lamotrigine 150 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103216,Marketed,2024-06-26,02543710,AG-lamoTRIgine,1,N03AX09,Lamotrigine,Tablet,Oral,02543710,AG-LAMOTRIGINE (lamotrigine 25 mg oral tablet) ANGITA PHARMA INC.,Active,9000593,lamotrigine 25 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103217,Marketed,2024-06-26,02543729,AG-lamoTRIgine,1,N03AX09,Lamotrigine,Tablet,Oral,02543729,AG-LAMOTRIGINE (lamotrigine 100 mg oral tablet) ANGITA PHARMA INC.,Active,9000591,lamotrigine 100 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103218,Marketed,2024-06-26,02543737,AG-lamoTRIgine,1,N03AX09,Lamotrigine,Tablet,Oral,02543737,AG-LAMOTRIGINE (lamotrigine 150 mg oral tablet) ANGITA PHARMA INC.,Active,9000592,lamotrigine 150 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
17160,Marketed,2002-03-07,02142112,Lamictal,1,N03AX09,Lamotrigine,Tablet,Oral,02142112,LAMICTAL (lamotrigine 150 mg oral tablet) GLAXOSMITHKLINE INC,Active,9000592,lamotrigine 150 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
17201,Marketed,2002-05-22,02142104,Lamictal,1,N03AX09,Lamotrigine,Tablet,Oral,02142104,LAMICTAL (lamotrigine 100 mg oral tablet) GLAXOSMITHKLINE INC,Active,9000591,lamotrigine 100 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
17203,Marketed,2002-06-14,02142082,Lamictal,1,N03AX09,Lamotrigine,Tablet,Oral,02142082,LAMICTAL (lamotrigine 25 mg oral tablet) GLAXOSMITHKLINE INC,Active,9000593,lamotrigine 25 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
63629,Marketed,2002-09-05,02240115,Lamictal,1,N03AX09,Lamotrigine,Tablet,Oral,02240115,LAMICTAL (lamotrigine 5 mg oral tablet) GLAXOSMITHKLINE INC,Active,9000853,lamotrigine 5 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
67741,Marketed,2001-09-13,02243803,Lamictal,1,N03AX09,Lamotrigine,Tablet,Oral,02243803,LAMICTAL (lamotrigine 2 mg oral tablet) GLAXOSMITHKLINE INC,Active,9000961,lamotrigine 2 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
69223,Marketed,2002-03-18,02245208,Apo-lamoTRIgine,1,N03AX09,Lamotrigine,Tablet,Oral,02245208,APO-LAMOTRIGINE (lamotrigine 25 mg oral tablet) APOTEX INC,Active,9000593,lamotrigine 25 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
69224,Marketed,2017-08-04,02245209,Apo-lamoTRIgine,1,N03AX09,Lamotrigine,Tablet,Oral,02245209,APO-LAMOTRIGINE (lamotrigine 100 mg oral tablet) APOTEX INC,Active,9000591,lamotrigine 100 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
69225,Marketed,2002-03-18,02245210,Apo-lamoTRIgine,1,N03AX09,Lamotrigine,Tablet,Oral,02245210,APO-LAMOTRIGINE (lamotrigine 150 mg oral tablet) APOTEX INC,Active,9000592,lamotrigine 150 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75095,Marketed,2009-10-22,02265494,Mylan-lamoTRIgine,1,N03AX09,Lamotrigine,Tablet,Oral,02265494,MYLAN-LAMOTRIGINE (lamotrigine 25 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000593,lamotrigine 25 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75096,Marketed,2009-10-21,02265508,Mylan-lamoTRIgine,1,N03AX09,Lamotrigine,Tablet,Oral,02265508,MYLAN-LAMOTRIGINE (lamotrigine 100 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000591,lamotrigine 100 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75097,Marketed,2009-10-26,02265516,Mylan-lamoTRIgine,1,N03AX09,Lamotrigine,Tablet,Oral,02265516,MYLAN-LAMOTRIGINE (lamotrigine 150 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000592,lamotrigine 150 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78826,Marketed,2008-03-07,02302969,lamoTRIgine-25,1,N03AX09,Lamotrigine,Tablet,Oral,02302969,LAMOTRIGINE-25 (lamotrigine 25 mg oral tablet) PRO DOC LIMITEE,Active,9000593,lamotrigine 25 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78830,Marketed,2008-03-08,02302985,lamoTRIgine-100,1,N03AX09,Lamotrigine,Tablet,Oral,02302985,LAMOTRIGINE-100 (lamotrigine 100 mg oral tablet) PRO DOC LIMITEE,Active,9000591,lamotrigine 100 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78831,Marketed,2008-03-07,02302993,lamoTRIgine-150,1,N03AX09,Lamotrigine,Tablet,Oral,02302993,LAMOTRIGINE-150 (lamotrigine 150 mg oral tablet) PRO DOC LIMITEE,Active,9000592,lamotrigine 150 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82850,Marketed,2010-02-16,02343010,lamoTRIgine,1,N03AX09,Lamotrigine,Tablet,Oral,02343010,LAMOTRIGINE (lamotrigine 25 mg oral tablet) SANIS HEALTH INC,Active,9000593,lamotrigine 25 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82851,Marketed,2010-02-16,02343029,lamoTRIgine,1,N03AX09,Lamotrigine,Tablet,Oral,02343029,LAMOTRIGINE (lamotrigine 100 mg oral tablet) SANIS HEALTH INC,Active,9000591,lamotrigine 100 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82852,Marketed,2010-02-16,02343037,lamoTRIgine,1,N03AX09,Lamotrigine,Tablet,Oral,02343037,LAMOTRIGINE (lamotrigine 150 mg oral tablet) SANIS HEALTH INC,Active,9000592,lamotrigine 150 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86718,Marketed,2012-06-13,02381354,Auro-lamoTRIgine,1,N03AX09,Lamotrigine,Tablet,Oral,02381354,AURO-LAMOTRIGINE (lamotrigine 25 mg oral tablet) AURO PHARMA INC,Active,9000593,lamotrigine 25 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86719,Marketed,2012-06-13,02381362,Auro-lamoTRIgine,1,N03AX09,Lamotrigine,Tablet,Oral,02381362,AURO-LAMOTRIGINE (lamotrigine 100 mg oral tablet) AURO PHARMA INC,Active,9000591,lamotrigine 100 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86720,Marketed,2012-06-13,02381370,Auro-lamoTRIgine,1,N03AX09,Lamotrigine,Tablet,Oral,02381370,AURO-LAMOTRIGINE (lamotrigine 150 mg oral tablet) AURO PHARMA INC,Active,9000592,lamotrigine 150 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91268,Marketed,2014-10-08,02428202,lamoTRIgine,1,N03AX09,Lamotrigine,Tablet,Oral,02428202,LAMOTRIGINE (lamotrigine 25 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000593,lamotrigine 25 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91269,Marketed,2014-10-08,02428210,lamoTRIgine,1,N03AX09,Lamotrigine,Tablet,Oral,02428210,LAMOTRIGINE (lamotrigine 100 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000591,lamotrigine 100 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91270,Marketed,2014-10-08,02428229,lamoTRIgine,1,N03AX09,Lamotrigine,Tablet,Oral,02428229,LAMOTRIGINE (lamotrigine 150 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000592,lamotrigine 150 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106718,Marketed,2026-04-20,02564483,Takhzyro,1,B06AC05,Lanadelumab,Solution,Subcutaneous,02564483,TAKHZYRO (lanadelumab 300 mg per 2 mL solution for injection pen) TAKEDA CANADA INC,Active,9015421,lanadelumab 300 mg per 2 mL solution for injection pen,8002029,lanadelumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen(s),,,,Schedule D
106718,Marketed,2026-04-20,02564483,Takhzyro,1,B06AC05,Lanadelumab,Solution,Subcutaneous,02564483,TAKHZYRO (lanadelumab 300 mg per 2 mL solution for injection pen) TAKEDA CANADA INC,Active,9015421,lanadelumab 300 mg per 2 mL solution for injection pen,8002029,lanadelumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen(s),,,,Prescription
97159,Marketed,2022-01-12,02480948,Takhzyro,1,B06AC05,Lanadelumab,Solution,Subcutaneous,02480948,TAKHZYRO (lanadelumab 300 mg per 2 mL solution for injection vial) TAKEDA CANADA INC,Active,9013447,lanadelumab 300 mg per 2 mL solution for injection vial,8002029,lanadelumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
97159,Marketed,2022-01-12,02480948,Takhzyro,1,B06AC05,Lanadelumab,Solution,Subcutaneous,02480948,TAKHZYRO (lanadelumab 300 mg per 2 mL solution for injection vial) TAKEDA CANADA INC,Active,9013447,lanadelumab 300 mg per 2 mL solution for injection vial,8002029,lanadelumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
99498,Marketed,2022-02-28,02505614,Takhzyro,1,B06AC05,Lanadelumab,Solution,Subcutaneous,02505614,TAKHZYRO (lanadelumab 300 mg per 2 mL solution for injection syringe) TAKEDA CANADA INC,Active,9014456,lanadelumab 300 mg per 2 mL solution for injection syringe,8002029,lanadelumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
99498,Marketed,2022-02-28,02505614,Takhzyro,1,B06AC05,Lanadelumab,Solution,Subcutaneous,02505614,TAKHZYRO (lanadelumab 300 mg per 2 mL solution for injection syringe) TAKEDA CANADA INC,Active,9014456,lanadelumab 300 mg per 2 mL solution for injection syringe,8002029,lanadelumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
103179,Marketed,2024-08-11,02543338,Sibboran,1,C07AB14,Landiolol,Powder for solution,Intravenous,02543338,SIBBORAN (landiolol hydrochloride 300 mg per vial powder for solution for injection) TRIMEDIC THERAPEUTICS INC.,Active,9015072,landiolol hydrochloride 300 mg per vial powder for solution for injection,8002512,landiolol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,,,,Prescription
104459,Marketed,2025-06-06,02555867,Mytolac,1,H01CB03,Lanreotide,Solution (extended release),Subcutaneous,02555867,MYTOLAC (lanreotide (lanreotide acetate) 60 mg per 0.2 mL prolonged-release solution for injection syringe) ADVANZ PHARMA CANADA INC.,Active,9013968,lanreotide (lanreotide acetate) 60 mg per 0.2 mL prolonged-release solution for injection syringe,8001826,lanreotide,738984000,Parenteral,1231833006,Prolonged-release solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
104460,Marketed,2025-06-06,02555875,Mytolac,1,H01CB03,Lanreotide,Solution (extended release),Subcutaneous,02555875,MYTOLAC (lanreotide (lanreotide acetate) 90 mg per 0.3 mL prolonged-release solution for injection syringe) ADVANZ PHARMA CANADA INC.,Active,9013969,lanreotide (lanreotide acetate) 90 mg per 0.3 mL prolonged-release solution for injection syringe,8001826,lanreotide,738984000,Parenteral,1231833006,Prolonged-release solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
104461,Marketed,2025-06-06,02555883,Mytolac,1,H01CB03,Lanreotide,Solution (extended release),Subcutaneous,02555883,MYTOLAC (lanreotide (lanreotide acetate) 120 mg per 0.5 mL prolonged-release solution for injection syringe) ADVANZ PHARMA CANADA INC.,Active,9013967,lanreotide (lanreotide acetate) 120 mg per 0.5 mL prolonged-release solution for injection syringe,8001826,lanreotide,738984000,Parenteral,1231833006,Prolonged-release solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
76900,Marketed,2022-02-16,02283395,Somatuline Autogel,1,H01CB03,Lanreotide,Solution (extended release),Subcutaneous,02283395,SOMATULINE AUTOGEL (lanreotide (lanreotide acetate) 60 mg per 0.2 mL prolonged-release solution for injection syringe) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9013968,lanreotide (lanreotide acetate) 60 mg per 0.2 mL prolonged-release solution for injection syringe,8001826,lanreotide,738984000,Parenteral,1231833006,Prolonged-release solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
76901,Marketed,2022-02-16,02283409,Somatuline Autogel,1,H01CB03,Lanreotide,Solution (extended release),Subcutaneous,02283409,SOMATULINE AUTOGEL (lanreotide (lanreotide acetate) 90 mg per 0.3 mL prolonged-release solution for injection syringe) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9013969,lanreotide (lanreotide acetate) 90 mg per 0.3 mL prolonged-release solution for injection syringe,8001826,lanreotide,738984000,Parenteral,1231833006,Prolonged-release solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
76902,Marketed,2021-12-15,02283417,Somatuline Autogel,1,H01CB03,Lanreotide,Solution (extended release),Subcutaneous,02283417,SOMATULINE AUTOGEL (lanreotide (lanreotide acetate) 120 mg per 0.5 mL prolonged-release solution for injection syringe) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9013967,lanreotide (lanreotide acetate) 120 mg per 0.5 mL prolonged-release solution for injection syringe,8001826,lanreotide,738984000,Parenteral,1231833006,Prolonged-release solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
18515,Marketed,2008-10-10,02165503,Prevacid,1,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02165503,PREVACID (lansoprazole 15 mg gastro-resistant capsule) TAKEDA PHARMACEUTICALS AMERICA INC,Active,9000594,lansoprazole 15 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
18516,Marketed,2008-10-10,02165511,Prevacid,1,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02165511,PREVACID (lansoprazole 30 mg gastro-resistant capsule) TAKEDA PHARMACEUTICALS AMERICA INC,Active,9000595,lansoprazole 30 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
73429,Marketed,2008-10-10,02249464,Prevacid Fastab,1,A02BC03,Lansoprazole,Tablet (delayed-release),Oral,02249464,PREVACID FASTAB (lansoprazole 15 mg gastro-resistant tablet) TAKEDA PHARMACEUTICALS AMERICA INC,Active,9001181,lansoprazole 15 mg gastro-resistant tablet,8000215,lansoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73430,Marketed,2008-10-10,02249472,Prevacid Fastab,1,A02BC03,Lansoprazole,Tablet (delayed-release),Oral,02249472,PREVACID FASTAB (lansoprazole 30 mg gastro-resistant tablet) TAKEDA PHARMACEUTICALS AMERICA INC,Active,9001133,lansoprazole 30 mg gastro-resistant tablet,8000215,lansoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76617,Marketed,2011-04-22,02280515,Teva-Lansoprazole,1,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02280515,TEVA-LANSOPRAZOLE (lansoprazole 15 mg gastro-resistant capsule) TEVA CANADA LIMITED,Active,9000594,lansoprazole 15 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
76618,Marketed,2011-04-22,02280523,Teva-Lansoprazole,1,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02280523,TEVA-LANSOPRAZOLE (lansoprazole 30 mg gastro-resistant capsule) TEVA CANADA LIMITED,Active,9000595,lansoprazole 30 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
77919,Marketed,2009-06-03,02293811,Apo-Lansoprazole,1,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02293811,APO-LANSOPRAZOLE (lansoprazole 15 mg gastro-resistant capsule) APOTEX INC,Active,9000594,lansoprazole 15 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
77920,Marketed,2009-06-03,02293838,Apo-Lansoprazole,1,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02293838,APO-LANSOPRAZOLE (lansoprazole 30 mg gastro-resistant capsule) APOTEX INC,Active,9000595,lansoprazole 30 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
83904,Marketed,2010-06-18,02353830,Mylan-Lansoprazole,1,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02353830,MYLAN-LANSOPRAZOLE (lansoprazole 15 mg gastro-resistant capsule) MYLAN PHARMACEUTICALS ULC,Active,9000594,lansoprazole 15 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
83905,Marketed,2010-06-18,02353849,Mylan-Lansoprazole,1,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02353849,MYLAN-LANSOPRAZOLE (lansoprazole 30 mg gastro-resistant capsule) MYLAN PHARMACEUTICALS ULC,Active,9000595,lansoprazole 30 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
84278,Marketed,2020-11-23,02357682,Lansoprazole,1,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02357682,LANSOPRAZOLE (lansoprazole 15 mg gastro-resistant capsule) SANIS HEALTH INC,Active,9000594,lansoprazole 15 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
84279,Marketed,2020-11-23,02357690,Lansoprazole,1,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02357690,LANSOPRAZOLE (lansoprazole 30 mg gastro-resistant capsule) SANIS HEALTH INC,Active,9000595,lansoprazole 30 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
85113,Marketed,2025-12-08,02366282,Pro-Lansoprazole,1,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02366282,PRO-LANSOPRAZOLE (lansoprazole 30 mg gastro-resistant capsule) PRO DOC LIMITEE,Active,9000595,lansoprazole 30 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87127,Marketed,2012-07-03,02385643,Sandoz Lansoprazole,1,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02385643,SANDOZ LANSOPRAZOLE (lansoprazole 15 mg gastro-resistant capsule) SANDOZ CANADA INCORPORATED,Active,9000594,lansoprazole 15 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87128,Marketed,2012-07-03,02385651,Sandoz Lansoprazole,1,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02385651,SANDOZ LANSOPRAZOLE (lansoprazole 30 mg gastro-resistant capsule) SANDOZ CANADA INCORPORATED,Active,9000595,lansoprazole 30 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87138,Marketed,2024-06-07,02385767,Lansoprazole,1,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02385767,LANSOPRAZOLE (lansoprazole 15 mg gastro-resistant capsule) SIVEM PHARMACEUTICALS ULC,Active,9000594,lansoprazole 15 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88746,Marketed,2021-04-16,02402610,Taro-Lansoprazole,1,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02402610,TARO-LANSOPRAZOLE (lansoprazole 15 mg gastro-resistant capsule) SUN PHARMA CANADA INC,Active,9000594,lansoprazole 15 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88747,Marketed,2021-04-16,02402629,Taro-Lansoprazole,1,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02402629,TARO-LANSOPRAZOLE (lansoprazole 30 mg gastro-resistant capsule) SUN PHARMA CANADA INC,Active,9000595,lansoprazole 30 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
89503,Marketed,2024-06-07,02410389,Lansoprazole,1,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02410389,LANSOPRAZOLE (lansoprazole 30 mg gastro-resistant capsule) SIVEM PHARMACEUTICALS ULC,Active,9000595,lansoprazole 30 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90747,Marketed,2015-04-15,02422816,Riva-Lansoprazole,1,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02422816,RIVA-LANSOPRAZOLE (lansoprazole 30 mg gastro-resistant capsule) LABORATOIRE RIVA INC.,Active,9000595,lansoprazole 30 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95983,Marketed,2022-10-04,02470780,AA-Lansoprazole-Amoxicillin-Clarithromycin,3,A02BD07,"Lansoprazole, amoxicillin and clarithromycin","Kit,Capsule,Tablet,Capsule (delayed release)",Oral,02470780,AA-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN (amoxicillin 500 mg oral capsule with clarithromycin 500 mg oral tablet with lansoprazole 30 mg gastro-resistant capsule) AA PHARMA INC,Active,9012653,amoxicillin 500 mg oral capsule with clarithromycin 500 mg oral tablet with lansoprazole 30 mg gastro-resistant capsule,8000907,amoxicillin and clarithromycin and lansoprazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule,,,,Prescription
98843,Marketed,2020-07-21,02498731,Nat-Lanthanum,1,V03AE03,Lanthanum carbonate,Tablet (chewable),Oral,02498731,NAT-LANTHANUM (lanthanum (lanthanum carbonate dihydrate) 250 mg chewable tablet) NATCO PHARMA (CANADA) INC,Active,9013181,lanthanum (lanthanum carbonate) 250 mg chewable tablet,8001827,lanthanum,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Prescription
98844,Marketed,2020-07-21,02498758,Nat-Lanthanum,1,V03AE03,Lanthanum carbonate,Tablet (chewable),Oral,02498758,NAT-LANTHANUM (lanthanum (lanthanum carbonate dihydrate) 500 mg chewable tablet) NATCO PHARMA (CANADA) INC,Active,9013182,lanthanum (lanthanum carbonate) 500 mg chewable tablet,8001827,lanthanum,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Prescription
98845,Marketed,2020-07-21,02498766,Nat-Lanthanum,1,V03AE03,Lanthanum carbonate,Tablet (chewable),Oral,02498766,NAT-LANTHANUM (lanthanum (lanthanum carbonate dihydrate) 750 mg chewable tablet) NATCO PHARMA (CANADA) INC,Active,9013183,lanthanum (lanthanum carbonate) 750 mg chewable tablet,8001827,lanthanum,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Prescription
98846,Marketed,2020-07-21,02498774,Nat-Lanthanum,1,V03AE03,Lanthanum carbonate,Tablet (chewable),Oral,02498774,NAT-LANTHANUM (lanthanum (lanthanum carbonate dihydrate) 1000 mg chewable tablet) NATCO PHARMA (CANADA) INC,Active,9013180,lanthanum (lanthanum carbonate) 1000 mg chewable tablet,8001827,lanthanum,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Prescription
81179,Marketed,2016-04-19,02326442,Tykerb,1,L01EH01,Lapatinib,Tablet,Oral,02326442,TYKERB (lapatinib (lapatinib ditosylate) 250 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9013184,lapatinib (lapatinib ditosylate) 250 mg oral tablet,8001828,lapatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
73940,Marketed,2025-10-01,02254506,Aldurazyme,1,A16AB05,Laronidase,Solution,Intravenous,02254506,ALDURAZYME (laronidase 2.9 mg per 5 mL solution for injection vial) SANOFI-AVENTIS CANADA INC,Active,9013185,laronidase 2.9 mg per 5 mL solution for injection vial,8001829,laronidase,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
73940,Marketed,2025-10-01,02254506,Aldurazyme,1,A16AB05,Laronidase,Solution,Intravenous,02254506,ALDURAZYME (laronidase 2.9 mg per 5 mL solution for injection vial) SANOFI-AVENTIS CANADA INC,Active,9013185,laronidase 2.9 mg per 5 mL solution for injection vial,8001829,laronidase,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
98037,Marketed,2020-11-13,02490315,Vitrakvi,1,L01EX12,Larotrectinib,Capsule,Oral,02490315,VITRAKVI (larotrectinib (larotrectinib sulfate) 25 mg oral capsule) BAYER INC,Active,9014404,larotrectinib (larotrectinib sulfate) 25 mg oral capsule,8002297,larotrectinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
98038,Marketed,2020-11-13,02490323,Vitrakvi,1,L01EX12,Larotrectinib,Capsule,Oral,02490323,VITRAKVI (larotrectinib (larotrectinib sulfate) 100 mg oral capsule) BAYER INC,Active,9014403,larotrectinib (larotrectinib sulfate) 100 mg oral capsule,8002297,larotrectinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
98039,Marketed,2019-09-04,02490331,Vitrakvi,1,L01EX12,Larotrectinib,Solution,Oral,02490331,VITRAKVI (larotrectinib (larotrectinib sulfate) 20 mg per mL oral solution) BAYER INC,Active,9014155,larotrectinib (larotrectinib sulfate) 20 mg per mL oral solution,8002297,larotrectinib,26643006,Oral,385023001,Oral solution,,,1.0,,,Prescription
100250,Marketed,2021-11-10,02513285,M-Latanoprost,1,S01EE01,Latanoprost,Solution,Ophthalmic,02513285,M-LATANOPROST (latanoprost 50 mcg per mL ophthalmic drops) MANTRA PHARMA INC,Active,9000737,latanoprost 50 mcg per mL ophthalmic drops,8000244,latanoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
102373,Marketed,2024-08-16,02534835,AG-Latanoprost,1,S01EE01,Latanoprost,Solution,Ophthalmic,02534835,AG-LATANOPROST (latanoprost 50 mcg per mL ophthalmic drops) ANGITA PHARMA INC.,Active,9000737,latanoprost 50 mcg per mL ophthalmic drops,8000244,latanoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
50823,Marketed,2023-07-31,02231493,Xalatan,1,S01EE01,Latanoprost,Solution,Ophthalmic,02231493,XALATAN (latanoprost 50 mcg per mL ophthalmic drops) BGP PHARMA ULC,Active,9000737,latanoprost 50 mcg per mL ophthalmic drops,8000244,latanoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
73994,Marketed,2019-01-31,02254786,Teva-Latanoprost,1,S01EE01,Latanoprost,Solution,Ophthalmic,02254786,TEVA-LATANOPROST (latanoprost 50 mcg per mL ophthalmic drops) TEVA CANADA LIMITED,Active,9000737,latanoprost 50 mcg per mL ophthalmic drops,8000244,latanoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
78185,Marketed,2018-07-03,02296527,Apo-Latanoprost,1,S01EE01,Latanoprost,Solution,Ophthalmic,02296527,APO-LATANOPROST (latanoprost 50 mcg per mL ophthalmic drops) APOTEX INC,Active,9000737,latanoprost 50 mcg per mL ophthalmic drops,8000244,latanoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
82663,Marketed,2015-05-28,02341085,Riva-Latanoprost,1,S01EE01,Latanoprost,Solution,Ophthalmic,02341085,RIVA-LATANOPROST (latanoprost 50 mcg per mL ophthalmic drops) LABORATOIRE RIVA INC.,Active,9000737,latanoprost 50 mcg per mL ophthalmic drops,8000244,latanoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
85213,Marketed,2011-12-06,02367335,Sandoz Latanoprost,1,S01EE01,Latanoprost,Solution,Ophthalmic,02367335,SANDOZ LATANOPROST (latanoprost 50 mcg per mL ophthalmic drops) SANDOZ CANADA INCORPORATED,Active,9000737,latanoprost 50 mcg per mL ophthalmic drops,8000244,latanoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
85817,Marketed,2023-11-16,02373041,Mylan-Latanoprost,1,S01EE01,Latanoprost,Solution,Ophthalmic,02373041,MYLAN-LATANOPROST (latanoprost 50 mcg per mL ophthalmic drops) MYLAN PHARMACEUTICALS ULC,Active,9000737,latanoprost 50 mcg per mL ophthalmic drops,8000244,latanoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
91148,Marketed,2015-01-09,02426935,Med-Latanoprost,1,S01EE01,Latanoprost,Solution,Ophthalmic,02426935,MED-LATANOPROST (latanoprost 50 mcg per mL ophthalmic drops) GENERIC MEDICAL PARTNERS INC,Active,9000737,latanoprost 50 mcg per mL ophthalmic drops,8000244,latanoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
93988,Marketed,2023-10-13,02453355,JAMP Latanoprost,1,S01EE01,Latanoprost,Solution,Ophthalmic,02453355,JAMP LATANOPROST (latanoprost 50 mcg per mL ophthalmic drops) JAMP PHARMA CORPORATION,Active,9000737,latanoprost 50 mcg per mL ophthalmic drops,8000244,latanoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
94312,Marketed,2018-01-03,02456230,Monoprost,1,S01EE01,Latanoprost,Solution,Ophthalmic,02456230,MONOPROST (latanoprost 50 mcg per mL ophthalmic drops) LABORATOIRES THEA,Active,9000737,latanoprost 50 mcg per mL ophthalmic drops,8000244,latanoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
97453,Marketed,2019-05-17,02484218,Vyzulta,1,S01EE06,Latanoprostene bunod,Solution,Ophthalmic,02484218,VYZULTA (latanoprostene bunod 0.024 % ophthalmic drops) BAUSCH & LOMB INC,Active,9013970,latanoprostene bunod 0.024 % ophthalmic drops,8002260,latanoprostene bunod,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
104468,Marketed,2025-04-28,02555964,Lazcluze,1,L01EB09,Lazertinib,Tablet,Oral,02555964,LAZCLUZE (lazertinib (lazertinib mesylate) 80 mg oral tablet) JANSSEN INC,Active,9015205,lazertinib (lazertinib mesylate) 80 mg oral tablet,8002544,lazertinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,,Prescription
104469,Marketed,2025-04-28,02555972,Lazcluze,1,L01EB09,Lazertinib,Tablet,Oral,02555972,LAZCLUZE (lazertinib (lazertinib mesylate) 240 mg oral tablet) JANSSEN INC,Active,9015204,lazertinib (lazertinib mesylate) 240 mg oral tablet,8002544,lazertinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,,Prescription
103800,Marketed,2024-09-19,02549123,Ebglyss,1,D11AH10,Lebrikizumab,Solution,Subcutaneous,02549123,EBGLYSS (lebrikizumab 250 mg per 2 mL solution for injection pen) ELI LILLY CANADA INC,Active,9015097,lebrikizumab 250 mg per 2 mL solution for injection pen,8002514,lebrikizumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Prescription
103800,Marketed,2024-09-19,02549123,Ebglyss,1,D11AH10,Lebrikizumab,Solution,Subcutaneous,02549123,EBGLYSS (lebrikizumab 250 mg per 2 mL solution for injection pen) ELI LILLY CANADA INC,Active,9015097,lebrikizumab 250 mg per 2 mL solution for injection pen,8002514,lebrikizumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
103801,Marketed,2024-11-26,02549131,Ebglyss,1,D11AH10,Lebrikizumab,Solution,Subcutaneous,02549131,EBGLYSS (lebrikizumab 250 mg per 2 mL solution for injection syringe) ELI LILLY CANADA INC,Active,9015138,lebrikizumab 250 mg per 2 mL solution for injection syringe,8002514,lebrikizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe,,,,Schedule D
103801,Marketed,2024-11-26,02549131,Ebglyss,1,D11AH10,Lebrikizumab,Solution,Subcutaneous,02549131,EBGLYSS (lebrikizumab 250 mg per 2 mL solution for injection syringe) ELI LILLY CANADA INC,Active,9015138,lebrikizumab 250 mg per 2 mL solution for injection syringe,8002514,lebrikizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe,,,,Prescription
106527,Marketed,2025-12-16,02562383,Leqembi,1,N06DX04,Lecanemab,Solution,Intravenous,77701197,LEQEMBI (lecanemab 200 mg per 2 mL solution for injection vial) EISAI LIMITED,Active,9015304,lecanemab 200 mg per 2 mL solution for injection vial,8002566,lecanemab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,,,,Prescription
106527,Marketed,2025-12-16,02562383,Leqembi,1,N06DX04,Lecanemab,Solution,Intravenous,77701198,LEQEMBI (lecanemab 500 mg per 5 mL solution for injection vial) EISAI LIMITED,Active,9015305,lecanemab 500 mg per 5 mL solution for injection vial,8002566,lecanemab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,,,,Prescription
106527,Marketed,2025-12-16,02562383,Leqembi,1,N06DX04,Lecanemab,Solution,Intravenous,77701197,LEQEMBI (lecanemab 200 mg per 2 mL solution for injection vial) EISAI LIMITED,Active,9015304,lecanemab 200 mg per 2 mL solution for injection vial,8002566,lecanemab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,,,,Schedule D
106527,Marketed,2025-12-16,02562383,Leqembi,1,N06DX04,Lecanemab,Solution,Intravenous,77701198,LEQEMBI (lecanemab 500 mg per 5 mL solution for injection vial) EISAI LIMITED,Active,9015305,lecanemab 500 mg per 5 mL solution for injection vial,8002566,lecanemab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,,,,Schedule D
103203,Marketed,2024-06-03,02543575,Leflunomide,1,L04AK01,Leflunomide,Tablet,Oral,02543575,LEFLUNOMIDE (leflunomide 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9003479,leflunomide 10 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
103204,Marketed,2024-06-03,02543583,Leflunomide,1,L04AK01,Leflunomide,Tablet,Oral,02543583,LEFLUNOMIDE (leflunomide 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9003480,leflunomide 20 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
104061,Marketed,2024-12-04,02551918,Mar-Leflunomide,1,L04AK01,Leflunomide,Tablet,Oral,02551918,MAR-LEFLUNOMIDE (leflunomide 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9003479,leflunomide 10 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
104062,Marketed,2024-12-04,02551926,Mar-Leflunomide,1,L04AK01,Leflunomide,Tablet,Oral,02551926,MAR-LEFLUNOMIDE (leflunomide 20 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9003480,leflunomide 20 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
65558,Marketed,2008-11-03,02241888,Arava,1,L04AK01,Leflunomide,Tablet,Oral,02241888,ARAVA (leflunomide 10 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9003479,leflunomide 10 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
65559,Marketed,2008-10-10,02241889,Arava,1,L04AK01,Leflunomide,Tablet,Oral,02241889,ARAVA (leflunomide 20 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9003480,leflunomide 20 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
74173,Marketed,2004-09-14,02256495,Apo-Leflunomide,1,L04AK01,Leflunomide,Tablet,Oral,02256495,APO-LEFLUNOMIDE (leflunomide 10 mg oral tablet) APOTEX INC,Active,9003479,leflunomide 10 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
74174,Marketed,2004-09-14,02256509,Apo-Leflunomide,1,L04AK01,Leflunomide,Tablet,Oral,02256509,APO-LEFLUNOMIDE (leflunomide 20 mg oral tablet) APOTEX INC,Active,9003480,leflunomide 20 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
74665,Marketed,2014-02-14,02261251,Teva-Leflunomide,1,L04AK01,Leflunomide,Tablet,Oral,02261251,TEVA-LEFLUNOMIDE (leflunomide 10 mg oral tablet) TEVA CANADA LIMITED,Active,9003479,leflunomide 10 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
74666,Marketed,2014-02-14,02261278,Teva-Leflunomide,1,L04AK01,Leflunomide,Tablet,Oral,02261278,TEVA-LEFLUNOMIDE (leflunomide 20 mg oral tablet) TEVA CANADA LIMITED,Active,9003480,leflunomide 20 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
76953,Marketed,2006-08-15,02283964,Sandoz Leflunomide,1,L04AK01,Leflunomide,Tablet,Oral,02283964,SANDOZ LEFLUNOMIDE (leflunomide 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003479,leflunomide 10 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
76954,Marketed,2006-08-15,02283972,Sandoz Leflunomide,1,L04AK01,Leflunomide,Tablet,Oral,02283972,SANDOZ LEFLUNOMIDE (leflunomide 20 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003480,leflunomide 20 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
83692,Marketed,2014-07-12,02351668,Leflunomide,1,L04AK01,Leflunomide,Tablet,Oral,02351668,LEFLUNOMIDE (leflunomide 10 mg oral tablet) SANIS HEALTH INC,Active,9003479,leflunomide 10 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
83693,Marketed,2014-07-12,02351676,Leflunomide,1,L04AK01,Leflunomide,Tablet,Oral,02351676,LEFLUNOMIDE (leflunomide 20 mg oral tablet) SANIS HEALTH INC,Active,9003480,leflunomide 20 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
90041,Marketed,2025-11-27,02415828,Pro-Leflunomide,1,L04AK01,Leflunomide,Tablet,Oral,02415828,PRO-LEFLUNOMIDE (leflunomide 10 mg oral tablet) PRO DOC LIMITEE,Active,9003479,leflunomide 10 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
90042,Marketed,2025-11-27,02415836,Pro-Leflunomide,1,L04AK01,Leflunomide,Tablet,Oral,02415836,PRO-LEFLUNOMIDE (leflunomide 20 mg oral tablet) PRO DOC LIMITEE,Active,9003480,leflunomide 20 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
96957,Marketed,2019-09-19,02478862,Accel-Leflunomide,1,L04AK01,Leflunomide,Tablet,Oral,02478862,ACCEL-LEFLUNOMIDE (leflunomide 10 mg oral tablet) ACCEL PHARMA INC,Active,9003479,leflunomide 10 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
96958,Marketed,2019-09-19,02478870,Accel-Leflunomide,1,L04AK01,Leflunomide,Tablet,Oral,02478870,ACCEL-LEFLUNOMIDE (leflunomide 20 mg oral tablet) ACCEL PHARMA INC,Active,9003480,leflunomide 20 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99675,Marketed,2020-11-06,02507366,Dayvigo,1,N05CJ02,Lemborexant,Tablet,Oral,02507366,DAYVIGO (lemborexant 5 mg oral tablet) EISAI LIMITED,Active,9014458,lemborexant 5 mg oral tablet,8002363,lemborexant,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99676,Marketed,2020-11-06,02507374,Dayvigo,1,N05CJ02,Lemborexant,Tablet,Oral,02507374,DAYVIGO (lemborexant 10 mg oral tablet) EISAI LIMITED,Active,9014457,lemborexant 10 mg oral tablet,8002363,lemborexant,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102149,Marketed,2023-03-15,02532468,Sunlenca,1,J05AX31,Lenacapavir,Tablet,Oral,02532468,SUNLENCA (lenacapavir (lenacapavir sodium) 300 mg oral tablet) GILEAD SCIENCES CANADA INC,Active,9014847,lenacapavir (lenacapavir sodium) 300 mg oral tablet,8002465,lenacapavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102150,Marketed,2023-03-15,02532476,Sunlenca,1,J05AX31,Lenacapavir,Solution,Subcutaneous,02532476,SUNLENCA (lenacapavir (lenacapavir sodium) 463.5 mg per 1.5 mL solution for injection vial) GILEAD SCIENCES CANADA INC,Active,9014848,lenacapavir (lenacapavir sodium) 463.5 mg per 1.5 mL solution for injection vial,8002465,lenacapavir,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
100787,Marketed,2021-09-07,02518562,Sandoz Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02518562,SANDOZ LENALIDOMIDE (lenalidomide 2.5 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9006081,lenalidomide 2.5 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
100788,Marketed,2021-09-07,02518570,Sandoz Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02518570,SANDOZ LENALIDOMIDE (lenalidomide 5 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9004378,lenalidomide 5 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
100789,Marketed,2021-09-07,02518589,Sandoz Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02518589,SANDOZ LENALIDOMIDE (lenalidomide 10 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9004377,lenalidomide 10 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
100790,Marketed,2021-09-07,02518597,Sandoz Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02518597,SANDOZ LENALIDOMIDE (lenalidomide 15 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9004465,lenalidomide 15 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
100791,Marketed,2021-09-07,02518600,Sandoz Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02518600,SANDOZ LENALIDOMIDE (lenalidomide 20 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9005785,lenalidomide 20 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
100792,Marketed,2021-09-07,02518619,Sandoz Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02518619,SANDOZ LENALIDOMIDE (lenalidomide 25 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9004466,lenalidomide 25 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
79016,Marketed,2025-01-31,02304899,Revlimid,1,L04AX04,Lenalidomide,Capsule,Oral,02304899,REVLIMID (lenalidomide 5 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9004378,lenalidomide 5 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
79017,Marketed,2025-01-31,02304902,Revlimid,1,L04AX04,Lenalidomide,Capsule,Oral,02304902,REVLIMID (lenalidomide 10 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9004377,lenalidomide 10 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
80322,Marketed,2025-02-03,02317699,Revlimid,1,L04AX04,Lenalidomide,Capsule,Oral,02317699,REVLIMID (lenalidomide 15 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9004465,lenalidomide 15 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
80324,Marketed,2025-01-31,02317710,Revlimid,1,L04AX04,Lenalidomide,Capsule,Oral,02317710,REVLIMID (lenalidomide 25 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9004466,lenalidomide 25 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
92497,Marketed,2025-02-05,02440601,Revlimid,1,L04AX04,Lenalidomide,Capsule,Oral,02440601,REVLIMID (lenalidomide 20 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9005785,lenalidomide 20 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
94664,Marketed,2024-11-22,02459418,Revlimid,1,L04AX04,Lenalidomide,Capsule,Oral,02459418,REVLIMID (lenalidomide 2.5 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9006081,lenalidomide 2.5 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
97342,Marketed,2021-09-01,02483017,Reddy-Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02483017,REDDY-LENALIDOMIDE (lenalidomide 5 mg oral capsule) DR REDDY'S LABORATORIES LTD,Active,9004378,lenalidomide 5 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
97343,Marketed,2021-09-01,02483025,Reddy-Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02483025,REDDY-LENALIDOMIDE (lenalidomide 10 mg oral capsule) DR REDDY'S LABORATORIES LTD,Active,9004377,lenalidomide 10 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
97344,Marketed,2021-09-01,02483033,Reddy-Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02483033,REDDY-LENALIDOMIDE (lenalidomide 15 mg oral capsule) DR REDDY'S LABORATORIES LTD,Active,9004465,lenalidomide 15 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
97345,Marketed,2021-09-01,02483041,Reddy-Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02483041,REDDY-LENALIDOMIDE (lenalidomide 20 mg oral capsule) DR REDDY'S LABORATORIES LTD,Active,9005785,lenalidomide 20 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
97346,Marketed,2021-09-01,02483068,Reddy-Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02483068,REDDY-LENALIDOMIDE (lenalidomide 25 mg oral capsule) DR REDDY'S LABORATORIES LTD,Active,9004466,lenalidomide 25 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
97500,Marketed,2021-09-01,02484714,Reddy-Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02484714,REDDY-LENALIDOMIDE (lenalidomide 2.5 mg oral capsule) DR REDDY'S LABORATORIES LTD,Active,9006081,lenalidomide 2.5 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
98383,Marketed,2021-09-01,02493837,Nat-Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02493837,NAT-LENALIDOMIDE (lenalidomide 2.5 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9006081,lenalidomide 2.5 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
98384,Marketed,2021-09-01,02493845,Nat-Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02493845,NAT-LENALIDOMIDE (lenalidomide 5 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9004378,lenalidomide 5 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
98386,Marketed,2021-09-01,02493861,Nat-Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02493861,NAT-LENALIDOMIDE (lenalidomide 10 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9004377,lenalidomide 10 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
98387,Marketed,2021-09-01,02493888,Nat-Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02493888,NAT-LENALIDOMIDE (lenalidomide 15 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9004465,lenalidomide 15 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
98388,Marketed,2021-09-01,02493896,Nat-Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02493896,NAT-LENALIDOMIDE (lenalidomide 20 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9005785,lenalidomide 20 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
98389,Marketed,2021-09-01,02493918,Nat-Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02493918,NAT-LENALIDOMIDE (lenalidomide 25 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9004466,lenalidomide 25 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
99548,Marketed,2022-02-02,02506130,JAMP Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02506130,JAMP LENALIDOMIDE (lenalidomide 2.5 mg oral capsule) JAMP PHARMA CORPORATION,Active,9006081,lenalidomide 2.5 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
99549,Marketed,2022-02-02,02506149,JAMP Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02506149,JAMP LENALIDOMIDE (lenalidomide 5 mg oral capsule) JAMP PHARMA CORPORATION,Active,9004378,lenalidomide 5 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
99550,Marketed,2022-02-02,02506157,JAMP Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02506157,JAMP LENALIDOMIDE (lenalidomide 10 mg oral capsule) JAMP PHARMA CORPORATION,Active,9004377,lenalidomide 10 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
99551,Marketed,2022-02-02,02506165,JAMP Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02506165,JAMP LENALIDOMIDE (lenalidomide 15 mg oral capsule) JAMP PHARMA CORPORATION,Active,9004465,lenalidomide 15 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
99552,Marketed,2022-02-02,02506173,JAMP Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02506173,JAMP LENALIDOMIDE (lenalidomide 20 mg oral capsule) JAMP PHARMA CORPORATION,Active,9005785,lenalidomide 20 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
99553,Marketed,2022-02-02,02506181,JAMP Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02506181,JAMP LENALIDOMIDE (lenalidomide 25 mg oral capsule) JAMP PHARMA CORPORATION,Active,9004466,lenalidomide 25 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
99724,Marketed,2022-06-13,02507862,Taro-Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02507862,TARO-LENALIDOMIDE (lenalidomide 2.5 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9006081,lenalidomide 2.5 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
99725,Marketed,2022-06-13,02507870,Taro-Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02507870,TARO-LENALIDOMIDE (lenalidomide 5 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9004378,lenalidomide 5 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
99726,Marketed,2022-06-13,02507889,Taro-Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02507889,TARO-LENALIDOMIDE (lenalidomide 10 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9004377,lenalidomide 10 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
99727,Marketed,2022-06-13,02507897,Taro-Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02507897,TARO-LENALIDOMIDE (lenalidomide 15 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9004465,lenalidomide 15 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
99728,Marketed,2022-06-13,02507900,Taro-Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02507900,TARO-LENALIDOMIDE (lenalidomide 20 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9005785,lenalidomide 20 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
99729,Marketed,2022-06-13,02507919,Taro-Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02507919,TARO-LENALIDOMIDE (lenalidomide 25 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9004466,lenalidomide 25 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
99730,Marketed,2021-09-01,02507927,Apo-Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02507927,APO-LENALIDOMIDE (lenalidomide 2.5 mg oral capsule) APOTEX INC,Active,9006081,lenalidomide 2.5 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
99731,Marketed,2021-09-01,02507935,Apo-Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02507935,APO-LENALIDOMIDE (lenalidomide 5 mg oral capsule) APOTEX INC,Active,9004378,lenalidomide 5 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
99732,Marketed,2021-09-01,02507943,Apo-Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02507943,APO-LENALIDOMIDE (lenalidomide 10 mg oral capsule) APOTEX INC,Active,9004377,lenalidomide 10 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
99733,Marketed,2021-09-01,02507951,Apo-Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02507951,APO-LENALIDOMIDE (lenalidomide 15 mg oral capsule) APOTEX INC,Active,9004465,lenalidomide 15 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
99734,Marketed,2021-09-01,02507978,Apo-Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02507978,APO-LENALIDOMIDE (lenalidomide 20 mg oral capsule) APOTEX INC,Active,9005785,lenalidomide 20 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
99735,Marketed,2021-09-01,02507986,Apo-Lenalidomide,1,L04AX04,Lenalidomide,Capsule,Oral,02507986,APO-LENALIDOMIDE (lenalidomide 25 mg oral capsule) APOTEX INC,Active,9004466,lenalidomide 25 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
93643,Marketed,2016-03-31,02450291,Lenvima,1,L01EX08,Lenvatinib,Capsule,Oral,02450291,LENVIMA (lenvatinib (lenvatinib mesylate) 24 mg oral capsule) EISAI LIMITED,Active,9005922,lenvatinib (lenvatinib mesylate) 24 mg oral capsule,8001832,lenvatinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
93644,Marketed,2016-03-31,02450305,Lenvima,1,L01EX08,Lenvatinib,Capsule,Oral,02450305,LENVIMA (lenvatinib (lenvatinib mesylate) 20 mg oral capsule) EISAI LIMITED,Active,9005921,lenvatinib (lenvatinib mesylate) 20 mg oral capsule,8001832,lenvatinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
93645,Marketed,2016-03-31,02450313,Lenvima,1,L01EX08,Lenvatinib,Capsule,Oral,02450313,LENVIMA (lenvatinib (lenvatinib mesylate) 14 mg oral capsule) EISAI LIMITED,Active,9005920,lenvatinib (lenvatinib mesylate) 14 mg oral capsule,8001832,lenvatinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
93646,Marketed,2016-03-31,02450321,Lenvima,1,L01EX08,Lenvatinib,Capsule,Oral,02450321,LENVIMA (lenvatinib (lenvatinib mesylate) 10 mg oral capsule) EISAI LIMITED,Active,9005919,lenvatinib (lenvatinib mesylate) 10 mg oral capsule,8001832,lenvatinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
95663,Marketed,2018-05-08,02468220,Lenvima,1,L01EX08,Lenvatinib,Capsule,Oral,02468220,LENVIMA (lenvatinib (lenvatinib mesylate) 8 mg oral capsule) EISAI LIMITED,Active,9013187,lenvatinib (lenvatinib mesylate) 8 mg oral capsule,8001832,lenvatinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
95664,Marketed,2018-05-08,02468239,Lenvima,1,L01EX08,Lenvatinib,Capsule,Oral,02468239,LENVIMA (lenvatinib (lenvatinib mesylate) 18 mg oral capsule) EISAI LIMITED,Active,9013186,lenvatinib (lenvatinib mesylate) 18 mg oral capsule,8001832,lenvatinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
97438,Marketed,2019-10-21,02484056,Lenvima,1,L01EX08,Lenvatinib,Capsule,Oral,02484056,LENVIMA (lenvatinib (lenvatinib mesylate) 4 mg oral capsule) EISAI LIMITED,Active,9014177,lenvatinib (lenvatinib mesylate) 4 mg oral capsule,8001832,lenvatinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
97445,Marketed,2019-10-21,02484129,Lenvima,1,L01EX08,Lenvatinib,Capsule,Oral,02484129,LENVIMA (lenvatinib (lenvatinib mesylate) 12 mg oral capsule) EISAI LIMITED,Active,9014176,lenvatinib (lenvatinib mesylate) 12 mg oral capsule,8001832,lenvatinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
95815,Marketed,2017-12-20,02469367,Prevymis,1,J05AX18,Letermovir,Solution,Intravenous,02469367,PREVYMIS 240 MG/12 ML SINGLE-DOSE VIAL (letermovir 240 mg per 12 mL solution for injection vial) MERCK CANADA INC,Active,9012506,letermovir 240 mg per 12 mL solution for injection vial,8001140,letermovir,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
100968,Marketed,2022-03-25,02520486,Nra-Letrozole,1,L02BG04,Letrozole,Tablet,Oral,02520486,NRA-LETROZOLE (letrozole 2.5 mg oral tablet) NORA PHARMA INC,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101329,Marketed,2022-07-18,02524244,Letrozole,1,L02BG04,Letrozole,Tablet,Oral,02524244,LETROZOLE (letrozole 2.5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
103052,Marketed,2024-08-20,02541912,JAMP Letrozole Tablets,1,L02BG04,Letrozole,Tablet,Oral,02541912,JAMP LETROZOLE TABLETS (letrozole 2.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
103188,Marketed,2024-08-20,02543419,AG-Letrozole Tablets,1,L02BG04,Letrozole,Tablet,Oral,02543419,AG-LETROZOLE TABLETS (letrozole 2.5 mg oral tablet) ANGITA PHARMA INC.,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
103878,Marketed,2025-04-25,02549972,M-Letrozole,1,L02BG04,Letrozole,Tablet,Oral,02549972,M-LETROZOLE (letrozole 2.5 mg oral tablet) MANTRA PHARMA INC,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
50695,Marketed,1997-09-02,02231384,Femara,1,L02BG04,Letrozole,Tablet,Oral,02231384,FEMARA (letrozole 2.5 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
79471,Marketed,2010-04-28,02309114,PMS-Letrozole,1,L02BG04,Letrozole,Tablet,Oral,02309114,PMS-LETROZOLE (letrozole 2.5 mg oral tablet) PHARMASCIENCE INC,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
82411,Marketed,2014-05-03,02338459,ACH-Letrozole,1,L02BG04,Letrozole,Tablet,Oral,02338459,ACH-LETROZOLE (letrozole 2.5 mg oral tablet) ACCORD HEALTHCARE INC,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
82909,Marketed,2013-07-08,02343657,Teva-Letrozole,1,L02BG04,Letrozole,Tablet,Oral,02343657,TEVA-LETROZOLE (letrozole 2.5 mg oral tablet) TEVA CANADA LIMITED,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
83029,Marketed,2010-04-27,02344815,Sandoz Letrozole,1,L02BG04,Letrozole,Tablet,Oral,02344815,SANDOZ LETROZOLE (letrozole 2.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
84356,Marketed,2020-11-24,02358514,Apo-Letrozole,1,L02BG04,Letrozole,Tablet,Oral,02358514,APO-LETROZOLE (letrozole 2.5 mg oral tablet) APOTEX INC,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
85813,Marketed,2022-05-16,02373009,JAMP-Letrozole,1,L02BG04,Letrozole,Tablet,Oral,02373009,JAMP-LETROZOLE (letrozole 2.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
85857,Marketed,2022-02-09,02373424,Mar-Letrozole,1,L02BG04,Letrozole,Tablet,Oral,02373424,MAR-LETROZOLE (letrozole 2.5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
85979,Marketed,2022-05-16,02374439,AG-Letrozole,1,L02BG04,Letrozole,Tablet,Oral,02374439,AG-LETROZOLE (letrozole 2.5 mg oral tablet) ANGITA PHARMA INC.,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
87776,Marketed,2024-11-20,02392496,Bio-Letrozole,1,L02BG04,Letrozole,Tablet,Oral,02392496,BIO-LETROZOLE (letrozole 2.5 mg oral tablet) BIOMED PHARMA,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
88359,Marketed,2024-07-03,02398656,Riva-Letrozole,1,L02BG04,Letrozole,Tablet,Oral,02398656,RIVA-LETROZOLE (letrozole 2.5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
88690,Marketed,2013-02-14,02402025,Letrozole,1,L02BG04,Letrozole,Tablet,Oral,02402025,LETROZOLE (letrozole 2.5 mg oral tablet) PRO DOC LIMITEE,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
90623,Marketed,2015-02-03,02421585,Nat-Letrozole,1,L02BG04,Letrozole,Tablet,Oral,02421585,NAT-LETROZOLE (letrozole 2.5 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99389,Marketed,2026-02-25,02504472,Letrozole,1,L02BG04,Letrozole,Tablet,Oral,02504472,LETROZOLE (letrozole 2.5 mg oral tablet) SANIS HEALTH INC,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99746,Marketed,2026-05-05,02508109,Mint-Letrozole,1,L02BG04,Letrozole,Tablet,Oral,02508109,MINT-LETROZOLE (letrozole 2.5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
10318,Marketed,2013-12-11,00836273,Lupron Depot,1,L02AE02,Leuprorelin,"Powder for suspension, sustained-release",Intramuscular,00836273,LUPRON DEPOT (leuprolide acetate 7.5 mg powder for prolonged-release suspension for injection with diluent solution per syringe) ABBVIE CORPORATION,Active,9013311,leuprolide acetate 7.5 mg powder for prolonged-release suspension for injection with diluent solution per syringe,8001834,leuprolide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
106570,Marketed,2026-01-28,02562855,Lupron Depot,1,L02AE02,Leuprorelin,"Powder for suspension, sustained-release",Intramuscular,02562855,LUPRON DEPOT (leuprolide acetate 45 mg powder for prolonged-release suspension for injection with diluent solution per syringe) ABBVIE CORPORATION,Active,9015357,leuprolide acetate 45 mg powder for prolonged-release suspension for injection with diluent solution per syringe,8001834,leuprolide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733020007,Syringe,1.0,,,Prescription
13443,Marketed,2013-12-01,00884502,Lupron Depot,1,L02AE02,Leuprorelin,"Powder for suspension, sustained-release",Intramuscular,00884502,LUPRON DEPOT (leuprolide acetate 3.75 mg powder for prolonged-release suspension for injection with diluent solution per syringe) ABBVIE CORPORATION,Active,9013306,leuprolide acetate 3.75 mg powder for prolonged-release suspension for injection with diluent solution per syringe,8001834,leuprolide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
48922,Marketed,2013-12-09,02230248,Lupron Depot,1,L02AE02,Leuprorelin,"Powder for suspension, sustained-release",Intramuscular,02230248,LUPRON DEPOT (leuprolide acetate 22.5 mg powder for prolonged-release suspension for injection with diluent solution per syringe) ABBVIE CORPORATION,Active,9013305,leuprolide acetate 22.5 mg powder for prolonged-release suspension for injection with diluent solution per syringe,8001834,leuprolide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
63320,Marketed,2013-12-17,02239833,Lupron Depot,1,L02AE02,Leuprorelin,"Powder for suspension, sustained-release",Intramuscular,02239833,LUPRON DEPOT (leuprolide acetate 30 mg powder for prolonged-release suspension for injection with diluent solution per syringe) ABBVIE CORPORATION,Active,9013308,leuprolide acetate 30 mg powder for prolonged-release suspension for injection with diluent solution per syringe,8001834,leuprolide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
63321,Marketed,2013-11-04,02239834,Lupron Depot,1,L02AE02,Leuprorelin,"Powder for suspension, sustained-release",Intramuscular,02239834,LUPRON DEPOT (leuprolide acetate 11.25 mg powder for prolonged-release suspension for injection with diluent solution per syringe) ABBVIE CORPORATION,Active,9013303,leuprolide acetate 11.25 mg powder for prolonged-release suspension for injection with diluent solution per syringe,8001834,leuprolide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
72576,Marketed,2022-05-30,02248239,Eligard,1,L02AE02,Leuprorelin,"Powder for suspension, sustained-release",Subcutaneous,02248239,ELIGARD (leuprolide acetate 7.5 mg per syringe powder for prolonged-release solution for injection with diluent solution syringe) TOLMAR INTERNATIONAL LTD.,Active,9013310,leuprolide acetate 7.5 mg per syringe powder for prolonged-release solution for injection with diluent solution syringe,8001834,leuprolide,738984000,Parenteral,1231833006,Prolonged-release solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
72577,Marketed,2022-03-25,02248240,Eligard,1,L02AE02,Leuprorelin,"Powder for suspension, sustained-release",Subcutaneous,02248240,ELIGARD (leuprolide acetate 22.5 mg per syringe powder for prolonged-release solution for injection with diluent solution syringe) TOLMAR INTERNATIONAL LTD.,Active,9013304,leuprolide acetate 22.5 mg per syringe powder for prolonged-release solution for injection with diluent solution syringe,8001834,leuprolide,738984000,Parenteral,1231833006,Prolonged-release solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
73384,Marketed,2022-04-08,02248999,Eligard,1,L02AE02,Leuprorelin,"Powder for suspension, sustained-release",Subcutaneous,02248999,ELIGARD (leuprolide acetate 30 mg per syringe powder for prolonged-release solution for injection with diluent solution syringe) TOLMAR INTERNATIONAL LTD.,Active,9013307,leuprolide acetate 30 mg per syringe powder for prolonged-release solution for injection with diluent solution syringe,8001834,leuprolide,738984000,Parenteral,1231833006,Prolonged-release solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
75428,Marketed,2022-04-22,02268892,Eligard,1,L02AE02,Leuprorelin,"Powder for suspension, sustained-release",Subcutaneous,02268892,ELIGARD (leuprolide acetate 45 mg per syringe powder for prolonged-release suspension for injection with diluent solution syringe) TOLMAR INTERNATIONAL LTD.,Active,9013309,leuprolide acetate 45 mg per syringe powder for prolonged-release suspension for injection with diluent solution syringe,8001834,leuprolide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
91439,Marketed,2019-10-08,02429977,Zeulide Depot,1,L02AE02,Leuprorelin,"Kit,Powder for suspension, sustained-release",Intramuscular,02429977,ZEULIDE DEPOT (leuprolide acetate 3.75 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe) VERITY PHARMACEUTICALS INC.,Active,9014179,leuprolide acetate 3.75 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe,8001834,leuprolide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
95052,Marketed,2019-10-08,02462699,Zeulide Depot,1,L02AE02,Leuprorelin,"Powder for suspension, sustained-release,Kit",Intramuscular,02462699,ZEULIDE DEPOT (leuprolide acetate 22.5 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe) VERITY PHARMACEUTICALS INC.,Active,9014178,leuprolide acetate 22.5 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe,8001834,leuprolide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
100470,Marketed,2025-12-22,02515318,Pharma-Levetiracetam,1,N03AX14,Levetiracetam,Solution,Oral,02515318,PHARMA-LEVETIRACETAM (levetiracetam 100 mg per mL oral solution) PHARMASCIENCE INC,Active,9014311,levetiracetam 100 mg per mL oral solution,8000328,levetiracetam,26643006,Oral,385023001,Oral solution,,,,,,Prescription
101358,Marketed,2022-08-23,02524562,M-Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02524562,M-LEVETIRACETAM (levetiracetam 250 mg oral tablet) MANTRA PHARMA INC,Active,9001035,levetiracetam 250 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101359,Marketed,2022-08-23,02524570,M-Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02524570,M-LEVETIRACETAM (levetiracetam 500 mg oral tablet) MANTRA PHARMA INC,Active,9001036,levetiracetam 500 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101360,Marketed,2022-08-23,02524589,M-Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02524589,M-LEVETIRACETAM (levetiracetam 750 mg oral tablet) MANTRA PHARMA INC,Active,9001037,levetiracetam 750 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101643,Marketed,2022-08-05,02527375,Levetiracetam Injection USP,1,N03AX14,Levetiracetam,Solution,Intravenous,02527375,LEVETIRACETAM INJECTION USP (levetiracetam 500 mg per 5 mL solution for injection vial) STERIMAX INC,Active,9014195,levetiracetam 500 mg per 5 mL solution for injection vial,8000328,levetiracetam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
103901,Marketed,2025-05-05,02550172,Levetiracetam Injection USP,1,N03AX14,Levetiracetam,Solution,Intravenous,02550172,LEVETIRACETAM INJECTION USP (levetiracetam 500 mg per 5 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9014195,levetiracetam 500 mg per 5 mL solution for injection vial,8000328,levetiracetam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
106166,Marketed,2025-08-14,02558416,Mint-Levetiracetam Solution,1,N03AX14,Levetiracetam,Solution,Oral,02558416,MINT-LEVETIRACETAM SOLUTION (levetiracetam 100 mg per mL oral solution) MINT PHARMACEUTICALS INC,Active,9014311,levetiracetam 100 mg per mL oral solution,8000328,levetiracetam,26643006,Oral,385023001,Oral solution,,,,,,Prescription
71262,Marketed,2010-09-10,02247027,Keppra,1,N03AX14,Levetiracetam,Tablet,Oral,02247027,KEPPRA (levetiracetam 250 mg oral tablet) UCB CANADA INC,Active,9001035,levetiracetam 250 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71263,Marketed,2010-09-13,02247028,Keppra,1,N03AX14,Levetiracetam,Tablet,Oral,02247028,KEPPRA (levetiracetam 500 mg oral tablet) UCB CANADA INC,Active,9001036,levetiracetam 500 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71264,Marketed,2011-06-02,02247029,Keppra,1,N03AX14,Levetiracetam,Tablet,Oral,02247029,KEPPRA (levetiracetam 750 mg oral tablet) UCB CANADA INC,Active,9001037,levetiracetam 750 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75964,Marketed,2020-12-17,02274183,Teva-Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02274183,TEVA-LEVETIRACETAM (levetiracetam 250 mg oral tablet) TEVA CANADA LIMITED,Active,9001035,levetiracetam 250 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75965,Marketed,2020-12-17,02274191,Teva-Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02274191,TEVA-LEVETIRACETAM (levetiracetam 500 mg oral tablet) TEVA CANADA LIMITED,Active,9001036,levetiracetam 500 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75966,Marketed,2020-12-17,02274205,Teva-Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02274205,TEVA-LEVETIRACETAM (levetiracetam 750 mg oral tablet) TEVA CANADA LIMITED,Active,9001037,levetiracetam 750 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77141,Marketed,2006-10-20,02285924,Apo-Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02285924,APO-LEVETIRACETAM (levetiracetam 250 mg oral tablet) APOTEX INC,Active,9001035,levetiracetam 250 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77142,Marketed,2006-10-20,02285932,Apo-Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02285932,APO-LEVETIRACETAM (levetiracetam 500 mg oral tablet) APOTEX INC,Active,9001036,levetiracetam 500 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77143,Marketed,2006-10-20,02285940,Apo-Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02285940,APO-LEVETIRACETAM (levetiracetam 750 mg oral tablet) APOTEX INC,Active,9001037,levetiracetam 750 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78145,Marketed,2021-09-30,02296101,PMS-Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02296101,PMS-LEVETIRACETAM (levetiracetam 250 mg oral tablet) PHARMASCIENCE INC,Active,9001035,levetiracetam 250 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78146,Marketed,2021-09-30,02296128,PMS-Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02296128,PMS-LEVETIRACETAM (levetiracetam 500 mg oral tablet) PHARMASCIENCE INC,Active,9001036,levetiracetam 500 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78147,Marketed,2021-09-30,02296136,PMS-Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02296136,PMS-LEVETIRACETAM (levetiracetam 750 mg oral tablet) PHARMASCIENCE INC,Active,9001037,levetiracetam 750 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79695,Marketed,2020-02-11,02311372,Pro-Levetiracetam - 250,1,N03AX14,Levetiracetam,Tablet,Oral,02311372,PRO-LEVETIRACETAM - 250 (levetiracetam 250 mg oral tablet) PRO DOC LIMITEE,Active,9001035,levetiracetam 250 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79696,Marketed,2009-06-16,02311380,Pro-Levetiracetam - 500,1,N03AX14,Levetiracetam,Tablet,Oral,02311380,PRO-LEVETIRACETAM - 500 (levetiracetam 500 mg oral tablet) PRO DOC LIMITEE,Active,9001036,levetiracetam 500 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79697,Marketed,2009-10-08,02311399,Pro-Levetiracetam - 750,1,N03AX14,Levetiracetam,Tablet,Oral,02311399,PRO-LEVETIRACETAM - 750 (levetiracetam 750 mg oral tablet) PRO DOC LIMITEE,Active,9001037,levetiracetam 750 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83854,Marketed,2023-07-04,02353342,Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02353342,LEVETIRACETAM (levetiracetam 250 mg oral tablet) SANIS HEALTH INC,Active,9001035,levetiracetam 250 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83855,Marketed,2023-07-04,02353350,Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02353350,LEVETIRACETAM (levetiracetam 500 mg oral tablet) SANIS HEALTH INC,Active,9001036,levetiracetam 500 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83856,Marketed,2023-07-04,02353369,Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02353369,LEVETIRACETAM (levetiracetam 750 mg oral tablet) SANIS HEALTH INC,Active,9001037,levetiracetam 750 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86064,Marketed,2012-02-14,02375249,Auro-Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02375249,AURO-LEVETIRACETAM (levetiracetam 250 mg oral tablet) AURO PHARMA INC,Active,9001035,levetiracetam 250 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86065,Marketed,2012-03-15,02375257,Auro-Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02375257,AURO-LEVETIRACETAM (levetiracetam 500 mg oral tablet) AURO PHARMA INC,Active,9001036,levetiracetam 500 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86066,Marketed,2012-02-14,02375265,Auro-Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02375265,AURO-LEVETIRACETAM (levetiracetam 750 mg oral tablet) AURO PHARMA INC,Active,9001037,levetiracetam 750 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88462,Marketed,2023-04-14,02399776,ACH-Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02399776,ACH-LEVETIRACETAM (levetiracetam 250 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001035,levetiracetam 250 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88463,Marketed,2023-03-29,02399784,ACH-Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02399784,ACH-LEVETIRACETAM (levetiracetam 500 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001036,levetiracetam 500 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88464,Marketed,2023-03-31,02399792,ACH-Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02399792,ACH-LEVETIRACETAM (levetiracetam 750 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001037,levetiracetam 750 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92674,Marketed,2021-06-28,02442388,Mint-Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02442388,MINT-LEVETIRACETAM (levetiracetam 250 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001035,levetiracetam 250 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92675,Marketed,2021-06-28,02442396,Mint-Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02442396,MINT-LEVETIRACETAM (levetiracetam 500 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001036,levetiracetam 500 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92676,Marketed,2021-06-28,02442418,Mint-Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02442418,MINT-LEVETIRACETAM (levetiracetam 750 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001037,levetiracetam 750 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92688,Marketed,2018-04-13,02442531,Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02442531,LEVETIRACETAM (levetiracetam 250 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001035,levetiracetam 250 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92689,Marketed,2018-04-13,02442558,Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02442558,LEVETIRACETAM (levetiracetam 500 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001036,levetiracetam 500 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92690,Marketed,2018-04-13,02442566,Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02442566,LEVETIRACETAM (levetiracetam 750 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001037,levetiracetam 750 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94973,Marketed,2017-08-04,02461986,Sandoz Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02461986,SANDOZ LEVETIRACETAM (levetiracetam 250 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001035,levetiracetam 250 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94974,Marketed,2017-08-04,02461994,Sandoz Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02461994,SANDOZ LEVETIRACETAM (levetiracetam 500 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001036,levetiracetam 500 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94975,Marketed,2017-08-04,02462001,Sandoz Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02462001,SANDOZ LEVETIRACETAM (levetiracetam 750 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001037,levetiracetam 750 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94976,Marketed,2018-06-01,02462028,Sandoz Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02462028,SANDOZ LEVETIRACETAM (levetiracetam 1000 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9012827,levetiracetam 1000 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97544,Marketed,2022-03-02,02485192,AG-Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02485192,AG-LEVETIRACETAM (levetiracetam 250 mg oral tablet) ANGITA PHARMA INC.,Active,9001035,levetiracetam 250 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97545,Marketed,2022-03-02,02485206,AG-Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02485206,AG-LEVETIRACETAM (levetiracetam 500 mg oral tablet) ANGITA PHARMA INC.,Active,9001036,levetiracetam 500 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97546,Marketed,2022-03-02,02485214,AG-Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02485214,AG-LEVETIRACETAM (levetiracetam 750 mg oral tablet) ANGITA PHARMA INC.,Active,9001037,levetiracetam 750 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98048,Marketed,2019-10-30,02490439,PDP-Levetiracetam,1,N03AX14,Levetiracetam,Solution,Intravenous,02490439,PDP-LEVETIRACETAM (levetiracetam 500 mg per 5 mL solution for injection vial) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9014195,levetiracetam 500 mg per 5 mL solution for injection vial,8000328,levetiracetam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
98049,Marketed,2020-05-01,02490447,PDP-Levetiracetam,1,N03AX14,Levetiracetam,Solution,Oral,02490447,PDP-LEVETIRACETAM (levetiracetam 100 mg per mL oral solution) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9014311,levetiracetam 100 mg per mL oral solution,8000328,levetiracetam,26643006,Oral,385023001,Oral solution,,,,,,Prescription
98894,Marketed,2021-02-17,02499193,Nra-Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02499193,NRA-LEVETIRACETAM (levetiracetam 250 mg oral tablet) NORA PHARMA INC,Active,9001035,levetiracetam 250 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98895,Marketed,2021-02-17,02499207,Nra-Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02499207,NRA-LEVETIRACETAM (levetiracetam 500 mg oral tablet) NORA PHARMA INC,Active,9001036,levetiracetam 500 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98896,Marketed,2021-02-17,02499215,Nra-Levetiracetam,1,N03AX14,Levetiracetam,Tablet,Oral,02499215,NRA-LEVETIRACETAM (levetiracetam 750 mg oral tablet) NORA PHARMA INC,Active,9001037,levetiracetam 750 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99397,Marketed,2022-06-10,02504553,JAMP Levetiracetam Tablets,1,N03AX14,Levetiracetam,Tablet,Oral,02504553,JAMP LEVETIRACETAM TABLETS (levetiracetam 250 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001035,levetiracetam 250 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99398,Marketed,2022-06-10,02504561,JAMP Levetiracetam Tablets,1,N03AX14,Levetiracetam,Tablet,Oral,02504561,JAMP LEVETIRACETAM TABLETS (levetiracetam 500 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001036,levetiracetam 500 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99399,Marketed,2022-06-10,02504588,JAMP Levetiracetam Tablets,1,N03AX14,Levetiracetam,Tablet,Oral,02504588,JAMP LEVETIRACETAM TABLETS (levetiracetam 750 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001037,levetiracetam 750 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
18903,Marketed,2018-05-07,02144344,Carnitor,1,A16AA01,Levocarnitine,Solution,Intravenous,02144344,"CARNITOR (levocarnitine 1000 mg per 5 mL solution for injection vial) LEADIANT BIOSCIENCES, INC",Active,9013572,levocarnitine 1000 mg per 5 mL solution for injection vial,8002134,levocarnitine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
18931,Marketed,2019-01-28,02144328,Carnitor,1,A16AA01,Levocarnitine,Tablet,Oral,02144328,"CARNITOR (levocarnitine 330 mg oral tablet) LEADIANT BIOSCIENCES, INC",Active,9002839,levocarnitine 330 mg oral tablet,8002134,levocarnitine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
19094,Marketed,2018-08-02,02144336,Carnitor,1,A16AA01,Levocarnitine,Solution,Oral,02144336,"CARNITOR (levocarnitine 100 mg per mL oral solution) LEADIANT BIOSCIENCES, INC",Active,9006634,levocarnitine 100 mg per mL oral solution,8002134,levocarnitine,26643006,Oral,385023001,Oral solution,,,,,,Prescription
98210,Marketed,2019-11-18,02492105,Odan Levocarnitine,1,A16AA01,Levocarnitine,Solution,Oral,02492105,ODAN LEVOCARNITINE (levocarnitine 100 mg per mL oral solution) ODAN LABORATORIES LTD,Active,9006634,levocarnitine 100 mg per mL oral solution,8002134,levocarnitine,26643006,Oral,385023001,Oral solution,,,,,,Prescription
102071,Marketed,2023-04-28,02531593,Auro-Levocarb,2,N04BA02,Levodopa and decarboxylase inhibitor,Tablet,Oral,02531593,AURO-LEVOCARB (carbidopa 10 mg and levodopa 100 mg oral tablet) AURO PHARMA INC,Active,9000125,carbidopa 10 mg and levodopa 100 mg oral tablet,8000054,carbidopa and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102072,Marketed,2023-04-14,02531607,Auro-Levocarb,2,N04BA02,Levodopa and decarboxylase inhibitor,Tablet,Oral,02531607,AURO-LEVOCARB (carbidopa 25 mg and levodopa 100 mg oral tablet) AURO PHARMA INC,Active,9000144,carbidopa 25 mg and levodopa 100 mg oral tablet,8000054,carbidopa and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102073,Marketed,2023-04-14,02531615,Auro-Levocarb,2,N04BA02,Levodopa and decarboxylase inhibitor,Tablet,Oral,02531615,AURO-LEVOCARB (carbidopa 25 mg and levodopa 250 mg oral tablet) AURO PHARMA INC,Active,9000087,carbidopa 25 mg and levodopa 250 mg oral tablet,8000054,carbidopa and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103509,Marketed,2024-12-13,02546396,JAMP Levocarb,2,N04BA02,Levodopa and decarboxylase inhibitor,Tablet,Oral,02546396,JAMP LEVOCARB (carbidopa 10 mg and levodopa 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000125,carbidopa 10 mg and levodopa 100 mg oral tablet,8000054,carbidopa and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103510,Marketed,2024-12-13,02546418,JAMP Levocarb,2,N04BA02,Levodopa and decarboxylase inhibitor,Tablet,Oral,02546418,JAMP LEVOCARB (carbidopa 25 mg and levodopa 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000144,carbidopa 25 mg and levodopa 100 mg oral tablet,8000054,carbidopa and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103511,Marketed,2024-12-13,02546426,JAMP Levocarb,2,N04BA02,Levodopa and decarboxylase inhibitor,Tablet,Oral,02546426,JAMP LEVOCARB (carbidopa 25 mg and levodopa 250 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000087,carbidopa 25 mg and levodopa 250 mg oral tablet,8000054,carbidopa and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103853,Marketed,2025-03-05,02549719,PMS-Levodopa-Carbidopa,2,N04BA02,Levodopa and decarboxylase inhibitor,Tablet,Oral,02549719,PMS-LEVODOPA-CARBIDOPA (carbidopa 10 mg and levodopa 100 mg oral tablet) PHARMASCIENCE INC,Active,9000125,carbidopa 10 mg and levodopa 100 mg oral tablet,8000054,carbidopa and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103854,Marketed,2025-03-05,02549727,PMS-Levodopa-Carbidopa,2,N04BA02,Levodopa and decarboxylase inhibitor,Tablet,Oral,02549727,PMS-LEVODOPA-CARBIDOPA (carbidopa 25 mg and levodopa 100 mg oral tablet) PHARMASCIENCE INC,Active,9000144,carbidopa 25 mg and levodopa 100 mg oral tablet,8000054,carbidopa and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103855,Marketed,2025-03-05,02549735,PMS-Levodopa-Carbidopa,2,N04BA02,Levodopa and decarboxylase inhibitor,Tablet,Oral,02549735,PMS-LEVODOPA-CARBIDOPA (carbidopa 25 mg and levodopa 250 mg oral tablet) PHARMASCIENCE INC,Active,9000087,carbidopa 25 mg and levodopa 250 mg oral tablet,8000054,carbidopa and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104009,Marketed,2024-12-17,02551365,AG-Levocarb,2,N04BA02,Levodopa and decarboxylase inhibitor,Tablet,Oral,02551365,AG-LEVOCARB (carbidopa 25 mg and levodopa 100 mg oral tablet) ANGITA PHARMA INC.,Active,9000144,carbidopa 25 mg and levodopa 100 mg oral tablet,8000054,carbidopa and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
20189,Marketed,2024-08-27,02195933,Apo-Levocarb,2,N04BA02,Levodopa and decarboxylase inhibitor,Tablet,Oral,02195933,APO-LEVOCARB (carbidopa 10 mg and levodopa 100 mg oral tablet) APOTEX INC,Active,9000125,carbidopa 10 mg and levodopa 100 mg oral tablet,8000054,carbidopa and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
20190,Marketed,2024-08-27,02195968,Apo-Levocarb,2,N04BA02,Levodopa and decarboxylase inhibitor,Tablet,Oral,02195968,APO-LEVOCARB (carbidopa 25 mg and levodopa 250 mg oral tablet) APOTEX INC,Active,9000087,carbidopa 25 mg and levodopa 250 mg oral tablet,8000054,carbidopa and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
20239,Marketed,2024-08-27,02195941,Apo-Levocarb,2,N04BA02,Levodopa and decarboxylase inhibitor,Tablet,Oral,02195941,APO-LEVOCARB (carbidopa 25 mg and levodopa 100 mg oral tablet) APOTEX INC,Active,9000144,carbidopa 25 mg and levodopa 100 mg oral tablet,8000054,carbidopa and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
2723,Marketed,1977-12-31,00386464,Prolopa Capsules 100-25,2,N04BA02,Levodopa and decarboxylase inhibitor,Capsule,Oral,00386464,PROLOPA CAP 100-25 (benserazide (benserazide hydrochloride) 25 mg and levodopa 100 mg oral capsule) HOFFMANN-LA ROCHE LIMITED,Active,9001775,benserazide (benserazide hydrochloride) 25 mg and levodopa 100 mg oral capsule,8001342,benserazide and levodopa,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
2724,Marketed,1977-12-31,00386472,Prolopa Capsules 200-50,2,N04BA02,Levodopa and decarboxylase inhibitor,Capsule,Oral,00386472,PROLOPA CAP 200-50 (benserazide (benserazide hydrochloride) 50 mg and levodopa 200 mg oral capsule) HOFFMANN-LA ROCHE LIMITED,Active,9001776,benserazide (benserazide hydrochloride) 50 mg and levodopa 200 mg oral capsule,8001342,benserazide and levodopa,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
4459,Marketed,1981-12-31,00522597,Prolopa Capsules 50-12.5,2,N04BA02,Levodopa and decarboxylase inhibitor,Capsule,Oral,00522597,PROLOPA CAP 50-12.5 (benserazide (benserazide hydrochloride) 12.5 mg and levodopa 50 mg oral capsule) HOFFMANN-LA ROCHE LIMITED,Active,9001898,benserazide (benserazide hydrochloride) 12.5 mg and levodopa 50 mg oral capsule,8001342,benserazide and levodopa,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
68471,Marketed,2011-12-13,02244495,Teva-Levocarbidopa,2,N04BA02,Levodopa and decarboxylase inhibitor,Tablet,Oral,02244495,TEVA-LEVOCARBIDOPA (carbidopa 25 mg and levodopa 100 mg oral tablet) TEVA CANADA LIMITED,Active,9000144,carbidopa 25 mg and levodopa 100 mg oral tablet,8000054,carbidopa and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
68472,Marketed,2011-12-13,02244496,Teva-Levocarbidopa,2,N04BA02,Levodopa and decarboxylase inhibitor,Tablet,Oral,02244496,TEVA-LEVOCARBIDOPA (carbidopa 25 mg and levodopa 250 mg oral tablet) TEVA CANADA LIMITED,Active,9000087,carbidopa 25 mg and levodopa 250 mg oral tablet,8000054,carbidopa and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
69226,Marketed,2020-06-12,02245211,AA-Levocarb CR,2,N04BA02,Levodopa and decarboxylase inhibitor,Tablet (extended-release),Oral,02245211,AA-LEVOCARB CR (carbidopa 50 mg and levodopa 200 mg prolonged-release oral tablet) AA PHARMA INC,Active,9000376,carbidopa 50 mg and levodopa 200 mg prolonged-release oral tablet,8000054,carbidopa and levodopa,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75839,Marketed,2020-05-26,02272873,AA-Levocarb CR,2,N04BA02,Levodopa and decarboxylase inhibitor,Tablet (extended-release),Oral,02272873,AA-LEVOCARB CR (carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet) AA PHARMA INC,Active,9000458,carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet,8000054,carbidopa and levodopa,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77753,Marketed,2013-07-17,02292165,Duodopa,2,N04BA02,Levodopa and decarboxylase inhibitor,Gel,Intraintestinal (upper),02292165,DUODOPA (carbidopa (carbidopa monohydrate) 5 mg per mL and levodopa 20 mg per mL intestinal gel) ABBVIE CORPORATION,Active,9001258,carbidopa 5 mg per mL and levodopa 20 mg per mL intestinal gel,8000054,carbidopa and levodopa,417985001,Enteral,385100002,Gel,,,,,,Prescription
94498,Marketed,2026-01-12,02457954,Mint-Levocarb,2,N04BA02,Levodopa and decarboxylase inhibitor,Tablet,Oral,02457954,MINT-LEVOCARB (carbidopa 10 mg and levodopa 100 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000125,carbidopa 10 mg and levodopa 100 mg oral tablet,8000054,carbidopa and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94499,Marketed,2024-09-20,02457962,Mint-Levocarb,2,N04BA02,Levodopa and decarboxylase inhibitor,Tablet,Oral,02457962,MINT-LEVOCARB (carbidopa 25 mg and levodopa 100 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000144,carbidopa 25 mg and levodopa 100 mg oral tablet,8000054,carbidopa and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79150,Marketed,2020-07-24,02305933,Stalevo,3,N04BA03,"Levodopa,decarboxylase inhibitor, and comt inhibitor",Tablet,Oral,02305933,STALEVO (carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9004414,carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet,8000967,carbidopa and entacapone and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79151,Marketed,2020-07-24,02305941,Stalevo,3,N04BA03,"Levodopa,decarboxylase inhibitor, and comt inhibitor",Tablet,Oral,02305941,STALEVO (carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9004415,carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet,8000967,carbidopa and entacapone and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79152,Marketed,2020-07-24,02305968,Stalevo,3,N04BA03,"Levodopa,decarboxylase inhibitor, and comt inhibitor",Tablet,Oral,02305968,STALEVO (carbidopa 37.5 mg and entacapone 200 mg and levodopa 150 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9004416,carbidopa 37.5 mg and entacapone 200 mg and levodopa 150 mg oral tablet,8000967,carbidopa and entacapone and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82347,Marketed,2020-07-24,02337827,Stalevo,3,N04BA03,"Levodopa,decarboxylase inhibitor, and comt inhibitor",Tablet,Oral,02337827,STALEVO (carbidopa 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9004629,carbidopa 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet,8000967,carbidopa and entacapone and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82348,Marketed,2020-07-24,02337835,Stalevo,3,N04BA03,"Levodopa,decarboxylase inhibitor, and comt inhibitor",Tablet,Oral,02337835,STALEVO (carbidopa 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9004630,carbidopa 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet,8000967,carbidopa and entacapone and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102578,Marketed,2023-10-23,02537079,Levofloxacin In 5% Dextrose Injection,1,J01MA12,Levofloxacin,Solution,Intravenous,77701134,LEVOFLOXACIN IN 5% DEXTROSE INJECTION (levofloxacin 500 mg per 100 mL solution for injection bag) HIKMA CANADA LIMITED,Active,9012557,levofloxacin 500 mg per 100 mL solution for injection bag,8000947,levofloxacin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Prescription
102578,Marketed,2023-10-23,02537079,Levofloxacin In 5% Dextrose Injection,1,J01MA12,Levofloxacin,Solution,Intravenous,77701135,LEVOFLOXACIN IN 5% DEXTROSE INJECTION (levofloxacin 750 mg per 150 mL solution for injection bag) HIKMA CANADA LIMITED,Active,9012558,levofloxacin 750 mg per 150 mL solution for injection bag,8000947,levofloxacin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Prescription
102578,Marketed,2023-10-23,02537079,Levofloxacin In 5% Dextrose Injection,1,J01MA12,Levofloxacin,Solution,Intravenous,77701136,LEVOFLOXACIN IN 5% DEXTROSE INJECTION (levofloxacin 250 mg per 50 mL solution for injection bag) HIKMA CANADA LIMITED,Active,9012556,levofloxacin 250 mg per 50 mL solution for injection bag,8000947,levofloxacin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Prescription
77026,Marketed,2009-06-24,02284707,Apo-Levofloxacin,1,J01MA12,Levofloxacin,Tablet,Oral,02284707,APO-LEVOFLOXACIN (levofloxacin (levofloxacin hemihydrate) 250 mg oral tablet) APOTEX INC,Active,9003981,levofloxacin 250 mg oral tablet,8000947,levofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77027,Marketed,2009-06-24,02284715,Apo-Levofloxacin,1,J01MA12,Levofloxacin,Tablet,Oral,02284715,APO-LEVOFLOXACIN (levofloxacin (levofloxacin hemihydrate) 500 mg oral tablet) APOTEX INC,Active,9003982,levofloxacin 500 mg oral tablet,8000947,levofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78395,Marketed,2009-06-24,02298635,Sandoz Levofloxacin,1,J01MA12,Levofloxacin,Tablet,Oral,02298635,SANDOZ LEVOFLOXACIN (levofloxacin (levofloxacin hemihydrate) 250 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003981,levofloxacin 250 mg oral tablet,8000947,levofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78396,Marketed,2009-06-24,02298643,Sandoz Levofloxacin,1,J01MA12,Levofloxacin,Tablet,Oral,02298643,SANDOZ LEVOFLOXACIN (levofloxacin (levofloxacin hemihydrate) 500 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003982,levofloxacin 500 mg oral tablet,8000947,levofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78397,Marketed,2009-06-24,02298651,Sandoz Levofloxacin,1,J01MA12,Levofloxacin,Tablet,Oral,02298651,SANDOZ LEVOFLOXACIN (levofloxacin (levofloxacin hemihydrate) 750 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9004560,levofloxacin 750 mg oral tablet,8000947,levofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80046,Marketed,2017-08-31,02314932,Levofloxacin In 5% Dextrose Injection,1,J01MA12,Levofloxacin,Solution,Intravenous,77700578,LEVOFLOXACIN IN 5% DEXTROSE INJECTION (levofloxacin 250 mg per 50 mL solution for injection bag) PFIZER CANADA ULC,Active,9012556,levofloxacin 250 mg per 50 mL solution for injection bag,8000947,levofloxacin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Prescription
80046,Marketed,2017-08-31,02314932,Levofloxacin In 5% Dextrose Injection,1,J01MA12,Levofloxacin,Solution,Intravenous,77700579,LEVOFLOXACIN IN 5% DEXTROSE INJECTION (levofloxacin 750 mg per 150 mL solution for injection bag) PFIZER CANADA ULC,Active,9012558,levofloxacin 750 mg per 150 mL solution for injection bag,8000947,levofloxacin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Prescription
80046,Marketed,2017-08-31,02314932,Levofloxacin In 5% Dextrose Injection,1,J01MA12,Levofloxacin,Solution,Intravenous,77700580,LEVOFLOXACIN IN 5% DEXTROSE INJECTION (levofloxacin 500 mg per 100 mL solution for injection bag) PFIZER CANADA ULC,Active,9012557,levofloxacin 500 mg per 100 mL solution for injection bag,8000947,levofloxacin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Prescription
80096,Marketed,2025-10-16,02315424,Teva-Levofloxacin,1,J01MA12,Levofloxacin,Tablet,Oral,02315424,TEVA-LEVOFLOXACIN (levofloxacin (levofloxacin hemihydrate) 250 mg oral tablet) TEVA CANADA LIMITED,Active,9003981,levofloxacin 250 mg oral tablet,8000947,levofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80097,Marketed,2025-10-16,02315432,Teva-Levofloxacin,1,J01MA12,Levofloxacin,Tablet,Oral,02315432,TEVA-LEVOFLOXACIN (levofloxacin (levofloxacin hemihydrate) 500 mg oral tablet) TEVA CANADA LIMITED,Active,9003982,levofloxacin 500 mg oral tablet,8000947,levofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80098,Marketed,2025-10-16,02315440,Teva-Levofloxacin,1,J01MA12,Levofloxacin,Tablet,Oral,02315440,TEVA-LEVOFLOXACIN (levofloxacin (levofloxacin hemihydrate) 750 mg oral tablet) TEVA CANADA LIMITED,Active,9004560,levofloxacin 750 mg oral tablet,8000947,levofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81129,Marketed,2009-06-24,02325942,Apo-Levofloxacin,1,J01MA12,Levofloxacin,Tablet,Oral,02325942,APO-LEVOFLOXACIN (levofloxacin (levofloxacin hemihydrate) 750 mg oral tablet) APOTEX INC,Active,9004560,levofloxacin 750 mg oral tablet,8000947,levofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90046,Marketed,2026-02-03,02415879,Pro-Levofloxacin,1,J01MA12,Levofloxacin,Tablet,Oral,02415879,PRO-LEVOFLOXACIN (levofloxacin (levofloxacin hemihydrate) 500 mg oral tablet) PRO DOC LIMITEE,Active,9003982,levofloxacin 500 mg oral tablet,8000947,levofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92667,Marketed,2017-05-01,02442302,Quinsair,1,J01MA12,Levofloxacin,Solution,Inhalation,02442302,QUINSAIR (levofloxacin (levofloxacin hemihydrate) 240 mg per 2.4 mL nebulizer solution unit dose vial) HORIZON THERAPEUTICS IRELAND DAC,Active,9012508,levofloxacin 240 mg per 2.4 mL nebulizer solution unit dose vial,8000947,levofloxacin,447694001,Inhalation,385198000,Solution for nebuliser,733026001,Vial (unit of presentation),,,,Prescription
99781,Marketed,2024-07-19,02508443,JAMP Levofloxacin,1,J01MA12,Levofloxacin,Tablet,Oral,02508443,JAMP LEVOFLOXACIN (levofloxacin (levofloxacin hemihydrate) 250 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003981,levofloxacin 250 mg oral tablet,8000947,levofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99782,Marketed,2024-07-19,02508451,JAMP Levofloxacin,1,J01MA12,Levofloxacin,Tablet,Oral,02508451,JAMP LEVOFLOXACIN (levofloxacin (levofloxacin hemihydrate) 500 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003982,levofloxacin 500 mg oral tablet,8000947,levofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99783,Marketed,2024-07-22,02508478,JAMP Levofloxacin,1,J01MA12,Levofloxacin,Tablet,Oral,02508478,JAMP LEVOFLOXACIN (levofloxacin (levofloxacin hemihydrate) 750 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004560,levofloxacin 750 mg oral tablet,8000947,levofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
13163,Marketed,2023-12-19,01927698,Nozinan,1,N05AA02,Levomepromazine,Solution,"Intramuscular,Intravenous",01927698,NOZINAN (methotrimeprazine (methotrimeprazine hydrochloride) 25 mg per 1 mL solution for injection ampoule) NEURAXPHARM ARZNEIMITTEL GMBH,Active,9012518,methotrimeprazine (methotrimeprazine hydrochloride) 25 mg per 1 mL solution for injection ampoule,8001143,methotrimeprazine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
61820,Marketed,2013-06-24,02238403,Methoprazine,1,N05AA02,Levomepromazine,Tablet,Oral,02238403,METHOPRAZINE (methotrimeprazine (methotrimeprazine maleate) 2 mg oral tablet) AA PHARMA INC,Active,9003267,methotrimeprazine (methotrimeprazine maleate) 2 mg oral tablet,8001143,methotrimeprazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
61821,Marketed,2013-06-27,02238404,Methoprazine,1,N05AA02,Levomepromazine,Tablet,Oral,02238404,METHOPRAZINE (methotrimeprazine (methotrimeprazine maleate) 5 mg oral tablet) AA PHARMA INC,Active,9002725,methotrimeprazine (methotrimeprazine maleate) 5 mg oral tablet,8001143,methotrimeprazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
61822,Marketed,2014-04-14,02238405,Methoprazine,1,N05AA02,Levomepromazine,Tablet,Oral,02238405,METHOPRAZINE (methotrimeprazine (methotrimeprazine maleate) 25 mg oral tablet) AA PHARMA INC,Active,9003032,methotrimeprazine (methotrimeprazine maleate) 25 mg oral tablet,8001143,methotrimeprazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
61823,Marketed,2014-04-23,02238406,Methoprazine,1,N05AA02,Levomepromazine,Tablet,Oral,02238406,METHOPRAZINE (methotrimeprazine (methotrimeprazine maleate) 50 mg oral tablet) AA PHARMA INC,Active,9003171,methotrimeprazine (methotrimeprazine maleate) 50 mg oral tablet,8001143,methotrimeprazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92533,Marketed,2023-10-11,02440970,Fetzima,1,N06AX28,Levomilnacipran,Capsule (extended release),Oral,02440970,FETZIMA (levomilnacipran (levomilnacipran hydrochloride) 20 mg prolonged-release oral capsule) ABBVIE CORPORATION,Active,9005811,levomilnacipran (levomilnacipran hydrochloride) 20 mg prolonged-release oral capsule,8001836,levomilnacipran,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
92534,Marketed,2023-10-10,02440989,Fetzima,1,N06AX28,Levomilnacipran,Capsule (extended release),Oral,02440989,FETZIMA (levomilnacipran (levomilnacipran hydrochloride) 40 mg prolonged-release oral capsule) ABBVIE CORPORATION,Active,9005812,levomilnacipran (levomilnacipran hydrochloride) 40 mg prolonged-release oral capsule,8001836,levomilnacipran,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
92535,Marketed,2023-10-10,02440997,Fetzima,1,N06AX28,Levomilnacipran,Capsule (extended release),Oral,02440997,FETZIMA (levomilnacipran (levomilnacipran hydrochloride) 80 mg prolonged-release oral capsule) ABBVIE CORPORATION,Active,9005949,levomilnacipran (levomilnacipran hydrochloride) 80 mg prolonged-release oral capsule,8001836,levomilnacipran,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
92536,Marketed,2024-03-04,02441004,Fetzima,1,N06AX28,Levomilnacipran,Capsule (extended release),Oral,02441004,FETZIMA (levomilnacipran (levomilnacipran hydrochloride) 120 mg prolonged-release oral capsule) ABBVIE CORPORATION,Active,9005948,levomilnacipran (levomilnacipran hydrochloride) 120 mg prolonged-release oral capsule,8001836,levomilnacipran,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
103734,Marketed,2025-06-10,02548461,Mystep,1,G03AD01,Levonorgestrel,Tablet,Oral,02548461,MYSTEP (levonorgestrel 1.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9005743,levonorgestrel 1.5 mg oral tablet,8000915,levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Non-Prescription Drugs
77922,Marketed,2018-10-11,02293854,Plan B,1,G03AD01,Levonorgestrel,Tablet,Oral,02293854,"PLAN B (levonorgestrel 1.5 mg oral tablet) FOUNDATION CONSUMER HEALTHCARE, LLC",Active,9005743,levonorgestrel 1.5 mg oral tablet,8000915,levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Non-Prescription Drugs
90967,Marketed,2026-05-29,02425009,Contingency One,1,G03AD01,Levonorgestrel,Tablet,Oral,02425009,CONTINGENCY ONE (levonorgestrel 1.5 mg oral tablet) SENADOR LABORATORIES PRIVATE LIMITED ,Active,9005743,levonorgestrel 1.5 mg oral tablet,8000915,levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Non-Prescription Drugs
91790,Marketed,2016-06-07,02433532,Backup Plan Onestep,1,G03AD01,Levonorgestrel,Tablet,Oral,02433532,BACKUP PLAN ONESTEP (levonorgestrel 1.5 mg oral tablet) APOTEX INC,Active,9005743,levonorgestrel 1.5 mg oral tablet,8000915,levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Non-Prescription Drugs
102123,Marketed,2023-06-09,02532174,Audrina 21,2,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02532174,AUDRINA 21 (ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet) JAMP PHARMA CORPORATION,Active,9009376,ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102124,Marketed,2023-06-08,02532182,Audrina 28,2,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02532182,AUDRINA 28 (ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet with lactose oral tablet) JAMP PHARMA CORPORATION,Active,9009377,ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet with lactose oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
18754,Marketed,2011-12-05,02042320,Min-Ovral 21,2,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02042320,MIN-OVRAL 21 (ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet) PFIZER CANADA ULC,Active,9009383,ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
18755,Marketed,2011-11-25,02042339,Min-Ovral 28,2,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02042339,MIN-OVRAL 28 (ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet with lactose oral tablet) PFIZER CANADA ULC,Active,9009385,ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet with lactose oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
60269,Marketed,2012-04-10,02236974,Alesse 21,2,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02236974,ALESSE 21 (ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet) PFIZER CANADA ULC,Active,9009376,ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
60270,Marketed,2012-03-16,02236975,Alesse 28,2,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02236975,ALESSE 28 (ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet with lactose oral tablet) PFIZER CANADA ULC,Active,9009377,ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet with lactose oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
78129,Marketed,2015-05-28,02295946,Portia 21,2,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02295946,PORTIA 21 (ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet) TEVA CANADA LIMITED,Active,9009383,ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
78130,Marketed,2015-05-28,02295954,Portia 28,2,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02295954,PORTIA 28 (ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet with lactose oral tablet) TEVA CANADA LIMITED,Active,9009385,ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet with lactose oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
78201,Marketed,2022-09-26,02296659,Seasonale,2,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02296659,SEASONALE (ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet with lactose oral tablet) TEVA CANADA LIMITED,Active,9009385,ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet with lactose oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
78383,Marketed,2015-05-20,02298538,Aviane 21,2,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02298538,AVIANE 21 (ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet) TEVA CANADA LIMITED,Active,9009376,ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
78384,Marketed,2015-05-20,02298546,Aviane 28,2,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02298546,AVIANE 28 (ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet with lactose oral tablet) TEVA CANADA LIMITED,Active,9009377,ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet with lactose oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
8123,Marketed,2008-05-21,00707503,Triquilar 28,6,G03AB03,Levonorgestrel and estrogen,Tablet,Oral,00707503,TRIQUILAR 28 (ethinyl estradiol 30 mcg and levonorgestrel 50 mcg oral tablet with ethinyl estradiol 30 mcg and levonorgestrel 125 mcg oral tablet with ethinyl estradiol 40 mcg and levonorgestrel 750 mcg oral tablet with lactose oral tablet) BAYER INC,Active,9009387,ethinyl estradiol 30 mcg and levonorgestrel 50 mcg oral tablet with ethinyl estradiol 30 mcg and levonorgestrel 125 mcg oral tablet with ethinyl estradiol 40 mcg and levonorgestrel 750 mcg oral tablet with lactose oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
8124,Marketed,2008-07-03,00707600,Triquilar 21,6,G03AB03,Levonorgestrel and estrogen,Tablet,Oral,00707600,TRIQUILAR 21 (ethinyl estradiol 30 mcg and levonorgestrel 50 mcg oral tablet with ethinyl estradiol 30 mcg and levonorgestrel 125 mcg oral tablet with ethinyl estradiol 40 mcg and levonorgestrel 750 mcg oral tablet) BAYER INC,Active,9009386,ethinyl estradiol 30 mcg and levonorgestrel 50 mcg oral tablet with ethinyl estradiol 30 mcg and levonorgestrel 125 mcg oral tablet with ethinyl estradiol 40 mcg and levonorgestrel 750 mcg oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
83160,Marketed,2022-06-21,02346176,Seasonique,3,G03AB03,Levonorgestrel and estrogen,Tablet,Oral,02346176,SEASONIQUE (ethinyl estradiol 10 mcg oral tablet with ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet) TEVA CANADA LIMITED,Active,9013289,ethinyl estradiol 10 mcg oral tablet with ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
87265,Marketed,2013-08-27,02387085,Ovima 21,2,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02387085,OVIMA 21 (ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet) APOTEX INC,Active,9009383,ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
87266,Marketed,2013-08-27,02387093,Ovima 28,2,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02387093,OVIMA 28 (ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet with lactose oral tablet) APOTEX INC,Active,9009385,ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet with lactose oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
87345,Marketed,2012-11-19,02387875,Alysena 21,2,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02387875,ALYSENA 21 (ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet) APOTEX INC,Active,9009376,ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
87346,Marketed,2012-11-19,02387883,Alysena 28,2,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02387883,ALYSENA 28 (ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet with lactose oral tablet) APOTEX INC,Active,9009377,ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet with lactose oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
88378,Marketed,2016-09-01,02398869,Indayo,2,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02398869,INDAYO (ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet with lactose oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9009385,ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet with lactose oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
90899,Marketed,2023-11-10,02424282,Laylaa 21,2,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02424282,LAYLAA 21 (ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet) LUPIN PHARMA CANADA LIMITED,Active,9009376,ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
90900,Marketed,2023-11-10,02424290,Laylaa 28,2,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02424290,LAYLAA 28 (ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet with lactose oral tablet) LUPIN PHARMA CANADA LIMITED,Active,9009377,ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet with lactose oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102359,Marketed,2025-03-17,02534681,Apo-Levothyroxine,1,H03AA01,Levothyroxine sodium,Tablet,Oral,02534681,APO-LEVOTHYROXINE (levothyroxine sodium 100 mcg oral tablet) APOTEX INC,Active,9000681,levothyroxine sodium 100 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102360,Marketed,2025-03-17,02534703,Apo-Levothyroxine,1,H03AA01,Levothyroxine sodium,Tablet,Oral,02534703,APO-LEVOTHYROXINE (levothyroxine sodium 300 mcg oral tablet) APOTEX INC,Active,9000687,levothyroxine sodium 300 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103949,Marketed,2025-03-17,02550709,Apo-Levothyroxine,1,H03AA01,Levothyroxine sodium,Tablet,Oral,02550709,APO-LEVOTHYROXINE (levothyroxine sodium 25 mcg oral tablet) APOTEX INC,Active,9000686,levothyroxine sodium 25 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103950,Marketed,2025-03-17,02550717,Apo-Levothyroxine,1,H03AA01,Levothyroxine sodium,Tablet,Oral,02550717,APO-LEVOTHYROXINE (levothyroxine sodium 50 mcg oral tablet) APOTEX INC,Active,9000002,levothyroxine sodium 50 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103951,Marketed,2025-03-07,02550725,Apo-Levothyroxine,1,H03AA01,Levothyroxine sodium,Tablet,Oral,02550725,APO-LEVOTHYROXINE (levothyroxine sodium 75 mcg oral tablet) APOTEX INC,Active,9000688,levothyroxine sodium 75 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103952,Marketed,2025-03-17,02550733,Apo-Levothyroxine,1,H03AA01,Levothyroxine sodium,Tablet,Oral,02550733,APO-LEVOTHYROXINE (levothyroxine sodium 88 mcg oral tablet) APOTEX INC,Active,9000689,levothyroxine sodium 88 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103953,Marketed,2025-03-17,02550741,Apo-Levothyroxine,1,H03AA01,Levothyroxine sodium,Tablet,Oral,02550741,APO-LEVOTHYROXINE (levothyroxine sodium 112 mcg oral tablet) APOTEX INC,Active,9000682,levothyroxine sodium 112 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103954,Marketed,2025-03-17,02550768,Apo-Levothyroxine,1,H03AA01,Levothyroxine sodium,Tablet,Oral,02550768,APO-LEVOTHYROXINE (levothyroxine sodium 125 mcg oral tablet) APOTEX INC,Active,9000683,levothyroxine sodium 125 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103955,Marketed,2025-03-17,02550776,Apo-Levothyroxine,1,H03AA01,Levothyroxine sodium,Tablet,Oral,02550776,APO-LEVOTHYROXINE (levothyroxine sodium 137 mcg oral tablet) APOTEX INC,Active,9001052,levothyroxine sodium 137 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103956,Marketed,2025-03-17,02550784,Apo-Levothyroxine,1,H03AA01,Levothyroxine sodium,Tablet,Oral,02550784,APO-LEVOTHYROXINE (levothyroxine sodium 150 mcg oral tablet) APOTEX INC,Active,9000078,levothyroxine sodium 150 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103957,Marketed,2025-03-17,02550792,Apo-Levothyroxine,1,H03AA01,Levothyroxine sodium,Tablet,Oral,02550792,APO-LEVOTHYROXINE (levothyroxine sodium 175 mcg oral tablet) APOTEX INC,Active,9000684,levothyroxine sodium 175 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103958,Marketed,2025-03-17,02550806,Apo-Levothyroxine,1,H03AA01,Levothyroxine sodium,Tablet,Oral,02550806,APO-LEVOTHYROXINE (levothyroxine sodium 200 mcg oral tablet) APOTEX INC,Active,9000685,levothyroxine sodium 200 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
19587,Marketed,2016-03-10,02172070,Synthroid,1,H03AA01,Levothyroxine sodium,Tablet,Oral,02172070,SYNTHROID (levothyroxine sodium 50 mcg oral tablet) BGP PHARMA ULC,Active,9000002,levothyroxine sodium 50 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
19588,Marketed,2016-03-18,02172062,Synthroid,1,H03AA01,Levothyroxine sodium,Tablet,Oral,02172062,SYNTHROID (levothyroxine sodium 25 mcg oral tablet) BGP PHARMA ULC,Active,9000686,levothyroxine sodium 25 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
19589,Marketed,2016-03-18,02171228,Synthroid,1,H03AA01,Levothyroxine sodium,Tablet,Oral,02171228,SYNTHROID (levothyroxine sodium 112 mcg oral tablet) BGP PHARMA ULC,Active,9000682,levothyroxine sodium 112 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
19594,Marketed,2016-03-18,02172119,Synthroid,1,H03AA01,Levothyroxine sodium,Tablet,Oral,02172119,SYNTHROID (levothyroxine sodium 125 mcg oral tablet) BGP PHARMA ULC,Active,9000683,levothyroxine sodium 125 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
19595,Marketed,2016-03-10,02172089,Synthroid,1,H03AA01,Levothyroxine sodium,Tablet,Oral,02172089,SYNTHROID (levothyroxine sodium 75 mcg oral tablet) BGP PHARMA ULC,Active,9000688,levothyroxine sodium 75 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
19596,Marketed,2016-08-19,02172151,Synthroid,1,H03AA01,Levothyroxine sodium,Tablet,Oral,02172151,SYNTHROID (levothyroxine sodium 300 mcg oral tablet) BGP PHARMA ULC,Active,9000687,levothyroxine sodium 300 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
19597,Marketed,2016-03-10,02172143,Synthroid,1,H03AA01,Levothyroxine sodium,Tablet,Oral,02172143,SYNTHROID (levothyroxine sodium 200 mcg oral tablet) BGP PHARMA ULC,Active,9000685,levothyroxine sodium 200 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
19598,Marketed,2016-03-10,02172127,Synthroid,1,H03AA01,Levothyroxine sodium,Tablet,Oral,02172127,SYNTHROID (levothyroxine sodium 150 mcg oral tablet) BGP PHARMA ULC,Active,9000078,levothyroxine sodium 150 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
19599,Marketed,2016-04-20,02172097,Synthroid,1,H03AA01,Levothyroxine sodium,Tablet,Oral,02172097,SYNTHROID (levothyroxine sodium 88 mcg oral tablet) BGP PHARMA ULC,Active,9000689,levothyroxine sodium 88 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
19600,Marketed,2016-03-17,02172135,Synthroid,1,H03AA01,Levothyroxine sodium,Tablet,Oral,02172135,SYNTHROID (levothyroxine sodium 175 mcg oral tablet) BGP PHARMA ULC,Active,9000684,levothyroxine sodium 175 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
19601,Marketed,2016-03-17,02172100,Synthroid,1,H03AA01,Levothyroxine sodium,Tablet,Oral,02172100,SYNTHROID (levothyroxine sodium 100 mcg oral tablet) BGP PHARMA ULC,Active,9000681,levothyroxine sodium 100 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
36945,Marketed,2018-03-15,02213192,Eltroxin,1,H03AA01,Levothyroxine sodium,Tablet,Oral,02213192,ELTROXIN (levothyroxine sodium 50 mcg oral tablet) ASPEN PHARMACARE CANADA INC.,Active,9000002,levothyroxine sodium 50 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
36946,Marketed,2018-04-06,02213206,Eltroxin,1,H03AA01,Levothyroxine sodium,Tablet,Oral,02213206,ELTROXIN (levothyroxine sodium 100 mcg oral tablet) ASPEN PHARMACARE CANADA INC.,Active,9000681,levothyroxine sodium 100 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
36947,Marketed,2018-04-06,02213214,Eltroxin,1,H03AA01,Levothyroxine sodium,Tablet,Oral,02213214,ELTROXIN (levothyroxine sodium 150 mcg oral tablet) ASPEN PHARMACARE CANADA INC.,Active,9000078,levothyroxine sodium 150 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
36948,Marketed,2017-10-26,02213222,Eltroxin,1,H03AA01,Levothyroxine sodium,Tablet,Oral,02213222,ELTROXIN (levothyroxine sodium 200 mcg oral tablet) ASPEN PHARMACARE CANADA INC.,Active,9000685,levothyroxine sodium 200 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
53868,Marketed,2016-03-10,02233852,Synthroid,1,H03AA01,Levothyroxine sodium,Tablet,Oral,02233852,SYNTHROID (levothyroxine sodium 137 mcg oral tablet) BGP PHARMA ULC,Active,9001052,levothyroxine sodium 137 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
70072,Marketed,2016-01-21,02245948,Levothyroxine Sodium For Injection,1,H03AA01,Levothyroxine sodium,Powder for solution,"Intramuscular,Intravenous",02245948,LEVOTHYROXINE SODIUM FOR INJECTION (levothyroxine sodium 500 mcg per vial powder for solution for injection) FRESENIUS KABI CANADA LTD,Active,9000997,levothyroxine sodium 500 mcg per vial powder for solution for injection,8000001,levothyroxine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
94948,Marketed,2019-11-15,02461714,Levothyroxine Sodium For Injection,1,H03AA01,Levothyroxine sodium,Powder for solution,"Intramuscular,Intravenous",02461714,LEVOTHYROXINE SODIUM FOR INJECTION (levothyroxine sodium 200 mcg per vial powder for solution for injection) AVIR PHARMA INC.,Active,9014196,levothyroxine sodium 200 mcg per vial powder for solution for injection,8000001,levothyroxine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
94949,Marketed,2018-09-26,02461722,Levothyroxine Sodium For Injection,1,H03AA01,Levothyroxine sodium,Powder for solution,"Intramuscular,Intravenous",02461722,LEVOTHYROXINE SODIUM FOR INJECTION (levothyroxine sodium 500 mcg per vial powder for solution for injection) AVIR PHARMA INC.,Active,9000997,levothyroxine sodium 500 mcg per vial powder for solution for injection,8000001,levothyroxine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
98962,Marketed,2022-06-10,02499916,Levothyroxine Sodium Injection,1,H03AA01,Levothyroxine sodium,Solution,"Intravenous,Intramuscular",02499916,LEVOTHYROXINE SODIUM INJECTION (levothyroxine sodium 200 mcg per 5 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9014740,levothyroxine sodium 200 mcg per 5 mL solution for injection vial,8000001,levothyroxine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
98963,Marketed,2022-06-10,02499924,Levothyroxine Sodium Injection,1,H03AA01,Levothyroxine sodium,Solution,"Intramuscular,Intravenous",02499924,LEVOTHYROXINE SODIUM INJECTION (levothyroxine sodium 500 mcg per 5 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9014741,levothyroxine sodium 500 mcg per 5 mL solution for injection vial,8000001,levothyroxine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
100915,Marketed,2022-01-27,02519917,Alocane,1,D04AB01,Lidocaine,Gel,Topical,02519917,"ALOCANE (lidocaine hydrochloride 4 % cutaneous gel) QUEST PRODUCTS, LLC",Active,9014659,lidocaine hydrochloride 4 % cutaneous gel,8001837,lidocaine,448598008,Cutaneous,385100002,Gel,,,,,,Non-Prescription Drugs
101141,Marketed,2023-04-19,02522268,Lidocaine Hydrochloride Injection,1,C01BB01,Lidocaine,Solution,Intravenous,02522268,LIDOCAINE HYDROCHLORIDE INJECTION (lidocaine hydrochloride 100 mg per 5 mL solution for injection syringe) LABORATOIRE AGUETTANT,Active,9013915,lidocaine hydrochloride 100 mg per 5 mL solution for injection syringe,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Ethical
101485,Marketed,2023-05-01,02525860,Numbskin,1,D04AB01,Lidocaine,Cream,Topical,02525860,NUMBSKIN (lidocaine 5 % cutaneous cream) SHINPHARMA INC,Active,9003802,lidocaine 5 % cutaneous cream,8001837,lidocaine,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
101961,Marketed,2022-09-10,02530422,The Solution Anorectal Spray Temporary Pain Relief,2,D04AB01,Lidocaine,Spray,Topical,02530422,THE SOLUTION ANORECTAL SPRAY TEMPORARY PAIN RELIEF (epinephrine (epinephrine hydrochloride) 0.01 % and lidocaine hydrochloride 5 % cutaneous spray) SCALP TECH INC.,Active,9014759,epinephrine (epinephrine hydrochloride) 0.01 % and lidocaine hydrochloride 5 % cutaneous spray,8001762,epinephrine and lidocaine,448598008,Cutaneous,421720008,Spray,,,,,,Non-Prescription Drugs
101963,Marketed,2024-10-07,02530449,Lidocaine Injection BP,1,N01BB02,Lidocaine,Solution,Block/infiltration,02530449,LIDOCAINE INJECTION BP (lidocaine hydrochloride 200 mg per 20 mL solution for injection vial) EUGIA PHARMA INC.,Active,9013214,lidocaine hydrochloride 200 mg per 20 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
101964,Marketed,2024-10-07,02530457,Lidocaine Injection BP,1,N01BB02,Lidocaine,Solution,Block/infiltration,02530457,LIDOCAINE INJECTION BP (lidocaine hydrochloride 400 mg per 20 mL solution for injection vial) EUGIA PHARMA INC.,Active,9013216,lidocaine hydrochloride 400 mg per 20 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
102372,Marketed,2026-01-23,02534827,Lidocaine Hydrochloride Injection USP,1,N01BB02,Lidocaine,Solution,"Block/infiltration,Epidural",77701150,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 50 mg per 5 mL solution for injection ampoule) FORMATIVE PHARMA INC.,Active,9013218,lidocaine hydrochloride 50 mg per 5 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
102372,Marketed,2026-01-23,02534827,Lidocaine Hydrochloride Injection USP,1,N01BB02,Lidocaine,Solution,"Block/infiltration,Epidural",77701151,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 50 mg per 5 mL solution for injection vial) FORMATIVE PHARMA INC.,Active,9013219,lidocaine hydrochloride 50 mg per 5 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
103135,Marketed,2024-06-17,02542838,Solarcaine Burn Pain Relief,1,D04AB01,Lidocaine,"Spray, bag-on-valve",Topical,02542838,SOLARCAINE BURN PAIN RELIEF (lidocaine hydrochloride 4 % cutaneous spray) WELLSPRING PHARMACEUTICAL CANADA CORP,Active,9015056,lidocaine hydrochloride 4 % cutaneous spray,8001837,lidocaine,448598008,Cutaneous,385105007,Cutaneous spray,,,,,,Non-Prescription Drugs
103677,Marketed,2026-01-23,02547856,Lidocaine Hydrochloride Injection USP,1,N01BB02,Lidocaine,Solution,"Epidural,Block/infiltration",02547856,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 100 mg per 5 mL solution for injection vial) FORMATIVE PHARMA INC.,Active,9013312,lidocaine hydrochloride 100 mg per 5 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
103697,Marketed,2026-03-06,02548070,Precise Pain Relief Cream,1,D04AB01,Lidocaine,Cream,Topical,02548070,PRECISE PAIN RELIEF CREAM (lidocaine 4 % cutaneous cream) KENVUE CANADA INC.,Active,9003801,lidocaine 4 % cutaneous cream,8001837,lidocaine,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
103717,Marketed,2026-02-02,02548283,Seaford Nifedipine And Lidocaine Hydrochloride Cream,2,C05AD01,Lidocaine,Cream,Rectal,02548283,SEAFORD NIFEDIPINE AND LIDOCAINE HYDROCHLORIDE CREAM (lidocaine hydrochloride 1.5 % and nifedipine 0.3 % rectal cream) SEAFORD PHARMACEUTICALS INC,Active,9015358,lidocaine hydrochloride 1.5 % and nifedipine 0.3 % rectal cream,8002577,lidocaine and nifedipine,37161004,Rectal,385182007,Rectal cream,,,,,,Prescription
10519,Marketed,2019-12-20,00828602,0.4% Lidocaine Hydrochloride And 5% Dextrose Injection,2,C01BB01,Lidocaine,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
106400,Marketed,2026-02-27,02560992,Icy Hot With Lidocaine No Mess Roll On Pain Relief,1,D04AB01,Lidocaine,Gel,Topical,02560992,ICY HOT WITH LIDOCAINE NO MESS ROLL ON PAIN RELIEF (lidocaine hydrochloride 4 % cutaneous gel) SANOFI CONSUMER HEALTH INC,Active,9014659,lidocaine hydrochloride 4 % cutaneous gel,8001837,lidocaine,448598008,Cutaneous,385100002,Gel,,,,,,Non-Prescription Drugs
12645,Marketed,2019-07-02,00884154,Lidocaine Hydrochloride Injection USP,1,N01BB02,Lidocaine,Solution,Block/infiltration,77700825,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 50 mg per 5 mL solution for injection ampoule) PFIZER CANADA ULC,Active,9013218,lidocaine hydrochloride 50 mg per 5 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
12645,Marketed,2019-07-02,00884154,Lidocaine Hydrochloride Injection USP,1,N01BB02,Lidocaine,Solution,Block/infiltration,77700826,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 500 mg per 50 mL solution for injection vial) PFIZER CANADA ULC,Active,9013220,lidocaine hydrochloride 500 mg per 50 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
12645,Marketed,2019-07-02,00884154,Lidocaine Hydrochloride Injection USP,1,N01BB02,Lidocaine,Solution,Block/infiltration,77700827,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 20 mg per 2 mL solution for injection ampoule) PFIZER CANADA ULC,Active,9013210,lidocaine hydrochloride 20 mg per 2 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
12645,Marketed,2019-07-02,00884154,Lidocaine Hydrochloride Injection USP,1,N01BB02,Lidocaine,Solution,Block/infiltration,77700828,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 200 mg per 20 mL solution for injection vial) PFIZER CANADA ULC,Active,9013214,lidocaine hydrochloride 200 mg per 20 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
14240,Marketed,2021-02-12,02003767,Xylocaine Spray,1,N01BB02,Lidocaine,"Spray, metered dose",Topical,02003767,XYLOCAINE SPRAY (lidocaine 10 mg per actuation nasal/oromucosal spray) ASPEN PHARMACARE CANADA INC.,Active,9014459,lidocaine 10 mg per actuation nasal/oromucosal spray,8001837,lidocaine,372473007,Oromucosal,421720008,Spray,732981002,Actuation (unit of presentation),,,,Ethical
16823,Marketed,1994-12-31,01968823,Lidodan Viscous 2%,1,N01BB02,Lidocaine,Solution,Buccal,01968823,LIDODAN VISCOUS 2% (lidocaine hydrochloride 2 % oromucosal/laryngopharyngeal solution) ODAN LABORATORIES LTD,Active,9013917,lidocaine hydrochloride 2 % oromucosal/laryngopharyngeal solution,8001837,lidocaine,255204007,Multiple (oromucosal or laryngopharyngeal),385070000,Oromucosal solution,,,,,,Non-Prescription Drugs
17236,Marketed,1994-12-31,02083795,Lidodan Ointment 5%,1,D04AB01,Lidocaine,Ointment,Topical,02083795,LIDODAN OINTMENT 5% (lidocaine 5 % cutaneous ointment) ODAN LABORATORIES LTD,Active,9001544,lidocaine 5 % cutaneous ointment,8001837,lidocaine,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Ethical
18012,Marketed,2019-07-02,01901982,Lidocaine Hydrochloride Injection USP,1,N01BB02,Lidocaine,Solution,Block/infiltration,77700831,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 400 mg per 20 mL solution for injection vial) PFIZER CANADA ULC,Active,9013216,lidocaine hydrochloride 400 mg per 20 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
18012,Marketed,2019-07-02,01901982,Lidocaine Hydrochloride Injection USP,1,N01BB02,Lidocaine,Solution,Block/infiltration,77700832,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 1000 mg per 50 mL solution for injection vial) PFIZER CANADA ULC,Active,9013208,lidocaine hydrochloride 1000 mg per 50 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
18012,Marketed,2019-07-02,01901982,Lidocaine Hydrochloride Injection USP,1,N01BB02,Lidocaine,Solution,Block/infiltration,77700833,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 100 mg per 5 mL solution for injection vial) PFIZER CANADA ULC,Active,9013312,lidocaine hydrochloride 100 mg per 5 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
18012,Marketed,2019-07-02,01901982,Lidocaine Hydrochloride Injection USP,1,N01BB02,Lidocaine,Solution,Block/infiltration,77700834,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 200 mg per 10 mL solution for injection ampoule) PFIZER CANADA ULC,Active,9013213,lidocaine hydrochloride 200 mg per 10 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
18012,Marketed,2019-07-02,01901982,Lidocaine Hydrochloride Injection USP,1,N01BB02,Lidocaine,Solution,Block/infiltration,77700835,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 40 mg per 2 mL solution for injection ampoule) PFIZER CANADA ULC,Active,9013215,lidocaine hydrochloride 40 mg per 2 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
19488,Marketed,2016-02-16,02150379,Bactine First Aid Spray,2,D04AB01,Lidocaine,Spray,Topical,02150379,BACTINE FIRST AID SPRAY (benzalkonium chloride 0.13 % and lidocaine hydrochloride 2.5 % cutaneous spray) WELLSPRING PHARMACEUTICAL CANADA CORP,Active,9002745,benzalkonium chloride 0.13 % and lidocaine hydrochloride 2.5 % cutaneous spray,8001002,benzalkonium and lidocaine,448598008,Cutaneous,421720008,Spray,,,,,,Non-Prescription Drugs
211,Marketed,2018-08-21,00001961,Xylocaine Ointment 5%,1,D04AB01,Lidocaine,Ointment,Topical,00001961,XYLOCAINE OINTMENT 5% (lidocaine 5 % cutaneous ointment) ASPEN PHARMACARE CANADA INC.,Active,9001544,lidocaine 5 % cutaneous ointment,8001837,lidocaine,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Ethical
212,Marketed,2018-06-27,00001694,Xylocaine Jelly 2%,1,N01BB02,Lidocaine,Gel,Topical,00001694,XYLOCAINE JELLY 2% (lidocaine hydrochloride 2 % mucosal gel 30 mL tube) ASPEN PHARMACARE CANADA INC.,Active,9013973,lidocaine hydrochloride 2 % mucosal gel 30 mL tube,8001837,lidocaine,35071000087107,Mucosal,385100002,Gel,,,,,,Ethical
2935,Marketed,2018-07-18,00385484,Xylocaine Jelly 2%,1,N01BB02,Lidocaine,Gel,Topical,00385484,XYLOCAINE JELLY 2% (lidocaine hydrochloride 2 % mucosal gel 10 mL syringe) ASPEN PHARMACARE CANADA INC.,Active,9013971,lidocaine hydrochloride 2 % mucosal gel 10 mL syringe,8001837,lidocaine,35071000087107,Mucosal,385100002,Gel,733020007,Syringe (unit of presentation),,,,Ethical
31563,Marketed,2002-03-27,02143879,Lidodan Jelly 2%,1,D04AB01,Lidocaine,Jelly,Topical,02143879,LIDODAN JELLY 2% (lidocaine hydrochloride 2 % cutaneous gel) ODAN LABORATORIES LTD,Active,9002691,lidocaine hydrochloride 2 % cutaneous gel,8001837,lidocaine,448598008,Cutaneous,385100002,Gel,,,,,,Non-Prescription Drugs
4478,Marketed,2018-10-09,00001937,Xylocard,1,C01BB01,Lidocaine,Solution,Intravenous,00001937,XYLOCARD (lidocaine hydrochloride 100 mg per 5 mL solution for injection ampoule) ASPEN PHARMACARE CANADA INC.,Active,9013207,lidocaine hydrochloride 100 mg per 5 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
46020,Marketed,2009-01-27,01901532,Stud 100,1,D04AB01,Lidocaine,"Spray, metered dose",Topical,01901532,STUD 100 (lidocaine 9.6 % cutaneous spray) POUND INTERNATIONAL LTD.,Active,9003119,lidocaine 9.6 % cutaneous spray,8001837,lidocaine,448598008,Cutaneous,421720008,Spray,,,,,,Non-Prescription Drugs
50454,Marketed,1998-07-22,02231147,Lidodan Endotracheal Non-Aerosol Spray,1,N01BB02,Lidocaine,"Spray, metered dose",Topical,02231147,LIDODAN ENDOTRACHEAL NON-AEROSOL SPRAY (lidocaine (lidocaine hydrochloride) 10 mg per actuation endotracheopulmonary instillation) ODAN LABORATORIES LTD,Active,9013913,lidocaine (lidocaine hydrochloride) 10 mg per actuation endotracheopulmonary instillation,8001837,lidocaine,372452007,Endotracheopulmonary,385247002,Solution for endotracheopulmonary instillation,732981002,Actuation (unit of presentation),,,,Ethical
585,Marketed,2018-06-06,00001732,Xylocaine 1%,1,N01BB02,Lidocaine,Solution,Block/infiltration,77700700,XYLOCAINE 1% (lidocaine hydrochloride 20 mg per 2 mL solution for injection ampoule) ASPEN PHARMACARE CANADA INC.,Active,9013210,lidocaine hydrochloride 20 mg per 2 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
585,Marketed,2018-06-06,00001732,Xylocaine 1%,1,N01BB02,Lidocaine,Solution,Block/infiltration,77700701,XYLOCAINE 1% (lidocaine hydrochloride 100 mg per 10 mL solution for injection ampoule) ASPEN PHARMACARE CANADA INC.,Active,9013205,lidocaine hydrochloride 100 mg per 10 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
585,Marketed,2018-06-06,00001732,Xylocaine 1%,1,N01BB02,Lidocaine,Solution,Block/infiltration,77700702,XYLOCAINE 1% (lidocaine hydrochloride 50 mg per 5 mL solution for injection ampoule) ASPEN PHARMACARE CANADA INC.,Active,9013218,lidocaine hydrochloride 50 mg per 5 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
587,Marketed,2018-07-16,00036641,Xylocaine 2%,1,N01BB02,Lidocaine,Solution,Block/infiltration,77700703,XYLOCAINE 2% (lidocaine hydrochloride 200 mg per 10 mL solution for injection ampoule) ASPEN PHARMACARE CANADA INC.,Active,9013213,lidocaine hydrochloride 200 mg per 10 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
587,Marketed,2018-07-16,00036641,Xylocaine 2%,1,N01BB02,Lidocaine,Solution,Block/infiltration,77700704,XYLOCAINE 2% (lidocaine hydrochloride 40 mg per 2 mL solution for injection ampoule) ASPEN PHARMACARE CANADA INC.,Active,9013215,lidocaine hydrochloride 40 mg per 2 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
587,Marketed,2018-07-16,00036641,Xylocaine 2%,1,N01BB02,Lidocaine,Solution,Block/infiltration,77700705,XYLOCAINE 2% (lidocaine hydrochloride 100 mg per 5 mL solution for injection ampoule) ASPEN PHARMACARE CANADA INC.,Active,9013207,lidocaine hydrochloride 100 mg per 5 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
68513,Marketed,2004-12-22,02244533,Maxilene 4,1,D04AB01,Lidocaine,Cream,Topical,02244533,MAXILENE 4 (lidocaine 4 % cutaneous cream) RGR PHARMA LTD.,Active,9003801,lidocaine 4 % cutaneous cream,8001837,lidocaine,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
70063,Marketed,2005-01-06,02245939,Maxilene 5,1,D04AB01,Lidocaine,Cream,Topical,02245939,MAXILENE 5 (lidocaine 5 % cutaneous cream) RGR PHARMA LTD.,Active,9003802,lidocaine 5 % cutaneous cream,8001837,lidocaine,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
78773,Marketed,2018-09-10,02302411,Xylocaine 1%,1,N01BB02,Lidocaine,Solution,Block/infiltration,77700740,XYLOCAINE 1% (lidocaine hydrochloride 500 mg per 50 mL solution for injection vial) ASPEN PHARMACARE CANADA INC.,Active,9013220,lidocaine hydrochloride 500 mg per 50 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
78773,Marketed,2018-09-10,02302411,Xylocaine 1%,1,N01BB02,Lidocaine,Solution,Block/infiltration,77700741,XYLOCAINE 1% (lidocaine hydrochloride 200 mg per 20 mL solution for injection vial) ASPEN PHARMACARE CANADA INC.,Active,9013214,lidocaine hydrochloride 200 mg per 20 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
78774,Marketed,2018-08-21,02302438,Xylocaine 2%,1,N01BB02,Lidocaine,Solution,Block/infiltration,77700742,XYLOCAINE 2% (lidocaine hydrochloride 1000 mg per 50 mL solution for injection vial) ASPEN PHARMACARE CANADA INC.,Active,9013208,lidocaine hydrochloride 1000 mg per 50 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
78774,Marketed,2018-08-21,02302438,Xylocaine 2%,1,N01BB02,Lidocaine,Solution,Block/infiltration,77700743,XYLOCAINE 2% (lidocaine hydrochloride 400 mg per 20 mL solution for injection vial) ASPEN PHARMACARE CANADA INC.,Active,9013216,lidocaine hydrochloride 400 mg per 20 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
79467,Marketed,2018-01-16,02309076,TPR 20,2,D04AB01,Lidocaine,Cream,Topical,02309076,TPR20 (lidocaine hydrochloride 5 % and menthol 1 % cutaneous cream) HUMN PHARMACEUTICALS INC,Active,9004544,lidocaine hydrochloride 5 % and menthol 1 % cutaneous cream,8001838,lidocaine and menthol,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
8351,Marketed,2018-11-09,00436208,Lidocaine Hydrochloride Injection USP,1,C01BB01,Lidocaine,Solution,Intravenous,00436208,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 100 mg per 5 mL solution for injection syringe) PFIZER CANADA ULC,Active,9013915,lidocaine hydrochloride 100 mg per 5 mL solution for injection syringe,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Ethical
83969,Marketed,2015-08-18,02354527,Dr. Numb,1,D04AB01,Lidocaine,Cream,Topical,02354527,DR. NUMB (lidocaine 5 % cutaneous cream) SHINPHARMA INC,Active,9003802,lidocaine 5 % cutaneous cream,8001837,lidocaine,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
85604,Marketed,2020-09-28,02370840,Cathejell,1,N01BB02,Lidocaine,Gel,Topical,02370840,CATHEJELL (lidocaine hydrochloride 2 % mucosal gel 12.5 g syringe) PHARMAZEUTISCHE FABRIK MONTAVIT GES M.B.H.,Active,9013972,lidocaine hydrochloride 2 % mucosal gel 12.5 g syringe,8001837,lidocaine,35071000087107,Mucosal,385100002,Gel,733020007,Syringe (unit of presentation),,,,Ethical
85810,Marketed,2018-05-24,02372983,Xylocaine 0.5%,1,N01BB02,Lidocaine,Solution,Block/infiltration,02372983,XYLOCAINE 0.5% (lidocaine hydrochloride 100 mg per 20 mL solution for injection vial) ASPEN PHARMACARE CANADA INC.,Active,9013206,lidocaine hydrochloride 100 mg per 20 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
90413,Marketed,2014-02-20,02419505,Lidodan 4% Topical Solution,1,D04AB01,Lidocaine,Solution,Topical,02419505,LIDODAN 4% TOPICAL SOLUTION (lidocaine hydrochloride 4 % cutaneous solution) ODAN LABORATORIES LTD,Active,9005434,lidocaine hydrochloride 4 % cutaneous solution,8001837,lidocaine,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Non-Prescription Drugs
90668,Marketed,2023-07-31,02421984,Lidocaine Hydrochloride Injection USP,1,N01BB02,Lidocaine,Solution,Block/infiltration,77700798,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 50 mg per 5 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9013219,lidocaine hydrochloride 50 mg per 5 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
90668,Marketed,2023-07-31,02421984,Lidocaine Hydrochloride Injection USP,1,N01BB02,Lidocaine,Solution,Block/infiltration,77700799,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 50 mg per 5 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9013218,lidocaine hydrochloride 50 mg per 5 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
90668,Marketed,2023-07-31,02421984,Lidocaine Hydrochloride Injection USP,1,N01BB02,Lidocaine,Solution,Block/infiltration,77700800,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 100 mg per 10 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9013205,lidocaine hydrochloride 100 mg per 10 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
90670,Marketed,2023-03-16,02422018,Lidocaine Hydrochloride Injection USP,1,N01BB02,Lidocaine,Solution,Block/infiltration,77700801,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 500 mg per 50 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9013220,lidocaine hydrochloride 500 mg per 50 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
90670,Marketed,2023-03-16,02422018,Lidocaine Hydrochloride Injection USP,1,N01BB02,Lidocaine,Solution,Block/infiltration,77700802,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 200 mg per 20 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9013214,lidocaine hydrochloride 200 mg per 20 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
90671,Marketed,2023-08-14,02421992,Lidocaine Hydrochloride Injection USP,1,N01BB02,Lidocaine,Solution,Block/infiltration,77700803,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 100 mg per 5 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9013207,lidocaine hydrochloride 100 mg per 5 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
90671,Marketed,2023-08-14,02421992,Lidocaine Hydrochloride Injection USP,1,N01BB02,Lidocaine,Solution,Block/infiltration,77700804,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 200 mg per 10 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9013213,lidocaine hydrochloride 200 mg per 10 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
90672,Marketed,2023-04-17,02422026,Lidocaine Hydrochloride Injection USP,1,N01BB02,Lidocaine,Solution,Block/infiltration,77700805,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 1000 mg per 50 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9013208,lidocaine hydrochloride 1000 mg per 50 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
90672,Marketed,2023-04-17,02422026,Lidocaine Hydrochloride Injection USP,1,N01BB02,Lidocaine,Solution,Block/infiltration,77700806,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 400 mg per 20 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9013216,lidocaine hydrochloride 400 mg per 20 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
93551,Marketed,2016-05-20,02449684,Zensa,1,D04AB01,Lidocaine,Cream,Topical,02449684,ZENSA (lidocaine 5 % cutaneous cream) ALERA SKIN CARE PRODUCTS INC.,Active,9003802,lidocaine 5 % cutaneous cream,8001837,lidocaine,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
95020,Marketed,2021-06-09,02462443,Lidocaine Injection BP,1,N01BB02,Lidocaine,Solution,Block/infiltration,02462443,LIDOCAINE INJECTION BP (lidocaine hydrochloride 200 mg per 20 mL solution for injection vial) AURO PHARMA INC,Active,9013214,lidocaine hydrochloride 200 mg per 20 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
95021,Marketed,2021-06-09,02462451,Lidocaine Injection BP,1,N01BB02,Lidocaine,Solution,Block/infiltration,02462451,LIDOCAINE INJECTION BP (lidocaine hydrochloride 400 mg per 20 mL solution for injection vial) AURO PHARMA INC,Active,9013216,lidocaine hydrochloride 400 mg per 20 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
95780,Marketed,2018-05-28,02469146,Jelido,1,N01BB02,Lidocaine,Gel,Topical,,,,,,,,,,,,,,,,,Ethical
97557,Marketed,2019-05-21,02485311,Lidocaine,1,D04AB01,Lidocaine,Gel,Topical,02485311,LIDOCAINE (lidocaine 4 % cutaneous gel) THE MENTHOLATUM COMPANY OF CANADA LTD,Active,9013914,lidocaine 4 % cutaneous gel,8001837,lidocaine,448598008,Cutaneous,385100002,Gel,,,,,,Non-Prescription Drugs
98886,Marketed,2021-02-17,02499118,After Sun Gel,1,D04AB01,Lidocaine,Gel,Topical,02499118,"AFTER SUN GEL (lidocaine (lidocaine hydrochloride) 0.8 % cutaneous gel) FRUIT OF THE EARTH, INC",Active,9014894,lidocaine (lidocaine hydrochloride) 0.8 % cutaneous gel,8001837,lidocaine,448598008,Cutaneous,385100002,Gel,,,,,,Non-Prescription Drugs
99031,Marketed,2023-05-15,02500647,Lidocaine Hydrochloride Injection,1,N01BB02,Lidocaine,Solution,Block/infiltration,02500647,LIDOCAINE HYDROCHLORIDE INJECTION (lidocaine hydrochloride 100 mg per 10 mL solution for injection syringe) LABORATOIRE AGUETTANT,Active,9014866,lidocaine hydrochloride 100 mg per 10 mL solution for injection syringe,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Ethical
99032,Marketed,2023-05-15,02500655,Lidocaine Hydrochloride Injection,1,N01BB02,Lidocaine,Solution,Block/infiltration,02500655,LIDOCAINE HYDROCHLORIDE INJECTION (lidocaine hydrochloride 200 mg per 10 mL solution for injection syringe) LABORATOIRE AGUETTANT,Active,9014867,lidocaine hydrochloride 200 mg per 10 mL solution for injection syringe,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Ethical
12648,Marketed,2019-04-08,01901915,Lidocaine Hydrochloride And Epinephrine Injection USP,2,N01BB52,"Lidocaine, combinations",Solution,Block/infiltration,01901915,LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP (epinephrine 0.2 mg per 20 mL and lidocaine hydrochloride 400 mg per 20 mL solution for injection vial) PFIZER CANADA ULC,Active,9014109,epinephrine 0.2 mg per 20 mL and lidocaine hydrochloride 400 mg per 20 mL solution for injection vial,8001762,epinephrine and lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
1830,Marketed,2018-06-06,00284106,Xylocaine 2% W Epinephrine 1:200000,2,N01BB52,"Lidocaine, combinations",Solution,Epidural,00284106,XYLOCAINE 2% W EPINEPHRINE 1:200000 (epinephrine (epinephrine bitartrate) 0.1 mg per 20 mL and lidocaine hydrochloride 400 mg per 20 mL solution for injection vial) ASPEN PHARMACARE CANADA INC.,Active,9013873,epinephrine (epinephrine bitartrate) 0.1 mg per 20 mL and lidocaine hydrochloride 400 mg per 20 mL solution for injection vial,8001762,epinephrine and lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
2506,Marketed,1976-12-31,00375799,Lignospan Forte,2,N01BB52,"Lidocaine, combinations",Solution,Block/infiltration,00375799,LIGNOSPAN FORTE (epinephrine (epinephrine bitartrate) 0.02 mg per mL and lidocaine hydrochloride 20 mg per mL solution for injection 1.8 mL cartridge) SEPTODONT,Active,9013872,epinephrine (epinephrine bitartrate) 0.02 mg per mL and lidocaine hydrochloride 20 mg per mL solution for injection 1.8 mL cartridge,8001762,epinephrine and lidocaine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Ethical
2541,Marketed,1976-12-31,00375780,Lignospan Standard,2,N01BB52,"Lidocaine, combinations",Solution,Block/infiltration,00375780,LIGNOSPAN STANDARD (epinephrine (epinephrine bitartrate) 0.01 mg per mL and lidocaine hydrochloride 20 mg per mL solution for injection 1.8 mL cartridge) SEPTODONT,Active,9013871,epinephrine (epinephrine bitartrate) 0.01 mg per mL and lidocaine hydrochloride 20 mg per mL solution for injection 1.8 mL cartridge,8001762,epinephrine and lidocaine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Ethical
37164,Marketed,1997-03-26,02218607,Xylonor,2,N01BB52,"Lidocaine, combinations","Spray, metered dose",Buccal,02218607,XYLONOR (cetrimide 0.1 mg per actuation and lidocaine 10 mg per actuation oromucosal spray) SEPTODONT,Active,9014015,cetrimide 0.1 mg per actuation and lidocaine 10 mg per actuation oromucosal spray,8002103,cetrimide and lidocaine,372473007,Oromucosal,421720008,Spray,732981002,Actuation (unit of presentation),,,,Ethical
589,Marketed,2018-12-14,00001791,Xylocaine 1% W Epinephrine 1:100000,2,N01BB52,"Lidocaine, combinations",Solution,Block/infiltration,00001791,XYLOCAINE 1% W EPINEPHRINE 1:100000 (epinephrine (epinephrine bitartrate) 0.2 mg per 20 mL and lidocaine hydrochloride 200 mg per 20 mL solution for injection vial) ASPEN PHARMACARE CANADA INC.,Active,9013874,epinephrine (epinephrine bitartrate) 0.2 mg per 20 mL and lidocaine hydrochloride 200 mg per 20 mL solution for injection vial,8001762,epinephrine and lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
590,Marketed,2018-07-16,00001805,Xylocaine 1% W Epinephrine 1:200000,2,N01BB52,"Lidocaine, combinations",Solution,Block/infiltration,00001805,XYLOCAINE 1% W EPINEPHRINE 1:200000 (epinephrine (epinephrine bitartrate) 0.1 mg per 20 mL and lidocaine hydrochloride 200 mg per 20 mL solution for injection vial) ASPEN PHARMACARE CANADA INC.,Active,9014106,epinephrine (epinephrine bitartrate) 0.1 mg per 20 mL and lidocaine hydrochloride 200 mg per 20 mL solution for injection vial,8001762,epinephrine and lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
635,Marketed,1964-12-31,00151874,Octocaine HCL 2% Epinephrine 1:50000,2,N01BB52,"Lidocaine, combinations",Solution,Subcutaneous,00151874,OCTOCAINE HCL 2% EPINEPHRINE 1:50000 (epinephrine (epinephrine bitartrate) 0.02 mg per mL and lidocaine hydrochloride 20 mg per mL solution for injection 1.8 mL cartridge) NOVOCOL PHARMACEUTICAL OF CANADA INC,Active,9013872,epinephrine (epinephrine bitartrate) 0.02 mg per mL and lidocaine hydrochloride 20 mg per mL solution for injection 1.8 mL cartridge,8001762,epinephrine and lidocaine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Ethical
636,Marketed,1964-12-31,00151866,Octocaine HCL 2% Epinephrine 1:100000,2,N01BB52,"Lidocaine, combinations",Solution,Subcutaneous,00151866,OCTOCAINE HCL 2% EPINEPHRINE 1:100000 (epinephrine (epinephrine bitartrate) 0.01 mg per mL and lidocaine hydrochloride 20 mg per mL solution for injection 1.8 mL cartridge) NOVOCOL PHARMACEUTICAL OF CANADA INC,Active,9013871,epinephrine (epinephrine bitartrate) 0.01 mg per mL and lidocaine hydrochloride 20 mg per mL solution for injection 1.8 mL cartridge,8001762,epinephrine and lidocaine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Ethical
78032,Marketed,2013-07-04,02294990,Instillagel,2,N01BB52,"Lidocaine, combinations",Gel,Urethral,77700933,INSTILLAGEL (chlorhexidine gluconate 0.05 % and lidocaine hydrochloride (lidocaine hydrochloride monohydrate) 2 % urethral gel 6 mL syringe) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9014188,chlorhexidine gluconate 0.05 % and lidocaine hydrochloride 2 % urethral gel 6 mL syringe,8001720,chlorhexidine and lidocaine,90028008,Urethral,385100002,Gel,733020007,Syringe (unit of presentation),,,,Ethical
78032,Marketed,2013-07-04,02294990,Instillagel,2,N01BB52,"Lidocaine, combinations",Gel,Urethral,77700934,INSTILLAGEL (chlorhexidine gluconate 0.05 % and lidocaine hydrochloride (lidocaine hydrochloride monohydrate) 2 % urethral gel 11 mL syringe) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9014187,chlorhexidine gluconate 0.05 % and lidocaine hydrochloride 2 % urethral gel 11 mL syringe,8001720,chlorhexidine and lidocaine,90028008,Urethral,385100002,Gel,733020007,Syringe (unit of presentation),,,,Ethical
81732,Marketed,2009-10-19,02331640,"Xylocaine Dental Lidocaine HCL 2% And Epinephrine 1:100,000",2,N01BB52,"Lidocaine, combinations",Solution,Block/infiltration,02331640,"XYLOCAINE DENTAL LIDOCAINE HCL 2% AND EPINEPHRINE 1:100,000 (epinephrine (epinephrine bitartrate) 0.01 mg per mL and lidocaine hydrochloride 20 mg per mL solution for injection 1.8 mL cartridge) DENTSPLY CANADA LIMITED",Active,9013871,epinephrine (epinephrine bitartrate) 0.01 mg per mL and lidocaine hydrochloride 20 mg per mL solution for injection 1.8 mL cartridge,8001762,epinephrine and lidocaine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Ethical
83052,Marketed,2010-07-29,02345072,"Xylocaine Dental Lidocaine Hydrochloride 2% And Epinephrine 1:50,000",2,N01BB52,"Lidocaine, combinations",Solution,Block/infiltration,02345072,"XYLOCAINE DENTAL LIDOCAINE HYDROCHLORIDE 2% AND EPINEPHRINE 1:50,000 (epinephrine (epinephrine bitartrate) 0.02 mg per mL and lidocaine hydrochloride 20 mg per mL solution for injection 1.8 mL cartridge) DENTSPLY CANADA LIMITED",Active,9013872,epinephrine (epinephrine bitartrate) 0.02 mg per mL and lidocaine hydrochloride 20 mg per mL solution for injection 1.8 mL cartridge,8001762,epinephrine and lidocaine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Ethical
85829,Marketed,2018-08-21,02373130,Xylocaine 2% With Epinephrine 1:200000,2,N01BB52,"Lidocaine, combinations",Solution,Block/infiltration,02373130,XYLOCAINE 2% WITH EPINEPHRINE 1:200000 (epinephrine (epinephrine bitartrate) 0.1 mg per 20 mL and lidocaine hydrochloride 400 mg per 20 mL solution for injection vial) ASPEN PHARMACARE CANADA INC.,Active,9013873,epinephrine (epinephrine bitartrate) 0.1 mg per 20 mL and lidocaine hydrochloride 400 mg per 20 mL solution for injection vial,8001762,epinephrine and lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
88297,Marketed,2021-11-25,02398028,Pliaglis,2,N01BB52,"Lidocaine, combinations",Cream,Topical,02398028,PLIAGLIS (lidocaine 7 % and tetracaine 7 % cutaneous cream) SCIENCES DE LA PEAU CRESCITA INC. / CRESCITA SKIN SCIENCES INC.,Active,9005786,lidocaine 7 % and tetracaine 7 % cutaneous cream,8001911,lidocaine and tetracaine,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
92056,Marketed,2023-09-22,02436221,Lidocaine Hydrochloride And Epinephrine Injection USP,2,N01BB52,"Lidocaine, combinations",Solution,Block/infiltration,77701000,LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP (epinephrine (epinephrine bitartrate) 0.2 mg per 20 mL and lidocaine hydrochloride 400 mg per 20 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9013875,epinephrine (epinephrine bitartrate) 0.2 mg per 20 mL and lidocaine hydrochloride 400 mg per 20 mL solution for injection vial,8001762,epinephrine and lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
92056,Marketed,2023-09-22,02436221,Lidocaine Hydrochloride And Epinephrine Injection USP,2,N01BB52,"Lidocaine, combinations",Solution,Block/infiltration,77701001,LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP (epinephrine (epinephrine bitartrate) 0.5 mg per 50 mL and lidocaine hydrochloride 1000 mg per 50 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9013876,epinephrine (epinephrine bitartrate) 0.5 mg per 50 mL and lidocaine hydrochloride 1000 mg per 50 mL solution for injection vial,8001762,epinephrine and lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
96290,Marketed,2019-04-29,02473518,"Lidocaine 2% And Epinephrine 1:100,000",2,N01BB52,"Lidocaine, combinations",Solution,Block/infiltration,02473518,"LIDOCAINE 2% AND EPINEPHRINE 1:100,000 (epinephrine (epinephrine bitartrate) 0.01 mg per mL and lidocaine hydrochloride 20 mg per mL solution for injection 1.8 mL cartridge) SEPTODONT",Active,9013871,epinephrine (epinephrine bitartrate) 0.01 mg per mL and lidocaine hydrochloride 20 mg per mL solution for injection 1.8 mL cartridge,8001762,epinephrine and lidocaine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Ethical
96291,Marketed,2019-05-10,02473526,"Lidocaine 2% And Epinephrine 1:50,000",2,N01BB52,"Lidocaine, combinations",Solution,Block/infiltration,02473526,"LIDOCAINE 2% AND EPINEPHRINE 1:50,000 (epinephrine (epinephrine bitartrate) 0.02 mg per mL and lidocaine hydrochloride 20 mg per mL solution for injection 1.8 mL cartridge) SEPTODONT",Active,9013872,epinephrine (epinephrine bitartrate) 0.02 mg per mL and lidocaine hydrochloride 20 mg per mL solution for injection 1.8 mL cartridge,8001762,epinephrine and lidocaine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Ethical
96012,Marketed,2024-08-20,02471027,Xiidra,1,S01XA25,Lifitegrast,Solution,Ophthalmic,02471027,XIIDRA (lifitegrast 5 % ophthalmic drops) BAUSCH & LOMB INC,Active,9012509,lifitegrast 5 % ophthalmic drops,8001149,lifitegrast,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
90180,Marketed,2023-12-11,02417162,Constella,1,A06AX04,Linaclotide,Capsule,Oral,02417162,CONSTELLA (linaclotide 145 mcg oral capsule) ABBVIE CORPORATION,Active,9005503,linaclotide 145 mcg oral capsule,8001125,linaclotide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90181,Marketed,2023-12-15,02417170,Constella,1,A06AX04,Linaclotide,Capsule,Oral,02417170,CONSTELLA (linaclotide 290 mcg oral capsule) ABBVIE CORPORATION,Active,9005625,linaclotide 290 mcg oral capsule,8001125,linaclotide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95831,Marketed,2024-08-01,02469510,Constella,1,A06AX04,Linaclotide,Capsule,Oral,02469510,CONSTELLA (linaclotide 72 mcg oral capsule) ABBVIE CORPORATION,Active,9012577,linaclotide 72 mcg oral capsule,8001125,linaclotide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
85612,Marketed,2011-09-13,02370921,Trajenta,1,A10BH05,Linagliptin,Tablet,Oral,02370921,TRAJENTA (linagliptin 5 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9004923,linagliptin 5 mg oral tablet,8001397,linagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100955,Marketed,2022-10-31,02520354,JAMP Linezolid,1,J01XX08,Linezolid,Tablet,Oral,02520354,JAMP LINEZOLID (linezolid 600 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003587,linezolid 600 mg oral tablet,8001489,linezolid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
67615,Marketed,2006-02-07,02243685,Zyvoxam,1,J01XX08,Linezolid,Solution,Intravenous,02243685,ZYVOXAM (linezolid 600 mg per 300 mL solution for injection bag) PFIZER CANADA ULC,Active,9012829,linezolid 600 mg per 300 mL solution for injection bag,8001489,linezolid,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Prescription
67616,Marketed,2010-08-04,02243686,Zyvoxam,1,J01XX08,Linezolid,Powder for suspension,Oral,02243686,ZYVOXAM (linezolid 100 mg per 5 mL oral suspension) PFIZER CANADA ULC,Active,9013784,linezolid 100 mg per 5 mL oral suspension,8001489,linezolid,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
90735,Marketed,2014-08-25,02422689,Sandoz Linezolid,1,J01XX08,Linezolid,Tablet,Oral,02422689,SANDOZ LINEZOLID (linezolid 600 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003587,linezolid 600 mg oral tablet,8001489,linezolid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91113,Marketed,2019-10-31,02426552,Apo-Linezolid,1,J01XX08,Linezolid,Tablet,Oral,02426552,APO-LINEZOLID (linezolid 600 mg oral tablet) APOTEX INC,Active,9003587,linezolid 600 mg oral tablet,8001489,linezolid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91526,Marketed,2015-06-12,02430827,Linezolid Injection,1,J01XX08,Linezolid,Solution,Intravenous,02430827,LINEZOLID INJECTION (linezolid 600 mg per 300 mL solution for injection bag) FRESENIUS KABI CANADA LTD,Active,9012829,linezolid 600 mg per 300 mL solution for injection bag,8001489,linezolid,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Prescription
97176,Marketed,2019-12-30,02481278,Linezolid Injection,1,J01XX08,Linezolid,Solution,Intravenous,02481278,LINEZOLID INJECTION (linezolid 600 mg per 300 mL solution for injection bag) JAMP PHARMA CORPORATION,Active,9012829,linezolid 600 mg per 300 mL solution for injection bag,8001489,linezolid,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Prescription
103880,Marketed,2025-09-18,02549999,Auro-Liothyronine,1,H03AA02,Liothyronine sodium,Tablet,Oral,02549999,AURO-LIOTHYRONINE (liothyronine (liothyronine sodium) 5 mcg oral tablet) AURO PHARMA INC,Active,9002592,liothyronine (liothyronine sodium) 5 mcg oral tablet,8001665,liothyronine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103881,Marketed,2025-09-18,02550008,Auro-Liothyronine,1,H03AA02,Liothyronine sodium,Tablet,Oral,02550008,AURO-LIOTHYRONINE (liothyronine (liothyronine sodium) 25 mcg oral tablet) AURO PHARMA INC,Active,9002591,liothyronine (liothyronine sodium) 25 mcg oral tablet,8001665,liothyronine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106427,Marketed,2026-01-15,02561298,ZDS-Liothyronine,1,H03AA02,Liothyronine sodium,Tablet,Oral,02561298,ZDS-LIOTHYRONINE (liothyronine (liothyronine sodium) 5 mcg oral tablet) ZYDUS LIFESCIENCES LIMITED,Active,9002592,liothyronine (liothyronine sodium) 5 mcg oral tablet,8001665,liothyronine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106428,Marketed,2026-01-15,02561301,ZDS-Liothyronine,1,H03AA02,Liothyronine sodium,Tablet,Oral,02561301,ZDS-LIOTHYRONINE (liothyronine (liothyronine sodium) 25 mcg oral tablet) ZYDUS LIFESCIENCES LIMITED,Active,9002591,liothyronine (liothyronine sodium) 25 mcg oral tablet,8001665,liothyronine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
15908,Marketed,2013-03-20,01919466,Cytomel,1,H03AA02,Liothyronine sodium,Tablet,Oral,01919466,CYTOMEL (liothyronine (liothyronine sodium) 25 mcg oral tablet) PFIZER CANADA ULC,Active,9002591,liothyronine (liothyronine sodium) 25 mcg oral tablet,8001665,liothyronine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
15909,Marketed,2013-03-20,01919458,Cytomel,1,H03AA02,Liothyronine sodium,Tablet,Oral,01919458,CYTOMEL (liothyronine (liothyronine sodium) 5 mcg oral tablet) PFIZER CANADA ULC,Active,9002592,liothyronine (liothyronine sodium) 5 mcg oral tablet,8001665,liothyronine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98436,Marketed,2020-07-10,02494337,Teva-Liothyronine,1,H03AA02,Liothyronine sodium,Tablet,Oral,02494337,TEVA-LIOTHYRONINE (liothyronine (liothyronine sodium) 5 mcg oral tablet) TEVA CANADA LIMITED,Active,9002592,liothyronine (liothyronine sodium) 5 mcg oral tablet,8001665,liothyronine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98437,Marketed,2020-07-10,02494345,Teva-Liothyronine,1,H03AA02,Liothyronine sodium,Tablet,Oral,02494345,TEVA-LIOTHYRONINE (liothyronine (liothyronine sodium) 25 mcg oral tablet) TEVA CANADA LIMITED,Active,9002591,liothyronine (liothyronine sodium) 25 mcg oral tablet,8001665,liothyronine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
11629,Marketed,1991-12-31,01935348,Mineral Oil (Heavy),1,A06AA01,Liquid paraffin,Liquid,Oral,01935348,MINERAL OIL (HEAVY) (mineral oil heavy 100 % oral liquid) RW CONSUMER PRODUCTS LTD,Active,9013712,mineral oil heavy 100 % oral liquid,8002204,mineral oil heavy,26643006,Oral,420699003,Liquid,,,,,,Non-Prescription Drugs
20312,Marketed,2004-11-22,02186926,Lansoyl Sugar Free - Jelly - 78%,1,A06AA01,Liquid paraffin,Gel,Oral,02186926,LANSOYL SUGAR FREE - JELLY - 78% (mineral oil heavy 78 % oral gel) AURIUM PHARMA INC.,Active,9013718,mineral oil heavy 78 % oral gel,8002204,mineral oil heavy,26643006,Oral,385100002,Gel,,,,,,Non-Prescription Drugs
41536,Marketed,2013-05-15,00485802,Mineral Oil,1,A06AA01,Liquid paraffin,Liquid,Oral,00485802,MINERAL OIL (mineral oil heavy 100 % oral liquid) TEVA CANADA LIMITED,Active,9013712,mineral oil heavy 100 % oral liquid,8002204,mineral oil heavy,26643006,Oral,420699003,Liquid,,,,,,Non-Prescription Drugs
41698,Marketed,1998-04-08,00704172,Huile Minerale Lourde Liquid 100% USP,1,A06AA01,Liquid paraffin,Liquid,Oral,00704172,HUILE MINERALE LOURDE LIQ 100% USP (mineral oil heavy 100 % oral liquid) LABORATOIRE ATLAS INC,Active,9013712,mineral oil heavy 100 % oral liquid,8002204,mineral oil heavy,26643006,Oral,420699003,Liquid,,,,,,Non-Prescription Drugs
5792,Marketed,2004-11-22,00608734,Lansoyl Gel 78%,1,A06AA01,Liquid paraffin,Gel,Oral,00608734,LANSOYL GEL 78% (mineral oil heavy 78 % oral gel) AURIUM PHARMA INC.,Active,9013718,mineral oil heavy 78 % oral gel,8002204,mineral oil heavy,26643006,Oral,385100002,Gel,,,,,,Non-Prescription Drugs
721,Marketed,2018-04-02,00107875,Fleet Enema Mineral Oil,1,A06AA01,Liquid paraffin,Enema,Rectal,00107875,FLEET ENEMA MINERAL OIL (mineral oil heavy 100 % rectal liquid) C B FLEET COMPANY INC,Active,9013713,mineral oil heavy 100 % rectal liquid,8002204,mineral oil heavy,37161004,Rectal,420699003,Liquid,,,,,,Non-Prescription Drugs
86767,Marketed,2019-02-06,02381834,Mineral Oil USP,1,A06AA01,Liquid paraffin,Solution,Oral,02381834,"MINERAL OIL USP (mineral oil heavy 100 % oral liquid) VI-JON, LLC",Active,9013712,mineral oil heavy 100 % oral liquid,8002204,mineral oil heavy,26643006,Oral,420699003,Liquid,,,,,,Non-Prescription Drugs
83627,Marketed,2010-05-27,02351064,Victoza,1,A10BJ02,Liraglutide,Solution,Subcutaneous,02351064,VICTOZA (liraglutide 6 mg per mL solution for injection 3 mL pen) NOVO NORDISK CANADA INC,Active,9013000,liraglutide 6 mg per mL solution for injection 3 mL pen,8001119,liraglutide,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
83627,Marketed,2010-05-27,02351064,Victoza,1,A10BJ02,Liraglutide,Solution,Subcutaneous,02351064,VICTOZA (liraglutide 6 mg per mL solution for injection 3 mL pen) NOVO NORDISK CANADA INC,Active,9013000,liraglutide 6 mg per mL solution for injection 3 mL pen,8001119,liraglutide,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Prescription
92226,Marketed,2015-05-27,02437899,Saxenda,1,A10BJ02,Liraglutide,Solution,Subcutaneous,02437899,SAXENDA (liraglutide 6 mg per mL solution for injection 3 mL pen) NOVO NORDISK CANADA INC,Active,9013000,liraglutide 6 mg per mL solution for injection 3 mL pen,8001119,liraglutide,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
92226,Marketed,2015-05-27,02437899,Saxenda,1,A10BJ02,Liraglutide,Solution,Subcutaneous,02437899,SAXENDA (liraglutide 6 mg per mL solution for injection 3 mL pen) NOVO NORDISK CANADA INC,Active,9013000,liraglutide 6 mg per mL solution for injection 3 mL pen,8001119,liraglutide,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Prescription
102234,Marketed,2024-06-04,02533340,Taro-Lisdexamfetamine Chewable Tablets,1,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02533340,TARO-LISDEXAMFETAMINE CHEWABLE TABLETS (lisdexamfetamine dimesylate 10 mg chewable tablet) TARO PHARMACEUTICALS INC,Active,9014113,lisdexamfetamine dimesylate 10 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA I)
102235,Marketed,2024-06-04,02533359,Taro-Lisdexamfetamine Chewable Tablets,1,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02533359,TARO-LISDEXAMFETAMINE CHEWABLE TABLETS (lisdexamfetamine dimesylate 20 mg chewable tablet) TARO PHARMACEUTICALS INC,Active,9014114,lisdexamfetamine dimesylate 20 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA I)
102236,Marketed,2024-06-04,02533367,Taro-Lisdexamfetamine Chewable Tablets,1,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02533367,TARO-LISDEXAMFETAMINE CHEWABLE TABLETS (lisdexamfetamine dimesylate 30 mg chewable tablet) TARO PHARMACEUTICALS INC,Active,9014115,lisdexamfetamine dimesylate 30 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA I)
102237,Marketed,2024-06-04,02533375,Taro-Lisdexamfetamine Chewable Tablets,1,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02533375,TARO-LISDEXAMFETAMINE CHEWABLE TABLETS (lisdexamfetamine dimesylate 40 mg chewable tablet) TARO PHARMACEUTICALS INC,Active,9014116,lisdexamfetamine dimesylate 40 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA I)
102238,Marketed,2024-06-04,02533383,Taro-Lisdexamfetamine Chewable Tablets,1,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02533383,TARO-LISDEXAMFETAMINE CHEWABLE TABLETS (lisdexamfetamine dimesylate 50 mg chewable tablet) TARO PHARMACEUTICALS INC,Active,9014117,lisdexamfetamine dimesylate 50 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA I)
102239,Marketed,2024-06-04,02533391,Taro-Lisdexamfetamine Chewable Tablets,1,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02533391,TARO-LISDEXAMFETAMINE CHEWABLE TABLETS (lisdexamfetamine dimesylate 60 mg chewable tablet) TARO PHARMACEUTICALS INC,Active,9014118,lisdexamfetamine dimesylate 60 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA I)
102335,Marketed,2025-05-23,02534444,Apo-Lisdexamfetamine Chewable Tablets,1,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02534444,APO-LISDEXAMFETAMINE CHEWABLE TABLETS (lisdexamfetamine dimesylate 10 mg chewable tablet) APOTEX INC,Active,9014113,lisdexamfetamine dimesylate 10 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA I)
102337,Marketed,2025-05-23,02534452,Apo-Lisdexamfetamine Chewable Tablets,1,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02534452,APO-LISDEXAMFETAMINE CHEWABLE TABLETS (lisdexamfetamine dimesylate 20 mg chewable tablet) APOTEX INC,Active,9014114,lisdexamfetamine dimesylate 20 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA I)
102338,Marketed,2025-05-23,02534460,Apo-Lisdexamfetamine Chewable Tablets,1,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02534460,APO-LISDEXAMFETAMINE CHEWABLE TABLETS (lisdexamfetamine dimesylate 30 mg chewable tablet) APOTEX INC,Active,9014115,lisdexamfetamine dimesylate 30 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA I)
102339,Marketed,2025-05-23,02534479,Apo-Lisdexamfetamine Chewable Tablets,1,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02534479,APO-LISDEXAMFETAMINE CHEWABLE TABLETS (lisdexamfetamine dimesylate 40 mg chewable tablet) APOTEX INC,Active,9014116,lisdexamfetamine dimesylate 40 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA I)
102340,Marketed,2025-05-23,02534487,Apo-Lisdexamfetamine Chewable Tablets,1,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02534487,APO-LISDEXAMFETAMINE CHEWABLE TABLETS (lisdexamfetamine dimesylate 50 mg chewable tablet) APOTEX INC,Active,9014117,lisdexamfetamine dimesylate 50 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA I)
102341,Marketed,2025-05-23,02534495,Apo-Lisdexamfetamine Chewable Tablets,1,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02534495,APO-LISDEXAMFETAMINE CHEWABLE TABLETS (lisdexamfetamine dimesylate 60 mg chewable tablet) APOTEX INC,Active,9014118,lisdexamfetamine dimesylate 60 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA I)
102400,Marketed,2025-07-17,02535122,JAMP Lisdexamfetamine,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02535122,JAMP LISDEXAMFETAMINE (lisdexamfetamine dimesylate 10 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001446,lisdexamfetamine dimesylate 10 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
102401,Marketed,2025-07-17,02535130,JAMP Lisdexamfetamine,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02535130,JAMP LISDEXAMFETAMINE (lisdexamfetamine dimesylate 20 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001310,lisdexamfetamine dimesylate 20 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
102402,Marketed,2025-07-17,02535149,JAMP Lisdexamfetamine,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02535149,JAMP LISDEXAMFETAMINE (lisdexamfetamine dimesylate 30 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001278,lisdexamfetamine dimesylate 30 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
102403,Marketed,2025-07-17,02535157,JAMP Lisdexamfetamine,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02535157,JAMP LISDEXAMFETAMINE (lisdexamfetamine dimesylate 40 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001311,lisdexamfetamine dimesylate 40 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
102404,Marketed,2025-07-17,02535165,JAMP Lisdexamfetamine,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02535165,JAMP LISDEXAMFETAMINE (lisdexamfetamine dimesylate 50 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001279,lisdexamfetamine dimesylate 50 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
102405,Marketed,2025-07-17,02535173,JAMP Lisdexamfetamine,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02535173,JAMP LISDEXAMFETAMINE (lisdexamfetamine dimesylate 60 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001312,lisdexamfetamine dimesylate 60 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
102406,Marketed,2025-07-17,02535181,JAMP Lisdexamfetamine,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02535181,JAMP LISDEXAMFETAMINE (lisdexamfetamine dimesylate 70 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001472,lisdexamfetamine dimesylate 70 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
103460,Marketed,2024-06-03,02545861,Teva-Lisdexamfetamine,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02545861,TEVA-LISDEXAMFETAMINE (lisdexamfetamine dimesylate 10 mg oral capsule) TEVA CANADA LIMITED,Active,9001446,lisdexamfetamine dimesylate 10 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
103461,Marketed,2024-06-03,02545888,Teva-Lisdexamfetamine,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02545888,TEVA-LISDEXAMFETAMINE (lisdexamfetamine dimesylate 20 mg oral capsule) TEVA CANADA LIMITED,Active,9001310,lisdexamfetamine dimesylate 20 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
103462,Marketed,2024-06-03,02545896,Teva-Lisdexamfetamine,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02545896,TEVA-LISDEXAMFETAMINE (lisdexamfetamine dimesylate 30 mg oral capsule) TEVA CANADA LIMITED,Active,9001278,lisdexamfetamine dimesylate 30 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
103463,Marketed,2024-06-03,02545918,Teva-Lisdexamfetamine,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02545918,TEVA-LISDEXAMFETAMINE (lisdexamfetamine dimesylate 40 mg oral capsule) TEVA CANADA LIMITED,Active,9001311,lisdexamfetamine dimesylate 40 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
103464,Marketed,2024-06-03,02545926,Teva-Lisdexamfetamine,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02545926,TEVA-LISDEXAMFETAMINE (lisdexamfetamine dimesylate 50 mg oral capsule) TEVA CANADA LIMITED,Active,9001279,lisdexamfetamine dimesylate 50 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
103465,Marketed,2024-06-03,02545934,Teva-Lisdexamfetamine,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02545934,TEVA-LISDEXAMFETAMINE (lisdexamfetamine dimesylate 60 mg oral capsule) TEVA CANADA LIMITED,Active,9001312,lisdexamfetamine dimesylate 60 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
103466,Marketed,2024-06-03,02545942,Teva-Lisdexamfetamine,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02545942,TEVA-LISDEXAMFETAMINE (lisdexamfetamine dimesylate 70 mg oral capsule) TEVA CANADA LIMITED,Active,9001472,lisdexamfetamine dimesylate 70 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
103495,Marketed,2024-06-04,02546248,Sandoz Lisdexamfetamine Capsules,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02546248,SANDOZ LISDEXAMFETAMINE CAPSULES (lisdexamfetamine dimesylate 10 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001446,lisdexamfetamine dimesylate 10 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
103496,Marketed,2024-06-04,02546256,Sandoz Lisdexamfetamine Capsules,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02546256,SANDOZ LISDEXAMFETAMINE CAPSULES (lisdexamfetamine dimesylate 20 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001310,lisdexamfetamine dimesylate 20 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
103497,Marketed,2024-09-23,02546264,Sandoz Lisdexamfetamine Capsules,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02546264,SANDOZ LISDEXAMFETAMINE CAPSULES (lisdexamfetamine dimesylate 30 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001278,lisdexamfetamine dimesylate 30 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
103498,Marketed,2024-06-04,02546272,Sandoz Lisdexamfetamine Capsules,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02546272,SANDOZ LISDEXAMFETAMINE CAPSULES (lisdexamfetamine dimesylate 40 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001311,lisdexamfetamine dimesylate 40 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
103499,Marketed,2024-06-04,02546280,Sandoz Lisdexamfetamine Capsules,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02546280,SANDOZ LISDEXAMFETAMINE CAPSULES (lisdexamfetamine dimesylate 50 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001279,lisdexamfetamine dimesylate 50 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
103500,Marketed,2024-06-04,02546299,Sandoz Lisdexamfetamine Capsules,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02546299,SANDOZ LISDEXAMFETAMINE CAPSULES (lisdexamfetamine dimesylate 60 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001312,lisdexamfetamine dimesylate 60 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
103501,Marketed,2024-06-04,02546302,Sandoz Lisdexamfetamine Capsules,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02546302,SANDOZ LISDEXAMFETAMINE CAPSULES (lisdexamfetamine dimesylate 70 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001472,lisdexamfetamine dimesylate 70 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
103532,Marketed,2025-02-18,02546647,Apo-Lisdexamfetamine Capsules,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02546647,APO-LISDEXAMFETAMINE CAPSULES (lisdexamfetamine dimesylate 10 mg oral capsule) APOTEX INC,Active,9001446,lisdexamfetamine dimesylate 10 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
103533,Marketed,2025-02-18,02546655,Apo-Lisdexamfetamine Capsules,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02546655,APO-LISDEXAMFETAMINE CAPSULES (lisdexamfetamine dimesylate 20 mg oral capsule) APOTEX INC,Active,9001310,lisdexamfetamine dimesylate 20 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
103534,Marketed,2025-02-18,02546663,Apo-Lisdexamfetamine Capsules,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02546663,APO-LISDEXAMFETAMINE CAPSULES (lisdexamfetamine dimesylate 30 mg oral capsule) APOTEX INC,Active,9001278,lisdexamfetamine dimesylate 30 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
103535,Marketed,2025-02-18,02546671,Apo-Lisdexamfetamine Capsules,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02546671,APO-LISDEXAMFETAMINE CAPSULES (lisdexamfetamine dimesylate 40 mg oral capsule) APOTEX INC,Active,9001311,lisdexamfetamine dimesylate 40 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
103536,Marketed,2025-02-18,02546698,Apo-Lisdexamfetamine Capsules,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02546698,APO-LISDEXAMFETAMINE CAPSULES (lisdexamfetamine dimesylate 50 mg oral capsule) APOTEX INC,Active,9001279,lisdexamfetamine dimesylate 50 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
103537,Marketed,2025-02-18,02546701,Apo-Lisdexamfetamine Capsules,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02546701,APO-LISDEXAMFETAMINE CAPSULES (lisdexamfetamine dimesylate 60 mg oral capsule) APOTEX INC,Active,9001312,lisdexamfetamine dimesylate 60 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
103538,Marketed,2025-02-18,02546728,Apo-Lisdexamfetamine Capsules,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02546728,APO-LISDEXAMFETAMINE CAPSULES (lisdexamfetamine dimesylate 70 mg oral capsule) APOTEX INC,Active,9001472,lisdexamfetamine dimesylate 70 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
103569,Marketed,2024-12-10,02547031,Pro-Lisdexamfetamine,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02547031,PRO-LISDEXAMFETAMINE (lisdexamfetamine dimesylate 10 mg oral capsule) PRO DOC LIMITEE,Active,9001446,lisdexamfetamine dimesylate 10 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
103570,Marketed,2024-12-10,02547058,Pro-Lisdexamfetamine,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02547058,PRO-LISDEXAMFETAMINE (lisdexamfetamine dimesylate 20 mg oral capsule) PRO DOC LIMITEE,Active,9001310,lisdexamfetamine dimesylate 20 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
103571,Marketed,2024-12-10,02547066,Pro-Lisdexamfetamine,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02547066,PRO-LISDEXAMFETAMINE (lisdexamfetamine dimesylate 30 mg oral capsule) PRO DOC LIMITEE,Active,9001278,lisdexamfetamine dimesylate 30 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
103572,Marketed,2024-12-10,02547074,Pro-Lisdexamfetamine,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02547074,PRO-LISDEXAMFETAMINE (lisdexamfetamine dimesylate 40 mg oral capsule) PRO DOC LIMITEE,Active,9001311,lisdexamfetamine dimesylate 40 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
103573,Marketed,2024-12-10,02547082,Pro-Lisdexamfetamine,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02547082,PRO-LISDEXAMFETAMINE (lisdexamfetamine dimesylate 50 mg oral capsule) PRO DOC LIMITEE,Active,9001279,lisdexamfetamine dimesylate 50 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
103574,Marketed,2024-12-10,02547090,Pro-Lisdexamfetamine,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02547090,PRO-LISDEXAMFETAMINE (lisdexamfetamine dimesylate 60 mg oral capsule) PRO DOC LIMITEE,Active,9001312,lisdexamfetamine dimesylate 60 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
103575,Marketed,2024-12-10,02547104,Pro-Lisdexamfetamine,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02547104,PRO-LISDEXAMFETAMINE (lisdexamfetamine dimesylate 70 mg oral capsule) PRO DOC LIMITEE,Active,9001472,lisdexamfetamine dimesylate 70 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
80843,Marketed,2021-04-19,02322951,Vyvanse,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02322951,VYVANSE (lisdexamfetamine dimesylate 30 mg oral capsule) TAKEDA CANADA INC,Active,9001278,lisdexamfetamine dimesylate 30 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
80844,Marketed,2021-05-31,02322978,Vyvanse,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02322978,VYVANSE (lisdexamfetamine dimesylate 50 mg oral capsule) TAKEDA CANADA INC,Active,9001279,lisdexamfetamine dimesylate 50 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
83254,Marketed,2021-04-14,02347156,Vyvanse,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02347156,VYVANSE (lisdexamfetamine dimesylate 20 mg oral capsule) TAKEDA CANADA INC,Active,9001310,lisdexamfetamine dimesylate 20 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
83255,Marketed,2021-03-30,02347164,Vyvanse,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02347164,VYVANSE (lisdexamfetamine dimesylate 40 mg oral capsule) TAKEDA CANADA INC,Active,9001311,lisdexamfetamine dimesylate 40 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
83256,Marketed,2021-06-24,02347172,Vyvanse,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02347172,VYVANSE (lisdexamfetamine dimesylate 60 mg oral capsule) TAKEDA CANADA INC,Active,9001312,lisdexamfetamine dimesylate 60 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
92401,Marketed,2021-06-18,02439603,Vyvanse,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02439603,VYVANSE (lisdexamfetamine dimesylate 10 mg oral capsule) TAKEDA CANADA INC,Active,9001446,lisdexamfetamine dimesylate 10 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
94514,Marketed,2021-07-26,02458071,Vyvanse,1,N06BA12,Lisdexamfetamine,Capsule,Oral,02458071,VYVANSE (lisdexamfetamine dimesylate 70 mg oral capsule) TAKEDA CANADA INC,Active,9001472,lisdexamfetamine dimesylate 70 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA I)
98028,Marketed,2021-12-09,02490226,Vyvanse,1,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02490226,VYVANSE (lisdexamfetamine dimesylate 10 mg chewable tablet) TAKEDA CANADA INC,Active,9014113,lisdexamfetamine dimesylate 10 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA I)
98029,Marketed,2021-06-01,02490234,Vyvanse,1,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02490234,VYVANSE (lisdexamfetamine dimesylate 20 mg chewable tablet) TAKEDA CANADA INC,Active,9014114,lisdexamfetamine dimesylate 20 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA I)
98030,Marketed,2021-11-02,02490242,Vyvanse,1,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02490242,VYVANSE (lisdexamfetamine dimesylate 30 mg chewable tablet) TAKEDA CANADA INC,Active,9014115,lisdexamfetamine dimesylate 30 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA I)
98031,Marketed,2021-12-10,02490250,Vyvanse,1,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02490250,VYVANSE (lisdexamfetamine dimesylate 40 mg chewable tablet) TAKEDA CANADA INC,Active,9014116,lisdexamfetamine dimesylate 40 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA I)
98032,Marketed,2021-12-15,02490269,Vyvanse,1,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02490269,VYVANSE (lisdexamfetamine dimesylate 50 mg chewable tablet) TAKEDA CANADA INC,Active,9014117,lisdexamfetamine dimesylate 50 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA I)
98033,Marketed,2021-12-15,02490277,Vyvanse,1,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02490277,VYVANSE (lisdexamfetamine dimesylate 60 mg chewable tablet) TAKEDA CANADA INC,Active,9014118,lisdexamfetamine dimesylate 60 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA I)
101418,Marketed,2025-03-17,02525186,Lisinopril (Type Z),1,C09AA03,Lisinopril,Tablet,Oral,02525186,LISINOPRIL (TYPE Z) (lisinopril 5 mg oral tablet) SANIS HEALTH INC,Active,9000529,lisinopril 5 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101419,Marketed,2025-03-17,02525194,Lisinopril (Type Z),1,C09AA03,Lisinopril,Tablet,Oral,02525194,LISINOPRIL (TYPE Z) (lisinopril 10 mg oral tablet) SANIS HEALTH INC,Active,9000358,lisinopril 10 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101420,Marketed,2025-03-17,02525208,Lisinopril (Type Z),1,C09AA03,Lisinopril,Tablet,Oral,02525208,LISINOPRIL (TYPE Z) (lisinopril 20 mg oral tablet) SANIS HEALTH INC,Active,9000359,lisinopril 20 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104333,Marketed,2025-12-29,02554488,Lisinopril Tablets,1,C09AA03,Lisinopril,Tablet,Oral,02554488,LISINOPRIL TABLETS (lisinopril (lisinopril dihydrate) 5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000529,lisinopril 5 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104334,Marketed,2025-12-29,02554496,Lisinopril Tablets,1,C09AA03,Lisinopril,Tablet,Oral,02554496,LISINOPRIL TABLETS (lisinopril (lisinopril dihydrate) 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000358,lisinopril 10 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104335,Marketed,2025-12-29,02554518,Lisinopril Tablets,1,C09AA03,Lisinopril,Tablet,Oral,02554518,LISINOPRIL TABLETS (lisinopril (lisinopril dihydrate) 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000359,lisinopril 20 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
17123,Marketed,2022-02-28,02049384,Zestril,1,C09AA03,Lisinopril,Tablet,Oral,02049384,ZESTRIL (lisinopril 20 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9000359,lisinopril 20 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
17126,Marketed,2022-02-28,02049333,Zestril,1,C09AA03,Lisinopril,Tablet,Oral,02049333,ZESTRIL (lisinopril 5 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9000529,lisinopril 5 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
17215,Marketed,2022-02-28,02049376,Zestril,1,C09AA03,Lisinopril,Tablet,Oral,02049376,ZESTRIL (lisinopril 10 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9000358,lisinopril 10 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77062,Marketed,2010-12-09,02285118,Teva-Lisinopril (Type Z),1,C09AA03,Lisinopril,Tablet,Oral,02285118,TEVA-LISINOPRIL (TYPE Z) (lisinopril 5 mg oral tablet) TEVA CANADA LIMITED,Active,9000529,lisinopril 5 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77063,Marketed,2010-12-09,02285126,Teva-Lisinopril (Type Z),1,C09AA03,Lisinopril,Tablet,Oral,02285126,TEVA-LISINOPRIL (TYPE Z) (lisinopril 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000358,lisinopril 10 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77064,Marketed,2010-12-09,02285134,Teva-Lisinopril (Type Z),1,C09AA03,Lisinopril,Tablet,Oral,02285134,TEVA-LISINOPRIL (TYPE Z) (lisinopril 20 mg oral tablet) TEVA CANADA LIMITED,Active,9000359,lisinopril 20 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87181,Marketed,2012-06-11,02386232,Lisinopril,1,C09AA03,Lisinopril,Tablet,Oral,02386232,LISINOPRIL (lisinopril 5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000529,lisinopril 5 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87182,Marketed,2012-06-11,02386240,Lisinopril,1,C09AA03,Lisinopril,Tablet,Oral,02386240,LISINOPRIL (lisinopril 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000358,lisinopril 10 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87183,Marketed,2012-06-11,02386259,Lisinopril,1,C09AA03,Lisinopril,Tablet,Oral,02386259,LISINOPRIL (lisinopril 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000359,lisinopril 20 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87963,Marketed,2013-02-12,02394472,Auro-Lisinopril,1,C09AA03,Lisinopril,Tablet,Oral,02394472,AURO-LISINOPRIL (lisinopril (lisinopril dihydrate) 5 mg oral tablet) AURO PHARMA INC,Active,9000529,lisinopril 5 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87964,Marketed,2013-02-12,02394480,Auro-Lisinopril,1,C09AA03,Lisinopril,Tablet,Oral,02394480,AURO-LISINOPRIL (lisinopril (lisinopril dihydrate) 10 mg oral tablet) AURO PHARMA INC,Active,9000358,lisinopril 10 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87965,Marketed,2013-02-12,02394499,Auro-Lisinopril,1,C09AA03,Lisinopril,Tablet,Oral,02394499,AURO-LISINOPRIL (lisinopril (lisinopril dihydrate) 20 mg oral tablet) AURO PHARMA INC,Active,9000359,lisinopril 20 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
16636,Marketed,2022-02-28,02103729,Zestoretic,2,C09BA03,Lisinopril and diuretics,Tablet,Oral,02103729,ZESTORETIC (hydrochlorothiazide 12.5 mg and lisinopril 10 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9000525,hydrochlorothiazide 12.5 mg and lisinopril 10 mg oral tablet,8000201,hydrochlorothiazide and lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
16903,Marketed,2022-02-28,02045737,Zestoretic,2,C09BA03,Lisinopril and diuretics,Tablet,Oral,02045737,ZESTORETIC (hydrochlorothiazide 12.5 mg and lisinopril 20 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9000526,hydrochlorothiazide 12.5 mg and lisinopril 20 mg oral tablet,8000201,hydrochlorothiazide and lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
17903,Marketed,2021-07-21,02045729,Zestoretic,2,C09BA03,Lisinopril and diuretics,Tablet,Oral,02045729,ZESTORETIC (hydrochlorothiazide 25 mg and lisinopril 20 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9000577,hydrochlorothiazide 25 mg and lisinopril 20 mg oral tablet,8000201,hydrochlorothiazide and lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78710,Marketed,2010-12-09,02301768,Teva-Lisinopril/HCTZ (Type Z),2,C09BA03,Lisinopril and diuretics,Tablet,Oral,02301768,TEVA-LISINOPRIL/HCTZ (TYPE Z) (hydrochlorothiazide 12.5 mg and lisinopril (lisinopril dihydrate) 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000525,hydrochlorothiazide 12.5 mg and lisinopril 10 mg oral tablet,8000201,hydrochlorothiazide and lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78711,Marketed,2010-12-09,02301776,Teva-Lisinopril/HCTZ (Type Z),2,C09BA03,Lisinopril and diuretics,Tablet,Oral,02301776,TEVA-LISINOPRIL/HCTZ (TYPE Z) (hydrochlorothiazide 12.5 mg and lisinopril (lisinopril dihydrate) 20 mg oral tablet) TEVA CANADA LIMITED,Active,9000526,hydrochlorothiazide 12.5 mg and lisinopril 20 mg oral tablet,8000201,hydrochlorothiazide and lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78712,Marketed,2010-12-09,02301784,Teva-Lisinopril/HCTZ (Type Z),2,C09BA03,Lisinopril and diuretics,Tablet,Oral,02301784,TEVA-LISINOPRIL/HCTZ (TYPE Z) (hydrochlorothiazide 25 mg and lisinopril (lisinopril dihydrate) 20 mg oral tablet) TEVA CANADA LIMITED,Active,9000577,hydrochlorothiazide 25 mg and lisinopril 20 mg oral tablet,8000201,hydrochlorothiazide and lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78769,Marketed,2007-11-21,02302365,Sandoz Lisinopril HCTZ,2,C09BA03,Lisinopril and diuretics,Tablet,Oral,02302365,SANDOZ LISINOPRIL HCT (hydrochlorothiazide 12.5 mg and lisinopril (lisinopril dihydrate) 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000525,hydrochlorothiazide 12.5 mg and lisinopril 10 mg oral tablet,8000201,hydrochlorothiazide and lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78770,Marketed,2007-11-21,02302373,Sandoz Lisinopril HCTZ,2,C09BA03,Lisinopril and diuretics,Tablet,Oral,02302373,SANDOZ LISINOPRIL HCT (hydrochlorothiazide 12.5 mg and lisinopril (lisinopril dihydrate) 20 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000526,hydrochlorothiazide 12.5 mg and lisinopril 20 mg oral tablet,8000201,hydrochlorothiazide and lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78771,Marketed,2007-11-21,02302381,Sandoz Lisinopril HCTZ,2,C09BA03,Lisinopril and diuretics,Tablet,Oral,02302381,SANDOZ LISINOPRIL HCT (hydrochlorothiazide 25 mg and lisinopril (lisinopril dihydrate) 20 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000577,hydrochlorothiazide 25 mg and lisinopril 20 mg oral tablet,8000201,hydrochlorothiazide and lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84793,Marketed,2014-12-12,02362945,Lisinopril/HCTZ (Type Z),2,C09BA03,Lisinopril and diuretics,Tablet,Oral,02362945,LISINOPRIL/HCTZ (TYPE Z) (hydrochlorothiazide 12.5 mg and lisinopril (lisinopril dihydrate) 10 mg oral tablet) SANIS HEALTH INC,Active,9000525,hydrochlorothiazide 12.5 mg and lisinopril 10 mg oral tablet,8000201,hydrochlorothiazide and lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84794,Marketed,2014-12-12,02362953,Lisinopril/HCTZ (Type Z),2,C09BA03,Lisinopril and diuretics,Tablet,Oral,02362953,LISINOPRIL/HCTZ (TYPE Z) (hydrochlorothiazide 12.5 mg and lisinopril (lisinopril dihydrate) 20 mg oral tablet) SANIS HEALTH INC,Active,9000526,hydrochlorothiazide 12.5 mg and lisinopril 20 mg oral tablet,8000201,hydrochlorothiazide and lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84795,Marketed,2014-12-12,02362961,Lisinopril/HCTZ (Type Z),2,C09BA03,Lisinopril and diuretics,Tablet,Oral,02362961,LISINOPRIL/HCTZ (TYPE Z) (hydrochlorothiazide 25 mg and lisinopril (lisinopril dihydrate) 20 mg oral tablet) SANIS HEALTH INC,Active,9000577,hydrochlorothiazide 25 mg and lisinopril 20 mg oral tablet,8000201,hydrochlorothiazide and lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101618,Marketed,2024-11-19,02527138,Breyanzi,1,L01XL08,Lisocabtagene maraleucel,Suspension,Intravenous,,,,,,,,,,,,,,,,,Schedule D
101618,Marketed,2024-11-19,02527138,Breyanzi,1,L01XL08,Lisocabtagene maraleucel,Suspension,Intravenous,,,,,,,,,,,,,,,,,Prescription
1327,Marketed,2019-06-03,00236683,Carbolith,1,N05AN01,Lithium,Capsule,Oral,00236683,"CARBOLITH (lithium carbonate 300 mg oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9000054,lithium carbonate 300 mg oral capsule,8000041,lithium carbonate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
13429,Marketed,2019-06-03,02011239,Carbolith,1,N05AN01,Lithium,Capsule,Oral,02011239,"CARBOLITH (lithium carbonate 600 mg oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9000428,lithium carbonate 600 mg oral capsule,8000041,lithium carbonate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
13626,Marketed,2022-09-23,02013231,Lithane,1,N05AN01,Lithium,Capsule,Oral,02013231,LITHANE (lithium carbonate 150 mg oral capsule) SEARCHLIGHT PHARMA INC,Active,9000130,lithium carbonate 150 mg oral capsule,8000041,lithium carbonate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
19894,Marketed,1996-12-31,02216132,PMS-Lithium Carbonate - Capsules 150 mg,1,N05AN01,Lithium,Capsule,Oral,02216132,PMS-LITHIUM CARBONATE - CAP 150MG (lithium carbonate 150 mg oral capsule) PHARMASCIENCE INC,Active,9000130,lithium carbonate 150 mg oral capsule,8000041,lithium carbonate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
3192,Marketed,2022-09-22,00406775,Lithane,1,N05AN01,Lithium,Capsule,Oral,00406775,LITHANE (lithium carbonate 300 mg oral capsule) SEARCHLIGHT PHARMA INC,Active,9000054,lithium carbonate 300 mg oral capsule,8000041,lithium carbonate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
3414,Marketed,2019-06-03,00461733,Carbolith,1,N05AN01,Lithium,Capsule,Oral,00461733,"CARBOLITH (lithium carbonate 150 mg oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9000130,lithium carbonate 150 mg oral capsule,8000041,lithium carbonate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
66667,Marketed,2001-02-12,02242837,Apo-Lithium Carbonate,1,N05AN01,Lithium,Capsule,Oral,02242837,APO-LITHIUM CARBONATE (lithium carbonate 150 mg oral capsule) APOTEX INC,Active,9000130,lithium carbonate 150 mg oral capsule,8000041,lithium carbonate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
75210,Marketed,2011-01-14,02266695,Lithmax,1,N05AN01,Lithium,Tablet (extended-release),Oral,02266695,LITHMAX (lithium carbonate 300 mg prolonged-release oral tablet) AA PHARMA INC,Active,9001110,lithium carbonate 300 mg prolonged-release oral tablet,8000041,lithium carbonate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
13591,Marketed,2018-03-16,00893560,Alomide,1,S01GX05,Lodoxamide,Solution,Ophthalmic,00893560,ALOMIDE (lodoxamide (lodoxamide tromethamine) 0.1 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012830,lodoxamide (lodoxamide tromethamine) 0.1 % ophthalmic drops,8001490,lodoxamide,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
90495,Marketed,2024-03-18,02420341,Juxtapid,1,C10AX12,Lomitapide,Capsule,Oral,02420341,JUXTAPID (lomitapide (lomitapide mesylate) 5 mg oral capsule) CHIESI FARMACEUTICI S.P.A.,Active,9005518,lomitapide (lomitapide mesylate) 5 mg oral capsule,8001315,lomitapide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
90496,Marketed,2024-02-23,02420376,Juxtapid,1,C10AX12,Lomitapide,Capsule,Oral,02420376,JUXTAPID (lomitapide (lomitapide mesylate) 10 mg oral capsule) CHIESI FARMACEUTICI S.P.A.,Active,9005516,lomitapide (lomitapide mesylate) 10 mg oral capsule,8001315,lomitapide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
90498,Marketed,2024-02-23,02420384,Juxtapid,1,C10AX12,Lomitapide,Capsule,Oral,02420384,JUXTAPID (lomitapide (lomitapide mesylate) 20 mg oral capsule) CHIESI FARMACEUTICI S.P.A.,Active,9005517,lomitapide (lomitapide mesylate) 20 mg oral capsule,8001315,lomitapide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
2530,Marketed,2009-12-14,00360422,CeeNU,1,L01AD02,Lomustine,Capsule,Oral,00360422,CEENU (lomustine 40 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9001763,lomustine 40 mg oral capsule,8001842,lomustine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
2531,Marketed,2010-02-18,00360430,CeeNU,1,L01AD02,Lomustine,Capsule,Oral,00360430,CEENU (lomustine 10 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9001762,lomustine 10 mg oral capsule,8001842,lomustine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
103360,Marketed,2025-03-14,02544989,JAMP Loperamide,1,A07DA03,Loperamide,Capsule,Oral,02544989,JAMP LOPERAMIDE (loperamide hydrochloride 2 mg oral capsule) JAMP PHARMA CORPORATION,Active,9005282,loperamide hydrochloride 2 mg oral capsule,8001213,loperamide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
104101,Marketed,2025-08-19,02552337,Diarrhea Relief Liquid Gels,1,A07DA03,Loperamide,Capsule,Oral,02552337,DIARRHEA RELIEF LIQUID GELS (loperamide hydrochloride 2 mg oral capsule) LABORATOIRE RIVA INC.,Active,9005282,loperamide hydrochloride 2 mg oral capsule,8001213,loperamide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
14567,Marketed,1993-12-31,02016095,PMS-Loperamide Hydrochloride Solution.2 mg/mL,1,A07DA03,Loperamide,Solution,Oral,02016095,PMS-LOPERAMIDE HYDROCHLORIDE SOLUTION.2MG/ML (loperamide hydrochloride 0.2 mg per mL oral solution) PHARMASCIENCE INC,Active,9002593,loperamide hydrochloride 0.2 mg per mL oral solution,8001213,loperamide,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
18071,Marketed,2016-12-23,02132591,Teva-Loperamide,1,A07DA03,Loperamide,Tablet,Oral,02132591,TEVA-LOPERAMIDE (loperamide hydrochloride 2 mg oral tablet) TEVA CANADA LIMITED,Active,9002841,loperamide hydrochloride 2 mg oral tablet,8001213,loperamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
43419,Marketed,2014-05-26,02225182,Loperamide-2,1,A07DA03,Loperamide,Tablet,Oral,02225182,LOPERAMIDE-2 (loperamide hydrochloride 2 mg oral tablet) PRO DOC LIMITEE,Active,9002841,loperamide hydrochloride 2 mg oral tablet,8001213,loperamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
43486,Marketed,1996-09-12,02228351,PMS-Loperamide - Caplet 2 mg,1,A07DA03,Loperamide,Tablet,Oral,02228351,PMS-LOPERAMIDE - CAPLET 2MG (loperamide hydrochloride 2 mg oral tablet) PHARMASCIENCE INC,Active,9002841,loperamide hydrochloride 2 mg oral tablet,8001213,loperamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
49614,Marketed,2026-03-12,02230542,Imodium Quick Dissolve,1,A07DA03,Loperamide,Tablet (orally disintegrating),Oral,02230542,IMODIUM QUICK DISSOLVE (loperamide hydrochloride 2 mg orodispersible tablet) KENVUE CANADA INC.,Active,9013221,loperamide hydrochloride 2 mg orodispersible tablet,8001213,loperamide,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
61604,Marketed,1998-08-27,02238211,Riva-Loperamide,1,A07DA03,Loperamide,Tablet,Oral,02238211,RIVA-LOPERAMIDE (loperamide hydrochloride 2 mg oral tablet) LABORATOIRE RIVA INC.,Active,9002841,loperamide hydrochloride 2 mg oral tablet,8001213,loperamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
73379,Marketed,2004-06-11,02248994,Diarrhea Relief,1,A07DA03,Loperamide,Tablet,Oral,02248994,DIARRHEA RELIEF (loperamide hydrochloride 2 mg oral tablet) PHARMASCIENCE INC,Active,9002841,loperamide hydrochloride 2 mg oral tablet,8001213,loperamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
74169,Marketed,2004-12-19,02256452,Diarrhea Relief,1,A07DA03,Loperamide,Tablet,Oral,02256452,DIARRHEA RELIEF (loperamide hydrochloride 2 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9002841,loperamide hydrochloride 2 mg oral tablet,8001213,loperamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
77716,Marketed,2026-03-12,02291800,Imodium Calming Liquid,1,A07DA03,Loperamide,Solution,Oral,02291800,IMODIUM CALMING LIQUID (loperamide hydrochloride 2 mg per 15 mL oral solution) KENVUE CANADA INC.,Active,9004307,loperamide hydrochloride 2 mg per 15 mL oral solution,8001213,loperamide,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
86147,Marketed,2026-03-12,02376016,Imodium Liqui-Gels,1,A07DA03,Loperamide,Capsule,Oral,02376016,IMODIUM LIQUI-GELS (loperamide hydrochloride 2 mg oral capsule) KENVUE CANADA INC.,Active,9005282,loperamide hydrochloride 2 mg oral capsule,8001213,loperamide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
98925,Marketed,2022-05-30,02499517,Diarrhea Relief Fast Dissolve,1,A07DA03,Loperamide,Tablet (orally disintegrating),Oral,02499517,DIARRHEA RELIEF FAST DISSOLVE (loperamide hydrochloride 2 mg orodispersible tablet) JUNO OTC INC,Active,9013221,loperamide hydrochloride 2 mg orodispersible tablet,8001213,loperamide,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
69200,Marketed,2025-11-28,02245185,Imodium Complete,2,A07DA53,"Loperamide, combinations",Tablet,Oral,02245185,IMODIUM COMPLETE (loperamide hydrochloride 2 mg and simethicone 125 mg oral tablet) KENVUE CANADA INC.,Active,9003731,loperamide hydrochloride 2 mg and simethicone 125 mg oral tablet,8002135,loperamide and simethicone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
67570,Marketed,2014-06-09,02243644,Kaletra,2,J05AR10,Lopinavir and ritonavir,Solution,Oral,02243644,KALETRA (lopinavir 400 mg per 5 mL and ritonavir 100 mg per 5 mL oral solution) ABBVIE CORPORATION,Active,9013451,lopinavir 400 mg per 5 mL and ritonavir 100 mg per 5 mL oral solution,8001491,lopinavir and ritonavir,26643006,Oral,385023001,Oral solution,,,,,,Prescription
77104,Marketed,2015-01-14,02285533,Kaletra,2,J05AR10,Lopinavir and ritonavir,Tablet,Oral,02285533,KALETRA (lopinavir 200 mg and ritonavir 50 mg oral tablet) ABBVIE CORPORATION,Active,9004211,lopinavir 200 mg and ritonavir 50 mg oral tablet,8001491,lopinavir and ritonavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79781,Marketed,2014-11-25,02312301,Kaletra,2,J05AR10,Lopinavir and ritonavir,Tablet,Oral,02312301,KALETRA (lopinavir 100 mg and ritonavir 25 mg oral tablet) ABBVIE CORPORATION,Active,9004452,lopinavir 100 mg and ritonavir 25 mg oral tablet,8001491,lopinavir and ritonavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
10533,Marketed,2020-02-27,00782696,Claritin Allergy,1,R06AX13,Loratadine,Tablet,Oral,00782696,CLARITIN ALLERGY (loratadine 10 mg oral tablet) BAYER INC,Active,9002125,loratadine 10 mg oral tablet,8001492,loratadine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
61088,Marketed,2014-12-19,02237734,Claritin Rapid Dissolve,1,R06AX13,Loratadine,Tablet (orally disintegrating),Oral,02237734,CLARITIN RAPID DISSOLVE (loratadine 10 mg orodispersible tablet) BAYER INC,Active,9003251,loratadine 10 mg orodispersible tablet,8001492,loratadine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
65175,Marketed,2017-03-01,02241523,Claritin Kids,1,R06AX13,Loratadine,Syrup,Oral,02241523,CLARITIN KIDS (loratadine 5 mg per 5 mL syrup) BAYER INC,Active,9013453,loratadine 5 mg per 5 mL syrup,8001492,loratadine,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
67821,Marketed,2010-10-09,02243880,Apo-Loratadine,1,R06AX13,Loratadine,Tablet,Oral,02243880,APO-LORATADINE (loratadine 10 mg oral tablet) APOTEX INC,Active,9002125,loratadine 10 mg oral tablet,8001492,loratadine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
76583,Marketed,2010-09-24,02280159,24 Hour Allergy Remedy,1,R06AX13,Loratadine,Tablet,Oral,02280159,24 HOUR ALLERGY REMEDY (loratadine 10 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9002125,loratadine 10 mg oral tablet,8001492,loratadine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
85127,Marketed,2013-04-18,02366444,Loratadine,1,R06AX13,Loratadine,Tablet,Oral,02366444,LORATADINE (loratadine 10 mg oral tablet) APOTEX INC,Active,9002125,loratadine 10 mg oral tablet,8001492,loratadine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
86145,Marketed,2024-02-01,02375990,Allergy Remedy,1,R06AX13,Loratadine,Tablet,Oral,02375990,ALLERGY REMEDY (loratadine 10 mg oral tablet) APOTEX INC,Active,9002125,loratadine 10 mg oral tablet,8001492,loratadine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
86538,Marketed,2012-09-07,02379481,Loratadine Soft Gel Capsules,1,R06AX13,Loratadine,Capsule,Oral,02379481,LORATADINE SOFT GEL CAPSULES (loratadine 10 mg oral capsule) APOTEX INC,Active,9005099,loratadine 10 mg oral capsule,8001492,loratadine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
87582,Marketed,2013-10-31,02390388,Allertin,1,R06AX13,Loratadine,Capsule,Oral,02390388,ALLERTIN (loratadine 10 mg oral capsule) APOTEX INC,Active,9005099,loratadine 10 mg oral capsule,8001492,loratadine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
88925,Marketed,2016-05-31,02404494,Claritin Liquid Capsules,1,R06AX13,Loratadine,Capsule,Oral,02404494,CLARITIN LIQUID CAPSULES (loratadine 10 mg oral capsule) BAYER INC,Active,9005099,loratadine 10 mg oral capsule,8001492,loratadine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
99811,Marketed,2021-09-20,02508761,Claritin Kids Rapid Dissolve,1,R06AX13,Loratadine,Tablet (orally disintegrating),Oral,02508761,CLARITIN KIDS RAPID DISSOLVE (loratadine 5 mg orodispersible tablet) BAYER INC,Active,9014609,loratadine 5 mg orodispersible tablet,8001492,loratadine,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
103972,Marketed,2026-01-20,02550962,"Lorazepam Injection, USP",1,N05BA06,Lorazepam,Solution,"Intramuscular,Intravenous",02550962,"LORAZEPAM INJECTION, USP (lorazepam 4 mg per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9000942,lorazepam 4 mg per 1 mL solution for injection vial,8000109,lorazepam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Targeted Substances (CDSA IV)
16118,Marketed,2025-12-01,02041464,Ativan,1,N05BA06,Lorazepam,Tablet,Sublingual,02041464,ATIVAN (lorazepam 1 mg sublingual tablet) PFIZER CANADA ULC,Active,9000531,lorazepam 1 mg sublingual tablet,8000109,lorazepam,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
17817,Marketed,2025-12-01,02041456,Ativan,1,N05BA06,Lorazepam,Tablet,Sublingual,02041456,ATIVAN (lorazepam 0.5 mg sublingual tablet) PFIZER CANADA ULC,Active,9000596,lorazepam 0.5 mg sublingual tablet,8000109,lorazepam,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
6135,Marketed,2014-01-11,00637742,Teva-Lorazepam,1,N05BA06,Lorazepam,Tablet,Oral,00637742,TEVA-LORAZEPAM (lorazepam 1 mg oral tablet) TEVA CANADA LIMITED,Active,9000225,lorazepam 1 mg oral tablet,8000109,lorazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
6136,Marketed,2014-01-11,00637750,Teva-Lorazepam,1,N05BA06,Lorazepam,Tablet,Oral,00637750,TEVA-LORAZEPAM (lorazepam 2 mg oral tablet) TEVA CANADA LIMITED,Active,9000226,lorazepam 2 mg oral tablet,8000109,lorazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
6295,Marketed,1985-12-31,00655740,Apo-Lorazepam,1,N05BA06,Lorazepam,Tablet,Oral,00655740,APO-LORAZEPAM (lorazepam 0.5 mg oral tablet) APOTEX INC,Active,9000224,lorazepam 0.5 mg oral tablet,8000109,lorazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
6296,Marketed,1985-12-31,00655759,Apo-Lorazepam,1,N05BA06,Lorazepam,Tablet,Oral,00655759,APO-LORAZEPAM (lorazepam 1 mg oral tablet) APOTEX INC,Active,9000225,lorazepam 1 mg oral tablet,8000109,lorazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
6297,Marketed,1985-12-31,00655767,Apo-Lorazepam,1,N05BA06,Lorazepam,Tablet,Oral,00655767,APO-LORAZEPAM (lorazepam 2 mg oral tablet) APOTEX INC,Active,9000226,lorazepam 2 mg oral tablet,8000109,lorazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
6656,Marketed,2022-03-22,00655643,Pro-Lorazepam,1,N05BA06,Lorazepam,Tablet,Oral,00655643,PRO-LORAZEPAM (lorazepam 0.5 mg oral tablet) PRO DOC LIMITEE,Active,9000224,lorazepam 0.5 mg oral tablet,8000109,lorazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
6657,Marketed,2022-03-22,00655651,Pro-Lorazepam,1,N05BA06,Lorazepam,Tablet,Oral,00655651,PRO-LORAZEPAM (lorazepam 1 mg oral tablet) PRO DOC LIMITEE,Active,9000225,lorazepam 1 mg oral tablet,8000109,lorazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
6658,Marketed,2022-03-22,00655678,Pro-Lorazepam,1,N05BA06,Lorazepam,Tablet,Oral,00655678,PRO-LORAZEPAM (lorazepam 2 mg oral tablet) PRO DOC LIMITEE,Active,9000226,lorazepam 2 mg oral tablet,8000109,lorazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
67176,Marketed,2005-09-21,02243278,Lorazepam Injection USP,1,N05BA06,Lorazepam,Solution,"Intravenous,Intramuscular",02243278,LORAZEPAM INJECTION USP (lorazepam 4 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000942,lorazepam 4 mg per 1 mL solution for injection vial,8000109,lorazepam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Targeted Substances (CDSA IV)
7314,Marketed,2014-01-11,00711101,Teva-Lorazepam,1,N05BA06,Lorazepam,Tablet,Oral,00711101,TEVA-LORAZEPAM (lorazepam 0.5 mg oral tablet) TEVA CANADA LIMITED,Active,9000224,lorazepam 0.5 mg oral tablet,8000109,lorazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
89541,Marketed,2018-01-15,02410745,Lorazepam Sublingual,1,N05BA06,Lorazepam,Tablet,Sublingual,02410745,LORAZEPAM SUBLINGUAL (lorazepam 0.5 mg sublingual tablet) AA PHARMA INC,Active,9000596,lorazepam 0.5 mg sublingual tablet,8000109,lorazepam,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
89542,Marketed,2018-01-15,02410753,Lorazepam Sublingual,1,N05BA06,Lorazepam,Tablet,Sublingual,02410753,LORAZEPAM SUBLINGUAL (lorazepam 1 mg sublingual tablet) AA PHARMA INC,Active,9000531,lorazepam 1 mg sublingual tablet,8000109,lorazepam,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
89543,Marketed,2018-01-15,02410761,Lorazepam Sublingual,1,N05BA06,Lorazepam,Tablet,Sublingual,02410761,LORAZEPAM SUBLINGUAL (lorazepam 2 mg sublingual tablet) AA PHARMA INC,Active,9000532,lorazepam 2 mg sublingual tablet,8000109,lorazepam,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
9349,Marketed,1988-12-31,00728187,PMS-Lorazepam,1,N05BA06,Lorazepam,Tablet,Oral,00728187,PMS-LORAZEPAM (lorazepam 0.5 mg oral tablet) PHARMASCIENCE INC,Active,9000224,lorazepam 0.5 mg oral tablet,8000109,lorazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
9423,Marketed,1988-12-31,00728195,PMS-Lorazepam,1,N05BA06,Lorazepam,Tablet,Oral,00728195,PMS-LORAZEPAM (lorazepam 1 mg oral tablet) PHARMASCIENCE INC,Active,9000225,lorazepam 1 mg oral tablet,8000109,lorazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
9424,Marketed,1988-12-31,00728209,PMS-Lorazepam,1,N05BA06,Lorazepam,Tablet,Oral,00728209,PMS-LORAZEPAM (lorazepam 2 mg oral tablet) PHARMASCIENCE INC,Active,9000226,lorazepam 2 mg oral tablet,8000109,lorazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
97619,Marketed,2019-04-22,02485966,Lorbrena,1,L01ED05,Lorlatinib,Tablet,Oral,02485966,LORBRENA (lorlatinib 25 mg oral tablet) PFIZER CANADA ULC,Active,9013975,lorlatinib 25 mg oral tablet,8002261,lorlatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
97620,Marketed,2019-04-22,02485974,Lorbrena,1,L01ED05,Lorlatinib,Tablet,Oral,02485974,LORBRENA (lorlatinib 100 mg oral tablet) PFIZER CANADA ULC,Active,9013974,lorlatinib 100 mg oral tablet,8002261,lorlatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
19167,Marketed,2022-02-21,02182815,Cozaar,1,C09CA01,Losartan,Tablet,Oral,02182815,COZAAR (losartan potassium 25 mg oral tablet) ORGANON CANADA INC.,Active,9000597,losartan potassium 25 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
19168,Marketed,2022-01-05,02182874,Cozaar,1,C09CA01,Losartan,Tablet,Oral,02182874,COZAAR (losartan potassium 50 mg oral tablet) ORGANON CANADA INC.,Active,9000598,losartan potassium 50 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
44255,Marketed,2022-01-07,02182882,Cozaar,1,C09CA01,Losartan,Tablet,Oral,02182882,COZAAR (losartan potassium 100 mg oral tablet) ORGANON CANADA INC.,Active,9000775,losartan potassium 100 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79542,Marketed,2020-12-16,02309750,PMS-Losartan,1,C09CA01,Losartan,Tablet,Oral,02309750,PMS-LOSARTAN (losartan potassium 25 mg oral tablet) PHARMASCIENCE INC,Active,9000597,losartan potassium 25 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79543,Marketed,2020-11-05,02309769,PMS-Losartan,1,C09CA01,Losartan,Tablet,Oral,02309769,PMS-LOSARTAN (losartan potassium 50 mg oral tablet) PHARMASCIENCE INC,Active,9000598,losartan potassium 50 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79544,Marketed,2012-01-25,02309777,PMS-Losartan,1,C09CA01,Losartan,Tablet,Oral,02309777,PMS-LOSARTAN (losartan potassium 100 mg oral tablet) PHARMASCIENCE INC,Active,9000775,losartan potassium 100 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79886,Marketed,2012-01-25,02313332,Sandoz Losartan,1,C09CA01,Losartan,Tablet,Oral,02313332,SANDOZ LOSARTAN (losartan potassium 25 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000597,losartan potassium 25 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79887,Marketed,2012-01-25,02313340,Sandoz Losartan,1,C09CA01,Losartan,Tablet,Oral,02313340,SANDOZ LOSARTAN (losartan potassium 50 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000598,losartan potassium 50 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79888,Marketed,2012-01-25,02313359,Sandoz Losartan,1,C09CA01,Losartan,Tablet,Oral,02313359,SANDOZ LOSARTAN (losartan potassium 100 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000775,losartan potassium 100 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84304,Marketed,2012-01-25,02357968,Teva-Losartan,1,C09CA01,Losartan,Tablet,Oral,02357968,TEVA-LOSARTAN (losartan potassium 50 mg oral tablet) TEVA CANADA LIMITED,Active,9000598,losartan potassium 50 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84305,Marketed,2012-01-25,02357976,Teva-Losartan,1,C09CA01,Losartan,Tablet,Oral,02357976,TEVA-LOSARTAN (losartan potassium 100 mg oral tablet) TEVA CANADA LIMITED,Active,9000775,losartan potassium 100 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86659,Marketed,2012-02-28,02380838,Teva-Losartan,1,C09CA01,Losartan,Tablet,Oral,02380838,TEVA-LOSARTAN (losartan potassium 25 mg oral tablet) TEVA CANADA LIMITED,Active,9000597,losartan potassium 25 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87431,Marketed,2025-06-12,02388790,Losartan,1,C09CA01,Losartan,Tablet,Oral,02388790,LOSARTAN (losartan potassium 25 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000597,losartan potassium 25 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87432,Marketed,2025-06-12,02388804,Losartan,1,C09CA01,Losartan,Tablet,Oral,02388804,LOSARTAN (losartan potassium 50 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000598,losartan potassium 50 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87433,Marketed,2025-06-12,02388812,Losartan,1,C09CA01,Losartan,Tablet,Oral,02388812,LOSARTAN (losartan potassium 100 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000775,losartan potassium 100 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87441,Marketed,2012-07-20,02388863,Losartan,1,C09CA01,Losartan,Tablet,Oral,02388863,LOSARTAN (losartan potassium 25 mg oral tablet) SANIS HEALTH INC,Active,9000597,losartan potassium 25 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87442,Marketed,2012-07-20,02388871,Losartan,1,C09CA01,Losartan,Tablet,Oral,02388871,LOSARTAN (losartan potassium 50 mg oral tablet) SANIS HEALTH INC,Active,9000598,losartan potassium 50 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87443,Marketed,2012-07-20,02388898,Losartan,1,C09CA01,Losartan,Tablet,Oral,02388898,LOSARTAN (losartan potassium 100 mg oral tablet) SANIS HEALTH INC,Active,9000775,losartan potassium 100 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88375,Marketed,2016-06-01,02398834,JAMP-Losartan,1,C09CA01,Losartan,Tablet,Oral,02398834,JAMP-LOSARTAN (losartan potassium 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000597,losartan potassium 25 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88376,Marketed,2016-06-01,02398842,JAMP-Losartan,1,C09CA01,Losartan,Tablet,Oral,02398842,JAMP-LOSARTAN (losartan potassium 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000598,losartan potassium 50 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88377,Marketed,2016-06-01,02398850,JAMP-Losartan,1,C09CA01,Losartan,Tablet,Oral,02398850,JAMP-LOSARTAN (losartan potassium 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000775,losartan potassium 100 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88814,Marketed,2013-03-26,02403323,Auro-Losartan,1,C09CA01,Losartan,Tablet,Oral,02403323,AURO-LOSARTAN (losartan potassium 25 mg oral tablet) AURO PHARMA INC,Active,9000597,losartan potassium 25 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88815,Marketed,2013-03-26,02403331,Auro-Losartan,1,C09CA01,Losartan,Tablet,Oral,02403331,AURO-LOSARTAN (losartan potassium 50 mg oral tablet) AURO PHARMA INC,Active,9000598,losartan potassium 50 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88816,Marketed,2013-03-26,02403358,Auro-Losartan,1,C09CA01,Losartan,Tablet,Oral,02403358,AURO-LOSARTAN (losartan potassium 100 mg oral tablet) AURO PHARMA INC,Active,9000775,losartan potassium 100 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89050,Marketed,2024-03-22,02405733,Mint-Losartan,1,C09CA01,Losartan,Tablet,Oral,02405733,MINT-LOSARTAN (losartan potassium 25 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000597,losartan potassium 25 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89051,Marketed,2024-03-22,02405741,Mint-Losartan,1,C09CA01,Losartan,Tablet,Oral,02405741,MINT-LOSARTAN (losartan potassium 50 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000598,losartan potassium 50 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89052,Marketed,2024-03-22,02405768,Mint-Losartan,1,C09CA01,Losartan,Tablet,Oral,02405768,MINT-LOSARTAN (losartan potassium 100 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000775,losartan potassium 100 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
48580,Marketed,2022-03-03,02230047,Hyzaar,2,C09DA01,Losartan and diuretics,Tablet,Oral,02230047,HYZAAR (hydrochlorothiazide 12.5 mg and losartan potassium 50 mg oral tablet) ORGANON CANADA INC.,Active,9000672,hydrochlorothiazide 12.5 mg and losartan potassium 50 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
64599,Marketed,2022-04-01,02241007,Hyzaar DS,2,C09DA01,Losartan and diuretics,Tablet,Oral,02241007,HYZAAR DS (hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet) ORGANON CANADA INC.,Active,9000878,hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78318,Marketed,2022-04-05,02297841,Hyzaar,2,C09DA01,Losartan and diuretics,Tablet,Oral,02297841,HYZAAR (hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet) ORGANON CANADA INC.,Active,9001208,hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79890,Marketed,2012-01-25,02313375,Sandoz Losartan HCTZ,2,C09DA01,Losartan and diuretics,Tablet,Oral,02313375,SANDOZ LOSARTAN HCT (hydrochlorothiazide 12.5 mg and losartan potassium 50 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000672,hydrochlorothiazide 12.5 mg and losartan potassium 50 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79891,Marketed,2012-01-25,02313383,Sandoz Losartan HCTZ DS,2,C09DA01,Losartan and diuretics,Tablet,Oral,02313383,SANDOZ LOSARTAN HCT DS (hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000878,hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84332,Marketed,2012-04-16,02358263,Teva-Losartan/HCTZ,2,C09DA01,Losartan and diuretics,Tablet,Oral,02358263,TEVA-LOSARTAN/HCTZ (hydrochlorothiazide 12.5 mg and losartan potassium 50 mg oral tablet) TEVA CANADA LIMITED,Active,9000672,hydrochlorothiazide 12.5 mg and losartan potassium 50 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84745,Marketed,2012-01-25,02362449,Sandoz Losartan HCTZ,2,C09DA01,Losartan and diuretics,Tablet,Oral,02362449,SANDOZ LOSARTAN HCT (hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001208,hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86273,Marketed,2012-01-25,02377144,Teva-Losartan/HCTZ,2,C09DA01,Losartan and diuretics,Tablet,Oral,02377144,TEVA-LOSARTAN/HCTZ (hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet) TEVA CANADA LIMITED,Active,9001208,hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86274,Marketed,2012-01-25,02377152,Teva-Losartan/HCTZ,2,C09DA01,Losartan and diuretics,Tablet,Oral,02377152,TEVA-LOSARTAN/HCTZ (hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet) TEVA CANADA LIMITED,Active,9000878,hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87449,Marketed,2025-10-07,02388960,Losartan HCTZ,2,C09DA01,Losartan and diuretics,Tablet,Oral,02388960,LOSARTAN HCT (hydrochlorothiazide 12.5 mg and losartan potassium 50 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000672,hydrochlorothiazide 12.5 mg and losartan potassium 50 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87450,Marketed,2025-10-07,02388979,Losartan HCTZ,2,C09DA01,Losartan and diuretics,Tablet,Oral,02388979,LOSARTAN HCT (hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001208,hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87451,Marketed,2025-10-07,02388987,Losartan HCTZ DS,2,C09DA01,Losartan and diuretics,Tablet,Oral,02388987,LOSARTAN HCT DS (hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000878,hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87515,Marketed,2024-06-14,02389657,Mint-Losartan/HCTZ,2,C09DA01,Losartan and diuretics,Tablet,Oral,02389657,MINT-LOSARTAN/HCTZ (hydrochlorothiazide 12.5 mg and losartan potassium 50 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000672,hydrochlorothiazide 12.5 mg and losartan potassium 50 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87516,Marketed,2024-06-14,02389665,Mint-Losartan/HCTZ,2,C09DA01,Losartan and diuretics,Tablet,Oral,02389665,MINT-LOSARTAN/HCTZ (hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001208,hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87517,Marketed,2024-06-14,02389673,Mint-Losartan/HCTZ DS,2,C09DA01,Losartan and diuretics,Tablet,Oral,02389673,MINT-LOSARTAN/HCTZ DS (hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000878,hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87750,Marketed,2012-09-04,02392224,PMS-Losartan-HCTZ,2,C09DA01,Losartan and diuretics,Tablet,Oral,02392224,PMS-LOSARTAN-HCTZ (hydrochlorothiazide 12.5 mg and losartan potassium 50 mg oral tablet) PHARMASCIENCE INC,Active,9000672,hydrochlorothiazide 12.5 mg and losartan potassium 50 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87751,Marketed,2012-09-04,02392232,PMS-Losartan-HCTZ,2,C09DA01,Losartan and diuretics,Tablet,Oral,02392232,PMS-LOSARTAN-HCTZ (hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet) PHARMASCIENCE INC,Active,9001208,hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87752,Marketed,2012-09-04,02392240,PMS-Losartan-HCTZ,2,C09DA01,Losartan and diuretics,Tablet,Oral,02392240,PMS-LOSARTAN-HCTZ (hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet) PHARMASCIENCE INC,Active,9000878,hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90835,Marketed,2014-04-29,02423642,Auro-Losartan HCTZ,2,C09DA01,Losartan and diuretics,Tablet,Oral,02423642,AURO-LOSARTAN HCT (hydrochlorothiazide 12.5 mg and losartan potassium 50 mg oral tablet) AURO PHARMA INC,Active,9000672,hydrochlorothiazide 12.5 mg and losartan potassium 50 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90836,Marketed,2014-04-29,02423650,Auro-Losartan HCTZ,2,C09DA01,Losartan and diuretics,Tablet,Oral,02423650,AURO-LOSARTAN HCT (hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet) AURO PHARMA INC,Active,9001208,hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90837,Marketed,2014-04-29,02423669,Auro-Losartan HCTZ,2,C09DA01,Losartan and diuretics,Tablet,Oral,02423669,AURO-LOSARTAN HCT (hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet) AURO PHARMA INC,Active,9000878,hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91215,Marketed,2014-07-25,02427648,Losartan/HCTZ,2,C09DA01,Losartan and diuretics,Tablet,Oral,02427648,LOSARTAN/HCTZ (hydrochlorothiazide 12.5 mg and losartan potassium 50 mg oral tablet) SANIS HEALTH INC,Active,9000672,hydrochlorothiazide 12.5 mg and losartan potassium 50 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91216,Marketed,2020-08-25,02427656,Losartan/HCTZ,2,C09DA01,Losartan and diuretics,Tablet,Oral,02427656,LOSARTAN/HCTZ (hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet) SANIS HEALTH INC,Active,9001208,hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91217,Marketed,2014-07-25,02427664,Losartan/HCTZ,2,C09DA01,Losartan and diuretics,Tablet,Oral,02427664,LOSARTAN/HCTZ (hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet) SANIS HEALTH INC,Active,9000878,hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80634,Marketed,2009-06-24,02320924,Alrex,1,S01BA14,Loteprednol,Suspension,Ophthalmic,02320924,ALREX (loteprednol etabonate 0.2 % ophthalmic drops) BAUSCH & LOMB INC,Active,9004561,loteprednol etabonate 0.2 % ophthalmic drops,8001285,loteprednol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
80652,Marketed,2009-06-24,02321114,Lotemax,1,S01BA14,Loteprednol,Suspension,Ophthalmic,02321114,LOTEMAX (loteprednol etabonate 0.5 % ophthalmic drops) BAUSCH & LOMB INC,Active,9004562,loteprednol etabonate 0.5 % ophthalmic drops,8001285,loteprednol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
90664,Marketed,2014-10-29,02421941,Lotemax Ointment,1,S01BA14,Loteprednol,Ointment,Ophthalmic,02421941,LOTEMAX OINTMENT (loteprednol etabonate 0.5 % ophthalmic ointment) BAUSCH & LOMB INC,Active,9005607,loteprednol etabonate 0.5 % ophthalmic ointment,8001285,loteprednol,54485002,Ophthalmic,385123004,Ophthalmic ointment,,,,,,Prescription
92020,Marketed,2015-06-25,02435853,Lotemax Gel,1,S01BA14,Loteprednol,Gel,Ophthalmic,02435853,LOTEMAX GEL (loteprednol etabonate 0.5 % ophthalmic gel) BAUSCH & LOMB INC,Active,9005735,loteprednol etabonate 0.5 % ophthalmic gel,8001285,loteprednol,54485002,Ophthalmic,385100002,Gel,,,,,,Prescription
43279,Marketed,2021-06-15,02220172,Lovastatin,1,C10AA02,Lovastatin,Tablet,Oral,02220172,LOVASTATIN (lovastatin 20 mg oral tablet) AA PHARMA INC,Active,9003074,lovastatin 20 mg oral tablet,8001286,lovastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
43280,Marketed,2021-06-15,02220180,Lovastatin,1,C10AA02,Lovastatin,Tablet,Oral,02220180,LOVASTATIN (lovastatin 40 mg oral tablet) AA PHARMA INC,Active,9003075,lovastatin 40 mg oral tablet,8001286,lovastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
34560,Marketed,2005-10-06,02169991,Loxapac Im,1,N05AH01,Loxapine,Solution,Intramuscular,02169991,LOXAPAC IM (loxapine (loxapine hydrochloride) 50 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9013004,loxapine (loxapine hydrochloride) 50 mg per 1 mL solution for injection ampoule,8001666,loxapine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
50116,Marketed,2013-09-20,02230838,Xylac,1,N05AH01,Loxapine,Tablet,Oral,02230838,XYLAC (loxapine (loxapine succinate) 10 mg oral tablet) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9003239,loxapine (loxapine succinate) 10 mg oral tablet,8001666,loxapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
50117,Marketed,2013-11-11,02230839,Xylac,1,N05AH01,Loxapine,Tablet,Oral,02230839,XYLAC (loxapine (loxapine succinate) 25 mg oral tablet) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9003116,loxapine (loxapine succinate) 25 mg oral tablet,8001666,loxapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
66699,Marketed,2014-04-14,02242868,Xylac,1,N05AH01,Loxapine,Tablet,Oral,02242868,XYLAC (loxapine (loxapine succinate) 2.5 mg oral tablet) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9003526,loxapine (loxapine succinate) 2.5 mg oral tablet,8001666,loxapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101476,Marketed,2022-05-05,02525755,Oxlumo,1,A16AX18,Lumasiran,Solution,Subcutaneous,02525755,OXLUMO (lumasiran (lumasiran sodium) 94.5 mg per 0.5 mL solution for injection vial) ALNYLAM NETHERLANDS B.V.,Active,9014722,lumasiran (lumasiran sodium) 94.5 mg per 0.5 mL solution for injection vial,8002424,lumasiran,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
100317,Marketed,2023-10-30,02513986,Auro-Lurasidone,1,N05AE05,Lurasidone,Tablet,Oral,02513986,AURO-LURASIDONE (lurasidone hydrochloride 20 mg oral tablet) AURO PHARMA INC,Active,9005491,lurasidone hydrochloride 20 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100318,Marketed,2023-10-30,02513994,Auro-Lurasidone,1,N05AE05,Lurasidone,Tablet,Oral,02513994,AURO-LURASIDONE (lurasidone hydrochloride 40 mg oral tablet) AURO PHARMA INC,Active,9005098,lurasidone hydrochloride 40 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100319,Marketed,2023-10-30,02514001,Auro-Lurasidone,1,N05AE05,Lurasidone,Tablet,Oral,02514001,AURO-LURASIDONE (lurasidone hydrochloride 60 mg oral tablet) AURO PHARMA INC,Active,9005467,lurasidone hydrochloride 60 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100320,Marketed,2023-10-30,02514028,Auro-Lurasidone,1,N05AE05,Lurasidone,Tablet,Oral,02514028,AURO-LURASIDONE (lurasidone hydrochloride 80 mg oral tablet) AURO PHARMA INC,Active,9005096,lurasidone hydrochloride 80 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100321,Marketed,2023-10-30,02514036,Auro-Lurasidone,1,N05AE05,Lurasidone,Tablet,Oral,02514036,AURO-LURASIDONE (lurasidone hydrochloride 120 mg oral tablet) AURO PHARMA INC,Active,9005097,lurasidone hydrochloride 120 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100577,Marketed,2022-05-02,02516438,JAMP Lurasidone,1,N05AE05,Lurasidone,Tablet,Oral,02516438,JAMP LURASIDONE (lurasidone hydrochloride 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9005491,lurasidone hydrochloride 20 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100578,Marketed,2022-05-02,02516446,JAMP Lurasidone,1,N05AE05,Lurasidone,Tablet,Oral,02516446,JAMP LURASIDONE (lurasidone hydrochloride 40 mg oral tablet) JAMP PHARMA CORPORATION,Active,9005098,lurasidone hydrochloride 40 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100579,Marketed,2022-05-02,02516454,JAMP Lurasidone,1,N05AE05,Lurasidone,Tablet,Oral,02516454,JAMP LURASIDONE (lurasidone hydrochloride 60 mg oral tablet) JAMP PHARMA CORPORATION,Active,9005467,lurasidone hydrochloride 60 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100580,Marketed,2022-05-02,02516462,JAMP Lurasidone,1,N05AE05,Lurasidone,Tablet,Oral,02516462,JAMP LURASIDONE (lurasidone hydrochloride 80 mg oral tablet) JAMP PHARMA CORPORATION,Active,9005096,lurasidone hydrochloride 80 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100581,Marketed,2022-09-02,02516470,JAMP Lurasidone,1,N05AE05,Lurasidone,Tablet,Oral,02516470,JAMP LURASIDONE (lurasidone hydrochloride 120 mg oral tablet) JAMP PHARMA CORPORATION,Active,9005097,lurasidone hydrochloride 120 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101030,Marketed,2022-04-07,02521075,Sandoz Lurasidone,1,N05AE05,Lurasidone,Tablet,Oral,02521075,SANDOZ LURASIDONE (lurasidone hydrochloride 20 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005491,lurasidone hydrochloride 20 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101032,Marketed,2022-04-07,02521091,Sandoz Lurasidone,1,N05AE05,Lurasidone,Tablet,Oral,02521091,SANDOZ LURASIDONE (lurasidone hydrochloride 40 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005098,lurasidone hydrochloride 40 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101033,Marketed,2022-04-07,02521105,Sandoz Lurasidone,1,N05AE05,Lurasidone,Tablet,Oral,02521105,SANDOZ LURASIDONE (lurasidone hydrochloride 60 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005467,lurasidone hydrochloride 60 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101034,Marketed,2022-04-07,02521113,Sandoz Lurasidone,1,N05AE05,Lurasidone,Tablet,Oral,02521113,SANDOZ LURASIDONE (lurasidone hydrochloride 80 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005096,lurasidone hydrochloride 80 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101035,Marketed,2023-06-01,02521121,Sandoz Lurasidone,1,N05AE05,Lurasidone,Tablet,Oral,02521121,SANDOZ LURASIDONE (lurasidone hydrochloride 120 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005097,lurasidone hydrochloride 120 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101145,Marketed,2024-09-23,02522314,Nra-Lurasidone,1,N05AE05,Lurasidone,Tablet,Oral,02522314,NRA-LURASIDONE (lurasidone hydrochloride 20 mg oral tablet) NORA PHARMA INC,Active,9005491,lurasidone hydrochloride 20 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101146,Marketed,2024-09-23,02522322,Nra-Lurasidone,1,N05AE05,Lurasidone,Tablet,Oral,02522322,NRA-LURASIDONE (lurasidone hydrochloride 40 mg oral tablet) NORA PHARMA INC,Active,9005098,lurasidone hydrochloride 40 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101147,Marketed,2024-09-23,02522330,Nra-Lurasidone,1,N05AE05,Lurasidone,Tablet,Oral,02522330,NRA-LURASIDONE (lurasidone hydrochloride 60 mg oral tablet) NORA PHARMA INC,Active,9005467,lurasidone hydrochloride 60 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101148,Marketed,2024-09-23,02522349,Nra-Lurasidone,1,N05AE05,Lurasidone,Tablet,Oral,02522349,NRA-LURASIDONE (lurasidone hydrochloride 80 mg oral tablet) NORA PHARMA INC,Active,9005096,lurasidone hydrochloride 80 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103744,Marketed,2024-12-17,02548585,Lurasidone,1,N05AE05,Lurasidone,Tablet,Oral,02548585,LURASIDONE (lurasidone hydrochloride 20 mg oral tablet) SANIS HEALTH INC,Active,9005491,lurasidone hydrochloride 20 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103745,Marketed,2024-12-17,02548593,Lurasidone,1,N05AE05,Lurasidone,Tablet,Oral,02548593,LURASIDONE (lurasidone hydrochloride 40 mg oral tablet) SANIS HEALTH INC,Active,9005098,lurasidone hydrochloride 40 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103746,Marketed,2024-12-17,02548607,Lurasidone,1,N05AE05,Lurasidone,Tablet,Oral,02548607,LURASIDONE (lurasidone hydrochloride 60 mg oral tablet) SANIS HEALTH INC,Active,9005467,lurasidone hydrochloride 60 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103747,Marketed,2024-12-17,02548615,Lurasidone,1,N05AE05,Lurasidone,Tablet,Oral,02548615,LURASIDONE (lurasidone hydrochloride 80 mg oral tablet) SANIS HEALTH INC,Active,9005096,lurasidone hydrochloride 80 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87334,Marketed,2025-09-08,02387751,Latuda,1,N05AE05,Lurasidone,Tablet,Oral,02387751,"LATUDA (lurasidone hydrochloride 40 mg oral tablet) SUMITOMO PHARMA CANADA, INC.",Active,9005098,lurasidone hydrochloride 40 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87335,Marketed,2024-01-19,02387778,Latuda,1,N05AE05,Lurasidone,Tablet,Oral,02387778,"LATUDA (lurasidone hydrochloride 80 mg oral tablet) SUMITOMO PHARMA CANADA, INC.",Active,9005096,lurasidone hydrochloride 80 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89804,Marketed,2024-01-19,02413361,Latuda,1,N05AE05,Lurasidone,Tablet,Oral,02413361,"LATUDA (lurasidone hydrochloride 60 mg oral tablet) SUMITOMO PHARMA CANADA, INC.",Active,9005467,lurasidone hydrochloride 60 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90675,Marketed,2024-01-19,02422050,Latuda,1,N05AE05,Lurasidone,Tablet,Oral,02422050,"LATUDA (lurasidone hydrochloride 20 mg oral tablet) SUMITOMO PHARMA CANADA, INC.",Active,9005491,lurasidone hydrochloride 20 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99391,Marketed,2022-05-02,02504499,Taro-Lurasidone,1,N05AE05,Lurasidone,Tablet,Oral,02504499,TARO-LURASIDONE (lurasidone hydrochloride 20 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9005491,lurasidone hydrochloride 20 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99392,Marketed,2022-05-02,02504502,Taro-Lurasidone,1,N05AE05,Lurasidone,Tablet,Oral,02504502,TARO-LURASIDONE (lurasidone hydrochloride 40 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9005098,lurasidone hydrochloride 40 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99393,Marketed,2022-05-02,02504510,Taro-Lurasidone,1,N05AE05,Lurasidone,Tablet,Oral,02504510,TARO-LURASIDONE (lurasidone hydrochloride 60 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9005467,lurasidone hydrochloride 60 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99394,Marketed,2022-05-02,02504529,Taro-Lurasidone,1,N05AE05,Lurasidone,Tablet,Oral,02504529,TARO-LURASIDONE (lurasidone hydrochloride 80 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9005096,lurasidone hydrochloride 80 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99395,Marketed,2022-05-02,02504537,Taro-Lurasidone,1,N05AE05,Lurasidone,Tablet,Oral,02504537,TARO-LURASIDONE (lurasidone hydrochloride 120 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9005097,lurasidone hydrochloride 120 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99523,Marketed,2022-05-02,02505878,PMS-Lurasidone,1,N05AE05,Lurasidone,Tablet,Oral,02505878,PMS-LURASIDONE (lurasidone hydrochloride 20 mg oral tablet) PHARMASCIENCE INC,Active,9005491,lurasidone hydrochloride 20 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99524,Marketed,2022-05-02,02505886,PMS-Lurasidone,1,N05AE05,Lurasidone,Tablet,Oral,02505886,PMS-LURASIDONE (lurasidone hydrochloride 40 mg oral tablet) PHARMASCIENCE INC,Active,9005098,lurasidone hydrochloride 40 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99525,Marketed,2022-05-02,02505894,PMS-Lurasidone,1,N05AE05,Lurasidone,Tablet,Oral,02505894,PMS-LURASIDONE (lurasidone hydrochloride 60 mg oral tablet) PHARMASCIENCE INC,Active,9005467,lurasidone hydrochloride 60 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99526,Marketed,2022-05-02,02505908,PMS-Lurasidone,1,N05AE05,Lurasidone,Tablet,Oral,02505908,PMS-LURASIDONE (lurasidone hydrochloride 80 mg oral tablet) PHARMASCIENCE INC,Active,9005096,lurasidone hydrochloride 80 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99527,Marketed,2022-05-02,02505916,PMS-Lurasidone,1,N05AE05,Lurasidone,Tablet,Oral,02505916,PMS-LURASIDONE (lurasidone hydrochloride 120 mg oral tablet) PHARMASCIENCE INC,Active,9005097,lurasidone hydrochloride 120 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101003,Marketed,2021-12-06,02520834,Zepzelca,1,L01XX69,Lurbinectedin,Powder,Intravenous,02520834,ZEPZELCA (lurbinectedin 4 mg per vial powder for solution for injection) JAZZ PHARMACEUTICALS IRELAND LIMITED,Active,9014641,lurbinectedin 4 mg per vial powder for solution for injection,8002403,lurbinectedin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99492,Marketed,2025-02-24,02505541,Reblozyl,1,B03XA06,Luspatercept,Powder for solution,Subcutaneous,02505541,REBLOZYL (luspatercept 25 mg per vial powder for solution for injection) BRISTOL-MYERS SQUIBB CANADA,Active,9014549,luspatercept 25 mg per vial powder for solution for injection,8002376,luspatercept,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
99492,Marketed,2025-02-24,02505541,Reblozyl,1,B03XA06,Luspatercept,Powder for solution,Subcutaneous,02505541,REBLOZYL (luspatercept 25 mg per vial powder for solution for injection) BRISTOL-MYERS SQUIBB CANADA,Active,9014549,luspatercept 25 mg per vial powder for solution for injection,8002376,luspatercept,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
99493,Marketed,2025-02-19,02505568,Reblozyl,1,B03XA06,Luspatercept,Powder for solution,Subcutaneous,02505568,REBLOZYL (luspatercept 75 mg per vial powder for solution for injection) BRISTOL-MYERS SQUIBB CANADA,Active,9014550,luspatercept 75 mg per vial powder for solution for injection,8002376,luspatercept,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
99493,Marketed,2025-02-19,02505568,Reblozyl,1,B03XA06,Luspatercept,Powder for solution,Subcutaneous,02505568,REBLOZYL (luspatercept 75 mg per vial powder for solution for injection) BRISTOL-MYERS SQUIBB CANADA,Active,9014550,luspatercept 75 mg per vial powder for solution for injection,8002376,luspatercept,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
97485,Marketed,2024-02-28,02484552,Lutathera,1,V10XX04,Lutetium (177lu) oxodotreotide,Solution,Intravenous,,,,,,,,,,,,,,,,,Schedule C
101939,Marketed,2024-09-02,02530198,Pluvicto,1,V10XX05,Lutetium (177lu) vipivotide tetraxetan,Solution,Intravenous,,,,,,,,,,,,,,,,,Schedule C
75446,Marketed,2005-06-28,02269066,Luveris,1,G03GA07,Lutropin alfa,Powder for solution,Subcutaneous,02269066,"LUVERIS (lutropin alfa 75 unit per vial powder for solution for injection with diluent solution) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013222,lutropin alfa 75 unit per vial powder for solution for injection with diluent solution,8001843,lutropin alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
75446,Marketed,2005-06-28,02269066,Luveris,1,G03GA07,Lutropin alfa,Powder for solution,Subcutaneous,02269066,"LUVERIS (lutropin alfa 75 unit per vial powder for solution for injection with diluent solution) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013222,lutropin alfa 75 unit per vial powder for solution for injection with diluent solution,8001843,lutropin alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
106406,Marketed,2026-01-27,02561069,Opsumit,1,C02KX04,Macitentan,Tablet for suspension,Oral,02561069,OPSUMIT (macitentan 2.5 mg dispersible oral tablet) JANSSEN INC,Active,9015359,macitentan 2.5 mg dispersible oral tablet,8001494,macitentan,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet,1.0,,,Prescription
90029,Marketed,2019-09-09,02415690,Opsumit,1,C02KX04,Macitentan,Tablet,Oral,02415690,OPSUMIT (macitentan 10 mg oral tablet) JANSSEN INC,Active,9005397,macitentan 10 mg oral tablet,8001494,macitentan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101031,Marketed,2021-11-25,02521083,Opsynvi,2,C02KX54,Macitentan and tadalafil,Tablet,Oral,02521083,OPSYNVI (macitentan 10 mg and tadalafil 40 mg oral tablet) JANSSEN INC,Active,9014625,macitentan 10 mg and tadalafil 40 mg oral tablet,8002396,macitentan and tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100998,Marketed,2023-01-30,02520796,Peg 3350,1,A06AD15,Macrogol,Powder for solution,Oral,02520796,PEG 3350 (polyethylene glycol 3350 100 % powder for oral solution) ANGITA PHARMA INC.,Active,9004589,polyethylene glycol 3350 100 % powder for oral solution,8002072,polyethylene glycol 3350,26643006,Oral,385026009,Powder for oral solution,,,,,,Non-Prescription Drugs
103776,Marketed,2025-12-16,02548933,Laxative,1,A06AD15,Macrogol,Powder for solution,Oral,02548933,LAXATIVE (polyethylene glycol 3350 100 % powder for oral solution) PHARMASCIENCE INC,Active,9004589,polyethylene glycol 3350 100 % powder for oral solution,8002072,polyethylene glycol 3350,26643006,Oral,385026009,Powder for oral solution,,,,,,Non-Prescription Drugs
80321,Marketed,2008-12-10,02317680,Lax-A-Day,1,A06AD15,Macrogol,Powder for solution,Oral,02317680,LAX-A-DAY (polyethylene glycol 3350 100 % powder for oral solution) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9004589,polyethylene glycol 3350 100 % powder for oral solution,8002072,polyethylene glycol 3350,26643006,Oral,385026009,Powder for oral solution,,,,,,Non-Prescription Drugs
80366,Marketed,2017-01-12,02318164,Restoralax,1,A06AD15,Macrogol,Powder for solution,Oral,02318164,RESTORALAX (polyethylene glycol 3350 100 % powder for oral solution) BAYER INC,Active,9004589,polyethylene glycol 3350 100 % powder for oral solution,8002072,polyethylene glycol 3350,26643006,Oral,385026009,Powder for oral solution,,,,,,Non-Prescription Drugs
81040,Marketed,2011-06-28,02324989,Clearlax,1,A06AD15,Macrogol,Powder for solution,Oral,02324989,CLEARLAX (polyethylene glycol 3350 100 % powder for oral solution) PERRIGO INTERNATIONAL,Active,9004589,polyethylene glycol 3350 100 % powder for oral solution,8002072,polyethylene glycol 3350,26643006,Oral,385026009,Powder for oral solution,,,,,,Non-Prescription Drugs
83209,Marketed,2023-01-04,02346672,Relaxa,1,A06AD15,Macrogol,Powder for solution,Oral,02346672,RELAXA (polyethylene glycol 3350 100 % powder for oral solution) MEDEXUS PHARMACEUTICALS INC.,Active,9004589,polyethylene glycol 3350 100 % powder for oral solution,8002072,polyethylene glycol 3350,26643006,Oral,385026009,Powder for oral solution,,,,,,Non-Prescription Drugs
84310,Marketed,2012-03-28,02358034,Peg 3350,1,A06AD15,Macrogol,Powder for solution,Oral,02358034,PEG 3350 (polyethylene glycol 3350 100 % powder for oral solution) MEDISCA PHARMACEUTIQUE INC,Active,9004589,polyethylene glycol 3350 100 % powder for oral solution,8002072,polyethylene glycol 3350,26643006,Oral,385026009,Powder for oral solution,,,,,,Non-Prescription Drugs
85934,Marketed,2015-10-04,02374137,Emolax,1,A06AD15,Macrogol,Powder for solution,Oral,02374137,EMOLAX (polyethylene glycol 3350 100 % powder for oral solution) JAMP PHARMA CORPORATION,Active,9004589,polyethylene glycol 3350 100 % powder for oral solution,8002072,polyethylene glycol 3350,26643006,Oral,385026009,Powder for oral solution,,,,,,Non-Prescription Drugs
93607,Marketed,2025-06-19,02450070,Colaxor,1,A06AD15,Macrogol,Powder for solution,Oral,02450070,COLAXOR (polyethylene glycol 3350 100 % powder for oral solution) MANTRA PHARMA INC,Active,9004589,polyethylene glycol 3350 100 % powder for oral solution,8002072,polyethylene glycol 3350,26643006,Oral,385026009,Powder for oral solution,,,,,,Non-Prescription Drugs
93973,Marketed,2016-08-30,02453193,Lax-A-Day Pharma,1,A06AD15,Macrogol,Powder for solution,Oral,02453193,LAX-A-DAY PHARMA (polyethylene glycol 3350 100 % powder for oral solution) PHARMASCIENCE INC,Active,9004589,polyethylene glycol 3350 100 % powder for oral solution,8002072,polyethylene glycol 3350,26643006,Oral,385026009,Powder for oral solution,,,,,,Non-Prescription Drugs
94758,Marketed,2017-08-20,02460297,Comfilax,1,A06AD15,Macrogol,Powder for solution,Oral,02460297,COMFILAX (polyethylene glycol 3350 100 % powder for oral solution) CELLCHEM PHARMACEUTICALS INC.,Active,9004589,polyethylene glycol 3350 100 % powder for oral solution,8002072,polyethylene glycol 3350,26643006,Oral,385026009,Powder for oral solution,,,,,,Non-Prescription Drugs
96245,Marketed,2019-04-26,02473119,Hydralax,1,A06AD15,Macrogol,Powder for solution,Oral,02473119,HYDRALAX (polyethylene glycol 3350 100 % powder for oral solution) JUNO OTC INC,Active,9004589,polyethylene glycol 3350 100 % powder for oral solution,8002072,polyethylene glycol 3350,26643006,Oral,385026009,Powder for oral solution,,,,,,Non-Prescription Drugs
6616,Marketed,2013-04-01,00677442,Colyte,5,A06AD65,"Macrogol, combinations",Powder for solution,"Oral,Nasogastric",,,,,,,,,,,,,,,,,Ethical
84451,Marketed,2020-08-13,02359499,Moviprep,6,A06AD65,"Macrogol, combinations",Powder for solution,Oral,,,,,,,,,,,,,,,,,Ethical
86414,Marketed,2025-06-17,02378329,Jamplyte,5,A06AD65,"Macrogol, combinations",Powder,Oral,,,,,,,,,,,,,,,,,Ethical
100227,Marketed,2021-10-01,02513161,"Magnesium Sulfate Injection, BP 49.3%",1,B05XA05,Magnesium sulphate,Solution,Intravenous,02513161,"MAGNESIUM SULFATE INJECTION, BP 49.3% (magnesium sulfate 493 mg per mL solution for injection 500 mL bag) BAXTER CORPORATION",Active,9014610,magnesium sulfate 493 mg per mL solution for injection 500 mL bag,8001845,magnesium sulfate,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Ethical
103075,Marketed,2024-11-18,02542153,Magnesium Sulfate In Water For Injection,1,B05XA05,Magnesium sulphate,Solution,Intravenous,77701168,MAGNESIUM SULFATE IN WATER FOR INJECTION (magnesium sulfate 2000 mg per 50 mL solution for injection bag) BAXTER CORPORATION,Active,9015139,magnesium sulfate 2000 mg per 50 mL solution for injection bag,8001845,magnesium sulfate,738984000,Parenteral,385219001,Solution for injection,732982009,Bag,,,,Ethical
103075,Marketed,2024-11-18,02542153,Magnesium Sulfate In Water For Injection,1,B05XA05,Magnesium sulphate,Solution,Intravenous,77701169,MAGNESIUM SULFATE IN WATER FOR INJECTION (magnesium sulfate 4000 mg per 100 mL solution for injection bag) BAXTER CORPORATION,Active,9015140,magnesium sulfate 4000 mg per 100 mL solution for injection bag,8001845,magnesium sulfate,738984000,Parenteral,385219001,Solution for injection,732982009,Bag,,,,Ethical
106513,Marketed,2026-04-21,02562235,Magnesium Sulfate Injection USP,1,B05XA05,Magnesium sulphate,Solution,"Intramuscular,Intravenous",77701205,MAGNESIUM SULFATE INJECTION USP (magnesium sulfate 500 mg per mL solution for injection 50 mL vial) STERIMAX INC,Active,9013456,magnesium sulfate 500 mg per mL solution for injection 50 mL vial,8001845,magnesium sulfate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Non-Prescription Drugs
106513,Marketed,2026-04-21,02562235,Magnesium Sulfate Injection USP,1,B05XA05,Magnesium sulphate,Solution,"Intramuscular,Intravenous",77701206,MAGNESIUM SULFATE INJECTION USP (magnesium sulfate 5000 mg per 10 mL solution for injection vial) STERIMAX INC,Active,9013457,magnesium sulfate 5000 mg per 10 mL solution for injection vial,8001845,magnesium sulfate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Non-Prescription Drugs
106513,Marketed,2026-04-21,02562235,Magnesium Sulfate Injection USP,1,B05XA05,Magnesium sulphate,Solution,"Intramuscular,Intravenous",77701205,MAGNESIUM SULFATE INJECTION USP (magnesium sulfate 500 mg per mL solution for injection 50 mL vial) STERIMAX INC,Active,9013456,magnesium sulfate 500 mg per mL solution for injection 50 mL vial,8001845,magnesium sulfate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
106513,Marketed,2026-04-21,02562235,Magnesium Sulfate Injection USP,1,B05XA05,Magnesium sulphate,Solution,"Intramuscular,Intravenous",77701206,MAGNESIUM SULFATE INJECTION USP (magnesium sulfate 5000 mg per 10 mL solution for injection vial) STERIMAX INC,Active,9013457,magnesium sulfate 5000 mg per 10 mL solution for injection vial,8001845,magnesium sulfate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
19701,Marketed,2022-12-14,02139499,"Magnesium Sulfate Injection, USP",1,B05XA05,Magnesium sulphate,Solution,"Intramuscular,Intravenous",77700916,"MAGNESIUM SULFATE INJECTION, USP (magnesium sulfate 500 mg per mL solution for injection 50 mL vial) FRESENIUS KABI CANADA LTD",Active,9013456,magnesium sulfate 500 mg per mL solution for injection 50 mL vial,8001845,magnesium sulfate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
19701,Marketed,2022-12-14,02139499,"Magnesium Sulfate Injection, USP",1,B05XA05,Magnesium sulphate,Solution,"Intramuscular,Intravenous",77700917,"MAGNESIUM SULFATE INJECTION, USP (magnesium sulfate 5000 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013457,magnesium sulfate 5000 mg per 10 mL solution for injection vial,8001845,magnesium sulfate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
3088,Marketed,1978-12-31,00392618,Magnesium Sulfate Injection USP,1,B05XA05,Magnesium sulphate,Liquid,"Intravenous,Intramuscular",00392618,MAGNESIUM SULFATE INJECTION USP (magnesium sulfate 2000 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013455,magnesium sulfate 2000 mg per 10 mL solution for injection vial,8001845,magnesium sulfate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
10516,Marketed,2020-05-21,00060437,Osmitrol Injection 20%,1,B05BC01,Mannitol,Solution,Intravenous,00060437,OSMITROL INJECTION 20% (mannitol 20 % solution for injection 500 mL bag) BAXTER CORPORATION,Active,9013920,mannitol 20 % solution for injection 500 mL bag,8002138,mannitol,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Ethical
10517,Marketed,2020-05-21,00060410,Osmitrol Injection 10%,1,B05BC01,Mannitol,Solution,Intravenous,00060410,OSMITROL INJECTION 10% (mannitol 10 % solution for injection 1000 mL bag) BAXTER CORPORATION,Active,9013919,mannitol 10 % solution for injection 1000 mL bag,8002138,mannitol,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Ethical
1181,Marketed,2017-11-10,00038024,Mannitol Injection USP,1,B05BC01,Mannitol,Solution,Intravenous,00038024,MANNITOL INJECTION USP (mannitol 25 % solution for injection 50 mL vial) PFIZER CANADA ULC,Active,9013921,mannitol 25 % solution for injection 50 mL vial,8002138,mannitol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
1740,Marketed,2020-03-05,00038016,Mannitol Injection USP,1,B05BC01,Mannitol,Solution,Intravenous,00038016,MANNITOL INJECTION USP (mannitol 20 % solution for injection 500 mL bag) ICU MEDICAL CANADA INC,Active,9013920,mannitol 20 % solution for injection 500 mL bag,8002138,mannitol,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Ethical
67055,Marketed,2022-10-19,02243176,"Mannitol Injection, USP",1,B05BC01,Mannitol,Solution,Intravenous,02243176,"MANNITOL INJECTION, USP (mannitol 25 % solution for injection 50 mL vial) FRESENIUS KABI CANADA LTD",Active,9013921,mannitol 25 % solution for injection 50 mL vial,8002138,mannitol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
102861,Marketed,2023-08-11,02539888,Livmarli,1,A05AX04,Maraliximab chloride,Solution,Oral,02539888,"LIVMARLI (maralixibat (maralixibat chloride) 9.5 mg per mL oral solution) MIRUM PHARMACEUTICALS, INC.",Active,9014905,maralixibat (maralixibat chloride) 9.5 mg per mL oral solution,8002476,maralixibat,26643006,Oral,385023001,Oral solution,,,,,,Prescription
106785,Marketed,2026-04-13,02565234,Livmarli,1,A05AX04,Maraliximab chloride,Tablet,Oral,02565234,"LIVMARLI (maralixibat (maralixibat chloride) 10 mg oral tablet) MIRUM PHARMACEUTICALS, INC.",Active,9015397,maralixibat (maralixibat chloride) 10 mg oral tablet,8002476,maralixibat,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,,Prescription
106786,Marketed,2026-04-13,02565242,Livmarli,1,A05AX04,Maraliximab chloride,Tablet,Oral,02565242,"LIVMARLI (maralixibat (maralixibat chloride) 15 mg oral tablet) MIRUM PHARMACEUTICALS, INC.",Active,9015398,maralixibat (maralixibat chloride) 15 mg oral tablet,8002476,maralixibat,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,,Prescription
106787,Marketed,2026-04-13,02565250,Livmarli,1,A05AX04,Maraliximab chloride,Tablet,Oral,02565250,"LIVMARLI (maralixibat (maralixibat chloride) 20 mg oral tablet) MIRUM PHARMACEUTICALS, INC.",Active,9015400,maralixibat (maralixibat chloride) 20 mg oral tablet,8002476,maralixibat,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,,Prescription
106788,Marketed,2026-04-13,02565269,Livmarli,1,A05AX04,Maraliximab chloride,Tablet,Oral,02565269,"LIVMARLI (maralixibat (maralixibat chloride) 30 mg oral tablet) MIRUM PHARMACEUTICALS, INC.",Active,9015401,maralixibat (maralixibat chloride) 30 mg oral tablet,8002476,maralixibat,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,,Prescription
106789,Marketed,2026-04-13,02565277,Livmarli,1,A05AX04,Maraliximab chloride,Solution,Oral,02565277,"LIVMARLI (maralixibat (maralixibat chloride) 19 mg per mL oral solution) MIRUM PHARMACEUTICALS, INC.",Active,9015399,maralixibat (maralixibat chloride) 19 mg per mL oral solution,8002476,maralixibat,26643006,Oral,385023001,Oral solution,,,,,,Prescription
106485,Marketed,2026-05-11,02561921,Waymade-Maraviroc,1,J05AX09,Maraviroc,Tablet,Oral,02561921,WAYMADE-MARAVIROC (maraviroc 150 mg oral tablet) WAYMADE CANADA INC.,Active,9004335,maraviroc 150 mg oral tablet,8001214,maraviroc,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106486,Marketed,2026-05-11,02561948,Waymade-Maraviroc,1,J05AX09,Maraviroc,Tablet,Oral,02561948,WAYMADE-MARAVIROC (maraviroc 300 mg oral tablet) WAYMADE CANADA INC.,Active,9004336,maraviroc 300 mg oral tablet,8001214,maraviroc,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78519,Marketed,2014-08-30,02299844,Celsentri,1,J05AX09,Maraviroc,Tablet,Oral,02299844,CELSENTRI (maraviroc 150 mg oral tablet) VIIV HEALTHCARE ULC,Active,9004335,maraviroc 150 mg oral tablet,8001214,maraviroc,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78520,Marketed,2014-08-30,02299852,Celsentri,1,J05AX09,Maraviroc,Tablet,Oral,02299852,CELSENTRI (maraviroc 300 mg oral tablet) VIIV HEALTHCARE ULC,Active,9004336,maraviroc 300 mg oral tablet,8001214,maraviroc,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101989,Marketed,2022-10-25,02530740,Livtencity,1,J05AX10,Maribavir,Tablet,Oral,02530740,LIVTENCITY (maribavir 200 mg oral tablet) TAKEDA CANADA INC,Active,9014796,maribavir 200 mg oral tablet,8002449,maribavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,,Prescription
102157,Marketed,2023-01-09,02532549,Camzyos,1,C01EB24,Mavacamten,Capsule,Oral,02532549,CAMZYOS (mavacamten 2.5 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9014821,mavacamten 2.5 mg oral capsule,8002458,mavacamten,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
102158,Marketed,2023-01-09,02532557,Camzyos,1,C01EB24,Mavacamten,Capsule,Oral,02532557,CAMZYOS (mavacamten 5 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9014822,mavacamten 5 mg oral capsule,8002458,mavacamten,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
102159,Marketed,2023-06-13,02532565,Camzyos,1,C01EB24,Mavacamten,Capsule,Oral,02532565,CAMZYOS (mavacamten 10 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9014868,mavacamten 10 mg oral capsule,8002458,mavacamten,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
102160,Marketed,2023-08-08,02532573,Camzyos,1,C01EB24,Mavacamten,Capsule,Oral,02532573,CAMZYOS (mavacamten 15 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9014906,mavacamten 15 mg oral capsule,8002458,mavacamten,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
3569,Marketed,2024-12-03,00466085,M-M-R II,3,J07BD52,"Measles, combin. with mumps and rubella, live attenuated",Powder for solution,"Subcutaneous,Intramuscular",,,,,,,,,,,,,,,,,Schedule D
62666,Marketed,2026-02-23,02239208,Priorix,3,J07BD52,"Measles, combin. with mumps and rubella, live attenuated","Powder for solution,Kit","Intramuscular,Subcutaneous",,,,,,,,,,,,,,,,,Schedule D
78322,Marketed,2026-03-02,02297884,Priorix-Tetra,4,J07BD54,"Measles, combinations with mumps, rubella and varicella, live attenuated",Powder for solution,"Intramuscular,Subcutaneous",,,,,,,,,,,,,,,,,Schedule D
88411,Marketed,2014-05-09,02399229,Proquad,4,J07BD54,"Measles, combinations with mumps, rubella and varicella, live attenuated",Powder for solution,Subcutaneous,,,,,,,,,,,,,,,,,Schedule D
4743,Marketed,2001-11-08,00556734,Vermox,1,P02CA01,Mebendazole,Tablet,Oral,00556734,VERMOX (mebendazole 100 mg oral tablet) JANSSEN INC,Active,9001946,mebendazole 100 mg oral tablet,8001398,mebendazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99902,Marketed,2026-05-08,02509733,Increlex,1,H01AC03,Mecasermin,Solution,Subcutaneous,02509733,INCRELEX (mecasermin 40 mg per 4 mL solution for injection vial) ESTEVE PHARMACEUTICALS S.A.,Active,9014475,mecasermin 40 mg per 4 mL solution for injection vial,8002368,mecasermin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99902,Marketed,2026-05-08,02509733,Increlex,1,H01AC03,Mecasermin,Solution,Subcutaneous,02509733,INCRELEX (mecasermin 40 mg per 4 mL solution for injection vial) ESTEVE PHARMACEUTICALS S.A.,Active,9014475,mecasermin 40 mg per 4 mL solution for injection vial,8002368,mecasermin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
13896,Marketed,1993-12-31,02014343,"Carbon Dioxide, Compressed Air Medical G.Mix.",2,V03AN05,Medical air,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
19291,Marketed,2020-08-06,02154781,Medical Air U.S.P.,2,V03AN05,Medical air,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
5684,Marketed,1911-12-31,00572837,Medical Air 100%,1,V03AN05,Medical air,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
11058,Marketed,1997-05-02,00882755,Carbon Dioxide 7.1% W Oxygen,2,V03AN,Medical gases,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
11060,Marketed,2024-07-02,00882771,Carbon Dioxide 23.1% W Oxygen,2,V03AN,Medical gases,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
13885,Marketed,2022-03-08,02014483,Medical Air USP,2,V03AN,Medical gases,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
13920,Marketed,1993-12-31,02014424,"Carbon Monox, Helium, Oxygen, Nitrogen L.D.M.",4,V03AN,Medical gases,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
46353,Marketed,1997-05-02,01906801,Helium-Oxygen Mix Gas,2,V03AN,Medical gases,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
5686,Marketed,1911-12-31,00572853,Oxygen Carbon Dioxide Mixture,2,V03AN,Medical gases,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
5689,Marketed,1911-12-31,00572896,Helium Oxygen Mixture,2,V03AN,Medical gases,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
8185,Marketed,1997-05-02,00588075,Lung Diffusion Test Mix No Ne Co,4,V03AN,Medical gases,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
102646,Marketed,2023-11-15,02537680,Activated Charcoal Capsules,1,A07BA01,Medicinal charcoal,Capsule,Oral,,,,,,,,,,,,,,,,,Non-Prescription Drugs
16533,Marketed,1997-10-17,02056429,Charac-25,1,A07BA01,Medicinal charcoal,Suspension,Oral,,,,,,,,,,,,,,,,,Non-Prescription Drugs
22917,Marketed,2018-05-14,00789674,Activated Charcoal 260 mg,1,A07BA01,Medicinal charcoal,Capsule,Oral,,,,,,,,,,,,,,,,,Non-Prescription Drugs
59931,Marketed,1998-10-07,02236563,Activated Charcoal,1,A07BA01,Medicinal charcoal,Capsule,Oral,,,,,,,,,,,,,,,,,Non-Prescription Drugs
6317,Marketed,1997-10-17,00637955,Charac-50,1,A07BA01,Medicinal charcoal,Suspension,Oral,,,,,,,,,,,,,,,,,Non-Prescription Drugs
7267,Marketed,1997-10-17,00649236,Charactol-50,1,A07BA01,Medicinal charcoal,Suspension,Oral,,,,,,,,,,,,,,,,,Non-Prescription Drugs
88060,Marketed,2026-01-06,02395517,Wampole Activated Charcoal,1,A07BA01,Medicinal charcoal,Capsule,Oral,,,,,,,,,,,,,,,,,Non-Prescription Drugs
90525,Marketed,2019-02-01,02420694,Activated Charcoal,1,A07BA01,Medicinal charcoal,Capsule,Oral,,,,,,,,,,,,,,,,,Non-Prescription Drugs
90843,Marketed,2016-01-15,02423715,Charco Caps,1,A07BA01,Medicinal charcoal,Capsule,Oral,,,,,,,,,,,,,,,,,Non-Prescription Drugs
99412,Marketed,2021-03-31,02504723,Activated Charcoal Capsules,1,A07BA01,Medicinal charcoal,Capsule,Oral,,,,,,,,,,,,,,,,,Non-Prescription Drugs
101256,Marketed,2022-04-25,02523493,Depo-Provera,1,G03AC06,Medroxyprogesterone,Suspension,Intramuscular,02523493,DEPO-PROVERA (medroxyprogesterone acetate 150 mg per 1 mL suspension for injection syringe) PFIZER CANADA ULC,Active,9014702,medroxyprogesterone acetate 150 mg per 1 mL suspension for injection syringe,8000018,medroxyprogesterone,738984000,Parenteral,385220007,Suspension for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
43299,Marketed,2011-01-19,02221284,Teva-Medroxyprogesterone,1,G03DA02,Medroxyprogesterone,Tablet,Oral,02221284,TEVA-MEDROXYPROGESTERONE (medroxyprogesterone acetate 2.5 mg oral tablet) TEVA CANADA LIMITED,Active,9000429,medroxyprogesterone acetate 2.5 mg oral tablet,8000018,medroxyprogesterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
43300,Marketed,2011-01-19,02221292,Teva-Medroxyprogesterone,1,G03DA02,Medroxyprogesterone,Tablet,Oral,02221292,TEVA-MEDROXYPROGESTERONE (medroxyprogesterone acetate 5 mg oral tablet) TEVA CANADA LIMITED,Active,9000027,medroxyprogesterone acetate 5 mg oral tablet,8000018,medroxyprogesterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
43301,Marketed,2011-01-19,02221306,Teva-Medroxyprogesterone,1,G03DA02,Medroxyprogesterone,Tablet,Oral,02221306,TEVA-MEDROXYPROGESTERONE (medroxyprogesterone acetate 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000275,medroxyprogesterone acetate 10 mg oral tablet,8000018,medroxyprogesterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
68715,Marketed,2024-11-15,02244726,AA-Medroxy,1,G03DA02,Medroxyprogesterone,Tablet,Oral,02244726,AA-MEDROXY (medroxyprogesterone acetate 2.5 mg oral tablet) AA PHARMA INC,Active,9000429,medroxyprogesterone acetate 2.5 mg oral tablet,8000018,medroxyprogesterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
68716,Marketed,2024-12-16,02244727,AA-Medroxy,1,G03DA02,Medroxyprogesterone,Tablet,Oral,02244727,AA-MEDROXY (medroxyprogesterone acetate 5 mg oral tablet) AA PHARMA INC,Active,9000027,medroxyprogesterone acetate 5 mg oral tablet,8000018,medroxyprogesterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
75305,Marketed,2024-12-16,02267640,AA-Medroxy,1,G03DA02,Medroxyprogesterone,Tablet,Oral,02267640,AA-MEDROXY (medroxyprogesterone acetate 100 mg oral tablet) AA PHARMA INC,Active,9001124,medroxyprogesterone acetate 100 mg oral tablet,8000018,medroxyprogesterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
76294,Marketed,2024-11-15,02277298,AA-Medroxy,1,G03DA02,Medroxyprogesterone,Tablet,Oral,02277298,AA-MEDROXY (medroxyprogesterone acetate 10 mg oral tablet) AA PHARMA INC,Active,9000275,medroxyprogesterone acetate 10 mg oral tablet,8000018,medroxyprogesterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
47338,Marketed,2024-09-03,02229452,Mefenamic,1,M01AG01,Mefenamic acid,Capsule,Oral,02229452,MEFENAMIC (mefenamic acid 250 mg oral capsule) AA PHARMA INC,Active,9001621,mefenamic acid 250 mg oral capsule,8001495,mefenamic acid,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
68334,Marketed,2011-05-31,02244366,Mefloquine,1,P01BC02,Mefloquine,Tablet,Oral,02244366,MEFLOQUINE (mefloquine (mefloquine hydrochloride) 250 mg oral tablet) AA PHARMA INC,Active,9003737,mefloquine (mefloquine hydrochloride) 250 mg oral tablet,8001399,mefloquine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
20026,Marketed,2021-09-23,02195925,Megestrol,1,L02AB01,Megestrol,Tablet,Oral,02195925,MEGESTROL (megestrol acetate 160 mg oral tablet) AA PHARMA INC,Active,9002845,megestrol acetate 160 mg oral tablet,8001496,megestrol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
20029,Marketed,2021-09-23,02195917,Megestrol,1,L02AB01,Megestrol,Tablet,Oral,02195917,MEGESTROL (megestrol acetate 40 mg oral tablet) AA PHARMA INC,Active,9002846,megestrol acetate 40 mg oral tablet,8001496,megestrol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
72606,Marketed,2003-11-07,02248267,PMS-Meloxicam,1,M01AC06,Meloxicam,Tablet,Oral,02248267,PMS-MELOXICAM (meloxicam 7.5 mg oral tablet) PHARMASCIENCE INC,Active,9000920,meloxicam 7.5 mg oral tablet,8000290,meloxicam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
72607,Marketed,2003-11-07,02248268,PMS-Meloxicam,1,M01AC06,Meloxicam,Tablet,Oral,02248268,PMS-MELOXICAM (meloxicam 15 mg oral tablet) PHARMASCIENCE INC,Active,9000919,meloxicam 15 mg oral tablet,8000290,meloxicam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73355,Marketed,2004-02-13,02248973,Apo-Meloxicam,1,M01AC06,Meloxicam,Tablet,Oral,02248973,APO-MELOXICAM (meloxicam 7.5 mg oral tablet) APOTEX INC,Active,9000920,meloxicam 7.5 mg oral tablet,8000290,meloxicam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73356,Marketed,2004-02-13,02248974,Apo-Meloxicam,1,M01AC06,Meloxicam,Tablet,Oral,02248974,APO-MELOXICAM (meloxicam 15 mg oral tablet) APOTEX INC,Active,9000919,meloxicam 15 mg oral tablet,8000290,meloxicam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74353,Marketed,2010-07-19,02258315,Teva-Meloxicam,1,M01AC06,Meloxicam,Tablet,Oral,02258315,TEVA-MELOXICAM (meloxicam 7.5 mg oral tablet) TEVA CANADA LIMITED,Active,9000920,meloxicam 7.5 mg oral tablet,8000290,meloxicam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74354,Marketed,2010-07-19,02258323,Teva-Meloxicam,1,M01AC06,Meloxicam,Tablet,Oral,02258323,TEVA-MELOXICAM (meloxicam 15 mg oral tablet) TEVA CANADA LIMITED,Active,9000919,meloxicam 15 mg oral tablet,8000290,meloxicam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83836,Marketed,2021-12-17,02353148,Meloxicam,1,M01AC06,Meloxicam,Tablet,Oral,02353148,MELOXICAM (meloxicam 7.5 mg oral tablet) SANIS HEALTH INC,Active,9000920,meloxicam 7.5 mg oral tablet,8000290,meloxicam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83837,Marketed,2021-12-17,02353156,Meloxicam,1,M01AC06,Meloxicam,Tablet,Oral,02353156,MELOXICAM (meloxicam 15 mg oral tablet) SANIS HEALTH INC,Active,9000919,meloxicam 15 mg oral tablet,8000290,meloxicam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87627,Marketed,2012-10-19,02390884,Auro-Meloxicam,1,M01AC06,Meloxicam,Tablet,Oral,02390884,AURO-MELOXICAM (meloxicam 7.5 mg oral tablet) AURO PHARMA INC,Active,9000920,meloxicam 7.5 mg oral tablet,8000290,meloxicam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87628,Marketed,2012-10-18,02390892,Auro-Meloxicam,1,M01AC06,Meloxicam,Tablet,Oral,02390892,AURO-MELOXICAM (meloxicam 15 mg oral tablet) AURO PHARMA INC,Active,9000919,meloxicam 15 mg oral tablet,8000290,meloxicam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
1195,Marketed,2018-04-26,00004715,Alkeran,1,L01AA03,Melphalan,Tablet,Oral,00004715,ALKERAN (melphalan 2 mg oral tablet) ASPEN PHARMACARE CANADA INC.,Active,9012831,melphalan 2 mg oral tablet,8001497,melphalan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
18786,Marketed,2017-06-19,02087286,Alkeran,2,L01AA03,Melphalan,"Solution,Kit,Powder for solution","Intra-arterial,Intravenous",02087286,ALKERAN (melphalan (melphalan hydrochloride) 50 mg per vial powder for solution for injection with diluent solution) ASPEN PHARMACARE CANADA INC.,Active,9013005,melphalan (melphalan hydrochloride) 50 mg per vial powder for solution for injection with diluent solution,8001497,melphalan,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
96274,Marketed,2018-06-18,02473348,Melphalan For Injection,2,L01AA03,Melphalan,"Solution,Powder for solution,Kit","Intravenous,Intra-arterial",02473348,MELPHALAN FOR INJECTION (melphalan (melphalan hydrochloride) 50 mg per vial powder for solution for injection with diluent solution) MARCAN PHARMACEUTICALS INC,Active,9013005,melphalan (melphalan hydrochloride) 50 mg per vial powder for solution for injection with diluent solution,8001497,melphalan,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
97057,Marketed,2021-01-25,02480026,Taro-Melphalan,2,L01AA03,Melphalan,"Kit,Powder for solution","Intra-arterial,Intravenous",02480026,TARO-MELPHALAN (melphalan (melphalan hydrochloride) 50 mg per vial powder for solution for injection with diluent solution) TARO PHARMACEUTICALS INC,Active,9013005,melphalan (melphalan hydrochloride) 50 mg per vial powder for solution for injection with diluent solution,8001497,melphalan,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
102097,Marketed,2025-02-11,02531887,Mint-Memantine,1,N06DX01,Memantine,Tablet,Oral,02531887,MINT-MEMANTINE (memantine hydrochloride 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9003989,memantine hydrochloride 10 mg oral tablet,8001288,memantine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74607,Marketed,2004-12-16,02260638,Ebixa,1,N06DX01,Memantine,Tablet,Oral,02260638,EBIXA (memantine hydrochloride 10 mg oral tablet) LUNDBECK CANADA INC,Active,9003989,memantine hydrochloride 10 mg oral tablet,8001288,memantine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80653,Marketed,2009-11-04,02321130,PMS-Memantine,1,N06DX01,Memantine,Tablet,Oral,02321130,PMS-MEMANTINE (memantine hydrochloride 10 mg oral tablet) PHARMASCIENCE INC,Active,9003989,memantine hydrochloride 10 mg oral tablet,8001288,memantine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80955,Marketed,2020-04-06,02324067,Act Memantine,1,N06DX01,Memantine,Tablet,Oral,02324067,ACT MEMANTINE (memantine hydrochloride 10 mg oral tablet) TEVA CANADA LIMITED,Active,9003989,memantine hydrochloride 10 mg oral tablet,8001288,memantine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83428,Marketed,2010-06-14,02348950,Riva-Memantine,1,N06DX01,Memantine,Tablet,Oral,02348950,RIVA-MEMANTINE (memantine hydrochloride 10 mg oral tablet) LABORATOIRE RIVA INC.,Active,9003989,memantine hydrochloride 10 mg oral tablet,8001288,memantine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85130,Marketed,2020-05-25,02366487,Apo-Memantine,1,N06DX01,Memantine,Tablet,Oral,02366487,APO-MEMANTINE (memantine hydrochloride 10 mg oral tablet) APOTEX INC,Active,9003989,memantine hydrochloride 10 mg oral tablet,8001288,memantine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86095,Marketed,2014-07-17,02375532,Sandoz Memantine FCT,1,N06DX01,Memantine,Tablet,Oral,02375532,SANDOZ MEMANTINE FCT (memantine hydrochloride 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003989,memantine hydrochloride 10 mg oral tablet,8001288,memantine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86864,Marketed,2015-03-02,02382830,PMS-Memantine,1,N06DX01,Memantine,Tablet,Oral,02382830,PMS-MEMANTINE (memantine hydrochloride 5 mg oral tablet) PHARMASCIENCE INC,Active,9005670,memantine hydrochloride 5 mg oral tablet,8001288,memantine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92762,Marketed,2017-06-14,02443082,Memantine,1,N06DX01,Memantine,Tablet,Oral,02443082,MEMANTINE (memantine hydrochloride 10 mg oral tablet) SANIS HEALTH INC,Active,9003989,memantine hydrochloride 10 mg oral tablet,8001288,memantine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93131,Marketed,2018-06-08,02446049,Memantine,1,N06DX01,Memantine,Tablet,Oral,02446049,MEMANTINE (memantine hydrochloride 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9003989,memantine hydrochloride 10 mg oral tablet,8001288,memantine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95723,Marketed,2018-01-31,02468751,Trumenba,2,J07AH,Meningococcal vaccines,Suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
90167,Marketed,2016-09-08,02417030,Bexsero,4,J07AH09,"Meningococcus b, multicomponent vaccine",Suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
69061,Marketed,2015-12-03,02245057,Neisvac-C,2,J07AH07,"Meningococcus c, purified polysaccharides antigen conjugated",Suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
88773,Marketed,2017-05-17,02402904,Nimenrix,5,J07AH04,"Meningococcus, a, c, y, w-135, tetraval. purified polysacc. antigen","Powder for solution,Kit",Intramuscular,,,,,,,,,,,,,,,,,Schedule D
106585,Marketed,2026-04-13,02563029,Menveo,4,J07AH08,"Meningococcus, a, c, y, w-135, tetraval. purified polysacc. antigen conjugated",Solution,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
83276,Marketed,2017-03-27,02347393,Menveo,5,J07AH08,"Meningococcus, a, c, y, w-135, tetraval. purified polysacc. antigen conjugated","Solution,Powder for solution",Intramuscular,,,,,,,,,,,,,,,,,Schedule D
99657,Marketed,2025-04-01,02507161,Menquadfi,5,J07AH08,"Meningococcus, a, c, y, w-135, tetraval. purified polysacc. antigen conjugated",Solution,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
2743,Marketed,1977-12-31,00364304,Isocaine HCL Inj 3%,1,N01BB03,Mepivacaine,Solution,Block/infiltration,00364304,ISOCAINE HCL INJ 3% (mepivacaine hydrochloride 30 mg per mL solution for injection 1.8 mL cartridge) NOVOCOL PHARMACEUTICAL OF CANADA INC,Active,9014040,mepivacaine hydrochloride 30 mg per mL solution for injection 1.8 mL cartridge,8001849,mepivacaine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Ethical
3804,Marketed,1980-12-31,00479934,Scandonest 3% Plain Inj,1,N01BB03,Mepivacaine,Solution,Block/infiltration,00479934,SCANDONEST 3% PLAIN INJ (mepivacaine hydrochloride 30 mg per mL solution for injection 1.8 mL cartridge) SEPTODONT,Active,9014040,mepivacaine hydrochloride 30 mg per mL solution for injection 1.8 mL cartridge,8001849,mepivacaine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Ethical
65669,Marketed,2017-08-02,02241999,Carbocaine 1%,1,N01BB03,Mepivacaine,Solution,"Intracaudal,Epidural",02241999,CARBOCAINE 1% 30ML SINGLE USE VIAL (mepivacaine hydrochloride 300 mg per 30 mL solution for injection vial) PFIZER CANADA ULC,Active,9014041,mepivacaine hydrochloride 300 mg per 30 mL solution for injection vial,8001849,mepivacaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
65670,Marketed,2017-08-02,02242000,Carbocaine 1%,1,N01BB03,Mepivacaine,Solution,Block/infiltration,02242000,CARBOCAINE 1% (mepivacaine hydrochloride 500 mg per 50 mL solution for injection vial) PFIZER CANADA ULC,Active,9014042,mepivacaine hydrochloride 500 mg per 50 mL solution for injection vial,8001849,mepivacaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
65671,Marketed,2017-08-02,02242001,Carbocaine 2%,1,N01BB03,Mepivacaine,Solution,"Epidural,Intracaudal",02242001,CARBOCAINE 2% (mepivacaine hydrochloride 400 mg per 20 mL solution for injection vial) PFIZER CANADA ULC,Active,9013225,mepivacaine hydrochloride 400 mg per 20 mL solution for injection vial,8001849,mepivacaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
81649,Marketed,2009-10-19,02330733,3% Polocaine Dental,1,N01BB03,Mepivacaine,Liquid,Block/infiltration,02330733,3% POLOCAINE DENTAL (mepivacaine hydrochloride 30 mg per mL solution for injection 1.8 mL cartridge) DENTSPLY CANADA LIMITED,Active,9014040,mepivacaine hydrochloride 30 mg per mL solution for injection 1.8 mL cartridge,8001849,mepivacaine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Ethical
96420,Marketed,2019-05-07,02474174,Carbocaine 3%,1,N01BB03,Mepivacaine,Solution,Block/infiltration,02474174,CARBOCAINE 3% (mepivacaine hydrochloride 30 mg per mL solution for injection 1.8 mL cartridge) SEPTODONT,Active,9014040,mepivacaine hydrochloride 30 mg per mL solution for injection 1.8 mL cartridge,8001849,mepivacaine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Ethical
101998,Marketed,2023-02-13,02530821,Nucala,1,R03DX09,Mepolizumab,Solution,Subcutaneous,02530821,NUCALA (mepolizumab 40 mg per 0.4 mL solution for injection syringe) GLAXOSMITHKLINE INC,Active,9014833,mepolizumab 40 mg per 0.4 mL solution for injection syringe,8001066,mepolizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
101998,Marketed,2023-02-13,02530821,Nucala,1,R03DX09,Mepolizumab,Solution,Subcutaneous,02530821,NUCALA (mepolizumab 40 mg per 0.4 mL solution for injection syringe) GLAXOSMITHKLINE INC,Active,9014833,mepolizumab 40 mg per 0.4 mL solution for injection syringe,8001066,mepolizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
98296,Marketed,2019-12-10,02492989,Nucala,1,R03DX09,Mepolizumab,Solution,Subcutaneous,02492989,NUCALA PRE-FILLED AUTOINJECTOR (mepolizumab 100 mg per 1 mL solution for injection syringe) GLAXOSMITHKLINE INC,Active,9014223,mepolizumab 100 mg per 1 mL solution for injection syringe,8001066,mepolizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
98296,Marketed,2019-12-10,02492989,Nucala,1,R03DX09,Mepolizumab,Solution,Subcutaneous,02492989,NUCALA PRE-FILLED AUTOINJECTOR (mepolizumab 100 mg per 1 mL solution for injection syringe) GLAXOSMITHKLINE INC,Active,9014223,mepolizumab 100 mg per 1 mL solution for injection syringe,8001066,mepolizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
98297,Marketed,2019-12-10,02492997,Nucala,1,R03DX09,Mepolizumab,Solution,Subcutaneous,02492997,NUCALA PRE-FILLED SYRINGE (mepolizumab 100 mg per 1 mL solution for injection syringe) GLAXOSMITHKLINE INC,Active,9014223,mepolizumab 100 mg per 1 mL solution for injection syringe,8001066,mepolizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
98297,Marketed,2019-12-10,02492997,Nucala,1,R03DX09,Mepolizumab,Solution,Subcutaneous,02492997,NUCALA PRE-FILLED SYRINGE (mepolizumab 100 mg per 1 mL solution for injection syringe) GLAXOSMITHKLINE INC,Active,9014223,mepolizumab 100 mg per 1 mL solution for injection syringe,8001066,mepolizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
95283,Marketed,2025-04-17,02464705,Procysbi,1,A16AA04,Mercaptamine,Capsule (delayed release),Oral,02464705,PROCYSBI (cysteamine (cysteamine bitartrate) 25 mg gastro-resistant capsule) AMGEN CANADA INC,Active,9012428,cysteamine (cysteamine bitartrate) 25 mg gastro-resistant capsule,8001131,cysteamine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95284,Marketed,2025-04-17,02464713,Procysbi,1,A16AA04,Mercaptamine,Capsule (delayed release),Oral,02464713,PROCYSBI (cysteamine (cysteamine bitartrate) 75 mg gastro-resistant capsule) AMGEN CANADA INC,Active,9012429,cysteamine (cysteamine bitartrate) 75 mg gastro-resistant capsule,8001131,cysteamine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97584,Marketed,2019-05-15,02485605,Cystadrops,1,S01XA21,Mercaptamine,Solution,Ophthalmic,02485605,CYSTADROPS (cysteamine (cysteamine hydrochloride) 0.37 % ophthalmic drops) RECORDATI RARE DISEASES CANADA INC,Active,9013952,cysteamine (cysteamine hydrochloride) 0.37 % ophthalmic drops,8001131,cysteamine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
89989,Marketed,2013-11-27,02415275,Mercaptopurine Tablets USP,1,L01BB02,Mercaptopurine,Tablet,Oral,02415275,MERCAPTOPURINE TABLETS USP (mercaptopurine 50 mg oral tablet) STERIMAX INC,Active,9001549,mercaptopurine 50 mg oral tablet,8001850,mercaptopurine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
960,Marketed,2014-03-19,00004723,Purinethol,1,L01BB02,Mercaptopurine,Tablet,Oral,00004723,PURINETHOL (mercaptopurine 50 mg oral tablet) TEVA CANADA LIMITED,Active,9001549,mercaptopurine 50 mg oral tablet,8001850,mercaptopurine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101800,Marketed,2024-08-19,02528819,Meropenem For Injection,1,J01DH02,Meropenem,Powder for solution,Intravenous,02528819,MEROPENEM FOR INJECTION (meropenem (meropenem trihydrate) 500 mg per vial powder for solution for injection) EUGIA PHARMA INC.,Active,9002957,meropenem 500 mg per vial powder for solution for injection,8001215,meropenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
101801,Marketed,2024-08-19,02528827,Meropenem For Injection,1,J01DH02,Meropenem,Powder for solution,Intravenous,02528827,MEROPENEM FOR INJECTION (meropenem (meropenem trihydrate) 1 g per vial powder for solution for injection) EUGIA PHARMA INC.,Active,9002962,meropenem 1 g per vial powder for solution for injection,8001215,meropenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
102515,Marketed,2024-03-26,02536374,Meropenem For Injection,1,J01DH02,Meropenem,Powder for solution,Intravenous,02536374,MEROPENEM FOR INJECTION (meropenem (meropenem trihydrate) 1 g per vial powder for solution for injection) JAMP PHARMA CORPORATION,Active,9002962,meropenem 1 g per vial powder for solution for injection,8001215,meropenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
103285,Marketed,2025-03-25,02544334,Meropenem For Injection USP And Sodium Chloride Injection USP,1,J01DH02,Meropenem,Powder for solution,Intravenous,02544334,MEROPENEM FOR INJECTION USP AND SODIUM CHLORIDE INJECTION USP (meropenem 500 mg powder for solution for injection with diluent solution per bag) B. BRAUN MEDICAL INC,Active,9015192,meropenem 500 mg powder for solution for injection with diluent solution per bag,8001215,meropenem,738984000,Parenteral,385223009,Powder for solution for injection,732982009,Bag,,,,Prescription
103286,Marketed,2025-03-25,02544342,Meropenem For Injection USP And Sodium Chloride Injection USP,1,J01DH02,Meropenem,Powder for solution,Intravenous,02544342,MEROPENEM FOR INJECTION USP AND SODIUM CHLORIDE INJECTION USP (meropenem 1 g powder for solution for injection with diluent solution per bag) B. BRAUN MEDICAL INC,Active,9015191,meropenem 1 g powder for solution for injection with diluent solution per bag,8001215,meropenem,738984000,Parenteral,385223009,Powder for solution for injection,732982009,Bag,,,,Prescription
86463,Marketed,2012-01-26,02378787,Meropenem For Injection,1,J01DH02,Meropenem,Powder for solution,Intravenous,02378787,MEROPENEM FOR INJECTION (meropenem (meropenem trihydrate) 500 mg per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9002957,meropenem 500 mg per vial powder for solution for injection,8001215,meropenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
86467,Marketed,2012-01-26,02378795,Meropenem For Injection,1,J01DH02,Meropenem,Powder for solution,Intravenous,02378795,MEROPENEM FOR INJECTION (meropenem (meropenem trihydrate) 1 g per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9002962,meropenem 1 g per vial powder for solution for injection,8001215,meropenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
89983,Marketed,2021-03-25,02415216,"Meropenem For Injection, USP",1,J01DH02,Meropenem,Powder for solution,Intravenous,02415216,"MEROPENEM FOR INJECTION, USP (meropenem 500 mg per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9002957,meropenem 500 mg per vial powder for solution for injection,8001215,meropenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
89984,Marketed,2021-03-25,02415224,"Meropenem For Injection, USP",1,J01DH02,Meropenem,Powder for solution,Intravenous,02415224,"MEROPENEM FOR INJECTION, USP (meropenem 1 g per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9002962,meropenem 1 g per vial powder for solution for injection,8001215,meropenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
90612,Marketed,2021-06-11,02421518,Taro-Meropenem,1,J01DH02,Meropenem,Powder for solution,Intravenous,02421518,TARO-MEROPENEM (meropenem (meropenem trihydrate) 500 mg per vial powder for solution for injection) SUN PHARMA CANADA INC,Active,9002957,meropenem 500 mg per vial powder for solution for injection,8001215,meropenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
90613,Marketed,2021-06-11,02421526,Taro-Meropenem,1,J01DH02,Meropenem,Powder for solution,Intravenous,02421526,TARO-MEROPENEM (meropenem (meropenem trihydrate) 1 g per vial powder for solution for injection) SUN PHARMA CANADA INC,Active,9002962,meropenem 1 g per vial powder for solution for injection,8001215,meropenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
95075,Marketed,2017-10-20,02462885,Meropenem For Injection,1,J01DH02,Meropenem,Powder for solution,Intravenous,02462885,MEROPENEM FOR INJECTION (meropenem (meropenem trihydrate) 500 mg per vial powder for solution for injection) AURO PHARMA INC,Active,9002957,meropenem 500 mg per vial powder for solution for injection,8001215,meropenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
95076,Marketed,2017-10-20,02462893,Meropenem For Injection,1,J01DH02,Meropenem,Powder for solution,Intravenous,02462893,MEROPENEM FOR INJECTION (meropenem (meropenem trihydrate) 1 g per vial powder for solution for injection) AURO PHARMA INC,Active,9002962,meropenem 1 g per vial powder for solution for injection,8001215,meropenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
98335,Marketed,2021-05-25,02493330,Meropenem For Injection,1,J01DH02,Meropenem,Powder for solution,Intravenous,02493330,MEROPENEM FOR INJECTION (meropenem (meropenem trihydrate) 500 mg per vial powder for solution for injection) STERIMAX INC,Active,9002957,meropenem 500 mg per vial powder for solution for injection,8001215,meropenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
98336,Marketed,2021-02-22,02493349,Meropenem For Injection,1,J01DH02,Meropenem,Powder for solution,Intravenous,02493349,MEROPENEM FOR INJECTION (meropenem (meropenem trihydrate) 1 g per vial powder for solution for injection) STERIMAX INC,Active,9002962,meropenem 1 g per vial powder for solution for injection,8001215,meropenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
104303,Marketed,2025-06-30,02554151,Vabomere,2,J01DH52,Meropenem and vaborbactam,Powder for solution,Intravenous,02554151,VABOMERE (meropenem (meropenem trihydrate) 1 g per vial and vaborbactam 1 g per vial powder for solution for injection) XEDITON PHARMACEUTICALS INC,Active,9015236,meropenem 1 g per vial and vaborbactam 1 g per vial powder for solution for injection,8002549,meropenem and vaborbactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,,,,Prescription
101350,Marketed,2022-10-05,02524481,Mezera,1,A07EC02,Mesalazine,Tablet (delayed-release),Oral,02524481,MEZERA (mesalazine 500 mg gastro-resistant tablet) AVIR PHARMA INC.,Active,9010499,mesalazine 500 mg gastro-resistant tablet,8000183,mesalazine,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101886,Marketed,2023-03-02,02529610,Octasa,1,A07EC02,Mesalazine,Tablet (delayed-release),Oral,02529610,OCTASA (mesalazine 1.6 g gastro-resistant tablet) TILLOTTS PHARMA AG,Active,9014840,mesalazine 1.6 g gastro-resistant tablet,8000183,mesalazine,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103363,Marketed,2024-07-26,02545012,Mezera,1,A07EC02,Mesalazine,Tablet (delayed-release),Oral,02545012,MEZERA (mesalazine 1 g gastro-resistant tablet) AVIR PHARMA INC.,Active,9015073,mesalazine 1 g gastro-resistant tablet,8000183,mesalazine,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106525,Marketed,2026-03-11,02562367,ZDS-Mesalamine Suppositories,1,A07EC02,Mesalazine,Suppository,Rectal,02562367,ZDS-MESALAMINE SUPPOSITORIES (mesalazine 1 g suppository) ZYDUS LIFESCIENCES LIMITED,Active,9010493,mesalazine 1 g suppository,8000183,mesalazine,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,,Prescription
16855,Marketed,1999-04-01,02099683,Pentasa,1,A07EC02,Mesalazine,Tablet (extended-release),Oral,02099683,PENTASA (mesalazine 500 mg prolonged-release oral tablet) FERRING INC,Active,9010500,mesalazine 500 mg prolonged-release oral tablet,8000183,mesalazine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
18212,Marketed,2024-07-10,02112760,Salofalk,1,A07EC02,Mesalazine,Suppository,Rectal,02112760,SALOFALK (mesalazine 500 mg suppository) ABBVIE CORPORATION,Active,9010501,mesalazine 500 mg suppository,8000183,mesalazine,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,,Prescription
18214,Marketed,2024-01-23,02112787,Salofalk,1,A07EC02,Mesalazine,Tablet (delayed-release),Oral,02112787,SALOFALK (mesalazine 500 mg gastro-resistant tablet) ABBVIE CORPORATION,Active,9010499,mesalazine 500 mg gastro-resistant tablet,8000183,mesalazine,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
18493,Marketed,1999-11-09,02153564,Pentasa,1,A07EC02,Mesalazine,Suppository,Rectal,02153564,PENTASA (mesalazine 1 g suppository) FERRING INC,Active,9010493,mesalazine 1 g suppository,8000183,mesalazine,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,,Prescription
18494,Marketed,1999-11-08,02153556,Pentasa,1,A07EC02,Mesalazine,Suspension,Rectal,02153556,PENTASA (mesalazine 4 g per 100 mL rectal suspension) FERRING INC,Active,9010496,mesalazine 4 g per 100 mL rectal suspension,8000183,mesalazine,37161004,Rectal,739008005,Suspension,,,,,,Prescription
18496,Marketed,1999-11-09,02153521,Pentasa,1,A07EC02,Mesalazine,Suspension,Rectal,02153521,PENTASA (mesalazine 1 g per 100 mL rectal suspension) FERRING INC,Active,9010491,mesalazine 1 g per 100 mL rectal suspension,8000183,mesalazine,37161004,Rectal,739008005,Suspension,,,,,,Prescription
18509,Marketed,2024-06-12,02112809,Salofalk,1,A07EC02,Mesalazine,Suspension,Rectal,02112809,SALOFALK (mesalazine 4 g per 60 mL rectal suspension) ABBVIE CORPORATION,Active,9010497,mesalazine 4 g per 60 mL rectal suspension,8000183,mesalazine,37161004,Rectal,739008005,Suspension,,,,,,Prescription
18510,Marketed,2024-07-16,02112795,Salofalk,1,A07EC02,Mesalazine,Suspension,Rectal,02112795,SALOFALK (mesalazine 2 g per 60 mL rectal suspension) ABBVIE CORPORATION,Active,9010495,mesalazine 2 g per 60 mL rectal suspension,8000183,mesalazine,37161004,Rectal,739008005,Suspension,,,,,,Prescription
19524,Marketed,2015-05-12,02171929,Teva-5 ASA,1,A07EC02,Mesalazine,Tablet (enteric-coated),Oral,02171929,TEVA-5 ASA (mesalazine 400 mg gastro-resistant tablet) TEVA CANADA LIMITED,Active,9010498,mesalazine 400 mg gastro-resistant tablet,8000183,mesalazine,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
65824,Marketed,2024-03-28,02242146,Salofalk,1,A07EC02,Mesalazine,Suppository,Rectal,02242146,SALOFALK (mesalazine 1 g suppository) ABBVIE CORPORATION,Active,9010493,mesalazine 1 g suppository,8000183,mesalazine,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,,Prescription
78289,Marketed,2021-11-22,02297558,Mezavant,1,A07EC02,Mesalazine,Tablet (delayed and extended release),Oral,02297558,MEZAVANT (mesalazine 1.2 g modified-release oral tablet) TAKEDA CANADA INC,Active,9010494,mesalazine 1.2 g modified-release oral tablet,8000183,mesalazine,26643006,Oral,385061003,Modified-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88434,Marketed,2013-03-12,02399466,Pentasa,1,A07EC02,Mesalazine,Tablet (extended-release),Oral,02399466,PENTASA (mesalazine 1 g prolonged-release oral tablet) FERRING INC,Active,9010492,mesalazine 1 g prolonged-release oral tablet,8000183,mesalazine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95399,Marketed,2022-09-28,02465752,Octasa,1,A07EC02,Mesalazine,Tablet (delayed-release),Oral,02465752,OCTASA (mesalazine 800 mg gastro-resistant tablet) TILLOTTS PHARMA AG,Active,9010502,mesalazine 800 mg gastro-resistant tablet,8000183,mesalazine,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96402,Marketed,2018-07-13,02474018,Mezera,1,A07EC02,Mesalazine,Suppository,Rectal,02474018,MEZERA (mesalazine 1 g suppository) AVIR PHARMA INC.,Active,9010493,mesalazine 1 g suppository,8000183,mesalazine,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,,Prescription
96403,Marketed,2018-07-13,02474026,Mezera,1,A07EC02,Mesalazine,Foam,Rectal,02474026,MEZERA (mesalazine 1 g per actuation rectal foam) AVIR PHARMA INC.,Active,9012832,mesalazine 1 g per actuation rectal foam,8000183,mesalazine,37161004,Rectal,421166008,Foam,732981002,Actuation (unit of presentation),,,,Prescription
65047,Marketed,2004-01-16,02241411,Uromitexan,1,V03AF01,Mesna,Solution,"Intravenous,Oral",77700723,UROMITEXAN (mesna 1000 mg per 10 mL solution for injection ampoule) BAXTER CORPORATION,Active,9013227,mesna 1000 mg per 10 mL solution for injection ampoule,8001851,mesna,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
65047,Marketed,2004-01-16,02241411,Uromitexan,1,V03AF01,Mesna,Solution,"Intravenous,Oral",77700724,UROMITEXAN (mesna 400 mg per 4 mL solution for injection ampoule) BAXTER CORPORATION,Active,9013229,mesna 400 mg per 4 mL solution for injection ampoule,8001851,mesna,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
68929,Marketed,2016-05-09,02244931,Mesna For Injection,1,V03AF01,Mesna,Solution,Intravenous,02244931,MESNA FOR INJECTION (mesna 1000 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9013228,mesna 1000 mg per 10 mL solution for injection vial,8001851,mesna,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
85696,Marketed,2012-04-13,02371839,Uromitexan,1,V03AF01,Mesna,Solution,Intravenous,77700758,UROMITEXAN (mesna 1000 mg per 10 mL solution for injection vial) BAXTER CORPORATION,Active,9013228,mesna 1000 mg per 10 mL solution for injection vial,8001851,mesna,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
85696,Marketed,2012-04-13,02371839,Uromitexan,1,V03AF01,Mesna,Solution,Intravenous,77700759,UROMITEXAN (mesna 5000 mg per 50 mL solution for injection vial) BAXTER CORPORATION,Active,9013230,mesna 5000 mg per 50 mL solution for injection vial,8001851,mesna,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
100366,Marketed,2022-02-04,02514486,Metformin Tablets,1,A10BA02,Metformin,Tablet,Oral,02514486,METFORMIN TABLETS (metformin hydrochloride 500 mg oral tablet) GRANULES INDIA LIMITED,Active,9000473,metformin hydrochloride 500 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100367,Marketed,2022-02-04,02514494,Metformin Tablets,1,A10BA02,Metformin,Tablet,Oral,02514494,METFORMIN TABLETS (metformin hydrochloride 850 mg oral tablet) GRANULES INDIA LIMITED,Active,9000609,metformin hydrochloride 850 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100951,Marketed,2022-02-04,02520303,PMSC-Metformin,1,A10BA02,Metformin,Tablet,Oral,02520303,PMSC-METFORMIN (metformin hydrochloride 500 mg oral tablet) PHARMASCIENCE INC,Active,9000473,metformin hydrochloride 500 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100952,Marketed,2022-02-04,02520311,PMSC-Metformin,1,A10BA02,Metformin,Tablet,Oral,02520311,PMSC-METFORMIN (metformin hydrochloride 850 mg oral tablet) PHARMASCIENCE INC,Active,9000609,metformin hydrochloride 850 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102098,Marketed,2023-04-14,02531895,PRZ-Metformin,1,A10BA02,Metformin,Tablet,Oral,02531895,PRZ-METFORMIN (metformin hydrochloride 500 mg oral tablet) PHARMARIS CANADA INC,Active,9000473,metformin hydrochloride 500 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102099,Marketed,2023-04-14,02531909,PRZ-Metformin,1,A10BA02,Metformin,Tablet,Oral,02531909,PRZ-METFORMIN (metformin hydrochloride 850 mg oral tablet) PHARMARIS CANADA INC,Active,9000609,metformin hydrochloride 850 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102358,Marketed,2023-05-23,02534673,PRZ-Metformin,1,A10BA02,Metformin,Tablet,Oral,02534673,PRZ-METFORMIN (metformin hydrochloride 1000 mg oral tablet) PHARMARIS CANADA INC,Active,9014870,metformin hydrochloride 1000 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102521,Marketed,2023-08-03,02536439,Nra-Metformin,1,A10BA02,Metformin,Tablet,Oral,02536439,NRA-METFORMIN (metformin hydrochloride 500 mg oral tablet) NORA PHARMA INC,Active,9000473,metformin hydrochloride 500 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102522,Marketed,2023-08-03,02536447,Nra-Metformin,1,A10BA02,Metformin,Tablet,Oral,02536447,NRA-METFORMIN (metformin hydrochloride 850 mg oral tablet) NORA PHARMA INC,Active,9000609,metformin hydrochloride 850 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103593,Marketed,2024-10-02,02547309,Mint-Metformin XR,1,A10BA02,Metformin,Tablet (extended-release),Oral,02547309,MINT-METFORMIN XR (metformin hydrochloride 500 mg prolonged-release oral tablet) MINT PHARMACEUTICALS INC,Active,9001130,metformin hydrochloride 500 mg prolonged-release oral tablet,8000184,metformin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103594,Marketed,2024-10-31,02547317,Mint-Metformin XR,1,A10BA02,Metformin,Tablet (extended-release),Oral,02547317,MINT-METFORMIN XR (metformin hydrochloride 1000 mg prolonged-release oral tablet) MINT PHARMACEUTICALS INC,Active,9001233,metformin hydrochloride 1000 mg prolonged-release oral tablet,8000184,metformin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103669,Marketed,2024-11-14,02547767,M-Metformin,1,A10BA02,Metformin,Tablet,Oral,02547767,M-METFORMIN (metformin hydrochloride 500 mg oral tablet) MANTRA PHARMA INC,Active,9000473,metformin hydrochloride 500 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103670,Marketed,2024-11-14,02547775,M-Metformin,1,A10BA02,Metformin,Tablet,Oral,02547775,M-METFORMIN (metformin hydrochloride 850 mg oral tablet) MANTRA PHARMA INC,Active,9000609,metformin hydrochloride 850 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103716,Marketed,2024-11-14,02548275,M-Metformin,1,A10BA02,Metformin,Tablet,Oral,02548275,M-METFORMIN (metformin hydrochloride 1000 mg oral tablet) MANTRA PHARMA INC,Active,9014870,metformin hydrochloride 1000 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103931,Marketed,2024-10-21,02550504,Mar-Metformin XR,1,A10BA02,Metformin,Tablet (extended-release),Oral,02550504,MAR-METFORMIN XR (metformin hydrochloride 500 mg prolonged-release oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001130,metformin hydrochloride 500 mg prolonged-release oral tablet,8000184,metformin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103932,Marketed,2024-10-02,02550512,Mar-Metformin XR,1,A10BA02,Metformin,Tablet (extended-release),Oral,02550512,MAR-METFORMIN XR (metformin hydrochloride 1000 mg prolonged-release oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001233,metformin hydrochloride 1000 mg prolonged-release oral tablet,8000184,metformin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104056,Marketed,2025-09-23,02551845,M-Metformin XR,1,A10BA02,Metformin,Tablet (extended-release),Oral,02551845,M-METFORMIN XR (metformin hydrochloride 500 mg prolonged-release oral tablet) MANTRA PHARMA INC,Active,9001130,metformin hydrochloride 500 mg prolonged-release oral tablet,8000184,metformin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104057,Marketed,2025-09-23,02551853,M-Metformin XR,1,A10BA02,Metformin,Tablet (extended-release),Oral,02551853,M-METFORMIN XR (metformin hydrochloride 1000 mg prolonged-release oral tablet) MANTRA PHARMA INC,Active,9001233,metformin hydrochloride 1000 mg prolonged-release oral tablet,8000184,metformin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104072,Marketed,2025-10-15,02552027,Taro-Metformin XR,1,A10BA02,Metformin,Tablet (extended-release),Oral,02552027,TARO-METFORMIN XR (metformin hydrochloride 500 mg prolonged-release oral tablet) TARO PHARMACEUTICALS INC,Active,9001130,metformin hydrochloride 500 mg prolonged-release oral tablet,8000184,metformin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106200,Marketed,2026-01-08,02558785,Metformin ER,1,A10BA02,Metformin,Tablet (extended-release),Oral,02558785,METFORMIN ER (metformin hydrochloride 500 mg prolonged-release oral tablet) SANIS HEALTH INC,Active,9001130,metformin hydrochloride 500 mg prolonged-release oral tablet,8000184,metformin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106201,Marketed,2025-12-29,02558793,Metformin ER,1,A10BA02,Metformin,Tablet (extended-release),Oral,02558793,METFORMIN ER (metformin hydrochloride 1000 mg prolonged-release oral tablet) SANIS HEALTH INC,Active,9001233,metformin hydrochloride 1000 mg prolonged-release oral tablet,8000184,metformin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106812,Marketed,2026-05-07,02565536,Taro-Metformin XR,1,A10BA02,Metformin,Tablet (extended-release),Oral,02565536,TARO-METFORMIN XR (metformin hydrochloride 1000 mg prolonged-release oral tablet) TARO PHARMACEUTICALS INC,Active,9001233,metformin hydrochloride 1000 mg prolonged-release oral tablet,8000184,metformin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
17104,Marketed,2007-10-09,02099233,Glucophage,1,A10BA02,Metformin,Tablet,Oral,02099233,GLUCOPHAGE (metformin hydrochloride 500 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9000473,metformin hydrochloride 500 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
18835,Marketed,2008-01-29,02162849,Glucophage,1,A10BA02,Metformin,Tablet,Oral,02162849,GLUCOPHAGE (metformin hydrochloride 850 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9000609,metformin hydrochloride 850 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
62536,Marketed,2022-11-15,02239081,Riva-Metformin,1,A10BA02,Metformin,Tablet,Oral,02239081,RIVA-METFORMIN (metformin hydrochloride 500 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000473,metformin hydrochloride 500 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
66606,Marketed,2022-11-15,02242783,Riva-Metformin,1,A10BA02,Metformin,Tablet,Oral,02242783,RIVA-METFORMIN (metformin hydrochloride 850 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000609,metformin hydrochloride 850 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71020,Marketed,2006-01-12,02246820,Sandoz Metformin Film-coated,1,A10BA02,Metformin,Tablet,Oral,02246820,SANDOZ METFORMIN FC (metformin hydrochloride 500 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000473,metformin hydrochloride 500 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71021,Marketed,2006-01-12,02246821,Sandoz Metformin Film-coated,1,A10BA02,Metformin,Tablet,Oral,02246821,SANDOZ METFORMIN FC (metformin hydrochloride 850 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000609,metformin hydrochloride 850 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74296,Marketed,2023-06-15,02257726,Teva-Metformin,1,A10BA02,Metformin,Tablet,Oral,02257726,TEVA-METFORMIN (metformin hydrochloride 500 mg oral tablet) TEVA CANADA LIMITED,Active,9000473,metformin hydrochloride 500 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74297,Marketed,2023-06-15,02257734,Teva-Metformin,1,A10BA02,Metformin,Tablet,Oral,02257734,TEVA-METFORMIN (metformin hydrochloride 850 mg oral tablet) TEVA CANADA LIMITED,Active,9000609,metformin hydrochloride 850 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75387,Marketed,2020-12-22,02268493,Glumetza,1,A10BA02,Metformin,Tablet (extended-release),Oral,02268493,"GLUMETZA (metformin hydrochloride 500 mg prolonged-release oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9001130,metformin hydrochloride 500 mg prolonged-release oral tablet,8000184,metformin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78575,Marketed,2020-12-22,02300451,Glumetza,1,A10BA02,Metformin,Tablet (extended-release),Oral,02300451,"GLUMETZA (metformin hydrochloride 1000 mg prolonged-release oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9001233,metformin hydrochloride 1000 mg prolonged-release oral tablet,8000184,metformin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79043,Marketed,2023-06-30,02305062,Apo-Metformin ER,1,A10BA02,Metformin,Tablet (extended-release),Oral,02305062,APO-METFORMIN ER (metformin hydrochloride 500 mg prolonged-release oral tablet) APOTEX INC,Active,9001130,metformin hydrochloride 500 mg prolonged-release oral tablet,8000184,metformin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80042,Marketed,2025-07-24,02314894,Pro-Metformin,1,A10BA02,Metformin,Tablet,Oral,02314894,PRO-METFORMIN (metformin hydrochloride 850 mg oral tablet) PRO DOC LIMITEE,Active,9000609,metformin hydrochloride 850 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80043,Marketed,2025-07-08,02314908,Pro-Metformin,1,A10BA02,Metformin,Tablet,Oral,02314908,PRO-METFORMIN (metformin hydrochloride 500 mg oral tablet) PRO DOC LIMITEE,Active,9000473,metformin hydrochloride 500 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83857,Marketed,2019-05-30,02353377,Metformin,1,A10BA02,Metformin,Tablet,Oral,02353377,METFORMIN (metformin hydrochloride 500 mg oral tablet) SANIS HEALTH INC,Active,9000473,metformin hydrochloride 500 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83858,Marketed,2019-05-30,02353385,Metformin,1,A10BA02,Metformin,Tablet,Oral,02353385,METFORMIN (metformin hydrochloride 850 mg oral tablet) SANIS HEALTH INC,Active,9000609,metformin hydrochloride 850 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86441,Marketed,2023-06-26,02378620,Mar-Metformin,1,A10BA02,Metformin,Tablet,Oral,02378620,MAR-METFORMIN (metformin hydrochloride 500 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000473,metformin hydrochloride 500 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86442,Marketed,2023-06-26,02378639,Mar-Metformin,1,A10BA02,Metformin,Tablet,Oral,02378639,MAR-METFORMIN (metformin hydrochloride 850 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000609,metformin hydrochloride 850 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86602,Marketed,2019-09-24,02380196,JAMP Metformin,1,A10BA02,Metformin,Tablet,Oral,02380196,JAMP METFORMIN (metformin hydrochloride 500 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000473,metformin hydrochloride 500 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86603,Marketed,2019-09-24,02380218,JAMP Metformin,1,A10BA02,Metformin,Tablet,Oral,02380218,JAMP METFORMIN (metformin hydrochloride 850 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000609,metformin hydrochloride 850 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87098,Marketed,2026-05-20,02385341,Metformin,1,A10BA02,Metformin,Tablet,Oral,02385341,METFORMIN (metformin hydrochloride 500 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000473,metformin hydrochloride 500 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87099,Marketed,2026-05-20,02385368,Metformin,1,A10BA02,Metformin,Tablet,Oral,02385368,METFORMIN (metformin hydrochloride 850 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000609,metformin hydrochloride 850 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87428,Marketed,2023-11-16,02388766,Mint-Metformin,1,A10BA02,Metformin,Tablet,Oral,02388766,MINT-METFORMIN (metformin hydrochloride 500 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000473,metformin hydrochloride 500 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87429,Marketed,2023-11-16,02388774,Mint-Metformin,1,A10BA02,Metformin,Tablet,Oral,02388774,MINT-METFORMIN (metformin hydrochloride 850 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000609,metformin hydrochloride 850 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92264,Marketed,2017-02-22,02438275,Auro-Metformin,1,A10BA02,Metformin,Tablet,Oral,02438275,AURO-METFORMIN (metformin hydrochloride 500 mg oral tablet) AURO PHARMA INC,Active,9000473,metformin hydrochloride 500 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92265,Marketed,2017-02-22,02438283,Auro-Metformin,1,A10BA02,Metformin,Tablet,Oral,02438283,AURO-METFORMIN (metformin hydrochloride 850 mg oral tablet) AURO PHARMA INC,Active,9000609,metformin hydrochloride 850 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94808,Marketed,2017-10-02,02460653,Apo-Metformin ER,1,A10BA02,Metformin,Tablet (extended-release),Oral,02460653,APO-METFORMIN ER (metformin hydrochloride 1000 mg prolonged-release oral tablet) APOTEX INC,Active,9001233,metformin hydrochloride 1000 mg prolonged-release oral tablet,8000184,metformin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98443,Marketed,2023-01-04,02494418,AG-Metformin,1,A10BA02,Metformin,Tablet,Oral,02494418,AG-METFORMIN (metformin hydrochloride 500 mg oral tablet) ANGITA PHARMA INC.,Active,9000473,metformin hydrochloride 500 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98445,Marketed,2023-01-04,02494442,AG-Metformin,1,A10BA02,Metformin,Tablet,Oral,02494442,AG-METFORMIN (metformin hydrochloride 850 mg oral tablet) ANGITA PHARMA INC.,Active,9000609,metformin hydrochloride 850 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90185,Marketed,2014-04-30,02417219,Kazano,2,A10BD13,Metformin and alogliptin,Tablet,Oral,02417219,KAZANO (alogliptin (alogliptin benzoate) 12.5 mg and metformin hydrochloride 500 mg oral tablet) TAKEDA CANADA INC,Active,9005506,alogliptin (alogliptin benzoate) 12.5 mg and metformin hydrochloride 500 mg oral tablet,8001073,alogliptin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90186,Marketed,2014-04-30,02417227,Kazano,2,A10BD13,Metformin and alogliptin,Tablet,Oral,02417227,KAZANO (alogliptin (alogliptin benzoate) 12.5 mg and metformin hydrochloride 850 mg oral tablet) TAKEDA CANADA INC,Active,9005507,alogliptin (alogliptin benzoate) 12.5 mg and metformin hydrochloride 850 mg oral tablet,8001073,alogliptin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90187,Marketed,2014-04-30,02417235,Kazano,2,A10BD13,Metformin and alogliptin,Tablet,Oral,02417235,KAZANO (alogliptin (alogliptin benzoate) 12.5 mg and metformin hydrochloride 1000 mg oral tablet) TAKEDA CANADA INC,Active,9005505,alogliptin (alogliptin benzoate) 12.5 mg and metformin hydrochloride 1000 mg oral tablet,8001073,alogliptin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94221,Marketed,2016-06-28,02455404,Invokamet,2,A10BD16,Metformin and canagliflozin,Tablet,Oral,02455404,INVOKAMET (canagliflozin 50 mg and metformin hydrochloride 500 mg oral tablet) JANSSEN INC,Active,9005989,canagliflozin 50 mg and metformin hydrochloride 500 mg oral tablet,8001016,canagliflozin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94223,Marketed,2016-06-28,02455420,Invokamet,2,A10BD16,Metformin and canagliflozin,Tablet,Oral,02455420,INVOKAMET (canagliflozin 50 mg and metformin hydrochloride 1000 mg oral tablet) JANSSEN INC,Active,9005988,canagliflozin 50 mg and metformin hydrochloride 1000 mg oral tablet,8001016,canagliflozin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94226,Marketed,2016-06-28,02455455,Invokamet,2,A10BD16,Metformin and canagliflozin,Tablet,Oral,02455455,INVOKAMET (canagliflozin 150 mg and metformin hydrochloride 1000 mg oral tablet) JANSSEN INC,Active,9005985,canagliflozin 150 mg and metformin hydrochloride 1000 mg oral tablet,8001016,canagliflozin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102210,Marketed,2023-05-16,02533073,Auro-Dapagliflozin / Metformin,2,A10BD15,Metformin and dapagliflozin,Tablet,Oral,02533073,AURO-DAPAGLIFLOZIN / METFORMIN (dapagliflozin 5 mg and metformin hydrochloride 850 mg oral tablet) AURO PHARMA INC,Active,9014862,dapagliflozin 5 mg and metformin hydrochloride 850 mg oral tablet,8001257,dapagliflozin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102211,Marketed,2023-05-16,02533081,Auro-Dapagliflozin / Metformin,2,A10BD15,Metformin and dapagliflozin,Tablet,Oral,02533081,AURO-DAPAGLIFLOZIN / METFORMIN (dapagliflozin 5 mg and metformin hydrochloride 1000 mg oral tablet) AURO PHARMA INC,Active,9014861,dapagliflozin 5 mg and metformin hydrochloride 1000 mg oral tablet,8001257,dapagliflozin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102496,Marketed,2023-12-14,02536153,Apo-Dapagliflozin-Metformin,2,A10BD15,Metformin and dapagliflozin,Tablet,Oral,02536153,APO-DAPAGLIFLOZIN-METFORMIN (dapagliflozin 5 mg and metformin hydrochloride 850 mg oral tablet) APOTEX INC,Active,9014862,dapagliflozin 5 mg and metformin hydrochloride 850 mg oral tablet,8001257,dapagliflozin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102497,Marketed,2023-12-01,02536161,Apo-Dapagliflozin-Metformin,2,A10BD15,Metformin and dapagliflozin,Tablet,Oral,02536161,APO-DAPAGLIFLOZIN-METFORMIN (dapagliflozin 5 mg and metformin hydrochloride 1000 mg oral tablet) APOTEX INC,Active,9014861,dapagliflozin 5 mg and metformin hydrochloride 1000 mg oral tablet,8001257,dapagliflozin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93580,Marketed,2016-02-08,02449935,Xigduo,2,A10BD15,Metformin and dapagliflozin,Tablet,Oral,02449935,XIGDUO (dapagliflozin (dapagliflozin propanediol monohydrate) 5 mg and metformin hydrochloride 850 mg oral tablet) ASTRAZENECA CANADA INC,Active,9012663,dapagliflozin (dapagliflozin propanediol) 5 mg and metformin hydrochloride 850 mg oral tablet,8001257,dapagliflozin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93581,Marketed,2016-02-08,02449943,Xigduo,2,A10BD15,Metformin and dapagliflozin,Tablet,Oral,02449943,XIGDUO (dapagliflozin (dapagliflozin propanediol monohydrate) 5 mg and metformin hydrochloride 1000 mg oral tablet) ASTRAZENECA CANADA INC,Active,9012662,dapagliflozin (dapagliflozin propanediol) 5 mg and metformin hydrochloride 1000 mg oral tablet,8001257,dapagliflozin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94357,Marketed,2016-08-03,02456575,Synjardy,2,A10BD20,Metformin and empagliflozin,Tablet,Oral,02456575,SYNJARDY (empagliflozin 5 mg and metformin hydrochloride 500 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9006022,empagliflozin 5 mg and metformin hydrochloride 500 mg oral tablet,8001018,empagliflozin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94358,Marketed,2016-08-03,02456583,Synjardy,2,A10BD20,Metformin and empagliflozin,Tablet,Oral,02456583,SYNJARDY (empagliflozin 5 mg and metformin hydrochloride 850 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9006023,empagliflozin 5 mg and metformin hydrochloride 850 mg oral tablet,8001018,empagliflozin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94359,Marketed,2016-08-03,02456591,Synjardy,2,A10BD20,Metformin and empagliflozin,Tablet,Oral,02456591,SYNJARDY (empagliflozin 5 mg and metformin hydrochloride 1000 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9006021,empagliflozin 5 mg and metformin hydrochloride 1000 mg oral tablet,8001018,empagliflozin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94360,Marketed,2016-08-03,02456605,Synjardy,2,A10BD20,Metformin and empagliflozin,Tablet,Oral,02456605,SYNJARDY (empagliflozin 12.5 mg and metformin hydrochloride 500 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9006019,empagliflozin 12.5 mg and metformin hydrochloride 500 mg oral tablet,8001018,empagliflozin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94361,Marketed,2016-08-03,02456613,Synjardy,2,A10BD20,Metformin and empagliflozin,Tablet,Oral,02456613,SYNJARDY (empagliflozin 12.5 mg and metformin hydrochloride 850 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9006020,empagliflozin 12.5 mg and metformin hydrochloride 850 mg oral tablet,8001018,empagliflozin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94362,Marketed,2016-08-03,02456621,Synjardy,2,A10BD20,Metformin and empagliflozin,Tablet,Oral,02456621,SYNJARDY (empagliflozin 12.5 mg and metformin hydrochloride 1000 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9006018,empagliflozin 12.5 mg and metformin hydrochloride 1000 mg oral tablet,8001018,empagliflozin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88807,Marketed,2013-04-17,02403250,Jentadueto,2,A10BD11,Metformin and linagliptin,Tablet,Oral,02403250,JENTADUETO (linagliptin 2.5 mg and metformin hydrochloride 500 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9005222,linagliptin 2.5 mg and metformin hydrochloride 500 mg oral tablet,8001000,linagliptin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88808,Marketed,2013-04-17,02403269,Jentadueto,2,A10BD11,Metformin and linagliptin,Tablet,Oral,02403269,JENTADUETO (linagliptin 2.5 mg and metformin hydrochloride 850 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9005223,linagliptin 2.5 mg and metformin hydrochloride 850 mg oral tablet,8001000,linagliptin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88809,Marketed,2013-04-17,02403277,Jentadueto,2,A10BD11,Metformin and linagliptin,Tablet,Oral,02403277,JENTADUETO (linagliptin 2.5 mg and metformin hydrochloride 1000 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9005221,linagliptin 2.5 mg and metformin hydrochloride 1000 mg oral tablet,8001000,linagliptin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87467,Marketed,2014-11-19,02389169,Komboglyze,2,A10BD10,Metformin and saxagliptin,Tablet,Oral,02389169,KOMBOGLYZE (metformin hydrochloride 500 mg and saxagliptin (saxagliptin hydrochloride) 2.5 mg oral tablet) ASTRAZENECA CANADA INC,Active,9005228,metformin hydrochloride 500 mg and saxagliptin (saxagliptin hydrochloride) 2.5 mg oral tablet,8001001,metformin and saxagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87468,Marketed,2014-11-27,02389177,Komboglyze,2,A10BD10,Metformin and saxagliptin,Tablet,Oral,02389177,KOMBOGLYZE (metformin hydrochloride 850 mg and saxagliptin (saxagliptin hydrochloride) 2.5 mg oral tablet) ASTRAZENECA CANADA INC,Active,9005229,metformin hydrochloride 850 mg and saxagliptin (saxagliptin hydrochloride) 2.5 mg oral tablet,8001001,metformin and saxagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100969,Marketed,2024-09-24,02520494,Teva-Sitagliptin Malate / Metformin,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02520494,TEVA-SITAGLIPTIN MALATE / METFORMIN (metformin hydrochloride 500 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet) TEVA CANADA LIMITED,Active,9014871,metformin hydrochloride 500 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100970,Marketed,2024-09-24,02520508,Teva-Sitagliptin Malate / Metformin,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02520508,TEVA-SITAGLIPTIN MALATE / METFORMIN (metformin hydrochloride 850 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet) TEVA CANADA LIMITED,Active,9014872,metformin hydrochloride 850 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100971,Marketed,2024-09-24,02520516,Teva-Sitagliptin Malate / Metformin,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02520516,TEVA-SITAGLIPTIN MALATE / METFORMIN (metformin hydrochloride 1000 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet) TEVA CANADA LIMITED,Active,9014869,metformin hydrochloride 1000 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101829,Marketed,2023-03-22,02529106,Sandoz Sitagliptin-Metformin XR,2,A10BD07,Metformin and sitagliptin,Tablet (extended-release),Oral,02529106,SANDOZ SITAGLIPTIN-METFORMIN XR (metformin hydrochloride 500 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9001438,metformin hydrochloride 500 mg and sitagliptin (sitagliptin phosphate) 50 mg prolonged-release oral tablet,8000390,metformin and sitagliptin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101830,Marketed,2023-03-22,02529114,Sandoz Sitagliptin-Metformin XR,2,A10BD07,Metformin and sitagliptin,Tablet (extended-release),Oral,02529114,SANDOZ SITAGLIPTIN-METFORMIN XR (metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9001411,metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate) 50 mg prolonged-release oral tablet,8000390,metformin and sitagliptin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101831,Marketed,2023-03-22,02529122,Sandoz Sitagliptin-Metformin XR,2,A10BD07,Metformin and sitagliptin,Tablet (extended-release),Oral,02529122,SANDOZ SITAGLIPTIN-METFORMIN XR (metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate monohydrate) 100 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9001437,metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate) 100 mg prolonged-release oral tablet,8000390,metformin and sitagliptin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101839,Marketed,2023-02-06,02529157,Sitagliptin-Metformin,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02529157,SITAGLIPTIN-METFORMIN (metformin hydrochloride 500 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001292,metformin hydrochloride 500 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101840,Marketed,2023-02-06,02529165,Sitagliptin-Metformin,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02529165,SITAGLIPTIN-METFORMIN (metformin hydrochloride 850 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001293,metformin hydrochloride 850 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101841,Marketed,2023-02-06,02529173,Sitagliptin-Metformin,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02529173,SITAGLIPTIN-METFORMIN (metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001291,metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102317,Marketed,2023-02-01,02534223,Pro-Sitagliptin Malate / Metformin Hydrochloride,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02534223,PRO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE (metformin hydrochloride 500 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet) PRO DOC LIMITEE,Active,9014871,metformin hydrochloride 500 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102318,Marketed,2023-02-01,02534231,Pro-Sitagliptin Malate / Metformin Hydrochloride,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02534231,PRO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE (metformin hydrochloride 850 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet) PRO DOC LIMITEE,Active,9014872,metformin hydrochloride 850 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102319,Marketed,2023-02-01,02534258,Pro-Sitagliptin Malate / Metformin Hydrochloride,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02534258,PRO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE (metformin hydrochloride 1000 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet) PRO DOC LIMITEE,Active,9014869,metformin hydrochloride 1000 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102882,Marketed,2023-10-05,02540118,Reddy-Sitagliptin And Metformin Hydrochloride,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02540118,REDDY-SITAGLIPTIN AND METFORMIN HYDROCHLORIDE (metformin hydrochloride 500 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9001292,metformin hydrochloride 500 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102883,Marketed,2023-10-05,02540126,Reddy-Sitagliptin And Metformin Hydrochloride,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02540126,REDDY-SITAGLIPTIN AND METFORMIN HYDROCHLORIDE (metformin hydrochloride 850 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9001293,metformin hydrochloride 850 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102884,Marketed,2023-10-05,02540134,Reddy-Sitagliptin And Metformin Hydrochloride,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02540134,REDDY-SITAGLIPTIN AND METFORMIN HYDROCHLORIDE (metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9001291,metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103673,Marketed,2025-07-22,02547805,Auro-Sitagliptin Hydrochloride And Metformin Hydrochloride,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02547805,AURO-SITAGLIPTIN HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE (metformin hydrochloride 500 mg and sitagliptin (sitagliptin hydrochloride monohydrate) 50 mg oral tablet) AURO PHARMA INC,Active,9015238,metformin hydrochloride 500 mg and sitagliptin (sitagliptin hydrochloride) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,,Prescription
103674,Marketed,2025-07-22,02547813,Auro-Sitagliptin Hydrochloride And Metformin Hydrochloride,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02547813,AURO-SITAGLIPTIN HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE (metformin hydrochloride 850 mg and sitagliptin (sitagliptin hydrochloride monohydrate) 50 mg oral tablet) AURO PHARMA INC,Active,9015239,metformin hydrochloride 850 mg and sitagliptin (sitagliptin hydrochloride) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,,Prescription
103675,Marketed,2025-07-22,02547821,Auro-Sitagliptin Hydrochloride And Metformin Hydrochloride,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02547821,AURO-SITAGLIPTIN HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE (metformin hydrochloride 1000 mg and sitagliptin (sitagliptin hydrochloride monohydrate) 50 mg oral tablet) AURO PHARMA INC,Active,9015237,metformin hydrochloride 1000 mg and sitagliptin (sitagliptin hydrochloride) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,,Prescription
104178,Marketed,2026-04-07,02552817,Pro-Sitagliptin-Metformin,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02552817,PRO-SITAGLIPTIN-METFORMIN (metformin hydrochloride 500 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) PRO DOC LIMITEE,Active,9001292,metformin hydrochloride 500 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104488,Marketed,2025-07-10,02556189,JAMP Sitagliptin Hydrochloride / Metformin,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02556189,JAMP SITAGLIPTIN HYDROCHLORIDE / METFORMIN (metformin hydrochloride 500 mg and sitagliptin (sitagliptin hydrochloride monohydrate) 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9015238,metformin hydrochloride 500 mg and sitagliptin (sitagliptin hydrochloride) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,,Prescription
104489,Marketed,2025-07-11,02556197,JAMP Sitagliptin Hydrochloride / Metformin,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02556197,JAMP SITAGLIPTIN HYDROCHLORIDE / METFORMIN (metformin hydrochloride 850 mg and sitagliptin (sitagliptin hydrochloride monohydrate) 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9015239,metformin hydrochloride 850 mg and sitagliptin (sitagliptin hydrochloride) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,,Prescription
104490,Marketed,2025-07-04,02556200,JAMP Sitagliptin Hydrochloride / Metformin,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02556200,JAMP SITAGLIPTIN HYDROCHLORIDE / METFORMIN (metformin hydrochloride 1000 mg and sitagliptin (sitagliptin hydrochloride monohydrate) 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9015237,metformin hydrochloride 1000 mg and sitagliptin (sitagliptin hydrochloride) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,,Prescription
106101,Marketed,2025-07-22,02557711,AG-Sitagliptin Hydrochloride / Metformin,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02557711,AG-SITAGLIPTIN HYDROCHLORIDE / METFORMIN (metformin hydrochloride 500 mg and sitagliptin (sitagliptin hydrochloride monohydrate) 50 mg oral tablet) ANGITA PHARMA INC.,Active,9015238,metformin hydrochloride 500 mg and sitagliptin (sitagliptin hydrochloride) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,,Prescription
106102,Marketed,2025-07-22,02557738,AG-Sitagliptin Hydrochloride / Metformin,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02557738,AG-SITAGLIPTIN HYDROCHLORIDE / METFORMIN (metformin hydrochloride 850 mg and sitagliptin (sitagliptin hydrochloride monohydrate) 50 mg oral tablet) ANGITA PHARMA INC.,Active,9015239,metformin hydrochloride 850 mg and sitagliptin (sitagliptin hydrochloride) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,,Prescription
106103,Marketed,2025-07-22,02557746,AG-Sitagliptin Hydrochloride / Metformin,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02557746,AG-SITAGLIPTIN HYDROCHLORIDE / METFORMIN (metformin hydrochloride 1000 mg and sitagliptin (sitagliptin hydrochloride monohydrate) 50 mg oral tablet) ANGITA PHARMA INC.,Active,9015237,metformin hydrochloride 1000 mg and sitagliptin (sitagliptin hydrochloride) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,,Prescription
106351,Marketed,2026-03-16,02560445,Sitagliptin/Metformin,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02560445,SITAGLIPTIN/METFORMIN (metformin hydrochloride 500 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) SANIS HEALTH INC,Active,9001292,metformin hydrochloride 500 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106352,Marketed,2026-03-16,02560453,Sitagliptin/Metformin,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02560453,SITAGLIPTIN/METFORMIN (metformin hydrochloride 850 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) SANIS HEALTH INC,Active,9001293,metformin hydrochloride 850 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106353,Marketed,2026-03-16,02560461,Sitagliptin/Metformin,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02560461,SITAGLIPTIN/METFORMIN (metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) SANIS HEALTH INC,Active,9001291,metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81954,Marketed,2009-10-08,02333856,Janumet,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02333856,JANUMET (metformin hydrochloride 500 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) MERCK CANADA INC,Active,9001292,metformin hydrochloride 500 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81956,Marketed,2009-10-08,02333872,Janumet,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02333872,JANUMET (metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) MERCK CANADA INC,Active,9001291,metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90139,Marketed,2015-01-13,02416786,Janumet XR,2,A10BD07,Metformin and sitagliptin,Tablet (extended-release),Oral,02416786,JANUMET XR (metformin hydrochloride 500 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg prolonged-release oral tablet) MERCK CANADA INC,Active,9001438,metformin hydrochloride 500 mg and sitagliptin (sitagliptin phosphate) 50 mg prolonged-release oral tablet,8000390,metformin and sitagliptin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90140,Marketed,2014-01-15,02416794,Janumet XR,2,A10BD07,Metformin and sitagliptin,Tablet (extended-release),Oral,02416794,JANUMET XR (metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg prolonged-release oral tablet) MERCK CANADA INC,Active,9001411,metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate) 50 mg prolonged-release oral tablet,8000390,metformin and sitagliptin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90141,Marketed,2015-01-13,02416808,Janumet XR,2,A10BD07,Metformin and sitagliptin,Tablet (extended-release),Oral,02416808,JANUMET XR (metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate monohydrate) 100 mg prolonged-release oral tablet) MERCK CANADA INC,Active,9001437,metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate) 100 mg prolonged-release oral tablet,8000390,metformin and sitagliptin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92012,Marketed,2026-01-29,02435772,Apo-Sitagliptin-Metformin,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02435772,APO-SITAGLIPTIN-METFORMIN (metformin hydrochloride 500 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) APOTEX INC,Active,9001292,metformin hydrochloride 500 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92013,Marketed,2026-01-29,02435780,Apo-Sitagliptin-Metformin,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02435780,APO-SITAGLIPTIN-METFORMIN (metformin hydrochloride 850 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) APOTEX INC,Active,9001293,metformin hydrochloride 850 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92014,Marketed,2026-01-29,02435799,Apo-Sitagliptin-Metformin,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02435799,APO-SITAGLIPTIN-METFORMIN (metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) APOTEX INC,Active,9001291,metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99341,Marketed,2023-01-10,02503956,Sandoz Sitagliptin-Metformin,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02503956,SANDOZ SITAGLIPTIN-METFORMIN (metformin hydrochloride 500 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001292,metformin hydrochloride 500 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99342,Marketed,2023-01-05,02503964,Sandoz Sitagliptin-Metformin,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02503964,SANDOZ SITAGLIPTIN-METFORMIN (metformin hydrochloride 850 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001293,metformin hydrochloride 850 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99343,Marketed,2023-01-05,02503972,Sandoz Sitagliptin-Metformin,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02503972,SANDOZ SITAGLIPTIN-METFORMIN (metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001291,metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99561,Marketed,2022-11-07,02506270,Apo-Sitagliptin/Metformin XR,2,A10BD07,Metformin and sitagliptin,Tablet (extended-release),Oral,02506270,APO-SITAGLIPTIN/METFORMIN XR (metformin hydrochloride 500 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg prolonged-release oral tablet) APOTEX INC,Active,9001438,metformin hydrochloride 500 mg and sitagliptin (sitagliptin phosphate) 50 mg prolonged-release oral tablet,8000390,metformin and sitagliptin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99562,Marketed,2022-11-07,02506289,Apo-Sitagliptin/Metformin XR,2,A10BD07,Metformin and sitagliptin,Tablet (extended-release),Oral,02506289,APO-SITAGLIPTIN/METFORMIN XR (metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg prolonged-release oral tablet) APOTEX INC,Active,9001411,metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate) 50 mg prolonged-release oral tablet,8000390,metformin and sitagliptin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99563,Marketed,2022-11-07,02506297,Apo-Sitagliptin/Metformin XR,2,A10BD07,Metformin and sitagliptin,Tablet (extended-release),Oral,02506297,APO-SITAGLIPTIN/METFORMIN XR (metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate monohydrate) 100 mg prolonged-release oral tablet) APOTEX INC,Active,9001437,metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate) 100 mg prolonged-release oral tablet,8000390,metformin and sitagliptin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99871,Marketed,2022-11-07,02509415,Apo-Sitagliptin Malate / Metformin Hydrochloride,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02509415,APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE (metformin hydrochloride 500 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet) APOTEX INC,Active,9014871,metformin hydrochloride 500 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99872,Marketed,2022-11-07,02509423,Apo-Sitagliptin Malate / Metformin Hydrochloride,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02509423,APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE (metformin hydrochloride 850 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet) APOTEX INC,Active,9014872,metformin hydrochloride 850 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99873,Marketed,2022-11-07,02509431,Apo-Sitagliptin Malate / Metformin Hydrochloride,2,A10BD07,Metformin and sitagliptin,Tablet,Oral,02509431,APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE (metformin hydrochloride 1000 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet) APOTEX INC,Active,9014869,metformin hydrochloride 1000 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102261,Marketed,2024-03-08,02533642,Apo-Methadone,1,N07BC02,Methadone,Tablet,Oral,02533642,APO-METHADONE (methadone hydrochloride 1 mg oral tablet) APOTEX INC,Active,9001042,methadone hydrochloride 1 mg oral tablet,8000285,methadone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
102262,Marketed,2024-03-08,02533650,Apo-Methadone,1,N07BC02,Methadone,Tablet,Oral,02533650,APO-METHADONE (methadone hydrochloride 5 mg oral tablet) APOTEX INC,Active,9001044,methadone hydrochloride 5 mg oral tablet,8000285,methadone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
102263,Marketed,2024-03-08,02533669,Apo-Methadone,1,N07BC02,Methadone,Tablet,Oral,02533669,APO-METHADONE (methadone hydrochloride 10 mg oral tablet) APOTEX INC,Active,9001041,methadone hydrochloride 10 mg oral tablet,8000285,methadone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
102264,Marketed,2024-03-08,02533677,Apo-Methadone,1,N07BC02,Methadone,Tablet,Oral,02533677,APO-METHADONE (methadone hydrochloride 25 mg oral tablet) APOTEX INC,Active,9001043,methadone hydrochloride 25 mg oral tablet,8000285,methadone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
104168,Marketed,2025-02-14,02552728,PMS-Methadone Hydrochloride Oral Concentrate,1,N07BC02,Methadone,Solution,Oral,02552728,"PMS-METHADONE HYDROCHLORIDE ORAL CONCENTRATE DYE-FREE, SUGAR-FREE, UNFLAVORED (methadone hydrochloride 10 mg per mL oral solution) PHARMASCIENCE INC",Active,9001395,methadone hydrochloride 10 mg per mL oral solution,8000285,methadone,26643006,Oral,385023001,Oral solution,,,,1.0,,Narcotics (CDSA I)
104169,Marketed,2025-02-14,02552736,PMS-Methadone Hydrochloride Oral Concentrate,1,N07BC02,Methadone,Solution,Oral,02552736,PMS-METHADONE HYDROCHLORIDE ORAL CONCENTRATE CHERRY FLAVORED (methadone hydrochloride 10 mg per mL oral solution) PHARMASCIENCE INC,Active,9001395,methadone hydrochloride 10 mg per mL oral solution,8000285,methadone,26643006,Oral,385023001,Oral solution,,,,1.0,,Narcotics (CDSA I)
65010,Marketed,2026-03-20,02241377,Metadol,1,N07BC02,Methadone,Solution,Oral,02241377,METADOL (methadone hydrochloride 10 mg per mL oral solution) KNIGHT THERAPEUTICS INC.,Active,9001395,methadone hydrochloride 10 mg per mL oral solution,8000285,methadone,26643006,Oral,385023001,Oral solution,,,,1.0,,Narcotics (CDSA I)
68257,Marketed,2026-03-05,02244290,Metadol-D,1,N07BC02,Methadone,Solution,Oral,02244290,METADOL-D (methadone hydrochloride 10 mg per mL oral solution) KNIGHT THERAPEUTICS INC.,Active,9001395,methadone hydrochloride 10 mg per mL oral solution,8000285,methadone,26643006,Oral,385023001,Oral solution,,,,1.0,,Narcotics (CDSA I)
71619,Marketed,2026-03-05,02247374,Metadol-D,1,N07BC02,Methadone,Solution,Oral,02247374,METADOL-D (methadone hydrochloride 1 mg per mL oral solution) KNIGHT THERAPEUTICS INC.,Active,9001034,methadone hydrochloride 1 mg per mL oral solution,8000285,methadone,26643006,Oral,385023001,Oral solution,,,,1.0,,Narcotics (CDSA I)
71958,Marketed,2026-03-20,02247694,Metadol,1,N07BC02,Methadone,Solution,Oral,02247694,METADOL (methadone hydrochloride 1 mg per mL oral solution) KNIGHT THERAPEUTICS INC.,Active,9001034,methadone hydrochloride 1 mg per mL oral solution,8000285,methadone,26643006,Oral,385023001,Oral solution,,,,1.0,,Narcotics (CDSA I)
71959,Marketed,2026-03-20,02247698,Metadol,1,N07BC02,Methadone,Tablet,Oral,02247698,METADOL (methadone hydrochloride 1 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9001042,methadone hydrochloride 1 mg oral tablet,8000285,methadone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
71963,Marketed,2026-03-20,02247699,Metadol,1,N07BC02,Methadone,Tablet,Oral,02247699,METADOL (methadone hydrochloride 5 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9001044,methadone hydrochloride 5 mg oral tablet,8000285,methadone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
71964,Marketed,2026-03-20,02247700,Metadol,1,N07BC02,Methadone,Tablet,Oral,02247700,METADOL (methadone hydrochloride 10 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9001041,methadone hydrochloride 10 mg oral tablet,8000285,methadone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
71965,Marketed,2026-03-20,02247701,Metadol,1,N07BC02,Methadone,Tablet,Oral,02247701,METADOL (methadone hydrochloride 25 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9001043,methadone hydrochloride 25 mg oral tablet,8000285,methadone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
87974,Marketed,2013-01-03,02394596,Methadose,1,N07BC02,Methadone,Solution,Oral,02394596,METHADOSE (methadone hydrochloride 10 mg per mL oral solution) MALLINCKRODT CANADA ULC,Active,9001395,methadone hydrochloride 10 mg per mL oral solution,8000285,methadone,26643006,Oral,385023001,Oral solution,,,,1.0,,Narcotics (CDSA I)
87975,Marketed,2013-01-03,02394618,Methadose,1,N07BC02,Methadone,Solution,Oral,02394618,"METHADOSE DYE FREE, SUGAR FREE, UNFLAVORED (methadone hydrochloride 10 mg per mL oral solution) MALLINCKRODT CANADA ULC",Active,9001395,methadone hydrochloride 10 mg per mL oral solution,8000285,methadone,26643006,Oral,385023001,Oral solution,,,,1.0,,Narcotics (CDSA I)
98568,Marketed,2020-10-30,02495783,JAMP Methadone Oral Concentrate,1,N07BC02,Methadone,Solution,Oral,02495783,JAMP METHADONE ORAL CONCENTRATE (methadone hydrochloride 10 mg per mL oral solution) JAMP PHARMA CORPORATION,Active,9001395,methadone hydrochloride 10 mg per mL oral solution,8000285,methadone,26643006,Oral,385023001,Oral solution,,,,1.0,,Narcotics (CDSA I)
98577,Marketed,2020-06-17,02495872,Odan-Methadone,1,N07BC02,Methadone,Solution,Oral,02495872,ODAN-METHADONE (methadone hydrochloride 10 mg per mL oral solution) ODAN LABORATORIES LTD,Active,9001395,methadone hydrochloride 10 mg per mL oral solution,8000285,methadone,26643006,Oral,385023001,Oral solution,,,,1.0,,Narcotics (CDSA I)
98578,Marketed,2020-06-17,02495880,Odan-Methadone,1,N07BC02,Methadone,Solution,Oral,02495880,"ODAN-METHADONE DYE FREE, SUGAR FREE, UNFLAVORED (methadone hydrochloride 10 mg per mL oral solution) ODAN LABORATORIES LTD",Active,9001395,methadone hydrochloride 10 mg per mL oral solution,8000285,methadone,26643006,Oral,385023001,Oral solution,,,,1.0,,Narcotics (CDSA I)
69999,Marketed,2011-05-10,02245882,Methazolamide,1,S01EC05,Methazolamide,Tablet,Oral,02245882,METHAZOLAMIDE (methazolamide 50 mg oral tablet) AA PHARMA INC,Active,9003738,methazolamide 50 mg oral tablet,8001853,methazolamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
13624,Marketed,2024-11-19,01932187,Robaxin 750,1,M03BA03,Methocarbamol,Tablet,Oral,01932187,ROBAXIN 750 (methocarbamol 750 mg oral tablet) HALEON CANADA ULC,Active,9002595,methocarbamol 750 mg oral tablet,8001854,methocarbamol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
14509,Marketed,2024-09-24,02026805,Robaxacet,2,M03BA53,"Methocarbamol, combinations excl psycholeptics",Tablet,Oral,02026805,ROBAXACET (acetaminophen 325 mg and methocarbamol 400 mg oral tablet) HALEON CANADA ULC,Active,9002511,acetaminophen 325 mg and methocarbamol 400 mg oral tablet,8000869,acetaminophen and methocarbamol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
50062,Marketed,2001-10-17,02230790,Muscle & Back Pain Relief Caplets,2,M03BA53,"Methocarbamol, combinations excl psycholeptics",Tablet,Oral,02230790,MUSCLE & BACK PAIN RELIEF CAPLETS (acetaminophen 325 mg and methocarbamol 400 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9002511,acetaminophen 325 mg and methocarbamol 400 mg oral tablet,8000869,acetaminophen and methocarbamol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
50227,Marketed,2024-10-09,02230949,Robaxisal Extra Strength,2,M03BA53,"Methocarbamol, combinations excl psycholeptics",Tablet,Oral,02230949,ROBAXISAL EXTRA STRENGTH (acetylsalicylic acid 500 mg and methocarbamol 400 mg oral tablet) HALEON CANADA ULC,Active,9003112,acetylsalicylic acid 500 mg and methocarbamol 400 mg oral tablet,8000901,acetylsalicylic acid and methocarbamol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
50484,Marketed,2024-12-02,02231176,Robaxacet Extra Strength,2,M03BA53,"Methocarbamol, combinations excl psycholeptics",Tablet,Oral,02231176,ROBAXACET EXTRA STRENGTH (acetaminophen 500 mg and methocarbamol 400 mg oral tablet) HALEON CANADA ULC,Active,9003111,acetaminophen 500 mg and methocarbamol 400 mg oral tablet,8000869,acetaminophen and methocarbamol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
62597,Marketed,2002-01-23,02239141,Extra Strength Muscle & Back Pain Relief,2,M03BA53,"Methocarbamol, combinations excl psycholeptics",Tablet,Oral,02239141,EXTRA STRENGTH MUSCLE & BACK PAIN RELIEF (acetaminophen 500 mg and methocarbamol 400 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9003111,acetaminophen 500 mg and methocarbamol 400 mg oral tablet,8000869,acetaminophen and methocarbamol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
71388,Marketed,2025-08-28,02247147,Robax Platinum,2,M03BA53,"Methocarbamol, combinations excl psycholeptics",Tablet,Oral,02247147,ROBAX PLATINUM (ibuprofen 200 mg and methocarbamol 500 mg oral tablet) HALEON CANADA ULC,Active,9003811,ibuprofen 200 mg and methocarbamol 500 mg oral tablet,8000936,ibuprofen and methocarbamol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
73710,Marketed,2005-05-01,02252228,Extra Strength Muscle & Back Pain ASA 500 mg Methocarbamol 400 mg & Acetylsalicylic Acid 500 mg,2,M03BA53,"Methocarbamol, combinations excl psycholeptics",Tablet,Oral,02252228,EXTRA STRENGTH MUSCLE & BACK PAIN ASA 500 MG METHOCARBAMOL 400 MG & ACETYLSALICYLIC ACID 500 MG (acetylsalicylic acid 500 mg and methocarbamol 400 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9003112,acetylsalicylic acid 500 mg and methocarbamol 400 mg oral tablet,8000901,acetylsalicylic acid and methocarbamol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
77584,Marketed,2026-04-09,02290510,Extra Strength Tylenol Back Pain,2,M03BA53,"Methocarbamol, combinations excl psycholeptics",Tablet,Oral,02290510,EXTRA STRENGTH TYLENOL BACK PAIN (acetaminophen 500 mg and methocarbamol 400 mg oral tablet) KENVUE CANADA INC.,Active,9003111,acetaminophen 500 mg and methocarbamol 400 mg oral tablet,8000869,acetaminophen and methocarbamol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
84247,Marketed,2026-04-08,02357356,Extra Strength Tylenol Body Pain Night,2,M03BA53,"Methocarbamol, combinations excl psycholeptics",Tablet,Oral,02357356,EXTRA STRENGTH TYLENOL BODY PAIN NIGHT (acetaminophen 500 mg and methocarbamol 400 mg oral tablet) KENVUE CANADA INC.,Active,9003111,acetaminophen 500 mg and methocarbamol 400 mg oral tablet,8000869,acetaminophen and methocarbamol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
90351,Marketed,2026-02-26,02418967,Motrin Platinum Muscle & Body,2,M03BA53,"Methocarbamol, combinations excl psycholeptics",Tablet,Oral,02418967,MOTRIN PLATINUM MUSCLE & BODY (ibuprofen 200 mg and methocarbamol 500 mg oral tablet) KENVUE CANADA INC.,Active,9003811,ibuprofen 200 mg and methocarbamol 500 mg oral tablet,8000936,ibuprofen and methocarbamol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
90673,Marketed,2014-06-17,02422042,Muscle And Back Pain Platinum Relief,2,M03BA53,"Methocarbamol, combinations excl psycholeptics",Tablet,Oral,02422042,MUSCLE AND BACK PAIN PLATINUM RELIEF (ibuprofen 200 mg and methocarbamol 500 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9003811,ibuprofen 200 mg and methocarbamol 500 mg oral tablet,8000936,ibuprofen and methocarbamol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
91119,Marketed,2014-09-04,02426625,Extra Strength Muscle & Back Pain Relief With ASA,2,M03BA53,"Methocarbamol, combinations excl psycholeptics",Tablet,Oral,02426625,EXTRA STRENGTH MUSCLE & BACK PAIN RELIEF WITH ASA (acetylsalicylic acid 500 mg and methocarbamol 400 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9003112,acetylsalicylic acid 500 mg and methocarbamol 400 mg oral tablet,8000901,acetylsalicylic acid and methocarbamol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
93755,Marketed,2018-04-03,02451298,Muscle And Back Pain Relief,2,M03BA53,"Methocarbamol, combinations excl psycholeptics",Tablet,Oral,02451298,MUSCLE AND BACK PAIN RELIEF (acetaminophen 500 mg and methocarbamol 400 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9003111,acetaminophen 500 mg and methocarbamol 400 mg oral tablet,8000869,acetaminophen and methocarbamol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
101306,Marketed,2023-02-02,02524023,Auro-Methotrexate,1,L04AX03,Methotrexate,Tablet,Oral,02524023,AURO-METHOTREXATE (methotrexate 2.5 mg oral tablet) AURO PHARMA INC,Active,9000870,methotrexate 2.5 mg oral tablet,8000217,methotrexate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101993,Marketed,2025-07-02,02530775,Methofill Self-Dose Injector,1,L04AX03,Methotrexate,Solution,Subcutaneous,02530775,METHOFILL SELF-DOSE INJECTOR (methotrexate (methotrexate sodium) 10 mg per 0.2 mL solution for injection syringe) ACCORD HEALTHCARE INC,Active,9014180,methotrexate (methotrexate sodium) 10 mg per 0.2 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
101994,Marketed,2025-07-02,02530783,Methofill Self-Dose Injector,1,L04AX03,Methotrexate,Solution,Subcutaneous,02530783,METHOFILL SELF-DOSE INJECTOR (methotrexate (methotrexate sodium) 12.5 mg per 0.25 mL solution for injection syringe) ACCORD HEALTHCARE INC,Active,9014181,methotrexate (methotrexate sodium) 12.5 mg per 0.25 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
101995,Marketed,2025-07-02,02530791,Methofill Self-Dose Injector,1,L04AX03,Methotrexate,Solution,Subcutaneous,02530791,METHOFILL SELF-DOSE INJECTOR (methotrexate (methotrexate sodium) 15 mg per 0.3 mL solution for injection syringe) ACCORD HEALTHCARE INC,Active,9013923,methotrexate (methotrexate sodium) 15 mg per 0.3 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
101996,Marketed,2025-07-02,02530805,Methofill Self-Dose Injector,1,L04AX03,Methotrexate,Solution,Subcutaneous,02530805,METHOFILL SELF-DOSE INJECTOR (methotrexate (methotrexate sodium) 17.5 mg per 0.35 mL solution for injection syringe) ACCORD HEALTHCARE INC,Active,9012579,methotrexate (methotrexate sodium) 17.5 mg per 0.35 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
101999,Marketed,2025-07-02,02530813,Methofill Self-Dose Injector,1,L04AX03,Methotrexate,Solution,Subcutaneous,02530813,METHOFILL SELF-DOSE INJECTOR (methotrexate (methotrexate sodium) 20 mg per 0.4 mL solution for injection syringe) ACCORD HEALTHCARE INC,Active,9012580,methotrexate (methotrexate sodium) 20 mg per 0.4 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
102001,Marketed,2025-07-02,02530848,Methofill Self-Dose Injector,1,L04AX03,Methotrexate,Solution,Subcutaneous,02530848,METHOFILL SELF-DOSE INJECTOR (methotrexate (methotrexate sodium) 22.5 mg per 0.45 mL solution for injection syringe) ACCORD HEALTHCARE INC,Active,9012581,methotrexate (methotrexate sodium) 22.5 mg per 0.45 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
102002,Marketed,2025-07-02,02530856,Methofill Self-Dose Injector,1,L04AX03,Methotrexate,Solution,Subcutaneous,02530856,METHOFILL SELF-DOSE INJECTOR (methotrexate (methotrexate sodium) 25 mg per 0.5 mL solution for injection syringe) ACCORD HEALTHCARE INC,Active,9012582,methotrexate (methotrexate sodium) 25 mg per 0.5 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
102380,Marketed,2024-04-24,02534916,M-Methotrexate,1,L01BA01,Methotrexate,Tablet,Oral,02534916,M-METHOTREXATE (methotrexate 2.5 mg oral tablet) MANTRA PHARMA INC,Active,9000870,methotrexate 2.5 mg oral tablet,8000217,methotrexate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102835,Marketed,2024-03-14,02539608,PMS-Methotrexate Injection,1,L04AX03,Methotrexate,Solution,Subcutaneous,02539608,PMS-METHOTREXATE INJECTION (methotrexate (methotrexate sodium) 10 mg per 0.2 mL solution for injection syringe) PHARMASCIENCE INC,Active,9014180,methotrexate (methotrexate sodium) 10 mg per 0.2 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
102836,Marketed,2024-03-14,02539616,PMS-Methotrexate Injection,1,L04AX03,Methotrexate,Solution,Subcutaneous,02539616,PMS-METHOTREXATE INJECTION (methotrexate (methotrexate sodium) 12.5 mg per 0.25 mL solution for injection syringe) PHARMASCIENCE INC,Active,9014181,methotrexate (methotrexate sodium) 12.5 mg per 0.25 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
102837,Marketed,2024-03-14,02539624,PMS-Methotrexate Injection,1,L04AX03,Methotrexate,Solution,Subcutaneous,02539624,PMS-METHOTREXATE INJECTION (methotrexate (methotrexate sodium) 15 mg per 0.3 mL solution for injection syringe) PHARMASCIENCE INC,Active,9013923,methotrexate (methotrexate sodium) 15 mg per 0.3 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
102838,Marketed,2024-03-14,02539632,PMS-Methotrexate Injection,1,L04AX03,Methotrexate,Solution,Subcutaneous,02539632,PMS-METHOTREXATE INJECTION (methotrexate (methotrexate sodium) 17.5 mg per 0.35 mL solution for injection syringe) PHARMASCIENCE INC,Active,9012579,methotrexate (methotrexate sodium) 17.5 mg per 0.35 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
102839,Marketed,2024-03-14,02539640,PMS-Methotrexate Injection,1,L04AX03,Methotrexate,Solution,Subcutaneous,02539640,PMS-METHOTREXATE INJECTION (methotrexate (methotrexate sodium) 20 mg per 0.4 mL solution for injection syringe) PHARMASCIENCE INC,Active,9012580,methotrexate (methotrexate sodium) 20 mg per 0.4 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
102840,Marketed,2024-03-14,02539659,PMS-Methotrexate Injection,1,L04AX03,Methotrexate,Solution,Subcutaneous,02539659,PMS-METHOTREXATE INJECTION (methotrexate (methotrexate sodium) 22.5 mg per 0.45 mL solution for injection syringe) PHARMASCIENCE INC,Active,9012581,methotrexate (methotrexate sodium) 22.5 mg per 0.45 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
102841,Marketed,2024-03-14,02539667,PMS-Methotrexate Injection,1,L04AX03,Methotrexate,Solution,Subcutaneous,02539667,PMS-METHOTREXATE INJECTION (methotrexate (methotrexate sodium) 25 mg per 0.5 mL solution for injection syringe) PHARMASCIENCE INC,Active,9012582,methotrexate (methotrexate sodium) 25 mg per 0.5 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
104265,Marketed,2025-06-10,02553740,JAMP Methotrexate Tablets,1,L01BA01,Methotrexate,Tablet,Oral,02553740,JAMP METHOTREXATE TABLETS (methotrexate 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001077,methotrexate 10 mg oral tablet,8000217,methotrexate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
106487,Marketed,2025-11-28,02561956,PMS-Methotrexate Tablets,1,L01BA01,Methotrexate,Tablet,Oral,02561956,PMS-METHOTREXATE TABLETS (methotrexate 10 mg oral tablet) PHARMASCIENCE INC,Active,9001077,methotrexate 10 mg oral tablet,8000217,methotrexate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
19681,Marketed,2017-08-31,02099705,Methotrexate Sodium Injection,1,L01BA01,Methotrexate,Solution,"Intrathecal,Intravenous,Intramuscular,Intra-arterial,Intracerebroventricular",77700329,METHOTREXATE SODIUM INJECTION (methotrexate (methotrexate sodium) 1000 mg per 40 mL solution for injection vial) TEVA CANADA LIMITED,Active,9000610,methotrexate (methotrexate sodium) 1000 mg per 40 mL solution for injection vial,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
19681,Marketed,2017-08-31,02099705,Methotrexate Sodium Injection,1,L01BA01,Methotrexate,Solution,"Intrathecal,Intravenous,Intramuscular,Intra-arterial,Intracerebroventricular",77700330,METHOTREXATE SODIUM INJECTION (methotrexate (methotrexate sodium) 500 mg per 20 mL solution for injection vial) TEVA CANADA LIMITED,Active,9000611,methotrexate (methotrexate sodium) 500 mg per 20 mL solution for injection vial,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
19681,Marketed,2017-08-31,02099705,Methotrexate Sodium Injection,1,L01BA01,Methotrexate,Solution,"Intrathecal,Intravenous,Intramuscular,Intra-arterial,Intracerebroventricular",77700331,METHOTREXATE SODIUM INJECTION (methotrexate (methotrexate sodium) 50 mg per 2 mL solution for injection vial) TEVA CANADA LIMITED,Active,9000612,methotrexate (methotrexate sodium) 50 mg per 2 mL solution for injection vial,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
42842,Marketed,2017-08-17,02182750,"Methotrexate Tablets, USP",1,L01BA01,Methotrexate,Tablet,Oral,02182750,"METHOTREXATE TABLETS, USP (methotrexate 10 mg oral tablet) PFIZER CANADA ULC",Active,9001077,methotrexate 10 mg oral tablet,8000217,methotrexate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
42844,Marketed,2018-08-23,02182777,Methotrexate Injection USP,1,L01BA01,Methotrexate,Solution,"Intravenous,Intra-arterial,Intramuscular",77701012,METHOTREXATE INJECTION USP WITH PRESERVATIVE (MULTIDOSE VIALS) (methotrexate (methotrexate sodium) 500 mg per 20 mL solution for injection vial) PFIZER CANADA ULC,Active,9000611,methotrexate (methotrexate sodium) 500 mg per 20 mL solution for injection vial,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
42844,Marketed,2018-08-23,02182777,Methotrexate Injection USP,1,L01BA01,Methotrexate,Solution,"Intravenous,Intra-arterial,Intramuscular",77701013,METHOTREXATE INJECTION USP WITH PRESERVATIVE (MULTIDOSE VIALS) (methotrexate (methotrexate sodium) 50 mg per 2 mL solution for injection vial) PFIZER CANADA ULC,Active,9000612,methotrexate (methotrexate sodium) 50 mg per 2 mL solution for injection vial,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
44161,Marketed,2018-10-04,02170698,PMS-Methotrexate,1,L01BA01,Methotrexate,Tablet,Oral,02170698,PMS-METHOTREXATE (methotrexate 2.5 mg oral tablet) PHARMASCIENCE INC,Active,9000870,methotrexate 2.5 mg oral tablet,8000217,methotrexate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
44261,Marketed,2017-06-06,02182947,Methotrexate Injection USP,1,L01BA01,Methotrexate,Solution,"Intravenous,Intramuscular,Intracerebroventricular,Intra-arterial,Intrathecal",02182947,METHOTREXATE INJECTION USP (methotrexate (methotrexate sodium) 20 mg per 2 mL solution for injection vial) PFIZER CANADA ULC,Active,9000738,methotrexate (methotrexate sodium) 20 mg per 2 mL solution for injection vial,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
44262,Marketed,2017-06-06,02182955,Methotrexate Injection USP,1,L01BA01,Methotrexate,Solution,"Intrathecal,Intravenous,Intracerebroventricular,Intramuscular,Intra-arterial",02182955,METHOTREXATE INJECTION USP SINGLE USE VIALS. PRESERVATIVE-FREE (methotrexate (methotrexate sodium) 50 mg per 2 mL solution for injection vial) PFIZER CANADA ULC,Active,9000612,methotrexate (methotrexate sodium) 50 mg per 2 mL solution for injection vial,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
44263,Marketed,2021-07-22,02182963,Apo-Methotrexate,1,L01BA01,Methotrexate,Tablet,Oral,02182963,APO-METHOTREXATE (methotrexate 2.5 mg oral tablet) APOTEX INC,Active,9000870,methotrexate 2.5 mg oral tablet,8000217,methotrexate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
44264,Marketed,2018-04-23,02182971,Methotrexate Injection USP,1,L01BA01,Methotrexate,Solution,Intravenous,77701014,METHOTREXATE INJECTION USP PRESERVATIVE-FREE (PHARMACY BULK VIAL) (methotrexate (methotrexate sodium) 2500 mg per 100 mL solution for injection vial) PFIZER CANADA ULC,Active,9014050,methotrexate (methotrexate sodium) 2500 mg per 100 mL solution for injection vial,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
44264,Marketed,2018-04-23,02182971,Methotrexate Injection USP,1,L01BA01,Methotrexate,Solution,Intravenous,77701015,METHOTREXATE INJECTION USP PRESERVATIVE-FREE (PHARMACY BULK VIAL) (methotrexate (methotrexate sodium) 1000 mg per 40 mL solution for injection vial) PFIZER CANADA ULC,Active,9000610,methotrexate (methotrexate sodium) 1000 mg per 40 mL solution for injection vial,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
44264,Marketed,2018-04-23,02182971,Methotrexate Injection USP,1,L01BA01,Methotrexate,Solution,Intravenous,77701016,METHOTREXATE INJECTION USP PRESERVATIVE-FREE (PHARMACY BULK VIAL) (methotrexate (methotrexate sodium) 500 mg per 20 mL solution for injection vial) PFIZER CANADA ULC,Active,9000611,methotrexate (methotrexate sodium) 500 mg per 20 mL solution for injection vial,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
81253,Marketed,2019-08-26,02327236,Methotrexate Injection BP,1,L01BA01,Methotrexate,Solution,"Intravenous,Intracerebroventricular,Intrathecal,Intramuscular,Intra-arterial",77700324,METHOTREXATE INJECTION BP (methotrexate (methotrexate sodium) 50 mg per 2 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9000612,methotrexate (methotrexate sodium) 50 mg per 2 mL solution for injection vial,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
90687,Marketed,2024-09-12,02422166,"Methotrexate Injection, BP",1,L01BA01,Methotrexate,Solution,"Intramuscular,Intravenous",02422166,"METHOTREXATE INJECTION, BP (methotrexate (methotrexate sodium) 7.5 mg per 0.3 mL solution for injection syringe) PHARMASCIENCE INC",Active,9013828,methotrexate (methotrexate sodium) 7.5 mg per 0.3 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
90688,Marketed,2024-09-12,02422174,"Methotrexate Injection, BP",1,L01BA01,Methotrexate,Solution,"Intravenous,Intramuscular",02422174,"METHOTREXATE INJECTION, BP (methotrexate (methotrexate sodium) 10 mg per 0.4 mL solution for injection syringe) PHARMASCIENCE INC",Active,9013825,methotrexate (methotrexate sodium) 10 mg per 0.4 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
90689,Marketed,2024-09-12,02422182,"Methotrexate Injection, BP",1,L01BA01,Methotrexate,Solution,"Intravenous,Intramuscular",02422182,"METHOTREXATE INJECTION, BP (methotrexate (methotrexate sodium) 15 mg per 0.6 mL solution for injection syringe) PHARMASCIENCE INC",Active,9013826,methotrexate (methotrexate sodium) 15 mg per 0.6 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
90690,Marketed,2024-09-12,02422190,"Methotrexate Injection, BP",1,L01BA01,Methotrexate,Solution,"Intramuscular,Intravenous",02422190,"METHOTREXATE INJECTION, BP (methotrexate (methotrexate sodium) 20 mg per 0.8 mL solution for injection syringe) PHARMASCIENCE INC",Active,9013827,methotrexate (methotrexate sodium) 20 mg per 0.8 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
90691,Marketed,2024-09-12,02422204,"Methotrexate Injection, BP",1,L01BA01,Methotrexate,Solution,"Intravenous,Intramuscular",02422204,"METHOTREXATE INJECTION, BP (methotrexate (methotrexate sodium) 25 mg per 1 mL solution for injection syringe) PHARMASCIENCE INC",Active,9013231,methotrexate (methotrexate sodium) 25 mg per 1 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
94144,Marketed,2019-09-16,02454750,Metoject Subcutaneous,1,L04AX03,Methotrexate,Solution,Subcutaneous,02454750,METOJECT SUBCUTANEOUS (methotrexate (methotrexate sodium) 12.5 mg per 0.25 mL solution for injection syringe) MEDEXUS PHARMACEUTICALS INC.,Active,9014181,methotrexate (methotrexate sodium) 12.5 mg per 0.25 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
94145,Marketed,2016-12-02,02454769,Metoject Subcutaneous,1,L04AX03,Methotrexate,Solution,Subcutaneous,02454769,METOJECT SUBCUTANEOUS (methotrexate (methotrexate sodium) 17.5 mg per 0.35 mL solution for injection syringe) MEDEXUS PHARMACEUTICALS INC.,Active,9012579,methotrexate (methotrexate sodium) 17.5 mg per 0.35 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
94146,Marketed,2016-12-02,02454777,Metoject Subcutaneous,1,L04AX03,Methotrexate,Solution,Subcutaneous,02454777,METOJECT SUBCUTANEOUS (methotrexate (methotrexate sodium) 22.5 mg per 0.45 mL solution for injection syringe) MEDEXUS PHARMACEUTICALS INC.,Active,9012581,methotrexate (methotrexate sodium) 22.5 mg per 0.45 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
94161,Marketed,2019-09-16,02454831,Metoject Subcutaneous,1,L04AX03,Methotrexate,Solution,Subcutaneous,02454831,METOJECT SUBCUTANEOUS (methotrexate (methotrexate sodium) 10 mg per 0.2 mL solution for injection syringe) MEDEXUS PHARMACEUTICALS INC.,Active,9014180,methotrexate (methotrexate sodium) 10 mg per 0.2 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
94162,Marketed,2018-11-30,02454858,Metoject Subcutaneous,1,L04AX03,Methotrexate,Solution,Subcutaneous,02454858,METOJECT SUBCUTANEOUS (methotrexate (methotrexate sodium) 15 mg per 0.3 mL solution for injection syringe) MEDEXUS PHARMACEUTICALS INC.,Active,9013923,methotrexate (methotrexate sodium) 15 mg per 0.3 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
94163,Marketed,2016-12-02,02454866,Metoject Subcutaneous,1,L04AX03,Methotrexate,Solution,Subcutaneous,02454866,METOJECT SUBCUTANEOUS (methotrexate (methotrexate sodium) 20 mg per 0.4 mL solution for injection syringe) MEDEXUS PHARMACEUTICALS INC.,Active,9012580,methotrexate (methotrexate sodium) 20 mg per 0.4 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
94164,Marketed,2016-12-02,02454874,Metoject Subcutaneous,1,L04AX03,Methotrexate,Solution,Subcutaneous,02454874,METOJECT SUBCUTANEOUS (methotrexate (methotrexate sodium) 25 mg per 0.5 mL solution for injection syringe) MEDEXUS PHARMACEUTICALS INC.,Active,9012582,methotrexate (methotrexate sodium) 25 mg per 0.5 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
95252,Marketed,2020-10-22,02464365,Methotrexate Injection BP,1,L01BA01,Methotrexate,Solution,"Intravenous,Intra-arterial,Intramuscular",77701021,METHOTREXATE INJECTION BP WITH PRESERVATIVE (MULTIDOSE VIALS) (methotrexate (methotrexate sodium) 50 mg per 2 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9000612,methotrexate (methotrexate sodium) 50 mg per 2 mL solution for injection vial,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
95252,Marketed,2020-10-22,02464365,Methotrexate Injection BP,1,L01BA01,Methotrexate,Solution,"Intravenous,Intra-arterial,Intramuscular",77701022,METHOTREXATE INJECTION BP WITH PRESERVATIVE (MULTIDOSE VIALS) (methotrexate (methotrexate sodium) 500 mg per 20 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9000611,methotrexate (methotrexate sodium) 500 mg per 20 mL solution for injection vial,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
96492,Marketed,2019-04-23,02474735,Methotrexate Injection BP,1,L01BA01,Methotrexate,Solution,Intravenous,02474735,METHOTREXATE INJECTION BP WITHOUT PRESERVATIVE (20 ML SINGLE-USE VIALS) (methotrexate (methotrexate sodium) 500 mg per 20 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9000611,methotrexate (methotrexate sodium) 500 mg per 20 mL solution for injection vial,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
96511,Marketed,2019-04-23,02474891,Methotrexate Injection BP,1,L01BA01,Methotrexate,Solution,Intravenous,02474891,METHOTREXATE INJECTION BP (methotrexate (methotrexate sodium) 1000 mg per 40 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9000610,methotrexate (methotrexate sodium) 1000 mg per 40 mL solution for injection vial,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
98130,Marketed,2025-10-20,02491281,Methotrexate Subcutaneous,1,L04AX03,Methotrexate,Solution,Subcutaneous,02491281,METHOTREXATE SUBCUTANEOUS (methotrexate (methotrexate sodium) 10 mg per 0.2 mL solution for injection syringe) ACCORD HEALTHCARE INC,Active,9014180,methotrexate (methotrexate sodium) 10 mg per 0.2 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
98131,Marketed,2025-10-20,02491303,Methotrexate Subcutaneous,1,L04AX03,Methotrexate,Solution,Subcutaneous,02491303,METHOTREXATE SUBCUTANEOUS (methotrexate (methotrexate sodium) 12.5 mg per 0.25 mL solution for injection syringe) ACCORD HEALTHCARE INC,Active,9014181,methotrexate (methotrexate sodium) 12.5 mg per 0.25 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
98132,Marketed,2020-06-02,02491311,Methotrexate Subcutaneous,1,L04AX03,Methotrexate,Solution,Subcutaneous,02491311,METHOTREXATE SUBCUTANEOUS (methotrexate (methotrexate sodium) 15 mg per 0.3 mL solution for injection syringe) ACCORD HEALTHCARE INC,Active,9013923,methotrexate (methotrexate sodium) 15 mg per 0.3 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
98133,Marketed,2020-02-28,02491338,Methotrexate Subcutaneous,1,L04AX03,Methotrexate,Solution,Subcutaneous,02491338,METHOTREXATE SUBCUTANEOUS (methotrexate (methotrexate sodium) 17.5 mg per 0.35 mL solution for injection syringe) ACCORD HEALTHCARE INC,Active,9012579,methotrexate (methotrexate sodium) 17.5 mg per 0.35 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
98134,Marketed,2020-02-28,02491346,Methotrexate Subcutaneous,1,L04AX03,Methotrexate,Solution,Subcutaneous,02491346,METHOTREXATE SUBCUTANEOUS (methotrexate (methotrexate sodium) 20 mg per 0.4 mL solution for injection syringe) ACCORD HEALTHCARE INC,Active,9012580,methotrexate (methotrexate sodium) 20 mg per 0.4 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
98135,Marketed,2020-02-28,02491354,Methotrexate Subcutaneous,1,L04AX03,Methotrexate,Solution,Subcutaneous,02491354,METHOTREXATE SUBCUTANEOUS (methotrexate (methotrexate sodium) 22.5 mg per 0.45 mL solution for injection syringe) ACCORD HEALTHCARE INC,Active,9012581,methotrexate (methotrexate sodium) 22.5 mg per 0.45 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
98136,Marketed,2020-02-28,02491362,Methotrexate Subcutaneous,1,L04AX03,Methotrexate,Solution,Subcutaneous,02491362,METHOTREXATE SUBCUTANEOUS (methotrexate (methotrexate sodium) 25 mg per 0.5 mL solution for injection syringe) ACCORD HEALTHCARE INC,Active,9012582,methotrexate (methotrexate sodium) 25 mg per 0.5 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
99838,Marketed,2021-10-21,02509067,ACH-Methotrexate,1,L01BA01,Methotrexate,Tablet,Oral,02509067,ACH-METHOTREXATE (methotrexate 2.5 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000870,methotrexate 2.5 mg oral tablet,8000217,methotrexate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
89096,Marketed,2013-12-09,02406233,Uvadex,1,D05BA02,"Methoxalen, systemic",Solution,Extracorporeal,02406233,UVADEX (methoxsalen 200 mcg per 10 mL solution for blood fraction modification vial) THERAKOS LLC,Active,9015308,methoxsalen 200 mcg per 10 mL solution for blood fraction modification vial,8001855,methoxsalen,385432009,Not applicable,1008211000202107,Conventional release solution for blood fraction modification (dose form),733026001,Vial,1.0,,,Prescription
96490,Marketed,2022-10-22,02474719,Penthrox,1,N02BG09,Methoxyflurane,Solution,Inhalation,,,,,,,,,,,,,,,,,Prescription
96491,Marketed,2022-10-22,02474727,Penthrox,1,N02BG09,Methoxyflurane,"Solution,Kit",Inhalation,,,,,,,,,,,,,,,,,Prescription
80876,Marketed,2009-06-16,02323273,Metvix,1,L01XD03,Methyl aminolevulinate,Cream,Topical,02323273,METVIX (methyl aminolevulinate (methyl aminolevulinate hydrochloride) 168 mg per g cutaneous cream) GALDERMA CANADA INC.,Active,9004556,methyl aminolevulinate (methyl aminolevulinate hydrochloride) 168 mg per g cutaneous cream,8001563,aminolevulinic acid,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
2470,Marketed,2011-04-04,00360252,Methyldopa,1,C02AB02,Methyldopa (racemic),Tablet,Oral,00360252,METHYLDOPA (methyldopa 125 mg oral tablet) AA PHARMA INC,Active,9001866,methyldopa 125 mg oral tablet,8001145,methyldopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
2471,Marketed,2011-04-04,00360260,Methyldopa,1,C02AB02,Methyldopa (racemic),Tablet,Oral,00360260,METHYLDOPA (methyldopa 250 mg oral tablet) AA PHARMA INC,Active,9001764,methyldopa 250 mg oral tablet,8001145,methyldopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
2909,Marketed,2011-05-10,00426830,Methyldopa,1,C02AB02,Methyldopa (racemic),Tablet,Oral,00426830,METHYLDOPA (methyldopa 500 mg oral tablet) AA PHARMA INC,Active,9001813,methyldopa 500 mg oral tablet,8001145,methyldopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79388,Marketed,2021-01-18,02308215,Relistor,1,A06AH01,Methylnaltrexone bromide,Solution,Subcutaneous,02308215,RELISTOR (methylnaltrexone bromide 12 mg per 0.6 mL solution for injection vial) SALIX PHARMACEUTICALS INC,Active,9013233,methylnaltrexone bromide 12 mg per 0.6 mL solution for injection vial,8001857,methylnaltrexone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
102567,Marketed,2023-10-30,02536943,PMS-Methylphenidate CR,1,N06BA04,Methylphenidate,Capsule (extended release),Oral,02536943,PMS-METHYLPHENIDATE CR (methylphenidate hydrochloride 10 mg prolonged-release oral capsule) PHARMASCIENCE INC,Active,9001165,methylphenidate hydrochloride 10 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA III)
102568,Marketed,2023-10-30,02536951,PMS-Methylphenidate CR,1,N06BA04,Methylphenidate,Capsule (extended release),Oral,02536951,PMS-METHYLPHENIDATE CR (methylphenidate hydrochloride 15 mg prolonged-release oral capsule) PHARMASCIENCE INC,Active,9001166,methylphenidate hydrochloride 15 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA III)
102569,Marketed,2023-10-30,02536978,PMS-Methylphenidate CR,1,N06BA04,Methylphenidate,Capsule (extended release),Oral,02536978,PMS-METHYLPHENIDATE CR (methylphenidate hydrochloride 20 mg prolonged-release oral capsule) PHARMASCIENCE INC,Active,9001167,methylphenidate hydrochloride 20 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA III)
102570,Marketed,2023-10-30,02536986,PMS-Methylphenidate CR,1,N06BA04,Methylphenidate,Capsule (extended release),Oral,02536986,PMS-METHYLPHENIDATE CR (methylphenidate hydrochloride 30 mg prolonged-release oral capsule) PHARMASCIENCE INC,Active,9001168,methylphenidate hydrochloride 30 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA III)
102571,Marketed,2023-10-30,02536994,PMS-Methylphenidate CR,1,N06BA04,Methylphenidate,Capsule (extended release),Oral,02536994,PMS-METHYLPHENIDATE CR (methylphenidate hydrochloride 40 mg prolonged-release oral capsule) PHARMASCIENCE INC,Active,9001169,methylphenidate hydrochloride 40 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA III)
102572,Marketed,2023-10-30,02537001,PMS-Methylphenidate CR,1,N06BA04,Methylphenidate,Capsule (extended release),Oral,02537001,PMS-METHYLPHENIDATE CR (methylphenidate hydrochloride 50 mg prolonged-release oral capsule) PHARMASCIENCE INC,Active,9001170,methylphenidate hydrochloride 50 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA III)
102573,Marketed,2023-10-30,02537028,PMS-Methylphenidate CR,1,N06BA04,Methylphenidate,Capsule (extended release),Oral,02537028,PMS-METHYLPHENIDATE CR (methylphenidate hydrochloride 60 mg prolonged-release oral capsule) PHARMASCIENCE INC,Active,9001171,methylphenidate hydrochloride 60 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA III)
102574,Marketed,2023-10-30,02537036,PMS-Methylphenidate CR,1,N06BA04,Methylphenidate,Capsule (extended release),Oral,02537036,PMS-METHYLPHENIDATE CR (methylphenidate hydrochloride 80 mg prolonged-release oral capsule) PHARMASCIENCE INC,Active,9001189,methylphenidate hydrochloride 80 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA III)
102767,Marketed,2026-05-01,02539004,Taro-Methylphenidate ER,1,N06BA04,Methylphenidate,Tablet (extended-release),Oral,02539004,TARO-METHYLPHENIDATE ER (methylphenidate hydrochloride 18 mg prolonged-release oral tablet) SUN PHARMA CANADA INC,Active,9001038,methylphenidate hydrochloride 18 mg prolonged-release oral tablet,8000010,methylphenidate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA III)
102768,Marketed,2026-05-01,02539012,Taro-Methylphenidate ER,1,N06BA04,Methylphenidate,Tablet (extended-release),Oral,02539012,TARO-METHYLPHENIDATE ER (methylphenidate hydrochloride 27 mg prolonged-release oral tablet) SUN PHARMA CANADA INC,Active,9001100,methylphenidate hydrochloride 27 mg prolonged-release oral tablet,8000010,methylphenidate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA III)
102769,Marketed,2026-05-01,02539020,Taro-Methylphenidate ER,1,N06BA04,Methylphenidate,Tablet (extended-release),Oral,02539020,TARO-METHYLPHENIDATE ER (methylphenidate hydrochloride 36 mg prolonged-release oral tablet) SUN PHARMA CANADA INC,Active,9001039,methylphenidate hydrochloride 36 mg prolonged-release oral tablet,8000010,methylphenidate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA III)
102770,Marketed,2026-05-01,02539039,Taro-Methylphenidate ER,1,N06BA04,Methylphenidate,Tablet (extended-release),Oral,02539039,TARO-METHYLPHENIDATE ER (methylphenidate hydrochloride 54 mg prolonged-release oral tablet) SUN PHARMA CANADA INC,Active,9001040,methylphenidate hydrochloride 54 mg prolonged-release oral tablet,8000010,methylphenidate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA III)
103024,Marketed,2024-06-24,02541602,Quillivant ER Chewable Tablets,1,N06BA04,Methylphenidate,"Tablet (chewable, extended-release)",Oral,02541602,QUILLIVANT ER CHEWABLE TABLETS (methylphenidate hydrochloride 20 mg prolonged-release chewable tablet) KYE PHARMACEUTICALS INC.,Active,9015064,methylphenidate hydrochloride 20 mg prolonged-release chewable tablet,8000010,methylphenidate,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA III)
103025,Marketed,2024-06-24,02541610,Quillivant ER Chewable Tablets,1,N06BA04,Methylphenidate,"Tablet (chewable, extended-release)",Oral,02541610,QUILLIVANT ER CHEWABLE TABLETS (methylphenidate hydrochloride 30 mg prolonged-release chewable tablet) KYE PHARMACEUTICALS INC.,Active,9015065,methylphenidate hydrochloride 30 mg prolonged-release chewable tablet,8000010,methylphenidate,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA III)
103026,Marketed,2024-06-24,02541629,Quillivant ER Chewable Tablets,1,N06BA04,Methylphenidate,"Tablet (chewable, extended-release)",Oral,02541629,QUILLIVANT ER CHEWABLE TABLETS (methylphenidate hydrochloride 40 mg prolonged-release chewable tablet) KYE PHARMACEUTICALS INC.,Active,9015066,methylphenidate hydrochloride 40 mg prolonged-release chewable tablet,8000010,methylphenidate,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA III)
103027,Marketed,2024-08-19,02541637,Quillivant ER Oral Suspension,1,N06BA04,Methylphenidate,Powder (extended release),Oral,02541637,QUILLIVANT ER ORAL SUSPENSION (methylphenidate hydrochloride 5 mg per mL powder for prolonged-release oral suspension) KYE PHARMACEUTICALS INC.,Active,9015083,methylphenidate hydrochloride 5 mg per mL powder for prolonged-release oral suspension,8000010,methylphenidate,26643006,Oral,422353003,Prolonged-release oral suspension,,,,,,Controlled Drugs (CDSA III)
10398,Marketed,1998-12-15,00584991,PMS-Methylphenidate,1,N06BA04,Methylphenidate,Tablet,Oral,00584991,PMS-METHYLPHENIDATE (methylphenidate hydrochloride 10 mg oral tablet) PHARMASCIENCE INC,Active,9000015,methylphenidate hydrochloride 10 mg oral tablet,8000010,methylphenidate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA III)
10399,Marketed,1998-12-15,00585009,PMS-Methylphenidate,1,N06BA04,Methylphenidate,Tablet,Oral,00585009,PMS-METHYLPHENIDATE (methylphenidate hydrochloride 20 mg oral tablet) PHARMASCIENCE INC,Active,9000023,methylphenidate hydrochloride 20 mg oral tablet,8000010,methylphenidate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA III)
104199,Marketed,2025-11-06,02553023,Jornay PM,1,N06BA04,Methylphenidate,Capsule (delayed and extended release),Oral,02553023,JORNAY PM (methylphenidate hydrochloride 100 mg modified-release oral capsule) KNIGHT THERAPEUTICS INC.,Active,9012448,methylphenidate hydrochloride 100 mg modified-release oral capsule,8000010,methylphenidate,26643006,Oral,385054002,Modified-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA III)
104200,Marketed,2025-11-06,02553031,Jornay PM,1,N06BA04,Methylphenidate,Capsule (delayed and extended release),Oral,02553031,JORNAY PM (methylphenidate hydrochloride 80 mg modified-release oral capsule) KNIGHT THERAPEUTICS INC.,Active,9015318,methylphenidate hydrochloride 80 mg modified-release oral capsule,8000010,methylphenidate,26643006,Oral,385054002,Modified-release oral capsule,732937005,Capsule,,,,Controlled Drugs (CDSA III)
104201,Marketed,2025-11-06,02553058,Jornay PM,1,N06BA04,Methylphenidate,Capsule (delayed and extended release),Oral,02553058,JORNAY PM (methylphenidate hydrochloride 60 mg modified-release oral capsule) KNIGHT THERAPEUTICS INC.,Active,9015316,methylphenidate hydrochloride 60 mg modified-release oral capsule,8000010,methylphenidate,26643006,Oral,385054002,Modified-release oral capsule,732937005,Capsule,,,,Controlled Drugs (CDSA III)
104202,Marketed,2025-11-06,02553066,Jornay PM,1,N06BA04,Methylphenidate,Capsule (delayed and extended release),Oral,02553066,JORNAY PM (methylphenidate hydrochloride 40 mg modified-release oral capsule) KNIGHT THERAPEUTICS INC.,Active,9015313,methylphenidate hydrochloride 40 mg modified-release oral capsule,8000010,methylphenidate,26643006,Oral,385054002,Modified-release oral capsule,732937005,Capsule,,,,Controlled Drugs (CDSA III)
104203,Marketed,2025-11-06,02553074,Jornay PM,1,N06BA04,Methylphenidate,Capsule (delayed and extended release),Oral,02553074,JORNAY PM (methylphenidate hydrochloride 20 mg modified-release oral capsule) KNIGHT THERAPEUTICS INC.,Active,9015310,methylphenidate hydrochloride 20 mg modified-release oral capsule,8000010,methylphenidate,26643006,Oral,385054002,Modified-release oral capsule,732937005,Capsule,,,,Controlled Drugs (CDSA III)
55866,Marketed,1997-10-24,02234749,PMS-Methylphenidate,1,N06BA04,Methylphenidate,Tablet,Oral,02234749,PMS-METHYLPHENIDATE (methylphenidate hydrochloride 5 mg oral tablet) PHARMASCIENCE INC,Active,9000753,methylphenidate hydrochloride 5 mg oral tablet,8000010,methylphenidate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA III)
72012,Marketed,2003-07-23,02247732,Concerta,1,N06BA04,Methylphenidate,Tablet (extended-release),Oral,02247732,CONCERTA (methylphenidate hydrochloride 18 mg prolonged-release oral tablet) JANSSEN INC,Active,9001038,methylphenidate hydrochloride 18 mg prolonged-release oral tablet,8000010,methylphenidate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA III)
72013,Marketed,2003-07-23,02247733,Concerta,1,N06BA04,Methylphenidate,Tablet (extended-release),Oral,02247733,CONCERTA (methylphenidate hydrochloride 36 mg prolonged-release oral tablet) JANSSEN INC,Active,9001039,methylphenidate hydrochloride 36 mg prolonged-release oral tablet,8000010,methylphenidate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA III)
72014,Marketed,2003-07-23,02247734,Concerta,1,N06BA04,Methylphenidate,Tablet (extended-release),Oral,02247734,CONCERTA (methylphenidate hydrochloride 54 mg prolonged-release oral tablet) JANSSEN INC,Active,9001040,methylphenidate hydrochloride 54 mg prolonged-release oral tablet,8000010,methylphenidate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA III)
73416,Marketed,2004-11-02,02249324,Apo-Methylphenidate,1,N06BA04,Methylphenidate,Tablet,Oral,02249324,APO-METHYLPHENIDATE (methylphenidate hydrochloride 10 mg oral tablet) APOTEX INC,Active,9000015,methylphenidate hydrochloride 10 mg oral tablet,8000010,methylphenidate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA III)
73417,Marketed,2004-11-02,02249332,Apo-Methylphenidate,1,N06BA04,Methylphenidate,Tablet,Oral,02249332,APO-METHYLPHENIDATE (methylphenidate hydrochloride 20 mg oral tablet) APOTEX INC,Active,9000023,methylphenidate hydrochloride 20 mg oral tablet,8000010,methylphenidate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA III)
73505,Marketed,2005-01-06,02250241,Concerta,1,N06BA04,Methylphenidate,Tablet (extended-release),Oral,02250241,CONCERTA (methylphenidate hydrochloride 27 mg prolonged-release oral tablet) JANSSEN INC,Active,9001100,methylphenidate hydrochloride 27 mg prolonged-release oral tablet,8000010,methylphenidate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA III)
75209,Marketed,2026-03-23,02266687,AA-Methylphenidate SR,1,N06BA04,Methylphenidate,Tablet (extended-release),Oral,02266687,AA-METHYLPHENIDATE SR (methylphenidate hydrochloride 20 mg prolonged-release oral tablet) AA PHARMA INC,Active,9000208,methylphenidate hydrochloride 20 mg prolonged-release oral tablet,8000010,methylphenidate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA III)
75941,Marketed,2006-02-01,02273950,Apo-Methylphenidate,1,N06BA04,Methylphenidate,Tablet,Oral,02273950,APO-METHYLPHENIDATE (methylphenidate hydrochloride 5 mg oral tablet) APOTEX INC,Active,9000753,methylphenidate hydrochloride 5 mg oral tablet,8000010,methylphenidate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA III)
76279,Marketed,2020-09-03,02277131,Biphentin,1,N06BA04,Methylphenidate,Capsule (extended release),Oral,02277131,BIPHENTIN (methylphenidate hydrochloride 15 mg prolonged-release oral capsule) ELVIUM LIFE SCIENCES,Active,9001166,methylphenidate hydrochloride 15 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA III)
76280,Marketed,2020-09-03,02277158,Biphentin,1,N06BA04,Methylphenidate,Capsule (extended release),Oral,02277158,BIPHENTIN (methylphenidate hydrochloride 20 mg prolonged-release oral capsule) ELVIUM LIFE SCIENCES,Active,9001167,methylphenidate hydrochloride 20 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA III)
76281,Marketed,2020-09-08,02277166,Biphentin,1,N06BA04,Methylphenidate,Capsule (extended release),Oral,02277166,BIPHENTIN (methylphenidate hydrochloride 10 mg prolonged-release oral capsule) ELVIUM LIFE SCIENCES,Active,9001165,methylphenidate hydrochloride 10 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA III)
76282,Marketed,2020-09-08,02277174,Biphentin,1,N06BA04,Methylphenidate,Capsule (extended release),Oral,02277174,BIPHENTIN (methylphenidate hydrochloride 30 mg prolonged-release oral capsule) ELVIUM LIFE SCIENCES,Active,9001168,methylphenidate hydrochloride 30 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA III)
76283,Marketed,2020-09-08,02277182,Biphentin,1,N06BA04,Methylphenidate,Capsule (extended release),Oral,02277182,BIPHENTIN (methylphenidate hydrochloride 40 mg prolonged-release oral capsule) ELVIUM LIFE SCIENCES,Active,9001169,methylphenidate hydrochloride 40 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA III)
76284,Marketed,2020-09-03,02277190,Biphentin,1,N06BA04,Methylphenidate,Capsule (extended release),Oral,02277190,BIPHENTIN (methylphenidate hydrochloride 50 mg prolonged-release oral capsule) ELVIUM LIFE SCIENCES,Active,9001170,methylphenidate hydrochloride 50 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA III)
76285,Marketed,2020-09-03,02277204,Biphentin,1,N06BA04,Methylphenidate,Capsule (extended release),Oral,02277204,BIPHENTIN (methylphenidate hydrochloride 60 mg prolonged-release oral capsule) ELVIUM LIFE SCIENCES,Active,9001171,methylphenidate hydrochloride 60 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA III)
76286,Marketed,2020-09-03,02277212,Biphentin,1,N06BA04,Methylphenidate,Capsule (extended release),Oral,02277212,BIPHENTIN (methylphenidate hydrochloride 80 mg prolonged-release oral capsule) ELVIUM LIFE SCIENCES,Active,9001189,methylphenidate hydrochloride 80 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Controlled Drugs (CDSA III)
81611,Marketed,2016-07-22,02330377,Apo-Methylphenidate ER,1,N06BA04,Methylphenidate,Tablet (extended-release),Oral,02330377,APO-METHYLPHENIDATE ER (methylphenidate hydrochloride 54 mg prolonged-release oral tablet) APOTEX INC,Active,9001040,methylphenidate hydrochloride 54 mg prolonged-release oral tablet,8000010,methylphenidate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA III)
92630,Marketed,2020-03-03,02441934,Act Methylphenidate ER,1,N06BA04,Methylphenidate,Tablet (extended-release),Oral,02441934,ACT METHYLPHENIDATE ER (methylphenidate hydrochloride 18 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9001038,methylphenidate hydrochloride 18 mg prolonged-release oral tablet,8000010,methylphenidate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA III)
92631,Marketed,2020-03-03,02441942,Act Methylphenidate ER,1,N06BA04,Methylphenidate,Tablet (extended-release),Oral,02441942,ACT METHYLPHENIDATE ER (methylphenidate hydrochloride 27 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9001100,methylphenidate hydrochloride 27 mg prolonged-release oral tablet,8000010,methylphenidate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA III)
92632,Marketed,2020-03-03,02441950,Act Methylphenidate ER,1,N06BA04,Methylphenidate,Tablet (extended-release),Oral,02441950,ACT METHYLPHENIDATE ER (methylphenidate hydrochloride 36 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9001039,methylphenidate hydrochloride 36 mg prolonged-release oral tablet,8000010,methylphenidate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA III)
92633,Marketed,2020-03-03,02441969,Act Methylphenidate ER,1,N06BA04,Methylphenidate,Tablet (extended-release),Oral,02441969,ACT METHYLPHENIDATE ER (methylphenidate hydrochloride 54 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9001040,methylphenidate hydrochloride 54 mg prolonged-release oral tablet,8000010,methylphenidate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA III)
93914,Marketed,2016-07-22,02452731,Apo-Methylphenidate ER,1,N06BA04,Methylphenidate,Tablet (extended-release),Oral,02452731,APO-METHYLPHENIDATE ER (methylphenidate hydrochloride 18 mg prolonged-release oral tablet) APOTEX INC,Active,9001038,methylphenidate hydrochloride 18 mg prolonged-release oral tablet,8000010,methylphenidate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA III)
93915,Marketed,2016-07-22,02452758,Apo-Methylphenidate ER,1,N06BA04,Methylphenidate,Tablet (extended-release),Oral,02452758,APO-METHYLPHENIDATE ER (methylphenidate hydrochloride 27 mg prolonged-release oral tablet) APOTEX INC,Active,9001100,methylphenidate hydrochloride 27 mg prolonged-release oral tablet,8000010,methylphenidate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA III)
93916,Marketed,2016-07-22,02452766,Apo-Methylphenidate ER,1,N06BA04,Methylphenidate,Tablet (extended-release),Oral,02452766,APO-METHYLPHENIDATE ER (methylphenidate hydrochloride 36 mg prolonged-release oral tablet) APOTEX INC,Active,9001039,methylphenidate hydrochloride 36 mg prolonged-release oral tablet,8000010,methylphenidate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA III)
95927,Marketed,2020-09-08,02470292,Foquest,1,N06BA04,Methylphenidate,Capsule (controlled release),Oral,02470292,FOQUEST (methylphenidate hydrochloride 25 mg prolonged-release oral capsule) ELVIUM LIFE SCIENCES,Active,9015311,methylphenidate hydrochloride 25 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule,,,,Controlled Drugs (CDSA III)
95928,Marketed,2020-09-08,02470306,Foquest,1,N06BA04,Methylphenidate,Capsule (controlled release),Oral,02470306,FOQUEST (methylphenidate hydrochloride 35 mg prolonged-release oral capsule) ELVIUM LIFE SCIENCES,Active,9015312,methylphenidate hydrochloride 35 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule,,,,Controlled Drugs (CDSA III)
95929,Marketed,2020-09-08,02470314,Foquest,1,N06BA04,Methylphenidate,Capsule (controlled release),Oral,02470314,FOQUEST (methylphenidate hydrochloride 45 mg prolonged-release oral capsule) ELVIUM LIFE SCIENCES,Active,9015314,methylphenidate hydrochloride 45 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule,,,,Controlled Drugs (CDSA III)
95930,Marketed,2020-09-08,02470322,Foquest,1,N06BA04,Methylphenidate,Capsule (controlled release),Oral,02470322,FOQUEST (methylphenidate hydrochloride 55 mg prolonged-release oral capsule) ELVIUM LIFE SCIENCES,Active,9015315,methylphenidate hydrochloride 55 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule,,,,Controlled Drugs (CDSA III)
95931,Marketed,2020-09-08,02470330,Foquest,1,N06BA04,Methylphenidate,Capsule (controlled release),Oral,02470330,FOQUEST (methylphenidate hydrochloride 70 mg prolonged-release oral capsule) ELVIUM LIFE SCIENCES,Active,9015317,methylphenidate hydrochloride 70 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule,,,,Controlled Drugs (CDSA III)
95932,Marketed,2020-09-10,02470349,Foquest,1,N06BA04,Methylphenidate,Capsule (controlled release),Oral,02470349,FOQUEST (methylphenidate hydrochloride 85 mg prolonged-release oral capsule) ELVIUM LIFE SCIENCES,Active,9015319,methylphenidate hydrochloride 85 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule,,,,Controlled Drugs (CDSA III)
95933,Marketed,2020-09-03,02470357,Foquest,1,N06BA04,Methylphenidate,Capsule (controlled release),Oral,02470357,FOQUEST (methylphenidate hydrochloride 100 mg prolonged-release oral capsule) ELVIUM LIFE SCIENCES,Active,9015309,methylphenidate hydrochloride 100 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule,,,,Controlled Drugs (CDSA III)
1130,Marketed,2009-02-03,00036137,Solu-Medrol,1,H02AB04,Methylprednisolone,Powder for solution,"Intravenous,Intramuscular",00036137,SOLU-MEDROL (methylprednisolone (methylprednisolone sodium succinate) 1 g per vial powder for solution for injection with diluent solution) PFIZER CANADA ULC,Active,9013008,methylprednisolone (methylprednisolone sodium succinate) 1 g per vial powder for solution for injection with diluent solution,8001667,methylprednisolone (base),738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
1132,Marketed,2009-02-03,00030678,Solu-Medrol,1,H02AB04,Methylprednisolone,Powder for solution,"Intramuscular,Intravenous",00030678,SOLU-MEDROL (methylprednisolone (methylprednisolone sodium succinate) 500 mg per vial powder for solution for injection with diluent solution) PFIZER CANADA ULC,Active,9013012,methylprednisolone (methylprednisolone sodium succinate) 500 mg per vial powder for solution for injection with diluent solution,8001667,methylprednisolone (base),738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
1134,Marketed,2004-01-08,00030759,Depo-Medrol,1,H02AB04,Methylprednisolone,Suspension,"Intra-articular,Intrasynovial,Intramuscular,Intralesional",00030759,DEPO-MEDROL (methylprednisolone acetate 40 mg per 1 mL suspension for injection vial) PFIZER CANADA ULC,Active,9012838,methylprednisolone acetate 40 mg per 1 mL suspension for injection vial,8001291,methylprednisolone acetate,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,,Prescription
1396,Marketed,2009-02-03,00036129,Medrol,1,H02AB04,Methylprednisolone,Tablet,Oral,00036129,MEDROL (methylprednisolone 16 mg oral tablet) PFIZER CANADA ULC,Active,9001639,methylprednisolone 16 mg oral tablet,8001667,methylprednisolone (base),26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
1397,Marketed,2006-01-10,00030988,Medrol,1,H02AB04,Methylprednisolone,Tablet,Oral,00030988,MEDROL (methylprednisolone 4 mg oral tablet) PFIZER CANADA ULC,Active,9001578,methylprednisolone 4 mg oral tablet,8001667,methylprednisolone (base),26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
16275,Marketed,2009-02-03,01934333,Depo-Medrol,1,H02AB04,Methylprednisolone,Suspension,"Intralesional,Intra-articular,Intrasynovial,Intramuscular",77700634,DEPO-MEDROL (methylprednisolone acetate 200 mg per 5 mL suspension for injection vial) PFIZER CANADA ULC,Active,9012837,methylprednisolone acetate 200 mg per 5 mL suspension for injection vial,8001291,methylprednisolone acetate,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,,Prescription
16275,Marketed,2009-02-03,01934333,Depo-Medrol,1,H02AB04,Methylprednisolone,Suspension,"Intralesional,Intra-articular,Intrasynovial,Intramuscular",77700635,DEPO-MEDROL (methylprednisolone acetate 80 mg per 2 mL suspension for injection vial) PFIZER CANADA ULC,Active,9012841,methylprednisolone acetate 80 mg per 2 mL suspension for injection vial,8001291,methylprednisolone acetate,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,,Prescription
16276,Marketed,2009-02-03,01934341,Depo-Medrol,1,H02AB04,Methylprednisolone,Suspension,"Intramuscular,Intra-articular,Intralesional,Intrasynovial",01934341,DEPO-MEDROL (methylprednisolone acetate 400 mg per 5 mL suspension for injection vial) PFIZER CANADA ULC,Active,9012839,methylprednisolone acetate 400 mg per 5 mL suspension for injection vial,8001291,methylprednisolone acetate,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,,Prescription
18988,Marketed,2006-05-03,01934325,Depo-Medrol,1,H02AB04,Methylprednisolone,Suspension,"Intralesional,Intra-articular,Intramuscular,Intrasynovial",01934325,DEPO-MEDROL (methylprednisolone acetate 100 mg per 5 mL suspension for injection vial) PFIZER CANADA ULC,Active,9012836,methylprednisolone acetate 100 mg per 5 mL suspension for injection vial,8001291,methylprednisolone acetate,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,,Prescription
789,Marketed,2004-03-16,00030767,Depo-Medrol,1,H02AB04,Methylprednisolone,Suspension,"Intrasynovial,Intralesional,Intramuscular,Intra-articular",00030767,DEPO-MEDROL (methylprednisolone acetate 80 mg per 1 mL suspension for injection vial) PFIZER CANADA ULC,Active,9012840,methylprednisolone acetate 80 mg per 1 mL suspension for injection vial,8001291,methylprednisolone acetate,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,,Prescription
85277,Marketed,2012-01-11,02367947,Solu-Medrol,1,H02AB04,Methylprednisolone,"Powder for solution,Kit","Intramuscular,Intravenous",02367947,SOLU-MEDROL (methylprednisolone (methylprednisolone sodium succinate) 40 mg powder for solution for injection with diluent solution per vial) PFIZER CANADA ULC,Active,9013011,methylprednisolone (methylprednisolone sodium succinate) 40 mg powder for solution for injection with diluent solution per vial,8001667,methylprednisolone (base),738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
85278,Marketed,2012-01-18,02367955,Solu-Medrol,1,H02AB04,Methylprednisolone,"Powder for solution,Kit","Intramuscular,Intravenous",02367955,SOLU-MEDROL (methylprednisolone (methylprednisolone sodium succinate) 125 mg powder for solution for injection with diluent solution per vial) PFIZER CANADA ULC,Active,9013010,methylprednisolone (methylprednisolone sodium succinate) 125 mg powder for solution for injection with diluent solution per vial,8001667,methylprednisolone (base),738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
85279,Marketed,2012-01-18,02367963,Solu-Medrol,1,H02AB04,Methylprednisolone,"Powder for solution,Kit","Intramuscular,Intravenous",02367963,SOLU-MEDROL (methylprednisolone (methylprednisolone sodium succinate) 500 mg powder for solution for injection with diluent solution per vial) PFIZER CANADA ULC,Active,9013013,methylprednisolone (methylprednisolone sodium succinate) 500 mg powder for solution for injection with diluent solution per vial,8001667,methylprednisolone (base),738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
85280,Marketed,2012-02-07,02367971,Solu-Medrol,1,H02AB04,Methylprednisolone,"Kit,Powder for solution","Intramuscular,Intravenous",02367971,SOLU-MEDROL (methylprednisolone (methylprednisolone sodium succinate) 1 g powder for solution for injection with diluent solution per vial) PFIZER CANADA ULC,Active,9013009,methylprednisolone (methylprednisolone sodium succinate) 1 g powder for solution for injection with diluent solution per vial,8001667,methylprednisolone (base),738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
1619,Marketed,2022-05-20,00260428,Depo-Medrol With Lidocaine,2,H02BX01,"Methylprednisolone, combinations",Suspension,"Intra-articular,Intrasynovial,Intrabursal,Periarticular",77700706,DEPO-MEDROL WITH LIDOCAINE (lidocaine hydrochloride 50 mg per 5 mL and methylprednisolone acetate 200 mg per 5 mL suspension for injection vial) PFIZER CANADA ULC,Active,9013217,lidocaine hydrochloride 50 mg per 5 mL and methylprednisolone acetate 200 mg per 5 mL suspension for injection vial,8001839,lidocaine and methylprednisolone acetate,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,,Prescription
1619,Marketed,2022-05-20,00260428,Depo-Medrol With Lidocaine,2,H02BX01,"Methylprednisolone, combinations",Suspension,"Intra-articular,Intrasynovial,Intrabursal,Periarticular",77700707,DEPO-MEDROL WITH LIDOCAINE (lidocaine hydrochloride 10 mg per 1 mL and methylprednisolone acetate 40 mg per 1 mL suspension for injection vial) PFIZER CANADA ULC,Active,9013202,lidocaine hydrochloride 10 mg per 1 mL and methylprednisolone acetate 40 mg per 1 mL suspension for injection vial,8001839,lidocaine and methylprednisolone acetate,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,,Prescription
1619,Marketed,2022-05-20,00260428,Depo-Medrol With Lidocaine,2,H02BX01,"Methylprednisolone, combinations",Suspension,"Intra-articular,Intrasynovial,Intrabursal,Periarticular",77700708,DEPO-MEDROL WITH LIDOCAINE (lidocaine hydrochloride 20 mg per 2 mL and methylprednisolone acetate 80 mg per 2 mL suspension for injection vial) PFIZER CANADA ULC,Active,9013209,lidocaine hydrochloride 20 mg per 2 mL and methylprednisolone acetate 80 mg per 2 mL suspension for injection vial,8001839,lidocaine and methylprednisolone acetate,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,,Prescription
68,Marketed,1951-12-31,00050466,Methylene Bleu Liquid 1%,1,V04CG05,Methylthionine,Liquid,Oral,00050466,METHYLENE BLEU LIQ 1% (methylene blue 10 mg per mL oral solution) LABORATOIRE ATLAS INC,Active,9013829,methylene blue 10 mg per mL oral solution,8002140,methylene blue,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
50032,Marketed,2001-03-11,02230770,Methylene Blue Injection USP,1,V03AB17,Methylthioninium chloride,Liquid,Intravenous,77700969,METHYLENE BLUE INJECTION USP (methylene blue 10 mg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013577,methylene blue 10 mg per 1 mL solution for injection vial,8002140,methylene blue,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
50032,Marketed,2001-03-11,02230770,Methylene Blue Injection USP,1,V03AB17,Methylthioninium chloride,Liquid,Intravenous,77700970,METHYLENE BLUE INJECTION USP (methylene blue 50 mg per 5 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013579,methylene blue 50 mg per 5 mL solution for injection vial,8002140,methylene blue,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
97817,Marketed,2020-09-22,02487993,Methylene Blue Injection,1,V03AB17,Methylthioninium chloride,Solution,Intravenous,02487993,METHYLENE BLUE INJECTION (methylene blue 50 mg per 5 mL solution for injection vial) PHEBRA PTY LTD,Active,9013579,methylene blue 50 mg per 5 mL solution for injection vial,8002140,methylene blue,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
100715,Marketed,2021-07-29,02517795,Mar-Metoclopramide,1,A03FA01,Metoclopramide,Tablet,Oral,02517795,MAR-METOCLOPRAMIDE (metoclopramide hydrochloride 5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000330,metoclopramide hydrochloride 5 mg oral tablet,8000130,metoclopramide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102085,Marketed,2024-06-04,02531747,Metoclopramide Hydrochloride Injection,1,A03FA01,Metoclopramide,Solution,"Intravenous,Intramuscular",02531747,METOCLOPRAMIDE HYDROCHLORIDE INJECTION (metoclopramide hydrochloride 10 mg per 2 mL solution for injection vial) BAXTER CORPORATION,Active,9000613,metoclopramide hydrochloride 10 mg per 2 mL solution for injection vial,8000130,metoclopramide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
102611,Marketed,2024-02-08,02537397,Metoclopramide Hydrochloride Injection,1,A03FA01,Metoclopramide,Solution,"Intramuscular,Intravenous",,,,,,,,,,,,,,,,,Prescription
103759,Marketed,2025-04-30,02548747,PRZ-Metoclopramide,1,A03FA01,Metoclopramide,Tablet,Oral,02548747,PRZ-METOCLOPRAMIDE (metoclopramide hydrochloride 5 mg oral tablet) PHARMARIS CANADA INC,Active,9000330,metoclopramide hydrochloride 5 mg oral tablet,8000130,metoclopramide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103760,Marketed,2025-04-29,02548755,PRZ-Metoclopramide,1,A03FA01,Metoclopramide,Tablet,Oral,02548755,PRZ-METOCLOPRAMIDE (metoclopramide hydrochloride 10 mg oral tablet) PHARMARIS CANADA INC,Active,9000329,metoclopramide hydrochloride 10 mg oral tablet,8000130,metoclopramide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
19409,Marketed,2005-09-21,02185431,Metoclopramide Hydrochloride Injection,1,A03FA01,Metoclopramide,Liquid,"Intramuscular,Intravenous",77700199,METOCLOPRAMIDE HYDROCHLORIDE INJECTION (metoclopramide hydrochloride 10 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000613,metoclopramide hydrochloride 10 mg per 2 mL solution for injection vial,8000130,metoclopramide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
19409,Marketed,2005-09-21,02185431,Metoclopramide Hydrochloride Injection,1,A03FA01,Metoclopramide,Liquid,"Intramuscular,Intravenous",77700200,METOCLOPRAMIDE HYDROCHLORIDE INJECTION (metoclopramide hydrochloride 50 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000615,metoclopramide hydrochloride 50 mg per 10 mL solution for injection vial,8000130,metoclopramide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
19409,Marketed,2005-09-21,02185431,Metoclopramide Hydrochloride Injection,1,A03FA01,Metoclopramide,Liquid,"Intramuscular,Intravenous",77700201,METOCLOPRAMIDE HYDROCHLORIDE INJECTION (metoclopramide hydrochloride 150 mg per 30 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000614,metoclopramide hydrochloride 150 mg per 30 mL solution for injection vial,8000130,metoclopramide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
49332,Marketed,2021-10-29,02230431,PMS-Metoclopramide Tablets,1,A03FA01,Metoclopramide,Tablet,Oral,02230431,PMS-METOCLOPRAMIDE TABLETS (metoclopramide hydrochloride 5 mg oral tablet) PHARMASCIENCE INC,Active,9000330,metoclopramide hydrochloride 5 mg oral tablet,8000130,metoclopramide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
49340,Marketed,2021-10-29,02230433,PMS-Metoclopramide Oral Solution,1,A03FA01,Metoclopramide,Solution,Oral,02230433,PMS-METOCLOPRAMIDE ORAL SOLUTION (metoclopramide hydrochloride 5 mg per 5 mL oral solution) PHARMASCIENCE INC,Active,9006556,metoclopramide hydrochloride 5 mg per 5 mL oral solution,8000130,metoclopramide,26643006,Oral,385023001,Oral solution,,,,,,Prescription
67481,Marketed,2024-04-12,02243563,Metoclopramide Injection USP,1,A03FA01,Metoclopramide,Solution,"Intramuscular,Intravenous",77700202,METOCLOPRAMIDE INJECTION USP (metoclopramide hydrochloride 10 mg per 2 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9000613,metoclopramide hydrochloride 10 mg per 2 mL solution for injection vial,8000130,metoclopramide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
67481,Marketed,2024-04-12,02243563,Metoclopramide Injection USP,1,A03FA01,Metoclopramide,Solution,"Intramuscular,Intravenous",77700203,METOCLOPRAMIDE INJECTION USP (metoclopramide hydrochloride 50 mg per 10 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9000615,metoclopramide hydrochloride 50 mg per 10 mL solution for injection vial,8000130,metoclopramide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
67481,Marketed,2024-04-12,02243563,Metoclopramide Injection USP,1,A03FA01,Metoclopramide,Solution,"Intramuscular,Intravenous",77700204,METOCLOPRAMIDE INJECTION USP (metoclopramide hydrochloride 150 mg per 30 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9000614,metoclopramide hydrochloride 150 mg per 30 mL solution for injection vial,8000130,metoclopramide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
99999,Marketed,2021-07-23,02510790,PMS-Metoclopramide Hydrochloride Injection,1,A03FA01,Metoclopramide,Solution,"Intramuscular,Intravenous",77701092,PMS-METOCLOPRAMIDE HYDROCHLORIDE INJECTION (metoclopramide hydrochloride 50 mg per 10 mL solution for injection vial) PHARMASCIENCE INC,Active,9000615,metoclopramide hydrochloride 50 mg per 10 mL solution for injection vial,8000130,metoclopramide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
99999,Marketed,2021-07-23,02510790,PMS-Metoclopramide Hydrochloride Injection,1,A03FA01,Metoclopramide,Solution,"Intramuscular,Intravenous",77701093,PMS-METOCLOPRAMIDE HYDROCHLORIDE INJECTION (metoclopramide hydrochloride 10 mg per 2 mL solution for injection vial) PHARMASCIENCE INC,Active,9000613,metoclopramide hydrochloride 10 mg per 2 mL solution for injection vial,8000130,metoclopramide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
99999,Marketed,2021-07-23,02510790,PMS-Metoclopramide Hydrochloride Injection,1,A03FA01,Metoclopramide,Solution,"Intramuscular,Intravenous",77701094,PMS-METOCLOPRAMIDE HYDROCHLORIDE INJECTION (metoclopramide hydrochloride 150 mg per 30 mL solution for injection vial) PHARMASCIENCE INC,Active,9000614,metoclopramide hydrochloride 150 mg per 30 mL solution for injection vial,8000130,metoclopramide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
13126,Marketed,2008-01-21,00888400,Zaroxolyn,1,C03BA08,Metolazone,Tablet,Oral,00888400,ZAROXOLYN (metolazone 2.5 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9001718,metolazone 2.5 mg oral tablet,8001400,metolazone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
50067,Marketed,1998-04-16,02230803,PMS-Metoprolol-L,1,C07AB02,Metoprolol,Tablet,Oral,02230803,PMS-METOPROLOL-L (metoprolol tartrate 50 mg oral tablet) PHARMASCIENCE INC,Active,9000101,metoprolol tartrate 50 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
50068,Marketed,1998-04-16,02230804,PMS-Metoprolol-L,1,C07AB02,Metoprolol,Tablet,Oral,02230804,PMS-METOPROLOL-L (metoprolol tartrate 100 mg oral tablet) PHARMASCIENCE INC,Active,9000100,metoprolol tartrate 100 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
5818,Marketed,1984-12-31,00618632,Apo-Metoprolol,1,C07AB02,Metoprolol,Tablet,Oral,00618632,APO-METOPROLOL (metoprolol tartrate 50 mg oral tablet) APOTEX INC,Active,9000101,metoprolol tartrate 50 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
5819,Marketed,1984-12-31,00618640,Apo-Metoprolol,1,C07AB02,Metoprolol,Tablet,Oral,00618640,APO-METOPROLOL (metoprolol tartrate 100 mg oral tablet) APOTEX INC,Active,9000100,metoprolol tartrate 100 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
6512,Marketed,2026-03-19,00648019,Pro-Metoprolol-L,1,C07AB02,Metoprolol,Tablet,Oral,00648019,PRO-METOPROLOL-L (metoprolol tartrate 50 mg oral tablet) PRO DOC LIMITEE,Active,9000101,metoprolol tartrate 50 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
6513,Marketed,2026-03-13,00648027,Pro-Metoprolol-L,1,C07AB02,Metoprolol,Tablet,Oral,00648027,PRO-METOPROLOL-L (metoprolol tartrate 100 mg oral tablet) PRO DOC LIMITEE,Active,9000100,metoprolol tartrate 100 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
6611,Marketed,2011-01-25,00648035,Teva-Metoprolol,1,C07AB02,Metoprolol,Tablet,Oral,00648035,TEVA-METOPROLOL FILM COATED (metoprolol tartrate 50 mg oral tablet) TEVA CANADA LIMITED,Active,9000101,metoprolol tartrate 50 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
6612,Marketed,2011-01-25,00648043,Teva-Metoprolol,1,C07AB02,Metoprolol,Tablet,Oral,00648043,TEVA-METOPROLOL FILM COATED (metoprolol tartrate 100 mg oral tablet) TEVA CANADA LIMITED,Active,9000100,metoprolol tartrate 100 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
70136,Marketed,2002-10-08,02246010,Apo-Metoprolol,1,C07AB02,Metoprolol,Tablet,Oral,02246010,APO-METOPROLOL (metoprolol tartrate 25 mg oral tablet) APOTEX INC,Active,9001001,metoprolol tartrate 25 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73226,Marketed,2004-03-19,02248855,PMS-Metoprolol-L,1,C07AB02,Metoprolol,Tablet,Oral,02248855,PMS-METOPROLOL-L (metoprolol tartrate 25 mg oral tablet) PHARMASCIENCE INC,Active,9001001,metoprolol tartrate 25 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74725,Marketed,2012-02-15,02261898,Teva-Metoprolol,1,C07AB02,Metoprolol,Tablet,Oral,02261898,TEVA-METOPROLOL (metoprolol tartrate 25 mg oral tablet) TEVA CANADA LIMITED,Active,9001001,metoprolol tartrate 25 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75326,Marketed,2005-10-05,02267853,Metoprolol Tartrate Injection USP,1,C07AB02,Metoprolol,Solution,Intravenous,02267853,METOPROLOL TARTRATE INJECTION USP (metoprolol tartrate 5 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9001120,metoprolol tartrate 5 mg per 5 mL solution for injection vial,8000063,metoprolol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
77067,Marketed,2022-10-13,02285169,AA-Metoprolol SR,1,C07AB02,Metoprolol,Tablet (extended-release),Oral,02285169,AA-METOPROLOL SR (metoprolol tartrate 100 mg prolonged-release oral tablet) AA PHARMA INC,Active,9000227,metoprolol tartrate 100 mg prolonged-release oral tablet,8000063,metoprolol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78208,Marketed,2026-02-25,02296713,Pro-Metoprolol,1,C07AB02,Metoprolol,Tablet,Oral,02296713,PRO-METOPROLOL (metoprolol tartrate 25 mg oral tablet) PRO DOC LIMITEE,Active,9001001,metoprolol tartrate 25 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80085,Marketed,2008-09-10,02315300,Riva-Metoprolol-L,1,C07AB02,Metoprolol,Tablet,Oral,02315300,RIVA-METOPROLOL-L (metoprolol tartrate 25 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001001,metoprolol tartrate 25 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80086,Marketed,2008-09-10,02315319,Riva-Metoprolol-L,1,C07AB02,Metoprolol,Tablet,Oral,02315319,RIVA-METOPROLOL-L (metoprolol tartrate 50 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000101,metoprolol tartrate 50 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80087,Marketed,2008-09-10,02315327,Riva-Metoprolol-L,1,C07AB02,Metoprolol,Tablet,Oral,02315327,RIVA-METOPROLOL-L (metoprolol tartrate 100 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000100,metoprolol tartrate 100 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83560,Marketed,2014-05-24,02350394,Metoprolol,1,C07AB02,Metoprolol,Tablet,Oral,02350394,METOPROLOL (metoprolol tartrate 50 mg oral tablet) SANIS HEALTH INC,Active,9000101,metoprolol tartrate 50 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83561,Marketed,2014-05-24,02350408,Metoprolol,1,C07AB02,Metoprolol,Tablet,Oral,02350408,METOPROLOL (metoprolol tartrate 100 mg oral tablet) SANIS HEALTH INC,Active,9000100,metoprolol tartrate 100 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84194,Marketed,2018-05-04,02356813,JAMP-Metoprolol-L,1,C07AB02,Metoprolol,Tablet,Oral,02356813,JAMP-METOPROLOL-L (metoprolol tartrate 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001001,metoprolol tartrate 25 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84195,Marketed,2018-05-04,02356821,JAMP-Metoprolol-L,1,C07AB02,Metoprolol,Tablet,Oral,02356821,JAMP-METOPROLOL-L (metoprolol tartrate 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000101,metoprolol tartrate 50 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84196,Marketed,2018-05-04,02356848,JAMP-Metoprolol-L,1,C07AB02,Metoprolol,Tablet,Oral,02356848,JAMP-METOPROLOL-L (metoprolol tartrate 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000100,metoprolol tartrate 100 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
8602,Marketed,1988-12-31,00751170,Apo-Metoprolol (Type L),1,C07AB02,Metoprolol,Tablet,Oral,00751170,APO-METOPROLOL (TYPE L) (metoprolol tartrate 100 mg oral tablet) APOTEX INC,Active,9000100,metoprolol tartrate 100 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
8603,Marketed,1988-12-31,00749354,Apo-Metoprolol (Type L),1,C07AB02,Metoprolol,Tablet,Oral,00749354,APO-METOPROLOL (TYPE L) (metoprolol tartrate 50 mg oral tablet) APOTEX INC,Active,9000101,metoprolol tartrate 50 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92647,Marketed,2021-09-17,02442116,Metoprolol-L,1,C07AB02,Metoprolol,Tablet,Oral,02442116,METOPROLOL-L (metoprolol tartrate 25 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001001,metoprolol tartrate 25 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92648,Marketed,2021-09-13,02442124,Metoprolol-L,1,C07AB02,Metoprolol,Tablet,Oral,02442124,METOPROLOL-L (metoprolol tartrate 50 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000101,metoprolol tartrate 50 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92649,Marketed,2021-09-13,02442132,Metoprolol-L,1,C07AB02,Metoprolol,Tablet,Oral,02442132,METOPROLOL-L (metoprolol tartrate 100 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000100,metoprolol tartrate 100 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96432,Marketed,2026-05-14,02474271,Metoprolol Tartrate Injection USP,1,C07AB02,Metoprolol,Solution,Intravenous,02474271,METOPROLOL TARTRATE INJECTION USP (metoprolol tartrate 5 mg per 5 mL solution for injection vial) JUNO PHARMA CANADA INC.,Active,9001120,metoprolol tartrate 5 mg per 5 mL solution for injection vial,8000063,metoprolol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
9886,Marketed,2011-01-25,00842648,Teva-Metoprolol,1,C07AB02,Metoprolol,Tablet,Oral,00842648,TEVA-METOPROLOL UNCOATED (metoprolol tartrate 50 mg oral tablet) TEVA CANADA LIMITED,Active,9000101,metoprolol tartrate 50 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
9887,Marketed,2011-01-25,00842656,Teva-Metoprolol,1,C07AB02,Metoprolol,Tablet,Oral,00842656,TEVA-METOPROLOL UNCOATED (metoprolol tartrate 100 mg oral tablet) TEVA CANADA LIMITED,Active,9000100,metoprolol tartrate 100 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103314,Marketed,2024-10-25,02544555,Myalepta,1,A16AA07,Metreleptin,Powder for solution,Subcutaneous,02544555,MYALEPTA (metreleptin 3 mg per vial powder for solution for injection) CHIESI FARMACEUTICI S.P.A.,Active,9015122,metreleptin 3 mg per vial powder for solution for injection,8002511,metreleptin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
103314,Marketed,2024-10-25,02544555,Myalepta,1,A16AA07,Metreleptin,Powder for solution,Subcutaneous,02544555,MYALEPTA (metreleptin 3 mg per vial powder for solution for injection) CHIESI FARMACEUTICI S.P.A.,Active,9015122,metreleptin 3 mg per vial powder for solution for injection,8002511,metreleptin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
103315,Marketed,2024-10-25,02544563,Myalepta,1,A16AA07,Metreleptin,Powder for solution,Subcutaneous,02544563,MYALEPTA (metreleptin 5.8 mg per vial powder for solution for injection) CHIESI FARMACEUTICI S.P.A.,Active,9015123,metreleptin 5.8 mg per vial powder for solution for injection,8002511,metreleptin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
103315,Marketed,2024-10-25,02544563,Myalepta,1,A16AA07,Metreleptin,Powder for solution,Subcutaneous,02544563,MYALEPTA (metreleptin 5.8 mg per vial powder for solution for injection) CHIESI FARMACEUTICI S.P.A.,Active,9015123,metreleptin 5.8 mg per vial powder for solution for injection,8002511,metreleptin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
103316,Marketed,2024-08-02,02544571,Myalepta,1,A16AA07,Metreleptin,Powder for solution,Subcutaneous,02544571,MYALEPTA (metreleptin 11.3 mg per vial powder for solution for injection) CHIESI FARMACEUTICI S.P.A.,Active,9015067,metreleptin 11.3 mg per vial powder for solution for injection,8002511,metreleptin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
103316,Marketed,2024-08-02,02544571,Myalepta,1,A16AA07,Metreleptin,Powder for solution,Subcutaneous,02544571,MYALEPTA (metreleptin 11.3 mg per vial powder for solution for injection) CHIESI FARMACEUTICI S.P.A.,Active,9015067,metreleptin 11.3 mg per vial powder for solution for injection,8002511,metreleptin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
100806,Marketed,2022-05-19,02518767,Metronidazole,1,P01AB01,Metronidazole,Capsule,Oral,02518767,METRONIDAZOLE (metronidazole 500 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000131,metronidazole 500 mg oral capsule,8000038,metronidazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
100899,Marketed,2022-03-04,02519755,M-Metronidazole,1,P01AB01,Metronidazole,Capsule,Oral,02519755,M-METRONIDAZOLE (metronidazole 500 mg oral capsule) MANTRA PHARMA INC,Active,9000131,metronidazole 500 mg oral capsule,8000038,metronidazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
102350,Marketed,2023-12-21,02534592,Metronidazole,1,P01AB01,Metronidazole,Capsule,Oral,02534592,METRONIDAZOLE (metronidazole 500 mg oral capsule) SANIS HEALTH INC,Active,9000131,metronidazole 500 mg oral capsule,8000038,metronidazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
102463,Marketed,2023-09-07,02535807,Mint-Metronidazole,1,P01AB01,Metronidazole,Tablet,Oral,02535807,MINT-METRONIDAZOLE (metronidazole 250 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000055,metronidazole 250 mg oral tablet,8000038,metronidazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
10871,Marketed,2019-09-03,00870420,"Metronidazole Injection, USP",1,J01XD01,Metronidazole,Solution,Intravenous,77700015,"METRONIDAZOLE INJECTION, USP (metronidazole 500 mg per 100 mL solution for injection bag) BAXTER CORPORATION",Active,9000279,metronidazole 500 mg per 100 mL solution for injection bag,8000038,metronidazole,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Prescription
10871,Marketed,2019-09-03,00870420,"Metronidazole Injection, USP",1,J01XD01,Metronidazole,Solution,Intravenous,77700016,"METRONIDAZOLE INJECTION, USP (metronidazole 1500 mg per 300 mL solution for injection bag) BAXTER CORPORATION",Active,9000360,metronidazole 1500 mg per 300 mL solution for injection bag,8000038,metronidazole,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Prescription
16852,Marketed,2021-08-18,02125226,Nidagel,1,G01AF01,Metronidazole,Gel,Vaginal,02125226,"NIDAGEL (metronidazole 0.75 % vaginal gel) BAUSCH HEALTH, CANADA INC.",Active,9000535,metronidazole 0.75 % vaginal gel,8000038,metronidazole,16857009,Vaginal,385100002,Gel,,,,,,Prescription
17824,Marketed,1994-12-31,02092832,Metrogel 0.75%,1,D06BX01,Metronidazole,Gel,Topical,02092832,METROGEL 0.75% (metronidazole 0.75 % cutaneous gel) GALDERMA CANADA INC.,Active,9000534,metronidazole 0.75 % cutaneous gel,8000038,metronidazole,448598008,Cutaneous,385100002,Gel,,,,,,Prescription
19257,Marketed,2019-05-07,02156091,Noritate,1,D06BX01,Metronidazole,Cream,Topical,02156091,"NORITATE (metronidazole 1 % cutaneous cream) BAUSCH HEALTH, CANADA INC.",Active,9000616,metronidazole 1 % cutaneous cream,8000038,metronidazole,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
4902,Marketed,2024-05-22,00545066,Apo-Metronidazole Tablets,1,P01AB01,Metronidazole,Tablet,Oral,00545066,APO-METRONIDAZOLE TABLETS (metronidazole 250 mg oral tablet) APOTEX INC,Active,9000055,metronidazole 250 mg oral tablet,8000038,metronidazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
72917,Marketed,2018-04-26,02248562,Apo-Metronidazole,1,P01AB01,Metronidazole,Capsule,Oral,02248562,APO-METRONIDAZOLE (metronidazole 500 mg oral capsule) APOTEX INC,Active,9000131,metronidazole 500 mg oral capsule,8000038,metronidazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
78314,Marketed,2007-12-20,02297809,Metrogel 1%,1,D06BX01,Metronidazole,Gel,Topical,02297809,METROGEL 1% (metronidazole 1 % cutaneous gel) GALDERMA CANADA INC.,Active,9001230,metronidazole 1 % cutaneous gel,8000038,metronidazole,448598008,Cutaneous,385100002,Gel,,,,,,Prescription
95926,Marketed,2018-04-03,02470284,Auro-Metronidazole,1,P01AB01,Metronidazole,Capsule,Oral,02470284,AURO-METRONIDAZOLE (metronidazole 500 mg oral capsule) AURO PHARMA INC,Active,9000131,metronidazole 500 mg oral capsule,8000038,metronidazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
9910,Marketed,2021-04-29,00783137,PMS-Metronidazole,1,J01XD01,Metronidazole,Capsule,Oral,00783137,PMS-METRONIDAZOLE (metronidazole 500 mg oral capsule) PHARMASCIENCE INC,Active,9000131,metronidazole 500 mg oral capsule,8000038,metronidazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
102557,Marketed,2024-04-08,02536846,Mint-Mexiletine,1,C01BB02,Mexiletine,Capsule,Oral,02536846,MINT-MEXILETINE (mexiletine hydrochloride 100 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9012842,mexiletine hydrochloride 100 mg oral capsule,8001499,mexiletine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
102558,Marketed,2024-01-18,02536854,Mint-Mexiletine,1,C01BB02,Mexiletine,Capsule,Oral,02536854,MINT-MEXILETINE (mexiletine hydrochloride 200 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9012843,mexiletine hydrochloride 200 mg oral capsule,8001499,mexiletine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
49155,Marketed,2016-07-21,02230359,Teva-Mexiletine,1,C01BB02,Mexiletine,Capsule,Oral,02230359,TEVA-MEXILETINE (mexiletine hydrochloride 100 mg oral capsule) TEVA CANADA LIMITED,Active,9012842,mexiletine hydrochloride 100 mg oral capsule,8001499,mexiletine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
49157,Marketed,2016-07-21,02230360,Teva-Mexiletine,1,C01BB02,Mexiletine,Capsule,Oral,02230360,TEVA-MEXILETINE (mexiletine hydrochloride 200 mg oral capsule) TEVA CANADA LIMITED,Active,9012843,mexiletine hydrochloride 200 mg oral capsule,8001499,mexiletine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
101398,Marketed,2023-07-17,02524953,Micafungin Sodium For Injection,1,J02AX05,Micafungin,Powder for solution,Intravenous,,,,,,,,,,,,,,,,,Prescription
101399,Marketed,2023-07-17,02524961,Micafungin Sodium For Injection,1,J02AX05,Micafungin,Powder for solution,Intravenous,,,,,,,,,,,,,,,,,Prescription
102138,Marketed,2023-05-29,02532344,Micafungin Sodium For Injection,1,J02AX05,Micafungin,Powder for solution,Intravenous,02532344,MICAFUNGIN SODIUM FOR INJECTION (micafungin sodium 50 mg per vial powder for solution for injection) HIKMA CANADA LIMITED,Active,9004329,micafungin sodium 50 mg per vial powder for solution for injection,8001216,micafungin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
102140,Marketed,2023-05-29,02532360,Micafungin Sodium For Injection,1,J02AX05,Micafungin,Powder for solution,Intravenous,02532360,MICAFUNGIN SODIUM FOR INJECTION (micafungin sodium 100 mg per vial powder for solution for injection) HIKMA CANADA LIMITED,Active,9004610,micafungin sodium 100 mg per vial powder for solution for injection,8001216,micafungin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
103585,Marketed,2024-12-12,02547228,Micafungin Sodium For Injection,1,J02AX05,Micafungin,Powder for solution,Intravenous,,,,,,,,,,,,,,,,,Prescription
103586,Marketed,2024-11-19,02547236,Micafungin Sodium For Injection,1,J02AX05,Micafungin,Powder for solution,Intravenous,,,,,,,,,,,,,,,,,Prescription
77957,Marketed,2025-03-20,02294222,Mycamine,1,J02AX05,Micafungin,Powder for solution,Intravenous,02294222,MYCAMINE (micafungin sodium 50 mg per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9004329,micafungin sodium 50 mg per vial powder for solution for injection,8001216,micafungin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
79665,Marketed,2025-03-25,02311054,Mycamine,1,J02AX05,Micafungin,Powder for solution,Intravenous,02311054,MYCAMINE (micafungin sodium 100 mg per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9004610,micafungin sodium 100 mg per vial powder for solution for injection,8001216,micafungin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
16608,Marketed,2012-10-10,02084309,Monistat 7 Vaginal Cream,1,G01AF04,Miconazole,Cream,Vaginal,02084309,"MONISTAT 7 VAGINAL CREAM (miconazole nitrate 2 % vaginal cream) INSIGHT PHARMACEUTICALS, LLC",Active,9001814,miconazole nitrate 2 % vaginal cream,8001401,miconazole,16857009,Vaginal,385165005,Vaginal cream,,,,,,Non-Prescription Drugs
16609,Marketed,2021-09-10,02085852,Micatin Miconazole Nitrate Cream 2% USP,1,D01AC02,Miconazole,Cream,Topical,02085852,MICATIN MICONAZOLE NITRATE CREAM 2% USP (miconazole nitrate 2 % cutaneous cream) WELLSPRING PHARMACEUTICAL CANADA CORP,Active,9001719,miconazole nitrate 2 % cutaneous cream,8001401,miconazole,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
16611,Marketed,2012-12-11,02126257,Monistat 7 Dual-Pak,2,G01AF04,Miconazole,"Suppository,Cream","Topical,Vaginal",02126257,"MONISTAT 7 DUAL-PAK (miconazole nitrate 2 % cutaneous cream with miconazole nitrate 100 mg pessary) INSIGHT PHARMACEUTICALS, LLC",Active,9012844,miconazole nitrate 2 % cutaneous cream with miconazole nitrate 100 mg pessary,8001401,miconazole,6064005,Topical,419179001,Kit,733007009,Pessary,,,,Non-Prescription Drugs
17832,Marketed,2012-08-30,02126567,Monistat Derm Cream,1,D01AC02,Miconazole,Cream,Topical,02126567,"MONISTAT DERM CREAM (miconazole nitrate 2 % cutaneous cream) INSIGHT PHARMACEUTICALS, LLC",Active,9001719,miconazole nitrate 2 % cutaneous cream,8001401,miconazole,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
19677,Marketed,2002-02-28,02171775,Miconazole 3 Day Ovule Treatment 400 mg,1,G01AF04,Miconazole,Suppository,Vaginal,02171775,MICONAZOLE 3 DAY OVULE TREATMENT 400MG (miconazole nitrate 400 mg pessary) VITA HEALTH PRODUCTS INC,Active,9001912,miconazole nitrate 400 mg pessary,8001401,miconazole,16857009,Vaginal,385174007,Pessary,733007009,Pessary (unit of presentation),,,,Non-Prescription Drugs
49064,Marketed,2008-10-10,02230304,Micatin Powder Spray   - Unscented 2%,1,D01AC02,Miconazole,Aerosol,Topical,02230304,MICATIN POWDER SPRAY   - UNSCENTED 2% (miconazole nitrate 2 % cutaneous spray) WELLSPRING PHARMACEUTICAL CANADA CORP,Active,9003106,miconazole nitrate 2 % cutaneous spray,8001401,miconazole,448598008,Cutaneous,421720008,Spray,,,,,,Non-Prescription Drugs
50876,Marketed,1997-08-12,02231533,"Miconazole Nitrate Vaginal Cream USP, 2%",1,G01AF04,Miconazole,Cream,Vaginal,02231533,"MICONAZOLE NITRATE VAGINAL CREAM USP, 2% (miconazole nitrate 2 % vaginal cream) TARO PHARMACEUTICALS INC",Active,9001814,miconazole nitrate 2 % vaginal cream,8001401,miconazole,16857009,Vaginal,385165005,Vaginal cream,,,,,,Non-Prescription Drugs
67948,Marketed,2012-11-02,02244005,Monistat 3 Vaginal Cream,1,G01AF04,Miconazole,Cream,Vaginal,02244005,"MONISTAT 3 VAGINAL CREAM (miconazole nitrate 4 % vaginal cream) INSIGHT PHARMACEUTICALS, LLC",Active,9003654,miconazole nitrate 4 % vaginal cream,8001401,miconazole,16857009,Vaginal,385165005,Vaginal cream,,,,,,Non-Prescription Drugs
69637,Marketed,2003-03-13,02245546,Miconazole Nitrate Vaginal Cream 2%,1,G01AF04,Miconazole,Cream,Vaginal,02245546,MICONAZOLE NITRATE VAGINAL CREAM 2% (miconazole nitrate 2 % vaginal cream) VITA HEALTH PRODUCTS INC,Active,9001814,miconazole nitrate 2 % vaginal cream,8001401,miconazole,16857009,Vaginal,385165005,Vaginal cream,,,,,,Non-Prescription Drugs
67049,Marketed,2009-08-04,02243173,Definity,1,V08DA04,Microspheres of phospholipids,Suspension,Intravenous,,,,,,,,,,,,,,,,,Prescription
104206,Marketed,2025-12-04,02553104,Midazolam Injection USP,1,N05CD08,Midazolam,Solution,Intravenous,77701195,MIDAZOLAM INJECTION USP (midazolam 50 mg per 50 mL solution for injection bag) HIKMA CANADA LIMITED,Active,9015320,midazolam 50 mg per 50 mL solution for injection bag,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,732982009,Bag,,,,Targeted Substances (CDSA IV)
104206,Marketed,2025-12-04,02553104,Midazolam Injection USP,1,N05CD08,Midazolam,Solution,Intravenous,77701196,MIDAZOLAM INJECTION USP (midazolam 100 mg per 100 mL solution for injection bag) HIKMA CANADA LIMITED,Active,9014405,midazolam 100 mg per 100 mL solution for injection bag,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Targeted Substances (CDSA IV)
106271,Marketed,2026-02-20,02559579,Buccolam,1,N05CD08,Midazolam,Solution,Buccal,02559579,"BUCCOLAM (midazolam (midazolam hydrochloride) 2.5 mg per 0.5 mL oromucosal solution) NEURAXPHARM PHARMACEUTICALS, S.L.",Active,9015361,midazolam (midazolam hydrochloride) 2.5 mg per 0.5 mL oromucosal solution,8001107,midazolam,372473007,Oromucosal,385070000,Oromucosal solution,,,,,,Targeted Substances (CDSA IV)
106272,Marketed,2026-02-20,02559587,Buccolam,1,N05CD08,Midazolam,Solution,Buccal,02559587,"BUCCOLAM (midazolam (midazolam hydrochloride) 5 mg per 1 mL oromucosal solution) NEURAXPHARM PHARMACEUTICALS, S.L.",Active,9015362,midazolam (midazolam hydrochloride) 5 mg per 1 mL oromucosal solution,8001107,midazolam,372473007,Oromucosal,385070000,Oromucosal solution,,,,,,Targeted Substances (CDSA IV)
106273,Marketed,2026-02-20,02559595,Buccolam,1,N05CD08,Midazolam,Solution,Buccal,02559595,"BUCCOLAM (midazolam (midazolam hydrochloride) 7.5 mg per 1.5 mL oromucosal solution) NEURAXPHARM PHARMACEUTICALS, S.L.",Active,9015363,midazolam (midazolam hydrochloride) 7.5 mg per 1.5 mL oromucosal solution,8001107,midazolam,372473007,Oromucosal,385070000,Oromucosal solution,,,,,,Targeted Substances (CDSA IV)
106274,Marketed,2026-02-20,02559609,Buccolam,1,N05CD08,Midazolam,Solution,Buccal,02559609,"BUCCOLAM (midazolam (midazolam hydrochloride) 10 mg per 2 mL oromucosal solution) NEURAXPHARM PHARMACEUTICALS, S.L.",Active,9015360,midazolam (midazolam hydrochloride) 10 mg per 2 mL oromucosal solution,8001107,midazolam,372473007,Oromucosal,385070000,Oromucosal solution,,,,,,Targeted Substances (CDSA IV)
63823,Marketed,2005-10-06,02240285,Midazolam Injection,1,N05CD08,Midazolam,Solution,"Intravenous,Intramuscular",77700595,MIDAZOLAM INJECTION (midazolam 5 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012740,midazolam 5 mg per 5 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Targeted Substances (CDSA IV)
63823,Marketed,2005-10-06,02240285,Midazolam Injection,1,N05CD08,Midazolam,Solution,"Intravenous,Intramuscular",77700596,MIDAZOLAM INJECTION (midazolam 2 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012736,midazolam 2 mg per 2 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Targeted Substances (CDSA IV)
63823,Marketed,2005-10-06,02240285,Midazolam Injection,1,N05CD08,Midazolam,Solution,"Intravenous,Intramuscular",77700597,MIDAZOLAM INJECTION (midazolam 10 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012731,midazolam 10 mg per 10 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Targeted Substances (CDSA IV)
63824,Marketed,2005-10-06,02240286,Midazolam Injection,1,N05CD08,Midazolam,Solution,"Intravenous,Intramuscular",77700598,MIDAZOLAM INJECTION (midazolam 10 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012733,midazolam 10 mg per 2 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Targeted Substances (CDSA IV)
63824,Marketed,2005-10-06,02240286,Midazolam Injection,1,N05CD08,Midazolam,Solution,"Intravenous,Intramuscular",77700599,MIDAZOLAM INJECTION (midazolam 5 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012738,midazolam 5 mg per 1 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Targeted Substances (CDSA IV)
63824,Marketed,2005-10-06,02240286,Midazolam Injection,1,N05CD08,Midazolam,Solution,"Intravenous,Intramuscular",77700600,MIDAZOLAM INJECTION (midazolam 50 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012742,midazolam 50 mg per 10 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Targeted Substances (CDSA IV)
66736,Marketed,2025-06-09,02242904,"Midazolam Injection, USP",1,N05CD08,Midazolam,Solution,"Intravenous,Intramuscular",77700603,"MIDAZOLAM INJECTION, USP (midazolam 10 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9012731,midazolam 10 mg per 10 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Targeted Substances (CDSA IV)
66736,Marketed,2025-06-09,02242904,"Midazolam Injection, USP",1,N05CD08,Midazolam,Solution,"Intravenous,Intramuscular",77700604,"MIDAZOLAM INJECTION, USP (midazolam 2 mg per 2 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9012736,midazolam 2 mg per 2 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Targeted Substances (CDSA IV)
66736,Marketed,2025-06-09,02242904,"Midazolam Injection, USP",1,N05CD08,Midazolam,Solution,"Intravenous,Intramuscular",77700605,"MIDAZOLAM INJECTION, USP (midazolam 5 mg per 5 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9012740,midazolam 5 mg per 5 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Targeted Substances (CDSA IV)
66737,Marketed,2025-06-09,02242905,"Midazolam Injection, USP",1,N05CD08,Midazolam,Solution,"Intravenous,Intramuscular",77700606,"MIDAZOLAM INJECTION, USP (midazolam 5 mg per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9012738,midazolam 5 mg per 1 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Targeted Substances (CDSA IV)
66737,Marketed,2025-06-09,02242905,"Midazolam Injection, USP",1,N05CD08,Midazolam,Solution,"Intravenous,Intramuscular",77700607,"MIDAZOLAM INJECTION, USP (midazolam 10 mg per 2 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9012733,midazolam 10 mg per 2 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Targeted Substances (CDSA IV)
66737,Marketed,2025-06-09,02242905,"Midazolam Injection, USP",1,N05CD08,Midazolam,Solution,"Intravenous,Intramuscular",77700608,"MIDAZOLAM INJECTION, USP (midazolam 50 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9012742,midazolam 50 mg per 10 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Targeted Substances (CDSA IV)
86819,Marketed,2017-10-25,02382342,Midazolam Injection USP,1,N05CD08,Midazolam,Solution,"Intravenous,Intramuscular",77700611,MIDAZOLAM INJECTION USP PRESERVATIVE-FREE (midazolam 5 mg per 5 mL solution for injection vial) PFIZER CANADA ULC,Active,9012740,midazolam 5 mg per 5 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Targeted Substances (CDSA IV)
86819,Marketed,2017-10-25,02382342,Midazolam Injection USP,1,N05CD08,Midazolam,Solution,"Intravenous,Intramuscular",77700612,MIDAZOLAM INJECTION USP PRESERVATIVE-FREE (midazolam 2 mg per 2 mL solution for injection vial) PFIZER CANADA ULC,Active,9012736,midazolam 2 mg per 2 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Targeted Substances (CDSA IV)
86821,Marketed,2017-10-25,02382350,Midazolam Injection USP,1,N05CD08,Midazolam,Solution,"Intravenous,Intramuscular",77700613,MIDAZOLAM INJECTION USP PRESERVATIVE-FREE (midazolam 5 mg per 1 mL solution for injection vial) PFIZER CANADA ULC,Active,9012738,midazolam 5 mg per 1 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Targeted Substances (CDSA IV)
86821,Marketed,2017-10-25,02382350,Midazolam Injection USP,1,N05CD08,Midazolam,Solution,"Intravenous,Intramuscular",77700614,MIDAZOLAM INJECTION USP PRESERVATIVE-FREE (midazolam 10 mg per 2 mL solution for injection vial) PFIZER CANADA ULC,Active,9012733,midazolam 10 mg per 2 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Targeted Substances (CDSA IV)
86822,Marketed,2017-10-25,02382377,Midazolam Injection USP,1,N05CD08,Midazolam,Solution,"Intramuscular,Intravenous",02382377,MIDAZOLAM INJECTION USP WITH PRESERVATIVE (midazolam 10 mg per 10 mL solution for injection vial) PFIZER CANADA ULC,Active,9012731,midazolam 10 mg per 10 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Targeted Substances (CDSA IV)
86823,Marketed,2017-10-25,02382385,Midazolam Injection USP,1,N05CD08,Midazolam,Solution,"Intramuscular,Intravenous",02382385,MIDAZOLAM INJECTION USP WITH PRESERVATIVE (midazolam 50 mg per 10 mL solution for injection vial) PFIZER CANADA ULC,Active,9012742,midazolam 50 mg per 10 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Targeted Substances (CDSA IV)
98782,Marketed,2020-10-26,02498022,Midazolam Injection USP,1,N05CD08,Midazolam,Solution,Intravenous,02498022,MIDAZOLAM INJECTION USP (midazolam 100 mg per 100 mL solution for injection bag) STERINOVA INC.,Active,9014405,midazolam 100 mg per 100 mL solution for injection bag,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Targeted Substances (CDSA IV)
100707,Marketed,2022-02-21,02517701,JAMP Midodrine,1,C01CA17,Midodrine,Tablet,Oral,02517701,JAMP MIDODRINE (midodrine hydrochloride 2.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004172,midodrine hydrochloride 2.5 mg oral tablet,8001402,midodrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100708,Marketed,2025-08-07,02517728,JAMP Midodrine,1,C01CA17,Midodrine,Tablet,Oral,02517728,JAMP MIDODRINE (midodrine hydrochloride 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004173,midodrine hydrochloride 5 mg oral tablet,8001402,midodrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102221,Marketed,2023-05-31,02533200,Midodrine,1,C01CA17,Midodrine,Tablet,Oral,02533200,MIDODRINE (midodrine hydrochloride 2.5 mg oral tablet) SANIS HEALTH INC,Active,9004172,midodrine hydrochloride 2.5 mg oral tablet,8001402,midodrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102222,Marketed,2023-05-31,02533219,Midodrine,1,C01CA17,Midodrine,Tablet,Oral,02533219,MIDODRINE (midodrine hydrochloride 5 mg oral tablet) SANIS HEALTH INC,Active,9004173,midodrine hydrochloride 5 mg oral tablet,8001402,midodrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103576,Marketed,2024-10-23,02547112,M-Midodrine,1,C01CA17,Midodrine,Tablet,Oral,02547112,M-MIDODRINE (midodrine hydrochloride 2.5 mg oral tablet) MANTRA PHARMA INC,Active,9004172,midodrine hydrochloride 2.5 mg oral tablet,8001402,midodrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103577,Marketed,2024-12-17,02547120,M-Midodrine,1,C01CA17,Midodrine,Tablet,Oral,02547120,M-MIDODRINE (midodrine hydrochloride 5 mg oral tablet) MANTRA PHARMA INC,Active,9004173,midodrine hydrochloride 5 mg oral tablet,8001402,midodrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76425,Marketed,2018-12-10,02278677,Apo-Midodrine,1,C01CA17,Midodrine,Tablet,Oral,02278677,APO-MIDODRINE (midodrine hydrochloride 2.5 mg oral tablet) APOTEX INC,Active,9004172,midodrine hydrochloride 2.5 mg oral tablet,8001402,midodrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76426,Marketed,2018-12-10,02278685,Apo-Midodrine,1,C01CA17,Midodrine,Tablet,Oral,02278685,APO-MIDODRINE (midodrine hydrochloride 5 mg oral tablet) APOTEX INC,Active,9004173,midodrine hydrochloride 5 mg oral tablet,8001402,midodrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96400,Marketed,2018-08-03,02473984,Mar-Midodrine,1,C01CA17,Midodrine,Tablet,Oral,02473984,MAR-MIDODRINE (midodrine hydrochloride 2.5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9004172,midodrine hydrochloride 2.5 mg oral tablet,8001402,midodrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96401,Marketed,2018-08-03,02473992,Mar-Midodrine,1,C01CA17,Midodrine,Tablet,Oral,02473992,MAR-MIDODRINE (midodrine hydrochloride 5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9004173,midodrine hydrochloride 5 mg oral tablet,8001402,midodrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95454,Marketed,2017-09-08,02466236,Rydapt,1,L01EX10,Midostaurin,Capsule,Oral,02466236,RYDAPT (midostaurin 25 mg oral capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014642,midostaurin 25 mg oral capsule,8002404,midostaurin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
106361,Marketed,2026-02-03,02560569,Femyso,2,G03XB51,"Mifepristone, combinations","Tablet,Kit","Buccal,Oral",02560569,FEMYSO (mifepristone 200 mg oral tablet with misoprostol 200 mcg buccal tablet) LUPIN PHARMA CANADA LIMITED,Active,9013785,mifepristone 200 mg oral tablet with misoprostol 200 mcg buccal tablet,8001020,mifepristone and misoprostol,54471007,Buccal,385085006,Buccal tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
92881,Marketed,2017-01-10,02444038,Mifegymiso,2,G03XB51,"Mifepristone, combinations","Kit,Tablet","Buccal,Oral",02444038,MIFEGYMISO (mifepristone 200 mg oral tablet with misoprostol 200 mcg buccal tablet) LINEPHARMA INTERNATIONAL LIMITED,Active,9013785,mifepristone 200 mg oral tablet with misoprostol 200 mcg buccal tablet,8001020,mifepristone and misoprostol,54471007,Buccal,385085006,Buccal tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
95640,Marketed,2023-08-03,02468042,Galafold,1,A16AX14,Migalastat,Capsule,Oral,02468042,GALAFOLD (migalastat (migalastat hydrochloride) 123 mg oral capsule) AMICUS THERAPEUTICS CANADA INC.,Active,9012519,migalastat (migalastat hydrochloride) 123 mg oral capsule,8001151,migalastat,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
106020,Marketed,2025-12-05,02556812,Opfolda,1,A16AX06,Miglustat,Capsule,Oral,02556812,OPFOLDA (miglustat 65 mg oral capsule) AMICUS THERAPEUTICS CANADA INC.,Active,9015321,miglustat 65 mg oral capsule,8001858,miglustat,26643006,Oral,420692007,Oral capsule,732937005,Capsule,,,,Prescription
73533,Marketed,2020-02-04,02250519,Zavesca,1,A16AX06,Miglustat,Capsule,Oral,02250519,ZAVESCA (miglustat 100 mg oral capsule) JANSSEN INC,Active,9003909,miglustat 100 mg oral capsule,8001858,miglustat,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
94314,Marketed,2020-04-20,02456257,Sandoz Miglustat,1,A16AX06,Miglustat,Capsule,Oral,02456257,SANDOZ MIGLUSTAT (miglustat 100 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9003909,miglustat 100 mg oral capsule,8001858,miglustat,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
101060,Marketed,2023-05-31,02521407,Milrinone Lactate Injection USP,1,C01CE02,Milrinone,Solution,Intravenous,77701125,MILRINONE LACTATE INJECTION USP (milrinone (milrinone lactate) 10 mg per 10 mL solution for injection vial) MARCAN PHARMACEUTICALS INC,Active,9013234,milrinone (milrinone lactate) 10 mg per 10 mL solution for injection vial,8001859,milrinone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
101060,Marketed,2023-05-31,02521407,Milrinone Lactate Injection USP,1,C01CE02,Milrinone,Solution,Intravenous,77701126,MILRINONE LACTATE INJECTION USP (milrinone (milrinone lactate) 20 mg per 20 mL solution for injection vial) MARCAN PHARMACEUTICALS INC,Active,9013235,milrinone (milrinone lactate) 20 mg per 20 mL solution for injection vial,8001859,milrinone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
68609,Marketed,2022-11-02,02244622,"Milrinone Lactate Injection, USP",1,C01CE02,Milrinone,Solution,Intravenous,77700728,"MILRINONE LACTATE INJECTION, USP (milrinone (milrinone lactate) 10 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013234,milrinone (milrinone lactate) 10 mg per 10 mL solution for injection vial,8001859,milrinone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
68609,Marketed,2022-11-02,02244622,"Milrinone Lactate Injection, USP",1,C01CE02,Milrinone,Solution,Intravenous,77700729,"MILRINONE LACTATE INJECTION, USP (milrinone (milrinone lactate) 20 mg per 20 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013235,milrinone (milrinone lactate) 20 mg per 20 mL solution for injection vial,8001859,milrinone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
9351,Marketed,2013-05-22,00777838,Peglyte Powder,5,A06AD10,Mineral salts in combination,Powder for solution,Oral,,,,,,,,,,,,,,,,,Ethical
15925,Marketed,2020-01-03,02084104,Minocycline,1,J01AA08,Minocycline,Capsule,Oral,02084104,MINOCYCLINE (minocycline (minocycline hydrochloride) 100 mg oral capsule) AA PHARMA INC,Active,9000536,minocycline (minocycline hydrochloride) 100 mg oral capsule,8000205,minocycline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
15927,Marketed,2019-12-20,02084090,Minocycline,1,J01AA08,Minocycline,Capsule,Oral,02084090,MINOCYCLINE (minocycline (minocycline hydrochloride) 50 mg oral capsule) AA PHARMA INC,Active,9000537,minocycline (minocycline hydrochloride) 50 mg oral capsule,8000205,minocycline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
76380,Marketed,2011-01-20,02278219,Arestin Microspheres,1,A01AB23,Minocycline,Powder (extended release),Subgingival,02278219,ARESTIN MICROSPHERES (minocycline (minocycline hydrochloride) 1 mg per 4 mg prolonged-release periodontal powder) ORA PHARMA INC.,Active,9001254,minocycline (minocycline hydrochloride) 1 mg per 4 mg prolonged-release periodontal powder,8000205,minocycline,447052000,Periodontal,739005008,Powder,,,,,,Prescription
4010,Marketed,2006-03-09,00514500,Loniten 10 mg,1,C02DC01,Minoxidil,Tablet,Oral,00514500,LONITEN 10MG (minoxidil 10 mg oral tablet) PFIZER CANADA ULC,Active,9010663,minoxidil 10 mg oral tablet,8000824,minoxidil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
4011,Marketed,2005-11-21,00514497,Loniten 2.5 mg,1,C02DC01,Minoxidil,Tablet,Oral,00514497,LONITEN 2.5MG (minoxidil 2.5 mg oral tablet) PFIZER CANADA ULC,Active,9010664,minoxidil 2.5 mg oral tablet,8000824,minoxidil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101842,Marketed,2023-09-19,02529238,JAMP Minoxidil Solution,1,D11AX01,"Minoxidil, topical",Solution,Topical,02529238,JAMP MINOXIDIL SOLUTION (minoxidil 20 mg per mL cutaneous solution) JAMP PHARMA CORPORATION,Active,9010665,minoxidil 20 mg per mL cutaneous solution,8000824,minoxidil,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Non-Prescription Drugs
104015,Marketed,2026-02-17,02551446,Men's Hair Regrowth Treatment,1,D11AX01,"Minoxidil, topical","Aerosol, foam",Topical,02551446,MEN'S HAIR REGROWTH TREATMENT (minoxidil 5 % cutaneous foam) TARO PHARMACEUTICALS INC,Active,9010666,minoxidil 5 % cutaneous foam,8000824,minoxidil,448598008,Cutaneous,421166008,Foam,,,,,,Non-Prescription Drugs
104038,Marketed,2026-02-18,02551659,Women's Hair Regrowth Treatment,1,D11AX01,"Minoxidil, topical","Aerosol, foam",Topical,02551659,WOMEN'S HAIR REGROWTH TREATMENT (minoxidil 5 % cutaneous foam) TARO PHARMACEUTICALS INC,Active,9010666,minoxidil 5 % cutaneous foam,8000824,minoxidil,448598008,Cutaneous,421166008,Foam,,,,,,Non-Prescription Drugs
104240,Marketed,2025-07-04,02553465,Men's GLN-Minoxidil,1,D11AX01,"Minoxidil, topical","Aerosol, foam",Topical,02553465,MEN'S GLN-MINOXIDIL (minoxidil 5 % cutaneous foam) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9010666,minoxidil 5 % cutaneous foam,8000824,minoxidil,448598008,Cutaneous,421166008,Foam,,,,,,Non-Prescription Drugs
7084,Marketed,2025-12-24,00708925,Men's Rogaine,1,D11AX01,"Minoxidil, topical",Solution,Topical,00708925,MEN'S ROGAINE (minoxidil 20 mg per mL cutaneous solution) KENVUE CANADA INC.,Active,9010665,minoxidil 20 mg per mL cutaneous solution,8000824,minoxidil,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Non-Prescription Drugs
84173,Marketed,2011-04-15,02356597,Hair Regrowth Formula,1,D11AX01,"Minoxidil, topical",Solution,Topical,02356597,HAIR REGROWTH FORMULA (minoxidil 20 mg per mL cutaneous solution) VITA HEALTH PRODUCTS INC,Active,9010665,minoxidil 20 mg per mL cutaneous solution,8000824,minoxidil,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Non-Prescription Drugs
85367,Marketed,2025-12-24,02368684,Men's Rogaine Foam 5%,1,D11AX01,"Minoxidil, topical","Aerosol, foam",Topical,02368684,MEN'S ROGAINE FOAM 5% (minoxidil 5 % cutaneous foam) KENVUE CANADA INC.,Active,9010666,minoxidil 5 % cutaneous foam,8000824,minoxidil,448598008,Cutaneous,421166008,Foam,,,,,,Non-Prescription Drugs
90937,Marketed,2025-12-24,02424703,Women's Rogaine Foam 5%,1,D11AX01,"Minoxidil, topical","Aerosol, foam",Topical,02424703,WOMEN'S ROGAINE FOAM 5% (minoxidil 5 % cutaneous foam) KENVUE CANADA INC.,Active,9010666,minoxidil 5 % cutaneous foam,8000824,minoxidil,448598008,Cutaneous,421166008,Foam,,,,,,Non-Prescription Drugs
106762,Marketed,2026-04-01,02564963,Apo-Mirabegron,1,G04BD12,Mirabegron,Tablet (extended-release),Oral,02564963,APO-MIRABEGRON (mirabegron 25 mg prolonged-release oral tablet) APOTEX INC,Active,9005209,mirabegron 25 mg prolonged-release oral tablet,8001124,mirabegron,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106763,Marketed,2026-04-01,02564971,Apo-Mirabegron,1,G04BD12,Mirabegron,Tablet (extended-release),Oral,02564971,APO-MIRABEGRON (mirabegron 50 mg prolonged-release oral tablet) APOTEX INC,Active,9005210,mirabegron 50 mg prolonged-release oral tablet,8001124,mirabegron,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88771,Marketed,2013-03-28,02402882,Myrbetriq,1,G04BD12,Mirabegron,Tablet (extended-release),Oral,02402882,MYRBETRIQ (mirabegron 50 mg prolonged-release oral tablet) ASTELLAS PHARMA CANADA INC,Active,9005210,mirabegron 50 mg prolonged-release oral tablet,8001124,mirabegron,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102858,Marketed,2025-10-22,02539845,Omvoh,1,L04AC24,Mirikizumab,Solution,Subcutaneous,02539845,OMVOH (mirikizumab 100 mg per 1 mL solution for injection pen) ELI LILLY CANADA INC,Active,9014981,mirikizumab 100 mg per 1 mL solution for injection pen,8002483,mirikizumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Prescription
102858,Marketed,2025-10-22,02539845,Omvoh,1,L04AC24,Mirikizumab,Solution,Subcutaneous,02539845,OMVOH (mirikizumab 100 mg per 1 mL solution for injection pen) ELI LILLY CANADA INC,Active,9014981,mirikizumab 100 mg per 1 mL solution for injection pen,8002483,mirikizumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
102859,Marketed,2025-10-22,02539853,Omvoh,1,L04AC24,Mirikizumab,Solution,Subcutaneous,02539853,OMVOH (mirikizumab 100 mg per 1 mL solution for injection syringe) ELI LILLY CANADA INC,Active,9014982,mirikizumab 100 mg per 1 mL solution for injection syringe,8002483,mirikizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
102859,Marketed,2025-10-22,02539853,Omvoh,1,L04AC24,Mirikizumab,Solution,Subcutaneous,02539853,OMVOH (mirikizumab 100 mg per 1 mL solution for injection syringe) ELI LILLY CANADA INC,Active,9014982,mirikizumab 100 mg per 1 mL solution for injection syringe,8002483,mirikizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
102860,Marketed,2023-10-03,02539861,Omvoh,1,L04AC24,Mirikizumab,Solution,Intravenous,02539861,OMVOH (mirikizumab 300 mg per 15 mL solution for injection vial) ELI LILLY CANADA INC,Active,9014944,mirikizumab 300 mg per 15 mL solution for injection vial,8002483,mirikizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
102860,Marketed,2023-10-03,02539861,Omvoh,1,L04AC24,Mirikizumab,Solution,Intravenous,02539861,OMVOH (mirikizumab 300 mg per 15 mL solution for injection vial) ELI LILLY CANADA INC,Active,9014944,mirikizumab 300 mg per 15 mL solution for injection vial,8002483,mirikizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
106238,Marketed,2025-10-22,02559218,Omvoh,1,L04AC24,Mirikizumab,Solution,Subcutaneous,02559218,OMVOH (mirikizumab 200 mg per 2 mL solution for injection pen) ELI LILLY CANADA INC,Active,9015285,mirikizumab 200 mg per 2 mL solution for injection pen,8002483,mirikizumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen(s),,,,Prescription
106238,Marketed,2025-10-22,02559218,Omvoh,1,L04AC24,Mirikizumab,Solution,Subcutaneous,02559218,OMVOH (mirikizumab 200 mg per 2 mL solution for injection pen) ELI LILLY CANADA INC,Active,9015285,mirikizumab 200 mg per 2 mL solution for injection pen,8002483,mirikizumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen(s),,,,Schedule D
106239,Marketed,2025-10-22,02559226,Omvoh,1,L04AC24,Mirikizumab,Solution,Subcutaneous,02559226,OMVOH (mirikizumab 200 mL per 2 mL solution for injection syringe) ELI LILLY CANADA INC,Active,9015286,mirikizumab 200 mL per 2 mL solution for injection syringe,8002483,mirikizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe,,,,Schedule D
106239,Marketed,2025-10-22,02559226,Omvoh,1,L04AC24,Mirikizumab,Solution,Subcutaneous,02559226,OMVOH (mirikizumab 200 mL per 2 mL solution for injection syringe) ELI LILLY CANADA INC,Active,9015286,mirikizumab 200 mL per 2 mL solution for injection syringe,8002483,mirikizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe,,,,Prescription
106240,Marketed,2025-10-22,02559234,Omvoh,2,L04AC24,Mirikizumab,Kit,Subcutaneous,02559234,OMVOH (mirikizumab 100 mg per 1 mL solution for injection syringe with mirikizumab 200 mg per 2 mL solution for injection syringe) ELI LILLY CANADA INC,Active,9015284,mirikizumab 100 mg per 1 mL solution for injection syringe with mirikizumab 200 mg per 2 mL solution for injection syringe,8002483,mirikizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe,,,,Prescription
106240,Marketed,2025-10-22,02559234,Omvoh,2,L04AC24,Mirikizumab,Kit,Subcutaneous,02559234,OMVOH (mirikizumab 100 mg per 1 mL solution for injection syringe with mirikizumab 200 mg per 2 mL solution for injection syringe) ELI LILLY CANADA INC,Active,9015284,mirikizumab 100 mg per 1 mL solution for injection syringe with mirikizumab 200 mg per 2 mL solution for injection syringe,8002483,mirikizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe,,,,Schedule D
106241,Marketed,2025-10-22,02559242,Omvoh,2,L04AC24,Mirikizumab,Kit,Subcutaneous,02559242,OMVOH (mirikizumab 100 mg per 1 mL solution for injection pen with mirikizumab 200 mg per 2 mL solution for injection pen) ELI LILLY CANADA INC,Active,9015283,mirikizumab 100 mg per 1 mL solution for injection pen with mirikizumab 200 mg per 2 mL solution for injection pen,8002483,mirikizumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen(s),,,,Schedule D
106241,Marketed,2025-10-22,02559242,Omvoh,2,L04AC24,Mirikizumab,Kit,Subcutaneous,02559242,OMVOH (mirikizumab 100 mg per 1 mL solution for injection pen with mirikizumab 200 mg per 2 mL solution for injection pen) ELI LILLY CANADA INC,Active,9015283,mirikizumab 100 mg per 1 mL solution for injection pen with mirikizumab 200 mg per 2 mL solution for injection pen,8002483,mirikizumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen(s),,,,Prescription
102170,Marketed,2023-10-12,02532689,Mirtazapine,1,N06AX11,Mirtazapine,Tablet,Oral,02532689,MIRTAZAPINE (mirtazapine 15 mg oral tablet) SANIS HEALTH INC,Active,9001075,mirtazapine 15 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102381,Marketed,2023-07-27,02534924,Nra-Mirtazapine,1,N06AX11,Mirtazapine,Tablet,Oral,02534924,NRA-MIRTAZAPINE (mirtazapine 15 mg oral tablet) NORA PHARMA INC,Active,9001075,mirtazapine 15 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102382,Marketed,2023-07-27,02534932,Nra-Mirtazapine,1,N06AX11,Mirtazapine,Tablet,Oral,02534932,NRA-MIRTAZAPINE (mirtazapine 30 mg oral tablet) NORA PHARMA INC,Active,9000940,mirtazapine 30 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102383,Marketed,2023-07-27,02534940,Nra-Mirtazapine,1,N06AX11,Mirtazapine,Tablet,Oral,02534940,NRA-MIRTAZAPINE (mirtazapine 45 mg oral tablet) NORA PHARMA INC,Active,9001088,mirtazapine 45 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103021,Marketed,2024-09-03,02541572,Teva-Mirtazapine,1,N06AX11,Mirtazapine,Tablet,Oral,02541572,TEVA-MIRTAZAPINE (mirtazapine 15 mg oral tablet) TEVA CANADA LIMITED,Active,9001075,mirtazapine 15 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103022,Marketed,2024-09-03,02541580,Teva-Mirtazapine,1,N06AX11,Mirtazapine,Tablet,Oral,02541580,TEVA-MIRTAZAPINE (mirtazapine 45 mg oral tablet) TEVA CANADA LIMITED,Active,9001088,mirtazapine 45 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
67852,Marketed,2022-05-17,02243910,Remeron,1,N06AX11,Mirtazapine,Tablet,Oral,02243910,REMERON (mirtazapine 30 mg oral tablet) ORGANON CANADA INC.,Active,9000940,mirtazapine 30 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
72897,Marketed,2022-05-24,02248542,Remeron RD,1,N06AX11,Mirtazapine,Tablet (orally disintegrating),Oral,02248542,REMERON RD (mirtazapine 15 mg orodispersible tablet) ORGANON CANADA INC.,Active,9001061,mirtazapine 15 mg orodispersible tablet,8000298,mirtazapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
72898,Marketed,2022-08-04,02248543,Remeron RD,1,N06AX11,Mirtazapine,Tablet (orally disintegrating),Oral,02248543,REMERON RD (mirtazapine 30 mg orodispersible tablet) ORGANON CANADA INC.,Active,9001062,mirtazapine 30 mg orodispersible tablet,8000298,mirtazapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
72899,Marketed,2022-11-04,02248544,Remeron RD,1,N06AX11,Mirtazapine,Tablet (orally disintegrating),Oral,02248544,REMERON RD (mirtazapine 45 mg orodispersible tablet) ORGANON CANADA INC.,Active,9001063,mirtazapine 45 mg orodispersible tablet,8000298,mirtazapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
73540,Marketed,2006-01-27,02250594,Sandoz Mirtazapine,1,N06AX11,Mirtazapine,Tablet,Oral,02250594,SANDOZ MIRTAZAPINE (mirtazapine 15 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001075,mirtazapine 15 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73541,Marketed,2006-01-27,02250608,Sandoz Mirtazapine,1,N06AX11,Mirtazapine,Tablet,Oral,02250608,SANDOZ MIRTAZAPINE (mirtazapine 30 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000940,mirtazapine 30 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74133,Marketed,2009-10-21,02256096,Mylan-Mirtazapine,1,N06AX11,Mirtazapine,Tablet,Oral,02256096,MYLAN-MIRTAZAPINE (mirtazapine 15 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9001075,mirtazapine 15 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74134,Marketed,2009-10-09,02256118,Mylan-Mirtazapine,1,N06AX11,Mirtazapine,Tablet,Oral,02256118,MYLAN-MIRTAZAPINE (mirtazapine 30 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000940,mirtazapine 30 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74135,Marketed,2010-10-20,02256126,Mylan-Mirtazapine,1,N06AX11,Mirtazapine,Tablet,Oral,02256126,MYLAN-MIRTAZAPINE (mirtazapine 45 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9001088,mirtazapine 45 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74461,Marketed,2023-09-18,02259354,Teva-Mirtazapine,1,N06AX11,Mirtazapine,Tablet,Oral,02259354,TEVA-MIRTAZAPINE (mirtazapine 30 mg oral tablet) TEVA CANADA LIMITED,Active,9000940,mirtazapine 30 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77206,Marketed,2006-10-04,02286610,Apo-Mirtazapine,1,N06AX11,Mirtazapine,Tablet,Oral,02286610,APO-MIRTAZAPINE (mirtazapine 15 mg oral tablet) APOTEX INC,Active,9001075,mirtazapine 15 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77207,Marketed,2006-10-04,02286629,Apo-Mirtazapine,1,N06AX11,Mirtazapine,Tablet,Oral,02286629,APO-MIRTAZAPINE (mirtazapine 30 mg oral tablet) APOTEX INC,Active,9000940,mirtazapine 30 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77208,Marketed,2006-10-04,02286637,Apo-Mirtazapine,1,N06AX11,Mirtazapine,Tablet,Oral,02286637,APO-MIRTAZAPINE (mirtazapine 45 mg oral tablet) APOTEX INC,Active,9001088,mirtazapine 45 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78516,Marketed,2010-12-20,02299801,Auro-Mirtazapine Od,1,N06AX11,Mirtazapine,Tablet (orally disintegrating),Oral,02299801,AURO-MIRTAZAPINE OD (mirtazapine 15 mg orodispersible tablet) AURO PHARMA INC,Active,9001061,mirtazapine 15 mg orodispersible tablet,8000298,mirtazapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
78517,Marketed,2010-12-20,02299828,Auro-Mirtazapine Od,1,N06AX11,Mirtazapine,Tablet (orally disintegrating),Oral,02299828,AURO-MIRTAZAPINE OD (mirtazapine 30 mg orodispersible tablet) AURO PHARMA INC,Active,9001062,mirtazapine 30 mg orodispersible tablet,8000298,mirtazapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
78518,Marketed,2010-12-20,02299836,Auro-Mirtazapine Od,1,N06AX11,Mirtazapine,Tablet (orally disintegrating),Oral,02299836,AURO-MIRTAZAPINE OD (mirtazapine 45 mg orodispersible tablet) AURO PHARMA INC,Active,9001063,mirtazapine 45 mg orodispersible tablet,8000298,mirtazapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
79829,Marketed,2024-03-11,02312778,Pro-Mirtazapine,1,N06AX11,Mirtazapine,Tablet,Oral,02312778,PRO-MIRTAZAPINE (mirtazapine 15 mg oral tablet) PRO DOC LIMITEE,Active,9001075,mirtazapine 15 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79830,Marketed,2024-03-11,02312786,Pro-Mirtazapine,1,N06AX11,Mirtazapine,Tablet,Oral,02312786,PRO-MIRTAZAPINE (mirtazapine 30 mg oral tablet) PRO DOC LIMITEE,Active,9000940,mirtazapine 30 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85581,Marketed,2025-10-28,02370689,Mirtazapine,1,N06AX11,Mirtazapine,Tablet,Oral,02370689,MIRTAZAPINE (mirtazapine 30 mg oral tablet) SANIS HEALTH INC,Active,9000940,mirtazapine 30 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89629,Marketed,2013-10-16,02411695,Auro-Mirtazapine,1,N06AX11,Mirtazapine,Tablet,Oral,02411695,AURO-MIRTAZAPINE (mirtazapine 15 mg oral tablet) AURO PHARMA INC,Active,9001075,mirtazapine 15 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89630,Marketed,2013-10-16,02411709,Auro-Mirtazapine,1,N06AX11,Mirtazapine,Tablet,Oral,02411709,AURO-MIRTAZAPINE (mirtazapine 30 mg oral tablet) AURO PHARMA INC,Active,9000940,mirtazapine 30 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89632,Marketed,2013-10-16,02411717,Auro-Mirtazapine,1,N06AX11,Mirtazapine,Tablet,Oral,02411717,AURO-MIRTAZAPINE (mirtazapine 45 mg oral tablet) AURO PHARMA INC,Active,9001088,mirtazapine 45 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98652,Marketed,2020-10-22,02496666,Mirtazapine,1,N06AX11,Mirtazapine,Tablet,Oral,02496666,MIRTAZAPINE (mirtazapine 15 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001075,mirtazapine 15 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98653,Marketed,2020-10-22,02496674,Mirtazapine,1,N06AX11,Mirtazapine,Tablet,Oral,02496674,MIRTAZAPINE (mirtazapine 30 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000940,mirtazapine 30 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98654,Marketed,2020-10-22,02496682,Mirtazapine,1,N06AX11,Mirtazapine,Tablet,Oral,02496682,MIRTAZAPINE (mirtazapine 45 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001088,mirtazapine 45 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106381,Marketed,2026-01-09,02560771,Elahere,1,L01FX26,Mirvetuximab soravtansine,Solution,Intravenous,02560771,ELAHERE (mirvetuximab soravtansine 100 mg per 20 mL solution for injection vial) ABBVIE CORPORATION,Active,9015364,mirvetuximab soravtansine 100 mg per 20 mL solution for injection vial,8002573,mirvetuximab soravtansine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,1.0,,,Prescription
106381,Marketed,2026-01-09,02560771,Elahere,1,L01FX26,Mirvetuximab soravtansine,Solution,Intravenous,02560771,ELAHERE (mirvetuximab soravtansine 100 mg per 20 mL solution for injection vial) ABBVIE CORPORATION,Active,9015364,mirvetuximab soravtansine 100 mg per 20 mL solution for injection vial,8002573,mirvetuximab soravtansine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,1.0,,,Schedule D
67965,Marketed,2011-12-14,02244022,Misoprostol,1,A02BB01,Misoprostol,Tablet,Oral,02244022,MISOPROSTOL (misoprostol 100 mcg oral tablet) AA PHARMA INC,Active,9003613,misoprostol 100 mcg oral tablet,8000921,misoprostol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
67966,Marketed,2011-08-06,02244023,Misoprostol,1,A02BB01,Misoprostol,Tablet,Oral,02244023,MISOPROSTOL (misoprostol 200 mcg oral tablet) AA PHARMA INC,Active,9003614,misoprostol 200 mcg oral tablet,8000921,misoprostol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102103,Marketed,2023-02-27,02531941,"Mitomycin For Injection, USP",1,L01DC03,Mitomycin,Powder for solution,"Intravesical,Intravenous",02531941,"MITOMYCIN FOR INJECTION, USP (mitomycin 20 mg per vial powder for solution for injection) HIKMA CANADA LIMITED",Active,9003172,mitomycin 20 mg per vial powder for solution for injection,8001860,mitomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
49400,Marketed,2012-09-27,02230451,Mitomycin For Injection,1,L01DC03,Mitomycin,Powder for solution,"Intravesical,Intravenous",02230451,MITOMYCIN FOR INJECTION (mitomycin 20 mg per vial powder for solution for injection) TEVA CANADA LIMITED,Active,9003172,mitomycin 20 mg per vial powder for solution for injection,8001860,mitomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
95282,Marketed,2018-04-30,02464691,Mitomycin For Injection USP,1,L01DC03,Mitomycin,Powder for solution,"Intravenous,Intravesical",02464691,MITOMYCIN FOR INJECTION USP (mitomycin 20 mg per vial powder for solution for injection) ACCORD HEALTHCARE INC,Active,9003172,mitomycin 20 mg per vial powder for solution for injection,8001860,mitomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
3348,Marketed,2025-06-26,00463221,Lysodren,1,L01XX23,Mitotane,Tablet,Oral,00463221,LYSODREN (mitotane 500 mg oral tablet) ESTEVE PHARMACEUTICALS S.A.,Active,9001853,mitotane 500 mg oral tablet,8001861,mitotane,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
77176,Marketed,2015-12-30,02286300,mitoXANTRONE Injection,1,L01DB07,Mitoxantrone,Solution,Intravenous,02286300,MITOXANTRONE INJECTION (mitoxantrone (mitoxantrone hydrochloride) 20 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9013236,mitoxantrone (mitoxantrone hydrochloride) 20 mg per 10 mL solution for injection vial,8001862,mitoxantrone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
13256,Marketed,2021-06-24,00899356,Manerix,1,N06AG02,Moclobemide,Tablet,Oral,00899356,"MANERIX (moclobemide 150 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9002480,moclobemide 150 mg oral tablet,8001668,moclobemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
18969,Marketed,2021-06-24,02166747,Manerix,1,N06AG02,Moclobemide,Tablet,Oral,02166747,"MANERIX (moclobemide 300 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9002850,moclobemide 300 mg oral tablet,8001668,moclobemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
51594,Marketed,2018-03-27,02232148,Moclobemide,1,N06AG02,Moclobemide,Tablet,Oral,02232148,MOCLOBEMIDE (moclobemide 100 mg oral tablet) AA PHARMA INC,Active,9003151,moclobemide 100 mg oral tablet,8001668,moclobemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
51595,Marketed,2018-05-24,02232150,Moclobemide,1,N06AG02,Moclobemide,Tablet,Oral,02232150,MOCLOBEMIDE (moclobemide 150 mg oral tablet) AA PHARMA INC,Active,9002480,moclobemide 150 mg oral tablet,8001668,moclobemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
64019,Marketed,2017-11-14,02240456,Moclobemide,1,N06AG02,Moclobemide,Tablet,Oral,02240456,MOCLOBEMIDE (moclobemide 300 mg oral tablet) AA PHARMA INC,Active,9002850,moclobemide 300 mg oral tablet,8001668,moclobemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101944,Marketed,2022-12-19,02530244,Modafinil,1,N06BA07,Modafinil,Tablet,Oral,02530244,MODAFINIL (modafinil 100 mg oral tablet) SANIS HEALTH INC,Active,9003367,modafinil 100 mg oral tablet,8001863,modafinil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
63139,Marketed,2014-11-20,02239665,Alertec,1,N06BA07,Modafinil,Tablet,Oral,02239665,ALERTEC (modafinil 100 mg oral tablet) TEVA CANADA LIMITED,Active,9003367,modafinil 100 mg oral tablet,8001863,modafinil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77089,Marketed,2014-09-19,02285398,Apo-Modafinil,1,N06BA07,Modafinil,Tablet,Oral,02285398,APO-MODAFINIL (modafinil 100 mg oral tablet) APOTEX INC,Active,9003367,modafinil 100 mg oral tablet,8001863,modafinil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90485,Marketed,2014-07-02,02420260,Teva-Modafinil,1,N06BA07,Modafinil,Tablet,Oral,02420260,TEVA-MODAFINIL (modafinil 100 mg oral tablet) TEVA CANADA LIMITED,Active,9003367,modafinil 100 mg oral tablet,8001863,modafinil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91494,Marketed,2014-10-24,02430487,Auro-Modafinil,1,N06BA07,Modafinil,Tablet,Oral,02430487,AURO-MODAFINIL (modafinil 100 mg oral tablet) AURO PHARMA INC,Active,9003367,modafinil 100 mg oral tablet,8001863,modafinil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91701,Marketed,2015-01-09,02432560,Mar-Modafinil,1,N06BA07,Modafinil,Tablet,Oral,02432560,MAR-MODAFINIL (modafinil 100 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9003367,modafinil 100 mg oral tablet,8001863,modafinil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99317,Marketed,2021-03-11,02503727,JAMP Modafinil,1,N06BA07,Modafinil,Tablet,Oral,02503727,JAMP MODAFINIL (modafinil 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003367,modafinil 100 mg oral tablet,8001863,modafinil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101691,Marketed,2024-03-27,02527715,Poteligeo,1,L01FX09,Mogamulizumab,Solution,Intravenous,02527715,"POTELIGEO (mogamulizumab 20 mg per 5 mL solution for injection vial) KYOWA KIRIN, INC.",Active,9015047,mogamulizumab 20 mg per 5 mL solution for injection vial,8002506,mogamulizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
101691,Marketed,2024-03-27,02527715,Poteligeo,1,L01FX09,Mogamulizumab,Solution,Intravenous,02527715,"POTELIGEO (mogamulizumab 20 mg per 5 mL solution for injection vial) KYOWA KIRIN, INC.",Active,9015047,mogamulizumab 20 mg per 5 mL solution for injection vial,8002506,mogamulizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
104193,Marketed,2025-01-21,02552965,Ojjaara,1,L01EJ04,Momelotinib,Tablet,Oral,02552965,OJJAARA (momelotinib (momelotinib dihydrochloride) 100 mg oral tablet) GLAXOSMITHKLINE INC,Active,9015150,momelotinib (momelotinib dihydrochloride) 100 mg oral tablet,8002528,momelotinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,,Prescription
104194,Marketed,2025-01-21,02552973,Ojjaara,1,L01EJ04,Momelotinib,Tablet,Oral,02552973,OJJAARA (momelotinib (momelotinib dihydrochloride) 150 mg oral tablet) GLAXOSMITHKLINE INC,Active,9015151,momelotinib (momelotinib dihydrochloride) 150 mg oral tablet,8002528,momelotinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,,Prescription
104195,Marketed,2025-01-21,02552981,Ojjaara,1,L01EJ04,Momelotinib,Tablet,Oral,02552981,OJJAARA (momelotinib (momelotinib dihydrochloride) 200 mg oral tablet) GLAXOSMITHKLINE INC,Active,9015152,momelotinib (momelotinib dihydrochloride) 200 mg oral tablet,8002528,momelotinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,,Prescription
100840,Marketed,2022-05-30,02519127,Mometasone,1,R01AD09,Mometasone,"Spray, metered dose",Nasal,02519127,MOMETASONE (mometasone furoate (mometasone furoate monohydrate) 50 mcg per actuation nasal spray) SANIS HEALTH INC,Active,9006259,mometasone furoate 50 mcg per actuation nasal spray,8000148,mometasone,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,,Prescription
104047,Marketed,2025-06-06,02551756,Mometasone,1,R01AD09,Mometasone,"Spray, metered dose",Nasal,02551756,MOMETASONE (mometasone furoate (mometasone furoate monohydrate) 50 mcg per actuation nasal spray) SIVEM PHARMACEUTICALS ULC,Active,9006259,mometasone furoate 50 mcg per actuation nasal spray,8000148,mometasone,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,,Prescription
11196,Marketed,2023-05-23,00851744,Elocom,1,D07AC13,Mometasone,Cream,Topical,00851744,ELOCOM (mometasone furoate 0.1 % cutaneous cream) ORGANON CANADA INC.,Active,9000386,mometasone furoate 0.1 % cutaneous cream,8000148,mometasone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
11443,Marketed,2022-06-21,00871095,Elocom,1,D07AC13,Mometasone,Lotion,Topical,00871095,ELOCOM (mometasone furoate 0.1 % lotion) ORGANON CANADA INC.,Active,9006222,mometasone furoate 0.1 % lotion,8000148,mometasone,448598008,Cutaneous,739000003,Lotion,,,,,,Prescription
11444,Marketed,2022-08-18,00851736,Elocom,1,D07AC13,Mometasone,Ointment,Topical,00851736,ELOCOM (mometasone furoate 0.1 % cutaneous ointment) ORGANON CANADA INC.,Active,9000387,mometasone furoate 0.1 % cutaneous ointment,8000148,mometasone,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Prescription
61885,Marketed,2022-04-14,02238465,Nasonex,1,R01AD09,Mometasone,"Spray, metered dose",Nasal,02238465,NASONEX (mometasone furoate 50 mcg per actuation nasal spray) ORGANON CANADA INC.,Active,9006259,mometasone furoate 50 mcg per actuation nasal spray,8000148,mometasone,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,,Prescription
67513,Marketed,2022-08-12,02243595,Asmanex Twisthaler,1,R03BA07,Mometasone,Powder,Inhalation,02243595,ASMANEX TWISTHALER (mometasone furoate 200 mcg per actuation inhalation powder) ORGANON CANADA INC.,Active,9001370,mometasone furoate 200 mcg per actuation inhalation powder,8000148,mometasone,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
67514,Marketed,2022-01-04,02243596,Asmanex Twisthaler,1,R03BA07,Mometasone,Powder,Inhalation,02243596,ASMANEX TWISTHALER (mometasone furoate 400 mcg per actuation inhalation powder) ORGANON CANADA INC.,Active,9001371,mometasone furoate 400 mcg per actuation inhalation powder,8000148,mometasone,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
72459,Marketed,2018-01-17,02248130,Teva-Mometasone,1,D07AC13,Mometasone,Ointment,Topical,02248130,TEVA-MOMETASONE (mometasone furoate 0.1 % cutaneous ointment) TEVA CANADA LIMITED,Active,9000387,mometasone furoate 0.1 % cutaneous ointment,8000148,mometasone,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Prescription
75180,Marketed,2009-12-01,02266385,Taro-Mometasone Lotion,1,D07AC13,Mometasone,Lotion,Topical,02266385,TARO-MOMETASONE LOTION (mometasone furoate 0.1 % lotion) TARO PHARMACEUTICALS INC,Active,9006222,mometasone furoate 0.1 % lotion,8000148,mometasone,448598008,Cutaneous,739000003,Lotion,,,,,,Prescription
85196,Marketed,2011-06-08,02367157,Taro-Mometasone Cream,1,D07AC13,Mometasone,Cream,Topical,02367157,TARO-MOMETASONE CREAM (mometasone furoate 0.1 % cutaneous cream) TARO PHARMACEUTICALS INC,Active,9000386,mometasone furoate 0.1 % cutaneous cream,8000148,mometasone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
88837,Marketed,2013-03-25,02403587,Apo-Mometasone,1,R01AD09,Mometasone,"Spray, metered dose",Nasal,02403587,APO-MOMETASONE (mometasone furoate 50 mcg per actuation nasal spray) APOTEX INC,Active,9006259,mometasone furoate 50 mcg per actuation nasal spray,8000148,mometasone,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,,Prescription
92309,Marketed,2022-08-04,02438690,Asmanex Twisthaler,1,R03BA07,Mometasone,Powder,Inhalation,02438690,ASMANEX TWISTHALER (mometasone furoate 100 mcg per actuation inhalation powder) ORGANON CANADA INC.,Active,9001441,mometasone furoate 100 mcg per actuation inhalation powder,8000148,mometasone,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
93568,Marketed,2016-07-27,02449811,Sandoz Mometasone,1,R01AD09,Mometasone,"Spray, metered dose",Nasal,02449811,SANDOZ MOMETASONE (mometasone furoate (mometasone furoate monohydrate) 50 mcg per actuation nasal spray) SANDOZ CANADA INCORPORATED,Active,9006259,mometasone furoate 50 mcg per actuation nasal spray,8000148,mometasone,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,,Prescription
96662,Marketed,2018-10-02,02475863,Teva-Mometasone,1,R01AD09,Mometasone,"Spray, metered dose",Nasal,02475863,TEVA-MOMETASONE (mometasone furoate 50 mcg per actuation nasal spray) TEVA CANADA LIMITED,Active,9006259,mometasone furoate 50 mcg per actuation nasal spray,8000148,mometasone,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,,Prescription
102033,Marketed,2023-03-17,02531186,Ryaltris,2,R01AD59,"Mometasone, combinations","Spray, metered dose",Nasal,02531186,RYALTRIS (mometasone furoate (mometasone furoate monohydrate) 25 mcg per actuation and olopatadine hydrochloride 665 mcg per actuation nasal spray) GLENMARK SPECIALTY SA,Active,9014895,mometasone furoate 25 mcg per actuation and olopatadine hydrochloride 665 mcg per actuation nasal spray,8002470,mometasone and olopatadine,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,,Prescription
100428,Marketed,2022-08-26,02514877,JAMP Montelukast Chewable Tablets,1,R03DC03,Montelukast,Tablet (chewable),Oral,02514877,JAMP MONTELUKAST CHEWABLE TABLETS (montelukast (montelukast sodium) 4 mg chewable tablet) JAMP PHARMA CORPORATION,Active,9000939,montelukast (montelukast sodium) 4 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Prescription
100429,Marketed,2022-08-26,02514885,JAMP Montelukast Chewable Tablets,1,R03DC03,Montelukast,Tablet (chewable),Oral,02514885,JAMP MONTELUKAST CHEWABLE TABLETS (montelukast (montelukast sodium) 5 mg chewable tablet) JAMP PHARMA CORPORATION,Active,9000810,montelukast (montelukast sodium) 5 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Prescription
101128,Marketed,2022-12-19,02522136,Nat-Montelukast,1,R03DC03,Montelukast,Tablet,Oral,02522136,NAT-MONTELUKAST (montelukast (montelukast sodium) 10 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
61609,Marketed,2022-06-23,02238216,Singulair,1,R03DC03,Montelukast,Tablet (chewable),Oral,02238216,SINGULAIR (montelukast (montelukast sodium) 5 mg chewable tablet) ORGANON CANADA INC.,Active,9000810,montelukast (montelukast sodium) 5 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Prescription
61610,Marketed,2022-09-23,02238217,Singulair,1,R03DC03,Montelukast,Tablet,Oral,02238217,SINGULAIR (montelukast (montelukast sodium) 10 mg oral tablet) ORGANON CANADA INC.,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
67521,Marketed,2022-03-28,02243602,Singulair,1,R03DC03,Montelukast,Tablet (chewable),Oral,02243602,SINGULAIR (montelukast (montelukast sodium) 4 mg chewable tablet) ORGANON CANADA INC.,Active,9000939,montelukast (montelukast sodium) 4 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Prescription
81411,Marketed,2011-10-11,02328593,Sandoz Montelukast,1,R03DC03,Montelukast,Tablet,Oral,02328593,SANDOZ MONTELUKAST (montelukast (montelukast sodium) 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81612,Marketed,2011-10-11,02330385,Sandoz Montelukast,1,R03DC03,Montelukast,Tablet (chewable),Oral,02330385,SANDOZ MONTELUKAST (montelukast (montelukast sodium) 4 mg chewable tablet) SANDOZ CANADA INCORPORATED,Active,9000939,montelukast (montelukast sodium) 4 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Prescription
81613,Marketed,2011-10-11,02330393,Sandoz Montelukast,1,R03DC03,Montelukast,Tablet (chewable),Oral,02330393,SANDOZ MONTELUKAST (montelukast (montelukast sodium) 5 mg chewable tablet) SANDOZ CANADA INCORPORATED,Active,9000810,montelukast (montelukast sodium) 5 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Prescription
84016,Marketed,2011-10-11,02354977,PMS-Montelukast,1,R03DC03,Montelukast,Tablet (chewable),Oral,02354977,PMS-MONTELUKAST (montelukast (montelukast sodium) 4 mg chewable tablet) PHARMASCIENCE INC,Active,9000939,montelukast (montelukast sodium) 4 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Prescription
84017,Marketed,2011-10-11,02354985,PMS-Montelukast,1,R03DC03,Montelukast,Tablet (chewable),Oral,02354985,PMS-MONTELUKAST (montelukast (montelukast sodium) 5 mg chewable tablet) PHARMASCIENCE INC,Active,9000810,montelukast (montelukast sodium) 5 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Prescription
84073,Marketed,2011-10-11,02355507,Teva-Montelukast,1,R03DC03,Montelukast,Tablet (chewable),Oral,02355507,TEVA-MONTELUKAST (montelukast (montelukast sodium) 4 mg chewable tablet) TEVA CANADA LIMITED,Active,9000939,montelukast (montelukast sodium) 4 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Prescription
84074,Marketed,2011-10-11,02355515,Teva-Montelukast,1,R03DC03,Montelukast,Tablet (chewable),Oral,02355515,TEVA-MONTELUKAST (montelukast (montelukast sodium) 5 mg chewable tablet) TEVA CANADA LIMITED,Active,9000810,montelukast (montelukast sodium) 5 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Prescription
84075,Marketed,2011-10-11,02355523,Teva-Montelukast,1,R03DC03,Montelukast,Tablet,Oral,02355523,TEVA-MONTELUKAST (montelukast (montelukast sodium) 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84365,Marketed,2011-10-11,02358611,Sandoz Montelukast,1,R03DC03,Montelukast,Granules,Oral,02358611,SANDOZ MONTELUKAST (montelukast (montelukast sodium) 4 mg per sachet oral granules) SANDOZ CANADA INCORPORATED,Active,9014703,montelukast (montelukast sodium) 4 mg per sachet oral granules,8000261,montelukast,26643006,Oral,420509004,Oral granules,733013000,Sachet (unit of presentation),,,,Prescription
85916,Marketed,2011-10-11,02373947,PMS-Montelukast Film-coated,1,R03DC03,Montelukast,Tablet,Oral,02373947,PMS-MONTELUKAST FC (montelukast (montelukast sodium) 10 mg oral tablet) PHARMASCIENCE INC,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85993,Marketed,2020-02-26,02374609,Apo-Montelukast,1,R03DC03,Montelukast,Tablet,Oral,02374609,APO-MONTELUKAST (montelukast (montelukast sodium) 10 mg oral tablet) APOTEX INC,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86341,Marketed,2020-04-01,02377608,Apo-Montelukast,1,R03DC03,Montelukast,Tablet (chewable),Oral,02377608,APO-MONTELUKAST (montelukast (montelukast sodium) 4 mg chewable tablet) APOTEX INC,Active,9000939,montelukast (montelukast sodium) 4 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Prescription
86342,Marketed,2020-04-01,02377616,Apo-Montelukast,1,R03DC03,Montelukast,Tablet (chewable),Oral,02377616,APO-MONTELUKAST (montelukast (montelukast sodium) 5 mg chewable tablet) APOTEX INC,Active,9000810,montelukast (montelukast sodium) 5 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Prescription
86511,Marketed,2023-01-25,02379236,ACH-Montelukast,1,R03DC03,Montelukast,Tablet,Oral,02379236,ACH-MONTELUKAST (montelukast (montelukast sodium) 10 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86520,Marketed,2022-09-28,02379325,Montelukast,1,R03DC03,Montelukast,Tablet (chewable),Oral,02379325,MONTELUKAST (montelukast (montelukast sodium) 5 mg chewable tablet) SANIS HEALTH INC,Active,9000810,montelukast (montelukast sodium) 5 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Prescription
86521,Marketed,2022-09-20,02379333,Montelukast,1,R03DC03,Montelukast,Tablet,Oral,02379333,MONTELUKAST (montelukast (montelukast sodium) 10 mg oral tablet) SANIS HEALTH INC,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86569,Marketed,2012-03-29,02379821,Montelukast,1,R03DC03,Montelukast,Tablet (chewable),Oral,02379821,MONTELUKAST (montelukast (montelukast sodium) 4 mg chewable tablet) PRO DOC LIMITEE,Active,9000939,montelukast (montelukast sodium) 4 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Prescription
86570,Marketed,2012-03-29,02379848,Montelukast,1,R03DC03,Montelukast,Tablet (chewable),Oral,02379848,MONTELUKAST (montelukast (montelukast sodium) 5 mg chewable tablet) PRO DOC LIMITEE,Active,9000810,montelukast (montelukast sodium) 5 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Prescription
86571,Marketed,2012-03-29,02379856,Montelukast,1,R03DC03,Montelukast,Tablet,Oral,02379856,MONTELUKAST (montelukast (montelukast sodium) 10 mg oral tablet) PRO DOC LIMITEE,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86829,Marketed,2018-03-26,02382458,Montelukast,1,R03DC03,Montelukast,Tablet (chewable),Oral,02382458,MONTELUKAST (montelukast (montelukast sodium) 4 mg chewable tablet) SIVEM PHARMACEUTICALS ULC,Active,9000939,montelukast (montelukast sodium) 4 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Prescription
86830,Marketed,2018-03-26,02382466,Montelukast,1,R03DC03,Montelukast,Tablet (chewable),Oral,02382466,MONTELUKAST (montelukast (montelukast sodium) 5 mg chewable tablet) SIVEM PHARMACEUTICALS ULC,Active,9000810,montelukast (montelukast sodium) 5 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Prescription
86831,Marketed,2018-03-26,02382474,Montelukast,1,R03DC03,Montelukast,Tablet,Oral,02382474,MONTELUKAST (montelukast (montelukast sodium) 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87502,Marketed,2025-04-15,02389517,SPC-Montelukast,1,R03DC03,Montelukast,Tablet,Oral,02389517,SPC-MONTELUKAST (montelukast (montelukast sodium) 10 mg oral tablet) SUN PHARMA CANADA INC,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87677,Marketed,2020-03-25,02391422,JAMP-Montelukast,1,R03DC03,Montelukast,Tablet,Oral,02391422,JAMP-MONTELUKAST (montelukast (montelukast sodium) 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88374,Marketed,2026-01-21,02398826,Riva-Montelukast Film-coated,1,R03DC03,Montelukast,Tablet,Oral,02398826,RIVA-MONTELUKAST FC (montelukast (montelukast sodium) 10 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88483,Marketed,2018-11-20,02399997,Mar-Montelukast,1,R03DC03,Montelukast,Tablet,Oral,02399997,MAR-MONTELUKAST (montelukast (montelukast sodium) 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88618,Marketed,2013-03-04,02401274,Auro-Montelukast,1,R03DC03,Montelukast,Tablet,Oral,02401274,AURO-MONTELUKAST (montelukast (montelukast sodium) 10 mg oral tablet) AURO PHARMA INC,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89336,Marketed,2013-10-17,02408627,Mint-Montelukast,1,R03DC03,Montelukast,Tablet (chewable),Oral,02408627,MINT-MONTELUKAST (montelukast (montelukast sodium) 4 mg chewable tablet) MINT PHARMACEUTICALS INC,Active,9000939,montelukast (montelukast sodium) 4 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Prescription
89337,Marketed,2013-10-17,02408635,Mint-Montelukast,1,R03DC03,Montelukast,Tablet (chewable),Oral,02408635,MINT-MONTELUKAST (montelukast (montelukast sodium) 5 mg chewable tablet) MINT PHARMACEUTICALS INC,Active,9000810,montelukast (montelukast sodium) 5 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Prescription
89338,Marketed,2013-10-17,02408643,Mint-Montelukast,1,R03DC03,Montelukast,Tablet,Oral,02408643,MINT-MONTELUKAST (montelukast (montelukast sodium) 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90752,Marketed,2022-05-10,02422867,Auro-Montelukast Chewable Tablet,1,R03DC03,Montelukast,Tablet (chewable),Oral,02422867,AURO-MONTELUKAST CHEWABLE TABLET (montelukast (montelukast sodium) 4 mg chewable tablet) AURO PHARMA INC,Active,9000939,montelukast (montelukast sodium) 4 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Prescription
90753,Marketed,2022-05-10,02422875,Auro-Montelukast Chewable Tablet,1,R03DC03,Montelukast,Tablet (chewable),Oral,02422875,AURO-MONTELUKAST CHEWABLE TABLET (montelukast (montelukast sodium) 5 mg chewable tablet) AURO PHARMA INC,Active,9000810,montelukast (montelukast sodium) 5 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Prescription
93101,Marketed,2024-12-05,02445735,Bio-Montelukast,1,R03DC03,Montelukast,Tablet,Oral,02445735,BIO-MONTELUKAST (montelukast (montelukast sodium) 10 mg oral tablet) BIOMED PHARMA,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97324,Marketed,2022-12-29,02482835,AG-Montelukast,1,R03DC03,Montelukast,Tablet,Oral,02482835,AG-MONTELUKAST (montelukast (montelukast sodium) 10 mg oral tablet) ANGITA PHARMA INC.,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97829,Marketed,2024-12-23,02488183,M-Montelukast,1,R03DC03,Montelukast,Tablet,Oral,02488183,M-MONTELUKAST (montelukast (montelukast sodium) 10 mg oral tablet) MANTRA PHARMA INC,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97990,Marketed,2024-06-10,02489821,Nra-Montelukast,1,R03DC03,Montelukast,Tablet,Oral,02489821,NRA-MONTELUKAST (montelukast (montelukast sodium) 10 mg oral tablet) NORA PHARMA INC,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103861,Marketed,2024-07-29,02549794,PMS-Morphine Sulfate,1,N02AA01,Morphine,Tablet,Oral,02549794,PMS-MORPHINE SULFATE (morphine sulfate 5 mg oral tablet) PHARMASCIENCE INC,Active,9000233,morphine sulfate 5 mg oral tablet,8000071,morphine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
103862,Marketed,2024-07-29,02549808,PMS-Morphine Sulfate,1,N02AA01,Morphine,Tablet,Oral,02549808,PMS-MORPHINE SULFATE (morphine sulfate 10 mg oral tablet) PHARMASCIENCE INC,Active,9000229,morphine sulfate 10 mg oral tablet,8000071,morphine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
106285,Marketed,2026-03-23,02559722,Kadian,1,N02AA01,Morphine,Capsule (extended release),Oral,02559722,KADIAN (morphine sulfate 200 mg prolonged-release oral capsule) BGP PHARMA ULC,Active,9000618,morphine sulfate 200 mg prolonged-release oral capsule,8000071,morphine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,,Narcotics (CDSA I)
11597,Marketed,2025-03-12,00614505,Doloral Sirop,1,N02AA01,Morphine,Syrup,Oral,00614505,DOLORAL SIROP (morphine hydrochloride 5 mg per mL syrup) LABORATOIRE ATLAS INC,Active,9000228,morphine hydrochloride 5 mg per mL syrup,8000071,morphine,26643006,Oral,739009002,Syrup,,,,1.0,,Narcotics (CDSA I)
13966,Marketed,2005-08-12,02021056,Morphine LP Epidural,1,N02AA01,Morphine,Solution,"Intravenous,Epidural,Subcutaneous",02021056,MORPHINE LP EPIDURAL (morphine sulfate 5 mg per 10 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9000432,morphine sulfate 5 mg per 10 mL solution for injection ampoule,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,,Narcotics (CDSA I)
14020,Marketed,2005-08-12,02021048,Morphine LP Epidural,1,N02AA01,Morphine,Solution,"Intravenous,Epidural,Subcutaneous",02021048,MORPHINE LP EPIDURAL (morphine sulfate 5 mg per 5 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9000433,morphine sulfate 5 mg per 5 mL solution for injection ampoule,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,,Narcotics (CDSA I)
14142,Marketed,1993-12-31,02014327,MS Contin,1,N02AA01,Morphine,Tablet (extended-release),Oral,02014327,MS CONTIN (morphine sulfate 200 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9000478,morphine sulfate 200 mg prolonged-release oral tablet,8000071,morphine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
14144,Marketed,1993-12-31,02014211,MS.IR,1,N02AA01,Morphine,Tablet (immediate release),Oral,02014211,MS.IR (morphine sulfate 10 mg oral tablet) PURDUE PHARMA,Active,9000229,morphine sulfate 10 mg oral tablet,8000071,morphine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
14176,Marketed,1993-12-31,02014297,MS Contin,1,N02AA01,Morphine,Tablet (extended-release),Oral,02014297,MS CONTIN (morphine sulfate 30 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9000480,morphine sulfate 30 mg prolonged-release oral tablet,8000071,morphine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
14178,Marketed,1993-12-31,02014319,MS Contin,1,N02AA01,Morphine,Tablet (extended-release),Oral,02014319,MS CONTIN (morphine sulfate 100 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9000475,morphine sulfate 100 mg prolonged-release oral tablet,8000071,morphine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
14394,Marketed,1993-12-31,02014300,MS Contin,1,N02AA01,Morphine,Tablet (extended-release),Oral,02014300,MS CONTIN (morphine sulfate 60 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9000482,morphine sulfate 60 mg prolonged-release oral tablet,8000071,morphine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
14395,Marketed,1993-12-31,02015439,MS Contin,1,N02AA01,Morphine,Tablet (extended-release),Oral,02015439,MS CONTIN (morphine sulfate 15 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9000477,morphine sulfate 15 mg prolonged-release oral tablet,8000071,morphine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
14502,Marketed,2006-08-07,02019949,M-Eslon,1,N02AA01,Morphine,Capsule (extended release),Oral,02019949,M-ESLON (morphine sulfate 30 mg prolonged-release oral capsule) ETHYPHARM INC,Active,9000479,morphine sulfate 30 mg prolonged-release oral capsule,8000071,morphine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,,Narcotics (CDSA I)
14541,Marketed,2006-08-17,02019965,M-Eslon,1,N02AA01,Morphine,Capsule (extended release),Oral,02019965,M-ESLON (morphine sulfate 100 mg prolonged-release oral capsule) ETHYPHARM INC,Active,9000474,morphine sulfate 100 mg prolonged-release oral capsule,8000071,morphine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,,Narcotics (CDSA I)
14542,Marketed,2006-07-31,02019957,M-Eslon,1,N02AA01,Morphine,Capsule (extended release),Oral,02019957,M-ESLON (morphine sulfate 60 mg prolonged-release oral capsule) ETHYPHARM INC,Active,9000481,morphine sulfate 60 mg prolonged-release oral capsule,8000071,morphine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,,Narcotics (CDSA I)
14543,Marketed,2006-08-22,02019930,M-Eslon,1,N02AA01,Morphine,Capsule (extended release),Oral,02019930,M-ESLON (morphine sulfate 10 mg prolonged-release oral capsule) ETHYPHARM INC,Active,9000476,morphine sulfate 10 mg prolonged-release oral capsule,8000071,morphine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,,Narcotics (CDSA I)
16102,Marketed,1991-12-31,02014203,MS.IR,1,N02AA01,Morphine,Tablet (immediate release),Oral,02014203,MS.IR (morphine sulfate 5 mg oral tablet) PURDUE PHARMA,Active,9000233,morphine sulfate 5 mg oral tablet,8000071,morphine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
16480,Marketed,1991-12-31,02014238,MS.IR,1,N02AA01,Morphine,Tablet (immediate release),Oral,02014238,MS.IR (morphine sulfate 20 mg oral tablet) PURDUE PHARMA,Active,9000389,morphine sulfate 20 mg oral tablet,8000071,morphine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
16481,Marketed,1991-12-31,02014254,MS.IR,1,N02AA01,Morphine,Tablet (immediate release),Oral,02014254,MS.IR (morphine sulfate 30 mg oral tablet) PURDUE PHARMA,Active,9000390,morphine sulfate 30 mg oral tablet,8000071,morphine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
18877,Marketed,2006-09-05,02177757,M-Eslon,1,N02AA01,Morphine,Capsule (extended release),Oral,02177757,M-ESLON (morphine sulfate 200 mg prolonged-release oral capsule) ETHYPHARM INC,Active,9000618,morphine sulfate 200 mg prolonged-release oral capsule,8000071,morphine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,,Narcotics (CDSA I)
18878,Marketed,2006-07-17,02177749,M-Eslon,1,N02AA01,Morphine,Capsule (extended release),Oral,02177749,M-ESLON (morphine sulfate 15 mg prolonged-release oral capsule) ETHYPHARM INC,Active,9000617,morphine sulfate 15 mg prolonged-release oral capsule,8000071,morphine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,,Narcotics (CDSA I)
3042,Marketed,2005-08-09,00392561,Morphine Sulfate Inj 15 mg/mL USP,1,N02AA01,Morphine,Liquid,"Intramuscular,Subcutaneous,Intravenous",00392561,MORPHINE SULFATE INJ 15MG/ML USP (morphine sulfate 15 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9000111,morphine sulfate 15 mg per 1 mL solution for injection ampoule,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,,Narcotics (CDSA I)
3043,Marketed,2005-08-09,00392588,Morphine Sulfate Inj 10 mg/mL USP,1,N02AA01,Morphine,Liquid,"Intramuscular,Subcutaneous,Intravenous",00392588,MORPHINE SULFATE INJ 10MG/ML USP (morphine sulfate 10 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9000299,morphine sulfate 10 mg per 1 mL solution for injection ampoule,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,,Narcotics (CDSA I)
42846,Marketed,2016-05-26,02184435,Kadian,1,N02AA01,Morphine,Capsule (extended release),Oral,02184435,KADIAN (morphine sulfate 20 mg prolonged-release oral capsule) BGP PHARMA ULC,Active,9000665,morphine sulfate 20 mg prolonged-release oral capsule,8000071,morphine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,,Narcotics (CDSA I)
42847,Marketed,2016-05-26,02184443,Kadian,1,N02AA01,Morphine,Capsule (extended release),Oral,02184443,KADIAN (morphine sulfate 50 mg prolonged-release oral capsule) BGP PHARMA ULC,Active,9000664,morphine sulfate 50 mg prolonged-release oral capsule,8000071,morphine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,,Narcotics (CDSA I)
42848,Marketed,2016-08-09,02184451,Kadian,1,N02AA01,Morphine,Capsule (extended release),Oral,02184451,KADIAN (morphine sulfate 100 mg prolonged-release oral capsule) BGP PHARMA ULC,Active,9000474,morphine sulfate 100 mg prolonged-release oral capsule,8000071,morphine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,,Narcotics (CDSA I)
6171,Marketed,2025-03-12,00614491,Doloral Sirop,1,N02AA01,Morphine,Syrup,Oral,00614491,DOLORAL SIROP (morphine hydrochloride 1 mg per mL syrup) LABORATOIRE ATLAS INC,Active,9000209,morphine hydrochloride 1 mg per mL syrup,8000071,morphine,26643006,Oral,739009002,Syrup,,,,1.0,,Narcotics (CDSA I)
65841,Marketed,2016-05-26,02242163,Kadian,1,N02AA01,Morphine,Capsule (extended release),Oral,02242163,KADIAN (morphine sulfate 10 mg prolonged-release oral capsule) BGP PHARMA ULC,Active,9000476,morphine sulfate 10 mg prolonged-release oral capsule,8000071,morphine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,,Narcotics (CDSA I)
66221,Marketed,2005-08-09,02242484,Morphine Sulfate Injection USP,1,N02AA01,Morphine,Liquid,"Intramuscular,Intravenous,Subcutaneous",02242484,MORPHINE SULFATE INJECTION USP (morphine sulfate 2 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9006227,morphine sulfate 2 mg per 1 mL solution for injection vial,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
6754,Marketed,2026-03-05,00594644,Statex,1,N02AA01,Morphine,Tablet,Oral,00594644,STATEX (morphine sulfate 10 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9000229,morphine sulfate 10 mg oral tablet,8000071,morphine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
6755,Marketed,2026-03-05,00594652,Statex,1,N02AA01,Morphine,Tablet,Oral,00594652,STATEX (morphine sulfate 5 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9000233,morphine sulfate 5 mg oral tablet,8000071,morphine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
68780,Marketed,2010-12-11,02244790,Sandoz Morphine SR,1,N02AA01,Morphine,Tablet (extended-release),Oral,02244790,SANDOZ MORPHINE SR (morphine sulfate 15 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9000477,morphine sulfate 15 mg prolonged-release oral tablet,8000071,morphine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
68781,Marketed,2010-12-11,02244791,Sandoz Morphine SR,1,N02AA01,Morphine,Tablet (extended-release),Oral,02244791,SANDOZ MORPHINE SR (morphine sulfate 30 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9000480,morphine sulfate 30 mg prolonged-release oral tablet,8000071,morphine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
68782,Marketed,2010-12-11,02244792,Sandoz Morphine SR,1,N02AA01,Morphine,Tablet (extended-release),Oral,02244792,SANDOZ MORPHINE SR (morphine sulfate 60 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9000482,morphine sulfate 60 mg prolonged-release oral tablet,8000071,morphine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
7421,Marketed,2005-08-05,00617288,Morphine HP 50,1,N02AA01,Morphine,Solution,"Subcutaneous,Intramuscular,Intravenous",77700347,MORPHINE HP 50 (morphine sulfate 250 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9006211,morphine sulfate 250 mg per 5 mL solution for injection vial,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
7421,Marketed,2005-08-05,00617288,Morphine HP 50,1,N02AA01,Morphine,Solution,"Subcutaneous,Intramuscular,Intravenous",77700348,MORPHINE HP 50 (morphine sulfate 500 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9006212,morphine sulfate 500 mg per 10 mL solution for injection vial,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
7421,Marketed,2005-08-05,00617288,Morphine HP 50,1,N02AA01,Morphine,Solution,"Subcutaneous,Intramuscular,Intravenous",77700349,MORPHINE HP 50 (morphine sulfate 50 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9006213,morphine sulfate 50 mg per 1 mL solution for injection vial,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
7421,Marketed,2005-08-05,00617288,Morphine HP 50,1,N02AA01,Morphine,Solution,"Subcutaneous,Intramuscular,Intravenous",77700350,MORPHINE HP 50 (morphine sulfate 50 mg per mL solution for injection 50 mL vial) SANDOZ CANADA INCORPORATED,Active,9006214,morphine sulfate 50 mg per mL solution for injection 50 mL vial,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
78808,Marketed,2011-06-03,02302764,Teva-Morphine SR,1,N02AA01,Morphine,Tablet (extended-release),Oral,02302764,TEVA-MORPHINE SR (morphine sulfate 15 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9000477,morphine sulfate 15 mg prolonged-release oral tablet,8000071,morphine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
78809,Marketed,2011-06-03,02302772,Teva-Morphine SR,1,N02AA01,Morphine,Tablet (extended-release),Oral,02302772,TEVA-MORPHINE SR (morphine sulfate 30 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9000480,morphine sulfate 30 mg prolonged-release oral tablet,8000071,morphine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
78810,Marketed,2011-06-03,02302780,Teva-Morphine SR,1,N02AA01,Morphine,Tablet (extended-release),Oral,02302780,TEVA-MORPHINE SR (morphine sulfate 60 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9000482,morphine sulfate 60 mg prolonged-release oral tablet,8000071,morphine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
78811,Marketed,2011-06-03,02302799,Teva-Morphine SR,1,N02AA01,Morphine,Tablet (extended-release),Oral,02302799,TEVA-MORPHINE SR (morphine sulfate 100 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9000475,morphine sulfate 100 mg prolonged-release oral tablet,8000071,morphine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
78812,Marketed,2011-06-03,02302802,Teva-Morphine SR,1,N02AA01,Morphine,Tablet (extended-release),Oral,02302802,TEVA-MORPHINE SR (morphine sulfate 200 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9000478,morphine sulfate 200 mg prolonged-release oral tablet,8000071,morphine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
80582,Marketed,2025-06-13,02320398,M-Ediat,1,N02AA01,Morphine,Capsule (immediate release),Oral,02320398,M-EDIAT (morphine sulfate 5 mg oral capsule) ETHYPHARM INC,Active,9001466,morphine sulfate 5 mg oral capsule,8000071,morphine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,1.0,,Narcotics (CDSA I)
80584,Marketed,2025-06-13,02320428,M-Ediat,1,N02AA01,Morphine,Capsule (immediate release),Oral,02320428,M-EDIAT (morphine sulfate 10 mg oral capsule) ETHYPHARM INC,Active,9001463,morphine sulfate 10 mg oral capsule,8000071,morphine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,1.0,,Narcotics (CDSA I)
80585,Marketed,2025-06-13,02320436,M-Ediat,1,N02AA01,Morphine,Capsule (immediate release),Oral,02320436,M-EDIAT (morphine sulfate 20 mg oral capsule) ETHYPHARM INC,Active,9001464,morphine sulfate 20 mg oral capsule,8000071,morphine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,1.0,,Narcotics (CDSA I)
80586,Marketed,2025-06-13,02320444,M-Ediat,1,N02AA01,Morphine,Capsule (immediate release),Oral,02320444,M-EDIAT (morphine sulfate 30 mg oral capsule) ETHYPHARM INC,Active,9001465,morphine sulfate 30 mg oral capsule,8000071,morphine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,1.0,,Narcotics (CDSA I)
86878,Marketed,2012-10-18,02382997,Morphine Sulfate Injection SDZ,1,N02AA01,Morphine,Solution,"Intramuscular,Intravenous,Subcutaneous",77700356,MORPHINE SULFATE INJECTION SDZ (morphine sulfate 10 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9000299,morphine sulfate 10 mg per 1 mL solution for injection ampoule,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,,Narcotics (CDSA I)
86878,Marketed,2012-10-18,02382997,Morphine Sulfate Injection SDZ,1,N02AA01,Morphine,Solution,"Intramuscular,Intravenous,Subcutaneous",77700357,MORPHINE SULFATE INJECTION SDZ (morphine sulfate 50 mg per 5 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9001392,morphine sulfate 50 mg per 5 mL solution for injection ampoule,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,,Narcotics (CDSA I)
96526,Marketed,2018-09-21,02474980,Morphine Sulfate Injection BP,1,N02AA01,Morphine,Solution,"Intravenous,Intramuscular,Subcutaneous",02474980,MORPHINE SULFATE INJECTION BP (morphine sulfate 10 mg per 1 mL solution for injection ampoule) STERIMAX INC,Active,9000299,morphine sulfate 10 mg per 1 mL solution for injection ampoule,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,,Narcotics (CDSA I)
96959,Marketed,2018-12-19,02478889,Sandoz Morphine SR,1,N02AA01,Morphine,Tablet (extended-release),Oral,02478889,SANDOZ MORPHINE SR (morphine sulfate 100 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9000475,morphine sulfate 100 mg prolonged-release oral tablet,8000071,morphine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
96961,Marketed,2018-12-19,02478897,Sandoz Morphine SR,1,N02AA01,Morphine,Tablet (extended-release),Oral,02478897,SANDOZ MORPHINE SR (morphine sulfate 200 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9000478,morphine sulfate 200 mg prolonged-release oral tablet,8000071,morphine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
97311,Marketed,2019-12-17,02482681,"Morphine Sulfate Injection, USP",1,N02AA01,Morphine,Solution,"Intravenous,Subcutaneous,Intramuscular",02482681,"MORPHINE SULFATE INJECTION, USP (morphine sulfate 2 mg per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9006227,morphine sulfate 2 mg per 1 mL solution for injection vial,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
97315,Marketed,2019-12-17,02482746,"Morphine Sulfate Injection, USP",1,N02AA01,Morphine,Solution,"Intravenous,Intramuscular,Subcutaneous",02482746,"MORPHINE SULFATE INJECTION, USP (morphine sulfate 10 mg per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9014225,morphine sulfate 10 mg per 1 mL solution for injection vial,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
98194,Marketed,2020-08-25,02491931,Morphine Sulfate Injection USP,1,N02AA01,Morphine,Solution,Intravenous,02491931,MORPHINE SULFATE INJECTION USP (morphine sulfate 100 mg per 100 mL solution for injection bag) STERINOVA INC.,Active,9014366,morphine sulfate 100 mg per 100 mL solution for injection bag,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,1.0,,Narcotics (CDSA I)
98805,Marketed,2021-05-21,02498278,Morphine Sulfate Injection Epidural,1,N02AA01,Morphine,Solution,Epidural,02498278,MORPHINE SULFATE INJECTION EPIDURAL (morphine sulfate 5 mg per 10 mL solution for injection vial) STERIMAX INC,Active,9014552,morphine sulfate 5 mg per 10 mL solution for injection vial,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
98806,Marketed,2021-06-02,02498286,Morphine Sulfate Injection Epidural,1,N02AA01,Morphine,Solution,Epidural,02498286,MORPHINE SULFATE INJECTION EPIDURAL (morphine sulfate 5 mg per 5 mL solution for injection vial) STERIMAX INC,Active,9006229,morphine sulfate 5 mg per 5 mL solution for injection vial,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
99036,Marketed,2021-04-29,02500701,Morphine Sulfate Injection,1,N02AA01,Morphine,Solution,"Intramuscular,Subcutaneous,Intravenous",02500701,MORPHINE SULFATE INJECTION (morphine sulfate 2 mg per 1 mL solution for injection ampoule) JAMP PHARMA CORPORATION,Active,9000331,morphine sulfate 2 mg per 1 mL solution for injection ampoule,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,,Narcotics (CDSA I)
99037,Marketed,2021-04-29,02500728,Morphine Sulfate Injection,1,N02AA01,Morphine,Solution,"Subcutaneous,Intramuscular,Intravenous",02500728,MORPHINE SULFATE INJECTION (morphine sulfate 10 mg per 1 mL solution for injection ampoule) JAMP PHARMA CORPORATION,Active,9000299,morphine sulfate 10 mg per 1 mL solution for injection ampoule,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,,Narcotics (CDSA I)
99038,Marketed,2021-04-29,02500736,Morphine Sulfate Injection,1,N02AA01,Morphine,Solution,"Intravenous,Intramuscular,Subcutaneous",02500736,MORPHINE SULFATE INJECTION (morphine sulfate 15 mg per 1 mL solution for injection ampoule) JAMP PHARMA CORPORATION,Active,9000111,morphine sulfate 15 mg per 1 mL solution for injection ampoule,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,,Narcotics (CDSA I)
106784,Marketed,2026-05-05,02565226,Lunsumio,1,L01FX25,Mosunetuzumab,Solution,Intravenous,77701207,LUNSUMIO (mosunetuzumab 1 mg per 1 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9015425,mosunetuzumab 1 mg per 1 mL solution for injection vial,8002596,mosunetuzumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,,,,Prescription
106784,Marketed,2026-05-05,02565226,Lunsumio,1,L01FX25,Mosunetuzumab,Solution,Intravenous,77701208,LUNSUMIO (mosunetuzumab 30 mg per 30 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9015426,mosunetuzumab 30 mg per 30 mL solution for injection vial,8002596,mosunetuzumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,,,,Prescription
106784,Marketed,2026-05-05,02565226,Lunsumio,1,L01FX25,Mosunetuzumab,Solution,Intravenous,77701207,LUNSUMIO (mosunetuzumab 1 mg per 1 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9015425,mosunetuzumab 1 mg per 1 mL solution for injection vial,8002596,mosunetuzumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,,,,Schedule D
106784,Marketed,2026-05-05,02565226,Lunsumio,1,L01FX25,Mosunetuzumab,Solution,Intravenous,77701208,LUNSUMIO (mosunetuzumab 30 mg per 30 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9015426,mosunetuzumab 30 mg per 30 mL solution for injection vial,8002596,mosunetuzumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,,,,Schedule D
100991,Marketed,2022-04-04,02520710,Moxifloxacin,1,J01MA14,Moxifloxacin,Tablet,Oral,02520710,MOXIFLOXACIN (moxifloxacin (moxifloxacin hydrochloride) 400 mg oral tablet) SANIS HEALTH INC,Active,9000923,moxifloxacin (moxifloxacin hydrochloride) 400 mg oral tablet,8000291,moxifloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101826,Marketed,2022-12-21,02529076,Moxifloxacin,1,S01AE07,Moxifloxacin,Solution,Ophthalmic,02529076,MOXIFLOXACIN (moxifloxacin (moxifloxacin hydrochloride) 0.5 % ophthalmic drops) SANIS HEALTH INC,Active,9001078,moxifloxacin (moxifloxacin hydrochloride) 0.5 % ophthalmic drops,8000291,moxifloxacin,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
73714,Marketed,2018-03-15,02252260,Vigamox,1,S01AE07,Moxifloxacin,Solution,Ophthalmic,02252260,VIGAMOX (moxifloxacin (moxifloxacin hydrochloride) 0.5 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9001078,moxifloxacin (moxifloxacin hydrochloride) 0.5 % ophthalmic drops,8000291,moxifloxacin,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
86112,Marketed,2015-11-04,02375702,Teva-Moxifloxacin,1,J01MA14,Moxifloxacin,Tablet,Oral,02375702,TEVA-MOXIFLOXACIN (moxifloxacin (moxifloxacin hydrochloride) 400 mg oral tablet) TEVA CANADA LIMITED,Active,9000923,moxifloxacin (moxifloxacin hydrochloride) 400 mg oral tablet,8000291,moxifloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86914,Marketed,2017-11-30,02383381,Sandoz Moxifloxacin,1,J01MA14,Moxifloxacin,Tablet,Oral,02383381,SANDOZ MOXIFLOXACIN (moxifloxacin (moxifloxacin hydrochloride) 400 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000923,moxifloxacin (moxifloxacin hydrochloride) 400 mg oral tablet,8000291,moxifloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89109,Marketed,2015-11-19,02406373,Apo-Moxifloxacin,1,S01AE07,Moxifloxacin,Solution,Ophthalmic,02406373,APO-MOXIFLOXACIN (moxifloxacin (moxifloxacin hydrochloride) 0.5 % ophthalmic drops) APOTEX INC,Active,9001078,moxifloxacin (moxifloxacin hydrochloride) 0.5 % ophthalmic drops,8000291,moxifloxacin,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
89614,Marketed,2015-10-29,02411520,Sandoz Moxifloxacin,1,S01AE07,Moxifloxacin,Solution,Ophthalmic,02411520,SANDOZ MOXIFLOXACIN (moxifloxacin (moxifloxacin hydrochloride) 0.5 % ophthalmic drops) SANDOZ CANADA INCORPORATED,Active,9001078,moxifloxacin (moxifloxacin hydrochloride) 0.5 % ophthalmic drops,8000291,moxifloxacin,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
91667,Marketed,2015-12-21,02432218,PMS-Moxifloxacin,1,S01AE07,Moxifloxacin,Solution,Ophthalmic,02432218,PMS-MOXIFLOXACIN (moxifloxacin (moxifloxacin hydrochloride) 0.5 % ophthalmic drops) PHARMASCIENCE INC,Active,9001078,moxifloxacin (moxifloxacin hydrochloride) 0.5 % ophthalmic drops,8000291,moxifloxacin,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
91672,Marketed,2015-11-04,02432242,Auro-Moxifloxacin,1,J01MA14,Moxifloxacin,Tablet,Oral,02432242,AURO-MOXIFLOXACIN (moxifloxacin (moxifloxacin hydrochloride) 400 mg oral tablet) AURO PHARMA INC,Active,9000923,moxifloxacin (moxifloxacin hydrochloride) 400 mg oral tablet,8000291,moxifloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91749,Marketed,2017-08-16,02433087,Moxifloxacin Injection,1,J01MA14,Moxifloxacin,Solution,Intravenous,02433087,MOXIFLOXACIN INJECTION (moxifloxacin (moxifloxacin hydrochloride) 400 mg per 250 mL solution for injection 250 mL bag) FRESENIUS KABI CANADA LTD,Active,9001032,moxifloxacin (moxifloxacin hydrochloride) 400 mg per 250 mL solution for injection 250 mL bag,8000291,moxifloxacin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Prescription
92870,Marketed,2025-10-31,02443929,JAMP-Moxifloxacin,1,J01MA14,Moxifloxacin,Tablet,Oral,02443929,JAMP-MOXIFLOXACIN (moxifloxacin (moxifloxacin hydrochloride) 400 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000923,moxifloxacin (moxifloxacin hydrochloride) 400 mg oral tablet,8000291,moxifloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95086,Marketed,2020-10-30,02462974,Moxifloxacin,1,J01MA14,Moxifloxacin,Tablet,Oral,02462974,MOXIFLOXACIN (moxifloxacin (moxifloxacin hydrochloride) 400 mg oral tablet) PRO DOC LIMITEE,Active,9000923,moxifloxacin (moxifloxacin hydrochloride) 400 mg oral tablet,8000291,moxifloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96210,Marketed,2024-01-10,02472791,M-Moxifloxacin,1,J01MA14,Moxifloxacin,Tablet,Oral,02472791,M-MOXIFLOXACIN (moxifloxacin (moxifloxacin hydrochloride) 400 mg oral tablet) MANTRA PHARMA INC,Active,9000923,moxifloxacin (moxifloxacin hydrochloride) 400 mg oral tablet,8000291,moxifloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
13302,Marketed,2015-11-20,01985205,Creon Minimicrospheres 25,3,A09AA02,"Multienzymes (lipase, protease etc)",Capsule (delayed release),Oral,01985205,CREON MINIMICROSPHERES 25 (amylase 25500 unit and lipase 25000 unit and protease 1600 unit gastro-resistant capsule) BGP PHARMA ULC,Active,9013641,amylase 25500 unit and lipase 25000 unit and protease 1600 unit gastro-resistant capsule,8002151,pancrelipase,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
1649,Marketed,2022-01-07,00263818,Cotazym,3,A09AA02,"Multienzymes (lipase, protease etc)",Capsule (immediate release),Oral,00263818,COTAZYM (amylase 40000 unit and lipase 10000 unit and protease 35000 unit oral capsule) ORGANON CANADA INC.,Active,9001695,amylase 40000 unit and lipase 10000 unit and protease 35000 unit oral capsule,8002151,pancrelipase,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
36179,Marketed,2015-11-20,02200104,Creon Minimicrospheres 10,3,A09AA02,"Multienzymes (lipase, protease etc)",Capsule (delayed release),Oral,02200104,CREON MINIMICROSPHERES 10 (amylase 11200 unit and lipase 10000 unit and protease 730 unit gastro-resistant capsule) BGP PHARMA ULC,Active,9013640,amylase 11200 unit and lipase 10000 unit and protease 730 unit gastro-resistant capsule,8002151,pancrelipase,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
3891,Marketed,2021-11-01,00502790,Cotazym Ecs 8,3,A09AA02,"Multienzymes (lipase, protease etc)",Capsule (delayed release),Oral,00502790,COTAZYM ECS 8 (amylase 42000 unit and lipase 10800 unit and protease 45000 unit gastro-resistant capsule) ORGANON CANADA INC.,Active,9001871,amylase 42000 unit and lipase 10800 unit and protease 45000 unit gastro-resistant capsule,8002151,pancrelipase,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
48551,Marketed,2020-07-02,02230019,Viokace,3,A09AA02,"Multienzymes (lipase, protease etc)",Tablet,Oral,02230019,VIOKACE (amylase 56400 unit and lipase 10440 unit and protease 57100 unit oral tablet) NESTLE ENTERPRISES S.A.,Active,9003052,amylase 56400 unit and lipase 10440 unit and protease 57100 unit oral tablet,8002151,pancrelipase,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
65603,Marketed,2020-07-02,02241933,Viokace,3,A09AA02,"Multienzymes (lipase, protease etc)",Tablet,Oral,02241933,VIOKACE (amylase 113400 unit and lipase 20880 unit and protease 112500 unit oral tablet) NESTLE ENTERPRISES S.A.,Active,9003495,amylase 113400 unit and lipase 20880 unit and protease 112500 unit oral tablet,8002151,pancrelipase,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93037,Marketed,2015-11-18,02445158,Creon Minimicrospheres Micro,3,A09AA02,"Multienzymes (lipase, protease etc)","Granules for suspension, delayed release",Oral,02445158,CREON MINIMICROSPHERES MICRO (amylase 5100 unit per 100 mg and lipase 5000 unit per 100 mg and protease 320 unit per 100 mg gastro-resistant granules for oral suspension) BGP PHARMA ULC,Active,9013642,amylase 5100 unit per 100 mg and lipase 5000 unit per 100 mg and protease 320 unit per 100 mg gastro-resistant granules for oral suspension,8002151,pancrelipase,26643006,Oral,385029002,Granules for oral suspension,,,,,,Prescription
9512,Marketed,2019-08-09,00789429,Pancrease MT 16,3,A09AA02,"Multienzymes (lipase, protease etc)",Capsule (delayed release),Oral,00789429,PANCREASE MT 16 (amylase 70000 unit and lipase 16800 unit and protease 40000 unit gastro-resistant capsule) VIVUS LLC.,Active,9002135,amylase 70000 unit and lipase 16800 unit and protease 40000 unit gastro-resistant capsule,8002151,pancrelipase,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
9513,Marketed,2019-08-02,00789437,Pancrease MT 10,3,A09AA02,"Multienzymes (lipase, protease etc)",Capsule (delayed release),Oral,00789437,PANCREASE MT 10 (amylase 43750 unit and lipase 10500 unit and protease 25000 unit gastro-resistant capsule) VIVUS LLC.,Active,9002134,amylase 43750 unit and lipase 10500 unit and protease 25000 unit gastro-resistant capsule,8002151,pancrelipase,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
9514,Marketed,2019-08-01,00789445,Pancrease MT 4,3,A09AA02,"Multienzymes (lipase, protease etc)",Capsule (delayed release),Oral,00789445,PANCREASE MT 4 (amylase 17500 unit and lipase 4200 unit and protease 10000 unit gastro-resistant capsule) VIVUS LLC.,Active,9002133,amylase 17500 unit and lipase 4200 unit and protease 10000 unit gastro-resistant capsule,8002151,pancrelipase,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98463,Marketed,2021-01-26,02494639,Creon Minimicrospheres 35,3,A09AA02,"Multienzymes (lipase, protease etc)",Capsule (delayed release),Oral,02494639,CREON MINIMICROSPHERES 35 (amylase 35700 unit and lipase 35000 unit and protease 2240 unit gastro-resistant capsule) BGP PHARMA ULC,Active,9014473,amylase 35700 unit and lipase 35000 unit and protease 2240 unit gastro-resistant capsule,8002151,pancrelipase,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
9892,Marketed,2021-12-17,00821373,Cotazym Ecs 20,3,A09AA02,"Multienzymes (lipase, protease etc)",Capsule (delayed release),Oral,00821373,COTAZYM ECS 20 (amylase 100000 unit and lipase 25000 unit and protease 100000 unit gastro-resistant capsule) ORGANON CANADA INC.,Active,9002174,amylase 100000 unit and lipase 25000 unit and protease 100000 unit gastro-resistant capsule,8002151,pancrelipase,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
99291,Marketed,2020-12-21,02503433,Pancrease MT 2,3,A09AA02,"Multienzymes (lipase, protease etc)",Capsule (delayed release),Oral,02503433,PANCREASE MT 2 (amylase 10850 unit and lipase 2600 unit and protease 6200 unit gastro-resistant capsule) VIVUS LLC.,Active,9014421,amylase 10850 unit and lipase 2600 unit and protease 6200 unit gastro-resistant capsule,8002151,pancrelipase,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Schedule D
99291,Marketed,2020-12-21,02503433,Pancrease MT 2,3,A09AA02,"Multienzymes (lipase, protease etc)",Capsule (delayed release),Oral,02503433,PANCREASE MT 2 (amylase 10850 unit and lipase 2600 unit and protease 6200 unit gastro-resistant capsule) VIVUS LLC.,Active,9014421,amylase 10850 unit and lipase 2600 unit and protease 6200 unit gastro-resistant capsule,8002151,pancrelipase,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
99292,Marketed,2020-12-21,02503441,Pancrease MT 20,3,A09AA02,"Multienzymes (lipase, protease etc)",Capsule (delayed release),Oral,02503441,PANCREASE MT 20 (amylase 61000 unit and lipase 21000 unit and protease 37000 unit gastro-resistant capsule) VIVUS LLC.,Active,9014422,amylase 61000 unit and lipase 21000 unit and protease 37000 unit gastro-resistant capsule,8002151,pancrelipase,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Schedule D
99292,Marketed,2020-12-21,02503441,Pancrease MT 20,3,A09AA02,"Multienzymes (lipase, protease etc)",Capsule (delayed release),Oral,02503441,PANCREASE MT 20 (amylase 61000 unit and lipase 21000 unit and protease 37000 unit gastro-resistant capsule) VIVUS LLC.,Active,9014422,amylase 61000 unit and lipase 21000 unit and protease 37000 unit gastro-resistant capsule,8002151,pancrelipase,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
76560,Marketed,2006-07-10,02279983,Taro-Mupirocin,1,D06AX09,Mupirocin,Ointment,Topical,02279983,TARO-MUPIROCIN (mupirocin 2 % cutaneous ointment) TARO PHARMACEUTICALS INC,Active,9002481,mupirocin 2 % cutaneous ointment,8000866,mupirocin,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Non-Prescription Drugs
97385,Marketed,2019-06-05,02483459,Stramucin,1,D06AX09,Mupirocin,Cream,Topical,02483459,STRAMUCIN (mupirocin (mupirocin calcium) 2 % cutaneous cream) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9012520,mupirocin (mupirocin calcium) 2 % cutaneous cream,8000866,mupirocin,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
100086,Marketed,2021-04-07,02511673,Mar-Mycophenolic Acid,1,L04AA06,Mycophenolic acid,Tablet (enteric-coated),Oral,02511673,MAR-MYCOPHENOLIC ACID (mycophenolic acid (mycophenolate sodium) 180 mg gastro-resistant tablet) MARCAN PHARMACEUTICALS INC,Active,9004016,mycophenolic acid (mycophenolate sodium) 180 mg gastro-resistant tablet,8001292,mycophenolic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100087,Marketed,2021-04-07,02511681,Mar-Mycophenolic Acid,1,L04AA06,Mycophenolic acid,Tablet (enteric-coated),Oral,02511681,MAR-MYCOPHENOLIC ACID (mycophenolic acid (mycophenolate sodium) 360 mg gastro-resistant tablet) MARCAN PHARMACEUTICALS INC,Active,9004017,mycophenolic acid (mycophenolate sodium) 360 mg gastro-resistant tablet,8001292,mycophenolic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100782,Marketed,2025-03-13,02518511,JAMP Mycophenolic Acid,1,L04AA06,Mycophenolic acid,Tablet (enteric-coated),Oral,02518511,JAMP MYCOPHENOLIC ACID (mycophenolic acid (mycophenolate sodium) 360 mg gastro-resistant tablet) JAMP PHARMA CORPORATION,Active,9004017,mycophenolic acid (mycophenolate sodium) 360 mg gastro-resistant tablet,8001292,mycophenolic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100783,Marketed,2025-03-13,02518538,JAMP Mycophenolic Acid,1,L04AA06,Mycophenolic acid,Tablet (enteric-coated),Oral,02518538,JAMP MYCOPHENOLIC ACID (mycophenolic acid (mycophenolate sodium) 180 mg gastro-resistant tablet) JAMP PHARMA CORPORATION,Active,9004016,mycophenolic acid (mycophenolate sodium) 180 mg gastro-resistant tablet,8001292,mycophenolic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101138,Marketed,2022-02-03,02522233,Mar-Mycophenolate Mofetil,1,L04AA06,Mycophenolic acid,Powder for suspension,Oral,02522233,MAR-MYCOPHENOLATE MOFETIL (mycophenolate mofetil 200 mg per mL oral suspension) MARCAN PHARMACEUTICALS INC,Active,9006375,mycophenolate mofetil 200 mg per mL oral suspension,8001292,mycophenolic acid,26643006,Oral,385024007,Oral suspension,,,1.0,,,Prescription
19525,Marketed,1995-12-31,02192748,Cellcept,1,L04AA06,Mycophenolic acid,Capsule,Oral,02192748,CELLCEPT (mycophenolate mofetil 250 mg oral capsule) HOFFMANN-LA ROCHE LIMITED,Active,9002851,mycophenolate mofetil 250 mg oral capsule,8001292,mycophenolic acid,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
60818,Marketed,1998-11-11,02237484,Cellcept,1,L04AA06,Mycophenolic acid,Tablet,Oral,02237484,CELLCEPT (mycophenolate mofetil 500 mg oral tablet) HOFFMANN-LA ROCHE LIMITED,Active,9003330,mycophenolate mofetil 500 mg oral tablet,8001292,mycophenolic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
63885,Marketed,1999-12-20,02240347,Cellcept IV,1,L04AA06,Mycophenolic acid,Powder for solution,Intravenous,02240347,CELLCEPT I.V. (mycophenolate mofetil (mycophenolate mofetil hydrochloride) 500 mg per vial powder for solution for injection) HOFFMANN-LA ROCHE LIMITED,Active,9003442,mycophenolate mofetil (mycophenolate mofetil hydrochloride) 500 mg per vial powder for solution for injection,8001292,mycophenolic acid,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
65823,Marketed,2002-08-27,02242145,Cellcept,1,L04AA06,Mycophenolic acid,Powder for suspension,Oral,02242145,CELLCEPT (mycophenolate mofetil 200 mg per mL oral suspension) HOFFMANN-LA ROCHE LIMITED,Active,9006375,mycophenolate mofetil 200 mg per mL oral suspension,8001292,mycophenolic acid,26643006,Oral,385024007,Oral suspension,,,1.0,,,Prescription
75000,Marketed,2026-01-08,02264560,Myfortic,1,L04AA06,Mycophenolic acid,Tablet (delayed-release),Oral,02264560,MYFORTIC (mycophenolic acid (mycophenolate sodium) 180 mg gastro-resistant tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9004016,mycophenolic acid (mycophenolate sodium) 180 mg gastro-resistant tablet,8001292,mycophenolic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
75001,Marketed,2026-01-08,02264579,Myfortic,1,L04AA06,Mycophenolic acid,Tablet (delayed-release),Oral,02264579,MYFORTIC (mycophenolic acid (mycophenolate sodium) 360 mg gastro-resistant tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9004017,mycophenolic acid (mycophenolate sodium) 360 mg gastro-resistant tablet,8001292,mycophenolic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
79937,Marketed,2012-02-03,02313855,Sandoz Mycophenolate Mofetil,1,L04AA06,Mycophenolic acid,Tablet,Oral,02313855,SANDOZ MYCOPHENOLATE MOFETIL (mycophenolate mofetil 500 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003330,mycophenolate mofetil 500 mg oral tablet,8001292,mycophenolic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
80604,Marketed,2012-02-03,02320630,Sandoz Mycophenolate Mofetil,1,L04AA06,Mycophenolic acid,Capsule,Oral,02320630,SANDOZ MYCOPHENOLATE MOFETIL (mycophenolate mofetil 250 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9002851,mycophenolate mofetil 250 mg oral capsule,8001292,mycophenolic acid,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
83402,Marketed,2017-08-08,02348675,Teva-Mycophenolate,1,L04AA06,Mycophenolic acid,Tablet,Oral,02348675,TEVA-MYCOPHENOLATE (mycophenolate mofetil 500 mg oral tablet) TEVA CANADA LIMITED,Active,9003330,mycophenolate mofetil 500 mg oral tablet,8001292,mycophenolic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
84976,Marketed,2017-08-08,02364883,Teva-Mycophenolate,1,L04AA06,Mycophenolic acid,Capsule,Oral,02364883,TEVA-MYCOPHENOLATE (mycophenolate mofetil 250 mg oral capsule) TEVA CANADA LIMITED,Active,9002851,mycophenolate mofetil 250 mg oral capsule,8001292,mycophenolic acid,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
85782,Marketed,2014-07-02,02372738,Apo-Mycophenolic Acid,1,L04AA06,Mycophenolic acid,Tablet (enteric-coated),Oral,02372738,APO-MYCOPHENOLIC ACID (mycophenolic acid (mycophenolate sodium) 180 mg gastro-resistant tablet) APOTEX INC,Active,9004016,mycophenolic acid (mycophenolate sodium) 180 mg gastro-resistant tablet,8001292,mycophenolic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
85783,Marketed,2014-07-02,02372746,Apo-Mycophenolic Acid,1,L04AA06,Mycophenolic acid,Tablet (enteric-coated),Oral,02372746,APO-MYCOPHENOLIC ACID (mycophenolic acid (mycophenolate sodium) 360 mg gastro-resistant tablet) APOTEX INC,Active,9004017,mycophenolic acid (mycophenolate sodium) 360 mg gastro-resistant tablet,8001292,mycophenolic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
86436,Marketed,2023-03-28,02378574,ACH-Mycophenolate,1,L04AA06,Mycophenolic acid,Tablet,Oral,02378574,ACH-MYCOPHENOLATE (mycophenolate mofetil 500 mg oral tablet) ACCORD HEALTHCARE INC,Active,9003330,mycophenolate mofetil 500 mg oral tablet,8001292,mycophenolic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
86955,Marketed,2014-05-08,02383780,ACH-Mycophenolate,1,L04AA06,Mycophenolic acid,Capsule,Oral,02383780,ACH-MYCOPHENOLATE (mycophenolate mofetil 250 mg oral capsule) ACCORD HEALTHCARE INC,Active,9002851,mycophenolate mofetil 250 mg oral capsule,8001292,mycophenolic acid,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
87198,Marketed,2025-10-07,02386399,JAMP-Mycophenolate Capsules,1,L04AA06,Mycophenolic acid,Capsule,Oral,02386399,JAMP-MYCOPHENOLATE CAPSULES (mycophenolate mofetil 250 mg oral capsule) JAMP PHARMA CORPORATION,Active,9002851,mycophenolate mofetil 250 mg oral capsule,8001292,mycophenolic acid,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
93003,Marketed,2019-04-23,02444836,"Mycophenolate Mofetil For Injection, USP",1,L04AA06,Mycophenolic acid,Powder for solution,Intravenous,02444836,"MYCOPHENOLATE MOFETIL FOR INJECTION, USP (mycophenolate mofetil (mycophenolate mofetil hydrochloride) 500 mg per vial powder for solution for injection) ACCORD HEALTHCARE INC",Active,9003442,mycophenolate mofetil (mycophenolate mofetil hydrochloride) 500 mg per vial powder for solution for injection,8001292,mycophenolic acid,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
94442,Marketed,2016-09-29,02457369,Mycophenolate Mofetil,1,L04AA06,Mycophenolic acid,Capsule,Oral,02457369,MYCOPHENOLATE MOFETIL (mycophenolate mofetil 250 mg oral capsule) SANIS HEALTH INC,Active,9002851,mycophenolate mofetil 250 mg oral capsule,8001292,mycophenolic acid,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
94443,Marketed,2016-09-29,02457377,Mycophenolate Mofetil,1,L04AA06,Mycophenolic acid,Tablet,Oral,02457377,MYCOPHENOLATE MOFETIL (mycophenolate mofetil 500 mg oral tablet) SANIS HEALTH INC,Active,9003330,mycophenolate mofetil 500 mg oral tablet,8001292,mycophenolic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
4941,Marketed,2019-05-27,00548375,Cesamet,1,A04AD11,Nabilone,Capsule,Oral,00548375,"CESAMET (nabilone 1 mg oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9001947,nabilone 1 mg oral capsule,8001093,nabilone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Narcotics (CDSA II)
74143,Marketed,2019-05-27,02256193,Cesamet,1,A04AD11,Nabilone,Capsule,Oral,02256193,"CESAMET (nabilone 0.5 mg oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9003937,nabilone 0.5 mg oral capsule,8001093,nabilone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Narcotics (CDSA II)
79778,Marketed,2019-05-27,02312263,Cesamet,1,A04AD11,Nabilone,Capsule,Oral,02312263,"CESAMET (nabilone 0.25 mg oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9004457,nabilone 0.25 mg oral capsule,8001093,nabilone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Narcotics (CDSA II)
86665,Marketed,2021-01-22,02380897,PMS-Nabilone,1,A04AD11,Nabilone,Capsule,Oral,02380897,PMS-NABILONE (nabilone 0.25 mg oral capsule) PHARMASCIENCE INC,Active,9004457,nabilone 0.25 mg oral capsule,8001093,nabilone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Narcotics (CDSA II)
86666,Marketed,2012-03-26,02380900,PMS-Nabilone,1,A04AD11,Nabilone,Capsule,Oral,02380900,PMS-NABILONE (nabilone 0.5 mg oral capsule) PHARMASCIENCE INC,Active,9003937,nabilone 0.5 mg oral capsule,8001093,nabilone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Narcotics (CDSA II)
86667,Marketed,2012-03-26,02380919,PMS-Nabilone,1,A04AD11,Nabilone,Capsule,Oral,02380919,PMS-NABILONE (nabilone 1 mg oral capsule) PHARMASCIENCE INC,Active,9001947,nabilone 1 mg oral capsule,8001093,nabilone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Narcotics (CDSA II)
87056,Marketed,2012-05-23,02384884,Teva-Nabilone,1,A04AD11,Nabilone,Capsule,Oral,02384884,TEVA-NABILONE (nabilone 0.5 mg oral capsule) TEVA CANADA LIMITED,Active,9003937,nabilone 0.5 mg oral capsule,8001093,nabilone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Narcotics (CDSA II)
87057,Marketed,2012-05-23,02384892,Teva-Nabilone,1,A04AD11,Nabilone,Capsule,Oral,02384892,TEVA-NABILONE (nabilone 1 mg oral capsule) TEVA CANADA LIMITED,Active,9001947,nabilone 1 mg oral capsule,8001093,nabilone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Narcotics (CDSA II)
87819,Marketed,2013-05-27,02392925,Teva-Nabilone,1,A04AD11,Nabilone,Capsule,Oral,02392925,TEVA-NABILONE (nabilone 0.25 mg oral capsule) TEVA CANADA LIMITED,Active,9004457,nabilone 0.25 mg oral capsule,8001093,nabilone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Narcotics (CDSA II)
62067,Marketed,2021-11-08,02238639,Nabumetone,1,M01AX01,Nabumetone,Tablet,Oral,02238639,NABUMETONE (nabumetone 500 mg oral tablet) AA PHARMA INC,Active,9003286,nabumetone 500 mg oral tablet,8001669,nabumetone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
9176,Marketed,2021-02-26,00782467,Apo-Nadolol,1,C07AA12,Nadolol,Tablet,Oral,00782467,APO-NADOLOL (nadolol 80 mg oral tablet) APOTEX INC,Active,9010784,nadolol 80 mg oral tablet,8000842,nadolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
9177,Marketed,2021-02-26,00782475,Apo-Nadolol,1,C07AA12,Nadolol,Tablet,Oral,00782475,APO-NADOLOL (nadolol 160 mg oral tablet) APOTEX INC,Active,9010782,nadolol 160 mg oral tablet,8000842,nadolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
9178,Marketed,2020-11-05,00782505,Apo-Nadolol,1,C07AA12,Nadolol,Tablet,Oral,00782505,APO-NADOLOL (nadolol 40 mg oral tablet) APOTEX INC,Active,9010783,nadolol 40 mg oral tablet,8000842,nadolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98626,Marketed,2020-07-21,02496380,Mint-Nadolol,1,C07AA12,Nadolol,Tablet,Oral,02496380,MINT-NADOLOL (nadolol 40 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9010783,nadolol 40 mg oral tablet,8000842,nadolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98627,Marketed,2020-08-19,02496399,Mint-Nadolol,1,C07AA12,Nadolol,Tablet,Oral,02496399,MINT-NADOLOL (nadolol 80 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9010784,nadolol 80 mg oral tablet,8000842,nadolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
42902,Marketed,2003-10-09,02188783,Synarel,1,H01CA02,Nafarelin,Metered-dose aerosol,Nasal,02188783,SYNAREL (nafarelin (nafarelin acetate) 200 mcg per actuation nasal spray) PFIZER CANADA ULC,Active,9013586,nafarelin (nafarelin acetate) 200 mcg per actuation nasal spray,8001670,nafarelin,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),1.0,,,Prescription
13803,Marketed,2006-11-17,01913980,Nubain Injection 10 mg/mL,1,N02AF02,Nalbufine,Solution,"Intravenous,Subcutaneous,Intramuscular",01913980,NUBAIN INJECTION 10MG/ML (nalbuphine hydrochloride 10 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9012743,nalbuphine hydrochloride 10 mg per 1 mL solution for injection ampoule,8001403,nalbuphine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Controlled Drugs (CDSA IV)
92652,Marketed,2018-09-28,02442167,Movantik,1,A06AH03,Naloxegol,Tablet,Oral,02442167,MOVANTIK (naloxegol (naloxegol oxalate) 12.5 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9005763,naloxegol (naloxegol oxalate) 12.5 mg oral tablet,8002148,naloxegol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92653,Marketed,2018-09-28,02442175,Movantik,1,A06AH03,Naloxegol,Tablet,Oral,02442175,MOVANTIK (naloxegol (naloxegol oxalate) 25 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9005764,naloxegol (naloxegol oxalate) 25 mg oral tablet,8002148,naloxegol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100074,Marketed,2024-01-08,02511568,Teva-Naloxone Nasal Spray,1,V03AB15,Naloxone,"Spray, metered dose",Nasal,02511568,TEVA-NALOXONE NASAL SPRAY (naloxone hydrochloride 4 mg per 0.1 mL nasal spray) TEVA CANADA LIMITED,Active,9012409,naloxone hydrochloride 4 mg per 0.1 mL nasal spray,8000891,naloxone,46713006,Nasal,385157007,Nasal spray,,,,,,Ethical
103708,Marketed,2024-09-26,02548194,Naloxone Hydrochloride Injection USP,1,V03AB15,Naloxone,Solution,"Subcutaneous,Intramuscular",02548194,NALOXONE HYDROCHLORIDE INJECTION USP (naloxone hydrochloride 0.4 mg per 1 mL solution for injection syringe) STERINOVA INC.,Active,9015100,naloxone hydrochloride 0.4 mg per 1 mL solution for injection syringe,8000891,naloxone,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Ethical
18024,Marketed,2005-10-04,02148714,Naloxone HCL Injection - 1 mg/mL USP,1,V03AB15,Naloxone,Liquid,"Subcutaneous,Intravenous,Intramuscular",02148714,NALOXONE HCL INJECTION - 1MG/ML USP (naloxone hydrochloride 2 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012523,naloxone hydrochloride 2 mg per 2 mL solution for injection vial,8000891,naloxone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
18025,Marketed,2005-10-04,02148706,Naloxone HCL Injection - 0.4 mg/mL USP,1,V03AB15,Naloxone,Liquid,"Subcutaneous,Intravenous,Intramuscular",77700524,NALOXONE HCL INJECTION - 0.4MG/ML USP (naloxone hydrochloride 4 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012524,naloxone hydrochloride 4 mg per 10 mL solution for injection vial,8000891,naloxone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
18025,Marketed,2005-10-04,02148706,Naloxone HCL Injection - 0.4 mg/mL USP,1,V03AB15,Naloxone,Liquid,"Subcutaneous,Intravenous,Intramuscular",77700525,NALOXONE HCL INJECTION - 0.4MG/ML USP (naloxone hydrochloride 0.4 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9012521,naloxone hydrochloride 0.4 mg per 1 mL solution for injection ampoule,8000891,naloxone,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
86832,Marketed,2024-04-29,02382482,Naloxone Hydrochloride Injection USP,1,V03AB15,Naloxone,Solution,"Intravenous,Subcutaneous,Intramuscular",02382482,NALOXONE HYDROCHLORIDE INJECTION USP (naloxone hydrochloride (naloxone hydrochloride dihydrate) 0.4 mg per 1 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9012521,naloxone hydrochloride 0.4 mg per 1 mL solution for injection ampoule,8000891,naloxone,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
87828,Marketed,2024-10-16,02393034,Naloxone Hydrochloride Injection,1,V03AB15,Naloxone,Solution,"Intravenous,Intramuscular,Subcutaneous",02393034,NALOXONE HYDROCHLORIDE INJECTION (naloxone hydrochloride (naloxone hydrochloride dihydrate) 0.4 mg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9012522,naloxone hydrochloride 0.4 mg per 1 mL solution for injection vial,8000891,naloxone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
87829,Marketed,2024-06-26,02393042,Naloxone Hydrochloride Injection,1,V03AB15,Naloxone,Solution,"Subcutaneous,Intramuscular,Intravenous",02393042,NALOXONE HYDROCHLORIDE INJECTION (naloxone hydrochloride (naloxone hydrochloride dihydrate) 2 mg per 2 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9012523,naloxone hydrochloride 2 mg per 2 mL solution for injection vial,8000891,naloxone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
93978,Marketed,2016-06-21,02453258,S.O.S. Naloxone Hydrochloride Injection,1,V03AB15,Naloxone,Solution,"Intravenous,Subcutaneous,Intramuscular",02453258,S.O.S. NALOXONE HYDROCHLORIDE INJECTION (naloxone hydrochloride 0.4 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9012521,naloxone hydrochloride 0.4 mg per 1 mL solution for injection ampoule,8000891,naloxone,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
94280,Marketed,2016-08-05,02455935,Injectable Naloxone Hydrochloride,1,V03AB15,Naloxone,Solution,"Subcutaneous,Intramuscular,Intravenous",02455935,INJECTABLE NALOXONE HYDROCHLORIDE (naloxone hydrochloride (naloxone hydrochloride dihydrate) 0.4 mg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9012522,naloxone hydrochloride 0.4 mg per 1 mL solution for injection vial,8000891,naloxone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
94523,Marketed,2021-03-09,02458187,Narcan Nasal Spray,1,V03AB15,Naloxone,"Spray, metered dose",Nasal,02458187,NARCAN NASAL SPRAY (naloxone hydrochloride 4 mg per 0.1 mL nasal spray) EMERGENT OPERATIONS IRELAND LIMITED,Active,9012409,naloxone hydrochloride 4 mg per 0.1 mL nasal spray,8000891,naloxone,46713006,Nasal,385157007,Nasal spray,,,,,,Ethical
94572,Marketed,2022-05-19,02458578,Naloxone Injectable,1,V03AB15,Naloxone,Solution,"Subcutaneous,Intravenous,Intramuscular",02458578,NALOXONE INJECTABLE (naloxone hydrochloride 0.4 mg per 1 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9012521,naloxone hydrochloride 0.4 mg per 1 mL solution for injection ampoule,8000891,naloxone,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
43143,Marketed,2015-05-06,02213826,Revia,1,N07BB04,Naltrexone,Tablet,Oral,02213826,REVIA (naltrexone hydrochloride 50 mg oral tablet) TEVA CANADA LIMITED,Active,9003173,naltrexone hydrochloride 50 mg oral tablet,8001404,naltrexone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92924,Marketed,2015-11-10,02444275,Apo-Naltrexone,1,N07BB04,Naltrexone,Tablet,Oral,02444275,APO-NALTREXONE (naltrexone hydrochloride 50 mg oral tablet) APOTEX INC,Active,9003173,naltrexone hydrochloride 50 mg oral tablet,8001404,naltrexone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93829,Marketed,2017-05-30,02451883,Naltrexone Hydrochloride Tablets USP,1,N07BB04,Naltrexone,Tablet,Oral,02451883,NALTREXONE HYDROCHLORIDE TABLETS USP (naltrexone hydrochloride 50 mg oral tablet) STERINOVA INC.,Active,9003173,naltrexone hydrochloride 50 mg oral tablet,8001404,naltrexone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
7203,Marketed,2022-07-01,00674354,Collyre Bleu Laiter,2,S01GA01,Naphazoline,Drops,Ophthalmic,00674354,COLLYRE BLEU LAITER (methylene blue 0.2 mg per mL and naphazoline nitrate 0.5 mg per mL ophthalmic drops) FRILAB SA,Active,9002073,methylene blue 0.2 mg per mL and naphazoline nitrate 0.5 mg per mL ophthalmic drops,8002141,methylene blue and naphazoline,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
72380,Marketed,2004-03-24,02248060,Clear Eyes,1,S01GA01,Naphazoline,Liquid,Ophthalmic,02248060,CLEAR EYES (naphazoline hydrochloride 0.012 % ophthalmic drops) PRESTIGE BRANDS INC,Active,9002148,naphazoline hydrochloride 0.012 % ophthalmic drops,8001864,naphazoline,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
934,Marketed,2025-05-15,00001147,Albalon,1,S01GA01,Naphazoline,Drops,Ophthalmic,00001147,ALBALON (naphazoline hydrochloride 0.1 % ophthalmic drops) ABBVIE CORPORATION,Active,9001665,naphazoline hydrochloride 0.1 % ophthalmic drops,8001864,naphazoline,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
3743,Marketed,2019-10-17,00481408,Naphcon A,2,S01GA51,"Naphazoline, combinations",Solution,Ophthalmic,00481408,NAPHCON A (naphazoline hydrochloride 0.025 % and pheniramine maleate 0.3 % ophthalmic drops) ALCON CANADA INC,Active,9001891,naphazoline hydrochloride 0.025 % and pheniramine maleate 0.3 % ophthalmic drops,8001912,naphazoline and pheniramine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
66582,Marketed,2016-03-09,02242764,Visine For Allergy With Antihistamine,2,S01GA51,"Naphazoline, combinations",Drops,Ophthalmic,02242764,VISINE FOR ALLERGY WITH ANTIHISTAMINE (naphazoline hydrochloride 0.025 % and pheniramine maleate 0.3 % ophthalmic drops) JOHNSON & JOHNSON INC,Active,9001891,naphazoline hydrochloride 0.025 % and pheniramine maleate 0.3 % ophthalmic drops,8001912,naphazoline and pheniramine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
72379,Marketed,2004-03-24,02248059,Clear Eyes Allergy,3,S01GA51,"Naphazoline, combinations",Liquid,Ophthalmic,02248059,CLEAR EYES ALLERGY (glycerin 0.26 % and naphazoline hydrochloride 0.012 % and zinc sulfate 0.25 % ophthalmic drops) PRESTIGE BRANDS INC,Active,9013560,glycerin 0.26 % and naphazoline hydrochloride 0.012 % and zinc sulfate 0.25 % ophthalmic drops,8002124,glycerin and naphazoline and zinc sulfate,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
8155,Marketed,2016-05-01,00750794,Soothe Allergy,2,S01GA51,"Naphazoline, combinations",Drops,Ophthalmic,00750794,SOOTHE ALLERGY (naphazoline hydrochloride 0.02675 % and pheniramine maleate 0.315 % ophthalmic drops) BAUSCH & LOMB INC,Active,9002111,naphazoline hydrochloride 0.02675 % and pheniramine maleate 0.315 % ophthalmic drops,8001912,naphazoline and pheniramine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
84583,Marketed,2011-04-27,02360837,Clear Eyes Extra Strength Redness Relief,2,S01GA51,"Naphazoline, combinations",Solution,Ophthalmic,02360837,CLEAR EYES EXTRA STRENGTH REDNESS RELIEF (glycerin 0.5 % and naphazoline hydrochloride 0.03 % ophthalmic drops) PRESTIGE BRANDS INC,Active,9013562,glycerin 0.5 % and naphazoline hydrochloride 0.03 % ophthalmic drops,8002123,glycerin and naphazoline,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
10035,Marketed,1989-12-31,00784354,Apo-Napro-Na,1,M01AE02,Naproxen,Tablet,Oral,00784354,APO-NAPRO-NA (naproxen sodium 275 mg oral tablet) APOTEX INC,Active,9000300,naproxen sodium 275 mg oral tablet,8000218,naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
13848,Marketed,2010-07-20,02026600,Teva-Naproxen Sodium DS,1,M01AE02,Naproxen,Tablet,Oral,02026600,TEVA-NAPROXEN SODIUM DS (naproxen sodium 550 mg oral tablet) TEVA CANADA LIMITED,Active,9000484,naproxen sodium 550 mg oral tablet,8000218,naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
14048,Marketed,1993-12-31,01940309,Apo-Napro-Na DS,1,M01AE02,Naproxen,Tablet,Oral,01940309,APO-NAPRO-NA DS (naproxen sodium 550 mg oral tablet) APOTEX INC,Active,9000484,naproxen sodium 550 mg oral tablet,8000218,naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
17199,Marketed,2019-06-20,00887056,Naproxen-Na,1,M01AE02,Naproxen,Tablet,Oral,00887056,NAPROXEN-NA (naproxen sodium 275 mg oral tablet) PRO DOC LIMITEE,Active,9000300,naproxen sodium 275 mg oral tablet,8000218,naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
19313,Marketed,2025-06-25,02162717,Anaprox DS,1,M01AE02,Naproxen,Tablet,Oral,02162717,ANAPROX DS (naproxen sodium 550 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9000484,naproxen sodium 550 mg oral tablet,8000218,naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
19314,Marketed,2025-04-24,02162466,Naprosyn,1,M01AE02,Naproxen,Tablet (extended-release),Oral,02162466,NAPROSYN (naproxen 750 mg prolonged-release oral tablet) SEARCHLIGHT PHARMA INC,Active,9000621,naproxen 750 mg prolonged-release oral tablet,8000218,naproxen,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
19315,Marketed,2025-04-24,02162423,Naprosyn,1,M01AE02,Naproxen,Tablet (delayed-release),Oral,02162423,NAPROSYN (naproxen 500 mg gastro-resistant tablet) SEARCHLIGHT PHARMA INC,Active,9000620,naproxen 500 mg gastro-resistant tablet,8000218,naproxen,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
19446,Marketed,2025-06-26,02162725,Anaprox,1,M01AE02,Naproxen,Tablet,Oral,02162725,ANAPROX (naproxen sodium 275 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9000300,naproxen sodium 275 mg oral tablet,8000218,naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
19661,Marketed,2022-12-20,02162431,Pediapharm Naproxen Suspension,1,M01AE02,Naproxen,Suspension,Oral,02162431,PEDIAPHARM NAPROXEN SUSPENSION (naproxen 25 mg per mL oral suspension) MEDEXUS PHARMACEUTICALS INC.,Active,9006252,naproxen 25 mg per mL oral suspension,8000218,naproxen,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
44029,Marketed,2019-06-20,02153386,Naproxen-Na DF,1,M01AE02,Naproxen,Tablet,Oral,02153386,NAPROXEN-NA DF (naproxen sodium 550 mg oral tablet) PRO DOC LIMITEE,Active,9000484,naproxen sodium 550 mg oral tablet,8000218,naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
4980,Marketed,1982-12-31,00522651,Apo-Naproxen,1,M01AE02,Naproxen,Tablet,Oral,00522651,APO-NAPROXEN (naproxen 250 mg oral tablet) APOTEX INC,Active,9000179,naproxen 250 mg oral tablet,8000218,naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
5036,Marketed,2010-08-04,00565350,Teva-Naproxen,1,M01AE02,Naproxen,Tablet,Oral,00565350,TEVA-NAPROXEN (naproxen 250 mg oral tablet) TEVA CANADA LIMITED,Active,9000179,naproxen 250 mg oral tablet,8000218,naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
5183,Marketed,2010-08-04,00589861,Teva-Naproxen,1,M01AE02,Naproxen,Tablet,Oral,00589861,TEVA-NAPROXEN (naproxen 500 mg oral tablet) TEVA CANADA LIMITED,Active,9000193,naproxen 500 mg oral tablet,8000218,naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
5222,Marketed,1983-12-31,00592277,Apo-Naproxen,1,M01AE02,Naproxen,Tablet,Oral,00592277,APO-NAPROXEN (naproxen 500 mg oral tablet) APOTEX INC,Active,9000193,naproxen 500 mg oral tablet,8000218,naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
5508,Marketed,1983-12-31,00600806,Apo-Naproxen,1,M01AE02,Naproxen,Tablet,Oral,00600806,APO-NAPROXEN (naproxen 375 mg oral tablet) APOTEX INC,Active,9000192,naproxen 375 mg oral tablet,8000218,naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
5860,Marketed,2010-08-04,00627097,Teva-Naproxen,1,M01AE02,Naproxen,Tablet,Oral,00627097,TEVA-NAPROXEN (naproxen 375 mg oral tablet) TEVA CANADA LIMITED,Active,9000192,naproxen 375 mg oral tablet,8000218,naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
67215,Marketed,2010-08-04,02243312,Teva-Naproxen EC,1,M01AE02,Naproxen,Tablet (enteric-coated),Oral,02243312,TEVA-NAPROXEN EC (naproxen 250 mg gastro-resistant tablet) TEVA CANADA LIMITED,Active,9000936,naproxen 250 mg gastro-resistant tablet,8000218,naproxen,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
67216,Marketed,2010-08-04,02243313,Teva-Naproxen EC,1,M01AE02,Naproxen,Tablet (enteric-coated),Oral,02243313,TEVA-NAPROXEN EC (naproxen 375 mg gastro-resistant tablet) TEVA CANADA LIMITED,Active,9000619,naproxen 375 mg gastro-resistant tablet,8000218,naproxen,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
67217,Marketed,2010-08-04,02243314,Teva-Naproxen EC,1,M01AE02,Naproxen,Tablet (enteric-coated),Oral,02243314,TEVA-NAPROXEN EC (naproxen 500 mg gastro-resistant tablet) TEVA CANADA LIMITED,Active,9000620,naproxen 500 mg gastro-resistant tablet,8000218,naproxen,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
70894,Marketed,2003-04-23,02246699,Apo-Naproxen EC Tablets,1,M01AE02,Naproxen,Tablet (enteric-coated),Oral,02246699,APO-NAPROXEN EC TABLETS (naproxen 250 mg gastro-resistant tablet) APOTEX INC,Active,9000936,naproxen 250 mg gastro-resistant tablet,8000218,naproxen,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
70895,Marketed,2003-04-23,02246700,Apo-Naproxen EC,1,M01AE02,Naproxen,Tablet (enteric-coated),Oral,02246700,APO-NAPROXEN EC (naproxen 375 mg gastro-resistant tablet) APOTEX INC,Active,9000619,naproxen 375 mg gastro-resistant tablet,8000218,naproxen,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
70896,Marketed,2003-04-23,02246701,Apo-Naproxen EC,1,M01AE02,Naproxen,Tablet (enteric-coated),Oral,02246701,APO-NAPROXEN EC (naproxen 500 mg gastro-resistant tablet) APOTEX INC,Active,9000620,naproxen 500 mg gastro-resistant tablet,8000218,naproxen,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78704,Marketed,2021-09-09,02301733,Aleve Caplets,1,M01AE02,Naproxen,Tablet,Oral,02301733,ALEVE CAPLETS (naproxen sodium 220 mg oral tablet) BAYER INC,Active,9001275,naproxen sodium 220 mg oral tablet,8000218,naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
79657,Marketed,2019-10-25,02310953,Pro-Naproxen EC,1,M01AE02,Naproxen,Tablet (enteric-coated),Oral,02310953,PRO-NAPROXEN EC (naproxen 500 mg gastro-resistant tablet) PRO DOC LIMITEE,Active,9000620,naproxen 500 mg gastro-resistant tablet,8000218,naproxen,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84684,Marketed,2011-09-12,02361795,Aleve Liquid Gels,1,M01AE02,Naproxen,Capsule,Oral,02361795,ALEVE LIQUID GELS (naproxen sodium 220 mg oral capsule) BAYER INC,Active,9001354,naproxen sodium 220 mg oral capsule,8000218,naproxen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
84744,Marketed,2013-09-13,02362430,Naproxen,1,M01AE02,Naproxen,Tablet,Oral,02362430,NAPROXEN (naproxen sodium 220 mg oral tablet) PHARMASCIENCE INC,Active,9001275,naproxen sodium 220 mg oral tablet,8000218,naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
85812,Marketed,2012-05-17,02372991,Maxidol Liquid Gels,1,M01AE02,Naproxen,Capsule,Oral,02372991,MAXIDOL LIQUID GELS (naproxen sodium 220 mg oral capsule) BAYER INC,Active,9001354,naproxen sodium 220 mg oral capsule,8000218,naproxen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
88106,Marketed,2014-01-24,02396009,Naproxen Menstrual Pain Relief,1,M01AE02,Naproxen,Tablet,Oral,02396009,NAPROXEN MENSTRUAL PAIN RELIEF (naproxen sodium 220 mg oral tablet) PHARMASCIENCE INC,Active,9001275,naproxen sodium 220 mg oral tablet,8000218,naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
92069,Marketed,2015-06-30,02436337,Aleve Back And Body Pain,1,M01AE02,Naproxen,Capsule,Oral,02436337,ALEVE BACK AND BODY PAIN (naproxen sodium 220 mg oral capsule) BAYER INC,Active,9001354,naproxen sodium 220 mg oral capsule,8000218,naproxen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
9241,Marketed,2010-07-20,00778389,Teva-Naproxen Sodium,1,M01AE02,Naproxen,Tablet,Oral,00778389,TEVA-NAPROXEN SODIUM (naproxen sodium 275 mg oral tablet) TEVA CANADA LIMITED,Active,9000300,naproxen sodium 275 mg oral tablet,8000218,naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92965,Marketed,2016-02-24,02444593,Aleve Nighttime,2,M01AE02,Naproxen,Tablet,Oral,02444593,ALEVE NIGHTTIME (diphenhydramine hydrochloride 25 mg and naproxen sodium 220 mg oral tablet) BAYER INC,Active,9005895,diphenhydramine hydrochloride 25 mg and naproxen sodium 220 mg oral tablet,8001189,diphenhydramine and naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
84676,Marketed,2022-02-28,02361701,Vimovo,2,M01AE52,Naproxen and esomeprazole,Tablet (immediate and delayed-release),Oral,02361701,VIMOVO (esomeprazole (esomeprazole magnesium trihydrate) 20 mg and naproxen 375 mg modified-release oral tablet) XEDITON PHARMACEUTICALS INC,Active,9001334,esomeprazole (esomeprazole magnesium) 20 mg and naproxen 375 mg modified-release oral tablet,8000398,esomeprazole and naproxen,26643006,Oral,385061003,Modified-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84677,Marketed,2022-02-28,02361728,Vimovo,2,M01AE52,Naproxen and esomeprazole,Tablet (immediate and delayed-release),Oral,02361728,VIMOVO (esomeprazole (esomeprazole magnesium trihydrate) 20 mg and naproxen 500 mg modified-release oral tablet) XEDITON PHARMACEUTICALS INC,Active,9001335,esomeprazole (esomeprazole magnesium) 20 mg and naproxen 500 mg modified-release oral tablet,8000398,esomeprazole and naproxen,26643006,Oral,385061003,Modified-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92813,Marketed,2017-02-10,02443449,Mylan-Naproxen/Esomeprazole MR,2,M01AE52,Naproxen and esomeprazole,Tablet (immediate and delayed-release),Oral,02443449,MYLAN-NAPROXEN/ESOMEPRAZOLE MR (esomeprazole (esomeprazole magnesium) 20 mg and naproxen 500 mg modified-release oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9001335,esomeprazole (esomeprazole magnesium) 20 mg and naproxen 500 mg modified-release oral tablet,8000398,esomeprazole and naproxen,26643006,Oral,385061003,Modified-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94575,Marketed,2017-02-27,02458608,Mylan-Naproxen/Esomeprazole MR,2,M01AE52,Naproxen and esomeprazole,Tablet (immediate and delayed-release),Oral,02458608,MYLAN-NAPROXEN/ESOMEPRAZOLE MR (esomeprazole (esomeprazole magnesium) 20 mg and naproxen 375 mg modified-release oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9001334,esomeprazole (esomeprazole magnesium) 20 mg and naproxen 375 mg modified-release oral tablet,8000398,esomeprazole and naproxen,26643006,Oral,385061003,Modified-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79985,Marketed,2018-02-28,02314290,Teva-Naratriptan,1,N02CC02,Naratriptan,Tablet,Oral,02314290,TEVA-NARATRIPTAN (naratriptan (naratriptan hydrochloride) 1 mg oral tablet) TEVA CANADA LIMITED,Active,9003252,naratriptan (naratriptan hydrochloride) 1 mg oral tablet,8001104,naratriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79986,Marketed,2012-01-14,02314304,Teva-Naratriptan,1,N02CC02,Naratriptan,Tablet,Oral,02314304,TEVA-NARATRIPTAN (naratriptan (naratriptan hydrochloride) 2.5 mg oral tablet) TEVA CANADA LIMITED,Active,9003253,naratriptan (naratriptan hydrochloride) 2.5 mg oral tablet,8001104,naratriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80778,Marketed,2018-01-19,02322323,Sandoz Naratriptan,1,N02CC02,Naratriptan,Tablet,Oral,02322323,SANDOZ NARATRIPTAN (naratriptan (naratriptan hydrochloride) 2.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003253,naratriptan (naratriptan hydrochloride) 2.5 mg oral tablet,8001104,naratriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77184,Marketed,2006-11-21,02286386,Tysabri,1,L04AG03,Natalizumab,Solution,Intravenous,02286386,TYSABRI (natalizumab 300 mg per 15 mL solution for injection vial) BIOGEN CANADA INC,Active,9013458,natalizumab 300 mg per 15 mL solution for injection vial,8002032,natalizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
77184,Marketed,2006-11-21,02286386,Tysabri,1,L04AG03,Natalizumab,Solution,Intravenous,02286386,TYSABRI (natalizumab 300 mg per 15 mL solution for injection vial) BIOGEN CANADA INC,Active,9013458,natalizumab 300 mg per 15 mL solution for injection vial,8002032,natalizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
14318,Marketed,2014-06-30,02016109,Survanta,1,R07AA02,Natural phospholipids,Suspension,Intratracheal,77700652,SURVANTA (beractant 100 mg per 4 mL endotracheopulmonary instillation vial) ABBVIE CORPORATION,Active,9012908,beractant 100 mg per 4 mL endotracheopulmonary instillation vial,8001583,beractant,372452007,Endotracheopulmonary,385250004,Suspension for endotrachealbronchial installation,733026001,Vial (unit of presentation),,,,Prescription
14318,Marketed,2014-06-30,02016109,Survanta,1,R07AA02,Natural phospholipids,Suspension,Intratracheal,77700653,SURVANTA (beractant 200 mg per 8 mL endotracheopulmonary instillation vial) ABBVIE CORPORATION,Active,9012909,beractant 200 mg per 8 mL endotracheopulmonary instillation vial,8001583,beractant,372452007,Endotracheopulmonary,385250004,Suspension for endotrachealbronchial installation,733026001,Vial (unit of presentation),,,,Prescription
65204,Marketed,2016-12-19,02241551,Curosurf,1,R07AA02,Natural phospholipids,Suspension,Intratracheal,77700924,CUROSURF (poractant alfa 120 mg per 1.5 mL endotracheopulmonary instillation vial) CHIESI FARMACEUTICI S.P.A.,Active,9013512,poractant alfa 120 mg per 1.5 mL endotracheopulmonary instillation vial,8002078,poractant alfa,372452007,Endotracheopulmonary,385250004,Suspension for endotrachealbronchial installation,733026001,Vial (unit of presentation),,,,Prescription
65204,Marketed,2016-12-19,02241551,Curosurf,1,R07AA02,Natural phospholipids,Suspension,Intratracheal,77700925,CUROSURF (poractant alfa 240 mg per 3 mL endotracheopulmonary instillation vial) CHIESI FARMACEUTICI S.P.A.,Active,9013513,poractant alfa 240 mg per 3 mL endotracheopulmonary instillation vial,8002078,poractant alfa,372452007,Endotracheopulmonary,385250004,Suspension for endotrachealbronchial installation,733026001,Vial (unit of presentation),,,,Prescription
69524,Marketed,2002-02-05,02245464,Bles,2,R07AA02,Natural phospholipids,Suspension,Intratracheal,77700971,BLES (phospholipid 81 mg per 3 mL and surfactant-associated proteins sp-b and sp-c 1500 mcg per 3 mL endotracheopulmonary instillation vial) BLES BIOCHEMICALS INC,Active,9013598,phospholipid 81 mg per 3 mL and surfactant-associated proteins sp-b and sp-c 1500 mcg per 3 mL endotracheopulmonary instillation vial,8002224,phospholipid and surfactant-associated proteins sp-b and sp-c,372452007,Endotracheopulmonary,385250004,Suspension for endotrachealbronchial installation,733026001,Vial (unit of presentation),,,,Ethical
69524,Marketed,2002-02-05,02245464,Bles,2,R07AA02,Natural phospholipids,Suspension,Intratracheal,77700972,BLES (phospholipid 135 mg per 5 mL and surfactant-associated proteins sp-b and sp-c 2500 mcg per 5 mL endotracheopulmonary instillation vial) BLES BIOCHEMICALS INC,Active,9013597,phospholipid 135 mg per 5 mL and surfactant-associated proteins sp-b and sp-c 2500 mcg per 5 mL endotracheopulmonary instillation vial,8002224,phospholipid and surfactant-associated proteins sp-b and sp-c,372452007,Endotracheopulmonary,385250004,Suspension for endotrachealbronchial installation,733026001,Vial (unit of presentation),,,,Ethical
69524,Marketed,2002-02-05,02245464,Bles,2,R07AA02,Natural phospholipids,Suspension,Intratracheal,77700973,BLES (phospholipid 108 mg per 4 mL and surfactant-associated proteins sp-b and sp-c 2000 mcg per 4 mL endotracheopulmonary instillation vial) BLES BIOCHEMICALS INC,Active,9013596,phospholipid 108 mg per 4 mL and surfactant-associated proteins sp-b and sp-c 2000 mcg per 4 mL endotracheopulmonary instillation vial,8002224,phospholipid and surfactant-associated proteins sp-b and sp-c,372452007,Endotracheopulmonary,385250004,Suspension for endotrachealbronchial installation,733026001,Vial (unit of presentation),,,,Ethical
103196,Marketed,2024-09-16,02543508,JAMP Nebivolol,1,C07AB12,Nebivolol,Tablet,Oral,02543508,JAMP NEBIVOLOL (nebivolol (nebivolol hydrochloride) 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9010822,nebivolol (nebivolol hydrochloride) 5 mg oral tablet,8000999,nebivolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103755,Marketed,2025-12-18,02548704,PRZ-Nebivolol,1,C07AB12,Nebivolol,Tablet,Oral,02548704,PRZ-NEBIVOLOL (nebivolol (nebivolol hydrochloride) 2.5 mg oral tablet) PHARMARIS CANADA INC,Active,9010820,nebivolol (nebivolol hydrochloride) 2.5 mg oral tablet,8000999,nebivolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103756,Marketed,2025-12-18,02548712,PRZ-Nebivolol,1,C07AB12,Nebivolol,Tablet,Oral,02548712,PRZ-NEBIVOLOL (nebivolol (nebivolol hydrochloride) 5 mg oral tablet) PHARMARIS CANADA INC,Active,9010822,nebivolol (nebivolol hydrochloride) 5 mg oral tablet,8000999,nebivolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103757,Marketed,2025-12-18,02548720,PRZ-Nebivolol,1,C07AB12,Nebivolol,Tablet,Oral,02548720,PRZ-NEBIVOLOL (nebivolol (nebivolol hydrochloride) 10 mg oral tablet) PHARMARIS CANADA INC,Active,9010819,nebivolol (nebivolol hydrochloride) 10 mg oral tablet,8000999,nebivolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103758,Marketed,2025-12-19,02548739,PRZ-Nebivolol,1,C07AB12,Nebivolol,Tablet,Oral,02548739,PRZ-NEBIVOLOL (nebivolol (nebivolol hydrochloride) 20 mg oral tablet) PHARMARIS CANADA INC,Active,9010821,nebivolol (nebivolol hydrochloride) 20 mg oral tablet,8000999,nebivolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88390,Marketed,2024-04-19,02398990,Bystolic,1,C07AB12,Nebivolol,Tablet,Oral,02398990,BYSTOLIC (nebivolol (nebivolol hydrochloride) 2.5 mg oral tablet) ABBVIE CORPORATION,Active,9010820,nebivolol (nebivolol hydrochloride) 2.5 mg oral tablet,8000999,nebivolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88391,Marketed,2023-11-22,02399008,Bystolic,1,C07AB12,Nebivolol,Tablet,Oral,02399008,BYSTOLIC (nebivolol (nebivolol hydrochloride) 5 mg oral tablet) ABBVIE CORPORATION,Active,9010822,nebivolol (nebivolol hydrochloride) 5 mg oral tablet,8000999,nebivolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88392,Marketed,2024-08-19,02399016,Bystolic,1,C07AB12,Nebivolol,Tablet,Oral,02399016,BYSTOLIC (nebivolol (nebivolol hydrochloride) 10 mg oral tablet) ABBVIE CORPORATION,Active,9010819,nebivolol (nebivolol hydrochloride) 10 mg oral tablet,8000999,nebivolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88393,Marketed,2024-07-02,02399024,Bystolic,1,C07AB12,Nebivolol,Tablet,Oral,02399024,BYSTOLIC (nebivolol (nebivolol hydrochloride) 20 mg oral tablet) ABBVIE CORPORATION,Active,9010821,nebivolol (nebivolol hydrochloride) 20 mg oral tablet,8000999,nebivolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78527,Marketed,2022-11-30,02299925,Atriance,1,L01BB07,Nelarabine,Solution,Intravenous,02299925,ATRIANCE (nelarabine 250 mg per 50 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013014,nelarabine 250 mg per 50 mL solution for injection vial,8001672,nelarabine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
106644,Marketed,2026-02-24,02563673,Nemluvio,1,D11AH12,Nemolizumab,Powder for solution,Subcutaneous,02563673,NEMLUVIO (nemolizumab 30 mg powder for solution for injection with diluent solution per pen) GALDERMA CANADA INC.,Active,9015375,nemolizumab 30 mg powder for solution for injection with diluent solution per pen,8002585,nemolizumab,738984000,Parenteral,385223009,Powder for solution for injection,733006000,Pen(s),,,,Schedule D
106644,Marketed,2026-02-24,02563673,Nemluvio,1,D11AH12,Nemolizumab,Powder for solution,Subcutaneous,02563673,NEMLUVIO (nemolizumab 30 mg powder for solution for injection with diluent solution per pen) GALDERMA CANADA INC.,Active,9015375,nemolizumab 30 mg powder for solution for injection with diluent solution per pen,8002585,nemolizumab,738984000,Parenteral,385223009,Powder for solution for injection,733006000,Pen(s),,,,Prescription
102622,Marketed,2024-03-28,02537516,"Neostigmine Methylsulfate Injection, USP",1,N07AA01,Neostigmine,Solution,"Intravenous,Intramuscular,Subcutaneous",02537516,"NEOSTIGMINE METHYLSULFATE INJECTION, USP (neostigmine methylsulfate 5 mg per 10 mL solution for injection vial) JAMP PHARMA CORPORATION",Active,9013462,neostigmine methylsulfate 5 mg per 10 mL solution for injection vial,8002033,neostigmine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
49701,Marketed,1999-07-23,02230592,Neostigmine Omega,1,N07AA01,Neostigmine,Liquid,"Intramuscular,Intravenous,Subcutaneous",02230592,NEOSTIGMINE OMEGA (neostigmine methylsulfate 10 mg per 10 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013460,neostigmine methylsulfate 10 mg per 10 mL solution for injection vial,8002033,neostigmine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
49702,Marketed,1999-07-23,02230593,Neostigmine Omega,1,N07AA01,Neostigmine,Liquid,"Intravenous,Subcutaneous,Intramuscular",77700920,NEOSTIGMINE OMEGA (neostigmine methylsulfate 5 mg per 10 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013462,neostigmine methylsulfate 5 mg per 10 mL solution for injection vial,8002033,neostigmine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
49702,Marketed,1999-07-23,02230593,Neostigmine Omega,1,N07AA01,Neostigmine,Liquid,"Intravenous,Subcutaneous,Intramuscular",77700921,NEOSTIGMINE OMEGA (neostigmine methylsulfate 0.5 mg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013459,neostigmine methylsulfate 0.5 mg per 1 mL solution for injection vial,8002033,neostigmine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
87274,Marketed,2013-04-17,02387166,Neostigmine Omega,1,N07AA01,Neostigmine,Solution,"Intravenous,Subcutaneous,Intramuscular",02387166,NEOSTIGMINE OMEGA (neostigmine methylsulfate 12.5 mg per 5 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013461,neostigmine methylsulfate 12.5 mg per 5 mL solution for injection vial,8002033,neostigmine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
96586,Marketed,2019-03-26,02475480,Neostigmine Methylsulfate Injection USP,1,N07AA01,Neostigmine,Solution,"Intramuscular,Intravenous,Subcutaneous",02475480,NEOSTIGMINE METHYLSULFATE INJECTION USP (neostigmine methylsulfate 5 mg per 10 mL solution for injection vial) MARCAN PHARMACEUTICALS INC,Active,9013462,neostigmine methylsulfate 5 mg per 10 mL solution for injection vial,8002033,neostigmine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
96587,Marketed,2019-03-26,02475499,Neostigmine Methylsulfate Injection USP,1,N07AA01,Neostigmine,Solution,"Intravenous,Subcutaneous,Intramuscular",02475499,NEOSTIGMINE METHYLSULFATE INJECTION USP (neostigmine methylsulfate 10 mg per 10 mL solution for injection vial) MARCAN PHARMACEUTICALS INC,Active,9013460,neostigmine methylsulfate 10 mg per 10 mL solution for injection vial,8002033,neostigmine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
79459,Marketed,2018-09-17,02308983,Nevanac,1,S01BC10,Nepafenac,Suspension,Ophthalmic,02308983,NEVANAC (nepafenac 0.1 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012647,nepafenac 0.1 % ophthalmic drops,8001294,nepafenac,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
89601,Marketed,2018-03-21,02411393,Ilevro,1,S01BC10,Nepafenac,Suspension,Ophthalmic,02411393,ILEVRO (nepafenac 0.3 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012648,nepafenac 0.3 % ophthalmic drops,8001294,nepafenac,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
98057,Marketed,2019-12-20,02490536,Nerlynx,1,L01EH02,Neratinib,Tablet,Oral,02490536,NERLYNX (neratinib (neratinib maleate) 40 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9014210,neratinib (neratinib maleate) 40 mg oral tablet,8002309,neratinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
80408,Marketed,2020-11-20,02318601,Auro-Nevirapine,1,J05AG01,Nevirapine,Tablet,Oral,02318601,AURO-NEVIRAPINE (nevirapine 200 mg oral tablet) AURO PHARMA INC,Active,9003307,nevirapine 200 mg oral tablet,8001218,nevirapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
87331,Marketed,2012-06-20,02387727,Mylan-Nevirapine,1,J05AG01,Nevirapine,Tablet,Oral,02387727,MYLAN-NEVIRAPINE (nevirapine 200 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9003307,nevirapine 200 mg oral tablet,8001218,nevirapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
89053,Marketed,2019-10-09,02405776,JAMP Nevirapine,1,J05AG01,Nevirapine,Tablet,Oral,02405776,JAMP NEVIRAPINE (nevirapine 200 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003307,nevirapine 200 mg oral tablet,8001218,nevirapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100066,Marketed,2022-05-17,02511460,AG-Nifedipine ER,1,C08CA05,Nifedipine,Tablet (extended-release),Oral,02511460,AG-NIFEDIPINE ER (nifedipine 60 mg prolonged-release oral tablet) ANGITA PHARMA INC.,Active,9000436,nifedipine 60 mg prolonged-release oral tablet,8000123,nifedipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100083,Marketed,2022-04-27,02511649,M-Nifedipine ER,1,C08CA05,Nifedipine,Tablet (extended-release),Oral,02511649,M-NIFEDIPINE ER (nifedipine 60 mg prolonged-release oral tablet) MANTRA PHARMA INC,Active,9000436,nifedipine 60 mg prolonged-release oral tablet,8000123,nifedipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100090,Marketed,2022-05-12,02511711,JAMP Nifedipine ER,1,C08CA05,Nifedipine,Tablet (extended-release),Oral,02511711,JAMP NIFEDIPINE ER (nifedipine 60 mg prolonged-release oral tablet) JAMP PHARMA CORPORATION,Active,9000436,nifedipine 60 mg prolonged-release oral tablet,8000123,nifedipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102233,Marketed,2023-03-21,02533332,PMSC-Nifedipine ER,1,C08CA05,Nifedipine,Tablet (extended-release),Oral,02533332,PMSC-NIFEDIPINE ER (nifedipine 30 mg prolonged-release oral tablet) PHARMASCIENCE INC,Active,9000435,nifedipine 30 mg prolonged-release oral tablet,8000123,nifedipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102374,Marketed,2023-04-24,02534843,Pro-Nifedipine ER,1,C08CA05,Nifedipine,Tablet (extended-release),Oral,02534843,PRO-NIFEDIPINE ER (nifedipine 30 mg prolonged-release oral tablet) PRO DOC LIMITEE,Active,9000435,nifedipine 30 mg prolonged-release oral tablet,8000123,nifedipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
19099,Marketed,1995-02-28,02155907,Adalat XL,1,C08CA05,Nifedipine,Tablet (extended-release),Oral,02155907,ADALAT XL (nifedipine 30 mg prolonged-release oral tablet) BAYER INC,Active,9000435,nifedipine 30 mg prolonged-release oral tablet,8000123,nifedipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80655,Marketed,2009-12-21,02321149,Mylan-Nifedipine Extended Release,1,C08CA05,Nifedipine,Tablet (extended-release),Oral,02321149,MYLAN-NIFEDIPINE EXTENDED RELEASE (nifedipine 60 mg prolonged-release oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000436,nifedipine 60 mg prolonged-release oral tablet,8000123,nifedipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83448,Marketed,2010-04-23,02349167,Mylan-Nifedipine Extended Release,1,C08CA05,Nifedipine,Tablet (extended-release),Oral,02349167,MYLAN-NIFEDIPINE EXTENDED RELEASE (nifedipine 30 mg prolonged-release oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000435,nifedipine 30 mg prolonged-release oral tablet,8000123,nifedipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
8376,Marketed,2011-01-13,00755907,Nifedipine,1,C08CA05,Nifedipine,Capsule,Oral,00755907,NIFEDIPINE (nifedipine 10 mg oral capsule) AA PHARMA INC,Active,9000301,nifedipine 10 mg oral capsule,8000123,nifedipine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90087,Marketed,2015-03-17,02416301,PMS-Nifedipine ER,1,C08CA05,Nifedipine,Tablet (extended-release),Oral,02416301,PMS-NIFEDIPINE ER (nifedipine 60 mg prolonged-release oral tablet) PHARMASCIENCE INC,Active,9000436,nifedipine 60 mg prolonged-release oral tablet,8000123,nifedipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90629,Marketed,2015-01-13,02421658,Nifedipine ER,1,C08CA05,Nifedipine,Tablet (extended-release),Oral,02421658,NIFEDIPINE ER (nifedipine 60 mg prolonged-release oral tablet) PRO DOC LIMITEE,Active,9000436,nifedipine 60 mg prolonged-release oral tablet,8000123,nifedipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
9938,Marketed,2010-11-25,00725110,Nifedipine,1,C08CA05,Nifedipine,Capsule,Oral,00725110,NIFEDIPINE (nifedipine 5 mg oral capsule) AA PHARMA INC,Active,9000332,nifedipine 5 mg oral capsule,8000123,nifedipine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
103966,Marketed,2025-02-13,02550881,Apo-niLOtinib,1,L01EA03,Nilotinib,Capsule,Oral,02550881,APO-NILOTINIB (nilotinib (nilotinib hydrochloride monohydrate) 150 mg oral capsule) APOTEX INC,Active,9013463,nilotinib (nilotinib hydrochloride) 150 mg oral capsule,8002034,nilotinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
103967,Marketed,2025-02-13,02550903,Apo-niLOtinib,1,L01EA03,Nilotinib,Capsule,Oral,02550903,APO-NILOTINIB (nilotinib (nilotinib hydrochloride monohydrate) 200 mg oral capsule) APOTEX INC,Active,9013464,nilotinib (nilotinib hydrochloride) 200 mg oral capsule,8002034,nilotinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
106003,Marketed,2025-04-24,02556634,Reddy-niLOtinib,1,L01EA03,Nilotinib,Capsule,Oral,02556634,REDDY-NILOTINIB (nilotinib (nilotinib hydrochloride monohydrate) 150 mg oral capsule) DR REDDY'S LABORATORIES LTD,Active,9013463,nilotinib (nilotinib hydrochloride) 150 mg oral capsule,8002034,nilotinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
106004,Marketed,2025-04-24,02556642,Reddy-niLOtinib,1,L01EA03,Nilotinib,Capsule,Oral,02556642,REDDY-NILOTINIB (nilotinib (nilotinib hydrochloride monohydrate) 200 mg oral capsule) DR REDDY'S LABORATORIES LTD,Active,9013464,nilotinib (nilotinib hydrochloride) 200 mg oral capsule,8002034,nilotinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
80138,Marketed,2008-09-30,02315874,Tasigna,1,L01EA03,Nilotinib,Capsule,Oral,02315874,TASIGNA (nilotinib (nilotinib hydrochloride monohydrate) 200 mg oral capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9013464,nilotinib (nilotinib hydrochloride) 200 mg oral capsule,8002034,nilotinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
85322,Marketed,2011-07-15,02368250,Tasigna,1,L01EA03,Nilotinib,Capsule,Oral,02368250,TASIGNA (nilotinib (nilotinib hydrochloride monohydrate) 150 mg oral capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9013463,nilotinib (nilotinib hydrochloride) 150 mg oral capsule,8002034,nilotinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
81127,Marketed,2025-08-18,02325926,Nimotop,1,C08CA06,Nimodipine,Tablet,Oral,02325926,NIMOTOP (nimodipine 30 mg oral tablet) LABORATOIRE X.0,Active,9004575,nimodipine 30 mg oral tablet,8001674,nimodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101595,Marketed,2025-12-22,02526891,Auro-Nintedanib,1,L01EX09,Nintedanib,Capsule,Oral,,,,,,,,,,,,,,,,,Prescription
101596,Marketed,2025-12-22,02526905,Auro-Nintedanib,1,L01EX09,Nintedanib,Capsule,Oral,,,,,,,,,,,,,,,,,Prescription
102944,Marketed,2025-12-22,02540762,JAMP Nintedanib,1,L01EX09,Nintedanib,Capsule,Oral,02540762,JAMP NINTEDANIB (nintedanib (nintedanib esilate) 150 mg oral capsule) JAMP PHARMA CORPORATION,Active,9005737,nintedanib (nintedanib esilate) 150 mg oral capsule,8002035,nintedanib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
103962,Marketed,2025-12-22,02550849,JAMP Nintedanib,1,L01EX09,Nintedanib,Capsule,Oral,02550849,JAMP NINTEDANIB (nintedanib (nintedanib esilate) 100 mg oral capsule) JAMP PHARMA CORPORATION,Active,9005736,nintedanib (nintedanib esilate) 100 mg oral capsule,8002035,nintedanib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
92756,Marketed,2015-06-29,02443066,Ofev,1,L01EX09,Nintedanib,Capsule,Oral,02443066,OFEV (nintedanib (nintedanib esilate) 100 mg oral capsule) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9005736,nintedanib (nintedanib esilate) 100 mg oral capsule,8002035,nintedanib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
92761,Marketed,2015-06-29,02443074,Ofev,1,L01EX09,Nintedanib,Capsule,Oral,02443074,OFEV (nintedanib (nintedanib esilate) 150 mg oral capsule) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9005737,nintedanib (nintedanib esilate) 150 mg oral capsule,8002035,nintedanib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
106628,Marketed,2026-01-23,02563509,Imaavy,1,L04AL03,Nipocalimab,Solution,Intravenous,02563509,IMAAVY (nipocalimab 300 mg per 1.62 mL solution for injection vial) JANSSEN INC,Active,9015377,nipocalimab 300 mg per 1.62 mL solution for injection vial,8002578,nipocalimab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,,,,Prescription
106628,Marketed,2026-01-23,02563509,Imaavy,1,L04AL03,Nipocalimab,Solution,Intravenous,02563509,IMAAVY (nipocalimab 300 mg per 1.62 mL solution for injection vial) JANSSEN INC,Active,9015377,nipocalimab 300 mg per 1.62 mL solution for injection vial,8002578,nipocalimab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,,,,Schedule D
106629,Marketed,2026-01-23,02563517,Imaavy,1,L04AL03,Nipocalimab,Solution,Intravenous,02563517,IMAAVY (nipocalimab 1200 mg per 6.5 mL solution for injection vial) JANSSEN INC,Active,9015376,nipocalimab 1200 mg per 6.5 mL solution for injection vial,8002578,nipocalimab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,,,,Prescription
106629,Marketed,2026-01-23,02563517,Imaavy,1,L04AL03,Nipocalimab,Solution,Intravenous,02563517,IMAAVY (nipocalimab 1200 mg per 6.5 mL solution for injection vial) JANSSEN INC,Active,9015376,nipocalimab 1200 mg per 6.5 mL solution for injection vial,8002578,nipocalimab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,,,,Schedule D
101925,Marketed,2023-09-13,02530031,Zejula,1,L01XK02,Niraparib,Tablet,Oral,02530031,ZEJULA (niraparib (niraparib tosylate) 100 mg oral tablet) GLAXOSMITHKLINE INC,Active,9014919,niraparib (niraparib tosylate) 100 mg oral tablet,8002312,niraparib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102726,Marketed,2023-08-14,02538555,Akeega,2,L01XK52,Niraparib and abiraterone,Tablet,Oral,02538555,AKEEGA (abiraterone acetate 500 mg and niraparib (niraparib tosylate) 50 mg oral tablet) JANSSEN INC,Active,9014901,abiraterone acetate 500 mg and niraparib (niraparib tosylate) 50 mg oral tablet,8002474,abiraterone and niraparib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102728,Marketed,2023-08-14,02538563,Akeega,2,L01XK52,Niraparib and abiraterone,Tablet,Oral,02538563,AKEEGA (abiraterone acetate 500 mg and niraparib (niraparib tosylate) 100 mg oral tablet) JANSSEN INC,Active,9014900,abiraterone acetate 500 mg and niraparib (niraparib tosylate) 100 mg oral tablet,8002474,abiraterone and niraparib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101307,Marketed,2022-01-18,02524031,Paxlovid,2,J05AE30,Nirmatrelvir and ritonavir,Tablet,Oral,02524031,PAXLOVID (nirmatrelvir 150 mg oral tablet with ritonavir 100 mg oral tablet) PFIZER CANADA ULC,Active,9014643,nirmatrelvir 150 mg oral tablet with ritonavir 100 mg oral tablet,8002405,nirmatrelvir and ritonavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102594,Marketed,2024-10-21,02537206,Beyfortus,1,J06BD08,Nirsevimab,Solution,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
102595,Marketed,2024-11-04,02537214,Beyfortus,1,J06BD08,Nirsevimab,Solution,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
94475,Marketed,2016-10-20,02457717,MDK-Nitisinone,1,A16AX04,Nitisinone,Capsule,Oral,02457717,MDK-NITISINONE (nitisinone 2 mg oral capsule) MENDELIKABS INC,Active,9006053,nitisinone 2 mg oral capsule,8001675,nitisinone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
94476,Marketed,2016-10-20,02457725,MDK-Nitisinone,1,A16AX04,Nitisinone,Capsule,Oral,02457725,MDK-NITISINONE (nitisinone 5 mg oral capsule) MENDELIKABS INC,Active,9006054,nitisinone 5 mg oral capsule,8001675,nitisinone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
94477,Marketed,2025-10-15,02457733,MDK-Nitisinone,1,A16AX04,Nitisinone,Capsule,Oral,02457733,MDK-NITISINONE (nitisinone 10 mg oral capsule) MENDELIKABS INC,Active,9006052,nitisinone 10 mg oral capsule,8001675,nitisinone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
94699,Marketed,2017-02-17,02459698,Orfadin,1,A16AX04,Nitisinone,Capsule,Oral,02459698,ORFADIN (nitisinone 2 mg oral capsule) SWEDISH ORPHAN BIOVITRUM AB (PUBL),Active,9006053,nitisinone 2 mg oral capsule,8001675,nitisinone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
94700,Marketed,2017-02-17,02459701,Orfadin,1,A16AX04,Nitisinone,Capsule,Oral,02459701,ORFADIN (nitisinone 5 mg oral capsule) SWEDISH ORPHAN BIOVITRUM AB (PUBL),Active,9006054,nitisinone 5 mg oral capsule,8001675,nitisinone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
94701,Marketed,2017-02-17,02459728,Orfadin,1,A16AX04,Nitisinone,Capsule,Oral,02459728,ORFADIN (nitisinone 10 mg oral capsule) SWEDISH ORPHAN BIOVITRUM AB (PUBL),Active,9006052,nitisinone 10 mg oral capsule,8001675,nitisinone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
94702,Marketed,2017-02-17,02459736,Orfadin,1,A16AX04,Nitisinone,Capsule,Oral,02459736,ORFADIN (nitisinone 20 mg oral capsule) SWEDISH ORPHAN BIOVITRUM AB (PUBL),Active,9006131,nitisinone 20 mg oral capsule,8001675,nitisinone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95850,Marketed,2018-07-10,02469693,Orfadin,1,A16AX04,Nitisinone,Suspension,Oral,02469693,ORFADIN (nitisinone 4 mg per mL oral suspension) SWEDISH ORPHAN BIOVITRUM AB (PUBL),Active,9013015,nitisinone 4 mg per mL oral suspension,8001675,nitisinone,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
3991,Marketed,2014-04-16,00511528,Mogadon,1,N05CD02,Nitrazepam,Tablet,Oral,00511528,MOGADON (nitrazepam 5 mg oral tablet) AA PHARMA INC,Active,9001893,nitrazepam 5 mg oral tablet,8001092,nitrazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
3992,Marketed,2014-04-16,00511536,Mogadon,1,N05CD02,Nitrazepam,Tablet,Oral,00511536,MOGADON (nitrazepam 10 mg oral tablet) AA PHARMA INC,Active,9001892,nitrazepam 10 mg oral tablet,8001092,nitrazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
75619,Marketed,2005-11-23,02270846,Inomax,1,R07AX01,Nitric oxide,Gas,Inhalation,,,,,,,,,,,,,,,,,Prescription
93757,Marketed,2022-04-30,02451328,Kinox,1,R07AX01,Nitric oxide,Gas,Inhalation,,,,,,,,,,,,,,,,,Prescription
103357,Marketed,2025-02-18,02544954,JAMP Nitrofurantoin Bid,1,J01XE01,Nitrofurantoin,Capsule,Oral,02544954,JAMP NITROFURANTOIN BID (nitrofurantoin 100 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000485,nitrofurantoin 100 mg oral capsule,8000050,nitrofurantoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
2093,Marketed,2011-10-25,00312738,Nitrofurantoin,1,J01XE01,Nitrofurantoin,Tablet,Oral,00312738,NITROFURANTOIN (nitrofurantoin 100 mg oral tablet) AA PHARMA INC,Active,9000079,nitrofurantoin 100 mg oral tablet,8000050,nitrofurantoin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
2094,Marketed,2010-11-29,00319511,Nitrofurantoin,1,J01XE01,Nitrofurantoin,Tablet,Oral,00319511,NITROFURANTOIN (nitrofurantoin 50 mg oral tablet) AA PHARMA INC,Active,9000080,nitrofurantoin 50 mg oral tablet,8000050,nitrofurantoin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
50295,Marketed,2011-10-19,02231015,Teva-Nitrofurantoin,1,J01XE01,Nitrofurantoin,Capsule,Oral,02231015,TEVA-NITROFURANTOIN (nitrofurantoin 50 mg oral capsule) TEVA CANADA LIMITED,Active,9000725,nitrofurantoin 50 mg oral capsule,8000050,nitrofurantoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
50297,Marketed,2011-10-19,02231016,Teva-Nitrofurantoin,1,J01XE01,Nitrofurantoin,Capsule,Oral,02231016,TEVA-NITROFURANTOIN (nitrofurantoin 100 mg oral capsule) TEVA CANADA LIMITED,Active,9000485,nitrofurantoin 100 mg oral capsule,8000050,nitrofurantoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
94248,Marketed,2021-08-11,02455676,PMS-Nitrofurantoin Bid,1,J01XE01,Nitrofurantoin,Capsule,Oral,02455676,PMS-NITROFURANTOIN BID (nitrofurantoin 100 mg oral capsule) PHARMASCIENCE INC,Active,9000485,nitrofurantoin 100 mg oral capsule,8000050,nitrofurantoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95474,Marketed,2020-09-09,02466392,Auro-Nitrofurantoin Bid,1,J01XE01,Nitrofurantoin,Capsule,Oral,02466392,AURO-NITROFURANTOIN BID (nitrofurantoin 100 mg oral capsule) AURO PHARMA INC,Active,9000485,nitrofurantoin 100 mg oral capsule,8000050,nitrofurantoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98541,Marketed,2025-04-02,02495503,JAMP Nitrofurantoin,1,J01XE01,Nitrofurantoin,Capsule,Oral,02495503,JAMP NITROFURANTOIN (nitrofurantoin 50 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000725,nitrofurantoin 50 mg oral capsule,8000050,nitrofurantoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98542,Marketed,2025-04-02,02495511,JAMP Nitrofurantoin,1,J01XE01,Nitrofurantoin,Capsule,Oral,02495511,JAMP NITROFURANTOIN (nitrofurantoin 100 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000485,nitrofurantoin 100 mg oral capsule,8000050,nitrofurantoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
13882,Marketed,2022-04-20,02014394,Nitrogen Nf,1,V03AN04,Nitrogen,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
19292,Marketed,2020-08-04,02154803,Nitrogen N.F.,1,V03AN04,Nitrogen,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
5221,Marketed,1983-12-31,00591645,Gaseous Nitrogen 99%,1,V03AN04,Nitrogen,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
5683,Marketed,1911-12-31,00572829,Nitrogen 100%,1,V03AN04,Nitrogen,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
78261,Marketed,2025-01-27,02297248,Liquid Nitrogen Nf,1,V03AN04,Nitrogen,Liquid,Topical,,,,,,,,,,,,,,,,,Ethical
85318,Marketed,2011-09-13,02368218,Liquid Nitrogen,1,V03AN04,Nitrogen,Liquid,Topical,,,,,,,,,,,,,,,,,Ethical
92092,Marketed,2015-10-20,02436590,Liquid Nitrogen Nf,1,V03AN04,Nitrogen,Liquid,Topical,,,,,,,,,,,,,,,,,Ethical
103072,Marketed,2025-02-13,02542129,Sodium Nitroprusside For Injection,1,C02DD01,Nitroprusside,Solution,Intravenous,,,,,,,,,,,,,,,,,Prescription
84678,Marketed,2017-08-02,02361736,Nipride,1,C02DD01,Nitroprusside,Solution,Intravenous,02361736,NIPRIDE (sodium nitroprusside 50 mg per 2 mL solution for injection vial) PFIZER CANADA ULC,Active,9013343,sodium nitroprusside 50 mg per 2 mL solution for injection vial,8001913,nitroprusside,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
93610,Marketed,2021-04-26,02450089,Sodium Nitroprusside For Injection,1,C02DD01,Nitroprusside,Solution,Intravenous,02450089,SODIUM NITROPRUSSIDE FOR INJECTION (sodium nitroprusside 50 mg per 2 mL solution for injection vial) STERIMAX INC,Active,9013343,sodium nitroprusside 50 mg per 2 mL solution for injection vial,8001913,nitroprusside,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
96981,Marketed,2019-04-15,02479109,Sodium Nitroprusside For Injection,1,C02DD01,Nitroprusside,Solution,Intravenous,02479109,SODIUM NITROPRUSSIDE FOR INJECTION (sodium nitroprusside 50 mg per 2 mL solution for injection vial) MARCAN PHARMACEUTICALS INC,Active,9013343,sodium nitroprusside 50 mg per 2 mL solution for injection vial,8001913,nitroprusside,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
99680,Marketed,2021-05-26,02507404,Sodium Nitroprusside For Injection,1,C02DD01,Nitroprusside,Solution,Intravenous,02507404,SODIUM NITROPRUSSIDE FOR INJECTION (sodium nitroprusside 50 mg per 2 mL solution for injection vial) DR REDDY'S LABORATORIES LTD,Active,9013343,sodium nitroprusside 50 mg per 2 mL solution for injection vial,8001913,nitroprusside,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
13887,Marketed,2022-03-08,02014467,Nitrous Oxide USP,1,N01AX13,Nitrous oxide,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
19262,Marketed,2020-08-04,02154811,Nitrous Oxide U.S.P.,1,N01AX13,Nitrous oxide,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
5685,Marketed,1911-12-31,00572845,Nitrous Oxide 100%,1,N01AX13,Nitrous oxide,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
18513,Marketed,1995-12-31,02071010,Alnox Gas,2,N01AX63,"Nitrous oxide,combinations",Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
19102,Marketed,2022-01-28,02154757,Meopa,2,N01AX63,"Nitrous oxide,combinations",Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
6850,Marketed,1997-05-02,00693596,Liqui-Med Analgesic Gas,2,N01AX63,"Nitrous oxide,combinations",Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
106066,Marketed,2025-12-30,02557320,Opdivo SC,1,L01FF01,Nivolumab,Solution,Subcutaneous,02557320,OPDIVO SC (nivolumab 600 mg per 5 mL solution for injection vial) BRISTOL-MYERS SQUIBB CANADA,Active,9015342,nivolumab 600 mg per 5 mL solution for injection vial,8001676,nivolumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,1.0,,,Prescription
106066,Marketed,2025-12-30,02557320,Opdivo SC,1,L01FF01,Nivolumab,Solution,Subcutaneous,02557320,OPDIVO SC (nivolumab 600 mg per 5 mL solution for injection vial) BRISTOL-MYERS SQUIBB CANADA,Active,9015342,nivolumab 600 mg per 5 mL solution for injection vial,8001676,nivolumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,1.0,,,Schedule D
93204,Marketed,2015-10-23,02446626,Opdivo,1,L01FF01,Nivolumab,Solution,Intravenous,02446626,OPDIVO (nivolumab 40 mg per 4 mL solution for injection vial) BRISTOL-MYERS SQUIBB CANADA,Active,9013017,nivolumab 40 mg per 4 mL solution for injection vial,8001676,nivolumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
93204,Marketed,2015-10-23,02446626,Opdivo,1,L01FF01,Nivolumab,Solution,Intravenous,02446626,OPDIVO (nivolumab 40 mg per 4 mL solution for injection vial) BRISTOL-MYERS SQUIBB CANADA,Active,9013017,nivolumab 40 mg per 4 mL solution for injection vial,8001676,nivolumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
93205,Marketed,2015-10-23,02446634,Opdivo,1,L01FF01,Nivolumab,Solution,Intravenous,02446634,OPDIVO (nivolumab 10 mg per mL solution for injection vial) BRISTOL-MYERS SQUIBB CANADA,Active,9013016,nivolumab 10 mg per mL solution for injection vial,8001676,nivolumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
93205,Marketed,2015-10-23,02446634,Opdivo,1,L01FF01,Nivolumab,Solution,Intravenous,02446634,OPDIVO (nivolumab 10 mg per mL solution for injection vial) BRISTOL-MYERS SQUIBB CANADA,Active,9013016,nivolumab 10 mg per mL solution for injection vial,8001676,nivolumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
103005,Marketed,2024-02-12,02541416,Opdualag,2,L01FY02,Nivolumab and relatlimab,Solution,Intravenous,02541416,OPDUALAG (nivolumab 240 mg per 20 mL and relatlimab 80 mg per 20 mL solution for injection vial) BRISTOL-MYERS SQUIBB CANADA,Active,9015027,nivolumab 240 mg per 20 mL and relatlimab 80 mg per 20 mL solution for injection vial,8002502,nivolumab and relatlimab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
103005,Marketed,2024-02-12,02541416,Opdualag,2,L01FY02,Nivolumab and relatlimab,Solution,Intravenous,02541416,OPDUALAG (nivolumab 240 mg per 20 mL and relatlimab 80 mg per 20 mL solution for injection vial) BRISTOL-MYERS SQUIBB CANADA,Active,9015027,nivolumab 240 mg per 20 mL and relatlimab 80 mg per 20 mL solution for injection vial,8002502,nivolumab and relatlimab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
8915,Marketed,2013-09-26,00778338,Axid,1,A02BA04,Nizatidine,Capsule,Oral,00778338,AXID (nizatidine 150 mg oral capsule) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9002150,nizatidine 150 mg oral capsule,8001406,nizatidine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
72637,Marketed,2022-10-25,02248297,Evra,2,G03AA13,Norelgestromin and estrogen,Patch (extended release),Transdermal,02248297,EVRA (ethinyl estradiol 35 mcg per 24 hour and norelgestromin 200 mcg per 24 hour transdermal patch) SEARCHLIGHT PHARMA INC,Active,9013290,ethinyl estradiol 35 mcg per 24 hour and norelgestromin 200 mcg per 24 hour transdermal patch,8000334,ethinyl estradiol and norelgestromin,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),1.0,,,Prescription
102932,Marketed,2024-04-30,02540630,Norepinephrine Bitartrate Injection,1,C01CA03,Norepinephrine,Solution,Intravenous,02540630,NOREPINEPHRINE BITARTRATE INJECTION (norepinephrine (norepinephrine bitartrate) 4 mg per 4 mL solution for injection vial) JUNO PHARMACEUTICALS CORP.,Active,9013466,norepinephrine (norepinephrine bitartrate) 4 mg per 4 mL solution for injection vial,8002036,norepinephrine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
11641,Marketed,2023-12-12,00893285,Norepinephrine Bitartrate Injection USP,1,C01CA03,Norepinephrine,Solution,Intravenous,00893285,NOREPINEPHRINE BITARTRATE INJECTION USP (norepinephrine (norepinephrine bitartrate) 4 mg per 4 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013466,norepinephrine (norepinephrine bitartrate) 4 mg per 4 mL solution for injection vial,8002036,norepinephrine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
84377,Marketed,2024-09-20,02358743,"Norepinephrine Bitartrate Injection, USP",1,C01CA03,Norepinephrine,Solution,Intravenous,02358743,"NOREPINEPHRINE BITARTRATE INJECTION, USP (norepinephrine (norepinephrine bitartrate) 4 mg per 4 mL solution for injection vial) STERIMAX INC",Active,9013466,norepinephrine (norepinephrine bitartrate) 4 mg per 4 mL solution for injection vial,8002036,norepinephrine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
97591,Marketed,2020-05-04,02485680,Norepinephrine Bitartrate Injection USP,1,C01CA03,Norepinephrine,Solution,Intravenous,02485680,NOREPINEPHRINE BITARTRATE INJECTION USP (norepinephrine (norepinephrine bitartrate) 4 mg per 4 mL solution for injection ampoule) GENERIC MEDICAL PARTNERS INC,Active,9013465,norepinephrine (norepinephrine bitartrate) 4 mg per 4 mL solution for injection ampoule,8002036,norepinephrine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
99106,Marketed,2021-07-20,02501430,Norepinephrine Bitartrate In 5% Dextrose Injection,1,C01CA03,Norepinephrine,Solution,Intravenous,02501430,NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTION (norepinephrine (norepinephrine bitartrate) 4 mg per 250 mL solution for injection bag) BAXTER CORPORATION,Active,9014585,norepinephrine (norepinephrine bitartrate) 4 mg per 250 mL solution for injection bag,8002036,norepinephrine,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Ethical
99107,Marketed,2021-07-20,02501449,Norepinephrine Bitartrate In 5% Dextrose Injection,1,C01CA03,Norepinephrine,Solution,Intravenous,02501449,NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTION (norepinephrine (norepinephrine bitartrate) 8 mg per 250 mL solution for injection bag) BAXTER CORPORATION,Active,9014586,norepinephrine (norepinephrine bitartrate) 8 mg per 250 mL solution for injection bag,8002036,norepinephrine,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Ethical
1401,Marketed,2022-10-14,00023760,Norlutate,1,G03DC02,Norethisterone,Tablet,Oral,00023760,NORLUTATE (norethindrone acetate 5 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9000028,norethindrone acetate 5 mg oral tablet,8000020,norethindrone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
89495,Marketed,2016-05-18,02410303,Movisse,1,G03AC01,Norethisterone,Tablet,Oral,02410303,MOVISSE (norethindrone 0.35 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000062,norethindrone 0.35 mg oral tablet,8000020,norethindrone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
92570,Marketed,2018-08-14,02441306,Jencycla,1,G03AC01,Norethisterone,Tablet,Oral,02441306,JENCYCLA (norethindrone 0.35 mg oral tablet) LUPIN PHARMA CANADA LIMITED,Active,9000062,norethindrone 0.35 mg oral tablet,8000020,norethindrone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
94584,Marketed,2022-12-16,02458683,Maeve,1,G03AC01,Norethisterone,Tablet,Oral,02458683,MAEVE (norethindrone 0.35 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9000062,norethindrone 0.35 mg oral tablet,8000020,norethindrone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
104242,Marketed,2026-04-20,02553481,Elfy,3,G03AB04,Norethisterone and estrogen,Tablet,Oral,02553481,ELFY (ethinyl estradiol 10 mcg oral tablet with ethinyl estradiol 10 mcg and norethindrone acetate 1 mg oral tablet with lactose oral tablet) APOTEX INC,Active,9009374,ethinyl estradiol 10 mcg oral tablet with ethinyl estradiol 10 mcg and norethindrone acetate 1 mg oral tablet with lactose oral tablet,8000049,ethinyl estradiol and norethindrone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
20162,Marketed,2009-02-03,02187086,Brevicon 0.5/35 Tablets (21-Day Pack),2,G03AA05,Norethisterone and estrogen,Tablet,Oral,02187086,BREVICON 0.5/35 TABLETS (21-DAY PACK) (ethinyl estradiol 35 mcg and norethindrone 0.5 mg oral tablet) PFIZER CANADA ULC,Active,9009390,ethinyl estradiol 35 mcg and norethindrone 0.5 mg oral tablet,8000049,ethinyl estradiol and norethindrone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
42888,Marketed,2006-04-18,02187094,Brevicon 0.5/35 Tablets (28-Day Pack),2,G03AA05,Norethisterone and estrogen,Tablet,Oral,02187094,BREVICON 0.5/35 TABLETS (28-DAY PACK) (ethinyl estradiol 35 mcg and norethindrone 0.5 mg oral tablet with lactose oral tablet) PFIZER CANADA ULC,Active,9009393,ethinyl estradiol 35 mcg and norethindrone 0.5 mg oral tablet with lactose oral tablet,8000049,ethinyl estradiol and norethindrone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
42889,Marketed,2009-02-03,02187108,Synphasic 21 Tablets,4,G03AB04,Norethisterone and estrogen,Tablet,Oral,02187108,SYNPHASIC 21 TABLETS (ethinyl estradiol 35 mcg and norethindrone 0.5 mg oral tablet with ethinyl estradiol 35 mcg and norethindrone 1 mg oral tablet) PFIZER CANADA ULC,Active,9009395,ethinyl estradiol 35 mcg and norethindrone 0.5 mg oral tablet with ethinyl estradiol 35 mcg and norethindrone 1 mg oral tablet,8000049,ethinyl estradiol and norethindrone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
42890,Marketed,2006-07-20,02187116,Synphasic 28 Tablets,4,G03AB04,Norethisterone and estrogen,Tablet,Oral,02187116,SYNPHASIC 28 TABLETS (ethinyl estradiol 35 mcg and norethindrone 0.5 mg oral tablet with ethinyl estradiol 35 mcg and norethindrone 1 mg oral tablet with lactose oral tablet) PFIZER CANADA ULC,Active,9009396,ethinyl estradiol 35 mcg and norethindrone 0.5 mg oral tablet with ethinyl estradiol 35 mcg and norethindrone 1 mg oral tablet with lactose oral tablet,8000049,ethinyl estradiol and norethindrone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
42921,Marketed,2009-02-03,02189054,Brevicon 1/35 Tablets (21-Day Pack),2,G03AA05,Norethisterone and estrogen,Tablet,Oral,02189054,BREVICON 1/35 TABLETS (21-DAY PACK) (ethinyl estradiol 35 mcg and norethindrone 1 mg oral tablet) PFIZER CANADA ULC,Active,9009394,ethinyl estradiol 35 mcg and norethindrone 1 mg oral tablet,8000049,ethinyl estradiol and norethindrone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
42922,Marketed,2009-02-03,02189062,Brevicon 1/35 Tablets (28-Day Pack),2,G03AA05,Norethisterone and estrogen,Tablet,Oral,02189062,BREVICON 1/35 TABLETS (28-DAY PACK) (ethinyl estradiol 35 mcg and norethindrone 1 mg oral tablet with lactose oral tablet) PFIZER CANADA ULC,Active,9009397,ethinyl estradiol 35 mcg and norethindrone 1 mg oral tablet with lactose oral tablet,8000049,ethinyl estradiol and norethindrone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
42952,Marketed,2006-02-22,02197502,Select 1/35 (21-Day),2,G03AA05,Norethisterone and estrogen,Tablet,Oral,02197502,SELECT 1/35 (21-DAY) (ethinyl estradiol 35 mcg and norethindrone 1 mg oral tablet) PFIZER CANADA ULC,Active,9009394,ethinyl estradiol 35 mcg and norethindrone 1 mg oral tablet,8000049,ethinyl estradiol and norethindrone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
42960,Marketed,2005-01-13,02199297,Select 1/35 (28-Day),2,G03AA05,Norethisterone and estrogen,Tablet,Oral,02199297,SELECT 1/35 (28-DAY) (ethinyl estradiol 35 mcg and norethindrone 1 mg oral tablet with lactose oral tablet) PFIZER CANADA ULC,Active,9009397,ethinyl estradiol 35 mcg and norethindrone 1 mg oral tablet with lactose oral tablet,8000049,ethinyl estradiol and norethindrone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
65502,Marketed,2022-12-06,02241835,Estalis 140/50 mcg,2,G03FA01,Norethisterone and estrogen,Patch,Transdermal,02241835,ESTALIS 140/50 MCG (estradiol 50 mcg per 24 hour and norethindrone acetate 140 mcg per 24 hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9012362,estradiol 50 mcg per 24 hour and norethindrone acetate 140 mcg per 24 hour transdermal patch,8000917,estradiol and norethindrone,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),1.0,,,Prescription
65503,Marketed,2022-12-06,02241837,Estalis 250/50 mcg,2,G03FA01,Norethisterone and estrogen,Patch,Transdermal,02241837,ESTALIS 250/50 MCG (estradiol 50 mcg per 24 hour and norethindrone acetate 250 mcg per 24 hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9006577,estradiol 50 mcg per 24 hour and norethindrone acetate 250 mcg per 24 hour transdermal patch,8000917,estradiol and norethindrone,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),1.0,,,Prescription
73420,Marketed,2008-05-16,02249405,Activelle,2,G03FA01,Norethisterone and estrogen,Tablet,Oral,02249405,ACTIVELLE (estradiol 1 mg and norethindrone acetate 0.5 mg oral tablet) NOVO NORDISK CANADA INC,Active,9004423,estradiol 1 mg and norethindrone acetate 0.5 mg oral tablet,8000917,estradiol and norethindrone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
79461,Marketed,2008-05-16,02309009,Activelle LD,2,G03FA01,Norethisterone and estrogen,Tablet,Oral,02309009,ACTIVELLE LD (estradiol 0.5 mg and norethindrone acetate 0.1 mg oral tablet) NOVO NORDISK CANADA INC,Active,9004422,estradiol 0.5 mg and norethindrone acetate 0.1 mg oral tablet,8000917,estradiol and norethindrone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
90215,Marketed,2024-05-06,02417456,Lolo,3,G03AB04,Norethisterone and estrogen,Tablet,Oral,02417456,LOLO (ethinyl estradiol 10 mcg oral tablet with ethinyl estradiol 10 mcg and norethindrone acetate 1 mg oral tablet with lactose oral tablet) ABBVIE CORPORATION,Active,9009374,ethinyl estradiol 10 mcg oral tablet with ethinyl estradiol 10 mcg and norethindrone acetate 1 mg oral tablet with lactose oral tablet,8000049,ethinyl estradiol and norethindrone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
47429,Marketed,2018-09-18,02229524,Norfloxacin,1,J01MA06,Norfloxacin,Tablet,Oral,02229524,NORFLOXACIN (norfloxacin 400 mg oral tablet) AA PHARMA INC,Active,9003268,norfloxacin 400 mg oral tablet,8001219,norfloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88684,Marketed,2021-03-23,02401967,Tri-Cira Lo 21,6,G03AB09,Norgestimate and ethinylestradiol,Tablet,Oral,02401967,TRI-CIRA LO 21 (ethinyl estradiol 25 mcg and norgestimate 180 mcg oral tablet with ethinyl estradiol 25 mcg and norgestimate 215 mcg oral tablet with ethinyl estradiol 25 mcg and norgestimate 250 mcg oral tablet) APOTEX INC,Active,9009380,ethinyl estradiol 25 mcg and norgestimate 180 mcg oral tablet with ethinyl estradiol 25 mcg and norgestimate 215 mcg oral tablet with ethinyl estradiol 25 mcg and norgestimate 250 mcg oral tablet,8000164,ethinyl estradiol and norgestimate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
88685,Marketed,2021-03-23,02401975,Tri-Cira Lo 28,6,G03AB09,Norgestimate and ethinylestradiol,Tablet,Oral,02401975,TRI-CIRA LO 28 (ethinyl estradiol 25 mcg and norgestimate 180 mcg oral tablet with ethinyl estradiol 25 mcg and norgestimate 215 mcg oral tablet with ethinyl estradiol 25 mcg and norgestimate 250 mcg oral tablet with lactose oral tablet) APOTEX INC,Active,9009381,ethinyl estradiol 25 mcg and norgestimate 180 mcg oral tablet with ethinyl estradiol 25 mcg and norgestimate 215 mcg oral tablet with ethinyl estradiol 25 mcg and norgestimate 250 mcg oral tablet with lactose oral tablet,8000164,ethinyl estradiol and norgestimate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
97651,Marketed,2020-07-08,02486296,Tri-Jordyna 21,6,G03AB09,Norgestimate and ethinylestradiol,Tablet,Oral,02486296,TRI-JORDYNA 21 (ethinyl estradiol 35 mcg and norgestimate 180 mcg oral tablet with ethinyl estradiol 35 mcg and norgestimate 215 mcg oral tablet with ethinyl estradiol 35 mcg and norgestimate 250 mcg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9009398,ethinyl estradiol 35 mcg and norgestimate 180 mcg oral tablet with ethinyl estradiol 35 mcg and norgestimate 215 mcg oral tablet with ethinyl estradiol 35 mcg and norgestimate 250 mcg oral tablet,8000164,ethinyl estradiol and norgestimate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
97652,Marketed,2020-03-18,02486318,Tri-Jordyna 28,6,G03AB09,Norgestimate and ethinylestradiol,Tablet,Oral,02486318,TRI-JORDYNA 28 (ethinyl estradiol 35 mcg and norgestimate 180 mcg oral tablet with ethinyl estradiol 35 mcg and norgestimate 215 mcg oral tablet with ethinyl estradiol 35 mcg and norgestimate 250 mcg oral tablet with lactose oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9009399,ethinyl estradiol 35 mcg and norgestimate 180 mcg oral tablet with ethinyl estradiol 35 mcg and norgestimate 215 mcg oral tablet with ethinyl estradiol 35 mcg and norgestimate 250 mcg oral tablet with lactose oral tablet,8000164,ethinyl estradiol and norgestimate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99744,Marketed,2021-03-19,02508087,Tri-Cira 21,6,G03AB09,Norgestimate and ethinylestradiol,Tablet,Oral,02508087,TRI-CIRA 21 (ethinyl estradiol 35 mcg and norgestimate 180 mcg oral tablet with ethinyl estradiol 35 mcg and norgestimate 215 mcg oral tablet with ethinyl estradiol 35 mcg and norgestimate 250 mcg oral tablet) APOTEX INC,Active,9009398,ethinyl estradiol 35 mcg and norgestimate 180 mcg oral tablet with ethinyl estradiol 35 mcg and norgestimate 215 mcg oral tablet with ethinyl estradiol 35 mcg and norgestimate 250 mcg oral tablet,8000164,ethinyl estradiol and norgestimate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99745,Marketed,2021-03-08,02508095,Tri-Cira 28,6,G03AB09,Norgestimate and ethinylestradiol,Tablet,Oral,02508095,TRI-CIRA 28 (ethinyl estradiol 35 mcg and norgestimate 180 mcg oral tablet with ethinyl estradiol 35 mcg and norgestimate 215 mcg oral tablet with ethinyl estradiol 35 mcg and norgestimate 250 mcg oral tablet with lactose oral tablet) APOTEX INC,Active,9009399,ethinyl estradiol 35 mcg and norgestimate 180 mcg oral tablet with ethinyl estradiol 35 mcg and norgestimate 215 mcg oral tablet with ethinyl estradiol 35 mcg and norgestimate 250 mcg oral tablet with lactose oral tablet,8000164,ethinyl estradiol and norgestimate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
15,Marketed,2022-01-10,00015229,Aventyl,1,N06AA10,Nortriptyline,Capsule,Oral,00015229,AVENTYL (nortriptyline (nortriptyline hydrochloride) 10 mg oral capsule) AA PHARMA INC,Active,9000034,nortriptyline (nortriptyline hydrochloride) 10 mg oral capsule,8000026,nortriptyline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
16,Marketed,2022-01-10,00015237,Aventyl,1,N06AA10,Nortriptyline,Capsule,Oral,00015237,AVENTYL (nortriptyline (nortriptyline hydrochloride) 25 mg oral capsule) AA PHARMA INC,Active,9000035,nortriptyline (nortriptyline hydrochloride) 25 mg oral capsule,8000026,nortriptyline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95389,Marketed,2017-08-29,02465663,Spinraza,1,M09AX07,Nusinersen,Solution,Intrathecal,02465663,SPINRAZA (nusinersen (nusinersen sodium) 12 mg per 5 mL solution for injection vial) BIOGEN CANADA INC,Active,9012526,nusinersen (nusinersen sodium) 12 mg per 5 mL solution for injection vial,8001132,nusinersen,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
35795,Marketed,2018-05-02,02194163,Teva-Nystatin,1,G01AA01,Nystatin,Cream,Vaginal,02194163,TEVA-NYSTATIN (nystatin 100000 unit per g vaginal cream) TEVA CANADA LIMITED,Active,9000820,nystatin 100000 unit per g vaginal cream,8000078,nystatin,16857009,Vaginal,385165005,Vaginal cream,,,,,,Prescription
35798,Marketed,2018-05-02,02194201,Teva-Nystatin,1,A07AA02,Nystatin,Suspension,Oral,02194201,TEVA-NYSTATIN (nystatin 100000 unit per mL oral suspension) TEVA CANADA LIMITED,Active,9000335,nystatin 100000 unit per mL oral suspension,8000078,nystatin,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
8977,Marketed,1979-12-31,00716871,Nyaderm,1,D01AA01,Nystatin,Cream,Topical,00716871,NYADERM (nystatin 100000 unit per g cutaneous cream) TARO PHARMACEUTICALS INC,Active,9000132,nystatin 100000 unit per g cutaneous cream,8000078,nystatin,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
91783,Marketed,2015-01-09,02433443,JAMP-Nystatin Oral Suspension USP,1,A07AA02,Nystatin,Suspension,Oral,02433443,JAMP-NYSTATIN ORAL SUSPENSION USP (nystatin 100000 unit per mL oral suspension) JAMP PHARMA CORPORATION,Active,9000335,nystatin 100000 unit per mL oral suspension,8000078,nystatin,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
9277,Marketed,2022-07-22,00716901,Nyaderm,1,G01AA01,Nystatin,Cream,Vaginal,00716901,"NYADERM (nystatin 25000 unit per g vaginal cream) TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Active,9000134,nystatin 25000 unit per g vaginal cream,8000078,nystatin,16857009,Vaginal,385165005,Vaginal cream,,,,,,Prescription
9973,Marketed,1989-12-31,00792667,PMS-Nystatin Suspension 100000 units/mL,1,A07AA02,Nystatin,Suspension,Oral,00792667,PMS-NYSTATIN SUSPENSION 100000 UNIT/ML (nystatin 100000 unit per mL oral suspension) PHARMASCIENCE INC,Active,9000335,nystatin 100000 unit per mL oral suspension,8000078,nystatin,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
12654,Marketed,2007-12-11,01926829,Flagystatin,2,G01AA51,"Nystatin, combinations",Ovule,Vaginal,01926829,FLAGYSTATIN (metronidazole 500 mg and nystatin 100000 unit pessary) SANOFI-AVENTIS CANADA INC,Active,9001852,metronidazole 500 mg and nystatin 100000 unit pessary,8000814,metronidazole and nystatin,16857009,Vaginal,385174007,Pessary,733007009,Pessary (unit of presentation),,,,Prescription
95104,Marketed,2023-12-08,02463121,Ocaliva,1,A05AA04,Obeticholic acid,Tablet,Oral,02463121,OCALIVA (obeticholic acid 5 mg oral tablet) ADVANZ PHARMA CANADA INC.,Active,9006182,obeticholic acid 5 mg oral tablet,8002037,obeticholic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95105,Marketed,2023-12-07,02463148,Ocaliva,1,A05AA04,Obeticholic acid,Tablet,Oral,02463148,OCALIVA (obeticholic acid 10 mg oral tablet) ADVANZ PHARMA CANADA INC.,Active,9006181,obeticholic acid 10 mg oral tablet,8002037,obeticholic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91910,Marketed,2014-11-28,02434806,Gazyva,1,L01FA03,Obinutuzumab,Solution,Intravenous,02434806,GAZYVA (obinutuzumab 1000 mg per 40 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9013467,obinutuzumab 1000 mg per 40 mL solution for injection vial,8002038,obinutuzumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
91910,Marketed,2014-11-28,02434806,Gazyva,1,L01FA03,Obinutuzumab,Solution,Intravenous,02434806,GAZYVA (obinutuzumab 1000 mg per 40 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9013467,obinutuzumab 1000 mg per 40 mL solution for injection vial,8002038,obinutuzumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
95561,Marketed,2017-09-21,02467224,Ocrevus,1,L04AG08,Ocrelizumab,Solution,Intravenous,02467224,OCREVUS (ocrelizumab 300 mg per 10 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9012527,ocrelizumab 300 mg per 10 mL solution for injection vial,8001135,ocrelizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
95561,Marketed,2017-09-21,02467224,Ocrevus,1,L04AG08,Ocrelizumab,Solution,Intravenous,02467224,OCREVUS (ocrelizumab 300 mg per 10 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9012527,ocrelizumab 300 mg per 10 mL solution for injection vial,8001135,ocrelizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
106332,Marketed,2026-01-05,02560240,Octreotide Injection,1,H01CB02,Octreotide,Solution,"Subcutaneous,Intravenous",02560240,OCTREOTIDE INJECTION (octreotide (octreotide acetate) 100 mcg per 1 mL solution for injection vial) STERIMAX INC,Active,9013472,octreotide (octreotide acetate) 100 mcg per 1 mL solution for injection vial,8002040,octreotide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
106336,Marketed,2026-01-07,02560283,Octreotide Injection,1,H01CB02,Octreotide,Solution,"Subcutaneous,Intravenous",02560283,OCTREOTIDE INJECTION (octreotide (octreotide acetate) 1000 mcg per 5 mL solution for injection vial) STERIMAX INC,Active,9013473,octreotide (octreotide acetate) 1000 mcg per 5 mL solution for injection vial,8002040,octreotide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
106337,Marketed,2026-01-05,02560291,Octreotide Injection,1,H01CB02,Octreotide,Solution,"Intravenous,Subcutaneous",02560291,OCTREOTIDE INJECTION (octreotide (octreotide acetate) 500 mcg per 1 mL solution for injection vial) STERIMAX INC,Active,9013479,octreotide (octreotide acetate) 500 mcg per 1 mL solution for injection vial,8002040,octreotide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
107015,Marketed,2026-05-28,02567776,Octreotide Depot,1,H01CB02,Octreotide,"Powder for suspension, sustained-release",Intramuscular,,,,,,,,,,,,,,,,,Prescription
107016,Marketed,2026-05-28,02567784,Octreotide Depot,1,H01CB02,Octreotide,"Powder for suspension, sustained-release",Intramuscular,,,,,,,,,,,,,,,,,Prescription
107017,Marketed,2026-05-29,02567792,Octreotide Depot,1,H01CB02,Octreotide,"Powder for suspension, sustained-release",Intramuscular,,,,,,,,,,,,,,,,,Prescription
62792,Marketed,1999-01-27,02239323,Sandostatin Lar,1,H01CB02,Octreotide,"Powder for suspension, sustained-release",Intramuscular,02239323,SANDOSTATIN LAR (octreotide (octreotide acetate) 10 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9013470,octreotide (octreotide acetate) 10 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe,8002040,octreotide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),,,,Prescription
62793,Marketed,1999-01-27,02239324,Sandostatin Lar,1,H01CB02,Octreotide,"Powder for suspension, sustained-release",Intramuscular,02239324,SANDOSTATIN LAR (octreotide (octreotide acetate) 20 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9013474,octreotide (octreotide acetate) 20 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe,8002040,octreotide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),,,,Prescription
62794,Marketed,1999-01-27,02239325,Sandostatin Lar,1,H01CB02,Octreotide,"Powder for suspension, sustained-release",Intramuscular,02239325,SANDOSTATIN LAR (octreotide (octreotide acetate) 30 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9013475,octreotide (octreotide acetate) 30 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe,8002040,octreotide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),,,,Prescription
72996,Marketed,2004-02-26,02248639,Octreotide Acetate Omega,1,H01CB02,Octreotide,Solution,"Intravenous,Subcutaneous",02248639,OCTREOTIDE ACETATE OMEGA (octreotide (octreotide acetate) 50 mcg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013478,octreotide (octreotide acetate) 50 mcg per 1 mL solution for injection vial,8002040,octreotide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
72997,Marketed,2004-02-26,02248640,Octreotide Acetate Omega,1,H01CB02,Octreotide,Solution,"Intravenous,Subcutaneous",02248640,OCTREOTIDE ACETATE OMEGA (octreotide (octreotide acetate) 100 mcg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013472,octreotide (octreotide acetate) 100 mcg per 1 mL solution for injection vial,8002040,octreotide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
72998,Marketed,2004-02-26,02248641,Octreotide Acetate Omega,1,H01CB02,Octreotide,Solution,"Subcutaneous,Intravenous",02248641,OCTREOTIDE ACETATE OMEGA (octreotide (octreotide acetate) 500 mcg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013479,octreotide (octreotide acetate) 500 mcg per 1 mL solution for injection vial,8002040,octreotide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
72999,Marketed,2004-03-11,02248642,Octreotide Acetate Omega,1,H01CB02,Octreotide,Solution,"Intravenous,Subcutaneous",02248642,OCTREOTIDE ACETATE OMEGA (octreotide (octreotide acetate) 1000 mcg per 5 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013473,octreotide (octreotide acetate) 1000 mcg per 5 mL solution for injection vial,8002040,octreotide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
9915,Marketed,1998-04-15,00839191,Sandostatin,1,H01CB02,Octreotide,Solution,"Subcutaneous,Intravenous",00839191,SANDOSTATIN (octreotide (octreotide acetate) 50 mcg per 1 mL solution for injection ampoule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9013476,octreotide (octreotide acetate) 50 mcg per 1 mL solution for injection ampoule,8002040,octreotide,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
87257,Marketed,2012-05-30,02387018,True Match Lumi,1,D02BA02,Octyl methoxycinnamate,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
94450,Marketed,2017-01-01,02457458,Lise Watier CC  Creme FPS 25 SPF,1,D02BA02,Octyl methoxycinnamate,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
103119,Marketed,2024-02-07,02542641,Bylvay,1,A05AX05,Odevixibat,Capsule,Oral,02542641,BYLVAY (odevixibat 200 mcg oral capsule) MEDISON PHARMA CANADA INC.,Active,9015029,odevixibat 200 mcg oral capsule,8002503,odevixibat,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
103121,Marketed,2024-02-07,02542676,Bylvay,1,A05AX05,Odevixibat,Capsule,Oral,02542676,BYLVAY (odevixibat 400 mcg oral capsule) MEDISON PHARMA CANADA INC.,Active,9015030,odevixibat 400 mcg oral capsule,8002503,odevixibat,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
103122,Marketed,2024-03-06,02542684,Bylvay,1,A05AX05,Odevixibat,Capsule,Oral,02542684,BYLVAY (odevixibat 600 mcg oral capsule) MEDISON PHARMA CANADA INC.,Active,9015031,odevixibat 600 mcg oral capsule,8002503,odevixibat,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
103123,Marketed,2024-02-07,02542692,Bylvay,1,A05AX05,Odevixibat,Capsule,Oral,02542692,BYLVAY (odevixibat 1200 mcg oral capsule) MEDISON PHARMA CANADA INC.,Active,9015028,odevixibat 1200 mcg oral capsule,8002503,odevixibat,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
100057,Marketed,2021-04-08,02511355,Kesimpta,1,L04AG12,Ofatumumab,Solution,Subcutaneous,02511355,KESIMPTA (ofatumumab 20 mg per 0.4 mL solution for injection pen) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014489,ofatumumab 20 mg per 0.4 mL solution for injection pen,8001500,ofatumumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
100057,Marketed,2021-04-08,02511355,Kesimpta,1,L04AG12,Ofatumumab,Solution,Subcutaneous,02511355,KESIMPTA (ofatumumab 20 mg per 0.4 mL solution for injection pen) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014489,ofatumumab 20 mg per 0.4 mL solution for injection pen,8001500,ofatumumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Prescription
18491,Marketed,2024-05-27,02143291,Ocuflox,1,S01AE01,Ofloxacin,Solution,Ophthalmic,02143291,OCUFLOX (ofloxacin 0.3 % ophthalmic drops) ABBVIE CORPORATION,Active,9002857,ofloxacin 0.3 % ophthalmic drops,8001407,ofloxacin,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
102498,Marketed,2024-04-08,02536188,Nra-Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02536188,NRA-OLANZAPINE ODT (olanzapine 5 mg orodispersible tablet) NORA PHARMA INC,Active,9000934,olanzapine 5 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
102499,Marketed,2024-04-08,02536196,Nra-Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02536196,NRA-OLANZAPINE ODT (olanzapine 10 mg orodispersible tablet) NORA PHARMA INC,Active,9000935,olanzapine 10 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
102500,Marketed,2024-04-08,02536218,Nra-Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02536218,NRA-OLANZAPINE ODT (olanzapine 15 mg orodispersible tablet) NORA PHARMA INC,Active,9001068,olanzapine 15 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
102501,Marketed,2024-04-08,02536226,Nra-Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02536226,NRA-OLANZAPINE ODT (olanzapine 20 mg orodispersible tablet) NORA PHARMA INC,Active,9001186,olanzapine 20 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
103433,Marketed,2024-04-08,02545586,Nra-Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02545586,NRA-OLANZAPINE (olanzapine 2.5 mg oral tablet) NORA PHARMA INC,Active,9000766,olanzapine 2.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103434,Marketed,2024-04-08,02545594,Nra-Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02545594,NRA-OLANZAPINE (olanzapine 5 mg oral tablet) NORA PHARMA INC,Active,9000670,olanzapine 5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103435,Marketed,2024-04-08,02545608,Nra-Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02545608,NRA-OLANZAPINE (olanzapine 7.5 mg oral tablet) NORA PHARMA INC,Active,9000667,olanzapine 7.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103436,Marketed,2024-04-08,02545616,Nra-Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02545616,NRA-OLANZAPINE (olanzapine 10 mg oral tablet) NORA PHARMA INC,Active,9000669,olanzapine 10 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103437,Marketed,2024-04-08,02545624,Nra-Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02545624,NRA-OLANZAPINE (olanzapine 15 mg oral tablet) NORA PHARMA INC,Active,9000993,olanzapine 15 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103438,Marketed,2024-04-08,02545632,Nra-Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02545632,NRA-OLANZAPINE (olanzapine 20 mg oral tablet) NORA PHARMA INC,Active,9001199,olanzapine 20 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
43530,Marketed,2026-02-25,02229250,Zyprexa,1,N05AH03,Olanzapine,Tablet,Oral,02229250,ZYPREXA (olanzapine 2.5 mg oral tablet) CHEPLAPHARM REGISTRATION GMBH,Active,9000766,olanzapine 2.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
43531,Marketed,2026-02-25,02229269,Zyprexa,1,N05AH03,Olanzapine,Tablet,Oral,02229269,ZYPREXA (olanzapine 5 mg oral tablet) CHEPLAPHARM REGISTRATION GMBH,Active,9000670,olanzapine 5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
43532,Marketed,2025-01-30,02229277,Zyprexa,1,N05AH03,Olanzapine,Tablet,Oral,02229277,ZYPREXA (olanzapine 7.5 mg oral tablet) CHEPLAPHARM REGISTRATION GMBH,Active,9000667,olanzapine 7.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
43533,Marketed,2025-01-30,02229285,Zyprexa,1,N05AH03,Olanzapine,Tablet,Oral,02229285,ZYPREXA (olanzapine 10 mg oral tablet) CHEPLAPHARM REGISTRATION GMBH,Active,9000669,olanzapine 10 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
62290,Marketed,2025-01-30,02238850,Zyprexa,1,N05AH03,Olanzapine,Tablet,Oral,02238850,ZYPREXA (olanzapine 15 mg oral tablet) CHEPLAPHARM REGISTRATION GMBH,Active,9000993,olanzapine 15 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
62291,Marketed,2025-01-30,02238851,Zyprexa,1,N05AH03,Olanzapine,Tablet,Oral,02238851,ZYPREXA (olanzapine 20 mg oral tablet) CHEPLAPHARM REGISTRATION GMBH,Active,9001199,olanzapine 20 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
66953,Marketed,2026-03-24,02243086,Zyprexa Zydis,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02243086,ZYPREXA ZYDIS (olanzapine 5 mg orodispersible tablet) CHEPLAPHARM REGISTRATION GMBH,Active,9000934,olanzapine 5 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
66954,Marketed,2026-03-24,02243087,Zyprexa Zydis,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02243087,ZYPREXA ZYDIS (olanzapine 10 mg orodispersible tablet) CHEPLAPHARM REGISTRATION GMBH,Active,9000935,olanzapine 10 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
66955,Marketed,2025-01-30,02243088,Zyprexa Zydis,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02243088,ZYPREXA ZYDIS (olanzapine 15 mg orodispersible tablet) CHEPLAPHARM REGISTRATION GMBH,Active,9001068,olanzapine 15 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
66956,Marketed,2025-01-30,02243089,Zyprexa Zydis,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02243089,ZYPREXA ZYDIS (olanzapine 20 mg orodispersible tablet) CHEPLAPHARM REGISTRATION GMBH,Active,9001186,olanzapine 20 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
71336,Marketed,2025-12-15,02247099,Zyprexa Intramuscular,1,N05AH03,Olanzapine,Powder for solution,Intramuscular,02247099,ZYPREXA INTRAMUSCULAR (olanzapine (olanzapine tartrate) 10 mg per vial powder for solution for injection) CHEPLAPHARM REGISTRATION GMBH,Active,9001069,olanzapine (olanzapine tartrate) 10 mg per vial powder for solution for injection,8000226,olanzapine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
76239,Marketed,2010-04-30,02276712,Teva-Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02276712,TEVA-OLANZAPINE (olanzapine 2.5 mg oral tablet) TEVA CANADA LIMITED,Active,9000766,olanzapine 2.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76240,Marketed,2010-04-30,02276720,Teva-Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02276720,TEVA-OLANZAPINE (olanzapine 5 mg oral tablet) TEVA CANADA LIMITED,Active,9000670,olanzapine 5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76241,Marketed,2010-04-30,02276739,Teva-Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02276739,TEVA-OLANZAPINE (olanzapine 7.5 mg oral tablet) TEVA CANADA LIMITED,Active,9000667,olanzapine 7.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76242,Marketed,2010-04-30,02276747,Teva-Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02276747,TEVA-OLANZAPINE (olanzapine 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000669,olanzapine 10 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76243,Marketed,2010-04-30,02276755,Teva-Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02276755,TEVA-OLANZAPINE (olanzapine 15 mg oral tablet) TEVA CANADA LIMITED,Active,9000993,olanzapine 15 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76745,Marketed,2009-10-09,02281791,Apo-Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02281791,APO-OLANZAPINE (olanzapine 2.5 mg oral tablet) APOTEX INC,Active,9000766,olanzapine 2.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76746,Marketed,2009-10-09,02281805,Apo-Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02281805,APO-OLANZAPINE (olanzapine 5 mg oral tablet) APOTEX INC,Active,9000670,olanzapine 5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76747,Marketed,2009-10-09,02281813,Apo-Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02281813,APO-OLANZAPINE (olanzapine 7.5 mg oral tablet) APOTEX INC,Active,9000667,olanzapine 7.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76748,Marketed,2009-10-09,02281821,Apo-Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02281821,APO-OLANZAPINE (olanzapine 10 mg oral tablet) APOTEX INC,Active,9000669,olanzapine 10 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76749,Marketed,2009-10-09,02281848,Apo-Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02281848,APO-OLANZAPINE (olanzapine 15 mg oral tablet) APOTEX INC,Active,9000993,olanzapine 15 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78844,Marketed,2008-04-02,02303116,PMS-Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02303116,PMS-OLANZAPINE (olanzapine 2.5 mg oral tablet) PHARMASCIENCE INC,Active,9000766,olanzapine 2.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78848,Marketed,2008-04-02,02303159,PMS-Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02303159,PMS-OLANZAPINE (olanzapine 5 mg oral tablet) PHARMASCIENCE INC,Active,9000670,olanzapine 5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78849,Marketed,2008-04-02,02303167,PMS-Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02303167,PMS-OLANZAPINE (olanzapine 7.5 mg oral tablet) PHARMASCIENCE INC,Active,9000667,olanzapine 7.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78850,Marketed,2008-04-02,02303175,PMS-Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02303175,PMS-OLANZAPINE (olanzapine 10 mg oral tablet) PHARMASCIENCE INC,Active,9000669,olanzapine 10 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78851,Marketed,2008-04-02,02303183,PMS-Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02303183,PMS-OLANZAPINE (olanzapine 15 mg oral tablet) PHARMASCIENCE INC,Active,9000993,olanzapine 15 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78852,Marketed,2009-10-15,02303191,PMS-Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02303191,PMS-OLANZAPINE ODT (olanzapine 5 mg orodispersible tablet) PHARMASCIENCE INC,Active,9000934,olanzapine 5 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
78853,Marketed,2009-10-15,02303205,PMS-Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02303205,PMS-OLANZAPINE ODT (olanzapine 10 mg orodispersible tablet) PHARMASCIENCE INC,Active,9000935,olanzapine 10 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
78854,Marketed,2009-10-15,02303213,PMS-Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02303213,PMS-OLANZAPINE ODT (olanzapine 15 mg orodispersible tablet) PHARMASCIENCE INC,Active,9001068,olanzapine 15 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
79599,Marketed,2009-12-06,02310341,Sandoz Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02310341,SANDOZ OLANZAPINE (olanzapine 2.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000766,olanzapine 2.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79600,Marketed,2009-12-06,02310368,Sandoz Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02310368,SANDOZ OLANZAPINE (olanzapine 5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000670,olanzapine 5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79601,Marketed,2009-12-06,02310376,Sandoz Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02310376,SANDOZ OLANZAPINE (olanzapine 7.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000667,olanzapine 7.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79602,Marketed,2009-12-06,02310384,Sandoz Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02310384,SANDOZ OLANZAPINE (olanzapine 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000669,olanzapine 10 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79603,Marketed,2009-12-06,02310392,Sandoz Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02310392,SANDOZ OLANZAPINE (olanzapine 15 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000993,olanzapine 15 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79749,Marketed,2019-01-31,02311968,Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02311968,OLANZAPINE (olanzapine 2.5 mg oral tablet) PRO DOC LIMITEE,Active,9000766,olanzapine 2.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79750,Marketed,2019-03-20,02311976,Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02311976,OLANZAPINE (olanzapine 5 mg oral tablet) PRO DOC LIMITEE,Active,9000670,olanzapine 5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79751,Marketed,2019-01-31,02311984,Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02311984,OLANZAPINE (olanzapine 7.5 mg oral tablet) PRO DOC LIMITEE,Active,9000667,olanzapine 7.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79752,Marketed,2019-02-13,02311992,Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02311992,OLANZAPINE (olanzapine 10 mg oral tablet) PRO DOC LIMITEE,Active,9000669,olanzapine 10 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79753,Marketed,2018-12-11,02312018,Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02312018,OLANZAPINE (olanzapine 15 mg oral tablet) PRO DOC LIMITEE,Active,9000993,olanzapine 15 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81318,Marketed,2010-02-26,02327775,Sandoz Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02327775,SANDOZ OLANZAPINE ODT (olanzapine 5 mg orodispersible tablet) SANDOZ CANADA INCORPORATED,Active,9000934,olanzapine 5 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
81319,Marketed,2010-02-26,02327783,Sandoz Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02327783,SANDOZ OLANZAPINE ODT (olanzapine 10 mg orodispersible tablet) SANDOZ CANADA INCORPORATED,Active,9000935,olanzapine 10 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
81320,Marketed,2010-02-26,02327791,Sandoz Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02327791,SANDOZ OLANZAPINE ODT (olanzapine 15 mg orodispersible tablet) SANDOZ CANADA INCORPORATED,Active,9001068,olanzapine 15 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
81321,Marketed,2010-02-26,02327805,Sandoz Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02327805,SANDOZ OLANZAPINE ODT (olanzapine 20 mg orodispersible tablet) SANDOZ CANADA INCORPORATED,Active,9001186,olanzapine 20 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
81866,Marketed,2009-10-09,02333015,Apo-Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02333015,APO-OLANZAPINE (olanzapine 20 mg oral tablet) APOTEX INC,Active,9001199,olanzapine 20 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82431,Marketed,2018-12-11,02338645,Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02338645,OLANZAPINE ODT (olanzapine 5 mg orodispersible tablet) PRO DOC LIMITEE,Active,9000934,olanzapine 5 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
82432,Marketed,2018-12-14,02338653,Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02338653,OLANZAPINE ODT (olanzapine 10 mg orodispersible tablet) PRO DOC LIMITEE,Active,9000935,olanzapine 10 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
82433,Marketed,2018-12-11,02338661,Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02338661,OLANZAPINE ODT (olanzapine 15 mg orodispersible tablet) PRO DOC LIMITEE,Active,9001068,olanzapine 15 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
82910,Marketed,2018-06-08,02343665,Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02343665,OLANZAPINE ODT (olanzapine 5 mg orodispersible tablet) SIVEM PHARMACEUTICALS ULC,Active,9000934,olanzapine 5 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
82911,Marketed,2018-06-08,02343673,Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02343673,OLANZAPINE ODT (olanzapine 10 mg orodispersible tablet) SIVEM PHARMACEUTICALS ULC,Active,9000935,olanzapine 10 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
82912,Marketed,2018-06-08,02343681,Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02343681,OLANZAPINE ODT (olanzapine 15 mg orodispersible tablet) SIVEM PHARMACEUTICALS ULC,Active,9001068,olanzapine 15 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
82913,Marketed,2018-06-08,02343703,Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02343703,OLANZAPINE ODT (olanzapine 20 mg orodispersible tablet) SIVEM PHARMACEUTICALS ULC,Active,9001186,olanzapine 20 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
83820,Marketed,2022-03-25,02352974,Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02352974,OLANZAPINE ODT (olanzapine 5 mg orodispersible tablet) SANIS HEALTH INC,Active,9000934,olanzapine 5 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
83821,Marketed,2022-03-25,02352982,Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02352982,OLANZAPINE ODT (olanzapine 10 mg orodispersible tablet) SANIS HEALTH INC,Active,9000935,olanzapine 10 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
83822,Marketed,2022-03-25,02352990,Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02352990,OLANZAPINE ODT (olanzapine 15 mg orodispersible tablet) SANIS HEALTH INC,Active,9001068,olanzapine 15 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
84470,Marketed,2011-04-28,02359707,Teva-Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02359707,TEVA-OLANZAPINE (olanzapine 20 mg oral tablet) TEVA CANADA LIMITED,Active,9001199,olanzapine 20 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84558,Marketed,2011-11-16,02360616,Apo-Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02360616,APO-OLANZAPINE ODT (olanzapine 5 mg orodispersible tablet) APOTEX INC,Active,9000934,olanzapine 5 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
84559,Marketed,2011-08-08,02360624,Apo-Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02360624,APO-OLANZAPINE ODT (olanzapine 10 mg orodispersible tablet) APOTEX INC,Active,9000935,olanzapine 10 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
84560,Marketed,2011-08-08,02360632,Apo-Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02360632,APO-OLANZAPINE ODT (olanzapine 15 mg orodispersible tablet) APOTEX INC,Active,9001068,olanzapine 15 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
84561,Marketed,2011-08-08,02360640,Apo-Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02360640,APO-OLANZAPINE ODT (olanzapine 20 mg orodispersible tablet) APOTEX INC,Active,9001186,olanzapine 20 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
85790,Marketed,2015-10-28,02372819,Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02372819,OLANZAPINE (olanzapine 2.5 mg oral tablet) SANIS HEALTH INC,Active,9000766,olanzapine 2.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85791,Marketed,2015-10-28,02372827,Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02372827,OLANZAPINE (olanzapine 5 mg oral tablet) SANIS HEALTH INC,Active,9000670,olanzapine 5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85792,Marketed,2015-10-28,02372835,Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02372835,OLANZAPINE (olanzapine 7.5 mg oral tablet) SANIS HEALTH INC,Active,9000667,olanzapine 7.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85793,Marketed,2015-10-28,02372843,Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02372843,OLANZAPINE (olanzapine 10 mg oral tablet) SANIS HEALTH INC,Active,9000669,olanzapine 10 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85794,Marketed,2015-10-28,02372851,Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02372851,OLANZAPINE (olanzapine 15 mg oral tablet) SANIS HEALTH INC,Active,9000993,olanzapine 15 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87147,Marketed,2012-06-12,02385864,Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02385864,OLANZAPINE (olanzapine 2.5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000766,olanzapine 2.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87148,Marketed,2012-06-12,02385872,Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02385872,OLANZAPINE (olanzapine 5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000670,olanzapine 5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87149,Marketed,2012-06-12,02385880,Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02385880,OLANZAPINE (olanzapine 7.5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000667,olanzapine 7.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87150,Marketed,2012-06-12,02385899,Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02385899,OLANZAPINE (olanzapine 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000669,olanzapine 10 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87151,Marketed,2012-06-12,02385902,Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02385902,OLANZAPINE (olanzapine 15 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000993,olanzapine 15 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87152,Marketed,2023-07-06,02385910,Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02385910,OLANZAPINE (olanzapine 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001199,olanzapine 20 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89131,Marketed,2026-03-10,02406624,JAMP Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02406624,JAMP OLANZAPINE ODT (olanzapine 5 mg orodispersible tablet) JAMP PHARMA CORPORATION,Active,9000934,olanzapine 5 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
89132,Marketed,2026-03-10,02406632,JAMP Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02406632,JAMP OLANZAPINE ODT (olanzapine 10 mg orodispersible tablet) JAMP PHARMA CORPORATION,Active,9000935,olanzapine 10 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
89133,Marketed,2026-03-10,02406640,JAMP Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02406640,JAMP OLANZAPINE ODT (olanzapine 15 mg orodispersible tablet) JAMP PHARMA CORPORATION,Active,9001068,olanzapine 15 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
89134,Marketed,2026-03-10,02406659,JAMP Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02406659,JAMP OLANZAPINE ODT (olanzapine 20 mg orodispersible tablet) JAMP PHARMA CORPORATION,Active,9001186,olanzapine 20 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
89481,Marketed,2019-09-18,02410141,Mint-Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02410141,MINT-OLANZAPINE (olanzapine 2.5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000766,olanzapine 2.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89482,Marketed,2019-09-18,02410168,Mint-Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02410168,MINT-OLANZAPINE (olanzapine 5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000670,olanzapine 5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89483,Marketed,2019-09-18,02410176,Mint-Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02410176,MINT-OLANZAPINE (olanzapine 7.5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000667,olanzapine 7.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89484,Marketed,2019-09-18,02410184,Mint-Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02410184,MINT-OLANZAPINE (olanzapine 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000669,olanzapine 10 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89485,Marketed,2019-09-18,02410192,Mint-Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02410192,MINT-OLANZAPINE (olanzapine 15 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000993,olanzapine 15 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90188,Marketed,2015-06-05,02417243,JAMP Olanzapine Film-coated,1,N05AH03,Olanzapine,Tablet,Oral,02417243,JAMP OLANZAPINE FC (olanzapine 2.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000766,olanzapine 2.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90189,Marketed,2015-06-05,02417251,JAMP Olanzapine Film-coated,1,N05AH03,Olanzapine,Tablet,Oral,02417251,JAMP OLANZAPINE FC (olanzapine 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000670,olanzapine 5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90190,Marketed,2015-06-05,02417278,JAMP Olanzapine Film-coated,1,N05AH03,Olanzapine,Tablet,Oral,02417278,JAMP OLANZAPINE FC (olanzapine 7.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000667,olanzapine 7.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90191,Marketed,2015-06-05,02417286,JAMP Olanzapine Film-coated,1,N05AH03,Olanzapine,Tablet,Oral,02417286,JAMP OLANZAPINE FC (olanzapine 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000669,olanzapine 10 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90192,Marketed,2015-06-05,02417294,JAMP Olanzapine Film-coated,1,N05AH03,Olanzapine,Tablet,Oral,02417294,JAMP OLANZAPINE FC (olanzapine 15 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000993,olanzapine 15 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90193,Marketed,2015-06-05,02417308,JAMP Olanzapine Film-coated,1,N05AH03,Olanzapine,Tablet,Oral,02417308,JAMP OLANZAPINE FC (olanzapine 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001199,olanzapine 20 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90636,Marketed,2019-06-28,02421704,Olanzapine,1,N05AH03,Olanzapine,Tablet,Oral,02421704,OLANZAPINE (olanzapine 20 mg oral tablet) PRO DOC LIMITEE,Active,9001199,olanzapine 20 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90977,Marketed,2026-04-15,02425114,Pro-Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02425114,PRO-OLANZAPINE ODT (olanzapine 20 mg orodispersible tablet) PRO DOC LIMITEE,Active,9001186,olanzapine 20 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
92128,Marketed,2015-03-18,02436965,Mint-Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02436965,MINT-OLANZAPINE ODT (olanzapine 5 mg orodispersible tablet) MINT PHARMACEUTICALS INC,Active,9000934,olanzapine 5 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
92129,Marketed,2015-03-18,02436973,Mint-Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02436973,MINT-OLANZAPINE ODT (olanzapine 10 mg orodispersible tablet) MINT PHARMACEUTICALS INC,Active,9000935,olanzapine 10 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
92130,Marketed,2015-03-18,02436981,Mint-Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02436981,MINT-OLANZAPINE ODT (olanzapine 15 mg orodispersible tablet) MINT PHARMACEUTICALS INC,Active,9001068,olanzapine 15 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
93444,Marketed,2015-12-01,02448726,Auro-Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02448726,AURO-OLANZAPINE ODT (olanzapine 5 mg orodispersible tablet) AURO PHARMA INC,Active,9000934,olanzapine 5 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
93445,Marketed,2015-12-01,02448734,Auro-Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02448734,AURO-OLANZAPINE ODT (olanzapine 10 mg orodispersible tablet) AURO PHARMA INC,Active,9000935,olanzapine 10 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
93446,Marketed,2015-12-01,02448742,Auro-Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02448742,AURO-OLANZAPINE ODT (olanzapine 15 mg orodispersible tablet) AURO PHARMA INC,Active,9001068,olanzapine 15 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
93447,Marketed,2015-12-01,02448750,Auro-Olanzapine ODT,1,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02448750,AURO-OLANZAPINE ODT (olanzapine 20 mg orodispersible tablet) AURO PHARMA INC,Active,9001186,olanzapine 20 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
96554,Marketed,2018-05-23,02475200,Lynparza,1,L01XK01,Olaparib,Tablet,Oral,02475200,LYNPARZA (olaparib 100 mg oral tablet) ASTRAZENECA CANADA INC,Active,9013480,olaparib 100 mg oral tablet,8002041,olaparib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
96555,Marketed,2018-05-23,02475219,Lynparza,1,L01XK01,Olaparib,Tablet,Oral,02475219,LYNPARZA (olaparib 150 mg oral tablet) ASTRAZENECA CANADA INC,Active,9013481,olaparib 150 mg oral tablet,8002041,olaparib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
103447,Marketed,2024-10-18,02545721,Xenpozyme,1,A16AB25,Olipudase alfa,Powder for solution,Intravenous,02545721,XENPOZYME (olipudase alfa 20 mg per vial powder for solution for injection) SANOFI-AVENTIS CANADA INC,Active,9015124,olipudase alfa 20 mg per vial powder for solution for injection,8002521,olipudase alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
103447,Marketed,2024-10-18,02545721,Xenpozyme,1,A16AB25,Olipudase alfa,Powder for solution,Intravenous,02545721,XENPOZYME (olipudase alfa 20 mg per vial powder for solution for injection) SANOFI-AVENTIS CANADA INC,Active,9015124,olipudase alfa 20 mg per vial powder for solution for injection,8002521,olipudase alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
80414,Marketed,2023-08-03,02318660,Olmetec,1,C09CA08,Olmesartan medoxomil,Tablet,Oral,02318660,OLMETEC (olmesartan medoxomil 20 mg oral tablet) ORGANON CANADA INC.,Active,9001265,olmesartan medoxomil 20 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80415,Marketed,2023-04-13,02318679,Olmetec,1,C09CA08,Olmesartan medoxomil,Tablet,Oral,02318679,OLMETEC (olmesartan medoxomil 40 mg oral tablet) ORGANON CANADA INC.,Active,9001266,olmesartan medoxomil 40 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92655,Marketed,2023-03-10,02442191,Teva-Olmesartan,1,C09CA08,Olmesartan medoxomil,Tablet,Oral,02442191,TEVA-OLMESARTAN (olmesartan medoxomil 20 mg oral tablet) TEVA CANADA LIMITED,Active,9001265,olmesartan medoxomil 20 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92656,Marketed,2023-03-10,02442205,Teva-Olmesartan,1,C09CA08,Olmesartan medoxomil,Tablet,Oral,02442205,TEVA-OLMESARTAN (olmesartan medoxomil 40 mg oral tablet) TEVA CANADA LIMITED,Active,9001266,olmesartan medoxomil 40 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92810,Marketed,2017-05-01,02443414,Sandoz Olmesartan,1,C09CA08,Olmesartan medoxomil,Tablet,Oral,02443414,SANDOZ OLMESARTAN (olmesartan medoxomil 20 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001265,olmesartan medoxomil 20 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92811,Marketed,2017-05-01,02443422,Sandoz Olmesartan,1,C09CA08,Olmesartan medoxomil,Tablet,Oral,02443422,SANDOZ OLMESARTAN (olmesartan medoxomil 40 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001266,olmesartan medoxomil 40 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92863,Marketed,2017-05-01,02443864,Auro-Olmesartan,1,C09CA08,Olmesartan medoxomil,Tablet,Oral,02443864,AURO-OLMESARTAN (olmesartan medoxomil 20 mg oral tablet) AURO PHARMA INC,Active,9001265,olmesartan medoxomil 20 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92864,Marketed,2017-05-01,02443872,Auro-Olmesartan,1,C09CA08,Olmesartan medoxomil,Tablet,Oral,02443872,AURO-OLMESARTAN (olmesartan medoxomil 40 mg oral tablet) AURO PHARMA INC,Active,9001266,olmesartan medoxomil 40 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94319,Marketed,2020-05-06,02456311,ACH-Olmesartan,1,C09CA08,Olmesartan medoxomil,Tablet,Oral,02456311,ACH-OLMESARTAN (olmesartan medoxomil 20 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001265,olmesartan medoxomil 20 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94320,Marketed,2020-05-06,02456338,ACH-Olmesartan,1,C09CA08,Olmesartan medoxomil,Tablet,Oral,02456338,ACH-OLMESARTAN (olmesartan medoxomil 40 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001266,olmesartan medoxomil 40 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94881,Marketed,2017-06-02,02461307,PMS-Olmesartan,1,C09CA08,Olmesartan medoxomil,Tablet,Oral,02461307,PMS-OLMESARTAN (olmesartan medoxomil 20 mg oral tablet) PHARMASCIENCE INC,Active,9001265,olmesartan medoxomil 20 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94882,Marketed,2017-06-02,02461315,PMS-Olmesartan,1,C09CA08,Olmesartan medoxomil,Tablet,Oral,02461315,PMS-OLMESARTAN (olmesartan medoxomil 40 mg oral tablet) PHARMASCIENCE INC,Active,9001266,olmesartan medoxomil 40 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94931,Marketed,2021-10-28,02461641,JAMP Olmesartan,1,C09CA08,Olmesartan medoxomil,Tablet,Oral,02461641,JAMP OLMESARTAN (olmesartan medoxomil 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001265,olmesartan medoxomil 20 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94932,Marketed,2021-10-28,02461668,JAMP Olmesartan,1,C09CA08,Olmesartan medoxomil,Tablet,Oral,02461668,JAMP OLMESARTAN (olmesartan medoxomil 40 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001266,olmesartan medoxomil 40 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95870,Marketed,2019-03-05,02469812,GLN-Olmesartan,1,C09CA08,Olmesartan medoxomil,Tablet,Oral,02469812,GLN-OLMESARTAN (olmesartan medoxomil 20 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9001265,olmesartan medoxomil 20 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95871,Marketed,2019-03-05,02469820,GLN-Olmesartan,1,C09CA08,Olmesartan medoxomil,Tablet,Oral,02469820,GLN-OLMESARTAN (olmesartan medoxomil 40 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9001266,olmesartan medoxomil 40 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97140,Marketed,2020-02-21,02481057,Olmesartan,1,C09CA08,Olmesartan medoxomil,Tablet,Oral,02481057,OLMESARTAN (olmesartan medoxomil 20 mg oral tablet) SANIS HEALTH INC,Active,9001265,olmesartan medoxomil 20 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97141,Marketed,2020-02-21,02481065,Olmesartan,1,C09CA08,Olmesartan medoxomil,Tablet,Oral,02481065,OLMESARTAN (olmesartan medoxomil 40 mg oral tablet) SANIS HEALTH INC,Active,9001266,olmesartan medoxomil 40 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97883,Marketed,2019-07-09,02488744,Olmesartan,1,C09CA08,Olmesartan medoxomil,Tablet,Oral,02488744,OLMESARTAN (olmesartan medoxomil 20 mg oral tablet) PRO DOC LIMITEE,Active,9001265,olmesartan medoxomil 20 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97884,Marketed,2019-07-09,02488752,Olmesartan,1,C09CA08,Olmesartan medoxomil,Tablet,Oral,02488752,OLMESARTAN (olmesartan medoxomil 40 mg oral tablet) PRO DOC LIMITEE,Active,9001266,olmesartan medoxomil 40 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98899,Marketed,2020-11-04,02499258,Nra-Olmesartan,1,C09CA08,Olmesartan medoxomil,Tablet,Oral,02499258,NRA-OLMESARTAN (olmesartan medoxomil 20 mg oral tablet) NORA PHARMA INC,Active,9001265,olmesartan medoxomil 20 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98900,Marketed,2020-11-04,02499266,Nra-Olmesartan,1,C09CA08,Olmesartan medoxomil,Tablet,Oral,02499266,NRA-OLMESARTAN (olmesartan medoxomil 40 mg oral tablet) NORA PHARMA INC,Active,9001266,olmesartan medoxomil 40 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80508,Marketed,2022-10-31,02319616,Olmetec Plus,2,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02319616,OLMETEC PLUS (hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet) ORGANON CANADA INC.,Active,9001262,hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80509,Marketed,2023-01-03,02319624,Olmetec Plus,2,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02319624,OLMETEC PLUS (hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet) ORGANON CANADA INC.,Active,9001263,hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80510,Marketed,2022-12-16,02319632,Olmetec Plus,2,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02319632,OLMETEC PLUS (hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet) ORGANON CANADA INC.,Active,9001264,hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92768,Marketed,2023-12-01,02443112,Teva-Olmesartan / HCTZ,2,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02443112,TEVA-OLMESARTAN / HCTZ (hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet) TEVA CANADA LIMITED,Active,9001262,hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92771,Marketed,2023-12-01,02443120,Teva-Olmesartan / HCTZ,2,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02443120,TEVA-OLMESARTAN / HCTZ (hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet) TEVA CANADA LIMITED,Active,9001263,hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92772,Marketed,2023-12-01,02443139,Teva-Olmesartan / HCTZ,2,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02443139,TEVA-OLMESARTAN / HCTZ (hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet) TEVA CANADA LIMITED,Active,9001264,hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95759,Marketed,2019-06-27,02468948,ACH-Olmesartan HCTZ,2,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02468948,ACH-OLMESARTAN HCTZ (hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001262,hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95760,Marketed,2019-06-27,02468956,ACH-Olmesartan HCTZ,2,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02468956,ACH-OLMESARTAN HCTZ (hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001263,hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95761,Marketed,2019-06-27,02468964,ACH-Olmesartan HCTZ,2,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02468964,ACH-OLMESARTAN HCTZ (hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001264,hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96608,Marketed,2020-02-28,02475707,GLN-Olmesartan HCTZ,2,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02475707,GLN-OLMESARTAN HCTZ (hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9001262,hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96609,Marketed,2020-02-28,02475715,GLN-Olmesartan HCTZ,2,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02475715,GLN-OLMESARTAN HCTZ (hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9001263,hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96610,Marketed,2020-02-28,02475723,GLN-Olmesartan HCTZ,2,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02475723,GLN-OLMESARTAN HCTZ (hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9001264,hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96741,Marketed,2019-01-29,02476487,Auro-Olmesartan HCTZ,2,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02476487,AURO-OLMESARTAN HCTZ (hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet) AURO PHARMA INC,Active,9001262,hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96742,Marketed,2019-01-29,02476495,Auro-Olmesartan HCTZ,2,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02476495,AURO-OLMESARTAN HCTZ (hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet) AURO PHARMA INC,Active,9001263,hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96743,Marketed,2019-01-29,02476509,Auro-Olmesartan HCTZ,2,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02476509,AURO-OLMESARTAN HCTZ (hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet) AURO PHARMA INC,Active,9001264,hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99766,Marketed,2021-07-20,02508273,Nra-Olmesartan HCTZ,2,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02508273,NRA-OLMESARTAN HCTZ (hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet) NORA PHARMA INC,Active,9001262,hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99767,Marketed,2021-07-20,02508281,Nra-Olmesartan HCTZ,2,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02508281,NRA-OLMESARTAN HCTZ (hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet) NORA PHARMA INC,Active,9001263,hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99768,Marketed,2021-07-20,02508303,Nra-Olmesartan HCTZ,2,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02508303,NRA-OLMESARTAN HCTZ (hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet) NORA PHARMA INC,Active,9001264,hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99889,Marketed,2026-04-07,02509601,Olmesartan/HCTZ,2,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02509601,OLMESARTAN/HCTZ (hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet) SANIS HEALTH INC,Active,9001262,hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99890,Marketed,2026-04-13,02509628,Olmesartan/HCTZ,2,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02509628,OLMESARTAN/HCTZ (hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet) SANIS HEALTH INC,Active,9001264,hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99891,Marketed,2026-04-13,02509636,Olmesartan/HCTZ,2,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02509636,OLMESARTAN/HCTZ (hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet) SANIS HEALTH INC,Active,9001263,hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92626,Marketed,2015-05-29,02441888,Inspiolto Respimat,2,R03AL06,Olodaterol and tiotropium bromide,Solution,Inhalation,02441888,INSPIOLTO RESPIMAT (olodaterol (olodaterol hydrochloride) 2.5 mcg per actuation and tiotropium (tiotropium bromide monohydrate) 2.5 mcg per actuation inhalation solution) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9005723,olodaterol (olodaterol hydrochloride) 2.5 mcg per actuation and tiotropium (tiotropium bromide) 2.5 mcg per actuation inhalation solution,8001085,olodaterol and tiotropium,447694001,Inhalation,420641004,Solution for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
101039,Marketed,2022-07-13,02521172,Olopatadine,1,S01GX09,Olopatadine,Solution,Ophthalmic,02521172,OLOPATADINE (olopatadine (olopatadine hydrochloride) 0.1 % ophthalmic drops) SANIS HEALTH INC,Active,9000778,olopatadine (olopatadine hydrochloride) 0.1 % ophthalmic drops,8000251,olopatadine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
103030,Marketed,2024-04-08,02541653,Olopatadine 0.2%,1,S01GX09,Olopatadine,Solution,Ophthalmic,02541653,OLOPATADINE 0.2% (olopatadine (olopatadine hydrochloride) 0.2 % ophthalmic drops) SANIS HEALTH INC,Active,9001342,olopatadine (olopatadine hydrochloride) 0.2 % ophthalmic drops,8000251,olopatadine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
53275,Marketed,2018-06-13,02233143,Patanol,1,S01GX09,Olopatadine,Solution,Ophthalmic,02233143,PATANOL (olopatadine (olopatadine hydrochloride) 0.1 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9000778,olopatadine (olopatadine hydrochloride) 0.1 % ophthalmic drops,8000251,olopatadine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
84395,Marketed,2013-02-04,02358913,Sandoz Olopatadine,1,S01GX09,Olopatadine,Solution,Ophthalmic,02358913,SANDOZ OLOPATADINE (olopatadine (olopatadine hydrochloride) 0.1 % ophthalmic drops) SANDOZ CANADA INCORPORATED,Active,9000778,olopatadine (olopatadine hydrochloride) 0.1 % ophthalmic drops,8000251,olopatadine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
84721,Marketed,2018-05-09,02362171,Pataday,1,S01GX09,Olopatadine,Solution,Ophthalmic,02362171,PATADAY (olopatadine (olopatadine hydrochloride) 0.2 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9001342,olopatadine (olopatadine hydrochloride) 0.2 % ophthalmic drops,8000251,olopatadine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
90478,Marketed,2014-02-24,02420171,Sandoz Olopatadine 0.2%,1,S01GX09,Olopatadine,Solution,Ophthalmic,02420171,SANDOZ OLOPATADINE 0.2% (olopatadine (olopatadine hydrochloride) 0.2 % ophthalmic drops) SANDOZ CANADA INCORPORATED,Active,9001342,olopatadine (olopatadine hydrochloride) 0.2 % ophthalmic drops,8000251,olopatadine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
90739,Marketed,2014-07-29,02422727,Mint-Olopatadine,1,S01GX09,Olopatadine,Solution,Ophthalmic,02422727,MINT-OLOPATADINE (olopatadine (olopatadine hydrochloride) 0.1 % ophthalmic drops) MINT PHARMACEUTICALS INC,Active,9000778,olopatadine (olopatadine hydrochloride) 0.1 % ophthalmic drops,8000251,olopatadine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
94571,Marketed,2018-03-12,02458551,Pazeo,1,S01GX09,Olopatadine,Solution,Ophthalmic,02458551,PAZEO (olopatadine (olopatadine hydrochloride) 0.7 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012587,olopatadine (olopatadine hydrochloride) 0.7 % ophthalmic drops,8000251,olopatadine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
99796,Marketed,2021-12-17,02508605,Mint-Olopatadine 0.2%,1,S01GX09,Olopatadine,Solution,Ophthalmic,02508605,MINT-OLOPATADINE 0.2% (olopatadine (olopatadine hydrochloride) 0.2 % ophthalmic drops) MINT PHARMACEUTICALS INC,Active,9001342,olopatadine (olopatadine hydrochloride) 0.2 % ophthalmic drops,8000251,olopatadine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
17893,Marketed,2025-04-08,02063808,Dipentum,1,A07EC03,Olsalazine,Capsule,Oral,02063808,DIPENTUM (olsalazine sodium 250 mg oral capsule) SEARCHLIGHT PHARMA INC,Active,9002858,olsalazine sodium 250 mg oral capsule,8001408,olsalazine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
103392,Marketed,2024-09-25,02545136,Xolair,1,R03DX05,Omalizumab,Solution,Subcutaneous,02545136,XOLAIR (omalizumab 75 mg per 0.5 mL solution for injection pen) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9015102,omalizumab 75 mg per 0.5 mL solution for injection pen,8001060,omalizumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
103392,Marketed,2024-09-25,02545136,Xolair,1,R03DX05,Omalizumab,Solution,Subcutaneous,02545136,XOLAIR (omalizumab 75 mg per 0.5 mL solution for injection pen) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9015102,omalizumab 75 mg per 0.5 mL solution for injection pen,8001060,omalizumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Prescription
103393,Marketed,2024-09-25,02545144,Xolair,1,R03DX05,Omalizumab,Solution,Subcutaneous,02545144,XOLAIR (omalizumab 150 mg per 1 mL solution for injection pen) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9015101,omalizumab 150 mg per 1 mL solution for injection pen,8001060,omalizumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
103393,Marketed,2024-09-25,02545144,Xolair,1,R03DX05,Omalizumab,Solution,Subcutaneous,02545144,XOLAIR (omalizumab 150 mg per 1 mL solution for injection pen) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9015101,omalizumab 150 mg per 1 mL solution for injection pen,8001060,omalizumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Prescription
103395,Marketed,2025-10-15,02545160,Xolair,1,R03DX05,Omalizumab,Solution,Subcutaneous,02545160,XOLAIR (omalizumab 300 mg per 2 mL solution for injection syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9015268,omalizumab 300 mg per 2 mL solution for injection syringe,8001060,omalizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe,,,,Schedule D
103395,Marketed,2025-10-15,02545160,Xolair,1,R03DX05,Omalizumab,Solution,Subcutaneous,02545160,XOLAIR (omalizumab 300 mg per 2 mL solution for injection syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9015268,omalizumab 300 mg per 2 mL solution for injection syringe,8001060,omalizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe,,,,Prescription
104271,Marketed,2025-03-04,02553805,Omlyclo,1,R03DX05,Omalizumab,Solution,Subcutaneous,02553805,OMLYCLO (omalizumab 75 mg per 0.5 mL solution for injection syringe) CELLTRION INC.,Active,9012530,omalizumab 75 mg per 0.5 mL solution for injection syringe,8001060,omalizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
104271,Marketed,2025-03-04,02553805,Omlyclo,1,R03DX05,Omalizumab,Solution,Subcutaneous,02553805,OMLYCLO (omalizumab 75 mg per 0.5 mL solution for injection syringe) CELLTRION INC.,Active,9012530,omalizumab 75 mg per 0.5 mL solution for injection syringe,8001060,omalizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
104272,Marketed,2025-03-04,02553813,Omlyclo,1,R03DX05,Omalizumab,Solution,Subcutaneous,02553813,OMLYCLO (omalizumab 150 mg per 1 mL solution for injection syringe) CELLTRION INC.,Active,9012588,omalizumab 150 mg per 1 mL solution for injection syringe,8001060,omalizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
104272,Marketed,2025-03-04,02553813,Omlyclo,1,R03DX05,Omalizumab,Solution,Subcutaneous,02553813,OMLYCLO (omalizumab 150 mg per 1 mL solution for injection syringe) CELLTRION INC.,Active,9012588,omalizumab 150 mg per 1 mL solution for injection syringe,8001060,omalizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
74602,Marketed,2005-02-03,02260565,Xolair,1,R03DX05,Omalizumab,Powder for solution,Subcutaneous,02260565,XOLAIR (omalizumab 150 mg per vial powder for solution for injection) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9004010,omalizumab 150 mg per vial powder for solution for injection,8001060,omalizumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
74602,Marketed,2005-02-03,02260565,Xolair,1,R03DX05,Omalizumab,Powder for solution,Subcutaneous,02260565,XOLAIR (omalizumab 150 mg per vial powder for solution for injection) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9004010,omalizumab 150 mg per vial powder for solution for injection,8001060,omalizumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
94711,Marketed,2017-06-28,02459787,Xolair,1,R03DX05,Omalizumab,Solution,Subcutaneous,02459787,XOLAIR (omalizumab 75 mg per 0.5 mL solution for injection syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012530,omalizumab 75 mg per 0.5 mL solution for injection syringe,8001060,omalizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
94711,Marketed,2017-06-28,02459787,Xolair,1,R03DX05,Omalizumab,Solution,Subcutaneous,02459787,XOLAIR (omalizumab 75 mg per 0.5 mL solution for injection syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012530,omalizumab 75 mg per 0.5 mL solution for injection syringe,8001060,omalizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
94712,Marketed,2017-07-06,02459795,Xolair,1,R03DX05,Omalizumab,Solution,Subcutaneous,02459795,XOLAIR (omalizumab 150 mg per 1 mL solution for injection syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012588,omalizumab 150 mg per 1 mL solution for injection syringe,8001060,omalizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
94712,Marketed,2017-07-06,02459795,Xolair,1,R03DX05,Omalizumab,Solution,Subcutaneous,02459795,XOLAIR (omalizumab 150 mg per 1 mL solution for injection syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012588,omalizumab 150 mg per 1 mL solution for injection syringe,8001060,omalizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
98517,Marketed,2020-02-07,02495244,Vascepa,1,C10AX06,Omega-3-triglycerides incl. other esters and acids,Capsule,Oral,02495244,VASCEPA (icosapent ethyl 1 g oral capsule) HLS THERAPEUTICS INC,Active,9014244,icosapent ethyl 1 g oral capsule,8002318,icosapent,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
66187,Marketed,2021-06-16,02242462,Losec Mups,1,A02BC01,Omeprazole,Tablet (delayed-release),Oral,02242462,LOSEC MUPS (omeprazole (omeprazole magnesium) 20 mg gastro-resistant tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9000691,omeprazole (omeprazole magnesium) 20 mg gastro-resistant tablet,8000131,omeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
69062,Marketed,2004-01-28,02245058,Apo-Omeprazole,1,A02BC01,Omeprazole,Capsule (delayed release),Oral,02245058,APO-OMEPRAZOLE (omeprazole 20 mg gastro-resistant capsule) APOTEX INC,Active,9000336,omeprazole 20 mg gastro-resistant capsule,8000131,omeprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
78071,Marketed,2013-11-14,02295407,Teva-Omeprazole,1,A02BC01,Omeprazole,Tablet (delayed-release),Oral,02295407,TEVA-OMEPRAZOLE (omeprazole (omeprazole magnesium) 10 mg gastro-resistant tablet) TEVA CANADA LIMITED,Active,9000724,omeprazole (omeprazole magnesium) 10 mg gastro-resistant tablet,8000131,omeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78072,Marketed,2013-07-04,02295415,Teva-Omeprazole,1,A02BC01,Omeprazole,Tablet (delayed-release),Oral,02295415,TEVA-OMEPRAZOLE (omeprazole (omeprazole magnesium) 20 mg gastro-resistant tablet) TEVA CANADA LIMITED,Active,9000691,omeprazole (omeprazole magnesium) 20 mg gastro-resistant tablet,8000131,omeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78176,Marketed,2007-09-14,02296446,Sandoz Omeprazole,1,A02BC01,Omeprazole,Capsule (delayed release),Oral,02296446,SANDOZ OMEPRAZOLE (omeprazole 20 mg gastro-resistant capsule) SANDOZ CANADA INCORPORATED,Active,9000336,omeprazole 20 mg gastro-resistant capsule,8000131,omeprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
82550,Marketed,2010-02-05,02339927,Omeprazole,1,A02BC01,Omeprazole,Capsule (delayed release),Oral,02339927,OMEPRAZOLE (omeprazole 20 mg gastro-resistant capsule) PRO DOC LIMITEE,Active,9000336,omeprazole 20 mg gastro-resistant capsule,8000131,omeprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
83404,Marketed,2016-12-22,02348691,Omeprazole,1,A02BC01,Omeprazole,Capsule (delayed release),Oral,02348691,OMEPRAZOLE (omeprazole 20 mg gastro-resistant capsule) SANIS HEALTH INC,Active,9000336,omeprazole 20 mg gastro-resistant capsule,8000131,omeprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88725,Marketed,2015-08-12,02402416,Riva-Omeprazole Dr,1,A02BC01,Omeprazole,Tablet (delayed-release),Oral,02402416,RIVA-OMEPRAZOLE DR (omeprazole (omeprazole magnesium) 20 mg gastro-resistant tablet) LABORATOIRE RIVA INC.,Active,9000691,omeprazole (omeprazole magnesium) 20 mg gastro-resistant tablet,8000131,omeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89644,Marketed,2013-10-23,02411857,Omeprazole-20,1,A02BC01,Omeprazole,Capsule (delayed release),Oral,02411857,OMEPRAZOLE-20 (omeprazole 20 mg gastro-resistant capsule) SIVEM PHARMACEUTICALS ULC,Active,9000336,omeprazole 20 mg gastro-resistant capsule,8000131,omeprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90114,Marketed,2024-05-22,02416549,ACH-Omeprazole,1,A02BC01,Omeprazole,Tablet (delayed-release),Oral,02416549,ACH-OMEPRAZOLE (omeprazole (omeprazole magnesium) 20 mg gastro-resistant tablet) ACCORD HEALTHCARE INC,Active,9000691,omeprazole (omeprazole magnesium) 20 mg gastro-resistant tablet,8000131,omeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90479,Marketed,2016-02-10,02420198,JAMP-Omeprazole Dr,1,A02BC01,Omeprazole,Tablet (delayed-release),Oral,02420198,JAMP-OMEPRAZOLE DR (omeprazole (omeprazole magnesium) 20 mg gastro-resistant tablet) JAMP PHARMA CORPORATION,Active,9000691,omeprazole (omeprazole magnesium) 20 mg gastro-resistant tablet,8000131,omeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92002,Marketed,2015-03-12,02435683,Heartburn Control,1,A02BC01,Omeprazole,Capsule (delayed release),Oral,02435683,HEARTBURN CONTROL (omeprazole 20 mg gastro-resistant capsule) APOTEX INC,Active,9000336,omeprazole 20 mg gastro-resistant capsule,8000131,omeprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
93579,Marketed,2016-09-07,02449927,Bio-Omeprazole,1,A02BC01,Omeprazole,Tablet (delayed-release),Oral,02449927,BIO-OMEPRAZOLE (omeprazole (omeprazole magnesium) 20 mg gastro-resistant tablet) BIOMED PHARMA,Active,9000691,omeprazole (omeprazole magnesium) 20 mg gastro-resistant tablet,8000131,omeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
9823,Marketed,2020-11-03,00846503,Losec,1,A02BC01,Omeprazole,Capsule (delayed release),Oral,00846503,LOSEC (omeprazole 20 mg gastro-resistant capsule) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9000336,omeprazole 20 mg gastro-resistant capsule,8000131,omeprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701036,ZOLGENSMA (onasemnogene abeparvovec 2.212e15 vg per 110.6 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014511,onasemnogene abeparvovec 2.212e15 vg per 110.6 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701037,ZOLGENSMA (onasemnogene abeparvovec 5.52e14 vg per 27.6 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014518,onasemnogene abeparvovec 5.52e14 vg per 27.6 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701038,ZOLGENSMA (onasemnogene abeparvovec 3.32e14 vg per 16.6 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014514,onasemnogene abeparvovec 3.32e14 vg per 16.6 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701039,ZOLGENSMA (onasemnogene abeparvovec 2.158e15 vg per 107.9 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014510,onasemnogene abeparvovec 2.158e15 vg per 107.9 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701040,ZOLGENSMA (onasemnogene abeparvovec 1.604e15 vg per 80.2 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014500,onasemnogene abeparvovec 1.604e15 vg per 80.2 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701041,ZOLGENSMA (onasemnogene abeparvovec 1.714e15 vg per 85.7 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014502,onasemnogene abeparvovec 1.714e15 vg per 85.7 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701042,ZOLGENSMA (onasemnogene abeparvovec 2.046e15 vg per 102.3 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014508,onasemnogene abeparvovec 2.046e15 vg per 102.3 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701043,ZOLGENSMA (onasemnogene abeparvovec 4.98e14 vg per 24.9 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014517,onasemnogene abeparvovec 4.98e14 vg per 24.9 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701044,ZOLGENSMA (onasemnogene abeparvovec 2.324e15 vg per 116.2 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014513,onasemnogene abeparvovec 2.324e15 vg per 116.2 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701045,ZOLGENSMA (onasemnogene abeparvovec 1.826e15 vg per 91.3 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014504,onasemnogene abeparvovec 1.826e15 vg per 91.3 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701046,ZOLGENSMA (onasemnogene abeparvovec 1.382e15 vg per 69.1 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014496,onasemnogene abeparvovec 1.382e15 vg per 69.1 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701047,ZOLGENSMA (onasemnogene abeparvovec 2.268e15 vg per 113.4 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014512,onasemnogene abeparvovec 2.268e15 vg per 113.4 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701048,ZOLGENSMA (onasemnogene abeparvovec 1.548e15 vg per 77.4 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014499,onasemnogene abeparvovec 1.548e15 vg per 77.4 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701049,ZOLGENSMA (onasemnogene abeparvovec 8.3e14 vg per 41.5 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014523,onasemnogene abeparvovec 8.3e14 vg per 41.5 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701050,ZOLGENSMA (onasemnogene abeparvovec 2.102e15 vg per 105.1 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014509,onasemnogene abeparvovec 2.102e15 vg per 105.1 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701051,ZOLGENSMA (onasemnogene abeparvovec 7.18e14 vg per 35.9 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014521,onasemnogene abeparvovec 7.18e14 vg per 35.9 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701052,ZOLGENSMA (onasemnogene abeparvovec 6.08e14 vg per 30.4 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014519,onasemnogene abeparvovec 6.08e14 vg per 30.4 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701053,ZOLGENSMA (onasemnogene abeparvovec 1.88e15 vg per 94 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014505,onasemnogene abeparvovec 1.88e15 vg per 94 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701054,ZOLGENSMA (onasemnogene abeparvovec 1.992e15 vg per 99.6 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014507,onasemnogene abeparvovec 1.992e15 vg per 99.6 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701055,ZOLGENSMA (onasemnogene abeparvovec 1.438e15 vg per 71.9 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014497,onasemnogene abeparvovec 1.438e15 vg per 71.9 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701056,ZOLGENSMA (onasemnogene abeparvovec 9.96e14 vg per 49.8 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014526,onasemnogene abeparvovec 9.96e14 vg per 49.8 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701057,ZOLGENSMA (onasemnogene abeparvovec 9.4e14 vg per 47 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014525,onasemnogene abeparvovec 9.4e14 vg per 47 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701058,ZOLGENSMA (onasemnogene abeparvovec 1.66e15 vg per 83 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014501,onasemnogene abeparvovec 1.66e15 vg per 83 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701059,ZOLGENSMA (onasemnogene abeparvovec 1.936e15 vg per 96.8 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014506,onasemnogene abeparvovec 1.936e15 vg per 96.8 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701060,ZOLGENSMA (onasemnogene abeparvovec 6.64e14 vg per 33.2 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014520,onasemnogene abeparvovec 6.64e14 vg per 33.2 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701061,ZOLGENSMA (onasemnogene abeparvovec 1.77e15 vg per 88.5 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014503,onasemnogene abeparvovec 1.77e15 vg per 88.5 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701062,ZOLGENSMA (onasemnogene abeparvovec 4.42e14 vg per 22.1 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014516,onasemnogene abeparvovec 4.42e14 vg per 22.1 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701063,ZOLGENSMA (onasemnogene abeparvovec 1.162e15 vg per 58.1 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014492,onasemnogene abeparvovec 1.162e15 vg per 58.1 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701064,ZOLGENSMA (onasemnogene abeparvovec 1.272e15 vg per 63.6 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014494,onasemnogene abeparvovec 1.272e15 vg per 63.6 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701065,ZOLGENSMA (onasemnogene abeparvovec 3.86e14 vg per 19.3 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014515,onasemnogene abeparvovec 3.86e14 vg per 19.3 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701066,ZOLGENSMA (onasemnogene abeparvovec 1.05e15 vg per 52.5 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014490,onasemnogene abeparvovec 1.05e15 vg per 52.5 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701067,ZOLGENSMA (onasemnogene abeparvovec 1.216e15 vg per 60.8 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014493,onasemnogene abeparvovec 1.216e15 vg per 60.8 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701068,ZOLGENSMA (onasemnogene abeparvovec 7.74e14 vg per 38.7 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014522,onasemnogene abeparvovec 7.74e14 vg per 38.7 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701069,ZOLGENSMA (onasemnogene abeparvovec 1.494e15 vg per 74.7 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014498,onasemnogene abeparvovec 1.494e15 vg per 74.7 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701070,ZOLGENSMA (onasemnogene abeparvovec 1.106e15 vg per 55.3 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014491,onasemnogene abeparvovec 1.106e15 vg per 55.3 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701071,ZOLGENSMA (onasemnogene abeparvovec 1.328e15 vg per 66.4 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014495,onasemnogene abeparvovec 1.328e15 vg per 66.4 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701072,ZOLGENSMA (onasemnogene abeparvovec 8.84e14 vg per 44.2 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014524,onasemnogene abeparvovec 8.84e14 vg per 44.2 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701036,ZOLGENSMA (onasemnogene abeparvovec 2.212e15 vg per 110.6 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014511,onasemnogene abeparvovec 2.212e15 vg per 110.6 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701037,ZOLGENSMA (onasemnogene abeparvovec 5.52e14 vg per 27.6 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014518,onasemnogene abeparvovec 5.52e14 vg per 27.6 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701038,ZOLGENSMA (onasemnogene abeparvovec 3.32e14 vg per 16.6 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014514,onasemnogene abeparvovec 3.32e14 vg per 16.6 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701039,ZOLGENSMA (onasemnogene abeparvovec 2.158e15 vg per 107.9 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014510,onasemnogene abeparvovec 2.158e15 vg per 107.9 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701040,ZOLGENSMA (onasemnogene abeparvovec 1.604e15 vg per 80.2 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014500,onasemnogene abeparvovec 1.604e15 vg per 80.2 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701041,ZOLGENSMA (onasemnogene abeparvovec 1.714e15 vg per 85.7 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014502,onasemnogene abeparvovec 1.714e15 vg per 85.7 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701042,ZOLGENSMA (onasemnogene abeparvovec 2.046e15 vg per 102.3 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014508,onasemnogene abeparvovec 2.046e15 vg per 102.3 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701043,ZOLGENSMA (onasemnogene abeparvovec 4.98e14 vg per 24.9 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014517,onasemnogene abeparvovec 4.98e14 vg per 24.9 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701044,ZOLGENSMA (onasemnogene abeparvovec 2.324e15 vg per 116.2 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014513,onasemnogene abeparvovec 2.324e15 vg per 116.2 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701045,ZOLGENSMA (onasemnogene abeparvovec 1.826e15 vg per 91.3 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014504,onasemnogene abeparvovec 1.826e15 vg per 91.3 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701046,ZOLGENSMA (onasemnogene abeparvovec 1.382e15 vg per 69.1 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014496,onasemnogene abeparvovec 1.382e15 vg per 69.1 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701047,ZOLGENSMA (onasemnogene abeparvovec 2.268e15 vg per 113.4 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014512,onasemnogene abeparvovec 2.268e15 vg per 113.4 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701048,ZOLGENSMA (onasemnogene abeparvovec 1.548e15 vg per 77.4 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014499,onasemnogene abeparvovec 1.548e15 vg per 77.4 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701049,ZOLGENSMA (onasemnogene abeparvovec 8.3e14 vg per 41.5 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014523,onasemnogene abeparvovec 8.3e14 vg per 41.5 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701050,ZOLGENSMA (onasemnogene abeparvovec 2.102e15 vg per 105.1 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014509,onasemnogene abeparvovec 2.102e15 vg per 105.1 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701051,ZOLGENSMA (onasemnogene abeparvovec 7.18e14 vg per 35.9 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014521,onasemnogene abeparvovec 7.18e14 vg per 35.9 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701052,ZOLGENSMA (onasemnogene abeparvovec 6.08e14 vg per 30.4 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014519,onasemnogene abeparvovec 6.08e14 vg per 30.4 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701053,ZOLGENSMA (onasemnogene abeparvovec 1.88e15 vg per 94 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014505,onasemnogene abeparvovec 1.88e15 vg per 94 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701054,ZOLGENSMA (onasemnogene abeparvovec 1.992e15 vg per 99.6 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014507,onasemnogene abeparvovec 1.992e15 vg per 99.6 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701055,ZOLGENSMA (onasemnogene abeparvovec 1.438e15 vg per 71.9 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014497,onasemnogene abeparvovec 1.438e15 vg per 71.9 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701056,ZOLGENSMA (onasemnogene abeparvovec 9.96e14 vg per 49.8 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014526,onasemnogene abeparvovec 9.96e14 vg per 49.8 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701057,ZOLGENSMA (onasemnogene abeparvovec 9.4e14 vg per 47 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014525,onasemnogene abeparvovec 9.4e14 vg per 47 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701058,ZOLGENSMA (onasemnogene abeparvovec 1.66e15 vg per 83 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014501,onasemnogene abeparvovec 1.66e15 vg per 83 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701059,ZOLGENSMA (onasemnogene abeparvovec 1.936e15 vg per 96.8 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014506,onasemnogene abeparvovec 1.936e15 vg per 96.8 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701060,ZOLGENSMA (onasemnogene abeparvovec 6.64e14 vg per 33.2 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014520,onasemnogene abeparvovec 6.64e14 vg per 33.2 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701061,ZOLGENSMA (onasemnogene abeparvovec 1.77e15 vg per 88.5 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014503,onasemnogene abeparvovec 1.77e15 vg per 88.5 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701062,ZOLGENSMA (onasemnogene abeparvovec 4.42e14 vg per 22.1 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014516,onasemnogene abeparvovec 4.42e14 vg per 22.1 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701063,ZOLGENSMA (onasemnogene abeparvovec 1.162e15 vg per 58.1 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014492,onasemnogene abeparvovec 1.162e15 vg per 58.1 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701064,ZOLGENSMA (onasemnogene abeparvovec 1.272e15 vg per 63.6 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014494,onasemnogene abeparvovec 1.272e15 vg per 63.6 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701065,ZOLGENSMA (onasemnogene abeparvovec 3.86e14 vg per 19.3 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014515,onasemnogene abeparvovec 3.86e14 vg per 19.3 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701066,ZOLGENSMA (onasemnogene abeparvovec 1.05e15 vg per 52.5 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014490,onasemnogene abeparvovec 1.05e15 vg per 52.5 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701067,ZOLGENSMA (onasemnogene abeparvovec 1.216e15 vg per 60.8 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014493,onasemnogene abeparvovec 1.216e15 vg per 60.8 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701068,ZOLGENSMA (onasemnogene abeparvovec 7.74e14 vg per 38.7 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014522,onasemnogene abeparvovec 7.74e14 vg per 38.7 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701069,ZOLGENSMA (onasemnogene abeparvovec 1.494e15 vg per 74.7 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014498,onasemnogene abeparvovec 1.494e15 vg per 74.7 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701070,ZOLGENSMA (onasemnogene abeparvovec 1.106e15 vg per 55.3 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014491,onasemnogene abeparvovec 1.106e15 vg per 55.3 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701071,ZOLGENSMA (onasemnogene abeparvovec 1.328e15 vg per 66.4 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014495,onasemnogene abeparvovec 1.328e15 vg per 66.4 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99897,Marketed,2021-02-04,02509695,Zolgensma,1,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701072,ZOLGENSMA (onasemnogene abeparvovec 8.84e14 vg per 44.2 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014524,onasemnogene abeparvovec 8.84e14 vg per 44.2 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
100050,Marketed,2021-12-23,02511282,Auro-Ondansetron ODT,1,A04AA01,Ondansetron,Tablet (orally disintegrating),Oral,02511282,AURO-ONDANSETRON ODT (ondansetron 4 mg orodispersible tablet) AURO PHARMA INC,Active,9003372,ondansetron 4 mg orodispersible tablet,8001106,ondansetron,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
100051,Marketed,2021-12-23,02511290,Auro-Ondansetron ODT,1,A04AA01,Ondansetron,Tablet (orally disintegrating),Oral,02511290,AURO-ONDANSETRON ODT (ondansetron 8 mg orodispersible tablet) AURO PHARMA INC,Active,9003373,ondansetron 8 mg orodispersible tablet,8001106,ondansetron,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
100436,Marketed,2022-04-05,02514966,Mar-Ondansetron ODT,1,A04AA01,Ondansetron,Tablet (orally disintegrating),Oral,02514966,MAR-ONDANSETRON ODT (ondansetron 4 mg orodispersible tablet) MARCAN PHARMACEUTICALS INC,Active,9003372,ondansetron 4 mg orodispersible tablet,8001106,ondansetron,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
100437,Marketed,2022-04-05,02514974,Mar-Ondansetron ODT,1,A04AA01,Ondansetron,Tablet (orally disintegrating),Oral,02514974,MAR-ONDANSETRON ODT (ondansetron 8 mg orodispersible tablet) MARCAN PHARMACEUTICALS INC,Active,9003373,ondansetron 8 mg orodispersible tablet,8001106,ondansetron,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
100851,Marketed,2022-04-25,02519232,Ondansetron ODT,1,A04AA01,Ondansetron,Tablet (orally disintegrating),Oral,02519232,ONDANSETRON ODT (ondansetron 4 mg orodispersible tablet) JAMP PHARMA CORPORATION,Active,9003372,ondansetron 4 mg orodispersible tablet,8001106,ondansetron,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
100852,Marketed,2022-04-25,02519240,Ondansetron ODT,1,A04AA01,Ondansetron,Tablet (orally disintegrating),Oral,02519240,ONDANSETRON ODT (ondansetron 8 mg orodispersible tablet) JAMP PHARMA CORPORATION,Active,9003373,ondansetron 8 mg orodispersible tablet,8001106,ondansetron,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
100871,Marketed,2022-04-14,02519445,PMS-Ondansetron ODT,1,A04AA01,Ondansetron,Tablet (orally disintegrating),Oral,02519445,PMS-ONDANSETRON ODT (ondansetron 4 mg orodispersible tablet) PHARMASCIENCE INC,Active,9003372,ondansetron 4 mg orodispersible tablet,8001106,ondansetron,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
100872,Marketed,2022-04-14,02519453,PMS-Ondansetron ODT,1,A04AA01,Ondansetron,Tablet (orally disintegrating),Oral,02519453,PMS-ONDANSETRON ODT (ondansetron 8 mg orodispersible tablet) PHARMASCIENCE INC,Active,9003373,ondansetron 8 mg orodispersible tablet,8001106,ondansetron,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
101313,Marketed,2024-09-11,02524090,Mint-Ondansetron Solution,1,A04AA01,Ondansetron,Solution,Oral,02524090,MINT-ONDANSETRON SOLUTION (ondansetron (ondansetron hydrochloride) 4 mg per 5 mL oral solution) MINT PHARMACEUTICALS INC,Active,9012534,ondansetron (ondansetron hydrochloride) 4 mg per 5 mL oral solution,8001106,ondansetron,26643006,Oral,385023001,Oral solution,,,,,,Prescription
101331,Marketed,2025-07-08,02524279,Ondansetron ODT,1,A04AA01,Ondansetron,Tablet (orally disintegrating),Oral,02524279,ONDANSETRON ODT (ondansetron 4 mg orodispersible tablet) SANIS HEALTH INC,Active,9003372,ondansetron 4 mg orodispersible tablet,8001106,ondansetron,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
101332,Marketed,2025-07-08,02524287,Ondansetron ODT,1,A04AA01,Ondansetron,Tablet (orally disintegrating),Oral,02524287,ONDANSETRON ODT (ondansetron 8 mg orodispersible tablet) SANIS HEALTH INC,Active,9003373,ondansetron 8 mg orodispersible tablet,8001106,ondansetron,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
102417,Marketed,2023-12-19,02535319,Accel-Ondansetron ODT,1,A04AA01,Ondansetron,Tablet (orally disintegrating),Oral,02535319,ACCEL-ONDANSETRON ODT (ondansetron 4 mg orodispersible tablet) ACCEL PHARMA INC,Active,9003372,ondansetron 4 mg orodispersible tablet,8001106,ondansetron,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
102418,Marketed,2023-12-19,02535327,Accel-Ondansetron ODT,1,A04AA01,Ondansetron,Tablet (orally disintegrating),Oral,02535327,ACCEL-ONDANSETRON ODT (ondansetron 8 mg orodispersible tablet) ACCEL PHARMA INC,Active,9003373,ondansetron 8 mg orodispersible tablet,8001106,ondansetron,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
103000,Marketed,2024-05-10,02541351,JAMP Ondansetron Odf,1,A04AA01,Ondansetron,"Film, soluble",Oral,02541351,JAMP ONDANSETRON ODF (ondansetron 4 mg orodispersible film) JAMP PHARMA CORPORATION,Active,9005179,ondansetron 4 mg orodispersible film,8001106,ondansetron,26643006,Oral,447050008,Orodispersible film,732995004,Film (unit of presentation),,,,Prescription
103001,Marketed,2024-05-10,02541378,JAMP Ondansetron Odf,1,A04AA01,Ondansetron,"Film, soluble",Oral,02541378,JAMP ONDANSETRON ODF (ondansetron 8 mg orodispersible film) JAMP PHARMA CORPORATION,Active,9005180,ondansetron 8 mg orodispersible film,8001106,ondansetron,26643006,Oral,447050008,Orodispersible film,732995004,Film (unit of presentation),,,,Prescription
103007,Marketed,2024-03-25,02541424,Ondansetron,1,A04AA01,Ondansetron,Tablet,Oral,02541424,ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 4 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9004408,ondansetron (ondansetron hydrochloride) 4 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103008,Marketed,2024-03-25,02541432,Ondansetron,1,A04AA01,Ondansetron,Tablet,Oral,02541432,ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 8 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9004409,ondansetron (ondansetron hydrochloride) 8 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103346,Marketed,2024-10-08,02544822,Eugia-Ondansetron Injection,1,A04AA01,Ondansetron,Solution,Intravenous,02544822,EUGIA-ONDANSETRON INJECTION (ondansetron (ondansetron hydrochloride dihydrate) 4 mg per 2 mL solution for injection vial) EUGIA PHARMA INC.,Active,9012533,ondansetron (ondansetron hydrochloride) 4 mg per 2 mL solution for injection vial,8001106,ondansetron,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
103347,Marketed,2024-10-08,02544830,Eugia-Ondansetron Injection,1,A04AA01,Ondansetron,Solution,Intravenous,02544830,EUGIA-ONDANSETRON INJECTION (ondansetron (ondansetron hydrochloride dihydrate) 8 mg per 4 mL solution for injection vial) EUGIA PHARMA INC.,Active,9012536,ondansetron (ondansetron hydrochloride) 8 mg per 4 mL solution for injection vial,8001106,ondansetron,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
74341,Marketed,2006-04-19,02258188,PMS-Ondansetron,1,A04AA01,Ondansetron,Tablet,Oral,02258188,PMS-ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 4 mg oral tablet) PHARMASCIENCE INC,Active,9004408,ondansetron (ondansetron hydrochloride) 4 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74342,Marketed,2006-04-19,02258196,PMS-Ondansetron,1,A04AA01,Ondansetron,Tablet,Oral,02258196,PMS-ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 8 mg oral tablet) PHARMASCIENCE INC,Active,9004409,ondansetron (ondansetron hydrochloride) 8 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75976,Marketed,2006-04-19,02274310,Sandoz Ondansetron,1,A04AA01,Ondansetron,Tablet,Oral,02274310,SANDOZ ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 4 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9004408,ondansetron (ondansetron hydrochloride) 4 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75977,Marketed,2006-04-19,02274329,Sandoz Ondansetron,1,A04AA01,Ondansetron,Tablet,Oral,02274329,SANDOZ ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 8 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9004409,ondansetron (ondansetron hydrochloride) 8 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75986,Marketed,2012-06-28,02274418,Ondansetron Hydrochloride Dihydrate Injection,1,A04AA01,Ondansetron,Solution,Intravenous,77700581,ONDANSETRON HYDROCHLORIDE DIHYDRATE INJECTION (ondansetron (ondansetron hydrochloride dihydrate) 4 mg per 2 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9012532,ondansetron (ondansetron hydrochloride) 4 mg per 2 mL solution for injection ampoule,8001106,ondansetron,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
75986,Marketed,2012-06-28,02274418,Ondansetron Hydrochloride Dihydrate Injection,1,A04AA01,Ondansetron,Solution,Intravenous,77700582,ONDANSETRON HYDROCHLORIDE DIHYDRATE INJECTION (ondansetron (ondansetron hydrochloride dihydrate) 8 mg per 4 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9012535,ondansetron (ondansetron hydrochloride) 8 mg per 4 mL solution for injection ampoule,8001106,ondansetron,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
76501,Marketed,2006-04-19,02279428,Ondansetron Injection USP   -(Preservative Free),1,A04AA01,Ondansetron,Solution,Intravenous,77700541,ONDANSETRON INJECTION USP   -(PRESERVATIVE FREE) (ondansetron (ondansetron hydrochloride dihydrate) 4 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012533,ondansetron (ondansetron hydrochloride) 4 mg per 2 mL solution for injection vial,8001106,ondansetron,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
76501,Marketed,2006-04-19,02279428,Ondansetron Injection USP   -(Preservative Free),1,A04AA01,Ondansetron,Solution,Intravenous,77700542,ONDANSETRON INJECTION USP   -(PRESERVATIVE FREE) (ondansetron (ondansetron hydrochloride dihydrate) 8 mg per 4 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012536,ondansetron (ondansetron hydrochloride) 8 mg per 4 mL solution for injection vial,8001106,ondansetron,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
76502,Marketed,2006-04-19,02279436,Ondansetron Injection USP   -(With Preservative),1,A04AA01,Ondansetron,Solution,Intravenous,02279436,ONDANSETRON INJECTION USP   -(WITH PRESERVATIVE) (ondansetron (ondansetron hydrochloride dihydrate) 2 mg per mL solution for injection 20 mL vial) SANDOZ CANADA INCORPORATED,Active,9012531,ondansetron (ondansetron hydrochloride) 2 mg per mL solution for injection 20 mL vial,8001106,ondansetron,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
77362,Marketed,2006-11-16,02288184,Apo-Ondansetron,1,A04AA01,Ondansetron,Tablet,Oral,02288184,APO-ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 4 mg oral tablet) APOTEX INC,Active,9004408,ondansetron (ondansetron hydrochloride) 4 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77363,Marketed,2006-11-16,02288192,Apo-Ondansetron,1,A04AA01,Ondansetron,Tablet,Oral,02288192,APO-ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 8 mg oral tablet) APOTEX INC,Active,9004409,ondansetron (ondansetron hydrochloride) 8 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77733,Marketed,2020-12-17,02291967,Apo-Ondansetron,1,A04AA01,Ondansetron,Solution,Oral,02291967,APO-ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 4 mg per 5 mL oral solution) APOTEX INC,Active,9012534,ondansetron (ondansetron hydrochloride) 4 mg per 5 mL oral solution,8001106,ondansetron,26643006,Oral,385023001,Oral solution,,,,,,Prescription
78168,Marketed,2022-05-09,02296349,Teva-Ondansetron,1,A04AA01,Ondansetron,Tablet,Oral,02296349,TEVA-ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 4 mg oral tablet) TEVA CANADA LIMITED,Active,9004408,ondansetron (ondansetron hydrochloride) 4 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78169,Marketed,2022-05-09,02296357,Teva-Ondansetron,1,A04AA01,Ondansetron,Tablet,Oral,02296357,TEVA-ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 8 mg oral tablet) TEVA CANADA LIMITED,Active,9004409,ondansetron (ondansetron hydrochloride) 8 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78319,Marketed,2011-04-08,02297868,Mylan-Ondansetron,1,A04AA01,Ondansetron,Tablet,Oral,02297868,MYLAN-ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 4 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9004408,ondansetron (ondansetron hydrochloride) 4 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78320,Marketed,2010-05-21,02297876,Mylan-Ondansetron,1,A04AA01,Ondansetron,Tablet,Oral,02297876,MYLAN-ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 8 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9004409,ondansetron (ondansetron hydrochloride) 8 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79079,Marketed,2013-10-31,02305259,Mint-Ondansetron,1,A04AA01,Ondansetron,Tablet,Oral,02305259,MINT-ONDANSETRON (ondansetron (ondansetron hydrochloride) 4 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9004408,ondansetron (ondansetron hydrochloride) 4 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79080,Marketed,2013-10-31,02305267,Mint-Ondansetron,1,A04AA01,Ondansetron,Tablet,Oral,02305267,MINT-ONDANSETRON (ondansetron (ondansetron hydrochloride) 8 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9004409,ondansetron (ondansetron hydrochloride) 8 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79919,Marketed,2008-09-26,02313685,JAMP-Ondansetron,1,A04AA01,Ondansetron,Tablet,Oral,02313685,JAMP-ONDANSETRON (ondansetron (ondansetron hydrochloride) 4 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004408,ondansetron (ondansetron hydrochloride) 4 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79920,Marketed,2008-09-26,02313693,JAMP-Ondansetron,1,A04AA01,Ondansetron,Tablet,Oral,02313693,JAMP-ONDANSETRON (ondansetron (ondansetron hydrochloride) 8 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004409,ondansetron (ondansetron hydrochloride) 8 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81057,Marketed,2023-11-07,02325160,Ondansetron,1,A04AA01,Ondansetron,Tablet,Oral,02325160,ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 8 mg oral tablet) PRO DOC LIMITEE,Active,9004409,ondansetron (ondansetron hydrochloride) 8 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85687,Marketed,2012-12-21,02371731,Mar-Ondansetron,1,A04AA01,Ondansetron,Tablet,Oral,02371731,MAR-ONDANSETRON (ondansetron (ondansetron hydrochloride) 4 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9004408,ondansetron (ondansetron hydrochloride) 4 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85688,Marketed,2012-12-21,02371758,Mar-Ondansetron,1,A04AA01,Ondansetron,Tablet,Oral,02371758,MAR-ONDANSETRON (ondansetron (ondansetron hydrochloride) 8 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9004409,ondansetron (ondansetron hydrochloride) 8 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87545,Marketed,2013-02-08,02389983,Ondissolve Odf,1,A04AA01,Ondansetron,"Film, soluble",Oral,02389983,ONDISSOLVE ODF (ondansetron 4 mg orodispersible film) TAKEDA CANADA INC,Active,9005179,ondansetron 4 mg orodispersible film,8001106,ondansetron,26643006,Oral,447050008,Orodispersible film,732995004,Film (unit of presentation),,,,Prescription
87546,Marketed,2013-02-08,02389991,Ondissolve Odf,1,A04AA01,Ondansetron,"Film, soluble",Oral,02389991,ONDISSOLVE ODF (ondansetron 8 mg orodispersible film) TAKEDA CANADA INC,Active,9005180,ondansetron 8 mg orodispersible film,8001106,ondansetron,26643006,Oral,447050008,Orodispersible film,732995004,Film (unit of presentation),,,,Prescription
90245,Marketed,2015-03-18,02417839,Nat-Ondansetron,1,A04AA01,Ondansetron,Tablet,Oral,02417839,NAT-ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 4 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9004408,ondansetron (ondansetron hydrochloride) 4 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90246,Marketed,2015-03-18,02417847,Nat-Ondansetron,1,A04AA01,Ondansetron,Tablet,Oral,02417847,NAT-ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 8 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9004409,ondansetron (ondansetron hydrochloride) 8 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90603,Marketed,2017-09-27,02421402,Ondansetron,1,A04AA01,Ondansetron,Tablet,Oral,02421402,ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 4 mg oral tablet) SANIS HEALTH INC,Active,9004408,ondansetron (ondansetron hydrochloride) 4 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90604,Marketed,2017-09-27,02421410,Ondansetron,1,A04AA01,Ondansetron,Tablet,Oral,02421410,ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 8 mg oral tablet) SANIS HEALTH INC,Active,9004409,ondansetron (ondansetron hydrochloride) 8 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94903,Marketed,2021-10-07,02461420,Ondansetron Injection BP,1,A04AA01,Ondansetron,Solution,Intravenous,77701095,ONDANSETRON INJECTION BP (ondansetron (ondansetron hydrochloride dihydrate) 8 mg per 4 mL solution for injection ampoule) AURO PHARMA INC,Active,9012535,ondansetron (ondansetron hydrochloride) 8 mg per 4 mL solution for injection ampoule,8001106,ondansetron,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
94903,Marketed,2021-10-07,02461420,Ondansetron Injection BP,1,A04AA01,Ondansetron,Solution,Intravenous,77701096,ONDANSETRON INJECTION BP (ondansetron (ondansetron hydrochloride dihydrate) 4 mg per 2 mL solution for injection ampoule) AURO PHARMA INC,Active,9012532,ondansetron (ondansetron hydrochloride) 4 mg per 2 mL solution for injection ampoule,8001106,ondansetron,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
94995,Marketed,2021-04-28,02462257,Ondansetron Injection USP,1,A04AA01,Ondansetron,Solution,Intravenous,02462257,ONDANSETRON INJECTION USP (ondansetron (ondansetron hydrochloride dihydrate) 2 mg per mL solution for injection 20 mL vial) STERIMAX INC,Active,9012531,ondansetron (ondansetron hydrochloride) 2 mg per mL solution for injection 20 mL vial,8001106,ondansetron,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
95270,Marketed,2018-05-22,02464578,Ondansetron Injection USP,1,A04AA01,Ondansetron,Solution,Intravenous,77700587,ONDANSETRON INJECTION USP (ondansetron (ondansetron hydrochloride dihydrate) 4 mg per 2 mL solution for injection vial) STERIMAX INC,Active,9012533,ondansetron (ondansetron hydrochloride) 4 mg per 2 mL solution for injection vial,8001106,ondansetron,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
95270,Marketed,2018-05-22,02464578,Ondansetron Injection USP,1,A04AA01,Ondansetron,Solution,Intravenous,77700588,ONDANSETRON INJECTION USP (ondansetron (ondansetron hydrochloride dihydrate) 8 mg per 4 mL solution for injection vial) STERIMAX INC,Active,9012536,ondansetron (ondansetron hydrochloride) 8 mg per 4 mL solution for injection vial,8001106,ondansetron,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
96963,Marketed,2019-09-19,02478927,Accel-Ondansetron,1,A04AA01,Ondansetron,Tablet,Oral,02478927,ACCEL-ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 4 mg oral tablet) ACCEL PHARMA INC,Active,9004408,ondansetron (ondansetron hydrochloride) 4 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96964,Marketed,2019-09-19,02478935,Accel-Ondansetron,1,A04AA01,Ondansetron,Tablet,Oral,02478935,ACCEL-ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 8 mg oral tablet) ACCEL PHARMA INC,Active,9004409,ondansetron (ondansetron hydrochloride) 8 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97221,Marketed,2019-05-15,02481723,Ondansetron ODT,1,A04AA01,Ondansetron,Tablet (orally disintegrating),Oral,02481723,ONDANSETRON ODT (ondansetron 4 mg orodispersible tablet) SANDOZ CANADA INCORPORATED,Active,9003372,ondansetron 4 mg orodispersible tablet,8001106,ondansetron,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
97222,Marketed,2019-05-15,02481731,Ondansetron ODT,1,A04AA01,Ondansetron,Tablet (orally disintegrating),Oral,02481731,ONDANSETRON ODT (ondansetron 8 mg orodispersible tablet) SANDOZ CANADA INCORPORATED,Active,9003373,ondansetron 8 mg orodispersible tablet,8001106,ondansetron,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
97750,Marketed,2019-10-16,02487330,Mint-Ondansetron ODT,1,A04AA01,Ondansetron,Tablet (orally disintegrating),Oral,02487330,MINT-ONDANSETRON ODT (ondansetron 4 mg orodispersible tablet) MINT PHARMACEUTICALS INC,Active,9003372,ondansetron 4 mg orodispersible tablet,8001106,ondansetron,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
97751,Marketed,2019-10-16,02487349,Mint-Ondansetron ODT,1,A04AA01,Ondansetron,Tablet (orally disintegrating),Oral,02487349,MINT-ONDANSETRON ODT (ondansetron 8 mg orodispersible tablet) MINT PHARMACEUTICALS INC,Active,9003373,ondansetron 8 mg orodispersible tablet,8001106,ondansetron,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
98068,Marketed,2020-04-22,02490617,JAMP Ondansetron,1,A04AA01,Ondansetron,Solution,Oral,02490617,JAMP ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 4 mg per 5 mL oral solution) JAMP PHARMA CORPORATION,Active,9012534,ondansetron (ondansetron hydrochloride) 4 mg per 5 mL oral solution,8001106,ondansetron,26643006,Oral,385023001,Oral solution,,,,,,Prescription
98138,Marketed,2021-10-07,02491524,Auro-Ondansetron Injection,1,A04AA01,Ondansetron,Solution,Intravenous,02491524,AURO-ONDANSETRON INJECTION (ondansetron (ondansetron hydrochloride dihydrate) 4 mg per 2 mL solution for injection vial) AURO PHARMA INC,Active,9012533,ondansetron (ondansetron hydrochloride) 4 mg per 2 mL solution for injection vial,8001106,ondansetron,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
98152,Marketed,2021-07-29,02491532,Auro-Ondansetron Injection,1,A04AA01,Ondansetron,Solution,Intravenous,02491532,AURO-ONDANSETRON INJECTION (ondansetron (ondansetron hydrochloride dihydrate) 8 mg per 4 mL solution for injection vial) AURO PHARMA INC,Active,9012536,ondansetron (ondansetron hydrochloride) 8 mg per 4 mL solution for injection vial,8001106,ondansetron,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
99334,Marketed,2021-05-10,02503905,Ondansetron Injection USP,1,A04AA01,Ondansetron,Solution,Intravenous,02503905,ONDANSETRON INJECTION USP (ondansetron (ondansetron hydrochloride dihydrate) 4 mg per 2 mL solution for injection vial) MARCAN PHARMACEUTICALS INC,Active,9012533,ondansetron (ondansetron hydrochloride) 4 mg per 2 mL solution for injection vial,8001106,ondansetron,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
94350,Marketed,2017-03-23,02456532,Bepreve,1,S01,Ophthalmologicals,Solution,Ophthalmic,02456532,BEPREVE (bepotastine besilate 1.5 % ophthalmic drops) BAUSCH & LOMB INC,Active,9006144,bepotastine besilate 1.5 % ophthalmic drops,8001582,bepotastine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
101203,Marketed,2024-08-19,02522950,Jack & Jill Honey Cough & Cold,2,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02522950,JACK & JILL HONEY COUGH & COLD (dextromethorphan hydrobromide 5 mg per 5 mL and guaifenesin 50 mg per 5 mL syrup) HALEON CANADA ULC,Active,9014904,dextromethorphan hydrobromide 5 mg per 5 mL and guaifenesin 50 mg per 5 mL syrup,8001370,dextromethorphan and guaifenesin,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
102784,Marketed,2026-02-26,02539195,Cough & Chest Congestion,2,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02539195,COUGH & CHEST CONGESTION (dextromethorphan hydrobromide 5 mg per 5 mL and guaifenesin 100 mg per 5 mL syrup) JUNO OTC INC,Active,9014097,dextromethorphan hydrobromide 5 mg per 5 mL and guaifenesin 100 mg per 5 mL syrup,8001370,dextromethorphan and guaifenesin,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
102796,Marketed,2026-02-15,02539322,Cough & Congestion,3,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02539322,COUGH & CONGESTION (dextromethorphan hydrobromide 20 mg per 20 mL and guaifenesin 400 mg per 20 mL and phenylephrine hydrochloride 10 mg per 20 mL oral solution) JUNO OTC INC,Active,9015070,dextromethorphan hydrobromide 20 mg per 20 mL and guaifenesin 400 mg per 20 mL and phenylephrine hydrochloride 10 mg per 20 mL oral solution,8002381,dextromethorphan and guaifenesin and phenylephrine,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
102948,Marketed,2025-11-18,02540800,Cough & Cold Relief Extra Strength,3,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02540800,COUGH & COLD RELIEF EXTRA STRENGTH (dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL syrup) CRLS,Active,9002452,dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL syrup,8001371,dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
102957,Marketed,2024-12-30,02540908,Mucus & Phlegm Relief With Cough Control Extra Strength,2,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02540908,MUCUS & PHLEGM RELIEF WITH COUGH CONTROL EXTRA STRENGTH (dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL syrup) CRLS,Active,9003243,dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL syrup,8001370,dextromethorphan and guaifenesin,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
12449,Marketed,2019-09-03,01944762,Benylin Regular Strength Cough Plus Chest Congestion Relief,2,R05FA02,Opium derivatives and expectorants,Syrup,Oral,01944762,BENYLIN REGULAR STRENGTH COUGH PLUS CHEST CONGESTION RELIEF (dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 100 mg per 5 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9002350,dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 100 mg per 5 mL syrup,8001370,dextromethorphan and guaifenesin,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
13296,Marketed,2024-06-12,01931024,Robitussin Cough Control,2,R05FA02,Opium derivatives and expectorants,Syrup,Oral,01931024,ROBITUSSIN COUGH CONTROL (dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 100 mg per 5 mL syrup) HALEON CANADA ULC,Active,9002350,dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 100 mg per 5 mL syrup,8001370,dextromethorphan and guaifenesin,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
13440,Marketed,2019-09-03,02003317,Benylin Extra Strength Cough & Chest Congestion With Warming Sensation,3,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02003317,BENYLIN EXTRA STRENGTH COUGH & CHEST CONGESTION WITH WARMING SENSATION (dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9002452,dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL syrup,8001371,dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
15618,Marketed,2018-03-05,02053403,Teva-Cotridin Expectorant,4,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02053403,TEVA-COTRIDIN EXPECTORANT (codeine phosphate 10 mg per 5 mL and guaifenesin 100 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL and triprolidine hydrochloride 2 mg per 5 mL syrup) TEVA CANADA LIMITED,Active,9002653,codeine phosphate 10 mg per 5 mL and guaifenesin 100 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL and triprolidine hydrochloride 2 mg per 5 mL syrup,8002112,codeine and guaifenesin and pseudoephedrine and triprolidine,26643006,Oral,739009002,Syrup,,,,,,Narcotics (CDSA I)
19026,Marketed,2024-05-31,02142775,Robitussin Extra Strength Cough Control,2,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02142775,ROBITUSSIN EXTRA STRENGTH COUGH CONTROL (dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL syrup) HALEON CANADA ULC,Active,9003243,dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL syrup,8001370,dextromethorphan and guaifenesin,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
19060,Marketed,2024-05-23,02172380,Robitussin Extra Strength Cough & Cold,3,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02172380,ROBITUSSIN EXTRA STRENGTH COUGH & COLD (dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL syrup) HALEON CANADA ULC,Active,9002452,dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL syrup,8001371,dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
19625,Marketed,2013-04-23,02099748,Cough Syrup With Codeine,3,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02099748,COUGH SYRUP WITH CODEINE (codeine phosphate 3.3 mg per 5 mL and guaifenesin 100 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL syrup) TEVA CANADA LIMITED,Active,9002768,codeine phosphate 3.3 mg per 5 mL and guaifenesin 100 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL syrup,8001364,codeine and guaifenesin and pseudoephedrine,26643006,Oral,739009002,Syrup,,,,,,Narcotics (CDSA I)
19690,Marketed,2013-04-16,02198630,Calmylin Ace,3,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02198630,CALMYLIN ACE (codeine phosphate 10 mg per 5 mL and guaifenesin 100 mg per 5 mL and pheniramine maleate 7.5 mg per 5 mL syrup) TEVA CANADA LIMITED,Active,9002543,codeine phosphate 10 mg per 5 mL and guaifenesin 100 mg per 5 mL and pheniramine maleate 7.5 mg per 5 mL syrup,8001900,codeine and guaifenesin and pheniramine,26643006,Oral,739009002,Syrup,,,,,,Narcotics (CDSA I)
34650,Marketed,2013-05-03,02172917,Calmylin Pse With Codeine,3,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02172917,CALMYLIN PSE WITH CODEINE (codeine phosphate 3.3 mg per 5 mL and guaifenesin 100 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL syrup) TEVA CANADA LIMITED,Active,9002768,codeine phosphate 3.3 mg per 5 mL and guaifenesin 100 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL syrup,8001364,codeine and guaifenesin and pseudoephedrine,26643006,Oral,739009002,Syrup,,,,,,Narcotics (CDSA I)
4469,Marketed,2013-04-24,00535230,Calmylin,3,R05FA02,Opium derivatives and expectorants,Syrup,Oral,00535230,CALMYLIN (ammonium chloride 125 mg per 5 mL and codeine phosphate 3.3 mg per 5 mL and diphenhydramine hydrochloride 12.5 mg per 5 mL syrup) TEVA CANADA LIMITED,Active,9003752,ammonium chloride 125 mg per 5 mL and codeine phosphate 3.3 mg per 5 mL and diphenhydramine hydrochloride 12.5 mg per 5 mL syrup,8001692,ammonium chloride and codeine and diphenhydramine,26643006,Oral,739009002,Syrup,,,,,,Narcotics (CDSA I)
6844,Marketed,2013-04-11,00690074,Cough Syrup,3,R05FA02,Opium derivatives and expectorants,Syrup,Oral,00690074,COUGH SYRUP (ammonium chloride 125 mg per 5 mL and codeine phosphate 3.3 mg per 5 mL and diphenhydramine hydrochloride 12.5 mg per 5 mL syrup) TEVA CANADA LIMITED,Active,9003752,ammonium chloride 125 mg per 5 mL and codeine phosphate 3.3 mg per 5 mL and diphenhydramine hydrochloride 12.5 mg per 5 mL syrup,8001692,ammonium chloride and codeine and diphenhydramine,26643006,Oral,739009002,Syrup,,,,,,Narcotics (CDSA I)
69689,Marketed,2002-09-13,02245592,Damylin With Codeine Syrup,3,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02245592,DAMYLIN WITH CODEINE SYRUP (ammonium chloride 125 mg per 5 mL and codeine phosphate 3.3 mg per 5 mL and diphenhydramine hydrochloride 12.5 mg per 5 mL syrup) LABORATOIRE RIVA INC.,Active,9003752,ammonium chloride 125 mg per 5 mL and codeine phosphate 3.3 mg per 5 mL and diphenhydramine hydrochloride 12.5 mg per 5 mL syrup,8001692,ammonium chloride and codeine and diphenhydramine,26643006,Oral,739009002,Syrup,,,,,,Narcotics (CDSA I)
72923,Marketed,2022-04-04,02248568,Robitussin Sugar Free Cough Control,2,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02248568,ROBITUSSIN SUGAR FREE COUGH CONTROL (dextromethorphan hydrobromide 10 mg per 5 mL and guaifenesin 100 mg per 5 mL syrup) GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC,Active,9014268,dextromethorphan hydrobromide 10 mg per 5 mL and guaifenesin 100 mg per 5 mL syrup,8001370,dextromethorphan and guaifenesin,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
75087,Marketed,2020-04-30,02265400,Benylin Extra Strength Cough Complete,4,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02265400,BENYLIN EXTRA STRENGTH COUGH COMPLETE (dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL and menthol 15 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9004091,dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL and menthol 15 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL syrup,8001747,dextromethorphan and guaifenesin and menthol and pseudoephedrine,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
75088,Marketed,2026-04-13,02265419,Benylin Extra Strength Cough & Chest Congestion,3,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02265419,BENYLIN EXTRA STRENGTH COUGH & CHEST CONGESTION (dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL and menthol 15 mg per 5 mL syrup) KENVUE CANADA INC.,Active,9004029,dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL and menthol 15 mg per 5 mL syrup,8001746,dextromethorphan and guaifenesin and menthol,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
80637,Marketed,2011-10-07,02320959,Benylin Extra Strength Mucus & Phlegm Plus Cough Control,3,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02320959,BENYLIN EXTRA STRENGTH MUCUS & PHLEGM PLUS COUGH CONTROL (dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL and menthol 15 mg per 5 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9004029,dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL and menthol 15 mg per 5 mL syrup,8001746,dextromethorphan and guaifenesin and menthol,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
91764,Marketed,2026-03-19,02433249,"Mucinex Multi-Action Congestion, Stuffy Nose & Cough Liquid",3,R05FA02,Opium derivatives and expectorants,Solution,Oral,02433249,"MUCINEX MULTI-ACTION CONGESTION, STUFFY NOSE & COUGH LIQUID (dextromethorphan hydrobromide 20 mg per 20 mL and guaifenesin 400 mg per 20 mL and phenylephrine hydrochloride 10 mg per 20 mL oral solution) RECKITT BENCKISER (CANADA) INC",Active,9015070,dextromethorphan hydrobromide 20 mg per 20 mL and guaifenesin 400 mg per 20 mL and phenylephrine hydrochloride 10 mg per 20 mL oral solution,8002381,dextromethorphan and guaifenesin and phenylephrine,26643006,Oral,385023001,Oral solution,,,,,,Non-Prescription Drugs
91765,Marketed,2026-04-23,02433257,Mucinex Congestion & Cough,2,R05FA02,Opium derivatives and expectorants,Solution,Oral,02433257,MUCINEX CONGESTION & COUGH (dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 100 mg per 5 mL syrup) RECKITT BENCKISER (CANADA) INC,Active,9002350,dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 100 mg per 5 mL syrup,8001370,dextromethorphan and guaifenesin,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
92082,Marketed,2017-09-28,02436485,Benylin Extra Strength For People With Diabetes,3,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02436485,BENYLIN EXTRA STRENGTH FOR PEOPLE WITH DIABETES (dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL and menthol 15 mg per 5 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9004029,dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL and menthol 15 mg per 5 mL syrup,8001746,dextromethorphan and guaifenesin and menthol,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
97576,Marketed,2024-05-17,02485524,Robitussin Extra Strength Honey Cough & Congestion,2,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02485524,ROBITUSSIN EXTRA STRENGTH HONEY COUGH & CONGESTION (dextromethorphan hydrobromide 5 mg per 5 mL and guaifenesin 100 mg per 5 mL syrup) HALEON CANADA ULC,Active,9014097,dextromethorphan hydrobromide 5 mg per 5 mL and guaifenesin 100 mg per 5 mL syrup,8001370,dextromethorphan and guaifenesin,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
99274,Marketed,2021-07-19,02503247,Dayquil Cough DM + Congestion,3,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02503247,DAYQUIL COUGH DM + CONGESTION (dextromethorphan hydrobromide 20 mg per 30 mL and guaifenesin 400 mg per 30 mL and phenylephrine hydrochloride 10 mg per 30 mL syrup) PROCTER & GAMBLE INC,Active,9014566,dextromethorphan hydrobromide 20 mg per 30 mL and guaifenesin 400 mg per 30 mL and phenylephrine hydrochloride 10 mg per 30 mL syrup,8002381,dextromethorphan and guaifenesin and phenylephrine,26643006,Oral,739009002,Syrup,,,,,,Non-Prescription Drugs
10217,Marketed,2003-04-04,00623709,Stomaax Plus,3,A02AF02,Ordinary salt combinations and antiflatulents,Suspension,Oral,00623709,STOMAAX PLUS (aluminum hydroxide 200 mg per 5 mL and dimethicone 25 mg per 5 mL and magnesium hydroxide 200 mg per 5 mL oral suspension) LABORATOIRE ATLAS INC,Active,9002172,aluminum hydroxide 200 mg per 5 mL and dimethicone 25 mg per 5 mL and magnesium hydroxide 200 mg per 5 mL oral suspension,8002090,aluminum hydroxide and dimethicone and magnesium hydroxide,26643006,Oral,385024007,Oral suspension,,,,,,Non-Prescription Drugs
102897,Marketed,2024-07-29,02540274,Tums Chewy Bites With Gas Relief,2,A02AF02,Ordinary salt combinations and antiflatulents,Tablet (chewable),Oral,02540274,TUMS CHEWY BITES WITH GAS RELIEF (calcium carbonate 750 mg and simethicone 80 mg chewable tablet) HALEON CANADA ULC,Active,9015058,calcium carbonate 750 mg and simethicone 80 mg chewable tablet,8002510,calcium carbonate and simethicone,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
44552,Marketed,1997-04-09,00815527,Almagel Plus Suspension,3,A02AF02,Ordinary salt combinations and antiflatulents,Suspension,Oral,00815527,ALMAGEL PLUS SUS (aluminum hydroxide 200 mg per 5 mL and dimethicone 25 mg per 5 mL and magnesium hydroxide 200 mg per 5 mL oral suspension) LABORATOIRE ATLAS INC,Active,9002172,aluminum hydroxide 200 mg per 5 mL and dimethicone 25 mg per 5 mL and magnesium hydroxide 200 mg per 5 mL oral suspension,8002090,aluminum hydroxide and dimethicone and magnesium hydroxide,26643006,Oral,385024007,Oral suspension,,,,,,Non-Prescription Drugs
89449,Marketed,2024-12-12,02409836,Gelusil Antacid And Anti-Gas,3,A02AF02,Ordinary salt combinations and antiflatulents,Tablet (chewable),Oral,02409836,GELUSIL ANTACID AND ANTI-GAS (aluminum hydroxide 200 mg and magnesium hydroxide 200 mg and simethicone 25 mg chewable tablet) PHARMASCIENCE INC,Active,9013941,aluminum hydroxide 200 mg and magnesium hydroxide 200 mg and simethicone 25 mg chewable tablet,8002091,aluminum hydroxide and magnesium hydroxide and simethicone,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
63865,Marketed,2018-06-01,02240325,Xenical,1,A08AB01,Orlistat,Capsule,Oral,02240325,XENICAL (orlistat 120 mg oral capsule) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9003383,orlistat 120 mg oral capsule,8001677,orlistat,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
67477,Marketed,2005-12-23,02243559,Sandoz Orphenadrine,1,M03BC01,Orphenadrine (citrate),Tablet (extended-release),Oral,02243559,SANDOZ ORPHENADRINE (orphenadrine citrate 100 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9003564,orphenadrine citrate 100 mg prolonged-release oral tablet,8001409,orphenadrine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
65111,Marketed,1999-12-23,02241472,Tamiflu,1,J05AH02,Oseltamivir,Capsule,Oral,02241472,TAMIFLU (oseltamivir (oseltamivir phosphate) 75 mg oral capsule) HOFFMANN-LA ROCHE LIMITED,Active,9003445,oseltamivir (oseltamivir phosphate) 75 mg oral capsule,8001297,oseltamivir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
79011,Marketed,2008-12-01,02304848,Tamiflu,1,J05AH02,Oseltamivir,Capsule,Oral,02304848,TAMIFLU (oseltamivir (oseltamivir phosphate) 30 mg oral capsule) HOFFMANN-LA ROCHE LIMITED,Active,9004473,oseltamivir (oseltamivir phosphate) 30 mg oral capsule,8001297,oseltamivir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
79012,Marketed,2008-12-08,02304856,Tamiflu,1,J05AH02,Oseltamivir,Capsule,Oral,02304856,TAMIFLU (oseltamivir (oseltamivir phosphate) 45 mg oral capsule) HOFFMANN-LA ROCHE LIMITED,Active,9004476,oseltamivir (oseltamivir phosphate) 45 mg oral capsule,8001297,oseltamivir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
86768,Marketed,2012-09-10,02381842,Tamiflu,1,J05AH02,Oseltamivir,Powder for suspension,Oral,02381842,TAMIFLU (oseltamivir (oseltamivir phosphate) 6 mg per mL oral suspension) HOFFMANN-LA ROCHE LIMITED,Active,9006402,oseltamivir (oseltamivir phosphate) 6 mg per mL oral suspension,8001297,oseltamivir,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
94501,Marketed,2016-09-29,02457989,Nat-Oseltamivir,1,J05AH02,Oseltamivir,Capsule,Oral,02457989,NAT-OSELTAMIVIR (oseltamivir (oseltamivir phosphate) 75 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9003445,oseltamivir (oseltamivir phosphate) 75 mg oral capsule,8001297,oseltamivir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96194,Marketed,2018-02-06,02472635,Nat-Oseltamivir,1,J05AH02,Oseltamivir,Capsule,Oral,02472635,NAT-OSELTAMIVIR (oseltamivir (oseltamivir phosphate) 30 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9004473,oseltamivir (oseltamivir phosphate) 30 mg oral capsule,8001297,oseltamivir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96195,Marketed,2018-02-06,02472643,Nat-Oseltamivir,1,J05AH02,Oseltamivir,Capsule,Oral,02472643,NAT-OSELTAMIVIR (oseltamivir (oseltamivir phosphate) 45 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9004476,oseltamivir (oseltamivir phosphate) 45 mg oral capsule,8001297,oseltamivir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98723,Marketed,2020-09-24,02497409,JAMP Oseltamivir,1,J05AH02,Oseltamivir,Capsule,Oral,02497409,JAMP OSELTAMIVIR (oseltamivir (oseltamivir phosphate) 30 mg oral capsule) JAMP PHARMA CORPORATION,Active,9004473,oseltamivir (oseltamivir phosphate) 30 mg oral capsule,8001297,oseltamivir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98725,Marketed,2020-09-24,02497425,JAMP Oseltamivir,1,J05AH02,Oseltamivir,Capsule,Oral,02497425,JAMP OSELTAMIVIR (oseltamivir (oseltamivir phosphate) 75 mg oral capsule) JAMP PHARMA CORPORATION,Active,9003445,oseltamivir (oseltamivir phosphate) 75 mg oral capsule,8001297,oseltamivir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98727,Marketed,2023-10-18,02497441,Mint-Oseltamivir,1,J05AH02,Oseltamivir,Capsule,Oral,02497441,MINT-OSELTAMIVIR (oseltamivir (oseltamivir phosphate) 30 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9004473,oseltamivir (oseltamivir phosphate) 30 mg oral capsule,8001297,oseltamivir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98729,Marketed,2023-10-18,02497476,Mint-Oseltamivir,1,J05AH02,Oseltamivir,Capsule,Oral,02497476,MINT-OSELTAMIVIR (oseltamivir (oseltamivir phosphate) 75 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9003445,oseltamivir (oseltamivir phosphate) 75 mg oral capsule,8001297,oseltamivir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98960,Marketed,2020-09-29,02499894,Nat-Oseltamivir,1,J05AH02,Oseltamivir,Powder for suspension,Oral,02499894,NAT-OSELTAMIVIR (oseltamivir (oseltamivir phosphate) 6 mg per mL oral suspension) NATCO PHARMA (CANADA) INC,Active,9006402,oseltamivir (oseltamivir phosphate) 6 mg per mL oral suspension,8001297,oseltamivir,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
99346,Marketed,2025-04-15,02504006,Sandoz Oseltamivir,1,J05AH02,Oseltamivir,Capsule,Oral,02504006,SANDOZ OSELTAMIVIR (oseltamivir (oseltamivir phosphate) 30 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9004473,oseltamivir (oseltamivir phosphate) 30 mg oral capsule,8001297,oseltamivir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
99347,Marketed,2025-04-15,02504014,Sandoz Oseltamivir,1,J05AH02,Oseltamivir,Capsule,Oral,02504014,SANDOZ OSELTAMIVIR (oseltamivir (oseltamivir phosphate) 45 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9004476,oseltamivir (oseltamivir phosphate) 45 mg oral capsule,8001297,oseltamivir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
99348,Marketed,2025-04-15,02504022,Sandoz Oseltamivir,1,J05AH02,Oseltamivir,Capsule,Oral,02504022,SANDOZ OSELTAMIVIR (oseltamivir (oseltamivir phosphate) 75 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9003445,oseltamivir (oseltamivir phosphate) 75 mg oral capsule,8001297,oseltamivir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
106212,Marketed,2025-12-17,02558912,Isturisa,1,H02CA02,Osilodrostat,Tablet,Oral,02558912,ISTURISA (osilodrostat (osilodrostat phosphate) 1 mg oral tablet) RECORDATI RARE DISEASES CANADA INC,Active,9015343,osilodrostat (osilodrostat phosphate) 1 mg oral tablet,8002574,osilodrostat,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,,Prescription
106213,Marketed,2025-12-17,02558920,Isturisa,1,H02CA02,Osilodrostat,Tablet,Oral,02558920,ISTURISA (osilodrostat (osilodrostat phosphate) 5 mg oral tablet) RECORDATI RARE DISEASES CANADA INC,Active,9015344,osilodrostat (osilodrostat phosphate) 5 mg oral tablet,8002574,osilodrostat,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,,Prescription
106214,Marketed,2026-02-19,02558939,Isturisa,1,H02CA02,Osilodrostat,Tablet,Oral,02558939,ISTURISA (osilodrostat (osilodrostat phosphate) 10 mg oral tablet) RECORDATI RARE DISEASES CANADA INC,Active,9015402,osilodrostat (osilodrostat phosphate) 10 mg oral tablet,8002574,osilodrostat,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,,Prescription
94310,Marketed,2016-07-19,02456214,Tagrisso,1,L01EB04,Osimertinib,Tablet,Oral,02456214,TAGRISSO (osimertinib (osimertinib mesylate) 40 mg oral tablet) ASTRAZENECA CANADA INC,Active,9006001,osimertinib (osimertinib mesylate) 40 mg oral tablet,8002042,osimertinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94311,Marketed,2016-07-19,02456222,Tagrisso,1,L01EB04,Osimertinib,Tablet,Oral,02456222,TAGRISSO (osimertinib (osimertinib mesylate) 80 mg oral tablet) ASTRAZENECA CANADA INC,Active,9006002,osimertinib (osimertinib mesylate) 80 mg oral tablet,8002042,osimertinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100744,Marketed,2022-01-13,02518112,Osphena,1,G03XC05,Ospemifene,Tablet,Oral,02518112,OSPHENA (ospemifene 60 mg oral tablet) DUCHESNAY INC,Active,9014644,ospemifene 60 mg oral tablet,8002406,ospemifene,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
103822,Marketed,2025-08-07,02549379,Fosaprepitant For Injection,1,A04AD,Other antiemetics,Powder for solution,Intravenous,02549379,FOSAPREPITANT FOR INJECTION (fosaprepitant (fosaprepitant dimeglumine) 150 mg per vial powder for solution for injection) JUNO PHARMACEUTICALS CORP.,Active,9004861,fosaprepitant (fosaprepitant dimeglumine) 150 mg per vial powder for solution for injection,8001656,fosaprepitant,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
84835,Marketed,2011-04-04,02363356,Emend IV,1,A04AD,Other antiemetics,Powder for solution,Intravenous,02363356,EMEND IV (fosaprepitant (fosaprepitant dimeglumine) 150 mg per vial powder for solution for injection) MERCK CANADA INC,Active,9004861,fosaprepitant (fosaprepitant dimeglumine) 150 mg per vial powder for solution for injection,8001656,fosaprepitant,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
103870,Marketed,2024-10-29,02549883,Apo-Bilastine Tablets,1,R06AX,Other antihistamines for systemic use,Tablet,Oral,02549883,APO-BILASTINE TABLETS (bilastine 20 mg oral tablet) APOTEX INC,Active,9006072,bilastine 20 mg oral tablet,8001590,bilastine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95816,Marketed,2017-12-20,02469375,Prevymis,1,J05AX,Other antivirals,Tablet,Oral,02469375,PREVYMIS (letermovir 240 mg oral tablet) MERCK CANADA INC,Active,9012444,letermovir 240 mg oral tablet,8001140,letermovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95817,Marketed,2017-12-20,02469383,Prevymis,1,J05AX,Other antivirals,Tablet,Oral,02469383,PREVYMIS (letermovir 480 mg oral tablet) MERCK CANADA INC,Active,9012445,letermovir 480 mg oral tablet,8001140,letermovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71860,Marketed,2007-05-29,02247600,Boostrix,5,J07AX,Other bacterial vaccines,Suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
81349,Marketed,2018-09-04,02328003,Cardiolite,1,V09GX,Other cardiovascular system diagnostic radiopharm.,Powder for solution,Intravenous,,,,,,,,,,,,,,,,,Schedule C
2175,Marketed,2012-01-03,00328693,Pre-Pen,1,V04CX,Other diagnostic agents,Solution,Intradermal,,,,,,,,,,,,,,,,,Prescription
3486,Marketed,2014-03-18,00405396,Patent Blue Sodium Injection,1,V04CX,Other diagnostic agents,Solution,"Subcutaneous,Intravenous",,,,,,,,,,,,,,,,,Ethical
3781,Marketed,2019-05-30,00505005,Fluorescite,1,V04CX,Other diagnostic agents,Solution,Intravenous,00505005,FLUORESCITE (fluorescein (fluorescein sodium) 100 mg per mL solution for injection 5 mL vial) ALCON CANADA INC,Active,9013819,fluorescein (fluorescein sodium) 100 mg per mL solution for injection 5 mL vial,8001469,fluorescein,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
63128,Marketed,1999-12-08,02239656,Provocholine,1,V04CX,Other diagnostic agents,Powder for solution,Inhalation,02239656,PROVOCHOLINE (methacholine chloride 100 mg per vial powder for nebulizer solution) METHAPHARM INC,Active,9003375,methacholine chloride 100 mg per vial powder for nebulizer solution,8001852,methacholine,447694001,Respiratory tract,385201005,Powder for nebulizer solution,733026001,Vial (unit of presentation),,,,Prescription
67775,Marketed,2001-09-24,02243834,Provocholine,1,V04CX,Other diagnostic agents,Powder for solution,Inhalation,02243834,PROVOCHOLINE (methacholine chloride 1280 mg per vial powder for nebulizer solution) METHAPHARM INC,Active,9003649,methacholine chloride 1280 mg per vial powder for nebulizer solution,8001852,methacholine,447694001,Respiratory tract,385201005,Powder for nebulizer solution,733026001,Vial (unit of presentation),,,,Prescription
74930,Marketed,2006-03-27,02263890,Methacholine Omega,1,V04CX,Other diagnostic agents,Powder for solution,Inhalation,02263890,METHACHOLINE OMEGA (methacholine chloride 100 mg per vial powder for nebulizer solution) OMEGA LABORATORIES LIMITED,Active,9003375,methacholine chloride 100 mg per vial powder for nebulizer solution,8001852,methacholine,447694001,Respiratory tract,385201005,Powder for nebulizer solution,733026001,Vial (unit of presentation),,,,Prescription
74932,Marketed,2006-07-03,02263912,Methacholine Omega,1,V04CX,Other diagnostic agents,Powder for solution,Inhalation,02263912,METHACHOLINE OMEGA (methacholine chloride 1600 mg per vial powder for nebulizer solution) OMEGA LABORATORIES LIMITED,Active,9004182,methacholine chloride 1600 mg per vial powder for nebulizer solution,8001852,methacholine,447694001,Respiratory tract,385201005,Powder for nebulizer solution,733026001,Vial (unit of presentation),,,,Prescription
77421,Marketed,2008-02-28,02288826,Provocholine,1,V04CX,Other diagnostic agents,Powder for solution,Inhalation,02288826,PROVOCHOLINE (methacholine chloride 1600 mg per vial powder for nebulizer solution) METHAPHARM INC,Active,9004182,methacholine chloride 1600 mg per vial powder for nebulizer solution,8001852,methacholine,447694001,Respiratory tract,385201005,Powder for nebulizer solution,733026001,Vial (unit of presentation),,,,Prescription
92096,Marketed,2022-01-24,02436639,Cysview,1,V04CX,Other diagnostic agents,"Kit,Powder for solution",Intravesical,,,,,,,,,,,,,,,,,Prescription
97957,Marketed,2024-07-30,02489562,Aridol,4,V04CX,Other diagnostic agents,"Powder,Kit",Inhalation,02489562,ARIDOL (mannitol 5 mg inhalation powder capsule with mannitol 10 mg inhalation powder capsule with mannitol 20 mg inhalation powder capsule with mannitol 40 mg inhalation powder capsule) PHARMAXIS EUROPE LIMITED,Active,9014348,mannitol 5 mg inhalation powder capsule with mannitol 10 mg inhalation powder capsule with mannitol 20 mg inhalation powder capsule with mannitol 40 mg inhalation powder capsule,8002138,mannitol,447694001,Respiratory tract,385207009,Powder for inhalation,732937005,Capsule,,,,Prescription Recommended
98280,Marketed,2020-07-29,02492806,Galli Eo,1,V09IX,Other diagnostic radiopharm. for tumor detection,Solution,0-unassigned,,,,,,,,,,,,,,,,,Schedule C
99306,Marketed,2023-07-10,02503603,Galliapharm,1,V09X,Other diagnostic radiopharmaceuticals,Solution,0-unassigned,,,,,,,,,,,,,,,,,Schedule C
76520,Marketed,2019-05-09,02279592,Resultz,1,P03AX,"Other ectoparasiticides, incl scabicides",Solution,Topical,02279592,RESULTZ (isopropyl myristate 50 % cutaneous solution) ARALEZ PHARMACEUTICALS CANADA INC,Active,9004209,isopropyl myristate 50 % cutaneous solution,8002131,isopropyl myristate,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Non-Prescription Drugs
106662,Marketed,2026-02-04,02563886,Tryngolza,1,C10AX,Other lipid modifying agents,Solution,Subcutaneous,02563886,TRYNGOLZA (olezarsen (olezarsen sodium) 80 mg per 0.8 mL solution for injection syringe) THERATECHNOLOGIES INC,Active,9015378,olezarsen (olezarsen sodium) 80 mg per 0.8 mL solution for injection syringe,8002586,olezarsen,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe,,,,Prescription
13486,Marketed,2006-07-29,00786942,Micro MN,1,A12CX,Other mineral products,Solution,Intravenous,00786942,MICRO MN (manganese (manganese sulfate) 1 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013223,manganese (manganese sulfate) 1 mg per 10 mL solution for injection vial,8001846,manganese sulfate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
13523,Marketed,2006-07-15,00786985,Micro CR,1,A12CX,Other mineral products,Solution,Intravenous,00786985,MICRO CR (chromium (chromic chloride) 40 mcg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013050,chromium (chromic chloride) 40 mcg per 10 mL solution for injection vial,8001725,chromic chloride,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
13559,Marketed,2006-06-17,01986007,Micro Se,1,A12CX,Other mineral products,Solution,Intravenous,01986007,MICRO SE (selenium (selenious acid) 400 mcg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013342,selenium (selenious acid) 400 mcg per 10 mL solution for injection vial,8001933,selenium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
13563,Marketed,2006-07-15,00786969,Micro Cu,1,A12CX,Other mineral products,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
13600,Marketed,2006-06-17,01974548,Micro I,1,A12CX,Other mineral products,Liquid,Intravenous,,,,,,,,,,,,,,,,,Ethical
104491,Marketed,2025-05-29,02556219,Skyclarys,1,N07XX,Other nervous system drugs,Capsule,Oral,02556219,SKYCLARYS (omaveloxolone 50 mg oral capsule) BIOGEN CANADA INC,Active,9015222,omaveloxolone 50 mg oral capsule,8002547,omaveloxolone,26643006,Oral,420692007,Oral capsule,732937005,Capsule,1.0,,,Prescription
36788,Marketed,2024-08-06,02209594,Preparation H-Pe Gel,2,C05AX03,"Other preparations, combinations",Gel,"Rectal,Topical",02209594,PREPARATION H-PE GEL (hamamelis virginiana 50 % and phenylephrine hydrochloride 0.25 % rectal gel) HALEON CANADA ULC,Active,9003095,hamamelis virginiana 50 % and phenylephrine hydrochloride 0.25 % rectal gel,8000900,hamamelis virginiana and phenylephrine,37161004,Rectal,385100002,Gel,,,,,,Non-Prescription Drugs
99088,Marketed,2022-03-07,02501252,Hemorrhoidal Ointment,3,C05AX03,"Other preparations, combinations",Ointment,Topical,02501252,HEMORRHOIDAL OINTMENT (mineral oil heavy 14.05 % and petrolatum 74.9 % and phenylephrine hydrochloride 0.25 % cutaneous ointment) PERRIGO INTERNATIONAL,Active,9014918,mineral oil heavy 14.05 % and petrolatum 74.9 % and phenylephrine hydrochloride 0.25 % cutaneous ointment,8002479,mineral oil heavy and petrolatum and phenylephrine,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Non-Prescription Drugs
106280,Marketed,2025-07-31,02559676,Alyftrek,3,R07AX,Other respiratory system products,Tablet,Oral,02559676,ALYFTREK (deutivacaftor 50 mg and tezacaftor 20 mg and vanzacaftor (vanzacaftor calcium) 4 mg oral tablet) VERTEX PHARMACEUTICALS (CANADA) INCORPORATED,Active,9015390,deutivacaftor 50 mg and tezacaftor 20 mg and vanzacaftor (vanzacaftor calcium) 4 mg oral tablet,8002589,deutivacaftor and tezacaftor and vanzacaftor,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,,Prescription
106281,Marketed,2025-07-31,02559684,Alyftrek,3,R07AX,Other respiratory system products,Tablet,Oral,02559684,ALYFTREK (deutivacaftor 125 mg and tezacaftor 50 mg and vanzacaftor (vanzacaftor calcium) 10 mg oral tablet) VERTEX PHARMACEUTICALS (CANADA) INCORPORATED,Active,9015389,deutivacaftor 125 mg and tezacaftor 50 mg and vanzacaftor (vanzacaftor calcium) 10 mg oral tablet,8002589,deutivacaftor and tezacaftor and vanzacaftor,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,,Prescription
91937,Marketed,2015-12-16,02435071,Oxaliplatin Injection,1,L01XA03,Oxaliplatin,Solution,Intravenous,77700935,OXALIPLATIN INJECTION (oxaliplatin 50 mg per 10 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013485,oxaliplatin 50 mg per 10 mL solution for injection vial,8002043,oxaliplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
91937,Marketed,2015-12-16,02435071,Oxaliplatin Injection,1,L01XA03,Oxaliplatin,Solution,Intravenous,77700936,OXALIPLATIN INJECTION (oxaliplatin 100 mg per 20 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013482,oxaliplatin 100 mg per 20 mL solution for injection vial,8002043,oxaliplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
91937,Marketed,2015-12-16,02435071,Oxaliplatin Injection,1,L01XA03,Oxaliplatin,Solution,Intravenous,77700937,OXALIPLATIN INJECTION (oxaliplatin 200 mg per 40 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013484,oxaliplatin 200 mg per 40 mL solution for injection vial,8002043,oxaliplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
92127,Marketed,2015-12-17,02436957,Oxaliplatin Injection,1,L01XA03,Oxaliplatin,Solution,Intravenous,77700941,OXALIPLATIN INJECTION (oxaliplatin 100 mg per 20 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013482,oxaliplatin 100 mg per 20 mL solution for injection vial,8002043,oxaliplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
92127,Marketed,2015-12-17,02436957,Oxaliplatin Injection,1,L01XA03,Oxaliplatin,Solution,Intravenous,77700942,OXALIPLATIN INJECTION (oxaliplatin 50 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013485,oxaliplatin 50 mg per 10 mL solution for injection vial,8002043,oxaliplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
92127,Marketed,2015-12-17,02436957,Oxaliplatin Injection,1,L01XA03,Oxaliplatin,Solution,Intravenous,77700943,OXALIPLATIN INJECTION (oxaliplatin 200 mg per 40 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013484,oxaliplatin 200 mg per 40 mL solution for injection vial,8002043,oxaliplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
92127,Marketed,2015-12-17,02436957,Oxaliplatin Injection,1,L01XA03,Oxaliplatin,Solution,Intravenous,77700944,OXALIPLATIN INJECTION (oxaliplatin 150 mg per 30 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013483,oxaliplatin 150 mg per 30 mL solution for injection vial,8002043,oxaliplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
92996,Marketed,2019-01-16,02444763,Oxaliplatin,1,L01XA03,Oxaliplatin,Solution,Intravenous,77700951,OXALIPLATIN (oxaliplatin 200 mg per 40 mL solution for injection vial) PFIZER CANADA ULC,Active,9013484,oxaliplatin 200 mg per 40 mL solution for injection vial,8002043,oxaliplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
92996,Marketed,2019-01-16,02444763,Oxaliplatin,1,L01XA03,Oxaliplatin,Solution,Intravenous,77700952,OXALIPLATIN (oxaliplatin 100 mg per 20 mL solution for injection vial) PFIZER CANADA ULC,Active,9013482,oxaliplatin 100 mg per 20 mL solution for injection vial,8002043,oxaliplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
92996,Marketed,2019-01-16,02444763,Oxaliplatin,1,L01XA03,Oxaliplatin,Solution,Intravenous,77700953,OXALIPLATIN (oxaliplatin 50 mg per 10 mL solution for injection vial) PFIZER CANADA ULC,Active,9013485,oxaliplatin 50 mg per 10 mL solution for injection vial,8002043,oxaliplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
94448,Marketed,2022-03-31,02457423,"Oxaliplatin Injection, USP",1,L01XA03,Oxaliplatin,Solution,Intravenous,77701102,"OXALIPLATIN INJECTION, USP (oxaliplatin 200 mg per 40 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013484,oxaliplatin 200 mg per 40 mL solution for injection vial,8002043,oxaliplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
94448,Marketed,2022-03-31,02457423,"Oxaliplatin Injection, USP",1,L01XA03,Oxaliplatin,Solution,Intravenous,77701103,"OXALIPLATIN INJECTION, USP (oxaliplatin 50 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013485,oxaliplatin 50 mg per 10 mL solution for injection vial,8002043,oxaliplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
94448,Marketed,2022-03-31,02457423,"Oxaliplatin Injection, USP",1,L01XA03,Oxaliplatin,Solution,Intravenous,77701104,"OXALIPLATIN INJECTION, USP (oxaliplatin 100 mg per 20 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013482,oxaliplatin 100 mg per 20 mL solution for injection vial,8002043,oxaliplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
94551,Marketed,2022-07-13,02458403,"Oxaliplatin Injection, USP",1,L01XA03,Oxaliplatin,Solution,Intravenous,77701113,"OXALIPLATIN INJECTION, USP (oxaliplatin 200 mg per 40 mL solution for injection vial) DR REDDY'S LABORATORIES LTD",Active,9013484,oxaliplatin 200 mg per 40 mL solution for injection vial,8002043,oxaliplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
94551,Marketed,2022-07-13,02458403,"Oxaliplatin Injection, USP",1,L01XA03,Oxaliplatin,Solution,Intravenous,77701114,"OXALIPLATIN INJECTION, USP (oxaliplatin 50 mg per 10 mL solution for injection vial) DR REDDY'S LABORATORIES LTD",Active,9013485,oxaliplatin 50 mg per 10 mL solution for injection vial,8002043,oxaliplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
94551,Marketed,2022-07-13,02458403,"Oxaliplatin Injection, USP",1,L01XA03,Oxaliplatin,Solution,Intravenous,77701115,"OXALIPLATIN INJECTION, USP (oxaliplatin 100 mg per 20 mL solution for injection vial) DR REDDY'S LABORATORIES LTD",Active,9013482,oxaliplatin 100 mg per 20 mL solution for injection vial,8002043,oxaliplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
3463,Marketed,1979-12-31,00402680,Apo-Oxazepam,1,N05BA04,Oxazepam,Tablet,Oral,00402680,APO-OXAZEPAM (oxazepam 10 mg oral tablet) APOTEX INC,Active,9000135,oxazepam 10 mg oral tablet,8000079,oxazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
3464,Marketed,1979-12-31,00402737,Apo-Oxazepam,1,N05BA04,Oxazepam,Tablet,Oral,00402737,APO-OXAZEPAM (oxazepam 30 mg oral tablet) APOTEX INC,Active,9000137,oxazepam 30 mg oral tablet,8000079,oxazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
3465,Marketed,1979-12-31,00402745,Apo-Oxazepam,1,N05BA04,Oxazepam,Tablet,Oral,00402745,APO-OXAZEPAM (oxazepam 15 mg oral tablet) APOTEX INC,Active,9000136,oxazepam 15 mg oral tablet,8000079,oxazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
3806,Marketed,2023-07-18,00497754,Pro-Oxazepam,1,N05BA04,Oxazepam,Tablet,Oral,00497754,PRO-OXAZEPAM (oxazepam 10 mg oral tablet) PRO DOC LIMITEE,Active,9000135,oxazepam 10 mg oral tablet,8000079,oxazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
3807,Marketed,2023-07-19,00497762,Pro-Oxazepam,1,N05BA04,Oxazepam,Tablet,Oral,00497762,PRO-OXAZEPAM (oxazepam 15 mg oral tablet) PRO DOC LIMITEE,Active,9000136,oxazepam 15 mg oral tablet,8000079,oxazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
3808,Marketed,2023-07-19,00497770,Pro-Oxazepam,1,N05BA04,Oxazepam,Tablet,Oral,00497770,PRO-OXAZEPAM (oxazepam 30 mg oral tablet) PRO DOC LIMITEE,Active,9000137,oxazepam 30 mg oral tablet,8000079,oxazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
5213,Marketed,2007-03-21,00568406,Riva-Oxazepam,1,N05BA04,Oxazepam,Tablet,Oral,00568406,RIVA-OXAZEPAM (oxazepam 15 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000136,oxazepam 15 mg oral tablet,8000079,oxazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
5214,Marketed,2007-03-21,00568414,Riva-Oxazepam,1,N05BA04,Oxazepam,Tablet,Oral,00568414,RIVA-OXAZEPAM (oxazepam 30 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000137,oxazepam 30 mg oral tablet,8000079,oxazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
5563,Marketed,2007-03-21,00568392,Riva-Oxazepam,1,N05BA04,Oxazepam,Tablet,Oral,00568392,RIVA-OXAZEPAM (oxazepam 10 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000135,oxazepam 10 mg oral tablet,8000079,oxazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
65741,Marketed,2002-04-01,02242068,Trileptal 300 mg,1,N03AF02,Oxcarbazepine,Tablet,Oral,02242068,TRILEPTAL 300 MG (oxcarbazepine 300 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9003707,oxcarbazepine 300 mg oral tablet,8002044,oxcarbazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
65742,Marketed,2002-04-01,02242069,Trileptal 600 mg,1,N03AF02,Oxcarbazepine,Tablet,Oral,02242069,TRILEPTAL 600 MG (oxcarbazepine 600 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9003708,oxcarbazepine 600 mg oral tablet,8002044,oxcarbazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
68661,Marketed,2002-09-05,02244673,Trileptal Oral Suspension,1,N03AF02,Oxcarbazepine,Suspension,Oral,02244673,TRILEPTAL ORAL SUSPENSION (oxcarbazepine 300 mg per 5 mL oral suspension) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9013831,oxcarbazepine 300 mg per 5 mL oral suspension,8002044,oxcarbazepine,26643006,Oral,385024007,Oral suspension,,,1.0,,,Prescription
76987,Marketed,2022-02-08,02284294,Apo-Oxcarbazepine,1,N03AF02,Oxcarbazepine,Tablet,Oral,02284294,APO-OXCARBAZEPINE (oxcarbazepine 150 mg oral tablet) APOTEX INC,Active,9003706,oxcarbazepine 150 mg oral tablet,8002044,oxcarbazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
76988,Marketed,2016-06-08,02284308,Apo-Oxcarbazepine,1,N03AF02,Oxcarbazepine,Tablet,Oral,02284308,APO-OXCARBAZEPINE (oxcarbazepine 300 mg oral tablet) APOTEX INC,Active,9003707,oxcarbazepine 300 mg oral tablet,8002044,oxcarbazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
76989,Marketed,2016-06-08,02284316,Apo-Oxcarbazepine,1,N03AF02,Oxcarbazepine,Tablet,Oral,02284316,APO-OXCARBAZEPINE (oxcarbazepine 600 mg oral tablet) APOTEX INC,Active,9003708,oxcarbazepine 600 mg oral tablet,8002044,oxcarbazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
18355,Marketed,2022-01-25,02163543,Apo-Oxybutynin,1,G04BD04,Oxybutynin,Tablet,Oral,02163543,APO-OXYBUTYNIN (oxybutynin chloride 5 mg oral tablet) APOTEX INC,Active,9000627,oxybutynin chloride 5 mg oral tablet,8000219,oxybutynin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
43358,Marketed,1996-09-04,02223376,PMS-Oxybutynin,1,G04BD04,Oxybutynin,Syrup,Oral,02223376,PMS-OXYBUTYNIN (oxybutynin chloride 5 mg per 5 mL syrup) PHARMASCIENCE INC,Active,9006249,oxybutynin chloride 5 mg per 5 mL syrup,8000219,oxybutynin,26643006,Oral,739009002,Syrup,,,,,,Prescription
49219,Marketed,2015-07-27,02230394,Teva-Oxybutynin,1,G04BD04,Oxybutynin,Tablet,Oral,02230394,TEVA-OXYBUTYNIN (oxybutynin chloride 5 mg oral tablet) TEVA CANADA LIMITED,Active,9000627,oxybutynin chloride 5 mg oral tablet,8000219,oxybutynin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
64119,Marketed,1999-11-22,02240549,PMS-Oxybutynin,1,G04BD04,Oxybutynin,Tablet,Oral,02240549,PMS-OXYBUTYNIN (oxybutynin chloride 2.5 mg oral tablet) PHARMASCIENCE INC,Active,9000876,oxybutynin chloride 2.5 mg oral tablet,8000219,oxybutynin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
64120,Marketed,1999-11-22,02240550,PMS-Oxybutynin,1,G04BD04,Oxybutynin,Tablet,Oral,02240550,PMS-OXYBUTYNIN (oxybutynin chloride 5 mg oral tablet) PHARMASCIENCE INC,Active,9000627,oxybutynin chloride 5 mg oral tablet,8000219,oxybutynin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78474,Marketed,2008-06-09,02299364,Riva-Oxybutynin,1,G04BD04,Oxybutynin,Tablet,Oral,02299364,RIVA-OXYBUTYNIN (oxybutynin chloride 5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000627,oxybutynin chloride 5 mg oral tablet,8000219,oxybutynin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
10433,Marketed,2005-08-05,00789739,Supeudol 5,1,N02AA05,Oxycodone,Tablet,Oral,00789739,SUPEUDOL 5 (oxycodone hydrochloride 5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000367,oxycodone hydrochloride 5 mg oral tablet,8000045,oxycodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
3996,Marketed,2005-08-05,00443948,Supeudol 10,1,N02AA05,Oxycodone,Tablet,Oral,00443948,SUPEUDOL 10 (oxycodone hydrochloride 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000153,oxycodone hydrochloride 10 mg oral tablet,8000045,oxycodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
51386,Marketed,2000-03-31,02231934,Oxy.IR,1,N02AA05,Oxycodone,Tablet,Oral,02231934,OXY.IR (oxycodone hydrochloride 5 mg oral tablet) PURDUE PHARMA,Active,9000367,oxycodone hydrochloride 5 mg oral tablet,8000045,oxycodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
63645,Marketed,2000-03-31,02240131,Oxy.IR,1,N02AA05,Oxycodone,Tablet,Oral,02240131,OXY.IR (oxycodone hydrochloride 10 mg oral tablet) PURDUE PHARMA,Active,9000153,oxycodone hydrochloride 10 mg oral tablet,8000045,oxycodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
63646,Marketed,2000-03-31,02240132,Oxy.IR,1,N02AA05,Oxycodone,Tablet (immediate release),Oral,02240132,OXY.IR (oxycodone hydrochloride 20 mg oral tablet) PURDUE PHARMA,Active,9000890,oxycodone hydrochloride 20 mg oral tablet,8000045,oxycodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
74839,Marketed,2024-10-04,02262983,Supeudol 20,1,N02AA05,Oxycodone,Tablet,Oral,02262983,SUPEUDOL 20 (oxycodone hydrochloride 20 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000890,oxycodone hydrochloride 20 mg oral tablet,8000045,oxycodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
79224,Marketed,2012-11-26,02306530,Apo-Oxycodone CR,1,N02AA05,Oxycodone,Tablet (extended-release),Oral,02306530,APO-OXYCODONE CR (oxycodone hydrochloride 40 mg prolonged-release oral tablet) APOTEX INC,Active,9001359,oxycodone hydrochloride 40 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
79557,Marketed,2012-11-27,02309882,PMS-Oxycodone CR,1,N02AA05,Oxycodone,Tablet (extended-release),Oral,02309882,PMS-OXYCODONE CR (oxycodone hydrochloride 10 mg prolonged-release oral tablet) PHARMASCIENCE INC,Active,9001355,oxycodone hydrochloride 10 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
79558,Marketed,2012-11-27,02309890,PMS-Oxycodone CR,1,N02AA05,Oxycodone,Tablet (extended-release),Oral,02309890,PMS-OXYCODONE CR (oxycodone hydrochloride 20 mg prolonged-release oral tablet) PHARMASCIENCE INC,Active,9001357,oxycodone hydrochloride 20 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
79559,Marketed,2012-11-27,02309904,PMS-Oxycodone CR,1,N02AA05,Oxycodone,Tablet (extended-release),Oral,02309904,PMS-OXYCODONE CR (oxycodone hydrochloride 40 mg prolonged-release oral tablet) PHARMASCIENCE INC,Active,9001359,oxycodone hydrochloride 40 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
79560,Marketed,2012-11-27,02309912,PMS-Oxycodone CR,1,N02AA05,Oxycodone,Tablet (extended-release),Oral,02309912,PMS-OXYCODONE CR (oxycodone hydrochloride 80 mg prolonged-release oral tablet) PHARMASCIENCE INC,Active,9001361,oxycodone hydrochloride 80 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
80542,Marketed,2008-12-03,02319977,PMS-Oxycodone,1,N02AA05,Oxycodone,Tablet,Oral,02319977,PMS-OXYCODONE (oxycodone hydrochloride 5 mg oral tablet) PHARMASCIENCE INC,Active,9000367,oxycodone hydrochloride 5 mg oral tablet,8000045,oxycodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
80543,Marketed,2008-12-03,02319985,PMS-Oxycodone,1,N02AA05,Oxycodone,Tablet,Oral,02319985,PMS-OXYCODONE (oxycodone hydrochloride 10 mg oral tablet) PHARMASCIENCE INC,Active,9000153,oxycodone hydrochloride 10 mg oral tablet,8000045,oxycodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
80544,Marketed,2008-12-03,02319993,PMS-Oxycodone,1,N02AA05,Oxycodone,Tablet,Oral,02319993,PMS-OXYCODONE (oxycodone hydrochloride 20 mg oral tablet) PHARMASCIENCE INC,Active,9000890,oxycodone hydrochloride 20 mg oral tablet,8000045,oxycodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
85157,Marketed,2012-11-26,02366746,Apo-Oxycodone CR,1,N02AA05,Oxycodone,Tablet (extended-release),Oral,02366746,APO-OXYCODONE CR (oxycodone hydrochloride 5 mg prolonged-release oral tablet) APOTEX INC,Active,9001393,oxycodone hydrochloride 5 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
85158,Marketed,2018-05-17,02366754,Apo-Oxycodone CR,1,N02AA05,Oxycodone,Tablet (extended-release),Oral,02366754,APO-OXYCODONE CR (oxycodone hydrochloride 10 mg prolonged-release oral tablet) APOTEX INC,Active,9001355,oxycodone hydrochloride 10 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
85159,Marketed,2012-11-26,02366762,Apo-Oxycodone CR,1,N02AA05,Oxycodone,Tablet (extended-release),Oral,02366762,APO-OXYCODONE CR (oxycodone hydrochloride 20 mg prolonged-release oral tablet) APOTEX INC,Active,9001357,oxycodone hydrochloride 20 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
85161,Marketed,2012-11-26,02366789,Apo-Oxycodone CR,1,N02AA05,Oxycodone,Tablet (extended-release),Oral,02366789,APO-OXYCODONE CR (oxycodone hydrochloride 80 mg prolonged-release oral tablet) APOTEX INC,Active,9001361,oxycodone hydrochloride 80 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
85760,Marketed,2011-09-13,02372525,Oxyneo,1,N02AA05,Oxycodone,Tablet (extended-release),Oral,02372525,OXYNEO (oxycodone hydrochloride 10 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9001355,oxycodone hydrochloride 10 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
85765,Marketed,2011-09-13,02372533,Oxyneo,1,N02AA05,Oxycodone,Tablet (extended-release),Oral,02372533,OXYNEO (oxycodone hydrochloride 15 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9001356,oxycodone hydrochloride 15 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
85766,Marketed,2011-09-13,02372541,Oxyneo,1,N02AA05,Oxycodone,Tablet (extended-release),Oral,02372541,OXYNEO (oxycodone hydrochloride 30 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9001358,oxycodone hydrochloride 30 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
85767,Marketed,2011-09-13,02372568,Oxyneo,1,N02AA05,Oxycodone,Tablet (extended-release),Oral,02372568,OXYNEO (oxycodone hydrochloride 40 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9001359,oxycodone hydrochloride 40 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
85768,Marketed,2011-09-13,02372576,Oxyneo,1,N02AA05,Oxycodone,Tablet (extended-release),Oral,02372576,OXYNEO (oxycodone hydrochloride 60 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9001360,oxycodone hydrochloride 60 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
85769,Marketed,2011-09-13,02372584,Oxyneo,1,N02AA05,Oxycodone,Tablet (extended-release),Oral,02372584,OXYNEO (oxycodone hydrochloride 80 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9001361,oxycodone hydrochloride 80 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
85788,Marketed,2011-09-13,02372797,Oxyneo,1,N02AA05,Oxycodone,Tablet (extended-release),Oral,02372797,OXYNEO (oxycodone hydrochloride 20 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9001357,oxycodone hydrochloride 20 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
87990,Marketed,2012-11-27,02394766,Apo-Oxycodone CR,1,N02AA05,Oxycodone,Tablet (extended-release),Oral,02394766,APO-OXYCODONE CR (oxycodone hydrochloride 15 mg prolonged-release oral tablet) APOTEX INC,Active,9001356,oxycodone hydrochloride 15 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
87991,Marketed,2018-06-13,02394774,Apo-Oxycodone CR,1,N02AA05,Oxycodone,Tablet (extended-release),Oral,02394774,APO-OXYCODONE CR (oxycodone hydrochloride 30 mg prolonged-release oral tablet) APOTEX INC,Active,9001358,oxycodone hydrochloride 30 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
87993,Marketed,2012-11-27,02394782,Apo-Oxycodone CR,1,N02AA05,Oxycodone,Tablet (extended-release),Oral,02394782,APO-OXYCODONE CR (oxycodone hydrochloride 60 mg prolonged-release oral tablet) APOTEX INC,Active,9001360,oxycodone hydrochloride 60 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
5777,Marketed,2017-12-21,00608157,Teva-Oxycodan,2,N02AJ18,Oxycodone and acetylsalicylic acid,Tablet,Oral,00608157,TEVA-OXYCODAN (acetylsalicylic acid 325 mg and oxycodone hydrochloride 5 mg oral tablet) TEVA CANADA LIMITED,Active,9000195,acetylsalicylic acid 325 mg and oxycodone hydrochloride 5 mg oral tablet,8000774,acetylsalicylic acid and oxycodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
82520,Marketed,2010-10-05,02339609,Targin,2,N02AA55,Oxycodone and naloxone,Tablet (extended-release),Oral,02339609,TARGIN (naloxone hydrochloride 5 mg and oxycodone hydrochloride 10 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9001324,naloxone hydrochloride 5 mg and oxycodone hydrochloride 10 mg prolonged-release oral tablet,8000783,naloxone and oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
82521,Marketed,2010-10-05,02339617,Targin,2,N02AA55,Oxycodone and naloxone,Tablet (extended-release),Oral,02339617,TARGIN (naloxone hydrochloride 10 mg and oxycodone hydrochloride 20 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9001322,naloxone hydrochloride 10 mg and oxycodone hydrochloride 20 mg prolonged-release oral tablet,8000783,naloxone and oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
82522,Marketed,2010-10-05,02339625,Targin,2,N02AA55,Oxycodone and naloxone,Tablet (extended-release),Oral,02339625,TARGIN (naloxone hydrochloride 20 mg and oxycodone hydrochloride 40 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9001323,naloxone hydrochloride 20 mg and oxycodone hydrochloride 40 mg prolonged-release oral tablet,8000783,naloxone and oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
87301,Marketed,2012-10-16,02387425,Targin,2,N02AA55,Oxycodone and naloxone,Tablet (extended-release),Oral,02387425,TARGIN (naloxone hydrochloride 2.5 mg and oxycodone hydrochloride 5 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9001391,naloxone hydrochloride 2.5 mg and oxycodone hydrochloride 5 mg prolonged-release oral tablet,8000783,naloxone and oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
5778,Marketed,2017-07-07,00608165,Teva-Oxycocet,2,N02AJ17,Oxycodone and paracetamol,Tablet,Oral,00608165,TEVA-OXYCOCET (acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet) TEVA CANADA LIMITED,Active,9000094,acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet,8000059,acetaminophen and oxycodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
66193,Marketed,2001-12-12,02242468,Rivacocet,2,N02AJ17,Oxycodone and paracetamol,Tablet,Oral,02242468,RIVACOCET (acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000094,acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet,8000059,acetaminophen and oxycodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
81005,Marketed,2009-05-22,02324628,Apo-Oxycodone/Acet,2,N02AJ17,Oxycodone and paracetamol,Tablet,Oral,02324628,APO-OXYCODONE/ACET (acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet) APOTEX INC,Active,9000094,acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet,8000059,acetaminophen and oxycodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
13886,Marketed,2022-05-04,02014408,Oxygen USP,1,V03AN01,Oxygen,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
18663,Marketed,1995-12-31,02170175,Oxygene - Gas Inh,1,V03AN01,Oxygen,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
19299,Marketed,2020-04-08,02154838,Oxygen USP,1,V03AN01,Oxygen,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
20349,Marketed,1998-09-11,02219719,Oxygen USP - Gas 100%,1,V03AN01,Oxygen,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
27306,Marketed,2004-03-23,02052881,Oxygen USP,1,V03AN01,Oxygen,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
50235,Marketed,1997-03-11,02230956,Oxygen U.S.P.,1,V03AN01,Oxygen,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
5682,Marketed,1911-12-31,00572810,Oxygen 100%,1,V03AN01,Oxygen,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
64194,Marketed,2005-08-01,02240621,Oxygen USP,1,V03AN01,Oxygen,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
66284,Marketed,2000-07-13,02242542,Oxygen USP,1,V03AN01,Oxygen,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
6826,Marketed,1986-12-31,00591629,Oxygen 99%,1,V03AN01,Oxygen,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
72159,Marketed,2003-07-03,02247852,Oxygen USP,1,V03AN01,Oxygen,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
96434,Marketed,2018-03-26,02474298,Oxygen,1,V03AN01,Oxygen,Gas,Inhalation,,,,,,,,,,,,,,,,,Ethical
41903,Marketed,2016-05-18,00740861,Drixoral Decongestant Nasal Spray,1,R01AA05,Oxymetazoline,Solution,Nasal,00740861,DRIXORAL DECONGESTANT NASAL SPRAY (oxymetazoline hydrochloride 0.05 % nasal spray) BAYER INC,Active,9002052,oxymetazoline hydrochloride 0.05 % nasal spray,8002150,oxymetazoline,46713006,Nasal,385157007,Nasal spray,,,,,,Non-Prescription Drugs
41954,Marketed,2021-01-26,01929372,Long Lasting Dristan Nasal Mist,1,R01AA05,Oxymetazoline,Spray,Nasal,01929372,"LONG LASTING DRISTAN NASAL MIST (oxymetazoline hydrochloride 0.05 % nasal spray) FOUNDATION CONSUMER BRANDS, LLC",Active,9002052,oxymetazoline hydrochloride 0.05 % nasal spray,8002150,oxymetazoline,46713006,Nasal,385157007,Nasal spray,,,,,,Non-Prescription Drugs
41970,Marketed,2021-01-26,01929380,Long Lasting Dristan Mentholated Nasal Spray,1,R01AA05,Oxymetazoline,Spray,Nasal,01929380,"LONG LASTING DRISTAN MENTHOLATED NASAL SPRAY (oxymetazoline hydrochloride 0.05 % nasal spray) FOUNDATION CONSUMER BRANDS, LLC",Active,9002052,oxymetazoline hydrochloride 0.05 % nasal spray,8002150,oxymetazoline,46713006,Nasal,385157007,Nasal spray,,,,,,Non-Prescription Drugs
67620,Marketed,2017-04-13,02243690,Claritin Allergy Decongestant,1,R01AA05,Oxymetazoline,Solution,Nasal,02243690,CLARITIN ALLERGY DECONGESTANT (oxymetazoline hydrochloride 0.05 % nasal spray) BAYER INC,Active,9002052,oxymetazoline hydrochloride 0.05 % nasal spray,8002150,oxymetazoline,46713006,Nasal,385157007,Nasal spray,,,,,,Non-Prescription Drugs
69670,Marketed,2016-12-21,02245575,Drixoral No Drip Extra Moisturizing,1,R01AA05,Oxymetazoline,Spray,Nasal,02245575,DRIXORAL NO DRIP EXTRA MOISTURIZING (oxymetazoline hydrochloride 0.05 % nasal spray) BAYER INC,Active,9002052,oxymetazoline hydrochloride 0.05 % nasal spray,8002150,oxymetazoline,46713006,Nasal,385157007,Nasal spray,,,,,,Non-Prescription Drugs
69673,Marketed,2016-07-28,02245578,Drixoral No Drip Original Unscented,1,R01AA05,Oxymetazoline,Spray,Nasal,02245578,DRIXORAL NO DRIP ORIGINAL UNSCENTED (oxymetazoline hydrochloride 0.05 % nasal spray) BAYER INC,Active,9002052,oxymetazoline hydrochloride 0.05 % nasal spray,8002150,oxymetazoline,46713006,Nasal,385157007,Nasal spray,,,,,,Non-Prescription Drugs
69676,Marketed,2018-08-02,02245580,Drixoral No Drip Cooling Menthol,1,R01AA05,Oxymetazoline,Spray,Nasal,02245580,DRIXORAL NO DRIP COOLING MENTHOL (oxymetazoline hydrochloride 0.05 % nasal spray) BAYER INC,Active,9002052,oxymetazoline hydrochloride 0.05 % nasal spray,8002150,oxymetazoline,46713006,Nasal,385157007,Nasal spray,,,,,,Non-Prescription Drugs
86596,Marketed,2016-03-03,02380129,Drixoral Nasal Congestion,1,R01AA05,Oxymetazoline,Spray,Nasal,02380129,DRIXORAL NASAL CONGESTION (oxymetazoline hydrochloride 0.05 % nasal spray) BAYER INC,Active,9002052,oxymetazoline hydrochloride 0.05 % nasal spray,8002150,oxymetazoline,46713006,Nasal,385157007,Nasal spray,,,,,,Non-Prescription Drugs
94094,Marketed,2017-05-28,02454351,Long Lasting Decongestant Nasal Spray,1,R01AA05,Oxymetazoline,Spray,Nasal,02454351,LONG LASTING DECONGESTANT NASAL SPRAY (oxymetazoline hydrochloride 0.05 % nasal spray) CRLS,Active,9002052,oxymetazoline hydrochloride 0.05 % nasal spray,8002150,oxymetazoline,46713006,Nasal,385157007,Nasal spray,,,,,,Non-Prescription Drugs
94800,Marketed,2018-06-27,02460572,Extra Moisturizing Nasal Spray,1,R01AA05,Oxymetazoline,"Spray, metered dose",Nasal,02460572,EXTRA MOISTURIZING NASAL SPRAY (oxymetazoline hydrochloride 0.05 % nasal spray) JUNO OTC INC,Active,9002052,oxymetazoline hydrochloride 0.05 % nasal spray,8002150,oxymetazoline,46713006,Nasal,385157007,Nasal spray,,,,,,Non-Prescription Drugs
94802,Marketed,2018-06-28,02460599,Nasal Congestion Spray,1,R01AA05,Oxymetazoline,"Spray, metered dose",Nasal,02460599,NASAL CONGESTION SPRAY (oxymetazoline hydrochloride 0.05 % nasal spray) JUNO OTC INC,Active,9002052,oxymetazoline hydrochloride 0.05 % nasal spray,8002150,oxymetazoline,46713006,Nasal,385157007,Nasal spray,,,,,,Non-Prescription Drugs
98807,Marketed,2021-03-08,02498294,Drixoral No Drip Nasal Congestion,1,R01AA05,Oxymetazoline,Spray,Nasal,02498294,DRIXORAL NO DRIP NASAL CONGESTION (oxymetazoline hydrochloride 0.05 % nasal spray) BAYER INC,Active,9002052,oxymetazoline hydrochloride 0.05 % nasal spray,8002150,oxymetazoline,46713006,Nasal,385157007,Nasal spray,,,,,,Non-Prescription Drugs
98808,Marketed,2021-03-08,02498308,Drixoral No Drip Nasal Congestion With Menthol,1,R01AA05,Oxymetazoline,Spray,Nasal,02498308,DRIXORAL NO DRIP NASAL CONGESTION WITH MENTHOL (oxymetazoline hydrochloride 0.05 % nasal spray) BAYER INC,Active,9002052,oxymetazoline hydrochloride 0.05 % nasal spray,8002150,oxymetazoline,46713006,Nasal,385157007,Nasal spray,,,,,,Non-Prescription Drugs
103903,Marketed,2025-08-26,02550199,"Oxytocin Injection, USP",1,H01BB02,Oxytocin,Solution,"Intramuscular,Intravenous",02550199,"OXYTOCIN INJECTION, USP (oxytocin 10 unit per 1 mL solution for injection ampoule) HIKMA CANADA LIMITED",Active,9013486,oxytocin 10 unit per 1 mL solution for injection ampoule,8002046,oxytocin,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),1.0,,,Prescription
31361,Marketed,2021-02-24,02139561,"Oxytocin Injection, USP",1,H01BB02,Oxytocin,Solution,"Intravenous,Intramuscular",77700918,"OXYTOCIN INJECTION, USP (oxytocin 100 unit per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013488,oxytocin 100 unit per 10 mL solution for injection vial,8002046,oxytocin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
31361,Marketed,2021-02-24,02139561,"Oxytocin Injection, USP",1,H01BB02,Oxytocin,Solution,"Intravenous,Intramuscular",77700919,"OXYTOCIN INJECTION, USP (oxytocin 10 unit per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013487,oxytocin 10 unit per 1 mL solution for injection vial,8002046,oxytocin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
4293,Marketed,2017-10-16,00497398,Oxytocin Injection USP,1,H01BB02,Oxytocin,Solution,"Intramuscular,Intravenous",77700912,OXYTOCIN INJECTION USP (oxytocin 10 unit per 1 mL solution for injection ampoule) PFIZER CANADA ULC,Active,9013486,oxytocin 10 unit per 1 mL solution for injection ampoule,8002046,oxytocin,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),1.0,,,Prescription
4293,Marketed,2017-10-16,00497398,Oxytocin Injection USP,1,H01BB02,Oxytocin,Solution,"Intramuscular,Intravenous",77700913,OXYTOCIN INJECTION USP (oxytocin 50 unit per 5 mL solution for injection ampoule) PFIZER CANADA ULC,Active,9013489,oxytocin 50 unit per 5 mL solution for injection ampoule,8002046,oxytocin,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),1.0,,,Prescription
99535,Marketed,2024-09-03,02505991,Zeposia,1,L04AE02,Ozanimod,Capsule,Oral,02505991,ZEPOSIA (ozanimod (ozanimod hydrochloride) 0.92 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9014464,ozanimod (ozanimod hydrochloride) 0.92 mg oral capsule,8002365,ozanimod,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
99536,Marketed,2025-02-14,02506009,Zeposia,2,L04AE02,Ozanimod,Capsule,Oral,02506009,ZEPOSIA (ozanimod (ozanimod hydrochloride) 0.23 mg oral capsule with ozanimod (ozanimod hydrochloride) 0.46 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9014480,ozanimod (ozanimod hydrochloride) 0.23 mg oral capsule with ozanimod (ozanimod hydrochloride) 0.46 mg oral capsule,8002365,ozanimod,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
68340,Marketed,2003-06-16,02244372,PACLitaxel For Injection,1,L01CD01,Paclitaxel,Solution,Intravenous,,,,,,,,,,,,,,1.0,,,Prescription
76673,Marketed,2025-01-24,02281066,Abraxane For Injectable Suspension,1,L01CD01,Paclitaxel,Powder for suspension,Intravenous,,,,,,,,,,,,,,1.0,,,Prescription
80560,Marketed,2015-03-31,02320150,PACLitaxel Injection USP,1,L01CD01,Paclitaxel,Solution,Intravenous,,,,,,,,,,,,,,1.0,,,Prescription
87681,Marketed,2014-07-02,02391465,PACLitaxel Injection USP,1,L01CD01,Paclitaxel,Solution,Intravenous,,,,,,,,,,,,,,1.0,,,Prescription
98597,Marketed,2023-10-27,02496097,"PACLitaxel Powder For Injectable Suspension Nanoparticle, Albumin-Bound PACLitaxel",1,L01CD01,Paclitaxel,Powder for suspension,Intravenous,,,,,,,,,,,,,,1.0,,,Prescription
103657,Marketed,2024-09-17,02547635,Taro-Palbociclib,1,L01EF01,Palbociclib,Tablet,Oral,02547635,TARO-PALBOCICLIB (palbociclib 75 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9014388,palbociclib 75 mg oral tablet,8002048,palbociclib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103658,Marketed,2024-09-17,02547643,Taro-Palbociclib,1,L01EF01,Palbociclib,Tablet,Oral,02547643,TARO-PALBOCICLIB (palbociclib 100 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9014386,palbociclib 100 mg oral tablet,8002048,palbociclib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103659,Marketed,2024-09-17,02547651,Taro-Palbociclib,1,L01EF01,Palbociclib,Tablet,Oral,02547651,TARO-PALBOCICLIB (palbociclib 125 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9014387,palbociclib 125 mg oral tablet,8002048,palbociclib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104081,Marketed,2024-09-27,02552124,PMS-Palbociclib,1,L01EF01,Palbociclib,Tablet,Oral,02552124,PMS-PALBOCICLIB (palbociclib 75 mg oral tablet) PHARMASCIENCE INC,Active,9014388,palbociclib 75 mg oral tablet,8002048,palbociclib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104082,Marketed,2024-09-27,02552132,PMS-Palbociclib,1,L01EF01,Palbociclib,Tablet,Oral,02552132,PMS-PALBOCICLIB (palbociclib 100 mg oral tablet) PHARMASCIENCE INC,Active,9014386,palbociclib 100 mg oral tablet,8002048,palbociclib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104083,Marketed,2024-09-27,02552140,PMS-Palbociclib,1,L01EF01,Palbociclib,Tablet,Oral,02552140,PMS-PALBOCICLIB (palbociclib 125 mg oral tablet) PHARMASCIENCE INC,Active,9014387,palbociclib 125 mg oral tablet,8002048,palbociclib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98354,Marketed,2020-09-21,02493535,Ibrance,1,L01EF01,Palbociclib,Tablet,Oral,02493535,IBRANCE (palbociclib 75 mg oral tablet) PFIZER CANADA ULC,Active,9014388,palbociclib 75 mg oral tablet,8002048,palbociclib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98355,Marketed,2020-09-21,02493543,Ibrance,1,L01EF01,Palbociclib,Tablet,Oral,02493543,IBRANCE (palbociclib 100 mg oral tablet) PFIZER CANADA ULC,Active,9014386,palbociclib 100 mg oral tablet,8002048,palbociclib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98356,Marketed,2020-09-21,02493551,Ibrance,1,L01EF01,Palbociclib,Tablet,Oral,02493551,IBRANCE (palbociclib 125 mg oral tablet) PFIZER CANADA ULC,Active,9014387,palbociclib 125 mg oral tablet,8002048,palbociclib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78559,Marketed,2007-10-02,02300273,Invega,1,N05AX13,Paliperidone,Tablet (extended-release),Oral,02300273,INVEGA (paliperidone 3 mg prolonged-release oral tablet) JANSSEN INC,Active,9004337,paliperidone 3 mg prolonged-release oral tablet,8001298,paliperidone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78560,Marketed,2007-10-02,02300281,Invega,1,N05AX13,Paliperidone,Tablet (extended-release),Oral,02300281,INVEGA (paliperidone 6 mg prolonged-release oral tablet) JANSSEN INC,Active,9004338,paliperidone 6 mg prolonged-release oral tablet,8001298,paliperidone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78561,Marketed,2007-10-02,02300303,Invega,1,N05AX13,Paliperidone,Tablet (extended-release),Oral,02300303,INVEGA (paliperidone 9 mg prolonged-release oral tablet) JANSSEN INC,Active,9004339,paliperidone 9 mg prolonged-release oral tablet,8001298,paliperidone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83941,Marketed,2010-07-21,02354217,Invega Sustenna,1,N05AX13,Paliperidone,Suspension (extended-release),Intramuscular,02354217,INVEGA SUSTENNA (paliperidone (paliperidone palmitate) 50 mg per 0.5 mL prolonged-release suspension for injection syringe) JANSSEN INC,Active,9012682,paliperidone (paliperidone palmitate) 50 mg per 0.5 mL prolonged-release suspension for injection syringe,8001298,paliperidone,738984000,Parenteral,420873008,Prolonged-release suspension for injection,733020007,Syringe (unit of presentation),,,,Prescription
83942,Marketed,2010-07-21,02354225,Invega Sustenna,1,N05AX13,Paliperidone,Suspension (extended-release),Intramuscular,02354225,INVEGA SUSTENNA (paliperidone (paliperidone palmitate) 75 mg per 0.75 mL prolonged-release suspension for injection syringe) JANSSEN INC,Active,9012684,paliperidone (paliperidone palmitate) 75 mg per 0.75 mL prolonged-release suspension for injection syringe,8001298,paliperidone,738984000,Parenteral,420873008,Prolonged-release suspension for injection,733020007,Syringe (unit of presentation),,,,Prescription
83943,Marketed,2010-07-21,02354233,Invega Sustenna,1,N05AX13,Paliperidone,Suspension (extended-release),Intramuscular,02354233,INVEGA SUSTENNA (paliperidone (paliperidone palmitate) 100 mg per 1 mL prolonged-release suspension for injection syringe) JANSSEN INC,Active,9012677,paliperidone (paliperidone palmitate) 100 mg per 1 mL prolonged-release suspension for injection syringe,8001298,paliperidone,738984000,Parenteral,420873008,Prolonged-release suspension for injection,733020007,Syringe (unit of presentation),,,,Prescription
83944,Marketed,2010-07-21,02354241,Invega Sustenna,1,N05AX13,Paliperidone,Suspension (extended-release),Intramuscular,02354241,INVEGA SUSTENNA (paliperidone (paliperidone palmitate) 150 mg per 1.5 mL prolonged-release suspension for injection syringe) JANSSEN INC,Active,9012678,paliperidone (paliperidone palmitate) 150 mg per 1.5 mL prolonged-release suspension for injection syringe,8001298,paliperidone,738984000,Parenteral,420873008,Prolonged-release suspension for injection,733020007,Syringe (unit of presentation),,,,Prescription
94281,Marketed,2016-07-25,02455943,Invega Trinza,1,N05AX13,Paliperidone,Suspension (extended-release),Intramuscular,02455943,INVEGA TRINZA (paliperidone (paliperidone palmitate) 175 mg per 0.875 mL prolonged-release suspension for injection syringe) JANSSEN INC,Active,9012679,paliperidone (paliperidone palmitate) 175 mg per 0.875 mL prolonged-release suspension for injection syringe,8001298,paliperidone,738984000,Parenteral,420873008,Prolonged-release suspension for injection,733020007,Syringe (unit of presentation),,,,Prescription
94284,Marketed,2016-07-25,02455986,Invega Trinza,1,N05AX13,Paliperidone,Suspension (extended-release),Intramuscular,02455986,INVEGA TRINZA (paliperidone (paliperidone palmitate) 263 mg per 1.315 mL prolonged-release suspension for injection syringe) JANSSEN INC,Active,9012680,paliperidone (paliperidone palmitate) 263 mg per 1.315 mL prolonged-release suspension for injection syringe,8001298,paliperidone,738984000,Parenteral,420873008,Prolonged-release suspension for injection,733020007,Syringe (unit of presentation),,,,Prescription
94285,Marketed,2016-07-25,02455994,Invega Trinza,1,N05AX13,Paliperidone,Suspension (extended-release),Intramuscular,02455994,INVEGA TRINZA (paliperidone (paliperidone palmitate) 350 mg per 1.75 mL prolonged-release suspension for injection syringe) JANSSEN INC,Active,9012681,paliperidone (paliperidone palmitate) 350 mg per 1.75 mL prolonged-release suspension for injection syringe,8001298,paliperidone,738984000,Parenteral,420873008,Prolonged-release suspension for injection,733020007,Syringe (unit of presentation),,,,Prescription
94286,Marketed,2016-07-25,02456001,Invega Trinza,1,N05AX13,Paliperidone,Suspension (extended-release),Intramuscular,02456001,INVEGA TRINZA (paliperidone (paliperidone palmitate) 525 mg per 2.625 mL prolonged-release suspension for injection syringe) JANSSEN INC,Active,9012683,paliperidone (paliperidone palmitate) 525 mg per 2.625 mL prolonged-release suspension for injection syringe,8001298,paliperidone,738984000,Parenteral,420873008,Prolonged-release suspension for injection,733020007,Syringe (unit of presentation),,,,Prescription
92275,Marketed,2022-03-24,02438372,Synagis,1,J06BD01,Palivizumab,Solution,Intramuscular,02438372,SYNAGIS (palivizumab 50 mg per 0.5 mL solution for injection vial) ASTRAZENECA CANADA INC,Active,9013491,palivizumab 50 mg per 0.5 mL solution for injection vial,8002049,palivizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
92275,Marketed,2022-03-24,02438372,Synagis,1,J06BD01,Palivizumab,Solution,Intramuscular,02438372,SYNAGIS (palivizumab 50 mg per 0.5 mL solution for injection vial) ASTRAZENECA CANADA INC,Active,9013491,palivizumab 50 mg per 0.5 mL solution for injection vial,8002049,palivizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
86757,Marketed,2022-12-02,02381710,Aloxi,1,A04AA05,Palonosetron,Solution,Intravenous,02381710,ALOXI (palonosetron (palonosetron hydrochloride) 0.25 mg per 5 mL solution for injection vial) KNIGHT THERAPEUTICS INC.,Active,9012589,palonosetron (palonosetron hydrochloride) 0.25 mg per 5 mL solution for injection vial,8001153,palonosetron,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
95721,Marketed,2022-11-30,02468735,Akynzeo,2,A04AA55,"Palonosetron, combinations",Capsule,Oral,02468735,AKYNZEO (netupitant 300 mg and palonosetron (palonosetron hydrochloride) 0.5 mg oral capsule) KNIGHT THERAPEUTICS INC.,Active,9012525,netupitant 300 mg and palonosetron (palonosetron hydrochloride) 0.5 mg oral capsule,8001152,netupitant and palonosetron,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
101365,Marketed,2022-06-20,02524627,Sohonos,1,M09AX11,Palovarotene,Capsule,Oral,02524627,SOHONOS (palovarotene 1 mg oral capsule) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9014723,palovarotene 1 mg oral capsule,8002426,palovarotene,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
101366,Marketed,2022-06-20,02524635,Sohonos,1,M09AX11,Palovarotene,Capsule,Oral,02524635,SOHONOS (palovarotene 1.5 mg oral capsule) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9014724,palovarotene 1.5 mg oral capsule,8002426,palovarotene,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
101367,Marketed,2022-06-20,02524643,Sohonos,1,M09AX11,Palovarotene,Capsule,Oral,02524643,SOHONOS (palovarotene 2.5 mg oral capsule) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9014726,palovarotene 2.5 mg oral capsule,8002426,palovarotene,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
101368,Marketed,2022-06-20,02524651,Sohonos,1,M09AX11,Palovarotene,Capsule,Oral,02524651,SOHONOS (palovarotene 5 mg oral capsule) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9014727,palovarotene 5 mg oral capsule,8002426,palovarotene,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
101369,Marketed,2022-06-20,02524678,Sohonos,1,M09AX11,Palovarotene,Capsule,Oral,02524678,SOHONOS (palovarotene 10 mg oral capsule) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9014725,palovarotene 10 mg oral capsule,8002426,palovarotene,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
68533,Marketed,2018-02-21,02244550,Pamidronate Disodium For Injection,1,M05BA03,Pamidronic acid,Solution,Intravenous,02244550,PAMIDRONATE DISODIUM FOR INJECTION (pamidronate disodium 30 mg per 10 mL solution for injection vial) PFIZER CANADA ULC,Active,9012745,pamidronate disodium 30 mg per 10 mL solution for injection vial,8001410,pamidronate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
68534,Marketed,2018-03-21,02244551,Pamidronate Disodium For Injection,1,M05BA03,Pamidronic acid,Solution,Intravenous,02244551,PAMIDRONATE DISODIUM FOR INJECTION (pamidronate disodium 60 mg per 10 mL solution for injection vial) PFIZER CANADA ULC,Active,9012746,pamidronate disodium 60 mg per 10 mL solution for injection vial,8001410,pamidronate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
68535,Marketed,2018-07-25,02244552,Pamidronate Disodium For Injection,1,M05BA03,Pamidronic acid,Solution,Intravenous,02244552,PAMIDRONATE DISODIUM FOR INJECTION (pamidronate disodium 90 mg per 10 mL solution for injection vial) PFIZER CANADA ULC,Active,9012747,pamidronate disodium 90 mg per 10 mL solution for injection vial,8001410,pamidronate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
70784,Marketed,2015-07-07,02246597,Pamidronate Disodium For Injection,1,M05BA03,Pamidronic acid,Solution,Intravenous,02246597,PAMIDRONATE DISODIUM FOR INJECTION (pamidronate disodium 30 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9012745,pamidronate disodium 30 mg per 10 mL solution for injection vial,8001410,pamidronate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
70785,Marketed,2015-07-07,02246598,Pamidronate Disodium For Injection,1,M05BA03,Pamidronic acid,Solution,Intravenous,02246598,PAMIDRONATE DISODIUM FOR INJECTION (pamidronate disodium 60 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9012746,pamidronate disodium 60 mg per 10 mL solution for injection vial,8001410,pamidronate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
70786,Marketed,2015-07-09,02246599,Pamidronate Disodium For Injection,1,M05BA03,Pamidronic acid,Solution,Intravenous,02246599,PAMIDRONATE DISODIUM FOR INJECTION (pamidronate disodium 90 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9012747,pamidronate disodium 90 mg per 10 mL solution for injection vial,8001410,pamidronate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
73448,Marketed,2006-05-24,02249677,Pamidronate Disodium Omega 6 mg/mL,1,M05BA03,Pamidronic acid,Solution,Intravenous,02249677,PAMIDRONATE DISODIUM OMEGA 6 MG/ML (pamidronate disodium 60 mg per 10 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9012746,pamidronate disodium 60 mg per 10 mL solution for injection vial,8001410,pamidronate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
73449,Marketed,2005-07-27,02249685,Pamidronate Disodium Omega 9 mg/mL,1,M05BA03,Pamidronic acid,Solution,Intravenous,02249685,PAMIDRONATE DISODIUM OMEGA 9 MG/ML (pamidronate disodium 90 mg per 10 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9012747,pamidronate disodium 90 mg per 10 mL solution for injection vial,8001410,pamidronate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
79412,Marketed,2008-05-27,02308487,Vectibix,1,L01FE02,Panitumumab,Solution,Intravenous,02308487,VECTIBIX (panitumumab 100 mg per 5 mL solution for injection vial) AMGEN CANADA INC,Active,9013492,panitumumab 100 mg per 5 mL solution for injection vial,8002051,panitumumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
79412,Marketed,2008-05-27,02308487,Vectibix,1,L01FE02,Panitumumab,Solution,Intravenous,02308487,VECTIBIX (panitumumab 100 mg per 5 mL solution for injection vial) AMGEN CANADA INC,Active,9013492,panitumumab 100 mg per 5 mL solution for injection vial,8002051,panitumumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
79414,Marketed,2017-01-03,02308509,Vectibix,1,L01FE02,Panitumumab,Solution,Intravenous,02308509,VECTIBIX (panitumumab 400 mg per 20 mL solution for injection vial) AMGEN CANADA INC,Active,9013493,panitumumab 400 mg per 20 mL solution for injection vial,8002051,panitumumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
79414,Marketed,2017-01-03,02308509,Vectibix,1,L01FE02,Panitumumab,Solution,Intravenous,02308509,VECTIBIX (panitumumab 400 mg per 20 mL solution for injection vial) AMGEN CANADA INC,Active,9013493,panitumumab 400 mg per 20 mL solution for injection vial,8002051,panitumumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
100525,Marketed,2022-03-25,02515857,Pantoprazole Sodium For Injection,1,A02BC02,Pantoprazole,Powder for solution,Intravenous,02515857,PANTOPRAZOLE SODIUM FOR INJECTION (pantoprazole (pantoprazole sodium) 40 mg per vial powder for solution for injection) JAMP PHARMA CORPORATION,Active,9001196,pantoprazole (pantoprazole sodium) 40 mg per vial powder for solution for injection,8000236,pantoprazole,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
100878,Marketed,2023-02-07,02519534,Pantoprazole Magnesium,1,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02519534,PANTOPRAZOLE MAGNESIUM (pantoprazole (pantoprazole magnesium hemipentahydrate) 40 mg gastro-resistant tablet) SIVEM PHARMACEUTICALS ULC,Active,9001139,pantoprazole (pantoprazole magnesium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101802,Marketed,2024-10-29,02528835,Pantoprazole For Injection,1,A02BC02,Pantoprazole,Powder for solution,Intravenous,02528835,PANTOPRAZOLE FOR INJECTION (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg per vial powder for solution for injection) EUGIA PHARMA INC.,Active,9001196,pantoprazole (pantoprazole sodium) 40 mg per vial powder for solution for injection,8000236,pantoprazole,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
102493,Marketed,2023-11-17,02536137,Pantoprazole,1,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02536137,PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 20 mg gastro-resistant tablet) SANIS HEALTH INC,Active,9000895,pantoprazole (pantoprazole sodium) 20 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103598,Marketed,2024-11-01,02547368,Pantoprazole,1,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02547368,PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) 10445517 CANADA INC / NORTH PHARMACEUTICALS / DAC PHARMACEUTICALS,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106065,Marketed,2025-10-03,02557304,NB-Pantoprazole,1,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02557304,NB-PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) NB PHARMA INC.,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
47339,Marketed,2013-01-09,02229453,Pantoloc,1,A02BC02,Pantoprazole,Tablet (enteric-coated),Oral,02229453,PANTOLOC (pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet) TAKEDA CANADA INC,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
65469,Marketed,2013-01-09,02241804,Pantoloc,1,A02BC02,Pantoprazole,Tablet (enteric-coated),Oral,02241804,PANTOLOC (pantoprazole (pantoprazole sodium) 20 mg gastro-resistant tablet) TAKEDA CANADA INC,Active,9000895,pantoprazole (pantoprazole sodium) 20 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75263,Marketed,2013-06-21,02267233,Tecta,1,A02BC02,Pantoprazole,Tablet (enteric-coated),Oral,02267233,TECTA (pantoprazole (pantoprazole magnesium) 40 mg gastro-resistant tablet) TAKEDA CANADA INC,Active,9001139,pantoprazole (pantoprazole magnesium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77096,Marketed,2023-03-22,02285479,Teva-Pantoprazole,1,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02285479,TEVA-PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 20 mg gastro-resistant tablet) TEVA CANADA LIMITED,Active,9000895,pantoprazole (pantoprazole sodium) 20 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77097,Marketed,2023-03-22,02285487,Teva-Pantoprazole,1,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02285487,TEVA-PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) TEVA CANADA LIMITED,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77826,Marketed,2008-03-05,02292912,Apo-Pantoprazole,1,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02292912,APO-PANTOPRAZOLE (pantoprazole (pantoprazole sodium) 20 mg gastro-resistant tablet) APOTEX INC,Active,9000895,pantoprazole (pantoprazole sodium) 20 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77827,Marketed,2008-03-05,02292920,Apo-Pantoprazole,1,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02292920,APO-PANTOPRAZOLE (pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet) APOTEX INC,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78642,Marketed,2008-06-03,02301075,Sandoz Pantoprazole,1,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02301075,SANDOZ PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 20 mg gastro-resistant tablet) SANDOZ CANADA INCORPORATED,Active,9000895,pantoprazole (pantoprazole sodium) 20 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78643,Marketed,2008-06-03,02301083,Sandoz Pantoprazole,1,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02301083,SANDOZ PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) SANDOZ CANADA INCORPORATED,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79041,Marketed,2025-10-09,02305046,SPC-Pantoprazole,1,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02305046,SPC-PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) SUN PHARMA CANADA INC,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79242,Marketed,2008-03-11,02306727,Pantoprazole Sodium For Injection,1,A02BC02,Pantoprazole,Powder for solution,Intravenous,02306727,PANTOPRAZOLE SODIUM FOR INJECTION (pantoprazole (pantoprazole sodium) 40 mg per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9001196,pantoprazole (pantoprazole sodium) 40 mg per vial powder for solution for injection,8000236,pantoprazole,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
79355,Marketed,2008-06-04,02307871,PMS-Pantoprazole,1,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02307871,PMS-PANTOPRAZOLE (pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet) PHARMASCIENCE INC,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80417,Marketed,2009-01-29,02318695,Pantoprazole,1,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02318695,PANTOPRAZOLE (pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet) PRO DOC LIMITEE,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83745,Marketed,2015-11-03,02352214,Pantoprazole For Injection,1,A02BC02,Pantoprazole,Powder for solution,Intravenous,02352214,PANTOPRAZOLE FOR INJECTION (pantoprazole (pantoprazole sodium) 40 mg per vial powder for solution for injection) FRESENIUS KABI CANADA LTD,Active,9001196,pantoprazole (pantoprazole sodium) 40 mg per vial powder for solution for injection,8000236,pantoprazole,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
84215,Marketed,2020-06-15,02357054,JAMP-Pantoprazole,1,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02357054,JAMP-PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) JAMP PHARMA CORPORATION,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85592,Marketed,2023-10-30,02370808,Pantoprazole,1,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02370808,PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) SANIS HEALTH INC,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87787,Marketed,2021-11-26,02392615,JAMP Pantoprazole Sodium,1,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02392615,JAMP PANTOPRAZOLE SODIUM (pantoprazole (pantoprazole sodium sesquihydrate) 20 mg gastro-resistant tablet) JAMP PHARMA CORPORATION,Active,9000895,pantoprazole (pantoprazole sodium) 20 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87788,Marketed,2021-03-18,02392623,JAMP Pantoprazole Sodium,1,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02392623,JAMP PANTOPRAZOLE SODIUM (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) JAMP PHARMA CORPORATION,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89331,Marketed,2015-08-31,02408570,Mylan-Pantoprazole T,1,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02408570,MYLAN-PANTOPRAZOLE T (pantoprazole (pantoprazole magnesium hemipentahydrate) 40 mg gastro-resistant tablet) MYLAN PHARMACEUTICALS ULC,Active,9001139,pantoprazole (pantoprazole magnesium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89982,Marketed,2016-02-06,02415208,Auro-Pantoprazole,1,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02415208,AURO-PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) AURO PHARMA INC,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90116,Marketed,2014-07-18,02416565,Mar-Pantoprazole,1,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02416565,MAR-PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) MARCAN PHARMACEUTICALS INC,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90206,Marketed,2014-01-16,02417448,Mint-Pantoprazole,1,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02417448,MINT-PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) MINT PHARMACEUTICALS INC,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91265,Marketed,2024-03-21,02428172,Pantoprazole,1,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02428172,PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 20 mg gastro-resistant tablet) SIVEM PHARMACEUTICALS ULC,Active,9000895,pantoprazole (pantoprazole sodium) 20 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91266,Marketed,2025-10-01,02428180,Pantoprazole,1,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02428180,PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) SIVEM PHARMACEUTICALS ULC,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91574,Marketed,2014-10-16,02431327,Pantoprazole,1,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02431327,PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) LABORATOIRE RIVA INC.,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92500,Marketed,2015-11-16,02440628,Teva-Pantoprazole Magnesium,1,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02440628,TEVA-PANTOPRAZOLE MAGNESIUM (pantoprazole (pantoprazole magnesium) 40 mg gastro-resistant tablet) TEVA CANADA LIMITED,Active,9001139,pantoprazole (pantoprazole magnesium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92591,Marketed,2017-11-20,02441527,Pantoprazole Sodium For Injection,1,A02BC02,Pantoprazole,Powder for solution,Intravenous,02441527,PANTOPRAZOLE SODIUM FOR INJECTION (pantoprazole (pantoprazole sodium) 40 mg per vial powder for solution for injection) GENERIC MEDICAL PARTNERS INC,Active,9001196,pantoprazole (pantoprazole sodium) 40 mg per vial powder for solution for injection,8000236,pantoprazole,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
93114,Marketed,2024-03-13,02445867,Bio-Pantoprazole,1,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02445867,BIO-PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) BIOMED PHARMA,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94611,Marketed,2017-10-20,02458969,Pantoprazole For Injection,1,A02BC02,Pantoprazole,Powder for solution,Intravenous,02458969,PANTOPRAZOLE FOR INJECTION (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg per vial powder for solution for injection) AURO PHARMA INC,Active,9001196,pantoprazole (pantoprazole sodium) 40 mg per vial powder for solution for injection,8000236,pantoprazole,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
95445,Marketed,2017-10-25,02466147,Pantoprazole T,1,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02466147,PANTOPRAZOLE T (pantoprazole (pantoprazole magnesium hemipentahydrate) 40 mg gastro-resistant tablet) SANIS HEALTH INC,Active,9001139,pantoprazole (pantoprazole magnesium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95575,Marketed,2024-08-21,02467372,M-Pantoprazole,1,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02467372,M-PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) MANTRA PHARMA INC,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95779,Marketed,2025-11-11,02469138,Alta-Pantoprazole,1,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02469138,ALTA-PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) ALTAMED PHARMA,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96103,Marketed,2024-05-27,02471825,Nra-Pantoprazole,1,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02471825,NRA-PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) NORA PHARMA INC,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97204,Marketed,2018-12-27,02481588,AG-Pantoprazole Sodium,1,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02481588,AG-PANTOPRAZOLE SODIUM (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) ANGITA PHARMA INC.,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
160,Marketed,2005-08-20,00009881,Papaverine Hydrochloride Injection USP,1,A03AD01,Papaverine,Liquid,"Subcutaneous,Intravenous,Intramuscular",00009881,PAPAVERINE HYDROCHLORIDE INJECTION USP (papaverine hydrochloride 65 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013494,papaverine hydrochloride 65 mg per 2 mL solution for injection vial,8002052,papaverine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
82773,Marketed,2010-02-10,02342227,Cervarix,2,J07BM02,"Papillomavirus (human types 16,18)",Suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
92136,Marketed,2015-03-18,02437058,Gardasil 9,9,J07BM03,"Papillomavirus (human types 6,11,16,18,31,33,45,52,58)",Suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
16701,Marketed,2022-10-14,02078759,Humatin,1,A07AA06,Paromomycin,Capsule,Oral,02078759,HUMATIN (paromomycin (paromomycin sulfate) 250 mg oral capsule) SEARCHLIGHT PHARMA INC,Active,9002704,paromomycin (paromomycin sulfate) 250 mg oral capsule,8002053,paromomycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
14007,Marketed,2002-09-13,01940481,Paxil Tablets 20 mg,1,N06AB05,Paroxetine,Tablet,Oral,01940481,PAXIL TAB 20MG (paroxetine (paroxetine hydrochloride) 20 mg oral tablet) GLAXOSMITHKLINE INC,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
64498,Marketed,2003-10-24,02240907,Apo-Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02240907,APO-PAROXETINE (paroxetine (paroxetine hydrochloride) 10 mg oral tablet) APOTEX INC,Active,9000697,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
64499,Marketed,2003-10-24,02240908,Apo-Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02240908,APO-PAROXETINE (paroxetine (paroxetine hydrochloride) 20 mg oral tablet) APOTEX INC,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
64500,Marketed,2003-10-24,02240909,Apo-Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02240909,APO-PAROXETINE (paroxetine (paroxetine hydrochloride) 30 mg oral tablet) APOTEX INC,Active,9000488,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
72042,Marketed,2018-09-05,02247750,PMS-Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02247750,PMS-PAROXETINE (paroxetine (paroxetine hydrochloride) 10 mg oral tablet) PHARMASCIENCE INC,Active,9000697,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
72043,Marketed,2003-10-29,02247751,PMS-Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02247751,PMS-PAROXETINE (paroxetine (paroxetine hydrochloride) 20 mg oral tablet) PHARMASCIENCE INC,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
72044,Marketed,2003-10-29,02247752,PMS-Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02247752,PMS-PAROXETINE (paroxetine (paroxetine hydrochloride) 30 mg oral tablet) PHARMASCIENCE INC,Active,9000488,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
72855,Marketed,2004-01-05,02248503,Paxil CR,1,N06AB05,Paroxetine,Tablet (extended-release),Oral,02248503,PAXIL CR (paroxetine (paroxetine hydrochloride) 12.5 mg prolonged-release oral tablet) GLAXOSMITHKLINE INC,Active,9001066,paroxetine (paroxetine hydrochloride) 12.5 mg prolonged-release oral tablet,8000185,paroxetine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
72856,Marketed,2004-01-05,02248504,Paxil CR,1,N06AB05,Paroxetine,Tablet (extended-release),Oral,02248504,PAXIL CR (paroxetine (paroxetine hydrochloride) 25 mg prolonged-release oral tablet) GLAXOSMITHKLINE INC,Active,9001067,paroxetine (paroxetine hydrochloride) 25 mg prolonged-release oral tablet,8000185,paroxetine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
72911,Marketed,2024-02-15,02248556,Teva-Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02248556,TEVA-PAROXETINE (paroxetine (paroxetine hydrochloride acetone solvate) 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000697,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
72912,Marketed,2024-02-15,02248557,Teva-Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02248557,TEVA-PAROXETINE (paroxetine (paroxetine hydrochloride acetone solvate) 20 mg oral tablet) TEVA CANADA LIMITED,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
72913,Marketed,2024-02-15,02248558,Teva-Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02248558,TEVA-PAROXETINE (paroxetine (paroxetine hydrochloride acetone solvate) 30 mg oral tablet) TEVA CANADA LIMITED,Active,9000488,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
72914,Marketed,2016-04-22,02248559,Riva-Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02248559,RIVA-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 10 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000697,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
72915,Marketed,2016-04-22,02248560,Riva-Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02248560,RIVA-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 20 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
72916,Marketed,2016-04-22,02248561,Riva-Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02248561,RIVA-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 30 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000488,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
73287,Marketed,2026-02-19,02248913,Pro-Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02248913,PRO-PAROXETINE (paroxetine (paroxetine hydrochloride) 10 mg oral tablet) PRO DOC LIMITEE,Active,9000697,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
73288,Marketed,2025-10-16,02248914,Pro-Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02248914,PRO-PAROXETINE (paroxetine (paroxetine hydrochloride) 20 mg oral tablet) PRO DOC LIMITEE,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
73289,Marketed,2026-02-10,02248915,Pro-Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02248915,PRO-PAROXETINE (paroxetine (paroxetine hydrochloride) 30 mg oral tablet) PRO DOC LIMITEE,Active,9000488,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
76846,Marketed,2021-09-27,02282844,Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02282844,PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 10 mg oral tablet) SANIS HEALTH INC,Active,9000697,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
76847,Marketed,2021-09-27,02282852,Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02282852,PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 20 mg oral tablet) SANIS HEALTH INC,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
76848,Marketed,2021-09-27,02282860,Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02282860,PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 30 mg oral tablet) SANIS HEALTH INC,Active,9000488,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
85384,Marketed,2016-01-18,02368870,JAMP-Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02368870,JAMP-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
86903,Marketed,2012-07-24,02383276,Auro-Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02383276,AURO-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 10 mg oral tablet) AURO PHARMA INC,Active,9000697,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
86904,Marketed,2012-07-24,02383284,Auro-Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02383284,AURO-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 20 mg oral tablet) AURO PHARMA INC,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
86905,Marketed,2012-07-24,02383292,Auro-Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02383292,AURO-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 30 mg oral tablet) AURO PHARMA INC,Active,9000488,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
87377,Marketed,2016-02-09,02388227,Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02388227,PAROXETINE (paroxetine (paroxetine hydrochloride) 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000697,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
87378,Marketed,2016-02-09,02388235,Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02388235,PAROXETINE (paroxetine (paroxetine hydrochloride) 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
87379,Marketed,2016-02-09,02388243,Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02388243,PAROXETINE (paroxetine (paroxetine hydrochloride) 30 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000488,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
89652,Marketed,2014-06-24,02411954,Mar-Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02411954,MAR-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 20 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
89654,Marketed,2014-06-24,02411946,Mar-Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02411946,MAR-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000697,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
89655,Marketed,2014-06-24,02411962,Mar-Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02411962,MAR-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 30 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000488,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
90600,Marketed,2014-03-17,02421372,Mint-Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02421372,MINT-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000697,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
90601,Marketed,2014-03-17,02421380,Mint-Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02421380,MINT-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 20 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
90602,Marketed,2014-03-17,02421399,Mint-Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02421399,MINT-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 30 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000488,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
93013,Marketed,2016-12-21,02444909,Bio-Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02444909,BIO-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 10 mg oral tablet) BIOMED PHARMA,Active,9000697,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
93014,Marketed,2016-12-21,02444917,Bio-Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02444917,BIO-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 20 mg oral tablet) BIOMED PHARMA,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
93015,Marketed,2016-12-21,02444925,Bio-Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02444925,BIO-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 30 mg oral tablet) BIOMED PHARMA,Active,9000488,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
95578,Marketed,2018-03-07,02467402,M-Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02467402,M-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 10 mg oral tablet) MANTRA PHARMA INC,Active,9000697,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
95579,Marketed,2018-03-07,02467410,M-Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02467410,M-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 20 mg oral tablet) MANTRA PHARMA INC,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
95580,Marketed,2018-07-30,02467429,M-Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02467429,M-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 30 mg oral tablet) MANTRA PHARMA INC,Active,9000488,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
96844,Marketed,2023-03-22,02477823,Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02477823,PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 10 mg oral tablet) ALTAMED PHARMA,Active,9000697,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
96845,Marketed,2023-02-22,02477831,Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02477831,PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 20 mg oral tablet) ALTAMED PHARMA,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
96846,Marketed,2023-03-29,02477858,Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02477858,PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 30 mg oral tablet) ALTAMED PHARMA,Active,9000488,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
97010,Marketed,2018-12-10,02479753,Nra-Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02479753,NRA-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 10 mg oral tablet) NORA PHARMA INC,Active,9000697,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
97011,Marketed,2018-12-10,02479761,Nra-Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02479761,NRA-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 20 mg oral tablet) NORA PHARMA INC,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
97012,Marketed,2018-12-10,02479788,Nra-Paroxetine,1,N06AB05,Paroxetine,Tablet,Oral,02479788,NRA-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 30 mg oral tablet) NORA PHARMA INC,Active,9000488,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99717,Marketed,2022-01-03,02507773,JAMP Paroxetine Tablets,1,N06AB05,Paroxetine,Tablet,Oral,02507773,JAMP PAROXETINE TABLETS (paroxetine (paroxetine hydrochloride) 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000697,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99718,Marketed,2022-01-03,02507781,JAMP Paroxetine Tablets,1,N06AB05,Paroxetine,Tablet,Oral,02507781,JAMP PAROXETINE TABLETS (paroxetine (paroxetine hydrochloride) 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99719,Marketed,2021-12-30,02507803,JAMP Paroxetine Tablets,1,N06AB05,Paroxetine,Tablet,Oral,02507803,JAMP PAROXETINE TABLETS (paroxetine (paroxetine hydrochloride) 30 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000488,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99970,Marketed,2022-03-18,02510480,AG-Paroxetine Tablets,1,N06AB05,Paroxetine,Tablet,Oral,02510480,AG-PAROXETINE TABLETS (paroxetine (paroxetine hydrochloride) 10 mg oral tablet) ANGITA PHARMA INC.,Active,9000697,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99971,Marketed,2022-03-18,02510499,AG-Paroxetine Tablets,1,N06AB05,Paroxetine,Tablet,Oral,02510499,AG-PAROXETINE TABLETS (paroxetine (paroxetine hydrochloride) 20 mg oral tablet) ANGITA PHARMA INC.,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99973,Marketed,2022-03-18,02510510,AG-Paroxetine Tablets,1,N06AB05,Paroxetine,Tablet,Oral,02510510,AG-PAROXETINE TABLETS (paroxetine (paroxetine hydrochloride) 30 mg oral tablet) ANGITA PHARMA INC.,Active,9000488,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
89797,Marketed,2020-05-21,02413299,Signifor,1,H01CB05,Pasireotide,Solution,Subcutaneous,02413299,SIGNIFOR (pasireotide (pasireotide diaspartate) 0.3 mg per 1 mL solution for injection ampoule) RECORDATI RARE DISEASES CANADA INC,Active,9013495,pasireotide (pasireotide diaspartate) 0.3 mg per 1 mL solution for injection ampoule,8002054,pasireotide,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),1.0,,,Prescription
89798,Marketed,2020-05-21,02413302,Signifor,1,H01CB05,Pasireotide,Solution,Subcutaneous,02413302,SIGNIFOR (pasireotide (pasireotide diaspartate) 0.6 mg per 1 mL solution for injection ampoule) RECORDATI RARE DISEASES CANADA INC,Active,9013496,pasireotide (pasireotide diaspartate) 0.6 mg per 1 mL solution for injection ampoule,8002054,pasireotide,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),1.0,,,Prescription
89799,Marketed,2020-05-21,02413310,Signifor,1,H01CB05,Pasireotide,Solution,Subcutaneous,02413310,SIGNIFOR (pasireotide (pasireotide diaspartate) 0.9 mg per 1 mL solution for injection ampoule) RECORDATI RARE DISEASES CANADA INC,Active,9013497,pasireotide (pasireotide diaspartate) 0.9 mg per 1 mL solution for injection ampoule,8002054,pasireotide,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),1.0,,,Prescription
92155,Marketed,2020-05-21,02437252,Signifor Lar,1,H01CB05,Pasireotide,"Kit,Powder for suspension, sustained-release",Intramuscular,02437252,SIGNIFOR LAR (pasireotide (pasireotide pamoate) 20 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe) RECORDATI RARE DISEASES CANADA INC,Active,9013498,pasireotide (pasireotide pamoate) 20 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe,8002054,pasireotide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
92156,Marketed,2020-05-21,02437279,Signifor Lar,1,H01CB05,Pasireotide,"Powder for suspension, sustained-release,Kit",Intramuscular,02437279,SIGNIFOR LAR (pasireotide (pasireotide pamoate) 60 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe) RECORDATI RARE DISEASES CANADA INC,Active,9013500,pasireotide (pasireotide pamoate) 60 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe,8002054,pasireotide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
92157,Marketed,2020-05-21,02437260,Signifor Lar,1,H01CB05,Pasireotide,"Powder for suspension, sustained-release,Kit",Intramuscular,02437260,SIGNIFOR LAR (pasireotide (pasireotide pamoate) 40 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe) RECORDATI RARE DISEASES CANADA INC,Active,9013499,pasireotide (pasireotide pamoate) 40 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe,8002054,pasireotide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
97095,Marketed,2020-05-21,02480425,Signifor Lar,1,H01CB05,Pasireotide,"Powder for suspension, sustained-release,Kit",Intramuscular,02480425,SIGNIFOR LAR (pasireotide (pasireotide pamoate) 10 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe) RECORDATI RARE DISEASES CANADA INC,Active,9014055,pasireotide (pasireotide pamoate) 10 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe,8002054,pasireotide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
97096,Marketed,2020-05-21,02480433,Signifor Lar,1,H01CB05,Pasireotide,"Powder for suspension, sustained-release,Kit",Intramuscular,02480433,SIGNIFOR LAR (pasireotide (pasireotide pamoate) 30 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe) RECORDATI RARE DISEASES CANADA INC,Active,9014057,pasireotide (pasireotide pamoate) 30 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe,8002054,pasireotide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
97184,Marketed,2020-03-09,02481359,Veltassa,1,V03AE09,Patiromer calcium,Powder for suspension,Oral,02481359,VELTASSA (patiromer (patiromer sorbitex calcium) 8.4 g per sachet powder for oral suspension) VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD,Active,9014272,patiromer (patiromer sorbitex calcium) 8.4 g per sachet powder for oral suspension,8002310,patiromer,26643006,Oral,385027000,Powder for oral suspension,733013000,Sachet (unit of presentation),,,,Prescription
97185,Marketed,2019-11-27,02481367,Veltassa,1,V03AE09,Patiromer calcium,Powder for suspension,Oral,02481367,VELTASSA (patiromer (patiromer sorbitex calcium) 16.8 g per sachet powder for oral suspension) VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD,Active,9014227,patiromer (patiromer sorbitex calcium) 16.8 g per sachet powder for oral suspension,8002310,patiromer,26643006,Oral,385027000,Powder for oral suspension,733013000,Sachet (unit of presentation),,,,Prescription
97933,Marketed,2019-07-25,02489252,Onpattro,1,N07XX12,Patisiran,Solution,Intravenous,02489252,ONPATTRO (patisiran (patisiran sodium lipid complex) 10 mg per 5 mL solution for injection vial) ALNYLAM NETHERLANDS B.V.,Active,9014156,patisiran (patisiran sodium lipid complex) 10 mg per 5 mL solution for injection vial,8002298,patisiran (lipid complex),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
101466,Marketed,2022-08-31,02525666,PMS-Pazopanib,1,L01EX03,Pazopanib,Tablet,Oral,02525666,PMS-PAZOPANIB (pazopanib (pazopanib hydrochloride) 200 mg oral tablet) PHARMASCIENCE INC,Active,9004763,pazopanib (pazopanib hydrochloride) 200 mg oral tablet,8002055,pazopanib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
104192,Marketed,2026-01-02,02552957,Auro-Pazopanib,1,L01EX03,Pazopanib,Tablet,Oral,02552957,AURO-PAZOPANIB (pazopanib (pazopanib hydrochloride) 200 mg oral tablet) AURO PHARMA INC,Active,9004763,pazopanib (pazopanib hydrochloride) 200 mg oral tablet,8002055,pazopanib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
83758,Marketed,2016-09-07,02352303,Votrient,1,L01EX03,Pazopanib,Tablet,Oral,02352303,VOTRIENT (pazopanib (pazopanib hydrochloride) 200 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9004763,pazopanib (pazopanib hydrochloride) 200 mg oral tablet,8002055,pazopanib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
94965,Marketed,2019-05-27,02461900,Oncaspar,1,L01XX24,Pegaspargase,Solution,"Intravenous,Intramuscular",02461900,ONCASPAR (pegaspargase 3750 unit per 5 mL solution for injection vial) SERVIER CANADA INC,Active,9013501,pegaspargase 3750 unit per 5 mL solution for injection vial,8002056,pegaspargase,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
94965,Marketed,2019-05-27,02461900,Oncaspar,1,L01XX24,Pegaspargase,Solution,"Intravenous,Intramuscular",02461900,ONCASPAR (pegaspargase 3750 unit per 5 mL solution for injection vial) SERVIER CANADA INC,Active,9013501,pegaspargase 3750 unit per 5 mL solution for injection vial,8002056,pegaspargase,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
102229,Marketed,2023-02-15,02533294,Empaveli,1,L04AJ03,Pegcetacoplan,Solution,Subcutaneous,02533294,EMPAVELI (pegcetacoplan 1080 mg per 20 mL solution for injection vial) SWEDISH ORPHAN BIOVITRUM AB (PUBL),Active,9014841,pegcetacoplan 1080 mg per 20 mL solution for injection vial,8002464,pegcetacoplan,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
101856,Marketed,2022-11-28,02529343,Lapelga,1,L03AA13,Pegfilgrastim,Solution,Subcutaneous,02529343,LAPELGA SINGLE-USE PRE-FILLED AUTOINJECTOR (filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe) APOTEX INC,Active,9013502,filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe,8002057,filgrastim (pegfilgrastim),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
101856,Marketed,2022-11-28,02529343,Lapelga,1,L03AA13,Pegfilgrastim,Solution,Subcutaneous,02529343,LAPELGA SINGLE-USE PRE-FILLED AUTOINJECTOR (filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe) APOTEX INC,Active,9013502,filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe,8002057,filgrastim (pegfilgrastim),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
103564,Marketed,2025-02-12,02546973,Niopeg,1,L03AA13,Pegfilgrastim,Solution,Subcutaneous,02546973,NIOPEG (filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe) NORA PHARMA INC,Active,9013502,filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe,8002057,filgrastim (pegfilgrastim),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
103564,Marketed,2025-02-12,02546973,Niopeg,1,L03AA13,Pegfilgrastim,Solution,Subcutaneous,02546973,NIOPEG (filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe) NORA PHARMA INC,Active,9013502,filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe,8002057,filgrastim (pegfilgrastim),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
104284,Marketed,2025-09-09,02553945,Pexegra,1,L03AA13,Pegfilgrastim,Solution,Subcutaneous,02553945,PEXEGRA (filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe) JAMP PHARMA CORPORATION,Active,9013502,filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe,8002057,filgrastim (pegfilgrastim),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
104284,Marketed,2025-09-09,02553945,Pexegra,1,L03AA13,Pegfilgrastim,Solution,Subcutaneous,02553945,PEXEGRA (filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe) JAMP PHARMA CORPORATION,Active,9013502,filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe,8002057,filgrastim (pegfilgrastim),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
73463,Marketed,2004-03-12,02249790,Neulasta,1,L03AA13,Pegfilgrastim,Solution,Subcutaneous,02249790,NEULASTA (filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe) AMGEN CANADA INC,Active,9013502,filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe,8002057,filgrastim (pegfilgrastim),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
73463,Marketed,2004-03-12,02249790,Neulasta,1,L03AA13,Pegfilgrastim,Solution,Subcutaneous,02249790,NEULASTA (filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe) AMGEN CANADA INC,Active,9013502,filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe,8002057,filgrastim (pegfilgrastim),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
96479,Marketed,2019-02-27,02474565,Lapelga,1,L03AA13,Pegfilgrastim,Solution,Subcutaneous,02474565,LAPELGA SINGLE-USE PREFILLED SYRINGE (filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe) APOTEX INC,Active,9013502,filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe,8002057,filgrastim (pegfilgrastim),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
96479,Marketed,2019-02-27,02474565,Lapelga,1,L03AA13,Pegfilgrastim,Solution,Subcutaneous,02474565,LAPELGA SINGLE-USE PREFILLED SYRINGE (filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe) APOTEX INC,Active,9013502,filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe,8002057,filgrastim (pegfilgrastim),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
97449,Marketed,2024-04-04,02484153,Fulphila,1,L03AA13,Pegfilgrastim,Solution,Subcutaneous,02484153,FULPHILA (filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe) BIOSIMILAR COLLABORATIONS IRELAND LIMITED,Active,9013502,filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe,8002057,filgrastim (pegfilgrastim),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
97449,Marketed,2024-04-04,02484153,Fulphila,1,L03AA13,Pegfilgrastim,Solution,Subcutaneous,02484153,FULPHILA (filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe) BIOSIMILAR COLLABORATIONS IRELAND LIMITED,Active,9013502,filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe,8002057,filgrastim (pegfilgrastim),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
98722,Marketed,2020-05-15,02497395,Ziextenzo,1,L03AA13,Pegfilgrastim,Solution,Subcutaneous,02497395,ZIEXTENZO (filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9013502,filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe,8002057,filgrastim (pegfilgrastim),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
98722,Marketed,2020-05-15,02497395,Ziextenzo,1,L03AA13,Pegfilgrastim,Solution,Subcutaneous,02497395,ZIEXTENZO (filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9013502,filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe,8002057,filgrastim (pegfilgrastim),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
99556,Marketed,2021-01-18,02506238,Nyvepria,1,L03AA13,Pegfilgrastim,Solution,Subcutaneous,02506238,NYVEPRIA (filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe) PFIZER CANADA ULC,Active,9013502,filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe,8002057,filgrastim (pegfilgrastim),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
99556,Marketed,2021-01-18,02506238,Nyvepria,1,L03AA13,Pegfilgrastim,Solution,Subcutaneous,02506238,NYVEPRIA (filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe) PFIZER CANADA ULC,Active,9013502,filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe,8002057,filgrastim (pegfilgrastim),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
72399,Marketed,2024-06-03,02248077,Pegasys,1,L03AB11,Peginterferon alfa-2a,Solution,Subcutaneous,02248077,PEGASYS (interferon alfa-2a (peginterferon alfa-2a) 180 mcg per 0.5 mL solution for injection syringe) PHARMAAND GMBH,Active,9014152,interferon alfa-2a (peginterferon alfa-2a) 180 mcg per 0.5 mL solution for injection syringe,8002294,interferon alfa-2a (peginterferon alfa-2a),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
72399,Marketed,2024-06-03,02248077,Pegasys,1,L03AB11,Peginterferon alfa-2a,Solution,Subcutaneous,02248077,PEGASYS (interferon alfa-2a (peginterferon alfa-2a) 180 mcg per 0.5 mL solution for injection syringe) PHARMAAND GMBH,Active,9014152,interferon alfa-2a (peginterferon alfa-2a) 180 mcg per 0.5 mL solution for injection syringe,8002294,interferon alfa-2a (peginterferon alfa-2a),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
92943,Marketed,2015-09-29,02444399,Plegridy,1,L03AB13,Peginterferon beta-1a,Liquid,Subcutaneous,02444399,PLEGRIDY (interferon beta-1a (peginterferon beta-1a) 125 mcg per 0.5 mL solution for injection syringe) BIOGEN CANADA INC,Active,9014153,interferon beta-1a (peginterferon beta-1a) 125 mcg per 0.5 mL solution for injection syringe,8002296,interferon beta-1a (peginterferon beta-1a),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
92943,Marketed,2015-09-29,02444399,Plegridy,1,L03AB13,Peginterferon beta-1a,Liquid,Subcutaneous,02444399,PLEGRIDY (interferon beta-1a (peginterferon beta-1a) 125 mcg per 0.5 mL solution for injection syringe) BIOGEN CANADA INC,Active,9014153,interferon beta-1a (peginterferon beta-1a) 125 mcg per 0.5 mL solution for injection syringe,8002296,interferon beta-1a (peginterferon beta-1a),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
92944,Marketed,2015-09-25,02444402,Plegridy,2,L03AB13,Peginterferon beta-1a,"Liquid,Kit",Subcutaneous,02444402,PLEGRIDY (interferon beta-1a (peginterferon beta-1a) 63 mcg per 0.5 mL solution for injection syringe with interferon beta-1a (peginterferon beta-1a) 94 mcg per 0.5 mL solution for injection syringe) BIOGEN CANADA INC,Active,9014175,interferon beta-1a (peginterferon beta-1a) 63 mcg per 0.5 mL solution for injection syringe with interferon beta-1a (peginterferon beta-1a) 94 mcg per 0.5 mL solution for injection syringe,8002296,interferon beta-1a (peginterferon beta-1a),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
92944,Marketed,2015-09-25,02444402,Plegridy,2,L03AB13,Peginterferon beta-1a,"Liquid,Kit",Subcutaneous,02444402,PLEGRIDY (interferon beta-1a (peginterferon beta-1a) 63 mcg per 0.5 mL solution for injection syringe with interferon beta-1a (peginterferon beta-1a) 94 mcg per 0.5 mL solution for injection syringe) BIOGEN CANADA INC,Active,9014175,interferon beta-1a (peginterferon beta-1a) 63 mcg per 0.5 mL solution for injection syringe with interferon beta-1a (peginterferon beta-1a) 94 mcg per 0.5 mL solution for injection syringe,8002296,interferon beta-1a (peginterferon beta-1a),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
101536,Marketed,2022-08-26,02526247,Palynziq,1,A16AB19,Pegvaliase,Solution,Subcutaneous,02526247,PALYNZIQ (pegvaliase 2.5 mg per 0.5 mL solution for injection syringe) BIOMARIN INTERNATIONAL LIMITED,Active,9014783,pegvaliase 2.5 mg per 0.5 mL solution for injection syringe,8002437,pegvaliase,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
101536,Marketed,2022-08-26,02526247,Palynziq,1,A16AB19,Pegvaliase,Solution,Subcutaneous,02526247,PALYNZIQ (pegvaliase 2.5 mg per 0.5 mL solution for injection syringe) BIOMARIN INTERNATIONAL LIMITED,Active,9014783,pegvaliase 2.5 mg per 0.5 mL solution for injection syringe,8002437,pegvaliase,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Schedule D
101537,Marketed,2022-08-26,02526255,Palynziq,1,A16AB19,Pegvaliase,Solution,Subcutaneous,02526255,PALYNZIQ (pegvaliase 10 mg per 0.5 mL solution for injection syringe) BIOMARIN INTERNATIONAL LIMITED,Active,9014782,pegvaliase 10 mg per 0.5 mL solution for injection syringe,8002437,pegvaliase,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Schedule D
101537,Marketed,2022-08-26,02526255,Palynziq,1,A16AB19,Pegvaliase,Solution,Subcutaneous,02526255,PALYNZIQ (pegvaliase 10 mg per 0.5 mL solution for injection syringe) BIOMARIN INTERNATIONAL LIMITED,Active,9014782,pegvaliase 10 mg per 0.5 mL solution for injection syringe,8002437,pegvaliase,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
101538,Marketed,2022-08-26,02526263,Palynziq,1,A16AB19,Pegvaliase,Solution,Subcutaneous,02526263,PALYNZIQ (pegvaliase 20 mg per 1 mL solution for injection syringe) BIOMARIN INTERNATIONAL LIMITED,Active,9014784,pegvaliase 20 mg per 1 mL solution for injection syringe,8002437,pegvaliase,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
101538,Marketed,2022-08-26,02526263,Palynziq,1,A16AB19,Pegvaliase,Solution,Subcutaneous,02526263,PALYNZIQ (pegvaliase 20 mg per 1 mL solution for injection syringe) BIOMARIN INTERNATIONAL LIMITED,Active,9014784,pegvaliase 20 mg per 1 mL solution for injection syringe,8002437,pegvaliase,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Schedule D
75772,Marketed,2006-01-24,02272199,Somavert,1,H01AX01,Pegvisomant,"Powder for solution,Kit",Subcutaneous,02272199,SOMAVERT (pegvisomant 10 mg per vial powder for solution for injection with diluent solution syringe) PFIZER CANADA ULC,Active,9013590,pegvisomant 10 mg per vial powder for solution for injection with diluent solution syringe,8002060,pegvisomant,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
75772,Marketed,2006-01-24,02272199,Somavert,1,H01AX01,Pegvisomant,"Powder for solution,Kit",Subcutaneous,02272199,SOMAVERT (pegvisomant 10 mg per vial powder for solution for injection with diluent solution syringe) PFIZER CANADA ULC,Active,9013590,pegvisomant 10 mg per vial powder for solution for injection with diluent solution syringe,8002060,pegvisomant,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
75774,Marketed,2006-01-24,02272202,Somavert,1,H01AX01,Pegvisomant,"Kit,Powder for solution",Subcutaneous,02272202,SOMAVERT (pegvisomant 15 mg per vial powder for solution for injection with diluent solution syringe) PFIZER CANADA ULC,Active,9013591,pegvisomant 15 mg per vial powder for solution for injection with diluent solution syringe,8002060,pegvisomant,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
75774,Marketed,2006-01-24,02272202,Somavert,1,H01AX01,Pegvisomant,"Kit,Powder for solution",Subcutaneous,02272202,SOMAVERT (pegvisomant 15 mg per vial powder for solution for injection with diluent solution syringe) PFIZER CANADA ULC,Active,9013591,pegvisomant 15 mg per vial powder for solution for injection with diluent solution syringe,8002060,pegvisomant,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
75775,Marketed,2006-01-24,02272210,Somavert,1,H01AX01,Pegvisomant,"Kit,Powder for solution",Subcutaneous,02272210,SOMAVERT (pegvisomant 20 mg per vial powder for solution for injection with diluent solution syringe) PFIZER CANADA ULC,Active,9013592,pegvisomant 20 mg per vial powder for solution for injection with diluent solution syringe,8002060,pegvisomant,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
75775,Marketed,2006-01-24,02272210,Somavert,1,H01AX01,Pegvisomant,"Kit,Powder for solution",Subcutaneous,02272210,SOMAVERT (pegvisomant 20 mg per vial powder for solution for injection with diluent solution syringe) PFIZER CANADA ULC,Active,9013592,pegvisomant 20 mg per vial powder for solution for injection with diluent solution syringe,8002060,pegvisomant,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
93460,Marketed,2016-03-10,02448831,Somavert,1,H01AX01,Pegvisomant,"Kit,Powder for solution",Subcutaneous,02448831,SOMAVERT (pegvisomant 25 mg per vial powder for solution for injection with diluent solution syringe) PFIZER CANADA ULC,Active,9013593,pegvisomant 25 mg per vial powder for solution for injection with diluent solution syringe,8002060,pegvisomant,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
93460,Marketed,2016-03-10,02448831,Somavert,1,H01AX01,Pegvisomant,"Kit,Powder for solution",Subcutaneous,02448831,SOMAVERT (pegvisomant 25 mg per vial powder for solution for injection with diluent solution syringe) PFIZER CANADA ULC,Active,9013593,pegvisomant 25 mg per vial powder for solution for injection with diluent solution syringe,8002060,pegvisomant,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
93461,Marketed,2016-03-10,02448858,Somavert,1,H01AX01,Pegvisomant,"Powder for solution,Kit",Subcutaneous,02448858,SOMAVERT (pegvisomant 30 mg per vial powder for solution for injection with diluent solution syringe) PFIZER CANADA ULC,Active,9013594,pegvisomant 30 mg per vial powder for solution for injection with diluent solution syringe,8002060,pegvisomant,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
93461,Marketed,2016-03-10,02448858,Somavert,1,H01AX01,Pegvisomant,"Powder for solution,Kit",Subcutaneous,02448858,SOMAVERT (pegvisomant 30 mg per vial powder for solution for injection with diluent solution syringe) PFIZER CANADA ULC,Active,9013594,pegvisomant 30 mg per vial powder for solution for injection with diluent solution syringe,8002060,pegvisomant,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
106799,Marketed,2026-03-05,02565382,Keytruda SC,1,L01FF02,Pembrolizumab,Solution,Subcutaneous,,,,,,,,,,,,,,,,,Prescription
106799,Marketed,2026-03-05,02565382,Keytruda SC,1,L01FF02,Pembrolizumab,Solution,Subcutaneous,,,,,,,,,,,,,,,,,Schedule D
94388,Marketed,2017-07-13,02456869,Keytruda,1,L01FF02,Pembrolizumab,Solution,Intravenous,02456869,KEYTRUDA (pembrolizumab 100 mg per 4 mL solution for injection vial) MERCK CANADA INC,Active,9013503,pembrolizumab 100 mg per 4 mL solution for injection vial,8002061,pembrolizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
94388,Marketed,2017-07-13,02456869,Keytruda,1,L01FF02,Pembrolizumab,Solution,Intravenous,02456869,KEYTRUDA (pembrolizumab 100 mg per 4 mL solution for injection vial) MERCK CANADA INC,Active,9013503,pembrolizumab 100 mg per 4 mL solution for injection vial,8002061,pembrolizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
100483,Marketed,2022-05-10,02515423,Pemetrexed For Injection,1,L01BA04,Pemetrexed,Solution,Intravenous,77701105,PEMETREXED FOR INJECTION (pemetrexed (pemetrexed disodium hemipentahydrate) 850 mg per 34 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9014707,pemetrexed (pemetrexed disodium) 850 mg per 34 mL solution for injection vial,8001501,pemetrexed,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
100483,Marketed,2022-05-10,02515423,Pemetrexed For Injection,1,L01BA04,Pemetrexed,Solution,Intravenous,77701106,PEMETREXED FOR INJECTION (pemetrexed (pemetrexed disodium hemipentahydrate) 100 mg per 4 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9014704,pemetrexed (pemetrexed disodium) 100 mg per 4 mL solution for injection vial,8001501,pemetrexed,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
100483,Marketed,2022-05-10,02515423,Pemetrexed For Injection,1,L01BA04,Pemetrexed,Solution,Intravenous,77701107,PEMETREXED FOR INJECTION (pemetrexed (pemetrexed disodium hemipentahydrate) 500 mg per 20 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9014706,pemetrexed (pemetrexed disodium) 500 mg per 20 mL solution for injection vial,8001501,pemetrexed,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
100483,Marketed,2022-05-10,02515423,Pemetrexed For Injection,1,L01BA04,Pemetrexed,Solution,Intravenous,77701108,PEMETREXED FOR INJECTION (pemetrexed (pemetrexed disodium hemipentahydrate) 1000 mg per 40 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9014705,pemetrexed (pemetrexed disodium) 1000 mg per 40 mL solution for injection vial,8001501,pemetrexed,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
100701,Marketed,2022-09-15,02517639,Pemetrexed Disodium For Injection,1,L01BA04,Pemetrexed,Powder for solution,Intravenous,02517639,PEMETREXED DISODIUM FOR INJECTION (pemetrexed (pemetrexed disodium) 100 mg per vial powder for solution for injection) AURO PHARMA INC,Active,9004485,pemetrexed (pemetrexed disodium) 100 mg per vial powder for solution for injection,8001501,pemetrexed,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
100702,Marketed,2022-09-15,02517647,Pemetrexed Disodium For Injection,1,L01BA04,Pemetrexed,Powder for solution,Intravenous,02517647,PEMETREXED DISODIUM FOR INJECTION (pemetrexed (pemetrexed disodium) 500 mg per vial powder for solution for injection) AURO PHARMA INC,Active,9003927,pemetrexed (pemetrexed disodium) 500 mg per vial powder for solution for injection,8001501,pemetrexed,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
101793,Marketed,2024-10-08,02528746,Pemetrexed Disodium For Injection,1,L01BA04,Pemetrexed,Powder for solution,Intravenous,02528746,PEMETREXED DISODIUM FOR INJECTION (pemetrexed (pemetrexed disodium) 100 mg per vial powder for solution for injection) EUGIA PHARMA INC.,Active,9004485,pemetrexed (pemetrexed disodium) 100 mg per vial powder for solution for injection,8001501,pemetrexed,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
101794,Marketed,2024-10-08,02528754,Pemetrexed Disodium For Injection,1,L01BA04,Pemetrexed,Powder for solution,Intravenous,02528754,PEMETREXED DISODIUM FOR INJECTION (pemetrexed (pemetrexed disodium) 500 mg per vial powder for solution for injection) EUGIA PHARMA INC.,Active,9003927,pemetrexed (pemetrexed disodium) 500 mg per vial powder for solution for injection,8001501,pemetrexed,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
87938,Marketed,2017-03-31,02394227,Pemetrexed Disodium For Injection,1,L01BA04,Pemetrexed,Powder for solution,Intravenous,02394227,PEMETREXED DISODIUM FOR INJECTION (pemetrexed (pemetrexed disodium) 500 mg per vial powder for solution for injection) TEVA CANADA LIMITED,Active,9003927,pemetrexed (pemetrexed disodium) 500 mg per vial powder for solution for injection,8001501,pemetrexed,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
91363,Marketed,2018-10-18,02429195,Taro-Pemetrexed,1,L01BA04,Pemetrexed,Powder for solution,Intravenous,02429195,TARO-PEMETREXED (pemetrexed (pemetrexed disodium) 100 mg per vial powder for solution for injection) TARO PHARMACEUTICALS INC,Active,9004485,pemetrexed (pemetrexed disodium) 100 mg per vial powder for solution for injection,8001501,pemetrexed,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
91364,Marketed,2017-02-15,02429209,Taro-Pemetrexed,1,L01BA04,Pemetrexed,Powder for solution,Intravenous,02429209,TARO-PEMETREXED (pemetrexed (pemetrexed disodium) 500 mg per vial powder for solution for injection) TARO PHARMACEUTICALS INC,Active,9003927,pemetrexed (pemetrexed disodium) 500 mg per vial powder for solution for injection,8001501,pemetrexed,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
92306,Marketed,2017-05-24,02438674,Pemetrexed Disodium For Injection,1,L01BA04,Pemetrexed,Powder for solution,Intravenous,02438674,PEMETREXED DISODIUM FOR INJECTION (pemetrexed (pemetrexed disodium hemipentahydrate) 100 mg per vial powder for solution for injection) ACCORD HEALTHCARE INC,Active,9004485,pemetrexed (pemetrexed disodium) 100 mg per vial powder for solution for injection,8001501,pemetrexed,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
92307,Marketed,2017-05-29,02438682,Pemetrexed Disodium For Injection,1,L01BA04,Pemetrexed,Powder for solution,Intravenous,02438682,PEMETREXED DISODIUM FOR INJECTION (pemetrexed (pemetrexed disodium hemipentahydrate) 500 mg per vial powder for solution for injection) ACCORD HEALTHCARE INC,Active,9003927,pemetrexed (pemetrexed disodium) 500 mg per vial powder for solution for injection,8001501,pemetrexed,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
94667,Marketed,2017-03-31,02459434,Pemetrexed Disodium For Injection,1,L01BA04,Pemetrexed,Powder for solution,Intravenous,02459434,PEMETREXED DISODIUM FOR INJECTION (pemetrexed (pemetrexed disodium) 100 mg per vial powder for solution for injection) TEVA CANADA LIMITED,Active,9004485,pemetrexed (pemetrexed disodium) 100 mg per vial powder for solution for injection,8001501,pemetrexed,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
95098,Marketed,2022-06-17,02463083,"Pemetrexed For Injection, USP",1,L01BA04,Pemetrexed,Powder for solution,Intravenous,02463083,"PEMETREXED FOR INJECTION, USP (pemetrexed (pemetrexed disodium) 100 mg per vial powder for solution for injection) DR REDDY'S LABORATORIES LTD",Active,9004485,pemetrexed (pemetrexed disodium) 100 mg per vial powder for solution for injection,8001501,pemetrexed,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
95099,Marketed,2022-06-17,02463091,"Pemetrexed For Injection, USP",1,L01BA04,Pemetrexed,Powder for solution,Intravenous,02463091,"PEMETREXED FOR INJECTION, USP (pemetrexed (pemetrexed disodium) 500 mg per vial powder for solution for injection) DR REDDY'S LABORATORIES LTD",Active,9003927,pemetrexed (pemetrexed disodium) 500 mg per vial powder for solution for injection,8001501,pemetrexed,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
97105,Marketed,2021-05-07,02480492,Taro-Pemetrexed,1,L01BA04,Pemetrexed,Powder for solution,Intravenous,02480492,TARO-PEMETREXED (pemetrexed (pemetrexed disodium) 1000 mg per vial powder for solution for injection) TARO PHARMACEUTICALS INC,Active,9014538,pemetrexed (pemetrexed disodium) 1000 mg per vial powder for solution for injection,8001501,pemetrexed,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
100917,Marketed,2022-01-06,02519933,Pemazyre,1,L01EN02,Pemigatinib,Tablet,Oral,02519933,PEMAZYRE (pemigatinib 4.5 mg oral tablet) INCYTE CORPORATION,Active,9014646,pemigatinib 4.5 mg oral tablet,8002407,pemigatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100918,Marketed,2021-11-30,02519941,Pemazyre,1,L01EN02,Pemigatinib,Tablet,Oral,02519941,PEMAZYRE (pemigatinib 9 mg oral tablet) INCYTE CORPORATION,Active,9014647,pemigatinib 9 mg oral tablet,8002407,pemigatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100919,Marketed,2021-11-26,02519968,Pemazyre,1,L01EN02,Pemigatinib,Tablet,Oral,02519968,PEMAZYRE (pemigatinib 13.5 mg oral tablet) INCYTE CORPORATION,Active,9014645,pemigatinib 13.5 mg oral tablet,8002407,pemigatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
287,Marketed,2019-12-13,00016055,Cuprimine,1,M01CC01,Penicillamine,Capsule,Oral,00016055,"CUPRIMINE (penicillamine 250 mg oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9013018,penicillamine 250 mg oral capsule,8001678,penicillamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
100704,Marketed,2021-10-14,02517663,Pentamidine Isetionate For Injection BP,1,P01CX01,Pentamidine isethionate,Powder for solution,"Intramuscular,Intravenous",02517663,PENTAMIDINE ISETIONATE FOR INJECTION BP (pentamidine isetionate 300 mg per vial powder for solution for injection) MARCAN PHARMACEUTICALS INC,Active,9012849,pentamidine isetionate 300 mg per vial powder for solution for injection,8001502,pentamidine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
44273,Marketed,2018-06-27,02183080,Pentamidine Isetionate For Injection BP,1,P01CX01,Pentamidine isethionate,Powder for solution,"Intramuscular,Intravenous",02183080,PENTAMIDINE ISETIONATE FOR INJECTION BP (pentamidine isetionate 300 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9012849,pentamidine isetionate 300 mg per vial powder for solution for injection,8001502,pentamidine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
14161,Marketed,2003-02-13,02029448,Elmiron,1,C05BA04,Pentostan polysulfate sodium,Capsule,Oral,02029448,ELMIRON (pentosan polysulfate sodium 100 mg oral capsule) JANSSEN INC,Active,9002604,pentosan polysulfate sodium 100 mg oral capsule,8002062,pentosan polysulfate sodium,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
103158,Marketed,2024-09-20,02543087,JAMP Pentoxifylline SR,1,C04AD03,Pentoxifylline,Tablet (extended-release),Oral,02543087,JAMP PENTOXIFYLLINE SR (pentoxifylline 400 mg prolonged-release oral tablet) JAMP PHARMA CORPORATION,Active,9003044,pentoxifylline 400 mg prolonged-release oral tablet,8001412,pentoxifylline,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
48622,Marketed,2025-06-25,02230090,Apo-Pentoxifylline SR,1,C04AD03,Pentoxifylline,Tablet (extended-release),Oral,02230090,APO-PENTOXIFYLLINE SR (pentoxifylline 400 mg prolonged-release oral tablet) APOTEX INC,Active,9003044,pentoxifylline 400 mg prolonged-release oral tablet,8001412,pentoxifylline,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101174,Marketed,2023-12-04,02522632,Taro-Perampanel,1,N03AX22,Perampanel,Tablet,Oral,02522632,TARO-PERAMPANEL (perampanel 2 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9005269,perampanel 2 mg oral tablet,8002063,perampanel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101175,Marketed,2023-12-04,02522640,Taro-Perampanel,1,N03AX22,Perampanel,Tablet,Oral,02522640,TARO-PERAMPANEL (perampanel 4 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9005270,perampanel 4 mg oral tablet,8002063,perampanel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101176,Marketed,2023-12-04,02522659,Taro-Perampanel,1,N03AX22,Perampanel,Tablet,Oral,02522659,TARO-PERAMPANEL (perampanel 6 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9005271,perampanel 6 mg oral tablet,8002063,perampanel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101177,Marketed,2023-12-04,02522667,Taro-Perampanel,1,N03AX22,Perampanel,Tablet,Oral,02522667,TARO-PERAMPANEL (perampanel 8 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9005272,perampanel 8 mg oral tablet,8002063,perampanel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101178,Marketed,2023-12-04,02522675,Taro-Perampanel,1,N03AX22,Perampanel,Tablet,Oral,02522675,TARO-PERAMPANEL (perampanel 10 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9005260,perampanel 10 mg oral tablet,8002063,perampanel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101179,Marketed,2023-12-04,02522683,Taro-Perampanel,1,N03AX22,Perampanel,Tablet,Oral,02522683,TARO-PERAMPANEL (perampanel 12 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9005249,perampanel 12 mg oral tablet,8002063,perampanel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88927,Marketed,2013-06-19,02404516,Fycompa,1,N03AX22,Perampanel,Tablet,Oral,02404516,FYCOMPA (perampanel 2 mg oral tablet) EISAI LIMITED,Active,9005269,perampanel 2 mg oral tablet,8002063,perampanel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88928,Marketed,2013-05-17,02404567,Fycompa,1,N03AX22,Perampanel,Tablet,Oral,02404567,FYCOMPA (perampanel 12 mg oral tablet) EISAI LIMITED,Active,9005249,perampanel 12 mg oral tablet,8002063,perampanel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88929,Marketed,2013-06-19,02404524,Fycompa,1,N03AX22,Perampanel,Tablet,Oral,02404524,FYCOMPA (perampanel 4 mg oral tablet) EISAI LIMITED,Active,9005270,perampanel 4 mg oral tablet,8002063,perampanel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88930,Marketed,2013-06-19,02404532,Fycompa,1,N03AX22,Perampanel,Tablet,Oral,02404532,FYCOMPA (perampanel 6 mg oral tablet) EISAI LIMITED,Active,9005271,perampanel 6 mg oral tablet,8002063,perampanel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88931,Marketed,2013-06-19,02404540,Fycompa,1,N03AX22,Perampanel,Tablet,Oral,02404540,FYCOMPA (perampanel 8 mg oral tablet) EISAI LIMITED,Active,9005272,perampanel 8 mg oral tablet,8002063,perampanel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88932,Marketed,2013-06-03,02404559,Fycompa,1,N03AX22,Perampanel,Tablet,Oral,02404559,FYCOMPA (perampanel 10 mg oral tablet) EISAI LIMITED,Active,9005260,perampanel 10 mg oral tablet,8002063,perampanel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
12425,Marketed,2023-01-27,01926772,Neuleptil,1,N05AC01,Periciazine,Capsule,Oral,01926772,NEULEPTIL (periciazine 10 mg oral capsule) SEARCHLIGHT PHARMA INC,Active,9001647,periciazine 10 mg oral capsule,8001503,periciazine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
12653,Marketed,2023-01-27,01926780,Neuleptil,1,N05AC01,Periciazine,Capsule,Oral,01926780,NEULEPTIL (periciazine 5 mg oral capsule) SEARCHLIGHT PHARMA INC,Active,9001648,periciazine 5 mg oral capsule,8001503,periciazine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
13159,Marketed,2023-01-27,01926756,Neuleptil,1,N05AC01,Periciazine,Drops,Oral,01926756,NEULEPTIL (periciazine 10 mg per mL oral drops) SEARCHLIGHT PHARMA INC,Active,9001767,periciazine 10 mg per mL oral drops,8001503,periciazine,26643006,Oral,385018001,Oral drops,732994000,Drop (unit of presentation),,,,Prescription
101623,Marketed,2022-12-15,02527200,JAMP Perindopril Erbumine,1,C09AA04,Perindopril,Tablet,Oral,02527200,JAMP PERINDOPRIL ERBUMINE (perindopril erbumine 2 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101626,Marketed,2022-12-15,02527219,JAMP Perindopril Erbumine,1,C09AA04,Perindopril,Tablet,Oral,02527219,JAMP PERINDOPRIL ERBUMINE (perindopril erbumine 4 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101627,Marketed,2022-12-16,02527227,JAMP Perindopril Erbumine,1,C09AA04,Perindopril,Tablet,Oral,02527227,JAMP PERINDOPRIL ERBUMINE (perindopril erbumine 8 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101869,Marketed,2022-12-16,02529491,AG-Perindopril Erbumine,1,C09AA04,Perindopril,Tablet,Oral,02529491,AG-PERINDOPRIL ERBUMINE (perindopril erbumine 2 mg oral tablet) ANGITA PHARMA INC.,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101874,Marketed,2022-12-16,02529505,AG-Perindopril Erbumine,1,C09AA04,Perindopril,Tablet,Oral,02529505,AG-PERINDOPRIL ERBUMINE (perindopril erbumine 4 mg oral tablet) ANGITA PHARMA INC.,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101875,Marketed,2022-12-16,02529513,AG-Perindopril Erbumine,1,C09AA04,Perindopril,Tablet,Oral,02529513,AG-PERINDOPRIL ERBUMINE (perindopril erbumine 8 mg oral tablet) ANGITA PHARMA INC.,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104444,Marketed,2025-07-16,02555697,NB-Perindopril,1,C09AA04,Perindopril,Tablet,Oral,02555697,NB-PERINDOPRIL (perindopril erbumine 2 mg oral tablet) NB PHARMA INC.,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104445,Marketed,2025-07-16,02555700,NB-Perindopril,1,C09AA04,Perindopril,Tablet,Oral,02555700,NB-PERINDOPRIL (perindopril erbumine 4 mg oral tablet) NB PHARMA INC.,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104446,Marketed,2025-07-16,02555719,NB-Perindopril,1,C09AA04,Perindopril,Tablet,Oral,02555719,NB-PERINDOPRIL (perindopril erbumine 8 mg oral tablet) NB PHARMA INC.,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
16879,Marketed,1994-12-31,02123282,Coversyl,1,C09AA04,Perindopril,Tablet,Oral,02123282,COVERSYL (perindopril erbumine 4 mg oral tablet) SERVIER CANADA INC,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
16880,Marketed,1994-12-31,02123274,Coversyl,1,C09AA04,Perindopril,Tablet,Oral,02123274,COVERSYL (perindopril erbumine 2 mg oral tablet) SERVIER CANADA INC,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
70814,Marketed,2003-09-11,02246624,Coversyl,1,C09AA04,Perindopril,Tablet,Oral,02246624,COVERSYL (perindopril erbumine 8 mg oral tablet) SERVIER CANADA INC,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77465,Marketed,2020-12-18,02289261,Apo-Perindopril,1,C09AA04,Perindopril,Tablet,Oral,02289261,APO-PERINDOPRIL (perindopril erbumine 2 mg oral tablet) APOTEX INC,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77466,Marketed,2020-12-18,02289288,Apo-Perindopril,1,C09AA04,Perindopril,Tablet,Oral,02289288,APO-PERINDOPRIL (perindopril erbumine 4 mg oral tablet) APOTEX INC,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77467,Marketed,2020-12-18,02289296,Apo-Perindopril,1,C09AA04,Perindopril,Tablet,Oral,02289296,APO-PERINDOPRIL (perindopril erbumine 8 mg oral tablet) APOTEX INC,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94713,Marketed,2018-03-07,02459817,Auro-Perindopril,1,C09AA04,Perindopril,Tablet,Oral,02459817,AURO-PERINDOPRIL (perindopril erbumine 2 mg oral tablet) AURO PHARMA INC,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94714,Marketed,2018-03-07,02459825,Auro-Perindopril,1,C09AA04,Perindopril,Tablet,Oral,02459825,AURO-PERINDOPRIL (perindopril erbumine 4 mg oral tablet) AURO PHARMA INC,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94715,Marketed,2018-03-07,02459833,Auro-Perindopril,1,C09AA04,Perindopril,Tablet,Oral,02459833,AURO-PERINDOPRIL (perindopril erbumine 8 mg oral tablet) AURO PHARMA INC,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95319,Marketed,2018-03-07,02464985,Teva-Perindopril,1,C09AA04,Perindopril,Tablet,Oral,02464985,TEVA-PERINDOPRIL (perindopril erbumine 2 mg oral tablet) TEVA CANADA LIMITED,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95320,Marketed,2018-03-07,02464993,Teva-Perindopril,1,C09AA04,Perindopril,Tablet,Oral,02464993,TEVA-PERINDOPRIL (perindopril erbumine 4 mg oral tablet) TEVA CANADA LIMITED,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95321,Marketed,2018-03-07,02465000,Teva-Perindopril,1,C09AA04,Perindopril,Tablet,Oral,02465000,TEVA-PERINDOPRIL (perindopril erbumine 8 mg oral tablet) TEVA CANADA LIMITED,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95921,Marketed,2018-03-05,02470225,Sandoz Perindopril Erbumine,1,C09AA04,Perindopril,Tablet,Oral,02470225,SANDOZ PERINDOPRIL ERBUMINE (perindopril erbumine 2 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95922,Marketed,2018-03-05,02470233,Sandoz Perindopril Erbumine,1,C09AA04,Perindopril,Tablet,Oral,02470233,SANDOZ PERINDOPRIL ERBUMINE (perindopril erbumine 4 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95923,Marketed,2018-03-05,02470241,Sandoz Perindopril Erbumine,1,C09AA04,Perindopril,Tablet,Oral,02470241,SANDOZ PERINDOPRIL ERBUMINE (perindopril erbumine 8 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95968,Marketed,2018-03-07,02470675,PMS-Perindopril,1,C09AA04,Perindopril,Tablet,Oral,02470675,PMS-PERINDOPRIL (perindopril erbumine 2 mg oral tablet) PHARMASCIENCE INC,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95969,Marketed,2018-03-07,02470683,PMS-Perindopril,1,C09AA04,Perindopril,Tablet,Oral,02470683,PMS-PERINDOPRIL (perindopril erbumine 4 mg oral tablet) PHARMASCIENCE INC,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95970,Marketed,2018-03-07,02470691,PMS-Perindopril,1,C09AA04,Perindopril,Tablet,Oral,02470691,PMS-PERINDOPRIL (perindopril erbumine 8 mg oral tablet) PHARMASCIENCE INC,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96126,Marketed,2018-03-07,02472015,Riva-Perindopril,1,C09AA04,Perindopril,Tablet,Oral,02472015,RIVA-PERINDOPRIL (perindopril erbumine 2 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96127,Marketed,2018-03-07,02472023,Riva-Perindopril,1,C09AA04,Perindopril,Tablet,Oral,02472023,RIVA-PERINDOPRIL (perindopril erbumine 4 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96128,Marketed,2018-03-07,02472031,Riva-Perindopril,1,C09AA04,Perindopril,Tablet,Oral,02472031,RIVA-PERINDOPRIL (perindopril erbumine 8 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96501,Marketed,2019-04-11,02474824,Mar-Perindopril,1,C09AA04,Perindopril,Tablet,Oral,02474824,MAR-PERINDOPRIL (perindopril erbumine 2 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96502,Marketed,2019-04-11,02474832,Mar-Perindopril,1,C09AA04,Perindopril,Tablet,Oral,02474832,MAR-PERINDOPRIL (perindopril erbumine 4 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96503,Marketed,2019-04-11,02474840,Mar-Perindopril,1,C09AA04,Perindopril,Tablet,Oral,02474840,MAR-PERINDOPRIL (perindopril erbumine 8 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96760,Marketed,2019-03-22,02476762,Mint-Perindopril,1,C09AA04,Perindopril,Tablet,Oral,02476762,MINT-PERINDOPRIL (perindopril erbumine 2 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96761,Marketed,2019-01-23,02476770,Mint-Perindopril,1,C09AA04,Perindopril,Tablet,Oral,02476770,MINT-PERINDOPRIL (perindopril erbumine 4 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96762,Marketed,2019-01-23,02476789,Mint-Perindopril,1,C09AA04,Perindopril,Tablet,Oral,02476789,MINT-PERINDOPRIL (perindopril erbumine 8 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97044,Marketed,2019-02-13,02479877,Perindopril Erbumine,1,C09AA04,Perindopril,Tablet,Oral,02479877,PERINDOPRIL ERBUMINE (perindopril erbumine 2 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97045,Marketed,2019-02-13,02479885,Perindopril Erbumine,1,C09AA04,Perindopril,Tablet,Oral,02479885,PERINDOPRIL ERBUMINE (perindopril erbumine 4 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97046,Marketed,2019-02-13,02479893,Perindopril Erbumine,1,C09AA04,Perindopril,Tablet,Oral,02479893,PERINDOPRIL ERBUMINE (perindopril erbumine 8 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97209,Marketed,2022-08-04,02481634,Perindopril Erbumine,1,C09AA04,Perindopril,Tablet,Oral,02481634,PERINDOPRIL ERBUMINE (perindopril erbumine 2 mg oral tablet) SANIS HEALTH INC,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97210,Marketed,2022-08-04,02481642,Perindopril Erbumine,1,C09AA04,Perindopril,Tablet,Oral,02481642,PERINDOPRIL ERBUMINE (perindopril erbumine 4 mg oral tablet) SANIS HEALTH INC,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97211,Marketed,2022-08-04,02481650,Perindopril Erbumine,1,C09AA04,Perindopril,Tablet,Oral,02481650,PERINDOPRIL ERBUMINE (perindopril erbumine 8 mg oral tablet) SANIS HEALTH INC,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97332,Marketed,2019-07-23,02482924,M-Perindopril Erbumine,1,C09AA04,Perindopril,Tablet,Oral,02482924,M-PERINDOPRIL ERBUMINE (perindopril erbumine 2 mg oral tablet) MANTRA PHARMA INC,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97333,Marketed,2019-07-23,02482932,M-Perindopril Erbumine,1,C09AA04,Perindopril,Tablet,Oral,02482932,M-PERINDOPRIL ERBUMINE (perindopril erbumine 4 mg oral tablet) MANTRA PHARMA INC,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97334,Marketed,2019-07-23,02482940,M-Perindopril Erbumine,1,C09AA04,Perindopril,Tablet,Oral,02482940,M-PERINDOPRIL ERBUMINE (perindopril erbumine 8 mg oral tablet) MANTRA PHARMA INC,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97901,Marketed,2019-07-09,02488949,Perindopril Erbumine,1,C09AA04,Perindopril,Tablet,Oral,02488949,PERINDOPRIL ERBUMINE (perindopril erbumine 2 mg oral tablet) PRO DOC LIMITEE,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97902,Marketed,2019-07-09,02488957,Perindopril Erbumine,1,C09AA04,Perindopril,Tablet,Oral,02488957,PERINDOPRIL ERBUMINE (perindopril erbumine 4 mg oral tablet) PRO DOC LIMITEE,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97903,Marketed,2019-07-09,02488965,Perindopril Erbumine,1,C09AA04,Perindopril,Tablet,Oral,02488965,PERINDOPRIL ERBUMINE (perindopril erbumine 8 mg oral tablet) PRO DOC LIMITEE,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97907,Marketed,2019-10-24,02489015,Nra-Perindopril,1,C09AA04,Perindopril,Tablet,Oral,02489015,NRA-PERINDOPRIL (perindopril erbumine 2 mg oral tablet) NORA PHARMA INC,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97908,Marketed,2019-10-24,02489023,Nra-Perindopril,1,C09AA04,Perindopril,Tablet,Oral,02489023,NRA-PERINDOPRIL (perindopril erbumine 4 mg oral tablet) NORA PHARMA INC,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97909,Marketed,2019-10-24,02489031,Nra-Perindopril,1,C09AA04,Perindopril,Tablet,Oral,02489031,NRA-PERINDOPRIL (perindopril erbumine 8 mg oral tablet) NORA PHARMA INC,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99093,Marketed,2020-07-13,02501309,Bio-Perindopril,1,C09AA04,Perindopril,Tablet,Oral,02501309,BIO-PERINDOPRIL (perindopril erbumine 2 mg oral tablet) BIOMED PHARMA,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99094,Marketed,2020-07-13,02501317,Bio-Perindopril,1,C09AA04,Perindopril,Tablet,Oral,02501317,BIO-PERINDOPRIL (perindopril erbumine 4 mg oral tablet) BIOMED PHARMA,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99095,Marketed,2020-07-13,02501325,Bio-Perindopril,1,C09AA04,Perindopril,Tablet,Oral,02501325,BIO-PERINDOPRIL (perindopril erbumine 8 mg oral tablet) BIOMED PHARMA,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103033,Marketed,2024-02-21,02541696,PMS-Perindopril-amLODIPine,2,C09BB04,Perindopril and amlodipine,Tablet,Oral,02541696,PMS-PERINDOPRIL-AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg and perindopril arginine 3.5 mg oral tablet) PHARMASCIENCE INC,Active,9005925,amlodipine (amlodipine besylate) 2.5 mg and perindopril arginine 3.5 mg oral tablet,8001014,amlodipine and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103034,Marketed,2024-02-21,02541718,PMS-Perindopril-amLODIPine,2,C09BB04,Perindopril and amlodipine,Tablet,Oral,02541718,PMS-PERINDOPRIL-AMLODIPINE (amlodipine (amlodipine besylate) 5 mg and perindopril arginine 7 mg oral tablet) PHARMASCIENCE INC,Active,9005926,amlodipine (amlodipine besylate) 5 mg and perindopril arginine 7 mg oral tablet,8001014,amlodipine and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103035,Marketed,2024-02-21,02541726,PMS-Perindopril-amLODIPine,2,C09BB04,Perindopril and amlodipine,Tablet,Oral,02541726,PMS-PERINDOPRIL-AMLODIPINE (amlodipine (amlodipine besylate) 10 mg and perindopril arginine 14 mg oral tablet) PHARMASCIENCE INC,Active,9005924,amlodipine (amlodipine besylate) 10 mg and perindopril arginine 14 mg oral tablet,8001014,amlodipine and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93782,Marketed,2016-04-05,02451530,Viacoram,2,C09BB04,Perindopril and amlodipine,Tablet,Oral,02451530,VIACORAM (amlodipine (amlodipine besylate) 2.5 mg and perindopril arginine 3.5 mg oral tablet) SERVIER CANADA INC,Active,9005925,amlodipine (amlodipine besylate) 2.5 mg and perindopril arginine 3.5 mg oral tablet,8001014,amlodipine and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93783,Marketed,2016-04-05,02451549,Viacoram,2,C09BB04,Perindopril and amlodipine,Tablet,Oral,02451549,VIACORAM (amlodipine (amlodipine besylate) 5 mg and perindopril arginine 7 mg oral tablet) SERVIER CANADA INC,Active,9005926,amlodipine (amlodipine besylate) 5 mg and perindopril arginine 7 mg oral tablet,8001014,amlodipine and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93784,Marketed,2016-04-05,02451557,Viacoram,2,C09BB04,Perindopril and amlodipine,Tablet,Oral,02451557,VIACORAM (amlodipine (amlodipine besylate) 10 mg and perindopril arginine 14 mg oral tablet) SERVIER CANADA INC,Active,9005924,amlodipine (amlodipine besylate) 10 mg and perindopril arginine 14 mg oral tablet,8001014,amlodipine and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95699,Marketed,2019-06-03,02468565,Apo-Perindopril/amLODIPine,2,C09BB04,Perindopril and amlodipine,Tablet,Oral,02468565,APO-PERINDOPRIL/AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg and perindopril arginine 3.5 mg oral tablet) APOTEX INC,Active,9005925,amlodipine (amlodipine besylate) 2.5 mg and perindopril arginine 3.5 mg oral tablet,8001014,amlodipine and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95700,Marketed,2019-06-03,02468573,Apo-Perindopril/amLODIPine,2,C09BB04,Perindopril and amlodipine,Tablet,Oral,02468573,APO-PERINDOPRIL/AMLODIPINE (amlodipine (amlodipine besylate) 5 mg and perindopril arginine 7 mg oral tablet) APOTEX INC,Active,9005926,amlodipine (amlodipine besylate) 5 mg and perindopril arginine 7 mg oral tablet,8001014,amlodipine and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95701,Marketed,2019-06-03,02468581,Apo-Perindopril/amLODIPine,2,C09BB04,Perindopril and amlodipine,Tablet,Oral,02468581,APO-PERINDOPRIL/AMLODIPINE (amlodipine (amlodipine besylate) 10 mg and perindopril arginine 14 mg oral tablet) APOTEX INC,Active,9005924,amlodipine (amlodipine besylate) 10 mg and perindopril arginine 14 mg oral tablet,8001014,amlodipine and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100896,Marketed,2021-12-15,02519720,Perindopril/Indapamide,2,C09BA04,Perindopril and diuretics,Tablet,Oral,02519720,PERINDOPRIL/INDAPAMIDE (indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet) SANIS HEALTH INC,Active,9001009,indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100897,Marketed,2021-12-15,02519739,Perindopril/Indapamide,2,C09BA04,Perindopril and diuretics,Tablet,Oral,02519739,PERINDOPRIL/INDAPAMIDE (indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet) SANIS HEALTH INC,Active,9001274,indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101211,Marketed,2023-01-20,02523035,Perindopril Erbumine/Indapamide,2,C09BA04,Perindopril and diuretics,Tablet,Oral,02523035,PERINDOPRIL ERBUMINE/INDAPAMIDE (indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet) PRO DOC LIMITEE,Active,9001009,indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101212,Marketed,2023-01-20,02523043,Perindopril Erbumine/Indapamide HD,2,C09BA04,Perindopril and diuretics,Tablet,Oral,02523043,PERINDOPRIL ERBUMINE/INDAPAMIDE HD (indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet) PRO DOC LIMITEE,Active,9001274,indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102673,Marketed,2023-08-29,02537990,PMS-Perindopril-Indapamide,2,C09BA04,Perindopril and diuretics,Tablet,Oral,02537990,PMS-PERINDOPRIL-INDAPAMIDE (indapamide 0.625 mg and perindopril erbumine 2 mg oral tablet) PHARMASCIENCE INC,Active,9001028,indapamide 0.625 mg and perindopril erbumine 2 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102674,Marketed,2023-08-29,02538008,PMS-Perindopril-Indapamide,2,C09BA04,Perindopril and diuretics,Tablet,Oral,02538008,PMS-PERINDOPRIL-INDAPAMIDE (indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet) PHARMASCIENCE INC,Active,9001009,indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102675,Marketed,2023-08-29,02537982,PMS-Perindopril-Indapamide,2,C09BA04,Perindopril and diuretics,Tablet,Oral,02537982,PMS-PERINDOPRIL-INDAPAMIDE (indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet) PHARMASCIENCE INC,Active,9001274,indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104299,Marketed,2025-12-16,02554119,JAMP Perindopril/Indapamide,2,C09BA04,Perindopril and diuretics,Tablet,Oral,02554119,JAMP PERINDOPRIL/INDAPAMIDE (indapamide 0.625 mg and perindopril erbumine 2 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001028,indapamide 0.625 mg and perindopril erbumine 2 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104300,Marketed,2025-12-16,02554127,JAMP Perindopril/Indapamide,2,C09BA04,Perindopril and diuretics,Tablet,Oral,02554127,JAMP PERINDOPRIL/INDAPAMIDE (indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001009,indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104301,Marketed,2025-12-16,02554135,JAMP Perindopril/Indapamide,2,C09BA04,Perindopril and diuretics,Tablet,Oral,02554135,JAMP PERINDOPRIL/INDAPAMIDE (indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001274,indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
70751,Marketed,2007-10-02,02246568,Coversyl Plus LD,2,C09BA04,Perindopril and diuretics,Tablet,Oral,02246568,COVERSYL PLUS LD (indapamide 0.625 mg and perindopril erbumine 2 mg oral tablet) SERVIER CANADA INC,Active,9001028,indapamide 0.625 mg and perindopril erbumine 2 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
70752,Marketed,2003-10-10,02246569,Coversyl Plus,2,C09BA04,Perindopril and diuretics,Tablet,Oral,02246569,COVERSYL PLUS (indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet) SERVIER CANADA INC,Active,9001009,indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78291,Marketed,2021-02-02,02297574,Apo-Perindopril-Indapamide,2,C09BA04,Perindopril and diuretics,Tablet,Oral,02297574,APO-PERINDOPRIL-INDAPAMIDE (indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet) APOTEX INC,Active,9001009,indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80705,Marketed,2009-05-07,02321653,Coversyl Plus HD,2,C09BA04,Perindopril and diuretics,Tablet,Oral,02321653,COVERSYL PLUS HD (indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet) SERVIER CANADA INC,Active,9001274,indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93369,Marketed,2025-12-16,02447991,AG-Perindopril / Indapamide,2,C09BA04,Perindopril and diuretics,Tablet,Oral,02447991,AG-PERINDOPRIL / INDAPAMIDE (indapamide 0.625 mg and perindopril erbumine 2 mg oral tablet) ANGITA PHARMA INC.,Active,9001028,indapamide 0.625 mg and perindopril erbumine 2 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93370,Marketed,2025-12-16,02448009,AG-Perindopril / Indapamide,2,C09BA04,Perindopril and diuretics,Tablet,Oral,02448009,AG-PERINDOPRIL / INDAPAMIDE (indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet) ANGITA PHARMA INC.,Active,9001009,indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93371,Marketed,2025-12-16,02448017,AG-Perindopril / Indapamide,2,C09BA04,Perindopril and diuretics,Tablet,Oral,02448017,AG-PERINDOPRIL / INDAPAMIDE (indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet) ANGITA PHARMA INC.,Active,9001274,indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93947,Marketed,2021-02-02,02453061,Apo-Perindopril-Indapamide,2,C09BA04,Perindopril and diuretics,Tablet,Oral,02453061,APO-PERINDOPRIL-INDAPAMIDE (indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet) APOTEX INC,Active,9001274,indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95215,Marketed,2018-03-07,02464039,Teva-Perindopril/Indapamide,2,C09BA04,Perindopril and diuretics,Tablet,Oral,02464039,TEVA-PERINDOPRIL/INDAPAMIDE (indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet) TEVA CANADA LIMITED,Active,9001274,indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95216,Marketed,2018-03-07,02464020,Teva-Perindopril/Indapamide,2,C09BA04,Perindopril and diuretics,Tablet,Oral,02464020,TEVA-PERINDOPRIL/INDAPAMIDE (indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet) TEVA CANADA LIMITED,Active,9001009,indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95939,Marketed,2018-03-05,02470411,Sandoz Perindopril Erbumine/ Indapamide LD,2,C09BA04,Perindopril and diuretics,Tablet,Oral,02470411,SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE LD (indapamide 0.625 mg and perindopril erbumine 2 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001028,indapamide 0.625 mg and perindopril erbumine 2 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95940,Marketed,2018-03-05,02470438,Sandoz Perindopril Erbumine/ Indapamide,2,C09BA04,Perindopril and diuretics,Tablet,Oral,02470438,SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE (indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001009,indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95941,Marketed,2018-03-05,02470446,Sandoz Perindopril Erbumine/ Indapamide HD,2,C09BA04,Perindopril and diuretics,Tablet,Oral,02470446,SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE HD (indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001274,indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97039,Marketed,2022-01-20,02479834,Perindopril Erbumine/ Indapamide,2,C09BA04,Perindopril and diuretics,Tablet,Oral,02479834,PERINDOPRIL ERBUMINE/ INDAPAMIDE (indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001009,indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97042,Marketed,2022-01-20,02479842,Perindopril Erbumine/ Indapamide HD,2,C09BA04,Perindopril and diuretics,Tablet,Oral,02479842,PERINDOPRIL ERBUMINE/ INDAPAMIDE HD (indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001274,indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
37239,Marketed,2024-04-05,02219905,Nix Dermal Cream,1,P03AC04,Permethrin,Cream,Topical,02219905,NIX DERMAL CREAM (permethrin 5 % cutaneous cream) HALEON CANADA ULC,Active,9003393,permethrin 5 % cutaneous cream,8001299,permethrin,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
50657,Marketed,2013-02-15,02231348,Kwellada-P Lotion,1,P03AC04,Permethrin,Lotion,Topical,02231348,KWELLADA-P LOTION (permethrin 5 % lotion) MEDTECH PRODUCTS INC,Active,9003168,permethrin 5 % lotion,8001299,permethrin,448598008,Cutaneous,739000003,Lotion,,,,,,Non-Prescription Drugs
50804,Marketed,2013-02-15,02231480,Kwellada-P Crème Rinse,1,P03AC04,Permethrin,Liquid,Topical,02231480,KWELLADA-P CRÈME RINSE (permethrin 1 % cutaneous solution) MEDTECH PRODUCTS INC,Active,9013832,permethrin 1 % cutaneous solution,8001299,permethrin,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Non-Prescription Drugs
8964,Marketed,2003-05-01,00771368,Nix Creme Rinse,1,P03AC04,Permethrin,Cream,Topical,00771368,"NIX CREME RINSE (permethrin 1 % cutaneous solution) INSIGHT PHARMACEUTICALS, LLC",Active,9013832,permethrin 1 % cutaneous solution,8001299,permethrin,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Non-Prescription Drugs
2365,Marketed,2010-11-25,00335096,Perphenazine,1,N05AB03,Perphenazine,Tablet,Oral,00335096,PERPHENAZINE (perphenazine 16 mg oral tablet) AA PHARMA INC,Active,9001769,perphenazine 16 mg oral tablet,8001504,perphenazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
2366,Marketed,2010-10-22,00335118,Perphenazine,1,N05AB03,Perphenazine,Tablet,Oral,00335118,PERPHENAZINE (perphenazine 8 mg oral tablet) AA PHARMA INC,Active,9001772,perphenazine 8 mg oral tablet,8001504,perphenazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
2367,Marketed,2010-10-19,00335126,Perphenazine,1,N05AB03,Perphenazine,Tablet,Oral,00335126,PERPHENAZINE (perphenazine 4 mg oral tablet) AA PHARMA INC,Active,9001771,perphenazine 4 mg oral tablet,8001504,perphenazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
2368,Marketed,2010-11-23,00335134,Perphenazine,1,N05AB03,Perphenazine,Tablet,Oral,00335134,PERPHENAZINE (perphenazine 2 mg oral tablet) AA PHARMA INC,Active,9001770,perphenazine 2 mg oral tablet,8001504,perphenazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
63789,Marketed,2006-07-27,02240255,Adacel,6,J07AJ52,"Pertussis, purified antigen, comb. with toxoids",Suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
88984,Marketed,2013-05-08,02405016,Perjeta,1,L01FD02,Pertuzumab,Solution,Intravenous,02405016,PERJETA (pertuzumab 420 mg per 14 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9013504,pertuzumab 420 mg per 14 mL solution for injection vial,8002064,pertuzumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
88984,Marketed,2013-05-08,02405016,Perjeta,1,L01FD02,Pertuzumab,Solution,Intravenous,02405016,PERJETA (pertuzumab 420 mg per 14 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9013504,pertuzumab 420 mg per 14 mL solution for injection vial,8002064,pertuzumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
100216,Marketed,2021-04-08,02512912,Phesgo,2,L01FY01,Pertuzumab and trastuzumab,Solution,Subcutaneous,02512912,PHESGO (pertuzumab 1200 mg per 15 mL and trastuzumab 600 mg per 15 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9014527,pertuzumab 1200 mg per 15 mL and trastuzumab 600 mg per 15 mL solution for injection vial,8002065,pertuzumab and trastuzumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
100216,Marketed,2021-04-08,02512912,Phesgo,2,L01FY01,Pertuzumab and trastuzumab,Solution,Subcutaneous,02512912,PHESGO (pertuzumab 1200 mg per 15 mL and trastuzumab 600 mg per 15 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9014527,pertuzumab 1200 mg per 15 mL and trastuzumab 600 mg per 15 mL solution for injection vial,8002065,pertuzumab and trastuzumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
100217,Marketed,2021-04-09,02512920,Phesgo,2,L01FY01,Pertuzumab and trastuzumab,Solution,Subcutaneous,02512920,PHESGO (pertuzumab 600 mg per 10 mL and trastuzumab 600 mg per 10 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9014528,pertuzumab 600 mg per 10 mL and trastuzumab 600 mg per 10 mL solution for injection vial,8002065,pertuzumab and trastuzumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
100217,Marketed,2021-04-09,02512920,Phesgo,2,L01FY01,Pertuzumab and trastuzumab,Solution,Subcutaneous,02512920,PHESGO (pertuzumab 600 mg per 10 mL and trastuzumab 600 mg per 10 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9014528,pertuzumab 600 mg per 10 mL and trastuzumab 600 mg per 10 mL solution for injection vial,8002065,pertuzumab and trastuzumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
88985,Marketed,2013-05-09,02405024,Perjeta-Herceptin,2,L01FY01,Pertuzumab and trastuzumab,"Kit,Solution,Powder for solution",Intravenous,02405024,PERJETA-HERCEPTIN (pertuzumab 420 mg per 14 mL solution for injection vial with trastuzumab 440 mg per vial powder for solution for injection with diluent solution) HOFFMANN-LA ROCHE LIMITED,Active,9013505,pertuzumab 420 mg per 14 mL solution for injection vial with trastuzumab 440 mg per vial powder for solution for injection with diluent solution,8002065,pertuzumab and trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
88985,Marketed,2013-05-09,02405024,Perjeta-Herceptin,2,L01FY01,Pertuzumab and trastuzumab,"Kit,Solution,Powder for solution",Intravenous,02405024,PERJETA-HERCEPTIN (pertuzumab 420 mg per 14 mL solution for injection vial with trastuzumab 440 mg per vial powder for solution for injection with diluent solution) HOFFMANN-LA ROCHE LIMITED,Active,9013505,pertuzumab 420 mg per 14 mL solution for injection vial with trastuzumab 440 mg per vial powder for solution for injection with diluent solution,8002065,pertuzumab and trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
8121,Marketed,2005-10-05,00725765,Meperidine Hydrochloride Injection USP,1,N02AB02,Pethidine,Solution,"Intravenous,Subcutaneous,Intramuscular",00725765,MEPERIDINE HYDROCHLORIDE INJECTION USP (meperidine hydrochloride 50 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9006548,meperidine hydrochloride 50 mg per 1 mL solution for injection ampoule,8000782,meperidine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,,Narcotics (CDSA I)
4388,Marketed,2025-07-07,00476714,Pyridium,1,G04BX06,Phenazopyridine,Tablet,Oral,00476714,PYRIDIUM (phenazopyridine hydrochloride 100 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9001703,phenazopyridine hydrochloride 100 mg oral tablet,8002311,phenazopyridine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
4309,Marketed,2022-10-04,00476552,Nardil,1,N06AF03,Phenelzine,Tablet,Oral,00476552,NARDIL (phenelzine (phenelzine sulfate) 15 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9001914,phenelzine (phenelzine sulfate) 15 mg oral tablet,8001505,phenelzine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106108,Marketed,2026-04-17,02557789,JAMP Phenobarbital,1,N03AA02,Phenobarbital,Tablet,Oral,02557789,JAMP PHENOBARBITAL (phenobarbital 15 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001557,phenobarbital 15 mg oral tablet,8000799,phenobarbital,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA IV)
106109,Marketed,2026-04-17,02557797,JAMP Phenobarbital,1,N03AA02,Phenobarbital,Tablet,Oral,02557797,JAMP PHENOBARBITAL (phenobarbital 30 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001558,phenobarbital 30 mg oral tablet,8000799,phenobarbital,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA IV)
106110,Marketed,2026-04-17,02557800,JAMP Phenobarbital,1,N03AA02,Phenobarbital,Tablet,Oral,02557800,JAMP PHENOBARBITAL (phenobarbital 60 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001559,phenobarbital 60 mg oral tablet,8000799,phenobarbital,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA IV)
106111,Marketed,2026-04-17,02557819,JAMP Phenobarbital,1,N03AA02,Phenobarbital,Tablet,Oral,02557819,JAMP PHENOBARBITAL (phenobarbital 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001556,phenobarbital 100 mg oral tablet,8000799,phenobarbital,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA IV)
405,Marketed,2012-03-19,00178799,Phenobarb,1,N03AA02,Phenobarbital,Tablet,Oral,00178799,PHENOBARB (phenobarbital 15 mg oral tablet) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9001557,phenobarbital 15 mg oral tablet,8000799,phenobarbital,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA IV)
406,Marketed,2012-03-05,00178802,Phenobarb,1,N03AA02,Phenobarbital,Tablet,Oral,00178802,PHENOBARB (phenobarbital 30 mg oral tablet) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9001558,phenobarbital 30 mg oral tablet,8000799,phenobarbital,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA IV)
407,Marketed,2012-03-05,00178810,Phenobarb,1,N03AA02,Phenobarbital,Tablet,Oral,00178810,PHENOBARB (phenobarbital 60 mg oral tablet) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9001559,phenobarbital 60 mg oral tablet,8000799,phenobarbital,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA IV)
408,Marketed,2012-03-05,00178829,Phenobarb,1,N03AA02,Phenobarbital,Tablet,Oral,00178829,PHENOBARB (phenobarbital 100 mg oral tablet) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9001556,phenobarbital 100 mg oral tablet,8000799,phenobarbital,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Controlled Drugs (CDSA IV)
6095,Marketed,2012-03-05,00645575,Phenobarb Elixir,1,N03AA02,Phenobarbital,Solution,Oral,00645575,PHENOBARB ELIXIR (phenobarbital 5 mg per mL oral solution) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9001616,phenobarbital 5 mg per mL oral solution,8000799,phenobarbital,26643006,Oral,385023001,Oral solution,,,,,,Controlled Drugs (CDSA IV)
78939,Marketed,2008-02-29,02304082,"Phenobarbital Sodium Injection, USP",1,N03AA02,Phenobarbital,Solution,"Intramuscular,Intravenous",02304082,"PHENOBARBITAL SODIUM INJECTION, USP (phenobarbital sodium 30 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED",Active,9013507,phenobarbital sodium 30 mg per 1 mL solution for injection ampoule,8000799,phenobarbital,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Controlled Drugs (CDSA IV)
78940,Marketed,2008-02-29,02304090,"Phenobarbital Sodium Injection, USP",1,N03AA02,Phenobarbital,Solution,"Intravenous,Intramuscular",02304090,"PHENOBARBITAL SODIUM INJECTION, USP (phenobarbital sodium 120 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED",Active,9013506,phenobarbital sodium 120 mg per 1 mL solution for injection ampoule,8000799,phenobarbital,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Controlled Drugs (CDSA IV)
6421,Marketed,2014-09-05,00642215,Pen-VK,1,J01CE02,Phenoxymethylpenicillin,Tablet,Oral,00642215,PEN-VK (penicillin V potassium 300 mg oral tablet) AA PHARMA INC,Active,9006206,penicillin V potassium 300 mg oral tablet,8000064,penicillin V,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
67670,Marketed,2005-08-18,02243737,Phentolamine Mesylate Injection Sandoz Standard,1,C04AB01,Phentolamine,Solution,"Intramuscular,Intravenous",02243737,PHENTOLAMINE MESYLATE INJECTION SANDOZ STANDARD (phentolamine mesylate 5 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013508,phentolamine mesylate 5 mg per 1 mL solution for injection vial,8002066,phentolamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
90632,Marketed,2014-09-17,02421666,Oraverse,1,V03AB36,Phentolamine,Solution,Submucosal,02421666,ORAVERSE (phentolamine mesylate 0.4 mg per 1.7 mL solution for injection cartridge) SEPTODONT,Active,9013833,phentolamine mesylate 0.4 mg per 1.7 mL solution for injection cartridge,8002066,phentolamine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Prescription
12889,Marketed,2005-08-09,01953583,Phenylephrine Hydrochloride Injection USP,1,C01CA06,Phenylephrine,Liquid,"Intravenous,Intramuscular,Subcutaneous",77700593,PHENYLEPHRINE HYDROCHLORIDE INJECTION USP (phenylephrine (phenylephrine hydrochloride) 10 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012748,phenylephrine (phenylephrine hydrochloride) 10 mg per 1 mL solution for injection vial,8000823,phenylephrine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
12889,Marketed,2005-08-09,01953583,Phenylephrine Hydrochloride Injection USP,1,C01CA06,Phenylephrine,Liquid,"Intravenous,Intramuscular,Subcutaneous",77700594,PHENYLEPHRINE HYDROCHLORIDE INJECTION USP (phenylephrine (phenylephrine hydrochloride) 50 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012749,phenylephrine (phenylephrine hydrochloride) 50 mg per 5 mL solution for injection vial,8000823,phenylephrine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
18759,Marketed,2022-12-29,02148455,Minims Phenylephrine Hydrochloride,1,S01FB01,Phenylephrine,Solution,Ophthalmic,02148455,MINIMS PHENYLEPHRINE HYDROCHLORIDE (phenylephrine hydrochloride 10 % ophthalmic drops) BAUSCH & LOMB INC,Active,9002861,phenylephrine hydrochloride 10 % ophthalmic drops,8000823,phenylephrine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
18860,Marketed,2022-12-29,02148447,Minims Phenylephrine Hydrochloride,1,S01FB01,Phenylephrine,Solution,Ophthalmic,02148447,MINIMS PHENYLEPHRINE HYDROCHLORIDE (phenylephrine hydrochloride 2.5 % ophthalmic drops) BAUSCH & LOMB INC,Active,9001859,phenylephrine hydrochloride 2.5 % ophthalmic drops,8000823,phenylephrine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Ethical
3319,Marketed,2019-04-30,00465763,Mydfrin,1,S01FB01,Phenylephrine,Solution,Ophthalmic,00465763,MYDFRIN (phenylephrine hydrochloride 2.5 % ophthalmic drops) ALCON CANADA INC,Active,9001859,phenylephrine hydrochloride 2.5 % ophthalmic drops,8000823,phenylephrine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Ethical
37384,Marketed,2023-02-10,02224860,Soframycin Nasal Spray,3,R01AB01,Phenylephrine,Spray,Nasal,02224860,SOFRAMYCIN NASAL SPRAY (framycetin sulfate 12.5 mg per mL and gramicidin 0.05 mg per mL and phenylephrine hydrochloride 2.5 mg per mL nasal spray) SEARCHLIGHT PHARMA INC,Active,9003597,framycetin sulfate 12.5 mg per mL and gramicidin 0.05 mg per mL and phenylephrine hydrochloride 2.5 mg per mL nasal spray,8000920,framycetin and gramicidin and phenylephrine,46713006,Nasal,385157007,Nasal spray,,,,,,Prescription
61817,Marketed,2001-07-30,02238400,Phenylephrine Hydrochloride Injection USP 1%,1,C01CA06,Phenylephrine,Solution,"Intramuscular,Intravenous,Subcutaneous",02238400,PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 1% (phenylephrine hydrochloride 10 mg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9012751,phenylephrine hydrochloride 10 mg per 1 mL solution for injection vial,8000823,phenylephrine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
94130,Marketed,2021-11-25,02454599,Phenylephrine Hydrochloride Injection,1,C01CA06,Phenylephrine,Solution,Intravenous,02454599,PHENYLEPHRINE HYDROCHLORIDE INJECTION (phenylephrine hydrochloride 500 mcg per 10 mL solution for injection syringe) LABORATOIRE AGUETTANT,Active,9012752,phenylephrine hydrochloride 500 mcg per 10 mL solution for injection syringe,8000823,phenylephrine,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Ethical
96812,Marketed,2019-03-26,02477254,Phenylephrine Hydrochloride Injection USP,1,C01CA06,Phenylephrine,Solution,"Intravenous,Subcutaneous,Intramuscular",02477254,PHENYLEPHRINE HYDROCHLORIDE INJECTION USP (phenylephrine hydrochloride 10 mg per 1 mL solution for injection vial) MARCAN PHARMACEUTICALS INC,Active,9012751,phenylephrine hydrochloride 10 mg per 1 mL solution for injection vial,8000823,phenylephrine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
96967,Marketed,2022-07-06,02479281,Phenylephrine Hydrochloride Injection USP 1%,1,C01CA06,Phenylephrine,Solution,"Intramuscular,Subcutaneous,Intravenous",02479281,PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 1% (phenylephrine hydrochloride 10 mg per 1 mL solution for injection vial) MONT-PHARMA INC,Active,9012751,phenylephrine hydrochloride 10 mg per 1 mL solution for injection vial,8000823,phenylephrine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
99396,Marketed,2021-06-02,02504545,Phenylephrine Hydrochloride Injection USP,1,C01CA06,Phenylephrine,Solution,"Subcutaneous,Intramuscular,Intravenous",77701079,PHENYLEPHRINE HYDROCHLORIDE INJECTION USP (phenylephrine hydrochloride 10 mg per 1 mL solution for injection vial) STERIMAX INC,Active,9012751,phenylephrine hydrochloride 10 mg per 1 mL solution for injection vial,8000823,phenylephrine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
99396,Marketed,2021-06-02,02504545,Phenylephrine Hydrochloride Injection USP,1,C01CA06,Phenylephrine,Solution,"Subcutaneous,Intramuscular,Intravenous",77701080,PHENYLEPHRINE HYDROCHLORIDE INJECTION USP (phenylephrine hydrochloride 100 mg per 10 mL solution for injection vial) STERIMAX INC,Active,9014553,phenylephrine hydrochloride 100 mg per 10 mL solution for injection vial,8000823,phenylephrine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
99396,Marketed,2021-06-02,02504545,Phenylephrine Hydrochloride Injection USP,1,C01CA06,Phenylephrine,Solution,"Subcutaneous,Intramuscular,Intravenous",77701081,PHENYLEPHRINE HYDROCHLORIDE INJECTION USP (phenylephrine hydrochloride 50 mg per 5 mL solution for injection vial) STERIMAX INC,Active,9014554,phenylephrine hydrochloride 50 mg per 5 mL solution for injection vial,8000823,phenylephrine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
1036,Marketed,2023-06-07,00022772,Dilantin,1,N03AB02,Phenytoin,Capsule,Oral,00022772,DILANTIN (phenytoin sodium 30 mg oral capsule) BGP PHARMA ULC,Active,9000007,phenytoin sodium 30 mg oral capsule,8000004,phenytoin sodium,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
1037,Marketed,2023-06-07,00022780,Dilantin,1,N03AB02,Phenytoin,Capsule,Oral,00022780,DILANTIN (phenytoin sodium 100 mg oral capsule) BGP PHARMA ULC,Active,9000006,phenytoin sodium 100 mg oral capsule,8000004,phenytoin sodium,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
1086,Marketed,2023-08-02,00023698,Dilantin Infatabs,1,N03AB02,Phenytoin,Tablet (chewable),Oral,00023698,DILANTIN INFATABS (phenytoin 50 mg chewable tablet) BGP PHARMA ULC,Active,9014908,phenytoin 50 mg chewable tablet,8000005,phenytoin (base),26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
13063,Marketed,2026-05-26,00498335,Phenytoin Sodium Injection USP,1,N03AB02,Phenytoin,Solution,"Intramuscular,Intravenous",77700157,PHENYTOIN SODIUM INJECTION USP (phenytoin sodium 100 mg per 2 mL solution for injection vial) JUNO PHARMA CANADA INC.,Active,9000437,phenytoin sodium 100 mg per 2 mL solution for injection vial,8000004,phenytoin sodium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
13063,Marketed,2026-05-26,00498335,Phenytoin Sodium Injection USP,1,N03AB02,Phenytoin,Solution,"Intramuscular,Intravenous",77700158,PHENYTOIN SODIUM INJECTION USP (phenytoin sodium 250 mg per 5 mL solution for injection vial) JUNO PHARMA CANADA INC.,Active,9000438,phenytoin sodium 250 mg per 5 mL solution for injection vial,8000004,phenytoin sodium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
73583,Marketed,2005-05-03,02250896,Taro-Phenytoin,1,N03AB02,Phenytoin,Suspension,Oral,02250896,TARO-PHENYTOIN (phenytoin 125 mg per 5 mL oral suspension) TARO PHARMACEUTICALS INC,Active,9000009,phenytoin 125 mg per 5 mL oral suspension,8000005,phenytoin (base),26643006,Oral,385024007,Oral suspension,,,1.0,,,Prescription
91579,Marketed,2024-02-16,02431378,Phenytoin Sodium Injection USP,1,N03AB02,Phenytoin,Solution,"Intravenous,Intramuscular",77700131,PHENYTOIN SODIUM INJECTION USP (phenytoin sodium 100 mg per 2 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9000437,phenytoin sodium 100 mg per 2 mL solution for injection vial,8000004,phenytoin sodium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
91579,Marketed,2024-02-16,02431378,Phenytoin Sodium Injection USP,1,N03AB02,Phenytoin,Solution,"Intravenous,Intramuscular",77700132,PHENYTOIN SODIUM INJECTION USP (phenytoin sodium 250 mg per 5 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9000438,phenytoin sodium 250 mg per 5 mL solution for injection vial,8000004,phenytoin sodium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
9398,Marketed,2005-10-01,00780626,Phenytoin Sodium Injection USP,1,N03AB02,Phenytoin,Liquid,"Intravenous,Intramuscular",77700013,PHENYTOIN SODIUM INJECTION USP (phenytoin sodium 100 mg per 2 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9000303,phenytoin sodium 100 mg per 2 mL solution for injection ampoule,8000004,phenytoin sodium,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),1.0,,,Prescription
9398,Marketed,2005-10-01,00780626,Phenytoin Sodium Injection USP,1,N03AB02,Phenytoin,Liquid,"Intravenous,Intramuscular",77700014,PHENYTOIN SODIUM INJECTION USP (phenytoin sodium 250 mg per 5 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9000304,phenytoin sodium 250 mg per 5 mL solution for injection ampoule,8000004,phenytoin sodium,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),1.0,,,Prescription
94843,Marketed,2021-07-13,02460912,Phenytoin Sodium,1,N03AB02,Phenytoin,Capsule,Oral,02460912,PHENYTOIN SODIUM (phenytoin sodium 100 mg oral capsule) AA PHARMA INC,Active,9000006,phenytoin sodium 100 mg oral capsule,8000004,phenytoin sodium,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
9993,Marketed,2024-02-16,00781878,Vitamin K 1,1,B02BA01,Phytomenadione,Emulsion,"Subcutaneous,Intramuscular,Intravenous",00781878,VITAMIN K1 (phytonadione 1 mg per 0.5 mL emulsion for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9013719,phytonadione 1 mg per 0.5 mL emulsion for injection ampoule,8002209,phytonadione,738984000,Parenteral,385221006,Emulsion for injection,732978007,Ampule (unit of presentation),,,,Prescription
9994,Marketed,2024-02-16,00804312,Vitamin K 1,1,B02BA01,Phytomenadione,Emulsion,"Intramuscular,Intravenous,Subcutaneous",00804312,VITAMIN K1 (phytonadione 10 mg per 1 mL emulsion for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9013720,phytonadione 10 mg per 1 mL emulsion for injection ampoule,8002209,phytonadione,738984000,Parenteral,385221006,Emulsion for injection,732978007,Ampule (unit of presentation),,,,Prescription
18744,Marketed,2023-02-03,02148463,Minims Pilocarpine Nitrate,1,S01EB01,Pilocarpine,Drops,Ophthalmic,02148463,MINIMS PILOCARPINE NITRATE (pilocarpine nitrate 2 % ophthalmic drops) BAUSCH & LOMB INC,Active,9002862,pilocarpine nitrate 2 % ophthalmic drops,8001506,pilocarpine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
2375,Marketed,2017-12-08,00000868,Isopto Carpine,1,S01EB01,Pilocarpine,Solution,Ophthalmic,00000868,ISOPTO CARPINE (pilocarpine hydrochloride 2 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9002708,pilocarpine hydrochloride 2 % ophthalmic drops,8001506,pilocarpine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
43182,Marketed,2020-07-21,02216345,Salagen,1,N07AX01,Pilocarpine,Tablet,Oral,02216345,SALAGEN (pilocarpine hydrochloride 5 mg oral tablet) AMDIPHARM LIMITED,Active,9003078,pilocarpine hydrochloride 5 mg oral tablet,8001506,pilocarpine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98599,Marketed,2021-06-14,02496119,M-Pilocarpine,1,N07AX01,Pilocarpine,Tablet,Oral,02496119,M-PILOCARPINE (pilocarpine hydrochloride 5 mg oral tablet) MANTRA PHARMA INC,Active,9003078,pilocarpine hydrochloride 5 mg oral tablet,8001506,pilocarpine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99887,Marketed,2021-04-30,02509571,JAMP Pilocarpine,1,N07AX01,Pilocarpine,Tablet,Oral,02509571,JAMP PILOCARPINE (pilocarpine hydrochloride 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003078,pilocarpine hydrochloride 5 mg oral tablet,8001506,pilocarpine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71480,Marketed,2020-01-20,02247238,Elidel,1,D11AH02,Pimecrolimus,Cream,Topical,02247238,"ELIDEL (pimecrolimus 1 % cutaneous cream) BAUSCH HEALTH, CANADA INC.",Active,9003789,pimecrolimus 1 % cutaneous cream,8002067,pimecrolimus,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
69484,Marketed,2014-08-22,02245432,Pimozide,1,N05AG02,Pimozide,Tablet,Oral,02245432,PIMOZIDE (pimozide 2 mg oral tablet) AA PHARMA INC,Active,9001741,pimozide 2 mg oral tablet,8001507,pimozide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
69485,Marketed,2016-02-10,02245433,Pimozide,1,N05AG02,Pimozide,Tablet,Oral,02245433,PIMOZIDE (pimozide 4 mg oral tablet) AA PHARMA INC,Active,9001742,pimozide 4 mg oral tablet,8001507,pimozide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
15176,Marketed,2016-03-09,01950592,Dicetel,1,A03AX04,Pinaverium,Tablet,Oral,01950592,DICETEL (pinaverium bromide 50 mg oral tablet) BGP PHARMA ULC,Active,9002606,pinaverium bromide 50 mg oral tablet,8001300,pinaverium,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
49943,Marketed,2016-03-09,02230684,Dicetel,1,A03AX04,Pinaverium,Tablet,Oral,02230684,DICETEL (pinaverium bromide 100 mg oral tablet) BGP PHARMA ULC,Active,9003401,pinaverium bromide 100 mg oral tablet,8001300,pinaverium,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95848,Marketed,2021-08-16,02469677,Pinaverium,1,A03AX04,Pinaverium,Tablet,Oral,02469677,PINAVERIUM (pinaverium bromide 50 mg oral tablet) AA PHARMA INC,Active,9002606,pinaverium bromide 50 mg oral tablet,8001300,pinaverium,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95849,Marketed,2021-08-16,02469685,Pinaverium,1,A03AX04,Pinaverium,Tablet,Oral,02469685,PINAVERIUM (pinaverium bromide 100 mg oral tablet) AA PHARMA INC,Active,9003401,pinaverium bromide 100 mg oral tablet,8001300,pinaverium,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
10949,Marketed,2011-10-20,00869007,Teva-Pindolol,1,C07AA03,Pindolol,Tablet,Oral,00869007,TEVA-PINDOLOL (pindolol 5 mg oral tablet) TEVA CANADA LIMITED,Active,9011416,pindolol 5 mg oral tablet,8000819,pindolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
10950,Marketed,2011-10-20,00869015,Teva-Pindolol,1,C07AA03,Pindolol,Tablet,Oral,00869015,TEVA-PINDOLOL (pindolol 10 mg oral tablet) TEVA CANADA LIMITED,Active,9011414,pindolol 10 mg oral tablet,8000819,pindolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
10951,Marketed,2011-10-20,00869023,Teva-Pindolol,1,C07AA03,Pindolol,Tablet,Oral,00869023,TEVA-PINDOLOL (pindolol 15 mg oral tablet) TEVA CANADA LIMITED,Active,9011415,pindolol 15 mg oral tablet,8000819,pindolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78818,Marketed,2025-12-12,02302861,Teva-Pioglitazone,1,A10BG03,Pioglitazone,Tablet,Oral,02302861,TEVA-PIOGLITAZONE (pioglitazone (pioglitazone hydrochloride) 15 mg oral tablet) TEVA CANADA LIMITED,Active,9000916,pioglitazone (pioglitazone hydrochloride) 15 mg oral tablet,8000289,pioglitazone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78819,Marketed,2025-12-12,02302888,Teva-Pioglitazone,1,A10BG03,Pioglitazone,Tablet,Oral,02302888,TEVA-PIOGLITAZONE (pioglitazone (pioglitazone hydrochloride) 30 mg oral tablet) TEVA CANADA LIMITED,Active,9000917,pioglitazone (pioglitazone hydrochloride) 30 mg oral tablet,8000289,pioglitazone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78820,Marketed,2025-12-12,02302896,Teva-Pioglitazone,1,A10BG03,Pioglitazone,Tablet,Oral,02302896,TEVA-PIOGLITAZONE (pioglitazone (pioglitazone hydrochloride) 45 mg oral tablet) TEVA CANADA LIMITED,Active,9000918,pioglitazone (pioglitazone hydrochloride) 45 mg oral tablet,8000289,pioglitazone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81184,Marketed,2022-03-03,02326477,Mint-Pioglitazone,1,A10BG03,Pioglitazone,Tablet,Oral,02326477,MINT-PIOGLITAZONE (pioglitazone (pioglitazone hydrochloride) 15 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000916,pioglitazone (pioglitazone hydrochloride) 15 mg oral tablet,8000289,pioglitazone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81185,Marketed,2022-03-03,02326485,Mint-Pioglitazone,1,A10BG03,Pioglitazone,Tablet,Oral,02326485,MINT-PIOGLITAZONE (pioglitazone (pioglitazone hydrochloride) 30 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000917,pioglitazone (pioglitazone hydrochloride) 30 mg oral tablet,8000289,pioglitazone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81186,Marketed,2022-03-03,02326493,Mint-Pioglitazone,1,A10BG03,Pioglitazone,Tablet,Oral,02326493,MINT-PIOGLITAZONE (pioglitazone (pioglitazone hydrochloride) 45 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000918,pioglitazone (pioglitazone hydrochloride) 45 mg oral tablet,8000289,pioglitazone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82518,Marketed,2014-10-31,02339587,ACH-Pioglitazone,1,A10BG03,Pioglitazone,Tablet,Oral,02339587,ACH-PIOGLITAZONE (pioglitazone (pioglitazone hydrochloride) 30 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000917,pioglitazone (pioglitazone hydrochloride) 30 mg oral tablet,8000289,pioglitazone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82519,Marketed,2014-10-31,02339595,ACH-Pioglitazone,1,A10BG03,Pioglitazone,Tablet,Oral,02339595,ACH-PIOGLITAZONE (pioglitazone (pioglitazone hydrochloride) 45 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000918,pioglitazone (pioglitazone hydrochloride) 45 mg oral tablet,8000289,pioglitazone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85042,Marketed,2025-03-04,02365529,JAMP Pioglitazone,1,A10BG03,Pioglitazone,Tablet,Oral,02365529,JAMP PIOGLITAZONE (pioglitazone (pioglitazone hydrochloride) 30 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000917,pioglitazone (pioglitazone hydrochloride) 30 mg oral tablet,8000289,pioglitazone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85043,Marketed,2025-03-04,02365537,JAMP Pioglitazone,1,A10BG03,Pioglitazone,Tablet,Oral,02365537,JAMP PIOGLITAZONE (pioglitazone (pioglitazone hydrochloride) 45 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000918,pioglitazone (pioglitazone hydrochloride) 45 mg oral tablet,8000289,pioglitazone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87693,Marketed,2014-10-31,02391600,ACH-Pioglitazone,1,A10BG03,Pioglitazone,Tablet,Oral,02391600,ACH-PIOGLITAZONE (pioglitazone (pioglitazone hydrochloride) 15 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000916,pioglitazone (pioglitazone hydrochloride) 15 mg oral tablet,8000289,pioglitazone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88227,Marketed,2025-03-04,02397307,JAMP Pioglitazone,1,A10BG03,Pioglitazone,Tablet,Oral,02397307,JAMP PIOGLITAZONE (pioglitazone (pioglitazone hydrochloride) 15 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000916,pioglitazone (pioglitazone hydrochloride) 15 mg oral tablet,8000289,pioglitazone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101072,Marketed,2022-04-29,02521539,Piperacillin And Tazobactam For Injection,2,J01CR05,Piperacillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02521539,PIPERACILLIN AND TAZOBACTAM FOR INJECTION (piperacillin (piperacillin sodium) 36 g per vial and tazobactam (tazobactam sodium) 4.5 g per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9005772,piperacillin (piperacillin sodium) 36 g per vial and tazobactam (tazobactam sodium) 4.5 g per vial powder for solution for injection,8001413,piperacillin and tazobactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
101789,Marketed,2024-11-06,02528673,Piperacillin And Tazobactam For Injection,2,J01CR05,Piperacillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02528673,PIPERACILLIN AND TAZOBACTAM FOR INJECTION (piperacillin (piperacillin sodium) 2 g per vial and tazobactam (tazobactam sodium) 0.25 g per vial powder for solution for injection) EUGIA PHARMA INC.,Active,9004347,piperacillin (piperacillin sodium) 2 g per vial and tazobactam (tazobactam sodium) 0.25 g per vial powder for solution for injection,8001413,piperacillin and tazobactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
101790,Marketed,2024-10-07,02528703,Piperacillin And Tazobactam For Injection,2,J01CR05,Piperacillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02528703,PIPERACILLIN AND TAZOBACTAM FOR INJECTION (piperacillin (piperacillin sodium) 3 g per vial and tazobactam (tazobactam sodium) 0.375 g per vial powder for solution for injection) EUGIA PHARMA INC.,Active,9004348,piperacillin (piperacillin sodium) 3 g per vial and tazobactam (tazobactam sodium) 0.375 g per vial powder for solution for injection,8001413,piperacillin and tazobactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
101791,Marketed,2024-10-07,02528711,Piperacillin And Tazobactam For Injection,2,J01CR05,Piperacillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02528711,PIPERACILLIN AND TAZOBACTAM FOR INJECTION (piperacillin (piperacillin sodium) 4 g per vial and tazobactam (tazobactam sodium) 0.5 g per vial powder for solution for injection) EUGIA PHARMA INC.,Active,9004349,piperacillin (piperacillin sodium) 4 g per vial and tazobactam (tazobactam sodium) 0.5 g per vial powder for solution for injection,8001413,piperacillin and tazobactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
78500,Marketed,2021-10-22,02299623,Piperacillin And Tazobactam For Injection,2,J01CR05,Piperacillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02299623,PIPERACILLIN AND TAZOBACTAM FOR INJECTION (piperacillin (piperacillin sodium) 2 g per vial and tazobactam (tazobactam sodium) 0.25 g per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9004347,piperacillin (piperacillin sodium) 2 g per vial and tazobactam (tazobactam sodium) 0.25 g per vial powder for solution for injection,8001413,piperacillin and tazobactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
78501,Marketed,2021-10-22,02299631,Piperacillin And Tazobactam For Injection,2,J01CR05,Piperacillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02299631,PIPERACILLIN AND TAZOBACTAM FOR INJECTION (piperacillin (piperacillin sodium) 3 g per vial and tazobactam (tazobactam sodium) 0.375 g per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9004348,piperacillin (piperacillin sodium) 3 g per vial and tazobactam (tazobactam sodium) 0.375 g per vial powder for solution for injection,8001413,piperacillin and tazobactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
78502,Marketed,2021-10-22,02299658,Piperacillin And Tazobactam For Injection,2,J01CR05,Piperacillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02299658,PIPERACILLIN AND TAZOBACTAM FOR INJECTION (piperacillin (piperacillin sodium) 4 g per vial and tazobactam (tazobactam sodium) 0.5 g per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9004349,piperacillin (piperacillin sodium) 4 g per vial and tazobactam (tazobactam sodium) 0.5 g per vial powder for solution for injection,8001413,piperacillin and tazobactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
81627,Marketed,2021-10-22,02330547,Piperacillin And Tazobactam For Injection,2,J01CR05,Piperacillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02330547,PIPERACILLIN AND TAZOBACTAM FOR INJECTION (piperacillin (piperacillin sodium) 12 g per vial and tazobactam (tazobactam sodium) 1.5 g per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9004666,piperacillin (piperacillin sodium) 12 g per vial and tazobactam (tazobactam sodium) 1.5 g per vial powder for solution for injection,8001413,piperacillin and tazobactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
84762,Marketed,2011-08-29,02362619,Piperacillin And Tazobactam For Injection,2,J01CR05,Piperacillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02362619,PIPERACILLIN AND TAZOBACTAM FOR INJECTION (piperacillin (piperacillin sodium) 2 g per vial and tazobactam (tazobactam sodium) 0.25 g per vial powder for solution for injection) STERIMAX INC,Active,9004347,piperacillin (piperacillin sodium) 2 g per vial and tazobactam (tazobactam sodium) 0.25 g per vial powder for solution for injection,8001413,piperacillin and tazobactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
84763,Marketed,2011-08-29,02362627,Piperacillin And Tazobactam For Injection,2,J01CR05,Piperacillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02362627,PIPERACILLIN AND TAZOBACTAM FOR INJECTION (piperacillin (piperacillin sodium) 3 g per vial and tazobactam (tazobactam sodium) 0.375 g per vial powder for solution for injection) STERIMAX INC,Active,9004348,piperacillin (piperacillin sodium) 3 g per vial and tazobactam (tazobactam sodium) 0.375 g per vial powder for solution for injection,8001413,piperacillin and tazobactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
84764,Marketed,2011-08-29,02362635,Piperacillin And Tazobactam For Injection,2,J01CR05,Piperacillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02362635,PIPERACILLIN AND TAZOBACTAM FOR INJECTION (piperacillin (piperacillin sodium) 4 g per vial and tazobactam (tazobactam sodium) 0.5 g per vial powder for solution for injection) STERIMAX INC,Active,9004349,piperacillin (piperacillin sodium) 4 g per vial and tazobactam (tazobactam sodium) 0.5 g per vial powder for solution for injection,8001413,piperacillin and tazobactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
86356,Marketed,2012-03-13,02377748,Piperacillin And Tazobactam For Injection,2,J01CR05,Piperacillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02377748,PIPERACILLIN AND TAZOBACTAM FOR INJECTION (piperacillin (piperacillin sodium) 12 g per vial and tazobactam (tazobactam sodium) 1.5 g per vial powder for solution for injection) STERIMAX INC,Active,9004666,piperacillin (piperacillin sodium) 12 g per vial and tazobactam (tazobactam sodium) 1.5 g per vial powder for solution for injection,8001413,piperacillin and tazobactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
88693,Marketed,2021-06-09,02402068,Piperacillin And Tazobactam For Injection,2,J01CR05,Piperacillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02402068,PIPERACILLIN AND TAZOBACTAM FOR INJECTION (piperacillin (piperacillin sodium) 2 g per vial and tazobactam (tazobactam sodium) 0.25 g per vial powder for solution for injection) AURO PHARMA INC,Active,9004347,piperacillin (piperacillin sodium) 2 g per vial and tazobactam (tazobactam sodium) 0.25 g per vial powder for solution for injection,8001413,piperacillin and tazobactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
88694,Marketed,2021-06-09,02402076,Piperacillin And Tazobactam For Injection,2,J01CR05,Piperacillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02402076,PIPERACILLIN AND TAZOBACTAM FOR INJECTION (piperacillin (piperacillin sodium) 3 g per vial and tazobactam (tazobactam sodium) 0.375 g per vial powder for solution for injection) AURO PHARMA INC,Active,9004348,piperacillin (piperacillin sodium) 3 g per vial and tazobactam (tazobactam sodium) 0.375 g per vial powder for solution for injection,8001413,piperacillin and tazobactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
88695,Marketed,2021-06-09,02402084,Piperacillin And Tazobactam For Injection,2,J01CR05,Piperacillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02402084,PIPERACILLIN AND TAZOBACTAM FOR INJECTION (piperacillin (piperacillin sodium) 4 g per vial and tazobactam (tazobactam sodium) 0.5 g per vial powder for solution for injection) AURO PHARMA INC,Active,9004349,piperacillin (piperacillin sodium) 4 g per vial and tazobactam (tazobactam sodium) 0.5 g per vial powder for solution for injection,8001413,piperacillin and tazobactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
92352,Marketed,2015-09-11,02439131,Piperacillin And Tazobactam For Injection,2,J01CR05,Piperacillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02439131,PIPERACILLIN AND TAZOBACTAM FOR INJECTION (piperacillin (piperacillin sodium) 36 g per vial and tazobactam (tazobactam sodium) 4.5 g per vial powder for solution for injection) STERIMAX INC,Active,9005772,piperacillin (piperacillin sodium) 36 g per vial and tazobactam (tazobactam sodium) 4.5 g per vial powder for solution for injection,8001413,piperacillin and tazobactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
100410,Marketed,2021-10-08,02514702,JAMP Pirfenidone,1,L04AX05,Pirfenidone,Tablet,Oral,02514702,JAMP PIRFENIDONE (pirfenidone 267 mg oral tablet) JAMP PHARMA CORPORATION,Active,9013509,pirfenidone 267 mg oral tablet,8002070,pirfenidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100411,Marketed,2021-10-07,02514710,JAMP Pirfenidone,1,L04AX05,Pirfenidone,Tablet,Oral,02514710,JAMP PIRFENIDONE (pirfenidone 801 mg oral tablet) JAMP PHARMA CORPORATION,Active,9013510,pirfenidone 801 mg oral tablet,8002070,pirfenidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102064,Marketed,2023-04-26,02531526,PMS-Pirfenidone,1,L04AX05,Pirfenidone,Tablet,Oral,02531526,PMS-PIRFENIDONE (pirfenidone 267 mg oral tablet) PHARMASCIENCE INC,Active,9013509,pirfenidone 267 mg oral tablet,8002070,pirfenidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102065,Marketed,2023-04-26,02531534,PMS-Pirfenidone,1,L04AX05,Pirfenidone,Tablet,Oral,02531534,PMS-PIRFENIDONE (pirfenidone 801 mg oral tablet) PHARMASCIENCE INC,Active,9013510,pirfenidone 801 mg oral tablet,8002070,pirfenidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102653,Marketed,2024-03-05,02537753,Auro-Pirfenidone,1,L04AX05,Pirfenidone,Tablet,Oral,02537753,AURO-PIRFENIDONE (pirfenidone 267 mg oral tablet) AURO PHARMA INC,Active,9013509,pirfenidone 267 mg oral tablet,8002070,pirfenidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102654,Marketed,2024-03-05,02537761,Auro-Pirfenidone,1,L04AX05,Pirfenidone,Tablet,Oral,02537761,AURO-PIRFENIDONE (pirfenidone 801 mg oral tablet) AURO PHARMA INC,Active,9013510,pirfenidone 801 mg oral tablet,8002070,pirfenidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103943,Marketed,2025-01-29,02550644,M-Pirfenidone,1,L04AX05,Pirfenidone,Tablet,Oral,02550644,M-PIRFENIDONE (pirfenidone 267 mg oral tablet) MANTRA PHARMA INC,Active,9013509,pirfenidone 267 mg oral tablet,8002070,pirfenidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103944,Marketed,2025-01-29,02550652,M-Pirfenidone,1,L04AX05,Pirfenidone,Tablet,Oral,02550652,M-PIRFENIDONE (pirfenidone 801 mg oral tablet) MANTRA PHARMA INC,Active,9013510,pirfenidone 801 mg oral tablet,8002070,pirfenidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95262,Marketed,2017-07-26,02464489,Esbriet,1,L04AX05,Pirfenidone,Tablet,Oral,02464489,ESBRIET (pirfenidone 267 mg oral tablet) HOFFMANN-LA ROCHE LIMITED,Active,9013509,pirfenidone 267 mg oral tablet,8002070,pirfenidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95264,Marketed,2017-07-26,02464500,Esbriet,1,L04AX05,Pirfenidone,Tablet,Oral,02464500,ESBRIET (pirfenidone 801 mg oral tablet) HOFFMANN-LA ROCHE LIMITED,Active,9013510,pirfenidone 801 mg oral tablet,8002070,pirfenidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97860,Marketed,2021-05-04,02488507,Sandoz Pirfenidone Tablets,1,L04AX05,Pirfenidone,Tablet,Oral,02488507,SANDOZ PIRFENIDONE TABLETS (pirfenidone 267 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9013509,pirfenidone 267 mg oral tablet,8002070,pirfenidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97861,Marketed,2021-05-04,02488515,Sandoz Pirfenidone Tablets,1,L04AX05,Pirfenidone,Tablet,Oral,02488515,SANDOZ PIRFENIDONE TABLETS (pirfenidone 801 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9013510,pirfenidone 801 mg oral tablet,8002070,pirfenidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97891,Marketed,2021-10-25,02488833,Sandoz Pirfenidone Capsules,1,L04AX05,Pirfenidone,Capsule,Oral,02488833,SANDOZ PIRFENIDONE CAPSULES (pirfenidone 267 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9005153,pirfenidone 267 mg oral capsule,8002070,pirfenidone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
99919,Marketed,2021-06-04,02509938,JAMP Pirfenidone,1,L04AX05,Pirfenidone,Capsule,Oral,02509938,JAMP PIRFENIDONE (pirfenidone 267 mg oral capsule) JAMP PHARMA CORPORATION,Active,9005153,pirfenidone 267 mg oral capsule,8002070,pirfenidone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
6714,Marketed,1986-12-31,00642886,Apo Piroxicam Capsules 10 mg,1,M01AC01,Piroxicam,Capsule,Oral,00642886,APO PIROXICAM CAP 10MG (piroxicam 10 mg oral capsule) APOTEX INC,Active,9002081,piroxicam 10 mg oral capsule,8001508,piroxicam,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
6715,Marketed,1986-12-31,00642894,Apo Piroxicam Capsules 20 mg,1,M01AC01,Piroxicam,Capsule,Oral,00642894,APO PIROXICAM CAP 20MG (piroxicam 20 mg oral capsule) APOTEX INC,Active,9002082,piroxicam 20 mg oral capsule,8001508,piroxicam,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
6812,Marketed,2015-07-15,00695696,Teva-Piroxicam,1,M01AC01,Piroxicam,Capsule,Oral,00695696,TEVA-PIROXICAM (piroxicam 20 mg oral capsule) TEVA CANADA LIMITED,Active,9002082,piroxicam 20 mg oral capsule,8001508,piroxicam,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
6813,Marketed,2015-07-15,00695718,Teva-Piroxicam,1,M01AC01,Piroxicam,Capsule,Oral,00695718,TEVA-PIROXICAM (piroxicam 10 mg oral capsule) TEVA CANADA LIMITED,Active,9002081,piroxicam 10 mg oral capsule,8001508,piroxicam,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
106492,Marketed,2025-11-28,02562006,Jaypirca,1,L01EL05,Pirtobrutinib,Tablet,Oral,02562006,JAYPIRCA (pirtobrutinib 50 mg oral tablet) ELI LILLY CANADA INC,Active,9015323,pirtobrutinib 50 mg oral tablet,8002567,pirtobrutinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,,Prescription
106493,Marketed,2025-11-28,02562014,Jaypirca,1,L01EL05,Pirtobrutinib,Tablet,Oral,02562014,JAYPIRCA (pirtobrutinib 100 mg oral tablet) ELI LILLY CANADA INC,Active,9015322,pirtobrutinib 100 mg oral tablet,8002567,pirtobrutinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,,Prescription
100561,Marketed,2026-05-12,02516241,Wakix,1,N07XX11,Pitolisant,Tablet,Oral,02516241,WAKIX (pitolisant hydrochloride 5 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9014649,pitolisant hydrochloride 5 mg oral tablet,8002408,pitolisant,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100562,Marketed,2026-05-12,02516268,Wakix,1,N07XX11,Pitolisant,Tablet,Oral,02516268,WAKIX (pitolisant hydrochloride 20 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9014648,pitolisant hydrochloride 20 mg oral tablet,8002408,pitolisant,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
4222,Marketed,2025-11-28,00511552,Sandomigran DS,1,N02CX01,Pizotifen,Tablet,Oral,00511552,SANDOMIGRAN DS (pizotifen (pizotifen malate) 1 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9001895,pizotifen (pizotifen malate) 1 mg oral tablet,8001414,pizotifen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
66845,Marketed,2007-11-22,02243005,Mirena,1,G02BA03,Plastic iud with progestogens,Insert (extended-release),Intrauterine,02243005,MIRENA (levonorgestrel 52 mg intrauterine delivery system) BAYER INC,Active,9003563,levonorgestrel 52 mg intrauterine delivery system,8000915,levonorgestrel,62226000,Intrauterine,1237073006,Prolonged-release intrauterine delivery system,733021006,System (unit of presentation),1.0,,,Prescription
94684,Marketed,2017-01-10,02459523,Kyleena,1,G02BA03,Plastic iud with progestogens,Insert (extended-release),Intrauterine,02459523,KYLEENA (levonorgestrel 19.5 mg intrauterine delivery system) BAYER INC,Active,9006096,levonorgestrel 19.5 mg intrauterine delivery system,8000915,levonorgestrel,62226000,Intrauterine,1237073006,Prolonged-release intrauterine delivery system,733021006,System (unit of presentation),1.0,,,Prescription
98299,Marketed,2022-01-12,02493012,Trulance,1,A06AX07,Plecanatide,Tablet,Oral,02493012,"TRULANCE (plecanatide 3 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9014650,plecanatide 3 mg oral tablet,8002409,plecanatide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101905,Marketed,2023-08-31,02529815,Plerixafor Injection,1,L03AX16,Plerixafor,Solution,Subcutaneous,02529815,PLERIXAFOR INJECTION (plerixafor 24 mg per 1.2 mL solution for injection vial) JAMP PHARMA CORPORATION,Active,9013511,plerixafor 24 mg per 1.2 mL solution for injection vial,8002071,plerixafor,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
102820,Marketed,2024-01-05,02539454,Plerixafor Injection,1,L03AX16,Plerixafor,Solution,Subcutaneous,02539454,PLERIXAFOR INJECTION (plerixafor 24 mg per 1.2 mL solution for injection vial) EUGIA PHARMA INC.,Active,9013511,plerixafor 24 mg per 1.2 mL solution for injection vial,8002071,plerixafor,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
101153,Marketed,2022-09-02,02522403,Vaxneuvance,16,J07AL02,"Pneumococcus, purified polysacc.antigen conjugated",Suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
101610,Marketed,2022-07-08,02527049,Prevnar 20,21,J07AL02,"Pneumococcus, purified polysacc.antigen conjugated",Suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
103871,Marketed,2024-08-29,02549891,Capvaxive,22,J07AL02,"Pneumococcus, purified polysacc.antigen conjugated",Solution,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
100484,Marketed,2021-10-26,02515431,Polivy,1,L01FX14,Polatuzumab vedotin,Powder for solution,Intravenous,02515431,POLIVY (polatuzumab vedotin 30 mg per vial powder for solution for injection) HOFFMANN-LA ROCHE LIMITED,Active,9014626,polatuzumab vedotin 30 mg per vial powder for solution for injection,8002358,polatuzumab vedotin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
100484,Marketed,2021-10-26,02515431,Polivy,1,L01FX14,Polatuzumab vedotin,Powder for solution,Intravenous,02515431,POLIVY (polatuzumab vedotin 30 mg per vial powder for solution for injection) HOFFMANN-LA ROCHE LIMITED,Active,9014626,polatuzumab vedotin 30 mg per vial powder for solution for injection,8002358,polatuzumab vedotin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
98934,Marketed,2020-11-25,02499614,Polivy,1,L01FX14,Polatuzumab vedotin,Powder for solution,Intravenous,02499614,POLIVY (polatuzumab vedotin 140 mg per vial powder for solution for injection) HOFFMANN-LA ROCHE LIMITED,Active,9014433,polatuzumab vedotin 140 mg per vial powder for solution for injection,8002358,polatuzumab vedotin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
98934,Marketed,2020-11-25,02499614,Polivy,1,L01FX14,Polatuzumab vedotin,Powder for solution,Intravenous,02499614,POLIVY (polatuzumab vedotin 140 mg per vial powder for solution for injection) HOFFMANN-LA ROCHE LIMITED,Active,9014433,polatuzumab vedotin 140 mg per vial powder for solution for injection,8002358,polatuzumab vedotin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
44019,Marketed,2007-03-22,01959042,Imovax Polio,3,J07BF03,"Poliomyelitis, trivalent, inactivated, whole virus",Solution,Subcutaneous,,,,,,,,,,,,,,,,,Schedule D
17205,Marketed,2008-07-18,02017741,Resonium Calcium,1,V03AE01,Polystyrene sulphonate,Powder for solution,"Oral,Rectal",02017741,RESONIUM CALCIUM (calcium polystyrene sulfonate 999 mg per g powder for oral/rectal suspension) SANOFI-AVENTIS CANADA INC,Active,9006313,calcium polystyrene sulfonate 999 mg per g powder for oral/rectal suspension,8001712,calcium polystyrene sulfonate,255204007,Multiple (oral or rectal),739008005,Suspension,,,,,,Ethical
17752,Marketed,2009-02-06,02026961,Kayexalate,1,V03AE01,Polystyrene sulphonate,Powder for suspension,"Oral,Rectal",02026961,KAYEXALATE (sodium polystyrene sulfonate 1 g per g powder for oral/rectal suspension) SANOFI-AVENTIS CANADA INC,Active,9013345,sodium polystyrene sulfonate 1 g per g powder for oral/rectal suspension,8001941,sodium polystyrene sulfonate,255204007,Multiple (oral or rectal),739008005,Suspension,,,,,,Prescription
8918,Marketed,2014-01-28,00755338,Solystat,1,V03AE01,Polystyrene sulphonate,Powder for suspension,"Oral,Rectal",00755338,SOLYSTAT (sodium polystyrene sulfonate 1 g per g powder for oral/rectal suspension) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9013345,sodium polystyrene sulfonate 1 g per g powder for oral/rectal suspension,8001941,sodium polystyrene sulfonate,255204007,Multiple (oral or rectal),739008005,Suspension,,,,,,Prescription
9611,Marketed,2012-06-19,00769541,Solystat,1,V03AE01,Polystyrene sulphonate,Suspension,Oral,00769541,SOLYSTAT (sodium polystyrene sulfonate 250 mg per mL oral suspension) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9002224,sodium polystyrene sulfonate 250 mg per mL oral suspension,8001941,sodium polystyrene sulfonate,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
96396,Marketed,2018-10-25,02473941,Odan-Sodium Polystyrene Sulfonate,1,V03AE01,Polystyrene sulphonate,Powder for suspension,"Oral,Rectal",02473941,ODAN-SODIUM POLYSTYRENE SULFONATE (sodium polystyrene sulfonate 1 g per g powder for oral/rectal suspension) ODAN LABORATORIES LTD,Active,9013345,sodium polystyrene sulfonate 1 g per g powder for oral/rectal suspension,8001941,sodium polystyrene sulfonate,255204007,Multiple (oral or rectal),739008005,Suspension,,,,,,Prescription
96397,Marketed,2018-12-11,02473968,Odan-Sodium Polystyrene Sulfonate,1,V03AE01,Polystyrene sulphonate,Suspension,"Rectal,Oral",02473968,ODAN-SODIUM POLYSTYRENE SULFONATE (sodium polystyrene sulfonate 250 mg per mL oral/rectal suspension) ODAN LABORATORIES LTD,Active,9013727,sodium polystyrene sulfonate 250 mg per mL oral/rectal suspension,8001941,sodium polystyrene sulfonate,255204007,Multiple (oral or rectal),739008005,Suspension,,,,,,Prescription
98738,Marketed,2021-02-04,02497557,JAMP Sodium Polystyrene Sulfonate,1,V03AE01,Polystyrene sulphonate,Powder for suspension,"Oral,Rectal",02497557,JAMP SODIUM POLYSTYRENE SULFONATE (sodium polystyrene sulfonate 1 g per g powder for oral/rectal suspension) JAMP PHARMA CORPORATION,Active,9013345,sodium polystyrene sulfonate 1 g per g powder for oral/rectal suspension,8001941,sodium polystyrene sulfonate,255204007,Multiple (oral or rectal),739008005,Suspension,,,,,,Prescription
100962,Marketed,2023-02-28,02520427,Apo-Pomalidomide,1,L04AX06,Pomalidomide,Capsule,Oral,02520427,APO-POMALIDOMIDE (pomalidomide 1 mg oral capsule) APOTEX INC,Active,9005437,pomalidomide 1 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
100963,Marketed,2023-02-28,02520435,Apo-Pomalidomide,1,L04AX06,Pomalidomide,Capsule,Oral,02520435,APO-POMALIDOMIDE (pomalidomide 2 mg oral capsule) APOTEX INC,Active,9005438,pomalidomide 2 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
100964,Marketed,2023-02-28,02520443,Apo-Pomalidomide,1,L04AX06,Pomalidomide,Capsule,Oral,02520443,APO-POMALIDOMIDE (pomalidomide 3 mg oral capsule) APOTEX INC,Active,9005439,pomalidomide 3 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
100965,Marketed,2023-02-28,02520451,Apo-Pomalidomide,1,L04AX06,Pomalidomide,Capsule,Oral,02520451,APO-POMALIDOMIDE (pomalidomide 4 mg oral capsule) APOTEX INC,Active,9005440,pomalidomide 4 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
101302,Marketed,2023-02-28,02523973,Sandoz Pomalidomide,1,L04AX06,Pomalidomide,Capsule,Oral,02523973,SANDOZ POMALIDOMIDE (pomalidomide 1 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9005437,pomalidomide 1 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
101303,Marketed,2023-02-28,02523981,Sandoz Pomalidomide,1,L04AX06,Pomalidomide,Capsule,Oral,02523981,SANDOZ POMALIDOMIDE (pomalidomide 2 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9005438,pomalidomide 2 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
101304,Marketed,2023-02-28,02524007,Sandoz Pomalidomide,1,L04AX06,Pomalidomide,Capsule,Oral,02524007,SANDOZ POMALIDOMIDE (pomalidomide 3 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9005439,pomalidomide 3 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
101305,Marketed,2023-02-28,02524015,Sandoz Pomalidomide,1,L04AX06,Pomalidomide,Capsule,Oral,02524015,SANDOZ POMALIDOMIDE (pomalidomide 4 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9005440,pomalidomide 4 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
102681,Marketed,2023-08-01,02538059,JAMP Pomalidomide,1,L04AX06,Pomalidomide,Capsule,Oral,02538059,JAMP POMALIDOMIDE (pomalidomide 1 mg oral capsule) JAMP PHARMA CORPORATION,Active,9005437,pomalidomide 1 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
102682,Marketed,2023-08-01,02538075,JAMP Pomalidomide,1,L04AX06,Pomalidomide,Capsule,Oral,02538075,JAMP POMALIDOMIDE (pomalidomide 2 mg oral capsule) JAMP PHARMA CORPORATION,Active,9005438,pomalidomide 2 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
102683,Marketed,2023-08-01,02538083,JAMP Pomalidomide,1,L04AX06,Pomalidomide,Capsule,Oral,02538083,JAMP POMALIDOMIDE (pomalidomide 3 mg oral capsule) JAMP PHARMA CORPORATION,Active,9005439,pomalidomide 3 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
102684,Marketed,2023-08-01,02538091,JAMP Pomalidomide,1,L04AX06,Pomalidomide,Capsule,Oral,02538091,JAMP POMALIDOMIDE (pomalidomide 4 mg oral capsule) JAMP PHARMA CORPORATION,Active,9005440,pomalidomide 4 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
90423,Marketed,2024-11-11,02419580,Pomalyst,1,L04AX06,Pomalidomide,Capsule,Oral,02419580,POMALYST (pomalidomide 1 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9005437,pomalidomide 1 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
90424,Marketed,2025-01-31,02419599,Pomalyst,1,L04AX06,Pomalidomide,Capsule,Oral,02419599,POMALYST (pomalidomide 2 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9005438,pomalidomide 2 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
90425,Marketed,2025-02-03,02419602,Pomalyst,1,L04AX06,Pomalidomide,Capsule,Oral,02419602,POMALYST (pomalidomide 3 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9005439,pomalidomide 3 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
90426,Marketed,2025-01-31,02419610,Pomalyst,1,L04AX06,Pomalidomide,Capsule,Oral,02419610,POMALYST (pomalidomide 4 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9005440,pomalidomide 4 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
99353,Marketed,2023-03-15,02504073,Reddy-Pomalidomide,1,L04AX06,Pomalidomide,Capsule,Oral,02504073,REDDY-POMALIDOMIDE (pomalidomide 1 mg oral capsule) DR REDDY'S LABORATORIES LTD,Active,9005437,pomalidomide 1 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
99354,Marketed,2023-03-15,02504081,Reddy-Pomalidomide,1,L04AX06,Pomalidomide,Capsule,Oral,02504081,REDDY-POMALIDOMIDE (pomalidomide 2 mg oral capsule) DR REDDY'S LABORATORIES LTD,Active,9005438,pomalidomide 2 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
99355,Marketed,2023-03-15,02504103,Reddy-Pomalidomide,1,L04AX06,Pomalidomide,Capsule,Oral,02504103,REDDY-POMALIDOMIDE (pomalidomide 3 mg oral capsule) DR REDDY'S LABORATORIES LTD,Active,9005439,pomalidomide 3 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
99356,Marketed,2023-03-15,02504111,Reddy-Pomalidomide,1,L04AX06,Pomalidomide,Capsule,Oral,02504111,REDDY-POMALIDOMIDE (pomalidomide 4 mg oral capsule) DR REDDY'S LABORATORIES LTD,Active,9005440,pomalidomide 4 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
99576,Marketed,2023-02-28,02506394,Nat-Pomalidomide,1,L04AX06,Pomalidomide,Capsule,Oral,02506394,NAT-POMALIDOMIDE (pomalidomide 1 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9005437,pomalidomide 1 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
99577,Marketed,2023-02-28,02506408,Nat-Pomalidomide,1,L04AX06,Pomalidomide,Capsule,Oral,02506408,NAT-POMALIDOMIDE (pomalidomide 2 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9005438,pomalidomide 2 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
99578,Marketed,2023-02-28,02506416,Nat-Pomalidomide,1,L04AX06,Pomalidomide,Capsule,Oral,02506416,NAT-POMALIDOMIDE (pomalidomide 3 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9005439,pomalidomide 3 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
99579,Marketed,2023-02-28,02506424,Nat-Pomalidomide,1,L04AX06,Pomalidomide,Capsule,Oral,02506424,NAT-POMALIDOMIDE (pomalidomide 4 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9005440,pomalidomide 4 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
92168,Marketed,2023-06-29,02437333,Iclusig,1,L01EA05,Ponatinib,Tablet,Oral,02437333,"ICLUSIG (ponatinib (ponatinib hydrochloride) 15 mg oral tablet) TAKEDA PHARMACEUTICALS U.S.A., INC.",Active,9005760,ponatinib (ponatinib hydrochloride) 15 mg oral tablet,8002077,ponatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100487,Marketed,2025-08-25,02515482,Ponvory,1,L04AE04,Ponesimod,Tablet,Oral,02515482,PONVORY (ponesimod 20 mg oral tablet) VANDA PHARMACEUTICALS INC.,Active,9014628,ponesimod 20 mg oral tablet,8002397,ponesimod,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101953,Marketed,2023-05-24,02530333,JAMP Posaconazole,1,J02AC04,Posaconazole,Suspension,Oral,02530333,JAMP POSACONAZOLE (posaconazole 200 mg per 5 mL oral suspension) JAMP PHARMA CORPORATION,Active,9013599,posaconazole 200 mg per 5 mL oral suspension,8001511,posaconazole,26643006,Oral,385024007,Oral suspension,,,1.0,,,Prescription
103062,Marketed,2023-10-04,02542021,GLN-Posaconazole,1,J02AC04,Posaconazole,Tablet (delayed-release),Oral,02542021,GLN-POSACONAZOLE (posaconazole 100 mg gastro-resistant tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9005523,posaconazole 100 mg gastro-resistant tablet,8001511,posaconazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
103180,Marketed,2024-03-25,02543311,Taro-Posaconazole,1,J02AC04,Posaconazole,Tablet (delayed-release),Oral,02543311,TARO-POSACONAZOLE (posaconazole 100 mg gastro-resistant tablet) TARO PHARMACEUTICALS INC,Active,9005523,posaconazole 100 mg gastro-resistant tablet,8001511,posaconazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
103321,Marketed,2024-07-25,02544644,Mint-Posaconazole,1,J02AC04,Posaconazole,Tablet (delayed-release),Oral,02544644,MINT-POSACONAZOLE (posaconazole 100 mg gastro-resistant tablet) MINT PHARMACEUTICALS INC,Active,9005523,posaconazole 100 mg gastro-resistant tablet,8001511,posaconazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
77877,Marketed,2011-03-18,02293404,Posanol,1,J02AC04,Posaconazole,Suspension,Oral,02293404,POSANOL (posaconazole 200 mg per 5 mL oral suspension) MERCK CANADA INC,Active,9013599,posaconazole 200 mg per 5 mL oral suspension,8001511,posaconazole,26643006,Oral,385024007,Oral suspension,,,1.0,,,Prescription
90930,Marketed,2014-05-21,02424622,Posanol,1,J02AC04,Posaconazole,Tablet (delayed-release),Oral,02424622,POSANOL (posaconazole 100 mg gastro-resistant tablet) MERCK CANADA INC,Active,9005523,posaconazole 100 mg gastro-resistant tablet,8001511,posaconazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
91710,Marketed,2014-11-24,02432676,Posanol,1,J02AC04,Posaconazole,Solution,Intravenous,02432676,POSANOL (posaconazole 300 mg per 16.7 mL solution for injection vial) MERCK CANADA INC,Active,9013600,posaconazole 300 mg per 16.7 mL solution for injection vial,8001511,posaconazole,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
98612,Marketed,2020-12-08,02496259,Sandoz Posaconazole,1,J02AC04,Posaconazole,Tablet (delayed-release),Oral,02496259,SANDOZ POSACONAZOLE (posaconazole 100 mg gastro-resistant tablet) SANDOZ CANADA INCORPORATED,Active,9005523,posaconazole 100 mg gastro-resistant tablet,8001511,posaconazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
84760,Marketed,2025-10-10,02362597,Potassium Acetate Injection USP,1,B05XA17,Potassium acetate,Solution,Intravenous,02362597,POTASSIUM ACETATE INJECTION USP (potassium (potassium acetate) 4 mmol per mL solution for injection 50 mL vial) JUNO PHARMA CANADA INC.,Active,9013932,potassium (potassium acetate) 4 mmol per mL solution for injection 50 mL vial,8001869,potassium acetate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
101903,Marketed,2022-10-03,02529793,Potassium Chloride For Hemodialysis 7.55,1,A12BA01,Potassium chloride,Powder for solution,Haemodialysis,,,,,,,,,,,,,,,,,Ethical
2527,Marketed,2017-09-14,00037869,Potassium Chloride For Injection Concentrate USP,1,B05XA01,Potassium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
3394,Marketed,2019-08-02,00402206,Potassium Chloride For Injection Concentrate,1,B05XA01,Potassium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
65336,Marketed,2000-08-10,02241676,Potassium Chloride Injection,1,B05XA01,Potassium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
65337,Marketed,2000-08-10,02241677,Potassium Chloride Injection,1,B05XA01,Potassium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
65339,Marketed,2000-08-10,02241679,Potassium Chloride Injection,1,B05XA01,Potassium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
97058,Marketed,2019-08-03,02480034,Potassium Chloride For Injection Concentrate,1,B05XA01,Potassium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
97592,Marketed,2020-03-25,02485699,Potassium Chloride For Injection Concentrate USP,1,B05XA01,Potassium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
83921,Marketed,2011-02-11,02353997,Urocit-K,1,A12BA02,Potassium citrate,Tablet (extended-release),Oral,02353997,UROCIT-K (potassium citrate 10 mEq prolonged-release oral tablet) MISSION PHARMACAL COMPANY,Active,9013987,potassium citrate 10 mEq prolonged-release oral tablet,8001871,potassium citrate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
10509,Marketed,2006-07-06,00804789,Potassium Phosphates,2,B05XA06,Potassium phos incl comb w/0th pot. salts,Liquid,Intravenous,,,,,,,,,,,,,,,,,Ethical
19442,Marketed,2015-12-22,02139545,"Potassium Phosphates Injection, USP",2,B05XA06,Potassium phos incl comb w/0th pot. salts,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
8119,Marketed,2006-05-31,00711306,Potassium Phosphate Monobasic Injection,1,B05XA06,Potassium phos incl comb w/0th pot. salts,Solution,Intravenous,00711306,POTASSIUM PHOSPHATE MONOBASIC INJECTION (phosphorus (potassium phosphate monobasic) 12.9 mmol per 10 mL and potassium (potassium phosphate monobasic) 12.9 mmol per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013928,phosphorus (potassium phosphate monobasic) 12.9 mmol per 10 mL and potassium (potassium phosphate monobasic) 12.9 mmol per 10 mL solution for injection vial,8002155,potassium phosphate monobasic,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
97230,Marketed,2019-01-15,02481820,Folotyn,1,L01BA05,Pralatrexate%,Solution,Intravenous,02481820,FOLOTYN (pralatrexate 20 mg per 1 mL solution for injection vial) SERVIER CANADA INC,Active,9013989,pralatrexate 20 mg per 1 mL solution for injection vial,8002265,pralatrexate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
60463,Marketed,1998-02-26,02237145,Mirapex,1,N04BC05,Pramipexole,Tablet,Oral,02237145,MIRAPEX (pramipexole dihydrochloride monohydrate 0.25 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9000783,pramipexole dihydrochloride 0.25 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77772,Marketed,2007-02-26,02292378,Apo-Pramipexole,1,N04BC05,Pramipexole,Tablet,Oral,02292378,APO-PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 0.25 mg oral tablet) APOTEX INC,Active,9000783,pramipexole dihydrochloride 0.25 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77773,Marketed,2007-02-26,02292386,Apo-Pramipexole,1,N04BC05,Pramipexole,Tablet,Oral,02292386,APO-PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 0.5 mg oral tablet) APOTEX INC,Active,9000889,pramipexole dihydrochloride 0.5 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77774,Marketed,2007-02-26,02292394,Apo-Pramipexole,1,N04BC05,Pramipexole,Tablet,Oral,02292394,APO-PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 1 mg oral tablet) APOTEX INC,Active,9000785,pramipexole dihydrochloride 1 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77776,Marketed,2007-02-26,02292408,Apo-Pramipexole,1,N04BC05,Pramipexole,Tablet,Oral,02292408,APO-PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 1.5 mg oral tablet) APOTEX INC,Active,9000784,pramipexole dihydrochloride 1.5 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78262,Marketed,2008-07-09,02297256,Mirapex,1,N04BC05,Pramipexole,Tablet,Oral,02297256,MIRAPEX (pramipexole dihydrochloride monohydrate 0.125 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9001252,pramipexole dihydrochloride 0.125 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78267,Marketed,2020-04-27,02297302,Act Pramipexole,1,N04BC05,Pramipexole,Tablet,Oral,02297302,ACT PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 0.25 mg oral tablet) TEVA CANADA LIMITED,Active,9000783,pramipexole dihydrochloride 0.25 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78268,Marketed,2020-04-27,02297310,Act Pramipexole,1,N04BC05,Pramipexole,Tablet,Oral,02297310,ACT PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 0.5 mg oral tablet) TEVA CANADA LIMITED,Active,9000889,pramipexole dihydrochloride 0.5 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78269,Marketed,2020-04-27,02297329,Act Pramipexole,1,N04BC05,Pramipexole,Tablet,Oral,02297329,ACT PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 1 mg oral tablet) TEVA CANADA LIMITED,Active,9000785,pramipexole dihydrochloride 1 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78270,Marketed,2020-04-27,02297337,Act Pramipexole,1,N04BC05,Pramipexole,Tablet,Oral,02297337,ACT PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 1.5 mg oral tablet) TEVA CANADA LIMITED,Active,9000784,pramipexole dihydrochloride 1.5 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79472,Marketed,2018-09-13,02309122,Pramipexole,1,N04BC05,Pramipexole,Tablet,Oral,02309122,PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 0.25 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000783,pramipexole dihydrochloride 0.25 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79473,Marketed,2018-09-13,02309130,Pramipexole,1,N04BC05,Pramipexole,Tablet,Oral,02309130,PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 0.5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000889,pramipexole dihydrochloride 0.5 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79474,Marketed,2018-11-23,02309149,Pramipexole,1,N04BC05,Pramipexole,Tablet,Oral,02309149,PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 1 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000785,pramipexole dihydrochloride 1 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79475,Marketed,2018-11-23,02309157,Pramipexole,1,N04BC05,Pramipexole,Tablet,Oral,02309157,PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 1.5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000784,pramipexole dihydrochloride 1.5 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80080,Marketed,2008-08-14,02315262,Sandoz Pramipexole,1,N04BC05,Pramipexole,Tablet,Oral,02315262,SANDOZ PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 0.25 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000783,pramipexole dihydrochloride 0.25 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80081,Marketed,2008-08-14,02315270,Sandoz Pramipexole,1,N04BC05,Pramipexole,Tablet,Oral,02315270,SANDOZ PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 0.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000889,pramipexole dihydrochloride 0.5 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80082,Marketed,2008-08-14,02315289,Sandoz Pramipexole,1,N04BC05,Pramipexole,Tablet,Oral,02315289,SANDOZ PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 1 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000785,pramipexole dihydrochloride 1 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80083,Marketed,2008-08-14,02315297,Sandoz Pramipexole,1,N04BC05,Pramipexole,Tablet,Oral,02315297,SANDOZ PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 1.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000784,pramipexole dihydrochloride 1.5 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81116,Marketed,2018-06-13,02325802,Pramipexole,1,N04BC05,Pramipexole,Tablet,Oral,02325802,PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 0.25 mg oral tablet) PRO DOC LIMITEE,Active,9000783,pramipexole dihydrochloride 0.25 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81117,Marketed,2018-05-15,02325810,Pramipexole,1,N04BC05,Pramipexole,Tablet,Oral,02325810,PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 0.5 mg oral tablet) PRO DOC LIMITEE,Active,9000889,pramipexole dihydrochloride 0.5 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81118,Marketed,2018-06-18,02325829,Pramipexole,1,N04BC05,Pramipexole,Tablet,Oral,02325829,PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 1 mg oral tablet) PRO DOC LIMITEE,Active,9000785,pramipexole dihydrochloride 1 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81119,Marketed,2018-06-18,02325837,Pramipexole,1,N04BC05,Pramipexole,Tablet,Oral,02325837,PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 1.5 mg oral tablet) PRO DOC LIMITEE,Active,9000784,pramipexole dihydrochloride 1.5 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85244,Marketed,2022-03-28,02367602,Pramipexole,1,N04BC05,Pramipexole,Tablet,Oral,02367602,PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 0.25 mg oral tablet) SANIS HEALTH INC,Active,9000783,pramipexole dihydrochloride 0.25 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85245,Marketed,2022-03-28,02367610,Pramipexole,1,N04BC05,Pramipexole,Tablet,Oral,02367610,PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 0.5 mg oral tablet) SANIS HEALTH INC,Active,9000889,pramipexole dihydrochloride 0.5 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85247,Marketed,2022-03-28,02367629,Pramipexole,1,N04BC05,Pramipexole,Tablet,Oral,02367629,PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 1 mg oral tablet) SANIS HEALTH INC,Active,9000785,pramipexole dihydrochloride 1 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90879,Marketed,2014-04-29,02424061,Auro-Pramipexole,1,N04BC05,Pramipexole,Tablet,Oral,02424061,AURO-PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 0.25 mg oral tablet) AURO PHARMA INC,Active,9000783,pramipexole dihydrochloride 0.25 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90880,Marketed,2014-04-29,02424088,Auro-Pramipexole,1,N04BC05,Pramipexole,Tablet,Oral,02424088,AURO-PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 0.5 mg oral tablet) AURO PHARMA INC,Active,9000889,pramipexole dihydrochloride 0.5 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90881,Marketed,2014-04-29,02424096,Auro-Pramipexole,1,N04BC05,Pramipexole,Tablet,Oral,02424096,AURO-PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 1 mg oral tablet) AURO PHARMA INC,Active,9000785,pramipexole dihydrochloride 1 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90882,Marketed,2014-04-29,02424118,Auro-Pramipexole,1,N04BC05,Pramipexole,Tablet,Oral,02424118,AURO-PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 1.5 mg oral tablet) AURO PHARMA INC,Active,9000784,pramipexole dihydrochloride 1.5 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103690,Marketed,2026-03-27,02547996,Precise Cooling Pain Relief Cream,2,D04AB07,Pramocaine,Cream,Topical,02547996,PRECISE COOLING PAIN RELIEF CREAM (lidocaine 4 % and menthol 1 % cutaneous cream) KENVUE CANADA INC.,Active,9015221,lidocaine 4 % and menthol 1 % cutaneous cream,8001838,lidocaine and menthol,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
12763,Marketed,2017-03-03,01945904,Anusol Plus Suppositories,2,C05AD07,Pramocaine,Suppository,Rectal,01945904,ANUSOL PLUS SUPPOSITORIES (pramoxine hydrochloride 20 mg and zinc sulfate 10 mg suppository) CHURCH & DWIGHT CANADA CORP,Active,9002492,pramoxine hydrochloride 20 mg and zinc sulfate 10 mg suppository,8001873,pramoxine and zinc sulfate,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,,Non-Prescription Drugs
12764,Marketed,2017-03-03,01945912,Anusol Plus Ointment,2,C05AD07,Pramocaine,Ointment,"Rectal,Topical",01945912,ANUSOL PLUS OINTMENT (pramoxine hydrochloride 1 % and zinc sulfate 0.5 % rectal ointment) CHURCH & DWIGHT CANADA CORP,Active,9002491,pramoxine hydrochloride 1 % and zinc sulfate 0.5 % rectal ointment,8001873,pramoxine and zinc sulfate,37161004,Rectal,385184008,Rectal ointment,,,,,,Non-Prescription Drugs
60289,Marketed,2011-12-16,02236991,Gold Bond Medicated Anti-Itch Cream,2,D04AB07,Pramocaine,Cream,Topical,02236991,GOLD BOND MEDICATED ANTI-ITCH CREAM (menthol 1 % and pramoxine hydrochloride 1 % cutaneous cream) SANOFI CONSUMER HEALTH INC,Active,9003350,menthol 1 % and pramoxine hydrochloride 1 % cutaneous cream,8001848,menthol and pramoxine,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
63620,Marketed,2026-03-25,02240105,Aveeno Anti-Itch Lotion,2,D04AB07,Pramocaine,Lotion,Topical,02240105,AVEENO ANTI-ITCH LOTION (calamine 3 % and pramoxine hydrochloride 1 % lotion) KENVUE CANADA INC.,Active,9003490,calamine 3 % and pramoxine hydrochloride 1 % lotion,8001708,calamine and pramoxine,448598008,Cutaneous,739000003,Lotion,,,,,,Non-Prescription Drugs
70300,Marketed,2026-03-27,02246156,Polysporin Itch Relief,2,D04AB07,Pramocaine,Lotion,Topical,02246156,POLYSPORIN ITCH RELIEF (pramoxine hydrochloride 1 % and zinc acetate 0.1 % lotion) KENVUE CANADA INC.,Active,9003791,pramoxine hydrochloride 1 % and zinc acetate 0.1 % lotion,8001872,pramoxine and zinc acetate,448598008,Cutaneous,739000003,Lotion,,,,,,Non-Prescription Drugs
80397,Marketed,2011-11-19,02318482,Gold Bond Anti-Itch Lotion,3,D04AB07,Pramocaine,Lotion,Topical,02318482,GOLD BOND ANTI-ITCH LOTION (dimethicone 5 % and menthol 0.5 % and pramoxine hydrochloride 1 % lotion) SANOFI CONSUMER HEALTH INC,Active,9004520,dimethicone 5 % and menthol 0.5 % and pramoxine hydrochloride 1 % lotion,8001749,dimethicone and menthol and pramoxine,448598008,Cutaneous,739000003,Lotion,,,,,,Non-Prescription Drugs
97516,Marketed,2021-02-01,02484889,Itch Relief Moisturizing Cream,1,D04AB07,Pramocaine,Cream,Topical,02484889,ITCH RELIEF MOISTURIZING CREAM (pramoxine hydrochloride 1 % cutaneous cream) CERAVE CANADA,Active,9014465,pramoxine hydrochloride 1 % cutaneous cream,8002336,pramoxine,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
97705,Marketed,2021-02-01,02486881,Itch Relief Moisturizing Lotion,1,D04AB07,Pramocaine,Lotion,Topical,02486881,ITCH RELIEF MOISTURIZING LOTION (pramoxine hydrochloride 1 % lotion) CERAVE CANADA,Active,9014466,pramoxine hydrochloride 1 % lotion,8002336,pramoxine,448598008,Cutaneous,739000003,Lotion,,,,,,Non-Prescription Drugs
98351,Marketed,2024-05-28,02493500,Intrarosa,1,G03XX01,Prasterone,Ovule,Vaginal,02493500,"INTRAROSA (prasterone 6.5 mg pessary) COSETTE PHARMACEUTICALS, INC.",Active,9014766,prasterone 6.5 mg pessary,8002438,prasterone,16857009,Vaginal,385174007,Pessary,733007009,Pessary (unit of presentation),,,,Controlled Drugs (CDSA IV)
99200,Marketed,2021-05-14,02502429,JAMP Prasugrel,1,B01AC22,Prasugrel,Tablet,Oral,02502429,JAMP PRASUGREL (prasugrel (prasugrel hydrochloride) 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004728,prasugrel (prasugrel hydrochloride) 10 mg oral tablet,8001681,prasugrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102450,Marketed,2025-09-10,02535653,Nra-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02535653,NRA-PRAVASTATIN (pravastatin sodium 10 mg oral tablet) NORA PHARMA INC,Active,9000932,pravastatin sodium 10 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102451,Marketed,2025-09-10,02535661,Nra-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02535661,NRA-PRAVASTATIN (pravastatin sodium 20 mg oral tablet) NORA PHARMA INC,Active,9000368,pravastatin sodium 20 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102452,Marketed,2025-09-03,02535688,Nra-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02535688,NRA-PRAVASTATIN (pravastatin sodium 40 mg oral tablet) NORA PHARMA INC,Active,9000647,pravastatin sodium 40 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
67424,Marketed,2001-02-27,02243506,Apo-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02243506,APO-PRAVASTATIN (pravastatin sodium 10 mg oral tablet) APOTEX INC,Active,9000932,pravastatin sodium 10 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
67425,Marketed,2001-02-27,02243507,Apo-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02243507,APO-PRAVASTATIN (pravastatin sodium 20 mg oral tablet) APOTEX INC,Active,9000368,pravastatin sodium 20 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
67426,Marketed,2001-02-27,02243508,Apo-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02243508,APO-PRAVASTATIN (pravastatin sodium 40 mg oral tablet) APOTEX INC,Active,9000647,pravastatin sodium 40 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
67763,Marketed,2025-04-17,02243824,Pro-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02243824,PRO-PRAVASTATIN (pravastatin sodium 10 mg oral tablet) PRO DOC LIMITEE,Active,9000932,pravastatin sodium 10 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
67764,Marketed,2026-03-17,02243825,Pro-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02243825,PRO-PRAVASTATIN (pravastatin sodium 20 mg oral tablet) PRO DOC LIMITEE,Active,9000368,pravastatin sodium 20 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
67765,Marketed,2026-01-20,02243826,Pro-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02243826,PRO-PRAVASTATIN (pravastatin sodium 40 mg oral tablet) PRO DOC LIMITEE,Active,9000647,pravastatin sodium 40 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71241,Marketed,2012-02-16,02247008,Teva-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02247008,TEVA-PRAVASTATIN (pravastatin sodium 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000932,pravastatin sodium 10 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71242,Marketed,2012-02-16,02247009,Teva-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02247009,TEVA-PRAVASTATIN (pravastatin sodium 20 mg oral tablet) TEVA CANADA LIMITED,Active,9000368,pravastatin sodium 20 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71243,Marketed,2012-02-16,02247010,Teva-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02247010,TEVA-PRAVASTATIN (pravastatin sodium 40 mg oral tablet) TEVA CANADA LIMITED,Active,9000647,pravastatin sodium 40 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71918,Marketed,2003-07-21,02247655,PMS-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02247655,PMS-PRAVASTATIN (pravastatin sodium 10 mg oral tablet) PHARMASCIENCE INC,Active,9000932,pravastatin sodium 10 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71919,Marketed,2003-07-21,02247656,PMS-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02247656,PMS-PRAVASTATIN (pravastatin sodium 20 mg oral tablet) PHARMASCIENCE INC,Active,9000368,pravastatin sodium 20 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71920,Marketed,2003-07-21,02247657,PMS-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02247657,PMS-PRAVASTATIN (pravastatin sodium 40 mg oral tablet) PHARMASCIENCE INC,Active,9000647,pravastatin sodium 40 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77000,Marketed,2022-12-09,02284421,Taro-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02284421,TARO-PRAVASTATIN (pravastatin sodium 10 mg oral tablet) SUN PHARMA CANADA INC,Active,9000932,pravastatin sodium 10 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77001,Marketed,2022-12-09,02284448,Taro-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02284448,TARO-PRAVASTATIN (pravastatin sodium 20 mg oral tablet) SUN PHARMA CANADA INC,Active,9000368,pravastatin sodium 20 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77002,Marketed,2022-12-09,02284456,Taro-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02284456,TARO-PRAVASTATIN (pravastatin sodium 40 mg oral tablet) SUN PHARMA CANADA INC,Active,9000647,pravastatin sodium 40 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80298,Marketed,2024-03-08,02317451,Mint-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02317451,MINT-PRAVASTATIN (pravastatin sodium 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000932,pravastatin sodium 10 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80299,Marketed,2024-03-08,02317478,Mint-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02317478,MINT-PRAVASTATIN (pravastatin sodium 20 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000368,pravastatin sodium 20 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80300,Marketed,2024-03-08,02317486,Mint-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02317486,MINT-PRAVASTATIN (pravastatin sodium 40 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000647,pravastatin sodium 40 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81669,Marketed,2015-06-19,02330954,JAMP-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02330954,JAMP-PRAVASTATIN (pravastatin sodium 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000932,pravastatin sodium 10 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81670,Marketed,2015-06-19,02330962,JAMP-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02330962,JAMP-PRAVASTATIN (pravastatin sodium 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000368,pravastatin sodium 20 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81671,Marketed,2015-06-19,02330970,JAMP-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02330970,JAMP-PRAVASTATIN (pravastatin sodium 40 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000647,pravastatin sodium 40 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84168,Marketed,2025-04-24,02356546,Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02356546,PRAVASTATIN (pravastatin sodium 10 mg oral tablet) SANIS HEALTH INC,Active,9000932,pravastatin sodium 10 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84169,Marketed,2025-04-24,02356554,Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02356554,PRAVASTATIN (pravastatin sodium 20 mg oral tablet) SANIS HEALTH INC,Active,9000368,pravastatin sodium 20 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84170,Marketed,2025-04-24,02356562,Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02356562,PRAVASTATIN (pravastatin sodium 40 mg oral tablet) SANIS HEALTH INC,Active,9000647,pravastatin sodium 40 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87519,Marketed,2024-05-01,02389703,Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02389703,PRAVASTATIN (pravastatin sodium 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000932,pravastatin sodium 10 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87521,Marketed,2024-05-01,02389738,Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02389738,PRAVASTATIN (pravastatin sodium 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000368,pravastatin sodium 20 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87522,Marketed,2024-05-01,02389746,Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02389746,PRAVASTATIN (pravastatin sodium 40 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000647,pravastatin sodium 40 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91649,Marketed,2023-08-21,02432048,Mar-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02432048,MAR-PRAVASTATIN (pravastatin sodium 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000932,pravastatin sodium 10 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91650,Marketed,2023-08-21,02432056,Mar-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02432056,MAR-PRAVASTATIN (pravastatin sodium 20 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000368,pravastatin sodium 20 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91651,Marketed,2023-08-21,02432064,Mar-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02432064,MAR-PRAVASTATIN (pravastatin sodium 40 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000647,pravastatin sodium 40 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92501,Marketed,2019-12-11,02440644,ACH-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02440644,ACH-PRAVASTATIN (pravastatin sodium 10 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000932,pravastatin sodium 10 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92502,Marketed,2020-02-24,02440652,ACH-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02440652,ACH-PRAVASTATIN (pravastatin sodium 20 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000368,pravastatin sodium 20 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92503,Marketed,2020-02-24,02440660,ACH-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02440660,ACH-PRAVASTATIN (pravastatin sodium 40 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000647,pravastatin sodium 40 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93068,Marketed,2016-08-17,02446251,Bio-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02446251,BIO-PRAVASTATIN (pravastatin sodium 10 mg oral tablet) BIOMED PHARMA,Active,9000932,pravastatin sodium 10 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93069,Marketed,2016-08-17,02446278,Bio-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02446278,BIO-PRAVASTATIN (pravastatin sodium 20 mg oral tablet) BIOMED PHARMA,Active,9000368,pravastatin sodium 20 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93070,Marketed,2016-08-17,02446286,Bio-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02446286,BIO-PRAVASTATIN (pravastatin sodium 40 mg oral tablet) BIOMED PHARMA,Active,9000647,pravastatin sodium 40 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94613,Marketed,2018-05-22,02458977,Auro-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02458977,AURO-PRAVASTATIN (pravastatin sodium 10 mg oral tablet) AURO PHARMA INC,Active,9000932,pravastatin sodium 10 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94614,Marketed,2018-05-22,02458985,Auro-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02458985,AURO-PRAVASTATIN (pravastatin sodium 20 mg oral tablet) AURO PHARMA INC,Active,9000368,pravastatin sodium 20 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94615,Marketed,2018-05-22,02458993,Auro-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02458993,AURO-PRAVASTATIN (pravastatin sodium 40 mg oral tablet) AURO PHARMA INC,Active,9000647,pravastatin sodium 40 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96641,Marketed,2020-01-13,02476142,AG-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02476142,AG-PRAVASTATIN (pravastatin sodium 10 mg oral tablet) ANGITA PHARMA INC.,Active,9000932,pravastatin sodium 10 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96642,Marketed,2019-12-04,02476150,AG-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02476150,AG-PRAVASTATIN (pravastatin sodium 20 mg oral tablet) ANGITA PHARMA INC.,Active,9000368,pravastatin sodium 20 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96643,Marketed,2019-12-04,02476169,AG-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02476169,AG-PRAVASTATIN (pravastatin sodium 40 mg oral tablet) ANGITA PHARMA INC.,Active,9000647,pravastatin sodium 40 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96728,Marketed,2025-04-17,02476274,M-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02476274,M-PRAVASTATIN (pravastatin sodium 10 mg oral tablet) MANTRA PHARMA INC,Active,9000932,pravastatin sodium 10 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96729,Marketed,2025-04-16,02476282,M-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02476282,M-PRAVASTATIN (pravastatin sodium 20 mg oral tablet) MANTRA PHARMA INC,Active,9000368,pravastatin sodium 20 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96730,Marketed,2025-04-28,02476290,M-Pravastatin,1,C10AA03,Pravastatin,Tablet,Oral,02476290,M-PRAVASTATIN (pravastatin sodium 40 mg oral tablet) MANTRA PHARMA INC,Active,9000647,pravastatin sodium 40 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
10828,Marketed,2025-01-23,00882801,Apo-Prazo,1,C02CA01,Prazosin,Tablet,Oral,00882801,APO-PRAZO (prazosin (prazosin hydrochloride) 1 mg oral tablet) APOTEX INC,Active,9011504,prazosin (prazosin hydrochloride) 1 mg oral tablet,8000836,prazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
10829,Marketed,2025-01-23,00882828,Apo-Prazo,1,C02CA01,Prazosin,Tablet,Oral,00882828,APO-PRAZO (prazosin (prazosin hydrochloride) 2 mg oral tablet) APOTEX INC,Active,9011505,prazosin (prazosin hydrochloride) 2 mg oral tablet,8000836,prazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
10830,Marketed,2025-01-23,00882836,Apo-Prazo,1,C02CA01,Prazosin,Tablet,Oral,00882836,APO-PRAZO (prazosin (prazosin hydrochloride) 5 mg oral tablet) APOTEX INC,Active,9011506,prazosin (prazosin hydrochloride) 5 mg oral tablet,8000836,prazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
12451,Marketed,2011-10-20,01934198,Teva-Prazosin,1,C02CA01,Prazosin,Tablet,Oral,01934198,TEVA-PRAZOSIN (prazosin (prazosin hydrochloride) 1 mg oral tablet) TEVA CANADA LIMITED,Active,9011504,prazosin (prazosin hydrochloride) 1 mg oral tablet,8000836,prazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
12452,Marketed,2011-10-20,01934201,Teva-Prazosin,1,C02CA01,Prazosin,Tablet,Oral,01934201,TEVA-PRAZOSIN (prazosin (prazosin hydrochloride) 2 mg oral tablet) TEVA CANADA LIMITED,Active,9011505,prazosin (prazosin hydrochloride) 2 mg oral tablet,8000836,prazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
12453,Marketed,2011-10-20,01934228,Teva-Prazosin,1,C02CA01,Prazosin,Tablet,Oral,01934228,TEVA-PRAZOSIN (prazosin (prazosin hydrochloride) 5 mg oral tablet) TEVA CANADA LIMITED,Active,9011506,prazosin (prazosin hydrochloride) 5 mg oral tablet,8000836,prazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
49818,Marketed,2020-12-03,02230642,Dermatop Emollient Cream,1,D07AC18,Prednicarbate,Cream,Topical,02230642,"DERMATOP EMOLLIENT CREAM (prednicarbate 0.1 % cutaneous cream) BAUSCH HEALTH, CANADA INC.",Active,9003577,prednicarbate 0.1 % cutaneous cream,8001874,prednicarbate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
13946,Marketed,2005-08-06,01916203,Sandoz Prednisolone,1,S01BA04,Prednisolone,Suspension,Ophthalmic,01916203,SANDOZ PREDNISOLONE (prednisolone acetate 1 % ophthalmic drops) SANDOZ CANADA INCORPORATED,Active,9000082,prednisolone acetate 1 % ophthalmic drops,8000051,prednisolone,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
18750,Marketed,2023-01-26,02148498,Minims Prednisolone Sodium Phosphate,1,S01BA04,Prednisolone,Drops,Ophthalmic,02148498,MINIMS PREDNISOLONE SODIUM PHOSPHATE (prednisolone sodium phosphate 0.5 % ophthalmic drops) BAUSCH & LOMB INC,Active,9000629,prednisolone sodium phosphate 0.5 % ophthalmic drops,8000051,prednisolone,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
1937,Marketed,2024-09-25,00301175,Pred Forte,1,S01BA04,Prednisolone,Suspension,Ophthalmic,00301175,PRED FORTE (prednisolone acetate 1 % ophthalmic drops) ABBVIE CORPORATION,Active,9000082,prednisolone acetate 1 % ophthalmic drops,8000051,prednisolone,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
69619,Marketed,2002-03-19,02245532,PMS-Prednisolone,1,H02AB06,Prednisolone,Solution,Oral,02245532,PMS-PREDNISOLONE (prednisolone (prednisolone sodium phosphate) 5 mg per 5 mL oral solution) PHARMASCIENCE INC,Active,9000975,prednisolone (prednisolone sodium phosphate) 5 mg per 5 mL oral solution,8000051,prednisolone,26643006,Oral,385023001,Oral solution,,,,,,Prescription
7042,Marketed,2018-04-20,00700401,Teva-Prednisolone,1,S01BA04,Prednisolone,Suspension,Ophthalmic,00700401,TEVA-PREDNISOLONE (prednisolone acetate 1 % ophthalmic drops) TEVA CANADA LIMITED,Active,9000082,prednisolone acetate 1 % ophthalmic drops,8000051,prednisolone,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
1286,Marketed,2015-06-12,00232378,Teva-Prednisone,1,H02AB07,Prednisone,Tablet,Oral,00232378,TEVA-PREDNISONE (prednisone 50 mg oral tablet) TEVA CANADA LIMITED,Active,9000063,prednisone 50 mg oral tablet,8000014,prednisone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
3076,Marketed,2013-12-11,00271373,Winpred,1,H02AB07,Prednisone,Tablet,Oral,00271373,WINPRED (prednisone 1 mg oral tablet) AA PHARMA INC,Active,9000112,prednisone 1 mg oral tablet,8000014,prednisone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
4732,Marketed,1982-12-31,00312770,Apo Prednisone Tablets 5 mg,1,H02AB07,Prednisone,Tablet,Oral,00312770,APO PREDNISONE TAB 5MG (prednisone 5 mg oral tablet) APOTEX INC,Active,9000024,prednisone 5 mg oral tablet,8000014,prednisone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
4736,Marketed,1982-12-31,00550957,Apo Prednisone Tablets 50 mg,1,H02AB07,Prednisone,Tablet,Oral,00550957,APO PREDNISONE TAB 50MG (prednisone 50 mg oral tablet) APOTEX INC,Active,9000063,prednisone 50 mg oral tablet,8000014,prednisone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
507,Marketed,2015-06-12,00021695,Teva-Prednisone,1,H02AB07,Prednisone,Tablet,Oral,00021695,TEVA-PREDNISONE (prednisone 5 mg oral tablet) TEVA CANADA LIMITED,Active,9000024,prednisone 5 mg oral tablet,8000014,prednisone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102979,Marketed,2024-02-29,02541122,Bio-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02541122,BIO-PREGABALIN (pregabalin 25 mg oral capsule) BIOMED PHARMA,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
102980,Marketed,2024-03-11,02541130,Bio-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02541130,BIO-PREGABALIN (pregabalin 50 mg oral capsule) BIOMED PHARMA,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
102981,Marketed,2024-02-29,02541149,Bio-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02541149,BIO-PREGABALIN (pregabalin 75 mg oral capsule) BIOMED PHARMA,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
102983,Marketed,2024-02-29,02541165,Bio-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02541165,BIO-PREGABALIN (pregabalin 150 mg oral capsule) BIOMED PHARMA,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
102986,Marketed,2024-04-08,02541203,Bio-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02541203,BIO-PREGABALIN (pregabalin 300 mg oral capsule) BIOMED PHARMA,Active,9001117,pregabalin 300 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
103057,Marketed,2024-04-04,02541963,M-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02541963,M-PREGABALIN (pregabalin 300 mg oral capsule) MANTRA PHARMA INC,Active,9001117,pregabalin 300 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
104365,Marketed,2025-06-05,02554836,NB-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02554836,NB-PREGABALIN (pregabalin 25 mg oral capsule) NB PHARMA INC.,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
104366,Marketed,2025-06-05,02554844,NB-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02554844,NB-PREGABALIN (pregabalin 50 mg oral capsule) NB PHARMA INC.,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
104367,Marketed,2025-06-05,02554852,NB-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02554852,NB-PREGABALIN (pregabalin 75 mg oral capsule) NB PHARMA INC.,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
104368,Marketed,2025-06-05,02554860,NB-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02554860,NB-PREGABALIN (pregabalin 150 mg oral capsule) NB PHARMA INC.,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
104370,Marketed,2025-06-05,02554887,NB-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02554887,NB-PREGABALIN (pregabalin 300 mg oral capsule) NB PHARMA INC.,Active,9001117,pregabalin 300 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
75379,Marketed,2023-05-11,02268418,Lyrica,1,N02BF02,Pregabalin,Capsule,Oral,02268418,LYRICA (pregabalin 25 mg oral capsule) BGP PHARMA ULC,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
75380,Marketed,2023-05-11,02268426,Lyrica,1,N02BF02,Pregabalin,Capsule,Oral,02268426,LYRICA (pregabalin 50 mg oral capsule) BGP PHARMA ULC,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
75381,Marketed,2023-05-11,02268434,Lyrica,1,N02BF02,Pregabalin,Capsule,Oral,02268434,LYRICA (pregabalin 75 mg oral capsule) BGP PHARMA ULC,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
75383,Marketed,2023-05-11,02268450,Lyrica,1,N02BF02,Pregabalin,Capsule,Oral,02268450,LYRICA (pregabalin 150 mg oral capsule) BGP PHARMA ULC,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
75385,Marketed,2023-05-11,02268477,Lyrica,1,N02BF02,Pregabalin,Capsule,Oral,02268477,LYRICA (pregabalin 225 mg oral capsule) BGP PHARMA ULC,Active,9001297,pregabalin 225 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
75386,Marketed,2023-05-11,02268485,Lyrica,1,N02BF02,Pregabalin,Capsule,Oral,02268485,LYRICA (pregabalin 300 mg oral capsule) BGP PHARMA ULC,Active,9001117,pregabalin 300 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
84460,Marketed,2013-02-14,02359596,PMS-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02359596,PMS-PREGABALIN (pregabalin 25 mg oral capsule) PHARMASCIENCE INC,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
84461,Marketed,2013-02-14,02359618,PMS-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02359618,PMS-PREGABALIN (pregabalin 50 mg oral capsule) PHARMASCIENCE INC,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
84462,Marketed,2013-02-14,02359626,PMS-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02359626,PMS-PREGABALIN (pregabalin 75 mg oral capsule) PHARMASCIENCE INC,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
84463,Marketed,2013-02-14,02359634,PMS-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02359634,PMS-PREGABALIN (pregabalin 150 mg oral capsule) PHARMASCIENCE INC,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
84464,Marketed,2013-02-14,02359642,PMS-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02359642,PMS-PREGABALIN (pregabalin 300 mg oral capsule) PHARMASCIENCE INC,Active,9001117,pregabalin 300 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
84620,Marketed,2013-03-06,02361159,Teva-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02361159,TEVA-PREGABALIN (pregabalin 25 mg oral capsule) TEVA CANADA LIMITED,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
84623,Marketed,2013-03-06,02361175,Teva-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02361175,TEVA-PREGABALIN (pregabalin 50 mg oral capsule) TEVA CANADA LIMITED,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
84624,Marketed,2013-03-06,02361183,Teva-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02361183,TEVA-PREGABALIN (pregabalin 75 mg oral capsule) TEVA CANADA LIMITED,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
84626,Marketed,2013-03-06,02361205,Teva-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02361205,TEVA-PREGABALIN (pregabalin 150 mg oral capsule) TEVA CANADA LIMITED,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
84628,Marketed,2013-03-06,02361221,Teva-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02361221,TEVA-PREGABALIN (pregabalin 225 mg oral capsule) TEVA CANADA LIMITED,Active,9001297,pregabalin 225 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
84629,Marketed,2013-03-06,02361248,Teva-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02361248,TEVA-PREGABALIN (pregabalin 300 mg oral capsule) TEVA CANADA LIMITED,Active,9001117,pregabalin 300 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
86261,Marketed,2013-02-15,02377039,Riva-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02377039,RIVA-PREGABALIN (pregabalin 25 mg oral capsule) LABORATOIRE RIVA INC.,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
86262,Marketed,2013-02-15,02377047,Riva-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02377047,RIVA-PREGABALIN (pregabalin 50 mg oral capsule) LABORATOIRE RIVA INC.,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
86263,Marketed,2013-02-15,02377055,Riva-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02377055,RIVA-PREGABALIN (pregabalin 75 mg oral capsule) LABORATOIRE RIVA INC.,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
86264,Marketed,2013-02-15,02377063,Riva-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02377063,RIVA-PREGABALIN (pregabalin 150 mg oral capsule) LABORATOIRE RIVA INC.,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
86265,Marketed,2013-02-15,02377071,Riva-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02377071,RIVA-PREGABALIN (pregabalin 300 mg oral capsule) LABORATOIRE RIVA INC.,Active,9001117,pregabalin 300 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87621,Marketed,2013-02-15,02390817,Sandoz Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02390817,SANDOZ PREGABALIN (pregabalin 25 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87622,Marketed,2013-02-15,02390825,Sandoz Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02390825,SANDOZ PREGABALIN (pregabalin 50 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87623,Marketed,2013-02-15,02390833,Sandoz Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02390833,SANDOZ PREGABALIN (pregabalin 75 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87624,Marketed,2013-02-15,02390841,Sandoz Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02390841,SANDOZ PREGABALIN (pregabalin 150 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87625,Marketed,2013-02-15,02390868,Sandoz Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02390868,SANDOZ PREGABALIN (pregabalin 300 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001117,pregabalin 300 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87804,Marketed,2020-06-02,02392801,Taro-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02392801,TARO-PREGABALIN (pregabalin 25 mg oral capsule) SUN PHARMA CANADA INC,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87805,Marketed,2020-06-02,02392828,Taro-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02392828,TARO-PREGABALIN (pregabalin 50 mg oral capsule) SUN PHARMA CANADA INC,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87806,Marketed,2020-06-02,02392836,Taro-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02392836,TARO-PREGABALIN (pregabalin 75 mg oral capsule) SUN PHARMA CANADA INC,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87807,Marketed,2020-06-02,02392844,Taro-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02392844,TARO-PREGABALIN (pregabalin 150 mg oral capsule) SUN PHARMA CANADA INC,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87808,Marketed,2020-06-02,02392852,Taro-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02392852,TARO-PREGABALIN (pregabalin 225 mg oral capsule) SUN PHARMA CANADA INC,Active,9001297,pregabalin 225 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87809,Marketed,2020-06-02,02392860,Taro-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02392860,TARO-PREGABALIN (pregabalin 300 mg oral capsule) SUN PHARMA CANADA INC,Active,9001117,pregabalin 300 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88153,Marketed,2013-02-15,02396483,Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02396483,PREGABALIN (pregabalin 25 mg oral capsule) PRO DOC LIMITEE,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88156,Marketed,2013-02-15,02396505,Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02396505,PREGABALIN (pregabalin 50 mg oral capsule) PRO DOC LIMITEE,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88157,Marketed,2013-02-15,02396513,Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02396513,PREGABALIN (pregabalin 75 mg oral capsule) PRO DOC LIMITEE,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88158,Marketed,2013-02-15,02396521,Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02396521,PREGABALIN (pregabalin 150 mg oral capsule) PRO DOC LIMITEE,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88159,Marketed,2013-02-15,02396548,Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02396548,PREGABALIN (pregabalin 300 mg oral capsule) PRO DOC LIMITEE,Active,9001117,pregabalin 300 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88302,Marketed,2013-02-19,02398079,PMS-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02398079,PMS-PREGABALIN (pregabalin 225 mg oral capsule) PHARMASCIENCE INC,Active,9001297,pregabalin 225 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88848,Marketed,2021-08-20,02403692,Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02403692,PREGABALIN (pregabalin 25 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88849,Marketed,2021-08-20,02403706,Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02403706,PREGABALIN (pregabalin 50 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88850,Marketed,2021-08-20,02403714,Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02403714,PREGABALIN (pregabalin 75 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88851,Marketed,2021-08-20,02403722,Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02403722,PREGABALIN (pregabalin 150 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88852,Marketed,2021-08-20,02403730,Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02403730,PREGABALIN (pregabalin 300 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9001117,pregabalin 300 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
89032,Marketed,2016-01-27,02405539,Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02405539,PREGABALIN (pregabalin 25 mg oral capsule) SANIS HEALTH INC,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
89033,Marketed,2016-01-27,02405547,Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02405547,PREGABALIN (pregabalin 50 mg oral capsule) SANIS HEALTH INC,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
89034,Marketed,2016-01-27,02405555,Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02405555,PREGABALIN (pregabalin 75 mg oral capsule) SANIS HEALTH INC,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
89035,Marketed,2016-01-27,02405563,Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02405563,PREGABALIN (pregabalin 150 mg oral capsule) SANIS HEALTH INC,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
89037,Marketed,2016-01-27,02405598,Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02405598,PREGABALIN (pregabalin 300 mg oral capsule) SANIS HEALTH INC,Active,9001117,pregabalin 300 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90207,Marketed,2022-04-28,02417529,Mar-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02417529,MAR-PREGABALIN (pregabalin 25 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90208,Marketed,2022-04-28,02417537,Mar-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02417537,MAR-PREGABALIN (pregabalin 50 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90209,Marketed,2022-04-28,02417545,Mar-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02417545,MAR-PREGABALIN (pregabalin 75 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90211,Marketed,2022-04-28,02417561,Mar-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02417561,MAR-PREGABALIN (pregabalin 150 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90851,Marketed,2014-06-12,02423804,Mint-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02423804,MINT-PREGABALIN (pregabalin 25 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90852,Marketed,2014-06-12,02423812,Mint-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02423812,MINT-PREGABALIN (pregabalin 50 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90890,Marketed,2014-06-12,02424185,Mint-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02424185,MINT-PREGABALIN (pregabalin 75 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90892,Marketed,2014-06-12,02424207,Mint-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02424207,MINT-PREGABALIN (pregabalin 150 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
91825,Marketed,2015-03-02,02433869,Auro-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02433869,AURO-PREGABALIN (pregabalin 25 mg oral capsule) AURO PHARMA INC,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
91826,Marketed,2015-03-02,02433877,Auro-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02433877,AURO-PREGABALIN (pregabalin 50 mg oral capsule) AURO PHARMA INC,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
91827,Marketed,2015-03-02,02433885,Auro-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02433885,AURO-PREGABALIN (pregabalin 75 mg oral capsule) AURO PHARMA INC,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
91829,Marketed,2015-03-02,02433907,Auro-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02433907,AURO-PREGABALIN (pregabalin 150 mg oral capsule) AURO PHARMA INC,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
92031,Marketed,2019-10-01,02435977,JAMP-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02435977,JAMP-PREGABALIN (pregabalin 25 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
92032,Marketed,2018-07-25,02435985,JAMP-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02435985,JAMP-PREGABALIN (pregabalin 50 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
92033,Marketed,2018-07-25,02435993,JAMP-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02435993,JAMP-PREGABALIN (pregabalin 75 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
92034,Marketed,2018-07-25,02436000,JAMP-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02436000,JAMP-PREGABALIN (pregabalin 150 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
92035,Marketed,2019-09-27,02436019,JAMP-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02436019,JAMP-PREGABALIN (pregabalin 300 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001117,pregabalin 300 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
93569,Marketed,2021-05-27,02449838,ACH-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02449838,ACH-PREGABALIN (pregabalin 25 mg oral capsule) ACCORD HEALTHCARE INC,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
93570,Marketed,2021-05-27,02449846,ACH-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02449846,ACH-PREGABALIN (pregabalin 50 mg oral capsule) ACCORD HEALTHCARE INC,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
93571,Marketed,2021-05-27,02449854,ACH-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02449854,ACH-PREGABALIN (pregabalin 75 mg oral capsule) ACCORD HEALTHCARE INC,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
93573,Marketed,2021-05-31,02449870,ACH-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02449870,ACH-PREGABALIN (pregabalin 150 mg oral capsule) ACCORD HEALTHCARE INC,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
93575,Marketed,2021-05-27,02449897,ACH-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02449897,ACH-PREGABALIN (pregabalin 225 mg oral capsule) ACCORD HEALTHCARE INC,Active,9001297,pregabalin 225 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
93576,Marketed,2021-05-27,02449900,ACH-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02449900,ACH-PREGABALIN (pregabalin 300 mg oral capsule) ACCORD HEALTHCARE INC,Active,9001117,pregabalin 300 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95568,Marketed,2023-10-06,02467291,M-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02467291,M-PREGABALIN (pregabalin 25 mg oral capsule) MANTRA PHARMA INC,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95569,Marketed,2023-10-06,02467305,M-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02467305,M-PREGABALIN (pregabalin 50 mg oral capsule) MANTRA PHARMA INC,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95570,Marketed,2023-10-06,02467313,M-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02467313,M-PREGABALIN (pregabalin 75 mg oral capsule) MANTRA PHARMA INC,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95571,Marketed,2023-10-06,02467321,M-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02467321,M-PREGABALIN (pregabalin 150 mg oral capsule) MANTRA PHARMA INC,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96443,Marketed,2018-08-22,02474352,Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02474352,PREGABALIN (pregabalin 25 mg oral capsule) ALTAMED PHARMA,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96444,Marketed,2018-08-22,02474360,Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02474360,PREGABALIN (pregabalin 50 mg oral capsule) ALTAMED PHARMA,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96445,Marketed,2018-08-22,02474379,Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02474379,PREGABALIN (pregabalin 75 mg oral capsule) ALTAMED PHARMA,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96446,Marketed,2018-08-22,02474387,Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02474387,PREGABALIN (pregabalin 150 mg oral capsule) ALTAMED PHARMA,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96708,Marketed,2018-10-22,02479117,Nra-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02479117,NRA-PREGABALIN (pregabalin 25 mg oral capsule) NORA PHARMA INC,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96709,Marketed,2018-10-22,02479125,Nra-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02479125,NRA-PREGABALIN (pregabalin 50 mg oral capsule) NORA PHARMA INC,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96710,Marketed,2018-10-22,02479133,Nra-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02479133,NRA-PREGABALIN (pregabalin 75 mg oral capsule) NORA PHARMA INC,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96712,Marketed,2018-10-22,02479168,Nra-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02479168,NRA-PREGABALIN (pregabalin 150 mg oral capsule) NORA PHARMA INC,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96715,Marketed,2021-12-23,02479192,Nra-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02479192,NRA-PREGABALIN (pregabalin 300 mg oral capsule) NORA PHARMA INC,Active,9001117,pregabalin 300 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97125,Marketed,2018-09-28,02480727,AG-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02480727,AG-PREGABALIN (pregabalin 25 mg oral capsule) ANGITA PHARMA INC.,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97126,Marketed,2018-09-28,02480735,AG-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02480735,AG-PREGABALIN (pregabalin 50 mg oral capsule) ANGITA PHARMA INC.,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97127,Marketed,2018-09-28,02480743,AG-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02480743,AG-PREGABALIN (pregabalin 75 mg oral capsule) ANGITA PHARMA INC.,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97128,Marketed,2018-09-28,02480751,AG-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02480751,AG-PREGABALIN (pregabalin 150 mg oral capsule) ANGITA PHARMA INC.,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97129,Marketed,2018-09-28,02480778,AG-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02480778,AG-PREGABALIN (pregabalin 300 mg oral capsule) ANGITA PHARMA INC.,Active,9001117,pregabalin 300 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98482,Marketed,2020-05-07,02494841,Nat-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02494841,NAT-PREGABALIN (pregabalin 25 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98483,Marketed,2020-05-07,02494868,Nat-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02494868,NAT-PREGABALIN (pregabalin 50 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98484,Marketed,2020-05-07,02494876,Nat-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02494876,NAT-PREGABALIN (pregabalin 75 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98485,Marketed,2020-05-07,02494884,Nat-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02494884,NAT-PREGABALIN (pregabalin 150 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98486,Marketed,2020-05-07,02494892,Nat-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02494892,NAT-PREGABALIN (pregabalin 225 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9001297,pregabalin 225 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98487,Marketed,2020-05-07,02494906,Nat-Pregabalin,1,N02BF02,Pregabalin,Capsule,Oral,02494906,NAT-PREGABALIN (pregabalin 300 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9001117,pregabalin 300 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
100605,Marketed,2022-02-22,02516713,Flexacrème Pain Relief Rub,1,M02AC,Preparations with salicylic acid derivatives,Cream,Topical,02516713,FLEXACRÈME PAIN RELIEF RUB (trolamine salicylate 15 % cutaneous cream) CRLS,Active,9002037,trolamine salicylate 15 % cutaneous cream,8001980,trolamine salicylate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
33476,Marketed,2018-10-10,02226022,Myoflex Extra Strength,1,M02AC,Preparations with salicylic acid derivatives,Cream,Topical,02226022,MYOFLEX EXTRA STRENGTH (trolamine salicylate 15 % cutaneous cream) EXZELL PHARMA INC,Active,9002037,trolamine salicylate 15 % cutaneous cream,8001980,trolamine salicylate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
42373,Marketed,2011-11-19,02074702,Extra Strength Aspercreme Creme Rub 15%,1,M02AC,Preparations with salicylic acid derivatives,Cream,Topical,02074702,EXTRA STRENGTH ASPERCREME CREME RUB 15% (trolamine salicylate 15 % cutaneous cream) SANOFI CONSUMER HEALTH INC,Active,9002037,trolamine salicylate 15 % cutaneous cream,8001980,trolamine salicylate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
42699,Marketed,2019-02-15,02152827,Myoflex Regular Strength,1,M02AC,Preparations with salicylic acid derivatives,Cream,Topical,02152827,MYOFLEX REGULAR STRENGTH (trolamine salicylate 10 % cutaneous cream) EXZELL PHARMA INC,Active,9003038,trolamine salicylate 10 % cutaneous cream,8001980,trolamine salicylate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
68558,Marketed,2019-02-14,02244573,Myoflex Maximum Strength,1,M02AC,Preparations with salicylic acid derivatives,Cream,Topical,02244573,MYOFLEX MAXIMUM STRENGTH (trolamine salicylate 20 % cutaneous cream) EXZELL PHARMA INC,Active,9003700,trolamine salicylate 20 % cutaneous cream,8001980,trolamine salicylate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
84320,Marketed,2024-07-03,02358131,Pain Relief Cream Regular Strength,1,M02AC,Preparations with salicylic acid derivatives,Cream,Topical,02358131,PAIN RELIEF CREAM REGULAR STRENGTH (trolamine salicylate 13.3 % cutaneous cream) CRLS,Active,9002617,trolamine salicylate 13.3 % cutaneous cream,8001980,trolamine salicylate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
89554,Marketed,2018-03-21,02410907,Pain Relief Rub Triethanolamine Salicylate Cream,1,M02AC,Preparations with salicylic acid derivatives,Cream,Topical,02410907,PAIN RELIEF RUB TRIETHANOLAMINE SALICYLATE CREAM (trolamine salicylate 15 % cutaneous cream) CRLS,Active,9002037,trolamine salicylate 15 % cutaneous cream,8001980,trolamine salicylate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
89811,Marketed,2024-06-24,02413442,Pain Relief Cream Extra Strength,1,M02AC,Preparations with salicylic acid derivatives,Cream,Topical,02413442,PAIN RELIEF CREAM EXTRA STRENGTH (trolamine salicylate 20 % cutaneous cream) CRLS,Active,9003700,trolamine salicylate 20 % cutaneous cream,8001980,trolamine salicylate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
96248,Marketed,2018-09-24,02473135,Muscle & Joint No Odour Extra Strength,1,M02AC,Preparations with salicylic acid derivatives,Cream,Topical,02473135,MUSCLE & JOINT NO ODOUR EXTRA STRENGTH (trolamine salicylate 20 % cutaneous cream) CHURCH & DWIGHT CANADA CORP,Active,9003700,trolamine salicylate 20 % cutaneous cream,8001980,trolamine salicylate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
96250,Marketed,2018-08-31,02473143,Muscle & Joint No Odour Regular Strength,1,M02AC,Preparations with salicylic acid derivatives,Cream,Topical,02473143,MUSCLE & JOINT NO ODOUR REGULAR STRENGTH (trolamine salicylate 13.3 % cutaneous cream) CHURCH & DWIGHT CANADA CORP,Active,9002617,trolamine salicylate 13.3 % cutaneous cream,8001980,trolamine salicylate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
97690,Marketed,2019-10-28,02486725,Arthritis Pain Relief,3,M02AC,Preparations with salicylic acid derivatives,Lotion,Topical,02486725,ARTHRITIS PAIN RELIEF (capsaicin 0.035 % and menthol 1.25 % and trolamine salicylate 10 % lotion) CHURCH & DWIGHT CANADA CORP,Active,9013276,capsaicin 0.035 % and menthol 1.25 % and trolamine salicylate 10 % lotion,8001894,capsaicin and menthol and trolamine salicylate,448598008,Cutaneous,739000003,Lotion,,,,,,Non-Prescription Drugs
91954,Marketed,2015-12-23,02435276,4% Citanest Plain Dental,1,N01BB04,Prilocaine,Solution,Block/infiltration,02435276,4% CITANEST PLAIN DENTAL (prilocaine hydrochloride 40 mg per mL solution for injection 1.8 mL cartridge) DENTSPLY CANADA LIMITED,Active,9013240,prilocaine hydrochloride 40 mg per mL solution for injection 1.8 mL cartridge,8001875,prilocaine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Ethical
11440,Marketed,2018-06-01,00886858,Emla Cream,2,N01BB54,"Prilocaine, combinations",Cream,Topical,00886858,EMLA CREAM (lidocaine 2.5 % and prilocaine 2.5 % cutaneous cream) ASPEN PHARMACARE CANADA INC.,Active,9006325,lidocaine 2.5 % and prilocaine 2.5 % cutaneous cream,8001841,lidocaine and prilocaine,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Ethical
16733,Marketed,2018-05-08,02057794,Emla Patch,2,N01BB54,"Prilocaine, combinations",Patch,Topical,02057794,EMLA PATCH (lidocaine 2.5 % and prilocaine 2.5 % cutaneous patch) ASPEN PHARMACARE CANADA INC.,Active,9002690,lidocaine 2.5 % and prilocaine 2.5 % cutaneous patch,8001841,lidocaine and prilocaine,448598008,Cutaneous,739003001,Patch,733005001,Patch (unit of presentation),,,,Ethical
2828,Marketed,1977-12-31,00393746,Prilocaine HCL 4% Epineph 1:200000 Inj,2,N01BB54,"Prilocaine, combinations",Solution,Block/infiltration,00393746,PRILOCAINE HCL 4% EPINEPH 1:200000INJ (epinephrine 0.005 mg per mL and prilocaine hydrochloride 40 mg per mL solution for injection 1.8 mL cartridge) NOVOCOL PHARMACEUTICAL OF CANADA INC,Active,9014024,epinephrine 0.005 mg per mL and prilocaine hydrochloride 40 mg per mL solution for injection 1.8 mL cartridge,8001763,epinephrine and prilocaine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Ethical
83307,Marketed,2011-01-18,02347695,"4% Citanest Forte Dental With Epinephrine 1:200,000",2,N01BB54,"Prilocaine, combinations",Solution,Block/infiltration,02347695,"4% CITANEST FORTE DENTAL WITH EPINEPHRINE 1:200,000 (epinephrine 0.005 mg per mL and prilocaine hydrochloride 40 mg per mL solution for injection 1.8 mL cartridge) DENTSPLY CANADA LIMITED",Active,9014024,epinephrine 0.005 mg per mL and prilocaine hydrochloride 40 mg per mL solution for injection 1.8 mL cartridge,8001763,epinephrine and prilocaine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Ethical
18330,Marketed,2009-03-26,02017776,Primaquine,1,P01BA03,Primaquine,Tablet,Oral,02017776,PRIMAQUINE (primaquine phosphate 26.3 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9001494,primaquine phosphate 26.3 mg oral tablet,8002079,primaquine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
2750,Marketed,2011-07-21,00396761,Primidone,1,N03AA03,Primidone,Tablet,Oral,00396761,PRIMIDONE (primidone 250 mg oral tablet) AA PHARMA INC,Active,9001794,primidone 250 mg oral tablet,8001301,primidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
2751,Marketed,2011-07-21,00399310,Primidone,1,N03AA03,Primidone,Tablet,Oral,00399310,PRIMIDONE (primidone 125 mg oral tablet) AA PHARMA INC,Active,9001793,primidone 125 mg oral tablet,8001301,primidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
19357,Marketed,2005-09-27,02184486,Procainamide Hydrochloride Injection USP,1,C01BA02,Procainamide,Solution,"Intramuscular,Intravenous",02184486,PROCAINAMIDE HYDROCHLORIDE INJECTION USP (procainamide hydrochloride 1000 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013020,procainamide hydrochloride 1000 mg per 10 mL solution for injection vial,8001416,procainamide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
938,Marketed,2018-05-09,00012750,Matulane,1,L01XB01,Procarbazine,Capsule,Oral,00012750,"MATULANE (procarbazine (procarbazine hydrochloride) 50 mg oral capsule) LEADIANT BIOSCIENCES, INC",Active,9001667,procarbazine (procarbazine hydrochloride) 50 mg oral capsule,8002080,procarbazine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
45324,Marketed,2013-04-30,00886432,Prochlorazine,1,N05AB04,Prochlorperazine,Tablet,Oral,00886432,PROCHLORAZINE (prochlorperazine (prochlorperazine maleate) 10 mg oral tablet) AA PHARMA INC,Active,9002218,prochlorperazine (prochlorperazine maleate) 10 mg oral tablet,8001302,prochlorperazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
45325,Marketed,2013-04-30,00886440,Prochlorazine,1,N05AB04,Prochlorperazine,Tablet,Oral,00886440,PROCHLORAZINE (prochlorperazine (prochlorperazine maleate) 5 mg oral tablet) AA PHARMA INC,Active,9002219,prochlorperazine (prochlorperazine maleate) 5 mg oral tablet,8001302,prochlorperazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
9919,Marketed,2024-11-18,00789720,Odan-Prochlorperazine,1,N05AB04,Prochlorperazine,Suppository,Rectal,00789720,ODAN-PROCHLORPERAZINE (prochlorperazine 10 mg suppository) ODAN LABORATORIES LTD,Active,9002217,prochlorperazine 10 mg suppository,8001302,prochlorperazine,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,,Prescription
12549,Marketed,2022-10-14,01927744,Parsitan 50,1,N04AA05,Profenamine,Tablet,Oral,01927744,PARSITAN 50 (ethopropazine (ethopropazine hydrochloride) 50 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9001537,ethopropazine (ethopropazine hydrochloride) 50 mg oral tablet,8001649,ethopropazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100552,Marketed,2022-08-19,02516187,Progesterone,1,G03DA04,Progesterone,Capsule,Oral,02516187,PROGESTERONE (progesterone 100 mg oral capsule) SANIS HEALTH INC,Active,9000630,progesterone 100 mg oral capsule,8000220,progesterone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
102091,Marketed,2023-04-28,02531828,"Progesterone Injection, USP",1,G03DA04,Progesterone,Solution,Intramuscular,02531828,"PROGESTERONE INJECTION, USP (progesterone 500 mg per 10 mL solution for injection vial) HIKMA CANADA LIMITED",Active,9001457,progesterone 500 mg per 10 mL solution for injection vial,8000220,progesterone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
18500,Marketed,2022-02-18,02166704,Prometrium,1,G03DA04,Progesterone,Capsule,Oral,02166704,PROMETRIUM (progesterone 100 mg oral capsule) ORGANON CANADA INC.,Active,9000630,progesterone 100 mg oral capsule,8000220,progesterone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
64606,Marketed,2000-06-12,02241013,Crinone,1,G03DA04,Progesterone,Gel,Vaginal,02241013,"CRINONE (progesterone 8 % vaginal gel) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9000904,progesterone 8 % vaginal gel,8000220,progesterone,16857009,Vaginal,385100002,Gel,,,1.0,,,Prescription
92431,Marketed,2015-04-16,02439913,Teva-Progesterone,1,G03DA04,Progesterone,Capsule,Oral,02439913,TEVA-PROGESTERONE (progesterone 100 mg oral capsule) TEVA CANADA LIMITED,Active,9000630,progesterone 100 mg oral capsule,8000220,progesterone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
93234,Marketed,2020-05-12,02446820,Act Progesterone Injection,1,G03DA04,Progesterone,Solution,Intramuscular,02446820,ACT PROGESTERONE INJECTION (progesterone 500 mg per 10 mL solution for injection vial) TEVA CANADA LIMITED,Active,9001457,progesterone 500 mg per 10 mL solution for injection vial,8000220,progesterone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
95102,Marketed,2018-08-09,02463113,Reddy-Progesterone,1,G03DA04,Progesterone,Capsule,Oral,02463113,REDDY-PROGESTERONE (progesterone 100 mg oral capsule) DR. REDDY'S LABORATORIES INC,Active,9000630,progesterone 100 mg oral capsule,8000220,progesterone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
96745,Marketed,2018-08-08,02476576,PMS-Progesterone,1,G03DA04,Progesterone,Capsule,Oral,02476576,PMS-PROGESTERONE (progesterone 100 mg oral capsule) PHARMASCIENCE INC,Active,9000630,progesterone 100 mg oral capsule,8000220,progesterone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
98357,Marketed,2020-03-16,02493578,Auro-Progesterone,1,G03DA04,Progesterone,Capsule,Oral,02493578,AURO-PROGESTERONE (progesterone 100 mg oral capsule) AURO PHARMA INC,Active,9000630,progesterone 100 mg oral capsule,8000220,progesterone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
103802,Marketed,2026-02-11,02549158,ACH-Progesterone,1,G03FA04,Progesterone and estrogen,Capsule,Oral,02549158,ACH-PROGESTERONE (progesterone 100 mg oral capsule) ACCORD HEALTHCARE INC,Active,9000630,progesterone 100 mg oral capsule,8000220,progesterone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
103999,Marketed,2025-07-18,02551268,M-Progesterone,1,G03FA04,Progesterone and estrogen,Capsule,Oral,02551268,M-PROGESTERONE (progesterone 100 mg oral capsule) MANTRA PHARMA INC,Active,9000630,progesterone 100 mg oral capsule,8000220,progesterone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
99458,Marketed,2024-01-31,02505223,Bijuva,2,G03FA04,Progesterone and estrogen,Capsule,Oral,02505223,BIJUVA (estradiol (estradiol hemihydrate) 1 mg and progesterone 100 mg oral capsule) KNIGHT THERAPEUTICS INC.,Active,9015017,estradiol 1 mg and progesterone 100 mg oral capsule,8002500,estradiol and progesterone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
61542,Marketed,2002-08-20,02238151,Malarone,2,P01BB51,Proguanil and atovaquone,Tablet,Oral,02238151,MALARONE (atovaquone 250 mg and proguanil hydrochloride 100 mg oral tablet) GLAXOSMITHKLINE INC,Active,9003275,atovaquone 250 mg and proguanil hydrochloride 100 mg oral tablet,8001437,atovaquone and proguanil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75044,Marketed,2005-05-17,02264935,Malarone Pediatric,2,P01BB51,Proguanil and atovaquone,Tablet,Oral,02264935,MALARONE PEDIATRIC (atovaquone 62.5 mg and proguanil hydrochloride 25 mg oral tablet) GLAXOSMITHKLINE INC,Active,9004047,atovaquone 62.5 mg and proguanil hydrochloride 25 mg oral tablet,8001437,atovaquone and proguanil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86668,Marketed,2012-03-01,02380927,Teva-Atovaquone Proguanil,2,P01BB51,Proguanil and atovaquone,Tablet,Oral,02380927,TEVA-ATOVAQUONE PROGUANIL (atovaquone 250 mg and proguanil hydrochloride 100 mg oral tablet) TEVA CANADA LIMITED,Active,9003275,atovaquone 250 mg and proguanil hydrochloride 100 mg oral tablet,8001437,atovaquone and proguanil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88703,Marketed,2013-10-16,02402165,Mylan-Atovaquone/Proguanil,2,P01BB51,Proguanil and atovaquone,Tablet,Oral,02402165,MYLAN-ATOVAQUONE/PROGUANIL (atovaquone 250 mg and proguanil hydrochloride 100 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9003275,atovaquone 250 mg and proguanil hydrochloride 100 mg oral tablet,8001437,atovaquone and proguanil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90605,Marketed,2014-05-22,02421429,Atovaquone Proguanil,2,P01BB51,Proguanil and atovaquone,Tablet,Oral,02421429,ATOVAQUONE PROGUANIL (atovaquone 250 mg and proguanil hydrochloride 100 mg oral tablet) SANIS HEALTH INC,Active,9003275,atovaquone 250 mg and proguanil hydrochloride 100 mg oral tablet,8001437,atovaquone and proguanil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95514,Marketed,2017-10-30,02466783,Atovaquone And Proguanil Hydrochloride Tablets,2,P01BB51,Proguanil and atovaquone,Tablet,Oral,02466783,ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS (atovaquone 250 mg and proguanil hydrochloride 100 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9003275,atovaquone 250 mg and proguanil hydrochloride 100 mg oral tablet,8001437,atovaquone and proguanil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
5369,Marketed,1983-12-31,00575186,Histantil Tablets 50 mg,1,R06AD02,Promethazine,Tablet,Oral,00575186,HISTANTIL TAB 50MG (promethazine hydrochloride 50 mg oral tablet) PHARMASCIENCE INC,Active,9001995,promethazine hydrochloride 50 mg oral tablet,8001512,promethazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
67227,Marketed,2001-02-22,02243324,Apo-Propafenone,1,C01BC03,Propafenone,Tablet,Oral,02243324,APO-PROPAFENONE (propafenone hydrochloride 150 mg oral tablet) APOTEX INC,Active,9002154,propafenone hydrochloride 150 mg oral tablet,8001417,propafenone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
67228,Marketed,2018-08-31,02243325,Apo-Propafenone,1,C01BC03,Propafenone,Tablet,Oral,02243325,APO-PROPAFENONE (propafenone hydrochloride 300 mg oral tablet) APOTEX INC,Active,9002155,propafenone hydrochloride 300 mg oral tablet,8001417,propafenone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
8464,Marketed,2016-08-12,00603708,Rythmol,1,C01BC03,Propafenone,Tablet,Oral,00603708,RYTHMOL (propafenone hydrochloride 150 mg oral tablet) BGP PHARMA ULC,Active,9002154,propafenone hydrochloride 150 mg oral tablet,8001417,propafenone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
8465,Marketed,2016-06-17,00603716,Rythmol,1,C01BC03,Propafenone,Tablet,Oral,00603716,RYTHMOL (propafenone hydrochloride 300 mg oral tablet) BGP PHARMA ULC,Active,9002155,propafenone hydrochloride 300 mg oral tablet,8001417,propafenone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94424,Marketed,2017-10-31,02457164,Mylan-Propafenone,1,C01BC03,Propafenone,Tablet,Oral,02457164,MYLAN-PROPAFENONE (propafenone hydrochloride 300 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9002155,propafenone hydrochloride 300 mg oral tablet,8001417,propafenone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94425,Marketed,2017-10-31,02457172,Mylan-Propafenone,1,C01BC03,Propafenone,Tablet,Oral,02457172,MYLAN-PROPAFENONE (propafenone hydrochloride 150 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9002154,propafenone hydrochloride 150 mg oral tablet,8001417,propafenone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94755,Marketed,2017-05-08,02460262,Mictoryl,1,G04BD06,Propiverine,Capsule (extended release),Oral,02460262,MICTORYL (propiverine hydrochloride 30 mg prolonged-release oral capsule) DUCHESNAY INC,Active,9015287,propiverine hydrochloride 30 mg prolonged-release oral capsule,8001513,propiverine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule,,,,Prescription
94756,Marketed,2017-05-08,02460270,Mictoryl,1,G04BD06,Propiverine,Capsule (extended release),Oral,02460270,MICTORYL (propiverine hydrochloride 45 mg prolonged-release oral capsule) DUCHESNAY INC,Active,9015288,propiverine hydrochloride 45 mg prolonged-release oral capsule,8001513,propiverine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule,,,,Prescription
94757,Marketed,2017-04-13,02460289,Mictoryl Pediatric,1,G04BD06,Propiverine,Tablet,Oral,02460289,MICTORYL PEDIATRIC (propiverine hydrochloride 5 mg oral tablet) DUCHESNAY INC,Active,9006148,propiverine hydrochloride 5 mg oral tablet,8001513,propiverine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101486,Marketed,2023-04-18,02525879,Propofol Injection,1,N01AX10,Propofol,Emulsion,Intravenous,77701122,PROPOFOL INJECTION (propofol 200 mg per 20 mL emulsion for injection vial) MARCAN PHARMACEUTICALS INC,Active,9013516,propofol 200 mg per 20 mL emulsion for injection vial,8002081,propofol,738984000,Parenteral,738998008,Emulsion,733026001,Vial (unit of presentation),,,,Prescription
101486,Marketed,2023-04-18,02525879,Propofol Injection,1,N01AX10,Propofol,Emulsion,Intravenous,77701123,PROPOFOL INJECTION (propofol 500 mg per 50 mL emulsion for injection vial) MARCAN PHARMACEUTICALS INC,Active,9013517,propofol 500 mg per 50 mL emulsion for injection vial,8002081,propofol,738984000,Parenteral,738998008,Emulsion,733026001,Vial (unit of presentation),,,,Prescription
101486,Marketed,2023-04-18,02525879,Propofol Injection,1,N01AX10,Propofol,Emulsion,Intravenous,77701124,PROPOFOL INJECTION (propofol 1000 mg per 100 mL emulsion for injection vial) MARCAN PHARMACEUTICALS INC,Active,9013514,propofol 1000 mg per 100 mL emulsion for injection vial,8002081,propofol,738984000,Parenteral,738998008,Emulsion,733026001,Vial (unit of presentation),,,,Prescription
14476,Marketed,2018-07-16,02018950,Diprivan 1%,1,N01AX10,Propofol,Emulsion,Intravenous,77700966,DIPRIVAN 1% (propofol 1000 mg per 100 mL emulsion for injection vial) ASPEN PHARMACARE CANADA INC.,Active,9013514,propofol 1000 mg per 100 mL emulsion for injection vial,8002081,propofol,738984000,Parenteral,738998008,Emulsion,733026001,Vial (unit of presentation),,,,Prescription
14476,Marketed,2018-07-16,02018950,Diprivan 1%,1,N01AX10,Propofol,Emulsion,Intravenous,77700967,DIPRIVAN 1% (propofol 500 mg per 50 mL emulsion for injection vial) ASPEN PHARMACARE CANADA INC.,Active,9013517,propofol 500 mg per 50 mL emulsion for injection vial,8002081,propofol,738984000,Parenteral,738998008,Emulsion,733026001,Vial (unit of presentation),,,,Prescription
14476,Marketed,2018-07-16,02018950,Diprivan 1%,1,N01AX10,Propofol,Emulsion,Intravenous,77700968,DIPRIVAN 1% (propofol 200 mg per 20 mL emulsion for injection vial) ASPEN PHARMACARE CANADA INC.,Active,9013516,propofol 200 mg per 20 mL emulsion for injection vial,8002081,propofol,738984000,Parenteral,738998008,Emulsion,733026001,Vial (unit of presentation),,,,Prescription
68347,Marketed,2022-09-21,02244379,Propofol Injection,1,N01AX10,Propofol,Emulsion,Intravenous,77700926,PROPOFOL INJECTION (propofol 200 mg per 20 mL emulsion for injection ampoule) BAXTER CORPORATION,Active,9013515,propofol 200 mg per 20 mL emulsion for injection ampoule,8002081,propofol,738984000,Parenteral,385221006,Emulsion for injection,732978007,Ampule (unit of presentation),,,,Prescription
68347,Marketed,2022-09-21,02244379,Propofol Injection,1,N01AX10,Propofol,Emulsion,Intravenous,77700927,PROPOFOL INJECTION (propofol 500 mg per 50 mL emulsion for injection vial) BAXTER CORPORATION,Active,9013517,propofol 500 mg per 50 mL emulsion for injection vial,8002081,propofol,738984000,Parenteral,738998008,Emulsion,733026001,Vial (unit of presentation),,,,Prescription
68347,Marketed,2022-09-21,02244379,Propofol Injection,1,N01AX10,Propofol,Emulsion,Intravenous,77700928,PROPOFOL INJECTION (propofol 1000 mg per 100 mL emulsion for injection vial) BAXTER CORPORATION,Active,9013514,propofol 1000 mg per 100 mL emulsion for injection vial,8002081,propofol,738984000,Parenteral,738998008,Emulsion,733026001,Vial (unit of presentation),,,,Prescription
92203,Marketed,2015-06-01,02437643,Propofol Injection,1,N01AX10,Propofol,Emulsion,Intravenous,77700945,PROPOFOL INJECTION (propofol 1000 mg per 100 mL emulsion for injection vial) FRESENIUS KABI CANADA LTD,Active,9013514,propofol 1000 mg per 100 mL emulsion for injection vial,8002081,propofol,738984000,Parenteral,738998008,Emulsion,733026001,Vial (unit of presentation),,,,Prescription
92203,Marketed,2015-06-01,02437643,Propofol Injection,1,N01AX10,Propofol,Emulsion,Intravenous,77700946,PROPOFOL INJECTION (propofol 200 mg per 20 mL emulsion for injection vial) FRESENIUS KABI CANADA LTD,Active,9013516,propofol 200 mg per 20 mL emulsion for injection vial,8002081,propofol,738984000,Parenteral,738998008,Emulsion,733026001,Vial (unit of presentation),,,,Prescription
92203,Marketed,2015-06-01,02437643,Propofol Injection,1,N01AX10,Propofol,Emulsion,Intravenous,77700947,PROPOFOL INJECTION (propofol 500 mg per 50 mL emulsion for injection vial) FRESENIUS KABI CANADA LTD,Active,9013517,propofol 500 mg per 50 mL emulsion for injection vial,8002081,propofol,738984000,Parenteral,738998008,Emulsion,733026001,Vial (unit of presentation),,,,Prescription
103959,Marketed,2025-04-30,02550814,PRZ-Propranolol,1,C07AA05,Propranolol,Tablet,Oral,02550814,PRZ-PROPRANOLOL (propranolol hydrochloride 20 mg oral tablet) PHARMARIS CANADA INC,Active,9000265,propranolol hydrochloride 20 mg oral tablet,8000086,propranolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103960,Marketed,2025-04-30,02550822,PRZ-Propranolol,1,C07AA05,Propranolol,Tablet,Oral,02550822,PRZ-PROPRANOLOL (propranolol hydrochloride 40 mg oral tablet) PHARMARIS CANADA INC,Active,9000155,propranolol hydrochloride 40 mg oral tablet,8000086,propranolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103961,Marketed,2025-04-30,02550830,PRZ-Propranolol,1,C07AA05,Propranolol,Tablet,Oral,02550830,PRZ-PROPRANOLOL (propranolol hydrochloride 80 mg oral tablet) PHARMARIS CANADA INC,Active,9000156,propranolol hydrochloride 80 mg oral tablet,8000086,propranolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
4254,Marketed,2011-10-25,00496480,Teva-Propranolol,1,C07AA05,Propranolol,Tablet,Oral,00496480,TEVA-PROPRANOLOL (propranolol hydrochloride 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000154,propranolol hydrochloride 10 mg oral tablet,8000086,propranolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
4255,Marketed,2011-10-25,00496499,Teva-Propranolol,1,C07AA05,Propranolol,Tablet,Oral,00496499,TEVA-PROPRANOLOL (propranolol hydrochloride 40 mg oral tablet) TEVA CANADA LIMITED,Active,9000155,propranolol hydrochloride 40 mg oral tablet,8000086,propranolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
4256,Marketed,2011-10-25,00496502,Teva-Propranolol,1,C07AA05,Propranolol,Tablet,Oral,00496502,TEVA-PROPRANOLOL (propranolol hydrochloride 80 mg oral tablet) TEVA CANADA LIMITED,Active,9000156,propranolol hydrochloride 80 mg oral tablet,8000086,propranolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
43431,Marketed,2005-09-27,02225883,Propranolol Hydrochloride Injection USP,1,C07AA05,Propranolol,Solution,Intravenous,02225883,PROPRANOLOL HYDROCHLORIDE INJECTION USP (propranolol hydrochloride 1 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9000659,propranolol hydrochloride 1 mg per 1 mL solution for injection ampoule,8000086,propranolol,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
7349,Marketed,2011-10-25,00740675,Teva-Propranolol,1,C07AA05,Propranolol,Tablet,Oral,00740675,TEVA-PROPRANOLOL (propranolol hydrochloride 20 mg oral tablet) TEVA CANADA LIMITED,Active,9000265,propranolol hydrochloride 20 mg oral tablet,8000086,propranolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94488,Marketed,2017-03-23,02457857,Hemangiol,1,C07AA05,Propranolol,Solution,Oral,02457857,HEMANGIOL (propranolol (propranolol hydrochloride) 3.75 mg per mL oral solution) PIERRE FABRE DERMO-COSMETIQUE CANADA INC,Active,9006576,propranolol (propranolol hydrochloride) 3.75 mg per mL oral solution,8000086,propranolol,26643006,Oral,385023001,Oral solution,,,,,,Prescription
98190,Marketed,2023-06-30,02491893,Lupin-Propranolol LA,1,C07AA05,Propranolol,Capsule (extended release),Oral,02491893,LUPIN-PROPRANOLOL LA (propranolol hydrochloride 60 mg prolonged-release oral capsule) LUPIN PHARMA CANADA LIMITED,Active,9000631,propranolol hydrochloride 60 mg prolonged-release oral capsule,8000086,propranolol,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98191,Marketed,2023-06-30,02491907,Lupin-Propranolol LA,1,C07AA05,Propranolol,Capsule (extended release),Oral,02491907,LUPIN-PROPRANOLOL LA (propranolol hydrochloride 80 mg prolonged-release oral capsule) LUPIN PHARMA CANADA LIMITED,Active,9000543,propranolol hydrochloride 80 mg prolonged-release oral capsule,8000086,propranolol,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98192,Marketed,2023-06-30,02491915,Lupin-Propranolol LA,1,C07AA05,Propranolol,Capsule (extended release),Oral,02491915,LUPIN-PROPRANOLOL LA (propranolol hydrochloride 120 mg prolonged-release oral capsule) LUPIN PHARMA CANADA LIMITED,Active,9000541,propranolol hydrochloride 120 mg prolonged-release oral capsule,8000086,propranolol,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98193,Marketed,2023-06-30,02491923,Lupin-Propranolol LA,1,C07AA05,Propranolol,Capsule (extended release),Oral,02491923,LUPIN-PROPRANOLOL LA (propranolol hydrochloride 160 mg prolonged-release oral capsule) LUPIN PHARMA CANADA LIMITED,Active,9000542,propranolol hydrochloride 160 mg prolonged-release oral capsule,8000086,propranolol,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
101028,Marketed,2022-03-23,02521059,Halycil,1,H03BA02,Propylthiouracil,Tablet,Oral,02521059,HALYCIL (propylthiouracil 50 mg oral tablet) HALEWOOD CHEMICALS LIMITED,Active,9001524,propylthiouracil 50 mg oral tablet,8001514,propylthiouracil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101209,Marketed,2022-07-21,02523019,Propylthiouracil Tablets,1,H03BA02,Propylthiouracil,Tablet,Oral,02523019,PROPYLTHIOURACIL TABLETS (propylthiouracil 50 mg oral tablet) PHEBRA CANADA INC,Active,9001524,propylthiouracil 50 mg oral tablet,8001514,propylthiouracil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
19443,Marketed,2016-05-19,02139537,"Protamine Sulfate Injection, USP",1,V03AB14,Protamine,Solution,Intravenous,77700914,"PROTAMINE SULFATE INJECTION, USP (protamine sulfate 250 mg per 25 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013518,protamine sulfate 250 mg per 25 mL solution for injection vial,8002082,protamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
19443,Marketed,2016-05-19,02139537,"Protamine Sulfate Injection, USP",1,V03AB14,Protamine,Solution,Intravenous,77700915,"PROTAMINE SULFATE INJECTION, USP (protamine sulfate 50 mg per 5 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013519,protamine sulfate 50 mg per 5 mL solution for injection vial,8002082,protamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
51049,Marketed,2005-08-18,02231674,Protamine Sulfate Injection USP,1,V03AB14,Protamine,Solution,Intravenous,77700922,PROTAMINE SULFATE INJECTION USP (protamine sulfate 250 mg per 25 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013518,protamine sulfate 250 mg per 25 mL solution for injection vial,8002082,protamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
51049,Marketed,2005-08-18,02231674,Protamine Sulfate Injection USP,1,V03AB14,Protamine,Solution,Intravenous,77700923,PROTAMINE SULFATE INJECTION USP (protamine sulfate 50 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013519,protamine sulfate 50 mg per 5 mL solution for injection vial,8002082,protamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
99639,Marketed,2021-06-01,02506971,Water Drench,4,D02BA,Protectives against uv-radiation for topical use,Lotion,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
1172,Marketed,2019-08-21,00035076,Alcaine,1,S01HA04,Proxymetacaine,Drops,Ophthalmic,00035076,ALCAINE (proparacaine hydrochloride 0.5 % ophthalmic drops) ALCON CANADA INC,Active,9014228,proparacaine hydrochloride 0.5 % ophthalmic drops,8002313,proparacaine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Ethical
103919,Marketed,2024-10-28,02550377,Nra-Prucalopride,1,A06AX05,Prucalopride,Tablet,Oral,02550377,NRA-PRUCALOPRIDE (prucalopride (prucalopride succinate) 1 mg oral tablet) NORA PHARMA INC,Active,9004970,prucalopride (prucalopride succinate) 1 mg oral tablet,8002083,prucalopride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103920,Marketed,2024-10-28,02550385,Nra-Prucalopride,1,A06AX05,Prucalopride,Tablet,Oral,02550385,NRA-PRUCALOPRIDE (prucalopride (prucalopride succinate) 2 mg oral tablet) NORA PHARMA INC,Active,9004971,prucalopride (prucalopride succinate) 2 mg oral tablet,8002083,prucalopride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106220,Marketed,2025-11-19,02559005,Prucalopride,1,A06AX05,Prucalopride,Tablet,Oral,02559005,PRUCALOPRIDE (prucalopride (prucalopride succinate) 1 mg oral tablet) SANIS HEALTH INC,Active,9004970,prucalopride (prucalopride succinate) 1 mg oral tablet,8002083,prucalopride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106221,Marketed,2025-11-19,02559013,Prucalopride,1,A06AX05,Prucalopride,Tablet,Oral,02559013,PRUCALOPRIDE (prucalopride (prucalopride succinate) 2 mg oral tablet) SANIS HEALTH INC,Active,9004971,prucalopride (prucalopride succinate) 2 mg oral tablet,8002083,prucalopride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86259,Marketed,2024-10-30,02377012,Resotran,1,A06AX05,Prucalopride,Tablet,Oral,02377012,RESOTRAN (prucalopride (prucalopride succinate) 1 mg oral tablet) AMDIPHARM LIMITED,Active,9004970,prucalopride (prucalopride succinate) 1 mg oral tablet,8002083,prucalopride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86260,Marketed,2025-01-02,02377020,Resotran,1,A06AX05,Prucalopride,Tablet,Oral,02377020,RESOTRAN (prucalopride (prucalopride succinate) 2 mg oral tablet) AMDIPHARM LIMITED,Active,9004971,prucalopride (prucalopride succinate) 2 mg oral tablet,8002083,prucalopride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98158,Marketed,2020-01-27,02491591,Apo-Prucalopride,1,A06AX05,Prucalopride,Tablet,Oral,02491591,APO-PRUCALOPRIDE (prucalopride (prucalopride succinate) 1 mg oral tablet) APOTEX INC,Active,9004970,prucalopride (prucalopride succinate) 1 mg oral tablet,8002083,prucalopride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98159,Marketed,2020-01-27,02491605,Apo-Prucalopride,1,A06AX05,Prucalopride,Tablet,Oral,02491605,APO-PRUCALOPRIDE (prucalopride (prucalopride succinate) 2 mg oral tablet) APOTEX INC,Active,9004971,prucalopride (prucalopride succinate) 2 mg oral tablet,8002083,prucalopride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98349,Marketed,2021-02-26,02493489,JAMP Prucalopride,1,A06AX05,Prucalopride,Tablet,Oral,02493489,JAMP PRUCALOPRIDE (prucalopride (prucalopride succinate) 1 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004970,prucalopride (prucalopride succinate) 1 mg oral tablet,8002083,prucalopride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98350,Marketed,2021-02-26,02493497,JAMP Prucalopride,1,A06AX05,Prucalopride,Tablet,Oral,02493497,JAMP PRUCALOPRIDE (prucalopride (prucalopride succinate) 2 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004971,prucalopride (prucalopride succinate) 2 mg oral tablet,8002083,prucalopride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
11974,Marketed,2017-03-20,01945157,Claritin Allergy + Sinus,2,R01BA52,"Pseudoephedrine, combinations",Tablet (immediate and extended release),Oral,01945157,CLARITIN ALLERGY + SINUS (loratadine 5 mg and pseudoephedrine sulfate 120 mg prolonged-release oral tablet) BAYER INC,Active,9015307,loratadine 5 mg and pseudoephedrine sulfate 120 mg prolonged-release oral tablet,8001493,loratadine and pseudoephedrine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet,,,,Non-Prescription Drugs
63341,Marketed,2020-01-31,02239853,Allegra-D,2,R01BA52,"Pseudoephedrine, combinations",Tablet (immediate and extended release),Oral,02239853,ALLEGRA-D (fexofenadine hydrochloride 60 mg and pseudoephedrine hydrochloride 120 mg prolonged-release oral tablet) SANOFI CONSUMER HEALTH INC,Active,9015301,fexofenadine hydrochloride 60 mg and pseudoephedrine hydrochloride 120 mg prolonged-release oral tablet,8001467,fexofenadine and pseudoephedrine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet,,,,Non-Prescription Drugs
70312,Marketed,2026-03-12,02246162,Reactine Complete,2,R01BA52,"Pseudoephedrine, combinations",Tablet (extended-release),Oral,02246162,REACTINE COMPLETE (cetirizine hydrochloride 5 mg and pseudoephedrine hydrochloride 120 mg prolonged-release oral tablet) KENVUE CANADA INC.,Active,9003783,cetirizine hydrochloride 5 mg and pseudoephedrine hydrochloride 120 mg prolonged-release oral tablet,8001348,cetirizine and pseudoephedrine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
74601,Marketed,2015-09-11,02260557,Claritin Allergy + Sinus Extra Strength,2,R01BA52,"Pseudoephedrine, combinations",Tablet (immediate and extended release),Oral,02260557,CLARITIN ALLERGY + SINUS EXTRA STRENGTH (loratadine 10 mg and pseudoephedrine sulfate 240 mg prolonged-release oral tablet) BAYER INC,Active,9015306,loratadine 10 mg and pseudoephedrine sulfate 240 mg prolonged-release oral tablet,8001493,loratadine and pseudoephedrine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet,,,,Non-Prescription Drugs
79491,Marketed,2026-03-17,02309300,Aerius Sinus + Allergy,2,R01BA52,"Pseudoephedrine, combinations",Tablet (extended-release),Oral,02309300,AERIUS SINUS + ALLERGY (desloratadine 2.5 mg and pseudoephedrine sulfate 120 mg prolonged-release oral tablet) BAYER INC,Active,9004639,desloratadine 2.5 mg and pseudoephedrine sulfate 120 mg prolonged-release oral tablet,8001367,desloratadine and pseudoephedrine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
102431,Marketed,2025-02-17,02535467,Riva-Pyrantel Pamoate,1,P02CC01,Pyrantel,Tablet,Oral,02535467,RIVA-PYRANTEL PAMOATE (pyrantel (pyrantel pamoate) 125 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001704,pyrantel (pyrantel pamoate) 125 mg oral tablet,8002084,pyrantel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
12926,Marketed,2026-05-15,01944363,Combantrin Tablets 125 mg,1,P02CC01,Pyrantel,Tablet,Oral,01944363,COMBANTRIN TAB 125MG (pyrantel (pyrantel pamoate) 125 mg oral tablet) KENVUE CANADA INC.,Active,9001704,pyrantel (pyrantel pamoate) 125 mg oral tablet,8002084,pyrantel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
86640,Marketed,2018-08-22,02380617,JAMP-Pyrantel Pamoate,1,P02CC01,Pyrantel,Tablet,Oral,02380617,JAMP-PYRANTEL PAMOATE (pyrantel (pyrantel pamoate) 125 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001704,pyrantel (pyrantel pamoate) 125 mg oral tablet,8002084,pyrantel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
89708,Marketed,2017-12-08,02412470,JAMP-Pyrantel Pamoate Suspension,1,P02CC01,Pyrantel,Suspension,Oral,02412470,JAMP-PYRANTEL PAMOATE SUSPENSION (pyrantel (pyrantel pamoate) 50 mg per mL oral suspension) JAMP PHARMA CORPORATION,Active,9001705,pyrantel (pyrantel pamoate) 50 mg per mL oral suspension,8002084,pyrantel,26643006,Oral,385024007,Oral suspension,,,,,,Non-Prescription Drugs
6130,Marketed,2014-03-05,00618810,PDP-Pyrazinamide,1,J04AK01,Pyrazinamide,Tablet,Oral,00618810,PDP-PYRAZINAMIDE (pyrazinamide 500 mg oral tablet) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9001706,pyrazinamide 500 mg oral tablet,8001223,pyrazinamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
18634,Marketed,2013-03-01,02125447,R & C Shampoo With Conditioner,2,P03AC51,"Pyrethrum, combinations",Shampoo,Topical,02125447,R & C SHAMPOO WITH CONDITIONER (piperonyl butoxide 3 % and pyrethrins 0.33 % shampoo) MEDTECH PRODUCTS INC,Active,9002863,piperonyl butoxide 3 % and pyrethrins 0.33 % shampoo,8002069,piperonyl butoxide and pyrethrins,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
10567,Marketed,2019-07-04,00869961,Mestinon,1,N07AA02,Pyridostigmine,Tablet,Oral,00869961,"MESTINON (pyridostigmine bromide 60 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9002322,pyridostigmine bromide 60 mg oral tablet,8001516,pyridostigmine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
11135,Marketed,2019-07-04,00869953,Mestinon-SR,1,N07AA02,Pyridostigmine,Tablet (extended-release),Oral,00869953,"MESTINON-SR (pyridostigmine bromide 180 mg prolonged-release oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9002384,pyridostigmine bromide 180 mg prolonged-release oral tablet,8001516,pyridostigmine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98554,Marketed,2020-08-24,02495643,Riva-Pyridostigmine,1,N07AA02,Pyridostigmine,Tablet,Oral,02495643,RIVA-PYRIDOSTIGMINE (pyridostigmine bromide 60 mg oral tablet) LABORATOIRE RIVA INC.,Active,9002322,pyridostigmine bromide 60 mg oral tablet,8001516,pyridostigmine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99773,Marketed,2023-03-07,02508362,JAMP Pyridostigmine Bromide,1,N07AA02,Pyridostigmine,Tablet,Oral,02508362,JAMP PYRIDOSTIGMINE BROMIDE (pyridostigmine bromide 60 mg oral tablet) JAMP PHARMA CORPORATION,Active,9002322,pyridostigmine bromide 60 mg oral tablet,8001516,pyridostigmine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
69230,Marketed,2018-08-03,02245215,"Pyridoxine Hydrochloride Injection, USP",1,A11HA02,Pyridoxine (vit b6),Solution,"Intramuscular,Intravenous",02245215,"PYRIDOXINE HYDROCHLORIDE INJECTION, USP (pyridoxine hydrochloride 3000 mg per 30 mL solution for injection vial) MYLAN PHARMACEUTICALS ULC",Active,9013601,pyridoxine hydrochloride 3000 mg per 30 mL solution for injection vial,8001916,pyridoxine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
101112,Marketed,2025-04-23,02521954,Pyrithione Zinc Dandruff Shampoo Hydrating Coconut 2 In 1,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02521954,PYRITHIONE ZINC DANDRUFF SHAMPOO HYDRATING COCONUT 2IN1 (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
101113,Marketed,2025-04-22,02521962,Pyrithione Zinc Dandruff Shampoo Hydrating Coconut,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02521962,PYRITHIONE ZINC DANDRUFF SHAMPOO HYDRATING COCONUT  (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
101166,Marketed,2021-12-30,02522543,Pyrithione Zinc Dandruff Shampoo Lemon Oil 2 In 1,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02522543,PYRITHIONE ZINC DANDRUFF SHAMPOO LEMON OIL 2IN1 (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
101904,Marketed,2023-03-15,02529807,Pyrithione Zinc Dandruff Shampoo Ginger 2 In 1,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02529807,PYRITHIONE ZINC DANDRUFF SHAMPOO GINGER 2IN1 (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
101926,Marketed,2023-03-15,02530058,Pyrithione Zinc Dandruff Shampoo 2 In 1 Men Eucalyptus & Neem,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02530058,PYRITHIONE ZINC DANDRUFF SHAMPOO 2IN1 MEN EUCALYPTUS & NEEM (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
102048,Marketed,2025-04-24,02531348,Pyrithione Zinc Dandruff Conditioner Sulfate Free Shea Butter,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02531348,PYRITHIONE ZINC DANDRUFF CONDITIONER SULFATE FREE SHEA BUTTER (pyrithione zinc 0.5 % shampoo) PROCTER & GAMBLE INC,Active,9005596,pyrithione zinc 0.5 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
102049,Marketed,2025-04-10,02531356,Pyrithione Zinc Dandruff Shampoo Sulfate Free Shea Butter,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02531356,PYRITHIONE ZINC DANDRUFF SHAMPOO SULFATE FREE SHEA BUTTER (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
102102,Marketed,2023-03-15,02531933,Pyrithione Zinc Dandruff Shampoo Avocado Oil,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02531933,PYRITHIONE ZINC DANDRUFF SHAMPOO AVOCADO OIL (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
102104,Marketed,2023-03-15,02531968,Pyrithione Zinc Dandruff Shampoo Deep Scalp Hydration,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02531968,PYRITHIONE ZINC DANDRUFF SHAMPOO DEEP SCALP HYDRATION (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
102106,Marketed,2024-07-01,02531984,Pyrithione Zinc Dandruff Shampoo Deep Scalp Cleanse,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02531984,PYRITHIONE ZINC DANDRUFF SHAMPOO DEEP SCALP CLEANSE (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
102107,Marketed,2024-07-01,02531992,Pyrithione Zinc Dandruff Shampoo Deep Scalp Cleanse 2 In 1,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02531992,PYRITHIONE ZINC DANDRUFF SHAMPOO DEEP SCALP CLEANSE 2IN1 (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
102109,Marketed,2023-03-15,02532026,Pyrithione Zinc Dandruff Shampoo Deep Scalp Hydration 2 In 1,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02532026,PYRITHIONE ZINC DANDRUFF SHAMPOO DEEP SCALP HYDRATION 2IN1 (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
102553,Marketed,2024-02-01,02536781,Pyrithione Zinc Dandruff Shampoo Avocado Oil 2 In 1,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02536781,PYRITHIONE ZINC DANDRUFF SHAMPOO AVOCADO OIL 2IN1 (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
102662,Marketed,2024-02-01,02537869,Bare Minimal Ingredients Shampoo Soothing Hydration,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02537869,BARE MINIMAL INGREDIENTS SHAMPOO SOOTHING HYDRATION (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
102664,Marketed,2024-02-01,02537885,Bare Minimal Ingredients Shampoo Pure Clean,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02537885,BARE MINIMAL INGREDIENTS SHAMPOO PURE CLEAN (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
103358,Marketed,2025-07-01,02544962,Bare Minimal Ingredients Shampoo Itch Control,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02544962,BARE MINIMAL INGREDIENTS SHAMPOO ITCH CONTROL (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
103517,Marketed,2025-07-01,02546485,Bare Minimal Ingredients 2 In 1 Shampoo Pure Clean,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02546485,BARE MINIMAL INGREDIENTS 2IN1 SHAMPOO PURE CLEAN (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
103913,Marketed,2025-03-01,02550318,Anti-Dandruff Hydrating Conditioner,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02550318,ANTI-DANDRUFF HYDRATING CONDITIONER (pyrithione zinc 0.5 % shampoo) CERAVE CANADA,Active,9005596,pyrithione zinc 0.5 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
103939,Marketed,2025-03-01,02550598,Anti-Dandruff 2 In 1,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02550598,ANTI-DANDRUFF 2 IN 1 (pyrithione zinc 1 % shampoo) CERAVE CANADA,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
103970,Marketed,2025-03-01,02550946,Anti-Dandruff Hydrating Shampoo,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02550946,ANTI-DANDRUFF HYDRATING SHAMPOO (pyrithione zinc 1 % shampoo) CERAVE CANADA,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
10999,Marketed,1990-12-31,00800686,Z-Plus Shampoo,2,D11AX12,Pyrithione zinc,Shampoo,Topical,00800686,Z-PLUS SHAMPOO (menthol 0.3 % and pyrithione zinc 2 % shampoo) DORMER LABORATORIES INC.,Active,9002318,menthol 0.3 % and pyrithione zinc 2 % shampoo,8002031,menthol and pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
80576,Marketed,2011-11-19,02320320,Selsun Blue Anti-Dandruff Shampoo,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02320320,SELSUN BLUE ANTI-DANDRUFF SHAMPOO (pyrithione zinc 1 % shampoo) SANOFI CONSUMER HEALTH INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
84283,Marketed,2016-07-29,02357739,Dove Men+Care Fortifying Shampoo + Conditioner Anti-Dandruff 2 In 1,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02357739,DOVE MEN+CARE FORTIFYING SHAMPOO + CONDITIONER ANTI-DANDRUFF 2 IN 1 (pyrithione zinc 1 % shampoo) UNILEVER CANADA,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
88440,Marketed,2023-03-15,02399520,Pyrithione Zinc Dandruff Shampoo Itchy Scalp Care,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02399520,PYRITHIONE ZINC DANDRUFF SHAMPOO ITCHY SCALP CARE (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
88442,Marketed,2022-09-09,02399547,Pyrithione Zinc Dandruff Shampoo Dry Scalp Care 2 In 1,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02399547,PYRITHIONE ZINC DANDRUFF SHAMPOO DRY SCALP CARE 2IN1 (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
88443,Marketed,2023-03-15,02399555,Pyrithione Zinc Dandruff Shampoo Green Apple,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02399555,PYRITHIONE ZINC DANDRUFF SHAMPOO GREEN APPLE (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
88444,Marketed,2023-03-15,02399563,Pyrithione Zinc Dandruff Shampoo Green Apple 2 In 1,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02399563,PYRITHIONE ZINC DANDRUFF SHAMPOO GREEN APPLE 2IN1 (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
88449,Marketed,2023-03-15,02399636,Pyrithione Zinc Dandruff Shampoo Classic Clean 2 In 1,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02399636,PYRITHIONE ZINC DANDRUFF SHAMPOO CLASSIC CLEAN 2IN1 (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
88450,Marketed,2023-03-15,02399644,Pyrithione Zinc Dandruff Shampoo Classic Clean,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02399644,PYRITHIONE ZINC DANDRUFF SHAMPOO CLASSIC CLEAN (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
88452,Marketed,2023-03-15,02399660,Pyrithione Zinc Dandruff Shampoo Citrus Breeze,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02399660,PYRITHIONE ZINC DANDRUFF SHAMPOO CITRUS BREEZE (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
88453,Marketed,2023-03-15,02399679,Pyrithione Zinc Dandruff Shampoo Dry Scalp Care,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02399679,PYRITHIONE ZINC DANDRUFF SHAMPOO DRY SCALP CARE (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
88454,Marketed,2023-03-15,02399687,Pyrithione Zinc Dandruff Shampoo Itchy Scalp Care 2 In 1,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02399687,PYRITHIONE ZINC DANDRUFF SHAMPOO ITCHY SCALP CARE 2IN1 (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
88455,Marketed,2023-03-15,02399695,Pyrithione Zinc Dandruff Shampoo Smooth & Silky,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02399695,PYRITHIONE ZINC DANDRUFF SHAMPOO SMOOTH & SILKY (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
88456,Marketed,2023-03-15,02399709,Pyrithione Zinc Dandruff Shampoo Smooth & Silky 2 In 1,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02399709,PYRITHIONE ZINC DANDRUFF SHAMPOO SMOOTH & SILKY 2IN1 (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
91022,Marketed,2014-07-02,02425580,Scalpsync Anti-Dandruff,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02425580,SCALPSYNC ANTI-DANDRUFF (pyrithione zinc 1 % shampoo) MATRIX CANADA,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
93449,Marketed,2016-04-13,02448769,Pyrithione Zinc Dandruff Shampoo And Conditioner Classic Clean 2 In 1,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02448769,PYRITHIONE ZINC DANDRUFF SHAMPOO AND CONDITIONER CLASSIC CLEAN 2 IN 1 (pyrithione zinc 1 % shampoo) CANADIAN CUSTOM PACKAGING COMPANY,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
93469,Marketed,2016-04-13,02448912,Pyrithione Zinc Dandruff Shampoo Classic Clean,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02448912,PYRITHIONE ZINC DANDRUFF SHAMPOO CLASSIC CLEAN (pyrithione zinc 1 % shampoo) CANADIAN CUSTOM PACKAGING COMPANY,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
93592,Marketed,2016-05-17,02449986,Pyrithione Zinc Dandruff Shampoo Refresh,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02449986,PYRITHIONE ZINC DANDRUFF SHAMPOO REFRESH (pyrithione zinc 1 % shampoo) CANADIAN CUSTOM PACKAGING COMPANY,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
93593,Marketed,2016-06-13,02449994,Pyrithione Zinc Dandruff Shampoo Scalp Care,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02449994,PYRITHIONE ZINC DANDRUFF SHAMPOO SCALP CARE (pyrithione zinc 1 % shampoo) CANADIAN CUSTOM PACKAGING COMPANY,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
93597,Marketed,2016-04-27,02450011,Pyrithione Zinc Dandruff Shampoo Citrus,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02450011,PYRITHIONE ZINC DANDRUFF SHAMPOO CITRUS (pyrithione zinc 1 % shampoo) CANADIAN CUSTOM PACKAGING COMPANY,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
94483,Marketed,2023-06-15,02457806,Head & Shoulders Pyrithione Zinc Dandruff Conditioner Green Apple,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02457806,HEAD & SHOULDERS PYRITHIONE ZINC DANDRUFF CONDITIONER GREEN APPLE (pyrithione zinc 0.5 % shampoo) PROCTER & GAMBLE INC,Active,9005596,pyrithione zinc 0.5 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
94485,Marketed,2023-06-15,02457822,Head & Shoulders Pyrithione Zinc Dandruff Conditioner Smooth & Silky,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02457822,HEAD & SHOULDERS PYRITHIONE ZINC DANDRUFF CONDITIONER SMOOTH & SILKY (pyrithione zinc 0.5 % shampoo) PROCTER & GAMBLE INC,Active,9005596,pyrithione zinc 0.5 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
94486,Marketed,2023-06-15,02457830,Head & Shoulders Pyrithione Zinc Dandruff Conditioner Dry Scalp Care,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02457830,HEAD & SHOULDERS PYRITHIONE ZINC DANDRUFF CONDITIONER DRY SCALP CARE (pyrithione zinc 0.5 % shampoo) PROCTER & GAMBLE INC,Active,9005596,pyrithione zinc 0.5 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
94487,Marketed,2023-06-15,02457849,Head & Shoulders Pyrithione Zinc Dandruff Conditioner Classic Clean,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02457849,HEAD & SHOULDERS PYRITHIONE ZINC DANDRUFF CONDITIONER CLASSIC CLEAN (pyrithione zinc 0.5 % shampoo) PROCTER & GAMBLE INC,Active,9005596,pyrithione zinc 0.5 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
94885,Marketed,2023-06-15,02461358,Head & Shoulders Pyrithione Zinc Dandruff Shampoo Deep Moisture 2 In 1,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02461358,HEAD & SHOULDERS PYRITHIONE ZINC DANDRUFF SHAMPOO DEEP MOISTURE 2IN1 (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
94999,Marketed,2023-06-15,02462249,Head & Shoulders Pyrithione Zinc Dandruff Shampoo Deep Moisture,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02462249,HEAD & SHOULDERS PYRITHIONE ZINC DANDRUFF SHAMPOO DEEP MOISTURE (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
95440,Marketed,2018-02-01,02466090,Dove Derma+Care Scalp Anti-Dandruff Dryness & Itch Relief,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02466090,DOVE DERMA+CARE SCALP ANTI-DANDRUFF DRYNESS & ITCH RELIEF (pyrithione zinc 1 % shampoo) UNILEVER CANADA,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
95558,Marketed,2018-02-01,02467194,Dove Men+Care Derma+Care Scalp Anti-Dandruff Dryness & Itch Relief 2 In 1,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02467194,DOVE MEN+CARE DERMA+CARE SCALP ANTI-DANDRUFF DRYNESS & ITCH RELIEF 2 IN 1 (pyrithione zinc 1 % shampoo) UNILEVER CANADA,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
95560,Marketed,2018-02-01,02467216,Dove Men+Care Derma+Care Scalp Anti-Dandruff Gentle Clean 2 In 1,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02467216,DOVE MEN+CARE DERMA+CARE SCALP ANTI-DANDRUFF GENTLE CLEAN 2 IN 1 (pyrithione zinc 1 % shampoo) UNILEVER CANADA,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
96721,Marketed,2024-02-07,02476193,Pyrithione Zinc Dandruff Shampoo Men 2 In 1 Swagger,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02476193,PYRITHIONE ZINC DANDRUFF SHAMPOO MEN 2IN1 SWAGGER (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
96727,Marketed,2023-03-15,02476266,Pyrithione Zinc Dandruff Shampoo Men Swagger,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02476266,PYRITHIONE ZINC DANDRUFF SHAMPOO MEN SWAGGER (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
96806,Marketed,2024-02-07,02477211,Pyrithione Zinc Dandruff Shampoo Men 2 In 1 Pure Sport,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02477211,PYRITHIONE ZINC DANDRUFF SHAMPOO MEN 2IN1 PURE SPORT (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
96807,Marketed,2023-03-15,02477238,Pyrithione Zinc Dandruff Shampoo Men Pure Sport,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02477238,PYRITHIONE ZINC DANDRUFF SHAMPOO MEN PURE SPORT (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
96824,Marketed,2024-02-07,02477289,Pyrithione Zinc Dandruff Shampoo Men 2 In 1 Fiji,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02477289,PYRITHIONE ZINC DANDRUFF SHAMPOO MEN 2IN1 FIJI (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
96975,Marketed,2026-02-06,02479044,Dandruff Shampoo-Classic Clean,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02479044,DANDRUFF SHAMPOO-CLASSIC CLEAN (pyrithione zinc 1 % shampoo) APOLLO HEALTH AND BEAUTY CARE,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
96976,Marketed,2024-06-15,02479052,Green Apple Pomme Verte Dandruff Pyrithione Zinc Shampoo,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02479052,GREEN APPLE POMME VERTE DANDRUFF PYRITHIONE ZINC SHAMPOO (pyrithione zinc 1 % shampoo) APOLLO HEALTH AND BEAUTY CARE,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
96978,Marketed,2019-11-09,02479079,Cleansing Nettoyant Dandruff Pyrithione Zinc Shampoo,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02479079,CLEANSING NETTOYANT DANDRUFF PYRITHIONE ZINC SHAMPOO (pyrithione zinc 1 % shampoo) APOLLO HEALTH AND BEAUTY CARE,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
96980,Marketed,2024-06-15,02479095,Green Apple Pomme Verte Dandruff Pyrithione Zinc Shampoo & Conditioner,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02479095,GREEN APPLE POMME VERTE DANDRUFF PYRITHIONE ZINC SHAMPOO & CONDITIONER (pyrithione zinc 1 % shampoo) APOLLO HEALTH AND BEAUTY CARE,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
97824,Marketed,2020-05-26,02488132,Scalp Relief,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02488132,SCALP RELIEF (pyrithione zinc 1 % shampoo) REDKEN 5TH AVENUE NYC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
98145,Marketed,2020-01-31,02491443,Pyrithione Zinc Dandruff Shampoo Suprême Nourish,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02491443,PYRITHIONE ZINC DANDRUFF SHAMPOO SUPRÊME NOURISH (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
98147,Marketed,2020-01-31,02491478,Pyrithione Zinc Dandruff Shampoo Suprême Purify & Hydrate,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02491478,PYRITHIONE ZINC DANDRUFF SHAMPOO SUPRÊME PURIFY & HYDRATE (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
98150,Marketed,2020-01-31,02491508,Pyrithione Zinc Dandruff Conditioner Suprême Nourish,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02491508,PYRITHIONE ZINC DANDRUFF CONDITIONER SUPRÊME NOURISH (pyrithione zinc 0.5 % shampoo) PROCTER & GAMBLE INC,Active,9005596,pyrithione zinc 0.5 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
98151,Marketed,2020-01-31,02491516,Pyrithione Zinc Dandruff Conditioner Suprême Purify & Hydrate,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02491516,PYRITHIONE ZINC DANDRUFF CONDITIONER SUPRÊME PURIFY & HYDRATE (pyrithione zinc 0.5 % shampoo) PROCTER & GAMBLE INC,Active,9005596,pyrithione zinc 0.5 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
98326,Marketed,2019-11-11,02493284,Tea Tree Oil 2 In 1,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02493284,TEA TREE OIL 2IN1 (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
98327,Marketed,2023-03-15,02493292,Pyrithione Zinc Dandruff Shampoo Tea Tree Oil,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02493292,PYRITHIONE ZINC DANDRUFF SHAMPOO TEA TREE OIL (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
99696,Marketed,2023-06-15,02507595,Pyrithione Zinc Dandruff Shampoo Apple Cider Vinegar,1,D11AX12,Pyrithione zinc,Shampoo,Topical,02507595,PYRITHIONE ZINC DANDRUFF SHAMPOO APPLE CIDER VINEGAR (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
100627,Marketed,2022-07-14,02516934,AG-Quetiapine Fumarate,1,N05AH04,Quetiapine,Tablet (immediate release),Oral,02516934,AG-QUETIAPINE FUMARATE (quetiapine (quetiapine fumarate) 25 mg oral tablet) ANGITA PHARMA INC.,Active,9000769,quetiapine (quetiapine fumarate) 25 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100628,Marketed,2023-01-31,02516942,AG-Quetiapine Fumarate,1,N05AH04,Quetiapine,Tablet (immediate release),Oral,02516942,AG-QUETIAPINE FUMARATE (quetiapine (quetiapine fumarate) 100 mg oral tablet) ANGITA PHARMA INC.,Active,9000767,quetiapine (quetiapine fumarate) 100 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100629,Marketed,2023-02-01,02516950,AG-Quetiapine Fumarate,1,N05AH04,Quetiapine,Tablet (immediate release),Oral,02516950,AG-QUETIAPINE FUMARATE (quetiapine (quetiapine fumarate) 200 mg oral tablet) ANGITA PHARMA INC.,Active,9000768,quetiapine (quetiapine fumarate) 200 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100630,Marketed,2023-02-01,02516969,AG-Quetiapine Fumarate,1,N05AH04,Quetiapine,Tablet (immediate release),Oral,02516969,AG-QUETIAPINE FUMARATE (quetiapine (quetiapine fumarate) 300 mg oral tablet) ANGITA PHARMA INC.,Active,9000954,quetiapine (quetiapine fumarate) 300 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100885,Marketed,2022-04-27,02519607,Quetiapine XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02519607,QUETIAPINE XR (quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet) JAMP PHARMA CORPORATION,Active,9001214,quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100898,Marketed,2022-04-27,02519747,Quetiapine XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02519747,QUETIAPINE XR (quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet) JAMP PHARMA CORPORATION,Active,9001212,quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100976,Marketed,2022-04-27,02520567,AG-Quetiapine XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02520567,AG-QUETIAPINE XR (quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet) ANGITA PHARMA INC.,Active,9001212,quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101136,Marketed,2022-04-07,02522217,Mint-Quetiapine XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02522217,MINT-QUETIAPINE XR (quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet) MINT PHARMACEUTICALS INC,Active,9001212,quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106021,Marketed,2026-03-24,02556820,NB-Quetiapine XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02556820,NB-QUETIAPINE XR (quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet) NB PHARMA INC.,Active,9001214,quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106022,Marketed,2026-03-24,02556839,NB-Quetiapine XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02556839,NB-QUETIAPINE XR (quetiapine (quetiapine fumarate) 150 mg prolonged-release oral tablet) NB PHARMA INC.,Active,9001273,quetiapine (quetiapine fumarate) 150 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106023,Marketed,2026-03-24,02556847,NB-Quetiapine XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02556847,NB-QUETIAPINE XR (quetiapine (quetiapine fumarate) 200 mg prolonged-release oral tablet) NB PHARMA INC.,Active,9001211,quetiapine (quetiapine fumarate) 200 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106024,Marketed,2026-03-24,02556855,NB-Quetiapine XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02556855,NB-QUETIAPINE XR (quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet) NB PHARMA INC.,Active,9001212,quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106025,Marketed,2026-03-24,02556863,NB-Quetiapine XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02556863,NB-QUETIAPINE XR (quetiapine (quetiapine fumarate) 400 mg prolonged-release oral tablet) NB PHARMA INC.,Active,9001213,quetiapine (quetiapine fumarate) 400 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
60245,Marketed,2025-11-28,02236951,Seroquel,1,N05AH04,Quetiapine,Tablet,Oral,02236951,SEROQUEL (quetiapine (quetiapine fumarate) 25 mg oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9000769,quetiapine (quetiapine fumarate) 25 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
60246,Marketed,2026-04-27,02236952,Seroquel,1,N05AH04,Quetiapine,Tablet,Oral,02236952,SEROQUEL (quetiapine (quetiapine fumarate) 100 mg oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9000767,quetiapine (quetiapine fumarate) 100 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
60247,Marketed,2025-10-24,02236953,Seroquel,1,N05AH04,Quetiapine,Tablet,Oral,02236953,SEROQUEL (quetiapine (quetiapine fumarate) 200 mg oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9000768,quetiapine (quetiapine fumarate) 200 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
68066,Marketed,2025-11-21,02244107,Seroquel,1,N05AH04,Quetiapine,Tablet,Oral,02244107,SEROQUEL (quetiapine (quetiapine fumarate) 300 mg oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9000954,quetiapine (quetiapine fumarate) 300 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78188,Marketed,2008-09-04,02296551,PMS-Quetiapine,1,N05AH04,Quetiapine,Tablet,Oral,02296551,PMS-QUETIAPINE (quetiapine (quetiapine fumarate) 25 mg oral tablet) PHARMASCIENCE INC,Active,9000769,quetiapine (quetiapine fumarate) 25 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78189,Marketed,2008-09-04,02296578,PMS-Quetiapine,1,N05AH04,Quetiapine,Tablet,Oral,02296578,PMS-QUETIAPINE (quetiapine (quetiapine fumarate) 100 mg oral tablet) PHARMASCIENCE INC,Active,9000767,quetiapine (quetiapine fumarate) 100 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78191,Marketed,2008-09-04,02296594,PMS-Quetiapine,1,N05AH04,Quetiapine,Tablet,Oral,02296594,PMS-QUETIAPINE (quetiapine (quetiapine fumarate) 200 mg oral tablet) PHARMASCIENCE INC,Active,9000768,quetiapine (quetiapine fumarate) 200 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78192,Marketed,2008-09-04,02296608,PMS-Quetiapine,1,N05AH04,Quetiapine,Tablet,Oral,02296608,PMS-QUETIAPINE (quetiapine (quetiapine fumarate) 300 mg oral tablet) PHARMASCIENCE INC,Active,9000954,quetiapine (quetiapine fumarate) 300 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78550,Marketed,2025-11-05,02300184,Seroquel XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02300184,SEROQUEL XR (quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9001214,quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78551,Marketed,2025-12-12,02300192,Seroquel XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02300192,SEROQUEL XR (quetiapine (quetiapine fumarate) 200 mg prolonged-release oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9001211,quetiapine (quetiapine fumarate) 200 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78552,Marketed,2025-11-05,02300206,Seroquel XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02300206,SEROQUEL XR (quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9001212,quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78553,Marketed,2025-03-18,02300214,Seroquel XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02300214,SEROQUEL XR (quetiapine (quetiapine fumarate) 400 mg prolonged-release oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9001213,quetiapine (quetiapine fumarate) 400 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80161,Marketed,2019-12-06,02316080,Act Quetiapine,1,N05AH04,Quetiapine,Tablet,Oral,02316080,ACT QUETIAPINE (quetiapine (quetiapine fumarate) 25 mg oral tablet) TEVA CANADA LIMITED,Active,9000769,quetiapine (quetiapine fumarate) 25 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80162,Marketed,2019-12-06,02316099,Act Quetiapine,1,N05AH04,Quetiapine,Tablet,Oral,02316099,ACT QUETIAPINE (quetiapine (quetiapine fumarate) 100 mg oral tablet) TEVA CANADA LIMITED,Active,9000767,quetiapine (quetiapine fumarate) 100 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80164,Marketed,2019-12-06,02316110,Act Quetiapine,1,N05AH04,Quetiapine,Tablet,Oral,02316110,ACT QUETIAPINE (quetiapine (quetiapine fumarate) 200 mg oral tablet) TEVA CANADA LIMITED,Active,9000768,quetiapine (quetiapine fumarate) 200 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80165,Marketed,2019-12-06,02316129,Act Quetiapine,1,N05AH04,Quetiapine,Tablet,Oral,02316129,ACT QUETIAPINE (quetiapine (quetiapine fumarate) 300 mg oral tablet) TEVA CANADA LIMITED,Active,9000954,quetiapine (quetiapine fumarate) 300 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80220,Marketed,2013-06-25,02316692,Riva-Quetiapine,1,N05AH04,Quetiapine,Tablet,Oral,02316692,RIVA-QUETIAPINE (quetiapine (quetiapine fumarate) 25 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000769,quetiapine (quetiapine fumarate) 25 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80221,Marketed,2013-06-25,02316706,Riva-Quetiapine,1,N05AH04,Quetiapine,Tablet,Oral,02316706,RIVA-QUETIAPINE (quetiapine (quetiapine fumarate) 100 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000767,quetiapine (quetiapine fumarate) 100 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80223,Marketed,2013-06-25,02316722,Riva-Quetiapine,1,N05AH04,Quetiapine,Tablet,Oral,02316722,RIVA-QUETIAPINE (quetiapine (quetiapine fumarate) 200 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000768,quetiapine (quetiapine fumarate) 200 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80224,Marketed,2013-06-25,02316730,Riva-Quetiapine,1,N05AH04,Quetiapine,Tablet,Oral,02316730,RIVA-QUETIAPINE (quetiapine (quetiapine fumarate) 300 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000954,quetiapine (quetiapine fumarate) 300 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80287,Marketed,2025-07-17,02317346,Pro-Quetiapine,1,N05AH04,Quetiapine,Tablet,Oral,02317346,PRO-QUETIAPINE (quetiapine (quetiapine fumarate) 25 mg oral tablet) PRO DOC LIMITEE,Active,9000769,quetiapine (quetiapine fumarate) 25 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80288,Marketed,2025-07-17,02317354,Pro-Quetiapine,1,N05AH04,Quetiapine,Tablet,Oral,02317354,PRO-QUETIAPINE (quetiapine (quetiapine fumarate) 100 mg oral tablet) PRO DOC LIMITEE,Active,9000767,quetiapine (quetiapine fumarate) 100 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80289,Marketed,2025-07-17,02317362,Pro-Quetiapine,1,N05AH04,Quetiapine,Tablet,Oral,02317362,PRO-QUETIAPINE (quetiapine (quetiapine fumarate) 200 mg oral tablet) PRO DOC LIMITEE,Active,9000768,quetiapine (quetiapine fumarate) 200 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80290,Marketed,2025-07-17,02317370,Pro-Quetiapine,1,N05AH04,Quetiapine,Tablet,Oral,02317370,PRO-QUETIAPINE (quetiapine (quetiapine fumarate) 300 mg oral tablet) PRO DOC LIMITEE,Active,9000954,quetiapine (quetiapine fumarate) 300 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80341,Marketed,2016-08-12,02317893,Quetiapine,1,N05AH04,Quetiapine,Tablet,Oral,02317893,QUETIAPINE (quetiapine (quetiapine fumarate) 25 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000769,quetiapine (quetiapine fumarate) 25 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80342,Marketed,2016-08-12,02317907,Quetiapine,1,N05AH04,Quetiapine,Tablet,Oral,02317907,QUETIAPINE (quetiapine (quetiapine fumarate) 100 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000767,quetiapine (quetiapine fumarate) 100 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80344,Marketed,2016-07-12,02317923,Quetiapine,1,N05AH04,Quetiapine,Tablet,Oral,02317923,QUETIAPINE (quetiapine (quetiapine fumarate) 200 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000768,quetiapine (quetiapine fumarate) 200 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80345,Marketed,2016-08-12,02317931,Quetiapine,1,N05AH04,Quetiapine,Tablet,Oral,02317931,QUETIAPINE (quetiapine (quetiapine fumarate) 300 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000954,quetiapine (quetiapine fumarate) 300 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80692,Marketed,2025-03-18,02321513,Seroquel XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02321513,SEROQUEL XR (quetiapine (quetiapine fumarate) 150 mg prolonged-release oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9001273,quetiapine (quetiapine fumarate) 150 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83838,Marketed,2010-07-26,02353164,Quetiapine,1,N05AH04,Quetiapine,Tablet,Oral,02353164,QUETIAPINE (quetiapine (quetiapine fumarate) 25 mg oral tablet) SANIS HEALTH INC,Active,9000769,quetiapine (quetiapine fumarate) 25 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83839,Marketed,2010-07-26,02353172,Quetiapine,1,N05AH04,Quetiapine,Tablet,Oral,02353172,QUETIAPINE (quetiapine (quetiapine fumarate) 100 mg oral tablet) SANIS HEALTH INC,Active,9000767,quetiapine (quetiapine fumarate) 100 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83841,Marketed,2010-07-26,02353199,Quetiapine,1,N05AH04,Quetiapine,Tablet,Oral,02353199,QUETIAPINE (quetiapine (quetiapine fumarate) 200 mg oral tablet) SANIS HEALTH INC,Active,9000768,quetiapine (quetiapine fumarate) 200 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83842,Marketed,2010-07-26,02353202,Quetiapine,1,N05AH04,Quetiapine,Tablet,Oral,02353202,QUETIAPINE (quetiapine (quetiapine fumarate) 300 mg oral tablet) SANIS HEALTH INC,Active,9000954,quetiapine (quetiapine fumarate) 300 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84693,Marketed,2011-01-21,02361892,PMS-Quetiapine,1,N05AH04,Quetiapine,Tablet,Oral,02361892,PMS-QUETIAPINE (quetiapine (quetiapine fumarate) 50 mg oral tablet) PHARMASCIENCE INC,Active,9001333,quetiapine (quetiapine fumarate) 50 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87337,Marketed,2024-04-03,02387794,ACH-Quetiapine,1,N05AH04,Quetiapine,Tablet (immediate release),Oral,02387794,ACH-QUETIAPINE (quetiapine (quetiapine fumarate) 25 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000769,quetiapine (quetiapine fumarate) 25 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87338,Marketed,2024-04-03,02387808,ACH-Quetiapine,1,N05AH04,Quetiapine,Tablet (immediate release),Oral,02387808,ACH-QUETIAPINE (quetiapine (quetiapine fumarate) 100 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000767,quetiapine (quetiapine fumarate) 100 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87339,Marketed,2024-04-03,02387816,ACH-Quetiapine,1,N05AH04,Quetiapine,Tablet (immediate release),Oral,02387816,ACH-QUETIAPINE (quetiapine (quetiapine fumarate) 150 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001256,quetiapine (quetiapine fumarate) 150 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87340,Marketed,2024-04-03,02387824,ACH-Quetiapine,1,N05AH04,Quetiapine,Tablet (immediate release),Oral,02387824,ACH-QUETIAPINE (quetiapine (quetiapine fumarate) 200 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000768,quetiapine (quetiapine fumarate) 200 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87341,Marketed,2024-04-03,02387832,ACH-Quetiapine,1,N05AH04,Quetiapine,Tablet (immediate release),Oral,02387832,ACH-QUETIAPINE (quetiapine (quetiapine fumarate) 300 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000954,quetiapine (quetiapine fumarate) 300 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87560,Marketed,2021-11-03,02390140,JAMP Quetiapine Fumarate,1,N05AH04,Quetiapine,Tablet (immediate release),Oral,02390140,JAMP QUETIAPINE FUMARATE (quetiapine (quetiapine fumarate) 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000769,quetiapine (quetiapine fumarate) 25 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87561,Marketed,2021-11-03,02390159,JAMP Quetiapine Fumarate,1,N05AH04,Quetiapine,Tablet (immediate release),Oral,02390159,JAMP QUETIAPINE FUMARATE (quetiapine (quetiapine fumarate) 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000767,quetiapine (quetiapine fumarate) 100 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87562,Marketed,2021-11-03,02390167,JAMP Quetiapine Fumarate,1,N05AH04,Quetiapine,Tablet (immediate release),Oral,02390167,JAMP QUETIAPINE FUMARATE (quetiapine (quetiapine fumarate) 200 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000768,quetiapine (quetiapine fumarate) 200 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87563,Marketed,2021-11-03,02390175,JAMP Quetiapine Fumarate,1,N05AH04,Quetiapine,Tablet (immediate release),Oral,02390175,JAMP QUETIAPINE FUMARATE (quetiapine (quetiapine fumarate) 300 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000954,quetiapine (quetiapine fumarate) 300 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87566,Marketed,2012-10-18,02390205,Auro-Quetiapine,1,N05AH04,Quetiapine,Tablet,Oral,02390205,AURO-QUETIAPINE (quetiapine (quetiapine fumarate) 25 mg oral tablet) AURO PHARMA INC,Active,9000769,quetiapine (quetiapine fumarate) 25 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87567,Marketed,2012-10-18,02390213,Auro-Quetiapine,1,N05AH04,Quetiapine,Tablet,Oral,02390213,AURO-QUETIAPINE (quetiapine (quetiapine fumarate) 100 mg oral tablet) AURO PHARMA INC,Active,9000767,quetiapine (quetiapine fumarate) 100 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87569,Marketed,2012-10-18,02390248,Auro-Quetiapine,1,N05AH04,Quetiapine,Tablet,Oral,02390248,AURO-QUETIAPINE (quetiapine (quetiapine fumarate) 200 mg oral tablet) AURO PHARMA INC,Active,9000768,quetiapine (quetiapine fumarate) 200 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87570,Marketed,2012-10-18,02390256,Auro-Quetiapine,1,N05AH04,Quetiapine,Tablet,Oral,02390256,AURO-QUETIAPINE (quetiapine (quetiapine fumarate) 300 mg oral tablet) AURO PHARMA INC,Active,9000954,quetiapine (quetiapine fumarate) 300 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88053,Marketed,2013-03-08,02395444,Teva-Quetiapine XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02395444,TEVA-QUETIAPINE XR (quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9001214,quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88054,Marketed,2013-03-08,02395452,Teva-Quetiapine XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02395452,TEVA-QUETIAPINE XR (quetiapine (quetiapine fumarate) 150 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9001273,quetiapine (quetiapine fumarate) 150 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88055,Marketed,2013-03-08,02395460,Teva-Quetiapine XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02395460,TEVA-QUETIAPINE XR (quetiapine (quetiapine fumarate) 200 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9001211,quetiapine (quetiapine fumarate) 200 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88056,Marketed,2013-03-08,02395479,Teva-Quetiapine XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02395479,TEVA-QUETIAPINE XR (quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9001212,quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88057,Marketed,2013-03-08,02395487,Teva-Quetiapine XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02395487,TEVA-QUETIAPINE XR (quetiapine (quetiapine fumarate) 400 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9001213,quetiapine (quetiapine fumarate) 400 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89240,Marketed,2017-11-07,02407671,Sandoz Quetiapine XRT,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02407671,SANDOZ QUETIAPINE XRT (quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9001214,quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89241,Marketed,2017-11-07,02407701,Sandoz Quetiapine XRT,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02407701,SANDOZ QUETIAPINE XRT (quetiapine (quetiapine fumarate) 200 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9001211,quetiapine (quetiapine fumarate) 200 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89242,Marketed,2017-11-07,02407728,Sandoz Quetiapine XRT,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02407728,SANDOZ QUETIAPINE XRT (quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9001212,quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89243,Marketed,2017-11-07,02407736,Sandoz Quetiapine XRT,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02407736,SANDOZ QUETIAPINE XRT (quetiapine (quetiapine fumarate) 400 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9001213,quetiapine (quetiapine fumarate) 400 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89244,Marketed,2017-11-07,02407698,Sandoz Quetiapine XRT,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02407698,SANDOZ QUETIAPINE XRT (quetiapine (quetiapine fumarate) 150 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9001273,quetiapine (quetiapine fumarate) 150 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90198,Marketed,2025-06-11,02417359,Quetiapine XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02417359,QUETIAPINE XR (quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001214,quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90199,Marketed,2025-06-11,02417367,Quetiapine XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02417367,QUETIAPINE XR (quetiapine (quetiapine fumarate) 150 mg prolonged-release oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001273,quetiapine (quetiapine fumarate) 150 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90200,Marketed,2025-06-11,02417375,Quetiapine XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02417375,QUETIAPINE XR (quetiapine (quetiapine fumarate) 200 mg prolonged-release oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001211,quetiapine (quetiapine fumarate) 200 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90201,Marketed,2025-06-11,02417383,Quetiapine XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02417383,QUETIAPINE XR (quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001212,quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90202,Marketed,2025-06-11,02417391,Quetiapine XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02417391,QUETIAPINE XR (quetiapine (quetiapine fumarate) 400 mg prolonged-release oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001213,quetiapine (quetiapine fumarate) 400 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90240,Marketed,2022-09-23,02417782,Quetiapine XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02417782,QUETIAPINE XR (quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet) PRO DOC LIMITEE,Active,9001214,quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90241,Marketed,2022-09-23,02417790,Quetiapine XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02417790,QUETIAPINE XR (quetiapine (quetiapine fumarate) 150 mg prolonged-release oral tablet) PRO DOC LIMITEE,Active,9001273,quetiapine (quetiapine fumarate) 150 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90242,Marketed,2022-09-23,02417804,Quetiapine XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02417804,QUETIAPINE XR (quetiapine (quetiapine fumarate) 200 mg prolonged-release oral tablet) PRO DOC LIMITEE,Active,9001211,quetiapine (quetiapine fumarate) 200 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90243,Marketed,2022-09-23,02417812,Quetiapine XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02417812,QUETIAPINE XR (quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet) PRO DOC LIMITEE,Active,9001212,quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90244,Marketed,2022-09-23,02417820,Quetiapine XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02417820,QUETIAPINE XR (quetiapine (quetiapine fumarate) 400 mg prolonged-release oral tablet) PRO DOC LIMITEE,Active,9001213,quetiapine (quetiapine fumarate) 400 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92237,Marketed,2015-03-19,02438003,Mint-Quetiapine,1,N05AH04,Quetiapine,Tablet,Oral,02438003,MINT-QUETIAPINE (quetiapine (quetiapine fumarate) 25 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000769,quetiapine (quetiapine fumarate) 25 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92238,Marketed,2015-03-19,02438011,Mint-Quetiapine,1,N05AH04,Quetiapine,Tablet,Oral,02438011,MINT-QUETIAPINE (quetiapine (quetiapine fumarate) 100 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000767,quetiapine (quetiapine fumarate) 100 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92240,Marketed,2015-03-19,02438046,Mint-Quetiapine,1,N05AH04,Quetiapine,Tablet,Oral,02438046,MINT-QUETIAPINE (quetiapine (quetiapine fumarate) 200 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000768,quetiapine (quetiapine fumarate) 200 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92241,Marketed,2015-03-19,02438054,Mint-Quetiapine,1,N05AH04,Quetiapine,Tablet,Oral,02438054,MINT-QUETIAPINE (quetiapine (quetiapine fumarate) 300 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000954,quetiapine (quetiapine fumarate) 300 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93276,Marketed,2016-09-07,02447193,Bio-Quetiapine,1,N05AH04,Quetiapine,Tablet (immediate release),Oral,02447193,BIO-QUETIAPINE (quetiapine (quetiapine fumarate) 25 mg oral tablet) BIOMED PHARMA,Active,9000769,quetiapine (quetiapine fumarate) 25 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93699,Marketed,2020-10-21,02450860,ACH-Quetiapine Fumarate XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02450860,ACH-QUETIAPINE FUMARATE XR (quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet) ACCORD HEALTHCARE INC,Active,9001214,quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93700,Marketed,2020-10-21,02450879,ACH-Quetiapine Fumarate XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02450879,ACH-QUETIAPINE FUMARATE XR (quetiapine (quetiapine fumarate) 150 mg prolonged-release oral tablet) ACCORD HEALTHCARE INC,Active,9001273,quetiapine (quetiapine fumarate) 150 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93701,Marketed,2020-10-21,02450887,ACH-Quetiapine Fumarate XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02450887,ACH-QUETIAPINE FUMARATE XR (quetiapine (quetiapine fumarate) 200 mg prolonged-release oral tablet) ACCORD HEALTHCARE INC,Active,9001211,quetiapine (quetiapine fumarate) 200 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93702,Marketed,2021-01-21,02450895,ACH-Quetiapine Fumarate XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02450895,ACH-QUETIAPINE FUMARATE XR (quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet) ACCORD HEALTHCARE INC,Active,9001212,quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93703,Marketed,2020-10-29,02450909,ACH-Quetiapine Fumarate XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02450909,ACH-QUETIAPINE FUMARATE XR (quetiapine (quetiapine fumarate) 400 mg prolonged-release oral tablet) ACCORD HEALTHCARE INC,Active,9001213,quetiapine (quetiapine fumarate) 400 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94432,Marketed,2026-04-13,02457245,Apo-Quetiapine XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02457245,APO-QUETIAPINE XR (quetiapine (quetiapine fumarate) 200 mg prolonged-release oral tablet) APOTEX INC,Active,9001211,quetiapine (quetiapine fumarate) 200 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94433,Marketed,2020-10-23,02457253,Apo-Quetiapine XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02457253,APO-QUETIAPINE XR (quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet) APOTEX INC,Active,9001212,quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97646,Marketed,2022-11-09,02486237,Nra-Quetiapine,1,N05AH04,Quetiapine,Tablet (immediate release),Oral,02486237,NRA-QUETIAPINE (quetiapine (quetiapine fumarate) 25 mg oral tablet) NORA PHARMA INC,Active,9000769,quetiapine (quetiapine fumarate) 25 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99126,Marketed,2021-07-28,02501643,Apo-Quetiapine Fumarate,1,N05AH04,Quetiapine,Tablet (immediate release),Oral,02501643,APO-QUETIAPINE FUMARATE (quetiapine (quetiapine fumarate) 100 mg oral tablet) APOTEX INC,Active,9000767,quetiapine (quetiapine fumarate) 100 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99987,Marketed,2021-07-20,02510677,Nra-Quetiapine XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02510677,NRA-QUETIAPINE XR (quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet) NORA PHARMA INC,Active,9001214,quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99988,Marketed,2021-07-20,02510685,Nra-Quetiapine XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02510685,NRA-QUETIAPINE XR (quetiapine (quetiapine fumarate) 150 mg prolonged-release oral tablet) NORA PHARMA INC,Active,9001273,quetiapine (quetiapine fumarate) 150 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99989,Marketed,2021-07-20,02510693,Nra-Quetiapine XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02510693,NRA-QUETIAPINE XR (quetiapine (quetiapine fumarate) 200 mg prolonged-release oral tablet) NORA PHARMA INC,Active,9001211,quetiapine (quetiapine fumarate) 200 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99990,Marketed,2021-07-20,02510707,Nra-Quetiapine XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02510707,NRA-QUETIAPINE XR (quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet) NORA PHARMA INC,Active,9001212,quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99991,Marketed,2021-07-20,02510715,Nra-Quetiapine XR,1,N05AH04,Quetiapine,Tablet (extended-release),Oral,02510715,NRA-QUETIAPINE XR (quetiapine (quetiapine fumarate) 400 mg prolonged-release oral tablet) NORA PHARMA INC,Active,9001213,quetiapine (quetiapine fumarate) 400 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100684,Marketed,2023-12-19,02517450,JAMP Quinapril,1,C09AA06,Quinapril,Tablet,Oral,02517450,JAMP QUINAPRIL (quinapril (quinapril hydrochloride) 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000440,quinapril (quinapril hydrochloride) 10 mg oral tablet,8000170,quinapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100685,Marketed,2023-12-19,02517469,JAMP Quinapril,1,C09AA06,Quinapril,Tablet,Oral,02517469,JAMP QUINAPRIL (quinapril (quinapril hydrochloride) 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000441,quinapril (quinapril hydrochloride) 20 mg oral tablet,8000170,quinapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100686,Marketed,2023-12-19,02517477,JAMP Quinapril,1,C09AA06,Quinapril,Tablet,Oral,02517477,JAMP QUINAPRIL (quinapril (quinapril hydrochloride) 40 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000442,quinapril (quinapril hydrochloride) 40 mg oral tablet,8000170,quinapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82614,Marketed,2013-11-18,02340569,PMS-Quinapril,1,C09AA06,Quinapril,Tablet,Oral,02340569,PMS-QUINAPRIL (quinapril (quinapril hydrochloride) 10 mg oral tablet) PHARMASCIENCE INC,Active,9000440,quinapril (quinapril hydrochloride) 10 mg oral tablet,8000170,quinapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82615,Marketed,2013-11-18,02340577,PMS-Quinapril,1,C09AA06,Quinapril,Tablet,Oral,02340577,PMS-QUINAPRIL (quinapril (quinapril hydrochloride) 20 mg oral tablet) PHARMASCIENCE INC,Active,9000441,quinapril (quinapril hydrochloride) 20 mg oral tablet,8000170,quinapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82616,Marketed,2013-11-18,02340585,PMS-Quinapril,1,C09AA06,Quinapril,Tablet,Oral,02340585,PMS-QUINAPRIL (quinapril (quinapril hydrochloride) 40 mg oral tablet) PHARMASCIENCE INC,Active,9000442,quinapril (quinapril hydrochloride) 40 mg oral tablet,8000170,quinapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103639,Marketed,2025-03-18,02547430,JAMP Quinapril / HCTZ,2,C09BA06,Quinapril and diuretics,Tablet,Oral,02547430,JAMP QUINAPRIL / HCTZ (hydrochlorothiazide 12.5 mg and quinapril (quinapril hydrochloride) 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000814,hydrochlorothiazide 12.5 mg and quinapril (quinapril hydrochloride) 10 mg oral tablet,8000262,hydrochlorothiazide and quinapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103640,Marketed,2025-03-18,02547449,JAMP Quinapril / HCTZ,2,C09BA06,Quinapril and diuretics,Tablet,Oral,02547449,JAMP QUINAPRIL / HCTZ (hydrochlorothiazide 25 mg and quinapril (quinapril hydrochloride) 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001030,hydrochlorothiazide 25 mg and quinapril (quinapril hydrochloride) 20 mg oral tablet,8000262,hydrochlorothiazide and quinapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89352,Marketed,2025-06-16,02408767,Apo-Quinapril/HCTZ,2,C09BA06,Quinapril and diuretics,Tablet,Oral,02408767,APO-QUINAPRIL/HCTZ (hydrochlorothiazide 12.5 mg and quinapril (quinapril hydrochloride) 10 mg oral tablet) APOTEX INC,Active,9000814,hydrochlorothiazide 12.5 mg and quinapril (quinapril hydrochloride) 10 mg oral tablet,8000262,hydrochlorothiazide and quinapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89353,Marketed,2025-06-16,02408775,Apo-Quinapril/HCTZ,2,C09BA06,Quinapril and diuretics,Tablet,Oral,02408775,APO-QUINAPRIL/HCTZ (hydrochlorothiazide 12.5 mg and quinapril (quinapril hydrochloride) 20 mg oral tablet) APOTEX INC,Active,9000815,hydrochlorothiazide 12.5 mg and quinapril (quinapril hydrochloride) 20 mg oral tablet,8000262,hydrochlorothiazide and quinapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89354,Marketed,2025-06-16,02408783,Apo-Quinapril/HCTZ,2,C09BA06,Quinapril and diuretics,Tablet,Oral,02408783,APO-QUINAPRIL/HCTZ (hydrochlorothiazide 25 mg and quinapril (quinapril hydrochloride) 20 mg oral tablet) APOTEX INC,Active,9001030,hydrochlorothiazide 25 mg and quinapril (quinapril hydrochloride) 20 mg oral tablet,8000262,hydrochlorothiazide and quinapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96270,Marketed,2019-02-01,02473291,Auro-Quinapril HCTZ,2,C09BA06,Quinapril and diuretics,Tablet,Oral,02473291,AURO-QUINAPRIL HCTZ (hydrochlorothiazide 12.5 mg and quinapril (quinapril hydrochloride) 10 mg oral tablet) AURO PHARMA INC,Active,9000814,hydrochlorothiazide 12.5 mg and quinapril (quinapril hydrochloride) 10 mg oral tablet,8000262,hydrochlorothiazide and quinapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96271,Marketed,2019-02-01,02473305,Auro-Quinapril HCTZ,2,C09BA06,Quinapril and diuretics,Tablet,Oral,02473305,AURO-QUINAPRIL HCTZ (hydrochlorothiazide 12.5 mg and quinapril (quinapril hydrochloride) 20 mg oral tablet) AURO PHARMA INC,Active,9000815,hydrochlorothiazide 12.5 mg and quinapril (quinapril hydrochloride) 20 mg oral tablet,8000262,hydrochlorothiazide and quinapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96273,Marketed,2019-02-01,02473321,Auro-Quinapril HCTZ,2,C09BA06,Quinapril and diuretics,Tablet,Oral,02473321,AURO-QUINAPRIL HCTZ (hydrochlorothiazide 25 mg and quinapril (quinapril hydrochloride) 20 mg oral tablet) AURO PHARMA INC,Active,9001030,hydrochlorothiazide 25 mg and quinapril (quinapril hydrochloride) 20 mg oral tablet,8000262,hydrochlorothiazide and quinapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
290,Marketed,2011-11-26,00021016,Teva-quiNINE,1,P01BC01,Quinine,Capsule,Oral,00021016,TEVA-QUININE (quinine sulfate 300 mg oral capsule) TEVA CANADA LIMITED,Active,9000040,quinine sulfate 300 mg oral capsule,8000029,quinine sulfate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
38056,Marketed,2005-02-10,00695459,quiNINE - Odan,1,P01BC01,Quinine,Capsule,Oral,00695459,QUININE - ODAN (quinine sulfate 300 mg oral capsule) ODAN LABORATORIES LTD,Active,9000040,quinine sulfate 300 mg oral capsule,8000029,quinine sulfate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
651,Marketed,2011-11-26,00021008,Teva-quiNINE,1,P01BC01,Quinine,Capsule,Oral,00021008,TEVA-QUININE (quinine sulfate 200 mg oral capsule) TEVA CANADA LIMITED,Active,9000039,quinine sulfate 200 mg oral capsule,8000029,quinine sulfate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
79680,Marketed,2020-06-22,02311216,Pro-quiNINE - 200,1,P01BC01,Quinine,Capsule,Oral,02311216,PRO-QUININE - 200 (quinine sulfate 200 mg oral capsule) PRO DOC LIMITEE,Active,9000039,quinine sulfate 200 mg oral capsule,8000029,quinine sulfate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
79681,Marketed,2020-05-21,02311224,Pro-quiNINE - 300,1,P01BC01,Quinine,Capsule,Oral,02311224,PRO-QUININE - 300 (quinine sulfate 300 mg oral capsule) PRO DOC LIMITEE,Active,9000040,quinine sulfate 300 mg oral capsule,8000029,quinine sulfate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
106161,Marketed,2025-10-30,02558351,Vanflyta,1,L01EX11,Quizartinib,Tablet,Oral,02558351,VANFLYTA (quizartinib (quizartinib hydrochloride) 17.7 mg oral tablet) DAIICHI SANKYO PHARMA CANADA LIMITED,Active,9015289,quizartinib (quizartinib hydrochloride) 17.7 mg oral tablet,8002560,quizartinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,,Prescription
106162,Marketed,2026-03-30,02558378,Vanflyta,1,L01EX11,Quizartinib,Tablet,Oral,02558378,VANFLYTA (quizartinib (quizartinib hydrochloride) 26.5 mg oral tablet) DAIICHI SANKYO PHARMA CANADA LIMITED,Active,9015405,quizartinib (quizartinib hydrochloride) 26.5 mg oral tablet,8002560,quizartinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,,Prescription
67734,Marketed,2002-04-02,02243796,"Pariet, Enteric-Coated Tablet 10 mg",1,A02BC04,Rabeprazole,Tablet (enteric-coated),Oral,02243796,"PARIET, ENTERIC-COATED TABLET 10MG (rabeprazole sodium 10 mg gastro-resistant tablet) JANSSEN INC",Active,9000980,rabeprazole sodium 10 mg gastro-resistant tablet,8000314,rabeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
67735,Marketed,2002-04-02,02243797,"Pariet, Enteric-Coated Tablet 20 mg",1,A02BC04,Rabeprazole,Tablet (enteric-coated),Oral,02243797,"PARIET, ENTERIC-COATED TABLET 20MG (rabeprazole sodium 20 mg gastro-resistant tablet) JANSSEN INC",Active,9000981,rabeprazole sodium 20 mg gastro-resistant tablet,8000314,rabeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79974,Marketed,2008-07-29,02314177,Sandoz Rabeprazole,1,A02BC04,Rabeprazole,Tablet (enteric-coated),Oral,02314177,SANDOZ RABEPRAZOLE (rabeprazole sodium 10 mg gastro-resistant tablet) SANDOZ CANADA INCORPORATED,Active,9000980,rabeprazole sodium 10 mg gastro-resistant tablet,8000314,rabeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79975,Marketed,2008-07-29,02314185,Sandoz Rabeprazole,1,A02BC04,Rabeprazole,Tablet (enteric-coated),Oral,02314185,SANDOZ RABEPRAZOLE (rabeprazole sodium 20 mg gastro-resistant tablet) SANDOZ CANADA INCORPORATED,Active,9000981,rabeprazole sodium 20 mg gastro-resistant tablet,8000314,rabeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84166,Marketed,2019-05-30,02356511,Rabeprazole EC,1,A02BC04,Rabeprazole,Tablet (enteric-coated),Oral,02356511,RABEPRAZOLE EC (rabeprazole sodium 10 mg gastro-resistant tablet) SANIS HEALTH INC,Active,9000980,rabeprazole sodium 10 mg gastro-resistant tablet,8000314,rabeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84167,Marketed,2019-05-30,02356538,Rabeprazole EC,1,A02BC04,Rabeprazole,Tablet (enteric-coated),Oral,02356538,RABEPRAZOLE EC (rabeprazole sodium 20 mg gastro-resistant tablet) SANIS HEALTH INC,Active,9000981,rabeprazole sodium 20 mg gastro-resistant tablet,8000314,rabeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87107,Marketed,2012-06-10,02385449,Rabeprazole,1,A02BC04,Rabeprazole,Tablet (enteric-coated),Oral,02385449,RABEPRAZOLE (rabeprazole sodium 10 mg gastro-resistant tablet) SIVEM PHARMACEUTICALS ULC,Active,9000980,rabeprazole sodium 10 mg gastro-resistant tablet,8000314,rabeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87108,Marketed,2012-06-10,02385457,Rabeprazole,1,A02BC04,Rabeprazole,Tablet (enteric-coated),Oral,02385457,RABEPRAZOLE (rabeprazole sodium 20 mg gastro-resistant tablet) SIVEM PHARMACEUTICALS ULC,Active,9000981,rabeprazole sodium 20 mg gastro-resistant tablet,8000314,rabeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97288,Marketed,2020-04-06,02482436,Kamrab,1,J06BB05,Rabies immunoglobulin,Solution,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
97677,Marketed,2019-07-02,02486571,Hyperrab,1,J06BB05,Rabies immunoglobulin,Solution,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
46832,Marketed,2006-04-12,01908286,Imovax Rabies,1,J07BG01,"Rabies, inactivated, whole virus",Powder for suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
75308,Marketed,2021-01-14,02267667,Rabavert,1,J07BG01,"Rabies, inactivated, whole virus",Powder for solution,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
90297,Marketed,2018-07-26,02418398,Xofigo,1,V10XX03,Radium (223ra) dichloride,Solution,Intravenous,,,,,,,,,,,,,,,,,Schedule C
102937,Marketed,2024-06-28,02540681,JAMP Raloxifene,1,G03XC01,Raloxifene,Tablet,Oral,02540681,JAMP RALOXIFENE (raloxifene hydrochloride 60 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003333,raloxifene hydrochloride 60 mg oral tablet,8001682,raloxifene,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
76475,Marketed,2009-03-31,02279215,Apo-Raloxifene,1,G03XC01,Raloxifene,Tablet,Oral,02279215,APO-RALOXIFENE (raloxifene hydrochloride 60 mg oral tablet) APOTEX INC,Active,9003333,raloxifene hydrochloride 60 mg oral tablet,8001682,raloxifene,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
84388,Marketed,2020-04-16,02358840,Act Raloxifene,1,G03XC01,Raloxifene,Tablet,Oral,02358840,ACT RALOXIFENE (raloxifene hydrochloride 60 mg oral tablet) TEVA CANADA LIMITED,Active,9003333,raloxifene hydrochloride 60 mg oral tablet,8001682,raloxifene,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
78722,Marketed,2009-03-05,02301881,Isentress,1,J05AJ01,Raltegravir,Tablet,Oral,02301881,ISENTRESS (raltegravir (raltegravir potassium) 400 mg oral tablet) MERCK CANADA INC,Active,9004356,raltegravir (raltegravir potassium) 400 mg oral tablet,8001224,raltegravir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95353,Marketed,2017-09-11,02465337,Isentress HD,1,J05AJ01,Raltegravir,Tablet,Oral,02465337,ISENTRESS HD (raltegravir (raltegravir potassium) 600 mg oral tablet) MERCK CANADA INC,Active,9012590,raltegravir (raltegravir potassium) 600 mg oral tablet,8001224,raltegravir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
47482,Marketed,2021-12-08,02229566,Tomudex,1,L01BA03,Raltitrexed,Powder for solution,Intravenous,02229566,TOMUDEX (raltitrexed 2 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9014637,raltitrexed 2 mg per vial powder for solution for injection,8001225,raltitrexed,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
103904,Marketed,2025-10-03,02550202,PMSC-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02550202,PMSC-RAMIPRIL (ramipril 1.25 mg oral capsule) PHARMASCIENCE INC,Active,9000727,ramipril 1.25 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
103905,Marketed,2025-10-03,02550210,PMSC-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02550210,PMSC-RAMIPRIL (ramipril 2.5 mg oral capsule) PHARMASCIENCE INC,Active,9000722,ramipril 2.5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
103906,Marketed,2025-10-03,02550229,PMSC-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02550229,PMSC-RAMIPRIL (ramipril 5 mg oral capsule) PHARMASCIENCE INC,Active,9000723,ramipril 5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
103907,Marketed,2025-10-03,02550237,PMSC-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02550237,PMSC-RAMIPRIL (ramipril 10 mg oral capsule) PHARMASCIENCE INC,Active,9000712,ramipril 10 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
43308,Marketed,2021-01-11,02221829,Altace,1,C09AA05,Ramipril,Capsule,Oral,02221829,"ALTACE (ramipril 1.25 mg oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9000727,ramipril 1.25 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
43309,Marketed,2021-01-11,02221837,Altace,1,C09AA05,Ramipril,Capsule,Oral,02221837,"ALTACE (ramipril 2.5 mg oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9000722,ramipril 2.5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
43310,Marketed,2021-01-11,02221845,Altace,1,C09AA05,Ramipril,Capsule,Oral,02221845,"ALTACE (ramipril 5 mg oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9000723,ramipril 5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
43311,Marketed,2021-01-11,02221853,Altace,1,C09AA05,Ramipril,Capsule,Oral,02221853,"ALTACE (ramipril 10 mg oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9000712,ramipril 10 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
72255,Marketed,2010-05-27,02247945,Teva-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02247945,TEVA-RAMIPRIL (ramipril 2.5 mg oral capsule) TEVA CANADA LIMITED,Active,9000722,ramipril 2.5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
72256,Marketed,2010-05-27,02247946,Teva-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02247946,TEVA-RAMIPRIL (ramipril 5 mg oral capsule) TEVA CANADA LIMITED,Active,9000723,ramipril 5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
72257,Marketed,2010-05-27,02247947,Teva-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02247947,TEVA-RAMIPRIL (ramipril 10 mg oral capsule) TEVA CANADA LIMITED,Active,9000712,ramipril 10 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
73644,Marketed,2006-12-12,02251515,Apo-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02251515,APO-RAMIPRIL (ramipril 1.25 mg oral capsule) APOTEX INC,Active,9000727,ramipril 1.25 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
73646,Marketed,2006-12-12,02251531,Apo-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02251531,APO-RAMIPRIL (ramipril 2.5 mg oral capsule) APOTEX INC,Active,9000722,ramipril 2.5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
73648,Marketed,2006-12-12,02251574,Apo-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02251574,APO-RAMIPRIL (ramipril 5 mg oral capsule) APOTEX INC,Active,9000723,ramipril 5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
73650,Marketed,2006-12-12,02251582,Apo-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02251582,APO-RAMIPRIL (ramipril 10 mg oral capsule) APOTEX INC,Active,9000712,ramipril 10 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
74047,Marketed,2017-11-13,02255316,Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02255316,RAMIPRIL (ramipril 2.5 mg oral capsule) LABORATOIRE RIVA INC.,Active,9000722,ramipril 2.5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
74048,Marketed,2017-11-03,02255324,Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02255324,RAMIPRIL (ramipril 5 mg oral capsule) LABORATOIRE RIVA INC.,Active,9000723,ramipril 5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
74051,Marketed,2017-11-03,02255332,Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02255332,RAMIPRIL (ramipril 10 mg oral capsule) LABORATOIRE RIVA INC.,Active,9000712,ramipril 10 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
77332,Marketed,2018-04-26,02287927,Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02287927,RAMIPRIL (ramipril 2.5 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000722,ramipril 2.5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
77334,Marketed,2018-04-26,02287935,Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02287935,RAMIPRIL (ramipril 5 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000723,ramipril 5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
77335,Marketed,2018-04-26,02287943,Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02287943,RAMIPRIL (ramipril 10 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000712,ramipril 10 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
79402,Marketed,2018-04-26,02308363,Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02308363,RAMIPRIL (ramipril 1.25 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000727,ramipril 1.25 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
79569,Marketed,2011-11-25,02310023,Pro-Ramipril - 1.25,1,C09AA05,Ramipril,Capsule,Oral,02310023,PRO-RAMIPRIL - 1.25 (ramipril 1.25 mg oral capsule) PRO DOC LIMITEE,Active,9000727,ramipril 1.25 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
79571,Marketed,2011-11-25,02310066,Pro-Ramipril - 2.5,1,C09AA05,Ramipril,Capsule,Oral,02310066,PRO-RAMIPRIL - 2.5 (ramipril 2.5 mg oral capsule) PRO DOC LIMITEE,Active,9000722,ramipril 2.5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
79574,Marketed,2011-11-25,02310074,Pro-Ramipril - 5,1,C09AA05,Ramipril,Capsule,Oral,02310074,PRO-RAMIPRIL - 5 (ramipril 5 mg oral capsule) PRO DOC LIMITEE,Active,9000723,ramipril 5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
79575,Marketed,2011-11-25,02310104,Pro-Ramipril - 10,1,C09AA05,Ramipril,Capsule,Oral,02310104,PRO-RAMIPRIL - 10 (ramipril 10 mg oral capsule) PRO DOC LIMITEE,Active,9000712,ramipril 10 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
79613,Marketed,2020-02-10,02310503,Taro-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02310503,TARO-RAMIPRIL (ramipril 1.25 mg oral capsule) SUN PHARMA CANADA INC,Active,9000727,ramipril 1.25 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
79614,Marketed,2020-02-10,02310511,Taro-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02310511,TARO-RAMIPRIL (ramipril 2.5 mg oral capsule) SUN PHARMA CANADA INC,Active,9000722,ramipril 2.5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
79615,Marketed,2020-02-04,02310538,Taro-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02310538,TARO-RAMIPRIL (ramipril 5 mg oral capsule) SUN PHARMA CANADA INC,Active,9000723,ramipril 5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
79616,Marketed,2020-02-04,02310546,Taro-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02310546,TARO-RAMIPRIL (ramipril 10 mg oral capsule) SUN PHARMA CANADA INC,Active,9000712,ramipril 10 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
81078,Marketed,2009-05-01,02325381,Apo-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02325381,APO-RAMIPRIL (ramipril 15 mg oral capsule) APOTEX INC,Active,9001172,ramipril 15 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
81684,Marketed,2015-09-01,02331128,JAMP-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02331128,JAMP-RAMIPRIL (ramipril 2.5 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000722,ramipril 2.5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
81685,Marketed,2015-09-01,02331136,JAMP-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02331136,JAMP-RAMIPRIL (ramipril 5 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000723,ramipril 5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
81686,Marketed,2015-09-01,02331144,JAMP-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02331144,JAMP-RAMIPRIL (ramipril 10 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000712,ramipril 10 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
86019,Marketed,2016-01-06,02374846,Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02374846,RAMIPRIL (ramipril 2.5 mg oral capsule) SANIS HEALTH INC,Active,9000722,ramipril 2.5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
86020,Marketed,2016-01-06,02374854,Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02374854,RAMIPRIL (ramipril 5 mg oral capsule) SANIS HEALTH INC,Active,9000723,ramipril 5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
86021,Marketed,2016-01-06,02374862,Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02374862,RAMIPRIL (ramipril 10 mg oral capsule) SANIS HEALTH INC,Active,9000712,ramipril 10 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87297,Marketed,2012-09-13,02387387,Auro-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02387387,AURO-RAMIPRIL (ramipril 1.25 mg oral capsule) AURO PHARMA INC,Active,9000727,ramipril 1.25 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87298,Marketed,2012-09-13,02387395,Auro-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02387395,AURO-RAMIPRIL (ramipril 2.5 mg oral capsule) AURO PHARMA INC,Active,9000722,ramipril 2.5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87299,Marketed,2012-09-13,02387409,Auro-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02387409,AURO-RAMIPRIL (ramipril 5 mg oral capsule) AURO PHARMA INC,Active,9000723,ramipril 5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87300,Marketed,2012-09-13,02387417,Auro-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02387417,AURO-RAMIPRIL (ramipril 10 mg oral capsule) AURO PHARMA INC,Active,9000712,ramipril 10 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90505,Marketed,2015-01-09,02420465,Mar-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02420465,MAR-RAMIPRIL (ramipril 2.5 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000722,ramipril 2.5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90506,Marketed,2015-01-09,02420473,Mar-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02420473,MAR-RAMIPRIL (ramipril 5 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000723,ramipril 5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90507,Marketed,2015-01-09,02420481,Mar-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02420481,MAR-RAMIPRIL (ramipril 10 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000712,ramipril 10 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90508,Marketed,2014-09-10,02420503,Mar-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02420503,MAR-RAMIPRIL (ramipril 15 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9001172,ramipril 15 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90594,Marketed,2014-03-17,02421305,Mint-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02421305,MINT-RAMIPRIL (ramipril 2.5 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9000722,ramipril 2.5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90595,Marketed,2014-03-17,02421313,Mint-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02421313,MINT-RAMIPRIL (ramipril 5 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9000723,ramipril 5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90596,Marketed,2014-03-17,02421321,Mint-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02421321,MINT-RAMIPRIL (ramipril 10 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9000712,ramipril 10 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95770,Marketed,2018-04-16,02469057,Pharma-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02469057,PHARMA-RAMIPRIL (ramipril 1.25 mg oral capsule) PHARMASCIENCE INC,Active,9000727,ramipril 1.25 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95771,Marketed,2018-04-16,02469065,Pharma-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02469065,PHARMA-RAMIPRIL (ramipril 2.5 mg oral capsule) PHARMASCIENCE INC,Active,9000722,ramipril 2.5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95772,Marketed,2018-04-16,02469073,Pharma-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02469073,PHARMA-RAMIPRIL (ramipril 5 mg oral capsule) PHARMASCIENCE INC,Active,9000723,ramipril 5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95773,Marketed,2018-04-16,02469081,Pharma-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02469081,PHARMA-RAMIPRIL (ramipril 10 mg oral capsule) PHARMASCIENCE INC,Active,9000712,ramipril 10 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96784,Marketed,2018-09-06,02477572,AG-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02477572,AG-RAMIPRIL (ramipril 2.5 mg oral capsule) ANGITA PHARMA INC.,Active,9000722,ramipril 2.5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96785,Marketed,2018-09-06,02477580,AG-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02477580,AG-RAMIPRIL (ramipril 5 mg oral capsule) ANGITA PHARMA INC.,Active,9000723,ramipril 5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96786,Marketed,2018-09-06,02477599,AG-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02477599,AG-RAMIPRIL (ramipril 10 mg oral capsule) ANGITA PHARMA INC.,Active,9000712,ramipril 10 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97640,Marketed,2019-09-20,02486172,Nra-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02486172,NRA-RAMIPRIL (ramipril 2.5 mg oral capsule) NORA PHARMA INC,Active,9000722,ramipril 2.5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97641,Marketed,2019-09-20,02486180,Nra-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02486180,NRA-RAMIPRIL (ramipril 5 mg oral capsule) NORA PHARMA INC,Active,9000723,ramipril 5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97642,Marketed,2019-09-20,02486199,Nra-Ramipril,1,C09AA05,Ramipril,Capsule,Oral,02486199,NRA-RAMIPRIL (ramipril 10 mg oral capsule) NORA PHARMA INC,Active,9000712,ramipril 10 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
76877,Marketed,2025-08-01,02283158,Altace HCTZ,2,C09BA05,Ramipril and diuretics,Tablet,Oral,02283158,"ALTACE HCT (hydrochlorothiazide 12.5 mg and ramipril 5 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9001178,hydrochlorothiazide 12.5 mg and ramipril 5 mg oral tablet,8000368,hydrochlorothiazide and ramipril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76878,Marketed,2021-03-03,02283166,Altace HCTZ,2,C09BA05,Ramipril and diuretics,Tablet,Oral,02283166,"ALTACE HCT (hydrochlorothiazide 12.5 mg and ramipril 10 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9001176,hydrochlorothiazide 12.5 mg and ramipril 10 mg oral tablet,8000368,hydrochlorothiazide and ramipril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82765,Marketed,2010-02-03,02342154,PMS-Ramipril-HCTZ,2,C09BA05,Ramipril and diuretics,Tablet,Oral,02342154,PMS-RAMIPRIL-HCTZ (hydrochlorothiazide 12.5 mg and ramipril 10 mg oral tablet) PHARMASCIENCE INC,Active,9001176,hydrochlorothiazide 12.5 mg and ramipril 10 mg oral tablet,8000368,hydrochlorothiazide and ramipril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82767,Marketed,2010-02-03,02342170,PMS-Ramipril-HCTZ,2,C09BA05,Ramipril and diuretics,Tablet,Oral,02342170,PMS-RAMIPRIL-HCTZ (hydrochlorothiazide 25 mg and ramipril 10 mg oral tablet) PHARMASCIENCE INC,Active,9001179,hydrochlorothiazide 25 mg and ramipril 10 mg oral tablet,8000368,hydrochlorothiazide and ramipril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93527,Marketed,2023-11-04,02449439,Taro-Ramipril HCTZ,2,C09BA05,Ramipril and diuretics,Tablet,Oral,02449439,TARO-RAMIPRIL HCTZ (hydrochlorothiazide 12.5 mg and ramipril 2.5 mg oral tablet) SUN PHARMA CANADA INC,Active,9001177,hydrochlorothiazide 12.5 mg and ramipril 2.5 mg oral tablet,8000368,hydrochlorothiazide and ramipril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93528,Marketed,2023-12-12,02449447,Taro-Ramipril HCTZ,2,C09BA05,Ramipril and diuretics,Tablet,Oral,02449447,TARO-RAMIPRIL HCTZ (hydrochlorothiazide 12.5 mg and ramipril 5 mg oral tablet) SUN PHARMA CANADA INC,Active,9001178,hydrochlorothiazide 12.5 mg and ramipril 5 mg oral tablet,8000368,hydrochlorothiazide and ramipril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93529,Marketed,2023-12-12,02449455,Taro-Ramipril HCTZ,2,C09BA05,Ramipril and diuretics,Tablet,Oral,02449455,TARO-RAMIPRIL HCTZ (hydrochlorothiazide 12.5 mg and ramipril 10 mg oral tablet) SUN PHARMA CANADA INC,Active,9001176,hydrochlorothiazide 12.5 mg and ramipril 10 mg oral tablet,8000368,hydrochlorothiazide and ramipril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93530,Marketed,2023-12-12,02449463,Taro-Ramipril HCTZ,2,C09BA05,Ramipril and diuretics,Tablet,Oral,02449463,TARO-RAMIPRIL HCTZ (hydrochlorothiazide 25 mg and ramipril 5 mg oral tablet) SUN PHARMA CANADA INC,Active,9001180,hydrochlorothiazide 25 mg and ramipril 5 mg oral tablet,8000368,hydrochlorothiazide and ramipril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93531,Marketed,2023-11-04,02449471,Taro-Ramipril HCTZ,2,C09BA05,Ramipril and diuretics,Tablet,Oral,02449471,TARO-RAMIPRIL HCTZ (hydrochlorothiazide 25 mg and ramipril 10 mg oral tablet) SUN PHARMA CANADA INC,Active,9001179,hydrochlorothiazide 25 mg and ramipril 10 mg oral tablet,8000368,hydrochlorothiazide and ramipril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92855,Marketed,2015-09-10,02443805,Cyramza,1,L01FG02,Ramucirumab,Solution,Intravenous,77700903,CYRAMZA (ramucirumab 100 mg per 10 mL solution for injection vial) ELI LILLY CANADA INC,Active,9013316,ramucirumab 100 mg per 10 mL solution for injection vial,8001917,ramucirumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
92855,Marketed,2015-09-10,02443805,Cyramza,1,L01FG02,Ramucirumab,Solution,Intravenous,77700904,CYRAMZA (ramucirumab 500 mg per 50 mL solution for injection vial) ELI LILLY CANADA INC,Active,9013317,ramucirumab 500 mg per 50 mL solution for injection vial,8001917,ramucirumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
92855,Marketed,2015-09-10,02443805,Cyramza,1,L01FG02,Ramucirumab,Solution,Intravenous,77700903,CYRAMZA (ramucirumab 100 mg per 10 mL solution for injection vial) ELI LILLY CANADA INC,Active,9013316,ramucirumab 100 mg per 10 mL solution for injection vial,8001917,ramucirumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
92855,Marketed,2015-09-10,02443805,Cyramza,1,L01FG02,Ramucirumab,Solution,Intravenous,77700904,CYRAMZA (ramucirumab 500 mg per 50 mL solution for injection vial) ELI LILLY CANADA INC,Active,9013317,ramucirumab 500 mg per 50 mL solution for injection vial,8001917,ramucirumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
101483,Marketed,2025-11-07,02525852,Melvizo,1,S01LA04,Ranibizumab,Solution,Intravitreal,02525852,"MELVIZO (ranibizumab 10 mg per mL solution for injection 0.23 mL vial) SAMSUNG BIOEPIS CO., LTD",Active,9012754,ranibizumab 10 mg per mL solution for injection 0.23 mL vial,8001303,ranibizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
101483,Marketed,2025-11-07,02525852,Melvizo,1,S01LA04,Ranibizumab,Solution,Intravitreal,02525852,"MELVIZO (ranibizumab 10 mg per mL solution for injection 0.23 mL vial) SAMSUNG BIOEPIS CO., LTD",Active,9012754,ranibizumab 10 mg per mL solution for injection 0.23 mL vial,8001303,ranibizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
103083,Marketed,2024-02-26,02542250,Ranopto,1,S01LA04,Ranibizumab,Solution,Intravitreal,02542250,RANOPTO (ranibizumab 10 mg per mL solution for injection 0.23 mL vial) TEVA CANADA LIMITED,Active,9012754,ranibizumab 10 mg per mL solution for injection 0.23 mL vial,8001303,ranibizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
103083,Marketed,2024-02-26,02542250,Ranopto,1,S01LA04,Ranibizumab,Solution,Intravitreal,02542250,RANOPTO (ranibizumab 10 mg per mL solution for injection 0.23 mL vial) TEVA CANADA LIMITED,Active,9012754,ranibizumab 10 mg per mL solution for injection 0.23 mL vial,8001303,ranibizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
78217,Marketed,2014-05-29,02296810,Lucentis,1,S01LA04,Ranibizumab,Solution,Intravitreal,02296810,LUCENTIS (ranibizumab 10 mg per mL solution for injection 0.23 mL vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012754,ranibizumab 10 mg per mL solution for injection 0.23 mL vial,8001303,ranibizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
78217,Marketed,2014-05-29,02296810,Lucentis,1,S01LA04,Ranibizumab,Solution,Intravitreal,02296810,LUCENTIS (ranibizumab 10 mg per mL solution for injection 0.23 mL vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012754,ranibizumab 10 mg per mL solution for injection 0.23 mL vial,8001303,ranibizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
91026,Marketed,2014-09-18,02425629,Lucentis,1,S01LA04,Ranibizumab,Solution,Intravitreal,02425629,LUCENTIS (ranibizumab 10 mg per mL solution for injection 0.165 mL syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012753,ranibizumab 10 mg per mL solution for injection 0.165 mL syringe,8001303,ranibizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
91026,Marketed,2014-09-18,02425629,Lucentis,1,S01LA04,Ranibizumab,Solution,Intravitreal,02425629,LUCENTIS (ranibizumab 10 mg per mL solution for injection 0.165 mL syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012753,ranibizumab 10 mg per mL solution for injection 0.165 mL syringe,8001303,ranibizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
101547,Marketed,2022-10-07,02526379,Mint-Ranitidine,1,A02BA02,Ranitidine,Tablet,Oral,02526379,MINT-RANITIDINE (ranitidine (ranitidine hydrochloride) 150 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000282,ranitidine (ranitidine hydrochloride) 150 mg oral tablet,8000120,ranitidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101548,Marketed,2022-10-07,02526387,Mint-Ranitidine,1,A02BA02,Ranitidine,Tablet,Oral,02526387,MINT-RANITIDINE (ranitidine (ranitidine hydrochloride) 300 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000283,ranitidine (ranitidine hydrochloride) 300 mg oral tablet,8000120,ranitidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77884,Marketed,2024-08-01,02293471,Maximum Strength Acid Reducer Without Prescription,1,A02BA02,Ranitidine,Tablet,Oral,02293471,MAXIMUM STRENGTH ACID REDUCER WITHOUT PRESCRIPTION (ranitidine (ranitidine hydrochloride) 150 mg oral tablet) PHARMASCIENCE INC,Active,9000282,ranitidine (ranitidine hydrochloride) 150 mg oral tablet,8000120,ranitidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
92844,Marketed,2018-11-09,02443708,Mar-Ranitidine,1,A02BA02,Ranitidine,Tablet,Oral,02443708,MAR-RANITIDINE (ranitidine (ranitidine hydrochloride) 150 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000282,ranitidine (ranitidine hydrochloride) 150 mg oral tablet,8000120,ranitidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92845,Marketed,2018-11-09,02443716,Mar-Ranitidine,1,A02BA02,Ranitidine,Tablet,Oral,02443716,MAR-RANITIDINE (ranitidine (ranitidine hydrochloride) 300 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000283,ranitidine (ranitidine hydrochloride) 300 mg oral tablet,8000120,ranitidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106532,Marketed,2026-05-06,02562448,Mar-Ranolazine XR,1,C01EB18,Ranolazine,Tablet (extended-release),Oral,02562448,MAR-RANOLAZINE XR (ranolazine 500 mg prolonged-release oral tablet) MARCAN PHARMACEUTICALS INC,Active,9014539,ranolazine 500 mg prolonged-release oral tablet,8002371,ranolazine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99945,Marketed,2021-05-03,02510219,Corzyna,1,C01EB18,Ranolazine,Tablet (extended-release),Oral,02510219,CORZYNA (ranolazine 500 mg prolonged-release oral tablet) KYE PHARMACEUTICALS INC.,Active,9014539,ranolazine 500 mg prolonged-release oral tablet,8002371,ranolazine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99946,Marketed,2023-05-24,02510227,Corzyna,1,C01EB18,Ranolazine,Tablet (extended-release),Oral,02510227,CORZYNA (ranolazine 1000 mg prolonged-release oral tablet) KYE PHARMACEUTICALS INC.,Active,9014855,ranolazine 1000 mg prolonged-release oral tablet,8002371,ranolazine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77019,Marketed,2021-06-03,02284642,Azilect,1,N04BD02,Rasagiline,Tablet,Oral,02284642,AZILECT (rasagiline (rasagiline mesylate) 0.5 mg oral tablet) TEVA CANADA LIMITED,Active,9004213,rasagiline (rasagiline mesylate) 0.5 mg oral tablet,8001683,rasagiline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
77020,Marketed,2021-06-03,02284650,Azilect,1,N04BD02,Rasagiline,Tablet,Oral,02284650,AZILECT (rasagiline (rasagiline mesylate) 1 mg oral tablet) TEVA CANADA LIMITED,Active,9004214,rasagiline (rasagiline mesylate) 1 mg oral tablet,8001683,rasagiline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
88948,Marketed,2016-01-12,02404680,Apo-Rasagiline,1,N04BD02,Rasagiline,Tablet,Oral,02404680,APO-RASAGILINE (rasagiline (rasagiline mesylate) 0.5 mg oral tablet) APOTEX INC,Active,9004213,rasagiline (rasagiline mesylate) 0.5 mg oral tablet,8001683,rasagiline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
88949,Marketed,2016-01-12,02404699,Apo-Rasagiline,1,N04BD02,Rasagiline,Tablet,Oral,02404699,APO-RASAGILINE (rasagiline (rasagiline mesylate) 1 mg oral tablet) APOTEX INC,Active,9004214,rasagiline (rasagiline mesylate) 1 mg oral tablet,8001683,rasagiline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
90300,Marketed,2016-05-30,02418436,Teva-Rasagiline,1,N04BD02,Rasagiline,Tablet,Oral,02418436,TEVA-RASAGILINE (rasagiline (rasagiline mesylate) 0.5 mg oral tablet) TEVA CANADA LIMITED,Active,9004213,rasagiline (rasagiline mesylate) 0.5 mg oral tablet,8001683,rasagiline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
90301,Marketed,2016-05-30,02418444,Teva-Rasagiline,1,N04BD02,Rasagiline,Tablet,Oral,02418444,TEVA-RASAGILINE (rasagiline (rasagiline mesylate) 1 mg oral tablet) TEVA CANADA LIMITED,Active,9004214,rasagiline (rasagiline mesylate) 1 mg oral tablet,8001683,rasagiline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98198,Marketed,2020-09-04,02491974,JAMP Rasagiline,1,N04BD02,Rasagiline,Tablet,Oral,02491974,JAMP RASAGILINE (rasagiline (rasagiline mesylate) 0.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004213,rasagiline (rasagiline mesylate) 0.5 mg oral tablet,8001683,rasagiline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98199,Marketed,2020-09-04,02491982,JAMP Rasagiline,1,N04BD02,Rasagiline,Tablet,Oral,02491982,JAMP RASAGILINE (rasagiline (rasagiline mesylate) 1 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004214,rasagiline (rasagiline mesylate) 1 mg oral tablet,8001683,rasagiline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
72766,Marketed,2006-11-03,02248416,Fasturtec,1,V03AF07,Rasburicase,Powder for solution,Intravenous,02248416,FASTURTEC (rasburicase 1.5 mg per vial powder for solution for injection with diluent solution) SANOFI-AVENTIS CANADA INC,Active,9013318,rasburicase 1.5 mg per vial powder for solution for injection with diluent solution,8001918,rasburicase,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
72766,Marketed,2006-11-03,02248416,Fasturtec,1,V03AF07,Rasburicase,Powder for solution,Intravenous,02248416,FASTURTEC (rasburicase 1.5 mg per vial powder for solution for injection with diluent solution) SANOFI-AVENTIS CANADA INC,Active,9013318,rasburicase 1.5 mg per vial powder for solution for injection with diluent solution,8001918,rasburicase,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
102243,Marketed,2023-04-19,02533448,Ultomiris,1,L04AJ02,Ravulizumab,Solution,Intravenous,02533448,ULTOMIRIS (ravulizumab 300 mg per 3 mL solution for injection vial) ALEXION PHARMA GMBH,Active,9014857,ravulizumab 300 mg per 3 mL solution for injection vial,8002392,ravulizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
102243,Marketed,2023-04-19,02533448,Ultomiris,1,L04AJ02,Ravulizumab,Solution,Intravenous,02533448,ULTOMIRIS (ravulizumab 300 mg per 3 mL solution for injection vial) ALEXION PHARMA GMBH,Active,9014857,ravulizumab 300 mg per 3 mL solution for injection vial,8002392,ravulizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
102244,Marketed,2023-04-19,02533456,Ultomiris,1,L04AJ02,Ravulizumab,Solution,Intravenous,02533456,ULTOMIRIS (ravulizumab 1100 mg per 11 mL solution for injection vial) ALEXION PHARMA GMBH,Active,9014856,ravulizumab 1100 mg per 11 mL solution for injection vial,8002392,ravulizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
102244,Marketed,2023-04-19,02533456,Ultomiris,1,L04AJ02,Ravulizumab,Solution,Intravenous,02533456,ULTOMIRIS (ravulizumab 1100 mg per 11 mL solution for injection vial) ALEXION PHARMA GMBH,Active,9014856,ravulizumab 1100 mg per 11 mL solution for injection vial,8002392,ravulizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
88820,Marketed,2013-04-02,02403390,Stivarga,1,L01EX05,Regorafenib,Tablet,Oral,02403390,STIVARGA (regorafenib 40 mg oral tablet) BAYER INC,Active,9005215,regorafenib 40 mg oral tablet,8001919,regorafenib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
103073,Marketed,2025-11-05,02542137,Orgovyx,1,L02BX04,Relugolix,Tablet,Oral,02542137,ORGOVYX (relugolix 120 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9015006,relugolix 120 mg oral tablet,8002495,relugolix,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
103029,Marketed,2025-10-28,02541742,Myfembree,3,H01CC54,"Relugolix, estradiol and norethisterone",Tablet,Oral,02541742,MYFEMBREE (estradiol 1 mg and norethindrone acetate 0.5 mg and relugolix 40 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9015016,estradiol 1 mg and norethindrone acetate 0.5 mg and relugolix 40 mg oral tablet,8002499,estradiol and norethindrone and relugolix,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99173,Marketed,2020-10-16,02502143,Veklury,1,J05AB16,Remdesivir,Powder for solution,Intravenous,02502143,VEKLURY (remdesivir 100 mg per vial powder for solution for injection) GILEAD SCIENCES CANADA INC,Active,9014406,remdesivir 100 mg per vial powder for solution for injection,8002350,remdesivir,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
85131,Marketed,2011-09-27,02366460,Remifentanil Hydrochloride For Injection,1,N01AH06,Remifentanil,Powder for solution,Intravenous,02366460,REMIFENTANIL HYDROCHLORIDE FOR INJECTION (remifentanil (remifentanil hydrochloride) 1 mg per vial powder for solution for injection) STERIMAX INC,Active,9004933,remifentanil (remifentanil hydrochloride) 1 mg per vial powder for solution for injection,8001920,remifentanil,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Narcotics (CDSA I)
85132,Marketed,2011-09-29,02366479,Remifentanil Hydrochloride For Injection,1,N01AH06,Remifentanil,Powder for solution,Intravenous,02366479,REMIFENTANIL HYDROCHLORIDE FOR INJECTION (remifentanil (remifentanil hydrochloride) 2 mg per vial powder for solution for injection) STERIMAX INC,Active,9004935,remifentanil (remifentanil hydrochloride) 2 mg per vial powder for solution for injection,8001920,remifentanil,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Narcotics (CDSA I)
84011,Marketed,2023-03-07,02354926,JAMP Repaglinide,1,A10BX02,Repaglinide,Tablet,Oral,02354926,JAMP REPAGLINIDE (repaglinide 0.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000856,repaglinide 0.5 mg oral tablet,8000273,repaglinide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84012,Marketed,2023-03-07,02354934,JAMP Repaglinide,1,A10BX02,Repaglinide,Tablet,Oral,02354934,JAMP REPAGLINIDE (repaglinide 1 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000857,repaglinide 1 mg oral tablet,8000273,repaglinide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84013,Marketed,2023-03-07,02354942,JAMP Repaglinide,1,A10BX02,Repaglinide,Tablet,Oral,02354942,JAMP REPAGLINIDE (repaglinide 2 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000858,repaglinide 2 mg oral tablet,8000273,repaglinide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84259,Marketed,2011-02-17,02357453,Sandoz Repaglinide,1,A10BX02,Repaglinide,Tablet,Oral,02357453,SANDOZ REPAGLINIDE (repaglinide 0.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000856,repaglinide 0.5 mg oral tablet,8000273,repaglinide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84260,Marketed,2011-02-17,02357461,Sandoz Repaglinide,1,A10BX02,Repaglinide,Tablet,Oral,02357461,SANDOZ REPAGLINIDE (repaglinide 1 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000857,repaglinide 1 mg oral tablet,8000273,repaglinide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84261,Marketed,2011-02-17,02357488,Sandoz Repaglinide,1,A10BX02,Repaglinide,Tablet,Oral,02357488,SANDOZ REPAGLINIDE (repaglinide 2 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000858,repaglinide 2 mg oral tablet,8000273,repaglinide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90056,Marketed,2016-12-16,02415968,Repaglinide,1,A10BX02,Repaglinide,Tablet,Oral,02415968,REPAGLINIDE (repaglinide 0.5 mg oral tablet) PRO DOC LIMITEE,Active,9000856,repaglinide 0.5 mg oral tablet,8000273,repaglinide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90057,Marketed,2016-12-16,02415976,Repaglinide,1,A10BX02,Repaglinide,Tablet,Oral,02415976,REPAGLINIDE (repaglinide 1 mg oral tablet) PRO DOC LIMITEE,Active,9000857,repaglinide 1 mg oral tablet,8000273,repaglinide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90058,Marketed,2016-12-16,02415984,Repaglinide,1,A10BX02,Repaglinide,Tablet,Oral,02415984,REPAGLINIDE (repaglinide 2 mg oral tablet) PRO DOC LIMITEE,Active,9000858,repaglinide 2 mg oral tablet,8000273,repaglinide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90896,Marketed,2014-04-30,02424258,Auro-Repaglinide,1,A10BX02,Repaglinide,Tablet,Oral,02424258,AURO-REPAGLINIDE (repaglinide 0.5 mg oral tablet) AURO PHARMA INC,Active,9000856,repaglinide 0.5 mg oral tablet,8000273,repaglinide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90897,Marketed,2014-04-30,02424266,Auro-Repaglinide,1,A10BX02,Repaglinide,Tablet,Oral,02424266,AURO-REPAGLINIDE (repaglinide 1 mg oral tablet) AURO PHARMA INC,Active,9000857,repaglinide 1 mg oral tablet,8000273,repaglinide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90898,Marketed,2014-04-30,02424274,Auro-Repaglinide,1,A10BX02,Repaglinide,Tablet,Oral,02424274,AURO-REPAGLINIDE (repaglinide 2 mg oral tablet) AURO PHARMA INC,Active,9000858,repaglinide 2 mg oral tablet,8000273,repaglinide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94330,Marketed,2016-12-19,02456419,Cinqair,1,R03DX08,Reslizumab,Solution,Intravenous,02456419,CINQAIR (reslizumab 100 mg per 10 mL solution for injection vial) TEVA CANADA LIMITED,Active,9012406,reslizumab 100 mg per 10 mL solution for injection vial,8001067,reslizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
94330,Marketed,2016-12-19,02456419,Cinqair,1,R03DX08,Reslizumab,Solution,Intravenous,02456419,CINQAIR (reslizumab 100 mg per 10 mL solution for injection vial) TEVA CANADA LIMITED,Active,9012406,reslizumab 100 mg per 10 mL solution for injection vial,8001067,reslizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
102891,Marketed,2023-09-06,02540207,Arexvy,1,J07BX05,Respiratory syncytial virus vaccine,Powder for suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
103244,Marketed,2024-05-22,02544040,Abrysvo,2,J07BX05,Respiratory syncytial virus vaccine,"Kit,Powder for solution",Intramuscular,,,,,,,,,,,,,,,,,Schedule D
104399,Marketed,2025-08-14,02555239,Zynyz,1,L01FF10,Retifanlimab,Solution,Intravenous,02555239,ZYNYZ (retifanlimab 500 mg per 20 mL solution for injection vial) INCYTE CORPORATION,Active,9015324,retifanlimab 500 mg per 20 mL solution for injection vial,8002561,retifanlimab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,1.0,,,Prescription
104399,Marketed,2025-08-14,02555239,Zynyz,1,L01FF10,Retifanlimab,Solution,Intravenous,02555239,ZYNYZ (retifanlimab 500 mg per 20 mL solution for injection vial) INCYTE CORPORATION,Active,9015324,retifanlimab 500 mg per 20 mL solution for injection vial,8002561,retifanlimab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,1.0,,,Schedule D
34574,Marketed,2020-09-30,02170140,Virazole,1,J05AP01,Ribavirin,"Aerosol,Powder for solution",Inhalation,02170140,"VIRAZOLE (ribavirin 6 g per vial powder for nebulizer solution) BAUSCH HEALTH, CANADA INC.",Active,9002980,ribavirin 6 g per vial powder for nebulizer solution,8001517,ribavirin,447694001,Inhalation,385201005,Powder for nebulizer solution,733026001,Vial (unit of presentation),1.0,,,Prescription
96295,Marketed,2018-04-27,02473569,Kisqali,1,L01EF02,Ribociclib,Tablet,Oral,02473569,KISQALI (ribociclib (ribociclib succinate) 200 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012857,ribociclib (ribociclib succinate) 200 mg oral tablet,8001518,ribociclib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
18081,Marketed,2005-02-16,02063786,Mycobutin,1,J04AB04,Rifabutin,Capsule,Oral,02063786,MYCOBUTIN (rifabutin 150 mg oral capsule) PFIZER CANADA ULC,Active,9002866,rifabutin 150 mg oral capsule,8001226,rifabutin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
2863,Marketed,2019-07-02,00343617,Rofact,1,J04AB02,Rifampicin,Capsule,Oral,00343617,"ROFACT (rifampin 300 mg oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9001796,rifampin 300 mg oral capsule,8001227,rifampin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
2866,Marketed,2019-07-02,00393444,Rofact,1,J04AB02,Rifampicin,Capsule,Oral,00393444,"ROFACT (rifampin 150 mg oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9001795,rifampin 150 mg oral capsule,8001227,rifampin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
89537,Marketed,2013-11-07,02410702,Zaxine,1,A07AA11,Rifaximin,Tablet,Oral,02410702,ZAXINE (rifaximin 550 mg oral tablet) SALIX PHARMACEUTICALS INC,Active,9005360,rifaximin 550 mg oral tablet,8001921,rifaximin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85574,Marketed,2014-09-09,02370603,Edurant,1,J05AG05,Rilpivirine,Tablet,Oral,02370603,EDURANT (rilpivirine (rilpivirine hydrochloride) 25 mg oral tablet) JANSSEN INC,Active,9004920,rilpivirine (rilpivirine hydrochloride) 25 mg oral tablet,8001228,rilpivirine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
66576,Marketed,2007-01-08,02242763,Rilutek,1,N07XX02,Riluzole,Tablet,Oral,02242763,RILUTEK (riluzole 50 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9003531,riluzole 50 mg oral tablet,8001419,riluzole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83784,Marketed,2022-09-23,02352583,Apo-Riluzole,1,N07XX02,Riluzole,Tablet,Oral,02352583,APO-RILUZOLE (riluzole 50 mg oral tablet) APOTEX INC,Active,9003531,riluzole 50 mg oral tablet,8001419,riluzole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87574,Marketed,2012-10-23,02390299,Mylan-Riluzole,1,N07XX02,Riluzole,Tablet,Oral,02390299,MYLAN-RILUZOLE (riluzole 50 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9003531,riluzole 50 mg oral tablet,8001419,riluzole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103205,Marketed,2024-03-25,02543605,Nurtec ODT,1,N02CD06,Rimegepant,Tablet (orally disintegrating),Oral,02543605,NURTEC ODT (rimegepant (rimegepant sulfate) 75 mg orodispersible tablet) PFIZER CANADA ULC,Active,9015038,rimegepant (rimegepant sulfate) 75 mg orodispersible tablet,8002507,rimegepant,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102253,Marketed,2024-04-29,02533545,Sandoz Riociguat,1,C02KX05,Riociguat,Tablet,Oral,02533545,SANDOZ RIOCIGUAT (riociguat 0.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005338,riociguat 0.5 mg oral tablet,8001922,riociguat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102255,Marketed,2024-04-29,02533561,Sandoz Riociguat,1,C02KX05,Riociguat,Tablet,Oral,02533561,SANDOZ RIOCIGUAT (riociguat 1 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005340,riociguat 1 mg oral tablet,8001922,riociguat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102256,Marketed,2024-04-29,02533588,Sandoz Riociguat,1,C02KX05,Riociguat,Tablet,Oral,02533588,SANDOZ RIOCIGUAT (riociguat 1.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005339,riociguat 1.5 mg oral tablet,8001922,riociguat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102257,Marketed,2024-04-29,02533618,Sandoz Riociguat,1,C02KX05,Riociguat,Tablet,Oral,02533618,SANDOZ RIOCIGUAT (riociguat 2.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005341,riociguat 2.5 mg oral tablet,8001922,riociguat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102258,Marketed,2024-04-29,02533596,Sandoz Riociguat,1,C02KX05,Riociguat,Tablet,Oral,02533596,SANDOZ RIOCIGUAT (riociguat 2 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005342,riociguat 2 mg oral tablet,8001922,riociguat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
89742,Marketed,2013-09-25,02412764,Adempas,1,C02KX05,Riociguat,Tablet,Oral,02412764,ADEMPAS (riociguat 0.5 mg oral tablet) BAYER INC,Active,9005338,riociguat 0.5 mg oral tablet,8001922,riociguat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
89743,Marketed,2013-09-25,02412772,Adempas,1,C02KX05,Riociguat,Tablet,Oral,02412772,ADEMPAS (riociguat 1 mg oral tablet) BAYER INC,Active,9005340,riociguat 1 mg oral tablet,8001922,riociguat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
89745,Marketed,2013-09-25,02412799,Adempas,1,C02KX05,Riociguat,Tablet,Oral,02412799,ADEMPAS (riociguat 1.5 mg oral tablet) BAYER INC,Active,9005339,riociguat 1.5 mg oral tablet,8001922,riociguat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
89746,Marketed,2013-09-25,02412802,Adempas,1,C02KX05,Riociguat,Tablet,Oral,02412802,ADEMPAS (riociguat 2 mg oral tablet) BAYER INC,Active,9005342,riociguat 2 mg oral tablet,8001922,riociguat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
89747,Marketed,2013-09-25,02412810,Adempas,1,C02KX05,Riociguat,Tablet,Oral,02412810,ADEMPAS (riociguat 2.5 mg oral tablet) BAYER INC,Active,9005341,riociguat 2.5 mg oral tablet,8001922,riociguat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99049,Marketed,2020-12-10,02500833,Qinlock,1,L01EX19,Ripretinib,Tablet,Oral,02500833,QINLOCK (ripretinib 50 mg oral tablet) DECIPHERA PHARMACEUTICALS. LLC,Active,9014434,ripretinib 50 mg oral tablet,8002359,ripretinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100434,Marketed,2021-05-19,02514931,Evrysdi,1,M09AX10,Risdiplam,Powder for solution,Oral,02514931,EVRYSDI (risdiplam 0.75 mg per mL oral solution) HOFFMANN-LA ROCHE LIMITED,Active,9014555,risdiplam 0.75 mg per mL oral solution,8002377,risdiplam,26643006,Oral,385023001,Oral solution,,,1.0,,,Prescription
106378,Marketed,2025-11-27,02560747,Evrysdi,1,M09AX10,Risdiplam,Tablet,Oral,02560747,EVRYSDI (risdiplam 5 mg oral tablet) HOFFMANN-LA ROCHE LIMITED,Active,9015325,risdiplam 5 mg oral tablet,8002377,risdiplam,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,,Prescription
101771,Marketed,2022-10-05,02528460,Risedronate,1,M05BA07,Risedronic acid,Tablet,Oral,02528460,RISEDRONATE (risedronate sodium (risedronate sodium hemipentahydrate) 150 mg oral tablet) SANIS HEALTH INC,Active,9001260,risedronate sodium 150 mg oral tablet,8000278,risedronate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106478,Marketed,2026-05-12,02561859,NB-Risedronate,1,M05BA07,Risedronic acid,Tablet,Oral,02561859,NB-RISEDRONATE (risedronate sodium (risedronate sodium hemipentahydrate) 35 mg oral tablet) NB PHARMA INC.,Active,9001008,risedronate sodium 35 mg oral tablet,8000278,risedronate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71123,Marketed,2025-03-05,02246896,Actonel,1,M05BA07,Risedronic acid,Tablet,Oral,02246896,ACTONEL (risedronate sodium (risedronate sodium hemipentahydrate) 35 mg oral tablet) ABBVIE CORPORATION,Active,9001008,risedronate sodium 35 mg oral tablet,8000278,risedronate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78367,Marketed,2011-06-03,02298376,Teva-Risedronate,1,M05BA07,Risedronic acid,Tablet,Oral,02298376,TEVA-RISEDRONATE (risedronate sodium (risedronate sodium monohydrate) 5 mg oral tablet) TEVA CANADA LIMITED,Active,9000912,risedronate sodium 5 mg oral tablet,8000278,risedronate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78368,Marketed,2011-06-03,02298384,Teva-Risedronate,1,M05BA07,Risedronic acid,Tablet,Oral,02298384,TEVA-RISEDRONATE (risedronate sodium (risedronate sodium monohydrate) 30 mg oral tablet) TEVA CANADA LIMITED,Active,9000868,risedronate sodium 30 mg oral tablet,8000278,risedronate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78369,Marketed,2011-06-03,02298392,Teva-Risedronate,1,M05BA07,Risedronic acid,Tablet,Oral,02298392,TEVA-RISEDRONATE (risedronate sodium (risedronate sodium monohydrate) 35 mg oral tablet) TEVA CANADA LIMITED,Active,9001008,risedronate sodium 35 mg oral tablet,8000278,risedronate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78754,Marketed,2010-07-27,02302209,PMS-Risedronate,1,M05BA07,Risedronic acid,Tablet,Oral,02302209,PMS-RISEDRONATE (risedronate sodium (risedronate sodium hemipentahydrate) 35 mg oral tablet) PHARMASCIENCE INC,Active,9001008,risedronate sodium 35 mg oral tablet,8000278,risedronate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80233,Marketed,2025-05-05,02316838,Actonel,1,M05BA07,Risedronic acid,Tablet,Oral,02316838,ACTONEL (risedronate sodium (risedronate sodium hemipentahydrate) 150 mg oral tablet) ABBVIE CORPORATION,Active,9001260,risedronate sodium 150 mg oral tablet,8000278,risedronate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81259,Marketed,2010-07-28,02327295,Sandoz Risedronate,1,M05BA07,Risedronic acid,Tablet,Oral,02327295,SANDOZ RISEDRONATE (risedronate sodium (risedronate sodium hemipentahydrate) 35 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001008,risedronate sodium 35 mg oral tablet,8000278,risedronate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82662,Marketed,2010-07-28,02341077,Riva-Risedronate,1,M05BA07,Risedronic acid,Tablet,Oral,02341077,RIVA-RISEDRONATE (risedronate sodium (risedronate sodium hemipentahydrate) 35 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001008,risedronate sodium 35 mg oral tablet,8000278,risedronate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83286,Marketed,2020-09-15,02347474,Risedronate,1,M05BA07,Risedronic acid,Tablet,Oral,02347474,RISEDRONATE (risedronate sodium (risedronate sodium hemipentahydrate) 35 mg oral tablet) PRO DOC LIMITEE,Active,9001008,risedronate sodium 35 mg oral tablet,8000278,risedronate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83888,Marketed,2012-06-20,02353687,Apo-Risedronate,1,M05BA07,Risedronic acid,Tablet,Oral,02353687,APO-RISEDRONATE (risedronate sodium (risedronate sodium hemipentahydrate) 35 mg oral tablet) APOTEX INC,Active,9001008,risedronate sodium 35 mg oral tablet,8000278,risedronate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85541,Marketed,2025-02-13,02370255,Risedronate,1,M05BA07,Risedronic acid,Tablet,Oral,02370255,RISEDRONATE (risedronate sodium (risedronate sodium hemipentahydrate) 35 mg oral tablet) SANIS HEALTH INC,Active,9001008,risedronate sodium 35 mg oral tablet,8000278,risedronate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85557,Marketed,2025-05-22,02370417,Actonel Dr,1,M05BA07,Risedronic acid,Tablet (delayed-release),Oral,02370417,ACTONEL DR (risedronate sodium (risedronate sodium hemipentahydrate) 35 mg gastro-resistant tablet) ABBVIE CORPORATION,Active,9001353,risedronate sodium 35 mg gastro-resistant tablet,8000278,risedronate,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86354,Marketed,2012-05-17,02377721,Apo-Risedronate,1,M05BA07,Risedronic acid,Tablet,Oral,02377721,APO-RISEDRONATE (risedronate sodium (risedronate sodium hemipentahydrate) 150 mg oral tablet) APOTEX INC,Active,9001260,risedronate sodium 150 mg oral tablet,8000278,risedronate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89102,Marketed,2013-07-08,02406306,Auro-Risedronate,1,M05BA07,Risedronic acid,Tablet,Oral,02406306,AURO-RISEDRONATE (risedronate sodium (risedronate sodium hemipentahydrate) 35 mg oral tablet) AURO PHARMA INC,Active,9001008,risedronate sodium 35 mg oral tablet,8000278,risedronate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89602,Marketed,2024-02-01,02411407,Risedronate,1,M05BA07,Risedronic acid,Tablet,Oral,02411407,RISEDRONATE (risedronate sodium (risedronate sodium monohydrate) 35 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001008,risedronate sodium 35 mg oral tablet,8000278,risedronate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89845,Marketed,2013-10-10,02413809,Teva-Risedronate,1,M05BA07,Risedronic acid,Tablet,Oral,02413809,TEVA-RISEDRONATE (risedronate sodium (risedronate sodium monohydrate) 150 mg oral tablet) TEVA CANADA LIMITED,Active,9001260,risedronate sodium 150 mg oral tablet,8000278,risedronate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90889,Marketed,2014-05-28,02424177,PMS-Risedronate,1,M05BA07,Risedronic acid,Tablet,Oral,02424177,PMS-RISEDRONATE (risedronate sodium (risedronate sodium hemipentahydrate) 150 mg oral tablet) PHARMASCIENCE INC,Active,9001260,risedronate sodium 150 mg oral tablet,8000278,risedronate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98324,Marketed,2023-09-08,02493268,AA-Risedronate Dr,1,M05BA07,Risedronic acid,Tablet (delayed-release),Oral,02493268,AA-RISEDRONATE DR (risedronate sodium (risedronate sodium hemipentahydrate) 35 mg gastro-resistant tablet) AA PHARMA INC,Active,9001353,risedronate sodium 35 mg gastro-resistant tablet,8000278,risedronate,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102277,Marketed,2023-11-09,02533804,Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02533804,RISPERIDONE (risperidone 0.25 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000871,risperidone 0.25 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102288,Marketed,2023-11-09,02533928,Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02533928,RISPERIDONE (risperidone 0.5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000872,risperidone 0.5 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102289,Marketed,2023-11-09,02533936,Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02533936,RISPERIDONE (risperidone 1 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000489,risperidone 1 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102290,Marketed,2023-11-09,02533944,Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02533944,RISPERIDONE (risperidone 2 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000490,risperidone 2 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102291,Marketed,2023-11-09,02533952,Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02533952,RISPERIDONE (risperidone 3 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000491,risperidone 3 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102292,Marketed,2023-11-09,02533960,Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02533960,RISPERIDONE (risperidone 4 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000492,risperidone 4 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103318,Marketed,2025-05-27,02544601,Okedi,1,N05AX08,Risperidone,"Powder for suspension, sustained-release,Kit",Intramuscular,02544601,"OKEDI (risperidone 75 mg per syringe powder for prolonged-release suspension for injection with diluent solution syringe) LABORATORIOS FARMACEUTICOS ROVI, S.A.",Active,9015224,risperidone 75 mg per syringe powder for prolonged-release suspension for injection with diluent solution syringe,8000187,risperidone,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733020007,Syringe,,,,Prescription
103319,Marketed,2025-05-27,02544628,Okedi,1,N05AX08,Risperidone,"Powder for suspension, sustained-release,Kit",Intramuscular,02544628,"OKEDI (risperidone 100 mg per syringe powder for prolonged-release suspension for injection with diluent solution syringe) LABORATORIOS FARMACEUTICOS ROVI, S.A.",Active,9015223,risperidone 100 mg per syringe powder for prolonged-release suspension for injection with diluent solution syringe,8000187,risperidone,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733020007,Syringe,,,,Prescription
73690,Marketed,2006-07-05,02252007,PMS-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02252007,PMS-RISPERIDONE (risperidone 0.25 mg oral tablet) PHARMASCIENCE INC,Active,9000871,risperidone 0.25 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73691,Marketed,2006-07-05,02252015,PMS-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02252015,PMS-RISPERIDONE (risperidone 0.5 mg oral tablet) PHARMASCIENCE INC,Active,9000872,risperidone 0.5 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73692,Marketed,2006-07-05,02252023,PMS-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02252023,PMS-RISPERIDONE (risperidone 1 mg oral tablet) PHARMASCIENCE INC,Active,9000489,risperidone 1 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73693,Marketed,2006-07-05,02252031,PMS-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02252031,PMS-RISPERIDONE (risperidone 2 mg oral tablet) PHARMASCIENCE INC,Active,9000490,risperidone 2 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73694,Marketed,2006-07-05,02252058,PMS-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02252058,PMS-RISPERIDONE (risperidone 3 mg oral tablet) PHARMASCIENCE INC,Active,9000491,risperidone 3 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73695,Marketed,2006-07-05,02252066,PMS-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02252066,PMS-RISPERIDONE (risperidone 4 mg oral tablet) PHARMASCIENCE INC,Active,9000492,risperidone 4 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74089,Marketed,2004-09-08,02255707,Risperdal Consta,1,N05AX08,Risperidone,"Kit,Powder for suspension, sustained-release",Intramuscular,02255707,RISPERDAL CONSTA (risperidone 25 mg per vial powder for prolonged-release suspension for injection with diluent solution) JANSSEN INC,Active,9006473,risperidone 25 mg per vial powder for prolonged-release suspension for injection with diluent solution,8000187,risperidone,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),,,,Prescription
74091,Marketed,2004-09-08,02255723,Risperdal Consta,1,N05AX08,Risperidone,"Powder for suspension, sustained-release,Kit",Intramuscular,02255723,RISPERDAL CONSTA (risperidone 37.5 mg per vial powder for prolonged-release suspension for injection with diluent solution) JANSSEN INC,Active,9006472,risperidone 37.5 mg per vial powder for prolonged-release suspension for injection with diluent solution,8000187,risperidone,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),,,,Prescription
74093,Marketed,2004-09-08,02255758,Risperdal Consta,1,N05AX08,Risperidone,"Kit,Powder for suspension, sustained-release",Intramuscular,02255758,RISPERDAL CONSTA (risperidone 50 mg per vial powder for prolonged-release suspension for injection with diluent solution) JANSSEN INC,Active,9006474,risperidone 50 mg per vial powder for prolonged-release suspension for injection with diluent solution,8000187,risperidone,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),,,,Prescription
74963,Marketed,2022-10-26,02264196,Teva-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02264196,TEVA-RISPERIDONE (risperidone 1 mg oral tablet) TEVA CANADA LIMITED,Active,9000489,risperidone 1 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74964,Marketed,2022-10-26,02264218,Teva-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02264218,TEVA-RISPERIDONE (risperidone 2 mg oral tablet) TEVA CANADA LIMITED,Active,9000490,risperidone 2 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74965,Marketed,2022-10-26,02264226,Teva-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02264226,TEVA-RISPERIDONE (risperidone 3 mg oral tablet) TEVA CANADA LIMITED,Active,9000491,risperidone 3 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74966,Marketed,2022-10-26,02264234,Teva-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02264234,TEVA-RISPERIDONE (risperidone 4 mg oral tablet) TEVA CANADA LIMITED,Active,9000492,risperidone 4 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76481,Marketed,2006-07-05,02279266,PMS-Risperidone,1,N05AX08,Risperidone,Solution,Oral,02279266,PMS-RISPERIDONE (risperidone (risperidone tartrate) 1 mg per mL oral solution) PHARMASCIENCE INC,Active,9000788,risperidone (risperidone tartrate) 1 mg per mL oral solution,8000187,risperidone,26643006,Oral,385023001,Oral solution,,,,,,Prescription
76539,Marketed,2006-07-05,02279800,Sandoz Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02279800,SANDOZ RISPERIDONE (risperidone 1 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000489,risperidone 1 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76540,Marketed,2006-07-05,02279819,Sandoz Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02279819,SANDOZ RISPERIDONE (risperidone 2 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000490,risperidone 2 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76541,Marketed,2006-07-05,02279827,Sandoz Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02279827,SANDOZ RISPERIDONE (risperidone 3 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000491,risperidone 3 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76542,Marketed,2006-07-05,02279835,Sandoz Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02279835,SANDOZ RISPERIDONE (risperidone 4 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000492,risperidone 4 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76778,Marketed,2006-07-05,02282119,Apo-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02282119,APO-RISPERIDONE (risperidone 0.25 mg oral tablet) APOTEX INC,Active,9000871,risperidone 0.25 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76779,Marketed,2006-07-05,02282127,Apo-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02282127,APO-RISPERIDONE (risperidone 0.5 mg oral tablet) APOTEX INC,Active,9000872,risperidone 0.5 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76780,Marketed,2006-07-05,02282135,Apo-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02282135,APO-RISPERIDONE (risperidone 1 mg oral tablet) APOTEX INC,Active,9000489,risperidone 1 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76781,Marketed,2006-07-05,02282143,Apo-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02282143,APO-RISPERIDONE (risperidone 2 mg oral tablet) APOTEX INC,Active,9000490,risperidone 2 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76782,Marketed,2006-07-05,02282151,Apo-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02282151,APO-RISPERIDONE (risperidone 3 mg oral tablet) APOTEX INC,Active,9000491,risperidone 3 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76783,Marketed,2006-07-05,02282178,Apo-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02282178,APO-RISPERIDONE (risperidone 4 mg oral tablet) APOTEX INC,Active,9000492,risperidone 4 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76833,Marketed,2022-10-26,02282690,Teva-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02282690,TEVA-RISPERIDONE (risperidone 0.25 mg oral tablet) TEVA CANADA LIMITED,Active,9000871,risperidone 0.25 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76916,Marketed,2017-07-11,02283565,Riva-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02283565,RIVA-RISPERIDONE (risperidone 0.25 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000871,risperidone 0.25 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76917,Marketed,2017-07-11,02283573,Riva-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02283573,RIVA-RISPERIDONE (risperidone 0.5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000872,risperidone 0.5 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76918,Marketed,2017-07-11,02283581,Riva-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02283581,RIVA-RISPERIDONE (risperidone 1 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000489,risperidone 1 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76919,Marketed,2017-07-11,02283603,Riva-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02283603,RIVA-RISPERIDONE (risperidone 2 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000490,risperidone 2 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76920,Marketed,2017-07-11,02283611,Riva-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02283611,RIVA-RISPERIDONE (risperidone 3 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000491,risperidone 3 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76921,Marketed,2017-07-11,02283638,Riva-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02283638,RIVA-RISPERIDONE (risperidone 4 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000492,risperidone 4 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78377,Marketed,2007-10-24,02298465,Risperdal Consta,1,N05AX08,Risperidone,"Powder for suspension, sustained-release,Kit",Intramuscular,02298465,RISPERDAL CONSTA (risperidone 12.5 mg per vial powder for prolonged-release suspension for injection with diluent solution) JANSSEN INC,Active,9006486,risperidone 12.5 mg per vial powder for prolonged-release suspension for injection with diluent solution,8000187,risperidone,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),,,,Prescription
78897,Marketed,2007-12-21,02303655,Sandoz Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02303655,SANDOZ RISPERIDONE (risperidone 0.25 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000871,risperidone 0.25 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78898,Marketed,2007-12-21,02303663,Sandoz Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02303663,SANDOZ RISPERIDONE (risperidone 0.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000872,risperidone 0.5 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79823,Marketed,2008-07-09,02312700,Pro-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02312700,PRO-RISPERIDONE (risperidone 0.25 mg oral tablet) PRO DOC LIMITEE,Active,9000871,risperidone 0.25 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79824,Marketed,2008-07-09,02312719,Pro-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02312719,PRO-RISPERIDONE (risperidone 0.5 mg oral tablet) PRO DOC LIMITEE,Active,9000872,risperidone 0.5 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79825,Marketed,2008-07-09,02312727,Pro-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02312727,PRO-RISPERIDONE (risperidone 1 mg oral tablet) PRO DOC LIMITEE,Active,9000489,risperidone 1 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79826,Marketed,2008-07-09,02312735,Pro-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02312735,PRO-RISPERIDONE (risperidone 2 mg oral tablet) PRO DOC LIMITEE,Active,9000490,risperidone 2 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79827,Marketed,2008-07-09,02312743,Pro-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02312743,PRO-RISPERIDONE (risperidone 3 mg oral tablet) PRO DOC LIMITEE,Active,9000491,risperidone 3 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79828,Marketed,2008-07-09,02312751,Pro-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02312751,PRO-RISPERIDONE (risperidone 4 mg oral tablet) PRO DOC LIMITEE,Active,9000492,risperidone 4 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84200,Marketed,2016-08-19,02356880,Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02356880,RISPERIDONE (risperidone 0.25 mg oral tablet) SANIS HEALTH INC,Active,9000871,risperidone 0.25 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84201,Marketed,2016-08-19,02356899,Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02356899,RISPERIDONE (risperidone 0.5 mg oral tablet) SANIS HEALTH INC,Active,9000872,risperidone 0.5 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84202,Marketed,2016-08-19,02356902,Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02356902,RISPERIDONE (risperidone 1 mg oral tablet) SANIS HEALTH INC,Active,9000489,risperidone 1 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84203,Marketed,2016-08-19,02356910,Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02356910,RISPERIDONE (risperidone 2 mg oral tablet) SANIS HEALTH INC,Active,9000490,risperidone 2 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84204,Marketed,2016-08-19,02356929,Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02356929,RISPERIDONE (risperidone 3 mg oral tablet) SANIS HEALTH INC,Active,9000491,risperidone 3 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84205,Marketed,2016-08-19,02356937,Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02356937,RISPERIDONE (risperidone 4 mg oral tablet) SANIS HEALTH INC,Active,9000492,risperidone 4 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84454,Marketed,2010-12-23,02359529,JAMP-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02359529,JAMP-RISPERIDONE (risperidone 0.25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000871,risperidone 0.25 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84455,Marketed,2010-12-23,02359537,JAMP-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02359537,JAMP-RISPERIDONE (risperidone 0.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000872,risperidone 0.5 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84456,Marketed,2010-12-23,02359545,JAMP-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02359545,JAMP-RISPERIDONE (risperidone 1 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000489,risperidone 1 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84457,Marketed,2010-12-23,02359553,JAMP-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02359553,JAMP-RISPERIDONE (risperidone 2 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000490,risperidone 2 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84458,Marketed,2010-12-23,02359561,JAMP-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02359561,JAMP-RISPERIDONE (risperidone 3 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000491,risperidone 3 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84459,Marketed,2010-12-23,02359588,JAMP-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02359588,JAMP-RISPERIDONE (risperidone 4 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000492,risperidone 4 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84478,Marketed,2011-01-05,02359790,Mint-Risperidon,1,N05AX08,Risperidone,Tablet,Oral,02359790,MINT-RISPERIDON (risperidone 0.25 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000871,risperidone 0.25 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84479,Marketed,2011-01-05,02359804,Mint-Risperidon,1,N05AX08,Risperidone,Tablet,Oral,02359804,MINT-RISPERIDON (risperidone 0.5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000872,risperidone 0.5 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84480,Marketed,2011-01-05,02359812,Mint-Risperidon,1,N05AX08,Risperidone,Tablet,Oral,02359812,MINT-RISPERIDON (risperidone 1 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000489,risperidone 1 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84481,Marketed,2011-01-05,02359820,Mint-Risperidon,1,N05AX08,Risperidone,Tablet,Oral,02359820,MINT-RISPERIDON (risperidone 2 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000490,risperidone 2 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84482,Marketed,2011-01-05,02359839,Mint-Risperidon,1,N05AX08,Risperidone,Tablet,Oral,02359839,MINT-RISPERIDON (risperidone 3 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000491,risperidone 3 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84483,Marketed,2011-01-05,02359847,Mint-Risperidon,1,N05AX08,Risperidone,Tablet,Oral,02359847,MINT-RISPERIDON (risperidone 4 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000492,risperidone 4 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85689,Marketed,2013-04-17,02371766,Mar-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02371766,MAR-RISPERIDONE (risperidone 0.25 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000871,risperidone 0.25 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85690,Marketed,2013-04-17,02371774,Mar-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02371774,MAR-RISPERIDONE (risperidone 0.5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000872,risperidone 0.5 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85691,Marketed,2013-04-17,02371782,Mar-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02371782,MAR-RISPERIDONE (risperidone 1 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000489,risperidone 1 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85692,Marketed,2026-02-13,02371790,Mar-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02371790,MAR-RISPERIDONE (risperidone 2 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000490,risperidone 2 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85693,Marketed,2026-02-13,02371804,Mar-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02371804,MAR-RISPERIDONE (risperidone 3 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000491,risperidone 3 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85694,Marketed,2026-02-13,02371812,Mar-Risperidone,1,N05AX08,Risperidone,Tablet,Oral,02371812,MAR-RISPERIDONE (risperidone 4 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000492,risperidone 4 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103199,Marketed,2024-02-13,02543532,Litfulo,1,L04AF08,Ritlecitinib,Capsule,Oral,02543532,LITFULO (ritlecitinib (ritlecitinib tosylate) 50 mg oral capsule) PFIZER CANADA ULC,Active,9015021,ritlecitinib (ritlecitinib tosylate) 50 mg oral capsule,8002501,ritlecitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
101271,Marketed,2022-09-08,02523620,Auro-Ritonavir,1,J05AE03,Ritonavir,Tablet,Oral,02523620,AURO-RITONAVIR (ritonavir 100 mg oral tablet) AURO PHARMA INC,Active,9004799,ritonavir 100 mg oral tablet,8001229,ritonavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84270,Marketed,2014-04-30,02357593,Norvir,1,J05AE03,Ritonavir,Tablet,Oral,02357593,NORVIR (ritonavir 100 mg oral tablet) ABBVIE CORPORATION,Active,9004799,ritonavir 100 mg oral tablet,8001229,ritonavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
65597,Marketed,2000-03-20,02241927,Rituxan,1,L01FA01,Rituximab,Solution,Intravenous,77700854,RITUXAN (rituximab 100 mg per 10 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9013319,rituximab 100 mg per 10 mL solution for injection vial,8001923,rituximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
65597,Marketed,2000-03-20,02241927,Rituxan,1,L01FA01,Rituximab,Solution,Intravenous,77700855,RITUXAN (rituximab 500 mg per 50 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9013322,rituximab 500 mg per 50 mL solution for injection vial,8001923,rituximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
65597,Marketed,2000-03-20,02241927,Rituxan,1,L01FA01,Rituximab,Solution,Intravenous,77700854,RITUXAN (rituximab 100 mg per 10 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9013319,rituximab 100 mg per 10 mL solution for injection vial,8001923,rituximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
65597,Marketed,2000-03-20,02241927,Rituxan,1,L01FA01,Rituximab,Solution,Intravenous,77700855,RITUXAN (rituximab 500 mg per 50 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9013322,rituximab 500 mg per 50 mL solution for injection vial,8001923,rituximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
94441,Marketed,2016-11-22,02457350,Rituxan SC,1,L01FA01,Rituximab,Solution,Subcutaneous,02457350,RITUXAN SC (rituximab 1400 mg per 11.7 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9013320,rituximab 1400 mg per 11.7 mL solution for injection vial,8001923,rituximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
94441,Marketed,2016-11-22,02457350,Rituxan SC,1,L01FA01,Rituximab,Solution,Subcutaneous,02457350,RITUXAN SC (rituximab 1400 mg per 11.7 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9013320,rituximab 1400 mg per 11.7 mL solution for injection vial,8001923,rituximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
96398,Marketed,2018-04-24,02473976,Rituxan SC,1,L01FA01,Rituximab,Solution,Subcutaneous,02473976,RITUXAN SC (rituximab 1600 mg per 13.4 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9013321,rituximab 1600 mg per 13.4 mL solution for injection vial,8001923,rituximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
96398,Marketed,2018-04-24,02473976,Rituxan SC,1,L01FA01,Rituximab,Solution,Subcutaneous,02473976,RITUXAN SC (rituximab 1600 mg per 13.4 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9013321,rituximab 1600 mg per 13.4 mL solution for injection vial,8001923,rituximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
96914,Marketed,2025-11-24,02478382,Truxima,1,L01FA01,Rituximab,Solution,Intravenous,02478382,TRUXIMA (rituximab 100 mg per 10 mL solution for injection vial) CELLTRION INC.,Active,9013319,rituximab 100 mg per 10 mL solution for injection vial,8001923,rituximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
96914,Marketed,2025-11-24,02478382,Truxima,1,L01FA01,Rituximab,Solution,Intravenous,02478382,TRUXIMA (rituximab 100 mg per 10 mL solution for injection vial) CELLTRION INC.,Active,9013319,rituximab 100 mg per 10 mL solution for injection vial,8001923,rituximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
96915,Marketed,2025-11-24,02478390,Truxima,1,L01FA01,Rituximab,Solution,Intravenous,02478390,TRUXIMA (rituximab 500 mg per 50 mL solution for injection vial) CELLTRION INC.,Active,9013322,rituximab 500 mg per 50 mL solution for injection vial,8001923,rituximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
96915,Marketed,2025-11-24,02478390,Truxima,1,L01FA01,Rituximab,Solution,Intravenous,02478390,TRUXIMA (rituximab 500 mg per 50 mL solution for injection vial) CELLTRION INC.,Active,9013322,rituximab 500 mg per 50 mL solution for injection vial,8001923,rituximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
98562,Marketed,2020-05-26,02495724,Ruxience,1,L01FA01,Rituximab,Solution,Intravenous,77701017,RUXIENCE (rituximab 500 mg per 50 mL solution for injection vial) PFIZER CANADA ULC,Active,9013322,rituximab 500 mg per 50 mL solution for injection vial,8001923,rituximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
98562,Marketed,2020-05-26,02495724,Ruxience,1,L01FA01,Rituximab,Solution,Intravenous,77701018,RUXIENCE (rituximab 100 mg per 10 mL solution for injection vial) PFIZER CANADA ULC,Active,9013319,rituximab 100 mg per 10 mL solution for injection vial,8001923,rituximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
98562,Marketed,2020-05-26,02495724,Ruxience,1,L01FA01,Rituximab,Solution,Intravenous,77701017,RUXIENCE (rituximab 500 mg per 50 mL solution for injection vial) PFIZER CANADA ULC,Active,9013322,rituximab 500 mg per 50 mL solution for injection vial,8001923,rituximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
98562,Marketed,2020-05-26,02495724,Ruxience,1,L01FA01,Rituximab,Solution,Intravenous,77701018,RUXIENCE (rituximab 100 mg per 10 mL solution for injection vial) PFIZER CANADA ULC,Active,9013319,rituximab 100 mg per 10 mL solution for injection vial,8001923,rituximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
98809,Marketed,2020-05-22,02498316,Riximyo,1,L01FA01,Rituximab,Solution,Intravenous,77701019,RIXIMYO (rituximab 100 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013319,rituximab 100 mg per 10 mL solution for injection vial,8001923,rituximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
98809,Marketed,2020-05-22,02498316,Riximyo,1,L01FA01,Rituximab,Solution,Intravenous,77701020,RIXIMYO (rituximab 500 mg per 50 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013322,rituximab 500 mg per 50 mL solution for injection vial,8001923,rituximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
98809,Marketed,2020-05-22,02498316,Riximyo,1,L01FA01,Rituximab,Solution,Intravenous,77701019,RIXIMYO (rituximab 100 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013319,rituximab 100 mg per 10 mL solution for injection vial,8001923,rituximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
98809,Marketed,2020-05-22,02498316,Riximyo,1,L01FA01,Rituximab,Solution,Intravenous,77701020,RIXIMYO (rituximab 500 mg per 50 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013322,rituximab 500 mg per 50 mL solution for injection vial,8001923,rituximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
100127,Marketed,2023-11-01,02512041,PMS-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02512041,PMS-RIVAROXABAN (rivaroxaban 10 mg oral tablet) PHARMASCIENCE INC,Active,9001257,rivaroxaban 10 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100128,Marketed,2023-11-01,02512068,PMS-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02512068,PMS-RIVAROXABAN (rivaroxaban 15 mg oral tablet) PHARMASCIENCE INC,Active,9001374,rivaroxaban 15 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100129,Marketed,2023-11-01,02512076,PMS-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02512076,PMS-RIVAROXABAN (rivaroxaban 20 mg oral tablet) PHARMASCIENCE INC,Active,9001375,rivaroxaban 20 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100565,Marketed,2024-02-05,02516292,JAMP Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02516292,JAMP RIVAROXABAN (rivaroxaban 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001257,rivaroxaban 10 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100566,Marketed,2024-02-05,02516306,JAMP Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02516306,JAMP RIVAROXABAN (rivaroxaban 15 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001374,rivaroxaban 15 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100567,Marketed,2024-02-05,02516314,JAMP Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02516314,JAMP RIVAROXABAN (rivaroxaban 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001375,rivaroxaban 20 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101353,Marketed,2023-11-01,02524503,Reddy-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02524503,REDDY-RIVAROXABAN (rivaroxaban 2.5 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9013323,rivaroxaban 2.5 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101584,Marketed,2023-11-01,02526786,Taro-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02526786,TARO-RIVAROXABAN (rivaroxaban 2.5 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9013323,rivaroxaban 2.5 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101660,Marketed,2023-11-01,02527537,PMS-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02527537,PMS-RIVAROXABAN (rivaroxaban 2.5 mg oral tablet) PHARMASCIENCE INC,Active,9013323,rivaroxaban 2.5 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101726,Marketed,2024-08-22,02527995,AG-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02527995,AG-RIVAROXABAN (rivaroxaban 10 mg oral tablet) ANGITA PHARMA INC.,Active,9001257,rivaroxaban 10 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101727,Marketed,2024-08-22,02528002,AG-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02528002,AG-RIVAROXABAN (rivaroxaban 15 mg oral tablet) ANGITA PHARMA INC.,Active,9001374,rivaroxaban 15 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101728,Marketed,2024-08-22,02528010,AG-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02528010,AG-RIVAROXABAN (rivaroxaban 20 mg oral tablet) ANGITA PHARMA INC.,Active,9001375,rivaroxaban 20 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102663,Marketed,2023-11-01,02537877,Sandoz Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02537877,SANDOZ RIVAROXABAN (rivaroxaban 2.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9013323,rivaroxaban 2.5 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102951,Marketed,2023-11-06,02540835,Riva Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02540835,RIVA RIVAROXABAN (rivaroxaban 2.5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9013323,rivaroxaban 2.5 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102952,Marketed,2023-11-06,02540843,Riva Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02540843,RIVA RIVAROXABAN (rivaroxaban 10 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001257,rivaroxaban 10 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102953,Marketed,2023-11-06,02540851,Riva Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02540851,RIVA RIVAROXABAN (rivaroxaban 15 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001374,rivaroxaban 15 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102954,Marketed,2023-11-06,02540878,Riva Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02540878,RIVA RIVAROXABAN (rivaroxaban 20 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001375,rivaroxaban 20 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102959,Marketed,2023-11-02,02540967,Pro-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02540967,PRO-RIVAROXABAN (rivaroxaban 2.5 mg oral tablet) PRO DOC LIMITEE,Active,9013323,rivaroxaban 2.5 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102960,Marketed,2023-11-02,02540975,Pro-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02540975,PRO-RIVAROXABAN (rivaroxaban 10 mg oral tablet) PRO DOC LIMITEE,Active,9001257,rivaroxaban 10 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102961,Marketed,2023-11-02,02540983,Pro-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02540983,PRO-RIVAROXABAN (rivaroxaban 15 mg oral tablet) PRO DOC LIMITEE,Active,9001374,rivaroxaban 15 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102962,Marketed,2023-11-02,02540991,Pro-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02540991,PRO-RIVAROXABAN (rivaroxaban 20 mg oral tablet) PRO DOC LIMITEE,Active,9001375,rivaroxaban 20 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103011,Marketed,2023-11-08,02541467,Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02541467,RIVAROXABAN (rivaroxaban 2.5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9013323,rivaroxaban 2.5 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103012,Marketed,2023-11-08,02541475,Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02541475,RIVAROXABAN (rivaroxaban 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001257,rivaroxaban 10 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103013,Marketed,2023-11-08,02541483,Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02541483,RIVAROXABAN (rivaroxaban 15 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001374,rivaroxaban 15 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103014,Marketed,2023-11-08,02541491,Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02541491,RIVAROXABAN (rivaroxaban 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001375,rivaroxaban 20 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103036,Marketed,2023-11-01,02541734,Apo-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02541734,APO-RIVAROXABAN (rivaroxaban 2.5 mg oral tablet) APOTEX INC,Active,9013323,rivaroxaban 2.5 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103592,Marketed,2024-11-26,02547295,Teva-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02547295,TEVA-RIVAROXABAN (rivaroxaban 2.5 mg oral tablet) TEVA CANADA LIMITED,Active,9013323,rivaroxaban 2.5 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103681,Marketed,2024-12-13,02547899,Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02547899,RIVAROXABAN (rivaroxaban 2.5 mg oral tablet) SANIS HEALTH INC,Active,9013323,rivaroxaban 2.5 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103682,Marketed,2024-12-13,02547902,Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02547902,RIVAROXABAN (rivaroxaban 10 mg oral tablet) SANIS HEALTH INC,Active,9001257,rivaroxaban 10 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103683,Marketed,2024-12-13,02547910,Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02547910,RIVAROXABAN (rivaroxaban 15 mg oral tablet) SANIS HEALTH INC,Active,9001374,rivaroxaban 15 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103684,Marketed,2024-12-13,02547929,Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02547929,RIVAROXABAN (rivaroxaban 20 mg oral tablet) SANIS HEALTH INC,Active,9001375,rivaroxaban 20 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103818,Marketed,2025-01-14,02549328,Bio-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02549328,BIO-RIVAROXABAN (rivaroxaban 2.5 mg oral tablet) BIOMED PHARMA,Active,9013323,rivaroxaban 2.5 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103819,Marketed,2025-01-14,02549336,Bio-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02549336,BIO-RIVAROXABAN (rivaroxaban 10 mg oral tablet) BIOMED PHARMA,Active,9001257,rivaroxaban 10 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103820,Marketed,2025-01-14,02549344,Bio-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02549344,BIO-RIVAROXABAN (rivaroxaban 15 mg oral tablet) BIOMED PHARMA,Active,9001374,rivaroxaban 15 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103821,Marketed,2025-01-14,02549352,Bio-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02549352,BIO-RIVAROXABAN (rivaroxaban 20 mg oral tablet) BIOMED PHARMA,Active,9001375,rivaroxaban 20 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104033,Marketed,2024-12-19,02551608,M-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02551608,M-RIVAROXABAN (rivaroxaban 2.5 mg oral tablet) MANTRA PHARMA INC,Active,9013323,rivaroxaban 2.5 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104034,Marketed,2024-12-19,02551616,M-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02551616,M-RIVAROXABAN (rivaroxaban 10 mg oral tablet) MANTRA PHARMA INC,Active,9001257,rivaroxaban 10 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104035,Marketed,2024-12-19,02551624,M-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02551624,M-RIVAROXABAN (rivaroxaban 15 mg oral tablet) MANTRA PHARMA INC,Active,9001374,rivaroxaban 15 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104036,Marketed,2024-12-19,02551632,M-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02551632,M-RIVAROXABAN (rivaroxaban 20 mg oral tablet) MANTRA PHARMA INC,Active,9001375,rivaroxaban 20 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104230,Marketed,2025-06-10,02553368,JAMP Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02553368,JAMP RIVAROXABAN (rivaroxaban 2.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9013323,rivaroxaban 2.5 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104390,Marketed,2025-06-05,02555107,NB-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02555107,NB-RIVAROXABAN (rivaroxaban 2.5 mg oral tablet) NB PHARMA INC.,Active,9013323,rivaroxaban 2.5 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104391,Marketed,2025-06-05,02555115,NB-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02555115,NB-RIVAROXABAN (rivaroxaban 10 mg oral tablet) NB PHARMA INC.,Active,9001257,rivaroxaban 10 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104392,Marketed,2025-06-05,02555123,NB-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02555123,NB-RIVAROXABAN (rivaroxaban 15 mg oral tablet) NB PHARMA INC.,Active,9001374,rivaroxaban 15 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104393,Marketed,2025-06-05,02555131,NB-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02555131,NB-RIVAROXABAN (rivaroxaban 20 mg oral tablet) NB PHARMA INC.,Active,9001375,rivaroxaban 20 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104404,Marketed,2025-07-21,02555255,AG-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02555255,AG-RIVAROXABAN (rivaroxaban 2.5 mg oral tablet) ANGITA PHARMA INC.,Active,9013323,rivaroxaban 2.5 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80247,Marketed,2008-09-16,02316986,Xarelto,1,B01AF01,Rivaroxaban,Tablet,Oral,02316986,XARELTO (rivaroxaban 10 mg oral tablet) BAYER INC,Active,9001257,rivaroxaban 10 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86439,Marketed,2012-01-17,02378604,Xarelto,1,B01AF01,Rivaroxaban,Tablet,Oral,02378604,XARELTO (rivaroxaban 15 mg oral tablet) BAYER INC,Active,9001374,rivaroxaban 15 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86440,Marketed,2012-01-17,02378612,Xarelto,1,B01AF01,Rivaroxaban,Tablet,Oral,02378612,XARELTO (rivaroxaban 20 mg oral tablet) BAYER INC,Active,9001375,rivaroxaban 20 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95947,Marketed,2023-11-01,02470497,Apo-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02470497,APO-RIVAROXABAN (rivaroxaban 10 mg oral tablet) APOTEX INC,Active,9001257,rivaroxaban 10 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95948,Marketed,2023-11-01,02470500,Apo-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02470500,APO-RIVAROXABAN (rivaroxaban 15 mg oral tablet) APOTEX INC,Active,9001374,rivaroxaban 15 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95949,Marketed,2023-11-01,02470519,Apo-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02470519,APO-RIVAROXABAN (rivaroxaban 20 mg oral tablet) APOTEX INC,Active,9001375,rivaroxaban 20 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96172,Marketed,2023-11-01,02472414,Reddy-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02472414,REDDY-RIVAROXABAN (rivaroxaban 10 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9001257,rivaroxaban 10 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96173,Marketed,2023-11-01,02472430,Reddy-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02472430,REDDY-RIVAROXABAN (rivaroxaban 15 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9001374,rivaroxaban 15 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96174,Marketed,2023-11-01,02472422,Reddy-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02472422,REDDY-RIVAROXABAN (rivaroxaban 20 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9001375,rivaroxaban 20 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97146,Marketed,2018-09-28,02480808,Xarelto,1,B01AF01,Rivaroxaban,Tablet,Oral,02480808,XARELTO (rivaroxaban 2.5 mg oral tablet) BAYER INC,Active,9013323,rivaroxaban 2.5 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97270,Marketed,2023-11-01,02482223,Sandoz Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02482223,SANDOZ RIVAROXABAN (rivaroxaban 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001257,rivaroxaban 10 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97271,Marketed,2023-11-01,02482231,Sandoz Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02482231,SANDOZ RIVAROXABAN (rivaroxaban 15 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001374,rivaroxaban 15 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97272,Marketed,2023-11-01,02482258,Sandoz Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02482258,SANDOZ RIVAROXABAN (rivaroxaban 20 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001375,rivaroxaban 20 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97416,Marketed,2023-11-01,02483807,Taro-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02483807,TARO-RIVAROXABAN (rivaroxaban 10 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9001257,rivaroxaban 10 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97417,Marketed,2023-11-01,02483815,Taro-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02483815,TARO-RIVAROXABAN (rivaroxaban 15 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9001374,rivaroxaban 15 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97418,Marketed,2023-11-01,02483823,Taro-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02483823,TARO-RIVAROXABAN (rivaroxaban 20 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9001375,rivaroxaban 20 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99659,Marketed,2023-11-01,02507196,Teva-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02507196,TEVA-RIVAROXABAN (rivaroxaban 10 mg oral tablet) TEVA CANADA LIMITED,Active,9001257,rivaroxaban 10 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99660,Marketed,2023-11-01,02507218,Teva-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02507218,TEVA-RIVAROXABAN (rivaroxaban 15 mg oral tablet) TEVA CANADA LIMITED,Active,9001374,rivaroxaban 15 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99661,Marketed,2023-11-01,02507226,Teva-Rivaroxaban,1,B01AF01,Rivaroxaban,Tablet,Oral,02507226,TEVA-RIVAROXABAN (rivaroxaban 20 mg oral tablet) TEVA CANADA LIMITED,Active,9001375,rivaroxaban 20 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99940,Marketed,2021-06-11,02510162,Xarelto,1,B01AF01,Rivaroxaban,Granules for suspension,Oral,02510162,XARELTO FOR LESS THAN 4 KG (rivaroxaban 1 mg per mL oral suspension) BAYER INC,Active,9014572,rivaroxaban 1 mg per mL oral suspension,8000379,rivaroxaban,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
99941,Marketed,2021-06-11,02510170,Xarelto,1,B01AF01,Rivaroxaban,Granules for suspension,Oral,02510170,XARELTO FOR 4 KG OR MORE (rivaroxaban 1 mg per mL oral suspension) BAYER INC,Active,9014572,rivaroxaban 1 mg per mL oral suspension,8000379,rivaroxaban,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
104093,Marketed,2025-07-11,02552256,JAMP Rivastigmine Capsules,1,N06DA03,Rivastigmine,Capsule,Oral,02552256,JAMP RIVASTIGMINE CAPSULES (rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg oral capsule) JAMP PHARMA CORPORATION,Active,9011704,rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
104094,Marketed,2025-07-11,02552264,JAMP Rivastigmine Capsules,1,N06DA03,Rivastigmine,Capsule,Oral,02552264,JAMP RIVASTIGMINE CAPSULES (rivastigmine (rivastigmine hydrogen tartrate) 3 mg oral capsule) JAMP PHARMA CORPORATION,Active,9011706,rivastigmine (rivastigmine hydrogen tartrate) 3 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
104095,Marketed,2025-07-11,02552272,JAMP Rivastigmine Capsules,1,N06DA03,Rivastigmine,Capsule,Oral,02552272,JAMP RIVASTIGMINE CAPSULES (rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg oral capsule) JAMP PHARMA CORPORATION,Active,9011707,rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
104096,Marketed,2025-07-11,02552280,JAMP Rivastigmine Capsules,1,N06DA03,Rivastigmine,Capsule,Oral,02552280,JAMP RIVASTIGMINE CAPSULES (rivastigmine (rivastigmine hydrogen tartrate) 6 mg oral capsule) JAMP PHARMA CORPORATION,Active,9011708,rivastigmine (rivastigmine hydrogen tartrate) 6 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
65791,Marketed,2022-11-24,02242115,Exelon,1,N06DA03,Rivastigmine,Capsule,Oral,02242115,EXELON (rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg oral capsule) KNIGHT THERAPEUTICS INC.,Active,9011704,rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
65792,Marketed,2022-12-09,02242116,Exelon,1,N06DA03,Rivastigmine,Capsule,Oral,02242116,EXELON (rivastigmine (rivastigmine hydrogen tartrate) 3 mg oral capsule) KNIGHT THERAPEUTICS INC.,Active,9011706,rivastigmine (rivastigmine hydrogen tartrate) 3 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
65793,Marketed,2022-11-17,02242117,Exelon,1,N06DA03,Rivastigmine,Capsule,Oral,02242117,EXELON (rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg oral capsule) KNIGHT THERAPEUTICS INC.,Active,9011707,rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
65794,Marketed,2022-11-28,02242118,Exelon,1,N06DA03,Rivastigmine,Capsule,Oral,02242118,EXELON (rivastigmine (rivastigmine hydrogen tartrate) 6 mg oral capsule) KNIGHT THERAPEUTICS INC.,Active,9011708,rivastigmine (rivastigmine hydrogen tartrate) 6 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
69257,Marketed,2022-11-18,02245240,Exelon,1,N06DA03,Rivastigmine,Solution,Oral,02245240,EXELON (rivastigmine (rivastigmine hydrogen tartrate) 2 mg per mL oral solution) KNIGHT THERAPEUTICS INC.,Active,9011705,rivastigmine (rivastigmine hydrogen tartrate) 2 mg per mL oral solution,8000287,rivastigmine,26643006,Oral,385023001,Oral solution,,,,,,Prescription
78816,Marketed,2022-10-26,02302845,Exelon Patch 5,1,N06DA03,Rivastigmine,Patch,Transdermal,02302845,EXELON PATCH 5 (rivastigmine 4.6 mg per 24 hour transdermal patch) KNIGHT THERAPEUTICS INC.,Active,9011710,rivastigmine 4.6 mg per 24 hour transdermal patch,8000287,rivastigmine,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,,Prescription
78817,Marketed,2022-11-10,02302853,Exelon Patch 10,1,N06DA03,Rivastigmine,Patch,Transdermal,02302853,EXELON PATCH 10 (rivastigmine 9.5 mg per 24 hour transdermal patch) KNIGHT THERAPEUTICS INC.,Active,9011711,rivastigmine 9.5 mg per 24 hour transdermal patch,8000287,rivastigmine,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,,Prescription
81001,Marketed,2009-07-21,02324563,Sandoz Rivastigmine,1,N06DA03,Rivastigmine,Capsule,Oral,02324563,SANDOZ RIVASTIGMINE (rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9011704,rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
81002,Marketed,2009-07-21,02324571,Sandoz Rivastigmine,1,N06DA03,Rivastigmine,Capsule,Oral,02324571,SANDOZ RIVASTIGMINE (rivastigmine (rivastigmine hydrogen tartrate) 3 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9011706,rivastigmine (rivastigmine hydrogen tartrate) 3 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
81003,Marketed,2009-07-21,02324598,Sandoz Rivastigmine,1,N06DA03,Rivastigmine,Capsule,Oral,02324598,SANDOZ RIVASTIGMINE (rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9011707,rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
81004,Marketed,2009-07-21,02324601,Sandoz Rivastigmine,1,N06DA03,Rivastigmine,Capsule,Oral,02324601,SANDOZ RIVASTIGMINE (rivastigmine (rivastigmine hydrogen tartrate) 6 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9011708,rivastigmine (rivastigmine hydrogen tartrate) 6 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
82234,Marketed,2010-04-07,02336715,Apo-Rivastigmine,1,N06DA03,Rivastigmine,Capsule,Oral,02336715,APO-RIVASTIGMINE (rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg oral capsule) APOTEX INC,Active,9011704,rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
82235,Marketed,2010-04-07,02336723,Apo-Rivastigmine,1,N06DA03,Rivastigmine,Capsule,Oral,02336723,APO-RIVASTIGMINE (rivastigmine (rivastigmine hydrogen tartrate) 3 mg oral capsule) APOTEX INC,Active,9011706,rivastigmine (rivastigmine hydrogen tartrate) 3 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
82236,Marketed,2010-04-07,02336731,Apo-Rivastigmine,1,N06DA03,Rivastigmine,Capsule,Oral,02336731,APO-RIVASTIGMINE (rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg oral capsule) APOTEX INC,Active,9011707,rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
82237,Marketed,2010-04-07,02336758,Apo-Rivastigmine,1,N06DA03,Rivastigmine,Capsule,Oral,02336758,APO-RIVASTIGMINE (rivastigmine (rivastigmine hydrogen tartrate) 6 mg oral capsule) APOTEX INC,Active,9011708,rivastigmine (rivastigmine hydrogen tartrate) 6 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88650,Marketed,2013-11-27,02401614,Med-Rivastigmine,1,N06DA03,Rivastigmine,Capsule,Oral,02401614,MED-RIVASTIGMINE (rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg oral capsule) GENERIC MEDICAL PARTNERS INC,Active,9011704,rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88651,Marketed,2013-11-27,02401622,Med-Rivastigmine,1,N06DA03,Rivastigmine,Capsule,Oral,02401622,MED-RIVASTIGMINE (rivastigmine (rivastigmine hydrogen tartrate) 3 mg oral capsule) GENERIC MEDICAL PARTNERS INC,Active,9011706,rivastigmine (rivastigmine hydrogen tartrate) 3 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88652,Marketed,2014-11-12,02401630,Med-Rivastigmine,1,N06DA03,Rivastigmine,Capsule,Oral,02401630,MED-RIVASTIGMINE (rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg oral capsule) GENERIC MEDICAL PARTNERS INC,Active,9011707,rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88653,Marketed,2013-11-27,02401649,Med-Rivastigmine,1,N06DA03,Rivastigmine,Capsule,Oral,02401649,MED-RIVASTIGMINE (rivastigmine (rivastigmine hydrogen tartrate) 6 mg oral capsule) GENERIC MEDICAL PARTNERS INC,Active,9011708,rivastigmine (rivastigmine hydrogen tartrate) 6 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90814,Marketed,2016-12-05,02423413,Mylan-Rivastigmine Patch 5,1,N06DA03,Rivastigmine,Patch,Transdermal,02423413,MYLAN-RIVASTIGMINE PATCH 5 (rivastigmine 4.6 mg per 24 hour transdermal patch) MYLAN PHARMACEUTICALS ULC,Active,9011710,rivastigmine 4.6 mg per 24 hour transdermal patch,8000287,rivastigmine,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,,Prescription
90815,Marketed,2016-12-05,02423421,Mylan-Rivastigmine Patch 10,1,N06DA03,Rivastigmine,Patch,Transdermal,02423421,MYLAN-RIVASTIGMINE PATCH 10 (rivastigmine 9.5 mg per 24 hour transdermal patch) MYLAN PHARMACEUTICALS ULC,Active,9011711,rivastigmine 9.5 mg per 24 hour transdermal patch,8000287,rivastigmine,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,,Prescription
91089,Marketed,2016-11-30,02426293,Sandoz Rivastigmine Patch 5,1,N06DA03,Rivastigmine,Patch,Transdermal,02426293,SANDOZ RIVASTIGMINE PATCH 5 (rivastigmine 4.6 mg per 24 hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9011710,rivastigmine 4.6 mg per 24 hour transdermal patch,8000287,rivastigmine,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,,Prescription
91090,Marketed,2016-11-30,02426307,Sandoz Rivastigmine Patch 10,1,N06DA03,Rivastigmine,Patch,Transdermal,02426307,SANDOZ RIVASTIGMINE PATCH 10 (rivastigmine 9.5 mg per 24 hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9011711,rivastigmine 9.5 mg per 24 hour transdermal patch,8000287,rivastigmine,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,,Prescription
91722,Marketed,2022-10-26,02432803,Exelon Patch 15,1,N06DA03,Rivastigmine,Patch,Transdermal,02432803,EXELON PATCH 15 (rivastigmine 13.3 mg per 24 hour transdermal patch) KNIGHT THERAPEUTICS INC.,Active,9011709,rivastigmine 13.3 mg per 24 hour transdermal patch,8000287,rivastigmine,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,,Prescription
97561,Marketed,2020-02-10,02485362,JAMP Rivastigmine,1,N06DA03,Rivastigmine,Capsule,Oral,02485362,JAMP RIVASTIGMINE (rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg oral capsule) JAMP PHARMA CORPORATION,Active,9011704,rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97562,Marketed,2020-02-10,02485370,JAMP Rivastigmine,1,N06DA03,Rivastigmine,Capsule,Oral,02485370,JAMP RIVASTIGMINE (rivastigmine (rivastigmine hydrogen tartrate) 3 mg oral capsule) JAMP PHARMA CORPORATION,Active,9011706,rivastigmine (rivastigmine hydrogen tartrate) 3 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97563,Marketed,2020-02-10,02485389,JAMP Rivastigmine,1,N06DA03,Rivastigmine,Capsule,Oral,02485389,JAMP RIVASTIGMINE (rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg oral capsule) JAMP PHARMA CORPORATION,Active,9011707,rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97564,Marketed,2020-02-10,02485397,JAMP Rivastigmine,1,N06DA03,Rivastigmine,Capsule,Oral,02485397,JAMP RIVASTIGMINE (rivastigmine (rivastigmine hydrogen tartrate) 6 mg oral capsule) JAMP PHARMA CORPORATION,Active,9011708,rivastigmine (rivastigmine hydrogen tartrate) 6 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
100855,Marketed,2022-06-01,02519283,Skyrizi,1,L04AC18,Rizankizumab,Solution,Subcutaneous,02519283,SKYRIZI (risankizumab 150 mg per 1 mL solution for injection syringe) ABBVIE CORPORATION,Active,9014729,risankizumab 150 mg per 1 mL solution for injection syringe,8002266,risankizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
100855,Marketed,2022-06-01,02519283,Skyrizi,1,L04AC18,Rizankizumab,Solution,Subcutaneous,02519283,SKYRIZI (risankizumab 150 mg per 1 mL solution for injection syringe) ABBVIE CORPORATION,Active,9014729,risankizumab 150 mg per 1 mL solution for injection syringe,8002266,risankizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Schedule D
100857,Marketed,2022-06-01,02519291,Skyrizi,1,L04AC18,Rizankizumab,Solution,Subcutaneous,02519291,SKYRIZI (risankizumab 150 mg per 1 mL solution for injection pen) ABBVIE CORPORATION,Active,9014728,risankizumab 150 mg per 1 mL solution for injection pen,8002266,risankizumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,,Prescription
100857,Marketed,2022-06-01,02519291,Skyrizi,1,L04AC18,Rizankizumab,Solution,Subcutaneous,02519291,SKYRIZI (risankizumab 150 mg per 1 mL solution for injection pen) ABBVIE CORPORATION,Active,9014728,risankizumab 150 mg per 1 mL solution for injection pen,8002266,risankizumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,,Schedule D
102116,Marketed,2023-03-14,02532093,Skyrizi,1,L04AC18,Rizankizumab,Solution,Subcutaneous,02532093,SKYRIZI (risankizumab 360 mg per 2.4 mL solution for injection cartridge) ABBVIE CORPORATION,Active,9014843,risankizumab 360 mg per 2.4 mL solution for injection cartridge,8002266,risankizumab,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),1.0,,,Schedule D
102116,Marketed,2023-03-14,02532093,Skyrizi,1,L04AC18,Rizankizumab,Solution,Subcutaneous,02532093,SKYRIZI (risankizumab 360 mg per 2.4 mL solution for injection cartridge) ABBVIE CORPORATION,Active,9014843,risankizumab 360 mg per 2.4 mL solution for injection cartridge,8002266,risankizumab,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),1.0,,,Prescription
102117,Marketed,2022-12-01,02532107,Skyrizi,1,L04AC18,Rizankizumab,Solution,Intravenous,02532107,SKYRIZI (risankizumab 600 mg per 10 mL solution for injection vial) ABBVIE CORPORATION,Active,9014812,risankizumab 600 mg per 10 mL solution for injection vial,8002266,risankizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
102117,Marketed,2022-12-01,02532107,Skyrizi,1,L04AC18,Rizankizumab,Solution,Intravenous,02532107,SKYRIZI (risankizumab 600 mg per 10 mL solution for injection vial) ABBVIE CORPORATION,Active,9014812,risankizumab 600 mg per 10 mL solution for injection vial,8002266,risankizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
104147,Marketed,2025-02-14,02552507,Skyrizi,1,L04AC18,Rizankizumab,Solution,Subcutaneous,02552507,SKYRIZI (risankizumab 180 mg per 1.2 mL solution for injection cartridge) ABBVIE CORPORATION,Active,9015206,risankizumab 180 mg per 1.2 mL solution for injection cartridge,8002266,risankizumab,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge,1.0,,,Prescription
104147,Marketed,2025-02-14,02552507,Skyrizi,1,L04AC18,Rizankizumab,Solution,Subcutaneous,02552507,SKYRIZI (risankizumab 180 mg per 1.2 mL solution for injection cartridge) ABBVIE CORPORATION,Active,9015206,risankizumab 180 mg per 1.2 mL solution for injection cartridge,8002266,risankizumab,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge,1.0,,,Schedule D
100607,Marketed,2022-01-07,02516756,Rizatriptan,1,N02CC04,Rizatriptan,Tablet,Oral,02516756,RIZATRIPTAN (rizatriptan (rizatriptan benzoate) 10 mg oral tablet) SANIS HEALTH INC,Active,9000864,rizatriptan (rizatriptan benzoate) 10 mg oral tablet,8000276,rizatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103664,Marketed,2025-01-29,02547716,M-Rizatriptan,1,N02CC04,Rizatriptan,Tablet,Oral,02547716,M-RIZATRIPTAN (rizatriptan (rizatriptan benzoate) 10 mg oral tablet) MANTRA PHARMA INC,Active,9000864,rizatriptan (rizatriptan benzoate) 10 mg oral tablet,8000276,rizatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103764,Marketed,2025-06-10,02548801,M-Rizatriptan ODT,1,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02548801,M-RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet) MANTRA PHARMA INC,Active,9000897,rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
103765,Marketed,2025-06-10,02548828,M-Rizatriptan ODT,1,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02548828,M-RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet) MANTRA PHARMA INC,Active,9000865,rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
64089,Marketed,2023-05-29,02240518,Maxalt RPD,1,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02240518,MAXALT RPD (rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet) ORGANON CANADA INC.,Active,9000897,rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
64090,Marketed,2023-03-06,02240519,Maxalt RPD,1,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02240519,MAXALT RPD (rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet) ORGANON CANADA INC.,Active,9000865,rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
64092,Marketed,2022-09-20,02240521,Maxalt,1,N02CC04,Rizatriptan,Tablet,Oral,02240521,MAXALT (rizatriptan (rizatriptan benzoate) 10 mg oral tablet) ORGANON CANADA INC.,Active,9000864,rizatriptan (rizatriptan benzoate) 10 mg oral tablet,8000276,rizatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83711,Marketed,2012-01-30,02351870,Sandoz Rizatriptan ODT,1,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02351870,SANDOZ RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet) SANDOZ CANADA INCORPORATED,Active,9000897,rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
83712,Marketed,2012-01-30,02351889,Sandoz Rizatriptan ODT,1,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02351889,SANDOZ RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet) SANDOZ CANADA INCORPORATED,Active,9000865,rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
86508,Marketed,2012-01-31,02379198,Mylan-Rizatriptan ODT,1,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02379198,MYLAN-RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet) MYLAN PHARMACEUTICALS ULC,Active,9000897,rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
86509,Marketed,2012-01-31,02379201,Mylan-Rizatriptan ODT,1,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02379201,MYLAN-RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet) MYLAN PHARMACEUTICALS ULC,Active,9000865,rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
86554,Marketed,2018-11-05,02379678,Mar-Rizatriptan,1,N02CC04,Rizatriptan,Tablet,Oral,02379678,MAR-RIZATRIPTAN (rizatriptan (rizatriptan benzoate) 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000864,rizatriptan (rizatriptan benzoate) 10 mg oral tablet,8000276,rizatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86627,Marketed,2021-05-06,02380463,JAMP Rizatriptan,1,N02CC04,Rizatriptan,Tablet,Oral,02380463,JAMP RIZATRIPTAN (rizatriptan (rizatriptan benzoate) 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000864,rizatriptan (rizatriptan benzoate) 10 mg oral tablet,8000276,rizatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86756,Marketed,2020-05-06,02381702,Act Rizatriptan,1,N02CC04,Rizatriptan,Tablet,Oral,02381702,ACT RIZATRIPTAN (rizatriptan (rizatriptan benzoate) 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000864,rizatriptan (rizatriptan benzoate) 10 mg oral tablet,8000276,rizatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87859,Marketed,2012-10-30,02393360,PMS-Rizatriptan RDT,1,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02393360,PMS-RIZATRIPTAN RDT (rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet) PHARMASCIENCE INC,Active,9000897,rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
87860,Marketed,2012-10-30,02393379,PMS-Rizatriptan RDT,1,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02393379,PMS-RIZATRIPTAN RDT (rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet) PHARMASCIENCE INC,Active,9000865,rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
87868,Marketed,2013-03-06,02393468,Apo-Rizatriptan,1,N02CC04,Rizatriptan,Tablet,Oral,02393468,APO-RIZATRIPTAN (rizatriptan (rizatriptan benzoate) 5 mg oral tablet) APOTEX INC,Active,9001382,rizatriptan (rizatriptan benzoate) 5 mg oral tablet,8000276,rizatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87869,Marketed,2013-03-06,02393476,Apo-Rizatriptan,1,N02CC04,Rizatriptan,Tablet,Oral,02393476,APO-RIZATRIPTAN (rizatriptan (rizatriptan benzoate) 10 mg oral tablet) APOTEX INC,Active,9000864,rizatriptan (rizatriptan benzoate) 10 mg oral tablet,8000276,rizatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88170,Marketed,2014-11-04,02396661,Teva-Rizatriptan ODT,1,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02396661,TEVA-RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet) TEVA CANADA LIMITED,Active,9000897,rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
88171,Marketed,2014-11-04,02396688,Teva-Rizatriptan ODT,1,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02396688,TEVA-RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet) TEVA CANADA LIMITED,Active,9000865,rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
90039,Marketed,2013-11-28,02415798,Rizatriptan RDT,1,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02415798,RIZATRIPTAN RDT (rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet) PRO DOC LIMITEE,Active,9000897,rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
90040,Marketed,2013-11-28,02415801,Rizatriptan RDT,1,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02415801,RIZATRIPTAN RDT (rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet) PRO DOC LIMITEE,Active,9000865,rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
92741,Marketed,2015-07-23,02442906,Rizatriptan ODT,1,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02442906,RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet) SANIS HEALTH INC,Active,9000897,rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
92742,Marketed,2015-07-23,02442914,Rizatriptan ODT,1,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02442914,RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet) SANIS HEALTH INC,Active,9000865,rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
93138,Marketed,2018-02-13,02446111,Rizatriptan ODT,1,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02446111,RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet) SIVEM PHARMACEUTICALS ULC,Active,9000897,rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
93139,Marketed,2018-02-13,02446138,Rizatriptan ODT,1,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02446138,RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet) SIVEM PHARMACEUTICALS ULC,Active,9000865,rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
95062,Marketed,2018-02-15,02462788,Mar-Rizatriptan ODT,1,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02462788,MAR-RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet) MARCAN PHARMACEUTICALS INC,Active,9000897,rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
95063,Marketed,2018-02-15,02462796,Mar-Rizatriptan ODT,1,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02462796,MAR-RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet) MARCAN PHARMACEUTICALS INC,Active,9000865,rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
95327,Marketed,2018-02-12,02465086,JAMP-Rizatriptan ODT,1,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02465086,JAMP-RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet) JAMP PHARMA CORPORATION,Active,9000897,rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
95328,Marketed,2018-02-12,02465094,JAMP-Rizatriptan ODT,1,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02465094,JAMP-RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet) JAMP PHARMA CORPORATION,Active,9000865,rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
97371,Marketed,2019-10-07,02483270,Accel-Rizatriptan ODT,1,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02483270,ACCEL-RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet) ACCEL PHARMA INC,Active,9000897,rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
97372,Marketed,2019-10-07,02483289,Accel-Rizatriptan ODT,1,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02483289,ACCEL-RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet) ACCEL PHARMA INC,Active,9000865,rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
97947,Marketed,2022-04-06,02489384,Nra-Rizatriptan ODT,1,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02489384,NRA-RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet) NORA PHARMA INC,Active,9000865,rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
98249,Marketed,2021-08-06,02492482,AG-Rizatriptan ODT,1,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02492482,AG-RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet) ANGITA PHARMA INC.,Active,9000897,rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
98250,Marketed,2020-11-25,02492490,AG-Rizatriptan ODT,1,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02492490,AG-RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet) ANGITA PHARMA INC.,Active,9000865,rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
100710,Marketed,2023-09-29,02517744,Rocuronium Bromide Injection,1,M03AC09,Rocuronium bromide,Solution,Intravenous,02517744,ROCURONIUM BROMIDE INJECTION (rocuronium bromide 50 mg per 5 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9013325,rocuronium bromide 50 mg per 5 mL solution for injection vial,8001924,rocuronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
101786,Marketed,2024-10-08,02528657,Rocuronium Bromide Injection,1,M03AC09,Rocuronium bromide,Solution,Intravenous,77701164,ROCURONIUM BROMIDE INJECTION (rocuronium bromide 50 mg per 5 mL solution for injection vial) EUGIA PHARMA INC.,Active,9013325,rocuronium bromide 50 mg per 5 mL solution for injection vial,8001924,rocuronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
101786,Marketed,2024-10-08,02528657,Rocuronium Bromide Injection,1,M03AC09,Rocuronium bromide,Solution,Intravenous,77701165,ROCURONIUM BROMIDE INJECTION (rocuronium bromide 100 mg per 10 mL solution for injection vial) EUGIA PHARMA INC.,Active,9013324,rocuronium bromide 100 mg per 10 mL solution for injection vial,8001924,rocuronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
101907,Marketed,2024-02-26,02529831,Rocuronium Bromide Injection,1,M03AC09,Rocuronium bromide,Solution,Intravenous,02529831,ROCURONIUM BROMIDE INJECTION (rocuronium bromide 50 mg per 5 mL solution for injection vial) JAMP PHARMA CORPORATION,Active,9013325,rocuronium bromide 50 mg per 5 mL solution for injection vial,8001924,rocuronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
80390,Marketed,2008-10-24,02318415,Rocuronium Bromide Injection,1,M03AC09,Rocuronium bromide,Solution,Intravenous,02318415,ROCURONIUM BROMIDE INJECTION (rocuronium bromide 50 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013325,rocuronium bromide 50 mg per 5 mL solution for injection vial,8001924,rocuronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
95863,Marketed,2026-05-05,02469774,Rocuronium Bromide Injection,1,M03AC09,Rocuronium bromide,Solution,Intravenous,02469774,ROCURONIUM BROMIDE INJECTION (rocuronium bromide 50 mg per 5 mL solution for injection vial) JUNO PHARMA CANADA INC.,Active,9013325,rocuronium bromide 50 mg per 5 mL solution for injection vial,8001924,rocuronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
98856,Marketed,2020-11-24,02498820,Rocuronium Bromide Injection,1,M03AC09,Rocuronium bromide,Solution,Intravenous,77701028,ROCURONIUM BROMIDE INJECTION (rocuronium bromide 100 mg per 10 mL solution for injection vial) AURO PHARMA INC,Active,9013324,rocuronium bromide 100 mg per 10 mL solution for injection vial,8001924,rocuronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
98856,Marketed,2020-11-24,02498820,Rocuronium Bromide Injection,1,M03AC09,Rocuronium bromide,Solution,Intravenous,77701029,ROCURONIUM BROMIDE INJECTION (rocuronium bromide 50 mg per 5 mL solution for injection vial) AURO PHARMA INC,Active,9013325,rocuronium bromide 50 mg per 5 mL solution for injection vial,8001924,rocuronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
102624,Marketed,2025-04-29,02537532,Zoryve,1,D05AX06,Roflumilast,Cream,Topical,02537532,"ZORYVE (roflumilast 0.3 % cutaneous cream) ARCUTIS CANADA, INC.",Active,9014875,roflumilast 0.3 % cutaneous cream,8001155,roflumilast,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
104152,Marketed,2024-10-22,02552566,Zoryve,1,D05AX06,Roflumilast,Foam,Topical,02552566,"ZORYVE (roflumilast 0.3 % cutaneous foam) ARCUTIS CANADA, INC.",Active,9015125,roflumilast 0.3 % cutaneous foam,8001155,roflumilast,448598008,Cutaneous,385103000,Conventional release cutaneous foam,,,,,,Prescription
104484,Marketed,2025-03-18,02556146,Zoryve,1,D05AX06,Roflumilast,Cream,Topical,02556146,"ZORYVE (roflumilast 0.15 % cutaneous cream) ARCUTIS CANADA, INC.",Active,9015178,roflumilast 0.15 % cutaneous cream,8001155,roflumilast,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
84447,Marketed,2017-07-20,02359456,Daxas,1,R03DX07,Roflumilast,Tablet,Oral,02359456,DAXAS (roflumilast 500 mcg oral tablet) ASTRAZENECA CANADA INC,Active,9012538,roflumilast 500 mcg oral tablet,8001155,roflumilast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89895,Marketed,2025-11-04,02414295,Istodax,1,L01XH02,Romidepsin,"Powder for solution,Kit",Intravenous,02414295,ISTODAX (romidepsin 10 mg per vial powder for solution for injection with diluent solution) BRISTOL-MYERS SQUIBB CANADA,Active,9013326,romidepsin 10 mg per vial powder for solution for injection with diluent solution,8001925,romidepsin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
80832,Marketed,2009-04-15,02322854,Nplate,1,B02BX04,Romiplostim,Powder for solution,Subcutaneous,02322854,NPLATE (romiplostim 375 mcg per vial powder for solution for injection) AMGEN CANADA INC,Active,9015225,romiplostim 375 mcg per vial powder for solution for injection,8001926,romiplostim,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,,,,Prescription
80832,Marketed,2009-04-15,02322854,Nplate,1,B02BX04,Romiplostim,Powder for solution,Subcutaneous,02322854,NPLATE (romiplostim 375 mcg per vial powder for solution for injection) AMGEN CANADA INC,Active,9015225,romiplostim 375 mcg per vial powder for solution for injection,8001926,romiplostim,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,,,,Schedule D
80833,Marketed,2009-04-15,02322862,Nplate,1,B02BX04,Romiplostim,Powder for solution,Subcutaneous,02322862,NPLATE (romiplostim 625 mcg per vial powder for solution for injection) AMGEN CANADA INC,Active,9015226,romiplostim 625 mcg per vial powder for solution for injection,8001926,romiplostim,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,,,,Prescription
80833,Marketed,2009-04-15,02322862,Nplate,1,B02BX04,Romiplostim,Powder for solution,Subcutaneous,02322862,NPLATE (romiplostim 625 mcg per vial powder for solution for injection) AMGEN CANADA INC,Active,9015226,romiplostim 625 mcg per vial powder for solution for injection,8001926,romiplostim,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,,,,Schedule D
97967,Marketed,2019-08-12,02489597,Evenity,1,M05BX06,Romosozumab,Solution,Subcutaneous,02489597,EVENITY (romosozumab 105 mg per 1.17 mL solution for injection syringe) AMGEN CANADA INC,Active,9014157,romosozumab 105 mg per 1.17 mL solution for injection syringe,8002287,romosozumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Schedule D
97967,Marketed,2019-08-12,02489597,Evenity,1,M05BX06,Romosozumab,Solution,Subcutaneous,02489597,EVENITY (romosozumab 105 mg per 1.17 mL solution for injection syringe) AMGEN CANADA INC,Active,9014157,romosozumab 105 mg per 1.17 mL solution for injection syringe,8002287,romosozumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
79955,Marketed,2025-06-26,02314037,SPC-Ropinirole,1,N04BC04,Ropinirole,Tablet,Oral,02314037,SPC-ROPINIROLE (ropinirole (ropinirole hydrochloride) 0.25 mg oral tablet) SUN PHARMA CANADA INC,Active,9003165,ropinirole (ropinirole hydrochloride) 0.25 mg oral tablet,8001519,ropinirole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79957,Marketed,2025-06-26,02314053,SPC-Ropinirole,1,N04BC04,Ropinirole,Tablet,Oral,02314053,SPC-ROPINIROLE (ropinirole (ropinirole hydrochloride) 1 mg oral tablet) SUN PHARMA CANADA INC,Active,9003161,ropinirole (ropinirole hydrochloride) 1 mg oral tablet,8001519,ropinirole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79958,Marketed,2025-06-26,02314061,SPC-Ropinirole,1,N04BC04,Ropinirole,Tablet,Oral,02314061,SPC-ROPINIROLE (ropinirole (ropinirole hydrochloride) 2 mg oral tablet) SUN PHARMA CANADA INC,Active,9003162,ropinirole (ropinirole hydrochloride) 2 mg oral tablet,8001519,ropinirole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79959,Marketed,2025-06-26,02314088,SPC-Ropinirole,1,N04BC04,Ropinirole,Tablet,Oral,02314088,SPC-ROPINIROLE (ropinirole (ropinirole hydrochloride) 5 mg oral tablet) SUN PHARMA CANADA INC,Active,9003163,ropinirole (ropinirole hydrochloride) 5 mg oral tablet,8001519,ropinirole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80234,Marketed,2020-05-22,02316846,Teva-Ropinirole,1,N04BC04,Ropinirole,Tablet,Oral,02316846,TEVA-ROPINIROLE (ropinirole (ropinirole hydrochloride) 0.25 mg oral tablet) TEVA CANADA LIMITED,Active,9003165,ropinirole (ropinirole hydrochloride) 0.25 mg oral tablet,8001519,ropinirole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80235,Marketed,2020-05-22,02316854,Teva-Ropinirole,1,N04BC04,Ropinirole,Tablet,Oral,02316854,TEVA-ROPINIROLE (ropinirole (ropinirole hydrochloride) 1 mg oral tablet) TEVA CANADA LIMITED,Active,9003161,ropinirole (ropinirole hydrochloride) 1 mg oral tablet,8001519,ropinirole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80236,Marketed,2020-05-22,02316862,Teva-Ropinirole,1,N04BC04,Ropinirole,Tablet,Oral,02316862,TEVA-ROPINIROLE (ropinirole (ropinirole hydrochloride) 2 mg oral tablet) TEVA CANADA LIMITED,Active,9003162,ropinirole (ropinirole hydrochloride) 2 mg oral tablet,8001519,ropinirole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80237,Marketed,2020-05-22,02316870,Teva-Ropinirole,1,N04BC04,Ropinirole,Tablet,Oral,02316870,TEVA-ROPINIROLE (ropinirole (ropinirole hydrochloride) 5 mg oral tablet) TEVA CANADA LIMITED,Active,9003163,ropinirole (ropinirole hydrochloride) 5 mg oral tablet,8001519,ropinirole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
47216,Marketed,2017-07-28,02229411,Naropin,1,N01BB09,Ropivacaine,Solution,"Epidural,Block/infiltration",77700848,NAROPIN (ropivacaine hydrochloride 200 mg per 100 mL solution for injection bag) ASPEN PHARMACARE CANADA INC.,Active,9013331,ropivacaine hydrochloride 200 mg per 100 mL solution for injection bag,8001927,ropivacaine,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Ethical
47216,Marketed,2017-07-28,02229411,Naropin,1,N01BB09,Ropivacaine,Solution,"Epidural,Block/infiltration",77700849,NAROPIN (ropivacaine hydrochloride 400 mg per 200 mL solution for injection bag) ASPEN PHARMACARE CANADA INC.,Active,9013334,ropivacaine hydrochloride 400 mg per 200 mL solution for injection bag,8001927,ropivacaine,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Ethical
47220,Marketed,2018-09-20,02229415,Naropin,1,N01BB09,Ropivacaine,Solution,"Block/infiltration,Epidural",02229415,NAROPIN (ropivacaine hydrochloride 100 mg per 20 mL solution for injection ampoule) ASPEN PHARMACARE CANADA INC.,Active,9013329,ropivacaine hydrochloride 100 mg per 20 mL solution for injection ampoule,8001927,ropivacaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
47225,Marketed,2019-01-11,02229418,Naropin,1,N01BB09,Ropivacaine,Solution,Epidural,77700850,NAROPIN (ropivacaine hydrochloride 200 mg per 20 mL solution for injection ampoule) ASPEN PHARMACARE CANADA INC.,Active,9013332,ropivacaine hydrochloride 200 mg per 20 mL solution for injection ampoule,8001927,ropivacaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
47225,Marketed,2019-01-11,02229418,Naropin,1,N01BB09,Ropivacaine,Solution,Epidural,77700851,NAROPIN (ropivacaine hydrochloride 100 mg per 10 mL solution for injection ampoule) ASPEN PHARMACARE CANADA INC.,Active,9013327,ropivacaine hydrochloride 100 mg per 10 mL solution for injection ampoule,8001927,ropivacaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
92374,Marketed,2018-09-28,02439379,"Ropivacaine Hydrochloride Injection, USP",1,N01BB09,Ropivacaine,Solution,"Infiltration,Epidural",77700978,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP (ropivacaine hydrochloride 400 mg per 200 mL solution for injection bag) FRESENIUS KABI CANADA LTD",Active,9013334,ropivacaine hydrochloride 400 mg per 200 mL solution for injection bag,8001927,ropivacaine,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Ethical
92374,Marketed,2018-09-28,02439379,"Ropivacaine Hydrochloride Injection, USP",1,N01BB09,Ropivacaine,Solution,"Infiltration,Epidural",77700979,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP (ropivacaine hydrochloride 40 mg per 20 mL solution for injection ampoule) FRESENIUS KABI CANADA LTD",Active,9013604,ropivacaine hydrochloride 40 mg per 20 mL solution for injection ampoule,8001927,ropivacaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
92374,Marketed,2018-09-28,02439379,"Ropivacaine Hydrochloride Injection, USP",1,N01BB09,Ropivacaine,Solution,"Infiltration,Epidural",77700980,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP (ropivacaine hydrochloride 200 mg per 100 mL solution for injection bag) FRESENIUS KABI CANADA LTD",Active,9013331,ropivacaine hydrochloride 200 mg per 100 mL solution for injection bag,8001927,ropivacaine,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Ethical
92374,Marketed,2018-09-28,02439379,"Ropivacaine Hydrochloride Injection, USP",1,N01BB09,Ropivacaine,Solution,"Infiltration,Epidural",77700981,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP (ropivacaine hydrochloride 20 mg per 10 mL solution for injection ampoule) FRESENIUS KABI CANADA LTD",Active,9013603,ropivacaine hydrochloride 20 mg per 10 mL solution for injection ampoule,8001927,ropivacaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
92375,Marketed,2019-09-13,02439387,"Ropivacaine Hydrochloride Injection, USP",1,N01BB09,Ropivacaine,Solution,"Block/infiltration,Epidural",02439387,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP (ropivacaine hydrochloride 50 mg per 10 mL solution for injection ampoule) FRESENIUS KABI CANADA LTD",Active,9014247,ropivacaine hydrochloride 50 mg per 10 mL solution for injection ampoule,8001927,ropivacaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
92377,Marketed,2019-02-26,02439409,"Ropivacaine Hydrochloride Injection, USP",1,N01BB09,Ropivacaine,Solution,Epidural,77701002,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP (ropivacaine hydrochloride 200 mg per 20 mL solution for injection ampoule) FRESENIUS KABI CANADA LTD",Active,9013332,ropivacaine hydrochloride 200 mg per 20 mL solution for injection ampoule,8001927,ropivacaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
92377,Marketed,2019-02-26,02439409,"Ropivacaine Hydrochloride Injection, USP",1,N01BB09,Ropivacaine,Solution,Epidural,77701003,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP (ropivacaine hydrochloride 100 mg per 10 mL solution for injection ampoule) FRESENIUS KABI CANADA LTD",Active,9013327,ropivacaine hydrochloride 100 mg per 10 mL solution for injection ampoule,8001927,ropivacaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
88817,Marketed,2019-09-17,02403366,Rosiglitazone,1,A10BG02,Rosiglitazone,Tablet,Oral,02403366,ROSIGLITAZONE (rosiglitazone (rosiglitazone maleate) 2 mg oral tablet) AA PHARMA INC,Active,9003473,rosiglitazone (rosiglitazone maleate) 2 mg oral tablet,8001087,rosiglitazone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88818,Marketed,2019-09-17,02403374,Rosiglitazone,1,A10BG02,Rosiglitazone,Tablet,Oral,02403374,ROSIGLITAZONE (rosiglitazone (rosiglitazone maleate) 4 mg oral tablet) AA PHARMA INC,Active,9003474,rosiglitazone (rosiglitazone maleate) 4 mg oral tablet,8001087,rosiglitazone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88819,Marketed,2019-09-17,02403382,Rosiglitazone,1,A10BG02,Rosiglitazone,Tablet,Oral,02403382,ROSIGLITAZONE (rosiglitazone (rosiglitazone maleate) 8 mg oral tablet) AA PHARMA INC,Active,9003475,rosiglitazone (rosiglitazone maleate) 8 mg oral tablet,8001087,rosiglitazone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102535,Marketed,2023-09-14,02536595,Nra-Rosuvastatin Tablets,1,C10AA07,Rosuvastatin,Tablet,Oral,02536595,NRA-ROSUVASTATIN TABLETS (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) NORA PHARMA INC,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102537,Marketed,2023-09-12,02536609,Nra-Rosuvastatin Tablets,1,C10AA07,Rosuvastatin,Tablet,Oral,02536609,NRA-ROSUVASTATIN TABLETS (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) NORA PHARMA INC,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102538,Marketed,2023-09-12,02536625,Nra-Rosuvastatin Tablets,1,C10AA07,Rosuvastatin,Tablet,Oral,02536625,NRA-ROSUVASTATIN TABLETS (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) NORA PHARMA INC,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102539,Marketed,2023-09-12,02536633,Nra-Rosuvastatin Tablets,1,C10AA07,Rosuvastatin,Tablet,Oral,02536633,NRA-ROSUVASTATIN TABLETS (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) NORA PHARMA INC,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104423,Marketed,2025-06-05,02555492,NB-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02555492,NB-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) NB PHARMA INC.,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104424,Marketed,2025-06-05,02555506,NB-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02555506,NB-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) NB PHARMA INC.,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104425,Marketed,2025-06-05,02555514,NB-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02555514,NB-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) NB PHARMA INC.,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104426,Marketed,2025-06-05,02555522,NB-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02555522,NB-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) NB PHARMA INC.,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71404,Marketed,2003-02-19,02247162,Crestor - 10 mg,1,C10AA07,Rosuvastatin,Tablet,Oral,02247162,CRESTOR - 10MG (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) ASTRAZENECA CANADA INC,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71405,Marketed,2003-02-19,02247163,Crestor - 20 mg,1,C10AA07,Rosuvastatin,Tablet,Oral,02247163,CRESTOR - 20MG (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) ASTRAZENECA CANADA INC,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71406,Marketed,2003-02-19,02247164,Crestor - 40 mg,1,C10AA07,Rosuvastatin,Tablet,Oral,02247164,CRESTOR - 40MG (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) ASTRAZENECA CANADA INC,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75100,Marketed,2005-03-18,02265540,Crestor - 5 mg,1,C10AA07,Rosuvastatin,Tablet,Oral,02265540,CRESTOR - 5MG (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) ASTRAZENECA CANADA INC,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82362,Marketed,2012-04-02,02337975,Apo-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02337975,APO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) APOTEX INC,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82363,Marketed,2012-04-02,02337983,Apo-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02337983,APO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) APOTEX INC,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82364,Marketed,2012-04-02,02337991,Apo-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02337991,APO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) APOTEX INC,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82365,Marketed,2012-04-02,02338009,Apo-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02338009,APO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) APOTEX INC,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82437,Marketed,2012-03-15,02338726,Sandoz Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02338726,SANDOZ ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82438,Marketed,2012-03-15,02338734,Sandoz Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02338734,SANDOZ ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82439,Marketed,2012-03-15,02338742,Sandoz Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02338742,SANDOZ ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82440,Marketed,2012-03-15,02338750,Sandoz Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02338750,SANDOZ ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83977,Marketed,2012-03-15,02354608,Teva-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02354608,TEVA-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) TEVA CANADA LIMITED,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83978,Marketed,2012-03-15,02354616,Teva-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02354616,TEVA-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) TEVA CANADA LIMITED,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83979,Marketed,2012-03-15,02354624,Teva-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02354624,TEVA-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) TEVA CANADA LIMITED,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83980,Marketed,2012-03-15,02354632,Teva-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02354632,TEVA-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) TEVA CANADA LIMITED,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86432,Marketed,2012-03-15,02378523,PMS-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02378523,PMS-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) PHARMASCIENCE INC,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86433,Marketed,2012-03-15,02378531,PMS-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02378531,PMS-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) PHARMASCIENCE INC,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86434,Marketed,2012-03-15,02378558,PMS-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02378558,PMS-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) PHARMASCIENCE INC,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86435,Marketed,2012-03-15,02378566,PMS-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02378566,PMS-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) PHARMASCIENCE INC,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86586,Marketed,2025-11-25,02380013,Riva-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02380013,RIVA-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86589,Marketed,2025-11-25,02380056,Riva-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02380056,RIVA-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86590,Marketed,2025-11-25,02380064,Riva-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02380064,RIVA-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86594,Marketed,2025-11-25,02380102,Riva-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02380102,RIVA-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86695,Marketed,2025-09-03,02381176,Pro-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02381176,PRO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) PRO DOC LIMITEE,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86696,Marketed,2025-09-03,02381184,Pro-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02381184,PRO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) PRO DOC LIMITEE,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86697,Marketed,2025-09-03,02381192,Pro-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02381192,PRO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) PRO DOC LIMITEE,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86698,Marketed,2025-09-03,02381206,Pro-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02381206,PRO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) PRO DOC LIMITEE,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86846,Marketed,2020-03-01,02382644,Taro-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02382644,TARO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) SUN PHARMA CANADA INC,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86847,Marketed,2020-03-01,02382652,Taro-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02382652,TARO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) SUN PHARMA CANADA INC,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86848,Marketed,2020-03-01,02382660,Taro-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02382660,TARO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) SUN PHARMA CANADA INC,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86849,Marketed,2020-03-01,02382679,Taro-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02382679,TARO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) SUN PHARMA CANADA INC,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88271,Marketed,2025-11-04,02397781,Mint-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02397781,MINT-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88272,Marketed,2025-11-04,02397803,Mint-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02397803,MINT-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88273,Marketed,2025-11-04,02397811,Mint-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02397811,MINT-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88274,Marketed,2025-11-04,02397838,Mint-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02397838,MINT-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89039,Marketed,2022-09-01,02405628,Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02405628,ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) SANIS HEALTH INC,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89040,Marketed,2022-09-01,02405636,Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02405636,ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) SANIS HEALTH INC,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89041,Marketed,2022-09-01,02405644,Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02405644,ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) SANIS HEALTH INC,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89042,Marketed,2022-09-01,02405652,Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02405652,ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) SANIS HEALTH INC,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89622,Marketed,2024-01-12,02411628,Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02411628,ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89623,Marketed,2024-02-02,02411636,Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02411636,ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89624,Marketed,2024-02-02,02411644,Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02411644,ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89625,Marketed,2024-02-13,02411652,Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02411652,ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89772,Marketed,2023-06-09,02413051,Mar-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02413051,MAR-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89773,Marketed,2023-06-09,02413078,Mar-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02413078,MAR-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89774,Marketed,2023-06-09,02413086,Mar-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02413086,MAR-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89775,Marketed,2023-06-09,02413108,Mar-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02413108,MAR-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92329,Marketed,2019-05-23,02438917,ACH-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02438917,ACH-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92330,Marketed,2019-05-23,02438925,ACH-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02438925,ACH-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92331,Marketed,2019-05-23,02438933,ACH-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02438933,ACH-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92332,Marketed,2019-05-23,02438941,ACH-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02438941,ACH-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92691,Marketed,2015-11-30,02442574,Auro-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02442574,AURO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) AURO PHARMA INC,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92692,Marketed,2015-11-30,02442582,Auro-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02442582,AURO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) AURO PHARMA INC,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92693,Marketed,2015-11-30,02442590,Auro-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02442590,AURO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) AURO PHARMA INC,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92694,Marketed,2015-11-30,02442604,Auro-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02442604,AURO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) AURO PHARMA INC,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93018,Marketed,2021-08-11,02444968,Bio-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02444968,BIO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) BIOMED PHARMA,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93019,Marketed,2021-08-11,02444976,Bio-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02444976,BIO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) BIOMED PHARMA,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93020,Marketed,2021-08-11,02444984,Bio-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02444984,BIO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) BIOMED PHARMA,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93021,Marketed,2021-08-11,02444992,Bio-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02444992,BIO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) BIOMED PHARMA,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98639,Marketed,2023-12-21,02496534,M-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02496534,M-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) MANTRA PHARMA INC,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98640,Marketed,2024-02-28,02496542,M-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02496542,M-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) MANTRA PHARMA INC,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98641,Marketed,2024-02-19,02496550,M-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02496550,M-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) MANTRA PHARMA INC,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98642,Marketed,2024-04-29,02496569,M-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02496569,M-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) MANTRA PHARMA INC,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98811,Marketed,2025-07-15,02498332,JAMP Rosuvastatin Tablets,1,C10AA07,Rosuvastatin,Tablet,Oral,02498332,JAMP ROSUVASTATIN TABLETS (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98812,Marketed,2025-07-16,02498340,JAMP Rosuvastatin Tablets,1,C10AA07,Rosuvastatin,Tablet,Oral,02498340,JAMP ROSUVASTATIN TABLETS (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98813,Marketed,2025-07-15,02498359,JAMP Rosuvastatin Tablets,1,C10AA07,Rosuvastatin,Tablet,Oral,02498359,JAMP ROSUVASTATIN TABLETS (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98814,Marketed,2025-07-15,02498367,JAMP Rosuvastatin Tablets,1,C10AA07,Rosuvastatin,Tablet,Oral,02498367,JAMP ROSUVASTATIN TABLETS (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98984,Marketed,2025-08-29,02500132,AG-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02500132,AG-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) ANGITA PHARMA INC.,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98985,Marketed,2025-08-29,02500140,AG-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02500140,AG-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) ANGITA PHARMA INC.,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98986,Marketed,2025-08-29,02500159,AG-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02500159,AG-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) ANGITA PHARMA INC.,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98987,Marketed,2025-08-29,02500167,AG-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02500167,AG-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) ANGITA PHARMA INC.,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99494,Marketed,2021-10-12,02505576,PRZ-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02505576,PRZ-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) PHARMARIS CANADA INC,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99495,Marketed,2021-10-12,02505584,PRZ-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02505584,PRZ-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) PHARMARIS CANADA INC,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99496,Marketed,2021-10-12,02505592,PRZ-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02505592,PRZ-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) PHARMARIS CANADA INC,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99497,Marketed,2021-10-12,02505606,PRZ-Rosuvastatin,1,C10AA07,Rosuvastatin,Tablet,Oral,02505606,PRZ-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) PHARMARIS CANADA INC,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78588,Marketed,2021-04-06,02300591,Rotarix,1,J07BH01,"Rota virus, live attenuated",Suspension,Oral,,,,,,,,,,,,,,,,,Schedule D
76999,Marketed,2006-10-16,02284413,Rotateq,5,J07BH02,"Rota virus, pentavalent, live, reassorted",Solution,Oral,,,,,,,,,,,,,,,,,Schedule D
88866,Marketed,2013-12-19,02403897,Neupro,1,N04BC09,Rotigotine,Patch,Transdermal,02403897,NEUPRO (rotigotine 1 mg per 24 hour transdermal patch) UCB CANADA INC,Active,9005382,rotigotine 1 mg per 24 hour transdermal patch,8001520,rotigotine,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,,Prescription
88867,Marketed,2013-06-27,02403900,Neupro,1,N04BC09,Rotigotine,Patch,Transdermal,02403900,NEUPRO (rotigotine 2 mg per 24 hour transdermal patch) UCB CANADA INC,Active,9005275,rotigotine 2 mg per 24 hour transdermal patch,8001520,rotigotine,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,,Prescription
88868,Marketed,2013-12-19,02403919,Neupro,1,N04BC09,Rotigotine,Patch,Transdermal,02403919,NEUPRO (rotigotine 3 mg per 24 hour transdermal patch) UCB CANADA INC,Active,9005383,rotigotine 3 mg per 24 hour transdermal patch,8001520,rotigotine,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,,Prescription
88869,Marketed,2013-06-27,02403927,Neupro,1,N04BC09,Rotigotine,Patch,Transdermal,02403927,NEUPRO (rotigotine 4 mg per 24 hour transdermal patch) UCB CANADA INC,Active,9005276,rotigotine 4 mg per 24 hour transdermal patch,8001520,rotigotine,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,,Prescription
88870,Marketed,2013-06-27,02403935,Neupro,1,N04BC09,Rotigotine,Patch,Transdermal,02403935,NEUPRO (rotigotine 6 mg per 24 hour transdermal patch) UCB CANADA INC,Active,9005277,rotigotine 6 mg per 24 hour transdermal patch,8001520,rotigotine,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,,Prescription
88871,Marketed,2013-06-27,02403943,Neupro,1,N04BC09,Rotigotine,Patch,Transdermal,02403943,NEUPRO (rotigotine 8 mg per 24 hour transdermal patch) UCB CANADA INC,Active,9005278,rotigotine 8 mg per 24 hour transdermal patch,8001520,rotigotine,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,,Prescription
104480,Marketed,2025-09-05,02556081,Rystiggo,1,L04AL02,Rozanolixizumab,Solution,Subcutaneous,02556081,RYSTIGGO (rozanolixizumab 280 mg per 2 mL solution for injection vial) UCB CANADA INC,Active,9015269,rozanolixizumab 280 mg per 2 mL solution for injection vial,8002556,rozanolixizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,,,,Prescription
104480,Marketed,2025-09-05,02556081,Rystiggo,1,L04AL02,Rozanolixizumab,Solution,Subcutaneous,02556081,RYSTIGGO (rozanolixizumab 280 mg per 2 mL solution for injection vial) UCB CANADA INC,Active,9015269,rozanolixizumab 280 mg per 2 mL solution for injection vial,8002556,rozanolixizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,,,,Schedule D
103472,Marketed,2024-07-04,02545985,Auro-Rufinamide,1,N03AF03,Rufinamide,Tablet,Oral,02545985,AURO-RUFINAMIDE (rufinamide 200 mg oral tablet) AURO PHARMA INC,Active,9004918,rufinamide 200 mg oral tablet,8001521,rufinamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103473,Marketed,2024-07-04,02545993,Auro-Rufinamide,1,N03AF03,Rufinamide,Tablet,Oral,02545993,AURO-RUFINAMIDE (rufinamide 400 mg oral tablet) AURO PHARMA INC,Active,9004921,rufinamide 400 mg oral tablet,8001521,rufinamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85454,Marketed,2011-10-20,02369613,Banzel,1,N03AF03,Rufinamide,Tablet,Oral,02369613,BANZEL (rufinamide 100 mg oral tablet) EISAI LIMITED,Active,9004943,rufinamide 100 mg oral tablet,8001521,rufinamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85455,Marketed,2011-08-29,02369621,Banzel,1,N03AF03,Rufinamide,Tablet,Oral,02369621,BANZEL (rufinamide 200 mg oral tablet) EISAI LIMITED,Active,9004918,rufinamide 200 mg oral tablet,8001521,rufinamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85456,Marketed,2011-09-01,02369648,Banzel,1,N03AF03,Rufinamide,Tablet,Oral,02369648,BANZEL (rufinamide 400 mg oral tablet) EISAI LIMITED,Active,9004921,rufinamide 400 mg oral tablet,8001521,rufinamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104156,Marketed,2025-01-21,02552604,PMS-Rupatadine,1,R06AX28,Rupatadine,Tablet,Oral,02552604,PMS-RUPATADINE (rupatadine (rupatadine fumarate) 10 mg oral tablet) PHARMASCIENCE INC,Active,9006104,rupatadine (rupatadine fumarate) 10 mg oral tablet,8001522,rupatadine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104211,Marketed,2025-01-21,02553155,Apo-Rupatadine,1,R06AX28,Rupatadine,Tablet,Oral,02553155,APO-RUPATADINE (rupatadine (rupatadine fumarate) 10 mg oral tablet) APOTEX INC,Active,9006104,rupatadine (rupatadine fumarate) 10 mg oral tablet,8001522,rupatadine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106320,Marketed,2025-11-05,02560119,Riva-Rupatadine,1,R06AX28,Rupatadine,Tablet,Oral,02560119,RIVA-RUPATADINE (rupatadine (rupatadine fumarate) 10 mg oral tablet) LABORATOIRE RIVA INC.,Active,9006104,rupatadine (rupatadine fumarate) 10 mg oral tablet,8001522,rupatadine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94335,Marketed,2023-02-02,02456451,Rupall,1,R06AX28,Rupatadine,Tablet,Oral,02456451,RUPALL (rupatadine (rupatadine fumarate) 10 mg oral tablet) MEDEXUS PHARMACEUTICALS INC.,Active,9006104,rupatadine (rupatadine fumarate) 10 mg oral tablet,8001522,rupatadine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94336,Marketed,2023-02-02,02456478,Rupall,1,R06AX28,Rupatadine,Solution,Oral,02456478,RUPALL (rupatadine (rupatadine fumarate) 1 mg per mL oral solution) MEDEXUS PHARMACEUTICALS INC.,Active,9006112,rupatadine (rupatadine fumarate) 1 mg per mL oral solution,8001522,rupatadine,26643006,Oral,385023001,Oral solution,,,,,,Prescription
104109,Marketed,2024-11-28,02552434,Opzelura,1,D11AH09,Ruxolitinib,Cream,Topical,02552434,OPZELURA (ruxolitinib (ruxolitinib phosphate) 1.5 % cutaneous cream) INCYTE CORPORATION,Active,9015141,ruxolitinib (ruxolitinib phosphate) 1.5 % cutaneous cream,8001928,ruxolitinib,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
87357,Marketed,2012-07-19,02388006,Jakavi,1,L01EJ01,Ruxolitinib,Tablet,Oral,02388006,JAKAVI (ruxolitinib (ruxolitinib phosphate) 5 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9005068,ruxolitinib (ruxolitinib phosphate) 5 mg oral tablet,8001928,ruxolitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87358,Marketed,2012-07-19,02388014,Jakavi,1,L01EJ01,Ruxolitinib,Tablet,Oral,02388014,JAKAVI (ruxolitinib (ruxolitinib phosphate) 15 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9005066,ruxolitinib (ruxolitinib phosphate) 15 mg oral tablet,8001928,ruxolitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87359,Marketed,2012-07-19,02388022,Jakavi,1,L01EJ01,Ruxolitinib,Tablet,Oral,02388022,JAKAVI (ruxolitinib (ruxolitinib phosphate) 20 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9005067,ruxolitinib (ruxolitinib phosphate) 20 mg oral tablet,8001928,ruxolitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91911,Marketed,2015-04-15,02434814,Jakavi,1,L01EJ01,Ruxolitinib,Tablet,Oral,02434814,JAKAVI (ruxolitinib (ruxolitinib phosphate) 10 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9005700,ruxolitinib (ruxolitinib phosphate) 10 mg oral tablet,8001928,ruxolitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100997,Marketed,2021-11-22,02520788,Trodelvy,1,L01FX17,Sacituzumab govitecan,Powder for solution,Intravenous,02520788,TRODELVY (sacituzumab govitecan 180 mg per vial powder for solution for injection) GILEAD SCIENCES CANADA INC,Active,9014630,sacituzumab govitecan 180 mg per vial powder for solution for injection,8002399,sacituzumab govitecan,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
100997,Marketed,2021-11-22,02520788,Trodelvy,1,L01FX17,Sacituzumab govitecan,Powder for solution,Intravenous,02520788,TRODELVY (sacituzumab govitecan 180 mg per vial powder for solution for injection) GILEAD SCIENCES CANADA INC,Active,9014630,sacituzumab govitecan 180 mg per vial powder for solution for injection,8002399,sacituzumab govitecan,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
97492,Marketed,2019-07-08,02484641,Onstryv,1,N04BD03,Safinamide,Tablet,Oral,02484641,ONSTRYV (safinamide (safinamide mesylate) 50 mg oral tablet) VALEO PHARMA INC,Active,9014064,safinamide (safinamide mesylate) 50 mg oral tablet,8002272,safinamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97495,Marketed,2019-07-08,02484668,Onstryv,1,N04BD03,Safinamide,Tablet,Oral,02484668,ONSTRYV (safinamide (safinamide mesylate) 100 mg oral tablet) VALEO PHARMA INC,Active,9014063,safinamide (safinamide mesylate) 100 mg oral tablet,8002272,safinamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
13550,Marketed,2012-07-06,01926934,Teva-Salbutamol Sterinebs P.F.,1,R03AC02,Salbutamol,Solution,Inhalation,01926934,TEVA-SALBUTAMOL STERINEBS P.F. (salbutamol (salbutamol sulfate) 2.5 mg per 2.5 mL nebulizer solution unit dose vial) TEVA CANADA LIMITED,Active,9000444,salbutamol (salbutamol sulfate) 2.5 mg per 2.5 mL nebulizer solution unit dose vial,8000132,salbutamol,738984000,Parenteral,420641004,Solution for inhalation,733026001,Vial (unit of presentation),,,,Prescription
19058,Marketed,2012-07-05,02173360,Teva-Salbutamol Sterinebs P.F.,1,R03AC02,Salbutamol,Solution,Inhalation,02173360,TEVA-SALBUTAMOL STERINEBS P.F. (salbutamol (salbutamol sulfate) 5 mg per 2.5 mL nebulizer solution unit dose vial) TEVA CANADA LIMITED,Active,9000634,salbutamol (salbutamol sulfate) 5 mg per 2.5 mL nebulizer solution unit dose vial,8000132,salbutamol,738984000,Parenteral,385198000,Solution for nebuliser,733026001,Vial (unit of presentation),,,,Prescription
19761,Marketed,2010-05-07,02208245,PMS-Salbutamol,1,R03AC02,Salbutamol,Solution,Inhalation,02208245,PMS-SALBUTAMOL (salbutamol (salbutamol sulfate) 1.25 mg per 2.5 mL nebulizer solution unit dose vial) PHARMASCIENCE INC,Active,9000692,salbutamol (salbutamol sulfate) 1.25 mg per 2.5 mL nebulizer solution unit dose vial,8000132,salbutamol,447694001,Inhalation,385198000,Solution for nebuliser,733026001,Vial (unit of presentation),,,,Prescription
19762,Marketed,2010-05-07,02208237,PMS-Salbutamol,1,R03AC02,Salbutamol,Solution,Inhalation,02208237,PMS-SALBUTAMOL (salbutamol (salbutamol sulfate) 5 mg per 2.5 mL nebulizer solution unit dose vial) PHARMASCIENCE INC,Active,9000634,salbutamol (salbutamol sulfate) 5 mg per 2.5 mL nebulizer solution unit dose vial,8000132,salbutamol,738984000,Parenteral,385198000,Solution for nebuliser,733026001,Vial (unit of presentation),,,,Prescription
19763,Marketed,2010-05-07,02208229,PMS-Salbutamol,1,R03AC02,Salbutamol,Solution,Inhalation,02208229,PMS-SALBUTAMOL (salbutamol (salbutamol sulfate) 2.5 mg per 2.5 mL nebulizer solution unit dose vial) PHARMASCIENCE INC,Active,9000444,salbutamol (salbutamol sulfate) 2.5 mg per 2.5 mL nebulizer solution unit dose vial,8000132,salbutamol,738984000,Parenteral,420641004,Solution for inhalation,733026001,Vial (unit of presentation),,,,Prescription
43104,Marketed,2002-11-19,02213451,Ventolin IV Infusion Solution 5 mg Salbutamol In 5 mL (1000 mcg/mL),1,R03CC02,Salbutamol,Solution,Intravenous,02213451,VENTOLIN I.V. INFUSION SOLUTION 5.0MG SALBUTAMOL IN 5ML (1000MCG/ML) (salbutamol (salbutamol sulfate) 5 mg per 5 mL solution for injection ampoule) GLAXOSMITHKLINE INC,Active,9000849,salbutamol (salbutamol sulfate) 5 mg per 5 mL solution for injection ampoule,8000132,salbutamol,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
43108,Marketed,2002-08-26,02213486,Ventolin Respirator Solution,1,R03AC02,Salbutamol,Solution,Inhalation,02213486,VENTOLIN RESPIRATOR SOLUTION (salbutamol (salbutamol sulfate) 5 mg per mL nebulizer solution 10 mL bottle) GLAXOSMITHKLINE INC,Active,9000338,salbutamol (salbutamol sulfate) 5 mg per mL nebulizer solution 10 mL bottle,8000132,salbutamol,738984000,Parenteral,385198000,Solution for nebuliser,,,,,,Prescription
65137,Marketed,2001-11-22,02241497,Ventolin HFA,1,R03AC02,Salbutamol,Metered-dose aerosol,Inhalation,02241497,VENTOLIN HFA (salbutamol (salbutamol sulfate) 100 mcg per actuation pressurized inhalation) GLAXOSMITHKLINE INC,Active,9000996,salbutamol (salbutamol sulfate) 100 mcg per actuation pressurized inhalation,8000132,salbutamol,447694001,447694001,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,,Prescription
66984,Marketed,2002-03-08,02243115,Ventolin Diskus,1,R03AC02,Salbutamol,Powder,Inhalation,02243115,VENTOLIN DISKUS (salbutamol (salbutamol sulfate) 200 mcg per actuation inhalation powder) GLAXOSMITHKLINE INC,Active,9012387,salbutamol (salbutamol sulfate) 200 mcg per actuation inhalation powder,8000132,salbutamol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
69769,Marketed,2019-12-16,02245669,Apo-Salbutamol HFA,1,R03AC02,Salbutamol,Metered-dose aerosol,Inhalation,02245669,APO-SALBUTAMOL HFA (salbutamol (salbutamol sulfate) 100 mcg per actuation pressurized inhalation) APOTEX INC,Active,9000996,salbutamol (salbutamol sulfate) 100 mcg per actuation pressurized inhalation,8000132,salbutamol,447694001,447694001,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,,Prescription
81180,Marketed,2018-03-21,02326450,Teva-Salbutamol HFA,1,R03AC02,Salbutamol,Metered-dose aerosol,Inhalation,02326450,TEVA-SALBUTAMOL HFA (salbutamol (salbutamol sulfate) 100 mcg per actuation pressurized inhalation) TEVA CANADA LIMITED,Active,9000996,salbutamol (salbutamol sulfate) 100 mcg per actuation pressurized inhalation,8000132,salbutamol,447694001,447694001,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,,Prescription
90447,Marketed,2014-02-13,02419858,Salbutamol HFA,1,R03AC02,Salbutamol,Metered-dose aerosol,Inhalation,02419858,SALBUTAMOL HFA (salbutamol (salbutamol sulfate) 100 mcg per actuation pressurized inhalation) SANIS HEALTH INC,Active,9000996,salbutamol (salbutamol sulfate) 100 mcg per actuation pressurized inhalation,8000132,salbutamol,447694001,447694001,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,,Prescription
75820,Marketed,2012-07-17,02272695,Teva-Combo Sterinebs,2,R03AL02,Salbutamol and ipratropium bromide,Solution,Inhalation,02272695,TEVA-COMBO STERINEBS (ipratropium bromide (ipratropium bromide monohydrate) 0.5 mg per 2.5 mL and salbutamol (salbutamol sulfate) 2.5 mg per 2.5 mL nebulizer solution unit dose vial) TEVA CANADA LIMITED,Active,9012555,ipratropium bromide 0.5 mg per 2.5 mL and salbutamol (salbutamol sulfate) 2.5 mg per 2.5 mL nebulizer solution unit dose vial,8000903,ipratropium and salbutamol,447694001,Inhalation,385198000,Solution for nebuliser,733026001,Vial (unit of presentation),,,,Prescription
90364,Marketed,2014-09-16,02419106,Combivent Respimat,2,R03AL02,Salbutamol and ipratropium bromide,Solution,Inhalation,02419106,COMBIVENT RESPIMAT (ipratropium bromide (ipratropium bromide monohydrate) 20 mcg per actuation and salbutamol (salbutamol sulfate) 100 mcg per actuation inhalation solution) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9005585,ipratropium bromide 20 mcg per actuation and salbutamol (salbutamol sulfate) 100 mcg per actuation inhalation solution,8000903,ipratropium and salbutamol,447694001,Inhalation,420641004,Solution for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
97384,Marketed,2022-10-17,02483394,Ipratropium Bromide And Salbutamol Sulphate Inhalation Solution,2,R03AL02,Salbutamol and ipratropium bromide,Solution,Inhalation,02483394,IPRATROPIUM BROMIDE AND SALBUTAMOL SULPHATE INHALATION SOLUTION (ipratropium bromide (ipratropium bromide monohydrate) 0.5 mg per 2.5 mL and salbutamol (salbutamol sulfate) 2.5 mg per 2.5 mL nebulizer solution unit dose vial) JUNO PHARMACEUTICALS CORP.,Active,9012555,ipratropium bromide 0.5 mg per 2.5 mL and salbutamol (salbutamol sulfate) 2.5 mg per 2.5 mL nebulizer solution unit dose vial,8000903,ipratropium and salbutamol,447694001,Inhalation,385198000,Solution for nebuliser,733026001,Vial (unit of presentation),,,,Prescription
50436,Marketed,2003-01-16,02231129,Serevent Diskus (50 mcg/Dose),1,R03AC12,Salmeterol,Powder,Inhalation,02231129,SEREVENT DISKUS (50MCG/DOSE) (salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder) GLAXOSMITHKLINE INC,Active,9012458,salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder,8000905,salmeterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
64426,Marketed,2002-03-12,02240835,Advair 100 Diskus,2,R03AK06,Salmeterol and fluticasone,Powder,Inhalation,02240835,ADVAIR 100 DISKUS (fluticasone propionate 100 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder) GLAXOSMITHKLINE INC,Active,9006268,fluticasone propionate 100 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder,8000279,fluticasone and salmeterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
64427,Marketed,2002-04-03,02240836,Advair 250 Diskus,2,R03AK06,Salmeterol and fluticasone,Powder,Inhalation,02240836,ADVAIR 250 DISKUS (fluticasone propionate 250 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder) GLAXOSMITHKLINE INC,Active,9006269,fluticasone propionate 250 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder,8000279,fluticasone and salmeterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
64428,Marketed,2002-03-08,02240837,Advair 500 Diskus,2,R03AK06,Salmeterol and fluticasone,Powder,Inhalation,02240837,ADVAIR 500 DISKUS (fluticasone propionate 500 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder) GLAXOSMITHKLINE INC,Active,9006270,fluticasone propionate 500 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder,8000279,fluticasone and salmeterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
69136,Marketed,2001-12-21,02245126,Advair,2,R03AK06,Salmeterol and fluticasone,"Aerosol, metered dose",Inhalation,02245126,ADVAIR (fluticasone propionate 125 mcg per actuation and salmeterol (salmeterol xinafoate) 25 mcg per actuation pressurized inhalation) GLAXOSMITHKLINE INC,Active,9006275,fluticasone propionate 125 mcg per actuation and salmeterol (salmeterol xinafoate) 25 mcg per actuation pressurized inhalation,8000279,fluticasone and salmeterol,447694001,Inhalation,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,,Prescription
69137,Marketed,2001-12-21,02245127,Advair,2,R03AK06,Salmeterol and fluticasone,"Aerosol, metered dose",Inhalation,02245127,ADVAIR (fluticasone propionate 250 mcg per actuation and salmeterol (salmeterol xinafoate) 25 mcg per actuation pressurized inhalation) GLAXOSMITHKLINE INC,Active,9006276,fluticasone propionate 250 mcg per actuation and salmeterol (salmeterol xinafoate) 25 mcg per actuation pressurized inhalation,8000279,fluticasone and salmeterol,447694001,Inhalation,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,,Prescription
98451,Marketed,2020-03-05,02494507,PMS-Fluticasone Propionate/Salmeterol Dpi,2,R03AK06,Salmeterol and fluticasone,Powder,Inhalation,02494507,PMS-FLUTICASONE PROPIONATE/SALMETEROL DPI (fluticasone propionate 100 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder) PHARMASCIENCE INC,Active,9006268,fluticasone propionate 100 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder,8000279,fluticasone and salmeterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
98452,Marketed,2020-03-05,02494515,PMS-Fluticasone Propionate/Salmeterol Dpi,2,R03AK06,Salmeterol and fluticasone,Powder,Inhalation,02494515,PMS-FLUTICASONE PROPIONATE/SALMETEROL DPI (fluticasone propionate 250 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder) PHARMASCIENCE INC,Active,9006269,fluticasone propionate 250 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder,8000279,fluticasone and salmeterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
98453,Marketed,2020-03-05,02494523,PMS-Fluticasone Propionate/Salmeterol Dpi,2,R03AK06,Salmeterol and fluticasone,Powder,Inhalation,02494523,PMS-FLUTICASONE PROPIONATE/SALMETEROL DPI (fluticasone propionate 500 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder) PHARMASCIENCE INC,Active,9006270,fluticasone propionate 500 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder,8000279,fluticasone and salmeterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
98549,Marketed,2020-02-13,02495597,Wixela Inhub,2,R03AK06,Salmeterol and fluticasone,Powder,Inhalation,02495597,WIXELA INHUB (fluticasone propionate 100 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder) MYLAN PHARMACEUTICALS ULC,Active,9006268,fluticasone propionate 100 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder,8000279,fluticasone and salmeterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
98550,Marketed,2020-02-13,02495600,Wixela Inhub,2,R03AK06,Salmeterol and fluticasone,Powder,Inhalation,02495600,WIXELA INHUB (fluticasone propionate 250 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder) MYLAN PHARMACEUTICALS ULC,Active,9006269,fluticasone propionate 250 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder,8000279,fluticasone and salmeterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
98551,Marketed,2020-02-13,02495619,Wixela Inhub,2,R03AK06,Salmeterol and fluticasone,Powder,Inhalation,02495619,WIXELA INHUB (fluticasone propionate 500 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder) MYLAN PHARMACEUTICALS ULC,Active,9006270,fluticasone propionate 500 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder,8000279,fluticasone and salmeterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
102345,Marketed,2023-12-11,02534533,Reddy-Sapropterin,1,A16AX07,Sapropterin,Powder for solution,Oral,02534533,REDDY-SAPROPTERIN (sapropterin dihydrochloride 100 mg per sachet powder for oral solution) DR REDDY'S LABORATORIES LTD,Active,9014273,sapropterin dihydrochloride 100 mg per sachet powder for oral solution,8001929,sapropterin,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,,Prescription
102445,Marketed,2023-12-19,02535610,Reddy-Sapropterin,1,A16AX07,Sapropterin,Powder for solution,Oral,02535610,REDDY-SAPROPTERIN (sapropterin dihydrochloride 500 mg per sachet powder for oral solution) DR REDDY'S LABORATORIES LTD,Active,9014274,sapropterin dihydrochloride 500 mg per sachet powder for oral solution,8001929,sapropterin,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,,Prescription
83577,Marketed,2019-04-11,02350580,Kuvan,1,A16AX07,Sapropterin,Tablet,Oral,02350580,KUVAN (sapropterin dihydrochloride 100 mg oral tablet) BIOMARIN INTERNATIONAL LIMITED,Active,9004745,sapropterin dihydrochloride 100 mg oral tablet,8001929,sapropterin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97268,Marketed,2019-12-05,02482207,Kuvan,1,A16AX07,Sapropterin,Powder,Oral,02482207,KUVAN (sapropterin dihydrochloride 100 mg per sachet powder for oral solution) BIOMARIN INTERNATIONAL LIMITED,Active,9014273,sapropterin dihydrochloride 100 mg per sachet powder for oral solution,8001929,sapropterin,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,,Prescription
94797,Marketed,2017-02-08,02460548,Kevzara,1,L04AC14,Sarilumab,Solution,Subcutaneous,02460548,KEVZARA (sarilumab 200 mg per 1.14 mL solution for injection syringe) SANOFI-AVENTIS CANADA INC,Active,9013338,sarilumab 200 mg per 1.14 mL solution for injection syringe,8001930,sarilumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
94797,Marketed,2017-02-08,02460548,Kevzara,1,L04AC14,Sarilumab,Solution,Subcutaneous,02460548,KEVZARA (sarilumab 200 mg per 1.14 mL solution for injection syringe) SANOFI-AVENTIS CANADA INC,Active,9013338,sarilumab 200 mg per 1.14 mL solution for injection syringe,8001930,sarilumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
96232,Marketed,2018-06-21,02472961,Kevzara,1,L04AC14,Sarilumab,Solution,Subcutaneous,02472961,KEVZARA (sarilumab 150 mg per 1.14 mL solution for injection pen) SANOFI-AVENTIS CANADA INC,Active,9013335,sarilumab 150 mg per 1.14 mL solution for injection pen,8001930,sarilumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Prescription
96232,Marketed,2018-06-21,02472961,Kevzara,1,L04AC14,Sarilumab,Solution,Subcutaneous,02472961,KEVZARA (sarilumab 150 mg per 1.14 mL solution for injection pen) SANOFI-AVENTIS CANADA INC,Active,9013335,sarilumab 150 mg per 1.14 mL solution for injection pen,8001930,sarilumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
96233,Marketed,2018-06-21,02472988,Kevzara,1,L04AC14,Sarilumab,Solution,Subcutaneous,02472988,KEVZARA (sarilumab 200 mg per 1.14 mL solution for injection pen) SANOFI-AVENTIS CANADA INC,Active,9013337,sarilumab 200 mg per 1.14 mL solution for injection pen,8001930,sarilumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
96233,Marketed,2018-06-21,02472988,Kevzara,1,L04AC14,Sarilumab,Solution,Subcutaneous,02472988,KEVZARA (sarilumab 200 mg per 1.14 mL solution for injection pen) SANOFI-AVENTIS CANADA INC,Active,9013337,sarilumab 200 mg per 1.14 mL solution for injection pen,8001930,sarilumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Prescription
98941,Marketed,2020-08-26,02499681,Enspryng,1,L04AC19,Satralizumab,Solution,Subcutaneous,02499681,ENSPRYNG (satralizumab 120 mg per 1 mL solution for injection syringe) HOFFMANN-LA ROCHE LIMITED,Active,9014390,satralizumab 120 mg per 1 mL solution for injection syringe,8002346,satralizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
98941,Marketed,2020-08-26,02499681,Enspryng,1,L04AC19,Satralizumab,Solution,Subcutaneous,02499681,ENSPRYNG (satralizumab 120 mg per 1 mL solution for injection syringe) HOFFMANN-LA ROCHE LIMITED,Active,9014390,satralizumab 120 mg per 1 mL solution for injection syringe,8002346,satralizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
81917,Marketed,2014-12-03,02333554,Onglyza,1,A10BH03,Saxagliptin,Tablet,Oral,02333554,ONGLYZA (saxagliptin (saxagliptin hydrochloride) 5 mg oral tablet) ASTRAZENECA CANADA INC,Active,9001296,saxagliptin (saxagliptin hydrochloride) 5 mg oral tablet,8000391,saxagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86124,Marketed,2015-02-18,02375842,Onglyza,1,A10BH03,Saxagliptin,Tablet,Oral,02375842,ONGLYZA (saxagliptin (saxagliptin hydrochloride) 2.5 mg oral tablet) ASTRAZENECA CANADA INC,Active,9001372,saxagliptin (saxagliptin hydrochloride) 2.5 mg oral tablet,8000391,saxagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95702,Marketed,2021-03-08,02468603,Sandoz sAXagliptin,1,A10BH03,Saxagliptin,Tablet,Oral,02468603,SANDOZ SAXAGLIPTIN (saxagliptin (saxagliptin hydrochloride) 2.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001372,saxagliptin (saxagliptin hydrochloride) 2.5 mg oral tablet,8000391,saxagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95703,Marketed,2021-03-08,02468611,Sandoz sAXagliptin,1,A10BH03,Saxagliptin,Tablet,Oral,02468611,SANDOZ SAXAGLIPTIN (saxagliptin (saxagliptin hydrochloride) 5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001296,saxagliptin (saxagliptin hydrochloride) 5 mg oral tablet,8000391,saxagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99686,Marketed,2021-03-29,02507471,Apo-sAXagliptin,1,A10BH03,Saxagliptin,Tablet,Oral,02507471,APO-SAXAGLIPTIN (saxagliptin (saxagliptin hydrochloride) 2.5 mg oral tablet) APOTEX INC,Active,9001372,saxagliptin (saxagliptin hydrochloride) 2.5 mg oral tablet,8000391,saxagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99687,Marketed,2021-03-29,02507498,Apo-sAXagliptin,1,A10BH03,Saxagliptin,Tablet,Oral,02507498,APO-SAXAGLIPTIN (saxagliptin (saxagliptin hydrochloride) 5 mg oral tablet) APOTEX INC,Active,9001296,saxagliptin (saxagliptin hydrochloride) 5 mg oral tablet,8000391,saxagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
66635,Marketed,2008-05-31,02242810,Scopolamine Hydrobromide Injection,1,N05CM05,Scopolamine,Liquid,"Subcutaneous,Intravenous,Intramuscular",02242810,SCOPOLAMINE HYDROBROMIDE INJECTION (scopolamine hydrobromide 0.4 mg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013242,scopolamine hydrobromide 0.4 mg per 1 mL solution for injection vial,8002211,scopolamine hydrobromide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
66636,Marketed,2008-07-08,02242811,Scopolamine Hydrobromide Injection,1,N05CM05,Scopolamine,Liquid,"Intramuscular,Subcutaneous,Intravenous",02242811,SCOPOLAMINE HYDROBROMIDE INJECTION (scopolamine hydrobromide 0.6 mg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013244,scopolamine hydrobromide 0.6 mg per 1 mL solution for injection vial,8002211,scopolamine hydrobromide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
95840,Marketed,2018-04-05,02469596,Kanuma,1,A16AB14,Sebelipase alfa,Solution,Intravenous,02469596,KANUMA (sebelipase alfa 20 mg per 10 mL solution for injection vial) ALEXION PHARMA GMBH,Active,9013339,sebelipase alfa 20 mg per 10 mL solution for injection vial,8001931,sebelipase alfa,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
95840,Marketed,2018-04-05,02469596,Kanuma,1,A16AB14,Sebelipase alfa,Solution,Intravenous,02469596,KANUMA (sebelipase alfa 20 mg per 10 mL solution for injection vial) ALEXION PHARMA GMBH,Active,9013339,sebelipase alfa 20 mg per 10 mL solution for injection vial,8001931,sebelipase alfa,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
101457,Marketed,2022-06-02,02525569,Cosentyx,1,L04AC10,Secukinumab,Solution,Subcutaneous,02525569,COSENTYX (secukinumab 75 mg per 0.5 mL solution for injection syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014730,secukinumab 75 mg per 0.5 mL solution for injection syringe,8001932,secukinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
101457,Marketed,2022-06-02,02525569,Cosentyx,1,L04AC10,Secukinumab,Solution,Subcutaneous,02525569,COSENTYX (secukinumab 75 mg per 0.5 mL solution for injection syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014730,secukinumab 75 mg per 0.5 mL solution for injection syringe,8001932,secukinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
101890,Marketed,2025-09-17,02529653,Cosentyx,1,L04AC10,Secukinumab,Solution,Subcutaneous,02529653,COSENTYX (secukinumab 300 mg per 2 mL solution for injection syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9015271,secukinumab 300 mg per 2 mL solution for injection syringe,8001932,secukinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe,,,,Schedule D
101890,Marketed,2025-09-17,02529653,Cosentyx,1,L04AC10,Secukinumab,Solution,Subcutaneous,02529653,COSENTYX (secukinumab 300 mg per 2 mL solution for injection syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9015271,secukinumab 300 mg per 2 mL solution for injection syringe,8001932,secukinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe,,,,Prescription
101891,Marketed,2025-08-21,02529661,Cosentyx,1,L04AC10,Secukinumab,Solution,Subcutaneous,02529661,COSENTYX (secukinumab 300 mg per 2 mL solution for injection pen) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9015250,secukinumab 300 mg per 2 mL solution for injection pen,8001932,secukinumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen(s),,,,Prescription
101891,Marketed,2025-08-21,02529661,Cosentyx,1,L04AC10,Secukinumab,Solution,Subcutaneous,02529661,COSENTYX (secukinumab 300 mg per 2 mL solution for injection pen) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9015250,secukinumab 300 mg per 2 mL solution for injection pen,8001932,secukinumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen(s),,,,Schedule D
103665,Marketed,2025-04-17,02547724,Cosentyx,1,L04AC10,Secukinumab,Solution,Subcutaneous,02547724,COSENTYX (secukinumab 150 mg per 1 mL solution for injection syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9013341,secukinumab 150 mg per 1 mL solution for injection syringe,8001932,secukinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
103665,Marketed,2025-04-17,02547724,Cosentyx,1,L04AC10,Secukinumab,Solution,Subcutaneous,02547724,COSENTYX (secukinumab 150 mg per 1 mL solution for injection syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9013341,secukinumab 150 mg per 1 mL solution for injection syringe,8001932,secukinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
92243,Marketed,2015-04-10,02438070,Cosentyx,1,L04AC10,Secukinumab,Solution,Subcutaneous,77700900,COSENTYX (secukinumab 150 mg per 1 mL solution for injection pen) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9013340,secukinumab 150 mg per 1 mL solution for injection pen,8001932,secukinumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Prescription
92243,Marketed,2015-04-10,02438070,Cosentyx,1,L04AC10,Secukinumab,Solution,Subcutaneous,77700900,COSENTYX (secukinumab 150 mg per 1 mL solution for injection pen) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9013340,secukinumab 150 mg per 1 mL solution for injection pen,8001932,secukinumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
106445,Marketed,2025-11-25,02561492,Lyvdelzi,1,A05AX07,Seladelpar,Capsule,Oral,02561492,LYVDELZI (seladelpar (seladelpar lysine) 10 mg oral capsule) GILEAD SCIENCES CANADA INC,Active,9015326,seladelpar (seladelpar lysine) 10 mg oral capsule,8002568,seladelpar,26643006,Oral,420692007,Oral capsule,732937005,Capsule,,,,Prescription
49813,Marketed,2021-08-23,02230641,Selegiline,1,N04BD01,Selegiline,Tablet,Oral,02230641,SELEGILINE (selegiline hydrochloride 5 mg oral tablet) AA PHARMA INC,Active,9002715,selegiline hydrochloride 5 mg oral tablet,8001524,selegiline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93741,Marketed,2020-03-17,02451158,Uptravi,1,B01AC27,Selexipag,Tablet,Oral,02451158,UPTRAVI (selexipag 200 mcg oral tablet) JANSSEN INC,Active,9005942,selexipag 200 mcg oral tablet,8001934,selexipag,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93742,Marketed,2019-12-16,02451166,Uptravi,1,B01AC27,Selexipag,Tablet,Oral,02451166,UPTRAVI (selexipag 400 mcg oral tablet) JANSSEN INC,Active,9005943,selexipag 400 mcg oral tablet,8001934,selexipag,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93743,Marketed,2020-03-17,02451174,Uptravi,1,B01AC27,Selexipag,Tablet,Oral,02451174,UPTRAVI (selexipag 600 mcg oral tablet) JANSSEN INC,Active,9005944,selexipag 600 mcg oral tablet,8001934,selexipag,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93744,Marketed,2020-03-23,02451182,Uptravi,1,B01AC27,Selexipag,Tablet,Oral,02451182,UPTRAVI (selexipag 800 mcg oral tablet) JANSSEN INC,Active,9005945,selexipag 800 mcg oral tablet,8001934,selexipag,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93745,Marketed,2020-03-17,02451190,Uptravi,1,B01AC27,Selexipag,Tablet,Oral,02451190,UPTRAVI (selexipag 1000 mcg oral tablet) JANSSEN INC,Active,9005938,selexipag 1000 mcg oral tablet,8001934,selexipag,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93746,Marketed,2020-01-08,02451204,Uptravi,1,B01AC27,Selexipag,Tablet,Oral,02451204,UPTRAVI (selexipag 1200 mcg oral tablet) JANSSEN INC,Active,9005939,selexipag 1200 mcg oral tablet,8001934,selexipag,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93747,Marketed,2020-01-06,02451212,Uptravi,1,B01AC27,Selexipag,Tablet,Oral,02451212,UPTRAVI (selexipag 1400 mcg oral tablet) JANSSEN INC,Active,9005940,selexipag 1400 mcg oral tablet,8001934,selexipag,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93748,Marketed,2019-11-08,02451220,Uptravi,1,B01AC27,Selexipag,Tablet,Oral,02451220,UPTRAVI (selexipag 1600 mcg oral tablet) JANSSEN INC,Active,9005941,selexipag 1600 mcg oral tablet,8001934,selexipag,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101672,Marketed,2022-07-07,02527677,Xpovio,1,L01XX66,Selinexor,Tablet,Oral,02527677,XPOVIO (selinexor 20 mg oral tablet) FORUS THERAPEUTICS INC.,Active,9014742,selinexor 20 mg oral tablet,8002428,selinexor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100625,Marketed,2025-11-06,02516918,Retevmo,1,L01EX22,Selpercatinib,Capsule,Oral,02516918,RETEVMO (selpercatinib 40 mg oral capsule) ELI LILLY CANADA INC,Active,9014743,selpercatinib 40 mg oral capsule,8002429,selpercatinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
100626,Marketed,2025-11-06,02516926,Retevmo,1,L01EX22,Selpercatinib,Capsule,Oral,02516926,RETEVMO (selpercatinib 80 mg oral capsule) ELI LILLY CANADA INC,Active,9014744,selpercatinib 80 mg oral capsule,8002429,selpercatinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
101934,Marketed,2024-04-26,02530139,Koselugo,1,L01EE04,Selumetinib,Capsule,Oral,02530139,KOSELUGO (selumetinib (selumetinib sulfate) 10 mg oral capsule) ALEXION PHARMA GMBH,Active,9014823,selumetinib (selumetinib sulfate) 10 mg oral capsule,8002459,selumetinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
101935,Marketed,2024-10-02,02530147,Koselugo,1,L01EE04,Selumetinib,Capsule,Oral,02530147,KOSELUGO (selumetinib (selumetinib sulfate) 25 mg oral capsule) ALEXION PHARMA GMBH,Active,9014824,selumetinib (selumetinib sulfate) 25 mg oral capsule,8002459,selumetinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
101765,Marketed,2024-03-28,02528509,Wegovy,1,A10BJ06,Semaglutide,Solution,Subcutaneous,02528509,WEGOVY MULTI-DOSE PRE-FILLED PEN (semaglutide 0.25 mg per actuation solution for injection pre-filled pen) NOVO NORDISK CANADA INC,Active,9015039,semaglutide 0.25 mg per actuation solution for injection pre-filled pen,8001525,semaglutide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation,1.0,,,Prescription
101765,Marketed,2024-03-28,02528509,Wegovy,1,A10BJ06,Semaglutide,Solution,Subcutaneous,02528509,WEGOVY MULTI-DOSE PRE-FILLED PEN (semaglutide 0.25 mg per actuation solution for injection pre-filled pen) NOVO NORDISK CANADA INC,Active,9015039,semaglutide 0.25 mg per actuation solution for injection pre-filled pen,8001525,semaglutide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation,1.0,,,Schedule D
101773,Marketed,2024-04-02,02528517,Wegovy,1,A10BJ06,Semaglutide,Solution,Subcutaneous,02528517,WEGOVY MULTI-DOSE PRE-FILLED PEN (semaglutide 0.5 mg per actuation solution for injection pre-filled pen) NOVO NORDISK CANADA INC,Active,9015040,semaglutide 0.5 mg per actuation solution for injection pre-filled pen,8001525,semaglutide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation,1.0,,,Prescription
101773,Marketed,2024-04-02,02528517,Wegovy,1,A10BJ06,Semaglutide,Solution,Subcutaneous,02528517,WEGOVY MULTI-DOSE PRE-FILLED PEN (semaglutide 0.5 mg per actuation solution for injection pre-filled pen) NOVO NORDISK CANADA INC,Active,9015040,semaglutide 0.5 mg per actuation solution for injection pre-filled pen,8001525,semaglutide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation,1.0,,,Schedule D
101774,Marketed,2024-03-28,02528525,Wegovy,1,A10BJ06,Semaglutide,Solution,Subcutaneous,02528525,WEGOVY MULTI-DOSE PRE-FILLED PEN (semaglutide 1 mg per actuation solution for injection pre-filled pen) NOVO NORDISK CANADA INC,Active,9013605,semaglutide 1 mg per actuation solution for injection pre-filled pen,8001525,semaglutide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation (unit of presentation),1.0,,,Schedule D
101774,Marketed,2024-03-28,02528525,Wegovy,1,A10BJ06,Semaglutide,Solution,Subcutaneous,02528525,WEGOVY MULTI-DOSE PRE-FILLED PEN (semaglutide 1 mg per actuation solution for injection pre-filled pen) NOVO NORDISK CANADA INC,Active,9013605,semaglutide 1 mg per actuation solution for injection pre-filled pen,8001525,semaglutide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation (unit of presentation),1.0,,,Prescription
101775,Marketed,2024-04-02,02528533,Wegovy,1,A10BJ06,Semaglutide,Solution,Subcutaneous,02528533,WEGOVY MULTI-DOSE PRE-FILLED PEN (semaglutide 1.7 mg per actuation solution for injection pre-filled pen) NOVO NORDISK CANADA INC,Active,9015041,semaglutide 1.7 mg per actuation solution for injection pre-filled pen,8001525,semaglutide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation,1.0,,,Schedule D
101775,Marketed,2024-04-02,02528533,Wegovy,1,A10BJ06,Semaglutide,Solution,Subcutaneous,02528533,WEGOVY MULTI-DOSE PRE-FILLED PEN (semaglutide 1.7 mg per actuation solution for injection pre-filled pen) NOVO NORDISK CANADA INC,Active,9015041,semaglutide 1.7 mg per actuation solution for injection pre-filled pen,8001525,semaglutide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation,1.0,,,Prescription
101776,Marketed,2024-04-22,02528541,Wegovy,1,A10BJ06,Semaglutide,Solution,Subcutaneous,02528541,WEGOVY MULTI-DOSE PRE-FILLED PEN (semaglutide 2.4 mg per actuation solution for injection pre-filled pen) NOVO NORDISK CANADA INC,Active,9015042,semaglutide 2.4 mg per actuation solution for injection pre-filled pen,8001525,semaglutide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation,1.0,,,Schedule D
101776,Marketed,2024-04-22,02528541,Wegovy,1,A10BJ06,Semaglutide,Solution,Subcutaneous,02528541,WEGOVY MULTI-DOSE PRE-FILLED PEN (semaglutide 2.4 mg per actuation solution for injection pre-filled pen) NOVO NORDISK CANADA INC,Active,9015042,semaglutide 2.4 mg per actuation solution for injection pre-filled pen,8001525,semaglutide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation,1.0,,,Prescription
102895,Marketed,2023-12-22,02540258,Ozempic,1,A10BJ06,Semaglutide,Solution,Subcutaneous,02540258,OZEMPIC MULTI-DOSE PRE-FILLED PEN DISPENSES 0.25 MG OR 0.5 MG DOSES (semaglutide 0.68 mg per mL solution for injection 3 mL pen) NOVO NORDISK CANADA INC,Active,9015008,semaglutide 0.68 mg per mL solution for injection 3 mL pen,8001525,semaglutide,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,,Schedule D
102895,Marketed,2023-12-22,02540258,Ozempic,1,A10BJ06,Semaglutide,Solution,Subcutaneous,02540258,OZEMPIC MULTI-DOSE PRE-FILLED PEN DISPENSES 0.25 MG OR 0.5 MG DOSES (semaglutide 0.68 mg per mL solution for injection 3 mL pen) NOVO NORDISK CANADA INC,Active,9015008,semaglutide 0.68 mg per mL solution for injection 3 mL pen,8001525,semaglutide,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,,Prescription
103977,Marketed,2026-03-13,02551012,Rybelsus,1,A10BJ06,Semaglutide,Tablet,Oral,02551012,RYBELSUS (semaglutide 1.5 mg oral tablet) NOVO NORDISK CANADA INC,Active,9015381,semaglutide 1.5 mg oral tablet,8001525,semaglutide,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,,Schedule D
103977,Marketed,2026-03-13,02551012,Rybelsus,1,A10BJ06,Semaglutide,Tablet,Oral,02551012,RYBELSUS (semaglutide 1.5 mg oral tablet) NOVO NORDISK CANADA INC,Active,9015381,semaglutide 1.5 mg oral tablet,8001525,semaglutide,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,,Prescription
103978,Marketed,2026-03-13,02551020,Rybelsus,1,A10BJ06,Semaglutide,Tablet,Oral,02551020,RYBELSUS (semaglutide 4 mg oral tablet) NOVO NORDISK CANADA INC,Active,9015382,semaglutide 4 mg oral tablet,8001525,semaglutide,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,,Schedule D
103978,Marketed,2026-03-13,02551020,Rybelsus,1,A10BJ06,Semaglutide,Tablet,Oral,02551020,RYBELSUS (semaglutide 4 mg oral tablet) NOVO NORDISK CANADA INC,Active,9015382,semaglutide 4 mg oral tablet,8001525,semaglutide,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,,Prescription
103979,Marketed,2026-03-13,02551039,Rybelsus,1,A10BJ06,Semaglutide,Tablet,Oral,02551039,RYBELSUS (semaglutide 9 mg oral tablet) NOVO NORDISK CANADA INC,Active,9015383,semaglutide 9 mg oral tablet,8001525,semaglutide,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,,Schedule D
103979,Marketed,2026-03-13,02551039,Rybelsus,1,A10BJ06,Semaglutide,Tablet,Oral,02551039,RYBELSUS (semaglutide 9 mg oral tablet) NOVO NORDISK CANADA INC,Active,9015383,semaglutide 9 mg oral tablet,8001525,semaglutide,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,,Prescription
107018,Marketed,2026-05-06,02567806,Semaglutide Injection,1,A10BJ06,Semaglutide,Solution,Subcutaneous,02567806,SEMAGLUTIDE INJECTION MULTI-DOSE PRE-FILLED PEN DISPENSES 0.25 MG OR 0.5 MG DOSES (semaglutide 1.34 mg per mL solution for injection 1.5 mL pen) DR REDDY'S LABORATORIES LTD,Active,9013021,semaglutide 1.34 mg per mL solution for injection 1.5 mL pen,8001525,semaglutide,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,,Prescription
107019,Marketed,2026-05-06,02567814,Semaglutide Injection,1,A10BJ06,Semaglutide,Solution,Subcutaneous,02567814,SEMAGLUTIDE INJECTION MULTI-DOSE PRE-FILLED PEN DISPENSES 1 MG DOSES (semaglutide 1 mg per actuation solution for injection pre-filled pen) DR REDDY'S LABORATORIES LTD,Active,9013605,semaglutide 1 mg per actuation solution for injection pre-filled pen,8001525,semaglutide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation (unit of presentation),1.0,,,Prescription
107037,Marketed,2026-05-14,02568012,Apo-Semaglutide Injection,1,A10BJ06,Semaglutide,Solution,Subcutaneous,02568012,APO-SEMAGLUTIDE INJECTION MULTI-DOSE PRE-FILLED PEN DISPENSES 1 MG DOSES (semaglutide 1 mg per actuation solution for injection pre-filled pen) APOTEX INC,Active,9013605,semaglutide 1 mg per actuation solution for injection pre-filled pen,8001525,semaglutide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation (unit of presentation),1.0,,,Prescription
107038,Marketed,2026-05-14,02568020,Apo-Semaglutide Injection,1,A10BJ06,Semaglutide,Solution,Subcutaneous,02568020,APO-SEMAGLUTIDE INJECTION (semaglutide 0.68 mg per mL solution for injection 3 mL pen) APOTEX INC,Active,9015008,semaglutide 0.68 mg per mL solution for injection 3 mL pen,8001525,semaglutide,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,,Prescription
96058,Marketed,2018-02-22,02471469,Ozempic,1,A10BJ06,Semaglutide,Solution,Subcutaneous,02471469,OZEMPIC MULTI-DOSE PRE-FILLED PEN DISPENSES 1 MG DOSES (semaglutide 1 mg per actuation solution for injection pre-filled pen) NOVO NORDISK CANADA INC,Active,9013605,semaglutide 1 mg per actuation solution for injection pre-filled pen,8001525,semaglutide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation (unit of presentation),1.0,,,Schedule D
96058,Marketed,2018-02-22,02471469,Ozempic,1,A10BJ06,Semaglutide,Solution,Subcutaneous,02471469,OZEMPIC MULTI-DOSE PRE-FILLED PEN DISPENSES 1 MG DOSES (semaglutide 1 mg per actuation solution for injection pre-filled pen) NOVO NORDISK CANADA INC,Active,9013605,semaglutide 1 mg per actuation solution for injection pre-filled pen,8001525,semaglutide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation (unit of presentation),1.0,,,Prescription
96059,Marketed,2018-02-22,02471477,Ozempic,1,A10BJ06,Semaglutide,Solution,Subcutaneous,02471477,OZEMPIC MULTIDOSE PREFILLED PEN DISPENSES 0.25MG OR 0.5MG DOSE (semaglutide 1.34 mg per mL solution for injection 1.5 mL pen) NOVO NORDISK CANADA INC,Active,9013021,semaglutide 1.34 mg per mL solution for injection 1.5 mL pen,8001525,semaglutide,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,,Schedule D
96059,Marketed,2018-02-22,02471477,Ozempic,1,A10BJ06,Semaglutide,Solution,Subcutaneous,02471477,OZEMPIC MULTIDOSE PREFILLED PEN DISPENSES 0.25MG OR 0.5MG DOSE (semaglutide 1.34 mg per mL solution for injection 1.5 mL pen) NOVO NORDISK CANADA INC,Active,9013021,semaglutide 1.34 mg per mL solution for injection 1.5 mL pen,8001525,semaglutide,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,,Prescription
98740,Marketed,2020-04-19,02497581,Rybelsus,1,A10BJ06,Semaglutide,Tablet,Oral,02497581,RYBELSUS (semaglutide 3 mg oral tablet) NOVO NORDISK CANADA INC,Active,9014276,semaglutide 3 mg oral tablet,8001525,semaglutide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98740,Marketed,2020-04-19,02497581,Rybelsus,1,A10BJ06,Semaglutide,Tablet,Oral,02497581,RYBELSUS (semaglutide 3 mg oral tablet) NOVO NORDISK CANADA INC,Active,9014276,semaglutide 3 mg oral tablet,8001525,semaglutide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Schedule D
98741,Marketed,2020-04-19,02497603,Rybelsus,1,A10BJ06,Semaglutide,Tablet,Oral,02497603,RYBELSUS (semaglutide 7 mg oral tablet) NOVO NORDISK CANADA INC,Active,9014277,semaglutide 7 mg oral tablet,8001525,semaglutide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98741,Marketed,2020-04-19,02497603,Rybelsus,1,A10BJ06,Semaglutide,Tablet,Oral,02497603,RYBELSUS (semaglutide 7 mg oral tablet) NOVO NORDISK CANADA INC,Active,9014277,semaglutide 7 mg oral tablet,8001525,semaglutide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Schedule D
98742,Marketed,2020-04-19,02497611,Rybelsus,1,A10BJ06,Semaglutide,Tablet,Oral,02497611,RYBELSUS (semaglutide 14 mg oral tablet) NOVO NORDISK CANADA INC,Active,9014275,semaglutide 14 mg oral tablet,8001525,semaglutide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98742,Marketed,2020-04-19,02497611,Rybelsus,1,A10BJ06,Semaglutide,Tablet,Oral,02497611,RYBELSUS (semaglutide 14 mg oral tablet) NOVO NORDISK CANADA INC,Active,9014275,semaglutide 14 mg oral tablet,8001525,semaglutide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Schedule D
100558,Marketed,2025-05-23,02516209,Colace Plus Stimulant Laxative,2,A06AB56,"Senna glycosides, combinations",Tablet,Oral,02516209,COLACE PLUS STIMULANT LAXATIVE (docusate sodium 50 mg and sennosides 8.6 mg oral tablet) PHARMASCIENCE INC,Active,9003784,docusate sodium 50 mg and sennosides 8.6 mg oral tablet,8000811,docusate and sennosides,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
104191,Marketed,2026-04-01,02553007,Sennosides 8.6 mg And Docusate Sodium 50 mg Tablets,2,A06AB56,"Senna glycosides, combinations",Tablet,Oral,02553007,"SENNOSIDES 8.6 MG AND DOCUSATE SODIUM 50 MG TABLETS (docusate sodium 50 mg and sennosides 8.6 mg oral tablet) TIME-CAP LABORATORIES, INC",Active,9003784,docusate sodium 50 mg and sennosides 8.6 mg oral tablet,8000811,docusate and sennosides,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
2133,Marketed,2025-09-17,00026123,Senokot S,2,A06AB56,"Senna glycosides, combinations",Tablet,Oral,00026123,SENOKOT S (docusate sodium 50 mg and sennosides 8.6 mg oral tablet) INOVA PHARMACEUTICALS (AUSTRALIA) PTY LIMITED,Active,9003784,docusate sodium 50 mg and sennosides 8.6 mg oral tablet,8000811,docusate and sennosides,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
71178,Marketed,2024-12-31,02246951,Senna S. Tablets,2,A06AB56,"Senna glycosides, combinations",Tablet,Oral,02246951,SENNA S. TABLETS (docusate sodium 50 mg and sennosides 8.6 mg oral tablet) SIGMA LIFE SCIENCES INC.,Active,9003784,docusate sodium 50 mg and sennosides 8.6 mg oral tablet,8000811,docusate and sennosides,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
71374,Marketed,2003-03-07,02247134,Senna Laxative And Docusate Sodium Tablets,2,A06AB56,"Senna glycosides, combinations",Tablet,Oral,02247134,SENNA LAXATIVE AND DOCUSATE SODIUM TABLETS (docusate sodium 50 mg and sennosides 8.6 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9003784,docusate sodium 50 mg and sennosides 8.6 mg oral tablet,8000811,docusate and sennosides,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
71635,Marketed,2017-12-27,02247390,Sandoz Senna S,2,A06AB56,"Senna glycosides, combinations",Tablet,Oral,02247390,SANDOZ SENNA S (docusate sodium 50 mg and sennosides 8.6 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003784,docusate sodium 50 mg and sennosides 8.6 mg oral tablet,8000811,docusate and sennosides,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
106475,Marketed,2025-12-01,02561824,Sephience,1,A16AX28,Sepiapterin,Powder,Oral,02561824,SEPHIENCE (sepiapterin 250 mg per sachet powder for oral suspension) PTC THERAPEUTICS INTERNATIONAL LIMITED,Active,9015328,sepiapterin 250 mg per sachet powder for oral suspension,8002569,sepiapterin,26643006,Oral,385027000,Powder for oral suspension,733013000,Sachet,,,,Prescription
106476,Marketed,2025-12-01,02561832,Sephience,2,A16AX28,Sepiapterin,Powder,Oral,02561832,SEPHIENCE (sepiapterin 1000 mg per sachet powder for oral suspension) PTC THERAPEUTICS INTERNATIONAL LIMITED,Active,9015327,sepiapterin 1000 mg per sachet powder for oral suspension,8002569,sepiapterin,26643006,Oral,385027000,Powder for oral suspension,733013000,Sachet,,,,Prescription
102010,Marketed,2023-03-20,02530937,M-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02530937,M-SERTRALINE (sertraline (sertraline hydrochloride) 25 mg oral capsule) MANTRA PHARMA INC,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
102011,Marketed,2023-03-20,02530945,M-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02530945,M-SERTRALINE (sertraline (sertraline hydrochloride) 50 mg oral capsule) MANTRA PHARMA INC,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
102012,Marketed,2023-03-20,02530953,M-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02530953,M-SERTRALINE (sertraline (sertraline hydrochloride) 100 mg oral capsule) MANTRA PHARMA INC,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
102599,Marketed,2024-04-09,02537249,Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02537249,SERTRALINE (sertraline (sertraline hydrochloride) 25 mg oral capsule) ALTAMED PHARMA,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
102600,Marketed,2023-12-21,02537265,Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02537265,SERTRALINE (sertraline (sertraline hydrochloride) 50 mg oral capsule) ALTAMED PHARMA,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
102602,Marketed,2023-12-13,02537281,Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02537281,SERTRALINE (sertraline (sertraline hydrochloride) 100 mg oral capsule) ALTAMED PHARMA,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
104494,Marketed,2025-07-16,02556235,NB-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02556235,NB-SERTRALINE (sertraline (sertraline hydrochloride) 25 mg oral capsule) NB PHARMA INC.,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
104495,Marketed,2025-07-16,02556243,NB-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02556243,NB-SERTRALINE (sertraline (sertraline hydrochloride) 50 mg oral capsule) NB PHARMA INC.,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
104496,Marketed,2025-07-16,02556251,NB-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02556251,NB-SERTRALINE (sertraline (sertraline hydrochloride) 100 mg oral capsule) NB PHARMA INC.,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
12662,Marketed,2023-08-22,01962817,Zoloft,1,N06AB06,Sertraline,Capsule,Oral,01962817,ZOLOFT (sertraline (sertraline hydrochloride) 50 mg oral capsule) BGP PHARMA ULC,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
13392,Marketed,2023-08-22,01962779,Zoloft,1,N06AB06,Sertraline,Capsule,Oral,01962779,ZOLOFT (sertraline (sertraline hydrochloride) 100 mg oral capsule) BGP PHARMA ULC,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
18005,Marketed,2023-08-22,02132702,Zoloft,1,N06AB06,Sertraline,Capsule,Oral,02132702,ZOLOFT (sertraline (sertraline hydrochloride) 25 mg oral capsule) BGP PHARMA ULC,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
61676,Marketed,1999-09-01,02238280,Apo-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02238280,APO-SERTRALINE (sertraline (sertraline hydrochloride) 25 mg oral capsule) APOTEX INC,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
61677,Marketed,1999-09-01,02238281,Apo-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02238281,APO-SERTRALINE (sertraline (sertraline hydrochloride) 50 mg oral capsule) APOTEX INC,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
61678,Marketed,1999-09-01,02238282,Apo-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02238282,APO-SERTRALINE (sertraline (sertraline hydrochloride) 100 mg oral capsule) APOTEX INC,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
64051,Marketed,2010-11-13,02240481,Teva-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02240481,TEVA-SERTRALINE (sertraline (sertraline hydrochloride) 100 mg oral capsule) TEVA CANADA LIMITED,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
64054,Marketed,2010-11-13,02240484,Teva-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02240484,TEVA-SERTRALINE (sertraline (sertraline hydrochloride) 50 mg oral capsule) TEVA CANADA LIMITED,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
64055,Marketed,2010-11-13,02240485,Teva-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02240485,TEVA-SERTRALINE (sertraline (sertraline hydrochloride) 25 mg oral capsule) TEVA CANADA LIMITED,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
64918,Marketed,2026-03-20,02241302,Pro-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02241302,PRO-SERTRALINE (sertraline (sertraline hydrochloride) 25 mg oral capsule) PRO DOC LIMITEE,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
64919,Marketed,2026-03-20,02241303,Pro-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02241303,PRO-SERTRALINE (sertraline (sertraline hydrochloride) 50 mg oral capsule) PRO DOC LIMITEE,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
64920,Marketed,2026-03-20,02241304,Pro-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02241304,PRO-SERTRALINE (sertraline (sertraline hydrochloride) 100 mg oral capsule) PRO DOC LIMITEE,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
68828,Marketed,2002-01-30,02244838,PMS-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02244838,PMS-SERTRALINE (sertraline (sertraline hydrochloride) 25 mg oral capsule) PHARMASCIENCE INC,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
68829,Marketed,2002-01-30,02244839,PMS-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02244839,PMS-SERTRALINE (sertraline (sertraline hydrochloride) 50 mg oral capsule) PHARMASCIENCE INC,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
68830,Marketed,2002-01-30,02244840,PMS-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02244840,PMS-SERTRALINE (sertraline (sertraline hydrochloride) 100 mg oral capsule) PHARMASCIENCE INC,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
72848,Marketed,2024-06-27,02248496,Riva-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02248496,RIVA-SERTRALINE (sertraline (sertraline hydrochloride) 25 mg oral capsule) LABORATOIRE RIVA INC.,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
72849,Marketed,2024-06-27,02248497,Riva-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02248497,RIVA-SERTRALINE (sertraline (sertraline hydrochloride) 50 mg oral capsule) LABORATOIRE RIVA INC.,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
72850,Marketed,2024-06-27,02248498,Riva-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02248498,RIVA-SERTRALINE (sertraline (sertraline hydrochloride) 100 mg oral capsule) LABORATOIRE RIVA INC.,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
83874,Marketed,2022-06-21,02353520,Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02353520,SERTRALINE (sertraline (sertraline hydrochloride) 25 mg oral capsule) SANIS HEALTH INC,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
83875,Marketed,2022-06-21,02353539,Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02353539,SERTRALINE (sertraline (sertraline hydrochloride) 50 mg oral capsule) SANIS HEALTH INC,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
83876,Marketed,2022-06-21,02353547,Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02353547,SERTRALINE (sertraline (sertraline hydrochloride) 100 mg oral capsule) SANIS HEALTH INC,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87166,Marketed,2019-04-05,02386070,Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02386070,SERTRALINE (sertraline (sertraline hydrochloride) 25 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87167,Marketed,2019-04-05,02386089,Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02386089,SERTRALINE (sertraline (sertraline hydrochloride) 50 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87168,Marketed,2019-04-05,02386097,Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02386097,SERTRALINE (sertraline (sertraline hydrochloride) 100 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87629,Marketed,2012-10-18,02390906,Auro-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02390906,AURO-SERTRALINE (sertraline (sertraline hydrochloride) 25 mg oral capsule) AURO PHARMA INC,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87630,Marketed,2012-10-18,02390914,Auro-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02390914,AURO-SERTRALINE (sertraline (sertraline hydrochloride) 50 mg oral capsule) AURO PHARMA INC,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87631,Marketed,2012-10-18,02390922,Auro-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02390922,AURO-SERTRALINE (sertraline (sertraline hydrochloride) 100 mg oral capsule) AURO PHARMA INC,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88430,Marketed,2014-01-16,02399415,Mar-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02399415,MAR-SERTRALINE (sertraline (sertraline hydrochloride) 25 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88431,Marketed,2014-01-06,02399423,Mar-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02399423,MAR-SERTRALINE (sertraline (sertraline hydrochloride) 50 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88432,Marketed,2014-01-16,02399431,Mar-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02399431,MAR-SERTRALINE (sertraline (sertraline hydrochloride) 100 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88721,Marketed,2013-04-29,02402378,Mint-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02402378,MINT-SERTRALINE (sertraline (sertraline hydrochloride) 25 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88722,Marketed,2013-04-29,02402394,Mint-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02402394,MINT-SERTRALINE (sertraline (sertraline hydrochloride) 50 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
88723,Marketed,2013-04-29,02402408,Mint-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02402408,MINT-SERTRALINE (sertraline (sertraline hydrochloride) 100 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
93025,Marketed,2016-11-23,02445042,Bio-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02445042,BIO-SERTRALINE (sertraline (sertraline hydrochloride) 25 mg oral capsule) BIOMED PHARMA,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
93026,Marketed,2016-11-23,02445050,Bio-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02445050,BIO-SERTRALINE (sertraline (sertraline hydrochloride) 50 mg oral capsule) BIOMED PHARMA,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
93027,Marketed,2016-12-08,02445069,Bio-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02445069,BIO-SERTRALINE (sertraline (sertraline hydrochloride) 100 mg oral capsule) BIOMED PHARMA,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95842,Marketed,2018-01-17,02469626,Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02469626,SERTRALINE (sertraline (sertraline hydrochloride) 25 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95843,Marketed,2018-01-17,02469634,Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02469634,SERTRALINE (sertraline (sertraline hydrochloride) 50 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
95844,Marketed,2018-01-17,02469642,Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02469642,SERTRALINE (sertraline (sertraline hydrochloride) 100 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96809,Marketed,2018-09-06,02477882,AG-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02477882,AG-SERTRALINE (sertraline (sertraline hydrochloride) 25 mg oral capsule) ANGITA PHARMA INC.,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96810,Marketed,2018-09-06,02477890,AG-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02477890,AG-SERTRALINE (sertraline (sertraline hydrochloride) 50 mg oral capsule) ANGITA PHARMA INC.,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96811,Marketed,2018-09-06,02477904,AG-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02477904,AG-SERTRALINE (sertraline (sertraline hydrochloride) 100 mg oral capsule) ANGITA PHARMA INC.,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97852,Marketed,2019-09-04,02488434,Nra-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02488434,NRA-SERTRALINE (sertraline (sertraline hydrochloride) 25 mg oral capsule) NORA PHARMA INC,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97853,Marketed,2019-09-04,02488442,Nra-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02488442,NRA-SERTRALINE (sertraline (sertraline hydrochloride) 50 mg oral capsule) NORA PHARMA INC,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97854,Marketed,2019-09-04,02488450,Nra-Sertraline,1,N06AB06,Sertraline,Capsule,Oral,02488450,NRA-SERTRALINE (sertraline (sertraline hydrochloride) 100 mg oral capsule) NORA PHARMA INC,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
102647,Marketed,2023-07-12,02537745,Imcivree,1,A08AA12,Setmelanotide,Solution,Subcutaneous,02537745,"IMCIVREE (setmelanotide (setmelanotide acetate) 10 mg per 1 mL solution for injection vial) RHYTHM PHARMACEUTICALS, INC.",Active,9014896,setmelanotide (setmelanotide acetate) 10 mg per 1 mL solution for injection vial,8002473,setmelanotide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
106622,Marketed,2026-04-24,02563444,Hyrnuo,1,L01EH06,Sevabertinib,Tablet,Oral,02563444,HYRNUO (sevabertinib 10 mg oral tablet) BAYER INC,Active,9015430,sevabertinib 10 mg oral tablet,8002597,sevabertinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,,Prescription
68278,Marketed,2015-02-13,02244310,Renagel,1,V03AE02,Sevelamer,Tablet,Oral,02244310,RENAGEL (sevelamer hydrochloride 800 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9003668,sevelamer hydrochloride 800 mg oral tablet,8001877,sevelamer,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83974,Marketed,2014-07-24,02354586,Renvela,1,V03AE02,Sevelamer,Tablet,Oral,02354586,RENVELA (sevelamer carbonate 800 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9004792,sevelamer carbonate 800 mg oral tablet,8001877,sevelamer,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94913,Marketed,2017-11-08,02461501,Accel-Sevelamer,1,V03AE02,Sevelamer,Tablet,Oral,02461501,ACCEL-SEVELAMER (sevelamer carbonate 800 mg oral tablet) ACCEL PHARMA INC,Active,9004792,sevelamer carbonate 800 mg oral tablet,8001877,sevelamer,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
19497,Marketed,2014-06-19,02172763,Sevorane Af,1,N01AB08,Sevoflurane,Liquid,Inhalation,,,,,,,,,,,,,,,,,Prescription
75141,Marketed,2007-04-11,02265974,Sevoflurane,1,N01AB08,Sevoflurane,Liquid,Inhalation,,,,,,,,,,,,,,,,,Prescription
79344,Marketed,2022-06-27,02307766,Sevoflurane,1,N01AB08,Sevoflurane,Liquid,Inhalation,,,,,,,,,,,,,,,,,Prescription
102652,Marketed,2024-03-12,02537737,Sildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02537737,SILDENAFIL (sildenafil (sildenafil citrate) 100 mg oral tablet) ALTAMED PHARMA,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102945,Marketed,2024-07-11,02540770,Sildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02540770,SILDENAFIL (sildenafil (sildenafil citrate) 25 mg oral tablet) SANIS HEALTH INC,Active,9000837,sildenafil (sildenafil citrate) 25 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103103,Marketed,2025-04-03,02542463,UpHSildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02542463,UPH-SILDENAFIL (sildenafil (sildenafil citrate) 100 mg oral tablet) UPHEALTH PHARMA INC.,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103270,Marketed,2024-09-26,02544172,Viagra,1,G04BE03,Sildenafil,"Film, soluble",Oral,02544172,VIAGRA (sildenafil (sildenafil citrate) 50 mg orodispersible film) BGP PHARMA ULC,Active,9015105,sildenafil (sildenafil citrate) 50 mg orodispersible film,8000268,sildenafil,26643006,Oral,447050008,Orodispersible film,732995004,Film,,,,Prescription
63248,Marketed,2023-07-28,02239766,Viagra,1,G04BE03,Sildenafil,Tablet,Oral,02239766,VIAGRA (sildenafil (sildenafil citrate) 25 mg oral tablet) BGP PHARMA ULC,Active,9000837,sildenafil (sildenafil citrate) 25 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
63249,Marketed,2023-07-28,02239767,Viagra,1,G04BE03,Sildenafil,Tablet,Oral,02239767,VIAGRA (sildenafil (sildenafil citrate) 50 mg oral tablet) BGP PHARMA ULC,Active,9000838,sildenafil (sildenafil citrate) 50 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
63250,Marketed,2023-07-28,02239768,Viagra,1,G04BE03,Sildenafil,Tablet,Oral,02239768,VIAGRA (sildenafil (sildenafil citrate) 100 mg oral tablet) BGP PHARMA ULC,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
72537,Marketed,2012-11-14,02248201,Apo-Sildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02248201,APO-SILDENAFIL (sildenafil (sildenafil citrate) 25 mg oral tablet) APOTEX INC,Active,9000837,sildenafil (sildenafil citrate) 25 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
72538,Marketed,2012-11-14,02248202,Apo-Sildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02248202,APO-SILDENAFIL (sildenafil (sildenafil citrate) 50 mg oral tablet) APOTEX INC,Active,9000838,sildenafil (sildenafil citrate) 50 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
72539,Marketed,2012-11-09,02248203,Apo-Sildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02248203,APO-SILDENAFIL (sildenafil (sildenafil citrate) 100 mg oral tablet) APOTEX INC,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79435,Marketed,2012-12-19,02308738,Teva-Sildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02308738,TEVA-SILDENAFIL (sildenafil (sildenafil citrate) 25 mg oral tablet) TEVA CANADA LIMITED,Active,9000837,sildenafil (sildenafil citrate) 25 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79436,Marketed,2012-12-19,02308746,Teva-Sildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02308746,TEVA-SILDENAFIL (sildenafil (sildenafil citrate) 50 mg oral tablet) TEVA CANADA LIMITED,Active,9000838,sildenafil (sildenafil citrate) 50 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79437,Marketed,2012-12-19,02308754,Teva-Sildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02308754,TEVA-SILDENAFIL (sildenafil (sildenafil citrate) 100 mg oral tablet) TEVA CANADA LIMITED,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80308,Marketed,2013-08-05,02317559,Sildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02317559,SILDENAFIL (sildenafil (sildenafil citrate) 25 mg oral tablet) PHARMASCIENCE INC,Active,9000837,sildenafil (sildenafil citrate) 25 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80310,Marketed,2013-08-05,02317575,Sildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02317575,SILDENAFIL (sildenafil (sildenafil citrate) 50 mg oral tablet) PHARMASCIENCE INC,Active,9000838,sildenafil (sildenafil citrate) 50 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80311,Marketed,2013-08-05,02317583,Sildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02317583,SILDENAFIL (sildenafil (sildenafil citrate) 100 mg oral tablet) PHARMASCIENCE INC,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87831,Marketed,2025-11-07,02393069,Mint-Sildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02393069,MINT-SILDENAFIL (sildenafil (sildenafil citrate) 25 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000837,sildenafil (sildenafil citrate) 25 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87832,Marketed,2013-02-15,02393077,Mint-Sildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02393077,MINT-SILDENAFIL (sildenafil (sildenafil citrate) 50 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000838,sildenafil (sildenafil citrate) 50 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87833,Marketed,2013-02-15,02393085,Mint-Sildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02393085,MINT-SILDENAFIL (sildenafil (sildenafil citrate) 100 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88547,Marketed,2024-04-29,02400693,Sildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02400693,SILDENAFIL (sildenafil (sildenafil citrate) 25 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000837,sildenafil (sildenafil citrate) 25 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88548,Marketed,2024-04-29,02400707,Sildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02400707,SILDENAFIL (sildenafil (sildenafil citrate) 50 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000838,sildenafil (sildenafil citrate) 50 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88549,Marketed,2024-04-29,02400715,Sildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02400715,SILDENAFIL (sildenafil (sildenafil citrate) 100 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88737,Marketed,2017-01-11,02402548,Mar-Sildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02402548,MAR-SILDENAFIL (sildenafil (sildenafil citrate) 100 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89088,Marketed,2024-04-01,02406152,Sildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02406152,SILDENAFIL (sildenafil (sildenafil citrate) 50 mg oral tablet) SANIS HEALTH INC,Active,9000838,sildenafil (sildenafil citrate) 50 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89089,Marketed,2024-06-25,02406160,Sildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02406160,SILDENAFIL (sildenafil (sildenafil citrate) 100 mg oral tablet) SANIS HEALTH INC,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89902,Marketed,2019-05-17,02414368,Auro-Sildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02414368,AURO-SILDENAFIL (sildenafil (sildenafil citrate) 25 mg oral tablet) AURO PHARMA INC,Active,9000837,sildenafil (sildenafil citrate) 25 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89903,Marketed,2019-05-17,02414376,Auro-Sildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02414376,AURO-SILDENAFIL (sildenafil (sildenafil citrate) 50 mg oral tablet) AURO PHARMA INC,Active,9000838,sildenafil (sildenafil citrate) 50 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89904,Marketed,2019-05-17,02414384,Auro-Sildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02414384,AURO-SILDENAFIL (sildenafil (sildenafil citrate) 100 mg oral tablet) AURO PHARMA INC,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90902,Marketed,2014-10-07,02424312,Sildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02424312,SILDENAFIL (sildenafil (sildenafil citrate) 50 mg oral tablet) PRO DOC LIMITEE,Active,9000838,sildenafil (sildenafil citrate) 50 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90903,Marketed,2014-10-07,02424320,Sildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02424320,SILDENAFIL (sildenafil (sildenafil citrate) 100 mg oral tablet) PRO DOC LIMITEE,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91445,Marketed,2015-06-04,02430037,M-Sildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02430037,M-SILDENAFIL (sildenafil (sildenafil citrate) 100 mg oral tablet) MANTRA PHARMA INC,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93880,Marketed,2023-07-20,02452413,Riva-Sildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02452413,RIVA-SILDENAFIL (sildenafil (sildenafil citrate) 100 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95698,Marketed,2021-08-20,02468557,PRZ-Sildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02468557,PRZ-SILDENAFIL (sildenafil (sildenafil citrate) 100 mg oral tablet) PHARMARIS CANADA INC,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96718,Marketed,2018-12-04,02476819,Nra-Sildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02476819,NRA-SILDENAFIL (sildenafil (sildenafil citrate) 100 mg oral tablet) NORA PHARMA INC,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97038,Marketed,2019-08-15,02479796,Accel-Sildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02479796,ACCEL-SILDENAFIL (sildenafil (sildenafil citrate) 25 mg oral tablet) ACCEL PHARMA INC,Active,9000837,sildenafil (sildenafil citrate) 25 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97040,Marketed,2019-08-15,02479818,Accel-Sildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02479818,ACCEL-SILDENAFIL (sildenafil (sildenafil citrate) 50 mg oral tablet) ACCEL PHARMA INC,Active,9000838,sildenafil (sildenafil citrate) 50 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97041,Marketed,2019-08-15,02479826,Accel-Sildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02479826,ACCEL-SILDENAFIL (sildenafil (sildenafil citrate) 100 mg oral tablet) ACCEL PHARMA INC,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97103,Marketed,2019-07-02,02480980,Bio-Sildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02480980,BIO-SILDENAFIL (sildenafil (sildenafil citrate) 100 mg oral tablet) BIOMED PHARMA,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99282,Marketed,2021-07-30,02503344,AG-Sildenafil Tablets,1,G04BE03,Sildenafil,Tablet,Oral,02503344,AG-SILDENAFIL TABLETS (sildenafil (sildenafil citrate) 100 mg oral tablet) ANGITA PHARMA INC.,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99297,Marketed,2021-01-27,02503506,JAMP Sildenafil Tablets,1,G04BE03,Sildenafil,Tablet,Oral,02503506,JAMP SILDENAFIL TABLETS (sildenafil (sildenafil citrate) 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99450,Marketed,2021-08-20,02505150,PRZ-Sildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02505150,PRZ-SILDENAFIL (sildenafil (sildenafil citrate) 25 mg oral tablet) PHARMARIS CANADA INC,Active,9000837,sildenafil (sildenafil citrate) 25 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99451,Marketed,2021-08-20,02505169,PRZ-Sildenafil,1,G04BE03,Sildenafil,Tablet,Oral,02505169,PRZ-SILDENAFIL (sildenafil (sildenafil citrate) 50 mg oral tablet) PHARMARIS CANADA INC,Active,9000838,sildenafil (sildenafil citrate) 50 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101693,Marketed,2023-02-14,02527731,Cicaplast Baume B5 Conditioning Pro-Vitamin B5 Pro-Vitamine B5 Revitalisante,1,D02AA,Silicone products,Cream,Topical,02527731,CICAPLAST BAUME B5 CONDITIONING PRO-VITAMIN B5 PRO-VITAMINE B5 REVITALISANTE (dimethicone 9 % cutaneous cream) LABORATOIRES LA ROCHE-POSAY CANADA,Active,9014829,dimethicone 9 % cutaneous cream,8001633,dimethicone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
27514,Marketed,2002-10-02,02060841,Barriere Cream 20%,1,D02AA,Silicone products,Cream,Topical,02060841,BARRIERE CREAM 20% (silicone 20 % cutaneous cream) WELLSPRING PHARMACEUTICAL CANADA CORP,Active,9003079,silicone 20 % cutaneous cream,8002157,silicone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
67909,Marketed,2026-03-09,02243966,Medline Remedy Essentials Cleanse Baza Cleanse & Protect,1,D02AA,Silicone products,Lotion,Topical,02243966,"MEDLINE REMEDY ESSENTIALS CLEANSE BAZA CLEANSE & PROTECT (dimethicone 2 % lotion) MEDLINE INDUSTRIES, LP",Active,9003726,dimethicone 2 % lotion,8001633,dimethicone,448598008,Cutaneous,739000003,Lotion,,,,,,Non-Prescription Drugs
69988,Marketed,2004-12-10,02245871,Comfort Shield,1,D02AA,Silicone products,Wipe,Topical,02245871,COMFORT SHIELD (dimethicone 3 % wipe) SAGE PRODUCTS LLC,Active,9003988,dimethicone 3 % wipe,8001633,dimethicone,448598008,Cutaneous,465925000,Wipe,465925000,Skin-cleaning wipe (physical object),,,,Non-Prescription Drugs
73513,Marketed,2009-06-18,02250322,Sween 24,1,D02AA,Silicone products,Cream,Topical,02250322,SWEEN 24 (dimethicone 6 % cutaneous cream) COLOPLAST A/S,Active,9003979,dimethicone 6 % cutaneous cream,8001633,dimethicone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
74220,Marketed,2015-11-26,02256975,Proshield Plus,1,D02AA,Silicone products,Ointment,Topical,02256975,PROSHIELD PLUS (dimethicone 1 % cutaneous ointment) SMITH & NEPHEW INC,Active,9004015,dimethicone 1 % cutaneous ointment,8001633,dimethicone,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Non-Prescription Drugs
78703,Marketed,2008-05-30,02301725,Dimethicone Protectant,1,D02AA,Silicone products,Cream,Topical,02301725,DIMETHICONE PROTECTANT (dimethicone 5 % cutaneous cream) SMITH & NEPHEW INC,Active,9004425,dimethicone 5 % cutaneous cream,8001633,dimethicone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
94265,Marketed,2026-04-23,02455838,Cavilon Durable Barrier Cream,1,D02AA,Silicone products,Cream,Topical,02455838,CAVILON DURABLE BARRIER CREAM (dimethicone 1.3 % cutaneous cream) SOLVENTUM CANADA LIMITED,Active,9006166,dimethicone 1.3 % cutaneous cream,8001633,dimethicone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
13362,Marketed,2024-04-10,00896675,Gas-X Extra Strength,1,A03AX13,Silicones,Tablet (chewable),Oral,00896675,GAS-X EXTRA STRENGTH (simethicone 125 mg chewable tablet) HALEON CANADA ULC,Active,9002385,simethicone 125 mg chewable tablet,8002158,simethicone,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
1889,Marketed,2016-11-29,00292990,Ovol For Gas 80 mg Tablet,1,A03AX13,Silicones,Tablet,Oral,00292990,OVOL FOR GAS 80 MG TABLET (simethicone 80 mg oral tablet) CHURCH & DWIGHT CANADA CORP,Active,9001724,simethicone 80 mg oral tablet,8002158,simethicone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
198,Marketed,2021-01-11,00013617,Ovol Drops,1,A03AX13,Silicones,Drops,Oral,00013617,OVOL DROPS (simethicone 40 mg per mL oral drops) CHURCH & DWIGHT CANADA CORP,Active,9001600,simethicone 40 mg per mL oral drops,8002158,simethicone,26643006,Oral,385018001,Oral drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
61044,Marketed,2013-12-06,02237698,Ultra Strength Phazyme 180 mg Softgels,1,A03AX13,Silicones,Capsule,Oral,02237698,ULTRA STRENGTH PHAZYME 180MG SOFTGELS (simethicone 180 mg oral capsule) C B FLEET COMPANY INC,Active,9003321,simethicone 180 mg oral capsule,8002158,simethicone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
62764,Marketed,2016-12-02,02239298,Ovol For Gas 180 mg Capsule,1,A03AX13,Silicones,Capsule,Oral,02239298,OVOL FOR GAS 180 MG CAPSULE (simethicone 180 mg oral capsule) CHURCH & DWIGHT CANADA CORP,Active,9003321,simethicone 180 mg oral capsule,8002158,simethicone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
68167,Marketed,2010-07-01,02244204,Ultra Strength Gas Relief,1,A03AX13,Silicones,Capsule,Oral,02244204,ULTRA STRENGTH GAS RELIEF (simethicone 180 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9003321,simethicone 180 mg oral capsule,8002158,simethicone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
69597,Marketed,2004-05-21,02245510,Pediacol,1,A03AX13,Silicones,Drops,Oral,02245510,PEDIACOL (simethicone 40 mg per mL oral drops) EURO-PHARM INTERNATIONAL CANADA INC,Active,9001600,simethicone 40 mg per mL oral drops,8002158,simethicone,26643006,Oral,385018001,Oral drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
71367,Marketed,2016-12-02,02247127,Ovol For Gas 180 mg Tablet,1,A03AX13,Silicones,Tablet,Oral,02247127,OVOL FOR GAS 180 MG TABLET (simethicone 180 mg oral tablet) CHURCH & DWIGHT CANADA CORP,Active,9003803,simethicone 180 mg oral tablet,8002158,simethicone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
72943,Marketed,2025-07-04,02248588,Infacol,1,A03AX13,Silicones,Suspension,Oral,02248588,INFACOL (simethicone 40 mg per mL oral drops) PHOENIX LABS UNLIMITED COMPANY,Active,9001600,simethicone 40 mg per mL oral drops,8002158,simethicone,26643006,Oral,385018001,Oral drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
78612,Marketed,2024-05-23,02300761,Gas X Ultra Strength,1,A03AX13,Silicones,Capsule,Oral,02300761,GAS X ULTRA STRENGTH (simethicone 180 mg oral capsule) HALEON CANADA ULC,Active,9003321,simethicone 180 mg oral capsule,8002158,simethicone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Non-Prescription Drugs
81363,Marketed,2010-03-25,02328127,Gas Relief Tablets,1,A03AX13,Silicones,Tablet (chewable),Oral,02328127,GAS RELIEF TABLETS (simethicone 125 mg chewable tablet) GUARDIAN DRUG COMPANY INC,Active,9002385,simethicone 125 mg chewable tablet,8002158,simethicone,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Non-Prescription Drugs
100713,Marketed,2021-10-21,02517779,PMS-Silodosin,1,G04CA04,Silodosin,Capsule,Oral,02517779,PMS-SILODOSIN (silodosin 4 mg oral capsule) PHARMASCIENCE INC,Active,9012394,silodosin 4 mg oral capsule,8001120,silodosin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
100714,Marketed,2021-10-21,02517787,PMS-Silodosin,1,G04CA04,Silodosin,Capsule,Oral,02517787,PMS-SILODOSIN (silodosin 8 mg oral capsule) PHARMASCIENCE INC,Active,9012395,silodosin 8 mg oral capsule,8001120,silodosin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
102827,Marketed,2024-05-22,02539519,JAMP Silodosin,1,G04CA04,Silodosin,Capsule,Oral,02539519,JAMP SILODOSIN (silodosin 4 mg oral capsule) JAMP PHARMA CORPORATION,Active,9012394,silodosin 4 mg oral capsule,8001120,silodosin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
102828,Marketed,2024-05-22,02539527,JAMP Silodosin,1,G04CA04,Silodosin,Capsule,Oral,02539527,JAMP SILODOSIN (silodosin 8 mg oral capsule) JAMP PHARMA CORPORATION,Active,9012395,silodosin 8 mg oral capsule,8001120,silodosin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96581,Marketed,2021-01-08,02475421,Sandoz Silodosin,1,G04CA04,Silodosin,Capsule,Oral,02475421,SANDOZ SILODOSIN (silodosin 4 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9012394,silodosin 4 mg oral capsule,8001120,silodosin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96582,Marketed,2021-01-08,02475448,Sandoz Silodosin,1,G04CA04,Silodosin,Capsule,Oral,02475448,SANDOZ SILODOSIN (silodosin 8 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9012395,silodosin 8 mg oral capsule,8001120,silodosin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96929,Marketed,2022-02-16,02478501,Auro-Silodosin,1,G04CA04,Silodosin,Capsule,Oral,02478501,AURO-SILODOSIN (silodosin 4 mg oral capsule) AURO PHARMA INC,Active,9012394,silodosin 4 mg oral capsule,8001120,silodosin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96930,Marketed,2022-02-16,02478528,Auro-Silodosin,1,G04CA04,Silodosin,Capsule,Oral,02478528,AURO-SILODOSIN (silodosin 8 mg oral capsule) AURO PHARMA INC,Active,9012395,silodosin 8 mg oral capsule,8001120,silodosin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
91940,Marketed,2024-07-30,02435128,Sylvant,1,L04AC11,Siltuximab,Powder for solution,Intravenous,02435128,SYLVANT (siltuximab 100 mg per vial powder for solution for injection) RECORDATI RARE DISEASES CANADA INC,Active,9005671,siltuximab 100 mg per vial powder for solution for injection,8001935,siltuximab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
91940,Marketed,2024-07-30,02435128,Sylvant,1,L04AC11,Siltuximab,Powder for solution,Intravenous,02435128,SYLVANT (siltuximab 100 mg per vial powder for solution for injection) RECORDATI RARE DISEASES CANADA INC,Active,9005671,siltuximab 100 mg per vial powder for solution for injection,8001935,siltuximab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
91941,Marketed,2024-07-30,02435136,Sylvant,1,L04AC11,Siltuximab,Powder for solution,Intravenous,02435136,SYLVANT (siltuximab 400 mg per vial powder for solution for injection) RECORDATI RARE DISEASES CANADA INC,Active,9005672,siltuximab 400 mg per vial powder for solution for injection,8001935,siltuximab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
91941,Marketed,2024-07-30,02435136,Sylvant,1,L04AC11,Siltuximab,Powder for solution,Intravenous,02435136,SYLVANT (siltuximab 400 mg per vial powder for solution for injection) RECORDATI RARE DISEASES CANADA INC,Active,9005672,siltuximab 400 mg per vial powder for solution for injection,8001935,siltuximab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
103845,Marketed,2025-05-30,02549638,PMSC-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02549638,PMSC-SIMVASTATIN (simvastatin 5 mg oral tablet) PHARMASCIENCE INC,Active,9001010,simvastatin 5 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103846,Marketed,2025-05-30,02549646,PMSC-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02549646,PMSC-SIMVASTATIN (simvastatin 10 mg oral tablet) PHARMASCIENCE INC,Active,9000369,simvastatin 10 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103847,Marketed,2025-05-30,02549654,PMSC-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02549654,PMSC-SIMVASTATIN (simvastatin 20 mg oral tablet) PHARMASCIENCE INC,Active,9000545,simvastatin 20 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103848,Marketed,2025-05-30,02549662,PMSC-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02549662,PMSC-SIMVASTATIN (simvastatin 40 mg oral tablet) PHARMASCIENCE INC,Active,9000643,simvastatin 40 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103849,Marketed,2025-05-30,02549670,PMSC-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02549670,PMSC-SIMVASTATIN (simvastatin 80 mg oral tablet) PHARMASCIENCE INC,Active,9001011,simvastatin 80 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
10947,Marketed,2022-03-11,00884332,Zocor,1,C10AA01,Simvastatin,Tablet,Oral,00884332,ZOCOR (simvastatin 10 mg oral tablet) ORGANON CANADA INC.,Active,9000369,simvastatin 10 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
16473,Marketed,2022-04-01,00884340,Zocor,1,C10AA01,Simvastatin,Tablet,Oral,00884340,ZOCOR (simvastatin 20 mg oral tablet) ORGANON CANADA INC.,Active,9000545,simvastatin 20 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
46718,Marketed,2022-02-11,00884359,Zocor,1,C10AA01,Simvastatin,Tablet,Oral,00884359,ZOCOR (simvastatin 40 mg oral tablet) ORGANON CANADA INC.,Active,9000643,simvastatin 40 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71245,Marketed,2002-12-20,02247011,Apo-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02247011,APO-SIMVASTATIN (simvastatin 5 mg oral tablet) APOTEX INC,Active,9001010,simvastatin 5 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71246,Marketed,2002-12-20,02247012,Apo-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02247012,APO-SIMVASTATIN (simvastatin 10 mg oral tablet) APOTEX INC,Active,9000369,simvastatin 10 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71247,Marketed,2002-12-20,02247013,Apo-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02247013,APO-SIMVASTATIN (simvastatin 20 mg oral tablet) APOTEX INC,Active,9000545,simvastatin 20 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71248,Marketed,2002-12-20,02247014,Apo-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02247014,APO-SIMVASTATIN (simvastatin 40 mg oral tablet) APOTEX INC,Active,9000643,simvastatin 40 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71249,Marketed,2002-12-20,02247015,Apo-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02247015,APO-SIMVASTATIN (simvastatin 80 mg oral tablet) APOTEX INC,Active,9001011,simvastatin 80 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71463,Marketed,2026-01-20,02247221,Pro-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02247221,PRO-SIMVASTATIN (simvastatin 10 mg oral tablet) PRO DOC LIMITEE,Active,9000369,simvastatin 10 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71464,Marketed,2026-03-17,02247222,Pro-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02247222,PRO-SIMVASTATIN (simvastatin 20 mg oral tablet) PRO DOC LIMITEE,Active,9000545,simvastatin 20 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71465,Marketed,2025-06-03,02247223,Pro-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02247223,PRO-SIMVASTATIN (simvastatin 40 mg oral tablet) PRO DOC LIMITEE,Active,9000643,simvastatin 40 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71466,Marketed,2025-06-03,02247224,Pro-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02247224,PRO-SIMVASTATIN (simvastatin 80 mg oral tablet) PRO DOC LIMITEE,Active,9001011,simvastatin 80 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73495,Marketed,2010-05-01,02250144,Teva-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02250144,TEVA-SIMVASTATIN (simvastatin 5 mg oral tablet) TEVA CANADA LIMITED,Active,9001010,simvastatin 5 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73496,Marketed,2010-05-01,02250152,Teva-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02250152,TEVA-SIMVASTATIN (simvastatin 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000369,simvastatin 10 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73497,Marketed,2010-05-01,02250160,Teva-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02250160,TEVA-SIMVASTATIN (simvastatin 20 mg oral tablet) TEVA CANADA LIMITED,Active,9000545,simvastatin 20 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73498,Marketed,2010-05-01,02250179,Teva-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02250179,TEVA-SIMVASTATIN (simvastatin 40 mg oral tablet) TEVA CANADA LIMITED,Active,9000643,simvastatin 40 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73499,Marketed,2010-05-01,02250187,Teva-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02250187,TEVA-SIMVASTATIN (simvastatin 80 mg oral tablet) TEVA CANADA LIMITED,Active,9001011,simvastatin 80 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77028,Marketed,2021-03-03,02284723,Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02284723,SIMVASTATIN (simvastatin 5 mg oral tablet) SANIS HEALTH INC,Active,9001010,simvastatin 5 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77029,Marketed,2021-03-03,02284731,Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02284731,SIMVASTATIN (simvastatin 10 mg oral tablet) SANIS HEALTH INC,Active,9000369,simvastatin 10 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77030,Marketed,2021-03-03,02284758,Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02284758,SIMVASTATIN (simvastatin 20 mg oral tablet) SANIS HEALTH INC,Active,9000545,simvastatin 20 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77031,Marketed,2021-03-03,02284766,Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02284766,SIMVASTATIN (simvastatin 40 mg oral tablet) SANIS HEALTH INC,Active,9000643,simvastatin 40 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77032,Marketed,2021-03-03,02284774,Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02284774,SIMVASTATIN (simvastatin 80 mg oral tablet) SANIS HEALTH INC,Active,9001011,simvastatin 80 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81483,Marketed,2020-01-20,02329131,Taro-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02329131,TARO-SIMVASTATIN (simvastatin 5 mg oral tablet) SUN PHARMA CANADA INC,Active,9001010,simvastatin 5 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81484,Marketed,2020-01-20,02329158,Taro-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02329158,TARO-SIMVASTATIN (simvastatin 10 mg oral tablet) SUN PHARMA CANADA INC,Active,9000369,simvastatin 10 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81485,Marketed,2020-01-20,02329166,Taro-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02329166,TARO-SIMVASTATIN (simvastatin 20 mg oral tablet) SUN PHARMA CANADA INC,Active,9000545,simvastatin 20 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81486,Marketed,2020-01-20,02329174,Taro-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02329174,TARO-SIMVASTATIN (simvastatin 40 mg oral tablet) SUN PHARMA CANADA INC,Active,9000643,simvastatin 40 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81487,Marketed,2020-01-20,02329182,Taro-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02329182,TARO-SIMVASTATIN (simvastatin 80 mg oral tablet) SUN PHARMA CANADA INC,Active,9001011,simvastatin 80 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85804,Marketed,2011-09-07,02372932,Mint-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02372932,MINT-SIMVASTATIN (simvastatin 5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001010,simvastatin 5 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85805,Marketed,2011-09-07,02372940,Mint-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02372940,MINT-SIMVASTATIN (simvastatin 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000369,simvastatin 10 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85806,Marketed,2011-09-07,02372959,Mint-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02372959,MINT-SIMVASTATIN (simvastatin 20 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000545,simvastatin 20 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85807,Marketed,2011-09-07,02372967,Mint-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02372967,MINT-SIMVASTATIN (simvastatin 40 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000643,simvastatin 40 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85808,Marketed,2011-09-07,02372975,Mint-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02372975,MINT-SIMVASTATIN (simvastatin 80 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001011,simvastatin 80 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86044,Marketed,2012-12-20,02375044,Mar-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02375044,MAR-SIMVASTATIN (simvastatin 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000369,simvastatin 10 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86045,Marketed,2023-04-18,02375052,Mar-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02375052,MAR-SIMVASTATIN (simvastatin 20 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000545,simvastatin 20 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86046,Marketed,2023-05-25,02375060,Mar-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02375060,MAR-SIMVASTATIN (simvastatin 40 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000643,simvastatin 40 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86101,Marketed,2018-10-16,02375591,JAMP-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02375591,JAMP-SIMVASTATIN (simvastatin 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001010,simvastatin 5 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86102,Marketed,2018-10-17,02375605,JAMP-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02375605,JAMP-SIMVASTATIN (simvastatin 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000369,simvastatin 10 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86103,Marketed,2018-10-17,02375613,JAMP-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02375613,JAMP-SIMVASTATIN (simvastatin 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000545,simvastatin 20 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86104,Marketed,2018-10-17,02375621,JAMP-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02375621,JAMP-SIMVASTATIN (simvastatin 40 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000643,simvastatin 40 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86105,Marketed,2018-10-16,02375648,JAMP-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02375648,JAMP-SIMVASTATIN (simvastatin 80 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001011,simvastatin 80 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87187,Marketed,2022-05-31,02386291,Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02386291,SIMVASTATIN (simvastatin 5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001010,simvastatin 5 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87188,Marketed,2022-05-31,02386305,Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02386305,SIMVASTATIN (simvastatin 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000369,simvastatin 10 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87189,Marketed,2022-05-31,02386313,Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02386313,SIMVASTATIN (simvastatin 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000545,simvastatin 20 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87190,Marketed,2022-05-31,02386321,Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02386321,SIMVASTATIN (simvastatin 40 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000643,simvastatin 40 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87191,Marketed,2022-05-31,02386348,Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02386348,SIMVASTATIN (simvastatin 80 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001011,simvastatin 80 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88996,Marketed,2013-07-08,02405148,Auro-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02405148,AURO-SIMVASTATIN (simvastatin 5 mg oral tablet) AURO PHARMA INC,Active,9001010,simvastatin 5 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88997,Marketed,2013-07-08,02405172,Auro-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02405172,AURO-SIMVASTATIN (simvastatin 40 mg oral tablet) AURO PHARMA INC,Active,9000643,simvastatin 40 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88998,Marketed,2013-07-08,02405156,Auro-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02405156,AURO-SIMVASTATIN (simvastatin 10 mg oral tablet) AURO PHARMA INC,Active,9000369,simvastatin 10 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88999,Marketed,2013-07-08,02405164,Auro-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02405164,AURO-SIMVASTATIN (simvastatin 20 mg oral tablet) AURO PHARMA INC,Active,9000545,simvastatin 20 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89000,Marketed,2013-07-08,02405180,Auro-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02405180,AURO-SIMVASTATIN (simvastatin 80 mg oral tablet) AURO PHARMA INC,Active,9001011,simvastatin 80 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95892,Marketed,2017-11-29,02469979,Pharma-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02469979,PHARMA-SIMVASTATIN (simvastatin 5 mg oral tablet) PHARMASCIENCE INC,Active,9001010,simvastatin 5 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95893,Marketed,2017-11-29,02469987,Pharma-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02469987,PHARMA-SIMVASTATIN (simvastatin 10 mg oral tablet) PHARMASCIENCE INC,Active,9000369,simvastatin 10 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95894,Marketed,2017-11-29,02469995,Pharma-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02469995,PHARMA-SIMVASTATIN (simvastatin 20 mg oral tablet) PHARMASCIENCE INC,Active,9000545,simvastatin 20 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95895,Marketed,2017-11-29,02470004,Pharma-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02470004,PHARMA-SIMVASTATIN (simvastatin 40 mg oral tablet) PHARMASCIENCE INC,Active,9000643,simvastatin 40 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95896,Marketed,2017-11-29,02470012,Pharma-Simvastatin,1,C10AA01,Simvastatin,Tablet,Oral,02470012,PHARMA-SIMVASTATIN (simvastatin 80 mg oral tablet) PHARMASCIENCE INC,Active,9001011,simvastatin 80 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
37574,Marketed,1998-07-08,02228602,Kinevac,1,V04CC03,Sincalide,Powder for solution,Intravenous,02228602,KINEVAC (sincalide 5 mcg per vial powder for solution for injection) BRACCO IMAGING CANADA,Active,9003264,sincalide 5 mcg per vial powder for solution for injection,8001936,sincalide,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Ethical
98439,Marketed,2023-08-03,02494361,Sincalide For Injection,1,V04CC03,Sincalide,Powder for solution,Intravenous,02494361,SINCALIDE FOR INJECTION (sincalide 5 mcg per vial powder for solution for injection) AVIR PHARMA INC.,Active,9003264,sincalide 5 mcg per vial powder for solution for injection,8001936,sincalide,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Ethical
89643,Marketed,2026-04-20,02411849,Veregen,1,D06BB12,Sinecatechins,Ointment,Topical,02411849,VEREGEN (sinecatechins 10 % cutaneous ointment) KNIGHT THERAPEUTICS INC.,Active,9005548,sinecatechins 10 % cutaneous ointment,8001937,sinecatechins,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Prescription
98630,Marketed,2020-04-24,02496429,Mayzent,1,L04AE03,Siponimod,Tablet,Oral,02496429,MAYZENT (siponimod 0.25 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014299,siponimod 0.25 mg oral tablet,8002327,siponimod,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98631,Marketed,2020-04-24,02496437,Mayzent,1,L04AE03,Siponimod,Tablet,Oral,02496437,MAYZENT (siponimod 2 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014300,siponimod 2 mg oral tablet,8002327,siponimod,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
67127,Marketed,2013-06-10,02243237,Rapamune,1,L04AH01,Sirolimus,Solution,Oral,02243237,RAPAMUNE (sirolimus 1 mg per mL oral solution) PFIZER CANADA ULC,Active,9003600,sirolimus 1 mg per mL oral solution,8001938,sirolimus,26643006,Oral,385023001,Oral solution,,,1.0,,,Prescription
71350,Marketed,2012-02-28,02247111,Rapamune,1,L04AH01,Sirolimus,Tablet,Oral,02247111,RAPAMUNE (sirolimus 1 mg oral tablet) PFIZER CANADA ULC,Active,9003790,sirolimus 1 mg oral tablet,8001938,sirolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100176,Marketed,2023-05-12,02512475,ACH-Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02512475,ACH-SITAGLIPTIN (sitagliptin (sitagliptin phosphate) 25 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001387,sitagliptin (sitagliptin phosphate) 25 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100177,Marketed,2023-05-12,02512483,ACH-Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02512483,ACH-SITAGLIPTIN (sitagliptin (sitagliptin phosphate) 50 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001388,sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100178,Marketed,2023-05-12,02512491,ACH-Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02512491,ACH-SITAGLIPTIN (sitagliptin (sitagliptin phosphate) 100 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001232,sitagliptin (sitagliptin phosphate) 100 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101181,Marketed,2023-08-31,02522705,Teva-Sitagliptin Malate,1,A10BH01,Sitagliptin,Tablet,Oral,02522705,TEVA-SITAGLIPTIN MALATE (sitagliptin (sitagliptin malate) 25 mg oral tablet) TEVA CANADA LIMITED,Active,9014883,sitagliptin (sitagliptin malate) 25 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101182,Marketed,2023-08-31,02522713,Teva-Sitagliptin Malate,1,A10BH01,Sitagliptin,Tablet,Oral,02522713,TEVA-SITAGLIPTIN MALATE (sitagliptin (sitagliptin malate) 50 mg oral tablet) TEVA CANADA LIMITED,Active,9014884,sitagliptin (sitagliptin malate) 50 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101183,Marketed,2023-08-31,02522721,Teva-Sitagliptin Malate,1,A10BH01,Sitagliptin,Tablet,Oral,02522721,TEVA-SITAGLIPTIN MALATE (sitagliptin (sitagliptin malate) 100 mg oral tablet) TEVA CANADA LIMITED,Active,9014882,sitagliptin (sitagliptin malate) 100 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101823,Marketed,2023-01-26,02529033,Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02529033,SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 25 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001387,sitagliptin (sitagliptin phosphate) 25 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101824,Marketed,2023-01-26,02529041,Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02529041,SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001388,sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101825,Marketed,2023-01-26,02529068,Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02529068,SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 100 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001232,sitagliptin (sitagliptin phosphate) 100 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101909,Marketed,2023-01-05,02529866,Auro-Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02529866,AURO-SITAGLIPTIN (sitagliptin (sitagliptin hydrochloride monohydrate) 25 mg oral tablet) AURO PHARMA INC,Active,9014880,sitagliptin (sitagliptin hydrochloride) 25 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101910,Marketed,2023-01-05,02529874,Auro-Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02529874,AURO-SITAGLIPTIN (sitagliptin (sitagliptin hydrochloride monohydrate) 50 mg oral tablet) AURO PHARMA INC,Active,9014881,sitagliptin (sitagliptin hydrochloride) 50 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101911,Marketed,2023-01-05,02529882,Auro-Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02529882,AURO-SITAGLIPTIN (sitagliptin (sitagliptin hydrochloride monohydrate) 100 mg oral tablet) AURO PHARMA INC,Active,9014879,sitagliptin (sitagliptin hydrochloride) 100 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102075,Marketed,2023-01-05,02531631,Taro-Sitagliptin Fumarate,1,A10BH01,Sitagliptin,Tablet,Oral,02531631,TARO-SITAGLIPTIN FUMARATE (sitagliptin (sitagliptin fumarate) 25 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9014877,sitagliptin (sitagliptin fumarate) 25 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102076,Marketed,2023-01-05,02531658,Taro-Sitagliptin Fumarate,1,A10BH01,Sitagliptin,Tablet,Oral,02531658,TARO-SITAGLIPTIN FUMARATE (sitagliptin (sitagliptin fumarate) 50 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9014878,sitagliptin (sitagliptin fumarate) 50 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102078,Marketed,2023-01-05,02531666,Taro-Sitagliptin Fumarate,1,A10BH01,Sitagliptin,Tablet,Oral,02531666,TARO-SITAGLIPTIN FUMARATE (sitagliptin (sitagliptin fumarate) 100 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9014876,sitagliptin (sitagliptin fumarate) 100 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102308,Marketed,2023-02-02,02534134,JAMP Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02534134,JAMP SITAGLIPTIN (sitagliptin (sitagliptin hydrochloride monohydrate) 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9014880,sitagliptin (sitagliptin hydrochloride) 25 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102309,Marketed,2023-02-02,02534142,JAMP Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02534142,JAMP SITAGLIPTIN (sitagliptin (sitagliptin hydrochloride monohydrate) 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9014881,sitagliptin (sitagliptin hydrochloride) 50 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102310,Marketed,2023-02-02,02534150,JAMP Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02534150,JAMP SITAGLIPTIN (sitagliptin (sitagliptin hydrochloride monohydrate) 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9014879,sitagliptin (sitagliptin hydrochloride) 100 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102323,Marketed,2023-02-01,02534290,Pro-Sitagliptin Malate,1,A10BH01,Sitagliptin,Tablet,Oral,02534290,PRO-SITAGLIPTIN MALATE (sitagliptin (sitagliptin malate) 25 mg oral tablet) PRO DOC LIMITEE,Active,9014883,sitagliptin (sitagliptin malate) 25 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102324,Marketed,2023-02-01,02534304,Pro-Sitagliptin Malate,1,A10BH01,Sitagliptin,Tablet,Oral,02534304,PRO-SITAGLIPTIN MALATE (sitagliptin (sitagliptin malate) 50 mg oral tablet) PRO DOC LIMITEE,Active,9014884,sitagliptin (sitagliptin malate) 50 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102325,Marketed,2023-02-03,02534312,Pro-Sitagliptin Malate,1,A10BH01,Sitagliptin,Tablet,Oral,02534312,PRO-SITAGLIPTIN MALATE (sitagliptin (sitagliptin malate) 100 mg oral tablet) PRO DOC LIMITEE,Active,9014882,sitagliptin (sitagliptin malate) 100 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102387,Marketed,2026-05-11,02534983,M-Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02534983,M-SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 25 mg oral tablet) MANTRA PHARMA INC,Active,9001387,sitagliptin (sitagliptin phosphate) 25 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102388,Marketed,2026-05-11,02534991,M-Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02534991,M-SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) MANTRA PHARMA INC,Active,9001388,sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102389,Marketed,2026-05-11,02535009,M-Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02535009,M-SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 100 mg oral tablet) MANTRA PHARMA INC,Active,9001232,sitagliptin (sitagliptin phosphate) 100 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102436,Marketed,2023-12-01,02535513,AG-Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02535513,AG-SITAGLIPTIN (sitagliptin (sitagliptin hydrochloride monohydrate) 25 mg oral tablet) ANGITA PHARMA INC.,Active,9014880,sitagliptin (sitagliptin hydrochloride) 25 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102437,Marketed,2023-12-01,02535521,AG-Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02535521,AG-SITAGLIPTIN (sitagliptin (sitagliptin hydrochloride monohydrate) 50 mg oral tablet) ANGITA PHARMA INC.,Active,9014881,sitagliptin (sitagliptin hydrochloride) 50 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102438,Marketed,2023-12-01,02535548,AG-Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02535548,AG-SITAGLIPTIN (sitagliptin (sitagliptin hydrochloride monohydrate) 100 mg oral tablet) ANGITA PHARMA INC.,Active,9014879,sitagliptin (sitagliptin hydrochloride) 100 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103187,Marketed,2026-01-06,02543400,Nat-Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02543400,NAT-SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 100 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9001232,sitagliptin (sitagliptin phosphate) 100 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103457,Marketed,2026-02-10,02545837,PRZ-Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02545837,PRZ-SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 25 mg oral tablet) PHARMARIS CANADA INC,Active,9001387,sitagliptin (sitagliptin phosphate) 25 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103458,Marketed,2026-02-10,02545845,PRZ-Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02545845,PRZ-SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) PHARMARIS CANADA INC,Active,9001388,sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103459,Marketed,2026-02-10,02545853,PRZ-Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02545853,PRZ-SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 100 mg oral tablet) PHARMARIS CANADA INC,Active,9001232,sitagliptin (sitagliptin phosphate) 100 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103742,Marketed,2024-12-17,02548569,Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02548569,SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) SANIS HEALTH INC,Active,9001388,sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103743,Marketed,2024-12-17,02548577,Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02548577,SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 100 mg oral tablet) SANIS HEALTH INC,Active,9001232,sitagliptin (sitagliptin phosphate) 100 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104281,Marketed,2025-12-10,02553910,Mint-Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02553910,MINT-SITAGLIPTIN (sitagliptin (sitagliptin phosphate) 25 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001387,sitagliptin (sitagliptin phosphate) 25 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104282,Marketed,2025-12-10,02553929,Mint-Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02553929,MINT-SITAGLIPTIN (sitagliptin (sitagliptin phosphate) 50 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001388,sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104283,Marketed,2025-12-10,02553937,Mint-Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02553937,MINT-SITAGLIPTIN (sitagliptin (sitagliptin phosphate) 100 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001232,sitagliptin (sitagliptin phosphate) 100 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106144,Marketed,2026-01-06,02558157,Nat-Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02558157,NAT-SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 25 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9001387,sitagliptin (sitagliptin phosphate) 25 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106145,Marketed,2026-01-06,02558165,Nat-Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02558165,NAT-SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9001388,sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78924,Marketed,2008-01-02,02303922,Januvia,1,A10BH01,Sitagliptin,Tablet,Oral,02303922,JANUVIA (sitagliptin (sitagliptin phosphate monohydrate) 100 mg oral tablet) MERCK CANADA INC,Active,9001232,sitagliptin (sitagliptin phosphate) 100 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87438,Marketed,2012-09-17,02388839,Januvia,1,A10BH01,Sitagliptin,Tablet,Oral,02388839,JANUVIA (sitagliptin (sitagliptin phosphate monohydrate) 25 mg oral tablet) MERCK CANADA INC,Active,9001387,sitagliptin (sitagliptin phosphate) 25 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87439,Marketed,2012-09-17,02388847,Januvia,1,A10BH01,Sitagliptin,Tablet,Oral,02388847,JANUVIA (sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) MERCK CANADA INC,Active,9001388,sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91274,Marketed,2025-12-22,02428261,Apo-Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02428261,APO-SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 25 mg oral tablet) APOTEX INC,Active,9001387,sitagliptin (sitagliptin phosphate) 25 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91275,Marketed,2025-12-22,02428288,Apo-Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02428288,APO-SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) APOTEX INC,Active,9001388,sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91276,Marketed,2025-12-22,02428296,Apo-Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02428296,APO-SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 100 mg oral tablet) APOTEX INC,Active,9001232,sitagliptin (sitagliptin phosphate) 100 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99328,Marketed,2024-11-26,02503840,PMS-Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02503840,PMS-SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 25 mg oral tablet) PHARMASCIENCE INC,Active,9001387,sitagliptin (sitagliptin phosphate) 25 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99329,Marketed,2024-11-26,02503859,PMS-Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02503859,PMS-SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) PHARMASCIENCE INC,Active,9001388,sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99330,Marketed,2024-11-26,02503867,PMS-Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02503867,PMS-SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 100 mg oral tablet) PHARMASCIENCE INC,Active,9001232,sitagliptin (sitagliptin phosphate) 100 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99350,Marketed,2023-01-05,02504049,Sandoz Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02504049,SANDOZ SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 25 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001387,sitagliptin (sitagliptin phosphate) 25 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99351,Marketed,2023-01-05,02504057,Sandoz Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02504057,SANDOZ SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001388,sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99352,Marketed,2023-01-05,02504065,Sandoz Sitagliptin,1,A10BH01,Sitagliptin,Tablet,Oral,02504065,SANDOZ SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 100 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001232,sitagliptin (sitagliptin phosphate) 100 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99800,Marketed,2022-11-07,02508656,Apo-Sitagliptin Malate,1,A10BH01,Sitagliptin,Tablet,Oral,02508656,APO-SITAGLIPTIN MALATE (sitagliptin (sitagliptin malate) 25 mg oral tablet) APOTEX INC,Active,9014883,sitagliptin (sitagliptin malate) 25 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99801,Marketed,2022-11-07,02508664,Apo-Sitagliptin Malate,1,A10BH01,Sitagliptin,Tablet,Oral,02508664,APO-SITAGLIPTIN MALATE (sitagliptin (sitagliptin malate) 50 mg oral tablet) APOTEX INC,Active,9014884,sitagliptin (sitagliptin malate) 50 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99802,Marketed,2022-11-07,02508672,Apo-Sitagliptin Malate,1,A10BH01,Sitagliptin,Tablet,Oral,02508672,APO-SITAGLIPTIN MALATE (sitagliptin (sitagliptin malate) 100 mg oral tablet) APOTEX INC,Active,9014882,sitagliptin (sitagliptin malate) 100 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
31360,Marketed,2016-04-26,02139529,"Sodium Acetate Injection, USP",1,B05XA08,Sodium acetate,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
35083,Marketed,2024-01-11,02181746,Sodium Acetate Injection USP,1,B05XA08,Sodium acetate,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
100560,Marketed,2022-03-24,02516225,Sodium Bicarbonate Injection USP,1,B05XA02,Sodium bicarbonate,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
103051,Marketed,2024-05-08,02541904,Sodium Bicarbonate Injection USP,1,B05XA02,Sodium bicarbonate,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
1905,Marketed,2017-07-24,00261998,Sodium Bicarbonate Injection USP,1,B05XA02,Sodium bicarbonate,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
95595,Marketed,2017-10-20,02467585,Sodium Bicarbonate Injection USP,1,B05XA02,Sodium bicarbonate,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
97681,Marketed,2019-09-17,02486636,"Sodium Bicarbonate Injection, USP",1,B05XA02,Sodium bicarbonate,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
100335,Marketed,2022-07-06,02514184,"20% Sodium Chloride Injection, BP",1,B05XA03,Sodium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
10040,Marketed,2019-02-11,00060208,"0.9% Sodium Chloride Injection, USP",1,B05XA03,Sodium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
10442,Marketed,1990-12-31,00060186,Sodium Chloride 0.45% Inj,1,B05XA03,Sodium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
11039,Marketed,1990-12-31,00060232,Sodium Chloride 3% Inj,1,B05XA03,Sodium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
12185,Marketed,1998-04-25,01924303,0.9% Sodium Chloride Injection USP,1,B05XA03,Sodium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
1239,Marketed,2019-10-22,00037826,Sodium Chloride Irrigation USP,1,B05CB01,Sodium chloride,Solution,"Irrigation,Intraperitoneal",,,,,,,,,,,,,,,,,Ethical
14579,Marketed,1998-04-30,01927949,0.45% Sodium Chloride Injection USP,1,B05XA03,Sodium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
15492,Marketed,1998-04-30,01928007,5% Sodium Chloride Injection USP,1,B05XA03,Sodium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
18136,Marketed,2020-07-09,02150204,0.9% Sodium Chloride Injection USP,1,B05XA03,Sodium chloride,Solution,"Intravenous,Intramuscular,Subcutaneous",,,,,,,,,,,,,,,,,Ethical
18937,Marketed,2015-11-13,02139510,"Sodium Chloride Injection, USP",1,B05XA03,Sodium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
228,Marketed,2020-02-20,00037834,Sodium Chloride Irrigation USP,1,B05CB01,Sodium chloride,Solution,"Intraperitoneal,Topical,Irrigation",,,,,,,,,,,,,,,,,Ethical
3395,Marketed,1977-12-31,00402230,Sodium Chloride Inj 23.4%,1,B05XA03,Sodium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
4092,Marketed,2020-02-05,00037842,Sodium Chloride Injection USP,1,B05XA03,Sodium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
817,Marketed,2017-08-30,00037796,Sodium Chloride Injection USP,1,B05XA03,Sodium chloride,Solution,"Intramuscular,Intraperitoneal,Subcutaneous,Intravenous",,,,,,,,,,,,,,,,,Ethical
88027,Marketed,2023-02-24,02395150,0.9% Sodium Chloride Injection,1,B05XA03,Sodium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
9825,Marketed,2021-01-15,00786160,"0.9% Sodium Chloride Irrigation, USP",1,B05CB01,Sodium chloride,Solution,Irrigation,,,,,,,,,,,,,,,,,Ethical
81546,Marketed,2018-11-14,02329743,"Draximage Sodium Iodide I 131 Capsules, USP Therapeutic",1,V10XA01,Sodium iodide 131 i,Capsule,Oral,,,,,,,,,,,,,,,,,Schedule C
81548,Marketed,2018-11-14,02329778,"Draximage Sodium Iodide I 131 Solution, USP Therapeutic",1,V10XA01,Sodium iodide 131 i,Solution,Oral,,,,,,,,,,,,,,,,,Schedule C
92430,Marketed,2018-08-03,02439905,Sodium Iodide (131 I) Solution,1,V10XA01,Sodium iodide 131 i,Solution,Oral,,,,,,,,,,,,,,,,,Schedule C
92099,Marketed,2015-01-27,02436663,Pheburane,1,A16AX03,Sodium phenylbutyrate,Granules,Oral,02436663,PHEBURANE (sodium phenylbutyrate 483 mg per g oral granules) MEDUNIK CANADA,Active,9014708,sodium phenylbutyrate 483 mg per g oral granules,8001915,phenylbutyric acid,26643006,Oral,420509004,Oral granules,1141902006,Medicine spoon (physical object),1.0,,,Prescription
11258,Marketed,2006-07-22,00896187,Sodium Phosphates Injection USP,2,B05XA09,Sodium phosphate,Solution,Intravenous,00896187,SODIUM PHOSPHATES INJECTION USP (phosphorus (sodium phosphate dibasic and sodium phosphate monobasic) 30 mmol per 10 mL and sodium (sodium phosphate dibasic and sodium phosphate monobasic) 40 mmol per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013929,phosphorus (sodium phosphate dibasic and sodium phosphate monobasic) 30 mmol per 10 mL and sodium (sodium phosphate dibasic and sodium phosphate monobasic) 40 mmol per 10 mL solution for injection vial,8002162,sodium phosphate dibasic and sodium phosphate monobasic,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
73995,Marketed,2004-11-25,02254794,Pico-Salax,3,A06AB58,"Sodium picosulfate, combinations",Powder for solution,Oral,02254794,PICO-SALAX (citric acid 12 g per sachet and magnesium oxide 3.5 g per sachet and sodium picosulfate 10 mg per sachet powder for oral solution) FERRING INC,Active,9013538,citric acid 12 g per sachet and magnesium oxide 3.5 g per sachet and sodium picosulfate 10 mg per sachet powder for oral solution,8002108,citric acid and magnesium oxide and sodium picosulfate,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,,Ethical
80347,Marketed,2009-02-16,02317966,Purg-Odan,3,A06AB58,"Sodium picosulfate, combinations",Powder for solution,Oral,02317966,PURG-ODAN (citric acid 12 g per sachet and magnesium oxide 3.5 g per sachet and sodium picosulfate 10 mg per sachet powder for oral solution) ODAN LABORATORIES LTD,Active,9013538,citric acid 12 g per sachet and magnesium oxide 3.5 g per sachet and sodium picosulfate 10 mg per sachet powder for oral solution,8002108,citric acid and magnesium oxide and sodium picosulfate,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,,Ethical
8274,Marketed,1987-12-31,00511226,Tromboject 3%,1,C05BB04,Sodium tetradecyl sulphate,Solution,Intravenous,77700821,TROMBOJECT 3% (sodium tetradecyl sulfate 150 mg per 5 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013346,sodium tetradecyl sulfate 150 mg per 5 mL solution for injection vial,8001942,sodium tetradecyl sulfate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
8274,Marketed,1987-12-31,00511226,Tromboject 3%,1,C05BB04,Sodium tetradecyl sulphate,Solution,Intravenous,77700822,TROMBOJECT 3% (sodium tetradecyl sulfate 60 mg per 2 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013348,sodium tetradecyl sulfate 60 mg per 2 mL solution for injection vial,8001942,sodium tetradecyl sulfate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
8275,Marketed,1987-12-31,00511234,Tromboject 1%,1,C05BB04,Sodium tetradecyl sulphate,Solution,Intravenous,00511234,TROMBOJECT 1% (sodium tetradecyl sulfate 20 mg per 2 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013347,sodium tetradecyl sulfate 20 mg per 2 mL solution for injection vial,8001942,sodium tetradecyl sulfate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
98077,Marketed,2019-10-17,02490714,Lokelma,1,V03AE10,Sodium zirconium cyclosilicate,Powder for suspension,Oral,02490714,LOKELMA (sodium zirconium cyclosilicate 5 g per sachet powder for oral suspension) ASTRAZENECA CANADA INC,Active,9014200,sodium zirconium cyclosilicate 5 g per sachet powder for oral suspension,8002303,sodium zirconium cyclosilicate,26643006,Oral,385027000,Powder for oral suspension,733013000,Sachet (unit of presentation),,,,Prescription
98078,Marketed,2019-10-17,02490722,Lokelma,1,V03AE10,Sodium zirconium cyclosilicate,Powder for suspension,Oral,02490722,LOKELMA (sodium zirconium cyclosilicate 10 g per sachet powder for oral suspension) ASTRAZENECA CANADA INC,Active,9014199,sodium zirconium cyclosilicate 10 g per sachet powder for oral suspension,8002303,sodium zirconium cyclosilicate,26643006,Oral,385027000,Powder for oral suspension,733013000,Sachet (unit of presentation),,,,Prescription
96912,Marketed,2019-12-17,02478366,Sodium Iodide I-123 Oral Solution,1,V09FX02,Sodiunm iodide 123 i,Solution,Oral,,,,,,,,,,,,,,,,,Schedule C
81547,Marketed,2018-11-14,02329751,"Draximage Sodium Iodide I 131 Capsules, USP Diagnostic",1,V09FX03,Sodiunm iodide 131 i,Capsule,Oral,,,,,,,,,,,,,,,,,Schedule C
81549,Marketed,2018-11-14,02329786,"Draximage Sodium Iodide I 131 Solution, USP Diagnostic",1,V09FX03,Sodiunm iodide 131 i,Solution,Oral,,,,,,,,,,,,,,,,,Schedule C
90293,Marketed,2014-01-06,02418355,Sovaldi,1,J05AP08,Sofosbuvir,Tablet,Oral,02418355,SOVALDI (sofosbuvir 400 mg oral tablet) GILEAD SCIENCES CANADA INC,Active,9005390,sofosbuvir 400 mg oral tablet,8001156,sofosbuvir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91668,Marketed,2014-10-16,02432226,Harvoni,2,J05AP51,Sofosbuvir and ledipasvir,Tablet,Oral,02432226,HARVONI (ledipasvir 90 mg and sofosbuvir 400 mg oral tablet) GILEAD SCIENCES CANADA INC,Active,9005599,ledipasvir 90 mg and sofosbuvir 400 mg oral tablet,8001212,ledipasvir and sofosbuvir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94324,Marketed,2016-08-02,02456370,Epclusa,2,J05AP55,Sofosbuvir and velpatasvir,Tablet,Oral,02456370,EPCLUSA (sofosbuvir 400 mg and velpatasvir 100 mg oral tablet) GILEAD SCIENCES CANADA INC,Active,9006017,sofosbuvir 400 mg and velpatasvir 100 mg oral tablet,8001157,sofosbuvir and velpatasvir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95590,Marketed,2017-09-18,02467542,Vosevi,3,J05AP56,"Sofosbuvir, velpatasvir and voxilaprevir",Tablet,Oral,02467542,VOSEVI (sofosbuvir 400 mg and velpatasvir 100 mg and voxilaprevir 100 mg oral tablet) GILEAD SCIENCES CANADA INC,Active,9012539,sofosbuvir 400 mg and velpatasvir 100 mg and voxilaprevir 100 mg oral tablet,8001158,sofosbuvir and velpatasvir and voxilaprevir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100126,Marketed,2022-02-01,02512033,Baby Healing Ointment,1,D02AC,Soft paraffin and fat products,Ointment,Topical,02512033,BABY HEALING OINTMENT (petrolatum 46.5 % cutaneous ointment) CERAVE CANADA,Active,9013239,petrolatum 46.5 % cutaneous ointment,8001866,petrolatum,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Non-Prescription Drugs
100695,Marketed,2022-11-22,02517574,Bag Balm Skin Moisturizer,1,D02AC,Soft paraffin and fat products,Ointment,Topical,02517574,BAG BALM SKIN MOISTURIZER (petrolatum 84.3 % cutaneous ointment) VERMONT'S ORIGINAL LLC,Active,9014907,petrolatum 84.3 % cutaneous ointment,8001866,petrolatum,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Non-Prescription Drugs
102494,Marketed,2024-01-22,02536129,Protective Ointment,1,D02AC,Soft paraffin and fat products,Ointment,Topical,02536129,PROTECTIVE OINTMENT (petrolatum 98.85 % cutaneous ointment) SMITH & NEPHEW INC,Active,9015019,petrolatum 98.85 % cutaneous ointment,8001866,petrolatum,448598008,Cutaneous,385101003,Ointment,,,,,,Non-Prescription Drugs
103143,Marketed,2024-01-19,02542900,Repair & Protect,1,D02AC,Soft paraffin and fat products,Stick,Topical,02542900,REPAIR & PROTECT (petrolatum 45 % cutaneous stick) BLISTEX CORPORATION,Active,9015005,petrolatum 45 % cutaneous stick,8001866,petrolatum,448598008,Cutaneous,739007000,Stick,733016008,Stick (unit of presentation),,,,Non-Prescription Drugs
12947,Marketed,1992-12-31,01939068,Huile De Bain Therapeutique,2,D02AC,Soft paraffin and fat products,Solution,Topical,01939068,HUILE DE BAIN THERAPEUTIQUE (lanolin 3 % and mineral oil heavy 91.7 % cutaneous solution) LABORATOIRE ATLAS INC,Active,9013824,lanolin 3 % and mineral oil heavy 91.7 % cutaneous solution,8002201,lanolin and mineral oil heavy,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Non-Prescription Drugs
14042,Marketed,1993-12-31,01935321,Light Mineral Oil 100% Nf,1,D02AC,Soft paraffin and fat products,Liquid,Topical,01935321,LIGHT MINERAL OIL 100% NF (mineral oil light 100 % cutaneous liquid) RW CONSUMER PRODUCTS LTD,Active,9003625,mineral oil light 100 % cutaneous liquid,8002146,mineral oil light,448598008,Cutaneous,420699003,Liquid,,,,,,Non-Prescription Drugs
36404,Marketed,2019-12-05,02203375,Sterile Light Mineral Oil 100%,1,D02AC,Soft paraffin and fat products,Oil,Topical,02203375,STERILE LIGHT MINERAL OIL 100% (mineral oil light 100 % cutaneous liquid) OMEGA LABORATORIES LIMITED,Active,9003625,mineral oil light 100 % cutaneous liquid,8002146,mineral oil light,448598008,Cutaneous,420699003,Liquid,,,,,,Non-Prescription Drugs
41756,Marketed,1998-04-08,00790516,Petrolatum Blanc Ont USP,1,D02AC,Soft paraffin and fat products,Ointment,Topical,00790516,PETROLATUM BLANC ONT USP (white petrolatum 100 % cutaneous ointment) LABORATOIRE ATLAS INC,Active,9001536,white petrolatum 100 % cutaneous ointment,8001880,white petrolatum,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Non-Prescription Drugs
57,Marketed,1951-12-31,00050520,Minerale Legere Huile,1,D02AC,Soft paraffin and fat products,Liquid,Topical,00050520,MINERALE LEGERE HUILE (mineral oil light 100 % cutaneous liquid) LABORATOIRE ATLAS INC,Active,9003625,mineral oil light 100 % cutaneous liquid,8002146,mineral oil light,448598008,Cutaneous,420699003,Liquid,,,,,,Non-Prescription Drugs
76338,Marketed,2026-01-22,02277778,Medline Remedy Simplified Prevent Critic-Aid Clear,1,D02AC,Soft paraffin and fat products,Ointment,Topical,02277778,"MEDLINE REMEDY SIMPLIFIED PREVENT CRITIC-AID CLEAR (white petrolatum 71.5 % cutaneous ointment) MEDLINE INDUSTRIES, LP",Active,9004221,white petrolatum 71.5 % cutaneous ointment,8001880,white petrolatum,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Non-Prescription Drugs
79066,Marketed,2015-02-10,02305178,Compliments White Petroleum Jelly,1,D02AC,Soft paraffin and fat products,Ointment,Topical,02305178,COMPLIMENTS WHITE PETROLEUM JELLY (white petrolatum 100 % cutaneous ointment) GEMINI PACKAGING LTD,Active,9001536,white petrolatum 100 % cutaneous ointment,8001880,white petrolatum,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Non-Prescription Drugs
88479,Marketed,2020-02-10,02399954,Ointment With Moisturizing Vitamin E,1,D02AC,Soft paraffin and fat products,Ointment,Topical,02399954,OINTMENT WITH MOISTURIZING VITAMIN E (petrolatum 95.7 % cutaneous ointment) CRLS,Active,9005462,petrolatum 95.7 % cutaneous ointment,8001866,petrolatum,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Non-Prescription Drugs
90292,Marketed,2015-02-23,02418347,Diabetics' Dry Skin Relief Foot Cream,1,D02AC,Soft paraffin and fat products,Cream,Topical,02418347,DIABETICS' DRY SKIN RELIEF FOOT CREAM (white petrolatum 30 % cutaneous cream) SANOFI CONSUMER HEALTH INC,Active,9004048,white petrolatum 30 % cutaneous cream,8001880,white petrolatum,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
93145,Marketed,2024-06-24,02446189,Aquaphor Healing Ointment,1,D02AC,Soft paraffin and fat products,Ointment,Topical,02446189,AQUAPHOR HEALING OINTMENT (mineral oil heavy 52.74 % cutaneous ointment) BEIERSDORF CANADA INC,Active,9014365,mineral oil heavy 52.74 % cutaneous ointment,8002204,mineral oil heavy,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Non-Prescription Drugs
95080,Marketed,2024-01-01,02462915,Healing Ointment,1,D02AC,Soft paraffin and fat products,Ointment,Topical,02462915,HEALING OINTMENT (white petrolatum 46.5 % cutaneous ointment) CERAVE CANADA,Active,9015010,white petrolatum 46.5 % cutaneous ointment,8001880,white petrolatum,448598008,Cutaneous,385101003,Ointment,,,,,,Non-Prescription Drugs
9587,Marketed,2022-02-18,00741515,White Petrolatum Ointment,1,D02AC,Soft paraffin and fat products,Ointment,Topical,00741515,WHITE PETROLATUM OINTMENT (white petrolatum 100 % cutaneous ointment) CANADIAN CUSTOM PACKAGING COMPANY,Active,9001536,white petrolatum 100 % cutaneous ointment,8001880,white petrolatum,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Non-Prescription Drugs
100586,Marketed,2026-01-13,02516519,Bio-Solifenacin,1,G04BD08,Solifenacin,Tablet,Oral,02516519,BIO-SOLIFENACIN (solifenacin succinate 5 mg oral tablet) BIOMED PHARMA,Active,9001160,solifenacin succinate 5 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100587,Marketed,2026-01-13,02516527,Bio-Solifenacin,1,G04BD08,Solifenacin,Tablet,Oral,02516527,BIO-SOLIFENACIN (solifenacin succinate 10 mg oral tablet) BIOMED PHARMA,Active,9001159,solifenacin succinate 10 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101893,Marketed,2023-08-18,02529696,M-Solifenacin Succinate,1,G04BD08,Solifenacin,Tablet,Oral,02529696,M-SOLIFENACIN SUCCINATE (solifenacin succinate 5 mg oral tablet) MANTRA PHARMA INC,Active,9001160,solifenacin succinate 5 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101894,Marketed,2023-08-18,02529718,M-Solifenacin Succinate,1,G04BD08,Solifenacin,Tablet,Oral,02529718,M-SOLIFENACIN SUCCINATE (solifenacin succinate 10 mg oral tablet) MANTRA PHARMA INC,Active,9001159,solifenacin succinate 10 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76292,Marketed,2006-06-23,02277263,Vesicare,1,G04BD08,Solifenacin,Tablet,Oral,02277263,VESICARE (solifenacin succinate 5 mg oral tablet) ASTELLAS PHARMA CANADA INC,Active,9001160,solifenacin succinate 5 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76293,Marketed,2006-06-23,02277271,Vesicare,1,G04BD08,Solifenacin,Tablet,Oral,02277271,VESICARE (solifenacin succinate 10 mg oral tablet) ASTELLAS PHARMA CANADA INC,Active,9001159,solifenacin succinate 10 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88283,Marketed,2015-07-30,02397900,Teva-Solifenacin,1,G04BD08,Solifenacin,Tablet,Oral,02397900,TEVA-SOLIFENACIN (solifenacin succinate 5 mg oral tablet) TEVA CANADA LIMITED,Active,9001160,solifenacin succinate 5 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88284,Marketed,2015-07-30,02397919,Teva-Solifenacin,1,G04BD08,Solifenacin,Tablet,Oral,02397919,TEVA-SOLIFENACIN (solifenacin succinate 10 mg oral tablet) TEVA CANADA LIMITED,Active,9001159,solifenacin succinate 10 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88394,Marketed,2015-09-30,02399032,Sandoz Solifenacin,1,G04BD08,Solifenacin,Tablet,Oral,02399032,SANDOZ SOLIFENACIN (solifenacin succinate 5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001160,solifenacin succinate 5 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88395,Marketed,2015-09-30,02399040,Sandoz Solifenacin,1,G04BD08,Solifenacin,Tablet,Oral,02399040,SANDOZ SOLIFENACIN (solifenacin succinate 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001159,solifenacin succinate 10 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90235,Marketed,2015-10-28,02417723,PMS-Solifenacin,1,G04BD08,Solifenacin,Tablet,Oral,02417723,PMS-SOLIFENACIN (solifenacin succinate 5 mg oral tablet) PHARMASCIENCE INC,Active,9001160,solifenacin succinate 5 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90236,Marketed,2015-10-28,02417731,PMS-Solifenacin,1,G04BD08,Solifenacin,Tablet,Oral,02417731,PMS-SOLIFENACIN (solifenacin succinate 10 mg oral tablet) PHARMASCIENCE INC,Active,9001159,solifenacin succinate 10 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91336,Marketed,2024-01-25,02428911,JAMP Solifenacin Succinate,1,G04BD08,Solifenacin,Tablet,Oral,02428911,JAMP SOLIFENACIN SUCCINATE (solifenacin succinate 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001160,solifenacin succinate 5 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91337,Marketed,2024-01-25,02428938,JAMP Solifenacin Succinate,1,G04BD08,Solifenacin,Tablet,Oral,02428938,JAMP SOLIFENACIN SUCCINATE (solifenacin succinate 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001159,solifenacin succinate 10 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92234,Marketed,2019-12-11,02437988,Taro-Solifenacin,1,G04BD08,Solifenacin,Tablet,Oral,02437988,TARO-SOLIFENACIN (solifenacin succinate 5 mg oral tablet) SUN PHARMA CANADA INC,Active,9001160,solifenacin succinate 5 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92235,Marketed,2019-12-11,02437996,Taro-Solifenacin,1,G04BD08,Solifenacin,Tablet,Oral,02437996,TARO-SOLIFENACIN (solifenacin succinate 10 mg oral tablet) SUN PHARMA CANADA INC,Active,9001159,solifenacin succinate 10 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92372,Marketed,2023-03-20,02439344,ACH-Solifenacin Succinate,1,G04BD08,Solifenacin,Tablet,Oral,02439344,ACH-SOLIFENACIN SUCCINATE (solifenacin succinate 5 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001160,solifenacin succinate 5 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92373,Marketed,2023-03-20,02439352,ACH-Solifenacin Succinate,1,G04BD08,Solifenacin,Tablet,Oral,02439352,ACH-SOLIFENACIN SUCCINATE (solifenacin succinate 10 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001159,solifenacin succinate 10 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93171,Marketed,2016-01-04,02446375,Auro-Solifenacin,1,G04BD08,Solifenacin,Tablet,Oral,02446375,AURO-SOLIFENACIN (solifenacin succinate 5 mg oral tablet) AURO PHARMA INC,Active,9001160,solifenacin succinate 5 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93172,Marketed,2016-01-04,02446383,Auro-Solifenacin,1,G04BD08,Solifenacin,Tablet,Oral,02446383,AURO-SOLIFENACIN (solifenacin succinate 10 mg oral tablet) AURO PHARMA INC,Active,9001159,solifenacin succinate 10 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94519,Marketed,2016-10-27,02458144,Solifenacin,1,G04BD08,Solifenacin,Tablet,Oral,02458144,SOLIFENACIN (solifenacin succinate 5 mg oral tablet) PRO DOC LIMITEE,Active,9001160,solifenacin succinate 5 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94520,Marketed,2016-10-27,02458152,Solifenacin,1,G04BD08,Solifenacin,Tablet,Oral,02458152,SOLIFENACIN (solifenacin succinate 10 mg oral tablet) PRO DOC LIMITEE,Active,9001159,solifenacin succinate 10 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94535,Marketed,2016-11-03,02458241,Solifenacin,1,G04BD08,Solifenacin,Tablet,Oral,02458241,SOLIFENACIN (solifenacin succinate 5 mg oral tablet) SANIS HEALTH INC,Active,9001160,solifenacin succinate 5 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94536,Marketed,2016-11-03,02458268,Solifenacin,1,G04BD08,Solifenacin,Tablet,Oral,02458268,SOLIFENACIN (solifenacin succinate 10 mg oral tablet) SANIS HEALTH INC,Active,9001159,solifenacin succinate 10 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98302,Marketed,2020-11-13,02493039,PRZ-Solifenacin,1,G04BD08,Solifenacin,Tablet,Oral,02493039,PRZ-SOLIFENACIN (solifenacin succinate 5 mg oral tablet) PHARMARIS CANADA INC,Active,9001160,solifenacin succinate 5 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98303,Marketed,2020-11-13,02493047,PRZ-Solifenacin,1,G04BD08,Solifenacin,Tablet,Oral,02493047,PRZ-SOLIFENACIN (solifenacin succinate 10 mg oral tablet) PHARMARIS CANADA INC,Active,9001159,solifenacin succinate 10 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100521,Marketed,2022-11-17,02515814,Sunosi,1,N06BA14,Solriamfetol,Tablet,Oral,02515814,SUNOSI (solriamfetol (solriamfetol hydrochloride) 75 mg oral tablet) AXSOME MALTA LTD.,Active,9014589,solriamfetol (solriamfetol hydrochloride) 75 mg oral tablet,8002385,solriamfetol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100522,Marketed,2022-11-17,02515822,Sunosi,1,N06BA14,Solriamfetol,Tablet,Oral,02515822,SUNOSI (solriamfetol (solriamfetol hydrochloride) 150 mg oral tablet) AXSOME MALTA LTD.,Active,9014588,solriamfetol (solriamfetol hydrochloride) 150 mg oral tablet,8002385,solriamfetol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
115,Marketed,2017-08-30,00037818,Bacteriostatic Sodium Chloride Injection USP,1,V07AB,"Solvents and diluting agents, incl irrigat solut",Solution,"Intramuscular,Subcutaneous,Intravenous",,,,,,,,,,,,,,,,,Ethical
117,Marketed,2018-05-09,00038202,Bacteriostatic Water For Injection USP,1,V07AB,"Solvents and diluting agents, incl irrigat solut",Solution,"Intravenous,Intramuscular,Subcutaneous",,,,,,,,,,,,,,,,,Ethical
13509,Marketed,1998-06-17,01927930,Sterile Water For Injection USP,1,V07AB,"Solvents and diluting agents, incl irrigat solut",Liquid,Intravenous,,,,,,,,,,,,,,,,,Ethical
15867,Marketed,2015-01-01,02014882,"Sterile Water For Injection, USP",1,V07AB,"Solvents and diluting agents, incl irrigat solut",Liquid,Intravenous,,,,,,,,,,,,,,,,,Ethical
1911,Marketed,2005-01-17,00298409,Phenol Saline Inj,2,V07AB,"Solvents and diluting agents, incl irrigat solut",Liquid,"Intradermal,Subcutaneous",,,,,,,,,,,,,,,,,Ethical
1912,Marketed,2005-01-17,00298417,Glycerinated Phenol Saline,3,V07AB,"Solvents and diluting agents, incl irrigat solut",Liquid,"Intradermal,Subcutaneous",,,,,,,,,,,,,,,,,Ethical
19812,Marketed,2003-03-10,02214733,Sterile Water For Injection USP,1,V07AB,"Solvents and diluting agents, incl irrigat solut",Liquid,Intravenous,,,,,,,,,,,,,,,,,Ethical
20354,Marketed,2005-11-09,02215721,Bacteriostatic Water For Injection USP-Pre-Filled Syringe,1,V07AB,"Solvents and diluting agents, incl irrigat solut",Liquid,Intracavernosal,,,,,,,,,,,,,,,,,Ethical
31491,Marketed,2017-08-29,02142546,Sterile Water For Injection USP,1,V07AB,"Solvents and diluting agents, incl irrigat solut",Solution,"Intramuscular,Subcutaneous,Intraperitoneal,Intravenous",,,,,,,,,,,,,,,,,Ethical
3383,Marketed,2020-06-05,00402257,Sterile Water For Injection USP,1,V07AB,"Solvents and diluting agents, incl irrigat solut",Liquid,"Subcutaneous,Intravenous,Intramuscular",,,,,,,,,,,,,,,,,Ethical
3396,Marketed,1977-12-31,00402249,Sodium Chloride Bacteriostatic Inj,1,V07AB,"Solvents and diluting agents, incl irrigat solut",Liquid,"Intramuscular,Intravenous,Subcutaneous",,,,,,,,,,,,,,,,,Ethical
3822,Marketed,2019-11-28,00498785,Sterile Water For Irrigation USP,1,V07AB,"Solvents and diluting agents, incl irrigat solut",Liquid,"Irrigation,Intraperitoneal",,,,,,,,,,,,,,,,,Ethical
4913,Marketed,1982-12-31,00568082,BSS Plus,8,V07AB,"Solvents and diluting agents, incl irrigat solut","Solution,Kit",Intraocular,,,,,,,,,,,,,,,,,Ethical
6366,Marketed,2008-11-28,00512990,BSS Sterile Irrigating Solution,6,V07AB,"Solvents and diluting agents, incl irrigat solut",Solution,Irrigation,,,,,,,,,,,,,,,,,Ethical
76932,Marketed,2007-03-02,02283735,Sterile Diluent For Allergenic Extract - Albumin Saline With Phenol,1,V07AB,"Solvents and diluting agents, incl irrigat solut",Solution,Subcutaneous,,,,,,,,,,,,,,,,,Schedule D
78457,Marketed,2024-01-08,02299186,Sterile Water For Injection USP,1,V07AB,"Solvents and diluting agents, incl irrigat solut",Solution,"Intramuscular,Intravenous,Subcutaneous",,,,,,,,,,,,,,,,,Ethical
78963,Marketed,2024-05-09,02304341,0.9% Sodium Chloride Injection USP,1,V07AB,"Solvents and diluting agents, incl irrigat solut",Solution,"Subcutaneous,Intravenous,Intramuscular",,,,,,,,,,,,,,,,,Ethical
86658,Marketed,2023-10-12,02380811,"Sterile Diluent For Merck Sharp & Dohme LLC Live, Attenuated, Virus Vaccines",1,V07AB,"Solvents and diluting agents, incl irrigat solut",Liquid,Parenteral (unspecified),,,,,,,,,,,,,,,,,Ethical
92834,Marketed,2016-08-04,02443651,PH 12 Sterile Diluent For Flolan,3,V07AB,"Solvents and diluting agents, incl irrigat solut",Liquid,Intravenous,,,,,,,,,,,,,,,,,Ethical
9831,Marketed,2020-12-08,00799998,"Sterile Water For Irrigation, USP",1,V07AB,"Solvents and diluting agents, incl irrigat solut",Liquid,Irrigation,,,,,,,,,,,,,,,,,Ethical
99333,Marketed,2024-02-02,02503891,Sterile Water For Injection USP,1,V07AB,"Solvents and diluting agents, incl irrigat solut",Liquid,Intravenous,,,,,,,,,,,,,,,,,Ethical
102866,Marketed,2023-11-27,02539934,Sogroya,1,H01AC07,Somapacitan,Solution,Subcutaneous,02539934,SOGROYA (somapacitan 5 mg per 1.5 mL solution for injection pen) NOVO NORDISK CANADA INC,Active,9014991,somapacitan 5 mg per 1.5 mL solution for injection pen,8002493,somapacitan,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Prescription
102866,Marketed,2023-11-27,02539934,Sogroya,1,H01AC07,Somapacitan,Solution,Subcutaneous,02539934,SOGROYA (somapacitan 5 mg per 1.5 mL solution for injection pen) NOVO NORDISK CANADA INC,Active,9014991,somapacitan 5 mg per 1.5 mL solution for injection pen,8002493,somapacitan,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
102867,Marketed,2023-11-27,02539942,Sogroya,1,H01AC07,Somapacitan,Solution,Subcutaneous,02539942,SOGROYA (somapacitan 10 mg per 1.5 mL solution for injection pen) NOVO NORDISK CANADA INC,Active,9014989,somapacitan 10 mg per 1.5 mL solution for injection pen,8002493,somapacitan,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
102867,Marketed,2023-11-27,02539942,Sogroya,1,H01AC07,Somapacitan,Solution,Subcutaneous,02539942,SOGROYA (somapacitan 10 mg per 1.5 mL solution for injection pen) NOVO NORDISK CANADA INC,Active,9014989,somapacitan 10 mg per 1.5 mL solution for injection pen,8002493,somapacitan,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Prescription
102868,Marketed,2023-11-27,02539950,Sogroya,1,H01AC07,Somapacitan,Solution,Subcutaneous,02539950,SOGROYA (somapacitan 15 mg per 1.5 mL solution for injection pen) NOVO NORDISK CANADA INC,Active,9014990,somapacitan 15 mg per 1.5 mL solution for injection pen,8002493,somapacitan,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Prescription
102868,Marketed,2023-11-27,02539950,Sogroya,1,H01AC07,Somapacitan,Solution,Subcutaneous,02539950,SOGROYA (somapacitan 15 mg per 1.5 mL solution for injection pen) NOVO NORDISK CANADA INC,Active,9014990,somapacitan 15 mg per 1.5 mL solution for injection pen,8002493,somapacitan,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
101087,Marketed,2022-02-22,02521679,Ngenla,1,H01AC08,Somatrogon,Solution,Subcutaneous,02521679,NGENLA (somatrogon 24 mg per 1.2 mL solution for injection pen) PFIZER CANADA ULC,Active,9014682,somatrogon 24 mg per 1.2 mL solution for injection pen,8002414,somatrogon,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Prescription
101087,Marketed,2022-02-22,02521679,Ngenla,1,H01AC08,Somatrogon,Solution,Subcutaneous,02521679,NGENLA (somatrogon 24 mg per 1.2 mL solution for injection pen) PFIZER CANADA ULC,Active,9014682,somatrogon 24 mg per 1.2 mL solution for injection pen,8002414,somatrogon,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
101089,Marketed,2022-02-22,02521687,Ngenla,1,H01AC08,Somatrogon,Solution,Subcutaneous,02521687,NGENLA (somatrogon 60 mg per 1.2 mL solution for injection pen) PFIZER CANADA ULC,Active,9014683,somatrogon 60 mg per 1.2 mL solution for injection pen,8002414,somatrogon,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Prescription
101089,Marketed,2022-02-22,02521687,Ngenla,1,H01AC08,Somatrogon,Solution,Subcutaneous,02521687,NGENLA (somatrogon 60 mg per 1.2 mL solution for injection pen) PFIZER CANADA ULC,Active,9014683,somatrogon 60 mg per 1.2 mL solution for injection pen,8002414,somatrogon,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
101843,Marketed,2022-12-07,02529181,Norditropin Flexpro,1,H01AC01,Somatropin,Solution,Subcutaneous,02529181,NORDITROPIN FLEXPRO (somatropin 5 mg per 1.5 mL solution for injection pen) NOVO NORDISK CANADA INC,Active,9013748,somatropin 5 mg per 1.5 mL solution for injection pen,8001943,somatropin,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Prescription
101843,Marketed,2022-12-07,02529181,Norditropin Flexpro,1,H01AC01,Somatropin,Solution,Subcutaneous,02529181,NORDITROPIN FLEXPRO (somatropin 5 mg per 1.5 mL solution for injection pen) NOVO NORDISK CANADA INC,Active,9013748,somatropin 5 mg per 1.5 mL solution for injection pen,8001943,somatropin,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
101844,Marketed,2022-12-07,02529203,Norditropin Flexpro,1,H01AC01,Somatropin,Solution,Subcutaneous,02529203,NORDITROPIN FLEXPRO (somatropin 10 mg per 1.5 mL solution for injection pen) NOVO NORDISK CANADA INC,Active,9013736,somatropin 10 mg per 1.5 mL solution for injection pen,8001943,somatropin,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Prescription
101844,Marketed,2022-12-07,02529203,Norditropin Flexpro,1,H01AC01,Somatropin,Solution,Subcutaneous,02529203,NORDITROPIN FLEXPRO (somatropin 10 mg per 1.5 mL solution for injection pen) NOVO NORDISK CANADA INC,Active,9013736,somatropin 10 mg per 1.5 mL solution for injection pen,8001943,somatropin,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
101845,Marketed,2022-12-07,02529211,Norditropin Flexpro,1,H01AC01,Somatropin,Solution,Subcutaneous,02529211,NORDITROPIN FLEXPRO (somatropin 15 mg per 1.5 mL solution for injection pen) NOVO NORDISK CANADA INC,Active,9013742,somatropin 15 mg per 1.5 mL solution for injection pen,8001943,somatropin,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
101845,Marketed,2022-12-07,02529211,Norditropin Flexpro,1,H01AC01,Somatropin,Solution,Subcutaneous,02529211,NORDITROPIN FLEXPRO (somatropin 15 mg per 1.5 mL solution for injection pen) NOVO NORDISK CANADA INC,Active,9013742,somatropin 15 mg per 1.5 mL solution for injection pen,8001943,somatropin,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Prescription
61332,Marketed,1999-10-26,02237971,Saizen,1,H01AC01,Somatropin,Powder for solution,"Subcutaneous,Intramuscular",02237971,"SAIZEN (somatropin 5 mg per vial powder for solution for injection with diluent solution) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013750,somatropin 5 mg per vial powder for solution for injection with diluent solution,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
61332,Marketed,1999-10-26,02237971,Saizen,1,H01AC01,Somatropin,Powder for solution,"Subcutaneous,Intramuscular",02237971,"SAIZEN (somatropin 5 mg per vial powder for solution for injection with diluent solution) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013750,somatropin 5 mg per vial powder for solution for injection with diluent solution,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
62499,Marketed,1999-07-28,02239046,Serostim,2,H01AC01,Somatropin,Powder for solution,Subcutaneous,02239046,"SEROSTIM (somatropin 5 mg per vial powder for solution for injection with diluent solution) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013750,somatropin 5 mg per vial powder for solution for injection with diluent solution,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
62499,Marketed,1999-07-28,02239046,Serostim,2,H01AC01,Somatropin,Powder for solution,Subcutaneous,02239046,"SEROSTIM (somatropin 5 mg per vial powder for solution for injection with diluent solution) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013750,somatropin 5 mg per vial powder for solution for injection with diluent solution,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
81048,Marketed,2009-04-20,02325063,Omnitrope,1,H01AC01,Somatropin,Solution,Subcutaneous,02325063,OMNITROPE (somatropin 5 mg per 1.5 mL solution for injection cartridge) SANDOZ CANADA INCORPORATED,Active,9013747,somatropin 5 mg per 1.5 mL solution for injection cartridge,8001943,somatropin,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,1.0,Schedule D
81048,Marketed,2009-04-20,02325063,Omnitrope,1,H01AC01,Somatropin,Solution,Subcutaneous,02325063,OMNITROPE (somatropin 5 mg per 1.5 mL solution for injection cartridge) SANDOZ CANADA INCORPORATED,Active,9013747,somatropin 5 mg per 1.5 mL solution for injection cartridge,8001943,somatropin,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,1.0,Prescription
81049,Marketed,2009-04-20,02325071,Omnitrope,1,H01AC01,Somatropin,Solution,Subcutaneous,02325071,OMNITROPE (somatropin 10 mg per 1.5 mL solution for injection cartridge) SANDOZ CANADA INCORPORATED,Active,9013735,somatropin 10 mg per 1.5 mL solution for injection cartridge,8001943,somatropin,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,1.0,Prescription
81049,Marketed,2009-04-20,02325071,Omnitrope,1,H01AC01,Somatropin,Solution,Subcutaneous,02325071,OMNITROPE (somatropin 10 mg per 1.5 mL solution for injection cartridge) SANDOZ CANADA INCORPORATED,Active,9013735,somatropin 10 mg per 1.5 mL solution for injection cartridge,8001943,somatropin,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,1.0,Schedule D
83536,Marketed,2010-12-02,02350122,Saizen,1,H01AC01,Somatropin,Solution,Subcutaneous,02350122,"SAIZEN (somatropin 6 mg per 1.03 mL solution for injection cartridge) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013939,somatropin 6 mg per 1.03 mL solution for injection cartridge,8001943,somatropin,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Schedule D
83536,Marketed,2010-12-02,02350122,Saizen,1,H01AC01,Somatropin,Solution,Subcutaneous,02350122,"SAIZEN (somatropin 6 mg per 1.03 mL solution for injection cartridge) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013939,somatropin 6 mg per 1.03 mL solution for injection cartridge,8001943,somatropin,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Prescription
83537,Marketed,2010-12-02,02350130,Saizen,1,H01AC01,Somatropin,Solution,Subcutaneous,02350130,"SAIZEN (somatropin 12 mg per 1.5 mL solution for injection cartridge) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013738,somatropin 12 mg per 1.5 mL solution for injection cartridge,8001943,somatropin,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Prescription
83537,Marketed,2010-12-02,02350130,Saizen,1,H01AC01,Somatropin,Solution,Subcutaneous,02350130,"SAIZEN (somatropin 12 mg per 1.5 mL solution for injection cartridge) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013738,somatropin 12 mg per 1.5 mL solution for injection cartridge,8001943,somatropin,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Schedule D
83538,Marketed,2010-12-02,02350149,Saizen,1,H01AC01,Somatropin,Solution,Subcutaneous,02350149,"SAIZEN (somatropin 20 mg per 2.5 mL solution for injection cartridge) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013745,somatropin 20 mg per 2.5 mL solution for injection cartridge,8001943,somatropin,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Prescription
83538,Marketed,2010-12-02,02350149,Saizen,1,H01AC01,Somatropin,Solution,Subcutaneous,02350149,"SAIZEN (somatropin 20 mg per 2.5 mL solution for injection cartridge) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013745,somatropin 20 mg per 2.5 mL solution for injection cartridge,8001943,somatropin,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,,Schedule D
88659,Marketed,2013-09-18,02401703,Genotropin,1,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401703,GENOTROPIN (somatropin 5.3 mg powder for solution for injection with diluent solution per pen) PFIZER CANADA ULC,Active,9013751,somatropin 5.3 mg powder for solution for injection with diluent solution per pen,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
88659,Marketed,2013-09-18,02401703,Genotropin,1,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401703,GENOTROPIN (somatropin 5.3 mg powder for solution for injection with diluent solution per pen) PFIZER CANADA ULC,Active,9013751,somatropin 5.3 mg powder for solution for injection with diluent solution per pen,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733006000,Pen (unit of presentation),,,,Prescription
88660,Marketed,2013-09-18,02401711,Genotropin,1,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401711,GENOTROPIN (somatropin 12 mg powder for solution for injection with diluent solution per pen) PFIZER CANADA ULC,Active,9013740,somatropin 12 mg powder for solution for injection with diluent solution per pen,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733006000,Pen (unit of presentation),,,,Prescription
88660,Marketed,2013-09-18,02401711,Genotropin,1,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401711,GENOTROPIN (somatropin 12 mg powder for solution for injection with diluent solution per pen) PFIZER CANADA ULC,Active,9013740,somatropin 12 mg powder for solution for injection with diluent solution per pen,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
88662,Marketed,2020-09-17,02401746,Genotropin,1,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401746,GENOTROPIN (somatropin 0.2 mg powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9014391,somatropin 0.2 mg powder for solution for injection with diluent solution per syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
88662,Marketed,2020-09-17,02401746,Genotropin,1,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401746,GENOTROPIN (somatropin 0.2 mg powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9014391,somatropin 0.2 mg powder for solution for injection with diluent solution per syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
88663,Marketed,2020-09-17,02401754,Genotropin,1,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401754,GENOTROPIN (somatropin 0.4 mg powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9014392,somatropin 0.4 mg powder for solution for injection with diluent solution per syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
88663,Marketed,2020-09-17,02401754,Genotropin,1,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401754,GENOTROPIN (somatropin 0.4 mg powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9014392,somatropin 0.4 mg powder for solution for injection with diluent solution per syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
88664,Marketed,2013-09-18,02401762,Genotropin,1,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401762,GENOTROPIN (somatropin 0.6 mg powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9013728,somatropin 0.6 mg powder for solution for injection with diluent solution per syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
88664,Marketed,2013-09-18,02401762,Genotropin,1,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401762,GENOTROPIN (somatropin 0.6 mg powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9013728,somatropin 0.6 mg powder for solution for injection with diluent solution per syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
88665,Marketed,2013-09-18,02401770,Genotropin,1,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401770,GENOTROPIN (somatropin 0.8 mg powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9013729,somatropin 0.8 mg powder for solution for injection with diluent solution per syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
88665,Marketed,2013-09-18,02401770,Genotropin,1,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401770,GENOTROPIN (somatropin 0.8 mg powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9013729,somatropin 0.8 mg powder for solution for injection with diluent solution per syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
88666,Marketed,2013-09-18,02401789,Genotropin,1,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401789,GENOTROPIN (somatropin 1 mg powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9013730,somatropin 1 mg powder for solution for injection with diluent solution per syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
88666,Marketed,2013-09-18,02401789,Genotropin,1,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401789,GENOTROPIN (somatropin 1 mg powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9013730,somatropin 1 mg powder for solution for injection with diluent solution per syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
88667,Marketed,2013-09-18,02401797,Genotropin,1,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401797,GENOTROPIN (somatropin 1.2 mg powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9013731,somatropin 1.2 mg powder for solution for injection with diluent solution per syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
88667,Marketed,2013-09-18,02401797,Genotropin,1,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401797,GENOTROPIN (somatropin 1.2 mg powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9013731,somatropin 1.2 mg powder for solution for injection with diluent solution per syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
88668,Marketed,2013-09-18,02401800,Genotropin,1,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401800,GENOTROPIN (somatropin 1.4 mg powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9013732,somatropin 1.4 mg powder for solution for injection with diluent solution per syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
88668,Marketed,2013-09-18,02401800,Genotropin,1,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401800,GENOTROPIN (somatropin 1.4 mg powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9013732,somatropin 1.4 mg powder for solution for injection with diluent solution per syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
88669,Marketed,2013-09-18,02401819,Genotropin,1,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401819,GENOTROPIN (somatropin 1.6 mg powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9013733,somatropin 1.6 mg powder for solution for injection with diluent solution per syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
88669,Marketed,2013-09-18,02401819,Genotropin,1,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401819,GENOTROPIN (somatropin 1.6 mg powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9013733,somatropin 1.6 mg powder for solution for injection with diluent solution per syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
88670,Marketed,2013-09-18,02401827,Genotropin,1,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401827,GENOTROPIN (somatropin 1.8 mg powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9013734,somatropin 1.8 mg powder for solution for injection with diluent solution per syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
88670,Marketed,2013-09-18,02401827,Genotropin,1,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401827,GENOTROPIN (somatropin 1.8 mg powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9013734,somatropin 1.8 mg powder for solution for injection with diluent solution per syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
88671,Marketed,2013-09-18,02401835,Genotropin,1,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401835,GENOTROPIN (somatropin 2 mg powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9013743,somatropin 2 mg powder for solution for injection with diluent solution per syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
88671,Marketed,2013-09-18,02401835,Genotropin,1,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401835,GENOTROPIN (somatropin 2 mg powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9013743,somatropin 2 mg powder for solution for injection with diluent solution per syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
94695,Marketed,2017-08-14,02459647,Omnitrope,1,H01AC01,Somatropin,Solution,Subcutaneous,02459647,OMNITROPE (somatropin 15 mg per 1.5 mL solution for injection cartridge) SANDOZ CANADA INCORPORATED,Active,9013741,somatropin 15 mg per 1.5 mL solution for injection cartridge,8001943,somatropin,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,1.0,Prescription
94695,Marketed,2017-08-14,02459647,Omnitrope,1,H01AC01,Somatropin,Solution,Subcutaneous,02459647,OMNITROPE (somatropin 15 mg per 1.5 mL solution for injection cartridge) SANDOZ CANADA INCORPORATED,Active,9013741,somatropin 15 mg per 1.5 mL solution for injection cartridge,8001943,somatropin,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,1.0,Schedule D
99003,Marketed,2022-01-04,02500337,Odomzo,1,L01XJ02,Sonidegib,Capsule,Oral,02500337,ODOMZO (sonidegib (sonidegib phosphate) 200 mg oral capsule) SUN PHARMACEUTICAL INDUSTRIES LIMITED,Active,9014435,sonidegib (sonidegib phosphate) 200 mg oral capsule,8002360,sonidegib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
76977,Marketed,2006-07-31,02284227,Nexavar,1,L01EX02,Sorafenib,Tablet,Oral,02284227,NEXAVAR (sorafenib (sorafenib tosylate) 200 mg oral tablet) BAYER INC,Active,9004194,sorafenib (sorafenib tosylate) 200 mg oral tablet,8001945,sorafenib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
106801,Marketed,2026-05-20,02565404,Amb-Sotalol,1,C07AA07,Sotalol,Tablet,Oral,02565404,AMB-SOTALOL (sotalol hydrochloride 80 mg oral tablet) AMBICARE PHARMACEUTICALS INC.,Active,9011920,sotalol hydrochloride 80 mg oral tablet,8000893,sotalol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106802,Marketed,2026-05-20,02565412,Amb-Sotalol,1,C07AA07,Sotalol,Tablet,Oral,02565412,AMB-SOTALOL (sotalol hydrochloride 160 mg oral tablet) AMBICARE PHARMACEUTICALS INC.,Active,9011919,sotalol hydrochloride 160 mg oral tablet,8000893,sotalol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
18779,Marketed,2022-07-26,02167794,Apo-Sotalol,1,C07AA07,Sotalol,Tablet,Oral,02167794,APO-SOTALOL (sotalol hydrochloride 160 mg oral tablet) APOTEX INC,Active,9011919,sotalol hydrochloride 160 mg oral tablet,8000893,sotalol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
20002,Marketed,2022-07-26,02210428,Apo-Sotalol,1,C07AA07,Sotalol,Tablet,Oral,02210428,APO-SOTALOL (sotalol hydrochloride 80 mg oral tablet) APOTEX INC,Active,9011920,sotalol hydrochloride 80 mg oral tablet,8000893,sotalol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
61729,Marketed,1998-07-22,02238326,PMS-Sotalol - 80 mg,1,C07AA07,Sotalol,Tablet,Oral,02238326,PMS-SOTALOL - 80 MG (sotalol hydrochloride 80 mg oral tablet) PHARMASCIENCE INC,Active,9011920,sotalol hydrochloride 80 mg oral tablet,8000893,sotalol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
61730,Marketed,1998-07-22,02238327,PMS-Sotalol - 160 mg,1,C07AA07,Sotalol,Tablet,Oral,02238327,PMS-SOTALOL - 160 MG (sotalol hydrochloride 160 mg oral tablet) PHARMASCIENCE INC,Active,9011919,sotalol hydrochloride 160 mg oral tablet,8000893,sotalol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104003,Marketed,2025-02-12,02551306,Winrevair,1,C02KX06,Sotatercept,"Powder for solution,Kit",Subcutaneous,02551306,WINREVAIR (sotatercept 45 mg per vial powder for solution for injection with diluent solution syringe) MERCK CANADA INC,Active,9015179,sotatercept 45 mg per vial powder for solution for injection with diluent solution syringe,8002531,sotatercept,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,1.0,,,Schedule D
104003,Marketed,2025-02-12,02551306,Winrevair,1,C02KX06,Sotatercept,"Powder for solution,Kit",Subcutaneous,02551306,WINREVAIR (sotatercept 45 mg per vial powder for solution for injection with diluent solution syringe) MERCK CANADA INC,Active,9015179,sotatercept 45 mg per vial powder for solution for injection with diluent solution syringe,8002531,sotatercept,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,1.0,,,Prescription
104004,Marketed,2025-02-12,02551314,Winrevair,1,C02KX06,Sotatercept,"Kit,Powder for solution",Subcutaneous,02551314,WINREVAIR (sotatercept 60 mg per vial powder for solution for injection with diluent solution syringe) MERCK CANADA INC,Active,9015180,sotatercept 60 mg per vial powder for solution for injection with diluent solution syringe,8002531,sotatercept,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,1.0,,,Prescription
104004,Marketed,2025-02-12,02551314,Winrevair,1,C02KX06,Sotatercept,"Kit,Powder for solution",Subcutaneous,02551314,WINREVAIR (sotatercept 60 mg per vial powder for solution for injection with diluent solution syringe) MERCK CANADA INC,Active,9015180,sotatercept 60 mg per vial powder for solution for injection with diluent solution syringe,8002531,sotatercept,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,1.0,,,Schedule D
100931,Marketed,2021-10-22,02520095,Lumakras,1,L01XX73,Sotorasib,Tablet,Oral,02520095,LUMAKRAS (sotorasib 120 mg oral tablet) AMGEN CANADA INC,Active,9014613,sotorasib 120 mg oral tablet,8002393,sotorasib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
104162,Marketed,2025-10-14,02552655,Lumakras,1,L01XX73,Sotorasib,Tablet,Oral,02552655,LUMAKRAS (sotorasib 240 mg oral tablet) AMGEN CANADA INC,Active,9015272,sotorasib 240 mg oral tablet,8002393,sotorasib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,,Prescription
102523,Marketed,2026-03-26,02536455,Spevigo,1,L04AC22,Spesolimab,Solution,Intravenous,02536455,SPEVIGO (spesolimab 450 mg per 7.5 mL solution for injection vial) LEO PHARMA INC,Active,9014858,spesolimab 450 mg per 7.5 mL solution for injection vial,8002468,spesolimab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
102523,Marketed,2026-03-26,02536455,Spevigo,1,L04AC22,Spesolimab,Solution,Intravenous,02536455,SPEVIGO (spesolimab 450 mg per 7.5 mL solution for injection vial) LEO PHARMA INC,Active,9014858,spesolimab 450 mg per 7.5 mL solution for injection vial,8002468,spesolimab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
103912,Marketed,2026-03-26,02550296,Spevigo,1,L04AC22,Spesolimab,Solution,Subcutaneous,02550296,SPEVIGO (spesolimab 150 mg per 1 mL solution for injection syringe) LEO PHARMA INC,Active,9015126,spesolimab 150 mg per 1 mL solution for injection syringe,8002468,spesolimab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
103912,Marketed,2026-03-26,02550296,Spevigo,1,L04AC22,Spesolimab,Solution,Subcutaneous,02550296,SPEVIGO (spesolimab 150 mg per 1 mL solution for injection syringe) LEO PHARMA INC,Active,9015126,spesolimab 150 mg per 1 mL solution for injection syringe,8002468,spesolimab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
100812,Marketed,2022-07-14,02518821,JAMP Spironolactone,1,C03DA01,Spironolactone,Tablet,Oral,02518821,JAMP SPIRONOLACTONE (spironolactone 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000025,spironolactone 25 mg oral tablet,8000015,spironolactone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100813,Marketed,2022-07-14,02518848,JAMP Spironolactone,1,C03DA01,Spironolactone,Tablet,Oral,02518848,JAMP SPIRONOLACTONE (spironolactone 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000090,spironolactone 100 mg oral tablet,8000015,spironolactone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
1403,Marketed,2006-02-13,00028606,Aldactone 25 mg,1,C03DA01,Spironolactone,Tablet,Oral,00028606,ALDACTONE 25 MG (spironolactone 25 mg oral tablet) PFIZER CANADA ULC,Active,9000025,spironolactone 25 mg oral tablet,8000015,spironolactone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
2145,Marketed,2009-02-03,00285455,Aldactone 100 mg,1,C03DA01,Spironolactone,Tablet,Oral,00285455,ALDACTONE 100 MG (spironolactone 100 mg oral tablet) PFIZER CANADA ULC,Active,9000090,spironolactone 100 mg oral tablet,8000015,spironolactone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
5646,Marketed,2011-06-29,00613215,Teva-Spironolactone,1,C03DA01,Spironolactone,Tablet,Oral,00613215,TEVA-SPIRONOLACTONE (spironolactone 25 mg oral tablet) TEVA CANADA LIMITED,Active,9000025,spironolactone 25 mg oral tablet,8000015,spironolactone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
5647,Marketed,2011-06-29,00613223,Teva-Spironolactone,1,C03DA01,Spironolactone,Tablet,Oral,00613223,TEVA-SPIRONOLACTONE (spironolactone 100 mg oral tablet) TEVA CANADA LIMITED,Active,9000090,spironolactone 100 mg oral tablet,8000015,spironolactone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
97825,Marketed,2020-02-06,02488140,Mint-Spironolactone,1,C03DA01,Spironolactone,Tablet,Oral,02488140,MINT-SPIRONOLACTONE (spironolactone 25 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000025,spironolactone 25 mg oral tablet,8000015,spironolactone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
97826,Marketed,2020-02-06,02488159,Mint-Spironolactone,1,C03DA01,Spironolactone,Tablet,Oral,02488159,MINT-SPIRONOLACTONE (spironolactone 100 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000090,spironolactone 100 mg oral tablet,8000015,spironolactone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
88386,Marketed,2013-05-01,02398958,Diacomit,1,N03AX17,Stiripentol,Capsule,Oral,02398958,DIACOMIT (stiripentol 250 mg oral capsule) BIOCODEX SAS,Active,9005235,stiripentol 250 mg oral capsule,8002087,stiripentol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
88387,Marketed,2013-05-01,02398966,Diacomit,1,N03AX17,Stiripentol,Capsule,Oral,02398966,DIACOMIT (stiripentol 500 mg oral capsule) BIOCODEX SAS,Active,9005237,stiripentol 500 mg oral capsule,8002087,stiripentol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
88388,Marketed,2013-05-01,02398974,Diacomit,1,N03AX17,Stiripentol,Powder for suspension,Oral,02398974,DIACOMIT (stiripentol 250 mg per sachet powder for oral suspension) BIOCODEX SAS,Active,9013789,stiripentol 250 mg per sachet powder for oral suspension,8002087,stiripentol,26643006,Oral,385027000,Powder for oral suspension,733013000,Sachet (unit of presentation),1.0,,,Prescription
14504,Marketed,2011-06-18,02045702,Teva-Sucralfate,1,A02BX02,Sucralfate,Tablet,Oral,02045702,TEVA-SUCRALFATE (sucralfate 1 g oral tablet) TEVA CANADA LIMITED,Active,9002613,sucralfate 1 g oral tablet,8001304,sucralfate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
16656,Marketed,2026-05-13,02125250,Apo-Sucralfate - Tablets 1 G,1,A02BX02,Sucralfate,Tablet,Oral,02125250,APO-SUCRALFATE - TAB 1G (sucralfate 1 g oral tablet) APOTEX INC,Active,9002613,sucralfate 1 g oral tablet,8001304,sucralfate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
17250,Marketed,2025-10-31,02100622,Sulcrate,1,A02BX02,Sucralfate,Tablet,Oral,02100622,SULCRATE (sucralfate 1 g oral tablet) ABBVIE CORPORATION,Active,9002613,sucralfate 1 g oral tablet,8001304,sucralfate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
17852,Marketed,2025-04-23,02103567,Sulcrate Suspension Plus,1,A02BX02,Sucralfate,Suspension,Oral,02103567,SULCRATE SUSPENSION PLUS (sucralfate 1 g per 5 mL oral suspension) ABBVIE CORPORATION,Active,9002876,sucralfate 1 g per 5 mL oral suspension,8001304,sucralfate,26643006,Oral,385024007,Oral suspension,,,,,,Prescription
96073,Marketed,2019-11-20,02471574,Velphoro,1,V03AE05,Sucroferric oxyhydroxide,Tablet (chewable),Oral,02471574,VELPHORO (iron (sucroferric oxyhydroxide) 500 mg chewable tablet) VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD,Active,9014261,iron (sucroferric oxyhydroxide) 500 mg chewable tablet,8002322,sucroferric oxyhydroxide,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,,Prescription
68108,Marketed,2005-09-27,02244147,SUFentanil Citrate Injection USP,1,N01AH03,Sufentanil,Solution,"Epidural,Intravenous",77700856,SUFENTANIL CITRATE INJECTION USP (sufentanil (sufentanil citrate) 50 mcg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9013354,sufentanil (sufentanil citrate) 50 mcg per 1 mL solution for injection ampoule,8001947,sufentanil,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,,Narcotics (CDSA I)
68108,Marketed,2005-09-27,02244147,SUFentanil Citrate Injection USP,1,N01AH03,Sufentanil,Solution,"Epidural,Intravenous",77700857,SUFENTANIL CITRATE INJECTION USP (sufentanil (sufentanil citrate) 250 mcg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013353,sufentanil (sufentanil citrate) 250 mcg per 5 mL solution for injection vial,8001947,sufentanil,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,,Narcotics (CDSA I)
92657,Marketed,2019-05-27,02442213,SUFentanil Citrate Injection USP,1,N01AH03,Sufentanil,Solution,"Epidural,Intravenous",77700901,SUFENTANIL CITRATE INJECTION USP (sufentanil (sufentanil citrate) 50 mcg per 1 mL solution for injection ampoule) STERIMAX INC,Active,9013354,sufentanil (sufentanil citrate) 50 mcg per 1 mL solution for injection ampoule,8001947,sufentanil,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,,Narcotics (CDSA I)
92657,Marketed,2019-05-27,02442213,SUFentanil Citrate Injection USP,1,N01AH03,Sufentanil,Solution,"Epidural,Intravenous",77700902,SUFENTANIL CITRATE INJECTION USP (sufentanil (sufentanil citrate) 250 mcg per 5 mL solution for injection ampoule) STERIMAX INC,Active,9013352,sufentanil (sufentanil citrate) 250 mcg per 5 mL solution for injection ampoule,8001947,sufentanil,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,,Narcotics (CDSA I)
102779,Marketed,2026-02-24,02539144,Sugammadex Injection,1,V03AB35,Sugammadex,Solution,Intravenous,77701182,SUGAMMADEX INJECTION (sugammadex (sugammadex sodium) 200 mg per 2 mL solution for injection vial) JUNO PHARMA CANADA INC.,Active,9013355,sugammadex (sugammadex sodium) 200 mg per 2 mL solution for injection vial,8001948,sugammadex,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
102779,Marketed,2026-02-24,02539144,Sugammadex Injection,1,V03AB35,Sugammadex,Solution,Intravenous,77701183,SUGAMMADEX INJECTION (sugammadex (sugammadex sodium) 500 mg per 5 mL solution for injection vial) JUNO PHARMA CANADA INC.,Active,9013356,sugammadex (sugammadex sodium) 500 mg per 5 mL solution for injection vial,8001948,sugammadex,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
103751,Marketed,2025-06-16,02548666,Sugammadex Injection,1,V03AB35,Sugammadex,Solution,Intravenous,77701180,SUGAMMADEX INJECTION (sugammadex (sugammadex sodium) 200 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013355,sugammadex (sugammadex sodium) 200 mg per 2 mL solution for injection vial,8001948,sugammadex,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
103751,Marketed,2025-06-16,02548666,Sugammadex Injection,1,V03AB35,Sugammadex,Solution,Intravenous,77701181,SUGAMMADEX INJECTION (sugammadex (sugammadex sodium) 500 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013356,sugammadex (sugammadex sodium) 500 mg per 5 mL solution for injection vial,8001948,sugammadex,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
103887,Marketed,2025-02-13,02550067,PMS-Sugammadex,1,V03AB35,Sugammadex,Solution,Intravenous,77701173,PMS-SUGAMMADEX (sugammadex (sugammadex sodium) 200 mg per 2 mL solution for injection vial) PHARMASCIENCE INC,Active,9013355,sugammadex (sugammadex sodium) 200 mg per 2 mL solution for injection vial,8001948,sugammadex,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
103887,Marketed,2025-02-13,02550067,PMS-Sugammadex,1,V03AB35,Sugammadex,Solution,Intravenous,77701174,PMS-SUGAMMADEX (sugammadex (sugammadex sodium) 500 mg per 5 mL solution for injection vial) PHARMASCIENCE INC,Active,9013356,sugammadex (sugammadex sodium) 500 mg per 5 mL solution for injection vial,8001948,sugammadex,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
93817,Marketed,2016-02-19,02451816,Bridion,1,V03AB35,Sugammadex,Solution,Intravenous,77700905,BRIDION (sugammadex (sugammadex sodium) 200 mg per 2 mL solution for injection vial) MERCK CANADA INC,Active,9013355,sugammadex (sugammadex sodium) 200 mg per 2 mL solution for injection vial,8001948,sugammadex,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
93817,Marketed,2016-02-19,02451816,Bridion,1,V03AB35,Sugammadex,Solution,Intravenous,77700906,BRIDION (sugammadex (sugammadex sodium) 500 mg per 5 mL solution for injection vial) MERCK CANADA INC,Active,9013356,sugammadex (sugammadex sodium) 500 mg per 5 mL solution for injection vial,8001948,sugammadex,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
101490,Marketed,2023-06-26,02525917,"Sulfamethoxazole And Trimethoprim For Injection, USP",2,J01EE01,Sulfamethoxazole and trimethoprim,Solution,Intravenous,77701127,"SULFAMETHOXAZOLE AND TRIMETHOPRIM FOR INJECTION, USP (sulfamethoxazole 800 mg per 10 mL and trimethoprim 160 mg per 10 mL solution for injection vial) AURO PHARMA INC",Active,9014899,sulfamethoxazole 800 mg per 10 mL and trimethoprim 160 mg per 10 mL solution for injection vial,8000080,sulfamethoxazole and trimethoprim,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
101490,Marketed,2023-06-26,02525917,"Sulfamethoxazole And Trimethoprim For Injection, USP",2,J01EE01,Sulfamethoxazole and trimethoprim,Solution,Intravenous,77701128,"SULFAMETHOXAZOLE AND TRIMETHOPRIM FOR INJECTION, USP (sulfamethoxazole 400 mg per 5 mL and trimethoprim 80 mg per 5 mL solution for injection vial) AURO PHARMA INC",Active,9014898,sulfamethoxazole 400 mg per 5 mL and trimethoprim 80 mg per 5 mL solution for injection vial,8000080,sulfamethoxazole and trimethoprim,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
101490,Marketed,2023-06-26,02525917,"Sulfamethoxazole And Trimethoprim For Injection, USP",2,J01EE01,Sulfamethoxazole and trimethoprim,Solution,Intravenous,77701129,"SULFAMETHOXAZOLE AND TRIMETHOPRIM FOR INJECTION, USP (sulfamethoxazole 2400 mg per 30 mL and trimethoprim 480 mg per 30 mL solution for injection vial) AURO PHARMA INC",Active,9014897,sulfamethoxazole 2400 mg per 30 mL and trimethoprim 480 mg per 30 mL solution for injection vial,8000080,sulfamethoxazole and trimethoprim,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
3677,Marketed,2021-09-01,00445266,Sulfatrim Pediatric,2,J01EE01,Sulfamethoxazole and trimethoprim,Tablet,Oral,00445266,SULFATRIM PEDIATRIC (sulfamethoxazole 100 mg and trimethoprim 20 mg oral tablet) AA PHARMA INC,Active,9000138,sulfamethoxazole 100 mg and trimethoprim 20 mg oral tablet,8000080,sulfamethoxazole and trimethoprim,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
3678,Marketed,2019-06-07,00445274,Sulfatrim,2,J01EE01,Sulfamethoxazole and trimethoprim,Tablet,Oral,00445274,SULFATRIM (sulfamethoxazole 400 mg and trimethoprim 80 mg oral tablet) AA PHARMA INC,Active,9000139,sulfamethoxazole 400 mg and trimethoprim 80 mg oral tablet,8000080,sulfamethoxazole and trimethoprim,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
3679,Marketed,2019-04-10,00445282,Sulfatrim DS,2,J01EE01,Sulfamethoxazole and trimethoprim,Tablet,Oral,00445282,SULFATRIM DS (sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet) AA PHARMA INC,Active,9000140,sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet,8000080,sulfamethoxazole and trimethoprim,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
4703,Marketed,2018-01-18,00550086,Septra Injection,2,J01EE01,Sulfamethoxazole and trimethoprim,Solution,Intravenous,00550086,SEPTRA INJECTION (sulfamethoxazole 400 mg per 5 mL and trimethoprim 80 mg per 5 mL solution for injection ampoule) ASPEN PHARMACARE CANADA INC.,Active,9000180,sulfamethoxazole 400 mg per 5 mL and trimethoprim 80 mg per 5 mL solution for injection ampoule,8000080,sulfamethoxazole and trimethoprim,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
103322,Marketed,2025-12-10,02544652,JAMP Sulfasalazine,1,A07EC01,Sulfasalazine,Tablet,Oral,02544652,JAMP SULFASALAZINE (sulfasalazine 500 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001821,sulfasalazine 500 mg oral tablet,8001528,sulfasalazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
17416,Marketed,2006-01-11,02064480,Salazopyrin Tablets 500 mg,1,A07EC01,Sulfasalazine,Tablet,Oral,02064480,SALAZOPYRIN TAB 500MG (sulfasalazine 500 mg oral tablet) PFIZER CANADA ULC,Active,9001821,sulfasalazine 500 mg oral tablet,8001528,sulfasalazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
17417,Marketed,2009-02-03,02064472,Salazopyrin En-Tabs 500 mg,1,A07EC01,Sulfasalazine,Tablet (enteric-coated),Oral,02064472,SALAZOPYRIN EN-TABS 500 MG (sulfasalazine 500 mg gastro-resistant tablet) PFIZER CANADA ULC,Active,9002033,sulfasalazine 500 mg gastro-resistant tablet,8001528,sulfasalazine,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
5728,Marketed,1984-12-31,00598461,PMS-Sulfasalazine 500 mg/Tablets USP,1,A07EC01,Sulfasalazine,Tablet,Oral,00598461,PMS-SULFASALAZINE 500MG/TAB USP (sulfasalazine 500 mg oral tablet) PHARMASCIENCE INC,Active,9001821,sulfasalazine 500 mg oral tablet,8001528,sulfasalazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
5864,Marketed,1984-12-31,00598488,PMS-Sulfasalazine-E.C. Tablets 500 mg,1,A07EC01,Sulfasalazine,Tablet (enteric-coated),Oral,00598488,PMS-SULFASALAZINE-E.C. TAB 500MG (sulfasalazine 500 mg gastro-resistant tablet) PHARMASCIENCE INC,Active,9002033,sulfasalazine 500 mg gastro-resistant tablet,8001528,sulfasalazine,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77308,Marketed,2022-05-18,02287684,Sonovue,1,V08DA05,Sulfur hexafluoride,Powder for suspension,"Intravesical,Intravenous",,,,,,,,,,,,,,,,,Ethical
9238,Marketed,2011-06-18,00745588,Teva-Sulindac,1,M01AB02,Sulindac,Tablet,Oral,00745588,TEVA-SULINDAC (sulindac 150 mg oral tablet) TEVA CANADA LIMITED,Active,9002161,sulindac 150 mg oral tablet,8001529,sulindac,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
9239,Marketed,2011-06-18,00745596,Teva-Sulindac,1,M01AB02,Sulindac,Tablet,Oral,00745596,TEVA-SULINDAC (sulindac 200 mg oral tablet) TEVA CANADA LIMITED,Active,9002162,sulindac 200 mg oral tablet,8001529,sulindac,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103407,Marketed,2024-09-30,02545292,JAMP Sumatriptan DF,1,N02CC01,Sumatriptan,Tablet,Oral,02545292,JAMP SUMATRIPTAN DF (sumatriptan (sumatriptan succinate) 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001125,sumatriptan (sumatriptan succinate) 25 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103408,Marketed,2024-09-30,02545306,JAMP Sumatriptan DF,1,N02CC01,Sumatriptan,Tablet,Oral,02545306,JAMP SUMATRIPTAN DF (sumatriptan (sumatriptan succinate) 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000780,sumatriptan (sumatriptan succinate) 50 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103409,Marketed,2024-09-30,02545314,JAMP Sumatriptan DF,1,N02CC01,Sumatriptan,Tablet,Oral,02545314,JAMP SUMATRIPTAN DF (sumatriptan (sumatriptan succinate) 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000698,sumatriptan (sumatriptan succinate) 100 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103412,Marketed,2024-11-01,02545349,JAMP Sumatriptan,1,N02CC01,Sumatriptan,Tablet,Oral,02545349,JAMP SUMATRIPTAN (sumatriptan (sumatriptan succinate) 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001125,sumatriptan (sumatriptan succinate) 25 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103413,Marketed,2024-11-01,02545357,JAMP Sumatriptan,1,N02CC01,Sumatriptan,Tablet,Oral,02545357,JAMP SUMATRIPTAN (sumatriptan (sumatriptan succinate) 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000780,sumatriptan (sumatriptan succinate) 50 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103414,Marketed,2024-11-01,02545365,JAMP Sumatriptan,1,N02CC01,Sumatriptan,Tablet,Oral,02545365,JAMP SUMATRIPTAN (sumatriptan (sumatriptan succinate) 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000698,sumatriptan (sumatriptan succinate) 100 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103476,Marketed,2024-04-29,02546035,Sumatriptan,1,N02CC01,Sumatriptan,Tablet,Oral,02546035,SUMATRIPTAN (sumatriptan (sumatriptan succinate) 50 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000780,sumatriptan (sumatriptan succinate) 50 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103477,Marketed,2024-04-29,02546043,Sumatriptan,1,N02CC01,Sumatriptan,Tablet,Oral,02546043,SUMATRIPTAN (sumatriptan (sumatriptan succinate) 100 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000698,sumatriptan (sumatriptan succinate) 100 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
43077,Marketed,2004-08-30,02212161,Imitrex DF - Tablets 100 mg,1,N02CC01,Sumatriptan,Tablet,Oral,02212161,IMITREX DF - TAB 100MG (sumatriptan (sumatriptan succinate) 100 mg oral tablet) GLAXOSMITHKLINE INC,Active,9000698,sumatriptan (sumatriptan succinate) 100 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
43078,Marketed,2003-08-11,02212188,Imitrex,1,N02CC01,Sumatriptan,Solution,Subcutaneous,77700585,IMITREX (sumatriptan (sumatriptan succinate) 6 mg per 0.5 mL solution for injection vial) GLAXOSMITHKLINE INC,Active,9012652,sumatriptan (sumatriptan succinate) 6 mg per 0.5 mL solution for injection vial,8000234,sumatriptan,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
43078,Marketed,2003-08-11,02212188,Imitrex,1,N02CC01,Sumatriptan,Solution,Subcutaneous,77700586,IMITREX (sumatriptan (sumatriptan succinate) 6 mg per 0.5 mL solution for injection syringe) GLAXOSMITHKLINE INC,Active,9006267,sumatriptan (sumatriptan succinate) 6 mg per 0.5 mL solution for injection syringe,8000234,sumatriptan,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
49288,Marketed,2002-04-25,02230418,Imitrex,1,N02CC01,Sumatriptan,Spray,Nasal,02230418,IMITREX (sumatriptan (sumatriptan hemisulfate) 5 mg per actuation nasal spray) GLAXOSMITHKLINE INC,Active,9006255,sumatriptan (sumatriptan hemisulfate) 5 mg per actuation nasal spray,8000234,sumatriptan,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,,Prescription
49290,Marketed,2002-03-22,02230420,Imitrex,1,N02CC01,Sumatriptan,Spray,Nasal,02230420,IMITREX (sumatriptan (sumatriptan hemisulfate) 20 mg per actuation nasal spray) GLAXOSMITHKLINE INC,Active,9006254,sumatriptan (sumatriptan hemisulfate) 20 mg per actuation nasal spray,8000234,sumatriptan,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,,Prescription
62836,Marketed,2011-06-29,02239367,Teva-Sumatriptan,1,N02CC01,Sumatriptan,Tablet,Oral,02239367,TEVA-SUMATRIPTAN (sumatriptan (sumatriptan succinate) 100 mg oral tablet) TEVA CANADA LIMITED,Active,9000698,sumatriptan (sumatriptan succinate) 100 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74163,Marketed,2005-08-24,02256428,PMS-Sumatriptan,1,N02CC01,Sumatriptan,Tablet,Oral,02256428,PMS-SUMATRIPTAN (sumatriptan (sumatriptan succinate) 25 mg oral tablet) PHARMASCIENCE INC,Active,9001125,sumatriptan (sumatriptan succinate) 25 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74164,Marketed,2005-08-24,02256436,PMS-Sumatriptan,1,N02CC01,Sumatriptan,Tablet,Oral,02256436,PMS-SUMATRIPTAN (sumatriptan (sumatriptan succinate) 50 mg oral tablet) PHARMASCIENCE INC,Active,9000780,sumatriptan (sumatriptan succinate) 50 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74165,Marketed,2005-08-24,02256444,PMS-Sumatriptan,1,N02CC01,Sumatriptan,Tablet,Oral,02256444,PMS-SUMATRIPTAN (sumatriptan (sumatriptan succinate) 100 mg oral tablet) PHARMASCIENCE INC,Active,9000698,sumatriptan (sumatriptan succinate) 100 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75377,Marketed,2005-08-24,02268388,Apo-Sumatriptan,1,N02CC01,Sumatriptan,Tablet,Oral,02268388,APO-SUMATRIPTAN (sumatriptan (sumatriptan succinate) 50 mg oral tablet) APOTEX INC,Active,9000780,sumatriptan (sumatriptan succinate) 50 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75378,Marketed,2005-08-24,02268396,Apo-Sumatriptan,1,N02CC01,Sumatriptan,Tablet,Oral,02268396,APO-SUMATRIPTAN (sumatriptan (sumatriptan succinate) 100 mg oral tablet) APOTEX INC,Active,9000698,sumatriptan (sumatriptan succinate) 100 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75430,Marketed,2010-06-30,02268906,Mylan-Sumatriptan,1,N02CC01,Sumatriptan,Tablet,Oral,02268906,MYLAN-SUMATRIPTAN (sumatriptan (sumatriptan succinate) 25 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9001125,sumatriptan (sumatriptan succinate) 25 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75431,Marketed,2010-02-08,02268914,Mylan-Sumatriptan,1,N02CC01,Sumatriptan,Tablet,Oral,02268914,MYLAN-SUMATRIPTAN (sumatriptan (sumatriptan succinate) 50 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000780,sumatriptan (sumatriptan succinate) 50 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75432,Marketed,2010-01-12,02268922,Mylan-Sumatriptan,1,N02CC01,Sumatriptan,Tablet,Oral,02268922,MYLAN-SUMATRIPTAN (sumatriptan (sumatriptan succinate) 100 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000698,sumatriptan (sumatriptan succinate) 100 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77198,Marketed,2010-04-05,02286521,Sumatriptan,1,N02CC01,Sumatriptan,Tablet,Oral,02286521,SUMATRIPTAN (sumatriptan (sumatriptan succinate) 50 mg oral tablet) SANIS HEALTH INC,Active,9000780,sumatriptan (sumatriptan succinate) 50 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77199,Marketed,2010-04-05,02286548,Sumatriptan,1,N02CC01,Sumatriptan,Tablet,Oral,02286548,SUMATRIPTAN (sumatriptan (sumatriptan succinate) 100 mg oral tablet) SANIS HEALTH INC,Active,9000698,sumatriptan (sumatriptan succinate) 100 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77227,Marketed,2011-06-29,02286815,Teva-Sumatriptan DF,1,N02CC01,Sumatriptan,Tablet,Oral,02286815,TEVA-SUMATRIPTAN DF (sumatriptan (sumatriptan succinate) 25 mg oral tablet) TEVA CANADA LIMITED,Active,9001125,sumatriptan (sumatriptan succinate) 25 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77228,Marketed,2011-06-29,02286823,Teva-Sumatriptan DF,1,N02CC01,Sumatriptan,Tablet,Oral,02286823,TEVA-SUMATRIPTAN DF (sumatriptan (sumatriptan succinate) 50 mg oral tablet) TEVA CANADA LIMITED,Active,9000780,sumatriptan (sumatriptan succinate) 50 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77229,Marketed,2011-06-29,02286831,Teva-Sumatriptan DF,1,N02CC01,Sumatriptan,Tablet,Oral,02286831,TEVA-SUMATRIPTAN DF (sumatriptan (sumatriptan succinate) 100 mg oral tablet) TEVA CANADA LIMITED,Active,9000698,sumatriptan (sumatriptan succinate) 100 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81009,Marketed,2009-06-15,02324652,Sumatriptan,1,N02CC01,Sumatriptan,Tablet,Oral,02324652,SUMATRIPTAN (sumatriptan (sumatriptan succinate) 50 mg oral tablet) PRO DOC LIMITEE,Active,9000780,sumatriptan (sumatriptan succinate) 50 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81010,Marketed,2009-06-15,02324660,Sumatriptan,1,N02CC01,Sumatriptan,Tablet,Oral,02324660,SUMATRIPTAN (sumatriptan (sumatriptan succinate) 100 mg oral tablet) PRO DOC LIMITEE,Active,9000698,sumatriptan (sumatriptan succinate) 100 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84675,Marketed,2013-09-20,02361698,Taro-Sumatriptan,1,N02CC01,Sumatriptan,Solution,Subcutaneous,02361698,TARO-SUMATRIPTAN (sumatriptan (sumatriptan succinate) 6 mg per 0.5 mL solution for injection syringe) TARO PHARMACEUTICALS INC,Active,9006267,sumatriptan (sumatriptan succinate) 6 mg per 0.5 mL solution for injection syringe,8000234,sumatriptan,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
87118,Marketed,2023-06-01,02385570,Sumatriptan DF,1,N02CC01,Sumatriptan,Tablet,Oral,02385570,SUMATRIPTAN DF (sumatriptan (sumatriptan succinate) 50 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000780,sumatriptan (sumatriptan succinate) 50 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87119,Marketed,2023-06-01,02385589,Sumatriptan DF,1,N02CC01,Sumatriptan,Tablet,Oral,02385589,SUMATRIPTAN DF (sumatriptan (sumatriptan succinate) 100 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000698,sumatriptan (sumatriptan succinate) 100 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98619,Marketed,2020-07-24,02496305,Suvexx,2,N02CC51,Sumatriptan and naproxen,Tablet,Oral,02496305,SUVEXX (naproxen sodium 500 mg and sumatriptan (sumatriptan succinate) 85 mg oral tablet) ARALEZ PHARMACEUTICALS CANADA INC,Active,9014331,naproxen sodium 500 mg and sumatriptan (sumatriptan succinate) 85 mg oral tablet,8002335,naproxen and sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101308,Marketed,2023-01-17,02524058,Taro-SUNItinib,1,L01EX01,Sunitinib,Capsule,Oral,02524058,TARO-SUNITINIB (sunitinib (sunitinib malate) 12.5 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9004176,sunitinib (sunitinib malate) 12.5 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
101310,Marketed,2022-09-20,02524066,Taro-SUNItinib,1,L01EX01,Sunitinib,Capsule,Oral,02524066,TARO-SUNITINIB (sunitinib (sunitinib malate) 25 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9004177,sunitinib (sunitinib malate) 25 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
101312,Marketed,2022-09-20,02524082,Taro-SUNItinib,1,L01EX01,Sunitinib,Capsule,Oral,02524082,TARO-SUNITINIB (sunitinib (sunitinib malate) 50 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9004178,sunitinib (sunitinib malate) 50 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
101531,Marketed,2023-09-11,02526204,Teva-SUNItinib,1,L01EX01,Sunitinib,Capsule,Oral,02526204,TEVA-SUNITINIB (sunitinib (sunitinib malate) 12.5 mg oral capsule) TEVA CANADA LIMITED,Active,9004176,sunitinib (sunitinib malate) 12.5 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
101532,Marketed,2023-09-11,02526212,Teva-SUNItinib,1,L01EX01,Sunitinib,Capsule,Oral,02526212,TEVA-SUNITINIB (sunitinib (sunitinib malate) 25 mg oral capsule) TEVA CANADA LIMITED,Active,9004177,sunitinib (sunitinib malate) 25 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
101533,Marketed,2023-09-11,02526220,Teva-SUNItinib,1,L01EX01,Sunitinib,Capsule,Oral,02526220,TEVA-SUNITINIB (sunitinib (sunitinib malate) 50 mg oral capsule) TEVA CANADA LIMITED,Active,9004178,sunitinib (sunitinib malate) 50 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
102126,Marketed,2023-09-18,02532190,Auro-SUNItinib,1,L01EX01,Sunitinib,Capsule,Oral,02532190,AURO-SUNITINIB (sunitinib (sunitinib malate) 12.5 mg oral capsule) AURO PHARMA INC,Active,9004176,sunitinib (sunitinib malate) 12.5 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
102127,Marketed,2023-07-21,02532204,Auro-SUNItinib,1,L01EX01,Sunitinib,Capsule,Oral,02532204,AURO-SUNITINIB (sunitinib (sunitinib malate) 25 mg oral capsule) AURO PHARMA INC,Active,9004177,sunitinib (sunitinib malate) 25 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
102129,Marketed,2023-07-21,02532220,Auro-SUNItinib,1,L01EX01,Sunitinib,Capsule,Oral,02532220,AURO-SUNITINIB (sunitinib (sunitinib malate) 50 mg oral capsule) AURO PHARMA INC,Active,9004178,sunitinib (sunitinib malate) 50 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
102186,Marketed,2023-05-24,02532840,Sandoz SUNItinib,1,L01EX01,Sunitinib,Capsule,Oral,02532840,SANDOZ SUNITINIB (sunitinib 12.5 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9014885,sunitinib 12.5 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
102187,Marketed,2023-05-24,02532867,Sandoz SUNItinib,1,L01EX01,Sunitinib,Capsule,Oral,02532867,SANDOZ SUNITINIB (sunitinib 25 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9014886,sunitinib 25 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
102189,Marketed,2023-05-24,02532883,Sandoz SUNItinib,1,L01EX01,Sunitinib,Capsule,Oral,02532883,SANDOZ SUNITINIB (sunitinib 50 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9014887,sunitinib 50 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
102792,Marketed,2025-09-30,02539284,Nat-SUNItinib,1,L01EX01,Sunitinib,Capsule,Oral,02539284,NAT-SUNITINIB (sunitinib (sunitinib malate) 50 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9004178,sunitinib (sunitinib malate) 50 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
104182,Marketed,2025-09-30,02552906,Nat-SUNItinib,1,L01EX01,Sunitinib,Capsule,Oral,02552906,NAT-SUNITINIB (sunitinib (sunitinib malate) 25 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9004177,sunitinib (sunitinib malate) 25 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
104183,Marketed,2025-09-30,02552892,Nat-SUNItinib,1,L01EX01,Sunitinib,Capsule,Oral,02552892,NAT-SUNITINIB (sunitinib (sunitinib malate) 12.5 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9004176,sunitinib (sunitinib malate) 12.5 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
76647,Marketed,2006-06-22,02280795,Sutent,1,L01EX01,Sunitinib,Capsule,Oral,02280795,SUTENT (sunitinib (sunitinib malate) 12.5 mg oral capsule) PFIZER CANADA ULC,Active,9004176,sunitinib (sunitinib malate) 12.5 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
76648,Marketed,2006-06-22,02280809,Sutent,1,L01EX01,Sunitinib,Capsule,Oral,02280809,SUTENT (sunitinib (sunitinib malate) 25 mg oral capsule) PFIZER CANADA ULC,Active,9004177,sunitinib (sunitinib malate) 25 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
76649,Marketed,2006-06-22,02280817,Sutent,1,L01EX01,Sunitinib,Capsule,Oral,02280817,SUTENT (sunitinib (sunitinib malate) 50 mg oral capsule) PFIZER CANADA ULC,Active,9004178,sunitinib (sunitinib malate) 50 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
100024,Marketed,2021-09-30,02510995,Tissueblue,1,S01K,Surgical aids,Solution,Intravitreal,,,,,,,,,,,,,,,,,Prescription
227,Marketed,2017-06-23,00038172,Quelicin,1,M03AB01,Suxamethonium,Solution,Intravenous,77700819,QUELICIN (succinylcholine chloride 400 mg per 20 mL solution for injection vial) PFIZER CANADA ULC,Active,9013351,succinylcholine chloride 400 mg per 20 mL solution for injection vial,8001946,succinylcholine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
227,Marketed,2017-06-23,00038172,Quelicin,1,M03AB01,Suxamethonium,Solution,Intravenous,77700820,QUELICIN (succinylcholine chloride 200 mg per 10 mL solution for injection vial) PFIZER CANADA ULC,Active,9013350,succinylcholine chloride 200 mg per 10 mL solution for injection vial,8001946,succinylcholine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
90702,Marketed,2022-04-22,02422336,Succinylcholine Chloride Injection USP,1,M03AB01,Suxamethonium,Solution,Intravenous,77700895,SUCCINYLCHOLINE CHLORIDE INJECTION USP (succinylcholine chloride 400 mg per 20 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9013351,succinylcholine chloride 400 mg per 20 mL solution for injection vial,8001946,succinylcholine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
90702,Marketed,2022-04-22,02422336,Succinylcholine Chloride Injection USP,1,M03AB01,Suxamethonium,Solution,Intravenous,77700896,SUCCINYLCHOLINE CHLORIDE INJECTION USP (succinylcholine chloride 200 mg per 10 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9013350,succinylcholine chloride 200 mg per 10 mL solution for injection vial,8001946,succinylcholine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
99139,Marketed,2020-09-29,02501783,"Succinylcholine Chloride Injection, USP",1,M03AB01,Suxamethonium,Solution,Intravenous,02501783,"SUCCINYLCHOLINE CHLORIDE INJECTION, USP (succinylcholine chloride 200 mg per 10 mL solution for injection vial) DR REDDY'S LABORATORIES LTD",Active,9013350,succinylcholine chloride 200 mg per 10 mL solution for injection vial,8001946,succinylcholine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
101780,Marketed,2026-04-20,02528592,Sandoz Tacrolimus XR,1,L04AD02,Tacrolimus,Capsule (extended release),Oral,02528592,SANDOZ TACROLIMUS XR (tacrolimus 0.5 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED,Active,9001241,tacrolimus 0.5 mg prolonged-release oral capsule,8000222,tacrolimus,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
101781,Marketed,2025-11-25,02528606,Sandoz Tacrolimus XR,1,L04AD02,Tacrolimus,Capsule (extended release),Oral,02528606,SANDOZ TACROLIMUS XR (tacrolimus 1 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED,Active,9001242,tacrolimus 1 mg prolonged-release oral capsule,8000222,tacrolimus,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
101783,Marketed,2025-11-25,02528622,Sandoz Tacrolimus XR,1,L04AD02,Tacrolimus,Capsule (extended release),Oral,02528622,SANDOZ TACROLIMUS XR (tacrolimus 3 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED,Active,9001308,tacrolimus 3 mg prolonged-release oral capsule,8000222,tacrolimus,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
101784,Marketed,2025-11-25,02528630,Sandoz Tacrolimus XR,1,L04AD02,Tacrolimus,Capsule (extended release),Oral,02528630,SANDOZ TACROLIMUS XR (tacrolimus 5 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED,Active,9001243,tacrolimus 5 mg prolonged-release oral capsule,8000222,tacrolimus,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
44210,Marketed,2006-04-03,02175983,Prograf,1,L04AD02,Tacrolimus,Capsule,Oral,02175983,PROGRAF (tacrolimus 5 mg oral capsule) ASTELLAS PHARMA CANADA INC,Active,9000645,tacrolimus 5 mg oral capsule,8000222,tacrolimus,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
44211,Marketed,2006-04-03,02175991,Prograf,1,L04AD02,Tacrolimus,Capsule,Oral,02175991,PROGRAF (tacrolimus 1 mg oral capsule) ASTELLAS PHARMA CANADA INC,Active,9000644,tacrolimus 1 mg oral capsule,8000222,tacrolimus,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
44212,Marketed,2005-09-15,02176009,Prograf,1,L04AD02,Tacrolimus,Solution,Intravenous,02176009,PROGRAF (tacrolimus 5 mg per 1 mL solution for injection ampoule) ASTELLAS PHARMA CANADA INC,Active,9000646,tacrolimus 5 mg per 1 mL solution for injection ampoule,8000222,tacrolimus,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),1.0,,,Prescription
67015,Marketed,2005-11-07,02243144,Prograf,1,L04AD02,Tacrolimus,Capsule,Oral,02243144,PROGRAF (tacrolimus 0.5 mg oral capsule) ASTELLAS PHARMA CANADA INC,Active,9000937,tacrolimus 0.5 mg oral capsule,8000222,tacrolimus,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
68109,Marketed,2017-05-25,02244148,Protopic,1,D11AH01,Tacrolimus,Ointment,Topical,02244148,PROTOPIC (tacrolimus 0.1 % cutaneous ointment) LEO PHARMA INC,Active,9000960,tacrolimus 0.1 % cutaneous ointment,8000222,tacrolimus,448598008,Cutaneous,425753008,Cutaneous ointment,,,1.0,,,Prescription
68110,Marketed,2017-05-25,02244149,Protopic,1,D11AH01,Tacrolimus,Ointment,Topical,02244149,PROTOPIC (tacrolimus 0.03 % cutaneous ointment) LEO PHARMA INC,Active,9000959,tacrolimus 0.03 % cutaneous ointment,8000222,tacrolimus,448598008,Cutaneous,425753008,Cutaneous ointment,,,1.0,,,Prescription
78179,Marketed,2008-04-09,02296462,Advagraf,1,L04AD02,Tacrolimus,Capsule (extended release),Oral,02296462,ADVAGRAF (tacrolimus 0.5 mg prolonged-release oral capsule) ASTELLAS PHARMA CANADA INC,Active,9001241,tacrolimus 0.5 mg prolonged-release oral capsule,8000222,tacrolimus,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
78180,Marketed,2008-04-09,02296470,Advagraf,1,L04AD02,Tacrolimus,Capsule (extended release),Oral,02296470,ADVAGRAF (tacrolimus 1 mg prolonged-release oral capsule) ASTELLAS PHARMA CANADA INC,Active,9001242,tacrolimus 1 mg prolonged-release oral capsule,8000222,tacrolimus,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
78181,Marketed,2008-04-09,02296489,Advagraf,1,L04AD02,Tacrolimus,Capsule (extended release),Oral,02296489,ADVAGRAF (tacrolimus 5 mg prolonged-release oral capsule) ASTELLAS PHARMA CANADA INC,Active,9001243,tacrolimus 5 mg prolonged-release oral capsule,8000222,tacrolimus,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
81736,Marketed,2010-04-05,02331667,Advagraf,1,L04AD02,Tacrolimus,Capsule (extended release),Oral,02331667,ADVAGRAF (tacrolimus 3 mg prolonged-release oral capsule) ASTELLAS PHARMA CANADA INC,Active,9001308,tacrolimus 3 mg prolonged-release oral capsule,8000222,tacrolimus,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
90142,Marketed,2014-06-11,02416816,Sandoz Tacrolimus,1,L04AD02,Tacrolimus,Capsule (immediate release),Oral,02416816,SANDOZ TACROLIMUS (tacrolimus (tacrolimus monohydrate) 0.5 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9000937,tacrolimus 0.5 mg oral capsule,8000222,tacrolimus,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
90143,Marketed,2013-11-25,02416824,Sandoz Tacrolimus,1,L04AD02,Tacrolimus,Capsule (immediate release),Oral,02416824,SANDOZ TACROLIMUS (tacrolimus (tacrolimus monohydrate) 1 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9000644,tacrolimus 1 mg oral capsule,8000222,tacrolimus,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
90144,Marketed,2013-11-25,02416832,Sandoz Tacrolimus,1,L04AD02,Tacrolimus,Capsule (immediate release),Oral,02416832,SANDOZ TACROLIMUS (tacrolimus (tacrolimus monohydrate) 5 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9000645,tacrolimus 5 mg oral capsule,8000222,tacrolimus,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
94058,Marketed,2023-09-21,02454068,ACH-Tacrolimus,1,L04AD02,Tacrolimus,Capsule (immediate release),Oral,02454068,ACH-TACROLIMUS (tacrolimus 0.5 mg oral capsule) ACCORD HEALTHCARE INC,Active,9000937,tacrolimus 0.5 mg oral capsule,8000222,tacrolimus,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
94294,Marketed,2023-09-15,02456095,ACH-Tacrolimus,1,L04AD02,Tacrolimus,Capsule (immediate release),Oral,02456095,ACH-TACROLIMUS (tacrolimus 1 mg oral capsule) ACCORD HEALTHCARE INC,Active,9000644,tacrolimus 1 mg oral capsule,8000222,tacrolimus,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
94295,Marketed,2023-09-15,02456109,ACH-Tacrolimus,1,L04AD02,Tacrolimus,Capsule (immediate release),Oral,02456109,ACH-TACROLIMUS (tacrolimus 5 mg oral capsule) ACCORD HEALTHCARE INC,Active,9000645,tacrolimus 5 mg oral capsule,8000222,tacrolimus,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
97609,Marketed,2026-03-23,02485877,Envarsus Pa,1,L04AD02,Tacrolimus,Tablet (extended-release),Oral,02485877,ENVARSUS PA (tacrolimus 0.75 mg prolonged-release oral tablet) KNIGHT THERAPEUTICS INC.,Active,9013895,tacrolimus 0.75 mg prolonged-release oral tablet,8000222,tacrolimus,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
97610,Marketed,2026-03-23,02485885,Envarsus Pa,1,L04AD02,Tacrolimus,Tablet (extended-release),Oral,02485885,ENVARSUS PA (tacrolimus 1 mg prolonged-release oral tablet) KNIGHT THERAPEUTICS INC.,Active,9013896,tacrolimus 1 mg prolonged-release oral tablet,8000222,tacrolimus,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
97611,Marketed,2026-03-23,02485893,Envarsus Pa,1,L04AD02,Tacrolimus,Tablet (extended-release),Oral,02485893,ENVARSUS PA (tacrolimus 4 mg prolonged-release oral tablet) KNIGHT THERAPEUTICS INC.,Active,9013897,tacrolimus 4 mg prolonged-release oral tablet,8000222,tacrolimus,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100133,Marketed,2021-09-27,02512114,M-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02512114,M-TADALAFIL (tadalafil 5 mg oral tablet) MANTRA PHARMA INC,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100134,Marketed,2021-09-27,02512122,M-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02512122,M-TADALAFIL (tadalafil 10 mg oral tablet) MANTRA PHARMA INC,Active,9001060,tadalafil 10 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100135,Marketed,2021-09-27,02512130,M-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02512130,M-TADALAFIL (tadalafil 20 mg oral tablet) MANTRA PHARMA INC,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100156,Marketed,2021-09-27,02512262,PRZ-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02512262,PRZ-TADALAFIL (tadalafil 2.5 mg oral tablet) PHARMARIS CANADA INC,Active,9001236,tadalafil 2.5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100157,Marketed,2021-09-27,02512270,PRZ-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02512270,PRZ-TADALAFIL (tadalafil 5 mg oral tablet) PHARMARIS CANADA INC,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100158,Marketed,2021-09-27,02512289,PRZ-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02512289,PRZ-TADALAFIL (tadalafil 10 mg oral tablet) PHARMARIS CANADA INC,Active,9001060,tadalafil 10 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100159,Marketed,2021-09-27,02512297,PRZ-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02512297,PRZ-TADALAFIL (tadalafil 20 mg oral tablet) PHARMARIS CANADA INC,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100534,Marketed,2023-03-30,02515989,ACH-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02515989,ACH-TADALAFIL (tadalafil 5 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100535,Marketed,2023-03-30,02515997,ACH-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02515997,ACH-TADALAFIL (tadalafil 10 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001060,tadalafil 10 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100536,Marketed,2023-03-30,02516004,ACH-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02516004,ACH-TADALAFIL (tadalafil 20 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101018,Marketed,2022-10-13,02520931,Nra-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02520931,NRA-TADALAFIL (tadalafil 5 mg oral tablet) NORA PHARMA INC,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101020,Marketed,2022-10-13,02520966,Nra-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02520966,NRA-TADALAFIL (tadalafil 20 mg oral tablet) NORA PHARMA INC,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102542,Marketed,2024-08-29,02536676,Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02536676,TADALAFIL (tadalafil 2.5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001236,tadalafil 2.5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102543,Marketed,2024-08-29,02536684,Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02536684,TADALAFIL (tadalafil 5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102544,Marketed,2024-08-29,02536692,Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02536692,TADALAFIL (tadalafil 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001060,tadalafil 10 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102545,Marketed,2024-08-29,02536706,Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02536706,TADALAFIL (tadalafil 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
72410,Marketed,2007-09-12,02248088,Cialis,1,G04BE08,Tadalafil,Tablet,Oral,02248088,CIALIS (tadalafil 10 mg oral tablet) ELI LILLY CANADA INC,Active,9001060,tadalafil 10 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
72411,Marketed,2007-09-12,02248089,Cialis,1,G04BE08,Tadalafil,Tablet,Oral,02248089,CIALIS (tadalafil 20 mg oral tablet) ELI LILLY CANADA INC,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78223,Marketed,2008-01-18,02296888,Cialis,1,G04BE08,Tadalafil,Tablet,Oral,02296888,CIALIS (tadalafil 2.5 mg oral tablet) ELI LILLY CANADA INC,Active,9001236,tadalafil 2.5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78224,Marketed,2008-01-18,02296896,Cialis,1,G04BE08,Tadalafil,Tablet,Oral,02296896,CIALIS (tadalafil 5 mg oral tablet) ELI LILLY CANADA INC,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82395,Marketed,2010-01-19,02338327,Adcirca,1,G04BE08,Tadalafil,Tablet,Oral,02338327,ADCIRCA (tadalafil 20 mg oral tablet) ELI LILLY CANADA INC,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89412,Marketed,2020-05-22,02409410,PMS-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02409410,PMS-TADALAFIL (tadalafil 2.5 mg oral tablet) PHARMASCIENCE INC,Active,9001236,tadalafil 2.5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89413,Marketed,2020-05-21,02409429,PMS-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02409429,PMS-TADALAFIL (tadalafil 5 mg oral tablet) PHARMASCIENCE INC,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89414,Marketed,2020-05-21,02409437,PMS-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02409437,PMS-TADALAFIL (tadalafil 10 mg oral tablet) PHARMASCIENCE INC,Active,9001060,tadalafil 10 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89415,Marketed,2020-05-21,02409445,PMS-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02409445,PMS-TADALAFIL (tadalafil 20 mg oral tablet) PHARMASCIENCE INC,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89530,Marketed,2016-07-12,02410621,Mylan-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02410621,MYLAN-TADALAFIL (tadalafil 2.5 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9001236,tadalafil 2.5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89531,Marketed,2016-07-12,02410648,Mylan-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02410648,MYLAN-TADALAFIL (tadalafil 5 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89532,Marketed,2016-07-12,02410656,Mylan-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02410656,MYLAN-TADALAFIL (tadalafil 10 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9001060,tadalafil 10 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89533,Marketed,2016-07-12,02410664,Mylan-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02410664,MYLAN-TADALAFIL (tadalafil 20 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90663,Marketed,2015-10-15,02421933,Apo-Tadalafil Pah,1,G04BE08,Tadalafil,Tablet,Oral,02421933,APO-TADALAFIL PAH (tadalafil 20 mg oral tablet) APOTEX INC,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90680,Marketed,2016-07-12,02422085,Apo-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02422085,APO-TADALAFIL (tadalafil 2.5 mg oral tablet) APOTEX INC,Active,9001236,tadalafil 2.5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90681,Marketed,2016-07-12,02422093,Apo-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02422093,APO-TADALAFIL (tadalafil 5 mg oral tablet) APOTEX INC,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90682,Marketed,2016-07-12,02422107,Apo-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02422107,APO-TADALAFIL (tadalafil 10 mg oral tablet) APOTEX INC,Active,9001060,tadalafil 10 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90683,Marketed,2016-07-12,02422115,Apo-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02422115,APO-TADALAFIL (tadalafil 20 mg oral tablet) APOTEX INC,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92025,Marketed,2016-07-14,02435896,Auro-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02435896,AURO-TADALAFIL (tadalafil 2.5 mg oral tablet) AURO PHARMA INC,Active,9001236,tadalafil 2.5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92026,Marketed,2016-07-14,02435926,Auro-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02435926,AURO-TADALAFIL (tadalafil 5 mg oral tablet) AURO PHARMA INC,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92027,Marketed,2016-07-14,02435934,Auro-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02435934,AURO-TADALAFIL (tadalafil 10 mg oral tablet) AURO PHARMA INC,Active,9001060,tadalafil 10 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92028,Marketed,2016-07-14,02435942,Auro-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02435942,AURO-TADALAFIL (tadalafil 20 mg oral tablet) AURO PHARMA INC,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92452,Marketed,2016-07-12,02440148,Teva-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02440148,TEVA-TADALAFIL (tadalafil 2.5 mg oral tablet) TEVA CANADA LIMITED,Active,9001236,tadalafil 2.5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92453,Marketed,2016-07-12,02440156,Teva-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02440156,TEVA-TADALAFIL (tadalafil 5 mg oral tablet) TEVA CANADA LIMITED,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92454,Marketed,2016-07-12,02440164,Teva-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02440164,TEVA-TADALAFIL (tadalafil 10 mg oral tablet) TEVA CANADA LIMITED,Active,9001060,tadalafil 10 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92455,Marketed,2016-07-12,02440172,Teva-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02440172,TEVA-TADALAFIL (tadalafil 20 mg oral tablet) TEVA CANADA LIMITED,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93791,Marketed,2016-07-14,02451670,Mint-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02451670,MINT-TADALAFIL (tadalafil 5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93792,Marketed,2023-04-06,02451689,Mint-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02451689,MINT-TADALAFIL (tadalafil 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001060,tadalafil 10 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93793,Marketed,2016-07-14,02451697,Mint-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02451697,MINT-TADALAFIL (tadalafil 20 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93819,Marketed,2016-07-13,02451832,JAMP-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02451832,JAMP-TADALAFIL (tadalafil 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93820,Marketed,2016-07-13,02451840,JAMP-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02451840,JAMP-TADALAFIL (tadalafil 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001060,tadalafil 10 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93821,Marketed,2016-07-13,02451859,JAMP-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02451859,JAMP-TADALAFIL (tadalafil 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93848,Marketed,2016-07-13,02452278,Mar-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02452278,MAR-TADALAFIL (tadalafil 5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93849,Marketed,2016-07-13,02452251,Mar-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02452251,MAR-TADALAFIL (tadalafil 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001060,tadalafil 10 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93850,Marketed,2016-07-13,02452243,Mar-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02452243,MAR-TADALAFIL (tadalafil 20 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93851,Marketed,2024-03-08,02452073,Taro-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02452073,TARO-TADALAFIL (tadalafil 5 mg oral tablet) SUN PHARMA CANADA INC,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93854,Marketed,2024-03-08,02452111,Taro-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02452111,TARO-TADALAFIL (tadalafil 20 mg oral tablet) SUN PHARMA CANADA INC,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93886,Marketed,2025-12-04,02452480,Nra-Tadalafil Tablets,1,G04BE08,Tadalafil,Tablet,Oral,02452480,NRA-TADALAFIL TABLETS (tadalafil 5 mg oral tablet) NORA PHARMA INC,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93887,Marketed,2024-02-20,02452499,Nra-Tadalafil Tablets,1,G04BE08,Tadalafil,Tablet,Oral,02452499,NRA-TADALAFIL TABLETS (tadalafil 10 mg oral tablet) NORA PHARMA INC,Active,9001060,tadalafil 10 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93888,Marketed,2024-02-20,02452502,Nra-Tadalafil Tablets,1,G04BE08,Tadalafil,Tablet,Oral,02452502,NRA-TADALAFIL TABLETS (tadalafil 20 mg oral tablet) NORA PHARMA INC,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94141,Marketed,2022-11-25,02454726,Riva-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02454726,RIVA-TADALAFIL (tadalafil 5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94142,Marketed,2025-03-31,02454734,Riva-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02454734,RIVA-TADALAFIL (tadalafil 10 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001060,tadalafil 10 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94143,Marketed,2022-11-25,02454742,Riva-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02454742,RIVA-TADALAFIL (tadalafil 20 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94216,Marketed,2016-08-11,02455358,Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02455358,TADALAFIL (tadalafil 5 mg oral tablet) PRO DOC LIMITEE,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94217,Marketed,2016-09-09,02455366,Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02455366,TADALAFIL (tadalafil 10 mg oral tablet) PRO DOC LIMITEE,Active,9001060,tadalafil 10 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94218,Marketed,2016-08-11,02455374,Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02455374,TADALAFIL (tadalafil 20 mg oral tablet) PRO DOC LIMITEE,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94401,Marketed,2021-07-08,02457016,Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02457016,TADALAFIL (tadalafil 5 mg oral tablet) SANIS HEALTH INC,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94402,Marketed,2021-07-08,02457024,Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02457024,TADALAFIL (tadalafil 10 mg oral tablet) SANIS HEALTH INC,Active,9001060,tadalafil 10 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94403,Marketed,2021-07-13,02457032,Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02457032,TADALAFIL (tadalafil 20 mg oral tablet) SANIS HEALTH INC,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97173,Marketed,2022-03-16,02481405,AG-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02481405,AG-TADALAFIL (tadalafil 5 mg oral tablet) ANGITA PHARMA INC.,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97175,Marketed,2019-11-21,02481421,AG-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02481421,AG-TADALAFIL (tadalafil 20 mg oral tablet) ANGITA PHARMA INC.,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99807,Marketed,2021-07-28,02508729,Bio-Tadalafil,1,G04BE08,Tadalafil,Tablet,Oral,02508729,BIO-TADALAFIL (tadalafil 20 mg oral tablet) BIOMED PHARMA,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100720,Marketed,2021-09-15,02517841,Vyndamax,1,N07XX08,Tafamidis,Capsule,Oral,02517841,VYNDAMAX (tafamidis 61 mg oral capsule) PFIZER CANADA ULC,Active,9014813,tafamidis 61 mg oral capsule,8002328,tafamidis,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
98563,Marketed,2020-04-07,02495732,Vyndaqel,1,N07XX08,Tafamidis,Capsule,Oral,02495732,VYNDAQEL (tafamidis meglumine 20 mg oral capsule) PFIZER CANADA ULC,Active,9014301,tafamidis meglumine 20 mg oral capsule,8002328,tafamidis,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
100793,Marketed,2021-12-06,02518627,Minjuvi,1,L01FX12,Tafasitamab,Powder for solution,Intravenous,02518627,MINJUVI (tafasitamab 200 mg per vial powder for solution for injection) INCYTE CORPORATION,Active,9014653,tafasitamab 200 mg per vial powder for solution for injection,8002410,tafasitamab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
100793,Marketed,2021-12-06,02518627,Minjuvi,1,L01FX12,Tafasitamab,Powder for solution,Intravenous,02518627,MINJUVI (tafasitamab 200 mg per vial powder for solution for injection) INCYTE CORPORATION,Active,9014653,tafasitamab 200 mg per vial powder for solution for injection,8002410,tafasitamab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
104385,Marketed,2025-05-16,02555050,Talzenna,1,L01XK04,Talazoparib,Capsule,Oral,02555050,TALZENNA (talazoparib (talazoparib tosylate) 0.1 mg oral capsule) PFIZER CANADA ULC,Active,9015207,talazoparib (talazoparib tosylate) 0.1 mg oral capsule,8002545,talazoparib,26643006,Oral,420692007,Oral capsule,732937005,Capsule,1.0,,,Prescription
98204,Marketed,2025-05-16,02492032,Talzenna,1,L01XK04,Talazoparib,Capsule,Oral,02492032,TALZENNA (talazoparib (talazoparib tosylate) 0.25 mg oral capsule) PFIZER CANADA ULC,Active,9015208,talazoparib (talazoparib tosylate) 0.25 mg oral capsule,8002545,talazoparib,26643006,Oral,420692007,Oral capsule,732937005,Capsule,1.0,,,Prescription
103601,Marketed,2025-03-04,02547392,Talvey,1,L01FX29,Talquetamab,Solution,Subcutaneous,02547392,TALVEY (talquetamab 3 mg per 1.5 mL solution for injection vial) JANSSEN INC,Active,9015193,talquetamab 3 mg per 1.5 mL solution for injection vial,8002539,talquetamab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,1.0,,,Prescription
103601,Marketed,2025-03-04,02547392,Talvey,1,L01FX29,Talquetamab,Solution,Subcutaneous,02547392,TALVEY (talquetamab 3 mg per 1.5 mL solution for injection vial) JANSSEN INC,Active,9015193,talquetamab 3 mg per 1.5 mL solution for injection vial,8002539,talquetamab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,1.0,,,Schedule D
103602,Marketed,2025-03-04,02547406,Talvey,1,L01FX29,Talquetamab,Solution,Subcutaneous,02547406,TALVEY (talquetamab 40 mg per 1 mL solution for injection vial) JANSSEN INC,Active,9015194,talquetamab 40 mg per 1 mL solution for injection vial,8002539,talquetamab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,1.0,,,Prescription
103602,Marketed,2025-03-04,02547406,Talvey,1,L01FX29,Talquetamab,Solution,Subcutaneous,02547406,TALVEY (talquetamab 40 mg per 1 mL solution for injection vial) JANSSEN INC,Active,9015194,talquetamab 40 mg per 1 mL solution for injection vial,8002539,talquetamab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,1.0,,,Schedule D
10664,Marketed,1989-12-31,00812404,Apo-Tamox Tablets 10 mg,1,L02BA01,Tamoxifen,Tablet,Oral,00812404,APO-TAMOX TAB 10MG (tamoxifen (tamoxifen citrate) 10 mg oral tablet) APOTEX INC,Active,9002226,tamoxifen (tamoxifen citrate) 10 mg oral tablet,8001096,tamoxifen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
10762,Marketed,1989-12-31,00812390,Apo-Tamox Tablets 20 mg,1,L02BA01,Tamoxifen,Tablet,Oral,00812390,APO-TAMOX TAB 20MG (tamoxifen (tamoxifen citrate) 20 mg oral tablet) APOTEX INC,Active,9002227,tamoxifen (tamoxifen citrate) 20 mg oral tablet,8001096,tamoxifen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
10790,Marketed,2011-06-01,00851965,Teva-Tamoxifen,1,L02BA01,Tamoxifen,Tablet,Oral,00851965,TEVA-TAMOXIFEN (tamoxifen (tamoxifen citrate) 10 mg oral tablet) TEVA CANADA LIMITED,Active,9002226,tamoxifen (tamoxifen citrate) 10 mg oral tablet,8001096,tamoxifen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
10791,Marketed,2011-06-01,00851973,Teva-Tamoxifen,1,L02BA01,Tamoxifen,Tablet,Oral,00851973,TEVA-TAMOXIFEN (tamoxifen (tamoxifen citrate) 20 mg oral tablet) TEVA CANADA LIMITED,Active,9002227,tamoxifen (tamoxifen citrate) 20 mg oral tablet,8001096,tamoxifen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
103396,Marketed,2024-08-27,02545179,Auro-Tamsulosin CR,1,G04CA02,Tamsulosin,Tablet (extended-release),Oral,02545179,AURO-TAMSULOSIN CR (tamsulosin hydrochloride 0.4 mg prolonged-release oral tablet) AURO PHARMA INC,Active,9001127,tamsulosin hydrochloride 0.4 mg prolonged-release oral tablet,8000352,tamsulosin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80468,Marketed,2014-03-19,02319217,Sandoz Tamsulosin,1,G04CA02,Tamsulosin,Capsule (sustained-release),Oral,02319217,SANDOZ TAMSULOSIN (tamsulosin hydrochloride 0.4 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED,Active,9001188,tamsulosin hydrochloride 0.4 mg prolonged-release oral capsule,8000352,tamsulosin,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
82577,Marketed,2011-01-04,02340208,Sandoz Tamsulosin CR,1,G04CA02,Tamsulosin,Tablet (extended-release),Oral,02340208,SANDOZ TAMSULOSIN CR (tamsulosin hydrochloride 0.4 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9001127,tamsulosin hydrochloride 0.4 mg prolonged-release oral tablet,8000352,tamsulosin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83768,Marketed,2023-12-19,02352419,JAMP Tamsulosin,1,G04CA02,Tamsulosin,Capsule (sustained-release),Oral,02352419,JAMP TAMSULOSIN (tamsulosin hydrochloride 0.4 mg prolonged-release oral capsule) JAMP PHARMA CORPORATION,Active,9001188,tamsulosin hydrochloride 0.4 mg prolonged-release oral capsule,8000352,tamsulosin,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
84741,Marketed,2012-02-09,02362406,Apo-Tamsulosin CR,1,G04CA02,Tamsulosin,Tablet (extended-release),Oral,02362406,APO-TAMSULOSIN CR (tamsulosin hydrochloride 0.4 mg prolonged-release oral tablet) APOTEX INC,Active,9001127,tamsulosin hydrochloride 0.4 mg prolonged-release oral tablet,8000352,tamsulosin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85321,Marketed,2013-09-04,02368242,Teva-Tamsulosin CR,1,G04CA02,Tamsulosin,Tablet (extended-release),Oral,02368242,TEVA-TAMSULOSIN CR (tamsulosin hydrochloride 0.4 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9001127,tamsulosin hydrochloride 0.4 mg prolonged-release oral tablet,8000352,tamsulosin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89826,Marketed,2013-11-21,02413612,Tamsulosin CR,1,G04CA02,Tamsulosin,Tablet (extended-release),Oral,02413612,TAMSULOSIN CR (tamsulosin hydrochloride 0.4 mg prolonged-release oral tablet) PRO DOC LIMITEE,Active,9001127,tamsulosin hydrochloride 0.4 mg prolonged-release oral tablet,8000352,tamsulosin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91164,Marketed,2014-07-24,02427117,Tamsulosin CR,1,G04CA02,Tamsulosin,Tablet (extended-release),Oral,02427117,TAMSULOSIN CR (tamsulosin hydrochloride 0.4 mg prolonged-release oral tablet) SANIS HEALTH INC,Active,9001127,tamsulosin hydrochloride 0.4 mg prolonged-release oral tablet,8000352,tamsulosin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91411,Marketed,2014-10-08,02429667,Tamsulosin CR,1,G04CA02,Tamsulosin,Tablet (extended-release),Oral,02429667,TAMSULOSIN CR (tamsulosin hydrochloride 0.4 mg prolonged-release oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001127,tamsulosin hydrochloride 0.4 mg prolonged-release oral tablet,8000352,tamsulosin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85714,Marketed,2011-11-17,02372010,Jalyn,2,G04CA52,Tamsulosin and dutasteride,Capsule (immediate and extended release),Oral,02372010,JALYN (dutasteride 0.5 mg and tamsulosin hydrochloride 0.4 mg prolonged-release oral capsule) GLAXOSMITHKLINE INC,Active,9015296,dutasteride 0.5 mg and tamsulosin hydrochloride 0.4 mg prolonged-release oral capsule,8000988,dutasteride and tamsulosin,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule,1.0,,,Prescription
86409,Marketed,2026-03-06,02378272,Nucynta IR,1,N02AX06,Tapentadol,Tablet (immediate release),Oral,02378272,NUCYNTA IR (tapentadol (tapentadol hydrochloride) 50 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9005008,tapentadol (tapentadol hydrochloride) 50 mg oral tablet,8000789,tapentadol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
86410,Marketed,2026-03-06,02378280,Nucynta IR,1,N02AX06,Tapentadol,Tablet (immediate release),Oral,02378280,NUCYNTA IR (tapentadol (tapentadol hydrochloride) 75 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9005009,tapentadol (tapentadol hydrochloride) 75 mg oral tablet,8000789,tapentadol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
86411,Marketed,2026-03-06,02378299,Nucynta IR,1,N02AX06,Tapentadol,Tablet (immediate release),Oral,02378299,NUCYNTA IR (tapentadol (tapentadol hydrochloride) 100 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9005007,tapentadol (tapentadol hydrochloride) 100 mg oral tablet,8000789,tapentadol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
90016,Marketed,2026-03-05,02415577,Nucynta Extended-Release,1,N02AX06,Tapentadol,Tablet (extended-release),Oral,02415577,NUCYNTA EXTENDED-RELEASE (tapentadol (tapentadol hydrochloride) 50 mg prolonged-release oral tablet) KNIGHT THERAPEUTICS INC.,Active,9005496,tapentadol (tapentadol hydrochloride) 50 mg prolonged-release oral tablet,8000789,tapentadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
90017,Marketed,2026-03-05,02415585,Nucynta Extended-Release,1,N02AX06,Tapentadol,Tablet (extended-release),Oral,02415585,NUCYNTA EXTENDED-RELEASE (tapentadol (tapentadol hydrochloride) 100 mg prolonged-release oral tablet) KNIGHT THERAPEUTICS INC.,Active,9005492,tapentadol (tapentadol hydrochloride) 100 mg prolonged-release oral tablet,8000789,tapentadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
90018,Marketed,2026-03-05,02415593,Nucynta Extended-Release,1,N02AX06,Tapentadol,Tablet (extended-release),Oral,02415593,NUCYNTA EXTENDED-RELEASE (tapentadol (tapentadol hydrochloride) 150 mg prolonged-release oral tablet) KNIGHT THERAPEUTICS INC.,Active,9005493,tapentadol (tapentadol hydrochloride) 150 mg prolonged-release oral tablet,8000789,tapentadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
90019,Marketed,2026-03-05,02415607,Nucynta Extended-Release,1,N02AX06,Tapentadol,Tablet (extended-release),Oral,02415607,NUCYNTA EXTENDED-RELEASE (tapentadol (tapentadol hydrochloride) 200 mg prolonged-release oral tablet) KNIGHT THERAPEUTICS INC.,Active,9005494,tapentadol (tapentadol hydrochloride) 200 mg prolonged-release oral tablet,8000789,tapentadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
90020,Marketed,2026-03-06,02415615,Nucynta Extended-Release,1,N02AX06,Tapentadol,Tablet (extended-release),Oral,02415615,NUCYNTA EXTENDED-RELEASE (tapentadol (tapentadol hydrochloride) 250 mg prolonged-release oral tablet) KNIGHT THERAPEUTICS INC.,Active,9005495,tapentadol (tapentadol hydrochloride) 250 mg prolonged-release oral tablet,8000789,tapentadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,,Narcotics (CDSA I)
93392,Marketed,2025-09-25,02448254,Nduvra,2,D05AX07,Tapinarof,Cream,Topical,02448254,NDUVRA (tapinarof 1 % cutaneous cream) ORGANON CANADA INC.,Active,9015273,tapinarof 1 % cutaneous cream,8002558,tapinarof,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
104029,Marketed,2024-11-28,02551551,Imdelltra,1,L01FX33,Tarlatamab,Powder for solution,Intravenous,02551551,IMDELLTRA (tarlatamab 1 mg per vial powder for solution for injection with solution stabilizer) AMGEN CANADA INC,Active,9015155,tarlatamab 1 mg per vial powder for solution for injection with solution stabilizer,8002526,tarlatamab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,1.0,,,Prescription
104029,Marketed,2024-11-28,02551551,Imdelltra,1,L01FX33,Tarlatamab,Powder for solution,Intravenous,02551551,IMDELLTRA (tarlatamab 1 mg per vial powder for solution for injection with solution stabilizer) AMGEN CANADA INC,Active,9015155,tarlatamab 1 mg per vial powder for solution for injection with solution stabilizer,8002526,tarlatamab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,1.0,,,Schedule D
104030,Marketed,2024-11-28,02551578,Imdelltra,1,L01FX33,Tarlatamab,Powder for solution,Intravenous,02551578,IMDELLTRA (tarlatamab 10 mg per vial powder for solution for injection with solution stabilizer) AMGEN CANADA INC,Active,9015154,tarlatamab 10 mg per vial powder for solution for injection with solution stabilizer,8002526,tarlatamab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,1.0,,,Schedule D
104030,Marketed,2024-11-28,02551578,Imdelltra,1,L01FX33,Tarlatamab,Powder for solution,Intravenous,02551578,IMDELLTRA (tarlatamab 10 mg per vial powder for solution for injection with solution stabilizer) AMGEN CANADA INC,Active,9015154,tarlatamab 10 mg per vial powder for solution for injection with solution stabilizer,8002526,tarlatamab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,1.0,,,Prescription
102761,Marketed,2024-09-15,02538954,Coal-Tar Shampoo,1,D05AA,Tars,Shampoo,Topical,02538954,COAL-TAR SHAMPOO (coal tar 0.5 % shampoo) SEAFORD PHARMACEUTICALS INC,Active,9003517,coal tar 0.5 % shampoo,8002109,coal tar,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
1667,Marketed,1973-12-31,00266493,Tardan SHP,3,D05AA,Tars,Shampoo,Topical,00266493,TARDAN SHP (coal tar 5 % and salicylic acid 2 % and triclosan 0.3 % shampoo) ODAN LABORATORIES LTD,Active,9001699,coal tar 5 % and salicylic acid 2 % and triclosan 0.3 % shampoo,8002111,coal tar and salicylic acid and triclosan,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
6848,Marketed,1986-12-31,00666114,Sebcur-T,2,D05AA,Tars,Shampoo,Topical,00666114,SEBCUR-T (coal tar 10 % and salicylic acid 4 % shampoo) DERMTEK PHARMA INC,Active,9002064,coal tar 10 % and salicylic acid 4 % shampoo,8002110,coal tar and salicylic acid,41695006,Scalp structure,785908001,Shampoo,,,,,,Non-Prescription Drugs
93479,Marketed,2016-08-01,02448963,Derm Oil,1,D05AA,Tars,Solution,Topical,02448963,DERM OIL (coal tar 10 % cutaneous solution) DERMTEK PHARMA INC,Active,9006016,coal tar 10 % cutaneous solution,8002109,coal tar,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Non-Prescription Drugs
100721,Marketed,2021-09-16,02517868,Arazlo,1,D05AX05,Tazarotene,Lotion,Topical,02517868,"ARAZLO (tazarotene 0.045 % lotion) BAUSCH HEALTH, CANADA INC.",Active,9014604,tazarotene 0.045 % lotion,8001952,tazarotene,448598008,Cutaneous,739000003,Lotion,,,,,,Prescription
98967,Marketed,2020-08-04,02499967,Duobrii,2,D05AX05,Tazarotene,Lotion,Topical,02499967,"DUOBRII (halobetasol propionate 0.01 % and tazarotene 0.045 % lotion) BAUSCH HEALTH, CANADA INC.",Active,9014344,halobetasol propionate 0.01 % and tazarotene 0.045 % lotion,8002338,halobetasol and tazarotene,448598008,Cutaneous,739000003,Lotion,,,,,,Prescription
101664,Marketed,2022-08-23,02527588,Kimmtrak,1,L01XX75,Tebentafusp,Solution,Intravenous,02527588,KIMMTRAK (tebentafusp 100 mcg per 0.5 mL solution for injection vial) IMMUNOCORE IRELAND LIMITED,Active,9014786,tebentafusp 100 mcg per 0.5 mL solution for injection vial,8002439,tebentafusp,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
101664,Marketed,2022-08-23,02527588,Kimmtrak,1,L01XX75,Tebentafusp,Solution,Intravenous,02527588,KIMMTRAK (tebentafusp 100 mcg per 0.5 mL solution for injection vial) IMMUNOCORE IRELAND LIMITED,Active,9014786,tebentafusp 100 mcg per 0.5 mL solution for injection vial,8002439,tebentafusp,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
97623,Marketed,2019-03-24,02486008,Stannous Disida Kit,1,V09DA01,Technetium (99m tc) disofenin,"Kit,Solution",Intravenous,,,,,,,,,,,,,,,,,Schedule C
81468,Marketed,2019-01-17,02329034,Ceretec,1,V09HA02,Technetium (99m tc) exametazime labelled cells,Powder for solution,Intravenous,,,,,,,,,,,,,,,,,Schedule C
97437,Marketed,2019-04-15,02484048,Ceretec,1,V09HA02,Technetium (99m tc) exametazime labelled cells,"Powder for solution,Kit",Intravenous,,,,,,,,,,,,,,,,,Schedule C
82750,Marketed,2018-08-28,02342006,Draximage Gluceptate,2,V09CA04,Technetium (99m tc) gluceptate,Powder for solution,Intravenous,,,,,,,,,,,,,,,,,Schedule C
81495,Marketed,2022-05-10,02329263,Choletec,1,V09DA04,Technetium (99m tc) mebrofenin,Powder for solution,Intravenous,,,,,,,,,,,,,,,,,Schedule C
81492,Marketed,2018-08-23,02329239,Draximage MDP-25,1,V09BA02,Technetium (99m tc) medronic acid,Powder for solution,Intravenous,,,,,,,,,,,,,,,,,Schedule C
81515,Marketed,2018-08-23,02329409,Draximage MDP,1,V09BA02,Technetium (99m tc) medronic acid,Powder for solution,Intravenous,,,,,,,,,,,,,,,,,Schedule C
97605,Marketed,2019-03-23,02485834,Stannous MDP Kit,1,V09BA02,Technetium (99m tc) medronic acid,"Solution,Kit",Intravenous,,,,,,,,,,,,,,,,,Schedule C
81499,Marketed,2019-10-01,02329298,Technescan Mag 3,1,V09CA03,Technetium (99m tc) mertiatide,"Kit,Powder for solution",Intravenous,,,,,,,,,,,,,,,,,Schedule C
92599,Marketed,2019-10-23,02441608,Ultra-Technekow V 4,1,V09FX01,Technetium (99m tc) pertechnetate,Solution,Intravenous,,,,,,,,,,,,,,,,,Schedule C
100307,Marketed,2022-08-09,02513870,Kit For The Preparation Of Technetium (99 MTC) Pyrophosphate Injection,1,V09BA03,Technetium (99m tc) pyrophosphate,Powder for solution,Intravenous,,,,,,,,,,,,,,,,,Schedule C
97624,Marketed,2019-03-24,02486016,Stannous PYP Kit,1,V09BA03,Technetium (99m tc) pyrophosphate,"Kit,Solution",Intravenous,,,,,,,,,,,,,,,,,Schedule C
81314,Marketed,2018-08-23,02327732,Draximage Sestamibi,1,V09GA01,Technetium (99m tc) sestamibi,Powder for solution,Intravenous,,,,,,,,,,,,,,,,,Schedule C
81550,Marketed,2019-12-02,02329794,Kit For The Preparation Of Technetium TC 99 M Sestamibi Injection,1,V09GA01,Technetium (99m tc) sestamibi,"Powder for solution,Kit",Intravenous,,,,,,,,,,,,,,,,,Schedule C
81508,Marketed,2019-10-29,02329336,Ultratag RBC,1,V09GA06,Technetium (99m tc) stannous agent labelled cells,"Kit,Solution",Intravenous,,,,,,,,,,,,,,,,,Schedule C
81439,Marketed,2018-11-27,02328755,Myoview,1,V09GA02,Technetium (99m tc) tetrofosmin,Powder for solution,Intravenous,,,,,,,,,,,,,,,,,Schedule C
90686,Marketed,2018-11-27,02422158,Myoview 30 mL,1,V09GA02,Technetium (99m tc) tetrofosmin,Powder for solution,Intravenous,,,,,,,,,,,,,,,,,Schedule C
102408,Marketed,2024-05-26,02535211,Kids 50 Clear Sunscreen Spray,4,V07AV,Technical disinfectants,Spray,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102849,Marketed,2023-10-20,02539756,Tecvayli,1,L01FX24,Teclistamab,Solution,Subcutaneous,02539756,TECVAYLI (teclistamab 30 mg per 3 mL solution for injection vial) JANSSEN INC,Active,9014949,teclistamab 30 mg per 3 mL solution for injection vial,8002484,teclistamab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
102849,Marketed,2023-10-20,02539756,Tecvayli,1,L01FX24,Teclistamab,Solution,Subcutaneous,02539756,TECVAYLI (teclistamab 30 mg per 3 mL solution for injection vial) JANSSEN INC,Active,9014949,teclistamab 30 mg per 3 mL solution for injection vial,8002484,teclistamab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
102850,Marketed,2023-10-20,02539764,Tecvayli,1,L01FX24,Teclistamab,Solution,Subcutaneous,02539764,TECVAYLI (teclistamab 153 mg per 1.7 mL solution for injection vial) JANSSEN INC,Active,9014948,teclistamab 153 mg per 1.7 mL solution for injection vial,8002484,teclistamab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
102850,Marketed,2023-10-20,02539764,Tecvayli,1,L01FX24,Teclistamab,Solution,Subcutaneous,02539764,TECVAYLI (teclistamab 153 mg per 1.7 mL solution for injection vial) JANSSEN INC,Active,9014948,teclistamab 153 mg per 1.7 mL solution for injection vial,8002484,teclistamab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
93100,Marketed,2021-10-13,02445727,Revestive,1,A16AX08,Teduglutide,"Kit,Powder for solution",Subcutaneous,02445727,REVESTIVE (teduglutide 5 mg per vial powder for solution for injection with diluent solution syringe) TAKEDA CANADA INC,Active,9013023,teduglutide 5 mg per vial powder for solution for injection with diluent solution syringe,8001530,teduglutide,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
93100,Marketed,2021-10-13,02445727,Revestive,1,A16AX08,Teduglutide,"Kit,Powder for solution",Subcutaneous,02445727,REVESTIVE (teduglutide 5 mg per vial powder for solution for injection with diluent solution syringe) TAKEDA CANADA INC,Active,9013023,teduglutide 5 mg per vial powder for solution for injection with diluent solution syringe,8001530,teduglutide,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
64358,Marketed,1999-09-01,02240769,Micardis 40 mg Tablets,1,C09CA07,Telmisartan,Tablet,Oral,02240769,MICARDIS 40MG TAB (telmisartan 40 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9000866,telmisartan 40 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
64359,Marketed,1999-09-01,02240770,Micardis 80 mg Tablets,1,C09CA07,Telmisartan,Tablet,Oral,02240770,MICARDIS 80MG TAB (telmisartan 80 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9000867,telmisartan 80 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80562,Marketed,2012-01-09,02320177,Teva-Telmisartan,1,C09CA07,Telmisartan,Tablet,Oral,02320177,TEVA-TELMISARTAN (telmisartan 40 mg oral tablet) TEVA CANADA LIMITED,Active,9000866,telmisartan 40 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80563,Marketed,2012-01-09,02320185,Teva-Telmisartan,1,C09CA07,Telmisartan,Tablet,Oral,02320185,TEVA-TELMISARTAN (telmisartan 80 mg oral tablet) TEVA CANADA LIMITED,Active,9000867,telmisartan 80 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86141,Marketed,2012-01-04,02375958,Sandoz Telmisartan,1,C09CA07,Telmisartan,Tablet,Oral,02375958,SANDOZ TELMISARTAN (telmisartan 40 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000866,telmisartan 40 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86142,Marketed,2012-01-04,02375966,Sandoz Telmisartan,1,C09CA07,Telmisartan,Tablet,Oral,02375966,SANDOZ TELMISARTAN (telmisartan 80 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000867,telmisartan 80 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87235,Marketed,2020-12-29,02386755,JAMP Telmisartan,1,C09CA07,Telmisartan,Tablet,Oral,02386755,JAMP TELMISARTAN (telmisartan 40 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000866,telmisartan 40 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87236,Marketed,2020-12-29,02386763,JAMP Telmisartan,1,C09CA07,Telmisartan,Tablet,Oral,02386763,JAMP TELMISARTAN (telmisartan 80 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000867,telmisartan 80 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87447,Marketed,2023-08-29,02388944,Telmisartan,1,C09CA07,Telmisartan,Tablet,Oral,02388944,TELMISARTAN (telmisartan 40 mg oral tablet) SANIS HEALTH INC,Active,9000866,telmisartan 40 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87448,Marketed,2023-08-29,02388952,Telmisartan,1,C09CA07,Telmisartan,Tablet,Oral,02388952,TELMISARTAN (telmisartan 80 mg oral tablet) SANIS HEALTH INC,Active,9000867,telmisartan 80 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87579,Marketed,2025-07-23,02390345,Telmisartan,1,C09CA07,Telmisartan,Tablet,Oral,02390345,TELMISARTAN (telmisartan 40 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000866,telmisartan 40 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87580,Marketed,2025-07-23,02390353,Telmisartan,1,C09CA07,Telmisartan,Tablet,Oral,02390353,TELMISARTAN (telmisartan 80 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000867,telmisartan 80 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88034,Marketed,2012-11-22,02395223,Telmisartan,1,C09CA07,Telmisartan,Tablet,Oral,02395223,TELMISARTAN (telmisartan 40 mg oral tablet) PRO DOC LIMITEE,Active,9000866,telmisartan 40 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88035,Marketed,2012-11-22,02395231,Telmisartan,1,C09CA07,Telmisartan,Tablet,Oral,02395231,TELMISARTAN (telmisartan 80 mg oral tablet) PRO DOC LIMITEE,Active,9000867,telmisartan 80 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89217,Marketed,2023-04-14,02407485,ACH-Telmisartan,1,C09CA07,Telmisartan,Tablet,Oral,02407485,ACH-TELMISARTAN (telmisartan 40 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000866,telmisartan 40 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89218,Marketed,2022-08-03,02407493,ACH-Telmisartan,1,C09CA07,Telmisartan,Tablet,Oral,02407493,ACH-TELMISARTAN (telmisartan 80 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000867,telmisartan 80 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94012,Marketed,2016-04-08,02453568,Auro-Telmisartan,1,C09CA07,Telmisartan,Tablet,Oral,02453568,AURO-TELMISARTAN (telmisartan 40 mg oral tablet) AURO PHARMA INC,Active,9000866,telmisartan 40 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94013,Marketed,2016-04-08,02453576,Auro-Telmisartan,1,C09CA07,Telmisartan,Tablet,Oral,02453576,AURO-TELMISARTAN (telmisartan 80 mg oral tablet) AURO PHARMA INC,Active,9000867,telmisartan 80 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97483,Marketed,2021-10-12,02484536,AG-Telmisartan,1,C09CA07,Telmisartan,Tablet,Oral,02484536,AG-TELMISARTAN (telmisartan 40 mg oral tablet) ANGITA PHARMA INC.,Active,9000866,telmisartan 40 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97484,Marketed,2021-10-12,02484544,AG-Telmisartan,1,C09CA07,Telmisartan,Tablet,Oral,02484544,AG-TELMISARTAN (telmisartan 80 mg oral tablet) ANGITA PHARMA INC.,Active,9000867,telmisartan 80 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97657,Marketed,2020-04-16,02486369,Mint-Telmisartan,1,C09CA07,Telmisartan,Tablet,Oral,02486369,MINT-TELMISARTAN (telmisartan 40 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000866,telmisartan 40 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97658,Marketed,2020-03-18,02486377,Mint-Telmisartan,1,C09CA07,Telmisartan,Tablet,Oral,02486377,MINT-TELMISARTAN (telmisartan 80 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000867,telmisartan 80 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98935,Marketed,2021-03-25,02499622,PMS-Telmisartan,1,C09CA07,Telmisartan,Tablet,Oral,02499622,PMS-TELMISARTAN (telmisartan 40 mg oral tablet) PHARMASCIENCE INC,Active,9000866,telmisartan 40 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98936,Marketed,2021-03-25,02499630,PMS-Telmisartan,1,C09CA07,Telmisartan,Tablet,Oral,02499630,PMS-TELMISARTAN (telmisartan 80 mg oral tablet) PHARMASCIENCE INC,Active,9000867,telmisartan 80 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99323,Marketed,2024-10-16,02503794,Nra-Telmisartan,1,C09CA07,Telmisartan,Tablet,Oral,02503794,NRA-TELMISARTAN (telmisartan 40 mg oral tablet) NORA PHARMA INC,Active,9000866,telmisartan 40 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99324,Marketed,2024-10-16,02503808,Nra-Telmisartan,1,C09CA07,Telmisartan,Tablet,Oral,02503808,NRA-TELMISARTAN (telmisartan 80 mg oral tablet) NORA PHARMA INC,Active,9000867,telmisartan 80 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106296,Marketed,2025-11-13,02559854,Riva-Telmisartan/amLODIPine,2,C09DB04,Telmisartan and amlodipine,Tablet,Oral,02559854,RIVA-TELMISARTAN/AMLODIPINE (amlodipine (amlodipine besylate) 5 mg and telmisartan 40 mg oral tablet) LABORATOIRE RIVA INC.,Active,9004910,amlodipine (amlodipine besylate) 5 mg and telmisartan 40 mg oral tablet,8000985,amlodipine and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106297,Marketed,2025-10-21,02559862,Riva-Telmisartan/amLODIPine,2,C09DB04,Telmisartan and amlodipine,Tablet,Oral,02559862,RIVA-TELMISARTAN/AMLODIPINE (amlodipine (amlodipine besylate) 10 mg and telmisartan 40 mg oral tablet) LABORATOIRE RIVA INC.,Active,9004908,amlodipine (amlodipine besylate) 10 mg and telmisartan 40 mg oral tablet,8000985,amlodipine and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106298,Marketed,2025-10-21,02559870,Riva-Telmisartan/amLODIPine,2,C09DB04,Telmisartan and amlodipine,Tablet,Oral,02559870,RIVA-TELMISARTAN/AMLODIPINE (amlodipine (amlodipine besylate) 5 mg and telmisartan 80 mg oral tablet) LABORATOIRE RIVA INC.,Active,9004911,amlodipine (amlodipine besylate) 5 mg and telmisartan 80 mg oral tablet,8000985,amlodipine and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106299,Marketed,2025-10-21,02559889,Riva-Telmisartan/amLODIPine,2,C09DB04,Telmisartan and amlodipine,Tablet,Oral,02559889,RIVA-TELMISARTAN/AMLODIPINE (amlodipine (amlodipine besylate) 10 mg and telmisartan 80 mg oral tablet) LABORATOIRE RIVA INC.,Active,9004909,amlodipine (amlodipine besylate) 10 mg and telmisartan 80 mg oral tablet,8000985,amlodipine and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85622,Marketed,2011-08-11,02371022,Twynsta,2,C09DB04,Telmisartan and amlodipine,Tablet,Oral,02371022,TWYNSTA (amlodipine (amlodipine besylate) 5 mg and telmisartan 40 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9004910,amlodipine (amlodipine besylate) 5 mg and telmisartan 40 mg oral tablet,8000985,amlodipine and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85623,Marketed,2011-08-11,02371030,Twynsta,2,C09DB04,Telmisartan and amlodipine,Tablet,Oral,02371030,TWYNSTA (amlodipine (amlodipine besylate) 10 mg and telmisartan 40 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9004908,amlodipine (amlodipine besylate) 10 mg and telmisartan 40 mg oral tablet,8000985,amlodipine and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85624,Marketed,2011-08-11,02371049,Twynsta,2,C09DB04,Telmisartan and amlodipine,Tablet,Oral,02371049,TWYNSTA (amlodipine (amlodipine besylate) 5 mg and telmisartan 80 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9004911,amlodipine (amlodipine besylate) 5 mg and telmisartan 80 mg oral tablet,8000985,amlodipine and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85625,Marketed,2011-08-11,02371057,Twynsta,2,C09DB04,Telmisartan and amlodipine,Tablet,Oral,02371057,TWYNSTA (amlodipine (amlodipine besylate) 10 mg and telmisartan 80 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9004909,amlodipine (amlodipine besylate) 10 mg and telmisartan 80 mg oral tablet,8000985,amlodipine and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
68312,Marketed,2001-08-16,02244344,Micardis Plus,2,C09DA07,Telmisartan and diuretics,Tablet,Oral,02244344,MICARDIS PLUS (hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9000950,hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80418,Marketed,2008-12-02,02318709,Micardis Plus,2,C09DA07,Telmisartan and diuretics,Tablet,Oral,02318709,MICARDIS PLUS (hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9001261,hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
81603,Marketed,2012-02-16,02330288,Teva-Telmisartan HCTZ,2,C09DA07,Telmisartan and diuretics,Tablet,Oral,02330288,TEVA-TELMISARTAN HCTZ (hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet) TEVA CANADA LIMITED,Active,9000950,hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86513,Marketed,2012-02-06,02379252,Teva-Telmisartan HCTZ,2,C09DA07,Telmisartan and diuretics,Tablet,Oral,02379252,TEVA-TELMISARTAN HCTZ (hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet) TEVA CANADA LIMITED,Active,9001261,hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87541,Marketed,2020-12-29,02389940,JAMP Telmisartan-HCTZ,2,C09DA07,Telmisartan and diuretics,Tablet,Oral,02389940,JAMP TELMISARTAN-HCT (hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000950,hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87542,Marketed,2020-12-29,02389959,JAMP Telmisartan-HCTZ,2,C09DA07,Telmisartan and diuretics,Tablet,Oral,02389959,JAMP TELMISARTAN-HCT (hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001261,hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87575,Marketed,2025-08-14,02390302,Telmisartan HCTZ,2,C09DA07,Telmisartan and diuretics,Tablet,Oral,02390302,TELMISARTAN HCTZ (hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000950,hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87576,Marketed,2025-08-14,02390310,Telmisartan HCTZ,2,C09DA07,Telmisartan and diuretics,Tablet,Oral,02390310,TELMISARTAN HCTZ (hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001261,hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87877,Marketed,2012-09-28,02393557,Sandoz Telmisartan HCTZ,2,C09DA07,Telmisartan and diuretics,Tablet,Oral,02393557,SANDOZ TELMISARTAN HCT (hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000950,hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87878,Marketed,2012-09-28,02393565,Sandoz Telmisartan HCTZ,2,C09DA07,Telmisartan and diuretics,Tablet,Oral,02393565,SANDOZ TELMISARTAN HCT (hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001261,hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88046,Marketed,2012-11-12,02395355,Telmisartan/HCTZ,2,C09DA07,Telmisartan and diuretics,Tablet,Oral,02395355,TELMISARTAN/HCTZ (hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet) SANIS HEALTH INC,Active,9000950,hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88047,Marketed,2012-11-12,02395363,Telmisartan/HCTZ,2,C09DA07,Telmisartan and diuretics,Tablet,Oral,02395363,TELMISARTAN/HCTZ (hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet) SANIS HEALTH INC,Active,9001261,hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88061,Marketed,2025-05-29,02395525,Pro-Telmisartan-HCTZ,2,C09DA07,Telmisartan and diuretics,Tablet,Oral,02395525,PRO-TELMISARTAN-HCTZ (hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet) PRO DOC LIMITEE,Active,9000950,hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88062,Marketed,2025-05-29,02395533,Pro-Telmisartan-HCTZ,2,C09DA07,Telmisartan and diuretics,Tablet,Oral,02395533,PRO-TELMISARTAN-HCTZ (hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet) PRO DOC LIMITEE,Active,9001261,hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90365,Marketed,2014-11-24,02419114,ACH-Telmisartan HCTZ,2,C09DA07,Telmisartan and diuretics,Tablet,Oral,02419114,ACH-TELMISARTAN HCTZ (hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000950,hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90366,Marketed,2014-11-24,02419122,ACH-Telmisartan HCTZ,2,C09DA07,Telmisartan and diuretics,Tablet,Oral,02419122,ACH-TELMISARTAN HCTZ (hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001261,hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94325,Marketed,2016-08-23,02456389,Auro-Telmisartan HCTZ,2,C09DA07,Telmisartan and diuretics,Tablet,Oral,02456389,AURO-TELMISARTAN HCTZ (hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet) AURO PHARMA INC,Active,9000950,hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94326,Marketed,2016-08-23,02456397,Auro-Telmisartan HCTZ,2,C09DA07,Telmisartan and diuretics,Tablet,Oral,02456397,AURO-TELMISARTAN HCTZ (hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet) AURO PHARMA INC,Active,9001261,hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97487,Marketed,2022-09-07,02484579,Ag Telmisartan-HCTZ,2,C09DA07,Telmisartan and diuretics,Tablet,Oral,02484579,AG TELMISARTAN-HCT (hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet) ANGITA PHARMA INC.,Active,9001261,hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99357,Marketed,2024-10-16,02504138,Nra-Telmisartan/HCTZ,2,C09DA07,Telmisartan and diuretics,Tablet,Oral,02504138,NRA-TELMISARTAN/HCTZ (hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet) NORA PHARMA INC,Active,9001261,hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99358,Marketed,2024-10-16,02504146,Nra-Telmisartan/HCTZ,2,C09DA07,Telmisartan and diuretics,Tablet,Oral,02504146,NRA-TELMISARTAN/HCTZ (hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet) NORA PHARMA INC,Active,9000950,hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97200,Marketed,2024-07-02,02481553,Xermelo,1,A16AX15,Telotristat,Tablet,Oral,02481553,XERMELO (telotristat ethyl (telotristat etiprate) 250 mg oral tablet) SERB SAS,Active,9013754,telotristat ethyl (telotristat etiprate) 250 mg oral tablet,8002213,telotristat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
5616,Marketed,2018-01-31,00604453,Restoril,1,N05CD07,Temazepam,Capsule,Oral,00604453,RESTORIL (temazepam 15 mg oral capsule) AA PHARMA INC,Active,9000157,temazepam 15 mg oral capsule,8000087,temazepam,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Targeted Substances (CDSA IV)
5618,Marketed,2018-03-06,00604461,Restoril,1,N05CD07,Temazepam,Capsule,Oral,00604461,RESTORIL (temazepam 30 mg oral capsule) AA PHARMA INC,Active,9000158,temazepam 30 mg oral capsule,8000087,temazepam,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Targeted Substances (CDSA IV)
100615,Marketed,2022-07-27,02516799,JAMP Temozolomide,1,L01AX03,Temozolomide,Capsule,Oral,02516799,JAMP TEMOZOLOMIDE (temozolomide 5 mg oral capsule) JAMP PHARMA CORPORATION,Active,9003435,temozolomide 5 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
100616,Marketed,2022-08-05,02516802,JAMP Temozolomide,1,L01AX03,Temozolomide,Capsule,Oral,02516802,JAMP TEMOZOLOMIDE (temozolomide 20 mg oral capsule) JAMP PHARMA CORPORATION,Active,9003433,temozolomide 20 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
100617,Marketed,2022-07-25,02516810,JAMP Temozolomide,1,L01AX03,Temozolomide,Capsule,Oral,02516810,JAMP TEMOZOLOMIDE (temozolomide 100 mg oral capsule) JAMP PHARMA CORPORATION,Active,9003432,temozolomide 100 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
100618,Marketed,2022-07-26,02516829,JAMP Temozolomide,1,L01AX03,Temozolomide,Capsule,Oral,02516829,JAMP TEMOZOLOMIDE (temozolomide 140 mg oral capsule) JAMP PHARMA CORPORATION,Active,9004517,temozolomide 140 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
100620,Marketed,2022-07-26,02516845,JAMP Temozolomide,1,L01AX03,Temozolomide,Capsule,Oral,02516845,JAMP TEMOZOLOMIDE (temozolomide 250 mg oral capsule) JAMP PHARMA CORPORATION,Active,9003434,temozolomide 250 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
64696,Marketed,2012-03-15,02241093,Temodal,1,L01AX03,Temozolomide,Capsule,Oral,02241093,TEMODAL (temozolomide 5 mg oral capsule) MERCK CANADA INC,Active,9003435,temozolomide 5 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
64697,Marketed,2012-03-13,02241094,Temodal,1,L01AX03,Temozolomide,Capsule,Oral,02241094,TEMODAL (temozolomide 20 mg oral capsule) MERCK CANADA INC,Active,9003433,temozolomide 20 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
64698,Marketed,2012-03-28,02241095,Temodal,1,L01AX03,Temozolomide,Capsule,Oral,02241095,TEMODAL (temozolomide 100 mg oral capsule) MERCK CANADA INC,Active,9003432,temozolomide 100 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
64699,Marketed,2012-03-21,02241096,Temodal,1,L01AX03,Temozolomide,Capsule,Oral,02241096,TEMODAL (temozolomide 250 mg oral capsule) MERCK CANADA INC,Active,9003434,temozolomide 250 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
79831,Marketed,2012-03-23,02312794,Temodal,1,L01AX03,Temozolomide,Capsule,Oral,02312794,TEMODAL (temozolomide 140 mg oral capsule) MERCK CANADA INC,Active,9004517,temozolomide 140 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
87529,Marketed,2014-07-24,02389819,ACH-Temozolomide,1,L01AX03,Temozolomide,Capsule,Oral,02389819,ACH-TEMOZOLOMIDE (temozolomide 20 mg oral capsule) ACCORD HEALTHCARE INC,Active,9003433,temozolomide 20 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
87530,Marketed,2014-07-24,02389827,ACH-Temozolomide,1,L01AX03,Temozolomide,Capsule,Oral,02389827,ACH-TEMOZOLOMIDE (temozolomide 100 mg oral capsule) ACCORD HEALTHCARE INC,Active,9003432,temozolomide 100 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
87531,Marketed,2014-07-24,02389835,ACH-Temozolomide,1,L01AX03,Temozolomide,Capsule,Oral,02389835,ACH-TEMOZOLOMIDE (temozolomide 140 mg oral capsule) ACCORD HEALTHCARE INC,Active,9004517,temozolomide 140 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
87533,Marketed,2014-07-24,02389851,ACH-Temozolomide,1,L01AX03,Temozolomide,Capsule,Oral,02389851,ACH-TEMOZOLOMIDE (temozolomide 250 mg oral capsule) ACCORD HEALTHCARE INC,Active,9003434,temozolomide 250 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
88038,Marketed,2021-10-19,02395274,Teva-Temozolomide,1,L01AX03,Temozolomide,Capsule,Oral,02395274,TEVA-TEMOZOLOMIDE (temozolomide 20 mg oral capsule) TEVA CANADA LIMITED,Active,9003433,temozolomide 20 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
88039,Marketed,2021-10-19,02395282,Teva-Temozolomide,1,L01AX03,Temozolomide,Capsule,Oral,02395282,TEVA-TEMOZOLOMIDE (temozolomide 100 mg oral capsule) TEVA CANADA LIMITED,Active,9003432,temozolomide 100 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
88040,Marketed,2021-10-19,02395290,Teva-Temozolomide,1,L01AX03,Temozolomide,Capsule,Oral,02395290,TEVA-TEMOZOLOMIDE (temozolomide 140 mg oral capsule) TEVA CANADA LIMITED,Active,9004517,temozolomide 140 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
88042,Marketed,2021-10-19,02395312,Teva-Temozolomide,1,L01AX03,Temozolomide,Capsule,Oral,02395312,TEVA-TEMOZOLOMIDE (temozolomide 250 mg oral capsule) TEVA CANADA LIMITED,Active,9003434,temozolomide 250 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
92249,Marketed,2016-01-13,02438119,ACH-Temozolomide,1,L01AX03,Temozolomide,Capsule,Oral,02438119,ACH-TEMOZOLOMIDE (temozolomide 5 mg oral capsule) ACCORD HEALTHCARE INC,Active,9003435,temozolomide 5 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
92553,Marketed,2021-10-19,02441160,Teva-Temozolomide,1,L01AX03,Temozolomide,Capsule,Oral,02441160,TEVA-TEMOZOLOMIDE (temozolomide 5 mg oral capsule) TEVA CANADA LIMITED,Active,9003435,temozolomide 5 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
92817,Marketed,2015-07-23,02443473,Taro-Temozolomide,1,L01AX03,Temozolomide,Capsule,Oral,02443473,TARO-TEMOZOLOMIDE (temozolomide 5 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9003435,temozolomide 5 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
92818,Marketed,2015-07-23,02443481,Taro-Temozolomide,1,L01AX03,Temozolomide,Capsule,Oral,02443481,TARO-TEMOZOLOMIDE (temozolomide 20 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9003433,temozolomide 20 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
92820,Marketed,2015-07-23,02443511,Taro-Temozolomide,1,L01AX03,Temozolomide,Capsule,Oral,02443511,TARO-TEMOZOLOMIDE (temozolomide 100 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9003432,temozolomide 100 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
92821,Marketed,2015-07-23,02443538,Taro-Temozolomide,1,L01AX03,Temozolomide,Capsule,Oral,02443538,TARO-TEMOZOLOMIDE (temozolomide 140 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9004517,temozolomide 140 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
92823,Marketed,2015-07-23,02443554,Taro-Temozolomide,1,L01AX03,Temozolomide,Capsule,Oral,02443554,TARO-TEMOZOLOMIDE (temozolomide 250 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9003434,temozolomide 250 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
78941,Marketed,2011-07-11,02304104,Torisel,1,L01EG01,Temsirolimus,Solution,Intravenous,02304104,TORISEL (temsirolimus 30 mg per 1.2 mL solution for injection vial with diluent solution) PFIZER CANADA ULC,Active,9013024,temsirolimus 30 mg per 1.2 mL solution for injection vial with diluent solution,8001686,temsirolimus,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
98784,Marketed,2020-11-23,02498049,Ibsrela,1,A06AX08,Tenapanor,Tablet,Oral,02498049,IBSRELA (tenapanor (tenapanor hydrochloride) 50 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9014407,tenapanor (tenapanor hydrochloride) 50 mg oral tablet,8002351,tenapanor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
68816,Marketed,2001-10-18,02244826,Tnkase,1,B01AD11,Tenecteplase,Powder for solution,Intravenous,02244826,TNKASE (tenecteplase 50 mg per vial powder for solution for injection with diluent solution) HOFFMANN-LA ROCHE LIMITED,Active,9013357,tenecteplase 50 mg per vial powder for solution for injection with diluent solution,8001954,tenecteplase,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
68816,Marketed,2001-10-18,02244826,Tnkase,1,B01AD11,Tenecteplase,Powder for solution,Intravenous,02244826,TNKASE (tenecteplase 50 mg per vial powder for solution for injection with diluent solution) HOFFMANN-LA ROCHE LIMITED,Active,9013357,tenecteplase 50 mg per vial powder for solution for injection with diluent solution,8001954,tenecteplase,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
95241,Marketed,2017-06-20,02464241,Vemlidy,1,J05AF13,Tenofovir alafenamide,Tablet,Oral,02464241,VEMLIDY (tenofovir alafenamide (tenofovir alafenamide hemifumarate) 25 mg oral tablet) GILEAD SCIENCES CANADA INC,Active,9006196,tenofovir alafenamide (tenofovir alafenamide hemifumarate) 25 mg oral tablet,8001236,tenofovir alafenamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100162,Marketed,2021-08-20,02512327,Tenofovir,1,J05AF07,Tenofovir disoproxil,Tablet,Oral,02512327,TENOFOVIR (tenofovir disoproxil fumarate 300 mg oral tablet) SANIS HEALTH INC,Active,9003883,tenofovir disoproxil fumarate 300 mg oral tablet,8001237,tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100218,Marketed,2021-09-07,02512939,Mint-Tenofovir,1,J05AF07,Tenofovir disoproxil,Tablet,Oral,02512939,MINT-TENOFOVIR (tenofovir disoproxil fumarate 300 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9003883,tenofovir disoproxil fumarate 300 mg oral tablet,8001237,tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100454,Marketed,2021-06-14,02515156,Riva-Tenofovir,1,J05AF07,Tenofovir disoproxil,Tablet,Oral,02515156,RIVA-TENOFOVIR (tenofovir disoproxil fumarate 300 mg oral tablet) LABORATOIRE RIVA INC.,Active,9003883,tenofovir disoproxil fumarate 300 mg oral tablet,8001237,tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100563,Marketed,2022-06-09,02516276,AG-Tenofovir,1,J05AF07,Tenofovir disoproxil,Tablet,Oral,02516276,AG-TENOFOVIR (tenofovir disoproxil fumarate 300 mg oral tablet) ANGITA PHARMA INC.,Active,9003883,tenofovir disoproxil fumarate 300 mg oral tablet,8001237,tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101297,Marketed,2026-03-04,02523922,Tenofovir,1,J05AF07,Tenofovir disoproxil,Tablet,Oral,02523922,TENOFOVIR (tenofovir disoproxil fumarate 300 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9003883,tenofovir disoproxil fumarate 300 mg oral tablet,8001237,tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71368,Marketed,2009-05-21,02247128,Viread,1,J05AF07,Tenofovir disoproxil,Tablet,Oral,02247128,VIREAD (tenofovir disoproxil fumarate 300 mg oral tablet) GILEAD SCIENCES CANADA INC,Active,9003883,tenofovir disoproxil fumarate 300 mg oral tablet,8001237,tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88865,Marketed,2017-07-26,02403889,Teva-Tenofovir,1,J05AF07,Tenofovir disoproxil,Tablet,Oral,02403889,TEVA-TENOFOVIR (tenofovir disoproxil fumarate 300 mg oral tablet) TEVA CANADA LIMITED,Active,9003883,tenofovir disoproxil fumarate 300 mg oral tablet,8001237,tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93838,Marketed,2017-07-26,02451980,Apo-Tenofovir,1,J05AF07,Tenofovir disoproxil,Tablet,Oral,02451980,APO-TENOFOVIR (tenofovir disoproxil fumarate 300 mg oral tablet) APOTEX INC,Active,9003883,tenofovir disoproxil fumarate 300 mg oral tablet,8001237,tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93899,Marketed,2017-07-31,02452634,Mylan-Tenofovir Disoproxil,1,J05AF07,Tenofovir disoproxil,Tablet,Oral,02452634,MYLAN-TENOFOVIR DISOPROXIL (tenofovir disoproxil fumarate 300 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9003883,tenofovir disoproxil fumarate 300 mg oral tablet,8001237,tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94047,Marketed,2018-04-25,02453940,PMS-Tenofovir,1,J05AF07,Tenofovir disoproxil,Tablet,Oral,02453940,PMS-TENOFOVIR (tenofovir disoproxil fumarate 300 mg oral tablet) PHARMASCIENCE INC,Active,9003883,tenofovir disoproxil fumarate 300 mg oral tablet,8001237,tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94747,Marketed,2017-07-26,02460173,Auro-Tenofovir,1,J05AF07,Tenofovir disoproxil,Tablet,Oral,02460173,AURO-TENOFOVIR (tenofovir disoproxil fumarate 300 mg oral tablet) AURO PHARMA INC,Active,9003883,tenofovir disoproxil fumarate 300 mg oral tablet,8001237,tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96182,Marketed,2018-03-15,02472511,Nat-Tenofovir,1,J05AF07,Tenofovir disoproxil,Tablet,Oral,02472511,NAT-TENOFOVIR (tenofovir disoproxil fumarate 300 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9003883,tenofovir disoproxil fumarate 300 mg oral tablet,8001237,tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96979,Marketed,2018-10-24,02479087,JAMP-Tenofovir,1,J05AF07,Tenofovir disoproxil,Tablet,Oral,02479087,JAMP-TENOFOVIR (tenofovir disoproxil fumarate 300 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003883,tenofovir disoproxil fumarate 300 mg oral tablet,8001237,tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101073,Marketed,2022-08-11,02521547,Mint-Emtricitabine/Tenofovir,2,J05AR03,Tenofovir disoproxil and emtricitabine,Tablet,Oral,02521547,MINT-EMTRICITABINE/TENOFOVIR (emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9004149,emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet,8001198,emtricitabine and tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76043,Marketed,2009-05-21,02274906,Truvada,2,J05AR03,Tenofovir disoproxil and emtricitabine,Tablet,Oral,02274906,TRUVADA (emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet) GILEAD SCIENCES CANADA INC,Active,9004149,emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet,8001198,emtricitabine and tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88396,Marketed,2017-07-26,02399059,Teva-Emtricitabine/Tenofovir,2,J05AR03,Tenofovir disoproxil and emtricitabine,Tablet,Oral,02399059,TEVA-EMTRICITABINE/TENOFOVIR (emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet) TEVA CANADA LIMITED,Active,9004149,emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet,8001198,emtricitabine and tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92868,Marketed,2017-07-31,02443902,Mylan-Emtricitabine/Tenofovir Disoproxil,2,J05AR03,Tenofovir disoproxil and emtricitabine,Tablet,Oral,02443902,MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL (emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9004149,emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet,8001198,emtricitabine and tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93840,Marketed,2017-07-26,02452006,Apo-Emtricitabine-Tenofovir,2,J05AR03,Tenofovir disoproxil and emtricitabine,Tablet,Oral,02452006,APO-EMTRICITABINE-TENOFOVIR (emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet) APOTEX INC,Active,9004149,emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet,8001198,emtricitabine and tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94861,Marketed,2019-09-12,02461110,PMS-Emtricitabine-Tenofovir,2,J05AR03,Tenofovir disoproxil and emtricitabine,Tablet,Oral,02461110,PMS-EMTRICITABINE-TENOFOVIR (emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet) PHARMASCIENCE INC,Active,9004149,emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet,8001198,emtricitabine and tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97716,Marketed,2019-07-23,02487012,JAMP Emtricitabine/Tenofovir Disoproxil Fumarate,2,J05AR03,Tenofovir disoproxil and emtricitabine,Tablet,Oral,02487012,JAMP EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE (emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004149,emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet,8001198,emtricitabine and tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98074,Marketed,2023-03-01,02490684,Auro-Emtricitabine-Tenofovir,2,J05AR03,Tenofovir disoproxil and emtricitabine,Tablet,Oral,02490684,AURO-EMTRICITABINE-TENOFOVIR (emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet) AURO PHARMA INC,Active,9004149,emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet,8001198,emtricitabine and tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98623,Marketed,2020-11-09,02496356,AG-Emtricitabine / Tenofovir Disoproxil Fumarate,2,J05AR03,Tenofovir disoproxil and emtricitabine,Tablet,Oral,02496356,AG-EMTRICITABINE / TENOFOVIR DISOPROXIL FUMARATE (emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet) ANGITA PHARMA INC.,Active,9004149,emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet,8001198,emtricitabine and tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106068,Marketed,2025-08-20,02557347,Tzield,1,A10XX01,Teplizumab,Solution,Intravenous,02557347,TZIELD (teplizumab 2 mg per 2 mL solution for injection vial) SANOFI-AVENTIS CANADA INC,Active,9015260,teplizumab 2 mg per 2 mL solution for injection vial,8002553,teplizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,1.0,,,Schedule D
106068,Marketed,2025-08-20,02557347,Tzield,1,A10XX01,Teplizumab,Solution,Intravenous,02557347,TZIELD (teplizumab 2 mg per 2 mL solution for injection vial) SANOFI-AVENTIS CANADA INC,Active,9015260,teplizumab 2 mg per 2 mL solution for injection vial,8002553,teplizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,1.0,,,Prescription
100568,Marketed,2021-10-07,02516322,Tepmetko,1,L01EP02,Tepotinib,Tablet,Oral,02516322,"TEPMETKO (tepotinib (tepotinib hydrochloride) 225 mg oral tablet) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9014615,tepotinib (tepotinib hydrochloride) 225 mg oral tablet,8002395,tepotinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
106043,Marketed,2026-01-23,02557061,Tepezza,1,L04AG13,Teprotumumab,Powder for solution,Intravenous,02557061,TEPEZZA (teprotumumab 500 mg per vial powder for solution for injection) AMGEN CANADA INC,Active,9015367,teprotumumab 500 mg per vial powder for solution for injection,8002579,teprotumumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,,,,Schedule D
106043,Marketed,2026-01-23,02557061,Tepezza,1,L04AG13,Teprotumumab,Powder for solution,Intravenous,02557061,TEPEZZA (teprotumumab 500 mg per vial powder for solution for injection) AMGEN CANADA INC,Active,9015367,teprotumumab 500 mg per vial powder for solution for injection,8002579,teprotumumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,,,,Prescription
55839,Marketed,2021-09-23,02234502,Apo-Terazosin,1,G04CA03,Terazosin,Tablet,Oral,02234502,APO-TERAZOSIN (terazosin (terazosin hydrochloride) 1 mg oral tablet) APOTEX INC,Active,9000749,terazosin (terazosin hydrochloride) 1 mg oral tablet,8000247,terazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
55840,Marketed,2021-09-23,02234503,Apo-Terazosin,1,G04CA03,Terazosin,Tablet,Oral,02234503,APO-TERAZOSIN (terazosin (terazosin hydrochloride) 2 mg oral tablet) APOTEX INC,Active,9000750,terazosin (terazosin hydrochloride) 2 mg oral tablet,8000247,terazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
55841,Marketed,2021-09-23,02234504,Apo-Terazosin,1,G04CA03,Terazosin,Tablet,Oral,02234504,APO-TERAZOSIN (terazosin (terazosin hydrochloride) 5 mg oral tablet) APOTEX INC,Active,9000751,terazosin (terazosin hydrochloride) 5 mg oral tablet,8000247,terazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
55842,Marketed,2021-09-23,02234505,Apo-Terazosin,1,G04CA03,Terazosin,Tablet,Oral,02234505,APO-TERAZOSIN (terazosin (terazosin hydrochloride) 10 mg oral tablet) APOTEX INC,Active,9000748,terazosin (terazosin hydrochloride) 10 mg oral tablet,8000247,terazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
67437,Marketed,2001-02-23,02243518,PMS-Terazosin,1,G04CA03,Terazosin,Tablet,Oral,02243518,PMS-TERAZOSIN (terazosin (terazosin hydrochloride) 1 mg oral tablet) PHARMASCIENCE INC,Active,9000749,terazosin (terazosin hydrochloride) 1 mg oral tablet,8000247,terazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
67438,Marketed,2001-02-23,02243519,PMS-Terazosin,1,G04CA03,Terazosin,Tablet,Oral,02243519,PMS-TERAZOSIN (terazosin (terazosin hydrochloride) 2 mg oral tablet) PHARMASCIENCE INC,Active,9000750,terazosin (terazosin hydrochloride) 2 mg oral tablet,8000247,terazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
67439,Marketed,2001-02-23,02243520,PMS-Terazosin,1,G04CA03,Terazosin,Tablet,Oral,02243520,PMS-TERAZOSIN (terazosin (terazosin hydrochloride) 5 mg oral tablet) PHARMASCIENCE INC,Active,9000751,terazosin (terazosin hydrochloride) 5 mg oral tablet,8000247,terazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
67440,Marketed,2001-02-23,02243521,PMS-Terazosin,1,G04CA03,Terazosin,Tablet,Oral,02243521,PMS-TERAZOSIN (terazosin (terazosin hydrochloride) 10 mg oral tablet) PHARMASCIENCE INC,Active,9000748,terazosin (terazosin hydrochloride) 10 mg oral tablet,8000247,terazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
14532,Marketed,1999-02-23,02031094,Lamisil,1,D01AE15,Terbinafine,Cream,Topical,02031094,LAMISIL (terbinafine hydrochloride 1 % cutaneous cream) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9000494,terbinafine hydrochloride 1 % cutaneous cream,8000188,terbinafine,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
62135,Marketed,1999-01-05,02238703,Lamisil,1,D01AE15,Terbinafine,Spray,Topical,02238703,LAMISIL (terbinafine hydrochloride 1 % cutaneous spray) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9000832,terbinafine hydrochloride 1 % cutaneous spray,8000188,terbinafine,448598008,Cutaneous,421720008,Spray,,,,,,Prescription
63385,Marketed,2020-08-04,02239893,Apo-Terbinafine,1,D01BA02,Terbinafine,Tablet,Oral,02239893,APO-TERBINAFINE (terbinafine (terbinafine hydrochloride) 250 mg oral tablet) APOTEX INC,Active,9000495,terbinafine (terbinafine hydrochloride) 250 mg oral tablet,8000188,terbinafine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
66543,Marketed,2008-03-07,02242735,Terbinafine-250,1,D01BA02,Terbinafine,Tablet,Oral,02242735,TERBINAFINE-250 (terbinafine (terbinafine hydrochloride) 250 mg oral tablet) PRO DOC LIMITEE,Active,9000495,terbinafine (terbinafine hydrochloride) 250 mg oral tablet,8000188,terbinafine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
73989,Marketed,2024-12-20,02254727,Teva-Terbinafine,1,D01BA02,Terbinafine,Tablet,Oral,02254727,TEVA-TERBINAFINE (terbinafine (terbinafine hydrochloride) 250 mg oral tablet) TEVA CANADA LIMITED,Active,9000495,terbinafine (terbinafine hydrochloride) 250 mg oral tablet,8000188,terbinafine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77963,Marketed,2009-06-19,02294273,PMS-Terbinafine,1,D01BA02,Terbinafine,Tablet,Oral,02294273,PMS-TERBINAFINE (terbinafine (terbinafine hydrochloride) 250 mg oral tablet) PHARMASCIENCE INC,Active,9000495,terbinafine (terbinafine hydrochloride) 250 mg oral tablet,8000188,terbinafine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80558,Marketed,2011-05-30,02320134,Auro-Terbinafine,1,D01BA02,Terbinafine,Tablet,Oral,02320134,AURO-TERBINAFINE (terbinafine (terbinafine hydrochloride) 250 mg oral tablet) AURO PHARMA INC,Active,9000495,terbinafine (terbinafine hydrochloride) 250 mg oral tablet,8000188,terbinafine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87091,Marketed,2026-05-12,02385279,Terbinafine,1,D01BA02,Terbinafine,Tablet,Oral,02385279,TERBINAFINE (terbinafine (terbinafine hydrochloride) 250 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000495,terbinafine (terbinafine hydrochloride) 250 mg oral tablet,8000188,terbinafine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
10665,Marketed,2024-08-09,00786616,Bricanyl Turbuhaler,1,R03AC03,Terbutaline,Powder,Inhalation,00786616,BRICANYL TURBUHALER (terbutaline sulfate 0.5 mg per actuation inhalation powder) ASTRAZENECA CANADA INC,Active,9002327,terbutaline sulfate 0.5 mg per actuation inhalation powder,8001088,terbutaline,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
71914,Marketed,2004-09-21,02247651,Taro-Terconazole,1,G01AG02,Terconazole,Cream,Vaginal,02247651,TARO-TERCONAZOLE (terconazole 0.4 % vaginal cream) TARO PHARMACEUTICALS INC,Active,9003956,terconazole 0.4 % vaginal cream,8001420,terconazole,16857009,Vaginal,385165005,Vaginal cream,,,,,,Prescription
101289,Marketed,2022-05-16,02523833,M-Teriflunomide,1,L04AK02,Teriflunomide,Tablet,Oral,02523833,M-TERIFLUNOMIDE (teriflunomide 14 mg oral tablet) MANTRA PHARMA INC,Active,9005367,teriflunomide 14 mg oral tablet,8001687,teriflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99001,Marketed,2022-05-16,02500310,Nat-Teriflunomide,1,L04AK02,Teriflunomide,Tablet,Oral,02500310,NAT-TERIFLUNOMIDE (teriflunomide 14 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9005367,teriflunomide 14 mg oral tablet,8001687,teriflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99011,Marketed,2022-05-16,02500434,PMS-Teriflunomide,1,L04AK02,Teriflunomide,Tablet,Oral,02500434,PMS-TERIFLUNOMIDE (teriflunomide 14 mg oral tablet) PHARMASCIENCE INC,Active,9005367,teriflunomide 14 mg oral tablet,8001687,teriflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99030,Marketed,2022-05-16,02500639,Apo-Teriflunomide,1,L04AK02,Teriflunomide,Tablet,Oral,02500639,APO-TERIFLUNOMIDE (teriflunomide 14 mg oral tablet) APOTEX INC,Active,9005367,teriflunomide 14 mg oral tablet,8001687,teriflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99074,Marketed,2022-05-16,02501090,Teva-Teriflunomide,1,L04AK02,Teriflunomide,Tablet,Oral,02501090,TEVA-TERIFLUNOMIDE (teriflunomide 14 mg oral tablet) TEVA CANADA LIMITED,Active,9005367,teriflunomide 14 mg oral tablet,8001687,teriflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99361,Marketed,2022-05-16,02504170,JAMP Teriflunomide,1,L04AK02,Teriflunomide,Tablet,Oral,02504170,JAMP TERIFLUNOMIDE (teriflunomide 14 mg oral tablet) JAMP PHARMA CORPORATION,Active,9005367,teriflunomide 14 mg oral tablet,8001687,teriflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99522,Marketed,2022-05-16,02505843,Sandoz Teriflunomide,1,L04AK02,Teriflunomide,Tablet,Oral,02505843,SANDOZ TERIFLUNOMIDE (teriflunomide 14 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005367,teriflunomide 14 mg oral tablet,8001687,teriflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
97663,Marketed,2020-07-08,02486423,Teva-Teriparatide Injection,1,H05AA02,Teriparatide,Solution,Subcutaneous,02486423,TEVA-TERIPARATIDE INJECTION (teriparatide (teriparatide acetate) 20 mcg per actuation solution for injection pre-filled pen) TEVA CANADA LIMITED,Active,9014371,teriparatide (teriparatide acetate) 20 mcg per actuation solution for injection pre-filled pen,8001688,teriparatide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation (unit of presentation),,,,Prescription
98548,Marketed,2020-10-27,02495589,Osnuvo,1,H05AA02,Teriparatide,Solution,Subcutaneous,02495589,OSNUVO (teriparatide 600 mcg per 2.4 mL solution for injection cartridge) AVIR PHARMA INC.,Active,9014408,teriparatide 600 mcg per 2.4 mL solution for injection cartridge,8001688,teriparatide,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,1.0,Prescription
98548,Marketed,2020-10-27,02495589,Osnuvo,1,H05AA02,Teriparatide,Solution,Subcutaneous,02495589,OSNUVO (teriparatide 600 mcg per 2.4 mL solution for injection cartridge) AVIR PHARMA INC.,Active,9014408,teriparatide 600 mcg per 2.4 mL solution for injection cartridge,8001688,teriparatide,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,1.0,Schedule D
98854,Marketed,2024-12-04,02498804,Apo-Teriparatide Injection,1,H05AA02,Teriparatide,Solution,Subcutaneous,02498804,APO-TERIPARATIDE INJECTION (teriparatide 20 mcg per actuation solution for injection pre-filled pen) APOTEX INC,Active,9014070,teriparatide 20 mcg per actuation solution for injection pre-filled pen,8001688,teriparatide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation (unit of presentation),,,,Prescription
102510,Marketed,2024-01-30,02536315,"Testosterone Enanthate Injection, USP",1,G03BA03,Testosterone,Solution,Intramuscular,02536315,"TESTOSTERONE ENANTHATE INJECTION, USP (testosterone enanthate 1000 mg per 5 mL solution for injection vial) HIKMA CANADA LIMITED",Active,9015022,testosterone enanthate 1000 mg per 5 mL solution for injection vial,8000006,testosterone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Controlled Drugs (CDSA IV)
106652,Marketed,2026-04-24,02563770,Jatenzo,1,G03BA03,Testosterone,Capsule,Oral,02563770,JATENZO (testosterone undecanoate 158 mg oral capsule) TOLMAR INTERNATIONAL LTD.,Active,9015431,testosterone undecanoate 158 mg oral capsule,8000006,testosterone,26643006,Oral,420692007,Oral capsule,732937005,Capsule,1.0,,,Controlled Drugs (CDSA IV)
106653,Marketed,2026-04-24,02563789,Jatenzo,1,G03BA03,Testosterone,Capsule,Oral,02563789,JATENZO (testosterone undecanoate 198 mg oral capsule) TOLMAR INTERNATIONAL LTD.,Active,9015432,testosterone undecanoate 198 mg oral capsule,8000006,testosterone,26643006,Oral,420692007,Oral capsule,732937005,Capsule,1.0,,,Controlled Drugs (CDSA IV)
106654,Marketed,2026-04-24,02563797,Jatenzo,1,G03BA03,Testosterone,Capsule,Oral,02563797,JATENZO (testosterone undecanoate 237 mg oral capsule) TOLMAR INTERNATIONAL LTD.,Active,9015433,testosterone undecanoate 237 mg oral capsule,8000006,testosterone,26643006,Oral,420692007,Oral capsule,732937005,Capsule,1.0,,,Controlled Drugs (CDSA IV)
69384,Marketed,2016-04-07,02245345,Androgel,1,G03BA03,Testosterone,Gel,Transdermal,02245345,ANDROGEL (testosterone 1 % transdermal gel 2.5 g sachet) BGP PHARMA ULC,Active,9012541,testosterone 1 % transdermal gel 2.5 g sachet,8000006,testosterone,45890007,Transdermal,385100002,Gel,733013000,Sachet (unit of presentation),1.0,,,Controlled Drugs (CDSA IV)
69385,Marketed,2016-04-07,02245346,Androgel,1,G03BA03,Testosterone,Gel,Transdermal,02245346,ANDROGEL (testosterone 1 % transdermal gel 5 g sachet) BGP PHARMA ULC,Active,9012542,testosterone 1 % transdermal gel 5 g sachet,8000006,testosterone,45890007,Transdermal,385100002,Gel,733013000,Sachet (unit of presentation),1.0,,,Controlled Drugs (CDSA IV)
73432,Marketed,2016-04-07,02249499,Androgel,1,G03BA03,Testosterone,Gel,Transdermal,02249499,ANDROGEL (testosterone 12.5 mg per actuation transdermal gel) BGP PHARMA ULC,Active,9012592,testosterone 12.5 mg per actuation transdermal gel,8000006,testosterone,45890007,Transdermal,385100002,Gel,732981002,Actuation (unit of presentation),1.0,,,Controlled Drugs (CDSA IV)
76591,Marketed,2026-01-16,02280248,Testim 1%,1,G03BA03,Testosterone,Gel,Transdermal,02280248,TESTIM 1% (testosterone 1 % transdermal gel 5 g tube) KNIGHT THERAPEUTICS INC.,Active,9012543,testosterone 1 % transdermal gel 5 g tube,8000006,testosterone,45890007,Transdermal,385100002,Gel,,,1.0,,,Controlled Drugs (CDSA IV)
90578,Marketed,2014-09-02,02421186,Taro-Testosterone,1,G03BA03,Testosterone,Capsule,Oral,02421186,TARO-TESTOSTERONE (testosterone undecanoate 40 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9001294,testosterone undecanoate 40 mg oral capsule,8000006,testosterone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Controlled Drugs (CDSA IV)
93671,Marketed,2022-09-15,02450550,Natesto,1,G03BA03,Testosterone,Gel,Nasal,02450550,NATESTO (testosterone 4.5 % nasal gel) ACERUS BIOPHARMA INC,Active,9001458,testosterone 4.5 % nasal gel,8000006,testosterone,46713006,Nasal,385100002,Gel,,,1.0,,,Controlled Drugs (CDSA IV)
95189,Marketed,2017-10-31,02463792,Taro-Testosterone Gel,1,G03BA03,Testosterone,Gel,Transdermal,02463792,TARO-TESTOSTERONE GEL 2.5G/PACKET (testosterone 1 % transdermal gel 2.5 g sachet) TARO PHARMACEUTICALS INC,Active,9012541,testosterone 1 % transdermal gel 2.5 g sachet,8000006,testosterone,45890007,Transdermal,385100002,Gel,733013000,Sachet (unit of presentation),1.0,,,Controlled Drugs (CDSA IV)
95190,Marketed,2017-10-31,02463806,Taro-Testosterone Gel,1,G03BA03,Testosterone,Gel,Transdermal,02463806,TARO-TESTOSTERONE GEL 5G/PACKET (testosterone 1 % transdermal gel 5 g sachet) TARO PHARMACEUTICALS INC,Active,9012542,testosterone 1 % transdermal gel 5 g sachet,8000006,testosterone,45890007,Transdermal,385100002,Gel,733013000,Sachet (unit of presentation),1.0,,,Controlled Drugs (CDSA IV)
98589,Marketed,2020-10-20,02496003,Taro-Testosterone Cypionate Injection,1,G03BA03,Testosterone,Solution,Intramuscular,02496003,TARO-TESTOSTERONE CYPIONATE INJECTION (testosterone cypionate 1000 mg per 10 mL solution for injection vial) TARO PHARMACEUTICALS INC,Active,9000010,testosterone cypionate 1000 mg per 10 mL solution for injection vial,8000006,testosterone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Controlled Drugs (CDSA IV)
5537,Marketed,2004-10-22,00609692,Histatrol,1,V04CL,Tests for allergic diseases,Solution,Percutaneous,,,,,,,,,,,,,,,,,Ethical
5538,Marketed,2004-10-22,00609706,Histatrol,1,V04CL,Tests for allergic diseases,Solution,Intradermal,,,,,,,,,,,,,,,,,Ethical
92393,Marketed,2024-12-18,02439514,Positive Skin Test Control-Histamine,1,V04CL,Tests for allergic diseases,Solution,Percutaneous,,,,,,,,,,,,,,,,,Ethical
95465,Marketed,2017-09-13,02466325,Topical Hapten Gel,1,V04CL,Tests for allergic diseases,Gel,Topical,,,,,,,,,,,,,,,,,Schedule D
95467,Marketed,2017-09-13,02466333,Topical Hapten Gel,1,V04CL,Tests for allergic diseases,Gel,Topical,,,,,,,,,,,,,,,,,Schedule D
95469,Marketed,2017-09-13,02466341,Topical Hapten Liquid,1,V04CL,Tests for allergic diseases,Liquid,Topical,,,,,,,,,,,,,,,,,Schedule D
95470,Marketed,2017-09-13,02466368,Topical Hapten Liquid,1,V04CL,Tests for allergic diseases,Liquid,Topical,,,,,,,,,,,,,,,,,Schedule D
3378,Marketed,2006-06-15,00399736,L-Arginine Hydrochloride Injection,1,V04CD,Tests for pituitary function,Liquid,Intravenous,00399736,L-ARGININE HYDROCHLORIDE INJECTION (arginine hydrochloride 7500 mg per 30 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9014000,arginine hydrochloride 7500 mg per 30 mL solution for injection vial,8002275,arginine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
100930,Marketed,2021-12-13,02520087,Hypertet,1,J06BB02,Tetanus immunoglobulin,Solution,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
101763,Marketed,2024-04-09,02528401,TD Adsorbed,2,J07AM51,"Tetanus toxoid, comb. with diphtheria toxoid",Suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
42959,Marketed,2020-10-02,02199270,Nitoman,1,N07XX06,Tetrabenazine,Tablet,Oral,02199270,"NITOMAN (tetrabenazine 25 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9002981,tetrabenazine 25 mg oral tablet,8001533,tetrabenazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88726,Marketed,2013-02-26,02402424,PMS-Tetrabenazine,1,N07XX06,Tetrabenazine,Tablet,Oral,02402424,PMS-TETRABENAZINE (tetrabenazine 25 mg oral tablet) PHARMASCIENCE INC,Active,9002981,tetrabenazine 25 mg oral tablet,8001533,tetrabenazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89232,Marketed,2013-11-01,02407590,Apo-Tetrabenazine,1,N07XX06,Tetrabenazine,Tablet,Oral,02407590,APO-TETRABENAZINE (tetrabenazine 25 mg oral tablet) APOTEX INC,Active,9002981,tetrabenazine 25 mg oral tablet,8001533,tetrabenazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
18749,Marketed,2023-02-07,02148544,Minims Tetracaine Hydrochloride,1,S01HA03,Tetracaine,Drops,Ophthalmic,02148544,MINIMS TETRACAINE HYDROCHLORIDE (tetracaine hydrochloride 1 % ophthalmic drops) BAUSCH & LOMB INC,Active,9002878,tetracaine hydrochloride 1 % ophthalmic drops,8001956,tetracaine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Ethical
18751,Marketed,2023-02-07,02148528,Minims Tetracaine Hydrochloride,1,S01HA03,Tetracaine,Drops,Ophthalmic,02148528,MINIMS TETRACAINE HYDROCHLORIDE (tetracaine hydrochloride 0.5 % ophthalmic drops) BAUSCH & LOMB INC,Active,9002877,tetracaine hydrochloride 0.5 % ophthalmic drops,8001956,tetracaine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Ethical
49664,Marketed,2020-07-09,02230575,Ametop Gel 4%,1,D04AB06,Tetracaine,Gel,Topical,02230575,AMETOP GEL 4% (tetracaine (tetracaine hydrochloride) 40 mg per g cutaneous gel) VALEO PHARMA INC,Active,9003236,tetracaine (tetracaine hydrochloride) 40 mg per g cutaneous gel,8001956,tetracaine,448598008,Cutaneous,385100002,Gel,,,,,,Ethical
1954,Marketed,2004-05-19,00022381,Cortrosyn Inj 0.25 mg,1,H01AA02,Tetracosactide,Powder for solution,"Intravenous,Intramuscular",00022381,"CORTROSYN INJ 0.25MG (tetracosactide 0.25 mg per vial powder for solution for injection) AMPHASTAR PHARMACEUTICALS, INC.",Active,9001726,tetracosactide 0.25 mg per vial powder for solution for injection,8001957,tetracosactide,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
5293,Marketed,2011-07-12,00580929,Tetracycline,1,J01AA07,Tetracycline,Capsule,Oral,00580929,TETRACYCLINE (tetracycline hydrochloride 250 mg oral capsule) AA PHARMA INC,Active,9001996,tetracycline hydrochloride 250 mg oral capsule,8001421,tetracycline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
42015,Marketed,2007-01-20,01942425,Visine Original,1,S01GA02,Tetryzoline,Drops,Ophthalmic,01942425,VISINE ORIGINAL (tetrahydrozoline hydrochloride 0.05 % ophthalmic drops) JOHNSON & JOHNSON INC,Active,9001581,tetrahydrozoline hydrochloride 0.05 % ophthalmic drops,8001958,tetrahydrozoline,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
75893,Marketed,2025-01-22,02273446,Original Eye Drops,1,S01GA02,Tetryzoline,Solution,Ophthalmic,02273446,ORIGINAL EYE DROPS (tetrahydrozoline hydrochloride 0.05 % ophthalmic drops) JUNO OTC INC,Active,9001581,tetrahydrozoline hydrochloride 0.05 % ophthalmic drops,8001958,tetrahydrozoline,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
100752,Marketed,2025-09-12,02518201,Red Eye Triple Action,2,S01GA52,"Tetryzoline, combinations",Drops,Ophthalmic,02518201,RED EYE TRIPLE ACTION (polyethylene glycol 400 1 % and tetrahydrozoline hydrochloride 0.05 % ophthalmic drops) KENVUE CANADA INC.,Active,9014681,polyethylene glycol 400 1 % and tetrahydrozoline hydrochloride 0.05 % ophthalmic drops,8002420,polyethylene glycol 400 and tetrahydrozoline,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
100753,Marketed,2025-09-12,02518228,Red Eye Workplace,2,S01GA52,"Tetryzoline, combinations",Drops,Ophthalmic,02518228,RED EYE WORKPLACE (polyethylene glycol 400 1 % and tetrahydrozoline hydrochloride 0.05 % ophthalmic drops) KENVUE CANADA INC.,Active,9014681,polyethylene glycol 400 1 % and tetrahydrozoline hydrochloride 0.05 % ophthalmic drops,8002420,polyethylene glycol 400 and tetrahydrozoline,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
42685,Marketed,2015-09-01,02144093,Visine For Allergy 3 Symptom Relief,2,S01GA52,"Tetryzoline, combinations",Drops,Ophthalmic,02144093,VISINE FOR ALLERGY 3 SYMPTOM RELIEF (tetrahydrozoline hydrochloride 0.05 % and zinc sulfate 0.25 % ophthalmic drops) JOHNSON & JOHNSON INC,Active,9003035,tetrahydrozoline hydrochloride 0.05 % and zinc sulfate 0.25 % ophthalmic drops,8001959,tetrahydrozoline and zinc sulfate,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
77592,Marketed,2025-02-03,02290596,Allergy Eye Drops,2,S01GA52,"Tetryzoline, combinations",Solution,Ophthalmic,02290596,ALLERGY EYE DROPS (tetrahydrozoline hydrochloride 0.05 % and zinc sulfate 0.25 % ophthalmic drops) JUNO OTC INC,Active,9003035,tetrahydrozoline hydrochloride 0.05 % and zinc sulfate 0.25 % ophthalmic drops,8001959,tetrahydrozoline and zinc sulfate,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
78699,Marketed,2008-03-26,02301687,Clear Eyes Triple Action Relief,3,S01GA52,"Tetryzoline, combinations",Solution,Ophthalmic,02301687,CLEAR EYES TRIPLE ACTION RELIEF (polyvinyl alcohol 0.5 % and povidone 0.6 % and tetrahydrozoline hydrochloride 0.05 % ophthalmic drops) PRESTIGE BRANDS INC,Active,9004385,polyvinyl alcohol 0.5 % and povidone 0.6 % and tetrahydrozoline hydrochloride 0.05 % ophthalmic drops,8002075,polyvinyl alcohol and povidone and tetrahydrozoline,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
82425,Marketed,2026-04-02,02338602,Visine Multi-Symptom,2,S01GA52,"Tetryzoline, combinations",Drops,Ophthalmic,02338602,VISINE MULTI-SYMPTOM (tetrahydrozoline hydrochloride 0.05 % and zinc sulfate 0.25 % ophthalmic drops) KENVUE CANADA INC.,Active,9003035,tetrahydrozoline hydrochloride 0.05 % and zinc sulfate 0.25 % ophthalmic drops,8001959,tetrahydrozoline and zinc sulfate,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
82979,Marketed,2025-02-04,02344319,Advanced Relief Eye Drops,4,S01GA52,"Tetryzoline, combinations",Solution,Ophthalmic,02344319,ADVANCED RELIEF EYE DROPS (dextran 70 0.1 % and polyethylene glycol 400 1 % and povidone 1 % and tetrahydrozoline hydrochloride 0.05 % ophthalmic drops) JUNO OTC INC,Active,9004025,dextran 70 0.1 % and polyethylene glycol 400 1 % and povidone 1 % and tetrahydrozoline hydrochloride 0.05 % ophthalmic drops,8002117,dextran 70 and polyethylene glycol 400 and povidone and tetrahydrozoline,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
93478,Marketed,2025-02-03,02448955,8-Symptom Relief,2,S01GA52,"Tetryzoline, combinations",Solution,Ophthalmic,02448955,8-SYMPTOM RELIEF (tetrahydrozoline hydrochloride 0.05 % and zinc sulfate 0.25 % ophthalmic drops) JUNO OTC INC,Active,9003035,tetrahydrozoline hydrochloride 0.05 % and zinc sulfate 0.25 % ophthalmic drops,8001959,tetrahydrozoline and zinc sulfate,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Non-Prescription Drugs
101878,Marketed,2022-10-19,02529548,Tezspire,1,R03DX11,Tezepelumab,Solution,Subcutaneous,02529548,TEZSPIRE (tezepelumab 210 mg per 1.91 mL solution for injection syringe) ASTRAZENECA CANADA INC,Active,9014788,tezepelumab 210 mg per 1.91 mL solution for injection syringe,8002445,tezepelumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
101878,Marketed,2022-10-19,02529548,Tezspire,1,R03DX11,Tezepelumab,Solution,Subcutaneous,02529548,TEZSPIRE (tezepelumab 210 mg per 1.91 mL solution for injection syringe) ASTRAZENECA CANADA INC,Active,9014788,tezepelumab 210 mg per 1.91 mL solution for injection syringe,8002445,tezepelumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
101879,Marketed,2022-10-19,02529556,Tezspire,1,R03DX11,Tezepelumab,Solution,Subcutaneous,02529556,TEZSPIRE (tezepelumab 210 mg per 1.91 mL solution for injection pen) ASTRAZENECA CANADA INC,Active,9014787,tezepelumab 210 mg per 1.91 mL solution for injection pen,8002445,tezepelumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Prescription
101879,Marketed,2022-10-19,02529556,Tezspire,1,R03DX11,Tezepelumab,Solution,Subcutaneous,02529556,TEZSPIRE (tezepelumab 210 mg per 1.91 mL solution for injection pen) ASTRAZENECA CANADA INC,Active,9014787,tezepelumab 210 mg per 1.91 mL solution for injection pen,8002445,tezepelumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
84045,Marketed,2024-06-12,02355191,Thalomid,1,L04AX02,Thalidomide,Capsule,Oral,02355191,THALOMID (thalidomide 50 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9004789,thalidomide 50 mg oral capsule,8001960,thalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
84046,Marketed,2024-08-26,02355205,Thalomid,1,L04AX02,Thalidomide,Capsule,Oral,02355205,THALOMID (thalidomide 100 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9004828,thalidomide 100 mg oral capsule,8001960,thalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
14031,Marketed,2019-08-13,00692700,AA-Theo LA,1,R03DA04,Theophylline,Tablet (extended-release),Oral,00692700,AA-THEO LA (theophylline 300 mg prolonged-release oral tablet) AA PHARMA INC,Active,9002616,theophylline 300 mg prolonged-release oral tablet,8001094,theophylline,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
14032,Marketed,2020-05-28,00692697,AA-Theo LA,1,R03DA04,Theophylline,Tablet (extended-release),Oral,00692697,AA-THEO LA (theophylline 200 mg prolonged-release oral tablet) AA PHARMA INC,Active,9002615,theophylline 200 mg prolonged-release oral tablet,8001094,theophylline,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
14033,Marketed,2019-07-22,00692689,AA-Theo LA,1,R03DA04,Theophylline,Tablet (extended-release),Oral,00692689,AA-THEO LA (theophylline 100 mg prolonged-release oral tablet) AA PHARMA INC,Active,9002614,theophylline 100 mg prolonged-release oral tablet,8001094,theophylline,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
6170,Marketed,1985-12-31,00627410,Elixir De Theophylline,1,R03DA04,Theophylline,Elixir,Oral,00627410,ELIXIR DE THEOPHYLLINE (theophylline 80 mg per 15 mL oral solution) LABORATOIRE ATLAS INC,Active,9001863,theophylline 80 mg per 15 mL oral solution,8001094,theophylline,26643006,Oral,385023001,Oral solution,,,,,,Prescription
84507,Marketed,2011-06-23,02360101,Theo ER,1,R03DA04,Theophylline,Tablet (extended-release),Oral,02360101,THEO ER (theophylline 400 mg prolonged-release oral tablet) AA PHARMA INC,Active,9002117,theophylline 400 mg prolonged-release oral tablet,8001094,theophylline,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84508,Marketed,2011-06-23,02360128,Theo ER,1,R03DA04,Theophylline,Tablet (extended-release),Oral,02360128,THEO ER (theophylline 600 mg prolonged-release oral tablet) AA PHARMA INC,Active,9002118,theophylline 600 mg prolonged-release oral tablet,8001094,theophylline,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
4258,Marketed,2022-10-20,00476374,Choledyl Expectorant,2,R03DA54,"Theophylline, combinations excl. psycholeptics",Solution,Oral,00476374,CHOLEDYL EXPECTORANT (guaifenesin 50 mg per 5 mL and oxtriphylline 100 mg per 5 mL oral solution) SEARCHLIGHT PHARMA INC,Active,9001909,guaifenesin 50 mg per 5 mL and oxtriphylline 100 mg per 5 mL oral solution,8000826,guaifenesin and oxtriphylline,26643006,Oral,385023001,Oral solution,,,,,,Prescription
78139,Marketed,2025-12-19,02296039,Tapazole,1,H03BB02,Thiamazole,Tablet,Oral,02296039,TAPAZOLE (methimazole 10 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9014048,methimazole 10 mg oral tablet,8002271,methimazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
9,Marketed,2025-12-19,00015741,Tapazole,1,H03BB02,Thiamazole,Tablet,Oral,00015741,TAPAZOLE (methimazole 5 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9014049,methimazole 5 mg oral tablet,8002271,methimazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
97066,Marketed,2018-10-19,02480107,Mar-Methimazole,1,H03BB02,Thiamazole,Tablet,Oral,02480107,MAR-METHIMAZOLE (methimazole 5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9014049,methimazole 5 mg oral tablet,8002271,methimazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
97067,Marketed,2018-10-19,02480115,Mar-Methimazole,1,H03BB02,Thiamazole,Tablet,Oral,02480115,MAR-METHIMAZOLE (methimazole 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9014048,methimazole 10 mg oral tablet,8002271,methimazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98069,Marketed,2020-08-21,02490625,JAMP Methimazole,1,H03BB02,Thiamazole,Tablet,Oral,02490625,JAMP METHIMAZOLE (methimazole 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9014049,methimazole 5 mg oral tablet,8002271,methimazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98070,Marketed,2021-08-21,02490633,JAMP Methimazole,1,H03BB02,Thiamazole,Tablet,Oral,02490633,JAMP METHIMAZOLE (methimazole 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9014048,methimazole 10 mg oral tablet,8002271,methimazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
10063,Marketed,2006-10-25,00816078,Vitamin B1,1,A11DA01,Thiamine (vit b1),Solution,"Intravenous,Intramuscular",77700823,VITAMIN B1 (thiamine hydrochloride 100 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9013360,thiamine hydrochloride 100 mg per 1 mL solution for injection ampoule,8001961,thiamine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
10063,Marketed,2006-10-25,00816078,Vitamin B1,1,A11DA01,Thiamine (vit b1),Solution,"Intravenous,Intramuscular",77700824,VITAMIN B1 (thiamine hydrochloride 1000 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013361,thiamine hydrochloride 1000 mg per 10 mL solution for injection vial,8001961,thiamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
35700,Marketed,1998-07-16,02193221,Thiamiject Injection - Liquid Im IV 100 mg/mL,1,A11DA01,Thiamine (vit b1),Liquid,"Intramuscular,Intravenous",02193221,THIAMIJECT INJECTION - LIQ IM IV 100MG/ML (thiamine hydrochloride 1000 mg per 10 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013361,thiamine hydrochloride 1000 mg per 10 mL solution for injection vial,8001961,thiamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
31283,Marketed,2018-11-14,02137186,Sodium Thiosulfate Injection USP,1,V03AB06,Thiosulphate,Solution,Intravenous,02137186,SODIUM THIOSULFATE INJECTION USP (sodium thiosulfate 2500 mg per 10 mL solution for injection vial) PFIZER CANADA ULC,Active,9013839,sodium thiosulfate 2500 mg per 10 mL solution for injection vial,8002163,sodium thiosulfate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
87223,Marketed,2013-01-08,02386666,Seacalphyx,1,V03AB06,Thiosulphate,Solution,Intravenous,02386666,SEACALPHYX (sodium thiosulfate 25000 mg per 100 mL solution for injection vial) SEAFORD PHARMACEUTICALS INC,Active,9013618,sodium thiosulfate 25000 mg per 100 mL solution for injection vial,8002163,sodium thiosulfate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
91283,Marketed,2015-11-23,02428393,Sodium Thiosulfate Injection USP,1,V03AB06,Thiosulphate,Solution,Intravenous,02428393,SODIUM THIOSULFATE INJECTION USP (sodium thiosulfate 12500 mg per 50 mL solution for injection vial) HOPE PHARMACEUTICALS LTD,Active,9013617,sodium thiosulfate 12500 mg per 50 mL solution for injection vial,8002163,sodium thiosulfate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
101295,Marketed,2025-06-25,02523906,Tepadina,1,L01AC01,Thiotepa,Powder for solution,Intravenous,02523906,TEPADINA (thiotepa 400 mg powder for solution for injection with diluent solution per bag) ADIENNE SA,Active,9015240,thiotepa 400 mg powder for solution for injection with diluent solution per bag,8001128,thiotepa,738984000,Parenteral,385223009,Powder for solution for injection,732982009,Bag,1.0,,,Prescription
101551,Marketed,2023-02-15,02526417,Thiotepa For Injection USP,1,L01AC01,Thiotepa,Powder for solution,Intravenous,02526417,THIOTEPA FOR INJECTION USP (thiotepa 15 mg per vial powder for solution for injection) STERIMAX INC,Active,9012432,thiotepa 15 mg per vial powder for solution for injection,8001128,thiotepa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
101552,Marketed,2023-02-15,02526425,Thiotepa For Injection USP,1,L01AC01,Thiotepa,Powder for solution,Intravenous,02526425,THIOTEPA FOR INJECTION USP (thiotepa 100 mg per vial powder for solution for injection) STERIMAX INC,Active,9012431,thiotepa 100 mg per vial powder for solution for injection,8001128,thiotepa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
102559,Marketed,2023-06-27,02536862,"Thiotepa For Injection, BP",1,L01AC01,Thiotepa,Powder for solution,Intravenous,02536862,"THIOTEPA FOR INJECTION, BP (thiotepa 15 mg per vial powder for solution for injection) HIKMA CANADA LIMITED",Active,9012432,thiotepa 15 mg per vial powder for solution for injection,8001128,thiotepa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
102560,Marketed,2023-06-27,02536870,"Thiotepa For Injection, BP",1,L01AC01,Thiotepa,Powder for solution,Intravenous,02536870,"THIOTEPA FOR INJECTION, BP (thiotepa 100 mg per vial powder for solution for injection) HIKMA CANADA LIMITED",Active,9012431,thiotepa 100 mg per vial powder for solution for injection,8001128,thiotepa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
95050,Marketed,2017-11-06,02462680,Tepadina,1,L01AC01,Thiotepa,Powder for solution,Intravenous,02462680,TEPADINA (thiotepa 15 mg per vial powder for solution for injection) ADIENNE SA,Active,9012432,thiotepa 15 mg per vial powder for solution for injection,8001128,thiotepa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
95051,Marketed,2017-10-31,02462702,Tepadina,1,L01AC01,Thiotepa,Powder for solution,Intravenous,02462702,TEPADINA (thiotepa 100 mg per vial powder for solution for injection) ADIENNE SA,Active,9012431,thiotepa 100 mg per vial powder for solution for injection,8001128,thiotepa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
100340,Marketed,2022-01-19,02514230,Vistaseal,2,B02BD30,Thrombin,Solution,Topical,,,,,,,,,,,,,,,,,Schedule D
772,Marketed,2022-10-04,00023949,Thyroid,1,H03AA05,Thyroid gland preparations,Tablet,Oral,00023949,THYROID (thyroid 30 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9001532,thyroid 30 mg oral tablet,8001962,thyroid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
773,Marketed,2022-10-04,00023957,Thyroid,1,H03AA05,Thyroid gland preparations,Tablet,Oral,00023957,THYROID (thyroid 60 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9001533,thyroid 60 mg oral tablet,8001962,thyroid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
774,Marketed,2022-10-04,00023965,Thyroid,1,H03AA05,Thyroid gland preparations,Tablet,Oral,00023965,THYROID (thyroid 125 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9001531,thyroid 125 mg oral tablet,8001962,thyroid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
70142,Marketed,2025-09-16,02246016,Thyrogen,1,H01AB01,Thyrotrophin alfa,Powder for solution,Intramuscular,02246016,THYROGEN (thyrotropin alfa 0.9 mg per vial powder for solution for injection) SANOFI-AVENTIS CANADA INC,Active,9013619,thyrotropin alfa 0.9 mg per vial powder for solution for injection,8001963,thyrotropin alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
70142,Marketed,2025-09-16,02246016,Thyrogen,1,H01AB01,Thyrotrophin alfa,Powder for solution,Intramuscular,02246016,THYROGEN (thyrotropin alfa 0.9 mg per vial powder for solution for injection) SANOFI-AVENTIS CANADA INC,Active,9013619,thyrotropin alfa 0.9 mg per vial powder for solution for injection,8001963,thyrotropin alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
19720,Marketed,2011-06-01,02179679,Teva-Tiaprofenic Acid,1,M01AE11,Tiaprofenic acid,Tablet,Oral,02179679,TEVA-TIAPROFENIC ACID (tiaprofenic acid 200 mg oral tablet) TEVA CANADA LIMITED,Active,9002718,tiaprofenic acid 200 mg oral tablet,8001535,tiaprofenic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
19722,Marketed,2011-06-01,02179687,Teva-Tiaprofenic Acid,1,M01AE11,Tiaprofenic acid,Tablet,Oral,02179687,TEVA-TIAPROFENIC ACID (tiaprofenic acid 300 mg oral tablet) TEVA CANADA LIMITED,Active,9002719,tiaprofenic acid 300 mg oral tablet,8001535,tiaprofenic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97847,Marketed,2020-07-29,02488361,Tibella,1,G03CX01,Tibolone,Tablet,Oral,02488361,TIBELLA (tibolone 2.5 mg oral tablet) BIOSYENT PHARMA INC,Active,9014349,tibolone 2.5 mg oral tablet,8002340,tibolone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Controlled Drugs (CDSA IV)
101899,Marketed,2022-12-20,02529750,M-Ticagrelor,1,B01AC24,Ticagrelor,Tablet,Oral,02529750,M-TICAGRELOR (ticagrelor 60 mg oral tablet) MANTRA PHARMA INC,Active,9005982,ticagrelor 60 mg oral tablet,8001306,ticagrelor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
101900,Marketed,2022-11-11,02529769,M-Ticagrelor,1,B01AC24,Ticagrelor,Tablet,Oral,02529769,M-TICAGRELOR (ticagrelor 90 mg oral tablet) MANTRA PHARMA INC,Active,9004879,ticagrelor 90 mg oral tablet,8001306,ticagrelor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102089,Marketed,2024-03-28,02531798,JAMP Ticagrelor,1,B01AC24,Ticagrelor,Tablet,Oral,02531798,JAMP TICAGRELOR (ticagrelor 60 mg oral tablet) JAMP PHARMA CORPORATION,Active,9005982,ticagrelor 60 mg oral tablet,8001306,ticagrelor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102090,Marketed,2024-03-28,02531801,JAMP Ticagrelor,1,B01AC24,Ticagrelor,Tablet,Oral,02531801,JAMP TICAGRELOR (ticagrelor 90 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004879,ticagrelor 90 mg oral tablet,8001306,ticagrelor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102592,Marketed,2024-03-28,02537184,AG-Ticagrelor,1,B01AC24,Ticagrelor,Tablet,Oral,02537184,AG-TICAGRELOR (ticagrelor 60 mg oral tablet) ANGITA PHARMA INC.,Active,9005982,ticagrelor 60 mg oral tablet,8001306,ticagrelor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102593,Marketed,2024-03-28,02537192,AG-Ticagrelor,1,B01AC24,Ticagrelor,Tablet,Oral,02537192,AG-TICAGRELOR (ticagrelor 90 mg oral tablet) ANGITA PHARMA INC.,Active,9004879,ticagrelor 90 mg oral tablet,8001306,ticagrelor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85352,Marketed,2011-06-01,02368544,Brilinta,1,B01AC24,Ticagrelor,Tablet,Oral,02368544,BRILINTA (ticagrelor 90 mg oral tablet) ASTRAZENECA CANADA INC,Active,9004879,ticagrelor 90 mg oral tablet,8001306,ticagrelor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94181,Marketed,2016-06-13,02455005,Brilinta,1,B01AC24,Ticagrelor,Tablet,Oral,02455005,BRILINTA (ticagrelor 60 mg oral tablet) ASTRAZENECA CANADA INC,Active,9005982,ticagrelor 60 mg oral tablet,8001306,ticagrelor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97305,Marketed,2022-12-22,02482622,Apo-Ticagrelor,1,B01AC24,Ticagrelor,Tablet,Oral,02482622,APO-TICAGRELOR (ticagrelor 60 mg oral tablet) APOTEX INC,Active,9005982,ticagrelor 60 mg oral tablet,8001306,ticagrelor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97306,Marketed,2022-12-14,02482630,Apo-Ticagrelor,1,B01AC24,Ticagrelor,Tablet,Oral,02482630,APO-TICAGRELOR (ticagrelor 90 mg oral tablet) APOTEX INC,Active,9004879,ticagrelor 90 mg oral tablet,8001306,ticagrelor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98258,Marketed,2022-05-31,02492571,Taro-Ticagrelor,1,B01AC24,Ticagrelor,Tablet,Oral,02492571,TARO-TICAGRELOR (ticagrelor 60 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9005982,ticagrelor 60 mg oral tablet,8001306,ticagrelor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98259,Marketed,2022-04-29,02492598,Taro-Ticagrelor,1,B01AC24,Ticagrelor,Tablet,Oral,02492598,TARO-TICAGRELOR (ticagrelor 90 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9004879,ticagrelor 90 mg oral tablet,8001306,ticagrelor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77090,Marketed,2012-04-17,02285401,Tygacil,1,J01AA12,Tigecycline,Powder for solution,Intravenous,02285401,TYGACIL (tigecycline 50 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9004233,tigecycline 50 mg per vial powder for solution for injection,8001238,tigecycline,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
89406,Marketed,2014-10-23,02409356,Tigecycline,1,J01AA12,Tigecycline,Powder for solution,Intravenous,02409356,TIGECYCLINE (tigecycline 50 mg per vial powder for solution for injection) APOTEX INC,Active,9004233,tigecycline 50 mg per vial powder for solution for injection,8001238,tigecycline,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
100544,Marketed,2022-10-24,02516098,Ilumya,1,L04AC17,Tildrakizumab,Solution,Subcutaneous,02516098,ILUMYA (tildrakizumab 100 mg per 1 mL solution for injection syringe) SUN PHARMACEUTICAL INDUSTRIES LIMITED,Active,9014605,tildrakizumab 100 mg per 1 mL solution for injection syringe,8002386,tildrakizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
100544,Marketed,2022-10-24,02516098,Ilumya,1,L04AC17,Tildrakizumab,Solution,Subcutaneous,02516098,ILUMYA (tildrakizumab 100 mg per 1 mL solution for injection syringe) SUN PHARMACEUTICAL INDUSTRIES LIMITED,Active,9014605,tildrakizumab 100 mg per 1 mL solution for injection syringe,8002386,tildrakizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
106211,Marketed,2026-01-06,02558904,Ilumya,1,L04AC17,Tildrakizumab,Solution,Subcutaneous,02558904,ILUMYA (tildrakizumab 100 mg per 1 mL solution for injection pen) SUN PHARMACEUTICAL INDUSTRIES LIMITED,Active,9015345,tildrakizumab 100 mg per 1 mL solution for injection pen,8002386,tildrakizumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen(s),,,,Schedule D
106211,Marketed,2026-01-06,02558904,Ilumya,1,L04AC17,Tildrakizumab,Solution,Subcutaneous,02558904,ILUMYA (tildrakizumab 100 mg per 1 mL solution for injection pen) SUN PHARMACEUTICAL INDUSTRIES LIMITED,Active,9015345,tildrakizumab 100 mg per 1 mL solution for injection pen,8002386,tildrakizumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen(s),,,,Prescription
18778,Marketed,2020-09-02,02171899,Timoptic-Xe,1,S01ED01,Timolol,Solution (extended release),Ophthalmic,02171899,TIMOPTIC-XE (timolol (timolol maleate) 0.5 % prolonged-release eye drops) ELVIUM LIFE SCIENCES,Active,9000637,timolol (timolol maleate) 0.5 % prolonged-release eye drops,8000081,timolol,54485002,Ophthalmic,385128008,Prolonged-release eye drops,732994000,Drop (unit of presentation),,,,Prescription
19242,Marketed,2011-06-15,02166720,Sandoz Timolol,1,S01ED01,Timolol,Solution,Ophthalmic,02166720,SANDOZ TIMOLOL (timolol (timolol maleate) 0.5 % ophthalmic drops) SANDOZ CANADA INCORPORATED,Active,9000141,timolol (timolol maleate) 0.5 % ophthalmic drops,8000081,timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
19252,Marketed,2011-06-15,02166712,Sandoz Timolol,1,S01ED01,Timolol,Solution,Ophthalmic,02166712,SANDOZ TIMOLOL (timolol (timolol maleate) 0.25 % ophthalmic drops) SANDOZ CANADA INCORPORATED,Active,9000308,timolol (timolol maleate) 0.25 % ophthalmic drops,8000081,timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
3186,Marketed,2020-09-02,00451207,Timoptic,1,S01ED01,Timolol,Solution,Ophthalmic,00451207,TIMOPTIC (timolol (timolol maleate) 0.5 % ophthalmic drops) ELVIUM LIFE SCIENCES,Active,9000141,timolol (timolol maleate) 0.5 % ophthalmic drops,8000081,timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
65975,Marketed,2017-05-19,02242275,Timolol Maleate-Ex,1,S01ED01,Timolol,Solution (extended release),Ophthalmic,02242275,TIMOLOL MALEATE-EX (timolol (timolol maleate) 0.25 % prolonged-release eye drops) SANDOZ CANADA INCORPORATED,Active,9000636,timolol (timolol maleate) 0.25 % prolonged-release eye drops,8000081,timolol,54485002,Ophthalmic,385128008,Prolonged-release eye drops,732994000,Drop (unit of presentation),,,,Prescription
65976,Marketed,2017-05-19,02242276,Timolol Maleate-Ex,1,S01ED01,Timolol,Solution (extended release),Ophthalmic,02242276,TIMOLOL MALEATE-EX (timolol (timolol maleate) 0.5 % prolonged-release eye drops) SANDOZ CANADA INCORPORATED,Active,9000637,timolol (timolol maleate) 0.5 % prolonged-release eye drops,8000081,timolol,54485002,Ophthalmic,385128008,Prolonged-release eye drops,732994000,Drop (unit of presentation),,,,Prescription
8589,Marketed,2018-12-12,00755842,Timolol,1,C07AA06,Timolol,Tablet,Oral,00755842,TIMOLOL (timolol maleate 5 mg oral tablet) AA PHARMA INC,Active,9000307,timolol maleate 5 mg oral tablet,8000081,timolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
8590,Marketed,2018-02-27,00755850,Timolol,1,C07AA06,Timolol,Tablet,Oral,00755850,TIMOLOL (timolol maleate 10 mg oral tablet) AA PHARMA INC,Active,9000305,timolol maleate 10 mg oral tablet,8000081,timolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
8591,Marketed,2018-11-01,00755869,Timolol,1,C07AA06,Timolol,Tablet,Oral,00755869,TIMOLOL (timolol maleate 20 mg oral tablet) AA PHARMA INC,Active,9000306,timolol maleate 20 mg oral tablet,8000081,timolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93340,Marketed,2020-08-20,02447800,JAMP-Timolol,1,S01ED01,Timolol,Solution,Ophthalmic,02447800,JAMP-TIMOLOL (timolol (timolol maleate) 0.5 % ophthalmic drops) JAMP PHARMA CORPORATION,Active,9000141,timolol (timolol maleate) 0.5 % ophthalmic drops,8000081,timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
100369,Marketed,2021-11-10,02514516,M-Latanoprost-Timolol,2,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02514516,M-LATANOPROST-TIMOLOL (latanoprost 50 mcg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops) MANTRA PHARMA INC,Active,9003762,latanoprost 50 mcg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops,8000933,latanoprost and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
101119,Marketed,2023-06-12,02522020,Dorzolamide-Timolol,2,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02522020,DORZOLAMIDE-TIMOLOL (dorzolamide (dorzolamide hydrochloride) 20 mg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops) JAMP PHARMA CORPORATION,Active,9000850,dorzolamide (dorzolamide hydrochloride) 20 mg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops,8000272,dorzolamide and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
102081,Marketed,2023-07-21,02531704,JAMP Brimonidine/Timolol,2,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02531704,JAMP BRIMONIDINE/TIMOLOL (brimonidine tartrate 0.2 % and timolol (timolol maleate) 0.5 % ophthalmic drops) JAMP PHARMA CORPORATION,Active,9003850,brimonidine tartrate 0.2 % and timolol (timolol maleate) 0.5 % ophthalmic drops,8001111,brimonidine and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
102656,Marketed,2023-11-13,02537796,M-Dorzolamide-Timolol,2,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02537796,M-DORZOLAMIDE-TIMOLOL (dorzolamide (dorzolamide hydrochloride) 20 mg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops) MANTRA PHARMA INC,Active,9000850,dorzolamide (dorzolamide hydrochloride) 20 mg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops,8000272,dorzolamide and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
63627,Marketed,2020-08-31,02240113,Cosopt,2,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02240113,COSOPT (dorzolamide (dorzolamide hydrochloride) 20 mg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops) ELVIUM LIFE SCIENCES,Active,9000850,dorzolamide (dorzolamide hydrochloride) 20 mg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops,8000272,dorzolamide and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
70807,Marketed,2023-07-24,02246619,Xalacom,2,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02246619,XALACOM (latanoprost 50 mcg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops) BGP PHARMA ULC,Active,9003762,latanoprost 50 mcg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops,8000933,latanoprost and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
72692,Marketed,2023-12-13,02248347,Combigan,2,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02248347,COMBIGAN (brimonidine tartrate 0.2 % and timolol (timolol maleate) 0.5 % ophthalmic drops) ABBVIE CORPORATION,Active,9003850,brimonidine tartrate 0.2 % and timolol (timolol maleate) 0.5 % ophthalmic drops,8001111,brimonidine and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
74388,Marketed,2022-05-24,02258692,Cosopt Preservative-Free,2,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02258692,COSOPT PRESERVATIVE-FREE (dorzolamide (dorzolamide hydrochloride) 20 mg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops) ELVIUM LIFE SCIENCES,Active,9000850,dorzolamide (dorzolamide hydrochloride) 20 mg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops,8000272,dorzolamide and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
76384,Marketed,2018-01-19,02278251,Duotrav PQ,2,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02278251,DUOTRAV PQ (timolol (timolol maleate) 0.5 % and travoprost 0.004 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9004152,timolol (timolol maleate) 0.5 % and travoprost 0.004 % ophthalmic drops,8000955,timolol and travoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
78499,Marketed,2018-06-15,02299615,Apo-Dorzo-Timop,2,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02299615,APO-DORZO-TIMOP (dorzolamide (dorzolamide hydrochloride) 20 mg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops) APOTEX INC,Active,9000850,dorzolamide (dorzolamide hydrochloride) 20 mg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops,8000272,dorzolamide and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
81730,Marketed,2018-03-09,02331624,Azarga,2,S01ED51,"Timolol, combinations",Suspension,Ophthalmic,02331624,AZARGA (brinzolamide 1 % and timolol (timolol maleate) 0.5 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012375,brinzolamide 1 % and timolol (timolol maleate) 0.5 % ophthalmic drops,8001099,brinzolamide and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
82984,Marketed,2010-10-25,02344351,Sandoz Dorzolamide/Timolol,2,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02344351,SANDOZ DORZOLAMIDE/TIMOLOL (dorzolamide (dorzolamide hydrochloride) 20 mg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops) SANDOZ CANADA INCORPORATED,Active,9000850,dorzolamide (dorzolamide hydrochloride) 20 mg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops,8000272,dorzolamide and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
85818,Marketed,2023-11-16,02373068,Mylan-Latanoprost/Timolol,2,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02373068,MYLAN-LATANOPROST/TIMOLOL (latanoprost 50 mcg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops) MYLAN PHARMACEUTICALS ULC,Active,9003762,latanoprost 50 mcg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops,8000933,latanoprost and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
86073,Marketed,2022-11-09,02375311,Apo-Brimonidine-Timop,2,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02375311,APO-BRIMONIDINE-TIMOP (brimonidine tartrate 0.2 % and timolol (timolol maleate) 0.5 % ophthalmic drops) APOTEX INC,Active,9003850,brimonidine tartrate 0.2 % and timolol (timolol maleate) 0.5 % ophthalmic drops,8001111,brimonidine and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
89992,Marketed,2020-03-03,02415305,Apo-Travoprost-Timop PQ,2,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02415305,APO-TRAVOPROST-TIMOP PQ (timolol (timolol maleate) 0.5 % and travoprost 0.004 % ophthalmic drops) APOTEX INC,Active,9004152,timolol (timolol maleate) 0.5 % and travoprost 0.004 % ophthalmic drops,8000955,timolol and travoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
92058,Marketed,2025-01-10,02436256,Teva-Latanoprost-Timolol,2,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02436256,TEVA-LATANOPROST-TIMOLOL (latanoprost 50 mcg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops) TEVA CANADA LIMITED,Active,9003762,latanoprost 50 mcg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops,8000933,latanoprost and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
92207,Marketed,2016-05-17,02437686,Med-Dorzolamide-Timolol,2,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02437686,MED-DORZOLAMIDE-TIMOLOL (dorzolamide (dorzolamide hydrochloride) 20 mg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops) GENERIC MEDICAL PARTNERS INC,Active,9000850,dorzolamide (dorzolamide hydrochloride) 20 mg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops,8000272,dorzolamide and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
92604,Marketed,2015-07-22,02441659,Riva-Dorzolamide/Timolol,2,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02441659,RIVA-DORZOLAMIDE/TIMOLOL (dorzolamide (dorzolamide hydrochloride) 20 mg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops) LABORATOIRE RIVA INC.,Active,9000850,dorzolamide (dorzolamide hydrochloride) 20 mg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops,8000272,dorzolamide and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
94031,Marketed,2020-02-07,02453770,JAMP-Latanoprost/Timolol,2,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02453770,JAMP-LATANOPROST/TIMOLOL (latanoprost 50 mcg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops) JAMP PHARMA CORPORATION,Active,9003762,latanoprost 50 mcg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops,8000933,latanoprost and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
94108,Marketed,2019-08-22,02454505,Med-Latanoprost-Timolol,2,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02454505,MED-LATANOPROST-TIMOLOL (latanoprost 50 mcg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops) GENERIC MEDICAL PARTNERS INC,Active,9003762,latanoprost 50 mcg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops,8000933,latanoprost and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
19202,Marketed,1995-12-31,02167840,Innohep,1,B01AB10,Tinzaparin,Solution,Subcutaneous,02167840,INNOHEP (tinzaparin sodium 10000 unit per mL solution for injection 2 mL vial) LEO PHARMA INC,Active,9012756,tinzaparin sodium 10000 unit per mL solution for injection 2 mL vial,8001422,tinzaparin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
47420,Marketed,1997-02-28,02229515,Innohep,1,B01AB10,Tinzaparin,Solution,Subcutaneous,02229515,INNOHEP (tinzaparin sodium 20000 unit per mL solution for injection 2 mL vial) LEO PHARMA INC,Active,9012761,tinzaparin sodium 20000 unit per mL solution for injection 2 mL vial,8001422,tinzaparin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
47983,Marketed,2011-09-28,02229755,Innohep,1,B01AB10,Tinzaparin,Solution,Subcutaneous,02229755,INNOHEP (tinzaparin sodium 2500 unit per 0.25 mL solution for injection syringe) LEO PHARMA INC,Active,9012762,tinzaparin sodium 2500 unit per 0.25 mL solution for injection syringe,8001422,tinzaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
50802,Marketed,2011-09-08,02231478,Innohep,1,B01AB10,Tinzaparin,Solution,Subcutaneous,02231478,INNOHEP (tinzaparin sodium 10000 unit per 0.5 mL solution for injection syringe) LEO PHARMA INC,Active,9012755,tinzaparin sodium 10000 unit per 0.5 mL solution for injection syringe,8001422,tinzaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
84321,Marketed,2011-09-09,02358158,Innohep,1,B01AB10,Tinzaparin,Solution,Subcutaneous,02358158,INNOHEP (tinzaparin sodium 3500 unit per 0.35 mL solution for injection syringe) LEO PHARMA INC,Active,9012763,tinzaparin sodium 3500 unit per 0.35 mL solution for injection syringe,8001422,tinzaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
84322,Marketed,2011-12-10,02358166,Innohep,1,B01AB10,Tinzaparin,Solution,Subcutaneous,02358166,INNOHEP (tinzaparin sodium 4500 unit per 0.45 mL solution for injection syringe) LEO PHARMA INC,Active,9012764,tinzaparin sodium 4500 unit per 0.45 mL solution for injection syringe,8001422,tinzaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
84323,Marketed,2011-09-16,02358174,Innohep,1,B01AB10,Tinzaparin,Solution,Subcutaneous,02358174,INNOHEP (tinzaparin sodium 14000 unit per 0.7 mL solution for injection syringe) LEO PHARMA INC,Active,9012758,tinzaparin sodium 14000 unit per 0.7 mL solution for injection syringe,8001422,tinzaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
84324,Marketed,2011-09-13,02358182,Innohep,1,B01AB10,Tinzaparin,Solution,Subcutaneous,02358182,INNOHEP (tinzaparin sodium 18000 unit per 0.9 mL solution for injection syringe) LEO PHARMA INC,Active,9012760,tinzaparin sodium 18000 unit per 0.9 mL solution for injection syringe,8001422,tinzaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
91392,Marketed,2014-09-30,02429462,Innohep,1,B01AB10,Tinzaparin,Solution,Subcutaneous,02429462,INNOHEP (tinzaparin sodium 8000 unit per 0.4 mL solution for injection syringe) LEO PHARMA INC,Active,9012765,tinzaparin sodium 8000 unit per 0.4 mL solution for injection syringe,8001422,tinzaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
91393,Marketed,2014-09-30,02429470,Innohep,1,B01AB10,Tinzaparin,Solution,Subcutaneous,02429470,INNOHEP (tinzaparin sodium 12000 unit per 0.6 mL solution for injection syringe) LEO PHARMA INC,Active,9012757,tinzaparin sodium 12000 unit per 0.6 mL solution for injection syringe,8001422,tinzaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
91394,Marketed,2014-09-30,02429489,Innohep,1,B01AB10,Tinzaparin,Solution,Subcutaneous,02429489,INNOHEP (tinzaparin sodium 16000 unit per 0.8 mL solution for injection syringe) LEO PHARMA INC,Active,9012759,tinzaparin sodium 16000 unit per 0.8 mL solution for injection syringe,8001422,tinzaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
1812,Marketed,2020-07-10,00282081,Lanvis,1,L01BB03,Tioguanine,Tablet,Oral,00282081,LANVIS (thioguanine 40 mg oral tablet) ASPEN PHARMACARE CANADA INC.,Active,9012865,thioguanine 40 mg oral tablet,8001534,thioguanine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102661,Marketed,2023-12-18,02537850,Lupin-Tiotropium,1,R03BB04,Tiotropium bromide,Capsule,Inhalation,02537850,LUPIN-TIOTROPIUM (tiotropium (tiotropium bromide monohydrate) 18 mcg inhalation powder capsule) LUPIN PHARMA CANADA LIMITED,Active,9001003,tiotropium (tiotropium bromide) 18 mcg inhalation powder capsule,8000320,tiotropium,447694001,447694001,385207009,Powder for inhalation,732937005,Capsule,,,,Prescription
103964,Marketed,2025-01-23,02550865,Apo-Tiotropium,1,R03BB04,Tiotropium bromide,Capsule,Inhalation,02550865,APO-TIOTROPIUM (tiotropium (tiotropium bromide monohydrate) 18 mcg inhalation powder capsule) APOTEX INC,Active,9001003,tiotropium (tiotropium bromide) 18 mcg inhalation powder capsule,8000320,tiotropium,447694001,447694001,385207009,Powder for inhalation,732937005,Capsule,,,,Prescription
70993,Marketed,2002-11-21,02246793,Spiriva,1,R03BB04,Tiotropium bromide,Capsule,Inhalation,02246793,SPIRIVA (tiotropium (tiotropium bromide monohydrate) 18 mcg inhalation powder capsule) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9001003,tiotropium (tiotropium bromide) 18 mcg inhalation powder capsule,8000320,tiotropium,447694001,447694001,385207009,Powder for inhalation,732937005,Capsule,,,,Prescription
91971,Marketed,2014-12-19,02435381,Spiriva Respimat,1,R03BB04,Tiotropium bromide,Solution,Inhalation,02435381,SPIRIVA RESPIMAT (tiotropium (tiotropium bromide monohydrate) 2.5 mcg per actuation inhalation solution) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9001436,tiotropium (tiotropium bromide) 2.5 mcg per actuation inhalation solution,8000320,tiotropium,447694001,Inhalation,420641004,Solution for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
64293,Marketed,2021-07-29,02240706,Aggrastat,1,B01AC17,Tirofiban,Solution,Intravenous,02240706,AGGRASTAT (tirofiban (tirofiban hydrochloride) 12.5 mg per 250 mL solution for injection bag) CIPHER PHARMACEUTICALS INC,Active,9013362,tirofiban (tirofiban hydrochloride) 12.5 mg per 250 mL solution for injection bag,8001964,tirofiban,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Prescription
102972,Marketed,2023-10-23,02541041,Mounjaro,1,A10BX16,Tirzepatide,Solution,Subcutaneous,02541041,MOUNJARO (tirzepatide 2.5 mg per 0.5 mL solution for injection vial) ELI LILLY CANADA INC,Active,9014995,tirzepatide 2.5 mg per 0.5 mL solution for injection vial,8002488,tirzepatide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
102973,Marketed,2023-10-23,02541068,Mounjaro,1,A10BX16,Tirzepatide,Solution,Subcutaneous,02541068,MOUNJARO (tirzepatide 5 mg per 0.5 mL solution for injection vial) ELI LILLY CANADA INC,Active,9014996,tirzepatide 5 mg per 0.5 mL solution for injection vial,8002488,tirzepatide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
102974,Marketed,2023-10-23,02541076,Mounjaro,1,A10BX16,Tirzepatide,Solution,Subcutaneous,02541076,MOUNJARO (tirzepatide 7.5 mg per 0.5 mL solution for injection vial) ELI LILLY CANADA INC,Active,9014997,tirzepatide 7.5 mg per 0.5 mL solution for injection vial,8002488,tirzepatide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
102975,Marketed,2023-10-23,02541084,Mounjaro,1,A10BX16,Tirzepatide,Solution,Subcutaneous,02541084,MOUNJARO (tirzepatide 10 mg per 0.5 mL solution for injection vial) ELI LILLY CANADA INC,Active,9014992,tirzepatide 10 mg per 0.5 mL solution for injection vial,8002488,tirzepatide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
102976,Marketed,2023-10-23,02541092,Mounjaro,1,A10BX16,Tirzepatide,Solution,Subcutaneous,02541092,MOUNJARO (tirzepatide 12.5 mg per 0.5 mL solution for injection vial) ELI LILLY CANADA INC,Active,9014993,tirzepatide 12.5 mg per 0.5 mL solution for injection vial,8002488,tirzepatide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
102977,Marketed,2023-10-23,02541106,Mounjaro,1,A10BX16,Tirzepatide,Solution,Subcutaneous,02541106,MOUNJARO (tirzepatide 15 mg per 0.5 mL solution for injection vial) ELI LILLY CANADA INC,Active,9014994,tirzepatide 15 mg per 0.5 mL solution for injection vial,8002488,tirzepatide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
104065,Marketed,2024-12-10,02551950,Mounjaro Kwikpen,1,A10BX16,Tirzepatide,Solution,Subcutaneous,02551950,MOUNJARO KWIKPEN (tirzepatide 2.5 mg per actuation solution for injection pre-filled pen) ELI LILLY CANADA INC,Active,9015159,tirzepatide 2.5 mg per actuation solution for injection pre-filled pen,8002488,tirzepatide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation,1.0,,,Prescription
104066,Marketed,2024-12-10,02551969,Mounjaro Kwikpen,1,A10BX16,Tirzepatide,Solution,Subcutaneous,02551969,MOUNJARO KWIKPEN (tirzepatide 5 mg per actuation solution for injection pre-filled pen) ELI LILLY CANADA INC,Active,9015160,tirzepatide 5 mg per actuation solution for injection pre-filled pen,8002488,tirzepatide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation,1.0,,,Prescription
104067,Marketed,2024-12-10,02551977,Mounjaro Kwikpen,1,A10BX16,Tirzepatide,Solution,Subcutaneous,02551977,MOUNJARO KWIKPEN (tirzepatide 7.5 mg per actuation solution for injection pre-filled pen) ELI LILLY CANADA INC,Active,9015161,tirzepatide 7.5 mg per actuation solution for injection pre-filled pen,8002488,tirzepatide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation,1.0,,,Prescription
104068,Marketed,2024-12-10,02551985,Mounjaro Kwikpen,1,A10BX16,Tirzepatide,Solution,Subcutaneous,02551985,MOUNJARO KWIKPEN (tirzepatide 10 mg per actuation solution for injection pre-filled pen) ELI LILLY CANADA INC,Active,9015156,tirzepatide 10 mg per actuation solution for injection pre-filled pen,8002488,tirzepatide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation,1.0,,,Prescription
104069,Marketed,2024-12-10,02551993,Mounjaro Kwikpen,1,A10BX16,Tirzepatide,Solution,Subcutaneous,02551993,MOUNJARO KWIKPEN (tirzepatide 12.5 mg per actuation solution for injection pre-filled pen) ELI LILLY CANADA INC,Active,9015157,tirzepatide 12.5 mg per actuation solution for injection pre-filled pen,8002488,tirzepatide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation,1.0,,,Prescription
104070,Marketed,2024-12-10,02552000,Mounjaro Kwikpen,1,A10BX16,Tirzepatide,Solution,Subcutaneous,02552000,MOUNJARO KWIKPEN (tirzepatide 15 mg per actuation solution for injection pre-filled pen) ELI LILLY CANADA INC,Active,9015158,tirzepatide 15 mg per actuation solution for injection pre-filled pen,8002488,tirzepatide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation,1.0,,,Prescription
106082,Marketed,2026-02-12,02557509,Zepbound,1,A10BX16,Tirzepatide,Solution,Subcutaneous,02557509,ZEPBOUND (tirzepatide 2.5 mg per actuation solution for injection pre-filled pen) ELI LILLY CANADA INC,Active,9015159,tirzepatide 2.5 mg per actuation solution for injection pre-filled pen,8002488,tirzepatide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation,1.0,,,Prescription
106083,Marketed,2026-02-12,02557517,Zepbound,1,A10BX16,Tirzepatide,Solution,Subcutaneous,02557517,ZEPBOUND (tirzepatide 5 mg per actuation solution for injection pre-filled pen) ELI LILLY CANADA INC,Active,9015160,tirzepatide 5 mg per actuation solution for injection pre-filled pen,8002488,tirzepatide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation,1.0,,,Prescription
106084,Marketed,2026-02-16,02557525,Zepbound,1,A10BX16,Tirzepatide,Solution,Subcutaneous,02557525,ZEPBOUND (tirzepatide 7.5 mg per actuation solution for injection pre-filled pen) ELI LILLY CANADA INC,Active,9015161,tirzepatide 7.5 mg per actuation solution for injection pre-filled pen,8002488,tirzepatide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation,1.0,,,Prescription
106085,Marketed,2026-02-12,02557533,Zepbound,1,A10BX16,Tirzepatide,Solution,Subcutaneous,02557533,ZEPBOUND (tirzepatide 10 mg per actuation solution for injection pre-filled pen) ELI LILLY CANADA INC,Active,9015156,tirzepatide 10 mg per actuation solution for injection pre-filled pen,8002488,tirzepatide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation,1.0,,,Prescription
106086,Marketed,2026-02-12,02557541,Zepbound,1,A10BX16,Tirzepatide,Solution,Subcutaneous,02557541,ZEPBOUND (tirzepatide 12.5 mg per actuation solution for injection pre-filled pen) ELI LILLY CANADA INC,Active,9015157,tirzepatide 12.5 mg per actuation solution for injection pre-filled pen,8002488,tirzepatide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation,1.0,,,Prescription
106087,Marketed,2026-02-12,02557568,Zepbound,1,A10BX16,Tirzepatide,Solution,Subcutaneous,02557568,ZEPBOUND (tirzepatide 15 mg per actuation solution for injection pre-filled pen) ELI LILLY CANADA INC,Active,9015158,tirzepatide 15 mg per actuation solution for injection pre-filled pen,8002488,tirzepatide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation,1.0,,,Prescription
97104,Marketed,2019-05-24,02480514,Kymriah,1,L01XL04,Tisagenlecleucel,Suspension,Intravenous,,,,,,,,,,,,,,,,,Schedule D
97104,Marketed,2019-05-24,02480514,Kymriah,1,L01XL04,Tisagenlecleucel,Suspension,Intravenous,,,,,,,,,,,,,,,,,Prescription
106674,Marketed,2026-04-01,02564009,Tevimbra,1,L01FF09,Tislelizumab,Solution,Intravenous,02564009,TEVIMBRA (tislelizumab 100 mg per 10 mL solution for injection vial) BEONE MEDICINES I GMBH,Active,9015407,tislelizumab 100 mg per 10 mL solution for injection vial,8002591,tislelizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,1.0,,,Schedule D
106674,Marketed,2026-04-01,02564009,Tevimbra,1,L01FF09,Tislelizumab,Solution,Intravenous,02564009,TEVIMBRA (tislelizumab 100 mg per 10 mL solution for injection vial) BEONE MEDICINES I GMBH,Active,9015407,tislelizumab 100 mg per 10 mL solution for injection vial,8002591,tislelizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,1.0,,,Prescription
102551,Marketed,2023-09-07,02536765,Mint-Tizanidine,1,M03BX02,Tizanidine,Tablet,Oral,02536765,MINT-TIZANIDINE (tizanidine (tizanidine hydrochloride) 4 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9003427,tizanidine (tizanidine hydrochloride) 4 mg oral tablet,8001965,tizanidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
74515,Marketed,2024-05-06,02259893,Apo-Tizanidine,1,M03BX02,Tizanidine,Tablet,Oral,02259893,APO-TIZANIDINE (tizanidine (tizanidine hydrochloride) 4 mg oral tablet) APOTEX INC,Active,9003427,tizanidine (tizanidine hydrochloride) 4 mg oral tablet,8001965,tizanidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102212,Marketed,2024-05-16,02533103,Tobramycin Injection USP,1,J01GB01,Tobramycin,Solution,"Intravenous,Intramuscular",02533103,TOBRAMYCIN INJECTION USP (tobramycin (tobramycin sulfate) 80 mg per 2 mL solution for injection vial) JAMP PHARMA CORPORATION,Active,9012871,tobramycin (tobramycin sulfate) 80 mg per 2 mL solution for injection vial,8000827,tobramycin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
4571,Marketed,2018-09-10,00513962,Tobrex,1,S01AA12,Tobramycin,Solution,Ophthalmic,00513962,TOBREX (tobramycin 0.3 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9001920,tobramycin 0.3 % ophthalmic drops,8000827,tobramycin,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
49817,Marketed,2016-03-03,02230640,Tobramycin Injection,1,J01GB01,Tobramycin,Solution,"Intramuscular,Intravenous",77700640,TOBRAMYCIN INJECTION (tobramycin (tobramycin sulfate) 40 mg per mL solution for injection 30 mL vial) FRESENIUS KABI CANADA LTD,Active,9012870,tobramycin (tobramycin sulfate) 40 mg per mL solution for injection 30 mL vial,8000827,tobramycin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
49817,Marketed,2016-03-03,02230640,Tobramycin Injection,1,J01GB01,Tobramycin,Solution,"Intramuscular,Intravenous",77700641,TOBRAMYCIN INJECTION (tobramycin (tobramycin sulfate) 80 mg per 2 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9012871,tobramycin (tobramycin sulfate) 80 mg per 2 mL solution for injection vial,8000827,tobramycin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
5402,Marketed,2016-03-03,00533688,Tobramycin For Injection,1,J01GB01,Tobramycin,Powder for solution,Intravenous,00533688,TOBRAMYCIN FOR INJECTION (tobramycin (tobramycin sulfate) 1.2 g per vial powder for solution for injection) FRESENIUS KABI CANADA LTD,Active,9001997,tobramycin (tobramycin sulfate) 1.2 g per vial powder for solution for injection,8000827,tobramycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
5707,Marketed,2018-08-02,00614254,Tobrex,1,S01AA12,Tobramycin,Ointment,Ophthalmic,00614254,TOBREX (tobramycin 0.3 % ophthalmic ointment) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9002035,tobramycin 0.3 % ophthalmic ointment,8000827,tobramycin,54485002,Ophthalmic,385123004,Ophthalmic ointment,,,,,,Prescription
63101,Marketed,2021-10-06,02239630,Tobi,1,J01GB01,Tobramycin,Solution,Inhalation,02239630,TOBI (tobramycin (tobramycin sulfate) 300 mg per 5 mL nebulizer solution unit dose vial) BGP PHARMA ULC,Active,9012869,tobramycin (tobramycin sulfate) 300 mg per 5 mL nebulizer solution unit dose vial,8000827,tobramycin,447694001,Inhalation,385198000,Solution for nebuliser,733026001,Vial (unit of presentation),,,,Prescription
64815,Marketed,2005-08-26,02241209,Tobramycin Injection USP,1,J01GB01,Tobramycin,Solution,"Intravenous,Intramuscular",02241209,TOBRAMYCIN INJECTION USP (tobramycin (tobramycin sulfate) 20 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012868,tobramycin (tobramycin sulfate) 20 mg per 2 mL solution for injection vial,8000827,tobramycin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
64816,Marketed,2005-08-26,02241210,Tobramycin Injection USP,1,J01GB01,Tobramycin,Solution,"Intravenous,Intramuscular",77700644,TOBRAMYCIN INJECTION USP (tobramycin (tobramycin sulfate) 40 mg per mL solution for injection 30 mL vial) SANDOZ CANADA INCORPORATED,Active,9012870,tobramycin (tobramycin sulfate) 40 mg per mL solution for injection 30 mL vial,8000827,tobramycin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
64816,Marketed,2005-08-26,02241210,Tobramycin Injection USP,1,J01GB01,Tobramycin,Solution,"Intravenous,Intramuscular",77700645,TOBRAMYCIN INJECTION USP (tobramycin (tobramycin sulfate) 80 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012871,tobramycin (tobramycin sulfate) 80 mg per 2 mL solution for injection vial,8000827,tobramycin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
65418,Marketed,2005-10-08,02241755,Sandoz Tobramycin,1,S01AA12,Tobramycin,Solution,Ophthalmic,02241755,SANDOZ TOBRAMYCIN (tobramycin 0.3 % ophthalmic drops) SANDOZ CANADA INCORPORATED,Active,9001920,tobramycin 0.3 % ophthalmic drops,8000827,tobramycin,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
85000,Marketed,2020-03-11,02365154,Tobi Podhaler,1,J01GB01,Tobramycin,Capsule,Inhalation,02365154,TOBI PODHALER (tobramycin 28 mg inhalation powder capsule) BGP PHARMA ULC,Active,9004870,tobramycin 28 mg inhalation powder capsule,8000827,tobramycin,447694001,Inhalation,385207009,Powder for inhalation,732937005,Capsule,,,,Prescription
87512,Marketed,2016-02-03,02389622,Teva-Tobramycin,1,J01GB01,Tobramycin,Solution,Inhalation,02389622,TEVA-TOBRAMYCIN (tobramycin (tobramycin sulfate) 300 mg per 5 mL nebulizer solution unit dose vial) TEVA CANADA LIMITED,Active,9012869,tobramycin (tobramycin sulfate) 300 mg per 5 mL nebulizer solution unit dose vial,8000827,tobramycin,447694001,Inhalation,385198000,Solution for nebuliser,733026001,Vial (unit of presentation),,,,Prescription
99195,Marketed,2021-02-17,02502372,Tobramycin Injection USP,1,J01GB01,Tobramycin,Solution,"Intravenous,Intramuscular",02502372,TOBRAMYCIN INJECTION USP (tobramycin (tobramycin sulfate) 80 mg per 2 mL solution for injection vial) STERIMAX INC,Active,9012871,tobramycin (tobramycin sulfate) 80 mg per 2 mL solution for injection vial,8000827,tobramycin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
104142,Marketed,2025-04-14,02552450,Tyenne,1,L04AC07,Tocilizumab,Solution,Intravenous,02552450,TYENNE (tocilizumab 80 mg per 4 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9013366,tocilizumab 80 mg per 4 mL solution for injection vial,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
104142,Marketed,2025-04-14,02552450,Tyenne,1,L04AC07,Tocilizumab,Solution,Intravenous,02552450,TYENNE (tocilizumab 80 mg per 4 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9013366,tocilizumab 80 mg per 4 mL solution for injection vial,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
104143,Marketed,2025-04-14,02552469,Tyenne,1,L04AC07,Tocilizumab,Solution,Intravenous,02552469,TYENNE (tocilizumab 200 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9013364,tocilizumab 200 mg per 10 mL solution for injection vial,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
104143,Marketed,2025-04-14,02552469,Tyenne,1,L04AC07,Tocilizumab,Solution,Intravenous,02552469,TYENNE (tocilizumab 200 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9013364,tocilizumab 200 mg per 10 mL solution for injection vial,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
104144,Marketed,2025-04-14,02552477,Tyenne,1,L04AC07,Tocilizumab,Solution,Intravenous,02552477,TYENNE (tocilizumab 400 mg per 20 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9013365,tocilizumab 400 mg per 20 mL solution for injection vial,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
104144,Marketed,2025-04-14,02552477,Tyenne,1,L04AC07,Tocilizumab,Solution,Intravenous,02552477,TYENNE (tocilizumab 400 mg per 20 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9013365,tocilizumab 400 mg per 20 mL solution for injection vial,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
104145,Marketed,2025-04-14,02552485,Tyenne,1,L04AC07,Tocilizumab,Solution,Subcutaneous,02552485,TYENNE SINGLE USE AUTOINJECTOR (tocilizumab 162 mg per 0.9 mL solution for injection syringe) FRESENIUS KABI CANADA LTD,Active,9013363,tocilizumab 162 mg per 0.9 mL solution for injection syringe,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
104145,Marketed,2025-04-14,02552485,Tyenne,1,L04AC07,Tocilizumab,Solution,Subcutaneous,02552485,TYENNE SINGLE USE AUTOINJECTOR (tocilizumab 162 mg per 0.9 mL solution for injection syringe) FRESENIUS KABI CANADA LTD,Active,9013363,tocilizumab 162 mg per 0.9 mL solution for injection syringe,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
104146,Marketed,2025-04-14,02552493,Tyenne,1,L04AC07,Tocilizumab,Solution,Subcutaneous,02552493,TYENNE SINGLE USE PREFILLED SYRINGE (tocilizumab 162 mg per 0.9 mL solution for injection syringe) FRESENIUS KABI CANADA LTD,Active,9013363,tocilizumab 162 mg per 0.9 mL solution for injection syringe,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
104146,Marketed,2025-04-14,02552493,Tyenne,1,L04AC07,Tocilizumab,Solution,Subcutaneous,02552493,TYENNE SINGLE USE PREFILLED SYRINGE (tocilizumab 162 mg per 0.9 mL solution for injection syringe) FRESENIUS KABI CANADA LTD,Active,9013363,tocilizumab 162 mg per 0.9 mL solution for injection syringe,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
106494,Marketed,2026-01-14,02562022,Avtozma,1,L04AC07,Tocilizumab,Solution,Intravenous,02562022,AVTOZMA (tocilizumab 80 mg per 4 mL solution for injection vial) CELLTRION INC.,Active,9013366,tocilizumab 80 mg per 4 mL solution for injection vial,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
106494,Marketed,2026-01-14,02562022,Avtozma,1,L04AC07,Tocilizumab,Solution,Intravenous,02562022,AVTOZMA (tocilizumab 80 mg per 4 mL solution for injection vial) CELLTRION INC.,Active,9013366,tocilizumab 80 mg per 4 mL solution for injection vial,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
106495,Marketed,2026-01-14,02562030,Avtozma,1,L04AC07,Tocilizumab,Solution,Intravenous,02562030,AVTOZMA (tocilizumab 200 mg per 10 mL solution for injection vial) CELLTRION INC.,Active,9013364,tocilizumab 200 mg per 10 mL solution for injection vial,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
106495,Marketed,2026-01-14,02562030,Avtozma,1,L04AC07,Tocilizumab,Solution,Intravenous,02562030,AVTOZMA (tocilizumab 200 mg per 10 mL solution for injection vial) CELLTRION INC.,Active,9013364,tocilizumab 200 mg per 10 mL solution for injection vial,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
106496,Marketed,2026-01-14,02562049,Avtozma,1,L04AC07,Tocilizumab,Solution,Intravenous,02562049,AVTOZMA (tocilizumab 400 mg per 20 mL solution for injection vial) CELLTRION INC.,Active,9013365,tocilizumab 400 mg per 20 mL solution for injection vial,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
106496,Marketed,2026-01-14,02562049,Avtozma,1,L04AC07,Tocilizumab,Solution,Intravenous,02562049,AVTOZMA (tocilizumab 400 mg per 20 mL solution for injection vial) CELLTRION INC.,Active,9013365,tocilizumab 400 mg per 20 mL solution for injection vial,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
106497,Marketed,2026-01-14,02562057,Avtozma,1,L04AC07,Tocilizumab,Solution,Subcutaneous,02562057,AVTOZMA SINGLE-USE PRE-FILLED SYRINGE (tocilizumab 162 mg per 0.9 mL solution for injection syringe) CELLTRION INC.,Active,9013363,tocilizumab 162 mg per 0.9 mL solution for injection syringe,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
106497,Marketed,2026-01-14,02562057,Avtozma,1,L04AC07,Tocilizumab,Solution,Subcutaneous,02562057,AVTOZMA SINGLE-USE PRE-FILLED SYRINGE (tocilizumab 162 mg per 0.9 mL solution for injection syringe) CELLTRION INC.,Active,9013363,tocilizumab 162 mg per 0.9 mL solution for injection syringe,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
106498,Marketed,2026-01-14,02562065,Avtozma,1,L04AC07,Tocilizumab,Solution,Subcutaneous,02562065,AVTOZMA SINGLE-USE PRE-FILLED AUTOINJECTOR (tocilizumab 162 mg per 0.9 mL solution for injection syringe) CELLTRION INC.,Active,9013363,tocilizumab 162 mg per 0.9 mL solution for injection syringe,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
106498,Marketed,2026-01-14,02562065,Avtozma,1,L04AC07,Tocilizumab,Solution,Subcutaneous,02562065,AVTOZMA SINGLE-USE PRE-FILLED AUTOINJECTOR (tocilizumab 162 mg per 0.9 mL solution for injection syringe) CELLTRION INC.,Active,9013363,tocilizumab 162 mg per 0.9 mL solution for injection syringe,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
83533,Marketed,2010-05-26,02350092,Actemra,1,L04AC07,Tocilizumab,Solution,Intravenous,02350092,ACTEMRA (tocilizumab 80 mg per 4 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9013366,tocilizumab 80 mg per 4 mL solution for injection vial,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
83533,Marketed,2010-05-26,02350092,Actemra,1,L04AC07,Tocilizumab,Solution,Intravenous,02350092,ACTEMRA (tocilizumab 80 mg per 4 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9013366,tocilizumab 80 mg per 4 mL solution for injection vial,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
83534,Marketed,2010-05-26,02350106,Actemra,1,L04AC07,Tocilizumab,Solution,Intravenous,02350106,ACTEMRA (tocilizumab 200 mg per 10 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9013364,tocilizumab 200 mg per 10 mL solution for injection vial,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
83534,Marketed,2010-05-26,02350106,Actemra,1,L04AC07,Tocilizumab,Solution,Intravenous,02350106,ACTEMRA (tocilizumab 200 mg per 10 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9013364,tocilizumab 200 mg per 10 mL solution for injection vial,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
83535,Marketed,2010-05-26,02350114,Actemra,1,L04AC07,Tocilizumab,Solution,Intravenous,02350114,ACTEMRA (tocilizumab 400 mg per 20 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9013365,tocilizumab 400 mg per 20 mL solution for injection vial,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
83535,Marketed,2010-05-26,02350114,Actemra,1,L04AC07,Tocilizumab,Solution,Intravenous,02350114,ACTEMRA (tocilizumab 400 mg per 20 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9013365,tocilizumab 400 mg per 20 mL solution for injection vial,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
90943,Marketed,2014-05-30,02424770,Actemra,1,L04AC07,Tocilizumab,Solution,Subcutaneous,02424770,ACTEMRA PREFILLED SYRINGE (tocilizumab 162 mg per 0.9 mL solution for injection syringe) HOFFMANN-LA ROCHE LIMITED,Active,9013363,tocilizumab 162 mg per 0.9 mL solution for injection syringe,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
90943,Marketed,2014-05-30,02424770,Actemra,1,L04AC07,Tocilizumab,Solution,Subcutaneous,02424770,ACTEMRA PREFILLED SYRINGE (tocilizumab 162 mg per 0.9 mL solution for injection syringe) HOFFMANN-LA ROCHE LIMITED,Active,9013363,tocilizumab 162 mg per 0.9 mL solution for injection syringe,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
97376,Marketed,2019-01-15,02483327,Actemra,1,L04AC07,Tocilizumab,Solution,Subcutaneous,02483327,ACTEMRA PREFILLED AUTOINJECTOR (tocilizumab 162 mg per 0.9 mL solution for injection syringe) HOFFMANN-LA ROCHE LIMITED,Active,9013363,tocilizumab 162 mg per 0.9 mL solution for injection syringe,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
97376,Marketed,2019-01-15,02483327,Actemra,1,L04AC07,Tocilizumab,Solution,Subcutaneous,02483327,ACTEMRA PREFILLED AUTOINJECTOR (tocilizumab 162 mg per 0.9 mL solution for injection syringe) HOFFMANN-LA ROCHE LIMITED,Active,9013363,tocilizumab 162 mg per 0.9 mL solution for injection syringe,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
100052,Marketed,2022-11-28,02511304,Taro-Tofacitinib,1,L04AF01,Tofacitinib,Tablet,Oral,02511304,TARO-TOFACITINIB (tofacitinib (tofacitinib citrate) 5 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9005537,tofacitinib (tofacitinib citrate) 5 mg oral tablet,8001967,tofacitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100053,Marketed,2022-11-28,02511312,Taro-Tofacitinib,1,L04AF01,Tofacitinib,Tablet,Oral,02511312,TARO-TOFACITINIB (tofacitinib (tofacitinib citrate) 10 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9013790,tofacitinib (tofacitinib citrate) 10 mg oral tablet,8001967,tofacitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101191,Marketed,2022-11-25,02522799,PMS-Tofacitinib,1,L04AF01,Tofacitinib,Tablet,Oral,02522799,PMS-TOFACITINIB (tofacitinib (tofacitinib citrate) 5 mg oral tablet) PHARMASCIENCE INC,Active,9005537,tofacitinib (tofacitinib citrate) 5 mg oral tablet,8001967,tofacitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101198,Marketed,2023-10-20,02522896,JAMP Tofacitinib,1,L04AF01,Tofacitinib,Tablet,Oral,02522896,JAMP TOFACITINIB (tofacitinib (tofacitinib citrate) 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9005537,tofacitinib (tofacitinib citrate) 5 mg oral tablet,8001967,tofacitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101923,Marketed,2022-11-28,02530007,Auro-Tofacitinib,1,L04AF01,Tofacitinib,Tablet,Oral,02530007,AURO-TOFACITINIB (tofacitinib (tofacitinib citrate) 5 mg oral tablet) AURO PHARMA INC,Active,9005537,tofacitinib (tofacitinib citrate) 5 mg oral tablet,8001967,tofacitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101924,Marketed,2022-11-28,02530015,Auro-Tofacitinib,1,L04AF01,Tofacitinib,Tablet,Oral,02530015,AURO-TOFACITINIB (tofacitinib (tofacitinib citrate) 10 mg oral tablet) AURO PHARMA INC,Active,9013790,tofacitinib (tofacitinib citrate) 10 mg oral tablet,8001967,tofacitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
104042,Marketed,2025-08-27,02551691,Sandoz Tofacitinib,1,L04AF01,Tofacitinib,Tablet,Oral,02551691,SANDOZ TOFACITINIB (tofacitinib (tofacitinib citrate) 5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005537,tofacitinib (tofacitinib citrate) 5 mg oral tablet,8001967,tofacitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
104044,Marketed,2025-08-27,02551705,Sandoz Tofacitinib,1,L04AF01,Tofacitinib,Tablet,Oral,02551705,SANDOZ TOFACITINIB (tofacitinib (tofacitinib citrate) 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9013790,tofacitinib (tofacitinib citrate) 10 mg oral tablet,8001967,tofacitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
104287,Marketed,2025-03-03,02553988,Taro-Tofacitinib XR,1,L04AF01,Tofacitinib,Tablet (extended-release),Oral,02553988,TARO-TOFACITINIB XR (tofacitinib (tofacitinib citrate) 11 mg prolonged-release oral tablet) TARO PHARMACEUTICALS INC,Active,9013367,tofacitinib (tofacitinib citrate) 11 mg prolonged-release oral tablet,8001967,tofacitinib,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
90863,Marketed,2014-06-03,02423898,Xeljanz,1,L04AF01,Tofacitinib,Tablet,Oral,02423898,XELJANZ (tofacitinib (tofacitinib citrate) 5 mg oral tablet) PFIZER CANADA ULC,Active,9005537,tofacitinib (tofacitinib citrate) 5 mg oral tablet,8001967,tofacitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
95960,Marketed,2018-03-29,02470608,Xeljanz XR,1,L04AF01,Tofacitinib,Tablet (extended-release),Oral,02470608,XELJANZ XR (tofacitinib (tofacitinib citrate) 11 mg prolonged-release oral tablet) PFIZER CANADA ULC,Active,9013367,tofacitinib (tofacitinib citrate) 11 mg prolonged-release oral tablet,8001967,tofacitinib,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
97137,Marketed,2019-01-30,02480786,Xeljanz,1,L04AF01,Tofacitinib,Tablet,Oral,02480786,XELJANZ (tofacitinib (tofacitinib citrate) 10 mg oral tablet) PFIZER CANADA ULC,Active,9013790,tofacitinib (tofacitinib citrate) 10 mg oral tablet,8001967,tofacitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
104447,Marketed,2025-05-14,02555735,Qalsody,1,N07XX22,Tofersen,Solution,Intrathecal,02555735,QALSODY (tofersen 100 mg per 15 mL solution for injection vial) BIOGEN CANADA INC,Active,9015209,tofersen 100 mg per 15 mL solution for injection vial,8002546,tofersen,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,,,,Prescription
101690,Marketed,2023-06-01,02527723,Footrenew,1,D01AE18,Tolnaftate,Solution,Topical,02527723,FOOTRENEW (tolnaftate 1 % cutaneous solution) NAILRENEW CORP.,Active,9005400,tolnaftate 1 % cutaneous solution,8001968,tolnaftate,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Non-Prescription Drugs
106417,Marketed,2026-03-19,02561182,Athlete's Foot Cream,1,D01AE18,Tolnaftate,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
37941,Marketed,2010-03-10,02226707,"Tolnaftate Cream USP, 1%",1,D01AE18,Tolnaftate,Cream,Topical,02226707,"TOLNAFTATE CREAM USP, 1% (tolnaftate 1 % cutaneous cream) TARO PHARMACEUTICALS INC",Active,9001617,tolnaftate 1 % cutaneous cream,8001968,tolnaftate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
41608,Marketed,2016-07-25,00576034,Tinactin,1,D01AE18,Tolnaftate,Cream,Topical,00576034,TINACTIN (tolnaftate 1 % cutaneous cream) BAYER INC,Active,9001617,tolnaftate 1 % cutaneous cream,8001968,tolnaftate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
41611,Marketed,2018-05-22,00576042,Tinactin Powder,1,D01AE18,Tolnaftate,Powder,Topical,00576042,TINACTIN POWDER (tolnaftate 1 % cutaneous powder) BAYER INC,Active,9001618,tolnaftate 1 % cutaneous powder,8001968,tolnaftate,448598008,Cutaneous,385112003,Cutaneous powder,,,,,,Non-Prescription Drugs
41612,Marketed,2017-07-17,00576050,Tinactin Aerosol Powder,1,D01AE18,Tolnaftate,"Aerosol,Powder",Topical,00576050,TINACTIN AEROSOL POWDER (tolnaftate 1 % cutaneous spray powder) BAYER INC,Active,9013368,tolnaftate 1 % cutaneous spray powder,8001968,tolnaftate,448598008,Cutaneous,385112003,Cutaneous powder,30784000,Aerosol sprayer (physical object),,,,Non-Prescription Drugs
41933,Marketed,2023-02-10,01919245,Dr. Scholl's Athlete's Foot Spray Powder,1,D01AE18,Tolnaftate,"Powder,Aerosol",Topical,01919245,DR. SCHOLL'S ATHLETE'S FOOT SPRAY POWDER (tolnaftate 1 % cutaneous spray powder) SCHOLL'S WELLNESS COMPANY,Active,9013368,tolnaftate 1 % cutaneous spray powder,8001968,tolnaftate,448598008,Cutaneous,385112003,Cutaneous powder,30784000,Aerosol sprayer (physical object),,,,Non-Prescription Drugs
68767,Marketed,2014-10-27,02244777,Odor-Eaters,1,D01AE18,Tolnaftate,Aerosol,Topical,02244777,ODOR-EATERS (tolnaftate 1 % cutaneous spray) BLISTEX CORPORATION,Active,9001998,tolnaftate 1 % cutaneous spray,8001968,tolnaftate,448598008,Cutaneous,421720008,Spray,,,,,,Non-Prescription Drugs
78123,Marketed,2015-09-25,02295873,Flexitol Medicated Anti-Fungal Cream,1,D01AE18,Tolnaftate,Cream,Topical,02295873,FLEXITOL MEDICATED ANTI-FUNGAL CREAM (tolnaftate 1 % cutaneous cream) LACORIUM HEALTH INTERNATIONAL PTY LTD.,Active,9001617,tolnaftate 1 % cutaneous cream,8001968,tolnaftate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
80475,Marketed,2017-06-09,02319276,Tinactin Chill Deodorant Powder Spray,1,D01AE18,Tolnaftate,"Powder,Aerosol",Topical,02319276,TINACTIN CHILL DEODORANT POWDER SPRAY (tolnaftate 1 % cutaneous spray powder) BAYER INC,Active,9013368,tolnaftate 1 % cutaneous spray powder,8001968,tolnaftate,448598008,Cutaneous,385112003,Cutaneous powder,30784000,Aerosol sprayer (physical object),,,,Non-Prescription Drugs
80479,Marketed,2017-08-23,02319314,Tinactin Chill Liquid Spray,1,D01AE18,Tolnaftate,Aerosol,Topical,02319314,TINACTIN CHILL LIQUID SPRAY (tolnaftate 1 % cutaneous spray) BAYER INC,Active,9001998,tolnaftate 1 % cutaneous spray,8001968,tolnaftate,448598008,Cutaneous,421720008,Spray,,,,,,Non-Prescription Drugs
89839,Marketed,2024-06-04,02413760,Formula 3,1,D01AE18,Tolnaftate,Solution,Topical,02413760,FORMULA 3 (tolnaftate 1 % cutaneous solution) THE TETRA CORPORATION,Active,9005400,tolnaftate 1 % cutaneous solution,8001968,tolnaftate,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Non-Prescription Drugs
91618,Marketed,2020-04-07,02431718,Foot Care Foam,1,D01AE18,Tolnaftate,"Aerosol, foam",Topical,02431718,FOOT CARE FOAM (tolnaftate 1 % cutaneous foam) NSC PHARMA GMBH & CO.KG,Active,9005788,tolnaftate 1 % cutaneous foam,8001968,tolnaftate,448598008,Cutaneous,421166008,Foam,,,,,,Non-Prescription Drugs
62518,Marketed,2023-08-30,02239064,Detrol,1,G04BD07,Tolterodine,Tablet,Oral,02239064,DETROL (tolterodine tartrate 1 mg oral tablet) BGP PHARMA ULC,Active,9000826,tolterodine tartrate 1 mg oral tablet,8000265,tolterodine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
62519,Marketed,2023-08-30,02239065,Detrol,1,G04BD07,Tolterodine,Tablet,Oral,02239065,DETROL (tolterodine tartrate 2 mg oral tablet) BGP PHARMA ULC,Active,9000825,tolterodine tartrate 2 mg oral tablet,8000265,tolterodine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
68599,Marketed,2023-05-29,02244612,Detrol LA,1,G04BD07,Tolterodine,Capsule (extended release),Oral,02244612,DETROL LA (tolterodine tartrate 2 mg prolonged-release oral capsule) BGP PHARMA ULC,Active,9000978,tolterodine tartrate 2 mg prolonged-release oral capsule,8000265,tolterodine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
68600,Marketed,2023-05-29,02244613,Detrol LA,1,G04BD07,Tolterodine,Capsule (extended release),Oral,02244613,DETROL LA (tolterodine tartrate 4 mg prolonged-release oral capsule) BGP PHARMA ULC,Active,9000979,tolterodine tartrate 4 mg prolonged-release oral capsule,8000265,tolterodine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
78497,Marketed,2015-12-16,02299593,Teva-Tolterodine,1,G04BD07,Tolterodine,Tablet,Oral,02299593,TEVA-TOLTERODINE (tolterodine tartrate 1 mg oral tablet) TEVA CANADA LIMITED,Active,9000826,tolterodine tartrate 1 mg oral tablet,8000265,tolterodine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78498,Marketed,2021-08-16,02299607,Teva-Tolterodine,1,G04BD07,Tolterodine,Tablet,Oral,02299607,TEVA-TOLTERODINE (tolterodine tartrate 2 mg oral tablet) TEVA CANADA LIMITED,Active,9000825,tolterodine tartrate 2 mg oral tablet,8000265,tolterodine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89676,Marketed,2015-12-16,02412195,Teva-Tolterodine LA,1,G04BD07,Tolterodine,Capsule (extended release),Oral,02412195,TEVA-TOLTERODINE LA (tolterodine tartrate 2 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9000978,tolterodine tartrate 2 mg prolonged-release oral capsule,8000265,tolterodine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
89677,Marketed,2015-12-16,02412209,Teva-Tolterodine LA,1,G04BD07,Tolterodine,Capsule (extended release),Oral,02412209,TEVA-TOLTERODINE LA (tolterodine tartrate 4 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9000979,tolterodine tartrate 4 mg prolonged-release oral capsule,8000265,tolterodine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
89782,Marketed,2015-12-16,02413140,Sandoz Tolterodine LA,1,G04BD07,Tolterodine,Capsule (extended release),Oral,02413140,SANDOZ TOLTERODINE LA (tolterodine tartrate 2 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED,Active,9000978,tolterodine tartrate 2 mg prolonged-release oral capsule,8000265,tolterodine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
89783,Marketed,2015-12-16,02413159,Sandoz Tolterodine LA,1,G04BD07,Tolterodine,Capsule (extended release),Oral,02413159,SANDOZ TOLTERODINE LA (tolterodine tartrate 4 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED,Active,9000979,tolterodine tartrate 4 mg prolonged-release oral capsule,8000265,tolterodine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
90805,Marketed,2015-12-16,02423308,Mint-Tolterodine,1,G04BD07,Tolterodine,Tablet,Oral,02423308,MINT-TOLTERODINE (tolterodine tartrate 1 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000826,tolterodine tartrate 1 mg oral tablet,8000265,tolterodine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90806,Marketed,2015-12-16,02423316,Mint-Tolterodine,1,G04BD07,Tolterodine,Tablet,Oral,02423316,MINT-TOLTERODINE (tolterodine tartrate 2 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000825,tolterodine tartrate 2 mg oral tablet,8000265,tolterodine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98668,Marketed,2022-07-21,02496836,JAMP Tolterodine,1,G04BD07,Tolterodine,Tablet,Oral,02496836,JAMP TOLTERODINE (tolterodine tartrate 1 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000826,tolterodine tartrate 1 mg oral tablet,8000265,tolterodine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98669,Marketed,2022-07-21,02496844,JAMP Tolterodine,1,G04BD07,Tolterodine,Tablet,Oral,02496844,JAMP TOLTERODINE (tolterodine tartrate 2 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000825,tolterodine tartrate 2 mg oral tablet,8000265,tolterodine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106052,Marketed,2026-01-21,02557177,Lupin-Tolvaptan,2,C03XA01,Tolvaptan,Tablet,Oral,02557177,LUPIN-TOLVAPTAN (tolvaptan 15 mg oral tablet) LUPIN PHARMA CANADA LIMITED,Active,9012159,tolvaptan 15 mg oral tablet,8000986,tolvaptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106053,Marketed,2026-01-21,02557185,Lupin-Tolvaptan,2,C03XA01,Tolvaptan,Tablet,Oral,02557185,LUPIN-TOLVAPTAN (tolvaptan 15 mg oral tablet with tolvaptan 30 mg oral tablet) LUPIN PHARMA CANADA LIMITED,Active,9014278,tolvaptan 15 mg oral tablet with tolvaptan 30 mg oral tablet,8000986,tolvaptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106056,Marketed,2026-01-21,02557215,Lupin-Tolvaptan,2,C03XA01,Tolvaptan,Tablet,Oral,02557215,LUPIN-TOLVAPTAN (tolvaptan 30 mg oral tablet with tolvaptan 90 mg oral tablet) LUPIN PHARMA CANADA LIMITED,Active,9012163,tolvaptan 30 mg oral tablet with tolvaptan 90 mg oral tablet,8000986,tolvaptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85561,Marketed,2011-09-22,02370468,Samsca,1,C03XA01,Tolvaptan,Tablet,Oral,02370468,SAMSCA (tolvaptan 15 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9012159,tolvaptan 15 mg oral tablet,8000986,tolvaptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85562,Marketed,2011-09-22,02370476,Samsca,1,C03XA01,Tolvaptan,Tablet,Oral,02370476,SAMSCA (tolvaptan 30 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9012161,tolvaptan 30 mg oral tablet,8000986,tolvaptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92184,Marketed,2015-06-01,02437503,Jinarc,2,C03XA01,Tolvaptan,Tablet,Oral,02437503,JINARC (tolvaptan 15 mg oral tablet with tolvaptan 45 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9012160,tolvaptan 15 mg oral tablet with tolvaptan 45 mg oral tablet,8000986,tolvaptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92185,Marketed,2015-06-01,02437511,Jinarc,2,C03XA01,Tolvaptan,Tablet,Oral,02437511,JINARC (tolvaptan 30 mg oral tablet with tolvaptan 60 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9012162,tolvaptan 30 mg oral tablet with tolvaptan 60 mg oral tablet,8000986,tolvaptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92186,Marketed,2015-06-01,02437538,Jinarc,2,C03XA01,Tolvaptan,Tablet,Oral,02437538,JINARC (tolvaptan 30 mg oral tablet with tolvaptan 90 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9012163,tolvaptan 30 mg oral tablet with tolvaptan 90 mg oral tablet,8000986,tolvaptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98156,Marketed,2020-03-26,02491575,Jinarc,2,C03XA01,Tolvaptan,Tablet,Oral,02491575,JINARC (tolvaptan 15 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9012159,tolvaptan 15 mg oral tablet,8000986,tolvaptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98157,Marketed,2020-03-26,02491583,Jinarc,2,C03XA01,Tolvaptan,Tablet,Oral,02491583,JINARC (tolvaptan 15 mg oral tablet with tolvaptan 30 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9014278,tolvaptan 15 mg oral tablet with tolvaptan 30 mg oral tablet,8000986,tolvaptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
13347,Marketed,1992-12-31,01930699,Zap Topical Anesthetic Gel,2,D04AB30,"Topical anesthetics, combinations",Gel,Topical,01930699,ZAP TOPICAL ANESTHETIC GEL (benzocaine 18 % and tetracaine hydrochloride 2 % oromucosal gel) GERMIPHENE CORPORATION,Active,9003248,benzocaine 18 % and tetracaine hydrochloride 2 % oromucosal gel,8001891,benzocaine and tetracaine,372473007,Oromucosal,385100002,Gel,,,,,,Ethical
50238,Marketed,2024-01-03,02230958,One Touch Topical Anesthetic Gel,2,D04AB30,"Topical anesthetics, combinations",Gel,Buccal,02230958,ONE TOUCH TOPICAL ANESTHETIC GEL (benzocaine 18 % and tetracaine hydrochloride 2 % oromucosal gel) ABJ CUSTOM PACKAGING,Active,9003248,benzocaine 18 % and tetracaine hydrochloride 2 % oromucosal gel,8001891,benzocaine and tetracaine,372473007,Oromucosal,385100002,Gel,,,,,,Ethical
102548,Marketed,2023-07-19,02536722,AG-Topiramate Tablets,1,N03AX11,Topiramate,Tablet,Oral,02536722,AG-TOPIRAMATE TABLETS (topiramate 25 mg oral tablet) ANGITA PHARMA INC.,Active,9000715,topiramate 25 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102549,Marketed,2024-02-28,02536730,AG-Topiramate Tablets,1,N03AX11,Topiramate,Tablet,Oral,02536730,AG-TOPIRAMATE TABLETS (topiramate 100 mg oral tablet) ANGITA PHARMA INC.,Active,9000713,topiramate 100 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102717,Marketed,2024-01-11,02538458,Nra-Topiramate,1,N03AX11,Topiramate,Tablet,Oral,02538458,NRA-TOPIRAMATE (topiramate 100 mg oral tablet) NORA PHARMA INC,Active,9000713,topiramate 100 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102718,Marketed,2024-01-11,02538466,Nra-Topiramate,1,N03AX11,Topiramate,Tablet,Oral,02538466,NRA-TOPIRAMATE (topiramate 25 mg oral tablet) NORA PHARMA INC,Active,9000715,topiramate 25 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102719,Marketed,2024-01-11,02538474,Nra-Topiramate,1,N03AX11,Topiramate,Tablet,Oral,02538474,NRA-TOPIRAMATE (topiramate 200 mg oral tablet) NORA PHARMA INC,Active,9000714,topiramate 200 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
103293,Marketed,2024-08-28,02544377,JAMP Topiramate Tablets,1,N03AX11,Topiramate,Tablet,Oral,02544377,JAMP TOPIRAMATE TABLETS (topiramate 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001248,topiramate 50 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
104278,Marketed,2025-12-29,02553880,Topiramate,1,N03AX11,Topiramate,Tablet,Oral,02553880,TOPIRAMATE (topiramate 200 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000714,topiramate 200 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
50171,Marketed,1997-03-25,02230893,Topamax 25 mg,1,N03AX11,Topiramate,Tablet,Oral,02230893,TOPAMAX 25MG (topiramate 25 mg oral tablet) JANSSEN INC,Active,9000715,topiramate 25 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
50172,Marketed,1997-03-25,02230894,Topamax 100 mg,1,N03AX11,Topiramate,Tablet,Oral,02230894,TOPAMAX 100MG (topiramate 100 mg oral tablet) JANSSEN INC,Active,9000713,topiramate 100 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
50174,Marketed,1997-03-25,02230896,Topamax 200 mg,1,N03AX11,Topiramate,Tablet,Oral,02230896,TOPAMAX 200MG (topiramate 200 mg oral tablet) JANSSEN INC,Active,9000714,topiramate 200 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
63399,Marketed,1999-06-11,02239907,Topamax,1,N03AX11,Topiramate,Capsule,Oral,02239907,TOPAMAX (topiramate 15 mg oral capsule) JANSSEN INC,Active,9000854,topiramate 15 mg oral capsule,8000240,topiramate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
63400,Marketed,1999-06-11,02239908,Topamax,1,N03AX11,Topiramate,Capsule,Oral,02239908,TOPAMAX (topiramate 25 mg oral capsule) JANSSEN INC,Active,9000855,topiramate 25 mg oral capsule,8000240,topiramate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
73232,Marketed,2011-05-07,02248860,Teva-Topiramate,1,N03AX11,Topiramate,Tablet,Oral,02248860,TEVA-TOPIRAMATE (topiramate 25 mg oral tablet) TEVA CANADA LIMITED,Active,9000715,topiramate 25 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
73233,Marketed,2011-05-07,02248861,Teva-Topiramate,1,N03AX11,Topiramate,Tablet,Oral,02248861,TEVA-TOPIRAMATE (topiramate 100 mg oral tablet) TEVA CANADA LIMITED,Active,9000713,topiramate 100 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
73234,Marketed,2011-05-07,02248862,Teva-Topiramate,1,N03AX11,Topiramate,Tablet,Oral,02248862,TEVA-TOPIRAMATE (topiramate 200 mg oral tablet) TEVA CANADA LIMITED,Active,9000714,topiramate 200 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
74840,Marketed,2005-09-14,02262991,PMS-Topiramate,1,N03AX11,Topiramate,Tablet,Oral,02262991,PMS-TOPIRAMATE (topiramate 25 mg oral tablet) PHARMASCIENCE INC,Active,9000715,topiramate 25 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
74841,Marketed,2005-09-14,02263009,PMS-Topiramate,1,N03AX11,Topiramate,Tablet,Oral,02263009,PMS-TOPIRAMATE (topiramate 100 mg oral tablet) PHARMASCIENCE INC,Active,9000713,topiramate 100 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
74842,Marketed,2005-09-14,02263017,PMS-Topiramate,1,N03AX11,Topiramate,Tablet,Oral,02263017,PMS-TOPIRAMATE (topiramate 200 mg oral tablet) PHARMASCIENCE INC,Active,9000714,topiramate 200 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
74874,Marketed,2009-10-21,02263351,Mylan-Topiramate,1,N03AX11,Topiramate,Tablet,Oral,02263351,MYLAN-TOPIRAMATE (topiramate 25 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000715,topiramate 25 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
74875,Marketed,2010-02-04,02263378,Mylan-Topiramate,1,N03AX11,Topiramate,Tablet,Oral,02263378,MYLAN-TOPIRAMATE (topiramate 100 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000713,topiramate 100 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
74876,Marketed,2009-11-06,02263386,Mylan-Topiramate,1,N03AX11,Topiramate,Tablet,Oral,02263386,MYLAN-TOPIRAMATE (topiramate 200 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000714,topiramate 200 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
76522,Marketed,2006-04-21,02279614,Apo-Topiramate,1,N03AX11,Topiramate,Tablet,Oral,02279614,APO-TOPIRAMATE (topiramate 25 mg oral tablet) APOTEX INC,Active,9000715,topiramate 25 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
76524,Marketed,2006-04-21,02279630,Apo-Topiramate,1,N03AX11,Topiramate,Tablet,Oral,02279630,APO-TOPIRAMATE (topiramate 100 mg oral tablet) APOTEX INC,Active,9000713,topiramate 100 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
76525,Marketed,2006-04-21,02279649,Apo-Topiramate,1,N03AX11,Topiramate,Tablet,Oral,02279649,APO-TOPIRAMATE (topiramate 200 mg oral tablet) APOTEX INC,Active,9000714,topiramate 200 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
77316,Marketed,2021-09-28,02287765,GLN-Topiramate,1,N03AX11,Topiramate,Tablet,Oral,02287765,GLN-TOPIRAMATE (topiramate 25 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9000715,topiramate 25 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
77317,Marketed,2021-09-28,02287773,GLN-Topiramate,1,N03AX11,Topiramate,Tablet,Oral,02287773,GLN-TOPIRAMATE (topiramate 100 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9000713,topiramate 100 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
77318,Marketed,2021-09-28,02287781,GLN-Topiramate,1,N03AX11,Topiramate,Tablet,Oral,02287781,GLN-TOPIRAMATE (topiramate 200 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9000714,topiramate 200 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
79760,Marketed,2008-06-17,02312085,PMS-Topiramate,1,N03AX11,Topiramate,Tablet,Oral,02312085,PMS-TOPIRAMATE (topiramate 50 mg oral tablet) PHARMASCIENCE INC,Active,9001248,topiramate 50 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
79915,Marketed,2008-10-27,02313650,Pro-Topiramate,1,N03AX11,Topiramate,Tablet,Oral,02313650,PRO-TOPIRAMATE (topiramate 25 mg oral tablet) PRO DOC LIMITEE,Active,9000715,topiramate 25 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
79916,Marketed,2008-10-27,02313669,Pro-Topiramate,1,N03AX11,Topiramate,Tablet,Oral,02313669,PRO-TOPIRAMATE (topiramate 100 mg oral tablet) PRO DOC LIMITEE,Active,9000713,topiramate 100 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
79917,Marketed,2008-10-27,02313677,Pro-Topiramate,1,N03AX11,Topiramate,Tablet,Oral,02313677,PRO-TOPIRAMATE (topiramate 200 mg oral tablet) PRO DOC LIMITEE,Active,9000714,topiramate 200 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
80117,Marketed,2024-06-26,02315645,Mint-Topiramate,1,N03AX11,Topiramate,Tablet,Oral,02315645,MINT-TOPIRAMATE (topiramate 25 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000715,topiramate 25 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
80118,Marketed,2024-06-26,02315653,Mint-Topiramate,1,N03AX11,Topiramate,Tablet,Oral,02315653,MINT-TOPIRAMATE (topiramate 100 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000713,topiramate 100 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
80119,Marketed,2024-06-26,02315661,Mint-Topiramate,1,N03AX11,Topiramate,Tablet,Oral,02315661,MINT-TOPIRAMATE (topiramate 200 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000714,topiramate 200 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
83068,Marketed,2023-03-01,02345250,JAMP Topiramate Tablets,1,N03AX11,Topiramate,Tablet,Oral,02345250,JAMP TOPIRAMATE TABLETS (topiramate 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000715,topiramate 25 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
83069,Marketed,2024-02-28,02345269,JAMP Topiramate Tablets,1,N03AX11,Topiramate,Tablet,Oral,02345269,JAMP TOPIRAMATE TABLETS (topiramate 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000713,topiramate 100 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
83070,Marketed,2023-12-14,02345277,JAMP Topiramate Tablets,1,N03AX11,Topiramate,Tablet,Oral,02345277,JAMP TOPIRAMATE TABLETS (topiramate 200 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000714,topiramate 200 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
83123,Marketed,2020-03-31,02345803,Auro-Topiramate,1,N03AX11,Topiramate,Tablet,Oral,02345803,AURO-TOPIRAMATE (topiramate 25 mg oral tablet) AURO PHARMA INC,Active,9000715,topiramate 25 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
83125,Marketed,2020-03-31,02345838,Auro-Topiramate,1,N03AX11,Topiramate,Tablet,Oral,02345838,AURO-TOPIRAMATE (topiramate 100 mg oral tablet) AURO PHARMA INC,Active,9000713,topiramate 100 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
83126,Marketed,2020-03-31,02345846,Auro-Topiramate,1,N03AX11,Topiramate,Tablet,Oral,02345846,AURO-TOPIRAMATE (topiramate 200 mg oral tablet) AURO PHARMA INC,Active,9000714,topiramate 200 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
84197,Marketed,2010-10-06,02356856,Topiramate,1,N03AX11,Topiramate,Tablet,Oral,02356856,TOPIRAMATE (topiramate 25 mg oral tablet) SANIS HEALTH INC,Active,9000715,topiramate 25 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
84198,Marketed,2010-10-06,02356864,Topiramate,1,N03AX11,Topiramate,Tablet,Oral,02356864,TOPIRAMATE (topiramate 100 mg oral tablet) SANIS HEALTH INC,Active,9000713,topiramate 100 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
84199,Marketed,2010-10-06,02356872,Topiramate,1,N03AX11,Topiramate,Tablet,Oral,02356872,TOPIRAMATE (topiramate 200 mg oral tablet) SANIS HEALTH INC,Active,9000714,topiramate 200 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
87497,Marketed,2018-07-06,02389460,Topiramate,1,N03AX11,Topiramate,Tablet,Oral,02389460,TOPIRAMATE (topiramate 25 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000715,topiramate 25 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
87499,Marketed,2018-05-04,02389487,Topiramate,1,N03AX11,Topiramate,Tablet,Oral,02389487,TOPIRAMATE (topiramate 100 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000713,topiramate 100 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
86529,Marketed,2017-05-18,02379422,Topotecan Hydrochloride For Injection,1,L01CE01,Topotecan,Solution,Intravenous,02379422,TOPOTECAN HYDROCHLORIDE FOR INJECTION (topotecan (topotecan hydrochloride) 4 mg per 4 mL solution for injection vial) PFIZER CANADA ULC,Active,9013370,topotecan (topotecan hydrochloride) 4 mg per 4 mL solution for injection vial,8001969,topotecan,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
87637,Marketed,2014-02-05,02390981,Topotecan Injection,1,L01CE01,Topotecan,Solution,Intravenous,02390981,TOPOTECAN INJECTION (topotecan (topotecan hydrochloride) 4 mg per 4 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013370,topotecan (topotecan hydrochloride) 4 mg per 4 mL solution for injection vial,8001969,topotecan,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
88140,Marketed,2013-11-21,02396378,Topotecan Hydrochloride For Injection,1,L01CE01,Topotecan,Solution,Intravenous,77700890,TOPOTECAN HYDROCHLORIDE FOR INJECTION (topotecan (topotecan hydrochloride) 4 mg per 4 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9013370,topotecan (topotecan hydrochloride) 4 mg per 4 mL solution for injection vial,8001969,topotecan,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
88140,Marketed,2013-11-21,02396378,Topotecan Hydrochloride For Injection,1,L01CE01,Topotecan,Solution,Intravenous,77700891,TOPOTECAN HYDROCHLORIDE FOR INJECTION (topotecan (topotecan hydrochloride) 1 mg per 1 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9013369,topotecan (topotecan hydrochloride) 1 mg per 1 mL solution for injection vial,8001969,topotecan,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
92544,Marketed,2020-10-09,02441071,Teva-Topotecan,1,L01CE01,Topotecan,Powder for solution,Intravenous,02441071,TEVA-TOPOTECAN (topotecan (topotecan hydrochloride) 4 mg per vial powder for solution for injection) TEVA CANADA LIMITED,Active,9003109,topotecan (topotecan hydrochloride) 4 mg per vial powder for solution for injection,8001969,topotecan,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
106511,Marketed,2026-01-26,02562219,Loqtorzi,1,L01FF13,Toripalimab,Solution,Intravenous,02562219,LOQTORZI (toripalimab 240 mg per 6 mL solution for injection vial) APOTEX INC,Active,9015385,toripalimab 240 mg per 6 mL solution for injection vial,8002580,toripalimab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,,,,Schedule D
106511,Marketed,2026-01-26,02562219,Loqtorzi,1,L01FF13,Toripalimab,Solution,Intravenous,02562219,LOQTORZI (toripalimab 240 mg per 6 mL solution for injection vial) APOTEX INC,Active,9015385,toripalimab 240 mg per 6 mL solution for injection vial,8002580,toripalimab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,,,,Prescription
83679,Marketed,2020-08-24,02351528,Yondelis,1,L01CX01,Trabectedin,Powder for solution,Intravenous,02351528,YONDELIS (trabectedin 1 mg per vial powder for solution for injection) VALEO PHARMA INC,Active,9004760,trabectedin 1 mg per vial powder for solution for injection,8001970,trabectedin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
101050,Marketed,2022-03-17,02521288,Adtralza,1,D11AH07,Tralokinumab,Solution,Subcutaneous,02521288,ADTRALZA (tralokinumab 150 mg per 1 mL solution for injection syringe) LEO PHARMA INC,Active,9014709,tralokinumab 150 mg per 1 mL solution for injection syringe,8002421,tralokinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
101050,Marketed,2022-03-17,02521288,Adtralza,1,D11AH07,Tralokinumab,Solution,Subcutaneous,02521288,ADTRALZA (tralokinumab 150 mg per 1 mL solution for injection syringe) LEO PHARMA INC,Active,9014709,tralokinumab 150 mg per 1 mL solution for injection syringe,8002421,tralokinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
102890,Marketed,2024-06-03,02540193,Adtralza,1,D11AH07,Tralokinumab,Solution,Subcutaneous,02540193,ADTRALZA (tralokinumab 300 mg per 2 mL solution for injection pen) LEO PHARMA INC,Active,9015057,tralokinumab 300 mg per 2 mL solution for injection pen,8002421,tralokinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
102890,Marketed,2024-06-03,02540193,Adtralza,1,D11AH07,Tralokinumab,Solution,Subcutaneous,02540193,ADTRALZA (tralokinumab 300 mg per 2 mL solution for injection pen) LEO PHARMA INC,Active,9015057,tralokinumab 300 mg per 2 mL solution for injection pen,8002421,tralokinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
100805,Marketed,2023-02-08,02518759,JAMP Tramadol HCL,1,N02AX02,Tramadol,Tablet,Oral,02518759,JAMP TRAMADOL HCL (tramadol hydrochloride 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001318,tramadol hydrochloride 50 mg oral tablet,8000369,tramadol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
77188,Marketed,2006-12-07,02286424,Zytram XL,1,N02AX02,Tramadol,Tablet (extended-release),Oral,02286424,ZYTRAM XL (tramadol hydrochloride 150 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9001182,tramadol hydrochloride 150 mg prolonged-release oral tablet,8000369,tramadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
77189,Marketed,2006-12-07,02286432,Zytram XL,1,N02AX02,Tramadol,Tablet (extended-release),Oral,02286432,ZYTRAM XL (tramadol hydrochloride 200 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9001183,tramadol hydrochloride 200 mg prolonged-release oral tablet,8000369,tramadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
77190,Marketed,2006-12-07,02286440,Zytram XL,1,N02AX02,Tramadol,Tablet (extended-release),Oral,02286440,ZYTRAM XL (tramadol hydrochloride 300 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9001184,tramadol hydrochloride 300 mg prolonged-release oral tablet,8000369,tramadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
77191,Marketed,2006-12-07,02286459,Zytram XL,1,N02AX02,Tramadol,Tablet (extended-release),Oral,02286459,ZYTRAM XL (tramadol hydrochloride 400 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9001185,tramadol hydrochloride 400 mg prolonged-release oral tablet,8000369,tramadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
78172,Marketed,2026-03-09,02296381,Tridural,1,N02AX02,Tramadol,Tablet (extended-release),Oral,02296381,TRIDURAL (tramadol hydrochloride 100 mg prolonged-release oral tablet) KNIGHT THERAPEUTICS INC.,Active,9001207,tramadol hydrochloride 100 mg prolonged-release oral tablet,8000369,tramadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
78173,Marketed,2026-03-09,02296403,Tridural,1,N02AX02,Tramadol,Tablet (extended-release),Oral,02296403,TRIDURAL (tramadol hydrochloride 200 mg prolonged-release oral tablet) KNIGHT THERAPEUTICS INC.,Active,9001183,tramadol hydrochloride 200 mg prolonged-release oral tablet,8000369,tramadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
78174,Marketed,2026-03-09,02296411,Tridural,1,N02AX02,Tramadol,Tablet (extended-release),Oral,02296411,TRIDURAL (tramadol hydrochloride 300 mg prolonged-release oral tablet) KNIGHT THERAPEUTICS INC.,Active,9001184,tramadol hydrochloride 300 mg prolonged-release oral tablet,8000369,tramadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
78458,Marketed,2021-06-25,02299194,Ralivia,1,N02AX02,Tramadol,Tablet (extended-release),Oral,02299194,"RALIVIA (tramadol hydrochloride 100 mg prolonged-release oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9001207,tramadol hydrochloride 100 mg prolonged-release oral tablet,8000369,tramadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
78459,Marketed,2021-06-25,02299208,Ralivia,1,N02AX02,Tramadol,Tablet (extended-release),Oral,02299208,"RALIVIA (tramadol hydrochloride 200 mg prolonged-release oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9001183,tramadol hydrochloride 200 mg prolonged-release oral tablet,8000369,tramadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
78460,Marketed,2021-06-25,02299216,Ralivia,1,N02AX02,Tramadol,Tablet (extended-release),Oral,02299216,"RALIVIA (tramadol hydrochloride 300 mg prolonged-release oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9001184,tramadol hydrochloride 300 mg prolonged-release oral tablet,8000369,tramadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
84529,Marketed,2011-03-02,02360322,Zytram XL,1,N02AX02,Tramadol,Tablet (extended-release),Oral,02360322,ZYTRAM XL (tramadol hydrochloride 75 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9001336,tramadol hydrochloride 75 mg prolonged-release oral tablet,8000369,tramadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
84531,Marketed,2011-03-02,02360349,Zytram XL,1,N02AX02,Tramadol,Tablet (extended-release),Oral,02360349,ZYTRAM XL (tramadol hydrochloride 100 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9001207,tramadol hydrochloride 100 mg prolonged-release oral tablet,8000369,tramadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
85814,Marketed,2012-03-19,02373017,Durela,1,N02AX02,Tramadol,Capsule (extended release),Oral,02373017,DURELA (tramadol hydrochloride 100 mg prolonged-release oral capsule) CIPHER PHARMACEUTICALS INC,Active,9001379,tramadol hydrochloride 100 mg prolonged-release oral capsule,8000369,tramadol,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Narcotics (CDSA I)
85815,Marketed,2012-03-19,02373025,Durela,1,N02AX02,Tramadol,Capsule (extended release),Oral,02373025,DURELA (tramadol hydrochloride 200 mg prolonged-release oral capsule) CIPHER PHARMACEUTICALS INC,Active,9001380,tramadol hydrochloride 200 mg prolonged-release oral capsule,8000369,tramadol,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Narcotics (CDSA I)
85816,Marketed,2012-03-19,02373033,Durela,1,N02AX02,Tramadol,Capsule (extended release),Oral,02373033,DURELA (tramadol hydrochloride 300 mg prolonged-release oral capsule) CIPHER PHARMACEUTICALS INC,Active,9001381,tramadol hydrochloride 300 mg prolonged-release oral capsule,8000369,tramadol,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Narcotics (CDSA I)
91076,Marketed,2020-03-16,02426153,Apo-Tramadol,1,N02AX02,Tramadol,Tablet,Oral,02426153,APO-TRAMADOL (tramadol hydrochloride 50 mg oral tablet) APOTEX INC,Active,9001318,tramadol hydrochloride 50 mg oral tablet,8000369,tramadol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
93657,Marketed,2016-03-07,02450429,Taro-Tramadol ER,1,N02AX02,Tramadol,Tablet (extended-release),Oral,02450429,TARO-TRAMADOL ER (tramadol hydrochloride 100 mg prolonged-release oral tablet) TARO PHARMACEUTICALS INC,Active,9001207,tramadol hydrochloride 100 mg prolonged-release oral tablet,8000369,tramadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
93658,Marketed,2016-05-27,02450437,Taro-Tramadol ER,1,N02AX02,Tramadol,Tablet (extended-release),Oral,02450437,TARO-TRAMADOL ER (tramadol hydrochloride 200 mg prolonged-release oral tablet) TARO PHARMACEUTICALS INC,Active,9001183,tramadol hydrochloride 200 mg prolonged-release oral tablet,8000369,tramadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
93659,Marketed,2016-05-27,02450445,Taro-Tramadol ER,1,N02AX02,Tramadol,Tablet (extended-release),Oral,02450445,TARO-TRAMADOL ER (tramadol hydrochloride 300 mg prolonged-release oral tablet) TARO PHARMACEUTICALS INC,Active,9001184,tramadol hydrochloride 300 mg prolonged-release oral tablet,8000369,tramadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
97034,Marketed,2019-04-11,02479672,Auro-Tramadol,1,N02AX02,Tramadol,Tablet,Oral,02479672,AURO-TRAMADOL (tramadol hydrochloride 50 mg oral tablet) AURO PHARMA INC,Active,9001318,tramadol hydrochloride 50 mg oral tablet,8000369,tramadol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
97151,Marketed,2019-07-18,02480859,Mar-Tramadol,1,N02AX02,Tramadol,Tablet,Oral,02480859,MAR-TRAMADOL (tramadol hydrochloride 50 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001318,tramadol hydrochloride 50 mg oral tablet,8000369,tramadol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
82241,Marketed,2009-11-09,02336790,Apo-Tramadol/Acet,2,N02AJ13,Tramadol and paracetamol,Tablet,Oral,02336790,APO-TRAMADOL/ACET (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) APOTEX INC,Active,9001121,acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet,8000349,acetaminophen and tramadol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
83257,Marketed,2012-09-04,02347180,Teva-Tramadol/Acetaminophen,2,N02AJ13,Tramadol and paracetamol,Tablet,Oral,02347180,TEVA-TRAMADOL/ACETAMINOPHEN (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) TEVA CANADA LIMITED,Active,9001121,acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet,8000349,acetaminophen and tramadol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
87374,Marketed,2021-10-21,02388197,Taro-Tramadol/Acet,2,N02AJ13,Tramadol and paracetamol,Tablet,Oral,02388197,TARO-TRAMADOL/ACET (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) SUN PHARMA CANADA INC,Active,9001121,acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet,8000349,acetaminophen and tramadol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
87385,Marketed,2012-09-05,02388308,JAMP-Acet-Tramadol,2,N02AJ13,Tramadol and paracetamol,Tablet,Oral,02388308,JAMP-ACET-TRAMADOL (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001121,acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet,8000349,acetaminophen and tramadol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
87386,Marketed,2012-09-04,02388324,Mar-Tramadol/Acet,2,N02AJ13,Tramadol and paracetamol,Tablet,Oral,02388324,MAR-TRAMADOL/ACET (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001121,acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet,8000349,acetaminophen and tramadol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
87528,Marketed,2012-09-18,02389800,Mint-Tramadol/Acet,2,N02AJ13,Tramadol and paracetamol,Tablet,Oral,02389800,MINT-TRAMADOL/ACET (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001121,acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet,8000349,acetaminophen and tramadol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
88654,Marketed,2023-07-28,02401657,PMS-Tramadol-Acet,2,N02AJ13,Tramadol and paracetamol,Tablet,Oral,02401657,PMS-TRAMADOL-ACET (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) PHARMASCIENCE INC,Active,9001121,acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet,8000349,acetaminophen and tramadol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
92342,Marketed,2015-04-08,02439050,Auro-Tramadol/Acetaminophen,2,N02AJ13,Tramadol and paracetamol,Tablet,Oral,02439050,AURO-TRAMADOL/ACETAMINOPHEN (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) AURO PHARMA INC,Active,9001121,acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet,8000349,acetaminophen and tramadol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Narcotics (CDSA I)
102872,Marketed,2023-11-30,02539993,Mekinist,1,L01EE01,Trametinib,Powder for solution,Oral,02539993,MEKINIST (trametinib 0.05 mg/mL oral solution) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014998,trametinib 0.05 mg/mL oral solution,8001971,trametinib,26643006,Oral,739006009,Solution,733026001,Vial (unit of presentation),1.0,,,Prescription
89431,Marketed,2016-07-04,02409623,Mekinist,1,L01EE01,Trametinib,Tablet,Oral,02409623,MEKINIST (trametinib 0.5 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9005316,trametinib 0.5 mg oral tablet,8001971,trametinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
89433,Marketed,2015-07-31,02409658,Mekinist,1,L01EE01,Trametinib,Tablet,Oral,02409658,MEKINIST (trametinib 2 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9005317,trametinib 2 mg oral tablet,8001971,trametinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101407,Marketed,2022-11-10,02525046,Trandolapril,1,C09AA10,Trandolapril,Capsule,Oral,02525046,TRANDOLAPRIL (trandolapril 1 mg oral capsule) SANIS HEALTH INC,Active,9000773,trandolapril 1 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
101408,Marketed,2022-11-10,02525054,Trandolapril,1,C09AA10,Trandolapril,Capsule,Oral,02525054,TRANDOLAPRIL (trandolapril 2 mg oral capsule) SANIS HEALTH INC,Active,9000774,trandolapril 2 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
101409,Marketed,2022-11-19,02525070,Trandolapril,1,C09AA10,Trandolapril,Capsule,Oral,02525070,TRANDOLAPRIL (trandolapril 4 mg oral capsule) SANIS HEALTH INC,Active,9001053,trandolapril 4 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
101565,Marketed,2022-11-23,02526565,Trandolapril,1,C09AA10,Trandolapril,Capsule,Oral,02526565,TRANDOLAPRIL (trandolapril 1 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000773,trandolapril 1 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
101566,Marketed,2022-11-23,02526573,Trandolapril,1,C09AA10,Trandolapril,Capsule,Oral,02526573,TRANDOLAPRIL (trandolapril 2 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000774,trandolapril 2 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
101567,Marketed,2022-11-23,02526581,Trandolapril,1,C09AA10,Trandolapril,Capsule,Oral,02526581,TRANDOLAPRIL (trandolapril 4 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9001053,trandolapril 4 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
50773,Marketed,2015-05-05,02231457,Mavik,1,C09AA10,Trandolapril,Capsule,Oral,02231457,MAVIK (trandolapril 0.5 mg oral capsule) BGP PHARMA ULC,Active,9000776,trandolapril 0.5 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
50775,Marketed,2016-04-22,02231459,Mavik,1,C09AA10,Trandolapril,Capsule,Oral,02231459,MAVIK (trandolapril 1 mg oral capsule) BGP PHARMA ULC,Active,9000773,trandolapril 1 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
50776,Marketed,2016-04-14,02231460,Mavik,1,C09AA10,Trandolapril,Capsule,Oral,02231460,MAVIK (trandolapril 2 mg oral capsule) BGP PHARMA ULC,Active,9000774,trandolapril 2 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
62731,Marketed,2015-01-01,02239267,Mavik,1,C09AA10,Trandolapril,Capsule,Oral,02239267,MAVIK (trandolapril 4 mg oral capsule) BGP PHARMA ULC,Active,9001053,trandolapril 4 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
81109,Marketed,2018-07-12,02325721,Sandoz Trandolapril,1,C09AA10,Trandolapril,Capsule,Oral,02325721,SANDOZ TRANDOLAPRIL (trandolapril 0.5 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9000776,trandolapril 0.5 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
81110,Marketed,2018-07-12,02325748,Sandoz Trandolapril,1,C09AA10,Trandolapril,Capsule,Oral,02325748,SANDOZ TRANDOLAPRIL (trandolapril 1 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9000773,trandolapril 1 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
81111,Marketed,2018-07-12,02325756,Sandoz Trandolapril,1,C09AA10,Trandolapril,Capsule,Oral,02325756,SANDOZ TRANDOLAPRIL (trandolapril 2 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9000774,trandolapril 2 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
81112,Marketed,2018-07-12,02325764,Sandoz Trandolapril,1,C09AA10,Trandolapril,Capsule,Oral,02325764,SANDOZ TRANDOLAPRIL (trandolapril 4 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001053,trandolapril 4 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
84285,Marketed,2018-05-18,02357755,PMS-Trandolapril,1,C09AA10,Trandolapril,Capsule,Oral,02357755,PMS-TRANDOLAPRIL (trandolapril 0.5 mg oral capsule) PHARMASCIENCE INC,Active,9000776,trandolapril 0.5 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
84286,Marketed,2018-05-18,02357763,PMS-Trandolapril,1,C09AA10,Trandolapril,Capsule,Oral,02357763,PMS-TRANDOLAPRIL (trandolapril 1 mg oral capsule) PHARMASCIENCE INC,Active,9000773,trandolapril 1 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
84287,Marketed,2018-05-18,02357771,PMS-Trandolapril,1,C09AA10,Trandolapril,Capsule,Oral,02357771,PMS-TRANDOLAPRIL (trandolapril 2 mg oral capsule) PHARMASCIENCE INC,Active,9000774,trandolapril 2 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
84288,Marketed,2018-05-20,02357798,PMS-Trandolapril,1,C09AA10,Trandolapril,Capsule,Oral,02357798,PMS-TRANDOLAPRIL (trandolapril 4 mg oral capsule) PHARMASCIENCE INC,Active,9001053,trandolapril 4 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96106,Marketed,2018-09-27,02471868,Auro-Trandolapril,1,C09AA10,Trandolapril,Capsule,Oral,02471868,AURO-TRANDOLAPRIL (trandolapril 0.5 mg oral capsule) AURO PHARMA INC,Active,9000776,trandolapril 0.5 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96109,Marketed,2018-09-27,02471876,Auro-Trandolapril,1,C09AA10,Trandolapril,Capsule,Oral,02471876,AURO-TRANDOLAPRIL (trandolapril 1 mg oral capsule) AURO PHARMA INC,Active,9000773,trandolapril 1 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96110,Marketed,2018-09-27,02471884,Auro-Trandolapril,1,C09AA10,Trandolapril,Capsule,Oral,02471884,AURO-TRANDOLAPRIL (trandolapril 2 mg oral capsule) AURO PHARMA INC,Active,9000774,trandolapril 2 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96111,Marketed,2018-09-27,02471892,Auro-Trandolapril,1,C09AA10,Trandolapril,Capsule,Oral,02471892,AURO-TRANDOLAPRIL (trandolapril 4 mg oral capsule) AURO PHARMA INC,Active,9001053,trandolapril 4 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97878,Marketed,2019-07-09,02488698,Trandolapril,1,C09AA10,Trandolapril,Capsule,Oral,02488698,TRANDOLAPRIL (trandolapril 1 mg oral capsule) PRO DOC LIMITEE,Active,9000773,trandolapril 1 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97879,Marketed,2019-07-09,02488701,Trandolapril,1,C09AA10,Trandolapril,Capsule,Oral,02488701,TRANDOLAPRIL (trandolapril 2 mg oral capsule) PRO DOC LIMITEE,Active,9000774,trandolapril 2 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97880,Marketed,2019-07-09,02488728,Trandolapril,1,C09AA10,Trandolapril,Capsule,Oral,02488728,TRANDOLAPRIL (trandolapril 4 mg oral capsule) PRO DOC LIMITEE,Active,9001053,trandolapril 4 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
100846,Marketed,2022-02-23,02519194,Tranexamic Acid,1,B02AA02,Tranexamic acid,Tablet,Oral,02519194,TRANEXAMIC ACID (tranexamic acid 500 mg oral tablet) JAMP PHARMA CORPORATION,Active,9002881,tranexamic acid 500 mg oral tablet,8001972,tranexamic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102034,Marketed,2026-03-02,02531194,Tranexamic Acid Injection,1,B02AA02,Tranexamic acid,Solution,Intravenous,77701201,TRANEXAMIC ACID INJECTION (tranexamic acid 500 mg per 5 mL solution for injection ampoule) EUGIA PHARMA INC.,Active,9013374,tranexamic acid 500 mg per 5 mL solution for injection ampoule,8001972,tranexamic acid,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
102034,Marketed,2026-03-02,02531194,Tranexamic Acid Injection,1,B02AA02,Tranexamic acid,Solution,Intravenous,77701202,TRANEXAMIC ACID INJECTION (tranexamic acid 1000 mg per 10 mL solution for injection ampoule) EUGIA PHARMA INC.,Active,9013372,tranexamic acid 1000 mg per 10 mL solution for injection ampoule,8001972,tranexamic acid,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
102035,Marketed,2024-11-06,02531208,Tranexamic Acid Injection,1,B02AA02,Tranexamic acid,Solution,Intravenous,77701166,TRANEXAMIC ACID INJECTION (tranexamic acid 1000 mg per 10 mL solution for injection vial) EUGIA PHARMA INC.,Active,9013373,tranexamic acid 1000 mg per 10 mL solution for injection vial,8001972,tranexamic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
102035,Marketed,2024-11-06,02531208,Tranexamic Acid Injection,1,B02AA02,Tranexamic acid,Solution,Intravenous,77701167,TRANEXAMIC ACID INJECTION (tranexamic acid 500 mg per 5 mL solution for injection vial) EUGIA PHARMA INC.,Active,9013375,tranexamic acid 500 mg per 5 mL solution for injection vial,8001972,tranexamic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
103824,Marketed,2024-12-03,02549395,M-Tranexamic Acid,1,B02AA02,Tranexamic acid,Tablet,Oral,02549395,M-TRANEXAMIC ACID (tranexamic acid 500 mg oral tablet) MANTRA PHARMA INC,Active,9002881,tranexamic acid 500 mg oral tablet,8001972,tranexamic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
18072,Marketed,2005-07-08,02064405,Cyklokapron 500 mg,1,B02AA02,Tranexamic acid,Tablet,Oral,02064405,CYKLOKAPRON 500 MG (tranexamic acid 500 mg oral tablet) PFIZER CANADA ULC,Active,9002881,tranexamic acid 500 mg oral tablet,8001972,tranexamic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
18371,Marketed,2006-02-15,02064413,Cyklokapron 100 mg/mL,1,B02AA02,Tranexamic acid,Solution,Intravenous,77700836,CYKLOKAPRON 100 MG/ML (tranexamic acid 1000 mg per 10 mL solution for injection ampoule) PFIZER CANADA ULC,Active,9013372,tranexamic acid 1000 mg per 10 mL solution for injection ampoule,8001972,tranexamic acid,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
18371,Marketed,2006-02-15,02064413,Cyklokapron 100 mg/mL,1,B02AA02,Tranexamic acid,Solution,Intravenous,77700837,CYKLOKAPRON 100 MG/ML (tranexamic acid 500 mg per 5 mL solution for injection ampoule) PFIZER CANADA ULC,Active,9013374,tranexamic acid 500 mg per 5 mL solution for injection ampoule,8001972,tranexamic acid,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
70531,Marketed,2005-11-15,02246365,Tranexamic Acid Injection BP,1,B02AA02,Tranexamic acid,Solution,Intravenous,77700858,TRANEXAMIC ACID INJECTION BP (tranexamic acid 500 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013375,tranexamic acid 500 mg per 5 mL solution for injection vial,8001972,tranexamic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
70531,Marketed,2005-11-15,02246365,Tranexamic Acid Injection BP,1,B02AA02,Tranexamic acid,Solution,Intravenous,77700859,TRANEXAMIC ACID INJECTION BP (tranexamic acid 1000 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013373,tranexamic acid 1000 mg per 10 mL solution for injection vial,8001972,tranexamic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
70531,Marketed,2005-11-15,02246365,Tranexamic Acid Injection BP,1,B02AA02,Tranexamic acid,Solution,Intravenous,77700860,TRANEXAMIC ACID INJECTION BP (tranexamic acid 100 mg per mL solution for injection 50 mL vial) SANDOZ CANADA INCORPORATED,Active,9013371,tranexamic acid 100 mg per mL solution for injection 50 mL vial,8001972,tranexamic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
87801,Marketed,2013-03-27,02392763,Tranexamic Acid Injection,1,B02AA02,Tranexamic acid,Solution,Intravenous,77700887,TRANEXAMIC ACID INJECTION (tranexamic acid 500 mg per 5 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013375,tranexamic acid 500 mg per 5 mL solution for injection vial,8001972,tranexamic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
87801,Marketed,2013-03-27,02392763,Tranexamic Acid Injection,1,B02AA02,Tranexamic acid,Solution,Intravenous,77700888,TRANEXAMIC ACID INJECTION (tranexamic acid 1000 mg per 10 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013373,tranexamic acid 1000 mg per 10 mL solution for injection vial,8001972,tranexamic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
87801,Marketed,2013-03-27,02392763,Tranexamic Acid Injection,1,B02AA02,Tranexamic acid,Solution,Intravenous,77700889,TRANEXAMIC ACID INJECTION (tranexamic acid 100 mg per mL solution for injection 50 mL vial) OMEGA LABORATORIES LIMITED,Active,9013371,tranexamic acid 100 mg per mL solution for injection 50 mL vial,8001972,tranexamic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
88596,Marketed,2013-02-13,02401231,Tranexamic Acid Tablets,1,B02AA02,Tranexamic acid,Tablet,Oral,02401231,TRANEXAMIC ACID TABLETS (tranexamic acid 500 mg oral tablet) STERIMAX INC,Active,9002881,tranexamic acid 500 mg oral tablet,8001972,tranexamic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89382,Marketed,2014-03-07,02409097,GD-Tranexamic Acid,1,B02AA02,Tranexamic acid,Tablet,Oral,02409097,GD-TRANEXAMIC ACID (tranexamic acid 500 mg oral tablet) GENMED A DIVISION OF PFIZER CANADA ULC,Active,9002881,tranexamic acid 500 mg oral tablet,8001972,tranexamic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95428,Marketed,2021-06-09,02466015,Tranexamic Acid Injection,1,B02AA02,Tranexamic acid,Solution,Intravenous,77701077,TRANEXAMIC ACID INJECTION (tranexamic acid 500 mg per 5 mL solution for injection ampoule) AURO PHARMA INC,Active,9013374,tranexamic acid 500 mg per 5 mL solution for injection ampoule,8001972,tranexamic acid,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
95428,Marketed,2021-06-09,02466015,Tranexamic Acid Injection,1,B02AA02,Tranexamic acid,Solution,Intravenous,77701078,TRANEXAMIC ACID INJECTION (tranexamic acid 1000 mg per 10 mL solution for injection ampoule) AURO PHARMA INC,Active,9013372,tranexamic acid 1000 mg per 10 mL solution for injection ampoule,8001972,tranexamic acid,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
98610,Marketed,2020-06-04,02496232,Mar-Tranexamic Acid,1,B02AA02,Tranexamic acid,Tablet,Oral,02496232,MAR-TRANEXAMIC ACID (tranexamic acid 500 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9002881,tranexamic acid 500 mg oral tablet,8001972,tranexamic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98715,Marketed,2021-04-30,02497328,Tranexamic Acid Injection,1,B02AA02,Tranexamic acid,Solution,Intravenous,02497328,TRANEXAMIC ACID INJECTION (tranexamic acid 1000 mg per 10 mL solution for injection vial) JAMP PHARMA CORPORATION,Active,9013373,tranexamic acid 1000 mg per 10 mL solution for injection vial,8001972,tranexamic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
103077,Marketed,2025-03-07,02542188,M-Tranylcypromine,1,N06AF04,Tranylcypromine,Tablet,Oral,02542188,M-TRANYLCYPROMINE (tranylcypromine (tranylcypromine sulfate) 10 mg oral tablet) MANTRA PHARMA INC,Active,9002496,tranylcypromine (tranylcypromine sulfate) 10 mg oral tablet,8001538,tranylcypromine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
15231,Marketed,2002-07-16,01919598,Parnate,1,N06AF04,Tranylcypromine,Tablet,Oral,01919598,PARNATE (tranylcypromine (tranylcypromine sulfate) 10 mg oral tablet) GLAXOSMITHKLINE INC,Active,9002496,tranylcypromine (tranylcypromine sulfate) 10 mg oral tablet,8001538,tranylcypromine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100755,Marketed,2021-10-07,02518244,Kanjinti,1,L01FD01,Trastuzumab,Powder for solution,Intravenous,02518244,KANJINTI (trastuzumab 150 mg per vial powder for solution for injection) AMGEN CANADA INC,Active,9014072,trastuzumab 150 mg per vial powder for solution for injection,8001973,trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,1.0,Prescription
100755,Marketed,2021-10-07,02518244,Kanjinti,1,L01FD01,Trastuzumab,Powder for solution,Intravenous,02518244,KANJINTI (trastuzumab 150 mg per vial powder for solution for injection) AMGEN CANADA INC,Active,9014072,trastuzumab 150 mg per vial powder for solution for injection,8001973,trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,1.0,Schedule D
101335,Marketed,2022-07-20,02524317,Ontruzant,1,L01FD01,Trastuzumab,Powder for solution,Intravenous,02524317,"ONTRUZANT (trastuzumab 150 mg per vial powder for solution for injection) SAMSUNG BIOEPIS CO., LTD",Active,9014072,trastuzumab 150 mg per vial powder for solution for injection,8001973,trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,1.0,Schedule D
101335,Marketed,2022-07-20,02524317,Ontruzant,1,L01FD01,Trastuzumab,Powder for solution,Intravenous,02524317,"ONTRUZANT (trastuzumab 150 mg per vial powder for solution for injection) SAMSUNG BIOEPIS CO., LTD",Active,9014072,trastuzumab 150 mg per vial powder for solution for injection,8001973,trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,1.0,Prescription
101336,Marketed,2022-07-20,02524325,Ontruzant,1,L01FD01,Trastuzumab,Powder for solution,Intravenous,02524325,"ONTRUZANT (trastuzumab 440 mg per vial powder for solution for injection with diluent solution) SAMSUNG BIOEPIS CO., LTD",Active,9013525,trastuzumab 440 mg per vial powder for solution for injection with diluent solution,8001973,trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,1.0,Prescription
101336,Marketed,2022-07-20,02524325,Ontruzant,1,L01FD01,Trastuzumab,Powder for solution,Intravenous,02524325,"ONTRUZANT (trastuzumab 440 mg per vial powder for solution for injection with diluent solution) SAMSUNG BIOEPIS CO., LTD",Active,9013525,trastuzumab 440 mg per vial powder for solution for injection with diluent solution,8001973,trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,1.0,Schedule D
64277,Marketed,1999-08-23,02240692,Herceptin,1,L01FD01,Trastuzumab,Powder for solution,Intravenous,02240692,HERCEPTIN (trastuzumab 440 mg per vial powder for solution for injection with diluent solution) HOFFMANN-LA ROCHE LIMITED,Active,9013525,trastuzumab 440 mg per vial powder for solution for injection with diluent solution,8001973,trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
64277,Marketed,1999-08-23,02240692,Herceptin,1,L01FD01,Trastuzumab,Powder for solution,Intravenous,02240692,HERCEPTIN (trastuzumab 440 mg per vial powder for solution for injection with diluent solution) HOFFMANN-LA ROCHE LIMITED,Active,9013525,trastuzumab 440 mg per vial powder for solution for injection with diluent solution,8001973,trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
96453,Marketed,2023-12-18,02474425,Ogivri,1,L01FD01,Trastuzumab,Powder for solution,Intravenous,02474425,OGIVRI (trastuzumab 150 mg per vial powder for solution for injection) BIOSIMILAR COLLABORATIONS IRELAND LIMITED,Active,9014072,trastuzumab 150 mg per vial powder for solution for injection,8001973,trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,1.0,Schedule D
96453,Marketed,2023-12-18,02474425,Ogivri,1,L01FD01,Trastuzumab,Powder for solution,Intravenous,02474425,OGIVRI (trastuzumab 150 mg per vial powder for solution for injection) BIOSIMILAR COLLABORATIONS IRELAND LIMITED,Active,9014072,trastuzumab 150 mg per vial powder for solution for injection,8001973,trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,1.0,Prescription
96454,Marketed,2024-02-15,02474433,Ogivri,2,L01FD01,Trastuzumab,Powder for solution,Intravenous,02474433,OGIVRI (trastuzumab 440 mg per vial powder for solution for injection with diluent solution) BIOSIMILAR COLLABORATIONS IRELAND LIMITED,Active,9013525,trastuzumab 440 mg per vial powder for solution for injection with diluent solution,8001973,trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,1.0,Prescription
96454,Marketed,2024-02-15,02474433,Ogivri,2,L01FD01,Trastuzumab,Powder for solution,Intravenous,02474433,OGIVRI (trastuzumab 440 mg per vial powder for solution for injection with diluent solution) BIOSIMILAR COLLABORATIONS IRELAND LIMITED,Active,9013525,trastuzumab 440 mg per vial powder for solution for injection with diluent solution,8001973,trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,1.0,Schedule D
97124,Marketed,2018-10-12,02480697,Herceptin SC,1,L01FD01,Trastuzumab,Solution,Subcutaneous,02480697,HERCEPTIN SC (trastuzumab 600 mg per 5 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9013526,trastuzumab 600 mg per 5 mL solution for injection vial,8001973,trastuzumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
97124,Marketed,2018-10-12,02480697,Herceptin SC,1,L01FD01,Trastuzumab,Solution,Subcutaneous,02480697,HERCEPTIN SC (trastuzumab 600 mg per 5 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9013526,trastuzumab 600 mg per 5 mL solution for injection vial,8001973,trastuzumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
97138,Marketed,2025-11-28,02480794,Herzuma,1,L01FD01,Trastuzumab,"Powder for solution,Kit",Intravenous,02480794,HERZUMA (trastuzumab 440 mg per vial powder for solution for injection with diluent solution) CELLTRION INC.,Active,9013525,trastuzumab 440 mg per vial powder for solution for injection with diluent solution,8001973,trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,1.0,Schedule D
97138,Marketed,2025-11-28,02480794,Herzuma,1,L01FD01,Trastuzumab,"Powder for solution,Kit",Intravenous,02480794,HERZUMA (trastuzumab 440 mg per vial powder for solution for injection with diluent solution) CELLTRION INC.,Active,9013525,trastuzumab 440 mg per vial powder for solution for injection with diluent solution,8001973,trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,1.0,Prescription
97382,Marketed,2019-10-22,02483467,Trazimera,1,L01FD01,Trastuzumab,Powder for solution,Intravenous,02483467,TRAZIMERA (trastuzumab 440 mg per vial powder for solution for injection with diluent solution) PFIZER CANADA ULC,Active,9013525,trastuzumab 440 mg per vial powder for solution for injection with diluent solution,8001973,trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,1.0,Prescription
97382,Marketed,2019-10-22,02483467,Trazimera,1,L01FD01,Trastuzumab,Powder for solution,Intravenous,02483467,TRAZIMERA (trastuzumab 440 mg per vial powder for solution for injection with diluent solution) PFIZER CANADA ULC,Active,9013525,trastuzumab 440 mg per vial powder for solution for injection with diluent solution,8001973,trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,1.0,Schedule D
97383,Marketed,2019-10-22,02483475,Trazimera,1,L01FD01,Trastuzumab,Powder for solution,Intravenous,02483475,TRAZIMERA (trastuzumab 150 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9014072,trastuzumab 150 mg per vial powder for solution for injection,8001973,trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,1.0,Schedule D
97383,Marketed,2019-10-22,02483475,Trazimera,1,L01FD01,Trastuzumab,Powder for solution,Intravenous,02483475,TRAZIMERA (trastuzumab 150 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9014072,trastuzumab 150 mg per vial powder for solution for injection,8001973,trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,1.0,Prescription
98651,Marketed,2020-04-16,02496690,Kanjinti,1,L01FD01,Trastuzumab,"Powder for solution,Kit",Intravenous,02496690,KANJINTI (trastuzumab 420 mg per vial powder for solution for injection with diluent solution) AMGEN CANADA INC,Active,9014279,trastuzumab 420 mg per vial powder for solution for injection with diluent solution,8001973,trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,1.0,Schedule D
98651,Marketed,2020-04-16,02496690,Kanjinti,1,L01FD01,Trastuzumab,"Powder for solution,Kit",Intravenous,02496690,KANJINTI (trastuzumab 420 mg per vial powder for solution for injection with diluent solution) AMGEN CANADA INC,Active,9014279,trastuzumab 420 mg per vial powder for solution for injection with diluent solution,8001973,trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,1.0,Prescription
99555,Marketed,2024-10-03,02506211,Herzuma,1,L01FD01,Trastuzumab,Powder for solution,Intravenous,02506211,HERZUMA (trastuzumab 150 mg per vial powder for solution for injection) CELLTRION INC.,Active,9014072,trastuzumab 150 mg per vial powder for solution for injection,8001973,trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,1.0,Schedule D
99555,Marketed,2024-10-03,02506211,Herzuma,1,L01FD01,Trastuzumab,Powder for solution,Intravenous,02506211,HERZUMA (trastuzumab 150 mg per vial powder for solution for injection) CELLTRION INC.,Active,9014072,trastuzumab 150 mg per vial powder for solution for injection,8001973,trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,1.0,Prescription
100355,Marketed,2021-07-09,02514400,Enhertu,1,L01FD04,Trastuzumab deruxtecan,Powder for solution,Intravenous,02514400,ENHERTU (trastuzumab deruxtecan 100 mg per vial powder for solution for injection) ASTRAZENECA CANADA INC,Active,9014573,trastuzumab deruxtecan 100 mg per vial powder for solution for injection,8002382,trastuzumab deruxtecan,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
100355,Marketed,2021-07-09,02514400,Enhertu,1,L01FD04,Trastuzumab deruxtecan,Powder for solution,Intravenous,02514400,ENHERTU (trastuzumab deruxtecan 100 mg per vial powder for solution for injection) ASTRAZENECA CANADA INC,Active,9014573,trastuzumab deruxtecan 100 mg per vial powder for solution for injection,8002382,trastuzumab deruxtecan,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
89698,Marketed,2013-10-09,02412365,Kadcyla,1,L01FD03,Trastuzumab emtansine,Powder for solution,Intravenous,02412365,KADCYLA (trastuzumab emtansine 100 mg per vial powder for solution for injection) HOFFMANN-LA ROCHE LIMITED,Active,9013377,trastuzumab emtansine 100 mg per vial powder for solution for injection,8001974,trastuzumab emtansine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
89698,Marketed,2013-10-09,02412365,Kadcyla,1,L01FD03,Trastuzumab emtansine,Powder for solution,Intravenous,02412365,KADCYLA (trastuzumab emtansine 100 mg per vial powder for solution for injection) HOFFMANN-LA ROCHE LIMITED,Active,9013377,trastuzumab emtansine 100 mg per vial powder for solution for injection,8001974,trastuzumab emtansine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
96263,Marketed,2018-10-24,02473224,Kadcyla,1,L01FD03,Trastuzumab emtansine,Powder for solution,Intravenous,02473224,KADCYLA (trastuzumab emtansine 160 mg per vial powder for solution for injection) HOFFMANN-LA ROCHE LIMITED,Active,9013527,trastuzumab emtansine 160 mg per vial powder for solution for injection,8001974,trastuzumab emtansine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
96263,Marketed,2018-10-24,02473224,Kadcyla,1,L01FD03,Trastuzumab emtansine,Powder for solution,Intravenous,02473224,KADCYLA (trastuzumab emtansine 160 mg per vial powder for solution for injection) HOFFMANN-LA ROCHE LIMITED,Active,9013527,trastuzumab emtansine 160 mg per vial powder for solution for injection,8001974,trastuzumab emtansine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
103698,Marketed,2025-05-20,02548089,JAMP Travoprost Z,1,S01EE04,Travoprost,Solution,Ophthalmic,02548089,JAMP TRAVOPROST Z (travoprost 0.004 % ophthalmic drops) JAMP PHARMA CORPORATION,Active,9001259,travoprost 0.004 % ophthalmic drops,8000381,travoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
80351,Marketed,2018-02-01,02318008,Travatan Z,1,S01EE04,Travoprost,Solution,Ophthalmic,02318008,TRAVATAN Z (travoprost 0.004 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9001259,travoprost 0.004 % ophthalmic drops,8000381,travoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
89784,Marketed,2014-08-15,02413167,Sandoz Travoprost,1,S01EE04,Travoprost,Solution,Ophthalmic,02413167,SANDOZ TRAVOPROST (travoprost 0.004 % ophthalmic drops) SANDOZ CANADA INCORPORATED,Active,9001259,travoprost 0.004 % ophthalmic drops,8000381,travoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
94502,Marketed,2018-04-03,02457997,Izba,1,S01EE04,Travoprost,Solution,Ophthalmic,02457997,IZBA (travoprost 0.003 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9001475,travoprost 0.003 % ophthalmic drops,8000381,travoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
102666,Marketed,2024-04-23,02537907,AG-Trazodone,1,N06AX05,Trazodone,Tablet,Oral,02537907,AG-TRAZODONE (trazodone hydrochloride 50 mg oral tablet) ANGITA PHARMA INC.,Active,9000497,trazodone hydrochloride 50 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102667,Marketed,2024-04-23,02537915,AG-Trazodone,1,N06AX05,Trazodone,Tablet,Oral,02537915,AG-TRAZODONE (trazodone hydrochloride 100 mg oral tablet) ANGITA PHARMA INC.,Active,9000496,trazodone hydrochloride 100 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102668,Marketed,2024-04-23,02537923,AG-Trazodone,1,N06AX05,Trazodone,Tablet,Oral,02537923,AG-TRAZODONE (trazodone hydrochloride 150 mg oral tablet) ANGITA PHARMA INC.,Active,9000638,trazodone hydrochloride 150 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
13780,Marketed,1993-12-31,01937235,PMS Trazodone HCL Tablets 100 mg,1,N06AX05,Trazodone,Tablet,Oral,01937235,PMS TRAZODONE HCL TAB 100MG (trazodone hydrochloride 100 mg oral tablet) PHARMASCIENCE INC,Active,9000496,trazodone hydrochloride 100 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
18040,Marketed,1995-12-31,02147653,Apo-Trazodone D Tablets 150 mg,1,N06AX05,Trazodone,Tablet,Oral,02147653,APO-TRAZODONE D TABLETS 150MG (trazodone hydrochloride 150 mg oral tablet) APOTEX INC,Active,9000638,trazodone hydrochloride 150 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
18045,Marketed,1995-12-31,02147645,Apo-Trazodone Tablets 100 mg,1,N06AX05,Trazodone,Tablet,Oral,02147645,APO-TRAZODONE TABLETS 100MG (trazodone hydrochloride 100 mg oral tablet) APOTEX INC,Active,9000496,trazodone hydrochloride 100 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
18046,Marketed,1995-12-31,02147637,Apo-Trazodone Tablets 50 mg,1,N06AX05,Trazodone,Tablet,Oral,02147637,APO-TRAZODONE TABLETS 50MG (trazodone hydrochloride 50 mg oral tablet) APOTEX INC,Active,9000497,trazodone hydrochloride 50 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
18189,Marketed,2011-06-15,02144298,Teva-Trazodone,1,N06AX05,Trazodone,Tablet,Oral,02144298,TEVA-TRAZODONE (trazodone hydrochloride 150 mg oral tablet) TEVA CANADA LIMITED,Active,9000638,trazodone hydrochloride 150 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
18190,Marketed,2011-06-15,02144271,Teva-Trazodone,1,N06AX05,Trazodone,Tablet,Oral,02144271,TEVA-TRAZODONE (trazodone hydrochloride 100 mg oral tablet) TEVA CANADA LIMITED,Active,9000496,trazodone hydrochloride 100 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
18191,Marketed,2011-06-15,02144263,Teva-Trazodone,1,N06AX05,Trazodone,Tablet,Oral,02144263,TEVA-TRAZODONE (trazodone hydrochloride 50 mg oral tablet) TEVA CANADA LIMITED,Active,9000497,trazodone hydrochloride 50 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
19936,Marketed,1996-12-31,02164353,Trazodone-50,1,N06AX05,Trazodone,Tablet,Oral,02164353,TRAZODONE-50 (trazodone hydrochloride 50 mg oral tablet) PRO DOC LIMITEE,Active,9000497,trazodone hydrochloride 50 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
19937,Marketed,1996-12-31,02164361,Trazodone-100,1,N06AX05,Trazodone,Tablet,Oral,02164361,TRAZODONE-100 (trazodone hydrochloride 100 mg oral tablet) PRO DOC LIMITEE,Active,9000496,trazodone hydrochloride 100 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
19938,Marketed,1996-12-31,02164388,Trazodone-150 D,1,N06AX05,Trazodone,Tablet,Oral,02164388,TRAZODONE-150 D (trazodone hydrochloride 150 mg oral tablet) PRO DOC LIMITEE,Active,9000638,trazodone hydrochloride 150 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
4241,Marketed,1993-12-31,01937227,PMS Trazodone HCL Tablets 50 mg,1,N06AX05,Trazodone,Tablet,Oral,01937227,PMS TRAZODONE HCL TAB 50MG (trazodone hydrochloride 50 mg oral tablet) PHARMASCIENCE INC,Active,9000497,trazodone hydrochloride 50 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
60663,Marketed,1998-02-17,02237339,PMS-Trazodone,1,N06AX05,Trazodone,Tablet,Oral,02237339,PMS-TRAZODONE (trazodone hydrochloride 75 mg oral tablet) PHARMASCIENCE INC,Active,9000782,trazodone hydrochloride 75 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83411,Marketed,2014-07-31,02348772,Trazodone,1,N06AX05,Trazodone,Tablet,Oral,02348772,TRAZODONE (trazodone hydrochloride 50 mg oral tablet) SANIS HEALTH INC,Active,9000497,trazodone hydrochloride 50 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83412,Marketed,2014-07-31,02348780,Trazodone,1,N06AX05,Trazodone,Tablet,Oral,02348780,TRAZODONE (trazodone hydrochloride 100 mg oral tablet) SANIS HEALTH INC,Active,9000496,trazodone hydrochloride 100 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83413,Marketed,2014-07-31,02348799,Trazodone,1,N06AX05,Trazodone,Tablet,Oral,02348799,TRAZODONE (trazodone hydrochloride 150 mg oral tablet) SANIS HEALTH INC,Active,9000638,trazodone hydrochloride 150 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92726,Marketed,2021-12-07,02442809,JAMP Trazodone,1,N06AX05,Trazodone,Tablet,Oral,02442809,JAMP TRAZODONE (trazodone hydrochloride 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000497,trazodone hydrochloride 50 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92727,Marketed,2021-11-19,02442817,JAMP Trazodone,1,N06AX05,Trazodone,Tablet,Oral,02442817,JAMP TRAZODONE (trazodone hydrochloride 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000496,trazodone hydrochloride 100 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92729,Marketed,2021-11-19,02442825,JAMP Trazodone,1,N06AX05,Trazodone,Tablet,Oral,02442825,JAMP TRAZODONE (trazodone hydrochloride 150 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000638,trazodone hydrochloride 150 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
98787,Marketed,2020-09-28,02498073,Itulatek,1,V01AA05,Tree pollen,Tablet,Sublingual,,,,,,,,,,,,,,,,,Prescription
98787,Marketed,2020-09-28,02498073,Itulatek,1,V01AA05,Tree pollen,Tablet,Sublingual,,,,,,,,,,,,,,,,,Schedule D
102967,Marketed,2023-10-23,02541009,Imjudo,1,L01FX20,Tremelimumab,Solution,Intravenous,77701137,IMJUDO (tremelimumab 25 mg per 1.25 mL solution for injection vial) ASTRAZENECA CANADA INC,Active,9014956,tremelimumab 25 mg per 1.25 mL solution for injection vial,8002485,tremelimumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
102967,Marketed,2023-10-23,02541009,Imjudo,1,L01FX20,Tremelimumab,Solution,Intravenous,77701138,IMJUDO (tremelimumab 300 mg per 15 mL solution for injection vial) ASTRAZENECA CANADA INC,Active,9014957,tremelimumab 300 mg per 15 mL solution for injection vial,8002485,tremelimumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
100679,Marketed,2021-08-31,02517388,Trecondyv,1,L01AB02,Treosulfan,Powder,Intravenous,02517388,TRECONDYV (treosulfan 5 g per vial powder for solution for injection) MEDEXUS PHARMACEUTICALS INC.,Active,9014815,treosulfan 5 g per vial powder for solution for injection,8002457,treosulfan,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
106363,Marketed,2025-11-26,02560585,Treosulfan For Injection,1,L01AB02,Treosulfan,Powder,Intravenous,02560585,TREOSULFAN FOR INJECTION (treosulfan 5 g per vial powder for solution for injection) MARCAN PHARMACEUTICALS INC,Active,9014815,treosulfan 5 g per vial powder for solution for injection,8002457,treosulfan,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
70735,Marketed,2005-10-07,02246552,Remodulin,1,B01AC21,Treprostinil,Solution,"Subcutaneous,Intravenous",02246552,REMODULIN (treprostinil (treprostinil sodium) 20 mg per 20 mL solution for injection vial) UNITED THERAPEUTICS CORPORATION,Active,9013379,treprostinil (treprostinil sodium) 20 mg per 20 mL solution for injection vial,8001975,treprostinil,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
70736,Marketed,2005-10-07,02246553,Remodulin,1,B01AC21,Treprostinil,Solution,"Subcutaneous,Intravenous",02246553,REMODULIN (treprostinil (treprostinil sodium) 50 mg per 20 mL solution for injection vial) UNITED THERAPEUTICS CORPORATION,Active,9013381,treprostinil (treprostinil sodium) 50 mg per 20 mL solution for injection vial,8001975,treprostinil,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
70737,Marketed,2005-10-07,02246554,Remodulin,1,B01AC21,Treprostinil,Solution,"Subcutaneous,Intravenous",02246554,REMODULIN (treprostinil (treprostinil sodium) 100 mg per 20 mL solution for injection vial) UNITED THERAPEUTICS CORPORATION,Active,9013378,treprostinil (treprostinil sodium) 100 mg per 20 mL solution for injection vial,8001975,treprostinil,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
70738,Marketed,2005-10-07,02246555,Remodulin,1,B01AC21,Treprostinil,Solution,"Intravenous,Subcutaneous",02246555,REMODULIN (treprostinil (treprostinil sodium) 200 mg per 20 mL solution for injection vial) UNITED THERAPEUTICS CORPORATION,Active,9013380,treprostinil (treprostinil sodium) 200 mg per 20 mL solution for injection vial,8001975,treprostinil,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
100925,Marketed,2022-08-29,02520036,JAMP Tretinoin,1,L01XF01,Tretinoin,Capsule,Oral,02520036,JAMP TRETINOIN (tretinoin 10 mg oral capsule) JAMP PHARMA CORPORATION,Active,9002882,tretinoin 10 mg oral capsule,8001307,tretinoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
11152,Marketed,2019-12-13,00443794,Retin-A,1,D10AD01,Tretinoin,Cream,Topical,00443794,"RETIN-A (tretinoin 0.05 % cutaneous cream) BAUSCH HEALTH, CANADA INC.",Active,9001921,tretinoin 0.05 % cutaneous cream,8001307,tretinoin,448598008,Cutaneous,421628006,Cutaneous cream,,,1.0,,,Prescription
11153,Marketed,2019-12-13,00443816,Retin-A,1,D10AD01,Tretinoin,Gel,Topical,00443816,"RETIN-A (tretinoin 0.025 % cutaneous gel) BAUSCH HEALTH, CANADA INC.",Active,9002092,tretinoin 0.025 % cutaneous gel,8001307,tretinoin,448598008,Cutaneous,385100002,Gel,,,1.0,,,Prescription
12544,Marketed,2020-09-30,01926489,Vitamin A Acid,1,D10AD01,Tretinoin,Gel,Topical,01926489,"VITAMIN A ACID (tretinoin 0.05 % cutaneous gel) BAUSCH HEALTH, CANADA INC.",Active,9001823,tretinoin 0.05 % cutaneous gel,8001307,tretinoin,448598008,Cutaneous,385100002,Gel,,,1.0,,,Prescription
12753,Marketed,2020-09-30,01926462,Vitamin A Acid,1,D10AD01,Tretinoin,Gel,Topical,01926462,"VITAMIN A ACID (tretinoin 0.01 % cutaneous gel) BAUSCH HEALTH, CANADA INC.",Active,9001999,tretinoin 0.01 % cutaneous gel,8001307,tretinoin,448598008,Cutaneous,385100002,Gel,,,1.0,,,Prescription
12754,Marketed,2020-09-30,01926470,Vitamin A Acid,1,D10AD01,Tretinoin,Gel,Topical,01926470,"VITAMIN A ACID (tretinoin 0.025 % cutaneous gel) BAUSCH HEALTH, CANADA INC.",Active,9002092,tretinoin 0.025 % cutaneous gel,8001307,tretinoin,448598008,Cutaneous,385100002,Gel,,,1.0,,,Prescription
18080,Marketed,2013-10-21,02145839,Vesanoid,1,L01XF01,Tretinoin,Capsule,Oral,02145839,VESANOID (tretinoin 10 mg oral capsule) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9002882,tretinoin 10 mg oral capsule,8001307,tretinoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
67856,Marketed,2020-09-30,02243914,Retin-A Micro,1,D10AD01,Tretinoin,Gel,Topical,02243914,"RETIN-A MICRO (tretinoin 0.1 % cutaneous gel) BAUSCH HEALTH, CANADA INC.",Active,9003629,tretinoin 0.1 % cutaneous gel,8001307,tretinoin,448598008,Cutaneous,385100002,Gel,,,1.0,,,Prescription
75010,Marketed,2020-09-30,02264633,Retin-A Micro,1,D10AD01,Tretinoin,Gel,Topical,02264633,"RETIN-A MICRO (tretinoin 0.04 % cutaneous gel) BAUSCH HEALTH, CANADA INC.",Active,9004082,tretinoin 0.04 % cutaneous gel,8001307,tretinoin,448598008,Cutaneous,385100002,Gel,,,1.0,,,Prescription
13360,Marketed,2021-10-12,01964054,Oracort,1,A01AC01,Triamcinolone,Paste,Dental,01964054,"ORACORT (triamcinolone acetonide 0.1 % oromucosal paste) TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Active,9000449,triamcinolone acetonide 0.1 % oromucosal paste,8000030,triamcinolone acetonide,372473007,Oromucosal,739002006,Paste,,,,,,Prescription
13998,Marketed,2020-11-24,01977563,Triamcinolone Acetonide Injectable Suspension USP,1,H02AB08,Triamcinolone,Suspension,"Intramuscular,Intra-articular",01977563,TRIAMCINOLONE ACETONIDE INJECTABLE SUSPENSION USP (triamcinolone acetonide 200 mg per 5 mL suspension for injection vial) STERIMAX INC,Active,9000071,triamcinolone acetonide 200 mg per 5 mL suspension for injection vial,8000030,triamcinolone acetonide,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,,Prescription
15481,Marketed,2010-11-23,01999869,Kenalog-40 Injection,1,H02AB08,Triamcinolone,Suspension,"Intra-articular,Intramuscular",77700022,KENALOG-40 INJECTION (triamcinolone acetonide 40 mg per 1 mL suspension for injection vial) BRISTOL-MYERS SQUIBB CANADA,Active,9000072,triamcinolone acetonide 40 mg per 1 mL suspension for injection vial,8000030,triamcinolone acetonide,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,,Prescription
15481,Marketed,2010-11-23,01999869,Kenalog-40 Injection,1,H02AB08,Triamcinolone,Suspension,"Intra-articular,Intramuscular",77700023,KENALOG-40 INJECTION (triamcinolone acetonide 200 mg per 5 mL suspension for injection vial) BRISTOL-MYERS SQUIBB CANADA,Active,9000071,triamcinolone acetonide 200 mg per 5 mL suspension for injection vial,8000030,triamcinolone acetonide,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,,Prescription
15482,Marketed,2009-12-02,01999761,Kenalog-10 Injection,1,H02AB08,Triamcinolone,Suspension,"Intradermal,Intra-articular,Intrasynovial,Intrabursal",01999761,KENALOG-10 INJECTION (triamcinolone acetonide 50 mg per 5 mL suspension for injection vial) BRISTOL-MYERS SQUIBB CANADA,Active,9000041,triamcinolone acetonide 50 mg per 5 mL suspension for injection vial,8000030,triamcinolone acetonide,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,,Prescription
19807,Marketed,2022-07-16,02213834,Nasacort Aq,1,R01AD11,Triamcinolone,"Spray, metered dose",Nasal,02213834,NASACORT AQ (triamcinolone acetonide 55 mcg per actuation nasal spray) SANOFI CONSUMER HEALTH INC,Active,9000693,triamcinolone acetonide 55 mcg per actuation nasal spray,8000030,triamcinolone acetonide,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,,Prescription
35783,Marketed,2020-11-24,02194031,Aristocort R,1,D07AB09,Triamcinolone,Ointment,Topical,02194031,"ARISTOCORT R (triamcinolone acetonide 0.1 % cutaneous ointment) BAUSCH HEALTH, CANADA INC.",Active,9000309,triamcinolone acetonide 0.1 % cutaneous ointment,8000030,triamcinolone acetonide,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Prescription
35784,Marketed,2020-11-24,02194058,Aristocort R,1,D07AB09,Triamcinolone,Cream,Topical,02194058,"ARISTOCORT R (triamcinolone acetonide 0.1 % cutaneous cream) BAUSCH HEALTH, CANADA INC.",Active,9000143,triamcinolone acetonide 0.1 % cutaneous cream,8000030,triamcinolone acetonide,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
35785,Marketed,2020-11-24,02194066,Aristocort C,1,D07AB09,Triamcinolone,Cream,Topical,02194066,"ARISTOCORT C (triamcinolone acetonide 0.5 % cutaneous cream) BAUSCH HEALTH, CANADA INC.",Active,9000752,triamcinolone acetonide 0.5 % cutaneous cream,8000030,triamcinolone acetonide,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
85366,Marketed,2018-11-12,02368676,Triesence,1,S01BA05,Triamcinolone,Suspension,Intravitreal,02368676,TRIESENCE (triamcinolone acetonide 40 mg per 1 mL suspension for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9000072,triamcinolone acetonide 40 mg per 1 mL suspension for injection vial,8000030,triamcinolone acetonide,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,,Prescription
8573,Marketed,1979-12-31,00716960,Triaderm Crm 0.1%,1,D07AB09,Triamcinolone,Cream,Topical,00716960,TRIADERM CRM 0.1% (triamcinolone acetonide 0.1 % cutaneous cream) TARO PHARMACEUTICALS INC,Active,9000143,triamcinolone acetonide 0.1 % cutaneous cream,8000030,triamcinolone acetonide,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
90220,Marketed,2020-03-25,02417510,Nasacort Allergy 24 Hr,1,R01AD11,Triamcinolone,"Spray, metered dose",Nasal,02417510,NASACORT ALLERGY 24HR (triamcinolone acetonide 55 mcg per actuation nasal spray) SANOFI CONSUMER HEALTH INC,Active,9000693,triamcinolone acetonide 55 mcg per actuation nasal spray,8000030,triamcinolone acetonide,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,,Non-Prescription Drugs
92202,Marketed,2016-06-15,02437635,Apo-Triamcinolone Aq,1,R01AD11,Triamcinolone,"Spray, metered dose",Nasal,02437635,APO-TRIAMCINOLONE AQ (triamcinolone acetonide 55 mcg per actuation nasal spray) APOTEX INC,Active,9000693,triamcinolone acetonide 55 mcg per actuation nasal spray,8000030,triamcinolone acetonide,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,,Prescription
12862,Marketed,2018-01-10,00550507,Teva-Triacomb,4,D07CB01,Triamcinolone and antibiotics,Cream,Topical,00550507,TEVA-TRIACOMB (gramicidin 0.25 mg per g and neomycin (neomycin sulfate) 2.5 mg per g and nystatin 100000 unit per g and triamcinolone acetonide 1 mg per g cutaneous cream) TEVA CANADA LIMITED,Active,9001978,gramicidin 0.25 mg per g and neomycin (neomycin sulfate) 2.5 mg per g and nystatin 100000 unit per g and triamcinolone acetonide 1 mg per g cutaneous cream,8001909,gramicidin and neomycin and nystatin and triamcinolone acetonide,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
15598,Marketed,2000-05-01,02022818,Theraderm Cream,4,D07CB01,Triamcinolone and antibiotics,Cream,Topical,02022818,THERADERM CREAM (gramicidin 0.25 mg per g and neomycin (neomycin sulfate) 2.5 mg per g and nystatin 100000 unit per g and triamcinolone acetonide 1 mg per g cutaneous cream) BIMEDA-MTC ANIMAL HEALTH INC,Active,9001978,gramicidin 0.25 mg per g and neomycin (neomycin sulfate) 2.5 mg per g and nystatin 100000 unit per g and triamcinolone acetonide 1 mg per g cutaneous cream,8001909,gramicidin and neomycin and nystatin and triamcinolone acetonide,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
9448,Marketed,1983-12-31,00717002,Viaderm KC Crm,4,D07CB01,Triamcinolone and antibiotics,Cream,Topical,00717002,VIADERM KC CRM (gramicidin 0.25 mg per g and neomycin (neomycin sulfate) 2.5 mg per g and nystatin 100000 unit per g and triamcinolone acetonide 1 mg per g cutaneous cream) TARO PHARMACEUTICALS INC,Active,9001978,gramicidin 0.25 mg per g and neomycin (neomycin sulfate) 2.5 mg per g and nystatin 100000 unit per g and triamcinolone acetonide 1 mg per g cutaneous cream,8001909,gramicidin and neomycin and nystatin and triamcinolone acetonide,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
9449,Marketed,1983-12-31,00717029,Viaderm KC Ont,4,D07CB01,Triamcinolone and antibiotics,Ointment,Topical,00717029,VIADERM KC ONT (gramicidin 0.25 mg per g and neomycin (neomycin sulfate) 2.5 mg per g and nystatin 100000 unit per g and triamcinolone acetonide 1 mg per g cutaneous ointment) TARO PHARMACEUTICALS INC,Active,9001979,gramicidin 0.25 mg per g and neomycin (neomycin sulfate) 2.5 mg per g and nystatin 100000 unit per g and triamcinolone acetonide 1 mg per g cutaneous ointment,8001909,gramicidin and neomycin and nystatin and triamcinolone acetonide,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Prescription
9575,Marketed,2014-06-27,00808571,Triazolam,1,N05CD05,Triazolam,Tablet,Oral,00808571,TRIAZOLAM (triazolam 0.25 mg oral tablet) AA PHARMA INC,Active,9002228,triazolam 0.25 mg oral tablet,8001095,triazolam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
103443,Marketed,2024-08-01,02545683,Foaming Antibacterial Hand Cleanser,1,D08AE04,Triclosan,Solution,Topical (commercial),,,,,,,,,,,,,,,,,Non-Prescription Drugs
11537,Marketed,2000-07-01,00779237,Bacti-Stat 0.3%,1,D08AE04,Triclosan,Liquid,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
1668,Marketed,1973-12-31,00266507,Adasept Liquid 0.5%,1,D08AE04,Triclosan,Liquid,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
62780,Marketed,1999-04-30,02239311,Ecocare 250,1,D08AE04,Triclosan,Liquid,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
66676,Marketed,2000-11-15,02242846,Digiclean Antibacterial Foam Hand Soap,1,D08AE04,Triclosan,Liquid,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
67995,Marketed,2003-04-01,02244052,Keystone Antibacterial Foam Hand Soap,1,D08AE04,Triclosan,Liquid,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
75280,Marketed,2008-06-07,02267373,Ino-F Antibac Antibacterial Hand Soap,1,D08AE04,Triclosan,Liquid,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
76939,Marketed,2006-12-01,02283816,Antibacterial Clean & Smooth,1,D08AE04,Triclosan,Solution,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
100446,Marketed,2021-07-05,02515067,Waymade-Trientine,1,A16AX12,Trientine,Capsule,Oral,02515067,WAYMADE-TRIENTINE (trientine hydrochloride 250 mg oral capsule) WAYMADE PLC,Active,9014468,trientine hydrochloride 250 mg oral capsule,8002366,trientine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
99424,Marketed,2020-11-10,02504855,Mar-Trientine,1,A16AX12,Trientine,Capsule,Oral,02504855,MAR-TRIENTINE (trientine hydrochloride 250 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9014468,trientine hydrochloride 250 mg oral capsule,8002366,trientine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
98421,Marketed,2019-11-28,02494175,Aklief,1,D10AD06,Trifarotene,Cream,Topical,02494175,AKLIEF (trifarotene 50 mcg per g cutaneous cream) GALDERMA CANADA INC.,Active,9014302,trifarotene 50 mcg per g cutaneous cream,8002329,trifarotene,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
96138,Marketed,2018-03-22,02472104,Lonsurf,2,L01BC59,"Trifluridine, combinations",Tablet,Oral,02472104,"LONSURF (tipiracil (tipiracil hydrochloride) 6.14 mg and trifluridine 15 mg oral tablet) TAIHO PHARMA CANADA, INC.",Active,9012866,tipiracil (tipiracil hydrochloride) 6.14 mg and trifluridine 15 mg oral tablet,8001537,tipiracil and trifluridine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
96139,Marketed,2018-03-22,02472112,Lonsurf,2,L01BC59,"Trifluridine, combinations",Tablet,Oral,02472112,"LONSURF (tipiracil (tipiracil hydrochloride) 8.19 mg and trifluridine 20 mg oral tablet) TAIHO PHARMA CANADA, INC.",Active,9012867,tipiracil (tipiracil hydrochloride) 8.19 mg and trifluridine 20 mg oral tablet,8001537,tipiracil and trifluridine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100183,Marketed,2021-04-01,02512556,Dojolvi,1,A16AX17,Triheptanoin,Liquid,Oral,02512556,DOJOLVI (triheptanoin 100 % oral liquid) ULTRAGENYX PHARMACEUTICAL INC,Active,9014561,triheptanoin 100 % oral liquid,8002378,triheptanoin,26643006,Oral,420699003,Liquid,,,,,,Prescription
4901,Marketed,2012-03-01,00545058,Trihexyphenidyl,1,N04AA01,Trihexyphenidyl,Tablet,Oral,00545058,TRIHEXYPHENIDYL (trihexyphenidyl hydrochloride 2 mg oral tablet) AA PHARMA INC,Active,9001956,trihexyphenidyl hydrochloride 2 mg oral tablet,8001540,trihexyphenidyl,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
4903,Marketed,2014-06-12,00545074,Trihexyphenidyl,1,N04AA01,Trihexyphenidyl,Tablet,Oral,00545074,TRIHEXYPHENIDYL (trihexyphenidyl hydrochloride 5 mg oral tablet) AA PHARMA INC,Active,9001957,trihexyphenidyl hydrochloride 5 mg oral tablet,8001540,trihexyphenidyl,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102695,Marketed,2024-01-17,02538202,Mint-Trimebutine,1,A03AA05,Trimebutine,Tablet,Oral,02538202,MINT-TRIMEBUTINE (trimebutine maleate 100 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9003760,trimebutine maleate 100 mg oral tablet,8001978,trimebutine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102696,Marketed,2024-01-17,02538210,Mint-Trimebutine,1,A03AA05,Trimebutine,Tablet,Oral,02538210,MINT-TRIMEBUTINE (trimebutine maleate 200 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9002393,trimebutine maleate 200 mg oral tablet,8001978,trimebutine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
69763,Marketed,2024-05-09,02245663,Apo-Trimebutine,1,A03AA05,Trimebutine,Tablet,Oral,02245663,APO-TRIMEBUTINE (trimebutine maleate 100 mg oral tablet) APOTEX INC,Active,9003760,trimebutine maleate 100 mg oral tablet,8001978,trimebutine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
69764,Marketed,2024-09-13,02245664,Apo-Trimebutine,1,A03AA05,Trimebutine,Tablet,Oral,02245664,APO-TRIMEBUTINE (trimebutine maleate 200 mg oral tablet) APOTEX INC,Active,9002393,trimebutine maleate 200 mg oral tablet,8001978,trimebutine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
66985,Marketed,2011-05-07,02243116,Trimethoprim Tablets,1,J01EA01,Trimethoprim,Tablet,Oral,02243116,TRIMETHOPRIM TABLETS (trimethoprim 100 mg oral tablet) AA PHARMA INC,Active,9003551,trimethoprim 100 mg oral tablet,8000919,trimethoprim,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
66986,Marketed,2011-04-07,02243117,Trimethoprim Tablets,1,J01EA01,Trimethoprim,Tablet,Oral,02243117,TRIMETHOPRIM TABLETS (trimethoprim 200 mg oral tablet) AA PHARMA INC,Active,9003627,trimethoprim 200 mg oral tablet,8000919,trimethoprim,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
15592,Marketed,2013-04-08,02070987,Trimipramine,1,N06AA06,Trimipramine,Capsule,Oral,02070987,TRIMIPRAMINE (trimipramine (trimipramine maleate) 75 mg oral capsule) AA PHARMA INC,Active,9002720,trimipramine (trimipramine maleate) 75 mg oral capsule,8001423,trimipramine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
8065,Marketed,2014-06-12,00740799,Trimipramine,1,N06AA06,Trimipramine,Tablet,Oral,00740799,TRIMIPRAMINE (trimipramine (trimipramine maleate) 12.5 mg oral tablet) AA PHARMA INC,Active,9002121,trimipramine (trimipramine maleate) 12.5 mg oral tablet,8001423,trimipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
8066,Marketed,2011-01-17,00740802,Trimipramine,1,N06AA06,Trimipramine,Tablet,Oral,00740802,TRIMIPRAMINE (trimipramine (trimipramine maleate) 25 mg oral tablet) AA PHARMA INC,Active,9002122,trimipramine (trimipramine maleate) 25 mg oral tablet,8001423,trimipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
8067,Marketed,2011-05-09,00740810,Trimipramine,1,N06AA06,Trimipramine,Tablet,Oral,00740810,TRIMIPRAMINE (trimipramine (trimipramine maleate) 50 mg oral tablet) AA PHARMA INC,Active,9002123,trimipramine (trimipramine maleate) 50 mg oral tablet,8001423,trimipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
8106,Marketed,2012-01-06,00740829,Trimipramine,1,N06AA06,Trimipramine,Tablet,Oral,00740829,TRIMIPRAMINE (trimipramine (trimipramine maleate) 100 mg oral tablet) AA PHARMA INC,Active,9002120,trimipramine (trimipramine maleate) 100 mg oral tablet,8001423,trimipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
63507,Marketed,2020-09-08,02240000,Trelstar,1,L02AE04,Triptorelin,"Powder for suspension, sustained-release",Intramuscular,02240000,TRELSTAR (triptorelin (triptorelin pamoate) 3.75 mg per vial powder for prolonged-release suspension for injection) KNIGHT THERAPEUTICS INC.,Active,9004105,triptorelin (triptorelin pamoate) 3.75 mg per vial powder for prolonged-release suspension for injection,8001979,triptorelin,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
67797,Marketed,2020-09-14,02243856,Trelstar,1,L02AE04,Triptorelin,"Powder for suspension, sustained-release",Intramuscular,02243856,TRELSTAR (triptorelin (triptorelin pamoate) 11.25 mg per vial powder for prolonged-release suspension for injection) KNIGHT THERAPEUTICS INC.,Active,9004104,triptorelin (triptorelin pamoate) 11.25 mg per vial powder for prolonged-release suspension for injection,8001979,triptorelin,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
87478,Marketed,2012-08-09,02389282,Decapeptyl,1,L02AE04,Triptorelin,Solution,Subcutaneous,02389282,DECAPEPTYL (triptorelin acetate 0.1 mg per 1 mL solution for injection syringe) FERRING INC,Active,9013383,triptorelin acetate 0.1 mg per 1 mL solution for injection syringe,8001979,triptorelin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,,Prescription
89690,Marketed,2020-10-14,02412322,Trelstar,1,L02AE04,Triptorelin,"Powder for suspension, sustained-release",Intramuscular,02412322,TRELSTAR (triptorelin (triptorelin pamoate) 22.5 mg per vial powder for prolonged-release suspension for injection) KNIGHT THERAPEUTICS INC.,Active,9005355,triptorelin (triptorelin pamoate) 22.5 mg per vial powder for prolonged-release suspension for injection,8001979,triptorelin,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
104149,Marketed,2025-02-12,02552523,Daybue,1,N07XX24,Trofinetide,Solution,"Gastric,Oral",02552523,DAYBUE (trofinetide 200 mg per mL oral solution) ACADIA PHARMACEUTICALS INC.,Active,9015181,trofinetide 200 mg per mL oral solution,8002532,trofinetide,26643006,Oral,385023001,Oral solution,,,1.0,,,Prescription
18758,Marketed,2023-01-26,02148536,Minims Tropicamide,1,S01FA06,Tropicamide,Drops,Ophthalmic,02148536,MINIMS TROPICAMIDE (tropicamide 1 % ophthalmic drops) BAUSCH & LOMB INC,Active,9001650,tropicamide 1 % ophthalmic drops,8001542,tropicamide,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
260,Marketed,2019-04-24,00000981,Mydriacyl,1,S01FA06,Tropicamide,Solution,Ophthalmic,00000981,MYDRIACYL (tropicamide 0.5 % ophthalmic drops) ALCON CANADA INC,Active,9001534,tropicamide 0.5 % ophthalmic drops,8001542,tropicamide,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
6054,Marketed,2021-08-05,00622885,Odan-Tropicamide,1,S01FA06,Tropicamide,Solution,Ophthalmic,00622885,ODAN-TROPICAMIDE (tropicamide 1 % ophthalmic drops) ODAN LABORATORIES LTD,Active,9001650,tropicamide 1 % ophthalmic drops,8001542,tropicamide,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
780,Marketed,2019-03-14,00001007,Mydriacyl,1,S01FA06,Tropicamide,Solution,Ophthalmic,00001007,MYDRIACYL (tropicamide 1 % ophthalmic drops) ALCON CANADA INC,Active,9001650,tropicamide 1 % ophthalmic drops,8001542,tropicamide,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,,Prescription
97846,Marketed,2019-06-21,02488353,Mar-Trospium,1,G04BD09,Trospium,Tablet,Oral,02488353,MAR-TROSPIUM (trospium chloride 20 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9004146,trospium chloride 20 mg oral tablet,8001115,trospium,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99603,Marketed,2023-11-21,02506661,JAMP Trospium,1,G04BD09,Trospium,Tablet,Oral,02506661,JAMP TROSPIUM (trospium chloride 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004146,trospium chloride 20 mg oral tablet,8001115,trospium,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76514,Marketed,2023-08-08,02279525,Visionblue,1,S01KX02,Trypan blue,Solution,Intraocular,02279525,VISIONBLUE (trypan blue 0.06 % solution for injection 0.5 mL syringe) DUTCH OPHTHALMIC RESEARCH CENTER INTERNATIONAL BV,Active,9013384,trypan blue 0.06 % solution for injection 0.5 mL syringe,8001981,trypan blue,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Ethical
15485,Marketed,2021-06-11,02029456,Tryptan,1,N06AX02,Tryptophan,Tablet,Oral,02029456,"TRYPTAN (tryptophan 500 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9002721,tryptophan 500 mg oral tablet,8002164,tryptophan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
60571,Marketed,2013-01-03,02237250,Teva-Tryptophan,1,N06AX02,Tryptophan,Tablet,Oral,02237250,TEVA-TRYPTOPHAN (tryptophan 1 g oral tablet) TEVA CANADA LIMITED,Active,9002094,tryptophan 1 g oral tablet,8002164,tryptophan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
62795,Marketed,2021-06-11,02239326,Tryptan,1,N06AX02,Tryptophan,Tablet,Oral,02239326,"TRYPTAN (tryptophan 250 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9003348,tryptophan 250 mg oral tablet,8002164,tryptophan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
62796,Marketed,2021-06-11,02239327,Tryptan,1,N06AX02,Tryptophan,Tablet,Oral,02239327,"TRYPTAN (tryptophan 750 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9003349,tryptophan 750 mg oral tablet,8002164,tryptophan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
63872,Marketed,2013-01-03,02240333,Teva-Tryptophan,1,N06AX02,Tryptophan,Tablet,Oral,02240333,TEVA-TRYPTOPHAN (tryptophan 500 mg oral tablet) TEVA CANADA LIMITED,Active,9002721,tryptophan 500 mg oral tablet,8002164,tryptophan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
63873,Marketed,2013-01-03,02240334,Teva-Tryptophan,1,N06AX02,Tryptophan,Capsule,Oral,02240334,TEVA-TRYPTOPHAN (tryptophan 500 mg oral capsule) TEVA CANADA LIMITED,Active,9002095,tryptophan 500 mg oral capsule,8002164,tryptophan,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
7263,Marketed,2021-06-11,00718149,Tryptan,1,N06AX02,Tryptophan,Capsule,Oral,00718149,"TRYPTAN (tryptophan 500 mg oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9002095,tryptophan 500 mg oral capsule,8002164,tryptophan,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
7264,Marketed,2021-06-11,00654531,Tryptan,1,N06AX02,Tryptophan,Tablet,Oral,00654531,"TRYPTAN (tryptophan 1 g oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9002094,tryptophan 1 g oral tablet,8002164,tryptophan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
72892,Marketed,2003-12-09,02248538,Apo-Tryptophan,1,N06AX02,Tryptophan,Tablet,Oral,02248538,APO-TRYPTOPHAN (tryptophan 500 mg oral tablet) APOTEX INC,Active,9002721,tryptophan 500 mg oral tablet,8002164,tryptophan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
72893,Marketed,2003-12-09,02248539,Apo-Tryptophan,1,N06AX02,Tryptophan,Tablet,Oral,02248539,APO-TRYPTOPHAN (tryptophan 1 g oral tablet) APOTEX INC,Active,9002094,tryptophan 1 g oral tablet,8002164,tryptophan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
72895,Marketed,2003-12-09,02248540,Apo-Tryptophan,1,N06AX02,Tryptophan,Capsule,Oral,02248540,APO-TRYPTOPHAN (tryptophan 500 mg oral capsule) APOTEX INC,Active,9002095,tryptophan 500 mg oral capsule,8002164,tryptophan,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
94588,Marketed,2017-02-06,02458721,Apo-Tryptophan,1,N06AX02,Tryptophan,Tablet,Oral,02458721,APO-TRYPTOPHAN (tryptophan 750 mg oral tablet) APOTEX INC,Active,9003349,tryptophan 750 mg oral tablet,8002164,tryptophan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
2087,Marketed,2006-11-10,00317268,Tubersol,1,V04CF01,Tuberculin,Solution,Intradermal,,,,,,,,,,,,,,,,,Schedule D
98955,Marketed,2025-11-24,02499827,Tukysa,1,L01EH03,Tucatinib,Tablet,Oral,02499827,TUKYSA (tucatinib 50 mg oral tablet) PFIZER CANADA ULC,Active,9014437,tucatinib 50 mg oral tablet,8002361,tucatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98956,Marketed,2025-11-24,02499835,Tukysa,1,L01EH03,Tucatinib,Tablet,Oral,02499835,TUKYSA (tucatinib 150 mg oral tablet) PFIZER CANADA ULC,Active,9014436,tucatinib 150 mg oral tablet,8002361,tucatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98007,Marketed,2024-02-28,02490005,Netspot,1,V09I,Tumour detection,"Kit,Powder for solution",Intravenous,,,,,,,,,,,,,,,,,Schedule C
13630,Marketed,2024-11-14,00885975,Vivotif,1,J07AP01,"Typhoid, oral, live attenuated",Capsule (enteric-coated),Oral,,,,,,,,,,,,,,,,,Schedule D
20287,Marketed,2006-09-06,02130955,Typhim Vi,1,J07AP03,"Typhoid, purified polysaccharide antigen",Solution,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
102156,Marketed,2023-05-11,02532530,Ubrelvy,1,N02CD04,Ubrogepant,Tablet,Oral,02532530,UBRELVY (ubrogepant 50 mg oral tablet) ABBVIE CORPORATION,Active,9014859,ubrogepant 50 mg oral tablet,8002466,ubrogepant,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102161,Marketed,2023-04-04,02532581,Ubrelvy,1,N02CD04,Ubrogepant,Tablet,Oral,02532581,UBRELVY (ubrogepant 100 mg oral tablet) ABBVIE CORPORATION,Active,9014851,ubrogepant 100 mg oral tablet,8002466,ubrogepant,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
92065,Marketed,2015-09-01,02436329,Ella,1,G03AD02,Ulipristal,Tablet,Oral,02436329,ELLA (ulipristal acetate 30 mg oral tablet) LABORATOIRE HRA PHARMA,Active,9005765,ulipristal acetate 30 mg oral tablet,8001982,ulipristal,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
13909,Marketed,2019-10-15,01962728,Ultravate,1,D07AC21,Ulobetasol,Ointment,Topical,01962728,"ULTRAVATE (halobetasol propionate 0.05 % cutaneous ointment) BAUSCH HEALTH, CANADA INC.",Active,9002577,halobetasol propionate 0.05 % cutaneous ointment,8001660,halobetasol,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Prescription
13917,Marketed,2019-10-15,01962701,Ultravate,1,D07AC21,Ulobetasol,Cream,Topical,01962701,"ULTRAVATE (halobetasol propionate 0.05 % cutaneous cream) BAUSCH HEALTH, CANADA INC.",Active,9002576,halobetasol propionate 0.05 % cutaneous cream,8001660,halobetasol,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Prescription
99560,Marketed,2021-08-06,02506262,Bryhali,1,D07AC21,Ulobetasol,Lotion,Topical,02506262,"BRYHALI (halobetasol propionate 0.01 % lotion) BAUSCH HEALTH, CANADA INC.",Active,9014584,halobetasol propionate 0.01 % lotion,8001660,halobetasol,448598008,Cutaneous,739000003,Lotion,,,,,,Prescription
90830,Marketed,2015-04-27,02423596,Incruse Ellipta,1,R03BB07,Umeclidinium bromide,Powder,Inhalation,02423596,INCRUSE ELLIPTA (umeclidinium (umeclidinium bromide) 62.5 mcg per actuation inhalation powder) GLAXOSMITHKLINE INC,Active,9012402,umeclidinium (umeclidinium bromide) 62.5 mcg per actuation inhalation powder,8001089,umeclidinium,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
101013,Marketed,2021-10-28,02520893,Rinvoq,1,L04AF03,Upadacitinib,Tablet (extended-release),Oral,02520893,RINVOQ (upadacitinib 30 mg prolonged-release oral tablet) ABBVIE CORPORATION,Active,9014632,upadacitinib 30 mg prolonged-release oral tablet,8002315,upadacitinib,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102847,Marketed,2023-09-07,02539721,Rinvoq,1,L04AF03,Upadacitinib,Tablet (extended-release),Oral,02539721,RINVOQ (upadacitinib 45 mg prolonged-release oral tablet) ABBVIE CORPORATION,Active,9014920,upadacitinib 45 mg prolonged-release oral tablet,8002315,upadacitinib,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98509,Marketed,2020-01-16,02495155,Rinvoq,1,L04AF03,Upadacitinib,Tablet (extended-release),Oral,02495155,RINVOQ (upadacitinib 15 mg prolonged-release oral tablet) ABBVIE CORPORATION,Active,9014233,upadacitinib 15 mg prolonged-release oral tablet,8002315,upadacitinib,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
88770,Marketed,2013-03-28,02402874,Myrbetriq,1,G04BD,Urinary antispasmodics,Tablet (extended-release),Oral,02402874,MYRBETRIQ (mirabegron 25 mg prolonged-release oral tablet) ASTELLAS PHARMA CANADA INC,Active,9005209,mirabegron 25 mg prolonged-release oral tablet,8001124,mirabegron,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103245,Marketed,2024-07-17,02544024,Nra-Ursodiol,1,A05AA02,Ursodeoxycholic acid,Tablet,Oral,02544024,NRA-URSODIOL (ursodiol 500 mg oral tablet) NORA PHARMA INC,Active,9003780,ursodiol 500 mg oral tablet,8001308,ursodiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103246,Marketed,2024-07-17,02544032,Nra-Ursodiol,1,A05AA02,Ursodeoxycholic acid,Tablet,Oral,02544032,NRA-URSODIOL (ursodiol 250 mg oral tablet) NORA PHARMA INC,Active,9003327,ursodiol 250 mg oral tablet,8001308,ursodiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75898,Marketed,2006-05-01,02273497,PMS-Ursodiol C,1,A05AA02,Ursodeoxycholic acid,Tablet,Oral,02273497,PMS-URSODIOL C (ursodiol 250 mg oral tablet) PHARMASCIENCE INC,Active,9003327,ursodiol 250 mg oral tablet,8001308,ursodiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75899,Marketed,2006-05-01,02273500,PMS-Ursodiol C,1,A05AA02,Ursodeoxycholic acid,Tablet,Oral,02273500,PMS-URSODIOL C (ursodiol 500 mg oral tablet) PHARMASCIENCE INC,Active,9003780,ursodiol 500 mg oral tablet,8001308,ursodiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91144,Marketed,2021-07-23,02426900,GLN-Ursodiol,1,A05AA02,Ursodeoxycholic acid,Tablet,Oral,02426900,GLN-URSODIOL (ursodiol 250 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9003327,ursodiol 250 mg oral tablet,8001308,ursodiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91146,Marketed,2021-07-23,02426919,GLN-Ursodiol,1,A05AA02,Ursodeoxycholic acid,Tablet,Oral,02426919,GLN-URSODIOL (ursodiol 500 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9003780,ursodiol 500 mg oral tablet,8001308,ursodiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96170,Marketed,2018-09-28,02472392,JAMP-Ursodiol,1,A05AA02,Ursodeoxycholic acid,Tablet,Oral,02472392,JAMP-URSODIOL (ursodiol 250 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003327,ursodiol 250 mg oral tablet,8001308,ursodiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96171,Marketed,2024-11-14,02472406,JAMP-Ursodiol,1,A05AA02,Ursodeoxycholic acid,Tablet,Oral,02472406,JAMP-URSODIOL (ursodiol 500 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003780,ursodiol 500 mg oral tablet,8001308,ursodiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102598,Marketed,2024-07-02,02537257,Finlius,1,L04AC05,Ustekinumab,Solution,Subcutaneous,02537257,FINLIUS (ustekinumab 90 mg per 1 mL solution for injection syringe) JANSSEN INC,Active,9013388,ustekinumab 90 mg per 1 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
102598,Marketed,2024-07-02,02537257,Finlius,1,L04AC05,Ustekinumab,Solution,Subcutaneous,02537257,FINLIUS (ustekinumab 90 mg per 1 mL solution for injection syringe) JANSSEN INC,Active,9013388,ustekinumab 90 mg per 1 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
102603,Marketed,2024-07-02,02537303,Finlius,1,L04AC05,Ustekinumab,Solution,Subcutaneous,77701158,FINLIUS (ustekinumab 45 mg per 0.5 mL solution for injection vial) JANSSEN INC,Active,9013387,ustekinumab 45 mg per 0.5 mL solution for injection vial,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
102603,Marketed,2024-07-02,02537303,Finlius,1,L04AC05,Ustekinumab,Solution,Subcutaneous,77701159,FINLIUS (ustekinumab 45 mg per 0.5 mL solution for injection syringe) JANSSEN INC,Active,9013386,ustekinumab 45 mg per 0.5 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
102603,Marketed,2024-07-02,02537303,Finlius,1,L04AC05,Ustekinumab,Solution,Subcutaneous,77701158,FINLIUS (ustekinumab 45 mg per 0.5 mL solution for injection vial) JANSSEN INC,Active,9013387,ustekinumab 45 mg per 0.5 mL solution for injection vial,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
102603,Marketed,2024-07-02,02537303,Finlius,1,L04AC05,Ustekinumab,Solution,Subcutaneous,77701159,FINLIUS (ustekinumab 45 mg per 0.5 mL solution for injection syringe) JANSSEN INC,Active,9013386,ustekinumab 45 mg per 0.5 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
102604,Marketed,2024-07-02,02537311,Finlius IV,1,L04AC05,Ustekinumab,Solution,Intravenous,02537311,FINLIUS I.V. (ustekinumab 130 mg per 26 mL solution for injection vial) JANSSEN INC,Active,9013385,ustekinumab 130 mg per 26 mL solution for injection vial,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
102604,Marketed,2024-07-02,02537311,Finlius IV,1,L04AC05,Ustekinumab,Solution,Intravenous,02537311,FINLIUS I.V. (ustekinumab 130 mg per 26 mL solution for injection vial) JANSSEN INC,Active,9013385,ustekinumab 130 mg per 26 mL solution for injection vial,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
103153,Marketed,2024-03-01,02543036,Jamteki,1,L04AC05,Ustekinumab,Solution,Subcutaneous,02543036,JAMTEKI (ustekinumab 45 mg per 0.5 mL solution for injection syringe) JAMP PHARMA CORPORATION,Active,9013386,ustekinumab 45 mg per 0.5 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
103153,Marketed,2024-03-01,02543036,Jamteki,1,L04AC05,Ustekinumab,Solution,Subcutaneous,02543036,JAMTEKI (ustekinumab 45 mg per 0.5 mL solution for injection syringe) JAMP PHARMA CORPORATION,Active,9013386,ustekinumab 45 mg per 0.5 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
103154,Marketed,2024-03-01,02543044,Jamteki,1,L04AC05,Ustekinumab,Solution,Subcutaneous,02543044,JAMTEKI (ustekinumab 90 mg per 1 mL solution for injection syringe) JAMP PHARMA CORPORATION,Active,9013388,ustekinumab 90 mg per 1 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
103154,Marketed,2024-03-01,02543044,Jamteki,1,L04AC05,Ustekinumab,Solution,Subcutaneous,02543044,JAMTEKI (ustekinumab 90 mg per 1 mL solution for injection syringe) JAMP PHARMA CORPORATION,Active,9013388,ustekinumab 90 mg per 1 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
103271,Marketed,2024-03-01,02544180,Wezlana,1,L04AC05,Ustekinumab,Solution,Subcutaneous,02544180,WEZLANA (ustekinumab 45 mg per 0.5 mL solution for injection syringe) AMGEN CANADA INC,Active,9013386,ustekinumab 45 mg per 0.5 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
103271,Marketed,2024-03-01,02544180,Wezlana,1,L04AC05,Ustekinumab,Solution,Subcutaneous,02544180,WEZLANA (ustekinumab 45 mg per 0.5 mL solution for injection syringe) AMGEN CANADA INC,Active,9013386,ustekinumab 45 mg per 0.5 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
103272,Marketed,2024-03-01,02544199,Wezlana,1,L04AC05,Ustekinumab,Solution,Subcutaneous,02544199,WEZLANA (ustekinumab 90 mg per 1 mL solution for injection syringe) AMGEN CANADA INC,Active,9013388,ustekinumab 90 mg per 1 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
103272,Marketed,2024-03-01,02544199,Wezlana,1,L04AC05,Ustekinumab,Solution,Subcutaneous,02544199,WEZLANA (ustekinumab 90 mg per 1 mL solution for injection syringe) AMGEN CANADA INC,Active,9013388,ustekinumab 90 mg per 1 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
103273,Marketed,2024-03-01,02544202,Wezlana,1,L04AC05,Ustekinumab,Solution,Subcutaneous,02544202,WEZLANA (ustekinumab 45 mg per 0.5 mL solution for injection vial) AMGEN CANADA INC,Active,9013387,ustekinumab 45 mg per 0.5 mL solution for injection vial,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
103273,Marketed,2024-03-01,02544202,Wezlana,1,L04AC05,Ustekinumab,Solution,Subcutaneous,02544202,WEZLANA (ustekinumab 45 mg per 0.5 mL solution for injection vial) AMGEN CANADA INC,Active,9013387,ustekinumab 45 mg per 0.5 mL solution for injection vial,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
103274,Marketed,2024-03-01,02544210,Wezlana IV,1,L04AC05,Ustekinumab,Solution,Intravenous,02544210,WEZLANA I.V. (ustekinumab 130 mg per 26 mL solution for injection vial) AMGEN CANADA INC,Active,9013385,ustekinumab 130 mg per 26 mL solution for injection vial,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
103274,Marketed,2024-03-01,02544210,Wezlana IV,1,L04AC05,Ustekinumab,Solution,Intravenous,02544210,WEZLANA I.V. (ustekinumab 130 mg per 26 mL solution for injection vial) AMGEN CANADA INC,Active,9013385,ustekinumab 130 mg per 26 mL solution for injection vial,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
103908,Marketed,2024-08-29,02550245,Steqeyma,1,L04AC05,Ustekinumab,Solution,Subcutaneous,02550245,STEQEYMA (ustekinumab 45 mg per 0.5 mL solution for injection syringe) CELLTRION INC.,Active,9013386,ustekinumab 45 mg per 0.5 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
103908,Marketed,2024-08-29,02550245,Steqeyma,1,L04AC05,Ustekinumab,Solution,Subcutaneous,02550245,STEQEYMA (ustekinumab 45 mg per 0.5 mL solution for injection syringe) CELLTRION INC.,Active,9013386,ustekinumab 45 mg per 0.5 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
103909,Marketed,2024-08-29,02550253,Steqeyma,1,L04AC05,Ustekinumab,Solution,Subcutaneous,02550253,STEQEYMA (ustekinumab 90 mg per 1 mL solution for injection syringe) CELLTRION INC.,Active,9013388,ustekinumab 90 mg per 1 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
103909,Marketed,2024-08-29,02550253,Steqeyma,1,L04AC05,Ustekinumab,Solution,Subcutaneous,02550253,STEQEYMA (ustekinumab 90 mg per 1 mL solution for injection syringe) CELLTRION INC.,Active,9013388,ustekinumab 90 mg per 1 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
103910,Marketed,2024-08-29,02550261,Steqeyma IV,1,L04AC05,Ustekinumab,Solution,Intravenous,02550261,STEQEYMA IV (ustekinumab 130 mg per 26 mL solution for injection vial) CELLTRION INC.,Active,9013385,ustekinumab 130 mg per 26 mL solution for injection vial,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
103910,Marketed,2024-08-29,02550261,Steqeyma IV,1,L04AC05,Ustekinumab,Solution,Intravenous,02550261,STEQEYMA IV (ustekinumab 130 mg per 26 mL solution for injection vial) CELLTRION INC.,Active,9013385,ustekinumab 130 mg per 26 mL solution for injection vial,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
104208,Marketed,2026-05-19,02553120,Jamteki IV,1,L04AC05,Ustekinumab,Solution,Intravenous,02553120,JAMTEKI I.V. (ustekinumab 130 mg per 26 mL solution for injection vial) JAMP PHARMA CORPORATION,Active,9013385,ustekinumab 130 mg per 26 mL solution for injection vial,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
104208,Marketed,2026-05-19,02553120,Jamteki IV,1,L04AC05,Ustekinumab,Solution,Intravenous,02553120,JAMTEKI I.V. (ustekinumab 130 mg per 26 mL solution for injection vial) JAMP PHARMA CORPORATION,Active,9013385,ustekinumab 130 mg per 26 mL solution for injection vial,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
104225,Marketed,2025-02-05,02553309,Wezlana,1,L04AC05,Ustekinumab,Solution,Subcutaneous,02553309,WEZLANA (ustekinumab 90 mg per 1 mL solution for injection pen) AMGEN CANADA INC,Active,9015174,ustekinumab 90 mg per 1 mL solution for injection pen,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen(s),,,1.0,Schedule D
104225,Marketed,2025-02-05,02553309,Wezlana,1,L04AC05,Ustekinumab,Solution,Subcutaneous,02553309,WEZLANA (ustekinumab 90 mg per 1 mL solution for injection pen) AMGEN CANADA INC,Active,9015174,ustekinumab 90 mg per 1 mL solution for injection pen,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen(s),,,1.0,Prescription
104226,Marketed,2025-02-05,02553317,Wezlana,1,L04AC05,Ustekinumab,Solution,Subcutaneous,02553317,WEZLANA (ustekinumab 45 mg per 0.5 mL solution for injection pen) AMGEN CANADA INC,Active,9015173,ustekinumab 45 mg per 0.5 mL solution for injection pen,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen(s),,,1.0,Prescription
104226,Marketed,2025-02-05,02553317,Wezlana,1,L04AC05,Ustekinumab,Solution,Subcutaneous,02553317,WEZLANA (ustekinumab 45 mg per 0.5 mL solution for injection pen) AMGEN CANADA INC,Active,9015173,ustekinumab 45 mg per 0.5 mL solution for injection pen,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen(s),,,1.0,Schedule D
104315,Marketed,2025-04-15,02554283,Otulfi,1,L04AC05,Ustekinumab,Solution,Subcutaneous,02554283,OTULFI (ustekinumab 45 mg per 0.5 mL solution for injection syringe) FRESENIUS KABI CANADA LTD,Active,9013386,ustekinumab 45 mg per 0.5 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
104315,Marketed,2025-04-15,02554283,Otulfi,1,L04AC05,Ustekinumab,Solution,Subcutaneous,02554283,OTULFI (ustekinumab 45 mg per 0.5 mL solution for injection syringe) FRESENIUS KABI CANADA LTD,Active,9013386,ustekinumab 45 mg per 0.5 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
104316,Marketed,2025-04-15,02554291,Otulfi,1,L04AC05,Ustekinumab,Solution,Subcutaneous,02554291,OTULFI (ustekinumab 90 mg per 1 mL solution for injection syringe) FRESENIUS KABI CANADA LTD,Active,9013388,ustekinumab 90 mg per 1 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
104316,Marketed,2025-04-15,02554291,Otulfi,1,L04AC05,Ustekinumab,Solution,Subcutaneous,02554291,OTULFI (ustekinumab 90 mg per 1 mL solution for injection syringe) FRESENIUS KABI CANADA LTD,Active,9013388,ustekinumab 90 mg per 1 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
104317,Marketed,2025-04-16,02554305,Otulfi IV,1,L04AC05,Ustekinumab,Solution,Intravenous,02554305,OTULFI I.V. (ustekinumab 130 mg per 26 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9013385,ustekinumab 130 mg per 26 mL solution for injection vial,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
104317,Marketed,2025-04-16,02554305,Otulfi IV,1,L04AC05,Ustekinumab,Solution,Intravenous,02554305,OTULFI I.V. (ustekinumab 130 mg per 26 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9013385,ustekinumab 130 mg per 26 mL solution for injection vial,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
106500,Marketed,2026-05-21,02562081,Yesintek,1,L04AC05,Ustekinumab,Solution,Subcutaneous,77701199,YESINTEK (ustekinumab 45 mg per 0.5 mL solution for injection syringe) BIOCON BIOLOGICS CANADA INC,Active,9013386,ustekinumab 45 mg per 0.5 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
106500,Marketed,2026-05-21,02562081,Yesintek,1,L04AC05,Ustekinumab,Solution,Subcutaneous,77701200,YESINTEK (ustekinumab 45 mg per 0.5 mL solution for injection vial) BIOCON BIOLOGICS CANADA INC,Active,9013387,ustekinumab 45 mg per 0.5 mL solution for injection vial,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
106500,Marketed,2026-05-21,02562081,Yesintek,1,L04AC05,Ustekinumab,Solution,Subcutaneous,77701199,YESINTEK (ustekinumab 45 mg per 0.5 mL solution for injection syringe) BIOCON BIOLOGICS CANADA INC,Active,9013386,ustekinumab 45 mg per 0.5 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
106500,Marketed,2026-05-21,02562081,Yesintek,1,L04AC05,Ustekinumab,Solution,Subcutaneous,77701200,YESINTEK (ustekinumab 45 mg per 0.5 mL solution for injection vial) BIOCON BIOLOGICS CANADA INC,Active,9013387,ustekinumab 45 mg per 0.5 mL solution for injection vial,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
106501,Marketed,2026-05-21,02562103,Yesintek,1,L04AC05,Ustekinumab,Solution,Subcutaneous,02562103,YESINTEK (ustekinumab 90 mg per 1 mL solution for injection syringe) BIOCON BIOLOGICS CANADA INC,Active,9013388,ustekinumab 90 mg per 1 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Prescription
106501,Marketed,2026-05-21,02562103,Yesintek,1,L04AC05,Ustekinumab,Solution,Subcutaneous,02562103,YESINTEK (ustekinumab 90 mg per 1 mL solution for injection syringe) BIOCON BIOLOGICS CANADA INC,Active,9013388,ustekinumab 90 mg per 1 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0,Schedule D
106502,Marketed,2026-05-21,02562111,Yesintek IV,1,L04AC05,Ustekinumab,Solution,Intravenous,02562111,YESINTEK I.V. (ustekinumab 130 mg per 26 mL solution for injection vial) BIOCON BIOLOGICS CANADA INC,Active,9013385,ustekinumab 130 mg per 26 mL solution for injection vial,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Prescription
106502,Marketed,2026-05-21,02562111,Yesintek IV,1,L04AC05,Ustekinumab,Solution,Intravenous,02562111,YESINTEK I.V. (ustekinumab 130 mg per 26 mL solution for injection vial) BIOCON BIOLOGICS CANADA INC,Active,9013385,ustekinumab 130 mg per 26 mL solution for injection vial,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0,Schedule D
80608,Marketed,2009-01-05,02320673,Stelara,1,L04AC05,Ustekinumab,Solution,Subcutaneous,77700875,STELARA (ustekinumab 45 mg per 0.5 mL solution for injection syringe) JANSSEN INC,Active,9013386,ustekinumab 45 mg per 0.5 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
80608,Marketed,2009-01-05,02320673,Stelara,1,L04AC05,Ustekinumab,Solution,Subcutaneous,77700876,STELARA (ustekinumab 45 mg per 0.5 mL solution for injection vial) JANSSEN INC,Active,9013387,ustekinumab 45 mg per 0.5 mL solution for injection vial,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
80608,Marketed,2009-01-05,02320673,Stelara,1,L04AC05,Ustekinumab,Solution,Subcutaneous,77700875,STELARA (ustekinumab 45 mg per 0.5 mL solution for injection syringe) JANSSEN INC,Active,9013386,ustekinumab 45 mg per 0.5 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
80608,Marketed,2009-01-05,02320673,Stelara,1,L04AC05,Ustekinumab,Solution,Subcutaneous,77700876,STELARA (ustekinumab 45 mg per 0.5 mL solution for injection vial) JANSSEN INC,Active,9013387,ustekinumab 45 mg per 0.5 mL solution for injection vial,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
80609,Marketed,2013-01-07,02320681,Stelara,1,L04AC05,Ustekinumab,Solution,Subcutaneous,02320681,STELARA (ustekinumab 90 mg per 1 mL solution for injection syringe) JANSSEN INC,Active,9013388,ustekinumab 90 mg per 1 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
80609,Marketed,2013-01-07,02320681,Stelara,1,L04AC05,Ustekinumab,Solution,Subcutaneous,02320681,STELARA (ustekinumab 90 mg per 1 mL solution for injection syringe) JANSSEN INC,Active,9013388,ustekinumab 90 mg per 1 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
94698,Marketed,2018-01-02,02459671,Stelara IV,1,L04AC05,Ustekinumab,Solution,Intravenous,02459671,STELARA I.V. (ustekinumab 130 mg per 26 mL solution for injection vial) JANSSEN INC,Active,9013385,ustekinumab 130 mg per 26 mL solution for injection vial,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
94698,Marketed,2018-01-02,02459671,Stelara IV,1,L04AC05,Ustekinumab,Solution,Intravenous,02459671,STELARA I.V. (ustekinumab 130 mg per 26 mL solution for injection vial) JANSSEN INC,Active,9013385,ustekinumab 130 mg per 26 mL solution for injection vial,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
100924,Marketed,2021-09-29,02520028,Haloette,2,G02BB01,Vaginal ring with progestogen and estrogen,Ring (slow-release),Vaginal,02520028,HALOETTE (ethinyl estradiol 15 mcg per 24 hour and etonogestrel 120 mcg per 24 hour vaginal delivery system) SEARCHLIGHT PHARMA INC,Active,9006475,ethinyl estradiol 15 mcg per 24 hour and etonogestrel 120 mcg per 24 hour vaginal delivery system,8000343,ethinyl estradiol and etonogestrel,16857009,Vaginal,764772008,Prolonged-release vaginal ring,733021006,System (unit of presentation),1.0,,,Prescription
104295,Marketed,2026-03-23,02554070,Ringza,2,G02BB01,Vaginal ring with progestogen and estrogen,Ring (slow-release),Vaginal,02554070,RINGZA (ethinyl estradiol 13 mcg per 24 hour and segesterone acetate 150 mcg per 24 hour vaginal delivery system) DUCHESNAY INC,Active,9015392,ethinyl estradiol 13 mcg per 24 hour and segesterone acetate 150 mcg per 24 hour vaginal delivery system,8002583,ethinyl estradiol and segesterone,16857009,Vaginal,385292009,Vaginal dose form,733021006,System,1.0,,,Prescription
73815,Marketed,2022-02-01,02253186,Nuvaring,2,G02BB01,Vaginal ring with progestogen and estrogen,Ring (slow-release),Vaginal,02253186,NUVARING (ethinyl estradiol 15 mcg per 24 hour and etonogestrel 120 mcg per 24 hour vaginal delivery system) ORGANON CANADA INC.,Active,9006475,ethinyl estradiol 15 mcg per 24 hour and etonogestrel 120 mcg per 24 hour vaginal delivery system,8000343,ethinyl estradiol and etonogestrel,16857009,Vaginal,764772008,Prolonged-release vaginal ring,733021006,System (unit of presentation),1.0,,,Prescription
100883,Marketed,2022-05-23,02519585,Valacyclovir,1,J05AB11,Valaciclovir,Tablet,Oral,02519585,VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 1000 mg oral tablet) SANIS HEALTH INC,Active,9001314,valacyclovir (valacyclovir hydrochloride) 1000 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104244,Marketed,2025-11-27,02553511,Valacyclovir,1,J05AB11,Valaciclovir,Tablet,Oral,02553511,VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 1000 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001314,valacyclovir (valacyclovir hydrochloride) 1000 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106142,Marketed,2025-08-26,02558130,NB-Valacyclovir,1,J05AB11,Valaciclovir,Tablet,Oral,02558130,NB-VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet) NB PHARMA INC.,Active,9000694,valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106206,Marketed,2025-12-10,02558858,JAMP Valacyclovir,1,J05AB11,Valaciclovir,Tablet,Oral,02558858,JAMP VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 1000 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001314,valacyclovir (valacyclovir hydrochloride) 1000 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
20218,Marketed,2002-09-27,02219492,Valtrex,1,J05AB11,Valaciclovir,Tablet,Oral,02219492,VALTREX (valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet) GLAXOSMITHKLINE INC,Active,9000694,valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
70742,Marketed,2005-05-09,02246559,Valtrex,1,J05AB11,Valaciclovir,Tablet,Oral,02246559,VALTREX (valacyclovir (valacyclovir hydrochloride) 1000 mg oral tablet) GLAXOSMITHKLINE INC,Active,9001314,valacyclovir (valacyclovir hydrochloride) 1000 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78118,Marketed,2008-05-23,02295822,Apo-Valacyclovir,1,J05AB11,Valaciclovir,Tablet,Oral,02295822,APO-VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet) APOTEX INC,Active,9000694,valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
78376,Marketed,2008-05-16,02298457,PMS-Valacyclovir,1,J05AB11,Valaciclovir,Tablet,Oral,02298457,PMS-VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet) PHARMASCIENCE INC,Active,9000694,valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80073,Marketed,2009-02-10,02315173,Pro-Valacyclovir,1,J05AB11,Valaciclovir,Tablet,Oral,02315173,PRO-VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet) PRO DOC LIMITEE,Active,9000694,valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
80195,Marketed,2008-10-27,02316447,Riva-Valacyclovir,1,J05AB11,Valaciclovir,Tablet,Oral,02316447,RIVA-VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000694,valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83249,Marketed,2015-07-21,02347091,Sandoz Valacyclovir,1,J05AB11,Valaciclovir,Tablet,Oral,02347091,SANDOZ VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride monohydrate) 500 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000694,valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83683,Marketed,2010-05-25,02351579,Mylan-Valacyclovir,1,J05AB11,Valaciclovir,Tablet,Oral,02351579,MYLAN-VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000694,valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83684,Marketed,2010-05-25,02351560,Mylan-Valacyclovir,1,J05AB11,Valaciclovir,Tablet,Oral,02351560,MYLAN-VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 1000 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9001314,valacyclovir (valacyclovir hydrochloride) 1000 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
83987,Marketed,2011-10-21,02354705,Apo-Valacyclovir,1,J05AB11,Valaciclovir,Tablet,Oral,02354705,APO-VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 1000 mg oral tablet) APOTEX INC,Active,9001314,valacyclovir (valacyclovir hydrochloride) 1000 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84264,Marketed,2012-11-01,02357534,Teva-Valacyclovir,1,J05AB11,Valaciclovir,Tablet,Oral,02357534,TEVA-VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet) TEVA CANADA LIMITED,Active,9000694,valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
86701,Marketed,2012-03-13,02381230,PMS-Valacyclovir,1,J05AB11,Valaciclovir,Tablet,Oral,02381230,PMS-VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 1000 mg oral tablet) PHARMASCIENCE INC,Active,9001314,valacyclovir (valacyclovir hydrochloride) 1000 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88988,Marketed,2015-07-24,02405040,Auro-Valacyclovir,1,J05AB11,Valaciclovir,Tablet,Oral,02405040,AURO-VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet) AURO PHARMA INC,Active,9000694,valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
88989,Marketed,2021-01-09,02405059,Auro-Valacyclovir,1,J05AB11,Valaciclovir,Tablet,Oral,02405059,AURO-VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 1000 mg oral tablet) AURO PHARMA INC,Active,9001314,valacyclovir (valacyclovir hydrochloride) 1000 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92496,Marketed,2021-04-13,02440598,JAMP Valacyclovir,1,J05AB11,Valaciclovir,Tablet,Oral,02440598,JAMP VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000694,valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92637,Marketed,2018-05-04,02442000,Valacyclovir,1,J05AB11,Valaciclovir,Tablet,Oral,02442000,VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000694,valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94135,Marketed,2016-06-10,02454645,Valacyclovir,1,J05AB11,Valaciclovir,Tablet,Oral,02454645,VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet) SANIS HEALTH INC,Active,9000694,valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
99025,Marketed,2022-03-25,02500582,AG-Valacyclovir,1,J05AB11,Valaciclovir,Tablet,Oral,02500582,AG-VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet) ANGITA PHARMA INC.,Active,9000694,valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102433,Marketed,2023-09-13,02535483,Auro-Valganciclovir,1,J05AB14,Valganciclovir,Powder for solution,Oral,02535483,AURO-VALGANCICLOVIR (valganciclovir (valganciclovir hydrochloride) 50 mg per mL oral solution) AURO PHARMA INC,Active,9013791,valganciclovir (valganciclovir hydrochloride) 50 mg per mL oral solution,8001309,valganciclovir,26643006,Oral,385023001,Oral solution,,,1.0,,,Prescription
69890,Marketed,2022-07-19,02245777,Valcyte,1,J05AB14,Valganciclovir,Tablet,Oral,02245777,VALCYTE (valganciclovir (valganciclovir hydrochloride) 450 mg oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9003735,valganciclovir (valganciclovir hydrochloride) 450 mg oral tablet,8001309,valganciclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
79164,Marketed,2022-07-19,02306085,Valcyte,1,J05AB14,Valganciclovir,Powder for solution,Oral,02306085,VALCYTE (valganciclovir (valganciclovir hydrochloride) 50 mg per mL oral solution) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9013791,valganciclovir (valganciclovir hydrochloride) 50 mg per mL oral solution,8001309,valganciclovir,26643006,Oral,385023001,Oral solution,,,1.0,,,Prescription
89847,Marketed,2014-11-27,02413825,Teva-Valganciclovir,1,J05AB14,Valganciclovir,Tablet,Oral,02413825,TEVA-VALGANCICLOVIR (valganciclovir (valganciclovir hydrochloride) 450 mg oral tablet) TEVA CANADA LIMITED,Active,9003735,valganciclovir (valganciclovir hydrochloride) 450 mg oral tablet,8001309,valganciclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
91945,Marketed,2015-04-10,02435179,Auro-Valganciclovir,1,J05AB14,Valganciclovir,Tablet,Oral,02435179,AURO-VALGANCICLOVIR (valganciclovir (valganciclovir hydrochloride) 450 mg oral tablet) AURO PHARMA INC,Active,9003735,valganciclovir (valganciclovir hydrochloride) 450 mg oral tablet,8001309,valganciclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
98537,Marketed,2020-05-27,02495457,Mint-Valganciclovir,1,J05AB14,Valganciclovir,Tablet,Oral,02495457,MINT-VALGANCICLOVIR (valganciclovir (valganciclovir hydrochloride) 450 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9003735,valganciclovir (valganciclovir hydrochloride) 450 mg oral tablet,8001309,valganciclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102148,Marketed,2023-10-05,02532441,JAMP Valproic Acid Oral Solution,1,N03AG01,Valproic acid,Solution,Oral,02532441,JAMP VALPROIC ACID ORAL SOLUTION (valproic acid (sodium valproate) 250 mg per 5 mL oral solution) JAMP PHARMA CORPORATION,Active,9006541,valproic acid (sodium valproate) 250 mg per 5 mL oral solution,8000072,valproic acid (valproate),26643006,Oral,385023001,Oral solution,,,1.0,,,Prescription
103806,Marketed,2024-11-06,02549190,Odan-Valproic Acid,1,N03AG01,Valproic acid,Solution,Oral,02549190,ODAN-VALPROIC ACID (valproic acid (sodium valproate) 250 mg per 5 mL oral solution) ODAN LABORATORIES LTD,Active,9006541,valproic acid (sodium valproate) 250 mg per 5 mL oral solution,8000072,valproic acid (valproate),26643006,Oral,385023001,Oral solution,,,1.0,,,Prescription
3156,Marketed,2016-09-15,00443832,Depakene,1,N03AG01,Valproic acid,Solution,Oral,00443832,DEPAKENE (valproic acid (sodium valproate) 250 mg per 5 mL oral solution) BGP PHARMA ULC,Active,9006541,valproic acid (sodium valproate) 250 mg per 5 mL oral solution,8000072,valproic acid (valproate),26643006,Oral,385023001,Oral solution,,,1.0,,,Prescription
47553,Marketed,1996-12-13,02229628,PMS-Valproic Acid E.C.,1,N03AG01,Valproic acid,Capsule (enteric-coated),Oral,02229628,PMS-VALPROIC ACID E.C. (valproic acid 500 mg gastro-resistant capsule) PHARMASCIENCE INC,Active,9000677,valproic acid 500 mg gastro-resistant capsule,8000221,valproic acid (base),26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
50031,Marketed,1997-02-27,02230768,PMS-Valproic Acid,1,N03AG01,Valproic acid,Capsule,Oral,02230768,PMS-VALPROIC ACID (valproic acid 250 mg oral capsule) PHARMASCIENCE INC,Active,9000639,valproic acid 250 mg oral capsule,8000221,valproic acid (base),26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
5676,Marketed,2016-11-29,00596418,Epival,1,N03AG01,Valproic acid,Tablet (delayed-release),Oral,00596418,EPIVAL (valproic acid (divalproex sodium) 125 mg gastro-resistant tablet) BGP PHARMA ULC,Active,9000214,valproic acid (divalproex sodium) 125 mg gastro-resistant tablet,8000108,valproic acid (divalproex),26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
5677,Marketed,2016-07-22,00596426,Epival,1,N03AG01,Valproic acid,Tablet (delayed-release),Oral,00596426,EPIVAL (valproic acid (divalproex sodium) 250 mg gastro-resistant tablet) BGP PHARMA ULC,Active,9000215,valproic acid (divalproex sodium) 250 mg gastro-resistant tablet,8000108,valproic acid (divalproex),26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
5678,Marketed,2016-05-25,00596434,Epival,1,N03AG01,Valproic acid,Tablet (delayed-release),Oral,00596434,EPIVAL (valproic acid (divalproex sodium) 500 mg gastro-resistant tablet) BGP PHARMA ULC,Active,9000216,valproic acid (divalproex sodium) 500 mg gastro-resistant tablet,8000108,valproic acid (divalproex),26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
60096,Marketed,1997-11-20,02236807,PMS-Valproic Acid,1,N03AG01,Valproic acid,Solution,Oral,02236807,PMS-VALPROIC ACID (valproic acid (sodium valproate) 250 mg per 5 mL oral solution) PHARMASCIENCE INC,Active,9006541,valproic acid (sodium valproate) 250 mg per 5 mL oral solution,8000072,valproic acid (valproate),26643006,Oral,385023001,Oral solution,,,1.0,,,Prescription
61432,Marketed,2021-08-13,02238048,Apo-Valproic Acid,1,N03AG01,Valproic acid,Capsule,Oral,02238048,APO-VALPROIC ACID (valproic acid 250 mg oral capsule) APOTEX INC,Active,9000639,valproic acid 250 mg oral capsule,8000221,valproic acid (base),26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
63179,Marketed,2021-12-21,02239698,Apo-Divalproex,1,N03AG01,Valproic acid,Tablet (delayed-release),Oral,02239698,APO-DIVALPROEX (valproic acid (divalproex sodium) 125 mg gastro-resistant tablet) APOTEX INC,Active,9000214,valproic acid (divalproex sodium) 125 mg gastro-resistant tablet,8000108,valproic acid (divalproex),26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
63180,Marketed,2021-12-21,02239699,Apo-Divalproex,1,N03AG01,Valproic acid,Tablet (delayed-release),Oral,02239699,APO-DIVALPROEX (valproic acid (divalproex sodium) 250 mg gastro-resistant tablet) APOTEX INC,Active,9000215,valproic acid (divalproex sodium) 250 mg gastro-resistant tablet,8000108,valproic acid (divalproex),26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
63181,Marketed,2021-12-21,02239700,Apo-Divalproex,1,N03AG01,Valproic acid,Tablet (delayed-release),Oral,02239700,APO-DIVALPROEX (valproic acid (divalproex sodium) 500 mg gastro-resistant tablet) APOTEX INC,Active,9000216,valproic acid (divalproex sodium) 500 mg gastro-resistant tablet,8000108,valproic acid (divalproex),26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
94597,Marketed,2017-04-21,02458926,Mylan-Divalproex,1,N03AG01,Valproic acid,Tablet (delayed-release),Oral,02458926,MYLAN-DIVALPROEX (valproic acid (divalproex sodium) 125 mg gastro-resistant tablet) MYLAN PHARMACEUTICALS ULC,Active,9000214,valproic acid (divalproex sodium) 125 mg gastro-resistant tablet,8000108,valproic acid (divalproex),26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
94598,Marketed,2017-05-21,02458934,Mylan-Divalproex,1,N03AG01,Valproic acid,Tablet (delayed-release),Oral,02458934,MYLAN-DIVALPROEX (valproic acid (divalproex sodium) 250 mg gastro-resistant tablet) MYLAN PHARMACEUTICALS ULC,Active,9000215,valproic acid (divalproex sodium) 250 mg gastro-resistant tablet,8000108,valproic acid (divalproex),26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
94599,Marketed,2017-04-11,02459019,Mylan-Divalproex,1,N03AG01,Valproic acid,Tablet (delayed-release),Oral,02459019,MYLAN-DIVALPROEX (valproic acid (divalproex sodium) 500 mg gastro-resistant tablet) MYLAN PHARMACEUTICALS ULC,Active,9000216,valproic acid (divalproex sodium) 500 mg gastro-resistant tablet,8000108,valproic acid (divalproex),26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
68771,Marketed,2003-01-24,02244781,Diovan 80 mg Tablets,1,C09CA03,Valsartan,Tablet,Oral,02244781,DIOVAN 80MG TABLETS (valsartan 80 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9001014,valsartan 80 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
68772,Marketed,2003-01-24,02244782,Diovan 160 mg Tablets,1,C09CA03,Valsartan,Tablet,Oral,02244782,DIOVAN 160MG TABLETS (valsartan 160 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9001013,valsartan 160 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
75588,Marketed,2005-11-01,02270528,Diovan,1,C09CA03,Valsartan,Tablet,Oral,02270528,DIOVAN (valsartan 40 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9001128,valsartan 40 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
77486,Marketed,2007-02-14,02289504,Diovan,1,C09CA03,Valsartan,Tablet,Oral,02289504,DIOVAN (valsartan 320 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9001187,valsartan 320 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84178,Marketed,2011-02-16,02356643,Teva-Valsartan,1,C09CA03,Valsartan,Tablet,Oral,02356643,TEVA-VALSARTAN (valsartan 40 mg oral tablet) TEVA CANADA LIMITED,Active,9001128,valsartan 40 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84179,Marketed,2011-02-16,02356651,Teva-Valsartan,1,C09CA03,Valsartan,Tablet,Oral,02356651,TEVA-VALSARTAN (valsartan 80 mg oral tablet) TEVA CANADA LIMITED,Active,9001014,valsartan 80 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84180,Marketed,2011-02-16,02356678,Teva-Valsartan,1,C09CA03,Valsartan,Tablet,Oral,02356678,TEVA-VALSARTAN (valsartan 160 mg oral tablet) TEVA CANADA LIMITED,Active,9001013,valsartan 160 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84181,Marketed,2011-02-16,02356686,Teva-Valsartan,1,C09CA03,Valsartan,Tablet,Oral,02356686,TEVA-VALSARTAN (valsartan 320 mg oral tablet) TEVA CANADA LIMITED,Active,9001187,valsartan 320 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84187,Marketed,2014-09-16,02356740,Sandoz Valsartan,1,C09CA03,Valsartan,Tablet,Oral,02356740,SANDOZ VALSARTAN (valsartan 40 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001128,valsartan 40 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84188,Marketed,2014-09-16,02356759,Sandoz Valsartan,1,C09CA03,Valsartan,Tablet,Oral,02356759,SANDOZ VALSARTAN (valsartan 80 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001014,valsartan 80 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84189,Marketed,2014-09-16,02356767,Sandoz Valsartan,1,C09CA03,Valsartan,Tablet,Oral,02356767,SANDOZ VALSARTAN (valsartan 160 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001013,valsartan 160 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84190,Marketed,2014-09-16,02356775,Sandoz Valsartan,1,C09CA03,Valsartan,Tablet,Oral,02356775,SANDOZ VALSARTAN (valsartan 320 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001187,valsartan 320 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84808,Marketed,2021-08-18,02363062,Taro-Valsartan,1,C09CA03,Valsartan,Tablet,Oral,02363062,TARO-VALSARTAN (valsartan 40 mg oral tablet) SUN PHARMA CANADA INC,Active,9001128,valsartan 40 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84812,Marketed,2021-08-18,02363100,Taro-Valsartan,1,C09CA03,Valsartan,Tablet,Oral,02363100,TARO-VALSARTAN (valsartan 80 mg oral tablet) SUN PHARMA CANADA INC,Active,9001014,valsartan 80 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84813,Marketed,2021-08-18,02363119,Taro-Valsartan,1,C09CA03,Valsartan,Tablet,Oral,02363119,TARO-VALSARTAN (valsartan 160 mg oral tablet) SUN PHARMA CANADA INC,Active,9001013,valsartan 160 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85176,Marketed,2021-12-10,02366940,Valsartan,1,C09CA03,Valsartan,Tablet,Oral,02366940,VALSARTAN (valsartan 40 mg oral tablet) SANIS HEALTH INC,Active,9001128,valsartan 40 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85177,Marketed,2021-12-10,02366959,Valsartan,1,C09CA03,Valsartan,Tablet,Oral,02366959,VALSARTAN (valsartan 80 mg oral tablet) SANIS HEALTH INC,Active,9001014,valsartan 80 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85178,Marketed,2021-12-10,02366967,Valsartan,1,C09CA03,Valsartan,Tablet,Oral,02366967,VALSARTAN (valsartan 160 mg oral tablet) SANIS HEALTH INC,Active,9001013,valsartan 160 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85179,Marketed,2021-12-10,02366975,Valsartan,1,C09CA03,Valsartan,Tablet,Oral,02366975,VALSARTAN (valsartan 320 mg oral tablet) SANIS HEALTH INC,Active,9001187,valsartan 320 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85256,Marketed,2021-12-21,02367726,Valsartan,1,C09CA03,Valsartan,Tablet,Oral,02367726,VALSARTAN (valsartan 40 mg oral tablet) PRO DOC LIMITEE,Active,9001128,valsartan 40 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85257,Marketed,2021-12-21,02367734,Valsartan,1,C09CA03,Valsartan,Tablet,Oral,02367734,VALSARTAN (valsartan 80 mg oral tablet) PRO DOC LIMITEE,Active,9001014,valsartan 80 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85258,Marketed,2021-12-21,02367742,Valsartan,1,C09CA03,Valsartan,Tablet,Oral,02367742,VALSARTAN (valsartan 160 mg oral tablet) PRO DOC LIMITEE,Active,9001013,valsartan 160 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85259,Marketed,2021-12-21,02367750,Valsartan,1,C09CA03,Valsartan,Tablet,Oral,02367750,VALSARTAN (valsartan 320 mg oral tablet) PRO DOC LIMITEE,Active,9001187,valsartan 320 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87024,Marketed,2022-05-03,02384523,Valsartan,1,C09CA03,Valsartan,Tablet,Oral,02384523,VALSARTAN (valsartan 40 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001128,valsartan 40 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87025,Marketed,2022-05-03,02384531,Valsartan,1,C09CA03,Valsartan,Tablet,Oral,02384531,VALSARTAN (valsartan 80 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001014,valsartan 80 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87026,Marketed,2022-05-03,02384558,Valsartan,1,C09CA03,Valsartan,Tablet,Oral,02384558,VALSARTAN (valsartan 160 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001013,valsartan 160 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87027,Marketed,2022-05-03,02384566,Valsartan,1,C09CA03,Valsartan,Tablet,Oral,02384566,VALSARTAN (valsartan 320 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001187,valsartan 320 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89887,Marketed,2014-02-06,02414201,Auro-Valsartan,1,C09CA03,Valsartan,Tablet,Oral,02414201,AURO-VALSARTAN (valsartan 40 mg oral tablet) AURO PHARMA INC,Active,9001128,valsartan 40 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89888,Marketed,2014-02-06,02414228,Auro-Valsartan,1,C09CA03,Valsartan,Tablet,Oral,02414228,AURO-VALSARTAN (valsartan 80 mg oral tablet) AURO PHARMA INC,Active,9001014,valsartan 80 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89889,Marketed,2014-02-06,02414236,Auro-Valsartan,1,C09CA03,Valsartan,Tablet,Oral,02414236,AURO-VALSARTAN (valsartan 160 mg oral tablet) AURO PHARMA INC,Active,9001013,valsartan 160 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89890,Marketed,2014-02-06,02414244,Auro-Valsartan,1,C09CA03,Valsartan,Tablet,Oral,02414244,AURO-VALSARTAN (valsartan 320 mg oral tablet) AURO PHARMA INC,Active,9001187,valsartan 320 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
65570,Marketed,2000-05-10,02241900,Diovan-HCTZ,2,C09DA03,Valsartan and diuretics,Tablet,Oral,02241900,DIOVAN-HCT (hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9000899,hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
65571,Marketed,2000-05-10,02241901,Diovan-HCTZ,2,C09DA03,Valsartan and diuretics,Tablet,Oral,02241901,DIOVAN-HCT (hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9000898,hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
71182,Marketed,2003-01-24,02246955,Diovan-HCTZ,2,C09DA03,Valsartan and diuretics,Tablet,Oral,02246955,DIOVAN-HCT (hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9001012,hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79451,Marketed,2008-05-12,02308908,Diovan-HCTZ,2,C09DA03,Valsartan and diuretics,Tablet,Oral,02308908,DIOVAN-HCT (hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9001245,hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79452,Marketed,2008-05-12,02308916,Diovan-HCTZ,2,C09DA03,Valsartan and diuretics,Tablet,Oral,02308916,DIOVAN-HCT (hydrochlorothiazide 25 mg and valsartan 320 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9001246,hydrochlorothiazide 25 mg and valsartan 320 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84182,Marketed,2016-05-27,02356694,Sandoz Valsartan HCTZ,2,C09DA03,Valsartan and diuretics,Tablet,Oral,02356694,SANDOZ VALSARTAN HCT (hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000899,hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84183,Marketed,2016-05-27,02356708,Sandoz Valsartan HCTZ,2,C09DA03,Valsartan and diuretics,Tablet,Oral,02356708,SANDOZ VALSARTAN HCT (hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000898,hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84184,Marketed,2016-05-27,02356716,Sandoz Valsartan HCTZ,2,C09DA03,Valsartan and diuretics,Tablet,Oral,02356716,SANDOZ VALSARTAN HCT (hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001012,hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84185,Marketed,2016-05-27,02356724,Sandoz Valsartan HCTZ,2,C09DA03,Valsartan and diuretics,Tablet,Oral,02356724,SANDOZ VALSARTAN HCT (hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001245,hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84186,Marketed,2016-05-27,02356732,Sandoz Valsartan HCTZ,2,C09DA03,Valsartan and diuretics,Tablet,Oral,02356732,SANDOZ VALSARTAN HCT (hydrochlorothiazide 25 mg and valsartan 320 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001246,hydrochlorothiazide 25 mg and valsartan 320 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84210,Marketed,2011-02-16,02356996,Teva-Valsartan/HCTZ,2,C09DA03,Valsartan and diuretics,Tablet,Oral,02356996,TEVA-VALSARTAN/HCTZ (hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet) TEVA CANADA LIMITED,Active,9000899,hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84211,Marketed,2011-02-16,02357003,Teva-Valsartan/HCTZ,2,C09DA03,Valsartan and diuretics,Tablet,Oral,02357003,TEVA-VALSARTAN/HCTZ (hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet) TEVA CANADA LIMITED,Active,9000898,hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84212,Marketed,2011-02-16,02357011,Teva-Valsartan/HCTZ,2,C09DA03,Valsartan and diuretics,Tablet,Oral,02357011,TEVA-VALSARTAN/HCTZ (hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet) TEVA CANADA LIMITED,Active,9001012,hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84213,Marketed,2011-02-16,02357038,Teva-Valsartan/HCTZ,2,C09DA03,Valsartan and diuretics,Tablet,Oral,02357038,TEVA-VALSARTAN/HCTZ (hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet) TEVA CANADA LIMITED,Active,9001245,hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84214,Marketed,2011-02-16,02357046,Teva-Valsartan/HCTZ,2,C09DA03,Valsartan and diuretics,Tablet,Oral,02357046,TEVA-VALSARTAN/HCTZ (hydrochlorothiazide 25 mg and valsartan 320 mg oral tablet) TEVA CANADA LIMITED,Active,9001246,hydrochlorothiazide 25 mg and valsartan 320 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85182,Marketed,2022-02-18,02367009,Valsartan HCTZ,2,C09DA03,Valsartan and diuretics,Tablet,Oral,02367009,VALSARTAN HCT (hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet) SANIS HEALTH INC,Active,9000899,hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85183,Marketed,2022-02-18,02367017,Valsartan HCTZ,2,C09DA03,Valsartan and diuretics,Tablet,Oral,02367017,VALSARTAN HCT (hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet) SANIS HEALTH INC,Active,9000898,hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85184,Marketed,2022-02-18,02367025,Valsartan HCTZ,2,C09DA03,Valsartan and diuretics,Tablet,Oral,02367025,VALSARTAN HCT (hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet) SANIS HEALTH INC,Active,9001012,hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85185,Marketed,2022-02-18,02367033,Valsartan HCTZ,2,C09DA03,Valsartan and diuretics,Tablet,Oral,02367033,VALSARTAN HCT (hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet) SANIS HEALTH INC,Active,9001245,hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85186,Marketed,2022-02-18,02367041,Valsartan HCTZ,2,C09DA03,Valsartan and diuretics,Tablet,Oral,02367041,VALSARTAN HCT (hydrochlorothiazide 25 mg and valsartan 320 mg oral tablet) SANIS HEALTH INC,Active,9001246,hydrochlorothiazide 25 mg and valsartan 320 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85260,Marketed,2022-01-13,02367769,Valsartan-HCTZ,2,C09DA03,Valsartan and diuretics,Tablet,Oral,02367769,VALSARTAN-HCTZ (hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet) PRO DOC LIMITEE,Active,9000899,hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85261,Marketed,2022-01-13,02367777,Valsartan-HCTZ,2,C09DA03,Valsartan and diuretics,Tablet,Oral,02367777,VALSARTAN-HCTZ (hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet) PRO DOC LIMITEE,Active,9000898,hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
85262,Marketed,2022-01-13,02367785,Valsartan-HCTZ,2,C09DA03,Valsartan and diuretics,Tablet,Oral,02367785,VALSARTAN-HCTZ (hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet) PRO DOC LIMITEE,Active,9001012,hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87042,Marketed,2012-06-10,02384736,Valsartan HCTZ,2,C09DA03,Valsartan and diuretics,Tablet,Oral,02384736,VALSARTAN HCT (hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000899,hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87043,Marketed,2012-06-10,02384744,Valsartan HCTZ,2,C09DA03,Valsartan and diuretics,Tablet,Oral,02384744,VALSARTAN HCT (hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000898,hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87044,Marketed,2012-06-10,02384752,Valsartan HCTZ,2,C09DA03,Valsartan and diuretics,Tablet,Oral,02384752,VALSARTAN HCT (hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001012,hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87045,Marketed,2012-06-10,02384760,Valsartan HCTZ,2,C09DA03,Valsartan and diuretics,Tablet,Oral,02384760,VALSARTAN HCT (hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001245,hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89280,Marketed,2013-06-19,02408112,Auro-Valsartan HCTZ,2,C09DA03,Valsartan and diuretics,Tablet,Oral,02408112,AURO-VALSARTAN HCT (hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet) AURO PHARMA INC,Active,9000899,hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89287,Marketed,2013-06-19,02408120,Auro-Valsartan HCTZ,2,C09DA03,Valsartan and diuretics,Tablet,Oral,02408120,AURO-VALSARTAN HCT (hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet) AURO PHARMA INC,Active,9000898,hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89288,Marketed,2013-06-19,02408139,Auro-Valsartan HCTZ,2,C09DA03,Valsartan and diuretics,Tablet,Oral,02408139,AURO-VALSARTAN HCT (hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet) AURO PHARMA INC,Active,9001012,hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89289,Marketed,2013-06-19,02408147,Auro-Valsartan HCTZ,2,C09DA03,Valsartan and diuretics,Tablet,Oral,02408147,AURO-VALSARTAN HCT (hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet) AURO PHARMA INC,Active,9001245,hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89290,Marketed,2013-06-19,02408155,Auro-Valsartan HCTZ,2,C09DA03,Valsartan and diuretics,Tablet,Oral,02408155,AURO-VALSARTAN HCT (hydrochlorothiazide 25 mg and valsartan 320 mg oral tablet) AURO PHARMA INC,Active,9001246,hydrochlorothiazide 25 mg and valsartan 320 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103789,Marketed,2025-10-01,02549018,Sandoz Sacubitril-Valsartan,2,C09DX04,Valsartan and sacubitril,Tablet,Oral,02549018,SANDOZ SACUBITRIL-VALSARTAN (sacubitril (sacubitril valsartan sodium hydrate complex) 24 mg and valsartan (sacubitril valsartan sodium hydrate complex) 26 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9012858,sacubitril (sacubitril valsartan sodium hydrate complex) 24 mg and valsartan (sacubitril valsartan sodium hydrate complex) 26 mg oral tablet,8001523,sacubitril and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103790,Marketed,2025-10-01,02549026,Sandoz Sacubitril-Valsartan,2,C09DX04,Valsartan and sacubitril,Tablet,Oral,02549026,SANDOZ SACUBITRIL-VALSARTAN (sacubitril (sacubitril valsartan sodium hydrate complex) 49 mg and valsartan (sacubitril valsartan sodium hydrate complex) 51 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9012859,sacubitril (sacubitril valsartan sodium hydrate complex) 49 mg and valsartan (sacubitril valsartan sodium hydrate complex) 51 mg oral tablet,8001523,sacubitril and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103791,Marketed,2025-10-01,02549034,Sandoz Sacubitril-Valsartan,2,C09DX04,Valsartan and sacubitril,Tablet,Oral,02549034,SANDOZ SACUBITRIL-VALSARTAN (sacubitril (sacubitril valsartan sodium hydrate complex) 97 mg and valsartan (sacubitril valsartan sodium hydrate complex) 103 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9012860,sacubitril (sacubitril valsartan sodium hydrate complex) 97 mg and valsartan (sacubitril valsartan sodium hydrate complex) 103 mg oral tablet,8001523,sacubitril and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106713,Marketed,2026-01-22,02564432,PMS-Sacubitril-Valsartan,2,C09DX04,Valsartan and sacubitril,Tablet,Oral,,,,,,,,,,,,,,,,,Prescription
106714,Marketed,2026-01-22,02564440,PMS-Sacubitril-Valsartan,2,C09DX04,Valsartan and sacubitril,Tablet,Oral,,,,,,,,,,,,,,,,,Prescription
106715,Marketed,2026-01-22,02564459,PMS-Sacubitril-Valsartan,2,C09DX04,Valsartan and sacubitril,Tablet,Oral,,,,,,,,,,,,,,,,,Prescription
93249,Marketed,2016-08-04,02446928,Entresto,2,C09DX04,Valsartan and sacubitril,Tablet,Oral,02446928,ENTRESTO (sacubitril (sacubitril valsartan sodium hydrate complex) 24 mg and valsartan (sacubitril valsartan sodium hydrate complex) 26 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012858,sacubitril (sacubitril valsartan sodium hydrate complex) 24 mg and valsartan (sacubitril valsartan sodium hydrate complex) 26 mg oral tablet,8001523,sacubitril and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93250,Marketed,2016-08-04,02446936,Entresto,2,C09DX04,Valsartan and sacubitril,Tablet,Oral,02446936,ENTRESTO (sacubitril (sacubitril valsartan sodium hydrate complex) 49 mg and valsartan (sacubitril valsartan sodium hydrate complex) 51 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012859,sacubitril (sacubitril valsartan sodium hydrate complex) 49 mg and valsartan (sacubitril valsartan sodium hydrate complex) 51 mg oral tablet,8001523,sacubitril and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
93251,Marketed,2016-08-04,02446944,Entresto,2,C09DX04,Valsartan and sacubitril,Tablet,Oral,02446944,ENTRESTO (sacubitril (sacubitril valsartan sodium hydrate complex) 97 mg and valsartan (sacubitril valsartan sodium hydrate complex) 103 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012860,sacubitril (sacubitril valsartan sodium hydrate complex) 97 mg and valsartan (sacubitril valsartan sodium hydrate complex) 103 mg oral tablet,8001523,sacubitril and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106446,Marketed,2026-04-24,02561506,Agamree,1,H02AB18,Vamorolone,Suspension,Oral,02561506,AGAMREE (vamorolone 40 mg per mL oral suspension) KYE PHARMACEUTICALS INC.,Active,9015409,vamorolone 40 mg per mL oral suspension,8002592,vamorolone,26643006,Oral,385024007,Oral suspension,,,1.0,,,Prescription
102199,Marketed,2024-10-02,02532999,"Vancomycin Hydrochloride For Injection, USP",1,J01XA01,Vancomycin,Powder for solution,Intravenous,02532999,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (vancomycin (vancomycin hydrochloride) 500 mg per vial powder for solution for injection) EUGIA PHARMA INC.",Active,9002498,vancomycin (vancomycin hydrochloride) 500 mg per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
102202,Marketed,2024-10-02,02533006,"Vancomycin Hydrochloride For Injection, USP",1,J01XA01,Vancomycin,Powder for solution,Intravenous,02533006,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (vancomycin (vancomycin hydrochloride) 1 g per vial powder for solution for injection) EUGIA PHARMA INC.",Active,9002497,vancomycin (vancomycin hydrochloride) 1 g per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
103239,Marketed,2024-08-02,02543974,"Vancomycin Hydrochloride For Injection, USP",1,J01XA01,Vancomycin,Powder for solution,Intravenous,02543974,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (vancomycin (vancomycin hydrochloride) 500 mg per vial powder for solution for injection) HIKMA CANADA LIMITED",Active,9002498,vancomycin (vancomycin hydrochloride) 500 mg per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
103241,Marketed,2024-08-02,02543982,"Vancomycin Hydrochloride For Injection, USP",1,J01XA01,Vancomycin,Powder for solution,Intravenous,02543982,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (vancomycin (vancomycin hydrochloride) 1 g per vial powder for solution for injection) HIKMA CANADA LIMITED",Active,9002497,vancomycin (vancomycin hydrochloride) 1 g per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
19703,Marketed,2015-08-14,02139375,"Vancomycin Hydrochloride For Injection, USP",1,J01XA01,Vancomycin,Powder for solution,Intravenous,02139375,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (vancomycin (vancomycin hydrochloride) 500 mg per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9002498,vancomycin (vancomycin hydrochloride) 500 mg per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
19705,Marketed,2015-08-14,02139383,"Vancomycin Hydrochloride For Injection, USP",1,J01XA01,Vancomycin,Powder for solution,Intravenous,02139383,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (vancomycin (vancomycin hydrochloride) 1 g per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9002497,vancomycin (vancomycin hydrochloride) 1 g per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
43933,Marketed,2015-08-20,02139243,"Vancomycin Hydrochloride For Injection, USP",1,J01XA01,Vancomycin,Powder for solution,Intravenous,02139243,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (vancomycin (vancomycin hydrochloride) 5 g per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9002903,vancomycin (vancomycin hydrochloride) 5 g per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
65472,Marketed,2015-08-12,02241807,"Vancomycin Hydrochloride For Injection, USP",1,J01XA01,Vancomycin,Powder for solution,Intravenous,02241807,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (vancomycin (vancomycin hydrochloride) 10 g per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9003500,vancomycin (vancomycin hydrochloride) 10 g per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
82835,Marketed,2018-01-11,02342855,Vancomycin Hydrochloride For Injection USP,1,J01XA01,Vancomycin,Powder for solution,Intravenous,02342855,VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP (vancomycin (vancomycin hydrochloride) 500 mg per vial powder for solution for injection) STERIMAX INC,Active,9002498,vancomycin (vancomycin hydrochloride) 500 mg per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
82836,Marketed,2018-01-12,02342863,Vancomycin Hydrochloride For Injection USP,1,J01XA01,Vancomycin,Powder for solution,Intravenous,02342863,VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP (vancomycin (vancomycin hydrochloride) 1 g per vial powder for solution for injection) STERIMAX INC,Active,9002497,vancomycin (vancomycin hydrochloride) 1 g per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
87976,Marketed,2014-03-18,02394626,"Vancomycin Hydrochloride For Injection, USP",1,J01XA01,Vancomycin,Powder for solution,Intravenous,02394626,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (vancomycin (vancomycin hydrochloride) 500 mg per vial powder for solution for injection) SANDOZ CANADA INCORPORATED",Active,9002498,vancomycin (vancomycin hydrochloride) 500 mg per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
87977,Marketed,2014-03-18,02394634,"Vancomycin Hydrochloride For Injection, USP",1,J01XA01,Vancomycin,Powder for solution,Intravenous,02394634,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (vancomycin (vancomycin hydrochloride) 1 g per vial powder for solution for injection) SANDOZ CANADA INCORPORATED",Active,9002497,vancomycin (vancomycin hydrochloride) 1 g per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
87978,Marketed,2013-02-14,02394642,"Vancomycin Hydrochloride For Injection, USP",1,J01XA01,Vancomycin,Powder for solution,Intravenous,02394642,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (vancomycin (vancomycin hydrochloride) 5 g per vial powder for solution for injection) SANDOZ CANADA INCORPORATED",Active,9002903,vancomycin (vancomycin hydrochloride) 5 g per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
89059,Marketed,2020-10-19,02405822,Vancomycin Hydrochloride For Injection USP,1,J01XA01,Vancomycin,Powder for solution,Intravenous,02405822,VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP (vancomycin (vancomycin hydrochloride) 5 g per vial powder for solution for injection) STERIMAX INC,Active,9002903,vancomycin (vancomycin hydrochloride) 5 g per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
89060,Marketed,2018-01-12,02405830,Vancomycin Hydrochloride For Injection USP,1,J01XA01,Vancomycin,Powder for solution,Intravenous,02405830,VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP (vancomycin (vancomycin hydrochloride) 10 g per vial powder for solution for injection) STERIMAX INC,Active,9003500,vancomycin (vancomycin hydrochloride) 10 g per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
89123,Marketed,2024-06-10,02406535,"Vancomycin Hydrochloride For Injection, USP",1,J01XA01,Vancomycin,Powder for solution,Intravenous,02406535,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (vancomycin (vancomycin hydrochloride) 500 mg per vial powder for solution for injection) MARCAN PHARMACEUTICALS INC",Active,9002498,vancomycin (vancomycin hydrochloride) 500 mg per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
89124,Marketed,2024-06-10,02406543,"Vancomycin Hydrochloride For Injection, USP",1,J01XA01,Vancomycin,Powder for solution,Intravenous,02406543,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (vancomycin (vancomycin hydrochloride) 1 g per vial powder for solution for injection) MARCAN PHARMACEUTICALS INC",Active,9002497,vancomycin (vancomycin hydrochloride) 1 g per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
89125,Marketed,2024-08-07,02406551,"Vancomycin Hydrochloride For Injection, USP",1,J01XA01,Vancomycin,Powder for solution,Intravenous,02406551,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (vancomycin (vancomycin hydrochloride) 5 g per vial powder for solution for injection) MARCAN PHARMACEUTICALS INC",Active,9002903,vancomycin (vancomycin hydrochloride) 5 g per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
89245,Marketed,2021-06-17,02407744,JAMP Vancomycin,1,A07AA09,Vancomycin,Capsule,Oral,02407744,JAMP VANCOMYCIN (vancomycin (vancomycin hydrochloride) 125 mg oral capsule) JAMP PHARMA CORPORATION,Active,9002229,vancomycin (vancomycin hydrochloride) 125 mg oral capsule,8001424,vancomycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
89246,Marketed,2021-06-17,02407752,JAMP Vancomycin,1,A07AA09,Vancomycin,Capsule,Oral,02407752,JAMP VANCOMYCIN (vancomycin (vancomycin hydrochloride) 250 mg oral capsule) JAMP PHARMA CORPORATION,Active,9002230,vancomycin (vancomycin hydrochloride) 250 mg oral capsule,8001424,vancomycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
92006,Marketed,2017-07-27,02435713,Vancomycin Hydrochloride For Injection USP,1,J01XA01,Vancomycin,Powder for solution,Intravenous,02435713,VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP (vancomycin (vancomycin hydrochloride) 500 mg per vial powder for solution for injection) GENERIC MEDICAL PARTNERS INC,Active,9002498,vancomycin (vancomycin hydrochloride) 500 mg per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
92007,Marketed,2019-10-17,02435721,Vancomycin Hydrochloride For Injection USP,1,J01XA01,Vancomycin,Powder for solution,Intravenous,02435721,VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP (vancomycin (vancomycin hydrochloride) 1 g per vial powder for solution for injection) GENERIC MEDICAL PARTNERS INC,Active,9002497,vancomycin (vancomycin hydrochloride) 1 g per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
9593,Marketed,2019-04-02,00788716,Vancocin,1,A07AA09,Vancomycin,Capsule,Oral,00788716,VANCOCIN (vancomycin (vancomycin hydrochloride) 250 mg oral capsule) SEARCHLIGHT PHARMA INC,Active,9002230,vancomycin (vancomycin hydrochloride) 250 mg oral capsule,8001424,vancomycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
9594,Marketed,2019-04-02,00800430,Vancocin,1,A07AA09,Vancomycin,Capsule,Oral,00800430,VANCOCIN (vancomycin (vancomycin hydrochloride) 125 mg oral capsule) SEARCHLIGHT PHARMA INC,Active,9002229,vancomycin (vancomycin hydrochloride) 125 mg oral capsule,8001424,vancomycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97722,Marketed,2021-01-11,02487071,Vancomycin Injection USP In 0.9% Sodium Chloride,1,J01XA01,Vancomycin,Solution,Intravenous,02487071,VANCOMYCIN INJECTION USP IN 0.9% SODIUM CHLORIDE (vancomycin (vancomycin hydrochloride) 1000 mg per 200 mL solution for injection bag) BAXTER CORPORATION,Active,9014469,vancomycin (vancomycin hydrochloride) 1000 mg per 200 mL solution for injection bag,8001424,vancomycin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,,Prescription
99216,Marketed,2021-01-14,02502593,"Vancomycin Hydrochloride For Injection, USP",1,J01XA01,Vancomycin,Powder for solution,Intravenous,02502593,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (vancomycin (vancomycin hydrochloride) 500 mg per vial powder for solution for injection) JAMP PHARMA CORPORATION",Active,9002498,vancomycin (vancomycin hydrochloride) 500 mg per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
99217,Marketed,2021-01-14,02502607,"Vancomycin Hydrochloride For Injection, USP",1,J01XA01,Vancomycin,Powder for solution,Intravenous,02502607,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (vancomycin (vancomycin hydrochloride) 1 g per vial powder for solution for injection) JAMP PHARMA CORPORATION",Active,9002497,vancomycin (vancomycin hydrochloride) 1 g per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
86437,Marketed,2025-11-27,02378582,Caprelsa,1,L01EX04,Vandetanib,Tablet,Oral,02378582,CAPRELSA (vandetanib 100 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9012396,vandetanib 100 mg oral tablet,8001122,vandetanib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
86438,Marketed,2024-04-05,02378590,Caprelsa,1,L01EX04,Vandetanib,Tablet,Oral,02378590,CAPRELSA (vandetanib 300 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9012397,vandetanib 300 mg oral tablet,8001122,vandetanib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100959,Marketed,2022-03-25,02520397,Vardenafil,1,G04BE09,Vardenafil,Tablet,Oral,02520397,VARDENAFIL (vardenafil (vardenafil hydrochloride trihydrate) 10 mg oral tablet) SANIS HEALTH INC,Active,9003884,vardenafil (vardenafil hydrochloride) 10 mg oral tablet,8001543,vardenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
100960,Marketed,2022-03-25,02520400,Vardenafil,1,G04BE09,Vardenafil,Tablet,Oral,02520400,VARDENAFIL (vardenafil (vardenafil hydrochloride trihydrate) 20 mg oral tablet) SANIS HEALTH INC,Active,9003885,vardenafil (vardenafil hydrochloride) 20 mg oral tablet,8001543,vardenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95236,Marketed,2018-11-01,02464209,Mylan-Vardenafil,1,G04BE09,Vardenafil,Tablet,Oral,02464209,MYLAN-VARDENAFIL (vardenafil (vardenafil hydrochloride trihydrate) 5 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9003886,vardenafil (vardenafil hydrochloride) 5 mg oral tablet,8001543,vardenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95239,Marketed,2018-11-01,02464225,Mylan-Vardenafil,1,G04BE09,Vardenafil,Tablet,Oral,02464225,MYLAN-VARDENAFIL (vardenafil (vardenafil hydrochloride trihydrate) 10 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9003884,vardenafil (vardenafil hydrochloride) 10 mg oral tablet,8001543,vardenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95240,Marketed,2018-11-01,02464233,Mylan-Vardenafil,1,G04BE09,Vardenafil,Tablet,Oral,02464233,MYLAN-VARDENAFIL (vardenafil (vardenafil hydrochloride trihydrate) 20 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9003885,vardenafil (vardenafil hydrochloride) 20 mg oral tablet,8001543,vardenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96086,Marketed,2018-12-21,02471647,Apo-Vardenafil,1,G04BE09,Vardenafil,Tablet,Oral,02471647,APO-VARDENAFIL (vardenafil (vardenafil hydrochloride) 5 mg oral tablet) APOTEX INC,Active,9003886,vardenafil (vardenafil hydrochloride) 5 mg oral tablet,8001543,vardenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96087,Marketed,2018-12-21,02471655,Apo-Vardenafil,1,G04BE09,Vardenafil,Tablet,Oral,02471655,APO-VARDENAFIL (vardenafil (vardenafil hydrochloride) 10 mg oral tablet) APOTEX INC,Active,9003884,vardenafil (vardenafil hydrochloride) 10 mg oral tablet,8001543,vardenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96088,Marketed,2018-12-21,02471663,Apo-Vardenafil,1,G04BE09,Vardenafil,Tablet,Oral,02471663,APO-VARDENAFIL (vardenafil (vardenafil hydrochloride) 20 mg oral tablet) APOTEX INC,Active,9003885,vardenafil (vardenafil hydrochloride) 20 mg oral tablet,8001543,vardenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96605,Marketed,2018-11-01,02475677,JAMP-Vardenafil,1,G04BE09,Vardenafil,Tablet,Oral,02475677,JAMP-VARDENAFIL (vardenafil (vardenafil hydrochloride) 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003886,vardenafil (vardenafil hydrochloride) 5 mg oral tablet,8001543,vardenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96606,Marketed,2018-11-01,02475685,JAMP-Vardenafil,1,G04BE09,Vardenafil,Tablet,Oral,02475685,JAMP-VARDENAFIL (vardenafil (vardenafil hydrochloride) 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003884,vardenafil (vardenafil hydrochloride) 10 mg oral tablet,8001543,vardenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96607,Marketed,2018-11-01,02475693,JAMP-Vardenafil,1,G04BE09,Vardenafil,Tablet,Oral,02475693,JAMP-VARDENAFIL (vardenafil (vardenafil hydrochloride) 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003885,vardenafil (vardenafil hydrochloride) 20 mg oral tablet,8001543,vardenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96702,Marketed,2019-06-06,02476088,JAMP-Vardenafil ODT,1,G04BE09,Vardenafil,Tablet (orally disintegrating),Oral,02476088,JAMP-VARDENAFIL ODT (vardenafil (vardenafil hydrochloride trihydrate) 10 mg orodispersible tablet) JAMP PHARMA CORPORATION,Active,9004917,vardenafil (vardenafil hydrochloride) 10 mg orodispersible tablet,8001543,vardenafil,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
103147,Marketed,2024-06-19,02542951,Nra-Varenicline,1,N07BA03,Varenicline,Tablet,Oral,02542951,NRA-VARENICLINE (varenicline (varenicline tartrate) 0.5 mg oral tablet) NORA PHARMA INC,Active,9001197,varenicline (varenicline tartrate) 0.5 mg oral tablet,8000371,varenicline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103148,Marketed,2024-06-19,02542978,Nra-Varenicline,1,N07BA03,Varenicline,Tablet,Oral,02542978,NRA-VARENICLINE (varenicline (varenicline tartrate) 1 mg oral tablet) NORA PHARMA INC,Active,9001198,varenicline (varenicline tartrate) 1 mg oral tablet,8000371,varenicline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103149,Marketed,2024-06-19,02542986,Nra-Varenicline,2,N07BA03,Varenicline,"Kit,Tablet",Oral,02542986,NRA-VARENICLINE (varenicline (varenicline tartrate) 0.5 mg oral tablet with varenicline (varenicline tartrate) 1 mg oral tablet) NORA PHARMA INC,Active,9001216,varenicline (varenicline tartrate) 0.5 mg oral tablet with varenicline (varenicline tartrate) 1 mg oral tablet,8000371,varenicline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103561,Marketed,2024-10-28,02546949,Mint-Varenicline,1,N07BA03,Varenicline,Tablet,Oral,02546949,MINT-VARENICLINE (varenicline (varenicline tartrate) 0.5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001197,varenicline (varenicline tartrate) 0.5 mg oral tablet,8000371,varenicline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103562,Marketed,2024-10-28,02546957,Mint-Varenicline,1,N07BA03,Varenicline,Tablet,Oral,02546957,MINT-VARENICLINE (varenicline (varenicline tartrate) 1 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001198,varenicline (varenicline tartrate) 1 mg oral tablet,8000371,varenicline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103563,Marketed,2025-05-15,02546965,Mint-Varenicline,2,N07BA03,Varenicline,"Kit,Tablet",Oral,02546965,MINT-VARENICLINE (varenicline (varenicline tartrate) 0.5 mg oral tablet with varenicline (varenicline tartrate) 1 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001216,varenicline (varenicline tartrate) 0.5 mg oral tablet with varenicline (varenicline tartrate) 1 mg oral tablet,8000371,varenicline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104330,Marketed,2026-01-26,02554445,Auro-Varenicline,1,N07BA03,Varenicline,Tablet,Oral,02554445,AURO-VARENICLINE (varenicline (varenicline tartrate) 0.5 mg oral tablet) AURO PHARMA INC,Active,9001197,varenicline (varenicline tartrate) 0.5 mg oral tablet,8000371,varenicline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104331,Marketed,2026-01-26,02554453,Auro-Varenicline,1,N07BA03,Varenicline,Tablet,Oral,02554453,AURO-VARENICLINE (varenicline (varenicline tartrate) 1 mg oral tablet) AURO PHARMA INC,Active,9001198,varenicline (varenicline tartrate) 1 mg oral tablet,8000371,varenicline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106300,Marketed,2026-04-22,02559897,ZDS-Varenicline,1,N07BA03,Varenicline,Tablet,Oral,02559897,ZDS-VARENICLINE (varenicline (varenicline tartrate) 0.5 mg oral tablet) ZYDUS LIFESCIENCES LIMITED,Active,9001197,varenicline (varenicline tartrate) 0.5 mg oral tablet,8000371,varenicline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
106301,Marketed,2026-04-22,02559900,ZDS-Varenicline,1,N07BA03,Varenicline,Tablet,Oral,02559900,ZDS-VARENICLINE (varenicline (varenicline tartrate) 1 mg oral tablet) ZYDUS LIFESCIENCES LIMITED,Active,9001198,varenicline (varenicline tartrate) 1 mg oral tablet,8000371,varenicline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90450,Marketed,2018-05-02,02419882,Apo-Varenicline,1,N07BA03,Varenicline,Tablet,Oral,02419882,APO-VARENICLINE (varenicline (varenicline tartrate) 0.5 mg oral tablet) APOTEX INC,Active,9001197,varenicline (varenicline tartrate) 0.5 mg oral tablet,8000371,varenicline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90451,Marketed,2018-05-02,02419890,Apo-Varenicline,1,N07BA03,Varenicline,Tablet,Oral,02419890,APO-VARENICLINE (varenicline (varenicline tartrate) 1 mg oral tablet) APOTEX INC,Active,9001198,varenicline (varenicline tartrate) 1 mg oral tablet,8000371,varenicline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92001,Marketed,2024-12-23,02435675,Apo-Varenicline,2,N07BA03,Varenicline,"Tablet,Kit",Oral,02435675,APO-VARENICLINE (varenicline (varenicline tartrate) 0.5 mg oral tablet with varenicline (varenicline tartrate) 1 mg oral tablet) APOTEX INC,Active,9001216,varenicline (varenicline tartrate) 0.5 mg oral tablet with varenicline (varenicline tartrate) 1 mg oral tablet,8000371,varenicline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95685,Marketed,2018-01-02,02468425,Shingrix,1,J07BK,Varicella zoster vaccines,Suspension,Intramuscular,,,,,,,,,,,,,,,,,Schedule D
64641,Marketed,2026-03-02,02241047,Varilrix,1,J07BK01,"Varicella, live attenuated",Powder for solution,Subcutaneous,,,,,,,,,,,,,,,,,Schedule D
70216,Marketed,2024-10-11,02246081,Varivax III,1,J07BK01,"Varicella, live attenuated",Powder for solution,"Intramuscular,Subcutaneous",,,,,,,,,,,,,,,,,Schedule D
92654,Marketed,2022-07-11,02442183,Varizig,1,J06BB03,Varicella/zoster immunoglobulin,Solution,"Intravenous,Intramuscular",,,,,,,,,,,,,,,,,Schedule D
1090,Marketed,2013-04-20,00065927,Neo-Laryngobis,1,R02AA20,Various,Suppository,Rectal,00065927,NEO-LARYNGOBIS (bismuth dipropylacetate 135 mg suppository) TEVA CANADA LIMITED,Active,9001497,bismuth dipropylacetate 135 mg suppository,8001703,bismuth dipropylacetate,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,,Non-Prescription Drugs
1913,Marketed,2005-02-22,00299979,Allergenic Extract Non Pollens,1,V01AA20,Various,Liquid,"Subcutaneous,Intradermal,Percutaneous",,,,,,,,,,,,,,,,,Schedule D
1914,Marketed,2005-02-22,00299987,Allergenic Extract Pollens,1,V01AA20,Various,Liquid,"Percutaneous,Subcutaneous,Intradermal",,,,,,,,,,,,,,,,,Schedule D
37484,Marketed,2023-03-24,02226928,Allergenic Extract - Pollens,1,V01AA20,Various,Solution,"Subcutaneous,Percutaneous,Intradermal",,,,,,,,,,,,,,,,,Schedule D
37486,Marketed,2022-09-12,02226944,Allergenic Extract - Non-Pollens,1,V01AA20,Various,Solution,"Percutaneous,Subcutaneous,Intradermal",,,,,,,,,,,,,,,,,Schedule D
41939,Marketed,2021-08-18,01942271,Absorbine JR Extra Strength Liniment,2,M02AX10,Various,Liquid,Topical,01942271,ABSORBINE JR EXTRA STRENGTH LINIMENT (chloroxylenol 0.5 % and menthol 4 % cutaneous solution) BRIDGES CONSUMER HEALTHCARE LLC,Active,9013809,chloroxylenol 0.5 % and menthol 4 % cutaneous solution,8001721,chloroxylenol and menthol,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Non-Prescription Drugs
42113,Marketed,2021-10-08,01942301,Absorbine JR Liniment,2,M02AX10,Various,Solution,Topical,01942301,ABSORBINE JR LINIMENT (chloroxylenol 0.5 % and menthol 1.25 % cutaneous solution) BRIDGES CONSUMER HEALTHCARE LLC,Active,9013808,chloroxylenol 0.5 % and menthol 1.25 % cutaneous solution,8001721,chloroxylenol and menthol,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Non-Prescription Drugs
4410,Marketed,1981-12-31,00479896,Xylonor Gel,2,A01AD11,Various,Gel,Topical,00479896,XYLONOR GEL (cetrimide 0.15 % and lidocaine 5 % oromucosal gel) SEPTODONT,Active,9014016,cetrimide 0.15 % and lidocaine 5 % oromucosal gel,8002103,cetrimide and lidocaine,372473007,Oromucosal,385100002,Gel,,,,,,Non-Prescription Drugs
4885,Marketed,2012-01-21,00551805,Secaris,2,R01AX10,Various,Gel,Nasal,00551805,SECARIS (polyethylene glycol 3350 15 % and propylene glycol 20 % nasal gel) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9013930,polyethylene glycol 3350 15 % and propylene glycol 20 % nasal gel,8002250,polyethylene glycol 3350 and propylene glycol,46713006,Nasal,385100002,Gel,,,,,,Non-Prescription Drugs
72045,Marketed,2003-06-30,02247753,Omega Allergenic Extracts - Pollens (Aqueous),1,V01AA20,Various,Liquid,"Intradermal,Subcutaneous",,,,,,,,,,,,,,,,,Schedule D
72046,Marketed,2003-07-02,02247754,Omega Allergenic Extracts - Pollens (Glycerinated),1,V01AA20,Various,Liquid,"Intradermal,Subcutaneous",,,,,,,,,,,,,,,,,Schedule D
72047,Marketed,2003-07-02,02247755,Omega Allergenic Extracts - Pollens (Suspal),1,V01AA20,Various,Liquid,"Subcutaneous,Intradermal",,,,,,,,,,,,,,,,,Schedule D
72048,Marketed,2003-06-30,02247756,Omega Allergenic Extracts - Non-Pollens (Aqueous),1,V01AA20,Various,Solution,"Intradermal,Subcutaneous",,,,,,,,,,,,,,,,,Schedule D
72049,Marketed,2003-07-02,02247757,Omega Allergenic Extracts - Non-Pollens (Glycerinated),1,V01AA20,Various,Liquid,"Intradermal,Subcutaneous",,,,,,,,,,,,,,,,,Schedule D
72050,Marketed,2003-07-02,02247758,Omega Allergenic Extracts - Non-Pollens (Suspal),1,V01AA20,Various,Liquid,"Subcutaneous,Intradermal",,,,,,,,,,,,,,,,,Schedule D
83795,Marketed,2012-01-21,02352699,Rhinaris Nasal Gel,2,R01AX10,Various,Gel,Nasal,02352699,RHINARIS NASAL GEL (polyethylene glycol 3350 15 % and propylene glycol 20 % nasal gel) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9013930,polyethylene glycol 3350 15 % and propylene glycol 20 % nasal gel,8002250,polyethylene glycol 3350 and propylene glycol,46713006,Nasal,385100002,Gel,,,,,,Non-Prescription Drugs
83972,Marketed,2012-01-21,02354551,Rhinaris Nasal Mist,2,R01AX10,Various,"Spray, metered dose",Nasal,02354551,RHINARIS NASAL MIST (polyethylene glycol 3350 15 % and propylene glycol 5 % nasal spray) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9013931,polyethylene glycol 3350 15 % and propylene glycol 5 % nasal spray,8002250,polyethylene glycol 3350 and propylene glycol,46713006,Nasal,385157007,Nasal spray,,,,,,Non-Prescription Drugs
85754,Marketed,2012-08-29,02372428,Non Standardized Allergenic Extracts - Non Pollens,1,V01AA20,Various,Liquid,"Intradermal,Subcutaneous",,,,,,,,,,,,,,,,,Schedule D
85756,Marketed,2012-02-10,02372444,Non Standardized Allergenic Extracts - Pollens,1,V01AA20,Various,Liquid,"Subcutaneous,Intradermal",,,,,,,,,,,,,,,,,Schedule D
81460,Marketed,2019-03-12,02328933,Technetium TC 99 M TSC,1,V09XX,Various diagnostic radiopharmaceuticals,"Solution,Powder for solution,Kit","Intraperitoneal,Oral,Intravenous",,,,,,,,,,,,,,,,,Schedule C
84585,Marketed,2019-03-28,02360853,Antimony Sulfide Colloid Kit,1,V09XX,Various diagnostic radiopharmaceuticals,"Solution,Kit",Intradermal,,,,,,,,,,,,,,,,,Schedule C
97628,Marketed,2019-03-24,02486067,Sulfur Colloid Kit,1,V09XX,Various diagnostic radiopharmaceuticals,"Kit,Solution","Intravenous,Inhalation,Intradermal,Oral",,,,,,,,,,,,,,,,,Schedule C
31359,Marketed,2023-11-02,02139502,"Vasopressin Injection, USP",1,H01BA01,Vasopressin (argipressin),Solution,"Intramuscular,Subcutaneous",02139502,"VASOPRESSIN INJECTION, USP (vasopressin 20 unit per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013390,vasopressin 20 unit per 1 mL solution for injection vial,8001984,vasopressin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
72248,Marketed,2005-08-20,02247938,Vasopressin Injection USP,1,H01BA01,Vasopressin (argipressin),Solution,"Subcutaneous,Intramuscular",77700861,VASOPRESSIN INJECTION USP (vasopressin 100 unit per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013389,vasopressin 100 unit per 5 mL solution for injection vial,8001984,vasopressin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
72248,Marketed,2005-08-20,02247938,Vasopressin Injection USP,1,H01BA01,Vasopressin (argipressin),Solution,"Subcutaneous,Intramuscular",77700862,VASOPRESSIN INJECTION USP (vasopressin 40 unit per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013391,vasopressin 40 unit per 2 mL solution for injection vial,8001984,vasopressin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
92117,Marketed,2015-04-21,02436841,Entyvio,1,L04AG05,Vedolizumab,Powder for solution,Intravenous,02436841,ENTYVIO (vedolizumab 300 mg per vial powder for solution for injection) TAKEDA CANADA INC,Active,9005703,vedolizumab 300 mg per vial powder for solution for injection,8001985,vedolizumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
92117,Marketed,2015-04-21,02436841,Entyvio,1,L04AG05,Vedolizumab,Powder for solution,Intravenous,02436841,ENTYVIO (vedolizumab 300 mg per vial powder for solution for injection) TAKEDA CANADA INC,Active,9005703,vedolizumab 300 mg per vial powder for solution for injection,8001985,vedolizumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
98766,Marketed,2020-11-20,02497875,Entyvio,1,L04AG05,Vedolizumab,Solution,Subcutaneous,02497875,ENTYVIO (vedolizumab 108 mg per 0.68 mL solution for injection syringe) TAKEDA CANADA INC,Active,9014415,vedolizumab 108 mg per 0.68 mL solution for injection syringe,8001985,vedolizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Schedule D
98766,Marketed,2020-11-20,02497875,Entyvio,1,L04AG05,Vedolizumab,Solution,Subcutaneous,02497875,ENTYVIO (vedolizumab 108 mg per 0.68 mL solution for injection syringe) TAKEDA CANADA INC,Active,9014415,vedolizumab 108 mg per 0.68 mL solution for injection syringe,8001985,vedolizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
98767,Marketed,2020-07-08,02497867,Entyvio,1,L04AG05,Vedolizumab,Solution,Subcutaneous,02497867,ENTYVIO (vedolizumab 108 mg per 0.68 mL solution for injection pen) TAKEDA CANADA INC,Active,9014350,vedolizumab 108 mg per 0.68 mL solution for injection pen,8001985,vedolizumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Prescription
98767,Marketed,2020-07-08,02497867,Entyvio,1,L04AG05,Vedolizumab,Solution,Subcutaneous,02497867,ENTYVIO (vedolizumab 108 mg per 0.68 mL solution for injection pen) TAKEDA CANADA INC,Active,9014350,vedolizumab 108 mg per 0.68 mL solution for injection pen,8001985,vedolizumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,,Schedule D
84221,Marketed,2021-10-15,02357119,Vpriv,1,A16AB10,Velaglucerase alfa,Powder for solution,Intravenous,02357119,VPRIV (velaglucerase alfa 400 unit per vial powder for solution for injection) TAKEDA CANADA INC,Active,9004791,velaglucerase alfa 400 unit per vial powder for solution for injection,8001986,velaglucerase alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
84221,Marketed,2021-10-15,02357119,Vpriv,1,A16AB10,Velaglucerase alfa,Powder for solution,Intravenous,02357119,VPRIV (velaglucerase alfa 400 unit per vial powder for solution for injection) TAKEDA CANADA INC,Active,9004791,velaglucerase alfa 400 unit per vial powder for solution for injection,8001986,velaglucerase alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
86606,Marketed,2012-03-05,02380242,Zelboraf,1,L01EC01,Vemurafenib,Tablet,Oral,02380242,ZELBORAF (vemurafenib 240 mg oral tablet) HOFFMANN-LA ROCHE LIMITED,Active,9004996,vemurafenib 240 mg oral tablet,8001987,vemurafenib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
94509,Marketed,2016-10-31,02458039,Venclexta,1,L01XX52,Venetoclax,Tablet,Oral,02458039,VENCLEXTA (venetoclax 10 mg oral tablet) ABBVIE CORPORATION,Active,9006059,venetoclax 10 mg oral tablet,8001988,venetoclax,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
94510,Marketed,2016-10-31,02458047,Venclexta,1,L01XX52,Venetoclax,Tablet,Oral,02458047,VENCLEXTA (venetoclax 50 mg oral tablet) ABBVIE CORPORATION,Active,9006060,venetoclax 50 mg oral tablet,8001988,venetoclax,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
94511,Marketed,2016-10-31,02458055,Venclexta,1,L01XX52,Venetoclax,Tablet,Oral,02458055,VENCLEXTA (venetoclax 100 mg oral tablet) ABBVIE CORPORATION,Active,9006056,venetoclax 100 mg oral tablet,8001988,venetoclax,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
94512,Marketed,2016-10-31,02458063,Venclexta,3,L01XX52,Venetoclax,"Kit,Tablet",Oral,02458063,VENCLEXTA (venetoclax 10 mg oral tablet with venetoclax 50 mg oral tablet with venetoclax 100 mg oral tablet) ABBVIE CORPORATION,Active,9013392,venetoclax 10 mg oral tablet with venetoclax 50 mg oral tablet with venetoclax 100 mg oral tablet,8001988,venetoclax,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
100588,Marketed,2021-12-29,02516535,Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02516535,VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule) JAMP PHARMA CORPORATION,Active,9000790,venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
100589,Marketed,2022-01-13,02516543,Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02516543,VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule) JAMP PHARMA CORPORATION,Active,9000791,venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
100590,Marketed,2021-12-30,02516551,Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02516551,VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule) JAMP PHARMA CORPORATION,Active,9000789,venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
101065,Marketed,2022-09-23,02521466,PMSC-Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02521466,PMSC-VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule) PHARMASCIENCE INC,Active,9000790,venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
101066,Marketed,2022-08-30,02521474,PMSC-Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02521474,PMSC-VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule) PHARMASCIENCE INC,Active,9000789,venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
101067,Marketed,2022-08-30,02521482,PMSC-Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02521482,PMSC-VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule) PHARMASCIENCE INC,Active,9000791,venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
101205,Marketed,2025-03-06,02522977,Mint-Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02522977,MINT-VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule) MINT PHARMACEUTICALS INC,Active,9000790,venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
101206,Marketed,2025-03-06,02522985,Mint-Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02522985,MINT-VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule) MINT PHARMACEUTICALS INC,Active,9000791,venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
101207,Marketed,2025-03-06,02522993,Mint-Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02522993,MINT-VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule) MINT PHARMACEUTICALS INC,Active,9000789,venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
60600,Marketed,2023-08-09,02237279,Effexor XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02237279,EFFEXOR XR (venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule) BGP PHARMA ULC,Active,9000790,venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
60601,Marketed,2023-08-09,02237280,Effexor XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02237280,EFFEXOR XR (venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule) BGP PHARMA ULC,Active,9000791,venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
60603,Marketed,2023-08-09,02237282,Effexor XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02237282,EFFEXOR XR (venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule) BGP PHARMA ULC,Active,9000789,venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
76056,Marketed,2010-04-30,02275058,Teva-Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02275058,TEVA-VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9000789,venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
78960,Marketed,2019-03-01,02304317,Act Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02304317,ACT VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9000790,venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
78961,Marketed,2019-03-01,02304325,Act Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02304325,ACT VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9000791,venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
78962,Marketed,2019-03-01,02304333,Act Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02304333,ACT VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9000789,venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
79596,Marketed,2020-03-20,02310317,Sandoz Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02310317,SANDOZ VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED,Active,9000790,venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
79597,Marketed,2020-03-20,02310325,Sandoz Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02310325,SANDOZ VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED,Active,9000791,venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
79598,Marketed,2020-03-20,02310333,Sandoz Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02310333,SANDOZ VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED,Active,9000789,venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
82485,Marketed,2020-04-09,02339242,Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02339242,VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule) PRO DOC LIMITEE,Active,9000790,venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
82486,Marketed,2020-04-09,02339250,Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02339250,VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule) PRO DOC LIMITEE,Active,9000791,venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
82487,Marketed,2020-04-09,02339269,Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02339269,VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule) PRO DOC LIMITEE,Active,9000789,venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
83988,Marketed,2023-01-25,02354713,Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02354713,VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule) SANIS HEALTH INC,Active,9000790,venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
83989,Marketed,2023-05-23,02354721,Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02354721,VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule) SANIS HEALTH INC,Active,9000791,venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
83990,Marketed,2023-02-15,02354748,Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02354748,VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule) SANIS HEALTH INC,Active,9000789,venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
86591,Marketed,2020-10-16,02380072,Taro-Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02380072,TARO-VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule) SUN PHARMA CANADA INC,Active,9000790,venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
86592,Marketed,2020-10-16,02380080,Taro-Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02380080,TARO-VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule) SUN PHARMA CANADA INC,Active,9000791,venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
86593,Marketed,2020-10-16,02380099,Taro-Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02380099,TARO-VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule) SUN PHARMA CANADA INC,Active,9000789,venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87153,Marketed,2018-06-08,02385929,Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02385929,VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000790,venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87154,Marketed,2018-06-08,02385937,Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02385937,VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000791,venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
87155,Marketed,2018-06-08,02385945,Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02385945,VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000789,venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
93924,Marketed,2016-03-14,02452839,Auro-Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02452839,AURO-VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule) AURO PHARMA INC,Active,9000790,venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
93925,Marketed,2016-03-14,02452847,Auro-Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02452847,AURO-VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule) AURO PHARMA INC,Active,9000791,venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
93926,Marketed,2016-03-14,02452855,Auro-Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02452855,AURO-VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule) AURO PHARMA INC,Active,9000789,venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96039,Marketed,2026-03-05,02471280,M-Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02471280,M-VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule) MANTRA PHARMA INC,Active,9000790,venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96040,Marketed,2026-03-05,02471299,M-Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02471299,M-VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule) MANTRA PHARMA INC,Active,9000791,venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
96041,Marketed,2026-03-05,02471302,M-Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02471302,M-VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule) MANTRA PHARMA INC,Active,9000789,venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97974,Marketed,2019-08-07,02489678,Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02489678,VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule) LABORATOIRE RIVA INC.,Active,9000790,venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97975,Marketed,2019-08-07,02489686,Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02489686,VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule) LABORATOIRE RIVA INC.,Active,9000791,venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
97976,Marketed,2019-08-07,02489694,Venlafaxine XR,1,N06AX16,Venlafaxine,Capsule (extended release),Oral,02489694,VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule) LABORATOIRE RIVA INC.,Active,9000789,venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,,Prescription
10034,Marketed,2026-03-24,00782483,AA-Verap,1,C08DA01,Verapamil,Tablet,Oral,00782483,AA-VERAP (verapamil hydrochloride 80 mg oral tablet) AA PHARMA INC,Active,9012360,verapamil hydrochloride 80 mg oral tablet,8000124,verapamil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
11534,Marketed,2017-12-18,01907123,Isoptin SR,1,C08DA01,Verapamil,Tablet (extended-release),Oral,01907123,ISOPTIN SR (verapamil hydrochloride 120 mg prolonged-release oral tablet) BGP PHARMA ULC,Active,9012354,verapamil hydrochloride 120 mg prolonged-release oral tablet,8000124,verapamil,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
18614,Marketed,2005-09-03,02166739,Verapamil Hydrochloride Injection USP,1,C08DA01,Verapamil,Liquid,Intravenous,02166739,VERAPAMIL HYDROCHLORIDE INJECTION USP (verapamil hydrochloride 5 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012359,verapamil hydrochloride 5 mg per 2 mL solution for injection vial,8000124,verapamil,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
20018,Marketed,2022-06-13,02210347,Mylan-Verapamil SR,1,C08DA01,Verapamil,Tablet (extended-release),Oral,02210347,MYLAN-VERAPAMIL SR (verapamil hydrochloride 120 mg prolonged-release oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9012354,verapamil hydrochloride 120 mg prolonged-release oral tablet,8000124,verapamil,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
9940,Marketed,2026-03-24,00782491,AA-Verap,1,C08DA01,Verapamil,Tablet,Oral,00782491,AA-VERAP (verapamil hydrochloride 120 mg oral tablet) AA PHARMA INC,Active,9012352,verapamil hydrochloride 120 mg oral tablet,8000124,verapamil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102575,Marketed,2023-09-19,02537044,Verquvo,1,C01DX22,Vericiguat,Tablet,Oral,02537044,VERQUVO (vericiguat 2.5 mg oral tablet) BAYER INC,Active,9014923,vericiguat 2.5 mg oral tablet,8002481,vericiguat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102576,Marketed,2023-09-19,02537052,Verquvo,1,C01DX22,Vericiguat,Tablet,Oral,02537052,VERQUVO (vericiguat 5 mg oral tablet) BAYER INC,Active,9014924,vericiguat 5 mg oral tablet,8002481,vericiguat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
102577,Marketed,2023-09-19,02537060,Verquvo,1,C01DX22,Vericiguat,Tablet,Oral,02537060,VERQUVO (vericiguat 10 mg oral tablet) BAYER INC,Active,9014922,vericiguat 10 mg oral tablet,8002481,vericiguat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
95016,Marketed,2020-07-15,02462400,Brinavess,1,C01BG11,Vernakalant,Solution,Intravenous,02462400,BRINAVESS (vernakalant hydrochloride 500 mg per 25 mL solution for injection vial) CIPHER PHARMACEUTICALS INC,Active,9012548,vernakalant hydrochloride 500 mg per 25 mL solution for injection vial,8001160,vernakalant,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
66078,Marketed,2020-05-22,02242367,Visudyne,1,S01LA01,Verteporfin,Powder for solution,Intravenous,02242367,VISUDYNE (verteporfin 15 mg per vial powder for solution for injection) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9003498,verteporfin 15 mg per vial powder for solution for injection,8001989,verteporfin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Prescription
15532,Marketed,2009-10-07,02065819,Sabril,1,N03AG04,Vigabatrin,Tablet,Oral,02065819,SABRIL (vigabatrin 500 mg oral tablet) LUNDBECK PHARMACEUTICALS LLC,Active,9002722,vigabatrin 500 mg oral tablet,8001544,vigabatrin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
43682,Marketed,2009-10-07,02068036,Sabril,1,N03AG04,Vigabatrin,Powder for solution,Oral,02068036,SABRIL (vigabatrin 500 mg per sachet powder for oral solution) LUNDBECK PHARMACEUTICALS LLC,Active,9013626,vigabatrin 500 mg per sachet powder for oral solution,8001544,vigabatrin,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),1.0,,,Prescription
89362,Marketed,2013-11-29,02408872,Breo Ellipta,2,R03AK10,Vilanterol and fluticasone furoate,Powder,Inhalation,02408872,BREO ELLIPTA (fluticasone furoate 100 mcg per actuation and vilanterol (vilanterol trifenatate) 25 mcg per actuation inhalation powder) GLAXOSMITHKLINE INC,Active,9012398,fluticasone furoate 100 mcg per actuation and vilanterol (vilanterol trifenatate) 25 mcg per actuation inhalation powder,8001081,fluticasone and vilanterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
92906,Marketed,2015-10-02,02444186,Breo Ellipta,2,R03AK10,Vilanterol and fluticasone furoate,Powder,Inhalation,02444186,BREO ELLIPTA (fluticasone furoate 200 mcg per actuation and vilanterol (vilanterol trifenatate) 25 mcg per actuation inhalation powder) GLAXOSMITHKLINE INC,Active,9012403,fluticasone furoate 200 mcg per actuation and vilanterol (vilanterol trifenatate) 25 mcg per actuation inhalation powder,8001081,fluticasone and vilanterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
90298,Marketed,2014-03-14,02418401,Anoro Ellipta,2,R03AL03,Vilanterol and umeclidinium bromide,Powder,Inhalation,02418401,ANORO ELLIPTA (umeclidinium (umeclidinium bromide) 62.5 mcg per actuation and vilanterol (vilanterol trifenatate) 25 mcg per actuation inhalation powder) GLAXOSMITHKLINE INC,Active,9012546,umeclidinium (umeclidinium bromide) 62.5 mcg per actuation and vilanterol (vilanterol trifenatate) 25 mcg per actuation inhalation powder,8001090,umeclidinium and vilanterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
100515,Marketed,2021-09-13,02515776,Trelegy Ellipta,3,R03AL08,"Vilanterol, umeclidinium bromide and fluticasone furoate",Powder,Inhalation,02515776,TRELEGY ELLIPTA (fluticasone furoate 200 mcg per actuation and umeclidinium (umeclidinium bromide) 62.5 mcg per actuation and vilanterol (vilanterol trifenatate) 25 mcg per actuation inhalation powder) GLAXOSMITHKLINE INC,Active,9014608,fluticasone furoate 200 mcg per actuation and umeclidinium (umeclidinium bromide) 62.5 mcg per actuation and vilanterol (vilanterol trifenatate) 25 mcg per actuation inhalation powder,8001383,fluticasone and umeclidinium and vilanterol,447694001,Respiratory tract,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
96469,Marketed,2018-05-30,02474522,Trelegy Ellipta,3,R03AL08,"Vilanterol, umeclidinium bromide and fluticasone furoate",Powder,Inhalation,02474522,TRELEGY ELLIPTA (fluticasone furoate 100 mcg per actuation and umeclidinium (umeclidinium bromide) 62.5 mcg per actuation and vilanterol (vilanterol trifenatate) 25 mcg per actuation inhalation powder) GLAXOSMITHKLINE INC,Active,9012710,fluticasone furoate 100 mcg per actuation and umeclidinium (umeclidinium bromide) 62.5 mcg per actuation and vilanterol (vilanterol trifenatate) 25 mcg per actuation inhalation powder,8001383,fluticasone and umeclidinium and vilanterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
104053,Marketed,2025-02-21,02551810,Apo-Vilazodone,1,N06AX24,Vilazodone,Tablet,Oral,02551810,APO-VILAZODONE (vilazodone hydrochloride 10 mg oral tablet) APOTEX INC,Active,9012549,vilazodone hydrochloride 10 mg oral tablet,8001161,vilazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104054,Marketed,2025-02-21,02551829,Apo-Vilazodone,1,N06AX24,Vilazodone,Tablet,Oral,02551829,APO-VILAZODONE (vilazodone hydrochloride 20 mg oral tablet) APOTEX INC,Active,9012550,vilazodone hydrochloride 20 mg oral tablet,8001161,vilazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104055,Marketed,2025-02-21,02551837,Apo-Vilazodone,1,N06AX24,Vilazodone,Tablet,Oral,02551837,APO-VILAZODONE (vilazodone hydrochloride 40 mg oral tablet) APOTEX INC,Active,9012551,vilazodone hydrochloride 40 mg oral tablet,8001161,vilazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92846,Marketed,2024-01-17,02443724,Viibryd,1,N06AX24,Vilazodone,Tablet,Oral,02443724,VIIBRYD (vilazodone hydrochloride 10 mg oral tablet) ABBVIE CORPORATION,Active,9012549,vilazodone hydrochloride 10 mg oral tablet,8001161,vilazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92847,Marketed,2024-01-15,02443732,Viibryd,1,N06AX24,Vilazodone,Tablet,Oral,02443732,VIIBRYD (vilazodone hydrochloride 20 mg oral tablet) ABBVIE CORPORATION,Active,9012550,vilazodone hydrochloride 20 mg oral tablet,8001161,vilazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92848,Marketed,2024-01-24,02443740,Viibryd,1,N06AX24,Vilazodone,Tablet,Oral,02443740,VIIBRYD (vilazodone hydrochloride 40 mg oral tablet) ABBVIE CORPORATION,Active,9012551,vilazodone hydrochloride 40 mg oral tablet,8001161,vilazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
44270,Marketed,2018-07-31,02183056,vinBLAStine Sulfate Injection,1,L01CA01,Vinblastine,Solution,Intravenous,02183056,VINBLASTINE SULFATE INJECTION (vinblastine sulfate 10 mg per 10 mL solution for injection vial) PFIZER CANADA ULC,Active,9013394,vinblastine sulfate 10 mg per 10 mL solution for injection vial,8001990,vinblastine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
88636,Marketed,2013-02-08,02401460,vinBLAStine Sulphate Injection,1,L01CA01,Vinblastine,Solution,Intravenous,02401460,VINBLASTINE SULPHATE INJECTION (vinblastine sulfate 10 mg per 10 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013394,vinblastine sulfate 10 mg per 10 mL solution for injection vial,8001990,vinblastine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
19756,Marketed,2014-04-12,02143305,vinCRIStine Sulfate Injection,1,L01CA02,Vincristine,Solution,Intravenous,77700843,VINCRISTINE SULFATE INJECTION (vincristine sulfate 5 mg per 5 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013397,vincristine sulfate 5 mg per 5 mL solution for injection vial,8001991,vincristine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
19756,Marketed,2014-04-12,02143305,vinCRIStine Sulfate Injection,1,L01CA02,Vincristine,Solution,Intravenous,77700844,VINCRISTINE SULFATE INJECTION (vincristine sulfate 2 mg per 2 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013396,vincristine sulfate 2 mg per 2 mL solution for injection vial,8001991,vincristine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
19756,Marketed,2014-04-12,02143305,vinCRIStine Sulfate Injection,1,L01CA02,Vincristine,Solution,Intravenous,77700845,VINCRISTINE SULFATE INJECTION (vincristine sulfate 1 mg per 1 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013395,vincristine sulfate 1 mg per 1 mL solution for injection vial,8001991,vincristine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
44267,Marketed,2018-04-17,02183013,vinCRIStine Sulfate Injection USP,1,L01CA02,Vincristine,Solution,Intravenous,77700846,VINCRISTINE SULFATE INJECTION USP (vincristine sulfate 2 mg per 2 mL solution for injection vial) PFIZER CANADA ULC,Active,9013396,vincristine sulfate 2 mg per 2 mL solution for injection vial,8001991,vincristine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
44267,Marketed,2018-04-17,02183013,vinCRIStine Sulfate Injection USP,1,L01CA02,Vincristine,Solution,Intravenous,77700847,VINCRISTINE SULFATE INJECTION USP (vincristine sulfate 5 mg per 5 mL solution for injection vial) PFIZER CANADA ULC,Active,9013397,vincristine sulfate 5 mg per 5 mL solution for injection vial,8001991,vincristine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
100056,Marketed,2021-06-25,02511347,"Vinorelbine Injection, USP",1,L01CA04,Vinorelbine,Solution,Intravenous,77701087,"VINORELBINE INJECTION, USP (vinorelbine (vinorelbine tartrate) 10 mg per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013398,vinorelbine (vinorelbine tartrate) 10 mg per 1 mL solution for injection vial,8001992,vinorelbine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
100056,Marketed,2021-06-25,02511347,"Vinorelbine Injection, USP",1,L01CA04,Vinorelbine,Solution,Intravenous,77701088,"VINORELBINE INJECTION, USP (vinorelbine (vinorelbine tartrate) 50 mg per 5 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013399,vinorelbine (vinorelbine tartrate) 50 mg per 5 mL solution for injection vial,8001992,vinorelbine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
75669,Marketed,2014-04-02,02271214,Vinorelbine Tartrate For Injection,1,L01CA04,Vinorelbine,Solution,Intravenous,77700870,VINORELBINE TARTRATE FOR INJECTION (vinorelbine (vinorelbine tartrate) 10 mg per 1 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013398,vinorelbine (vinorelbine tartrate) 10 mg per 1 mL solution for injection vial,8001992,vinorelbine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
75669,Marketed,2014-04-02,02271214,Vinorelbine Tartrate For Injection,1,L01CA04,Vinorelbine,Solution,Intravenous,77700871,VINORELBINE TARTRATE FOR INJECTION (vinorelbine (vinorelbine tartrate) 50 mg per 5 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013399,vinorelbine (vinorelbine tartrate) 50 mg per 5 mL solution for injection vial,8001992,vinorelbine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
91557,Marketed,2017-08-01,02431130,"Vinorelbine Injection, USP",1,L01CA04,Vinorelbine,Solution,Intravenous,77700897,"VINORELBINE INJECTION, USP (vinorelbine (vinorelbine tartrate) 10 mg per 1 mL solution for injection vial) GENERIC MEDICAL PARTNERS INC",Active,9013398,vinorelbine (vinorelbine tartrate) 10 mg per 1 mL solution for injection vial,8001992,vinorelbine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
91557,Marketed,2017-08-01,02431130,"Vinorelbine Injection, USP",1,L01CA04,Vinorelbine,Solution,Intravenous,77700898,"VINORELBINE INJECTION, USP (vinorelbine (vinorelbine tartrate) 50 mg per 5 mL solution for injection vial) GENERIC MEDICAL PARTNERS INC",Active,9013399,vinorelbine (vinorelbine tartrate) 50 mg per 5 mL solution for injection vial,8001992,vinorelbine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
89398,Marketed,2013-08-09,02409267,Erivedge,1,L01XJ01,Vismodegib,Capsule,Oral,02409267,ERIVEDGE (vismodegib 150 mg oral capsule) HOFFMANN-LA ROCHE LIMITED,Active,9005304,vismodegib 150 mg oral capsule,8001993,vismodegib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
16462,Marketed,2025-10-23,02100606,Multi 12,12,B05XC,Vitamins,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
5613,Marketed,2005-10-07,00586315,Multi 1000,9,B05XC,Vitamins,Solution,Intravenous,,,,,,,,,,,,,,,,,Ethical
66277,Marketed,2006-07-06,02242529,Multi-12/K 1 Pediatric,13,B05XC,Vitamins,Liquid,Intravenous,,,,,,,,,,,,,,,,,Prescription
74661,Marketed,2007-09-27,02261219,Humate-P,2,B02BD06,Von willebrand factor and coag. fact. viii in comb,Powder for solution,Intravenous,02261219,HUMATE-P (coagulation factor VIII human 250 unit per vial and von Willebrand factor human 600 unit per vial powder for solution for injection with diluent solution) CSL BEHRING CANADA INC,Active,9014160,coagulation factor VIII human 250 unit per vial and von Willebrand factor human 600 unit per vial powder for solution for injection with diluent solution,8002290,coagulation factor VIII human and von Willebrand factor human,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
74662,Marketed,2007-10-09,02261227,Humate-P,2,B02BD06,Von willebrand factor and coag. fact. viii in comb,Powder for solution,Intravenous,02261227,HUMATE-P (coagulation factor VIII human 500 unit per vial and von Willebrand factor human 1200 unit per vial powder for solution for injection with diluent solution) CSL BEHRING CANADA INC,Active,9014161,coagulation factor VIII human 500 unit per vial and von Willebrand factor human 1200 unit per vial powder for solution for injection with diluent solution,8002290,coagulation factor VIII human and von Willebrand factor human,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
74663,Marketed,2007-10-09,02261235,Humate-P,2,B02BD06,Von willebrand factor and coag. fact. viii in comb,Powder for solution,Intravenous,02261235,HUMATE-P (coagulation factor VIII human 1000 unit per vial and von Willebrand factor human 2400 unit per vial powder for solution for injection with diluent solution) CSL BEHRING CANADA INC,Active,9014162,coagulation factor VIII human 1000 unit per vial and von Willebrand factor human 2400 unit per vial powder for solution for injection with diluent solution,8002290,coagulation factor VIII human and von Willebrand factor human,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,,Schedule D
77219,Marketed,2008-04-29,02286750,Wilate,3,B02BD06,Von willebrand factor and coag. fact. viii in comb,Powder for solution,Intravenous,,,,,,,,,,,,,,,,,Schedule D
77222,Marketed,2008-04-29,02286769,Wilate,3,B02BD06,Von willebrand factor and coag. fact. viii in comb,Powder for solution,Intravenous,,,,,,,,,,,,,,,,,Schedule D
103996,Marketed,2024-10-21,02551225,Voranigo,1,L01XM04,Vorasidenib,Tablet,Oral,02551225,VORANIGO (vorasidenib 10 mg oral tablet) SERVIER CANADA INC,Active,9015127,vorasidenib 10 mg oral tablet,8002522,vorasidenib,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
103997,Marketed,2024-10-21,02551233,Voranigo,1,L01XM04,Vorasidenib,Tablet,Oral,02551233,VORANIGO (vorasidenib 40 mg oral tablet) SERVIER CANADA INC,Active,9015128,vorasidenib 40 mg oral tablet,8002522,vorasidenib,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99512,Marketed,2022-03-14,02505851,Luxturna,1,S01XA27,Voretigene neparvovec,Solution,Subretinal,02505851,LUXTURNA (voretigene neparvovec 2.5e12 vg per 0.5 mL solution for injection vial with diluent solution) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014688,voretigene neparvovec 2.5e12 vg per 0.5 mL solution for injection vial with diluent solution,8002416,voretigene neparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
99512,Marketed,2022-03-14,02505851,Luxturna,1,S01XA27,Voretigene neparvovec,Solution,Subretinal,02505851,LUXTURNA (voretigene neparvovec 2.5e12 vg per 0.5 mL solution for injection vial with diluent solution) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014688,voretigene neparvovec 2.5e12 vg per 0.5 mL solution for injection vial with diluent solution,8002416,voretigene neparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Schedule D
101478,Marketed,2022-09-12,02525771,JAMP Voriconazole,1,J02AC03,Voriconazole,Tablet,Oral,02525771,JAMP VORICONAZOLE (voriconazole 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003974,voriconazole 50 mg oral tablet,8001545,voriconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
101479,Marketed,2022-09-12,02525798,JAMP Voriconazole,1,J02AC03,Voriconazole,Tablet,Oral,02525798,JAMP VORICONAZOLE (voriconazole 200 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003972,voriconazole 200 mg oral tablet,8001545,voriconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
74170,Marketed,2004-11-12,02256460,Vfend,1,J02AC03,Voriconazole,Tablet,Oral,02256460,VFEND (voriconazole 50 mg oral tablet) PFIZER CANADA ULC,Active,9003974,voriconazole 50 mg oral tablet,8001545,voriconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
74171,Marketed,2004-11-12,02256479,Vfend,1,J02AC03,Voriconazole,Tablet,Oral,02256479,VFEND (voriconazole 200 mg oral tablet) PFIZER CANADA ULC,Active,9003972,voriconazole 200 mg oral tablet,8001545,voriconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
74172,Marketed,2004-11-12,02256487,Vfend,1,J02AC03,Voriconazole,Powder for solution,Intravenous,02256487,VFEND (voriconazole 200 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9003973,voriconazole 200 mg per vial powder for solution for injection,8001545,voriconazole,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
76561,Marketed,2008-07-17,02279991,Vfend,1,J02AC03,Voriconazole,Powder for suspension,Oral,02279991,VFEND (voriconazole 200 mg per 5 mL oral suspension) PFIZER CANADA ULC,Active,9012873,voriconazole 200 mg per 5 mL oral suspension,8001545,voriconazole,26643006,Oral,385024007,Oral suspension,,,1.0,,,Prescription
86783,Marketed,2014-04-30,02381966,Voriconazole For Injection,1,J02AC03,Voriconazole,Powder for solution,Intravenous,02381966,VORICONAZOLE FOR INJECTION (voriconazole 200 mg per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9003973,voriconazole 200 mg per vial powder for solution for injection,8001545,voriconazole,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
88415,Marketed,2014-04-02,02399245,Sandoz Voriconazole,1,J02AC03,Voriconazole,Tablet,Oral,02399245,SANDOZ VORICONAZOLE (voriconazole 50 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003974,voriconazole 50 mg oral tablet,8001545,voriconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
88416,Marketed,2014-04-02,02399253,Sandoz Voriconazole,1,J02AC03,Voriconazole,Tablet,Oral,02399253,SANDOZ VORICONAZOLE (voriconazole 200 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003972,voriconazole 200 mg oral tablet,8001545,voriconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
96863,Marketed,2019-07-23,02477696,Voriconazole For Injection,1,J02AC03,Voriconazole,Powder for solution,Intravenous,02477696,VORICONAZOLE FOR INJECTION (voriconazole 200 mg per vial powder for solution for injection) JAMP PHARMA CORPORATION,Active,9003973,voriconazole 200 mg per vial powder for solution for injection,8001545,voriconazole,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
98382,Marketed,2021-09-01,02493829,Voriconazole For Injection,1,J02AC03,Voriconazole,Powder for solution,Intravenous,02493829,VORICONAZOLE FOR INJECTION (voriconazole 200 mg per vial powder for solution for injection) FRESENIUS KABI CANADA LTD,Active,9003973,voriconazole 200 mg per vial powder for solution for injection,8001545,voriconazole,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
81300,Marketed,2009-06-29,02327619,Zolinza,1,L01XH01,Vorinostat,Capsule,Oral,02327619,ZOLINZA (vorinostat 100 mg oral capsule) MERCK CANADA INC,Active,9004563,vorinostat 100 mg oral capsule,8002001,vorinostat,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
104171,Marketed,2025-04-15,02552744,Apo-Vortioxetine,1,N06AX26,Vortioxetine,Tablet,Oral,02552744,APO-VORTIOXETINE (vortioxetine (vortioxetine hydrobromide) 5 mg oral tablet) APOTEX INC,Active,9005606,vortioxetine (vortioxetine hydrobromide) 5 mg oral tablet,8002002,vortioxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104172,Marketed,2025-04-15,02552752,Apo-Vortioxetine,1,N06AX26,Vortioxetine,Tablet,Oral,02552752,APO-VORTIOXETINE (vortioxetine (vortioxetine hydrobromide) 10 mg oral tablet) APOTEX INC,Active,9005604,vortioxetine (vortioxetine hydrobromide) 10 mg oral tablet,8002002,vortioxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
104174,Marketed,2025-04-15,02552779,Apo-Vortioxetine,1,N06AX26,Vortioxetine,Tablet,Oral,02552779,APO-VORTIOXETINE (vortioxetine (vortioxetine hydrobromide) 20 mg oral tablet) APOTEX INC,Active,9005605,vortioxetine (vortioxetine hydrobromide) 20 mg oral tablet,8002002,vortioxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91732,Marketed,2014-10-28,02432919,Trintellix,1,N06AX26,Vortioxetine,Tablet,Oral,02432919,TRINTELLIX (vortioxetine (vortioxetine hydrobromide) 5 mg oral tablet) LUNDBECK CANADA INC,Active,9005606,vortioxetine (vortioxetine hydrobromide) 5 mg oral tablet,8002002,vortioxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91733,Marketed,2014-10-28,02432927,Trintellix,1,N06AX26,Vortioxetine,Tablet,Oral,02432927,TRINTELLIX (vortioxetine (vortioxetine hydrobromide) 10 mg oral tablet) LUNDBECK CANADA INC,Active,9005604,vortioxetine (vortioxetine hydrobromide) 10 mg oral tablet,8002002,vortioxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
91735,Marketed,2014-10-28,02432943,Trintellix,1,N06AX26,Vortioxetine,Tablet,Oral,02432943,TRINTELLIX (vortioxetine (vortioxetine hydrobromide) 20 mg oral tablet) LUNDBECK CANADA INC,Active,9005605,vortioxetine (vortioxetine hydrobromide) 20 mg oral tablet,8002002,vortioxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103100,Marketed,2023-12-15,02542420,Amvuttra,1,N07XX18,Vutrisiran,Solution,Subcutaneous,02542420,AMVUTTRA (vutrisiran (vutrisiran sodium) 25 mg per 0.5 mL solution for injection syringe) ALNYLAM NETHERLANDS B.V.,Active,9015009,vutrisiran (vutrisiran sodium) 25 mg per 0.5 mL solution for injection syringe,8002497,vutrisiran,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,,Prescription
66470,Marketed,2000-08-09,02242680,Taro-Warfarin,1,B01AA03,Warfarin,Tablet,Oral,02242680,TARO-WARFARIN (warfarin sodium 1 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9000020,warfarin sodium 1 mg oral tablet,8000013,warfarin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
66471,Marketed,2000-08-09,02242681,Taro-Warfarin,1,B01AA03,Warfarin,Tablet,Oral,02242681,TARO-WARFARIN (warfarin sodium 2 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9000498,warfarin sodium 2 mg oral tablet,8000013,warfarin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
66472,Marketed,2000-08-09,02242682,Taro-Warfarin,1,B01AA03,Warfarin,Tablet,Oral,02242682,TARO-WARFARIN (warfarin sodium 2.5 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9000450,warfarin sodium 2.5 mg oral tablet,8000013,warfarin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
66473,Marketed,2000-08-09,02242683,Taro-Warfarin,1,B01AA03,Warfarin,Tablet,Oral,02242683,TARO-WARFARIN (warfarin sodium 3 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9000861,warfarin sodium 3 mg oral tablet,8000013,warfarin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
66474,Marketed,2000-08-09,02242684,Taro-Warfarin,1,B01AA03,Warfarin,Tablet,Oral,02242684,TARO-WARFARIN (warfarin sodium 4 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9000451,warfarin sodium 4 mg oral tablet,8000013,warfarin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
66475,Marketed,2000-08-09,02242685,Taro-Warfarin,1,B01AA03,Warfarin,Tablet,Oral,02242685,TARO-WARFARIN (warfarin sodium 5 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9000021,warfarin sodium 5 mg oral tablet,8000013,warfarin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
66476,Marketed,2000-08-09,02242686,Taro-Warfarin,1,B01AA03,Warfarin,Tablet,Oral,02242686,TARO-WARFARIN (warfarin sodium 6 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9000914,warfarin sodium 6 mg oral tablet,8000013,warfarin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
66477,Marketed,2000-08-09,02242687,Taro-Warfarin,1,B01AA03,Warfarin,Tablet,Oral,02242687,TARO-WARFARIN (warfarin sodium 10 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9000019,warfarin sodium 10 mg oral tablet,8000013,warfarin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
66492,Marketed,2000-08-09,02242697,Taro-Warfarin,1,B01AA03,Warfarin,Tablet,Oral,02242697,TARO-WARFARIN (warfarin sodium 7.5 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9000915,warfarin sodium 7.5 mg oral tablet,8000013,warfarin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
66762,Marketed,2000-10-16,02242924,Apo-Warfarin,1,B01AA03,Warfarin,Tablet,Oral,02242924,APO-WARFARIN (warfarin sodium 1 mg oral tablet) APOTEX INC,Active,9000020,warfarin sodium 1 mg oral tablet,8000013,warfarin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
66763,Marketed,2000-10-16,02242925,Apo-Warfarin,1,B01AA03,Warfarin,Tablet,Oral,02242925,APO-WARFARIN (warfarin sodium 2 mg oral tablet) APOTEX INC,Active,9000498,warfarin sodium 2 mg oral tablet,8000013,warfarin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
66764,Marketed,2000-10-16,02242926,Apo-Warfarin,1,B01AA03,Warfarin,Tablet,Oral,02242926,APO-WARFARIN (warfarin sodium 2.5 mg oral tablet) APOTEX INC,Active,9000450,warfarin sodium 2.5 mg oral tablet,8000013,warfarin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
66765,Marketed,2000-10-16,02242927,Apo-Warfarin,1,B01AA03,Warfarin,Tablet,Oral,02242927,APO-WARFARIN (warfarin sodium 4 mg oral tablet) APOTEX INC,Active,9000451,warfarin sodium 4 mg oral tablet,8000013,warfarin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
66766,Marketed,2000-10-16,02242928,Apo-Warfarin,1,B01AA03,Warfarin,Tablet,Oral,02242928,APO-WARFARIN (warfarin sodium 5 mg oral tablet) APOTEX INC,Active,9000021,warfarin sodium 5 mg oral tablet,8000013,warfarin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
66767,Marketed,2000-10-16,02242929,Apo-Warfarin,1,B01AA03,Warfarin,Tablet,Oral,02242929,APO-WARFARIN (warfarin sodium 10 mg oral tablet) APOTEX INC,Active,9000019,warfarin sodium 10 mg oral tablet,8000013,warfarin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
69718,Marketed,2002-04-23,02245618,Apo-Warfarin,1,B01AA03,Warfarin,Tablet,Oral,02245618,APO-WARFARIN (warfarin sodium 3 mg oral tablet) APOTEX INC,Active,9000861,warfarin sodium 3 mg oral tablet,8000013,warfarin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
9361,Marketed,1984-12-31,00772011,Cantharone Plus,3,D11AF,Wart and anti-corn preparations,Liquid,Topical,00772011,CANTHARONE PLUS (cantharidin 1 % and podophyllin 2 % and salicylic acid 30 % cutaneous solution) DORMER LABORATORIES INC.,Active,9013805,cantharidin 1 % and podophyllin 2 % and salicylic acid 30 % cutaneous solution,8001715,cantharidin and podophyllin and salicylic acid,448598008,Cutaneous,385108009,Cutaneous solution,,,,,,Prescription
36767,Marketed,2024-06-18,02208903,Otrivin Medicated Cold & Allergy Relief With Moisturizers,1,R01AA07,Xylometazoline,Spray,Nasal,02208903,OTRIVIN MEDICATED COLD & ALLERGY RELIEF WITH MOISTURIZERS (xylometazoline hydrochloride 0.1 % nasal spray) HALEON CANADA ULC,Active,9001582,xylometazoline hydrochloride 0.1 % nasal spray,8002003,xylometazoline,46713006,Nasal,385157007,Nasal spray,,,,,,Non-Prescription Drugs
41684,Marketed,2024-06-18,00653330,Otrivin Medicated Cold & Allergy Relief,1,R01AA07,Xylometazoline,Spray,Nasal,00653330,OTRIVIN MEDICATED COLD & ALLERGY RELIEF (xylometazoline hydrochloride 0.1 % nasal spray) HALEON CANADA ULC,Active,9001582,xylometazoline hydrochloride 0.1 % nasal spray,8002003,xylometazoline,46713006,Nasal,385157007,Nasal spray,,,,,,Non-Prescription Drugs
81710,Marketed,2024-05-03,02331403,Otrivin Medicated Complete Nasal Care,1,R01AA07,Xylometazoline,Spray,Nasal,02331403,OTRIVIN MEDICATED COMPLETE NASAL CARE (xylometazoline hydrochloride 0.1 % nasal spray) HALEON CANADA ULC,Active,9001582,xylometazoline hydrochloride 0.1 % nasal spray,8002003,xylometazoline,46713006,Nasal,385157007,Nasal spray,,,,,,Non-Prescription Drugs
93922,Marketed,2017-03-07,02452812,Decongestant Nasal Spray,1,R01AA07,Xylometazoline,Spray,Nasal,02452812,DECONGESTANT NASAL SPRAY (xylometazoline hydrochloride 0.1 % nasal spray) CRLS,Active,9001582,xylometazoline hydrochloride 0.1 % nasal spray,8002003,xylometazoline,46713006,Nasal,385157007,Nasal spray,,,,,,Non-Prescription Drugs
93927,Marketed,2017-02-27,02452863,Nasal Decongestant Spray With Moisturizers,1,R01AA07,Xylometazoline,Spray,Nasal,02452863,NASAL DECONGESTANT SPRAY WITH MOISTURIZERS (xylometazoline hydrochloride 0.1 % nasal spray) CRLS,Active,9001582,xylometazoline hydrochloride 0.1 % nasal spray,8002003,xylometazoline,46713006,Nasal,385157007,Nasal spray,,,,,,Non-Prescription Drugs
2964,Marketed,2006-05-26,00428833,Yf-Vax,1,J07BL01,"Yellow fever, live attenuated",Powder for solution,Subcutaneous,,,,,,,,,,,,,,,,,Schedule D
64454,Marketed,2003-11-13,02240863,Relenza,1,J05AH01,Zanamivir,Powder,"Oral,Inhalation",02240863,RELENZA (zanamivir 5 mg per actuation inhalation powder) GLAXOSMITHKLINE INC,Active,9012874,zanamivir 5 mg per actuation inhalation powder,8001546,zanamivir,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,,Prescription
100221,Marketed,2025-11-24,02512963,Brukinsa,1,L01EL03,Zanubrutinib,Capsule,Oral,02512963,BRUKINSA (zanubrutinib 80 mg oral capsule) BEONE MEDICINES I GMBH,Active,9014562,zanubrutinib 80 mg oral capsule,8002379,zanubrutinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
104313,Marketed,2025-11-24,02554267,Brukinsa,1,L01EL03,Zanubrutinib,Tablet,Oral,02554267,BRUKINSA (zanubrutinib 160 mg oral tablet) BEONE MEDICINES I GMBH,Active,9015210,zanubrutinib 160 mg oral tablet,8002379,zanubrutinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,,Prescription
11342,Marketed,2011-02-11,01902644,Retrovir (Azt),1,J05AF01,Zidovudine,Solution,Intravenous,01902644,RETROVIR (AZT) (zidovudine 200 mg per 20 mL solution for injection vial) VIIV HEALTHCARE ULC,Active,9012594,zidovudine 200 mg per 20 mL solution for injection vial,8001240,zidovudine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
11942,Marketed,2010-05-10,01902652,Retrovir (Azt),1,J05AF01,Zidovudine,Syrup,Oral,01902652,RETROVIR (AZT) (zidovudine 50 mg per 5 mL syrup) VIIV HEALTHCARE ULC,Active,9002397,zidovudine 50 mg per 5 mL syrup,8001240,zidovudine,26643006,Oral,739009002,Syrup,,,1.0,,,Prescription
12839,Marketed,1992-12-31,01946323,Apo-Zidovudine,1,J05AF01,Zidovudine,Capsule,Oral,01946323,APO-ZIDOVUDINE (zidovudine 100 mg oral capsule) APOTEX INC,Active,9002329,zidovudine 100 mg oral capsule,8001240,zidovudine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
86096,Marketed,2016-01-22,02375540,Apo-lamiVUDine-Zidovudine,2,J05AR01,Zidovudine and lamivudine,Tablet,Oral,02375540,APO-LAMIVUDINE-ZIDOVUDINE (lamivudine 150 mg and zidovudine 300 mg oral tablet) APOTEX INC,Active,9003343,lamivudine 150 mg and zidovudine 300 mg oral tablet,8001211,lamivudine and zidovudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
89907,Marketed,2014-03-03,02414414,Auro-lamiVUDine/Zidovudine,2,J05AR01,Zidovudine and lamivudine,Tablet,Oral,02414414,AURO-LAMIVUDINE/ZIDOVUDINE (lamivudine 150 mg and zidovudine 300 mg oral tablet) AURO PHARMA INC,Active,9003343,lamivudine 150 mg and zidovudine 300 mg oral tablet,8001211,lamivudine and zidovudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
99234,Marketed,2022-03-14,02502801,JAMP lamiVUDine / Zidovudine,2,J05AR01,Zidovudine and lamivudine,Tablet,Oral,02502801,JAMP LAMIVUDINE / ZIDOVUDINE (lamivudine 150 mg and zidovudine 300 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003343,lamivudine 150 mg and zidovudine 300 mg oral tablet,8001211,lamivudine and zidovudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,,Prescription
103809,Marketed,2025-03-17,02549220,Zilbrysq,1,L04AJ06,Zilucoplan,Solution,Subcutaneous,02549220,ZILBRYSQ (zilucoplan (zilucoplan sodium) 16.6 mg per 0.416 mL solution for injection syringe) UCB CANADA INC,Active,9015195,zilucoplan (zilucoplan sodium) 16.6 mg per 0.416 mL solution for injection syringe,8002540,zilucoplan,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe,1.0,,,Prescription
103810,Marketed,2025-03-17,02549239,Zilbrysq,1,L04AJ06,Zilucoplan,Solution,Subcutaneous,02549239,ZILBRYSQ (zilucoplan (zilucoplan sodium) 23 mg per 0.574 mL solution for injection syringe) UCB CANADA INC,Active,9015196,zilucoplan (zilucoplan sodium) 23 mg per 0.574 mL solution for injection syringe,8002540,zilucoplan,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe,1.0,,,Prescription
103811,Marketed,2025-03-17,02549247,Zilbrysq,1,L04AJ06,Zilucoplan,Solution,Subcutaneous,02549247,ZILBRYSQ (zilucoplan (zilucoplan sodium) 32.4 mg per 0.81 mL solution for injection syringe) UCB CANADA INC,Active,9015197,zilucoplan (zilucoplan sodium) 32.4 mg per 0.81 mL solution for injection syringe,8002540,zilucoplan,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe,1.0,,,Prescription
62616,Marketed,2025-08-20,02239160,Zincofax Extra Strength,2,D02AB,Zinc products,Ointment,Topical,02239160,ZINCOFAX EXTRA STRENGTH (white petrolatum 47 % and zinc oxide 40 % cutaneous ointment) KNIGHT THERAPEUTICS INC.,Active,9003430,white petrolatum 47 % and zinc oxide 40 % cutaneous ointment,8001881,white petrolatum and zinc oxide,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Non-Prescription Drugs
62617,Marketed,2025-08-21,02239162,Zincofax,2,D02AB,Zinc products,Ointment,Topical,02239162,ZINCOFAX (white petrolatum 69 % and zinc oxide 15 % cutaneous ointment) KNIGHT THERAPEUTICS INC.,Active,9003441,white petrolatum 69 % and zinc oxide 15 % cutaneous ointment,8001881,white petrolatum and zinc oxide,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,,Non-Prescription Drugs
80131,Marketed,2009-05-20,02315793,Baza Protect II,2,D02AB,Zinc products,Cream,Topical,02315793,BAZA PROTECT II (dimethicone 1 % and zinc oxide 12 % cutaneous cream) COLOPLAST A/S,Active,9004550,dimethicone 1 % and zinc oxide 12 % cutaneous cream,8001752,dimethicone and zinc oxide,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
82304,Marketed,2010-04-19,02337452,Diaper Rash Cream,2,D02AB,Zinc products,Cream,Topical,02337452,DIAPER RASH CREAM (white petrolatum 80.3 % and zinc oxide 15 % cutaneous cream) H.J. SUTTON INDUSTRIES LTD.,Active,9004679,white petrolatum 80.3 % and zinc oxide 15 % cutaneous cream,8001881,white petrolatum and zinc oxide,448598008,Cutaneous,421628006,Cutaneous cream,,,,,,Non-Prescription Drugs
94227,Marketed,2019-07-22,02455463,Medline Remedy Essentials Protectant Paste,2,D02AB,Zinc products,Paste,Topical,02455463,"MEDLINE REMEDY ESSENTIALS PROTECTANT PASTE (white petrolatum 75 % and zinc oxide 20 % cutaneous paste) MEDLINE INDUSTRIES, LP",Active,9014142,white petrolatum 75 % and zinc oxide 20 % cutaneous paste,8001881,white petrolatum and zinc oxide,448598008,Cutaneous,739002006,Paste,,,,,,Non-Prescription Drugs
96358,Marketed,2018-09-07,02473852,Skin Renewing Day Cream,2,D02AB,Zinc products,Cream,Topical,,,,,,,,,,,,,,,,,Non-Prescription Drugs
102196,Marketed,2024-07-05,02532972,"Zinc Sulfate Injection, USP",1,B05XA18,Zinc sulfate,Solution,Intravenous,02532972,"ZINC SULFATE INJECTION, USP (zinc (zinc sulfate) 10 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013248,zinc (zinc sulfate) 10 mg per 10 mL solution for injection vial,8001882,zinc sulfate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
102198,Marketed,2023-09-08,02532980,"Zinc Sulfate Injection, USP",1,B05XA18,Zinc sulfate,Solution,Intravenous,02532980,"ZINC SULFATE INJECTION, USP (zinc (zinc sulfate) 25 mg per 5 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9014925,zinc (zinc sulfate) 25 mg per 5 mL solution for injection vial,8001882,zinc sulfate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,,,,Ethical
13416,Marketed,2006-07-20,00787000,Micro Zn,1,B05XA18,Zinc sulfate,Solution,Intravenous,00787000,MICRO ZN (zinc (zinc sulfate) 50 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013249,zinc (zinc sulfate) 50 mg per 10 mL solution for injection vial,8001882,zinc sulfate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
13451,Marketed,2006-07-20,00787019,Micro Zn,1,B05XA18,Zinc sulfate,Solution,Intravenous,00787019,MICRO ZN (zinc (zinc sulfate) 10 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013248,zinc (zinc sulfate) 10 mg per 10 mL solution for injection vial,8001882,zinc sulfate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Ethical
78389,Marketed,2023-09-15,02298597,Zeldox,1,N05AE04,Ziprasidone,Capsule,Oral,02298597,ZELDOX (ziprasidone (ziprasidone hydrochloride monohydrate) 20 mg oral capsule) BGP PHARMA ULC,Active,9012766,ziprasidone (ziprasidone hydrochloride) 20 mg oral capsule,8001425,ziprasidone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
78392,Marketed,2023-09-15,02298600,Zeldox,1,N05AE04,Ziprasidone,Capsule,Oral,02298600,ZELDOX (ziprasidone (ziprasidone hydrochloride monohydrate) 40 mg oral capsule) BGP PHARMA ULC,Active,9012767,ziprasidone (ziprasidone hydrochloride) 40 mg oral capsule,8001425,ziprasidone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
78393,Marketed,2023-09-15,02298619,Zeldox,1,N05AE04,Ziprasidone,Capsule,Oral,02298619,ZELDOX (ziprasidone (ziprasidone hydrochloride monohydrate) 60 mg oral capsule) BGP PHARMA ULC,Active,9012768,ziprasidone (ziprasidone hydrochloride) 60 mg oral capsule,8001425,ziprasidone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
78394,Marketed,2023-09-15,02298627,Zeldox,1,N05AE04,Ziprasidone,Capsule,Oral,02298627,ZELDOX (ziprasidone (ziprasidone hydrochloride monohydrate) 80 mg oral capsule) BGP PHARMA ULC,Active,9012769,ziprasidone (ziprasidone hydrochloride) 80 mg oral capsule,8001425,ziprasidone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
93537,Marketed,2018-03-19,02449544,Auro-Ziprasidone,1,N05AE04,Ziprasidone,Capsule,Oral,02449544,AURO-ZIPRASIDONE (ziprasidone (ziprasidone hydrochloride monohydrate) 20 mg oral capsule) AURO PHARMA INC,Active,9012766,ziprasidone (ziprasidone hydrochloride) 20 mg oral capsule,8001425,ziprasidone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
93538,Marketed,2018-03-19,02449552,Auro-Ziprasidone,1,N05AE04,Ziprasidone,Capsule,Oral,02449552,AURO-ZIPRASIDONE (ziprasidone (ziprasidone hydrochloride monohydrate) 40 mg oral capsule) AURO PHARMA INC,Active,9012767,ziprasidone (ziprasidone hydrochloride) 40 mg oral capsule,8001425,ziprasidone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
93539,Marketed,2018-03-19,02449560,Auro-Ziprasidone,1,N05AE04,Ziprasidone,Capsule,Oral,02449560,AURO-ZIPRASIDONE (ziprasidone (ziprasidone hydrochloride monohydrate) 60 mg oral capsule) AURO PHARMA INC,Active,9012768,ziprasidone (ziprasidone hydrochloride) 60 mg oral capsule,8001425,ziprasidone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
93540,Marketed,2018-03-19,02449579,Auro-Ziprasidone,1,N05AE04,Ziprasidone,Capsule,Oral,02449579,AURO-ZIPRASIDONE (ziprasidone (ziprasidone hydrochloride monohydrate) 80 mg oral capsule) AURO PHARMA INC,Active,9012769,ziprasidone (ziprasidone hydrochloride) 80 mg oral capsule,8001425,ziprasidone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,,Prescription
104288,Marketed,2025-04-01,02553996,Vyloy,1,L01FX31,Zolbetuximab,Powder for solution,Intravenous,02553996,VYLOY (zolbetuximab 100 mg per vial powder for solution for injection) ASTELLAS PHARMA CANADA INC,Active,9015198,zolbetuximab 100 mg per vial powder for solution for injection,8002541,zolbetuximab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,,,,Prescription
104288,Marketed,2025-04-01,02553996,Vyloy,1,L01FX31,Zolbetuximab,Powder for solution,Intravenous,02553996,VYLOY (zolbetuximab 100 mg per vial powder for solution for injection) ASTELLAS PHARMA CANADA INC,Active,9015198,zolbetuximab 100 mg per vial powder for solution for injection,8002541,zolbetuximab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,,,,Schedule D
72636,Marketed,2004-10-14,02248296,Zometa Concentrate,1,M05BA08,Zoledronic acid,Solution,Intravenous,02248296,ZOMETA CONCENTRATE (zoledronic acid (zoledronic acid monohydrate) 4 mg per 5 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012770,zoledronic acid 4 mg per 5 mL solution for injection vial,8001426,zoledronic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
75458,Marketed,2022-12-13,02269198,Aclasta,1,M05BA08,Zoledronic acid,Solution,Intravenous,02269198,ACLASTA (zoledronic acid (zoledronic acid monohydrate) 5 mg per 100 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012771,zoledronic acid 5 mg per 100 mL solution for injection vial,8001426,zoledronic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
88649,Marketed,2014-01-15,02401606,Zoledronic Acid - Z,1,M05BA08,Zoledronic acid,Solution,Intravenous,02401606,ZOLEDRONIC ACID - Z (zoledronic acid (zoledronic acid monohydrate) 4 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012770,zoledronic acid 4 mg per 5 mL solution for injection vial,8001426,zoledronic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
89980,Marketed,2014-02-26,02415186,Taro-Zoledronic Acid Concentrate,1,M05BA08,Zoledronic acid,Solution,Intravenous,02415186,TARO-ZOLEDRONIC ACID CONCENTRATE (zoledronic acid (zoledronic acid monohydrate) 4 mg per 5 mL solution for injection vial) TARO PHARMACEUTICALS INC,Active,9012770,zoledronic acid 4 mg per 5 mL solution for injection vial,8001426,zoledronic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
90711,Marketed,2014-05-28,02422425,Zoledronic Acid For Injection Concentrate,1,M05BA08,Zoledronic acid,Solution,Intravenous,02422425,ZOLEDRONIC ACID FOR INJECTION CONCENTRATE (zoledronic acid (zoledronic acid monohydrate) 4 mg per 5 mL solution for injection vial) DR REDDY'S LABORATORIES LTD,Active,9012770,zoledronic acid 4 mg per 5 mL solution for injection vial,8001426,zoledronic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
90712,Marketed,2014-05-28,02422433,Zoledronic Acid Injection,1,M05BA08,Zoledronic acid,Solution,Intravenous,02422433,ZOLEDRONIC ACID INJECTION (zoledronic acid (zoledronic acid monohydrate) 5 mg per 100 mL solution for injection vial) DR REDDY'S LABORATORIES LTD,Active,9012771,zoledronic acid 5 mg per 100 mL solution for injection vial,8001426,zoledronic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
91878,Marketed,2016-02-10,02434458,Zoledronic Acid For Injection,1,M05BA08,Zoledronic acid,Solution,Intravenous,02434458,ZOLEDRONIC ACID FOR INJECTION (zoledronic acid (zoledronic acid monohydrate) 4 mg per 5 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9012770,zoledronic acid 4 mg per 5 mL solution for injection vial,8001426,zoledronic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
96212,Marketed,2019-01-29,02472805,Zoledronic Acid For Injection,1,M05BA08,Zoledronic acid,Solution,Intravenous,02472805,ZOLEDRONIC ACID FOR INJECTION (zoledronic acid (zoledronic acid monohydrate) 4 mg per 5 mL solution for injection vial) MARCAN PHARMACEUTICALS INC,Active,9012770,zoledronic acid 4 mg per 5 mL solution for injection vial,8001426,zoledronic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
97282,Marketed,2020-01-20,02482525,JAMP-Zoledronic Acid,1,M05BA08,Zoledronic acid,Solution,Intravenous,02482525,JAMP-ZOLEDRONIC ACID (zoledronic acid (zoledronic acid monohydrate) 4 mg per 5 mL solution for injection vial) JAMP PHARMA CORPORATION,Active,9012770,zoledronic acid 4 mg per 5 mL solution for injection vial,8001426,zoledronic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,,Prescription
100209,Marketed,2023-01-11,02512831,Bio-Zolmitriptan,1,N02CC03,Zolmitriptan,Tablet,Oral,02512831,BIO-ZOLMITRIPTAN (zolmitriptan 2.5 mg oral tablet) BIOMED PHARMA,Active,9003315,zolmitriptan 2.5 mg oral tablet,8001105,zolmitriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
62089,Marketed,2023-01-12,02238660,Zomig,1,N02CC03,Zolmitriptan,Tablet,Oral,02238660,ZOMIG (zolmitriptan 2.5 mg oral tablet) XEDITON PHARMACEUTICALS INC,Active,9003315,zolmitriptan 2.5 mg oral tablet,8001105,zolmitriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
66907,Marketed,2023-01-12,02243045,Zomig Rapimelt,1,N02CC03,Zolmitriptan,Tablet (orally disintegrating),Oral,02243045,ZOMIG RAPIMELT (zolmitriptan 2.5 mg orodispersible tablet) XEDITON PHARMACEUTICALS INC,Active,9003566,zolmitriptan 2.5 mg orodispersible tablet,8001105,zolmitriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
73377,Marketed,2023-01-12,02248992,Zomig Nasal Spray,1,N02CC03,Zolmitriptan,Spray,"Oral,Nasal",02248992,ZOMIG NASAL SPRAY (zolmitriptan 2.5 mg per actuation nasal spray) XEDITON PHARMACEUTICALS INC,Active,9012552,zolmitriptan 2.5 mg per actuation nasal spray,8001105,zolmitriptan,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,,Prescription
73378,Marketed,2023-01-12,02248993,Zomig Nasal Spray,1,N02CC03,Zolmitriptan,Spray,"Nasal,Oral",02248993,ZOMIG NASAL SPRAY (zolmitriptan 5 mg per actuation nasal spray) XEDITON PHARMACEUTICALS INC,Active,9012553,zolmitriptan 5 mg per actuation nasal spray,8001105,zolmitriptan,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,,Prescription
79948,Marketed,2011-06-07,02313960,Teva-Zolmitriptan,1,N02CC03,Zolmitriptan,Tablet,Oral,02313960,TEVA-ZOLMITRIPTAN (zolmitriptan 2.5 mg oral tablet) TEVA CANADA LIMITED,Active,9003315,zolmitriptan 2.5 mg oral tablet,8001105,zolmitriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82803,Marketed,2011-06-07,02342545,Teva-Zolmitriptan Od,1,N02CC03,Zolmitriptan,Tablet (orally disintegrating),Oral,02342545,TEVA-ZOLMITRIPTAN OD (zolmitriptan 2.5 mg orodispersible tablet) TEVA CANADA LIMITED,Active,9003566,zolmitriptan 2.5 mg orodispersible tablet,8001105,zolmitriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
84796,Marketed,2011-06-07,02362988,Sandoz Zolmitriptan,1,N02CC03,Zolmitriptan,Tablet,Oral,02362988,SANDOZ ZOLMITRIPTAN (zolmitriptan 2.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003315,zolmitriptan 2.5 mg oral tablet,8001105,zolmitriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
84797,Marketed,2011-06-07,02362996,Sandoz Zolmitriptan ODT,1,N02CC03,Zolmitriptan,Tablet (orally disintegrating),Oral,02362996,SANDOZ ZOLMITRIPTAN ODT (zolmitriptan 2.5 mg orodispersible tablet) SANDOZ CANADA INCORPORATED,Active,9003566,zolmitriptan 2.5 mg orodispersible tablet,8001105,zolmitriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,,Prescription
88433,Marketed,2025-10-27,02399458,Mar-Zolmitriptan,1,N02CC03,Zolmitriptan,Tablet,Oral,02399458,MAR-ZOLMITRIPTAN (zolmitriptan 2.5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9003315,zolmitriptan 2.5 mg oral tablet,8001105,zolmitriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90415,Marketed,2021-12-02,02419521,Mint-Zolmitriptan,1,N02CC03,Zolmitriptan,Tablet,Oral,02419521,MINT-ZOLMITRIPTAN (zolmitriptan 2.5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9003315,zolmitriptan 2.5 mg oral tablet,8001105,zolmitriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90614,Marketed,2015-07-13,02421534,Nat-Zolmitriptan,1,N02CC03,Zolmitriptan,Tablet,Oral,02421534,NAT-ZOLMITRIPTAN (zolmitriptan 2.5 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9003315,zolmitriptan 2.5 mg oral tablet,8001105,zolmitriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
90627,Marketed,2022-04-13,02421623,JAMP-Zolmitriptan,1,N02CC03,Zolmitriptan,Tablet,Oral,02421623,JAMP-ZOLMITRIPTAN (zolmitriptan 2.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003315,zolmitriptan 2.5 mg oral tablet,8001105,zolmitriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
92700,Marketed,2015-10-14,02442655,Zolmitriptan,1,N02CC03,Zolmitriptan,Tablet,Oral,02442655,ZOLMITRIPTAN (zolmitriptan 2.5 mg oral tablet) SANIS HEALTH INC,Active,9003315,zolmitriptan 2.5 mg oral tablet,8001105,zolmitriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97162,Marketed,2020-03-18,02481030,Auro-Zolmitriptan,1,N02CC03,Zolmitriptan,Tablet,Oral,02481030,AURO-ZOLMITRIPTAN (zolmitriptan 2.5 mg oral tablet) AURO PHARMA INC,Active,9003315,zolmitriptan 2.5 mg oral tablet,8001105,zolmitriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97948,Marketed,2026-02-02,02489392,Nra-Zolmitriptan,1,N02CC03,Zolmitriptan,Tablet,Oral,02489392,NRA-ZOLMITRIPTAN (zolmitriptan 2.5 mg oral tablet) NORA PHARMA INC,Active,9003315,zolmitriptan 2.5 mg oral tablet,8001105,zolmitriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
102606,Marketed,2023-10-30,02537346,Pro-Zolpidem ODT,1,N05CF02,Zolpidem,Tablet (orally disintegrating),Sublingual,02537346,PRO-ZOLPIDEM ODT (zolpidem tartrate 5 mg sublingual tablet) PRO DOC LIMITEE,Active,9014746,zolpidem tartrate 5 mg sublingual tablet,8001121,zolpidem,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
102607,Marketed,2023-10-30,02537354,Pro-Zolpidem ODT,1,N05CF02,Zolpidem,Tablet (orally disintegrating),Sublingual,02537354,PRO-ZOLPIDEM ODT (zolpidem tartrate 10 mg sublingual tablet) PRO DOC LIMITEE,Active,9014745,zolpidem tartrate 10 mg sublingual tablet,8001121,zolpidem,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
102928,Marketed,2024-07-09,02540592,JAMP Zolpidem ODT,1,N05CF02,Zolpidem,Tablet (orally disintegrating),Sublingual,02540592,JAMP ZOLPIDEM ODT (zolpidem tartrate 5 mg sublingual tablet) JAMP PHARMA CORPORATION,Active,9014746,zolpidem tartrate 5 mg sublingual tablet,8001121,zolpidem,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
102929,Marketed,2024-07-09,02540606,JAMP Zolpidem ODT,1,N05CF02,Zolpidem,Tablet (orally disintegrating),Sublingual,02540606,JAMP ZOLPIDEM ODT (zolpidem tartrate 10 mg sublingual tablet) JAMP PHARMA CORPORATION,Active,9014745,zolpidem tartrate 10 mg sublingual tablet,8001121,zolpidem,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
85559,Marketed,2019-07-05,02370433,Sublinox,1,N05CF02,Zolpidem,Tablet (orally disintegrating),Sublingual,02370433,"SUBLINOX (zolpidem tartrate 10 mg sublingual tablet) BAUSCH HEALTH, CANADA INC.",Active,9014745,zolpidem tartrate 10 mg sublingual tablet,8001121,zolpidem,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
87699,Marketed,2019-07-05,02391678,Sublinox,1,N05CF02,Zolpidem,Tablet (orally disintegrating),Sublingual,02391678,"SUBLINOX (zolpidem tartrate 5 mg sublingual tablet) BAUSCH HEALTH, CANADA INC.",Active,9014746,zolpidem tartrate 5 mg sublingual tablet,8001121,zolpidem,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
91923,Marketed,2015-02-13,02434946,Apo-Zolpidem ODT,1,N05CF02,Zolpidem,Tablet (orally disintegrating),Sublingual,02434946,APO-ZOLPIDEM ODT (zolpidem tartrate 10 mg sublingual tablet) APOTEX INC,Active,9014745,zolpidem tartrate 10 mg sublingual tablet,8001121,zolpidem,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
92048,Marketed,2015-02-13,02436159,Apo-Zolpidem ODT,1,N05CF02,Zolpidem,Tablet (orally disintegrating),Sublingual,02436159,APO-ZOLPIDEM ODT (zolpidem tartrate 5 mg sublingual tablet) APOTEX INC,Active,9014746,zolpidem tartrate 5 mg sublingual tablet,8001121,zolpidem,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
92051,Marketed,2016-12-13,02436175,PMS-Zolpidem ODT,1,N05CF02,Zolpidem,Tablet (orally disintegrating),Sublingual,02436175,PMS-ZOLPIDEM ODT (zolpidem tartrate 5 mg sublingual tablet) PHARMASCIENCE INC,Active,9014746,zolpidem tartrate 5 mg sublingual tablet,8001121,zolpidem,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
92052,Marketed,2016-12-13,02436183,PMS-Zolpidem ODT,1,N05CF02,Zolpidem,Tablet (orally disintegrating),Sublingual,02436183,PMS-ZOLPIDEM ODT (zolpidem tartrate 10 mg sublingual tablet) PHARMASCIENCE INC,Active,9014745,zolpidem tartrate 10 mg sublingual tablet,8001121,zolpidem,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
96216,Marketed,2021-03-19,02472821,Mint-Zolpidem ODT,1,N05CF02,Zolpidem,Tablet (orally disintegrating),Sublingual,02472821,MINT-ZOLPIDEM ODT (zolpidem tartrate 5 mg sublingual tablet) MINT PHARMACEUTICALS INC,Active,9014746,zolpidem tartrate 5 mg sublingual tablet,8001121,zolpidem,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
96217,Marketed,2021-03-19,02472848,Mint-Zolpidem ODT,1,N05CF02,Zolpidem,Tablet (orally disintegrating),Sublingual,02472848,MINT-ZOLPIDEM ODT (zolpidem tartrate 10 mg sublingual tablet) MINT PHARMACEUTICALS INC,Active,9014745,zolpidem tartrate 10 mg sublingual tablet,8001121,zolpidem,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,,Targeted Substances (CDSA IV)
103814,Marketed,2025-03-26,02549271,JAMP Zopiclone,1,N05CF01,Zopiclone,Tablet,Oral,02549271,JAMP ZOPICLONE (zopiclone 3.75 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000995,zopiclone 3.75 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103816,Marketed,2025-08-08,02549298,JAMP Zopiclone,1,N05CF01,Zopiclone,Tablet,Oral,02549298,JAMP ZOPICLONE (zopiclone 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000779,zopiclone 5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
103817,Marketed,2025-08-28,02549301,JAMP Zopiclone,1,N05CF01,Zopiclone,Tablet,Oral,02549301,JAMP ZOPICLONE (zopiclone 7.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000370,zopiclone 7.5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
12426,Marketed,2006-06-13,01926799,Imovane,1,N05CF01,Zopiclone,Tablet,Oral,01926799,IMOVANE (zopiclone 7.5 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9000370,zopiclone 7.5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
43233,Marketed,1996-09-19,02218313,Apo-Zopiclone,1,N05CF01,Zopiclone,Tablet,Oral,02218313,APO-ZOPICLONE (zopiclone 7.5 mg oral tablet) APOTEX INC,Active,9000370,zopiclone 7.5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
64177,Marketed,1999-08-04,02240606,PMS-Zopiclone,1,N05CF01,Zopiclone,Tablet,Oral,02240606,PMS-ZOPICLONE (zopiclone 7.5 mg oral tablet) PHARMASCIENCE INC,Active,9000370,zopiclone 7.5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
66208,Marketed,2020-08-13,02242481,Teva-Zopiclone,1,N05CF01,Zopiclone,Tablet,Oral,02242481,TEVA-ZOPICLONE (zopiclone 7.5 mg oral tablet) TEVA CANADA LIMITED,Active,9000370,zopiclone 7.5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
67334,Marketed,2001-02-15,02243426,PMS-Zopiclone,1,N05CF01,Zopiclone,Tablet,Oral,02243426,PMS-ZOPICLONE (zopiclone 5 mg oral tablet) PHARMASCIENCE INC,Active,9000779,zopiclone 5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
69081,Marketed,2002-06-04,02245077,Apo-Zopiclone,1,N05CF01,Zopiclone,Tablet,Oral,02245077,APO-ZOPICLONE (zopiclone 5 mg oral tablet) APOTEX INC,Active,9000779,zopiclone 5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
70717,Marketed,2020-08-13,02246534,Teva-Zopiclone,1,N05CF01,Zopiclone,Tablet,Oral,02246534,TEVA-ZOPICLONE (zopiclone 5 mg oral tablet) TEVA CANADA LIMITED,Active,9000779,zopiclone 5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76362,Marketed,2006-10-10,02278030,Riva-Zopiclone,1,N05CF01,Zopiclone,Tablet,Oral,02278030,RIVA-ZOPICLONE (zopiclone 5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000779,zopiclone 5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76363,Marketed,2008-11-14,02278049,Riva-Zopiclone,1,N05CF01,Zopiclone,Tablet,Oral,02278049,RIVA-ZOPICLONE (zopiclone 7.5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000370,zopiclone 7.5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
76809,Marketed,2013-10-18,02282445,Zopiclone,1,N05CF01,Zopiclone,Tablet,Oral,02282445,ZOPICLONE (zopiclone 7.5 mg oral tablet) SANIS HEALTH INC,Active,9000370,zopiclone 7.5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79861,Marketed,2008-07-09,02313065,Pro-Zopiclone,1,N05CF01,Zopiclone,Tablet,Oral,02313065,PRO-ZOPICLONE (zopiclone 5 mg oral tablet) PRO DOC LIMITEE,Active,9000779,zopiclone 5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
79862,Marketed,2008-07-09,02313073,Pro-Zopiclone,1,N05CF01,Zopiclone,Tablet,Oral,02313073,PRO-ZOPICLONE (zopiclone 7.5 mg oral tablet) PRO DOC LIMITEE,Active,9000370,zopiclone 7.5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
82952,Marketed,2013-10-18,02344122,Zopiclone,1,N05CF01,Zopiclone,Tablet,Oral,02344122,ZOPICLONE (zopiclone 5 mg oral tablet) SANIS HEALTH INC,Active,9000779,zopiclone 5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87144,Marketed,2018-07-26,02385821,Zopiclone,1,N05CF01,Zopiclone,Tablet,Oral,02385821,ZOPICLONE (zopiclone 5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000779,zopiclone 5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87145,Marketed,2018-07-26,02385848,Zopiclone,1,N05CF01,Zopiclone,Tablet,Oral,02385848,ZOPICLONE (zopiclone 7.5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000370,zopiclone 7.5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87237,Marketed,2013-04-17,02386771,Mar-Zopiclone,1,N05CF01,Zopiclone,Tablet,Oral,02386771,MAR-ZOPICLONE (zopiclone 5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000779,zopiclone 5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87238,Marketed,2013-04-17,02386798,Mar-Zopiclone,1,N05CF01,Zopiclone,Tablet,Oral,02386798,MAR-ZOPICLONE (zopiclone 7.5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000370,zopiclone 7.5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87703,Marketed,2012-10-10,02391716,Mint-Zopiclone,1,N05CF01,Zopiclone,Tablet,Oral,02391716,MINT-ZOPICLONE (zopiclone 5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000779,zopiclone 5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
87704,Marketed,2012-10-10,02391724,Mint-Zopiclone,1,N05CF01,Zopiclone,Tablet,Oral,02391724,MINT-ZOPICLONE (zopiclone 7.5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000370,zopiclone 7.5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89162,Marketed,2014-01-08,02406969,JAMP-Zopiclone Tablets,1,N05CF01,Zopiclone,Tablet,Oral,02406969,JAMP-ZOPICLONE TABLETS (zopiclone 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000779,zopiclone 5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
89163,Marketed,2014-11-19,02406977,JAMP-Zopiclone Tablets,1,N05CF01,Zopiclone,Tablet,Oral,02406977,JAMP-ZOPICLONE TABLETS (zopiclone 7.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000370,zopiclone 7.5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
94567,Marketed,2017-01-01,02458543,PMS-Zopiclone,1,N05CF01,Zopiclone,Tablet,Oral,02458543,PMS-ZOPICLONE (zopiclone 3.75 mg oral tablet) PHARMASCIENCE INC,Active,9000995,zopiclone 3.75 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95631,Marketed,2018-04-16,02467941,M-Zopiclone,1,N05CF01,Zopiclone,Tablet,Oral,02467941,M-ZOPICLONE (zopiclone 5 mg oral tablet) MANTRA PHARMA INC,Active,9000779,zopiclone 5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95632,Marketed,2018-04-16,02467968,M-Zopiclone,1,N05CF01,Zopiclone,Tablet,Oral,02467968,M-ZOPICLONE (zopiclone 7.5 mg oral tablet) MANTRA PHARMA INC,Active,9000370,zopiclone 7.5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95682,Marketed,2021-04-23,02468395,JAMP-Zopiclone Tablets,1,N05CF01,Zopiclone,Tablet,Oral,02468395,JAMP-ZOPICLONE TABLETS (zopiclone 3.75 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000995,zopiclone 3.75 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95692,Marketed,2018-08-07,02468492,Zopiclone,1,N05CF01,Zopiclone,Tablet,Oral,02468492,ZOPICLONE (zopiclone 5 mg oral tablet) ALTAMED PHARMA,Active,9000779,zopiclone 5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
95781,Marketed,2018-08-07,02469154,Zopiclone,1,N05CF01,Zopiclone,Tablet,Oral,02469154,ZOPICLONE (zopiclone 7.5 mg oral tablet) ALTAMED PHARMA,Active,9000370,zopiclone 7.5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96656,Marketed,2018-07-25,02475839,AG-Zopiclone,1,N05CF01,Zopiclone,Tablet,Oral,02475839,AG-ZOPICLONE (zopiclone 5 mg oral tablet) ANGITA PHARMA INC.,Active,9000779,zopiclone 5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96657,Marketed,2018-07-25,02475847,AG-Zopiclone,1,N05CF01,Zopiclone,Tablet,Oral,02475847,AG-ZOPICLONE (zopiclone 7.5 mg oral tablet) ANGITA PHARMA INC.,Active,9000370,zopiclone 7.5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96835,Marketed,2018-08-30,02477378,Nra-Zopiclone,1,N05CF01,Zopiclone,Tablet,Oral,02477378,NRA-ZOPICLONE (zopiclone 5 mg oral tablet) NORA PHARMA INC,Active,9000779,zopiclone 5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
96836,Marketed,2018-08-30,02477386,Nra-Zopiclone,1,N05CF01,Zopiclone,Tablet,Oral,02477386,NRA-ZOPICLONE (zopiclone 7.5 mg oral tablet) NORA PHARMA INC,Active,9000370,zopiclone 7.5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97135,Marketed,2019-06-10,02481006,Bio-Zopiclone,1,N05CF01,Zopiclone,Tablet,Oral,02481006,BIO-ZOPICLONE (zopiclone 5 mg oral tablet) BIOMED PHARMA,Active,9000779,zopiclone 5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
97136,Marketed,2019-06-10,02481014,Bio-Zopiclone,1,N05CF01,Zopiclone,Tablet,Oral,02481014,BIO-ZOPICLONE (zopiclone 7.5 mg oral tablet) BIOMED PHARMA,Active,9000370,zopiclone 7.5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
49241,Marketed,1997-05-02,02230402,Clopixol,1,N05AF05,Zuclopenthixol,Tablet,Oral,02230402,CLOPIXOL (zuclopenthixol (zuclopenthixol hydrochloride) 10 mg oral tablet) LUNDBECK CANADA INC,Active,9003092,zuclopenthixol (zuclopenthixol hydrochloride) 10 mg oral tablet,8001547,zuclopenthixol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
49242,Marketed,1997-05-02,02230403,Clopixol,1,N05AF05,Zuclopenthixol,Tablet,Oral,02230403,CLOPIXOL (zuclopenthixol (zuclopenthixol hydrochloride) 25 mg oral tablet) LUNDBECK CANADA INC,Active,9003093,zuclopenthixol (zuclopenthixol hydrochloride) 25 mg oral tablet,8001547,zuclopenthixol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,,Prescription
49244,Marketed,1997-05-02,02230405,Clopixol Acuphase,1,N05AF05,Zuclopenthixol,Solution,Intramuscular,77700636,CLOPIXOL ACUPHASE  (zuclopenthixol acetate 50 mg per 1 mL solution for injection ampoule) LUNDBECK CANADA INC,Active,9012876,zuclopenthixol acetate 50 mg per 1 mL solution for injection ampoule,8001547,zuclopenthixol,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
49244,Marketed,1997-05-02,02230405,Clopixol Acuphase,1,N05AF05,Zuclopenthixol,Solution,Intramuscular,77700637,CLOPIXOL ACUPHASE  (zuclopenthixol acetate 100 mg per 2 mL solution for injection ampoule) LUNDBECK CANADA INC,Active,9012875,zuclopenthixol acetate 100 mg per 2 mL solution for injection ampoule,8001547,zuclopenthixol,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
49245,Marketed,1997-05-02,02230406,Clopixol Depot,1,N05AF05,Zuclopenthixol,Solution,Intramuscular,77700638,CLOPIXOL DEPOT (zuclopenthixol decanoate 200 mg per mL solution for injection 10 mL vial) LUNDBECK CANADA INC,Active,9012878,zuclopenthixol decanoate 200 mg per mL solution for injection 10 mL vial,8001547,zuclopenthixol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,,Prescription
49245,Marketed,1997-05-02,02230406,Clopixol Depot,1,N05AF05,Zuclopenthixol,Solution,Intramuscular,77700639,CLOPIXOL DEPOT (zuclopenthixol decanoate 200 mg per 1 mL solution for injection ampoule) LUNDBECK CANADA INC,Active,9012877,zuclopenthixol decanoate 200 mg per 1 mL solution for injection ampoule,8001547,zuclopenthixol,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Prescription
106630,Marketed,2026-03-17,02563525,Zurzuvae,1,N06AX31,Zuranolone,Capsule,Oral,02563525,ZURZUVAE (zuranolone 20 mg oral capsule) BIOGEN CANADA INC,Active,9015386,zuranolone 20 mg oral capsule,8002588,zuranolone,26643006,Oral,420692007,Oral capsule,732937005,Capsule,,,,Prescription
106631,Marketed,2026-03-17,02563533,Zurzuvae,1,N06AX31,Zuranolone,Capsule,Oral,02563533,ZURZUVAE (zuranolone 25 mg oral capsule) BIOGEN CANADA INC,Active,9015387,zuranolone 25 mg oral capsule,8002588,zuranolone,26643006,Oral,420692007,Oral capsule,732937005,Capsule,,,,Prescription
103078,Marketed,2026-05-27,02542196,Lidocaine Hydrochloride Injection,1,N01BB02,lidocaine,Solution,Block/infiltration,77701187,LIDOCAINE HYDROCHLORIDE INJECTION (lidocaine hydrochloride 50 mg per 5 mL solution for injection ampoule) JUNO PHARMA CANADA INC.,Active,9013218,lidocaine hydrochloride 50 mg per 5 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
103078,Marketed,2026-05-27,02542196,Lidocaine Hydrochloride Injection,1,N01BB02,lidocaine,Solution,Block/infiltration,77701188,LIDOCAINE HYDROCHLORIDE INJECTION (lidocaine hydrochloride 100 mg per 10 mL solution for injection ampoule) JUNO PHARMA CANADA INC.,Active,9013205,lidocaine hydrochloride 100 mg per 10 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
103079,Marketed,2026-05-27,02542218,Lidocaine Hydrochloride Injection,1,N01BB04,lidocaine,Solution,Block/infiltration,77701189,LIDOCAINE HYDROCHLORIDE INJECTION (lidocaine hydrochloride 100 mg per 5 mL solution for injection ampoule) JUNO PHARMA CANADA INC.,Active,9013207,lidocaine hydrochloride 100 mg per 5 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
103079,Marketed,2026-05-27,02542218,Lidocaine Hydrochloride Injection,1,N01BB04,lidocaine,Solution,Block/infiltration,77701190,LIDOCAINE HYDROCHLORIDE INJECTION (lidocaine hydrochloride 200 mg per 10 mL solution for injection ampoule) JUNO PHARMA CANADA INC.,Active,9013213,lidocaine hydrochloride 200 mg per 10 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,,Ethical
98574,Marketed,2026-02-27,02495848,Drax Exametazime,1,V09AA01,technetium (99mTc) exametazime,Powder for solution,Intravenous,,,,,,,,,,,,,,,,,Schedule C
